10,000 Matching Annotations
  1. Oct 2025
    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      Drawing on insights from preceding studies, the researchers pinpointed mutations within the spag7 gene that correlate with metabolic aberrations in mice. The precise function of spag7 has not been fully described yet, thereby the primary objective of this investigation is to unravel its pivotal role in the development of obesity and metabolic disease in mice. First, they generated a mice model lacking spag7 and observed that KO mice exhibited diminished birth size, which subsequently progressed to manifest obesity and impaired glucose tolerance upon reaching adulthood. This behaviour was primarily attributed to a reduction in energy expenditure. In fact, KO animals demonstrated compromised exercise endurance and muscle functionality, stemming from a deterioration in mitochondrial activity. Intriguingly, none of these effects was observed when using a tamoxifen-induced KO mouse model, implying that Spag7's influence is predominantly confined to the embryonic developmental phase. Explorations within placental tissue unveiled that mice afflicted by Spag7 deficiency experienced placental insufficiency, likely due to aberrant development of the placental junctional zone, a phenomenon that could impede optimal nutrient conveyance to the developing fetus. Overall, the authors assert that Spag7 emerges as a crucial determinant orchestrating accurate embryogenesis and subsequent energy balance in the later stages of life.

      The study boasts several noteworthy strengths. Notably, it employs a combination of animal models and a thorough analysis of metabolic and exercise parameters, underscoring a meticulous approach. Furthermore, the investigation encompasses a comprehensive evaluation of fetal loss across distinct pregnancy stages, alongside a transcriptomic analysis of skeletal muscle, thereby imparting substantial value. However, a pivotal weakness of the study centres on its translational applicability. While the authors claim that "SPAG7 is well-conserved with 97% of the amino acid sequence being identical in humans and mice", the precise role of spag7 in the human context remains enigmatic. This limitation hampers a direct extrapolation of findings to human scenarios. Additionally, the study's elucidation of the molecular underpinnings behind the spag7-mediated anomalous development of the placental junction zone remains incomplete. Finally, the hypothesis positing a reduction in nutrient availability to the fetus, though intriguing, requires further substantiation, leaving an aspect of the mechanism unexplored.

      Hence, in order to fortify the solidity of their conclusions, these concerns necessitate meticulous attention and resolution in the forthcoming version of the manuscript. Upon the comprehensive addressing of these aspects, the study is poised to exert a substantial influence on the field, its significance reverberating significantly. The methodologies and data presented undoubtedly hold the potential to facilitate the community's deeper understanding of the ramifications stemming from disruptions during pregnancy, shedding light on their enduring impact on the metabolic well-being of subsequent generations.

      Thanks to this reviewer for their thoughtful analysis and commentary. Human mutations in SPAG7 are exceedingly rare (SPAG7 | pLoF (genebass.org)), potentially because of the deleterious effects of SPAG7-deficiency on prenatal development. This makes investigation into the causative effects of SPAG7 in humans challenging. There exist mutations in the SPAG7 region of the genome that are associated with BMI, but no direct coding variants within the spag7 gene itself have been studied.

      We agree with the reviewer that the precise role of spag7 in the placenta remains unknown. However, given its robust expression and high protein levels in the placenta, including in key cells, such as the syncytiotrophoblast (https://www.proteinatlas.org/ENSG00000091640-SPAG7/tissue/Placenta), it is highly likely that spag7 is critical for normal placenta development and function. Multiple studies (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716072/) have recently shown that sperm associated RNAs play a critical role in embryonic and early placenta development. Our findings will provide the basis for future studies that can elucidate the role of spag7 in human placenta.

      Reviewer #2:

      Summary:

      The authors of this manuscript are interested in discovering and functionally characterizing genes that might cause obesity. To find such genes, they conducted a forward genetic screen in mice, selecting strains which displayed increased body weight and adiposity. They found a strain, with germ-line deficiency in the gene Spag7, which displayed significantly increased body weight, fat mass, and adipose depot sizes manifesting after the onset of adulthood (20 weeks). The mice also display decreased organ sizes, leading to decreased lean body mass. The increased adiposity was traced to decreased energy expenditure at both room temperature and thermoneutrality, correlating with decreased locomotor activity and muscle atrophy. Major metabolic abnormalities such as impaired glucose tolerance and insulin sensitivity also accompanied the phenotype. Unexpectedly, when the authors generated an inducible, whole body knockout mouse using a globally expressed Cre-ERT2 along with a globally floxed Spag7, and induced Spag7 knockout before the onset of obesity, none of the phenotypes seen in the original strain were recapitulated. The authors trace this discrepancy to the major effect of Spag7 being on placental development.

      Strengths:

      Strengths of the manuscript are its inherently unbiased approach, using a forward genetic screen to discover previously unknown genes linked to obesity phenotypes. Another strong aspect of the work was the generation of an independent, complementary, strain consisting of an inducible knockout model, in which the deficiency of the gene could be assessed in a more granular form. This approach enabled the discovery of Spag7 as a gene involved in the establishment of the mature placenta, which determines the metabolic fate of the offspring. Additional strengths include the extensive array of physiological parameters measured, which provided a deep understanding of the whole-body metabolic phenotype and pinpointed its likely origin to muscle energetic dysfunction.

      Weaknesses:

      Weaknesses that can be raised are the lack of molecular mechanistic understanding of the numerous phenotypic observations. For example, the specific role of Spag7 to promote placental development remains unclear. Also, the reason why placental developmental abnormalities lead to muscle dysfunction, and whether indeed the entire metabolic phenotype of the offspring can be attributed solely to decreased muscle energetics is not fully explored.

      Overall, the authors achieved a remarkable success in identifying genes associated with development of obesity and metabolic disease, discovering the role of Spag7 in placental development, and highlighting the fundamental role of in-utero development in setting future metabolic state of the offspring.

      We thank this reviewer for their thoughtful analysis and commentary. Significant effort has been made to understand the causes of the metabolic phenotypes observed in SPAG7-deficient mouse models. It is clear that hyperphagia is not the cause and the muscle energetics deficit is likely not the sole cause. We expect that decreased access to nutrition in utero will lead to widespread and varied metabolic adaptation.

      We agree with the reviewer that further work can be done to understand the molecular mechanism driving the metabolic phenotypes of SPAG7-deficient animals. We believe that full investigation of the processes behind the developmental abnormalities is beyond the scope of this paper and best to be done under a separate paper.

      Reviewer #3:

      Summary:

      The manuscript by Flaherty III S.E. et al identified SPAG7 gene in their forward mutagenetic screening and created the germline knockout and inducible knockout mice. The authors reported that the SPAG7 germline knockout mice had lower birth weight likely due to intrauterine growth restriction and placental insufficiency. The SPAG7 KO mice later developed obesity phenotype as a result of reduced energy expenditure. However, the inducible SPAG7 knockout mice had normal body weight and composition.

      Strengths:

      In this reviewer's opinion, this study has high significance in the field of metabolic research for the following reasons.

      1) The authors' findings are significant in the field of obesity research, especially from the perspective of maternal-fetal medicine. The authors created and analyzed the SPAG7 KO mice and found that the KO mice had a "thrifty phenotype" and developed obesity.

      2) SPAG7 gene function hasn't been thoroughly studied. The reported phenotype will fill the gap of knowledge.

      Overall, the authors have presented their results in a clear and logically organized structure, clearly stated the key question to be addressed, used the appropriate methodology, produced significant and innovative main findings.

      Weaknesses:

      The manuscript can be further strengthened with more clarification on the following points.

      1) The germline whole-body KO mice were female mice (Line293), however the inducible knockout mice were male mice (Line549). Sexual dimorphism is often observed in metabolic studies, therefore the metabolic phenotype of both female and male mice needs to be reported for the germline and inducible knockouts in order to make the justified conclusion.

      2) SPAG7 has an NLS. Does this protein function in gene expression? Whether the overall metabolic phenotype is the direct cause of SPAG7 ablation is unclear. For example, the Hsd17b10 gene was downregulated in all tissues in the KO mice. Could this have been coincidentally selected for and thus be the cause of the developmental issues and adulthood obesity? Do the iSpag7 mice demonstrate reduced expression of Hsd17b10?

      3) Figure 2c should display the energy expenditure normalized to body weight (or lean body mass).

      4) Please provide more information for the figure legend, including the statistical test that was conducted for each data set, animal numbers for each genotype and sexes.

      5) The authors should report how long after treatment the data was collected for figures 4F-M.

      6) The authors should justify ending the data collection after 8 weeks for the iSPAG7 mice in Figures 4C-E. In the WT vs germline KO mice, there was no clear difference in body weight or lean mass at 15 weeks of age.

      Response to point #1 (Weakness): We thank the reviewer for their thoughtful analysis and commentary. All inducible KO animals described in the paper are female (the typo in Line 549 has been corrected). We did perform studies in both male and female animals for both of these lines. Males display similar metabolic phenotypes, though not as robustly as the females. A table summarizing key data from male and female germline KO animals and inducible KO animals has been included below.

      Author response table 1.

      Author response table 2.

      Response to point #2 (Weakness): SPAG7 contains an R3H domain, which is predicted to bind polynucleotides, and other proteins that contain R3H domains are known to bind RNA or ssDNA. The iSPAG7 mice do display decreased hsd17b10 expression (to a lesser degree than the germline KOs) in the tissues examined. When we knock-down SPAG7 in specific tissues, we also see hsd17b10 expression decrease specifically in those tissues. These data all suggest that hsd17b10 expression is, at least, linked to spag7 expression. They also raise the question of why these animals have no metabolic phenotype. Some possible explanations are that hsd17b10 expression is essential only during early development, or that the lower magnitude of downregulation of hsd17b10 in the iSPAG7 is insufficient to produce the metabolic phenotypes seen in the germline Kos with higher magnitude of downregulation.

      Response to point #3 (Weakness): How best to normalize total energy expenditure data is a subject of debate within the energy expenditure field. As the animals have increased body weight and decreased lean mass, normalizing to either will skew the results in different directions. We have included the data normalized to body weight and to lean mass below. The decrease in total energy expenditure remains significant in either scenario.

      Author response image 1.

      Response to point #4 (Weakness): The information has been added to all figures.

      Response to point #5 (Weakness): Weeks after treatment have been added to the figure legends for Figures 4F-M.

      Response to point #6 (Weakness): Highly significant changes in fat mass, glucose tolerance and insulin sensitivity are already present in the germline SPAG7 KO mice at age of 15 week or earlier. Tamoxifen injection effectively induced SPA7 gene KO in less than a week in the iSPAG7 KO mice. Given the absence of significant changes or any trends towards significance in glucose and insulin tolerance test as well as other metabolic testes in the iSPAG7 KO mice at age of 15 week (same age as the germline KO when these changes observed) and 8 week after SPAG7 gene KO, we did not anticipate to see the changes beyond this point and decided to stop the study at 9 weeks after treatment.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This study uses state-of-the-art methods to label endogenous dopamine receptors in a subset of Drosophila mushroom body neuronal types. The authors report that DopR1 and Dop2R receptors, which have opposing effects in intracellular cAMP, are present in axons termini of Kenyon cells, as well as those of two classes of dopaminergic neurons that innervate the mushroom body indicative of autocrine modulation by dopaminergic neurons. Additional experiments showing opposing effects of starvation on DopR1 and DopR2 levels in mushroom body neurons are consistent with a role for dopamine receptor levels increasing the efficiency of learned food-odour associations in starved flies. Supported by solid data, this is a valuable contribution to the field.

      We thank the editors for the assessment, but request to change “DopR2” to “Dop2R”. The dopamine receptors in Drosophila have confusing names, but what we characterized in this study are called Dop1R1 (according to the Flybase; aka DopR1, dDA1, Dumb) and Dop2R (ibid; aka Dd2R). DopR2 is the name of a different dopamine receptor.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This is an important and interesting study that uses the split-GFP approach. Localization of receptors and correlating them to function is important in understanding the circuit basis of behavior.

      Strengths:

      The split-GFP approach allows visualization of subcellular enrichment of dopamine receptors in the plasma membrane of GAL4-expressing neurons allowing for a high level of specificity.

      The authors resolve the presynaptic localization of DopR1 and Dop2R, in "giant" Drosophila neurons differentiated from cytokinesis-arrested neuroblasts in culture as it is not clear in the lobes and calyx.

      Starvation-induced opposite responses of dopamine receptor expression in the PPL1 and PAM DANs provide key insights into models of appetitive learning.

      Starvation-induced increase in D2R allows for increased negative feedback that the authors test in D2R knockout flies where appetitive memory is diminished.

      This dual autoreceptor system is an attractive model for how amplitude and kinetics of dopamine release can be fine-tuned and controlled depending on the cellular function and this paper presents a good methodology to do it and a good system where the dynamics of dopamine release can be tested at the level of behavior.

      Weaknesses:

      LI measurements of Kenyon cells and lobes indicate that Dop2R was approximately twice as enriched in the lobe as the average density across the whole neuron, while the lobe enrichment of Dop1R1 was about 1.5 times the average, are these levels consistent during different times of the day and the state of the animal. How were these conditions controlled and how sensitive are receptor expression to the time of day of dissection, staining, etc.

      To answer this question, we repeated the experiment in two replicates at different times of day and confirmed that the receptor localization was consistent (Figure 3 – figure supplement 1); LI measurements showed that Dop2R is enriched more in the lobe and less in the calyx compared to Dop1R1 (Figure 3D). The states of animals that could affect LI (e.g. feeding state and anesthesia for sorting, see methods) were kept constant. 

      The authors assume without discussion as to why and how presynaptic enrichment of these receptors is similar in giant neurons and MB.

      In the revision, we added a short summary to recapitulate that the giant neurons exhibit many characteristics of mature neurons (Lines #152-156): "Importantly, these giant neurons exhibit characteristics of mature neurons, including firing patterns (Wu et al., 1990; Yao & Wu, 2001; Zhao & Wu, 1997) and acetylcholine release (Yao et al., 2000), both of which are regulated by cAMP and CaMKII signaling (Yao et al., 2000; Yao & Wu, 2001; Zhao & Wu, 1997)." In addition, we found punctate Brp accumulations localized to the axon terminals of the giant neurons (former Figure 4D and 4E). Therefore, the giant neuron serves as an excellent model to study the presynaptic localization of dopamine receptors in isolated large cells.

      Figures 1-3 show the expensive expression of receptors in alpha and beta lobes while Figure 5 focusses on PAM and localization in γ and β' projections of PAM leading to the conclusion that presynaptic dopamine neurons express these and have feedback regulation. Consistency between lobes or discussion of these differences is important to consider.

      In the revised manuscript, we show data in the γ KCs (Figure 4C, Figure 5 - figure supplement 1) in addition to α/β KCs, and demonstrate the consistent synaptic localization of Dop1R1 and Dop2R as in α/β KCs (Figure 4B and 5A). 

      Receptor expression in any learning-related MBONs is not discussed, and it would be intriguing as how receptors are organized in those cells. Given that these PAMs input to both KCs and MBONs these will have to work in some coordination.

      The subcellular localization of dopamine receptors in MBONs indeed provides important insights into the site of dopaminergic signaling in these neurons (Takemura et al., 2017; Pavlowsky et al., 2018; Pribbenow et al., 2022). Therefore, we added new data for Dop1R1 and Dop2R in MBON-γ1pedc>αβ (Figure 6). Interestingly, these receptors are localized to in the dendritic projection in the γ1 compartment as well as presynaptic boutons (Figure 6). 

      Although authors use the D2R enhancement post starvation to show that knocking down receptors eliminated appetitive memory, the knocking out is affecting multiple neurons within this circuit including PAMs and KCs. How does that account for the observed effect? Are those not important for appetitive learning? 

      In the appetitive memory experiment (Figure 9C), we knocked down Dop2R only in the select neurons of the PPL1 cluster, and this manipulation does not directly affect Dop2R expression in PAMs and KCs.

      Starvation-induced enhancement of Dop2R expression in the PPL1 neurons (Figure 8F) would attenuate their outputs and therefore disinhibit expression of appetitive memory in starved flies (Krashes et al., 2009). Consistently, Dop2R knock-down in PPL1 impaired appetitive memory in starved flies (Figure 9C). We revised the corresponding text to make this point clearer (Lines #224227).

      The evidence for fine-tuning is completely based on receptor expression and one behavioral outcome which could result from many possibilities. It is not clear if this fine-tuning and presynaptic feedback regulation-based dopamine release is a clear possibility. Alternate hypotheses and outcomes could be considered in the model as it is not completely substantiated by data at least as presented.

      The reviewer’s concern is valid, and the presynaptic dopamine tuning by autoreceptors may need more experimental support. We therefore additionally discussed another possibility (Lines #289-291): “Alternatively, these presynaptic receptors could potentially receive extrasynaptic dopamine released from other DANs. Therefore, the autoreceptor functions need to be experimentally clarified by manipulating the receptor expression in DANs.”

      Reviewer #2 (Public Review):

      Summary:

      Hiramatsu et al. investigated how cognate neurotransmitter receptors with antagonizing downstream effects localize within neurons when co-expressed. They focus on mapping the localization of the dopaminergic Dop1R1 and Dop2R receptors, which correspond to the mammalian D1- and D2-like dopamine receptors, which have opposing effects on intracellular cAMP levels, in neurons of the Drosophila mushroom body (MB). To visualize specific receptors in single neuron types within the crowded MB neuropil, the authors use existing dopamine receptor alleles tagged with 7 copies of split GFP to target reconstitution of GFP tags only in the neurons of interest as a read-out of receptor localization. The authors show that both Dop1R1 and Dop2R, with differing degrees, are enriched in axonal compartments of both the Kenyon Cells cholinergic presynaptic inputs and in different dopamine neurons (DANs), which project axons to the MB. Co-localization studies of dopamine receptors with the presynaptic marker Brp suggest that Dop1R1 and, to a larger extent Dop2R, localize in the proximity of release sites. This localization pattern in DANs suggests that Dop1R1 and Dop2R work in dual-feedback regulation as autoreceptors. Finally, they provide evidence that the balance of Dop1R1 and Dop2R in the axons of two different DAN populations is differentially modulated by starvation and that this regulation plays a role in regulating appetitive behaviors.

      Strengths:

      The authors use reconstitution of GFP fluorescence of split GFP tags knocked into the endogenous locus at the C-terminus of the dopamine receptors as a readout of dopamine receptor localization. This elegant approach preserves the endogenous transcriptional and post-transcriptional regulation of the receptor, which is essential for studies of protein localization.

      The study focuses on mapping the localization of dopamine receptors in neurons of the mushroom body. This is an excellent choice of system to address the question posed in this study, as the neurons are well-studied, and their connections are carefully reconstructed in the mushroom body connectome. Furthermore, the role of this circuit in different behaviors and associative memory permits the linking of patterns of receptor localization to circuit function and resulting behavior. Because of these features, the authors can provide evidence that two antagonizing dopamine receptors can act as autoreceptors within the axonal compartment of MB innervating DANs. The differential regulation of the balance of the two receptors under starvation in two distinct DAN innervations provides evidence of the role that regulation of this balance can play in circuit function and behavioral output.

      Weaknesses:

      The approach of using endogenously tagged alleles to study localization is a strength of this study, but the authors do not provide sufficient evidence that the insertion of 7 copies of split GFP to the C terminus of the dopamine receptors does not interfere with the endogenous localization pattern or function. Both sets of tagged alleles (1X Venus and 7X split GFP tagged) were previously reported (Kondo et al., 2020), but only the 1X Venus tagged alleles were further functionally validated in assays of olfactory appetitive memory. Despite the smaller size of the 7X split-GFP array tag knocked into the same location as the 1X venus tag, the reconstitution of 7 copies of GFP at the C terminus of the dopamine receptor, might substantially increase the molecular bulk at this site, potentially impeding the function of the receptor more significantly than the smaller, single Venus tag. The data presented by Kondo et al. 2020, is insufficient to conclude that the two alleles are equivalent.

      In the revision, we validated the function of these engineered receptors by a new set of olfactory learning experiments. Both these receptors in KCs were shown to be required for aversive memory (Kim et al., 2007, Scholz-Kornehl et al., 2016). As in the anatomical experiments, we induced GFP110 expression in KC of the flies homozygous for 7xGFP<sub>11</sub>-tagged receptors using MB-Switch and 3 days of RU486 feeding o. We confirmed STM performance of these flies were not significantly different from the control (Figure 2 – figure supplement 1). Thus, these fusion receptors are functional.

      The authors' conclusion that the receptors localize to presynaptic sites is weak. The analysis of the colocalization of the active zone marker Brp whole-brain staining with dopamine receptors labeled in specific neurons is insufficient to conclude that the receptors are localized at presynaptic sites. Given the highly crowded neuropil environment, the data cannot differentiate between the receptor localization postsynaptic to a dopamine release site or at a presynaptic site within the same neuron. The known distribution of presynaptic sites within the neurons analyzed in the study provides evidence that the receptors are enriched in axonal compartments, but co-labeling of presynaptic sites and receptors in the same neuron or super-resolution methods are needed to provide evidence of receptor localization at active zones.  The data presented in Figures 5K-5L provides compelling evidence that the receptors localize to neuronal varicosities in DANs where the receptors could play a role as autoreceptors.

      Given the highly crowded environment of the mushroom body neuropil, the analysis of dopamine receptor localization in Kenyon cells is not conclusive. The data is sufficient to conclude that the receptors are preferentially localizing to the axonal compartment of Kenyon cells, but co-localization with brain-wide Brp active zone immunostaining is not sufficient to determine if the receptor localizes juxtaposed to dopaminergic release sites, in proximity of release sites in Kenyon cells, or both.

      To better resolve the microcircuits of KCs, we triple-labeled the plasma membrane and DAR::rGFP in KCs, and Brp, and examined their localizations with high-resolution imaging with  Airyscan. This strategy revealed the receptor clusters associated with Brp accumulation within KCs (Figure 4). To further verify the association of DARs and active zones within KCs, we co-expressed Brp<sup>short</sup>::mStraw and GFP<sub>1-10</sub> and confirmed their colocalization (Figure 5A), suggesting presynaptic localization of DARs in KCs. With these additional characterizations, we now discuss the significance of receptors at the presynaptic sites of KCs.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      This is an important and interesting study that uses the split-GFP approach. Localization of receptors and correlating them to function is important in understanding the circuit basis of behavior.

      For Figure 1, the authors show PAM, PPL1 neurons, and the ellipsoid body as a validation of their tools (Dop1R1-T2A-GAL4 and Dop2R-T2A-GAL4) and the idea that these receptors are colocalized. However, it appears that the technique was applied to the whole brain so it would be great to see the whole brain to understand how much labelling is specific and how stochastic. Methods could include how dissection conditions were controlled and how sensitive are receptor expression to the time of day of dissection, staining, etc.

      The expression patterns of the receptor T2A-GAL4 lines (Figure 1A and 1B) are consistent in the multiple whole brains (Kondo et al., 2020, Author response image 1).

      Author response image 1.

      The significance of the expression of these two receptors in an active zone is not clearly discussed and presynaptic localization is not elaborated on. Would something like expansion microscopy be useful in resolving this? It would be important to discuss that as giant neurons in culture don't replicate many aspects of the MB system.

      In the revised manuscript, we elaborated discussion regarding the function of the two antagonizing receptors at the AZ (Lines #226-275).

      Does MB-GeneSwitch > GFP1-1 reliably express in gamma lobes? Most of the figures show alpha/beta lobes.

      Yes. MB-GeneSwitch is also expressed in γ KCs, but weakly. 12 hours of RU486 feeding, which we did in the previous experiments, was insufficient to induce GFP reconstitution in the γ KCs. By extending the time of transgene induction, we visualized expression of Dop1R1 and Dop2R more clearly in γ KCs. Their localization is similar to that in the α/β KCs (Figure 4C, Figure 5 - figure supplement 1).

      Figure 6, y-axis says protein level. At first, I thought it was related to starvation so maybe authors can be more specific as the protein level doesn't indicate any aspect of starvation.

      We appreciate this comment, and the labels on the y-axis were now changed to “rGFP levels” (Figure 8C and 8F, Figure 8 - figure supplement 1B, 1D and 1F).

      Reviewer #2 (Recommendations For The Authors):

      Title:

      The title of the manuscript focuses on the tagging of the receptors and their synaptic enrichment.

      Given that the alleles used in the study were generated in a previously published study (Kondo et al, 2020), which describes the receptor tagging and that the data currently provided is insufficient to conclude that the receptors are localizing to synapses, the title should be changed to reflect the focus on localizing antagonistic cognate neurotransmitter receptors in the same neuron and their putative role as autoreceptors in DANs.

      Following this advice, we removed the methodology from the title and revised it to “Synaptic enrichment and dynamic regulation of the two opposing dopamine receptors within the same neurons”.

      Minor issues with text and figures:

      Figure 1

      A conclusion from Figure 1 is that the two receptors are co-expressed in Kenyon cells. Please provide panels equivalent to the ones shown in D-G, with Kenyon cells cell bodies, or mark these cells in the existing panels, if present. Line 111 refers to panel 1D as the Kenyon cells panel, which is currently a PAM panel.

      We added images for coexpression of these receptors in the cell bodies of KCs (Figure 1 - figure supplement 1) and revised the text accordingly (Lines #89-90).

      Given that most of the study centers on visualizing receptor localization, it would benefit the reader to include labels in Figure 1 that help understand that these panels reflect expression patterns rather than receptor localization. For instance, rCD2::GFP could be indicated in the Dop1R1-LexA panels.

      As suggested, labels were added to indicate the UAS and lexAop markers (Figure 1D, 1E, 1G-1I and Figure 1 – figure supplement 1).

      Given that panels D-E focus on the cell bodies of the neurons, it could be beneficial for the reader to present the ellipsoid body neurons using a similar view that only shows the cell bodies. Similarly, one could just show the glial cell bodies .

      We now show the cell bodies of ring neurons (Figure 1G) and ensheathing glia (Figure 1I).

      For panel 1E, please indicate the subset of PPL1 neurons that both expressed Dop1R1 and Dop2R, as indicated in the text, as it is currently unclear from the image.

      Dop1R1-T2A-LexA was barely detected in all PPL1 (Figure 1E). We corrected the confusing text (Lines #95-96).

      Figure 2

      The cartoon of the cell-type-specific labeling should show that the tag is 7XFP-11 and the UAScomponent FP-10, as the current cartoon leads the reader to conclude that the receptors are tagged with a single copy of split GFP. The detail that the receptors are tagged with 7 copies of split GFP is only provided through the genotype of the allele in the resource table.  This design aspect should be made clear in the figure and the text when describing the allele and approach used to tag receptors in specific neuron types.

      We now added the construct design in the scheme (Figure 2A) and revised the corresponding text (Line #101-103).

      Panel A. The arrow representing the endogenous promoter in the yellow gene representation should be placed at the beginning of the coding sequence. Currently, the different colors of what I assume are coding (yellow) and non-coding (white) transcript regions are not described in the legend.  I would omit these or represent them in the same color as thinner boxes if the authors want to emphasize that the tag is inserted at the C terminus within the endogenous locus.

      The color scheme was revised to be more consistent and intuitive (Figure 2A).

      Figure 3

      Labels of the calyx and MB lobes would benefit readers not as familiar with the system used in the study. In addition, it would be beneficial to the reader to indicate in panel A the location of the compartments analyzed in panel H (e.g., peduncle, α3).

      Figure 3A was amended to clearly indicate the analyzed MB compartments.

      Adding frontal and sagittal to panels B-E, as in Figure 2, would help the reader interpret the data. 

      In Figure 3B, “Frontal” and “Sagittal” were indicated.

      Panel F-G. A scale bar should be provided for the data shown in the insets. Could the author comment on the localization of Dop1R1 in KCs? The data in the current panel suggests that only a subset of KCs express high levels of receptors in their axons, as a portion of the membrane is devoid of receptor signals. This would be in line with differential dopamine receptor expression in subsets of Kenyon cells, as shown in Kondo et al., 2020, which is currently not commented on in the paper. 

      We confirmed that the majority of the KCs express both Dop1R1 and Dop2R genes (Figure 1 - figure supplement 1). LIs should be compared within the same cells rather than the differences of protein levels between cell types as they also reflect the GAL4 expression levels. 

      Panel H. Some P values are shown as n.s. (p> 0.05). Other non-significant p values in this panel and in other figures throughout the paper are instead reported (e.g. peduncle P=0.164). For consistency, please report the values as n.s. as indicated in the methods for all non-significant tests in this panel and throughout the manuscript.

      We now present the new dataset, and the graph represents the appropriate statistical results (Figure 3D; see the methods section for details).

      The methods of labeling the receptors through the expression of the GeneSwitch-controlled GFP1-10 in Kenyon cells induced by RU486 are not provided in the methods. Please provide a description of this as referenced in the figure legend and the genotypes used in the analysis shown in the panels.

      The method of RU486 feeding has been added. We apologize for the missing method.

      Figure 4

      Please provide scale bars for the inset in panels A-B.

      Scale bars were added to all confocal images.

      The current analysis cannot distinguish between postsynaptic and presynaptic dopamine receptors in KCs, and the figure title should reflect this.

      We now present the new data dopamine receptors in KCs and clearly distinguish Brp clusters of the KCs and other cell types (Figure 4, Figure 5).

      The reader could benefit from additional details of using the giant neuron model, as it is not commonly used, and it is not clear how to relate this to interpret the localization of dopaminergic receptors within Kenyon cells. The use of the venus-tagged receptor variant should be introduced in the text, as using a different allele currently lacks context. Figures 4F-4J show that the receptor is localizing throughout the neuron. Quantifying the fraction of receptor signal colocalizing with Brp could aid in interpreting the data.  However, it would still not be clear how to interpret this data in the context of understanding the localization of the receptors in neurons within fly brain circuits. In the absence of additional data, the data provided in Figure 4 is inconclusive and could be omitted, keeping the focus of the study on the analysis of the two receptors in DANs. Co-expressing a presynaptic marker in Kenyon cells (e.g., by expressing Brp::SNAP)  in conjunction with rGFP labeled receptor would provide additional evidence of the relationship of release sites in Kenyon cells and tagged dopamine receptors in these same cells and could add evidence in support to the current conclusion.

      Following the advice, we added a short summary to recapitulate that the giant neurons exhibit many characteristics of mature neurons (Lines #152-156): "Importantly, these giant neurons exhibit characteristics of mature neurons, including firing patterns (Wu et al., 1990; Yao & Wu, 2001; Zhao & Wu, 1997) and acetylcholine release (Yao et al., 2000), both of which are regulated by cAMP and CaMKII signaling (Yao et al., 2000; Yao & Wu, 2001; Zhao & Wu, 1997)." Therefore, the giant neuron serves as an excellent model to study the presynaptic localization in large cells in isolation.

      To clarify polarized localization of Brp clusters and dopamine receptors but not "localizing throughout the neuron", we now show less magnified data (Figure 5C). It clearly demonstrates punctate Brp accumulations localized to the axon terminals of the giant neurons (former Figure 4D and 4E). This is the same membrane segment where Dop1R1 and Dop2R are localized (Figure 5C). Therefore, the association of Brp clusters and the dopamine receptors in the isolated giant neurons suggests that the subcellular localization in the brain neurons is independent of the circuit context. 

      As the giant neurons do not form intermingled circuits, venus-tagged receptors are sufficient for this experiment and simpler in genetics.

      Following the suggestion to clarify the AZ association of the receptors in KCs, we coexpressed Brpshort-mStraw and GFP1-10 in KCs and confirmed their colocalization (Figure 5A).

      Figure 6

      The data and analysis show that starvation induces changes in the α3 compartment in PPL1 neurons only, while the data provided shows no significant change for PPL1 neurons innervating other MB compartments. This should be clearly stated in lines 174-175, as it is implied that there is a difference in the analysis for compartments other than α3. Panel L of Figure 6 - supplement 1 shows no significant change for all three compartments analyzed and should be indicated as n.s. in all instances, as stated in the methods. 

      We revised the text to clarify that the starvation-induced differences of Dop2R expression were not significant (Lines #217-219). The reason to highlight the α3 compartment is that both Dop1R1 and Dop2R are coexpressed in this PPL1 neuron (Figure 8D).

      Additional minor comments:

      There are a few typos and errors throughout the manuscript. The text should be carefully proofread to correct these. Here are the ones that came to my attention:

      Please reference all figure panels in the text. For instance, Figure 3A is not mentioned and should be revised in line 112 as Figure 3A-E.

      Lines 103-104. The sentence "LI was visualized as the color of the membrane signals" is unclear and should be revised. 

      Figure 4 legend - dendritic claws should likely be B and C and not B and E.

      Lines 147 - Incorrect figure panels, should be 5C-L or 5D-E.

      Line 241 - DNAs should be DANs.

      Methods - please define what the abbreviation CS stands for.

      We really appreciate for careful reading of this reviewer. All these were corrected.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable study investigates how the neural representation of individual finger movements changes during the early period of sequence learning. By combining a new method for extracting features from human magnetoencephalography data and decoding analyses, the authors provide incomplete evidence of an early, swift change in the brain regions correlated with sequence learning, including a set of previously unreported frontal cortical regions. The addition of more control analyses to rule out that head movement artefacts influence the findings, and to further explain the proposal of offline contextualization during short rest periods as the basis for improvement performance would strengthen the manuscript.

      We appreciate the Editorial assessment on our paper’s strengths and novelty. We have implemented additional control analyses to show that neither task-related eye movements nor increasing overlap of finger movements during learning account for our findings, which are that contextualized neural representations in a network of bilateral frontoparietal brain regions actively contribute to skill learning. Importantly, we carried out additional analyses showing that contextualization develops predominantly during rest intervals.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study addresses the issue of rapid skill learning and whether individual sequence elements (here: finger presses) are differentially represented in human MEG data. The authors use a decoding approach to classify individual finger elements and accomplish an accuracy of around 94%. A relevant finding is that the neural representations of individual finger elements dynamically change over the course of learning. This would be highly relevant for any attempts to develop better brain machine interfaces - one now can decode individual elements within a sequence with high precision, but these representations are not static but develop over the course of learning.

      Strengths:

      The work follows a large body of work from the same group on the behavioural and neural foundations of sequence learning. The behavioural task is well established and neatly designed to allow for tracking learning and how individual sequence elements contribute. The inclusion of short offline rest periods between learning epochs has been influential because it has revealed that a lot, if not most of the gains in behaviour (ie speed of finger movements) occur in these socalled micro-offline rest periods. The authors use a range of new decoding techniques, and exhaustively interrogate their data in different ways, using different decoding approaches. Regardless of the approach, impressively high decoding accuracies are observed, but when using a hybrid approach that combines the MEG data in different ways, the authors observe decoding accuracies of individual sequence elements from the MEG data of up to 94%.

      We have previously showed that neural replay of MEG activity representing the practiced skill was prominent during rest intervals of early learning, and that the replay density correlated with micro-offline gains (Buch et al., 2021). These findings are consistent with recent reports (from two different research groups) that hippocampal ripple density increases during these inter-practice rest periods, and predict offline learning gains (Chen et al., 2024; Sjøgård et al., 2024). However, decoder performance in our earlier work (Buch et al., 2021) left room for improvement. Here, we reported a strategy to improve decoding accuracy that could benefit future studies of neural replay or BCI using MEG.

      Weaknesses:

      There are a few concerns which the authors may well be able to resolve. These are not weaknesses as such, but factors that would be helpful to address as these concern potential contributions to the results that one would like to rule out. Regarding the decoding results shown in Figure 2 etc, a concern is that within individual frequency bands, the highest accuracy seems to be within frequencies that match the rate of keypresses. This is a general concern when relating movement to brain activity, so is not specific to decoding as done here. As far as reported, there was no specific restraint to the arm or shoulder, and even then it is conceivable that small head movements would correlate highly with the vigor of individual finger movements. This concern is supported by the highest contribution in decoding accuracy being in middle frontal regions - midline structures that would be specifically sensitive to movement artefacts and don't seem to come to mind as key structures for very simple sequential keypress tasks such as this - and the overall pattern is remarkably symmetrical (despite being a unimanual finger task) and spatially broad. This issue may well be matching the time course of learning, as the vigor and speed of finger presses will also influence the degree to which the arm/shoulder and head move. This is not to say that useful information is contained within either of the frequencies or broadband data. But it raises the question of whether a lot is dominated by movement "artefacts" and one may get a more specific answer if removing any such contributions.

      Reviewer #1 expresses concern that the combination of the low-frequency narrow-band decoder results, and the bilateral middle frontal regions displaying the highest average intra-parcel decoding performance across subjects is suggestive that the decoding results could be driven by head movement or other artefacts.

      Head movement artefacts are highly unlikely to contribute meaningfully to our results for the following reasons. First, in addition to ICA denoising, all “recordings were visually inspected and marked to denoise segments containing other large amplitude artifacts due to movements” (see Methods). Second, the response pad was positioned in a manner that minimized wrist, arm or more proximal body movements during the task. Third, while online monitoring of head position was not performed for this study, it was assessed at the beginning and at the end of each recording. The head was restrained with an inflatable air bladder, and head movement between the beginning and end of each scan did not exceed 5mm for all participants included in the study.

      The Reviewer states a concern that “it is conceivable that small head movements would correlate highly with the vigor of individual finger movements”. We agree that despite the steps taken above, it is possible that minor head movements could still contribute to some remaining variance in the MEG data in our study. However, such correlations between small head movements and finger movements could only meaningfully contribute to decoding performance if: (A) they were consistent and pervasive throughout the recording (which might not be the case if the head movements were related to movement vigor and vigor changed over time); and (B) they systematically varied between different finger movements, and also between the same finger movement performed at different sequence locations (see 5-class decoding performance in Figure 4B). The possibility of any head movement artefacts meeting all these conditions is unlikely. Alternatively, for this task design a much more likely confound could be the contribution of eye movement artefacts to the decoder performance (an issue raised by Reviewer #3 in the comments below).

      Remember from Figure 1A in the manuscript that an asterisk marks the current position in the sequence and is updated at each keypress. Since participants make very few performance errors, the position of the asterisk on the display is highly correlated with the keypress being made in the sequence. Thus, it is possible that if participants are attending to the visual feedback provided on the display, they may generate eye movements that are systematically related to the task. Since we did record eye movements simultaneously with the MEG recordings (EyeLink 1000 Plus; Fs = 600 Hz), we were able to perform a control analysis to address this question. For each keypress event during trials in which no errors occurred (which is the same time-point that the asterisk position is updated), we extracted three features related to eye movements: 1) the gaze position at the time of asterisk position update (triggered by a KeyDown event), 2) the gaze position 150ms later, and 3) the peak velocity of the eye movement between the two positions. We then constructed a classifier from these features with the aim of predicting the location of the asterisk (ordinal positions 1-5) on the display. As shown in the confusion matrix below (Author response image 1), the classifier failed to perform above chance levels (overall cross-validated accuracy = 0.21817):

      Author response image 1.

      Confusion matrix showing that three eye movement features fail to predict asterisk position on the task display above chance levels (Fold 1 test accuracy = 0.21718; Fold 2 test accuracy = 0.22023; Fold 3 test accuracy = 0.21859; Fold 4 test accuracy = 0.22113; Fold 5 test accuracy = 0.21373; Overall cross-validated accuracy = 0.2181). Since the ordinal position of the asterisk on the display is highly correlated with the ordinal position of individual keypresses in the sequence, this analysis provides strong evidence that keypress decoding performance from MEG features is not explained by systematic relationships between finger movement behavior and eye movements (i.e. – behavioral artefacts) (end of figure legend).

      Remember that the task display does not provide explicit feedback related to performance, only information about the present position in the sequence. Thus, it is possible that participants did not actively attend to the feedback. In fact, inspection of the eye position data revealed that on majority of trials, participants displayed random-walk-like gaze patterns around a central fixation point located near the center of the screen. Thus, participants did not attend to the asterisk position on the display, but instead intrinsically generated the action sequence. A similar realworld example would be manually inputting a long password into a secure online application. In this case, one intrinsically generates the sequence from memory and receives similar feedback about the password sequence position (also provided as asterisks) as provided in the study task – feedback which is typically ignored by the user.

      The minimal participant engagement with the visual task display observed in this study highlights another important point – that the behavior in explicit sequence learning motor tasks is highly generative in nature rather than reactive to stimulus cues as in the serial reaction time task (SRTT). This is a crucial difference that must be carefully considered when designing investigations and comparing findings across studies.

      We observed that initial keypress decoding accuracy was predominantly driven by contralateral primary sensorimotor cortex in the initial practice trials before transitioning to bilateral frontoparietal regions by trials 11 or 12 as performance gains plateaued. The contribution of contralateral primary sensorimotor areas to early skill learning has been extensively reported in humans and non-human animals.(Buch et al., 2021; Classen et al., 1998; Karni et al., 1995; Kleim et al., 1998) Similarly, the increased involvement of bilateral frontal and parietal regions to decoding during early skill learning in the non-dominant hand is well known. Enhanced bilateral activation in both frontal and parietal cortex during skill learning has been extensively reported (Doyon et al., 2002; Grafton et al., 1992; Hardwick et al., 2013; Kennerley et al., 2004; Shadmehr & Holcomb, 1997; Toni, Ramnani, et al., 2001), and appears to be even more prominent during early fine motor skill learning in the non-dominant hand (Lee et al., 2019; Sawamura et al., 2019). The frontal regions identified in these studies are known to play crucial roles in executive control (Battaglia-Mayer & Caminiti, 2019), motor planning (Toni, Thoenissen, et al., 2001), and working memory (Andersen & Buneo, 2002; Buneo & Andersen, 2006; Shadmehr & Holcomb, 1997; Toni, Ramnani, et al., 2001; Wolpert et al., 1998) processes, while the same parietal regions are known to integrate multimodal sensory feedback and support visuomotor transformations (Andersen & Buneo, 2002; Buneo & Andersen, 2006; Shadmehr & Holcomb, 1997; Toni, Ramnani, et al., 2001; Wolpert et al., 1998), in addition to working memory (Grover et al., 2022). Thus, it is not surprising that these regions increasingly contribute to decoding as subjects internalize the sequential task. We now include a statement reflecting these considerations in the revised Discussion.

      A somewhat related point is this: when combining voxel and parcel space, a concern is whether a degree of circularity may have contributed to the improved accuracy of the combined data, because it seems to use the same MEG signals twice - the voxels most contributing are also those contributing most to a parcel being identified as relevant, as parcels reflect the average of voxels within a boundary. In this context, I struggled to understand the explanation given, ie that the improved accuracy of the hybrid model may be due to "lower spatially resolved whole-brain and higher spatially resolved regional activity patterns".

      We disagree with the Reviewer’s assertion that the construction of the hybrid-space decoder is circular for the following reasons. First, the base feature set for the hybrid-space decoder constructed for all participants includes whole-brain spatial patterns of MEG source activity averaged within parcels. As stated in the manuscript, these 148 inter-parcel features reflect “lower spatially resolved whole-brain activity patterns” or global brain dynamics. We then independently test how well spatial patterns of MEG source activity for all voxels distributed within individual parcels can decode keypress actions. Again, the testing of these intra-parcel spatial patterns, intended to capture “higher spatially resolved regional brain activity patterns”, is completely independent from one another and independent from the weighting of individual inter-parcel features. These intra-parcel features could, for example, provide additional information about muscle activation patterns or the task environment. These approximately 1150 intra-parcel voxels (on average, within the total number varying between subjects) are then combined with the 148 inter-parcel features to construct the final hybrid-space decoder. In fact, this varied spatial filter approach shares some similarities to the construction of convolutional neural networks (CNNs) used to perform object recognition in image classification applications (Srinivas et al., 2016). One could also view this hybrid-space decoding approach as a spatial analogue to common timefrequency based analyses such as theta-gamma phase amplitude coupling (θ/γ PAC), which assess interactions between two or more narrow-band spectral features derived from the same time-series data (Lisman & Jensen, 2013).

      We directly tested this hypothesis – that spatially overlapping intra- and inter-parcel features portray different information – by constructing an alternative hybrid-space decoder (Hybrid<sub>Alt</sub>) that excluded average inter-parcel features which spatially overlapped with intra-parcel voxel features, and comparing the performance to the decoder used in the manuscript (Hybrid<sub>Orig</sub>). The prediction was that if the overlapping parcel contained similar information to the more spatially resolved voxel patterns, then removing the parcel features (n=8) from the decoding analysis should not impact performance. In fact, despite making up less than 1% of the overall input feature space, removing those parcels resulted in a significant drop in overall performance greater than 2% (78.15% ± 7.03% SD for Hybrid<sub>Orig</sub> vs. 75.49% ± 7.17% for Hybrid<sub>Alt</sub>; Wilcoxon signed rank test, z = 3.7410, p = 1.8326e-04; Author response image 2).

      Author response image 2.

      Comparison of decoding performances with two different hybrid approaches. Hybrid<sub>Alt</sub>: Intra-parcel voxel-space features of top ranked parcels and inter-parcel features of remaining parcels. Hybrid<sub>Orig</sub>: Voxel-space features of top ranked parcels and whole-brain parcel-space features (i.e. – the version used in the manuscript). Dots represent decoding accuracy for individual subjects. Dashed lines indicate the trend in performance change across participants. Note, that Hybrid<sub>Orig</sub> (the approach used in our manuscript) significantly outperforms the Hybrid<sub>Alt</sub> approach, indicating that the excluded parcel features provide unique information compared to the spatially overlapping intra-parcel voxel patterns (end of figure legend).

      Firstly, there will be a relatively high degree of spatial contiguity among voxels because of the nature of the signal measured, i.e. nearby individual voxels are unlikely to be independent. Secondly, the voxel data gives a somewhat misleading sense of precision; the inversion can be set up to give an estimate for each voxel, but there will not just be dependence among adjacent voxels, but also substantial variation in the sensitivity and confidence with which activity can be projected to different parts of the brain. Midline and deeper structures come to mind, where the inversion will be more problematic than for regions along the dorsal convexity of the brain, and a concern is that in those midline structures, the highest decoding accuracy is seen.

      We agree with the Reviewer that some inter-parcel features representing neighboring (or spatially contiguous) voxels are likely to be correlated, an important confound in connectivity analyses (Colclough et al., 2015; Colclough et al., 2016), not performed in our investigation.

      In our study, correlations between adjacent voxels effectively reduce the dimensionality of the input feature space. However, as long as there are multiple groups of correlated voxels within each parcel (i.e. – the rank is greater than 1), the intra-parcel spatial patterns could meaningfully contribute to the decoder performance, as shown by the following results:

      First, we obtained higher decoding accuracy with voxel-space features (74.51% ± 7.34% SD) compared to parcel space features (68.77% ± 7.6%; Figure 3B), indicating individual voxels carry more information in decoding the keypresses than the averaged voxel-space features or parcel space features. Second, individual voxels within a parcel showed varying feature importance scores in decoding keypresses (Author response image 3). This finding shows that correlated voxels form mini subclusters that are much smaller spatially than the parcel they reside within.

      Author response image 3.:

      Feature importance score of individual voxels in decoding keypresses: MRMR was used to rank the individual voxel space features in decoding keypresses and the min-max normalized MRMR score was mapped to a structural brain surface. Note that individual voxels within a parcel showed different contribution to decoding (end of figure legend).

      Some of these concerns could be addressed by recording head movement (with enough precision) to regress out these contributions. The authors state that head movement was monitored with 3 fiducials, and their time courses ought to provide a way to deal with this issue. The ICA procedure may not have sufficiently dealt with removing movement-related problems, but one could eg relate individual components that were identified to the keypresses as another means for checking. An alternative could be to focus on frequency ranges above the movement frequencies. The accuracy for those still seems impressive and may provide a slightly more biologically plausible assessment.

      We have already addressed the issue of movement related artefacts in the first response above. With respect to a focus on frequency ranges above movement frequencies, the Reviewer states the “accuracy for those still seems impressive and may provide a slightly more biologically plausible assessment”. First, it is important to note that cortical delta-band oscillations measured with local field potentials (LFPs) in macaques is known to contain important information related to end-effector kinematics (Bansal et al., 2011; Mollazadeh et al., 2011) muscle activation patterns (Flint et al., 2012) and temporal sequencing (Churchland et al., 2012) during skilled reaching and grasping actions. Thus, there is a substantial body of evidence that low-frequency neural oscillatory activity in this range contains important information about the skill learning behavior investigated in the present study. Second, our own data shows (which the Reviewer also points out) that significant information related to the skill learning behavior is also present in higher frequency bands (see Figure 2A and Figure 3—figure supplement 1). As we pointed out in our earlier response to questions about the hybrid space decoder architecture (see above), it is likely that different, yet complimentary, information is encoded across different temporal frequencies (just as it is encoded across different spatial frequencies) (Heusser et al., 2016). Again, this interpretation is supported by our data as the highest performing classifiers in all cases (when holding all parameters constant) were always constructed from broadband input MEG data (Figure 2A and Figure 3—figure supplement 1).

      One question concerns the interpretation of the results shown in Figure 4. They imply that during the course of learning, entirely different brain networks underpin the behaviour. Not only that, but they also include regions that would seem rather unexpected to be key nodes for learning and expressing relatively simple finger sequences, such as here. What then is the biological plausibility of these results? The authors seem to circumnavigate this issue by moving into a distance metric that captures the (neural network) changes over the course of learning, but the discussion seems detached from which regions are actually involved; or they offer a rather broad discussion of the anatomical regions identified here, eg in the context of LFOs, where they merely refer to "frontoparietal regions".

      The Reviewer notes the shift in brain networks driving keypress decoding performance between trials 1, 11 and 36 as shown in Figure 4A. The Reviewer questions whether these shifts in brain network states underpinning the skill are biologically plausible, as well as the likelihood that bilateral superior and middle frontal and parietal cortex are important nodes within these networks.

      First, previous fMRI work in humans assessed changes in functional connectivity patterns while participants performed a similar sequence learning task to our present study (Bassett et al., 2011). Using a dynamic network analysis approach, Bassett et al. showed that flexibility in the composition of individual network modules (i.e. – changes in functional brain region membership of orthogonal brain networks) is up-regulated in novel learning environments and explains differences in learning rates across individuals. Thus, consistent with our findings, it is likely that functional brain networks rapidly reconfigure during early learning of novel sequential motor skills.

      Second, frontoparietal network activity is known to support motor memory encoding during early learning (Albouy et al., 2013; Albouy et al., 2012). For example, reactivation events in the posterior parietal (Qin et al., 1997) and medial prefrontal (Euston et al., 2007; Molle & Born, 2009) cortex (MPFC) have been temporally linked to hippocampal replay, and are posited to support memory consolidation across several memory domains (Frankland & Bontempi, 2005), including motor sequence learning (Albouy et al., 2015; Buch et al., 2021; F. Jacobacci et al., 2020). Further, synchronized interactions between MPFC and hippocampus are more prominent during early as opposed to later learning stages (Albouy et al., 2013; Gais et al., 2007; Sterpenich et al., 2009), perhaps reflecting “redistribution of hippocampal memories to MPFC” (Albouy et al., 2013). MPFC contributes to very early memory formation by learning association between contexts, locations, events and adaptive responses during rapid learning (Euston et al., 2012). Consistently, coupling between hippocampus and MPFC has been shown during initial memory encoding and during subsequent rest (van Kesteren et al., 2010; van Kesteren et al., 2012). Importantly, MPFC activity during initial memory encoding predicts subsequent recall (Wagner et al., 1998). Thus, the spatial map required to encode a motor sequence memory may be “built under the supervision of the prefrontal cortex” (Albouy et al., 2012), also engaged in the development of an abstract representation of the sequence (Ashe et al., 2006). In more abstract terms, the prefrontal, premotor and parietal cortices support novice performance “by deploying attentional and control processes” (Doyon et al., 2009; Hikosaka et al., 2002; Penhune & Steele, 2012) required during early learning (Doyon et al., 2009; Hikosaka et al., 2002; Penhune & Steele, 2012). The dorsolateral prefrontal cortex DLPFC specifically is thought to engage in goal selection and sequence monitoring during early skill practice (Schendan et al., 2003), all consistent with the schema model of declarative memory in which prefrontal cortices play an important role in encoding (Morris, 2006; Tse et al., 2007). Thus, several prefrontal and frontoparietal regions contributing to long term learning (Berlot et al., 2020) are also engaged in early stages of encoding. Altogether, there is strong biological support for the involvement of bilateral prefrontal and frontoparietal regions to decoding during early skill learning. We now address this issue in the revised manuscript.

      If I understand correctly, the offline neural representation analysis is in essence the comparison of the last keypress vs the first keypress of the next sequence. In that sense, the activity during offline rest periods is actually not considered. This makes the nomenclature somewhat confusing. While it matches the behavioural analysis, having only key presses one can't do it in any other way, but here the authors actually do have recordings of brain activity during offline rest. So at the very least calling it offline neural representation is misleading to this reviewer because what is compared is activity during the last and during the next keypress, not activity during offline periods. But it also seems a missed opportunity - the authors argue that most of the relevant learning occurs during offline rest periods, yet there is no attempt to actually test whether activity during this period can be useful for the questions at hand here.

      We agree with the Reviewer that our previous “offline neural representation” nomenclature could be misinterpreted. In the revised manuscript we refer to this difference as the “offline neural representational change”. Please, note that our previous work did link offline neural activity (i.e. – 16-22 Hz beta power (Bonstrup et al., 2019) and neural replay density (Buch et al., 2021) during inter-practice rest periods) to observed micro-offline gains.

      Reviewer #2 (Public review):

      Summary

      Dash et al. asked whether and how the neural representation of individual finger movements is "contextualized" within a trained sequence during the very early period of sequential skill learning by using decoding of MEG signal. Specifically, they assessed whether/how the same finger presses (pressing index finger) embedded in the different ordinal positions of a practiced sequence (4-1-3-2-4; here, the numbers 1 through 4 correspond to the little through the index fingers of the non-dominant left hand) change their representation (MEG feature). They did this by computing either the decoding accuracy of the index finger at the ordinal positions 1 vs. 5 (index_OP1 vs index_OP5) or pattern distance between index_OP1 vs. index_OP5 at each training trial and found that both the decoding accuracy and the pattern distance progressively increase over the course of learning trials. More interestingly, they also computed the pattern distance for index_OP5 for the last execution of a practice trial vs. index_OP1 for the first execution in the next practice trial (i.e., across the rest period). This "off-line" distance was significantly larger than the "on-line" distance, which was computed within practice trials and predicted micro-offline skill gain. Based on these results, the authors conclude that the differentiation of representation for the identical movement embedded in different positions of a sequential skill ("contextualization") primarily occurs during early skill learning, especially during rest, consistent with the recent theory of the "micro-offline learning" proposed by the authors' group. I think this is an important and timely topic for the field of motor learning and beyond.

      Strengths

      The specific strengths of the current work are as follows. First, the use of temporally rich neural information (MEG signal) has a large advantage over previous studies testing sequential representations using fMRI. This allowed the authors to examine the earliest period (= the first few minutes of training) of skill learning with finer temporal resolution. Second, through the optimization of MEG feature extraction, the current study achieved extremely high decoding accuracy (approx. 94%) compared to previous works. As claimed by the authors, this is one of the strengths of the paper (but see my comments). Third, although some potential refinement might be needed, comparing "online" and "offline" pattern distance is a neat idea.

      Weaknesses

      Along with the strengths I raised above, the paper has some weaknesses. First, the pursuit of high decoding accuracy, especially the choice of time points and window length (i.e., 200 msec window starting from 0 msec from key press onset), casts a shadow on the interpretation of the main result. Currently, it is unclear whether the decoding results simply reflect behavioral change or true underlying neural change. As shown in the behavioral data, the key press speed reached 3~4 presses per second already at around the end of the early learning period (11th trial), which means inter-press intervals become as short as 250-330 msec. Thus, in almost more than 60% of training period data, the time window for MEG feature extraction (200 msec) spans around 60% of the inter-press intervals. Considering that the preparation/cueing of subsequent presses starts ahead of the actual press (e.g., Kornysheva et al., 2019) and/or potential online planning (e.g., Ariani and Diedrichsen, 2019), the decoder likely has captured these future press information as well as the signal related to the current key press, independent of the formation of genuine sequential representation (e.g., "contextualization" of individual press). This may also explain the gradual increase in decoding accuracy or pattern distance between index_OP1 vs. index_OP5 (Figure 4C and 5A), which co-occurred with performance improvement, as shorter inter-press intervals are more favorable for the dissociating the two index finger presses followed by different finger presses. The compromised decoding accuracies for the control sequences can be explained in similar logic. Therefore, more careful consideration and elaborated discussion seem necessary when trying to both achieve high-performance decoding and assess early skill learning, as it can impact all the subsequent analyses.

      The Reviewer raises the possibility that (given the windowing parameters used in the present study) an increase in “contextualization” with learning could simply reflect faster typing speeds as opposed to an actual change in the underlying neural representation.

      We now include a new control analysis that addresses this issue as well as additional re-examination of previously reported results with respect to this issue – all of which are inconsistent with this alternative explanation that “contextualization” reflects a change in mixing of keypress related MEG features as opposed to a change in the underlying representations themselves. As correct sequences are generated at higher and higher speeds over training, MEG activity patterns related to the planning, execution, evaluation and memory of individual keypresses overlap more in time. Thus, increased overlap between the “4” and “1” keypresses (at the start of the sequence) and “2” and “4” keypresses (at the end of the sequence) could artefactually increase contextualization distances even if the underlying neural representations for the individual keypresses remain unchanged. One must also keep in mind that since participants repeat the sequence multiple times within the same trial, a majority of the index finger keypresses are performed adjacent to one another (i.e. - the “4-4” transition marking the end of one sequence and the beginning of the next). Thus, increased overlap between consecutive index finger keypresses as typing speed increased should increase their similarity and mask contextualization related changes to the underlying neural representations.

      We addressed this question by conducting a new multivariate regression analysis to directly assess whether the neural representation distance score could be predicted by the 4-1, 2-4 and 4-4 keypress transition times observed for each complete correct sequence (both predictor and response variables were z-score normalized within-subject). The results of this analysis also affirmed that the possible alternative explanation that contextualization effects are simple reflections of increased mixing is not supported by the data (Adjusted R<sup>2</sup> = 0.00431; F = 5.62). We now include this new negative control analysis in the revised manuscript.

      We also re-examined our previously reported classification results with respect to this issue. We reasoned that if mixing effects reflecting the ordinal sequence structure is an important driver of the contextualization finding, these effects should be observable in the distribution of decoder misclassifications. For example, “4” keypresses would be more likely to be misclassified as “1” or “2” keypresses (or vice versa) than as “3” keypresses. The confusion matrices presented in Figures 3C and 4B and Figure 3—figure supplement 3A display a distribution of misclassifications that is inconsistent with an alternative mixing effect explanation of contextualization.

      Based upon the increased overlap between adjacent index finger keypresses (i.e. – “4-4” transition), we also reasoned that the decoder tasked with separating individual index finger keypresses into two distinct classes based upon sequence position, should show decreased performance as typing speed increases. However, Figure 4C in our manuscript shows that this is not the case. The 2-class hybrid classifier actually displays improved classification performance over early practice trials despite greater temporal overlap. Again, this is inconsistent with the idea that the contextualization effect simply reflects increased mixing of individual keypress features.

      In summary, both re-examination of previously reported data and new control analyses all converged on the idea that the proximity between keypresses does not explain contextualization.

      We do agree with the Reviewer that the naturalistic, generative, self-paced task employed in the present study results in overlapping brain processes related to planning, execution, evaluation and memory of the action sequence. We also agree that there are several tradeoffs to consider in the construction of the classifiers depending on the study aim. Given our aim of optimizing keypress decoder accuracy in the present study, the set of trade-offs resulted in representations reflecting more the latter three processes, and less so the planning component. Whether separate decoders can be constructed to tease apart the representations or networks supporting these overlapping processes is an important future direction of research in this area. For example, work presently underway in our lab constrains the selection of windowing parameters in a manner that allows individual classifiers to be temporally linked to specific planning, execution, evaluation or memory-related processes to discern which brain networks are involved and how they adaptively reorganize with learning. Results from the present study (Figure 4—figure supplement 2) showing hybrid-space decoder prediction accuracies exceeding 74% for temporal windows spanning as little as 25ms and located up to 100ms prior to the KeyDown event strongly support the feasibility of such an approach.

      Related to the above point, testing only one particular sequence (4-1-3-2-4), aside from the control ones, limits the generalizability of the finding. This also may have contributed to the extremely high decoding accuracy reported in the current study.

      The Reviewer raises a question about the generalizability of the decoder accuracy reported in our study. Fortunately, a comparison between decoder performances on Day 1 and Day 2 datasets does provide insight into this issue. As the Reviewer points out, the classifiers in this study were trained and tested on keypresses performed while practicing a specific sequence (4-1-3-2-4). The study was designed this way as to avoid the impact of interference effects on learning dynamics. The cross-validated performance of classifiers on MEG data collected within the same session was 90.47% overall accuracy (4-class; Figure 3C). We then tested classifier performance on data collected during a separate MEG session conducted approximately 24 hours later (Day 2; see Figure 3 — figure supplement 3). We observed a reduction in overall accuracy rate to 87.11% when tested on MEG data recorded while participants performed the same learned sequence, and 79.44% when they performed several previously unpracticed sequences. Both changes in accuracy are important with regards to the generalizability of our findings. First, 87.11% performance accuracy for the trained sequence data on Day 2 (a reduction of only 3.36%) indicates that the hybrid-space decoder performance is robust over multiple MEG sessions, and thus, robust to variations in SNR across the MEG sensor array caused by small differences in head position between scans. This indicates a substantial advantage over sensor-space decoding approaches. Furthermore, when tested on data from unpracticed sequences, overall performance dropped an additional 7.67%. This difference reflects the performance bias of the classifier for the trained sequence, possibly caused by high-order sequence structure being incorporated into the feature weights. In the future, it will be important to understand in more detail how random or repeated keypress sequence training data impacts overall decoder performance and generalization. We strongly agree with the Reviewer that the issue of generalizability is extremely important and have added a new paragraph to the Discussion in the revised manuscript highlighting the strengths and weaknesses of our study with respect to this issue.

      In terms of clinical BCI, one of the potential relevance of the study, as claimed by the authors, it is not clear that the specific time window chosen in the current study (up to 200 msec since key press onset) is really useful. In most cases, clinical BCI would target neural signals with no overt movement execution due to patients' inability to move (e.g., Hochberg et al., 2012). Given the time window, the surprisingly high performance of the current decoder may result from sensory feedback and/or planning of subsequent movement, which may not always be available in the clinical BCI context. Of course, the decoding accuracy is still much higher than chance even when using signal before the key press (as shown in Figure 4 Supplement 2), but it is not immediately clear to me that the authors relate their high decoding accuracy based on post-movement signal to clinical BCI settings.

      The Reviewer questions the relevance of the specific window parameters used in the present study for clinical BCI applications, particularly for paretic patients who are unable to produce finger movements or for whom afferent sensory feedback is no longer intact. We strongly agree with the Reviewer that any intended clinical application must carefully consider the specific input feature constraints dictated by the clinical cohort, and in turn impose appropriate and complimentary constraints on classifier parameters that may differ from the ones used in the present study. We now highlight this issue in the Discussion of the revised manuscript and relate our present findings to published clinical BCI work within this context.

      One of the important and fascinating claims of the current study is that the "contextualization" of individual finger movements in a trained sequence specifically occurs during short rest periods in very early skill learning, echoing the recent theory of micro-offline learning proposed by the authors' group. Here, I think two points need to be clarified. First, the concept of "contextualization" is kept somewhat blurry throughout the text. It is only at the later part of the Discussion (around line #330 on page 13) that some potential mechanism for the "contextualization" is provided as "what-and-where" binding. Still, it is unclear what "contextualization" actually is in the current data, as the MEG signal analyzed is extracted from 0-200 msec after the keypress. If one thinks something is contextualizing an action, that contextualization should come earlier than the action itself.

      The Reviewer requests that we: 1) more clearly define our use of the term “contextualization” and 2) provide the rationale for assessing it over a 200ms window aligned to the KeyDown event. This choice of window parameters means that the MEG activity used in our analysis was coincident with, rather than preceding, the actual keypresses. We define contextualization as the differentiation of representation for the identical movement embedded in different positions of a sequential skill. That is, representations of individual action elements progressively incorporate information about their relationship to the overall sequence structure as the skill is learned. We agree with the Reviewer that this can be appropriately interpreted as “what-and-where” binding. We now incorporate this definition in the Introduction of the revised manuscript as requested.

      The window parameters for optimizing accurate decoding individual finger movements were determined using a grid search of the parameter space (a sliding window of variable width between 25-350 ms with 25 ms increments variably aligned from 0 to +100ms with 10ms increments relative to the KeyDown event). This approach generated 140 different temporal windows for each keypress for each participant, with the final parameter selection determined through comparison of the resulting performance between each decoder. Importantly, the decision to optimize for decoding accuracy placed an emphasis on keypress representations characterized by the most consistent and robust features shared across subjects, which in turn maximize statistical power in detecting common learning-related changes. In this case, the optimal window encompassed a 200ms epoch aligned to the KeyDown event (t<sub>0</sub> = 0 ms). We then asked if the representations (i.e. – spatial patterns of combined parcel- and voxel-space activity) of the same digit at two different sequence positions changed with practice within this optimal decoding window. Of course, our findings do not rule out the possibility that contextualization can also be found before or even after this time window, as we did not directly address this issue in the present study. Future work in our lab, as pointed out above, are investigating contextualization within different time windows tailored specifically for assessing sequence skill action planning, execution, evaluation and memory processes.

      The second point is that the result provided by the authors is not yet convincing enough to support the claim that "contextualization" occurs during rest. In the original analysis, the authors presented the statistical significance regarding the correlation between the "offline" pattern differentiation and micro-offline skill gain (Figure 5. Supplement 1), as well as the larger "offline" distance than "online" distance (Figure 5B). However, this analysis looks like regressing two variables (monotonically) increasing as a function of the trial. Although some information in this analysis, such as what the independent/dependent variables were or how individual subjects were treated, was missing in the Methods, getting a statistically significant slope seems unsurprising in such a situation. Also, curiously, the same quantitative evidence was not provided for its "online" counterpart, and the authors only briefly mentioned in the text that there was no significant correlation between them. It may be true looking at the data in Figure 5A as the online representation distance looks less monotonically changing, but the classification accuracy presented in Figure 4C, which should reflect similar representational distance, shows a more monotonic increase up to the 11th trial. Further, the ways the "online" and "offline" representation distance was estimated seem to make them not directly comparable. While the "online" distance was computed using all the correct press data within each 10 sec of execution, the "offline" distance is basically computed by only two presses (i.e., the last index_OP5 vs. the first index_OP1 separated by 10 sec of rest). Theoretically, the distance between the neural activity patterns for temporally closer events tends to be closer than that between the patterns for temporally far-apart events. It would be fairer to use the distance between the first index_OP1 vs. the last index_OP5 within an execution period for "online" distance, as well.

      The Reviewer suggests that the current data is not enough to show that contextualization occurs during rest and raises two important concerns: 1) the relationship between online contextualization and micro-online gains is not shown, and 2) the online distance was calculated differently from its offline counterpart (i.e. - instead of calculating the distance between last Index<sub>OP5</sub> and first Index<sub>OP1</sub> from a single trial, the distance was calculated for each sequence within a trial and then averaged).

      We addressed the first concern by performing individual subject correlations between 1) contextualization changes during rest intervals and micro-offline gains; 2) contextualization changes during practice trials and micro-online gains, and 3) contextualization changes during practice trials and micro-offline gains (Figure 5 – figure supplement 4). We then statistically compared the resulting correlation coefficient distributions and found that within-subject correlations for contextualization changes during rest intervals and micro-offline gains were significantly higher than online contextualization and micro-online gains (t = 3.2827, p = 0.0015) and online contextualization and micro-offline gains (t = 3.7021, p = 5.3013e-04). These results are consistent with our interpretation that micro-offline gains are supported by contextualization changes during the inter-practice rest periods.

      With respect to the second concern, we agree with the Reviewer that one limitation of the analysis comparing online versus offline changes in contextualization as presented in the original manuscript, is that it does not eliminate the possibility that any differences could simply be explained by the passage of time (which is smaller for the online analysis compared to the offline analysis). The Reviewer suggests an approach that addresses this issue, which we have now carried out. When quantifying online changes in contextualization from the first Index<sub>OP1</sub> the last Index<sub>OP5</sub> keypress in the same trial we observed no learning-related trend (Figure 5 – figure supplement 5, right panel). Importantly, offline distances were significantly larger than online distances regardless of the measurement approach and neither predicted online learning (Figure 5 – figure supplement 6).

      A related concern regarding the control analysis, where individual values for max speed and the degree of online contextualization were compared (Figure 5 Supplement 3), is whether the individual difference is meaningful. If I understood correctly, the optimization of the decoding process (temporal window, feature inclusion/reduction, decoder, etc.) was performed for individual participants, and the same feature extraction was also employed for the analysis of representation distance (i.e., contextualization). If this is the case, the distances are individually differently calculated and they may need to be normalized relative to some stable reference (e.g., 1 vs. 4 or average distance within the control sequence presses) before comparison across the individuals.

      The Reviewer makes a good point here. We have now implemented the suggested normalization procedure in the analysis provided in the revised manuscript.

      Reviewer #3 (Public review):

      Summary:

      One goal of this paper is to introduce a new approach for highly accurate decoding of finger movements from human magnetoencephalography data via dimension reduction of a "multiscale, hybrid" feature space. Following this decoding approach, the authors aim to show that early skill learning involves "contextualization" of the neural coding of individual movements, relative to their position in a sequence of consecutive movements. Furthermore, they aim to show that this "contextualization" develops primarily during short rest periods interspersed with skill training and correlates with a performance metric which the authors interpret as an indicator of offline learning.

      Strengths:

      A clear strength of the paper is the innovative decoding approach, which achieves impressive decoding accuracies via dimension reduction of a "multi-scale, hybrid space". This hybrid-space approach follows the neurobiologically plausible idea of the concurrent distribution of neural coding across local circuits as well as large-scale networks. A further strength of the study is the large number of tested dimension reduction techniques and classifiers (though the manuscript reveals little about the comparison of the latter).

      We appreciate the Reviewer’s comments regarding the paper’s strengths.

      A simple control analysis based on shuffled class labels could lend further support to this complex decoding approach. As a control analysis that completely rules out any source of overfitting, the authors could test the decoder after shuffling class labels. Following such shuffling, decoding accuracies should drop to chance level for all decoding approaches, including the optimized decoder. This would also provide an estimate of actual chance-level performance (which is informative over and beyond the theoretical chance level). Furthermore, currently, the manuscript does not explain the huge drop in decoding accuracies for the voxel-space decoding (Figure 3B). Finally, the authors' approach to cortical parcellation raises questions regarding the information carried by varying dipole orientations within a parcel (which currently seems to be ignored?) and the implementation of the mean-flipping method (given that there are two dimensions - space and time - what do the authors refer to when they talk about the sign of the "average source", line 477?).

      The Reviewer recommends that we: 1) conduct an additional control analysis on classifier performance using shuffled class labels, 2) provide a more detailed explanation regarding the drop in decoding accuracies for the voxel-space decoding following LDA dimensionality reduction (see Fig 3B), and 3) provide additional details on how problems related to dipole solution orientations were addressed in the present study.

      In relation to the first point, we have now implemented a random shuffling approach as a control for the classification analyses. The results of this analysis indicated that the chance level accuracy was 22.12% (± SD 9.1%) for individual keypress decoding (4-class classification), and 18.41% (± SD 7.4%) for individual sequence item decoding (5-class classification), irrespective of the input feature set or the type of decoder used. Thus, the decoding accuracy observed with the final model was substantially higher than these chance levels.

      Second, please note that the dimensionality of the voxel-space feature set is very high (i.e. – 15684). LDA attempts to map the input features onto a much smaller dimensional space (number of classes – 1; e.g. – 3 dimensions, for 4-class keypress decoding). Given the very high dimension of the voxel-space input features in this case, the resulting mapping exhibits reduced accuracy. Despite this general consideration, please refer to Figure 3—figure supplement 3, where we observe improvement in voxel-space decoder performance when utilizing alternative dimensionality reduction techniques.

      The decoders constructed in the present study assess the average spatial patterns across time (as defined by the windowing procedure) in the input feature space. We now provide additional details in the Methods of the revised manuscript pertaining to the parcellation procedure and how the sign ambiguity problem was addressed in our analysis.

      Weaknesses:

      A clear weakness of the paper lies in the authors' conclusions regarding "contextualization". Several potential confounds, described below, question the neurobiological implications proposed by the authors and provide a simpler explanation of the results. Furthermore, the paper follows the assumption that short breaks result in offline skill learning, while recent evidence, described below, casts doubt on this assumption.

      We thank the Reviewer for giving us the opportunity to address these issues in detail (see below).

      The authors interpret the ordinal position information captured by their decoding approach as a reflection of neural coding dedicated to the local context of a movement (Figure 4). One way to dissociate ordinal position information from information about the moving effectors is to train a classifier on one sequence and test the classifier on other sequences that require the same movements, but in different positions (Kornysheva et al., 2019). In the present study, however, participants trained to repeat a single sequence (4-1-3-2-4). As a result, ordinal position information is potentially confounded by the fixed finger transitions around each of the two critical positions (first and fifth press). Across consecutive correct sequences, the first keypress in a given sequence was always preceded by a movement of the index finger (=last movement of the preceding sequence), and followed by a little finger movement. The last keypress, on the other hand, was always preceded by a ring finger movement, and followed by an index finger movement (=first movement of the next sequence). Figure 4 - Supplement 2 shows that finger identity can be decoded with high accuracy (>70%) across a large time window around the time of the key press, up to at least +/-100 ms (and likely beyond, given that decoding accuracy is still high at the boundaries of the window depicted in that figure). This time window approaches the keypress transition times in this study. Given that distinct finger transitions characterized the first and fifth keypress, the classifier could thus rely on persistent (or "lingering") information from the preceding finger movement, and/or "preparatory" information about the subsequent finger movement, in order to dissociate the first and fifth keypress. Currently, the manuscript provides no evidence that the context information captured by the decoding approach is more than a by-product of temporally extended, and therefore overlapping, but independent neural representations of consecutive keypresses that are executed in close temporal proximity - rather than a neural representation dedicated to context.

      Such temporal overlap of consecutive, independent finger representations may also account for the dynamics of "ordinal coding"/"contextualization", i.e., the increase in 2-class decoding accuracy, across Day 1 (Figure 4C). As learning progresses, both tapping speed and the consistency of keypress transition times increase (Figure 1), i.e., consecutive keypresses are closer in time, and more consistently so. As a result, information related to a given keypress is increasingly overlapping in time with information related to the preceding and subsequent keypresses. The authors seem to argue that their regression analysis in Figure 5 - Figure Supplement 3 speaks against any influence of tapping speed on "ordinal coding" (even though that argument is not made explicitly in the manuscript). However, Figure 5 - Figure Supplement 3 shows inter-individual differences in a between-subject analysis (across trials, as in panel A, or separately for each trial, as in panel B), and, therefore, says little about the within-subject dynamics of "ordinal coding" across the experiment. A regression of trial-by-trial "ordinal coding" on trial-by-trial tapping speed (either within-subject or at a group-level, after averaging across subjects) could address this issue. Given the highly similar dynamics of "ordinal coding" on the one hand (Figure 4C), and tapping speed on the other hand (Figure 1B), I would expect a strong relationship between the two in the suggested within-subject (or group-level) regression. Furthermore, learning should increase the number of (consecutively) correct sequences, and, thus, the consistency of finger transitions. Therefore, the increase in 2-class decoding accuracy may simply reflect an increasing overlap in time of increasingly consistent information from consecutive keypresses, which allows the classifier to dissociate the first and fifth keypress more reliably as learning progresses, simply based on the characteristic finger transitions associated with each. In other words, given that the physical context of a given keypress changes as learning progresses - keypresses move closer together in time and are more consistently correct - it seems problematic to conclude that the mental representation of that context changes. To draw that conclusion, the physical context should remain stable (or any changes to the physical context should be controlled for).

      The issues raised by Reviewer #3 here are similar to two issues raised by Reviewer #2 above. We agree they must both be carefully considered in any evaluation of our findings.

      As both Reviewers pointed out, the classifiers in this study were trained and tested on keypresses performed while practicing a specific sequence (4-1-3-2-4). The study was designed this way as to avoid the impact of interference effects on learning dynamics. The cross-validated performance of classifiers on MEG data collected within the same session was 90.47% overall accuracy (4class; Figure 3C). We then tested classifier performance on data collected during a separate MEG session conducted approximately 24 hours later (Day 2; see Figure 3—supplement 3). We observed a reduction in overall accuracy rate to 87.11% when tested on MEG data recorded while participants performed the same learned sequence, and 79.44% when they performed several previously unpracticed sequences. This classification performance difference of 7.67% when tested on the Day 2 data could reflect the performance bias of the classifier for the trained sequence, possibly caused by mixed information from temporally close keypresses being incorporated into the feature weights.

      Along these same lines, both Reviewers also raise the possibility that an increase in “ordinal coding/contextualization” with learning could simply reflect an increase in this mixing effect caused by faster typing speeds as opposed to an actual change in the underlying neural representation. The basic idea is that as correct sequences are generated at higher and higher speeds over training, MEG activity patterns related to the planning, execution, evaluation and memory of individual keypresses overlap more in time. Thus, increased overlap between the “4” and “1” keypresses (at the start of the sequence) and “2” and “4” keypresses (at the end of the sequence) could artefactually increase contextualization distances even if the underlying neural representations for the individual keypresses remain unchanged (assuming this mixing of representations is used by the classifier to differentially tag each index finger press). If this were the case, it follows that such mixing effects reflecting the ordinal sequence structure would also be observable in the distribution of decoder misclassifications. For example, “4” keypresses would be more likely to be misclassified as “1” or “2” keypresses (or vice versa) than as “3” keypresses. The confusion matrices presented in Figures 3C and 4B and Figure 3—figure supplement 3A in the previously submitted manuscript do not show this trend in the distribution of misclassifications across the four fingers.

      Following this logic, it’s also possible that if the ordinal coding is largely driven by this mixing effect, the increased overlap between consecutive index finger keypresses during the 4-4 transition marking the end of one sequence and the beginning of the next one could actually mask contextualization-related changes to the underlying neural representations and make them harder to detect. In this case, a decoder tasked with separating individual index finger keypresses into two distinct classes based upon sequence position might show decreased performance with learning as adjacent keypresses overlapped in time with each other to an increasing extent. However, Figure 4C in our previously submitted manuscript does not support this possibility, as the 2-class hybrid classifier displays improved classification performance over early practice trials despite greater temporal overlap.

      As noted in the above reply to Reviewer #2, we also conducted a new multivariate regression analysis to directly assess whether the neural representation distance score could be predicted by the 4-1, 2-4 and 4-4 keypress transition times observed for each complete correct sequence (both predictor and response variables were z-score normalized within-subject). The results of this analysis affirmed that the possible alternative explanation put forward by the Reviewer is not supported by our data (Adjusted R<sup>2</sup> = 0.00431; F = 5.62). We now include this new negative control analysis result in the revised manuscript.

      Finally, the Reviewer hints that one way to address this issue would be to compare MEG responses before and after learning for sequences typed at a fixed speed. However, given that the speed-accuracy trade-off should improve with learning, a comparison between unlearned and learned skill states would dictate that the skill be evaluated at a very low fixed speed. Essentially, such a design presents the problem that the post-training test is evaluating the representation in the unlearned behavioral state that is not representative of the acquired skill. Thus, this approach would miss most learning effects on a task in which speed is the main learning metrics.

      A similar difference in physical context may explain why neural representation distances ("differentiation") differ between rest and practice (Figure 5). The authors define "offline differentiation" by comparing the hybrid space features of the last index finger movement of a trial (ordinal position 5) and the first index finger movement of the next trial (ordinal position 1). However, the latter is not only the first movement in the sequence but also the very first movement in that trial (at least in trials that started with a correct sequence), i.e., not preceded by any recent movement. In contrast, the last index finger of the last correct sequence in the preceding trial includes the characteristic finger transition from the fourth to the fifth movement. Thus, there is more overlapping information arising from the consistent, neighbouring keypresses for the last index finger movement, compared to the first index finger movement of the next trial. A strong difference (larger neural representation distance) between these two movements is, therefore, not surprising, given the task design, and this difference is also expected to increase with learning, given the increase in tapping speed, and the consequent stronger overlap in representations for consecutive keypresses. Furthermore, initiating a new sequence involves pre-planning, while ongoing practice relies on online planning (Ariani et al., eNeuro 2021), i.e., two mental operations that are dissociable at the level of neural representation (Ariani et al., bioRxiv 2023).

      The Reviewer argues that the comparison of last finger movement of a trial and the first in the next trial are performed in different circumstances and contexts. This is an important point and one we tend to agree with. For this task, the first sequence in a practice trial is pre-planned before the first keypress is performed. This occurs in a somewhat different context from the sequence iterations that follow, which involve temporally overlapping planning, execution and evaluation processes. The Reviewer is concerned about a difference in the temporal mixing effect issue raised above between the first and last keypresses performed in a trial. Please, note that since neural representations of individual actions are competitively queued during the pre-planning period in a manner that reflects the ordinal structure of the learned sequence (Kornysheva et al., 2019), mixing effects are most likely present also for the first keypress in a trial.

      Separately, the Reviewer suggests that contextualization during early learning may reflect preplanning or online planning. This is an interesting proposal. Given the decoding time-window used in this investigation, we cannot dissect separate contributions of planning, memory and sensory feedback to contextualization. Taking advantage of the superior temporal resolution of MEG relative to fMRI tools, work under way in our lab is investigating decoding time-windows more appropriate to address each of these questions.

      Given these differences in the physical context and associated mental processes, it is not surprising that "offline differentiation", as defined here, is more pronounced than "online differentiation". For the latter, the authors compared movements that were better matched regarding the presence of consistent preceding and subsequent keypresses (online differentiation was defined as the mean difference between all first vs. last index finger movements during practice). It is unclear why the authors did not follow a similar definition for "online differentiation" as for "micro-online gains" (and, indeed, a definition that is more consistent with their definition of "offline differentiation"), i.e., the difference between the first index finger movement of the first correct sequence during practice, and the last index finger of the last correct sequence. While these two movements are, again, not matched for the presence of neighbouring keypresses (see the argument above), this mismatch would at least be the same across "offline differentiation" and "online differentiation", so they would be more comparable.

      This is the same point made earlier by Reviewer #2, and we agree with this assessment. As stated in the response to Reviewer #2 above, we have now carried out quantification of online contextualization using this approach and included it in the revised manuscript. We thank the Reviewer for this suggestion.

      A further complication in interpreting the results regarding "contextualization" stems from the visual feedback that participants received during the task. Each keypress generated an asterisk shown above the string on the screen, irrespective of whether the keypress was correct or incorrect. As a result, incorrect (e.g., additional, or missing) keypresses could shift the phase of the visual feedback string (of asterisks) relative to the ordinal position of the current movement in the sequence (e.g., the fifth movement in the sequence could coincide with the presentation of any asterisk in the string, from the first to the fifth). Given that more incorrect keypresses are expected at the start of the experiment, compared to later stages, the consistency in visual feedback position, relative to the ordinal position of the movement in the sequence, increased across the experiment. A better differentiation between the first and the fifth movement with learning could, therefore, simply reflect better decoding of the more consistent visual feedback, based either on the feedback-induced brain response, or feedback-induced eye movements (the study did not include eye tracking). It is not clear why the authors introduced this complicated visual feedback in their task, besides consistency with their previous studies.

      We strongly agree with the Reviewer that eye movements related to task engagement are important to rule out as a potential driver of the decoding accuracy or contextualizaton effect. We address this issue above in response to a question raised by Reviewer #1 about the impact of movement related artefacts on our findings.

      First, the assumption the Reviewer makes here about the distribution of errors in this task is incorrect. On average across subjects, 2.32% ± 1.48% (mean ± SD) of all keypresses performed were errors, which were evenly distributed across the four possible keypress responses. While errors increased progressively over practice trials, they did so in proportion to the increase in correct keypresses, so that the overall ratio of correct-to-incorrect keypresses remained stable over the training session. Thus, the Reviewer’s assumptions that there is a higher relative frequency of errors in early trials, and a resulting systematic trend phase shift differences between the visual display updates (i.e. – a change in asterisk position above the displayed sequence) and the keypress performed is not substantiated by the data. To the contrary, the asterisk position on the display and the keypress being executed remained highly correlated over the entire training session. We now include a statement about the frequency and distribution of errors in the revised manuscript.

      Given this high correlation, we firmly agree with the Reviewer that the issue of eye movement related artefacts is still an important one to address. Fortunately, we did collect eye movement data during the MEG recordings so were able to investigate this. As detailed in the response to Reviewer #1 above, we found that gaze positions and eye-movement velocity time-locked to visual display updates (i.e. – a change in asterisk position above the displayed sequence) did not reflect the asterisk location above chance levels (Overall cross-validated accuracy = 0.21817; see Author response image 1). Furthermore, an inspection of the eye position data revealed that most participants on most trials displayed random walk gaze patterns around a center fixation point, indicating that participants did not attend to the asterisk position on the display. This is consistent with intrinsic generation of the action sequence, and congruent with the fact that the display does not provide explicit feedback related to performance. As pointed out above, a similar real-world example would be manually inputting a long password into a secure online application. In this case, one intrinsically generates the sequence from memory and receives similar feedback about the password sequence position (also provided as asterisks), which is typically ignored by the user.

      The minimal participant engagement with the visual display in this explicit sequence learning motor task (which is highly generative in nature) contrasts markedly with behavior observed when reactive responses to stimulus cues are needed in the serial reaction time task (SRTT). This is a crucial difference that must be carefully considered when comparing findings across studies using the two sequence learning tasks.

      The authors report a significant correlation between "offline differentiation" and cumulative microoffline gains. However, it would be more informative to correlate trial-by-trial changes in each of the two variables. This would address the question of whether there is a trial-by-trial relation between the degree of "contextualization" and the amount of micro-offline gains - are performance changes (micro-offline gains) less pronounced across rest periods for which the change in "contextualization" is relatively low? Furthermore, is the relationship between micro-offline gains and "offline differentiation" significantly stronger than the relationship between micro-offline gains and "online differentiation"?

      In response to a similar issue raised above by Reviewer #2, we now include new analyses comparing correlation magnitudes between (1) “online differentiation” vs micro-online gains, (2) “online differentiation” vs micro-offline gains and (3) “offline differentiation” and micro-offline gains (see Figure 5 – figure supplement  4, 5 and 6). These new analyses and results have been added to the revised manuscript. Once again, we thank both Reviewers for this suggestion.

      The authors follow the assumption that micro-offline gains reflect offline learning.

      We disagree with this statement. The original (Bonstrup et al., 2019) paper clearly states that micro-offline gains do not necessarily reflect offline learning in some cases and must be carefully interpreted based upon the behavioral context within which they are observed. Further, the paper lays out the conditions under which one can have confidence that micro-offline gains reflect offline learning. In fact, the excellent meta-analysis of (Pan & Rickard, 2015), which re-interprets the benefits of sleep in overnight skill consolidation from a “reactive inhibition” perspective, was a crucial resource in the experimental design of our initial study (Bonstrup et al., 2019), as well as in all our subsequent work. Pan & Rickard state:

      “Empirically, reactive inhibition refers to performance worsening that can accumulate during a period of continuous training (Hull, 1943 . It tends to dissipate, at least in part, when brief breaks are inserted between blocks of training. If there are multiple performance-break cycles over a training session, as in the motor sequence literature, performance can exhibit a scalloped effect, worsening during each uninterrupted performance block but improving across blocks(Brawn et al., 2010; Rickard et al., 2008 . Rickard, Cai, Rieth, Jones, and Ard (2008 and Brawn, Fenn, Nusbaum, and Margoliash (2010 (Brawn et al., 2010; Rickard et al., 2008 demonstrated highly robust scalloped reactive inhibition effects using the commonly employed 30 s–30 s performance break cycle, as shown for Rickard et al.’s (2008 massed practice sleep group in Figure 2. The scalloped effect is evident for that group after the first few 30 s blocks of each session. The absence of the scalloped effect during the first few blocks of training in the massed group suggests that rapid learning during that period masks any reactive inhibition effect.”

      Crucially, Pan & Rickard make several concrete recommendations for reducing the impact of the reactive inhibition confound on offline learning studies. One of these recommendations was to reduce practice times to 10s (most prior sequence learning studies up until that point had employed 30s long practice trials). They state:

      “The traditional design involving 30 s-30 s performance break cycles should be abandoned given the evidence that it results in a reactive inhibition confound, and alternative designs with reduced performance duration per block used instead (Pan & Rickard, 2015 . One promising possibility is to switch to 10 s performance durations for each performance-break cycle Instead (Pan & Rickard, 2015 . That design appears sufficient to eliminate at least the majority of the reactive inhibition effect (Brawn et al., 2010; Rickard et al., 2008 .”

      We mindfully incorporated recommendations from (Pan & Rickard, 2015) into our own study designs including 1) utilizing 10s practice trials and 2) constraining our analysis of micro-offline gains to early learning trials (where performance monotonically increases and 95% of overall performance gains occur), which are prior to the emergence of the “scalloped” performance dynamics that are strongly linked to reactive inhibition effects.

      However, there is no direct evidence in the literature that micro-offline gains really result from offline learning, i.e., an improvement in skill level.

      We strongly disagree with the Reviewer’s assertion that “there is no direct evidence in the literature that micro-offline gains really result from offline learning, i.e., an improvement in skill level.” The initial (Bonstrup et al., 2019) report was followed up by a large online crowd-sourcing study (Bonstrup et al., 2020). This second (and much larger) study provided several additional important findings supporting our interpretation of micro-offline gains in cases where the important behavioral conditions clarified above were met (see Author response image 4 below for further details on these conditions).

      Author response image 4.

      This Figure shows that micro-offline gains o ser ed in learning and nonlearning contexts are attri uted to different underl ing causes. Micro-offline and online changes relative to overall trial-by-trial learning. This figure is based on data from (Bonstrup et al., 2019). During early learning, micro-offline gains (red bars) closely track trial-by-trial performance gains (green line with open circle markers), with minimal contribution from micro-online gains (blue bars). The stated conclusion in Bönstrup et al. (2019) is that micro-offline gains only during this Early Learning stage reflect rapid memory consolidation (see also (Bonstrup et al., 2020)). After early learning, about practice trial 11, skill plateaus. This plateau skill period is characterized by a striking emergence of coupled (and relatively stable) micro-online drops and micro-offline increases. Bönstrup et al. (2019) as well as others in the literature (Brooks et al., 2024; Gupta & Rickard, 2022; Florencia Jacobacci et al., 2020), argue that micro-offline gains during the plateau period likely reflect recovery from inhibitory performance factors such as reactive inhibition or fatigue, and thus must be excluded from analyses relating micro-offline gains to skill learning. The Non-repeating groups in Experiments 3 and 4 from Das et al. (2024) suffer from a lack of consideration of these known confounds (end of Fig legend).

      Evidence documented in that paper (Bonstrup et al., 2020) showed that micro-offline gains during early skill learning were: 1) replicable and generalized to subjects learning the task in their daily living environment (n=389); 2) equivalent when significantly shortening practice period duration, thus confirming that they are not a result of recovery from performance fatigue (n=118); 3) reduced (along with learning rates) by retroactive interference applied immediately after each practice period relative to interference applied after passage of time (n=373), indicating stabilization of the motor memory at a microscale of several seconds consistent with rapid consolidation; and 4) not modified by random termination of the practice periods, ruling out a contribution of predictive motor slowing (N = 71) (Bonstrup et al., 2020). Altogether, our findings were strongly consistent with the interpretation that micro-offline gains reflect memory consolidation supporting early skill learning. This is precisely the portion of the learning curve (Pan & Rickard, 2015) refer to when they state “…rapid learning during that period masks any reactive inhibition effect”.

      This interpretation is further supported by brain imaging evidence linking known memory-related networks and consolidation mechanisms to micro-offline gains. First, we reported that the density of fast hippocampo-neocortical skill memory replay events increases approximately three-fold during early learning inter-practice rest periods with the density explaining differences in the magnitude of micro-offline gains across subjects (Buch et al., 2021). Second, Jacobacci et al. (2020) independently reproduced our original behavioral findings and reported BOLD fMRI changes in the hippocampus and precuneus (regions also identified in our MEG study (Buch et al., 2021)) linked to micro-offline gains during early skill learning. These functional changes were coupled with rapid alterations in brain microstructure in the order of minutes, suggesting that the same network that operates during rest periods of early learning undergoes structural plasticity over several minutes following practice (Deleglise et al., 2023). Crucial to this point, Chen et al. (2024) and Sjøgård et al (2024) provided direct evidence from intracranial EEG in humans linking sharp-wave ripple density during rest periods (which are known markers for neural replay (Buzsaki, 2015)) in the human hippocampus (80-120 Hz) to micro-offline gains during early skill learning.

      Thus, there is now substantial converging evidence in humans across different indirect noninvasive and direct invasive recording techniques linking hippocampal activity, neural replay dynamics and offline performance gains in skill learning.

      On the contrary, recent evidence questions this interpretation (Gupta & Rickard, npj Sci Learn 2022; Gupta & Rickard, Sci Rep 2024; Das et al., bioRxiv 2024). Instead, there is evidence that micro-offline gains are transient performance benefits that emerge when participants train with breaks, compared to participants who train without breaks, however, these benefits vanish within seconds after training if both groups of participants perform under comparable conditions (Das et al., bioRxiv 2024).

      The recent work of (Gupta & Rickard, 2022, 2024) does not present any data that directly opposes our finding that early skill learning (Bonstrup et al., 2019) is expressed as micro-offline gains during rest breaks. These studies are an extension of the Rickard et al (2008) paper that employed a massed (30s practice followed by 30s breaks) vs spaced (10s practice followed by 10s breaks) experimental design to assess if recovery from reactive inhibition effects could account for performance gains measured after several minutes or hours. Gupta & Rickard (2022) added two additional groups (30s practice/10s break and 10s practice/10s break as used in the work from our group). The primary aim of the study was to assess whether it was more likely that changes in performance when retested 5 minutes after skill training (consisting of 12 practice trials for the massed groups and 36 practice trials for the spaced groups) had ended reflected memory consolidation effects or recovery from reactive inhibition effects. The Gupta & Rickard (2024) follow-up paper employed a similar design with the primary difference being that participants performed a fixed number of sequences on each trial as opposed to trials lasting a fixed duration. This was done to facilitate the fitting of a quantitative statistical model to the data.

      To reiterate, neither study included any analysis of micro-online or micro-offline gains and did not include any comparison focused on skill gains during early learning trials (only at retest 5 min later). Instead, Gupta & Rickard (2022), reported evidence for reactive inhibition effects for all groups over much longer training periods than early learning. In fact, we reported the same findings for trials following the early learning period in our original 2019 paper (Bonstrup et al., 2019) (Author response image 4). Please, note that we also reported that cumulative microoffline gains over early learning did not correlate with overnight offline consolidation measured 24 hours later (Bonstrup et al., 2019) (see the Results section and further elaboration in the Discussion). We interpreted these findings as indicative that the mechanisms underlying offline gains over the micro-scale of seconds during early skill learning versus over minutes or hours very likely differ.

      In the recent preprint from (Das et al., 2024), the authors make the strong claim that “micro-offline gains during early learning do not reflect offline learning” which is not supported by their own data. The authors hypothesize that if “micro-offline gains represent offline learning, participants should reach higher skill levels when training with breaks, compared to training without breaks”. The study utilizes a spaced vs. massed practice groups between-subjects design inspired by the reactive inhibition work from Rickard and others to test this hypothesis.

      Crucially, their design incorporates only a small fraction of the training used in other investigations to evaluate early skill learning (Bonstrup et al., 2020; Bonstrup et al., 2019; Brooks et al., 2024; Buch et al., 2021; Deleglise et al., 2023; F. Jacobacci et al., 2020; Mylonas et al., 2024). A direct comparison between the practice schedule designs for the spaced and massed groups in Das et al., and the training schedule all participants experienced in the original Bönstrup et al. (2019) paper highlights this issue as well as several others (Author response image 5):

      Author response image 5.

      This figure shows (A) Comparison of Das et al. Spaced & Massed group training session designs, and the training session design from the original (Bonstrup et al., 2019) paper. Similar to the approach taken by Das et al., all practice is visualized as 10-second practice trials with a variable number (either 0, 1 or 30) of 10-second-long inter-practice rest intervals to allow for direct comparisons between designs. The two key takeaways from this comparison are that (1) the intervention differences (i.e. – practice schedules) between the Massed and Spaced groups from the Das et al. report are extremely small (less than 12% of the overall session schedule) (gaps in the red shaded area) and (2) the overall amount of practice is much less than compared to the design from the original Bönstrup report (Bonstrup et al., 2019) (which has been utilized in several subsequent studies). (B) Group-level learning curve data from Bönstrup et al. (2019) (Bonstrup et al., 2019) is used to estimate the performance range accounted for by the equivalent periods covering Test 1, Training 1 and Test 2 from Das et al (2024). Note that the intervention in the Das et al. study is limited to a period covering less than 50% of the overall learning range (end of figure legend).

      Participants in the original (Bonstrup et al., 2019) experienced 157.14% more practice time and 46.97% less inter-practice rest time than the Spaced group in the Das et al. study (Author response image 5). Thus, the overall amount of practice and rest differ substantially between studies, with much more limited training occurring for participants in Das et al.

      In addition, the training interventions (i.e. – the practice schedule differences between the Spaced and Massed groups) were designed in a manner that minimized any chance of effectively testing their hypothesis. First, the interventions were applied over an extremely short period relative to the length of the total training session (5% and 12% of the total training session for Massed and Spaced groups, respectively; see gaps in the red shaded area in Author response image 5). Second, the intervention was applied during a period in which only half of the known total learning occurs. Specifically, we know from Bönstrup et al. (2019) that only 46.57% of the total performance gains occur in the practice interval covered by Das et al Training 1 intervention. Thus, early skill learning as evaluated by multiple groups (Bonstrup et al., 2020; Bonstrup et al., 2019; Brooks et al., 2024; Buch et al., 2021; Deleglise et al., 2023; F. Jacobacci et al., 2020; Mylonas et al., 2024), is in the Das et al experiment amputated to about half.

      Furthermore, a substantial amount of learning takes place during Das et al’s Test 1 and Test 2 periods (32.49% of total gains combined). The fact that substantial learning is known to occur over both the Test 1 (18.06%) and Test 2 (14.43%) intervals presents a fundamental problem described by Pan and Rickard (Pan & Rickard, 2015). They reported that averaging over intervals where substantial performance gains occur (i.e. – performance is not stable) inject crucial artefacts into analyses of skill learning:

      “A large amount of averaging has the advantage of yielding more precise estimates of each subject’s pretest and posttest scores and hence more statistical power to detect a performance gain. However, calculation of gain scores using that strategy runs the risk that learning that occurs during the pretest and (or posttest periods (i.e., online learning is incorporated into the gain score (Rickard et al., 2008; Robertson et al., 2004 .”

      The above statement indicates that the Test 1 and Test 2 performance scores from Das et al. (2024) are substantially contaminated by the learning rate within these intervals. This is particularly problematic if the intervention design results in different Test 2 learning rates between the two groups. This in fact, is apparent in their data (Figure 1C,E of the Das et al., 2024 preprint) as the Test 2 learning rate for the Spaced group is negative (indicating a unique interference effect observable only for this group). Specifically, the Massed group continues to show an increase in performance during Test 2 and 4 relative to the last 10 seconds of practice during Training 1 and 2, respectively, while the Spaced group displays a marked decrease. This post-training performance decrease for the Spaced group is in stark contrast to the monotonic performance increases observed for both groups at all other time-points. One possible cause could be related to the structure of the Test intervals, which include 20 seconds of uninterrupted practice. For the Spaced group, this effectively is a switch to a Massed practice environment (i.e., two 10-secondlong practice trials merged into one long trial), which interferes with greater Training 1 interval gains observed for the Space group. Interestingly, when statistical comparisons between the groups are made at the time-points when the intervention is present (Figure 1E) then the stated hypothesis, “If micro-offline gains represent offline learning, participants should reach higher skill levels when training with breaks, compared to training without breaks”, is confirmed.

      In summary, the experimental design and analyses used by Das et al does not contradict the view that early skill learning is expressed as micro-offline gains during rest breaks. The data presented by Gupta and Rickard (2022, 2024) and Das et al. (2024) is in many ways more confirmatory of the constraints employed by our group and others with respect to experimental design, analysis and interpretation of study findings, rather than contradictory. Still, it does highlight a limitation of the current micro-online/offline framework, which was originally only intended to be applied to early skill learning over spaced practice schedules when reactive inhibition effects are minimized (Bonstrup et al., 2019; Pan & Rickard, 2015). Extrapolation of this current framework to postplateau performance periods, longer timespans, or non-learning situations (e.g. – the Nonrepeating groups from Das et al. (2024)), when reactive inhibition plays a more substantive role, is not warranted. Ultimately, it will be important to develop new paradigms allowing one to independently estimate the different coincident or antagonistic features (e.g. - memory consolidation, planning, working memory and reactive inhibition) contributing to micro-online and micro-offline gains during and after early skill learning within a unifying framework.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) I found Figure 2B too small to be useful, as the actual elements of the cells are very hard to read.

      We have removed the grid colormap panel (top-right) from Figure 2B. All of this colormap data is actually a subset of data presented in Figure 2 – figure supplement 1, so can still be found there.

      Reviewer #2 (Recommendations for the authors):

      (1) Related to the first point in my concerns, I would suggest the authors compare decoding accuracy between correct presses followed by correct vs. incorrect presses. This would clarify if the decoder is actually taking the MEG signal for subsequent press into account. I would also suggest the authors use pre-movement MEG features and post-movement features with shorter windows and compare each result with the results for the original post-movement MEG feature with a longer window.

      The present study does not contain enough errors to perform the analysis proposed by the Reviewer. As noted above, we did re-examine our data and now report a new control regression analysis, all of which indicate that the proximity between keypresses does not explain contextualization effects.

      (2) I was several times confused by the author's use of "neural representation of an action" or "sequence action representations" in understanding whether these terms refer to representation on the level of whole-brain, region (as defined by the specific parcellation used), or voxels. In fact, what is submitted to the decoder is some complicated whole-brain MEG feature (i.e., the "neural representation"), which is a hybrid of voxel and parcel features that is further dimension-reduced and not immediately interpretable. Clarifying this point early in the text and possibly using some more sensible terms, such as adding "brain-wise" before the "sequence action representation", would be the most helpful for the readers.

      We now clarified this terminology in the revised manuscript.

      (3) Although comparing many different ways in feature selection/reduction, time window selection, and decoder types is undoubtedly a meticulous work, the current version of the manuscript seems still lacking some explanation about the details of these methodological choices, like which decoding method was actually used to report the accuracy, whether or not different decoding methods were chosen for individual participants' data, how training data was selected (is it all of the correct presses in Day 1 data?), whether the frequency power or signal amplitude was used, and so on. I would highly appreciate these additional details in the Methods section.

      The reported accuracies were based on linear discriminant analysis classifier. A comparison of different decoders (Figure 3 – figure supplement 4) shows LDA was the optimal choice.

      Whether or not different decoding methods were chosen for individual participants' data

      We selected the same decoder (LDA) performance to report the final accuracy.

      How training data was selected (is it all of the correct presses in Day 1 data?),

      Decoder training was conducted as a randomized split of the data (all correct keypresses of Day 1) into training (90%) and test (10%) samples for 8 iterations.

      Whether the frequency power or signal amplitude was used

      Signal amplitude was used for feature calculation.

      (4) In terms of the Methods, please consider adding some references about the 'F1 score', the 'feature importance score,' and the 'MRMR-based feature ranking,' as the main readers of the current paper would not be from the machine learning community. Also, why did the LDA dimensionality reduction reduce accuracy specifically for the voxel feature?

      We have now added the following statements to the Methods section that provide more detailed descriptions and references for these metrics:

      “The F1 score, defined as the harmonic mean of the precision (percentage of true predictions that are actually true positive) and recall (percentage of true positives that were correctly predicted as true) scores, was used as a comprehensive metric for all one-versus-all keypress state decoders to assess class-wise performance that accounts for both false-positive and false-negative prediction tendencies [REF]. A weighted mean F1 score was then computed across all classes to assess the overall prediction performance of the multi-class model.”

      and

      “Feature Importance Scores

      The relative contribution of source-space voxels and parcels to decoding performance (i.e. – feature importance score) was calculated using minimum redundant maximum relevance (MRMR) and highlighted in topography plots. MRMR, an approach that combines both relevance and redundancy metrics, ranked individual features based upon their significance to the target variable (i.e. – keypress state identity) prediction accuracy and their non-redundancy with other features.”

      As stated in the Reviewer responses above, the dimensionality of the voxel-space feature set is very high (i.e. – 15684). LDA attempts to map the input features onto a much smaller dimensional space (number of classes-1; e.g. – 3 dimensions for 4-class keypress decoding). It is likely that the reduction in accuracy observed only for the voxel-space feature was due to the loss of relevant information during the mapping process that resulted in reduced accuracy. This reduction in accuracy for voxel-space decoding was specific to LDA. Figure 3—figure supplement 3 shows that voxel-space decoder performance actually improved when utilizing alternative dimensionality reduction techniques.

      (5) Paragraph 9, lines #139-142: "Notably, decoding associated with index finger keypresses (executed at two different ordinal positions in the sequence) exhibited the highest number of misclassifications of all digits (N = 141 or 47.5% of all decoding errors; Figure 3C), raising the hypothesis that the same action could be differentially represented when executed at different learning state or sequence context locations."

      This does not seem to be a fair comparison, as the index finger appears twice as many as the other fingers do in the sequence. To claim this, proper statistical analysis needs to be done taking this difference into account.

      We thank the Reviewer for bringing this issue to our attention. We have now corrected this comparison to evaluate relative false negative and false positive rates between individual keypress state decoders, and have revised this statement in the manuscript as follows:

      “Notably, decoding of index finger keypresses (executed at two different ordinal positions in the sequence) exhibited the highest false negative (0.116 per keypress) and false positive (0.043 per keypress) misclassification rates compared with all other digits (false negative rate range = [0.067 0.114]; false positive rate range = [0.020 0.037]; Figure 3C), raising the hypothesis that the same action could be differentially represented when executed within different contexts (i.e. - different learning states or sequence locations).”

      (6) Finally, the authors could consider acknowledging in the Discussion that the contribution of micro-offline learning to genuine skill learning is still under debate (e.g., Gupta and Rickard, 2023; 2024; Das et al., bioRxiv, 2024).

      We have added a paragraph in the Discussion that addresses this point.

      Reviewer #3 (Recommendations for the authors):

      In addition to the additional analyses suggested in the public review, I have the following suggestions/questions:

      (1) Given that the authors introduce a new decoding approach, it would be very helpful for readers to see a distribution of window sizes and window onsets eventually used across individuals, at least for the optimized decoder.

      We have now included a new supplemental figure (Figure 4 – figure Supplement 2) that provides this information.

      (2) Please explain in detail how you arrived at the (interpolated?) group-level plot shown in Figure 1B, starting from the discrete single-trial keypress transition times. Also, please specify what the shading shows.

      Instantaneous correct sequence speed (skill measure) was quantified as the inverse of time (in seconds) required to complete a single iteration of a correctly generated full 5-item sequence. Individual keypress responses were labeled as members of correct sequences if they occurred within a 5-item response pattern matching any possible circular shifts of the 5-item sequence displayed on the monitor (41324). This approach allowed us to quantify a measure of skill within each practice trial at the resolution of individual keypresses. The dark line indicates the group mean performance dynamics for each trial. The shaded region indicates the 95% confidence limit of the mean (see Methods).

      (3) Similarly, please explain how you arrived at the group-level plot shown in Figure 1C. What are the different colored lines (rows) within each trial? How exactly did the authors reach the conclusion that KTT variability stabilizes by trial 6?

      Figure 1C provides additional information to the correct sequence speed measure above, as it also tracks individual transition speed composition over learning. Figure 1C, thus, represents both changes in overall correct sequence speed dynamics (indicated by the overall narrowing of the horizontal speed lines moving from top to bottom) and the underlying composition of the individual transition patterns within and across trials. The coloring of the lines is a shading convention used to discriminate between different keypress transitions. These curves were sampled with 1ms resolution, as in Figure 1B. Addressing the underlying keypress transition patterns requires within-subject normalization before averaging across subjects. The distribution of KTTs was normalized to the median correct sequence time for each participant and centered on the mid-point for each full sequence iteration during early learning.

      (4) Maybe I missed it, but it was not clear to me which of the tested classifiers was eventually used. Or was that individualized as well? More generally, a comparison of the different classifiers would be helpful, similar to the comparison of dimension reduction techniques.

      We have now included a new supplemental figure that provides this information.

      (5) Please add df and effect sizes to all statistics.

      Done.

      (6) Please explain in more detail your power calculation.

      The study was powered to determine the minimum sample size needed to detect a significant change in skill performance following training using a one-sample t-test (two-sided; alpha = 0.05; 95% statistical power; Cohen’s D effect size = 0.8115 calculated from previously acquired data in our lab). The calculated minimum sample size was 22. The included study sample size (n = 27) exceeded this minimum.

      This information is now included in the revised manuscript.

      (7) The cut-off for the high-pass filter is unusually high and seems risky in terms of potential signal distortions (de Cheveigne, Neuron 2019). Why did the authors choose such a high cut-off?

      The 1Hz high-pass cut-off frequency for the 1-150Hz band-pass filter applied to the continuous raw MEG data during preprocessing has been used in multiple previous MEG publications (Barratt et al., 2018; Brookes et al., 2012; Higgins et al., 2021; Seedat et al., 2020; Vidaurre et al., 2018).

      (8) "Furthermore, the magnitude of offline contextualization predicted skill gains while online contextualization did not", lines 336/337 - where is that analysis?

      Additional details pertaining to this analysis are now provided in the Results section (Figure 5 – figure supplement 4).

      (9) How were feature importance scores computed?

      We have now added a new subheading in the Methods section with a more detailed description of how feature importance scores were computed.

      (10)  Please add x and y ticks plus tick labels to Figure 5 - Figure Supplement 3, panel A

      Done

      (11) Line 369, what does "comparable" mean in this context?

      The sentence in the “Study Participants” part of the Methods section referred to here has now been revised for clarity.

      (12) In lines 496/497, please specify what t=0 means (KeyDown event, I guess?).

      Yes, the KeyDown event occurs at t = 0. This has now been clarified in the revised manuscript.

      (13) Please specify consistent boundaries between alpha- and beta-bands (they are currently not consistent in the Results vs. Methods (14/15 Hz or 15/16 Hz)).

      We thank the Reviewer for alerting us to this discrepancy caused by a typographic error in the Methods. We have now corrected this so that the alpha (8-14 Hz) and beta-band (15-24 Hz) frequency limits are described consistently throughout the revised manuscript.

      References

      Albouy, G., Fogel, S., King, B. R., Laventure, S., Benali, H., Karni, A., Carrier, J., Robertson, E. M., & Doyon, J. (2015). Maintaining vs. enhancing motor sequence memories: respective roles of striatal and hippocampal systems. Neuroimage, 108, 423-434. https://doi.org/10.1016/j.neuroimage.2014.12.049

      Albouy, G., King, B. R., Maquet, P., & Doyon, J. (2013). Hippocampus and striatum: dynamics and interaction during acquisition and sleep-related motor sequence memory consolidation. Hippocampus, 23(11), 985-1004. https://doi.org/10.1002/hipo.22183 Albouy, G., Sterpenich, V., Vandewalle, G., Darsaud, A., Gais, S., Rauchs, G., Desseilles, M., Boly, M., Dang-Vu, T., Balteau, E., Degueldre, C., Phillips, C., Luxen, A., & Maquet, P. (2012). Neural correlates of performance variability during motor sequence acquisition. NeuroImage, 60(1), 324-331. https://doi.org/10.1016/j.neuroimage.2011.12.049

      Andersen, R. A., & Buneo, C. A. (2002). Intentional maps in posterior parietal cortex. Annu Rev Neurosci, 25, 189-220. https://doi.org/10.1146/annurev.neuro.25.112701.142922 112701.142922 [pii]

      Ashe, J., Lungu, O. V., Basford, A. T., & Lu, X. (2006). Cortical control of motor sequences. Curr Opin Neurobiol, 16(2), 213-221. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citati on&list_uids=16563734

      Bansal, A. K., Vargas-Irwin, C. E., Truccolo, W., & Donoghue, J. P. (2011). Relationships among low-frequency local field potentials, spiking activity, and three-dimensional reach and grasp kinematics in primary motor and ventral premotor cortices. J Neurophysiol, 105(4), 1603-1619. https://doi.org/10.1152/jn.00532.2010

      Barratt, E. L., Francis, S. T., Morris, P. G., & Brookes, M. J. (2018). Mapping the topological organisation of beta oscillations in motor cortex using MEG. NeuroImage, 181, 831-844. https://doi.org/10.1016/j.neuroimage.2018.06.041

      Bassett, D. S., Wymbs, N. F., Porter, M. A., Mucha, P. J., Carlson, J. M., & Grafton, S. T. (2011). Dynamic reconfiguration of human brain networks during learning. Proc Natl Acad Sci U S A, 108(18), 7641-7646. https://doi.org/10.1073/pnas.1018985108

      Battaglia-Mayer, A., & Caminiti, R. (2019). Corticocortical Systems Underlying High-Order Motor Control. J Neurosci, 39(23), 4404-4421. https://doi.org/10.1523/JNEUROSCI.2094-18.2019

      Berlot, E., Popp, N. J., & Diedrichsen, J. (2020). A critical re-evaluation of fMRI signatures of motor sequence learning. Elife, 9. https://doi.org/10.7554/eLife.55241

      Bonstrup, M., Iturrate, I., Hebart, M. N., Censor, N., & Cohen, L. G. (2020). Mechanisms of offline motor learning at a microscale of seconds in large-scale crowdsourced data. NPJ Sci Learn, 5, 7. https://doi.org/10.1038/s41539-020-0066-9

      Bonstrup, M., Iturrate, I., Thompson, R., Cruciani, G., Censor, N., & Cohen, L. G. (2019). A Rapid Form of Offline Consolidation in Skill Learning. Curr Biol, 29(8), 1346-1351 e1344. https://doi.org/10.1016/j.cub.2019.02.049

      Brawn, T. P., Fenn, K. M., Nusbaum, H. C., & Margoliash, D. (2010). Consolidating the effects of waking and sleep on motor-sequence learning. J Neurosci, 30(42), 13977-13982. https://doi.org/10.1523/JNEUROSCI.3295-10.2010

      Brookes, M. J., Woolrich, M. W., & Barnes, G. R. (2012). Measuring functional connectivity in MEG: a multivariate approach insensitive to linear source leakage. NeuroImage, 63(2), 910-920. https://doi.org/10.1016/j.neuroimage.2012.03.048

      Brooks, E., Wallis, S., Hendrikse, J., & Coxon, J. (2024). Micro-consolidation occurs when learning an implicit motor sequence, but is not influenced by HIIT exercise. NPJ Sci Learn, 9(1), 23. https://doi.org/10.1038/s41539-024-00238-6

      Buch, E. R., Claudino, L., Quentin, R., Bonstrup, M., & Cohen, L. G. (2021). Consolidation of human skill linked to waking hippocampo-neocortical replay. Cell Rep, 35(10), 109193. https://doi.org/10.1016/j.celrep.2021.109193

      Buneo, C. A., & Andersen, R. A. (2006). The posterior parietal cortex: sensorimotor interface for the planning and online control of visually guided movements. Neuropsychologia, 44(13), 2594-2606. https://doi.org/10.1016/j.neuropsychologia.2005.10.011

      Buzsaki, G. (2015). Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning. Hippocampus, 25(10), 1073-1188. https://doi.org/10.1002/hipo.22488

      Chen, P.-C., Stritzelberger, J., Walther, K., Hamer, H., & Staresina, B. P. (2024). Hippocampal ripples during offline periods predict human motor sequence learning. bioRxiv, 2024.2010.2006.614680. https://doi.org/10.1101/2024.10.06.614680

      Churchland, M. M., Cunningham, J. P., Kaufman, M. T., Foster, J. D., Nuyujukian, P., Ryu, S. I., & Shenoy, K. V. (2012). Neural population dynamics during reaching. Nature, 487(7405), 51-56. https://doi.org/10.1038/nature11129

      Classen, J., Liepert, J., Wise, S. P., Hallett, M., & Cohen, L. G. (1998). Rapid plasticity of human cortical movement representation induced by practice. J Neurophysiol, 79(2), 1117-1123. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citati on&list_uids=9463469

      Colclough, G. L., Brookes, M. J., Smith, S. M., & Woolrich, M. W. (2015). A symmetric multivariate leakage correction for MEG connectomes. NeuroImage, 117, 439-448. https://doi.org/10.1016/j.neuroimage.2015.03.071

      Colclough, G. L., Woolrich, M. W., Tewarie, P. K., Brookes, M. J., Quinn, A. J., & Smith, S. M. (2016). How reliable are MEG resting-state connectivity metrics? NeuroImage, 138, 284-293. https://doi.org/10.1016/j.neuroimage.2016.05.070

      Das, A., Karagiorgis, A., Diedrichsen, J., Stenner, M.-P., & Azanon, E. (2024). “Micro-offline gains” convey no benefit for motor skill learning. bioRxiv, 2024.2007.2011.602795. https://doi.org/10.1101/2024.07.11.602795

      Deleglise, A., Donnelly-Kehoe, P. A., Yeffal, A., Jacobacci, F., Jovicich, J., Amaro, E., Jr., Armony, J. L., Doyon, J., & Della-Maggiore, V. (2023). Human motor sequence learning drives transient changes in network topology and hippocampal connectivity early during memory consolidation. Cereb Cortex, 33(10), 6120-6131. https://doi.org/10.1093/cercor/bhac489

      Doyon, J., Bellec, P., Amsel, R., Penhune, V., Monchi, O., Carrier, J., Lehéricy, S., & Benali, H. (2009). Contributions of the basal ganglia and functionally related brain structures to motor learning. [Review]. Behavioural brain research, 199(1), 61-75. https://doi.org/10.1016/j.bbr.2008.11.012

      Doyon, J., Song, A. W., Karni, A., Lalonde, F., Adams, M. M., & Ungerleider, L. G. (2002). Experience-dependent changes in cerebellar contributions to motor sequence learning. Proc Natl Acad Sci U S A, 99(2), 1017-1022. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citati on&list_uids=11805340

      Euston, D. R., Gruber, A. J., & McNaughton, B. L. (2012). The role of medial prefrontal cortex in memory and decision making. Neuron, 76(6), 1057-1070. https://doi.org/10.1016/j.neuron.2012.12.002

      Euston, D. R., Tatsuno, M., & McNaughton, B. L. (2007). Fast-forward playback of recent memory sequences in prefrontal cortex during sleep. Science, 318(5853), 1147-1150. https://doi.org/10.1126/science.1148979

      Flint, R. D., Ethier, C., Oby, E. R., Miller, L. E., & Slutzky, M. W. (2012). Local field potentials allow accurate decoding of muscle activity. J Neurophysiol, 108(1), 18-24. https://doi.org/10.1152/jn.00832.2011

      Frankland, P. W., & Bontempi, B. (2005). The organization of recent and remote memories. Nat Rev Neurosci, 6(2), 119-130. https://doi.org/10.1038/nrn1607

      Gais, S., Albouy, G., Boly, M., Dang-Vu, T. T., Darsaud, A., Desseilles, M., Rauchs, G., Schabus, M., Sterpenich, V., Vandewalle, G., Maquet, P., & Peigneux, P. (2007). Sleep transforms the cerebral trace of declarative memories. Proc Natl Acad Sci U S A, 104(47), 1877818783. https://doi.org/10.1073/pnas.0705454104

      Grafton, S. T., Mazziotta, J. C., Presty, S., Friston, K. J., Frackowiak, R. S., & Phelps, M. E. (1992). Functional anatomy of human procedural learning determined with regional cerebral blood flow and PET. J Neurosci, 12(7), 2542-2548.

      Grover, S., Wen, W., Viswanathan, V., Gill, C. T., & Reinhart, R. M. G. (2022). Long-lasting, dissociable improvements in working memory and long-term memory in older adults with repetitive neuromodulation. Nat Neurosci, 25(9), 1237-1246. https://doi.org/10.1038/s41593-022-01132-3

      Gupta, M. W., & Rickard, T. C. (2022). Dissipation of reactive inhibition is sufficient to explain post-rest improvements in motor sequence learning. NPJ Sci Learn, 7(1), 25. https://doi.org/10.1038/s41539-022-00140-z

      Gupta, M. W., & Rickard, T. C. (2024). Comparison of online, offline, and hybrid hypotheses of motor sequence learning using a quantitative model that incorporate reactive inhibition. Sci Rep, 14(1), 4661. https://doi.org/10.1038/s41598-024-52726-9

      Hardwick, R. M., Rottschy, C., Miall, R. C., & Eickhoff, S. B. (2013). A quantitative metaanalysis and review of motor learning in the human brain. NeuroImage, 67, 283-297. https://doi.org/10.1016/j.neuroimage.2012.11.020

      Heusser, A. C., Poeppel, D., Ezzyat, Y., & Davachi, L. (2016). Episodic sequence memory is supported by a theta-gamma phase code. Nat Neurosci, 19(10), 1374-1380. https://doi.org/10.1038/nn.4374

      Higgins, C., Liu, Y., Vidaurre, D., Kurth-Nelson, Z., Dolan, R., Behrens, T., & Woolrich, M. (2021). Replay bursts in humans coincide with activation of the default mode and parietal alpha networks. Neuron, 109(5), 882-893 e887. https://doi.org/10.1016/j.neuron.2020.12.007

      Hikosaka, O., Nakamura, K., Sakai, K., & Nakahara, H. (2002). Central mechanisms of motor skill learning. Curr Opin Neurobiol, 12(2), 217-222. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citati on&list_uids=12015240

      Jacobacci, F., Armony, J. L., Yeffal, A., Lerner, G., Amaro, E., Jr., Jovicich, J., Doyon, J., & Della-Maggiore, V. (2020). Rapid hippocampal plasticity supports motor sequence learning. Proc Natl Acad Sci U S A, 117(38), 23898-23903. https://doi.org/10.1073/pnas.2009576117

      Jacobacci, F., Armony, J. L., Yeffal, A., Lerner, G., Amaro Jr, E., Jovicich, J., Doyon, J., & DellaMaggiore, V. (2020). Rapid hippocampal plasticity supports motor sequence learning.

      Proceedings of the National Academy of Sciences, 117(38), 23898-23903. Karni, A., Meyer, G., Jezzard, P., Adams, M. M., Turner, R., & Ungerleider, L. G. (1995). Functional MRI evidence for adult motor cortex plasticity during motor skill learning. Nature, 377(6545), 155-158. https://doi.org/10.1038/377155a0

      Kennerley, S. W., Sakai, K., & Rushworth, M. F. (2004). Organization of action sequences and the role of the pre-SMA. J Neurophysiol, 91(2), 978-993. https://doi.org/10.1152/jn.00651.2003 00651.2003 [pii]

      Kleim, J. A., Barbay, S., & Nudo, R. J. (1998). Functional reorganization of the rat motor cortex following motor skill learning. J Neurophysiol, 80, 3321-3325.

      Kornysheva, K., Bush, D., Meyer, S. S., Sadnicka, A., Barnes, G., & Burgess, N. (2019). Neural Competitive Queuing of Ordinal Structure Underlies Skilled Sequential Action. Neuron, 101(6), 1166-1180 e1163. https://doi.org/10.1016/j.neuron.2019.01.018

      Lee, S. H., Jin, S. H., & An, J. (2019). The difference in cortical activation pattern for complex motor skills: A functional near- infrared spectroscopy study. Sci Rep, 9(1), 14066. https://doi.org/10.1038/s41598-019-50644-9

      Lisman, J. E., & Jensen, O. (2013). The theta-gamma neural code. Neuron, 77(6), 1002-1016. https://doi.org/10.1016/j.neuron.2013.03.007

      Mollazadeh, M., Aggarwal, V., Davidson, A. G., Law, A. J., Thakor, N. V., & Schieber, M. H. (2011). Spatiotemporal variation of multiple neurophysiological signals in the primary motor cortex during dexterous reach-to-grasp movements. J Neurosci, 31(43), 15531-15543. https://doi.org/10.1523/JNEUROSCI.2999-11.2011

      Molle, M., & Born, J. (2009). Hippocampus whispering in deep sleep to prefrontal cortex--for good memories? Neuron, 61(4), 496-498. https://doi.org/10.1016/j.neuron.2009.02.002

      Morris, R. G. M. (2006). Elements of a neurobiological theory of hippocampal function: the role of synaptic plasticity, synaptic tagging and schemas. [Review]. The European journal of neuroscience, 23(11), 2829-2846. https://doi.org/10.1111/j.1460-9568.2006.04888.x

      Mylonas, D., Schapiro, A. C., Verfaellie, M., Baxter, B., Vangel, M., Stickgold, R., & Manoach, D. S. (2024). Maintenance of Procedural Motor Memory across Brief Rest Periods Requires the Hippocampus. J Neurosci, 44(14). https://doi.org/10.1523/JNEUROSCI.1839-23.2024

      Pan, S. C., & Rickard, T. C. (2015). Sleep and motor learning: Is there room for consolidation? Psychol Bull, 141(4), 812-834. https://doi.org/10.1037/bul0000009

      Penhune, V. B., & Steele, C. J. (2012). Parallel contributions of cerebellar, striatal and M1 mechanisms to motor sequence learning. Behav. Brain Res., 226(2), 579-591. https://doi.org/10.1016/j.bbr.2011.09.044

      Qin, Y. L., McNaughton, B. L., Skaggs, W. E., & Barnes, C. A. (1997). Memory reprocessing in corticocortical and hippocampocortical neuronal ensembles. Philos Trans R Soc Lond B Biol Sci, 352(1360), 1525-1533. https://doi.org/10.1098/rstb.1997.0139

      Rickard, T. C., Cai, D. J., Rieth, C. A., Jones, J., & Ard, M. C. (2008). Sleep does not enhance motor sequence learning. J Exp Psychol Learn Mem Cogn, 34(4), 834-842. https://doi.org/10.1037/0278-7393.34.4.834

      Robertson, E. M., Pascual-Leone, A., & Miall, R. C. (2004). Current concepts in procedural consolidation. Nat Rev Neurosci, 5(7), 576-582. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citati on&list_uids=15208699

      Sawamura, D., Sakuraba, S., Suzuki, Y., Asano, M., Yoshida, S., Honke, T., Kimura, M., Iwase, Y., Horimoto, Y., Yoshida, K., & Sakai, S. (2019). Acquisition of chopstick-operation skills with the non-dominant hand and concomitant changes in brain activity. Sci Rep, 9(1), 20397. https://doi.org/10.1038/s41598-019-56956-0

      Schendan, H. E., Searl, M. M., Melrose, R. J., & Stern, C. E. (2003). An FMRI study of the role of the medial temporal lobe in implicit and explicit sequence learning. Neuron, 37(6), 1013-1025. https://doi.org/10.1016/s0896-6273(03)00123-5

      Seedat, Z. A., Quinn, A. J., Vidaurre, D., Liuzzi, L., Gascoyne, L. E., Hunt, B. A. E., O'Neill, G. C., Pakenham, D. O., Mullinger, K. J., Morris, P. G., Woolrich, M. W., & Brookes, M. J. (2020). The role of transient spectral 'bursts' in functional connectivity: A magnetoencephalography study. NeuroImage, 209, 116537. https://doi.org/10.1016/j.neuroimage.2020.116537

      Shadmehr, R., & Holcomb, H. H. (1997). Neural correlates of motor memory consolidation. Science, 277, 821-824.

      Sjøgård, M., Baxter, B., Mylonas, D., Driscoll, B., Kwok, K., Tolosa, A., Thompson, M., Stickgold, R., Vangel, M., Chu, C., & Manoach, D. S. (2024). Hippocampal ripples mediate motor learning during brief rest breaks in humans. bioRxiv. https://doi.org/10.1101/2024.05.02.592200

      Srinivas, S., Sarvadevabhatla, R. K., Mopuri, K. R., Prabhu, N., Kruthiventi, S. S. S., & Babu, R. V. (2016). A Taxonomy of Deep Convolutional Neural Nets for Computer Vision [Technology Report]. Frontiers in Robotics and AI, 2. https://doi.org/10.3389/frobt.2015.00036

      Sterpenich, V., Albouy, G., Darsaud, A., Schmidt, C., Vandewalle, G., Dang Vu, T. T., Desseilles, M., Phillips, C., Degueldre, C., Balteau, E., Collette, F., Luxen, A., & Maquet, P. (2009). Sleep promotes the neural reorganization of remote emotional memory. J Neurosci, 29(16), 5143-5152. https://doi.org/10.1523/JNEUROSCI.0561-09.2009

      Toni, I., Ramnani, N., Josephs, O., Ashburner, J., & Passingham, R. E. (2001). Learning arbitrary visuomotor associations: temporal dynamic of brain activity. Neuroimage, 14(5), 10481057. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citati on&list_uids=11697936

      Toni, I., Thoenissen, D., & Zilles, K. (2001). Movement preparation and motor intention. NeuroImage, 14(1 Pt 2), S110-117. https://doi.org/10.1006/nimg.2001.0841

      Tse, D., Langston, R. F., Kakeyama, M., Bethus, I., Spooner, P. A., Wood, E. R., Witter, M. P., & Morris, R. G. (2007). Schemas and memory consolidation. Science, 316(5821), 76-82. https://doi.org/10.1126/science.1135935

      van Kesteren, M. T., Fernandez, G., Norris, D. G., & Hermans, E. J. (2010). Persistent schemadependent hippocampal-neocortical connectivity during memory encoding and postencoding rest in humans. Proc Natl Acad Sci U S A, 107(16), 7550-7555. https://doi.org/10.1073/pnas.0914892107

      van Kesteren, M. T., Ruiter, D. J., Fernandez, G., & Henson, R. N. (2012). How schema and novelty augment memory formation. Trends Neurosci, 35(4), 211-219. https://doi.org/10.1016/j.tins.2012.02.001

      Vidaurre, D., Hunt, L. T., Quinn, A. J., Hunt, B. A. E., Brookes, M. J., Nobre, A. C., & Woolrich, M. W. (2018). Spontaneous cortical activity transiently organises into frequency specific phase-coupling networks. Nat Commun, 9(1), 2987. https://doi.org/10.1038/s41467-01805316-z

      Wagner, A. D., Schacter, D. L., Rotte, M., Koutstaal, W., Maril, A., Dale, A. M., Rosen, B. R., & Buckner, R. L. (1998). Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. [Comment]. Science (New York, N.Y.), 281(5380), 1188-1191. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=9712582 &retmode=ref&cmd=prlinks

      Wolpert, D. M., Goodbody, S. J., & Husain, M. (1998). Maintaining internal representations: the role of the human superior parietal lobe. Nat Neurosci, 1(6), 529-533. https://doi.org/10.1038/2245

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this manuscript, the authors investigate the role of microtubule dynamics and its effects on neuronal aging. Using C. elegans as a model, the authors investigate the role of evolutionarily conserved Hippo pathway in microtubule dynamics of touch receptor neurons (TRNs) in an age-dependent manner. Using genetic, molecular, behavioral, and pharmacological approaches, the authors show that age-dependent loss of microtubule dynamics might underlie structural and functional aging of TRNs. Further, the authors show that the Hippo pathway specifically functions in these neurons to regulate microtubule dynamics. Specifically, authors show that hyperactivation of YAP-1, a downstream component of the Hippo pathway that is usually inhibited by the kinase activity of the upstream components of the pathway, results in microtubule stabilization and that might underlie the structural and functional decline of TRNs with age. However, how the Hippo pathway regulates microtubule dynamics and neuronal aging was not investigated by the authors.

      Strengths:

      This is a well-conducted and well-controlled study, and the authors have used multiple approaches to address different questions.

      Weaknesses:

      There are no major weaknesses identified, except that the effect of the Hippo pathway seems to be specific to only a subset of neurons. I would like the authors to address the specificity of the effect of the Hippo pathway in TRNs, in their resubmission.

      Although our genetic experiments, including TRNs-specific rescue/overexpression of YAP-1 and knockdown of WTS-1, strongly suggest that a cell-autonomous function of WTS-1-YAP-1 axis in TRNs, the Hpo pathway could have broader roles in neuroprotection. While this pathway may regulate microtubules stability in multiple neurons, other characteristics of TRNs, such as their anatomical localization near the cuticle or their long projections along body axis, could contribute to their susceptibilities to age-related deformation. Otherwise, the Hpo pathway may be truly TRNs-specific. TRNs have unique microtubules in both terms of composition and structure. Among nine α-, six β-tubulin genes in C. elegans, one α-tubulin (mec-12) and one β-tubulin (mec-7) showed highly enriched expression in TRNs [1, 2] and TRNs contain special 15-protofilament microtubule structure, while all other neurons in C. elegans have 11-protofilament microtubules [3]. Transcriptional regulation through YAP-1 may affect the specific microtubule structure of TRNs, leading to premature neuronal deformation. We have included this in the discussion section of the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      This study examines a novel role of the Hpo signaling pathway, specifically of wts-1/LATS and the downstream regulator of gene expression, yap, in age-related neurodegeneration in C. elegans touch-responsive mechanosensory neurons, ALM and PLM. The study shows that knockdown or deletion of wts-1/LATS causes age-associated morphological abnormalities of these neurons, accompanied by functional loss of touch responsiveness. This is further associated with enhanced, abnormal, microtubule stabilization in these neurons.

      Strengths:

      This study examines a novel role of the Hpo signaling pathway, specifically of wts-1/LATS and the downstream regulator of gene expression, yap, in age-related neurodegeneration in C. elegans touch-responsive mechanosensory neurons, ALM and PLM. The study shows that knockdown or deletion of wts-1/LATS causes age-associated morphological abnormalities of these neurons, accompanied by functional loss of touch responsiveness. This is further associated with enhanced, abnormal, microtubule stabilization in these neurons. Strong pharmacological and especially genetic manipulations of MT-stabilizing or severing proteins show a strong genetic link between yap and regulation of MTs stability. The study is strong and uses robust approaches, especially strong genetics. The demonstrations on the aging-related roles of the Hpo signaling pathway, and the link to MTs, are novel and compelling. Nevertheless, the study also has mechanistic weaknesses (see below).

      Weaknesses:

      Specific comments:

      (1) The study demonstrates age-specific roles of the Hpo pathway, specifically of wts-1/LATS and yap, specifically in TRN mechanosensory neurons, without observing developmental defects in these neurons, or effects in other neurons. This is a strong demonstration. Nevertheless, the study does not address whether there is a correlation of Hpo signaling pathway activity decline specifically in these neurons, and not other neurons, and at the observed L4 stage and onwards (including the first day of adulthood, 1DA stage). Such demonstrations of spatio-temporal regulation of the Hpo signaling pathway and its activation seem important for linking the Hpo pathway with the observed age-related neurodegeneration. Can this age-related response be correlated to indeed a decline in Hpo signaling during adulthood? Especially at L4 and onwards? It will be informative to measure this by examining the decline in wts1 as well as yap levels and yap nuclear localization.

      As described above, we have included possible explanations for the specificity of the Hpo pathway in TRNs. Since components of the Hpo pathway are expressed in various tissues, including the intestine and hypodermis, this pathway could have broader neuroprotective roles across multiple neurons. Alternatively, it could function in TRNs. Given that the TRNs possess unique microtubules in both structure and composition, and that Hpo pathway has crucial roles in microtubule stability regulation, the roles of the Hpo pathway may indeed be TRNs-specific. As we described in the manuscript, our observations, along with those of others, indicate that neuronal deformation of TRNs begins around the 4th day of adulthood. Additionally, the degree of morphological deformation in wts-1 mutants at the L4 stage is comparable to that of aged wild-type worms on the 15th day of adulthood. Therefore, to assess the functional decline of WTS-1 or nuclear localization of YAP-1, observations should begin in 4-day-old animals. Using fluorescence-tagged YAP-1 under the mec-4 promoter, we couldn’t detect a significant increase in nuclear YAP-1 in TRNs of 4-day-old adult. Additionally, we were unable to assess YAP-1 intercellular localization in older animals, such as 10-day-old animals, possibly due to the small cell size of neurons or morphological alteration along with aging of TRNs. Although we did not detect functional decline of WTS-1 or increased nuclear YAP-1 in TRNs, nuclear localization of YAP-1 increases with age in other tissues, such as the intestine and hypodermis (Author response image. 1). This may result from inactivation of the Hippo (Hpo) pathway, an indirect consequence of structural and functional decline—such as tissue stiffness associated with aging—or a combination of both. Additionally, given that morphological deformation of TRNs appears to begin around fourth day of adulthood, nuclear localization of YAP-1 in the intestine and hypodermis seems to have a later onset and be more moderate. It is possible that YAP-1 nuclear localization in TRNs occurs earlier or that other factors contribute early-stage touch neuronal deformation.

      Author response image 1.

      Quantification of the proportion of worms exhibiting nuclear localization of YAP-1. We used GFP-tagged YAP-1 driven by its own 4 kb promoter. A total of 90 animals were observed each day.

      (2) The Hpo pathway eventually activates gene expression via yap. Although the study uses robust genetic manipulations of yap and wts-1/LATS, it is not clear whether the observed effects are attributed to yap-mediated regulation of gene expression (see 3).

      Given that the neuronal deformation in the wts-1 mutant was completely restored by the loss of yap-1 or egl-44, it strongly suggests that YAP-TEAD-mediated transcriptional regulation is responsible for the premature neuronal degeneration of the wts-1 mutant. However, in this study, we were unable to identify specific transcriptional target genes associated with these phenomena, which represents a limitation of our research (please see below).

      (3) The observations on the abnormal MT stabilization, and the subsequent genetic examinations of MT-stability/severing genes, are a significant strength of the study. Nevertheless, despite the strong genetic links to yap and wts-1/LATS, it is not clear whether MT-regulatory genes are regulated by transcription downstream of the Hpo pathway, thus not enabling a strong causal link between MT regulation and Hpo-mediated gene expression, making this strong part of the study mechanistically circumstantial. Specifically, it will be good to examine whether the genes addressed herein, for example, Spastin, are transcriptionally regulated downstream of the Hpo pathway. This comment is augmented by the finding that in the wts-1/ yap-1 double mutants, MT abnormality, and subsequent neuronal morphology and touch responses are restored, clearly indicating that there is an associated transcriptional regulation

      If the target genes of YAP-1 are not identified, it will be difficult to fully understand how YAP-1 regulates microtubule stability. Microtubule-stabilizing genes, whose knockdown alleviates wts-1 mutant neuronal deformation, could be potential transcriptional targets of YAP-1. Among these genes, PTRN-1 and DLK-1 contain MCAT sequences (CATTCCA/T), a well-conserved DNA motif recognized by the TEAD transcription factor, in their promoters near the transcription start site (TSS). We hypothesized that the expression of fluorescence-tagged reporters of promoter regions containing these MCAT sequences would be enhanced in the absence of wts-1 activity. Although both reporters were expressed in TRNs, they did not show significant changes in the wts-1 mutant background. We also focused on spv-1, a worm homolog of ARHGAP29, which negatively regulates RhoA. YAP is known to modulate actin cytoskeleton rigidity through transcriptional regulation of ARHGAP29 [4]. The promoter of spv-1 contains 2 MCAT sequences and loss of spv-1 mitigated neuronal deformation of the wts-1 mutant. However, reporters of promoter regions containing MCAT sequences only weakly expressed in the process of TRNs. More importantly, ectopic expression of dominant-negative form of rho-1/rhoA did not lead to significant deformation of TRNs. While YAP typically functions as a transcriptional co-activator, it has also been reported to repress target gene expression, such as DDIT4 and Trail, in collaborated with TEAD transcriptional factor [5].  As a reviewer pointed out, spas-1 might be transcriptionally repressed by yap-1, given that its loss leads to premature deformation of TRNs. However, since the phenotype of the spas-1 mutant has a later onset than the wts-1 mutant and is relatively restricted to ALM, we excluded it from our candidate gene search. Despite extensive genetic approaches, we were unable to establish a strong causal link between YAP-1 and the regulation of microtubule stability. Unbiased screenings, such as tissue-specific transcriptome analysis, may help address the remaining questions. We have outlined the limitations of this study in the discussion section of the revised manuscript.

      Other comments:

      (1) The TRN-specific knockdown of wts-1 and yap-1 is a clear strength. Nevertheless, these do not necessarily show cell-autonomous effects, as the yap transcription factor may regulate the expression of external cues, secreted or otherwise, thus generating non-cell autonomous effects. For example, it is known that yap regulates TGF-beat expression and signaling.

      In the absence of LATS1/2 activity, activated YAP has been reported to drive biliary epithelial cell lineage specification by directly regulating TGF-β transcription during and after liver development [6]. Even when functioning in an autocrine manner, TGF-β can exhibit non-cell autonomous effects. While it primarily acts on the same cell that secretes it, some molecules may also affect neighboring cells, leading to paracrine effects. Additionally, TGF-β can modify the extracellular matrix (ECM), indirectly affecting surrounding cells. Similarly, if YAP regulates transcription of secretory protein in TRNs, the resulting extracellular factors or surrounding cells may influence touch neuronal microtubules in a non-cell-autonomous manner. Although our genetic data strongly suggest a cell-autonomous function of WTS-1-YAP-1 in TRNs, we could not exclude the possibility that YAP-1 functions non-cell-autonomously, as we were unable to identify its transcriptional targets. We have included this in the discussion section of the revised manuscript.

      (2) Continuing from comment (3) above, it seems that many of the MT-regulators chosen here for genetic examinations were chosen based on demonstrated roles in neurodegeneration in other studies. It would be good to show whether these MT-associated genes are directly regulated by transcription by the Hpo pathway.

      As we described above, several MT-associated genes­­, such as ptrn-1, dlk-1 and spv-1, contain MCAT sequences in their promoter and their knockdown alleviated wts-1-induced neuronal deformation. These genes were tested to determine whether they were directly regulated by WTS-1-YAP-1. Based on our findings, we concluded that they were unlikely to be regulated by the Hpo pathway in TRNs.

      (3) The impairment of the touch response may not be robust: it is only a 30-40% reduction at L4, and even less reduction at 1DA. It would be good to offer possible explanations for this finding.

      As pointed out by the reviewer, the impairment of touch responses of wts-1 mutants showed an approximately 33% reduction at both L4 and 1DA compared to age-matched wild-type animals. At the L4 stage, control worms responded to nearly every gentle touch (94%), whereas wts-1 mutants responded to only 60% of stimuli. By 1DA, control worms exhibited slightly decline in touch responses compared to L4 (82.5%), whereas wts-1 mutants displayed more pronounced impairment (55.7%) (Fig 1E). Regarding the severity and frequency of structural degeneration of wts-1 mutant at both stages, it appears to be relatively moderate. As we noted in the manuscript, our observations, along with those of others, indicate that structural abnormalities in ALM and PLM neurons begin to appear around the fourth day of adulthood and progressively worsen as the worms age [7]. In a previous study, Tank et al. categorized day 10-aged worms into two groups based on their movement ability and then assessed structural deformation in each animal to determine whether structural and functional degeneration of TRNs were correlated. In this same group of animals, they examined the gentle touch response and found that animals responded to gentle touch 46 ± 5.1 %, 84 ± 12.2 %, respectively [8]. It could be said that, on average, day 10 animals had 65% touch response on average, which is consistent with our observation in day 10 animals (Fig. 5E, 56.3%). Given these observations, the function of TRNs of wts-1 mutant or aged animals appears to be preserved despite severe structure failures. The gentle touch response evokes an escape behavior in which animals quickly move away from the stimulus; thus proper touch responses are essential for avoiding predators and ensuring survival. It has been reported to be necessary for evading fungal predation, such as escaping from a constricting hyphal ring [9]. Given that the gentle touch response is crucial for survival, its function is likely well preserved despite structural abnormalities, such as age-related deformation.

      Reviewer #1 (Recommendations for the authors):

      Major comments:

      (1) Why is the effect of the Hippo pathway on microtubule dynamics specific to TRNs? Is it the structure of TRNs that makes them prone to the effects of age-dependent decline in microtubule dynamics? The authors are advised to discuss it in their resubmission.

      As described above, we have included possible explanations for the tissue specificity of the Hpo pathway in TRNs and the vulnerability of TRNs to age-associated decline in the discussion section of the revised manuscript.

      (2) The authors are advised to explain the shorter life span of wts-1; yap-1 double mutants (with restored TRNs) compared to wts-1 single mutants in Figure 2F. The life span of yap-1 single mutants should be included in Figure 2F. Further, based on the data, the shorter lifespan of wts-1 mutants cannot be attributed to abnormal TRNs as the lifespan of wts-1; yap-1 double mutants is even shorter. The authors are advised to explain the shorter life span of wts-1 mutants compared to wild-type controls.

      wts-1 is known to be involved in various developmental processes, including the maintenance of apicobasal polarity in the intestine, growth rate control, and dauer formation [10-12]. Since WTS-1 activity is restored in the intestine of the mutant used for lifespan measurement, the shorter lifespan of the wts-1 mutant may result from the loss of WTS-1 in tissues other than the intestine. Although we were unable to include lifespan data for the yap-1 mutant, recent studies indicate that the yap-1(tm1416) mutant or yap-1 RNAi treated worms exhibit a shortened lifespan [13, 14]. Thus, our data showing a slightly shorter lifespan of the wts-1; yap-1 mutant compared with the wts-1 mutant may result from the synergistic action of yap-1 and yap-1-independent downstream factors of wts-1. While this study does not provide an explanation for the shortened lifespan of wts-1 or wts-1; yap-1 mutants, the fact that the wts-1; yap-1 double mutant with restored TRNs still have a shorter lifespan compared with the wts-1 mutant strongly suggests that premature deformation of the wts-1 neurons appear to be a touch neuron-specific event, rather than being associated with whole body, as described in the manuscript..

      Minor comments:

      (1) In the abstract, please provide definitions for LATS and YAP. Authors can mention that LATS is a kinase and YAP a transcriptional co-activator in the Hippo pathway.

      (2) In the last paragraph on page 9, change "these function" to "this function", and change "knock-downed" to "knocked down".

      (3) On page 10, paragraph 2, change "regarding the action mechanism" to "regarding the mechanism of action".

      (4) On page 11, paragraph 1, change "endogenous WTS-1 could inhibits" to "endogenous WTS-1 could inhibit".

      (5) On page 16, paragraph 1, change "consistent to the hypothesis" to "consistent with this hypothesis".

      (6) Overall, the paper is well written. However, there is still room to improve the language and diction used by the authors.

      We have revised all minor comments suggested by the reviewer in the revised manuscript.

      References

      (1) Hamelin M, Scott IM, Way JC, Culotti JG. The mec-7 beta-tubulin gene of Caenorhabditis elegans is expressed primarily in the touch receptor neurons. EMBO J. 1992;11(8):2885-93. Epub 1992/08/01. doi: 10.1002/j.1460-2075.1992.tb05357.x. PubMed PMID: 1639062; PubMed Central PMCID: PMCPMC556769.

      (2) Fukushige T, Siddiqui ZK, Chou M, Culotti JG, Gogonea CB, Siddiqui SS, et al. MEC-12, an alpha-tubulin required for touch sensitivity in C. elegans. J Cell Sci. 1999;112 ( Pt 3):395-403. Epub 1999/01/14. doi: 10.1242/jcs.112.3.395. PubMed PMID: 9885292.

      (3) Chalfie M, Thomson JN. Structural and functional diversity in the neuronal microtubules of Caenorhabditis elegans. J Cell Biol. 1982;93(1):15-23. Epub 1982/04/01. doi: 10.1083/jcb.93.1.15. PubMed PMID: 7068753; PubMed Central PMCID: PMCPMC2112106.

      (4) Qiao Y, Chen J, Lim YB, Finch-Edmondson ML, Seshachalam VP, Qin L, et al. YAP Regulates Actin Dynamics through ARHGAP29 and Promotes Metastasis. Cell Rep. 2017;19(8):1495-502. Epub 2017/05/26. doi: 10.1016/j.celrep.2017.04.075. PubMed PMID: 28538170.

      (5) Kim M, Kim T, Johnson RL, Lim DS. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Cell Rep. 2015;11(2):270-82. Epub 2015/04/07. doi: 10.1016/j.celrep.2015.03.015. PubMed PMID: 25843714.

      (6) Lee DH, Park JO, Kim TS, Kim SK, Kim TH, Kim MC, et al. LATS-YAP/TAZ controls lineage specification by regulating TGFbeta signaling and Hnf4alpha expression during liver development. Nat Commun. 2016;7:11961. Epub 2016/07/01. doi: 10.1038/ncomms11961. PubMed PMID: 27358050; PubMed Central PMCID: PMCPMC4931324.

      (7) Toth ML, Melentijevic I, Shah L, Bhatia A, Lu K, Talwar A, et al. Neurite sprouting and synapse deterioration in the aging Caenorhabditis elegans nervous system. J Neurosci. 2012;32(26):8778-90. Epub 2012/06/30. doi: 10.1523/JNEUROSCI.1494-11.2012. PubMed PMID: 22745480; PubMed Central PMCID: PMCPMC3427745.

      (8) Tank EM, Rodgers KE, Kenyon C. Spontaneous age-related neurite branching in Caenorhabditis elegans. J Neurosci. 2011;31(25):9279-88. Epub 2011/06/24. doi: 10.1523/JNEUROSCI.6606-10.2011. PubMed PMID: 21697377; PubMed Central PMCID: PMCPMC3148144.

      (9) Maguire SM, Clark CM, Nunnari J, Pirri JK, Alkema MJ. The C. elegans touch response facilitates escape from predacious fungi. Curr Biol. 2011;21(15):1326-30. Epub 2011/08/02. doi: 10.1016/j.cub.2011.06.063. PubMed PMID: 21802299; PubMed Central PMCID: PMCPMC3266163.

      (10) Cai Q, Wang W, Gao Y, Yang Y, Zhu Z, Fan Q. Ce-wts-1 plays important roles in Caenorhabditis elegans development. FEBS Lett. 2009;583(19):3158-64. Epub 2009/09/10. doi: 10.1016/j.febslet.2009.09.002. PubMed PMID: 19737560.

      (11) Kang J, Shin D, Yu JR, Lee J. Lats kinase is involved in the intestinal apical membrane integrity in the nematode Caenorhabditis elegans. Development. 2009;136(16):2705-15. Epub 20090715. doi: 10.1242/dev.035485. PubMed PMID: 19605499.

      (12) Lee H, Kang J, Ahn S, Lee J. The Hippo Pathway Is Essential for Maintenance of Apicobasal Polarity in the Growing Intestine of Caenorhabditis elegans. Genetics. 2019;213(2):501-15. Epub 20190729. doi: 10.1534/genetics.119.302477. PubMed PMID: 31358532; PubMed Central PMCID: PMCPMC6781910.

      (13) Teuscher AC, Statzer C, Goyala A, Domenig SA, Schoen I, Hess M, et al. Longevity interventions modulate mechanotransduction and extracellular matrix homeostasis in C. elegans. Nat Commun. 2024;15(1):276. Epub 2024/01/05. doi: 10.1038/s41467-023-44409-2. PubMed PMID: 38177158; PubMed Central PMCID: PMCPMC10766642.

      (14) Saul N, Dhondt I, Kuokkanen M, Perola M, Verschuuren C, Wouters B, et al. Identification of healthspan-promoting genes in Caenorhabditis elegans based on a human GWAS study. Biogerontology. 2022;23(4):431-52. Epub 2022/06/25. doi: 10.1007/s10522-022-09969-8. PubMed PMID: 35748965; PubMed Central PMCID: PMCPMC9388463.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Review:

      Reviewer #1 (Public review): 

      Summary: 

      Odor- and taste-sensing are mediated by two different systems, the olfactory and gustatory systems, and have different behavioral roles. In this study, Wei et al. challenge this dichotomy by showing that odors can activate gustatory receptor neurons (GRNs) in Drosophila to promote feeding responses, including the proboscis extension response (PER) that was previously thought to be driven only by taste. While previous studies suggested that odors can promote PER to appetitive tastants, Wei et al. go further to show that odors alone cause PER, this effect is mediated through sweet-sensing GRNs, and sugar receptors are required. The study also shows that odor detection by bitter-sensing GRNs suppresses PER. The authors' conclusions are supported by behavioral assays, calcium imaging, electrophysiological recordings, and genetic manipulations. The observation that both attractive and aversive odors promote PER leaves an open question as to why this effect is adaptive. Overall, the study sheds new light on chemosensation and multimodal integration by showing that odor and taste detection converge at the level of sensory neurons, a finding that is interesting and surprising while also being supported by another recent study (Dweck & Carlson, Sci Advances 2023).

      Strengths: 

      (1) The main finding that odors alone can promote PER by activating sweet-sensing GRNs is interesting and novel.

      (2) The study uses video tracking of the proboscis to quantify PER rather than manual scoring, which is typically used in the field. The tracking method is less subjective and provides a higherresolution readout of the behavior.

      (3) The study uses calcium imaging and electrophysiology to show that odors activate GRNs. These represent complementary techniques that measure activity at different parts of the GRN (axons versus dendrites, respectively) and strengthen the evidence for this conclusion. 

      (4) Genetic manipulations show that odor-evoked PER is primarily driven by sugar GRNs and sugar receptors rather than olfactory neurons. This is a major finding that distinguishes this work from previous studies of odor effects on PER and feeding (e.g., Reisenman & Scott, 2019; Shiraiwa, 2008) that assumed or demonstrated that odors were acting through olfactory neurons.

      We appreciate the reviewer’s positive assessment of the novelty and significance of our work.

      Weaknesses/Limitations: 

      (1) The authors may want to discuss why PER to odors alone has not been previously reported, especially as they argue that this is a broad effect evoked by many different odors. Previous studies testing the effect of odors on PER only observed odor enhancement of PER to sugar (Oh et al., 2021; Reisenman & Scott, 2019; Shiraiwa, 2008) and some of these studies explicitly show no effect of odor alone or odor with low sugar concentration; regardless, the authors likely would have noticed if PER to odor alone had occurred. Readers of this paper may also be aware of unpublished studies failing to observe an effect of PER on odor alone (including studies performed by this reviewer and unrelated work by other colleagues in the field), which of course the authors are not expected to directly address but may further motivate the authors to provide possible explanations.

      We appreciate the reviewer’s comment. We believe that the difference in genotype is likely the largest reason behind this point. This is because the strength varied widely across genotypes and was quite weak in some strains including commonly used w[1118] empty Gal4 and w[1118] empty spit Gal4 as shown in Figure1- figure supplement 3 (Figure S3 in original submission). However, given that we observed odor-evoked PER in various genotypes (many in main Figures and three in Figure1- figure supplement 3 including Drosophila simulans), the data illustrate that it is a general phenomenon in Drosophila. Indeed, although Oh et al. (2021) did not emphasize it in the text, their Fig. 1E showed that yeast odor evoked PER at a probability of 20%, which is much higher than the rate of spontaneous PER in many genotypes. Therefore, this literature may represent another support for the presence of odor-evoked PER. We have expanded our text in the Discussion to describe these issues.

      Another possibility is our use of DeepLabcut to quantitatively track the kinematics of proboscis movement, which may have facilitated the detection of PER.

      (2) Many of the odor effects on behavior or neuronal responses were only observed at very high concentrations. Most effects seemed to require concentrations of at least 10-2 (0.01 v/v), which is at the high end of the concentration range used in olfactory studies (e.g., Hallem et al., 2004), and most experiments in the paper used a far higher concentration of 0.5 v/v. It is unclear whether these are concentrations that would be naturally encountered by flies.

      We acknowledge that the concentrations used are on the higher side, suggesting that GRNs may need to be stimulated with relatively concentrated odors to induce PER. Although it is difficult to determine the naturalistic range of odor concentration, it is at least widely reported that olfactory neurons including olfactory receptor neurons and projection neurons do not saturate, and exhibit odor identity-dependent responses at the concentration of 10<sup>-2</sup> where odor-evoked PER can be observed. Furthermore, we have shown in Figure 6 that low concentration (10<sup>-4</sup>) of banana odor, ethyl butyrate, and 4-methycyclohexanol all significantly increased the rate of odor-taste multisensory PER even in olfactory organs-removed flies, suggesting that low concentration odors can influence feeding behavior via GRNs in a natural context where odors and tastants coexist at food sites. Finally, we note that odors were further diluted by a factor of 0.375 by mixing the odor stream with the main air stream before being applied to the flies as described in Methods.

      (3) The calcium imaging data showing that sugar GRNs respond to a broad set of odors contrasts with results from Dweck & Carlson (Sci Adv, 2023) who recorded sugar neurons with electrophysiology and observed responses to organic acids, but not other odors. This discrepancy is not discussed.  

      As the reviewer points out, Dweck and Carlson (Sci Adv, 2023) reported using single sensillum electrophysiology (base recording) that sugar GRNs only respond to organic acids whereas we found using calcium imaging from a group of axons and single sensillum electrophysiology (tip recording) that these GRNs respond to a wide variety of odors. Given that we observed odor responses using two methods, the discrepancy is likely due to the differences in genotype examined. We now have discussed this point in the text.

      (4) Related to point #1, it would be useful to see a quantification of the percent of flies or trials showing PER for the key experiments in the paper, as this is the standard metric used in most studies and would help readers compare PER in this study to other studies. This is especially important for cases where the authors are claiming that odor-evoked PER is modulated in the same way as previously shown for sugar (e.g., the effect of starvation in Figure S4).

      For starved flies, we would like to remind the reviewer that the percentage of trials showing PER is reported in Fig. 1E, which shows a similar trend as the integrated PER duration. For fed flies, we have analyzed the percentage of PER and added the result to Figure 2-figure supplement 1C (Figure S4 in original submission).

      (5) Given the novelty of the finding that odors activate sugar GRNs, it would be useful to show more examples of GCaMP traces (or overlaid traces for all flies/trials) in Figure 3. Only one example trace is shown, and the boxplots do not give us a sense of the reliability or time course of the response. A related issue is that the GRNs appear to be persistently activated long after the odor is removed, which does not occur with tastes. Why should that occur? Does the time course of GRN activation align with the time course of PER, and do different odors show differences in the latency of GRN activation that correspond with differences in the latency of PER (Figure S1A)?

      Following the reviewer’s suggestion, we now report GCaMP responses for all the trials in all the flies (both Gr5a>GCaMP and Gr66a>GCaMP flies), where the time course and trial-to-trial/animal-toanimal variability of calcium responses can be observed (Figure 3-figure supplement 2).

      Regarding the second point, we recorded responses to both sucrose and odors in some flies and found that calcium responses of GRNs are long-lasting not only to odors but also to sucrose, as shown in Author response image 1. This may be due in part to the properties of GCaMP6s and slower decay of intracellular calcium concentration as compared to spikes.

      Author response image 1.

      Example calcium responses to sucrose and odor (MCH) in the same fly (normalized by the respective peak responses to better illustrate the time course of responses). Sucrose (blue) and odor (orange) concentrations are 100 mM, and 10<sup>-1</sup> respectively. Odor stimulation begins at 5 s and lasts for 2 s. Sucrose was also applied at the same timing for the same duration although there was a limitation in controlling the precise timing and duration of tastant application. Because of this limitation, we did not quantify the off time constant of two responses.

      To address whether the time course of GRN activation aligns with the time course of PER, and whether different odors evoke different latencies of GRN activation that correspond to latencies of PER, we plotted the time course of GRN responses and PER, and further compared the response latencies across odors and across two types of responses in Gr5a>GCaMP6s flies. As shown in Author response image 2, no significant differences were found in response latency between the six odors for PER and odor responses. Furthermore, Pearson correlation between GRN response latencies and PER latencies was not significant (r = 0.09, p = 0.872).

      Author response image 2.

      (A) PER duration in each second in Gr5a-Gal4>UAS-GCaMP6s flies. The black lines indicate the mean and the shaded areas indicate standard error of the mean. n = 25 flies. (B) Time course of calcium responses (ΔF/F) to nine odors in Gr5a GRNs. n = 5 flies. (C) Latency to the first odor-evoked PER in Gr5a-Gal4>UAS-GCaMP6s flies. Green bar indicates the odor application period. p = 0.67, one-way ANOVA. Box plots indicate the median (orange line), mean (black dot), quartiles (box), and 5-95% range (bar). Dots are outliers. (D) Latency of calcium responses (10% of rise to peak time) in Gr5a GRNs. Green bar indicates the odor application period. p = 0.32, one-way ANOVA. Box plots indicate the median (orange line), mean (black dot), quartiles (box), and 5-95% range (bar). Dots are outliers.

      (6) Several controls are missing, and in some cases, experimental and control groups are not directly compared. In general, Gal4/UAS experiments should include comparisons to both the Gal4/+ and UAS/+ controls, at least in cases where control responses vary substantially, which appears to be the case for this study. These controls are often missing, e.g. the Gal4/+ controls are not shown in Figure 2C-G and the UAS/+ controls are not shown in Figure 2J-L (also, the legend for the latter panels should be revised to clarify what the "control" flies are). For the experiments in Figure S5, the data are not directly compared to any control group. For several other experiments, the control and experimental groups are plotted in separate graphs (e.g., Figure 2C-G), and they would be easier to visually compare if they were together. In addition, for each experiment, the authors should denote which comparisons are statistically significant rather than just reporting an overall p-value in the legend (e.g., Figure 2H-L).

      We thank the reviewer for the input. We have conducted additional experiments for four Gal4/+controls in Figure 2 and added detailed information about control flies in the figure legend (Figure 2C-F).

      For the RNAi flies shown in Figure 2 and Figure 2-figure supplement 3, we used the recommended controls suggested by the VDRC. These control flies were crossed with tubulin-Gal4 lines to include both Gal4 and UAS control backgrounds.

      Regarding Figure S5 in original submission (current Figure 2-figure supplement 2), we now present the results of statistical tests which revealed that PER to certain odors is statistically significantly stronger than that to the solvent control (mineral oil) for both wing-removed and wing-leg-removed flies.

      For Figure 2C-F, we now plot the results for experimental and control groups side by side in each figure.

      Regarding the results of statistical tests, we have provided more information in the legend and also prepared a summary table (supplemental table). 

      (7) Additional controls would be useful in supporting the conclusions. For the Kir experiments, how do we know that Kir is effective, especially in cases where odor-evoked PER was not impaired (e.g., Orco/Kir)? The authors could perform controls testing odor aversion, for example. For the Gr5a mutant, few details are provided on the nature of the control line used and whether it is in the same genetic background as the mutant. Regardless, it would be important to verify that the Gr5a mutant retains a normal sense of smell and shows normal levels of PER to stimuli other than sugar, ruling out more general deficits. Finally, as the method of using DeepLabCut tracking to quantify PER was newly developed, it is important to show the accuracy and specificity of detecting PER events compared to manual scoring.  

      A previous study (Sato, 2023, Front Mol Neurosci) showed that the avoidance to 100 μM 2methylthiazoline was abolished, and the avoidance to 1 mM 2MT was partially impaired in Orco>Kir2.1 flies. However, because Orco-Gal4 does not label all the ORNs and we have more concrete results on flies in which all the olfactory organs are removed as well as specific GRNs and Gr are manipulated, we decided to remove the data for Orco>kir2.1 flies and have updated the text and Figure 2 accordingly.

      For the Gr5a mutant and its control, we have added detailed information about the genotype in the figure legend and in the Methods. We have used the exact same lines as reported in Dahanukar et al. (2007) by obtaining the lines from Dr. Dahanukar. Dahanukar et al. has already carefully examined that Gr5a mutant loses responses only to certain types of sugars (e.g. it even retains normal responses to some other sugars), demonstrating that Gr5a mutants do not exhibit general deficits.

      As for the PER scoring method, we manually scored PER duration and compared the results with those obtained using DeepLabCut in wild type flies for the representative data. The two results were similar (no statistical difference). We have reported the result in Figure1-figure supplement 1C.

      (8) The authors' explanation of why both attractive and aversive odors promote PER (lines 249-259) did not seem convincing. The explanation discusses the different roles of smell and taste but does not address the core question of why it would be adaptive for an aversive odor, which flies naturally avoid, to promote feeding behavior.  

      We have extended our explanation in the Discussion by adding the following possibility: “Enhancing PER to aversive odors might also be adaptive as animals often need to carry out the final check by tasting a trace amount of potentially dangerous substances to confirm that those should not be further consumed.”

      Reviewer #2 (Public review): 

      Summary: 

      A gustatory receptor and neuron enhances an olfactory behavioral response, proboscis extension. This manuscript clearly establishes a novel mechanism by which a gustatory receptor and neuron evokes an olfactory-driven behavioral response. The study expands recent observations by Dweck and Carlson (2023) that suggest new and remarkable properties among GRNs in Drosophila. Here, the authors articulate a clear instance of a novel neural and behavioral mechanism for gustatory receptors in an olfactory response.

      Strengths: 

      The systematic and logical use of genetic manipulation, imaging and physiology, and behavioral analysis makes a clear case that gustatory neurons are bona fide olfactory neurons with respect to proboscis extension behavior.

      Weaknesses: 

      No weaknesses were identified by this reviewer.  

      We appreciate the reviewer’s recognition of the novelty and significance of our work.

      Reviewer #3 (Public review): 

      Summary: 

      Using flies, Kazama et al. combined behavioral analysis, electrophysiological recordings, and calcium imaging experiments to elucidate how odors activate gustatory receptor neurons (GRNs) and elicit a proboscis extension response, which is interpreted as a feeding response. 

      The authors used DeepLabCut v2.0 to estimate the extension of the proboscis, which represents an unbiased and more precise method for describing this behavior compared to manual scoring.

      They demonstrated that the probability of eliciting a proboscis extension increases with higher odor concentrations. The most robust response occurs at a 0.5 v/v concentration, which, despite being diluted in the air stream, remains a relatively high concentration. Although the probability of response is not particularly high it is higher than control stimuli. Notably, flies respond with a proboscis extension to both odors that are considered positive and those regarded as negative.

      The authors used various transgenic lines to show that the response is mediated by GRNs.

      Specifically, inhibiting Gr5a reduces the response, while inhibiting Gr66a increases it in fed flies. Additionally, they find that odors induce a strong positive response in both types of GRNs, which is abolished when the labella of the proboscis are covered. This response was also confirmed through electrophysiological tip recordings.

      Finally, the authors demonstrated that the response increases when two stimuli of different modalities, such as sucrose and odors, are presented together, suggesting clear multimodal integration.

      Strengths: 

      The integration of various techniques, that collectively support the robustness of the results.

      The assessment of electrophysiological recordings in intact animals, preserving natural physiological conditions.

      We appreciate the reviewer’s recognition of the novelty and significance of our work.

      Weaknesses: 

      The behavioral response is observed in only a small proportion of animals.  

      We acknowledge that the probability of odor-evoked PER is lower compared to sucrose-evoked PER, which is close to 100 % depending on the concentration. To further quantify which proportion of animals exhibit odor-evoked PER, we now report this number besides the probability of PER for each odor shown in Fig. 1E. We found that, in wild type Dickinson flies, 73% and 68 % of flies exhibited PER to at least one odor presented at the concentration of 0.5 and 0.1.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors): 

      Minor comments/suggestions: 

      - Define "MO" in Figure 1D.  

      We have defined it as mineral oil in the figure legend.

      - Clarify how peak response was calculated for GCaMP traces (is it just the single highest frame per trial?).

      We extended the description in the Methods as follows: “The peak stimulus response was quantified by averaging ΔF/F across five frames at the peak, followed by averaging across three trials for each stimulus. Odor stimulation began at frame 11, and the frames used for peak quantification were 12 to 16.” We made sure that information about the image acquisition frame rate was provided earlier in the text.

      - Clarify how the labellum was covered in Figure 3 and show that this does not affect the fly's ability to do PER (e.g., test PER to sugar stimulation on tarsus) - otherwise one might think that gluing the labella could affect PER.

      In Figure 3, only calcium responses were recorded, and PER was not recorded simultaneously from the same flies. To ensure stable recording from GRN axons in the SEZ, we kept the fly’s proboscis in an extended position as gently as possible using a strip of parafilm. In some of the imaging experiments, we covered the labellum with UV curable glue, whose purpose was not to fix the labellum in an extended position but to prevent the odors from interacting with GRNs on the labellum. We have added a text in the Methods to explain how we covered the labellum.

      - Clarify how the coefficients for the linear equation were chosen in Figure 3G.  

      We used linear regression (implemented in Python using scikit-learn) to model the relationship between neural activity and behavior, aiming to predict the PER duration based on the calcium responses of two GRN types, Gr5a and Gr66a. The coefficients were estimated using the LinearRegression function. We added this description to the Methods. 

      - Typo in "L-type", Figure 4A.  

      We appreciate the reviewer for pointing out this error and have corrected it.

      - Clarify over what time period ephys recordings were averaged to obtain average responses.

      We have modified the description in the Methods as follows: “The average firing rate was quantified by using the spikes generated between 200 and 700 ms after the stimulus contact following the convention to avoid the contamination of motion artifact (Dahanukar and Benton, 2023; Delventhal et al., 2014; Hiroi et al., 2002).

      - The data and statistics indicate that MCH does not enhance feeding in Figure 6G, so the text in lines 207-208 is not accurate.

      We have modified the text as follows: “A similar result was observed with ethyl butyrate, and a slight, although not significant, increase was also observed with 4-methylcyclohexanol (Figure 6G).”

      - P-value for Figure S9 correlation is not reported.  

      We appreciate the reviewer for pointing this out. The p-value is 0.00044, and we have added it to the figure legend (current Figure 5-figure supplement 1).

      Reviewer #2 (Recommendations for the authors): 

      Honestly, I have no recommendations for improvement. The manuscript is extremely well-written and logical. The experiments are persuasive. A lapidary piece of work.

      We appreciate the reviewer for the positive assessment of our work.

      Reviewer #3 (Recommendations for the authors): 

      - I suggest explaining the rationale for selecting a 4-second interval, beginning 1 second after the onset of stimulation.

      Integrated PER duration was defined as the sum of PER duration over 4 s starting 1 s after the odor onset. This definition was set based on the following data.

      (1) We used a photoionization detector (PID) to measure the actual time that the odor reaches the position of a tethered fly, which was approximately 1.1 seconds after the odor valve was opened. Therefore, we began analyzing PER responses 1 second after the odor onset (valve opening) to align with the actual timing of stimulation.

      (2) As shown in Fig.1D and 1F, the majority of PER occurred within 4 s after the odor arrival.

      We have now added the above rationale in the Methods.

      - I could not find the statistical analysis for Figures 1E and 1G. If these figures are descriptive, I suggest the authors revise the sentences: 'Unexpectedly, we found that the odors alone evoked repetitive PER without an application of a tastant (Figures 1D-1G, and Movie S1). Different odors evoked PER with different probability (Figure 1E), latency (Figure S1A), and duration (Figures 1F, 1G, and S2)'.

      We have added the results of statistical analysis to the figure legend.

      - In Figure 2, the authors performed a Scheirer-Ray-Hare test, which, to my knowledge, is a nonparametric test for comparing responses across more than two groups with two factors. If this is the case, please provide the p-values for both factors and their interaction

      We now show the p-values for both factors, odor and group as well as their interaction in the supplementary table. 

      - In line 83, I suggest the authors avoid claiming that 'these data show the olfactory system modulates but is not required for odor-evoked PER,' as they are inhibiting most, but not all olfactory receptor neurons. In this regard, is it possible to measure the olfactory response to odors in these flies?  

      We thank the reviewer for the comment. Because Orco-Gal4 does not label all the ORNs and because we have more concrete results on flies in which all the olfactory organs are removed as well as specific GRNs and Gr are manipulated, we decided to remove the data for Orco>kir2.1 flies and have updated the text and Figure 2 accordingly.

      - In Figure 2, I wonder if there are differences in the contribution of various receptors in detecting different odors. A more detailed statistical analysis might help address this question.

      Although it might be possible to infer the contribution of different gustatory receptors by constructing a quantitative model to predict PER, it is a bit tricky because the activity of individual GRNs and not Grs are manipulated in Figure 2 except for Gr5a. The idea could be tested in the future by more systematically manipulating many Grs that are encoded in the fly genome.

      - For Figures 2J-L, please clarify which group serves as the control.  

      We have added this information to the legend. 

      - In Figure 3, I recommend including an air control in panels D and F to better appreciate the magnitude of the response under these conditions.

      The responses to all three controls, air, mineral oil and water, were almost zero. As the other reviewer suggested to present trial-to-trial variability as well, we now show responses to all the controls in all the trials in all the animals tested in Figure 3-figure supplement 2.

      - I had difficulty understanding Figure 3G. Could the authors provide a more detailed explanation of the model?

      We used linear regression (implemented in Python using scikit-learn) to model the relationship between neural activity and behavior, aiming to predict the PER duration based on the calcium responses of two GRN types, Gr5a and Gr66a. The weights for GRNs were estimated using the LinearRegression function. The weight for Gr5a and Gr66a was positive and negative, respectively, indicating that Gr5a contributes to enhance whereas Gr66a contributes to reduce PER.

      To evaluate the model performance, we calculated the coefficient of determination (R<sup>2</sup>), which was 0.81, meaning the model explained 81% of the variance in the PER data.

      The scatter plot in Fig. 3G shows a tight relationship between the predicted PER duration (y-axis) plotted against the actual PER duration (x-axis), demonstrating a strong predictive power of the model.

      We added the details to the Methods.

      - In Figure S4a, the reported p-value is 0.88, which seems to be a typo, as the text indicates that PER is enhanced in a starved state.

      Thank you for pointing this out. We have modified the figure legend to describe that PER was enhanced in a starved state only for the experiments conducted with odors at 10<sup>-1</sup> concentration (current Figure 2-figure supplement 1).

    1. Author Response

      The following is the authors’ response to the original reviews.

      We thank the editors and reviewers for their tremendously helpful comments. We outline below changes we have made to the manuscript in response to each point. These include new analyses and a substantial rewrite to address the concerns about lack of clarity.

      We believe the revisions strengthen the evidence for our conclusion that grid fields can be either anchored to or independent from a task reference frame, and that anchoring is selectively associated with successful path integration-dependent behaviour. Our additional analyses of non-grid cells indicate that while some are coherent with the grid population, many are not, suggesting cell populations within the MEC may implement grid-dependent and grid-independent computations in parallel.

      We hope the reviewers will agree that our novel experimental strategy complements and avoids limitations of perturbation-based approaches, and by providing evidence to dissociate the two major hypotheses for whether and when grid cells contribute to behaviour our results are likely to have a substantial impact on the field.

      Public Reviews:

      Reviewer #1 (Public Review):

      In this study, Clark et. al. uncovered an association between the positional encoding of grid cell activity with good performance in spatial navigation tasks that requires path integration, highlighting the contribution of grid firing to behaviour… The conclusions of this paper are mostly well supported by data, the finding about the association between grid cell encoding and behaviour in spatial memory tasks is important. However, some aspects of the analysis need to be clarified or extended.

      Thankyou for the overview and constructive comments.

      (1) While the current dataset aims to demonstrate a "correlation" between grid cell encoding and task performance, the other variables that could confound this correlation should be carefully examined.

      (1.1) The exact breakdown of the fraction of beaconed/non-beaconed/probe trials is never shown. if the session makeup has a significant effect on the coding scheme or other results, this variable should be accounted for.

      The lack of information about the trial organisation was a substantial oversight in our preparation of the first version of the manuscript. Session make up can not account for effects on grid stability and its relationship to behavioural outcome but this was not made at all clear.

      In all sessions trial types were varied in a fixed repeating sequence. Therefore, continuous blocks of trials on which grid firing is anchored (or independent from) the track can not be explained by the mouse experiencing a particular trial type. We have revised the manuscript to make this clearer, e.g. p 5, ‘These switches could not be explained by variation between trials in the availability of cues or rewards, as these were interleaved in blocks that repeated throughout a session (see Methods), whereas periods in which grid cell activity was in a given mode extended across the repeating blocks (e.g. Figures 3D,E, 4A, 5E,F).’ and methods p 12, ‘Trials were delivered in repeating blocks throughout a recording session…’

      (1.2) The manuscript did not provide information about whether individual mice experienced sessions with different combinations of the three trial types, and whether they show different preferences in position or distance encoding even in comparable sessions. This leads to the question of whether different behaviour and activity encoding were dominated by experimental or natural differences between individual mice. Presenting the data per mouse will be helpful.

      As we note above, because trial types were interleaved in a fixed sequence, experience of a particular trial type can not account for switching between task-anchored and taskindependent firing modes. This was insufficiently clear in the first version of the manuscript.

      We varied the proportions of trials of a particular type between sessions with the aim of maximising the number of non-beaconed and probe trials. This was necessary because we find that if we introduce too high a proportion of these trials early in training then mice appear to ‘lose interest’ in the task and their performance drops off. We therefore used an approach in which we increased the proportions of non-beaconed and probe trials over training days as mice became familiar with the task. This is now described in the methods (p 12).

      Because the decision for when to vary the proportion of trial types was based on the previous day’s performance, the experimental design was not optimised for addressing the reviewer’s question about dissociating experimental from natural differences in mice. To provide some initial insight we have analysed the relationship between task anchored coding and proportion of beaconed trials in a session (Figure 3, Figure Supplement 7). While on average there is a higher proportion of trials in which grid fields are task-anchored in sessions with more beaconed trials, this effect is small and most of the variance is independent from the proportion of beaconed trials.

      (1.3) Related to the above point, in Figure 5, the mice appeared to behave worse in probe trials than non-beaconed trials. If the mouse did not know if a trial is a probe or a non-beacon trial, they should behave equivalently until the reward location and thus should stop an equal amount. If this difference is because multiple probe trials are placed consecutively, did the mouse learn that it will not get a reward and then stop trying to get rewards? Did this affect switching between position and distance coding?

      Thankyou for flagging this. This reflected an inconsistency arising from the way we detected stops that we have now corrected. Briefly, the temporal resolution of the processed location data against which the stop detection threshold was applied was insufficiently high. As a result, stops in the non-beaconed group were picked up, as they tended to be longer because mice remained still to consume rewards, whereas some stops in the probe group were missed because they were relatively short. We have corrected this by repeating the analyses on raw position data at the highest temporal resolution available. This analysis is now clearly described in the Methods (see p13 “A stop was registered in Blender3D if the speed of the mouse dropped below 4.7 cm/s. Speed was calculated on a rolling basis from the previous 100 ms at a rate of 60 Hz.”).

      (1.4) It is not shown how the behaviours (e.g., running speed away from the reward zone, licking for reward) in beaconed/non-beaconed/probe trials were different and whether the difference in behaviours led to the different encoding schemes.

      Because trial types were interleaved and repeated with a period less than the length of typical trial sequences during which grid cell activity remained either task-anchored or taskindependent, differences between trial types are unlikely to explain use of the different coding schemes. Hopefully, this is clarified by the comments above.

      To further describe the relationship between behavioural outcomes, trial types and grid anchoring, we now also show running speed as a function of location for each combination of trial types and trial outcomes (Figure 6, Figure Supplement 1). This illustrates and replicates our previous findings (Tennant et al. 2018) that running speed profiles are similar for a given trial outcome regardless of trial type (Figure 6, Figure Supplement 1A), and further further shows that the behavioural profile for a given trial outcome and trial-type does not differ when grid cells are in task-anchored and task-independent modes (Figure 6, Figure Supplement 1B). This further argues against the possibility that difference in behaviours leads to the different encoding schemes.

      (2) Regarding the behaviour and activity encoding on a trial-by-trial basis, did the behavioural change occur first, or did the encoding switch occur first, or did they happen within the same trial? This analysis will potentially determine whether the encoding is causal for the behaviour, or the other way around.

      This is a good question but our experimental design lacks sufficient statistical power to address the timing of mode switches within a trial. This is because mode switching is relatively infrequent (so the n for switching is low) and only a subset of trials are uncued (making the relevant n even lower), while at a trial level the behavioural outcome is variable (increasing the required n for adequate power).

      (3) The author determined that the grid cell coding schemes were limited to distance encoding and position encoding. However, there could be other schemes, such as switching between different position encodings (with clear spatial fields but at different locations), as indicated by Low et. al., 2021, and switching between different distant encodings (with different distance periods). If these other schemes indeed existed in the data, they might contribute to the variation of the behaviours.

      Switching between position encoding schemes appears to be rare within our dataset and unlikely to contribute to variation in behaviour. In most sessions we did not observe switching between grid phases / position encodings (e.g. Figures 2A-B, 3B-E, 4A, 5C-D, F). In one session we found switching between different phases when grid cells were taskanchored. Because the grid period was unchanged, the spatial periodograms remained similar. We report this example in the revised manuscript (Figure 5E).

      (4) The percentage of neurons categorised in each coding scheme was similar between nongrid and grid cells. This implies that non-grid cells might switch coding schemes in sync with grid cells, which would mean the whole MEC network was switching between distance and position coding. This raises the question of whether the grid cell coding scheme was important per se, or just the MEC network coding scheme.

      We very much appreciate this suggestion. We note first that while the proportion of taskanchored grid and non-grid cells is similar, task-independent periodic firing of non-grid cells is much rarer than for grid cells (Figure 2E), suggesting a dissociation between the populations. To further address the question we have included additional analyses of nongrid cells (Figure 3, Figure Supplement 5). This shows that while some non-grid cells have anchoring that switches coherently with simultaneously recorded grid cells, others do not. Figures 4 and 5 now show examples of non-grid cell activity recorded simultaneously with grid cells.

      Together, our data suggest that the MEC implements multiple coding schemes: one that is associated with the grid network and includes some non-grid cells; and one (or more) that can be independent from the grid network. This dissociation adds to the insights into MEC function that are provided by our study and is now highlighted in the abstract and discussion.

      (5) In Figure 2 there are several cell examples that are categorised as distance or position coding but have a high fraction of the other coding scheme on a per-trial basis. Given this variation, the full session data in F should be interpreted carefully, since this included all cells and not just "stable" coding cells. It will be cleaner to show the activity comparison only between the stable cells.

      We have now included examples in Figure 2A-C where the grid mode is stable throughout a session. As the view of activity at a session level is important, we have not updated Figure 2F, but have clarified the terminology to now clearly refer to classification at either season or trial levels. In addition, we have repeated the analyses shown in Figure 2F but after grouping cells according to whether their firing has a single mode on >85% of the trials (Figure 3 Figure Supplement 4). This analysis supports similar conclusions to those of Figure 2F.

      (6) The manuscript is not well written. Throughout the manuscript, there are many unexplained concepts (especially in the introduction) and methods, mis-referenced figures, and unclear labels.

      We very much appreciate the feedback and have substantially rewritten the manuscript. We have paid particular attention to explaining key concepts in the introduction and have carefully checked the figures. We welcome further feedback on whether this is now clearer.

      Reviewer #2 (Public Review):

      Clark and Nolan's study aims to test whether the stability of grid cell firing fields is associated with better spatial behaviour performance on a virtual task… This study is very timely as there is a pressing need to identify/delimitate the contribution of grid cells to spatial behaviours. More studies in which grid cell activity can be associated with navigational abilities are needed.

      Thank you for the supportive comments and highlighting the importance of the question.

      The link proposed by Clark and Nolan between "virtual position" coding by grid cells and navigational performance is a significant step toward better understanding how grid cell activity might support behaviour. It should be noted that the study by Clark and Nolan is correlative. Therefore, the effect of selective manipulations of grid cell activity on the virtual task will be needed to evaluate whether the activity of grid cells is causally linked to the behavioural performance on this task. In a previous study by the same research group, it was shown that inactivating the synaptic output of stellate cells of the medial entorhinal cortex affected mice's performance of the same virtual task (Tennant et al., 2018). Although this manipulation likely affects non-grid cells, it is still one of the most selective manipulations of grid cells that are currently available.

      Again, thank you for the supportive comments. We recognise the previous version of the manuscript did not sufficiently clarify the motivation for our approach, or the benefits of capitalising on behavioural variable variability as a complementary strategy to perturbation approaches. We now make this clearer in the revised introduction (p 2, paragraphs 2 and 3).

      When interpreting the "position" and "distance" firing mode of grid cells, it is important to appreciate that the "position" code likely involves estimating distance. The visual cues on the virtual track appear to provide mainly optic flow to the animal. Thus, the animal has to estimate its position on the virtual track by estimating the distance run from the beginning of the track (or any other point in the virtual world).

      We appreciate the ambiguity here was confusing. We have re-named the groups to ‘taskanchored’, corresponding to when grid cells encode position on the track (as well as distance as the reviewer correctly points out), and ‘task-independent’, corresponding to the group we previously referred to as distance encoding.

      It is also interesting to consider how grid cells could remain anchored to virtual cues. Recent work shows that grid cell activity spans the surface of a torus (Gardner et al., 2022). A run on the track can be mapped to a trajectory on the torus. Assuming that grid cell activity is updated primarily from self-motion cues on the track and that the grid cell period is unlikely to be an integer of the virtual track length, having stable firing fields on the virtual track likely requires a resetting mechanism taking place on each trial. The resetting means that a specific virtual track position is mapped to a constant position on the torus. Thus, the "virtual position" mode of grid cells may involve 1) a trial-by-trial resetting process anchoring the grid pattern to the virtual cues and 2) a path integration mechanism. Just like the "virtual position" mode of grid cell activity, successful behavioural performance on non-beaconed trials requires the animal to anchor its spatial behaviour to VR cues.

      Reviewer #3 (Public Review):

      This study addresses the major question of 'whether and when grid cells contribute to behaviour'. There is no doubt that this is a very important question. My major concern is that I'm not convinced that this study gives a significant contribution to this question, although this study is well-performed and potentially interesting. This is mainly due to the fact that the relation between grid cell properties and behaviour is exclusively correlative and entirely based on single cell activity, although the introduction mentions quite often the grid cell network properties and dynamics. In general, this study gives the impression that grid cells exclusively support the cognitive processes involved in this task. This problem is in part related to the text.

      Thank you for the comments. We recognise now that the previous text was insufficiently clear. We have modified the introduction to clarify the value of an approach that takes advantage of behavioural variability. Importantly, this approach is complementary to perturbation strategies we and others have used previously. In particular it addresses critical limitations of perturbation strategies which can be confounded by off-target effects and possible adaptation, both of which are extremely difficult to fully rule out. We hope that with this additional clarification it is now clear that as for any important question multiple and complementary testing strategies are required to make progres, and second, that our study makes a new and important contribution by introducing a novel experimental approach and by following this up with careful analyses that clearly distinguish competing hypotheses.

      However, it would be interesting to look at the population level (even beyond grid cells) to test whether at the network level, the link between behavioural performance and neural activity is more straightforward compared to the single-cell level. This approach could reconcile the present results with those obtained in their previous study following MEC inactivation.

      We’re unclear here about what the reviewer means by ‘more straightforward’ as clear relationships between activity of single grid cells and populations of grid cells are well established (Gardner et al., 2021; Waaga et al., 2021; Yoon et al., 2013).

      To give a clearer indication of the corresponding population level representations, as mentioned in response to Reviewer #1, we now include additional data showing many simultaneously recorded neurons, and analyses of non-grid as well as grid cells (Figures 4, 5, Figure 5 Figure Supplement 2).

      To reconcile results with our previous study of MEC inactivation we have paid additional attention to the roles of non-grid cells (following suggestions by Reviewer #1). We show that while some non-grid cells show transitions between task-anchored and task-independent firing that are coherent with the grid population, many others have more stable firing that is independent of grid representations. This is consistent with the idea that the MEC supports localised behaviour in the cued and uncued versions of the task (Tennant et al., 2018), and suggests that while grid cells preferentially contribute when cues are absent, non-grid cells could also support the cued version. We make this additional implication clear in the revised abstract and discussion.

      The authors used a statistical method based on the computation of the frequency spectrum of the spatial periodicity of the neural firing to classify grid cells as 'position-coding' (with fields anchored to the virtual track) and 'distance-coding' (with fields repeating at regular intervals across trials). This is an interesting approach that has nonetheless the default to be based exclusively on autocorrelograms. It would be interesting to compare with a different method based on the similarities between raw maps.

      While our main analyses use a periodogram-based method to identify when grid cells are / are not anchored to the task environment, we validate these analyses by examination of the rate maps in each condition (Figures 2-4). For example, when grid cells are task-anchored, according to the periodogram analysis, the rate maps clearly show spatially aligned peaks, whereas when grid cells are not anchored the peaks in their rate maps are not aligned (Figure 2A vs 2B; Figure 3B-E; Figure 4C). We provide further validation by showing that spatial information (in the track reference frame) is substantially higher when grid cell activity is task-anchored vs task-independent (Figures 2F, 3G, 4F and Figure 3 Figure Supplement 4).

      To further address this point we have carried out additional complementary analyses in which we identify task anchored vs task independent modes using a template matching method applied to the raw rate maps (Figure 6, Figure Supplement 2). These analyses support similar conclusions to our periodogram-based analyses.

      Beyond this minor point, cell categorization is performed using all trial types.

      Each trial type (i.e. beacon or non-beacon) is supposed to force mice to use different strategies and should induce different spatial representations within the entorhinal-hippocampal circuit (and not only in the grid cell system). In that context, since all trials are mixed, it is difficult to extrapolate general information.

      We recognise that the description of the task design was insufficiently clear but are unsure why ‘it is difficult to extrapolate general information’. Before addressing this point, we should first be clear that mice are not ‘forced’ to adopt any particular strategy. Rather, on uncued trials a path integration strategy is the most efficient way to solve the task. However, mice could instead use a less efficient strategy, for example by stopping at short intervals they still obtain rewards. Detailed behavioural analyses indicate that such random stopping strategies are used by naive mice, while with training mice learn to use spatial stopping strategies (Tennant et al. 2018).

      In terms of ‘extracting general information’ from the task, the following findings lead to general predictions: 1) Grid cells can exist in either task-anchored or task-independent periodic firing modes; 2) These modes can be stable across a session, but often modeswitching occurs within a session; 3) While some non-grid cells show task-independent periodic firing, this is much less common than for grid cells, which suggests a model in which many non-grid MEC neurons operate independently from the grid network; 4) When a marker cue is available mice locate a reward equally well when grid cells are in taskanchored versus task-independent modes, which argues against theories in which grid cells are a key part of a general system for localisation; 5) When markers cues are absent taskanchored grid firing is associated with successful reward localisation, which corroborates a key prediction of theories in which grid cells contribute to path integration.

      In revising the manuscript we have attempted to improve the writing to make these advances clearer, and have clarified methodological details that made interpretation more challenging than it should have been. For example, as noted in our response to Reviewer #1, we have included additional details to clarify the organisation of trials and relationships between trials, behavioural outcomes and neural codes observed.

      On page 5 the authors state that 'Since only position representations should reliably predict the reward location, ..., we reasoned that the presence of positional coding could be used to assess whether grid firing contributes to the ongoing behaviour'. I do not agree with this statement. First of all, position coding should be more informative only in a cue-guided trial. Second, distance coding could be as informative as position coding since at the network level may provide information relevant to the task (such as distance from the reward).

      Again, this point perhaps reflects a lack of clarity on our part in writing the manuscript. When grid cells are anchored to the track reference frame (now called ‘tasked anchored’, previously ‘position encoding’), then the location of the rate peaks in grid firing is reliable from trial to trial. This is the case whether or not the trial is cued. When grid cells are independent of the track reference frame (now called ‘task independent’, previously ‘distance encoding’), then the location of the firing rate peaks vary from trial to trial. In the latter case, position can not be read out directly from trial to trial.

      In principle, in the task-independent mode track position could be calculated by storing the grid network configuration at the start of the track, which would differ on each trial, and then implementing a mechanism to readout relative distance as mice move along the track. However, if mice do use this computation we would expect them to do so equally well on cued and uncued trials. By contrast, our results clearly show a dissociation between trial types in the relationship between grid firing and behavioural outcome. We highlight and discuss this possibility in the revised manuscript (p 10, ‘Alternatively, mice could in principle estimate track location with a system that utilises information about distance travelled obtained from task-independent grid representations’).

      Third, position-coding is interpreted as more relevant because it predominates in correct trials. However, this does not imply that this coding scheme is indeed used to perform correct trials.

      We have revised the manuscript to clarify our goal of distinguishing major hypotheses for the roles of grid cells in behaviour (Introduction, ‘On the one hand, theoretical arguments that grid cell populations can generate high capacity codes imply that they could in principle contribute to all spatial behaviours (Fiete et al., 2008; Mathis et al., 2012; Sreenivasan and Fiete, 2011). On the other hand, if the behavioural importance of grid cells follows from their hypothesised ability to generate position representations by integrating self-motion signals (McNaughton et al., 2006), then their behavioural roles may be restricted to tasks that involve path integration strategies.’

      By showing that performance on cued trials is similar regardless of whether grid cells are task-anchored or not, we provide strong evidence against the idea that grid firing is in general necessary for location-based behaviours. By showing that task anchoring is associated with successful localisation when cues are absent we corroborate a key prediction of hypothesised roles for grid cells in path integration-dependent behaviour. Therefore, we substantially reduce the space of behaviours to which grid cells might contribute. Importantly, this space is much larger for the MEC, which is required for cued and uncued versions of the task. We have revised the introduction and discussion to make these points clearer.

      While we believe our results add a key piece of evidence to the puzzle of when and where grid cells contribute to behaviour, we agree that further work will be required to develop and test more refined hypotheses. Alternative models also remain plausible, for example perhaps the behaviourally relevant computations are implemented elsewhere in the brain with grid anchoring to the track as an indirect consequence. Nevertheless, explanations of this kind are more difficult to reconcile with evidence that inactivation of stellate cells in the MEC impairs learning of the task, and other manipulations that modify grid firing impair performance on similar tasks. We now discuss these possibilities (discussion p 10, ‘mice could in principle estimate track location with a system that utilises information about distance travelled obtained from task-independent grid representations’).

      It could be more informative to push forward the correlative analysis by looking at whether behavioural performance can be predicted by the coding scheme on a trial-by-trial basis.

      The previous version of the manuscript showed these analyses (now in Figure 6). Thus, task anchored grid firing predicts more successful performance on uncued trials at the session level (Figure 6A-B) and at the trial level (Figure 6C-D).

      Reviewer #1 (Recommendations For The Authors):

      (1) The author particularly mentioned that the 1D tracks are different from the "cue-rich environments that are typically used to study grid cells". It is not clear what conclusions would hold for a cue-rich environment or a track, which may require relatively less path integration compared to the cue-sparse environment. This point should be discussed.

      This is an important point that we did not pay sufficient attention to in the previous version of the manuscript. Our finding of successful localisation in the cued environment when grid cells are not task anchored implies that grid anchoring is not required to solve cued tasks. The implication here is that cue rich environments may then not be the most suitable for investigation of grid roles in behaviour as non-grid mechanisms may suffice, although this does not rule out the possibility that anchored grid codes may play important roles in learning about cue rich environments. We now address this point in the discussion (p 10, ‘An implication of this result is that cue rich tracks often used to investigate grid activity patterns may not engage behaviours that require anchored grid firing.’).

      (2) It would be good to see the statistics for the number of different cells (stable position or distance encoding, and unstable cells) identified per mouse/session and the number of grid cells per session.

      These are now added to Supplemental Data 2 and will also be accessible through code and datasets that we will make available alongside the version of record.

      (3) Figure 2F: any explanation about why AG cells had high spatial information?

      Previously the calculation used bits per spike and as aperiodic cells have low firing rates the spatial information was high. We have replaced this with bits per second, which provides a more intuitive measure and no longer implies high spatial information. We have amended this in the methods (p 15, ‘Spatial information was calculated in bits per second…’).

      (4) The following methods sections should provide additional details:

      (4.1) Details of the training protocol are largely left to reference papers. The reference papers give a general outline of the training protocol, but the details are not completely comparable given the single experiment performed on these mice. More details should be given on training stages and experience at the time of the experiment.

      The task is more clearly described in the introduction (p 3), and additional details of the training protocol are now provided in the methods (p 12-13).

      (4.2) The methods reference mean speed across sessions, but it is not clear where this was used.

      This was very poor wording. We have now changed this to ‘For each session the mean speed was calculated for each trial outcome’.

      (4.3) The calculation of the spatial autocorrelogram on a per-trial basis should be more explicitly stated. Is it the average of each 10 cm increment with the centre trial?

      We have added additional information to the methods (p 16-18).

      (4.4) 1D field detection is not sufficiently explained in Figure 1/S2. This information should also appear in the methods section.

      This is now clarified on page 16 in section ‘Analysis of neural activity and behaviour during the location memory task’.

      (5) The data in Figure 4A and B only shows speed vs. location for one example mouse. The combined per mouse or per session data should also be shown.

      This is now shown in Figure 5A and Figure 5, Figure Supplemental 2

      (6) Figure 5 is somewhat confusing. Why are A/B by session and C/D by trial? The methods imply that A/B are originally averaged by cell, but that duplicate cells in the same session are excluded because behaviour versus session type is identical. This method should be valid if all grid cells within a session are all "stable". This is likely given the synchrony of code-switching between grid cells, but not all co-active grid cells behaved identically.

      It is understandable that C/D are performed by trial, but it should be made clear that it is not a comparable analysis to A/B. It is unclear what N refers to in C. The figure says by trial, but the legend says the error bar is by cell. If data is calculated by trial and then averaged by cell, this should be more clearly stated.

      In Figure 6A/B (previously Figure 5A/B) we focus our analysis on sessions in which the mode of grid firing, either task-anchored or task-independent, was relatively stable on a trialto-trial basis (see Figure 3F for definitions). This enables us to then compare behaviour averaged across each session, with sessions categorised as task-anchored and task independent. This analysis has the advantage that it focuses on large blocks of time (whole sessions) in which the mode of grid firing is unambiguous, but the disadvantage is that it excludes many sessions in which grid firing switches between task-anchored and taskindependent modes.

      Figure 6C/D (previously Figure 5C/D) addresses this limitation by carrying out similar analyses with behaviour sorted into task-anchored versus task-independent groups at the level of trials. A potential limitation for this analysis is that grid firing is somewhat variable on a trial-by-trial basis and so some trials may be mis-classified. We don’t expect this to lead to systematic bias, but it may make the data more noisy. Nevertheless, these analyses are important to include as they allow assessment of whether conclusions from 6A/B hold when all sessions are considered.

      We have added additional clarification of the rationale for these analyses to the main text (p7-8, ‘’We addressed this by using additional trial-level comparisons’). We have also added clarification in the methods section for categorisation of task-anchored versus taskindependent trials when multiple grid cells were recorded simultaneously (p 17, ‘When assigning a common classification across a group of cells recorded simultaneously...’) and an explanation for the N in the figure legend. We also clarify that the analyses use a nested random effects design to account for dependencies at the levels of sessions and mice (methods, p 20, ‘Random effects had a nested structure to account for animals and sessions…’) .

      (7) Panels E and F of Figure 5 are not explained in the main text.

      This is now corrected (see p8, ‘Additional analyses…’).

      (8) Figure 5: Since stable grid cells and all grid cells are shown, it will be better to show unstable cells, which can be compared with grid cells.

      Given that the rationale for differences between Figure 6A/B and C/D (previously Figure 5AD) were not previously clear, the reason for focussing on stable grid cells here was likely also not clear (see point 6 above). We don’t show unstable grid cells in Figure 6A-B as the behaviour averaged at the level of a session would be a mix of trials when they are taskanchored and when they are task-independent. Therefore, the analysis would not test predictions about the relationship between task-anchored vs task-independent modes and behaviour. We hope this is now clear in the manuscript given the revisions introduced to address point 6 above.

      (9) The methods describing the statistics for these experiments are also confusing. The methods section should be written more clearly, and it should be made clear in the text or figure legend whether this data is the "original" data or is processed in relation to the model, such as excluding duplicate grid cells within a session. The figure legend should also state that a GLMM was used to calculate the statistics.

      We have revised the methods section with the goal of improving clarity, adding detail and removing ambiguity. This includes updates of the methods for the GLMM analysis, which are referred to within the Figure 6 legend. A clear definition of a stable session is now also added to the Figure 6 legend.

      Reviewer #2 (Recommendations For The Authors):

      When grid fields are anchored to the virtual world (position mode), there is probably small trialto-trial variability in the firing location of the firing fields. Is this trial-to-trial variability related to the variability in the stop location? This would provide a more direct link between path integration in grid cell networks and behaviour that depends on path integration.

      When attempting to address this we find that the firing of individual grid cells is too variable to allow sufficiently precise decoding of their fields at a single trial level. This is expected given the Poisson statistics of spike generation and previous evaluations of grid coding (e.g. (Stemmler et al., 2015)).

      The conclusion of the abstract is: "Our results suggest that positional anchoring of grid firing enhances the performance of tasks that require path integration." This statement is slightly confusing. The task requires 1) anchoring the behaviour to the visual cues presented at the start of the trial and 2) path integration from thereon to identify the rewarded location. The performance is higher when grid cells anchor to the visual cues presented at the start of the trial. What the results show is that the anchoring of grid firing fields to visual landmarks enhances the performance of tasks that require path integration from visual landmarks (i.e. grid cells being anchored to the reference frame that is behaviorally relevant).

      To try to more clearly explain the logic and conclusion we have rewritten the abstract, including the final sentence.

      Similar comment for the title of Figure 5: "Positional grid coding is not required for cued spatial localisation but promotes path integration-dependent localisation." Positional coding means that grid cells are anchored to the behaviorally relevant reference frame.

      To address the lack of clarity we have modified the little of Figure 6 (previously Figure 5) to read ‘Anchoring of grid firing to the task reference frame promotes localisation by path integration but is not required for cued localisation’.

      In Figure 1, there is a wide range of beaconed (40-80%) and non-beaconed (10-60%) trials given. It is not 100% clear whether these refer to the percentage of trials of a given type within the recording sessions. Was the proportion of non-beaconed trials manipulated? If so, was the likelihood of position and distance coding changing according to the percentage of nonbeaconed trials?

      The ranges given refer to proportions across different behavioural sessions. Within any given behavioural session the proportion was constant. We now make this clear in the figure legend and in the results and methods sections.

      We did not manipulate proportions of trial types during a session. Manipulations betweens sessions were carried out with the goal of maximising the numbers of uncued trials that the mice would carry out (see response to public comments above). While the effect of trial-type at the session level is not relevant to the hypotheses we aim to test here, we have included an additional analysis of the relationship between task anchoring and the proportions of trial types in a session (Figure 3, Figure Supplement 7)(also discussed above). As disentangling the effects of learning and motivation will be complex and likely require new experimental designs we have not drawn strong conclusions or pursued the analysis further..

      I was not convinced that the labels "position" and "distance" were appropriate for the two grid cell firing modes. My understanding is that the "position" code also requires the grid cell network to estimate distance. It seems that the main difference between the "position" and "distance" modes is that when in the "position" mode, the activity on the torus is reset to a constant toroidal location when the animal reaches a clearly identifiable location on the virtual track. In the "distance" mode, this resetting does not take place.

      As previously mentioned, we agree these terms weren’t the best and have since relabelled these as “task-anchored” and “task-independent”.

      There are a few sections in the manuscript that implicitly suggest that a causal link between grid cell activity and behaviour was demonstrated. For instance: "It has been challenging to directly test whether and when grid cells contribute to behaviour.": The assumption here is that the manuscript overcomes this challenge, but the study is correlative.

      We have modified the wording to be clear that we are introducing new tests of predictions made by hypotheses about causal relationships between grid coding and behaviour (introduction, p 1-2). We also clarify that our results argue against the hypothesis that grid cells provide a general coded for behaviour, but corroborate predictions of hypotheses in which they are specifically important for path integration (discussion, p 10).

      We have modified the title abstract and main text to try to treat claims about causality with care. We now more thoroughly introduce and contrast the approach we report here with previous experiments that use perturbations (introduction, p2). While it is tempting to make stronger claims for causality with these approaches, there are also logical limitations with perturbation-based approaches, for example the challenges of fully excluding off target effects and adaptation. We now explain how these strategies are complementary. Our view is that both strategies will be required to develop strong arguments for whether and when grid cells contribute to behaviour. From this perspective, it is encouraging that our conclusions are in agreement with what are probably the most specific perturbations of grid cells reported to date (Gil et al. 2017), while perturbations that more generally affect MEC function appear to impair cued and path integration-dependent behaviours (Tennant et al. 2018). We now discuss these points more clearly (introduction, p 2).

      I am slightly confused by the references to the panels in Figure 4.

      "In some sessions, localization of the reward occurred almost exclusively when grid cells were anchored to position and not when they encoded distance (Figure 4C). Figure 4C only shows position coding.

      "In other sessions, animals localised the reward when grid firing was anchored to position or distance, but overall performance was improved on positional trials (Figure 4D-E)." The reference should probably point to Figure 4E-F or just to 4E.

      "In a few sessions, we observed spatial stopping behaviour comparable to cued trials, even when grid firing almost exclusively encoded distance rather than position (Figure 4F)." From Figure 4F, it seems that the performance on non-beaconed trials is better during "position" coding.

      We have now updated Figure 5 (Figure 4 in the original manuscript) and references to the Figure in the text. Now Figure 5 shows the activity of cells recorded in stable and unstable task-anchored and task-independent sessions (see Figure 5C-F).

      Minor issues:

      Is this correct: (Figure 4A and Figure 4, Figure Supplement 1).

      This has been corrected.

      Figure 4B: There could be an additional label for position and distance.

      Figure 4B from the original manuscript has now been removed.

      Figure 4C-F. The panels on the right side should be explained in the Figure Legend.

      Legends for Figure 5C-F (previously Figure 4C-F) have now been updated.

      Reviewer #3 (Recommendations For The Authors):

      Specific questions :

      (1) Position coding reflects a coding scheme in which fields are spaced by a fixed distance; previous studies have shown that a virtual track grid map is a slice of the 2D classic grid. In that case, the fields are still anchored to the track but would produce a completely different map. Did the authors check whether it is the case at least for some cells? If not, what could explain such a major difference?

      Το avoid confusion we now use the term ‘task-anchored’ rather than ‘position coding’ (see comments above). We should further clarify that our conclusions rest on whether or not the grid fields are anchored to the track. Task anchored firing does not require that grid fields maintain their spacing from 2D environments, only that fields are at the same track position on each trial. Thus, whether the spacing of the fields corresponds to a slice through a 2D grid makes no difference to the hypotheses we test here.

      We agree that the relationship between 1D and 2D field organisation could be an interesting future direction, for example anchoring could involve resetting the grid phase while maintaining a stable period, or it could be achieved through local distortions in the grid period. However, since these outcomes would not help distinguish the hypotheses we test here we have not included analyses to address them.

      (2) Previous studies have highlighted the role of grid cells in goal coding. Here there is an explicit reward in a particular area. Are there any grid modifications around this area? This question is not addressed in this study.

      Again, we note that the hypotheses we test here relate to the firing mode of grid cells - taskanchored or task-independent - and interpretation of our results is independent from the specific pattern of grid fields on the track. This question nevertheless leads to an interesting prediction that if grid fields cluster in the goal area then this clustering should be apparent in the task-anchored but not the task-independent firing mode.

      We test this by considering the average distribution of firing fields across all grid cells in each firing mode (Reviewer Figure 1). We find that when grid firing is task-anchored there is a clear peak around the reward zone, which is consistent with previous work by Butler et al. and Boccara et al. Consistent with our other prediction, this peak is reduced when grid cells are in the task-independent mode.

      Author response image 1.

      Plot shows the grid field distribution during stable grid cell session (> 85 % task-anchored or task-independent) (A) or during task-anchored and task-independent trials (B). Shaded regions in A and B represent standard error of the mean measured across sessions and epochs respectively.

      (3) The behavioural procedure during recording is not fully explained. Do trial types alternate within the same session by blocks? How many trials are within a block? Is there any relation between trial alternation and the switch in the coding scheme observed in a large subset of the grid cells?

      We agree this wasn’t sufficiently clear in the previous version of the manuscript. Trial types were interleaved in a fixed order within each session. We have updated the results and methods sections to provide details (see responses above).

      (4) From the examples in Figure 2 it seems that firing fields tend to shift toward the start position. Is it the case in all cells? Could this reflect some reorganisation at the network level with cells signalling the starting as time progresses?

      This is inconsistent between cells. To make this variability clear we have included additional examples of spiking profiles from different grid cells (Figure 2 - 5). Because quantification of the phenomena would not, so far as we can tell, help distinguish our core hypotheses we have not included further analyses here.

      (5) Are grid cells with different coding properties recorded in different parts of the MEC? Are there any differences between these cell categories in the 2D map?

      The recordings we made are from the dorsal region of the MEC (stated at the start of the results section). We don’t have data to speak to other parts of the MEC.

      Minor:

      There are very few grid cell examples that repeat in the different figures. I would suggest showing more examples both in the main text and supplementary material.

      We have now provided multiple additional examples in Figures 2, 4 and 5. Grid cell examples repeat in the main figures twice, in both cases only when showing additional examples are shown from the same recording session (Figure 2A example #1 with Figure 5C, Figure 3E with Figure 4A). Further similar repeats are found in the supplemental figures (Figure 3D with Figure 5, Figure Supplement 2A, Figure 3C with Figure 5, Figure Supplement 2F).

      Fig1 A-B shows the predictions in a 1D track based on distance or position coding. The A inset represents the modification of field distribution from a 2D arena to a 1D track, as performed in this study. The inset B is misleading since it represents the modifications expected from a circular track to a 1D track as in Jacob et al 2019, that is not what the authors studied. It would be better to present either the predictions based on the present study or the prediction based on previous studies. In that case, they should mention the possibility that the 1D map is a slice of the 2D map.

      The goal of Figure 1A-B is to illustrate predictions (right) based on conclusions from previous studies (left). Figure 1A shows predicted 1D track firing given anchoring to the environment typically observed in grid cell studies in 2D arenas. Figure 1B shows predicted 1D track firing given the firing shifting firing patterns observed by Jacob et al. in a circular 2D track. To improve clarity, we have modified the legend to make clear that the schematics to the right are predictions given the previous evidence summarised to the left. As we outline above, the critical prediction relates to whether the representations anchor to the track. Whether the 1D representation is a perfect slice isn’t relevant to the hypotheses tested and so isn’t included in the schematic (see comments above).

    1. Author Response

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The authors of this study seek to visualize NS1 purified from dengue virus infected cells. They infect vero cells with DV2-WT and DV2 NS1-T164S (a mutant virus previously characterized by the authors). The authors utilize an anti-NS1 antibody to immunoprecipitate NS1 from cell supernatants and then elute the antibody/NS1 complex with acid. The authors evaluate the eluted NS1 by SDS-PAGE, Native Page, mass spec, negative-stain EM, and eventually Cryo-EM. SDS-PAGE, mas spec, and native page reveal a >250 Kd species containing both NS1 and the proteinaceous component of HDL (ApoA1). The authors produce evidence to suggest that this population is predominantly NS1 in complex with ApoA1. This contrasts with recombinantly produced NS1 (obtained from a collaborator) which did not appear to be in complex with or contain ApoA1 (Figure 1C). The authors then visualize their NS1 stock in complex with their monoclonal antibody by CryoEM. For NS1-WT, the major species visualized by the authors was a ternary complex of an HDL particle in complex with an NS1 dimer bound to their mAB. For their mutant NS1-T164S, they find similar structures, but in contrast to NS1-WT, they visualize free NS1 dimers in complex with 2 Fabs (similar to what's been reported previously) as one of the major species. This highlights that different NS1 species have markedly divergent structural dynamics. It's important to note that the electron density maps for their structures do appear to be a bit overfitted since there are many regions with electron density that do not have a predicted fit and their HDL structure does not appear to have any predicted secondary structure for ApoA1. The authors then map the interaction between NS1 and ApoA1 using cross-linking mass spectrometry revealing numerous NS1-ApoA1 contact sites in the beta-roll and wing domain. The authors find that NS1 isolated from DENV infected mice is also present as a >250 kD species containing ApoA1. They further determine that immunoprecipitation of ApoA1 out of the sera from a single dengue patient correlates with levels of NS1 (presumably COIPed by ApoA1) in a dose-dependent manner.

      In the end, the authors make some useful observations for the NS1 field (mostly confirmatory) providing additional insight into the propensity of NS1 to interact with HDL and ApoA1. The study does not provide any functional assays to demonstrate activity of their proteins or conduct mutagenesis (or any other assays) to support their interaction predications. The authors assertion that higher-order NS1 exists primarily as a NS1 dimer in complex with HDL is not well supported as their purification methodology of NS1 likely introduces bias as to what NS1 complexes are isolated. While their results clearly reveal NS1 in complex with ApoA1, the lack of other NS1 homo-oligomers may be explained by how they purify NS1 from virally infected supernatant. Because NS1 produced during viral infection is not tagged, the authors use an anti-NS1 monoclonal antibody to purify NS1. This introduces a source of bias since only NS1 oligomers with their mAb epitope exposed will be purified. Further, the use of acid to elute NS1 may denature or alter NS1 structure and the authors do not include controls to test functionality of their NS1 stocks (capacity to trigger endothelial dysfunction or immune cell activation). The acid elution may force NS1 homo-oligomers into dimers which then reassociate with ApoA1 in a manner that is not reflective of native conditions. Conducting CryoEM of NS1 stocks only in the presence of full-length mAbs or Fabs also severely biases what species of NS1 is visualized since any NS1 oligomers without the B-ladder domain exposed will not be visualized. If the residues obscured by their mAb are involved in formation of higher-order oligomers then this antibody would functionally inhibit these species from forming. The absence of critical controls, use of one mAb, and acid elution for protein purification severely limits the interpretation of these data and do not paint a clear picture of if NS1 produced during infection is structurally distinct from recombinant NS1. Certainly there is novelty in purifying NS1 from virally infected cells, but without using a few different NS1 antibodies to purify NS1 stocks (or better yet a polyclonal population of antibodies) it's unclear if the results of the authors are simply a consequence of the mAb they selected.

      Data produced from numerous labs studying structure and function of flavivirus NS1 proteins provide diverse lines of evidence that the oligomeric state of NS1 is dynamic and can shift depending on context and environment. This means that the methodology used for NS1 production and purification will strongly impact the results of a study. The data in this manuscript certainly capture one of these dynamic states and overall support the general model of a dynamic NS1 oligomer that can associate with both host proteins as well as itself but the assertions of this manuscript are overall too strong given their data, as there is little evidence in this manuscript, and none available in the large body of existing literature, to support that NS1 exists only as a dimer associated with ApoA1. More likely the results of this paper are a result of their NS1 purification methodology.

      Suggestions for the Authors:

      Major:

      (1) Because of the methodology used for NS1 purification, it is not clear from the data provided if NS1 from viral infection differs from recombinant NS1. Isolating NS1 from viral infection using a polyclonal antibody population would be better to answer their questions. On this point, Vero cells are also not the best candidate for their NS1 production given these cells do not come from a human. A more relevant cell line like U937-DC-SIGN would be preferable.

      We performed an optimization of sNS1 secretion from DENV infection in different cell lines (Author response image 1 below) to identify the best cell line candidate to obtain relatively high yield of sNS1 for the study. As shown in Author response image 1, the levels of sNS1 in the tested human cell lines Huh7 and HEK 293T were at least 3-5 fold lower than in Vero cells. Although using a monocytic cell line expressing DC-SIGN as suggested by the reviewer would be ideal, in our experience the low infectivity of DENV in monocytic cell lines will not yield sufficient amount of sNS1 needed for structural analysis. For these practical reasons we decided to use the closely related non-human primate cell line Vero for sNS1 production supported by our optimization data.

      Author response image 1.

      sNS1 secretion in different mammalian and mosquito cell lines after DENV2 infection. The NS1 secretion level is measured using PlateliaTM Dengue NS1 Ag ELISA kit (Bio-Rad) on day 3 (left) and day 5 (right) post infection respectively.

      (2) The authors need to support their interaction predictions and models via orthogonal assays like mutagenesis followed by HDL/ApoA1 complexing and even NS1 functional assays. The authors should be able to mutate NS1 at regions predicted to be critical for ApoA1/HDL interaction. This is critical to support the central conclusions of this manuscript.

      In our previous publication (Chan et al., 2019 Sci Transl Med), we used similarly purified sNS1 (immunoaffinity purification followed by acid elution) from infected culture supernatants from both DENV2 wild-type and T164S mutant (both also studied in the present work) to carry out stimulation assay on human PBMCs as described by other leading laboratories investigating NS1 (Modhiran et al., 2015 Sci Transl Med). For reader convenience we have extracted the data from our published paper and present it as Author response image 2 below.

      Author response image 2.

      (A) IL6 and (B) TNFa concentrations measured in the supernatants of human PBMCs incubated with either 1µg/ml or 10µg/ml of the BHK-21 immunoaffinity-purified WT and TS mutant sNS1 for 24 hours. Data is adapted from Chan et al., 2019.

      Incubation of immunoaffinity-purified sNS1 (WT and TS) with human PBMCs from 3 independent human donors triggered the production of proinflammatory cytokines IL6 and TNF in a concentration dependent manner (Author response image 2), consistent with the published data by Modhiran et al., 2015 Sci Transl Med. Interestingly the TS mutant derived sNS1 induced a higher proinflammatory cytokines production than WT virus derived sNS1 that appears to correlate with the more lethal and severe disease phenotype in mice as also reported in our previous work (Chan et al., 2019). Additionally, the functionality of our immune-affinity purified infection derived sNS1 (isNA1) is now further supported by our preliminary results on the NS1 induced endothelial cell permeability assay using the purified WT and mutant isNS1 (Author response image 3). As shown in Author response image 3, both the isNS1wt and isNS1ts mutant reduced the relative transendothelial resistance from 0 to 9 h post-treatment, with the peak resistance reduction observed at 6 h post-treatment, suggesting that the purified isNS1 induced endothelial dysfunction as reported in Puerta-Guardo et al., 2019, Cell Rep.) It is noteworthy that the isNS1 in our study behaves similarly as the commercial recombinant sNS1 (rsNS1 purchased from the same source used in study by Puerta-Guardo et al., 2019) in inducing endothelial hyperpermeability. Collectively our previous published and current data suggest that the purified isNS1 (as a complex with ApoA1) has a pathogenic role in disease pathogenesis that is also supported in a recent publication by Benfrid et al., EMBO 2022). The acid elution has not affected the functionality of NS1.

      Author response image 3.

      Functional assessment of isNS1wt and isNS1ts on vascular permeability in vitro. A trans-endothelial permeabilty assay via measurement of the transendothelial electrical resistance (TEER) on human umbilical vascular endothelial cells (hUVEC) was performed, as described previously (Puerta-Guardo et al., 2019, Cell Rep). Ovalbumin serves as the negative control, while TNF-α and rsNS1 serves as the positive controls.

      We agree with reviewer about the suggested mutagnesis study. We will perform site-directed mutagenesis at selected residues and further structural and functional analyses and report the results in a follow-up study.

      (3) The authors need to show that the NS1 stocks produced using acid elution are functional compared to standard recombinantly produced NS1. Do acidic conditions impact structure/function of NS1?

      We are providing the same response to comments 1 & 2 above. We would like to reiterate that we have previously used sNS1 from immunoaffinity purification followed by acid elution to test its function in stimulating PBMCs to produce pro-inflammatory cytokines (Chan et al., 2019; Author response image 2). Similar to Modhiran et al. (2015) and Benfrid et al. (2022), the sNS1 that we extracted using acid elution are capable of activating PBMCs to produce pro-inflammatory cytokines. We have now further demonstrated the ability of both WT and TS isNS1 in inducing endothelial permeability in vitro in hUVECs, using the TEER assay (Author response image 3). Based on the data presented in the rebuttal figures as well as our previous publication we do not think that the acid elution has a significant impact on function of isNS1.

      We performed affinity purification to enrich the complex for better imaging and analysis (Supp Fig. 1b) since the crude supernatant contains serum proteins and serum-free infections also do not provide sufficient isNS1. The major complex observed in negative stain is 1:1 (also under acidic conditions which implies that the complex are stable and intact). We agree that it is possible that other oligomers can form but we have observed only a small population (74 out of 3433 particles, 2.15%; 24 micrographs) of HDL:sNS1 complex at 1:2 ratio as shown in the Author response image 4 below and in the manuscript (p. 4 lines 114-117, Supp Fig. 1c). Other NS1 dimer:HDL ratios including 2:1 and 3:1 have been reported by Benfrid et al., 2022 by spiking healthy sera with recombinant sNS1 and subsequent re-affinity purification. However, this method used an approximately 8-fold higher sNS1 concentration (400 ug/mL) than the maximum clinically reported concentration (50 ug/mL) (Young et al., 2000; Alcon et al., 2002; Libraty et al., 2002). In our hands, the sNS1 concentration in the concentrated media from in vitro infection was quantified as 30 ug/mL which is more physiologically relevant.

      We conclude that the integrity of the HDL of the complex is not lost during sample preparation, as we are able to observe the complex under the negative staining EM as well as infer from XL-MS. Our rebuttal data and our previous studies with our acid-eluted isNS1 from immunoaffinity purification clearly show that our protein is functional and biologically relevant.

      Author response image 4.

      (A) Representative negative stain micrograph of sNS1wt (B) Representative 2D averages of negative stained isNS1wt. Red arrows indicating the characteristic wing-like protrusions of NS1 inserted in HDL. (C) Data adapted from Figure 2 in Benfrid et al. (2022).

      (4) Overall, the data obtained from the mutant NS1 (contrasted to WT NS1) reveals how dynamic the oligomeric state of NS1 proteins are but the authors do not provide any insight into how/why this is, some additional lines of evidence using either structural studies or mutagenesis to compare WT and their mutant and even NS1 from a different serotype of DENV would help the field to understand the dynamic nature of NS1.

      The T164S mutation in DENV2 NS1 was proposed as the residue associated with disease severity in 1997 Cuban dengue epidemic (Halsted SB. “Intraepidemic increases in dengue disease severity: applying lessons on surveillance and transmission”. Whitehorn, J., Farrar. J., Eds., Clinical Insights in Dengue: Transmission, Diagnosis & Surveillance. The Future Medicine (2014), pp. 83-101). Our previous manuscript examined this mutation by engineering it into a less virulent clade 2 DENV isolated in Singapore and showed that sNS1 production was higher without any change in viral RNA replication. Transcript profiling of mutant compared to WT virus showed that genes that are usually induced during vascular leakage were upregulated for the mutant. We also showed that infection of interferon deficient AG129 mice with the mutant virus resulted in disease severity, increased complement protein expression in the liver, tissue inflammation and greater mortality compared to WT virus infected mice. The lipid profiling in our study (Chan et al., 2019) suggested small differences with WT but was overall similar to HDL as described by Gutsche et al. (2011). We were intrigued by our functional results and wanted to explore more deeply the impact of the mutation on sNS1 structure which at that stage was widely believed to be a trimer of NS1 dimers with a central channel (~ X Å) stuffed with lipid as established in several seminal publications (Flamand et al., 1999; Gutsche et al., 2011; Muller et al., 2012). In fact “This Week in Virology” netcast (https://www.microbe.tv/twiv/twiv-725/) discussed two back-to-back publications in Science (Modhiran et al., 371(6625)190-194; Biering et al., Science 371(6625):194-200)) which showed that therapeutic antibodies can ameliorate the NS1 induced pathogenesis and expert discussants posed questions that also pointed to the need for more accurate definition of the molecular composition and architecture of the circulating NS1 complex during virus infection to get a clearer handle on its pathogenic mechanism. Our current studies and also the recent high resolution cryoEM structures (Shu et al., 2022) do not support the notion of a central channel “stuffed with lipid”. Even in the rare instances where trimer of dimers are shown, the narrow channel in the center could only accommodate one molecule of lipoid molecule no bigger than a typical triglyceride molecule. This hexamer model cannot explain the lipid proeotmics data in the literature.

      In our study we observed predominantly 1:1 NS1 dimer to HDL (~30 μg/mL) mirroring maximum clinically reported concentration of sNS1 in the sera of DENV patients (40-50 μg/mL) as we highlighted in our main text (P. 18, lines 461-471). What is often quoted (also see later) is the recent study of Flamand & co-workers which show 1-3 NS1 dimers per HDL (Benfrid et al, 2022) by spiking rsNS1 (400 μg/mL) with HDL. This should not be confused with the previous models which suggested a lipid filled central channel holding together the hexamer. The use of physiologically relevant concentrations is important for these studies as we have highlighted in our main text (P. 18, lines 461-471).

      Our interpretation for the mutant (isNS1ts) is that it is possible that the hydrophilic serine at residue 164 located in the greasy finger loop may weaken the isNS1ts binding to HDL hence the observation of free sNS1 dimers in our immunoaffinity purified (acid eluted sample). The disease severity and increased complement protein expression in AG129 mice liver can be ascribed to weakly bound mutant NS1 with fast on/off rate with HDL being transported to the liver where specific receptors bind to free sNS1 and interact with effector proteins such as complement to drive inflammation and associated pathology. Our indirect support for this is that the XL-MS analysis of purified isNS1ts identified only 7 isNS1ts:ApoA1 crosslinks while 25 isNS1wt:ApoA1 crosslinks were identified from purified isNS1wt (refer to Fig. 4 and Supp. Fig. 8).

      Taken together, the cryoEM and XL-MS analysis of purified isNS1ts suggest that isNS1ts has weaker affinity for HDL compared to isNS1wt. We welcome constructive discussion on our interpretation that we and others will hopefully obtain more data to support or deny our proposed explanation. Our focus has been to compare WT with mutant sNS1 from DENV2 and we agree that it will be useful to study other serotypes.

      Reviewer #2:

      CryoEM:

      Some of the neg-stain 2D class averages for sNS1 in Fig S1 clearly show 1 or 2 NS1 dimers on the surface of a spherical object, presumably HDL, and indicate the possibility of high-quality cryoEM results. However, the cryoEM results are disappointing. The cryo 2D class averages and refined EM map in Fig S4 are of poor quality, indicating sub-optimal grid preparation or some other sample problem. Some of the FSC curves (2 in Fig S7 and 1 in Fig S6) have extremely peculiar shapes, suggesting something amiss in the map refinement. The sharp drop in the "corrected" FSC curves in Figs S5c and S6c (upper) indicate severe problems. The stated resolutions (3.42 & 3.82 Å) for the sNS1ts-Fab56.2 are wildly incompatible with the images of the refined maps in Figs 3 & S7. At those resolutions, clear secondary structural elements should be visible throughout the map. From the 2D averages and 3D maps shown in the figures this does not seem to be the case. Local resolution maps should be shown for each structure.

      The same sample is used for negative staining and the cryoEM results presented. The cryoEM 2D class averages are similar to the negative stain ones, with many spherical-like densities with no discernible features, presumably HDL only or the NS1 features are averaged out. The key difference lies in the 2D class averages where the NS1 could be seen. The side views of NS1 (wing-like protrusion) are more obvious in the negative stain while the top views of NS1 (cross shaped-like protrusion) are more obvious under cryoEM. HDL particles are inherently heterogeneous and known to range from 70-120 Å, this has been highlighted in the main text (p. 8, lines 203 and 228). This helps to explain why the reviewer may find the cryoEM result disappointing. The sample is inherently challenging to resolve structurally as it is (not that the sample is of poor quality). In terms of grid preparation, Supp Fig 4b shows a representative motion-corrected micrograph of the isNS1ts sample whereby individual particles can be discerned and evenly distributed across the grid at high density.

      We acknowledge that most of the dips in the FSC curves (Fig S5-7) are irregular and affect the accuracy of the stated resolutions, particularly for the HDL-isNS1ts-Fab56.2 and isNS1ts-Fab56.2 maps for which the local resolution maps are shown (Fig S7d-e). Probable reasons affecting the FSC curves include (1) the heterogeneous nature of HDL, (2) preferred orientation issue (p 7, lines 198 -200), and (3) the data quality is intrinsically less ideal for high resolution single particle analysis. Optimizing of the dynamic masking such that the mask is not sharper than the resolution of the map for the near (default = 3 angstroms) and far (12 angstroms) parameters during data processing, ranging from 6 - 12 and 14 - 20 respectively, did not help to improve the FSC curves. To report a more accurate global resolution, we have revised the figures S5-7 with new FSC curve plots generated using the remote 3DFSC processing server.

      Regardless, the overall architecture and the relative arrangement of NS1 dimer, Fab, and HDL are clearly visible and identifiable in the map. These results agree well with our biochemical data and mass-spec data.

      The samples were clearly challenging for cryoEM, leading to poor quality maps that were difficult to interpret. None of the figures are convincing that NS1, Ab56.2 or Fab56.2 are correctly fit into EM maps. There is no indication of ApoA1 helices. Details of the fit of models to density for key regions of the higher-resolution EM maps should be shown and the models should be deposited in the PDB. An example of modeling difficulty is clear in the sNS1ts dimer with bound Fab56.2 (figs 3c & S7e). For this complex, the orientation of the Fab56.2 relative to the sNS1ts dimer in this submission (Fig 3c) is substantially different than in the bioRxiv preprint (Fig 3c). Regions of empty density in Fig 3c also illustrate the challenge of building a model into this map.

      We acknowledge the modelling challenge posed by low resolution maps in general, such as the handedness of the Fab molecule as pointed out by the reviewer (which is why others have developed the use of anti-fab nanobody to aid in structure determination among other methods). The change in orientation of the Fab56.2 relative to the sNS1ts dimer was informed by the HDX-MS results which was not done at the point of bioRxiv preprint mentioned. With regards to indication of ApoA1 helices, this is expected given the heterogeneous nature of HDL. To the best of our knowledge, engineered apoA1 helices were also not reported in many cryoEM structures of membrane proteins solved in membrane scaffold protein (MSP) nanodiscs. This is despite nanodiscs, comprised of engineered apoA1 helices, having well-defined size classifications.

      Regions of weak density in Fig 3c is expected due to the preferred orientation issue acknowledged in the results section of the main text (p. 9, line 245). The cryoEM density maps have been deposited in the Electron Microscopy Data Bank (EMDB) under accession codes EMD-36483 (isNS1ts:Fab56.2) and EMD-36480 (Fab56.2:isNS1ts:HDL). The protein model files for isNS1ts:Fab56.2 and Fab56.2:isNS1ts:HDL model are available upon request. Crosslinking MS raw files and the search results can be downloaded from https://repository.jpostdb.org/preview/14869768463bf85b347ac2 with the access code: 3827. The HDX-MS data is deposited to the ProteomeXchange consortium via PRIDE partner repository51 with the dataset identifier PXD042235.

      Mass spec:

      Crosslinking-mass spec was used to detect contacts between NS1 and ApoA1, providing strong validation of the sNS1-HDL association. As the crosslinks were detected in a bulk sample, they show that NS1 is near ApoA1 in many/most HDL particles, but they do not indicate a specific protein-protein complex. Thus, the data do not support the model of an NS1-ApoA1 complex in Fig 4d. Further, a specific NS1-ApoA1 interaction should have evidence in the EM maps (helical density for ApoA1), but none is shown or mentioned. If such exists, it could perhaps be visualized after focused refinement of the map for sNS1ts-HDL with Fab56.2 (Fig S7d). The finding that sNS1-ApoA1 crosslinks involved residues on the hydrophobic surface of the NS1 dimer confirms previous data that this NS1 surface engages with membranes and lipids.

      We thank the reviewer for the comment. The XL-MS is a method to identify the protein-protein interactions by proximity within the spacer arm length of the crosslinker. The crosslinking MS data do support the NS1-ApoA1 complex model obtained by cryo-EM because the identified crosslinks that are superimposed on the EM map are within the cut-off distance of 30 Å. We agree that the XL-MS data do not dictate the specific interactions between specific residues of NS1-ApoA1 in the EM model. We also do not claim that specific residue of NS1 in beta roll or wing domain is interacting with specific residue of ApoA1 in H4 and H5 domain. We claim that beta roll and wing domain regions of NS1 are interacting with ApoA1 in HDL indicating the proximity nature of NS1-ApoA1 interactions as warranted by the XL-MS data.

      As explained in the previous response on the lack of indication of ApoA1 helical density, this is expected given the heterogeneous nature of HDL. It is typical to see lipid membranes as unstructured and of lower density than the structured protein. In our study, local refinement was performed on either the global map (presented in Fig S7d) or focused on the NS1-Fab region only. Both yielded similar maps as illustrated in the real space slices shown in Author response image 5. The mask and map overlay is depicted in similar orientations to the real space slices, and at different contour thresholds at 0.05 (Author response image 5e) and 0.135 (Author response image 5f). While the overall map is of poor resolution and directional anisotropy evident, there is clear signal differences in the low density region (i.e. the HDL sphere) indicative of NS1 interaction with ApoA1 in HDL, extending from the NS1 wing to the base of the HDL sphere.

      Author response image 5.

      Real Space Slices of map and mask used during Local Refinement for overall structure (a-b) and focused mask on NS1 region (c-d). The corresponding map (grey) contoured at 0.05 (e) and 0.135 (f) in similar orientations as shown for the real space slices of map and masks. The focused mask of NS1 used is colored in semi-transparent yellow. Real Space Slices of map and mask are generated during data processing in Cryosparc 4.0 and the map figures were prepared using ChimeraX.

      Sample quality:

      The paper lacks any validation that the purified sNS1 retains established functions, for example the ability to enhance virus infectivity or to promote endothelial dysfunction.

      Please see detailed response for question 2 in Reviewer #1’s comments. In essence, we have showed that both isNS1wt and isNS1ts are capable of inducing endothelial permeability in an in vitro TEER assay (Rebuttal Fig 3) and also in our previous study that quantified inflammation in human PBMC’s (Rebuttal Fig 2).

      Peculiarities include the gel filtration profiles (Fig 2a), which indicate identical elution volumes (apparent MWs) for sNS1wt-HDL bound to Ab562 (~150 kDa) and to the ~3X smaller Fab56.2 (~50 kDa). There should also be some indication of sNS1wt-HDL pairs crosslinked by the full-length Ab, as can be seen in the raw cryoEM micrograph (Fig S5b).

      Obtaining high quality structures is often more demanding of sample integrity than are activity assays. Given the low quality of the cryoEM maps, it's possible that the acidification step in immunoaffinity purification damaged the HDL complex. No validation of HDL integrity, for example with acid-treated HDL, is reported.

      Please see detailed response for question 3 in Reviewer #1’s comments.

      Acid treatment is perhaps discounted by a statement (line 464) that another group also used immunoaffinity purification in a recent study (ref 20) reporting sNS1 bound to HDL. However the statement is incorrect; the cited study used affinity purification via a strep-tag on recombinant sNS1.

      We thank the Reviewer for pointing this out and have rewritten this paragraph instead (p 18, line 445-455). We also expanded our discussion to highlight our prior functional studies showing that acid-eluted isNS1 proteins do induce endothelial hyperpermeability (p 18-19, line 470-476).

      Discussion:

      The Discussion reflects a view that the NS1 secreted from virus-infected cells is a 1:1 sNS1dimer:HDL complex with the specific NS1-ApoA1 contacts detected by crosslinking mass spec. This is inconsistent with both the neg-stain 2D class average with 2 sNS1 dimers on an HDL (Fig S1c) and with the recent study of Flamand & co-workers showing 1-3 NS1 dimers per HDL (ref 20). It is also ignores the propensity of NS1 to associate with membranes and lipids. It is far more likely that NS1 association with HDL is driven by these hydrophobic interactions than by specific protein-protein contacts. A lengthy Discussion section (lines 461-522) includes several chemically dubious or inconsistent statements, all based on the assumption that specific ApoA1 contacts are essential to NS1 association with HDL and that sNS1 oligomers higher than the dimer necessarily involve ApoA1 interaction, conclusions that are not established by the data in this paper.

      We thank the Reviewer and have revised our discussion to cover available structural and functional data to draw conclusions that invariably also need further validation by others. One point that is repeatedly brought up by Reviewer 1 & 2 is the quality and functionality of our sample. Our conclusion now reiterates this point based on our own published data (Chan et al., 2019) and also the TEER assay data provided as Author response image 3.

      Reviewer #1 (Recommendations For The Authors):

      Minor:

      (1) Fig. S3B, should the label for lane 4 be isNS1? In figure 1C you do not see ApoA1 for rsNS1 but for S3B you do? Which is correct?

      This has been corrected in the Fig. S3B, the label for lane 4 has been corrected to isNS1 and lane 1 to rsNS1, where no ApoA1 band (25 kDa) is found.

      (2) Line 436, is this the correct reference? Reference 43?

      This has been corrected in the main text. (p 20, Line 507; Lee et al., 2020, J Exp Med).

      Reviewer #2 (Recommendations For The Authors):

      The cryoEM data analysis is incompletely described. The process (software, etc) leading to each refined EM map should be stated, including the use of reference structures in any step. These details are not in the Methods or in Figs S4-7, as claimed in the Methods. The use of DeepEMhancer (which refinements?) with the lack of defined secondary structural features in the maps and without any validation (or discussion of what was used as "ground truth") is concerning. At the least, the authors should show pre- and post-DeepEMhancer maps in the supplemental figures.

      The data processing steps in the Methods section have been described with improved clarity. DeepEMhancer is a deep learning solution for cryo-EM volume post-processing to reduce noise levels and obtain more detailed versions of the experimental maps (Sanchez-Garcia, et al., 2021). DeepEMhancer was only used to sharpen the maps and reduce the noise for classes 1 and 2 of isNS1wt in complex with Ab56.2 for visualization purpose only and not for any refinements. To avoid any confusion, the use of DeepEMhancer has been removed from the supp text and figures.

      Line 83 - "cryoEM structures...recently reported" isn't ref 17

      This reference has been corrected in to Shu et al. (2022) in p 3, line 83.

      Fig. S3 - mis-labeled gel lanes

      This has been corrected in the Fig. S3B, the label for lane 4 has been corrected to isNS1 and lane 1 to rsNS1.

      Fig S6c caption - "Representative 2D classes of each 3D classes, white bar 100 Å. Refined 3D map for classes 1 and 2 coloured by local resolution". The first sentence is unclear, and there is no white scale bar and no heat map.

      Fig S6c caption has been corrected to “Representative 3D classes contoured at 0.06 and its particle distribution as labelled and coloured in cyan. Scale bar of 100 Å as shown. Refined 3D maps and their respective FSC resolution charts and posterior precision directional distribution as generated in crysosparc4.0”.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Reviews):

      Weaknesses: 

      Overall I find the data presented compelling, but I feel that the number of observations is quite low (typically n=3-7 neurons, typically one per animal). While I understand that only a few slices can be obtained for the IPN from each animal, the strength of the novel findings would be more convincing with more frequent observations (larger n, more than one per animal). The findings here suggest that the authors have identified a novel mechanism for the normal function of neurotransmission in the IPN, so it would be expected to be observable in almost any animal. Thus,  it is not clear to me why the authors investigated so few neurons per slice and chose to combine different treatments into one group (e.g. Figure 2f), even if the treatments have the same expected effect.  

      This is a well taken suggestion. However, we must  point out that we do perform statistical analyses on the original datasets and we believe that our conclusions are justified as acknowledged by the Reviewer. As the Reviewer is aware,  the IPN is a small nucleus and with the slicing protocol used, we typically attain 1-2 slices per mouse that are suitable for recordings. Since most of the experiments in the manuscript deals with some form of pharmacological interrogation, we were reticent to use slices that are not naïve and therefore in general did not perform more than 1 cell recording per slice. Having said this, to comply with the Reviewer’s suggestion we have now performed additional experiments to increase the n number for certain experiments. We have amended all figures and legends to incorporate the additional data. We must point out that during the replotting of the data in the summary Figure 8i (previously Figure 7i) we noticed an error with the data representation of the TAC IPL data and have now corrected this oversight  

      Figure 2b,c. 

      500nM DAMGO effect on TAC IPL AMPAR EPSC – n increased from 5 to 9

      Figure 3g. 

      500nM DAMGO effect on CHAT IPR AMPAR EPSC – n increased from 8 to 16 Effect of CTAP on DAMGO on CHAT IPR AMPAR EPSC – n increased from 4 to 7

      Figure 3i. 

      500nm DAMGO or Met-enk effect in “silent” CHAT IPR AMPAR EPSC – n increased    from 7 to 9

      Figure 4e. 

      500nM DAMGO effect on ES coupling – Note: in the original version the n number was 5 and not 7 as written in the figure legend. We have now increased the n from 5 – 9.

      Figure 5e,f. 

      500nM DAMGO effect on TAC IPR AMPAR EPSC – n increased from 5 to 9

      Figure 7f.

      Effect of DHE on EPSC amplitude after application of DNQX/APV/4-AP or DTX-α – n increased from 7-9.

      Figure 7g.

      Emergence of nAChR EPSC after DTX – n increased from 4 to 7

      Figure 7i. 

      Effect of ambenonium on nAChR amplitude and charge – n increased from 4 to 7

      Supplementary Figure 3c and h

      Effect of DAMGO after DNQX – n increased from 4 to 7

      Effect of DNQX after DAMGO mediated potentiation – n increased from 3 to 5.

      Throughout the study (Figs. 3i, 7f and 8h in the revised manuscript)  we do indeed pool datasets that were amassed from different conditions since we were not directly investigating the possibility of any deviation in the extent of response between said treatments. For example, and as pointed out by the Reviewer, in Fig. 2F (now Fig. 3i) the use of DAMGO and met-ENK were merely employed to ascertain whether light-evoked synaptic transmission (ChATCre:ai32 mice) in cells that had no measurable EPSC could be pharmacologically “unsilenced” by mOR activation. Thus, the means by which mOR receptor was activated was not relevant to this specific question. Note: 2 more recordings are now added to this dataset (Fig. 3i) that were taken from ChATChR2/SSTCre:ai9 mice in response to the comment by this Reviewer below (“Are there baseline differences in the electrophysiological or morphological properties of these "silent" neurons compared to the responsive neurons?”).  Similarly, in the revised Fig.7f we pooled data investigating the pharmacological block of the EPSC that emerged following application of either DNQX/APV/4-AP or DNQX/APV/DTX. Low concentrations 4-AP or DTX were interchangeably employed to reveal the DNQX-insensitive EPSC that we go on to show is indeed the nAChR response. Finally, in Fig. 8h, we pooled data demonstrating a  lack of effect of DAMGO in potentiating  both the glutamatergic and cholinergic arms of synaptic transmission in the OPRM1 KO mice. Again, here we were only interested in determining whether removal of mOR expression prevented potentiation of transmission mediated by mHB ChAT neurons irrespective of neurotransmitter modality.  Thus, overall we were careful to only pool data in those instances where it  would not change the interpretation and hence conclusions reached. 

      There are also significant sex differences in nAChR expression in the IPN that might not be functionally apparent using the low n presented here. It would be helpful to know which of the recorded neurons came from each sex, rather than presenting only the pooled data.  

      As the reviewer correctly states there are veins of literature concerning a divergence, based on sex, of not only nicotinic receptor expression but also behaviors associated with nicotine addiction. However, we have reanalyzed our datasets focusing on the extent of the mOR potentiation of glutamatergic and cholinergic transmission mediated by mHB ChAT neurons in IPR  between male and female mice. Please refer to the Author response image 1 below. Although there is a possible trend towards a higher potentiation of nAChR in female mice, this was not found to be of statistical significance (see Author response image 1 below). We therefore chose not to split our data in the manuscript based on gender.

      Author response image 1.

      Comparison of the mOR (500nM DAMGO) mediated potentiation on evoked (a) AMPAR and (b) nAChR  EPSCs in IPR between male and female mice.  

      There are also some particularly novel observations that are presented but not followed up on, and this creates a somewhat disjointed story. For example, in Figure 2, the authors identify neurons in which no response is elicited by light stimulation of ChAT-neurons, but the application of DAMGO (mOR agonist) un-silences these neurons. Are there baseline differences in the electrophysiological or morphological properties of these "silent" neurons compared to the responsive neurons?  

      Unfortunately, we did not routinely measure intrinsic properties of the recorded postsynaptic neurons nor systematically recovered biocytin fills to assess morphology. Therefore, it remains unclear whether the  neurons in which there were none or minimal AMPAR-mediated EPSCs are distinct to the ones displaying measurable responses. The IPR is resident to GABAergic SST neurons that comprise the most numerous neuron type in this IPN subdivision. Although heavily outnumbered by the SST neurons there are additionally VGluT3+ glutamatergic neurons in IPN. The Reviewer is likely referring to a recent study investigating synaptic transmission specifically onto  SST+ and VGluT3+ neurons in IPN demonstrating that mHB cholinergic mediated glutamatergic input is “weaker” onto the glutamatergic neurons. Furthermore, in some instances synaptic transmission onto this latter population can be “unsilenced” by GABAB receptor activation in a similar manner to that seen with mOR activation in this manuscript when IPR neurons are blindly targeted(Stinson & Ninan, 2025).  Using a similar strategy as in this recent study(Stinson & Ninan, 2025), we now include experiments in which the ChATChR2 mouse was crossed with  a SSTCre:Ai14. This allowed for recording of postsynaptic EPSCs in directly identified SST IPR neurons. We demonstrate that DAMGO can indeed increase glutamatergic EPSCs and in 2 of the cells where light activation demonstrated no appreciable AMPAR EPSC upon maximal LED light activation, DAMGO clearly “unsilenced” transmission.  Thus, our additional analyses directly demonstrate that our original observations concerning mOR modulation extend to the mHb cholinergic AMPAR mediated input onto IPR SST neurons. This additional data is in the revised manuscript (Figure 3D-F, I). Future experimentation will be required to determine if the propensity of encountering a  “silent” input that can be converted to robust synaptic transmission by mOR differs between these two cell types. Furthermore, it will be of interest to investigate if any differences exist in the magnitude of the cholinergic input or the mOR mediated potentiation of co-transmission between postsynaptic SST GABA and glutamatergic neuronal subtypes. 

      Reviewer #2 (Public review)

      Weaknesses: 

      The genetic strategy used to target the mHb-IPN pathway (constitutive expression in all ChAT+ and Tac1+ neurons) is not specific to this projection.  

      This is an important point made. We are acutely aware that the source of the synaptic input in IPN mediated by conditional expression of ChR2 employing  using transgenic cre driver lines does not confer specificity to mHB. This is particularly relevant considering one of the novel observations here relates to  a previously unidentified functional input from TAC1 neurons to the IPR. At this juncture we would like to point the Reviewer to the publicly available Connectivity Atlas provided by the Allen Brain Institute (https://connectivity.brain-map.org/). With reference to mHB TAC1 neuronal output, targeted viral injection into the habenula of Tac1Cre mice allows conditional expression of EGFP to SP neurons as evidenced by the predominant expression of reported fluorescence in dorsal mHB (see Author response image 2 a,b below). Tracing the axonal projections to the IPN clearly demonstrates dense fibers in IPL as expected but also arborization in  IPR (Author response image 2 a,c) . This pattern is reminiscent of that seen in the transgenic Tac1Cre:ai9 or ai32 mice used in the current study (Figs. 1c, 2a, 5c). Closer inspection of the fibers in the IPR reveals putative synaptic bouton like structures as we have shown in Fig. 5a,b (Author response image 2 d below).

      Author response image 2.

      Sterotaxic viral injection into mHB pf Tac1Cre mice taken from Allen Brain connectivity atlas (Link to Connectivity Atlas for mHb SP neuronal projection pattern)

      These anatomical data suggest that part of the synaptic input to the IPR originates from mHB TAC1 neurons although we cannot fully discount additional synaptic input from other brain areas that may impinge on the IPR. Indeed, as the Reviewer points out, it is evident that other regions including the nucleus incertus send outputs to the IPN(Bueno et al., 2019; Liang et al., 2024; Lima et al., 2017). However, it is unclear if neuronal inputs from these alternate sources {Liang, 2024 #123;Lima, 2017 #33}{Bueno, 2019 #178} are glutamatergic in nature AND mediated by a TAC1/OPRM1-expressing neuronal population. Nevertheless, we have now modified text in the discussion to highlight the limitations of using a transgenic strategy (pg 12, para 1).

      In addition, a braking mechanism involving Kv1.2 has not been identified.

      It is unclear to what the Reviewer is referring to here. Although most of our experiments pertaining to the brake on cholinergic  transmission by potassium channels use low concentrations of 4-AP (50100M) which have been used to block Shaker Kv1 channels there although at these concentrations there are additional action at other K+-channels such as Kv3, for instance. However, we essentially demonstrate that a selective Kv1.1 and Kv1.2 antagonist dendrotoxin replicates the 4-AP effects. We have now also included RNAseq data demonstrating the relative expression levels of Kv1 channel mRNA in mHb ChAT neurons (KCNA1 through KCNA6; Figure 6b). The complete absence of KCNA1 yet a high expression level of KCNA2 transcripts highly suggests a central role of Kv1.2 in unmasking nAChR mediated synaptic transmission. 

      Reviewer #3 (Public review)

      Weaknesses:  

      The significance of the ratio of AMPA versus nACh EPSCs shown in Figure 6 is unclear since nAChR EPSCs measured in the K+ channel blockers are compared to AMPA EPSCs in control (presumably 4-AP would also increase AMPA EPSCs). 

      We understand the Reviewer’s concern regarding the calculation of nicotinic/AMPA ratios since they are measured under differing conditions i.e. absence and presence of 4-AP, respectively. As the reviewer correctly points point 4-AP likely increases the amplitude of the AMPA receptor mediated EPSC. However, our intention of calculating this ratio was not to ascertain a measure of relative strengths of fast glutamatergic vs cholinergic transmission onto a given postsynaptic IPN neuron per se. Rather, we used the ratio as a means to normalize the size of the nicotinic receptor EPSC to the strength of the light stimulation (using the AMPA EPSC as the normalizing factor) in each individual recording. This permits a more meaningful comparison across cells/slices/mice . We apologize for the confusion and have amended the text in the results section to reflect this (pg 9; para2).

      The mechanistic underpinnings of the most now  results are not pursued. For example, the experiments do not provide new insight into the differential effects of evoked and spontaneous glutamate/Ach release by Gi/o coupled mORs, nor the differential threshold for glutamate versus Ach release. 

      Our major goal of the current manuscript was to provide a much-needed roadmap outlining the effects of opioids in the habenulo-interpeduncular axis. Of course, a full understanding of the mechanisms underlying such complex opioid actions at the molecular level will be of great value. We feel that this is beyond the scope of this already quite result dense manuscript but will be essential if directed manipulation of the circuit is to be leveraged to alter maladaptive behaviors associated with addiction/emotion during adolescence and in adult. 

      The authors note that blocking Kv1 channels typically enhances transmitter release by slowing action potential repolarization. The idea that Kv1 channels serve as a brake for Ach release in this system would be strengthened by showing that these channels are the target of neuromodulators or that they contribute to activity-dependent regulation that allows the brake to be released. 

      The exact mechanistic underpinnings that can potentially titer Kv1.2 availability and hence nAChR transmission would be essential to shed light on potential in vivo conditions under which this arm of neurotransmission can be modulated. However, we feel that detailed mechanistic interrogation constitutes significant work but one that future studies should aim to achieve. Thus, it presently remains unclear under what physiological or pathological scenarios result in attenuation of Kv1.2 to subsequently promote nAChR mediated transmission but as mentioned in the existing discussion future work to decipher such mechanisms would be of great value.

      Reviewer #1 (Recommendations for the authors): 

      Overall I find this to be a very interesting and exciting paper, presenting novel findings that provide clarity for a problem that has persisted in the IPN field: that of the conundrum that light-evoked cholinergic signaling was challenging to observe despite the abundance of nAChRs in the IPN. 

      Major concerns: 

      (1) The n is quite low in most cases, and in many instances, data from one figure are replotted in another figure. Given that the findings presented here are expected in the normal condition, it should not be difficult to increase the n. A more robust number of observations would strengthen the novel findings presented here. 

      Please refer to the response to the public review above.

      (2) In general, I find the organization of the figures somewhat disjointed. Sometimes it feels as if parts of the information presented in the results are split between figures, where it would make more sense to be together in a figure. For example, all the histology for each of the lines is in Figure 1, but only ephys data for one line is included there. It would be more logical to include the histology and ephys data for each line in its own figure. It would also be helpful to show the overlap of mOR expression with Tac1-Cre and ChAT-Cre terminals in the IPN. Likewise, the summarized Tac1Cre:Ai32 IPR data is in Figure 4, but the individual data is in Figure 5. 

      We introduce both ChAT and TAC1 cre lines in Figure 1 as an overview particularly for those readers who are not entirely familiar with the distinct afferent systems operating with the habenulointerpeduncular pathway.  However, in compliance with the Reviewer’s suggestion we have now restructured the Figures. In the revised manuscript, the functional data pertaining to the various transmission modalities mediated by the distinct afferent systems impinging on the subdivision of the IPN tested are now split into their own dedicated figure as follows:

      Figure 2. 

      mOR effect on TAC1neuronal glutamatergic output in IPL.

      Figure 3. 

      mOR effect on CHAT neuronal glutamatergic output in IPR.

      Figure 5. 

      mOR effect on TAC1neuronal glutamatergic output in IPR.

      Figure 8.

      mOR effect on CHAT neuronal cholinergic output in IPC.

      Supp. Fig. 1 mOR effect on CHAT neuronal glutamatergic output in IPC.

      We thank the Reviewer for their suggestions regarding the style of the manuscript. The restructuring has now resulted in a much better flow of the presented data.

      (3) The discussion is largely satisfactory. However, a little more discussion of the integrative function of the IPN is warranted given the opposing effects of MOR activation in the Tac vs ChAT terminals, particularly in the context of both opioids and natural rewards. 

      We thank the reviewer for this comment. However, we feel the discussion is rather lengthy as is and therefore we refrained from including additional text.  

      Minor concerns: 

      (1)  The methods are missing key details. For example, the stock numbers of each of the strains of mice appear to have been left out. This is of particular importance for this paper as there are key differences between the ChAT-Cre lines that are available that would affect observed electrophysiological properties. As the authors indicate, the ChAT-ChR2 mice overexpress VAChT, while the ChAT-IRES-Cre mice do not have this problem. However, as presented it is unclear which mice are being used. 

      We apologize for the omission - the catalog numbers of the mice employed have now been included in the methods section.

      We have now clearly included in each figure panel (single trace examples and pooled data) from which mice the data are taken from – in some instances the pooled data are from the two CHAT mouse strains employed. Despite the tendency of the ChATChR2 mice to demonstrate more pronounced nAChR mediated transmission (Fig. 7h),  we justify pooling the data since we see no statistical significance in the effect of mOR activation on either potentiating AMPA or nAChR EPSCs (Please refer to response to Reviewer 2, Minor Concern point 2)

      (2) Likewise, antibody dilutions used for staining are presented as both dilution and concentration, which is not typical. 

      We thank the reviewer for pointing out this inconsistency. We have amended the text in the methods to include only the working dilution for all antibodies employed in the study.

      (3) There are minor typos throughout the manuscript. 

      All typos have been corrected.

      Reviewer #2 (Recommendations for the authors): 

      The authors provide a thorough investigation into the subregion, and cell-type effect of mu opioid receptor (MOR) signaling on neurotransmission in the medial habenula to interpeduncular nucleus circuit (mHb-IPN). This circuit largely comprises two distinct populations of neurons: mHb substance P (Tac1+) and cholinergic (ChAT+) neurons. Corroborating prior work, the authors report that Tac1+ neurons preferentially innervate the lateral IPN (IPL) and rostral IPN (IPR), while ChAT+ neurons preferentially innervate the central IPN (IPC) and IPR. The densest expression of MOR is observed in the IPL and MOR agonists produce a canonical presynaptic depression of glutamatergic neurotransmission in this region. Interestingly, MOR signaling in the ChAT+ mHb projection to the IPR potentiates light-evoked glutamate and acetylcholine-mediated currents (EPSC), and this effect is mediated by a MOR-induced inhibition of Kv2.1 channels. 

      Major concerns: 

      (1) The method used for expressing channelrhodopsin (ChR2) into cholinergic and neurokinin neurons in the mHb (Ai32 mice crossed with Cre-driver lines) has limitations because all Tac1+/ChAT+ inputs to the IPN express ChR2 in this mouse. Importantly, the IPN receives inputs from multiple brain regions besides the IPN-containing neurons capable of releasing these neurotransmitters (PMID: 39270652). Thus, it would be important to isolate the contributions of the mHb-IPN pathway using virally expressed ChR2 in the mHb of Cre driver mice. 

      Please refer to the response to the public review above. 

      (2) Figure 4: The authors conclude that the sEPSC recorded from IPR originate from Tac1+ mHbIPR projections. However, this cannot be stated conclusively without additional experimentation. For instance, an optogenetic asynchronous release experiment. For these experiments it would also be important to express ChR2 virus in the mHb in Tac1- and ChAT-Cre mice since glutamate originating from other brain regions could contribute to a change in asynchronous EPSCs induced by DAMGO. 

      This is a well taken point. The incongruent effect of DAMGO on evoked CHAT neuronal EPSC amplitude and sEPSC frequency prompted us  to consider the the possibility of differing effect of DAMGO on a  secondary input. We agree that we do not show directly if the sEPSCs originate from a TAC1 neuronal population. Therefore, we have tempered our wording with regards the origin of the sEPSCs and  have also restructured the Figure in question moving the sEPSC data into supplemental data (Supplemental Fig. 2) 

      (3) Figure 5D: lt would be useful to provide a quantitative measure in a few mice of mOR fluorescence across development (e.g. integrated density of fluorescence in IPR). 

      We have now included mOR expression density across development  (Fig. 6). Interestingly, the adult expression levels of mOR in the IPR are essentially reached at a very early developmental age (P10) yet we see stark differences in the role of mOR activation in modulating glutamatergic transmission mediated by mHB cholinergic neurons. Note: since we processed adult tissue (i.e. >p40) for these developmental analyses we utilized these slices to also include an analysis of the relative mOR expression density specifically in adults between the subdivisions of IPN in Fig. 1.

      (4) Figure 6B: It would be useful to quantify the expression of Kcna2 in ChAT and Tac1 neurons (e.g. using FISH). 

      We thank the Reviewer for this suggestion. We have now included mRNA expression levels available from publicly available 10X RNA sequencing dataset provided by the Allen Brain Institute (Figure 7b).  

      (5) It would be informative to examine what the effects of MOR activation are on mHb projections to the (central) . 

      In response to this suggestion, we now have included  additional data in the manuscript in putative IPC cells that clearly demonstrate a similar DAMGO elicited potentiation of AMPAR EPSC to that  seen in IPR. These data are now included in the revised manuscript  (Supplemental Fig. 1; Fig. 8i). 

      (6) What is the proposed link between MOR activation and the inhibition of Kv1.2 (e.g. beta-Arrestin signaling, G beta-gamma interaction with Kv1.2, PKA inhibition?) 

      We apologize for any confusion. We do not directly test whether the potentiation of EPSCs upon mOR activation occurs via inhibition of Kv1.2.Although we have not directly tested this possibility we find it an unlikely underlying cellular mechanism, especially for the potentiation of the cholinergic arm of neurotransmission since in the presence of DNQX/APV, the activation of mOR does not result in any emergence of any nAChR EPSC (see Supplementary Fig. 3a-c)

      Minor concerns: 

      (1) Methods: Jackson lab ID# for used mouse strains is missing. 

      We apologize for this omission and have now included the mouse strain catalog numbers.

      (2) The authors use data from both ChAT-Cre x Ai32 and ChAT-ChR2 mice. It would be helpful to show some comparisons between the lines to justify merging data sets for some of the analyses as there appear to be differences between the lines (e.g. Figure 6G). 

      This is a well taken point. We have now provided a figure for the Reviewer (see below) that illustrates the lack of  significant difference between the mOR mediated potentiation of both mHB CHAT neuronal AMPAR and nAChR transmission between the two mouse lines employed despite a divergence in the extent of glutamatergic vs cholinergic transmission shown in Fig. 7g (previously Figure 6g). We have chosen not to include this data in the revised manuscript.

      Author response image 3.

      Comparison of the mOR (500nM DAMGO) mediated potentiation on evoked AMPAR (a) and nAChR (b)EPSCs in IPR between ChATCre:Ai32  and ChATChR2 mice.

      (3)  Line 154: How was it determined that the EPSC is glutamatergic? 

      We apologize for any confusion. In the revised manuscript we now clearly point to the relevant figures (see Supplementary Figs. 2a and 3) in the Results section (pg. 4, para 2; pg 7, para 1; pg 8, para2) where we determine that both the sEPSCs and ChAT mediated light evoked EPSCs recorded under baseline conditions are totally blocked by DNQX and hence are exclusively AMPAR events 

      (4) It would be helpful to discuss the differences between GABA-B mediated potentiation of mHbIPN signaling and the current data in more detail. 

      We are unclear as to what differences the Reviewer is referring to. At least from the perspective of ChAT neuronal mediated synaptic transmission, other groups (and in the current study; Fig. 7h) have clearly shown that GABA<sub>B</sub> activation markedly potentiates synaptic transmission like mOR activation. Nevertheless, based on our novel findings it would be of interest to determine whether the influence of GABA<sub>B</sub> is inhibitory onto the TAC mediated input in IPR and whether there is a developmental regulation of this effect as we demonstrate upon mOR activation. These additional comparisons between the effect of the two Gi-linked receptors may shed light onto the similarity, or lack thereof, regarding the underlying cellular mechanisms. We now have included a few sentences in the discussion to highlight this (pg 11, para 1).

      Reviewer #3 (Recommendations for the authors): 

      The abstract was confusing at first read due to the complex language, particularly the sentence starting with... Further, specific potassium channels... 

      The authors might want to consider simplifying the description of the experiments and the results to clarify the content of the manuscript for readers who many only read the abstract. 

      We have altered the wording of the abstract and hope it is now more reader friendly.

      The opposite effect of mOR activation on spontaneous EPSCs versus electrical or ChR2-evoked EPSCs is very interesting and raises the issue of which measure is most physiologically relevant. For example, it is unclear whether sEPSCs arise primarily from cholinergic neurons (that are spontaneously active in the slice, Figure 3), and if so, does mOR activation suppress or enhance cholinergic neuron excitability and/or recruitment by ChR2? While a full analysis of this question is beyond the scope of this manuscript, the assumption that glutamate release assayed by electrical/ChR2 evoked transmission is the most physiologically relevant might merit some discussion since sEPSCs presumably also reflect action-potential dependent glutamate release. One wonders whether mORs hyperpolarize cholinergic neurons to reduce spontaneous spiking yet enhance fiber recruitment by ChR2 or an electrical stimulus (i.e. by removing Na channel inactivation). The authors have clearly stated that they do not know where the mORs are located, and that the effects arising from disinhibition are likely complex. But they also might discuss whether glutamate release following synchronous activation of a fiber pathway by ChR2 or electrode is more or less physiologically relevant than glutamate release assayed during spontaneous activity. It seems likely that an equivalent experiment to Figure 3D, E using spontaneous spiking of IPR neurons would show that spiking is reduced by mOR activation. 

      We thank the Reviewer for this comment. As pointed it would be of interest to dissect the “network” effect of mOR activation but as the Reviewer acknowledges this is beyond the scope of the current manuscript. The Reviewer is correct in postulating that mOR activation results in hyperpolarization of mHB ChAT neurons.  A recent study(Singhal et al 2025) demonstrate that a subpopulation of ChAT neurons undergoes a reduction in firing frequency following DAMGO application. This is corroborated by our own observations although we chose not to include this data in our current manuscript (but see below).

      Additionally, the Reviewer questions whether ChR2/electrical stimulation is physiological. This is a well taken point and of course the simultaneous activation of potentially all possible axonal release sites is not the mode under which the circuit operates. Nevertheless, our data clearly demonstrates the ability of mORs to modulate release under these circumstances that must reflect an impact on spontaneous action potential driven evoked release.  Although the suggested experiment  could shed light on the synaptic outcomes of mOR receptor activation on ES coupling of downstream IPN neurons. Interpretation of the outcome would be confounded by the fact that postsynaptic IPN neurons also express mORs . Thus,  we would not be able to isolate the effects of presynaptic changes in modulating ES coupling from any direct postsynaptic effect on the recorded cell when in current clamp. 

      Together these additional sites of action of mOR (i.e. mHB ChAT somatodendritic and postsynaptic IPN neuron) only serve to further highlight the complex nature of the actions of opioids on the habenulo-interpeduncular axis warranting  future work to fully understand the physiological and pathological effects on the habenulo-interpeduncular axis as a whole.

      The idea that Kv2.1 channels serve as a brake raises the question of whether they contribute to activity-dependent action potential broadening to facilitate Ach release during trains of stimuli. 

      This is an interesting suggestion and one that we had considered ourselves. Indeed, as the Reviewer is likely aware and as mentioned in the manuscript, previous studies have shown nAChR signaling can be revealed under conditions of multiple stimulations given at relatively high frequencies.  We therefore attempted to perform high frequency stimulation (20 stimulations at 25Hz and 50Hz) in the presence of ionotropic glutamatergic receptor antagonists DNQX and APV. We have now included this data in the revised manuscript (Supplementary Fig 3b). As shown, this failed to engage nAChR mediated synaptic transmission in our hands. Interestingly there is evidence from reduced expression systems demonstrating that Kv1.2 channels undergo use-dependent potentiation(Baronas et al., 2015) in contrast to that seen with other K+-channels. Whether this is the case for the axonal Kv1.2 channels on mHB axonal terminals in situ is not known but this may explain the inability to reveal nAChR EPSCs upon delivery of such stimulation paradigms.  

      References 

      Baronas, V. A., McGuinness, B. R., Brigidi, G. S., Gomm Kolisko, R. N., Vilin, Y. Y., Kim, R. Y., … Kurata, H. T. (2015). Use-dependent activation of neuronal Kv1.2 channel complexes. J Neurosci, 35(8), 3515-3524. doi:10.1523/JNEUROSCI.4518-13.2015

      Bueno, D., Lima, L. B., Souza, R., Goncalves, L., Leite, F., Souza, S., … Metzger, M. (2019). Connections of the laterodorsal tegmental nucleus with the habenular-interpeduncular-raphe system. J Comp Neurol, 527(18), 3046-3072. doi:10.1002/cne.24729

      Liang, J., Zhou, Y., Feng, Q., Zhou, Y., Jiang, T., Ren, M., … Luo, M. (2024). A brainstem circuit amplifies aversion. Neuron. doi:10.1016/j.neuron.2024.08.010

      Lima, L. B., Bueno, D., Leite, F., Souza, S., Goncalves, L., Furigo, I. C., … Metzger, M. (2017). Afferent and efferent connections of the interpeduncular nucleus with special reference to circuits involving the habenula and raphe nuclei. J Comp Neurol, 525(10), 2411-2442. doi:10.1002/cne.24217

      Singhal, S. M., Szlaga, A., Chen, Y. C., Conrad, W. S., & Hnasko, T. S. (2025). Mu-opioid receptor activation potentiates excitatory transmission at the habenulo-peduncular synapse. Cell Rep, 44(7), 115874. doi:10.1016/j.celrep.2025.115874

      Stinson, H.E., & Ninan, I. (2025). GABA(B) receptor-mediated potentiation of ventral medial habenula glutamatergic transmission in GABAergic and glutamatergic interpeduncular nucleus neurons. bioRxiv doi.10.1101/2025.01.03.631193

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      The authors performed experimental evolution of MreB mutants that have a slow-growing round phenotype and studied the subsequent evolutionary trajectory using analysis tools from molecular biology. It was remarkable and interesting that they found that the original phenotype was not restored (most common in these studies) but that the round phenotype was maintained. 

      Strengths: 

      The finding that the round phenotype was maintained during evolution rather than that the original phenotype, rod-shaped cells, was recovered is interesting. The paper extensively investigates what happens during adaptation with various different techniques. Also, the extensive discussion of the findings at the end of the paper is well thought through and insighXul. 

      Weaknesses: 

      I find there are three general weaknesses: 

      (1) Although the paper states in the abstract that it emphasizes "new knowledge to be gained" it remains unclear what this concretely is. On page 4 they state 3 three research questions, these could be more extensively discussed in the abstract. Also, these questions read more like genetics questions while the paper is a lot about cell biological findings. 

      Thank you for drawing attention to the unnecessary and gratuitous nature of the last sentence of the Abstract. We are in agreement. It has been modified, and we have taken  advantage of additional word space to draw attention to the importance of the two competing (testable) hypotheses laid out in the Discussion. 

      As to new knowledge, please see the Results and particularly the Discussion. But beyond this, and as recognised by others, there is real value for cell biology in seeing how (and whether) selection can compensate for effects that are deleterious to fitness. The results will very o_en depart from those delivered from, for example, suppressor analyses, or bottom up engineering. 

      In the work recounted in our paper, we chose to focus – by way of proof-of principle – on the most commonly observed mutations, namely, those within pbp1A.  But beyond this gene, we detected mutations  in other components of the cell shape / division machinery whose connections are not yet understood and which are the focus of on-going investigation.  

      As to the three questions posed at the end of the Introduction, the first concerns whether selection can compensate for deleterious effects of deleting mreB (a question that pertains to evolutionary aspects); the second seeks understanding of genetic factors; the third aims to shed light on the genotype-to-phenotype map (which is where the cell biology comes into play).  Given space restrictions, we cannot see how we could usefully expand, let alone discuss, the three questions raised at the end of the Introduction in restrictive space available in the Abstract.   

      (2) It is not clear to me from the text what we already know about the restoration of MreB loss from suppressors studies (in the literature). Are there suppressor screens in the literature and which part of the findings is consistent with suppressor screens and which parts are new knowledge?  

      As stated in the Introduction, a previous study with B. subtilis (which harbours three MreB isoforms and where the isoform named “MreB” is essential for growth under normal conditions), suppressors of MreB lethality were found to occur in ponA, a class A penicillin binding protein (Kawai et al., 2009). This led to recognition that MreB plays a role in recruiting Pbp1A to the lateral cell wall. On the other hand, Patel et al. (2020) have shown that deletion of classA PBPs leads to an up-regulation of rod complex activity. Although there is a connection between rod complex and class A PBPs, a further study has shown that the two systems work semi-autonomously (Cho et al., 2016). 

      Our work confirms a connection between MreB and Pbp1A, and has shed new light on how this interaction is established by means of natural selection, which targets the integrity of cell wall. Indeed, the Rod complex and class A PBPs have complementary activities in the building of the cell wall with each of the two systems able to compensate for the other in order to maintain cell wall integrity. Please see the major part of the Discussion. In terms of specifics, the connection between mreB and pbp1A (shown by Kawai et al (2009)) is indirect because it is based on extragenic transposon insertions. In our study, the genetic connection is mechanistically demonstrated.  In addition, we capture that the evolutionary dynamics is rapid and we finally enriched understanding of the genotype-to-phenotype map.

      (3) The clarity of the figures, captions, and data quantification need to be improved.  

      Modifications have been implemented. Please see responses to specific queries listed below.

      Reviewer #2 (Public Review): 

      Yulo et al. show that deletion of MreB causes reduced fitness in P. fluorescens SBW25 and that this reduction in fitness may be primarily caused by alterations in cell volume. To understand the effect of cell volume on proliferation, they performed an evolution experiment through which they predominantly obtained mutations in pbp1A that decreased cell volume and increased viability. Furthermore, they provide evidence to propose that the pbp1A mutants may have decreased PG cross-linking which might have helped in restoring the fitness by rectifying the disorganised PG synthesis caused by the absence of MreB. Overall this is an interesting study. 

      Queries: 

      Do the small cells of mreB null background indeed have have no DNA? It is not apparent from the DAPI images presented in Supplementary Figure 17. A more detailed analysis will help to support this claim. 

      It is entirely possible that small cells have no DNA, because if cell division is aberrant then division can occur prior to DNA segregation resulting in cells with no DNA. It is clear from microscopic observation that both small and large cells do not divide. It is, however, true, that we are unable to state – given our measures of DNA content – that small cells have no DNA. We have made this clear on page 13, paragraph 2.

      What happens to viability and cell morphology when pbp1A is removed in the mreB null background? If it is actually a decrease in pbp1A activity that leads to the rescue, then pbp1A- mreB- cells should have better viability, reduced cell volume and organised PG synthesis. Especially as the PG cross-linking is almost at the same level as the T362 or D484 mutant.  

      Please see fitness data in Supp. Fig. 13. Fitness of ∆mreBpbp1A is no different to that caused by a point mutation. Cells remain round.  

      What is the status of PG cross-linking in ΔmreB Δpflu4921-4925 (Line 7)? 

      This was not analysed as the focus of this experiment was PBPs. A priori, there is no obvious reason to suspect that ∆4921-25 (which lacks oprD) would be affected in PBP activity.

      What is the morphology of the cells in Line 2 and Line 5? It may be interesting to see if PG cross-linking and cell wall synthesis is also altered in the cells from these lines. 

      The focus of investigation was restricted to L1, L4 and L7. Indeed, it would be interesting to look at the mutants harbouring mutations in :sZ, but this is beyond scope of the present investigation (but is on-going). The morphology of L2 and L5 are shown in Supp. Fig. 9.

      The data presented in 4B should be quantified with appropriate input controls. 

      Band intensity has now been quantified (see new Supp. Fig .20). The controls are SBW25, SBW25∆pbp1A, SBW25 ∆mreB and SBW25 ∆mreBpbp1A as explained in the paper.

      What are the statistical analyses used in 4A and what is the significance value? 

      Our oversight. These were reported in Supp. Fig. 19, but should also have been presented in Fig. 4A. Data are means of three biological replicates. The statistical tests are comparisons between each mutant and SBW25, and assessed by paired t-tests.  

      A more rigorous statistical analysis indicating the number of replicates should be done throughout. 

      We have checked and made additions where necessary and where previously lacking. In particular, details are provided in Fig. 1E, Fig. 4A and Fig. 4B. For Fig. 4C we have produced quantitative measures of heterogeneity in new cell wall insertion. These are reported in Supp. Fig. 21 (and referred to in the text and figure caption) and show that patterns of cell wall insertion in ∆mreB are highly heterogeneous.

      Reviewer #3 (Public Review): 

      This paper addresses an understudied problem in microbiology: the evolution of bacterial cell shape. Bacterial cells can take a range of forms, among the most common being rods and spheres. The consensus view is that rods are the ancestral form and spheres the derived form. The molecular machinery governing these different shapes is fairly well understood but the evolutionary drivers responsible for the transition between rods and spheres are not. Enter Yulo et al.'s work. The authors start by noting that deletion of a highly conserved gene called MreB in the Gram-negative bacterium Pseudomonas fluorescens reduces fitness but does not kill the cell (as happens in other species like E. coli and B. subtilis) and causes cells to become spherical rather than their normal rod shape. They then ask whether evolution for 1000 generations restores the rod shape of these cells when propagated in a rich, benign medium. 

      The answer is no. The evolved lineages recovered fitness by the end of the experiment, growing just as well as the unevolved rod-shaped ancestor, but remained spherical. The authors provide an impressively detailed investigation of the genetic and molecular changes that evolved. Their leading results are: 

      (1) The loss of fitness associated with MreB deletion causes high variation in cell volume among sibling cells a_er cell division. 

      (2) Fitness recovery is largely driven by a single, loss-of-function point mutation that evolves within the first ~250 generations that reduces the variability in cell volume among siblings. 

      (3) The main route to restoring fitness and reducing variability involves loss of function mutations causing a reduction of TPase and peptidoglycan cross-linking, leading to a disorganized cell wall architecture characteristic of spherical cells. 

      The inferences made in this paper are on the whole well supported by the data. The authors provide a uniquely comprehensive account of how a key genetic change leads to gains in fitness and the spectrum of phenotypes that are impacted and provide insight into the molecular mechanisms underlying models of cell shape. 

      Suggested improvements and clarifications include: 

      (1) A schematic of the molecular interactions governing cell wall formation could be useful in the introduction to help orient readers less familiar with the current state of knowledge and key molecular players. 

      We understand that this would be desirable, but there are numerous recent reviews with detailed schematics that we think the interested reader would be better consulting. These are referenced in the text.

      (2) More detail on the bioinformatics approaches to assembling genomes and identifying the key compensatory mutations are needed, particularly in the methods section. This whole subject remains something of an art, with many different tools used. Specifying these tools, and the parameter sesngs used, will improve transparency and reproducibility, should it be needed. 

      We overlooked providing this detail, which has now been corrected by provision of more information in the Materials and Methods. In short we used Breseq, the clonal option, with default parameters. Additional analyses were conducted using Genieous. The BreSeq output files are provided https://doi.org/10.17617/3.CU5SX1 (which include all read data).

      (3) Corrections for multiple comparisons should be used and reported whenever more than one construct or strain is compared to the common ancestor, as in Supplementary Figure 19A (relative PG density of different constructs versus the SBW25 ancestor). 

      The data presented in Supp Fig 19A (and Fig 4A) do not involve multiple comparisons. In each instance the comparison is between SBW25 and each of the different mutants. A paired t-test is thus appropriate.

      (4) The authors refrain from making strong claims about the nature of selection on cell shape, perhaps because their main interest is the molecular mechanisms responsible. However, I think more can be said on the evolutionary side, along two lines. First, they have good evidence that cell volume is a trait under strong stabilizing selection, with cells of intermediate volume having the highest fitness. This is notable because there are rather few examples of stabilizing selection where the underlying mechanisms responsible are so well characterized. Second, this paper succeeds in providing an explanation for how spherical cells can readily evolve from a rod-shaped ancestor but leaves open how rods evolved in the first place. Can the authors speculate as to how the complex, coordinated system leading to rods first evolved? Or why not all cells have lost rod shape and become spherical, if it is so easy to achieve? These are important evolutionary questions that remain unaddressed. The manuscript could be improved by at least flagging these as unanswered questions deserving of further attention. 

      These are interesting points, but our capacity to comment is entirely speculative. Nonetheless, we have added an additional paragraph to the Discussion that expresses an opinion that has yet to receive attention:

      “Given the complexity of the cell wall synthesis machinery that defines rod-shape in bacteria, it is hard to imagine how rods could have evolved prior to cocci. However, the cylindrical shape offers a number of advantages. For a given biomass (or cell volume), shape determines surface area of the cell envelope, which is the smallest surface area associated with the spherical shape. As shape sets the surface/volume ratio, it also determines the ratio between supply (proportional to the surface) and demand (proportional to cell volume). From this point of view, it is more efficient to be cylindrical (Young 2006). This also holds for surface attachment and biofilm formation (Young 2006). But above all, for growing cells, the ratio between supply and demand is constant in rod shaped bacteria, whereas it decreases for cocci. This requires that spherical cells evolve complex regulatory networks capable of maintaining the correct concentration of cellular proteins despite changes in surface/volume ratio. From this point of view, rod-shaped bacteria offer opportunities to develop unsophisticated regulatory networks.”

      why not all cells have lost rod shape and become spherical.

      Please see Kevin Young’s 2006 review on the adaptive significance of cell shape

      The value of this paper stems both from the insight it provides on the underlying molecular model for cell shape and from what it reveals about some key features of the evolutionary process. The paper, as it currently stands, provides more on which to chew for the molecular side than the evolutionary side. It provides valuable insights into the molecular architecture of how cells grow and what governs their shape. The evolutionary phenomena emphasized by the authors - the importance of loss-of-function mutations in driving rapid compensatory fitness gains and that multiple genetic and molecular routes to high fitness are o_en available, even in the relatively short time frame of a few hundred generations - are wellunderstood phenomena and so arguably of less broad interest. The more compelling evolutionary questions concern the nature and cause of stabilizing selection (in this case cell volume) and the evolution of complexity. The paper misses an opportunity to highlight the former and, while claiming to shed light on the latter, provides rather little useful insight. 

      Thank you for these thoughts and comments. However, we disagree that the experimental results are an overlooked opportunity to discuss stabilising selection. Stabilising selection occurs when selection favours a particular phenotype causing a reduction in underpinning population-level genetic diversity. This is not happening when selection acts on SBW25 ∆mreB leading to a restoration of fitness. Driving the response are biophysical factors, primarily the critical need to balance elongation rate with rate of septation. This occurs without any change in underlying genetic diversity.  

      Recommendations for the authors:  

      Reviewer 1 (Recommendations for the Authors): 

      Hereby my suggestion for improvement of the quantification of the data, the figures, and the text. 

      -  p 14, what is the unit of elongation rate?  

      At first mention we have made clear that the unit is given in minutes^-1

      -  p 14, please give an error bar for both p=0.85 and f=0.77, to be able to conclude they are different 

      Error on the probability p is estimated at the 95% confidence interval by the formula:1.96 , where N is the total number of cells. This has been added in the paragraph p »probability » of the Image Analysis section in the Material and Methods. 

      We also added errors on p measurement in the main text.

      -  p 14, all the % differences need an errorbar 

      The error bars and means are given in Fig 3C and 3D.

      -  Figure 1B adds units to compactness, and what does it represent? Is the cell size the estimated volume (that is mentioned in the caption)? Shouldn't the datapoints have error bars? 

      Compactness is defined in the “Image Analysis” section of the Material and Methods. It is a dimensionless parameter. The distribution of individual cell shapes / sizes are depicted in Fig 1B. Error does arise from segmentation, but the degree of variance (few pixels) is much smaller than the representations of individual cells shown.

      -  Figure 1C caption, are the 50.000 cells? 

      Correct. Figure caption has been altered.

      -  Figure 1D, first the elongation rate is described as a volume per minute, but now, looking at the units it is a rate, how is it normalized? 

      Elongation rate is explained in the Materials and Methods (see the image analysis section) and is not volume per minute. It is dV/dt = r*V (the unit of r is min^-1). Page 9 includes specific mention of the unit of r.

      -  Figure 1E, how many cells (n) per replicate? 

      Our apologies. We have corrected the figure caption that now reads:

      “Proportion of live cells in ancestral SBW25 (black bar) and ΔmreB (grey bar) based on LIVE/DEAD BacLight Bacterial Viability Kit protocol. Cells were pelleted at 2,000 x g for 2 minutes to preserve ΔmreB cell integrity. Error bars are means and standard deviation of three biological replicates (n>100).”

      -  Figure 1G, how does this compare to the wildtype 

      The volume for wild type SBW25 is 3.27µm^3 (within the “white zone”). This is mentioned in the text.

      -  Figure 2B, is this really volume, not size? And can you add microscopy images? 

      The x-axis is volume (see Materials and Methods, subsection image analysis). Images are available in Supp. Fig. 9.

      -  Figure 3A what does L1, L4 and L7 refer too? Is it correct that these same lines are picked for WT and delta_mreB 

      Thank you for pointing this out. This was an earlier nomenclature. It was shorthand for the mutants that are specified everywhere else by genotype and has now been corrected. 

      -  Figure 3c: either way write out p, so which probability, or you need a simple cartoon that is plotted. 

      The value p is the probability to proceed to the next generation and is explained in Materials and Methods  subsection image analysis.  We feel this is intuitive and does not require a cartoon. We nonetheless added a sentence to the Materials and Methods to aid clarity.

      -  Figure 4B can you add a ladder to the gel? 

      No ladder was included, but the controls provide all the necessary information. The band corresponding to PBP1A is defined by presence in SBW25, but absence in SBW25 ∆pbp1A.

      -  Figure 4c, can you improve the quantification of these images? How were these selected and how well do they represent the community? 

      We apologise for the lack of quantitative description for data presented in Fig 4C. This has now been corrected. In brief, we measured the intensity of fluorescent signal from between 10 and 14 cells and computed the mean and standard deviation of pixel intensity for each cell. To rule out possible artifacts associated with variation of the mean intensity, we calculated the ratio of the standard deviation divided by the square root of the mean. These data reveal heterogeneity in cell wall synthesis and provide strong statistical support for the claim that cell wall synthesis in ∆mreB is significantly more heterogeneous than the control. The data are provided in new Supp. Fig. 21. 

      Minor comments: 

      -  It would be interesting if the findings of this experimental evolution study could be related to comparative studies (if these have ever been executed).  

      Little is possible, but Hendrickson and Yulo published a portion of the originally posted preprint separately. We include a citation to that paper. 

      -  p 13, halfway through the page, the second paragraph lacks a conclusion, why do we care about DNA content? 

      It is a minor observation that was included by way of providing a complete description of cell phenotype.  

      -  p 17, "suggesting that ... loss-of-function", I do no not understand what this is based upon. 

      We show that the fitness of a pbp1A deletion is indistinguishable from the fitness of one of the pbp1A point mutants. This fact establishes that the point mutation had the same effects as a gene deletion thus supporting the claim that the point mutations identified during the course of the selection experiment decrease (or destroy) PBP1A function.

      -  p 25, at the top of the page: do you have a reference for the statement that a disorganized cell wall architecture is suited to the topology of spherical cells? 

      The statement is a conclusion that comes from our reasoning. It stems from the fact that it is impossible to entirely map the surface of a sphere with parallel strands.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this study, Basha and colleagues aim to test whether the thalamic nucleus reuniens can facilitate the hippocampus/prefrontal cortex coupling during sleep. Considering the importance of sleep in memory consolidation, this study is important to understand the functional interaction between these three majorly involved regions. This work suggests that the thalamic nucleus reuniens has a functional role in synchronizing the hippocampus and prefrontal cortex.

      Strengths:

      The authors performed recordings in naturally sleeping cats, and analysed the correlation between the main slow wave sleep oscillatory hallmarks: slow waves, spindles, and hippocampal ripples, and with reuniens' neurons firing. They also associated intracellular recordings to assess the reuniens-prefrontal connectivity, and computational models of large networks in which they determined that the coupling of oscillations is modulated by the strength of hippocampal-thalamic connections.

      Thank you for your positive evaluation.

      Weaknesses:

      The authors' main claim is made on slow waves and spindle coupling, which are recorded both in the prefrontal cortex and surprisingly in reuniens. Known to be generated in the cortex by cortico-thalamic mechanisms, the slow waves and spindles recorded in reuniens show no evidence of local generation in the reuniens, which is not anatomically equipped to generate such activities. Until shown differently, these oscillations recorded in reuniens are most likely volume-conducted from nearby cortices. Therefore, such a caveat is a major obstacle to analysing their correlation (in time or frequency domains) with oscillations in other regions.

      (1) We fully agree with the reviewer that reuniens likely does not generate neither slow waves nor spindles. We do not make such claim, which we clearly stated in the discussion (lines 319-324). We propose that Reuniens neurons mediate different forms of activity. In the model, we introduced MD nucleus only because without MD we were unable to generate spindles. While the slow waves and spindles are generated in other thalamocortical regions, the REU neurons show these rhythms due to long-range projections from these regions to REU as has been shown in the model.

      (2) Definitely, we cannot exclude some influence of volume conductance on obtained LFP recordings in REU nucleus. However, we show modulation of spiking activity within REU by spindles. Spike modulation cannot be explained by volume conductance but can be explained by either synaptic drive (likely the case here) or some intrinsic neuronal processes (like T-current).

      (3) In our REU recordings for spike identification we used tetrode recordings. If slow waves and spindles are volume conducted, then slow waves and spindles recorded with tetrodes should have identical shape. Following reviewer comment, we took these recordings and subtracted one channel from another. The difference in signal during slow waves is in the order 0.1 mV. Considering that the distance between electrodes is in the order of 20 um, such a difference in voltage is major and can only be explained by local extracellular currents, likely due to synaptic activities originating in afferent structures.

      Finally, the choice of the animal model (cats) is the best suited one, as too few data, particularly anatomical ones regarding reuniens connectivity, are available to support functional results.

      (1) Thalamus of majority of mammals (definitely primates and carnivores, including cats) contain local circuit interneurons (about 30 % of all neurons). A vast majority of studies in rodents (except LGN nucleus) report either absence or extremally low (i.e. Jager P, Moore G, Calpin P, et al. Dual midbrain and forebrain origins of thalamic inhibitory interneurons. eLife. 2021; 10: e59272.) number of thalamic interneurons. Therefore, studies on other species than rodents are necessary, and bring new information, which is impossible to obtain in rodents.

      (2) Cats’ brain is much larger than the brain of mice or rats, therefore, the effects of volume conductance from cortex to REU are much smaller, if not negligible. The distance between REU and closest cortical structure (ectosylvian gyrus) in cats is about 15 mm.

      (3) Indeed, there is much less anatomical data on cats as opposed to rodents. This is why, we performed experiments shown in the figure 1. This figure contains functional anatomy data. Antidromic responses show that recorded structure projects to stimulated structure. Orthodromic responses show that stimulated structure projects to recorded structure.

      Reviewer #2 (Public Review):

      Summary:

      The interplay between the medial prefrontal cortex and ventral hippocampal system is critical for many cognitive processes, including memory and its consolidation over time. A prominent idea in recent research is that this relationship is mediated at least in part by the midline nucleus reuniens with respect to consolidation in particular. Whereas the bulk of evidence has focused on neuroanatomy and the effects of temproary or permanent lesions of the nucleus reuniens, the current work examined the electrophysiology of these three structures and how they inter-relate, especially during sleep, which is anticipated to be critical for consolidation. They provide evidence from intercellular recordings of the bi-directional functional connectivity among these structures. There is an emphasis on the interactions between these regions during sleep, especially slow-wave sleep. They provide evidence, in cats, that cortical slow waves precede reuniens slow waves and hippocampal sharp-wave ripples, which may reflect prefrontal control of the timing of thalamic and hippocampal events, They also find evidence that hippocampal sharp wave ripples trigger thalamic firing and precede the onset of reuniens and medial prefrontal cortex spindles. The authors suggest that the effectiveness of bidirectional connections between the reuniens and the (ventral) CA1 is particularly strong during non-rapid eye movement sleep in the cat. This is a very interesting, complex study on a highly topical subject.

      Strengths:

      An excellent array of different electrophysiological techniques and analyses are conducted. The temporal relationships described are novel findings that suggest mechanisms behind the interactions between the key regions of interest. These may be of value for future experimental studies to test more directly their association with memory consolidation.

      We thank this reviewer for very positive evaluation of our study.

      Weaknesses:

      Given the complexity and number of findings provided, clearer explanation(s) and organisation that directed the specific value and importance of different findings would improve the paper. Most readers may then find it easier to follow the specific relevance of key approaches and findings and their emphasis. For example, the fact that bidirectional connections exist in the model system is not new per se. How and why the specific findings add to existing literature would have more impact if this information was addressed more directly in the written text and in the figure legends.

      Thank you for this comment. In the revised version, we will do our best to simplify presentation and more clearly explain our findings.

      Reviewing Editor (Recommendations for Authors):

      Please discuss the ability of reuniens to generate spindles?

      We briefly discussed this in previous version. We now extended the discussion (p. 18).

      For population data, how many cats were used in acute and chronic experiments, where does the population data originate in Fig. 2? How repeatable were the findings across animals? Was histology verified in each animal?

      As previously stated in the beginning of method section we totally used 20 cats: 16 anesthetized (or acute) and 4 non-anesthetized (or chronic). We added number of cats in appropriate places in the result section. Population data in figure 2 comes from 48, 49 or 52 recording sessions (depending on the type of analysis, and indicated in the figure legend) from 4 chronic cats; we clarified this information in the legend. Results were highly repeatable across animals. Histology was verified in all chronic and acute animals, we added a sentence in the method section.

      Explanation of figures is very poor, values in figures should be reported in results so they can be compared in the context of the description.

      In this revised version, we report most numbers present in figures and their legend to the main text (result section).

      The depth of the recording tungsten electrodes are meaningless without the AP and ML coordinates given how heterogenous mPFC is. What is the ventromedial wall of the mPFC in the cat?

      We added the ML and AP coordinates in the method section. We corrected ventromedial wall for ventroposterior part of the mPFC.

      What are the two vertical lines in 1F?

      This was an error while preparing the figure. The panel was corrected.

      Line 90 mean +-SD of what? There are no numbers.

      Thanks, we now indicate the values.

      Panel 2L does not show increased spindling in reuniens prior to PFC as indicated in the results, please explain. It does show SWR in the hippocampus prior to spindles, what is the meaning of such a time relationship?

      Panel 2L did show an increased spindling reuniens prior to mPFC, but indeed at the time scale shown, it was not very clear. In this revised manuscript, we added an inset zooming around time zero to make this point clearer.

      Panel 2L indeed show an increase in SWR prior to the increase in spindle in both Reuniens and mPFC.

      As stated in the discussion, ‘We found that hippocampal SWRs trigger thalamic firing and precede the onset of reuniens and mPFC spindles, which points to SWRs as one of candidate events for spindle initiation.’

      It is unclear what the slow waves of PFC mean, these represent filtered PFC lfp, but is this a particular oscillation? They continue to occur during the spindle, while the slow waves supposedly trigger the spindle. Please explain and clarify.

      We recently published a review article involving several scientists studying both human and animal sleep that has inserted Box. 1 (Timofeev I, Schoch S, LeBourgeois M, Huber R, Riedner B, Kurth S. Spatio-temporal properties of sleep slow waves and implications for development. Current Opinion in Physiology. 2020; 15: 172–182). In this box among other terms, we provide current definition of slow waves vs slow oscillation. Briefly, if slow waves are repeated with a given rhythm, they typically form slow oscillation. However, if they occur in isolation or are not rhythmic, they remain slow waves, but cannot be called slow oscillation.

      Regarding relation of spindles and slow oscillation. We are currently systematically analyzing data on spindles and slow waves obtained from head-restrained and freely behaving cats. One of the main findings is that a majority of ‘cortical’ spindles are local. Local to the extent that spindles can occur in alternation in two neighboring cortical cells. Largely, LFP sleep spindles occur more or less synchronously within suprasylvian gyrus of cats where indeed a large majority of them was triggered by slow waves. The synchrony between LFP spindles in suprasylvian vs other other cortical areas is much less clear. So, it is not surprizing that spindles in one bran region can occur when there is a slow wave present in some other brain region. Something of a kind was also shown in human (Mölle M, Bergmann TO, Marshall L, Born J. Fast and slow spindles during the sleep slow oscillation: disparate coalescence and engagement in memory processing. Sleep. 2011; 34 (10): 1411-1421).

      In this regard, we are not ready to include modifications in the manuscript.

      Line 134, where is spindle amplitude shown? Plots report power within the spindle frequency band, which obviously captures more than just spindles.

      No, plots of figure 3 B, C show the phase-amplitude coupling (PAC) strength. These were calculated with detected spindles, therefore, while we cannot exclude some false spindle detections, we are confident that the false spindle detections are at a negligible level. We modified text and instead of spindle amplitude, we describe SW-spindle amplitude coupling. This reflects our analysis with exactitude.

      The discussion must include the medio dorsal nucleus which is the largest thalamic input to the prefrontal cortex and also receives input from the hippocampus. In particular, the case must be made for why reuniens would play a more important or different role than MD? (For example: Occurrence of Hippocampal Ripples is Associated with Activity Suppression in the Mediodorsal Thalamic Nucleus - PMC (nih.gov)).

      We cited the suggested study. We cannot say whether reuniens plays a more or less important role. What is clear is that hippocampal ripples at the onset of spindles trigger increased firing in both MD and reuniens. Our extracellular recordings (Fig. 4, K) suggest that the increased firing is associated with spike-bursts. We also have a parallel unpublished study done on anesthetized mice showing SWR triggered inhibitory potentials in both reuniens and MD that reverses around -65mV - -70 mV. Because the majority of SWR occurred at the onset of cortical up state, a relative role of cortico-thalamic vs hippocampo-thalamic drive is not easy to separate. We hope, we will convincingly do this in our forthcoming study, with the limitation that it was done on anesthetized mice.

      Reviewer #1 (Recommendations For The Authors):

      I strongly encourage the authors to perform current source density analyses on the LFP signals recorded in the nucleus reuniens to make sure that the observed oscillations are indeed locally generated. So far, the anatomical organisation in reuniens cannot support the local generation of oscillations, such as spindles and slow wave. At least in rodents (the cat reuniens does not seem too different, until shown differently), there were no oscillators found in reuniens, and at least not arranged like in cortical areas, allowing the summation in time, and particularly space, of rhythmic input currents. Bipolar recordings with pairs of twisted electrodes might also be useful to assess the local existence of spindles and slow waves.

      Current source density calculation is possible when one knows the exact distance between recording sites. As we used tetrodes made with 4 twisted platinum-iridium wires, we know more or less the range of distance between recording sites, but not the exact distance between any given pair of electrodes.

      Then, the physical distance between the reuniens and any cortical structure is about 8-9 mm. Therefore, with such distances, volume conductance is expected to be negligible. If slow waves and spindles are volume conducted, then slow waves and spindles recorded with tetrodes should have identical shape. Following reviewer comment, we took these recordings and subtracted one channel from another. The difference in signal during slow waves is in the order 0.1 mV. Considering that the distance between electrodes is in the order of 20 um, such a difference in voltage is major and can only be explained by local extracellular currents, likely due to synaptic activities originating in afferent structures.

      Below, we plotted the voltage of one channel of the tetrode versus another channel of the same tetrode. If the signal was simply volume conducted, one would expect to see the vast majority of points on the x=y line (red).

      Author response image 1.

      Below is a segment of mPFC LFP recording (upper black trace), mPFC LFP filtered for spindle frequency (7-15 Hz) and the spindle detected (black lines above the filtered trace. Then two LFP traces from a tetrode in the Reuniens (orange and light blue) are overlayed. The second trace (Blue) from bottom represents the substraction of Reuniens 1 minus Reuniens 2 channel, and just below (lower Blue trace) is this susbtraction trace filtered for spindle frequency (7-15 Hz) showing clear voltage difference in the spindle range between the two electrodes. Note also that around time 179-179.5 s, there is clear spindle oscillation in the mPFC recording which is not present in the Reuniens recordings.

      Author response image 2.

      Therefore, we are convinced that in our recordings, volume conductance did not play any significant role.

      Another concern regarding delays between events, like slow waves, measured between two regions (as exemplified by Figure 3). It appears that the delays were calculated from the filtered signal. Figure 3G shows a delay between the peak of the mPFC slow wave between the raw and the filtered signal, which might be artifactual of the processing. It is though not (or less) visible for the reuniens recording. Such mismatch might explain the observed differences in delays.

      Thanks for this comment. We recomputed the analysis using the original signal (smoothed) and obtained very similar results. Panels H and I of figure 3 were updated using the new analysis performed on original signal.

      The overall analyses of LFP-triggered reuniens MUA activity lack of statistics (at least z-scored firing to normalise the firings).

      Fig. 2 H and I are representative examples for histograms; statistical data are shown in circular plots as explained in the legend. Fig. 2 L, shows populational data and we provide now standard error. Fig. 4 C and D show individual example. Fig. 4 E shows histograms of activity of all identified putative single units. Units that show significant modulation are displayed above white line. Fig. 4 F shows populational data for significantly modified units.  

      A last point of detail in the model, which surprisingly shows reuniens to excitatory hippocampal cells' connectivity. Recent literature reports that reuniens only connect hippocampal interneurons, and not principal cells (at least in rodents, I could not find any report in cats). I wonder how changing this parameter would affect the results of the computational investigation, particularly the results shown in Figure 6.

      There are several studies in the literature showing a direct excitation from the Reuniens to pyramidal cells in the CA1, here are three of them:

      Goswamee, P., et al. (2021). "Nucleus Reuniens Afferents in Hippocampus Modulate CA1 Network Function via Monosynaptic Excitation and Polysynaptic Inhibition." Frontiers in Cellular Neuroscience 15.

      Dolleman-Van der Weel MJ, Lopes da Silva FH, Witter MP (1997) Nucleus Reuniens Thalami Modulates Activity in Hippocampal Field CA1 through Excitatory and Inhibitory Mechanisms. The Journal of Neuroscience 17:5640.

      Dolleman-van der Weel MJ, Lopes da Silva FH, Witter MP (2017) Interaction of nucleus reuniens and entorhinal cortex projections in hippocampal field CA1 of the rat. Brain Structure and Function 222:2421-2438.

      Because this is not a review paper, we opted to not cite all the papers describing connectivity between mPFC, hippocampus and thalamus.

      Reviewer #2 (Recommendations For The Authors):

      I respectively suggest that the earlier (public) comments listed above should be addressed. In addition, it would be useful to make it clearer when non-rapid eye movement sleep was being addressed and when rapid eye movement was being addressed. Is it of value to use a single term instead of adding "slow wave sleep" or else clarify when either term is used? The addition of more subheadings might help. Moreover, the relative contribution/value of evidence from these two sleep states was not addressed or was not very clear.

      We tried to make it clearer when NREM and when REM was analysed.

      We replaced slow-wave sleep with NREM sleep in the figure 5 title.

      We added several subheadings in the discussion.

      Relative contribution of NREM vs REM sleep was not addressed? Sorry but we do not clearly understand your question. Figs. 2 and 3 deal mainly with NREM sleep (Fig 2.B has an example of REM sleep). Fig. 4 essentially describes results obtained during REM sleep.

      I was not sure if the Abstract summarised the key take-home messages from the large amount of evidence provided. Some choices are needed, of course, but "evidence of bidirectional connectivity" struck me as less novel than other evidence provided. Given the huge amount of findings provided, which is commendable, it is still useful to present it perhaps in a more digestible fashion. For example, the headings or the first sentence(s) below headings could indicate the aim or the outcome of the specific method/analysis/findings.

      We rewrote abstract and we also added some conclusion to highlight major findings and their meaning.

      It is more common to use NRe or Re, rather than REU.

      We avoided using RE as, for decades, we used RE to abbreviate the thalamic reticular nucleus in several publications. In this revised version, we spell at full - Reuniens.

      Line 49 mentions "short-term" memory. Please specify this more clearly as it is otherwise ambiguous. Also, line 303.

      We rephrased the sentence: In particular, the hierarchical coupling of slow waves, spindles and SWRs is thought to play a key role in memory consolidation.

      Line 303 was likely about the ventromedial wall: we corrected that sentence.

      Line 62: the word, "required" (for memory function) is too strong because there is evidence that it is not always required.

      We modified the sentence for plays a major role.

      The focus within the medial prefrontal cortex could be specified more clearly / earlier.

      The mPFC is mentioned in the second sentence of the abstract and in the first sentence of the introduction.

      Line 134: The heading states "determine" and then mentions modulation. These terms may not be interchangeable or they need clarification.

      We changed it to slow wave-spindle amplitude coupling. This represents exactly our analysis.

      Line 204: Does "cortical network" mean prefrontal cortex network"?

      Yes, as described in lines 192-193, the two cortical networks (N1 and N2) of the model represent the mPFC layer 5 and 6 respectively.

      Lines 283 to 289: These were not very clear to me.

      These lines described the potential mechanisms for the responses to hippocampal and reuniens stimulation recorded intracellularly (results in figure 1). We modified this paragraph for clarity.

      Line 296: Specify the "claim".

      We modified the sentence for “[…] provides supporting evidence for this claim that nucleus Reuniens might synchronize the activity of ventral hippocampus and mPFC.”

      The discussion naturally focuses on the thalamic nucleus reuniens, but also occasionally mentions the thalamic mediodorsal nucleus. The distinction, assuming this is highly relevant, could be expressed more clearly (direct comparison with their previous papers).

      We never published a study on the mediodorsal nucleus. We do have some unpublished results from recordings in the MD nucleus and they reveal the presence of an inhibitory component at the beginning of cortical active states, therefore behaving in a similar way to first order nuclei. It is then possible that spindles recorded in the reuniens are actually generated in the MD nucleus and then transmitted to Reuniens through the thalamic reticular nucleus, as both MD and reuniens are connected to the rostral thalamic reticular nucleus. We added some discussion about this.

      Figure 1B: Do the authors have any additional evidence of the placements in the reuniens, because the photo provided suggests a large area beyond the reuniens boundary. Also, please confirm is the CEM between Rh and Re in the cat (I think the Rh and Re are adjacent in the rat).

      Figure 1B is from an electrolytic lesion, which is necessarily bigger than the tip of the electrode. Therefore the center of the electrolytic lesion indicates where the electrode tip was located which is well within the reuniens nucleus.

      Also, yes CE (Nucleus centralis thalami, pars medialis) is located between the reuniens and rhomboid in cats. This can be found in two cat atlas:  

      Reinoso-Suárez, F. (1961). Topographischer Hirnatlas der Katze für experimental-physiologische Untersuchungen (Merck).

      Berman AL, Jones EG (1982) The Thalamus and Basal Telencephalon of the Cat: A Cytoarchitectonic Atlas with Stereotaxic Coordinates: University of Wisconsin Press.

      The first mention of hippocampus in the figure legends should remind the reader by stating "ventral hippocampus".

      In this revised version, we added “ventral” in several instances both in the main text and in figure legend.

      Figure 2: It seems unusual to mention "unusually short NREM". Presumably, things are the same otherwise - if so, perhaps mention that, especially if some of the effects reflect an "unusual" episode.

      We display this particular segment because we want to show continuous recording in which still individual elements characterizing specific states are still visible.

      Some effects look like they are strong and others perhaps weaker. If so, how do these impact the final conclusions?

      Sorry, we did not understand clearly what is meant here by the reviewer. In general, if any effect has statistically significant difference (old fashion 0.05) we consider it as significant. Any other cases are described on individual basis.

      Perhaps "MAD" should be in full on the first occasion, if not already.

      It was spelled out at line 659, but we now spell it out also in the results section and in figure 2 legend.

      Methods: the key question is the use of rodent recordings to classify cat recordings. It would be good to have a reference indicating that this can be directly used for cats, which may have different sleep cycles and patterns compared to rats.

      We did not use rodent recordings to classify cat recordings, however we did used a state detection script that was developed with rodent recordings. As mentioned in the method section, we adapted the script to cat mPFC recordings and then manual corrections were made to correctly detect REM episodes. Respectfully, our lab investigates sleep-wake in non-anesthetized animals for a few decades; we developed state detection algorithm in mice, cats, marmosets when needed (to analyse months of recordings), and we have an extensive expertise in identifying states of vigilance from electrophysiological recordings.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary: 

      Seon and Chung's study investigates the hypothesis that individuals take more risks when observed by others because they perceive others to be riskier than themselves. To test this, the authors designed an innovative experimental paradigm where participants were informed that their decisions would be observed by a "risky" player and a "safe" player. Participants underwent fMRI scanning during the task. 

      Strengths: 

      The research question is sound, and the experimental paradigm is well-suited to address the hypothesis. 

      Weaknesses:

      I have several concerns. Most notably, the manuscript is difficult to read in parts, and I suggest a thorough revision of the writing for clarity, as some sections are nearly incomprehensible. Additionally, key statistical details are missing, and I have reservations about the choice of ROIs.

      We appreciate the reviewer’s interest in and positive assessment of our work, and we thank the reviewer for the constructive feedback. In the current revision, we have revised the manuscript for clarity and added previously omitted statistical details. Furthermore, in the response letter, we have also provided additional explanations to clarify our approach, including the rationale for the choice and use of ROIs.

      Reviewer #2 (Public review): 

      Summary: 

      This study aims to investigate how social observation influences risky decision-making. Using a gambling task, the study explored how participants adjusted their risk-taking behavior when they believed their decisions were being observed by either a risk-averse or risk-seeking partner. The authors hypothesized that individuals would simulate the choices of their observers based on learned preferences and integrate these simulated choices into their own decision-making. In addition to behavioral experiments, the study employed computational modeling to formalize decision processes and fMRI to identify the neural underpinnings of risky decision-making under social observation. 

      Strengths: 

      The study provides a fresh perspective on social influence in decision-making, moving beyond the simple notion that social observation leads to uniformly riskier behavior. Instead, it shows that individuals adjust their choices depending on their beliefs about the observer's risk preferences, offering a more nuanced understanding of how social contexts shape decision-making. The authors provide evidence using comprehensive approaches, including behavioral data based on a well-designed task, computational modeling, and neuroimaging. The three models are well selected to compare at which level (e.g., computing utility, risk preference shift, and choice probability) the social influence alters one's risky decision-making. This approach allows for a more precise understanding of the cognitive processes underlying decision-making under social observation. 

      Weaknesses: 

      While the neuroimaging results are generally consistent with the behavioral and computational findings, the strength of the neural evidence could be improved. The authors' claims about the involvement of the TPJ and mPFC in integrating social information are plausible, but further analysis, such as model comparisons at the neuroimaging level, is needed to decisively rule out alternative interpretations that other computational models suggest. 

      We appreciate the reviewer’s interest in and positive assessment of our work, and we thank the reviewer for the constructive feedback. In the current revision, we have included neural results from additional analyses, which we believe provide stronger support for our proposed computational model.

      Reviewer #3 (Public review): 

      Summary: 

      This is an important paper using a novel paradigm to examine how observation affects the social contagion of risk preferences. There is a lot of interest in the field about the mechanisms of social influence, and adding in the factor of whether observation also influences these contagion effects is intriguing.

      Strengths:

      (1) There is an impressive combination of a multi-stage behavioural task with computational modelling and neuroimaging.

      (2) The analyses are well conducted and the sample size is reasonable. 

      Weaknesses: 

      (1) Anatomically it would be helpful to more explicitly distinguish between dmPFC and vmPFC. Particularly at the end of the introduction when mPFC and vmPFC are distinguished, as the vmPFC is in the mPFC. 

      (2) The authors' definition of ROIs could be elaborated on further. They suggest that peaks are selected from neurosynth for different terms, but were there not multiple peaks identified within a functional or anatomical brain area? This section could be strengthened by confirming with anatomical ROIs where available, such as the atlases here http://www.rbmars.dds.nl/lab/CBPatlases.html and the Harvard-Oxford atlases. 

      (3) How did the authors ensure there were enough trials to generate a reliable BOLD signal? The scanned part of the study seems relatively short. 

      (4) It would be helpful to add whether any brain areas survived whole-brain correction. 

      (5) There is a concern that mediation cannot be used to make causal inferences and much larger samples are needed to support claims of mediation. The authors should change the term mediation in order to not imply causality (they could talk about indirect effects instead) and highlight that the mediation analyses are exploratory as they would not be sufficiently powered (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843527/). 

      (6) The authors may want to speculate on lifespan differences in this susceptibility to risk preferences given recent evidence that older adults are relatively more susceptible to impulsive social influence (Zhu et al, 2024, comms psychology). 

      We appreciate the reviewer’s interest in and positive assessment of our work, and we thank the reviewer for the constructive feedback. In the response letter below, we address each of the reviewer’s comments, including clarifications regarding the ROIs and the limitations of the current study in interpreting the results.

      Reviewer #1 (Recommendations for the authors):

      (1) The neuroimaging hypotheses seem post hoc to me. First, the term "social inference" is used very loosely. In line 103 the authors mentioned that TPJ has been reported to be involved in inferring other's intentions and learning about others. However, in their task, it is not clear where inference is needed. All participants need to do is recall others' "preferences", rather than inferring a hidden variable or hidden intention. In addition, in some of the studies that the authors have cited (e.g., Park et al. 2021), the hippocampus is the focus of the inference, which gets no mention here.

      How does solving this task require inference (as defined by the authors: inferring others' intentions)? And why do they choose TPJ while inference is not needed in this task?

      We regret any confusion and would like to take this chance to clarify our hypothesis on social inference. As the reviewer pointed out, participants were indeed instructed to predict their choices, through which we expected them to learn the demonstrators’ preferences. Our computational model suggests that during the main phase of the task, i.e., the Observed phase, participants simulated others’ choices based on these previously learned risk preferences of others. The gamble choices they encountered (payoffs and associated probabilities) did not overlap with those in the Learning phase, and therefore, we expected that the cognitive process triggered by the social context involved active simulation—what we describe as making inference about others—rather than simple ‘recall’ of previously learned information. In line with this reasoning, we hypothesized that the TPJ, a brain region previously implicated in simulating others’ actions and intentions, would play a key role during the Observed phase.

      Regarding the role of the hippocampus, the paper we cited by BoKyung Park et al. (2021), titled “The role of right temporoparietal junction in processing social prediction error across relationship contexts”, highlights the involvement of the rTPJ but does not mention the hippocampus. We are aware of the study by Seongmin A. Park et al. (2021), “Inferences on a multidimensional social hierarchy use a grid-like code”, which shows the involvement of the hippocampus and entorhinal cortex in making inferences about multidimensional social hierarchies; we believe the reviewer may have mistakenly assumed that we cited this article. As the study showed, the involvement of the hippocampus—and the use of its grid-like representation of social information—is likely tied to the multidimensional nature of task states. In our study, the hippocampus was not included as an ROI because we had no specific rationale to hypothesize that such grid-like representations would be recruited by our task.

      (2) Social influence can be motivated informationally (to improve accuracy) or normatively (to be aligned with others). To me, it seems that the authors have studied the latter, because, first, there is no objectively correct response in this task and second, because participants changed their risk preference according to the preference of the observing partner. This distinction has not been made throughout the manuscript. This is important because the two process (information and normative) are supported by different neural processes and it is extremely useful to understand neural basis of which process the authors are studying.

      We thank the reviewer for the opportunity to clarify the anticipated role of social influence in our study. As the reviewer pointed out, the gambling task used in our task does not have objectively correct or incorrect answers, and naturally, any social influence present during the task would align with normative social influence. To clarify this point, we have revised the discussion section as follows:

      [Page 9, Line 345]

      Observational learning and mimicry of others’ behavior are patterns commonly found in social animals, including nonhuman primates (Van de Waal et al., 2013). Such behaviors are thought to be driven either by a motivation to acquire additional information (‘informational conformity’) or by a motivation to align with group norm (‘normative conformity’), even when doing so does not necessarily lead to better outcomes (e.g., higher accuracy) (Cialdini & Goldstein, 2004). Given that there are no objectively correct or incorrect answers in the gambling task used in our study, the observed social influence is more consistent with normative conformity. However, we cannot rule out the possibility that individuals developed false beliefs about a particular observing partner—namely, that the partner had greater control over or insight into the gambling task. Future studies are needed to directly investigate whether individuals’ beliefs about others modulate informational social influence—that is, their motivation to use social information to gain additional insight by inferring others’ potential choices.

      (3) From Line 160 onward, the authors report several findings without providing any effect sizes or statistics. Please add effect size and statistics for each finding.

      We thank the reviewer for pointing this out. We have now added the corresponding effect sizes and statistical values for the reported findings, beginning from Line 160 in the revised manuscript.

      (4) Line 270: "In particular, bilateral TPJ, brain regions not implicated in the Solo phase, positively tracked trial-by-trial model-estimated decision probabilities". How can the authors conclude that TPJ is not involved in the solo phase? As far as I understood from the text, TPJ was not included as one of the ROIs for analysis of the Solo phase. If it was included, it should be mentioned in the text and there should be a direct comparison between the effect sizes of the solo and the observer phase. If not, "not implicated in the Solo phase" is not justified and should be removed.

      We apologize for the confusion. As the reviewer correctly pointed out, the TPJ was not included among the ROIs in our analysis of the Solo phase data; therefore, its involvement during the Solo phase was never directly assessed using an ROI-based approach.

      To examine brain responses during the Observed phase, we first assessed whether regions that tracked decision probabilities during the Solo phase—vmPFC, vStr, and dACC—were also engaged in the Observed phase. The involvement of the TPJ during the Observed phase was revealed through a subsequent whole-brain analysis. To clarify this point, we now have revised the corresponding part as follows:

      [Page 8, Line 276]

      In particular, bilateral TPJ positively, brain regions not implicated in the Solo phase, tracked trial-by-trial model-estimated decision probabilities

      à Notably, bilateral TPJ showed significant positive tracking of decision probabilities ~

      (5) I am a bit puzzled about the PPI analysis. Is the main finding increased connectivity within mPFC in the observing condition? PPI is often done between two separate brain regions. I am not sure what it means that connectivity within mPFC increases in one condition compared to another. What was the motivation for this analysis? Can you also please explain what it means?

      As the reviewer noted, psychophysiological interaction (PPI) analyses examine functional connectivity between brain regions as modulated by a psychological factor. To clarify our result, the reported ‘mPFC-mPFC connectivity’ refers to functional connectivity between the mPFC region responsive to the presence of an observing partner and an adjacent, anatomically distinct region within the mPFC. Note that we have revised the manuscript to refer to this region more specifically as the dorsomedial prefrontal cortex (dmPFC). Please see our response to Reviewer 3, Comment 1, for further details.

      During the Observed phase of our task, social information was processed at two distinct time points. First, at the beginning of each decision trial, individuals were cued with the presence (or absence) of an observing partner (‘Partner presentation’). Second, the gamble options, as well as the observing partner’s identity, were revealed (‘Options revealed’). Because participants had previously learned about the observing partner’s risk preferences, we expected them to simulate the choice the partner would likely make. We hypothesized that if individuals indeed simulated the partner’s choice and incorporated this information into their decision-making process, the brain region involved in recognizing the partner’s presence (dmPFC<sub>contrast</sub>) would be functionally connected to the region responsible for integrating social information into the final decision (TPJ). Our results showed that the two regions were functionally connected via an indirect path through an anatomically adjacent cluster within the mPFC (dmPFC<sub>PPI</sub>). Given that the recognition of the partner’s presence and the simulation of their choice occurred at two distinct time points, we interpreted the functional connectivity between the two dmPFC clusters (dmPFC<sub>contrast</sub> and dmPFC<sub>PPI</sub>) as evidence that the dmPFC<sub>PPI</sub>) remained engaged during the decision process to support simulation, rather than being involved solely in the passive recognition of the social context (i.e., observed vs not observed). Note that, consistent with this interpretation, functional connectivity was stronger in individuals who showed greater reliance on social information ('Social reliance' parameter in our model).

      To avoid confusion, we have now labeled the two dmPFC clusters as dmPFC<sub>contrast</sub>—the seed region identified at partner presentation—and dmPFC<sub>PPI</sub>—the target region identified in the PPI analysis.

      [Page 8, Line 284]

      This cue was intended to dissociate neural responses to the social context per se (i.e., the presence of an observing partner), which we hypothesized would initiate social processing, from the neural processes involved in incorporating this information during the subsequent decision-making phase.

      [Page 8, Line 291]

      We tested whether the dmPFC was also involved in incorporating social information during the decision process under social observation, particularly among individuals who relied more heavily on simulating others’ behavior.

      [Page 8, Line 297]

      We confirmed that the functional connectivity between the dmPFC<sub>contrast</sub> which is sensitive to cues regarding the presence of an observing partner, and its adjacent, anatomically distinct region within the dmPFC (‘dmPFC<sub>PPI</sub>’ hereafter; x = 3, y = 50, z = 5, k<sub>E</sub> = .74, cluster-level P<sub>FWE, SVC</sub> = 0.011; Fig. 4a, b, Table S5) was positively associated with individuals’ social reliance.

      (6) In Line 107 the authors say "excitatory stimulation of the TPJ improved social cognition". Improved social cognition is too general and unspecific. Please be more specific.

      We agree that the term ‘social cognition’ was too general and unspecific. In the revised manuscript, we have specified that the improvement was observed in tasks specifically involving the control of self-other representation, as demonstrated by Santiesteban et al. (2012).

      [Page 4, Line 106]

      Corroborating with these neuroimaging data, excitatory stimulation of the TPJ improved social cognition (Santiesteban et al., 2012),~

      à Corroborating these neuroimaging findings, excitatory stimulation of the TPJ improved social cognition involving the control of self-other representation (Santiesteban et al., 2012),~

      Writing:

      We thank the reviewer for their thorough evaluation of our manuscript. We have now made the necessary revisions in accordance with the provided comments.

      (7) Line 75: "one risky options" should be one risky option.

      [Page 3, Line 74]

      between one safe (i.e., guaranteed payoff) and one risky options.

      between a safe option (i.e., guaranteed payoff) and a risky option.

      (8) Line 82: were given with the same set of gamble should be "were given the same set of gamble".

      [Page 3, Line 81]

      In the third phase (‘Observed phase’), individuals were given with the same set of gamble choices they faced in the Solo phase,

      In the third phase (‘Observed phase’), individuals were given the same set of gamble choices they faced in the Solo phase,~

      (9) Line 63: and that the extent of such influence depends on the identity of the observer. It is not clear what the authors mean by the "identity of observer". Does it mean the preference of the observer?

      Van Hoorn et al. (2018) showed that the degree of social influence varies depending on whether individuals are being observed by parents or by peers. While one might attribute this difference to divergent preferences typically held by parents and peers, it is important to note that other factors may also differ between these social groups. To avoid overinterpretation while preserving the original meaning, we have revised the sentence as follows:

      [Page 3, Line 61]

      However, recent studies showed that the unidirectional influence of social others’ presence may be also observed in adults (Otterbring, 2021), and that the extent of such influence depends on the identity of the observer (Van Hoorn et al., 2018).  

      However, recent studies showed that the unidirectional influence of social others’ presence can also be observed in adults (Otterbring, 2021), and that the extent of this influence depends on the observer’s identity—specifically, whether the observer is a parent or a peer (Van Hoorn et al., 2018).

      (10) Line 103: "including inferring others' intention and in learning about others." An "in" is missing right before inferring.

      [Page 4, Line 101]

      The temporoparietal junction (TPJ) is another region known to play an important role in social cognitive functions, including inferring others’ intention and in learning about others (Behrens et al., 2008; Boorman et al., 2013; Charpentier et al., 2020; Park et al., 2021; Samson et al., 2004; Saxe & Kanwisher, 2003; Saxe & Kanwisher, 2013; Van Overwalle, 2009; Young et al., 2010).

      The temporoparietal junction (TPJ) is another region known to play an important role in a range of social cognitive functions, including simulating others’ intention and choices, as well as learning about others (Behrens et al., 2008; Boorman et al., 2013; Charpentier et al., 2020; Park et al., 2021; Samson et al., 2004; Saxe & Kanwisher, 2003; Saxe & Kanwisher, 2013; Van Overwalle, 2009; Young et al., 2010).

      (11) 106: "Corroborating with these neuroimaging data." It should be "corroborating these neuroimaging data".

      [Page 4, Line 106]

      Corroborating with these neuroimaging data, ~

      Corroborating these neuroimaging findings, ~

      (12) Lines 113-115. It is not clear what the authors are trying to say here.

      We have now revised the sentence as follows:

      [Page 4, Line 112]

      We hypothesized that even if others’ choices are not explicitly presented, simple presence of social others may trigger inference about others’ potential choices, and the same set of brain regions will play an important role in value-based decision-making.

      We hypothesized that, even in the absence of explicit information about others’ choices, the mere presence of social others could lead participants to conform to the option they believe others would choose. To do so, participants would need to simulate others’ potential choices, particularly when option values vary across trials. As a result, we propose that the same brain regions involved in simulating others’ decisions would also be engaged during value-based decision-making in the presence of social observers.

      (13) Line 151: This sentence is too long and hard to follow:

      We have now revised the sentence as follows:

      [Page 5, Line 154]

      Furthermore, individuals’ prediction responses on subsequent 10 prediction trials where no feedback was provided (Fig. 2b) as well as self-reports about the perceived riskiness of the partners collected at the end of the Learning phase (Fig. 1d) consistently showed that they were able to distinguish one partner from the other, and correctly estimate the partners’ risk preferences (Predicted risk preference: t(42) = -11.46, P = 1.66e-14; Self-report: t(42) = -35.83, P = 4.10e-33).

      Furthermore, individuals’ prediction responses during the subsequent 10 trials without feedback consistently indicated that they could distinguish between the two partners and accurately estimate each partner’s risk preferences (t(42) = -11.46, P = 1.66e-14; Fig. 2b). Self-reported ratings of the partners’ perceived riskiness, collected after the Learning phase, further supported this finding (t(42) = -35.83, P = 4.10e-33; Fig. 1d).

      (14) Line 178: This sentence is very hard to follow. I am not sure what the authors were trying to say here. Please clarify.

      We have now revised the sentence as follows:

      [Page 5, Line 183]

      Various previous studies examined the impacts of social context on decision-making processes, but the suggested mechanisms by which individuals were affected by the social information depended on how the information was presented.

      à Previous studies have shown that social context can influence decision-making processes. However, the underlying mechanisms proposed have varied depending on how the social information was presented.

      (15) Line 183: "when individuals were given with the chances" should be "when individuals were given the chance".

      [Page 5, Line 187]

      On the contrary, when individuals were given with the chances~

      On the contrary, when individuals were given the chances~

      (16) Line 192: "are sensitive to the identity of the currently observing partner...". Do the authors mean are sensitive to the preferences of the currently observing partner? If so, please clarify, it is hard to follow.

      We have now revised the sentence as follows:

      [Page 5, Line 195]

      We hypothesized that if individuals are sensitive to the identity of the currently observing partner, they would take into account the learned preferences of others in computing their choices rather than simply in guiding the direction how to change their own preferences.

      à We hypothesized that if individuals are sensitive to the learned preferences of the observing partner, they would use this information to simulate the partner’s likely choices, rather than simply aligning their own preferences with those of the partner.

      Reviewer #2 (Recommendations for the authors):

      (1) The current neuroimaging findings appear to support the decision processes of all three models. I recommend that the authors provide more detailed evidence of model comparisons in the neuroimaging analysis. This should go beyond simply comparing the goodness of fit of neural activity.

      We acknowledge that neuroimaging data alone often do not provide conclusive evidence for specific information processing. In our study, we examined brain regions that track decision probabilities and are associated with social cognition, such as simulating others’ choice tendencies. Because these processes are general and not tied to a specific computational model, neural responses supporting the occurrence of such processes cannot be used to rule out alternative decision models. For this reason, our approach prioritized a rigorous behavioral model comparison as a critical first step before probing the neural substrates underlying the proposed mechanism. Our behavioral model comparisons, including both quantitative fit indices and qualitative pattern predictions, indicated that the proposed model best accounted for participants' decision patterns across task conditions.

      More importantly, to further validate the model, we conducted a model recovery analysis (see Fig. S2b in SI), which confirmed that our model can be reliably distinguished from alternative accounts even when behavioral differences are subtle. This result suggests that our model captures unique and meaningful characteristics of the decision process that are not equally well explained by competing models.

      With this behavioral foundation, our neuroimaging analyses were designed not to serve as independent model arbiters, but rather to examine whether brain activity in regions of interest reflected the computations specified by the best-fitting model. We believe this two-step approach—first establishing behavioral validity, then linking model-derived variables to neural data—offers a principled framework for identifying the cognitive and neural mechanisms of decision-making.

      Nevertheless, per the reviewer’s suggestion, we further examined whether there is neural encoding of both the participant’s own utility and the observer’s utility—serving as potential neural evidence to differentiate our model from the two alternative models. Please see below for our response to Reviewer 2’s Comment (2).

      (2) Specifically, if participants are combining their own and simulated choices at the level of choice probability, we would expect to see neural encoding of both their own utility and the observer's utility. These may be observed in different areas of the mPFC, as demonstrated by Nicolle et al. (Neuron, 2012). In that study, decisions simulating others' choices were associated with activity in the dorsal mPFC, while one's own decisions were encoded in the vmPFC. On the contrary, if the brain encodes decision values based on the shifted risk preference, rather than encoding each decision's value in separate brain areas, this would support the alternative model.

      We thank the reviewer for this constructive comment. In our Social reliance model, we assumed that the decision probability based on an individual’s own risk preferences, as well as that based on the observing partner’s risk preferences, both contribute to the individual’s final choice. As the reviewer suggested, neural evidence that differentiates our model from the two alternative models—the Risk preference change model and the Other-conferred utility model—would involve demonstrating neural encoding of both the participant’s own utility and the observer’s utility.

      The utility differences between chosen and unchosen options from the two perspectives—self and observer—were highly correlated, preventing us from including both as regressors in the same design matrix. Instead, we defined ROIs along the ventral-to-dorsal axis of the mPFC, and examined whether each ROI more strongly reflected one’s own utility or that of the observer. Based on the meta-analysis by Clithero and Rangel (2014), we defined the most ventral mPFC ROI (ROI1) as a 10 mm-radius sphere centered at coordinate [x=-3, y=41, z=-7], a region previously associated with subjective value. From this ventral seed, we defined four additional spherical ROIs (10 mm radius each) at 12 mm intervals along the ventral-to-dorsal axis, resulting in five ROIs in total: ROI2 [x=-3, y=41, z=5], ROI3 [x=-3, y=41, z=17], ROI4 [x=-3, y=41, z=29], ROI5 [x=-3, y=41, z=41].

      Consistent with Nicolle et al. (2012), the representation of one’s own utility (labelled as ‘Own subjective value’) and that of the observer (‘Observer’s subjective value’) was organized along the ventral-to-dorsal axis of the mPFC. Specifically, utility signals from the participant’s own perspective (SV<sub>chosen, self</sub> – SV<sub>unchosen, self</sub>) were most prominently represented in the ventral-most ROIs (blue), whereas utility signals from the observer’s perspective (SV<sub>chosen, observer</sub> – SV<sub>unchosen, observer</sub>) were most strongly represented in the dorsal-most ROIs (orange).

      (3) Additionally, the authors may be able to detect neural signals related to conflict when the decisions of the individual and the observer differ, compared to when the decisions are congruent. These neural signatures would only be present if social influences are integrated at the choice level, as suggested by the authors.

      If individuals simulate the choices that others might make, they may compare them with the choices they would have made themselves. To investigate this possibility, we categorized task trials as Conflict or No-conflict trials based on greedy choice predictions derived from a softmax decision rule. Conflict trials were those in which the choice predicted from the participant’s own risk preference differed from that predicted for the observer, whereas No-conflict trials involved the same predicted choice from both perspectives. A contrast between Conflict and No-conflict trials revealed that the dACC and dlPFC—regions previously associated with conflict monitoring and cognitive control (Shenhav et al., 2013)—were sensitive to differences in choice tendencies between the self and observer perspectives.

      Author response image 1.

      dACC and dlPFC are associated with the discrepancy between participants’ own choice tendencies and those of observing partners, as estimated based on prior beliefs about the partners’ risk preferences.

      As the reviewer suggested, these results provide evidence in support of the Social Reliance model, which posits that participants simulate the observer's choice and integrate it with their own.

      (4) Incorporating these additional analyses would provide stronger evidence for distinguishing between the models.

      We again thank the reviewer for these constructive suggestions. Based on the new set of analyses and results, we have made the necessary revisions as noted above. We agree that these revisions provide stronger evidence for distinguishing between the models.

      Reviewer #3 (Recommendations for the authors):

      (1) Anatomically it would be helpful to more explicitly distinguish between dmPFC and vmPFC. Particularly at the end of the introduction when mPFC and vmPFC are distinguished, as the vmPFC is in the mPFC.

      We appreciate the reviewer’s suggestion regarding the anatomical distinction between the dmPFC and vmPFC, particularly in relation to our use of the term “mPFC.” We acknowledge that the dmPFC and vmPFC are subregions of the broader mPFC. In our original manuscript, we referred to one region as mPFC in line with prior studies highlighting its role in social cognition and contextual processing (Behrens et al., 2008; Sul et al., 2015; Wittmann et al., 2016). However, in response to the reviewer’s comment and to more clearly distinguish this region from the ventral portion of the mPFC (i.e., vmPFC), which is canonically associated with subjective valuation, we have now revised the manuscript to refer to this region as the dmPFC. This terminology better reflects its association with social cognition, including model-estimated social reliance and sensitivity to social cues in our study.

      (2) The authors' definition of ROIs could be elaborated on further. They suggest that peaks are selected from neurosynth for different terms, but were there not multiple peaks identified within a functional or anatomical brain area? This section could be strengthened by confirming with anatomical ROIs where available, such as the atlases here http://www.rbmars.dds.nl/lab/CBPatlases.html and the Harvard-Oxford atlases.

      We appreciate the opportunity to clarify how our ROIs were defined. To identify the ROIs, we drew upon both prior literature and results from a term-based meta-analysis using Neurosynth. For each meta-map, we applied an FDR-corrected threshold of p < 0.01 and a cluster extent threshold of k ≥ 100 voxels to identify distinct functional clusters. For each cluster, we constructed a spherical ROI (radius = 10 mm) centered on its center of gravity. Note that for each anatomically distinct brain region, only a single center of gravity was identified and used to define the ROI. The resulting ROIs were subsequently used for small volume correction (SVC) in the second-level fMRI analyses.

      For brain regions associated with decision-making processes, we obtained a meta-analytic activation map associated with the term “decision” from Neurosynth. After applying an FDR-corrected threshold of p < 0.001 and a cluster extent threshold of k ≥ 100 voxels, we identified five distinct clusters: vmPFC [x = -3, y = 38, z = -10]; right vStr [x = 12, y = 11, z = -7]; left vStr [x = -12, y = 8, z = -7]; dACC [x = 3, y = 26, z = 44]; and left Insula [x = -30, y = 23, z = -1]. To identify brain regions involved in decision-making under social observation, we used the Neurosynth meta-map associated with the term “social”, applying the same criteria (FDR p < 0.001, k ≥ 100). This analysis revealed several clusters, including bilateral TPJ: right TPJ [x = 51, y = -52, z = 14]; left TPJ [x = -51, y = -58, z = 17]. To isolate brain regions more specifically associated with social processing rather than valuation, we also constructed a conjunction map using the meta-maps for the terms “social” and “value.” We identified clusters present in the “social” map, but not in the “value” map. This analysis yielded, among others, a cluster in the dmPFC [x = 0, y = 50, z = 14].

      To clarify our ROI analysis methods, we have now revised the manuscript to include more detailed information about the procedures used, as follows:

      [Page 19, Line 746]

      Region-of-interest (ROI) analyses. To define ROIs for the neural analyses conducted in the Observed phase, we used significant clusters identified during the Solo phase. Specifically, regions showing significant activation for Prob(chosen) in the DM0 (thresholded at P < 0.001) were selected as ROIs. Three ROI clusters were defined: the vStr (peak voxel at [x = 3, y = 14, z = -10], k<sub>E</sub> = 9), vmPFC (peak voxel at [x = –3, y = 62, z = –13], k<sub>E</sub> = 99), and dACC (peak voxel at [x = 12, y = 32, z = 29], k<sub>E</sub> = 118). These ROIs were then applied in the Observed phase analyses to test whether similar neural representations are also engaged in social contexts.

      Term-based meta-analytic maps from Neurosynth for small volume correction. To reduce the likelihood of false positives arising from random significant activations and to enhance sensitivity within regions of theoretical interest, small volume correction (SVC) was applied using term-based meta-analytic maps from Neurosynth. This approach allows for hypothesis-driven correction by restricting statistical testing to anatomically and functionally defined ROI. Specifically, three meta-analytic maps were generated using Neurosynth’s term-based analyses (Yarkoni et al., 2011), with a false discovery rate (FDR) corrected P < 0.01 and a cluster size > 100 voxels. For each resulting cluster, we defined a spherical ROI with a 10 mm radius centered on the cluster’s center of gravity. For each anatomically distinct brain region, only a single center of gravity was identified and used to define the corresponding ROI.

      First, to identify regions encoding final decision probabilities during the Solo phase and enhance sensitivity, we used the meta-map associated with the term “decision” to identify neural substrates of value-based decision-making. This yielded three clusters: vmPFC ([x = -3, y = 38, z = -10]), vStr ([x = 12, y = 11, z = -7]), and dACC ([x = 3, y = 26, z = 44]) (Fig. 3a, S7). Second, to examine social processing during the Observed phase, we used the meta-map associated with the term “social” to identify brain regions typically involved in social cognition. This analysis revealed clusters, including the rTPJ ([x = 51, y = -52, z = 14]) and lTPJ ([x = -51, y = -58, z = 17]) (Fig. 3c, S8a). Third, to define an ROI involved in processing social cues independent of valuation, we used a meta-map associated with “social” but excluding “value”, isolating regions specific to non-valuation-related social cognition. This analysis revealed a cluster, including the dmPFC ([x = 0, y = 50, z = 14]) (Fig. 3d, 4a, S8b).

      (3) How did the authors ensure there were enough trials to generate a reliable BOLD signal? The scanned part of the study seems relatively short.

      We appreciate the reviewer’s concern regarding the number of trials and the potential implications for the reliability of the resulting BOLD signals. While we did not conduct formal statistical tests to determine the optimal number of trials, our task design, in general, followed well-established principles in functional neuroimaging. Specifically, we employed a jittered event-related design and used both temporal and dispersion derivatives in the GLM analyses. These strategies are widely recognized for enhancing the efficiency of BOLD signal deconvolution and improving model fit by accounting for inter-subject and inter-regional variability in the hemodynamic response function (HRF). Furthermore, the number of trials per condition in our study was comparable to those reported in previous publications (20-30 trials) that employed similar gambling paradigms to examine individual differences in the neural substrates of value-based decision-making (Chung et al., 2015; Chung et al., 2020).

      (4) It would be helpful to add whether any brain areas survived whole-brain correction.

      No brain regions survived whole-brain correction. Nevertheless, as described in the introduction, we had strong a priori hypotheses. Based on these hypotheses, we defined term-based ROIs using Neurosynth, and conducted small volume correction analyses. Per the reviewer’s suggestion, we have added information indicating that no brain regions survived whole-brain correction, as follows:

      [Page 8, Line 281]

      No additional regions survived whole-brain correction.

      (5) There is a concern that mediation cannot be used to make causal inferences and much larger samples are needed to support claims of mediation. The authors should change the term mediation in order to not imply causality (they could talk about indirect effects instead) and highlight that the mediation analyses are exploratory as they would not be sufficiently powered (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843527/).

      We acknowledge the reviewer’s concerns regarding the causal interpretation of mediation analysis results. Per this comment, we have revised the manuscript as follows to avoid overinterpreting these results and to refrain from implying any causal inference.

      [Page 9, Line 327]

      Given that our sample size is smaller than the recommended threshold for detecting mediation effects (Fritz & MacKinnon, 2007), this significant indirect effect should be interpreted with caution, particularly with respect to causal inference.

      (6) The authors may want to speculate on lifespan differences in this susceptibility to risk preferences given recent evidence that older adults are relatively more susceptible to impulsive social influence (Zhu et al, 2024, comms psychology).

      We thank the reviewer for the thoughtful suggestion—we believe the referenced work is Zhilin Su et al. (2024). As noted in our manuscript, all participants in the current study were young adults aged between 18 and 29 years. Given this limited age range, our dataset does not provide sufficient variability to directly examine age-related differences across the lifespan. However, we are planning a follow-up study using the same task with older adult participants, which we believe will provide a valuable opportunity to address this important gap in understanding susceptibility to social influence across the lifespan.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Weaknesses:

      INTRODUCTION & THEORY

      (1) Can the authors please clarify why the first trial of extinction in a standard protocol does NOT produce the retrieval-extinction effect? Particularly as the results section states: "Importantly, such a short-term effect is also retrieval dependent, suggesting the labile state of memory is necessary for the short-term memory update to take effect (Fig. 1e)." The importance of this point comes through at several places in the paper:

      1A. "In the current study, fear recovery was tested 30 minutes after extinction training, whereas the effect of memory reconsolidation was generally evident only several hours later and possibly with the help of sleep, leaving open the possibility of a different cognitive mechanism for the short-term fear dementia related to the retrieval-extinction procedure." ***What does this mean? The two groups in study 1 experienced a different interval between the first and second CS extinction trials; and the results varied with this interval: a longer interval (10 min) ultimately resulted in less reinstatement of fear than a shorter interval. Even if the different pattern of results in these two groups was shown/known to imply two different processes, there is absolutely no reason to reference any sort of cognitive mechanism or dementia - that is quite far removed from the details of the present study.

      Indeed, the only difference between the standard extinction paradigm and the retrieval-extinction paradigm is the difference between the first and second CS extinction trials. It has been shown before that a second CS+ presented 1 hour after the initial retrieval CS+ resulted in the dephosphorylation of GluR1 in rats, which was indicative of memory destabilization. The second CS+ presented only 3 minutes after the initial retrieval CS+, as in the standard extinction training, did not cause the GluR1 dephosphorylation effect (Monfils et al., 2009). Therefore, an isolated presentation of the CS+ seems to be important in preventing the return of fear expression. Behaviorally, when the CSs were presented in a more temporally spaced (vs. mass presentation) or a more gradual manner in the extinction training, the fear amnesia effects were more salient (Cain et al., 2003, Gershman et al., 2013). It has also been suggested that only when the old memory and new experience (through extinction) can be inferred to have been generated from the same underlying latent cause, the old memory can be successfully modified (Gershman et al., 2017). On the other hand, if the new experiences are believed to be generated by a different latent cause, then the old memory is less likely to be subject to modification. Therefore, the way the first and 2nd CS are temporally organized (retrieval-extinction or standard extinction) might affect how the latent cause is inferred and lead to different levels of fear expression from a theoretical perspective. These findings, together with studies in both fear and drug memories using the retrieval-extinction paradigm (Liu et al., 2014, Luo et al., 2015, Schiller et al., 2010, Xue et al., 2012), seem to suggest that the retrieval-extinction and the standard extinction procedures engage different cognitive and molecular mechanisms that lead to significant different behavioral outcomes. 

      In our study, we focus on the short-term and long-term amnesia effects of the retrieval-extinction procedure but also point out the critical role of retrieval in eliciting the short-term effect.

      1B. "Importantly, such a short-term effect is also retrieval dependent, suggesting the labile state of memory is necessary for the short-term memory update to take effect (Fig. 1e)." ***As above, what is "the short-term memory update"? At this point in the text, it would be appropriate for the authors to discuss why the retrieval-extinction procedure produces less recovery than a standard extinction procedure as the two protocols only differ in the interval between the first and second extinction trials. References to a "short-term memory update" process do not help the reader to understand what is happening in the protocol.

      Sorry for the lack of clarity here. By short-term memory update we meant the short-term amnesia in fear expression.

      (2) "Indeed, through a series of experiments, we identified a short-term fear amnesia effect following memory retrieval, in addition to the fear reconsolidation effect that appeared much later."

      ***The only reason for supposing two effects is because of the differences in responding to the CS2, which was subjected to STANDARD extinction, in the short- and long-term tests. More needs to be said about how and why the performance of CS2 is affected in the short-term test and recovers in the long-term test. That is, if the loss of performance to CS1 and CS2 is going to be attributed to some type of memory updating process across the retrieval-extinction procedure, one needs to explain the selective recovery of performance to CS2 when the extinction-to-testing interval extends to 24 hours. Instead of explaining this recovery, the authors note that performance to CS1 remains low when the extinction-to-testing interval is 24 hours and invoke something to do with memory reconsolidation as an explanation for their results: that is, they imply (I think) that reconsolidation of the CS1-US memory is disrupted across the 24-hour interval between extinction and testing even though CS1 evokes negligible responding just minutes after extinction.

      In our results, we did not only focus on the fear expression related to CS2. In fact, we also demonstrated that the CS1 related fear expression diminished in the short-term memory test but re-appeared in the long-term memory after the CS1 retrieval-extinction training.

      The “…recovery of performance to CS2 when the extinction-to-testing interval extends to 24 hours…” is a result that has been demonstrated in various previous studies (Kindt and Soeter, 2018, Kindt et al., 2009, Nader et al., 2000, Schiller et al., 2013, Schiller et al., 2010, Xue et al., 2012). That is, the reconsolidation framework stipulates that the pharmacological or behavioral intervention during the labile states of the reconsolidation window only modifies the fear memory linked to the reminded retrieval cue, but not for the non-reminded CS-US memory expression (but also see (Liu et al., 2014, Luo et al., 2015) for using the unconditioned stimulus as the reminder cue and the retrieval-extinction paradigm to prevent the return of fear memory associated with different CS).  In fact, we hypothesized the temporal dynamics of CS1 and CS2 related fear expressions were due to the interplay between the short-term and long-term (reconsolidation) effects of the retrieval-extinction paradigm in the last figure (Fig. 6). 

      (3) The discussion of memory suppression is potentially interesting but, in its present form, raises more questions than it answers. That is, memory suppression is invoked to explain a particular pattern of results but I, as the reader, have no sense of why a fear memory would be better suppressed shortly after the retrieval-extinction protocol compared to the standard extinction protocol; and why this suppression is NOT specific to the cue that had been subjected to the retrieval-extinction protocol.

      We discussed memory suppression as one of the potential mechanisms to account for the three characteristics of the short-term amnesia effects: cue-independence, temporal dynamics (short-term) and thought-control-ability relevance. According to the memory suppression theory, the memory suppression effect is NOT specific to the cue and this effect was demonstrated via the independent cue test in a variety of studies (Anderson and Floresco, 2022, Anderson and Green, 2001, Gagnepain et al., 2014, Zhu et al., 2022). Therefore, we suggest in the discussion that it might be possible the CS1 retrieval cue prompted an automatic suppression mechanism and yielded the short-term fear amnesia consistent with various predictions from the memory suppression theory:

      “In our experiments, subjects were not explicitly instructed to suppress their fear expression, yet the retrieval-extinction training significantly decreased short-term fear expression. These results are consistent with the short-term amnesia induced with the more explicit suppression intervention (Anderson et al., 1994; Kindt and Soeter, 2018; Speer et al., 2021; Wang et al., 2021; Wells and Davies, 1994). It is worth noting that although consciously repelling unwanted memory is a standard approach in memory suppression paradigm, it is possible that the engagement of the suppression mechanism can be unconscious. For example, in the retrieval-induced forgetting (RIF) paradigm, recall of a stored memory impairs the retention of related target memory and this forgetting effect emerges as early as 20 minutes after the retrieval procedure, suggesting memory suppression or inhibition can occur in a more spontaneous and automatic manner (Imai et al., 2014). Moreover, subjects with trauma histories exhibited more suppression-induced forgetting for both negative and neutral memories than those with little or no trauma (Hulbert and Anderson, 2018). Similarly, people with higher self-reported thought-control capabilities showed more severe cue-independent memory recall deficit, suggesting that suppression mechanism is associated with individual differences in spontaneous control abilities over intrusive thoughts (Küpper et al., 2014). It has also been suggested that similar automatic mechanisms might be involved in organic retrograde amnesia of traumatic childhood memories (Schacter et al., 2012; Schacter et al., 1996).”

      3A. Relatedly, how does the retrieval-induced forgetting (which is referred to at various points throughout the paper) relate to the retrieval-extinction effect? The appeal to retrieval-induced forgetting as an apparent justification for aspects of the present study reinforces points 2 and 3 above. It is not uninteresting but needs some clarification/elaboration.

      We introduced the retrieval-induced forgetting (RIF) to make the point that RIF was believed to be related to the memory suppression mechanism and the RIF effect can appear relatively early, consistent with what we observed in the short-term amnesia effect. We have re-written the manuscript to make this point clearer:

      “It is worth noting that although consciously repelling unwanted memory is a standard approach in memory suppression paradigm, it is possible that the engagement of the suppression mechanism can be unconscious. For example, in the retrieval-induced forgetting (RIF) paradigm, recall of a stored memory impairs the retention of related target memory and this forgetting effect emerges as early as 20 minutes after the retrieval procedure, suggesting memory suppression or inhibition can occur in a more spontaneous and automatic manner (Imai et al., 2014). Moreover, subjects with trauma histories exhibited more suppression-induced forgetting for both negative and neutral memories than those with little or no trauma (Hulbert and Anderson, 2018). Similarly, people with higher self-reported thought-control capabilities showed more severe cue-independent memory recall deficit, suggesting that suppression mechanism is associated with individual differences in spontaneous control abilities over intrusive thoughts (Küpper et al., 2014).”

      (4) Given the reports by Chalkia, van Oudenhove & Beckers (2020) and Chalkia et al (2020), some qualification needs to be inserted in relation to reference 6. That is, reference 6 is used to support the statement that "during the reconsolidation window, old fear memory can be updated via extinction training following fear memory retrieval". This needs a qualifying statement like "[but see Chalkia et al (2020a and 2020b) for failures to reproduce the results of 6]."

      https://pubmed.ncbi.nlm.nih.gov/32580869/

      https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115860/

      We have incorporated the reviewer’s suggestion into the revised manuscript in both the introduction:

      “Pharmacological blockade of protein synthesis and behavioral interventions can both eliminate the original fear memory expression in the long-term (24 hours later) memory test ( Lee, 2008; Lee et al., 2017; Schiller et al., 2013; Schiller et al., 2010), resulting in the cue-specific fear memory deficit (Debiec et al., 2002; Lee, 2008; Nader, Schafe, & LeDoux, 2000). For example, during the reconsolidation window, retrieving a fear memory allows it to be updated through extinction training (i.e., the retrieval-extinction paradigm (Lee, 2008; Lee et al., 2017; Schiller et al., 2013; Schiller et al., 2010), but also see (Chalkia, Schroyens, et al., 2020; Chalkia, Van Oudenhove, et al., 2020; D. Schiller, LeDoux, & Phelps, 2020)”

      And in the discussion:

      “It should be noted that while our long-term amnesia results were consistent with the fear memory reconsolidation literatures, there were also studies that failed to observe fear prevention (Chalkia, Schroyens, et al., 2020; Chalkia, Van Oudenhove, et al., 2020; Schroyens et al., 2023). Although the memory reconsolidation framework provides a viable explanation for the long-term amnesia, more evidence is required to validate the presence of reconsolidation, especially at the neurobiological level (Elsey et al., 2018). While it is beyond the scope of the current study to discuss the discrepancies between these studies, one possibility to reconcile these results concerns the procedure for the retrieval-extinction training. It has been shown that the eligibility for old memory to be updated is contingent on whether the old memory and new observations can be inferred to have been generated by the same latent cause (Gershman et al., 2017; Gershman and Niv, 2012). For example, prevention of the return of fear memory can be achieved through gradual extinction paradigm, which is thought to reduce the size of prediction errors to inhibit the formation of new latent causes (Gershman, Jones, et al., 2013). Therefore, the effectiveness of the retrieval-extinction paradigm might depend on the reliability of such paradigm in inferring the same underlying latent cause. Furthermore, other studies highlighted the importance of memory storage per se and suggested that memory retention was encoded in the memory engram cell ensemble connectivity whereas the engram cell synaptic plasticity is crucial for memory retrieval (Ryan et al., 2015; Tonegawa, Liu, et al., 2015; Tonegawa, Pignatelli, et al., 2015). It remains to be tested how the cue-independent short-term and cue-dependent long-term amnesia effects we observed could correspond to the engram cell synaptic plasticity and functional connectivity among engram cell ensembles (Figure 6). This is particularly important, since the cue-independent characteristic of the short-term amnesia suggest that either different memory cues fail to evoke engram cell activities, or the retrieval-extinction training transiently inhibits connectivity among engram cell ensembles. Finally, SCR is only one aspect of the fear expression, how the retrieval-extinction paradigm might affect subjects’ other emotional (such as the startle response) and cognitive fear expressions such as reported fear expectancy needs to be tested in future studies since they do not always align with each other (Kindt et al., 2009; Sevenster et al., 2012, 2013).”

      5A. What does it mean to ask: "whether memory retrieval facilitates update mechanisms other than memory reconsolidation"? That is, in what sense could or would memory retrieval be thought to facilitate a memory update mechanism?

      It is widely documented in the literatures that memory retrieval renders the old memory into a labile state susceptible for the memory reconsolidation process. However, as we mentioned in the manuscript, studies have shown that memory reconsolidation requires the de novo protein synthesis and usually takes hours to complete. What remains unknown is whether old memories are subject to modifications other than the reconsolidation process. Our task specifically tested the short-term effect of the retrieval-extinction paradigm and found that fear expression diminished 30mins after the retrieval-extinction training. Such an effect cannot be accounted for by the memory reconsolidation effect.

      5B. "First, we demonstrate that memory reactivation prevents the return of fear shortly after extinction training in contrast to the memory reconsolidation effect which takes several hours to emerge and such a short-term amnesia effect is cue independent (Study 1, N = 57 adults)."

      ***The phrasing here could be improved for clarity: "First, we demonstrate that the retrieval-extinction protocol prevents the return of fear shortly after extinction training (i.e., when testing occurs just min after the end of extinction)." Also, cue-dependence of the retrieval-extinction effect was assessed in study 2.

      We thank the reviewer and have modified the phrasing of the sentence:

      “First, we demonstrate that memory retrieval-extinction protocol prevents the return of fear expression shortly after extinction training and this short-term effect is memory reactivation dependent (Study 1, N = 57 adults).”

      5C. "Furthermore, memory reactivation also triggers fear memory reconsolidation and produces cue-specific amnesia at a longer and separable timescale (Study 2, N = 79 adults)." ***In study 2, the retrieval-extinction protocol produced a cue-specific disruption in responding when testing occurred 24 hours after the end of extinction. This result is interesting but cannot be easily inferred from the statement that begins "Furthermore..." That is, the results should be described in terms of the combined effects of retrieval and extinction, not in terms of memory reactivation alone; and the statement about memory reconsolidation is unnecessary. One can simply state that the retrieval-extinction protocol produced a cue-specific disruption in responding when testing occurred 24 hours after the end of extinction.

      We have revised the text according to the reviewer’s comment.

      “Furthermore, across different timescales, the memory retrieval-extinction paradigm triggers distinct types of fear amnesia in terms of cue-specificity and cognitive control dependence, suggesting that the short-term fear amnesia might be caused by different mechanisms from the cue-specific amnesia at a longer and separable timescale (Study 2, N = 79 adults).”

      5D. "...we directly manipulated brain activities in the dorsolateral prefrontal cortex and found that both memory retrieval and intact prefrontal cortex functions were necessary for the short-term fear amnesia."

      ***This could be edited to better describe what was shown: E.g., "...we directly manipulated brain activities in the dorsolateral prefrontal cortex and found that intact prefrontal cortex functions were necessary for the short-term fear amnesia after the retrieval-extinction protocol."

      Edited:

      “Finally, using continuous theta-burst stimulation (Study 3, N = 75 adults), we directly manipulated brain activity in the dorsolateral prefrontal cortex, and found that both memory reactivation and intact prefrontal cortex function were necessary for the short-term fear amnesia after the retrieval-extinction protocol.”

      5E. "The temporal scale and cue-specificity results of the short-term fear amnesia are clearly dissociable from the amnesia related to memory reconsolidation, and suggest that memory retrieval and extinction training trigger distinct underlying memory update mechanisms."

      ***The pattern of results when testing occurred just minutes after the retrieval-extinction protocol was different from that obtained when testing occurred 24 hours after the protocol. Describing this in terms of temporal scale is unnecessary, and suggesting that memory retrieval and extinction trigger different memory update mechanisms is not obviously warranted. The results of interest are due to the combined effects of retrieval+extinction and there is no sense in which different memory update mechanisms should be identified with retrieval (mechanism 1) and extinction (mechanism 2).

      We did not argue for different memory update mechanisms for the “retrieval (mechanism 1) and extinction (mechanism 2)” in our manuscript. Instead, we proposed that the retrieval-extinction procedure, which was mainly documented in the previous literatures for its association with the reconsolidation-related fear memory retention (the long-term effect), also had a much faster effect (the short-term effect). These two effects differed in many aspects, suggesting that different memory update mechanisms might be involved.

      5F. "These findings raise the possibility of concerted memory modulation processes related to memory retrieval..."

      ***What does this mean?

      As we mentioned in our response to the previous comment, we believe that the retrieval-extinction procedure triggers different types of memory update mechanisms working on different temporal scales.

      (6) "...suggesting that the fear memory might be amenable to a more immediate effect, in addition to what the memory reconsolidation theory prescribes..."

      ***What does it mean to say that the fear memory might be amenable to a more immediate effect?

      We intended to state that the retrieval-extinction procedure can produce a short-term amnesia effect and have thus revised the text.

      (7) "Parallel to the behavioral manifestation of long- and short-term memory deficits, concurrent neural evidence supporting memory reconsolidation theory emphasizes the long-term effect of memory retrieval by hypothesizing that synapse degradation and de novo protein synthesis are required for reconsolidation."

      ***This sentence needs to be edited for clarity.

      We have rewritten this sentence:

      “Corresponding to the long-term behavioral manifestation, concurrent neural evidence supporting memory reconsolidation hypothesis emphasizes that synapse degradation and de novo protein synthesis are required for reconsolidation.”

      (8) "previous behavioral manipulations engendering the short-term declarative memory effect..."

      ***What is the declarative memory effect? It should be defined.

      We meant the amnesia on declarative memory research, such as the memory deficit caused by the think/no-think paradigms. Texts have been modified for clarity:

      “On the contrary, previous behavioral manipulations engendering the short-term amnesia on declarative memory, such as the think/no-think paradigm, hinges on the intact activities in brain areas such as dorsolateral prefrontal cortex (cognitive control) and its functional coupling with specific brain regions such as hippocampus (memory retrieval) (Anderson and Green, 2001; Wimber et al., 2015).”

      (9) "The declarative amnesia effect emerges much earlier due to the online functional activity modulation..."

      ***Even if the declarative memory amnesia effect had been defined, the reference to online functional activity modulation is not clear.

      We have rephrased the sentence:

      “The declarative amnesia effect arises much earlier due to the more instant modulation of functional connectivity, rather than the slower processes of new protein synthesis in these brain regions.”

      (10) "However, it remains unclear whether memory retrieval might also precipitate a short-term amnesia effect for the fear memory, in addition to the long-term prevention orchestrated by memory consolidation."

      ***I found this sentence difficult to understand on my first pass through the paper. I think it is because of the phrasing of memory retrieval. That is, memory retrieval does NOT precipitate any type of short-term amnesia for the fear memory: it is the retrieval-extinction protocol that produces something like short-term amnesia. Perhaps this sentence should also be edited for clarity.

      We have changed “memory retrieval” to “retrieval-extinction” where applicable.

      I will also note that the usage of "short-term" at this point in the paper is quite confusing: Does the retrieval-extinction protocol produce a short-term amnesia effect, which would be evidenced by some recovery of responding to the CS when tested after a sufficiently long delay? I don't believe that this is the intended meaning of "short-term" as used throughout the majority of the paper, right?

      By “short-term”, we meant the lack of fear expression in the test phase (measured by skin conductance responses) shortly after the retrieval-extinction procedure (30 mins in studies 1 & 2 and 1 hour in study 3). It does not indicate that the effect is by itself “short-lived”.

      (11) "To fully comprehend the temporal dynamics of the memory retrieval effect..."<br /> ***What memory retrieval effect? This needs some elaboration.

      We’ve changed the phrase “memory retrieval effect” to “retrieval-extinction effect” to refer to the effect of retrieval-extinction on fear amnesia.

      (12) "We hypothesize that the labile state triggered by the memory retrieval may facilitate different memory update mechanisms following extinction training, and these mechanisms can be further disentangled through the lens of temporal dynamics and cue-specificities."

      ***What does this mean? The first part of the sentence is confusing around the usage of the term "facilitate"; and the second part of the sentence that references a "lens of temporal dynamics and cue-specificities" is mysterious. Indeed, as all rats received the same retrieval-extinction exposures in Study 2, it is not clear how or why any differences between the groups are attributed to "different memory update mechanisms following extinction".

      As the reviewer mentioned, if only one time point data were collected, we cannot differentiate whether different memory update mechanisms are involved. In study 2, however, the 3 groups only differed on the time onsets the reinstatement test was conducted. Accordingly, our results showed that the fear amnesia effects for CS1 and CS2 cannot be simply explained by forgetting: different memory update mechanisms must be at work to explain the characteristics of the SCR related to both CS1 and CS2 at three different time scales (30min, 6h and 24h). It was based on these results, together with the results from the TMS study (study 3), that we proposed the involvement of a short-term memory update mechanism in addition to the reconsolidation related fear amnesia (which should become evident much later) induced by the retrieval-extinction protocol.

      (13) "In the first study, we aimed to test whether there is a short-term amnesia effect of fear memory retrieval following the fear retrieval-extinction paradigm."

      ***Again, the language is confusing. The phrase, "a short-term amnesia effect" implies that the amnesia itself is temporary; but I don't think that this implication is intended. The problem is specifically in the use of the phrase "a short-term amnesia effect of fear memory retrieval." To the extent that short-term amnesia is evident in the data, it is not due to retrieval per se but, rather, the retrieval-extinction protocol.

      We have changed the wordings and replaced “memory retrieval” with “retrieval-extinction” where applicable.

      (14) The authors repeatedly describe the case where there was a 24-hour interval between extinction and testing as consistent with previous research on fear memory reconsolidation. Which research exactly? That is, in studies where a CS re-exposure was combined with a drug injection, responding to the CS was disrupted in a final test of retrieval from long-term memory which typically occurred 24 hours after the treatment. Is that what the authors are referring to as consistent? If so, which aspect of the results are consistent with those previous findings? Perhaps the authors mean to say that, in the case where there was a 24-hour interval between extinction and testing, the results obtained here are consistent with previous research that has used the retrieval-extinction protocol. This would clarify the intended meaning greatly.

      Our 24 hour test results after the retrieval-extinction protocol was consistent with both pharmacological and behavioral intervention studies in fear memory reconsolidation studies (Kindt and Soeter, 2018, Kindt et al., 2009, Liu et al., 2014, Luo et al., 2015, Monfils et al., 2009, Nader et al., 2000, Schiller et al., 2013, Schiller et al., 2010, Xue et al., 2012) since the final test phase typically occurred 24 hours after the treatment. At the 24-hour interval, the memory reconsolidation effect would become evident either via drug administration or behavioral intervention (extinction training).

      DATA

      (15) Points about data:

      5A. The eight participants who were discontinued after Day 1 in study 1 were all from the no-reminder group. Can the authors please comment on how participants were allocated to the two groups in this experiment so that the reader can better understand why the distribution of non-responders was non-random (as it appears to be)?

      15B. Similarly, in study 2, of the 37 participants that were discontinued after Day 2, 19 were from Group 30 min, and 5 were from Group 6 hours. Can the authors comment on how likely these numbers are to have been by chance alone? I presume that they reflect something about the way that participants were allocated to groups, but I could be wrong.

      We went back and checked out data. As we mentioned in the supplementary materials, we categorized subjects as non-responders if their SCR response to any CS was less than 0.02  in Day 1 (fear acquisition). Most of the discontinued participants (non-responders) in the no-reminder group (study 1) and the 30min & 24 h groups (study 2) were when the heating seasons just ended or were yet to start, respectively. It has been documented that human body thermal conditions were related to the quality of the skin conductance response (SCR) measurements (Bauer et al., 2022, Vila, 2004). We suspect that the non-responders might be related to the body thermal conditions caused by the lack of central heating.

      15C. "Post hoc t-tests showed that fear memories were resilient after regular extinction training, as demonstrated by the significant difference between fear recovery indexes of the CS+ and CS- for the no-reminder group (t26 = 7.441, P < 0.001; Fig. 1e), while subjects in the reminder group showed no difference of fear recovery between CS+ and CS- (t29 = 0.797, P = 0.432, Fig. 1e)."

      ***Is the fear recovery index shown in Figure 1E based on the results of the first test trial only? How can there have been a "significant difference between fear recovery indexes of the CS+ and CS- for the no-reminder group" when the difference in responding to the CS+ and CS- is used to calculate the fear recovery index shown in 1E? What are the t-tests comparing exactly, and what correction is used to account for the fact that they are applied post-hoc?

      As we mentioned in the results section of the manuscript, the fear recovery index was defined as “the SCR difference between the first test trial and the last extinction trial of a specific CS”. We then calculated the “differential fear recovery index” (figure legends of Fig. 1e) between CS+ and CS- for both the reminder and no-reminder groups. The post-hoc t-tests were used to examine whether there were significant fear recoveries (compare to 0) in both the reminder (t<sub>29</sub> = 0.797, P = 0.432, Fig. 1e) and no-reminder (t<sub>26</sub> = 7.441, P  < 0.001; Fig. 1e) groups. We realize that the description of Bonferroni correction was not specified in the original manuscript and hence added in the revision where applicable.

      15D. "Finally, there is no statistical difference between the differential fear recovery indexes between CS+ in the reminder and no reminder groups (t55 = -2.022, P = 0.048; Fig. 1c, also see Supplemental Material for direct test for the test phase)."

      ***Is this statement correct - i.e., that there is no statistically significant difference in fear recovery to the CS+ in the reminder and no reminder groups? I'm sure that the authors would like to claim that there IS such a difference; but if such a difference is claimed, one would be concerned by the fact that it is coming through in an uncorrected t-test, which is the third one of its kind in this paragraph. What correction (for the Type 1 error rate) is used to account for the fact that the t-tests are applied post-hoc? And if no correction, why not?

      We are sorry about the typo.  The reviewer was correct that we meant to claim here that “… there is a significant difference between the differential fear recovery indexes between CS+ in the reminder and no-reminder groups (t<sub>55</sub> =- 2.022, P = 0.048; Fig. 1e)”.  Note that the t-test performed here was a confirmatory test following our two-way ANOVA with main effects of group (reminder vs. no-reminder) and time (last extinction trial vs. first test trial) on the differential CS SCR response (CS+ minus CS-) and we found a significant group x time interaction effect (F<sub>1.55</sub> = 4.087, P = 0.048, η<sup>2</sup> = 0.069). The significant difference between the differential fear recovery indexes was simply a re-plot of the interaction effect mentioned above and therefore no multiple correction is needed. We have reorganized the sequence of the sentences such that this t-test now directly follows the results of the ANOVA:

      “The interaction effect was confirmed by the significant difference between the differential fear recovery indexes between CS1+ and CS2+ in the reminder and no-reminder groups (t<sub>55</sub> \= -2.022, P \= 0.048; Figure 1E, also see Supplemental Material for the direct test of the test phase).”

      15E. In study 2, why is responding to the CS- so high on the first test trial in Group 30 min? Is the change in responding to the CS- from the last extinction trial to the first test trial different across the three groups in this study? Inspection of the figure suggests that it is higher in Group 30 min relative to Groups 6 hours and 24 hours. If this is confirmed by the analysis, it has implications for the fear recovery index which is partly based on responses to the CS-. If not for differences in the CS- responses, Groups 30 minutes and 6 hours are otherwise identical.

      Following the reviewer’s comments, we went back and calculated the mean SCR difference of CS- between the first test trial and the last extinction trial for all three studies (see Author response image 1 below). In study 1, there was no difference in the mean CS- SCR (between the first test trial and last extinction trial) between the reminder and no-reminder groups (Kruskal-Wallis test , panel a), though both groups showed significant fear recovery even in the CS- condition (Wilcoxon signed rank test, reminder: P = 0.0043, no-reminder: P = 0.0037). Next, we examined the mean SCR for CS- for the 30min, 6h and 24h groups in study 2 and found that there was indeed a group difference (one-way ANOVA,F<sub>2.76</sub> = 5.3462, P = 0.0067, panel b), suggesting that the CS- related SCR was influenced by the test time (30min, 6h or 24h). We also tested the CS- related SCR for the 4 groups in study 3 (where test was conducted 1 hour after the retrieval-extinction training) and found that across TMS stimulation types (PFC vs. VER) and reminder types (reminder vs. no-reminder) the ANOVA analysis did not yield main effect of TMS stimulation type (F<sub>1.71</sub> = 0.322, P = 0.572) nor main effect of reminder type (F<sub>1.71</sub> = 0.0499, P = 0.824, panel c). We added the R-VER group results in study 3 (see panel c) to panel b and plotted the CS- SCR difference across 4 different test time points and found that CS- SCR decreased as the test-extinction delay increased (Jonckheere-Terpstra test, P = 0.00028). These results suggest a natural “forgetting” tendency for CS- related SCR and highlight the importance of having the CS- as a control condition to which the CS+ related SCR was compared with.

      Author response image 1.

      15F. Was the 6-hour group tested at a different time of day compared to the 30-minute and 24-hour groups; and could this have influenced the SCRs in this group?

      For the 30min and 24h groups, the test phase can be arranged in the morning, in the afternoon or at night. However, for the 6h group, the test phase was inevitably in the afternoon or at night since we wanted to exclude the potential influence of night sleep on the expression of fear memory (see Author response table 1 below). If we restricted the test time in the afternoon or at night for all three groups, then the timing of their extinction training was not matched.

      Author response table 1.

      Nevertheless, we also went back and examined the data for the subjects only tested in the afternoon or at nights in the 30min and 24h groups to match with the 6h group where all the subjects were tested either in the afternoon or at night. According to Author response table 1 above, we have 17 subjects for the 30min group (9+8),18 subjects for the 24h group (9 + 9) and 26 subjects for the 6h group (12 + 14). As Author response image 2 shows, the SCR patterns in the fear acquisition, extinction and test phases were similar to the results presented in the original figure.

      Author response image 2.

      15G. Why is the range of scores in "thought control ability" different in the 30-minute group compared to the 6-hour and 24-hour groups? I am not just asking about the scale on the x-axis: I am asking why the actual distribution of the scores in thought control ability is wider for the 30-minute group?

      We went back and tested whether the TCAQ score variance was the same across three groups. We found that there was significant difference in the variance of the TCAQ score distribution across three groups (F<sub>2.155</sub> = 4.324, P = 0.015, Levene test). However, post-hoc analyses found that the variance of TCAQ is not significantly different between the 30min and 6h groups (F<sub>26.25</sub> = 0.4788, P = 0.0697), nor between the 30min and 24h groups (i>F<sub>26.25</sub> = 0.4692, P = 0.0625). To further validate our correlational results between the TCAQ score and the fear recovery index, we removed the TCAQ scores that were outside the TCAQ score range of the 6h & 24h groups from the 30min group (resulting in 4 “outliner” TCAQ scores in the 30min group, panel a in Author response image 3 below) and the Levene test confirmed that the variance of the TCAQ scores showed no difference across groups after removing the 4 “outliner” data points in the 30min group (i>F<sub>2.147</sub> = 0.74028, P = 0.4788). Even with the 4 “outliers” removed from the 30min group, the correlational analysis of the TCAQ scores and the fear recovery index still yielded significant result in the 30min group (beta = -0.0148, t = -3.731, P = 0.0006, see panel b below), indicating our results were not likely due to the inclusion of subjects with extreme TCAQ scores.

      Author response image 3.

      (16) During testing in each experiment, how were the various stimuli presented? That is, was the presentation order for the CS+ and CS- pseudorandom according to some constraint, as it had been in extinction? This information should be added to the method section.

      We mentioned the order of the stimuli in the testing phase in the methods section “… For studies 2 & 3, …a pseudo-random stimulus order was generated for fear acquisition and extinction phases of three groups with the rule that no same trial- type (CS1+, CS2+ and CS-) repeated more than twice. In the test phase, to exclude the possibility that the difference between CS1+ and CS2+ was simply caused by the presentation sequence of CS1+ and CS2+, half of the participants completed the test phase using a pseudo-random stimuli sequence and the identities of CS1+ and CS2+ reversed in the other half of the participants.”

      (17) "These results are consistent with previous research which suggested that people with better capability to resist intrusive thoughts also performed better in motivated dementia in both declarative and associative memories."

      ***Which parts of the present results are consistent with such prior results? It is not clear from the descriptions provided here why thought control ability should be related to the present findings or, indeed, past ones in other domains. This should be elaborated to make the connections clear.

      In the 30min group, we found that subjects’ TCAQ scores were negatively correlated with their fear recovery indices. That is, people with better capacity to resist intrusive thoughts were also less likely to experience the return of fear memory, which are consistent with previous results. Together with our brain stimulation results, the short-term amnesia is related to subject’s cognitive control ability and intact dlPFC functions. It is because of these similarities that we propose that the short-term amnesia might be related to the automatic memory suppression mechanism originated from the declarative memory research. Since we have not provided all the evidence at this point of the results section, we briefly listed the connections with previous declarative and associative memory research.

      Reviewer #2 (Public Review):

      The fear acquisition data is converted to a differential fear SCR and this is what is analysed (early vs late). However, the figure shows the raw SCR values for CS+ and CS- and therefore it is unclear whether the acquisition was successful (despite there being an "early" vs "late" effect - no descriptives are provided).

      As the reviewer mentioned, the fear acquisition data was converted to a differential fear SCR and we conducted a two-way mixed ANOVA (reminder vs. no-reminder) x time (early vs. late part of fear acquisition) on the differential SCRs. We found a significant main effect of time (early vs. late; F<sub>1.55</sub> = 6.545, P = 0.013, η<sup>2</sup> = 0.106), suggesting successful fear acquisition in both groups. Fig. 1c also showed the mean differential SCR for the latter half of the acquisition phase in both the reminder and no-reminder groups and there was no significant difference in acquired SCRs between groups (early acquisition: t<sub>55</sub> = -0.063, P = 0.950; late acquisition: t<sub>55</sub> = -0.318, P = 0.751; Fig. 1c).

      In Experiment 1 (Test results) it is unclear whether the main conclusion stems from a comparison of the test data relative to the last extinction trial ("we defined the fear recovery index as the SCR difference between the first test trial and the last extinction trial for a specific CS") or the difference relative to the CS- ("differential fear recovery index between CS+ and CS-"). It would help the reader assess the data if Figure 1e presents all the indexes (both CS+ and CS-). In addition, there is one sentence that I could not understand "there is no statistical difference between the differential fear recovery indexes between CS+ in the reminder and no reminder groups (P=0.048)". The p-value suggests that there is a difference, yet it is not clear what is being compared here. Critically, any index taken as a difference relative to the CS- can indicate recovery of fear to the CS+ or absence of discrimination relative to the CS-, so ideally the authors would want to directly compare responses to the CS+ in the reminder and no-reminder groups. The latter issue is particularly relevant in Experiment 2, in which the CS- seems to vary between groups during the test and this can obscure the interpretation of the result.

      In all the experiments, the fear recovery index (FRI) was defined as the SCR difference between the first test trial and the last extinction trial for any CS. Subsequently, the differential fear recovery index (FRI) was defined between the FRI of a specific CS+ and the FRI of the CS-. The differential FRI would effectively remove the non-specific time related effect (using the CS- FRI as the baseline). We have revised the text accordingly.

      As we responded to reviewer #1, the CS- fear recovery indices (FIR) for the reminder and no-reminder groups were not statistically different (Kruskal-Wallis test , panel a, Author response image 1), though both groups showed significant fear recovery even in the CS- condition (Wilcoxon signed rank test, reminder: P = 0.0043, no-reminder: P = 0.0037, panel a). Next, we examined the mean SCR for CS- for the 30min, 6h and 24h groups in study 2 and found that there was indeed a group difference (one-way ANOVA,  one-way ANOVA,F<sub>2.76</sub> = 5.3462, P = 0.0067, panel b), suggesting that the CS- SCR was influenced by the test time delay. We also tested the CS- SCR for the 4 groups in study 3 and found that across TMS stimulation types (PFC vs. VER) and reminder types (reminder vs. no-reminder) the ANOVA analysis did not yield main effect of TMS stimulation type (F<sub>1.71</sub> = 0.322, P = 0.572) nor main effect of reminder type (F<sub>1.71</sub> = 0.0499, P = 0.824, panel c). We added the R-VER group results in study 3 (see panel c) to panel b and plotted the CS- SCR difference across 4 different test time points and found that CS- SCR decreased as the test-extinction delay increased (Jonckheere-Terpstra test, P = 0.00028). These results suggest a natural “forgetting” tendency for the CS- fear recovery index and highlight the importance of having the CS- as a control condition to compare the CS+ recovery index with (resulting in the Differential recovery index). Parametric and non-parametric analyses were adopted based on whether the data met the assumptions for the parametric analyses.

      In Experiment 1, the findings suggest that there is a benefit of retrieval followed by extinction in a short-term reinstatement test. In Experiment 2, the same effect is observed on a cue that did not undergo retrieval before extinction (CS2+), a result that is interpreted as resulting from cue-independence, rather than a failure to replicate in a within-subjects design the observations of Experiment 1 (between-subjects). Although retrieval-induced forgetting is cue-independent (the effect on items that are suppressed [Rp-] can be observed with an independent probe), it is not clear that the current findings are similar. Here, both cues have been extinguished and therefore been equally exposed during the critical stage.

      We appreciate the reviewer’s insight on this issue. Although in the discussion we raised the possibility of memory suppression to account for the short-term amnesia effect, we did not intend to compare our paradigm side-by-side with retrieval-induced forgetting. In our previous work (Wang et al., 2021), we reported that active suppression effect of CS+ related fear memory during the standard extinction training generalized to other CS+, yielding a cue-independent effect. In the current experiments, we did not implement active suppression; instead, we used the CS+ retrieval-extinction paradigm. It is thus possible that the CS+ retrieval cue may function to facilitate automatic suppression. Indeed, in the no-reminder group (standard extinction) of study 1, we did observe the return of fear expression, suggesting the critical role of CS+ reminder before the extinction training. Based on the results mentioned above, we believe our short-term amnesia results were consistent with the hypothesis that the retrieval CS+ (reminder) might prompt subjects to adopt an automatic suppress mechanism in the following extinction training, yielding cue-independent amnesia effects.

      The findings in Experiment 2 suggest that the amnesia reported in Experiment 1 is transient, in that no effect is observed when the test is delayed by 6 hours. The phenomena whereby reactivated memories transition to extinguished memories as a function of the amount of exposure (or number of trials) is completely different from the phenomena observed here. In the former, the manipulation has to do with the number of trials (or the total amount of time) that the cues are exposed to. In the current study, the authors did not manipulate the number of trials but instead the retention interval between extinction and test. The finding reported here is closer to a "Kamin effect", that is the forgetting of learned information which is observed with intervals of intermediate length (Baum, 1968). Because the Kamin effect has been inferred to result from retrieval failure, it is unclear how this can be explained here. There needs to be much more clarity on the explanations to substantiate the conclusions.

      Indeed, in our studies, we did not manipulate the amount of exposure (or number of trials) but only the retention interval between extinction and test. Our results demonstrated that the retrieval-extinction protocol yielded the short-term amnesia on fear memory, qualitatively different from the reconsolidation related amnesia proposed in the previous literatures. After examining the temporal dynamics, cue-specificity and TCAQ association with the short-term amnesia, we speculated that the short-term effect might be related to an automatic suppression mechanism. Of course, further studies will be required to test such a hypothesis.

      Our results might not be easily compared with the “Kamin effect”, a term coined to describe the “retention of a partially learned avoidance response over varying time intervals” using a learning-re-learning paradigm (Baum, 1968, Kamin, 1957). However, the retrieval-extinction procedure used in our studies was different from the learning-re-learning paradigm in the original paper (Kamin, 1957) and the reversal-learning paradigm the reviewer mentioned (Baum, 1968).

      There are many results (Ryan et al., 2015) that challenge the framework that the authors base their predictions on (consolidation and reconsolidation theory), therefore these need to be acknowledged. Similarly, there are reports that failed to observe the retrieval-extinction phenomenon (Chalkia et al., 2020), and the work presented here is written as if the phenomenon under consideration is robust and replicable. This needs to be acknowledged.

      We thank the reviewer pointing out the related literature and have added a separate paragraph about other results in the discussion (as well as citing relevant references in the introduction) to provide a full picture of the reconsolidation theory to the audience:

      “It should be noted that while our long-term amnesia results were consistent with the fear memory reconsolidation literatures, there were also studies that failed to observe fear prevention (Chalkia, Schroyens, et al., 2020; Chalkia, Van Oudenhove, et al., 2020; Schroyens et al., 2023). Although the memory reconsolidation framework provides a viable explanation for the long-term amnesia, more evidence is required to validate the presence of reconsolidation, especially at the neurobiological level (Elsey et al., 2018). While it is beyond the scope of the current study to discuss the discrepancies between these studies, one possibility to reconcile these results concerns the procedure for the retrieval-extinction training. It has been shown that the eligibility for old memory to be updated is contingent on whether the old memory and new observations can be inferred to have been generated by the same latent cause (Gershman et al., 2017; Gershman and Niv, 2012). For example, prevention of the return of fear memory can be achieved through gradual extinction paradigm, which is thought to reduce the size of prediction errors to inhibit the formation of new latent causes (Gershman, Jones, et al., 2013). Therefore, the effectiveness of the retrieval-extinction paradigm might depend on the reliability of such paradigm in inferring the same underlying latent cause. Furthermore, other studies highlighted the importance of memory storage per se and suggested that memory retention was encoded in the memory engram cell ensemble connectivity whereas the engram cell synaptic plasticity is crucial for memory retrieval (Ryan et al., 2015; Tonegawa, Liu, et al., 2015; Tonegawa, Pignatelli, et al., 2015). It remains to be tested how the cue-independent short-term and cue-dependent long-term amnesia effects we observed could correspond to the engram cell synaptic plasticity and functional connectivity among engram cell ensembles (Figure 6). This is particularly important, since the cue-independent characteristic of the short-term amnesia suggest that either different memory cues fail to evoke engram cell activities, or the retrieval-extinction training transiently inhibits connectivity among engram cell ensembles. Finally, SCR is only one aspect of the fear expression, how the retrieval-extinction paradigm might affect subjects’ other emotional (such as the startle response) and cognitive fear expressions such as reported fear expectancy needs to be tested in future studies since they do not always align with each other (Kindt et al., 2009; Sevenster et al., 2012, 2013).”

      The parallels between the current findings and the memory suppression literature are speculated in the general discussion, and there is the conclusion that "the retrieval-extinction procedure might facilitate a spontaneous memory suppression process". Because one of the basic tenets of the memory suppression literature is that it reflects an "active suppression" process, there is no reason to believe that in the current paradigm, the same phenomenon is in place, but instead, it is "automatic". In other words, the conclusions make strong parallels with the memory suppression (and cognitive control) literature, yet the phenomena that they observed are thought to be passive (or spontaneous/automatic).

      Ultimately, it is unclear why 10 mins between the reminder and extinction learning will "automatically" suppress fear memories. Further down in the discussion, it is argued that "For example, in the well-known retrieval-induced forgetting (RIF) phenomenon, the recall of a stored memory can impair the retention of related long-term memory and this forgetting effect emerges as early as 20 minutes after the retrieval procedure, suggesting memory suppression or inhibition can occur in a more spontaneous and automatic manner". I did not follow with the time delay between manipulation and test (20 mins) would speak about whether the process is controlled or automatic.

      In our previous research, we showed that the memory suppression instruction together with the extinction procedure successfully prevented the return of fear expression in the reinstatement test trials 30mins after the extinction training (Wang et al., 2021). In the current experiments, we replaced the suppression instruction with the retrieval cue before the extinction training (retrieval-extinction protocol) and observed similar short-term amnesia effects. These results prompted us to hypothesize in the discussion that the retrieval cue might facilitate an automatic suppression process. We made the analogy to RIF phenomenon in the discussion to suggest that the suppression of (competing) memories could be unintentional and fast (20 mins), both of which were consistent with our results. We agree with the reviewer that this hypothesis is more of a speculation (hence in the discussion), and more studies are required to further test such a hypothesis. However, what we want to emphasize in this paper is the report of the short-term amnesia effects which were clearly not related to the memory reconsolidation effect in a variety of aspects.

      Among the many conclusions, one is that the current study uncovers the "mechanism" underlying the short-term effects of retrieval extinction. There is little in the current report that uncovers the mechanism, even in the most psychological sense of the mechanism, so this needs to be clarified. The same applies to the use of "adaptive".

      Whilst I could access the data on the OFS site, I could not make sense of the Matlab files as there is no signposting indicating what data is being shown in the files. Thus, as it stands, there is no way of independently replicating the analyses reported.

      We have re-organized data on the OFS site, and they should be accessible now.

      The supplemental material shows figures with all participants, but only some statistical analyses are provided, and sometimes these are different from those reported in the main manuscript. For example, the test data in Experiment 1 is analysed with a two-way ANOVA with the main effects of group (reminder vs no-reminder) and time (last trial of extinction vs first trial of the test) in the main report. The analyses with all participants in the sup mat used a mixed two-way ANOVA with a group (reminder vs no reminder) and CS (CS+ vs CS-). This makes it difficult to assess the robustness of the results when including all participants. In addition, in the supplementary materials, there are no figures and analyses for Experiment 3.

      We are sorry for the lack of clarity in the supplementary materials. We have supplementary figures Fig. S1 & S2 for the data re-analysis with all the responders (learners + non-learners). The statistical analyses performed on the responders in both figures yielded similar results as those in the main text. For other analyses reported in the supplementary materials, we specifically provided different analysis results to demonstrate the robustness of our results. For example, to rule out the effects we observed in two-way ANOVA in the main text may be driven by the different SCR responses on the last extinction trial, we only tested the two-way ANOVA for the first trial SCR of test phase and these analyses provided similar results. Please note we did not include non-learners in these analyses (the texts of the supplementary materials).

      Since we did not exclude any non-learners in study 3, all the results were already reported in the main text.

      One of the overarching conclusions is that the "mechanisms" underlying reconsolidation (long term) and memory suppression (short term) phenomena are distinct, but memory suppression phenomena can also be observed after a 7-day retention interval (Storm et al., 2012), which then questions the conclusions achieved by the current study.

      As we stated before, the focus of the manuscript was to demonstrate a novel short-term fear amnesia effect following the retrieval-extinction procedure. We discussed memory suppression as one of the potential mechanisms for such a short-term effect. In fact, the durability of the memory suppression effect is still under debate. Although Storm et al. (2012) suggested that the retrieval-induced forgetting can persist for as long as a week, other studies, however, failed to observe long-term forgetting (after 24 hrs; (Carroll et al., 2007, Chan, 2009). It is also worth noting that Storm et al. (2012) tested RIF one week later using half of the items the other half of which were tested 5 minutes after the retrieval practice. Therefore, it can be argued that there is a possibility that the long-term RIF effect is contaminated by the test/re-test process on the same set of (albeit different) items at different time onsets (5mins & 1 week).

      Reviewer #3 (Public Review):

      (1) The entire study hinges on the idea that there is memory 'suppression' if (1) the CS+ was reminded before extinction and (2) the reinstatement and memory test takes place 30 minutes later (in Studies 1 & 2). However, the evidence supporting this suppression idea is not very strong. In brief, in Study 1, the effect seems to only just reach significance, with a medium effect size at best, and, moreover, it is unclear if this is the correct analysis (which is a bit doubtful, when looking at Figure 1D and E). In Study 2, there was no optimal control condition without reminder and with the same 30-min interval (which is problematic, because we can assume generalization between CS1+ and CS2+, as pointed out by the authors, and because generalization effects are known to be time-dependent). Study 3 is more convincing, but entails additional changes in comparison with Studies 1 and 2, i.e., applications of cTBS and an interval of 1 hour instead of 30 minutes (the reason for this change was not explained). So, although the findings of the 3 studies do not contradict each other and are coherent, they do not all provide strong evidence for the effect of interest on their own.

      Related to the comment above, I encourage the authors to double-check if this statement is correct: "Also, our results remain robust even with the "non-learners" included in the analysis (Fig. S1 in the Supplemental Material)". The critical analysis for Study 1 is a between-group comparison of the CS+ and CS- during the last extinction trial versus the first test trial. This result only just reached significance with the selected sample (p = .048), and Figures 1D and E even seem to suggest otherwise. I doubt that the analysis would reach significance when including the "non-learners" - assuming that this is what is shown in Supplemental Figure 1 (which shows the data from "all responded participants").

      Our subjects were categorized based on the criteria specified in supplementary table S1. More specifically, we excluded the non-responders (Mean CS SCR < 0.02 uS  in the fear acquisition phase), and non-learners and focused our analyses on the learners. Non-responders were dismissed after day 1 (the day of fear acquisition), but both learners and non-learners finished the experiments. This fact gave us the opportunity to examine data for both the learners and the responders (learners + non-learners). What we showed in fig. 1D and E were differential SCRs (CS+ minus CS-) of the last extinction trials and the differential fear recovery indices (CS+ minus CS-), respectively. We have double checked the figures and both the learners (Fig. 1) and the responders (i.e. learners and non-learners, supplementary Fig. 1) results showed significant differences between the reminder and no-reminder groups on the differential fear recovery index.

      Also related to the comment above, I think that the statement "suggesting a cue-independent short-term amnesia effect" in Study 2 is not correct and should read: "suggesting extinction of fear to the CS1+ and CS2+", given that the response to the CS+'s is similar to the response to the CS-, as was the case at the end of extinction. Also the next statement "This result indicates that the short-term amnesia effect observed in Study 2 is not reminder-cue specific and can generalize to the non-reminded cues" is not fully supported by the data, given the lack of an appropriate control group in this study (a group without reinstatement). The comparison with the effect found in Study 1 is difficult because the effect found there was relatively small (and may have to be double-checked, see remarks above), and it was obtained with a different procedure using a single CS+. The comparison with the 6-h and 24-h groups of Study 2 is not helpful as a control condition for this specific question (i.e., is there reinstatement of fear for any of the CS+'s) because of the large procedural difference with regard to the intervals between extinction and reinstatement (test).

      In Fig. 2e, we showed the differential fear recovery indices (FRI) for the CS+ in all three groups. Since the fear recovery index (FRI) was calculated as the SCR difference between the first test trial and the last extinction trial for any CS, the differential fear recovery indices (difference between CS+ FRI and CS- FRI) not significantly different from 0 should be interpreted as the lack of fear expression in the test phase. Since spontaneous recovery, reinstatement and renewal are considered canonical phenomena in demonstrating that extinction training does not really “erase” conditioned fear response, adding the no-reinstatement group as a control condition would effectively work as the spontaneous recovery group and the comparison between the reinstatement and no-instatement groups turns into testing the difference in fear recovery using different methods (reinstatement vs. spontaneous recovery).

      (2) It is unclear which analysis is presented in Figure 3. According to the main text, it either shows the "differential fear recovery index between CS+ and CS-" or "the fear recovery index of both CS1+ and CS2+". The authors should clarify what they are analyzing and showing, and clarify to which analyses the ** and NS refer in the graphs. I would also prefer the X-axes and particularly the Y-axes of Fig. 3a-b-c to be the same. The image is a bit misleading now. The same remarks apply to Figure 5.

      We are sorry about the lack of clarity here. Figures 3 & 5 showed the correlational analyses between TCAQ and the differential fear recovery index (FRI) between CS+ and CS-. That is, the differential FRI of CS1+ (CS1+ FRI minus CS- FRI) and the differential FRI of CS2+ (CS2+ FRI minus CS- FRI).

      We have rescaled both X and Y axes for figures 3 & 5 (please see the revised figures). 

      (3) In general, I think the paper would benefit from being more careful and nuanced in how the literature and findings are represented. First of all, the authors may be more careful when using the term 'reconsolidation'. In the current version, it is put forward as an established and clearly delineated concept, but that is not the case. It would be useful if the authors could change the text in order to make it clear that the reconsolidation framework is a theory, rather than something that is set in stone (see e.g., Elsey et al., 2018 (https://doi.org/10.1037/bul0000152), Schroyens et al., 2022 (https://doi.org/10.3758/s13423-022-02173-2)).

      In addition, the authors may want to reconsider if they want to cite Schiller et al., 2010 (https://doi.org/10.1038/nature08637), given that the main findings of this paper, nor the analyses could be replicated (see, Chalkia et al., 2020 (https://doi.org/10.1016/j.cortex.2020.04.017; https://doi.org/10.1016/j.cortex.2020.03.031).

      We thank the reviewer’s comments and have incorporated the mentioned papers into our revised manuscript by pointing out the extant debate surrounding the reconsolidation theory in the introduction:

      “Pharmacological blockade of protein synthesis and behavioral interventions can both eliminate the original fear memory expression in the long-term (24 hours later) memory test ( Lee, 2008; Lee et al., 2017; Schiller et al., 2013; Schiller et al., 2010), resulting in the cue-specific fear memory deficit (Debiec et al., 2002; Lee, 2008; Nader, Schafe, & LeDoux, 2000). For example, during the reconsolidation window, retrieving a fear memory allows it to be updated through extinction training (i.e., the retrieval-extinction paradigm (Lee, 2008; Lee et al., 2017; Schiller et al., 2013; Schiller et al., 2010), but also see (Chalkia, Schroyens, et al., 2020; Chalkia, Van Oudenhove, et al., 2020; D. Schiller, LeDoux, & Phelps, 2020). ”

      As well as in the discussion:

      “It should be noted that while our long-term amnesia results were consistent with the fear memory reconsolidation literatures, there were also studies that failed to observe fear prevention (Chalkia, Schroyens, et al., 2020; Chalkia, Van Oudenhove, et al., 2020; Schroyens et al., 2023). Although the memory reconsolidation framework provides a viable explanation for the long-term amnesia, more evidence is required to validate the presence of reconsolidation, especially at the neurobiological level (Elsey et al., 2018). While it is beyond the scope of the current study to discuss the discrepancies between these studies, one possibility to reconcile these results concerns the procedure for the retrieval-extinction training. It has been shown that the eligibility for old memory to be updated is contingent on whether the old memory and new observations can be inferred to have been generated by the same latent cause (Gershman et al., 2017; Gershman and Niv, 2012). For example, prevention of the return of fear memory can be achieved through gradual extinction paradigm, which is thought to reduce the size of prediction errors to inhibit the formation of new latent causes (Gershman, Jones, et al., 2013). Therefore, the effectiveness of the retrieval-extinction paradigm might depend on the reliability of such paradigm in inferring the same underlying latent cause. Furthermore, other studies highlighted the importance of memory storage per se and suggested that memory retention was encoded in the memory engram cell ensemble connectivity whereas the engram cell synaptic plasticity is crucial for memory retrieval (Ryan et al., 2015; Tonegawa, Liu, et al., 2015; Tonegawa, Pignatelli, et al., 2015). It remains to be tested how the cue-independent short-term and cue-dependent long-term amnesia effects we observed could correspond to the engram cell synaptic plasticity and functional connectivity among engram cell ensembles (Figure 6). This is particularly important, since the cue-independent characteristic of the short-term amnesia suggest that either different memory cues fail to evoke engram cell activities, or the retrieval-extinction training transiently inhibits connectivity among engram cell ensembles. Finally, SCR is only one aspect of the fear expression, how the retrieval-extinction paradigm might affect subjects’ other emotional (such as the startle response) and cognitive fear expressions such as reported fear expectancy needs to be tested in future studies since they do not always align with each other (Kindt et al., 2009; Sevenster et al., 2012, 2013).”

      Relatedly, it should be clarified that Figure 6 is largely speculative, rather than a proven model as it is currently presented. This is true for all panels, but particularly for panel c, given that the current study does not provide any evidence regarding the proposed reconsolidation mechanism.

      We agree with the reviewer that Figure 6 is largely speculative. We realize that there are still debates regarding the retrieval-extinction procedure and the fear reconsolidation hypothesis. We have provided a more elaborated discussion and pointed out that figure 6 is only a working hypothesis and more work should be done to test such a hypothesis:

      “Although mixed results have been reported regarding the durability of suppression effects in the declarative memory studies (Meier et al., 2011; Storm et al., 2012), future research will be needed to investigate whether the short-term effect we observed is specifically related to associative memory or the spontaneous nature of suppression (Figure 6C).”

      Lastly, throughout the paper, the authors equate skin conductance responses (SCR) with fear memory. It should at least be acknowledged that SCR is just one aspect of a fear response, and that it is unclear whether any of this would translate to verbal or behavioral effects. Such effects would be particularly important for any clinical application, which the authors put forward as the ultimate goal of the research.

      Again, we agree with the reviewer on this issue, and we have acknowledged that SCR is only one aspect of the fear response and caution should be exerted in clinical application:

      “Finally, SCR is only one aspect of the fear expression, how the retrieval-extinction paradigm might affect subjects’ other emotional (such as the startle response) and cognitive fear expressions such as reported fear expectancy needs to be tested in future studies since they do not always align with each other (Kindt et al., 2009; Sevenster et al., 2012, 2013).”

      (4) The Discussion quite narrowly focuses on a specific 'mechanism' that the authors have in mind. Although it is good that the Discussion is to the point, it may be worthwhile to entertain other options or (partial) explanations for the findings. For example, have the authors considered that there may be an important role for attention? When testing very soon after the extinction procedure (and thus after the reminder), attentional processes may play an important role (more so than with longer intervals). The retrieval procedure could perhaps induce heightened attention to the reminded CS+ (which could be further enhanced by dlPFC stimulation)?

      We thank the reviewer for this suggestion and have added more discussion on the potential mechanisms involved. Unfortunately, since the literature on attention and fear recovery is rather scarce, it is even more of a speculation given our study design and results are mainly about subjects’ skin conductance responses (SCR).

      (5) There is room for improvement in terms of language, clarity of the writing, and (presentation of the) statistical analyses, for all of which I have provided detailed feedback in the 'Recommendations for the authors' section. Idem for the data availability; they are currently not publicly available, in contrast with what is stated in the paper. In addition, it would be helpful if the authors would provide additional explanation or justification for some of the methodological choices (e.g., the 18-s interval and why stimulate 8 minutes after the reminder cue, the choice of stimulation parameters), and comment on reasons for (and implications of) the large amount of excluded participants (>25%).

      We have addressed the data accessibility issue and added the justifications for the methodological choices as well as the excluded participants. As we mentioned in the manuscript and the supplementary materials, adding the non-learners into data analysis did not change the results. Since the non-responders discontinued after Day 1 due to their non-measurable spontaneous SCR signals towards different CS, it’s hard to speculate whether or how the results might have changed. However, participants’ exclusion rate in the SCR studies were relatively high (Hu et al., 2018, Liu et al., 2014, Raio et al., 2017, Schiller et al., 2010, Schiller et al., 2012, Wang et al., 2021). The non-responders were mostly associated with participants being tested in the winter in our tasks. Cold weather and dry skins in the winter are likely to have caused the SCR hard to measure (Bauer et al., 2022, Vila, 2004). Different intervals between the reinstating US (electric shock) and the test trials were used in the previous literature such as 10min (Schiller et al., 2010, Schiller et al., 2013) and 18 or 19s (Kindt and Soeter, 2018, Kindt et al., 2009, Wang et al., 2021). We stuck with the 18s reinstatement interval in the current experiment. For the cTBS stimulation, since the stimulation itself lasted less than 2mins, we started the cTBS 8min after the onset of reminder cue to ensure that any effect caused by the cTBS stimulation occurred during the hypothesized time window, where the old fear memory becomes labile after memory retrieval. All the stimulation parameters were determined based on previous literature, which showed that with the transcranial magnetic stimulation (TMS) on the human dorsolateral prefrontal cortex could disrupt fear memory reconsolidation (Borgomaneri et al., 2020, Su et al., 2022).

      Finally, I think several statements made in the paper are overly strong in light of the existing literature (or the evidence obtained here) or imply causal relationships that were not directly tested.

      We have revised the texts accordingly.

      Reviewer #2 (Recommendations For The Authors):

      On numerous occasions there are typos and the autocorrect has changed "amnesia" for "dementia".

      We are sorry about this mistake and have revised the text accordingly.

      Reviewer #3 (Recommendations For The Authors):

      *"Neither of the studies reported in this article was preregistered. The data for both studies are publicly accessible at https://osf.io/9agvk". This excerpt from the text suggests that there are 2 studies, but there are 3 in the paper. Also, the data are only accessible upon request, not publicly available. I haven't requested them, as this could de-anonymize me as a reviewer.

      We are sorry for the accessibility of the link. The data should be available to the public now.

      *Please refrain from causal interpretations when they are not supported by the data:

      - Figure 3 "thought-control ability only affected fear recovery"; a correlation does not provide causal evidence.

      - "establishing a causal link between the dlPFC activity and short-term fear amnesia." I feel this statement is too strong; to what extent do we know for sure what the applied stimulation of (or more correct: near) the dlPFC does exactly?

      We thank the reviewer for the suggestion and have changed the wording related to figure 3. On the other hand, we’d like to argue that the causal relationship between the dlPFC activity and short-term fear amnesia is supported by the results from study 3. Although the exact functional role of the TMS on dlPFC can be debated, the fact that the TMS stimulation on the dlPFC (compared to the vertex group) brought back the otherwise diminished fear memory expression can be viewed as the causal evidence between the dlPFC activity and short-term fear amnesia.

      *The text would benefit from language editing, as it contains spelling and grammar mistakes, as well as wording that is vague or inappropriate. I suggest the authors check the whole text, but below are already some excerpts that caught my eye:

      "preludes memory reconsolidation"; "old fear memory can be updated"; "would cause short-term memory deficit"; "the its functional coupling"; "Subjects (...) yielded more severe amnesia in the memory suppression tasks"; "memory retrieval might also precipitate a short-term amnesia effect"; "more SEVERE amnesia in the memory suppression tasks"; "the effect size of reinstatement effect"; "the previous literatures"; "towards different CS"; "failed to show SCR response to the any stimuli"; "significant effect of age of TMS"; "each subject' left hand"; "latter half trials"; "Differntial fear recovery"; "fear dementia"; "the fear reinstatement effects at different time scale is related to"; "fear reocery index"; "thought-control abiliites"; "performed better in motivated dementia"; "we tested that in addition to the memory retrieval cue (reminder), whether the"; "during reconsolidation window"; "consisitent with the short-term dementia"; "low level of shock (5v)"

      We thank the reviewer for thorough reading and sorry about typos in the manuscript. We have corrected typos and grammar mistakes as much as we can find.

      *In line with the remark above, there are several places where the text could still be improved.

      - The last sentence of the Abstract is rather vague and doesn't really add anything.

      - Please reword or clarify: "the exact functional role played by the memory retrieval remains unclear".

      - Please reword or clarify: "the unbinding of the old memory trace".

      - "suggesting that the fear memory might be amenable to a more immediate effect, in addition to what the memory reconsolidation theory prescribes" shouldn't this rather read "in contrast with"?

      We have modified the manuscript.

      - In the Introduction, the authors state: "Specifically, memory reconsolidation effect will only be evident in the long-term (24h) memory test due to its requirement of new protein synthesis and is cue-dependent". They then continue about the more immediate memory update mechanisms that they want to study, but it is unclear from how the rationale is presented whether (and why (not)) they also expect this mechanism to be cue-dependent.

      Most of the previous studies on the fear memory reconsolidation using CS as the memory retrieval cues have demonstrated that the reconsolidation effect is cue-dependent (Kindt and Soeter, 2018, Kindt et al., 2009, Monfils et al., 2009, Nader et al., 2000, Schiller et al., 2013, Schiller et al., 2010, Xue et al., 2012). However, other studies using unconditioned stimulus retrieval-extinction paradigm showed that such protocol was able to prevent the return of fear memory expression associated with different CSs (Liu et al., 2014, Luo et al., 2015). In our task, we used CS+ as the memory retrieval cues and our results were consistent with results from previous studies using similar paradigms.

      - "The effects of cTBS over the right dlPFC after the memory reactivation were assessed using the similar mixed-effect four-way ANOVA". Please clarify what was analyzed here.<br /> - "designing novel treatment of psychiatric disorders". Please make this more concrete or remove the statement.

      This sentence was right after a similar analysis performed in the previous paragraph. While the previous graph focused on how the SCRs in the acquisition phase were modulated by factors such as CS+ (CS1+ and CS2+), reminder (reminder vs. no-reminder), cTBS site (right dlPFC vs. vertex) and trial numbers, this analysis focused instead on the SCR responses in the extinction training phase. We have made the modifications as the reviewer suggested.

      *I have several concerns related to the (presentation) of the statistical analyses/results:<br /> - Some statistical analyses, as well as calculation of certain arbitrary indices (e.g., differential fear recovery index) are not mentioned nor explained in the Methods section, but only mentioned in the Results section.

      We have added the explanation of the differential fear recovery index into the methods section:

      “To measure the extent to which fear returns after the presentation of unconditioned stimuli (US, electric shock) in the test phase, we defined the fear recovery index as the SCR difference between the first test trial and the last extinction trial for a specific CS for each subject. Similarly, in studies 2 and 3, differential fear recovery index was defined as the difference between fear recovery indices of CS+ and CS- for both CS1+ and CS2+.”

      - Figure 1C-E: It is unclear what the triple *** mean. Do they have the same meaning in Figure 1C and Figure 1E? I am not sure that that makes sense. The meaning is not explained in the figure caption (I think it is different from the single asterisk*) and is not crystal clear from the main text either.

      We explained the triple *** in the figure legend (Fig. 1): ***P < 0.001. The asterisk placed within each bar in Figure 1C-E indicates the statistical results of the post-hoc test of whether each bar was significant. For example, the *** placed inside bars in Figure 1E indicates that the differential fear recovery index is statistically significant in the no-reminder group (P < 0.001).

      - Supplemental Figure 1: "with all responded participants" Please clarify how you define 'responded participants' and include the n's.

      We presented the criteria for both the responder/non-responder and the learner/non-learner in the table of the supplementary materials and reported the number of subjects in each category (please see supplement Table 1).

      - "the differential SCRs (difference between CS+ and CS-) for the CS+". Please clarify what this means and/or how it is calculated exactly.

      Sorry, it means the difference between the SCRs invoked by CS+ and CS- for both CS1+ (CS1+ minus CS-) and CS2+ (CS2+ minus CS-).

      *I suggest that the authors provide a bit more explanation about the thought-control ability questionnaire. For example, the type of items, etc, as this is not a very commonly used questionnaire in the fear conditioning field.

      We provided a brief introduction to the thought-control ability questionnaire in the methods section:

      “The control ability over intrusive thought was measured by the 25-item Thought-Control Ability Questionnaire (TCAQ) scle(30). Participants were asked to rate on a five-point Likert-type scale the extent to which they agreed with the statement from 1 (completely disagree) to 5 (completely agree). At the end of the experiments, all participants completed the TCAQ scale to assess their perceived control abilities over intrusive thoughts in daily life(17).”

      We have added further description of the item types to the TCAQ scale.

      *The authors excluded more than 25% of the participants. It would be interesting to hear reasons for this relatively large number and some reflection on whether they think this selection affects their results (e.g., could being a (non)responder in skin conductance influence the susceptibility to reactivation-extinction in some way?).

      Participants exclusion rate in the SCR studies were relatively high (Hu et al., 2018, Liu et al., 2014, Raio et al., 2017, Schiller et al., 2010, Schiller et al., 2012, Wang et al., 2021). The non-responders were mostly associated with participants being tested in the winter in our tasks. Cold weather and dry skins in the winter are likely to have caused the SCR hard to measure (Bauer et al., 2022, Vila, 2004).

      *Minor comments that the authors may want to consider:

      - Please explain abbreviations upon first use, e.g., TMS.

      - In Figure 6, it is a bit counterintuitive that the right Y-axis goes from high to low.

      We added the explanation of TMS:

      “Continuous theta burst stimulation (cTBS), a specific form of repetitive transcranial magnetic stimulation (rTMS)…”

      We are sorry and agree that the right Y-axis was rather counterintuitive. However, since the direction of the fear recovery index (which was what we measured in the experiment) and the short/long-term amnesia effect are of the opposite directions, plotting one index from low to high would inevitably cause the other index to go from high to low.

      Reference:

      Anderson, M. C. and Floresco, S. B. 2022. Prefrontal-hippocampal interactions supporting the extinction of emotional memories: The retrieval stopping model. Neuropsychopharmacology, 47, 180-195.

      Anderson, M. C. and Green, C. 2001. Suppressing unwanted memories by executive control. Nature, 410, 366-9.

      Bauer, E. A., Wilson, K. A. and Macnamara, A. 2022. 3.03 - cognitive and affective psychophysiology. In: ASMUNDSON, G. J. G. (ed.) Comprehensive clinical psychology (second edition). Oxford: Elsevier.

      Baum, M. 1968. Reversal learning of an avoidance response and the kamin effect. J Comp Physiol Psychol, 66, 495-7.

      Borgomaneri, S., Battaglia, S., Garofalo, S., Tortora, F., Avenanti, A. and Di Pellegrino, G. 2020. State-dependent tms over prefrontal cortex disrupts fear-memory reconsolidation and prevents the return of fear. Curr Biol, 30, 3672-3679.e4.

      Cain, C. K., Blouin, A. M. and Barad, M. 2003. Temporally massed cs presentations generate more fear extinction than spaced presentations. J Exp Psychol Anim Behav Process, 29, 323-33.

      Carroll, M., Campbell-Ratcliffe, J., Murnane, H. and Perfect, T. 2007. Retrieval-induced forgetting in educational contexts: Monitoring, expertise, text integration, and test format. European Journal of Cognitive Psychology, 19, 580-606.

      Chan, J. C. K. 2009. When does retrieval induce forgetting and when does it induce facilitation? Implications for retrieval inhibition, testing effect, and text processing. Journal of Memory and Language, 61, 153-170.

      Gagnepain, P., Henson, R. N. and Anderson, M. C. 2014. Suppressing unwanted memories reduces their unconscious influence via targeted cortical inhibition. Proc Natl Acad Sci U S A, 111, E1310-9.

      Gershman, S. J., Jones, C. E., Norman, K. A., Monfils, M. H. and Niv, Y. 2013. Gradual extinction prevents the return of fear: Implications for the discovery of state. Front Behav Neurosci, 7, 164.

      Gershman, S. J., Monfils, M. H., Norman, K. A. and Niv, Y. 2017. The computational nature of memory modification. Elife, 6.

      Hu, J., Wang, W., Homan, P., Wang, P., Zheng, X. and Schiller, D. 2018. Reminder duration determines threat memory modification in humans. Sci Rep, 8, 8848.

      Kamin, L. J. 1957. The retention of an incompletely learned avoidance response. J Comp Physiol Psychol, 50, 457-60.

      Kindt, M. and Soeter, M. 2018. Pharmacologically induced amnesia for learned fear is time and sleep dependent. Nat Commun, 9, 1316.

      Kindt, M., Soeter, M. and Vervliet, B. 2009. Beyond extinction: Erasing human fear responses and preventing the return of fear. Nat Neurosci, 12, 256-8.

      Liu, J., Zhao, L., Xue, Y., Shi, J., Suo, L., Luo, Y., Chai, B., Yang, C., Fang, Q., Zhang, Y., Bao, Y., Pickens, C. L. and Lu, L. 2014. An unconditioned stimulus retrieval extinction procedure to prevent the return of fear memory. Biol Psychiatry, 76, 895-901.

      Luo, Y.-X., Xue, Y.-X., Liu, J.-F., Shi, H.-S., Jian, M., Han, Y., Zhu, W.-L., Bao, Y.-P., Wu, P., Ding, Z.-B., Shen, H.-W., Shi, J., Shaham, Y. and Lu, L. 2015. A novel ucs memory retrieval-extinction procedure to inhibit relapse to drug seeking. Nature Communications, 6, 7675.

      Monfils, M. H., Cowansage, K. K., Klann, E. and Ledoux, J. E. 2009. Extinction-reconsolidation boundaries: Key to persistent attenuation of fear memories. Science, 324, 951-5.

      Nader, K., Schafe, G. E. and Le Doux, J. E. 2000. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature, 406, 722-6.

      Raio, C. M., Hartley, C. A., Orederu, T. A., Li, J. and Phelps, E. A. 2017. Stress attenuates the flexible updating of aversive value. Proc Natl Acad Sci U S A, 114, 11241-11246.

      Schiller, D., Kanen, J. W., Ledoux, J. E., Monfils, M. H. and Phelps, E. A. 2013. Extinction during reconsolidation of threat memory diminishes prefrontal cortex involvement. Proc Natl Acad Sci U S A, 110, 20040-5.

      Schiller, D., Monfils, M. H., Raio, C. M., Johnson, D. C., Ledoux, J. E. and Phelps, E. A. 2010. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature, 463, 49-53.

      Schiller, D., Raio, C. M. and Phelps, E. A. 2012. Extinction training during the reconsolidation window prevents recovery of fear. J Vis Exp, e3893.

      Su, S., Deng, J., Yuan, K., Gong, Y., Zhang, Y., Li, H., Cao, K., Huang, X., Lin, X., Wu, P., Xue, Y., Bao, Y., Shi, J., Shi, L. and Lu, L. 2022. Continuous theta-burst stimulation over the right dorsolateral prefrontal cortex disrupts fear memory reconsolidation in humans. iScience, 25, 103614.

      Vila, J. 2004. Psychophysiological assessment. In: SPIELBERGER, C. D. (ed.) Encyclopedia of applied psychology. New York: Elsevier.

      Wang, Y., Zhu, Z., Hu, J., Schiller, D. and Li, J. 2021. Active suppression prevents the return of threat memory in humans. Commun Biol, 4, 609.

      Xue, Y. X., Luo, Y. X., Wu, P., Shi, H. S., Xue, L. F., Chen, C., Zhu, W. L., Ding, Z. B., Bao, Y. P., Shi, J., Epstein, D. H., Shaham, Y. and Lu, L. 2012. A memory retrieval-extinction procedure to prevent drug craving and relapse. Science, 336, 241-5.

      Zhu, Z., Anderson, M. C. and Wang, Y. 2022. Inducing forgetting of unwanted memories through subliminal reactivation. Nature communications, 13, 6496-6496.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Many drugs have off-target effects on the gut microbiota but the downstream consequences for drug efficacy and side effect profiles remain unclear. Herein, Wang et al. use a mouse model of liver injury coupled to antibiotic and microbiota transplantation experiments. Their results suggest that metformin-induced shifts in gut microbial community structure and metabolite levels may contribute to drug efficacy. This study provides valuable mechanistic insights that could be dissected further in future studies, including efforts to identify which specific bacterial species, genes, and metabolites play a causal role in drug response. Importantly, although some pilot data from human subjects is shown, the clinical relevance of these findings for liver disease remain to be determined.

      Thank you for reviewing our manuscript. We appreciate your valuable feedback. We agree that the downstream consequences of off-target effects on the gut microbiota by various drugs remain unclear. Our study aimed to shed light on this aspect by utilizing a mouse model of liver injury and conducting antibiotic and microbiota transplantation experiments. Our findings suggest that shifts in the structure and metabolite levels of the gut microbial community induced by metformin play a role in the drug’s efficacy. We believe that these mechanistic insights provide a strong foundation for further investigations. Specifically, future studies could focus on identifying the specific bacterial species, genes, and metabolites that have a causal role in drug response. While we have included some pilot data from human subjects, we acknowledge that the clinical relevance of our findings in the context of liver disease still requires further determination. In fact, we focused on the alteration of microbiota and metabolism caused by metformin in human bodies, which could capture the characteristics of changes in a more composite clinical direction, elucidating the potential role of metformin. We appreciate your attention to this aspect and thank you again for your thoughtful review and valuable suggestions.

      The major strength of this work is its scope, including detailed mouse phenotyping, inter-disciplinary methods, and numerous complementary experiments. The antibiotic depletion and FMT experiments provide support for a role of the gut microbiota in this mouse model.

      A major limitation is the lack of studies narrowing down which microbes are responsible. Sequencing data is shown, but no follow-up studies are done with bacterial isolates or defined communities.

      We acknowledge the limitation of our study in not narrowing down the specific microbes responsible for the observed effects. We hold the opinion that metformin exerts its effects through modulation of specific metabolic pathways unique to the microbial community. Previous study has shown that metformin can inhibit microbial folate metabolism, leading to longevity-promoting effects that are not attributed to a single colony or strain[1]. Similarly, the impact of metformin on amino acid metabolism in the microbial community appears to be widespread. While further investigations with bacterial isolates or defined communities are needed, our findings suggest that metformin's effects on microbial metabolism are complex and involve multiple members of the microbial community.

      The link to GABA is also somewhat tenuous. While it does match the phenotypic data, there are no targeted experiments in which GABA producing microbial communities/strains are compared to a control community/strain. As such, it seems difficult to know how much of the effects in this model are due to GABA vs. other metabolites.

      We agree with your point regarding the tenuous link to GABA in our study. While we did observe an increase in GABA as the only amino acid following metformin treatment, and this finding has not been reported previously, we acknowledge the need for targeted experiments comparing GABA-producing microbial communities/strains to control communities/strains. Previous literatures suggest that metformin's modulation of the microbiota can vary significantly depending on the disease context, with different microbial populations exhibiting differential responses[2-4]. Given this complexity, we opted to study the overall microbial community response to metformin rather than focusing on specific strains. Additionally, our detection of key enzymes involved in GABA synthesis at the community level further supports our findings.

      My major recommendation would be to revise the title, abstract, and discussion to provide more qualification and to consider alternative interpretations.

      We appreciate your feedback and understand your concern regarding the need for more qualification and consideration of alternative interpretations. We hope to have more specific and detailed suggestions you may have to enhance the clarity and qualification of our title and abstract. Furthermore, we have tried to revise discussion in order to enhance the scientific rigor and logical coherence of our study. If you have any specific recommendations or insights, we would be more than willing to make further revisions to address those concerns.

      Some key controls are also missing, which could be addressed by repeat experiments in the mouse model.

      We appreciate your suggestion to include additional key controls in the mouse model experiments. We have conducted repeat experiments to test the effect of antibiotics in the absence of metformin to differentiate between the effects of the model itself and the interaction of metformin with antibiotics. As results of liver injury indicators shown, there were no significance among Control, Control+Met, Control+FMT and Control+Abx groups, revealing that metformin and its treated feces, and antibiotics had no effect on liver function in normal mice (Figure 1).

      Author response image 1.

      Figure1 a: Liver MDA detection; b: Serum ALT level; c: Serum AST level.

      The antibiotic depletion experiment would be improved by testing the effect of antibiotics in the absence of metformin, to see if the effect is just driven by the model itself as opposed to an interaction between metformin and antibiotics.

      For the antibiotic depletion experiment, we had used antibiotics (Abx) for the mice of modeling, and the survival rate and liver function detection suggested that Abx had no extra effect on liver, which demonstrated that the effect is just driven by the model itself as opposed to an interaction between metformin and antibiotics (Figure 2).

      Author response image 2.

      Figure2 a: Survival rate between IR and IR + Abx group; b: Serum ALT level; c: Serum AST level.

      References

      [1] CABREIRO F, AU C, LEUNG K Y, et al. Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism [J]. Cell, 2013, 153(1): 228-39.

      [2] LIANG H, SONG H, ZHANG X, et al. Metformin attenuated sepsis-related liver injury by modulating gut microbiota [J]. Emerg Microbes Infect, 2022, 11(1): 815-28.

      [3] SUN L, XIE C, WANG G, et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin [J]. Nat Med, 2018, 24(12): 1919-29.

      [4] ZHAO H Y, LYU Y J, ZHAI R Q, et al. Metformin Mitigates Sepsis-Related Neuroinflammation via Modulating Gut Microbiota and Metabolites [J]. Frontiers in Immunology, 2022, 13:797312.

      Reviewer #2 (Public Review):

      The authors examine the use of metformin in the treatment of hepatic ischemia/reperfusion injury (HIRI) and suggest the mechanism of action is mediated in part by the gut microbiota and changes in hepatic ferroptosis. While the concept is intriguing, the experimental approaches are inadequate to support these conclusions.

      The histological and imaging studies were considered a strength and reveal a significant impact of metformin post-HIRI.

      Thank you for reviewing our paper titled “Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia/reperfusion injury through inhibiting ferroptosis”. We appreciate your insightful comments and suggestions, which have provided valuable insights into improving the quality and credibility of my research. We agree with your assessment that the experimental approaches used in this study may have limitations in supporting the conclusions drawn, and we appreciate your recognition of the strength of our histological and imaging studies, which clearly demonstrate the impact of metformin post-HIRI.

      Weaknesses largely stem from the experimental design. First, use of the iron chelator DFO would be strengthened using the ferroptosis inhibitor, liproxstatin.

      Your suggestion to employ the ferroptosis inhibitor, liproxstatin, in addition to the iron chelator DFO is well-taken. Incorporating liproxstatin into our experimental setup would provide a more comprehensive understanding of the involvement of hepatic ferroptosis in the mechanism of action of metformin. Therefore, we employed liproxstatin to inhibit HIRI and detected some core indicators of liver injury. As figure 3 shown, liproxstatin can reduce liver injury, restore liver GSH level and inhibit Fe accumulation, suggesting that ferroptosis plays an important role in HIRI. We hope this modification will enhance the credibility of our conclusions.

      Author response image 3.

      Figure3 a: Liver MDA detection; b: Serum ALT level; c: Serum AST level; d: Liver GSH level; e: Liver Fe level.

      Second, the impact of metformin on the microbiota is profound resulting in changes in bile acid, lipid, and glucose homeostasis. Throughout the manuscript no comparisons are made with metformin alone which would better capture the metformin-specific effects.

      Thank you for raising an important point regarding the impact of metformin on the microbiota and its potential effects on bile acid, lipid, and glucose homeostasis. It has well known that that the effects of metformin on normal blood glucose and lipid metabolism are minimal. Metformin primarily exerts its effects in cases of impaired glucose tolerance, which is why it is widely used for non-diabetic conditions. Regarding the changes in bile acid metabolism and chronic cholesterol and lipid elevation, these associations are typically observed in chronic liver disease models. Since our study focuses on an acute model of HIRI, we did not specifically investigate these changes.

      Lastly, the absence of proper controls including germ free mice, metformin treated mice, FMT treated mice, etc make it difficult to understand the outcomes and to properly reproduce the findings in other labs.

      Lastly, we acknowledge your concern regarding the absence of proper controls, including germ-free mice, metformin-treated mice, and FMT -treated mice. We understand that these controls are essential for robustly interpreting and reproducing our findings. Therefore, we have added a batch of experiments for verification. As results shown, there were no significance among Control, Control+Met, Control+FMT and Control+Abx groups, revealing that metformin and its treated feces, and antibiotics had no effect on liver function in normal mice (Figure 1). We hope the result of these controls could address your valid point and provide a more comprehensive framework for understanding the outcomes.

      Author response image 4.

      Figure1 a: Liver MDA detection; b: Serum ALT level; c: Serum AST level.

      Overall, while the concept is interesting and has the potential to better understand the pleiotropic functions of metformin, the limitations with the experimental design and lack of key controls make it challenging to support the conclusions.

      We genuinely appreciate your constructive criticism and the time you have taken to evaluate my work. Your feedback has shed light on the limitations of our experimental design and the need for key controls, which we have addressed in revised manuscript. If you have any further recommendations or concerns, we would be more than willing to incorporate them into my future work.

      Reviewer #3 (Public Review):

      The study presented in this paper explores the role of gut microbiota in the therapeutic effect of metformin on HIRI, as supported by fecal microbiota transplantation (FMT) experiments. Through high throughput sequencing and HPLC-MS/MS, the authors have successfully demonstrated that metformin administration leads to an increase in GABA-producing bacteria. Moreover, the study provides compelling evidence for the beneficial impact of GABA on HIRI.

      Thank you for your valuable feedback on our paper exploring the role of gut microbiota in the therapeutic effect of metformin on hepatic ischemia-reperfusion injury (HIRI). We appreciate your positive remarks and suggestions for improvement. In response to your comments, we have revised the manuscript accordingly. We have included additional details on the high throughput sequencing and HPLC-MS/MS methods used to analyze the gut microbiota and GABA levels. This should provide readers with a clearer understanding of our experimental approach and the evidence supporting our findings.

      Regarding your suggestion to further investigate the mechanisms underlying the beneficial impact of GABA on HIRI, we agree that this is an important direction for future research. We plan to conduct additional studies to explore the specific mechanisms by which GABA exerts its protective effects on HIRI in the future. We also supplemented discussion of potential therapeutic strategies targeting GABAergic pathways in the discussion section.

      Thank you once again for your insightful comments. We believe that these revisions have strengthened the manuscript and improved its scientific rigor. We hope that you find the revised version to be satisfactory and look forward to your further feedback.

      Reviewer #1 (Recommendations For The Authors):

      The writing could be improved. Multiple typos are found throughout and there is an overuse of adverbs like "expectedly". You should let the reader decide what is or is not expected. Try to avoid terms like "confirmed" or "validated", which only applies if you knew the result a priori. Remove underscores in species names. The Results section is also very difficult to interpret given the lack of explanation of experimental design. For example, the human study is only briefly mentioned within a larger paragraph on mouse data, without any explanation as to the study design. Similar issues are true for the transcriptomics and amplicon sequencing - it would help the reader to explain what samples were processed, the timepoints, etc.

      Thank you for your valuable feedback on our manuscript entitled “Gut microbiota-derived gamma-aminobutyric acid from metformin treatment reduces hepatic ischemia/reperfusion injury through inhibiting ferroptosis” We appreciate your constructive comments and insightful suggestions for improvement.

      We have carefully reviewed your comments and have made several revisions to enhance the clarity and readability of the manuscript. We have addressed the issue of multiple typos and have removed the overuse of adverbs, such as “expectedly,” to allow readers to draw their own conclusions from the results. Additionally, we have eliminated terms like “confirmed” or “validated” that may imply a priori knowledge of the results.

      We apologize for the lack of clarity regarding the experimental design in the Results section. We have now provided a more detailed explanation of the study design for the human study, transcriptomics, and amplicon sequencing experiments. This includes information on the samples processed, timepoints, and other relevant details, to aid readers in understanding the experimental procedures.

      In response to your comment about removing underscores in species names, we have revised the text accordingly to ensure consistency and accuracy in the species nomenclature used throughout the manuscript.

      Once again, we sincerely appreciate your valuable input, which has helped us improve the quality of our manuscript. We hope that the revised version now meets your expectations and look forward to any further feedback you may have.

      Thank you for your time and attention.

      Line 53 - prebiotics aren't "microbial agents"

      We apologize for this error, which we have corrected. (line 55: “Microbial agents, such as synbioticsprebiotics and probiotics…”)

      Line 88 - sequencing doesn't "verify the critical role of gut microbiota"

      We apologize for this error, which we have corrected. (line 90: “In order to verifyclarify the critical role of gut microbiota in the pleiotropic actions of metformin,22-24 fecal samples were collected from the mice to perform 16S rRNA sequencing.

      Line 92 - missing a citation for the "microbiota-gut-liver axis theory"

      We have corrected it in manuscript. (line 93: “Next, as the microbiota-gut-liver axis theory indicates,25 HIRI-induced dysfunction of the gut barrier may aggravate liver damage by disrupting the gut microbiota.”)

      Line 112 - it's very surprising to me that FMT led to lower alpha diversity, which seems impossible.

      We understand your surprise regarding the observed decrease in alpha diversity after FMT. Our findings indeed deviate from the commonly observed pattern of increased alpha diversity post-FMT. We have carefully re-examined our data and conducted additional analyses to ensure the accuracy of our results. After thorough investigation, we have identified a potential reason for this unexpected outcome, which we believe could shed light on this phenomenon. We hypothesize that the lower alpha diversity observed in our study might be attributed to the specific characteristics of the donor microbiota used for FMT. While the donor microbiota exhibited certain beneficial properties associated with the therapeutic effect on HIRI, it could have presented a limited diversity compared to the recipient’s original gut microbiota. This discrepancy in diversity could have contributed to the observed decrease in alpha diversity following FMT.

      To further support our hypothesis, we have included a discussion on this unexpected finding in the revised manuscript. We believe that this addition will provide a more comprehensive understanding of the results and help contextualize the observed decrease in alpha diversity following FMT.

      Line 117 - Antibiotics don't "identify the function of gut microbes." Need to specify which antibiotics were used and for how long.

      We have corrected it in manuscript. (line 119: “To further identify the function of gut microbes, experiments were designed, and combination treatment of antibiotics (1 mg/mL penicillin sulfate, 1 mg/mL neomycin sulfate, 1 mg/mL metronidazole and 0.16 mg/mL gentamicin) and metformin were employed for 1 week before IR treated.”)

      Line 120 - this experiment shows that the gut microbiota (or antibiotics more precisely) matters, not the "reshaped gut microbiota"

      We have corrected it in manuscript. (line 124: “The results confirmed that reshaped gut microbiota is critical for the effect of metformin against HIRI.”)

      Line 122 - need to reword this subheading and the concluding sentence. The main takeaway is that the FMT improved markers of ferroptosis, but no additional causal links are provided here.

      We have revised in manuscript. (line 125: “FMT alleviates HIRI-induced ferroptosis through reshaped fecal microbiota.”)

      Line 141 - need to explain what transcriptomics data was generated and how it was analyzed.

      We have revised in manuscript. (line 144: “To elucidate the molecular mechanisms through which pathway participates metformin-treated IR injury, we analysed gene expression profiles of each group mice. Transcriptome sequencing analysis revealed that 9697 genes were in common among four groups (Supplementary Figure 6). Therefore, we used these common genes for KEGG analysis, showing that The transcriptome analysis of liver tissues showed that similar mRNA changes between Met group and FMT group are mainly concentrated in the three top pathways: lipid metabolism, carbohydrate metabolism, and amino acid metabolism (Fig 4a).”)

      Line 150 - change to "16S rRNA gene sequencing". Typo: "mice microbes".

      We have revised in manuscript. (line 156: “Moreover, it was observed that the genus of Bacteroides had a significant increase based on the 16s rRNA gene sequencing of metformin-treated mice microbes.”)

      Line 152 - upregulated refers to gene expression, change to enriched.

      We have revised in manuscript. (line 171: “Detailedly, the species of Bacteroides containing Bacteroides thetaiotaomicron, Bacteroides unifomis, and Bacteroides salyersiae, were enriched in human gut after metformin administration (Fig. 4i).”)

      Line 159 - typo: "prokaryotes"

      We have revised in manuscript. (line 165: “In order to further identify the increased GABA originates from gut microbiota, two key enzymes of prokaryotes protokaryotic GABA synthesis, GAD and PAT, were detected on DNA level, finding that both of them are significantly increased in the feces from IR+Met and IR+FMT groups (Fig. 4h).”)

      Line 161 - the human study should be under a new sub-heading and provide more details.

      We have revised in manuscript. (line 168: In order to clarify the specific effects of metformin on microbiota, given the big safety margin, healthy volunteers were recruited for a 1 week of daily oral 500mg dose of metformin trial. Fecal samples were collected before and after oral administration of metformin for metagenomic analysis .”)

      Line 197 - It's unclear why the current study conflicts with prior literature. Is it due to the disease model, the starting microbiota, something else? Please add more discussion.

      Thank you for bringing this important point to our attention, and we appreciate your valuable input. We agree that it is important to discuss the potential reasons for the discrepancy between our findings and prior literature on metformin-reshaped microbiota. In our study, we used a disease model of HIRI, which may have unique characteristics compared to other disease models. It is possible that the specific disease model influenced the response of the gut microbiota. Additionally, the starting microbiota of the recipients and the characteristics of the donor microbiota used for FMT could also play a role in the disparity. We have expanded the discussion section of our revised manuscript to further address these potential factors and their implications. We hope that this additional information will provide a more comprehensive explanation for the discrepancy between our study and prior literature.

      Figure 1a - change to Kaplan Meier not ANOVA. Specify the contrast - which groups are being compared?

      We have revised in Figure 1a.

      Figure 1e, alpha diversity - relabel "sobs" with "observed OTUs". Change to 3 bars with error and add statistics.

      We have revised in Figure 1e.

      Figure 1e, PCA - this should be a separate panel (1f). Color of big red circle doesn't match the points. Add PERMANOVA p-value/R2. Change to OTUs not genera. Better yet, use amplicon sequence variants from DADA2.

      We have revised in Figure 1e..

      Figure 2a - Change to Kaplan Meier. Also, it's unclear if residual metformin could be in the donor samples.

      We have revised in Figure 2a.

      Figure 2f, alpha diversity - relabel "sobs" with "observed OTUs". Change to 3 bars with error and add statistics.

      We have revised in Figure 2f.

      Figure 2f, PCA - this should be a separate panel (2g). Color of big orange circle doesn't match the points. Add PERMANOVA p-value/R2. Change to OTUs not genera. Better yet, use amplicon sequence variants from DADA2.

      We have revised in Figure 2f.

      Figure 4b - check units, shouldn't this be ng/mg (i.e. weight not volume).

      We have revised in Figure 4b.

      Figure 4c,d - need more explanation in the legend and Results as to what is shown here.

      We have revised in Figure 4c,d.

      Figure 4d - unclear why only Bacteroides are shown here or if the p-values are adjusted for multiple comparisons.

      Thank you for your comment regarding Figure 4d in our manuscript. We apologize for the confusion caused. The reason why only Bacteroides is shown in Figure 4d is because we specifically wanted to investigate the changes in Bacteroides abundance following metformin treatment.

      In the mouse experiments, we observed a significant increase in Bacteroides after metformin treatment. To investigate if a similar change occurs in healthy volunteers, we examined the levels of Bacteroides in fecal samples before and after oral administration of metformin. We found that the abundance of Bacteroides also increased in the human gut after metformin administration, consistent with the results from the animal experiments. Regarding the p-values, we apologize for not mentioning whether they were adjusted for multiple comparisons in the figure legend. In our revised manuscript, we have provided a clarification stating that the p-values were adjusted using the appropriate method. We appreciate your feedback and hope that this explanation clarifies the rationale behind Figure 4d. Thank you for your valuable input.

      Reviewer #2 (Recommendations For The Authors):

      Below I've listed several suggestions to improve the paper.

      1. Controls - the authors should include metformin only treated mice, FMT only treated mice, etc. Additionally, germ free mice treated with metformin and HIRI would be helpful to better implicate the gut microbiome in these beneficial effects.

      Thank you for your suggestion regarding the inclusion of additional control groups in our study. We agree that including metformin only treated mice, FMT only treated mice, and germ-free mice treated with metformin and HIRI would provide valuable insights into the role of the gut microbiome in the observed beneficial effects.

      Therefore, we have included metformin only treated mice, FMT only treated mice and Abx only treated mice as supplement to better assess the specific contribution to the observed effects. As results shown, there were no significance among Control, Control+Met, Control+FMT and Control+Abx groups, revealing that metformin and its treated feces, and antibiotics had no effect on liver function in normal mice (figure1).

      We appreciate your input and believe that the inclusion of these additional control groups will strengthen our study and provide a more comprehensive understanding of the role of the gut microbiome in the therapeutic effects observed.

      Author response image 5.

      Figure1 a: Liver MDA detection; b: Serum ALT level; c: Serum AST level.

      1. More thorough characterization of metabolite pools. Metformin is known to influence many pathways including bile acids and lipids. These important molecules should be measures as they likely play a key role in the observed protective effect. In fact, many of the key changes displayed in Figure 3H are involved in lipid metabolism.

      Thank you for your valuable feedback regarding the characterization of metabolite pools in our study. We appreciate your suggestion to measure the influence of metformin on bile acids and lipid metabolism, as they are crucial pathways that may play a significant role in the observed protective effect.

      Regarding bile acids, we agree that they are important in the context of metformin’s influence on metabolic pathways. However, it is important to note that the impact of metformin on bile acids appears to be more prominent in chronic liver disease models. In our acute model, the changes in bile acids were not as significant. Instead, our results primarily indicate a close association between lipid changes and hepatic ferroptosis. Metformin significantly modulates lipid metabolism, thereby alleviating liver ferroptosis.

      Additionally, we have conducted metagenomic sequencing on the gut microbiota of healthy volunteers before and after oral administration of metformin. While analyzing the data, we did not observe significant changes in key genes involved in regulating bile acid variations. This might be attributed to the healthy volunteers used in our study, where significant changes in bile acids were not induced.

      We appreciate your insightful comments and suggestions, which have shed light on the importance of characterizing bile acids and lipid metabolism in our study. While the impact of bile acids may be more evident in chronic liver disease models, our findings highlight the significant influence of metformin on lipid metabolism, closely related to hepatic ferroptosis. We will take your suggestions into account for future studies to further explore the role of bile acids and their regulation by metformin.

      1. Imaging of lipid ROS is not quantitative. The authors should conduct more standard assays with BODIPY 581/591 C11 using cell lysates.

      We appreciate your suggestion to conduct more standard assays using BODIPY 581/591 C11 with cell lysates.

      We would like to clarify that we did indeed utilize assays with BODIPY 581/591 C11 to detect and measure lipid ROS in our study. The detailed description of these assays can be found in the Methods section of our paper. We followed established protocols and guidelines to ensure accurate and reliable measurements of lipid ROS levels.

      We acknowledge that imaging techniques may have limitations in providing quantitative data. However, we employed BODIPY 581/591 C11 assays as a widely accepted and commonly used method to assess lipid ROS levels. This allowed us to obtain qualitative and semi-quantitative information on the changes in lipid ROS levels in response to metformin treatment.

      1. Liproxstatin may be a better drug choice or at the very least should be used to compare with the DFO data

      Thank you for your suggestion. We have taken your advice into consideration and conducted an evaluation of Liproxstatin as a ferroptosis inhibitor. Our findings indicate that Liproxstatin significantly improves HIRI (Figure C). We believe that incorporating Liproxstatin in our research will provide valuable insights and allow for a comprehensive comparison with the DFO data.

      Author response image 6.

      Figure3 a: Liver MDA detection; b: Serum ALT level; c: Serum AST level; d: Liver GSH level; e: Liver Fe level.

      1. The rationale for how GABA was selected is not clear. I am surprised that there were not more significant metabolite changes. It might be better to show a volcano plot of heatmap of the significantly changed features.

      Thank you for raising an important question regarding the rationale for selecting GABA as the focus metabolite in our study. Initially, we also had concerns about the limited number of significant metabolite changes observed. However, through our comprehensive metabolomic profiling, we identified GABA as the most significantly altered metabolite following HIRI.

      It is worth noting that we specifically focused on the measurement of 22 essential amino acids in our analysis. While it is possible that changes in non-essential amino acids may have occurred, we did not examine them in this study. Nevertheless, we have since used additional methods to validate the upregulation of GABA levels, and the biological effects observed support the specific role of GABA in protecting against HIRI. Based on the fact that GABA was the only significant amino acid, the volcano plot was of little significance, so we did not supplement this plot.

      We appreciate your valuable input and thank you for bringing up this important issue.

      1. The manuscript needs to be proofread and edited. There are a variety of typos and grammar issues throughout.

      Thank you for your feedback. We acknowledge that the manuscript requires proofreading and editing, as we have identified several typos and grammar issues. We will try to ensure that the necessary revisions are made to improve the overall quality of the manuscript.

      Reviewer #3 (Recommendations For The Authors):

      However, I have some major concerns for the manuscript.

      1. Line 26 16S rRNA and metagenomic sequencing alone can't accurately confirm the improvement effect of GABA producing bacteria on HIRI. In fact, transcriptome analysis, HPLC-MS/MS and other methods were also used in this paper, so the language expression here is not appropriate

      Thank you for pointing out the language expression issue in line 26 of the manuscript. We apologize for any confusion caused. You are correct in stating that 16S rRNA and metagenomic sequencing alone may not accurately confirm the improvement effect of GABA-producing bacteria on HIRI. In our study, we employed a combination of multiple methods, including transcriptome analysis, HPLC-MS/MS, especially detection of bacteria GABA key synthetases, PAT and GAD, to comprehensively investigate the impact of GABA-producing bacteria on HIRI.

      We have revised the language in line 26 to reflect the broader range of methods used in our study to support the conclusions regarding the improvement effect of GABA-producing bacteria on HIRI.

      1. The Introduction section needs to add a description of the previous research on the association between HIRI and ferroptosis

      Thank you for your suggestion regarding the inclusion of a description of the association between HIRI and ferroptosis in the Introduction section. We agree that this is an important aspect to address. However, upon further consideration, we have decided to move the discussion of ferroptosis and its potential role in HIRI to the Discussion section, as it aligns better with the logical flow of the manuscript. This allows us to discuss the potential implications and future directions in a more organized and coherent manner.

      1. Authors should provide quantified figure or table next to the results of western blot that are more convenient to understand.

      We have revised in manuscript. (See sfigure 7)

      1. In this paper, FMT experiments are used to verify that metformin remodeled gut microbiota can play a role in improving HIRI. The operation steps of FMT should be described more specifically in the method part

      *What is the fecal donor information for FMT?

      *Line272 Did the IR + FMT group put the transplanted microbiota of FMT directly into the drinking water like the other treatment groups? Will such an operation affect the quality and quantification of the transplanted microbiota and lead to the loss of microbiota species? It is crucial for the authors to provide a clear and thorough clarification regarding these matters within the context of their FMT experiment.

      Thank you for your feedback regarding the need for a more detailed description of the fecal microbiota transplantation (FMT) procedure and clarification regarding the IR + FMT group in our manuscript. We appreciate your suggestions and we have taken them into consideration.

      In our study, the fecal donor for FMT was obtained from mice that had been orally administered metformin. The fecal microbiota was collected and processed to remove any residual metformin before transplantation. Specifically, the microbiota for the IR + FMT group was administered through gavage, as stated in line 272. This method does not affect the quality or quantity of the transplanted microbiota, nor does it lead to a loss of microbiota species. We understand the importance of providing clear and thorough clarification regarding these matters. Therefore, we have included additional specific details of the FMT procedure in the revised version of the manuscript. We hope that this clarification addresses your concerns and provides a more comprehensive understanding of our FMT experiment.

      1. The presentation of transcriptomic analysis results in the manuscript is insufficiently comprehensive and specific, as they are solely depicted through Fig 4a. Relying solely on Fig 4a is inadequate to establish the definitive roles of the met group and FMT group in ferroptosis compared to other groups. Therefore, the authors should provide additional transcriptomic analysis results to ascertain the specific effects of the met group and FMT group in ferroptosis, as well as their comparison with other groups.

      Thank you for your feedback regarding the comprehensiveness of our transcriptomic analysis results in the manuscript. We understand your concerns and appreciate your suggestion. In our study, we have provided additional data beyond Fig 4a to support the specific effects of the met group and FMT group in ferroptosis, as well as their comparison with other groups. Specifically, in Figure 3, we have included Western blot (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) data to confirm the involvement of ferroptosis in HIRI and the role of metformin in attenuating ferroptosis. Moreover, we have presented transcriptomic analysis results in Figure 3h, which includes a heatmap of genes related to lipid metabolism. These findings can strengthen our conclusions regarding the importance of ferroptosis in HIRI and the protective effects of metformin against ferroptosis. We hope that these data address your concerns and provide a more comprehensive understanding of our research findings.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Summary:

      The authors examine the eigenvalue spectrum of the covariance matrix of neural recordings in the whole-brain larval zebrafish during hunting and spontaneous behavior. They find that the spectrum is approximately power law, and, more importantly, exhibits scale-invariance under random subsampling of neurons. This property is not exhibited by conventional models of covariance spectra, motivating the introduction of the Euclidean random matrix model. The authors show that this tractable model captures the scale invariance they observe. They also examine the effects of subsampling based on anatomical location or functional relationships. Finally, they briefly discuss the benefit of neural codes which can be subsampled without significant loss of information.

      Strengths:

      With large-scale neural recordings becoming increasingly common, neuroscientists are faced with the question: how should we analyze them? To address that question, this paper proposes the Euclidean random matrix model, which embeds neurons randomly in an abstract feature space. This model is analytically tractable and matches two nontrivial features of the covariance matrix: approximate power law scaling, and invariance under subsampling. It thus introduces an important conceptual and technical advance for understanding large-scale simultaneously recorded neural activity.

      Weaknesses:

      The downside of using summary statistics is that they can be hard to interpret. Often the finding of scale invariance, and approximate power law behavior, points to something interesting. But here caution is in order: for instance, most critical phenomena in neural activity have been explained by relatively simple models that have very little to do with computation (Aitchison et al., PLoS CB 12:e1005110, 2016; Morrell et al., eLife 12, RP89337, 2024). Whether the same holds for the properties found here remains an open question.

      We are grateful for the thorough and constructive feedback provided on our manuscript. We have addressed each point raised by you.

      Regarding the main concern about power law behavior and scale invariance, we would like to clarify that our study does not aim to establish criticality. Instead, we focus on describing and understanding a specific scale-invariant property in terms of collapsed eigenspectra in neural activity. We tested Morrell et al.’s latent-variable model (eLife 12, RP89337, 2024, [1]), where a slowly varying latent factor drives population activity. Although it produces a seemingly power-law-like spectrum, random sampling does not replicate the strict spectral collapse observed in our data (second row in Fig. S23). This highlights that simply adding latent factors does not fully recapitulate the scale invariance we measure, suggesting richer or more intricate processes may be involved in real neural recordings.

      Specifically, we have incorporated five key revisions.

      • As mentioned, we evaluated the latent variable model proposed by Morrell et al., and found that they fail to reproduce the scale-invariant eigenspectra observed in our data; these results are now presented in the Discussion section and supported by a new Supplementary Figure (Fig. S23).

      • We included a comparison with the findings of Manley et al. (2024 [2]) regarding the issue of saturating dimension in the Discussion section, highlighting the methodological differences and their implications.

      • We added a new mathematical derivation in the Methods section, elucidating the bounded dimensionality using the spectral properties of our model. • We have added a sentence in the Discussion section to further emphasize the robustness of our findings by demonstrating their consistency across diverse datasets and experimental techniques.

      • We have incorporated a brief discussion on the implications for neural coding (lines 330-332). In particular, Fisher information can become unbounded when the slope of the power-law rank plot is less than one, as highlighted in the recent work by Moosavi et al. (bioRxiv 2024.08.23.608710, Aug, 2024 [3]).

      We believe these revisions address the concerns raised during the review process and collectively strengthen our manuscript to provides a more comprehensive and robust understanding of the geometry and dimensionality of brain-wide activity. We appreciate your consideration of our revised manuscript and look forward to your feedback.

      Recommendations for the authors:

      In particular, in our experience replies to the reviewers are getting longer than the paper, and we (and I’m sure you!) want to avoid that. Maybe just reply explicitly to the ones you disagree with? We’re pretty flexible on our end.

      (1) The main weakness, from our point of view, is whether the finding of scale invariance means something interesting, or should be expected from a null model. We can suggest such model; if it is inconsistent with the data, that would make the results far more interesting.

      Morrell et al. (eLife 12, RP89337,2024 [1]) suggest a very simple model in which the whole population is driven by a slowly time-varying quantity. It would be nice to determine whether it matched this data. If it couldn’t, that would add some evidence that there is something interesting going on.

      We appreciate your insightful suggestion to consider the model proposed by Morrell et al. (eLife 12, RP89337, 2024 [1]), where a slowly time-varying quantity drives the entire neural population. We conducted simulations using parameters from Morrell et al. [4, 1], as detailed below.

      Our simulations show that Morrell’s model can replicate a degree of scaleinvariance when using functional sampling or RG as referred to in Morrell et al, 2021, PRL [4] (FSap, Fig.S23A-D, Author response image 1). However, it fails to fully capture the scale-invariance of collapsing spectra we observed in data under random sampling (RSap, Fig.S23E-H). This discrepancy suggests that additional dynamics or structures in the neural activity are not captured by this simple model, indicating the presence of potentially novel and interesting features in the data that merit further investigation.

      Unlike random sampling, the collapse of eigenspectra under functional sampling does not require a stringent condition on the kernel function f(x) in our ERM theory (see Discussion line 269-275), potentially explaining the differing results between Fig.S23A-D and Fig.S23E-H.

      We have incorporated these findings into the Result section 2.1 (lines 100-101) and Discussion section (lines 277-282, quoted below):

      “Morrell et al. [4, 1] suggested a simple model in which a slow time-varying factor influences the entire neural population. To explore the effects of latent variables, we assessed if this model explains the scale invariance in our data. The model posits that neural activity is primarily driven by a few shared latent factors. Simulations showed that the resulting eigenspectra differed considerably from our findings (Fig. S23). Although the Morrell model demonstrated a degree of scale invariance under functional sampling, it did not align with the scale-invariant features under random sampling observed in our data, suggesting that this simple model might not capture all crucial features in our observations.”

      Author response image 1:

      Morrell’s latent model. A: We reproduce the results as presented in Morrell et al., PRL 126(11), 118302 (2021) [4]. Parameters are same as Fig. S23A. Sampled 16 to 256 neurons. Unlike in our study, the mean eigenvalues are not normalized to one. Dashed line: eigenvalues fitted to a power law. See also Morrell et al. [4] Fig.1C. Parameters are same as Author response image 1. µ is the power law exponent (black) of the fit, which is different from the µ parameter used to characterize the slow decay of the spatial correlation function, but corresponds to the parameter α in our study.

      (2) The quantification of the degree of scale invariance is done using a ”collapse index” (CI), which could be better explained/motivated. The fact that the measure is computed only for the non-leading eigenvalues makes sense but it is not clear when originally introduced. How does this measure compare to other measures of the distance between distributions?

      We thank you for raising this important point regarding the explanation and motivation for our Collapse Index (CI). We defined the Collapse Index (CI) instead of other measures of distance between distributions for two main reasons. First, the CI provides an intuitive quantification of the shift of the eigenspectrum motivated by our high-density theory for the ERM model (Eq. 3, Fig. 4A). This high-density theory is only valid for large eigenvalues excluding the leading ones, and hence we compute the CI measure with a similar restriction of the range of area integration. Second, when using distribution to assess the collapse (e.g., we can use kernel density method to estimate the distribution of eigenvalues and then calculate the KL divergence between the two distributions), it is necessary to first estimate the distributions. This estimation step introduces errors, such as inaccuracies in estimating the probability of large eigenvalues.

      We agree that a clearer explanation would enhance the manuscript and thus have made modifications accordingly. The CI is now introduced more clearly in the Results section (lines 145-148) and further detailed in the Methods section (lines 630-636). We have also revised the CI diagram in Fig. 4A to better illustrate the shift concept using a more intuitive cartoon representation.

      (3) The paper focuses on the case in which the dimensionality saturates to a finite value as the number of recorded neurons is increased. It would be useful to contrast with a case in which this does not occur. The paper would be strengthened by a comparison with Manley et al. 2024, which argued that, unlike this study, dimensionality of activity in spontaneously behaving head-fixed mice did not saturate.

      Thank you for highlighting this comparison. We have included a discussion (lines 303-309) comparing our approach with Manley et al. (2024) [2]. While Manley et al. [2] primarily used shared variance component analysis (SVCA) to estimate neural dimensionality, they observed that using PCA led to dimensionality saturation (see Figure S4D, Manley et al. [2]), consistent with our findings (Fig. 2D). We acknowledge the value of SVCA as an alternative approach and agree that it is an interesting avenue for future research. In our study, we chose to use PCA for several reasons. PCA is a well-established and widely trusted method in the neuroscience community, with a proven track record of revealing meaningful patterns in neural data. Its mathematical properties are well understood, making it particularly suitable for our theoretical analysis. While we appreciate the insights that newer methods like SVCA can provide, we believe PCA remains the most appropriate tool for addressing our specific research questions.

      (4) More importantly, we don’t understand why dimensionality saturates. For the rank plot given in Eq. 3,

      where k is rank. Using this, one can estimate sums over eigenvalues by integrals. Focusing on the N-dependence, we have

      This gives

      We don’t think you ever told us what mu/d was (see point 13 below), but in the discussion you implied that it was around 1/2 (line 249). In that case, D<sub>PR</sub> should be approximately linear in N. Could you explain why it isn’t?

      Thank you for your careful derivation. Along this line of calculations you suggested, we have now added derivations on using the ERM spectrum to estimate the upper bound of the dimension in the Methods (section 4.14.4). To deduce D<sub>PR</sub> from the spectrum, we focus on the high-density region, where an analytical expression for large eigenvalues λ is given by:

      Here, d is dimension of functional space, L is the linear size of functional space, ρ is the neuron density and γ is the coefficient in Eq. (3), which only depends on d, µ and E(σ<sup>2</sup>). The primary difference between your derivation and ours is that the eigenvalue λ<sub>r</sub> decays rapidly after the threshold r \= β(N), which significantly affects the summations and . Since we did not discuss the small eigenvalues in the article, we represent them here as an unknown function η(r,N,L).

      The sum is the trace of the covariance matrix C. As emphasized in the Methods section, without changing the properties the covariance spectrum, we always consider a normalized covariance matrix such that the mean neural activity variance E(σ<sup>2</sup>) = 1. Thus

      rather than

      The issue stems from overlooking that Eq. (3) is valid only for large eigenvalues (λ > 1).

      Using the Cauchy–Schwarz inequality, we have a upper bound of

      Conversely, provides a lower bound of :

      As a result, we must have

      In random sampling (RSap), L is fixed. We thus must have a bounded dimensionality that is independent of N for our ERM model. In functional sampling (FSap), L varies while the neuronal density ρ is fixed, leading to a different scaling relationship of the upper bound, see Methods (section 4.14.4) for further discussion.

      (5) The authors work directly with ROIs rather than attempting to separate the signals from each neuron in an ROI. It would be worth discussing whether this has a significant effect on the results.

      We appreciate your thoughtful question on the potential impact of using ROIs. The use of ROIs likely does not impact our key findings since they are validated across multiple datasets with various recording techniques and animal models, from zebrafish calcium imaging to mouse brain multi-electrode recordings (see Figure S2, S24). The consistency of the scale-invariant covariance spectrum in diverse datasets suggests that ROIs in zebrafish data do not significantly alter the conclusions, and they together enhance the generalizability of our results. We highlight this in the Discussion section (lines 319-323).

      (6) Does the Euclidean random matrix model allow the authors to infer the value of D or µ? Since the measured observables only depend on µ/D it seems that one cannot infer the latent dimension where distances between neurons are computed. Are there any experiments that one could, in principle, perform to measure D or mu? Currently the conclusion from the model and data is that D/µ is a large number so that the spectrum is independent of neuron density rho. What about the heterogeneity of the scales σ<sub>i</sub>, can this be constrained by data?

      Measuring d and µ in the ERM Model

      We agree with you that the individual values of d and µ cannot be determined separately from our analysis. In our analysis using the Euclidean Random Matrix (ERM) model, we fit the ratio µ/d, rather than the individual values of d (dimension of the functional space) or µ (exponent of the distance-dependent kernel function). This limitation is inherent because the model’s predictions for observable quantities, such as the distribution of pairwise correlation, are dependent solely on this ratio.

      Currently there are no directly targeted experiments to measure d. The dimensions of the functional space is largely a theoretical construct: it could serve to represent latent variables encoding cognitive factors that are distributed throughout the brain or specific sensory or motor feature maps within a particular brain region. It may also be viewed as the embedding space to describe functional connectivity between neurons. Thus, a direct experimental measurement of the dimensions of the functional space could be challenging. Although there are variations in the biological interpretation of the functional space, the consistent scale invariance observed across various brain regions indicates that the neuronal relationships within the functional space can be described by a uniform slowly decaying kernel function.

      Regarding the Heterogeneity of σ<sub>i</sub>

      The heterogeneity of neuronal activity variances ( σ<sub>i</sub>) is a critical factor in our analysis. Our findings indicate that this heterogeneity:

      (1) Enhances scale invariance: The covariance matrix spectrum, which incorporates the heterogeneity of , exhibits stronger scale invariance compared to the correlation matrix spectrum, which imposes for all neurons. This observation is supported by both experimental data and theoretical predictions from the ERM model, particularly in the intermediate density regime.

      (2) Can be constrained by data: We fit a log-normal distribution to the experimentally observed σ<sup>2</sup> values to capture the heterogeneity in our model which leads to excellent agreement with data (section 4.8.1). Figure S10 provides evidence for this by directly comparing the eigenspectra obtained from experimental data (Fig S10A-F) with those generated by the fitted ERM model (Fig S10M-R). These results suggest that the data provides valuable information about the distribution of neuronal activity variances.

      In conclusion, the ERM model and our analysis cannot separately determine d and µ. We also highlight that the neuronal activity variance heterogeneity, constrained by experimental data, plays a crucial role in improving the scale invariance.

      (7) Does the fitting procedure for the positions x in the latent space recover a ground truth in your statistical regime (for the number of recorded neurons)? Suppose you sampled some neurons from a Euclidean random matrix theory. Does the MDS technique the authors use recover the correct distances?

      While sampling neurons from a Euclidean random matrix model, we demonstrated numerically that the MDS technique can accurately recover the true distances, provided that the true parameter f(x) is known. To quantify the precision of recovery, we applied the CCA analysis (Section 4.9) and compared the true coordinates from the original Euclidean random matrix with the fitted coordinates obtained through our MDS procedure. The CCA correlation between the true and fitted coordinates in each spatial dimension is nearly 1 (the difference from 1 is less than 10<sup>−7</sup>). When fitting with experimental data, one source of error arises from parameter estimation. To evaluate this, we assess the estimation error of the fitted parameters. When we choose µ \= 0_.5 in our ERM model and then fit the distribution of the pairwise correlation (Eq. 21), the estimated parameter is = 0.503 ± 0._007 (standard deviation). Then, we use the MDS-recovered distances to fit the coordinates with the fitted kernel function , which is determined by the fitted parameter . The CCA correlation between the true and fitted coordinates in each direction remains nearly 1 (the difference from 1 is less than 10<sup>−5</sup>).

      (8) l. 49: ”... both the dimensionality and covariance spectrum remain invariant ...”. Just to be clear, if the spectrum is invariant, then the dimensionality automatically is too. Correct?

      Thanks for the question. In fact, there is no direct causal relationship between eigenvalue spectrum invariance and dimensionality invariance as we elaborate below and added discussions in lines 311-317. For eigenvalue spectrum invariance, we focus on the large eigenvalues, whereas dimensionality invariance considers the second order statistics of all eigenvalues. Consequently, the invariance results for these two concepts may differ. And dimensional and spectral invariance have different requirements:

      (1) The condition for dimensional saturation is finite mean square covariance

      The participation ratio D<sub>PR</sub> for random sampling (RSap) is given by Eq. 5:

      This expression becomes invariant as N → ∞ if the mean square covariance is finite. In contrast, neural dynamics models, such as the balanced excitatory-inhibitory (E-I) neural network [5], exhibit a different behavior, where , leading to unbounded dimensionality (see discussion lines 291-295, section 6.9 in SI).

      (2) The requirements for spectral invariance involving the kernel function

      In our Euclidean Random Matrix (ERM) model, the eigenvalue distribution follows:

      For spectral invariance to emerge: (1) The eigenvalue distribution must remain unchanged after sampling. (2) Since sampling reduces the neuronal density ρ. (3) The ratio µ/d must approach 0 to maintain invariance.

      We can also demonstrate that D<sub>PR</sub> is independent of density ρ in the large N limit (see the answer of question 4).

      In conclusion, there is no causal relationship between spectral invariance and dimensionality invariance. This is also the reason why we need to consider both properties separately in our analysis.

      (9) In Eq. 1, the exact expression, which includes i=j, isn’t a lot harder than the one with i=j excluded. So why i≠j?

      The choice is for illustration purposes. In Eq. 1, we wanted to demonstrate that the dimension saturates to a value independent of N. When dividing the numerator and denominator of this expression by N<sup>2</sup>, the term is independent of the neuron number N, but the term associated with the diagonal entries is of order O(1_/N_) and can be ignored for large N.

      (10) Fig. 2D: Could you explain where the theory line comes from?

      We first estimate ] from all neurons, and then compute D<sub>PR</sub> for different neuron numbers N using Eq.5 (). This is further clarified in lines 511-512.

      (11) l 94-5: ”It [scale invariance] is also absent when replacing the neural covariance matrix eigenvectors with random ones, keeping the eigenvalues identical (Fig. 2H).” If eigenvalues are identical, why does the spectrum change?

      The eigenspectra of the covariance matrices in full size are the same by construction, but the eigenspectra of the sampled covariance matrices are different because the eigenvectors affect the sampling results. Please also refer to the construction process described in section 4.3 where this is also discussed: “The composite covariance matrix with substituted eigenvectors in (Fig. 2H) was created as described in the following steps. First, we generated a random orthogonal matrix U<sub>r<.sup> (based on the Haar measure) for the new eigenvectors. This was achieved by QR decomposition A=U<sub>r</sub>R of a random matrix A with i.i.d. entries A<sub>ij</sub> ∼ N(0_,1/N_). The composite covariance matrix C<sub>r</sub> was then defined as, where Λ is a diagonal matrix that contains the eigenvalues of C. Note that since all the eigenvalues are real and U<sub>r</sub> is orthogonal, the resulting C<sub>r</sub> is a real and symmetric matrix. By construction, C<sub>r</sub> and C have the same eigenvalues, but their sampled eigenspectra can differ.”

      (12) Eq 3: There’s no dependence on the distribution of sigma. Is that correct?

      Indeed, this is true in the high-density regime when the neuron density ρ is large. The p(λ) depends only on E(σ<sup>2</sup>) rather than the distribution of σ (see Eq. 8). However, in the intermediate density regime, p(λ) depends on the distribution of σ (see Eq.9 and Eq.10). In our analysis, we consider E(σ<sup>4</sup>) as a measure of heterogeneity.

      (13) Please tell us the best fit values of µ/d.

      This information now is added in the figure caption of Fig S10: µ/d \= [0_.456,0.258,0.205,0.262,0.302,0._308] in fish 1-6.

      (14) l 133: ”The eigenspectrum is rho-independent whenever µ/d ≈ 0.”

      It looks to me like rho sets the scale but not the shape. Correct? If so, why do we care about the overall scale – isn’t it the shape that’s important?

      Yes, our study focuses on the overall scale not only the shape, because many models, such as the ERM with other kernel functions, random RNNs, Morrell’s latent model [4, 1], can exhibit a power-law spectrum. However, these models do not exhibit scale-invariance in terms of spectrum curve collapsing. Therefore, considering the overall scale reveal additional non-trivial phenomenon.

      (15) Figs. 3 and 4: Are the grey dots the same as in previous figures? Either way, please specify what they are in the figure caption.

      Yes, they are the same, and thank you for pointing it out. It has been specified in the figure caption now.

      (16) Fig. 4B: Top is correlation matrix, bottom is covariance matrix, correct? If so, that should be explicit. If not, it should be clear what the plots are.

      That is correct. Both matrices (correlation - top, covariance - bottom) are labeled in the figure caption and plot (text in the lower left corner).

      (17) l 158: ”First, the shape of the kernel function f(x) over a small distance ...”. What does ”over a small distance” mean?

      We thank you for seeking clarification on this point. We understand that the phrase ”over a small distance” could be made clearer. We made a revised explanation in lines 164-165 Here, “over a small distance” refers to modifications of the particular kernel function f(x) we use Eq. 11 near x \= 0 in the functional space, while preserving the overall power-law decay at larger distances. The t-distribution based f(x) (Eq. 11) has a natural parameter ϵ that describes the transition to near 0. So we modified f(x) in different ways, all within this interval of |x| ≤ ϵ, and considered different values of ϵ. Table S3 and Figure S7 provide a summary of these modifications. Figure S7 visually compares these modifications to the standard power-law kernel function, highlighting the differences in shape near x \= 0.

      Our findings indicate that these alterations to the kernel function at small distances do not significantly affect the distribution of large eigenvalues in the covariance spectrum. This supports our conclusion that the large eigenvalues are primarily determined by the slow decay of the kernel function at larger distances in the functional space, as this characteristic governs the overall correlations in neural activity.

      (18) l390 . This x<sub>i</sub> is, we believe, different from the x<sub>i</sub> which is position in feature space. Given the difficulty of this paper, it doesn’t help to use the same symbol to mean two different things. But maybe we’re wrong?

      Thank you for your careful reading and suggestion. Indeed here x<sub>i</sub> was representing activity rather than feature space position. We have thus revised the notation (Line 390 has been updated to line 439 as well.):

      In this revised notation: a<sub>i</sub>(t) represents the neural activity of neuron i at time t (typically the firing rate we infer from calcium imaging). is simply the mean activity of neuron i across time. Meanwhile, we’ll keep x<sub>i</sub> exclusively for denoting positions in the functional space.

      This change should make it much easier to distinguish between neural activity measurements and spatial coordinates in the functional space.

      (19) Eq. 19: is it correct that g(u) is not normalized to 1? If so, does that matter?

      It is correct that the approximation of g(u) is not normalized to 1, as Eq. 19 provides an approximation suitable only for small pairwise distances (i.e., large correlation). Therefore, we believe this does not pose an issue. We have newly added this note in lines 691-693.

      (20) I get a different answer in Eq. 20:

      Whereas in Eq. 20,

      µ

      Which is correct?

      Thank you for your careful derivation. We believe the difference arises in the calculation of g(u).In our calculations:

      ,

      (Your first equation seems to missed an 1_/µ_ in R’s exponent.)

      ,

      That is, Eq. 20 is correct. From these, we obtain

      rather than

      We hope this clarifies the question.

      (21) I’m not sure we fully understand the CCA analysis. First, our guess as to what you did: After sampling (either Asap or Fsap), you used ERM to embed the neurons in a 2-D space, and then applied canonical correlation analysis (CCA). Is that correct? If so, it would be nice if that were more clear.

      We first used ERM to embed all the neurons in a 2-D functional space, before any sampling. Once we have the embedding, we can quantify how similar the functional coordinates are with the anatomical coordinates using R<sub>CCA</sub> (section 2.4). We can then use the anatomical and functional coordinates to perform ASap and FSap, respectively. Our theory in section 2.4 predicts the effect on dimension under these samplings given the value of R<sub>CCA</sub> estimated earlier (Fig. 5D). The detailed description of the CCA analysis is in section 4.9, where we explain how CCA is used to find the axes in both anatomical and functional spaces that maximize the correlation between projections of neuron coordinates.

      As to how you sampled under Fsap, I could not figure that out – even after reading supplementary information. A clearer explanation would be very helpful.

      Thank you for your feedback. Functional sampling (FSap) entails the expansion of regions of interest (ROIs) within the functional space, as illustrated in Figure 5A, concurrently with the calculation of the covariance matrix for all neurons contained within the ROI. Technically, we implemented the sampling using the RG approach [6], which is further elaborated in Section 4.12 (lines 852-899), quoted below.

      Stage (i): Iterative Clustering We begin with N</sub>0</sub> neurons, where N</sub>0</sub> is assumed to be a power of 2. In the first iteration, we compute Pearson’s correlation coefficients for all neuron pairs. We then search greedily for the most correlated pairs and group the half pairs with the highest correlation into the first cluster; the remaining neurons form the second cluster. For each pair (a,b), we define a coarse-grained variable according to:

      ,

      Where normalizes the average to ensure unit nonzero activity. This process reduces the number of neurons to N<sub>1</sub> = N<sub>0</sub>/2. In subsequent iterations, we continue grouping the most correlated pairs of the coarse-grained neurons, iteratively reducing the number of neurons by half at each step. This process continues until the desired level of coarse-graining is achieved.

      When applying the RG approach to ERM, instead of combining neural activity, we merge correlation matrices to traverse different scales. During the _k_th iteration, we compute the coarse-grained covariance as:

      and the variance as:

      Following these calculations, we normalize the coarse-grained covariance matrix to ensure that all variances are equal to one. Note that these coarse-grained covariances are only used in stage (i) and not used to calculate the spectrum.

      Stage (ii): Eigenspectrum Calculation The calculation of eigenspectra at different scales proceeds through three sequential steps. First, for each cluster identified in Stage (i), we compute the covariance matrix using the original firing rates of neurons within that cluster (not the coarse-grained activities). Second, we calculate the eigenspectrum for each cluster. Finally, we average these eigenspectra across all clusters at a given iteration level to obtain the representative eigenspectrum for that scale.

      In stage (ii), we calculate the eigenspectra of the sub-covariance matrices across different cluster sizes as described in [6]. Let N<sub>0</sub> = 2<sup>n</sub> be the original number of neurons. To reduce it to size N \= N<sub>0</sub>/2<sup>k</sup> = 2<sup>n-k</sup>, where k is the kth reduction step, consider the coarse-grained neurons in step nk in stage (i). Each coarse-grained neuron is a cluster of 2<sup>n-k</sup> neurons. We then calculate spectrum of the block of the original covariance matrix corresponding to neurons of each cluster (there are 2<sup>k</sup> such blocks). Lastly, an average of these 2<sup>k</sup> spectra is computed.

      For example, when reducing from N<sub>0</sub> = 2<sup>3</sup> = 8 to N \= 2<sup>3−1</sup> = 4 neurons (k \= 1), we would have two clusters of 4 neurons each. We calculate the eigenspectrum for each 4x4 block of the original covariance matrix, then average these two spectra together. To better understand this process through a concrete example, consider a hypothetical scenario where a set of eight neurons, labeled 1,2,3,...,7,8, are subjected to a two-step clustering procedure. In the first step, neurons are grouped based on their maximum correlation pairs, for example, resulting in the formation of four pairs: {1,2},{3,4},{5,6}, and {7,8} (see Fig. S22). Subsequently, the neurons are further grouped into two clusters based on the results of the RG step mentioned above. Specifically, if the correlation between the coarse-grained variables of the pair {1,2} and the pair {3,4} is found to be the largest among all other pairs of coarse-grained variables, the first group consists of neurons {1,2,3,4}, while the second group contains neurons {5,6,7,8}. Next, take the size of the cluster N = 4 for example. The eigenspectra of the covariance matrices of the four neurons within each cluster are computed. This results in two eigenspectra, one for each cluster. The correlation matrices used to compute the eigenspectra of different sizes do not involve coarse-grained neurons. It is the real neurons 1,2,3,...,7,8, but with expanding cluster sizes. Finally, the average of the eigenspectra of the two clusters is calculated.

      (22) Line 37: ”even if two cell assemblies have the same D<sub>PR</sub>, they can have different shapes.” What is meant by shape here isn’t clear.

      Thank you for pointing out this potential ambiguity. The “shape” here refers to the geometric configuration of the neural activity space characterized as a highdimensional ellipsoid by the covariance. Specifically, if we denote the eigenvalues of the covariance matrix as λ<sub>1</sub>,λ<sub>2</sub>,...,λ<sub>N</sub>, then corresponds to the length of the i-th semi-axis of this ellipsoid (Figure 1B). As shown in Figure 1C, two neural populations with the same dimensionality (D<sub>PR</sub> = 25/11 ≈ 2.27) exhibit different eigenvalue spectra, leading to differently shaped ellipsoids. This clarification is now included in lines 39-40.

      (23) Please discuss if any information about the latent dimension or kernel function can be inferred from the measurements.

      Same as comment(6): we would like to clarify that in our analysis using the Euclidean Random Matrix (ERM) model, we fit the ratio µ/d, rather than the individual values of d (dimension of the functional space) or µ (exponent of the distancedependent kernel function). This limitation is inherent because the model’s predictions for observable quantities, such as the eigenvalue spectrum of the covariance matrix, are dependent solely on this ratio.

      For the kernel function, once the d is chosen, we can infer the general shape of the kernel function from data (Figs S12 and S13), up to a certain extent (see also lines 164-166). In particular, we can compare the eigenspectrum of the simulation results for different kernel functions with the eigenspectrum of our data. This allows us to qualitatively exclude certain kernel functions, such as the exponential and Gaussian kernels (Fig. S4), which show clear differences from our data.

      References

      (1) M. C. Morrell, I. Nemenman, A. Sederberg, Neural criticality from effective latent variables. eLife 12, RP89337 (2024).

      (2) J. Manley, S. Lu, K. Barber, J. Demas, H. Kim, D. Meyer, F. M. Traub, A. Vaziri, Simultaneous, cortex-wide dynamics of up to 1 million neurons reveal unbounded scaling of dimensionality with neuron number. Neuron (2024).

      (3) S. A. Moosavi, S. S. R. Hindupur, H. Shimazaki, Population coding under the scale-invariance of high-dimensional noise (2024).

      (4) M. C. Morrell, A. J. Sederberg, I. Nemenman, Latent dynamical variables produce signatures of spatiotemporal criticality in large biological systems. Physical Review Letters 126, 118302 (2021).

      (5) A. Renart, J. De La Rocha, P. Bartho, L. Hollender, N. Parga, A. Reyes, K. D. Harris, The asynchronous state in cortical circuits. science 327, 587–590 (2010).

      (6) L. Meshulam, J. L. Gauthier, C. D. Brody, D. W. Tank, W. Bialek, Coarse graining, fixed points, and scaling in a large population of neurons. Physical Review Letters 123, 178103 (2019).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      This study explores the sequence characteristics and features of high-occupancy target (HOT) loci across the human genome. The computational analyses presented in this paper provide information into the correlation of TF binding and regulatory networks at HOT loci that were regarded as lacking sequence specificity.

      By leveraging hundreds of ChIP-seq datasets from the ENCODE Project to delineate HOT loci in HepG2, K562, and H1-hESC cells, the investigators identified the regulatory significance and participation in 3D chromatin interactions of HOT loci. Subsequent exploration focused on the interaction of DNA-associated proteins (DAPs) with HOT loci using computational models. The models established that the potential formation of HOT loci is likely embedded in their DNA sequences and is significantly influenced by GC contents. Further inquiry exposed contrasting roles of HOT loci in housekeeping and tissue-specific functions spanning various cell types, with distinctions between embryonic and differentiated states, including instances of polymorphic variability. The authors conclude with a speculative model that HOT loci serve as anchors where phase-separated transcriptional condensates form. The findings presented here open avenues for future research, encouraging more exploration of the functional implications of HOT loci.

      Strengths:

      The concept of using computational models to define characteristics of HOT loci is refreshing and allows researchers to take a different approach to identifying potential targets. The major strengths of the study lies in the very large number of datasets analyzed, with hundreds of ChIP-seq data sets for both HepG2 and K562 cells as part of the ENCODE project. Such quantitative power allowed the authors to delve deeply into HOT loci, which were previously thought to be artifacts.

      Weaknesses:

      While this study contributes to our knowledge of HOT loci, there are critical weaknesses that need to be addressed. There are questions on the validity of the assumptions made for certain analyses. The speculative nature of the proposed model involving transcriptional condensates needs either further validation or be toned down. Furthermore, some apparent contradictions exist among the main conclusions, and these either need to be better explained or corrected. Lastly, several figure panels could be better explained or described in the figure legends.

      We thank the reviewer for their valuable comments.

      - We have extended the study and included a new chapter focusing on the condensate hypothesis, added more supporting evidence (including the ones suggested by the reviewer), and made explicit statements on the speculative nature of this model.

      - We have restructured the text to remove the sentences which might be construed as contradictory.

      Reviewer #2 (Public Review):

      Summary:

      The paper 'Sequence characteristic and an accurate model of abundant hyperactive loci in human genome' by Hydaiberdiev and Ovcharenko offers comprehensive analyses and insights about the 'high-occupancy target' (HOT) loci in the human genome. These are considered genomic regions that overlap with transcription factor binding sites. The authors provided very comprehensive analyses of the TF composition characteristics of these HOT loci. They showed that these HOT loci tend to overlap with annotated promoters and enhancers, GC-rich regions, open chromatin signals, and highly conserved regions, and that these loci are also enriched with potentially causal variants with different traits.

      Strengths:

      Overall, the HOT loci' definition is clear and the data of HOT regions across the genome can be a useful dataset for studies that use HepG2 or K562 as a model. I appreciate the authors' efforts in presenting many analyses and plots backing up each statement.

      Weaknesses:

      It is noteworthy that the HOT concept and their signature characteristics as being highly functional regions of the genome are not presented for the first time here. Additionally, I find the main manuscript, though very comprehensive, long-winded and can be put in a shorter, more digestible format without sacrificing scientific content.

      The introduction's mention of the blacklisted region can be rather misleading because when I read it, I was anticipating that we are uncovering new regulatory regions within the blacklisted region. However, the paper does not seem to address the question of whether the HOT regions overlap, if any, with the ENCODE blacklisted regions afterward. This plays into the central assessment that this manuscript is long-winded.

      The introduction also mentioned that HOT regions correspond to 'genomic regions that seemingly get bound by a large number of TFs with no apparent DNA sequence specificity' (this point of 'no sequence specificity' is reiterated in the discussion lines 485-486). However, later on in the paper, the authors also presented models such as convolutional neural networks that take in one-hot-encoded DNA sequence to predict HOT performed really well. It means that the sequence contexts with potential motifs can still play a role in forming the HOT loci. At the same time, lines 59-60 also cited studies that "detected putative drive motifs at the core segments of the HOT loci". The authors should edit the manuscript to clarify (or eradicate) contradictory statements.

      We thank the reviewer for their valuable comments. Below are our responses to each paragraph in the given order:

      We added a statement in the commenting and summarizing other publications that studied the functional aspects of HOT loci with the following sentence in the introduction part:

      “Other studies have concluded that these regions are highly functionally consequential regions enriched in epigenetic signals of active regulatory elements such as histone modification regions and high chromatin accessibility”.

      We significantly shortened the manuscript by a) moving the detailed analyses of the computational model to the supplemental materials, and b) shortening the discussions by around half, focusing on core analyses that would be most beneficial to the field.

      Given that the ENCODE blacklisted regions are the regions that are recommended by the ENCODE guidelines to be avoided in mapping the ChIP-seq (and other NGS), we excluded them from our analyzed regions before mapping to the genome. Instead, we relied on the conclusions of other publications on HOT loci that the initial assessments of a fraction of HOT loci were the result of factoring in these loci which later were included in blacklisted regions.

      We addressed the potential confusion by using the expression of “no sequence specificity” by a) changing the sentence in the introduction by adding a clarification as “... with no apparent DNA sequence specificity in terms of detectible binding motifs of corresponding motifs” and b) removing that part from the sentence in the discussions.

      Reviewer #3 (Public Review):

      Summary:

      Hudaiberdiev and Ovcharenko investigate regions within the genome where a high abundance of DNA-associated proteins are located and identify DNA sequence features enriched in these regions, their conservation in evolution, and variation in disease. Using ChIP-seq binding profiles of over 1,000 proteins in three human cell lines (HepG2, K562, and H1) as a data source they're able to identify nearly 44,000 high-occupancy target loci (HOT) that form at promoter and enhancer regions, thus suggesting these HOT loci regulate housekeeping and cell identity genes. Their primary investigative tool is HepG2 cells, but they employ K562 and H1 cells as tools to validate these assertions in other human cell types. Their analyses use RNA pol II signal, super-enhancer, regular-enhancer, and epigenetic marks to support the identification of these regions. The work is notable, in that it identifies a set of proteins that are invariantly associated with high-occupancy enhancers and promoters and argues for the integration of these molecules at different genomic loci. These observations are leveraged by the authors to argue HOT loci as potential sites of transcriptional condensates, a claim that they are well poised to provide information in support of. This work would benefit from refinement and some additional work to support the claims.

      Comments:

      (1) Condensates are thought to be scaffolded by one or more proteins or RNA molecules that are associated together to induce phase separation. The authors can readily provide from their analysis a check of whether HOT loci exist within different condensate compartments (or a marker for them). Generally, ChIPSeq signal from MED1 and Ronin (THAP11) would be anticipated to correspond with transcriptional condensates of different flavors, other coactivator proteins (e.g., BRD4), would be useful to include as well. Similarly, condensate scaffolding proteins of facultative and constitutive heterochromatin (HP1a and EZH2/1) would augment the authors' model by providing further evidence that HOT Loci occur at transcriptional condensates and not heterochromatin condensates. Sites of splicing might be informative as well, splicing condensates (or nuclear speckles) are scaffolded by SRRM/SON, which is probably not in their data set, but members of the serine arginine-rich splicing factor family of proteins can serve as a proxy-SRSF2 is the best studied of this set. This would provide a significant improvement to their proposed model and be expected since the authors note that these proteins occur at the enhancers and promoter regions of highly expressed genes.

      (2) It is curious that MAX is found to be highly enriched without its binding partner Myc, is Myc's signal simply lower in abundance, or is it absent from HOT loci? How could it be possible that a pair of proteins, which bind DNA as a heterodimer are found in HOT loci without invoking a condensate model to interpret the results?

      (3) Numerous studies have linked the physical properties of transcription factor proteins to their role in the genome. The authors here provide a limited analysis of the proteins found at different HOT-loci by employing go terms. Is there evidence for specific types of structural motifs, disordered motifs, or related properties of these proteins present in specific loci?

      (4) Condensates themselves possess different emergent properties, but it is a product of the proteins and RNAs that concentrate in them and not a result of any one specific function (condensates can have multiple functions!)

      (5) Transcriptional condensates serve as functional bodies. The notion the authors present in their discussion is not held by practitioners of condensate science, in that condensates exist to perform biochemical functions and are dissolved in response to satisfying that need, not that they serve simply as reservoirs of active molecules. For example, transcriptional condensates form at enhancers or promoters that concentrate factors involved in the activation and expression of that gene and are subsequently dissolved in response to a regulatory signal (in transcription this can be the nascently synthesized RNA itself or other factors). The association reactions driving the formation of active biochemical machinery within condensates are materially changed, as are the kinetics of assembly. It is unnecessary and inaccurate to qualify transcriptional condensates as depots for transcriptional machinery.

      6) This work has the potential to advance the field forward by providing a detailed perspective on what proteins are located in what regions of the genome. Publication of this information alongside the manuscript would advance the field materially.

      We thank the reviewer for constructive comments and suggestions. Below are our point-by-point responses:

      (1) We added a new short section “Transcriptional condensates as a model for explaining the HOT regions” with additional support for the condensate hypothesis, wherein some of the points raised here were addressed. Specifically, we used a curated LLPS proteins (CD-CODE) database and provided statistics of those annotation condensate-related DAPs.

      Regarding the DAPs mentioned in this question, we observed that the distributions corresponding ChIP-seq peaks confirm the patterns expected by the reviewer (Author response image 1). Namely:

      - MED1 and Ronin (THAP11) are abundant in the HOT loci, being present 67% and 64% of HOT loci respectively.

      - While the BRD4 is present in 28% of the HOT loci, we observed that the DAPs with annotated LLPS activity ranged from 3% to 73%, providing further support for the condensate hypothesis.

      - ENCODE database does not contain ChIP-seq dataset for HP1A. EZH2 peaks were absent in the HOT loci (0.4% overlap), suggesting the lack of heterochromatin condensate involvement.

      - Serine-rich splicing factor family proteins were present only in 7.7% of the HOT loci, suggesting the absence or limited overlap with splicing condensates or nuclear speckles.

      Author response image 1.

      (2) In this study we selected the TF ChIP-seq datasets with stringent quality metrics, excluding those which had attached audit warning and errors. As a result, the set of DAPs analyzed in HepG2 did not include MYC, since the corresponding ChIP-seq dataset had the audit warning tags of "borderline replicate concordance, insufficient read length, insufficient read depth, extremely low read depth". Analyses in K562 and H1 did include MYC (alongside MAX) ChIP-seq dataset.

      To address this question, we added the mentioned ChIP-seq dataset (ENCODE ID: ENCFF800JFG) and analyzed the colocalization patterns of MYC and MAX. We observed that the MYC ChIP-seq peaks in HepG2 display spurious results, overlapping with only 5% of HOT loci. Meanwhile in K562 and H1, MYC and MAX are jointly present in 54% and 44% of the HOT loci, respectively (Author response image 2).

      Author response image 2.

      These observations were also supported by Jaccard indices between the MYC and MAX ChIP-seq peaks. To do this analysis, we calculated the pairwise Jaccard indices between MYC and MAX and divided them by the average Jaccard indices of 2000 randomly selected DAP pairs. In K562 and H1, the Jaccard indices between MYC and MAX are 5.72x and 2.53x greater than the random background, respectively. For HepG2, the ratio was 0.21x, clearly indicating that HepG2 MYC ChIP-seq dataset is likely erroneous.

      Author response image 3.

      (3) Despite numerous publications focusing on different structural domains in transcription factors, we could not find an extensive database or a survey study focusing on annotations of structural motifs in human TFs. Therefore, surveying such a scale would be outside of this study’s scope. We added only the analysis of intrinsically disordered regions, as it pertains to the condensate hypothesis. To emphasize this shortcoming, we added the following sentence to the end of the discussions section.

      “Further, one of the hallmarks of LLPS proteins that have been associated with their abilities to phase-separate is the overrepresentation of certain structural motifs, which we did not pursue due to size limitations.”

      (4, 5) We agree with these statements and thank the reviewer for pointing out this faulty statement. We modified the sections in the discussions related to the condensates and removed the part where we implied that the condensate model could be because of mostly a single function of TF reservoir.

      (6) We added a table to the supplemental materials (Zenodo repository) with detailed annotation of HOT and non-HOT DAP-bound loci in the genome.

      Recommendations for the authors:

      Reviewing Editor (Recommendations For The Authors):

      The clause with "inadequate" would be dropped if the authors sufficiently address reviewer concerns about clarity of writing, including:

      (1) Editing the title to better reflect the findings of the paper.

      (2) Making clear that the condensate model is speculative and not explicitly tested in this study (and may be better described as a hypothesis).

      (3) Resolving apparent contradictions regarding DNA sequence specificity and the interpretation of ChIP-seq signal intensity.

      (4) Better specifying and justifying model parameters, thresholds, and assumptions.

      (5) Shortening the manuscript to emphasize the main, well-supported claims and to enhance readability (especially the discussion section).

      We thank the Editor for their work. We followed their advice and implemented changes and additions to address all 5 points.

      Reviewer #1 (Recommendations For The Authors):

      (1) The title "Sequence characteristics and an accurate model of abundant hyperactive loci in the human genome" does not accurately reflect the findings of the paper. We are unclear as to what the 'accurate model' refers to. Is it the proposed model 'based on the existence of large transcriptional condensates' (abstract)? If so, there are concerns below regarding this statement (see comment 2). If the authors are referring to the computational modeling presented in Figure 5, it is unclear that any one of them performed that much better than the others and the best single model was not identified. Furthermore, the models being developed in the study constitute only a portion of the paper and lacked validation through additional datasets. Additionally, sequence characteristics were not a primary focus of the study. Only figure 5 talks about the model and sequence characteristics, the rest of the figures are left out of the equation.

      We agree with and thank the reviewer for this idea of clarifying the intended meaning.

      (1) We changed the title and clarified that the computational model is meant:

      “Functional characteristics and a computational model of abundant hyperactive loci in the human genome”.

      (2) Shortened the part of the manuscript discussing the computational models and pointed out the CNNs as “the best single model”.

      (2) The abstract and discussion (and perhaps the title) propose a model of transcriptional condensates in relation to HOT loci. However, there is no data provided in the manuscript that relates to condensates. Therefore, anything relating to condensates is primarily speculative. This distinction needs to be properly made, especially in the abstract (and cannot be included in the title). Otherwise, these statements are misleading. Although the field of transcriptional condensates is relatively new, there have been several factors studied. The authors could include in Figure 2d which factors have been shown to form transcriptional condensates. This might provide some support for the model, though it would still largely remain speculative unless further testing is done.

      We added a new short chapter “Transcriptional condensates as a model for explaining the HOT regions”,  with additional analyses testing the condensates hypothesis. We provided supportive evidence by analyzing the metrics used as hallmarks of condensates including the distributions of annotated condensate-related proteins, nascent transcription, and protein-RNA interaction levels in HOT loci. Still, we acknowledge that this is a speculative hypothesis and we clarified that with the following statement in the discussions:

      “It is important to note here that our proposed condensate model is a speculative hypothesis. Further experimental studies in the field are needed to confirm or reject it.”

      (3) Several apparent contradictions exist throughout the manuscript. For example, "HOT locus formation are likely encoded in their DNA sequences" (lines 329-330) vs the proposed model of formation through condensates (abstract). These two statements do not seem compatible, or at the very least, the authors can explain how they are consistent with each other. Another example: "ChIP-seq signal intensity as a proxy for... binding affinity" (line 229) vs. "ChIP-seq signal intensities do not seem to be a function of the DNA-binding properties of the DAPs" (lines 259-260). The first statement is the assumption for subsequent analyses, which has its own concerns (see comment 4). But the conclusion from that analysis seems to contradict the assumption, at least as it is stated.

      In this study, we argue that the two statements may not necessarily contradict each other. We aimed to a) demonstrate that the observed intensity of DAP-DNA interactions as measured by ChIP-seq experiments at HOT loci cannot be explained with direct DNA-binding events of the DAPs alone and b) propose a hypothesis that this observation can be at least partially explained if the HOT loci have the propensity to either facilitate or take part in the formation of transcriptional condensates.

      One of the conditions for condensates to form at enhancers was shown to be the presence of strong binding sites of key TFs (Shrinivas et al. 2019 “Enhancer features that drive the formation of transcriptional condensates”), where the study was conducted using only one TF (OCT4) and one coactivator (MED1). To the best of our knowledge, no such study has been conducted involving many TFs and cofactors simultaneously. We also know that the factors that lead to liquid-to-liquid phase separation include weak multivalent IDR-IDR, IDR-DNA, and IDR-RNA interactions. As a result, the observed total sum of ChIP-seq peaks in HOT loci is the direct DNA-binding events combined with the indirect DAP-DNA interactions, some of which may be facilitated by condensates. And, the fact that CNNs can recognize the HOT loci with high accuracy suggests that there must be an underlying motif grammar specific to HOT loci.

      We emphasized this conclusion in the discussions.

      The comment on using the ChIP-seq signal as a proxy for DNA-binding affinity is addressed under comment 4.

      (4) In lines 229-230, the authors used "the ChIP-seq signal intensity as a proxy for the DAP binding affinity." What is the basis for this assumption? If there is a study that can be referenced, it should be added. However, ChIP-seq signal intensity is generally regarded as a combination of abundance, frequency, or percentage of cells with binding. RNA Pol2 is a good example of this as it has no specific binding affinity but the peak heights indicate level of expression. Therefore, the analyses and conclusions in Figure 4, particularly panel A, are problematic. In addition, clarification from lines 258-260 is needed as it contradicts the earlier premise of the section (see comment 3).

      We thank the reviewer for pointing out this error. The main conclusion of the paragraph is that the average ChIP-seq signal values at HOT loci do not correlate well with the sequence-specificity of TFs. We reworded the paragraph stating that we are analyzing the patterns of ChIP-seq signals across the HOT loci, removing the part that we use them as a proxy for sequence-specific binding affinity.

      (5) In Figure 1A, the authors show that "the distribution of the number of loci is not multimodal, but rather follows a uniform spectrum, and thus, this definition of HOT loci is ad-hoc" (lines 92-95). The threshold to determine how a locus is considered to be HOT is unclear. How did the authors decide to use the current threshold given the uniform spectrum observed? How does this method of calling HOT loci compare to previous studies? How much overlap is there in the HOT loci in this study versus previous ones?

      We moved the corresponding explanation from the supplemental methods to the main methods section of the manuscript.

      Briefly, our reasoning was as follows: assuming that an average TFBS is 8bp long and given that we analyze the loci of length 400bp, we can set the theoretical maximum number of simultaneous binding events to be 50. Hence, if there are >50 TF ChIP-seq peaks in a given 400bp locus, it is highly unlikely that the majority of ChIP-seq peaks can be explained by direct TF-DNA interactions. The condition of >50 TFs corresponded to the last four bins of our binning scale, which was used as an operational definition for HOT loci.

      We have compared our definition of HOT loci to those reported in previous studies by Remaker et al. and Boyle et al. The results of our analyses are in lines 147-154.

      (6) In Figure 3B, the authors state that of "the loop anchor regions with >3 overlapping loops, 51% contained at least one HOT locus, suggesting an interplay between chromatin loops and HOT loci." However, it is unclear how "51%" is calculated from the figure. Similarly, in the following sentence, "94% of HOT loci are located in regions with at least one chromatin interaction". It is unclear as to how the number was obtained based on the referenced figure.

      Initially, the x-axis on the Figure 3B was missing, making it hard to understand what we meant. We added the x-axis numbers and changed the “51%” to “more than half”. We intend to say that, of the loci with 4 and 5 overlapping loops, exactly 50% contain at least one HOT locus. However, since for x=6 the percentage is 100% (since there’s only one such locus), the percentage is technically “more than half”.

      The percentage of HOT loci engaging in chromatin interaction regions (91%) was calculated by simply overlapping the HOT regions with Hi-C long-range contact anchors. The details of extracting these regions using FitHiChip are described in Supplemental Methods 1.3.

      (7) While we have a limited basis to evaluate computational models, we would like to see a clearer explanation of the model set-up in terms of the number of trained vs. test datasets. In addition, it would be interesting to see if the models can be applied to data from different cell lines.

      We added the table with the sizes of the datasets used for classification in Supplemental Methods 1.6.1.

      Evaluating the models trained on the HOT loci of HepG2 and K562 on other cell lines would pose challenges since the number of available ENCODE TF ChIP-seq datasets is significantly less compared to the mentioned cell lines. Therefore, we conducted the proposed analysis between the studied cell lines. Specifically, we used the CNN models trained on HOT and regular enhancers of HepG2 and K562. Then, we evaluated each model on the test sets of each classification experiment (Author response image 4). We observed that the classification results of the HOT loci demonstrated a higher level of tissue-specificity compared to the same classification results of the regular enhancers.

      Author response image 4.

      (8) Lines 349-351. The significance of highly expressed genes being more prone to having multiple HOT loci, and vice versa, appears conventional and remains unclear. Intuitively, it makes sense for higher expressed genes to have more of the transcriptional machinery bound, and would bias the analysis. One way to circumvent this is to only analyze sequence-specific TFs and remove ones that are directly related to transcription machinery.

      We thank the reviewer for this suggestion. Our attempt to re-annotate the HOT loci with only sequence-specific TFs led to a significantly different set of loci, which would not be strictly comparable to the HOT loci defined by this study. Analyzing these new sets of loci would create a noticeable departure from the flow of the manuscript and further extend the already long scope of the study.

      Moreover, numerous studies have shown that super-enhancers recruit large numbers of TFs via transcriptional condensates (Boija et al., 2018; Cho et al., 2018; Sabari et al., 2018). We hope that our results can serve as data-driven supportive evidence for those studies.

      (9) Lines 393-396. We would like to see a reference to the models shown in the figures, if these models have been published previously.

      We could not understand the question. The lines 393-396 contains the following sentence:

      “However, many of the features of the loci that we’ve analyzed so far demonstrated similar patterns (GC contents, target gene expressions, ChIP-seq signal values etc.) when compared to the DAP-bound loci in HepG2 and K562, suggesting that albeit limited, the distribution of the DAPs in H1 likely reflects the true distribution of HOT loci.”

      In case the question was about the models that we trained to classify the HOT loci, we included the models and codebase to Zenodo and GitHub repository.

      (10) Values in Figure 7D are not reflected in the text. Specifically, the text states "Average ... phastCons of the developmental HOT loci are 1.3x higher than K562 and HepG2 HOT loci (Figure 7D)" (lines 408-409). Figure 7D shows conservation scores between HOT enhancers vs promoters for each cell line, and does not seem to reflect the text.

      We modified the figure to reflect the statement appropriately.

      (11) Methodology should include a justification for the use of the Mann-Whitney U-test (non-parametric) over other statistical tests.

      We added the following description to the methods section:

      “For calculating the statistical significance, we used the non-parametric Mann-Whitney U-test when the compared data points are non-linearly correlated and multi-modal. When the data distributions are bell-curve shaped, the Student’s t-test was used.“

      Minor:

      (1) Figure 2b was never mentioned in the paper. This can be added alongside Figure S6C, line 148.

      Indeed, Figure 2B was supposed to be listed together with Figure S6C, which was omitted by mistake. It was corrected.

      (2) Supplementary Figure 8 has two Cs. Needs to be corrected to D.

      Fixed.

      (3) Figure 3B is missing labels on the x-axis.

      Fixed.

      (4) The horizontal bar graph on the bottom left of Figure 1E needs to be described in the figure legend.

      Description added to the figure caption.

      (5) Line 345, Fig 15A should be Fig S15A.

      Corrected.

      Reviewer #2 (Recommendations For The Authors):

      I listed all my concerns about the paper in the public comments. I think the manuscript is very comprehensive and it is valuable, but it should be cut short and presented in a more digestible way.

      We thank the reviewer for their valuable comments and suggestions. We addressed all the concerns listed in the public comments. We shortened the manuscript by reducing the paragraph that focuses on computational classification models and reduced the discussions by about half in length.

      Line 55: What are chromatin-associated proteins, i.e. are they histone modifications?

      To clarify the definition used from the citation we changed the sentence to the following:

      “For instance, Partridge et al. studied the HOT loci in the context of 208 proteins including TFs, cofactors, and chromatin regulators which they called chromatin-associated proteins.”

      Though most of the paper can be cut short to avoid analysis paralysis for readers, there are details that still need filling in. For example, how did the authors perform PCA analysis, i.e. what are the features of each data point in the PCA analysis? Lines 214-215: How do we calculate the number of multi-way contacts in Hi-C data?

      We added clarifying descriptions and changed the mentioned sentences to the following:

      PCA:

      “To analyze the signatures of unique DAPs in HOT loci, we performed a PCA analysis where each HOT locus is represented by a binary (presence/absence) vector of length equal to the total number of DAPs analyzed.”

      Multi-way contacts on loop anchors:

      “To investigate further, we analyzed the loop anchor regions harboring HOT loci and observed that the number of multi-way contacts on loop anchors (i.e. loci which serve as anchors to multiple loops) correlates with the number of bound DAPs (rho=0.84 p-value<10E-4; Pearson correlation). “

      - Lines 251-252: How did the referenced study categorize DAPs? It is important for any manuscript to be self-contained.

      We added the explanation and changed the sentence to the following:

      “To test this hypothesis, we classified the DAPs into those two categories using the definitions provided in the study (Lambert et al. 2018) 28, where the TFs are classified by manual curation through extensive literature review and supported by annotations such as the presence of DNA-binding domains and validated binding motifs. Based on this classification, we categorized the ChIP-seq signal values into these two groups.“

      - Lines 181-185, sentences starting with 'To test' can be moved to the methods, leaving only brief mentions of the statistic tests if needed.

      We removed the mentioned sentence and moved to the supplemental methods (1.4).

      - Lines 217-220: I find this sentence extremely redundant unless it can offer more specific insights about a particular set of DAPs or if the DAPs are closer/or a proven distal enhancer to a confirmed causal gene.

      We removed the mentioned sentence from the text.

      - Lines 243-246: How did the authors determine the set DAPs that have stabilizing effects, and how exactly are the 'stabilizing effects' observed/measured?

      We added explanations to Supplemental Methods 3.1 and Fig S18, S19.

      While addressing this comment we realized that the reported value of the ratio is 1.91x, not 1.7x. We corrected that value in the main text and added the p-value.

      - When discussing the phastCons scores analyses, such as in lines 268-271, how did the authors calculate the relationship between phastCons scores and HOT loci, i.e. was the score averaged across the 400-bp locus to obtain a locus-specific conservation score?

      Yes, per-locus conservation scores were averaged over the bps of loci. We added this clarification to the methods.

      - Line 311: What is the role of the 'control sets' in the analyses of the sequence's relationship with HOT?

      In this specific case, the control sets are used as background or negative sets to set up the classification tasks. In other words, we are asking, whether the HOT loci can be distinguished when compared to random chromatin-accessible regions, promoters, or regular enhancers. We clarified this in the text.

      - I also find the discussion about different machine learning methods that classify HOT loci based on sequence contexts quite redundant UNLESS the authors decide to go further into the features' importance (such as motifs) in the models that predict/ are associated with HOT loci, which in itself can constitute another study.

      We agree with the reviewer, and shortened the part with the discussions of models by limiting it to only 3 main models and moved the rest to the supplemental materials.

      - Can the authors clarify where they obtain data on super-enhancers?

      We obtained the super-enhancer definitions from the original study (Hnisz et al. 2013, PMID: 24119843) where the super-enhancers were defined for multiple cell lines. We clarified this in the methods.

      - Figure 1B, the x and y axis should be clarified.

      We clarified it by using MAX as an example case in the figure caption as follows:

      “Prevalence of DAPs in HOT loci. Each dot represents a DAP. X-axis: percentage of HOT loci in which DAP is present (e.g. MAX is present in 80% of HOT loci). Y-axis: percentage of total peaks of DAPs that are located in HOT loci (e.g. 45% of all the ChIP-seq peaks of MAX is located in the HOT loci). Dot color and size are proportional to the total number of ChIP-seq peaks of DAP.”

      Reviewer #3 (Recommendations For The Authors):

      The list of proteins associated with different types of genomic loci at a meta level (enhancers, promoters, and gene body etc.), and an annotation of the genome at the specific loci level.

      The authors use a wide range of acronyms throughout the text and figure legends, they do a reasonably good job, but the main text section "HOT-loci are enriched in causal variants" and Figure 8 would be materially improved if they held it to the same standard.

      Size is a physical property and not a physicochemical property.

      We thank the reviewer for their comments and suggestions. We added a table to supplemental files with detailed annotations of analyzed loci.

      We reviewed the section “HOT loci are enriched in causal variants” and corrected a few mismatches in the acronyms.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary: 

      In this paper, Kalidindi and Crevecoeur ask why sequential movements are sometimes coarticulated. To answer this question, first, they modified a standard optimal controller to perform consecutive reaches to two targets (T1 and T2). They investigated the optimal solution with and without a constraint on the endpoint's velocity in the via target (T1). They observed that the controller coarticulates the movements only when there is no constraint on the speed at the via-point. They characterized coarticulation in two ways: First, T2 affected the curvature of the first reach in unperturbed reaches. Second, T2 affected corrective movements in response to a mechanical perturbation of the first reach. 

      Parallel to the modeling work, they ran the same experiment on human participants. The participants were instructed to either consider T1 as via point (go task) or to slow down in T1 and then continue to T2 (stop task). Mirroring the simulation results, they observed coarticulation only in the go task. Interestingly, in the go task, when the initial reach was occasionally perturbed, the long-latency feedback responses differed for different T2 targets, suggesting that the information about the final target was already present in the motor circuits that mediate the long-latency response. In summary, they conclude that coarticulation in sequential tasks depends on instruction, and when coarticulation happens, the corrections in earlier segments of movement reflect the entirety of the coarticulated sequence.

      Evaluation 

      Among many strengths of this paper, most notably, the results and the experiment design are grounded in, and guided by the optimal control simulation. The methods and procedures are appropriate and standard. The results and methods are explained sufficiently and the paper is written clearly. The results on modulation of long-latency response based on future goals are interesting and of broad interest for future experiments on motor control in sequential movement. However, I find the authors' framing of these results, mostly in the introduction section, somewhat complicated.

      The current version of the introduction motivates the study by suggesting that "coarticulation and separation of sub-movement [in sequential movements] have been formulated as distinct hypotheses" and this apparent distinction, which led to contradictory results, can be resolved by Optimal Feedback Control (OFC) framework in which task-optimized control gains control coarticulation. This framing seems complicated for two main reasons. First, the authors use chunking and coarticulation interchangeably. However, as originally proposed by (Miller 1956), the chunking of the sequence items may fully occur at an abstract level like working memory, with no motoric coarticulation of sequence elements at the level of motor execution. In this scenario, sequence production will be faster due to the proactive preparation of sequence elements. This simple dissociation between chunking and coarticulation may already explain the apparent contradiction between the previous works mentioned in the introduction section. Second, the authors propose the OFC as a novel approach for studying neural correlates of sequence production. While I agree that OFC simulations can be highly insightful as a normative model for understanding the importance of sequence elements, it is unclear to me how OFCs can generate new hypotheses regarding the neural implementation of sequential movements. For instance, if the control gains are summarizing the instruction of the task and the relevance of future targets, it is unclear in which brain areas, or how these control gains are implemented. I believe the manuscript will benefit from making points more clear in the introduction and the discussion sections. 

      We agree that chunking may occur at different levels that do not necessarily involve motor coarticulation. We clarified that our contribution is towards answering why sequence movements sometimes coarticulate, and how the way sequences are executed influences the representation of future goals in the sensorimotor system.

      To address this point, we made the following modifications in the introduction:

      Line 44:

      “It remains unclear how future goals are integrated in the sensorimotor system. For rapid execution of a sequence, one possible solution is to represent multiple goals within low-level control circuits (3, 16), enabling the execution of several elements as a single entity, called “motor chunk”. Note that chunking can also occur at a higher level such as in working memory-guided sequences, which in this case may or may not involve the production of a movement (17, 18).”

      Lines 50:

      “Recent neural recordings in the primary motor cortex (M1) have shown no specific influence of future goals on the population responses governing ongoing action (19, 20). Specifically, Zimnik and Churchland (20) observed in a two-reach sequence task that, there was no coarticulation in sub-movement kinematics although the execution got faster with practice. Notably, M1 displayed separate phases of execution related activity for each sub-movement. Using a neural network model, they interpreted that sequence goals could be separated and serially specified to the controller from regions upstream of M1 (Figure 1A). These findings contrast with earlier studies showing coarticulation of sub-movements and whole sequence representations in M1 (21–23). As a result, it has been suggested that coarticulation and separation in rapid sequences may involve distinct computations: coarticulation possibly involves replacing sub-movements with a motor chunk, while separation possibly indicates independent control of each sub-movement with chunking at a higher-level (4, 20).  Thus, there are unresolved questions regarding why sequential movements sometimes coarticulate, and how the representation of future goals in the sensorimotor system influences the way sequences are executed.”

      With respect to the second part of your concern about OFC, we agree that this framework does not make direct prediction about the neural implementation and our statements required clarifications. The first link between the model and prediction about neural data follows from the observation that long-latency circuits participate in task-dependent sequence production, thus indicating that transcortical pathways must express this task dependency. The second link between our work and neural activities is by providing a counter argument to previous interpretation: indeed, Zimnik and Churchland argued that independent or “holistic” sequence production should be associated with different representations in monkey’s brain. In contrast we suggest that the same controller can flexibly generate both kinds of sequences, without implying a different structure in the controller, only a different cost-function. We thus refine the expectation about neural correlates of sequence representations by showing that it potentially relates to the encoding of task constraints.

      To address this point, we added the following changes in the introduction and discussion:

      Line 69 in Introduction: 

      “The theory of optimal feedback control (OFC) has been particularly useful in predicting the influence of numerous task parameters on the controller (27–34), thus reproducing goal-directed motor commands during both unperturbed movements and feedback responses to disturbances (30). OFC has been used in numerous studies to interpret flexible feedback responses occurring in the long-latency response period (30, 35).” 

      Line 454 in Discussion:

      “Although OFC has been predominantly used as a behavioral level framework agnostic to neural activity patterns, it can shed light on the planning, state estimation and execution related computations in the transcortical feedback pathway (Takei et al.,). Using OFC, our study proposes a novel and precise definition of the difference to expect in neural activities in order to identify coarticulated versus independent sequence representations from a computational point of view. Because each condition (i.e., overlapping versus non-overlapping controllers as in Figure 2) was associated with different cost-functions and time-varying control gains, it is the process of deriving these control gains, using the internal representation of the task structure, that may differ across coarticulated and separated sequence conditions. To our knowledge, how and where this operation is performed is unknown. A corollary of this definition is that the preparatory activity (20, 50) may not discern independently planned or coarticulated sequences because these situations imply different control policies (and cost functions), as opposed to different initial states. Moreover, the nature of the sequence representation is potentially not dissociable from its execution for the same reason.”

      Reviewer #2 (Public Review):

      Summary: 

      In this manuscript, the authors examine the question of whether discrete action sequences and coarticulated continuous sequential actions can be produced from the same controller, without having to derive separate control policies for each sequential movement. Using modeling and behavioral experiments, the authors demonstrate that this is indeed possible if the constraints of the policy are appropriately specified. These results are of interest to those interested in motor sequences, but it is unclear whether these findings can be interpreted to apply to the control of sequences more broadly (see weaknesses below). 

      Strengths: 

      The authors provide an interesting and novel extension of the stochastic optimal control model to demonstrate how different temporal constraints can lead to either individual or coarticulated movements. The authors use this model to make predictions about patterns of behavior (e.g., in response to perturbations), which they then demonstrate in human participants both by measuring movement kinematics as well as EMG. Together this work supports the authors' primary claims regarding how changes in task instructions (i.e., task constraints) can result in coarticulated or separated movement sequences and the extent to which the subsequent movement goal affects the planning and control of the previous movement. 

      Weaknesses: 

      I reviewed a prior version of this manuscript, and appreciate the authors addressing many of my previous comments. However, there are some concerns, particularly with regard to how the authors interpret their findings. 

      We thank the reviewer for their continued assessment of our work and for helping us to improve the paper. We are convinced that this and the previous review helped us clarifying our work considerably.

      (1) It would be helpful for the authors to discuss whether they think there is a fundamental distinction between a coarticulated sequence and a single movement passing through a via point (or equivalently, avoiding an obstacle). The notion of a coarticulated sequence brings with it the notion of sequential (sub)movements and temporal structure, whereas the latter can be treated as more of a constraint on the production of a single continuous movement. If I am interpreting the authors' findings correctly it seems they are suggesting that these are not truly different kinds of movements at the level of a control policy, but it would be helpful for the authors to clarify this claim. 

      Indeed, this is our interpretation of the results/simulations. This suggestion can also be observed in Ramkumar et al., article on chunking. To clarify this, we added a statement in the discussion as follows: 

      Line 449: 

      “Notably, in the framework of optimal feedback control, an intermediate goal is equivalent to a via-point that constrains the execution of the sequence (similar to (13)). It is thus possible that coarticulation in motor systems be processed similarly as other kinds of movement constraints, such as via-points, avoiding obstacles, or changes in control policies.”

      (2) The authors' model clearly shows that each subsequent target only influences the movement of one target back, but not earlier ones (page 7 lines 199-204). This stands in contrast to the paper they cite from Kashefi 2023, in which those authors clearly show that people account for at least 2 targets in the future when planning/executing the current movement. It would be useful to know whether this distinction arises because of a difference in experimental methodology, or because the model is not capturing something about human behavior.  

      Thank you for raising this point. There are some differences between the study of Kashefi and colleagues (2023), and ours. Both studies looked into planning of more than one reach. In the study of Kashefi et al., the results of Figure 6 showed that in H2 condition, there was no significant curvature, and the curvature increases in H3 and H4 conditions (only in the 75ms dwell-time scenario). Note that H2 condition in their work meant the presentation of +2 target after the initiation of +1 reach. Hence, we think the GO task in our case should be compared to the H3 condition, resulting in similar curvature as in our study. These authors also showed that curvature increased even in the H4 condition (75 ms dwell). OFC also accommodates this observation, if we consider the relationship between the cost of intermediate goals and spatial location of the targets (see figure below, also added to Supplementary Figure 4). To see this, we performed additional 3 target simulations where the constraint on intermediate goal velocity (at T1 and T2) was varied to achieve similar dwell velocity at the intermediate targets (Supplementary Figure 4C). In this case, the hand curvature of the first reach differed while the dwell velocity was similar across T3 up and T3 down conditions, as may be instructed experimentally. Again, the task instructions and the spatial location of the future goals together determine how much the first reach components are influenced by the next ones, and this may impact several reaches ahead. 

      We added the following clarification in the result to describe this. 

      Line 199:

      “It is worth noting that the OFC model can be generalized to longer sequences (10) through the incorporation of additional cost terms (in Equation 10 of Methods) and targets, enabling simultaneous planning for more than two targets. Simulations of a sample three-reach sequence (Supplementary Figure S4) revealed that, varying the cost of dwell velocity at intermediate targets (w2 and w3 parameters in Methods) caused a variation in control gains. Different amount of change in control gains can be expected for intermediate versus late targets (Supplementary Figure 4A). Notably, even when we used the same dwell velocity cost (w2 = w3 = 0), the observed velocity profiles were different between the two sequences towards different final targets (T3 up and T3 down) (Supplementary Figure 4B). We tested a condition in which both sequence reaches were forced to have similar dwell velocity profiles by increasing the dwell velocity costs in the sequence towards one of the targets (T3 down), while leaving this parameter unchanged for the other target (T3 up). In this scenario, T3 up sequence had the parameters (w2, w3) = (0, 0), while T3 down sequence had the parameters (0.8, 0.8). In this case, the curvature of the first reach was different, and predominantly occurred due to differences in K2 between the two sequence reaches (Supplementary Figure S4C). These simulations highlight that, planning for a longer horizon sequence can indirectly influence the curvature of early reaches, due to the interaction between intermediate dwell constraints, spatial arrangement of targets, and sequence horizon in a task dependent manner.”

      (3) In my prior review I raised a concern that the authors seem to be claiming that because they can use a single control policy for both coarticulated and separated movement sequences, there need not be any higher-level or explicit specification of whether the movements are sequential. While much of that language has been removed, it still appears in a few places (e.g., p. 13, lines 403-404). As previously noted, the authors' control policy can generate both types of movements as long as the proper constraints are provided to the model. However, these constraints must be specified somewhere (potentially explicitly, as the authors do by providing them as task instructions). Moreover, in typical sequence tasks, although some movements become coarticulated, people also tend to form chunks with distinct chunk boundaries, which presumably means that there is at least some specification of the sequential ordering of these chunks that must exist (otherwise the authors' model might suggest that people can coarticulate forever without needing to exhibit any chunk boundaries). Hence the authors should limit themselves to the narrow claim that a single control policy can lead to separated or coarticulated movements given an appropriate set of constraints, but acknowledge that their work cannot speak to where or how those constraints are specified in humans (i.e., that there could still be an explicit sequence representation guiding coarticulation). 

      We thank the reviewer for raising this point. We do not dispute the statement that the controller needs to be set dependent on the constraints of the task that must be specified somewhere. In our view, this problem is similar to the question of how a cost-function (or a task representation) is transformed into a control policy in the brain, which is unknown in general. In the earlier version, our intention was to stress that separation can occur without necessarily implying that the goals be processed independently (as in Figure 1A and Zimnik 2021). To avoid confusion on this point, we modified this statement in the new version as follows:

      Line 405: 

      “A straightforward interpretation could be that the stopping at the first target invoked a completely different strategy in which the control of the two reaches was performed independently (Figure 1A), effectively separating the two movements, whereas executing them rapidly could produce the merging of the two sub-movements into a coarticulated sequence. While this is conceptually valid, it is not necessary and the model provides a more nuanced view: both apparent separation or coarticulation of the two motor patterns can be explained within the same framework of flexible feedback control. These different modes of sequence execution still require proper specification of the task constraints in the model, such as number of intermediate steps, dwell-time, or velocity limit. Such specifications must be considered as input to the controller.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Line 57: Distinct hypotheses. 

      Line 209, The term "planned holistically" is confusing here. Seems like the authors suggest that the sequence is "planned holistically" as long as all sequence elements are given during the optimization process. 

      We changed the sentence as follows.

      Line 218: 

      “Overall, the model predicted that even if a feedback control policy was computed by optimizing the whole sequence over a long time-horizon, the requirements associated with intermediate goals determine how early in the sequence the second (future) target can influence the feedback controller”

      Line 336, It was not clear to me why the authors explained "the weak significant" results of PEC shortening in R0 given the nonsignificant values in R1. 

      We wanted to be transparent about whether changing the statistical analysis will lead to different interpretations, such as the sequence encoding even before long latency epochs. But we realized that it could lead to confusion and we deleted this sentence in the updated manuscript.

      Reviewer #2 (Recommendations For The Authors): 

      About Weakness #2, to clarify this point the authors should either model and discuss what it would take for their model to account for multiple targets ahead, or else run a study to show that in this task people indeed only ever plan 1 target ahead.  

      Please see our response above (in Weakness #2).

      I am still puzzled by why people would resist the perturbation more when they eventually have to move in the direction of the perturbation (e.g., p 10 lines 313-314). Perhaps this is simply due to the geometry of the task, but it could also depend on what participants were trying to accomplish in the experiment. To help clarify this, the authors should report exactly what instructions were given to participants in each task condition.  

      The simulations suggest that the observed perturbation movements are an optimal way to perform the task given the task constraints on accuracy, control effort and constraints at intermediate goals. The intuition is that modulating the acceleration at the intermediate goal is preferred rather than missing it. This however depends on the cost parameter. 

      Below, in Author response figure 1, we show the simulations by varying the accuracy requirements at intermediate goal and the total motor cost parameters. Clearly, as expected, increasing the cost on accuracy of the intermediate reach, or decreasing the cost on motor output modulated the hand deviation (simulations not included in the article).

      Author response image 1.

      Impact of movement costs (motor effort and intermediate goal reach errors) on the hand path following a mechanical perturbation   

      Our observation suggests that participants’ behaviour agreed with the interpretation that can result from the model. We clarified the exact instructions in the methods section. Note that the instructions were given at the beginning of the task and did not differ across the different conditions involving changes in the location of T2 or perturbation direction:

      Line 594:

      Participants were given the following instructions verbally: “Wait in the starting circle until you receive a GO signal, where the target circles turn red and you will simultaneously hear a beep sound. When the circles turn red, react quickly, move as soon, and as straight as possible to target 1 and then move to target 2. You will get two points at the end of the trial if you reach T1 in the prescribed time window and then move to T2, and in all other cases you will not receive any points. Importantly, once you reach T1 you should try to come out of it quickly. If you stay in T1 for more than 150 ms then T2 will disappear and you will receive only one point. Additionally, in some trials, a force will perturb your hand towards the right or left direction randomly while moving towards T1. The instructions remain the same in the presence of perturbations. Try to score as many points as you can.”

      Additionally, we added the following lines in the results description:

      Line 284:

      “The influence of second target on the lateral hand deviation was qualitatively similar to that observed in model simulations, and counterintuitive to what we might expect without the help of the model simulations. As observed in the model simulations (see also Supplementary Figure S2), lateral hand deviation was smaller when the perturbation was in the direction of the second target (T2) and vice-versa. This was consistent for both rightward and leftward perturbation conditions. Both the model and humans expressed this strategy that can be seen as an emergent feature of efficient feedback control during production of movement sequences. Additionally, even though behavior was reproduced in simulations, changing the cost on control effort and/or accuracy of intermediate reaches could modulate the sequencedependent changes in curvature.”

      I am not sure if "the data and code for simulations can be provided by the corresponding author" satisfies the eLife/PLoS software guidelines (i.e., that it be deposited in a public repository).

      Thank you for pointing this out. This sentence was added by mistake.

      We modified this statement in the updated manuscript. 

      “The data and code from simulations and experiments is available in the public repository ‘figshare’ in the following link (https://figshare.com/s/865a8b77c264ef17a181).”

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1

      Recommendation 1: The authors reasoned upon the presence of a differential basal hydraulic stress in waves' valleys vs hills at first from the observation of "domes" formation upon 48h cultivation. I suggest performing a quantification to support the statement as a good scientific practice. Furthermore, it would strengthen the concept when the formation of domes was compared between the waves' dimensions as a different grade of cell extrusion was quantified. i.e., 50, 100, and 200 µm.

      Response 1: Upon seeing the phenomenon (Author response image 1 A), we performed a count for domes on the 100 µm and saw a significant effect. We refrained from including the results as it is the subject of ongoing research in our lab. In response to the reviewer’s suggestion, we have included a graph (Author response image 1 B) showing the increasing number of domes over 48 hours from three 100 µm wave samples.

      We have updated Figure 2A and B in the manuscript to include the new graph.

      Author response image 1.

      (A) shows dome (white arrows) over a 100 µm wave substrate. (B) is the number of accumulated domes in valley and hill regions, for 3 independent samples, over 48 hours.

      Recommendation 2: Using RICM microscopy to quantify the cell basal separation with the substrate and hydraulic stress is very clever. Nevertheless, I am in doubt if the different intensity reported for the hills vs valley (Fig. 2G and H) is a result of the signal reduction at deeper Z levels. Since there is no difference in extrusion and forces between valleys and hills in the 200 µm waves but only in 50µm and 100µm, I would add this to the quantification. I would expect no intensity difference from RICM for the 200 µm sample if this is not an artefact of imaging.

      Response 2: We performed additional experiments on blank wave substrates (both 100 and 200 µm) to ascertain the extent of reflection intensity drop (Author response image 2A). And, as correctly pointed out by Reviewer #1, there was a drop in intensity even without cells. On the 100 µm waves, hill reflections are on average ~27 % dimmer than valley reflections. Whereas, on the 200 µm waves, hill reflections are on average ~39 % dimmer.

      Using this information, we performed a calibration on the RICM results obtained from both the 100 and 200 µm waves (Author response image 3B). The calibrated 100 µm data showed residual signatures of difference, whereas the calibrated 200 µm distributions appeared very similar. We noticed large cross- sample variations in the registered intensities, which will negatively impact effect size if not accounted for. To do this, we subsequently normalized both hill and valley intensities against planar region intensities for each sample. As shown by the final output (Author response image 3C), we were able to remove the skewness in the distributions. Moreover, 1-way ANOVA followed by a post hoc analysis with BH correction revealed a significant reduction in 100 µm hill/flat intensity ratio compared to 100 µm valley/flat intensity ratios (Δ~-23 %). Conversely, no significance was observed for the same comparison on the 200 µm waves.

      Author response image 2.

      (A). RICM from blank wave samples reveal a reduction in reflection intensity in hill regions compared to flat and valley regions.

      Author response image 3.

      (B) shows the RICM intensities after adjusting for the inherent reflection intensity drop shown in (A). (C) show the RICM intensities after normalization against planar region signals; this removes cross-sample variations and improve effect size of differences.

      We have updated the manuscript Figure 2I and text accordingly. The blank wave results are included in Figure 2-figure supplement 1 along with updated text and summary data table in Supplementary File 4.

      Recommendation 3: To measure 3D forces on top of the hills and valleys, the use of PAA gels is necessary. Since in Fig 3B, the authors show a difference in cell extrusion number between substrates and stiffnesses, I think it is necessary to confirm the presence of more extrusion in valleys vs hills on PAA gels. This would ensure the conclusion between normal forces and extrusion.

      Response 3: We do have time-lapse data with monolayers on the PAA waves. However, we felt results from the flat regions were sufficient in supporting the point being made in the text. Specifically, our original intention with PAA gels was to show that the extrusion reductions seen in osmotic perturbations were by virtue of removing basal stress and not some cryptic osmotic response. Hydrogels were chosen because they can effectively dilute basal solute concentration and thereby reduce the osmotically induced water transport. Moreover, as fluid could freely move within the gel, the fluid stress can quickly equilibrate across the basal surface. In contrast, poorly water/solute permeable substrates could lead to localized spikes in solute concentration and transient basal regions with high fluid stress.

      To get a sense of the potential difference in basal solute concentration between the two materials, we can do a quick hand-waving estimation. For monolayers on non-water/solute permeable PDMS of 20x20 mm and using the laser wavelength (640 nm) for RICM as an extreme estimate of basal separation, we should expect ~0.25 µl of total basal water content. On the other hand, we typically produce our PAM gel slabs using ~150 µl of precursor solutions. This means that, given similar amounts of solute, PAM gels will lead to monolayer basal osmolarity that is around 3 orders of magnitude lower than monolayers on PDMS, producing significantly lower osmotic potential. This implies from the outset that we should expect high survivability of cells on these substrates irrespective of curvature domains. Indeed, later immunoblotting experiments showed MDCKs exhibiting hyper activated FAK and Akt on PAM gels.

      In response to Reviewer #1’s suggestion then, we have added another supporting time-lapse (Video 19) showing typical response of MDCK monolayers on 100 µm PAA waves (Author response image 4). Evident from the time-lapses, like the planar regions, cell extrusions were very rare. This supports the idea that on PAM gels the effects of basal hydraulic stress and asymmetric forces are marginal against the strong survival signals. And the response is similar to hyper-osmotic perturbations; there, we did not see a significant difference between valley and hill extrusions.

      Author response image 4.

      Time-lapse snapshot showing negligible MDCK extrusions 24 hours after confluency over PAM gel wave substrates.

      Recommendation 4: Before proceeding with the FAK inhibitor experiment, the authors should better justify why the 4.1 wt % sucrose vs DMSO or NaCl is the most inert treatment. This can be done by citing relevant papers or showing time-lapses (as it is done for the higher FAKI14 dose).

      Response 4: Although some cells have recently been shown to be able to transport and utilize sucrose, mammalian cells generally cannot directly take up polysaccharides for metabolism and this is frequently mentioned in literature: see (Ref. R1) for example. Without special enzymes to break sucrose down into monosaccharides, such as sucrase found in the gut, the sugars should remain spectators in the culture medium, contributing only to osmotic effects.

      DMSO on the other hand, besides changing osmolarity, can also be integrated into cell membrane and pass through cells over time. It has been reported to chronically affect cell membrane properties and gene expressions (Ref. R2).

      Finally, it is well known that both sodium and chloride ions are readily taken up and transported by cells (Ref R3). They help to regulate the transmembrane potential, which in turn can affect membrane bound proteins and biochemical reactions within a cell.

      Hence, comparing the 3 hyper-osmotic perturbations, adding sucrose should have the least off- target effects on both the inhibitor study and the subsequent immunoblotting. And, in response to the reviewer’s recommendation, we have updated the text accordingly and included new references to support our statement.

      Ref R1. H. Meyer, O. Vitavska, H. Wieczorek; Identification of an animal sucrose transporter. Journal of Cell Science 124, 1984–1991 (2011). Doi: 10.1242/jcs.082024

      Ref R2. B. Gironi, Z. Kahveci, B. McGill, B.-D. Lechner, S. Pagliara, J. Metz, A. Morresi, F. Palombo, P. Sassi, P. G. Petrov; Effect of DMSO on the Mechanical and Structural Properties of Model and Biological Membranes. Biophysical Journal 119, 274-286 (2020). Doi: doi.org/10.1016/j.bpj.2020.05.037

      Ref R3. X. Zhang, H. Li; Interplay between the electrostatic membrane potential and conformational changes in membrane proteins. Protein Science 28, 502-512 (2019). Doi: 10.1002/pro.3563

      Recommendation 5: The data showing a FAK-dependent phosphorylation of AKT responsible for a higher cell survival rate in the hills is not yet completely convincing. Please show a reduced AKT phosphorylation level after FAK inhibition in high osmolarity levels. Furthermore, the levels of AKT activation seem to increase slightly upon substrate softening independently of FAK activation or osmotic pressure (i.e., Fig. 4E, Soft PDMS). The authors should comment on this in connection with the results shown for PAA gels.

      Response 5: For the additional immunoblotting experiments, work is currently underway. We could not, however, complete these experiments in time for this revision, as both Cheng-Kuang and Xianbin will shortly be taking on new jobs elsewhere. David will continue with the immunoblotting studies and should be able to include the results in an update in the coming months. As for the apparent elevated levels of AKT seen on soft silicones, we speculate that it is because we cannot immunoblot cells that have died and were inevitably washed out at the start of the procedure. Inferring from the higher extrusion rates on these soft substrates, we could be missing a significant portion of stats. Specifically, we are missing all the cells that would have lowered AKT activation but died, and had we been able to collect those statistics, perhaps both the FAK and AKT should have shown lower levels. We risk committing survival bias on the results if we read too much into the data as is.

      Alternatively, another explanation could be that, by virtue of survival of the fittest, we might have effectively selected a subpopulation of cells that were able to survive on lower FAK signals, or completely irrespectively of it.

      At any rate, to prove our foregoing hypothesis would require us to perform comprehensive immunoblotting and total transcriptome analysis over different duration conditions. Unfortunately, we do not have the time to do that for the current article, but it could be developed into a stand-alone molecular biology investigation in future. We have included similar discussion in the main text.

      Recommendation 6: In the discussion, the authors suggest the reported findings be especially relevant for epithelia that significantly separate compartments and regulate water and soluble transport. These are for example kidney epithelia (i.e., MDCK is the best experimental choice), retinal epithelium or intestinal epithelium. I would suggest that some proof-of-concept experiments could be done to support this concept. For example, I would expect keratinocytes (i.e., HaCaT) not to show a strong difference in extrusion rate between valleys and hills since the monolayer is not so sealed as kidney epithelium. In general, this kind of experiment would significantly strengthen the finding of this work.

      Response 6: As recommended, we tracked the behavior of retina pigment epithelial cells (hTERT RPE-1 from ATCC) which do not form tight monolayers like MDCKs (Ref. R4). We did not detect extrusion events occurring from monolayers of these cells (Author response image 5). This is true even for portions of monolayers over waved regions.

      Author response image 5.

      Time-lapse snapshot showing non-existent o cell extrusions from RPE monolayers confluent for over 21 hours.

      We have updated these findings in the main text discussions and included a new supporting time- lapse (Video 15) in our article.

      Ref R4 F. Liu, T. Xu, S. Peng, R. A. Adelman, L. I. Rizzolo; Claudins regulate gene and protein expression of the retinal pigment epithelium independent of their association with tight junctions. Experimental Eye Research 198, 108157 (2020). Doi: 10.1016/j.exer.2020.108157

      Recommendation 7 (minor point): Figure S1 needs to have clear notes indicating in each step what is what. i.e., where is glass, PDMS, NOA73, etc? A more detailed caption will help the figure's comprehension. Also "Cy52" should be changed to "soft silicone" to be consistent with the text (or Cy52 should be mentioned in the text).

      Response 7 (minor point): Changes were made to Figure 1-figure supplement 1 to improve comprehension accordingly. CY52 was added to the main-text, next to the first appearance of the word soft silicone, to be consistent with the figures.

      Recommendation 8 (minor point): The authors often mentioned that epithelial monolayers are denser on PAA gels. Please add a reference(s) to this statement.

      Response 8 (minor point): The statement is an inference from visually comparing monolayers on PAM gels and PDMS. The difference is quite evident (Author response image 6). The density difference is in spite of the fact that the substrates share similar starting cell numbers.

      To address the reviewer’s comment, we have combined time-lapses of monolayers on silicones and PAM gels side-by-side in Video 17 to facilitate convenient comparisons.

      Author response image 6.

      Time-lapse snapshot at 24 hours after confluence, showing conspicuously higher density of MDCK monolayers on PAM gel compared to those on silicon elastomer.

      Reviewer #2

      Recommendation 1: The sinusoidal wavy substrate that the authors use in their investigation is interesting and relevant, but it is important to realize that this is a single-curved surface (also known as a developable surface). This means that the Gaussian curvature is zero and that monolayers need to undergo (almost) no stretching to conform to the curvature. The authors should at least discuss other curved surfaces as an option for future research, and highlight how the observations might change. Convex and concave hemispherical surfaces, for example, might induce stronger differences than observed on the sinusoidal substrates, due to potentially higher vertical resultant forces that the monolayer would experience. The authors could discuss this geometry aspect more in their manuscript and potentially link it to some other papers exploring cell-curvature interactions in more complex environments (e.g. non-zero Gaussian curvature).

      Response 1: In response to reviewer #2’s recommendation we have highlighted in the discussion of our text that our waves constitute a developable surface and that cells will experience little stretching for the most part. Based on our knowledge of how curvature can modulate forces and thus osmotic effects, we included some rudimentary analysis of what one would expect on hemispherical surfaces of two types: one that is periodic and contiguous (Ref. R5), and another with delineating flat regions (Ref. R6).

      For epithelial monolayers in the first scenario, and on poorly solute/water permeable substrates, we should also expect to see a relatively higher likelihood of extrusions from concave regions compared to convex ones. Moreover, as the surfaces are now curved in both principal directions (producing larger out-of-plane forces), we should see the onset of differential extrusions seen in this study, but at larger length scales. For example, the effects seen on 100 µm hemicylindrical waves might now happen at larger feature size for hemispherical waves. Furthermore, as this kind of surface would invariably contain hyperbolic regions (saddle points), we might expect an intermediate response from these locations. If the forces in both principal directions offset each other, the extrusion response may parallel planar regions. On the other hand, if one dominates over the other, we may see extrusion responses tending to the dominating curvature (concave of convex).

      On the other hand, on curved landscapes with discrete convex or concave regions, we should expect, within the curved surface, extrusion behaviors paralleling findings in this study. What would be interesting would be to see what happens at the rims (or skirt regions) of the features. At these locations we effectively have hyperbolically curved surfaces, and like before, we should expect some sort of competing effect between the forces generated from the principal directions. So, for dome skirts, we should see fewer extrusions when the domes are small, and vice versa, when they are larger. Meanwhile, for pit rims, we should see a reversed behavior. It should also be noted that the transitioning curvature between convex/concave and planar regions would also modulate the effect.

      These effects might have interesting developmental implications. For instance, in developing pillar like tissues (e.g., villi) structures, the strong curvatures of nascent lumps would favor accumulation of cell numbers. However, once the size of the lumps reaches some critical value, epithelial cell extrusions might begin to appear at the roots of the developing structures, offsetting cell division, and eventually halting growth.

      Ref R5. L. Pieuchot, J. Marteau, A. Guignandon, T. Dos Santos, I. Brigaud, P. Chauvy, T. Cloatre, A. Ponche, T. Petithory, P. Rougerie, M. Vassaux, J. Milan, N. T. Wakhloo, A. Spangenberg, M. Bigerelle, K. Anselme, Curvotaxis directs cell migration through cell-scale curvature landscapes. Nature Communications 9, 3995 (2018). Doi: 10.1038/s41467-018-06494-6

      Ref R6. M. Werner, S. B.G. Blanquer, S. P. Haimi, G. Korus, J. W. C. Dunlop, G. N. Duda, D. W. Grijpma, A. Petersen, Surface curvature differentially regulates stem cell migration and differentiation via altered attachment morphology and nuclear deformation. Advanced Science 4, 1–11 (2017). Doi: 10.1002/advs.201600347

      Recommendation 2: The discussion of the experiments on PAM gels is rather limited. The authors describe that cells on the PAM gels experience fewer extrusions than on the PDMS substrates, but this is not discussed in sufficient detail (e.g. why is this the case). Additionally, the description of the 3D traction force microscopy and its validation is quite limited and should be extended to provide more convincing evidence that the measured force differences are not an artefact of the undulations of the surface.

      Response 2: We first saw a significant reduction in cell extrusions when we performed hyper-osmotic perturbations, and to eliminate possible off-target effects of the compounds used to increase osmolarity, we used three different compounds to be sure. In spite of this, we felt it would further support our argument, that basal accumulation of fluid stress was responsible for the extrusions, if we had some other independent means of removing fluid stress without directly tuning osmolarity through addition of extraneous solutes. We hence thought of culturing MDCK monolayers on hydrogels.

      Hydrogels were chosen because they can effectively dilute basal solute concentration (for reference ions (Na+) are continuously pumped out basally by the monolayer) and thereby reduce the associated osmotically induced water transport. Moreover, as fluid could freely move within the gel, the fluid stress can quickly equilibrate across the basal surface. In contrast, poorly water/solute permeable substrates will lead to localized spikes in solute concentration and transient basal regions with high fluid stress.

      To get a sense of the extent of difference in basal solute concentration between the two materials, we can do a quick hand-waving estimation. For monolayers on non-water-permeable PDMS of 20x20 mm, and using the laser wavelength (640 nm) for RICM as an extreme estimate of basal separation, we should expect ~0.25 µl of total basal water content. On the other hand, we typically produce our PAM gel slabs using ~150 µl of precursor solutions. This means that, given similar amounts of solute, PAM gels will lead to monolayer basal osmolarity that is around 3 orders of magnitude lower than monolayers on PDMS, producing significantly lower osmotic potential. This implies from the outset that we should expect high survivability of cells on these substrates. Indeed, later immunoblotting experiments showed MDCKs exhibiting hyper activated FAK and Akt on PAM gels.

      As for the 3D TFM used in this study, it is actually implemented from a well-established finite element method to solve inverse problems in engineering and has been repeatedly validated in larger scale engineering contexts (Ref. R7). The novelty and contribution of our article is in its adaptation to reconstruct cellular forces at microscopic scales.

      In brief, soft materials, such as hydrogels used in our case, are doped with fluorescent particles, coated with ECM, and then seeded with cells. The cells would exert forces that deform the soft substrate, thereby displacing the fluorescent particles from their equilibrium positions. This particle displacement can be extracted by producing an image pair with microscopy; first one with the cells, and subsequent one of relaxed gel after removal of cells with acutely cytotoxic reagents, such as SDS. There are several ways in which the displacement field can be extracted from the image pair. These include particle tracking velocimetry, particle image velocimetry, digital volume correlation, and optical flow.

      We employed 3D Farneback optical flow in our study for its superior computational performance. The method was validated using synthetically generated images from Sample 14 of the Society for Experimental Mechanics DIC challenge. The accuracy of the calculated displacements using the 3D Farneback optical flow was then compared to the provided ground truth displacements. For the highest frequency displacement image pairs, an x-component root-mean-square-error (RMSE) value of 0.0113 was observed. This was lower than the 0.0141 RMSE value for the Augmented Lagrangian Digital Volume Correlation method. This suggested that the 3D Farneback optical flow is capable of accurately calculating the displacement between two bead images.

      The displacement fields are then fed into a finite element suite (ANSYS in our case) along with the model and mesh of the underlying substrate structure to obtain node specific displacements. This is required because mech nodes do not typically align with voxel positions of displacements. With these node specific displacements, we subsequently solve the inverse problem for the forces using Tikhonov regularization (Ref. R8). The outcome is a vector of node specific forces.

      In light of the above, to physically validate the method in our context would require the generation of a known ground truth force on the scale of pico- to nano-newtons and subsequently image the particle displacements from this force using confocal microscopy. The force must then be released in situ in order for the relaxed gel to be imaged again. This is not a straightforward feat at this scale, and a method that immediately springs to mind is magnetic tweezers. Unfortunately, this is a tool that we cannot develop within reasonable timeframes, as the method will have to be seamlessly integrated with our spinning-disk confocal. However, as a compromise, we have included an in-silico validation with our revised manuscript.

      Specifically, given a finite element model with a predefined curvature, a known force was applied to the surface of the model (Author response image 7A). The resulting displacements were then calculated from the finite element solution. A 10% random noise is then added to the resulting displacement. The traction force recovery (Fig. R2-1 B) was then performed using the in-silico noisy displacements. To evaluate the accuracy of the recovery, the cosine similarity along with the mean norm of the force vectors were calculated. A value closer to 1 for both evaluation metrics indicates a more accurate reconstruction of the simulated traction force. The cosine similarity of the recovered traction forces to the original applied force was 0.977±0.056 while the norm of the recovered traction forces as a proportion of the original applied force was 1.016±0.165. As both values are close to 1 (i.e., identical), this suggested that the traction forces could be satisfactorily recovered using the finite-element based method.

      In response to the reviewer’s recommendations then, additional content has been included in the main text to explain the use of PAM gels and the workings of our 3D TFM pipeline.

      Ref R7. James F. Doyle, Modern Experimental Stress Analysis: Completing the Solution of Partially Specified Problems (John Wiley & Sons, Chichester, 2004).

      Ref R8. Per Christian Hansen, Discrete Inverse Problems: Insight and Algorithms (siam, Philadelphia, 2010).

      Author response image 7.

      (A) shows simulated force field to generate simulated displacements. (B) shows force field reconstructed from simulated displacements with noise.

      Recommendation 3: The authors show nuclear deformation on the hills and use this as evidence for a resultant downward-pointing force vector. This has, indeed, also been observed in other works referenced by the authors (e.g. Werner et al.), and could be interesting evidence to support the current observations, provided the authors also show a nuclear shape on the concave and flat regions. The authors could potentially also characterize this shape change better using higher-resolution data.

      Response 3: We characterized nucleus deformation using Hoechst-stained samples as per recommendation. The deformation is estimated by dividing segmented nuclei volumes by best-fit ellipsoid volumes of same objects. In this way, objects exhibiting minimal bending will lead to values close to 1.0. The obtained graph is shown in figure Author response image 8B (and manuscript Figure 3D).

      Author response image 8.

      (A) an example of deformed nuclei on 50 µm wave hill region. (B) a Violin plot of calculated nuclear deformations across dimensions and features using segmented volume normalized against best-fit ellipsoid volume.

      Our quantifications show a statistically significant difference in nuclei deformation measure medians between hill and valley cells on the 50 µm (0.973 vs 0.982) and 100 µm (0.971 vs 0.979) waves; this indicates that cells on the hills tend to have more deformed nuclei compared to cells in the valleys. Meanwhile, no significant difference was found for a similar comparison on 200 µm (0.978 vs 0.978) samples. For reference, the median found for cells pooled from planar regions was 0.975.

      In response to the reviewer’s suggestions Figure 3 of our manuscript has been updated to include the new results on nuclei deformation. The text has also been updated to account for the new information to support our claims. The statistics are included in a new summary data table in Supplementary File 6.

      Recommendation 4: The U-net for extrusion detection is a central tool used within this study, though the explanation and particularly validation of the tool are somewhat lacking. More clarity in the explanation and more examples of good (or bad) detections would help establish this tool as a more robust component of the data collection (on all geometries).

      Response 4: The architecture of the neural network used in this study is outlined in supplementary figure S5a. To validate the performance of the model, a test dataset consisting of 200 positive examples and 100 negative examples were fed into the network and the resulting prediction was obtained from model. The confusion matrix of the model is shown in supplementary figure S5c. The weighted precision and recall of the model are 0.958 and 0.953 respectively.

      Additionally, we have included examples of false positive and false negative detections in Figure 1-figure supplement 5 (Author response image 8). For false positive detections, these were typically observed to be extrusions that were labelled to have occurred the frame prior to the frame of interest (Author response image 9 bottom sequence). However, as the extrusion process is incomplete in the prior frame, there are still changes in the extruded cell body and the network falsely predicts this as a detection.

      Author response image 9.

      Examples of false negative and false positive extrusions registration.

      Recommendation 5: The authors study the involvement of FAK in the observed curvature-dependent and hydraulic stress-dependent spatial regulation of cell extrusion. In one of the experiments, the authors supplement the cell medium with FAK inhibitors, though only in a hyper-osmotic medium. They show that FAK inhibition counteracts the extrusion-suppressing effect of a hyper-osmotic medium. However, no data is shown on the effect of FAK inhibitors within the control medium. Would the extrusion rates be even higher then?

      Response 4: We proceeded, as suggested by the reviewer, to explore the effects of the FAK inhibitor on MDCK monolayers in our control medium. The results revealed that, at the 3 µM FAK concentration, where cells in sucrose media showed an elevated extrusion rate, monolayers in control medium quickly suffered massive cell death (Author response image 10) similar to what was seen when 6 µM FAK was introduced to sucrose medium.

      This finding suggests that osmolarity protects against FAK inhibitors in a dose dependent manner. Moreover, as cell extrusions require an intact monolayer, its rates cannot increase indefinitely: a point will be reached where an intact monolayer can no longer be maintained.

      We have updated the main text of our article to mention this observation, and also included a new time-lapse (Video 22) to demonstrate the effect.

      Author response image 10.

      Timelapse snapshot of MDCK monolayers over waves 4 hours after inclusion of focal adhesion kinase inhibitor.

      Recommendation 6: The supplementary videos show two fields of view next to each other, which is not immediately clear to the viewer. I strongly advise the authors to add a clear border between the two panels, so that it is clear that the cells from one panel are not migrating into the next panel.

      Response 6: A distinctive border has been added to the movies to separate panels showing different focal planes of the same stack.

      Recommendation 7: The general quality and layout of the figures could be improved. Some figures would benefit from higher-resolution or larger cell images (e.g. Figure 2A, C, D), and the organisation of subpanels could be improved (e.g. especially in Figure 2). The box plots and bar graphs are also not consistent throughout the manuscript in terms of colouring and style, which should be improved.

      Response 7: We have enlarged the figures in question accordingly, at the cost of reducing some information. However, the full scope of the sub-figures remains accessible in the supplementary movies. We have also tried to change the placement of the panels to improve readability. We have also adjusted the valley, hill, and flat coloring scheme for the extrusion boxplots in Figures 1 and 2 to make them consistent.

      Recommendation 8: The graphs in Figures 3E and F are confusing and difficult to interpret. The x-axis states "Position along curve in radians" but it is unclear how to relate this to the position on the wavy substrate. The graphs also have a second vertical axis on the right ("valley-interface-hill"), which adds to the confusion. I would recommend the authors provide more explanation and consider a different approach of plotting this.

      Response 8: We have removed the confusing plot of cross-sectional profile from the force graphs. To indicate positions on the waves, we have augmented radian values with Hill, Interface, and Valley accordingly.

      Recommendation 9: Specify which silicone was used for the low-stiffness silicone substrates in the methods and in the main text.

      Response 9: CY52 has been added to the main-text, next to the first appearance of the word soft silicone, to be consistent with the figures.

      Recommendation 10: The flow lines that are plotted over the RICM data make it difficult to see the underlying RICM images. I would advise to also show the RICM images without the flow lines.

      Response 10: The original movie S15 (now Video 16) showing the RICM overlapped with optical flow paths has now been replaced by a movie showing the same, but with the flow paths and RICM in separate panels.

      Recommendation 11: In the first paragraph of the discussion, the authors write: "And this difference was both dependent on the sense (positive or negative)...". This is superfluous since the authors already mentioned earlier in the paragraph that the convex and concave regions (i.e. different signs of curvature) show differences in extrusion rates.

      Response 11: The sentence has been changed to “And this difference was also dependent on the degree of curvature.”

      Recommendation 12: In the second paragraph of the discussion, the authors mention that "basal fluid spaces under monolayers in hill regions were found consistently smaller than those in valley regions". Is this data shown in the figures of the manuscript? If so, a reference should be made because it was unclear to me.

      Response 12: This statement is an inference from the comparison of the hill and valley RICM grey values. Specifically, RICM intensities are direct surrogates for basal separations (i.e., fluid space (as there cannot be a vacuum)) by virtue of the physics underlying the effect. To be more precise then, “inferred from RICM intensity differences (Figure 2I)” has been added to support the statement.

      Recommendation 13: On page 7 of the discussion, the authors talk about positively and negatively curved surfaces. This type of description should be avoided, as this depends on the definition of the surface normal (i.e. is positive convex or concave?). Rather use convex and concave in this context.

      Response 13: The wording has been changed accordingly.

      Recommendation 14: The label of Table 8 reads "Table 2".

      Response 14: The error has been corrected.

      Reviewer #3

      Recommendation 1: The central finding seems to be opposite to an earlier report (J Cell Sci (2019) 132, jcs222372), where MDCK cells in curved alginate tubes exhibit increased extrusion on a convex surface. I suggest that you comment on possible explanations for the different behaviors.

      Response 1: The article in question primarily reported the phenomenon of MDCK and J3B1A monolayers detaching from the concave alginate tube walls coated with Matrigel. The authors attributed this to the curvature induced out-of-plane forces towards the center of the tubes. Up to this point, the findings and interpretation are consistent with our current study where we also find a similar force trend in concave regions.

      To further lend support to the importance of curvature in inducing detachment, the authors cleverly bent the tubes to introduce asymmetry in curvature between outer and inner surfaces. Specifically, the outside bend is concave in both principal directions, whereas the inside bend is convex in one of its principal directions. As expected, the authors found that detachment rates from the outer surface were much larger compared to the inner one. Again, the observations and interpretations are consistent with our own findings; the convex direction will generate out-of-plane forces pointing into the surface, serving to stabilize the monolayer against the substrate. It should be noted however, since the inner-side tube is characterized by both convex and concave curvatures in its two principal directions, the resulting behavior of overlaying monolayers will depend on which of the two resulting forces become dominant. So, for gradual bends, one should expect the monolayers to still be able to detach from the inner tube surface. This is what was reported in their findings.

      For their extrusion observations, I am surprised. Because their whole material (hydrogels) is presumably both solute and water permeable, I would be more inclined to expect very few extrusions irrespective of curvature. This is indeed the case with our study of MDCKs on PAM hydrogels, where the hydrogel substrate effectively buffers against the quick build-up of solute concentration and basal hydraulic stress. Without the latter, concave monolayer forces alone are unlikely to be able to disrupt cell focal adhesions. Indeed, the detachments seen in their study are more likely by exfoliation of Matrigel rather than pulling cells off Matrigel matrix entirely.

      My guess is that the extrusions seen in their study are solely of the canonical crowding effect. If this was the case, then the detached monolayer on the outside bend could buffer against crowding pressure by buckling. Meanwhile, the monolayer on the inside bend, being attached to the surface, can only regulate crowding pressure by removing cells through extrusions. This phenomenon should be particular to soft matrices such as Matrigel. Using stiffer and covalently bonded ECM should be sufficient to prevent monolayers from detaching, leading to similar extrusion behaviors. In response to the reviewer’s recommendation then, we have included a short paragraph to state the points discussed in this response.

      Recommendation 2: Fig 3E, F: The quantities displayed on the panels are not forces, but have units of pressure (or stress).

      Response 2: we have changed “force” to “stress” according to the reviewer’s suggestion. The reason we kept the use of force in the original text was due to the fact that we were reconstructing forces. Due to discretization, the resulting forces will inevitably be assigned to element nodes. In between the nodes, in the faces, there will be no information. So, in order to have some form of continuity to plot, the face forces are obtained by averaging the 4 nodes around the element face. Unfortunately, element face areas are not typically of the same size, therefore the average forces obtained needs to be further normalized against the face area, leading to a quantity that has units of stress.

      Recommendation 3: Fig 2D: Asterisks are hard to see.

      Response 3: the color of the asterisks has been changed to green for better clarity against a B&W background.

      Recommendation 4: p 19, l 7: Word missing in "the of molding"

      Response 4: the typo has been amended to “the molding of”.

    1. Author Response

      We thank you for the time you took to review our work and for your feedback!

      The major changes to the manuscript are:

      1. We have extended the range of locomotion velocity over which we compare its dependence with cholinergic activity in Figures 2E and S2H.

      2. We have quantified the contributions of cholinergic stimulation on multiplicative and additive gains on visual responses (Figure S7).

      3. We have provided single cell examples for the change in latency to visual response (Figure S12).

      4. We have added an analysis to compare layer 2/3 and layer 5 locomotion onset responses as a function of visuomotor condition (Figure S8).

      A detailed point-by-point response to all reviewer concerns is provided below.  

      Reviewer #1 (Public Review):

      The paper submitted by Yogesh and Keller explores the role of cholinergic input from the basal forebrain (BF) in the mouse primary visual cortex (V1). The study aims to understand the signals conveyed by BF cholinergic axons in the visual cortex, their impact on neurons in different cortical layers, and their computational significance in cortical visual processing. The authors employed two-photon calcium imaging to directly monitor cholinergic input from BF axons expressing GCaMP6 in mice running through a virtual corridor, revealing a strong correlation between BF axonal activity and locomotion. This persistent activation during locomotion suggests that BF input provides a binary locomotion state signal. To elucidate the impact of cholinergic input on cortical activity, the authors conducted optogenetic and chemogenetic manipulations, with a specific focus on L2/3 and L5 neurons. They found that cholinergic input modulates the responses of L5 neurons to visual stimuli and visuomotor mismatch, while not significantly affecting L2/3 neurons. Moreover, the study demonstrates that BF cholinergic input leads to decorrelation in the activity patterns of L2/3 and L5 neurons.

      This topic has garnered significant attention in the field, drawing the interest of many researchers actively investigating the role of BF cholinergic input in cortical activity and sensory processing. The experiments and analyses were thoughtfully designed and conducted with rigorous standards, leading to convincing results which align well with findings in previous studies. In other words, some of the main findings, such as the correlation between cholinergic input and locomotor activity and the effects of cholinergic input on V1 cortical activity, have been previously demonstrated by other labs (Goard and Dan, 2009; Pinto et al., 2013; Reimer et al., 2016). However, the study by Yogesh and Keller stands out by combining cutting-edge calcium imaging and optogenetics to provide compelling evidence of layerspecific differences in the impact of cholinergic input on neuronal responses to bottom-up (visual stimuli) and top-down inputs (visuomotor mismatch).

      We thank the reviewer for their feedback.

      Reviewer #2 (Public Review):

      The manuscript investigates the function of basal forebrain cholinergic axons in mouse primary visual cortex (V1) during locomotion using two-photon calcium imaging in head-fixed mice. Cholinergic modulation has previously been proposed to mediate the effects of locomotion on V1 responses. The manuscript concludes that the activity of basal forebrain cholinergic axons in visual cortex provides a signal which is more correlated with binary locomotion state than locomotion velocity of the animal. Cholinergic axons did not seem to respond to grating stimuli or visuomotor prediction error. Optogenetic stimulation of these axons increased the amplitude of responses to visual stimuli and decreased the response latency of layer 5 excitatory neurons, but not layer 2/3 neurons. Moreover, optogenetic or chemogenetic stimulation of cholinergic inputs reduced pairwise correlation of neuronal responses. These results provide insight into the role of cholinergic modulation to visual cortex and demonstrate that it affects different layers of visual cortex in a distinct manner. The experiments are well executed and the data appear to be of high quality. However, further analyses are required to fully support several of the study's conclusions.

      We thank the reviewer for their feedback.

      1) In experiments analysing the activity of V1 neurons, GCaMP6f was expressed using a ubiquitous Ef1a promoter, which is active in all neuronal cell types as well as potentially non-neuronal cells. The manuscript specifically refers to responses of excitatory neurons but it is unclear how excitatory neuron somata were identified and distinguished from that of inhibitory neurons or other cell types.

      This might be a misunderstanding. The Ef1α promoter has been reported to drive highly specific expression in neurons (Tsuchiya et al., 2002) with 99.7% of labeled cells in layer 2/3 of rat cortex being NeuN+ (a neuronal marker), with only 0.3% of labeled cells being GFAP+ (a glial marker) (Yaguchi et al., 2013). This bias was even stronger in layer 5 with 100% of labeled cells being NeuN+ and none GFAP+ (Yaguchi et al., 2013). The Ef1α promoter in an AAV vector, as we use it here, also biases expression to excitatory neurons. In layer 2/3 of mouse visual cortex, we have found that 96.8% ± 0.7% of labeled neurons are excitatory three weeks after viral injection (Attinger et al., 2017). Similar results have also been found in rats (Yaguchi et al., 2013), where on expressing GFP under Ef1a promoter delivered using Lenti virus, 95.2% of labeled neurons in layer 2/3 were excitatory and 94.1% in layer 5 were excitatory. These numbers are comparable to the ones obtained with promoters commonly used to target expression to excitatory neurons. To do this, typically two variants of promoters based on the transcription start region of CaMKIIα gene have been used. The first, the CaMKIIα-0.4 promoter, results in 95% excitatory specificity (Scheyltjens et al., 2015). The second, the CaMKIIα-1.3 promoter, results in only 82% excitatory specificity (Scheyltjens et al., 2015), and is thus not far from chance. We have clarified this in the manuscript. Nevertheless, we have removed the qualifier “excitatory” when talking about neurons in most instances, throughout the manuscript.

      2) The manuscript concludes that cholinergic axons convey a binary locomotion signal and are not tuned to running speed. The average running velocity of mice in this study is very slow - slower than 15 cm/s in the example trace in Figure 1D and speeds <6 cm/s were quantified in Figure 2E. However, mice can run at much faster speeds both under head-fixed and freely moving conditions (see e.g. Jordan and Keller, 2020, where example running speeds are ~35 cm/s). Given that the data in the present manuscript cover such a narrow range of running speeds, it is not possible to determine whether cholinergic axons are tuned to running speed or convey a binary locomotion signal.

      Our previous analysis window of 0-6.25 cm/s covered approximately 80% of all data. We have increased the analysis window to 0-35 cm/s that now covers more than 99% of the data (see below). Also, note that very high running speeds are probably overrepresented in the Jordan and Keller 2020 paper as mice had to be trained to run reliably before all experiments given the relatively short holding times of the intracellular recordings. The running speeds in our current dataset are comparable to other datasets we have acquired in similar experiments.

      Figure 2E has now been updated to reflect the larger range of data. Please note, as the number of mice that contribute to the data now differs as a function of velocity (some mice run faster than others), we have now switched to a variant of the plot based on hierarchical bootstrap sampling (see Methods). This does not overtly change the appearance of the plot. See Author response image 1 for a comparison of the original plot, the extended range without bootstrap sampling, and the extended range with bootstrap sampling currently used in the paper.

      Author response image 1.

      Average activity of cholinergic axons as a function of locomotion velocity. (A) As in the previous version of the manuscript. (B) As in A, but with the extended velocity range. (C) As in B, but using hierarchical bootstrap sampling to estimate median (red dots) and 95% confidence interval (shading) for each velocity bin.

      3) The analyses in Figure 4 only consider the average response to all grating orientations and directions. Without further analysing responses to individual grating directions it is unclear how stimulation of cholinergic inputs affects visual responses. Previous work (e.g. Datarlat and Stryker, 2017) has shown that locomotion can have both additive and multiplicative effects and it would be valuable to determine the type of modulation provided by cholinergic stimulation.

      We thank the reviewer for this suggestion. To address this, we quantified how cholinergic stimulation influenced the orientation tuning of V1 neurons. The stimuli we used were full field sinusoidal drifting gratings of 4 different orientations (2 directions each). For each neuron, we identified the preferred orientation and plotted responses relative to this preferred orientation as a function of whether the mouse was running, or we were stimulating cholinergic axons. Consistent with previous work, we found a mixture of a multiplicative and an additive components during running. With cholinergic axon stimulation, the multiplicative effect was stronger than the additive effect. This is now quantified in Figure S7.

      4) The difference between the effects of locomotion and optogenetic stimulation of cholinergic axons in Figure 5 may be confounded by differences in the visual stimulus. These experiments are carried out under open-loop conditions, where mice may adapt their locomotion based on the speed of the visual stimulus. Consequently, locomotion onsets are likely to occur during periods of higher visual flow. Since optogenetic stimulation is presented randomly, it is likely to occur during periods of lower visual flow speed. Consequently, the difference between the effect of locomotion and optogenetic stimulation may be explained by differences in visual flow speed and it is important to exclude this possibility.

      We find that in general locomotion is unaffected by visual flow in open loop conditions in this type of experiment (in this particular dataset, there was a small negative correlation between locomotion and visual flow in the open loop condition, Author response image 2).

      Author response image 2.

      Correlation between visual flow and locomotion in open loop conditions. Average correlation of locomotion velocity and visual flow speed in open loop for all mice in Figure 5. Each dot is an imaging site. In the open loop, the correlation between locomotion and visual flow speed is close to zero, but significantly negative in this dataset.

      However, to directly address the concern that our results are influenced by visual flow, we can restrict our analysis only to locomotion onsets that occurred in absence of visual flow (Author response image 3A and R3B). These responses are not substantially different from those when including all data (Figures 5A and 5B). Thus, the difference between the effect of locomotion and optogenetic stimulation cannot be explained by differences in visual flow speed.

      Author response image 3.

      Open loop locomotion onset responses without visual flow. (A) Average calcium response of layer 2/3 neurons in visual cortex to locomotion onset in open loop in the absence of visual flow. Shading indicates SEM. (B) As in A, but for layer 5 neurons.

      5) It is unclear why chemogenetic manipulations of cholinergic inputs had no effect on pairwise correlations of L2/3 neuronal responses while optogenetic stimulation did.

      This is correct – we do not know why that is the case and can only speculate. There are at least two possible explanations for this difference:

      1) Local vs. systemic. The optogenetic manipulation is relatively local, while the chemogenetic manipulation is systemic. It is not clear how cholinergic release in other brain regions influences the correlation structure in visual cortex. It is conceivable that a cortex-wide change in cholinergic release results in a categorically different state with a specific correlation structure in layer 2/3 neurons different from the one induced by the more local optogenetic manipulation.

      2) Layer-specificity of activation. Cholinergic projections to visual cortex arrive both in superficial and deep layers. We activate the axons in visual cortex optogenetically by illuminating the cortical surface. Thus, in our optogenetic experiments, we are primarily activating the axons arriving superficially, while in the chemogenetic experiment, we are likely influencing superficial and deep axons similarly. Thus, we might expect a bias in the optogenetic activation to influencing superficial layers more strongly than the chemogenetic activation does.

      6) The effects of locomotion and optogenetic stimulation on the latency of L5 responses in Figure 7 are very large - ~100 ms. Indeed, typical latencies in mouse V1 measured using electrophysiology are themselves shorter than 100 ms (see e.g. Durand et al., 2016). Visual response latencies in stationary conditions or without optogenetic stimulation appear surprisingly long - much longer than reported in previous studies even under anaesthesia. Such large and surprising results require careful analysis to ensure they are not confounded by artefacts. However, as in Figure 4, this analysis is based only on average responses across all gratings and no individual examples are shown.

      This is correct and we speculate this is the consequence of a combination of different reasons.

      1) Calcium imaging is inherently slower than electrophysiological recordings. While measuring spiking responses using electrophysiology, response latencies of on the order of 100 ms have indeed been reported, as the reviewer points out. Using calcium imaging these latencies are typically 4 times longer (Kuznetsova et al., 2021). This is likely a combination of a) calcium signals that are slower than electrical changes, b) delays in the calcium sensor itself, and c) temporal sampling used for imaging that is about 3 orders of magnitude slower than what typically used for electrophysiology.

      2) Different neurons included in analysis. The calcium imaging likely has very different biases than electrophysiological recordings. Historically, the fraction of visually responsive neurons in visual cortex based on extracellular electrophysiological recordings has been systematically overestimated (Olshausen and Field, 2005). One key contributor to this is the fact that recordings are biased to visually responsive neurons. The criteria for inclusion of “responsive neurons” strongly influences the “average” response latency. In addition, calcium imaging has biases that relate to the vertical position of the somata in cortex. Both layer 2/3 and layer 5 recordings are likely biased to superficial layer 2/3 and superficial layer 5 neurons. Conversely, electrical recordings are likely biased to layer 4 and layer 5 neurons. Thus, comparisons at this level of resolution between data obtained with these two methods are difficult to make.

      We have added example neurons as Figure S12, as suggested.  

      Reviewer #1 (Recommendations For The Authors):

      While the study showcases valuable insights, I have a couple of concerns regarding the novelty of their research and the interpretation of results. By addressing these concerns, the authors can clarify the positioning of their research and strengthen the significance of their findings.

      (Major comments)

      1) Page 1, Line 21: The authors claim, "Our results suggest that acetylcholine augments the responsiveness of layer 5 neurons to inputs from outside of the local network, enabling faster switching between internal representations during locomotion." However, it is not clear which specific data or results support the claim of "switching between internal representations." Overall, their study primarily presents responses averaged across all neurons imaged, lacking a detailed exploration of individual neuron response patterns. Population analysis, such as PCA and decoding, can be used to assess the encoding of each stimulus by V1 neurons - "internal representation."<br /> To strengthen their claim regarding "switching between internal representations," the authors could consider an experiment measuring the speed at which the population activity pattern A transitions to the population activity pattern B when the visual stimulus switches from A to B. Such experiments would significantly enhance the impact of their study, providing a clearer understanding of how BF cholinergic input influences the dynamic representation of stimuli during locomotion.

      We thank the reviewer for bringing this up. That acetylcholine enables a faster switching between internal representations in layer 5 is a speculation. We have attempted to make this clearer in the discussion. Our speculation is based on the finding that the population response in layer 5 to sensory input is faster under high levels of acetylcholine (Figures 4D and 7B). In line with the reviewer’s intuition, the neuronal response to a change in visual stimulus, in our experiment from a uniform grey visual stimulus to a sinusoidal grating stimulus, is indeed faster. Based on evidence in favor of layer 5 encoding internal representation (Heindorf and Keller, 2023; Keller and Mrsic-Flogel, 2018; Suzuki and Larkum, 2020), we interpret the decrease in latency of the population response as a faster change in internal representation. We are not sure a decoding analysis would add much to this, given that a trivial decoder simply based on mean population response would already find a faster transition. We have expanded on our explanation of these points in the manuscript.

      2) Page 4, Line 103: "..., a direct measurement of the activity of cholinergic projection from basal forebrain to the visual cortex during locomotion has not been made." This statement is incorrect. An earlier study by Reimer et al. indeed imaged cholinergic axons in the visual cortex of mice running on a wheel. They found that "After walking onset, ... ACh activation, and a large pupil diameter, were sustained throughout the walking period in both cortical areas V1 and A1." Their findings are very similar to the results presented by Yogesh and Keller - that is, BF cholinergic axons exhibited locomotion statedependent activity. The authors should clarify the positioning of this study relative to previous studies.

      Reimer, J., McGinley, M., Liu, Y. et al. Pupil fluctuations track rapid changes in adrenergic and cholinergic activity in cortex. Nat Commun 7, 13289 (2016). https://doi.org/10.1038/ncomms13289

      We have clarified this as suggested. However, we disagree slightly with the reviewer here. The key question is whether the cholinergic axons imaged originate in basal forebrain. While Reimer et al. 2016 did set out to do this, we believe a number of methodological considerations prevent this conclusion:

      1) In their analysis, Reimer et al. 2016 combine data from mice with cholinergic axons labeled with either viral injection to basal forebrain or germline cross of ChAT-cre mice with reporter line. Unfortunately, it is unclear what the exact number of mice labeled with either strategy was. Based on the information in the paper, we can conclude that of the 6 mice used for experiments between 2 and 5 were germline cross. The problem with germline labeling of ChAT positive neurons is that when using a cross, VIP-ChAT+ neurons in cortex are also labeled. Based on the fact that Reimer et al. 2016 find an anticipatory increase in activity on locomotion onset, that is also seen by Larsen et al. 2018 (they use a germline cross strategy), an effect we do not see in our data, we speculate that a significant part of the signals reported in the Reimer et al. 2016 paper are from local VIP-ChAT+ neurons.

      2) In their analysis, Reimer et al. 2016 also combine all imaging data obtained from both primary auditory cortex and primary visual cortex. Given the heterogeneity in the basal forebrain cholinergic neuronal population and their projection selectivity, to better understand these signals, it’s important to acquire the signals from cholinergic axons selectively in specific cortical regions, which we do in visual cortex. Based on the information provided in their paper, we were unfortunately not able to discern the injection location for their viral labeling strategy. Given the topographic selectivity in projection from basal forebrain, this could give hints as to the relative contribution of cholinergic projections to A1 vs V1 in their data. The injection coordinates given in the methods of the Reimer paper, of 4 mm lateral and 0.5 mm posterior to bregma to target basal forebrain, are likely wrong (they fall outside the head of the mouse).

      Given the heterogeneity in the basal forebrain cholinergic neuronal population and their projection selectivity, to better understand these signals, it’s important to acquire the signals from cholinergic axons both selectively in a cortical region, as we do in visual cortex, and purely originating from basal forebrain. Collins et al. 2023 inject more laterally and thus characterize cholinergic input to S1 and A1, while Lohani et al. 2022 use GRAB sensors which complement our findings. Please note, we don’t think there is any substantial disagreement in the results of previous studies and ours, with very few exceptions, like the anticipatory increase in cholinergic activity that precedes locomotion onset in the Reimer et al. 2016 data, but not in ours. This is a rather critical point in the context of the literature of motor-related neuronal activity in mouse V1. Based on early work on the topic, it is frequently assumed that motor-related activity in V1 is driven by a cholinergic input. This is very likely incorrect given our results, hence we feel it is important to highlight this methodological caveat of earlier work.

      3) Fig. 4H: The authors found that L5 neurons exhibit positive responses at the onset of locomotion in a closed-loop configuration. Moreover, these responses are further enhanced by photostimulation of BF axons.

      In a previous study from the same authors' group (Heindorf and Keller, 2023), they reported 'negative' responses in L5a IT neurons during closed-loop locomotion. This raises a question about the potential influence of different L5 neuron types on the observed results between the two studies. Do the author think that the involvement of the other neuronal type in L5, the PT neurons, might explain the positive responses seen in the present study? Discussing this point in the paper would provide valuable insights into the underlying mechanisms.

      Yes, we do think the positive response observed on locomotion onset in closed loop is due to non-Tlx3+ neurons. Given that Tlx3-cre only labels a subset of inter-telencephalic (IT) neurons (Gerfen et al., 2013; Heindorf and Keller, 2023), it’s not clear whether the positive response is explained by the pyramidal tract (PT) neurons, or the non-Tlx3+ IT neurons. Dissecting the response profiles of different subsets of layer 5 neurons is an active area of research in the lab and we hope to be able to answer these points more comprehensively in future publications. We have expanded on this in the discussion as suggested.

      Furthermore, it would be valuable to investigate whether the effects of photostimulation of BF axons vary depending on neuronal responsiveness. This could help elucidate how neurons with positive responses, potentially putative PT neurons, differ from neurons with negative responses, putative IT neurons, in their response to BF axon photostimulation during locomotion.

      We have attempted an analysis of the form suggested. In short, we found no relationship between a neuron’s response to optogenetic stimulation of ChAT axons and its response to locomotion onset, or its mean activity. Based on their response to locomotion onset in closed loop, we split layer 5 neurons into three groups, 30% most strongly decreasing (putative Tlx3+), 30% most strongly increasing, and the rest. We did not see a response to optogenetic stimulation of basal forebrain cholinergic axons in any of the three groups (Author response image 4A). We also found no obvious relationship between the mean activity of neurons and their response to optogenetic stimulation (Author response image 4B).

      Author response image 4.

      Neither putative layer 5 cell types nor neuronal responsiveness correlates with the response to optogenetic stimulation of cholinergic axons. (A) Average calcium response of layer 5 neurons split into putative Tlx3 (closed loop locomotion onset suppressed) and non-Tlx3 like (closed loop locomotion onset activated) to optogenetic stimulation of cholinergic axons. (B) Average calcium response of layer 5 neurons to optogenetic stimulation of cholinergic axons as a function of their mean response throughout the experimental session. Left: Each dot is a neuron. Right: Average correlation in the response of layer 5 to optogenetic stimulation and mean activity over all neurons per imaging site. Each dot is an imaging site.

      (Minor comments)

      1) It is unclear which BF subregion(s) were targeted in this study.

      Thanks for pointing this out. We targeted the entire basal forebrain (medial septum, vertical and horizontal limbs of the diagonal band, and nucleus basalis) with our viral injections. All our axonal imaging data comes from visual cortex and given the sensory modality-selectivity of cholinergic projections to cortex, the labeled axons originate from medial septum and the diagonal bands (Kim et al., 2016). We have now added the labels for basal forebrain subregions targeted next to the injection coordinates in the manuscript.

      2) Page 43, Line 818: The journal name of the cited paper Collins et al. is missing.

      Fixed.

      3) In the optogenetic experiments, how long is the inter-trial interval? Simulation of BF is known to have long-lasting effects on cortical activity and plasticity. It is, therefore, important to have a sufficient interval between trials.

      The median inter-trial interval for different stimulation events are as follows:

      • Optogenetic stimulation only : 15 s

      • Optogenetic stimulation + grating : 12 s

      • Optogenetic stimulation + mismatch: 35 s

      • Optogenetic stimulation + locomotion onset: 45 s

      We have added this information to the methods in the manuscript.

      Assuming locomotion is the primary driver of acetylcholine release (as we argue in Figures 1 and 2), the frequency of stimulation roughly corresponds to the frequency of acetylcholine release experienced endogenously. It is of course possible that being awake and mobile puts the entire system in a longlasting acetylcholine driven state different from what would be observed during long-term quite wakefulness or during sleep. But the main focus of the optogenetic stimulation experiments we performed was to investigate the consequences of the rapid acetylcholine release driven by locomotion.

      4) Page 11, Line 313: "..., we cannot exclude the possibility of a systemic contribution to the effects we observe through shared projections between different cortical and subcortical target." This possibility can be tested by examining the effect of optogenetic stimulation of cholinergic axons on locomotor activity, as they did for the chemogenetic experiments (Fig. S7). If the optogenetic manipulation changes locomotor activity, it is likely that this manipulation has some impact on subcortical activity and systemic contribution to the changes in cortical responses observed.

      Based on the reviewer suggestion we tested this and found no change in the locomotor activity of the mice on optogenetic stimulation of cholinergic axons locally in visual cortex (we have added this as Figure S5 to the manuscript). Please note however, we can of course not exclude a systemic contribution based on this.

      5) Fig. 4 and 5: In a closed-loop configuration, L2/3 neurons exhibit a transient increase in response at the onset of locomotion, while in an open-loop configuration, their response is more prolonged. On the other hand, L5 neurons show a sustained response in both configurations. Do the authors have any speculation on this difference?

      This is correct. Locomotion onset responses in layer 2/3 are strongly modulated by whether the locomotion onset occurs in closed loop or open loop configurations (Widmer et al., 2022). This difference is absent in our layer 5 data here. We suspect this is a function of a differential within-layer cell type bias in the different recordings. In the layer 2/3 recordings we are likely biased strongly towards superficial L2/3 neurons that tend to be negative prediction error neurons (top-down excited and bottom-up inhibited), see e.g. (O’Toole et al., 2023). A reduction of locomotion onset responses in closed loop is what one would expect for negative prediction error neurons. While layer 5 neurons exhibit mismatch responses, they do not exhibit opposing top-down and bottom-up input that would result in such a suppression (Jordan and Keller, 2020).

      We can illustrate this by splitting all layer 2/3 neurons based on their response to gratings and to visuomotor mismatch into a positive prediction error (PE) type (top 30% positive grating response), a negative prediction error type (top 30% positive visuomotor mismatch response), and the rest (remaining neurons and neurons responsive to both grating and visuomotor mismatch). Plotting the response of these neurons to locomotion onset in closed loop and open loop, we find that negative PE neurons have a transient response to locomotion onset in closed loop while positive PE neurons have a sustained increase in response in closed loop. In open loop the response of the two populations is indistinguishable. Splitting the layer 5 neurons using the same criteria, we don’t find a striking difference between closed and open loop between the two groups of neurons. We have added this as Figure S8.

      Reviewer #2 (Recommendations For The Authors):

      Major concerns:

      1) As a ubiquitous promoter was used to drive GCaMP expression, please explain how excitatory neurons were identified.

      2) As the data cover a very small range of running speeds, it is important to confirm that the binary locomotion signal model still applies when mice run at higher speeds - either by selecting recordings where mice have a wider range of running speeds or conducting additional experiments. In addition, please show the running speed tuning of individual axons.

      3) Please provide a more detailed analysis of the effects of locomotion and cholinergic modulation on visual responses. How does cholinergic modulation affect orientation and direction tuning? Are the effects multiplicative or additive? How does this compare to the effects of locomotion on single neurons?

      4) To ensure that the analyses in Figure 5 are not confounded by differences in the visual stimulus, please include average visual flow speed traces for each condition.

      5) Please clarify why chemogenetic manipulations of cholinergic inputs had no effect on pairwise correlations in L2/3.

      6) The latency effect is quite an extraordinary claim and requires careful analysis. Please provide examples of single neurons illustrating the latency effect - including responses across individual grating orientations/directions. One possible confound is that grating presentation could itself trigger locomotion or other movements. In the stationary / noOpto conditions, the grating response might not be apparent in the average trace until the animal begins to move. Thus the large latency in the stationary / noOpto conditions may reflect movement-related rather than visual responses.

      Please see our responses to these points in the public review part above.

      There are some minor points where text and figures could be improved:

      1) When discussing the decorrelation of neuronal responses by cholinergic axon activation, it is important to make it clear that Figure 6D quantifies the responses of layer 5 apical dendrites rather than neurons.

      We have added this information to the results section.

      2) In Figure S7, please clarify why velocity is in arbitrary units.

      This was an oversight and has been fixed.

      3) Please clarify how locomotion and stational trials are selected in Figure 4.

      We thank the reviewers for pointing this out. Trials were classified as occurring during locomotion or while mice were stationary as follows. We used a time-window of -0.5 s to +1 s around stimulus onset. If mice exhibited uninterrupted locomotion above a threshold of 0.25 cm/s in this time-window, we considered the stimulus as occurring during locomotion, otherwise it was defined as occurring while the mice were stationary. Note, the same criteria to define locomotion state was used to isolate visuomotor mismatch events, and also during control optogenetic stimulation experiments. We have added this information to the methods.

      4) When testing whether cholinergic activation is sufficient to explain locomotion-induced decorrelation in Figure 6G-H, please show pre-CNO and post-CNO delta-correlation, not just their difference.

      We can do that, but the results are harder to parse this way. We have added this as Figure S11 to the manuscript. The problem with parsing the figure is that the pre-CNO levels are different in different groups. This is likely a function of mouse-to-mouse variability and makes it harder to identify what the CNO induced changes are. Using the pre-post difference removes the batch influence. Hence, we have left this as the main analysis in Figure 6G and 6H.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Wang et al. generate XAP5 and XAP5L knockout mice and find that they are male infertile due to meiotic arrest and reduced sperm motility, respectively. RNA-Seq was subsequently performed and the authors concluded that XAP5 and XAP5L are antagonistic transcription factors of cilliogenesis (in XAP5-KO P16 testis: 554 genes were unregulated and 1587 genes were downregulated; in XAP5L-KO sperm: 2093 genes were unregulated and 267 genes were downregulated).

      We are grateful for the comprehensive summary.

      Strengths:

      Knockout mouse models provided strong evidence to indicate that XAP5 and XAP5L are critical for spermatogenesis and male fertility.

      Thank you for your positive comment.

      Weaknesses:

      The key conclusions are not supported by evidence. First, the authors claim that XAP5 and XAP5L transcriptionally regulate sperm flagella development; however, detailed molecular experiments related to transcription regulation are lacking. How do XAP5 and XAP5L regulate their targets? Only RNA-Seq is not enough. Second, the authors declare that XAP5 and XAP5L are antagonistic transcription factors; however, how do XAP5 and XAP5L regulate sperm flagella development antagonistically? Only RNA-Seq is not enough. Third, I am concerned about whether XAP5 really regulates sperm flagella development. XAP5 is specifically expressed in spermatogonia and XAP5-cKO mice are in meiotic arrest, indicating that XAP5 regulates meiosis rather than sperm flagella development.

      Thank you for the critical comments. To strengthen our conclusions, we have included XAP5/XAP5L CUT&Tag data in our revised manuscript. This highly sensitive method has allowed us to identify direct target genes of XAP5 and XAP5L (Table S1, Figure S6). Notably, our results demonstrate that both FOXJ1 and RFX2 are occupied by XAP5 (Figure 4G). Additionally, real-time PCR validation confirmed that RFX2 is also associated with XAP5L, even though enriched peaks for the RFX2 gene were not detected in the initial CUT&Tag data (Figure 4G). These findings indicate that XAP5 and XAP5L regulate the expression of FOXJ1 and RFX2 by directly binding to these genes. De novo motif analyses revealed that XAP5 and XAP5L shared a conserved binding sequence (CCCCGCCC/GGGCGGGG) (Figure S6C), and the bound regions of FOXJ1 and RFX2 contain this sequence. Further analysis shows that many XAP5L target genes are also targets of XAP5 (Figure S6G), despite the limited number of identified XAP5L target genes. This differential binding and regulation of shared target genes underscore the antagonistic relationship between XAP5 and XAP5L. Collectively, these findings provide additional support for the idea that XAP5 and XAP5L function as antagonistic transcription factors, acting upstream of transcription factor families, including FOXJ1 and RFX factors, to coordinate ciliogenesis during spermatogenesis.

      While we agree that XAP5 primarily regulates meiosis during spermatogenesis, our data also indicate that many cilia-related genes, including key transcription regulators of spermiogenesis such as RFX2 and SOX30, are downregulated in XAP5-cKO mice and are bound by XAP5 (Figure 4, Figures S4 and S6). It is important to note that genes coding for flagella components are expressed sequentially and in a germ cell-specific manner during development. When we refer to "regulating sperm flagella development", we mean the spatiotemporal regulation. We have revised the manuscript to clarify this point.

      Reviewer #2 (Public Review):

      In this study, Wang et al., report the significance of XAP5L and XAP5 in spermatogenesis, involved in transcriptional regulation of the ciliary gene in testes. In previous studies, the authors demonstrate that XAP5 is a transcription factor required for flagellar assembly in Chlamydomonas. Continuing from their previous study, the authors examine the conserved role of the XAP5 and XAP5L, which are the orthologue pair in mammals.

      XAP5 and XAP5L express ubiquitously and testis specifically, respectively, and their absence in the testes causes male infertility with defective spermatogenesis. Interestingly, XAP5 deficiency arrests germ cell development at the pachytene stage, whereas XAP5L absence causes impaired flagellar formation. RNA-seq analyses demonstrated that XAP5 deficiency suppresses ciliary gene expression including Foxj1 and Rfx family genes in early testis. By contrast, XAP5L deficiency abnormally remains Foxj1 and Rfx genes in mature sperm. From the results, the authors conclude that XAP5 and XAP5L are the antagonistic transcription factors that function upstream of Foxj1 and Rfx family genes.

      This reviewer thinks the overall experiments are performed well and that the manuscript is clear. However, the current results do not directly support the authors' conclusion. For example, the transcriptional function of XAP5 and XAP5L requires more evidence. In addition, this reviewer wonders about the conserved XAP5 function of ciliary/flagellar gene transcription in mammals - the gene is ubiquitously expressed despite its functional importance in flagellar assembly in Chlamydomonas. Thus, this reviewer thinks authors are required to show more direct evidence to clearly support their conclusion with more descriptions of its role in ciliary/flagellar assembly.

      Thank you for your thoughtful review of our work. We appreciate your positive feedback on the overall quality of the experiments and the clarity of the manuscript. In response to your concerns, we have included new experimental data and made revisions to the manuscript (lines 193-217) to better support our conclusions, particularly regarding the transcriptional function of XAP5 and XAP5L. Additionally, we have expanded on the role of XAP5 in ciliary and flagellar assembly to provide more direct evidence for its functional importance. Thank you for your insights.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      The title (Control of ciliary transcriptional programs during spermatogenesis by antagonistic transcription factors) is not specific and does tend to exaggerate.

      Thank you for the comment, and we appreciate the opportunity to clarify the appropriateness of the title. Our paper extensively investigates the transcriptional regulation of ciliary genes during spermatogenesis. It demonstrates that XAP5/XAP5L are key transcription factors involved in this process. The title reflects our primary focus on the transcriptional programs that govern ciliary gene expression. Moreover, our paper shows that XAP5 positively regulates the expression of ciliary genes, particularly during the early stages of spermatogenesis, while XAP5L negatively regulates these genes. This antagonistic relationship is a crucial aspect of the study and is effectively conveyed in the title. In addition, our revised paper provides detailed insights into how XAP5/XAP5L control ciliary gene expression during spermatogenesis.

      Figure 4C: FOXJ1 and RFX2 are absent in sperm from WT mice. Are you sure? They are highly expressed in WT testes.

      Thank you for your careful review. While FOXJ1 and RFX2 are indeed highly expressed in the testes of wild-type (WT) mice, our data show that they are not detectable in mature sperm. This observation is consistent with published single-cell RNA-seq data(Jung et al., 2019), which indicate that FOXJ1 and RFX2 are primarily expressed in spermatocytes but not in spermatids (Figure S7). This expression pattern aligns with that that of IFT-particle proteins, which are essential for the formation but not the maintenance of mammalian sperm flagella(San Agustin, Pazour, & Witman, 2015).

      XAP5 is specifically expressed in spermatogonia and XAP5-cKO mice are in meiotic arrest, indicating that XAP5 regulates meiosis rather than sperm flagella development.

      We appreciate your insightful comments. As mentioned above, we agree that XAP5 primarily regulates meiosis during spermatogenesis. When we mentioned "regulating sperm flagella development," we were referring to the spatiotemporal regulation of these processes. We have revised the manuscript to clarify this distinction. Thank you for your understanding.

      The title of Figure 2 (XAP5L is required for normal sperm formation) is not accurate because the progress of spermatogenesis and sperm count is normal in XAP5L-KO mice (only sperm motility is reduced).

      We apologize for any confusion caused by the previous figure. It did not accurately convey the changes in sperm count. In the revised Figure 2B, we clearly demonstrate that the sperm count in XAP5L-KO mice is indeed lower than that in WT mice. This revision aims to provide a more accurate representation of the effects of XAP5L deficiency on spermatogenesis. Thank you for bringing this to our attention.

      Reviewer #2 (Recommendations For The Authors):

      (1) Although XAP5 and XAP5L deficiency alters the transcription of Foxj1 and Rfx family genes, which are the essential transcription factors for the ciliogenesis, current data do not directly support that XAP5 and XAP5L are the upstream transcription factors. The authors need to show more direct evidence such as CHIP-Seq data.

      Thank you for your valuable feedback! In this revised manuscript, we have included data identifying candidate direct targets of XAP5 and XAP5L using the highly sensitive CUT&Tag method (Kaya-Okur et al., 2019). Our results show that XAP5 occupies both FOXJ1 and RFX2 (Figure 4G). Furthermore, real-time PCR validation of the CUT&Tag experiments confirmed that RFX2 is also occupied by XAP5L (Figure 4G), despite the initial CUT&Tag data not revealing enriched peaks for the RFX2 gene (Table S1). Unfortunately, the limited number of enriched peaks identified for XAP5L (Table S1) suggests that the XAP5L antibody used in the CUT&Tag experiment might have suboptimal performance, which prevented us from detecting occupancy on the FOXJ1 promoter. Nevertheless, these additional data provide strong evidence that XAP5 and XAP5L function as upstream transcription factors for FOXJ1 and RFX family genes, supporting their essential roles in ciliogenesis.

      (2) Shared transcripts that are altered by the absence of either XAP5 or XAP5L do not clearly support they are antagonistic transcription factors.

      Thank you for your insightful comment. In our revised manuscript, we performed CUT&Tag analysis to identify target genes of XAP5 and XAP5L. Motif enrichment analysis revealed conserved binding sequences for both factors (Figures S6C), indicating a subset of shared downstream genes between XAP5 and XAP5L. Among the downregulated genes in XAP5 cKO germ cells, 891 genes were bound by XAP5 (Figure S6D). Although the number of enriched peaks identified for XAP5L was limited, 75 of the upregulated genes in XAP5L KO sperm were bound by XAP5L (Figure S6E). Importantly, of these 75 XAP5L target genes, approximately 30% (22 genes) were also identified as targets of XAP5 (Figure S6G), further support the idea that XAP5 and XAP5L function as antagonistic transcription factors.

      (3) XAP5 seems to be an ancient transcription factor for cilia and flagellar assembly. However, XAP5 expresses ubiquitously in mice. How can this discrepancy be explained? Is it also required for primary cilia assembly? Are their expression also directly linked to ciliogenesis in other types of cells?

      Thank you for the thoughtful questions. The ubiquitous expression of XAP5 in mice can be understood in light of its role as an ancient transcription factor for cilia and flagellar assembly. Given that cilia are present on nearly every cell type in the mammalian body (O'Connor et al., 2013), this broad expression pattern makes sense. In fact, XAP5 serves not only as a master regulator of ciliogenesis but also as a critical regulator of various developmental processes (Kim et al., 2018; Lee et al., 2020; Xie et al., 2023).

      Our current unpublished work demonstrates that XAP5 is essential for primary cilia assembly in different cell lines. The loss of XAP5 protein results in abnormal ciliogenesis, further supporting its vital role in ciliary formation across different cell types.

      We believe that the widespread expression of XAP5 reflects its fundamental importance in multiple cellular processes, including ciliogenesis, development, and potentially other cellular functions yet to be discovered.

      (4) XAP5L causes impairs flagellar assembly. Have the authors observed any other physiological defects in the absence of XAP5L in mouse models? Such as hydrocephalus and/or tracheal defects?

      Thank you for the questions. We have carefully examined XAP5L KO mice for other physiological defects. To date, we have not observed any additional physiological abnormalities. Specifically, we assessed the condition of tracheal cilia in XAP5L KO mice and found no significant differences compared to wild-type (WT) mice, as illustrated in Author response image 1 below.

      Author response image 1.

      References

      Jung, M., Wells, D., Rusch, J., Ahmad, S., Marchini, J., Myers, S. R., & Conrad, D. F. (2019). Unified single-cell analysis of testis gene regulation and pathology in five mouse strains. Elife, 8. doi:10.7554/eLife.43966

      Kaya-Okur, H. S., Wu, S. J., Codomo, C. A., Pledger, E. S., Bryson, T. D., Henikoff, J. G., . . . Henikoff, S. (2019). CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat Commun, 10(1), 1930. doi:10.1038/s41467-019-09982-5

      Kim, Y., Hur, S. W., Jeong, B. C., Oh, S. H., Hwang, Y. C., Kim, S. H., & Koh, J. T. (2018). The Fam50a positively regulates ameloblast differentiation via interacting with Runx2. J Cell Physiol, 233(2), 1512-1522. doi:10.1002/jcp.26038

      Lee, Y.-R., Khan, K., Armfield-Uhas, K., Srikanth, S., Thompson, N. A., Pardo, M., . . . Schwartz, C. E. (2020). Mutations in FAM50A suggest that Armfield XLID syndrome is a spliceosomopathy. Nature Communications, 11(1). doi:10.1038/s41467-020-17452-6

      O'Connor, A. K., Malarkey, E. B., Berbari, N. F., Croyle, M. J., Haycraft, C. J., Bell, P. D., . . . Yoder, B. K. (2013). An inducible CiliaGFP mouse model for in vivo visualization and analysis of cilia in live tissue. Cilia, 2(1), 8. doi:10.1186/2046-2530-2-8

      San Agustin, J. T., Pazour, G. J., & Witman, G. B. (2015). Intraflagellar transport is essential for mammalian spermiogenesis but is absent in mature sperm. Mol Biol Cell, 26(24), 4358-4372. doi:10.1091/mbc.E15-08-0578

      Xie, X., Li, L., Tao, S., Chen, M., Fei, L., Yang, Q., . . . Chen, L. (2023). Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo. Int J Mol Sci, 24(4). doi:10.3390/ijms24043217

    1. Author response:

      The following is the authors’ response to the original reviews.

      Joint Public Review:

      Previously, this group showed that Tgfbr1 regulates the reorganization of the epiblast and primitive streak into the chordo-neural hinge and tailbud during the trunk-to-tail transition. Gdf11 signaling plays a crucial role in orchestrating the transition from trunk to tail tissues in vertebrate embryos, including the reallocation of axial progenitors into the tailbud and Tgfbr1 plays a key role in mediating its signaling activity. Progenitors that contribute to the extension of the neural tube and paraxial mesoderm into the tail are located in this region. In this work, the authors show that Tgfbr1 also regulates the reorganization of the posterior primitive streak/base of allantois and the endoderm as well. 

      By analyzing the morphological phenotypes and marker gene expression in Tgfbr1 mutant mouse embryos, they show that it regulates the merger of somatic and splanchnic layers of the lateral plate mesoderm, the posterior streak derivative. They also present evidence suggesting that Tgfbr1 acts upstream of Isl1 (key effector of Gdf11 signaling for controlling differentiation of lateral mesoderm progenitors) and regulates the remodelling of the major blood vessels, the lateral plate mesoderm and endoderm associated with the trunk-to-tail transition. Through a detailed phenotypic analysis, the authors observed that, similarly to Isl1 mutants, the lack of Tgfbr1 in mouse embryos hinders the activation of hindlimb and external genitalia maker genes and results in a failure of lateral plate mesoderm layers to converge during tail development. As a result, they interpret that ventral lateral mesoderm, which generates the peri cloacal mesenchyme and genital tuberculum, fails to specify. 

      They also show defects in the morphogenesis of the dorsal aorta at the trunk/tail juncture, resulting in an aberrant embryonic/extraembryonic vascular connection. Endoderm reorganization defects following abnormal morphogenesis of the gut tube in the Tgfbr1 mutants cause failure of tailgut formation and cloacal enlargement. Thus, Tgfbr1 activity regulates the morphogenesis of the trunk/tail junction and the morphogenetic switch in all germ layers required for continuing post-anal tail development. Taken together with the previous studies, this work places Gdf11/8 - Tgfbr1 signaling at the pivot of trunk-to-tail transition and the authors speculate that critical signaling through Tgfbr1 occurs in the posterior-most part of the caudal epiblast, close to the allantois. 

      Strengths: 

      The data shown is solid with excellent embryology/developmental biology. This work demonstrates meticulous execution and is presented in a comprehensive and coherent manner. Although not completely novel, the results/conclusions add to the known function of Gdf11 signaling during the trunk-to-tail transition. 

      Weaknesses: 

      The authors rely on the expression of a small number of key regulatory genes to interpret the developmental defects. The alternative possibilities remain to be ruled out thoroughly. The manuscript is also quite descriptive and would benefit from more focused highlighting of the novelty regarding the absence of Tgfbr1 in the mouse embryo. They should also strengthen some of their conclusions with more details in the results.

      Although we used a limited number of key regulatory genes to interpret the phenotype, these genes were carefully chosen to focus on specific processes involving the lateral mesoderm, its derivatives, and the endoderm. In addition to these markers, we included references to other relevant markers that were previously analyzed and initially led us to examine the lateral plate mesoderm and tail gut in Tgfbr1 mutants. To strengthen our analysis, we have now incorporated additional data to clarify specific phenotypes. For instance, in situ hybridization (ISH) for Shh further confirms abnormalities at the caudal end of the endoderm in mutant embryos, while no endodermal defects are observed in the trunk region. We also included an analysis of the intermediate mesoderm, which shows abnormalities at the same level as those found in the lateral plate mesoderm and endoderm of Tgfbr1 mutants.

      It’s important to note that using additional markers to assess the epiblast/primitive streak of Tgfbr1 mutants at E7.5–E8.5, as suggested by a reviewer, is unlikely to yield new insights. At these early stages, Tgfbr1 mutant embryos do not display observable phenotypes in the main body axis. Data in this manuscript already demonstrate the absence of abnormalities at this stage, as shown in Figure 3 and Supplementary Figure 6. Additionally, the expression of certain genes showing abnormalities when the embryo would enter tail development, in the trunk their expression remains unaffected, indicating that trunk extension is not significantly impacted by Tgfbr1 deficiency. While transcriptomic analysis of these Tgfbr1 mutants could provide interesting insights, it would be more appropriate to focus on later developmental stages, which would be beyond the scope of the current study.

      The second major critique was that the manuscript is primarily descriptive. We disagree with this assessment. Several hypotheses were rigorously tested using genetic approaches, including Isl1 knockout experiments, cell tracing from the primitive streak with a newly generated Cre driver to activate a reporter from the ROSA26 locus, and assessment of extraembryonic endoderm fate in Tgfbr1 mutants by introducing the Afp-GFP transgene into the Tgfbr1 mutant background. Additionally, we conducted tracing analyses of tail bud cell contributions to the tail gut via DiI injection and embryo incubation. To address potential concerns regarding this experiment, we have included data showing the DiI position immediately after injection to confirm that it does not contact the tail gut. We also considered and accounted for potential DiI leakage into neuromesodermal progenitors to clarify the endodermal results.

      Our genetic and DiI experiments were specifically designed to differentiate between alternative hypotheses and to confirm hypotheses generated from other analyses. Additionally, improvements in some of the imaging data have helped address remaining concerns.

      Reviewer #1 (Recommendations For The Authors): 

      I have listed my suggestions as queries. The authors may perform experiments or clarify by editing the text to address them. 

      The authors state on Page 11 and elsewhere that the ventral lateral mesoderm is absent in the Tgfbr1 mutant. What is the basis for this conclusion? Are there specific markers for PCM or GT primordium? 

      The specific marker of PCM and GT primordium is Isl1. The absence of this marker in the Tgfbr1 mutants is shown in (Dias et al, 2020). The reference is introduced in the manuscript.

      A schematic illustrating the VLM and the expression patterns of Tgfbr1, Gdf11, etc., would be helpful. 

      Characterization of Gdf11 expression has been previously reported (e.g. McPherron et al 1999, cited in our manuscript). It is expressed in the region containing of axial progenitors before the trunk to tail transition and not expressed in the VLM. As for Tgfbr1 expression is hard to detect, likely because it is ubiquitously expressed at low level. We include in this document some pictures of an ISH, including a control using the Tgfbr1 mutants to illustrate that the staining resembling background actually represents Tgfbr1 expression. If the reviewers find it important, we can also incorporate these data into the manuscript. Under these circumstances, we feel that a schematic might not be very informative.

      Author response image 1.

      Image showing an example of an ISH procedure with a probe against Tgfbr1, showing widespread and low expression. The lower picture shows a ventral view of a stained wild type E10.5 embryo.

      Foxf1+ cells in the 'extended LPM' of Tgfbr1 mutants suggest fate transformation, or does it indicate the misexpression of marker gene otherwise suppressed by Tgfbr1 activity? The authors suggest that Foxf1+ cells are VLM progenitors from posterior PS trapped in the extended LPM. Do they continue to express PS markers? 

      The observation that both in wild type and Tgfbr1 mutant embryos Foxf1 expression in the trunk is restricted to the splanchnic LPM indicates that the absence of this marker in the somatic LPM is not the result of a suppression of its expression by Tgfbr1. In wild type embryos Foxf1 is also expressed in the posterior PS, regulated independently of its expression in the LPM (i.e. Shh-independent) and later in the pericloacal mesoderm (our supplementary figure 2). As Foxf1 expression in the posterior PS was not suppressed in the Tgfbr1 mutants, together with the absence of pericloacal mesoderm, we interpret that the Foxf1-positive cells in the two layers around the extended celomic cavity in the posterior end of the mutant embryos derived from the posterior PS, resulting from the absence of its normal progression through the embryonic tissues.

      We did not find expression of PS markers giving rise to paraxial mesoderm, like Tbxt, further suggesting that those cells could derive from the restricted set of cells within the posterior PS that contribute to the pericloacal mesoderm

      For example, the misexpression of Apela is interpreted as mis-localized endoderm cells. They show scattered Keratin 8 misexpression to support the interpretation. It would be more convincing if the authors tested the expression of other endoderm markers. 

      As indicated in the manuscript, we suggest that these cells are endoderm progenitors (p. 13), like those present at the posterior end of the gut tube at E9.5 and E10.5, that are unable to incorporate into the gut tube. Apela is not a general endodermal marker: it is expressed in the foregut pocket and the nascent cells of the hindgut/tail gut, becoming down regulated as cells take typical endodermal signatures. The presence of ectopic Apela expression in the extended LPM of the mutant embryos might indeed indicate the presence of progenitors that failed to downregulate Apela resulting from the lack differentiation-associated downregulation. This would also implicate the absence of definitive endodermal markers.

      The Nodal signaling pathway in the anterior PS drives endoderm development. It acts through Alk7. Does Tgfbr1 (Alk5) mutation impact endoderm development, in general? It isn't easy to assess this from the Foxa2 in situ RNA hybridization shown in Figures 6A and B. It would be helpful for the readers if the authors clarified this point. 

      In the pictures shown in Figure 7D-D’ it is already shown that the endoderm is mostly preserved until the region of the trunk to tail transition. The presence of a rather normal endoderm in the embryonic trunk can also be seen with Shh, a figure added as Supplementary Fig.5.

      Reviewer #2 (Recommendations For The Authors): 

      The authors mention two interesting novel points which they should develop in the discussion, and probably also in the results. 

      (1) The authors speculate about the possible involvement of the posterior PS as a mediator of Gdf11/Tgfbr1 signaling activity. However, as mentioned in the manuscript, their experiments do not allow regional sublocalization within the PS... Here it would be important to assess/discuss in more detail which progenitors respond to this signaling activity and when they do it. At the very least, the authors should provide high-resolution spatiotemporal data of the expression of Tgfbr1 in the PS. 

      Tgfbr1 expression at this embryonic stage does not give clear differential patterns. The data reported for this expression in Andersson et al 2006 is very low quality and we have not been able to reproduce the reported pattern. On the contrary, all our efforts over the years provided a very general staining that could even be interpreted as background. When we now included Tgfbr1 mutants as controls, it became clear that the ubiquitous and low level signal observed in wild type embryos indeed represent Tgfbr1 expression pattern: low level and ubiquitous. We are attaching a figure to this document illustrating these observations. If required, this can also be included in the manuscript as a supplementary figure. 

      Also, the work of Wymeersch et al., 2019 regarding the lateral plate mesoderm progenitors (LPMPs) should be referred to and discussed here. 

      This was now added in the results (page 11) and in discussion (page 16). 

      For instance, are the LPMP transcriptomic differences detected between E7.5 and E8.5 caused by Tgfbr1 signaling activity? This question could be easily answered through a comparative bulk RNAseq analysis of the posterior-most region of the PS of mutant and WT embryos. The possible colocalization of Tgfb1 (Wymeersch et al., 2019) and Tgfbr1 in the LPMPs should also be addressed. 

      We agree with the suggestion that RNA-seq in the posterior PS of WT and mutant embryos might be informative. However, it is very likely that within the proposed timeframe (E7.5 to E8.5) that there are no significant differences between the wild type and the Tgfbr1 mutant embryos because there is no apparent axial phenotype in Tgfbr1 mutant embryos before the trunk to tail transition. Therefore, at this stage, we think that this experiment is out of the scope of the present manuscript. 

      (2) The activity of Tgfbr1 during the trunk-to-tail transition is critical for the development of tail endodermal tissues. Here the authors suggest again the involvement of the posterior PS/allantois region, but a similar phenotype can also be observed for instance in the absence of Snai1 in the caudal epiblast (Dias et al., 2020)... It would be important to assess/discuss the origin of those morphogenetic problems in the gut. Is it due to the reallocation of NMC cells into the CNH? The tailbud-EMT process? LPMPs specification?... Regional mutations or gain of functions of Snai1 or Tgfbr1 in the caudal epiblast would help answer the question.  

      The endodermal phenotype in the Snai1 mutants is different to that observed in the Tgfbr1 mutants. As can be observed in Figures 3, 4 and 5 of Dias et al. the absence of tailbud is replaced by a structure that extends the epiblast. As a consequence, the endoderm finishes at the base of that structure, even expanding to make a structure resembling the cloaca, which is different to what is seen in the Tgfbr1 mutants. In this case, the lack of tail gut is likely to result either from the lack of formation of the progenitors of the gut endoderm or from the dissociation of what would be the tail bud from the LPM. Actually, hindlimb/pericloacal mesoderm markers, like Tbx4, are preserved in the Snai1 mutant. As for the gain of function of Snai1 experiment, already reported also in Dias et al 2020, the destiny of these cells is not clear. The ISH for Foxa2 showed extra signals but as it is not an exclusive marker for endoderm it is not possible to know whether any of these signals correspond to endodermal tissues.

      Regarding the development of tail endodermal tissues, the authors suggest that it occurs from a structure derived from the PS that is located posteriorly, in the tailbud, after the tip of the growing gut. This is an important and novel point as it suggests that the primordia of the endoderm is not wholly specified during gastrulation. So the observation should be well supported. How can Anastasiia et al. distinguish such "structure" from the actual developing gut? Does it have a distinct molecular signature or any morphological landmark that enables its separation from the actual gut? The data suggests that the region highlighted in Supplementary Figure 4Ab contains part of the actual gut tube (the same is suggested in Figure 5B). If the authors think otherwise, they must characterize that region of the tailbud by doing a thorough morphological and gene/protein expression analysis and assess its potency, via transplantation experiments. Also, the authors' claim mostly relies on the DiI experiments and those have three problems: #1 Anastasiia et al. assess "tail" endodermal growth at E9.5 when the correct stage to do it is after E10.5 (after tailbud formation). 2# Incongruencies, low number (only three embryos), and diversity in the results shown in Figure 8 and Supplementary Figure 4. For instance, despite similar staining at 0h, the extension and amount of DiI present in the gut tube after 20h varies significantly amongst the differently labeled embryos. A possible explanation lies in the abnormal leakiness of the DiI labelings and that is confirmed by the observations shown in Supplementary Figure 4M-O; the same for Supplementary Figure 4G, which shows a substantial amount of DiI in the neural tube. 3# The authors must provide high-quality data showing which tissues/regions were labelled at time 0h, including transversal and sagittal sections as they did for the 20h time-point. Additionally, it is important to re-orient the sagittal optical sections to a position that also shows the neural tube (like a mid-sagittal section) and include information concerning the AP/DV axis, as well as the location of the transversal optical sections in the sagittal image. 

      As described in the reply to reviewer 1, Apela is expressed in the nascent tail gut endoderm but not in more anterior areas except for a foregut pocket, and becomes downregulated as the tube acquires endodermal signatures. Therefore, the structure to which the reviewer refers to might indeed represent a group of progenitors that extend the tail gut. And the observation that this property is observed only in the tail gut as it grows, already separates this region of the gut, which in the end do not contribute to mature organs, from more anterior areas of the endoderm (essentially anterior to the cloaca) that will become a relevant tissue of the intestinal organs. Our DiI labelling experiment was aimed to test whether this pool of cells contributes to the gut but does not allow to determine the nature of those cells, a question that will require further research (discussed on p. 17) and we think is beyond the scope of the present manuscript.

      Regarding the labelling at E10.5, we agree that the tail bud in terms of NMCs is not completely formed, for example, at E9.5 the neuropore is not yet closed. However, we are more interested in regression of the epiblast, which is complete by E9.5. Injecting at E9.5 also has technical advantages for us, first, because in our hands earlier embryos grow better in culture, and second, because it is easier to inject in the tailbud at E9.5 because it is a little bit bigger than at E10.5. Therefore, injecting at E9.5 is less prone to technical artifacts due to injection inaccuracy and compromised growth in culture.

      We agree that the injected DiI could also leak into NMPs, which might be located in the same area. However, while this could result in labeling of the neural tube, it would not affect the interpretation of the finding of labeled cells in the tail gut. Indeed, the presence of this label in the gut epithelium indicates the presence of progenitors in the injected region of the tail gut. We added some considerations of this the possible leakage into the results section of the manuscript (p. 15). We thank the reviewer for drawing our attention to this issue. 

      We also now provide high quality data showing labelled tissue at 0h in Supplementary figure 8A-c’, higher magnification images in Fig. 8, and reoriented optical sections in Fig.6 and in Supplementary Fig. 7, including axis and location of the sections as suggested by the reviewer.

      Minor concerns/comments: 

      (1) The abstract is quite long, though this might be fine for this journal. 

      (2) In relation to the comment on the abstract, the manuscript needs an initial Figure descrbing the events that are described in the introduction. Otherwise, the manuscript will only be accessible to mouse embryologists.

      We have a figure summarizing the results at the end of the manuscript, we think that including similar figure in the beginning might be redundant. What we could do, if required, is to include this type of schematic as a graphical abstract.

      (3) The authors need to clarify what they mean when they use the following expressions "PS fate" and "fate of the posterior PS".

      I do not think that we have used such expressions. Indeed, they did not come out when we run a “find” in the word document. However, they would mean the tissue that would come out from them at later developmental stages.

      (4) The assessment of Isl1 expression in Tgfbr1 mutant and transgenic mouse embryos would be better indicative of their molecular relationship than a comparative phenotypic analysis. 

      These data have been reported in Dias et al 2020 and Jurberg et al 2013, both cited in the manuscript.  

      (5) The authors should explain or discuss what the upregulation of Foxa2 in the posterior end of Tgfbr1 mutants means.

      While an upregulation is apparent in the figure, looking at other pictures we cannot be sure of this being a significantly quantifiable up-regulation. We therefore removed the statement from the text.

      (6) What happens to the intermediate mesoderm during the trunk-to-tail transition? Is Tgfbr1 involved in the regulation of its development?

      We have tested this using Pax2 and added the relevant data in Supplementary Fig. 1 and described in the results.

      (7) The term "potential" should not be used during the description of DiI labeling experiments as this technique only assesses cell fate.

      Corrected

      (8) Some figures lack AP/DV axis information (e.g. Figures 6, C, and D).

      Corrected

    1. Author Response

      The following is the authors’ response to the original reviews.

      We would like to extend our gratitude to the reviewers for their meticulous analysis and constructive feedback on our manuscript. We have revised our paper based on the suggestions regarding supporting literature and the theory behind CAPs along with detailed insights regarding our methods. Their suggestions have been extremely useful in strengthening the clarity and rigor of our manuscript.

      Reviewer #1 (Recommendations For The Authors):

      (1) There are no obvious problems with this paper and it is relatively straightforward. There are some challenges that I would like to suggest. These variants have multiple mutations, so it would be interesting if you could drill down to find out which mutation is the most important for the collective changes reported here. I would like to see a sequence alignment of these variants, perhaps in the supplemental material, just to get some indication of the extent of mutations involved.

      Finding the most important mutation within a set is a tricky question, as each mutation changes the way future mutations will affect function due to epistasis. Indeed, this is what we aim to explore in this work. To illustrate this point, we included a new supplementary figure S5A. Three critical mutations that emerged quickly, and were frequently observed in other dominant variants, were S477N, T478K, and N501Y. Thus, we computed the EpiScore values of these three mutations, with several critical residues contributing to hACE2 binding. The EpiScore distribution indicates that residues 477, 478, and 501 have strong epistatic (i.e., non-additive) interactions, as indicated by EpiScore values above 2.0.

      To further investigate these epistatic interactions, we first conducted MD simulations and computed the DFI profile of these three single mutants. We analyzed how different the DFI scores of the hACE2 binding interface residues of the RBD are, across three single mutants with Omicron, Delta, and Omicron XBB variants (Fig S5B). Fig S5B shows how mutations at these particular sites affect the binding interface DFI in various backgrounds, as the three mutations are also observed in the Omicron, XBB, and XBB 1.5 variants. If the difference in the DFI profile of the mutant and the given variant is close to 0, then we could safely state that this mutation affected the variant the most. However, what we observe is quite the opposite: the DFI profile of the mutation is significantly different in different variant backgrounds. While these mutations may change overall behavior, their individual contributions to overall function are more difficult to pin down because overall function is dependent on the non-additive interactions between many different residues.

      Author response image 1.

      (A) Three critical mutations that emerged quickly, and were frequently observed in other dominant variants, were S477N, T478K, and N501Y. EpiScores of sites 477, 478, and 501 with one another are shown with k = the binding interface of the open chain. These residues are highly epistatic, producing higher responses than expected when perturbed together. (B) The difference in the dynamic flexibility profiles between the single mutants and the most common variants for the hACE2 binding residues of the RBD. DFI profiles exhibit significant variation from zero, and also show different flexibility in each background variant, highlighting the critical non-additive interactions of the other mutation in the given background variant. Thus, these three critical mutations, impacting binding affinity, do not solely contribute to the binding. There are epistatic interactions with the other mutations in VOCs that shape the dynamics of the binding interface to modulate binding affinity with hACE2.

      As we discussed above, while the epistatic interactions are crucial and the collective impact of the mutations shape the mutational landscape of the spike protein, we would like note that mutation S486P is one of the critical mutations we identify, modulating both antibody and hACE2 binding and our analysis reveals the strong non-additive interactions with the other mutational sites. This mutational site appears in both XBB1.5 and earlier Omicron strains which highlights its importance in functional evolution of the spike protein. CAPs 346R, 486F, and 498Q also may be important, as they have a high EpiScore, indicating critical epistatic interaction with many mutation sites.

      Regarding to the suggestion about presenting the alignment of the different variants, we have attached a mutation table, highlighting the mutated residues for each strain compared to the reference sequence as supplemental Figure S1 along with the full alignment file.

      (2) Also, I am wondering if it would be possible to insert some of these flexibilities and their correlations directly into the elastic network models to enable a simpler interpretation of these results. I realize this is beyond the scope of the present work, but such an effort might help in understanding these relatively complex effects.

      This is great suggestion. A similar analysis has been performed for different proteins by Mcleash (See doi: 10.1016/j.bpj.2015.08.009) by modulating the spring constants of specific position to alter specific flexibility and evaluate change in elastic free energy to identify critical mutation (in particular, allosteric mutation) sites. We will be happy to pursue this as future work.

      Minor

      (3) 1 typo on line 443 - should be binding instead of biding.

      Fixed, thanks for spotting that.

      (4) The two shades of blue in Fig. 4B were not distinguishable in my version.

      To fix this, we have changed the overlapping residues between Delta and Omicron to a higher contrast shade of blue.

      (5) Compensatory is often used in an entirely different way - additional mutations that help to recover native function in the presence of a deleterious mutation.

      Although our previous study (Ose et al. 2022, Biophysical Journal) shows that compensatory mutations were generally additive, the two ideas are not one and the same. We thank the reviewer for pointing this out. Therefore, to clarify, we have now described our results in terms of dynamic additivity, rather than compensation.

      Reviewer #2 (Recommendations For The Authors):

      (1) The authors note that the identified CAPs overlap with those of others (Cagliani et al. 2020; Singh and Yi 2021; Starr, Zepeda, et al. 2022). In itself, this merits a deeper discussion and explicit indication of which positions are not identified. However, there is one point that I believe may represent a fundamental flaw in this study in that the calculation of EP from the alignment of S proteins ignores entirely the differences in the interacting interface with which S for different coronaviruses in the alignment interact in the different receptors in each host species. This may be the reason why so many "CAPs" are in the RBD. The authors should at the very least make a convincing case of why they are not simply detecting constraints imposed by the different interacting partners, at least in the case of positions within the RBD interface with ACE2. Another point that the authors should discuss is that ACE2 is not the only receptor that facilitates infection, TMPRSS2 and possibly others have been identified as well. The results should be discussed in light of this.

      To begin with, we have now explicitly noted (on line 135) that “sites 478, 486, 498, and 681 have already been implicated in SARS-CoV-2 evolution, leaving the remaining 11 CAPs as undiscovered candidate sites for adaptation.” Evolutionary analyses are done using orthologous protein sequences, so there is no way to integrate information on different receptors in each host species in the calculation of EPs. However, we appreciate that the preponderance of CAPs in the RBD is likely due to different binding environments. We have added the following text (on line 83) to clarify our point: “Adaptation in this case means a virus which can successfully infect human hosts. As CAPs are unexpected polymorphisms under neutral theory, their existence implies a non-neutral effect. This can come in the form of functional changes (Liu et al. 2016) or compensation for functional changes (Ose et al. 2022). Therefore, we suspect that these CAPs, being unexpected changes from coronaviruses across other host species with different binding substrates, may be partially responsible for the functional change of allowing human infection.” This hypothesis is supported by the overlap of CAPs we identified with the positions identified in other studies (e.g., 478, 486, 498, and 681). Binding to TMPRSS2 and other substrates are also covered by this analysis as it is a measure of overall evolutionary fitness, rather than binding to any specific substrate. Our paper does focus on discussing hACE2 binding and mentions furin cleavage, but indeed lacks discussion on the role of TMPRSS2. We have added the following text to line 157: “Another host cell protease, TMPRSS2, facilitates viral attachment to the surface of target cells upon binding either to sites Arg815/Ser816, or Arg685/Ser686 which overlaps with the furin cleavage site 676-689, further emphasizing the importance of this area (Hoffmann et al. 2020b; Fraser et al. 2022).”

      (2) Turning now to the computational methods utilized to study dynamics, I have serious reservations about the novelty of the results as well as the validity of the methodology. First of all, the authors mention the work of Teruel et al. (PLOS Comp Bio 2021) in an extremely superficial fashion and do not mention at all a second manuscript by Teruel et al. (Biorxiv 2021.12.14.472622 (2021)). However, the work by Teruel et al. identifies positions and specific mutations that affect the dynamics of S and the evolution of the SARS-CoV-2 virus in light of immune escape, ACE2 binding, and open and closed state dynamics. The specific differences in approach should be noted but the results specifically should be compared. This omission is evident throughout the manuscript. Several other groups have also published on the use of nomal-mode analysis methods to understand the Spike protein, among them Verkhivker et al., Zhou et al., Majumder et al., etc.

      Thank you for your suggestions. Upon further examination of the listed papers, we have added citations to other groups employing similar methods. However, it's worth noting that the results of Teruel et al.'s studies are generally not directly comparable to our own. Particularly, they examine specific individual mutations and overall dynamical signatures associated with them, whereas our results are always considered in the context of epistasis and joint effects with CAPs, and all mutations belong to the common variants. Although important mutations may be highlighted in both cases, it is for very different reasons. Nevertheless, we provide a more detailed mention of the results of both studies. See lines 178, 255, and 393.

      (3) The last concern that I have is with respect to the methodology. The dynamic couplings and the derived index (DCI) are entirely based on the use of the elastic network model presented which is strictly sequence-agnostic. Only C-alpha positions are taken into consideration and no information about the side-chain is considered in any manner. Of course, the specific sequence of a protein will affect the unique placement of C-alpha atoms (i.e., mutations affect structure), therefore even ANM or ENM can to some extent predict the effect of mutations in as much as these have an effect on the structure, either experimentally determined or correctly and even incorrectly modelled. However, such an approach needs to be discussed in far deeper detail when it comes to positions on the surface of a protein such that the reader can gauge if the observed effects are the result of modelling errors.

      We would like to clarify that most of our results do not involve simulations of different variants, but rather how characteristic mutation sites for those variants contribute to overall dynamics. For the full spike, we operate on only two simulations: open and closed. When we do analyze different variants, starting on line 438, the observed difference does not come from the structure, but from the covariance matrix obtained from molecular dynamics (MD) simulations, which are sensitive to single amino acid changes.

      Reviewer #3 (Recommendations For The Authors):

      (1) On line 99 there is a misspelling, 'withing'.

      It has been fixed. Thanks for spotting that.

      (2) Some graphical suggestions to make the figures easier to read:

      In Figure 1C, a labeled circle around the important sites, the receptor binding domain, and the Furin cleavage site, would help the reader orient themselves. Moreover, it would make clear which CAPs are NOT in the noteworthy sites described in the text.

      Good idea. We have added transparent spheres and labels to show hACE2 binding sites and Furin cleavage sites.

      In Figure 2C the colors are a bit low contrast; moreover, there are multiple text sizes on the same figure which should perhaps be avoided to ensure legibility.

      We have made yellow brighter and standardized font sizes.

      Figure 3 is a bit dry, perhaps indicating in which bins the 'interesting' sites could be informative.

      Thank you for the suggestion, but the overall goal of Figure 3 is to illustrate that the mutational landscape is governed by the equilibrium dynamics in which flexible sites undergo more mutations during the evolution of the CoV2 spike protein. Therefore, adding additional positional information may complicate our message.

      Figure 4, the previous suggestions about readability apply.

      We ensured same sized text and higher contrast colors.

      Figure 5B, the residue labels are too small.

      We increased the font size of the residue labels.

      In Figure 8 maybe adding Delta to let the reader orient themselves would be helpful to the discussion.

      Unfortunately, there is no single work that has experimentally quantified binding affinities towards hACE2 for all the variants. When we conducted the same analysis for the Delta variant in Figure 8, the experimental values were obtained from a different source (doi: 10.1016/j.cell.2022.01.001) and the values were significantly different from the experimental work we used for Omicron (Yue et al. 2023). When we could adjust based on the difference in experimentally measured binding affinity values of the original Wuhan strain in these two separate studies, we observed a similar correlation, as seen below. However, we think this might not be a proper representation. Therefore, we chose to keep the original figure.

      Author response image 2.

      The %DFI calculations for variants Delta, Omicron, XBB, and XBB 1.5. (A) %DFI profile of the variants are plotted in the same panel. The grey shaded areas and dashed lines indicate the ACE2 binding regions, whereas the red dashed lines show the antibody binding residues. (B) The sum of %DFI values of RBD-hACE2 interface residues. The trend of total %DFI with the log of Kd values overlaps with the one seen with the experiments. (C) The RBD antibody binding residues are used to calculate the sum of %DFI. The ranking captured with the total %DFI agrees with the susceptibility fold reduction values from the experiments.

      (3) Replicas of the MD simulations would make the conclusions stronger in my opinion.

      We ran a 1µs long simulation and performed convergence analysis for the MD simulations using the prior work (Sawle L, Ghosh K. 2016.) More importantly, we also evaluated the statistical significance of computed DFI values as explained in detail below (Please see the answer to question 3 of Reviewer #3 (Public Review):)

      Reviewer #3 (Public Review):

      (1) A longer discussion of how the 19 orthologous coronavirus sequences were chosen would be helpful, as the rest of the paper hinges on this initial choice.

      The following explanation has been added on line 114: EP scores of the amino acid variants of the S protein were obtained using a Maximum Likelihood phylogeny (Kumar et al. 2018) built from 19 orthologous coronavirus sequences. Sequences were selected by examining available non-human sequences with a sequence identity of 70% or above to the human SARS CoV-2’s S protein sequence. This cutoff allows for divergence over evolutionary history such that each amino acid position had ample time to experience purifying selection, whilst limiting ourselves to closely related coronaviruses. (Figure 1A).

      (2) The 'reasonable similarity' with previously published data is not well defined, nor there was any comment about some of the residues analyzed (namely 417-484). We have revised this part of the manuscript and add to the revised version.

      We removed the line about reasonable similarity as it was vague, added a line about residues 417-484, and revised the text accordingly, starting on line 354.

      (3) There seem to be no replicas of the MD simulations, nor a discussion of the convergence of these simulations. A more detailed description of the equilibration and production schemes used in MD would be helpful. Moreover, there is no discussion of how the equilibration procedure is evaluated, in particular for non-experts this would be helpful in judging the reliability of the procedure.

      We opted for a single, extended equilibrium simulation to comprehensively explore the longterm behavior of the system. Given the specific nature of our investigation and resource constraints, a well-converged, prolonged simulation was deemed a practical and scientifically valid approach, providing a thorough understanding of the system's dynamics. (doi: 10.33011/livecoms.1.1.5957, https://doi.org/10.1146/annurev-biophys-042910-155255 )

      We updated our methods section starting on line 605 with extended information about the MD simulations and the converge criteria for the equilibrium simulations. We also added a section that explains our analysis to check statistical significance of obtained DFI values.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations for authors):

      (1) Motivation for studying SUL1 in RLS

      Considering that the regulation of cellular metabolism in response to nutrient availability is crucial for cell survival and lifespan, and several organic nutrient transporters have also been implicated in the mediation of aging, we believe that transporters of specific nutrients can transduce the signal downstream to control genes responsible for survival. However, the impact of inorganic nutrient transporters, including phosphate and sulfate, on longevity remains largely unexplored. And another work of our group utilized a LASSO model derived from multi-omics data related to yeast aging, identifying SUL1 as a key candidate for regulating lifespan, which aroused our interest.

      (2) Discrepancy with prior RLS data (PMID: 26456335)​​

      Previous literature (PMID: 26456335) reported a limited number of experimental cells (n=25), which may have contributed to the observed variability in results. To enhance the reliability of our work, we have expanded the number of experimental cells for the sul1Δ strain to 400 (see Figure 1A). In contrast, the lifespan data for other mutant strains have been increased to 200 (see Figure 1B). This confirms the reproducibility of the lifespan extension observed in the sul1Δ strain.

      (3) Mechanistic link between sulfate transport and lifespan​​

      Sulfate absorption assays were performed on the WT, SUL1Δ, SUL2Δ, and SUL1<sup>E427Q</sup> strains (Figure 1C). Compared to the wild type (WT), the SUL1Δ, SUL2Δ, and SUL1<sup>E427Q</sup> strains exhibited delayed sulfate intracellular transportation. However, there was no significant difference in the final concentration of intracellular sulfur ions among all groups. This result reinforces our conclusion that the extended lifespan of SUL1Δ is not associated with sulfate transport.

      (4) Testing the RLS of SUL1ΔMSN4Δ double mutants​​

      The replicative lifespan data for the SUL1ΔMSN4Δ double mutant were further analyzed (shown in the following supplementary figure). It was observed that the extension of the SUL1Δ lifespan was not rescued by the knockout of MSN4, supporting the hypothesis that MSN2 may serve as the downstream transcription factor responsible for the increased lifespan of SUL1Δ.

      Author response image 1.

      Replicative life span of MSN4 deletion mutants in WT and SUL1Δ strains.

      Reviewer #2 (Recommendations for authors):

      (1) Inconsistent WT lifespan in Figure 1B

      All measurements of life expectancy were conducted under controlled conditions (30°C, 2% glucose). The revised Figure 1C illustrates that across three independent experiments (n=200 cells), the average lifespan of wild-type (WT) cells was 29.1 generations, which is comparable to the average lifespan of 25.6 generations reported in Figure 1A after data expansion (n=400 cells). This similarity may be attributed to experimental variability arising from multiple trials; however, it does not compromise the validity of our conclusions.

      (2) Sulfate level measurements​​

      Intracellular sulfate levels were measured by quantitatively assessing the sulfate concentrations in wild-type (WT), SUL1Δ, SUL2Δ, and SUL<sup>E427</sup> cells, as detailed in the methods section (Figure 1C). The results indicated that all mutant strains showed a delayed sulfur uptake process, but there was no significant difference in the final concentration of intracellular sulfur ions in all groups.

      (3) RNA-seq for non-lifespan-extending mutants​​

      RNA-seq data for the SUL2Δ and SULE427 mutants can be found in Supplementary Figure 1. These mutants do not exhibit a significant upregulation of stress-response genes, such as HSP12 and TPS1, which reinforces the specificity of the pathways induced by SUL1Δ.

      (4) Improved Msn2/4 imaging​​

      Figure 3C and supplementary Figure 4A present high-resolution confocal images (using a 63× objective lens) of cell nuclei labeled with MSN2-GFP and DAPI. The GFP intensity within the nucleus was normalized against the DAPI signal to account for differences in nuclear size.​​

      ​​Reviewer #3 (Recommendations for authors):

      (1) Nuclear size normalization​​

      The verification data for MSN2 and MSN4 were re-evaluated through DAPI signal normalization. The revised figures are presented in Figure 3C and Supplementary Figure 4A.

      (2) Strain nomenclature​​

      All strain names (e.g., SUL1Δ) were updated to follow SGD guidelines.

      (3) Grammar and formatting​​

      We have carefully revised the text to improve readability. And the manuscript was proofread by a native English speaker. Citations (e.g., "trehalose (Lillie and Pringle, 1980)") and spacing errors were corrected.

      (4) Microscopy resolution​​

      In the revised figures (Figures 3C, 3E, 4B, 4E, Supplementary Figure 3A, 4A, 4C), all fluorescence images are displayed as separate channels (EGFP, DAPI, BF). The scale and arrows have been added to the figure for clarity.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We greatly appreciate the recommendations of the reviewers and have performed further analyses with existing data where requested. 

      Below are our responses to each of the individual points. 

      Reviewer #1 (Recommendations For The Authors):

      (1) P11 mouse retina is still quite young, would MG isolated from adult retina be more interesting and relevant to disease-oriented cell replacement therapy? How efficiently would the sci-Plex system work for in vitro screen of mature murine MG?

      Thank you for bringing this up. While a protocol for the conversion of MG to neurons with adult mice in vivo exists, it has proven to be more difficult to maintain adult MG in dissociated cell cultures, due to their more limited proliferation in vitro. This makes it difficult to use the sci-Plex assay, since cell number is limiting for treatment conditions. Therefore, we have chosen the strategy of screening on P11, where MG undergo proliferative cell divisions in dissociated cultures, allowing us to grow the millions of cells needed for this assay, and then to test the efficacy of the compounds we find from the screen with an adult in vivo assay.

      (2) The study identified and tested the compounds individually, how would a combination of the compounds work in vivo? It would be interesting to examine how different combinations may affect the reprogramming efficiency and neuronal compositions.

      We agree that this would be very interesting to investigate.  However, the number of treatment conditions then expands beyond the scale of the current sci-Plex technology with the number of MG that we are able to collect.  We instead adopted the strategy of casting a very wide net to identify additional molecular pathways that might be important in the reprogramming process.

      (3) In-depth mechanistic and/or functional studies of the reprogrammed MG are highly desirable to improve the quality and significance of the study and to better understand how the compounds may influence the signaling and the reprogramming process.

      While we agree that this would strengthen the study, this would increase the scope of the required revisions considerably. We are very interested in following up on some of the hits and look forward to providing additional details of mechanisms in future publications.  However, we feel that reporting this method and the results will stimulate those interested in reprogramming glia in other areas of the nervous system to test the compounds we identified in this assay.

      Reviewer #2 (Recommendations For The Authors):

      (1) The authors employed two protocols to initiate direct reprogramming of MG into retinal neurons in vitro. These protocols, referred to as "Timecourse" and "Pulse," involved short-term treatments lasting no more than 5 days. However, the findings obtained indicate that these brief treatments were insufficient to achieve a stable conversion. This conclusion is supported by the comparison between the "4 days (Timecourse)" and "4 days (Pulse)" conditions, as depicted in Figure 1 (D and E). In this set of experiments, labeling cells that express specific neuronal markers as neurons raises concerns, as these cells may have multiple fates, either died, reverted, arrested in certain intermediate stages, or converted to functional neurons. It is thus critical to determine whether the conversion to functional neurons is enhanced.

      We thank you for your concern about this. We aimed to be very careful in our naming. In our naming scheme for this figure, we only consider the small number of cells with specific Bipolar markers (Trpm1, Grm6, Capb5, Otx2) neurons based on previous publications ((Jorstad et al. 2017; Todd et al. 2021; Todd et al. 2022; Todd et al. 2020)). The other cells that have some neuronal markers are identified as neuronal precursors (NeuPre) and are, as you mentioned, not necessarily mature/functional. While these NeuPre cells may eventually have multiple fates/may die/may revert to more ProL cells at some rate we believe it’s fair to define them as Neuronal Precursors due to the genes they are expressing (Dcx, Snap25, Elavl3, Gap43) at the moment of collection.  

      Furthermore, your statement indicating that “the findings obtained indicate that these brief treatments were insufficient to achieve a stable conversion” is not what we intended to demonstrate. The text will be reworked to reflect what we hoped to convey. We acknowledge that 1) the majority cells are not stably converted, and 2) the levels of NeuPre cells are lower in the Pulse experiment overall, but this is true even at Day 5 when the conditions should be the same across experiments. The Pulse and Timecourse experiments were done on different days, and having previously found that there are differences in MG to BP conversion rate from experiment to experiment, these results were not unexpected. Of more note to us was that while ProL cells, Transition cells, and MG have very different patterns of abundance across time when comparing the experiments, the NeuPre cells accumulate at a similar time and pattern across the two experiments. This indicated to us that they uniquely have some amount of Ascl1 independent stability in their cell fate even when exposed to Ascl1 for as little as 3 days. See Author response image 1 below. This plot will be added to Fig. S1.

      Author response image 1.

      (2) The authors made a claim that a pseudo time value of 15 represents a crucial timepoint where the transition in cell fate becomes stable and ceases to rely on ectopic Ascl1 expression. However, it is essential to provide concrete evidence to substantiate this assertion. It is prudent to perform quantitative analyses rather than relying solely on the deduced trajectory to make this claim.

      This is a fair point, the value of 15 was estimated by eye. We have returned to the data and estimated a density function for the pseudotime scores of the cells from the 1, 2, 3, and 4 day conditions in both the Pulse and Timecourse experiments (Author response image 2A-B below). We then calculated 16 to be the local minima between the pseudotime values of 10-20 for the Pulse experiment (Blue line). When comparing the two experiments, it’s apparent that there is a massive accumulation of cells with a pseudotime value just lower than 16 in the Timecouse experiment (values 10-15), and very few cells across the same region for the Pulse experiment, indicating some dependence on continued Ascl1 expression for the cell fate that exists from pseudotime 10-16 (mostly ProL cells). To the contrary, cells with greater pseudotime values exist across both experiments at similar levels.

      We have also looked at the expression of Ascl1 along the pseudotime trajectory in the Timecourse experiment. Interestingly, and consistent with experiments in previous studies, both in vitro and in vivo (Todd et al. 2021; Todd et al. 2022; Todd et al. 2020), we see a decrease in Ascl1 expression as the cells move towards the end of the pseudotime trajectory (C below). It’s intriguing to us that the downregulation also happens right after a pseudotime value of 16. The temporal coalescence of the loss of Ascl1 expression in the Timecourse experiment with the persistence of cells with pseudotime values > 16 in the Pulse experiment provides strong evidence that we have identified the point at which cells stop expressing Ascl1 while maintaining more mature cell fates. The plots below will be added to the manuscript.

      Author response image 2.

      (3) It is intriguing to observe that the expression of Ascl1 was down-regulated in both neuronal precursors and bipolar cells in the mouse retina following tamoxifen and NMDA treatment (refer to Fig. 3C). However, the expression of ectopical Ascl1 should have been constitutively activated by tamoxifen. Therefore, if the GFP+ bipolar cells and neuronal precursors were indeed converted from Müller cells, we would expect to capture a high level of Ascl1 expression. How to account for this discrepancy? How is the expression exogenous Ascl1 expressed from a constitutive promoter attenuated?

      As discussed above, this has been observed previously. Ascl1 driven from the TTA transgenic mouse line is high in the MG, but declines as these cells are reprogrammed into neurons in vivo or in vitro.  One possibility is that the TTA is not as active in neurons as in MG, but in other lines of transgenic mice, eg. TRE-Atoh1 mice, the transgene continues to be expressed at a high level even in the differentiating neurons, so this downregulation appears to be unique to Ascl1.  We do not understand why Ascl1 levels decline in the differentiating neurons, but this has been a consistent finding across several studies of in vivo and in vitro reprogramming.

      (4) Exogenous Ascl1 was shut down after other neuronal specific genes were induced during MG reprogramming in vitro. Is this also the case during Ascl1-mediated reprogramming in vivo? If so, do converting cells show a distinct gene expression program if exogenous Ascl1 is constitutively overexpressed?

      Yes, as can be seen in Fig 3C Ascl1 expression is high in the MG and Transition cell populations, but decreases in the NeuPre and Bipolar cells. As stated above, continued high Ascl1 expression keeps cells in a more progenitor-like state. This is true in vivo and in vitro. It has been more clearly addressed upon revision.  

      (5) As previously documented in their Science Advances publication, the authors have established the requirement of NMDA injury for facilitating the successful induction of neuronal conversion through Ascl1 over-expression. Why is injury required for MG conversion in vivo, but not in vitro? This is related to question #1 above that certain signals may be required for the full conversion process, not just the initial induction of a few neuronal specific genes.

      While the in vitro and in vivo systems share similarities, there are key differences, which affect what must be done to the cells in order to produce converted neurons. In our initial publication demonstrating that Ascl1 can reprogram mouse MG to a neurogenic state, we carried out our experiments in dissociated cell cultures (Pollak et al 2013) like those described in this report.  At that time, we did not need to add either NMDA or TSA to the cultures to induce neurogenesis from Ascl1.  However, when we attempted the reprogramming in vivo, we found that after postnatal day 8, injury and TSA were required in vivo (Ueki et al; Jorstad et al). We surmise that the massive neuronal loss that occurs in establishing dissociated MG cultures replaces the NMDA injury we carry out in vivo.   

      To your second point about the requirement for more than “just the initial induction of a few neuronal specific genes”. This is definitely true. When we carry out reprogramming in vivo with Ascl1 or other transcription factors, the MG-derived neurons acquire neuronal morphology, develop neuron-like electrophysiological properties, integrate into the retinal circuit and respond to light stimulus; however, they are still not identical in gene expression or morphology to normal retinal neurons. This  is why we are continuously looking for more compounds or conditions that can help improve the process.

      (6) The discovery that Metformin acts as a stimulator for MG-to-neuron conversion is interesting.

      However, before drawing definitive conclusions, several questions need to be addressed:

      (a) As specific small molecules have been identified to change cell fates, the question is whether Metformin and other effective compounds can function alone or have to effect in conjunction with Ascl1? This can and should be tested in vitro by simply treating MG with Metformin but not doxycycline.

      To our knowledge there are no convincing in vivo trials in which neurons have been generated from MG using only combinations of small molecules. Because Metformin was identified in vitro due to the increase in recovered cells and not an increase in % neurons, we especially doubt it would have the desired increase in neurons without expression of a transcription factor.  

      (b) Metformin is known to target AMPK, but this is unlikely the only target of the drug. Does AMPK knockdown have the same enhancement effect?

      In the drug screen, we also tested the AMPK inhibitor Dorsomorphin dihydrochloride, but it didn’t have any effect. However, Metformin is an activator, so it would be interesting to see in future studies if Dorsomorphin dihydrochloride could inhibit the effect of Metformin or if the enhancement is acting independently.  

      (c) Is the effect of Metformin specific for Ascl1 or any TF(s) that stimulates MG-to-neuron conversion?

      We would like to follow up with this in future.

    1. Author Response

      The following is the authors’ response to the original reviews.

      eLife assessment:

      This important study advances the understanding of physiological mechanisms in deep-sea Planctomycetes bacteria, revealing unique characteristics such as the only known Phycisphaerae using a budding mode of division, extensive involvement in nitrate assimilation and release phage particles without cell death. The study uses convincing evidence, based on experiments using growth assays, phylogenetics, transcriptomics, and gene expression data. The work will be of interest to bacteriologists and microbiologists in general.

      Response: Thanks for the Editor’s and Reviewers’ positive comments, which help us improve the quality of our manuscript entitled “Physiological and metabolic insights into the first cultured anaerobic representative of deep-sea Planctomycetes bacteria” (paper#eLife-RP-RA-2023-89874). The comments are all valuable, and we have studied the comments carefully and have made corresponding revisions according to the suggestions. Revised portions are marked in blue in the modified manuscript.

      Please find the detailed responses as following.

      Public Reviews:

      Reviewer #1 (Public Review):

      The authors of the manuscript cultivated a Planctomycetes strain affiliated with Phycisphaerae. The strain was one of the few Planctomycetes from deep-sea environments and demonstrated several unique characteristics, such as being the only known Phycisphaerae using a budding mode of division, extensive involvement in nitrate assimilation, and being able to release phage particles without cell death. The manuscript is generally well-written. However, a few issues need to be more clearly addressed, especially regarding the identification and characterization of the phage.

      Response: Thanks for your positive comments. Please find the detailed responses as following.

      Reviewer #1 (Recommendations For The Authors):

      • Line 75-77, add a reference for this statement.

      Response: Thanks for your suggestion. We have added a reference (Fuerst and Sagulenko, 2011) for this statement in the revised manuscript (Line 77).

      References related to this response:

      Fuerst, J.A., and Sagulenko, E. Beyond the bacterium: planctomycetes challenge our concepts of microbial structure and function. Nat Rev Microbiol. 2011;9:403-413.

      • Line 124-134, add key statistics (such as ANI) of strain ZRK32 and KS4 to this section.

      Response: Thanks for your suggestion. We added the key statistics of strain ZRK32 and KS4, and described as “Based on the 16S rRNA sequence of strain ZRK32, a sequence similarity calculation using the NCBI server indicated that the closest relatives of strain ZRK32 were Poriferisphaera corsica KS4T (98.06%), Algisphaera agarilytica 06SJR6-2T (88.04%), Phycisphaera mikurensis NBRC 102666T (85.28%), and Tepidisphaera mucosa 2842T (82.94%). Recently, the taxonomic threshold for species based on 16S rRNA gene sequence identity value was 98.65% (Kim et al., 2014). Based on these criteria, we proposed that strain ZRK32 might be a novel representative of the genus Poriferisphaera. In addition, to clarify the phylogenetic position of strain ZRK32, the genome relatedness values were calculated by the average nucleotide identity (ANI), the tetranucleotide signatures (Tetra), and in silico DNA-DNA similarity (isDDH), against the genomes of strains ZRK32 and KS4. The ANIb, ANIm, Tetra, and isDDH values were 72.89%, 85.34%, 0.97385, and 20.90%, respectively (Table S1). These results together demonstrated the strain ZRK32 genome to be obviously below established ‘cut-off’ values (ANIb: 95%, ANIm: 95%, Tetra: 0.99, isDDH: 70%) for defining bacterial species, suggesting strain ZRK32 represents a novel strain within the genus Poriferisphaera.” in the revised manuscript (Lines 124-139).

      • Fig. 2A missing description for figure key.

      Response: Thanks for your comments. We modified the Figure 2A, shown as below:

      Author response image 1.

      Figure. 2. Growth assay and transcriptomic analysis of P. heterotrophicis ZRK32 strains cultivated in basal medium and rich medium.

      • Regarding the page released, could this be a membrane vesicle-engulfed phage? I would recommend checking "Spontaneous Prophage Induction Contributes to the Production of Membrane Vesicles by the Gram-Positive Bacterium Lacticaseibacillus casei BL23" and "Chronic Release of Tailless Phage Particles from Lactococcus lactis" for further references.

      Response: Thanks for your valuable comments. We carefully read these two papers and found that phage ZRK32 is most likely a membrane vesicle-engulfed phage. We added the corresponding description as “Moreover, it has recently been reported that the tailless Caudoviricetes phage particles are enclosed in lipid membrane and are released from the host cells by a nonlytic mechanism (Liu et al., 2022), and the prophage induction contributes to the production of membrane vesicles by Lacticaseibacillus casei BL23 during cell growth (da Silva Barreira et al., 2022). Considering that strain ZRK32 has a large number of membrane vesicles during cell growth (Figure S9), we speculated that Phage-ZRK32 might be a membrane vesicle-engulfed phage and its release should be related to membrane vesicles.” in the revised manuscript (Lines 381-388).

      References related to this response:

      Liu Y, Alexeeva S, Bachmann H, Guerra Martníez J.A, Yeremenko N, Abee T et al. Chronic release of tailless phage particles from Lactococcus lactis. Appl Environ Microbiol. 2022; 88: e0148321.

      Silva Barreira, D., Lapaquette, P., Novion Ducassou, J., Couté, Y., Guzzo, J., and Rieu, A. Spontaneous prophage induction contributes to the production of membrane vesicles by the gram-positive bacterium Lacticaseibacillus casei BL23. mBio. 2022;13:e0237522.

      • How were the reference sequences for Fig. S10-S13 retrieved, was it by blasting the phage gene against the entire NCBI database, or only the virus sequence within the NCBI? Please clarify this.

      Response: Thanks for your comments. The reference sequences for Fig. S10-S13 were retrieved by blasting the phage gene against the entire NCBI database. We clarified this as “The reference sequences of four AMGs encoding amidoligase, glutamine amidotransferase, gamma-glutamylcyclotransferase, and glutathione synthase were retrieved by blasting the phage gene against the entire NCBI database, respectively.” in the revised manuscript (Lines 444-447).

      Reviewer #2 (Public Review):

      Summary:

      Planctomycetes encompass a group of bacteria with unique biological traits, the compartmentalized cells make them appear to be organisms in between prokaryotes and eukaryotes. However, only a few of the Planctomycetes bacteria are cultured thus far, and this hampers insight into the biological traits of these evolutionarily important organisms. This work reports the methodology details of how to isolate the deep-sea bacteria that could be recalcitrant to laboratory cultivation, and further reveals the distinct characteristics of the new species of a deep-sea Planctomycetes bacterium, such as the chronic phage release without breaking the host and promote the host and related bacteria in nitrogen utilization. Therefore, the finding of this work is of importance in extending our knowledge of bacteria.

      Response: Thanks for your positive comments.

      Strengths:

      Through the combination of microscopic, physiological, genomics, and molecular biological approaches, this reports the isolation and comprehensive investigation of the first anaerobic representative of the deep-sea Planctomycetes bacterium, in particular in that of the budding division, and release phage without lysis of the cells. Most of the results and conclusions are supported by the experimental evidence.

      Response: Thanks for your positive comments.

      Weaknesses:

      1. While EMP glycolysis is predicted to be involved in energy conservation, no experimental evidence indicated any sugar utilization by the bacterium.

      Response: Thanks for your comments. We have previously tested the sugar utilization of strain ZRK32, and now added this description as “Consistent with the presence of EMP glycolysis pathway in strain ZRK32, we found that it could use a variety of sugars including glucose, maltose, fructose, isomaltose, galactose, D-mannose, and rhamnose (Table S2).” in the revised manuscript (Lines 281-284).

      1. "anaerobic representative" is indicated in the Title, the contrary, TCA in energy metabolism is predicted by the bacterium.

      Response: Thanks for your valuable comments. Currently, anaerobic microorganisms can use other alternative electron acceptors (such as sulfate reducers, nitrate reducers, iron reducers, etc) in place of oxygen for the TCA cycle. For example, Proteus mirabilis uses the whole oxidative TCA cycle without using oxygen as the final electron acceptor when it performs multicellular swarming (Alteri et al., 2012). In this study, all the genes involved in the TCA cycle were present in anaerobic strain ZRK32 and most of them are upregulated, thus we speculate that it might function through the complete TCA metabolic pathway to obtain energy. We added the related description as “Notably, when growing in the rich medium, the expressions of most genes involved in the TCA cycle and EMP glycolysis pathway in strain ZRK32 were upregulated (Figure 2B-D, Figure S5B and Figure S6), suggesting that strain ZRK32 might function through the complete TCA metabolic pathway and EMP glycolysis pathway to obtain energy for growth (Figure S8) (Zheng et al., 2021b). Consistent with the presence of EMP glycolysis pathway in strain ZRK32, we found that it could use a variety of sugars including glucose, maltose, fructose, isomaltose, galactose, D-mannose, and rhamnose (Table S2). As for the presence of TCA cycle in the anaerobic strain ZRK32, we propose that it might use other alternative electron acceptors (such as sulfate reducers, nitrate reducers, iron reducers, etc) in place of oxygen for the TCA cycle, as shown in other anaerobic bacteria (Alteri et al., 2012).” in the revised manuscript (Lines 277-287).

      References related to this response:

      Alteri CJ, Himpsl SD, Engstrom MD, Mobley HL. Anaerobic respiration using a complete oxidative TCA cycle drives multicellular swarming in Proteus mirabilis. mBio. 2012; 3(6): e00365-12.

      1. The possible mechanisms of the chronic phage release without breaking the host are not discussed.

      Response: Thanks for your valuable comments. The possible mechanism of the chronic phage release without breaking the host might be that it was enclosed in lipid membrane and released from the host cells by a nonlytic mechanism. We added the corresponding description as “Moreover, it has recently been reported that the tailless Caudoviricetes phage particles are enclosed in lipid membrane and are released from the host cells by a nonlytic mechanism (Liu et al., 2022), and the prophage induction contributes to the production of membrane vesicles by Lacticaseibacillus casei BL23 during cell growth (da Silva Barreira et al., 2022). Considering that strain ZRK32 has a large number of membrane vesicles during cell growth (Figure S9), we speculated that Phage-ZRK32 might be a membrane vesicle-engulfed phage and its release should be related to membrane vesicles.” in the revised manuscript (Lines 381-388).

      References related to this response:

      Liu Y, Alexeeva S, Bachmann H, Guerra Martníez J.A, Yeremenko N, Abee T et al. Chronic release of tailless phage particles from Lactococcus lactis. Appl Environ Microbiol. 2022; 88: e0148321. da Silva Barreira, D., Lapaquette, P., Novion Ducassou, J., Couté, Y., Guzzo, J., and Rieu, A. Spontaneous prophage induction contributes to the production of membrane vesicles by the gram-positive bacterium Lacticaseibacillus casei BL23. mBio. 2022;13:e0237522.

      Reviewer #2 (Recommendations For The Authors):

      • Have you tested whether strain ZRK32 uses any sugars? If not, why it uses EMP pathway to obtain energy?

      Response: Thanks for your comments. We have previously tested the sugar utilization of strain ZRK32, and now added this description as “Consistent with the presence of EMP glycolysis pathway in strain ZRK32, we found that it could use a variety of sugars including glucose, maltose, fructose, isomaltose, galactose, D-mannose, and rhamnose (Table S2).” in the revised manuscript (Lines 281-284).

      • Further discussion on possible mechanisms of the chronic phage release without breaking the host is expected.

      Response: Thanks for your valuable comments. The possible mechanism of the chronic phage release without breaking the host might be that it was enclosed in lipid membrane and released from the host cells by a nonlytic mechanism. We added the corresponding description as “Moreover, it has recently been reported that the tailless Caudoviricetes phage particles are enclosed in lipid membrane and are released from the host cells by a nonlytic mechanism (Liu et al., 2022), and the prophage induction contributes to the production of membrane vesicles by Lacticaseibacillus casei BL23 during cell growth (da Silva Barreira et al., 2022). Considering that strain ZRK32 has a large number of membrane vesicles during cell growth (Figure S9), we speculated that Phage-ZRK32 might be a membrane vesicle-engulfed phage and its release should be related to membrane vesicles.” in the revised manuscript (Lines 381-388).

      References related to this response:

      Liu Y, Alexeeva S, Bachmann H, Guerra Martníez J.A, Yeremenko N, Abee T et al. Chronic release of tailless phage particles from Lactococcus lactis. Appl Environ Microbiol. 2022; 88: e0148321.

      da Silva Barreira, D., Lapaquette, P., Novion Ducassou, J., Couté, Y., Guzzo, J., and Rieu, A. Spontaneous prophage induction contributes to the production of membrane vesicles by the gram-positive bacterium Lacticaseibacillus casei BL23. mBio. 2022;13:e0237522.

      • It is recommended that the writing is improved, including presentation style and grammar.

      Response: Thanks for your comments. We have invited an English native speaker (Dr. Diana Walsh from Life Science Editors, USA) to revise our manuscript, which we hope to meet your approval.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this study, Millard and colleagues investigated if the analgesic effect of nicotine on pain sensitivity, assessed with two pain models, is mediated by Peak Alpha Frequency (PAF) recorded with resting state EEG. The authors found indeed that nicotine (4 mg, gum) reduced pain ratings during phasic heat pain but not cuff pressor algometry compared to placebo conditions. Nicotine also increased PAF (globally). However, mediation analysis revealed that the reduction in pain ratings elicited by the phasic heat pain after taking nicotine was not mediated by the changes in PAF. Also, the authors only partially replicated the correlation between PAF and pain sensitivity at baseline (before nicotine treatment). At the group-level no correlation was found, but an exploratory analysis showed that the negative correlation (lower PAF, higher pain sensitivity) was present in males but not in females. The authors discuss the lack of correlation.

      In general, the study is rigorous, methodology is sound and the paper is well-written. Results are compelling and sufficiently discussed.

      Strengths:

      Strengths of this study are the pre-registration, proper sample size calculation, and data analysis. But also the presence of the analgesic effect of nicotine and the change in PAF.

      Weaknesses:

      It would even be more convincing if they had manipulated PAF directly.

      We thank Reviewer #1 for their positive and constructive comments regarding our study. We appreciate the view that the study was rigorous and methodologically sound, that the paper was well-written, and that the strengths included our pre-registration, sample size calculation, and data analysis.

      In response to the reviewer's comment about more directly manipulating Peak Alpha Frequency (PAF), we agree that such an approach could provide a more direct investigation of the role of PAF in pain processing. We chose nicotine to modulate PAF as the literature suggested it was associated with a reliable increase in PAF speed. As mentioned in our Discussion, there are several alternative methods to manipulate PAF, such as non-invasive brain stimulation techniques (NIBS) like transcranial alternating current stimulation (tACS) or neurofeedback training. These approaches could help clarify whether a causal relationship exists between PAF and pain sensitivity. Although methods such as NIBS still require further investigation as there is little evidence for these approaches changing PAF (Millard et al., 2024).

      Reviewer #2 (Public Review):

      Summary:

      The study by Millard et al. investigates the effect of nicotine on alpha peak frequency and pain in a very elaborate experimental design. According to the statistical analysis, the authors found a factor-corrected significant effect for prolonged heat pain but not for alpha peak frequency in response to the nicotine treatment.

      Strengths:

      I very much like the study design and that the authors followed their research line by aiming to provide a complete picture of the pain-related cortical impact of alpha peak frequency. This is very important work, even in the absence of any statistical significance. I also appreciate the preregistration of the study and the well-written and balanced introduction. However, it is important to give access to the preregistration beforehand.

      Weaknesses:

      The weakness of the study revolves around three aspects:

      (1) I am not entirely convinced that the authors' analysis strategy provides a sufficient signal-tonoise ratio to estimate the peak alpha frequency in each participant reliably. A source separation (ICA or similar) would have been better suited than electrode ROIs to extract the alpha signal. By using a source separation approach, different sources of alpha (mu, occipital alpha, laterality) could be disentangled.

      (2) Also, there's a hint in the literature (reference 49 in the manuscript) that the nicotine treatment may not work as intended. Instead, the authors' decision to use nicotine to modulate the peak alpha frequency and pain relied on other, not suitable work on chronic pain and permanent smokers. In the present study, the authors use nicotine treatment and transient painful stimulation on nonsmokers.

      (3) In my view, the discussion could be more critical for some aspects and the authors speculate towards directions their findings can not provide any evidence. Speculations are indeed very important to generate new ideas but should be restricted to the context of the study (experimental pain, acute interventions). The unfortunate decision to use nicotine severely hampered the authors' aim of the study.

      Impact:

      The impact of the study could be to show what has not worked to answer the research questions of the authors. The authors claim that their approach could be used to define a biomarker of pain. This is highly desirable but requires refined methods and, in order to make the tool really applicable, more accurate approaches at subject level.

      We thank reviewer #2 for their recognition of the study’s design, the importance of this research area, and the pre-registration of our study. In response to the weaknesses highlighted:

      (1) We appreciate the reviewer’s suggestion to improve the signal-to-noise ratio by applying source separation techniques, such as ICA, which have now been performed and incorporated into the manuscript. Our original decision to use sensor-level ROIs followed the precedent set in previous studies, our rationale being to improve reproducibility and avoid  biases from picking individual electrodes or manually picking sources. We have  added analyses using an automated pipeline that selects components based on the presence of a peak in the alpha range and alignment with a predefined template topography representing sensorimotor sites. Here again we found no significant differences in the mediation results that used a sensor space sensorimotor ROI, further supporting the robustness of the chosen approach. ICA could still potentially disentangle different sources of alpha, such as occipital alpha and mu rhythm, and provide new insights into the PAF-pain relationship. We have now added a discussion in the manuscript about the potential advantages of source separation techniques and suggest that the possible contributions of separate alpha sources be investigated and compared to sensor space PAF as a direction for future research.

      (2) We recognise the reviewer's concern regarding our choice of nicotine as a modulator of pain and alpha peak frequency (PAF). The meta-analysis by Ditre et al. (2016) indeed points to small effect sizes for nicotine's impact on experimental pain and highlights the potential for publication bias. However, our decision to use nicotine in this study was not primarily based on its direct analgesic effects, but rather on its well-documented ability to modulate PAF, in smoking and non-smoker populations, as outlined in our study aims.

      In this regard, the intentional use of nicotine was to assess whether changes in PAF could mediate alterations in pain. This approach aligns with the broader concept that a direct effect of an intervention is not necessary to observe indirect effects (Fairchild & McDaniel, 2017). We have, however, revised our introduction to further clarify this rationale, highlighting that nicotine was used as a tool for PAF modulation, not solely for its potential analgesic properties.

      (3) We agree with the reviewer’s observation that certain aspects of the Discussion could be more cautious, particularly regarding speculations about nicotine’s effects and PAF as a biomarker of pain. We have revised the Discussion to ensure that our interpretations are better grounded in the data from this study, clearly stating the limitations and avoiding overgeneralization. This revision focuses on a more critical evaluation of the potential relationships between PAF, nicotine, and pain sensitivity based solely on our experimental context.

      Finally, We also apologize for not providing access to the preregistration earlier. This was an oversight on our end, and we will ensure that future preregistrations are made available upfront.

      Reviewer #3 (Public Review):

      In this manuscript, Millard et al. investigate the effects of nicotine on pain sensitivity and peak alpha frequency (PAF) in resting state EEG. To this end, they ran a pre-registered, randomized, double-blind, placebo-controlled experiment involving 62 healthy adults who received either 4 mg nicotine gum (n=29) or placebo (n=33). Prolonged heat and pressure were used as pain models. Resting state EEG and pain intensity (assessed with a visual analog scale) were measured before and after the intervention. Additionally, several covariates (sex at birth, depression and anxiety symptoms, stress, sleep quality, among others) were recorded. Data was analyzed using ANCOVAequivalent two-wave latent change score models, as well as repeated measures analysis of variance. Results do not show *experimentally relevant* changes of PAF or pain intensity scores for either of the prolonged pain models due to nicotine intake.

      The main strengths of the manuscript are its solid conceptual framework and the thorough experimental design. The researchers make a good case in the introduction and discussion for the need to further investigate the association of PAF and pain sensitivity. Furthermore, they proceed to carefully describe every aspect of the experiment in great detail, which is excellent for reproducibility purposes. Finally, they analyse the data from almost every possible angle and provide an extensive report of their results.

      The main weakness of the manuscript is the interpretation of these results. Even though some of the differences are statistically significant (e.g., global PAF, pain intensity ratings during heat pain), these differences are far from being experimentally or clinically relevant. The effect sizes observed are not sufficiently large to consider that pain sensitivity was modulated by the nicotine intake, which puts into question all the answers to the research questions posed in the study.

      We would like to express our gratitude to Reviewer #3 for their thoughtful and constructive review, including the positive feedback on the strengths of our study's conceptual framework, experimental design, and thorough methodological descriptions.

      We acknowledge the concern regarding the experimental and clinical relevance of some statistically significant results (e.g., global PAF and pain intensity during heat pain) and agree that small effect sizes may limit their practical implications. However, our primary goal was to assess whether nicotine-induced changes in PAF mediate pain changes, rather than to demonstrate large direct effects on pain sensitivity. Nicotine was chosen for its known ability to modulate PAF, and our focus was on the mechanistic role of PAF in pain perception. To clarify this, we have revised the discussion to better differentiate between statistical significance, experimental relevance, and clinical applicability. We emphasize that this study represents a preliminary step towards understanding PAF’s mechanistic role in pain, rather than a direct clinical application.

      We appreciate the suggestion to refine our interpretation. We have adjusted our language to ensure it aligns with the effect sizes observed and made recommendations for future research, such as testing different nicotine doses, to potentially uncover stronger or more clinically relevant effects.

      Although modest, we believe these findings offer valuable insights into the potential mechanisms by which nicotine affects alpha oscillations and pain. We have also discussed how these small effects could become more pronounced in different populations (e.g., chronic pain patients) and over time, offering guidance for future research on PAF modulation and pain sensitivity.

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      I have a number of points that the authors may want to consider for this or future work.

      (1) By reviewing the literature provided by the authors in the introduction I think that using nicotine as a means to modulate pain and alpha peak frequency was a mistake. The only work that may give a hint on whether nicotine can modulate experimental pain is the meta-analysis by Ditre and colleagues (2016). They suggest that their small effect may contain a publication bias. I think the other "large body of evidence" is testing something else than analgesia.

      Thank you for your consideration of our choice of nicotine in the study. The meta-analysis by Ditre and colleagues (2016) suggests small effect sizes for nicotine's impact on experimental pain, compared to the moderate effects claimed in some papers, especially when accounting for the potential publication bias you mentioned. However, our selection of nicotine was primarily driven by its documented ability to modulate PAF rather than its direct analgesic effects, as clearly stated in our aims. Therefore, we do not view our decision to use nicotine as a mistake; instead, it was aligned with our goal of assessing whether changes in PAF mediate alterations in pain and thus served as a valuable tool. This perspective aligns with the broader concept that a direct effect is not a prerequisite for observing indirect effects of an intervention on an outcome (Fairchild &

      McDaniel, 2017). To further enhance clarity, we've revised the introduction to emphasize the role of nicotine in manipulating PAF in relation to our study's aims.

      Previously we wrote: “A large body of evidence suggests that nicotine is an ideal choice for manipulating PAF, as both nicotine and smoking increase PAF speed [37,40–47] as well as pain thresholds and tolerance [48–52].” This has been changed to read: “Because evidence suggests that nicotine can modulate PAF, where both nicotine and smoking increase PAF speed [37,40–47], we chose nicotine to assess our aim of whether changes in PAF mediate changes in pain in a ‘mediation by design’ approach [48]. In addition, given evidence that nicotine may increase experimental pain thresholds and tolerance [49–53], nicotine could also influence pain ratings during tonic pain.”

      (2) As mentioned above, the OSF page is not accessible.

      We apologise for this. We had not realised that the pre-registration was under embargo, but we have now made it available.

      (3) I generally struggle with the authors' approach to investigating alpha. With the approach the authors used to detect peak alpha frequency it might be that the alpha signal may just show such a low amplitude that it is impossible to reliably detect it at electrode level. In my view, the approach is not accurate enough, which can be seen by the "jagged" shape of the individual alpha peak frequency. In my view, a source separation technique would have been more useful. I wonder which of the known cortical alphas contributes to the effects the authors have reported previously: occipital, mu rhythms projections or something else? A source separation approach disentangles the different alphas and will increase the SNR. My suggestion would be to work on ICA components or similar approaches. The advantage is that the components are almost completely free of any artefacts. ICAs could be run on the entire data or separately for each individual. In the latter case, it might be that some participants do not exhibit any alpha component.

      We appreciate your thoughtful consideration of our approach to investigating alpha. The calculation of PAF involves various methods and analysis steps across the literature (Corcoran et al., 2018; Gil Avila et al., 2023; McLain et al., 2022). Your query about which known cortical alphas contribute to reported effects is important. Initially focusing on a sensorimotor component from an ICA in Furman et al., 2018, subsequent work from our labs suggested a broader relationship between PAF and pain across the scalp (Furman et al., 2019; Furman et al., 2020; Millard et al., 2022), and a desire to conduct analyses at the sensor level in order to improve the reproducibility of the methods (Furman et al., 2020). However, based on your comment we have made several additions to the manuscript, including: explaining why we did not use manual ICA methods, suggest this for future research, and added an exploratory analysis using a recently developed automated pipeline that selects components based on the presence of a peak in the alpha range and alignment with a predefined template topography representing activity from occipital or motor sites.

      While we acknowledge that ICA components can offer a better signal-to-noise ratio (SNR) and possibly smoother spectral plots, we opted for our chosen method to avoid potential bias inherent in deciding on a component following source separation. The desire for a quick, automated, replicable, and unbiased pipeline, crucial for potential clinical applications of PAF as a biomarker, influenced this decision. At the time of analysis registration, automated methods for deciding which alpha components to extract following ICA were not apparent. We have now added this reasoning to Methods.

      “Contrary to some previous studies that used ICA to isolate sensory region alpha sources (Furman et al., 2018; De Martino et al., 2021; Valentini et al., 2022), we used pre-determined sensor level ROIs to improve reproducibility and reduce the potential for bias when individually selecting ICA components. Using sensor level ROIs may decrease the signal-to-noise ratio of the data; however, this approach has still been effective for observing the relationship between PAF and experimental pain (Furman et al., 2019; Furman et al., 2020).”

      We have also added use of ICA and development of methods as a suggestion for future research in the discussion:

      “Additionally, the use of global PAF may have introduced mediation measurement error into our mediation analysis. The spatial precision used in the current study was based on previous literature on PAF as a biomarker of pain sensitivity, which have used global and/or sensorimotor ROIs (Furman et al., 2018; Furman et al., 2020). Identification and use of the exploratory electrode clusters found in this study could build upon the current work (e.g., Furman et al., 2021). However, exploratory analysis of the clusters found in the present analysis demonstrated no influence on mediation analysis results (Supplementary Materials 3.8-3.10). Alternatively, independent component analysis (ICA) could be used to identify separate sources of alpha oscillations (Choi et al., 2005), as used in other experimental PAF-pain studies (Furman et al., 2018; Valentini et al., 2022), which could aid to disentangle the potential relevance of different alpha sources in the PAFpain relationship. Although this comes with the need to develop more reproducible and automated methods for identifying such components.”

      The specific location or source of PAF that relates to pain remains unclear. Because of this, we did employ an exploratory cluster-based permutation analysis to assess the potential for variations in the presence of PAF changes across the scalp at sensor level, and emphasise that location of PAF change could be explored in future. However, we have now conducted the mediation analysis (difference score 2W-LCS model) using averages from the data-driven parietal cluster, frontal cluster, and both clusters together. For these we see a stronger effect of gum on PAF change, which was expected given the data driven approach of picking electrodes. There was still a total and direct effect of nicotine on pain during the PHP model, but still no indirect effect via change in PAF. For the CPA models, there were still no significant total, direct, or indirect effects of nicotine on CPA ratings. Therefore, using these data-driven clusters did not alter results compared to the model using the global PAF variable.

      The reader has been directed to this supplementary material so:

      “The potential mediating effect of this change in PAF on change in PHP and CPA was explored (not pre-registered) by averaging within each cluster (central-parietal: CP1, CP2, Cpz, P1, P2, P3, P4, Pz, POz; right-frontal: F8, FT8, FT10) and across both clusters. This averaging across electrodes produced three new variables, each assessed in relation to mediating effects on PHP and CPA ratings. The resulting in six exploratory mediation analysis (difference score 2W-LCS) models demonstrated minimal differences from the main analysis of global PAF (8-12 Hz), except for the

      expected stronger effect of nicotine on change in PAF (bs = 0.11-0.14, ps < .003; Supplementary

      Materials 3.8-3.10).”

      Moreover, our team has been working on an automated method for selecting ICA components, so in response to your comment we assessed whether using this method altered the results of the current analysis. The in-depth methodology behind this new automatic pipeline will be published with a validation from some co-authors in the current collaboration in due course. At present, in summary, this automatic pipeline conducts independent component analysis (ICA) 10 times for each resting state, and selects the component with the highest topographical correlation to a template created of a sensorimotor alpha component from Furman et al., (2018). 

      The results of the PHP or CPA mediation models were not substantially different using the PAF calculated from independent components than that using the global PAF. For the PHP model, the total effect (b = -0.648, p \= .033) and direct effects (b = -0.666, p \= .035) were still significant, and there was still no significant indirect effect (b = 0.018, p \= .726). The general fit was reduced, as although the CFI was above 0.90, akin to the original model, the RMSEA and SRMR were not below 0.08, unlike the original models (Little, 2013). For the CPA model, there were still no significant total (b = -0.371, p \= .357), direct (b = -0.364, p \= .386), or indirect effects (b = -0.007, p \= .906), and the model fit also decreased, with CFI below 0.90 and RMSEA and SRMR above 0.08. See supplementary material (3.11). Note that still no correlations were seen between this IC sensorimotor PAF and pain (PHP: r = 0.11, p = .4; CPA: r \= -0.064, p = .63).

      Interestingly, in both models, there was now no longer a significant a-path (PHP: b = 0.08, p =

      0.292; CPA: b = 0.039, p = 0.575), unlike previously observed (PHP: b = 0.085, p = 0.018; CPA: b = 0.089, p = 0.011). We interpret this as supporting the previously highlighted difference between finding an effect on PAF globally but not in a sensorimotor ROI (and now a sensorimotor IC), justifying the exploratory CBPA and the suggestion in the discussion to explore methodology.

      We understand that this analysis does not fully uncover the reviewer’s question in which they wondered which of the known cortical alphas contributes to the effects reported in our previous work. However, we consider this exploration to be beyond the scope of the current paper, as it would be more appropriately addressed with larger datasets or combinations of datasets, potentially incorporating MEG to better disentangle oscillatory sources. The highlighted differences seen between global PAF, sensorimotor ROI PAF, sensorimotor IC PAF, as well as the CBPA of PAF changes provide ample directions for future research to build upon: 1) which alpha (sensor or source space) are related to pain, 2) how are these alpha signals represented robustly in a replicable way, and 3) which alpha (sensor or source space) are manipulable through interventions. These are all excellent questions for future studies to investigate.

      The below text has been added to the Discussion:

      In-house code was developed to compare a sensorimotor component to the results presented in this manuscript (Supplementary Material 3.11), showing similar results to the sensorimotor ROI mediation analysis presented here. However, examination of which alpha - be it sensor or source space - are related to pain, how they can be robustly represented, and how they can be manipulated are ripe avenues for future study.

      (4) I have my doubts that you can get a reliable close to bell-shaped amplitude distribution for every participant. The argument that the peak detection procedure is hampered by the high-amplitude lower frequency can be easily solved by subtracting the "slope" before determining the peak. My issue is that the entire analysis is resting on the assumption that each participant has a reliable alpha effect at electrode level. This is not the case. Non-alpha participants can severely distort the statistics. ICA-based analyses would be more sensitive but not every participant will show alpha. You may want to argue with robust group effects but In my view, every single participant counts, particularly for this type of data analysis, where in the case of a low SNR the "peak" can easily shift to the extremes. In case there is an alpha effect for a specific subject, we should see a smooth bump in the frequency spectrum between 8 and 12 12Hz. Anything beyond that is hard to believe. The long stimulation period allows a broad FFT analysis window with a good frequency resolution in order to detect the alpha frequency bump.

      The reviewer is correct that non-alpha participants can distort the statistics. We did visually assess the EEG of each individual’s spectra at baseline to establish the presence of global peaks, as we believe this is good practice to aid understanding of the data. Please see Author response image 1 for individual spectra seen at baseline. Although not all participants had a ‘smooth bump in the frequency spectrum between 8 and 12 Hz’, we prefer to not apply/necessitate this assumption to our data. Chiang et al., (2011) suggest that ~3% of individuals do not have a discernible alpha peak, and in our data we observed only one participant without a very obvious spectral peak (px-39). But, this participant does have enough activity within the alpha range to identify PAF by the CoG method (i.e. not just flat spectra and activity on top of 1/f characteristics). Without a pre-registered and standardised decision process to remove such a participant in place, we opted to not remove any participants to avoid curation of our data.

      Author response image 1.

      (5) I find reports on frequent channel rejections reflect badly on the data quality. Bad channels can be avoided with proper EEG preparation. EEG should be continuously monitored during recording in order to obtain best data quality. Have any of the ROI channels been rejected?

      We appreciate your attention to the channel rejection. We believe that the average channels removed (0.94, 0.98, 0.74, and 0.87 [range: 0-4] for each of the four resting states out of 64 channels) does not suggest overly frequent rejection, as it was less than one electrode on average and the numbers are below the accepted number of bad channels to remove/interpolate (i.e. 10%) in EEG pipelines (Debnath et al., 2020; Kayhan et al., 2022). To maintain data quality, consistently poor channels were identified and replaced over time. We hope you will accept our transparency on this issue and note that by stating how channel removal decisions were made (i.e. 8 or more deviations) and reporting the number of channels removed, we adhere to the COBIDAS guidelines (Pernet et al., 2018; 2020).

      During analysis, cases of sensorimotor ROI channels being rejected were noted and are now specified in our manuscript. “Out of 248 resting states recorded, 14 resting states had 4 ROI channels instead of 5. Importantly, no resting state had fewer than 4 channels for the sensorimotor ROI.”

      Note, we also realised that we had not specified that we did interpolate channels for the cluster based permutation analysis. This has been corrected with the following sentence:

      “Removed channels were not interpolated for the pre-registered global and sensorimotor ROI averaged analyses, but were interpolated for an exploratory cluster based permutation analysis using the nearest neighbour average method in `Fieldtrip`.”

      (6) I have some issues buying the authors' claims that there is an effect of nicotine on prolonged pain. By looking at the mean results for the nicotine and placebo condition, this can not be right. What was the point in including the variables in the equation? In my view, in this within-subject design the effect of nicotine should be universal, no matter what gender, age, or depression. The unconditional effect of nicotine is close to zero. I can not get my head around how any of the variables can turn the effects into significance. There must be higher or lower variable scores that might be related to a higher or lower effect on nicotine. The question is not to consider these variables as a nuisance but to show how they modulate the pain-related effect of nicotine treatment. Still, the overall nicotine effect of the entire group is basically zero.

      Another point is that for within-subject analyses even tiny effects can become statistically significant if they are systematically in one direction. This might be the case here. There might be a significant effect of nicotine on pain but the actual effect size (5.73 vs. 5.78) is actually not interpretable. I think it would be interesting for the reader how (in terms of pain rating difference) each of the variables can change the effect of nicotine.

      Thank you for your comments. We recognize the concern about interpreting the effect of nicotine on prolonged pain solely based on mean results, and in fact wish to discourage this approach. It's crucial to note that both PAF and pain are highly individual measures (i.e. high inter-individual variance), necessitating the use of random intercepts for participants in our analyses to acknowledge the inherent variability at baseline across participants. Including random intercepts rather than only considering the means helps address the heterogeneity in baseline levels among participants. We also recognise that displaying the mean PHP ratings for all participants in Table 2 could be misleading, firstly because these means do not have weight in an analysis that takes into account a random-effects intercept for participants, and secondly because two participants (one from each group) did not have post-gum PHP assessments and were not included in the mediation analysis due to list-wise deletion of missing data. Therefore, to reduce the potential for misinterpretation, we have added extra detail to display both the full sample and CPA mediation analysis (i.e. N=62) and the data used for PHP mediation analysis (i.e. n=60) in Table 2. We hope that the extra details added to this table will help the readers interpretation of results.

      In light of this, we have also altered the PAF Table 3 to reflect both the pre-post values used for the CPA mediation and baseline correlations with CPA and PHP pain (i.e. N=62), and the pre-post values used for the PHP mediation (i.e. n=60).

      It is inherently difficult to visualise the findings of a mediation analysis with confounding variables that also used latent change scores (LCS) and random-effect intercepts for participants. LCS was specifically used because of issues of regression to the mean that occur if you calculate a straightforward ‘difference-score’, therefore calculating the difference in order to demonstrate the results of the statistical model in a figure, for example, does not provide a full description of the data assessed (Valente & McKinnon, 2017). Nevertheless, if we look at the data descriptively with this in mind, then calculating the change in PHP ratings does indicate that, for the nicotine group, the mean change in PHP ratings was -0.047 (SD = 1.05, range: -4.13, 1.45). Meanwhile, for the placebo group the mean change in PHP ratings was 0.33 (SD = 0.75, range: -1.37, 1.66). Therefore suggesting a slight decrease in pain ratings on average for the nicotine group compared to a slight increase on average for the placebo group. With control for pre-determined confounders, we found that the latent change score was -0.63 lower for the nicotine group compared to the control group (i.e. the direct effect of nicotine on change in pain).

      If the reviewer is only discussing the effect of nicotine on pain, we do not believe that this effect ‘should be universal’. There is clear evidence that effects of nicotine on other measures can vary greatly across individuals (Ettinger et al., 2009; Falco & Bevins, 2015; Pomerleau et al., 1995). Our intention would not be to propose a universal effect but to understand how these variables may influence nicotine's impact on pain for individuals. Here we focus on the effects of nicotine on PAF and pain sensitivity, but attempted to control for the potential influence of these other confounding factors. Therefore, our statistical approach goes beyond mean values, incorporating variables like sex at birth, age, and depression to control for and explore potential modulating factors. Control for confounding factors is an important aspect of mediation analysis (Lederer et al., 2019; VanderWeele, 2019).

      Regarding the seemingly small effect size, we understand your concern. Indeed ‘tiny effects can become statistically significant if they are systematically in one direction’, which may be what we see in this analysis. We do not agree that the effect is ‘not interpretable’, rather that it should be interpreted in light of its small effect size (effect size being the beta coefficient in our analysis, rather than the mean group difference). We agree on the importance of considering practical significance alongside statistical significance and hope to conduct additional experiments and analyses in future to elucidate the contribution of each variable to the subtle and therefore not entirely conclusive overall effect you mention.

      Your feedback on this is valuable, and we have ensured a more detailed discussion in the revised manuscript on how these factors should be interpreted alongside some additional post-hoc analyses of confounding factors that were significant in our mediation, with the note that investigation of these interactions is exploratory. We had already discussed the potential contribution of sex on the effect of nicotine on PAF, with exploratory post-hoc analysis on this included in supplementary materials. In addition, we have now added an exploratory post-hoc analysis on the potential contribution of stress on the effect of nicotine on pain. This then shows the stratified effects by the covariates that our model suggest are influencing change in PAF and pain.

      Results edits:

      “There was also a significant effect of perceived stress at baseline on change in PHP ratings when controlling for group allocation and other confounding variables (b = -0.096, p = .048, bootstrapped 95% CI: [-0.19, -0.000047]), where higher perceived stress resulted in larger decreases in PHP ratings (see Supplementary Material 3.3 for post-hoc analysis of stress).”

      Supplementary material addition:

      “3.3 Exploratory analysis of the influence of perceived stress on the effects of nicotine on change in PHP ratings “

      “Due to the significant estimated effects of perceived stress on change in PHP ratings in the 2WLCS mediation model, we also explored post-hoc effects of stress on change in PHP ratings. We found that there is strong evidence for a negative correlation between stress and change in PHP rating within the nicotine group (n = 28, r = −0.39, BF10 = 13.65; Figure 3) that is not present in the placebo group, with equivocal evidence (n = 32, r = −0.14, BF10 = 0.46). This suggests that those with higher baseline stress who had nicotine gum experienced greater decreases in PHP ratings. Note that there was less, but still sufficient evidence for this relationship within the nicotine group when the participant who was a potential outlier for change in PHP rating was removed (n = 27, r = −0.32, BF10 = 1.45). “

      Author response image 2.

      Spearman correlations od baseline perceived stress with the change in phasic heat pain (PHP) ratings, suggest strong evidence for a negative relationship for the nicotine gum groupin orange (n=28; BF<sub>10</sub>=13.65) but not for the placebo group in grey (n=32; BF<sub>10</sub>=0.46). Regression lines and 95% confidence intervals.

      Discussion edits:

      “For example, in addition to the effect of nicotine on prolonged heat pain ratings, our results suggest an effect of stress on changes in heat pain ratings, with those self-reporting higher stress at baseline having greater reductions in pain. Our post-hoc analysis suggested that this relationship between higher stress and larger decrease in PHP ratings was only present for the nicotine group (Supplementary Material 3.3). As stress is linked to nicotine use [69,70] and pain [71–73], these interactions should be explored in future.”

      (7) Is the differential effect of nicotine vs. placebo based on the pre vs. post treatment effect of the placebo condition or on the pre vs. post effect of the nicotine treatment? Can the mediation model be adapted and run for each condition separately? The placebo condition seems to have a stronger effect and may have driven the result.

      Thank you for your comments. In our mediation analysis, the differential effect of nicotine vs. placebo is assessed as a comparison between the pre-post difference within each condition. A latent change score (i.e. pre-post) is calculated for each condition (nicotine and placebo), and then the effect of being in the nicotine group (dummy coded as 1) is compared to being in the placebo group (dummy coded as 0). The comparison between conditions is needed for this model (Valente & MacKinnon, 2017), as we are assessing the change in PAF and pain in the nicotine group compared to the change in the placebo group.

      However, to address your response, it is possible to simplify and assess the relationship between the change in peak alpha frequency (PAF) and change in pain within each gum group (nicotine and placebo) independently, without including the intervention as a factor. To do this, the mediation model can be simplified to regression analysis with latent change scores that focus purely on these relationships. The results of this can help to understand whether change in PAF influences change in pain within each group separately. As with the main analysis, we see no significant influence of change in PAF on change in pain while controlling for the same confounding variables within the nicotine group (Beta = -0.146 +/- 1.105, p = 0.895, 95% CI: -2.243, 2.429) or the placebo group (Beta = 0.730 +/- 2.061, p = 0.723, 95% CI: -4.177, 3.625).

      When suggesting that the “the placebo condition seems to have a stronger effect and may have driven the result”, we believe you are referring to the increase in mean PHP ratings within the placebo group from pre (5.51 +/- 2.53) to post-placebo gum (5.84 +/- 2.67). Indeed there was a significant increase in pain ratings pre to post chewing placebo gum (t(31) = -2.53, p = 0.0165, 95% CI: -0.603, -0.0653), that was not seen after chewing nicotine gum (t(27) = 0.237, p = 0.81, 95% CI: -0.358, 0.452). In lieu of a control where no gum was chewed (i.e. simply a second pain assessment ~30 minutes after the first), we assume the gum without nicotine is a good reference that controls for the effect of time plus expectation of chewing nicotine gum. With this in mind, as we describe in our results, the change in PHP ratings is reduced in the nicotine group compared to the placebo group. Note that this phrasing keeps the effect of placebo on pain as our reference from which to view the effect of nicotine on pain. However, you are correct that we need to ensure we emphasise that the change in pain in the PHP group is reduced in comparison to the change seen after placebo.

      We have not included these extra statistics in our revised manuscript, but hope that they aid the your understanding and interpretation of the included analyses and have highlighted these nuances in the discussion.

      “However, we note that the observed effect of nicotine on pain was small in magnitude, and most prominent in comparison to the effect of placebo, where pain ratings increased after chewing, which brings into question whether this reduction in pain is meaningful in practice.”

      (8) I would not dare to state that nicotine can function as an acute analgesic. Acute analgesics need to work for everyone. The average effect here is close to zero.

      In light of your feedback, we have refined our language to avoid a sweeping assertion of universal analgesic effects and emphasize individual variability. Nicotine's role as a coping strategy for pain is acknowledged in the literature (Robinson et al., 2022), with the meta-analysis by Ditre et al. (2016) discussing its potential as an acute analgesic in humans, along with some evidence from animal research (Zhang et al., 2020). Our revised discussion underscores the need for further exploration into factors influencing nicotine's potential impact on pain. We have also specified the short-term nature of nicotine use in this context to distinguish acute effects from potential opposing effects after long-term use (Zhang et al., 2020).

      “Short-term nicotine use is thought to have acute analgesic properties in experimental settings, with a review reporting that nicotine increased pain thresholds and pain tolerance [49]. In addition, research in a rat model suggests analgesic effects on mechanical thresholds after short-term nicotine use (Zhang et al., 2020). However, previous research has not assessed the acute effects of nicotine on prolonged experimental pain models. The present study found that 4 mg of nicotine reduced heat pain ratings during prolonged heat pain compared to placebo for our human participants, but that prolonged pressure pain decreased irrespective of which gum was chewed. Our findings are thus partly consistent with the idea that nicotine may have acute analgesic properties [49], although further research is required to explore factors that may influence nicotine’s potential impact on a variety of prolonged pain models. We further advance the literature by reporting this effect in a

      model of prolonged heat pain, which better approximates the experience of clinical pain than short lasting models used to assess thresholds and tolerance [50]. However, we note that the observed effect of nicotine on pain was small in magnitude, and most prominent in comparison to the effect of placebo, where pain ratings increased after chewing, which brings into question whether this reduction in pain is meaningful in practice. Future research should examine whether effects on pain increase in magnitude with different nicotine administration regimens (i.e. dose and frequency).”

      (9) Figures 2E and 2F are not particularly intuitive. Usually, the colour green in "jet" colour coding is being used for "zero" values. I would suggest to cut off the blue and use only the range between red green and red.

      We have chosen to retain the current colour scale for several reasons. In our analysis, green represents the middle of the frequency range (approx 10 Hz in this case), and if we were to use green as zero, it would effectively remove both blue and green from the plot, resulting in only red shades. Additionally, we have provided a clear colour scale for reference next to the plot, which allows readers to interpret the data accurately. Our intention is to maintain clarity and precision in representing the data, rather than conforming strictly to conventional practices in color coding.

      We believe that the current representation effectively conveys the results of our study while allowing readers to interpret the data within the context provided. Thank you again for your suggestion, and we hope you understand our reasoning in this matter.

      (10) Did the authors do their analysis on the parietal ROI or on the pre-registerred ROI?

      The analysis was conducted on the pre-registered sensorimotor ROI and on the global values. We have now also conducted the analysis with the regions suggested with the cluster based permutation analysis as requested by reviewer 2, comment 3.

      (11) Point 3.2 in the discussion. I would be very cautious to discuss smoking and chronic pain in the context of the manuscript. The authors can not provide any additional knowledge with their design targeting non-smokers, acute nicotine and experimental pain. The information might be interesting in the introduction in order to provide the reader with some context but is probably misleading in the discussion.

      We appreciate your perspective and agree with your caution regarding the discussion of smoking and chronic pain. While our study specifically targets non-smokers and focuses on acute nicotine effects in experimental pain, we understand the importance of contextual clarity. We have removed these points from the discussion to not mislead the reader.

      Previously we wrote, and have removed: “For those with chronic pain, smoking and nicotine use is reported as a coping strategy for pain [52]; abstinence can increase pain sensitivity [48,50], and pain is thus seen as a barrier to smoking cessation due to fear of worsening pain [51,52]. Therefore, continued understanding of the acute effects of nicotine on models of prolonged pain could improve understanding of the role of nicotine and smoking use in chronic pain [49,51,52].”

      (12) I very much appreciate section 3.3 of the discussion. I would not give up on PAF as a target to modulate pain. A modulation might not be possible in such a short period of experimental intervention. PAF might need longer and different interventions to gradually shift in order to attenuate the intensity of pain. As discussed by the authors themselves, I would also consider other targets for alpha analysis (as mentioned above not other electrodes or ROIs but separated sources.)

      Thank you for your comments on section 3.3. We appreciate your recognition of the potential significance of PAF as a target for pain modulation. Your insights align with our considerations that the experimental intervention duration or type might be a limiting factor in observing substantial shifts in PAF to attenuate pain intensity. We had mentioned the use of the exploratory electrode clusters in future work, but have now also mentioned that the use of ICA to identify separate ICA sources may provide an alternative approach. See responses to your previous ICA comment regarding separate sources.

      REFERENCES for responses to reviewer 2

      Chiang, A. K. I., Rennie, C. J., Robinson, P. A., Van Albada, S. J., & Kerr, C. C. (2011). Age trends and sex differences of alpha rhythms including split alpha peaks. Clinical Neurophysiology, 122(8), 1505-1517.

      Debnath, R., Buzzell, G. A., Morales, S., Bowers, M. E., Leach, S. C., & Fox, N. A. (2020). The Maryland analysis of developmental EEG (MADE) pipeline. Psychophysiology, 57(6), e13580.

      Ettinger, U., Williams, S. C., Patel, D., Michel, T. M., Nwaigwe, A., Caceres, A., ... & Kumari, V. (2009). Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity. Neuroimage, 45(2), 549-561.

      Falco, A. M., & Bevins, R. A. (2015). Individual differences in the behavioral effects of nicotine: a review of the preclinical animal literature. Pharmacology Biochemistry and Behavior, 138, 80-90.

      Kayhan, E., Matthes, D., Haresign, I. M., Bánki, A., Michel, C., Langeloh, M., ... & Hoehl, S. (2022). DEEP: A dual EEG pipeline for developmental hyperscanning studies. Developmental cognitive neuroscience, 54, 101104.

      Lederer, D. J., Bell, S. C., Branson, R. D., Chalmers, J. D., Marshall, R., Maslove, D. M., ... & Vincent, J. L. (2019). Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals. Annals of the American Thoracic Society, 16(1), 22-28.

      Little TD. Longitudinal structural equation modeling. Guilford press; 2013.

      Pernet, C., Garrido, M., Gramfort, A., Maurits, N., Michel, C. M., Pang, E., ... & Puce, A. (2018). Best practices in data analysis and sharing in neuroimaging using MEEG.

      Pernet, C., Garrido, M. I., Gramfort, A., Maurits, N., Michel, C. M., Pang, E., ... & Puce, A. (2020). Issues and recommendations from the OHBM COBIDAS MEEG committee for reproducible EEG and MEG research. Nature neuroscience, 23(12), 1473-1483.

      Pomerleau, O. F. (1995). Individual differences in sensitivity to nicotine: implications for genetic research on nicotine dependence. Behavior genetics, 25(2), 161-177.

      Robinson, C. L., Kim, R. S., Li, M., Ruan, Q. Z., Surapaneni, S., Jones, M., ... & Southerland, W. (2022). The Impact of Smoking on the Development and Severity of Chronic Pain. Current Pain and Headache Reports, 26(8), 575-581.

      Xia, J., Mazaheri, A., Segaert, K., Salmon, D. P., Harvey, D., Shapiro, K., ... & Olichney, J. M. (2020). Event-related potential and EEG oscillatory predictors of verbal memory in mild cognitive impairment. Brain communications, 2(2), fcaa213.

      VanderWeele, T. J. (2019). Principles of confounder selection. European journal of epidemiology, 34, 211-219.

      Valente, M. J., & MacKinnon, D. P. (2017). Comparing models of change to estimate the mediated effect in the pretest–posttest control group design. Structural Equation Modeling: A Multidisciplinary Journal, 24(3), 428-450.

      Vimolratana, O., Aneksan, B., Siripornpanich, V., Hiengkaew, V., Prathum, T., Jeungprasopsuk, W., ... & Klomjai, W. (2024). Effects of anodal tDCS on resting state eeg power and motor function in acute stroke: a randomized controlled trial. Journal of NeuroEngineering and Rehabilitation, 21(1), 1-15.

      Zhang, Y., Yang, J., Sevilla, A., Weller, R., Wu, J., Su, C., ... & Candiotti, K. A. (2020). The mechanism of chronic nicotine exposure and nicotine withdrawal on pain perception in an animal model. Neuroscience letters, 715, 134627.

      Reviewer #3 (Recommendations For The Authors):

      Introduction

      (1) Rationale and link to chronic pain. I am not sure I agree with the statement "The ability to identify those at greater risk of developing chronic pain is limited". I believe there is an abundance of literature associating risk factors with the different instances of chronic pain (e.g., Mills et al., 2019). The fact that the authors cite studies involving potential neuroimaging biomarkers leads me to believe that they perhaps did not intend to make such a broad statement, or that they wanted to focus on individual prediction instead of population risk.

      We thank the reviewer for the thought put into this comment. We did indeed wish to refer to individual prediction, but also realise that the focus on predicting pain might not be the most appropriate opening for this manuscript. Therefore, we have adjusted the below sentence to refer to the need to identify modifiable factors rather than the need to predict pain.

      “Identifying modifiable factors that influence pain sensitivity could be a key step in reducing the presence and burden of chronic pain (van der Miesen et al., 2019; Davis et al., 2020; Tracey et al., 2021).”

      (2) The statement "Individual peak alpha frequency (PAF) is an electro-physiological brain measure that shows promise as a biomarker of pain sensitivity, and thus may prove useful for predicting chronic pain development" is a non sequitur. PAF may very well be a biomarker of pain sensitivity, but the best measures of pain sensitivity we have (selfreported pain intensity ratings) in general are not in themselves predictive of the development of chronic pain. Conversely, features that are not related to pain sensitivity could be useful for predicting chronic pain (e.g., Tanguay-Sabourin et al., 2023).

      We agree that it is essential to acknowledge that self-reported pain intensity ratings alone are not definitive predictors of chronic pain development. To align with this, we have revised the sentence, removing the second clause to avoid overstatement. The adjusted sentence now reads, "Individual peak alpha frequency (PAF) is an electrophysiological brain measure that shows promise as a biomarker of pain sensitivity."

      (3) Finally, some of the statements in the discussion comparing a tonic heat pain model with chronic neuropathic pain might be an overstatement. Whereas it is true that some of the descriptors are similar, the time courses and mechanisms are vastly different.

      We appreciate this comment, and agree that it is difficult to compare the heat pain model used to clinical neuropathic pain. This was an oversight and with further understanding we have removed this comment from the introduction and the discussion:

      “In parallel, we saw no indication of a relationship between PAF and pain ratings during CPA. The introduction of the CPA model, specifically calibrated to a moderate pain threshold, provides further support for the notion that the relationship between PAF and pain is specific to certain pain types [17,28]. Prolonged heat pain was pre-dominantly described as moderate/severe shooting, sharp, and hot pain, whereas prolonged pressure pain was predominantly described as mild/moderate throbbing, cramping, and aching in the present study. It is possible that the PAF–pain relationship is specific to particular pain models and protocols [12,17].”

      Methodology

      (4) or the benefit of good science. However, I am compelled to highlight that I could not access the preregistered files, even though I waited for almost two weeks after requesting permission to do so. This was a problem on two levels: the main one is that I could not check the hypothesized effect sizes of the sample size estimation, which are not only central to my review, and in general negate all the benefits that should go with preregistration (i.e., avoiding phacking, publication bias, data dredging, HARKing, etc.). The second one is that I had to provide an email address to request access. This allows the authors to potentially identify the reviewers. Whereas I have no issues with this and I support transparent peer review practices (https://elifesciences.org/inside-elife/e3e90410/increasingtransparency-in-elife-s-review-process), I also note that this might condition other reviewers.

      We apologise for this. We had not realised that the pre-registration was under embargo, but we have now made it available.

      Interpretation of results

      (5)To be perfectly clear, I trust the results of this study more than some of the cited studies regarding nicotine and pain because it was preregistered, the sample size is considerably larger, and it seems carefully controlled. I just do not agree with the interpretation of the results, stated in the first paragraph of the Discussion. Quoting J. Cohen, "The primary product of a research inquiry is one or more measures of effect size, not P values" (Cohen, 1990). As I am sure the authors are aware of, even tiny differences between conditions, treatments or groups will eventually be statistically significant given arbitrarily large sample sizes. What really matters then is the magnitude of these differences. In general, the authors hypothesize on why there were no differences on the pressure pain model, and why decreases in heat pain were not mediated by PAF, but do not seem to consider the possibility that the intervention just did not cause the intended effect on the nociceptive system, which would be a much more straightforward explanations for all observations.

      While acknowledging and agreeing with the concern that 'even tiny differences between conditions, treatments, or groups will eventually be statistically significant given arbitrarily large sample sizes,' it's crucial to clarify that our sample size of N=62 does not fall into the category of arbitrarily large. We carefully considered the observed outcomes in the pressure pain model and the lack of PAF mediation in heat pain, as dictated by our statistical approach and the obtained results.

      The suggestion of a straightforward explanation aligning with the intervention not causing the intended effect on the nociceptive system is a valid consideration. We did contemplate the possibility of a false positive, emphasising this in the limitations of our findings and the need for replication to draw stronger conclusions to follow up this initial study.

      (6) In this regard, I do not believe that an average *increase* of 0.05 / 10 (Nicotine post - pre) can be considered a "reduction of pain ratings", regardless of the contrast with placebo (average increase of 0.24 / 10). This tiny effect size is more relevant in the context of the considerable inter-individual variation, in which subjects scored the same heat pain model anywhere from 1 to 10, and the same pressure pain model anywhere from 1 to 8.5. In this regard, the minimum clinically or experimentally important differences (MID) in pain ratings varies from study to study and across painful conditions but is rarely below 1 / 10 in a VAS or NRS scale, see f. ex. (Olsen et al., 2017). It is not my intention to question whether nicotine can function as an acute analgesic in general (as stated in the Discussion), but instead, if it worked as such under these very specific experimental conditions. I also acknowledge that the authors note this issue in two lines in the Discussion, but I believe that this is not weighed properly.

      We appreciate your perspective on the interpretation of the effect size, and we understand the importance of considering it in the context of individual variation.

      As also discussed in response to comment 6 From reviewer 2, we recognize the concern about interpreting the effect of nicotine on prolonged pain solely based on mean results, and in fact wish to discourage this approach. It's crucial to note that both PAF and pain are highly individual measures (i.e. high inter-individual variance), necessitating the use of random intercepts for participants in our analyses to acknowledge the inherent variability at baseline across participants. Including random intercepts rather than only considering the means helps address the heterogeneity in baseline levels among participants. We also recognise that displaying the mean PHP ratings for all participants in Table 2 could be misleading, firstly because these means do not have weight in an analysis that takes into account a random-effects intercept for participants, and secondly because two participants (one from each group) did not have post-gum PHP assessments and were not included in the mediation analysis due to list-wise deletion of missing data. Therefore, to reduce the potential for misinterpretation, we have added extra detail to display both the full sample and CPA mediation analysis (i.e. N=62) and the data used for PHP mediation analysis (i.e. n=60) in Table 2. We hope that the extra details added to this table will help the readers interpretation of results.

      Moreover, we have made sure refer to the comparison with the placebo group when discussing the reduction or decrease in pain seen in the nicotine group, for example:

      “2) nicotine reduced prolonged heat pain intensity but not prolonged pressure pain intensity compared to placebo gum;”

      “The nicotine group had a decrease in heat pain ratings compared to the placebo group and increased PAF speed across the scalp from pre to post-gum, driven by changes at central-parietal and right-frontal regions.”

      We have kept our original comment of whether this effect on pain is meaningful in practice to refer to the minimum clinically or experimentally important differences in pain ratings as highlighted by Olsen et al., 2017.

      “While acknowledging the modest effect size, it’s essential to consider the broader context of our study’s focus. Assessing the clinical relevance of pain reduction is pertinent in applications involving the use of any intervention for pain management [69]. However, from a mechanistic standpoint, particularly in understanding the implications of and relation to PAF, the specific magnitude of the pain effect becomes less pivotal. Nevertheless, future research should examine whether effects on pain increase in magnitude with different nicotine administration regimens (i.e. dose and frequency).”

      (7) In line with the topic of effect sizes, average effect sizes for PAF in the study cited in the manuscript range from around 1 Hz (Boord et al., 2008; Wydenkeller et al., 2009; Lim et al., 2016), to 2 Hz (Foulds et al., 1994), compared with changes of 0.06 Hz (Nicotine post - pre) or -0.01 Hz (Placebo post - pre). MIDs are not so clearly established for peak frequencies in EEG bands, but they should be certainly larger than some fractions of a Hertz (which is considerably below the reliability of the measurement).

      We appreciate your care of these nuances. We acknowledge the differences in effect sizes between our study and those referenced in the manuscript. Given the current state of the literature, it's noteworthy that ‘MIDs’ for peak frequencies in EEG bands, particularly PAF changes, are not clearly established, other than a recent publication suggesting that even small changes in PAF are reliable and meaningful (Furman et al., 2021). In light of this, we have addressed the uncertainty around the existence and determination of MIDs in our revision, highlighting the need for further research in this area.

      In addition, our study employed a greater frequency resolution (0.2 Hz) compared to some of the referenced studies, with approximately 0.5 Hz resolution (Boord et al., 2008; Wydenkeller et al., 2009; Foulds et al., 1994). This improved resolution allows for a more precise measurement of changes in PAF. Considering this, it is plausible that studies with lower resolution might have conflated increases in PAF, and our higher resolution contributes to a more accurate representation of the observed changes.

      We have also incorporated this insight into the manuscript, emphasising the methodological advancements in our study and their potential impact on the interpretation of PAF changes. Thank you for your thoughtful feedback.

      “The ability to detect changes in PAF can be considerably impacted by the frequency resolution used during Fourier Transformations, an element that is overlooked in recent methodological studies on PAF calculation [16,95]. Changes in PAF within individuals might be obscured or conflated by lower frequency resolutions, which should be considered further in future research.”

      (8) The authors also ran alternative statistical models to analyze the data and did not find consistent results in terms of PHP ratings (PAF modulation was still statistically significantly different). The authors attribute this to the necessity of controlling for covariates. Now, considering the effects sizes, aren't these statistically significant differences just artifacts stemming from the inclusion of too many covariates (Simmons et al., 2011)? How much influence should be attributable to depression and anxiety symptoms, stress, sleep quality and past pain, considering that these are healthy volunteers? Should these contrasting differences call the authors to question the robustness of the findings (i.e., whether the same data subjected to different analysis provides the same results), particularly when the results do not align with the preregistered hypothesis (PAF modulation should occur on sensorimotor ROIs)?

      Thank you for your comments on our alternative statistical models. By including these covariates, we aim to provide a more nuanced understanding of the complexities within our data by considering their potential impact on the effects of interest. The decision to include covariates was preregistered (apologies again that this was not available) and made with consideration of balancing model complexity and avoiding potential confounding. Moreover, we hope that the insights gained from these analyses will offer valuable information about the behaviour of our data and aid future research in terms of power calculations, expected variance, and study design.

      (9) Beyond that, I believe in some cases that the authors overreach in an attempt to provide explanations for their results. While I agree that sex might be a relevant covariate, I cannot say whether the authors are confirming a pre-registered hypothesis regarding the gender-specific correlation of PAF and pain, or if this is just a post hoc subgroup analysis. Given the large number of analyses performed (considering the main document and the supplementary files), caution should be exercised on the selective interpretation of those that align with the researchers' hypotheses.

      We chose to explore the influence of sex on the correlation between PAF and pain, because this has also been investigated in previous publications of the relationship (Furman et al., 2020).  We state that the assessment by sex is exploratory in our results on p.17: “in an exploratory analysis of separate correlations in males and females (Figure 5, plot C)”. For clarity regarding whether this was a pre-registered exploration or not, we have adjusted this to be: “in an exploratory analysis (not pre-registered) of separate correlations in males and females (Figure 5, plot C), akin to those conducted in previous research on this topic (Furman et al., 2020),

      We have made sure to state this in the discussion also. Therefore, when we previously said on p.22:

      “Regarding the relationship between PAF and pain at baseline, the negative correlation between PAF and pain seen in previous work [7–11,15] was only observed here for male participants during the PHP model for global PAF.” We have now changed this to: “Regarding the relationship between PAF and pain at baseline, the negative correlation between PAF and pain seen in previous work [7– 11,15] was only observed here for male participants during the PHP model for global PAF in an exploratory analysis.”

      Please also note that we altered the colour and shape of points on the correlation plot (Figure 5 in initial submission), the male brown was changed to a dark brown as we realised that the light brown colour was difficult to read. The shape was then changed for male points so that the two groups can be distinguished in grey-scale.

      Overall, your thoughtful feedback is instrumental in refining the interpretation of our findings, and we look forward to presenting a more comprehensive and nuanced discussion. Thank you for your comments.

      REFERENCES for responses to reviewer 3

      Arendt-Nielsen, L., & Yarnitsky, D. (2009). Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. The Journal of Pain, 10(6), 556-572.

      Chowdhury, N. S., Skippen, P., Si, E., Chiang, A. K., Millard, S. K., Furman, A. J., ... & Seminowicz, D. A. (2023). The reliability of two prospective cortical biomarkers for pain: EEG peak alpha frequency and TMS corticomotor excitability. Journal of Neuroscience Methods, 385, 109766.

      Fishbain, D. A., Lewis, J. E., & Gao, J. (2013). Is There Significant Correlation between SelfReported Low Back Pain Visual Analogue Scores and Low Back Pain Scores Determined by Pressure Pain Induction Matching?. Pain practice, 13(5), 358-363.

      Furman, A. J., Prokhorenko, M., Keaser, M. L., Zhang, J., Chen, S., Mazaheri, A., & Seminowicz, D. A. (2021). Prolonged pain reliably slows peak alpha frequency by reducing fast alpha power.

      bioRxiv, 2021-07.

      Heitmann, H., Ávila, C. G., Nickel, M. M., Dinh, S. T., May, E. S., Tiemann, L., ... & Ploner, M. (2022). Longitudinal resting-state electroencephalography in patients with chronic pain undergoing interdisciplinary multimodal pain therapy. Pain, 163(9), e997.

      McLain, N. J., Yani, M. S., & Kutch, J. J. (2022). Analytic consistency and neural correlates of peak alpha frequency in the study of pain. Journal of neuroscience methods, 368, 109460.

      Ngernyam, N., Jensen, M. P., Arayawichanon, P., Auvichayapat, N., Tiamkao, S., Janjarasjitt, S., ... & Auvichayapat, P. (2015). The effects of transcranial direct current stimulation in patients with neuropathic pain from spinal cord injury. Clinical Neurophysiology, 126(2), 382-390.

      Parker, T., Huang, Y., Raghu, A. L., FitzGerald, J., Aziz, T. Z., & Green, A. L. (2021). Supraspinal effects of dorsal root ganglion stimulation in chronic pain patients. Neuromodulation: Technology at the Neural Interface, 24(4), 646-654.

      Petersen-Felix, S., & Arendt-Nielsen, L. (2002). From pain research to pain treatment: the role of human experimental pain models. Best Practice & Research Clinical Anaesthesiology, 16(4), 667680.

      Sarnthein, J., Stern, J., Aufenberg, C., Rousson, V., & Jeanmonod, D. (2006). Increased EEG power and slowed dominant frequency in patients with neurogenic pain. Brain, 129(1), 55-64.

      Sato, G., Osumi, M., & Morioka, S. (2017). Effects of wheelchair propulsion on neuropathic pain and resting electroencephalography after spinal cord injury. Journal of Rehabilitation Medicine, 49(2), 136-143.

      Sufianov, A. A., Shapkin, A. G., Sufianova, G. Z., Elishev, V. G., Barashin, D. A., Berdichevskii, V. B., & Churkin, S. V. (2014). Functional and metabolic changes in the brain in neuropathic pain syndrome against the background of chronic epidural electrostimulation of the spinal cord. Bulletin of experimental biology and medicine, 157(4), 462-465.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study probes the role of the NF-κB inhibitor IκBa in the regulation of pluripotency in mouse embyronic stem cells (mESCs). It follows from previous work that identified a chromatin-specific role for IκBa in the regulation of tissue stem cell differentiation. The work presented here shows that a fraction of IκBa specifically associates with chromatin in pluripotent stem cells. Using three Nfkbia-knockout lines, the authors show that IκBa ablation impairs the exit from pluripotency, with embryonic bodies (an in vitro model of mESC multi-lineage differentiation) still expressing high levels of pluripotency markers after sustained exposure to differentiation signals. The maintenance of aberrant pluripotency gene expression under differentiation conditions is accompanied by pluripotency-associated epigenetic profiles of DNA methylation and histone marks. Using elegant separation of function mutants identified in a separate study, the authors generate versions of IκBa that are either impaired in histone/chromatin binding or NF-κB binding. They show that the provision of the WT IκBa, or the NF-κB-binding mutant can rescue the changes in gene expression driven by loss of IκBa, but the chromatin-binding mutant can not. Thus the study identifies a chromatin-specific, NF-κB-independent role of IκBa as a regulator of exit from pluripotency.

      Strengths:

      The strengths of the manuscript lie in: (a) the use of several orthogonal assays to support the conclusions on the effects of exit from pluripotency; (b) the use of three independent clonal Nfkbia-KO mESC lines (lacking IκBa), which increase confidence in the conclusions; and (c) the use of separation of function mutants to determine the relative contributions of the chromatin-associated and NF-κB-associated IκBa, which would otherwise be very difficult to unpick.

      Weaknesses:

      In this reviewer's view, the term "differentiation" is used inappropriately in this manuscript. The data showing aberrant expression of pluripotency markers during embryoid body formation are supported by several lines of evidence and are convincing. However, the authors call the phenotype of Nfkbia-KO cells a "differentiation impairment" while the data on differentiation markers are not shown (beyond the fact that H3K4me1, marking poised enhancers, is reduced in genes underlying GO processes associated with differentiation and organ development). Data on differentiation marker expression from the transcriptomic and embryoid body immunofluorescent experiments, for example, should be at hand without the need to conduct many more experiments and would help to support the conclusions of the study or make them more specific. The lack of probing the differentiation versus pluripotency genes may be a missed opportunity in gaining in-depth understanding of the phenotype associated with loss of the chromatin-associated function of IκBa.

      Reviewer #2 (Public review):

      Summary:

      This manuscript investigates the role of IκBα in regulating mouse embryonic stem cell (ESC) pluripotency and differentiation. The authors demonstrate that IκBα knockout impairs the exit from the naïve pluripotent state during embryoid body differentiation. Through mechanistic studies using various mutants, they show that IκBα regulates ESC differentiation through chromatin-related functions, independent of the canonical NFκB pathway.

      Strengths:

      The authors nicely investigate the role of IκBα in pluripotency exit, using embryoid body formation and complementing the phenotypic analysis with a number of genome-wide approaches, including transcriptomic, histone marks deposition, and DNA methylation analyses. Moreover, they generate a first-of-its-kind mutant set that allows them to uncouple IκBα's function in chromatin regulation versus its NF-κB-related functions. This work contributes to our understanding of cellular plasticity and development, potentially interesting a broad audience including developmental biologists, chromatin biology researchers, and cell signaling experts.

      Weaknesses:

      - The study's main limitation is the lack of crucial controls using bona fide naïve cells across key experiments, including DNA methylation analysis, gene expression profiling in embryoid bodies, and histone mark deposition. This omission makes it difficult to evaluate whether the observed changes in IκBα-KO cells truly reflect naïve pluripotency characteristics.

      - Several conclusions in the manuscript require a more measured interpretation. The authors should revise their statements regarding the strength of the pluripotency exit block, the extent of hypomethylation, and the global nature of chromatin changes. - From a methodological perspective, the manuscript would benefit from additional orthogonal approaches to strengthen the knockout findings, which may be influenced by clonal expansion of ES cells.

      Overall, this study makes an important contribution to the field. However, the concerns raised regarding controls, data interpretation, and methodology should be addressed to strengthen the manuscript and support the authors' conclusions.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      I have the following comments and suggestions for the authors to consider:

      (1) Fig, 1D: the number of replicates for this experiment is not mentioned. It would be good to see if the apparent accumulation of IκBa on chromatin of S/L cells is reproducible. If it is, does the accumulation of IκBa "prime" chromatin for differentiation?

      We apologize for missing this information in the figure legend. We have repeated the experiment two independent times, and confirmed the localization of IκBα in the chromatin fraction of mESCs cultured in Serum/LIF (S/L). We have included the information in the figure legend.

      Regarding the second question, we do believe that the presence of IκBα primes mESCs to exit from differentiation. Previous data from the lab (Mulero et al Cancer Cell 2012; Marruecos et al EMBO Reports 2020) demonstrated that IκBα regulates important developmental genes (Hox genes and differentiation-related genes), which become dysregulated upon IκBα depletion. Based on those previous results, together with our results that demonstrated that lack of IκBα hyperactivates the pluripotency network, we conclude that IκBα is a crucial element to attenuate pluripotency programs, allowing a successful exit from naïve pluripotency and differentiation.

      (2) Fig. 1E: From what is shown, Rela doesn't agree (i.e. no enrichment in EpiSCs in the Atlasi data). Are the culture conditions in Atlasi 2020 the same as in this paper (base medium etc.)? Also, why not label all genes/proteins that are shown in 1C?

      Differences observed between our data and the in-silico data might be due to differences in culture conditions used in Atlasi and colleagues. In particular, Atlasi et al. cultured the mESCs in 2i/LIF for 2 consecutive months, whereas we induced ground state of naïve pluripotency (2i/LIF) for only 96h. In the case of EpiSC differentiation, similar protocols are used in both our work and in Atlasi et al. Nevertheless, despite existing differences, in both studies IκBα is enriched in the ground state of naive pluripotency. 

      The reason why some proteins that are missing in Figure 1E but appearing in Figure 1C is because they are not detected in the mass spectrometry experiment.

      (3) Fig. 1F: The word "clustering" here is misleading. While Nfkbia shows similar dynamics as pluripotency genes, clustering should not be used unless clusters of genes are shown in the same heatmap (and the transcripts naturally cluster together). The figure would be even more informative if all the genes from the 4 different categories were presented on the same heatmap.

      As suggested by the reviewer, we have generated a heatmap where the  genes from the different four categories (Figure 1F) are displayed  and clustered together:

      Author response image 1.

      Heatmap including all the genes from Figure 1F of the manuscript and clustering is simultaneously conducted over the four categories.

      As shown in previous heatmap, we can confirm that most of the Nf-kB genes (except for Nfkbia and Nfkbid) clustered together with differentiation markers.   

      Nonetheless, to be more conservative with original Figure 1F and for clarity upon gene categories,  we have updated the figure  with a combined heatmap, sliced by gene categories.  In this updated version, we can observe how IkBα gene, though classified by the biological process where it classically belongs (NF-kB pathway), is higher at pluripotency, whereas it decreases upon differentiation induction, similarly as most of the pluripotency genes.

      We have also changed the text accordingly and have added the following sentences in the main text (lines 121-125): “The expression pattern of Nfkbia was similar to the pluripotency genes whereas most of the NF-κB genes were upregulated upon differentiation, showing an analogous expression dynamics as developmental genes, as previously described”.

      (4) This reviewer felt that the statement "Notably, several polycomb elements were highly expressed in mESCs, consistent with the possibility that chromatin-bound IκBα modulates PRC2 activity in the pluripotent state" (p.5, lines 125-127) is premature here. While similar expression dynamics may be consistent with a linked function, they in no way suggest this. This can be more accurately stated to point out that Nfkbia shows similar expression dynamics in pluripotency and differentiation as Polycomb component      genes.

      We agree that the statement is premature and we have changed it by: “Previous reports have demonstrated that chromatin-bound IκBα modulates PRC2 activity in different adult stem cell models [27]. Interestingly, we observed that most of the Polycomb target genes follow a similar expression pattern of Nfkbia and pluripotency, with higher expression in mESCs (Figure 1F).” (lines 125-128 in the manucript).

      (5) Top of p. 6: the results are mis-attributed to Fig. 1, it should be Fig. 2.

      We thank the reviewer for this observation. We have corrected it in the main text.

      (6) Fig. 1B and Fig. 5I: the images of the AP stains are very difficult to see, better resolution images should be used.

      We have increased both the resolution and the size of the AP colonies.

      (7) Line 142 (p.6): Fig. S1B should be S1C. In general the manuscript would benefit from review of the order and labeling of the figure panels as there are a number of inconsistencies.

      We have better organized the figures in the new version of the manuscript. In particular, we have reorganized the Figure S1 to have a more logical order. We have done the same for the Figure 2 and Figure 5 and they are updated in the new version of the reviewed manuscript.

      (8) The authors call the phenotype of Nfkbia-KO cells a "differentiation impairment". Do the EBs shown in Fig. 2 also express differentiation markers? Do they fail to up-regulate those markers or just fail to down-regulate pluripotency markers? At the transcriptomic level the Nfkbia-KO cells still change significantly upon provision of differentiation signals (Fig. 2C), what types of gene processes underlie the differences between WT and KO cells and which processes are common? Also, based on this figure, the phenotype looks to be more of a delay than a failure in differentiation, as the cells still follow the same trajectory but lag behind the WT cells. It is difficult to discern whether this is the case based on Fig. 2E-G as we don't see the later time point (up to Day 9).

      In general, with the data presented in Fig. 2C and Fig. S1, the authors show that many of the hallmarks of exit from pluripotency are impaired in Nfkbia-KO cells, as well as the general "transcriptional status" of the cells, but they don't show differentiation markers (which would be necessary to conclude an impairment in differentiation). The data should be readily available in the datasets that are in the manuscript already and it will be informative to extract and present them. The data are not currently publicly accessible (unavailable until July 2025) so it was not possible to mine them.

      We appreciate the observation, and we have included more data to confirm that the IκBα-KO cells show a differentiation impairment. In the first version of the manuscript, differentiation markers are displayed from Figures 2E-G, where genes from the three germ layers (ectoderm, mesoderm and endoderm) are not activated in IκBα-KO EBs at 48h and 96h. Moreover, the volcano plot displayed in Figure S1F of the first version clearly shows a downregulation of important differentiation genes such as a T, Eomes, Lhx1 and Foxa2. We agree that 96h EBs is an early time point to talk about differentiation impairment. For that reason, we have also included the same pluripotent and differentiation genes in 216h EBs (Figures S1F-G of the newer version of the manuscript). It is clearly observed that IκBα-KO 216h EBs maintain an upregulation of pluripotency programs which negatively correlate with a lower differentiation capability. Moreover, the impairment in the differentiation with a higher expression of pluripotency markers is confirmed by the presence of high SSEA-1 expression in IκBα-KO 216h EBs (Figure S1C of the manuscript) and alkaline phosphatase (AP) staining (Figure 2C of the manuscript). Lastly, the fact that IκBα-KO teratomas contain higher proportion of OCT3/4+ cells further confirming that IκBα-KO cells cannot differentiate because of the inability to exit from pluripotency.

      Finally, generated data (and deposited in GEO repository with SuperSeries id GSE239565) is already publicly available. 

      (9) Fig. 5A: even if there are no global changes in NF-κB target genes, could a small subset of NF-κB target genes still mediate the IκBa effects?

      We have analyzed the whole NF-κB signature, and we have identified a small cluster of genes that are differentially expressed at 96h EBs between IκBα-KO and IκBα-WT (Author response image 2). Interestingly, what we observed is the opposite as expected since we see un downregulation of that subset in the IκBα-KO 96h EBs (Author response image 3). For that reason, detected changes in the NF-κB target gene expression after deletion of Nfkbia do not support an NF-κB inhibitory role for IkBa in pluripotent ESC.

      Author response image 2.

      Heatmap of NF-κB genes expression at the different time points of differentiation (mESCs, 48h EBs, 96h EBs). Highlighted region marks the genes that are differentially expressed between both genotypes at 96h EBs.

       

      Author response image 3.

      Violin plot of genes from the NF-κB pathway which are differentially expressed at 96h EBs.

      (10) Lines 233-238, the part of the text is repeated.

      We appreciate the observation and have deleted the repeated part.

      (11) The data in Fig. 5D-E make it difficult to be sure whether the conclusions on the relative subcellular localisations of the different mutants are accurate, as the chromatin-binding mutant seems to be less abundant than the other mutants (judging from the Input in Fig. 5C and also from the tubulin loading controls in Fig. 5D-E). Showing the IκBa levels in total extracts would make the interpretation of these data more robust. The authors do mention that the chromatin-binding mutant IκBa protein is consistently expressed at lower levels but they do not comment on how this may affect the data interpretation - could the lack of rescue be due to lower levels of the chromatin-binding mutant IκBa relative to the wild-type IκBa? This should be addressed in the Discussion, if not tested formally by normalising the expression levels of the different forms of IκBa in the rescue experiments.

      Although protein stability is different among the SOF mutants, IκBα<sup>ΔChromatin</sup> is exclusively detected in the cytoplasm, with lack of detection in the chromatin compartment (Figures 5D-E of the reviewed manuscript). For this reason, we believe that the quantitative differences in protein levels of the different mutants cannot explain the subcellular localization differences and the phenotype observed.

      Nonetheless, we cannot discard that differences in the protein levels between SOF mutants can affect the rescue phenotype, and we have specified so in the discussion section of the manuscript. 

      (12) Lines 260-261: "Induction of i-IκBαWT and i-IκBαΔNF-κB reduced the expression levels of the naive pluripotent genes Zfp42, Klf2, Sox2 and Tbx3, which were increased by i-IκBαΔChromatin (Figure 5F)." This is not an accurate statement. The expression was not reduced by the ΔChrom mutant in the same way as it was by the WT and the ΔNF-κB mutant, but it was not increased.

      We have better specified the description of the results displayed in Figure 5F (lines 258-261 of the main manuscript):

      “Induction of i-IκBα<sup>WT</sup> and i-IκBα<sup>ΔNF-κB</sup> reduced the expression levels of the naïve pluripotent genes Zfp42, Klf2, Sox2 and Tbx3. On the other hand, the same genes either do not change their expression (Zfp42, Sox2, Klf2) or increase their levels (Tbx3) upon i-IκBα<sup>ΔChromatin</sup>  induction (Figure 5F).”

      (13) In Fig. 5J the images will ideally be shown before and after Doxycycline treatment, to better support the conclusions.

      We have included a new panel in Figure S4 (Figure S4E in the reviewed manuscript) where the No doxycycline control 216 EBs between the different conditions (i-IκBα<sup>WT</sup>, i-IκBα<sup>ΔChrom</sup> and i-IκBα<sup>ΔNF-κB</sup>) are included.

      Reviewer #2 (Recommendations for the authors):

      - The PCA analysis in Figure 2 appears to contradict the authors' conclusions about global transcriptome changes in KO cells. Furthermore, there is a discrepancy between immunofluorescence data showing near-complete methylation loss and the methylation array analysis results.

      Although there is a differentiation block in the IkBa KO EBs, this is not complete and they show some differentiation trend after 96h (Fig 2C), moreover, acquisition of differentiation genes from all three germ layers is strongly affected (Figure 2E of the reviewed manuscript) and these programs remain downregulated and pluripotency genes are still expressed in IκBα-KO EBs at later time points (216h) (Fig 2B). Altogether demonstrates that the lack of IκBα impairs differentiation and the silencing of the pluripotency network.

      Discrepancies between methylation array and immunofluorescence are expected since immunofluorescence is not quantitative and the methylation array is very precise.  

      - The authors should revise their statements regarding the strength of the pluripotency exit block, the extent of hypomethylation, and the global nature of chromatin changes. For example, the observed chromatin changes, including H3K27ac modifications, appear relatively modest and should be described as such. - The manuscript would benefit from additional orthogonal approaches to strengthen the knockout findings, which may be influenced by clonal expansion of ES cells. Additionally, the emphasis on overlapping H3K4me3 and H3K27me3 regions should be reduced, as these represent a minor fraction of the affected regions (only 41 regions).

      We have revised the text and have included it in the discussion section the following text (lines 327-331 in the reviewed manuscript):

      “Although IκBα KO  mESCs  exhibit a transcriptional phenotype and hypomethylation state  that resembles the ground state of naïve pluripotency, there are only modest changes on histone marks associated to enhancers (H3K27Ac) or gene regulation (H3K4me3 and H3K27me3). Altogether indicates that further experiments are required to fully elucidate the effect of chromatin IκBα.”

      We have also included Fig S3E-S3F to show that similar differences as WT and KO in H3K4me3 and H3K27me3 are observed in a serum/LIF and 2i conditions, further supporting the fact that KO cells in Serum/LIF resemble WT cells in 2i condition.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      In an important fMRI study with an elegant experimental design and rigorous cross-decoding analyses, this work shows a solid dissociation between two parietal regions in visually processing actions. Specifically, aIPL is found to be sensitive to the causal effects of observed actions, while SPL is sensitive to the patterns of body motion involved in those actions. Additional analysis and explanation would help to determine the strength of evidence and the mechanistic underpinnings would benefit from closer consideration. Nevertheless, the work will be of broad interest to cognitive neuroscientists, particularly vision and action researchers.

      We thank the editor and the reviewers for their assessment and their excellent comments and suggestions. We really believe they helped us to provide a stronger and more nuanced paper. In our revision, we addressed all points raised by the reviewers. Most importantly, we added a new section on a series of analyses to characterize in more detail the representations isolated by the action-animation and action-PLD cross-decoding. Together, these analyses strengthen the conclusion that aIPL and LOTC represent action effect structures at a categorical rather than specific level, that is, the type of change (e.g., of location or configuration) rather than the specific effect type (e.g. division, compression). SPL is sensitive to body-specific representations, specifically manuality (unimanual vs. bimanual) and movement kinematics. We also added several other analyses and addressed each point of the reviewers. Please find our responses below.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The authors report a study aimed at understanding the brain's representations of viewed actions, with a particular aim to distinguish regions that encode observed body movements, from those that encode the effects of actions on objects. They adopt a cross-decoding multivariate fMRI approach, scanning adult observers who viewed full-cue actions, pantomimes of those actions, minimal skeletal depictions of those actions, and abstract animations that captured analogous effects to those actions. Decoding across different pairs of these actions allowed the authors to pull out the contributions of different action features in a given region's representation. The main hypothesis, which was largely confirmed, was that the superior parietal lobe (SPL) more strongly encodes movements of the body, whereas the anterior inferior parietal lobe (aIPL) codes for action effects of outcomes. Specifically, region of interest analyses showed dissociations in the successful cross-decoding of action category across full-cue and skeletal or abstract depictions. Their analyses also highlight the importance of the lateral occipito-temporal cortex (LOTC) in coding action effects. They also find some preliminary evidence about the organisation of action kinds in the regions examined.

      Strengths:

      The paper is well-written, and it addresses a topic of emerging interest where social vision and intuitive physics intersect. The use of cross-decoding to examine actions and their effects across four different stimulus formats is a strength of the study. Likewise, the a priori identification of regions of interest (supplemented by additional full-brain analyses) is a strength.

      Weaknesses:

      I found that the main limitation of the article was in the underpinning theoretical reasoning. The authors appeal to the idea of "action effect structures (AES)", as an abstract representation of the consequences of an action that does not specify (as I understand it) the exact means by which that effect is caused, nor the specific objects involved. This concept has some face validity, but it is not developed very fully in the paper, rather simply asserted. The authors make the claim that "The identification of action effect structure representations in aIPL has implications for theories of action understanding" but it would have been nice to hear more about what those theoretical implications are. More generally, I was not very clear on the direction of the claim here. Is there independent evidence for AES (if so, what is it?) and this study tests the following prediction, that AES should be associated with a specific brain region that does not also code other action properties such as body movements? Or, is the idea that this finding -- that there is a brain region that is sensitive to outcomes more than movements -- is the key new evidence for AES?

      Thank you for raising this important issue. We reasoned that AES should exist to support the recognition of perceptually variable actions, including those that we have never experienced before. To the best of our knowledge, there is only indirect evidence for the existence of AES, namely that humans effortlessly and automatically recognize actions (and underlying intentions and feelings) in movements of abstract shapes, as in the famous Heider and Simmel (1949) animations. As these animations do not contain any body posture or movement information at all, the only available cues are the spatiotemporal relations between entities and entity parts in the perceived scene. We think that the effortless and automatic attribution of actions to these stimuli points toward an evolutionary optimized mechanism to capture action effect structures from highly variable action instantiations (so general that it even works for abstract animations). Our study thus aimed to test for the existence of such a level of representation in the brain. We clarified this point in the introduction.

      In our revised manuscript, we also revised our discussion of the implications of the finding of AES representations in the brain:

      "The identification of action effect structure representations in aIPL and LOTC has implications for theories of action understanding: Current theories (see for review e.g. Zentgraf et al., 2011; Kemmerer, 2021; Lingnau and Downing, 2024) largely ignore the fact that the recognition of many goal-directed actions requires a physical analysis of the action-induced effect, that is, a state change of the action target. Moreover, premotor and inferior parietal cortex are usually associated with motor- or body-related processing during action observation. Our results, together with the finding that premotor and inferior parietal cortex are similarly sensitive to actions and inanimate object events (Karakose-Akbiyik et al., 2023), suggest that large parts of the 'action observation network' are less specific for body-related processing in action perception than usually thought. Rather, this network might provide a substrate for the physical analysis and predictive simulation of dynamic events in general (Schubotz, 2007; Fischer, 2024). In addition, our finding that the (body-independent) representation of action effects substantially draws on right LOTC contradicts strong formulations of a 'social perception' pathway in LOTC that is selectively tuned to the processing of moving faces and bodies (Pitcher and Ungerleider, 2021). The finding of action effect representation in right LOTC/pSTS might also offer a novel interpretation of a right pSTS subregion thought to specialized for social interaction recognition: Right pSTS shows increased activation for the observation of contingent action-reaction pairs (e.g. agent A points toward object; agent B picks up object) as compared to two independent actions (i.e., the action of agent A has no effect on the action of agent B) (Isik et al., 2017). Perhaps the activation reflects the representation of a social action effect - the change of an agent's state induced by someone else's action. Thus, the representation of action effects might not be limited to physical object changes but might also comprise social effects not induced by a physical interaction between entities. Finally, not all actions induce an observable change in the world. It remains to be tested whether the recognition of, e.g., communication (e.g. speaking, gesturing) and perception actions (e.g. observing, smelling) similarly relies on structural action representations in aIPL and LOTC"

      On a more specific but still important point, I was not always clear that the significant, but numerically rather small, decoding effects are sufficient to support strong claims about what is encoded or represented in a region. This concern of course applies to many multivariate decoding neuroimaging studies. In this instance, I wondered specifically whether the decoding effects necessarily reflected fully five-way distinction amongst the action kinds, or instead (for example) a significantly different pattern evoked by one action compared to all of the other four (which in turn might be similar). This concern is partly increased by the confusion matrices that are presented in the supplementary materials, which don't necessarily convey a strong classification amongst action kinds. The cluster analyses are interesting and appear to be somewhat regular over the different regions, which helps. However: it is hard to assess these findings statistically, and it may be that similar clusters would be found in early visual areas too.

      We agree that in our original manuscript, we did not statistically test what precisely drives the decoding, e.g., specific actions or rather broader categories. In our revised manuscript, we included a representational similarity analysis (RSA) that addressed this point. In short, we found that the action-animation decoding was driven by categorical distinctions between groups of actions (e.g. hit/place vs. the remaining actions) rather than a fully five-way distinction amongst all action kinds. The action-PLD decoding was mostly driven by , specifically manuality (unimanual vs. bimanual)) and movement kinematics; in left and right LOTC we found additional evidence for action-specific representations.

      Please find below the new paragraph on the RSA:

      "To explore in more detail what types of information were isolated by the action-animation and action-PLD cross-decoding, we performed a representational similarity analysis.

      We first focus on the representations identified by the action-animation decoding. To inspect and compare the representational organization in the ROIs, we extracted the confusion matrices of the action-animation decoding from the ROIs (Fig. 5A) and compared them with different similarity models (Fig. 5B) using multiple regression. Specifically, we aimed at testing at which level of granularity action effect structures are represented in aIPL and LOTC: Do these regions encode the broad type of action effects (change of shape, change of location, ingestion) or do they encode specific action effects (compression, division, etc.)? In addition, we aimed at testing whether the effects observed in EVC can be explained by a motion energy model that captures the similarities between actions and animations that we observed in the stimulus-based action-animation decoding using motion energy features. We therefore included V1 in the ROI analysis. We found clear evidence that the representational content in right aIPL and bilateral LOTC can be explained by the effect type model but not by the action-specific model (all p < 0.005; two-sided paired t-tests between models; Fig. 5C). In left V1, we found that the motion energy model could indeed explain some representational variance; however, in both left and right V1 we also found effects for the effect type model. We assume that there were additional visual similarities between the broad types of actions and animations that were not captured by the motion energy model (or other visual models; see Supplementary Information). A searchlight RSA revealed converging results, and additionally found effects for the effect type model in the ventral part of left aIPL and for the action-specific model in the left anterior temporal lobe, left dorsal central gyrus, and right EVC (Fig. 5D). The latter findings were unexpected and should be interpreted with caution, as these regions (except right EVC) were not found in the action-animation cross-decoding and therefore should not be considered reliable (Ritchie et al., 2017). The motion energy model did not reveal effects that survived the correction for multiple comparison, but a more lenient uncorrected threshold of p = 0.005 revealed clusters in left EVC and bilateral posterior SPL.

      To characterize the representations identified by the action-PLD cross-decoding, we used a manuality model that captures whether the actions were performed with both hands vs. one hand, an action-specific model as used in the action-animation RSA above, and a kinematics model that was based on the 3D kinematic marker positions of the PLDs (Fig. 6B). Since pSTS is a key region for biological motion perception, we included this region in the ROI analysis. The manuality model explained the representational variance in the parietal ROIs, pSTS, and LOTC, but not in V1 (all p < 0.002; two-sided paired t-tests between V1 and other ROIs; Fig. 6C). By contrast, the action-specific model revealed significant effects in V1 and LOTC, but not in pSTS and parietal ROIs (but note that effects in V1 and pSTS did not differ significantly from each other; all other two-sided paired t-tests between mentioned ROIs were significant at p < 0.0005). The kinematics model explained the representational variance in all ROIs. A searchlight RSA revealed converging results, and additionally found effects for the manuality model in bilateral dorsal/medial prefrontal cortex and in right ventral prefrontal cortex and insula (Fig. 6D).”

      We also included an ROI covering early visual cortex (V1) in our analysis. While there was significant decoding for action-animation in V1, the representational organization did not substantially match the organization found in aIPL and LOTC: A cluster analysis revealed much higher similarity between LOTC and aIPL than between these regions and V1:

      (please note that in this analysis we included the action-PLD RDMs as reference, and to test whether aIPL shows a similar representational organization in action-anim and action-PLD; see below)

      Given these results, we think that V1 captured different aspects in the action-animation cross-decoding than aIPL and LOTC. We address this point in more detail in our response to the "Recommendations for The Authors".

      Reviewer #2 (Public Review):

      Summary:

      This study uses an elegant design, using cross-decoding of multivariate fMRI patterns across different types of stimuli, to convincingly show a functional dissociation between two sub-regions of the parietal cortex, the anterior inferior parietal lobe (aIPL) and superior parietal lobe (SPL) in visually processing actions. Specifically, aIPL is found to be sensitive to the causal effects of observed actions (e.g. whether an action causes an object to compress or to break into two parts), and SPL to the motion patterns of the body in executing those actions.

      To show this, the authors assess how well linear classifiers trained to distinguish fMRI patterns of response to actions in one stimulus type can generalize to another stimulus type. They choose stimulus types that abstract away specific dimensions of interest. To reveal sensitivity to the causal effects of actions, regardless of low-level details or motion patterns, they use abstract animations that depict a particular kind of object manipulation: e.g. breaking, hitting, or squashing an object. To reveal sensitivity to motion patterns, independently of causal effects on objects, they use point-light displays (PLDs) of figures performing the same actions. Finally, full videos of actors performing actions are used as the stimuli providing the most complete, and naturalistic information. Pantomime videos, with actors mimicking the execution of an action without visible objects, are used as an intermediate condition providing more cues than PLDs but less than real action videos (e.g. the hands are visible, unlike in PLDs, but the object is absent and has to be inferred). By training classifiers on animations, and testing their generalization to full-action videos, the classifiers' sensitivity to the causal effect of actions, independently of visual appearance, can be assessed. By training them on PLDs and testing them on videos, their sensitivity to motion patterns, independent of the causal effect of actions, can be assessed, as PLDs contain no information about an action's effect on objects.

      These analyses reveal that aIPL can generalize between animations and videos, indicating that it is sensitive to action effects. Conversely, SPL is found to generalize between PLDs and videos, showing that it is more sensitive to motion patterns. A searchlight analysis confirms this pattern of results, particularly showing that action-animation decoding is specific to right aIPL, and revealing an additional cluster in LOTC, which is included in subsequent analyses. Action-PLD decoding is more widespread across the whole action observation network.

      This study provides a valuable contribution to the understanding of functional specialization in the action observation network. It uses an original and robust experimental design to provide convincing evidence that understanding the causal effects of actions is a meaningful component of visual action processing and that it is specifically localized in aIPL and LOTC.

      Strengths:

      The authors cleverly managed to isolate specific aspects of real-world actions (causal effects, motion patterns) in an elegant experimental design, and by testing generalization across different stimulus types rather than within-category decoding performance, they show results that are convincing and readily interpretable. Moreover, they clearly took great care to eliminate potential confounds in their experimental design (for example, by carefully ordering scanning sessions by increasing realism, such that the participants could not associate animation with the corresponding real-world action), and to increase stimulus diversity for different stimulus types. They also carefully examine their own analysis pipeline, and transparently expose it to the reader (for example, by showing asymmetries across decoding directions in Figure S3). Overall, this is an extremely careful and robust paper.

      Weaknesses:

      I list several ways in which the paper could be improved below. More than 'weaknesses', these are either ambiguities in the exact claims made, or points that could be strengthened by additional analyses. I don't believe any of the claims or analyses presented in the paper show any strong weaknesses, problematic confounds, or anything that requires revising the claims substantially.

      (1) Functional specialization claims: throughout the paper, it is not clear what the exact claims of functional specialization are. While, as can be seen in Figure 3A, the difference between action-animation cross-decoding is significantly higher in aIPL, decoding performance is also above chance in right SPL, although this is not a strong effect. More importantly, action-PLD cross-decoding is robustly above chance in both right and left aIPL, implying that this region is sensitive to motion patterns as well as causal effects. I am not questioning that the difference between the two ROIs exists - that is very convincingly shown. But sentences such as "distinct neural systems for the processing of observed body movements in SPL and the effect they induce in aIPL" (lines 111-112, Introduction) and "aIPL encodes abstract representations of action effect structures independently of motion and object identity" (lines 127-128, Introduction) do not seem fully justified when action-PLD cross-decoding is overall stronger than action-animation cross-decoding in aIPL. Is the claim, then, that in addition to being sensitive to motion patterns, aIPL contains a neural code for abstracted causal effects, e.g. involving a separate neural subpopulation or a different coding scheme. Moreover, if sensitivity to motion patterns is not specific to SPL, but can be found in a broad network of areas (including aIPL itself), can it really be claimed that this area plays a specific role, similar to the specific role of aIPL in encoding causal effects? There is indeed, as can be seen in Figure 3A, a difference between action-PLD decoding in SPL and aIPL, but based on the searchlight map shown in Figure 3B I would guess that a similar difference would be found by comparing aIPL to several other regions. The authors should clarify these ambiguities.

      We thank the reviewer for this careful assessment. The observation of action-PLD cross-decoding in aIPL is indeed not straightforward to interpret: It could mean that aIPL encodes both body movements and action effect structures by different neural subpopulations. Or it could mean that representations of action effect structures were also activated by the PLDs, which lead to successful decoding in the action-PLD cross-decoding. Our revision allows a more nuanced view on this issue:

      First, we included the results of a behavioral test show that PLDs at least weakly allow for recognition of the specific actions (see our response to the second comment), which in turn might activate action effect structure representations. Second, the finding that also the cross-decoding between animations and PLDs revealed effects in left and right aIPL (as pointed out by the reviewer in the second comment) supports the interpretation that PLDs have activated, to some extent, action effect structure representations.

      On the other hand, if aIPL encodes only action-effect-structures, that were also captured in the action-PLD cross-decoding, we would expect that the RDMs in aIPL are similar for the action-PLD and action-animation cross-decoding. However, the cluster analysis (see our response to Reviewer 1 above) does not show this; rather, all action-PLD RDMs are representationally more similar with each other than with action-animation RDMs, specifically with regard to aIPL. In addition, the RSA revealed sensitivity to manuality and kinematics also in aIPL. This suggests that the action-PLD decoding in aIPL was at least partially driven by representations related to body movements.

      Taken together, these findings suggest that aIPL encodes also body movements. In fact, we didn't want to make the strong claim that aIPL is selectively representing action effect structures. Rather, we think that our results show that aIPL and SPL are disproportionally sensitive to action effects and body movements, respectively. We added this in our revised discussion:

      "The action-PLD cross-decoding revealed widespread effects in LOTC and parietal cortex, including aIPL. What type of representation drove the decoding in aIPL? One possible interpretation is that aIPL encodes both body movements (isolated by the action-PLD cross-decoding) and action effect structures (isolated by the action-animation cross-decoding). Alternatively, aIPL selectively encodes action effect structures, which have been activated by the PLDs. A behavioral test showed that PLDs at least weakly allow for recognition of the specific actions (Tab. S2), which might have activated corresponding action effect structure representations. In addition, the finding that aIPL revealed effects for the cross-decoding between animations and PLDs further supports the interpretation that PLDs have activated, at least to some extent, action effect structure representations.  On the other hand, if aIPL encodes only action effect structures, we would expect that the representational similarity patterns in aIPL are similar for the action-PLD and action-animation cross-decoding. However, this was not the case; rather, the representational similarity pattern in aIPL was more similar to SPL for the action-PLD decoding, which argues against distinct representational content in aIPL vs. SPL isolated by the action-PLD decoding. In addition, the RSA revealed sensitivity to manuality and kinematics also in aIPL, which suggests that the action-PLD decoding in aIPL was at least partially driven by representations related to body movements. Taken together, these findings suggest that aIPL encodes not only action effect structures, but also representations related to body movements. Likewise, also SPL shows some sensitivity to action effect structures, as demonstrated by effects in SPL for the action-animation and pantomime-animation cross-decoding. Thus, our results suggest that aIPL and SPL are not selectively but disproportionally sensitive to action effects and body movements, respectively."

      A clarification to the sentence "aIPL encodes abstract representations of action effect structures independently of motion and object identity": Here we are referring to the action-animation cross decoding only; specifically, the fact that because the animations did not show body motion and concrete objects, the representations isolated in the action-animation cross decoding must be independent of body motion and concrete objects. This does not rule out that the same region encodes other kinds of representations in addition.

      And another side note to the RSA: It might be tempting to test the "effects" model (distinguishing change of shape, change of location and ingest) also in the action-PLD multiple regression RSA in order to test whether this model explains additional variance in aIPL, which would point towards action effect structure representations. However, the "effect type" model is relatively strongly correlated with the "manuality" model (VIF=4.2), indicating that multicollinearity might exist. We therefore decided to not include this model in the RSA. However, we nonetheless tested the inclusion of this model and did not find clear effects for the "effects" model in aIPL (but in LOTC). The other models revealed largely similar effects as the RSA without the "effects" model, but the effects appeared overall noisier. In general, we would like to emphasize that an RSA with just 5 actions is not ideal because of the small number of pairwise comparisons, which increases the chance for coincidental similarities between model and neural RDMs. We therefore marked this analysis as "exploratory" in the article.

      (2) Causal effect information in PLDs: the reasoning behind the use of PLD stimuli is to have a condition that isolates motion patterns from the causal effects of actions. However, it is not clear whether PLDs really contain as little information about action effects as claimed. Cross-decoding between animations and PLDs is significant in both aIPL and LOTC, as shown in Figure 4. This indicates that PLDs do contain some information about action effects. This could also be tested behaviorally by asking participants to assign PLDs to the correct action category. In general, disentangling the roles of motion patterns and implied causal effects in driving action-PLD cross-decoding (which is the main dependent variable in the paper) would strengthen the paper's message. For example, it is possible that the strong action-PLD cross-decoding observed in aIPL relies on a substantially different encoding from, say, SPL, an encoding that perhaps reflects causal effects more than motion patterns. One way to exploratively assess this would be to integrate the clustering analysis shown in Figure S1 with a more complete picture, including animation-PLD and action-PLD decoding in aIPL.

      With regard to the suggestion to behaviorally test how well participants can grasp the underlying action effect structures: We indeed did a behavioral experiment to assess the recognizability of actions in the PLD stick figures (as well as in the pantomimes). In short, this experiment revealed that participants could not well recognize the actions in the PLD stick figures and often confused them with kinematically similar but conceptually different actions (e.g. breaking --> shaking, hitting --> swiping, squashing --> knitting). However, the results also show that it was not possible to completely eliminate that PLDs contain some information about action effects.

      Because we considered this behavioral experiment as a standard assessment of the quality of the stimuli, we did not report them in the original manuscript. We now added an additional section to the methods that describes the behavioral experiments in detail:

      "To assess how much the animations, PLD stick figures, and pantomimes were associated with the specific action meanings of the naturalistic actions, we performed a behavioral experiment. 14 participants observed videos of the animations, PLDs (without stick figures), and pantomimes in three separate sessions (in that order) and were asked to describe what kind of actions the animations depict and give confidence ratings on a Likert scale from 1 (not confident at all) to 10 (very confident). Because the results for PLDs were unsatisfying (several participants did not recognize human motion in the PLDs), we added stick figures to the PLDs as described above and repeated the rating for PLD stick figures with 7 new participants, as reported below.

      A general observation was that almost no participant used verb-noun phrases (e.g. "breaking a stick") in their descriptions for all stimulus types. For the animations, the participants used more abstract verbs or nouns to describe the actions (e.g. dividing, splitting, division; Tab. S1). These abstract descriptions matched the intended action structures quite well, and participants were relatively confident about their responses (mean confidences between 6 and 7.8). These results suggest that the animations were not substantially associated with specific action meanings (e.g. "breaking a stick") but captured the coarse action structures. For the PLD stick figures (Tab. S2), responses were more variable and actions were often confused with kinematically similar but conceptually different actions (e.g. breaking --> shaking, hitting --> turning page, squashing --> knitting). Confidence ratings were relatively low (mean confidences between 3 and 5.1). These results suggest that PLD stick figures, too, were not substantially associated with specific action meanings and additionally did not clearly reveal the underlying action effect structures. Finally, pantomimes were recognized much better, which was also reflected in high confidence ratings (mean confidences between 8 and 9.2; Tab. S3). This suggests that, unlike PLD stick figures, pantomimes allowed much better to access the underlying action effect structures."

      We also agree with the second suggestion to investigate in more detail the representational profiles in aIPL and SPL. We think that the best way to do so is the RSA that we reported above. However, to provide a complete picture of the results, we also added the whole brain maps and RDMs for the animation-pantomime, animation-PLD, pantomime-PLD, and action-pantomime to the supplementary information.

      (3) Nature of the motion representations: it is not clear what the nature of the putatively motion-driven representation driving action-PLD cross-decoding is. While, as you note in the Introduction, other regions such as the superior temporal sulcus have been extensively studied, with the understanding that they are part of a feedforward network of areas analyzing increasingly complex motion patterns (e.g. Riese & Poggio, Nature Reviews Neuroscience 2003), it doesn't seem like the way in which SPL represents these stimuli are similarly well-understood. While the action-PLD cross-decoding shown here is a convincing additional piece of evidence for a motion-based representation in SPL, an interesting additional analysis would be to compare, for example, RDMs of different actions in this region with explicit computational models. These could be, for example, classic motion energy models inspired by the response characteristics of regions such as V5/MT, which have been shown to predict cortical responses and psychophysical performance both for natural videos (e.g. Nishimoto et al., Current Biology 2011) and PLDs (Casile & Giese Journal of Vision 2005). A similar cross-decoding analysis between videos and PLDs as that conducted on the fMRI patterns could be done on these models' features, obtaining RDMs that could directly be compared with those from SPL. This would be a very informative analysis that could enrich our knowledge of a relatively unexplored region in action recognition. Please note, however, that action recognition is not my field of expertise, so it is possible that there are practical difficulties in conducting such an analysis that I am not aware of. In this case, I kindly ask the authors to explain what these difficulties could be.

      Thank you for this very interesting suggestion. We conducted a cross-decoding analysis that was based on the features of motion energy models as described in Nishimoto et al. (2011). Control analyses within each stimulus type revealed high decoding accuracies (animations: 100%, PLDs: 100%, pantomimes: 65%, actions: 55%), which suggests that the motion energy data generally contains information that can be detected by a classifier. However, the cross-decoding between actions and PLDs was at chance (20%), and the classification matrix did not resemble the neural RDMs. We also tested optical flow vectors as input to the decoding, which revealed similarly high decoding for the within-stimulus-type decoding (animations: 75%, PLDs: 100%, pantomimes: 65%, actions: 40%), but again at-chance decoding for action-PLD (20%), notably with a very different classification pattern:

      Author response image 1.

      Given these mixed results, we decided not to use these models for a statistical comparison with the neural action-PLD RDMs.

      It is notable that the cross-decoding worked generally less well for decoding schemes that involve PLDs, which is likely due to highly different feature complexity of actions and PLDs: Naturalistic actions have much richer visual details, texture, and more complex motion cues. Therefore, motion energy features extracted from these videos likely capture a mixture of both fine-grained and broad motion information across different spatial frequencies. By contrast, motion energy features of PLDs are sparse and might not match the features of naturalistic actions. In a way, this was intended, as we were interested in higher-level body kinematics rather than lower-level motion features. We therefore decided to use a different approach to investigate the representational structure found in the action-PLD cross-decoding: As the PLDs were based on kinematic recordings of actions that were carried out in exactly the same manner as the naturalistic actions, we computed the dissimilarity of the 5 actions based on the kinematic marker positions. Specifically, we averaged the kinematic data across the 2 exemplars per PLD, vectorized the 3D marker positions of all time points of the PLDs (3 dimensions x 13 markers x 200 time points), computed the pairwise correlations between the 5 vectors, and converted the correlations into dissimilarity values by subtracting 1 - r. This RDM was then compared with the neural RDMs extracted from the action-PLD cross-decoding. This was done using a multiple regression RSA (see also our response to Reviewer 1's public comment 2), which allowed us to statistically test the kinematic model against other dissimilarity models: a categorical model of manuality (uni- vs. bimanual) and an action-specific model that discriminates each specific action from each other with equal distance.

      This analysis revealed interesting results: the kinematic model explained the representational variance in bilateral SPL and (particularly right) pSTS as well as in right fusiform cortex and early visual cortex. The action-specific model revealed effects restricted to bilateral LOTC. The manuality model revealed widespread effects throughout the action observation network but not in EVC.

      (4) Clustering analysis: I found the clustering analysis shown in Figure S1 very clever and informative. However, there are two things that I think the authors should clarify. First, it's not clear whether the three categories of object change were inferred post-hoc from the data or determined beforehand. It is completely fine if these were just inferred post-hoc, I just believe this ambiguity should be clarified explicitly. Second, while action-anim decoding in aIPL and LOTC looks like it is consistently clustered, the clustering of action-PLD decoding in SPL and LOTC looks less reliable. The authors interpret this clustering as corresponding to the manual vs. bimanual distinction, but for example "drink" (a unimanual action) is grouped with "break" and "squash" (bimanual actions) in left SPL and grouped entirely separately from the unimanual and bimanual clusters in left LOTC. Statistically testing the robustness of these clusters would help clarify whether it is the case that action-PLD in SPL and LOTC has no semantically interpretable organizing principle, as might be the case for a representation based entirely on motion pattern, or rather that it is a different organizing principle from action-anim, such as the manual vs. bimanual distinction proposed by the authors. I don't have much experience with statistical testing of clustering analyses, but I think a permutation-based approach, wherein a measure of cluster robustness, such as the Silhouette score, is computed for the clusters found in the data and compared to a null distribution of such measures obtained by permuting the data labels, should be feasible. In a quick literature search, I have found several papers describing similar approaches: e.g. Hennig (2007), "Cluster-wise assessment of cluster stability"; Tibshirani et al. (2001) "Estimating the Number of Clusters in a Data Set Via the Gap Statistic". These are just pointers to potentially useful approaches, the authors are much better qualified to pick the most appropriate and convenient method. However, I do think such a statistical test would strengthen the clustering analysis shown here. With this statistical test, and the more exhaustive exposition of results I suggested in point 2 above (e.g. including animation-PLD and action-PLD decoding in aIPL), I believe the clustering analysis could even be moved to the main text and occupy a more prominent position in the paper.

      With regard to the first point, we clarified in the methods that we inferred the 3 broad action effect categories after the stimulus selection: "This categorization was not planned before designing the study but resulted from the stimulus selection."

      Thank you for your suggestion to test more specifically the representational organization in the action-PLD and action-animation RDMs. However, after a careful assessment, we decided to replace the cluster analysis with an RSA. We did this for two reasons:

      First, we think that RSA is a better (and more conventional) approach to statistically investigate the representational structure in the ROIs (and in the whole brain). The RSA allowed us, for example, to specifically test the mentioned distinction between unimanual and bimanual actions, and to test it against other models, i.e., a kinematic model and an action-specific model. This indeed revealed interesting distinct representational profiles of SPL and LOTC.

      Second, we learned that the small number of items (5) is generally not ideal for cluster analyses (absolute minimum for meaningful interpretability is 4, but to form at least 2-3 clusters a minimum of 10-15 items is usually recommended). A similar rule of thumb applies to methods to statistically assess the reliability of cluster solutions (e.g., Silhouette Scores, Cophenetic Correlation Coefficient, Jaccard Coefficient). Finally, the small number of items is not ideal to run a permutation test because the number of unique permutations (for shuffling the data labels: 5! = 30) is insufficient to generate a meaningful null distribution. We therefore think it is best to discard the cluster analysis altogether. We hope you agree with this decision.

      (5) ROI selection: this is a minor point, related to the method used for assigning voxels to a specific ROI. In the description in the Methods (page 16, lines 514-24), the authors mention using the MNI coordinates of the center locations of Brodmann areas. Does this mean that then they extracted a sphere around this location, or did they use a mask based on the entire Brodmann area? The latter approach is what I'm most familiar with, so if the authors chose to use a sphere instead, could they clarify why? Or, if they did use the entire Brodmann area as a mask, and not just its center coordinates, this should be made clearer in the text.

      We indeed used a sphere around the center coordinate of the Brodmann areas. This was done to keep the ROI sizes / number of voxels constant across ROIs. Since we aimed at comparing the decoding accuracies between aIPL and SPL, we thereby minimized the possibility that differences in decoding accuracy between ROIs are due to ROI size differences. The approach of using spherical ROIs is a quite well established practice that we are using in our lab by default (e.g. Wurm & Caramazza, NatComm, 2019; Wurm & Caramazza, NeuroImage, 2019; Karakose, Caramazza, & Wurm, NatComm, 2023). We clarified that we used spherical ROIs to keep the ROI sizes constant in the revised manuscript.

      Reviewer #3 (Public Review):

      This study tests for dissociable neural representations of an observed action's kinematics vs. its physical effect in the world. Overall, it is a thoughtfully conducted study that convincingly shows that representations of action effects are more prominent in the anterior inferior parietal lobe (aIPL) than the superior parietal lobe (SPL), and vice versa for the representation of the observed body movement itself. The findings make a fundamental contribution to our understanding of the neural mechanisms of goal-directed action recognition, but there are a couple of caveats to the interpretation of the results that are worth noting:

      (1) Both a strength of this study and ultimately a challenge for its interpretation is the fact that the animations are so different in their visual content than the other three categories of stimuli. On one hand, as highlighted in the paper, it allows for a test of action effects that is independent of specific motion patterns and object identities. On the other hand, the consequence is also that Action-PLD cross-decoding is generally better than Action-Anim cross-decoding across the board (Figure 3A) - not surprising because the spatiotemporal structure is quite different between the actions and the animations. This pattern of results makes it difficult to interpret a direct comparison of the two conditions within a given ROI. For example, it would have strengthened the argument of the paper to show that Action-Anim decoding was better than Action-PLD decoding in aIPL; this result was not obtained, but that could simply be because the Action and PLD conditions are more visually similar to each other in a number of ways that influence decoding. Still, looking WITHIN each of the Action-Anim and Action-PLD conditions yields clear evidence for the main conclusion of the study.

      The reviewer is absolutely right: Because the PLDs are more similar to the actions than the animations, a comparison of the effects of the two decoding schemes is not informative. As we also clarified in our response to Reviewer 2, we cannot rule out that the action-PLD decoding picked up information related to action effect structures. Thus, the only firm conclusion that we can draw from our study is that aIPL and SPL are disproportionally sensitive to action effects and body movements, respectively. We clarified this point in our revised discussion.

      (2) The second set of analyses in the paper, shown in Figure 4, follows from the notion that inferring action effects from body movements alone (i.e., when the object is unseen) is easier via pantomimes than with PLD stick figures. That makes sense, but it doesn't necessarily imply that the richness of the inferred action effect is the only or main difference between these conditions. There is more visual information overall in the pantomime case. So, although it's likely true that observers can more vividly infer action effects from pantomimes vs stick figures, it's not a given that contrasting these two conditions is an effective way to isolate inferred action effects. The results in Figure 4 are therefore intriguing but do not unequivocally establish that aIPL is representing inferred rather than observed action effects.

      We agree that higher decoding accuracies for Action-Pant vs. Action-PLD and Pant-PLD could also be due to visual details (in particular of hands and body) that are more similar in actions and pantomimes relative to PLDs. However, please note that for this reason we included also the comparison of Anim-Pant vs. Anim-PLD. For this comparison, visual details should not influence the decoding. We clarified this point in our revision.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      It struck me that there are structural distinctions amongst the 5 action kinds that were not highlighted and may have been unintentional. Specifically, three of the actions are "unary" in a sense: break(object), squash(object), hit(object). One is "binary": place(object, surface), and the fifth (drink) is perhaps ternary - transfer(liquid, cup, mouth)? Might these distinctions be important for the organization of action effects (or actions generally)?

      This is an interesting aspect that we did not think of yet. We agree that for the organization of actions (and perhaps action effects) this distinction might be relevant. One issue we noticed, however, is that for the animations the suggested organization might be less clear, in particular for "drink" as ternary, and perhaps also for "place" as binary. Thus, in the action-animation cross-decoding, this distinction - if it exists in the brain - might be harder to capture. We nonetheless tested this distinction. Specifically, we constructed a dissimilarity model (using the proposed organization, valency model hereafter) and tested it in a multiple regression RSA against an effect type model and two other models for specific actions (discriminating each action from each other with the same distance) and motion energy (as a visual control model). This analysis revealed no effects for the "valency" model in the ROI-based RSA. Also a searchlight analysis revealed no effects for this model. Since we think that the valency model is not ideally suited to test representations of action effects (using data from the action-animation cross-decoding) and to make the description of the RSA not unnecessarily complicated, we decided to not include this model in the final RSA reported in the manuscript.

      In general, I found it surprising that the authors treated their LOTC findings as surprising or unexpected. Given the long literature associating this region with several high-level visual functions related to body perception, action perception, and action execution, I thought there were plenty of a priori reasons to investigate the LOTC's behaviour in this study. Looking at the supplementary materials, indeed some of the strongest effects seem to be in that region.

      (Likewise, classically, the posterior superior temporal sulcus is strongly associated with the perception of others' body movements; why not also examine this region of interest?)

      One control analysis that would considerably add to the strength of the authors' conclusions would be to examine how actions could be cross-decoded (or not) in the early visual cortex. Especially in comparisons of, for example, pantomime to full-cue video, we might expect a high degree of decoding accuracy, which might influence the way we interpret similar decoding in other "higher level" regions.

      We agree that it makes sense to also look into LOTC and pSTS, and also EVC. We therefore added ROIs for these regions: For EVC and LOTC we used the same approach based on Brodmann areas as for aIPL and SPL, i.e., we used BA 17 for V1 and BA 19 for LOTC. For pSTS, we defined the ROI based on a meta analysis contrast for human vs. non-human body movements (Grobras et al., HBM 2012). Indeed we find that the strongest effects (for both action effect structures and body movements) can be found in LOTC. We also found effects in EVC that, at least for the action-animation cross-decoding, are more difficult to interpret. To test for a coincidental visual confound between actions and animations, we included a control model for motion energy in the multiple regression RSA, which could indeed explain some of the representational content in V1. However, also the effect type model revealed effects in V1, suggesting that there were additional visual features that caused the action-animation cross-decoding in V1. Notably, as pointed out in our response to the Public comments, the representational organization in V1 was relatively distinct from the representational organization in aIPL and LOTC, which argues against the interpretation that effects in aIPL and LOTC were driven by the same (visual) features as in V1.

      Regarding the analyses reported in Figure 4: wouldn't it be important to also report similar tests for SPL?

      In the analysis of implied action effect structures, we focused on the brain regions that revealed robust effects for action-animation decoding in the ROI and the searchlight analysis, that is, aIPL and SPL. However, we performed a whole brain conjunction analysis to search for other brain regions that show a profile for implied action effect representation. This analysis (that we forgot to mention in our original manuscript; now corrected) did not find evidence for implied action effect representations in SPL.

      However, for completeness, we also added a ROI analysis for SPL. This analysis revealed a surprisingly complex pattern of results: We observed stronger decoding for Anim-Pant vs. Anim-PLD, whereas there were no differences for the comparisons of Action-Pant with Action-PLD and Pant-PLD:

      This pattern of results is not straightforward to explain: First, the equally strong decoding for Action-Pant, Action-PLD, and Pant-PLD suggests that SPL is not substantially sensitive to body part details. Rather, the decoding relied on the coarse body part movements, independently of the specific stimulus type (action, pantomime, PLD). However, the stronger difference between Anim-Pant and Anim-PLD suggests that SPL is also sensitive to implied AES. This appears unlikely, because no effects (in left aIPL) or only weak effects (in right SPL) were found for the more canonical Action-Anim cross-decoding. The Anim-Pant cross-decoding was even stronger than the Action-Anim cross-decoding, which is counterintuitive because naturalistic actions contain more information than pantomimes, specifically with regard to action effect structures. How can this pattern of results be interpreted? Perhaps, for pantomimes and animations, not only aIPL and LOTC but also SPL is involved in inferring (implied) action effect structures. However, for this conclusion, also differences for the comparison of Action-Pant with Action-PLD and for Action-Pant with Pant-PLD should be found. Another non-mutually exclusive interpretation is that both animations and pantomimes are more ambiguous in terms of the specific action, as opposed to naturalistic actions. For example, the squashing animation and pantomime are both ambiguous in terms of what is squashed/compressed, which might require additional load to infer both the action and the induced effect. The increased activation of action-related information might in turn increase the chance for a match between neural activation patterns of animations and pantomimes.

      In any case, these additional results in SPL do not question the effects reported in the main text, that is, disproportionate sensitivity for action effect structures in right aIPL and LOTC and for body movements in SPL and other AON regions. The evidence for implied action effect structures representation in SPL is mixed and should be interpreted with caution.

      We added this analysis and discussion as supplementary information.

      Statistical arguments that rely on "but not" are not very strong, e.g. "We found higher cross-decoding for animation-pantomime vs. animation-PLD in right aIPL and bilateral LOTC (all t(23) > 3.09, all p < 0.0025; one-tailed), but not in left aIPL (t(23) = 0.73, p = 0.23, one-tailed)." Without a direct statistical test between regions, it's not really possible to support a claim that they have different response profiles.

      Absolutely correct. Notably, we did not make claims about different profiles of the tested ROIs with regard to implied action effect representations. But of course it make sense to test for differential profiles of left vs. right aIPL, so we have added a repeated measures ANOVA to test for an interaction between TEST (animation-pantomime, animation-PLD) and ROI (left aIPL, right aIPL), which, however, was not significant (F(1,23)=3.66, p = 0.068). We included this analysis in the revised manuscript.

      Reviewer #2 (Recommendations for The Authors):

      (1) I haven't found any information about data and code availability in the paper: is the plan to release them upon publication? This should be made clear.

      Stimuli, MRI data, and code are deposited at the Open Science Framework (https://osf.io/am346/). We included this information in the revised manuscript.

      (2) Samples of videos of the stimuli (or even the full set) would be very informative for the reader to know exactly what participants were looking at.

      We have uploaded the full set of stimuli on OSF (https://osf.io/am346/).

      (3) Throughout the paper, decoding accuracies are averaged across decoding directions (A->B and B->A). To my knowledge, this approach was proposed in van den Hurk & Op de Beeck (2019), "Generalization asymmetry in multivariate cross-classification: When representation A generalizes better to representation B than B to A". I believe it would be fair to cite this paper.

      Absolutely, thank you very much for the hint. We included this reference in our revised manuscript.

      (4) Page 3, line 70: this is a very nitpicky point, but "This suggests that body movements and the effects they induce are at least partially processed independently from each other." is a bit of an inferential leap from "these are distinct aspects of real-world actions" to "then they should be processed independently in the brain". The fact that a distinction exists in the world is a prerequisite for this distinction existing in the brain in terms of functional specialization, but it's not in itself a reason to believe that functional specialization exists. It is a reason to hypothesize that the specialization might exist and to test that hypothesis. So I think this sentence should be rephrased as "This suggests that body movements and the effects they induce might be at least partially processed independently from each other.", or something to that effect.

      Your reasoning is absolutely correct. We revised the sentence following your suggestion.

      (5) Page 7, line 182: the text says "stronger decoding for action-animation vs. action-PLD" (main effect of TEST), which is the opposite of what can be seen in the figure. I assume this is a typo?

      Thanks for spotting this, it was indeed a typo. We corrected it: “…stronger decoding for action-PLD vs. action-animation cross-decoding..”

      (6) Page 7, Figure 3B: since the searchlight analysis is used to corroborate the distinction between aIPL and SPL, it would be useful to overlay the contours of these ROIs (and perhaps LOTC as well) on the brain maps.

      We found that overlaying the contours of the ROIs onto the decoding searchlight maps would make the figure too busy, and the contours would partially hide effects. However, we added a brain map with all ROIs in the supplementary information.

      (7) Page 9, Figure 4A: since the distinction between the significant difference between anim-pant and anim-PLD is quite relevant in the text, I believe highlighting the lack of difference between the two decoding schemes in left aIPL (for example, by writing "ns") in the figure would help guide the reader to see the relevant information. It is generally quite hard to notice the absence of something.

      We added “n.s.” to the left aIPL in Fig. 4A.

      (8) Page 11, line 300: "Left aIPL appears to be more sensitive to the type of interaction between entities, e.g. how a body part or an object exerts a force onto a target object" since the distinction between this and the effect induced by that interaction" is quite nuanced, I believe a concrete example would clarify this for the reader: e.g. I guess the former would involve a representation of the contact between hand and object when an object is pushed, while the latter would represent only the object's displacement following the push?

      Thank you for the suggestion. We added a concrete example: “Left aIPL appears to be more sensitive to the type of interaction between entities, that is, how a body part or an object exerts a force onto a target object (e.g. how a hand makes contact with an object to push it), whereas right aIPL appears to be more sensitive to the effect induced by that interaction (the displacement of the object following the push).”

      (9) Page 12, line 376: "Informed consent, and consent to publish, was obtained from the participant in Figure 2." What does this refer to? Was the person shown in the figure both a participant in the study and an actor in the stimulus videos? Since this is in the section about participants in the experiment, it sounds like all participants also appeared in the videos, which I guess is not the case. This ambiguity should be clarified.

      Right, the statement sounds misleading in the “Participants” section. We rephrased it and moved it to the “Stimuli” section: “actions…were shown in 4 different formats: naturalistic actions, pantomimes, point light display (PLD) stick figures, and abstract animations (Fig. 2; informed consent, and consent to publish, was obtained from the actor shown in the figure).”

      (10) Page 15, line 492: Here, "within-session analyses" are mentioned. However, these analyses are not mentioned in the text (only shown in Figure S2) and their purpose is not clarified. I imagine they were a sanity check to ensure that the stimuli within each stimulus type could be reliably distinguished. This should be explained somewhere.

      We clarified the purpose of the within session decoding analyses in the methods section: "Within-session decoding analyses were performed as sanity checks to ensure that for all stimulus types, the 5 actions could be reliably decoded (Fig. S2)."

      (11) Page 20, Figure S1: I recommend using the same color ranges for the two decoding schemes (action-anim and action-PLD) in A and C, to make them more directly comparable.

      Ok, done.

      Reviewer #3 (Recommendations For The Authors):

      (1) When first looking at Figure 1B, I had a hard time discerning what action effect was being shown (I thought maybe it was "passing through") Figure 2 later clarified it for me, but it would be helpful to note in the caption that it depicts breaking.

      Thank you for the suggestion. Done.

      (2) It would be helpful to show an image of the aIPL and SPL ROIs on a brain to help orient readers - both to help them examine the whole brain cross-decoding accuracy and to aid in comparisons with other studies.

      We added a brain map with all ROIs in the supplementary information.

      (3) Line 181: I'm wondering if there's an error, or if I'm reading it incorrectly. The line states "Moreover, we found ANOVA main effects of TEST (F(1,24)=33.08, p=7.4E-06), indicating stronger decoding for action-animation vs. action-PLD cross-decoding..." But generally, in Figure 3A, it looks like accuracy is lower for Action-Anim than Action-PLD in both hemispheres.

      You are absolutely right, thank you very much for spotting this error. We corrected the sentence: “…stronger decoding for action-PLD vs. action-animation cross-decoding..”

      (4) It might be useful to devote some more space in the Introduction to clarifying the idea of action-effect structures. E.g., as I read the manuscript I found myself wondering whether there is a difference between action effect structures and physical outcomes in general... would the same result be obtained if the physical outcomes occurred without a human actor involved? This question is raised in the discussion, but it may be helpful to set the stage up front.

      We clarified this point in the introduction:

      In our study, we define action effects as induced by intentional agents. However, the notion of action effect structures might be generalizable to physical outcomes or object changes as such (e.g. an object's change of location or configuration, independently of whether the change is induced by an agent or not).

      (5) Regarding my public comment #2, it would perhaps strengthen the argument to run the same analysis in the SPL ROIs. At least for the comparison of Anim-Pant with Anim-PLD, the prediction would be no difference, correct?

      The prediction would indeed be that there is no difference for the comparison of Anim-Pant with Anim-PLD, but also for the comparison of Action-Pant with Action-PLD and for Action-Pant with Pant-PLD, there should be no difference. As explained in our response to the public comment #2, we ran a whole brain conjunction (Fig. 4B) to test for the combination of these effects and did not find SPL in this analysis. However, we did found differences for Anim-Pant vs. Anim-PLD, which is not straightforward to interpret (see our response to your public comment #2 for a discussion of this finding).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Weaknesses:

      The weaknesses of the study include the following. 

      (1) It remains unclear whether the function described for CDK2 is regulatory, that is, it affects TBK1 levels during physiological responses such as viral infection or cell cycle progression, or if it is homeostatic, governing the basal abundance of TBK1 but not responding to signaling.

      The regulation of TBK1 by CDK2 described in this article occurs during viral infection. Simultaneously, we also investigated the effects of CDK2 overexpression and knockdown on TBK1 levels under non-infected state and observed a slight reduction, as shown in Figure 4K and 4L. Thus, we speculate that the regulation of TBK1 by CDK2 serves, on one hand, to maintain cellular homeostasis and, on the other hand, to respond to signaling triggered by viral infection.

      (2) The authors have not explored whether the catalytic activity of CDK2 is required for TBK1 ubiquitinoylation and, if so, what its target specificity is.

      We found that the ubiquitination modification of TBK1 was not affected by treatment with a CDK2 kinase activity inhibitor (SNS-032), as demonstrated in the results below (Author response image 1).

      Author response image 1.

      (3) Given the multitude of CDK isoforms in fish, it remains unexplored whether the identified fish CDK2 homolog is a requisite cell cycle regulator or if its action in the cell cycle is redundant with other CDKs.

      A comparison of the protein sequences of fish CDK2 and human CDK2 revealed a 90% similarity (Author response image 2). It has also been reported that the kinase activity of goldfish CDK2 significantly increases during oocyte maturation (ref. 1). Furthermore, UHRF1 phosphorylation by cyclin A2/CDK2 is crucial for zebrafish embryogenesis (ref. 2). Additionally, Red grouper nervous necrosis virus (RGNNV) infection activated the p53 pathway, leading to the upregulation of p21 and downregulation of cyclin E and CDK2, which forces infected cells to remain in the G1/S replicative phase (ref. 3). All these evidences suggest that fish CDK2 plays a vital role in cell cycle regulation, and there have been no reports of other CDKs demonstrating CDK2-like functions.

      References:

      (1) Hirai T, et al. (1992) Isolation and Characterization of Goldfish Cdk2, a Cognate Variant of the Cell-Cycle Regulator Cdc2. Developmental biology 152(1):113-120.

      (2) Chu J, et al. (2012) UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis. Molecular biology of the cell 23(1):59-70. 

      (3) Mai WJ, Liu HX, Chen HQ, Zhou YJ, & Chen Y (2018) RGNNV-induced cell cycle arrest at G1/S phase enhanced viral replication via p53-dependent pathway in GS cells. Virus Res 256:142-152.

      Author response image 2.

      Reviewer #2 (Public Review):

      Weaknesses:

      (1) While the study focuses on fish, the broader implications for other lower vertebrates and higher vertebrates are not extensively discussed.

      Thanks to your comment, we have added a paragraph to the Discussion section of the manuscript regarding the implications of the negative regulation of IFN expression by fish CDK2 for other vertebrates (lines 398-403). The details are as follows: first, we selected representative species from each of the six major vertebrate groups and compared their CDK2 protein sequences, finding that they are over 90% similar to one another (Author response image 3). This suggests that the function of CDK2 may be conserved to some extent across vertebrates. Additionally, CDK2 inhibition has been shown to enhance anti-tumor immunity by increasing the IFN response to endogenous retroviruses (ref. 1). Our studies provide evidence that fish CDK2 inhibits the IFN response by promoting the ubiquitination and degradation of TBK1, strongly supporting the role of CDK2 in the regulation of the immune response.

      Reference:

      (1) Chen Y, et al. (2022) CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses. Cancer Immunol Res 10(4):525-539.

      Author response image 3.

      (2) The study heavily relies on specific fish models, which may limit the generalizability of the findings across different species.

      Thank you for your comment. First, we compared the amino acid sequences of CDK2 proteins from fish and other vertebrates, which show over 90% similarity. Moreover, the small size, low cost, and external development of zebrafish make it an excellent model for vertebrate developmental biology. It has been reported that due to the high genomic and molecular similarities between zebrafish and other vertebrates, including humans, many significant discoveries in zebrafish development are relevant to humans (ref. 2). Our study concentrated on CDK2 in zebrafish, and the findings should be valuable for other vertebrates.

      Reference:

      (2) Veldman MB & Lin S (2008) Zebrafish as a Developmental Model Organism for Pediatric Research. Pediatr Res 64(5):470-476.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      The following additional data/discussion could improve the manuscript.

      (1) Investigate whether the catalytic activity of CDK2 is required to regulate TBK1 abundance. It is common for E3 ligases to be directed towards phosphorylated substrates, so it would be of interest to know if CDK2 phosphorylates TBK1 to facilitate its recognition for ubiquitinylation.

      We examined the effect of CDK2 on the TBK1 protein after inhibiting its kinase activity with SNS-032 treatment and found that it could still affect TBK1 expression, as shown in the results below (Figure R4). Our previous experiments investigating the effect of CDK2 on TBK1 did not show that CDK2 caused the migration of TBK1 bands (typically, proteins that undergo phosphorylation exhibit band migration). Furthermore, in this study, CDK2 did not function as an E3 ligase; instead, it recruited the E3 ligase Dtx4 to ubiquitinate TBK1.

      Author response image 4.

      (2) Investigate how CDK2 abundance is regulated by viral infection and whether viral infection impacts cell cycle progression in a CDK2-dependent manner.

      In fact, as illustrated in Figure 1, we investigated the changes in CDK2 at both the mRNA and protein levels following viral infection. Our findings revealed that SVCV infection resulted in an increase in CDK2 mRNA and protein expression. Additionally, our earlier reports have indicated that SVCV infection can induce alterations in the cell cycle, resulting in a notable increase in the S phase (Figure 1 of ref. 1). However, whether SVCV infection impacts cell cycle progression in a CDK2dependent manner will be explored in our upcoming study.

      Reference:

      (1) Li S, et al. Spring viraemia of carp virus modulates p53 expression using two distinct mechanisms. PLoS Pathog 15, e1007695 (2019).

      (3) Provide data/discussion concerning the role of fish CDK2 in the regulation of cell cycle progression and whether this process is impacted by viral infection (part 1). Are TBK1 abundance and interferon production differentially regulated across the cell cycle due to the action of CDK2 (part 2).

      Thank you for your advice. This concern is addressed in two parts, as follows: 

      For part 1: To date, there has been limited research conducted on fish CDK2 in the regulation of cell cycle progression. The details are as follows: It has been reported that the kinase activity of goldfish CDK2 significantly increases during oocyte maturation (ref. 1). Furthermore, UHRF1 phosphorylation by cyclin A2/CDK2 is crucial for zebrafish embryogenesis (ref. 2). Additionally, a novel CDK2 homolog has been identified in Japanese lamprey, which plays a crucial role in apoptosis (ref. 3). Red grouper nervous necrosis virus (RGNNV) infection activates the p53 pathway, leading to the upregulation of p21 and downregulation of cyclin E and CDK2, which forces infected cells to remain in the G1/S replicative phase (ref. 4). All this evidence suggests that fish CDK2 plays a vital role in cell cycle regulation, and this process is also impacted by viral infection. Relevant content has been added to the Discussion section in the revised manuscript (lines 389-398).

      References:

      (1) Hirai T, et al. (1992) Isolation and Characterization of Goldfish Cdk2, a Cognate Variant of the Cell-Cycle Regulator Cdc2. Developmental biology 152(1):113-120.

      (2) Chu J, et al. (2012) UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis. Molecular biology of the cell 23(1):5970.

      (3) Xu Y, Tian Y, Zhao H, Zheng N, Ren KX, Li QW. A novel CDK-2 homolog identified in lamprey, with roles in apoptosis. Fish Physiol Biochem 47, 189-189 (2021). 

      (4) Mai WJ, Liu HX, Chen HQ, Zhou YJ, & Chen Y (2018) RGNNV-induced cell cycle arrest at G1/S phase enhanced viral replication via p53-dependent pathway in GS cells. Virus Res 256:142-152.

      For part 2: TBK1 plays a crucial role in regulating IFN production. Variations in CDK2 activity during different phases of the cell cycle may lead to changes in the expression and function of TBK1. Our findings suggest that heightened CDK2 activity may suppress TBK1 expression, thereby hindering the cell's capacity to produce IFN. Conversely, during the late phase of the cell cycle or in an inhibited state, TBK1 expression may rise, enhancing IFN synthesis and release. In summary, CDK2 is involved in intracellular signaling by modulating TBK1 levels and IFN production, affecting the cellular immune response and cycle regulation—two processes that are notably distinct at various stages of the cell cycle. Relevant content has been added to the Discussion section in the revised manuscript (lines 377-384).

      Minor suggestions:

      (1) The authors introduce their study with the consideration that knowledge of fish signaling pathways can inform mammalian biology because mammals evolved from fish. This is not strictly true, since mammals and fish both evolved from an ancient common ancestor and the diversification of signaling in each species likely occurred in response to distinct evolutionary selective pressures.

      Thank you for your suggestion. We have revised the statement in the manuscript to eliminate the notion that mammals evolved from fish (lines 98-99). The immune systems of higher vertebrates (e.g., humans) and lower vertebrates (e.g., fish) generally exhibit some consistency, although there are notable differences.

      (2) On line 210 and line 276, the authors appear to have misstated the data. CDK2 knockout increases not decreases TBK1 and Dtx4 knockdown abrogated rather than restored CDK2 suppression of TBK1.

      Thanks for your reminder, I jumped to the wrong conclusions in these two places (line 204 and line 267) and have changed them as you suggested.

      Reviewer #2 (Recommendations For The Authors):

      The manuscript has some shortcomings that, if addressed, could improve the overall quality of the article.

      (1) Line 63-72, line 77-79, line 88-90- please add additional references for these sentences.

      Thanks to your comment, we have added references for these sentences (Line 63-72, line 77-79, line 88-90).

      (2) It is of the utmost importance to quantify the data presented in Figures 4J and 5D, as this will facilitate the visualization of the immunoblot.

      Thank you for your comment. We have quantified the data presented in Figures 4J and 5D to enhance the clarity of the immunoblot.

      (3) The scale in Figure 4E is difficult to discern.

      Thanks for your comment. To improve the visual clarity of the image, we have enlarged the scale label in Figure 4E.

      (4) In Figure 3B, shCDK2 is shown in italics, preferably in line with other standards such as Figures 3C and 3F.

      Thank you for your comment. We have revised the shCDK2 in Figure 3B.

      (5) The functions of CDK family members in immunity are hoped to be discussed.

      Thanks for your suggestion. We have discussed the functions of CDK family members in immunity (lines 363-387). The details are as follows: Recent studies have demonstrated that CDK activity is crucial for virus-induced innate immune responses. Reports indicate that CDKs are involved in the Toll-like receptor (TLR) signaling pathway, the nuclear factor-κB (NF-κB) signaling pathway, and the JAK-STAT signaling pathway. For instance, CDK8 and/or CDK19 enhanced the transcription of inflammatory genes, such as IL-8 and IL-10, in cells following TLR9 stimulation. CDKs and NF-κB establish a remarkable paradigm where CDKs can act directly on substrate proteins rather than depending solely on transcriptional control. It has been reported that CDK1 serves as a positive regulator of the IFN-I signaling pathway, facilitating STAT1 phosphorylation, which subsequently boosts the expression of ISGs. Furthermore, inhibiting CDK activity has been shown to obstruct STAT phosphorylation, proinflammatory gene activation, and ISG mRNA induction in response to SeV infection. It is important to note that no evidence suggests the involvement of CDKs in RLR signaling pathways. This study has shown that fish CDK2 functions as a negative regulator of the key kinase TBK1, which is involved in the RLR signaling pathway. A better understanding of the relationship between CDK2 and RLR signaling pathways will enhance our grasp of the regulatory mechanisms of CDKs in antiviral innate immunity.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Amaral et al. presents a study investigating the mesoscale modelling and dynamics of bolalipids.

      Strengths:

      The figures in this paper are exceptional. Both those to outline and introduce the lipid types, but also the quality and resolution of the plots. The data held within also appears to be outstanding and of significant (hopefully) general interest.

      We thank the reviewer for their kind words and the appreciation of our work.

      Weaknesses:

      In the introduction, I would like to have read more specifics on the biological role of bolalipids. Archaea are mentioned, but this kingdom is huge - there must be specific species that can be discussed where bolalipids are integral to archaeal life. The authors should go beyond ’extremophiles’. In short, they should unpack why the general audience should be interested in these lipids, within a subset of organisms that are often forgotten about.

      Following the reviewer’s advice we have revised the introduction of the manuscript, in which we now discuss specific species (Sulfolobus acidocaldarius and Thermococcus kodakarensis) and how in these species bolalipids are integral to archaeal life. We explain that the ratio between bilayer and bolalipids, and the number of cyclopentane rings contained within bolalipids can change to adapt to the environment. The revised parts of the introduction read (p.1 ):

      “Like for bacteria and eukaryotes, archaea must keep their lipid membranes in a fluid state (homeoviscous adaptation). This is important even under extreme environmental conditions, such as hot and cold temperatures, or high and low pH values [7]. Because of this, many archaea adapt to changes in their environment by tuning the lipid composition of their membranes: altering the ratio between bola- and bilayer lipids in their membranes [8, 9] and/or by changing the number of cyclopentane rings in their lipid tails, which are believed to make lipid molecules more rigid [5]. For example, Thermococcus kodakarensis increases its tetraether bolalipid ratio from around 50% to over 80% when the temperature of the environment increases from 60 to 85 C [10]. Along the same lines, the cell membrane of Sulfolobus acidocaldarius, can contain over 90 % of bolalipids with up to 8 cyclopentane rings at 70 C and pH 2.5 [5, 11]. It is worth mentioning that in exceptional cases bacteria also synthesise bolalipids in response to high temperatures [12], highlighting that the study of bolalipid membranes is relevant not only for archaeal biology but also from a general membrane biophysics perspective.”

      Reviewer #2 (Public review):

      Summary:

      The authors aimed to understand the biophysical properties of archeal membranes made of bolalipids. Bacterial and eukaryotic membranes are made of lipids that self-assemble into bilayers. Archea, instead, use bolalipids, lipids that have two headgroups and can span the entire bilayer. The authors wanted to determine if the unique characteristics of archaea, which are often extremophiles, are in part due to the fact that their membranes contain bolalipids.

      The authors develop a minimal computational model to compare the biophysics of bilayers made of lipids, bolalipids, and mixtures of the two. Their model enables them to determine essential parameters such as bilayer phase diagrams, mechanical moduli, and the bilayer behaviour upon cargo inclusion and remodelling.

      The author demonstrates that bolalipid bilayers behave as binary mixtures, containing bolalipids organized either in a straight conformation, spanning the entire bilayer, or in a u-shaped one, confined to a single leaflet. This dynamic mixture allows bolalipid bilayers to be very sturdy but also provides remodelling. However, remodelling is energetically more expensive than with standard lipids. The authors speculate that this might be why lipids were more abundant in the evolutionary process. Strengths:

      This is a wonderful paper, a very fine piece of scholarship. It is interesting from the point of view of biology, biophysics, and material science. The authors mastered the modelling and analysis of these complex systems. The evidence for their findings is really strong and complete. The paper is written superbly, the language is precise and the reading experience is very pleasant. The plots are very well-thought-out.

      Weaknesses:

      I would not talk about weaknesses, because this is really a nice paper. If I really had to find one, I would have liked to see some clear predictions of the model expressed in such a way that experimentalists could design validation experiments.

      We thank the reviewer for their very kind assessment. We incorporated their recommendations regarding experimental validation in the discussion section, as follows (p.14):

      “Our model makes a number of predictions that could be tested by experiment either in cells or in vitro. First, it predicts that a small increase in the fraction of archaeal bilayer lipids should be sufficient to soften a bolalipid-rich membrane. While this could be tested in the future, so far only very few studies have yet reported experimental analysis of archaeal membrane mixtures [18, 50]. Second, we observed that membranes with moderate bolalipid molecular rigidity k<sub>bola</sub> exhibit curvature-dependent bending rigidity. To experimentally verify this, one could extrude membrane tethers from cells while controlling for membrane tension. Finally, to get to the core mechanism underlying our findings, it will be important to develop experimental methods that will allow the fraction of U-shaped bolalipid conformers per leaflet to be imaged and measured.”

      Reviewer #3 (Public review):

      Summary:

      The authors have studied the mechanics of bolalipid and archaeal mixed-lipid membranes via comprehensive molecular dynamics simulations. The Cooke-Deserno 3-bead-per-lipid model is extended to bolalipids with 6 beads. Phase diagrams, bending rigidity, mechanical stability of curved membranes, and cargo uptake are studied. Effects such as the formation of U-shaped bolalipids, pore formation in highly curved regions, and changes in membrane rigidity are studied and discussed. The main aim has been to show how the mixture of bolalipids and regular bilayer lipids in archaeal membrane models enhances the fluidity and stability of these membranes.

      Strengths:

      The authors have presented a wide range of simulation results for different membrane conditions and conformations. For the most part, the analyses and their results are presented clearly and concisely. Figures, supplementary information, and movies very well present what has been studied. The manuscript is well-written and is easy to follow.

      We thank the reviewer for the detailed assessment of our work and their constructive feedback.

      Major issues

      R3.Q1: The Cooke-Deserno model, while very powerful for biophysical analysis of membranes at the mesoscale, is very much void of chemical information. It is parametrized such that it is good in producing fluid membranes and predicting values for bending rigidity, compressibility, and even thermalexpansioncoefficientfallingintheacceptedrangeofvaluesforbilayermembranes. But it still represents a generic membrane. Now, the authors have suggested a similar model for the archaeal bolalipids, which have chemically different lipids (the presence of cyclopentane rings for one), and there is no good justification for using the same pairwise interactions between their representative beads in the coarse-grained model. This does not necessarily diminish the worth of all the authors’ analyses. What is at risk here is the confusion between ”what we observe this model of bolalipidor mixed-membranes do” and ”how real bolalipid-containing archaeal membranes behave at these mechanical and thermal conditions.”.

      As the reviewer correctly notes, Cooke and Deserno used a minimal model, devoid of chemical detail, to represent fluid lipid membranes composed of bilayer lipids. Indeed archaeal lipids are chemically different compared to non-archaeal lipids, but just like non-archaeal lipids, they can be very different from one another. Given the chemical diversity of bolalipids between each other, instead of representing their complexity in a complicated model with many experimentally unconstrained parameters, we here defined a minimal model for bolalipids. The power of this minimal model is to represent the key physical/geometrical characteristics of archaeal membranes, namely the fact that lipid heads on two sides of the membrane are often connected, that bolalipids can exhibit a conformational change, and that bolalipids mix with some percentage of bilayer molecules. We then ask a general question: how do these unique geometrical characteristics of archaeal membranes influence their mechanics and reshaping? The reviewer is however right in pointing out that a model, regardless of its level of details (atomistic, coarse-grained, minimal), is still a model.

      Our approach of extending an established coarse-grained model for bilayer lipids to bolalipids is further supported by experimental observations, which report that archaeal bilayer lipids can form membranes of comparable bending rigidity to those of non-archaeal bilayer membranes [53]. Hence, different lipid linkages (archaeal vs. non-archaeal) give rise to fluid, deformable membranes of not too dissimilar rigidities, suggesting that both archaeal and non-archaeal bilayer lipids can be represented by a similar minimal coarse-grained model for the purpose of mesoscopic biophysical investigations. Since archaeal bolalipids have the same core chemical structure as two archaeal bilayer lipids joined by their tail ends, similarly we model a bolalipid by joining two bilayer lipids. Such an approach also efficiently enables us to compare bolalipid with bilayer membranes, and connect to the large body of knowledge on the physics of bilayer membranes.

      To conclude, our coarse-grained model is indeed intended to capture the main physical properties of bolalipid membranes, and not their chemical diversity.

      R3.Q2: Another more specific, major issue has to do with using the Hamm-Kozlov model for fitting the power spectrum of thermal undulations. The 1/q<sup>2</sup> term can very well be attributed to membrane tension. While a barostat is indeed used, have the authors made absolutely sure that the deviation from 1/q<sup>4</sup> behaviour does not correspond to lateral tension?

      To the casual observer, any 1/q<sup>2</sup> trend might point at membrane tension. However, the precise functional form is relevant as it determines whether the 1/q<sup>2</sup> dominates the 1/q<sup>4</sup> trend for small or large values of the wave number q in the fitted power spectrum.

      The first model (including lipid tilt) exhibits the functional form 1/(kq<sup>4</sup>) + 1/(kq<sup>2</sup>). In contrast, the second model (including membrane tension) exhibits the functional form 1/(kq<sup>4</sup> + ∑q<sup>2</sup>). Importantly, the two models obey a different functional form. Here k and k<sub>θ</sub>, are the bending and tilt moduli, which are assumed positive, and ∑ is the membrane tension, which can be either positive or negative. For the first model (with tilt), while for small q the amplitude is proportional to q<sup>-4</sup>, for large q the amplitude is proportional to q<sup>-2</sup>. In contrast, for the second model (with positive tension) while for small q the amplitude is proportional to q<sup>-2</sup>, for large q the amplitude is proportional to q<sup>-4</sup>. If membrane tension were to be negative in the second model, the slope would cross from negative infinity for small q to -4 for large q. The functional dependencies are summarized in Author response image 1A.

      For rigid bolalipid membranes, it is clearly visible that the slope of the power spectrum plotted against the wave number q decreases with increasing q (Author response image 1B). While the slope initially assumes a value close to 4, it gradually approaches 2 for larger values of q. We conclude that only the model including lipid tilt can fit the power spectrum of membrane fluctuations appropriately (solid-dashed line), whereas the model with tension fails to fit the data (dashed line). We note that the combined model containing both lipid tilt and membrane tension does not give a better fit (dotted line).

      To demonstrate that the tension model cannot fit the data, we included the best fits for both models for rigid bolalipid membranes in the new SI section 16 (p. S22) and show that only the tilt model leads to acceptable fits. We also measured the projected membrane tension - , where P<sub>x</sub>,P<sub>y</sub> are respectively the pressure in x and y direction and  L<sub>z</sub> is the dimension of the simulation box in z axis. We found the projected membrane tension to give a negligible value similarly to the one that we indirectly measured by fitting a combined model with both tension and tilt, further confirming our conjecture.

      Author response image 1.

      (A) Schematic showing the decay of the power spectrum as a function of the wave number q in the tilt model (top), in the tension model with positive membrane tension (middle), and in the tension model with negative membrane tension (bottom). (B) Fitted power spectrum as a function of q for rigid bolalipid membranes (k<sub>bola</sub>=5k<sub>B</sub>T). The fit shows that while the model with tension (dashed line) cannot fit the data, the model with tilt nicely fits the spectrum (solid-dashed line). The combined model including both tension and tilt does not fit the spectrum any better (dotted line).

      R3.Q3: I got more worried when I noticed in the SI that the simulations had been done with combined ”fix langevin” and ”fix nph” LAMMPS commands. This combination does not result in a proper isothermal-isobaric ensemble. The importance of tilt terms for bolalipids is indeed very interesting, but I believe more care is needed to establish that.

      In what follows, we show that there is no reason to worry. First of all we want to clarify that the physical setup we simulate is that of a membrane contained in a heat bath under negligible tension with correct diffusional dynamics. To achieve this physical setup, for which we use a Langevin thermostat combined with pressure control via an overdamped barostat, which we implement in LAMMPS by combining ”fix langevin” and ”fix nph”.

      In more detail: we simulated particles in an implicit solvent, for which we use a Langevin thermostat to get the right diffusional dynamics. To apply the theory of fitting fluctuation spectrums the simulation box length needs to be (near) constant. However, simulating membranes at a fixed box size results in an average non-zero membrane tension, making it hard to measure bending rigidity. The reason is that the effect of membrane tension is most influential on the largest wavelength modes, which are also most decisive when determining mechanical membrane properties like membrane rigidity. To minimize the effect of tension, we perform our simulation with an overdamped barostat (𝜏<sub>baro</sub> = 10 𝜏 <sub>langevin</sub>), which keeps the membrane near tensionless, as also done before [32]. In the revised manuscript, we have clarified the statement on the physical ensemble used (p.S2):

      “For simulating flat membrane patches of bolalipids, we combined the previously used Langevin thermostat with relaxation time of 1𝜏 with a Nosé–Hoover barostat with relaxation time of 10𝜏. In LAMMPS this amounts to combining the commands ’fix langevin’ with ’fix nph’. We configured the barostat to set lateral pressure P<sub>xy</sub> to zero by re-scaling the simulation box in the x-y plane. We compare this setup to a fixed box length setup, and an NPT ensemble setup, in SI section 17.”

      To connect our results with statistical mechanics ensemble theory we tested alternative setups. Similar setups, including the formal isothermal-isobaric ensemble, where N,P,T are kept constant using Nose-Hoover style equations for thermostating and barostating with modern corrections [34], which the reviewer refers to, result in very similar fluctuation spectrums. Consequently, our measurements of bending and tilt modulus hold true regardless of the integration scheme. However, such a setup does not correctly capture implicit solvent and diffusional dynamics.

      In even more detail: we tested our setup (implemented via ”fix langevin”+”fix nph”) versus a isothermal-isobaric ensemble (implemented via ”fix npt”). We measured volume mean and standard deviation, and found them matching for a reference LJ gas.

      To be completely sure, and to please the reviewer, we have performed additional verifications in the new SI section 17, which we summarize in the following. We simulated three representative membranes with different integration schemes: ”fix npt”, ”fix langevin”+”fix nph”, and ”fix langevin” (Langevin dynamics with projected area fixed at the average value obtained from a ”langevin+nph”). We checked that the ”fix nph” barostat is merely equilibrating the membrane to a tensionless configuration, after which the projected membrane area (A<sub>p</sub> = L<sub>x</sub>L<sub<y</sub>) is practically constant. Consequently, the different schemes resulted in minor changes in the longest wavelength modes that we tracked down to small changes in the negligible tension. The resulting measurements of bending modulus change by less than 10%, and our main text conclusions do not change. Author response image 2 compares the fluctuation spectrums for the different integration schemes.

      Author response image 2.

      Height fluctuation spectrum, for a bilayer membrane at T<sub>eff</sub> =1.1, simulated with Langevin dynamics (pink, ‘langevin‘), our setup (purple, ‘nph+langevin‘), and under an isothermal-isobaric ensemble (blue, ‘npt‘); fits are shown as dotted lines.

      R3.Q4: This issue is reinforced when considering Figure 3B. These results suggest that increasing the fraction of regular lipids increases the tilt modulus, with the maximum value achieved for a normal Cooke-Deserno bilayer void of bolalipids. But this is contradictory. For these bilayers, we don’t need the tilt modulus in the first place.

      We understand the concern why this might be counter-intuitive, and we thank the reviewer for pointing it out. We first want to stress that the tilt modulus can also be measured for bilayer membranes even if it is not needed to fit the fluctuation spectrum. If we measure the tilt modulus for a bilayer membrane, we obtain a value similar to the previously measured one [36]. Importantly, here we also report measurements for the tilt modulus for bolalipid membranes.

      To understand the seemingly contradictory behaviour of the tilt modulus, it is insightful to rewrite the expression for the fluctuation spectrum as done in Eq. (1):

      where is a characteristic length scale related to tilt, which we call the tilt persistence length. From the last equation it is easy to see that the tilt modulus 𝜅<sub>𝜃</sub> becomes relevant for the fluctuation spectrum if the tilt persistence length l<sub>𝜃</sub>  is not negligible. In other words, this means that we have to consider the tilt modulus 𝜅<sub>𝜃</sub> as relevant, if it is sufficiently small compared to the bending rigidity 𝜅.

      However, this is not only counter-intuitive, but also difficult to communicate graphically. Per the excellent reviewer’s suggestion, to make the interpretation more accessible, we converted in the main text and its figures the tilt modulus to the more directly interpretable tilt persistence length l<sub>𝜃</sub>, as this is small when tilt is irrelevant (for bilayer lipids and flexible bolalipids) and large otherwise (for rigid bolalipids). This includes changes to the main text on p.6 and p.8 , and to the insets in Figs. 2C and 3B. We note that for completeness we also report the tilt modulus 𝜅<sub>𝜃</sub>  in the SI.

      R3.Q5: Also, from the SI, I gathered that the authors have neglected the longest wavelength mode because it is not equilibrated. If this is indeed the case, it is a dangerous thing to do, because with a small membrane patch, this mode can very well change the general trend of the power spectrum. As a lot of other analyses in the manuscript rely on these measurements, I believe more elaboration is in order.

      We thank the reviewer for the careful examination of our supplementary material. For each fluctuation spectrum measurement, we ran multiple replicas. We observed that the largest wavelength modes were not fully equilibrated. In the simulations the first mode of the fluctuation spectrum is probed at different amplitudes and phases. We thus expected the potential systematic error would show up clearly when comparing spectrums of the different replicas. As we saw no correlation in these systematic offsets between replicas, we concluded that the simulations are sufficiently equilibrated and we could safely exclude the first mode of the fluctuation spectrum from our analysis.

      To show without doubt that this procedure does not randomly bias our results, we also ran simulations for three representative membranes until all modes were equilibrated. On the modes previously equilibrated, the resulting spectrums agree with our previous shorter simulations. On the largest wavelength modes that were previously not fully equilibrated, we noticed a small deviation from theory, specifically for flexible membranes (small bending modulus). These small deviations can be explained by including a negligible negative tension. Importantly, however, the resulting bending modulus σ stays nearly the same. We note that the small negative tension disappears when we halve the timestep (see Author response image 3). This verification is shown in SI section 17.

      R3.Q6: The authors have found that ”there is a strong dependency of the bending rigidity on the membrane mean curvature of stiffer bolalipids.” The effect is negative, with the membrane becoming less stiff at higher mean curvatures. Why is that? I would assume that with more flexible bolalipids, the possibility of reorganization into U-shaped chains should affect the bending rigidity more (as Figure 2E suggests). While for a stiff bolalipid, not much would change if you increase the mean curvature. This should be either a tilt effect, or have to do with asymmetry between the leaflets. But on the other hand, the tilt modulus is shown to decrease with increasing bolalipid rigidity. The authors get back to this issue only on page 10, when they consider U-shaped lipids in the inner and outer leaflets and write, ”this suggested that an additional membrane-curving mechanism must be involved.” But then again, in the Discussion, the authors write, ”It is striking that membranes made from stiffer bolalipids showed a curvature-dependent bending modulus, which is a clear signature that bolalipid membranes exhibit plastic behaviour during membrane reshaping,” adding to the confusion.

      Author response image 3.

      Height fluctuation spectrum, for a bilayer membrane at T<sub>eff</sub> =1.1, as simulated in the main text (grey, for 60⇥10<sup>3</sup>τ), for longer duration (1_.44⇥10<sup>6</sup>τ) (pink), and with the longer duration and halved timestep =0.005_τ(purple); fits are shown as dotted lines (tension and tilt) or dash-dot lines (tilt only).

      We thank the reviewer for asking this important question. Membrane bending rigidity in bolalipid membranes decreases dramatically once a small fraction of U-shapes is allowed to form, but then plateaus once this U-shape fraction reaches 20%. In a curved bolalipid membrane, U-shapes must accumulate in the outer leaflet to accommodate for area difference. Together, the bending rigidity non-linear dependence on U-shape fraction, and the promotion of U-shapes by curvature, explain why in a membrane made of moderately stiff bolalipids (k<sub>bola</sub> = 1k<sub>B</sub>T), which contain very few U-shapes in the flatstate, the bending rigidity of the membrane decreases as curvature increases. While in a membrane made of flexible bolalipid molecules (k<sub>bola</sub> = 0), where many U-shapes are present in the flat membrane, the bending rigidity does not change with curvature.

      Bending rigidity 𝜅 in flat membranes composed of bolalipids decreases dramatically once a small fraction of U-shapes is allowed to form, but plateaus once more than 20% of U-shaped bolalipids are present. In details, our data shows that with an increasing bolalipid molecular rigidity k<sub>bola</sub>, both the number of U-shaped bolalipids decreases (Fig. 2B) and the membrane rigidity 𝜅 increases (Fig. 2C). Thus, the correlation suggests that U-shaped bolalipids soften the membrane, in a non-linear way where most of the change in membrane bending rigidity happens for U-shaped bolalipid fraction < 20% (Figure S11).

      Separately, membrane curvature affects the area difference between curved membrane leaflets and thus drives U-shape accumulation. To be specific, a cylindrical membrane with area A, mean curvature H and thickness h has the outer leaflet with area A(1 + Hh) and the inner leaflet with smaller area A(1 Hh). This can be large, in our simulations up to an area change of Hh \= 25%. For pure bolalipid membranes, straight bolalipids occupy the same space in each leaflet. Area difference can then be achieved only by having a different amount of U-shaped bolalipids in each leaflet, which can result in a different U-shape fraction between leaflets and thus ’asymmetry between leaflets’. Figure S10 confirms U-shape head fraction asymmetry that increases with curvature, for both flexible (k<sub>bola</sub> = 0) and moderately stiff bolalipids (k<sub>bola</sub> = 1k<sub>B</sub>T).

      Together, these two effects result in membrane softening under curvature for the moderately stiff bolalipids, but constant rigidity for flexible bolalipids (Fig. 2F). In details: for membranes composed of moderately stiff bolalipid molecules (k<sub>bola</sub> = 1k<sub>B</sub>T), the U-shape bolalipid head fraction only increases in the outer leaflet, goingfrom10to20%(Figure S10). This is in the high sensitivity region where the bending rigidity is expected to change the most (Figure S11). We hypothesize that the molecular rigidity of a U-shaped bolalipid creates compression on the outer leaflet that stabilizes the membrane curvature and thus causes membrane softening. We suspect that for membranes composed of rigid bolalipids (k<sub></sub> > 1k<sub>B</sub>T), the effect is likely not present due to the absence of U-shape formation even under strong bending.

      By contrast, for membranes composed of flexible bolalipids (k<sub></sub> = 0), the U-shaped bolalipid head fraction changes relatively little from its value for flat membranes (from 50% to respectively 60 and 40% for the outer and inner leaflet, Figure S10). This is in the region where the membrane bending rigidity is expected to respond weakly to U-shape fraction (Figure S11). Additionally, the change is symmetric, so presumably the outer leaflet becomes softer as the inner leaflet becomes stiffer, thus creating opposing effects and only weakly affecting the membrane bending rigidity as a whole. We note that the distinction between the U-shape head fraction that we plot (Figure S10) and U-shape fraction (Figure S11) matters little for this analysis.

      We have added this deduction and its plots to SI section 8, and revised the corresponding statement in the main text accordingly (p.7 ).

      “Changing membrane curvature alters the area differently in the two membrane leaflets. To adapt to the area difference, we thus expect the fraction of U-shaped bolalipids to change as the membrane curvature changes. Moreover, the results of Fig. 2B and Fig. 2C showed that the U-shaped bolalipid fraction and the membrane bending rigidity are correlated. As a result, we predict that the fraction of straight versus U-shaped bolalipids in a membrane will change in response to membrane bending, in a way that makes the bending rigidity of a bolalipid membrane curvature dependent.”

      R3.Q7: This issue is repeated when the authors study nanoparticle uptake. They write: ”to reconcile these seemingly conflicting observations we reason that the bending rigidity, similar to Figure 2F, is not constant but softens upon increasing membrane curvature, due to dynamic change in the ratio between bolalipids in straight and U-shaped conformation. Hence, bolalipid membranes show stroking plastic behaviour as they soften during reshaping.” But the softening effect that they refer to, as shown in Figure 4B, occurs for very stiff bolalipids, for which not much switching to U-shaped conformation should occur.

      We thank the reviewer for locating a particularly dense sentence. We changed the text to explicitly refer to the range k<sub></sub> 2 [0,2] k<sub>B</sub>T for which there is significant change in U-shape fraction (p.8 ):

      “To reconcile these seemingly conflicting observations we reason that the bending rigidity κ, similar to Fig. 2F, is not constant but softens in the range k<sub></sub> 2 [0,2] k<sub>B</sub>T, upon increasing membrane curvature. This is due to the dynamic change in the ratio between bolalipids in straight and U-shaped conformation.”

      As for Fig. 4B, for k<sub></sub> > 2k<sub>B</sub>T, pores form thus explaining the plateau in adsorption energy.

      R3.Q8: Another major issue is with what the authors refer to as the ”effective temperature”. While plotting phase diagrams for kT/eps value is absolutely valid, I’m not a fan of calling this effective temperature. It is a dimensionless quantity that scales linearly with temperature, but is not a temperature. It is usually called a ”reduced temperature”. Then the authors refer to their findings as studying the stability of archaeal membranes at high temperatures. I have to disagree because eps is not the only potential parameter in the simulations (there are at least space exclusion and angle-bending stiffnesses) so one cannot identify changing eps with changing the global simulation temperature. This only works when you have one potential parameter, like an LJ gas.

      We indeed thought about this before and found that it makes little difference in our set-up. To thoroughly show that the distinction matters very little, per reviewer’s question, we computed our phase diagrams by scaling temperature T explicitly (and not lipid tail interactions T<sub>eff</sub> = k<sub>B</sub>T /ϵ<sub>p</sub>). We added these results to the SI section 14 and found no significant difference when comparing scaling tail interactions (Figure S15A) with scaling temperature explicitly (Figure S15B).

      We also computed Fig. 2A-C for scaling interactions (Figure S17A) and scaling temperature explicitly (Figure S17B). We found a slightly increased U-shaped bolalipid fraction for low k<sub></sub> when comparing scaling interactions (Figure S17A) with temperature scaling (Figure S17B). The reason is that the U-shaped fraction depends on temperature, as with higher temperature bolalipids can easier transition into the U-shape. Most importantly, however, we found no qualitative changes on the liquid region or the mechanical membrane properties when we compared the different scaling variants.

      The reason why both scaling variants match so well can be understood easily. All pair potentials, including volume exclusion interactions between head beads and other membrane beads, were also scaled in the same manner as tail-to-tail interactions, as described in the SI. In contrast, the energy scales for maintaining the lipid bonds, the bilayer lipid angles and the bolalipid angles are relatively large compared to the energy scales involved in tail-to-tail interactions. This separation of energy scales guarantees that there will be little effect when increasing global temperature. Regarding nomenclature, we take the reviewer’s advice and have added ’reduced temperature’ as an alias for T<sub>eff</sub> in the main text.

      In the revised version of the manuscript, we mention these observations in the SI section 14 and point towards these results in the main text (p.4 ):

      “This interaction strength governs the membrane phase behaviour and can be interpreted as the effective temperature or reduced temperature T<sub>eff</sub> = k<sub>B</sub>T /ϵ<sub>p</sub>. As the distinction between scaling interactions (T<sub>eff</sub>) or temperature (T) is not important for our analysis (see Supplemental Information (SI) section 14), for simplicity we refer to T<sub>eff</sub> as temperature in the following.”

      Minor issues

      R3.Q9: As the authors have noted, the fact that the membrane curvature can change the ratio of U-shaped to straight bolalipids would render the curvature elasticity non-linear (though the term ”plastic” should not be used, as this is still structurally reversible when the stress is removed. Technically, it is hypoelastic behaviour, possibly with hysteresis.) With this in mind, when the authors use essentially linear elastic models for fluctuation analysis, they should make a comparison of maximum curvatures occurring in simulations with a range that causes significant changes in bolalipid conformational ratios.

      We thank the reviewer for their suggestion on calling the non-linear behaviour of the curvature elasticity hypoelastic. We have edited the main text accordingly (p.8 ):

      “In an elastic material, the strain modulus holds constant and deformation is reversible. For bolalipid membranes at k<sub></sub> = 1k<sub>B</sub>T, however, the bending modulus decreases when deformation increases, rendering bolalipid membranes hypoelastic.”

      Moreover, regarding the maximum curvatures occurring in the fluctuation simulations: We first note that the ensemble average of the mean curvature H from the fluctuation measurements is indicated as a vertical line in Fig. 2F. As the average value is nearly zero, the membrane can be considered as flat in good approximation. To investigate the question in more detail, we extended the SI with a careful analysis of the validity of the maximum membrane curvature and the validity of the Monge gauge approximation (SI section 15).

      In short, we found that the involved membrane curvatures are small and therefore are unlikely to trigger any significant changes of the bending modulus. Moreover, since we are dealing with two bolalipid conformations, we also tested the homogeneity of the membrane. In our simulations of flat membrane patches we did not observe clustering or phase separation between the two bolalipid conformations beyond the [2,3]σ range. Furthermore, we get good agreement between our fluctuation measurement and the cylinder simulations in Fig. 2F. We now mention this verification in the revised version of the manuscript (p.8 ):

      “Fortunately, this dependency on curvature does not invalidate our fluctuation results, where the curvature is small enough that its effect on the bending modulus is negligible (SI section 15).”

      Last but least, simulating bending/unbending cycles of an arc-shaped membrane (frozen endpoints) shows agreement with cylinder membrane simulations, and no hysteresis at the rates of deformation employed (cf. M. Amaral’s thesis [54], soon to be out of the embargo period).

      R3.Q10: The Introduction section of the manuscript is written with a biochemical approach, with very minor attention to the simulation works on this system. Some molecular dynamics works are only cited as existing previous work, without mentioning what has already been studied in archaeal membranes. While some information, like the binding of ESCRT proteins to archaeal membranes, though interesting, helps little to place the study within the discipline. The Introduction should be revised to show what has already been studied with simulations (as the authors mention in the Discussion) and how the presented research complements it.

      The present research for the first time covers archaeal membranes with a single coarse-grained model capable of assuming both bolalipid in-membrane conformations and sweeps through temperature, membrane composition, and molecular rigidity. The work shows the first curvature dependent bending modulus for pure bolalipid membranes. It also investigates systematically bending modulus and Gaussian modulus, and tests the model in an all-encompassing budding simulation that incorporates topology changes. Existing atomistic or coarse-grained MD simulations (MARTINI or similar force fields) are limited to small patches of membrane, with no study of large-scale deformations or topology changes; plus, they rely on force fields that were parametrized for bilayer membranes.

      To give a comprehensive overview of the field, we revised the introduction section of the manuscript, in which we now discuss previous computational work investigating membrane diffusivity, U-shaped lipid fraction, and bending rigidity (p.3 ):

      “By contrast, only a few studies have investigated bolalipid membranes applying computational or theoretical tools [24, 25]. Specifically, the pore closure time in bolalipid membranes, and the role of cyclopentane rings for membrane properties has been investigated using all-atom simulations, showing decreased lateral mobility, reduced permeability to water, and increased lipid packing [26–28]. Moreover, using coarse-grained simulations, it was suggested that bolalipid membranes are thicker [29], exhibit a gel-to-liquid phase transition at higher temperature [30], and exhibit a reduced diffusivity [31]. However, little research has been devoted to investigating mechanics and reshaping of bolalipid membranes at the mesoscale despite the obvious importance of this question from evolutionary, biophysics, and biotechnological perspectives and although different membrane physics is expected to manifest.”

      Following the reviewer’s advice and to keep the introduction concise and focused on bolalipid membranes, we have removed the paragraph on ESCRT-III proteins in the revised manuscript.

      R3.Q11: The authors have been a bit loose with using the term ”stability”. I’d like to see the distinction in each case, as in ”chemical/thermal/mechanical/conformational stability”.

      We have clarified when applicable the type of stability throughout the manuscript. In all other instances, if not clear from context, we mean simply that the membrane persists being a membrane. At our coarse-grained level, this means the membrane does not disassemble into a gas phase.

      R3.Q12: In the original Cooke-Deserno model, a so-called ”poorman’s angle-bending term” is used, which is essentially a bond-stretching term between the first and third particle. However, I notice the authors using the full harmonic angle-bending potential. This should be mentioned.

      This is made clear in the SI (Eq. (S3)). Cooke and Deserno mention the harmonic angle potential as a valid alternative in their original publication. We now also added this detail to the main text (p.3 ):

      “The angle formed by the chain of three beads is kept near 180° via an angular potential with strength k<sub>0</sub>, instead of the approximation by a bond between end beads of the original model [32].”

      R3.Q13: The analysis of energy of U-shaped lipids with the linear model E \= c<sub>0</sub> + c<sub>1</sub>k<sub></sub> is indeed very interesting. I am curious, can this also be corroborated with mean energy measurements? The minor issue is calling the source of the favorability of U-shaped lipids ”entropic”, while clearly an energetic contribution is found. The two conformations, for example, might differ in the interactions with the neighbouring lipids.

      We were also curious and thank the reviewer for the suggestion of mean energy measurements. We concluded that there must be either an entropic contribution to the free energy or an intermolecular interaction energy favouring U-shaped bolalipids. We have now included these measurements in SI section 6 (p.S5 ):

      “By splitting the average potential energy between an internal contribution (bonds, angles and pair interactions between particles in the same molecule) and an external contribution (pair interactions between a molecule and its neighbours), we determined the transition energy from straight to U-shaped bolalipids in detail. We found that this transition lowers the internal potential energy of the bolalipid while increasing its interaction energy. In total, we obtained an energy barrier for the transition of ΔE<sub>s→u</sub> = 0.79±0.01k<sub>B</sub>T. Since the fit indicates, however, that the U-shaped bolalipid conformation is preferred over the straight conformation, we conclude that there must be either an entropic contribution to the free energy or an intermolecular interaction energy favouring U-shaped bolalipids.”

      We refer to these measurements in the main text (p.6 ):

      “For the fit it appears that c<sub>0</sub> < 0, which implies that bolalipids in U-shape conformation are slightly favoured over straight bolalipids at k<sub></sub> = 0 (explored in SI section 6).”

      R3.Q14: The authors write in the Discussion, ”In any case, our results indicate that membrane remodelling, such as membrane fission during membrane traffic, is much more difficult in bolalipid membranes [34].” Firstly, I’m not sure if studying the dependence of budding behaviour on adhesion energy with nanoparticles is enough to make claims about membrane fission. Secondly, why is the 2015 paper by Markus Deserno cited here?

      We thank the reviewer for giving us the opportunity to clarify. We make an energetic argument on membrane fission based on the observed difference in the ratio of .

      Splitting a spherical membrane vesicle into two spherical vesicles (fission) increases the bending energy by 8𝜋𝜅 and decreases the energy related to the Gaussian bending modulus by . The second part of the argument is given for example in the review by Markus Deserno (p.23, right column), that’s why we cite the paper here. Together, this gives an energy barrier, required for membrane fission in the considered geometry of ∆E<sub>fission</sub> = . We found that is around 0.5 for bolalipid membranes and around 1 for bilayer membranes. Since 𝜅 was typically larger in bolalipid membranes we thus expect the energy barrier for fission ∆E<sub>fission</sub> to be larger for bolalipid membranes. We therefore predict that membrane remodelling, such as membrane fission during membrane trafficking, is harder in bolalipid membranes. We explain our reasoning in the discussion of the revised manuscript (p.13 ):

      “Membrane remodelling, such as the fission of one spherical vesicle into two, increases the bending energy by 8πκ but decreases the energy related to the Gaussian modulus by – [39], giving rise to a fission energy barrier of ∆E<sub>fission</sub> = . Our results indicated that while in bolalipid membranes 𝜅 is larger, is smaller compared to bilayer membranes. Our results thus predict a larger energy barrier for membrane fission ∆E<sub>fission</sub> in bolalipid membranes compared to bilayer membranes.”

      R3.Q15: In the SI, where the measurement of the diffusion coefficient is discussed, the expression for D is missing the power 2 of displacement.

      We thank the reviewer for spotting this oversight. We corrected it in the revised version of the SI (p.S5 ).

      R3.Q16: Where cargo uptake is discussed, the term ”adsorption energy” is used. I think the more appropriate term would be ”adhesion energy”.

      For the sake of simplicity, we changed the term to adhesion energy (caption of Fig. 4, and p.10). We do not have a strong opinion on this, but we believe that adsorption energy would be equally correct as we describe the adsorption of many lipid head beads to a nanoparticle.

      R3.Q17: Typos:

      Page 1, paragraph 2: Adaption → Adaptation. Page 10, paragraph 1: Stroking → Striking.

      We thank the reviewer for spotting these typos which we have corrected in the revised version of the manuscript.

      Recommendations for the authors

      Reviewer #1 (Recommendations for the authors):

      A few thoughts (likely out of the scope of this paper but possibly to consider upon revision):

      R1.Q1: Do bolalipids always have the same headgroup? I don’t recall reading this in the introduction/discussion. R1 and R2 are in Figure 1, but I don’t know whether there are standard types. Could this be expanded upon? Is the model able to take these differences into account?

      We thank the reviewer for raising this important question. Similar to bacteria and eukaryotes, in archaea there is a huge variety in terms of the different head groups that lipids can contain and thus also lipid variety. Most archaeal lipids have head groups that contain either phosphate groups or sugar residues. Typically, archaeal bolalipids are asymmetric and contain a phosphatidyl and a sugar moiety at the two ends of the lipid molecule. Within the membrane the lipid is oriented such that the phosphatidyl moiety points towards the interior of the cell whereas the sugar moiety points towards the outside of the cell as it occupies more space [5].

      In our computational model, however, we consider symmetric bolalipids for the sake of simplicity and to decouple the role of ”connected geometry” from other effects. In principle, we could investigate the effect of lipid asymmetry by increasing the size of one of the lipid head beads. However, this investigation exceeds the scope of the present study and therefore requires future work.

      In the revised version of the manuscript, we now clarify that bolalipids can have different headgroups (p.1 and the caption of Fig. 1):

      “The hydrophilic heads can be composed of different functional groups with phosphatidyl and sugar being the most relevant moieties. For bolalipids the two head groups at either end of the molecule are typically distinct (Fig. 1A right) [5].”

      “The hydrophilic head of a bolalipid can be composed of different functional groups represented by R1 and R2 (right).”

      We also explicitly state that we neglect lipid head group asymmetry for the sake of simplicity (p.4 ):

      “To decouple the effect of the connected geometry of the bolalipids from that of lipid asymmetry, we assume both head beads of a bolalipid to share the same properties.”

      R1.Q2: Is it possible to compare the mesoscale models to either Coarse-grained or even all-atom lipid models? Have simulations previously been performed for bolalipids at those levels of description?

      A few studies have investigated bolalipids membranes in simulations previously. These studies either used all-atom or coarse-grained simulations. However, none of these studies investigated how bolalipids respond to membrane deformations. Therefore, it is currently not possible to directly compare our results to studies in the literature. However, to recapitulate our predictions experimentally is certainly something that could and should be done in the future. As a reply to this reviewer and reviewer 3, we discuss the current state of modelling bolalipid membranes in simulations in the revised version of the manuscript (p.3 ):

      “By contrast, only a few studies have investigated bolalipid membranes applying computational or theoretical tools [24, 25]. Specifically, the pore closure time in bolalipid membranes, and the role of cyclopentane rings for membrane properties has been investigated using all-atom simulations, showing decreased lateral mobility, reduced permeability to water, and increased lipid packing [26–28]. Moreover, using coarse-grained simulations, it was suggested that bolalipid membranes are thicker [29], exhibit a gel-to-liquid phase transition at higher temperature [30], and exhibit a reduced diffusivity [31]. However, little research has been devoted to investigating mechanics and reshaping of bolalipid membranes at the mesoscale despite the obvious importance of this question from evolutionary, biophysics, and biotechnological perspectives and although different membrane physics is expected to manifest.”

      We want to mention, however, that we do compare membrane diffusivity, U-shaped lipid fraction, and bending rigidity to the behaviour and values that have been previously measured in simulations in the discussion section. In general, we find good agreement between our results and previously reported behaviour/values (p.13 ):

      “While flexible bolalipid membranes are liquid under the same conditions as bilayer membranes, we found that stiff bolalipids form membranes that operate in the liquid regime at higher temperatures. These results agree well with previous molecular dynamics simulations that suggested that bolalipid membranes are more ordered and have a reduced diffusivity compared to bilayer membranes [24, 29]. In our simulations, this is due to the fact that completely flexible bolalipids molecules adopt both straight (transmembrane) as well as the U-shaped (loop) conformation with approximately the same frequency. In contrast, stiff bolalipids typically only take on the straight conformation when assembled in a membrane. These results agree with the previous coarse-grained molecular dynamics simulations using the MARTINI force field which showed that the ratio of straight to U-shaped bolalipids increased upon stiffening the linker between the lipid tails [29].

      [...]

      When we determined the bending rigidity of bolalipid membranes by measuring their response to thermal fluctuations, we found that membranes made from flexible bolalipids are only slightly more rigid than bilayer membranes. This result is consistent with previous atomistic simulations, which showed that the membrane rigidity was similar for membranes composed of bilayer lipids and flexible synthetic bolalipids [45].”

      R1.Q3: How would membrane proteins alter the behaviour of bolalipids? Either those integral to the membrane or those binding peripherally?

      The reviewer asks an important question. However, the question is difficult to answer due to its scope and the gaps in the current literature. Important examples of integral or peripheral membrane proteins that alter the behaviour of bolalipids and archaeal bolalipid membranes are involved in cell homeostasis, cell division, membrane trafficking, and lipid synthesis.

      The cells of many archaeal species are enclosed in a paracrystalline protein layer called the Slayer, which is attached to the lipid membrane [4, 55]. The main function of the S-layer is to keep the cell’s shape and to protect it against osmotic stress. Due to the embedding of the S-layer in the membrane at specific locations, it is to be expected that the membrane properties are influenced by the S-layer. Furthermore, archaea execute cell division by locally reshaping the membrane using FtsZ and ESCRT-III proteins [56]. While Asgard archaeal genomes encode proteins with homology to those regulating aspects of eukaryotic membrane remodelling and trafficking [57], they have yet to be observed undergoing a process like endocytosis [58]. In addition, it has been speculated that the proteins that drive the synthesis of two diether lipids into a tetraether lipid are either membrane associated or integral membrane proteins [59].

      However, to the best of our knowledge it is not known how membrane proteins specifically alter the behaviour of bolalipids. Future work will need to be executed to answer this question. Following the advice of reviewer 3 and to keep the introduction concise and focused on bolalipid membranes, we do not mention these observations in the revised manuscript.

      R1.Q4: Is there a mechanism in cells to convert or switch bolalipids from a straight to a u-shaped description? Does this happen spontaneously or are there enzymes responsible for this?

      We thank the reviewer for bringing up this important point. Despite the relevance of the question, little is currently known about the mechanism that make bolalipids transition between a straight and a U-shaped configuration mainly because there is to date no established experimental method.

      Besides our own results, most of what we know comes from coarse-grained molecular dynamics simulations, which showed that bolalipids can spontaneously transition between the straight and U-shaped configuration [29]. In addition, by using comparative genomic analysis, it has been predicted that many archaeal species contain flippases, i.e., membrane proteins that are able, upon the consumption of energy, to transfer (flipflop) bilayer lipids between the two membrane leaflets [43]. Moreover, it has been shown that Halobacterium salinarum (an archaeon with a bilayer lipid membrane) [44] contains scramblases, which are membrane proteins that passively transfer bilayer lipids from one membrane leaflet to the other. It is therefore tempting to speculate that similar proteins might exist for bolalipids which could facilitate the straight to U-shaped transition.

      In addition, it has been reported that vesicles composed of bolalipid membranes can undergo fusion with enveloped influenza viruses [17]. In this context, it has been suggested that the influenza fusion protein hemagglutinin may locally induce U-shaped bolalipids to facilitate membrane fusion. However, all these hints are by far no proof of a mechanism that can drive the straight to U-shaped bolalipid transition, and further work needs to be done to investigate this question in detail.

      In the revised version of the manuscript, we now discuss what is known about potential mechanisms to facilitate the straight to U-shaped transition in the discussion section (p.13 ):

      “While previous coarse-grained simulations predicted that bolalipids spontaneously transition between the straight and U-shaped conformations [29], how this happens in archaeal membranes and whether membrane proteins are involved in this conformational transition needs to be clarified in the future. Experimental studies suggest that archaeal membranes contain flippases and scramblases for the transitioning of bilayer lipids between membrane leaflets [43, 44], raising the possibility that similar proteins could also facilitate conformational transitions in bolalipids. In addition, it has been suggested that the viral fusion protein hemagglutinin could cause a transition from straight to U-shaped bolalipid conformation during the fusion of bolalipid vesicles with influenza viruses [17]. However, future investigation is required.”

      R1.Q5: Ideally, coordinates and any parameter files required to run the molecular simulations should be included for reproducibility.

      We absolutely share the reviewer’s concern with reproducibility and as such have included in the original submission as part of our data availability section a link to a code repository (available at: https://doi.org/10.5281/zenodo.13934991 [51]) that allows initializing and simulating flat membrane patches, with user control of the parameters explored in this paper (𝜔,T<sub>eff</sub>,k<sub>bola</sub>,f<sup>bi</sup>).

      Reviewer #2 (Recommendations for the authors):

      This is a great paper and I congratulate the authors for writing such a fine piece of scholarship. The only nitty-gritty feedback that I have is summarized in the following three points:

      R2.Q1: In the introduction the authors talk about archaea adapting their membrane to retain membrane fluidity. However, homeoviscous adaptation is also fundamental in bacteria and eukaryotes.

      The reviewer is correct, like archaea the membranes of bacteria and eukaryotes must balance between flexibility and stability. Moreover, the cell membranes in all 3 domains of life need to maintain membrane fluidity and provide mobility to the embedded lipids and membrane proteins (homeoviscous adaptation). The general idea is that these organisms change the ratio of different lipids to change membrane properties and thereby optimally adapt to their environments [10]. Importantly, however, there are differences of how homeoviscous adaptation is maintained across the different domains of life. As a reply to this reviewer and reviewer 3, we now discuss the underlying mechanisms in the revised parts of the introduction (p.1 ):

      “Like for bacteria and eukaryotes, archaea must keep their lipid membranes in a fluid state (homeoviscous adaptation). This is important even under extreme environmental conditions, such as hot and cold temperatures, or high and low pH values [7]. Because of this, many archaea adapt to changes in their environment by tuning the lipid composition of their membranes: altering the ratio between bola- and bilayer lipids in their membranes [8, 9] and/or by changing the number of cyclopentane rings in their lipid tails, which are believed to make lipid molecules more rigid [5]. For example, Thermococcus kodakarensis increases its tetraether bolalipid ratio from around 50% to over 80% when the temperature of the environment increases from 60 to 85 C [10]. Along the same lines, the cell membrane of Sulfolobus acidocaldarius, can contain over 90 % of bolalipids with up to 8 cyclopentane rings at 70 C and pH 2.5 [5, 11]. It is worth mentioning that in exceptional cases bacteria also synthesise bolalipids in response to high temperatures [12], highlighting that the study of bolalipid membranes is relevant not only for archaeal biology but also from a general membrane biophysics perspective.”

      R2.Q2: Uncertainties in Gaussian rigidity modulus estimates are not properly reported.

      The large uncertainties in the Gaussian rigidity modulus were due to the fact how they were calculated. In short, is determined in cap folding simulations [41] (SI section 9), by using the measured values of the dimensionless parameter 𝜉, related to the folding probability, the bending modulus 𝜅, the membrane line tension , and the cap radius R. In our case, the main source of uncertainty for determining comes from the uncertainty in the measurement of the bending rigidity 𝜅. To obtain 𝜅, previously, we fitted fluctuation spectra for different seeds and only then averaged the obtained values. In the revised version of the manuscript, we now first pool the fluctuation spectra of the different simulation seeds before we fit all spectra at the same time. This new approach results in smaller uncertainties for the bending rigidity 𝜅 and also the Gaussian rigidity modulus .

      As a consistency check, in addition to the simulations that we previously performed at T<sub>eff</sub> = 1.3, we have repeated the cap folding and line tension simulations at T<sub>eff</sub> = 1.2, resulting in similar values for . In the revised version of the manuscript, we report the newly calculated values and uncertainties for at T<sub>eff</sub>  = 1.2 in the main text (p.8 ):

      “At T<sub>eff</sub>  = 1.2, we obtained = 4.30±0.22kBT and thus a ratio of = 0.89±0.04 for bilayer membranes, similar to what has been reported previously [41]. For flexible bolalipid membranes, we got a slightly smaller value for = 5.04 ± 0.37kBT. Due to the larger bending modulus, however, flexible bolalipid membranes show a significantly smaller ratio = 0.64± 0.04 (k<sub></sub> = 0). At larger temperature (Teff = 1.3), the ratio can be even smaller = 0.45 ± 0.07 (see SI section 9).”

      In addition, we report the values at T<sub>eff</sub> = 1.3 and T<sub>eff</sub> = 1.2 in the SI (p.S15 , Tabl. S4):

      We have also adapted the discussion of the Gaussian bending modulus accordingly (p.13 ):

      “Another marked difference between bilayer and flexible bolalipid membranes is the ratio of the Gaussian rigidity to the bending modulus. Instead of being around 1 as for bilayer membranes [41], it is around 1/2 and therefore only half of that of bilayer lipids.”

      Reviewer #3 (Recommendations for the authors):

      While I think the bulk of the work presented is useful, some of the issues that I raised in my review are indeed major. Without properly addressing them, it is hard to accept the conclusions of the manuscript. I hope the authors can address them by revising their analysis.

      We thank the reviewer for their constructive feedback, which helped us to improve the manuscript. We have addressed all points raised by the reviewer in our detailed point-by-point response to the reviewer (see above). We hope the reviewer will now find it easier to accept our conclusions.

      (1) R. Phillips, J. Kondev, J. Theriot, and H. Garcia, Physical biology of the cell (Garland Science, New York, 2012).

      (2) H. T. McMahon and J. L. Gallop, Membrane curvature and mechanisms of dynamic cell membrane remodelling, Nature 438, 590 (2005).

      (3) S. B. Gould, Membranes and evolution, Curr. Biol. 28, R381 (2018).

      (4) S.-V. Albers and B. H. Meyer, The archaeal cell envelope, Nat. Rev. Microbiol. 9, 414 (2011).

      (5) P. M. Oger and A. Cario, Adaptation of the membrane in Archaea, Biophys. Chem. 183, 42 (2013).

      (6) K. Rastädter, D. J. Wurm, O. Spadiut, and J. Quehenberger, The Cell Membrane of Sulfolobus spp.—Homeoviscous Adaption and Biotechnological Applications, International Journal of Molecular Sciences 21, 3935 (2020).

      (7) P. L.-G. Chong, Archaebacterial bipolar tetraether lipids: Physico-chemical and membrane properties, Chem. Phys. Lipids 163, 253 (2010).

      (8) M. Tourte, P. Schaeffer, V. Grossi, and P. M. Oger, Functionalized Membrane Domains: An Ancestral Feature of Archaea?, Front. Microbiol. 11, 526 (2020).

      (9) Y. H. Kim, G. Leriche, K. Diraviyam, T. Koyanagi, K. Gao, D. Onofrei, J. Patterson, A. Guha, N. Gianneschi, G. P. Holland, M. K. Gilson, M. Mayer, D. Sept, and J. Yang, Entropic effects enable life at extreme temperatures, Sci. Adv. 5, eaaw4783 (2019).

      (10) M. F. Siliakus, J. van der Oost, and S. W. M. Kengen, Adaptations of archaeal and bacterial membranes to variations in temperature, pH and pressure, Extremophiles 21, 651 (2017).

      (11) D. W. Grogan, Phenotypic characterization of the archaebacterial genus sulfolobus: comparison of five wild-type strains, J. Bacteriol. 171, 6710 (1989).

      (12) D. X. Sahonero-Canavesi, M. F. Siliakus, A. Abdala Asbun, M. Koenen, F. von Meijenfeldt, S. Boeren, N. J. Bale, J. C. Engelman, K. Fiege, L. Strack van Schijndel, J. S. Sinninghe Damsté, and L. Villanueva, Disentangling the lipid divide: Identification of key enzymes for the biosynthesis of membrane-spanning and ether lipids in Bacteria, Sci. Adv. 8, eabq8652 (2022).

      (13) M. van Wolferen, A. A. Pulschen, B. Baum, S. Gribaldo, and S.-V. Albers, The cell biology of archaea, Nat. Microbiol. 10.1038/s41564-022-01215-8 (2022).

      (14) U. Bakowsky, U. Rothe, E. Antonopoulos, T. Martini, L. Henkel, and H.-J. Freisleben, Monomolecular organization of the main tetraether lipid from Thermoplasma acidophilum at the water–air interface, Chem. Phys. Lipids 105, 31 (2000).

      (15) C. Jeworrek, F. Evers, M. Erlkamp, S. Grobelny, M. Tolan, P. L.-G. Chong, and R. Winter, Structure and Phase Behavior of Archaeal Lipid Monolayers, Langmuir 27, 13113 (2011).

      (16) D. P. Brownholland, G. S. Longo, A. V. Struts, M. J. Justice, I. Szleifer, H. I. Petrache, M. F. Brown, and D. H. Thompson, Phase Separation in Binary Mixtures of Bipolar and Monopolar Lipid Dispersions Revealed by 2H NMR Spectroscopy, Small Angle X-Ray Scattering, and Molecular Theory, Biophysical Journal 97, 2700 (2009).

      (17) A. Bhattacharya, I. D. Falk, F. R. Moss, T. M. Weiss, K. N. Tran, N. Z. Burns, and S. G. Boxer, Structure–function relationships in pure archaeal bipolar tetraether lipids, Chem. Sci. 15, 14273 (2024).

      (18) V. Vitkova, D. Mitkova, V. Yordanova, P. Pohl, U. Bakowsky, G. Staneva, and O. Batishchev, Elasticity and phase behaviour of biomimetic membrane systems containing tetraether archaeal lipids, Colloids Surf. A Physicochem. Eng. Asp. 601, 124974 (2020).

      (19) E. Chang, Unusual thermal stability of liposomes made from bipolar tetraether lipids, Biochem. Biophys. Res. Commun. 202, 673 (1994).

      (20) O. V. Batishchev, A. S. Alekseeva, D. S. Tretiakova, T. R. Galimzyanov, A. Y. Chernyadyev, N. R. Onishchenko, P. E. Volynsky, and I. A. Boldyrev, Cyclopentane rings in hydrophobic chains of a phospholipid enhance the bilayer stability to electric breakdown, Soft Matter 16, 3216 (2020).

      (21) U. Seifert, Configurations of fluid membranes and vesicles, Adv. Phys. 46, 13 (1997).

      (22) H. Noguchi, Membrane Simulation Models from Nanometer to Micrometer Scale, J. Phys. Soc. Jpn. 78, 041007 (2009).

      (23) F. Frey and T. Idema, More than just a barrier: using physical models to couple membrane shape to cell function, Soft Matter 17, 3533 (2021).

      (24) C. Huguet, S. Fietz, A. Rosell-Melé, X. Daura, and L. Costenaro, Molecular dynamics simulation study of the effect of glycerol dialkyl glycerol tetraether hydroxylation on membrane thermostability, Biochimica et Biophysica Acta (BBA) - Biomembranes 1859, 966 (2017).

      (25) T. R. Galimzyanov, P. I. Kuzmin, P. Pohl, and S. A. Akimov, Elastic deformations of bolalipid membranes, Soft Matter 12, 2357 (2016).

      (26) T. R. Galimzyanov, P. E. Volynsky, and O. V. Batishchev, Continuum elasticity and molecular dynamics of a pore in archaeal bolalipid membranes, Soft Matter 21, 687 (2025).

      (27) A. O. Chugunov, P. E. Volynsky, N. A. Krylov, I. A. Boldyrev, and R. G. Efremov, Liquid but Durable: Molecular Dynamics Simulations Explain the Unique Properties of Archaeal-Like Membranes, Sci. Rep. 4, 7462 (2015).

      (28) L. F. Pineda De Castro, M. Dopson, and R. Friedman, Biological Membranes in Extreme Conditions: Simulations of Anionic Archaeal, PLoS One 11, e0155287 (2016).

      (29) M. Bulacu, X. Périole, and S. J. Marrink, In Silico Design of Robust Bolalipid Membranes, Biomacromolecules 13, 196 (2012).

      (30) C. H. Davis, H. Nie, and N. V. Dokholyan, Insights into thermophilic archaebacterial membrane stability from simplified models of lipid membranes, Phys. Rev. E 75, 051921 (2007).

      (31) S. Dey and J. Saha, Minimal Coarse-Grained Modeling toward Implicit Solvent Simulation of Generic Bolaamphiphiles, J. Phys. Chem. B 124, 2938 (2020).

      (32) I. R. Cooke and M. Deserno, Solvent-free model for self-assembling fluid bilayer membranes: Stabilization of the fluid phase based on broad attractive tail potentials, J. Chem. Phys. 123, 224710 (2005).

      (33) P. L.-G. Chong, U. Ayesa, V. Prakash Daswani, and E. C. Hur, On Physical Properties of Tetraether Lipid Membranes: Effects of Cyclopentane Rings, Archaea 2012, 1 (2012).

      (34) A. P. Thompson, H. M. Aktulga, R. Berger, D. S. Bolintineanu, W. M. Brown, P. S. Crozier, P. J. in ’t Veld, A. Kohlmeyer, S. G. Moore, T. D. Nguyen, R. Shan, M. J. Stevens, J. Tranchida, C. Trott, and S. J. Plimpton, LAMMPS - a flexible simulation tool for particle-based materials modeling at the atomic, meso, and continuum scales, Comput. Phys. Commun. 271, 108171 (2022).

      (35) A. Stukowski, Visualization and analysis of atomistic simulation data with ovito–the open visualization tool, Modelling and Simulation in Materials Science and Engineering 18, 015012 (2009).

      (36) E. R. May, A. Narang, and D. I. Kopelevich, Role of molecular tilt in thermal fluctuations of lipid membranes, Physical Review E 76, 021913 (2007).

      (37) W. Helfrich, Elastic Properties of Lipid Bilayers: Theory and Possible Experiments, Z. Naturforsch. C 28, 693 (1973).

      (38) M. Hamm and M. Kozlov, Elastic energy of tilt and bending of fluid membranes, Eur. Phys. J. E 3, 323 (2000).

      (39) M. Deserno, Fluid lipid membranes: From differential geometry to curvature stresses, Chemistry and Physics of Lipids 185, 11 (2015).

      (40) V. A. Harmandaris and M. Deserno, A novel method for measuring the bending rigidity of model lipid membranes by simulating tethers, The Journal of Chemical Physics 125, 204905 (2006).

      (41) M. Hu, J. J. Briguglio, and M. Deserno, Determining the Gaussian Curvature Modulus of Lipid Membranes in Simulations, Biophys. J. 102, 1403 (2012).

      (42) M. Deserno, Elastic deformation of a fluid membrane upon colloid binding, Phys. Rev. E 69, 031903 (2004), arXiv: cond-mat/0303656.

      (43) K. S. Makarova, M. Y. Galperin, and E. V. Koonin, Comparative genomic analysis of evolutionarily conserved but functionally uncharacterized membrane proteins in archaea: Prediction of novel components of secretion, membrane remodeling and glycosylation systems, Biochimie 118, 302 (2015).

      (44) A. Verchère, W.-L. Ou, B. Ploier, T. Morizumi, M. A. Goren, P. Bütikofer, O. P. Ernst, G. Khelashvili, and A. K. Menon, Light-independent phospholipid scramblase activity of bacteriorhodopsin from Halobacterium salinarum, Sci. Rep. 7, 9522 (2017).

      (45) T. B. H. Schroeder, G. Leriche, T. Koyanagi, M. A. Johnson, K. N. Haengel, O. M. Eggenberger, C. L. Wang, Y. H. Kim, K. Diraviyam, D. Sept, J. Yang, and M. Mayer, Effects of lipid tethering in extremophile-inspired membranes on H(+)/OH(-) flux at room temperature, Biophys. J. 110, 2430 (2016).

      (46) R. Xu, A. Dehghan, A.-C. Shi, and J. Zhou, Elastic property of membranes self-assembled from diblock and triblock copolymers, Chem. Phys. Lipids 221, 83 (2019).

      (47) Z. Dogic and S. Fraden, Ordered phases of filamentous viruses, Curr. Opin. Colloid Interface Sci. 11, 47 (2006).

      (48) E. Barry and Z. Dogic, Entropy driven self-assembly of nonamphiphilic colloidal membranes, Proc. Natl. Acad. Sci. U.S.A. 107, 10348 (2010).

      (49) A. J. Balchunas, R. A. Cabanas, M. J. Zakhary, T. Gibaud, S. Fraden, P. Sharma, M. F. Hagan, and Z. Dogic, Equation of state of colloidal membranes, Soft Matter 15, 6791 (2019).

      (50) M. Saracco, P. Schaeffer, M. Tourte, S.-V. Albers, Y. Louis, J. Peters, B. Demé, S. Fontanay, and P. M. Oger, Bilayer-Forming Lipids Enhance Archaeal Monolayer Membrane Stability, Int. J. Mol. Sci. 26, 3045 (2025).

      (51) M. Amaral, archaeal_membranes : code and examples (2024), available at https://doi.org/10.5281/zenodo. 13934991.

      (52) M. F. Ergüder and M. Deserno, Identifying systematic errors in a power spectral analysis of simulated lipid membranes, The Journal of Chemical Physics 154, 214103 (2021).

      (53) J. Genova, N. Ulrih, V. Kralj-Iglič, A. Iglič, and I. Bivas, Bending Elasticity Modulus of Giant Vesicles Composed of Aeropyrum Pernix K1 Archaeal Lipid, Life 5, 1101 (2015).

      (54) M. Amaral, Archaeal Membranes: In Silico Modelling and Design, Ph.D. thesis, Institute of Science and Technology Austria (2024).

      (55) M. Pohlschroder, F. Pfeiffer, S. Schulze, and M. F. A. Halim, Archaeal cell surface biogenesis, FEMS Microbiol. Rev. 42, 694 (2018).

      (56) K. S. Makarova, N. Yutin, S. D. Bell, and E. V. Koonin, Evolution of diverse cell division and vesicle formation systems in Archaea, Nat. Rev. Microbiol. 8, 731 (2010).

      (57) C. W. Stairs and T. J. Ettema, The Archaeal Roots of the Eukaryotic Dynamic Actin Cytoskeleton, Curr. Biol. 30, R521 (2020).

      (58) B. Baum and D. A. Baum, The merger that made us, BMC Biol. 18, 72 (2020).

      (59) Z. Zeng, H. Chen, H. Yang, Y. Chen, W. Yang, X. Feng, H. Pei, and P. V. Welander, Identification of a protein responsible for the synthesis of archaeal membrane-spanning GDGT lipids, Nat. Commun. 13, 1545 (2022).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This manuscript by Liu et al explores the role of the UPR and immune regulators in the evaluation of nutritional quality in C. elegans. They identify neuronal UPR activation and the MAPK PMK-1 as key responders to low food quality. In particular, the data suggest that these pathways are activated by low levels of vitamin C synthesis that result from the low sugar levels present in heat-killed E. coli.

      Strengths:

      The results are intriguing and expand our understanding both of physiological food evaluation systems, and of the known roles of stress response pathways in organismal physiology. The authors use a range of techniques, encompassing imaging, metabolomic analysis, gene expression analysis, and behavioural assays, to support their claims.

      Thank you for your thorough review and acknowledgment of the strengths of our study.

      Weaknesses:

      There is limited mechanistic analysis in the study. In particular, how does low vitamin C trigger UPR activation? This is an intriguing finding that, if followed up, could potentially reveal a novel mechanism of UPR activation. In addition, how is the activation of the PMK-1 pathway driven by/coordinated with UPR activation? The data in some figures is not as convincing as it could be: the magnitude of the effect size is small in the supplementation experiments, and the statistical tests used are not always appropriate to enable multiple comparisons.

      (1) There is limited mechanistic analysis in the study. In particular, how does low vitamin C trigger UPR activation? This is an intriguing finding that, if followed up, could potentially reveal a novel mechanism of UPR activation. 

      Thank you for highlighting the need for further mechanistic analysis in our study. We appreciate the opportunity to clarify the process by which low vitamin C triggers UPR activation.

      Our investigation revealed that the vitamin C content in heat-killed E. coli (HK-E. coli) is comparable to that of live E. coli or HK-yfbR mutant E. coli (Figure 4-figure supplement 1A), indicating that the induction of unfolded protein response (UPR) in C. elegans by HK-E. coli is not solely attributed to low vitamin C levels but rather involves other unidentified factors.

      Through metabolomic analysis, we observed significant decreases in sugar levels, including lactose, D-(+)-sucrose, and D-(+)-glucose, in HK-E. coli (Figure 3B, Table S1). Notably, supplementing D-(+)-glucose effectively inhibited UPRER, immune response, and avoidance behavior induced by HK-E. coli (Figure 3E-H). These findings suggest that the deficiency in sugars in HK-E. coli triggers a stress response and avoidance behavior in animals, which can be alleviated by D-(+)-glucose supplementation.

      Furthermore, when comparing heat-killed E. coli mutant yfbR (HK-yfbR) to HK-E. coli, we observed significantly higher sugar levels, including lactose and D-(+)-sucrose, in HK-yfbR (Figure 3B). This was accompanied by reduced UPRER in animals feeding on HK-yfbR (Figure 3-figure supplement 1B), indicating that higher sugar levels may inhibit the induction of UPRER by low-quality food.

      Considering that the synthesis of vitamin C (VC) occurs through the glucuronate pathway, utilizing D-glucose as a precursor 1, 2 (Figure 4A), we investigated whether the vitamin C biosynthesis pathway is involved in evaluating low-quality food using D-glucose. Contrary to our initial hypothesis, animals fed live E. coli did not exhibit higher glucose levels compared to those fed low-quality food (HK_-E. coli_). Our results indicate that animals maintain similar VC levels when fed ideal food (live E. coli) compared to low-quality food (HK-E. coli) (Figure 4B), suggesting that animals do not stimulate VC biosynthesis under favorable food conditions. However, supplementation of D-GlcA or E. coli-yfbR mutation in HK-E. coli significantly improved VC levels when animals were fed low-quality food (HK-OP50) (Figure 4B, 4C). Moreover, VC or D-glucuronate (D-GlcA) supplementation inhibited HK-E. coli-induced UPRER (Figure 4D), indicating that glucose boosts the animal's ability to adapt to unfavorable food environments by increasing VC levels, thereby inhibiting UPRER, but not under favorable food conditions.

      These findings shed light on the complex interplay between vitamin C, sugar levels, and UPR activation, providing valuable insights into the mechanisms underlying food evaluation and stress response pathways in organisms.

      Overall, we are grateful for the reviewer's constructive feedback, which motivates us to continue our efforts to understanding how the UPR response contributes to the complexities of food evaluation and behavioral responses in organisms.

      (2) In addition, how is the activation of the PMK-1 pathway driven by/coordinated with UPR activation?

      Thank you for your insightful inquiry. In our discussion section, we have addressed this question by integrating new data and discussion to provide insights into the coordination between PMK-1 pathway activation and UPR activation.

      Previous studies have demonstrated that activating innate immunity, specifically the PMK-1 MAPK pathway, results in a reduction in translation3, as well as a shutdown of food digestion in animals4, likely aimed at reducing protein translation and cellular metabolism. To further investigate this relationship, we measured the translation level of animals fed with heat-killed E. coli (HK-E. coli) and found a significant reduction in total translation ability in these animals (Figure 5-figure supplement 1D). This observation suggests that activating innate immunity through the PMK-1 MAPK pathway may serve as a mechanism to slow down translation progress, thereby alleviating the pressure on the unfolded protein response (UPR) and preventing excessive UPRER activation.

      By integrating these findings, we propose a model wherein activation of the PMK-1 pathway coordinates with UPR activation to regulate translation and cellular metabolism in response to low-quality food. This coordinated response likely serves to maintain cellular homeostasis and prevent detrimental effects associated with excessive UPRER activation.

      These insights contribute to our understanding of the intricate interplay between innate immunity, cellular stress responses, and metabolic regulation in organisms facing nutritional challenges.

      (3) The data in some figures is not as convincing as it could be: the magnitude of the effect size is small in the supplementation experiments, and the statistical tests used are not always appropriate to enable multiple comparisons.

      We appreciate the reviewers' concerns regarding the data presentation and statistical analyses in some of our figures. In response to this feedback, we have made revisions to improve the robustness and clarity of our statistical methods.

      All statistical analyses were conducted using GraphPad Prism 8.0 software. Specifically, a two-tailed unpaired t-test was employed for the statistical analysis of two groups of samples, while one-way or two-way ANOVA was utilized for the statistical analysis of more than two groups of samples. These adjustments ensure appropriate statistical comparisons and enhance the reliability of our findings.

      Reviewer #2 (Public Review):

      Summary:

      In this work, the authors aim to better understand how C. elegans detects and responds to heat-killed (HK) E. coli, a low-quality food. They find that HK food activates two canonical stress pathways, ER-UPR, and innate immunity, in the nervous system to promote food aversion. Through the creative use of E. coli genetics and metabolomics, the authors provide evidence that the altered carbohydrate content of HK food is the trigger for the activation of these stress responses and that supplementation of HK food with sugars (or their biosynthetic product, vitamin C), reduces stress pathway induction and food avoidance. This work makes a valuable addition to the literature on metabolite detection as a mechanism for the evaluation of nutritional value; it also provides some new insight into the physiologically relevant roles of well-known stress pathways in modulating behavior.

      Strengths:

      -The work addresses an important question by focusing on understanding how the nervous system evaluates food quality and couples this with behavioral change. -The work takes full advantage of the tools available in this powerful system and builds on extensive previous studies on feeding behavior and stress responses in C. elegans.

      -Creative use of E. coli genetics and metabolite profiling enabled the identification of carbohydrate metabolism as a candidate source of food-quality signals.

      -For the most part, the studies are rigorous and logically designed, providing good support for the authors' model.

      We deeply appreciate the reviewer's insightful assessment of our study's strengths. 

      Weaknesses:

      -It is not clear how the mechanism identified here is connected to previously described, related processes. In particular, it is not clear whether this mechanism has a role in the detection of other low-quality foods. Further, the specificity of the ability of sugar/vitamin C to suppress stress pathway induction is unclear (i.e., does sugar/vitamin C have any effect on the activation of these pathways through other means?). Additionally, the relationship of this pathway to the vitamin B2-sensing mechanism previously described by the senior author is unclear. These issues do not weaken confidence in the authors' conclusions, but they do reduce the potential significance of the work.

      (1) In particular, it is not clear whether this mechanism has a role in the detection of other low-quality foods. 

      Thank you for your valuable feedback. In response to your inquiry, we investigated whether the UPRER (IRE-1/XBP-1) - Innate immunity (PMK-1/p38 MAPK) axis is specific to evaluating low-quality food (HK-E. coli) or if it plays a broader role in food detection.

      We conducted behavioral assays using N2, pmk-1, and xbp-1 mutant animals fed with normal E. coli food, inedible food (Saprophytic staphylococci)4, and pathogenic food (Pseudomonas aeruginosa-PA14)5. We found that N2, pmk-1, and xbp-1 mutant worms did not exhibit avoidance behavior when presented with normal food (OP50). However, both N2 and xbp-1 mutant worms were able to escape from inedible food (N2 was predominantly found on the border areas of the bacterial lawn and xbp-1 mutant worms on border and in), Saprophytic staphylococci, whereas pmk-1 mutant worms did not exhibit this avoidance behavior. Notably, N2 and xbp-1 mutant worms exhibited even more pronounced avoidance behavior when exposed to Pseudomonas aeruginosa, whereas pmk-1 mutant worms were more susceptible to infection by this pathogen (Figure 2-figure supplement 2C). These findings suggest that the UPR-Immunity pathway plays a crucial role in helping animals avoid low-quality food (HK-E. coli) by triggering an avoidance response. In contrast, the Innate immunity pathway, mediated by PMK-1/p38 MAPK, appears to play a key role in evaluating unfavorable food sources, such as HK-E. coli, Saprophytic staphylococci, and Pseudomonas aeruginosa, and helping animals avoid these environments.

      (2) Further, the specificity of the ability of sugar/vitamin C to suppress stress pathway induction is unclear (i.e., does sugar/vitamin C have any effect on the activation of these pathways through other means?). 

      Thank you for your inquiry regarding the specificity of the ability of sugar/vitamin C to suppress stress pathway induction. We aimed to address this question by investigating whether high levels of VC inhibit other stress-induced UPRER pathways.

      Previous studies have shown that both Tunicamycin6 and pathogenic bacteria, such as Pseudomonas aeruginosa-PA145, induce UPRER in C. elegans. In response to your query, we conducted experiments to examine whether VC supplementation inhibits UPRER induced by these stressors. Our findings indicate that VC supplementation does not inhibit UPRER induced by either Tunicamycin or PA14 (Author response image 1).

      These results suggest that while sugar/vitamin C may suppress stress pathway induction in the context of low-quality food, its effects may not extend to other stressors that induce UPRER through different mechanisms. This insight helps clarify the specificity of sugar/vitamin C's role in modulating stress pathway activation, contributing to a better understanding of the broader regulatory networks involved in stress response in C. elegans.

      Author response image 1.

      VC supplementation does not inhibit Tunicamycin or PA14-induced UPRER.

      (3) Additionally, the relationship of this pathway to the vitamin B2-sensing mechanism previously described by the senior author is unclear.

      In response to your comment, we would like to clarify the relationship of our pathway to the previously described vitamin B2-sensing mechanism we found. Previous studies have demonstrated that heat-killed E. coli (HK-E. coli) serves as a low-quality food source incapable of supporting the growth of C. elegans larvae, whereas supplementation with vitamin B2 (VB2) can restore animal growth7

      This study investigates the role of sugar deficiency in HK-E. coli, which induces the UPRER-immune response and avoidance behavior in C. elegans. Surprisingly, our findings indicate that supplementing HK-E. coli with carbohydrates such as D-Glc and D-GlcA does not promote animal development (Figure 3-figure supplement 2G), suggesting that carbohydrates are not essential for supporting animal growth on this food source. However, we did observe that carbohydrates play a critical role in inhibiting the UPRER-immune response induced by sugar deficiency in HK-E. coli.

      -The authors claim that the induction of the innate immune pathway reporter irg-5::GFP is "abolished" in pmk-1(RNAi) animals, but Figure S2K seems to show a clear GFP signal when these animals are fed HK-OP50. Similarly, the claim that feeding WT animals HK-OP50 enriches phospho-PMK-1 levels (Fig 2E) is unconvincing - only one western blot is shown, with no quantification, and there is a smear in the critical first lane.

      (1) The authors claim that the induction of the innate immune pathway reporter irg-5::GFP is "abolished" in pmk-1(RNAi) animals, but Figure S2K seems to show a clear GFP signal when these animals are fed HK-OP50. 

      We sincerely appreciate the reviewer's attention. To address this concern, we have replaced the images with higher resolution, larger ones in Figure 2-figure supplement 1-I. These updated images provide a clearer representation of the data, ensuring that all details are readily visible and enabling a more accurate interpretation of the results.

      (2) Similarly, the claim that feeding WT animals HK-OP50 enriches phospho-PMK-1 levels (Fig 2E) is unconvincing - only one western blot is shown, with no quantification, and there is a smear in the critical first lane.

      Thank you, following reviewer’s suggestion, we also repeated some of the western. We now replace the Figure 2E and quantified relative intensity of pPMK-1/tublin. We also provide the uncropped western blots images as source data ( “raw-data WB” file). 

      -The rationales for some of the paper's hypotheses could be improved. For example, the rationale for screening the E. coli mutant library is that some mutants, when heat-killed, may be missing a metabolite that induces the ER-UPR. A more straightforward hypothesis might be that some mutant E. coli strains aberrantly induce the ER-UPR when *not* heat-killed, because they are missing a metabolite that prevents stress pathway induction. This is not in itself a major concern, but it would be useful for the authors to provide a rationale for their hypothesis.

      Thank you for the insightful suggestion. We acknowledge the importance of providing a clear rationale for our hypotheses in the paper. In response to this feedback, we have enhanced the discussion section to better elucidate the rationale behind our hypotheses.

      One limitation of our study is the lack of explanation for why HK-E. coli activates UPRER and immunity. We hypothesized that when heat-killed, HK-E. coli may lack or contain altered levels of certain metabolites that either activate or inhibit UPRER and immunity, respectively. Additionally, we speculated that E. coli mutants killed by heat may lack metabolites that activate UPRER and immunity, or conversely, have increased levels of metabolites that inhibit these pathways.

      Fortunately, our investigation led to the discovery of the E. coli mutant yfbR, which inhibits UPRER and immunity by increasing carbohydrates that aid in resisting these stress pathways. Moving forward, we intend to further explore the intricate relationship between HK-E. coli and UPRER-immunity. This will be a key focus of our future research efforts.

      -The authors do not provide any explanation for some unexpected results from the E. coli screen. Earlier in the paper, the authors found that innate immune signaling is downstream of ER-UPR activation. However, of the 20 E. coli mutants that, when heat-killed, "did not induce... the UPR-ER reporter," 9 of them still activate the innate immune response. This seems at odds with the authors' simple model since it suggests that low-quality food can induce innate immune signaling independently of the ER-UPR. Further, only one of the 9 has an effect on behavior, even though failure to activate the innate immune pathway might be expected to lead to a behavioral defect in all of these.

      Thank you for your understanding, and we apologize for any confusion caused by our earlier statement. To provide clarification, our study revealed that out of the 20 E. coli mutants examined, none activated the UPRER. Among these mutants, 9 did not induce immunity, and interestingly, one out of these 9 mutants demonstrated the ability to inhibit avoidance behavior.

      This diversity in phenotypic outcomes can be attributed to the varied metabolites present in different E. coli mutants. To thoroughly evaluate the effects of these mutants, we conducted a comprehensive three-step screening process, utilizing UPRER marker, immunity marker, and avoidance behavior assays.

      Through this rigorous approach, we identified the E. coli mutant, yfbR, which exhibited the desired inhibitory effects on UPRER, immunity, and avoidance behavior.

      Subsequently, we conducted a metabolomics analysis of various food qualities (HK-K12, HK-yfbR, and Live-K12). Our findings revealed higher sugar levels in

      HK-yfbR and Live-K12 compared to HK-K12 (Figure 3B, Figure 3-figure supplement 2A, and Table S1), indicating that sugar deficiency might trigger the UPRER, immunity responses, and subsequent avoidance behavior. 

      -In a number of places, the writing style can make the authors' arguments difficult to follow.

      Thanks for the reviewer’s efforts. We changed all of these errors and polish the language of this paper. 

      -Some of the effect sizes observed by the authors are exceedingly small (e.g, the suppression of hsp-4::gfp induction by sugar supplementation in Figs 3C-E), raising some concern about the biological significance of the effect.

      Thank you for your feedback. In response to your concern, we have included additional clarification in the manuscript.

      We have added the following statement: “While sugar effectively inhibits the HK-E. coli-induced UPRER and immune response, it does not fully suppress it to the extent observed with live-E. coli (Figure 3C-F). This implies that additional nutrients present in live-E. coli might also contribute to the inhibition of UPRER and immune response.”

      This addition helps to address the observation that some effect sizes appear small, providing context and suggesting potential factors that may influence the outcomes. 

      -In some cases, there is a discrepancy between the fluorescence images and their quantitation (e.g., Figure 3E, where the effect of glucose on GFP fluorescence seems much stronger in the image than in the graph).

      Thank you for your valuable suggestion. In response, we have revised our image selection process to ensure impartiality. We now randomly select images to ensure they accurately represent the quantified data without bias. More details regarding this update can be found in Author response image 2.

      Author response image 2.

      More original picture corresponding to Figure 3E 

      Reviewer #3 (Public Review):

      Summary:

      Animals can evaluate food quality in many ways. In contrast to the rapid sensory evaluation with smell and taste, the mechanism of slow nutrient sensation and its impact on food choice is unexplored. The authors utilize C. elegans larvae and their bacterial food as an elegant model to tackle this question and reveal the detailed molecular mechanism to avoid nutrient-poor foods.

      Strengths:

      The strength of this study is that they identified the molecular identities of the critical players in bacterial food and C. elegans using unbiased approaches, namely metabolome analysis, E. coli mutant screening, and RNA sequencing. Furthermore, they strengthen their findings by thorough experiments combining multiple methods such as genetics, fluorescent reporter analysis, and Western blot.

      Thank you for highlighting the strengths of our study. 

      Weaknesses:

      The major caveat of this study is the reporter genes. The transcriptional reporters were used to monitor the UPRER and immune responses in the intestine of C. elegans.

      However, their tissue-specific rescue experiments suggest that the genes in the UPRER and immune response function in the neurons. Thus, we should carefully interpret the results of the reporter genes.

      Thank you for your insightful comment. We appreciate the opportunity to address your concerns regarding the interpretation of our reporter gene data.

      Upon reevaluation, we observed strong induction of the UPRER reporter

      (Phsp-4::GFP)8 and immunity reporter (Pirg-5::GFP)9 both in the intestine (Figure 1F-G) and in neurons (Figure 1-figure supplement 2A) in response to feeding unfavorable food (HK-E. coli). This suggests that both the UPRER and immune pathways may indeed respond to low-quality food (HK-E. coli) in multiple tissues of C. elegans. While we acknowledge that our tissue-specific rescue experiments suggest a role for these pathways in neurons, the intestinal fluorescence of Phsp-4::GFP or Pirg-5::GFP is easily observable and scorable. Therefore, we chose to focus our further analyses on the intestine for practical reasons.

      Overall, this work provides convincing data to support their model. In the C. elegans field, the behaviors of larvae are not well studied compared to adults. This work will pose an interesting question about the difference between larvae and adults in nutrition sensing in C. elegans and provide a framework and candidate molecules to be studied in other organisms.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Major suggestions:

      (1) My major overall comment is that the paper would be substantially strengthened by more mechanistic analysis. In particular, how does low vitamin C trigger UPR activation? This is an intriguing finding and it would be important to see it more fully explored.  

      Our study revealed that the vitamin C content in HK_-E. coli_ is comparable to that of live E. coli or HK-yfbR (Figure 4-figure supplement 1A), suggesting that the induction of unfolded protein response (UPR) in C. elegans by HK-E. coli is not attributed to low vitamin C levels, but rather to unknown factors.

      Metabolomic analysis showed that the sugar levels, including lactose, D-(+)-sucrose, and D-(+)-glucose, were significantly decreased in HK-E. coli (Figure 3B, Table S1).

      Furthermore, we found that supplementing D-(+)-glucose effectively inhibited UPRER (Figure 3E), immune response (Figure 3F, 3G, and Figure 3-figure supplement 2D), and avoidance behavior (Figure 3H) induced by HK-E. coli. Our findings suggest that the deficiency in sugars in HK-E. coli triggers a stress response and avoidance behavior in animals, which can be alleviated by D-(+)-glucose supplementation.

      Notably, when E. coli was heat-killed, we observed that the sugar levels, including lactose and D-(+)-sucrose, were significantly higher in the heat-killed E. coli mutant yfbR (HK-yfbR) compared to HK-E. coli (Figure 3B). Moreover, we found that UPRER was reduced in animals feeding HK-yfbR (Figure 3-figure supplement 1B), indicating that higher sugar levels may inhibit the induction of UPRER by low-quality food.

      The synthesis of vitamin C (VC) occurs through the glucuronate pathway, utilizing D-glucose as a precursor 1, 2 (Figure 4A). This led us to investigate whether the vitamin C biosynthesis pathway is involved in evaluating low-quality food by using D-glucose. In this study, we found that animals feeding live E. coli, which should produce more VC, exhibit higher glucose levels. However, our results show that animals maintain similar VC levels when fed ideal food (live E. coli) compared to low-quality food (HK-E. coli) (Figure 4B), suggesting that animals do not stimulate VC biosynthesis under favorable food conditions. In contrast, when animals are fed low-quality food (HK-OP50), we found that supplementing D-GlcA (Figure 4C) or E. coli-yfbR mutation (Figure 4B) in HK-E. coli can improve VC levels. Moreover, we found that VC or D-glucuronate (D-GlcA) supplementation inhibited HK-E. coli induced UPRER (Figure 4D). These data indicate that glucose boosts the animal's ability to adapt to unfavorable food environments by increasing VC levels, thereby inhibiting UPRER, but not in favorable food conditions.

      In addition,we asked whether high level of VC inhibits other stress induced UPRER. Previous study shown that Tunicamycin6 and pathogenic bacteria-Pseudomonas aeruginosa-PA145 induce UPRER in C. elegans. We found that VC supplementation does not inhibit Tunicamycin or PA14-induced URPER (Author response image 3). 

      Author response image 3.

      VC supplementation does not inhibit Tunicamycin or PA14-induced UPRER.

      In addition, how is the activation of the PMK-1 pathway driven by/coordinated with UPR activation? 

      If the authors do not want to pursue these directions experimentally in this study, the discussion would be strengthened by considering these questions and identifying candidate regulatory mechanisms for further exploration.

      In this study, we found that heat-killed E. coli (HK-E. coli), a low-sugar food, triggers cellular unfolded protein response (UPRER) and immune response. We also demonstrated that 1) the activation of UPRER by low-quality food depends on the IRE-1/XBP-1, 2) activation of immune response (PMK-1) is downstream of XBP-1 in responding to low-quality food.

      how is the activation of the PMK-1 pathway driven by/coordinated with UPR activation? 

      In our discussion part, we added new data and discussion to answer reviewer’s question. 

      A previous study has shown that activating innate immunity (PMK-1 MAPK) leads to a reduction in translation 3. Our own previous research has also demonstrated that PMK-1 activation causes a shutdown of food digestion in animals4, likely to reduce protein translation and cellular metabolism. To investigate this further, we measured the translation level of animals fed with HK-E. coli and found that total translation ability is significantly reduced in these animals (Figure 5-figure supplement 1D). This finding suggests that activating innate immunity (PMK-1 MAPK) may serve as a mechanism to slow down translation progress, thereby alleviating the pressure on the unfolded protein response (UPR) and preventing excessive UPRER activation.

      (2) Figure 2C: The data shows that xbp-1 mutants are significantly more likely to leave heat-killed E. coli. However, no other conditions are examined. Is this avoidance defect specific to heat-killed E. coli, or is it a more general effect of xbp-1 mutants - that is, are other conditions that evoke avoidance also affected by mutation of xbp-1? Is feeding behavior on regular E. coli altered in this background? The finding would be more relevant if the authors could clarify or provide more context for their claims here.

      We then asked whether UPRER (IRE-1/XBP-1) - Innate immunity (PMK-1/p38 MAPK) axis is specific to evaluate low-quality food (HK-E. coli). We examined the avoidance behavior phenotype of wild-type and mutant L1 animals by placing them on various food conditions, including normal E. coli food, inedible food (Saprophytic staphylococci) and pathogenic food (Pseudomonas aeruginosa-PA14), for a 24-hour period. We found that N2, pmk-1, and xbp-1 mutant worms did not exhibit avoidance behavior when presented with normal food (OP50). However, both N2 and xbp-1 mutant worms were able to escape from inedible food, Saprophytic staphylococci, whereas pmk-1 mutant worms did not show this avoidance. Notably, xbp-1 mutant worms exhibited even more pronounced avoidance behavior when exposed to Pseudomonas aeruginosa, whereas pmk-1 mutant worms were more susceptible to infection by this pathogen (Figure 2-figure supplement 2C). These findings suggest that the UPR-Immunity pathway plays a crucial role in helping animals avoid low-quality food by triggering an avoidance response. In contrast, the Innate immunity pathway, which is mediated by PMK-1/p38 MAPK, appears to play a key role in evaluating unfavorable food sources, such as HK-E. coli, Saprophytic staphylococci, and Pseudomonas aeruginosa, and helping animals avoid these environments.

      (3) Figure 3C-F: The magnitude of the changes between conditions shown in these panels is small. To what extent does this supplementation represent a full rescue? The findings would be strengthened if figures/images for the control condition (non-HK E. coli) were shown for comparison to allow the reader to assess the extent to which UPR/PMK-1 activation is rescued.

      In response to a reviewer's suggestion, we included live-E. coli as a control in our study. Notably, our data revealed that the addition of lactose, D-(+)-sucrose, and D-(+)-glucose partially inhibited the HK-E. coli-induced unfolded protein response (UPRER) and immune response, suggesting that other nutrients present in live-E. coli may also play a role in inhibiting UPRER.

      We added this in manuscript: “While sugar effectively inhibits the HK-E. coli-induced UPRER and immune response, it does not fully suppress it to the extent observed with live-E. coli (Figure 3C-F). This implies that additional nutrients present in live-E. coli might also contribute to the inhibition of UPRER and immune response.” 

      (4) Figure 5B-D: The magnitude of changes shown between conditions here again appear to be very small, even those labelled as statistically significant. It is important to ensure that the correct statistical tests have been used to assess the significance of these differences (see below).

      All statistical analyses were performed in Graphpad prism 8.0. Two-tailed unpaired t test was used for statistical analysis of two groups of samples,one-way or two-way ANOVA was used for statistical analysis of more than two groups of samples.

      (5) Methods: In the "Statistical analysis" section, the authors state that "All statistical analyses were performed using Student's t-test". However, this is not the appropriate test to use in experiments where multiple comparisons are made, which is true in several instances across the paper. In these cases, a more appropriate statistical test should be used.

      All statistical analyses were performed in Graphpad prism 8.0. Two-tailed unpaired t test was used for statistical analysis of two groups of samples,one-way or two-way ANOVA was used for statistical analysis of more than two groups of samples.

      Minor suggestions:

      (1) Figure S2: RNAi is usually delivered in a different E. coli strain, HT115. Is this the case with the RNAi knockdowns in Figure S2, and given that diet can influence UPR activation, is it possible that this different diet could change the phenotypes observed?

      This should be clarified by the authors.

      In this study, all RNAi experiments involved bleaching adult animals under RNAi strain culture conditions to obtain L1 animals. Subsequently, L1 animals were transferred to HK-E. coli OP50 for phenotype analysis. In response to a reviewer's suggestion, we observed that L1 animals obtained from mothers fed E. coli strains OP50, HT115, or K12 exhibited similar UPR induction under HK-E. coli OP50 feeding conditions (Author response image 4). These findings suggest that variations in diet did not alter the UPR phenotypes.

      Author response image 4.

      L1 animals obtained from mothers fed E. coli strains OP50, HT115, or K12 exhibited similar UPR induction under HK-E. coli OP50 feeding conditions 

      Reviewer #2 (Recommendations For The Authors):

      Line 182: "irg-5::GFP" should be "hsp-4::gfp".

      Thanks for the reviewer’s efforts. We have changed this error.

      Reviewer #3 (Recommendations For The Authors):

      Major comments:

      (1) The reporter genes of UPRER and immune response were analyzed in the intestine throughout the study. On the other hand, their rescue experiments suggest that these pathways function in the neurons. They should provide the fluorescence data in the neurons at least for Figures 1F and 1G to confirm that the intestinal response matches the neuronal response and mention that further analyses were done in the intestine for easy scoring.

      Consistent with the results of the RNA sequencing (RNA-seq) analysis, the UPRER reporter (Phsp-4::GFP)8 and immunity reporter (Pirg-5::GFP)9 were strongly induced in intestinal (Figure 1F-G) and neurons (Figure 1-figure supplement 2A) by feeding unfavorable food (HK-E. coli), suggesting that UPRER and immune pathways may respond to low-quality food (HK-E. coli). As intestinal fluorescence (Phsp-4::GFP or Pirg-5::GFP) is easy observation and scoring, the further analyses were done in the intestine. 

      (2) I have concerns about the interpretation of the p-PMK-1 data. Although the authors described that "p-PMK-1 is prominently increased" in the text (Line 150), it is unclear on the data (Figure 2E). Similarly, the authors' statement "p-PMK-1 is decreased in animals with D-GlcA (F).." was not fully supported by the data in Figure 4F. The experiment should be repeated and quantified. Moreover, pPMK-1 showed single bands in Figure 2E, but double bands in Figure 3G, 4F, and 4G. The authors should explain why that is the case and which band we should look at for Figures 3G, 4F, and 4G.

      As reviewer’s suggestion, we also repeated some of the western. We found that after longer expose, there are two bands for pPMK-1 (Figure 2E, new data; and “raw-data WB” file). The VHP-1 phosphatase is known to inhibit PMK-13. In our previous study, we found that worms treated with vhp-1(RNAi), which hyperactivates p-PMK-1 (lower band) 4. In contrast, the two bands are disappeared in pmk-1 mutant (Author response image 5). Thus, the lower band indicates the pPMK-1. We now replace the Figure 2E and quantified relative intensity of pPMK-1/tublin. We also provide the uncropped western blots images as source data ( “raw-data WB” file). 

      Author response image 5.

      In our previous study, we found that worms treated with vhp-1(RNAi), which hyperactivates p-PMK-1 (lower band) 4. In contrast, the two bands are disappeared in pmk-1 mutant. These pictures are extracted from our previous study4.

      (3) Heat-killed E. coli (HK-E. coli) is low-quality because the lack of sugar cannot support the growth of C. elegans larvae (Qi and Han, Cell, 2018). Thus, animals do not show the UPRER-immune response and avoidance when HK-E. coli is supplemented with sugars such as glucose (Line 225-227). If these sugars are the key, C. elegans larvae should be able to grow better with HK-E. coli supplemented with glucose. Authors should address this possibility.

      Previous studies have shown that heat-killed E. coli (HK-E. coli) is a low-quality food source that cannot support the growth of C. elegans larvae7. Here, we found that sugar deficiency in HK-E. coli induces the UPRER-immune response and avoidance behavior in C. elegans. Given this, we investigated whether sugar supplementation could promote animal growth when fed HK-E. coli. To our surprise, supplementing HK-E. coli with carbohydrates (D-Glc, D-GlcA) did not support animal development (Figure 3-figure supplement 2G), suggesting that carbohydrates are not essential for supporting animal growth on this food source. However, we did find that carbohydrates are critical for inhibiting the UPRER-immune response induced by sugar deficiency in HK-E. coli.

      (4) Line 884: Instead of the Student's t-test, the ANOVA should be used for multiple comparisons.

      All statistical analyses were performed in Graphpad prism 8.0. Two-tailed unpaired t test was used for statistical analysis of two groups of samples,one-way or two-way ANOVA was used for statistical analysis of more than two groups of samples.

      (5) Although the results are interesting and convincing, the manuscript needs some careful editing and proofreading. As far as I could catch, there are more than 100 errors and typos, as I summarized in minor comments. I recommend the authors proofread thoroughly to make this work easier to read.

      Thanks for the reviewer’s efforts. We changed all of these errors and polish the language of this paper. 

      Minor comments:

      (1) Line 30: nature -> natural

      (2) Line 86: elegnas -> elegans

      (3) Line 93: the17h -> the 17h

      (4) Line 97: response -> respond

      (5) Line106: responded -> respond

      (6) Lien 107-109: Add references for the three reporters

      (7) Line 114: immune -> immune pathway

      (8) Line 118: immune depended -> immune-dependent

      (9) Line 128, 594, 596: deferentially -> differentially

      (10) Line 131: Explain what IRE-1-mediated splicing of xbp-1 with references

      (11) Line 170: XPB-1 -> XBP-1

      (12) Line 179: URP -> UPR

      (13) Line 181: hsp-4::GFP -> Phsp-4::GFP

      (14) Line 183: Italicize E. coli; mutant -> mutants

      (15) Line 184: irg-5::GFP -> Pirg-5::GFP (2 places)

      (16) Line 197, 203, 206, 207: Lactose -> lactose

      (17) Line 206, 209, 217, 225, 228, 232, 237, 262, 442, 445, 604, 739: Glucose -> glucose

      (18) Line 218: Sugars deficiency -> sugar deficiency

      (19) Line 229: found contribute to -> found to contribute to

      (20) Line 235, 537, 539, 587, 599, 642, 855: Italicize E. coli

      (21) Line 236: same -> the same

      (22) Line 239: I recommend adding "in C. elegans". This study uses both E. coli and C.

      elegans genetics. Sometimes, it is confusing which organism was mentioned. It should be applied where it is necessary.

      (23) Line 240: additional -> addition

      (24) Line 339, 642: Italicize kgb-1

      (25) Line 390: Italicize Pseudomonas aeruginosa, Bacillus thuringiensis,

      Staphylococcus aureus, and Serratia marcescens

      (26) Line 394: wiht -> with

      (27) Line 400, 550: Change ER to superscript; Italicize ire-1, xbp-1, and pmk-1

      (28) Line 415: xpb-1 -> xbp-1

      (29) Line 460, 525, 531, 532, 617, 655: Italicize yfbR

      (30) Line 457, 468, 472, 475, 482, 497, 513, 624, 629, 633, 733. 758: Vitamin -> vitamin

      (31) Line 459: Make it clear what is the relationship between vitamin C and TAA

      (32) Line 527: Do not italicize mutant

      (33) Line 538: Phsp-6:GFP -> Phsp-6::GFP (to match other descriptions)

      (34) Line 540: Phsp-4:GFP -> Phsp-4::GFP (to match other descriptions)

      (35) Line 540: Italicize hsp-4

      (36) Line 543: Pirg-5:GFP -> Pirg-5::GFP (to match other descriptions) and italicize irg-5

      (37) Line 550, 881: Innate -> innate

      (38) Line 557, 560, 564, 838: Do not italicize HK

      (39) Line 561: Remove the extra space before "three"

      (40) Line 575, 577: Reporter -> reporter

      (41) Line 575, 607: Italicize Phsp-4::GFP

      (42) Line 577: immunity -> Immunity; Italicize Pirg-5::GFP

      (43) Line 585, 653: keio -> Keio

      (44) Line 586: hsp-4::GFP -> Phsp-4::GFP

      (45) Line 586, 589 (2 places): irg-5::GFP -> Pirg-5::GFP

      (46) Line 597: Remove "all"

      (47) Line 600: Trehalose -> trehalose

      (48) Line 609: Italicize Pirg-5::GFP

      (49) Line 615: critically -> critical

      (50) Line 636: Remove "+"

      (51) Line 656 (2 places), 682: Do not italicize OP50

      (52) Line 664: Lead -> lead

      (53) Line 681: Describe the composition of NGM or show the reference. Since this paper examines nutrition, the composition of the medium is crucial.

      (54) Line 686-706: Italicize all allele names. Be consistent with how to write the promoter to avoid confusion (e.g., ttx-3p -> Pttx-3). Be consistent with how to describe the transgene (e.g., Phsp-4::GFP(zcIs4) -> zcIs4[Phsp-4::GFP])

      (55) Line 710: Describe the composition of LB or show the reference. Since this paper examines nutrition, the composition of the medium is crucial.

      (56) Line 709, 856 (2 places), 858: Do not italicize K12 to make it consistent

      (57) Line 719: Podr-1p:RFP -> Podr-1::RFP

      (58) Line 722, 724: Italicize ges-1 and xbp-1

      (59) Line 723: Pges-1:xbp-1::GFP -> Pges-1::xbp-1::GFP

      (60) Line 735: Glucuronic -> glucuronic

      (61) Line 748: I believe it is 5 mm instead of 0.5 mm

      (62) Line 750: The equation should be (5 mm)2/(17.5 mm)2

      (63) Line 759: Remove the period after "pattern".

      (64) Line 766: Describe how they were synchronized

      (65) Line 774: Italicize Psysm-1p::GFP

      (66) Line 785: Insert a space before "until"

      (67) Line 787: the mutant -> mutant

      (68) Line 789, 792, 793, 795 (2 places): GPF -> GFP

      (69) Line 791: next -> Next; an -> a

      (70) Line 799: Remove a space before "MRC".

      (71) Line 804: I do not understand what "until adulthood" means in this context;

      Remove a space before "by". (I recommend searching double space and correcting it.)

      (72) Line 853: Metabolome -> metabolome

      (73) Line 893-1082: Species and gene names should be italicized in Reference

      (74) Figures 1F, 1G, S2F, S2G: The panels' order should match the bar graphs' order. The apparent difference in the representative data does not match the marginal difference in the bar graph in Fig. 1G. The authors should double-check the results.

      (75) Figure 1F, 2A, 2B, 3C, 3D, 3E, 4D, 4I, S1J, S2A, S2B, S2I, S3B, S3F, S3H: hsp-4::GFP -> Phsp-4::GFP

      (76)  Figure 1G, 2D, 3F, 4E, 4J, S1K, S2H, S3C, S3I: irg-5::GFP -> Pirg-5::GFP

      (77)  Figure 6: Liquids -> Lipids; Italicize ire-1, xbp-1, pmk-1

      (78)  Figure S1I: hsp-6::GFP -> Phsp-6::GFP

      (79)  In the legend for Figure S1 after Figure S1, (A), (B)... were duplicated. It is OK in the corresponding main text (Line 530)

      (80)  Figure S2F, S3G, S4C, S4D: sysm-1::GFP -> Psysm-1::GFP

      (81)  Figure S2G: irg-1::GFP -> Pirg-1::GFP

      (82)  Figure S3H and S3I: Describe which ones are Glu + conditions

      References: 

      (1) Patananan AN, Budenholzer LM, Pedraza ME, Torres ER, Adler LN, Clarke SG. The invertebrate Caenorhabditis elegans biosynthesizes ascorbate. Arch Biochem Biophys 569, 32-44 (2015).

      (2) Yabuta Y_, et al. L-Ascorbate Biosynthesis Involves Carbon Skeleton Rearrangement in the Nematode Caenorhabditis elegans. _Metabolites 10,  (2020).

      (3) Weaver BP, Weaver YM, Omi S, Yuan W, Ewbank JJ, Han M. Non-Canonical Caspase Activity Antagonizes p38 MAPK Stress-Priming Function to Support Development. Dev Cell 53, 358-369 e356 (2020).

      (4) Geng S_, et al. Gut commensal E. coli outer membrane proteins activate the host food digestive system through neural-immune communication. _Cell Host Microbe 30, 1401-1416 e1408 (2022).

      (5)  Richardson CE, Kooistra T, Kim DH. An essential role for XBP-1 in host protection against immune activation in C. elegans. Nature 463, 1092-1095 (2010).

      (6) Harding HP_, et al. An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress. _Molecular Cell 11, 619-633 (2003).

      (7) Qi B, Kniazeva M, Han M. A vitamin-B2-sensing mechanism that regulates gut protease activity to impact animal’s food behavior and growth. eLife 6, e26243 (2017).

      (8) Calfon M_, et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. _Nature 415, 92-96 (2002).

      (9) Bolz DD, Tenor JL, Aballay A. A Conserved PMK-1/p38 MAPK Is Required in Caenorhabditis elegans Tissue-specific Immune Response to Yersinia pestis Infection*. The Journal of Biological Chemistry 285, 10832 - 10840 (2010).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      In Ryu et al., the authors use a cortical mouse astrocyte culture system to address the functional contribution of astrocytes to circadian rhythms in the brain. The authors' starting point is transcriptional output from serum-shocked culture, comparative informatics with existing tools and existing datasets. After fairly routine pathway analyses, they focus on the calcium homeostasis machinery and one gene, Herp, in particular. They argue that Herp is rhythmic at both mRNA and protein levels in astrocytes. They then use a calcium reporter targeted to the ER, mitochondria, or cytosol and show that Herp modulates calcium signaling as a function of circadian time. They argue that this occurs through the regulation of inositol receptors. They claim that the signaling pathway is clock-controlled by a limited examination of Bmal1 knockout astrocytes. Finally, they switch to calcium-mediated phosphorylation of the gap junction protein Connexin 43 but do not directly connect HERP-mediated circadian signaling to these observations. While these experiments address very important questions related to the critical role of astrocytes in regulating circadian signaling, the mechanistic arguments for HERP function, its role in circadian signaling through inositol receptors, the connection to gap junctions, and ultimately, the functional relevance of these findings is only partially substantiated by experimental evidence. 

      Strengths: 

      - The paper provides useful datasets of astrocyte gene expression in circadian time. 

      - Identifies HERP as a rhythmic output of the circadian clock. 

      - Demonstrates the circadian-specific sensitivity of ATP -> calcium signaling. 

      - Identifies possible rhythms in both Connexin 43 phosphorylation and rhythmic movement of calcium between cells. 

      Weaknesses: 

      - It is not immediately clear why the authors chose to focus on Ca2+ homeostasis or Herp from their initial screens as neither were the "most rhythmic" pathways in their primary analyses. 

      We appreciate the reviewer’s comment. We chose to focus on Ca2+ homeostasis processes because intracellular Ca2+ signaling plays crucial role in numerous astrocyte functions and is notably associated with sleep/wake status of animals, which is our primary interest (Bojarskaite et al., 2020; Ingiosi et al., 2020; Blum et al., 2021; Szabó et al., 2017). Among the genes involved in calcium ion homeostasis, Herp exhibited the most robust rhythmicity (supplementary table 1). The rationale for our focus on Ca2+ homeostasis and Herp is explained in the results section (line 143-150). We hope this provides a clear justification for our focus.

      - It would have been interesting (and potentially important) to know whether various methods of cellular synchronization would also render HERP rhythmic (e.g., temperature, forskolin, etc). If Herp is indeed relatively astrocyte-specific and rhythmic, it should be easy to assess its rhythmicity in vivo. 

      Thank you for the reviewer’s insightful comment. In response, we examined HERP expression in cultured astrocytes synchronized using either Dexamethasone or Forskolin treatment. We found that Herp exhibited rhythmic expression at both the the mRNA and protein levels under these conditions. These results have been added to Figure S3 and are explained in the manuscript (lines 173-175).

      Additionally, we measured HERP levels in the prefrontal cortex of mice at CT58 and CT70 and found no rhythmicity, as shown in Author response image 1. Given that Herp is expressed in various brain cell types, including microglia, endothelial cells, neurons, oligodendrocytes, and the astrocytes- with the highest expression in microglia(Cahoy et al., 2008), we reason that the potential rhythmic expression of HERP in astrocytes might be masked by its continuous expression in other cell types. Nonetheless, to assess HERP rhythmicity specifically in astrocytes in vivo, we attempted immunostaining using several anti-HERP antibodies, but none were successful. Consequently, we were unable to determine whether HERP exhibits rhythmic expression in astrocytes in vivo.

      Author response image 1.

      HERP levels were constant at CT58 and CT70. (A, B) Mice were entrained under 12h:12h LD cycle and maintained in constant dark. Prefrontal cortices were harvested at indicated time and processed for Western blot analysis. Representative image shows three independent samples. (B) Quantification of HERP levels normalized to VINCULIN. Values in graphs are mean ± SEM (*p < 0.05, **p < 0.005, ***p < 0.0005, and ****p < 0.00005; t-test)

      - The authors show that Herp suppression reduces ATP-mediated suppression of calcium whereas it initially increases Ca2+ in the cytosol and mitochondria and then suppresses it. The dynamics of the mitochondrial and cytosolic responses are not discussed in any detail and it is unclear what their direct relationship is to Herp-mediated ER signaling. What is the explanation for Herp (which is thought to be ER-specific) to calcium signaling in other organelles? 

      Our examination of cytosolic and mitochondrial Ca2+ responses was aimed at corroborating HERP’s effect on ER Ca2+ response. Upon ATP stimulation, Ca2+ is released from the ER via IP3R receptors (IP3Rs) and subsequently transmitted to other organelles including mitochondria (Carreras-Sureda et al., 2018; Giorgi et al., 2018). Ca2+ is directly transferred to the cytosol by IP3Rs located on the ER membrane, and to the mitochondria through a complex formed by IP3R and the voltage-dependent anion channel (VDAC) on the mitochondria (Giorgi et al., 2018).  Consistent with previous reports, we observed an increase of cytosolic and mitochondrial Ca2+ levels accompanied by decrease in ER Ca2+ levels following ATP treatment (See Fig. 3B, E, H, control siRNA). The ATP-stimulated ER Ca2+ release was enhanced by Herp knockdown. We reasoned that if Ca2+ release was enhanced, then cytosolic and mitochondrial Ca2+ uptakes would also be enhanced. The results were consistent with our hypothesis (See Fig. 3B, E, H, Herp siRNA). These observations are described in the Results section (lines 202-208) and in the Discussion (lines 333-348). We hope this explanation clarifies the relationship between Herp-mediated ER Ca2+ response and Ca2+ response in other organelles. Thank you for your consideration.

      - What is the functional significance of promoting ATP-mediated suppression of calcium in ER? 

      In astrocytes, intracellular Ca2+ plays crucial role in regulating several processes. In this study, among various downstream effects of intracellular Ca2+, we examined the gap junction channel (GJC) conductance, which affects astrocytic communication. As discussed in the manuscript (lines 357-381), circadian variation in HERP results in rhythmic Cx43 (S368) phosphorylation linked with GJC conductance. We propose that during the subjective night phase, heightened ATP induced ER Ca2+ release reduces GJC conductance, uncoupling astrocytes from the syncytium, making them better equipped for localized response. On the other hand, during the subjective day phase, increased GJC conductance may allow astrocytes to control a larger area for synchronous neuronal activity which is a key feature of sleep.

      - The authors then nicely show that the effect of ATP is dependent on intrinsic circadian timing but do not explain why these effects are antiphase in cytosol or mitochondria.

      Moreover, the ∆F/F for calcium in mitochondria and cytosol both rise, cross the abscissa, and then diminish - strongly suggesting a biphasic signaling event. Therefore, one wonders whether measuring the area under the curve is the most functionally relevant measurement of the change. 

      We appreciate the reviewer’s insightful comments. As explained in our previous response, Ca2+ released from the ER is transferred to the cytosol and mitochondria. This transfer explains why the fluorescent intensities of cytosolic and mitochondrial Ca2+ indicators show anti-phasic responses to those of the ER.

      We agree that cytosolic and mitochondrial Ca2+ responses may be biphasic. The decrease below the abscissa in mitochondria and cytosol likely reflects Ca2+ extrusion from these organelles. However, our primary focus was on the initial uptake of Ca2+ following ER Ca2+ release. Thus, when calculating the area under the curve (AUC), we measured the area between the ∆F/F graph and the y=0 (X-axis) for both mitochondria and cytosol. We reason that the measuring the area under the curve (above the abscissa) fits with our objective.

      While addressing your concerns, we noticed errors in the Y-axis labels of Fig. 3C, 4D, and 5C. For the ER Ca2+ dynamics, we measured the area above curve. These mistakes have now been corrected.

      - Why are mitochondrial and cytosolic calcium not also demonstrated for Bmal1 KO astrocytes? 

      In two sets of experiments (Fig. 3 and Fig. 4), we demonstrated that the increase in cytosolic and mitochondrial Ca2+ aligns with ER Ca2+ release. Since there were no circadian time differences in ER Ca2+ release in the Bmal1 KO cultures, we concluded that it was unnecessary to measure Ca2+ levels in the mitochondria and cytosol. Additionally, our primary focus is on the ER Ca2+ response rather than the Ca2+ dynamics in subcellular organelles. We hope this clarifies our rationale and maintains the focus of our study.

      - The authors claim that Herp acts by regulating the degradation of ITPRs but this hypothesis - rather central to the mechanisms proposed in this study - is not experimentally substantiated. 

      We appreciate the reviewer’s insightful comments regarding the role of HERP in the degradation of IP3Rs. In the original manuscript, we demonstrated that treating cells with Herp siRNA leads to an increase in the levels of ITPR1 and ITPR2, suggesting that HERP might be involved in the regulation of IP3Rs stability. This observation is consistent with previous studies, which showed that Herp siRNA treatment increases ITPR levels in HeLa and cardiac cells (Paredes et al., 2016; Torrealba et al., 2017). Torrealba et al. also showed that HERP regulates the polyubiquitination of IP3Rs. Based on our results and previous reports, we hypothesized that HERP similarly regulates ITPR degradation in cultured astrocytes.

      However, as the reviewer rightly pointed out, further evidence is needed to confirm that HERP specifically regulates ITPR degradation. To address this, we conducted new experiments examining the effect of XesC, an inhibitor of IP3Rs, on ER Ca2+ release. The treatment of XesC reduced the ER Ca2+ release and abolished the enhancement of ER Ca2+ release by Herp KD. These results demonstrated that HERP influences ER Ca2+ response through IP3Rs. These new findings have been added to Fig. 3N – 3P and explained in the Results section (lines 217-221).

      We believe these additional experiments and clarifications strengthen our hypothesis that HERP regulates IP3R degradation, thereby modulating ER Ca2+ responses.

      - There is no clear demonstration of the functional relevance of the circadian rhythms of ATP-mediated calcium signaling.

      As mentioned in the previous response, we examined Cx43 phosphorylation linked with GJC conductance in the context of ATP-mediated Ca2+ signaling. Our results demonstrated circadian variations in Cx43 Ser368 phosphorylation leading to variations of gap junction channel (GJC) conductance (Fig. 6C – F and Fig. 7D - I). We have discussed the significance of this circadian rhythm in ATP driven ER Ca2+ signaling concerning astrocytic function during sleep/wake states in the manuscript (lines 357 – 382) as follows.

      “ATP-stimulated Cx43 (S368) phosphorylation is higher at 30hr (subjective night phase) than at 42hr (subjective day phase) (Fig. 6C and 6D.), a finding further supported by in vivo experiments showing higher pCx43(S368) levels in the prefrontal cortex during the subjective night than during the day (Fig. 6E and 6F). What are the implications of this day/night variation in Cx43 (S368) phosphorylation? We reasoned that the circadian variation in Cx43 phosphorylation could significantly impact astrocyte functionality within the syncytium. Indeed, our cultured astrocytes exhibited circadian phase-dependent variation in gap junctional communication (Fig.7D – 7F). Astrocytes influence synaptic activity through the release of gliotransmitters such as glutamate, GABA, D-serine, and ATP, triggered by increases in intracellular Ca2+ in response to the activity of adjacent neurons and astrocytes (Verkhratsky & Nedergaard, 2018). Importantly, this increase in Ca2+ spreads to adjacent astrocytes through GJCs (Fujii et al., 2017), influencing a large area of the neuronal network. Considering that Cx43 Ser368 phosphorylation occurs to uncouple specific pathways in the astrocytic syncytium to focus local responses (Enkvist & McCarthy, 1992), our findings suggest that astrocytes better equipped for localized responses when presented with a stimulus during the active phase in mice. Conversely, during the rest period, characterized by more synchronous neuronal activity across broad brain areas (Vyazovskiy et al., 2009) higher GJC conductance might allow astrocytes to exert control over a larger area. In support of this idea, recent study showed that synchronized astrocytic Ca2+ activity advances the slow wave activity (SWA) of the brain, a key feature of non-REM sleep (Szabó et al., 2017). Blocking GJC was found to reduce SWA, further supporting this interpretation. However, conflicting findings have also been reported. For instance, Ingiosi et al. (Ingiosi et al., 2020) found that astrocytic synchrony was higher during wakefulness than sleep in the mouse frontal cortex. Whether these differing results in astrocyte synchrony during resting and active periods are attributable to differences in experimental context (e.g., brain regions, sleep-inducing condition) remains unclear. Indeed, astrocyte Ca2+ dynamics during wakefulness/sleep vary according to brain regions (Tsunematsu et al., 2021). While the extent of astrocyte synchrony might differ depending on brain region and/or stimulus, on our results suggest that the baseline state of astrocyte synchrony, which is affected by GJC conductance, varies with the day/night cycle.”

      Reviewer #2 (Public Review): 

      Summary: 

      The article entitled "Circadian regulation of endoplasmic reticulum calcium response in mouse cultured astrocytes" submitted by Ryu and colleagues describes the circadian control of astrocytic intracellular calcium levels in vitro. 

      Strengths: 

      The authors used a variety of technical approaches that are appropriate 

      We appreciate the reviewer’s acknowledgement of the strengths of our manuscript.

      Weaknesses: 

      Statistical analysis is poor and could lead to a misinterpretation of the data 

      Thank you for the comment. We have carefully reviewed our statistical analyses and applied appropriate methods where necessary. Please see below for the specific revisions and improvements made.

      For Fig. 2D-E, we initially used a t-test. However, after adding more replicates and conducting a normality test, we found that the data did not follow a normal distribution. Therefore, we switched to the Mann-Whitney U test. In Fig. 5D-E, we originally used a repeated measures two-way ANOVA, but we have now changed it to a standard two-way ANOVA. For Fig. 7C and I, we also observed non-normal distribution in the normality test and consequently replaced the t-test with the Mann-Whitney U test. For other analyses not specifically mentioned, normality tests confirmed normal distribution, allowing us to use t-tests or ANOVA as appropriate for statistical analysis.

      Several conceptual issues have been identified. 

      We have addressed the reviewer’s concerns. Please see our detailed point-by-point responses below.

      Overinterpretation of the data should be avoided. This is a mechanistic paper done completely in vitro, all references to the in vivo situation are speculative and should be avoided. 

      We appreciate the reviewer’s insightful comment. Following the reviewer’s suggestion, we have removed the interpretations of GO pathways in the context of in vivo situation.

      Reviewer #3 (Public Review): 

      Astrocyte biology is an active area of research and this study is timely and adds to a growing body of literature in the field. The RNA-seq, Herp expression, and Ca2+ release data across wild-type, Bmal1 knockout, and Herp knockdown cellular models are robust and lend considerable support to the study's conclusions, highlighting their importance. Despite these strengths, the manuscript presents a gap in elucidating the dynamics of HERP and the involvement of ITPR1/2 in modulating Ca2+ release patterns and their circadian variations, which remains insufficiently supported and characterized. While the Connexin data underscore the importance of rhythmic Ca2+ release triggered by ATP, the relationship here appears correlational and the role of HERP and ITPR in Cx function remains to be characterized. Moreover, enhancing the manuscript's clarity and readability could significantly benefit the presentation and comprehension of the findings. 

      We appreciate the reviewer’s acknowledgement of the strengths of our manuscript. Regarding the identified gaps, we have conducted several new experiments to clearly demonstrate the HERP-ITPR-Cx phosphorylation axis. Please see our detailed point-by-point responses below.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      - While HERP appears to be a clock-controlled gene and its protein levels appear to demonstrate rhythmicity as well, the data quality of the western blotting in Bmal1 knockout raises some concern about the accuracy of HERP protein quantification. 

      We understand the reviewer’s concern regarding the proximity of the HERP band to a nonspecific band in the Western blotting for the Bmal1 knockout. However, we took great care to ensure the accuracy of our HERP band quantification. We meticulously selected only the specific HERP band, excluding nonspecific band. Therefore, we are confident in the accuracy of our HERP protein measurements.

      - If HERP is rhythmic and ITPRs are not, if their model is correct, might we expect HERP suppression to result in 'unmasking' an ITPR rhythm? 

      Our model suggests that both HERP and ITPRs are rhythmic, with HERP regulating the degradation of ITPR proteins and driving their rhythms. Consistent with this, we observed that day/night variations in ITPR2 levels (Fig. 4N and 4O). Therefore, we concluded that circadian variations in HERP are sufficient to drive ITPR2 rhythms. We have explained this in detail in the Result section (lines 236-241) and the Discussion section (lines 324-332).

      - The authors make a rather abrupt switch to examining gap junctions and connexin 43 phosphorylation. While the data demonstrating that the phosphorylation of S368 may indeed be rhythmic - the authors do not connect these data to the rest of the manuscript by showing a connection to HERP-mediated calcium signaling, limiting the coherence of the narrative. 

      Thank you for the reviewer’s insightful comments. To address the reviewer's concern regarding the connection between Herp and the phosphorylation of CX43 at S368, we have conducted new experiments to test whether KD of Herp abolishes the rhythms of Cx43 phosphorylation at S368. We found that the phosphorylation of Cx43 at S368 is significantly enhanced at 30hrs post sync compared with 42hrs post sync in control siRNA-treated astrocytes consistent with our previous results (Fig. 6C & 6D). On the other hand, this circadian phase dependent difference in phosphorylation was abolished in Herp siRNA treated astrocytes. These results clearly indicate that circadian variations in Cx43 phosphorylation are driven by the HERP. These new results are now included in Fig. 6G and 6H and explained in the Results section (lines 276-281).

      - Comment on data presentation: the authors repeatedly present histograms with attached lines between data points - from my understanding of the experiments, this is inappropriate unless these were repeated measures from the same cells. Otherwise, the lines connecting one data point to another between different conditions (e.g., Ctrl or Herp knockdown) are arbitrary and possibly misleading (i.e., Figure 3K, 3M, 4L, 6D). 

      Thank you for the reviewer’s comment. We have updated the figures by removing the lines connecting data points in the relevant figures (Fig.3K, M, Fig4.N and Fig.6D)).

      Reviewer #2 (Recommendations For The Authors): 

      Most of the suggestions of this reviewer are related to the conceptual interpretation and presentation of the data and to the statistical analysis 

      In Figure 1 the authors analyzed the rhythmic transcriptome of cortical astrocytes synchronized with a serum shock in two different ways. The authors need to discuss what is the difference between the two methods used to detect rhythmic transcripts and make sense of them. 

      Following the reviewer’s suggestion, we have provided a more detailed explanation about MetaCycle and BioCycle, as well as the rationale for using both packages in our analysis as follows: “Various methods have been used to identify periodicity in time-series data, such as Lomb-Scargle (Glynn et al., 2006), JTK_CYCLE (Hughes et al., 2010) and ARSER (Yang & Su, 2010), each with distinct advantages and limitations. MetaCycle, integrates these three methods, facilitating the evaluation of periodicity in time-series data without requiring the selection of an optimal algorithm (Wu et al., 2016). Additionally, BioCycle has been developed using a deep neural network trained with extensive synthetic and biological time series datasets (Agostinelli et al., 2016). Because MetaCycle and Biocycle identify periodic signal based on different algorithms, we applied both packages to identify periodicity in our time-series transcriptome data. BioCycle and MetaCycle analyses detected 321 and 311 periodic transcripts, respectively (FDR corrected, q-value < 0.05) (Fig. 1B). Among these, 220 (53.4%) were detected by both methods, but many transcripts did not overlap. MetaCycle is known for its inability to detect asymmetric waveforms (Mei et al., 2020). In our analysis, genes with increasing waveforms like Adora1 and Mybph were identified as rhythmic only by BioCycle, while Plat and Il34 were identified as rhythmic only by MetaCycle (Fig. S1C). Despite these discrepancies, the clear circadian rhythmic expression profiles of these genes led us to conclude that using the union of the two lists compensates for the limitations of each algorithm.”

      Please refer to lines 105-117 in the Results section.

      The reasoning for comparing CT0 with the phase of the clock 8 hs after SS needs to be explained. Circadian time (CT) conceptually refers to the clock phase in the absence of entrainment cues in vivo, the direct transformation of "time after synchronization" in vitro to CT is misleading. 

      Thank you for the reviewer’s insightful comments. Initially, we believed that transforming TASS to CT, despite being in vitro data, might provide a more intuitive and physiologically relevant interpretation of our results. However, we agree that this approach might be misleading. Following the reviewer’s suggestion, we have revised our terminology by changing “CT” to “Time post sync (hr)”. Nonetheless, in Fig. 1F for circular peak phase map, we set 8hrs post sync to ZT0 based on a phase comparison result in Fig. 1D for physiologically relevant interpretation. We hope these revisions clarify our approach.

      Moreover, also by definition a CT cannot be defined in terms of "dark" or "light". Figure 6M needs to be changed. 

      Following the reviewer’s suggestion, we removed the labels CT22 and CT34. Instead. we have labeled the respective periods as “30hr post sync” and “42hr post sync”.

      In Figure 1D, the authors present a gene ontology analysis that is certainly interesting, however, it should not be overinterpreted when trying to explain processes that take place only in vivo (e.g. wound repair). 

      Thank you for the insightful comment. Following the reviewer’s feedback, we have removed the paragraph interpreting the cell migration process in relation to wound repair and have focused instead on Ca2+ ion homeostasis.

      In Figure 2A the relative expression of clock genes and Herp is again misleading by a white/grey shading indicating subjective night and subjective day when the system under study is a cell culture. 

      We understand the reviewer’s concern that a cell culture system is not equivalent to light/dark entrainment condition. However, we apply time-synchronizing stimuli to recapitulate in vivo entrainment. In addition, by comparing our data with CircaDB, we defined 8hrs post sync as corresponding to ZT0, thus aligning it with the beginning of the day. We have retained the shading to facilitate easier interpretation of our data in relation to in vivo situations. However, in response to the reviewer’s concern, we have revised the shading from white/grey to light grey/dark grey. We hope this adjustment addresses the reviewer’s concern, but if the reviewer still believes it is inappropriate, please let us know, we will gladly update it.

      In the Figure 2A legend, it is indicated that rhythmicity is assessed using MetaCycle with mean values obtained from n=2. The authors need to make clear whether this n=2 mean: 2 biological replicates or 2 technical replicates. This difference is relevant because it would make the analysis statistically valid or invalid, respectively. 

      Thank you for your feedback. n=2 refers to 2 biological replicates. Therefore, the analysis is statistically valid.

      In Figures 2C and D the authors applied a T-test, a parametric statistical test for one-to-one comparison that requires normality distribution of the data to be tested first. To test normality, the authors need at least 4 biological replicates. The suggestion of this reviewer is that these experiments have to be repeated and proper statistics applied. 

      Thank you for your feedback. In response to the reviewer's suggestion, we conducted additional experiments to increase the number of biological replicates to 4. After verifying the normality of the data, we applied a t-test for Figure 2C and a Mann-Whitney test for Figure 2D and 2E. These tests confirmed significant statistical difference between groups.

      Further evidence of Bmal1-dependent control of HERP circadian expression authors could check the presence of E-Box elements in the Herp promoter. 

      Thank you for the reviewer’s insightful comment. In the original version of our manuscript's Discussion section, we mentioned the absence of a canonical E-Box in the upstream of Herp gene. However, following the reviewer’s suggestion and considering the potential role of non-canonical E-Boxes, we conducted an additional analysis. This analysis identified several non-canonical E-Boxes within the 6 kb upstream region of the Herp gene (Table S2). Notably, we found one non-canonical E-Box, “CACGTT,” known to regulate circadian expression (Yoo et al., 2005) is close to the transcription start site (chr8:94386194-94386543). Moreover, this element is evolutionarily conserved across various mammals, including humans, rats, mice, dogs, and opossums (See Author response image 2). Therefore, we reasoned that these non-canonical E boxes might drive the CLOCK/BMAL1 dependent expression of Herp. We have updated the Discussion to reflect these findings in lines 315-319.

      Author response image 2.

      The calcium experiments shown in Figures 3A-I, could be more convincing if the authors showed that the different Ca2+ sensors are compartment-specific by showing co-localization with a subcellular marker. In the pictures shown it is not even possible to recognize the cell dimensions. 

      Following the reviewer’s suggestion, we performed co-staining experiments with organelle specific Ca2+ indicators and organelle markers. First, astrocytes were co-transfected with G-CEPIA1er, an ER specific Ca2+ indicator and ER targeted DsRed2 (with Calreticulin signal sequence). Live imaging analysis showed that the fluorescent intensities of G-CEPIA1er and DsRed2-ER-5 significantly overlapped in co-transfected cells. Secondly, astrocytes were transfected with Mito-R-GECO1 and Mitotracker, a cell permeable mitochondria dye, was applied. The fluorescent intensities of Mito-R-GECO1 and Mitotracker also significantly overlapped. These new data are included in Figure S4 and explained in the Result section (lines 194-195).

      Data analysis in Figure 3 K and M is misleading. According to the explanations of the results, each of the experiments to assess ITRP1 or 2 is run independently. Then it is not clear why the relative levels obtained with control or Herp siRNA are plotted as pairs. Same comment as above for Figure 4L and Figure 6D. 

      Thank you for the reviewer’s insightful comments. Reviewer1 raised similar issues. Following the reviewers’ suggestions, we have removed the lines connecting the data points in Fig. 3K, 3M, 4L, and 6D.

      In Figure 5E the authors need to explain why they consider that repeated measures 2-way ANOVA is the right statistical test to apply. According to the explained experimental design, cells transfected, synchronized, and then harvested independently at the indicated time after synchronization. 

      Thank you for the reviewer’s insightful comment. Upon reviewing the statistical methods as suggested, we have revised our approach. Instead of using repeated measures 2-way ANOVA, we have now applied a standard 2-way ANOVA, which is more appropriate given the experimental procedures were independent, as the reviewer pointed out.

      The English language needs to be revised throughout the text. 

      We have thoroughly revised the English language throughout the text.

      Reviewer #3 (Recommendations For The Authors): 

      (1) Figure 3. Clarify the physiological importance of 100 µM ATP. Would the Herp rhythm warrant Ca2+ release rhythms under basal conditions? In 3J-K, the relatively weak effect of Herp knockdown on ITPR1/2 levels, albeit statistically significant, may not be physiologically significant. This calls into question the claimed Herp-ITPR axis that underlies the Ca2+ release phenotype. Further, the correlation certainly exists but further characterization of Herp KD cells would be required to address the mechanism. 

      As previously reported, a broad range of ATP concentrations can induce Ca2+ activity in the astrocytes (Neary et al., 1988). Originally, we conducted an ATP dose-response analysis to observe ER Ca2+ release in our primary astrocyte culture. Our results show that ER Ca2+ release begins at 50 µM ATP and plateaus at 500 µM. Please refer to Author response image 3. We selected 100µM ATP for our experiments because it induces a medium level of ER Ca2+ response. Importantly, although measuring ATP concentrations at the synapse in vivo is challenging(Tan et al., 2017), estimates suggest synaptic ATP concentrations range from 5-500 µM (Pankratov et al., 2006). Thus, 100µM ATP is a physiologically relevant concentration that can affect nearby cells, including astrocytes, in the nervous system.

      Author response image 3.

      Cultured astrocytes were transfected with G-CEPIA1er ER and at 48hrs post transfection, cultured astrocytes were treated with various concentrations of ATP and Ca2+ imaging analysis was performed. (A) ΔF/F0 values over time following ATP application. (B) Area above curve values. Values in graphs are mean ± SEM (*p < 0.05, **p < 0.005, ***p < 0.0005, and ****p < 0.00005; one-way ANOVA).

      Regarding the comment on Ca2+ release rhythms under basal conditions, we interpret this as referring Ca2+ release in the absence of a stimulus. We typically observe Ca2+ release only upon stimulation, such as ATP treatment. However, we acknowledge that the modest effects of HERP knockdown on ITPR1/2 levels could question the HERP-ITPR axis’s role in ER Ca2+ release.

      To address this, we analyzed whether Herp KD induced increases in ER Ca2+ release were mediated through ITPRs by treating cells with Xestospongin C (XesC), an IP3R inhibitor. XesC treatment reduced ATP-induced ER Ca2+ release and eliminated the differences in ER Ca2+ release between control and Herp KD astrocytes (Fig. 3N – 3P). These results clearly indicate that HERP-ITPR axis plays critical role in controlling ER Ca2+ release. These new experiments have been included in Fig. 3 and explained in the result section (lines 217-221).

      Furthermore, following the reviewer’s suggestion, we examined whether HERP rhythms underlie the rhythms of ER Ca2+ response by analyzing ER Ca2+ response in Herp KD astrocyte in two different times following synchronization. In control astrocytes, ATP-induced ER Ca2+ responses vary depending on time, whereas these time-dependent variations were abolished in Herp KD astrocytes. These new experiments have been included in Fig. 4K – 4M and explained in the Results section (lines 232-235).

      Collectively, these results indicate that HERP rhythms lead to time-dependent differences in ER Ca2+ response through ITPRs.

      (2) Figure 4K-L. As data suggested the involvement of ITPR1 and ITPR2 (circadian effect), a reasonable next step is to determine their involvement, but the study did not pursue the hypothesis. 

      Thank you for your insightful comment. Our results indeed suggest that rhythms in ITPR2 levels may drive the time-dependent variations in ATP-induced ER Ca2+ release following synchronization. The newly conducted experiments demonstrated that treatment with the ITPR inhibitor XesC suppressed ATP-induced ER Ca2+ release at both control and Herp siRNA treatment conditions (Fig. 3). Based on these findings, we now further confirm that rhythms of ITPR levels, specifically ITPR2 underlie the circadian variations in ER Ca2+ release. While examining the effect of ITPR2 siRNA would directly prove the involvement of ITPR2, we have decided to pursue this experiment in the future studies.

      (3) Figure 5A-C. Data from WT cells should be included side by side with Bmal1-/- cells for comparison which is expected to be consistent with the HERP levels as in 5D-E. Again, the role of ITPR2 is suggested but not demonstrated. 

      Following the reviewer's suggestion, we conducted additional experiments including both WT and Bmal1-/- cultured astrocytes side-by-side. The results were consistent with our previous findings: WT astrocytes showed rhythms of ER Ca2+ release while Bmal1-/- astrocytes did not. We have updated the Figure 5A to 5C and the corresponding Results section in lines 242-245 accordingly.<br /> Regarding second comment, as mentioned in our previous response, we plan to examine the role of ITPR2 in further studies.

      (4) Figure 6. The Connexin data seems an addon and is correlative with the Ca2+ release. The role of Herp and Itpr in Connexin function is not addressed. Figure 6E-F was not called out in the results section. Suggest providing additional data to support the role of the HERP-ITPR axis in regulating Ca2+ release and Connexin activity. 

      We agree that additional data are needed to support the role of HERP in regulating CX43 phosphorylation. Therefore, we have conducted further experiments to determine whether rhythms of Cx43 phosphorylation are regulated by HERP. In the control astrocytes, ATP treatment induced time-dependent variations in Cx43 phosphorylation. However, these rhythms were abolished in Herp KD astrocytes. These results indicate that rhythms in HERP levels contribute to the time-dependent variations in Cx43 phosphorylation. These new experiments have included in Fig. 6G and 6H and explained in the results section (lines 276-281).

      Regarding second comment, we have corrected our oversight by properly referencing figures 6E-F in the results section. Please refer to lines 357-359 for clarification.

      (5) Discussion. This section should focus on noteworthy points to discuss, not repeating the results. 

      Based on the reviewer's valuable suggestions, we have revised the Discussion section to minimize repetition of the results. Thank you for your guidance.

      (6) The manuscript exhibits numerous grammatical and textual inaccuracies that necessitate careful revision by the authors. My observations here are confined to the title and the abstract alone. I recommend altering the title from "mouse cultured astrocytes" to "cultured mouse astrocytes" for clarity and grammatical correctness. The abstract, meanwhile, needs enhancements both in terms of its content and language. It should incorporate the results of the partitioning among the ER, cytoplasm, and mitochondria, and provide clear definitions for some of the critical terms used. It's worth noting that the abstract's second sentence contains a grammatical error. 

      Thank you for the reviewer’s valuable feedback. We have carefully revised the title, abstract, and main text to address the grammatical and textual issues. The title has been changed to “cultured mouse astrocytes”. Additionally, the abstract now includes results related to cytoplasmic Ca2+ dynamics and has been revised in several places. We appreciate your insights and have worked to enhance the content and language accordingly.

      Reference

      Agostinelli, F., Ceglia, N., Shahbaba, B., Sassone-Corsi, P., & Baldi, P. (2016). What time is it? Deep learning approaches for circadian rhythms. Bioinformatics, 32(12), i8-i17. https://doi.org/10.1093/bioinformatics/btw243

      Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., Thompson, W. J., & Barres, B. A. (2008). A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci, 28(1), 264-278. https://doi.org/10.1523/JNEUROSCI.4178-07.2008

      Carreras-Sureda, A., Pihán, P., & Hetz, C. (2018). Calcium signaling at the endoplasmic reticulum: fine-tuning stress responses. Cell Calcium, 70, 24-31. https://doi.org/10.1016/j.ceca.2017.08.004

      Enkvist, M. O., & McCarthy, K. D. (1992). Activation of protein kinase C blocks astroglial gap junction communication and inhibits the spread of calcium waves. J Neurochem, 59(2), 519-526. https://doi.org/10.1111/j.1471-4159.1992.tb09401.x

      Fujii, Y., Maekawa, S., & Morita, M. (2017). Astrocyte calcium waves propagate proximally by gap junction and distally by extracellular diffusion of ATP released from volume-regulated anion channels. Scientific Reports, 7(1), 13115. https://doi.org/10.1038/s41598-017-13243-0

      Giorgi, C., Marchi, S., & Pinton, P. (2018). The machineries, regulation and cellular functions of mitochondrial calcium. Nature Reviews Molecular Cell Biology, 19(11), 713-730. https://doi.org/10.1038/s41580-018-0052-8

      Glynn, E. F., Chen, J., & Mushegian, A. R. (2006). Detecting periodic patterns in unevenly spaced gene expression time series using Lomb-Scargle periodograms. Bioinformatics, 22(3), 310-316. https://doi.org/10.1093/bioinformatics/bti789

      Hughes, M. E., Hogenesch, J. B., & Kornacker, K. (2010). JTK_CYCLE: an efficient nonparametric algorithm for detecting rhythmic components in genome-scale data sets. J Biol Rhythms, 25(5), 372-380. https://doi.org/10.1177/0748730410379711

      Ingiosi, A. M., Hayworth, C. R., Harvey, D. O., Singletary, K. G., Rempe, M. J., Wisor, J. P., & Frank, M. G. (2020). A Role for Astroglial Calcium in Mammalian Sleep and Sleep Regulation. Curr Biol, 30(22), 4373-4383.e4377. https://doi.org/10.1016/j.cub.2020.08.052

      Mei, W., Jiang, Z., Chen, Y., Chen, L., Sancar, A., & Jiang, Y. (2020). Genome-wide circadian rhythm detection methods: systematic evaluations and practical guidelines. Briefings in Bioinformatics, 22(3). https://doi.org/10.1093/bib/bbaa135

      Neary, J. T., van Breemen, C., Forster, E., Norenberg, L. O., & Norenberg, M. D. (1988). ATP stimulates calcium influx in primary astrocyte cultures. Biochem Biophys Res Commun, 157(3), 1410-1416. https://doi.org/10.1016/s0006-291x(88)81032-5

      Pankratov, Y., Lalo, U., Verkhratsky, A., & North, R. A. (2006). Vesicular release of ATP at central synapses. Pflugers Arch, 452(5), 589-597. https://doi.org/10.1007/s00424-006-0061-x

      Paredes, F., Parra, V., Torrealba, N., Navarro-Marquez, M., Gatica, D., Bravo-Sagua, R., Troncoso, R., Pennanen, C., Quiroga, C., Chiong, M., Caesar, C., Taylor, W. R., Molgó, J., San Martin, A., Jaimovich, E., & Lavandero, S. (2016). HERPUD1 protects against oxidative stress-induced apoptosis through downregulation of the inositol 1,4,5-trisphosphate receptor. Free Radic Biol Med, 90, 206-218. https://doi.org/10.1016/j.freeradbiomed.2015.11.024

      Szabó, Z., Héja, L., Szalay, G., Kékesi, O., Füredi, A., Szebényi, K., Dobolyi, Á., Orbán, T. I., Kolacsek, O., Tompa, T., Miskolczy, Z., Biczók, L., Rózsa, B., Sarkadi, B., & Kardos, J. (2017). Extensive astrocyte synchronization advances neuronal coupling in slow wave activity in vivo. Scientific Reports, 7(1), 6018. https://doi.org/10.1038/s41598-017-06073-7

      Tan, Z., Liu, Y., Xi, W., Lou, H. F., Zhu, L., Guo, Z., Mei, L., & Duan, S. (2017). Glia-derived ATP inversely regulates excitability of pyramidal and CCK-positive neurons. Nat Commun, 8, 13772. https://doi.org/10.1038/ncomms13772

      Torrealba, N., Navarro-Marquez, M., Garrido, V., Pedrozo, Z., Romero, D., Eura, Y., Villalobos, E., Roa, J. C., Chiong, M., Kokame, K., & Lavandero, S. (2017). Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradation. Sci Rep, 7(1), 13402. https://doi.org/10.1038/s41598-017-13797-z

      Tsunematsu, T., Sakata, S., Sanagi, T., Tanaka, K. F., & Matsui, K. (2021). Region-specific and state-dependent astrocyte Ca<sup>2+</sup> dynamics during the sleep-wake cycle in mice. The Journal of Neuroscience, JN-RM-2912-2920. https://doi.org/10.1523/jneurosci.2912-20.2021

      Verkhratsky, A., & Nedergaard, M. (2018). Physiology of Astroglia. Physiol Rev, 98(1), 239-389. https://doi.org/10.1152/physrev.00042.2016

      Vyazovskiy, V. V., Olcese, U., Lazimy, Y. M., Faraguna, U., Esser, S. K., Williams, J. C., Cirelli, C., & Tononi, G. (2009). Cortical firing and sleep homeostasis. Neuron, 63(6), 865-878. https://doi.org/10.1016/j.neuron.2009.08.024

      Wu, G., Anafi, R. C., Hughes, M. E., Kornacker, K., & Hogenesch, J. B. (2016). MetaCycle: an integrated R package to evaluate periodicity in large scale data. Bioinformatics, 32(21), 3351-3353. https://doi.org/10.1093/bioinformatics/btw405

      Yang, R., & Su, Z. (2010). Analyzing circadian expression data by harmonic regression based on autoregressive spectral estimation. Bioinformatics, 26(12), i168-174. https://doi.org/10.1093/bioinformatics/btq189

      Yoo, S. H., Ko, C. H., Lowrey, P. L., Buhr, E. D., Song, E. J., Chang, S., Yoo, O. J., Yamazaki, S., Lee, C., & Takahashi, J. S. (2005). A noncanonical E-box enhancer drives mouse Period2 circadian oscillations in vivo. Proc Natl Acad Sci U S A, 102(7), 2608-2613. https://doi.org/10.1073/pnas.0409763102

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Yang, Hu et al. examined the molecular mechanisms underlying astrocyte activation and its implications for multiple sclerosis. This study shows that the glycolytic enzyme PKM2 relocates to astrocyte nuclei upon activation in EAE mice. Inhibiting PKM2's nuclear import reduces astrocyte activation, as evidenced by decreased proliferation, glycolysis, and inflammatory cytokine release. Crucially, the study identifies TRIM21 as pivotal in regulating PKM2 nuclear import via ubiquitination. TRIM21 interacts with PKM2, promoting its nuclear translocation and enhancing its activity, affecting multiple signaling pathways. Confirmatory analyses using single-cell RNA sequencing and immunofluorescence demonstrate TRIM21 upregulation in EAE astrocytes. Modulating TRIM21 expression in primary astrocytes impacts PKM2-dependent glycolysis and proliferation. In vivo experiments targeting this mechanism effectively mitigate disease severity, CNS inflammation, and demyelination in EAE.

      The authors supported their claims with various experimental approaches, however, some results should be supported with higher-quality images clearly depicting the conclusions and additional quantitative analyses of Western blots.

      Thanks for the reviewer’s comments. We agree with the reviewer and have added higher magnification images, for example Fig.2A to better visualize the localization of PKM2 in DASA-treated conditions, and Fig. 3A and Fig.3B to better visualize the pSTAT3 and pp65. Moreover, we have added quantitative analyses of Western blots for some key experiments, for example quantitative results for Fig.2D is added in Fig.S3 to show the change of PKM2 and p-c-myc in DASA-58-treated conditions and quantitative results for Fig. 3D are added in Fig.S4B and S4C to show the change of nuclear and cytoplasmic PKM2, STAT3 and NF-κB in different conditions.

      Strength:

      This study presents a comprehensive investigation into the function and molecular mechanism of metabolic reprogramming in the activation of astrocytes, a critical aspect of various neurological diseases, especially multiple sclerosis. The study uses the EAE mouse model, which closely resembles MS. This makes the results relevant and potentially translational. The research clarifies how TRIM21 regulates the nuclear import of PKM2 through ubiquitination by integrating advanced techniques. Targeting this axis may have therapeutic benefits since lentiviral vector-mediated knockdown of TRIM21 in vivo significantly reduces disease severity, CNS inflammation, and demyelination in EAE animals.

      We thank the reviewer for their positive and constructive comments on the manuscript.

      Weaknesses:

      The authors reported that PKM2 levels are elevated in the nucleus of astrocytes at different EAE phases compared to cytoplasmic localization. However, Figure 1 also shows elevated cytoplasmic expression of PKM2. The authors should clarify the nuclear localization of PKM2 by providing zoomed-in images. An explanation for the increased cytoplasmic PKM2 expression should provided. Similarly, while PKM2 translocation is inhibited by DASA-58, in addition to its nuclear localization, a decrease in the cytoplasmic localization of PKM2 is also observed. This situation brings to mind the possibility of a degradation mechanism being involved when its nuclear translocation of PKM2 is inhibited.

      According to the results of immunofluorescence staining of PKM2 in spinal cord of EAE mice and in cultured primary astrocytes, in addition to the observation of PKM2 nuclear translocation in EAE conditions, we showed an elevated expression of PKM2 in astrocytes, including the cytoplasmic and nuclear expression. In neurological diseases, various studies showed consistent results, for example, following spinal cord injury (SCI), not only the upregulated expressing of PKM2 but also nuclear translocation was observed in astrocytes (Zhang et al., 2015). In EAE conditions, CNS inflammation is elevated and several proinflammatory cytokines and chemokines might contribute to the upregulated expression of PKM2 in astrocytes. We have tested TNFα and IL-1β, which are recognized to play important roles in EAE and MS (Lin and Edelson, 2017, Wheeler et al., 2020), and results from western blots showed the increased expression of PKM2 upon stimulation with TNFα and IL-1β (Author response image 1). Moreover, according to the reviewer’s suggestions, we have added zoomed-in images for figure 2A.

      Additionally, the reviewer has noted the decrease in the cytoplasmic PKM2 level, degradation-related mechanism and other mechanisms might be involved in this process.

      Author response image 1.

      Upregulated expression of PKM2 in astrocytes following stimulation with TNF-α and IL-1β. Primary astrocytes were stimulated with TNF-α and IL-1β (50 ng/mL) for 48 h and western blotting analysis were performed.

      In Figure 3D, the authors claim that PKM2 expression causes nuclear retention of STAT3, p65, and p50, and inhibiting PKM2 localization with DASA-58 suppresses this retention. The western blot results for the MOG-stimulated group show high levels of STAT3, p50, and p65 in nuclear localization. However, in the MOG and DASA-58 treated group, one would expect high levels of p50, p65, and STAT3 proteins in the cytoplasm, while their levels decrease in the nucleus. These western blot results could be expanded. Additionally, intensity quantification for these results would be beneficial to see the statistical difference in their expressions, especially to observe the nuclear localization of PKM2.

      We agree with the reviewer’s comments and we have incorporated the quantification of STAT3,p50 and p65 for Fig.3D and Fig.S4B and Fig.S4C. Nevertheless, given that DASA-58 did not trigger a notable increase in the cytoplasmic level of PKM2, we did not detect an upregulation of STAT3, p50, or p65 in the cytoplasm of the MOG and DASA-58-treated groups. With the quantification results, it is more obvious to see the changes of these proteins in different conditions.

      The discrepancy between Figure 7A and its explaining text is confusing. The expectation from the knocking down of TRIM21 is the amelioration of activated astrocytes, leading to a decrease in inflammation and the disease state. The presented results support these expectations, while the images showing demyelination in EAE animals are not highly supportive. Clearly labeling demyelinated areas would enhance readers' understanding of the important impact of TRIM21 knockdown on reducing the disease severity.

      Thank you for pointing this out. We sincerely apologize for our carelessness. Based on your comments, we have made the corrections in the manuscript. As there is indeed a statistical difference in the mean clinical scores between shTRIM21-treated group and shVec group, we have accordingly revised the sentence for Figure 7A to state, “At the end time point at day 22 p.i., shTRIM21-treated group showed reduced disease scores compared to control groups (Fig. 7A).” .

      Additionally, we have added the whole image of the spinal cord for MBP in Author Response image 2. Moreover, we have labelled the demyelinated areas to facilitate readers’ understanding.

      Author response image 2.

      MBP staining of the whole spinal cord in EAE mice from shVec and shTRIM21 group. Scale bar: 100 μm. Demyelinated areas are marked with dashed lines.

      Reviewer #2 (Public Review):

      This study significantly advances our understanding of the metabolic reprogramming underlying astrocyte activation in neurological diseases such as multiple sclerosis. By employing an experimental autoimmune encephalomyelitis (EAE) mouse model, the authors discovered a notable nuclear translocation of PKM2, a key enzyme in glycolysis, within astrocytes.

      Preventing this nuclear import via DASA 58 substantially attenuated primary astrocyte activation, characterized by reduced proliferation, glycolysis, and inflammatory cytokine secretion.<br /> Moreover, the authors uncovered a novel regulatory mechanism involving the ubiquitin ligase TRIM21, which mediates PKM2 nuclear import. TRIM21 interaction with PKM2 facilitated its nuclear translocation, enhancing its activity in phosphorylating STAT3, NFκB, and c-myc. Single-cell RNA sequencing and immunofluorescence staining further supported the upregulation of TRIM21 expression in astrocytes during EAE.

      Manipulating this pathway, either through TRIM21 overexpression in primary astrocytes or knockdown of TRIM21 in vivo, had profound effects on disease severity, CNS inflammation, and demyelination in EAE mice. This comprehensive study provides invaluable insights into the pathological role of nuclear PKM2 and the ubiquitination-mediated regulatory mechanism driving astrocyte activation.

      The author's use of diverse techniques, including single-cell RNA sequencing, immunofluorescence staining, and lentiviral vector knockdown, underscores the robustness of their findings and interpretations. Ultimately, targeting this PKM2-TRIM21 axis emerges as a promising therapeutic strategy for neurological diseases involving astrocyte dysfunction.

      While the strengths of this piece of work are undeniable, some concerns could be addressed to refine its impact and clarity further; as outlined in the recommendations for the authors.

      Thanks for the reviewer’s comment and positive evaluation of our present work. We have further answered each question in recommendations section.

      Reviewer #3 (Public Review):

      Summary:

      Pyruvate kinase M2 (PKM2) is a rate-limiting enzyme in glycolysis and its translocation to the nucleus in astrocytes in various nervous system pathologies has been associated with a metabolic switch to glycolysis which is a sign of reactive astrogliosis. The authors investigated whether this occurs in experimental autoimmune encephalomyelitis (EAA), an animal model of multiple sclerosis (MS). They show that in EAA, PKM2 is ubiquitinated by TRIM21 and transferred to the nucleus in astrocytes. Inhibition of TRIM21-PKM2 axis efficiently blocks reactive gliosis and partially alleviates symptoms of EAA. Authors conclude that this axis can be a potential new therapeutic target in the treatment of MS.

      Strengths:

      The study is well-designed, controls are appropriate and a comprehensive battery of experiments has been successfully performed. Results of in vitro assays, single-cell RNA sequencing, immunoprecipitation, RNA interference, molecular docking, and in vivo modeling etc. complement and support each other.

      Weaknesses:

      Though EAA is a valid model of MS, a proposed new therapeutic strategy based on this study needs to have support from human studies.

      We agree that although we have clarified the therapeutic potential of targeting TRIM21 or PKM2 in the treatment of EAE, a mouse model of MS, the application in human studies warrants further studies. While considering the use of TRIM21 as a target for treating multiple sclerosis in clinical trials, several issues need to be addressed to ensure the safety, efficacy and feasibility. One such aspect is the development of drug that specifically target TRIM21 in brain, capable of crossing the blood-brain barrier and have minimal off-target effects. The translation of preclinical finding into clinical trials poses a significant challenge. To provide evidence for the similarities between the EAE model and multiple sclerosis, we have screened GEO databases (Author response image 3). In GSE214334 which analyzed transcriptional profiles of normal-appearing white matter from non-MS and different subtypes of disease (RRMS, SPMS and PPMS). Although no statistical difference was observed among different groups, the TRIM21 expression has tendency to increase in SPMS (secondary progressive MS) and PPMS (primary progressive MS) patients. In GSE83670, astrocytes from 3 control white matter and 4 multiple sclerosis normal appearing white matter (NAWM) were analyzed. TRIM21 mRNA expression is higher in MS group (78.73 ± 10.44) compared to control group (46.67 ± 24.15). Although these two GEO databases did not yield statistically significant differences, TRIM21 expression appears to be elevated in the white matter of MS patients compared to controls.

      To address this limitation, we have incorporated the following statement in the discussion section: “However, whether TRIM21-PKM2 could potentially serve as therapeutic targets in multiple sclerosis warrants further studies.”

      Author response image 3.

      TRIM21 expression in control and MS patients based on published GEO database. (A) The expression of TRIM21 in normal-appearing white matter in non-MS (Ctl) and different clinical subtypes of MS (RRMS, SPMS, PPMS) based on GSE214334 (one-way ANOVA). (B) The expression of TRIM21 from multiple sclerosis normal appearing white matter (NAWM) and control WM based on GSE83670. RRMS, relapsing--remitting MS; SPMS, secondary progressive MS; PPMS, primary progressive MS (unpaired Student's t test). Data are represented as the means ± SEM.

      Reviewer #4 (Public Review):

      Summary:

      The authors report the role of the Pyruvate Kinase M2 (PKM2) enzyme nuclear translocation as fundamental in the activation of astrocytes in a model of autoimmune encephalitis (EAE). They show that astrocytes, activated through culturing in EAE splenocytes medium, increase their nuclear PKM2 with consequent activation of NFkB and STAT3 pathways. Prevention of PKM2 nuclear translocation decreases astrocyte counteracts this activation. The authors found that the E3 ubiquitin ligase TRIM21 interacts with PKM2 and promotes its nuclear translocation. In vivo, either silencing of TRIM21 or inhibition of PKM2 nuclear translocation ameliorates the severity of the disease in the EAE model.

      Strengths:

      This work contributes to the knowledge of the complex action of the PKM2 enzyme in the context of an autoimmune-neurological disease, highlighting its nuclear role and a novel partner, TRIM21, and thus adding a novel rationale for therapeutic targeting.

      Weaknesses:

      Despite the relevance of the work and its goals, some of the conclusions drawn would require more thorough proof:

      I believe that the major weakness is the fact that TRIM21 is known to have per se many roles in autoimmune and immune pathways and some of the effects observed might be due to a PKM2-independent action. Some of the experiments to link the two proteins, besides their interaction, do not completely clarify the issue. On top of that, the in vivo experiments address the role of TRIM21 and the nuclear localisation of PKM2 independently, thus leaving the matter unsolved.

      We agree that TRIM21 has multifunctional roles and only some of their effects are due to PKM2-independent action. It is obvious that TRIM21 functions as ubiquitin ligases and its substrate are various. Here we identify PKM2 as one of its interacting proteins and our focus is the relationship between TRIM21 and the nuclear translocation PKM2, we have used diverse experiments to clarify their relationships, for example immunoprecipitation, western blotting, immunofluorescence, cyto-nuclear protein extraction. These aforementioned experiments are key points of our studies. From the results of in vitro experiments, targeting either TRIM21 or PKM2 might be potential targets for EAE treatment. Expectedly, from in vivo experiments, either targeting TRIM21 or PKM2 nuclear transport ameliorated EAE. In order to test the relationship of TRIM21 and PKM2 nuclear transport in vivo, we have stained PKM2 in shVec and shTRIM21-treated mice. Expectedly, knocking down TRIM21 led to a decrease in the nuclear staining of PKM2 in spinal cord astrocytes in EAE models (Figure S7A). This observation underscores that the therapeutic potential of inhibiting TRIM21 in astrocytes in vivo might be partially due to its role in triggering the reduced nuclear translocation of PKM2.

      Some experimental settings are not described to a level that is necessary to fully understand the data, especially for a non-expert audience: e.g. the EAE model and MOG treatment; action and reference of the different nuclear import inhibitors; use of splenocyte culture medium and the possible effect of non-EAE splenocytes.

      According to the reviewer’s suggestions, we have added more detailed descriptions in the materials and methods section, for example, the use of splenocytes culture medium, mass spectrometry, HE and LFB staining have been added. More details are incorporated in the part for “EAE induction and isolation and culture of primary astrocytes”. Moreover, the reference of DASA-58 in vitro and TEPP-46 in vivo as inhibitors of PKM2 nuclear transport were added.

      The statement that PKM2 is a substrate of TRIM21 ubiquitin ligase activity is an overinterpretation. There is no evidence that this interaction results in ubiquitin modification of PKM2; the ubiquitination experiment is minimal and is not performed in conditions that would allow us to see ubiquitination of PKM2 (e.g. denaturing conditions, reciprocal pull-down, catalytically inactive TRIM21, etc.).

      To prevent the misunderstanding, we have revised certain statements in the manuscript. In the updated version, the description is as follows: Hereby, we recognized PKM2 as an interacting protein of TRIM21, and further studies are required to determine if it is a substrate of E3 ligase TRIM21.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      General recommendations:

      - The whole manuscript needs language editing.

      We appreciate the comments of the reviewers. We have improved the writing of the manuscript. All modifications are underlined.

      - Details of many experiments are not given in the materials and methods.

      According to the reviewer’s suggestions, we have added more details for experiments in the materials and methods. For example, “Splenocyte isolation and supernatant of MOG35-55-stimulated-splenocytes”, “mass spectrometry”, “Hematoxylin-Eosin (HE) and Luxol Fast Blue (LFB) staining” were added in the section of Materials and Methods. More detailed information is given for EAE induction and isolation and culture of primary astrocytes.

      - Line properties in graphics should be corrected, some lines in box plots and error bars are very weak and hardly visible. Statistical tests should be included in figure legends as well. Statistical differences should be mentioned for control vs DASA-58 (alone) in all related figures.

      We have revised the figures to enhance their visibility by thickening the lines and error bars. In accordance with the reviewer’s suggestions, we have incorporated statistical tests in figure legends. Moreover, statistical analysis has been made among all groups, if there is no asterisk indicated in the figure legend and figure panels, it means there is no statistical difference between the control vs DASA-58 groups. For most of the experiments conducted in our studies, including lactate production, glucose consumption, the EdU analysis and CCK8 analysis, the change of STAT3 and NF-κB pathways, no statistical difference was observed between the control and DASA-58 group. The reason might be due to that in unstimulated astrocytes, the expression of PKM2 is low and nuclear translocation of PKM2 are few, which may explain why DASA-58 did not exert the anticipated effect. Thus, in our experiments, we have used MOGsup to stimulate astrocytes, enabling us to observe the impact of DASA-58 on the astrocyte proliferation and glycolysis in this condition.

      - Scale bars, arrows, and labeling in the images are not visible.

      We have improved the images according to the reviewer’s suggestions. The scale bars, arrows are made thicker and labeling are larger. The updated figures are visible.

      - Quantitative analysis of all western blot results and their statistics could be provided in every image and for every protein.

      For western blotting results which are further processed with quantitative analysis, for example, Fig.2D, fig. 5G, Fig. 6A and 6B, Fig. S4, we have added their statistics in the raw data sections. The other western blot results, for example, IP analysis, which are used to analyze protein-protein binding are not further processed with quantitative analysis.

      - Proteins that are used for normalizations in western blots should be stated in the text.

      We have added description of proteins that are used for normalization in western blots in figure legends. Moreover, in figure panels, proteins used for normalization are indicated. Globally, whole protein level is normalized to protein level of β-actin. For nuclear and cytoplasmic proteins, nuclear protein is normalized to the expression of lamin, cytoplasmic protein is normalized to the expression of tubulin. 

      - The manuscript investigates the role of TRIM21 in the nuclear localization of PKM2 in astrocytes in EAE mice, however almost no information is given about TRIM21 in the introduction. Extra information is given for PKM2, yet can be concisely explained.

      We have added a paragraph that describes the information of TRIM21 in the introduction section. The description is as follows: “TRIM21 belongs to the TRIM protein family which possess the E3 ubiquitin ligase activity. In addition to its well-recognized function in antiviral responses, emerging evidences have documented the multifaceted role of TRIM21 in cell cycle regulation, inflammation and metabolism (Chen et al., 2022). Nevertheless, the precise mechanisms underlying the involvement of TRIM21 in CNS diseases remain largely unexplored.”

      - "As such, deciphering glycolysis-dominant metabolic switch in astrocytes is the basis for understanding astrogliosis and the development of neurological diseases such as multiple sclerosis." The sentence could be supported by references.

      To support this sentence, we have added the following references:

      (1) Xiong XY, Tang Y, Yang QW. Metabolic changes favor the activity and heterogeneity of reactive astrocytes. Trends in endocrinology and metabolism: TEM 2022;33(6):390-400.

      (2) das Neves SP, Sousa JC, Magalhães R, Gao F, Coppola G, Mériaux S, et al. Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model. Cells 2023;12(20):2484.

      Figure 1/Result 1:

      - Figure 1A-B: Quality of the images should be improved.

      According to the reviewer’s suggestion, we have improved the quality of the image, images with higher resolution were added in figure 1A and figure 1B.

      - Control images of Figure 1B are not satisfying. GFAP staining is very dim. Images from control cells should be renewed.

      As mentioned by the reviewer’s, we have renewed the control images and added the DAPI staining figures for all groups. Compared with MOGsup stimulated astrocytes, the control cells are not in activated state and GFAP are relatively low.

      - Labelings on the images are not sufficient, arrows and scale bars are not visible.

      We have improved the images including labels, arrows and scale bars in all figures.

      - How splenocytes were obtained from MOG induced mice were not given in the material and methods section. Thus, it should be clearly stated how splenocyte supernatant is generated (treatment details).

      We have added the detailed information relating to splenocyte isolation and splenocyte supernatant entitled “Splenocyte isolation and supernatant of MOG35-55-stimulated-splenocytes” in the section of Materials and methods. “Splenocytes were isolated from EAE mice 15 d (disease onset) after MOG35-55 immunization. Briefly, spleen cells were suspended in RPMI-1640 medium containing 10% FBS. Splenocytes were plated in 12-well plates at 1x106 cells/well containing 50 μg/mL MOG35-55 and cultured at 37°C in 5% CO2. After stimulation for 60 h, cell suspension was centrifuged at 3000 rpm for 5 min and supernatants were collected. For the culture of MOGsup-stimulated astrocytes, astrocytes were grown in medium containing 70% DMEM supplemented with 10% FBS and 30% supernatant from MOG35-55-stimulated-splenocytes.”

      - For general astrocyte morphology: authors showed the cells are GFAP+ astrocytes. It is surprising that these cells do not bear classical astrocyte morphology in cell culture. How long do you culture astrocytes before treatment? How do you explain their morphological difference?

      Astrocytes were cultured for 2 to 3 weeks which correspond to 2-3 passages before treatment. There are several possible reasons for the morphological differences observed between GFAP+ astrocytes and their classical morphology. Firstly, the cell density. In low-density culture just as shown in Figure 1B, we have observed that astrocytes adopt a more flattened morphology. In high-density cultures, they adopt a stellate shape. Moreover, variations in culture conditions, such as the use of different fetal bovine serum, can also influence the morphology of astrocytes. In addition, the mechanical injury induced by the isolation procedures for astrocytes might contribute to variations in their morphology during in vitro cultivation. In summary, the morphological differences observed in GFAP+ astrocytes in cell culture likely result from a combination of culture conditions, cell density, and mechanical injury occured during astrocyte isolation etc.

      - Additional verification of reactive astrocytes could be performed by different reactive astrocyte markers, such as GLAST, Sox9, S100ß. Thus, quantitative analysis of activated astrocytes can be done by counting DAPI vs GLAST, Sox9 or S100ß positive cells.

      We really agree with the reviewer that there are other markers of reactive astrocytes such as GLAST, sox9 and S100β. However, numerous evidences support that GFAP is the most commonly used reactive astrocyte markers. Most of the cases, reactive astrocytes undergo GFAP overexpression. GFAP is one the most consistently induced gene in transcriptomic datasets of reactive astrocytes, confirming its usefulness as a reactive marker (Escartin et al., 2019). Thus, we have used GFAP as the marker of astrocyte activation in our study.

      - How you performed quantifications for Figures 1C and 1D should be clearly explained, details are not given.

      Quantification for Figure 1C and 1D were added in the figure legend. In general, Mean fluorescence intensity of PKM2 in different groups of (B) was calculated by ImageJ. The number of nuclear PKM2 was quantified by Image-Pro Plus software manually (eg. nuclear or cytoplasmic based on DAPI blue staining). The proportion of nuclear P KM2 is determined by normalizing the count of nuclear PKM2 to the count of nuclear DAPI, which represents the number of cell nuclei.

      - "Together, these data demonstrated the nuclear translocation of PKM2 in astrocytes from EAE mice." Here the usage of "suggests" instead of "demonstrated".

      Based on the reviewer's suggestion, we have revised the use of "demonstrated" to "suggest" in this sentence.

      Result 2 and 3:

      - In the literature, DASA-58 is shown to be the activator of PKM2 (https://www.nature.com/articles/nchembio.1060https://doi.org/10.1016/j.cmet.2019.10.015).

      - Providing references for the inhibitory use of DASA-58 for PKM2 would be appreciated.

      DASA-58 is referred to as “PKM2 activator” due to its ability to enforce the tetramerization of PKM2, enhancing the enzymatic ability of PKM2 to catalyze PEP to pyruvate conversion. However, the enforced conversion of tetramerization of PKM2 inhibited the dimer form of PKM2, thereby inhibiting its nuclear translocation. For this reason, DASA-58 is also used as the inhibitor of nuclear translocation of PKM2. In primary BMDMs, LPS induced nuclear PKM2. However, driving PKM2 into tetramers using DASA-58 and TEPP-46 inhibited LPS-induced PKM2 nuclear translocation (Palsson-McDermott et al., 2015). Consistently, FSTL1 induced PKM2 nuclear translocation was inhibited by DASA-58 in BMDMs (Rao et al., 2022). Accordingly, we have added these references in the manuscript.

      - Western blot results and statistics for PKM2 should be quantitatively given for all groups.

      According to the reviewer’s suggestions, we have added the quantification of PKM2 for western blots in figure 2 and figure 3. Quantification of PKM2 in figure 2D is added in Fig S3. Quantification of PKM2 in figure 3D is added in Fig.S4B and Fig. S4C.

      - Figure 3A-B: staining method/details are not mentioned in materials and methods.

      Staining methods is in the paragraph entitled “Immunofluorescence” in the section of materials and methods. The descriptions are as follows:

      For cell immunochemistry, cells cultured on glass coverslips were fixed with 4% PFA for 10 min at RT, followed by permeabilization with 0.3% Triton X-100. Non-specific binding was blocked with buffer containing 3% BSA for 30 min at RT. Briefly, samples were then incubated with primary antibodies and secondary antibodies. DAPI was used to stain the nuclei. Tissues and cells were observed and images were acquired using an EVOS FL Auto 2 Cell image system (Invitrogen). The fluorescence intensity was measured by ImageJ.

      - In Figure 3A, in only DASA-58 treated cells, it looks like GFAP staining is decreased. It would be better to include MFI analysis for GFAP in the supplementary information.

      We have added the MFI analysis for GFAP in Figure 3A in Fig.S4A. GFAP expression is decreased after DASA-58 treatment (in both control and MOGsup condition), the reason might be due to the effect of DASA-58 on inhibition of PKM2 nuclear transport, which subsequently suppress the activation of astrocytes, leading to the decreased expression of GFAP.

      Result 4

      - Detailed explanation of the mass spectrometry and IP experiments should be given in materials and methods. What are the conditions of the cells? Which groups were analyzed? Are they only MOG stimulated, MOG-DASA-58 treated, or only primary astrocytes without any treatment? The results should be interpreted according to the experimental group that has been analyzed.

      We have added the detailed information relating to mass spectrometry and immunoprecipitation in the materials and methods. In general, two groups of cells were subjected to mass spectrometry analysis, primary astrocytes without any treatment and MOGsup-stimulated primary astrocytes. These two groups were immunoprecipitated with anti-PKM2 antibody. Moreover, in the manuscript, we have revised the sentence concerning the description of mass spectrometry. The description is as follows: “To illustrate underlying mechanism accounting for nuclear translocation of PKM2 in astrocytes, we sought to identify PKM2-interacting proteins. Here, unstimulated and MOGsup-stimulated primary astrocytes were subjected to PKM2 immunoprecipitation, followed by mass spectrometry”. Furthermore, the description of these two groups of cells were added in the figure legend of Fig.4.

      Result 5:

      - For the reader, it would be better to start this part by explaining the role of TRIM21 in cells by referring to the literature.

      We agreed with the reviewer that beginning this part by explaining the role of TRIM21 would be better. Accordingly, we have added the following descriptions at the beginning of this part: “TRIM21 is a multifunctional E3 ubiquitin ligase that plays a crucial role in orchestrating diverse biological processes, including cell proliferation, antiviral responses, cell metabolism and inflammatory processes (Chen X. et al., 2022).” The relevant literature has been included: Chen X, Cao M, Wang P, Chu S, Li M, Hou P, et al. The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment. Front Immunol 2022;13:968755.

      - The source and the state of the cells (control vs MOG induced) should be stated (Figure 5A).

      In figure 5A to 5D, single-cell RNA-seq were performed from CNS tissues of naive and different phases of EAE mice (peak and chronic). We have added this detailed information in the figure legend of Figure 5.

      - Figure 5D can be placed after 5A. Data in Figure 5A is probably from naive animals, if so, it should be stated in the legend where A is explained. The group details of the data shown in Figure 5 should be clearly stated.

      According to the reviewer’s suggestions, we have placed 5D after 5A. Single-cell RNA seq analysis were performed from CNS tissues of naïve mice and EAE mice. This information is stated in the legend of Figure 5A-D. “Single-cell RNA-seq profiles from naive and EAE mice (peak and chronic phase) CNS tissues. Naive (n=2); peak (dpi 14–24, n=3); chronic (dpi 21–26, n=2).”

      - Immunofluorescence images should be replaced with better quality images, in control images, stainings are not visible.

      We have replaced with better quality images in figure 5H and in control images, the staining is now visible.

      Result 6:

      - Experimental procedures should be given in detail in materials and methods.

      We have revised the section of materials and methods, and more details are added. Detailed information was added for astrocyte isolation, immunoprecipitation. Moreover, mass spectrometry, Hematoxylin-Eosin (HE) and Luxol Fast Blue (LFB) staining, Splenocyte isolation and supernatant of MOG35-55-stimulated-splenocytes were added in materials and methods.

      Result 7:

      - In Figure 7A, the mean clinical score seems significantly reduced in the shTRIM21-treated group, although it is explained in the result text that it is not significant. Explain to us the difference between Figure 7A and the explaining text?

      Thank you for pointing this out. We sincerely apologize for our carelessness. Based on your comments, we have made the corrections in the manuscript. As there is indeed a statistical difference in the mean clinical scores between shTRIM21-treated group and shVec group, we have accordingly revised the sentence for Figure 7A to state, “At the end time point at day 22 p.i., shTRIM21-treated group showed reduced disease scores compared to control groups (Fig. 7A).” .

      - The staining methods for luxury fast blue and HE are not given in materials and methods.

      According to the reviewer’s comments, we have added the staining methods for HE and LFB in materials and methods.

      - In Figure 7E, authors claim that MBP staining is low in an image, however the image covers approximately 500 um area. One would like to see the demyelinated areas in dashed lines, and also the whole area of the spinal cord sections.

      In Author response image 2, we have added the images for MBP staining of the whole area of spinal cord sections. Demyelinated areas are marked with dashed lines.

      - "TEPP-46 is an allosteric activator that blocks the nuclear translocation of PKM2 by promoting its tetramerization." should be supported by references.

      We have added two references for this sentence. Anastasiou D et al. showed that TEPP-46 acts as an activator by stabilizing subunit interactions and promoting tetramer formation of PKM2. Angiari S et al. showed that TEPP-46 prevented the nuclear transport of PKM2 by promoting its tetramerization in T cells.

      These two references are added:

      Angiari S, Runtsch MC, Sutton CE, Palsson-McDermott EM, Kelly B, Rana N, et al. Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4(+) T Cell Pathogenicity and Suppresses Autoimmunity. Cell metabolism 2020;31(2):391-405.e8.

      Anastasiou D, Yu Y, Israelsen WJ, Jiang JK, Boxer MB, Hong BS, et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nature chemical biology 2012;8(10):839-47.

      - Could you explain what the prevention stage is?

      The term “prevention stage” was used to describe the administration of TEPP-46 before disease onset. To be more accurate, we have revised the phrase from “prevention stage” to “preventive treatment” as described in other references. For example, Ferrara et al. (Ferrara et al., 2020) used “preventive” and “preventive treatment” to mean administration before disease onset.

      The revised sentences are as follows: “To test the effect of TEPP-46 on the development of EAE, the “preventive treatment” (i.e, administration before disease onset) was administered. Intraperitoneal treatment with TEPP-46 at a dosage of 50 mg/kg every other day from day 0 to day 8 post-immunization with MOG35-55 resulted in decreased disease severity (Fig. S8A).”

      - In in vitro experiments, authors used DASA-58, and in vivo they used TEPP-46. What might be the reason that DASA-58 is not applied in vivo?

      The effects of DASA-58 and TEPP-46 in promoting PKM2 tetramerization have been tested in vitro and has been documented. Based on in vitro absorption, distribution, metabolism and excretion profiling studies, Anastasiou et al. predicted that TEPP-46 had better in vivo drug exposure compared to DASA-58. Moreover, TEPP-46, but not DASA-58, is pharmacokinetically validated in vivo (Anastasiou et al., 2012). Thus, we used TEPP-46 for in vivo studies.

      - Authors claim that TEPP-46 activates PKM2 and leads it its nuclear translocation, however, they did not verify PKM2 expression in the nucleus.

      To support that TEPP-46 exerts effects in inhibiting PKM2 nuclear translocation both in vivo and in vitro, we have performed western blotting analysis and immunofluorescence staining. In vitro, TEPP-46 administration inhibited the MOGsup-induced PKM2 nuclear translocation, which exerts similar effects as DASA-58 (Author response image 4). The in vivo effects of TEPP-46 was analyzed by co-immunostaining of PKM2 and GFAP. The results showed reduced nuclear staining of PKM2 in spinal cord astrocytes in TEPP-46-treated EAE mice compared with control EAE mice (Figure S7B).

      Author response image 4.

      TEPP-46 inhibited the nuclear transport of PKM2 in primary astrocytes. Nuclear-cytoplasmic protein extraction analysis showed the nuclear and cytoplasmic changes of PKM2 in TEPP-46 treated astrocytes and MOGsup-stimulated astrocytes. Primary astrocytes were pretreated with 50 μM TEPP-46 for 30 min and stimulated with MOGsup for 24 h.

      Supplementary Figure 3:

      - In Figure 3D, merge should be stated on top of the merged images, it is confusing to the reader.

      According to the reviewer’s comments, we have added merge on top of the merged images.

      Discussion:

      All results should be discussed in detail by interpreting them according to the literature.

      We have further discussed the results in the discussion n section. Firstly, we added a paragraph describing the role of nuclear translocation of PKM2 in diverse CNS diseases. Moreover, a paragraph discussing the nuclear function of PKM2 as a protein kinase or transcriptional co-activator was added. Now the discussion section is more comprehensive, which nearly discuss all the results by interpreting them according to the literature in detail.

      Reviewer #2 (Recommendations For The Authors):

      The authors could address the following points:

      (1) In Figure 1A, the authors present immunofluorescence staining of PKM2 in both control mice and MOG35-725 55-induced EAE mice across different stages of disease progression: onset, peak, and chronic stages. Observing the representative images suggests a notable increase in PKM2 levels, particularly within the nucleus of MOG35-725 55-induced EAE mice. However, to provide a more comprehensive analysis, it would be beneficial for the authors to include statistical data, such as average intensities {plus minus} standard deviation (SD), along with the nuclear PKM2 ratio, akin to the presentation for cultured primary astrocytes in vitro in panels B-D. Additionally, the authors should clearly specify the number of technical repeats and the total number of animals utilized for these data sets to ensure transparency and reproducibility of the findings.

      Thanks for the reviewer’s suggestion. Accordingly, for figure 1A, we have added the nuclear PKM2 ratio in astrocytes in control and different stages of EAE mice in Supplementary figure S1A. Moreover, the quantification of mean fluorescence intensity (MFI) for PKM2 was added in figure S1B. Moreover, we have added the number of animals used in each group in figure legend.

      (2) The blue hue observed in the merged images of Figure 1B (lower panel) presents a challenge for interpretation. The source of this coloration remains unclear from the provided information. Did the authors also include a co-stain for the nucleus in their imaging? To enhance clarity, especially for individuals with color vision deficiency, the authors might consider utilizing different color combinations, such as presenting PKM2 in green and GFAP in magenta, which would aid in distinguishing the two components. Furthermore, for in vitro cell analysis, incorporating a nuclear stain could provide valuable insights into estimating the cytosolic-to-nuclear ratio of PKM2.

      For the question relating to the merged images in figure 1B, PKM2 was presented in green, GFAP was presented in red and blue represents the nuclear staining by DAPI. “Merge” represents the merged images of these three colors. To enhance the clarity, we have added the images for the nuclear staining of DAPI.

      (3) To substantiate the conclusion of the authors regarding the enhancement of aerobic glycolysis due to PKM2 expression and nuclear translocation in MOGsup-stimulated astrocytes, employing supplementary methodologies such as high-resolution respirometry and metabolomics could offer valuable insights. These techniques would provide a more comprehensive understanding of metabolic alterations and further validate the observed changes in glycolytic activity.

      While we recognize the merits of techniques such as high-resolution respirometry and metabolomics, we believe that the conclusions regarding the enhancement of aerobic glycolysis due to PKM2 expression and nuclear translocation in MOGsup-stimulated astrocytes are sufficiently supported by the current experimental evidence. Our study has relied on a robust set of experiments, including lactate production, glucose consumption, cyto-nuclear localization analysis and western blotting analysis of key enzymes in glycolysis. These results, in conjunction with the literature on the role of PKM2 in various cancer cells, keratinocytes and immune cells, provide a strong foundation for our conclusions. Although metabolomics could offer a global view of the changes in metabolic states in astrocytes, as the end product of aerobic glycolysis is lactate, our study, which analyze the change of lactate levels in different experimental conditions might be more direct. However, we fully acknowledge that future studies employing these advanced methodologies could provide further insights into the precise mechanisms underlying PKM2's effects on aerobic glycolysis.

      (4) Minor: Why is the style of the columns different in Gig 2 panel D compared to those shown in panels B, C, and G of Figure 2.

      To maintain consistency in the column style across figure 2, we have updated the column in figure 2D. Now, we use same style of columns in Fig 2B, C, D and G.

      (5) The effect of stimulating astrocytes with MOGsup on cell proliferation, as shown in Figure 2E, is very moderate. Does DASA-58 reduce the proliferation of control cells in this assay?

      In response to the reviewer’s questions, we conducted a CCK8 analysis in astrocytes subjected to DASA-58 treatment. As depicted in Author response image 5, administration of DASA-58 did not reduce the proliferation of control cells. This result aligns with our other findings in the glycolysis assays and EdU analysis, where there is no statistical difference between control group and DASA-58-treated group. One plausible explanation for this is that in their steady state, astrocytes in the control group are not in a hyperproliferative state. Under such conditions, inhibiting the translocation of PKM2 via DASA-58 or other inhibitors did not significantly affect the proliferation of astrocytes.

      Author response image 5.

      CCK8 analysis of astrocyte proliferation. Primary astrocytes were pretreated with 50 μM DASA-58 for 30 min before stimulation with MOGsup. Data are represented as mean ± SEM. ***P<0.001. SEM, standard error of the mean.

      (6) The tables and lists in Figure 4, panels A-D, are notably small, hindering readability and comprehension. Consider relocating these components to the supplementary materials as larger versions.

      We have updated the tables and lists, the lines are made thicker. As suggested by the reviewer, we relocate theses components in Supplementary Figure S5.

      Reviewer #3 (Recommendations For The Authors):

      Higher magnification images that more clearly show nuclear translocation of PKM2 and pp65 and pSTAT3 immunoreactivity should be added to the figures panels, for example as inlets.

      Thank you for pointing out this issue in the manuscript. According to the reviewer’s comments we have included higher magnification images as inlets for Figure 3A, Figure 3B and Figure 2A. These enlarged images now provide a clearer visualization of the nuclear translocation state of PKM2, pp65, and pSTAT3.

      There are seldom wording errors like features => feathers at line 364.

      We are very sorry for our incorrect writing. We have corrected this spelling mistake in the manuscript.

      Reviewer #4 (Recommendations For The Authors):

      Here below are major and minor concerns on the data presented:

      (1) It is not clear from the Methods section what are the culture conditions defined as 'control' in Figure 1B-D. I believe the control should be culturing with the conditioned medium of normal (non-EAE) mice splenocytes to be sure the effect is not from cytokines naturally secreted by these cells.

      Thanks for the reviewer’s comments and we totally understand the reviewer's concern. The control means non-treated primary astrocytes cultured with traditional DMEM medium supplemented with 10% FBS. In fact, we have performed experiments to exclude the possibility that the observed effect of MOGsup on the activation of astrocytes is from cytokines secreted by splenocytes. Splenocytes from normal (non-EAE) mice were isolated, cultured in RPMI-1640 medium containing 10% FBS for 60 hours, and supernatant was collected. Immunofluorescence staining of PKM2 and GFAP were performed in non-treated primary astrocytes and astrocytes stimulated with supernatant from control splenocytes. As shown in Figure S1C, in both groups, no difference was observed in PKM2 expression and localization, PKM2 was located mainly in the cytoplasm in theses conditions. These results indicate that observed effect of PKM2 in MOGsup-stimulated condition is not due to the cytokines secreted from splenocytes. Thus, we used non-treated primary astrocytes as controls in our study. To clarify the control group, we have revised the description in the figure legend, The revised expression is as follows: “Immunofluorescence staining of PKM2 (green) with GFAP (red) in non-treated primary astrocytes (control) or primary astrocytes cultured with splenocytes supernatants of MOG35–55-induced EAE mice (MOGsup) for different time points (6 h, 12 h and 24 h). ”

      (2) Figure 3D: the presence of PMK2 in the nuclear fraction upon MOGSUP together with the DASA-58 (last lane of Figure 3D) is not supporting the hypothesis proposed and further may indicate that the reduction of pSTAT3, pp65, etc. observed is independent of PMK2 nuclear translocation/astrocyte activation being observed even in absence of MOGSUP.

      Thank you for pointing out this problem in manuscript. The representing image of nuclear level of PKM2 in Figure 3D is not obvious, as shown by figure 3D, which has raised doubts among the reviewers. To strengthen our conclusion that the reduction of STAT3 and p65 pathway is related to the inhibited nuclear level of PKM2 induced by DASA-58, nuclear PKM2 level was quantified and added in Figure S4B. From the quantification results, it is evident that DASA-58 administration decreased the nuclear level of PKM2 in MOGsup-stimulated astrocytes. To address this concern, we have updated the immunoblot image for PKM2 in figure 3D and incorporated quantification results in supplementary Figure S4.

      (3) Molecular docking indication and deletion co-immunoprecipitation reported in Figure 4 data are not concordant on TRIM21: N-terminal Phe23 and Thr87 (Figure 4E) predicted by MD to bind PMK2 are not in the PRY-SPRY domain suggested by the co-IP experiment (Figure 4I).

      The discrepancy between the molecular docking prediction and the co-immunoprecipitation can be explained as follows:

      Firstly, molecular docking is computational methods that predicts protein-protein interaction based on 3-D structures of the proteins. However, the accuracy of this predication can be influenced by the different models of 3D structures of TRIM21 and PKM2, as well as by factors such as post-translational modifications and flexibility of the proteins. Proteins in vivo are subject to post-translational modifications that can affect their interactions. These modifications are not fully captured in molecular docking analysis. For example, in our analysis, the predicted N-terminal Phe23 and Thr87 in TRIM21 hold the potential to interact with PKM2 by hydrogen bonds. However, such binding can be influenced by diverse biological environments, such as different cells and pathological conditions. Molecular docking predication may suggest the specific residues and binding pocked within the protein complex, however, the accuracy should be verified by experimental techniques such as immunoprecipitation. To address the predication results of molecular docking, the description has been revised as follows: “TRIM21 is predicted to bound to PKM2 via hydrogen bonds between the amino acids of the two molecules.”

      Co-immunoprecipitation that involves the use of truncated domains of TRIM21 and PKM2, is an experimental technique relies on the specific interaction between antibody and targeted proteins. This technique can provide insights into the precise binding domains between TRIM21 and PKM2. As demonstrated in our study, PRY-SPRY domain of TRIM21 is involved in this binding. In summary, while molecular docking and Co-IP are valuable tools for studying protein-protein interactions, their differing focus and limitations may result in discrepancies between the predicted interaction sites and the experimentally identified interaction domains.

      (4) The Authors state that PMK2 is a substrate of TRIM21 E3 ligase activity, however, this is not proved: i) interaction does not imply a ligase-substrate relationship; ii) the ubiquitination shown in Figure 6C is not performed in denaturing conditions thus the K63-Ub antibody can detect also interacting FLAG-IPed proteins (besides, only a single strong band is seen, not a chain; molecular weights in immunoblot should be indicated); iii) use of a catalytically inactive TRIM21 would be required as well.

      We appreciate the reviewer’s comments regarding the limitations of the immunoprecipitation and K63-antibody test, which could not lead to the conclusion that PKM2 is a substrate of TRIM21. To avoid any misunderstandings, we have revised the relevant sentence from “Hereby, we recognized PKM2 as a substrate of TRIM21” to “Hereby, we recognized PKM2 as an interacting protein of TRIM21, and further studies are required to determine if it is a substrate of E3 ligase TRIM21”. Moreover, we have revised the title of the relevant part in the results section, the previous title, “TRIM21 ubiquitylates and promotes the nuclear translocation of PKM2” has been replaced with “TRIM21 promotes ubiquitylation and the nuclear translocation of PKM2”. Moreover, molecular weights for all proteins in western blotting were indicated.

      (5) As above, molecular weights should always be indicated in immunoblot.

      Thanks for pointing out this problem in the figures. Accordingly, we have added the molecular weights for every protein tested in immunoblot.

      (6) The authors should describe the EAE mouse model in the text and in the material and methods as it may not be so well known to the entire reader audience, and the basic principle of MOG35-55 stimulation, in order to understand the experimental plan meaning.

      We appreciate the reviewer’s comments highlighting the importance of clarifying EAE model for a broader understanding of the reader audience. In response, we have described the EAE model both in the text and in the materials and methods section. In the text, the description of EAE model was added at the beginning of the first paragraph in the Results section. The description is as follows: “EAE is widely used as a mouse model of multiple sclerosis, which is typically induced by active immunization with different myelin-derived antigens along with adjuvants such as pertussis toxin (PTX). One widely used antigen is the myelin oligodendrocyte glycoprotein (MOG) 35-55 peptide (Nitsch et al., 2021), which was adopted in our current studies.”

      We have also added the detailed experimental procedures for EAE induction in the materials and methods section.

      (7) The authors should better explain and give the rationale for the use of splenocytes and why directly activated astrocytes (isolated from the EAE model) cannot be employed to confirm/prove some of the presented data.

      Firstly, splenocytes offer a heterogenous cell population, encompassing T cells and antigen presenting cells (APC), which may better mimic the microenvironment and complex immune responses observed in vivo.

      Myelin oligodendrocyte glycoprotein (MOG) 35-55 peptide is one widely used antigen for EAE induction. MOG35-55 elicits strong T responses and is highly encephalitogenic. Moreover, MOG35-55 induces T cell-mediated phenotype of multiple sclerosis in animal models. Thus, by isolating splenocytes from the onset stage of EAE mice, which contains APC and effector T cells, followed by stimulation with antigen MOG35-55 in vitro for 60 hours, the T-cell response in the acute stage of EAE diseases could be mimicked in vitro. The supernatant from MOG35-55 stimulated splenocytes has high levels of IFN-γ and IL-17A, which in part mimic the pathological process and environment in EAE, and this technique has been documented in the references (Chen et al., 2009, Kozela et al., 2015).

      Correspondingly, we have revised sentence for the use of MOG35-55 stimulates splenocytes in EAE mice and add the relevant references: “Supernatant of MOG35-55-stimulated splenocytes isolated from EAE mice were previously shown to elicit a T-cell response in the acute stage of EAE and are frequently used as an in vitro autoimmune model to investigate MS and EAE pathophysiology (Chen et al., 2009, Du et al., 2019, Kozela et al., 2015).”

      Secondly, activated astrocytes (isolated from the EAE model) can not be employed for in vitro culture for the following reasons:

      (1) Low cell viability. Compared to embryonic or neonatal mice, adult mice yield a limited number of viable cells. The is mainly because that adult tissues possess less proliferative capacity.

      (2) Disease changes. Astrocytes in EAE mice are exposed to microenvironment including inflammatory cytokines, antigens and other pathological factors. Without this environment, the function and morphology of astrocytes undergo changes, which make it difficult to interpret the results in vitro.

      For these reasons, the in vitro cultured primary astrocytes used the neonatal mice.

      (8) The authors should indicate the phosphorylation sites they are referring to when analysing p-c-myc, pSTAT3, pp65, etc...

      According to the reviewer’s suggestions, we have added the phosphorylation sites for pSTAT3 (Y705), pp65 (S536), p-c-myc (S62) and pIKK (S176+S180) in the figure panels.

      (9) Reference of DASA-58 and TEPP-46 inhibitors and their specificity should be given.

      According to the reviewer’s comments, we have added the relevant references for the use of DASA-58 and TEPP-46 as inhibitors of PKM2 nuclear transport. In primary BMDMs, LPS induced nuclear PKM2. However, driving PKM2 into tetramers using DASA-58 and TEPP-46 inhibited LPS-induced PKM2 nuclear translocation (Palsson-McDermott et al., 2015). Consistently, FSTL1 induced PKM2 nuclear translocation was inhibited by DASA-58 in BMDMs (Rao et al., 2022). Accordingly, we have added these references in the manuscript.

      To address the selectivity of TEPP-46 and add the references, the relevant sentence has been revised from “TEPP-46 is an allosteric activator that blocks the nuclear translocation of PKM2 by promoting its tetramerization” to “TEPP-46 is a selective allosteric activator for PKM2, showing little or no effect on other pyruvate isoforms. It promotes the tetramerization of PKM2, thereby diminishing its nuclear translocation (Anastasiou et al., 2012, Angiari et al., 2020).”

      Reviewing Editor (Recommendations For The Authors):

      The reviewing editor would appreciate it if the original blots from the western blot analysis, which were used to generate the final figures, could be provided.

      Thanks for the reviewing editor’s comment, accordingly, we will add the original blots for the western blots analysis.

      References

      Anastasiou D, Yu Y, Israelsen WJ, Jiang JK, Boxer MB, Hong BS, et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nature chemical biology 2012;8(10):839-47.

      Escartin C, Guillemaud O, Carrillo-de Sauvage M-A. Questions and (some) answers on reactive astrocytes. Glia 2019;67(12):2221-47.

      Ferrara G, Benzi A, Sturla L, Marubbi D, Frumento D, Spinelli S, et al. Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration. Journal of neuroinflammation 2020;17(1):228.

      Lin CC, Edelson BT. New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Journal of immunology (Baltimore, Md : 1950) 2017;198(12):4553-60.

      Palsson-McDermott Eva M, Curtis Anne M, Goel G, Lauterbach Mario AR, Sheedy Frederick J, Gleeson Laura E, et al. Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages. Cell metabolism 2015;21(1):65-80.Rao J, Wang H, Ni M, Wang Z, Wang Z, Wei S, et al. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut 2022;71(12):2539-50.

      Wheeler MA, Clark IC, Tjon EC, Li Z, Zandee SEJ, Couturier CP, et al. MAFG-driven astrocytes promote CNS inflammation. Nature 2020;578(7796):593-9.

      Zhang J, Feng G, Bao G, Xu G, Sun Y, Li W, et al. Nuclear translocation of PKM2 modulates astrocyte proliferation via p27 and -catenin pathway after spinal cord injury. Cell Cycle 2015;14(16):2609-18.

    1. Author Response

      The following is the authors’ response to the original reviews.

      We sincerely thank the reviewers for their constructive feedback. We have revised our manuscript to address some important concerns. The main changes are summarized as follows:

      (1) A major concern as reflected in the eLife assessment and reviewer comments, was that the “evidence supporting the conclusion that striatal neurons encode single-limb gait is incomplete.” We have now provided an expanded analysis of gait phase-locking to different limbs in Figure 2 – figure supplement 1. The analysis reveals three key new insights: 1) most striatal neurons are significantly entrained to only one or two limbs; 2) for neurons entrained to two limbs, most limb pairs are diagonal pairs, whose phases are closely aligned; 3) the strength of phase-locking, as measured by the mean vector length, is biased toward a single limb. From these results we conclude that striatal neurons are indeed better correlated with single-limb (as opposed to multiple limbs’) gait. However, we speculate that because of the inherently correlated motion across limbs, some neurons also display significant phaselocking to multiple limbs, particularly to diagonal pairs.

      (2) Reviewer 2 noted the lack of a manipulation experiment which would help establish the striatum’s relationship to gait control. We have therefore included the results of new experimental data in Figure 6 – figure supplement 2, in which we show that optogenetically activating D2 MSNs alters both some measures of whole-body motion and single-limb gait. We recognize that these experiments are not ideal, for example, the optical stimulation was not entrained to limb phase. Nevertheless, they hopefully allay any concern that the striatum is incapable of influencing gait performance.

      (3) We have further characterized the relationship between vector length and firing rate, and firing rate between D1 and D2 MSNs. We now show that: 1) vector length is negatively correlated with session-wide firing rate (Figure 2 – figure supplement 1E); 2) session-wide firing rates are similar between D1 and D2 MSNs in both healthy and dopamine lesioned animals (Figure 4D and Figure 6H). Thus, the imbalance in the vector length between D1 and D2 MSNs following dopamine lesions is unlikely to be explained by changes in the overall firing rates of these cells.

      (4) We have added new data similar to Figure 1 with distributions of stride frequency, duration, and length to illustrate the difference between sham and 6OHDA mice (Figure 5 – figure supplement 1B,C).

      (5) We have expanded the Discussion section to discuss a number of important points raised by the reviewers. These include: 1) speculating on the origins of gait coding in the striatum; 2) discussion of some literature which reported similar levels of D1/D2 MSN start coding in contrast to our results in healthy mice; 3) discussion of the finding that almost all phase-locked cells also have a firing rate related to speed or start/stop signals; 4) discussion of one of the limitations of the unilateral 6OHDA model, namely, the strong turning bias, and its potential implications for our results.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Yang et al combine high-speed video tracking of the limbs of freely moving mice with in vivo electrophysiology to demonstrate how striatal neurons encode single-limb gait. They also examine encoding other well-known aspects of locomotion, such as movement velocity and the initiation/termination of movement. The authors show that striatal neurons exhibit rhythmic firing phase-locked with mouse gait, while mice engage in spontaneous locomotion in an open field arena. Moreover, they describe gait deficits induced by severe unilateral dopamine neuron degeneration and associate these deficits with a relative strengthening of gait-modulation in the firing of D2-expressing MSNs. Although the source and function of this gait-modulation remain unclear, this manuscript uncovers an important physiological correlate of striatal activity with gait, which may have implications for gait deficits in Parkinson's Disease.

      Strengths:

      While some previous work has looked at the encoding of gait variables in the striatum and other basal ganglia nuclei, this paper uses more careful quantification of gait with video tracking. In addition, few if any papers do this in combination with optically-labeled recordings as were performed here.

      Weaknesses:

      The data collected has a great richness at the physiological and behavioral levels, and this is not fully described or explored in the manuscript. Additional analysis and display of data would greatly expand the interest and interpretability of the findings.

      There are also some caveats to the interpretation of the analyses presented here, including how to compare encoding of gait variables when animals have markedly different behaviors (eg comparing sham and unilaterally 6-OHDA treated mice), or how to interpret the loss of gait modulation when single unit activity is overall very low.

      (1) The authors use circular analysis to quantify the degree to which striatal neurons are phaselocked to individual limbs during gait. The result of this analysis is shown as the proportion of units phase-locked to each limb, vector length, and vector angle (Fig 2H-K; Fig 4E-F; Fig 6E-F). Given that gait is a cyclic oscillation of the trajectories of all four limbs, one could expect that if one unit is phase-locked to one limb, it will also be phase-locked to the other three limbs but at a different phase. Therefore, it is not clear in the manuscript how the authors determine to which limb each unit is locked, and how some units are locked to more than one limb (Fig 2H). More methodological/analytical detail would be especially helpful.

      We thank the reviewer for raising this important issue, which was not sufficiently explored in our original manuscript. This relates to a major concern that “evidence supporting the conclusion that striatal neurons encode single-limb gait is incomplete.” We have now prepared a new figure supplement to address whether neurons are preferentially entrained to only one or multiple limbs (Figure 2 – figure supplement 1, panels A-C).

      Author response image 1.

      Panels A-C. Phase-locking to different limbs.

      Panel A shows the percentage of striatal neurons (all neurons including untagged cells) with significant phase-locking to only 1, 2, 3, or all 4 limbs. The results indicate that most phaselocked cells are entrained to either only 1, or only 2 limbs, as opposed to 3 or all 4 limbs. We next looked more closely at the cells which were entrained to only 2 limbs: Panel B shows that a significant majority of those cells were coupled to diagonal limb pairs. This finding is insightful because diagonal limb pairs move at nearly the same phase during walking, thus some overlap in phase-locking to these limbs is to be expected. Finally, Panel C shows the mean vector length per neuron ranked from the highest to lowest value. The results reveal that the vector length is significantly biased toward the highest ranked limb. This bias would be absent if neurons were entrained to all 4 limbs with similar strength. Together, these results support the conclusion that striatal neuron spiking is preferentially coupled to single limbs as opposed to multiple limbs. However, we speculate that because of the inherently correlated motion across limbs, some neurons also display significant phase-locking to multiple limbs, particularly to diagonal pairs.

      (2) In Figures 2 and 3, the authors describe the modulation of striatal neurons by gait, velocity, and movement transitions (start/end), with most of their examples showing firing rates compatible with rates typical of striatal interneurons, not MSNs. In order to have a complete picture of the relationship between striatal activity and gait, a cell type-specific analysis should be performed. This could be achieved by classifying units into putative MSN, FS interneurons, and TANs using a spike waveform-based unit classification, as has been done in other papers using striatal single-unit electrophysiology. An example of each cell type's modulation with gait, as well as summary data on the % modulation, would be especially helpful.

      We appreciate the reviewer’s suggestion to analyze our data after classifying units into different putative cell types (MSN, FSI, TAN). Indeed, we have frequently adopted this practice in our other publications (e.g., Bakhurin & Masmanidis 2016, 2017; Lee & Masmanidis 2019). However, this study already relies on a more rigorous method – optogenetic tagging – to identify D1 and D2 MSNs. We felt that adding a second, more subjective and therefore less rigorous identification method based on spike waveforms would add unnecessary confusion in how the results are presented and interpreted. For example, we were unsure how to address the situation where an opto-tagged D1 or D2 MSN may be classified as a putative FSI or TAN according to spike waveform criteria. For this reason, we decided not to perform an analysis by putative MSN, FSI, and TAN. Finally, we have made all our electrophysiological data available should someone want to perform this analysis themselves.

      (3) By normalizing limb trajectories to the nose-tail axis, the analysis ignores whether the mouse is walking straight, or making left/right turns. Is the gait-modulation of striatal activity shaped by ipsi- and contralateral turning? This would be especially important to understand changes in the unilateral disease model, given the imbalance in turning of 6-OHDA mice.

      This is an important question, which our data are unfortunately underpowered to address. Lesioned mice turn sharply for nearly the entire duration of walking, while healthy mice walk in a nearly straight line, with occasional brief turning bouts. Thus, we do not have sufficient stride numbers during healthy turning to enable a rigorous analysis of gait phase locking during left/right turns. This raises some questions about the interpretation of the higher D2 MSN vector length in dopamine lesioned mice – does the higher vector length relate to the impaired gait, or the higher incidence of turning in this PD model? We have acknowledged this issue in the Discussion section as a limitation of the unilateral 6OHDA model. And, in future work we hope to investigate turning effects in more detail using behavioral arenas which force animals to turn left or right at specific locations.

      (4) It looks like the data presented in Figure 4 D-F comes from all opto-identified D1- and D2MSNs. How many of these are gait-modulated? This information is missing (line 110). Pooling all units may dilute differences specific to gait-modulated units, therefore a similar analysis only on gait-modulated units should be performed.

      The reviewer is correct that the data presented in Figure 4 comes from all optogenetically tagged cells. We have now included a new panel, Figure 4H, which shows the proportion of D1 and D2 MSNs which encode limb phase, body speed, or start/stop. The reviewer suggested that a similar analysis only gait-modulated units should be performed. We prefer to stick to our current approach (of using all cells, regardless of whether they show significant gait modulation) because it is less biased. For example, even cells which do not pass our threshold for statistical significance may display weak but visible gait modulation.

      (5) Since 6-OHDA lesions are on the right hemisphere, we would expect left limbs to be more affected than right limbs (although right limbs may also compensate). It is therefore surprising that RF and RR strides seem slightly shorter than LF and LR (Fig 5G), and no differences in other stride parameters (Fig 5H-J). Could the authors comment on that? It may be that this is due to rotational behavior. One interesting analysis would be to compare activity during similar movements in healthy and 6-OHDA mice, eg epochs in which mice are turning right (which should be present in both groups) or walking a few steps straight ahead (which are probably also present in both groups).

      Unilateral 6OHDA lesions are associated with ipsiversive turning (in this case, toward the right). The reviewer noted that the stride length is shorter for the two right compared to the two left limbs (Figure 5G), which is consistent with a right turning bias. In line with this observation, the stride speed for the right limbs also seemed slower than for the left limbs (Figure 5I), though we agree this is a bit difficult to see in the plot due to the choice of y-axis range. We appreciate the reviewer’s suggestion to analyze activity during similar movements in healthy and lesioned mice. As discussed in reply to their third comment above, our data did not contain sufficient bouts of straight walking in lesioned mice, or turning in healthy mice, to make such analysis possible. We have acknowledged this issue in the Discussion section as a limitation of the unilateral 6OHDA model. And, in future work we hope to investigate turning effects in more detail using behavioral arenas which force animals to turn left or right at specific locations.

      (6) Multiple publications have shown that firing rates of D1-MSN and D2-MSN are dramatically changed after dopamine neuron loss. Is it possible that changes observed in gait-modulation might be biased by changes in firing rates? For example, dMSNs have exceptionally low overall activity levels after dopamine depletion (eg Parker...Schnitzer, 2018; Ryan...Nelson, 2018; Maltese...Tritsch, 2021); this might reduce the ability to detect modulation in the firing of dMSNs as compared to iMSNs, which have similar or increased levels of activity in dopamine depleted mice. Does vector length correlate with firing rate? In addition, the normalization method used (dividing firing rate by minimum) may amplify very small changes in absolute rates, given that the firing rates for MSN are very low. The authors could show absolute values or Z-score firing rates (Figure 6 A, D).

      The reviewer asked a number of important questions here. First, is it possible that changes in gait modulation are biased by changes in firing rates? We have included a new analysis comparing the average session-wide firing rate of D1 and D2 MSNs (Figure 6D & 6H). This showed that firing rates were statistically similar between D1 and D2 MSNs for both sham and dopamine lesioned mice. Thus, it seems unlikely that the imbalance in vector length is purely due to changes in firing rate. The reviewer referenced some literature (e.g. Parker & Schnitzer; Ryan & Nelson; Maltese & Tritsch) which does appear to show significant changes in the relative firing levels of D1/D2 MSNs after dopamine lesions. While we can only speculate about the reason for the discrepancy (e.g., differences in measurement method, behavioral task, or analysis method), we note that not all prior literature has reported such changes (e.g., Ketzef & Silberberg 2017).

      Author response image 2.

      Panels D & H. No difference in firing between D1 and D2 MSNs.

      Second, does vector length correlate with firing rate? Interestingly, we found that indeed it does. We now show that vector length is negatively correlated with firing rate (Figure 2 – figure supplement 1E), implying that cells with higher overall firing rates tend to have weaker phaselocking to the gait cycle. Though not shown in the manuscript, we found a similar negative correlation for D1 and D2 MSNs in both healthy and dopamine lesioned mice.

      Author response image 3,

      Panel E. Vector length is negatively correlated to firing rate.

      Third, the reviewer asked about our normalization method in Figure 6A etc, in which we divide by the minimum rate. We would like to clarify that this normalization method was only used for visualizing our data, but not for calculating the vector length. Therefore, we chose to leave the plots as they are.

      (7) The analysis shown in Fig 3C should also be done for opto-identified D1- and D2-MSNs (and for waveform-based classified units as noted above).

      We have now performed the same analysis for optogenetically tagged D1 and D2 MSNs from healthy mice (Figure 4H). As with our original analysis, both populations showed a similar proportion of neurons which encoded limb phase, start of movement, body speed, and the combination of these. We did not perform this analysis for waveform-based classified units as per our reason outlined in reply to the reviewer’s second comment above.

      Author response image 4.

      Panel H. Venn diagrams showing the percentage of D1 and D2 MSNs with significant responses to limb phase of at least one limb, body speed, and start and/or stop of motion.

      (8) Discussion: the origin of the gait-modulation as well as the possible mechanisms driving the alterations observed in 6-OHDA mice should be discussed in more detail.

      Our Discussion section includes the following paragraph speculating on the origin of gait modulation: “Movement-related neural activity is widespread in many brain areas, and it is plausible that the striatum receives both motor and sensory signals involved in gait generation. For example, the primary motor cortex, which projects to dorsal striatum, has been shown to exhibit rhythmic spiking activity consistent with gait phase coding (Armstrong & Drew 1984), suggesting a shared mechanism underlying the production of this code.” We appreciate the request to also discuss the possible mechanisms driving the alterations in 6OHDA mice. But this is a very complex topic which our study is not aimed at addressing. The range of possible mechanisms uncovered in the literature is vast – from synaptic changes in striatal microcircuits, to altered intrinsic excitability of D1/D2 MSNs, and network-level alterations. Therefore, we preferred to keep the discussion focused on gait and movement coding.

      Reviewer #2 (Public Review):

      Summary:

      Yang et al. recorded the activity of D1- and D2-MSNs in the dorsal striatum and analyzed their firing activity in relation to single-limb gait in normal and 6-OHDA lesioned mice. Although some of the observations of striatal encoding are interesting, the novelty and implications of this firing activity in relation to gait behavior remain unclear. More specifically, the authors made two major claims. First, the striatal D1- and D2-MSNs were phase-locked to the walking gait cycles of individual limbs. Second, dopamine lesions led to enhanced phase-locking between D2-MSN activity and walking gait cycles. The second claim was supported by the increase of vector length in D2-MSNs after unilateral 6-OHDA administration to the medial forebrain bundle. However, for the first claim, the authors failed to convincingly demonstrate that striatal MSNs were more phase-locked to gait with single-limb and step resolution than to the global gait cycles.

      We thank the reviewer for their feedback and for their comment that “the authors failed to convincingly demonstrate that striatal MSNs were more phase-locked to gait with single-limb and step resolution than to the global gait cycles.” We now present new analysis demonstrating that neurons are more phase-locked to single-limb gait rather than multiple limbs (Figure 2 – figure supplement 1, panels A-C). These results are discussed in detail in response to Reviewer #1’s first comment. For conciseness we will not repeat the same response here but instead refer the reviewer to Reviewer #1, comment #1.

      Strengths:

      It is a technically advanced study.

      Weaknesses:

      (1) The authors focused on striatal encoding of gait information in current studies. However, it remains unclear whether the part of the striatum for which the authors performed neuronal recording is really responsible for or contributing to gait control. A lesion or manipulation experiment disrupting the part of the striatum recorded seems a necessary step to test or establish its relationship to gait control.

      We agree that our study – like many others which employ recordings – is largely correlative, and that a direct causal relationship was lacking. We have therefore decided to present some data which, despite some caveats, shows that the striatum is in principle capable of altering gait performance (Figure 6 – figure supplement 2).

      Author response image 5.

      Optogenetic activation of D2 MSNs alters whole-body movement and single-limb gait.

      These new results are from healthy mice (n=4) receiving optogenetic stimulation of D2 MSNs over a 5 minute period. Panels A-E show changes in a variety of whole-body measures of motion, mostly replicating the results of Kravitz & Kreitzer 2010. Panels F-I show changes (statistically significant or trending) in a variety of gait parameters, with the greatest effects found on the single-limb stride duration and stride speed. Interestingly, Kravitz & Kreitzer 2010 actually examined effects of this stimulation on gait; quoting from their paper: “we examined gait parameters in D1-ChR2 and D2-ChR2 mice in response to illumination, using a treadmill equipped with a high-speed camera. We quantified multiple gait parameters with the laser on and off, and found no significant differences in the average or variance of stride length, stance width, stride frequency, stance duration, swing duration, paw angle and paw area on belt for either line….This indicates that activation of direct and indirect pathways in the dorsomedial striatum regulates the pattern of motor activity, without changing the coordination of ambulation itself.” We wonder therefore if the reviewer’s comment about causality may have stemmed from the negative result in Kravitz & Kreitzer 2010. In any event, we now present results which firmly show a link between striatal D2 MSNs and gait. To be clear, we are not claiming that Kravitz & Kreitzer’s study was fundamentally flawed, but that perhaps their ability to resolve gait changes using a commercial treadmill system, or their choice of dorsomedial as opposed to more lateral regions of the striatum may have contributed to the negative result.

      It is also important to acknowledge a limitation of our optogenetic stimulation experiment. Our optical stimulation was not phase-locked to the gait cycle; thus, technically, we did not address whether the phase code per se is involved in producing gait. We mention this caveat in the manuscript. Despite this, we believe the new data address the reviewer’s concern about lack of causality.

      (2) The authors attributed one of the major novelties to phase-locking of striatal neural activities with single-limb gait cycles. The claim was not clearly supported, as the authors did not demonstrate that phase-locking to single-limb gaits was more significant than phase-locking to global walking gait cycles. In rhythmic walking, the LR and RF limbs were roughly anti-phase with the LF and RR limbs (Fig. 1D, E). In line with this relationship, striatal neurons were mainly in-phase with LR and RF limbs and anti-phase with LF and RR limbs (Fig. 2J, K). One could instead interpret this as the striatal neurons spanned all the phases of the global walking gait cycles (Fig. 3D). To demonstrate phase-locking with individual limb movements, the authors need to show that neural activities were better correlated with a specific limb than to the global gait cycles.

      We sincerely appreciate the reviewer’s comment. As described above we now present new analysis demonstrating that neurons are more phase-locked to single-limb gait rather than multiple limbs (Figure 2 – figure supplement 1, panels A-C). These results are discussed in detail in response to Reviewer #1’s first comment. For conciseness we will not repeat the same response here but instead refer the reviewer to Reviewer #1, comment #1.

      (3) The observation of the enhancement of coupling between D2 MSN firing and the gait cycles was interesting, but the physiological interpretation was not clear (as the authors also noted in the Discussion), which hampers the significance of the observation.

      In the Discussion we comment on the potential behavioral significance of our findings, keeping in mind the reviewer’s earlier concern about the correlative nature of recordings. For example, we speculate that the increase in D2 MSN limb phase-locking strength contributes to bradykinetic symptoms, specifically the production and maintenance of a normal gait cycle and rhythm. We respectfully disagree with the reviewer about the limited significance of the observations, as this is the first study to describe striatal gait phase coding in detail, noting that gait impairments are a major motor symptom in PD. We believe that progress in better understanding and eventually treating PD will be made through a combination of correlative observations (i.e., neural recordings) and causal manipulations. There are both advantages and disadvantages to correlative as well as causal experiments.

      (4) Due to the lack of causality experiments as mentioned in the first comment above, the observations of coupling between striatal neuronal activity and gait control might well result from a third brain region/factor serving as the common source to both, whether in normal or dopamine lesioned brain. If this is the case, the significance and implications of current findings will be greatly limited.

      As mentioned above we have included new data to address this concern (Figure 6 – figure supplement 2). Please refer to Reviewer #2, comment #4 for a detailed discussion of these results and their caveats.

      Reviewer #3 (Public Review):

      In this study, Yang et al. address a fundamental question of the role of dorsal striatum in neural coding of gait. The authors study the respective roles of D1 and D2 MSNs by linking their balanced activity to detailed gait parameters. In addition, they put in parallel the striatal activity related to whole-body measures such as initiation/cessation of movement or body speed. They are using an elegant combination of high-resolution single-limb motion tracking, identification of bouts of movements, and electrophysiological recordings of striatal neurons to correlate those different parameters. Subpopulations of striatal output neurons (D1 and D2 expressing neurons) are identified in neural recordings with optogenetic tagging. Those complementary approaches show that a subset of striatal neurons have phase-locked activity to individual limbs. In addition, more than a third of MSNs appear to encode all three aspects of motor behavior addressed here, initiation/cessation of movement, body speed, and gait. This activity is balanced between D1 and D2 neurons, with a higher activity of D1 neurons only for movement initiation. Finally, alterations of gait, and the associated striatal activity, are studied in a mouse model of Parkinson's Disease, using 6-OHDA lesions in the medial forebrain bundle (MFB). In the 6OHDA mice, there is an imbalance toward D2 activity.

      Strengths:

      There is a long-standing debate on the respective role of D1 and D2 MSNs on the control of movement. This study goes beyond prior work by providing detailed quantification of individual limb kinematics, in parallel with whole-body motion, and showing a high proportion of MSNs to be phase-locked to precise gait cycle and also encoding whole-body motion. The temporal resolution used here highlights the preferential activity of D1 MSN at the movement starts, whereas previous studies described a more balanced involvement. Finally, they reveal neural mechanisms of dopamine depletion-induced gait alterations, with a preponderant phase-locked activity of D2 neurons. The results are convincing, and the methodology supports the conclusions presented here.

      Weaknesses:

      Some more detailed explanations would improve the clarity of the results in the corresponding section. Analysis of the 6OHDA experiments could be expanded to extract more relevant information.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) Panels I and J from Figure 6 are referred to in the text (line 158) but they don't exist.

      Thank you, we have corrected this in the text.

      (2) For the classification of striatal units into putative MSN, FS interneurons, and TANs, see Gage et al. DOI: 10.1016/j.neuron.2010.06.034 or Thorn et al. DOI: 10.1523/JNEUROSCI.178213.2014.

      As explained in the Public Reviews, Reviewer #1 comment #2 we opted not to perform an analysis by putative MSN, FSI, and TAN. We have performed analysis of different putative cell types in several of our other publications (e.g., Bakhurin & Masmanidis 2016, 2017; Lee & Masmanidis 2019). However, this study already relies on a more rigorous method – optogenetic tagging – to identify D1 and D2 MSNs. We felt that adding a second, more subjective and therefore less rigorous identification method based on spike waveforms would add unnecessary confusion in how the results are presented and interpreted. For example, we were unsure how to address the situation where an opto-tagged D1 or D2 MSN may be classified as a putative FSI or TAN according to spike waveform criteria. For this reason, we decided not to perform an analysis by putative MSN, FSI, and TAN. Finally, we have made all our electrophysiological data available should someone want to perform this analysis themselves.

      (3) The discussion section could be improved by elaborating on the origin and function of these gait signals in the striatum, as well as the mechanisms underlying changes in the 6-OHDA model. In addition, it would be important to discuss the limitations of this model, since unilateral 6-OHDA lesions may not accurately recapitulate parkinsonian gait deficits, as it results in a very asymmetric gait.

      Our Discussion section includes a paragraph speculating on the origin of gait modulation in the striatum, and another paragraph addressing the limitation that unilateral 6OHDA lesions induce gait asymmetry. We appreciate the request to also discuss the possible mechanisms driving the alterations in 6OHDA mice. But this is a very complex topic which our study is not aimed at addressing. The range of possible mechanisms uncovered in the literature is vast – from synaptic changes in striatal microcircuits, to altered intrinsic excitability of D1/D2 MSNs, and network-level alterations. Therefore, we preferred to keep the discussion focused on gait and movement coding.

      Reviewer #2 (Recommendations For The Authors):

      (1) The authors denoted the limb movement sequences as LR-LF-RR-RF, with limbs on the same left/right side moving first. However, considering multiple gait cycles, the sequence could also be described as RF-LR-LF-RR, with movements of the diagonal limbs temporally closer to each other, which was more intuitive from the visual inspection of Fig. 1D. The LR-LF-RR-RF denotation would make more sense if the authors could demonstrate that a walking bout almost always started from LR, as seen in the two examples in Fig. 1D.

      We designated the sequence as LR-LF-RR-RF to illustrate the lateral sequence pattern. But the reviewer is correct that a shifted version of this sequence, such as RF-LR-LF-RR, is also valid. We are not making any claim that the LR limb is always the first to move in a walking bout, but rather, that limbs on the same side of the body move one after the other, followed by the limbs on the opposite side. We have edited the text to hopefully clarify this point: “Mice walked with a lateral sequence gait pattern (e.g., LRLFRRRF), with the limbs on the same side of the body moving one after the other, followed by movement of limbs on the opposite side (Figure 1E).”

      (2) The study identified a biased D1-MSN activation at movement initiation, which was not reported in previous studies that relied on measuring calcium dynamics. The authors attributed the difference to the temporal resolution of electrophysiological versus optic methods. The authors would probably notice that in some previous studies that relied also on optic-tagging and electrophysiological recordings, start/stop activity was not found to be different between direct and indirect pathway MSNs. The authors should discuss these studies and offer some possible explanations.

      This is an oversight on our part, and we thank the reviewer for noting this. We are aware of one such study (Jin & Costa 2014); we apologize if other studies were missed. The Discussion has been updated as follows to discuss this paper: “We also note that another study employing optogenetic tagging did not find significant D1/D2 MSN differences is start/stop activity (Jin & Costa 2014). However, the movement being measured was an instrumental action (rewardguided lever pressing), as opposed to self-initiated motion examined in our work. This suggests either that imbalances between D1 and D2 MSN start activity may be more pronounced under specific behavioral conditions, or that results vary depending on how movement initiation and cessation events are identified.”

      (3) The authors could add some denotations to the peak firing rates in Fig. 3D to aid visualization, so that readers could get a sense of the distribution of neurons preferring each phase of the movements.

      We appreciate this suggestion. We tried adding various colored lines to denote the peak firing rates, but ultimately, we felt the lines were not helpful and potential deleterious for some readers. We thus decided not to add any lines to the plot.

      (4) Although the relative strength of D1/D2-MSN coding of body speed and movement cessation was found after dopamine lesion, it seemed that D1-MSNs cessation coding, as well as D1- and D2-MSN speed coding, were all altered after dopamine lesion (Fig. S3). The authors could mention these to avoid misunderstandings.

      We thank the reviewer for their observation. In the Results, we now mention that “while speed coding remained balanced between D1 and D2 MSNs, there was a substantial reduction in the speed coding score of both cell types after dopamine lesions.” The stop modulation index did not change appreciably.

      Reviewer #3 (Recommendations For The Authors):

      (1) A suggestion would be to put more emphasis in the title on the first parts of the study, i.e. detailed correlation between striatal activity and quantified motion, and not only focus on the dopamine depletion model.

      We considered other titles, but felt that our current choice is appropriate given that the study’s climax is with the dopamine lesion results in Figures 5 & 6.

      (2) The calculation and the significance of the vector length should be more detailed in the results as it is used all along as a measure of "the strength of neural entrainment to the gait cycle".

      We have added the following statement in the Results section to clarify the significance of vector length: “The vector length is a unitless parameter which can theoretically vary from 0 to 1, with 0 representing a neuron whose spikes occur at random limb phases, and 1 representing a neuron which always spikes at the same phase. Thus, higher vector length indicates a stronger entrainment of spiking activity to a specific limb phase.” For details on how vector length is calculated we refer readers to our Methods, specifically the section entitled “Gait phase coding analysis.”

      (3) There is no difference in the ipsi- or contralateral limbs while recordings are made only in the right hemisphere. Given that MSNs receive inputs from IT and PT neurons from the motor cortex, would it not be expected to have differences in the phase-locked activity to right versus left limbs? This is a question also with the dopamine depletion model which is performed with unilateral 6OHDA injections.

      This is something we also wondered and were somewhat surprised by the lack of a contralateral bias in the phase locking vector length, as shown in Figure 2 – figure supplement 1D. We have two hypotheses as to why there is no ipsi/contra-lateral bias. First, it is possible that striatal neurons receive similar levels of synaptic input signaling ipsi/contra-lateral limb movements. Second, the strongly correlated motion of diagonally opposed limbs may give the appearance that neurons that are phase-locked to one limb (e.g., LF) are also locked to the diagonally opposite limb (i.e., RR). We see evidence of this diagonal limb coupling in Figure 2 – figure supplement 1B.

      (4) Among the 45% of striatal neurons that display significant phase-locking to at least one limb, it would be interesting to describe the % of neurons being phase-locked to several limbs and whether they are specific subtypes. Are there animals with more phase-locked cells in several limbs?

      This is indeed a very interesting and important point which relates to the major concern that “evidence supporting the conclusion that striatal neurons encode single-limb gait is incomplete.” As described above we now present new analysis demonstrating that neurons are more phaselocked to single-limb gait rather than multiple limbs (Figure 2 – figure supplement 1, panels AC). These results are discussed in detail in response to Reviewer #1’s first comment. For conciseness we will not repeat the same response here but instead refer the reviewer to Reviewer #1, comment #1. With regard to whether there are specific subtypes, we performed the same analysis on optogenetically identified D1/D2 MSNs and found similar trends, but did not show these results in the manuscript to avoid redundancy.

      (5) The Venn diagram in Fig. 3C shows ~40% of striatal cells encoding body speed, single-limb and start/stop information. Nevertheless, this percentage is limited by the number of single-limb phase-locked cells as almost all have a firing rate related to body speed and start/stop signals. This could be discussed.

      This is a very interesting observation. Basically, the reviewer is noting that almost all the phaselocked cells also encode start/stop and/or speed. We have now updated the Discussion to specifically discuss this observation: “We found a different percentage of striatal neurons which encoded limb phase, movement initiation or cessation, and speed (Figure 3). Among these three categories, limb phase coding cells represented the smallest population with ~45% of neurons, as opposed to ~90% for start/stop or speed. In addition, nearly all phase coding cells were also significantly responsive to start/stop or speed, whereas a sizable proportion of start/stop or speed coding cells were not entrained to limb phase. It is unclear, however, whether these population size differences reflect a proportionally smaller role for the striatum in regulating single-limb gait as opposed to whole-body movement initiation, cessation or speed.”

      (6) D1/D2 analysis:

      For optogenetic identification of D1 and D2 neurons, 39 D1 neurons and 40 D2 neurons were extracted from the total of 274 recorded neurons while 222 neurons were optogenetically tagged according to the mat and meth. Were there any technical difficulties that made it difficult to identify more neurons?

      The low yield of optogenetic tagging is quite common in the literature due to the rigorous criteria which must be satisfied in order to qualify as a tagged neuron (e.g., Kvitsiani & Kepecs 2013). The number 222 neurons quoted in the methods reflects the entirety of optogenetically tagged neurons in this study. Our study contained 33 mice, thus the average number of tagged units per animal was 222/33 ~ 6.7 units/animal. This is actually comparable to or slightly better than the yield reported in some other striatal literature (see for example, Figure 1 of Ryan & Nelson 2018).

      It is mentioned that "a subset" of these were phase-locked to a single limb. It would be interesting to specify the exact percentage of those neurons for D1 and D2 populations.

      Phase-locking of D2 neurons seems less sharp than D1 neurons, with a lower firing rate (Fig. 4D), please comment. Also difference in vector length for LR while none for other limbs, why? There is a balanced activity of D1 and D2 MSNs during walking (speed) and single-limb movements, but more D1 MSNs active at movement initiation. Is it also true for stop signals? Are they separated based on the speed threshold of 20 mm/s?

      As mentioned above, our new analysis specifically examines the percentage of all neurons which are phase locked to a single limb (Figure 2 – figure supplement 1, panels A-C). We have performed the same analysis on optogenetically tagged D1/D2 MSNs and found similar trends, but not show these results in the manuscript to avoid redundancy. With regard to whether phase-locking of D2 is less sharp than D1 MSNs, the “sharpness” of phase-locking is characterized by the mean vector length. And we show that on average, the vector length is statistically the same for D1 and D2 MSNs in healthy mice (Figure 4F). The reviewer noted that the D2 vector length in Figure 4F appears visibly higher for LR while not for other limbs, however, this difference is not statistically significant. With regard to whether more D1 MSNs are active during movement cessation, we show that both sham and dopamine lesioned mice have similar levels of D1/D2 MSN activity during stop (Figure 6 – figure supplement 1, panels A & B). Details of how start, stop, and speed are calculated are provided in the Methods.

      The relationship between firing and body speed (Fig. 4H) displays differences between D1 and D2. If a speed inferior to 20 mm/s, corresponds to "start or stop signal" as mentioned in the mat and meth, then early difference would correspond to start, but still there is a difference between 20 and 100 mm/s and after 150 mm/s. These results should be commented on.

      The reviewer is correct that in the plot of firing rate vs body speed (Figure 4J), there visibly appears to be a difference between D1 and D2 MSNs at low speeds. However, according to our pre-determined measure of speed coding which relies on the correlation coefficient between firing rate and speed, D1 and D2 MSNs have similar speed coding indices. Since there is a precedent for using the correlation coefficient to quantify speed coding (Fobbs & Kravitz 2020; Kropff & Moser 2015), we prefer to stick with this measure despite some caveats. Furthermore, the apparent difference between D1 and D2 MSNs in Figure 4J is not seen in either sham or dopamine lesioned mice (Figure 6 – figure supplement 1, panels D & E). Taken together, we do not believe the apparent speed coding difference in Figure 4J rises to the level of a consistent result.

      (7) The timing of normalized firing rate in relation to start/stop signals might be also quite interesting to comment on. D1 neurons have stronger activation for start signals and it seems that it is also earlier, with D2 activated after the onset of the movement (Fig. 4G).

      We appreciate the observation that D1 neurons appear to fire a little earlier than D2 neurons in Figure 4I. However, this did not rise to the level of a statistically significant result by our attempted quantitative analysis (not shown). Furthermore, the earlier timing of D1 is not apparent in sham lesioned animals in Figure 6I, thus overall we cannot make any confident statements about earlier timing of D1 start signals.

      In dopamine lesion experiments, in sham mice, it seems that both D1 and D2 have higher activity after the onset of the movement and that the peak of D2 activity is earlier (Fig. 6G). In 6OHDA mice, both peaks are after the onset of the movement although they are much less clearly defined.

      Both peaks become less sharp after 6OHDA lesions, but in terms of amplitude the main effect is a reduction in the D1 start signal. This is reflected in the reduced D1 start modulation index whereas the D2 index remains relatively constant.

      (8) 6OHDA model displays much fewer walking bouts with lower speed and initiation rate. It would be important to include in the figure a similar representation to Fig.1 with distributions of stride frequency, duration, and length to illustrate the difference between control and 6OHDA mice. On average, how many walking bouts were analyzed in control and 6OHDA animals?

      We have added new data similar to Figure 1 with distributions of stride frequency, duration, and length to illustrate the difference between sham and 6OHDA mice (Figure 5 – figure supplement 1, panels B & C). We also added the following information on the number of walking bouts: “The mean number of walking bouts per session was reduced from 124 ± 42 in sham to 47 ± 19 in dopamine lesioned mice (mean ± SD).”

      The initiation rate is particularly low in 6OHDA animals, 3-4 per minute, did the authors make longer behavioral recordings to extract enough initiation/stop signals for neural correlation analysis?

      All of our recordings were of the same duration (30 minutes). This duration was pre-determined at the beginning of the study to ensure consistency.

      The stride length seems smaller on the right limbs in 6OHDA mice and vector length in D2 neurons as well, while there is no change in D1 neurons. Is it a significant effect? If yes, it would be important to comment on this.

      The ANOVA test in those figures was not designed to perform post-hoc multiple comparisons between different limbs. However, if one changes the ANOVA design then the effect for stride length is significant. This is probably related to the ipsiversive turning bias in the unilateral 6OHDA lesion model. Though we have not changed the ANOVA design, in the Discussion we do comment on the shorter stride length on the right limbs in 6OHDA mice in Figure 5G. There is no significant difference in D2 vector length between different limbs.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Debeuf et al. introduce a new, fast method for the selection of suitable T cell clones to generate TCR transgenic mice, a method claimed to outperform traditional hybridoma-based approaches. Clone selection is based on the assessment of the expansion and phenotype of cells specific for a known epitope following immune stimulation. The analysis is facilitated by a new software tool for TCR repertoire and function analysis termed DALI. This work also introduces a potentially invaluable TCR transgenic mouse line specific for SARS-CoV-2.

      Strengths:

      The newly introduced method proved successful in the quick generation of a TCR transgenic mouse line. Clone selection is based on more comprehensive phenotypical information than traditional methods, providing the opportunity for a more rational T cell clone selection.

      The study provides a software tool for TCR repertoire analysis and its linkage with function.

      The findings entail general practical implications in the preclinical study of a potentially very broad range of infectious diseases or vaccination.

      A novel SARS-CoV-2 spike-specific TCR transgenic mouse line was generated.

      Weaknesses:

      The authors attempt to compare their novel method with a more conventional approach to developing TCR transgenic mice. In this reviewer's opinion, this comparison appears imperfect in several ways:

      (1) Work presenting the "traditional" method was inadequate to justify the selection of a suitable clone. It is therefore not surprising that it yielded negative results. More evidence would have been necessary to select clone 47 for further development of the TCR transgenic line, especially considering the significant time and investment required to create such a line.

      Based on Supplementary Figure 1A only, we understand the concern of the reviewer. However, the data presented in Supplementary Figure 1A is collected during the first rough screening of clones where only the production of IL-2 and IFN-y was measured as a readout for activation. Thereafter, a large selection of responsive clones was further grown and co-cultured with a dose-titration of the antigenic peptide pool. In this second co-culture, also flow cytometry readouts are included such as CD69 expression (as shown in Supplementary Figure 1B). Finally, a narrower selection of responder clones was co-cultured with the different individual peptides to unravel the specificity of the TCR of the clone. In conclusion, the clone was tested at least three times in three distinct set-ups with multiple different readouts.

      However, a good evaluation of a clone in an in vitro setting does not necessarily translate in optimal functioning of the cells in a biological context. For instance, some clones survive better in an in vitro setting than others or have already a more activated profile before stimulation.

      (2) The comparison is somewhat unfair, because the methods start at different points: while the traditional method was attempted using a pool of peptides whose immunogenicity does not appear to have been established, the new method starts by utilising tetramers to select T cells specific for a well-established epitope.

      Given the costs and time involved, only a single clone could be tested for either method, intrinsically making a proper comparison unfeasible. Even for their new method, the authors' ability to demonstrate that the selected clone is ideal is limited unless they made different clones with varying profiles to show that a particular profile was superior to others.

      In my view, there was no absolute need to compare this method with existing ones, as the proposed method holds intrinsic value.

      We acknowledge the importance of the well-established hydridoma technology and in no way intended to compare these methods head-to-head, nor do not want to question the validity of the classical methods. The reason why we also wanted to show the failed CORSET8 mouse was to highlight the parts of the TCR generating process which could be rationalized. We again want to emphasize that we do not want to compare methods in any way and recognise that we started from two different bases in terms of clone selection (peptide pool stimulation versus tetramer staining). While the tetramer staining that was employed in the generation of CORSET8 mice allowed to enrich the samples for specific responder clones, this enrichment step is not an absolute requirement for the implementation of the presented method or for the successful generation of a TCR Tg mouse model. An alternative approach could be to use the described method to select for activated and expanded clones upon immunisation and test their reactivity in subsequent steps using peptide stimulation before selecting a receptor. In conclusion, we merely wish to present a novel roadmap for others to use for the generation of their TCR Tg mouse to aid in the selection of the most preferable clone for their purposes.

      (3) While having more data to decide on clone selection is certainly beneficial, given the additional cost, it remains unclear whether knowing the expression profiles of different proteins in Figure 2 aids in selecting a candidate. Is a cell expressing more CD69 preferable to a cell expressing less of this marker? Would either have been effective? Are there any transcriptional differences between clonotype 1 and 2 (red colour in Figure 2G) that justify selecting clone 1, or was the decision to select the latter merely based on their different frequency? If all major clones (i.e. by clonotype count) present similar expression profiles, would it have been necessary to know much more about their expression profiles? Would TCR sequencing and an enumeration of clones have sufficed, and been a more cost-effective approach?

      The method we present in the paper serves as a proof-of-concept, to be adapted to the researcher’s own needs. We agree with the reviewer that for our intentions with the CORSET8 mice, TCRseq in combination with an enumeration of the clones could also have sufficed and would lower the cost of sequencing. However, we wish to present a roadmap for others to use for the generation of their TCR Tg mouse. Important in this, is that the cellular phenotype, and activation state can be taken into consideration, which might for some projects be essential.  

      Nonetheless, we do see clear interclonal differences regarding the expression of “activation” genes, where clone 1 is clearly one of the well activated and interferon producing clones (as shown in Author response image 1). As such, researchers could expand these types of analysis to probe for specific phenotypes of characteristics.

      Author response image 1.

      (4) Lastly, it appears that several of the experiments presented were conducted only once. This information should have been explicitly stated in the figure legends.

      To control for interexperimental variation, every experiment represented in the manuscript has been performed at least two times. We have added the additional information regarding the experimental repetitions and groups in the figure legends.

      Reviewer #2 (Public Review):

      Summary:

      The authors seek to use single-cell sequencing approaches to identify TCRs specific for the SARS CoV2 spike protein, select a candidate TCR for cloning, and use it to construct a TCR transgenic mouse. The argument is that this process is less cumbersome than the classical approach, which involves the identification of antigen-reactive T cells in vitro and the construction of T cell hybridomas prior to TCR cloning. TCRs identified by single-cell sequencing that are already paired to transcriptomic data would more rapidly identify TCRs that are likely to contribute to a functional response. The authors successfully identify TCRs that have expanded in response to SARS CoV2 spike protein immunization, bind to MHC tetramers, and express genes associated with functional response. They then select a TCR for cloning and construction of a transgenic mouse in order to test the response of resulting T cells in vivo following immunization with spike protein of coronavirus infection.

      Strengths:

      (1) The study provides proof of principle for the identification and characterization of TCRs based on single-cell sequencing data.

      (2) The authors employ a recently developed software tool (DALI) that assists in linking transcriptomic data to individual clones.

      (3) The authors successfully generate a TCR transgenic animal derived from the most promising T cell clone (CORSET8) using the TCR sequencing approach.

      (4) The authors provide initial evidence that CORSET8 T cells undergo activation and proliferation in vivo in response to immunization or infection.

      (5) Procedures are well-described and readily reproducible.

      Weaknesses:

      (1) The purpose of presenting a failed attempt to generate TCR transgenic mice using a traditional TCR hybridoma method is unclear. The reasons for the failure are uncertain, and the inclusion of this data does not really provide information on the likely success rate of the hybridoma vs single cell approach for TCR identification, as only a single example is provided for either.

      We refer to comments 2 and 3 of reviewer 1 for an answer to this point.

      (2) There is little information provided regarding the functional differentiation of the CORSET8 T cells following challenge in vivo, including expression of molecules associated with effector function, cytokine production, killing activity, and formation of memory. The study would be strengthened by some evidence that CORSET8 T cells are successfully recapitulating the functional features of the endogenous immune response (beyond simply proliferating and expressing CD44). This information is important to evaluate whether the presented sequencing-based identification and selection of TCRs is likely to result in T-cell responses that replicate the criteria for selecting the TCR in the first place.

      We agree with the reviewer that the data in the initial manuscript included only a limited in vivo functional validation of the CORSET8 T cells. Therefore, we extended these in vivo readouts and measured IFN-g production, CD69, T-bet expression (as measure for activation) and Ki-67 expression (as alternative readout than CTV for proliferation). In the single cell data, we saw that these markers were more pronounced in the selected clone compared to other clones. We could confirm these findings in vivo, and found a stronger induction of IFN-g, CD69, T-bet and Ki-67 in CORSET8 T cells compared to endogenous CD45.2 cells and even Spike-Tetramer+ CD45.2 endogenous cells. We added these data in Figure 4.

      (3) While I find the argument reasonable that the approach presented here has a lot of likely advantages over traditional approaches for generating TCR transgenic animals, the use of TCR sequencing data to identify TCRs for study in a variety of areas, including cancer immunotherapy and autoimmunity, is in broad use. While much of this work opts for alternative methods of TCR expression in primary T cells (i.e. CRISPR or retroviral approaches), the process of generating a TCR transgenic mouse from a cloned TCR is not in itself novel. It would be helpful if the authors could provide a more extensive discussion explaining the novelty of their approach for TCR identification in comparison to other more modern approaches, rather than only hybridoma generation.

      By integrating the recent technological advances in single cell sequencing into the generation of TCR Tg mice, possibilities arise to rationalize clone selection regarding clonal size, lineage/phenotype and functional characteristics. Often, the selection process based on hybridoma selection yields multiple epitope specific clones that upregulate CD69 or IL-2, and only minimal functional and phenotypic parameters are checked before prioritizing one clone to proceed with. In our experience, transgenic clones selected in this way sometimes render TCR clones unable to compete with endogenous polyclonal T clones in vivo. Taken all these caveats into account, the novelty we present here is that the researcher is fully able to select clones based on several layers of information without the need for extensive or repeated screening. Moreover, the selection of the TCR Tg clone can be done via the interactive and easily interpretable DALI tool. Owing to the browser-based interactive GUI, immunologists having limited coding experience can effectively analyse their complex datasets.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Regarding Supplementary Figure 1A was the experiment conducted more than once? Clone 47 seems minimally superior to the other clones. Incorporating a positive control, such as the response of the OT-I hybridoma to SIINFEKL, could have provided a benchmark to gauge the strength of the observed responses.

      Also, what was the concentration of the peptide used to restimulate the T cells in vitro? High peptide concentrations can lead to non-specific responses. Ideally, a titration should have been performed, perhaps in a subsequent experiment that only tested those clones that responded well initially. Given the resources required to create and maintain a transgenic mouse line, proceeding with the chosen clone based on the data presented seems to carry considerable risk.

      The experiment has been performed three times. The data presented in Supplementary Figure 1A is collected during the first rough screening of clones where only the production of IL-2 and IFN-y was measured as a readout for activation. Thereafter, a large selection of responsive clones was further grown and co-cultured with a dose-titration of the antigenic peptide pool. In this second co-culture, also flow cytometry readouts are included such as CD69 expression (as shown in Supplementary Figure 1B). Finally, a narrower selection of responder clones was co-cultured with the different individual peptides to unravel the specificity of the TCR of the clone. In conclusion, the clone was tested at least three times in three distinct set-ups with multiple different readouts.

      In Supplementary Figure 1C, no response to stimulation was detected. Ideally, this figure should have included a positive control, such as PMA/Ionomycin or aCD3/CD28 stimulation.

      We agree with the reviewer that this experiment should have included a positive control to validate the non-specific responsiveness of the clone and the technical feasibility of the experiment. Unfortunately, the initial CORSET8 line is frozen and is thus not easily available to repeat the experiment.

      Can the authors clarify their gating strategy in the legend of In Supplementary Figure 1D?

      Plotted cells are non-debris > single cells > viable cells > CD45+. We have added the information to the legend of Supplementary Figure 1D.

      In Figure 2, the figure legend should provide more detail on which cells were sorted for the single-cell RNA sequencing analysis. The materials and methods section explains that cells were stained for CD44. Were activated cells then sorted (either tetramer-positive or -negative), plus naïve CD8 T cells from a naïve mouse?

      Supplementary Figure 2 contains the detailed gating strategy during the sort for the single cell experiment. We have added additional red gates to the plots to clarify which samples were sent for sequencing. This has been adapted in the figure legends of both Figure 2 and Supplementary Figure 2. 

      In Figure 3, Rag1 sufficient transgenic mice display similar numbers of CD4 and CD8 T cells as WT mice in the spleen. Typically, transgenic mice present skewed frequencies of T cells towards the type generated (CD8 in this case), which the authors only found in the thymus of CORSET8 mice. Could this be discussed?

      The comment of the reviewer is valid as there is indeed a skewing towards CD8 T cells in the thymi of the CORSET8 mice. We looked back into the data of the experiments and noticed that poor resolution of some markers might have resulted in improper results. We have repeated this and added another T cell marker (TCRbeta) next to the already included CD3e marker. By including both markers, we were able to show that also in spleen the skewing towards the CD8 T cell phenotype is present.

      How many repetitions were performed for the experiments in Figures 3D and 3E? How many mice were analyzed for Figure 3E? Please provide this information in the figure legend. Also, include a proper quantification and statistical analysis of the data shown.

      New quantification graphs with statistical analysis have been added to Figure 3E. The accompanying figure legend has been adapted. The co-culture displayed in Figure 3D is a representative experiment of two repetitions.

      Figure 4C includes 3-4 mice per group. This experiment should have been replicated, and this information should be indicated in the figure legend.

      We apologise for omitting this data in the figure legend. The experiment presented in Figure 4A-C has been repeated twice, yielding results following the same trend. We were unable to pool the data as two different proliferation dyes were used in the separate experiments (CFSE and CTV). Furthermore, in the in vivo BSL3 experiments represented in figure 4E-H, we always took along the Spike/CpG-group as positive control. We have added the additional information regarding the experimental repetitions and groups in the figure legend.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review):

      Aging is associated with a number of physiologic changes including perturbed circadian rhythms. However, mechanisms by which rhythms are altered remain unknown. Here authors tested the hypothesis that age-dependent factors in the sera affect the core clock or outputs of the core clock in cultured fibroblasts. They find that both sera from young and old donors are equally potent at driving robust ~24h oscillations in gene expression, and report the surprising finding that the cyclic transcriptome after stimulation by young or old sera differs markedly. In particular, genes involved in the cell cycle and transcription/translation remain rhythmic in both conditions, while genes associated with oxidative phosphorylation and Alzheimer's Disease lose rhythmicity in the aged condition. Also, the expression of cycling genes associated with cholesterol biosynthesis increases in the cells entrained with old serum. Together, the findings suggest that age-dependent blood-borne factors, yet to be identified, affect circadian rhythms in the periphery. The most interesting aspect of the paper is that the data suggest that the same system (BJ-5TA), may significantly change its rhythmic transcriptome depending on how the cells are synchronized. While there is a succinct discussion point on this, it should be expanded and described whether there are parallels with previous works, as well as what would be possible mechanisms for such an effect.

      We’ve expanded our discussion in the manuscript to discuss possible mechanisms and also how the genes/pathways implicated in our study relate to other aging literature.  

      Major points: 

      Fig 1 and Table S1. Serum composition and levels of relevant blood-borne factors probably change in function of time. At what time of the day were the serum samples from the old and young groups collected? This important information should be provided in the text and added to Table S1. 

      We made sure to highlight the collection time in the abstract of the manuscript “We collected blood from apparently healthy young (age 25-30) and old (age 70-76) individuals at 14:001 and used the serum to synchronize cultured fibroblasts.” The time of blood draw is also in sections of the paper (Intro and Methods). Since Table S1 is demographic information, we did not think that the blood draw time fit best there, but hopefully it is now clear in the text.

      Fig 2A. Luminescence traces: the manuscript would greatly benefit from inclusion of raw luminescence traces.

      Raw luminescence traces have been added to Figure S3 (S3A).

      Fig 2. Of the many genes that change their rhythms after stimulation with young and old sera, what are the typical fold changes? For example, it would be useful to show histograms for the two groups. Does one group tend to have transcript rhythms of higher or lower fold changes? 

      We’ve presented these data in Figure S5. There are a few significant differences, but largely the groups are similar in terms of fold change.

      Fig. 2 Gene expression. Also here, the presentation would benefit from showing a few key examples for different types of responses. 

      Sample traces of genes that gain rhythmicity, lose rhythmicity, phase shift, and change MESOR are now illustrated in Figure S6.

      What was the rationale to use these cells over the more common U2OS cells? Are there similarities between the rhythmic transcriptomes of the BJ-5TA cells and that of U2OS cells or other human cells? This could easily be assessed using published datasets. 

      The original rationale to use BJ-5TA fibroblast cells was that we were aiming to build upon an observation found in a previous study2 which showed that circadian period changes with age in human fibroblasts. While our findings did not match theirs, we think an added benefit of using the BJ-5TA line is that unlike U2OS cells, it is not a carcinoma derived cell line. We’ve added this point in lines 98-101.

      Our study finds many more rhythmic transcripts compared to the previous studies examining U2OS cells. This can be attributed to several factors including differences in methods, including the use of human serum in our study, cell type differences, or decoupling of rhythms in some cancer cells. While a comparison of BJ-5TA cells and U2OS cells could be interesting, a proper comparison requires investigation of many data sets, since any pair of BJ-5TA and U2OS data sets will most likely differ in some detail of experimental design or data processing pipeline, which could contribute to observed differences in rhythmic transcripts.

      That being said, we compared clock reference genes (see Author response image 1) between BJ-5TA and U2OS cells, comparing circadian profiles obtained from our data with those available on CircaDB. These circadian profiles exhibit many similarities and a few differences. The peak to trough ratios (amplitudes) are quite similar for ARNTL, NR1D1, NR1D2, PER2, PER3, and are about 25% lower for CRY1 and somewhat higher for TEF (about 15%) in our data. We find that the MESORS are generally similar with the exception of NR1D1 which is much lower and NR1D2 which is much higher in our data.

      Author response image 1.

      BJ-5TA and U2OS Cells Exhibit Similar Profiles of Circadian Gene Transcription. We compared the transcriptomic profiles of the BJ-5TA cells in young and old serum (left) to the U2OS transcriptomic data (right) available on CircaDB, a database containing profiles of several circadian reference genes in U2OS cells. This figure suggests that circadian profiles of these genes exhibit many similarities. We find that the peak to trough ratios (amplitudes) are similar for ARNTL, NR1D1, NR1D2, Per2, PER3, and that the MESORS are similar (with the exception of NR1D1 which is much lower and NR1D2 which is much higher in the BJ-5TA cells). We find that the amplitudes of CRY1 is ~25% lower and TEF is ~15% higher for the BJ5TA cells. The axis for plots on the left show counts divided by 3.5 in order to made MESORs of ARNTL similar to ease comparison.

      For the rhythmic cell cycle genes, could this be the consequence of the serum which synchronizes also the cell cycle, or is it rather an effect of the circadian oscillator driving rhythms of cell cycle genes? 

      This is an interesting point. Given our previous data showing that the cell cycle gene cyclin D1 is regulated by clock transcription factors3, we believe the circadian oscillator drives, or at least contributes, to rhythms of cell cycle genes. However, the serum clearly makes a difference as we find that MESORs of cell cycle genes decrease with aged serum. This is consistent with the decreased proliferation previously observed in aged human tissue4.

      While the reduction of rhythmicity in the old serum for oxidative phosphorylation transcripts is very interesting and fits with the general theme that metabolic function decreases with age, it is puzzling that the recipient cells are the same, but it is only the synchronization by the old and young serum that changes. Are the authors thus suggesting that decrease of metabolic rhythms is primarily a non cell-autonomous and systemic phenomenon? What would be a potential mechanism? 

      We are indeed suggesting this, although it is also possible that it is not cycling per se, but rather an overall inefficiency of oxidative phosphorylation that is conveyed by the serum. Relating other work in the field to our findings, we’ve added the following to our discussion: “Previous work in the field demonstrates that synchronization of the circadian clock in culture results in cycling of mitochondrial respiratory activity5,6 further underscoring the different effects of old serum, which does not support oscillations of oxidative phosphorylation associated transcripts. Age-dependent decrease in oxidative phosphorylation and increase in mitochondrial dysfunction7 has been seen in aged fibroblasts8 and contributes to age-related diseases9. We suggest that the age-related inefficiency of oxidative phosphorylation is conferred by serum signals to the cells such that oxidative phosphorylation cycles are mitigated. On the other hand, loss of cycling could contribute to impairments in mitochondrial function with age.”

      The delayed shifts after aged serum for clock transcripts (but not for Bmal1) are interesting and indicate that there may be a decoupling of Bmal1 transcript levels from the other clock gene phases. How do the authors interpret this? could it be related to altered chronotypes in the elderly? 

      One possible explanation is that the delay of NPAS2, BMAL1’s binding partner, results in the delay of the transcription of clock controlled genes/negative arm genes. Since the RORs do not seem to be affected, Bmal is transcribed/translated as usual, but there isn’t enough NPAS2 to bind with BMAL1. In this case downstream genes are slower to transcribe causing the phase delay.

      Reviewer #2 (Public Review): 

      Schwarz et al. have presented a study aiming to investigate whether circulating factors in sera of subjects are able to synchronize depending on age, circadian rhythms of fibroblast. The authors used human serum taken from either old (age 70-76) or young (age 25-30) individuals to synchronise cultured fibroblasts containing a clock gene promoter driven luciferase reporter, followed by RNA sequencing to investigate whole gene expression. 

      This study has the potential to be very interesting, as evidence of circulating factors in sera that mediate peripheral rhythms has long been sought after. Moreover, the possibility that those factors are affected by age which could contribute to the weaken circadian rhythmicity observed with aging. 

      Here, the authors concluded that both old and young sera are equally competent at driving robust 24 hour oscillations, in particular for clock genes, although the cycling behaviour and nature of different genes is altered between the two groups, which is attributed to the age of the individuals. This conclusion could however be influenced by individual variabilities within and between the two age groups. The groups are relatively small, only four individual two females and two males, per group. And in addition, factors such as food intake and exercise prior to blood drawn, or/and chronotype, known to affect systemic signals, are not taken into consideration. As seen in figure 4, traces from different individuals vary heavily in terms of their patterns, which is not addressed in the text. Only analysing the summary average curve of the entire group may be masking the true data. More focus should be attributed to investigating the effects of serum from each individual and observing common patterns. Additionally, there are many potential causes of variability, instead or in addition to age, that may be contributing to the variation both, between the groups and between individuals within groups. All of this should be addressed by the authors and commented appropriately in the text. 

      We are not aware of any specific feature distinguishing the subjects (other than age) that could account for the differences between old and young. The fact that we see significant differences between the two groups, even with the relatively small size of the groups, suggests strongly that these differences are largely due to age. Nevertheless, we acknowledge that individual variability can be a contributing factor. For instance, the change in phase of clock genes appears to be driven largely by two subjects. We have commented on this and individual differences, in general, in the discussion.  

      The authors also note in the introduction that rhythms in different peripheral tissues vary in different ways with age, however the entire study is performed on only fibroblast, classified as peripheral tissue by the authors. It would be very interesting to investigate if the observed changes in fibroblast are extended or not to other cell lines from diverse organ origin. This could provide information about whether circulating circadian synchronising factors could exert their function systemically or on specific tissues. At the very least, this hypothesis should be addressed within the discussion. 

      It is likely that factors circulating in serum act on several tissues, and so their effects are relatively broad. However, this would require extensive investigation of other tissues. We now discuss this in the manuscript.

      In addition to the limitations indicated above I consider that the data of the study is an insufficiently analysis beyond the rhythmicity analysis. Results from the STRING and IPA analysis were merely descriptive and a more comprehensive bioinformatic analysis would provide additional information about potential molecular mechanism explaining the differential gene expression. For example, enrichment of transcription factors binding sites in those genes with different patters to pinpoint chromatin regulatory pathways.

      We performed LinC similarity analysis (LISA) to study enrichment of transcription factor binding. Results are displayed in Fig 3B and in lines 157-168. 

      Recommendations for the authors:

      The two reviewers and reviewing editor have agreed on the following recommendations for the authors: 

      Major: 

      (1) The bioinformatic analysis would benefit from a more thorough focus on variability between individuals. Specifically, the main conclusion of the manuscript could be significantly influenced by individual variabilities within and between the two age groups. This is of particular concern, as the groups are relatively small (four individual two females and two males, per group). In addition, the consideration of factors such as food intake and exercise prior to blood drawn, or/and chronotype, known to affect systemic signals should be more adequately explained. The lab is an experienced chronobiology lab, and thus we are confident that these factors had been thought of, but this needs to be better made clear.

      As seen in Figure 4, traces from different individuals vary heavily in terms of their patterns, which is not addressed in the text. Only analysing the summary average curve of the entire group may be masking the relevant data. Furthermore, there are many potential causes of variability, instead or in addition to age, that may be contributing to the variation both, between the groups and between individuals within groups. All of this should be addressed by the authors and commented appropriately in the text. 

      We are not aware of any specific feature distinguishing the subjects (other than age) that could account for the differences between old and young. The fact that we see significant differences between the two groups, even with the relatively small size of the groups, suggests strongly that these differences are largely due to age. Nevertheless, we acknowledge that individual variability can be a contributing factor. For instance, the change in phase of clock genes appears to be driven largely by two subjects. We have commented on this and individual differences, in general, in the discussion. 

      (2) The study would benefit from a more thorough analysis of the data beyond the rhythmicity analysis. Results from the STRING and IPA analysis were merely descriptive and a more comprehensive bioinformatic analysis would provide additional information about potential molecular mechanism explaining the differential gene expression. For example, enrichment of transcription factors binding sites in those genes with different patters to pinpoint chromatin regulatory pathways. This would provide additional value to the study, especially given the otherwise apparent lack of any mechanistic explanation. 

      We performed LinC similarity analysis (LISA) to study enrichment of transcription factor binding. Results are displayed in Fig 3B and in lines 157-168.

      (3) There were some questions about the amplitude of the core circadian clock gene rhythms raised, which in other human cell types would be much higher. A comment on this matter and the provision of the raw luminescence traces for Fig 2A would be greatly beneficial.

      Addressing the same topic: what are the typical fold changes of the many genes that change their rhythms after stimulation with young and old sera? For example, it would be useful to show histograms for the two groups. Does one group tend to have transcript rhythms of higher or lower fold changes? The presentation of the manuscript would further benefit from showing a few key examples for different types of responses. 

      The average luminescence trace for each individual serum sample from Fig 2A has been added to Fig S3A.

      We’ve presented the fold change data in Figure S5. There are a few significant differences, but largely the groups are similar in terms of fold change.

      (4) There are several points that we recommend to consider to add to the discussion: 

      What was the rationale to use these cells over the more common U2OS cells? Are there similarities between the rhythmic transcriptomes of the BJ-5TA cells and that of U2OS cells or other human cells? It should be relatively easy to address this point by assessing published datasets. 

      The original rationale to use BJ-5TA fibroblast cells was that we were aiming to build upon an observation found in a previous study2 which showed that circadian period changes with age in human fibroblasts. While our findings did not match theirs, we think an added benefit of using the BJ-5TA line is that unlike U2OS cells, it is not carcinoma derived cell line. We’ve added this point in lines 98-101. 

      Our study finds many more rhythmic transcripts compared to the previous studies examining U2OS cells. This can be attributed to several factors including differences in methods, including the use of human serum in our study, cell type differences, or decoupling of rhythms in some cancer cells. While a comparison of BJ-5TA cells and U2OS cells could be interesting, a proper comparison requires investigation of many data sets, since any pair of BJ-5TA and U2OS data sets will most likely differ in some detail of experimental design or data processing pipeline, which could contribute to observed differences in rhythmic transcripts.

      That being said, we compared clock reference genes (see Author response image 1) between BJ-5TA and U2OS cells, comparing circadian profiles obtained from our data with those available on CircaDB. These circadian profiles exhibit many similarities and a few differences. The peak to trough ratios (amplitudes) are quite similar for ARNTL, NR1D1, NR1D2, PER2, PER3, and are about 25% lower for CRY1 and somewhat higher for TEF (about 15%) in our data. We find that the MESORS are generally similar with the exception of NR1D1 which is much lower and NR1D2 which is much higher in our data.

      For the rhythmic cell cycle genes, could this be the consequence of the serum which synchronizes also the cell cycle, or is it rather an effect of the circadian oscillator driving rhythms of cell cycle genes? 

      This is an interesting point. Given our previous data showing that the cell cycle gene cyclin D1 is regulated by clock transcription factors3, we believe the circadian oscillator drives, or at least contributes to rhythms of cell cycle genes. However, the serum clearly makes a difference as we find that MESORs of cell cycle genes decrease with aged serum. This is consistent with the decreased proliferation previously observed in aged human tissue.

      While the reduction of rhythmicity in the old serum for oxidative phosphorylation transcripts is very interesting and fits with the general theme that metabolic function decreases with age, it is puzzling that the recipient cells are the same, but it is only the synchronization by the old and young serum that changes. Are the authors thus suggesting that decrease of metabolic rhythms is primarily a non cell-autonomous and systemic phenomenon? What would be a potential mechanism? 

      It may not be the cycling per se, but rather an overall inefficiency of oxidative phosphorylation that is conveyed by the serum. Relating other work in the field to our findings, we’ve added the following to our discussion: “Previous work in the field demonstrates that synchronization of the circadian clock in culture results in cycling of mitochondrial respiratory activity5,6 further underscoring the different effects of old serum, which does not support oscillations of oxidative phosphorylation associated transcripts. Age-dependent decrease in oxidative phosphorylation and increase in mitochondrial dysfunction7 is seen also in aged fibroblasts8 and contributes to age-related diseases9. We suggest that the age-related inefficiency of oxidative phosphorylation is conferred by serum signals to the cells such that oxidative phosphorylation cycles are mitigated. On the other hand, loss of cycling could contribute to impairments in mitochondrial function with age.”

      The delayed shifts after aged serum for clock transcripts (but not for Bmal1) are interesting and indicate that there may be a decoupling of Bmal1 transcript levels from the other clock gene phases. How do the authors interpret this? Could it be related to altered chronotypes in the elderly? 

      One possible explanation is that the delay of NPAS2, BMAL1’s binding partner, results in the delay of the transcription of clock controlled genes/negative arm genes. Since the RORs do not seem to be affected, Bmal is transcribed/translated as usual, but there isn’t enough NPAS2 to bind with BMAL1. In this case downstream genes are slower to transcribe causing the phase delay.

      The discussion would also benefit from mentioning parallels and dissimiliarities with previous works, as well as what would be possible mechanisms for such an effect. 

      We’ve expanded our discussion in the manuscript to discuss possible mechanisms and also how the genes/pathways implicated in our study relate to other aging literature.  

      Minor: 

      While time of serum collection is provided in the methods, it would be very useful to provide this information, along with the accompanying argumentation also at a more prominent position and to also add it to Table S1. 

      We made sure to highlight the collection time in the abstract of the manuscript “We collected blood from apparently healthy young (age 25-30) and old (age 70-76) individuals at 14:001 and used the serum to synchronize cultured fibroblasts.” The time of blood draw is also in sections of the paper (Intro and Methods). Since Table S1 is demographic information, we did not think that the blood draw time fit best there, but hopefully it is now clear in the text.

      L73 EKG: define the abbreviation 

      We rewrote this paragraph, but defined the term where it is used the paper.  

      L77: transfected BJ-5TA fibroblasts. Mention in the text that these are stably transfected cells. 

      We added this to the text.

      L88: Day 2 also revealed different phases of cyclic expression between young and old "groups" for a larger number of genes. Here it is only two donors, right? 

      Yes, we swapped out the word “groups” for “subjects”.

      L115. MESORs of steroid biosynthesis genes, particularly those relating to cholesterol biosynthesis, were also increased in the old sera condition. This is quite interesting, can the authors speculate on the significance of this finding? 

      We’ve added discussion about this finding in the context of the literature in our discussion.

      Fig 3. - FDRs are only listed for certain KEGG pathways, and gene counts for each pathway are also missing, which excludes some valuable context for drawing conclusions. Full tables of KEGG pathway enrichment outputs should be provided in supplementary materials. Input gene lists should also be uploaded as supplementary data files.

      Both output and input files are included in this submission as additional files.  

      Line 322 - How many replicates were excluded in the end for each group? Providing this information would strengthen the claim that the ability of both old and young serum to drive 24h oscillations in fibroblasts is robust and not only individual. 

      Each serum was tested in triplicate in two individual runs of the experiment. Of the 15 serum samples, on one of the runs, a triplicate for each of two serum samples (one old, one young) was excluded. Given that only one technical replicate in one run of the experiment had to be excluded for one old and one young individual out of all the samples assayed, this supports the idea that young and old serum drive robust oscillations.

      Line 373 - Should list which active interaction sources were used for analysis. 

      In this manuscript we used STRING (search tool for retrieval of interacting genes) analysis to broadly identify relevant pathways defined by different algorithms. From these data, we focused in particular on KEGG pathways.

      Reviewer #1 (Recommendations For The Authors): 

      These comments are in addition to those provided above: 

      Minor: 

      L73 EKG: define the abbreviation 

      We rewrote this paragraph, but defined the term where it is used the paper.  

      L77: transfected BJ-5TA fibroblasts. Mention in the text that these are stably transfected cells. 

      We added this to the text.

      L88: Day 2 also revealed different phases of cyclic expression between young and old "groups" for a larger number of genes. Here it is only two donor, right? 

      Yes, we swapped out the word “groups” for “subjects”.

      L115. MESORs of steroid biosynthesis genes, particularly those relating to cholesterol biosynthesis, were also increased in the old sera condition. This is quite interesting, can the authors speculate on the significance of this finding? 

      We’ve added discussion about this finding in the context of the literature.

      Fig.4 The fold change amplitude of the clock gene seems quite a bit lower than what is usually expected (for Nr1d1 it is usually 10 fold). The authors should provide an explanation and discuss this. 

      There are a variety of factors that contribute to the fold change amplitude of clock genes. First, the change in amplitude of clock genes is lower in vitro compared to in vivo samples. For example, in U2OS cell cultures the fold change in the cycling of Nr1d1 is only 2 fold and is not significantly different from the fold change we observe (as shown in the U2OS data from CircaDB plotted in Figure 1R). Second, the method of synchronization contributes to the strength of the rhythms. Serum synchronization is generally less effective at driving strong clock cycling than forskolin or dexamethasone although, as noted in the manuscript, it may promote the cycling of more genes. Lastly, rhythm amplitude is also dependent on the cell type in question so cell to cell variability also contributes to differences. However, overall, we do not find major differences in comparing the U2OS data and ours. Please note that the y-axis has a logarithmic scale.

      What is the authors' strategy to identify which serum components that are responsible for the reported changes? This should be discussed. 

      In the future, we intend to analyze the serum factors using a combination of fractionation and either proteomics or metabolomics to identify relevant factors. We have added this to the discussion.

      Reviewer #2 (Recommendations For The Authors): 

      Overall, the article is well-written but lacks some more rigorous data analysis as mentioned in the public review above. In addition to a more thorough analysis approach focusing much more heavily on individual variability, several other changes can be made to strengthen this study:

      Fig 3. - FDRs are only listed for certain KEGG pathways, and gene counts for each pathway are also missing, which excludes some valuable context for drawing conclusions. Full tables of KEGG pathway enrichment outputs should be provided in supplementary materials. Input gene lists should also be uploaded as supplementary data files. 

      Both output and input files are included in this submission as additional files.

      Fig 1A. - Only n=5 participants were used for this analysis, explanation of the exclusion criteria for the other participants would be useful. 

      As Figure 1A is a schematic, we assume the reviewer is referring to Figure 1B. We’ve provided a flow chart of subject inclusion/exclusion in Figure S2.

      Fig 2. - For circadian transcriptome analysis only n=4 participants were used - what criteria was used to exclude individuals, and why were only these individuals used in the end? 

      As patient recruitment was interrupted by COVID, we selected samples where we had sufficient serum to effectively carry out the RNA seq experiment and control for age and sex.

      Line 322 - How many replicates were excluded in the end for each group? Providing this information would strengthen the claim that the ability of both old and young serum to drive 24h oscillations in fibroblasts is robust and not only individual. 

      Each serum was tested in triplicate in two individual runs of the experiment. Of the 15 serum samples, on one of the runs, a triplicate for each of two serum samples (one old, one young) was excluded. Given that only one technical replicate in one run of the experiment had to be excluded for one old and one young individual out of all the samples assayed, this supports the idea that young and old serum drive robust oscillations.

      Line 373 - Should list which active interaction sources were used for analysis. 

      In this manuscript we used STRING (search tool for retrieval of interacting genes) analysis to identify relevant pathways. We do not present any STRING networks in the paper.

      Line 68 - "These novel findings suggest that it may be possible to treat impaired circadian physiology and the associated disease risks by targeting blood borne factors." This is a completed overstatement that are cannot be sustained by the limited findings provided by the authors. 

      We’ve modified this statement to avoid overstating results.

      (1) Pagani, L. et al. Serum factors in older individuals change cellular clock properties. Proceedings of the National Academy of Sciences 108, 7218–7223 (2011).

      (2) Pagani, L. et al. Serum factors in older individuals change cellular clock properties. Proc Natl Acad Sci U S A 108, 7218–7223 (2011).

      (3) Lee, Y. et al. G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment. PLOS Biology 17, e3000228 (2019).

      (4) Tomasetti, C. et al. Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence. Proceedings of the National Academy of Sciences 116, 20482–20488 (2019).

      (5) Cela, O. et al. Clock genes-dependent acetylation of complex I sets rhythmic activity of mitochondrial OxPhos. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863, 596–606 (2016).

      (6) Scrima, R. et al. Mitochondrial calcium drives clock gene-dependent activation of pyruvate dehydrogenase and of oxidative phosphorylation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1867, 118815 (2020).

      (7) Lesnefsky, E. J. & Hoppel, C. L. Oxidative phosphorylation and aging. Ageing Research Reviews 5, 402–433 (2006).

      (8) Greco, M. et al. Marked aging-related decline in efficiency of oxidative phosphorylation in human skin fibroblasts. The FASEB Journal 17, 1706–1708 (2003).

      (9) Federico, A. et al. Mitochondria, oxidative stress and neurodegeneration. Journal of the Neurological Sciences 322, 254–262 (2012).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1:

      We thank Reviewer 1 for their helpful comments and hope that the changes made to the revised manuscript have addressed their points.

      This study presents a novel application of the inverted encoding (i.e., decoding) approach to detect the correlates of crossmodal integration in the human EEG (electrophysiological) signal. The method is successfully applied to data from a group of 41 participants, performing a spatial localization task on auditory, visual, and audiovisual events. The analyses clearly show a behavioural superiority for audio-visual localization. Like previous studies, the results when using traditional univariate ERP analyses were inconclusive, showing once more the need for alternative, more sophisticated approaches. Instead, the principal approach of this study, harnessing the multivariate nature of the signal, captured clear signs of super-additive responses, considered by many as the hallmark of multisensory integration. Unfortunately, the manuscript lacks many important details in the descriptions of the methodology and analytical pipeline. Although some of these details can eventually be retrieved from the scripts that accompany this paper, the main text should be self-contained and sufficient to gain a clear understanding of what was done. (A list of some of these is included in the comments to the authors). Nevertheless, I believe the main weakness of this work is that the positive results obtained and reported in the results section are conditioned upon eye movements. When artifacts due to eye movements are removed, then the outcomes are no longer significant. 

      Therefore, whether the authors finally achieved the aims and showed that this method of analysis is truly a reliable way to assess crossmodal integration, does not stand on firm ground. The worst-case scenario is that the results are entirely accounted for by patterns of eye movements in the different conditions. In the best-case scenario, the method might truly work, but further experiments (and/or analyses) would be required to confirm the claims in a conclusive fashion.

      One first step toward this goal would be, perhaps, to facilitate the understanding of results in context by reporting both the uncorrected and corrected analyses in the main results section. Second, one could try to support the argument given in the discussion, pointing out the origin of the super-additive effects in posterior electrode sites, by also modelling frontal electrode clusters and showing they aren't informative as to the effect of interest.

      We performed several additional analyses to address concerns that our main result was caused by different eye movement patterns between conditions. We re-ran our key analyses using activity exclusively from frontal electrodes, which revealed poorer decoding performance than that from posterior electrodes. If eye movements were driving the non-linear enhancement in the audiovisual condition, we would expect stronger decoding using sensors closer to the source, i.e., the extraocular muscles. We also computed the correlations between average eye position and stimulus position for each condition to evaluate whether participants made larger eye movements in the audiovisual condition, which might have contributed to better decoding results. Though we did find evidence for eye movements toward stimuli, the degree of movement did not significantly differ between conditions.

      Furthermore, we note that the analysis using a stricter eye movement criterion, acknowledged in the Discussion section of the original manuscript, resulted in very similar results to the original analysis. There was significantly better decoding in the AV condition (as measured by d') than the MLE prediction, but this difference did not survive cluster correction. The most likely explanation for this is that the strict eye movement criterion combined with our conservative measure of (mass-based) cluster correction led to reduced power to detect true differences between conditions. Taken together with the additional analyses described in the revised manuscript and supplementary materials, the results show that eye movements are unlikely to account for differences between the multisensory and unisensory conditions. Instead, our decoding results likely reflect nonlinear neural integration between audio and visual sensory information.

      “Any experimental design that varies stimulus location needs to consider the potential contribution of eye movements. We computed correlations between participants’ average eye position and each stimulus position between the three sensory conditions (auditory, visual and audiovisual; Figure S1) and found evidence that participants made eye movements toward stimuli. A re-analysis of the data with a very strict eye-movement criterion (i.e., removing trials with eye movements >1.875º) revealed that the super-additive enhancement in decoding accuracy no longer survived cluster correction, suggesting that our results may be impacted by the consistent motor activity of saccades towards presented stimuli. Further investigation, however, suggests this is unlikely. Though the correlations were significantly different from 0, they were not significantly different from each other. If consistent saccades to audiovisual stimuli were responsible for the nonlinear multisensory benefit we observed, we would expect to find a higher positive correlation between horizontal eye position and stimulus location in the audiovisual condition than in the auditory or visual conditions. Interestingly, eye movements corresponded more to stimulus location in the auditory and audiovisual conditions than in the visual condition, indicating that it was the presence of a sound, rather than a visual stimulus, that drove small eye movements. This could indicate that participants inadvertently moved their eyes when localising the origin of sounds. We also re-ran our analyses using the activity measured from the frontal electrodes alone (Figure S2). If the source of the nonlinear decoding accuracy in the audiovisual condition was due to muscular activity produced by eye movements, there should be better decoding accuracy from sensors closer to the source. Instead, we found that decoding accuracy of stimulus location from the frontal electrodes (peak d' = 0.08) was less than half that of decoding accuracy from the more posterior electrodes (peak d' = 0.18). These results suggest that the source of neural activity containing information about stimulus position was located over occipito-parietal areas, consistent with our topographical analyses (inset of Figure 3).” 

      The univariate ERP analyses an outdated contrast, AV <> A + V to capture multisensory integration. A number of authors have pointed out the potential problem of double baseline subtraction when using this contrast, and have recommended a number of solutions, experimental and analytical. See for example: [1] and [2]. 

      (1) Teder-Salejarvi, W. A., McDonald, J. J., Di Russo, F., & Hillyard, S. A. (2002). Cognitive Brain Research, 14, 106-114. 

      (2) Talsma, D., & Woldorff, M. G. (2005). Journal of cognitive neuroscience, 17(7), 1098-1114.

      We thank the reviewer for raising this point. Comparing ERPs across different sensory conditions requires careful analytic choices to discern genuine sensory interactions within the signal. The AV <> (A +V) contrast has often been used to detect multisensory integration, though any non-signal related activity (i.e. anticipatory waves; Taslma & Woldorff, 2005) or pre-processing manipulation (e.g. baseline subtraction; Teder-Sälejärvi et al., 2002) will be doubled in (A + V) but not in AV. Critically, we did not apply a baseline correction during preprocessing and thus our results are not at risk of double-baseline subtraction in (A + V). Additionally, we temporally jittered the presentation of our stimuli to mitigate the potential influence of consistent overlapping ERP waves (Talsma & Woldorff, 2005). 

      The results section should provide the neurometric curve/s used to extract the slopes of the sensitivity plot (Figure 2B). 

      We thank the reviewer for raising this point of clarification. The sensitivity plots for Figures 2B and 2C were extracted from the behavioural performance of the behavioural and EEG tasks, respectively. The sensitivity plot for Figure 2B was extracted from individual psychometric curves, whereas the d’ values for Figure 2C were calculated from the behavioural data for the EEG task. This information has been clarified in the manuscript.

      “Figure 1. Behavioural performance is improved for audiovisual stimuli. A) Average accuracy of responses across participants in the behavioural session at each stimulus location for each stimulus condition, fitted to a psychometric curve. Steeper curves indicate greater sensitivity in identifying stimulus location. B) Average sensitivity across participants in the behavioural task, estimated from psychometric curves, for each stimulus condition. The red cross indicates estimated performance assuming optimal (MLE) integration of unisensory cues. C) Average behavioural sensitivity across participants in the EEG session for each stimulus condition. Error bars indicate ±1 SEM.”

      The encoding model was fitted for each electrode individually; I wonder if important information contained as combinations of (individually non-significant) electrodes was then lost in this process and if the authors consider that this is relevant. 

      Although the encoding model was fitted for each electrode individually for the topographic maps (Figure 4B), in all other analyses the encoding model was fitted across a selection of electrodes (see final inset of Figure 3). As this electrode set was used for all other neural analyses, our model would allow for the detection of important information contained in the neural patterns across electrodes. This information has been clarified in the manuscript.

      “Thus, for all subsequent analyses we only included signals from the central-temporal, parietal-occipital, occipital and inion sensors for computing the inverse model (see final inset of Figure 2). As the model was fitted for multiple electrodes, subtle patterns of neural information contained within combinations of sensors could be detected.”

      Neurobehavioral correlations could benefit from outlier rejection and the use of robust correlation statistics. 

      We thank the reviewer for raising this issue. Note, however, that the correlations we report are resistant to the influence of outliers because we used Spearman’s rho1 (as opposed to Pearson’s). This information has been communicated in the manuscript.

      (1) Wilcox, R.R. (2016), Comparing dependent robust correlations. British Journal of Mathematical & Statistical Psychology, 69(3), 215-224. https://doi.org/10.1111/bmsp.12069

      “Neurobehavioural correlations. As behavioural and neural data violated assumptions of normality, we calculated rank-order correlations (Spearman’s rho) between the average decoding sensitivity for each participant from 150-250 ms poststimulus onset and behavioural performance on the EEG task. As Spearman’s rho is resistant to outliers (Wilcox, 2016), we did not perform outlier rejection.”

      “Wilcox, R.R. (2016), Comparing dependent robust correlations. British Journal of Mathematical & Statistical Psychology, 69(3), 215-224. https://doi.org/10.1111/bmsp.12069”

      Many details that are important for the reader to evaluate the evidence and to understand the methods and analyses aren't given; this is a non-exhaustive list:  

      We thank the reviewer for highlighting these missing details. We have updated the manuscript where necessary to ensure the methods and analyses are fully detailed and replicable.

      - specific parameters of the stimuli and performance levels. Just saying "similarly difficult" or "marginally higher volume" is not enough to understand exactly what was done.  

      “The perceived source location of auditory stimuli was manipulated via changes to interaural level and timing (Whitworth & Jeffress, 1961; Wightman & Kistler, 1992). The precise timing of when each speaker delivered an auditory stimulus was calculated from the following formula:

      where x and z are the horizontal and forward distances in metres between the ears and the source of the sound on the display, respectively, r is the head radius, and s is the speed of sound. We used a constant approximate head radius of 8 cm for all participants. r was added to x for the left speaker and subtracted for the right speaker to produce the interaural time difference. For ±15° source locations, interaural timing difference was 1.7 ms. To simulate the decrease in sound intensity as a function of distance, we calculated interaural level differences for the left and right speakers by dividing the sounds by the left and right distance vectors. Finally, we resampled the sound using linear interpolation based on the calculations of the interaural level and timing differences. This process was used to calculate the soundwaves played by the left and right speakers for each of the possible stimulus locations on the display. The maximum interaural level difference between speakers was 0.14 A for ±15° auditory locations, and 0.07 A for ±7.5°.”

      - where are stimulus parameters adjusted individually or as a group? Which method was followed?  

      To clarify, stimulus parameters (frequency, size, luminance, volume, location, etc.) were manipulated throughout pilot testing only. Parameters were adjusted to achieve similar pilot behavioural results between the auditory and visual conditions. For the experiment proper, parameters remained constant for both tasks and were the same for all participants.

      “During pilot testing, stimulus features (size, luminance, volume, frequency etc.) were manipulated to make visual and auditory stimuli similarly difficult to spatially localize. These values were held constant in the main experiment.”

      - specify which response buttons were used.

      “Participants were presented with two consecutive stimuli and tasked with indicating, via button press, whether the first (‘1’ number-pad key) or second (‘2’ number-pad key) interval contained the more leftward stimulus.”

      “At the end of each sequence, participants were tasked with indicating, via button press, whether more presentations appeared on the right (‘right’ arrow key) or the left (‘left’ arrow key) of the display.”

      - no information is given as to how many trials per condition remained on average, for analysis.  

      The average number of remaining trials per condition after eye-movement analysis is now included in the Methods section of the revised manuscript.

      “We removed trials with substantial eye movements (>3.75 away from fixation) from the analyses. After the removal of eye movements, on average 2365 (SD \= 56.94), 2346 (SD \= 152.87) and 2350 (SD \= 132.47) trials remained for auditory, visual and audiovisual conditions, respectively, from the original 2400 per condition.”

      - no information is given on the specifics of participant exclusion criteria. (even if the attrition rate was surprisingly high, for such an easy task).  

      The behavioural session also served as a screening task. Although the task instructions were straightforward, perceptual discrimination was not easy due to the ambiguity of the stimuli. Auditory localization is not very precise, and the visual stimuli were brief, dim, and diffuse. The behavioural results reflect the difficulty of the task. Attrition rate was high as participants who scored below 60% correct in any condition were deemed unable to accurately perform the task, were not invited to complete the subsequent EEG session, and omitted from the analyses. We have included the specific criteria in the manuscript.

      “Participants were first required to complete a behavioural session with above 60% accuracy in all conditions to qualify for the EEG session (see Behavioural session for details).”

      - EEG pre-processing: what filter was used? How was artifact rejection done? (no parameters are reported); How were bad channels interpolated?  

      We used a 0.25 Hz high-pass filter to remove baseline drifts, but no low-pass filter. In line with recent studies on the undesirable influence of EEG preprocessing on ERPs1, we opted to avoid channel interpolation and artifact rejection. This was erroneously reported in the manuscript and has now been clarified. For the sake of clarity, here we demonstrate that a reanalysis of data using channel interpolation and artifact rejection returned the same pattern of results. 

      (1) Delorme, A. (2023). EEG is better left alone. Scientific Reports, 13, 2372. https://doi.org/10.1038/s41598-023-27528-0

      - specific electrode locations must be given or shown in a plot (just "primarily represented in posterior electrodes" is not sufficiently informative).  

      A diagram of the electrodes used in all analyses is included within Figure 3, and we have drawn readers’ attention to this in the revised manuscript.

      “Thus, for all subsequent analyses we only included signals from the central-temporal, parietal-occipital, occipital and inion sensors for computing the inverse model (see final inset of Figure 2).” 

      - ERP analysis: which channels were used? What is the specific cluster correction method?

      We used a conservative mass-based cluster correction from Pernet et al. (2015) - this information has been clarified in the manuscript.

      “A conservative mass-based cluster correction was applied to account for spurious differences across time (Pernet et al., 2015).” 

      “Pernet, C. R., Latinus, M., Nichols, T. E., & Rousselet, G. A. (2015). Cluster-based computational methods for mass univariate analyses of event-related brain potentials/fields: A simulation study. Journal of Neuroscience Methods, 250, 85-93. https://doi.org/https://doi.org/10.1016/j.jneumeth.2014.08.003” 

      - results: descriptive stats on performance must be given (instead of saying "participants performed well").  

      The mean and standard deviation of participants’ performance for each condition in the behavioural and EEG experiments are now explicitly mentioned in the manuscript.

      “A quantification of the behavioural sensitivity (i.e., steepness of the curves) revealed significantly higher sensitivity for the audiovisual stimuli (M = .04, SD = .02) than for the auditory stimuli alone (M = .03, SD = .01; Z = -3.09, p = .002), and than for the visual stimuli alone (M = .02, SD = .01; Z = -5.28, p = 1.288e-7; Figure 1B). Sensitivity for auditory stimuli was also significantly higher than sensitivity for visual stimuli (Z = 2.02, p = .044).” 

      “We found a similar pattern of results to those in the behavioural session; sensitivity for audiovisual stimuli (M = .85, SD = .33) was significantly higher than for auditory (M = .69, SD = .41; Z = -2.27, p = .023) and visual stimuli alone (M = .61, SD = .29; Z = -3.52, p = 4.345e-4), but not significantly different from the MLE prediction (Z = -1.07, p = .285).” 

      - sensitivity in the behavioural and EEG sessions is said to be different, but no comparison is given. It is not even the same stimulus set across the two tasks...  

      This relationship was noted as a potential explanation for the higher sensitivities obtained in the EEG task, and was not intended to stand up to statistical scrutiny. We agree it makes little sense to compare statistically between the EEG and behavioural results as they were obtained from different tasks. We would like to clarify, however, that the stimuli used in the two tasks were the same, with the exception that in the EEG task the stimuli were presented from 5 locations versus 8 in the behavioural task. To avoid potential confusion, we have removed the offending sentence from the manuscript:

      Reviewer 2:

      Their measure of neural responses is derived from the decoder responses, and this takes account of the reliability of the sensory representations - the d' statistics - which is an excellent thing. It also means if I understand their analysis correctly (it could bear clarifying - see below), that they can generate from it a prediction of the performance expected if an optimal decision is made combining the neural signals from the individual modalities. I believe this is the familiar root sum of squares d' calculation (or very similar). Their decoding of the audiovisual responses comfortably exceeds this prediction and forms part of the evidence for their claims. 

      Yet, superadditivity - including that in evidence in the principle of inverse effectiveness more typically quantifies the excess over the sum of proportions correct in each modality. Their MLE d' statistic can already predict this form of superadditivity. Therefore, the superadditivity they report here is not the same form of superadditivity that is usually referred to in behavioural studies. It is in fact a stiffer definition. What their analysis tests is that decoding performance exceeds what would be expected from an optimally weighted linear integration of the unisensory information. As this is not the common definition it is difficult to relate to behavioral superadditivity reported in much literature (of percentage correct). This distinction is not at all clear from the manuscript. 

      But the real puzzle is here: The behavioural data or this task do not exceed the optimal statistical decision predicted by signal detection theory (the MLE d'). Yet, the EEG data would suggest that the neural processing is exceeding it. So why, if the neural processing is there to yield better performance is it not reflected in the behaviour? I cannot explain this, but it strikes me that the behaviour and neural signals are for some reason not reflecting the same processing. 

      Be explicit and discuss this mismatch they observe between behaviour and neural responses. 

      Thank you, we agree that it is worth expanding on the observed disconnect between MSI in behaviour and neural signals. We have included an additional paragraph in the Discussion of the revised manuscript. Despite the mismatch, we believe the behavioural and neural responses still reflect the same underlying processing, but at different levels of sensitivity. The behavioural result likely reflects a coarse down-sampling of the precision in location representation, and thus less likely to reflect subtle MSI enhancements.

      “An interesting aspect of our results is the apparent mismatch between the behavioural and neural responses. While the behavioural results meet the optimal statistical threshold predicted by MLE, the decoding analyses suggest that the neural response exceeds it. Though non-linear neural responses and statistically optimal behavioural responses are reliable phenomena in multisensory integration (Alais & Burr, 2004; Ernst & Banks, 2002; Stanford & Stein, 2007), the question remains – if neural super-additivity exists to improve behavioural performance, why is it not reflected in behavioural responses? A possible explanation for this neurobehavioural discrepancy is the large difference in timing between sensory processing and behavioural responses. A motor response would typically occur some time after the neural response to a sensory stimulus (e.g., 70-200 ms), with subsequent neural processes between perception and action that introduce noise (Heekeren et al., 2008) and may obscure super-additive perceptual sensitivity. In the current experiment, participants reported either the distribution of 20 serially presented stimuli (EEG session) or compared the positions of two stimuli (behavioural session), whereas the decoder attempts to recover the location of every presented stimulus. While stimulus location could be represented with higher fidelity in multisensory relative to unisensory conditions, this would not necessarily result in better performance on a binary behavioural task in which multiple temporally separated stimuli are compared. One must also consider the inherent differences in how super-additivity is measured at the neural and behavioural levels. Neural super-additivity should manifest in responses to each individual stimulus. In contrast, behavioural super-additivity is often reported as proportion correct, which can only emerge between conditions after being averaged across multiple trials. The former is a biological phenomenon, while the latter is an analytical construct. In our experiment, we recorded neural responses for every presentation of a stimulus, but behavioural responses were only obtained after multiple stimulus presentations. Thus, the failure to find super-additivity in behavioural responses might be due to their operationalisation, with between-condition comparisons lacking sufficient sensitivity to detect super-additive sensory improvements. Future work should focus on experimental designs that can reveal super-additive responses in behaviour.”

      Re-work the introduction to explain more clearly the relationship between the behavioural superadditivities they review, the MLE model, and the superadditivity it actually tests. 

      We agree it is worth discussing how super-additivity is operationalised across neural and behavioural measures. However, we do not believe the behavioural studies we reviewed claimed super-additive behavioural enhancements. While MLE is often used as a behavioural marker of successful integration, it is not necessarily used as evidence for super-additivity within the behavioural response, as it relies on linear operations. 

      “It is important to consider the differences in how super-additivity is classified between neural and behavioural measures. At the level of single neurons, superadditivity is defined as a non-linear response enhancement, with the multisensory response exceeding the sum of the unisensory responses. In behaviour, meanwhile, it has been observed that the performance improvement from combining two senses is close to what is expected from optimal integration of information across the senses (Alais & Burr, 2004; Stanford & Stein, 2007). Critically, behavioural enhancement of this kind does not require non-linearity in the neural response, but can arise from a reliability-weighted average of sensory information. In short, behavioural performance that conforms to MLE is not necessarily indicative of neural super-additivity, and the MLE model can be considered a linear baseline for multisensory integration.”

      Regarding the auditory stimulus, this reviewer notes that interaural time differences are unlikely to survive free field presentation.

      Despite the free field presentation, in both the pilot test and the study proper participants were able to localize auditory stimuli significantly above chance. 

      "However, other studies have found super-additive enhancements to the amplitude of sensory event-related potentials (ERPs) for audiovisual stimuli (Molholm et al., 2002; Talsma et al., 2007), especially when considering the influence of stimulus intensity (Senkowski et al., 2011)." - this makes it obvious that there are some studies which show superadditivity. It would have been good to provide a little more depth here - as to what distinguished those studies that reported positive effects from those that did not.

      We have provided further detail on how super-additivity appears to manifest in neural measures.

      “In EEG, meanwhile, the evoked response to an audiovisual stimulus typically conforms to a sub-additive principle (Cappe et al., 2010; Fort et al., 2002; Giard & Peronnet, 1999; Murray et al., 2016; Puce et al., 2007; Stekelenburg & Vroomen, 2007; Teder- Sälejärvi et al., 2002; Vroomen & Stekelenburg, 2010). However, when the principle of inverse effectiveness is considered and relatively weak stimuli are presented together, there has been some evidence for super-additive responses (Senkowski et al., 2011).”

      “While behavioural outcomes for multisensory stimuli can be predicted by MLE, and single neuron responses follow the principles of inverse effectiveness and super- additivity, among others (Rideaux et al., 2021), how audiovisual super-additivity manifests within populations of neurons is comparatively unclear given the mixed findings from relevant fMRI and EEG studies. This uncertainty may be due to biophysical limitations of human neuroimaging techniques, but it may also be related to the analytic approaches used to study these recordings. For instance, superadditive responses to audiovisual stimuli in EEG studies are often reported from very small electrode clusters (Molholm et al., 2002; Senkowski et al., 2011; Talsma et al., 2007), suggesting that neural super-additivity in humans may be highly specific. However, information encoded by the brain can be represented as increased activity in some areas, accompanied by decreased activity in others, so simplifying complex neural responses to the average rise and fall of activity in specific sensors may obscure relevant multivariate patterns of activity evoked by a stimulus.”

      P9. "(25-75 W, 6 Ω)." This is not important, but it is a strange way to cite the power handling of a loudspeaker. 

      “The loudspeakers had a power handling capacity of 25-75 W and a nominal impedance of 6 Ω.” 

      I am struggling to understand the auditory stimulus: 

      "Auditory stimuli were 100 ms clicks". Is this a 100-ms long train of clicks? A single pulse which is 100ms long would not sound like a click, but two clicks once filtered by the loudspeaker. Perhaps they mean 100us. 

      "..with a flat 850 Hz tone embedded within a decay envelope". Does this mean the tone is gated - i.e. turns on and off slowly? Or is it constant?

      We thank the reviewer for catching this. ‘Click’ may not be the most apt way of defining the auditory stimulus. It was a 100 ms square wave tone with decay, i.e., with an onset at maximal volume before fading gradually. Given that the length of the stimulus was 100 ms, the decay occurs quickly and provides a more ‘click-like’ percept than a pure tone. We have provided a representation of the sound below for further clarification. This represents the amplitude from the L and R speakers for maximally-left and maximally-right stimuli. We have added this clarification in the revised manuscript. 

      Author response image 1.

      “Auditory stimuli were 100 ms, 850 Hz tones with a decay function (sample rate = 44, 100 Hz; volume = 60 dBA SPL, as measured at the ears).”

      P10. "Stimulus modality was either auditory, visual, or audiovisual. Trials were blocked with short (~2 min) breaks between conditions".

      Presumably the blocks were randomised across participants.

      Condition order was not randomised across participants, but counterbalanced. This has been clarified in the manuscript.

      “Stimulus modality was auditory, visual or audiovisual, presented in separate blocks with short breaks (~2 min) between conditions (see Figure 6A for an example trial). The order of conditions was counterbalanced across participants.” 

      P15. Feels like there is a step not described here: "The d' of the auditory and visual conditions can be used to estimate the predicted 'optimal' sensitivity of audiovisual signals as calculated through MLE." Do they mean sqrt[ (d'A)^2 + (d'V)^2] ? If it is so simple then it may as well be made explicit here. A quick calculation from eyeballing Figures 2B and 2C suggests this is the case.

      We thank the reviewer for raising this point of clarification. Yes, the ‘optimal’ audiovisual sensitivity was calculated as the hypotenuse of the auditory and visual sensitivities. This calculation has been made explicit in the revised manuscript.

      The d’ from the auditory and visual conditions can be used to estimate the predicted ‘optimal’ sensitivity to audiovisual signals as calculated through the following formula:

      "The perceived source location of auditory stimuli was manipulated via changes to interaural intensity and timing (Whitworth & Jeffress, 1961; Wightman & Kistler, 1992)." The stimuli were delivered by a pair of loudspeakers, and the incident sound at each ear would be a product of both speakers. And - if there were a time delay between the two speakers, then both ears could potentially receive separate pulses one after the other at different delays. Did they record this audio stimulus with manikin? If not, it would be very difficult to know what it was at the ears. I don't doubt that if they altered the relative volume of the loudspeakers then some directionality would be perceived but I cannot see how the interaural level and timing differences could be matched - as if the sound were from a single source. I doubt that this invalidates their results, but to present this as if it provided matched spatial and timing cues is wrong, and I cannot work out how they can attribute an azimuthal location to the sound. For replication purposes, it would be useful to know how far apart the loudspeakers were and what the timing and level differences actually were.

      The behavioural tasks each had evenly distributed ‘source locations’ on the horizontal azimuth of the computer display (8 for the behavioural session, 5 for the EEG session). We manipulated the perceived location of auditory stimuli through interaural time delays and interaural level differences. By first measuring the forward (z) and horizontal (x) distance of each source location to each ear, the method worked by calculating what the time-course of a sound wave should be at the location of the ear given the sound wave at the source. Then, for each source location, we can calculate the time delay between speakers given the vectors of x and z, the speed of sound and the width of the head.  As the intensity of sound drops inversely with the square of the distance, we can divide the sound wave by the distance for each source location to provide the interaural level difference. Though we did not record the auditory stimulus with a manikin, our behavioural analyses show that participants were able to detect the directions of auditory stimuli from our manipulations, even to a degree that significantly exceeded the localisation accuracy for visual stimuli (for the behavioural session task). This information has been clarified in the manuscript.

      “Auditory stimuli were played through two loudspeakers placed either side of the display (80 cm apart for the behavioural session, 58 cm apart for the EEG session).” 

      “The perceived source location of auditory stimuli was manipulated via changes to interaural level and timing (Whitworth & Jeffress, 1961; Wightman & Kistler, 1992). The precise timing of when each speaker delivered an auditory stimulus was calculated from the following formula:

      where x and z are the horizontal and forward distances in metres between the ears and the source of the sound on the display, respectively, r is the head radius, and s is the speed of sound. We used a constant approximate head radius of 8 cm for all participants. r was added to x for the left speaker and subtracted for the right speaker to produce the interaural time difference. For ±15° source locations, interaural timing difference was 1.7 ms. To simulate the decrease in sound intensity as a function of distance, we calculated interaural level differences for the left and right speakers by dividing the sounds by the left and right distance vectors. Finally, we resampled the sound using linear interpolation based on the calculations of the interaural level and timing differences. This process was used to calculate the soundwaves played by the left and right speakers for each of the possible stimulus locations on the display. The maximum interaural level difference between speakers was 0.14 A for ±15° auditory locations, and 0.07 A for ±7.5°.

      I am confused about this statement: "A quantification of the behavioural sensitivity (i.e., steepness of the curves) revealed significantly greater sensitivity for the audiovisual stimuli than for the auditory stimuli alone (Z = -3.09, p = .002)," It is not clear from the methods how they attributed sound source angle to the sounds. Conceivably they know the angle of the loudspeakers, and this would provide an outer bound on the perceived location of the sound for extreme interaural level differences (although free field interaural timing cues can create a wider sound field). 

      Our analysis of behavioural sensitivity was dependent on the set ‘source locations’ that were used to calculate the position of auditory and audiovisual stimuli.  In the behavioural task, participants judged the position of the target stimulus relative to a central stimulus. Thus, for each source location, we recorded how often participants correctly discriminated between presentations. The quoted analysis acknowledges that participants were more sensitive to audiovisual stimuli than auditory stimuli in the context of this task. A full explanation of how source location was implemented for auditory stimuli has been clarified in the manuscript. 

      It would be very nice to see some of the "channel" activity - to get a feel for the representation used by the decoder. 

      We have included responses for the five channels as a Supplemental Figure.

      Figure 6 appears to show that there is some agreement between behaviour and neural responses - for the audiovisual case alone. The positive correlation of behavioural and decoding sensitivity appears to be driven by one outlier - who could not perform the audiovisual task (and indeed presumably any of them). Furthermore, if we were simply Bonferonni correct for the three comparisons, this would become non-significant. It is also puzzling why the unisensory behaviour and EEG do not correlate - which seems to again suggest a poor correspondence between them. Opposite to the claim made.

      We understand the reviewer’s concern here. We would like to note, however, that each correlation used unique data sets – that is, the behavioural and neural data for each separate condition. In this case, we believe a Bonferroni correction for multiple comparisons is too conservative, as no data set was compared more than once. Neither the behavioural nor the neural data were normally distributed, and both contained outliers. Rather than reduce power through outlier rejection, we opted to test correlations using Spearman’s rho, which is resistant to outliers1. It is also worth noting that, without outlier rejection, the audiovisual correlation (p \= .003) would survive a Bonferroni correction for 3 comparisons. The nonsignificant correlation in the auditory and visual conditions might be due to the weaker responses elicited by unisensory stimuli, with the reduced signal-to-noise ratio obscuring potential correlations. Audiovisual stimuli elicited more precise responses both behaviourally and neurally, increasing the power to detect a correlation. 

      (1) Wilcox, R.R. (2016), Comparing dependent robust correlations. British Journal of Mathematical & Statistical Psychology, 69(3), 215-224. https://doi.org/10.1111/bmsp.12069

      “We also found a significant positive correlation between participants’ behavioural judgements in the EEG session and decoding sensitivity for audiovisual stimuli. This result suggests that participants who were better at identifying stimulus location also had more reliably distinct patterns of neural activity. The lack of neurobehavioural correlation in the unisensory conditions might suggest a poor correspondence between the different tasks, perhaps indicative of the differences between behavioural and neural measures explained previously. However, multisensory stimuli have consistently been found to elicit stronger neural responses than unisensory stimuli (Meredith & Stein, 1983; Puce et al., 2007; Senkowski et al., 2011; Vroomen & Stekelenburg, 2010), which has been associated with behavioural performance (Frens & Van Opstal, 1998; Wang et al., 2008). Thus, the weaker signalto-noise ratio in unisensory conditions may prevent correlations from being detected.”

      Further changes:

      (1)   To improve clarity, we shifted the Methods section to after the Discussion. This change included updating the figure numbers to match the new order (Figure 1 becomes Figure 6, Figure 2 becomes Figure 1, and so on).

      (2)   We also resolved an error on Figure 2 (previously Figure 3). The final graph (Difference between AV and A + V) displayed incorrect values on the Y axis.

      This has now been remedied.

    1. Author Response

      The following is the authors’ response to the original reviews.

      eLife assessment

      This study of extrachromosomal DNA (ecDNA) aims to identify genes that distinguish ecDNA+ and ecDNA- tumors. This timely study is important in addressing the genes responding to the amplification of the ecDNA. The data presented are for the most part solid, there were concerns regarding the clarity in the description of the analysis methods and whether the evidence for specific genes required to maintain the ecDNA+ state was entirely conclusive.

      Public Reviews:

      Reviewer #1 (Public Review):

      Recently discovered extrachromosomal DNA (ecDNA) provides an alternative non-chromosomal means for oncogene amplification and a potent substrate for selective evolution of tumors. The current work aims to identify key genes whose expression distinguishes ecDNA+ and ecDNA- tumors and the associated processes to shed light on the biological mechanisms underlying ecDNA genesis and their oncogenic effects. While this is clearly an important question, the analysis and the evidence supporting the claims are weak. The specific machine learning approach seems unnecessarily convoluted, insufficiently justified and explained, and the language used by the authors conflates correlation with causality. This work points to specific GO processes associated (up and down) with ecDNA+ tumors, many of which are expected but some seem intriguing, such as association with DSB pathways. My specific comments are listed below.

      Response. As some of the specific questions below address similar concerns, we have answered them briefly here. As a high level point, the reviewer is correct in that other statistical or ML approaches could potentially have been used, and that some are simpler. However, the test used here directly addresses the question: Find a collection of genes whose expression value is predictive of ecDNA status in the sample. Because the underlying method in the Boruta analysis uses random forests, it can test predictive power without relying on a linearity assumption implicit in other methods. In this revision, we also compare against a Generalized Linear Model and show that it is less suited to the specific task above. We also address the reviewer concerns about specific parameter choices by showing robustness to the specific parameter.

      (A) The claim of identifying genes required to 'maintain' ecDNA+ status is not justified - predictive features are not necessarily causal.

      Response. We agree with the reviewer that predictive features are correlative and not causal. In the manuscript, we identify genes whose expression (when used as a feature) is predictive of ecDNA presence or absence. Such predictive genes are consistently over-expressed or consistently under-expressed in ecDNA(+) samples relative to ecDNA(-) samples even though they are not required to be on ecDNA. To our knowledge, we did not claim that these genes are causal for ecDNA formation or maintenance, only that such genes and the underlying biological processes are worth investigating. In the beginning of the manuscript, we had written the following paragraph, but we have removed the last line (struck out here):

      “In lieu of identifying genes that are highly differentially expressed between ecDNA(+) and ecDNA(-) samples but driven by a small subset of cases (e.g. gene A in Fig. S1a), we sought to identify genes (e.g. gene B) whose expression level was predictive of ecDNA presence. We assumed that genes that were persistently over-expressed or under-expressed in ecDNA(+) samples relative to ecDNA(-) samples were more likely to be involved in ecDNA biogenesis or maintenance, or in mediating the cellular response to the presence of ecDNA.”

      We revised the manuscript to make sure that there are no claims that refer to causality. We revisited all phrases where the words like “maintain” were used and added appropriate disclaimers, or replaced them by the phrase, “ecDNA presence.” The remaining statements say, for example, “These results are consistent with a pan-cancer role of CorEx genes in ecDNA biogenesis and maintenance,” and do not claim causality.

      (B) The methods and procedures to identify the key genes is hyper-parameterized and convoluted and casts doubt on the robustness of the findings given the size and heterogeneity of the data.

      (a) In the first two paragraphs of Boruta Analysis Methods section, authors describe an iterative procedure where in each iteration, a binomial p-value is computed for each gene based on number of iterations thus far in which the gene was selected (higher GINI index than max of shadow features). But then in the third paragraph they simply perform Random Forest in 200 random 80% of samples and pick a gene if it is selected in at least 10/200. It is ultimately not clear what was done. Why 10/200? Also "the probability that a gene is a "hit" or "non-hit" in each iteration is 0.5" is unclear. That probability is of a gene achieving GINI index higher than the max of shadow features. How can it be 0.5?

      Response. We believe that there is some misunderstanding about the algorithm, and we agree that the description should have been more clear. We have greatly simplified the description in the manuscript. However, we want to provide some higher-level explanation here. Boruta is a standard feature extraction algorithm (Kursa, Journal of Statistical Software September 2010, Volume 36, Issue 11), and we used a Python implementation of the method. Given a gene expression data-set with class labels on samples, Boruta extracts features (genes) that best predict the class labels using a Random Forest Classifier, as long as the features are more predictive than permuted features added in each iteration. As we are using an implementation of a published method, we have removed non-essential details, referring directly to the publication. Nevertheless, to address the reviewer’s specific critique, the number of false-features added changes in each iteration (it equals the number of accepted+uncommitted features). Therefore, the choice of 0.5 by Boruta (it is fixed in the published method and not a user-specified parameter) is a conservative approach. If a gene was no better than a randomly chosen feature, its predictive performance would exceed the most predictive randomly chosen feature by at most 0.5 (but could be lower, making the choice of 0.5 conservative).

      While Boruta iteratively picks genes that are significantly better than random features, the list of genes predicted might be specific to the data-set, and might change with different data-sets. Therefore, we employed a bootstrapping strategy: we performed 200 trials each time picking 80% of the ecDNA(+) samples and 80% of the ecDNA(-) samples at random, thus generating many data-sets while maintaining class imbalance. For each of the 200 trials, we performed a Boruta analysis. Finally, we picked a gene if it was selected as a Boruta feature in at least 10 of 200 trials.

      The reviewer has a reasonable critique about why 10 (of 200) specifically, and why not fewer or more. Most genes are weak predictors by themselves. For example, RAE1, which is the top ranked gene, picked in all 200 Boruta trials, can only predict ecDNA status with poor recall for any meaningful precision.

      Author response image 1.

      Given the weakness of an individual gene as a classifier, its repeated selection in multiple Boruta trials is already a significant event. By requiring a gene to be picked in 5% of the trials (10/200), we were selecting a small, but more robust list of genes. However, to further explore the reviewer’s concerns, we also applied 8 other selection criteria ranging from 5 (of 200 Boruta trials) to 200 of 200 Boruta trials. See Figure below. The number of CorEx genes expectedly decreases. However, of the 187 GO terms that were enriched by 262 UP-genes using 10 of 200 Boruta trials as the selection criteria, 93 terms (49.7%) were enriched for each cut-off (see Author response image 2), and 155 terms (82.9%) were enriched in at least 5 of the 8 cut-off criteria. Given that the remaining analysis works on the hierarchy of GO terms and finds 4 GO-categories (Mitotic Cell Cycle, G1/S, G2/M; cell-division; DSB DNA Damage response; and the HOX Gene cluster) enriched by UP-regulated genes, those conclusions would hold regardless of the specific cut-off.

      Author response image 2.

      The number of GO terms that were enriched by DOWN-regulated genes is smaller, only 73, and falls rapidly for higher cut-offs, with 25 at a cut-off of 15. Therefore we see fewer terms enriched for more stringent cut-offs. However, they all support immune processes. These results do suggest that there are fewer genes that are consistently down-regulated in ecDNA(+) cancers, and expression change in a small number of genes may be sufficient to promote conditions for ecDNA.

      Finally, we note that in the final section we discuss the 65 most highly ranked genes with a harmonic mean rank <= 3. These 65 CorEx genes (or a member of their cluster) appear in each of 200 Boruta trials. Thus, their choice is also not dependent on the cut-off of 10 in 200. In summary, the conclusions of the paper do not depend upon the specific cut-off of 10 in 200 trials.

      We have added the figure as a supplemental figure and have added the following text to the manuscript on pages 17 and 18.

      “Any CorEx gene is either a Core gene that was selected as a feature in at least 5% of 200 Boruta trials, or be highly co-expressed with a Core gene. Because the selection criterion of 5% is arbitrary, we also tested robustness with 8 other cut-offs ranging from 5-of-200 to 200-of-200 Boruta trials. The number of CorEx genes expectedly decreases with more stringent cut-offs. However, of the 187 GO terms that were enriched by 262 CorEx UP-genes using 10 of 200 Boruta trials as the selection criteria, 93 terms (49.7%) were enriched for each cut-off (Fig. S9), and 155 terms (82.9%) were enriched in at least 5 of the 8 cut-offs. Given that our subsequent analyses utilized the hierarchy of GO terms and identified 4 GO-categories enriched by UP-regulated genes, the conclusions would hold regardless of the specific cut-off.”

      (b) The approach of combining genes with clusters is arbitrary. Why not start with clusters and evaluate each cluster (using some gene set summary score) for their ability to discriminate? Ultimately, one needs additional information to disambiguate correlated genes (i.e. in a coexpression cluster) in terms of causality.

      Response. In general, the approach proposed by the reviewer is reasonable. However, we did consider that possibility and found that our approach was easier to implement. For example, if we clustered first, we would have the challenge of choosing the correct set of clusters. Also, the Boruta analysis would become very difficult while dealing with clusters (e.g., how to define falsefeatures?). We tested other methods of picking genes that were suggested by other reviewers such as generalized linear models. They turned out not to be as predictive of ecDNA status, as described later in the response. Finally, we performed many experiments to ensure the validity of the clustering. Specifically, we had the following text in the paper:

      “Notably, among the 354 clusters, only 2 clusters (with 14 total genes) did not contain any Core genes. As most genes do not have completely identical expression patterns, we would expect one gene to be consistently picked as a Boruta gene over another co-expressed gene. Consistent with this hypothesis, most (344/354) clusters contained only 1 or 2 Core genes (Fig. 1c). When selecting clusters that contained at least 1 Core and 1 co-expressed gene, 53 of 71 clusters contained 1 to 3 Core genes (Fig. S1b), confirming that a few genes per co-expressed cluster provide sufficient predictive value, but other co-expressed genes might still play an important functional role in maintaining ecDNA(+) status.”

      These experiments suggest that the genes found by extending the Core genes through clustering do not radically change the Core genes, but only enhance the set.

      (c) The cross-validation procedure is not clear at all. There is a mention of 80-20 split but exactly how/if the evaluation is done on the 20% is muddled. The way precision-recall procedure is also a bit convoluted - why not simply use the area under the PR curve?

      Response. We apologize if the method was unclear. We have rewritten the methods part to make things clearer. As a high level point, there are two places where we use the same 80-20 split, and that resulted in some confusion. We start by randomly picking 80% of the ecDNA(+) and 80% of ecDNA(-) samples to create an 80-20 split of all samples. This procedure is repeated to generate 200 80-20 split data-sets. These data-sets are hereafter called 200 training and test samples.

      In the first usage, we use only the ‘training’ part of the 200 samples. We apply Boruta to each training set, and this helps us select the Core genes, which are then expanded to form the CorEx set. At this point, the CorEx genes are frozen for analysis in the rest of the paper. One question that we subsequently answer is what is the predictive power of the CorEx genes in determining if the sample is ecDNA(+) or ecDNA(-)? We also compare the predictive performance of CorEx genes relative to (a) Core genes, (b) LFC genes, and (c) random genes. In the revised manuscript, we have added another list of 3,012 genes selected using a single gene generalized linear model (GLM) for feature prediction. To make these comparisons, we utilized the same 200 training and test data-sets as before. In each test, we trained a random forest classifier on the training set and predicted on the ‘test’ set, for each of the 5 gene lists. This provided a uniform and fair method for testing which of the 5 gene lists was the better predictor of ecDNA status.

      The precision recall values are plotted in Fig. 2b (also included below). We note that none of the gene lists was a great predictor of ecDNA status of a sample. However, the CorEx and Core genes were significantly more predictive than GLM, LFC, and random genes. The predictive power of GLM genes was very similar to LFC, and better than random.

      For each of these 200 tests, we obtained a separate area under the precision-recall curve number for each of the gene-sets. To address the reviewer’s comments regarding a single number, we reported the average of the AUPRC for each of the gene-sets in the revision. The mean AUPRC values were added to the manuscript and are described here as well: Core_408_genes: 0.495 CorEx_643_genes: 0.48 Random_643_genes: 0.36 top_lfc_643_genes: 0.429 GLM_R_3012_genes: 0.426

      We also changed Figure 2b to show box-plots showing distribution of recall values for specific precision windows instead of maximum recall. For ease of checking, the figure is reproduced below.

      Author response image 3.

      (d) The claim is that Boruta genes are different from differentially expressed genes but the differential expression seems to be estimated without regards to cancer type, which would certainly be highly biased and misleading. Why not do a simple regression of gene expression by ecDNA status, cancer type and select the genes that show significant coefficient for ecDNA status?

      Response. As requested by the reviewer, and in the more detailed questions below, we added an alternative model with a generalized linear model (GLM) analysis that controlled for tumor subtype. The method itself is described in the Methods section and pasted below. The GLM genes were tested along with the LFC, CorEx, Core genes as described in response to the previous question, and those results are now presented in Figure 2b and on pages 6 and 7 of the revised manuscript.

      “We tested each of 16,309 genes independently in a separate logistic regression model using the glm() function in the R stats package (v4.2.0), and retained genes that were significant (p-value 0.01). Specifically, the model was defined as glm(𝑦 ~ 𝑔𝑗 + 𝑡𝑡, data = 𝑀, family = binomial(link = 'logit')), where y is the response vector where 𝑦𝑖=1 if sample 𝑖 ∈ {1, . . . ,870} is ecDNA(+) and 𝑦𝑖 =0 otherwise, 𝑔𝑗 is the vector of expression values for gene j ∈ {1, . . . ,16309} in samples 𝑖 ∈ {1,. . . ,870}, t is the covariate vector representing the tumor subtypes of samples 𝑖 ∈ {1, . . . ,870}, and 𝑀 is the data matrix containing values of gene expression, tumor subtype, and ecDNA status for all samples. The equation for the binomial logistic regression described above 𝑝𝑝 is formulated as where p is the probability that the dependent variable y is 1, 𝑋 are the independent variables, and 𝛽 are the coefficients of the model. In this case, k=1 represents independent variable gene j and k=2 represents the tumor subtype covariate t. Of the 16,309 genes tested independently, 3,012 genes were significant at pvalue<0.01.”

      (C) After identifying key features (which the authors inappropriate imply to be causal) they perform a series of enrichment/correlative analysis.

      Response. We have reviewed the document to ensure that we did not use the word ‘causal.’ If the reviewer can point to specific text, we are happy to change the phrasing.

      (a) It is known that ecDNA status associates with poor survival, and so are cell cycle related signal. Then the association between Boruta genes and those processes is entirely expected. Is it not? The same goes for downregulation of immune processes.

      Response. We agree with the reviewer that cell cycle related signals and immune related signals are associated with low survival, and so does ecDNA. However, many cellular processes could be associated with low survival (including for example, metabolic processes, protein and DNA biosynthesis, etc.). The unexpected part is that there appear to be only 4 major processes that are upregulated in ecDNA(+) cancers relative to ecDNA(-) cancers, and only one (immune response) that is downregulated.

      (b) The association with DSB specifically is interesting. Further analysis or discussion of why this should be would strengthen the work.

      Response. We thank the reviewer for their comment, and agree with their perspective. Note that we devoted a fair amount of text to analysis of DSB pathways. Specifically, we parsed the 4 main pathways in Figure 3b, and found our data to suggest that many genes in the classical nonhomologous end joining repair pathway are down-regulated in ecDNA(+) samples relative to ecDNA(-) samples. In contrast, Alternative end-joining and homology directed repair pathways are upregulated. This is a surprising result because c-NHEJ is considered to be an important mechanism of DSB repair. We have some lines in the discussion that address this:

      “The DNA damage genes are broadly up-regulated in ecDNA(+) samples, especially in double-strand break repair. Within this broad category of mechanisms, our analysis suggests that alternative DSB repair pathways such as Alt-EJ are preferred relative to classical NHEJ. This is consistent with previous observations of small microhomologies at breakpoint junctions, and has important implications in therapeutic selection that will need to be validated in future experimental studies. We note, however, the microhomology analyses typically study breakpoint junctions, and might ignore double-strand breaks in non-junctional sequences which could be observed, for example at replication-transcription junctions.”

      We note that additional experimental work to corroborate these findings is significant effort and will be part of ongoing research in our collaborators’ laboratories.

      (c) On page 15, second paragraph, when providing the up versus down CorEx genes, please also provide up versus down for non-CorEx genes as well to get a sense of magnitude.

      Response. We thank the reviewer for the comment. We note that Supplementary Table S15 has the complete contingency tables as well as the Fisher Exact Test statistic for all categories. For the specific categories mentioned in the paper, the chi-square tables are reproduced below. As we are citing TableS15 (containing all numbers and the statistic p-value) in the main text, we thought it was better to leave the text as it was.

      Category: Inflammation (p-value: 0.005)

      CorEx: 18 (UP), 76 (DOWN)

      Non-CorEx: 325 (UP), 657 (DOWN)

      Category: Leukocyte migration and chemotaxis (p-value: 0.03)

      CorEx: 13 (UP), 49 (DOWN)

      Non-CorEx: 213 (UP), 410 (DOWN)

      Category: Lymphocyte activation (p-value: 0.0075)

      CorEx: 23 (UP), 75 (DOWN)

      Non-CorEx: 334 (UP), 560 (DOWN)

      Category: Cytokine production (p-value: 0.117)

      CorEx: 6 (UP), 28 (DOWN)

      Non-CorEx: 93 (UP), 208 (DOWN)

      (d) The finding that Boruta genes are associated with high mutation burden is intriguing because in general mutation burden is associated with better survival and immunotherapy response. This counter-intuitive result should be scrutinized more to strengthen the work.

      Response. We agree with the reviewer that it is an intriguing observation. However, we are cautious in our interpretation. This is for the following reasons (all mentioned in the text):

      (1) The total mutation burden was significantly higher in ecDNA(+) samples relative to ecDNA(-) samples (Fig. 5a). However, when controlling for cancer type, only glioblastoma, low-grade gliomas, and uterine corpus endometrial carcinoma continued to show differential total mutational burden (Fig. S7b).

      (2) We tested if specific genes were differentially mutated between the two classes (Fig. 5b). For deleterious/high-impact mutations, TP53 was the only gene whose mutational patterns were significantly higher in ecDNA(+) compared to ecDNA(-) (OR 2.67, Bonferroni adjusted p-value 4.22e-07). BRAF mutations, however, were more common in ecDNA(-) samples and were significant to an adjusted p-value < 0.1 (OR 0.27).

      (3) In response to another reviewer’s comment, we also tested correlation with variant allele frequencies, and did not find any significant correlation except for TP53. We decided not to include that result in the paper.

      These tissue specific cases might be confounding the main observation, but we have placed all of them together so that the reader can gain a better understanding. It is worth noting that the correlation between high TMB and immunotherapy response is also now controversial, and perhaps not true for all cancer types. See for example (https://www.annalsofoncology.org/article/S0923-7534(21)00123-X/fulltext), which suggests that this relationship is not true for Glioma, and in Glioma (which is ecDNA enriched), higher TMB is associated with worse immunotherapy response. Our results are consistent with that finding. We have modified the discussion paragraph to better reflect this.

      “Mutation data alone does not provide as clear a picture of the genes involved in ecDNA maintenance. We did observe that the total mutation burden (TMB) was higher in ecDNA(+) samples. However, that relationship is much less clear after controlling for cancer type. High TMB has been positively correlated with sensitivity to immunotherapy52, and better patient outcomes; however, the gene expression patterns suggest that immunomodulatory genes are downregulated in ecDNA(+) samples, and patients with ecDNA(+) tumors have worse outcomes2. Notably, other results have suggested that the correlation between TMB and response to immunotherapy is not uniform, and it can vary across different tumor subtypes53. Specifically, our data is consistent with previous results which showed that Gliomas with high TMB have worse response to immunotherapy relative to gliomas with low TMB53. In general, no collection of gene mutations was predictive of ecDNA status, although mutations in TP53 were more likely in ecDNA(+) samples, and perhaps are an important driver for ecDNA formation5.”

      (e) On page 17 "12 of the 47 genes not specifically enriching any known GO biological Process" is confusing. How can individual gene enrich for a GO process?

      Response. We agree that the statement was incorrectly phrased. We have changed it to state that “Only 12 of the 47 genes were not included in the gene sets of any enriched GO term.”

      Reviewer #2 (Public Review):

      In their manuscript entitled "Transcriptional immune suppression and upregulation of double stranded DNA damage and repair repertoires in ecDNA-containing tumors" Lin et al. describe an important study on the transcriptional programs associated with the presence of extrachromosomal DNA in a cohort of 870 cancers of different origin. The authors find that compared to cancers lacking such amplifications, ecDNA+ cancers express higher levels of DNA damage repair-associated genes, but lower levels of immune-related gene programs.

      This work is very timely and its findings have the potential to be very impactful, as the transcriptional context differences between ecDNA+ and ecDNA- cancers are currently largely unknown. The observation that immune programs are downregulated in ecDNA+ cancers may initiate new preclinical and translational studies that impact the way ecDNA+ cancers are treated in the future. Thus, this study has important theoretical implications that have the potential to substantially advance our understanding of ecDNA+ cancers.

      Strengths

      The authors provide compelling evidence for their conclusions based on large patient datasets. The methods they used and analyses are rigorous.

      Weaknesses

      The biological interpretation of the data remains observational. The direct implication of these genes in ecDNA(+) tumors is not tested experimentally.

      Response. We agree with the reviewer that experimental tests would be ideal. Towards that, there are some challenges. The immune system genes cannot be tested in cell line models as they need a tumor microenvironment. Tests of DSB repair mechanisms and cell cycle control can be performed in cell-lines, but not with the TCGA samples which are not available. Some of our collaborators are actively working on these topics, but that extensive experimental work is beyond the scope of this paper.

      Reviewer #3 (Public Review):

      Summary:

      Using a combination of approaches, including automated feature selection and hierarchical clustering, the author identified a set of genes persistently associated with extrachromosomal DNA (ecDNA) presence across cancer types. The authors further validated the gene set identified using gene ontology enrichment analysis and identified that upregulated genes in extrachromosomal DNA-containing tumors are enriched in biological processes like DNA damage and cell proliferation, whereas downregulated genes are enriched in immune response processes.

      Major comments:

      (1) The authors presented a solid comparative analysis of ecDNA-containing and ecDNA-free tumors. An established automated feature selection approach, Boruta, was used to select differentially expressed genes (DEG) in ecDNA(+) and ecDNA(-) TCGA tumor samples, and the iterative selection process and two-tier multiple hypothesis testing ensured the selection of reliable DEGs. The author showed that the DEG selected using Boruta has stronger predictive power than genes with top log-fold changes.

      (2) The author performed a thorough interpretation of the findings with GO enrichment analysis of biological processes enriched in the identified DEG set, and presented interesting findings, including the enrichment in DNA damage process among the genes upregulated in ecDNA(+) tumors.

      (3) Overall, the authors achieved their aims with solid data mining and analysis approaches applied to public data tumor data sets.

      (4) While it may not be the scope of this study, it will be interesting to at least have some justification for choosing Boruta over other feature selection methods, such as Recursive Feature Elimination (RFE) and backward stepwise selection.

      Response. We actually agree with the reviewer that some other feature selection methods could work just as well, and note that the Boruta analysis is not our creation, but a published feature selection method (Kursa, Journal of Statistical Software September 2010, Volume 36, Issue 11). We use Boruta to identify relevant genes, but the bulk of the paper is to understand the biological processes driven by that gene selection. Even if we had chosen another method that performed slightly better, it likely would not change the main conclusions. However, to address the reviewers concerns on over-reliance on one method, we added a different gene list created by a generalized linear model analysis, with the goal of checking if the expression of a gene could predict the ecDNA status of the sample after controlling for tumor subtype. Thus, we tested 5 different genelists in terms of their power in predicting ecDNA. While none of the lists is a great predictor of ecDNA status, the Core and CorEx gene lists are significantly better than the other lists. The Figure below replaces the previous Figure panels 2b and 2c.

      Author response image 4.

      (1) The authors showed that DESEQ-selected DEGs with top log-fold changes have less strong predictive power and speculated that this may be due to the fact that genes with top log-fold changes (LFC) are confined only to a small subset of samples. It will be interesting to select DEGs with top log-fold changes after first partitioning the tumor samples. For example, randomly partition the tumor samples, identify the DEGs with top LFC, combine the DEGs identified from each partition, then evaluate the predictive power of these DEGs against the Boruta-selected DEGs.

      Response. This is a great comment. We added a generalized linear model test for selecting genes whose expression is predictive of ecDNA status. The GLM list described above uses a standard methodology (Analysis of Variance) controls for tumor type as a covariate, and its predictive performance is only slightly better than the Top-|LFC| genes, while improving over a random gene set.

      (2) While the authors showed that the presence of mutations was not able to classify ecDNA(+) and (-) tumor samples, it will be interesting to see if variant allele frequencies of the genes containing these mutations have predictive power.

      Response. This is a great suggestion. To address the reviewer’s question, we used allelic counts (REFs and ALTs) information from the MC3 variant callset, and calculated allele frequencies of all variants from samples where ecDNA status was available. Next, we conducted a Wilcoxon rank-sum test between VAFs of the ecDNA(+) group and VAFs of the ecDNA(-) group for every mutated gene. We found 1,073 genes with p<0.05, but among them, only TP53 passed the multiple testing correction (padj<0.05, Benjamini-Hochberg). As the results are identical to the tests based solely on presence of mutations, we decided not to include this data.

      Reviewer #1 (Recommendations For The Authors):

      (A) The presentation should be substantially streamlined.

      (B) Preferably use a more intuitive simpler ML approach with fewer parameters to make it more credible. Because there are relatively few samples across numerous cancer types with greater variability in representation, a simpler procedure with transparent controls will be more convincing.

      Response. We accept the reviewer’s criticism in that other statistical or ML approaches could potentially have been used, and that some are simpler. However, the test used here directly addresses the question: Find a collection of genes whose expression value is predictive of ecDNA status in the sample. Because the underlying method in the Boruta analysis uses random forests, it can test predictive power without relying on a linearity assumption implicit in other methods. In this revision, we also compare against a Generalized Linear Model (regression analysis) and show that it is less suited to the specific task above. We address the reviewer concerns about specific parameter choices by showing robustness to the specific parameter. All details are provided in the initial questions, and in the revised manuscript.

      (C) Avoid using any term implying causality unless you can bring in direct experimental evidence (e.g. mutagenesis experiment followed by ecDNA measurement. Some places you use the word 'maintain ecDNA' and other places 'ecDNA impact'. But these are all associations. How can you distinguish causal genes from downstream effects without additional data?

      Response. We note that the word causal does not appear anywhere in the manuscript, and was not intended. Additionally we have revised the manuscript and are open to specific changes requested by the reviewer or the editors.

      (D) Along these lines, if Boruta genes are indeed causal, one would expect Boruta-Up genes to be amplified more than expected in the ecDNA+; converse for Boruta-down genes.

      Response. We did not understand the reviewer’s question. By “amplified,” if the reviewer means “amplification of transcript level,” then that is exactly what the Boruta analysis is showing. Specifically, for each gene, we have the ability to pick a transcript level cut-off ‘t’ so that samples in which the expression is higher than t are more likely to be ecDNA(+). However, we are not claiming that there is causality, just that the transcript level is (weakly) predictive of the ecDNA status of the sample.

      (E) A strawman control should be a simple regression-based gene identification that controls for ecDNA status and cancer type.

      Response. We agree that this was a very good suggestion. In the revision, we have applied a GLM, which controls for tumor type. Thus, we have 5 gene-lists (including the Core and CorEx genes). As described in the revised manuscript but also in response to the main comments above, none of the lists are a great predictor. However, the CorEx and Core genes are significantly better at predicting ecDNA status of a sample.

      Reviewer #2 (Recommendations For The Authors):

      Comments

      (1) The analysis hinges on a classification of tumors into ecDNA(+) and ecDNA(-) using AmpliconClassifier. It would be good to know how robust the outcomes are with respect to the performance of AmpliconClassifier - how many false positives and negatives will AmpliconClassifier generate on this dataset and how would this influence the CorEx genes?

      Response. This is a very reasonable request. AA has been extensively tested on established cell-lines for its ability in predicting ecDNA status, and this information is published in multiple venues, including Kim, Nature genetics 2020, and shows precision 85% for recall 83%. For completeness, we have reproduced the relevant plot from that paper here, and the relevant text here, but are not including it in the manuscript.

      “To evaluate the accuracy of the AmpliconArchitect predictions, we analyzed whole-genome sequencing data from a panel of 44 cancer cell lines, and examined tumor cells in metaphase. We used 35 unique fluorescence in-situ hybridization (FISH) probes in combination with matched centromeric probes (81 distinct “cell-line, probe” combinations) to determine the intranuclear location of amplicons (Supplementary Table 2). Following automated analysis >1,600 images, we observed that 85% of amplicons characterized as ‘Circular’ by whole genome sequencing profile demonstrated an extrachromosomal fluorescent signal, representing the positive predictive value. Of the amplicons corresponding to extrachromosomally located FISH probes, 83% were classified as Circular, representing the sensitivity (Extended Data Fig. 1A).”

      Author response image 5.

      (2) It is unclear why genes are labeled Boruta genes when they are present in 10 out of 200 runs, this seems like an unexpectedly low number. How did the authors arrive at this number? Do the authors have any ground truth to estimate how well Boruta works in this setting and implementation?

      Response. This is a great question and asked by another reviewer as well. Given the weakness of an individual gene as a classifier, its repeated selection in multiple Boruta trials is already a significant event. By requiring a gene to be picked in 5% of the trials (10/200), we were selecting a small, but more robust list of genes. However, to further explore the reviewer’s concerns, we also applied 8 other selection criteria ranging from 5 (of 200 Boruta trials) to 200 of 200 Boruta trials. See Figure below. The number of CorEx genes expectedly decreases with increasing stringency. However, of the 187 GO terms that were enriched by UP-genes, 93 terms (50%) were enriched regardless of the cut-off (see Figure below), and 153 terms (82%) were enriched in at least 5 of the 8 cut-offs. Given that the remaining analysis works on the hierarchy of GO terms and finds 4 GO-categories (Mitotic Cell Cycle, G1/S, G2/M; cell-division; DSB DNA Damage response; and the HOX Gene cluster) enriched by UP-regulated genes, those conclusions would hold regardless of the specific cut-off.

      Author response image 6.

      The number of GO terms that were enriched by DOWN-regulated genes is smaller, only 73, and falls rapidly for higher cut-offs, with 25 at a cut-off of 15. Therefore we see fewer terms enriched for more stringent cut-offs. However, they all support immune processes. These results do suggest that there are fewer genes that are consistently down-regulated in ecDNA(+) cancers, and expression change in a small number of genes may be sufficient to promote conditions for ecDNA.

      We have added the figure as a supplemental figure and have added the following text to the manuscript on pages 17 and 18.

      “Any CorEx gene is either a Core gene that was selected as a feature in at least 5% of 200 Boruta trials, or be highly co-expressed with a Core gene. Because the selection criterion of 5% is arbitrary, we also tested robustness with 8 other cut-offs ranging from 5-of-200 to 200-of-200 Boruta trials. The number of CorEx genes expectedly decreases with more stringent cut-offs.

      However, of the 187 GO terms that were enriched by 262 CorEx UP-genes using 10 of 200 Boruta trials as the selection criteria, 93 terms (49.7%) were enriched for each cut-off (Fig. S9), and 155 terms (82.9%) were enriched in at least 5 of the 8 cut-offs. Given that our subsequent analyses utilized the hierarchy of GO terms and identified 4 GO-categories enriched by UP-regulated genes, the conclusions would hold regardless of the specific cut-off.”

      (3) Authors extend the core gene set with co-expressed genes, arguing that "gene C" would not add predictive power in addition to "gene B" and is therefore not identified as a Boruta gene. However, from its description in the manuscript (summarized: "Boruta [...] selects the highest feature importance score, s, of shadow features as a cut off, and returns features with a higher score than s."), it isn't immediately obvious to me why Boruta would not return both genes B and C. Maybe the authors could explain this better.

      Response. We consider the following.

      (1) Consider 100 ecDNA(+) and 100 ecDNA(-) samples. Let the expression levels of genes B and C in the data-sets be as described in the figure below; y-axis is the gene expression, and x-axis is just a listing of all samples, with green color denoting ecDNA(+) samples and orange color denoting ecDNA(-) samples.

      Author response image 7.

      (2) Then, if we choose gene B and a transcript level of 1.25, we have a perfect prediction of ecDNA status because all samples where gene B has a transcript level higher than 1.25 are ecDNA(+) and otherwise they are ecDNA(-). Similarly, using Gene C, we can get perfect predictions. Thus, when Boruta has to select a gene, it will pick either Gene B or Gene C, because picking both will not improve prediction. We can therefore use Boruta to pick one gene, and then co-expression clustering to pick the other gene.

      As an example, cluster #3 consists of 21 genes that were up-regulated in ecDNA(+) samples and enriched in cell-cycle related biological processes (Table S3). While these genes were expressed similarly in ecDNA(+) samples, and separately, in ecDNA(-) samples, out of the 21 genes, only 9 genes were selected in at least 10 out of 200 Boruta trials (i.e., Core genes). Of the 12 remaining genes (i.e., CorEx genes), 8 genes were not selected by the Boruta method at all, 3 genes were selected in less than 5 out of 200 Boruta trials, and 1 gene was selected in 9 out of 200 Boruta trials.

      Author response image 8.

      (4) In Fig 2a, I would like to see the variability of the precision and recall in the main text, not only the maximum values. Authors could plot mean + standard deviation for precision and recall separately, or use S2a/b.

      Response. We have replaced Figures 2b and 2c with a combined figure (Fig. 2b) that gives a box-plot describing the distribution of recall values for 5 gene lists: four from the original manuscript, and another gene list created using a Generalized Linear Model (GLM).

      Author response image 9.

      (5) Since the authors analyze bulk RNA, the gene expression signatures they notice could, in principle, originate from non-tumor cells as well. I do not believe this is the case, however, the paper would be strengthened by an analysis that shows that the difference in expression patterns of the Corex genes between ecDNA(+) and ecDNA(-)-samples does come from tumor cells. One way of showing this would be by using single-cell mRNA-sequencing data, and another way of showing this would be to show that Corex gene-expression correlates with tumor purity in bulk samples.

      Response. The reviewer is correct. Unfortunately, our analysis requires data with whole-genome sequencing (WGS) for ecDNA prediction, as well as RNA-seq for transcriptome profiling. The TCGA data-set is the only available data-set with a significant number of samples that includes both WGS and RNA-seq. They have not made tissue samples available for scRNA analysis, to our knowledge. The reviewer raises an important question regarding purity, but testing if CorEx gene expression correlates with tumor purity would require a large range of purity values, something that scientists would avoid when collecting samples.

      However, the presence of non-cancer tissue (impurity) could reduce sensitivity of ecDNA detection, and therefore, change the results. To better investigate this, we started with a publication that investigated multiple tumor purity metrics and devised a composite score (CPE; Aran et al., 2015). Using their composite tumor purity, we find that ecDNA(-) samples have slightly lower purity than ecDNA(+) samples (p-value 0.0036; Fig. S2a).

      This result is not surprising because one would expect lower detection of ecDNA in less pure samples. The presence of undetected ecDNA in ecDNA(-) samples would confound the results by reducing the discriminating power of genes, but would not give false results. To test this, we measured the expression directionality in CorEx genes in all samples versus samples which had a high tumor purity (CPE 0.8). The results suggest that the p-values of directionality in the pure samples were highly correlated with the expression data from all samples (Fig. S2b).

      Author response image 10.

      (6) The biological interpretation of the data remains a bit too observational. Can the authors offer an interpretation of the enriched GO terms? And are any of these genes already implicated in ecDNA(+) tumors?

      Response. To answer the second question first, prior to our study, the focus was on genes that were amplified on ecDNA. Indeed many oncogenes known to be amplified in cancer are in fact amplified on ecDNA (Turner, Nature 2017, Kim Nature genetics 2020). This study is unique in that it identifies genes whose expression values are predictive of ecDNA(+) status. The Figure below lists 24 genes most frequently amplified on ecDNA from Kim, Nature Genetics 2020. With the exception of EGFR and CDK4, none of these 24 genes was included in the list of the 65 genes reported by us as the most frequently selected genes in the Boruta trials (lowest harmonic rank). Thus, most persistent CorEx genes do not lie on ecDNA. However, they all play important roles in biological processes relevant to cancer pathology including Immune Response, Mitotic cell Cycle, Cell division, and DSB repair. We agree with the reviewer that the results are observational (although statistically significant in populations), and some of our collaborators are actively working to experimentally validate some of these genes. The experimental work, however, is beyond the scope of this paper.

      We have added the following statement to the manuscript. “Notably, of the 24 genes most frequently expressed on ecDNA,2 only EGFR and CDK4 were included in the list of 65 genes, suggesting that the most persistent CorEx genes do not themselves appear frequently on ecDNA.”

      Author response image 11.

      Reviewer #3 (Recommendations For The Authors):

      Minor comments:

      (1) The authors performed gene ontology enrichment test but referred to it as gene set enrichment analysis. Usually gene set enrichment analysis does not refer to Fischer's exact test-based analysis but rather the one described in Subramanian et al 2005. The term correction should be made to avoid confusion.

      Response. We have rephrased text in the manuscript to prevent confusion between enrichment analysis on gene sets using an one-sided Fisher’s exact test and the Gene Set Enrichment Analysis (GSEA) method that exists as a software. We have also revised the header in the methods section from “Gene set enrichment analysis” to “Gene Ontology (GO) enrichment analysis”.

      (2) A couple of figures could use more detailed labels and captions. In Figure 2c, it is unclear what the numbers 100 and 54 right next to the Cliff's Delta heatmap indicate. In Figures 3a and 4a, it is not immediately clear what the barplot on top of the heatmap indicates and there is no label for the y-axis.

      Response. These are good suggestions, and we have added descriptions to the figure captions.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations For The Authors):

      The manuscript is very well written, the data are clearly presented and the methodology is robust. I only have suggestions to improve the manuscript, to make the study more appealing or to discuss in more detail some questions raised by the work.

      1. In the study as it stands, PFG seems to come out of the blue. The authors apparently selected this protein based on sequence conservation between species but this is unlikely to be sufficient to identify novel TFs. Explaining in more detail the reasoning that led to PFG would make the story more appealing. Perhaps PFG was identified through a large reverse genetics screening?

      Response: Thank you for your suggestion. We identified this gene solely by the strategy we described in the manuscript. We decided on this strategy based on the findings of our previous study on AP2-Family TFs, whose DNA binding domains are highly conserved among Plasmodium orthologues. Using this screening strategy, we identified a novel AP2 family TF AP2-Z. The results of the present study demonstrated that this strategy is applicable to TFs other than those belonging to the AP2 family. We are aware that this strategy is not all-encompassing. In fact, we failed to identify HDP1 as a candidate TF when it was also in the target list of AP2-G. However, at present, this is our primary strategy for identifying novel TFs in the targetome.

      1. The authors propose that PFG and AP2-FG form a complex, but this is actually not shown. Did they try to document a physical interaction between the two proteins, for example using co-IP?

      Response: Even when the two molecules were identified to be at the same position by ChIPseq, it cannot be concluded that they form a physical complex because it is possible that they competitively occupy the region. However, in this study, we performed ChIP-seq in the absence of PFG and demonstrated that the cAP2-FG peaks disappeared while those of sAP2-FG remained. This result can only be explained by the two proteins forming a complex at this region, which excludes the possibility that AP2-FG binds the region independently.

      1. It is unclear how PFG can bind to DNA in the absence of DNA-binding domain. Did the authors search for unconventional domains in the protein? This should be at least discussed in the manuscript.

      Response: We speculate that the two highly conserved regions, region 1 and region 2, function as DNA-binding domains in PFG. However, this domain is not similar to any DNA binding domains reported thus far. A straightforward way to demonstrate this would be to perform in vitro binding assays using a recombinant protein. However, thus far, we have not succeeded in obtaining soluble recombinant proteins for these regions. We have added the following sentences to the results section.

      “At present, we speculate that PFG directly interacts with genomic DNA through two highly conserved regions; region 1 and region 2. However, these regions are not similar to any DNA binding domains reported thus far. In other apicomplexan orthologues, these two domains are located adjacent to one another in the protein (Fig. 1A). Therefore, these two regions may be separated by a long interval region but constitute a DNA binding domain of PFG as a result of protein folding.”

      1. How do the authors explain that PFG is still expressed in the absence of AP2-FG? Is AP2G alone sufficient to express sufficient levels of the protein? Is PFG down-regulated in the absence of AP2-FG?

      Response: Our previous ChIP-seq data indicate that PFG is a target of AP2-G. According to the study by Kent et al. (2018), this gene is up-regulated in the early period following conditional AP2-G induction. The results of the present study showed that PFG is capable of autoactivation through a transcriptional positive feed-back loop. These results suggest that PFG can maintain its expression to a certain level once activated by AP2-G, even in the absence of AP2-FG. In our previous microarray analysis, significant decreases in PFG expression were not observed in AP2-FG-diaruptedparasites.

      1. How do AP2-FG regulated genes (based on RNAseq) compare with the predicted cAP2FG/sAP2-FG predicted genes (based on ChIPseq)? Are the two subsets included in the genes that are actually down-regulated in AP2-FG(-)?

      Response: Disruption of the AP2-FG gene impairs gametocyte development. We considered that the direct effect of this disruption would be difficult to analyze in gametocyte-enriched blood, in which gametocytes are pooled during sulfadiazine treatment to deplete asexual stages. Therefore, in our previous paper, we performed microarray analysis between WT and KO parasites to detect the direct effect of AP2-FG disruption on target gene expression, using mice which were synchronously infected with parasites. According to our results, 206 genes were down-regulated in AP2-FG-disrupted parasites. Of these genes, 40 and 117 were targets of sAP2-FG and cAP2-FG, respectively. However, it is still possible that a significant proportion of genes were indirectly down-regulated by AP2-FG disruption, which may impair gametocyte development. Moreover, based on the results of the present study, expression of a significant proportion of AP2-FG target genes could be complemented by PFG transcription. We believe that it would be difficult to compare the direct effects of these TFs on gene expression via transcriptome analysis (therefore, targetome analysis is important). In this study, we compared the expression of target genes of sAP2-FG and cAP2FG between PFG(-) and WT parasites. We expected that down-regulation of PFG (cAP2FG) targets would be complemented with transcription by sAP2-FG.

      1. Minor points

      -Page 5 Line 10, remove "as"

      Response: We have corrected this.

      -Page 7 Lines 4-13: is it possible to perform the assay in PFG(-) parasites?

      Response: Thank you for your question. Even when the marker gene expression was decreased in PFG(-) parasites, we cannot conclude the reason to be a direct effect of the mutation. To determine the function of the motif, it is necessary to perform the assay using wild-type parasites.

      -Page 7 Line 45: Fig6C instead of 5C

      Response: Thank you for pointing this out. We have corrected this.

      -Page 8 Line 27: "decreases"

      Response: Thank you for pointing this out. We have corrected this.

      -Page 8 Line 36: PFG instead of PGP

      Response: We have corrected this.

      -Page 8 Line 39: remove "the fact"

      Response: We have removed this word.

      -Page 8 Line 42: Fig6G instead of 5G

      Response: We have corrected this.

      -Page 8 Line 43: PFG instead of PGP

      Response: We have corrected this.

      -Page 9 Line 23: "electroporation"

      Response: We have corrected this.

      -Page 9 Line 32: "BamHI"

      Response: We have corrected this.

      -Fig 2E: in the crosses did the authors check oocyst formation in the mosquito?

      Response: We did not check oocyst formation because abnormalities in males may not affect oocyst formation.

      -Page 17, legend Fig3, Line 14, there is probably an inversion between left and right for PFG versus AP2-FG (either in the legend or in the figure)

      Response: Thank you for pointing this out. PFG peaks are located in the center in both heat maps. The description “AP2-FG peaks” over the arrowhead in the left map was incorrect. We have corrected this to “PFG peaks”. The peaks in the left heat map must be located in the center; thus, this figure might be redundant.

      Reviewer #2 (Recommendations for the Authors):

      • Could the authors please state in the results section that PFG stands for partner of AP2FG.

      Response: Thank you for the comment. We have added the following to the results section:

      “Through this screening, a gene encoding a 2709 amino acid protein with two regions highly conserved among Plasmodium was identified (PBANKA0902300, designated as a partner of AP2-FG (PFG; Fig. 1A).”

      • Given that the transcriptional program is so dynamic, the timing of the ChIP-seq experiments is crucial. Could the authors clarify the timings of the different ChIP-seq experiments (AP2-FG, PFG, PFG in AP2-FG-, AP2-FG in PFG-, ...)

      Response: Thank you for the comment. To deplete any parasites in the asexual stages, all ChIP-seq experiments in this study were performed using blood from mice treated with sulfadiazine, namely, gametocyte-enriched blood. As the reviewer points out, timing is important, and samples from the period when TFs are maximally expressed are optimal for ChIP-seq. However, when parasites in the asexual stages are present, the background becomes higher. Thus we usually use gametocyte-enriched blood for ChIP-seq when expression of the TF is observed in mature gametocytes. The exception was our ChIP-seq analysis of AP2-G, because is not present in mature gametocytes.

      • Fig 4c is an example of great overlap of peaks, but it would be helpful if the authors could quantify the overlaps between experiments (and describe the overlap parameters used).

      Response: According to the comment, we have created a Venn diagram of overlapping peaks (attached below). However, the peaks used for this Venn diagram were selected after peakcalling via fold-enrichment values. Thus, even if the counterpart of a peak is absent in these selected peaks (non-overlapping peaks in the Venn diagram), it does not indicate that it is absent in the original read map. We believe the overlap of peaks would be estimated more correctly in the heat maps.

      Author response image 1.

      Legged: The Venn diagram shows the number of common peaks between these ChIP seq experiments (distance of peak summits < 150

      • Additionally, how were the promoter coordinates used for each gene when they associate ChIP peaks to a gene target. Did the authors choose 1-2kb? Or use a TSS/5utr dataset such as Adjalley 2016 or Chappell 2020?

      Response: We selected a 1.2 Kbp region for target prediction based on our previous studies. As the reviewer pointed out, target prediction using TSS information may be more accurate. However, reliable TSS information is not available for P. berghei to the best of our knowledge.

      The two papers are studies on P. falciparum.

      • In the absence of evidence of physical interaction, it remains unclear if AP2-FG and PFG actually interact directly or as part of the same complex. A more detailed characterisation with IPs/co-IPs followed by mass spectrometry of the GFP-tagged version of PFG in the presence and absence of AP2-FG would be highly informative.

      Response: Thank you for the comment. Even when these two TFs occupy the same genomic region, it cannot be conclusively said that they exist at the same time in the region: they might competitively occupy the region. However, we showed that the cAP2-FG peaks disappear from the region when PFG was disrupted, while sAP2-FG peaks remain. We believe that this is evidence that the two TFs physically interact with each other.

      • It was not clear if the assessment of motif binding using cytometry was performed using all the required controls and compensation. This section should be clarified.

      Response: Thank you for the comment. Condensation was performed using parasites expressing a single fluorescent protein. The results are attached below. The histogram of mCherry using control parasites expressing GFP under the control of the HSP70 promoter is also attached.

      Author response image 2.

      However, we found that descriptions of the filters for detecting red signals were not correct. This assay was performed using parasites which expressed GFP constitutively and mCherry under the control of the p28 promoter. These two fluorescent proteins were excited by independent lasers (488 and 561, respectively), and the emission spectra were detected using independent detectors (through 530/30 and 610/20 filters, respectively). We have revised the description regarding our FACS protocols as follows:

      “Flow cytometric analysis was performed using an LSR-II flow cytometer (BD Biosciences). In experiments using 820 parasites, the tail blood from infected mice was selected via gating with forward scatter and staining with Hoechst 33342 (excitation =355 nm, emission = 450/50). The gated population was then analyzed for GFP fluorescence (excitation = 488 nm, emission = 530/30) and RFP fluorescence (excitation = 561 nm, emission = 610/20). In the promoter assay (using parasites transfected with a centromere plasmid), the tail blood from infected mice was selected via gating with forward scatter and staining with Hoechst 33342 (excitation =355 nm, emission = 450/50), followed by GFP fluorescence (excitation = 488 nm, emission = 530/30). The gated population was analyzed for mCherry fluorescence (excitation = 561 nm, emission = 610/20). Analysis was performed using the DIVER program (BD Biosciences).”

      Minor points:

      • Page 4, line 37: The authors should specify the timing of expression of AP2-FG on the text.

      Response: We have added the following description to the text.

      “The timing of the expression was approximately four hours later than that of AP2-FG, which started at 16 hpi (9).” .

      • Ref 9 and 17 are repeated

      Response: Thank you for pointing this out. We have corrected this.

      • Fig 1D and 1F do not have scale bars

      Response: We have added scale bars to Fig. 1D.

      We have not changed Fig. 1F, because we believe that the scales can be estimated from the size of the erythrocyte.

      • Page 5, line 29-30. Could the authors specify how many and which of the de-regulated genes have a PFG in their promoter.

      Response: Thank you for the comment, As described in a later section (page 7; Impact of PFG disruption on the expression of AP2-FG target genes), among the 279 genes significantly downregulated in PFG(-) parasites, 165 genes were targets for PFG (unique for PFG or common for sAP2-FG and PFG). In contrast, only four genes were targets unique to sAP2-FG. Therefore, 165 genes harbor the upstream peaks of PFG. These genes are shown in Table S1.

      • Fig 5F. in the methods associated with this figure there seems to be a mixup with the description of the lasers. In addition, given the spillover of the red and green signal between detectors this experiment needs compensation parameters. The authors should provide the gating strategy before and after compensation as this is critical for the correct calculation of the number of red parasites. Indeed, the lowest red cloud on the gate shown could be green signal spill over.

      Response: Thank you for the comment. As described above, there were some incorrect descriptions about the conditions of our FACS protocols in the methods section. We have revised them.

      -Page 7, line 19. Could the authors explicitly say in the text that the 810 genes are those with 1 (or more?) PFG peaks in their promoter (out of a total of 1029) to best guide the reader. Additionally, it is important to define the maximum distance allowed between a peak and CDS for it to be associated with said CDS.

      Response: We have revised Table S2 by adding the nearest genes. The revised table shows the relationship between a PFG peak and its nearest genes, together with their distances.

      • Page 7, line 45: fig 6c, not 5c

      Response: Thank you for the comment. We have corrected this.

      • Page 7 last paragraph: This section is very hard to follow. For instance, on line 50 do the authors mean that the sAP2-FG unique targets are LESS de-regulated? On line 51: do the authors mean unique targets of cAP2-FG or unique targets of PFG? Line 53: do the authors mean that genes expressed in the "common" category are LESS de-regulated than the PFG unique targets?

      Response: We are sorry for the lack of clarity; after reviewing the manuscript, it appears to be unclear what the fold change means in this section. Here, fold change means the ratio of PFG(-)/wild type. Thus “High log2(fold change) value” means that the genes were less downregulated. We have revised the description as follows:

      “The log2 distribution (fold change = PFG(-)/wild type) in the three groups of target genes showed that the average value was significantly higher (i.e., less down-regulated) in targets unique to sAP2-FG than in the other two groups (targets unique to cAP2-FG or common targets for both), with p-values of 1.3 × 10-10 and 1.4 × 10-5, respectively, by two-tailed Student’s t-test (Fig. 6F). In addition, the average log2 (fold change) value of the common target genes was relatively higher (i.e., less down-regulated) than that of targets unique to PFG, suggesting that transcriptional activation by sAP2-FG partly complements the impact of PFG disruption on these common targets.”

      • Page 8, line 42: Fig 6G, not 5G

      Response: Thank you for pointing this out. We have corrected this.

      Reviewer #3 (Recommendations For The Authors):

      1. The gene at the center of this study (PBANKA_0902300) was identified in an earlier genetic screen by Russell et al. as being a female specific gene with essential role in transmission and named Fd2 (for female-defective 2). Since this name entered the literature first and is equally descriptive, the Fd2 name should be used instead of PFG to maintain clarity and avoid unnecessary confusion. Surprisingly, this study is neither cited nor acknowledged despite a preprint having been available since August of 2021. This should be remedied.

      Response: Thank you for the comment. We have added the paper by Russell et al. accordingly and mentioned the name FD2 in the revised manuscript. However, we have retained the use of PFG throughout the paper. We believe that this usage of PFG shouldn’t be confusing, as FD2 has only been used in one previous paper. We have added the following:

      “Through this screening, a gene encoding a 2709 amino acid protein with two regions highly conserved among Plasmodium was identified (PBANKA0902300, designated as a partner of AP2-FG (PFG; Fig. 1A). This gene is one of the P. berghei genes that were previously identified as genes involved in female gametocyte development (named FD2), based on mass screening combined with single cell RNA-seq (ref).”

      1. While it isn't really important how the authors came to arrive at studying the function of Fd2, the rationale/approach given in the first paragraph of the result section seems far too broad to lead to Fd2, given that it lacks identifiable domains and many other ortholog sets exist across these species.

      Response: We selected this gene from the list of AP2-G targets as a candidate for a sequence-specific TF based on the hypothesis that the amino acid sequences of DNAbinding domains are highly conserved. We successfully identified two TFs (including PFG) using this method. However, there may be TFs that do not fit this hypothesis which are also targets of AP2-G. In fact, we were unable to identify HDP1 as a TF candidate, despite being a AP2-G target.

      1. Fig. 1A-C: Gene IDs for the orthologs should be provided, as well as the methodology for generating the alignments.

      Response; We have added the gene IDs and method for alignment in the legend as follows:

      (A) Schematic diagram of PFG from P. berghei and its homologs in apicomplexan parasites. Regions homologous to Regions 1 and 2, which are highly conserved among Plasmodium species, are shown as yellow and blue rectangles, respectively. Nuclear localization signals were predicted using the cNLS mapper (http://nls-10 mapper.iab.keio.ac.jp/cgibin/NLS_Mapper_form.cgi). The gene IDs of P. berghei PFG, P. falciparum PFG, and their homologs in Toxoplasma gondii, Eimeria tenella and Vitrella brassicaformis are PBANKA_0902300, PF3D7_1146800, TGGT1_239670, ETH2_1252400, and Vbra_10234, respectively.

      (C) The amino acid sequences of Regions 1 and 2 from P. berghei PFG and its homologs from other apicomplexan parasites in (A) were aligned using the ClustalW program in MEGA X. The positions at which all these sequences have identical amino acids are indicated by two asterisks, and positions with amino acid residues possessing the same properties are indicated by one asterisk.

      1. Figure 2: The Phenotype of Fd2 knockout should be characterized more comprehensively.

      It remains unclear whether ∆Fd2 parasite generate the same number of females but these are defective upon fertilization or whether there is also a decrease in the number of female gametocytes. Is the defect just post-fertilization and zygotes lyse or are there fewer fertilization events? If so is activation of female GCs effected?

      The number of male and female gametocytes should be quantified using sex-specific markers not affected by Fd2 knockout rather than providing a single image of each. The ability of ∆Fd2 GCs should also be evaluated.

      This is also important for the interpretation of Fig 2G. Is the down-regulation of the genes due to fewer female GCs or are the down-regulated genes only a subset of female-specific genes.

      Response: In PFG(-) parasites, the rate of conversion into zygotes of female gametocytes decreased, and zygotes had lost capacity for developing into ookinetes. This indicates that gametocyte development (i.e., the ability to egress the erythrocyte and to fertilize) and zygote development were both impaired. This phenotype is consistent with the observation that genes expressed in female gametocytes are broadly downregulated. PFG is a TF, and its disruption led to decreased expression of hundreds of female genes. Thus, the observed phenotype may be derived from combined decreased expression of these genes. We believe further detailed phenotypic analyses will not generate much novel information on this TF. Instead, RNA-seq data in PFG(-) parasites and the targetome have promise in helping to characterize the functions of this TF.

      1. Figure 3: what fraction of down-regulated genes have the Fd2 10mer motif?

      Response: Thank you for the question. We investigated the upstream binding motifs of these genes. Of the 279 significantly down-regulated genes (containing 165 targets), 161 genes harbor the motif (including nine-base motifs that lack one lateral base which is likely not essential for binding) in their upstream regions (within 1,200 bp from the first methionine codon). However, this result has not been described in the revised manuscript because it is more important whether these regions harbor PFG peaks (upstream motifs can exist without being involved in the binding of PFG).

      1. sAP2-FG (single) vs cAP2-FG (complex) nomenclature is confusing and possibly misleading since few TFs function in isolation and sAP2-FG likely functions in a complex that doesn't contain Fd2, possibly with another DNA binding protein that binds the TGCACA hexamer. The name for the distinct peaks should refer to the presence or absence of Fd2 in the complex, or maybe simply refer to them as complex A & B.

      Response: As shown in the DIP-seq analysis results, AP2-FG can bind the motif by itself. In contrast, AP2-FG must form a complex with PFG to bind to the ten-base motif. The complex and single forms are named according to this difference (the presence or absence of PFG) and used solely in its relation with PFG. We wrote “In the following, we refer to the form with PFG as cAP2-FG or the complex form, and the form without PFG as sAP2-FG or the single form.” We believe that the nomenclature has sufficient clarity. However, we have partially (underlined) revised certain sentences in the discussion section as follows.

      “As the expression of PFG increases via this mechanism, AP2-FG recruited by PFG (cAP2FG) increases and eventually becomes predominant in the transcriptional regulation of female gametocytes.”

      “This suggests that the promoter of the CCP2 gene, which is a target of PFG only, is still active in AP2-FG(-)820 parasites.”

      We recently reported that the TGCACA motif is a cis-activation motif in early gametocytes and important for both male and female gametocyte development. Thus we speculate that sAP2-FG is not involved in cis-activation by the TGCACA motif. The p-value of the six-base motif is indeed comparable to that of the five-base motif. However, the pvalue (calculated by Fisher’s exact test) in six-base motifs tend to be lower than that calculated in five-base motifs, because the population is much large. We speculate that there is a sequence-specific TF that may be expressed in early gametocytes and bind this motif, independently of AP2-FG.

      1. I compared the overlap of peaks in the 4 ChIP-seq data sets:

      90% of the Fd2 peaks are shared with AP2-FG (binding 24% of shared peaks is lost in ∆AP2FG)

      10% are bound by Fd2 alone (binding at 35% of Fd2 is lost in ∆AP2-FG)

      75% of Fd2 peaks are bound independently of AP2-FG

      47% of AP2-FG peaks shared with Fd2 (binding at 71% of shared peaks is lost in ∆Fd2) 53% of AP2-FG peaks are bound only by AP2-FG (but binding at 82% of AP2-FG only peaks is still lost in the ∆Fd2)

      Binding at 78% of all AP2-FG peaks is lost in ∆Fd2

      This indicates that much of AP2-FG binding in regions even in regions devoid of Fd2 still depends on Fd2. What are possible explanations for this?

      https://elife-rp.msubmit.net/eliferp_files/2023/04/03/00117573/00/117573_0_attach_10_17936_convrt.pdf

      Response: In the ChIP-seq of AP2-FG in the absence of PFG, 441 peaks are still called. This means that at least 441 binding sites for AP2-FG independent of PFG exist. This is a straightforward conclusion from our ChIP-seq data. On the other hand, simple deduction of peaks between two ChIP-seq experiments (AP2-FG peaks minus PFG peaks) is not a precise method for determining sAP2-FG. Peak-calling is independently performed in each ChIP-seq experiment. Thus, peaks remaining after the deduction between two experiments can still contain peaks that are actually common, but which are differentially picked up through the process of peak calling. Even when using data obtained by the same ChIP-seq experiment, markedly different numbers of peaks are called according to the conditions for peak calling (in contrast, common peaks between two independent experiments increase the reliability of the data). If wanting to identify sAP2-FG peaks via comparisons between AP2-FG peaks and PFG peaks, the reviewer has to increase the number of PFG peaks by reducing the peak-calling threshold until the number of overlapping peaks between AP2-FG and PFG are saturated, and then deduce the overlapping peaks from the AP2-FG peaks. However, as described above, for the purposes of estimating the number of sAP2-FG, it would be better to perform ChIP-seq of AP2-FG in the absence of PFG.

      1. Possible explanations of why recombinant Fd2 doesn't bind the TGCACA hexamer. It would also be good to note that the GCTCA AP2-FG motif found in Fig4G is now perfect match for the motif identified by protein binding microarray in Campbell et al.

      Response: It is not known what sequence recombinant PFG binds. The TGCACA motif is not enriched in PFG peaks. If the reviewer is referring to AP2-FG, our findings that the recombinant AP2 domain binds the five-base motif strongly suggests that other TFs recognize this motif. As described in our response to comment 9, we recently reported that TGCACA is a cis-activating sequence important for the normal development of both male and female gametocytes. Therefore, we currently speculate that this motif is a binding motif of other TFs and is independent of AP2-FG.

      We have mentioned the protein binding microarray data in the Results section as follows.

      “The most enriched motif matched well with the binding sequence of the AP2 domain of P. falciparum AP2-FG, which was reported by Campbell et al.”

      1. What might explain the strong enrichment for TGCACA in ChIPseq but when pulled down by AP2-FG DBD: another binding partner? requires more of AP2-DF than just DBD?

      Response: As described above in our response to comment 6, we have recently submitted a preprint studying the roles of the remodeler subunit PbARID in gametocyte development. We reported that the remodeler subunit is recruited to the six-base motif and that the motif is a novel cis-activation element for early gametocyte development. We speculate that a proportion of AP2-FG targets are also targets of a TF that recognizes this motif and recruits the remodeler subunit. These two TFs may be involved in the regulation of early gametocyte genes but function independently.

      1. Calling DNA pulldown with recombinant AP2-FG DNA-binding domain DNAImmunoprecipitation sequencing (DIP-seq) is confusing since there are no antibodies involved. Describing it directly as a pulldown of fragmented DNA will be clearer to the reader.

      Response: Thank you for the comment. We have also recognized this discrepancy. However we called the method DIP-seq because the original paper reporting this method used this name, wherein it did not use antibodies to capture the MBP-fusion recombinant protein. Our experiment was performed using essentially the same methods, and thus we retained the name.

      1. The legends and methods are very sparse and should include substantially more detail.

      Response: Thank you for the comment. We have revised the description of the FACS experimental method for clarity.

      1. BigWig files for all ChIPseq enrichment used for analysis in this study need to be provided.

      (two replicates each of : Fd2 in WT, Fd2 in ∆AP2-GF, AP2-FG in WT, AP2-FG in ∆Fd2)

      Response: We have deposited the BigWig files to GEO (GSE.226028 and GSE114096).

      1. Tables of ChIP data need to have both summits and peaks and need to list nearest gene. Also the ChIPseq peaks for Fd2 are surprisingly broad (ChIP peaks are very large, e.g. 68% of Fd2 peaks (dataset2) are greater than 1000kb) give its specificity for a long motif. Why is this?

      Response: We have revised Table S2 to include the nearest genes. We are unsure why peaks in the over 1000-bp peak region exist in such high proportions. However, this proportion was also high in our previous ChIP-seq data. Therefore, we speculate that this is a tendency of peak-calling by MACS2. We did not use these values in this paper. For example, targets were predicted using peak summits, and binding motifs were calculated using the 100-base regions around peak summits.

      1. Figure 5E: The positions of the 10mer and 5mer motifs in the promoter should be indicated as well as the length of the promoter. Moreover, mutation of just the 5bp motifs would be valuable to understand if 10mer is sufficient for expression of the reporter.

      Response: Thank you for the comment. We have revised the figure accordingly. The majority of female-specific promoters only harbor ten-base motifs. Thus the ten-base motif is sufficient for evaluating reporter activity (i.e., it would function without five-base motifs).

      1. How is AP2-FG expression affected in ∆Fd2 and vice versa?

      Response: According to our previous microarray data, PFG expression was not significantly downregulated by disruption of AP2-FG. This may be because PFG transcriptionally activates itself through a positive feedback loop after being induced by AP2-G. Similarly, according to our present study, AP2-FG expression was not downregulated by PFG disruption. This may be because AP2-FG is transcriptionally activated by AP2-G.

      1. The single cell data in Russell et al. could easily be used to indicate the order of expression.

      Response: Determining the expression order of gametocyte TFs via the single cell RNA-seq data from Russel et al. is difficult, because only a small number of parasite cells were considered to be in the early gametocyte stage in this study. This is because the parasites were cultured for 24h before the analysis. The analysis suggested by the reviewer may be possible via single cell RNA-seq, but the experiments must be performed with more focus on the early gametocyte stage.

      1. A discussion of the implication of P. falciparum transmission would be appreciated.

      Response: Thank you for the comment. We have added the following to the Discussion section:

      “P. falciparum gametocytes require 9-12 days to mature, which is much longer than that of P. berghei. Meanwhile, it has been reported that the ten-base motif is highly enriched in the upstream regions of female-specific genes also in P. falciparum. Thus, despite the difference in maturation periods, PFG is likely to play an important role in the transcriptional regulation of female P. falciparum gametocyte development."

      1. The lack of identifiable DNA binding domains in Fd2 is intriguing given the strong sequence-specificity. Do the authors think they have identified a new DNA-binding fold ?

      Alphafold of the orthologs with contiguous regions 1&2 might offer insight.

      Response: We speculate that these regions function as DNA binding domains. We performed analysis using Alfafold2 according to the comment. However, the predicted structure of the region was not similar to any other canonical DNA-binding domains. Thus, it may be a novel DNA-binding fold as the reviewer mentioned. Further studies such as binding assays using recombinant proteins would be necessary to confirm this, but thus far we have not successfully obtained the soluble proteins of these regions.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Author response:

      Reviewer #1:

      The main objective of this study is to achieve the development of a synthetic autotroph using adaptive laboratory evolution. To accomplish this, the authors conducted chemostat cultivation of engineered E. coli strains under xylose-limiting conditions and identified autotrophic growth and the causative mutations. Additionally, the mutational mechanisms underlying these causative mutations were also explored with drill down assays. Overall, the authors demonstrated that only a small number of genetic changes were sufficient (i.e., 3) to construct an autotrophic E. coli when additional heterologous genes were added. While natural autotrophic microorganisms typically exhibit low genetic tractability, numerous studies have focused on constructing synthetic autotrophs using platform microorganisms such as E. coli. Consequently, this research will be of interest to synthetic biologists and systems biologists working on the development of synthetic autotrophic microorganisms. The conclusions of this paper are mostly well supported by appropriate experimental methods and logical reasoning. However, further experimental validation of the mutational mechanisms involving rpoB and crp would enhance readers' understanding and provide clearer insights, despite acknowledgement that these genes impact a broad set of additional genes. Additionally, a similar study, 10.1371/journal.pgen.1001186, where pgi was deleted from the E. coli genome and evolved to reveal an rpoB mutation is relevant to this work and should be placed in the context of the presented findings.

      We thank the reviewer for pointing this study out. It is very interesting that a mutation in a similar region in RpoB was observed in a related context of Pgi loss of activity. We have added a reference to this study in our text (Page 11, line 21).

      he authors addressed rpoB and crp as one unit and performed validation. They cultivated the mutant strain and wild type in a minimal xylose medium with or without formate, comparing their growth and NADH levels. The authors argued that the increased NADH level in the mutant strain might facilitate autotrophic growth. Although these phenotypes appear to be closely related, their relationship cannot be definitively concluded based on the findings presented in this paper alone. Therefore, one recommendation is to explore investigating transcriptomic changes induced by the rpoB and crp mutations. Otherwise, conducting experimental verification to determine whether the NADH level directly causes autotrophic growth would provide further support for the authors' claim.

      We appreciate the valuable comment and agree that the work was lacking such an analysis. Due to various reasons we have opted to use a proteomic approach which we feel fulfills the same purpose as the transcriptomics suggestion. We found interesting evidence in up-regulation of the fdoGH operon (comprising the native formate dehydrogenase O enzyme complex) which could indicate why there is an increase in NADH/NAD+ levels. We also hypothesize that this upregulation might be important more generally by drawing comparisons to natural chemo-autotrophs.

      Further experimental work (which we were not able to include in the current study) could help validate this link by deleting fdoGH and observing a loss of phenotype and, on the flip side, directly overexpressing the fdoGH operon and observing an increase in the NADH/NAD+ ratio. Indeed, if this overexpression were to prove sufficient for achieving an autotrophic phenotype without the mutations in the global transcription regulators, it would be a much more transparent design.

      We have added a section titled "Proteomic analysis reveals up-regulation of rPP cycle and formate-associated genes alongside down-regulation of catabolic genes" to the Results based on this analysis.

      • It would be beneficial to provide a more detailed explanation of the genetic background before the evolution stage, specifically regarding the ∆pfk and ∆zwf mutations. Furthermore, it is suggested to include a figure that provides a comprehensive depiction of the reductive pentose phosphate pathway and the bypass pathway. These will help readers grasp the concept of the "metabolic scaffold" as proposed by the authors.

      We agree with the reviewer that this could be helpful and we added a reference to the original paper Gleizer et al. 2019 that reported this design and also includes the relevant figure. We feel that the figure should not be added to the current manuscript as we continue to show that this design is not relevant in the context of the three reported mutations and such a figure could distract the attention of the reader from the main takeaways of the current study.

      • Despite the essentiality of the rpoB mutation (A1245V) to the autotrophic phenotype in the final strain, the inclusion of this mutation in step C1 does not appear to be justified. According to line 37 on page 3, the authors chose to retain the unintended mutation in rpoB based on its essentiality to the phenotype observed in other evolved strains. However, it should be noted that the mutations found in the evolved strain I, II, and III (P552T or D866E) were entirely different from the unintended mutation (A1245V) during genetic engineering. This aspect should be revised to avoid confusion among readers.

      Thank you for pointing this issue out, we added a clarification in the text (page 4 line 7) to avoid such confusion. We believe this point is much clearer now.

      The rpoB mutation which was shown to be essential in the study is indeed known to be common in ALE experiments in E. coli. Thus, I searched the different rpoB mutations in ALEdb in E. coli and I was able to find a similar mutation in a study where pgi was knocked out and then evolved. https://doi.org/10.1371/journal.pgen.1001186 This study seems very relevant given that pgi was a key mutation in the compact set of this work and the section "Modulation of a metabolic branch-point activity increased the concentration of rPP metabolites" informs that loss of function mutations in pgi were also found. The findings of this study should thus be put in the context of the previous related ALE study. I would recommend a similar analysis of crp mutations from studies in ALEdb to see if there are similar mutations in this gene as well or if this a unique mutation.

      We thank the reviewer for bringing this publication to our attention. We have addressed this observation in the main text (page 11 , line 21). We agree that it could have some connection to the pgi mutation yet we would not want to overspeculate about this role, as we also found the exact same mutation (A1245V) as an adaptation to higher temperature in another E. coli study (Tenaillon et al. 2012). We would like to bring forward the fact that the two reported rpoB mutations are always accompanied by another mutation with pleiotropic effects, either in the transcription factor Crp or in another RNA polymerase subunit (e.g RpoC). As such many epistatic effects could occur, one of which we also report here in page 13, line 18. In conclusion, although there could be a connection between the rpoB and pgi mutations, it could be a mere coincidence and the two mutations could exhibit two distinct roles in two distinct phenotypes.

      We also would like to thank the reviewer for suggesting a similar analysis for crp and found another mutation at a nearby residue with strong adaptive effects and mentioned it in our main text.

      Can the typical number of mutations found in a given ALE experiment be directly compared to those found in this study? It seems like a retrospective analysis of other ALE studies to show how many mutations typically occur in an ALE study and sets which were found to be causal to reproduce the phenotype of interest (through similar reverse engineering in the starting strain) should be presented. Again, the authors cite ALEdb which should provide direct numbers of mutations found in similar ALE studies with E. coli and one could then examine them to find sets of clearly causal mutations which recreate phenotypes of interest. Such an analysis would go a long way in supporting the main finding of "small number" of mutations.

      Discussion, page 12, line 42. "This could serve as a promising strategy for achieving minimally perturbed genotypes in future metabolic engineering attempts". There is an entire body of work around growth-coupled production which can be predicted and evolved with a genome-scale metabolic model and ALE. Thus, if this statement is going to be made, relevant studies should be cited and placed in context.

      The reviewer raises an important point which could indeed yield an interesting perspective. However, it would be difficult to perform this comparison in practice since many of the studies published on ALEdb have not isolated essential mutations from other mutation incidents nor have they determined the role of each mutation in the reported phenotypes. For example, many ALE trajectories include a hypermutator that greatly increases the number of irrelevant mutations and it is nearly impossible to sieve through them to find an essential set.

      Moreover, it is hard to compare the “level of difficulty” of achieving one phenotype over another and therefore feel that even though such an analysis would be insightful, it requires an amount of work which is outside the scope of this study.

      Finally, we would like to highlight our approach of using the iterative approach, isolating the relevant consensus mutations and repeating this process until no evolution process is required, we are not aware of prior studies that used this approach.

      We now clarified what we mean by "promising strategy" in the discussion in order to avoid any false claims about novelty (page 16 line 32): "Using metabolic growth-coupling as a temporary 'metabolic scaffold' that can be removed, could serve as a promising strategy for achieving minimally perturbed genotypes in future metabolic engineering attempts."

      Reviewer #2:

      Synthetic autotrophy of biotechnologically relevant microorganisms offers exciting chances for CO2 neutral or even CO2 negative production of goods. The authors' lab has recently published an engineered and evolved Escherichia coli strain that can grow on CO2 as its only carbon source. Lab evolution was necessary to achieve growth. Evolved strains displayed tens of mutations, of which likely not all are necessary for the desired phenotype.

      In the present paper the authors identify the mutations that are necessary and sufficient to enable autotrophic growth of engineered E. coli. Three mutations were identified, and their phenotypic role in enhancing growth via the introduced Calvin-Benson-Bassham cycle were characterized. It was demonstrated that these mutations allow autotrophic growth of E. coli with the introduced CBB cycle without any further metabolic intervention. Autotrophic growth is demonstrated by 13C labelling with 13C CO2, measured in proteinogenic amino acids. In Figures 2B and S1, the labeling data are shown, with an interval of the "predicted range under 13CO2".

      Here, the authors should describe how this interval was derived.

      The methodology is clearly described and appropriate.

      The present results will allow other labs to engineer E. coli and other microorganisms further to assimilate CO2 efficiently into biomass and metabolic products. The importance is evident in the opportunity to employ such strain in CO2 based biotech processes for the production of food and feed protein or chemicals, to reduce atmospheric CO2 levels and the consumption of fossil resources.

      Please describe in the methodology how the interval of the predicted range of 13C labeling was derived for Figures 2B and S1. Was it calculated by the dilution factor during 4 generations, or did you predict the label incorporation individually with a metabolic model?

      The text needs careful editing, some sentences are incomplete and there are frequent inconsistencies in writing metabolites and enzymes.

      P2L6: unclear sentence (incomplete?)

      P2L19: pastoris with lower case "p"

      P2L40: incomplete sentence

      P2L42: here, and at many other places, the writing of RuBisCO needs to be aligned. It is an abbreviation and should begin with a capital letter. Most commonly it is written as RuBisCO which I would suggest - please unify throughout the text.

      P3L3: formate dehydrogenase ... metabolites and enzymes with lower case letter. And, no hyphen here.

      P5L4: delete the : after unintentionally

      P6L16: carboxylation of RuBP (it is not CO2 that is carboxylated - if any, CO2 is carboxylating)

      P7L25: phosphoglucoisomerase (lower case)

      P8L5: in line

      P8L9: part of glycolysis/ ...

      P10L4: pentose phosphates (lower case, no hyphen).

      P10L4: all metabolites lower case

      P12L28: incomplete sentence

      P18L4: Escherichia coli in italics P18L15: Pseudomonas sp. in italics P18L16: ... promoter and with a strong ...

      P20, chapter Metabolomics: put the numbers of 12C and 13C in superscript P23L9: pentose phosphates ; all metabolites in lower case (as above) P23: all 12C and 13C with superscript numbers.

      Response to reviewer #2:

      We thank the reviewer for their comments, and for pointing out the need to clarify how we derived the predicted range of 13C labeling. We edited the text accordingly, and added the relevant calculation to the methods section (under the “13C Isotopic labeling experiment”). We would like to also thank the reviewer for the required text improvements, which were implemented. 

      Reviewer #3:

      The authors previously showed that expressing formate dehydrogenase, rubisco, carbonic anhydrase, and phosphoribulokinase in Escherichia coli, followed by experimental evolution, led to the generation of strains that can metabolise CO2. Using two rounds of experimental evolution, the authors identify mutations in three genes - pgi, rpoB, and crp - that allow cells to metabolise CO2 in their engineered strain background. The authors make a strong case that mutations in pgi are loss-of-function mutations that prevent metabolic efflux from the reductive pentose phosphate autocatalytic cycle. The authors also argue that mutations in crp and rpoB lead to an increase in the NADH/NAD+ ratio, which would increase the concentration of the electron donor for carbon fixation. While this may explain the role of the crp and rpoB mutations, there is good reason to think that the two mutations have independent effects, and that the change in NADH/NAD+ ratio may not be the major reason for their importance in the CO2-metabolising strain.

      We thank the reviewer for their comments and constructive feedback.

      We agree that there is probably a broader effect caused by the rpoB and crp mutations, besides the change in the NADH/NAD+ ratio. Hence, we performed a proteomics analysis, comparing the rpoB and crp mutations on a WT background to an autotrophic E.coli, searching for a mutual change in both strains compared to their "ancestors". We found up-regulation of rPP cycle and formate-associated genes, and a down-regulation of catabolic genes. We added a section dedicated to this matter under the title "Proteomic analysis reveals up-regulation of rPP cycle and formate-associated genes alongside down-regulation of catabolic genes".

      Specific comments:

      1. Deleting pgi rather than using a point mutation would allow the authors to more rigorously test whether loss-off-function mutants are being selected for in their experimental evolution pipeline. The same argument applies to crp.

      We appreciate this recommendation and indeed tried to delete pgi, but the genetic manipulation caused a knockout of other genes along with pgi (pepE, rluF, yjbD, lysC) so in the time available to us we cannot confidently determine whether the deletion alone is sufficient and can replace the mutation.

      Regarding crp, we do not think there is a reason to believe the mutation is a loss-of-function. In any case, the proteomics-based characterization of the crp mutation is now included in the SI.

      1. Page 10, lines 10-11, the authors state "Since Crp and RpoB are known to physically interact in the cell (26-28), we address them as one unit, as it is hard to decouple the effect of one from the other". CRP and RpoB are connected, but the authors' description of them is misleading. CRP activates transcription by interacting with RNA polymerase holoenzyme, of which the Beta subunit (encoded by rpoB) is a part. The specific interaction of CRP is with a different RNA polymerase subunit. The functions of CRP and RpoB, while both related to transcription, are otherwise very different. The mutations in crp and rpoB are unlikely to be directly functionally connected. Hence, they should be considered separately.

      Indeed, the fact that the proteins are interacting in the cell does not necessarily mean that the mutations are functionally connected. We therefore added as further justification in the new section:

      "As far as we know, the mutations in the Crp and RpoB genes affect the binding of the RNA polymerase complex to DNA and/or its transcription rates. Depending on the transcribed gene target, the effect of the two mutations might be additive, antagonistic, or synergistic. Since each one of these mutations individually (in combination with the pgi mutation) is not sufficient to achieve autotrophic growth, it is reasonable to assume that only the target genes whose levels of expression change significantly in the double-mutant are the ones relevant for the autotrophic phenotype”.

      In our proteomics analysis we considered each mutation separately. We found that in some cases the two mutations together have an additive effect, but in other cases we found that the two mutations together affect differently on the proteome, compared to the effect of each mutation alone. Since both mutations are essential to the phenotype, we decided to go with the approach of addressing the two mutations as one unit for the physiological and metabolic experiments.

      1. A Beta-galactosidase assay would provide a very simple test of CRP H22N activity. There are also simple in vivo and in vitro assays for transcription activation (two different modes of activation) and DNA-binding. H22 is not near the DNA-binding domain, but may impact overall protein structure.

      The mutation is located in “Activating Region 2”, interacting with RNA polymerase. We tried an in-vivo assay to determine the CRP H22N activity and got inconclusive results, we believe the proteomics analysis serves as a good method for understanding the global effect of the mutation.

      1. There are many high-resolution structures of both CRP and RpoB (in the context of RNA polymerase). The authors should compare the position of the sites of mutation of these proteins to known functional regions, assuming H22N is not a loss-of-function mutation in crp.

      We added a supplementary figure regarding the structural location of the two mutations, where it is demonstrated that crp H22N is located in a region interacting with the RNA polymerase and rpoB A1245V is located in proximity to regions interacting with the DNA.

      1. RNA-seq would provide a simple assay for the effects of the crp and rpoB mutations. While the precise effect of the rpoB mutation on RNA polymerase function may be hard to discern, the overall impact on gene expression would likely be informative.

      Indeed we agree that an omics approach to infer the global effect of these mutations is beneficial, we opted to use a proteomics approach and think it serves the purpose of clarifying the final, down-stream, effect on the cell.

      1. Page 2, lines 40-45, the authors should more clearly explain that the deletion of pfkA, pfkB and zwf was part of the experimental evolution strategy in their earlier work (Gleizer et al., 2019), and not a new strategy in the current study.

      We thank you for pointing this out, and edited the text accordingly.

      1. Page 3, line 27. Why did the authors compare the newly acquired mutants to only two mutants from the earlier work, not all 6?

      The 6 clones that were isolated in Gleizer et al., had 2 distinct mutation profiles. During the isolation process the lineage split into two groups. Three out of the 6 clones (clones 1,2,6) came from the same ancestor, and the other three (clones 3,4,5) came from another ancestor. Hence, these two groups shared almost all of their mutations (see Venn diagram). We decided to use for our comparison the representative with the highest number of mutations from each group (clones 5 and 6).

      Author response image 1.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Chen and colleagues first compared the cartilage tissues collected from OA and HA patients using histology and immunostaining. Then, a genome-wide DNA methylation analysis was performed, which informed the changes of a novel gene, TNXB. IHC confirmed that TNXB has a lower expression level in HA cartilage than OA. Next, the authors demonstrated that TNXB levels were reduced in the HA animal model, and intraarticular injection of AAV carrying TNXB siRNA induced cartilage degradation and promoted chondrocyte apoptosis. Based on KEGG enrichment, histopathological analysis, and western blot, the authors also showed the relationship between TNXB and AKT phosphorylation. Lastly, AKT agonist, specifically SC79 in this study, was shown to partially rescue the changes of in vitro-cultured chondrocytes induced by Tnxb knock-down. Overall, this is an interesting study and provided sufficient data to support their conclusion.

      Strengths:

      (1) Both human and mouse samples were examined.

      (2) The HA model was used.

      (3) Genome-wide DNA methylation analysis was performed.

      Weaknesses:

      (1) In some experiments, the selection of the control groups was not ideal.

      Thank you for comments. The reviewer raised the concerns about using human OA cartilage as control, instead of health cartilage. This is an important detail we didn’t describe in the previous version. We have added our explanation in revised Methods.

      (2) More details on analyzing methods and information on replicates need to be included.

      We greatly appreciate your careful review and helpful suggestions. We have added detailed information to our revised draft.

      (3) Discussion can be improved by comparing findings to other relevant studies.

      Thank the reviewer very much for the opportunity to improve our manuscript. We have improved discussions as reviewer suggested in Recommendation 13.

      (4) The use of transgenic mice with conditional Tnxb depletion can further define the physiological roles of Tnxb.

      Thanks for this valuable comment. We understand that conditional Tnxb-KO mice is much helpful for the study of biological roles of Tnxb, and it will be constructed and used in our future studies.

      Recommendations For the Authors:

      (1) Please add more information about HA such as incidence to highlight the importance of the study.

      We greatly appreciate your careful review and helpful suggestions. We have provided more information about the importance of HA study in revised Introduction. Please see lines 90-93 and 103-112.

      (2) Please justify the use of OA cartilage, instead of normal tissues, as the control.

      Thanks for your suggestion. We certainly would have liked to use healthy cartilage as control, but we were extremely difficult to obtain enough control samples from healthy individuals. Despite the mechanistic and phenotypic differences between HA and OA, OA is often used as “disease” control to reveal the characteristics in HA 1,2. Thus, we measured cartilage degeneration and DNA methylation difference in HA and OA patients. We have provided the statement and evidence in revised manuscript. Please see lines 144-145.

      (3) Please provide details of how to calculate the Cartilage wear area ratio in Figure 1D, and measure the positive staining area in Figure 1F.

      We apologize for the issue you pointed out. Here, we provide detailed information for how positively stained areas are calculated. Specifically, in Figure 1D, we obtained the cartilage area ratio by calculating the ratio of blue cartilage staining area to the whole tissue area by using image J software. In Figure 1F, the area of positive staining was determined upon secondary antibody treatment and color development using DAB chromogen (brown stain). We then obtained the positive staining area ratio by calculating the ratio of positive staining area to the whole cartilage area by using image J software.

      (4) Please label the location of hemorrhagic ferruginous deposits in Figure 1.

      Thank you for your valuable suggestion. We have used black arrows to indicate hemorrhagic ferruginous deposits in revised Figure 1A.

      (5) Please define the meaning of "n" in all figure legends, such as technical or biological replicates.

      Thanks for your suggestion. We have defined the meaning of "n" in all figure legends in revised manuscript.

      (6) In Figure 3, please increase the font size of B, D, F, H, and J. The same applies to other figures.

      Thank you for your valuable suggestion. We have increased the font size of figures in our revised manuscript.

      (7) Line 327, "(Figure 1, F and G)" should be Figure 2F, G.

      Thanks for your reminding. We have corrected it in the revision. Please see lines 347.

      (8) Reduced TNXB levels in human HA cartilage are one of the major findings in this study. Currently, only semi-quatative IHC was used to draw the conclusion. A second method, such as real-time PCR or western blot, is required.

      Thanks for your suggestion. We feel very sorry that we did not have enough samples of human HA cartilages for qPCR and WB experiments, due to severe erosion of the HA cartilage. We have pointed out this limitation in revised drafts. Please see lines 445-448.

      (9) Figure 3 shows that reduced Tnxb was accompanied by the increased Dnmt1. In addition, this study is about methylation. Have the authors tested the change of Dnmt1 levels when Tnxb was knocked down?

      Thanks for your suggestion. According to the reviewer's suggestion, we have tested the expression of Dnmt1 in Tnxb-KD chondrocytes, and no significant alteration was observed. Please see the following Figure.

      Author response image 1.

      Figure Legend: Representative IHC staining of Dnmt1 in articular cartilage from Tnxb-KD HA mice. Corresponding quantification of the proportion of Dnmt1 positive regions. Red arrows indicate positive cells. Scale bar: 100 μm. Data were presented as means ± SD; n = 5 in each group. ns = no significance by unpaired Student’s t test.

      (10) Also, is there a causal relationship between Tnxb levels and the distribution of methylation levels? Any related study was performed?

      Following the valuable suggestion of the reviewer, we used two well-known DNA methyltransferase inhibitors (RG108 or 5-Aza-dc) 3 to examine whether DNA methylation regulates transcriptional expression of TNXB. We found that both inhibitors significantly up-regulated Tnxb mRNA level. We have added this result to the revised Supplementary Figure 4 and draft (lines 292-296 and 369-374).

      (11) In Figure 6, what was the control of "AKT agnost" group?

      Thank you for your suggestion. We feel sorry for our negligence and we have added the vehicle group as a control for AKT agonists in Figure 6 in our revised manuscript.

      (12) Previous studies have reported the involvement of TNXB in TGF-β signaling. Have the authors examined the effect of TNXB on TGF-β signaling in chondrocytes?

      Thank you for your suggestion. Here, we examined the expression of TGF-β signaling in Tnxb-KD chondrocyte and no significant changes were observed. We have discussed this result in revised draft (lines 475-479). We have added this result to the revised Supplementary Figure 7.

      (13) Discussion can be improved. For example, have previous studies reported the association between TNXB and methylation in other cells/tissues? In addition to apoptosis, are there other potential mechanisms underlying the protective role of TNXB in chondrocytes?

      Thank you for your valuable comments. Previous studies have shown the different DNA methylation of TNXB in whole blood from rheumatoid arthritis patients and in retinal pigment epithelium from patients with age-related macular degeneration 4,5. Herein, we were the first to report the association between DNA methylation of TNXB and HA cartilage degeneration. As for TNXB, there are limited public studies regarding physiological function of TNXB, among which mostly report the effect of TNXB on extracellular matrix organization 6,7. In our work, we found that TNXB regulated the phosphorylation of AKT. Since previous reports showed AKT controlled the expression of Mmp13 8, we thought that TNXB might regulated the chondrocyte extracellular matrix organization, in addition to its function on apoptosis. We have discussed these in revised manuscript (lines 462-464, and 495-501).

      (14) The manuscript writing needs to be improved. Typos and grammar issues were noted.

      Thanks. We have modified and polished our language and we hope the revised version could be acceptable for you.

      Reviewer #2 (Public Review):

      Summary:

      This manuscript mainly studied the biological effect of tenascin XB (TNXB) on hemophilic arthropathy (HA) progression. Using bioinformatic and histopathological approaches, the authors identified the novel candidate gene TNXB for HA. Next, the authors showed that TNXB knockdown leads to chondrocyte apoptosis, matrix degeneration, and subchondral bone loss in vivo/vitro. Furthermore, AKT agonists promoted extracellular matrix synthesis and prevented apoptosis in TNXB knockdown chondrocytes.

      Strengths:

      In general, this study significantly advances our understanding of HA pathogenesis. The authors utilize comprehensive experimental strategies to demonstrate the role of TNXB in cartilage degeneration associated with HA. The results are clearly presented, and the conclusions appear appropriate.

      Weaknesses:

      Additional clarification is required regarding the gender of the F8-/- mouse in the study. Is the mouse male or female?

      We feel sorry that we did not provide enough information about the gender of the F8-/- mouse in the previous draft. Here, we used male F8-/- mice as the study subjects for our experiments. Hemophilia A is predominantly seen in males because of the X chromosome linkage 9.

      Recommendations For The Authors:

      Some issues need to be addressed in the manuscript:

      (1) During the progression of HA, in addition to cartilage degeneration, synovial hypertrophy and inflammation are also significant symptoms. How is the expression of TNXB in HA synovium?

      Thank you for your valuable comments. According to the reviewer's suggestion, we tested the expression of TNXB in the synovium, and there was no statistically significant difference in the expression level of TNXB in the synovium (Supplementary Figure. 2) Please see lines 347-349.

      (2) Lines 183-188. The methods of virus infection should be more detailed. What was the concentration of the AAVs injected? And how many doses were administrated?

      Thank you for your suggestion. We have added an explanation of virus infection and injected doses in revised methods section (lines 205-206).

      (3) Line 197-198. Could the author double-check the decalcification time for human cartilage samples? Is it for 3 months? Or for 3 weeks?

      Thank you for your suggestion. We have reconfirmed the decalcification of human cartilage samples for 3 months.

      (4) Line 343-344 "Above results suggest that TNXB might be protective against HA and its cartilage suppression is closely related to HA development." The conclusion is inappropriate, please revise it.

      Thanks for your suggestion. We have revised this conclusion into “Above results suggest that the suppression of TNXB in cartilage promotes the HA development”. Please see lines 365-366.

      (5) Line 326-327, the IHC staining for human samples is shown in Figure 2, not Figure 1. Please double check and revise it.

      Thanks for your reminding. We feel sorry for our negligence and we have corrected it in the revision.

      (6) For Figure 1B, it shows the MRI images of knee joints. However, the method section lacks details regarding the MRI imaging scan and analysis. Could the author include this information in the method section?

      Thank you for your valuable comments. We have added the method of MRI imaging scan and analysis in revised Methods. Please see lines 154-163.

      (7) In Figure 5, The statistical result of Bcl-2 is inconsistent with its Western blot band. Please check.

      Thanks for your reminding. We have modified it in the revision.

      (8) Please read through the text carefully to check for language problems. For example, in Line 68 "Our" not "our".

      Thanks for your reminding. In revision, we have corrected it. Please see Line 68.

      Reviewer #3 (Public Review):

      Summary:

      The manuscript by Dr. Chen et al. investigates the genes that are differentially methylated and associated with cartilage degeneration in hemophilia patients. The study demonstrates the functional mechanisms of the TNXB gene in chondrocytes and F8-/- mice. The authors first showed significant DNA methylation differences between hemophilic arthritis (HA) and osteoarthritis through genome-wide DNA methylation analysis. Subsequently, they showed a decreased expression of the differentially methylated TNXB gene in cartilage from HA patients and mice. By knocking down TNXB in vivo and in vitro, the results indicated that TNXB regulates extracellular matrix homeostasis and apoptosis by modulating p-AKT. The findings are novel and interesting, and the study presents valuable information in blood-induced arthritis research.

      Strengths:

      The authors adopted a comprehensive approach by combining genome-wide DNA methylation analysis, in vivo and in vitro experiments using human and mouse samples to illustrate the molecular mechanisms involved in HA progression, which is crucial for developing targeted therapeutic strategies. The study identifies Tenascin XB (TNXB) as a central mediator in cartilage matrix degradation. It provides mechanistic insights into how TNXB influences cartilage matrix degradation by regulating the activation of AKT. It opens avenues for future research and potential therapeutic interventions using AKT agonists for cartilage protection in hemophilic arthropathy. The conclusions drawn from the study are clear and directly tied to the findings.

      Weaknesses:

      (1) The study utilizes a small sample size (N=5 for both osteoarthritis and hemophilic arthropathy). A larger sample size would enhance the generalizability and statistical power of the findings.

      Thank you for pointing out this deficiency. Indeed, our sample size is relatively small, although the overall sample size was sufficient for statistical analyses. And we have added this limitation in discussion in revised manuscript. Please see line 445-448. Considering the small sample size, we subsequently performed functional validation study for TNXB, one of the most significant genes, and demonstrated that TNXB exerted critical impacts on chondrocytes apoptosis in HA pathogenesis in vivo and in vitro.

      (2) The use of an animal model (F8-/- mouse) to investigate the role of TNXB may not fully capture the complexity of human hemophilic arthropathy. Differences in the biology between species may affect the translatability of the findings to human patients.

      Thank you for your valuable comments. We recognize that biological differences between species can affect the clinical translation of research findings. In our work, we sequenced human cartilage samples to obtain the differentially methylated gene-TNXB. Meanwhile, we demonstrated that protein expression of TNXB protein was significantly down-regulated in HA human cartilage and F8-/- transgenic mouse cartilage. The F8-/- transgenic mouse serves as a well-accepted model for the study of hemophilia, which is phenotypically similar to that of human patients suffering from the disease and spontaneously bleeds into the joints and soft tissues. Besides, this model mouse has been widely used in the study of hemophilia and hemophilic arthritis 9-11.

      (3) The study primarily focuses on TNXB as a central mediator, but it might overlook other potentially relevant factors contributing to cartilage degradation in hemophilic arthropathy. A more holistic exploration of genetic and molecular factors could provide a broader understanding of the condition.

      Thanks for your suggestion. Since our human sample size is relatively small, we should interpret differentially methylated genes cautiously. Therefore, we mainly focused on the most top significant gene TNXB for functional study. In our further study, we will expand the sample size to more comprehensively explore the molecular mechanisms of HA.

      Recommendations For The Authors:

      The following are my suggestions:

      (1) Why do the authors choose to concentrate on the knee joint in the introduction when hemophilia, characterized by a deficiency in clotting factor F8, is recognized as a systemic disease?

      Thank you for your valuable comments. Although hemophilia a systemic disease, approximately 80%-90% of bleeding episodes in patients with hemophilia occur within the musculoskeletal system, especially in the knee joint 12.

      (2) While Figure 1 illustrates distinct expressions of Dnmt1 and Dnmt3a, only Dnmt1 results are presented in HA mice models in Figure 3. To address this, it is suggested that the expression of Dnmt3a be explored in animal models.

      Thank you for your suggestion. According to the reviewer's suggestion, we examined the expression of Dnmt3a in mouse articular cartilage, and the expression level of Dnmt3a was significantly up-regulated in both the 4W and 8W model groups compared with the control group (Figure 3). Please see line 364.

      (3) In Figure 3, the sample size for Dnmt1 is smaller than the other indicators; therefore, supplementing the sample count is recommended.

      Thanks for your reminding. We have corrected it in the revision.

      (4) Regarding Figure 4G, a few apoptotic cells were observed in the AAV NC group. It is advised that this figure be reviewed for accuracy.

      Thanks for your suggestion. In Figure 5D, the AAV-NC group is the case of needle-injected with AAV. Therefore, it is normal for apoptotic cells to appear in the cartilage layer.

      (5) The authors concluded that TNXB plays a role in apoptosis and AKT signaling. Providing expression data for Caspase9 would be valuable to strengthen this assertion, as PI3K/AKT signaling directly influences its activation during apoptosis.

      Thank you for your comments. We have examined the expression of Cleaved-Caspase9 protein, and found that knockdown of TNXB resulted in upregulation of Cleaved-Caspase9 protein expression, which was reversed by addition of SC79. This result has added in revised Figure 6 and manuscript. Please see line 414.

      (6) Quantitative analysis of the differences between the two groups in Supplemental Figures is necessary.

      Thank you for your suggestion. We have added the quantitative analysis of the differences between the two groups in Supplemental Figures.

      (7) With three major isoforms (homologs) of AKT in mammals-AKT1, 2, and 3 - why did the authors specifically focus on AKT1?

      Thank you for your comments. Based on the results of the KEGG enrichment analysis of differential methylated genes, we investigated the role of PI3K/AKT pathway in apoptosis of HA chondrocytes. AKT is universally acknowledged as a core factor in the PI3K/AKT pathway that plays critical roles in various cellular activities such as cell proliferation, cell differentiation, cell apoptosis, metabolism and so on 13,14, More notably, several studies demonstrated that in AKT family, Akt1 primarily was involved in regulation of chondrocyte survival and proteoglycan synthesis 15. Therefore, we detected phosphorylation of AKT1 in HA cartilages and TNXB-KD chondrocytes, and found that TNXB regulation chondrocytes ECM and apoptosis by AKT1. Reference:

      (1) Cooke, E.J., Zhou, J.Y., Wyseure, T., Joshi, S., Bhat, V., Durden, D.L., Mosnier, L.O., and von Drygalski, A. (2018). Vascular Permeability and Remodelling Coincide with Inflammatory and Reparative Processes after Joint Bleeding in Factor VIII-Deficient Mice. Thromb Haemost 118, 1036-1047. 10.1055/s-0038-1641755.

      (2) Kleiboer, B., Layer, M.A., Cafuir, L.A., Cuker, A., Escobar, M., Eyster, M.E., Kraut, E., Leavitt, A.D., Lentz, S.R., Quon, D., et al. (2022). Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study. J Thromb Haemost 20, 857-865. 10.1111/jth.15654.

      (3) Weiland, T., Weiller, M., Kunstle, G., and Wendel, A. (2009). Sensitization by 5-azacytidine toward death receptor-induced hepatic apoptosis. J Pharmacol Exp Ther 328, 107-115. 10.1124/jpet.108.143560.

      (4) Anaparti, V., Agarwal, P., Smolik, I., Mookherjee, N., and El-Gabalawy, H. (2020). Whole Blood Targeted Bisulfite Sequencing and Differential Methylation in the C6ORF10 Gene of Patients with Rheumatoid Arthritis. J Rheumatol 47, 1614-1623. 10.3899/jrheum.190376.

      (5) Porter, L.F., Saptarshi, N., Fang, Y., Rathi, S., den Hollander, A.I., de Jong, E.K., Clark, S.J., Bishop, P.N., Olsen, T.W., Liloglou, T., et al. (2019). Whole-genome methylation profiling of the retinal pigment epithelium of individuals with age-related macular degeneration reveals differential methylation of the SKI, GTF2H4, and TNXB genes. Clin Epigenetics 11, 6. 10.1186/s13148-019-0608-2.

      (6) Mao, J.R., Taylor, G., Dean, W.B., Wagner, D.R., Afzal, V., Lotz, J.C., Rubin, E.M., and Bristow, J. (2002). Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet 30, 421-425. 10.1038/ng850.

      (7) Zhang, K., Wang, X., Zeng, L.T., Yang, X., Cheng, X.F., Tian, H.J., Chen, C., Sun, X.J., Zhao, C.Q., Ma, H., and Zhao, J. (2023). Circular RNA PDK1 targets miR-4731-5p to enhance TNXB expression in ligamentum flavum hypertrophy. FASEB J 37, e22877. 10.1096/fj.202200022RR.

      (8) Guo, H., Yin, W., Zou, Z., Zhang, C., Sun, M., Min, L., Yang, L., and Kong, L. (2021). Quercitrin alleviates cartilage extracellular matrix degradation and delays ACLT rat osteoarthritis development: An in vivo and in vitro study. J Adv Res 28, 255-267. 10.1016/j.jare.2020.06.020.

      (9) Weitzmann, M.N., Roser-Page, S., Vikulina, T., Weiss, D., Hao, L., Baldwin, W.H., Yu, K., Del Mazo Arbona, N., McGee-Lawrence, M.E., Meeks, S.L., and Kempton, C.L. (2019). Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice. Blood Adv 3, 288-300. 10.1182/bloodadvances.2018027557.

      (10) Haxaire, C., Hakobyan, N., Pannellini, T., Carballo, C., McIlwain, D., Mak, T.W., Rodeo, S., Acharya, S., Li, D., Szymonifka, J., et al. (2018). Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-alpha pathway. Blood 132, 1064-1074. 10.1182/blood-2017-12-820571.

      (11) Vols, K.K., Kjelgaard-Hansen, M., Ley, C.D., Hansen, A.K., and Petersen, M. (2019). Bleed volume of experimental knee haemarthrosis correlates with the subsequent degree of haemophilic arthropathy. Haemophilia 25, 324-333. 10.1111/hae.13672.

      (12) Lobet, S., Peerlinck, K., Hermans, C., Van Damme, A., Staes, F., and Deschamps, K. (2020). Acquired multi-segment foot kinematics in haemophilic children, adolescents and young adults with or without haemophilic ankle arthropathy. Haemophilia 26, 701-710. 10.1111/hae.14076.

      (13) Garcia, D., and Shaw, R.J. (2017). AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance. Mol Cell 66, 789-800. 10.1016/j.molcel.2017.05.032.

      (14) Johnson, J., Chow, Z., Lee, E., Weiss, H.L., Evers, B.M., and Rychahou, P. (2021). Role of AMPK and Akt in triple negative breast cancer lung colonization. Neoplasia 23, 429-438. 10.1016/j.neo.2021.03.005.

      (15) Rao, Z., Wang, S., and Wang, J. (2017). Peroxiredoxin 4 inhibits IL-1beta-induced chondrocyte apoptosis via PI3K/AKT signaling. Biomed Pharmacother 90, 414-420. 10.1016/j.biopha.2017.03.075.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The manuscript by Rühling et al analyzes the mode of entry of S. aureus into mammalian cells in culture. The authors propose a novel mechanism of rapid entry that involves the release of calcium from lysosomes via NAADP-stimulated activation of TPC1, which in turn causes lysosomal exocytosis; exocytic release of lysosomal acid sphingomyelinase (ASM) is then envisaged to convert exofacial sphingomyelin to ceramide. These events not only induce the rapid entry of the bacteria into the host cells but are also described to alter the fate of the intracellular S. aureus, facilitating escape from the endocytic vacuole to the cytosol.

      Strengths:

      The proposed mechanism is novel and could have important biological consequences.

      Weaknesses:

      Unfortunately, the evidence provided is unconvincing and insufficient to document the multiple, complex steps suggested. In fact, there appear to be numerous internal inconsistencies that detract from the validity of the conclusions, which were reached mostly based on the use of pharmacological agents of imperfect specificity.

      We thank the reviewer for the detailed evaluation of our manuscript. We will address the criticism below.

      We agree with the reviewer that many of the experiments presented in our study rely on the usage of inhibitors. However, we want to emphasize that the main conclusion (invasion pathway affects the intracellular fate/phagosomal escape) was demonstrated without the use of inhibitors or genetic ablation in two key experiments (Figure5 D/E). These experiments were in line with the results we obtained with inhibitors (amitriptyline [Figure 4D], ARC39, PCK310, [Figure 4C] and Vacuolin-1 [Figure4E]). Importantly, the hypothesis was also supported by another key experiment, in which we showed the intracellular fate of bacteria is affected by removal of SM from the plasma membrane before invasion, but not by removal of SM from phagosomal membranes after bacteria internalization (Figure5A-C). Taken together, we thus believe that the main hypothesis is strongly supported by our data.

      Moreover, we either used different inhibitors for the same molecule (ASM was inhibited by ARC39, amitriptyline and PCK310 with similar outcome) or supported our hypothesis with gene-ablated cell pools (TPC1, Syt7, SARM1), as we will point out in more detail below.

      Firstly, the release of calcium from lysosomes is not demonstrated. Localized changes in the immediate vicinity of lysosomes need to be measured to ascertain that these organelles are the source of cytosolic calcium changes. In fact, 9-phenantrol, which the authors find to be the most potent inhibitor of invasion and hence of the putative calcium changes, is not a blocker of lysosomal calcium release but instead blocks plasmalemmal TRPM4 channels. On the other hand, invasion is seemingly independent of external calcium. These findings are inconsistent with each other and point to non-specific effects of 9-phenantrol. The fact that ionomycin decreases invasion efficiency is taken as additional evidence of the importance of lysosomal calcium release. It is not clear how these observations support involvement of lysosomal calcium release and exocytosis; in fact treatment with the ionophore should itself have induced lysosomal exocytosis and stimulated, rather than inhibited invasion. Yet, manipulations that increase and others that decrease cytosolic calcium both inhibited invasion.

      With respect to lysosomal Ca<sup>2<sup>+</sup></sup> release, we agree with the reviewer that direct visual demonstration of lysosomal Ca<sup>2<sup>+</sup></sup> release upon infection will improve the manuscript. We therefore performed live cell imaging to visualize lysosomal Ca<sup>2<sup>+</sup></sup> release by a previously published method.1 The approach is based on two dextran-coupled fluorophores that were incubated with host cells. The dyes are endocytosed and eventually stain the lysosomes. One of the dyes, Rhod-2, is Ca<sup>2<sup>+</sup></sup>-sensitive and can be used to estimate the lysosomal Ca<sup>2<sup>+</sup></sup> content. The second dye, AF647, is Ca<sup>2<sup>+</sup></sup>-insensitive and is used to visualize the lysosomes. If the ratio Rhod-2/AF647 within the lysosomes is decreasing, lysosomal Ca<sup>2<sup>+</sup></sup> release is indicated. We monitored lysosomal Ca<sup>2<sup>+</sup></sup> content during S. aureus infection with this method (Author response image 1 and Author response video 1). However, the lysosomes are very dynamic, and it is challenging to monitor the fluorescence intensities over time. Thus, quantitative measurements are not possible with our methodology, and we decided to not include these data in the main manuscript. However, one could speculate that lysosomal Ca<sup>2<sup>+</sup></sup> content in the selected ROI (Author response image 1 and Author response video 1) is decreased upon attachment of S. aureus to the host cells as indicated by a decrease in Rhod-2/AF647 ratio.

      Author response image 1.

      Lysosomal Ca<sup>2<sup>+</sup></sup> imaging during S. aureus infection. The lysosomes of HuLEC were stained with two dextran-coupled fluorescent dyes. A Ca<sup>2<sup>+</sup></sup>-sensitive dye Rhod-2 as well as Ca<sup>2<sup>+</sup></sup>insensitive AF647. Cells were infected with fluorescent S. aureus JE2 and monitored by live cell imaging (see Author response video 1). The intensity of Rhod-2/AF647 was measured close to a S. aureus-host contact site. Ratio of Rhod-2 vs. AF647 fluorescence intensity was calculated

      As to the TRPM4 involvement in S. aureus host cell internalization, it has been reported that TRPM4 is activated by cytosolic Ca<sup>2<sup>+</sup></sup>. However, the channel conducts monovalent cations such as K<sup>+</sup> or Na<sup>+</sup> but is impermeable for Ca<sup>2<sup>+</sup></sup> [2, 3]. The following of our observations are supporting this:

      i) S. aureus invasion is dependent on intracellular Ca<sup>2<sup>+</sup></sup>, but is independent from extracellular Ca<sup>2<sup>+</sup></sup>  (Figure 1A).

      ii) 9-phenantrol treatment reduces S. aureus internalization by host cells, illustrating the dependence of this process on TRPM4 (data removed from the manuscript) . We therefore hypothesize that TRPM4 is activated by Ca<sup>2<sup>+</sup></sup> released from lysosomes (see above).

      TRPM4 is localized to focal adhesions and is connected to actin cytoskeleton[4, 5] – a requisite of host cell entry of S. aureus.[6, 7] This speaks for an important function of TRPM4 in uptake of S. aureus in general, but does not necessarily have to be involved exclusively in the rapid uptake pathway.

      TRPM4 itself is not permeable for Ca<sup>2<sup>+</sup></sup> but is activated by the cation.  Thus, it is unlikely to cause lysosomal exocytosis. The stronger bacterial uptake reduction by treatment with 9-phenantrol when compared to Ned19 thus may be caused by the involvement of TRPM4 in additional pathways of S. aureus host cell entry involving that association of TRPM4 with focal adhesions or as pointed out by the reviewer, unspecific side effects of 9-phenantrol that we currently cannot exclude.  However, we think that experiments with 9-phenantrol distract from the main story (lysosomal Ca<sup>2<sup>+</sup></sup> and exocytosis) and might be confusing for the reader. We thus removed all data and discussion concerning 9phenantrol in the revised manuscript.

      Regarding the reduced S. aureus invasion after ionomycin treatment, we agree with the reviewer that ionomycin is known to lead to lysosomal exocytosis as was previously shown by others8 as well as our laboratory[9}. 

      We hypothesized that pretreatment with ionomycin would trigger lysosomal exocytosis and thus would reduce the pool of lysosomes that can undergo exocytosis before host cells are contacted by S. aureus. As a result, we should observe a marked reduction of S. aureus internalization in such “lysosome-depleted cells”, if the lysosomal exocytosis is coupled to bacterial uptake. Our observation of reduced bacterial internalization after ionomycin treatment supports this hypothesis.

      However, ionomycin treatment and S. aureus infection of host cells are distinct processes.  

      While ionomycin results in strong global and non-directional lysosomal exocytosis of all “releasable” lysosomes (~5-10 % of all lysosomes according to previous observations)8, we hypothesize that lysosomal exocytosis upon contact with S. aureus only involves a small proportion of lysosomes at host-bacteria contact sites. This is supported by experiments that demonstrate that ~30% of the lysosomes that are released by ionomycin treatment are exocytosed during S. aureus infection (see below and Figure 2, A-C). We added this new data as well as an according section to the discussion  (line 563 ff). Moreover, we moved the data obtained with ionomycin to Figure 2E and described our idea behind this experiment more precisely (line 166 ff).

      The proposed role of NAADP is based on the effects of "knocking out" TPC1 and on the pharmacological effects of Ned-19. It is noteworthy that TPC2, rather than TPC1, is generally believed to be the primary TPC isoform of lysosomes. Moreover, the gene ablation accomplished in the TPC1 "knockouts" is only partial and rather unsatisfactory. Definitive conclusions about the role of TPC1 can only be reached with proper, full knockouts. Even the pharmacological approach is unconvincing because the high doses of Ned-19 used should have blocked both TPC isoforms and presumably precluded invasion. Instead, invasion is reduced by only ≈50%. A much greater inhibition was reported using 9-phenantrol, the blocker of plasmalemmal calcium channels. How is the selective involvement of lysosomal TPC1 channels justified?

      As to partial gene ablation of TPC1: To avoid clonal variances, we usually perform pool sorting to obtain a cell population that predominantly contains cells -here- deficient in TPC1, but also a small proportion of wildtype cells as seen by the residual TPC1 protein on the Western blot. We observe a significant reduction in bacterial uptake in this cell pool suggesting that the uptake reduction in a pure K.O. population may be even more pronounced. 

      As to the inhibition by Ned19: 

      The scale of invasion reduction upon Ned19 treatment (50%, Figure 1B) is comparable with the reduction caused by other compounds that influence the ASM-dependent pathway (such as amitriptyline, ARC39 [Figure 2G], BAPTA-AM [Figure 1A], Vacuolin-1 [Figure 2D], β-toxin [Figure 2L] and ionomycin [Figure 2E]). Further, the partial reduction of invasion is most likely due to the concurrent activity of multiple internalization pathways which are not all targeted by the used compounds and which we briefly discuss in the manuscript.

      We agree with the reviewer that Ned19 inhibits TPC1 and TPC2. Since ablation of TPC1 reduced invasion of S. aureus, we concluded that TPC1 is important for S. aureus host cell invasion. We thus agree with the reviewer that a role for TPC2 cannot be excluded. We clarified this in the revised manuscript (Lines 552). It needs to be noted, however, that deficiency in either TPC1 or TPC2 alone was sufficient to prevent Ebola virus infection10, which is in line with our observations.

      In order to address the role of TPC2 for this review process, we kindly were gifted TPCN1/TPCN2 double knock-out HeLa cells by Norbert Klugbauer (Freiburg, Germany), which we tested for S. aureus internalization. We found that invasion was reduced in these cell lines supporting a role of lysosomal Ca<sup>2<sup>+</sup></sup> release in S. aureus host cell entry and a role for both TPC channels (Author response image 2, see end of the document). Since we did not have a single TPCN2 knock-out available we decided to exclude these data from the main manuscript.

      Author response image 2.

      Invasion efficiency is reduced in TPC1/TPC2 double K.O. HeLa cells. Invasion efficiency of S. aureus JE2 was determined in TPC1/TPC2 double K.O. cells after 10 and 30 min. Results were normalized to the parental HeLa WT cell line (set to 100 %).  

      Invoking an elevation of NAADP as the mediator of calcium release requires measurements of the changes in NAADP concentration in response to the bacteria. This was not performed. Instead, the authors analyzed the possible contribution of putative NAADP-generating systems and reported that the most active of these, CD38, was without effect, while the elimination of SARM1, another potential source of NAADP, had a very modest (≈20%) inhibitory effect that may have been due to clonal variation, which was not ruled out. In view of these data, the conclusion that NAADP is involved in the invasion process seems unwarranted.

      Our results from two independent experimental set-ups (Ned19 [Figure 1B] and TPC1 K.O. [Figure 1C & Figure 2N]) indicate the involvement of NAADP in the process. Together with the metabolomics unit at the Biocenter Würzburg, we attempted to measure cellular NAADP levels, however, this proved to be non-trivial and requires further optimization. However, we can rule out clonal variation in the SARM1 mutant since experiments were conducted with a cell pool as described above in order to avoid clonal variation of single clones.

      The mechanism behind biosynthesis of NAADP is still debated. CD38 was the first enzyme discovered to possess the ability of producing NAADP. However, it requires acidic pH to produce NAADP[11] -which does not match the characteristics of a cytosolic NAADP producer. HeLa cells do not express CD38 and hence, it is not surprising that inhibition of CD38 had no effect on S. aureus invasion in HeLa cells. However, NAADP production by HeLa cells was observed in absence of CD38[12]. Thus CD38independent NAADP generation is likely. SARM1 can produce NAADP at neutral pH[13] and is expressed in HeLa, thus providing a more promising candidate.  

      We agree with the reviewer that the reduction of S. aureus internalization after ablation of SARM1 is less pronounced than in other experiments of ours. This may be explained by NAADP originating from other enzymes, such as the recently discovered DUOX1, DUOX2, NOX1 and NOX2[14], which – with exception of DUOX2- possess a low expression even in HeLa cells. We add this to the discussion in the revised manuscript (line 579).

      We can, however, rule out clonal variation for the inhibitory effect. As stated above we generated K.O. cell pools specifically to avoid inherent problems of clonality. Thus, we also detect some residual wildtype cells within our cell pools.  

      The involvement of lysosomal secretion is, again, predicated largely on the basis of pharmacological evidence. No direct evidence is provided for the insertion of lysosomal components into the plasma membrane, or for the release of lysosomal contents to the medium. Instead, inhibition of lysosomal exocytosis by vacuolin-1 is the sole source of evidence. However, vacuolin-1 is by no means a specific inhibitor of lysosomal secretion: it is now known to act primarily as a PIKfyve inhibitor and to cause massive distortion of the endocytic compartment, including gross swelling of endolysosomes. The modest (20-25%) inhibition observed when using synaptotagmin 7 knockout cells is similarly not convincing proof of the requirement for lysosomal secretion.

      We agree with the reviewer that the manuscript will benefit from a functional analysis of lysosomal exocytosis and therefore conducted assays to investigate exocytosis in the revised manuscript. We previously showed i) by addition of specific antisera that LAMP1 transiently is exposed on the plasma membrane during ionomycin and pore-forming toxin challenge and ii) demonstrated the release of ASM activity into the culture medium under these conditions.[9] However, both measurements are not compatible with S. aureus infection, since LAMP1 antibodies also are non-specifically bound by protein A and another IgG-binding proteins on the S. aureus surface, which would bias the results. Since protein A also may serve as an adhesin in the investigated pathway, we cannot simply delete the ORF without changing other aspects of staphylococcal virulence. Further, FBS contains a ASM background activity that impedes activity measurements of cell culture medium. We previously removed this background activity by a specific heat-inactivation protocol.[9] However, S. aureus invasion is strongly reduced in culture medium containing this heat-inactivated FBS.

      We therefore developed a luminescence assay based on split NanoLuc luciferase that enables detection of LAMP1 exposed on the plasma membrane without usage of antibodies (Figure 2, A-C). We added a section on the assay in the revised manuscript. Briefly, we generated reporter cells by fusing a short peptide fragment of NanoLuc called HiBiT between the signal peptide and the mature luminal domain of LAMP1 and stably expressed the resulting protein in HeLa cells by lentiviral transduction. The LgBiT protein domain of NanoLuc luciferase (Promega) as well as the substrate Furimazine are added to the culture medium. HiBiT can reconstitute a functional NanoLuc with LgBiT and process Furimazine when lysosomes are exocytosed thereby generating luminescence measurable in a suitable plate reader. 

      With this assay we detected that  about 30% of lysosomes that were “releasable” by treatment with ionomycin are exocytosed during S. aureus infection. Lysosomal exocytosis was strongly reduced (even below the levels of untreated controls), if we treated cells with Vacuolin-1 or Ned19.  

      We agree with the reviewer that Vacuolin-1 to some extent has unspecific side effects as has been shown by others and which we addressed in the revised version of the manuscript (line 541 ff). However, our new results with the HiBiT reporter cell line clearly demonstrate a reduction of lysosomal exocytosis after Vacuolin-1 treatment. Supported by this and our other results we hypothesize that Vacuolin-1 decreases S. aureus internalization due to the inhibition of lysosomal exocytosis.

      As to the involvement of synaptotagmin 7: The effect of Syt7 K.O. on invasion was moderate in initial experiments, likely due to a high culture passage and presumably overgrowth of WT cells. However, reduction of invasion in Syt7 K.O.s was more pronounced in experiments with β-toxin complementation (Figure 2, N) and hence, we combined the two data sets (Figure 2, F). This demonstrates the reduction of bacterial invasion by ~40% in Syt7 K.O. cell pools. Moreover, Syt7 is not the only protein possibly involved in Ca<sup>2<sup>+</sup></sup>-dependent exocytosis. For instance, Syt1 has been shown to possess an overlapping function.[15] This may explain the differences between our Vacuolin-1 and Syt7 ablation experiments. We added this information to the discussion. 

      ASM is proposed to play a central role in the rapid invasion process. As above, most of the evidence offered in this regard is pharmacological and often inconsistent between inhibitors or among cell types. Some drugs affect some of the cells, but not others. It is difficult to reach general conclusions regarding the role of ASM. The argument is made even more complex by the authors' use of exogenous sphingomyelinase (beta-toxin). Pretreatment with the toxin decreased invasion efficiency, a seemingly paradoxical result. Incidentally, the effectiveness of the added toxin is never quantified/validated by directly measuring the generation of ceramide or the disappearance of SM.

      Although pharmacological inhibitors can have unspecific side effects, we want to emphasize that the inhibitors used in our study act on the enzyme ASM by completely different mechanisms. Amitriptyline is a so called functional inhibitor of ASM (FIASMA) which induces the detachment of ASM from lysosomal membranes resulting in degradation of the enzyme.[16] By contrast, ARC39 is a competitive inhibitor.[17, 18] 

      There are no inconsistencies in our data obtained with ASM inhibitors. Amitriptyline and ARC39 both reduce the invasion of S. aureus in HuLEC, HuVEC and HeLa cells (Figure 2G). ARC39 needs a longer pre-incubation, since its uptake by host cells is slower (to be published elsewhere). We observe a different outcome in 16HBE14o- and Ea.Hy 926 cells, with 16HBE14o- even demonstrating a slightly increased invasion of S. aureus upon ARC39 treatment. Amitriptyline had no effect (Figure 2G). 

      Thus, the ASM-dependent S. aureus internalization is cell type/line specific, which we state in the manuscript. The molecular origin of these differences is unclear and will require further investigation, e.g. in testing cell lines for potential differences in surface receptors. In a separate study we have already developed a biotinylation-based approach to identify potential novel host cell surface interaction partners during S. aureus infection.[19]

      Moreover, both inhibitors affected the invasion dynamics (Figure 3D), phagosomal escape (Figure 4C and Figure 4D) and Rab7 recruitment (Figure 4A and Supp. Figure 4A-C) in a similar fashion. Proper inhibition of ASM by both compounds in all cell lines used was validated by enzyme assays (Supp. Figure 2H), which again suggests that the ASM-dependent pathway does only exist in specific cell lines and also supports  that we do not observe unspecific side effects of the compounds. We clarified this in the revised manuscript.

      ASM is a key player for SM degradation and recycling. In clinical context, deficiency in ASM results in the so-called Niemann Pick disease type A/B. The lipid profile of ASM-deficient cells is massively altered[20], which will result in severe side effects. Short-term inhibition by small molecules therefore poses a clear benefit when compared to the usage of ASM K.O. cells. In order to satisfy the query of the reviewer, we generated two ASM K.O. cell pools (generated with two different sgRNAs) and tested these for S. aureus invasion efficiency (Figure 2, I). We did not observe bacterial invasion differences between WT and K.O. cells. However, when we treated the cells additionally with ASM inhibitor, we observed a strongly reduced invasion in WT cells, while invasion efficiency in ASM K.O. was only slightly affected (Figure 2, J). We concluded that the reduced invasion observed in inhibitor-treated WT cells  predominantly is due to absence of ASM, while the small reduction observed in ARC39treated ASM K.O.s is likely due to unspecific side effects.  

      We performed lipidomics on these cells and demonstrated a strongly altered sphingolipid profile in ASM K.O. cells compared to untreated and inhibitor-treated WT cells (Figure 2, K). We speculate that other ASM-independent bacterial invasion pathways are upregulated in ASM K.O.s., thereby obscuring the effect contributed by absence of ASM. We discussed this in the revised manuscript (line 518 ff).

      Moreover, we introduced the RFP-CWT escape marker into the ASM K.O. cells and measured phagosomal escape of S. aureus JE2 and Cowan I.  The latter strain is non-cytotoxic and serves as negative control, since it is known to possess a very low escape rate, due to its inability to produce toxin. Again, we compared early invaders (infection for 10 min) with early<sup>+</sup>late invaders (infection for 30 min). As observed  for JE2, “early invaders” possess lower escape rates than “early<sup>+</sup>late invaders”.

      We did not observe differences between WT and ASM K.O. cells, if we infected for only 10 min. By contrast, we observed a lower escape rate in ASM K.O (Author response image 3, see end of the document). compared to WT cells, when we infected for 30 min.  

      However, we usually observe an increased phagosomal escape, when we treated host cells with ASM inhibitors (Figure 4C and D). Reduced phagosomal escape of intracellular S. aureus in ASM K.O. cells may be caused by the altered sphingolipid profile(e.g., by interference with binding of bacterial toxins to phagosomal membranes or altered vesicular acidification). We hence think that these data are difficult to interpret, and clarification would require intense additional experimentation. Thus, we did not include this data in the manuscript. 

      Author response image 3.

      Phagosomal escape rates were established in either HeLa wild-type or ASM K.O. cells expressing the phagosomal escape reporter RFP-CWT. Host cells that were infected with the cytotoxic S. aureus strain JE2 or the non-cytotoxic strain Cowan I for 10 or 30 minutes and escape rates were determined by microscopy 3h p.i.

      As to the treatment with a bacterial sphingomyelinase:

      Treatment with the bacterial SMase (bSMase, here: β-toxin) was performed in two different ways:

      i) Pretreatment of host cells with β-toxin to remove SM from the host cell surface before infection. This removes the substrate of ASM from the cell surface prior to addition of the bacteria (Figure 2L, Figure 4A-C). Since SM is not present on the extracellular plasma membrane leaflet after treatment, a release of ASM cannot cause localized ceramide formation at the sites of lysosomal exocytosis. Similar observations were made by others.[21] 

      ii) Addition of bSMase to host cells together with the bacteria to complement for the absence of ASM (Figure 2N).  

      Removal of the ASM substrate before infection (i) prevents localized ASM-mediated conversion of SM to Cer during infection and resulted in a decreased invasion, while addition of the SMase during infection resulted in an increased invasion in TPC1 and Syt7 ablated cells. Thus, both experiments are consistent with each other and in line with our other observations. 

      Removal of SM from the plasma membrane by β-toxin was indirectly demonstrated by the absence of Lysenin recruitment to phagosomes/escaped bacteria when host cells were pretreatment with the toxin before infection (Figure5C). We also added another data set that demonstrates degradation of a fluorescence SM derivative upon β-toxin treatment of host cells (Supp Figure 2, M). In another publication, we recently quantified the effectiveness of β-toxin treatment, even though with slightly longer treatment times (75 min vs. 3h).[22]

      To clarify our experimental approaches to the readership we added an explanatory section to the revised manuscript (line 287 ff) and we also added a scheme to in Figure 2M describing the experimental settings.

      As to the general conclusions regarding the role of ASM: ASM and lysosomal exocytosis has been shown to be involved in uptake of a variety of pathogens[21, 23-27] supporting its role in the process.

      The use of fluorescent analogs of sphingomyelin and ceramide is not well justified and it is unclear what conclusions can be derived from these observations. Despite the low resolution of the images provided, it appears as if the labeled lipids are largely in endomembrane compartments, where they would presumably be inaccessible to the secreted ASM. Moreover, considering the location of the BODIPY probe, the authors would be unable to distinguish intact sphingomyelin from its breakdown product, ceramide. What can be concluded from these experiments? Incidentally, the authors report only 10% of BODIPY-positive events after 10 min. What are the implications of this finding? That 90% of the invasion events are unrelated to sphingomyelin, ASM, and ceramide?

      During the experiments with fluorescent SM analogues (Figure 3a,b), S. aureus was added to the samples immediately before the start of video recording. Hence, bacteria are slowly trickling onto the host cells, and we thus can image the initial contact between them and the bacteria, for instance, the bacteria depicted in Figure 3A contact the host cell about 9 min before becoming BODIPY-FL-positive (see Supp. Video 1, 55 min). Hence, in these cases we see the formation of phagosomes around bacteria rather than bacteria in endomembrane compartments. Since generation of phagosomes happens at the plasma membrane, SM is accessible to secreted ASM.  

      The “trickling” approach for infection is an experimental difference to our invasion measurements, in which we synchronized the infection by  centrifugation. This ensures that all bacteria have contact to host cells and are not just floating in the culture medium. However, live cell imaging of initial bacterialhost contact and synchronization of infection is hard to combine technically.

      In our invasion measurements -with synchronization-, we typically see internalization of ~20% of all added bacteria after 30 min. Hence, most bacteria that are visible in our videos likely are still extracellular and only a small proportion was internalized. This explains why only 10% of total bacteria are positive for BODIPY-FL-SM after 10 min. The proportion of internalized bacteria that are positive for BODIPY-FL-SM should be way higher but cannot be determined with this method.

      We agree with the reviewer that we cannot observe conversion of BODIPY-FL-SM by ASM. In order to do that, we attempted to visualize the conversion of a visible-range SM FRET probe (Supp. Figure 3), but the structure of the probe is not compatible with measurement of conversion on the plasma membrane, since the FITC fluorophore released into the culture medium by the ASM activity thereby gets lost for imaging. In general, the visualization of SM conversion with subcellular resolution is challenging and even with novel tools developed in our lab[28] visualization of SM on the plasma membrane is difficult. 

      The conclusions we draw from these experiments are that i.) S. aureus invasion is associated with SM and ii.) SM-associated invasion can be very fast, since bacteria are rapidly engulfed by BODIPY-FL-SM containing membranes.

      It is also unclear how the authors can distinguish lysenin entry into ruptured vacuoles from the entry of RFP-CWT, used as a criterion of bacterial escape. Surely the molecular weights of the probes are not sufficiently different to prevent the latter one from traversing the permeabilized membrane until such time that the bacteria escape from the vacuole.

      We here want to clarify that both Lysenin as well as the CWT reporter have access to ruptured vacuoles (Figure 4B). We used the Lysenin reporter in these experiments for estimation of SM content of phagosomal membranes. If a vacuole is ruptured, both the bacteria and the luminal leaflet of the phagosomal membrane remnants get in contact with the cytosol and hence with the cytosolically expressed reporters YFP-Lysenin as well as RFP-CWT resulting in “Lysenin-positive escape” when phagosomes contained SM (see Figure 5C). By contrast, either β-toxin expression by S. aureus or pretreatment with the bSMase resulted in absence of Lysenin recruitment suggesting that the phagosomal SM levels were decreased/undetectable (Figure 5C, Supp Figure 6F, G, I, J).

      Although this approach does not enable a quantitative measurement of phagosomal SM, this method is sufficient to show that β-toxin expression and pretreatment result in markedly decreased phagosomal SM levels in the host cells.

      The approach we used here to analyze “Lysenin-positive escape” can clearly be distinguished from Lysenin-based methods that were used by others.29 There Lysenin was used to show trans-bilayer movement of SM before rupture of bacteria-containing phagosomes.

      To clarify the function of Lysenin in our approach we added  additional figures (Figure 4F, Supp. Figure 5) and a movie (Supp. Video 4) to the revised manuscript.

      Both SMase inhibitors (Figure 4C) and SMase pretreatment increased bacterial escape from the vacuole. The former should prevent SM hydrolysis and formation of ceramide, while the latter treatment should have the exact opposite effects, yet the end result is the same. What can one conclude regarding the need and role of the SMase products in the escape process?

      As pointed out above, pretreatment of host cells with SMase removes SM from the plasma membrane and hence, ASM does not have access to its substrate. Hence, both treatment with either ASM inhibitors or pretreatment with bacterial SMase prevent ASM from being active on the plasma membrane and hence block the ASM-dependent uptake (Figure 2 G, L). Although overall less bacteria were internalized by host cells under these conditions, the bacteria that invaded host cells did so in an ASM-independent manner. 

      Since blockage of the ASM-dependent internalization pathway (with ASM inhibitor [Figure 4C, D], SMase pretreatment [Figure 5B] and Vacuolin-1[Figure.4E]) always resulted in enhanced phagosomal escape, we conclude that bacteria that were internalized in an ASM-independent fashion cause enhanced escape. Vice versa, bacteria that enter host cells in an ASM-dependent manner demonstrate lower escape rates. 

      This is supported by comparing the escape rates of “early” and “late” invaders [Figure 5D, E], which in our opinion is a key experiment that supports this hypothesis. The “early” invaders are predominantly ASM-dependent (see e.g. Figure 3E) and thus, bacteria that entered host cell in the first 10 min of infection should have been internalized predominantly in an ASM-dependent fashion, while slower entry pathways are active later during infection. The early ASM dependent invaders possessed lower escape rates, which is in line with the data obtained with inhibitors (e.g. Figure 4C, D).

      We hypothesize that the activity of ASM on the plasma membrane during invasion mediates the recruitment of a specific subset of receptors, which then influences downstream phagosomal maturation and escape. This hypothesis is supported by the fact that the subset of receptors interacting with S. aureus is altered upon inhibition of the ASM-dependent uptake pathway. We describe this in another study that is currently under evaluation elsewhere.  

      Reviewer #2 (Public review):

      Summary:

      In this manuscript, Ruhling et al propose a rapid uptake pathway that is dependent on lysosomal exocytosis, lysosomal Ca<sup>2<sup>+</sup></sup> and acid sphingomyelinase, and further suggest that the intracellular trafficking and fate of the pathogen is dictated by the mode of entry.

      The evidence provided is solid, methods used are appropriate and results largely support their conclusions, but can be substantiated further as detailed below. The weakness is a reliance on chemical inhibitors that can be non-specific to delineate critical steps.

      Specific comments:

      A large number of experiments rely on treatment with chemical inhibitors. While this approach is reasonable, many of the inhibitors employed such as amitriptyline and vacuolin1 have other or nondefined cellular targets and pleiotropic effects cannot be ruled out. Given the centrality of ASM for the manuscript, it will be important to replicate some key results with ASM KO cells.

      We thank the reviewer for the critical evaluation of our manuscript and plenty of constructive comments. 

      We agree with the reviewer, that ASM inhibitors such as functional inhibitors of ASM (FIASMA) like amitriptyline used in our study have unspecific side effects given their mode-of-action. FIASMAs induce the detachment of ASM from lysosomal membranes resulting in degradation of the enzyme.[16]  However, we want to emphasize that we also used the competitive inhibitor ARC39 in our study[17, 18] which acts on the enzyme by a completely different mechanism. All phenotypes (reduced invasion [Figure 2G], effect on invasion dynamics [Figure 3D], enhanced escape [Figure 4C, D] and differential recruitment of Rab7 [Supp. Figure 4A-C]) were observed with both inhibitors thereby supporting the role of ASM in the process.  

      We further agree that experiments with genetic evidence usually support and improve scientific findings. However, ASM is a cellular key player for SM degradation and recycling. In a clinical context, deficiency in ASM results in a so-called Niemann Pick disease type A/B. The lipid profile of ASMdeficient cells is massively altered[20], which in itself will result in severe side effects. Thus, the usage of inhibitors provides a clear benefit when compared to ASM K.O. cells, since ASM activity can be targeted in a short-term fashion thereby preventing larger alterations in cellular lipid composition.

      We nevertheless generated two ASM K.O. cell pools (generated with two different sgRNAs) and tested for invasion efficiency (Figure 2, I). Here, we did not observe differences between WT and mutants. However, if we treated the cells additionally with ASM inhibitor, we observed a strongly reduced invasion in WT cells, while invasion efficiency in ASM K.O. was only slightly affected (Figure 2, J). We concluded that the reduced invasion observed in WT cells upon inhibitor treatment predominantly is due to inhibition of ASM, whereas the small reduction observed in ARC39-treated ASM K.O.s is likely due to unspecific side effects. We also demonstrated a strongly altered sphingolipid profile in ASM K.O. cells when compared to untreated and inhibitor-treated WT cells (new Figure 2, K). We speculate that other ASM-independent invasion pathways are upregulated in ASM K.O.s., thereby making up for the absence of ASM. We discuss this in the revised manuscript (line 518 ff).

      We introduced the RFP-CWT escape marker into the ASM K.O. cells and measured phagosomal escape of S. aureus JE2 and Cowan I (Author response image 3). The latter serves as negative control, since it is known to possess a very low escape rate, due to its inability of toxin production. Again, we compared early invaders (infection for 10 min) with early<sup>+</sup>late invaders (infection for 30 min). As seen before for JE2, early invaders possess lower escape rates than early<sup>+</sup>late invaders. We did not observe differences between WT and K.O. cells, if we infected for 10 min. By contrast, we observed a lower escape rate in ASM K.O. compared to WT cells, when we infected for 30 min. However, we usually observe an increased phagosomal escape, when we treated host cells with ASM inhibitors (Figure 4C and D). We think that the reduced phagosomal escape in ASM K.O. is caused by the altered sphingolipid profile, which could have versatile effects (e.g., inference with binding of bacterial toxins to phagosomal membranes or changes in acidification). We hence think that these data are difficult to interpret, and clarification would require intense additional experimentation. Thus, we did not include this data in the manuscript. 

      Most experiments are done in HeLa cells. Given the pathway is projected as generic, it will be important to further characterize cell type specificity for the process. Some evidence for a similar mechanism in other cell types S. aureus infects, perhaps phagocytic cell type, might be good. 

      Whenever possible we performed the experiments not only in HeLa but also in HuLECs. For example, we refer to experiments concerning the role of Ca<sup>2<sup>+</sup></sup> (Figure 1A/Supp.Figure1A), lysosomal Ca<sup>2<sup>+</sup></sup>/Ned19 (Figure1B/Supp Figure 1C), lysosomal exocytosis/Vacuolin-1 (Figure 2D/Supp. Figure2D), ASM/ARC39 and amitriptyline (Figure 2G), surface SM/β-toxin (Figure 2L/Supp. Figure 2L), analysis of invasion dynamics (complete Figure 3) and measurement of cell death during infection (Figure 6C<sup>+</sup>E, Supp. Figure 8A<sup>+</sup>B).

      HuLECs, however, are not really genetically amenable and hence we were not able to generate gene deletions in these cells and upon introduction of the fluorescence escape reporter the cells are not readily growing. 

      As to ASM involvement in phagocytic cells: a role for ASM during the uptake of S. aureus by macrophages was previously reported by others.[25] However, in professional phagocytes S. aureus does not escape from the phagosome and replicates within the phagosome.[30]

      I'm a little confused about the role of ASM on the surface. Presumably, it converts SM to ceramide, as the final model suggests. Overexpression of b-toxin results in the near complete absence of SM on phagosomes (having representative images will help appreciate this), but why is phagosomal SM detected at high levels in untreated conditions? If bacteria are engulfed by SM-containing membrane compartments, what role does ASM play on the surface? If surface SM is necessary for phagosomal escape within the cell, do the authors imply that ASM is tuning the surface SM levels to a certain optimal range? Alternatively, can there be additional roles for ASM on the cell surface? Can surface SM levels be visualized (for example, in Figure 4 E, F)?

      We initially hypothesized that we would detect higher phagosomal SM levels upon inhibition of ASM, since our model suggests SM cleavage by ASM on the host cell surface during bacterial cell entry. However, we did not detect any changes in our experiments (Supp. Figure 4F). We currently favor the following explanation: SM is the most abundant sphingolipid in human cells.[31] If peripheral lysosomes are exocytosed and thereby release ASM, only a localized and relative small proportion of SM may get converted to Cer, which most likely is below our detection limit. In addition, the detection of cytosolically exposed phagosomal SM by YFP-Lysenin is not quantitative and provides a “Yes or No” measurement. Hence, we think that the rather limited SM to Cer conversion in combination with the high abundance of SM in cellular membranes does not visibly affect the recruitment of the Lysenin reporter. 

      In our experiments that employ BODIPY-FL-SM (Figure 3a<sup>+</sup>b), we cannot distinguish between native SM and downstream metabolites such as Cer. Hence, again we cannot make any assumptions on the extent to which SM is converted on the surface during bacterial internalization. Although our laboratory recently used trifunctional sphingolipid analogs to analyze the SM to Cer conversion[22], the visualization of this process on the plasma membrane is currently still challenging.

      Overall, we hypothesize that the localized generation of Cer on the surface by released ASM leads to generation of Cer-enriched platforms. Subsequently, a certain subset of receptors may be recruited to these platforms and influence the uptake process. These platforms are supposed to be very small, which also would explain that we did not detect changes in Lysenin recruitment.

      Related to that, why is ASM activity on the cell surface important? Its role in non-infectious or other contexts can be discussed.

      ASM release by lysosomal exocytosis is implied in plasma membrane repair upon injury. We added a short description of the role of extracellular ASM in the introduction (line 35).

      If SM removal is so crucial for uptake, can exocytosis of lysosomes alone provide sufficient ASM for SM removal? How much or to what extent is lysosomal exocytosis enhanced by initial signaling events? Do the authors envisage the early events in their model happening in localized confines of the PM, this can be discussed.

      Ionomycin treatment led to a release of ~10 % of all lysosomes and also increased extracellular ASM activity.[8, 9] In the revised manuscript, we developed an assay to determine lysosomal exocytosis during S. aureus infection (Figure 2, A-C). We detected lysosomal exocytosis of ~30% when compared to ionomycin treatment  during infection. Since this is only a fraction of the “releasable lysosomes”, we assume that the effects (lysosomal Ca<sup>2<sup>+</sup></sup> liberation, lysosomal exocytosis and ASM activity) are very localized and take place only at host-pathogen contact sites (see also above). We discuss this in the revised manuscript (line 563 ff). To our knowledge it is currently unclear to which extent the released ASM affects surface SM levels. We attempted to visualize the local ASM activity on the cell surface by using a visible range FRET probe (Supp. Fig. 3). Cleavage of the probe by ASM on the surface leads to release of FITC into the cell culture medium, which does not contribute a measurable signal at the surface. 

      How are inhibitor doses determined? How efficient is the removal of extracellular bacteria at 10 min? It will be good to substantiate the cfu experiments for infectivity with imaging-based methods. Are the roles of TPC1 and TPC2 redundant? If so, why does silencing TPC1 alone result in a decrease in infectivity? For these and other assays, it would be better to show raw values for infectivity. Please show alterations in lysosomal Ca<sup>2<sup>+</sup></sup> at the doses of inhibitors indicated. Is lysosomal Ca<sup>2<sup>+</sup></sup> released upon S. aureus binding to the cell surface? Will be good to directly visualize this.

      Concerning the inhibitor concentrations, we either used values established in published studies or recommendations of the suppliers (e.g. 2-APB, Ned19, Vacuolin-1). For ASM inhibitors, we determined proper inhibition of ASM by activity assays. Concentrations of ionomycin resulting in Ca<sup>2<sup>+</sup></sup> influx and lysosomal exocytosis was determined in earlier studies of our lab.[9, 32] 

      As to the removal of bacteria at 10 min p.i.: Lysostaphin is very efficient for removal of extracellular S. aureus and sterilizes the tissue culture supernatant. It significantly lyses bacteria within a few minutes, as determined by turbidity assays.[33]

      As to imaging-based infectivity assays: We performed imaging-based invasion assays to show reduced invasion efficiency with two ASM inhibitors in the revised manuscript with similar results as obtained by CFU counts (Supp. Figure 2, J).

      Regarding the roles of TPC1 and TPC2: from our data we cannot conclude whether the roles of TPC1 and TPC2 are redundant. One could speculate that since blockage of TPC1 alone is sufficient to reduce internalization of bacteria, that both channels may have distinct roles. On the other hand, there might be a Ca<sup>2<sup>+</sup></sup> threshold in order to initiate lysosomal exocytosis that can only be attained if TPC1 and TPC2 are activated in parallel. Thus, our observations are in line with another study that shows reduced Ebola virus infection in absence of either TPC1 or TPC2.[34] In order to address the role of TPC2 for this review process, we kindly were gifted TPCN1/TPCN2 double knock-out HeLa cells by Norbert Klugbauer (Freiburg, Germany), which we tested for S. aureus internalization. We found that invasion was reduced in these double KO cell lines even further supporting a role of lysosomal Ca<sup>2<sup>+</sup></sup> release in S. aureus host cell entry (Author response image 2, see end of the document). Since we did not have a single TPCN2 knockout available, we decided to exclude these data from the main manuscript.

      As to raw CFU counts: whereas the observed effects upon blocking the invasion of S. aureus are stable, the number of internalized bacteria varies between individual biological replicates, for instance, by differences in host cell fitness or growth differences in bacterial cultures, which are prepared freshly for each experiment.

      With respect to visualization of lysosomal Ca<sup>2<sup>+</sup></sup> release: we agree with the reviewer that direct visual demonstration of lysosomal Ca<sup>2<sup>+</sup></sup> release upon infection would improve the manuscript. We therefore performed live cell imaging to visualize lysosomal Ca<sup>2<sup>+</sup></sup> release by a previously published method.[1] The approach is based on two dextran-coupled fluorophores that were incubated with host cells. The dyes are endocytosed and eventually stain the lysosomes. One of the dyes, Rhod-2, is Ca<sup>2<sup>+</sup></sup>-sensitive and can be used to estimate the lysosomal Ca<sup>2<sup>+</sup></sup> content. The second dye, AF647, is Ca<sup>2<sup>+</sup></sup>-insensitive and is used to visualize the lysosomes. If the ratio Rhod-2/AF647 within the lysosomes is decreasing, lysosomal Ca<sup>2<sup>+</sup></sup> release is indicated. We monitored lysosomal Ca<sup>2<sup>+</sup></sup> content during S. aureus infection with this method (Author response image 1 and Author response video 1). However, the lysosomes are very dynamic, and it is challenging to monitor the fluorescence intensities over time. Thus, quantitative measurements are not possible with our methodology, and we decided to not include these data in the final manuscript. However, one could speculate that lysosomal Ca<sup>2<sup>+</sup></sup> content in the selected ROI (Author response image 1 and Author response video 1) is decreased upon attachment of S. aureus to the host cells as indicated by a decrease in Rhod-2/AF647 ratio.

      The precise identification of cytosolic vs phagosomal bacteria is not very easy to appreciate. The methods section indicates how this distinction is made, but how do the authors deal with partial overlaps and ambiguities generally associated with such analyses? Please show respective images.

      The number of events (individual bacteria) for the live cell imaging data should be clearly mentioned.

      We apologize for not having sufficiently explained the technology to detect escaped S. aureus. The cytosolic location of S. aureus is indicated by recruitment of RFP-CWT.[35] CWT is the cell wall targeting domain of lysostaphin, which efficiently binds to the pentaglycine cross bridge in the peptidoglycan of S. aureus. This reporter is exclusively and homogenously expressed in the host cytosol. Only upon rupture of phagoendosomal membranes, the reporter can be recruited to the cell wall of now cytosolically located bacteria. S. aureus mutants, for instance in the agr quorum sensing system, cannot break down the phagosomal membrane in non-professional phagocytes and thus stay unlabeled by the CWT-reporter.[35] We  include several images (Figure 4, F, Supp. Figure 5) /movies (Supp. Video 4) of escape events in the revised manuscript.  The bacteria numbers for live cell experiments are now shown in Supp. Figure 7.

      In the phagosome maturation experiments, what is the proportion of bacteria in Rab5 or Rab7 compartments at each time point? Will the decreased Rab7 association be accompanied by increased Rab5? Showing raw values and images will help appreciate such differences. Given the expertise and tools available in live cell imaging, can the authors trace Rab5 and Rab7 positive compartment times for the same bacteria?

      We included the proportion of Rab7-associated bacteria in the revised manuscript (Supp. Figure 4A and C) and also shortly mention these proportions in the text (line 353). Usually, we observe that Rab5 is only transiently (for a few minutes) present on phagosomes and only afterwards the phagosomes become positive for Rab7. We do not think that a decrease in Rab7-positive phagosomes would increase the proportion of Rab5-positive phagosomes. However, we cannot exclude this hypothesis with our data.

      We can achieve tracing of individual bacteria for recruitment of Rab5/Rab7 only manually, which impedes a quantitative evaluation. However, we included a Video (Supp. Video 3)  that illustrates the consecutive recruitment of the GTPases.

      The results with longer-term infection are interesting. Live cell imaging suggests that ASM-inhibited cells show accelerated phagosomal escape that reduces by 6 hpi. Where are the bacteria at this time point ? Presumably, they should have reached lysosomes. The relationship between cytosolic escape, replication, and host cell death is interesting, but the evidence, as presented is correlative for the populations. Given the use of live cell imaging, can the authors show these events in the same cell?

      We think that most bacteria-containing phagoendosomes should have fused with lysosomes 6 h p.i. as we have previously shown by acidification to pH of 5 and LAMP1 decoration.[36]

      The correlation between phagosomal escape and replication in the cytosol of non-professional phagocytes has been observed by us and others. In the revised manuscript we also provide images (Supp. Figure 5)/videos (Supp. Video 4) to show this correlation in our experiments.

      Given the inherent heterogeneity in uptake processes and the use of inhibitors in most experiments, the distinction between ASM-dependent and independent pathways might not be as clear-cut as the authors suggest. Some caution here will be good. Can the authors estimate what fraction of intracellular bacteria are taken up ASM-dependent?

      We agree with the reviewer that an overlap between internalization pathways is likely. A clear distinction is therefore certainly non-trivial. Alternative to ASM-dependent and ASM-independent pathways, the ASM activity may also accelerate one or several internalization pathways. We address this limitation in the discussion of the revised manuscript (line 596 ff).

      Early in infection (~10 min after contact with the cells), the proportion of bacteria that enter host cells ASM-dependently is relatively high amounting to roughly 75-80% in HuLEC. After 30 min, this proportion is decreasing to about 50%. We included a paragraph in the discussion of the revised manuscript (line 593 ff).

      Reviewer #2 (Recommendations for the authors):

      (1) The experiment in Figure 4H is interesting. Details on what proportion of the cell is double positive, and if only this fraction was used for analysis will be good.

      We did use all bacteria found in the images independently from whether host cells were infected with only one or both strains. We unfortunately cannot properly determine the proportion of cells that are double infected, since i) we record the samples with CLSM and hence, cannot exclude that there are intracellular bacteria found in higher or lower optical sections. ii) we visualized cells by staining Nuclei and did not stain the cell borders, thus we cannot precisely tell to which host cell the bacteria localize.

      (2) Data is sparse for steps 5 and 6 of the model (line 330).

      We apologize for the inconvenience. There is a related study published  elsewhere[19], in which we identified NRCAM and PTK7 as putative receptors involved in this invasion pathway. We included a section in the discussion with the corresponding citation (line 569).

      (3) Data for the reduced number of intracellular bacteria upon blocking ASM-dependent uptake (line 235) is not clear. Do they mean decreased invasion efficiency? These two need not be the same.

      We changed “reduced number of intracellular bacteria” to “invasion efficiency”.

      (4) b-toxin added to the surface can get endocytosed. Can its surface effect be delineated from endo/phagosomal effect?

      We attempted to delineate effects contributed by the toxin activity on the surface vs. within phagosomes (Figure 5 A-C). We see an increased phagosomal escape, when we pretreated host cells with β-toxin (removal of SM form the surface) and infected either in presence (toxin will be taken up together with the bacteria into the phagosome) or in absence (toxin was washed away shortly before infection) of β-toxin. By contrast, overexpression of β-toxin by S. aureus did not affect phagosomal escape rates. The proper activity of β-toxin was confirmed by absence of Lysenin recruitment during phagosomal escape in all three conditions. We concluded that the activity on the surface and not the activity in the phagosome is important.

      (5) The potential role(s) of bacterial factors in the uptake and subsequent intracellular stages can be discussed.

      There are multiple bacterial adhesins known in S. aureus. These usually are either covalently attached to the bacterial cell wall such as the sortase-dependently anchored Fibronectin-binding Proteins A and B but also secreted and “cell wall binding” proteins as well at non proteinaceous factor such as wall-teichoic acids. A discussion of these factors would thus be out of the scope of this manuscript, and we here suggest reverting to specialized reviews on that topic.

      (6) The manuscript is not very easy to read. The abstract could be rephrased for better clarity and succinctness, with a clearly stated problem statement. The introduction is somewhat haphazard, I feel it can be better structured.

      We apologize for the inconvenience. We stated the problem/research question in the abstract and tried to improve the introduction without adding too much unnecessary detail. In general, we tried  to improve the readability of the manuscript and hope that our results and conclusions can be easier understood by the reader in the revised version.

      (7) Typo in Figure 5F. Step 6 should read "accessory receptors"

      The typo was corrected.

      References

      (1) Lloyd-Evans, E. et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nature Medicine 14, 1247-1255 (2008).

      (2) Launay, P. et al. TRPM4 Is a Ca<sup>2<sup>+</sup></sup>-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization. Cell 109, 397-407 (2002).

      (3) Nilius, B. et al. The Ca<sup>2<sup>+</sup></sup>‐activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5‐biphosphate. The EMBO Journal 25, 467-478-478 (2006).

      (4) Cáceres, M. et al. TRPM4 Is a Novel Component of the Adhesome Required for Focal Adhesion Disassembly, Migration and Contractility. PLoS One 10, e0130540 (2015).

      (5) Silva, I., Brunett, M., Cáceres, M. & Cerda, O. TRPM4 modulates focal adhesion-associated calcium signals and dynamics. Biophysical Journal 123, 390a (2024).

      (6) Schlesier, T., Siegmund, A., Rescher, U. & Heilmann, C. Characterization of the Atl-mediated staphylococcal internalization mechanism. International Journal of Medical Microbiology 310, 151463 (2020).

      (7) Jevon, M. et al. Mechanisms of Internalization ofStaphylococcus aureus by Cultured Human Osteoblasts. Infection and Immunity 67, 2677-2681 (1999).

      (8) Rodriguez, A., Webster, P., Ortego, J. & Andrews, N.W. Lysosomes behave as Ca<sup>2<sup>+</sup></sup>-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol 137, 93-104 (1997).

      (9) Krones & Rühling et al. Staphylococcus aureus alpha-Toxin Induces Acid Sphingomyelinase Release From a Human Endothelial Cell Line. Front Microbiol 12, 694489 (2021).

      (10) Sakurai, Y. et al. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 347, 995-998 (2015).

      (11) Aarhus, R., Graeff, R.M., Dickey, D.M., Walseth, T.F. & Lee, H.C. ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP. J Biol Chem 270, 3032730333 (1995).

      (12) Schmid, F., Fliegert, R., Westphal, T., Bauche, A. & Guse, A.H. Nicotinic acid adenine dinucleotide phosphate (NAADP) degradation by alkaline phosphatase. J Biol Chem 287, 32525-32534 (2012).

      (13) Angeletti, C. et al. SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites. iScience 25, 103812 (2022).

      (14) Gu, F. et al. Dual NADPH oxidases DUOX1 and DUOX2 synthesize NAADP and are necessary for Ca(2<sup>+</sup>) signaling during T cell activation. Sci Signal 14, eabe3800 (2021).

      (15) Schonn, J.-S., Maximov, A., Lao, Y., Südhof, T.C. & Sørensen, J.B. Synaptotagmin-1 and -7 are functionally overlapping Ca<sup>2<sup>+</sup></sup> sensors for exocytosis in adrenal chromaffin cells. Proceedings of the National Academy of Sciences 105, 3998-4003 (2008).

      (16) Kornhuber, J. et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 26, 9-20 (2010).

      (17) Naser, E. et al. Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro. J Lipid Res 61, 896-910 (2020).

      (18) Roth, A.G. et al. Potent and selective inhibition of acid sphingomyelinase by bisphosphonates. Angew Chem Int Ed Engl 48, 7560-7563 (2009).

      (19) Rühling, M., Schmelz, F., Kempf, A., Paprotka, K. & Fraunholz Martin, J. Identification of the Staphylococcus aureus endothelial cell surface interactome by proximity labeling. mBio 0, e03654-03624 (2025).

      (20) Schuchman, E.H. & Desnick, R.J. Types A and B Niemann-Pick disease. Mol Genet Metab 120, 27-33 (2017).

      (21) Miller, M.E., Adhikary, S., Kolokoltsov, A.A. & Davey, R.A. Ebolavirus Requires Acid Sphingomyelinase Activity and Plasma Membrane Sphingomyelin for Infection. Journal of Virology 86, 7473-7483 (2012).

      (22) M. Rühling, L.K., F. Wagner, F. Schumacher, D. Wigger, D. A. Helmerich, T. Pfeuffer, R. Elflein, C. Kappe, M. Sauer, C. Arenz, B. Kleuser, T. Rudel, M. Fraunholz, J. Seibel Trifunctional sphingomyelin derivatives enable nanoscale resolution of sphingomyelin turnover in physiological and infection processes via expansion microscopy. Nat Commun accepted in principle (2024).

      (23) Peters, S. et al. Neisseria meningitidis Type IV Pili Trigger Ca(2<sup>+</sup>)-Dependent Lysosomal Trafficking of the Acid Sphingomyelinase To Enhance Surface Ceramide Levels. Infect Immun 87 (2019).

      (24) Grassmé, H. et al. Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 91, 605-615 (1997).

      (25) Li, C. et al. Regulation of Staphylococcus aureus Infection of Macrophages by CD44, Reactive Oxygen Species, and Acid Sphingomyelinase. Antioxid Redox Signal 28, 916-934 (2018).

      (26) Fernandes, M.C. et al. Trypanosoma cruzi subverts the sphingomyelinase-mediated plasma membrane repair pathway for cell invasion. J Exp Med 208, 909-921 (2011).

      (27) Luisoni, S. et al. Co-option of Membrane Wounding Enables Virus Penetration into Cells. Cell Host & Microbe 18, 75-85 (2015).

      (28) Rühling, M. et al. Trifunctional sphingomyelin derivatives enable nanoscale resolution of sphingomyelin turnover in physiological and infection processes via expansion microscopy. Nature Communications 15, 7456 (2024).

      (29) Ellison, C.J., Kukulski, W., Boyle, K.B., Munro, S. & Randow, F. Transbilayer Movement of Sphingomyelin Precedes Catastrophic Breakage of Enterobacteria-Containing Vacuoles. Curr Biol 30, 2974-2983 e2976 (2020).

      (30) Moldovan, A. & Fraunholz, M.J. In or out: Phagosomal escape of Staphylococcus aureus. Cell Microbiol 21, e12997 (2019).

      (31) Slotte, J.P. Biological functions of sphingomyelins. Progress in Lipid Research 52, 424-437 (2013).

      (32) Stelzner, K. et al. Intracellular Staphylococcus aureus Perturbs the Host Cell Ca(2<sup>+</sup>) Homeostasis To Promote Cell Death. mBio 11 (2020).

      (33) Kunz, T.C. et al. The Expandables: Cracking the Staphylococcal Cell Wall for Expansion Microscopy. Front Cell Infect Microbiol 11, 644750 (2021).

      (34) Sakurai, Y. et al. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 347, 995-998 (2015).

      (35) Grosz, M. et al. Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin alpha. Cell Microbiol 16, 451-465 (2014).

      (36) Giese, B. et al. Staphylococcal alpha-toxin is not sufficient to mediate escape from phagolysosomes in upper-airway epithelial cells. Infect Immun 77, 3611-3625 (2009).

    1. Author Response

      The following is the authors’ response to the original reviews.

      We would like to thank the editor and all the reviewers for their time and thoughtful consideration of our manuscript. We appreciate the valuable comments. Our provisional response to the “public review” has been published and now we have corrected factual errors and enhanced the clarity of writings based on the “recommendations for the authors.” We believe these corrections will improve the quality and accuracy of our manuscript.

      Specific responses to the reviewers' recommendations for the authors are as follows:

      Reviewer #1 (Recommendations For The Authors):

      1) Is the Slack current amplitude dependent on the Nav subtype? Differences in Slack current amplitude might explain the sensitization of Slack to quinidine.

      We appreciate the reviewer for raising this point. We examined Slack current amplitudes upon co-expression of Slack with specific NaV subtypes in HEK293 cells. The results have shown that there are no significant differences in Slack current amplitudes upon co-expression of Slack with different NaV channel subtypes (Author response image 1), suggesting whole-cell Slack current amplitudes cannot explain the varied ability of NaV subtypes to sensitize Slack to quinidine blockade.

      Author response image 1.

      The amplitudes of Slack currents upon co-expression of Slack with specific NaV subtypes in HEK293 cells. ns, p > 0.05, one-way ANOVA followed by Bonferroni’s post hoc test.

      2) Is the open probability changed by the presence of Nav1.6 and/or by the other Nav subtypes? Changes in open probability might explain the Nav1.6 induced sensitization of Slack to quinidine block.

      We appreciate the reviewer for raising this point. To investigate the effect of different NaV channel subtypes on Slack open probability, we will perform the single-channel recordings in future studies.

      3) Could the authors elaborate more on the coupling between INaT mediated sensitization of Slack to block by quinidine and the Nav1.6 N-and C-tail induced sensitization?

      We appreciate the reviewer for raising this point. We fully agree the importance of investigating the detailed mechanism underlying the sensitization of Slack to quinidine blockade. To address the questions, we plan to employ structural biological methods, such as cryo-electron microscopy (cryo-EM).

      4) Line 85: The authors use an outdated nomenclature of AMPAR subtypes. I would suggest changing to GluA1, GluA2, GluA3 and GluA4.

      We appreciate the reviewer’s suggestion. We have changed the term “GluR” to “GluA” in the revised manuscript.

      The authors do not explain the rationale by using the different homomeric AMPAR subtypes. Most often the AMPARs express as heteromeric receptors decorated by auxiliary subunits. Also, is the GluA2 the edited version?

      We thank the reviewer for raising this point. While AMPARs are often expressed as heteromeric receptors with auxiliary subunits, we focused on the homomeric AMPAR subtypes for initial screening. Through our investigation, we found no significant effects on sensitizing Slack to quinidine blockade. Additionally, the GluA2 used in our study is unedited.

      5) Line 144: I expect a reduction in current amplitude caused by blocking INaT and INaP is tested at +100mV?

      We thank the reviewer for raising this point. The reduction in current amplitude was indeed tested at +100 mV and we have included this information in the revised manuscript.

      6) Line 157 and line 162: Reference to Supplementary table S3 should be Table S2.

      We thank the reviewer for pointing this out. The reference to "Table S3" has been corrected to "Table S2" in the revised manuscript.

      7) How many times did the authors repeat the co-immunoprecipitation? Some of the bands are very weak, and repeats are necessary for all blots.

      We thank the reviewer for raising this concern. We performed the co-immunoprecipitation experiments three times independently.

      8) Line 288: The authors are showing the chimeric construct in Figures 7A and B but are referring to the full length Nav1.6 in the main text line 288.

      We apologize for the confusion. We have clarified in the revised manuscript that we used NaV1.5/6NC in our study.

      9) Figure 1 line 23: 1 uM quinidine must be 30 uM quinidine?

      We thank the reviewer for catching this error. We have corrected the concentration value in the caption of Figure 1 from "1 μΜ" to "30 μΜ" in the revised manuscript.

      10) Figure 2 line 53: I expect IC50 is measured at +100mV? Same question for line 60 in same figure text.

      We thank the reviewer for pointing this out. We have now included this information in the revised manuscript.

      11) Figure 4B color coding is confusing.

      We apologize for the confusion. We would like to clarify that Fig. 4B illustrates the domain architecture of the human NaV channel pore-forming α subunit, and we have changed the color from dark blue to black in the revised figure.

      12) Figure S6: Text for figure S6E and S6F has been swapped (line 96 to 106).

      We thank the reviewer for raising this point. We have rectified the swapped captions for Fig. S6E and Fig. S6F in the revised manuscript.

      13) Methods section line 652: Kainite acid should be changed to kainic acid

      We thank the reviewer for catching this typo. The term “kainite acid” has been corrected to “kainic acid” in the revised manuscript.

      Reviewer #2 (Recommendations For The Authors):

      1) Discuss limitations about the use of non-neuronal cells or cultured primary neurons rather than a more intact system.

      We thank the reviewer for raising this point. We have discussed the limitations about the use of non-neuronal cells or cultured primary neurons rather than a more intact system (line 344 to line 348).

      2) Riluzole is not a selective drug, so the limitations of this drug should be discussed.

      We thank the reviewer for raising this point. We have discussed the limitations of riluzole in the revised manuscript (line 360 to line 364).

      3) Remove the term in vivo.

      We thank the reviewer for raising this point. In our experiments, although we did not conduct experiments directly in living organisms, our results demonstrated the coimmunoprecipitation of NaV1.6 with Slack in homogenates from mouse cortical and hippocampal tissues (Fig. 3C). This result may support that the interaction between Slack and NaV1.6 occurs in vivo.

      4) Figure 1

      ①C Why does Nav1.2 have a small inward current before the large inward current in the inset? The slope of the rising phase of the larger sodium current seems greater than Nav1.6 or Nav1.5. Was this examined?

      We apologize for the confusion. We would like to clarify that the small inward current can be attributed to the current of membrane capacitance (slow capacitance or C-slow). The larger inward current is mediated by NaV1.2. Additionally, we did not compare the slope of the rising phase of NaV subtypes sodium currents but primarily focused on the current amplitudes.

      ②D-E

      For Nav1.5 the sodium current is very large compared to Nav1.6. Is it possible the greater effect of quinidine for Nav1.6 is due to the lesser sodium current of Nav1.6?

      We thank the reviewer for raising this point. We would like to clarify that our results indicate that transient sodium currents contribute to the sensitization of Slack to quinidine blockade (Fig. 2C,E). Therefore, it is unlikely that the greater effect observed for NaV1.6 in sensitizing Slack is due to its lower sodium currents.

      ③The differences between WT and KO in G -H are hard to appreciate. Could quantification be shown? The text uses words like "block" but this is not clear from the figure. It seems that the replacement of Na+ with Li+ did not block the outward current or effect of quinidine.

      We apologize for the confusion. We would like to clarify the methods used in this experiment. The lithium ion (Li+) is a much weaker activator of sodium-activated potassium channel Slack than sodium ion (Na+)1,2.

      1. Zhang Z, Rosenhouse-Dantsker A, Tang QY, Noskov S, Logothetis DE. The RCK2 domain uses a coordination site present in Kir channels to confer sodium sensitivity to Slo2.2 channels. J Neurosci. Jun 2 2010;30(22):7554-62. doi:10.1523/JNEUROSCI.0525-10.2010

      2. Kaczmarek LK. Slack, Slick and Sodium-Activated Potassium Channels. ISRN Neurosci. Apr 18 2013;2013(2013)doi:10.1155/2013/354262

      Therefore, we replaced Na+ with Li+ in the bath solution to measure the current amplitudes of sodium-activated potassium currents (IKNa)3.

      1. Budelli G, Hage TA, Wei A, et al. Na+-activated K+ channels express a large delayed outward current in neurons during normal physiology. Nat Neurosci. Jun 2009;12(6):745-50. doi:10.1038/nn.2313

      The following equation was used for quantification:

      Furthermore, the remaining IKNa after application of 3 μM quinidine in the bath solution was measured as the following:

      The quantification results were presented in Fig. 1K. The term "block" used in the text referred to the inhibitory effect of quinidine on IKNa.

      ④In K, for the WT, why is the effect of quinidine only striking for the largest currents?

      We thank the reviewer for raising this point. After conducting an analysis, we found no correlation between the inhibitory effect of quinidine and the amplitudes of baseline IKNa in WT neurons (p = 0.6294) (Author response image 2). Therefore, the effect of quinidine is not solely limited to targeting the larger currents.

      Author response image 2.

      The correlation between the inhibitory effect of quinidine and the amplitudes of baseline IKNa in WT neurons (data from manuscript Fig. 1K). r = 0.1555, p=0.6294, Pearson correlation analysis.

      5) Figure 2

      ①A. The argument could be better made if the same concentration of quinidine were used for Slack and Slack + Nav1.6. It is recognized a greater sensitivity to quinidine is to be shown but as presented the figure is a bit confusing.

      We apologize for the confusion. We would like to clarify that the presented concentrations of quinidine were chosen to be near the IC50 values for Slack and Slack+NaV1.6.

      ②C. Can the authors add the effect of quinidine to the condition where the prepulse potential was - 90?

      We apologize for the confusion. We would like to clarify that the condition of prepulse potential at -90 mV is the same as the condition in Fig. 1. We only changed one experiment condition where the prepulse potential was changed to -40 mV from -90 mV.

      6) Figure 3.

      ①line 80 should be coronal not coronary

      We thank the reviewer for catching this error. We have corrected the term “coronary” to “coronal” in the caption of Figure 3.

      ②A. Clarify these 6 panels.

      We thank the reviewer for raising this point. We have clarified the captions of Fig. 3A in the revised manuscript.

      ③Please enlarge fonts in D.

      We thank the reviewer’s suggestion. We’ve enlarged the fonts in Fig. 3D in the revised manuscript.

      ④F. The variances should be checked with a test to determine if they are significantly different because they look different - if so, data can be transformed and if transformed data have variances that are equivalent a t-test can be used on the transformed data. Otherwise, Mann-Whitney should be used.

      We thank the reviewer for pointing this out. We have reanalyzed the data in Fig. 3F using Mann Whitney test after identifying the different variances in the two groups.

      7) Figure 7. The images need more clarity. They are very hard to see. Text is also hard to see.

      We apologize for the lack of clarity in the images and text. we would like to provide a concise summary of the key findings shown in this figure.

      Figure 7 illustrates an innovative intervention for treating SlackG269S-induced seizures in mice by disrupting the Slack-NaV1.6 interaction. Our results showed that blocking NaV1.6-mediated sodium influx significantly reduced Slack current amplitudes (Fig. 2D,G), suggesting that the Slack-NaV1.6 interaction contributes to the current amplitudes of epilepsy-related Slack mutant variants, aggravating the gain-of-function phenotype. Additionally, Slack’s C-terminus is involved in the Slack-NaV1.6 interaction (Fig. 5D). We assumed that overexpressing Slack’s C-terminus can disrupt the Slack-NaV1.6 interaction (compete with Slack) and thereby encounter the current amplitudes of epilepsy-related Slack mutant variants.

      In HEK293 cells, overexpression of Slack’s C-terminus indeed significantly reduced the current amplitudes of epilepsy-related SlackG288S and SlackR398Q upon co-expression with NaV1.5/6NC (Fig. 7A,B). Subsequently, we evaluated this intervention in an in vivo epilepsy model by introducing the Slack G269S variant into C57BL/6N mice using AAV injection, mimicking the human Slack mutation G288S that we previously identified (Fig. 7C-G).

      ②It is not clear how data were obtained because injection of kainic acid does not lead to a convulsive seizure every 10 min for several hours, which is what appears to be shown. Individual seizures are just at the beginning and then they merge at the start of status epilepticus. After the onset of status epilepticus the animals twitch, have varied movements, sometime rear and fall, but there is not a return to normal behavior. Therefore one can not call them individual seizures. In some strains of mice, however, individual convulsive seizures do occur (even if the EEG shows status epilepticus is occurring) but there are rarely more than 5 over several hours and the graph has many more. Please explain.

      We apologize for the confusion. Regarding the data acquisition in relation to kainic acid injection, we initiated the timing following intraperitoneal injection of kainic acid and recorded the seizure scores of per mouse at ten-minute intervals, following the methodology described in previous studies4.

      1. Huang Z, Walker MC, Shah MM. Loss of dendritic HCN1 subunits enhances cortical excitability and epileptogenesis. J Neurosci. Sep 2 2009;29(35):10979-88. doi:10.1523/JNEUROSCI.1531-09.2009

      The seizure scores were determined using a modified Racine, Pinal, and Rovner scale5,6: (1) Facial movements; (2) head nodding; (3) forelimb clonus; (4) dorsal extension (rearing); (5) Loss of balance and falling; (6) Repeated rearing and failing; (7) Violent jumping and running; (8) Stage 7 with periods of tonus; (9) Dead.

      1. Pinel JP, Rovner LI. Electrode placement and kindling-induced experimental epilepsy. Exp Neurol. Jan 15 1978;58(2):335-46. doi:10.1016/0014-4886(78)90145-0

      2. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. Mar 1972;32(3):281-94. doi:10.1016/0013- 4694(72)90177-0

      8) The graphical abstract is quite complicated and somewhat hard to follow. Please simplify and clarify. One aspect of the abstract to clarify is the direction of what is first and second and third (etc.) because arrows point to many directions.

      We thank the review for raising this point. In the revised manuscript, we have included numbering of three components within the graphical abstract:

      1. Pathological phenotype: Increased Slack currents.

      2. Two types of interventions:

      2a. Disruption of the Slack-NaV1.6 interaction.

      2b. NaV1.6-mediated sensitization of Slack to quinidine blockade.

      1. Therapeutic effects: Reduced Slack currents.

      Reviewer #3 (Recommendations For The Authors):

      1) A reference to homozygous knockout is made in the abstract; however, only heterozygous mice are mentioned in the methods section. The genotype of the mice needs to be made clear in the manuscript. Furthermore, at what age were these mice used in the study. Since homozygous knockout of NaV1.6 is lethal at a very young age (<4 wks), it would be important to clarify that point as well.

      We thank the reviewer for pointing this out. In the revised manuscript, we have included information about the source of the primary cortical neurons used in our study. These neurons were obtained from postnatal homozygous NaV1.6 knockout C3HeB/FeJ mice and their wild-type littermate controls.

      2) Coimmunoprecipitation studies in Fig. 3C are not convincing. There appears to be a signal in the control lane. Furthermore, it appears that brightness levels were adjusted of that image, thereby removing completely the background.

      We thank the reviewer for pointing this out. We have replaced Fig. 3C with an unadjusted version in the revised manuscript.

      3) In Fig. 1B, the authors indicate that 30 microM of quinidine was used, while the corresponding figure legend suggest that 1 microM. Please clarify.

      We apologize for this error. We have corrected the concentration value in the caption of Figure 1 from "1 μΜ" to "30 μΜ" in the revised manuscript.

      4) How long were the cells exposed to quinidine before the functional measurement were performed?

      We thank the reviewer for pointing this out. The cells were exposed to the bath solution with quinidine for about one minute before applying step pulses.

      5) In Fig. 6B-D, it is not clear to what extent co-expression of Slack mutants and NaV1.6 increases sodium-activated potassium current.

      We thank the reviewer for pointing this out. We notice that the current amplitudes of Slack mutants exhibit a considerable degree of variation, ranging from less than 1 nA to over 20 nA (n = 5-8). To accurately measure the effects of NaV1.6 on increasing current amplitudes of Slack mutants, we plan to apply tetrodotoxin in the bath solution to block NaV1.6 sodium currents upon coexpression of Slack mutants with NaV1.6.

      6) In Fig.7A and B, it appears that some recordings had no sodium-activated potassium currents. Why were these included in analysis? How was transfection efficacy assessed?

      We apologize for the confusion. We would like to clarify that all recordings included in analysis indeed exhibited outward sodium-activated potassium currents. The current density data in Fig. 7A-B are listed in Author response table 1 (in pA/pF):

      Author response table 1.

      Regarding the assessment of transfection efficacy, we estimated it approximately by using fluorescence proteins as reporters, which were co-expressed with the relevant proteins via the selfcleaving 2A peptide.

      7) Greater detail needs to be provided for the generation of NaV1.5 and NaV1.6 chimeras. Specifically, what AA residues were changed between sodium channel isoforms?

      We thank reviewer for pointing this out. In the revised manuscript, we have included the specific amino acid residues that were changed between NaV1.5 and NaV1.6 to generate the chimeric constructs.

      8) In line 481, the authors refer to Fig. S2d instead of Fig. S6D. This should be corrected. Furthermore, the unusual shift in sodium current kinetics that the authors observe might be due in part to junction potential. Did the authors take that into consideration?

      We apologize for this error. The reference to "Fig. S2d" has been corrected to "Fig. S6D" in the revised manuscript.

      Regarding the unusual shift observed in the sodium current kinetics, we agree with the reviewer's suggestion that the junction potential may contribute to this phenomenon. During patch-clamp recordings, we ensure that the junction potential was properly compensated by the amplifier. Additionally, the replacement of CsF in pipette solution may have contributed to the observed unusual shift, as CsF in pipette solution has been reported to shift the voltage dependence of activation and fast/slow inactivation of NaV channels towards more negative potentials7.

      1. Korngreen A. Advanced patch-clamp analysis for neuroscientists. Neuromethods. Humana Press; 2016:xii, 350 pages.

      9) Legends for Fig.S6E and S6F are flipped. Please correct.

      We apologize for this error. We have rectified the flipped captions for figure S6E and S6F in the revised manuscript.

      10) Variance should be provided for the IC50 values and kinetic parameters of the sodium channels in the supplemental tables.

      We thank the reviewer for raising this point. We have included the 95% confidence interval (95%CI) for the IC50 values and kinetic parameters in the revised supplementary tables.

      Additionally, we have corrected some equations in the methods section:

      1. Line 500 and line 503: We have corrected equation (1) by adding the parameter hill coefficient.

      2. Line 514: We have revised equation (4) from to

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this manuscript, authors have investigated the effects of JNK inhibition on sucrose-induced metabolic dysfunction in rats. They used multi-tissue network analysis to study the effects of the JNK inhibitor JNK-IN-5A on metabolic dysfunction associated with excessive sucrose consumption. Their results show that JNK inhibition reduces triglyceride accumulation and inflammation in the liver and adipose tissues while promoting metabolic adaptations in skeletal muscle. The study provides new insights into how JNK inhibition can potentially treat metabolic dysfunction-associated fatty liver disease (MAFLD) by modulating inter-tissue communication and metabolic processes.

      Strengths:

      The study has several notable strengths:

      Comprehensive Multi-Tissue Analysis: The research provides a thorough multi-tissue evaluation, examining the effects of JNK inhibition across key metabolically active tissues, including the liver, visceral white adipose tissue, skeletal muscle, and brain. This comprehensive approach offers valuable insights into the systemic effects of JNK inhibition and its potential in treating MAFLD.

      Robust Use of Systems Biology: The study employs advanced systems biology techniques, including transcriptomic analysis and genome-scale metabolic modeling, to uncover the molecular mechanisms underlying JNK inhibition. This integrative approach strengthens the evidence supporting the role of JNK inhibitors in modulating metabolic pathways linked to MAFLD.

      Potential Therapeutic Insights: By demonstrating the effects of JNK inhibition on both hepatic and extrahepatic tissues, the study offers promising therapeutic insights into how JNK inhibitors could be used to mitigate metabolic dysfunction associated with excessive sucrose Behavioral and Metabolic Correlation: The inclusion of behavioral tests alongside metabolic assessments provides a more holistic view of the treatment's effects, allowing for a better understanding of the broader physiological implications of JNK inhibition.

      Weaknesses:

      While the study provides a comprehensive evaluation of JNK inhibitors in mitigating MAFLD conditions, addressing the following points will enhance the manuscript's quality:

      The authors should explicitly mention and provide a detailed list of metabolites affected by sucrose and JNK inhibition treatment that have been previously associated with MAFLD conditions. This will better contextualize the findings within the broader field of metabolic disease research.

      We fully agreed on this constructive suggestion to improve our understanding of the metabolic effect of JNK inhibition under sucrose overconsumption. While technical limitations made it challenging to directly analyze metabolites in the current study, we employed genome-scale metabolic modeling—a robust approach for studying metabolism—to predict the metabolic pathways potentially impacted by the interventions (Fig. 7 and Data S8). Additionally, as part of this revision, we conducted an extensive literature review to identify metabolites previously reported to be affected by sucrose consumption in MAFLD rodent models and MASLD patients. A detailed summary of these metabolites is now presented in attached Table 1 and several of these metabolites have been incorporated into the revised results section (Lines 308-314) to support some of the predicted metabolic activities.

      “Some of the predicted metabolic changes align with previous findings in rodents subjected to sucrose overconsumption. For example, Öztürk et al. reported altered tryptophan metabolism, including decreased serum levels of kynurenic acid and kynurenine, in rats consuming 10% sucrose in drinking water. Similarly, increased triglyceride-bound oleate, palmitate, and stearate were observed in the livers of rats fed a 10% sucrose solution, indicating JNK-IN-5A treatment may regulate lipid metabolism by modulating these metabolic activities.”

      It is important to note, however, that data on metabolites specifically affected by JNK inhibition in MASLD contexts remains lacking in the literature. The predicted metabolites and associated metabolic pathways in the current study could provide a starting point for such exploration in future studies. We have emphasized this in the revised manuscript and highlighted the need for further studies to explore these mechanisms in greater detail.

      Author response table 1.

      Metabolites associated with sucrose overconsumption in MASLD.

      The limitations of the study should be clearly stated, particularly the lack of evidence on the effects of chronic JNK inhibitor treatment and potential off-target effects. Addressing these concerns will offer a more balanced perspective on the therapeutic potential of JNK inhibition.

      Thank you for this constructive comment. We have acknowledged limitations of the current study in Discussion section (Lines 397-406) of the revised manuscript:

      “Nevertheless, several limitations warrant consideration. First, while we observed transcriptional adaptations in skeletal muscle tissue following treatment, the exact molecular mechanisms underlying these changes and their roles in skeletal muscle function and systemic metabolic homeostasis remain unclear. Further investigation is warranted to elucidate the muscle-specific effects of JNK inhibition. Second, our study did not investigate the dosedependent or potential off-target effects of JNK-IN-5A, particularly its activity on other members of the kinase family and associated signaling pathways. Lastly, the long-term effects of JNKIN-5A administration remain unexplored. Understanding its prolonged impact across different stages of MAFLD, including advanced MASH, is crucial for assessing the full therapeutic potential of JNK inhibition in the treatment of MAFLD.“

      The potential risks of using JNK inhibitors in non-MAFLD conditions should be highlighted, with a clear distinction made between the preventive and curative effects of these therapies in mitigating MAFLD conditions. This will ensure the therapeutic implications are properly framed.

      Thank you for this insightful suggestion. The potential risks of using JNK inhibitors in nonMAFLD conditions have been considered and are now highlighted in Lines 369-390 of the revised discussion

      “Although overactivated JNK activity presents an attractive opportunity to combat MAFLD, inhibition of JNK presents substantial challenges and potential risks due to its broad and multifaceted roles in many cellular processes. One key challenge is the dual role of JNK signaling (Lamb et al., 2003). For instance, long-term JNK inhibition may disrupt liver regeneration, as JNK plays a critical role in liver repair by regulating hepatocyte proliferation and survival following injury or stress (Papa and Bubici, 2018). In HCC, it has been reported that JNK acts as both a tumor promoter, driving inflammation, fibrosis, and metabolic dysregulation, and a tumor suppressor, facilitating apoptosis and cell cycle arrest in damaged hepatocytes. Its inhibition, therefore, carries the risk of inadvertently promoting tumor progression under certain conditions (Seki et al., 2012). Furthermore, the differential roles of JNK isoforms (JNK1, JNK2, JNK3) and a lack of specificity of JNK inhibitors present another layer of complexity. Given these challenges, while our study demonstrated the potential of JNK-IN-5A in mitigating early metabolic dysfunction in the liver and adipose tissues, JNK targeting strategies should be carefully tailored to the disease stage under investigation. For curative approaches targeting advanced MAFLD, such as MASH, future studies are warranted to address considerations related to dosing, tissue specificity, and the long-term effects.”

      The statistical analysis section could be strengthened by providing a justification for the chosen statistical tests and discussing the study's power. Additionally, a more detailed breakdown of the behavioral test results and their implications would be beneficial for the overall conclusions of the study.

      We would like to thank you for this constructive suggestion. In this study, differences among more than two groups were tested using ANOVA or Kruskal-Wallis test based on the normality testing (Shapiro–Wilk test) on the data (continuous variables from different measurements). Pairwise comparisons, were performed using Tukey’s post hoc test following ANOVA or Dunn’s multiple comparisons post hoc test following the Kruskal-Wallis test, as appropriate. 

      The study used 11 animals per group, a group size widely used in preclinical animal research [13]. To evaluate the power of this study design to detect group differences, we conducted a power analysis using G*Power 3.1 software [14], with ANOVA used as an example. The power analysis revealed the following:

      - For a small effect size (partial eta.sq = 0.01), the power was 7.5% at 𝑝<0.05.

      - For a medium effect size (partial eta.sq = 0.06), the power was 23.7% at 𝑝<0.05.

      - For a large effect size (partial eta.sq = 0.14), the power is 55.4% at 𝑝<0.05

      Bonapersona et al. reported that the median statistical power in animal studies is often between 15–22% [15], the achieved power of the current study design is within the range observed in most exploratory animal research. However, we acknowledge that the power for detecting smaller effects within groups is limited, which is also a common challenge in animal research due to ethical considerations on increasing sample sizes.

      As suggested, we’ve revised the ‘Statistical Analysis’ and ‘Result’ sections to improve clarity:

      “Statistical Analysis:

      Data were shown as mean ± standard deviation (SD), unless stated otherwise. The assumption of normality for continuous variables from behavior test, biometric measurements, and plasm biochemistry was determined using the Shapiro–Wilk test. Differences among multiple groups were tested by ANOVA or, for data that were not normally distributed, the non-parametric Kruskal-Wallis test. Pairwise comparisons were performed using Tukey’s post hoc test following the ANOVA or Dunn’s multiple comparisons post hoc test following the Kruskal-Wallis test, as appropriate. The Jaccard index was used to evaluate the similarity and diversity of two gene sets, and a  hypergeometric test was used to test the significance of their overlap. All results were considered statistically significant at p < 0.05, unless stated otherwise.”

      Behavior tests (Lines 150-157):

      “We found no significant differences among groups in retention latencies, a measure of learning and memory abilities in passive avoidance test (Data S3). Additionally, the locomotor activity test was used to analyze behaviors such as locomotion, anxiety, and depression in rat. No significant differences were observed among groups in stereotypical movements, ambulatory activity, rearing, resting percentage, and distance travelled (Data S4). Similarly, the elevated plus maze test (Walf and Frye, 2007), an assay for assessing anxiety-like behavior in rodents, showed that rats in all groups had comparable open-arm entries and durations (Data S5). Collectively, the behavior tests indicate the JNK-IN-5A-treated rats exhibit no evidence of anxiety and behavior disorders.”

      Reviewer #2 (Public review):

      Summary:

      Excessive sucrose is a possible initial factor for the development of metabolic dysfunctionassociated fatty liver disease (MAFLD). To investigate the possibility that intervention with JNK inhibitor could lead to the treatment of metabolic dysfunction caused by excessive sucrose intake, the authors performed multi-organ transcriptomics analysis (liver, visceral fat (vWAT), skeletal muscle, and brain) in a rat model of MAFLD induced by sucrose overtake (+ a selective JNK2 and JNK3 inhibitor (JNK-IN-5A) treatment). Their data suggested that changes in gene expression in the vWAT as well as in the liver contribute to the pathogenesis of their MAFLD model and revealed that the JNK inhibitor has a cross-organ therapeutic effect on it.

      Strengths:

      (1)It has been previously reported that inhibition of JNK signaling can contribute to the prevention of hepatic steatosis (HS) and related metabolic syndrome in other models, but the role of JNK signaling in the metabolic disruption caused by excessive intake of sucrose, a possible initial factor for the development of MAFLD, has not been well understood, and the authors have addressed this point.

      (2)This study is also important because pharmacological therapy for MAFLD has not yet been established.

      (3)By obtaining transcriptomic data in multiple organs and comprehensively analyzing the data using gene co-expression network (GCN) analysis and genome-scale metabolic models (GEM), the authors showed the multi-organ interaction in not only in the pathology of MAFLD caused by excessive sucrose intake but also in the treatment effects by JNK-IN-5A.

      (4) Since JNK signaling has diverse physiological functions in many organs, the authors effectively assessed possible side effects with a view to the clinical application of JNK-IN-5A.

      Weaknesses:

      (1) The metabolic process activities were evaluated using RNA-seq results in Figure 7, but direct data such as metabolite measurements are lacking.

      Thank you for these valuable insights. We fully agree that direct metabolite measurements would provide a deeper understanding of the metabolic impact of sucrose overconsumption and JNK-IN-5A administration. Unfortunately, due to technical limitations, we were unable to directly measure metabolites in this study. To address this, we supported our genome-scale metabolic modeling predictions with an extensive literature review, which is summarized in attached Table 1. This table highlights key metabolites and associated metabolic pathways that have been previously associated with sucrose overconsumption in MAFLD contexts. We incorporated some of these metabolites into the revised results section (Lines 308–314) to demonstrate the consistency between our predicted metabolic changes and experimental findings from the literature. For instance, studies have reported altered tryptophan metabolism, including decreased serum kynurenic acid and kynurenine levels, as well as increased triglyceride-bound oleate, palmitate, and stearate in sucrose-fed rodents. These findings align with our predictions of altered metabolic activities in fatty acid oxidation, fatty acid synthesis, and tryptophan metabolism.

      (2) There is a lack of consistency in the data between JNK-IN-5A_D1 and _D2, and there is no sufficient data-based explanation for why the effects observed in D1 were inconsistent in the D2 samples.

      Thank you for raising this important point regarding the differences between the two dosages. As this was not the primary focus of the current study and we do not have sufficient data to fully explain these observations. Our speculation is that this may arise from pharmacokinetic differences associated with the dosing of this small molecule inhibitor, including potential saturation of transport mechanisms, alter tissue distribution, or off-target effects.

      (3) Although it is valuable that the authors were able to suggest the possibility of JNK inhibitor as a therapeutic strategy for MAFLD, the evaluation of the therapeutic effect was limited to the evaluation of plasma TG, LDH, and gene expression changes. As there was no evaluation of liver tissue images, it is unclear what changes were brought about in the liver by the excessive sucrose intake and the treatment with JNK-IN-5A.

      We acknowledge that the lack of histological evaluations may limit to having a complete picture of the interventions' effects. However, as you noted, our transcriptional and systems-wide investigation across multiple tissues provides novel and significant insights into the molecular and systemic impacts of JNK-IN-5A treatment.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      (1) It would be useful to explain why the authors conducted their research using female rats but not male rats.

      Thank you for raising this insightful point. We chose female rats for the current study was based on several considerations. 1) Previous research has demonstrated that female rats exhibit metabolic dysfunction (e.g., hypertriglyceridemia, liver steatosis, insulin resistance) in response to dietary factors, such as high-sucrose feeding [16-19]. These metabolic characteristics made them an appropriate model for assessing the in vivo effects of JNK inhibition under high-sucrose conditions. 2) It is also reported that female rats show resilience to high-sucrose-induced metabolic dysfunction due to the protective effects of estrogen [8], we aimed to determine whether JNK inhibition could provide therapeutic benefits in this context. This allows us to evaluate the effect of JNK inhibition even in metabolically advantaged groups. 3) Our results from the tolerance test (Fig. 2a) indicated that female rats displayed more fluctuating variation to JNK-IN-5A administration. This variation allowed us to evaluate how JNK inhibition influences metabolic outcomes in a sex that is more responsive to the intervention. Nonetheless, we emphasize the importance of future studies involving male rats to better understand sex-specific responses to JNK inhibition and to provide more comprehensive guidance for the development of JNK-targeting therapies in MAFLD treatment.

      (2) Figure 2C shows that JNK-IN-5A administration reduces the mRNA levels of Mapk8 and Mapk9 in the liver and the SkM. It would be useful to provide the authors' insight into the data. 

      In the liver, the data in Fig. 2c in original submission and the attached Fig. 1 show that sucrose feeding induces opposite alterations in the mRNA expression of Mapk8 (Jnk1, increased, log2FC<sub>SucrosevsControl</sub>= 0.02) and Mapk9 (Jnk2, decreased, log2FC<sub>SucrosevsControl</sub>= -0.43), though these changes do not reach statistical significance. JNK-IN-5A administration reverses these effects, significantly decreasing Mapk8 expression (log2FC<sub>Sucrose+JNK_D1vsSucrose</sub>= -0.37) while increasing Mapk9 expression (log2FC<sub>Sucrose+JNK_D1vsSucrose</sub>= 0.42). This suggests potential differential yet compensatory roles of these two isoforms in regulating JNK activity during these interventions in the liver, keeping in line with the findings from Jnk1- and/or Jnk2-specific knockout studies [20, 21]. Additionally, emerging evidence indicates that Jnk1 plays a major role in diet-induced liver fibrosis and metabolic dysfunction [22-25]. Therefore, the reduced Mapk8 expression following JNK-IN-5A administration may contribute to the observed improvements in liver metabolism.

      Author response image 1.

      The spearman correlation between expression levels of Mapk8

      In skeletal muscle, the primary site for insulin-stimulated glucose uptake, insulin signaling is crucial for maintaining metabolic homeostasis [26]. Numerous studies have demonstrated that JNK activation promotes insulin resistance and targeting JNK might be a promising therapeutic strategy for the treatment of metabolic diseases associated with insulin resistance, such as MAFLD [24]. In our study, while sucrose overconsumption did not significantly alter the mRNA levels of JNK isoforms in this tissue, JNK-IN-5A at dosage 30 mg/kg/day administration significantly reduced the expression of both Jnk1 and Jnk2 as well as genes involved in insulin signaling (Fig. 5). This suggests a potential interplay between JNK inhibition and insulin signaling pathways in the skeletal muscle, where inhibition of JNK activity may improve insulin sensitivity by modulating these pathways. However, it is also crucial  to investigate the longterm effects of JNK-IN-5A administration and its broader impact on many other physiological processes regulated by the JNK pathway. These aspects will be a focus of our future studies.

      (3) The notations a and b in Figure S5 are missing.  

      Thank you for this constructive comment. We have corrected this in the revised figure S5.

      (4) Data S13 described in the figure legend for Figure 7 (lines 630 and 632) seems a mistake and should be Data S8.

      (5) The notations a, b, and c in Figure 7 are incorrect. The figure legend for Figure 7a doesn't seem to match the figure contents.

      We appreciate your attention to details regarding Fig. 7. We have corrected the reference and the figure legend in revised Fig. 7.

      Reference

      (1) Fujii, A., et al., Sucrose Solution Ingestion Exacerbates DinitrofluorobenzeneInduced Allergic Contact Dermatitis in Rats. Nutrients, 2024. 16(12).

      (2) Sun, S., et al., High sucrose diet-induced dysbiosis of gut microbiota promotes fatty liver and hyperlipidemia in rats. J Nutr Biochem, 2021. 93: p. 108621.

      (3) Qi, S., et al., Inositol and taurine ameliorate abnormal liver lipid metabolism induced by high sucrose intake. Food Bioscience, 2024. 60: p. 104368.

      (4) Ramos-Romero, S., et al., The Buckwheat Iminosugar d-Fagomine Attenuates Sucrose-Induced Steatosis and Hypertension in Rats. Mol Nutr Food Res, 2020. 64(1): p. e1900564.

      (5) Ortiz, S.R. and M.S. Field, Sucrose Intake Elevates Erythritol in Plasma and Urine in Male Mice. J Nutr, 2023. 153(7): p. 1889-1902.

      (6) Beckmann, M., et al., Changes in the human plasma and urinary metabolome associated with acute dietary exposure to sucrose and the identification of potential biomarkers of sucrose intake. Mol Nutr Food Res, 2016. 60(2): p. 444-57.

      (7) He, X., et al., High Fat Diet and High Sucrose Intake Divergently Induce Dysregulation of Glucose Homeostasis through Distinct Gut Microbiota-Derived Bile Acid Metabolism in Mice. J Agric Food Chem, 2024. 72(1): p. 230-244.

      (8) Stephenson, E.J., et al., Chronic intake of high dietary sucrose induces sexually dimorphic metabolic adaptations in mouse liver and adipose tissue. Nat Commun, 2022. 13(1): p. 6062.

      (9) Mock, K., et al., High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation. J Nutr Biochem, 2017. 39: p. 32-39.

      (10) Eryavuz Onmaz, D. and B. Ozturk, Altered Kynurenine Pathway Metabolism in Rats Fed Added Sugars. Genel Tıp Dergisi, 2022. 32(5): p. 525-529.

      (11) Gariani, K., et al., Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology, 2016. 63(4): p. 1190-204.

      (12) Togo, J., et al., Impact of dietary sucrose on adiposity and glucose homeostasis in C57BL/6J mice depends on mode of ingestion: liquid or solid. Mol Metab, 2019. 27: p. 22-32.

      (13) Arifin, W.N. and W.M. Zahiruddin, Sample Size Calculation in Animal Studies Using Resource Equation Approach. Malays J Med Sci, 2017. 24(5): p. 101-105.

      (14) Faul, F., et al., G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods, 2007. 39(2): p. 175-91.

      (15) Bonapersona, V., et al., Increasing the statistical power of animal experiments with historical control data. Nat Neurosci, 2021. 24(4): p. 470-477.

      (16) Kendig, M.D., et al., Metabolic EYects of Access to Sucrose Drink in Female Rats and Transmission of Some EYects to Their OYspring. PLoS One, 2015. 10(7): p. e0131107.

      (17) Harris, R.B.S., Source of dietary sucrose influences development of leptin resistance in male and female rats. Am J Physiol Regul Integr Comp Physiol, 2018. 314(4): p. R598-R610.

      (18) Velasco, M., et al., Sexual dimorphism in insulin resistance in a metabolic syndrome rat model. Endocr Connect, 2020. 9(9): p. 890-902.

      (19) Maniam, J., C.P. Antoniadis, and M.J. Morris, The eYect of early-life stress and chronic high-sucrose diet on metabolic outcomes in female rats. Stress, 2015. 18(5): p. 524-37.

      (20) Singh, R., et al., DiYerential eYects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology, 2009. 49(1): p. 87-96.

      (21) Sabapathy, K., et al., Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell, 2004. 15(5): p. 713-25.

      (22) Zhao, G., et al., Jnk1 in murine hepatic stellate cells is a crucial mediator of liver fibrogenesis. Gut, 2014. 63(7): p. 1159-72.

      (23) Czaja, M.J., JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab, 2010. 21(12): p. 707-13.

      (24) Solinas, G. and B. Becattini, JNK at the crossroad of obesity, insulin resistance, and cell stress response. Mol Metab, 2017. 6(2): p. 174-184.

      (25) Schattenberg, J.M., et al., JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology, 2006. 43(1): p. 163-72.

      (26) Sylow, L., et al., The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia. Cell Metab, 2021. 33(4): p. 758-780.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public Review):

      The study starts with the notion that in an AD-like disease model, ILC2s in the Rag1 knockout were expanded and contained relatively more IL-5<sup>+</sup> and IL-13<sup>+</sup> ILC2s. This was confirmed in the Rag2 knock-out mouse model.

      By using a chimeric mouse model in which wild-type knock-out splenocytes were injected into irradiated Rag1 knock-out mice, it was shown that even though the adaptive lymphocyte compartment was restored, there were increased AD-like symptoms and increased ILC2 expansion and activity. Moreover, in the reverse chimeric model, i.e. injecting a mix of wild-type and Rag1 knock-out splenocytes into irradiated wild-type animals, it was shown that the Rag1 knock-out ILC2s expanded more and were more active. Therefore, the authors could conclude that the RAG1 mediated effects were ILC2 cell-intrinsic.

      Subsequent fate-mapping experiments using the Rag1Cre;reporter mouse model showed that there were indeed RAGnaïve and RAGexp ILC2 populations within naïve mice. Lastly, the authors performed multi-omic profiling, using single-cell RNA sequencing and ATACsequencing, in which a specific gene expression profile was associated with ILC2. These included well-known genes but the authors notably also found expression of Ccl1 and Ccr8 within the ILC2. The authors confirmed their earlier observations that in the RAGexp ILC2 population, the Th2 regulome was more suppressed, i.e. more closed, compared to the RAGnaïve population, indicative of the suppressive function of RAG on ILC2 activity. I do agree with the authors' notion that the main weakness was that this study lacks the mechanism by which RAG regulates these changes in ILC2s.

      The manuscript is very well written and easy to follow, and the compelling conclusions are well supported by the data. The experiments are meticulously designed and presented. I wish to commend the authors for the study's quality.

      Even though the study is compelling and well supported by the presented data, some additional context could increase the significance:

      (1) The presence of the RAGnaïve and RAGexp ILC2 populations raises some questions on the (different?) origin of these populations. It is known that there are different waves of ILC2 origin (most notably shown in the Schneider et al Immunity 2019 publication, PMID 31128962). I believe it would be very interesting to further discuss or possibly show if there are different origins for these two ILC populations.

      Several publications describe the presence and origin of ILC2s in/from the thymus (PMIDs 33432227 24155745). Could the authors discuss whether there might be a common origin for the RAGexp ILC2 and Th2 cells from a thymic lineage? If true that the two populations would be derived from different populations, e.g. being the embryonic (possibly RAGnaïve) vs. adult bone marrow/thymus (possibly RAGexp), this would show a unique functional difference between the embryonic derived ILC2 vs. adult ILC2.

      We agree with the Reviewer that our findings raise important questions about ILC ontogeny. These are areas of ongoing investigation for us, and it is our hope this study may inform further investigation by others as well.

      Regarding the Schneider et al study, we have considered the possibility that RAG expression may mark a particular wave of ILC2 origin. In that study, the authors used a tamoxifen-based inducible Cre strategy in their experiments to precisely time the lineage tracing of a reporter from the Rosa26 locus. Those lineage tracing mice would overlap genetically with the RAG lineage tracing mice we used in our current study, thus performing combined timed migration fate mapping and RAG fate mapping experiments would require creating novel mouse strains.

      Similarly, the possible influence of the thymic or bone marrow environment on RAG expression in ILCs is an exciting possibility. Perhaps there are signals common to those environments that can influence all developing lymphocytes, including not only T and B cells but also ILCs, with one consequence being induction of RAG expression. While assessing levels of RAG-experienced ILCs in these tissues using our lineage tracing mouse may hint at these possibilities, conclusive evidence would require more precise control over the timing of RAG lineage tracing than our current reagents allow (e.g. to control for induction in those environments vs migration of previously fate-mapped cells to those environments).

      To answer these questions directly, we are developing orthogonal lineage tracing mouse strains, which can report on both timing of ILC development and RAG expression, but these mice are not available yet. Given the limitations of our currently available reagents, we were careful to focus our manuscript on the skin phenotype and the more descriptive aspects of the RAG-induced phenotype. We have elaborated on these important questions and referenced all the studies noted by the Reviewer in the Discussion section as areas of future inquiry on lines 421-433.  

      (2) On line 104 & Figures 1C/G etc. the authors describe that in the RAG knock-out ILC2 are relatively more abundant in the lineage negative fraction. On line 108 they further briefly mentioned that this observation is an indication of enhanced ILC2 expansion. Since the study includes an extensive multi-omics analysis, could the authors discuss whether they have seen a correlation of RAG expression in ILC2 with regulation of genes associated with proliferation, which could explain this phenomenon?

      We thank the Reviewer for pointing out this opportunity to further correlate our functional and multiomic findings. To address this, we first looked deeper into our prior analyses and found that among the pathways enriched in GSEA analysis of differentially expressed genes (DEGs) between RAG<sup>+</sup> and RAG<sup>-</sup> ILC2s, one of the pathways suppressed in RAG<sup>+</sup> ILC2s was “GOBP_EPITHELIAL_CELL_PROLIFERATION.”

      ( Author response image 1). There are a few other gene sets present in other databases such as MSigDB with terms including “proliferation,” but these are often highly specific to a particular cell type and experimental or disease condition (e.g. tissue-specific cancers). We did not find any of these enriched in our GSEA analysis.

      Author response image 1.

      GSEA plot of GOBP epithelial proliferation pathway in RAG-experienced vs RAG-naïve ILC2s.

      The ability to predict cellular proliferation states from transcriptomic data is an area of active research, and there does not appear to be any universally accepted method to do this reliably. We found two recent studies (PMIDs 34762642; 36201535) that identified novel “proliferation signatures.” Since these gene sets are not present in any curated database, we repeated our GSEA analysis using a customized database with the addition of these gene sets. However, we did not find enrichment of these sets in our RAG+/- ILC2 DEG list. We also applied our GPL strategy integrating analysis of our epigenomic data to the proliferation signature genes, but we did not see any clear trend. Conversely, our GSEA analysis did not identify any enrichment for apoptotic signatures as a potential mechanism by which RAG may suppress ILC2s.

      Notwithstanding the limitations of inferring ILC2 proliferation states from transcriptomic and epigenomic data, our experimental data suggest RAG exerts a suppressive effect on ILC2 proliferation. To formally test the hypothesis that RAG suppresses proliferation in the most rigorous way, we feel new mouse strains are needed that allow simultaneous RAG fate mapping and temporally restricted fate mapping. We elaborate on this in new additions to the discussion on lines 421-433.

      Reviewer #2 (Public Review):

      Summary:

      The study by Ver Heul et al., investigates the consequences of RAG expression for type 2 innate lymphoid cell (ILC2) function. RAG expression is essential for the generation of the receptors expressed by B and T cells and their subsequent development. Innate lymphocytes, which arise from the same initial progenitor populations, are in part defined by their ability to develop in the absence of RAG expression. However, it has been described in multiple studies that a significant proportion of innate lymphocytes show a history of Rag expression. In compelling studies several years ago, members of this research team revealed that early Rag expression during the development of Natural Killer cells (Karo et al., Cell 2014), the first described innate lymphocyte, had functional consequences.

      Here, the authors revisit this topic, a worthwhile endeavour given the broad history of Rag expression within all ILCs and the common use of RAG-deficient mice to specifically assess ILC function. Focusing on ILC2s and utilising state-of-the-art approaches, the authors sought to understand whether early expression of Rag during ILC2 development had consequences for activity, fitness, or function. Having identified cell-intrinsic effects in vivo, the authors investigated the causes of this, identifying epigenetic changes associated with the accessibility genes associated with core ILC2 functions.

      The manuscript is well written and does an excellent job of supporting the reader through reasonably complex transcriptional and epigenetic analyses, with considerate use of explanatory diagrams. Overall I think that the conclusions are fair, the topic is thoughtprovoking, and the research is likely of broad immunological interest. I think that the extent of functional data and mechanistic insight is appropriate.

      Strengths:

      - The logical and stepwise use of mouse models to first demonstrate the impact on ILC2 function in vivo and a cell-intrinsic role. Initial analyses show enhanced cytokine production by ILC2 from RAG-deficient mice. Then through two different chimeric mice (including BM chimeras), the authors convincingly show this is cell intrinsic and not simply as a result of lymphopenia. This is important given other studies implicating enhanced ILC function in RAG-/- mice reflect altered competition for resources (e.g. cytokines).

      - Use of Rag expression fate mapping to support analyses of how cells were impacted - this enables a robust platform supporting subsequent analyses of the consequences of Rag expression for ILC2.

      - Use of snRNA-seq supports gene expression and chromatin accessibility studies - these reveal clear differences in the data sets consistent with altered ILC2 function.

      - Convincing evidence of epigenetic changes associated with loci strongly linked to ILC2 function. This forms a detailed analysis that potentially helps explain some of the altered ILC2 functions observed in ex vivo stimulation assays.

      - Provision of a wealth of expression data and bioinformatics analyses that can serve as valuable resources to the field.

      We appreciate the strengths noted by the Reviewer for our study. We would like to especially highlight the last point about our single cell dataset and provision of supplemental data tables. Although our study is focused on AD-like skin disease and skin draining lymph nodes, we hope that our findings can serve as a valuable resource for future investigation into mechanisms of RAG modulation of ILC2s in other tissues and disease states.  

      Weaknesses:

      - Lack of insight into precisely how early RAG expression mediates its effects, although I think this is beyond the scale of this current manuscript. Really this is the fundamental next question from the data provided here.

      We thank the Reviewer for their recognition of the context of our current work and its future implications. We aimed to present compelling new observations within the scope of what our current data can substantiate. We believe answering the next fundamental question of the mechanisms by which RAG mediates its effects in ILC2s will require development of novel reagents. We are actively pursuing this, and we look forward to others building on our findings as well.

      - The epigenetic analyses provide evidence of differences in the state of chromatin, but there is no data on what may be interacting or binding at these sites, impeding understanding of what this means mechanistically.

      We thank the Reviewer for pointing out this aspect of the epigenomic data analysis and the opportunity to expand the scope of our manuscript. We performed additional analyses of our data to identify DNA binding motifs and infer potential transcription factors that may be driving the effects of a history of RAG expression that we observed. We hope that these additional data, analyses, and interpretation add meaningful insight for our readers.

      We first performed the analysis for the entire dataset and validated that the analysis yielded results consistent with prior studies (e.g. finding EOMES binding motifs as a marker in NK cells). Then, we examined the differences in RAG fate-mapped ILC2s. These analyses are in new Figure S10 and discussed on lines 277-316.  

      We also performed an analysis specifically on the Th2 locus, given the effects of RAG on type 2 cytokine expression. These analyses are in new Figure S12 and discussed on lines 366-378.

      - Focus on ILC2 from skin-draining lymph nodes rather than the principal site of ILC2 activity itself (the skin). This may well reflect the ease at which cells can be isolated from different tissues.

      We appreciate the Reviewer’s insight into the limitations of our study. Difficulties in isolating ILC2s from the skin were indeed a constraint in our study. In particular, we were unable to isolate enough ILC2s from the skin for stimulation and cytokine staining. Given that one of our main hypotheses was that RAG affects ILC2 function, we focused our studies on skin draining lymph nodes, which allowed measurement of the two main ILC2 functional cytokines, IL-5 and IL-13, as readouts in the key steady state and AD-like disease experiments.

      - Comparison with ILC2 from other sites would have helped to substantiate findings and compensate for the reliance on data on ILC2 from skin-draining lymph nodes, which are not usually assessed amongst ILC2 populations.

      We agree with the Reviewer that a broader survey of the RAG-mediated phenotype in other tissues and by extension other disease models would strengthen the generalizability of our observations. Indeed, we did a more expansive survey of tissues in our BM chimera experiments. We found a similar trend to our reported findings in the sdLN in tissues known to be affected by ILC2s ( Author response image 2) including the skin and lung and in other lymphoid tissues including spleen and mesenteric lymph nodes (mLN). We found that donor reconstitution in each tissue was robust except for the skin, where there was no significant difference between host and -donor CD45<sup>+</sup> immune cells and where CD45<sup>-</sup> parenchymal cells predominated ( Author response image 2A,C,E,G,I). This may explain why Rag1<sup>-/-</sup> donor ILC2s were significantly higher in proportion in all tissues except the skin, where we observed a similar trend that was not statistically significant ( Author response image 2B,D,F,H,J).

      Notwithstanding these results, given that we unexpectedly observed enhanced AD-like inflammation in the MC903 model in Rag1 KO mice, we concentrated our later experiments and analyses on defining the differences in skin draining ILC2s modulated by RAG. Our subsequent findings in the skin provoke many new hypotheses about the role of RAG in ILC2s in other tissues, and our tissue survey in the BM chimera provides additional rationale to pursue similar studies in disease models in other tissues. While this is an emerging area of investigation in our lab, we opted to focus this manuscript on our findings related to the AD-like disease model. We have ongoing studies to investigate other tissues, and we are still in the early stages of developing disease models to expand on these findings. However, if the reviewer feels strongly this additional data should be included in the manuscript, we are happy to add it. Considering the complexity of the data and concepts in the manuscript, we hoped to keep it focused to where we have strong molecular, cellular, and phenotypic outcomes.

      Author response image 2.

      Comparison of immune reconstitution in and ILC2 donor proportions in different tissues from BM chimeras. Equal quantities of bone marrow cells from Rag1<sup>-/-</sup> (CD45.2,CD90.2) and WT (CD45.2, CD90.1) C57Bl/6J donor mice were used to reconstitute the immune systems of irradiated recipient WT (CD45.1) C57Bl/6J mice. The proportion of live cells that are donor-derived (CD45.2), host-derived (CD45.1), or parenchymal (CD45-) [above] and proportion of ILC2s that are from Rag1<sup>-/-</sup> (CD90.2) or WT (CD90.1) donors [below] for A,B) skin C,D) sdLN E,F) lung G,H) spleen and I,J) mLN.

      - The studies of how ILC2 are impacted are a little limited, focused exclusively on IL-13 and IL-5 cytokine expression.

      We agree with the reviewer that our functional readout on IL-5 and IL-13 is relatively narrow. However, this focused experimental design was based on several considerations. First, IL-5 and IL-13 are widely recognized as major ILC2 effector molecules (Vivier et al, 2018, PMID 30142344). Second, in the MC903 model of AD-like disease, we have previously shown a clear correlation between ILC2s, levels of IL-5 and IL-13, and disease severity as measured by ear thickness (Kim et al, 2013, PMID 23363980). Depletion of ILC2s led to decreased levels of IL-13 and IL-5 and correspondingly reduced ear inflammation. However, while ILC2s are also recognized to produce other effector molecules such as IL-9 and Amphiregulin, which are likely involved in human atopic dermatitis (Namkung et al, 2011, PMID 21371865; Rojahn et al, 2020, PMID 32344053), there is currently no evidence linking these effectors to disease severity in the MC903 model. Third, IL-13 is emerging as a key cytokine driving atopic dermatitis in humans (Tsoi et al, 2019, PMID 30641038). Drugs targeting the IL-4/IL-13 receptor (dupilumab), or IL-13 itself (tralokinumab, lebrikizumab), have shown clear efficacy in treating atopic dermatitis. Interestingly, drugs targeting more upstream molecules, like TSLP (tezepelumab) or IL-33 (etokimab), have failed in atopic dermatitis. Taken together, these findings from both mouse and human studies suggest IL-13 is a critical therapeutic target, and thus functional readout, in determining the clinical implications of type 2 immune activation in atopic dermatitis.

      Aside from effector molecules, other readouts such as surface receptors may be of interest in understanding the mechanism of how RAG influences ILC2 function. For example, IL-18 has been shown to be an important co-stimulatory molecule along with TSLP in driving production of IL-13 by cutaneous ILC2s (Ricardo-Gonzalez et al, 2018, PMID 30201992). Our multiomic analysis showed decreased IL-18 receptor regulome activity in RAG-experienced ILC2s, which may be a mechanism by which RAG suppresses IL-13 production. Ultimately, in that study the role of IL-18 in enhancing MC903-induced inflammation through ILC2s was via increased production of IL-13, which was one of our major functional readouts. To clearly define mechanisms like these will require generation of new mice to interrogate RAG status in the context of tissue-specific knockout of other genes, such as the IL-18 receptor. We plan to perform these types of experiments in follow up studies. Notwithstanding this, we have now included additional discussion on lines 476508 to highlight why understanding how RAG impacts other regulatory and effector pathways would be an interesting area of future inquiry.

      Reviewer #3 (Public Review):

      In this study, Ver Heul et al. investigate the role of RAG expression in ILC2 functions. While RAG genes are not required for the development of ILCs, previous studies have reported a history of expression in these cells. The authors aim to determine the potential consequences of this expression in mature cells. They demonstrate that ILC2s from RAG1 or RAG2 deficient mice exhibit increased expression of IL-5 and IL-13 and suggest that these cells are expanded in the absence of RAG expression. However, it is unclear whether this effect is due to a direct impact of RAG genes or a consequence of the lack of T and B cells in this condition. This ambiguity represents a key issue with this study: distinguishing the direct effects of RAG genes from the indirect consequences of a lymphopenic environment.

      The authors focus their study on ILC2s found in the skin-draining lymph nodes, omitting analysis of tissues where ILC2s are more enriched, such as the gut, lungs, and fat tissue. This approach is surprising given the goal of evaluating the role of RAG genes in ILC2s across different tissues. The study shows that ILC2s derived from RAG-/- mice are more activated than those from WT mice, and RAG-deficient mice show increased inflammation in an atopic dermatitis (AD)-like disease model. The authors use an elegant model to distinguish ILC2s with a history of RAG expression from those that never expressed RAG genes. However, this model is currently limited to transcriptional and epigenomic analyses, which suggest that RAG genes suppress the type 2 regulome at the Th2 locus in ILC2s.

      We agree with the Reviewer that understanding the role of RAG in ILC2s across different tissues is an important goal. One of the primary inspirations for our paper was the clinical paradox that patients with Omenn syndrome, despite having profound adaptive T cell deficiency, develop AD with much greater penetrance than in the general population. Thus, there was always an appreciation for the likelihood that skin ILC2s have a unique proclivity towards the development of AD-like disease. Notwithstanding this, given the profound differences that can be found in ILC2s based on their tissue residence and disease state (as the Reviewer also points out below), we focused our investigations on characterizing the skin draining lymph nodes to better define factors underlying our initial observations of enhanced AD-like disease in Rag1<sup>-/-</sup> mice. While our findings in skin provoke the hypothesis that similar effects may be observed in other tissues and influence corresponding disease states, we were cautious not to suggest this may be the case by reporting surveys of other tissues without development of additional disease models to formally test these hypotheses. We present this manuscript now as a short, skin-focused study, rather than delaying publication to expand its scope. Truthfully, this project started in 2015 and has undergone many delays with the hopes of newer technologies and reagents coming to add greater clarity. We hope our study will enable others to pursue the goal of understanding the broader effects of RAG in ILC2s, and potentially other innate lymphoid lineages as well.

      We did a more expansive survey of tissues in our BM chimera experiments. We found a similar trend to our reported findings in the sdLN in tissues known to be affected by ILC2s ( Author response image 2) including the skin and lung and in other lymphoid tissues including spleen and mesenteric lymph nodes (mLN). We found that donor reconstitution in each tissue was robust except for the skin, where there was no significant difference between host and donor CD45<sup>+</sup> immune cells and where CD45<sup>-</sup> parenchymal cells predominated ( Author response image 2A,C,E,G,I). This may explain why Rag1<sup>-/-</sup> donor ILC2s were significantly higher in proportion in all tissues except the skin, where we observed a similar trend that was not statistically significant ( Author response image 2B,D,F,H,J). However, given the lack of correlation to disease readouts in other organ systems, we chose to not include this data in our manuscript. However, if the Reviewer feels these data should be included, we would be happy to include as a supplemental figure.

      The authors report a higher frequency of ILC2s in RAG-/- mice in skin-draining lymph nodes, which is expected as these mice lack T and B cells, leading to ILC expansion. Previous studies have reported hyper-activation of ILCs in RAG-deficient mice, suggesting that this is not necessarily an intrinsic phenomenon. For example, RAG-/- mice exhibit hyperphosphorylation of STAT3 in the gut, leading to hyperactivation of ILC3s. This study does not currently provide conclusive evidence of an intrinsic role of RAG genes in the hyperactivation of ILC2s. The splenocyte chimera model is artificial and does not reflect a normal environment in tissues other than the spleen. Similarly, the mixed BM model does not demonstrate an intrinsic role of RAG genes, as RAG1-/- BM cells cannot contribute to the B and T cell pool, leading to an expected expansion of ILC2s. As the data are currently presented it is expected that a proportion of IL-5-producing cells will come from the RAG1/- BM.

      The Reviewer raises an important point about the potential cell-intrinsic roles of RAG vs the many cell-extrinsic explanations that could affect ILC2 populations, with the most striking being the lack of T and B cells in RAG knockout mice. It is well-established that splenocyte transfer into T and B cell-deficient mice reconstitutes T cell-mediated effects (such as the T cell transfer colitis model pioneered by Powrie and others), and we were careful in our interpretation of the splenocyte chimera experiment to conclude only that lack of Tregs was unlikely to explain the enhanced ADlike disease in T (and B) cell-deficient mice.

      We agree with the Reviewer that the Rag1<sup>-/-</sup> BM will not contribute to the B and T cell pool. However, BM from the WT mice would be expected to contribute to development of the adaptive lymphocyte pool. Indeed, we found that most of the CD45<sup>+</sup> immune cells in the spleens of BM chimera mice were donor-derived ( Author response image 3A), and total levels of B cells and T cells showed reconstitution in a pattern similar to control spleens from donor WT mice, while spleens from donor Rag1<sup>-/-</sup> mice expectedly had essentially no detectable adaptive lymphocytes ( Author response image 3B-D). From this, we concluded the BM chimera experiment was successful in establishing an immune environment with the presence of adaptive lymphocytes, and the differences in ILC2 proportions we observed were in the context of developing alongside a normal number of B and T lymphocytes. Notwithstanding the potential role of the adaptive lymphocyte compartment in shaping ILC2 development, since we transplanted equal amounts of WT and Rag1<sup>-/-</sup> BM into the same recipient environment, we are not able to explain how cell-extrinsic effects alone would account for the unequal numbers of WT vs Rag1<sup>-/-</sup> ILC2s we observed after immune reconstitution.

      Author response image 3.

      Comparison of immune reconstitution in BM chimeras to controls. Equal quantities of bone marrow cells from Rag1<sup>-/-</sup> (CD45.2) and WT (CD45.2) C57Bl/6J donor mice were used to reconstitute the immune systems of irradiated recipient WT (CD45.1) C57Bl/6J mice. A) Number of WT recipient CD45.1+ immune cells in the spleens of recipient mice compared to number of donor CD45.2+ cells (WT and Rag1<sup>-/-</sup>) normalized to 100,000 live cells. Comparison of numbers of B cells, CD4+ T cells, and CD8+ T cells in spleens of B) BM chimera mice, C) control WT mice and D) control Rag1<sup>-/-</sup> mice.

      We also subsequently found transcriptional and epigenomic differences in RAG-experienced ILC2s compared to RAG-naïve ILC2s. Critically, these differences were present in ILC2s from the same mice that had developed normally within an intact immune system, rather than in the setting of a BM transplant or a defective immune background such as in Rag1<sup>-/-</sup> mice.

      We recognize that there are almost certainly cell-extrinsic factors affecting ILC2s in Rag1<sup>-/-</sup> mice due to lack of B and T cells, and that BM chimeras are not perfect substitutes for simulating normal hematopoietic development. However, the presence of cell-extrinsic effects does not negate the potential contribution of cell-intrinsic factors as well, and we respectfully stand by our conclusion that our data support a role, however significant, for cell-intrinsic effects of RAG in ILC2s.

      Finally, the Reviewer mentions the interesting observation that gut ILC3s exhibit hyperphosphorylation of STAT3 in Rag1<sup>-/-</sup> mice compared to WT as an example of cell-extrinsic effects of RAG deficiency (we assume this is in reference to Mao et al, 2018, PMID 29364878 and subsequent work). We now reference this paper and have included additional discussion on how our observations of ILC2s may be generalizable to not only other organ systems, but also other ILC subsets, limitations on these generalizations, and future directions on lines 477-520.

      Overall, the level of analysis could be improved. Total cell numbers are not presented, the response of other immune cells to IL-5 and IL-13 (except the eosinophils in the splenocyte chimera mice) is not analyzed, and the analysis is limited to skin-draining lymph nodes.

      We thank the Reviewer for the suggestions to add rigor to our analysis. ILC2 populations are relatively rare, and we designed our experiments to assess frequencies, rather than absolute numbers. We did not utilize counting beads, so our counts may not be comparable between samples. We have added additional data for absolute cell counts normalized to 100,000 live cells for each experiment (see below for a summary of new panels in each figure). Our new data on total cell numbers are consistent with the initial observations regarding frequency of ILC2s we reported from our experiments. For the BM chimera experiments, we presented the proportions of ILC2s, and IL-5 and IL-13 positive ILC2s, by donor source, as this is the critical question of the experiment. Notwithstanding our analysis by proportion, we found that the frequency of Rag1<sup>-/-</sup> ILC2s, IL-5<sup>+</sup> cells, or IL-13<sup>+</sup> cells within Lin- population was also significantly increased. While our initial submission included only the proportions for clarity and simplicity, we now include frequency and absolute numbers in new panels for more critical appraisal of our data by readers.

      In New Figure 1, we added new panels for ILC2 cell number in both the AD-like disease experiment (C) and in steady state (H).

      In New Figure S2, we added a panel for ILC2 cell number in steady state (B).

      In Figure 2 and associated supplemental data in Figure S4, we added several more panels. For the splenocyte chimera, we added a panel for ILC2 cell number in New Figure 2C.

      We incorporated multiple new panels in New Figure S4 to address the need for more data to be shown for the BM chimera (also requested by Reviewer #2). These included total cell counts and frequency for ILC2 (New Figure S4F,G), and IL-5<sup>+</sup> (New Figure S4I,K) and IL-13<sup>+</sup> (New Figure S4J,L) ILCs in addition to the proportions originally presented in Figure 2.  

      In terms of the limited analysis of other tissues, our initial observation of enhanced AD-like disease in Rag1<sup>-/-</sup> compared to WT mice built on our prior work elucidating the role of ILC2s in the MC903 model of AD-like disease in mice and AD in humans (Kim et al, 2013, PMID 23363980). Consequently, we focused on the skin to further develop our understanding of the role of RAG1 in this model. As in our prior studies, technical limitations in obtaining sufficient numbers of ILC2s from the skin itself for ex vivo stimulation to assess effector cytokine levels required performing these experiments in the skin draining lymph nodes.

      We agree that IL-5 and IL-13 are major mediators of type 2 pathology and studying their effects on immune cells is an important area of inquiry, particularly since there are multiple drugs available or in development targeting these pathways. However, our goal was not to study what was happening downstream of increased cytokine production from ILC2s, but instead to understand what was different about RAG-deficient or RAG-naïve ILC2s themselves that drive their expansion and production of effector cytokines compared to RAG-sufficient or RAGexperienced ILC2s. By utilizing the same MC903 model in which we previously showed a critical role for ILC2s in driving IL-5 and IL-13 production and subsequent inflammation in the skin, we were able to instead focus on defining the cell-intrinsic aspects of RAG function in ILC2s.

      The authors have a promising model in which they can track ILC2s that have expressed RAG or not. They need to perform a comprehensive characterization of ILC2s in these mice, which develop in a normal environment with T and B cells. Approximately 50% of the ILC2s have a history of RAG expression. It would be valuable to know whether these cells differ from ILC2s that never expressed RAG, in terms of proliferation and expression of IL5 and IL-13. These analyses should be conducted in different tissues, as ILC2s adapt their phenotype and transcriptional landscape to their environment. Additionally, the authors should perform their AD-like disease model in these mice.

      We agree with the Reviewer (and a similar comment from Reviewer #2) that a broader survey of the RAG-mediated phenotype in other tissues and by extension other disease models would strengthen the generalizability of our observations. Indeed, we did a more expansive survey of tissues in our BM chimera experiments. We found a similar trend to our reported findings in the sdLN in tissues known to be affected by ILC2s ( Author response image 2) including the skin and lung and in other lymphoid tissues including spleen and mesenteric lymph nodes (mLN). We found that donor reconstitution in each tissue was robust except for the skin, where there was no significant difference between host and donor CD45<sup>+</sup> immune cells and where CD45<sup>-</sup> parenchymal cells predominated (Author response image 2A,C,E,G,I). This may explain why Rag1<sup>-/-</sup> donor ILC2s were significantly higher in proportion in all tissues except the skin, where we observed a similar trend that was not statistically significant (Author response image 2B,D,F,H,J). We omitted these analyses to maintain the focus on the skin, but we will be happy to add this data to the manuscript if the Reviewer feels this figure should be helpful.

      Notwithstanding these results, given that we unexpectedly observed enhanced AD-like inflammation in the MC903 model in Rag1 KO mice, we concentrated our later experiments and analyses on defining the differences in skin draining ILC2s modulated by RAG. Our subsequent findings in the skin provoke many new hypotheses about the role of RAG in ILC2s in other tissues, and our tissue survey in the BM chimera provides additional rationale to pursue similar studies in disease models in other tissues. While this is an emerging area of investigation in our lab, we opted to focus this manuscript on our findings related to the AD-like disease model. We have ongoing studies to investigate other tissues, and we are still in the early stages of developing disease models to expand on these findings. However, if the reviewer feels strongly this additional data should be included in the manuscript, we are happy to add it. Considering the complexity of the data and concepts in the manuscript, we hoped to keep it focused to where we have strong molecular, cellular, and phenotypic outcomes. We elaborate on the implications of our work for future studies, including limitations of our study and currently available reagents and need for new mouse strains to rigorously answer these questions on lines 476-508

      The authors provide a valuable dataset of single-nuclei RNA sequencing (snRNA-seq) and ATAC sequencing (snATAC-seq) from RAGexp (RAG fate map-positive) and RAGnaïve (RAG fate map-negative) ILC2s. This elegant approach demonstrates that ILC2s with a history of RAG expression are epigenomically suppressed. However, key genes such as IL-5 and IL-13 do not appear to be differentially regulated between RAGexp and RAGnaïve ILC2s according to Table S5. Although the authors show that the regulome activity of IL-5 and IL-13 is decreased in RAGexp ILC2s, how do the authors explain that these genes are not differentially expressed between the RAGexp and RAGnaïve ILC2? I think that it is important to validate this in vivo.

      We thank the Reviewer for highlighting the value and possible elegance of our data. The Reviewer brings up an important issue that we grappled with in this study and that highlights a major technical limitation of single cell sequencing studies. Genes for secreted factors such as cytokines are often transcribed at low levels and are poorly detected in transcriptomic studies. This is particularly true in single cell studies with lower sequencing depth. Various efforts have been made to overcome these issues such as computational approaches to estimate missing data (e.g. van Djik et al, 2018, PMID 29961576; Huang et al, 2018, PMID 29941873), or recent use of cytokine reporter mice and dial-out PCR to enhance key cytokine signals in sequenced ILCs (Bielecki et al, 2021, PMID 33536623). We did not utilize computational methods to avoid the risk of introducing artifacts into the data, and we did not perform our study in cytokine reporter mice. Thus, cytokines were poorly detected in our transcriptomic data, as evidenced by lack of identification of cytokines as markers for specific clusters (e.g. IL-5 for ILC2s) or significant differential expression between RAG-naïve and RAG-experienced ILC2s.

      However, the multiomic features of our data allowed a synergistic analysis to identify effects on cytokines. For example, transcripts for the IL-4 and IL-5 were not detected at a high enough level to qualify as marker genes of the ILC2 cluster in the gene expression (GEX) assay but were identified as markers for the ILC2 cluster in the ATAC-seq data in the differentially accessible chromatin (DA) assay. Using the combined RNA-seq and ATAC-seq gene to peak links (GPL) analyses, many GPLs were identified in the Th2 locus for ILC2s, including for IL-13, which was not identified as a marker for ILC2s by any of the assays alone. Thus, our combined analysis took advantage of the potential of multiomic datasets to overcome a general weakness inherent to most scRNAseq datasets.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      - Line 168; Reference 23 also showed expression in the NK cells, please add this reference to reference 24.

      We thank the reviewer for catching this oversight, and we have corrected it in the revised manuscript.

      - Please add the full names for GPL and sdLN in the text of the manuscript when first using these abbreviations. They are now only explained in the legends.

      We reviewed the manuscript text and found that we defined sdLNs for the first time on line 104. We defined GPLs for the first time on line 248. We believe these definitions are placed appropriately near the first references to the corresponding figures/analysis, but if the Reviewer believes we should move these definitions earlier, we are happy to do so.

      Reviewer #2 (Recommendations For The Authors):

      I would suggest that the following reanalyses would improve the clarity of the data:

      - Can ILC2 numbers, rather than frequency, be used (e.g. in Figure 1C, S2B, and so on). This would substantiate the data that currently relies on percentages.

      This was a weakness also noted by Reviewer #3. We have added data on ILC2 numbers for each experiment as outlined below:

      In New Figure 1, we added new panels for ILC2 cell number in both the AD-like disease experiment (C) and in steady state (H).

      In New Figure S2, we added a panel for ILC2 cell number in steady state (B).

      In Figure 2 and associated supplemental data in Figure S4, we added several more panels. For the splenocyte chimera, we added a panel for ILC2 cell number in New Figure 2C.

      We incorporated multiple new panels in New Figure S4 to address the need for more data to be shown for the BM chimera (also requested by Reviewer #2). These included total cell counts and frequency for ILC2 (New Figure S4F,G), and IL-5<sup>+</sup> (New Figure S4I,K) and IL-13<sup>+</sup> (New Figure S4J,L) ILCs in addition to the proportions originally presented in Figure 2.  

      - Can the authors provide data on IL-33R expression on sdLN ILC2s? Expression of ST-2 (IL-33R) does vary between ILC2 populations and is impacted by the digestion of tissue. All of the data provided here requires ILC2 to be IL-33R<sup>+</sup>. In the control samples, the ILC2 compartment is very scarce - in LNs, ILC2s are rare. The gating strategy with limited resolution of positive and negative cells in the lineage gate doesn't help this analysis.

      The Reviewer raises a valid point regarding the IL-33R marker and ILC2s. We designed our initial experiments to be consistent with our earlier observations of skin ILC2s, which were defined as CD45<sup>+</sup>Lin-CD90+CD25+IL33+, and the scarcity of skin draining lymph node ILC2s at steady state was consistent with our prior findings (Kim et al, 2013, PMID 23363980). We can include MFI data on IL-33R expression in these cells if the reviewer feels strongly that this would add to the manuscript, but we did not include other ILC2-specific markers in these experiments that would give us an alternative total ILC2 count to calculate frequency of IL-33R<sup>+</sup> ILC2s, which would also make the context of the IL-33 MFI difficult to interpret.

      Other studies defining tissue specific expression patterns in ILC2s have called into question whether IL-33R is a reliable marker to define skin ILC2s (Ricardo-Gonzalez et al, 2018, PMID 30201992). However, there is evidence for region-specific expression of IL-33R (Kobayashi et al, 2019, PMID 30712873), with ILC2s in the subcutis expressing high levels of IL-33R and both IL5 and IL-13, while ILC2s in the epidermis and dermis have low levels of IL-33R and IL-5 expression. In contrast to the Kobayashi et al study, Ricardo-Gonzalez et al sequenced ILC2s from whole skin, thus the region-specific expression patterns were not preserved, and the lower expression of IL-33R in the epidermis and dermis may have diluted the signal from the ILC2s in the subcutis. These may also be the ILC2s most likely to drain into the lymph nodes, which is the tissue on which we focused our analyses (consistent with our prior work in Kim et al, 2013).

      - In Figure 2 (related to 2H, 2I) can flow plots of the IL-5 versus IL-13 gated on either CD90.1+CD45.2+ or CD90.2+CD45.2+ ILC2 be shown? I.e. gate on the ILC2s and show cytokine expression, rather than the proportion of donor IL5/13. The proportion of donor ILC2 is shown to be significantly higher in 2G. Therefore gating on the cells of interest and showing on a cellular basis their ability to produce the cytokines would better make the point I think.

      We agree that this is important additional data to include. We have added flow plots of sdLN ILC2s from the BM chimera divided by donor genotype showing IL-5 and IL-13 expression in New Figure S4H.

      I assume the authors have looked and there is no obvious data, but does analysis of transcription factor consensus binding sequences in the open chromatin provide any new insight?

      The Reviewer also commented on this in the public review. As copied from our response above:

      We found that the most enriched sites in the ILC2 gene loci contained the consensus sequence GGGCGG (or its reverse complement), a motif recognized by a variety of zinc finger transcription factors (TFs). Predictions from our analyses predicted the KLF family of zinc finger TFs as most likely to be enriched at the identified open chromatin regions. To infer which KLFs might be occupying these sites in the RAG-experienced or RAG-naïve cells, we also assessed the expression levels of these identified TFs. Interestingly, KLF2 and KLF6 are more expressed in RAG-experienced ILC2s. KLF6 is a tumor suppressor (PMID: 11752579), and both KLF6 and KLF2 were recently shown to be markers of “quiescent-like” ILCs (PMID: 33536623). Further, upon analysis of the Th2 locus, the (A/T)GATA(A/G) consensus site (or reverse complement) was enriched in identified open chromatin at that locus. The algorithm predicted multiple TFs from the GATA family as possible binding partners, but expression analysis showed only GATA3 was highly expressed in ILC2s, consistent with what would be predicted from prior studies (PMID: 9160750).

      We have added this data in new Figure S10 and new Figure S12, with corresponding text in the Results section on lines 277-316 and lines 366-378.

      In terms of phrasing and presentation:

      - It would help to provide some explanation of why all analyses focus on the draining LNs rather than the actual site of inflammation (the ear skin). I do not think it appropriate to ask for data on this as this would require extensive further experimentation, but there should be some discussion on this topic. This feels relevant given that the skin is the site of inflammatory insult and ILC2 is present here. How the ILC2 compartment in the skindraining lymph nodes relates to those in the skin is not completely clear, particularly given the prevailing dogma that ILC2 are tissue-resident.

      Given limitations of assessing cytokine production of the relatively rare population of skin-resident ILC2s, we focused on the skin-draining lymph nodes (sdLN). Our findings in the current manuscript are consistent with our prior work in Kim et al, 2013 (PMID 23363980), and more recently in Tamari et al, 2024 (PMID 38134932), which demonstrated correlation of increased ILC2s in sdLN with increased skin inflammation in the MC903 model. Similarly, Dutton et al (PMID 31152090) have demonstrated expansion of the sdLN ILC2 pool in response to MC903-induced AD-like inflammation in mice. We elaborate on the implications of our work for future studies, including limitations of our study (including the focus on the sdLN), and currently available reagents and need for new mouse strains to rigorously answer these questions on lines 476-508

      - I think the authors should explicitly state that cytokine production is assessed after ex vivo restimulation (e.g. Lines 112-113).

      We have added this statement to the revised text.

      - I also think that it would help to be consistent with axis scales where analyses are comparable (e.g. Figure 1D vs Figure 1H).

      We agree with the Reviewer and we have adjusted the axes for consistency. The data remains unchanged, but axes are slightly adjusted in New Figure 1 (D&I, E&J, F&K) and New Figure S2 (C-E match New Figure 1 D-F). This same axis scaling scheme is carried forward to New Figure 2 (D-E) and New Figure S4 (G,K,L). New data on cell counts is also included per request by Reviewers 2 and 3 (see above). However, we found results for total cells, including ILC2s (New Figure 1C,H, New Figure S2B, New Figure 2C, New Figure S4F), were consistent within experiments, but not between experiments, likely representing issues with normalizing counts (we did not include counting beads for more accurate total counts). Thus, the y-axes in those panels are not consistent between experiments/figures.

      We feel reporting the proportion of WT vs Rag1<sup>-/-</sup> donor cells for the BM chimera is most illustrative of the effect of RAG and have kept it in the main New Figure 2, but for the BM chimera experiment panels we also include the total counts of IL-5<sup>+</sup> and IL-13<sup>+</sup> ILC2s (New Figure S4I,J).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Given that KRAS inhibition approaches are a relatively new innovation and that resistance is now being observed to such therapies in patients with NSCLC, investigation of combination therapies is valuable. The manuscript furthers our understanding of combination therapy for KRAS mutant non-small cell lung cancer by providing evidence that combined inhibition of ULK1/2 (and therefore autophagy) and KRAS can inhibit KRAS-mutant lung cancer growth. The manuscript will be of interest to the lung cancer community but also to researchers in other cancer types where KRAS inhibition is relevant.

      Strengths:

      The manuscript combines cell line, cell line-derived xenograft, and genetically-engineered mouse model data to provide solid evidence for the proposed combination therapy.  The manuscript is well written, and experiments are broadly well performed and presented.

      We thank Reviewer #1 (R1) for the generally favorable review of our manuscript, and also for the more detailed critique that identifies potential weaknesses in the research, which we address on a point-by-point basis below. 

      Weaknesses:

      With 3-4 mice per group in many experiments, experimental power is a concern and some comparisons (e.g. mono vs combination therapy) seem to be underpowered to detect a difference. Both male and female mice are used in experiments which may increase variability.

      We thank R1 for pointing out concerns regarding statistical power in our various mouse models of NSCLC experiments, and agree that more mice per group would certainly increase statistical power.  However, there are certain logistical considerations that impact the generation of cohorts of experimental KrasLSL-G12C mice.  Because mice homozygous for the KrasLSL-G12C allele display embryonic lethality, we are required to generate experimental mice by crossing heterozygous male and female KrasLSL-G12C mice.  Although 66% of the progeny of such crosses are predicted to be KrasLSL-G12C/+, experience tells us that we only obtain ~40-50% heterozygous KrasLSL-G12C/+ mice with litter sizes around 6-8 mice from such crosses.  Therefore, there are usually only about 4 heterozygous KrasLSL-G12C mice per litter, which presents a substantial challenge in generating larger cohorts of age-matched mice suitable for experiments, especially under conditions where we wish to euthanize mice at multiple time points for analysis.  For the GEM model experiments, Figure 3B is the only experiment that has n=3.  All other experiments contain 4-6 mice per experimental condition.  We rationalized using both male and female mice because both human males and females have high lung cancer rates.

      Reviewer #2 (Public Review):

      Summary:

      In this manuscript, Ghazi et reported that inhibition of KRASG12C signaling increases autophagy in KRASG12C-expressing lung cancer cells. Moreover, the combination of DCC 3116, a selective ULK1/2 inhibitor, plus sotorasib displays cooperative/synergistic suppression of human KRASG12C-driven lung cancer cell proliferation in vitro and tumor growth in vivo. Additionally, in genetically engineered mouse models of KRASG12C-driven NSCLC, inhibition of either KRASG12C or ULK1/2 decreases tumor burden and increases mouse survival. Additionally, this study found that LKB1 deficiency diminishes the sensitivity of KRASG12C/LKB1Null-driven lung cancer to the combination treatment, perhaps through the emergence of mixed adeno/squamous cell carcinomas and mucinous adenocarcinomas.

      Strengths:

      Both human cancer cells and mouse models were employed in this study to illustrate that inhibiting ULK1/2 could enhance the responsiveness of KRASG12C lung cancer to sotorasib. This research holds translational importance.

      We thank Reviewer #2 (R2) for the generally favorable review of our manuscript, and also for the more detailed critique that identifies potential weaknesses in the research, which we address on a point-by-point basis below. 

      Weaknesses:

      Additional validation of certain data is necessary.

      (1) mCherry-EGFP-LC3 reporter was used to assess autophagy flux in Figure 1A. Please explain how autophagy status (high, medium, and low) was defined. It's also suggested to show WB of LC3 processing in different treatments as in Figure 1A at 48 hours.

      We thank the reviewer for this comment and agree that a more thorough description of how autophagy status is assessed using the Fluorescent Autophagy Reporter (FAR) would benefit the readers of our manuscript.  Cells engineered to express the FAR are analyzed by flow cytometry in which we defined autophagy status by gating viable (based Sytox Blue staining), DMSO-treated control cells into three bins based on the ratio of EGFP:mCherry fluorescence.  We gate all live cells into the 33% highest EGFP-positive cells (autophagy low) and the 33% highest mCherry-positive cells (autophagy high), and therefore, the proportion in the middle is also approximately 33% and considered the medium autophagy status.  Again, these gates are based entirely on the DMSO-treated control cells, and all other treatments within the experiment are compared to settings on these gates.  In response to a specific manipulation (sotorasib, trametinib, DCC-3116 etc) we assess how the specific treatment changes the percentages of cells in each of the pre-specified gates to assess increased autophagy (decreased EGFP:mCherry ratio) or decreased autophagy (increased increased EGFP:mCherry ratio). 

      Although LC3 processing and/or the expression of p62SQSTM1 are used by others as markers of autophagy, there is much debate in the literature as to how reliable immunoblotting analysis of LC3 processing or p62SQSTM1 expression are as measures of autophagy.  Certainly, in our hands, we find that the Fluorescent Autophagy Reporter is a much more sensitive measure of changes in autophagy in various different cancer cell lines as we have described in previous papers (Kinsey et al., PMID: 30833748, Truong et al., PMID: 32933997 and Silvis & Silva et al., PMID: 36719686).  Furthermore, in the omnibus publication that describes techniques for measuring autophagy (Klionsky et al., PMID: 33634751) the use of the FAR (or similarly configured reporters) is regarded as the gold standard for measuring autophagy status in cells.  We have amended the Materials & Methods section of our manuscript to better describe the use of the FAR in measuring autophagy. 

      (2) For Figures 1J, K, and L, please provide immunohistochemistry (IHC) images demonstrating RAS downstream signaling blockade by sotorasib and autophagy blockade by DCC 3116 in tumors.

      We thank the reviewer for the comment and have probed the tumors from the xenograft experiments in Figures 1J, K, and L for pERK1/2 and p62SQSTM1 to determine the biochemical activity of sotorasib or DCC-3116, respectively and have provided representative images below. We observed the expected decrease in pERK and p62 signal after sotorasib treatment in all three xenografted cell lines. We did observe the expected accumulation of p62 in the DCC-3116 treated tumors from the NCI-H2122 and NCI-H358 cell lines. There appears to be no difference between the vehicle and DCC-3116 treated tumors in the NCI-H358 cell line-derived tumors as detected by IHC.

      Author response image 1.

      (3) Given that both DCC 3116 and ULK1K46N exhibit the ability to inhibit autophagy and synergize with sotorasib in inhibiting cell proliferation, in addition to demonstrating decreased levels of pATG13 via ELISA assay, please include Western blot analyses of LC3 or p62 to confirm the blockade of autophagy by DCC 3116 and ULK1K46N in Figure 1 & Figure 2.

      We appreciate the reviewer's comment and have performed an immunoblot analysis of cells treated with DCC-3116 or expressing ULK1K46N and probed for p62SQSTM1 and LC3 expression.  We did observe the expected accumulation of p62 SQSTM1 in NCI-H2122 (ULK1K46N) cells treated with 1ug/ml doxycycline to induce expression of ULK1K46N compared to DMSO treatment.  Additionally, we treated the human cell lines from Figure 1 with sotorasib and/or DCC-3116 and tested for p62SQSTM1 expression after 48 hours of treatment. In the human cell lines NCI-H2122 and NCI-H358, there was a decrease in the p62 signal with increasing doses of sotorasib, as expected. There was no detectable change in p62 levels in the Calu-1 cells by immunoblot. For LC3-I/LC3-II, there was only one detectable band in the NCI-H2122 cells, which makes it difficult to interpret the results and further emphasizes why we use the fluorescent autophagy reporter which is more sensitive than immunoblotting. There is no detectable change in LC3-I/LC3-II in the Calu-1 cells treated with increasing doses of sotorasib, but the expected decrease in LC3-I is observed with sotorasib treatment in the NCI-H358 cells.

      Author response image 2.

      (4) Since adenocarcinomas, adenosquamous carcinomas (ASC), and mucinous adenocarcinomas were detected in KL lung tumors, please conduct immunohistochemistry (IHC) to detect these tumors, including markers such as p63, SOX2, Katrine 5.

      We have included IHC analysis of the adenosquamous carcinomas for the markers p63, SOX2, and Keratin 5 from the KL mouse in Figure 3 and the ASC tumors in Supplemental Figure 4, and thank the reviewer for this excellent suggestion. The straining for these markers is below. Of note, we tried two different SOX2 antibodies (cell signaling technologies #14962 and cell signaling technologies # 3728) and could not detect any staining in any section.

      Author response image 3.

      (5) Please provide the sample size (n) for each treatment group in the survival study (Figure 4E). It appears that all mice were sacrificed for tumor burden analysis in Figure 4F. However, there doesn't seem to be a significant difference among the treatment groups in Figure 4F, which contrasts with the survival analysis in Figure 4E. It is suggested to increase the sample size in each treatment group to reduce variation.

      We have updated Figure 4E to indicate sample size for each treatment group and thank the reviewer for this suggestion.  Any mice that remained on study through the entire 8-week treatment regimen were sacrificed after the last day of treatment (Day 56).  Figure 4F indicates analysis of total tumor burden in all mice that remained on treatment for the full 8 weeks and mice that reached euthanasia criteria before the end of the 8-week treatment.  Therefore, it is important to note that the mice in Figure 4F were not all euthanized on the same day.  There is no statistically significant difference between the 3 treatment groups (sotorasib, DCC-3116, combination).  This may be due to a lower sample size as well as ending the treatment at 8 weeks as opposed to continuing the treatment for a longer period of time.  Although we agree that increasing the sample size would benefit the study, due to how long the GEMM model experiments take (12-16 weeks of breeding, 6 weeks for the mice to reach adulthood, 10 weeks of tumor formation post-initiation, 8 weeks of treatment= ~40 weeks) we would respectfully submit that the analysis of additional mice is outside the scope of the current revised manuscript.

      (6) In KP mice (Figure 5), it seems that a single treatment alone is sufficient to inhibit established KP lung tumor growth. Combination treatment does not further enhance anti-tumor efficacy. Therefore, this result doesn't support the conclusion generated from human cancer cell lines. Please discuss.

      We thank the reviewer for this observation.  Indeed, KP lung tumors were sensitive to single agent DCC-3116 treatment, which is reflected in the tumor burden analysis.  This was somewhat surprising to us as we have not previously detected much anti-tumor activity using 4-amino-quinoloines (chloroquine or hydroxychloroquine) or other autophagy inhibitors.  It should be noted however that the KRASG12C/TP53R175H NSCLC model has a very low tumor burden overall (~4% in vehicle-treated mice).  Additionally, our microCT imager cannot detect AAH and small tumors at the settings/resolution used.  Therefore, we were limited in our ability to detect small tumors or hyperplasia by microCT imaging.  Although there was a decrease in overall tumor burden with single agent DCC-3116 treatment, we could not demonstrate using microCT imaging that KRASG12C/TP53R175H lung tumors were actually regressing with single agent DCC-3116 treatment.  The larger tumors that were detected appeared to show a cytostatic effect (i.e. no or slow growth) with DCC-3116 monotherapy.  This may reflect our inability to detect regression of AAH or small tumors with the microCT.  In all human cell lines tested, the only cell line that responded to single agent DCC-3116 treatment was NCI-H358 cells, which do have a complete heterozygous loss of the TRP53 gene and lack TP53 protein.  However, other cells that also have a loss of expression of TP53 expression (Calu-1) are insensitive to single-agent DCC-3116 treatment. Due to the low mutational burden of the KP mouse model compared to human NSCLC cell lines driven by mutationally-activated KRASG12C and the loss of TP53 function, it is difficult to directly compare GEM models to the human cell line models.  Most of the human cell lines have alterations in other genes that are not altered in the KP mouse model which could affect the sensitivity of treatment.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Minor comments:

      (1) Figure legends are currently not adequate - information about the number and nature of replicates, stats, and definitions of the labelling used for stats should be added throughout. In Figure 5B, only two lines of four are labelled with * or ns.

      We thank the reviewer for this comment and have included more details in the figure legends that describe replicates, statistical analysis and definitions of labeling.  We also note that the methods section has a detailed description of the statistical analysis used.

      (2) What statistical test is performed on Figure 5E to get a p < 0.05 between the vehicle and DCC group?

      We performed a one-way ANOVA for all statistical analyses with more than 2 experiential groups. We thank the reviewer for pointing out this typo. These data points (vehicle vs. DCC-3116) are not statistically significant, which has been revised in the figure.

      (3) The manuscript figures would be improved by the use of a colourblind-friendly palette.

      We have previously published multiple manuscripts using this color scheme for the fluorescent autophagy reporter experiments and chose to use red and green as the reporter uses EGFP and mCherry.  We wanted to keep this color scheme consistent across our publications and would prefer not to change the colors.  However, we agree with the reviewer that the data should be accessible to all people and, therefore, have updated these graphs to include slashes over the red color to ease in telling the differences between the red and green colors.  Thank you to the reviewer for this excellent suggestion.

      (4) The manuscript should be fully checked for mouse (sentence case) and human (caps) gene (italics) and protein (non-italics).

      In this manuscript we are using the nomenclatures approved by the HUGO Gene Nomenclature Committee (https://en.wikipedia.org/wiki/HUGO_Gene_Nomenclature_Committee) in which:

      Human genes are written as KRAS, TP53 etc i.e. ITALICIZED CAPS

      Mouse genes are written as Kras, Trp53 etc:  i.e. Italicized and sentence case

      Human and mouse proteins are written as KRAS, TP53 etc:  i.e. NON-ITALICIZED CAPS

      In response to the reviewer’s suggestion, we have gone through the manuscript to check for this and make any appropriate changes.  Of note, we intentionally refer to the mouse protein changes as KRASG12C/LKB1null or KRASG12C/TP53R172H (capitalized), as this references the protein change and not the nucleotide change that occurs in the gene.

      (5) Adenosquamous is the correct term for the disease.  In parts, it's referred to as adeno/squamous or adeno-squamous.  The abbreviation ADC is also defined many times.

      Thank you to the reviewer for this comment.  We have corrected the manuscript text to only use adenosquamous and only define ADC in the first instance.

      (6) Line 434 - "as previously described" but no reference.

      Typos:

      (1) Line 117 – either

      (2) Line 314 – synergistic

      (3) Line 317 – therefore

      (4) Line 502 – medium

      We thank the reviewer for pointing out these typos and have modified the text appropriately.

      Reviewer #2 (Recommendations For The Authors):

      (1) The statement on Page 4, Lines 119-120, lacks clarity: 'Furthermore, LKB1 silencing diminishes the sensitivity of KRASG12C/LKB1Null-driven lung cancer perhaps through the emergence of mixed adeno/squamous cell carcinomas and mucinous adenocarcinomas.  It is unclear whether this refers to the sensitivity to the combination treatment or to the KRASc inhibitor alone.

      We thank the reviewer for this comment and agree that the statement lacks clarity.  The intent of this statement was to refer to both single agent sotorasib treatment as well as the combination with DCC-3116.  

      (2) Page 5 Line 147 "KRASG12X ". Please correct this typo.

      We thank the reviewer for this comment, but this is not a typo. We intended for this line to state KRASG12X to refer to cell lines with any KRASG12 alteration, e.g KRASG12D, KRASG12C, KRASG12S, KRASG12R etc.  

      (3) The color of the dots in Figure 5B labeling does not match the dots in the graph.

      For all bar graphs in the manuscript, the dots representing individual mice are black, and the bar itself is color-coded based on treatment type. The dots in Figure 5B follow this pattern and are intended to be this way.

      (4) Figure 5C depicts lung weight rather than tumor growth, contrary to the text description "regression of pre-existing lung tumors was detected by microCT scanning (Figure 5C, Figure S5)".

      Figure 5C does not depict lung weight but the percent body weight change in treated mice, described in the figure legend.  We thank the reviewer for pointing this out because we referenced the wrong panel in the text.  The figures referenced should be Figure 5B, Figure S5.  We have corrected this in the text.

    1. Author response:

      The following is the authors’ response to the original reviews.

      In summary, the changes made in the revision process include:

      An addition of a paragraph in the result section that discusses the absolute values of measured Young’s moduli in the light of probing frequencies, accompanied by a new supplementary figure and a supplementary table that support that discussion

      - Fig. S10. Absolute Young’s modulus values across the frequencies characteristic for the three measurement methods.

      - Table S9. Operation parameters of the three methods used for characterizing the mechanical properties of cells.

      Three new supplementary figures that display the expression matrices for the genes from the identified modules in carcinoma datasets used for validation:

      - Fig. S4. Expression of identified target genes in the CCLE microarray dataset used for validation.

      - Fig. S5. Expression of identified target genes in the CCLE RNA-Seq dataset used for validation.

      - Fig. S6. Expression of identified target genes in the Genentech dataset used for validation.

      An addition of a paragraph in the discussion section that discusses the intracellular origins of resistance to deformation and the dominance of actin cortex at low deformations.

      - Refinement of the manuscript text and figures based on the specific feedback from the Reviewers.

      Please see below for detailed responses to the Reviewers’ comments.

      Reviewer #1 (Public Review)

      In this work, Urbanska and colleagues use a machine-learning based crossing of mechanical characterisations of various cells in different states and their transcriptional profiles. Using this approach, they identify a core set of five genes that systematically vary together with the mechanical state of the cells, although not always in the same direction depending on the conditions. They show that the combined transcriptional changes in this gene set is strongly predictive of a change in the cell mechanical properties, in systems that were not used to identify the genes (a validation set). Finally, they experimentally after the expression level of one of these genes, CAV1, that codes for the caveolin 1 protein, and show that, in a variety of cellular systems and contexts, perturbations in the expression level of CAV1 also induce changes in cell mechanics, cells with lower CAV1 expression being generally softer. 

      Overall the approach seems accessible, sound and is well described. My personal expertise is not suited to judge its validity, novelty or relevance, so I do not make comments on that. The results it provides seem to have been thoroughly tested by the authors (using different types of mechanical characterisations of the cells) and to be robust in their predictive value. The authors also show convincingly that one of the genes they identified, CAV1, is not only correlated with the mechanical properties of cells, but also that changing its expression level affects cell mechanics. At this stage, the study appears mostly focused on the description and validation of the methodological approach, and it is hard to really understand what the results obtain really mean, the importance of the biological finding - what is this set of 5 genes doing in the context of cell mechanics? Is it really central, or is it just one of the set of knobs on which the cell plays - and it is identified by this method because it is systematically modulated but maybe, for any given context, it is not the dominant player - all these fundamental questions remain unanswered at this stage. On one hand, it means that the study might have identified an important novel module of genes in cell mechanics, but on the other hand, it also reveals that it is not yet easy to interpret the results provided by this type of novel approach. 

      We thank the Reviewer #1 for the thoughtful evaluation of our manuscript. The primary goal of the manuscript was to present a demonstration of an unbiased approach for the identification of genes involved in the regulations of cell mechanics. The manuscript further provides a comprehensive computational validation of all genes from the identified network, and experimental validation of a selected gene, CAV1. 

      We agree that at the current stage, far-reaching conclusions about the biological meaning of the identified network cannot be made. We are, however, convinced that the identification of an apparently central player such as CAV1 across various cellular systems is per se meaningful, in particular since CAV1 modulation shows clear effects on the cell mechanical state in several cell types. 

      We anticipate that our findings will encourage more mechanistic studies in the future, investigating how these identified genes regulate mechanical properties and interact with each other. Notwithstanding, the identified genes (after testing in specific system of interest) can be readily used as genetic targets for modulating mechanical properties of cells. Access to such modifications is of huge relevance not only for performing further research on the functional consequence of cell mechanics changes (in particular in in-vivo systems where using chemical perturbations is not always possible), but also for the potential future implementation in modulating mechanical properties of the cells to prevent disease (for example to inhibit cancer metastasis or increase efficacy of cancer cell killing by cytotoxic T cells).

      We have now added a following sentence in the first paragraph of discussion to acknowledge the open ends of our study:

      “(...). Here we leveraged this opportunity by performing discriminative network analysis on transcriptomes associated with mechanical phenotype changes to elucidate a conserved module of five genes potentially involved in cell mechanical phenotype regulation. We provided evidence that the inferred conserved functional network module contains an ensemble of five genes that, in particular when combined in a unique combinatorial marker, are universal, specific and trustworthy markers of mechanical phenotype across the studied mouse and human systems. We further demonstrated on the example of a selected marker gene, CAV1, that its experimental up- and downregulation impacts the stiffness of the measured cells. This demonstrates that the level of CAV1 not only correlates with, but also is causative of mechanical phenotype change. The mechanistic insights into how precisely the identified genes are involved in regulating mechanical properties, how they interact with each other, and whether they are universal and dominant in various contexts all remain to be established in

      future studies.”

      Reviewer #2 (Public Review)

      A key strength is the quantitative approaches all add rigor to what is being attempted. The approach with very different cell culture lines will in principle help identify constitutive genes that vary in a particular and predictable way. To my knowledge, one other study that should be cited posed a similar pan-tissue question using mass spectrometry proteomics instead of gene expression, and also identified a caveolae component (cavin-1, PTRF) that exhibited a trend with stiffness across all sampled tissues. The study focused instead on a nuclear lamina protein that was also perturbed in vitro and shown to follow the expected mechanical trend (Swift et al 2013). 

      We thank the Reviewer #2 for the positive evaluation of the breadth of the results and for pointing us to the relevant reference for the proteomic analysis related to tissue stiffness (Swift et al., 2013). This study, which focused primarily on the tissue-level mechanical properties, identifying PTRF, a caveolar component, which links to our observation of another caveolar component, CAV1, at the single-cell level. 

      We have now included the citation in the following paragraph of the discussion:

      “To our knowledge, there are no prior studies that aim at identifying gene signatures associated with single-cell mechanical phenotype changes, in particular across different cell types. There are, however, several studies that investigated changes in expression upon exposure of specific cell types to mechanical stimuli such as compression (87, 88) or mechanical stretch (22, 80, 89), and one study that investigated difference in expression profiles between stiffer and softer cells sorted from the same population (90). Even though the studies concerned with response to mechanical stimuli answer a fundamentally different question (how gene expression changes upon exposure to external forces vs which genes are expressed in cells of different mechanical phenotype), we did observe some similarities in the identified genes. For example, in the differentially expressed genes identified in the lung epithelia exposed to compression (87), three genes from our module overlapped with the immediate response (CAV1, FHL2, TGLN) and four with the long-term one (CAV1, FHL2, TGLN, THBS1). We speculate that this substantial overlap is caused by the cells undergoing change in their stiffness during the response to compression (and concomitant unjamming transition). Another previous study explored the association between the stiffness of various tissues and their proteomes. Despite the focus on the tissue-scale rather than single-cell elasticity, the authors identified polymerase I and transcript release factor (PTRF, also known as cavin 1 and encoding for a structural component of the caveolae) as one of the proteins that scaled with tissue stiffness across samples (91).”

      Reviewer #3 (Public Review)

      In this work, Urbanska et al. link the mechanical phenotypes of human glioblastoma cell lines and murine iPSCs to their transcriptome, and using machine learning-based network analysis identify genes with putative roles in cell mechanics regulation. The authors identify 5 target genes whose transcription creates a combinatorial marker which can predict cell stiffness in human carcinoma and breast epithelium cell lines as well as in developing mouse neurons. For one of the target genes, caveolin1 (CAV1), the authors perform knockout, knockdown, overexpression and rescue experiments in human carcinoma and breast epithelium cell lines. They determine the cell stiffness via RT-DC, AFM indentation and AFM rheology and confirm that high CAV1 expression levels correlate with increased stiffness in those model systems. This work brings forward an interesting approach to identify novel genes in an unbiased manner, but surprisingly the authors validate caveolin 1, a target gene with known roles in cell mechanics regulation. 

      I have two main concerns with the current version of this work: 

      (1) The authors identify a network of 5 genes that can predict mechanics. What is the relationship between the 5 genes? If the authors aim to highlight the power of their approach by knockdown, knockout or over-expression of a single gene why choose CAV1 (which has an individual p-value of 0.16 in Fig S4)? To justify their choice, the authors claim that there is limited data supporting the direct impact of CAV1 on mechanical properties of cells but several studies have previously shown its role in for example zebrafish heart stiffness, where a knockout leads to higher stiffness (Grivas et al., Scientific Reports 2020), in cancer cells, where a knockdown leads to cell softening (Lin et al., Oncotarget 2015), or in endothelial cell, where a knockout leads to cell softening (Le Master et al., Scientific Reports 2022). 

      We thank the reviewer for their comments. First, we do acknowledge that studying the relationship between the five identified genes is an intriguing question and would be a natural extension of the currently presented work. It is, however, beyond the scope of presented manuscript, in which our primarily goal was to introduce a general pipeline for de novo identification of genes related to cell mechanics. We did add a following statement in the discussion (yellow highlight) to acknowledge the open ends of our study:

      “The mechanical phenotype of cells is recognized as a hallmark of many physiological and pathological processes. Understanding how to control it is a necessary next step that will facilitate exploring the impact of cell mechanics perturbations on cell and tissue function (76).

      The increasing availability of transcriptional profiles accompanying cell state changes has recently been complemented by the ease of screening for mechanical phenotypes of cells thanks to the advent of high-throughput microfluidic methods (77). This provides an opportunity for data-driven identification of genes associated with the mechanical cell phenotype change in a hypothesis-free manner. Here we leveraged this opportunity by performing discriminative network analysis on transcriptomes associated with mechanical phenotype changes to elucidate a conserved module of five genes potentially involved in cell mechanical phenotype regulation. We provided evidence that the inferred conserved functional network module contains an ensemble of five genes that, in particular when combined in a unique combinatorial marker, are universal, specific and trustworthy markers of mechanical phenotype across the studied mouse and human systems. We further demonstrated on the example of a selected marker gene, CAV1, that its experimental up- and downregulation impacts the stiffness of the measured cells. This demonstrates that the level of CAV1 not only correlates with, but also is causative of mechanical phenotype change. The mechanistic insights into how precisely the identified genes are involved in regulating mechanical properties, how they interact with each other, and whether they are universal and dominant in various contexts all remain to be established in future studies.”

      Regarding the selection of CAV1 as the gene that we used for validation experiment; as mentioned in the introductory paragraph of the result section “Perturbing expression levels of CAV1 changes cells stiffness” (copied below), we were encouraged by the previous data already linking CAV1 with cell mechanics when selecting it as our first target. The relationship between CAV1 and cell mechanics regulation, however, is not very well established (of note, two of the latest manuscripts came out after the initial findings of our study). 

      Regarding the citations suggested by the reviewer: two are already included in the original manuscript (Lin et al., Oncotarget 2015 – Ref (63), Le Master –2022 Ref (67)), along with an additional one (Hsu et al 2018 (66)), and the third one (Grivas et al, 2020 (68)) is now also added to the manuscript. Though, we would like to highlight that even though Grivas et al state that the CAV1 KO cells are stiffer, the AFM indentation measurements were performed on the cardiac tissue, with a spherical tip of 30 μm radius and likely reflect primarily supracelluar, tissue-scale properties, as opposed to cell-scale measurements performed in our study (we used cultured cells which mostly lack the extracellular tissue structures, deformability cytometry was performed on dissociated cells and picks up on cell properties exclusively, and in case of AFM measurements a spherical tip with 5 μm radius was used).

      “We decided to focus our attention on CAV1 as a potential target for modulating mechanical properties of cells, as it has previously been linked to processes intertwined with cell mechanics. In the context of mechanosensing, CAV1 is known to facilitate buffering of the membrane tension (45), play a role in β1-inegrin-dependent mechanotransduction (58) and modulate the mechanotransduction in response to substrate stiffness (59). CAV1 is also intimately linked with actin cytoskeleton — it was shown to be involved in cross-talk with Rho-signaling and actin cytoskeleton regulation (46, 60–62), filamin A-mediated interactions with actin filaments (63), and co-localization with peripheral actin (64). The evidence directly relating CAV1 levels with the mechanical properties of cells (47, 62, 65, 66) and tissues (66, 67) , is only beginning to emerge.”

      Regarding the cited p-value of 0.16, we would like to clarify that it is the p-value associated with the coefficient of the crude linear regression model fitted to the data for illustrative purposes in Fig S4. This value only says that from the linear fit we cannot conclude much about the correlation of the level of Cav1 with the Young’s modulus change. Much more relevant parameters to look at are the AUC-ROC values and associated p-values reported in the Table 4 in the main text (see below), which show good performance of CAV1 in separating soft and stiff cell states. 

      The positive hypothesis I assumes that markers are discriminative of samples with stiff/soft mechanical phenotype regardless of the studied biological system, and CAV1 has a clear trend with the minimum AUC-ROC on 3 datasets of 0.78, even though the p-value is below the significance level. The positive hypothesis II assumes that markers are discriminative of samples with stiff/soft mechanical phenotype in carcinoma regardless of data source, and CAV1 has a clear significance because the minimum AUC-ROC on 3 datasets is 0.89 and the p-value is 0.02.

      (2) The authors do not show how much does PC-Corr outperforms classical co-expression network analysis or an alternative gold standard. It is worth noting that PC-Corr was previously published by the same authors to infer phenotype-associated functional network modules from omics datasets (Ciucci et al., Scientific Reports 2017). 

      As pointed out by the Reviewer, PC-corr has been introduced and characterized in detail in a previous publication (Ciucci et al, 2017, Sci. Rep.), where it was compared against standard co-expression analysis (below reported as: p-value network) on molecules selected using univariate statistical analysis. 

      See the following fragment of Discussion in Ciucci et al, 2017:

      “The PC-corr networks were always compared to P-value networks. The first strategical difference lies in the way features are selected: while the PC-corr adopts a multivariate approach, i.e. it uses a combination of features that are responsible for the sample discrimination, in the P-value network the discriminating features are singly selected (one by one) with each Mann-Whitney test (followed by Benjamini-Hochberg procedure). The second strategical difference lies in the generation of the correlation weights in the network. PC-corr combines in parallel and at the same time in a unique formula the discrimination power of the PC-loadings and the association power of the Pearson correlation, directly providing in output discriminative omic associations. These are generated using a robust (because we use as merging factor the minimum operator, which is a very penalizing operator) mathematical trade-off between two important factors: multivariate discriminative significance and correlation association. In addition, as mentioned above, the minimum operator works as an AND logical gate in a digital circuit, therefore in order to have a high link weight in the PCcorr network, both the discrimination (the PC-loadings) and the association (the Pearson correlations) of the nodes adjacent to the link should be simultaneously high. Instead, the Pvalue procedure begins with the pre-selection of the significant omic features and, only in a second separated step, computes the associations between these features. Therefore, in P-value networks, the interaction weights are the result neither of multivariate discriminative significance, nor of a discrimination/association interplay.”

      Here we implement PC-corr for a particular application and do not see it as central to the message of the present manuscript to compare it with other available methods. We considered it much more relevant to focus on an in-silico validation on dataset not used during the PCcorr analysis (see Table 3 and 4 for details).

      Altogether, the authors provide an interesting approach to identify novel genes associated with cell mechanics changes, but the current version does not fulfill such potential by focusing on a single gene with known roles in cell mechanics. 

      Our manuscript presents a demonstration of an overall approach for the identification of genes involved in the regulation of cell mechanics, and the perturbations performed on CAV1 have a demonstrative role (please also refer to the explanations of why we decided to perform the verification focused on CAV1 above). The fact that we identify CAV1, which has been implicated in regulating cell mechanics in a handful of studies, de novo and in an unbiased way speaks to the power of our approach. We do agree that investigation into the effect of manipulating the expression of the remaining genes from the identified network module, as well as into the mutual relationships between those genes and their covariance in perturbation experiments, constitutes a desirable follow-up on the presented results. It is, however, beyond the scope of the current manuscript. Regardless, the other genes identified can be readily tested in systems of interest and used as potential knobs for tuning mechanical properties on demand.

      Reviewer #1 (Recommendations For Authors)

      I am not a specialist of the bio-informatics methods used in this study, so I will not make any specific technical comments on them. 

      In terms of mechanical characterisation of cells, the authors use well established methods and the fact that they systematically validate their findings with at least two independent methods (RT-DC and AFM for example) makes them very robust. So I have no concerns with this part.  The experiments of perturbations of CAV 1 are also performed to the best standards and the results are clear, no concern on that. 

      My main concerns are rather questions I was asking myself and could not answer when reading the article. Maybe the authors could find ways to clarify them - the discussion of their article is already very long and maybe it should not be lengthened to much. In my opinion, some of the points discussed are not really essential and rather redundant with other parts of the paper. This could be improved to give some space to clarify some of the points below:  

      We thank the Reviewer #1 for an overall positive evaluation of the manuscript as well as the points of criticism which we addressed in a point-by-point manner below.

      (1) This might be a misunderstanding of the method on my side, but I was wondering whether it is possible to proceed through the same steps but choose other pairs of training datasets amongst the 5 systems available (there are 10 such pairs if I am not mistaken) and ask whether they always give the same set of 5 genes. And if not, are the other sets also then predictive, robust, etc. Or is it that there are 'better' pairs than others in this respect. Or the set of 5 genes is the only one that could be found amongst these 5 datasets - and then could it imply that it is the only group 'universal' group of predictive genes for cell mechanics (when applied to any other dataset comprising similar mechanical measures and expression profiles, for other cells, other conditions)? 

      I apologize in case this question is just the result of a basic misunderstanding of the method on my side. But I could not answer the question myself based on what is in the article and it seems to be important to understand the significance of the finding and the robustness of the method. 

      We thank the Reviewer for this question. To clarify: while in general it is possible to proceed through the same analysis steps choosing a different pair of datasets (see below for examples), we have purposefully chosen those two and not any other datasets because they encompassed the highest number of samples per condition in the RNAseq data (see Fig 4 and Table R1 below), originated from two different species and concerned least related tissues (the other option for mouse would be neural progenitors which in combination with the glioblastoma would likely result in focusing on genes expressed in neural tissues). This is briefly explained in the following fragment of the manuscript on Page 10:

      “For the network construction, we chose two datasets that originate from different species, concern unrelated biological processes, and have a high number of samples included in the transcriptional analysis: human glioblastoma and murine iPSCs (Table 1).”

      To further address the comment of the reviewer: there is indeed a total of 10 possible two-set combinations of datasets, 6 of those pairs are human-mouse combinations (highlighted in orange in Author response Table 1), 3 are human-human combinations (highlighted in blue), and 1 is mousemouse (marked in green).

      Author response table 1.

      Possible two-set combinations of datasets. For each combination, the number of common genes is indicated. The number on the diagonal represents total number of transcripts in the individual datasets, n corresponds to the number of samples in the respective datasets.  * include non-coding genes.

      To reiterate, we have chosen the combination of set A (glioblastoma) and set D (iPSCs) to choose datasets from different species and with highest sample number. 

      As for the other combinations of human-mouse datasets:

      • set A & E lead to derivation of a conserved module, however as expected this module includes genes specific for neuronal tissues (such as brain & testis specific immunoglobulin IGSF11, or genes involved in neuronal development such as RFX4, SOX8)

      Author response image 1.

      • the remaining combinations (set B&D, B&E, C&D and C&E) do not lead to a derivation of a highly interconnected module

      Author response image 2.

      Author response image 3.

      Author response image 4.

      Author response image 5.

      Finally, it would have also been possible to perform the combined PC-corr procedure on all 5 datasets. However, this would prevent us from doing validation using unknown datasets.

      Hence, we decided to proceed with the 2 discovery and 4 validation datasets.

      For the sake of completeness, we present below some of the networks obtained from the analysis performed on all 5 datasets (which intersect at 8059 genes).

      Author response image 6.

      The above network was created by calculating mean/minimum PC-corr among all five datasets and applying the threshold. The thresholding can be additionally restricted in that we:

      a. constrain the directionality of the correlation between the genes (𝑠𝑔𝑛(𝑐) ) to be the same among all or at least n datasets

      b. constrain the directionality of the correlation between the cell stiffness and gene expression level (𝑠𝑔𝑛(𝑉)) for individual genes.

      Some of the resulting networks for such restrictions are presented below.

      Author response image 7.

      Author response image 8.

      Of note, some of the nodes from the original network presented in the paper (CAV1, FHL2, and IGFBP7) are preserved in the 5-set network (and highlighted with blue rims),

      (2) The authors already use several types of mechanical characterisation of the cells, but there are even more of them, in particular, some that might not directly correspond to global cell stiffness but to other aspects, like traction forces, or cell cortex rheology, or cell volume or passage time trough constrictions (active or passive) - they might all be in a way or another related, but they are a priori independent measures. Would the authors anticipate finding very different 'universal modules' for these other mechanical properties, or again the same one? Is there a way to get at least a hint based on some published characterisations for the cells used in the study? Basically, the question is whether the gene set identified is specific for a precise type of mechanical property of the cell, or is more generally related to cell mechanics modulation - maybe, as suggested by the authors because it is a set of molecular knobs acting upstream of general mechanics effectors like YAP/TAZ or acto-myosin? 

      We thank the Reviewer for this comment. We would like to first note that in our study, we focused on single-cell mechanical phenotype understood as a response of the cells to deformation at a global (RT-DC) or semi-local (AFM indentation with 5-μm bead) level and comparatively low deformations (1-3 μm, see Table S9). There is of course a variety of other methods for measuring cell mechanics and mechanics-related features, such as traction force microscopy mentioned by the reviewer. Though, traction force microscopy probes how the cells apply forces and interact with their environment rather than the inherent mechanical properties of the cells themselves which were the main interest of our study. 

      Nevertheless, as mentioned in the discussion, we found some overlap with the genes identified in other mechanical contexts, for example in the context of mechanical stretching of cells:

      “Furthermore, CAV1 is known to modulate the activation of transcriptional cofactor yesassociated protein, YAP, in response to changes in stiffness of cell substrate (60) and in the mechanical stretch-induced mesothelial to mesenchymal transition (74).”

      Which suggests that the genes identified here may be more broadly related to mechanical aspects of cells. 

      Of note, we do have some insights connected to the changes of cell volume — one of the biophysical properties mentioned by the reviewer — from our experiments.  For all measurements performed with RT-DC, we can also calculate cell volumes from 2D cell contours (see Author response images 9, 10, and 11). For most of the cases (all apart from MEF CAV1KO), the stiffer phenotype of the cells, associated with higher levels of CAV1, shows a higher volume.

      Author response image 9.

      Cell volumes for the divergent cell states in the five characterized biological systems. (A) Glioblastoma. (B) Carcinoma, (C) MCF10A, (D) iPSCs, (E) Developing neurons. Data corresponds to Figure 2. Cell volumes were estimated using Shape-Out 1.0.10 by rotation of the cell contours.

      Author response image 10.

      Cell volumes for CAV1 perturbation experiments. (A) CAV1 knock down performed in TGBC cells. (B) CAV1 overexpression in ECC4 and TGBC cells. Data corresponds to Figure 5. Cell volumes were estimated using Shape-Out 1.0.10 by rotation of the cell contours.  

      Author response image 11.

      Cell volumes for WT and CAV1KO MEFs. Data corresponds to Figure S9. Cell volumes were estimated using Shape-Out 1.0.10 by rotation of the cell contours.  

      (3) The authors have already tested a large number of conditions in which perturbations of the level of expression of CAV1 correlates with changes in cell mechanics, but I was wondering whether it also has some direct explanatory value for the initial datasets used - for example for the glioblastoma cells from Figure 2, in the different media, would a knock-down of CAV1 prevent the increase in stiffness observed upon addition of serum, or for the carcinoma cells from different tissues treated with different compounds - if I understand well, the authors have tested a subset of these (ECC4 versus TGBC in figure 5) - how did they choose these and how general is it that the mechanical phenotype changes reported in Figure 2 are all mostly dependant on CAV1 expression level? I must say that the way the text is written and the results shown, it is hard to tell whether CAV1 is really having a dominant effect on cell mechanics in most of these contexts or only a partial effect. I hope I am being clear in my question - I am not questioning the conclusions of Figures 5 and 6, but asking whether the level of expression of CAV1, in the datasets reported in Figure 2, is the dominant explanatory feature for the differences in cell mechanics. 

      We thank reviewer for this comment and appreciate the value of the question about the generality and dominance of CAV1 in influencing cell mechanics.

      On the computational side, we have addressed these issues by looking at the performance of CAV1 (among other identified genes) in classifying soft and stiff phenotypes across biological systems (positive hypothesis I), as well as across data of different type (sequencing vs microarray data) and origin (different research institutions) (positive hypothesis II). CAV1 showed strong classification performance (Table 4), suggesting it is a general marker of stiffness changes.  

      On the experimental side, we conducted the perturbation experiments in two systems of choice: two intestinal carcinoma cell lines (ECC4 and TGBC) and the MCF10A breast epithelial cell line. These choices were driven by ease of handling, accessibility, as well as (for MCF10A) connection with a former study (Taveres et al, 2017). While we observed correlations between CAV1 expression and cell mechanics in wide range of datasets, the precise role of CAV1 in each system may vary, and further perturbation experiments in specific systems could be performed to solidify the direct/dominant role of CAV1 in cell mechanics. We hypothesize that the suggested knockdown of CAV1 upon serum addition in glioblastoma cells could reduce or prevent the increase in stiffness observed, though this experiment has not been performed. 

      In conclusion, while the computational analysis gives us confidence that CAV1 is a good indicator of cell stiffness, we predict that it acts in concert with other genes and in specific context could be replaced by other changes. We suggest that the suitability of CAV1 for manipulation of the mechanical properties should be tested in each system of interested before use. 

      To highlight the fact that the relevance of CAV1 for modulating cell mechanics in specific systems of interest should be tested and the mechanistic insights into how CAV1 regulates cell mechanics are still missing, we have added the following sentence in the discussion:

      “The mechanical phenotype of cells is recognized as a hallmark of many physiological and pathological processes. Understanding how to control it is a necessary next step that will facilitate exploring the impact of cell mechanics perturbations on cell and tissue function (76). The increasing availability of transcriptional profiles accompanying cell state changes has recently been complemented by the ease of screening for mechanical phenotypes of cells thanks to the advent of high-throughput microfluidic methods (77). This provides an opportunity for data-driven identification of genes associated with the mechanical cell phenotype change in a hypothesis-free manner. Here we leveraged this opportunity by performing discriminative network analysis on transcriptomes associated with mechanical phenotype changes to elucidate a conserved module of five genes potentially involved in cell mechanical phenotype regulation. We provided evidence that the inferred conserved functional network module contains an ensemble of five genes that, in particular when combined in a unique combinatorial marker, are universal, specific and trustworthy markers of mechanical phenotype across the studied mouse and human systems. We further demonstrated on the example of a selected marker gene, CAV1, that its experimental up- and downregulation impacts the stiffness of the measured cells. This demonstrates that the level of CAV1 not only correlates with, but also is causative of mechanical phenotype change. The mechanistic insights into how precisely the identified genes are involved in regulating mechanical properties, how they interact with each other, and whether they are universal and dominant in various contexts all remain to be established in future studies.”

      (4) It would be nice that the authors try to more directly address, in their discussion, what is the biological meaning of the set of 5 genes that they found - is it really mostly a product of the methodology used, useful but with little specific relevance to any biology, or does it have a deeper meaning? Either at a system level, or at an evolutionary level. 

      We would like to highlight that our manuscript is focused on the method that we introduce to identify sets of genes involved in the regulation of cell mechanics. The first implementation included here is only the beginning of this line of work which, in the future, will include looking in detail at the biological meaning and the interconnectivity of the genes identified. Most likely, there is a deeper meaning of the identified module which could be revealed with a lot of dedicated future work. As it is a mere speculation at this point, we would like to refrain from going into more detail about it in the current manuscript. We provide below a few words of extended explanation and additional analysis that can shed light on the current limited knowledge of the connections between the genes and evolutionary preservation of the genes. 

      While it is difficult to prove at present, we do believe that the identified node of genes may have an actual biological meaning and is not a mere product of the used methodology. The PC-corr score used for applying the threshold and obtaining the gene network is high only if the Pearson’s correlation between the two genes is high, meaning that the high connected module of genes identified show corelated expression and is likely co-regulated. Additionally, we performed the GO Term analysis using DAVID to assess the connections between the genes (Figure S3). We have now performed an additional analysis using two orthogonal tools the functional protein association tool STRING and KEGG Mapper. 

      With STRING, we found a moderate connectivity using the five network nodes identified in our study, and many of the obtained connections were based on text mining and co-expression, rather than direct experimental evidence (Author response image 12A). A more connected network can be obtained by allowing STRING to introduce further nodes (Author response image 12B). Interestingly, some of the nodes included by STRING in the extended network are nodes identified with milder PCcorr thresholds in our study (such as CNN2 or IGFBP3, see Table S3). 

      With KEGG Mapper, we did not find an obvious pathway-based clustering of the genes from the module either. A maximum of two genes were assigned to one pathway and those included: 

      • focal adhesions (pathway hsa04510): CAV1 and THBS1

      • cytoskeleton in muscle cells (pathway hsa04820): FHL2 and THBS1

      • proteoglycans in cancer (pathway hsa05205): CAV1 and THBS1.

      As for the BRITE hierarchy, following classification was found:

      • membrane trafficking(hsa04131): CAV1, IGFBP7, TAGLN, THBS, with following subcategories:

      - endocytosis / lipid raft mediated endocytosis/caveolin-mediated endocytosis:

      CAV1

      - endocytosis / phagocytosis / opsonins: THBS1

      - endocytosis / others/ insulin-like growth factor-binding proteins: IGFBP7 o others / actin-binding proteins/others: TAGLN.

      Taken together, all that analyses (DAVID, STRING, KEGG) show that at present no direct relationship/single pathway can be found that integrates all the genes from the identified modules. Future experiments, including investigations of how other module nodes are affected when one of the genes is manipulated, will help to establish actual physical or regulatory interactions between the genes from our module. 

      To touch upon the evolutionary perspective, we provide an overview of occurrence of the genes from the identified module across the evolutionary tree. This overview shows that the five identified genes are preserved in phylum Chordata with quite high sequence similarity, and even more so within mammals (Author response image 13).

      Author response image 12.

      Visualisation of interactions between the nodes in the identified module using functional protein association networks tool STRING. (A) Connections obtained using multiple proteins search and entering the five network nodes. (B) Extended network that includes further genes to increase indirect connectivity. The genes are added automatically by STRING. Online version of STRING v12.0 was used with Homo sapiens as species of interest.   

      Author response image 13.

      Co-occurrence of genes from the network module across the evolutionary tree. Mammals are indicated with the green frame, glires (include mouse), as well as primates (include human) are indicated with yellow frames. The view was generated using online version of STRING 12.0.

      Reviewer #2 (Recommendations For Authors) 

      (1) The authors need to discuss the level of sensitivity of their mechanical measurements with RT-DC for changes to the membrane compared to changes in microtubules, nucleus, etc. The limited AFM measurements also seem membrane/cortex focused. For these and further reasons below, "universal" doesn't seem appropriate in the title or abstract, and should be deleted. 

      We thank the reviewer for this comment. Indeed, RT-DC is a technique that deforms the entire cell to a relatively low degree (inducing ca 17% mean strain, i.e. a deformation of approximately 2.5 µm on a cell with a 15 µm diameter, see Table S9 and Urbanska et al., Nat Methods 2020). Similarly, the AFM indentation experiments performed in this study (using a 5-µm diameter colloidal probe and 1 µm indentation) induce low strains, at which, according to current knowledge, the actin cortex dominates the measured deformations. However, other cellular components, including the membrane, microtubules, intermediate filaments, nucleus, other organelles, and cytoplasmic packing, can also contribute. We have reviewed these contributions in detail in a recent publication (Urbanska and Guck, 2024, Ann Rev Biophys., PMID 38382116). For a particular system, it is hard to speculate without further investigation which parts of the cell have a dominant effect on the measured deformability. We have added now a following paragraph in the discussion to include this information:

      “The mechanical phenotype of single cells is a global readout of cell’s resistance to deformation that integrates contributions from all cellular components. The two techniques implemented for measuring cell mechanical in this study — RT-DC and AFM indentation using a spherical indenter with 5 µm radius — exert comparatively low strain on cells (< 3 µm, see Table S9), at which the actin cortex is believed to dominate the measured response. However, other cellular components, including the membrane, microtubules, intermediate filaments, nucleus, other organelles, and cytoplasmic packing, also contribute to the measured deformations (reviewed in detail in (79)) and, for a particular system, it is hard to speculate without further investigation which parts of the cell have a dominant effect on the measured deformability.”

      The key strength of measuring the global mechanics is that such measurements are agnostic of the specific origin of the resistance to shape change. As such, the term “universal” could be seen as rather appropriate, as we are not testing specific contributions to cell mechanics, and we see the two methods used (RT-DC and AFM indentation) as representative when it comes to measuring global cell mechanics. And we highlighted many times throughout the text that we are measuring global single-cell mechanical phenotype. 

      Most importantly, however, we have used the term “universal” to capture that the genes are preserved across different systems and species, not in relation to the type of mechanical measurements performed and as such we would like to retain the term in the title.

      (2) Fig.2 cartoons of tissues is a good idea to quickly illustrate the range of cell culture lines studied. However, it obligates the authors to examine the relevant primary cell types in singlecell RNAseq of human and/or mouse tissues (e.g. Tabula Muris). They need to show CAV1 is expressed in glioblastoma, iPSCs, etc and not a cell culture artifact. CAV1 and the other genes also need to be plotted with literature values of tissue stiffness.  

      We thank the reviewer for this the comment; however, we do believe that the cartoons in Figure 2 should assist the reader to readily understand whether cultured cells derived from the respective tissues were used (see cartoons representing dishes), or the cells directly isolated from the tissue were measured (this is the case for the developing neurons dataset). 

      We did, however, follow the suggestion of the reviewer to use available resources and checked the expression of genes from the identified network module across various tissues in mouse and human. We first used the Mouse Genome Informatics (MGI; https://www.informatics.jax.org/) to visualize the expression of the genes across organs and organ systems (Author response image 14) as well as across more specific tissue structures (Author response image 15). These two figures show that the five identified genes are expressed quite broadly in mouse. We next looked at the expression of the five genes in the scRNASeq dataset from Tabula Muris (Author response image 16). Here, the expression of respective genes seemed more restricted to specific cell clusters. Finally, we also collected the cross-tissue expression of the genes from our module in human tissues from Human Protein Atlas v23 at both mRNA (Author response image 17) and protein (Author response image 18) levels. CAV1, IGFBP7, and THBS1 showed low tissue specificity at mRNA level, FHL2 was enriched in heart muscle and ovary (the heart enrichment is also visible in Author response image 15 for mouse) and TAGLN in endometrium and intestine. Interestingly, the expression at the protein level (Author response image 18) did not seem to follow faithfully the mRNA levels (Author response image 17). Overall, we conclude that the identified genes are expressed quite broadly across mouse and human tissues. 

      Author response image 14.

      Expression of genes from the identified module across various organ and organ systems in mouse. The expression matrices for organs (A) and organ systems (B) were generated using Tissue x Gene Matrix tool of Gene eXpression Database (https://www.informatics.jax.org/gxd/, accessed on 22nd September 2024). No pre-selection of stage (age) and assay type (includes RNA and protein-based assays) was applied. The colors in the grid (blues for expression detected and reds for expression not detected) get progressively darker when there are more supporting annotations. The darker colors do not denote higher or lower levels of expression, just more evidence.

      Author response image 15.

      Expression of genes from the identified module across various mouse tissue structures. The expression matrices for age-selected mouse marked as adult (A) or young individuals (collected ages labelled P42-84 / P w6-w12 / P m1.5-3.0) (B) are presented and were generated using RNASeq Heatmap tool of Gene eXpression Database (https://www.informatics.jax.org/gxd/, accessed on 2nd October 2024).

      Author response image 16.

      Expression of genes from the identified module across various cell types and organs in t-SNE embedding of Tabula Muris dataset. (A) t-SNE clustering color-coded by organ. (B-F) t-SNE clustering colorcoded for expression of CAV1 (B), IGFBP7 (C), FHL2 (D), TAGLN (E), and THBS1 (F). The plots were generated using FACS-collected cells data through the visualisation tool available at https://tabulamuris.sf.czbiohub.org/ (accessed on 22nd September 2024).

      Author response image 17.

      Expression of genes from the identified module at the mRNA level across various human tissues. (A-E) Expression levels of CAV1 (A), IGFBP7 (B), FHL2 (C), TAGLN (D), and THBS1 (E). The plots were generated using consensus dataset from Human Protein Atlas v23 https://www.proteinatlas.org/ (accessed on 22nd September 2024).

      Author response image 18.

      Protein levels of genes from the identified module across various human tissues. (A-E) Protein levels of CAV1 (A), IGFBP7 (B), FHL2 (C), TAGLN (D), and THBS1 (E). The plots were generated using Human Protein Atlas v23 https://www.proteinatlas.org/ (accessed on 22nd September 2024).

      Regarding literature values and tissue stiffness, we would like to argue that cell stiffness is not equivalent to tissue stiffness, and we are interested in the former. Tissue stiffness is governed by a combination of cell mechanical properties, cell adhesions, packing and the extracellular matrix. There can be, in fact, mechanically distinct cell types (for example characterized by different metabolic state, malignancy level etc) within one tissue of given stiffness. Hence, we consider that testing for the correlation between tissue stiffness and expression of identified genes is not immediately relevant.

      (3) Fig.5D,H show important time-dependent mechanics that need to be used to provide explanations of the differences in RT-DC (5B,F) and in standard AFM indentation expts (5C,G). In particular, it looks to me that RT-DC is a high-f/short-time measurement compared to the AFM indentation, and an additional Main or Supp Fig needs to somehow combine all of this data to clarify this issue. 

      We thank the reviewer for this comment. It is indeed the case, that cells typically display higher stiffness when probed at higher rates. We have now expanded on this aspect of the results and added a supplementary figure (Fig. S10) that illustrates the frequencies used in different methods and summarizes the apparent Young’s moduli values into one plot in a frequencyordered manner. Of note, we typically acquire RT-DC measurements at up to three flowrates, and the increase in measurement flow rates accompanying increase in flow rate also results in higher extracted apparent Young’s moduli (see Fig. S10 B,D). We have further added Table S9 that summarizes operating parameters of all three methods used for probing cell mechanics in this manuscript:

      “The three techniques for characterizing mechanical properties of cells — RT-DC, AFM indentation and AFM microrheology — differ in several aspects (summarized in Table S9), most notably in the frequency at which the force is applied to cells during the measurements, with RT-DC operating at the highest frequency (~600 Hz), AFM microrheology at a range of frequencies in-between (3–200 Hz), and AFM indentation operating at lowest frequency (5 Hz) (see Table S9 and Figure S10A). Even though the apparent Young’s moduli obtained for TGBCS cells were consistently higher than those for ECC4 cells across all three methods, the absolute values measured for a given cell line varied depending on the methods: RT-DC measurements yielded higher apparent Young’s moduli compared to AFM indentation, while the apparent Young’s moduli derived from AFM microrheology measurements were frequency-dependent and fell between the other two methods (Fig. 5B–D, Fig. S10B). The observed increase in apparent Young’s modulus with probing frequency aligns with previous findings on cell stiffening with increased probing rates observed for both AFM indentation (68, 69) and microrheology assays (70–72).”

      (4) The plots in Fig.S4 are important as main Figs, particularly given the cartoons of different tissues in Fig.1,2. However, positive correlations for a few genes (CAV1, IGFBP7, TAGLN) are most clear for the multiple lineages that are the same (stomach) or similar (gli, neural & pluri). The authors need to add green lines and pink lines in all plots to indicate the 'lineagespecific' correlations, and provide measures where possible. Some genes clearly don't show the same trends and should be discussed. 

      We thank reviewer for this comment. It is indeed an interesting observation (and worth highlighting by adding the fits to lineage-restricted data) that the relationship between relative change in Young’s modulus and the selected gene expression becomes steeper for samples from similar tissue contexts. 

      For the sake of keeping the main manuscript compact, we decided to keep Fig. S7 (formerly Fig. S4) in the supplement, however, we did add the linear fit to the glioblastoma dataset (pink line) and a fit to the related neural/embryonic datasets (gli, neural & pluri – purple line) as advised — see below.

      We did not pool the stomach data since it is represented by a single point in the figure, aligning with how the data is presented in the main text—stomach adenocarcinoma cell lines (MKN1 and MKN45) are pooled in Fig. 1B (see below).

      We have also amended the respective results section to emphasize that, in certain instances, the correlation between changes in mechanical phenotype and alterations in the expression of analysed genes may be less pronounced:

      “The relation between normalized apparent Young’s modulus change and fold-change in the expression of the target genes is presented in Fig. S7. The direction of changes in the expression levels between the soft and stiff cell states in the validation datasets was not always following the same direction (Fig. 4, C to F, Fig. S7). This suggests that the genes associated with cell mechanics may not have a monotonic relationship with cell stiffness, but rather are characterized by different expression regimes in which the expression change in opposite directions can have the same effect on cell stiffness. Additionally, in specific cases a relatively high change in Young’s modulus did not correspond to marked expression changes of a given gene — see for example low CAV1 changes observed in MCF10A PIK3CA mutant (Fig. S7A), or low IGFBP7 changes in intestine and lung carcinoma samples (Fig. S7C). This indicates that the importance of specific targets for the mechanical phenotype change may vary depending on the origin of the sample.”

      (5) Table-1 neuro: Perhaps I missed the use of the AFM measurements, but these need to be included more clearly in the Results somewhere. 

      To clarify: there were no AFM measurements performed for the developing neurons (neuro) dataset, and it is not marked as such in Table 1. There are previously published AFM measurements for the iPSCs dataset (maybe that caused the confusion?), and we referred to them as such in the table by citing the source (Urbanska et al (30)) as opposed to the statement “this paper” (see the last column of Table 1). We did not consider it necessary to include these previously published data. We have added additional horizontal lines to the table that will hopefully help in the table readability.

      Reviewer #3 (For Authors) 

      Major 

      -  I strongly encourage the authors to validate their approach with a gene for which mechanical data does not exist yet, or explore how the combination of the 5 identified genes is the novel regulator of cell mechanics. 

      We appreciate the reviewer’s insightful comment and agree that it would be highly interesting to validate further targets and perform combinatorial perturbations. However, it is not feasible at this point to expand the experimental data beyond the one already provided. We hope that in the future, the collective effort of the cell mechanics community will establish more genes that can be used for tuning of mechanical properties of cells.

      - If this paper aims at highlighting the power of PC-Corr as a novel inference approach, the authors should compare its predictive power to that of classical co-expression network analysis or an alternative gold standard. 

      We thank the reviewer for the suggestion to compare the predictive power of PC-Corr with classical co-expression network analysis or an alternative gold standard. PC-corr has been introduced and characterized in detail in a previous publication (Ciucci et al, 2017, Sci. Rep.), where it was compared against standard co-expression analysis methods. Here we implement PC-corr for a particular application. Thus, we do not see it as central to the message of the present manuscript to compare it with other available methods again.

      - The authors call their 5 identified genes "universal, trustworthy and specific". While they provide a great amount of data all is derived from human and mouse cell lines. I suggest toning this down. 

      We thank the reviewers for this comment. To clarify, the terms universal, trustworthy and specific are based on the specific hypotheses tested in the validation part of the manuscript, but we understand that it may cause confusion. We have now toned that the statement by adding “universal, trustworthy and specific across the studied mouse and human systems” in the following text fragments:

      (1) Abstract

      “(…) We validate in silico that the identified gene markers are universal, trustworthy and specific to the mechanical phenotype across the studied mouse and human systems, and demonstrate experimentally that a selected target, CAV1, changes the mechanical phenotype of cells accordingly when silenced or overexpressed. (...)”

      (2) Last paragraph of the introduction

      “(…) We then test the ability of each gene to classify cell states according to cell stiffness in silico on six further transcriptomic datasets and show that the individual genes, as well as their compression into a combinatorial marker, are universally, specifically and trustworthily associated with the mechanical phenotype across the studied mouse and human systems. (…)”

      (3) First paragraph of the discussion

      “We provided strong evidence that the inferred conserved functional network module contains an ensemble of five genes that, in particular when combined in a unique combinatorial marker, are universal, specific and trustworthy markers of mechanical phenotype across the studied mouse and human systems.”

      Minor suggestions 

      -  The authors point out how genes that regulate mechanics often display non-monotonic relations with their mechanical outcome. Indeed, in Fig.4 developing neurons have lower CAV1 in the stiff group. Perturbing CAV1 expression in that model could show the nonmonotonic relation and strengthen their claim. 

      We thank reviewer for highlighting this important point. It would indeed be interesting to explore the changes in cell stiffness upon perturbation of CAV1 in a system that has a potential to show an opposing behavior. Unfortunately, we are unable to expand the experimental part of the manuscript at this time. We do hope that this point can be addressed in future research, either by our team or other researchers in the field. 

      -  In their gene ontology enrichment assay, the authors claim that their results point towards reduced transcriptional activity and reduced growth/proliferation in stiff compared to soft cells. Proving this with a simple proliferation assay would be a nice addition to the paper. 

      This is a valuable suggestion that should be followed up on in detail in the future. To give a preliminary insight into this line of investigation, we have had a look at the cell count data for the CAV1 knock down experiments in TGBC cells. Since CAV1 is associated with the GO Term “negative regulation of proliferation/transcription” (high CAV1 – low proliferation), we would expect that lowering the levels of CAV1 results in increased proliferation and higher cell counts at the end of experiment (3 days post transfection). As illustrated in Author response image 19 below, the cell counts were higher for the samples treated with CAV1 siRNAs, though, not in a statistically significant way. Interestingly, the magnitude of the effect partially mirrored the trends observed for the cell stiffness (Figure 5F).

      Author response image 19.

      The impact of CAV1 knock down on cell counts in TGBC cells. (A) Absolute cell counts per condition in a 6-well format. Cell counts were performed when harvesting for RT-DC measurements using an automated cell counter (Countess II, Thermo Fisher Scientific). (B) The event rates observed during the RT-DC measurements. The harvested cells are resuspended in a specific volume of measuring buffer standardized per experiment (50-100 μl); thus, the event rates reflect the absolute cell numbers in the respective samples. Horizontal lines delineate medians with mean absolute deviation (MAD) as error, datapoints represent individual measurement replicates, with symbols corresponding to matching measurement days. Statistical analysis was performed using two sample two-sided Wilcoxon rank sum test.

      Methods

      - The AFM indentation experiments are performed with a very soft cantilever at very high speeds. Why? Also, please mention whether the complete AFM curve was fitted with the Hertz/Sneddon model or only a certain area around the contact point. 

      We thank the reviewer for this comment. However, we believe that the spring constants and indentation speeds used in our study are typical for measurements of cells and not a cause of concern. 

      For the indentation experiments, we used Arrow-TL1 cantilevers (nominal spring constant k = 0.035-0.045 N m<sup>−1</sup>, Nanoworld, Switzerland) which are used routinely for cell indentation (with over 200 search results on Google Scholar using the term: "Arrow-TL1"+"cell", and several former publications from our group, including Munder et al 2016, Tavares et al 2017, Urbanska et al 2017, Taubenberger et al 2019, Abuhattum et al 2022, among others). Additionally, cantilevers with the spring constants as low as 0.01 N m−1 can be used for cell measurements (Radmacher 2002, Thomas et al, 2013). 

      The indentation speed of 5 µm s<sup>−1</sup> is not unusually high and does not result in significant hydrodynamic drag. 

      For the microrheology experiments, we used slightly stiffer and shorter (100/200 µm compared to 500 µm for Arrow-TL1) cantilevers: PNP-TR-TL (nominal spring constant k = 0.08 N m<sup>−1</sup>, Nanoworld, Switzerland). The measurement frequencies of 3-200 Hz correspond to movements slightly faster than 5 µm s<sup>−1</sup>, but cells were indented only to 100 nm, and the data were corrected for the hydrodynamic drag (see equation (8) in Methods section).

      Author response image 20.

      Exemplary indentation curve obtained using arrow-TL1 decorated with a 5-µm sphere on a ECC4 cell. The shown plot is exported directly from JPK Data Processing software. The area shaded in grey is the area used for fitting the Sneddon model.  

      In the indentation experiments, the curves were fitted to a maximal indentation of 1.5 μm (rarely exceeded, see Author response image 20). We have now added this information to the methods section:

      - Could the authors include the dataset wt #1 in Fig 4D? Does it display the same trend? 

      We thank the reviewer for this comment. To clarify: in the MCF10A dataset (GEO: GSE69822) there are exactly three replicates of each wt (wild type) and ki (knock-in, referring to the H1047R mutation in the PIK3CA) samples. The numbering wt#2, wt#3, wt#4 originated from the short names that were used in the working files containing non-averaged RPKM (possibly to three different measurement replicates that may have not been exactly paired with the ki samples). We have now renamed the samples as wt#1, wt#2 and wt#3 to avoid the confusion. This naming also reflects better the sample description as deposited in the GSE69822 dataset (see Author response table 2).

      Author response table 2.

      - Reference (3) is an opinion article with the last author as the sole author. It is used twice as a self-standing reference, which is confusing, as it suggests there is previous experimental evidence. 

      We thank the reviewer for pointing this out and agree that it may not be appropriate to cite the article (Guck 2019 Biophysical Reviews, formerly Reference (3), currently Reference (76)) in all instances. The references to this opinion article have now been removed from the introduction:

      “The extent to which cells can be deformed by external loads is determined by their mechanical properties, such as cell stiffness. Since the mechanical phenotype of cells has been shown to reflect functional cell changes, it is now well established as a sensitive label-free biophysical marker of cell state in health and disease (1-2).”

      “Alternatively, the problem can be reverse-engineered, in that omics datasets for systems with known mechanical phenotype changes are used for prediction of genes involved in the regulation of mechanical phenotype in a mechanomics approach.”

      But has been kept in the discussion:

      “The mechanical phenotype of cells is recognized as a hallmark of many physiological and pathological processes. Understanding how to control it is a necessary next step that will facilitate exploring the impact of cell mechanics perturbations on cell and tissue function

      (76).”.

      This reference seems appropriate to us as it expands on the point that our ability to control cell mechanics will enable the exploration of its impact on cell and tissue function, which is central to the discussion of the current manuscript. 

      -The authors should mention what PC-corr means. Principle component correlation? Pearson's coefficient correlation? 

      PC-corr is a combination of loadings from the principal component (PC) analysis and Pearson’s correlation for each gene pair. We have aimed at conveying this in the “Discriminative network analysis on prediction datasets” result section. We have now added and extra sentence at the first appearance of PC-corr to clarify that for the readers from the start:

      “After characterizing the mechanical phenotype of the cell states, we set out to use the accompanying transcriptomic data to elucidate genes associated with the mechanical phenotype changes across the different model systems. To this end, we utilized a method for inferring phenotype-associated functional network modules from omics datasets termed PCCorr (28), that relies on combining loadings obtained from the principal component (PC) analysis and Pearson’s correlation (Corr) for every pair of genes. PC-Corr was performed individually on two prediction datasets, and the obtained results were overlayed to derive a conserved network module. Owing to the combination of the Pearson’s correlation coefficient and the discriminative information included in the PC loadings, the PC-corr analysis does not only consider gene co-expression — as is the case for classical co-expression network analysis — but also incorporates the relative relevance of each feature for discriminating between two or more conditions; in our case, the conditions representing soft and stiff phenotypes. The overlaying of the results from two different datasets allows for a multi-view analysis (utilizing multiple sets of features) and effectively merges the information from two different biological systems.”

      - The formatting of Table 1 is confusing. Horizontal lines should be added to make it clear to the reader which datasets are human and which mouse as well as which accession numbers belong to the carcinomas. 

      Horizontal lines have now been added to improve the readability of Table 1. We hope that makes the table easier to follow and satisfies the request. We assume that further modifications to the table appearance may occur during publishing process in accordance with the publisher’s guidelines. 

      - In many figures, data points are shown in different shapes without an explanation of what the shapes represent. 

      We thank the reviewer for this comment and apologize for not adding this information earlier. We have added explanations of the symbols to captions of Figures 2, 3, 5, and 6 in the main text:

      “Fig. 2. Mechanical properties of divergent cell states in five biological systems. Schematic overviews of the systems used in our study, alongside with the cell stiffness of individual cell states parametrized by Young’s moduli E. (…) Statistical analysis was performed using generalized linear mixed effects model. The symbol shapes represent measurements of cell lines derived from three different patients (A), matched experimental replicates (C), two different reprogramming series (D), and four different cell isolations (E). Data presented in (A) and (D) were previously published in ref (29) and (30), respectively.”

      “Fig. 3. Identification of putative targets involved in cell mechanics regulation. (A) Glioblastoma and iPSC transcriptomes used for the target prediction intersect at 9,452 genes. (B, C) PCA separation along two first principal components of the mechanically distinct cell states in the glioblastoma (B) and iPSC (C) datasets. The analysis was performed using the gene expression data from the intersection presented in (A). The symbol shapes in (B) represent cell lines derived from three different patients. (…)”

      “Fig. 5. Perturbing levels of CAV1 affects the mechanical phenotype of intestine carcinoma cells. (…) In (E), (F), (I), and (J), the symbol shapes represent experiment replicates.”

      “Fig. 6. Perturbations of CAV1 levels in MCF10A-ER-Src cells result in cell stiffness changes. (…)  Statistical analysis was performed using a two-sided Wilcoxon rank sum test. In (B), (D), and (E), the symbol shapes represent experiment replicates.”

      As well as to Figures S2, S9, and S11 in the supplementary material (in Figure S2, the symbol explanation was added to the legends in the figure panels as well): 

      “Fig. S2. Plots of area vs deformation for different cell states in the characterized systems. Panels correspond to the following systems: (A) glioblastoma, (B) carcinoma, (C) non-tumorigenic breast epithelia MCF10A, (D) induced pluripotent stem cells (iPSCs), and (E) developing neurons. 95%- and 50% density contours of data pooled from all measurements of given cell state are indicated by shaded areas and continuous lines, respectively. Datapoints indicate medians of individual measurements. The symbol shapes represent cell lines derived from three different patients (A), two different reprogramming series (D), and four different cell isolations (E), as indicated in the respective panels. (…).”

      “Fig. S9. CAV1 knock-out mouse embryonic fibroblasts (CAV1KO) have lower stiffness compared to the wild type cells (WT). (…) (C) Apparent Young’s modulus values estimated for WT and CAV1KO cells using areadeformation data in (B). The symbol shapes represent experimental replicates. (…)”

      “Fig. S11. Plots of area vs deformation from RT-DC measurements of cells with perturbed CAV1 levels. Panels correspond to the following experiments: (A and B) CAV1 knock-down in TGBC cells using esiRNA (A) and ONTarget siRNA (B), (C and D) transient CAV1 overexpression in ECC4 cells (C) and TGBC cells (D). Datapoints indicate medians of individual measurement replicates. The isoelasticity lines in the background (gray) indicate regions of of same apparent Young’s moduli. The symbol shapes represent experimental replicates.”

      - In Figure 2, the difference in stiffness appears bigger than it actually is because the y-axes are not starting at 0. 

      While we acknowledge that starting the y-axes at a value other than 0 is generally not ideal, we chose this approach to better display data variability and minimize empty space in the plots.

      A similar effect can be achieved with logarithmic scaling, which is a common practice (see  Author response image 21 for visualization). We believe our choice of axes cut-off enhances the interpretability of the data without misleading the viewer.

      Author response image 21.

      Visualization of different axis scaling strategies applied to the five datasets presented in Figure 2 of the manuscript. 

      Of note, apparent Young’s moduli obtained from RT-DC measurements typically span 0.5-3.0 kPa (see Figure 2.3 from Urbanska et al 2021, PhD thesis). Differences between treatments rarely exceed a few hundred pascals. For example, in an siRNA screen of mitotic cell mechanics regulators in Drosophila cells (Kc167), the strongest hits (e.g., Rho1, Rok, dia) showed changes in stiffness of 100-150 Pa (see Supplementary Figure 11 from Rosendahl, Plak et al 2018, Nature Methods 15(5): 355-358).

      - In Figure 3, I don't personally see the benefit of showing different cut-offs for PC-corr. In the end, the paper focuses on the 5 genes in the pentagram. I think only showing one of the cutoffs and better explaining why those target genes were picked would be sufficient and make it clearer for the reader. 

      We believe it is beneficial to show the extended networks for a few reasons. First, it demonstrates how the selected targets connect to the broader panel of the genes, and that the selected module is indeed much more interconnected than other nodes. Secondly, the chosen PC-corr cut-off is somewhat arbitrary and it may be interesting to look through the genes from the extended network as well, as they are likely also important for regulating cell mechanics. This broader view may help readers identify familiar genes and recognizing the connections to relevant signaling networks and processes of interest.

      - In Figure 4C, I suggest explaining why the FANTOM5 and not another dataset was used for the visualization here and mentioning whether the other datasets were similar. 

      In Figure 4C, we have chosen to present data corresponding to FANTOM5, because that was the only carcinoma dataset in which all the cell lines tested mechanically are presented. We have now added this information to the caption of Figure 4. Additionally, the clustergrams corresponding to the remaining carcinoma datasets (CCLE RNASeq, Genetech ) are presented in supplementary figures S4-S6. 

      “The target genes show clear differences in expression levels between the soft and stiff cell states and provide for clustering of the samples corresponding to different cell stiffnesses in both prediction and validation datasets (Fig. 4, Figs. S4-S6).”

      Typos 

      We would like to thank the Reviewer#3 for their detailed comments on the typos and details listed below. This is much appreciated as it improved the quality of our manuscript.

      -  In the first paragraph of the results section the 'and' should be removed from this sentence: Each dataset encompasses two or more cell states characterized by a distinct mechanical phenotype, and for which transcriptomic data is available. 

      The sentence has been corrected and now reads:

      “Each dataset encompasses two or more cell states characterized by a distinct mechanical phenotype, and for which transcriptomic data is available.”

      -  In the methods in the MCF10A PIK3CA cell lines part, it says cell liens instead of cell lines. 

      The sentence has been corrected and now reads:

      “The wt cells were additionally supplemented with 10 ng ml<sup>−1</sup> EGF (E9644, Sigma-Aldrich), while mutant cell lienes were maintained without EGF.”

      -  In the legend of Figure 6 "accession number: GSE17941, data previously published in ())" the reference is missing. 

      The reference has been added.

      -  In the legend of Figure 5 "(E) Verification of CAV1 knock-down in TGBC cells using two knock-down system" 'a' between using and two is missing. 

      The legend has been corrected (no ‘a’ is missing, but it should say systems (plural)):

      -  In Figure 5B one horizontal line is missing. 

      The Figure 5B has been corrected accordingly. 

      -  Terms such as de novo or in silico should be written in cursive. 

      We thank the Reviewer for this comment; however, we believe that in the style used by eLife, common Latin expressions such as de novo or in vitro are used in regular font.

      -  In the heading of Table 4 "The results presented in this table can be reproducible using the code and data available under the GitHub link reported in the methods section." It should say reproduced instead of reproducible. 

      Yes, indeed. It has been corrected.

      -  The citation of reference 20 contains several author names multiple times. 

      Indeed, it has been fixed now:

      -  In Figure S2 there is a vertical line in the zeros of the y axis labels. 

      I am not sure if there was some rendering issue, but we did not see a vertical line in the zeros of the y axis label in Figure S2.

      - The Text in Figure S4 is too small.                   

      We thank the reviewer for pointing this out. We have now revised Figure S7 (formerly Figure S4) to increase the text size, ensuring better readability. (It has also been updated to include additional fits as requested by Reviewer #2).

      - In Table 3 "positive hypothesis II markers are discriminative of samples with stiff/soft independent of data source" the words 'mechanical phenotype' are missing. 

      The column headings in Table 3 have now been updated accordingly.

      - In Table S3 explain in the table headline what vi1, vi2 and v are. I assume the loading for PC1, the loading for PC2 and the average of the previous two values. But it should be mentioned somewhere.

      The caption of table S3 has been updated to explain the meaning of vi1, vi2 and v.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this manuscript, the authors provide strong evidence that the cell surface E3 ubiquitin ligases RNF43 and ZNRF3, which are well known for their role in regulating cell surface levels of WNT receptors encoded by FZD genes, also target EGFR for degradation. This is a newly identified function for these ubiquitin ligases beyond their role in regulating WNT signaling. Loss of RNF43/ZNRF3 expression leads to elevated EGFR levels and signaling, suggesting a potential new axis to drive tumorigenesis, whereas overexpression of RNF43 or ZNRF3 decreases EGFR levels and signaling. Furthermore, RNF43 and ZNRF3 directly interact with EGFR through their extracellular domains.

      Strengths:

      The data showing that RNF43 and ZNRF3 interact with EGFR and regulate its levels and activity are thorough and convincing, and the conclusions are largely supported.

      Weaknesses:

      While the data support that EGFR is a target for RNF43/ZNRF3, some of the authors' interpretations of the data on EGFR's role relative to WNT's roles downstream of RNF43/ZNRF3 are overstated. The authors, perhaps not intentionally, promote the effect of RNF43/ZNRF3 on EGFR while minimizing their role in WNT signaling. This is the case in most of the biological assays (cell and organoid growth and mouse tumor models). For example, the conclusion of "no substantial activation of Wnt signaling" (page 14) in the prostate cancer model is currently not supported by the data and requires further examination. In fact, examination of the data presented here indicates effects on WNT/b-catenin signaling, consistent with previous studies.

      Cancers in which RNF43 or ZNRF3 are deleted are often considered to be "WNT addicted", and inhibition of WNT signaling generally potently inhibits tumor growth. In particular, treatment of WNT-addicted tumors with Porcupine inhibitors leads to tumor regression. The authors should test to what extent PORCN inhibition affects tumor (and APC-min intestinal organoid) growth. If the biological effects of RNF43/ZNRF3 loss are mediated primarily or predominantly through EGFR, then PORCN inhibition should not affect tumor or organoid growth.

      We thank the reviewer’s appreciation of the key strength of our study. We fully agree with the reviewer that RNF43/ZNRF3 play key roles in restraining WNT signaling and their deletions activate WNT signaling that leads  to cancer promotion, as discussed and cited in our manuscript (Hao et al, 2012; Koo et al, 2012). We have revised the language in this manuscript to avoid any confusion or appearance of downplaying this known signaling pathway in cancer progression.

      What we would like to highlight in this work is that our study uncovered an effect of RNF43/ZNRF3 on EGFR, leading to biological impact in multiple model systems. In particular, we included the APC-mutated human cancer cell line HT29 and Apc min mouse intestinal tumor organoids. In the context of APC mutations, β-catenin stabilization and the activation of WNT target genes are essentially decoupled from upstream WNT ligand binding to WNT receptors, thus we could primarily focus on the effect of RNF43/ZNRF3 on EGFR. Our statement of “no substantial activation of WNT signaling” as cited by the reviewer was made in describing the data in Fig. 7E where we did not observe β-catenin accumulation in the nucleus and reasoned no substantial activation of canonical WNT signaling. We agree that further examination would help strengthen the conclusion and appreciate the reviewer’s suggestion of PORCN inhibition experiments. While PORCN inhibition is a valuable experiment in models with abundance of WNT ligands/receptors and non-mutationally activated regulators of WNT signaling (Yu et al, 2020), in biological scenarios with existing APC mutations, another group has previously demonstrated that PORCN inhibition had no observable effect on WNT signaling in APC-deficient cells (PMID: 29533772). In our initial submission, we confirmed this predicted low response to manipulation of WNT signaling components upstream of a mutated APC. We showed that addition of RSPO1 in Apc min mouse intestinal tumor organoids failed to further activate WNT target expression (Fig. 6G). Furthermore, in this revised manuscript, we added new data on EGFR inhibition and PORCN inhibition in WT and Znrf3 KO MEFs (Fig. 6L). PORCN inhibition had no impact on cell growth in neither WT nor Znrf3 KO MEFs, suggesting that Znrf3 KO promoting MEF growth is WNT independent. In contrast, inhibition of EGFR downstream signaling components (Fig. 6L) significantly blocked MEF growth and abolished the impact of Znrf3 KO in MEF growth. This new evidence further supports our main conclusion that RNF43/ZNRF3 controls EGFR signaling to regulate cell growth.

      Reviewer #2 (Public Review):

      Using proteogenomic analysis of human cancer datasets, Yu et al, found that EGFR protein levels negatively correlate with ZNFR3/RNF43 expression across multiple cancers. Interestingly, they found that CRC harbouring the frequent RNF43 G659Vfs*41 mutation exhibits higher levels of EGFR when compared to RNF43 wild-type tumors. This is highly interesting since this mutation is generally not thought to influence Frizzled levels and Wnt-bcatenin pathway activity. Using CRISPR knockouts and overexpression experiments, the authors show that EGFR levels are modulated by ZNRF3/RNF43. Supporting these findings, modulation of ZNRF3/RNF43 activity using Rspondin also leads to increased EGFR levels. Mechanistically, the authors, show that ZNRF3/RNF43 ubiquitinate EGFR and leads to degradation. Finally, the authors present functional evidence that loss of ZNRF3/RNF43 unleashes EGFR-mediated cell growth in 2D culture and organoids and promotes tumor growth in vivo.

      Overall, the conclusions of the manuscript are well supported by the data presented, but some aspects of the mechanism presented need to be reinforced to fully support the claims made by the authors. Additionally, the title of the paper suggests that ZNRF3 and RNF43 loss leads to the hyperactivity of EGFR and that its signalling activity contributes to cancer initiation/progression. I don't think the authors convincingly showed this in their study.

      We thank the reviewer commenting that our “conclusions of the manuscript are well supported by the data presented.”  We address the concerns raised by this reviewer in an itemized way as detailed below:

      Major points:

      (1) EGFR ubiquitination. All of the experiments supporting that ZNFR3/RNF43 mediates EGFR ubiquitination are performed under overexpression conditions. A major caveat is also that none of the ubiquitination experiments are performed under denaturing conditions. Therefore, it is impossible to claim that the ubiquitin immunoreactivity observed on the western blots presented in Figure 4 corresponds to ubiquitinated-EGFR species. Another issue is that in Figure 4A, the experiments suggest that the RNF43-dependent ubiquitination of EGFR is promoted by EGF. However, there is no control showing the ubiquitination of EGFR in the absence of EGF but under RNF43 overexpression. According to the other experiments presented in Figures 4B, 4C, and 4F, there seems to be a constitutive ubiquitination of EGFR upon overexpression. How do the authors reconcile the role of ZNRF3/RNF43 vs c-cbl?

      We agree with this reviewer of the limitation of overexpression experiments. In this manuscript, we actually leveraged both overexpression and knockout systems to demonstrate that ZNRF3/RNF43 regulates EGFR ubiquitination: in Fig 4A, we showed that overexpression of RNF43 increased EGFR ubiquitination; in Fig 4B&C and Fig S3A, we showed that RNF43 knockout decreased EGFR ubiquitination; in Fig 4F, we showed that overexpression of ZNRF3 WT increased EGFR ubiquitination but overexpression of ZNRF3 RING domain deletion mutant failed to increase EGFR ubiquitination.

      We also appreciate the rigor with which the reviewer has approached our methodology. We acknowledge that denaturing conditions can provide additional validation, but the technical challenges associated with denaturing conditions include the potential disruption of epitope structures recognized by these antibodies. Our methodology was chosen to balance the need for accurate detection with the preservation of protein structure and function, which are crucial for understanding the biological implications of EGFR ubiquitination. Moreover, our immunoprecipitation and subsequent Western blotting were stringent with high SDS and 2-ME, optimized to minimize non-specific binding and enhance the specificity of detection. We believe that the data presented are robust and contribute significantly to the existing body of knowledge on EGFR ubiquitination.

      CBL is a well-known E3 ligase of EGFR, and it induces EGFR ubiquitination upon EGF ligand stimulation. Therefore, in order to have a fair comparison of RNF43 and CBL on EGFR ubiquitination, we designed Fig 4A and related experiments in the setting of EGF stimulation. We observed that RNF43 overexpression increased EGFR ubiquitination as potently as CBL did. Following this result, we further demonstrated that knockout of RNF43 decreased endogenous ubiquitinated EGFR level in the unstimulated/basal condition (Fig 4B) as well as in the EGF-stimulated condition (Fig 4C). We acknowledge the importance and interest in fully understanding how ZNRF3/RNF43 interplays with the functions of CBL in regulating EGFR ubiquitination. This line of investigation indeed holds the potential to uncover novel regulatory mechanisms in detail. However, the primary focus of the current study was to establish a foundational understanding of ZNRF3/RNF43 role in regulating EGFR ubiquitination. We look forward to exploring further in future work.

      (2) EGFR degradation vs internalization. In Figure 3C, the authors show experiments that demonstrate that RNF43 KO increases steady-state levels of EGFR and prevents its EGF-dependent proteolysis. Using flow cytometry they then present evidence that the reduction in cell surface levels of EGFR mediated by EGF is inhibited in the absence of RNF43. The authors conclude that this is due to inhibition of EGF-induced internalization of surface EGF. However, the experiments are not designed to study internalization and rather merely examine steady-state levels of surface EGFR pre and post-treatment. These changes are an integration of many things (retrograde and anterograde transport mechanisms presumable modulated by EGF). What process(es) is/are specifically affected by ZNFR3/RNF43? Are these processes differently regulated by c-cbl? If the authors are specifically interested in internalization/recycling, the use of cell surface biotinylation experiments and time courses are needed to examine the effect of EGF in the presence or absence of the E3 ligases.

      We agree that our study design primarily assesses EGFR levels on the cell surface before and after EGF treatment and does not comprehensively measure the whole internalization process. In response to the reviewer’s comments, we have revised the relevant sections of manuscript to clarify that our current findings are focused on changes in cell surface EGFR and do not extend to the detailed mechanisms of EGF-induced internalization or recycling.

      (3) RNF43 G659fs*41. The authors make a point in Figure 1D that this mutant leads to elevated EGFR in cancers but do not present evidence that this mutant is ineffective in mediated ubiquitination and degradation of EGFR. As this mutant maintains its ability to promote Frizzled ubiquitination and degradation, it would be important to show side by side that it does not affect EGFR. This would perhaps imply differential mechanisms for these two substrates.

      Fig 1D is based on bioinformatic analysis of colon cancer patient samples, showing that RNF43 G659Vfs*41 mutant tumors exhibited significantly higher levels of EGFR protein compared to RNF43 WT tumors. Following this lead, we investigated whether this RNF43 G659fs*41 hotspot mutation lost its role in downregulating EGFR. To this end, we transfected the same amount of control vector, RNF43 WT, RING deletion mutant, G659fs*41 mutant DNA into 293T cells and measured the level of EGFR (co-transfected). As shown in Author response image 1, overexpression of RNF43 WT decreased EGFR level while overexpression of RING deletion mutant had no impact on EGFR level as compared with the Vector group, which is consistent with our findings in the manuscript. Cells transfected with the RNF43 G659Vfs*41 mutant exhibited nearly normal levels of EGFR; however, we also observed that RNF43 G659Vfs*41 was less expressed than WT, even though the same amounts of DNA were transfected. Therefore, the insubstantial impact on EGFR levels could be attributed to both functional loss or compromised stability of RNF43 G659Vfs*41 mRNA or protein. Further investigation on RNF43 G659Vfs*41 mRNA and protein stability vs. RNF43 G659Vfs*41 protein function is needed to draw a solid conclusion.

      Author response image 1.

      (4) "Unleashing EGFR activity". The title of the paper implies that ZNRF3/RNF43 loss leads to increased EGFR expression and hence increased activity that underlies cancer. However, I could find only one direct evidence showing that increased proliferation of the HT29 cell line mutant for RNF43 could be inhibited by the EGFR inhibitor Erlotinib. All the other evidence presented that I could find is correlative or indirect (e.g. RPPA showing increased phosphorylation of pathway members upon RNF43 KO, increased proliferation of a cell line upon ZNRF3/ RNF43 KO, decreased proliferation of a cell line upon ZNRF3/RNF43 OE in vitro or in xeno...). Importantly, the authors claim that cancer initiation/ progression in ZNRF3/RNF43 mutants may in some contexts be independent of their regulation of Wnt-bcatenin signaling and relying on EGFR activity upregulation. However, this has not been tested directly. Could the authors leverage their znrf3/RNF43 prostate cancer model to test whether EGFR inhibition could lead to reduced cancer burden whereas a Frizzled or Wnt inhibitor does not?

      More broadly, if EGFR signaling were to be unleashed in cancer, then one prediction would be that these cells would be more sensitive to EGFR pathway inhibition. Could the authors provide evidence that this is the case? Perhaps using isogenic cell lines or a panel of patient-derived organoids (with known genotypes).

      We appreciate the reviewer’s suggestion to provide more direct evidence demonstrating the importance of the ZNRF3/RNF43-EGFR axis in cancer cell proliferation.   In this revised manuscript, we further studied this issue in the WT vs. Znrf3 KO MEF cells. We observed that treatment with the EGFR inhibitor erlotinib did not affect WT MEF but stunted the growth advantage of Znrf3 KO MEF cells (Fig. 6L). On the other hand, treatment with the porcupine inhibitor C59 did not impact either WT or Znrf3 KO MEF cells (Fig. 6L), suggesting a more important role of the ZNRF3/RNF43-EGFR axis in mediating the enhanced cell growth of MEF caused by Znrf3 knockout. Furthermore, considering EGFR is often mutated in human cancer, to increase the clinical relance of our study, we also tested the effect of RNF43 knockout on EGFR L858R (Fig. 2D), a common oncogenic EGFR mutant, and found that RNF43 knockout in HT29 boosted levels of this EGFR mutant detected by its FLAG tag, suggesting that RNF43 degrades both WT and mutated EGFR and its loss can enhance signaling of both WT EGFR and its oncogenic mutant .  However, we emphasize again that this manuscript is in no way written to diminish the proven importance of ZNRF3/RNF43-WNT-β-catenin axis in cancer and development.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      The main conclusion that EGFR is targeted for degradation by RNF43 and ZNRF3 is well supported and documented. Figures 1-5 and associated supplemental figures contain largely convincing data. Figures 6 and 7, however, require some modifications, as follows in order of appearance:

      Figure 6C: Growth of intestinal tumor organoids from Apcmin mice does not require Rspo, however, the authors show that these organoids grow larger in the presence of Rspo, an effect they attribute to increased EGFR activity, rather than increased WNT activity. While this conclusion may be correct, the authors should address this possibility by treating the organoids with PORCN inhibitor. The prediction would be that Rspo treatment still increases organoid size in the presence of PORCN inhibition. A further prediction would be that blocking EGFR (e.g. with Cetuximab) will abrogate the RSPO1 effect.

      Yes, we attributed the impact of Rspo on Apc min organoid growth to enhanced EGFR activity because we observed increased EGFR levels (Fig 6F) but no detectable increase in eight WNT target genes assayed. We agree that further pharmacologic experiments would further boost our conclusion, but our few attempts at treating organoids encountered technical difficulties. Hence, we switched to testing PORCN inhibition vs EGFR inhibition in WT and Znfr33 KO MEFs. As shown in the revised Fig. 6L, EGFR inhibition significantly reversed the growth advantage caused by Znrf3 KO but C59 did not.

      Figure 6G: It is unclear why the authors provide "8-day RSPO1 treatment" data. Here, EGFR mRNA appears to be elevated 2-fold (perhaps not statistically significant), and the Wnt targets Lef1 and Axin2 are decreased, as indicated by the statistical significance. What point is being made here?

      Our observation of increased size of APC min mouse intestinal tumor organoids and increased the EGFR protein levels were at 8 days of RSPO1 treatment. Therefore, we measured mRNA levels at the same time point with the 2-day time point also included for comparison. The goal of this qPCR experiment was to detect the contribution of WNT signaling, and we did not detect an increased transcriptional readout. We included EGFR mRNA levels for comparison, and we did not detect a statistically significant increase, consistent with our experiments concluding that ZNRF3/RNF43 regulate EGFR at the protein level. As stated in the preceding response, these data led us to attribute the impact of Rspo on Apc min organoid growth to enhanced EGFR activity.

      Figure 7A: This requires quantitation. How many mice were used per cell line? The data shown is not particularly convincing, with ZNRF3 overexpressing HT29 cells growing detectably. Showing representative mice is fine, but this should be supplemented with quantitation of all mice.

      We had provided this data. The BLI signal quantification was shown below the representative BLI images. Seven mice were used per cell line, as annotated at the top of the graph.

      Figure 7B: The authors assert that "canonical WNT signaling, based on levels of active-β-Catenin (non-phosphorylated at Ser33/37/Thr41; Figure 7B), remained unaffected". As shown, 2 of the 3 Myc-Znrf3 tumors have increased active-b-catenin signal over the GFP tumors. This indicates to me that canonical Wnt signaling was affected. The authors either need to present quantitative data that supports this claim or modify their conclusions. As presented, I don't think it is appropriate to decouple the effect of Znrf3 overexpression on EGFR from its effect on WNT.

      As requested, we have quantified the level of non-phospho β-Catenin at Ser33/37/Thr41 and found no significant differences (p > 0.05) between the control group vs. ZNRF3 overexpression group. We once again note that our manuscript was not meant to dispute the proven signaling and biological significance of WNT signaling regulation by ZNRF3/RNF43, and we have proof-read the manuscript multiple times to ensure that we did not make any generalized or misleading statements in this aspect.

      Author response image 2.

      Figure 7E: Here the authors assert that "no substantial activation of canonical Wnt signaling" in the Z&R KO tumors, however, the figure shows a substantial increase in active b-catenin staining. The current resolution is insufficient to claim that there is no increase in nuclear b-catenin. The authors' claim that WNT signaling is not involved here is not supported by the data presented here. One way to demonstrate that this effect is through EGFR activation and not through WNT activation is to treat mice with PORCN inhibitor. WNT-addicted tumors, such as by Rnf43 or Znrf3 deletion, regress upon PORCN inhibition. In this case, if the effect of Z&R KO is mediated through EGFR rather than WNT, then there should be no effect on tumor growth upon PORCN inhibition. This is a critical experiment in order to make this point.

      We appreciate the reviewer’s comments and suggestion of experiments. We based our initial statement on insubstantial nuclear β-catenin staining, but we agree that immunohistochemical staining lacks the resolution suitable for quantification. We could not generate the adequate number of KO animals for these in vivo experiments in the window of time planned for this revision. Rather, as shown in the newly added Fig. 6L, we tested EGFR inhibition and PORCN inhibition in Znrf3 KO MEFs and obtained strong data further supporting EGFR in mediating Znrf3 KO promotion of MEF growth. Notwithstanding, we have carefully revised our description of the in vivo data in Fig 7E to avoid any confusion or over-interpretation.

      Minor points:

      Figure 2A: provide quantitation of this immunoblot.

      We have revised manuscript with quantification result shown next to the immunoblot.

      Figure 2B: provide more detail in the figure legend and in the Materials and Methods section on how the KO MEFs were generated. Confirmation that Znrf3 (or in cases of Rnf43 KO) expression is lost in KO would be advisable.

      We have confirmed Znrf3 KO by genotyping and RNF43 KO by immunofluorescent staining. We have also tested multiple commercial anti-ZNRF3 antibodies and anti-RNF43 antibodies for Western blotting, but they all failed.

      Figure 4C is a little misleading. The schematic indicates that ECD-TM and TM-ICD truncations were analyzed for both ZNRF3 and RNF43. However, Figure 4 only shows data for ZNRF3, and the corresponding Figure S4 lacks data for the TM-ICD of Rnf43. A recommendation is to show only those schematics for which data is presented in that figure. On a related topic, the results using the deltaRING constructs (Figure S5) are not mentioned/described in the text.

      We think that the reviewer meant Fig 5C. We have revised the Fig 5C by removing the RNF43 label, and we confirm that  Results section does include the data in Fig S5.

      Figure S4A: Only ZNRF3 is indicated in this figure. Please explain why RNF43 is not represented here. Also, indicate what is plotted along the x-axis.

      We only detected the endogenous ZNRF3-EGFR interaction, possibly because the RNF43 protein level is relatively low in the cell line we used for the mass spec experiment. X-axis is the proteins ordered based on Y-axis values as detailed in the figure legend  -- each data point was arranged along the x axis based on the fold change of iBAQ of EGFR-associated proteins identified in EGF-stimulated vs. control in the log2 scale, from low to high (from left to right on x axis). We have added the phrase “Proteins detected by Mass-Spec” for X-axis.

      Reviewer #2 (Recommendations For The Authors):

      Minor Points.

      (1) In Figure 2B, the authors claim that Znrf3 KO enhanced both EGFR and p-EGFR levels both in the absence and presence of EGF. Although it is clear in the presence of EGF, the increased in p-EGFR in the absence of EGF is less than clear.

      We have revised the manuscript to more clearly state the result in Fig 2B.

      (2) Importantly the authors validated their findings using three independent RNF43 gRNA (fig S2D) but they do not show the editing efficiency obtained with the gRNA.

      We did not include RNF43 IB in this Figure due to lack of specific antibodies for detecting RNR43 in IB. We have no reasons to doubt adequate efficiency of knockout since EGFR was increased compared to the control group. As a result, we did not perform deep sequencing to validate knockout efficacy.

      (3) In S2E, the authors show that KO of either ZNRF3 or RNF43 enhance HER2 levels. This suggests that there is no redundancy between these E3 ligases, at least in this context. How do the authors reconcile that?

      The reviewer raised an interesting issue. Due to the lack of WB antibodies for these two proteins, we would not easily assess the feedback impact of knockout of either gene on the protein levels of the other gene. We speculate that there may be a threshold level of the sum of the two proteins that is needed for adequate degradation of HER2, leading to HER2 increase when either gene is knocked out. Detailed studies of this issue is beyond the scope of this current work.

      (4) Experiments performed in Fig 3C are performed in only one clone. The authors need to repeat in an additional clone or rescue this phenotype using a RNF43 cDNA.

      Our RNF43 KO HT29 line is a pool of KO cells, not a single clone.

      (5) In Figure 7E, the authors suggest that the absence of nuclear bcatenin means that canonical Wnt signaling is unaffected. It is widely known that nuclear bcatenin is often not correlating with pathway activity.

      As stated above, we have revised the manuscript to avoid confusion and misinterpretation.

      (6) What is the nature of the error bars in Fig 3c? Are the differences statistically significant?

      As mentioned in the figure legend, the error bars are SEM. The result is statistically significant, and p-value is noted in the graph.

      (7) In the Figure legends, it should be stated clearly how many biological replicates were performed for each experiment and single data points should be plotted where applicable (e.g. qPCR data). It would be helpful if the uncropped and unprocessed Western blot membranes and replicates that are not shown would be accessible to allow the reader a more comprehensive view of the acquired data, especially for blots that were quantified (e.g. Figure 2F, Figure 3C, there is clearly some defect on the blot).

      For WB representation, it would be helpful to include more size markers on the Western blots (especially on the Ips that show ubiquitin smear) and in general to use a reference protein (GAPDH, Actin, Vinculin) that is closer to the protein being accessed.

      More details should be added in the Methods section to explain how protocols were performed in detail. For example, it should be explained how the viruses used for infecting cells were produced (which plasmids were transfected using which transfection reagent, how long was the virus collected for, etc). Then, it should be stated how long the cells were undergoing selection before being harvested. Because the expression of the viral constructs potentially has an effect on cell proliferation through EGFR, this information is quite relevant. This is just an example, there are details missing in nearly every section (Flow: washing protocols, gating protocols (Live/dead stain?), WB: RIPA lysis buffer composition? How much protein was loaded on blots? How was protein quantification done? IP: how were washes performed and how often repeated?)

      Missing: antibody dilutions for IF, IHC, and WB, plasmid backbones, sequences and availability, qPCR primer sequences from Origene.

      Incucyte experiments are not described.

      We have revised the relevant sections to include more details.

      (8) Line 141: revise text: 2x mRNA abundance in the same sentence.

      Line 162: define intermediate expression better.

      Line 197/198: revise text ('the predominant one'?).

      Line 218/219: revise text (Internalisation of surface EGFR?).

      Line 245: clarify in text that it is endogenous EGFR that is being pulled down.

      Line 264: typo: conserved instead of conservative.

      Line 324: revise text (What does 'unknown significance' mean).

      Line 396/397: revise text: 2x Co-IP in the same sentence.

      Figure 3 D/E: more details on the Method in the figure legend.

      We have revised them accordingly.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations for the Authors):

      The authors provide their data and code via Github, and that shiny apps allow easy access to their data. However, spending a few minutes with the snRNAseq app I could not figure out how to search for individual genes (e.g. DBH) on their web interface. Some changes could help to make this app more user-friendly.

      While it was not possible to easily modify the user interface of the snRNA-seq app itself, we have instead added two additional supplementary figures displaying screenshots and schematics with sequential instructions that provide a short tutorial showing how to search for individual genes and display either spatial gene expression (for the Visium SRT data) or gene expression by cluster or population (for the snRNA-seq data) in each interactive web app (Figure 3-figure supplement 20-21). We hope this makes the apps more accessible and assists users to more easily query specific genes that they are interested in.

      The first sentence of the abstract and line 70 on page 2 need to be revised for language / grammar / clarity.

      We have revised these two sentences. Line 70 on page 2 contained a typo / copy-paste error. Thank you for pointing this out.

      Reviewer #2 (Recommendations For The Authors):

      While the efforts of the authors to identify NE neurons in the LC is appreciated, the data fall a little short of conclusively calling these neurons solely noradrenergic as there is an apparent lack of overlap between TH and SLC6A2 in the spots. Undoubtedly, some spots contain both which is consistent with the RNA scope results, but there is clearly a pattern that shows spots that don't contain both. It would be worth testing the presence of other catecholamines in some of these certain spots particularly dopamine (Kempadoo et al. 2016, Takeuchi et al., 2016, Devoto et al. 2005).

      We agree this is an important point. To more rigorously investigate whether TH is co-expressed within cells that produce other catecholamines, particularly dopamine (DA) in addition to norepinephrine (NE), we have included additional analyses of the snRNA-seq and Visium data, as well as generated additional RNAscope data in the revised manuscript, as follows.

      (i) We investigated the spatial expression of DA neuron marker genes besides TH, including SLC6A3 (encoding the dopamine transporter), ALDH1A1, and SLC26A7 in the Visium samples (Figure 3-figure supplement 15), which shows that these genes are not strongly expressed within the manually annotated LC regions in the Visium samples (see Figure 2-figure supplement 1).

      (ii) We investigated expression of DA neuron marker genes SLC6A3, ALDH1A1, and SLC26A7 in the snRNA-seq clustering (updated heatmap in Figure 3-figure supplement 8), which shows minimal expression of these genes within the NE neuron cluster (cluster 6).

      (iii) Despite the data above suggesting little expression of markers for DA neurons within the human LC, we wanted to investigate this question more thoroughly with an orthogonal method given that relatively lower coverage in the sequencing approaches may miss expression, particularly for more lowly expressed transcripts. We generated new high-resolution RNAscope smFISH images at 40x magnification for samples from 3 additional donors (Br8689, Br5529, and Br5426) showing expression of NE neuron marker genes (DBH and TH), a 5-HT neuron marker gene (TPH2), and a DA neuron marker gene (SLC6A3) within individual cells within the LC regions in these samples. Expression of SLC6A3 within individual NE neurons (identified by co-expression of DBH and TH) was not apparent in these RNAscope images (Figure 3-figure supplement 16).

      Together with the previous high-magnification RNAscope images showing co-expression of NE neuron marker genes (DBH, TH, and SLC6A2) within individual NE neurons (Figure 3-figure supplement 4), these new results further strengthen the conclusion that the observed TH+ cells we profiled in the LC are NE-producing neurons. In our view, the lack of observed co-expression of TH and SLC6A2 within some individual Visium spots is likely due to sampling variability and relatively lower sequencing coverage in the Visium data, rather than a true lack of co-expression. We have included additional text in the Results and Discussion further discussing this issue.

      Likewise, given the low throughput of RNA scope, and the fact that it was not done in a systematic manner, it does not conclusively identify the cell types in the region. It might be worth a systematic survey of the cells in the region with both NE and DA markers. Otherwise, it is suggested that the authors be more conservative with their annotations.

      As discussed above, we have now generated additional high-magnification RNAscope images for 3 independent donors (Br8689, Br5529, and Br5426), visualizing expression of two NE neuron marker genes (DBH and TH), one 5-HT neuron marker gene (TPH2), and one DA neuron marker gene (SLC6A3, encoding the dopamine transporter) within individual cells within the LC region in each sample (Figure 3-figure supplement 16). Expression of the DA neuron marker gene (SLC6A3) within individual NE neuron cell bodies (identified by co-expression of DBH and TH) was not apparent in these RNAscope images. Together with our previous RNAscope images showing co-expression of DBH, TH, and SLC6A2 within individual cells (Figure 3-figure supplement 4), in our view, these results provide strong evidence that the observed TH+ cells in the LC are NE-producing neurons, and the data do not provide supporting evidence for the existence of DA-synthesizing neurons in the human LC.

      For the manual annotation, it would be useful to include HE tissue images to better understand how the annotations were derived especially because the annotations are not well corroborated by the clustering.

      We have now included the H&E stained histology images for the Visium samples in Figure 2-figure supplement 2A, which can be compared with the previous figures showing the manual annotations for the LC regions (Figure 2-figure supplement 1). The histology images can also be viewed at higher resolution through the Shiny web app (https://libd.shinyapps.io/locus-c_Visium/).

      The unsupervised clustering is certainly contingent on the number of genes detected, which is in turn dependent on the quality of the material and the success of the experiment. It is unclear from the methods whether the samples were pooled for clustering. If they were pooled, the author might consider using only the samples with UMIs > 500. The low UMI may represent free-floating RNA, suggesting issues with tissue permeabilization in turn influencing the ability to confidently associate genes with spots. Sticking with the higher quality sample may improve the ability to perform unsupervised clustering.

      For the spot-level unsupervised clustering using BayesSpace, our aim was to demonstrate whether it is feasible to segment the LC and non-LC regions in the Visium samples in a data-driven manner using a spatial clustering algorithm, instead of relying on manual annotations. We performed clustering across samples (i.e. pooled) -- we have included additional wording in the text and figure caption to clarify this. We agree with the reviewer there may be further optimizations possible, such as filtering out spots or samples with low UMI counts. However, filtering out low-UMI spots may also confound the clustering if low-UMI spots are associated with biological signal (e.g. preferentially located in white matter regions).

      Overall, we found that applying data-driven methods such as BayesSpace to segment the LC and non-LC regions did not perform sufficiently to rely on for our downstream analyses (Figure 2-figure supplement 6), and, in our view, further incremental optimizations were unlikely to reach sufficient performance and robustness, so we chose to rely on the manual annotations instead. In addition, as noted in the Results, this avoids potentially inflated false discoveries due to issues of circularity when performing differential gene expression testing between regions defined by unsupervised clustering on the same sets of genes (Gao et al. 2022). We included the BayesSpace results (Figure 2-figure supplement 6) to provide information and ideas to method developers interested in using this dataset as a test case for further development of spatial clustering algorithms. However, further adapting or optimizing these spatial clustering algorithms ourselves was not within the scope of our current work.

      It is not entirely clear why the authors used FANS, especially with the scored tissue. Do the authors think this could have negatively influenced the capture of the desired cell type since FANS can compromise the integrity of the nuclei? In other words, have the authors considered that this may have resulted in a loss rather than enrichment? The proportion of "NE" neurons in the snRNA-Seq data is less than 2% in all cases and at its lowest in sample 6522 which does not correspond well with the proportion of tissue that was manually annotated as containing NE cells, even when taken into consideration the potential size difference of cells. In the same vein, in some samples, there are more "5-HT" neurons in the region than "NE" according to the numbers.

      As noted in our initial response to reviewers (“Response to Public Review Comments”), we used FANS to enrich for neurons based on our previous success with this approach to identify relatively rare neuronal populations in other brain regions (e.g. nucleus accumbens and amygdala; Tran and Maynard et al. 2021). Based on this previous work, our rationale was that without neuronal enrichment, we could potentially miss the LC-NE population, given the relative scarcity and low absolute number of this neuronal population (e.g. estimates of ~50K total in the entire human LC).

      We do not have a definitive answer to the question of whether our use of FANS to enrich for neurons may have led to damage and contributed to the low recovery rate of LC-NE neurons (as well as the relatively increased levels of mitochondrial contamination compared to other brain regions / preparations in the human brain in our hands). Due to our limited tissue resources for this study, we did not have sufficient tissue to perform a direct comparison with non-sorted data. However, we agree with the reviewer that this is plausible, and warrants further investigation in future work. In particular, the relatively large size and fragility of LC-NE neurons, as well as our use of a standard cell straining approach (70 µm, which may not be ideal for this population), may also be contributing factors.

      Systematically optimizing the preparation to attempt to increase recovery rate (and decrease mitochondrial contamination) are important avenues for future work, and we have decided to share our data and experiences now to assist other groups performing related work. We have included additional wording in the Discussion to further highlight these issues.

      The majority of the snRNA-seq remained unannotated "ambiguous" neurons. It would be highly advantageous to include an annotation for these numerous cells.

      These nuclei were unidentifiable due to ambiguous marker gene expression profiles, i.e. expression of pan-neuronal marker genes without clear expression of either excitatory or inhibitory neuronal marker genes (see Figure 3A and Figure 3-figure supplement 8). Since we were not able to clearly identify these clusters, and due to our additional concerns regarding the data quality (e.g. low recovery rate of the NE neuron population of interest, potential cell damage, and mitochondrial contamination), we decided to label these neuronal clusters as “ambiguous” instead of assigning low-confidence cluster labels. We have included additional wording in the Results section to explain this issue.

      The most likely explanation for identifying serotonergic neurons in these samples is the inclusion of the Raphe Nucleus within the dissection, especially since these cells do not map to the LC per se. As such, is there a way to neuroanatomically define the potential inclusion of this region from these tissue blocks used? Or to the contrary, definitively demonstrate the exclusion of the Raphe?

      As noted in our initial response to reviewers (“Response to Public Review Comments”), our dissection strategy in this initial study precluded the ability to keep track of the exact orientation of the tissue sections on the Visium arrays with respect to their location within the brainstem. Therefore, it is not possible to definitively answer the question of whether the dissections included the raphe nucleus, and if so, which portion of it, based on neuroanatomy from the tissue blocks.

      However, during the course of this study and in parallel, ongoing work for other small, challenging brain regions, we developed a number of specialized technical and logistical strategies for keeping track of orientation and mounting serial sections from the same tissue block onto a single spatial array, which is extremely technically challenging. We are now well-prepared for addressing these issues in future studies, e.g. keeping track of the orientation of the dissections and potential inclusion of adjacent neuroanatomical structures. We have included additional details on this issue in the Discussion.

      Given that one sample (Visium capture area) was excluded as it did not seem to contain a representation of the LC for the profiling of "NE" cells, does it make sense to include this sample in the analysis of 5HT cells given the authors are trying to make claims about the cell composition in and around the LC? Since there appears to be little 5HT contribution from this sample and its inclusion results in inconsistency across experiments and not any notable advantages, the authors might want to reconsider its inclusion in the results.

      We identified a cluster of 5-HT neurons in the snRNA-seq data (Figure 3) and used the Visium samples to further investigate the spatial distribution of this population (Figure 3-figure supplement 9). For the enrichment analyses in the Visium data (Figure 3-figure supplement 9C), we used only the 8 Visium samples that passed quality control (QC). We included the 9th sample (which did not pass QC) in the spot plot visualizations (Figure 3-figure supplement 9A-B) for completeness, but did not base our main conclusions on this sample (in this sample, the tissue resource was likely depleted during earlier sections, so the section for the Visium sample was taken slightly past the extent of the LC within this tissue block). We have included additional wording in the Results section and figure captions to clarify this issue.

      For the RNAscope images, it would be useful to include (draw) the manual annotation of the LC to facilitate interpretation. This is especially useful for demonstrating the separate populations of 5HT and "NE" cells. In general, it would be useful to keep a hashed line perimeter for all sections processed by Visium.

      We have now added a dashed outline indicating the manually annotated LC region in the RNAscope image showing the full tissue section (Figure 3-figure supplement 11). The high-magnification RNAscope images (Figure 3-figure supplement 4, 16, and 17) show regions entirely within the LC regions -- we have included additional wording to note this in the figure captions. For the Visium spot

      plots, we either labeled spots within the annotated regions within the figures or included additional wording in the figure captions to refer to the figures showing the annotations (Figure 2-figure supplement 1).

      The authors state that they successfully mapped the NE neuron population from snRNA-seq to the manually annotated regions on the Visium slides. Based on the color-coded map, these results are not very convincing since the abundance of the given transcript profile is extremely low. Here again, it would help to draw a hashed line perimeter on the slide to denote the manually annotated region. Perhaps the authors could try a different strategy for mapping snRNA signal to the slide? However, it appears that the mapping worked better for the capture areas with higher UMI/genes counts. Perhaps the authors should consider using only the slides with high gene/UMI counts.

      We agree that the performance of these analyses (Figure 3-figure supplement 14) was not clearly described in the previous version of the manuscript. We have rewritten the corresponding paragraph in the Results section to make it more clear that the mapping (spot-level deconvolution) performance was relatively poor overall, and that we did not use these results for further downstream analyses. We did however want to include these results from the cell2location algorithm to provide information and data for method developers on the challenges of these types of analyses in our dataset (e.g. due to the presence of rare populations, relatively subtle differences in expression profiles between neuronal subpopulations, and potential issues due to large nuclei size and high transcriptional activity for NE neurons). While further approaches for these types of analyses exist, and additional optimizations such as subsetting samples or spots with high UMI counts could also be investigated, in our view, these further optimizations lie outside the scope of our current work. We have also added wording in the figure caption to refer to Figure 2-figure supplement 1, which displays the corresponding annotated LC regions per sample.

      It is hard to see if the RNA scope image Supplementary Figure 11 shows co-localization of SLC6A2, TH, and DBH. Having the individual image from each microscope filter along with the merged image is required to properly assess the colocalization of the signals.

      We updated the multi-channel RNAscope images to show both the merged channels and individual channels in separate panels (Figure 3-figure supplement 4, 16, and 17), which makes the visualization more clear. Thank you for this suggestion. (Note that the previous Supplementary Figure 11 has been re-numbered to Figure 3-figure supplement 4.)

      The heatmap showing the level of marker transcripts shows a much lower expression of specific markers, TH, DBH, SLC6A2 in NE vs other clusters looks surprisingly low (particularly TH), while the much broader marker SLC18A2 (monoamine transporter) is considerably more differential. What do the authors make of this finding?

      This is correct. In the snRNA-seq data, we observed that SLC18A2 is one of the most highly differentially expressed (DE) genes in the NE neuron cluster vs. other neuronal clusters, with a high level of expression in the NE neuron cluster (Figure 3C). Note that this heatmap shows the top 70 DE genes (excluding mitochondrial genes) out of the full list of 327 statistically significant DE genes with elevated expression in the NE neuron cluster (the full list of 327 genes is provided in Supplementary File 2C). While all four of these genes (DBH, TH, SLC6A2, and SLC18A2) are identified as statistically significant DE genes, SLC18A2 is the most highly DE out of these and has an especially high level of expression in the NE neuron cluster, as noted by the reviewer (Figure 3C). This could be due to the fact that SLC18A2 transcripts are expressed at higher absolute levels in these neurons than the transcripts that are more specific to LC-NE neurons. While it is true that SLC18A2 is a “broader” marker in the sense that it is found in more cell types -- e.g. cell types within brain nuclei that contain monoaminergic as well as brain nuclei that contain catecholaminergic cells -- expression of SLC18A2 within the LC is highly specific to the catecholaminergic LC-NE neurons given its specialized functional role within monoamine and catecholamine neurons in packaging amine neurotransmitters into synaptic vesicles. We note that SLC18A2 plays a specialized role that is critical to the core function of LC-NE neurons, and hence we are not particularly surprised with this finding and think that one possibility is that this differential expression appears more robustly due to higher absolute levels of the marker.

      While it is understandable that the authors decided to include cells/nuclei with high mitochondrial reads, further work is needed to ensure these cells are of sufficient quality to use in an unbiased way knowing that a high percentage of mitochondrial reads in nuclei sequencing is usually indicative of low-quality nuclei. This can be assessed by evaluating the quality of the nuclei with GWA, which stains an intact nuclear membrane acting as a measure of the integrity of the nuclei.

      To further investigate these results, we added additional analyses evaluating quality control (QC) metrics for the NE neuron cluster in the snRNA-seq data, which had an unusually high proportion of mitochondrial reads (Figure 3-figure supplement 2, shown also below in comments for Reviewer 3) (see also related Figure 3-figure supplement 1, 3, which were included in the manuscript previously). These additional QC analyses do not show any other problematic values for this cluster, other than the high mitochondrial proportion, so we do not believe this is purely a data quality issue. We are aware that this is an unexpected result -- in most cell populations, a high proportion of mitochondrial reads would be indicative of cell damage and poor data quality. However, we have recently also observed high mitochondrial proportions in other relatively rare neuronal populations characterized by large size and high metabolic demand. As discussed below for Reviewer 3, we believe that this is mitochondrial “contamination”, as there should be no mitochondrial reads per se within the nuclear compartment.

      However, it may be possible that in cell populations that have abundant levels of mitochondria and high transcript expression of mitochondrial transcripts in the cell body, that the likelihood of ambient RNA capture of mitochondrial transcripts during nuclear preparation may be higher than for other cell types that have lower expression of mitochondrial transcripts. Hence, we believe that our interpretation is likely correct, i.e. that a combination of technical and biological factors contributes to the inclusion of a relatively high amount of mitochondrial RNA within the droplets for these nuclei. We agree with the reviewer that this finding warrants further investigation in future work. However, in our current study, the tissue resource is depleted for any further experimental validation of this question, so we preferred to provide our data to the community in its current form, while transparently noting this unexpected finding in our results. We have included additional text in the Results section describing the new QC analyses shown in Figure 3-figure supplement 2.

      Minor comments:

      Line 319-321 could be written more clearly to indicate that due to the lack of resolution in a given spot, there are "contaminating reads" that reduce the precision of the cell profile. This reduced precision is likely what results in the "lack of conservation" across species.

      We have added additional wording to this sentence to clarify this point.

      In the discussion, the authors write that the analyses "unbiasedly identified a number of genes enriched in human LC", however, given the manual annotation of the region for each capture area, this resulted in a biased assessment of the spots.

      We have replaced this wording to refer to “untargeted, transcriptome-wide” analyses (i.e. analyses that are not based on a targeted panel of genes) instead of “unbiased”. We agree that the meaning of “unbiased” is ambiguous in this context.

      Reviewer #3 (Recommendations For The Authors):

      Major points:

      Overall, the discovery of some cells in the LC region that express serotonergic markers is intriguing. However, no evidence is presented that these neurons actually produce 5-HT. Perhaps more conservative language would be appropriate (i.e. "cells that possess mRNA signatures of serotonergic neurons" or something like that). Did these cells co-express other markers one would expect in 5-HT neurons like 5-HT autoreceptors and SLC6A18? Also would be useful to compare expression profiles of these putative 5-HT neurons with any published material on bona fide dorsal raphe 5-HT neurons. For the RNAscope confirmation in the supplementary material, it would be helpful to show each marker separately as well as the overlay, and to include representative higher magnification images like were provided for the ACH markers.

      Thank you for this comment. In order to further investigate the identity of these cells, we have investigated the expression of several additional genes including SLC6A18, 5-HT autoreceptor genes (HTR1A, HTR1B), marker genes for 5-HT neurons (SLC18A2, FEV), and marker genes for 5-HT neuronal subpopulations within the dorsal and median raphe nuclei from the literature (Ren et al. 2019), in both the Visium and the snRNA-seq data.

      We observed some expression of SLC18A2 and FEV within the same areas as SLC6A4 and TPH2 in the Visium samples (Figure 3-figure supplement 10A-B, reproduced below; note that SLC18A2 is also a marker gene for NE neurons located within the LC regions), consistent with Ren et al. (2019). However, we did not observe a strong or consistent expression signal for the 5-HT autoreceptors (HTR1A, HTR1B) (Figure 3-figure supplement 10C-D, reproduced below), and we observed zero expression of SLC6A18 in the Visium samples. In the snRNA-seq data, within the cluster identified as 5-HT neurons, we observed some expression of SLC18A2, low expression of FEV, and almost zero expression of SLC6A18 (Figure 3-figure supplement 8, reproduced below; note that SLC6A18 is not shown since it was removed during filtering for low-expressed genes). Similarly, we observed very low expression of the 5-HT autoreceptors (HTR1A, HTR1B) and the additional marker genes for 5-HT neuronal subpopulations from Ren et al. (2019) -- with the possible exception of the neuropeptide receptor gene HCRTR2, which was identified by Ren et al. (2019) within several clusters in both the dorsal and median raphe in mice (Figure 3-figure supplement 8, reproduced below).

      Overall, these additional results give us some further confidence that these are likely 5-HT neurons (due to expression of SLC18A2 and FEV), while also raising further questions (due to the absence of 5-HT autoreceptor genes HTR1A, HTR1B and 5-HT neuronal subpopulation marker genes). While we believe that the most likely explanation is the inclusion of 5-HT neurons from the edges of the adjacent dorsal raphe nuclei in our samples, we acknowledge that the evidence presented is not fully conclusive and does not identify specific subpopulations of 5-HT neurons. In addition, the limited size of our dataset (number of samples and cells) and the lack of information on sample orientation precludes any definitive identification of subpopulations based on their association with specific anatomical regions within the dorsal raphe nuclei. We have updated the manuscript by (i) adjusting our language in the Results and Discussion, (ii) including the additional analyses, supplementary figures, and reference to the literature (Ren et al. 2019) discussed above, and (iii) including additional wording in the Discussion on improvements to the dissection strategy that would allow these questions to be addressed in future studies via a focused molecular profiling of the dorsal raphe nuclei across the rostral-caudal axis.

      Regarding the RNAscope images, we have included additional images showing channels side-by-side and higher magnification, as suggested (and also discussed above for Reviewers 1 and 2). In addition, we have added an outline highlighting the LC region in Figure 3-figure supplement 11 (as suggested above by Reviewer 2), and included an additional high-magnification RNAscope image demonstrating co-expression of 5-HT neuron marker genes (TPH2 and SLC6A4) within individual cells (Figure 3-figure supplement 12).

      Concerning the snRNA-seq experiments, why were only 3 of the 5 donors used, particularly given the low number of LC-NE nuclear transcriptomes obtained? How were the 3 donors chosen from the 5 total donors and how many 100 um sections were used from each donor? Are the 295 nuclei obtained truly representative of the LC population or are they just the most resilient LC nuclei? How many LC nuclei would be estimated to be captured from staining the 100 um tissue sections?

      As discussed in our previous response to reviewers (“Response to Public Review Comments”), the reason we included only 3 of the 5 donors for the snRNA-seq assays was due to tissue availability on the tissue blocks. In this study, we were working with a finite tissue resource. Due to the logistics and thickness of the required tissue sections for Visium (10 μm) and snRNA-seq (100 μm), running Visium first allowed us to ensure that we could collect data from both assays -- if we ran snRNA-seq first and captured no neurons, the tissue block would be depleted. Due to resource depletion, we did not have sufficient available tissue remaining on all tissue blocks to run the snRNA-seq assay for all donors. We have conducted extensive piloting in other brain regions on the amount (mg) of tissue that is needed from various sized cryosections, and the LC is particularly difficult since these are small tissue blocks and the extent of the structure is small. Hence, in some of the subjects, we did not have sufficient tissue available for the snRNA-seq assay.

      We have included details on the number of 100 μm sections used for each donor in Methods -- this varied between 10-15 sections per donor, approximating 50-80 mg of tissue per donor.

      Regarding the question about the representativeness / resilience of the LC nuclei -- as discussed in our previous response to reviewers (“Response to Public Review Comments”) and above for Reviewer 2, we agree that this is a concern. As discussed above for Reviewer 2, it is plausible that our use of FANS may have contributed to cell damage and the low recovery rate of LC-NE neurons. The relatively large size and fragility of LC-NE neurons, as well as our use of a standard cell straining approach (70 µm, which may not be ideal for this population), may also be contributing factors. Due to our limited tissue resource, we did not have sufficient tissue to perform a direct comparison with non-sorted data.

      Systematically optimizing the preparation to attempt to increase recovery rate is an important avenue for future work. We have included additional discussion of this issue in the Discussion.

      Regarding the question about the number of expected nuclei, we have now included estimates of the number of cells per spot within the LC regions in the Visium data (see also related point below, and Figure 2-figure supplement 2B reproduced below), based on the H&E stained histology images and use of cell segmentation software (VistoSeg; Tippani et al. 2022). While we do not have any confident estimates of the number of expected nuclei in the snRNA-seq data, these estimates of cell density from the Visium data could, together with information on additional factors such as the accuracy of the tissue scoring and the effectiveness of FANS, be used to help derive an an expected number of nuclei in future studies. We have included additional wording in the Discussion to note that these estimates could be used in this manner during future studies.

      The LC displays rostral/caudal and dorsal/ventral differences, including where they project, which functions they regulate, and which parts are vulnerable in neurodegenerative disease (e.g. Loughlin et al., Neuroscience 18:291-306, 1986; Dahl et al., Nat Hum Behav 3:1203-14, 2019; Beardmore et al., J Alzheimer's Dis 83:5-22, 2021; Gilvesy et al., Acta Neuropathol 144:651-76, 2022; Madelung et al., Mov Disord 37:479-89, 2022). Which part(s) of the LC was captured for the SRT and snRNAseq experiments?

      As discussed in our previous response to reviewers (“Response to Public Review Comments”), a limitation of this study was that we did not record the orientation of the anatomy of the tissue sections, precluding our ability to annotate the tissue sections with the rostral/caudal and dorsal/ventral axis labels. We agree with the reviewer that additional spatial studies, in future work, could offer needed and important information about expression profiles across the spatial axes (rostral/caudal, ventral/dorsal) of the LC. Our study provides us with insight about optimizing the dissections for spatial assays, as well as bringing to light a number of technical and logistical issues that we had not initially foreseen. For example, during the course of this study and parallel, ongoing work in other, small, challenging regions, we have now developed a number of specialized technical and logistical strategies for keeping track of orientation and mounting serial sections from the same tissue block onto a single spatial array, which is extremely technically challenging. We are now well-prepared for addressing these issues in future studies with larger numbers of donors and samples in order to make these types of insights. We have included additional details in the Discussion to further discuss this point.

      The authors mention that in other human SRT studies, there are typically between 1-10 cells per expression spot. I imagine that this depends heavily on the part of the brain being studied and neuronal density. In this specific case, can the authors estimate how many LC cells were contained in each expression spot?

      We have now performed additional analyses to provide an estimate of the number of cells per spot in the Visium data (Figure 2-figure supplement 2B), based on the application of cell segmentation software (VistoSeg; Tippani et al. 2022) to identify cell bodies in the H&E stained histology images. We applied this methodology and calculated summary statistics within the annotated LC regions for 6 samples (see Methods), and found that the median number of cells per spot within the LC regions ranged from 2 to 5 per sample. We note that these estimates include both NE neurons and other cell types within the LC regions, and that applying cell segmentation software in this brain region is particularly challenging due to the wide range in cell body sizes, with NE neurons being especially large. We have included these updated estimates in the Results and Discussion, and additional details in Methods.

      Regarding comparison of human LC-associated genes with rat or mouse LC-associated genes (Fig. 2D-F), the authors speculate that the modest degree of overlap may be due to species differences between rodent and human and/or methodological differences (SRT vs microarray vs TRAP). Was there greater overlap between mouse and rat than between mouse/rat and human? If so, that is evidence for the former. If not, that is evidence for the latter. Also would be useful for more in-depth comparison with snRNA-seq data from mouse LC. https://www.biorxiv.org/content/10.1101/2022.06.30.498327v1

      Our comparisons with the mouse (Mulvey et al. 2018) and rat (Grimm et al. 2004) data showed that we observed a relatively higher overlap between the human vs. mouse data than the human vs. rat data (Figures 2F-G and 3D-E). However, we note that the substantially different technologies used (TRAP-seq in mouse vs. laser capture microdissection and microarrays in rat) make it difficult to confidently interpret the degree of overlap between the two studies, and a direct comparison of these alternative platforms (TRAP-seq vs. LCM / microarray) or species (mouse vs. rat) lies outside the scope of our study. We have included updated wording in the Results and Discussion to explain this issue and help interpret these results.

      Regarding the newer mouse study using snRNA-seq (Luskin and Li et al. 2022), we have extended our analyses to perform a more in-depth comparison with this study. Specifically, we have evaluated the expression of an additional set of GABAergic neuron marker genes from this study within our secondary clustering of inhibitory neurons in the snRNA-seq data (Figure 3-figure supplement 13B). We observe some evidence of cluster-specific expression of several genes, including CCK, PCSK1, PCSK2, PCSK1N, PENK, PNOC, SST, and TAC1. We have also included additional text describing these results in the Results section.

      The finding of ACHE expression in LC neurons is intriguing. Susan Greenfield has published a series of papers suggesting that ACHE has functions independent of ACH metabolism that contributes to cellular vulnerability in neurodegenerative disease. This might be worth mentioning.

      We thank the reviewer for pointing this out. We were very surprised too by the observed expression of SLC5A7 and ACHE in the LC regions (Visium data) and within the LC-NE neuron cluster (snRNA-seq data), coupled with absence of other typical cholinergic marker genes (e.g. CHAT, SLC18A3), and we do not have a compelling explanation or theory for this. Hence, the work of Susan Greenfield and colleagues suggesting non-cholinergic actions of ACHE, particularly in other catecholaminergic neuron populations (e.g. dopaminergic neurons in the substantia nigra) is very interesting. We have included references to this work and how it could inform interpretation of this expression (Greenfield 1991; Halliday and Greenfield 2012) in the Discussion.

      High mitochondrial reads from snRNA-seq can indicate lower quality. Can the authors comment on this and explain why they are confident in the snRNA-seq data from presumptive LC-NE neurons?

      As mentioned above for Reviewer 2, we have included additional analyses to further compare quality control (QC) metrics for the NE neuron cluster (which had an unusually high proportion of mitochondrial reads) against other neuronal and non-neuronal clusters and nuclei in the snRNA-seq data (Figure 3-figure supplement 2). These additional QC analyses do not show any other problematic values for this cluster. Specifically, we show that the QC metric values for sum UMIs and detected genes per droplet for the NE neuron cluster fall within the range for (A) other neurons and (B) all other nuclei (excluding droplets with ambiguous / unidentifiable neuronal signatures). In addition, we observe that the droplets with the highest mitochondrial percentages (>75%) (C-D), which also have unusually low number of detected genes (D), tend to be from the ambiguous category (droplets with ambiguous / unidentifiable neuronal signatures), suggesting that true low-quality droplets are correctly identified and included within the ambiguous category (e.g. consisting of a mixture of debris from partial damaged nuclei) instead of as NE neurons. Since our QC analyses for the NE neuron cluster do not show any problems other than the high mitochondrial percentage, we do not believe these are simply mis-classified low-quality droplets. We also note that we have recently observed high mitochondrial proportions in other relatively rare neuronal populations characterized by large size and high metabolic demand in human data. We believe that our interpretation is correct -- i.e. that a combination of technical and biological factors has led to the inclusion of a relatively high amount of mitochondrial RNA within the droplets for these nuclei. We have included these additional QC analyses (Figure 3-figure supplement 2) and further discussion of this issue in the Results section.

      The Discussion could be expanded. Because there is a lot known and/or assumed about the LC, discussing all of it is certainly beyond the scope of this manuscript. However, perhaps the authors could pick a few more for confirmation and hypothesis generation. For example, one of the most well studied and important aspects of the LC is its regulation by neuromodulatory inputs. It would be interesting for the authors to discuss the expression of receptors for CRF, cannabinoids, orexin, galanin, 5-HT, etc, particularly when compared with the available rodent TRAP and snRNA-seq data (https://www.biorxiv.org/content/10.1101/2022.06.30.498327v1) contained some surprises, such as very low expression of CRF1 in LC-NE neurons, suggesting that the powerful activation of LC cells by CRF is indirect. Does this hold up in humans?

      We have expanded the Discussion to include additional discussion and references on several points, as discussed also above. Indeed these are interesting questions and these neuromodulatory systems are all of interest in the context of signaling within the LC in terms of function of the LC-NE system. We note that the manuscript serves primarily as a data resource and will be useful in many different ways depending on the different goals and interests of the readers. This is precisely why we wanted to take the time to make accessible and easy to use tools to interrogate and visualize the data. We have provided screenshots in Author response image 1-4 from the Shiny visualization app for the Visium data (https://libd.shinyapps.io/locus-c_Visium/) querying several main receptors of the neuromodulatory systems that this reviewer is particularly interested in to illustrate how the visualization apps can readily be used to query specific genes and systems of interest.

      Author response image 1.

      CRHR1:

      Author response image 2.

      CNR1:

      Author response image 3.

      OXR1:

      Author response image 4.

      GALR1:

      Minor points:

      Line 46 add stress responses to the key functions of LC neurons

      We have added this point and included additional references to support the findings.

      Line 47 add that the LC was so named "blue spot" because of its signature production of neuromelanin pigment

      We have added this point.

      Line 49 LC's capacity to synthesize NE is not "unique" - several other brainstem/medullary nuclei also synthesize NE (e.g. A1-A7; LC is A6)

      We have updated this wording.

      Line 54 Although prior evidence indicated age-related LC cell loss in people without frank neurodegenerative disease, recent studies that are better powered and used unbiased stereological methods have refuted the idea that LC neurons die during normal aging (reviewed in Matchett et al., Acta Neuropathologica 141:631-50, 2021)

      We have updated this part of the Introduction to focus on cell loss in the LC in neurodegenerative disease and removed the older references describing studies that suggested LC neurons die in normal aging.

      Line 62 Would also be worth mentioning the role of the LC in other mood disorders where adrenergic drugs are often prescribed, such as PTSD (e.g. prazosin), opioid withdrawal (e.g. lofexidine), anxiety and depression (e.g. NE reuptake inhibitors).

      We have added additional references to these disorders and their treatment with noradrenergic drugs in the Introduction.

      Additional updates from Public Review Comments:

      We have also included the following updates, in response to additional reviewer comments received during the initial round of “Public Review Comments” and which are not already described in the responses to the “Recommendations for the Authors” above.

      ● We included updated wording in the Results section and Figure 1C caption to more clearly describe the number of donors included in the final SRT and snRNA-seq data used for analyses after all quality control (QC) steps (4 donors for SRT data, 3 donors for snRNA-seq data).

      ● Figure 3-figure supplement 1D (number of nuclei per cluster in unsupervised clustering of snRNA-seq data) has been updated to show percentages of nuclei per cluster.

      ● We have added comparisons between the lists of differentially expressed (DE) genes identified in the Visium and snRNA-seq data. To make these sets comparable, we have added (i) snRNA-seq DE testing results between the NE neuron cluster and all other clusters (instead of other neuronal clusters only, as shown in the main results in Figure 3) (excluding ambiguous neuronal) (Figure 3-figure supplement 6 and Supplementary File 2D), and (ii) calculated overlaps and comparisons between the sets of DE genes between the Visium data (pseudobulked LC vs. non-LC regions) and the snRNA-seq data (NE neuron cluster vs. all other clusters excluding ambiguous neuronal). This comparison generated a list of 51 genes that were identified as statistically significant DE genes (FDR < 0.05 and FC > 2) in both the Visium and the snRNA-seq data (Figure 3-figure supplement 7 and Supplementary File 2E).

      Other additional updates:

      We have added an additional data repository (Globus). Raw data files (FASTQ sequencing data files and high-resolution TIF image files) are now available via Globus from the WeberDivecha2023_locus_coeruleus data collection from the jhpce#globus01 Globus endpoint, which is also listed at http://research.libd.org/globus/. The Globus repository is not publicly accessible due to individually identifiable donor genetic variants in the FASTQ files. Approved users may request access from the corresponding authors. This data repository is listed in the Data Availability section.

    1. Author Response

      The following is the authors’ response to the current reviews.

      I greatly appreciate your time and attention on our manuscript. I have carefully considered the reviewers’ comments and made modifications. Below are my responses to each comment and the revisions I have made.

      Reviewer #2 (Recommendations for The Authors):

      1) The authors address well with most of my concerns. I am fine with most of the responses except question 8. Actin is also reported to be located in nuclear (PMID: 31481797). It would be better to utlize other markers, like GAPDH. Moreover, the author did not address the issue of LXRa. I strongly suggest that the authors repeat this experiment to get a more solid result.

      Thank you for the comment! Actin is frequently used as a negative control for nucleus protein in many publications, such as DOI:10.1038/s41419-018-0428-x. Beta-actin is rich in cytoplasm protein that it only takes few seconds to reveal the strong band when performing western blot with cytoplasm. However, actin does not reveal when exposing western- blot with nucleus for minutes in many studies, including in this study. Even though as mentioned actin is also located in the nuclear, such a tiny amount in the nucleus may not be revealed in western blot with exposure in seconds. However, if nucleus protein is contaminated with total cell lysate, the action is quite easy to reveal. As a result, the use of actin as the nagtive control of nucleus protein is well-accepted.

      Author response image 1.

      2) In addition, the authors mentioned IL-1b but present IL-6 in the figure of Figure. 2F. Please correct.

      We appreciate your attention on the detail. “IL-1b” is corrected to “IL-6”.


      The following is the authors’ response to the original reviews.

      I greatly appreciate the time you and the reviewers have taken to review my paper and provide detailed feedback and suggestions. I have carefully considered the reviewers’ comments and made thorough modifications to the paper. Below are my responses to each comment and the revisions I have made.

      Reviewer #1 (Recommendations for The Authors):

      Although the paper has strengths in understanding better the pathway of activation leading to polarization, the mechanisms contributing to cytokine storm are weak. In the context of cellular in vitro changes, it would be very interesting to map these molecular changes to strengthen the pathways affected in this model. In vivo, stronger evidence is required to bridge the gap between the in vitro model and mechanisms regulating in vivo disease development. Reporting of experiments needs to be considerably strengthened. Individual data points are shown, however, it is unclear whether these represent biological or technical, or how many experiments have been undertaken. The addition of this information is essential for uznderstanding the robustness and repeatability of findings. Currently, these cannot be assessed from the information provided. Furthermore, it is unclear whether the error bars represent s.e.m or s.d. which greatly impacts data interpretation.

      Answer: thank you for the valuable comments! We have added some in vivo experiments to strengthen the bridge between the in vitro and in vivo model. 1) The depletion of macrophage by clodronate-liposomes (CLL) i.v. injection was performed in endotoxemic mice with leucine. The alleviation of LPS-induced cytokine production by leucine was muted with macrophage depletion (Figure 2E, F), suggesting the anti-inflammatory effect of leucine was exerted via the regulation of macrophage. 2) The LXRα inhibitor, GSK2033, was applied to mice via i.v. injection prior to LPS-challenge. In GSK2033 treated mice, the effects of leucine on the serum levels of inflammatory cytokines were neutralized (Supplementary Figure 4), partially indicating the importance of LXRα in the regulation of cytokine release. We acknowledge the limitation of LXRα inhibition by GSK2033 in this study. In our future study, we plan to use monocyte specific LXRα knockout mice by LysM-cre to elucidate the importance of LXRα in the progression of CSS, and specifically focuse on the molecular mechanism how mTORC1 interacts with LXRα to modulate M2 macrophage polarization. Additionally, we made modifications in the manuscript to clarify that the error bars represented as the standard error of the mean (SEM) (line 416).

      Reviewer #2 (Recommendations for The Authors):

      1. The whole manuscript is based on the 2% leucine from feed and 5% leucine from water. Is there any rationale for using these two types of different concentrations in this study? Often, a dose-dependent treatment is utilized in vivo in pharmacological study. Therefore, the authors should at least test two different concentrations in each type to confirm the conclusion.

      Answer: thank you for your comment and suggestion. The 2% leucine in feed and 5% leucine in water in this study were based on the literatures. In those studies, leucine was reported to activate mTORC1 and regulate metabolism at such types of different concentration as shown below, although there is lack of leucine in the regulation of macrophage activation. In this study, we found leucine supplementation in such types significantly increased the average body weight gain of mice, suggesting growth promoting and no toxicity of leucine on mice.

      (1) Jiang X, Zhang Y, Hu W, Liang Y, Zheng L, Zheng J, Wang B, Guo X. 2021. Different Effects of Leucine Supplementation and/or Exercise on Systemic Insulin Sensitivity in Mice. Front Endocrinol (Lausanne) 12:651303. doi:10.3389/fendo.2021.651303

      (2) Holler M, Grottke A, Mueck K, Manes J, Jücker M, Rodemann HP, Toulany M. 2016. Dual Targeting of Akt and mTORC1 Impairs Repair of DNA Double-Strand Breaks and Increases Radiation Sensitivity of Human Tumor Cells. PLoS One 11: e0154745. doi:10.1371/ journal. pone.0154745

      1. The authors focus on macrophage polarization as the major cellular event affected by leucine treatment; however, they also report that the proportion of multiple immune cell types has been suppressed by leucine treatment. As some of these immune cells can also produce inflammatory cytokines, the authors should confirm the anti-inflammatory effects of leucine were mainly mediated by modulating macrophage polarization as they suggested in the manuscript. For example, the authors could utilize Anti-CSF1 or clodronate to deplete macrophage and observed whether leucine-reduced inflammatory cytokines production was largely diminished.

      Answer: thank you for your valuable suggestion! We used clodronate-liposome (CLL) i.v. injection to deplete macrophages to further validate the specific contribution of macrophage polarization to the anti-inflammatory effects of leucine. The results revealed that clodronate treatment decreased blood monocyte counts and eliminated the effect of leucine in lowering serum inflammatory factors IL-6, IFN-γ and TNF-α (Figure 2E-F), suggesting the importance of leucine-mediacted macrophage activation on the anti-inflammation.

      1. It would be important to examine whether 10 mM leucine would exhibit cytotoxicity to bone marrow derived monocytes/macrophages. This would confirm that leucine treatment directly suppresses inflammatory cytokines production or reduces cell viability to indirectly modulates inflammatory responses.

      Answer: thank you for your valuable suggestion! We performed cell viability assays after treating BMDM with 2 mM and 10 mM leucine for 6h or 24h (consistent with the timing of leucine treatment in article). The results showed that at 6h, 2 mM leucine significantly increased cell viability, while 10 mM leucine had no significant effect on cell viability. At 24h, both 2 mM and 10 mM leucine significantly increased cell viability. In conclusion, 2 mM and 10 mM leucine were not cytotoxic to BMDM, and the anti-inflammatory effect of leucine was not derived from the reduction in cell viability (Supplementary Figure 2).

      1. The authors found that leucine promotes mTORC1-LXRα for arginase-1 transcription and M2 polarization. The pathway the authors elucidated is not surprising, which has already been reported in other studies. What about the other M2 markers? The authors could examine whether arginiase-1 deficiency would deplete leucine-increased other M2 marker genes expression. Moreover, what about the molecular mechanism for leucine-reduced M1 polarization?

      Answer: Thank you for the valuable comments! To clarify that Arginase-1 activity, mRNA expression of Fizz1, Mgl1, Mgl2, and Ym1 were well established markers for M2 macrophage. Specifically, Arginase-1 activity is important to define M2 functionality. These markers were used to define the level of M2 macrophage polarization. Only a few studies indicated the involvement of mTORC1 in the M2 polarization as shown below; however, there is no molecular mechanism about how mTORC1 modulates this process. In this study, we provide the evidence that LXRα mediated the mTORC1 associated M2 polarization, and leucine regulated mTORC1-LXRα to promote M2 polarization, which was in dependent of IL-4-induced STAT6 signaling. In our future study, we are focusing on the molecular mechanism how mTORC1 interacts with LXRα to modulate M2 macrophage polarization.

      (1) Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, Horng T. 2013. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun 4:2834. doi:10.1038/ncomms3834

      (2) Kimura T, Nada S, Takegahara N, Okuno T, Nojima S, Kang S, Ito D, Morimoto K, Hosokawa T, Hayama Y, Mitsui Y, Sakurai N, Sarashina-Kida H, Nishide M, Maeda Y, Takamatsu H, Okuzaki D, Yamada M, Okada M, Kumanogoh A. 2016. Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals. Nat Commun 7:13130. doi:10.1038/ncomms13130

      1. In Fig. 1A, what's the P-value among these two groups? Moreover, what about the result with combination treatment as the authors performed in other panels?

      Answer: thank you for the valuable comments from the reviewer! In Figure 1A, the P-value between the LPS and LPS+2% Leucine groups is 0.0031, and the P-value between the LPS and LPS+5% Leucine groups is 0.0009. I have marked the significance in Figure 1A accordingly. Due to the limited number of mice, we only treated mice in two different ways respectively. Initially, we performed survival experiment and observed that the addition of leucine prolonged survive of mice at lethal dose. Based on these findings, we further investigated whether a combination of the two methods would yield better results on the regulation of inflammation, but the combination exhibited the similar effect on cytokines production, and it is not necessary to repeat the survival experiment with the combination.

      1. It seems not much difference could be observed between 2% leucine from feed and 5% leucine from water in the expression of inflammatory genes and anti-inflammation-related markers. However, it seems that 5% leucine from water would exhibit a better survival rate than 2% leucine from feed. The authors should explain potential reasons and at least examine it in vitro.

      Answer: we appreciate the valuable comments from the reviewer! There are two possible reasons: 1) When lethal dose of LPS applied, mice were too weak to eat but still drank a small amount of water; 2) the absorption of leucine from the water were much easier than from the feed, thus leucine from the water exhibited much better efficiency in a short period of survival experiment. On the other hand, the cytokine levels and expressions were measure in non-lethal experiments, in which mice were in much better condition for lecine absorption.

      1. In Fig. 4A, the authors examined the expression of p-mTOR. The authors should further examine the expression of p-AKT (S473, T308) and p-S6 to clarify whether mTORC1 or mTORC2 has been modulated. As reported, leucine should act on GATOR2 for mTORC1 activation. However, the authors reported that Torin, a mTORC1/mTORC2 inhibitor, inhibited M2 polarization more significantly compared to rapamycin, a mTORC1 inhibitor. These observations seem to indicate that leucine has other targets except mTORC1, such as mTORC2, which might raise novel mechanisms that have never been reported before.

      Answer: thank you for the valuable comments! Akt-mTORC1 signaling integrates metabolic inputs to control macrophage activation. Wortamannin inhibition of AKT was followed by inhibition of M2 polarization, suggesting that AKT signaling is involved in M2 polarization. Studies reported that mTORC1 activation inhibits pAkt (T308), inhibition of mTORC1 in turn activate Akt (1), promoting M2 polarization as a feed back to compensate the inhibition of mTORC1 induced suppression of M2 polarization. mTORC2, directly phosphrlate Akt at S473, and inhibition of mTORC2 inhibits p-Akt (S473) (2), further inhibiting M2 porlarization. Torin1 is the inhibitor for both, while rapamycin is specially for mTORC1 (3). The explanation was included in Line 252-262

      (1) Leontieva OV, Demidenko ZN, Blagosklonny MV. 2014. Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium. Cell Death Dis 5: e1214. doi:10.1038/cddis.2014. 178Byles.

      (2) Holler M, Grottke A, Mueck K, Manes J, Jücker M, Rodemann HP, Toulany M. 2016. Dual Targeting of Akt and mTORC1 Impairs Repair of DNA Double-Strand Breaks and Increases Radiation Sensitivity of Human Tumor Cells. PLoS One 11: e0154745. doi:10.1371/journal. pone .0154745

      (3) V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, Horng T. 2013. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun 4:2834. doi:10.1038/ncomms3834.

      1. In Fig.5B, frankly speaking, I do not observe much difference in LXRα expression. Also, the actin band is too poor to get any conclusion.

      Answer: thank you for the valuable comments from the reviewer! In Fig. 5B, the extracted protein is specifically mentioned as nuclear protein in the text. It is stated that actin is expressed in the cytoplasm, while histone is expressed in the nucleus. The figure shows that actin expression is almost absent, which is mentioned to demonstrate the purity of the extracted nuclear protein.

      1. In Fig. 5C and 5D, it is amazing that GSK2033 would reduce urea production even largely greater than the basal condition (lane 1). As GSK2033 normalized IL-4 or IL-4 combination with Leucine raised urea production in cells, how GSK2033 could reduce urea in medium. The authors should explain this discrepancy.

      Answer: thank you for the valuable comments from the reviewer! In Fig. 5C, urea production was measured directly in the culture medium using a commercial assay kit, and GSK2033 indeed led to a significant decrease in urea production. In Fig. 5D, on the other hand, we assessed the activity of arginase-1 by lysing the cells, activating arginase-1, providing the substrate arginine, and then measuring urea production. In response to your question, the explanation is that in the assay measuring arginase-1 activity, we supplied a sufficient amount of substrate arginine, which may better reflect the enzyme’s activity and the results were consistent with our expectations. Additionally, when GSK2033 was used in combination with IL-4 or IL-4 plus leucine, it might interact with the IL-4 signaling pathway or leucine metabolism pathway, leading to an increase in urea production. This is just our preliminary explanation for the contradictory results, and we acknowledge that further research is needed to explore the mechanism of action of GSK2033 and its interactions with IL-4 or leucine.

      1. Line 98, "INF-gamma" should be IFN-gamma.

      Answer: We appreciate your attention to detail. We apologize for the error in line 98, where “INF-gamma” should indeed be corrected to “IFN-gamma (IFN-γ).” We will make the necessary correction in the revised version of the manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Tamoxifen resistance is a common problem in partially ER-positive patients undergoing endocrine therapy, and this manuscript has important research significance as it is based on clinical practical issues. The manuscript discovered that the absence of FRMD8 in breast epithelial cells can promote the progression of breast cancer, thus proposing the hypothesis that FRMD8 affects tamoxifen resistance and validating this hypothesis through a series of experiments. The manuscript has a certain theoretical reference value.

      Strengths:

      At present, research on the role of FRMD8 in breast cancer is very limited. This manuscript leverages the MMTV-Cre+;Frmd8fl/fl;PyMT mouse model to study the role of FRMD8 in tamoxifen resistance, and single-cell sequencing technology discovered the interaction between FRMD8 and ESR1. At the mechanistic level, this manuscript has demonstrated two ways in which FRMD8 affects ERα, providing some new insights into the development of ER-positive breast cancer in patients who are resistant to tamoxifen.

      Weaknesses:

      This manuscript repeatedly emphasizes the role of FRMD8/FOXO3A in tamoxifen resistance in ER-positive breast cancer, but the specific mechanisms have not yet been fully elucidated. Whether FRMD8 can become a biomarker should be verified in large clinical samples or clinical data.

      We appreciate your recognition and valuable suggestions. The proliferation of ERα-positive breast cancer cells is contingent upon the expression of ERα. Tamoxifen, a selective estrogen receptor modulator, competitively binds to ERα, thereby inhibiting the activation of the proliferation signaling pathway. Previous studies have demonstrated that the downregulation of ERα expression results in a reduction in the sensitivity of breast cancer cells to tamoxifen (PMID: 15894097; PMID: 922747). Our study revealed the molecular mechanism by which FRMD8 regulates ERα expression through FOXO3A and UBE3A, and thus FRMD8 deficiency is a cause of tamoxifen treatment resistance. 

      In this study, our results showed that low expression of FRMD8 predicts poor prognosis in breast cancer patients. We agree with this reviewer and will validate the role of FRMD8 in more patient samples and expand its application in different cancer types.

      Reviewer #2 (Public review):

      Summary:

      The manuscript presents a valuable finding on the impact of FRMD8 loss on tumor progression and the resistance to tamoxifen therapy. The author conducted systematic experiments to explore the role of FRMD8 in breast cancer and its potential regulatory mechanisms, confirming that FRMD8 could serve as a potential target to revere tamoxifen resistance.

      Strengths:

      The majority of the research is logically clear, smooth, and persuasive.

      Weaknesses:

      Some research in the article lacks depth and some sentences are poorly organized.

      Thank you for your helpful suggestion. We have carefully revised the manuscript again. 

      Recommendations for the authors:  

      Reviewer #1 (Recommendations for the authors):

      This manuscript suggests that the resistance of tamoxifen in breast cancer is linked to the loss of function of FRMD8. This is a relatively good and valuable contribution. However, there are several points that confused me.

      (1) The subfigures with important conclusions should include quantitative analysis, for example, Figure 4D, 4E, and 6A. In Figure 6F, which subtypes of normal and tumor tissues were investigated.

      Thank you for your helpful suggestions. We have quantified the bands in Figure 4D, 4E, and 6A and labelled them in the figures. 

      We have also provided details of the tumor samples in Table S3 and the “Materials and Methods” section. The majority of tumor tissues are invasive ductal carcinomas.

      (2) In the luminal epithelium-specific Frmd8 knockout mice (MMTV-Cre+; Frmd8fl/fl), the authors demonstrated that the loss of FRMD8 promotes the growth of breast tumors. In Figure 3A, the expression of ERα and PR in tumors is nearly negative. However, why was the validation of the mechanism performed in breast tumor cell lines and not in epithelial cells?

      Thanks for the question. Early-stage mammary tumors in MMTV-PyMT mice express ERα, while ERα is negative in advanced tumors of MMTV-PyMT mice. Figure 3A shows the results of tumors from four-month-old mice. Meanwhile, our supplementary results showed that loss of Frmd8 decreased ERα expression also in normal and atypical hyperplasia mammary tissues from 7-week-old MMTV-PyMT mice, when the mice had no palpable tumors and ERα is positive (Fig. S3E). We believe that the absence of FRMD8 contributes to the acceleration of the malignant progression during the dynamic evolution of breast cancer. Limited by the difficulty of transfection in breast normal epithelial cell line (MCF10A), we explored the subsequent mechanisms mainly in breast cancer cells and HEK293, a human embryonic kidney cell line. Besides, Figure S3E also showed the regulation of ERα expression by Frmd8 in mouse mammary

      epithelial cells.

      (3) To explore the mechanism by which FRMD8 inhibits ERα degradation, what is the reason for choosing HEK293A?

      Thank you for the good question. HEK293 cell line is commonly used in mechanistic studies. We also employed the breast cancer cell line T47D to verify the observations in HEK293 cells. Furthermore, the mass spectrometry result of HEK293A cells presented in Figure 5E was an additional experiment performed when we were exploring the regulation of the cell cycle by FRMD8, which is published in Cell Reports (PMID: 37527040). Based on the mass spectrometry result, we assumed that FRMD8 may influence ERα degradation mediated by UBE3A.

      Reviewer #2 (Recommendations for the authors):

      Introduction

      (1) In order for the reader to better understand the content of the article, it is better to briefly describe the role of ERα in the progression of breast cancer.

      Thank you for your suggestion. We have provided a brief description of the role of ERα in the introduction of revised manuscript:

      “ERα is a ligand-activated transcription factor that is activated by oestrogen, and promotes cell proliferation during breast cancer development (Harbeck et al., 2019).”

      (2) As ESR1 is mentioned in the second paragraph, a brief description of the relationship between ESR1 and ERα can make the article more logical.

      Thank you for the suggestion. We have added the description in the introduction:

      “Multiple transcription factors, such as AP-2γ, FOXO3, FOXM1, and GATA3, have been reported to bind to the promoter region of ESR1, the gene encoding ERα, and participate in transcriptional regulation of ESR1(Jia et al., 2019; Koš et al., 2001).”

      (3) In the text, there are two variations of the term FRMD8: 'FRMD8' and 'Frmd8'. It is best to standardize on one form throughout the document.

      We apologize for any confusion. The terms "FRMD8" and "Frmd8" are used to indicate proteins derived from human and mouse, respectively.

      Results

      (4) In Figure 2L, there is no noticeable difference in the expression levels of Pgr and Esr1 between the Cre+ tumor and Cre- tumor groups. Figure S2E is more suitable for inclusion in the main text compared to Figure 2L.

      Thank you for this suggestion. ERα and PR are positive in early-stage mammary tumors of MMTV-PyMT mice, while ERα and PR are gradually lost as the tumor progresses. In figure 2, mammary tumors from 4-month-old MMTV-PyMT mice were subjected to scRNA-seq analysis. Since the expression of ERα was very low in tumor cells at this time, there appears to be no difference between the two groups. We have exchanged Figure 2L and Figure S2E in the manuscript.

      (5) The CNV score can be used to assess the malignancy of cells, it would be better to compare the malignancy levels between the two groups.

      This is a very good suggestion. However, copy number variations usually occur randomly and have a high degree of heterogeneity. Due to the limited sample size in our study, we did not compare the difference between the two groups.

      (6) Enrichment analysis is crucial for single-cell sequencing studies. It is recommended to perform differential gene analysis and enrichment analysis between the Cre+ and Cre- groups to further explore the impact of FRMD8 deficiency on the functions of malignant cells.

      Thank you for your suggestion. We have performed differential gene analysis and biological process enrichment analysis on the results of scRNA sequence using the gene ontology (GO) database. Our results showed that upregulated genes in luminal progenitor (Lp) epithelial cells were enriched in epithelial cell proliferation and transmembrane receptor protein serine/threonine kinase signaling pathways, suggesting that Frmd8 deficiency significantly promotes epithelial cells proliferation in MMTV-PyMT mice.

      Author response image 1.

      (7) The coherent logic in lines 300 to 308 should be that FRMD8 is expressed at higher levels in normal Hsd epithelial cells in mice, hence further verification was conducted to examine the expression levels of FRMD8 in various human breast cancer cell lines.

      We have revised the figures and text as suggested.  

      Discussion

      (8) In lines 352 to 360, the background narrative in the first half seems to have little connection with the research findings in the second half; it is suggested to reorganize the language of this section.

      Thank you for the advice. We have rewritten this paragraph in the manuscript:

      “In MMTV-PyMT mice, early-stage mammary tumors express ERα and PR, but these receptors are gradually lost as the tumor progresses (Lapidus et al., 1998). Our scRNA-seq results revealed that mammary tumor epithelial cells in MMTV-PyMT mice fall into four clusters, with only Hsd epithelial cells showing ERα and PR expression. Additionally, Hsd epithelial cells exhibited the lowest CNV score, indicating a closer resemblance to normal epithelial cells. The loss of Frmd8 reduced the proportion of Hsd epithelial cells and led to a downregulation of ERα and PR expression, implying that Frmd8 deficiency promotes the loss of luminal features in the mammary gland and accelerates mammary tumor progression.”

      (9) As stated in the result section, the depletion of FRMD8 may lead to the decrease of the Hsd epithelial cells proportion, it might be beneficial to discuss the significance of this finding.

      We have added a discussion of the Hsd epithelial cell proportion in the third paragraph of this section (please refer to the above question (8) ).

      Figures

      (10) The structural layout of Figure 4 should be reorganized to make it more aesthetically pleasing.

      Thank you for this suggestion. We have rearranged Figure 4 as suggested.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      This paper presents a model of the whole somatosensory non-barrel cortex of the rat, with 4.2 million morphologically and electrically detailed neurons, with many aspects of the model constrained by a variety of data. The paper focuses on simulation experiments, testing a range of observations. These experiments are aimed at understanding how the multiscale organization of the cortical network shapes neural activity.

      Strengths:

      (1) The model is very large and detailed. With 4.2 million neurons and 13.2 billion synapses, as well as the level of biophysical realism employed, it is a highly comprehensive computational representation of the cortical network.

      (2) Large scope of work - the authors cover a variety of properties of the network structure and activity in this paper, from dendritic and synaptic physiology to multi-area neural activity.

      (3) Direct comparisons with experiments, shown throughout the paper, are laudable.

      (4) The authors make a number of observations, like describing how high-dimensional connectivity motifs shape patterns of neural activity, which can be useful for thinking about the relations between the structure and the function of the cortical network.

      (5) Sharing the simulation tools and a "large subvolume of the model" is appreciated.

      We thank the reviewer for these comments and are pleased they appreciated these aspects of the work.

      Weaknesses:

      (1) A substantial part of this paper - the first few figures - focuses on single-cell and single-synapse properties, with high similarity to what was shown in Markram et al., 2015. Details may differ, but overall it is quite similar.

      We thank the reviewer for this useful comment and agree that it is important to better highlight the incremental improvements to the model’s low-level physiology. The validity of any model can continuously be improved at all spatial scales and the validity of emergent network activity increases with improved validity at lower levels. For this reason, we felt it was valuable to improve the low-level physiology of the model.

      Regarding neuron physiology, we have added the following in Section 2.1 on page 5:

      “2.1 Improved modeling and validation of neuron physiology

      Similarly to Markram et al. (2015), electrical properties of single neurons were modelled by optimizing ion channel densities in specific compartment-types (soma, axon initial segment (AIS), basal dendrite, and apical dendrite) (Figure 2B) using an evolutionary algorithm (IBEA; Van Geit et al., 2016) so that each neuron recreates electrical features of its corresponding electrical type (e-type) under multiple standardized protocols. Compared to Markram et al. (2015), electrical models were optimized and validated using 1) additional in vitro data, features and protocols, 2) ion channel and electrophysiological data corrected for the liquid junction potential, and 3) stochastic channels (StochKv3) now including inactivation profiles. The methodology and resulting electrical models are described in Reva et al. (2023) (see Methods), and generated quantitatively more accurate electrical activity, including improved attenuation of excitatory postsynaptic potentials (EPSPs) and back-propagating action potentials.”

      And page 8:

      “The new neuron models saw a 5-fold improvement in generalizability compared to Markram et al. (2015) (Reva et al., 2023).”

      We have also made the descriptions of the improvements to synaptic physiology more explicit in Section 2.2 on page 9:

      “2.2 Improved modeling and validation of synaptic physiology

      The biological realism of synaptic physiology was improved relative to Markram et al. (2015) using additional data sources and by extending the stochastic version of the Tsodyks-Markram model (Tsodyks and Markram, 1997; Markram et al., 1998; Fuhrmann et al., 2002; Loebel et al., 2009) to feature multi-vesicular release, which in turn improved the accuracy of the coefficient of variations (CV; std/mean) of postsynaptic potentials (PSPs) as described in Barros-Zulaica et al. (2019) and Ecker et al. (2020). The model assumes a pool of available vesicles that is utilized by a presynaptic action potential, with a release probability dependent on the extracellular calcium concentration ([Ca2+]o; Ohana and Sakmann, 1998; Rozov et al., 2001; Borst, 2010). Additionally, single vesicles spontaneously release as an additional source of variability with a low frequency (with improved calibration relative to Markram et al. (2015)). The utilization of vesicles leads to a postsynaptic conductance with bi-exponential kinetics. Short-term plasticity (STP) dynamics in response to sustained presynaptic activation are either facilitating (E1/I1), depressing (E2/I2), or pseudo-linear (I3). E synaptic currents consist of both AMPA and NMDA components, whilst I currents consist of a single GABAA component, except for neurogliaform cells, whose synapses also feature a slow GABAB component. The NMDA component of E synaptic currents depends on the state of the Mg2+ block (Jahr and Stevens, 1990), with the improved fitting of parameters to cortical recordings from Vargas-Caballero and Robinson (2003) by Chindemi et al. (2022).”

      (2) Although the paper is about the model of the whole non-barrel somatosensory cortex, out of all figures, only one deals with simulations of the whole non-barrel somatosensory cortex. Most figures focus on simulations that involve one or a few "microcolumns". Again, it is rather similar to what was done by Markram et al., 2015 and constitutes relatively incremental progress.

      We thank the reviewer for this comment and have added the following text to the Discussion on page 33 to explain our rationale:

      “In keeping with the philosophy of compartmentalization of parameters and continuous model refinement (see Introduction), it was essential to improve validity at the columnar scale (relative to Markram et al. (2015)) as part of demonstrating validity of the full nbS1. Indeed, improved parametrization and validation at smaller scales was essential to parameterizing background input which generated robust nbS1 activity within realistic [Ca<sup>2+</sup>]<sub>o</sub> and firing rate ranges. We view this as a major achievement, as it was unknown whether the model would achieve a stable and meaningful regime at the start of our investigation. Whilst we would have liked to go further, our primary goal was to publish a well characterized model as an open resource that others could use to undertake further in-depth studies. In this regard, we are pleased that the parametrization of the nbS1 model has already been used to study EEG signals (Tharayil et al., 2024), as well as propagation of activity between two subregions (Bolaños-Puchet and Reimann, 2024).”

      We also make it clearer in the Introduction on page 4 that the improved validation of the emergent columnar regime was essential to stable activity at the larger scale:

      “These initial validations demonstrated that the model was in a more accurate regime compared to Markram et al. (2015) – an essential step before testing more complex or larger-scale validations. For example, under the same parameterization we then observed selective propagation of stimulus-evoked activity to downstream areas, and…”

      (3) With a model like this, one has an opportunity to investigate computations and interactions across an extensive cortical network in an in vivo-like context. However, the simulations presented are not addressing realistic specific situations corresponding to animals performing a task or perceiving a relevant somatosensory stimulus. This makes the insights into the roles of cell types or connectivity architecture less interesting, as they are presented for relatively abstract situations. It is hard to see their relationship to important questions that the community would be excited about - theoretical concepts like predictive coding, biophysical mechanisms like dendritic nonlinearities, or circuit properties like feedforward, lateral, and feedback processing across interacting cortical areas. In other words, what do we learn from this work conceptually, especially, about the whole non-barrel somatosensory cortex?

      We thank the reviewer for this comment and agree that it would be very interesting to explore such topics. In the Introduction on page 4, we have updated the list of papers which have so far used the model for more in depth studies:

      “…propagation of activity between cortical areas (Bolaños-Puchet and Reimann, 2024) the role of non-random connectivity motifs on network activity (Pokorny et al., 2024) and reliability (Egas Santander et al., 2024), the composition of high-level electrical signals such as the EEG (Tharayil et al., 2024), and how spike sorting biases population codes (Laquitaine et al., 2024).”

      In the Discussion on page 33 we also add our additional thoughts on this topic:

      “Whilst we would have liked to go further, our primary goal was to publish a well characterized model as an open resource that others could use to undertake further in-depth studies. In this regard, we are pleased that the parametrization of the nbS1 model has already been used to study EEG signals (Tharayil et al., 2024), as well as propagation of activity between two subregions (Bolaños-Puchet and Reimann, 2024). Investigation, improvement and validation must be continued at all spatial scales in follow up papers with detailed description, figures and analysis, which cannot be covered in this manuscript. Each new study increases the scope and validity of future investigations. In this way, this model and paper act as a stepping stone towards more complex questions of interest to the community such as perception, task performance, predictive coding and dendritic processing. This was similar for Markram et al. (2015) where the initial paper was followed by more detailed studies. Unlike the Markram et al. (2015) model, the new model can also be exploited by the community and has already been used in a number of follow up papers studying (Ecker et al., 2024a,b; Bolaños-Puchet and Reimann, 2024; Pokorny et al., 2024; Egas Santander et al., 2024; Tharayil et al., 2024; Laquitaine et al., 2024). We believe that the number of use cases for such a general model is vast, and is made larger by the increased size of the model.”

      (4) Most comparisons with in vivo-like activity are done using experimental data for whisker deflection (plus some from the visual stimulation in V1). But this model is for the non-barrel somatosensory cortex, so exactly the part of the cortex that has less to do with whiskers (or vision). Is it not possible to find any in vivo neural activity data from the non-barrel cortex?

      We agree with the reviewer that this is a weakness. We have expanded our discussion of the need to mix data sources to also consider our view for network level activity:

      “This paper and its companion paper serve to present a methodology for modeling micro- and mesoscale anatomy and physiology, which can be applied for other cortical regions and species. With the rapid increase in openly available data, efforts are already in progress to build models of mouse brain regions with reduced reliance on data mixing thanks to much larger quantities of available atlas-based data. This also includes data for the validation of emergent network level activity. Here we chose to compare network-level activity to data mostly from the barrel cortex, as well as a single study from primary visual cortex. Whilst a lot of the data used to build the model was from the barrel cortex, the barrel cortex also represents a very well characterized model of cortical processing for simple and controlled sensory stimuli. The initial comparison of population-wise responses in response to accurate thalamic input for single whisker deflections was essential to demonstrating that the model was closer to in vivo, and we were unaware of similar data for nonbarrel somatosensory regions. Moreover, our optogenetic & lesion study demonstrated the capacity to compare and extend studies of canonical cortical processing in the whisker system.”

      (5) The authors almost do not show raw spike rasters or firing rates. I am sure most readers would want to decide for themselves whether the model makes sense, and for that, the first thing to do is to look at raster plots and distributions of firing rates. Instead, the authors show comparisons with in vivo data using highly processed, normalized metrics.

      We thank the reviewer for this comment and agree that better visualizations of the network activity under different conditions is essential for helping the reader assess the work. In addition to raster plots in Video 1, Video 3, Fig 6, Fig 5C, Fig S9a, S16a, we have additionally:

      a) Changed the histograms of spontaneous activity in Fig 4G on page 13 to raster plots for the seven column subvolume for two contrasting meta-parameter regimes.

      b) Added 4 new videos (Video 6a,b and 8a,b) showing all spontaneous and evoked meta-parameter combinations in hex0 and hex39 of the nbS1:

      We have added improved plots showing the distributions of firing rates in the seven column subvolume on page 74:

      With more detailed consideration in the Results on page 15:

      “Long-tailed population firing rate distributions with means ∼ 1Hz

      To study the firing rate distributions of different subpopulations and m-types, we ran 50s simulations for the meta-parameter combinations: [Ca<sup>2+</sup>]<sub>o</sub>: 1.05mM, R<sub>OU</sub>: 0.4,P<sub>FR</sub>: 0.3, 0.7 (Figure S4). Different subpopulations showed different sparsity levels (proportion of neurons spiking at least once) ranging from 6.6 to 42.5%. Wohrer et al. (2013) considered in detail the biases and challenges in obtaining ground truth firing rate distributions in vivo, and discuss the wide heterogeneity of reports in different modalities using different recording techniques. They conclude that most evidence points towards longtailed distributions with peaks just below 1Hz. We confirmed that spontaneous firing rate distributions were long-tailed (approximately lognormally distributed) with means on the order of 1Hz for most subpopulations. Importantly the layer-wise means were just below 1Hz in all layers for the P<sub>FR</sub> = 0.3 meta-parameter combination. Moreover, our recent work applying spike sorting to extracellular activity using this meta-parameter combination found spike sorted firing rate distributions to be lognormally distributed and very similar to in vivo distributions obtained using the same probe geometry and spike sorter (Laquitaine et al., 2024).

      (6) While the authors claim that their model with one set of parameters reproduces many experimentally established metrics, that is not entirely what one finds. Instead, they provide different levels of overall stimulation to their model (adjusting the target "P_FR" parameter, with values from 0 to 1, and other parameters), and that influences results. If I get this right (the figures could really be improved with better organization and labeling), simulations withP<sub>FR</sub> closer to 1 provide more realistic firing rate levels for a few different cases, however, P<sub>FR</sub> of 0.3 and possibly above tends to cause highly synchronized activity - what the authors call bursting, but which also could be called epileptic-like activity in the network.

      We thank the reviewer for this comment. We can now see that the motivation for P<sub>FR</sub> parameter was introduced very briefly in the results and that the results of the calibration and analysis of the spontaneous activity regime are not interpreted in relation to this parameter.

      To address this, we have given more detail where it is first introduced in the Results on page 12:

      “to account for uncertainty in the firing rate bias during spontaneous activity from extracellular spike sorted recordings…”

      We then reconsider that it represents an unknown bias when interpreting the calibration and spontaneous activity results on page 15:

      “We reemphasize that the [Ca<sup>2+</sup>]<sub>o</sub>, R<sub>OU</sub> and P<sub>FR</sub> meta-parameters account for uncertainty of in vivo extracellular calcium concentration, the nature of inputs from other brain regions and the bias of extracellularly recorded firing rates. Whilst estimates for [Ca<sup>2+</sup>]<sub>o</sub> are between 1.0 - 1.1mM (Jones and Keep, 1988; Massimini and Amzica, 2001; Amzica et al., 2002; Gonzalez et al., 2022) and estimates for PFR are in the range of 0.1 - 0.3 (Olshausen and Field, 2006), combinations of these parameters supporting in vivo-like stimulus responses in later sections will offer a prediction for the true values of these parameters. Both these later results and our recent analysis of spike sorting bias using this model (Laquitaine et al., 2024) predict a spike sorting bias corresponding to P<sub>FR</sub> ∼ 0.3, confirming the prediction of Olshausen and Field (2006).”

      And in relation to the stimulus evoked responses on page 17:

      “Specifically, simulations with PFR from 0.1 to 0.5 robustly support realistic stimulus responses, with the middle of this range (0.3) corresponding with estimates of in vivo recording bias; both the previous estimates of Olshausen and Field (2006) and from a spike sorting study using this model (Laquitaine et al., 2024).”

      Following these considerations, the remainder of the experiments using the seven column subvolume only use a single meta-parameter on page 19.

      For the full nbS1 we further discuss the importance of a P_FR value between 0.1 and 0.3 in the Results on page 26:

      “Stable spontaneous activity only emerges in nbS1 at predicted in vivo firing rates

      After calibrating the model of extrinsic synaptic input for the seven column subvolume, we tested to what degree the calibration generalizes to the entire nbS1. Notably, this included the addition of mid-range connectivity (Reimann et al., 2024). The total number of local and mid-range synapses in the model was 9138 billion and 4075 billion, i.e., on average full model simulations increased the number of intrinsic synapses onto a neuron by 45%. Particularly, we ran simulations for P<sub>FR</sub></i ∈ [0.1, 0.15, ..., 0.3] using the OU parameters calibrated for the seven column subvolume for [Ca<sup>2+</sup>]<sub>o</sub> = 1.05mM and R<sub>OU</sub> = 0.4. Each of these full nbS1 simulations produced stable non-bursting activity (Figure 8A), except for the simulation for P<sub>FR</sub></i = 0.3, which produced network-wide bursting activity (Video 6). Activity levels in the simulations of spontaneous activity were heterogeneous (Figure 8B, Video 7). In some areas, firing rates were equal to the target P<sub>FR</sub>, whilst in others they increased above the target (Figure 8C). In the more active regions, mean firing rates (averaged over layers) were on the order of 30-35% of the in vivo references for the maximum non-bursting P<sub>FR</sub> simulation (target P<sub>FR</sub> : 0.25). This range of firing rates again fits with the estimate of firing rate bias from our paper studying spike sorting bias (Laquitaine et al., 2024) and the meta-parameter range supporting realistic stimulus responses in the seven column subvolume. This also predicts that the nbS1 cannot sustain higher firing rates without entering a bursting regime.

      Finally, we also added to our discussion of biases in extracellular firing rates in the Discussion on page 32:

      “This is also inline with our recent work using the model, which estimated a spike sorting bias corresponding to PFR = 0.3 using virtual extracellular electrodes (Laquitaine et al., 2024).”

      We also thank the reviewer for pointing out that we did not define the term “bursting” in the main text. We have added the following definition and discussion in the Results on page 15:

      “Note that the most correlated meta-parameter combination [Ca<sup>2+</sup>]<sub>o</sub>: 1.1mM, R<sub>OU</sub>: 0.2, P<sub>FR</sub>: 1.0 produced network-wide “bursting” activity, which we define as highly synchronous all or nothing events (Video 1). Such activity, which may be characteristic of epileptic activity, can be studied with the model but is not the focus of this study.”

      (7) The authors mention that the model is available online, but the "Resource availability" section does not describe that in substantial detail. As they mention in the Abstract, it is only a subvolume that is available. That might be fine, but more detail in appropriate parts of the paper would be useful.

      Firstly, we are pleased to say that the full nbS1 model is now available to download, in addition to the seven hexagon subvolume. In the manuscript, we have:

      a) Added to the Introduction at the bottom of page 4:

      “To provide a framework for further studies and integration of experimental data, the full model is made available with simulation tools, as well as a smaller subvolume with the optional new connectome capturing inhibitory targeting rules from electron microscopy”.

      b) Updated the open source panel of Figure 1:

      Secondly, we thank the reviewer for noticing that the description of the available model is not well described in the “Resource availability” statement and have addressed this by:

      a) Adding the following to the “Resource availability” statement on page 36:

      “Both the full nbS1 model and smaller seven hexagon subvolume are available on Harvard Dataverse and Zenodo respectively in SONATA format (Dai et al., 2020) with simulation code. DOIs are listed under the heading ``Final simulatable models'' in the Key resources table. An additional link is provided to the SM-Connectome with instructions on how to use it with the seven hexagon subvolume model.”

      b) Creating a new subheading in the “Key resources table” titled: “Final simulatable models” to make it clearer which links refer to the final models.

      Reviewer #2 (Public review):

      Summary:

      This paper is a companion to Reimann et al. (2022), presenting a large-scale, data-driven, biophysically detailed model of the non-barrel primary somatosensory cortex (nbS1). To achieve this unprecedented scale of a bottom-up model, approximately 140 times larger than the previous model (Markram et al., 2015), they developed new methods to account for inputs from missing brain areas, among other improvements. Isbister et al. focus on detailing these methodological advancements and describing the model's ability to reproduce in vivo-like spontaneous, stimulus-evoked, and optogenetically modified activity.

      Strengths:

      The model generated a series of predictions that are currently impossible in vivo, as summarized in Table S1. Additionally, the tools used in this study are made available online, fostering community-based exploration. Together with the companion paper, this study makes significant contributions by detailing the model's constraints, validations, and potential caveats, which are likely to serve as a basis for advancing further research in this area.

      We thank the reviewer for these comments, and are pleased they appreciate these aspects of the work.

      Weaknesses:

      That said, I have several suggestions to improve clarity and strengthen the validation of the model's in vivo relevance.

      Major:

      (1) For the stimulus-response simulations, the authors should also reference, analyze, and compare data from O'Connor et al. (2010; https://pubmed.ncbi.nlm.nih.gov/20869600/) and Yu et al .(2016; https://pubmed.ncbi.nlm.nih.gov/27749825/) in addition to Yu et al. 2019, which is the only data source the authors consider for an awake response. The authors mentioned bias in spike rate measurements, but O'Connor et al. used cell-attached recordings, which do not suffer from activity-based selection bias (in addition, they also performed Ca2+ imaging of L2/3). This was done in the exact same task as Yu et al., 2019, and they recorded from over 100 neurons across layers. Combining this data with Yu et al., 2019 would provide a comprehensive view of activity across layers and inhibitory cell types. Additionally, Yu et al. (2016) recorded VPM neurons in the same task, alongside whole-cell recordings in L4, showing that L4 PV neurons filter movement-related signals encoded in thalamocortical inputs during active touch. This dataset is more suitable for extracting VPM activity, as it was collected under the same behavior and from the same species (Unlike Diamond et al., 1992, which used anesthetized rats). Furthermore, this filtering is an interesting computation performed by the network the authors modeled. The validation would be significantly strengthened and more biologically interesting if the authors could also reproduce the filtering properties, membrane potential dynamics, and variability in the encoding of touch across neurons, not just the latency (which is likely largely determined by the distance and number of synapses).

      We thank the reviewer for pointing out these very useful studies. We have taken on board this suggestion for a future model of the mouse barrel cortex.

      (2) The authors mention that in the model, the response of the main activated downstream area was confined to L6. Is this consistent with in vivo observations? Additionally, is there any in vivo characterization of the distance dependence of spiking correlation to validate Figure 8I?

      We are not aware of data confirming the propagation of activity to downstream areas being confined to layer 6 but have considered the connectivity further between these two regions on page 27, as well as studying this further in follow up work:

      “Stable propagation of evoked activity through mid-range connectivity only emerges in nbS1 at predicted in vivo firing rates

      We repeated the previous single whisker deflection evoked activity experiment in the full model, providing a synchronous thalamic input into the forelimb sub-region (S1FL; Figure 8E; Video 8 & 9). Responses in S1FL were remarkably similar to the ones in the seven column subvolume, including the delays and decays of activity (Figure 8F). However, in addition to a localized primary response in S1FL within 350μm of the stimulus, we found several secondary responses at distal locations (Figure 8E; Video 9), which was suggestive of selective propagation of the stimulus-evoked signal to downstream areas efferently connected by mid-range connectivity. The response of the main activated downstream area (visible in Figure 8E) was confined to L6 (Figure 8G). In a follow up study using the model to explore the propagation of activity between cortical regions (Bolaños-Puchet and Reimann, 2024), it is described how the model contains both a feedforward projection pattern, which projects to principally to synapses in L1 & L23, and a feedback type pattern, which principally projects to synapses in L1 & L6. On visualizing the innervation profile from the stimulated hexagon to the downstream hexagon we can see that we have stimulated a feedback pathway (Figure S16)”

      With referenced Figure S16 on page 85:

      We did find in vivo evidence of similar layer-wise and distance dependence of correlations in the somatosensory cortex discussed on page 27 of the Results:

      “The distance dependence of correlations followed a similar profile to that observed in a dataset characterizing spontaneous activity in the somatosensory cortex (Reyes-Puerta et al., 2015a) (compare red line in Figure 8I with Figure S16). In the in vivo dataset spiking correlation was also low but highest in lower layers, with short “up-states” in spiking activity constrained to L5 & 6 (see Figure 1E,F in (Reyes-Puerta et al., 2015a)). In the model, they are constrained to L6.”

      With Figure S16a on page 85 showing the distance dependence of correlations in the anaesthetized barrel cortex during spontaneous activity (digitization from the reference paper):

      (3) Across the figures, activity is averaged across neurons within layers and E or I cell types, with a limited description of single-cell type and single-cell responses. Were there any predictions regarding the responses of particular cell types that significantly differ from others in the same layer? Such predictions could be valuable for future investigations and could showcase the advantages of a data-driven, biophysically detailed model.

      We thank the review for this comment. In addition to new analyses at higher granularity addressed in other comments, we have added the following comparison of stimulus-evoked membrane potential dynamics in different subpopulations for the original connectome and SM-connectome in Figure 7 on page 24.

      This gave interesting results discussed in a new subsection on page 26:

      “EM targeting trends hyperpolarize Sst+ and HT3aR+ late response, and disinhibit L5/6 E

      Studying somatic membrane potentials for different subpopulations in response to whisker deflections shows that PV+, L23E and L4E subpopulations are largely unaffected in the SM-connectome (Figure 7E). Interestingly, Sst+ and 5HT3aR+ subpopulations show a strong hyperpolarization in the late response that isn’t present in the original connectome. Interestingly, this corresponds with a stronger late response in L5/6 E populations, which could be caused by disinhibition due to the Sst+ and 5HT3aR+ hyperpolarization. This could be explored further in follow up studies using our connectome manipulator tool (Pokorny et al., 2024).”

      (4) 2.4: Are there caveats to assuming the OU process as a model for missing inputs? Inputs to the cortex are usually correlated and low-dimensional (i.e., communication subspace between cortical regions), but the OU process assumes independent conductance injection. Can (weakly) correlated inputs give rise to different activity regimes in the model? Can you add a discussion on this?

      We agree with the reviewer that there are caveats to assuming an OU process for the model of missing inputs and have added the following to the Discussion on page 31:

      “The calibration framework could optimize per population parameters for other compensation methods, whilst still offering an interpretable spectrum of firing rate regimes at different levels of P<sub>FR</sub>. For example, more realistic compensation schemes could be explored which introduce a) correlations between the inputs received by different neurons and b) compensation distributed across dendrites, as well as at the soma. We predict that such changes would make spontaneous activity more correlated at the lower spontaneous firing rates which supported in vivo like responses (P<sub>FR</sub> : 0.1 − 0.5), which would in turn make stimulus-responses more noise correlated.”

      (5) 2.6: The network structure is well characterized in the companion paper, where the authors report that correlations in higher dimensions were driven by a small number of neurons with high participation ratios. It would be interesting to identify which cell types exhibit high node participation in high-dimensional simplices and examine the spiking activity of cells within these motifs. This could generate testable predictions and inform theoretical cell-type-specific point neuron models for excitatory/inhibitory balanced networks and cortical processing.

      We thank the reviewer for this suggestion. We have added two supplementary figures to address this suggestion, which are discussed in the Results on Page 16:

      “Additionally, we studied the structural effect on the firing rate (here measured as the inverse of the inter-spike interval, ISI, which can be thought of as a proxy of non-zero firing rate). We found that for the connected circuit, the firing rate increases with simplex dimension; in contrast with the disconnected circuit, where this relationship remains flat (see Figure S6 red vs. blue curves and Methods).

      This also demonstrates high variability between neurons, in line with biology, both structurally (Towlson et al., 2013; Nigam et al., 2016) and functionally (Wohrer et al., 2013; Buzs´aki and Mizuseki, 2014). We next identified the cell types that are overexpressed in the group of neurons that have the 5% highest values of node participation across dimensions (Figure S7). This could inform theoretical point neuron models with cell-type specificity, for example. We found that while in dimension one (i.e., node degree) this consists mostly of inhibitory cells, in higher dimensions the cell types concentrate in layers 4, 5 and 6, especially for TPC neurons. This is in line with our structural layer-wise findings in Figure 8B in Reimann et al. (2024).”

      Which reference new Figures S6 and S7:

      With the methodology for S6 described on page 49 of the Methods:

      “For any numeric property of neurons, e.g., firing rate, we evaluate the effect of dimension on it by taking weighted averages across dimensions. That is for each dimension k, we take the weighted average of the property across neurons where the weights are given by node participation on dimension k. More precisely, let N be the number of neurons and −→V ∈ RN, be a vector of a property on all the neurons e.g., the vector of firing rates. Then in each dimension k we compute

      Where is the vector of node participation on dimension k for all neurons and ・ is the dot product.

      To measure the over and underexpression of the different m-types among those with the highest 5% of values of node participation, we used the hypergeometric distribution to determine the expected distribution of m-types in a random sample of the same size. More precisely, for each dimension k and m-type m, let N<sub>total</sub> be the total number of neurons in the circuit, Nm be the number of neurons of m-type m in the circuit, Ctop be the number of neurons with the highest 5% values of node participation in dimension k, Cm the number of neurons of mtype m among these, and let P = hypergeom(N<sub>total</sub<,N<sub>m</sub>,C<sub>top</sub>) be the hypergeometric distribution.

      By definition, P(x) describes the probability of sampling x neurons of m-type m in a random sample of size C<sub>top</sub>. Therefore, using the cumulative distribution F(x) = P(Counts ≤ x), we can compute the p-values as follows:

      Small values indicate under and over representation respectively….”

      Minor:

      (1) Since the previous model was published in 2015, the neuroscience field has seen significant advancements in single-cell and single-nucleus sequencing, leading to the clustering of transcriptomic cell types in the entire mouse brain. For instance, the Allen Institute has identified ~10 distinct glutamatergic cell types in layer 5, which exceeds the number incorporated into the current model. Could you discuss 1) the relationship between the modeled me-types and these transcriptomic cell types, and 2) how future models will evolve to integrate this new information? If there are gaps in knowledge in order to incorporate some transcriptome cell types into your model, it would be helpful to highlight them so that efforts can be directed toward addressing these areas.

      We thank the reviewer for this suggestion, particularly the idea to describe what types of data would be valuable towards improving the model in future. We have added the following to the Discussion on page 33:

      “In our previous work (Roussel et al., 2023) we linked mouse inhibitory me-models to transcriptomic types (t-types) in a whole mouse cortex transcriptomic dataset (Gouwens et al., 2019). This can provide a direct correspondence in future large-scale mouse models. As we model only a single electrical type for pyramidal cells there is no one-to-one correspondence between our me-models and the 10 different pyramidal cell types identified there. We are not currently aware of any method which can recreate the electrical features of different types of pyramidal cells using only generic ion channel models. To achieve the firing pattern behavior of more specific electrical types, usually ion channel kinetics are tweaked, and this would violate the compartmentalization of parameters. In future we hope to build morpho-electric-transcriptomic type (met-type) models by selecting gene-specific ion channel models (Ranjan et al., 2019, 2024) based on the met-type’s gene expression. Data specific to different neuron sections (i.e. soma, AIS, apical/basel dendrites) of different met-types, such as gene expression, distribution of ion channels, and voltage recordings under standard single cell protocols would be particularly useful.”

      (2) For the optogenetic manipulation, it would be interesting if the model could reproduce the paradoxical effects (for example, Mahrach et al. reported paradoxical effects caused by PV manipulation in S1; https://pubmed.ncbi.nlm.nih.gov/31951197/). This seems a more relevant and non-trivial network phenomenon than the V1 manipulation the authors attempted to replicate.

      We thank the reviewer for this valuable idea. Indeed, our model is able to reproduce paradoxical effects under certain conditions. We added the following new supplementary Figure S12 demonstrating this finding (black arrows).

      Which we discuss in the Results on page 22:

      “However, at high contrasts, we observed a paradoxical effect of the optogenetic stimulation on L6 PV+ neurons, reducing their activity with increasing stimulation strength (Figure S12B; cf. Mahrach et al. (2020)). This effect did not occur under grey screen conditions (i.e., at contrast 0.0) with a constant background firing rate of 0.2 Hz or 5 Hz respectively (not shown). The individual…”

      and added to the Discussion on page 32:

      “Also, we predicted a paradoxical effect of optogenetic stimulation on L6 PV+ interneurons, namely a decrease in firing with increased stimulus strength. This is reminiscent of the paradoxical responses found by Mahrach et al. (2020) in the mouse anterior lateral motor cortex (in L5, but not in L2/3) and barrel cortex (no layer distinction) respectively. While Mahrach et al. (2020) conducted their recordings in awake mice not engaged in any behavior, we observed this effect only when drifting grating patterns with high contrast were presented. Nevertheless, consistent with their findings, we found the effect only in deep but not in superficial layers, and only for PV+ interneurons but not for PCs. Our model could therefore be used to improve the understanding of this paradoxical effect in follow up studies. These examples demonstrate that the approach of modeling entire brain regions can be used to further probe the topics of the original articles and cortical processing.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      My specific comments are in the Public Review. The summarizing point is that this is a sprawling paper, and it is easy for readers to get confused. Focusing on specific connections between known functional properties and findings in this model, especially for the full-scale model, will be helpful.

      We thank the reviewer for this comment and for their related recommendation (4) below, and have added subheadings through-out the results.

      Reviewer #2 (Recommendations for the authors):

      (1) P4. What are the 10 free parameters?

      We thank the reviewer for pointing out that it would be useful to summarize the 10 parameters at this stage of the text, and have adjusted the sentence to:

      “As a result, the emerging in-vivo like activity is the consequence of only 10 free parameters representing the strength of extrinsic input from other brain regions into 9 layer-specific excitatory and inhibitory populations, and a parameter controlling the noise structure of this extrinsic input.”

      (2) Table 1 and S1 are extremely useful. Could you provide a table summarizing the major assumptions or gaps in the model, their potential influence on the results, and possible ways to collect data that could support or challenge these assumptions? Currently, this information is scattered throughout the manuscript.

      We thank the reviewer for this very useful suggestion and have added a Table S8 on page 68:

      (3) Figure 4F is important, but the legend is unclear. What is the unit on the x-axis? The values seem too large to represent per-neuron measurements.

      Thank you to the reviewer for raising this. Indeed the values are estimated mean numbers of missing number synapses per neuron by population. Such numbers are difficult to estimate but we have further discussed our rationale, justification and consideration of whether these numbers are accurate in the Results, as follows:

      “Heterogeneity in synaptic density within and across neuron classes and sections makes estimating the number of missing synapses challenging (DeFelipe and Fariñas, 1992). Changing the assumed synaptic density value of 1.1 synapses/μm would only change the slope of the relationship, however. Estimates of mean number of existing and missing synapses per population were within reasonable ranges; even the larger estimate for L5 E (due to higher dendritic length; Figure S3) was within biological estimates of 13,000 ± 3,500 total afferent synapses (DeFelipe and Fariñas, 1992).”

      This text references the new supplementary Figure S3:

      Moreover, these numbers represent the number of synapses, rather than the number of connections. The number of connections is usually used for quantifications such as indegree, and are usually much lower.

      We have also updated the caption and axis labels of the original figure:

      (4) Including additional subsections or improving the indexing in the Results section could be beneficial. In its current format, it's difficult to distinguish where the model description ends and where the validation begins. Some readers may want to focus more on the validation than other parts, so clearer segmentation would improve readability.

      We have addressed this comment with the opening comment in the authors “Recommendations for authors”.

      (5) P4. 2nd paragraph. Original vs rewired connectome. The term "rewired connectome" may give the impression that it refers to an artificial manipulation rather than a modification based on the latest data. It might be helpful to use a different term (e.g., SM-connectome as described later in the paper?).

      We have adjusted the text in the introduction:

      “Additionally, we generated a new connectome which captured recently characterized spatially-specific targeting rules for different inhibitory neuron types (Schneider-Mizell et al., 2023) in the MICrONS electron microscopy dataset (MICrONS-Consortium et al., 2021), such as increased perisomatic targeting by PV+ neurons, and increased targeting of inhibitory populations by VIP+ neurons. Comparing activity to the original connectome gave predictions about the role of these additional targeting rules.”

      (6) Figures 7 B, C, D: what is v1/v2? Original vs SM-Connectome?

      We thank the reviewer for noticing this and have corrected the figure to use “Orig” and “SM” consistent with the rest of the figure.

      (7) Page 23, 2.10: what is phi?

      We thank the reviewer for noticing this inconsistency with the earlier text, and have updated the text to read: “Particularly, we ran simulations for PF R ∈ [0.1, 0.15, ..., 0.3] using the OU para-maters calibrated for the seven column subvolume for [Ca<sup>2+</sup>] = 1.05 mM and R<sub>OU</sub> = 0.4.”

    1. Author response:

      The following is the authors’ response to the current reviews.

      We thank you for sending our manuscript for the second round of review.  We are encouraged by the comments from reviewer #2 that our supplementary work on naïve T cells and antibody blockade work satisfied their previous concerns and is important for our work.

      The Editors raised concerns that we have shared preliminary data on Nrn1 and AMPAR double knockout mice.  We apologize for our enthusiasm for these studies.  Because of the publication model by eLife, we shared that data not because we needed to persuade the reviewer for publication purposes but rather to agree with the reviewer that the molecular target of Nrn1 is important, and we are progressing in understanding this subject.


      The following is the authors’ response to the original reviews.

      To Reviewer #1:

      Thank you for your thorough review and comments on our work, which you described as “the role of neuritin in T cell biology studied here is new and interesting.”.  We have summarized your comments into two categories: biology and investigation approach, experimental rigor, and data presentation.

      Biology and Investigation approach comments:

      (1) Questions regarding the T cell anergy model:

      Major point “(4) Figure 1E-H. The authors assume that this immunization protocol induces anergic cells, but they provide no experimental evidence for this. It would be useful to show that T cells are indeed anergic in this model, especially those that are OVA-specific. The lack of IL-2 production by Cltr cells could be explained by the presence of fewer OVA-specific cells, rather than by an anergic status.”

      T cell anergy is a well-established concept first described by Schwartz’s group. It refers to the hyporesponsive T cell functional state in antigen-experienced CD4 T cells (Chappert and Schwartz, 2010; Fathman and Lineberry, 2007; Jenkins and Schwartz, 1987; Quill and Schwartz, 1987).  Anergic T cells are characterized by their inability to expand and to produce IL2 upon subsequent antigen re-challenge. In this paper, we have borrowed the existing in vivo T cell anergy induction model used by Mueller’s group for T cell anergy induction (Vanasek et al., 2006).  Specifically, Thy1.1+ Ctrl or Nrn1-/- TCR transgenic OTII cells were co-transferred with the congenically marked Thy1.2+ WT polyclonal Treg cells into TCR-/- mice.  After anergy induction, the congenically marked TCR transgenic T cells were recovered by sorting based on Thy1.1+ congenic marker, and subsequently re-stimulation ex vivo with OVA323-339 peptide. We evaluated the T cell anergic state based on OTII cell expansion in vivo and IL2 production upon OVA323-339 restimulation ex vivo.  

      “The authors assume that this immunization protocol induces anergic cells, but they provide no experimental evidence for this.”

      Because the anergy model by Mueller's group is well established (Vanasek et al., 2006), we did not feel that additional effort was required to validate this model as the reviewer suggested. Moreover, the limited IL2 production among the control cells upon restimulation confirms the validity of this model.

      “The lack of IL-2 production by Cltr cells could be explained by the presence of fewer OVAspecific cells, rather than by an anergic status”.

      Cells from Ctrl and Nrn1-/- mice on a homogeneous TCR transgenic (OTII) background were used in these experiments. The possibility that substantial variability of TCR expression or different expression levels of the transgenic TCR could have impacted IL2 production rather than anergy induction is unlikely.

      Overall, we used this in vivo anergy model to evaluate the Nrn1-/- T cell functional state in comparison to Ctrl cells under the anergy induction condition following the evaluation of Nrn1 expression, particularly in anergic T cells.  Through studies using this anergy model, we observed a significant change in Treg induction among OTII cells. We decided to pursue the role of Nrn1 in Treg cell development and function rather than the biology of T cell anergy as evidenced by subsequent experiments.

      Minor points “(6) On which markers are anergic cells sorted for RNAseq analysis?”

      Cells were sorted out based on their congenic marker marking Ctrl or Nrn1-/- OTII cells transferred into the host mice.  We did not specifically isolate anergic cells for sequencing.

      (2) Question regarding the validity of iTreg differentiation model.

      Major point: “(5) Figure 2A-C and Figure 3. The use of iTregs to try to understand what is happening in vivo is problematic. iTregs are cells that have probably no equivalent in vivo, and so may have no physiological relevance. In any case, they are different from pTreg cells generated in vivo. Working with pTreg may be challenging, that is why I would suggest generating data with purified nTreg. Moreover, it was shown in the article of Gonzalez-Figueroa 2021 that Nrn1-/- nTreg retained a normal suppressive function, which would not be what is concluded by the authors of this manuscript. Moreover, we do not even know what the % of Foxp3 cells is in the iTreg used (after differentiation and 20h of re-stimulation) and whether this % is the same between Ctlr and Nrn1 KO cells.”.

      We thank Reviewer #1 for their feedback. While it is true that iTregs made in vitro and in vivo generated pTregs display several distinctions (e. g., differences in Foxp3 expression stability, for example), we strongly disagree with this statement by Revieweer#1 “The use of iTregs to try to understand what is happening in vivo is problematic. iTregs are cells that have probably no equivalent in vivo, and so may have no physiological relevance.”  The induced Treg cell (iTreg) model was established over 20 years ago (Chen et al., 2003; Zheng et al., 2002), and the model is widely adopted with over 2000 citations. Further, it has been instrumental in understanding different aspects of regulatory T cell biology (Hurrell et al., 2022; John et al., 2022; Schmitt and Williams, 2013; Sugiura et al., 2022).   

      Because we have observed reduced pTreg generation in vivo, we choose to use the in vitro iTreg model system to understand the mechanistic changes involved in Treg cell differentiation and function, specifically, neuritin’s role in this process. We have made no claim that iTreg cell biology is identical to pTreg generated in vivo or nTreg cells. However, the iTreg culture system has proved to be a good in vitro system for deciphering molecular events involved in complex processes. As such, it remains a commonly used approach by many research groups in the Treg cell field (Hurrell et al., 2022; John et al., 2022; Sugiura et al., 2022). Moreover, applying the iTreg in vitro culture system has been instrumental in helping us identify the cell electrical state change in Nrn1-/- CD4 cells and revealed the biological link between Nrn1 and the ionotropic AMPA receptor (AMPAR), which we will discuss in the subsequent discussion. It is technically challenging to use nTreg cells for T cell electrical state studies due to their heterogeneous nature from development in an in vivo environment and the effect of manipulation during the nTreg cell isolation process, which can both affect the T cell electrical state.   

      “Moreover, it was shown in the article of Gonzalez-Figueroa 2021 that Nrn1-/- nTreg retained a normal suppressive function, which would not be what is concluded by the authors of this manuscript.” 

      We have also carried out nTreg studies in vitro in addition to iTreg cells. Similar to Gonzalez-Figueroa et al.'s findings, we did not observe differences in suppression function between Nrn1-/- and WT nTreg using the in vitro suppression assay. However, Nrn1-/- nTreg cells revealed reduced suppression function in vivo (Fig. 2D-L). In fact, Gonzalez-Figueroa et al. observed reduced plasma cell formation after OVA immunization in Treg-specific Nrn1-/- mice, implicating reduced suppression from Nrn1-/- follicular regulatory T (Tfr) cells. Thus, our observation of the reduced suppression function of Nrn1-/- nTreg toward effector T cell expansion, as presented in Fig. 2D-L, does not contradict the results from Gonzalez-Figueroa et al. Rather, the conclusions of these two studies agree that Nrn1 can play important roles in immune suppression observable in vivo that are not captured readily by the in vitro suppression assay.

      “Moreover, we do not even know what the % of Foxp3 cells is in the iTreg used (after differentiation and 20h of re-stimulation) and whether this % is the same between Ctlr and Nrn1 KO cells.”

      We have stated in the manuscript on page 7 line 208 that “Similar proportions of Foxp3+ cells were observed in Nrn1-/- and Ctrl cells under the iTreg culture condition, suggesting that Nrn1 deficiency does not significantly impact Foxp3+ cell differentiation”. In the revised manuscript, we will include the data on the proportion of Foxp3+ cells before iTreg restimulation.

      (3) Confirmation of transcriptomic data regarding amino acids or electrolytes transport change

      Minor point“(3) Would not it be possible to perform experiments showing the ability of cells to transport amino acids or electrolytes across the plasma membrane? This would be a more interesting demonstration than transcriptomic data.”

      We appreciate Review# 1’s suggestion regarding “perform experiments showing the ability of cells to transport amino acids or electrolytes across the plasma membrane”.  We have indeed already performed such experiments corroborating the transcriptomics data on differential amino acid and nutrient transporter expression. Specifically, we loaded either iTreg or Th0 cells with membrane potential (MP) dye and measured MP level change after adding the complete set of amino acids (complete AA).  Upon entry, the charge carried by AAs may transiently affect cell membrane potential. Different AA transporter expression patterns may show different MP change patterns upon AA entry, as we showed in Author response image 1. We observed reduced MP change in Nrn1-/- iTreg compared to the Ctrl, whereas in the context of Th0 cells, Nrn1-/- showed enhanced MP change than the Ctrl. We can certainly include these data in the revised manuscript.

      Author response image 1.

      Membrane potential change induced by amino acids entry. a. Nrn1-/- or WT iTreg cells loaded with MP dye and MP change was measured upon the addition of a complete set of AAs. b. Nrn1-/- or WT Th0 cells loaded with MP dye and MP change was measured upon the addition of a complete set of AAs.

      (4) EAE experiment data assessment

      Minor point ”(5) Figure 5F. How are cells re-stimulated? If polyclonal stimulation is used, the experiment is not interesting because the analysis is done with lymph node cells. This analysis should either be performed with cells from the CNS or with MOG restimulation with lymph node cells.”

      In the EAE study, the Nrn1-/- mice exhibit similar disease onset but a protracted non-resolving disease phenotype compared to the WT control mice.  Several reasons may contribute to this phenotype: 1. Enhanced T effector cell infiltration/persistence in the central nervous system (CNS); 2. Reduced Treg cell-mediated suppression to the T effector cells in the CNS; 3. Protracted non-resolving inflammation at the immunization site has the potential to continue sending T effector cells into CNS, contributing to persistent inflammation. Based on this reasoning, we examined the infiltrating T effector cell number and Treg cell proportion in the CNS.  We also restimulated cells from draining lymph nodes close to the inflammation site, looking for evidence of persistent inflammation.  When mice were harvested around day 16 after immunization, the inflammation at the local draining lymph node should be at the contraction stage.  We stimulated cells with PMA and ionomycin intended to observe all potential T effector cells involved in the draining lymph node rather than only MOG antigen-specific cells.  We disagree with Reviewer #1’s assumption that “This analysis should either be performed with cells from the CNS or with MOG restimulation with lymph node cells.”. We think the experimental approach we have taken has been appropriately tailored to the biological questions we intended to answer.

      Experimental rigor and data presentation.

      (1) data labeling and additional supporting data

      Major points

      (2) The authors use Nrn1+/+ and Nrn1+/- cells indiscriminately as control cells on the basis of similar biology between Nrn1+/+ and Nrn1+/- cells at homeostasis. However, it is quite possible that the Nrn1+/- cells have a phenotype in situations of in vitro activation or in vivo inflammation (cancer, EAE). It would be important to discriminate Nrn1+/- and Nrn1+/+ cells in the data or to show that both cell types have the same phenotype in these conditions too.

      (3) Figure 1A-D. Since the authors are using the Nrp1 KO mice, it would be important to confirm the specificity of the anti-Nrn1 mAb by FACS. Once verified, it would be important to add FACS results with this mAb in Figures 1A-C to have single-cell and quantitative data as well.

      Minor points  

      (1) Line 119, 120 of the text. It is said that one of the most up-regulated genes in anergic cells is Nrn1 but the data is not shown.

      (2) For all figures showing %, the titles of the Y axes are written in an odd way. For example, it is written "Foxp3% CD4". It would be more conventional and clearer to write "% Foxp3+ / CD4+" or "% Foxp3+ among CD4+".

      (4) For certain staining (Figure 3E, H) it would be important to show the raw data, in addition to MFI or % values.

      We can adapt the labeling and provide additional data, including Nrn1 staining on Treg cells and flow graphs for pmTOR and pS6 staining (Fig. 3H), as requested by Reviewer #1.

      (2) Experimental rigor:

      General comments:

      “However, it is disappointing that reading this manuscript leaves an impression of incomplete work done too quickly.”

      We were discouraged to receive the comment, “this manuscript leaves an impression of incomplete work done too quickly.” Our study of this novel molecule began without any existing biological tools such as antibodies, knockout mice, etc.  Over the past several years, we have established our own antibodies for Nrn1 detection, obtained and characterized Nrn1 knockout mice, and utilized multiple approaches to identify the molecular mechanism of Nrn1 function. Through the use of the in vitro iTreg system described in this manuscript, we identified the association of Nrn1 deficiency with cell electrical state change, potentially connected to AMPAR function. We have further corroborated our findings by generating Nrn1 and AMPAR T cell specific double knockout mice and confirmed that T cell specific AMPAR deletion could abrogate the phenotype caused by the Nrn1 deficiency (see Support Figure 2).  We did not include the double knockout data in the current manuscript because AMPAR function has not yet been studied thoroughly in T cell biology, and we feel this topic warrants examination in its own right.  However, the unpublished data support the finding that Nrn1 modulates the T cell electrical state and, consequently, metabolism, ultimately influencing tolerance and immunity.  In its current form, the manuscript represents the first characterization of the novel molecule Nrn1 in anergic cells, Tregs, and effector T cells. While this work has led to several exciting additional questions, we disagree that the novel characterization we have presented Is incomplete. We feel that our present data set, which squarely highlights Nrn1’s role as an important immune regulator while shedding unprecedented light on the molecular events involved, will be of considerable interest to a broad field of researchers.

      “Multiple models have been used, but none has been studied thoroughly enough to provide really conclusive and unambiguous data. For example, 5 different models were used to study T cells in vivo. It would have been preferable to use fewer, but to go further in the study of mechanisms.”

      We have indeed used multiple in vivo models to reveal Nrn1's function in Treg differentiation, Treg suppression function, T effector cell differentiation and function, and the overall impact on autoimmune disease. Because the impact of ion channel function is often context-dependent, we examined the biological outcome of Nrn1 deficiency in several in vivo contexts.  We would appreciate it if Reviewer#1 would provide a specific example, given the Nrn1 phenotype, of how to proceed deeper to investigate the electrical change in the in vivo models.

      “Major points

      (1) A real weakness of this work is the fact that in most of the results shown, there are few biological replicates with differences that are often small between Ctrl and Nrn1 -/-. The systematic use of student's t-test may lead to thinking that the differences are significant, which is often misleading given the small number of samples, which makes it impossible to know whether the distributions are Gaussian and whether a parametric test can be used. RNAseq bulk data are based on biological duplicates, which is open to criticism.”

      We respectfully disagree with Reviewer #1 on the question of statistical power and significance to our work. We have used 5-8 mice/group for each in vivo model and 3-4 technical replicates for the in vitro studies, with a minimum of 2-3 replicate experiments. These group sizes and replication numbers are in line with those seen in high-impact publications. While some differences between Ctrl and Nrn1-/- appear small, they have significant biological consequences, as evidenced by the various Nrn1-/- in vivo phenotypes. Furthermore, we believe we have subjected our data to the appropriate statistical tests to ensure rigorous analysis and representation of our findings.

      To Reviewer #2.

      We thank Reviewer #2 for the careful review of the manuscript. We especially appreciate the comments that “The characterizations of T cell Nrn1 expression both in vitro and in vivo are comprehensive and convincing. The in vivo functional studies of anergy development, Treg suppression, and EAE development are also well done to strengthen the notion that Nrn1 is an important regulator of CD4 responsiveness.”

      “The major weakness of this study stems from a lack of a clear molecular mechanism involving Nrn1. “  

      We fully understand this comment from Reviewer #2. The main mechanism we identified contributing to the functional defect of Nrn1-/- T cells involves novel effects on the electric and metabolic state of the cells. Although we referenced neuronal studies that indicate Nrn1 is the auxiliary protein for the ionotropic AMPA-type glutamate receptor (AMPAR) and may affect AMPAR function, we did not provide any evidence in this manuscript as the topic requires further in-depth study.   

      For the benefit of this discussion, we include our preliminary Nrn1 and AMPAR double knockout data (Author response image 2), which indicates that abrogating AMPAR expression can compensate for the defect caused by Nrn1 deficiency in vitro and in vivo. This preliminary data supports the notion that Nrn1 modulates AMPAR function, which causes changes in T cell electric and metabolic state, influencing T cell differentiation and function.  

      Author response image 2.

      Deletion of AMPAR expression in T cells compensates for the defect caused by Nrn1 deficiency. Nrn1-/- mice were crossed with T cell-specific AMPAR knockout mice (AMPARfl/flCD4Cre+) mice. The following mice were generated and used in the experiment: T cell specific AMPAR-knockout and Nrn1 knockout mice (AKONKO), Nrn1 knockout mice (AWTNKO), Ctrl mice (AWTNWT). a. Deletion of AMPAR compensates for the iTreg cell defect observed in Nrn1-/- CD4 cells. iTreg live cell proportion, cell number, and Ki67 expression among Foxp3+ cells 3 days after aCD3 restimulation. b. Deletion of AMPAR in T cells abrogates the enhanced autoimmune response in Nrn1-/- Mouse in the EAE disease model. Mouse relative weight change and disease score progression after EAE disease induction.  

      Ion channels can influence cell metabolism through multiple means (Vaeth and Feske, 2018; Wang et al., 2020). First, ion channels are involved in maintaining cell resting membrane potential. This electrical potential difference across the cell membrane is essential for various cellular processes, including metabolism (Abdul Kadir et al., 2018; Blackiston et al., 2009; Nagy et al., 2018; Yu et al., 2022). Second, ion channels facilitate the movement of ions across cell membranes. These ions are essential for various metabolic processes. For example, ions like calcium (Ca2+), potassium (K+), and sodium (Na+) play crucial roles in signaling pathways that regulate metabolism (Kahlfuss et al., 2020). Third, ion channel activity can influence cellular energy balance due to ATP consumption associated with ion transport to maintain ion balances (Erecińska and Dagani, 1990; Gerkau et al., 2019). This, in turn, can impact processes like ATP production, which is central to cellular metabolism. Thus, ion channel expression and function determine the cell’s bioelectric state and contribute to cell metabolism (Levin, 2021).

      Because the AMPAR function has not been thoroughly studied using a genetic approach in T cells, we do not intend to include the double knockout data in this manuscript before fully characterizing the T cell-specific AMPAR knockout mice.  

      “Although the biochemical and informatics studies are well-performed, it is my opinion that these results are inconclusive in part due to the absence of key "naive" control groups. This limits my ability to understand the significance of these data.

      Specifically, studies of the electrical and metabolic state of Nrn1-/- inducible Treg cells (iTregs) would benefit from similar data collected from wild-type and Nrn1-/- naive CD4 T cells.”

      We appreciate the reviewer’s comments. This comment reflects two concerns in data interpretation:

      (1) Are Nrn1-/- naïve T cells fundamentally different from WT cells? Does this fundamental difference contribute to the observed electrical and metabolic phenotype in iTreg or Th0 cells? This is a very good question we will perform the experiments as the reviewer suggested. While Nrn1 is expressed at a basal (low) level in naïve T cells, deletion of Nrn1 may cause changes in naïve T cell phenotype.   

      (2) Is the Nrn1-/- phenotype caused by Nrn1 functional deficiency or due to the secondary effect of Nrn1 deletion, such as non-physiological cell membrane structure changes?

      We have done the following experiment to address this concern.  We have cultured WT T cells in the presence of Nrn1 antibody and compared the outcome with Nrn1-/- iTreg cells (Figure 3-figure supplement 2D,E,F). WT iTreg cells under antibody blockade exhibited similar changes as Nrn1-/- iTreg cells, confirming the physiological relevance of the Nrn1-/- phenotype.

      Manuscript Revision based on the Reviewer’s suggestions:

      Reviewer #1:

      Major points (3) Figure 1A-D. Since the authors are using the Nrp1 KO mice, it would be important to confirm the specificity of the anti-Nrn1 mAb by FACS. 

      Following the suggestion by Reviewer#1, We have included the Nrn1 Ab staining on activated Nrn1-/- CD4 cells in Figure 1D. We have also added the staining of cell surface Nrn1 on Treg cells in Figure 1-figure supplement 1D.

      Major point: (5) “Moreover, we do not even know what the % of Foxp3 cells is in the iTreg used (after differentiation and 20h of re-stimulation) and whether this % is the same between Ctlr and Nrn1 KO cells.”

      In the revised manuscript, we have included the proportion of Foxp3+ cells among Nrn1-/- and ctrl iTreg cells developed under the iTreg culture condition in Figure 2A.

      Minor points  

      (2) For all figures showing %, the titles of the Y axes are written in an odd way. For example, it is written "Foxp3% CD4". It would be more conventional and clearer to write "% Foxp3+ / CD4+" or "% Foxp3+ among CD4+".

      Following reviewer#1’s suggestion, we have changed the Y-axis label in all the relevant figures.

      (3) Would not it be possible to perform experiments showing the ability of cells to transport amino acids or electrolytes across the plasma membrane? This would be a more interesting demonstration than transcriptomic data.”

      We appreciate Review# 1’s suggestion regarding “perform experiments showing the ability of cells to transport amino acids or electrolytes across the plasma membrane”.  We have used AAinduced cellular MP changes to confirm differential AA transporter expression patterns and their impact on cellular MP levels.  The data are included in the revised manuscript in Figure 3H and Figure 4K.

      (4) For certain staining (Figure 3E, H) it would be important to show the raw data, in addition to MFI or % values.

      We appreciated Reviewer #1’s suggestion and have included the histogram staining data for Figure 3E. We have moved the original Figure 3H to the supplemental figure and included the histogram staining data in Figure 3-figure supplement 1C.  Similarly, we have included the histogram staining data in Figure 4-figure supplement 1C.

      Reviewer#2:

      “Although the biochemical and informatics studies are well-performed, it is my opinion that these results are inconclusive in part due to the absence of key "naive" control groups. This limits my ability to understand the significance of these data.

      Specifically, studies of the electrical and metabolic state of Nrn1-/- inducible Treg cells (iTregs) would benefit from similar data collected from wild-type and Nrn1-/- naive CD4 T cells.”

      We greatly appreciate Reviewer#2’s suggestion and have carried out experiments on naïve CD4 cells derived from Nrn1-/- and WT mice. We have compared membrane potential, AA-induced MP change between Nrn1-/- and WT naïve T cells, and the metabolic state of Nrn1-/- and WT naïve T cells by carrying out glucose stress tests and mitochondria stress tests using a seahorse assay.  Moreover, to investigate whether the phenotype revealed in Nrn1-/- CD4 cells was caused by a secondary effect of cell membrane structure change due to Nrn1 deletion, we carried out Nrn1 antibody blockade in WT CD4 cells and investigated the phenotypic change. These new results are included in Figure 3-figure supplement 2.

      Reference:

      Abdul Kadir, L., M. Stacey, and R. Barrett-Jolley. 2018. Emerging Roles of the Membrane Potential: Action Beyond the Action Potential. Front Physiol 9:1661.

      Blackiston, D.J., K.A. McLaughlin, and M. Levin. 2009. Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle. Cell Cycle 8:3527-3536.

      Chappert, P., and R.H. Schwartz. 2010. Induction of T cell anergy: integration of environmental cues and infectious tolerance. Current opinion in immunology 22:552-559.

      Chen, W., W. Jin, N. Hardegen, K.J. Lei, L. Li, N. Marinos, G. McGrady, and S.M. Wahl. 2003. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. The Journal of experimental medicine 198:1875-1886.

      Erecińska, M., and F. Dagani. 1990. Relationships between the neuronal sodium/potassium pump and energy metabolism. Effects of K+, Na+, and adenosine triphosphate in isolated brain synaptosomes. J Gen Physiol 95:591-616.

      Fathman, C.G., and N.B. Lineberry. 2007. Molecular mechanisms of CD4+ T-cell anergy. Nat Rev Immunol 7:599-609.

      Gerkau, N.J., R. Lerchundi, J.S.E. Nelson, M. Lantermann, J. Meyer, J. Hirrlinger, and C.R. Rose. 2019. Relation between activity-induced intracellular sodium transients and ATP dynamics in mouse hippocampal neurons. The Journal of physiology 597:5687-5705.

      Hurrell, B.P., D.G. Helou, E. Howard, J.D. Painter, P. Shafiei-Jahani, A.H. Sharpe, and O. Akbari. 2022. PD-L2 controls peripherally induced regulatory T cells by maintaining metabolic activity and Foxp3 stability. Nature communications 13:5118.

      Jenkins, M.K., and R.H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. The Journal of experimental medicine 165:302-319.

      John, P., M.C. Pulanco, P.M. Galbo, Jr., Y. Wei, K.C. Ohaegbulam, D. Zheng, and X. Zang. 2022. The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy. Nature communications 13:2506.

      Kahlfuss, S., U. Kaufmann, A.R. Concepcion, L. Noyer, D. Raphael, M. Vaeth, J. Yang, P. Pancholi, M. Maus, J. Muller, L. Kozhaya, A. Khodadadi-Jamayran, Z. Sun, P. Shaw, D. Unutmaz, P.B. Stathopulos, C. Feist, S.B. Cameron, S.E. Turvey, and S. Feske. 2020. STIM1-mediated calcium influx controls antifungal immunity and the metabolic function of nonpathogenic Th17 cells. EMBO molecular medicine 12:e11592.

      Levin, M. 2021. Bioelectric signaling: Reprogrammable circuits underlying embryogenesis, regeneration, and cancer. Cell 184:1971-1989.

      Nagy, E., G. Mocsar, V. Sebestyen, J. Volko, F. Papp, K. Toth, S. Damjanovich, G. Panyi, T.A. Waldmann, A. Bodnar, and G. Vamosi. 2018. Membrane Potential Distinctly Modulates Mobility and Signaling of IL-2 and IL-15 Receptors in T Cells. Biophys J 114:2473-2482.

      Quill, H., and R.H. Schwartz. 1987. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. Journal of immunology (Baltimore, Md. : 1950) 138:3704-3712.

      Schmitt, E.G., and C.B. Williams. 2013. Generation and function of induced regulatory T cells. Frontiers in immunology 4:152.

      Sugiura, A., G. Andrejeva, K. Voss, D.R. Heintzman, X. Xu, M.Z. Madden, X. Ye, K.L. Beier, N.U. Chowdhury, M.M. Wolf, A.C. Young, D.L. Greenwood, A.E. Sewell, S.K. Shahi, S.N. Freedman, A.M. Cameron, P. Foerch, T. Bourne, J.C. Garcia-Canaveras, J. Karijolich, D.C. Newcomb, A.K. Mangalam, J.D. Rabinowitz, and J.C. Rathmell. 2022. MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function. Immunity 55:65-81.e69.

      Vaeth, M., and S. Feske. 2018. Ion channelopathies of the immune system. Current opinion in immunology 52:39-50.

      Vanasek, T.L., S.L. Nandiwada, M.K. Jenkins, and D.L. Mueller. 2006. CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia. Journal of immunology (Baltimore, Md. : 1950) 176:5880-5889.

      Wang, Y., A. Tao, M. Vaeth, and S. Feske. 2020. Calcium regulation of T cell metabolism. Current opinion in physiology 17:207-223.

      Yu, W., Z. Wang, X. Yu, Y. Zhao, Z. Xie, K. Zhang, Z. Chi, S. Chen, T. Xu, D. Jiang, X. Guo, M. Li, J. Zhang, H. Fang, D. Yang, Y. Guo, X. Yang, X. Zhang, Y. Wu, W. Yang, and D. Wang. 2022. Kir2.1-mediated membrane potential promotes nutrient acquisition and inflammation through regulation of nutrient transporters. Nature communications 13:3544.

      Zheng, S.G., J.D. Gray, K. Ohtsuka, S. Yamagiwa, and D.A. Horwitz. 2002. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. Journal of immunology (Baltimore, Md. : 1950) 169:4183-4189.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Koumoundourou et al., identify a pathway downstream of Bcl11b that controls synapse morphology and plasticity of hippocampal mossy fiber synapses. Using an elegant combination of in vivo, ex vivo, and in vitro approaches, the authors build on their previous work that indicated C1ql2 as a functional target of Bcl11b (De Bruyckere et al., 2018). Here, they examine the functional implications of C1ql2 at MF synapses in Bcl11b cKO mice and following C1ql2 shRNA. The authors find that Bcl11b KO and shRNA against C1ql2 significantly reduces the recruitment of synaptic vesicles and impairs LTP at MF synapses. Importantly, the authors test a role for the previously identified C1ql2 binding partner, exon 25b-containing Nrxn3 (Matsuda et al., 2016), as relevant at MF synapses to maintain synaptic vesicle recruitment. To test this, the authors developed a K262E C1ql2 mutant that disrupts binding to Nrxn3. Curiously, while Bcl11b KO and C1ql2 KD largely phenocopy (reduced vesicle recruitment and impaired LTP), only vesicle recruitment is dependent on C1ql2-Nrxn3 interactions. These findings provide new insight into the functional role of C1ql2 at MF synapses. While the authors convincingly demonstrate a role for C1ql2-Nrxn3(25b+) interaction for vesicle recruitment and a Nrxn3(25b+)independent role for C1ql2 in LTP, the underlying mechanisms remain inconclusive. Additionally, a discussion of how these findings relate to previous work on C1ql2 at mossy fiber synapses and how the findings contribute to the biology of Nrxn3 would increase the interpretability of this work.

      As suggested by reviewer #1, we extended our discussion of previous work on C1ql2 and additionally discussed the biology of Nrxn3 and how our work relates to it. Moreover, we extended our mechanistic analysis of how Bcl11b/C1ql2/Nrxn3 pathway controls synaptic vesicle recruitment as well as LTP (please see also response to reviewer #2 points 5 and 8 and reviewer #3 point 4 of public reviews below for detailed discussion).

      Reviewer #2 (Public Review):

      This manuscript describes experiments that further investigate the actions of the transcription factor Bcl11b in regulating mossy fiber (MF) synapses in the hippocampus. Prior work from the same group had demonstrated that loss of Bcl11b results in loss of MF synapses as well as a decrease in LTP. Here the authors focus on a target of Bcl11b a secreted synaptic organizer C1ql2 which is almost completely lost in Bcl11b KO. Viral reintroduction of C1ql2 rescues the synaptic phenotypes, whereas direct KD of C1ql2 recapitulates the Bcl1 phenotype. C1ql2 itself interacts directly with Nrxn3 and replacement with a binding deficient mutant C1q was not able to rescue the Bcl11b KO phenotype. Overall there are some interesting observations in the study, however there are also some concerns about the measures and interpretation of data.

      The authors state that they used a differential transcriptomic analysis to screen for candidate targets of Bcl11b, yet they do not present any details of this screen. This should be included and at the very least a table of all DE genes included. It is likely that many other genes are also regulated by Bcl11b so it would be important to the reader to see the rationale for focusing attention on C1ql2 in this study.

      The transcriptome analysis mentioned in our manuscript was published in detail in our previous study (De Bruyckere et al., 2018), including chromatin-immunoprecipitation that revealed C1ql2 as a direct transcriptional target of Bcl11b. Upon revision of the manuscript, we made sure that this was clearly stated within the main text module to avoid future confusion. In the same publication (De Bruyckere et al., 2018), we discuss in detail several identified candidate genes such as Sema5b, Ptgs2, Pdyn and Penk as putative effectors of Bcl11b in the structural and functional integrity of MFS. C1ql2 has been previously demonstrated to be almost exclusively expressed in DG neurons and localized to the MFS.

      There it bridges the pre- and post-synaptic sides through interaction with Nrxn3 and KAR subunits, respectively, and regulates synaptic function (Matsuda et al., 2016). Taken together, C1ql2 was a very good candidate to study as a potential effector downstream of Bcl11b in the maintenance of MFS structure and function. However, as our data reveal, not all Bcl11b mutant phenotypes were rescued by C1ql2 (see supplementary figures 2d-f of revised manuscript). We expect additional candidate genes, identified in our transcriptomic screen, to act downstream of Bcl11b in the control of MFS.

      All viral-mediated expression uses AAVs which are known to ablate neurogenesis in the DG (Johnston DOI: 10.7554/eLife.59291) through the ITR regions and leads to hyperexcitability of the dentate. While it is not clear how this would impact the measurements the authors make in MF-CA3 synapses, this should be acknowledged as a potential caveat in this study.

      We agree with reviewer #2 and are aware that it has been demonstrated that AAV-mediated gene expression ablates neurogenesis in the DG. To avoid potential interference of the AAVs with the interpretability of our phenotypes, we made sure during the design of the study that all of our control groups were treated in the same way as our groups of interest, and were, thus, injected with control AAVs. Moreover, the observed phenotypes were first described in Bcl11b mutants that were not injected with AVVs (De Bruyckere et al., 2018). Finally, we thoroughly examined the individual components of the proposed mechanism (rescue of C1ql2 expression, over-expression of C1ql3 and introduction of mutant C1ql2 in Bcl11b cKOs, KD of C1ql2 in WT mice, and Nrxn123 cKO) and reached similar conclusions. Together, this strongly supports that the observed phenotypes occur as a result of the physiological function of the proteins involved in the described mechanism and not due to interference of the AAVs with these biological processes. We have now addressed this point in the main text module of the revised ms.

      The authors claim that the viral re-introduction "restored C1ql2 protein expression to control levels. This is misleading given that the mean of the data is 2.5x the control (Figure 1d and also see Figure 6c). The low n and large variance are a problem for these data. Moreover, they are marked ns but the authors should report p values for these. At the least, this likely large overexpression and variability should be acknowledged. In addition, the use of clipped bands on Western blots should be avoided. Please show the complete protein gel in primary figures of supplemental information.

      We agree with reviewer #2 that C1ql2 expression after its re-introduction in Bcl11b cKO mice was higher compared to controls and that this should be taken into consideration for proper interpretation of the data. To address this, based also on the suggestion of reviewer #3 point 1 below, we overexpressed C1ql2 in DG neurons of control animals. We found no changes in synaptic vesicle organization upon C1ql2 over-expression compared to controls. This further supports that the observed effect upon rescue of C1ql2 expression in Bcl11b cKOs is due to the physiological function of C1ql2 and not as result of the overexpression. These data are included in supplementary figure 2g-j and are described in detail in the results part of the revised manuscript.

      Additionally, we looked at the effects of C1ql2 overexpression in Bcl11b cKO DGN on basal synaptic transmission. We plotted fEPSP slopes versus fiber volley amplitudes, measured in slices from rescue animals, as we had previously done for the control and Bcl11b cKO (Author response image 1a). Although regression analysis revealed a trend towards steeper slopes in the rescue mice (Author response image 1a and b), the observation did not prove to be statistically significant, indicating that C1ql2 overexpression in Bcl11b cKO animals does not strongly alter basal synaptic transmission at MFS. Overall, our previous and new findings support that the observed effects of the C1ql2 rescue are not caused by the artificially elevated levels of C1ql2, as compared to controls, but are rather a result of the physiological function of C1ql2.

      Following the suggestion of reviewer #2 all western blot clipped bands were exchanged for images of the full blot. This includes figures 1c, 4c, 6b and supplementary figure 2g of the revised manuscript. P-value for Figure 1d has now been included.

      Author response image 1.

      C1ql2 reintroduction in Bcl11b cKO DGN does not significantly alter basal synaptic transmission at mossy fiber-CA3 synapses. a Input-output curves generated by plotting fEPSP slope against fiber volley amplitude at increasing stimulation intensities. b Quantification of regression line slopes for input-output curves for all three conditions. Control+EGFP, 35 slices from 16 mice; Bcl11b cKO+EGFP, 32 slices from 14 mice; Bcl11b cKO+EGFP-2A-C1ql2, 22 slices from 11 mice. The data are presented as means, error bars represent SEM. Kruskal-Wallis test (non-parametric ANOVA) followed by Dunn’s post hoc pairwise comparisons. p=0.106; ns, not significant.

      Measurement of EM micrographs: As prior work suggested that MF synapse structure is disrupted the authors should report active zone length as this may itself affect "synapse score" defined by the number of vesicles docked. More concerning is that the example KO micrographs seem to have lost all the densely clustered synaptic vesicles that are away from the AZ in normal MF synapses e.g. compare control and KO terminals in Fig 2a or 6f or 7f. These terminals look aberrant and suggest that the important measure is not what is docked but what is present in the terminal cytoplasm that normally makes up the reserve pool. This needs to be addressed with further analysis and modifications to the manuscript.

      As requested by reviewer #2 we analyzed and reported in the revised manuscript the active zone length. We found that the active zone length remained unchanged in all conditions (control/Bcl11b cKO/C1ql2 rescue, WT/C1ql2 KD, control/K262E and control/Nrxn123 cKO), strengthening our results that the described Bcl11b/C1ql2/Nrxn3 mechanism is involved in the recruitment of synaptic vesicles. These data have been included in supplementary figures 2c, 4h, 5f and 6g and are described in the results part of the revised manuscript.

      We want to clarify that the synapse score is not defined by the number of docked vesicles to the plasma membrane. The synapse score, which is described in great detail in our materials and methods part and has been previously published (De Bruyckere et al., 2018), rates MFS based on the number of synaptic vesicles and their distance from the active zone and was designed according to previously described properties of the vesicle pools at the MFS. The EM micrographs refer to the general misdistribution of SV in the proximity of MFS. Upon revision of the manuscript, we made sure that this was clearly stated in the main text module to avoid further confusion.

      The study also presents correlated changes in MF LTP in Bcl11b KO which are rescued by C1ql2 expression. It is not clear whether the structural and functional deficits are causally linked and this should be made clearer in the manuscript. It is also not apparent why this functional measure was chosen as it is unlikely that C1ql2 plays a direct role in presynaptic plasticity mechanisms that are through a cAMP/ PKA pathway and likely disrupted LTP is due to dysfunctional synapses rather than a specific LTP effect.

      The inclusion of functional experiments in this and our previous study (de Bruyckere et al., 2018) was first and foremost intended to determine whether the structural alterations observed at MFB disrupt MFS signaling. From the signaling properties we tested, basal synaptic transmission (this study) and short-term potentiation (de Bruyckere et al., 2018) were unaltered by Bcl11b KO, whereas MF LTP was found to be abolished (de Bruyckere et al., 2018). Indeed, because MF LTP largely depends on presynaptic mechanisms, including the redistribution of the readily releasable pool and recruitment of new active zones (Orlando et al., 2021; Vandael et al., 2020), it appears to be particularly sensitive to the specific structural changes we observed. We therefore believe that it is valuable information that MF LTP is affected in Bcl11b cKO animals - it conveys a direct proof for the functional importance of the observed morphological alterations, while basic transmission remains largely normal. Furthermore, it subsequently provided a functional marker for testing whether the reintroduction of C1ql2 in Bcl11b cKO animals or the KD of C1ql2 in WT animals can functionally recapitulate the control or the Bcl11b KO phenotype, respectively.

      We fully agree with the reviewer that C1ql2 is unlikely to directly participate in the cAMP/PKA pathway and that the ablation of C1ql2 likely disrupts MF LTP through an alternative mode of action. Our original wording in the paragraph describing the results of the forskolin-induced LTP experiment might have overstressed the importance of the cAMP pathway. We have now rephrased that paragraph to better describe the main idea behind the forskolin experiment, namely to circumvent the initial Ca2+ influx in order to test whether deficient presynaptic Ca2+ channel/KAR signaling might be responsible for the loss of LTP in Bcl11b cKO. The results are strongly indicative of a downstream mechanism and further investigation is needed to determine the specific mechanisms by which C1ql2 regulates MFLTP, especially in light of the result that C1ql2.K262E rescued LTP, while it was unable to rescue the SV recruitment at the MF presynapse. This raises the possibility that C1ql2 can influence MF-LTP through additional, yet uncharacterized mechanisms, independent of SV recruitment. As such, a causal link between the structural and functional deficits remains tentative and we have now emphasized that point by adding a respective sentence to the discussion of our revised manuscript. Nevertheless, we again want to stress that the main rationale behind the LTP experiments was to assess the functional significance of structural changes at MFS and not to elucidate the mechanisms by which MF LTP is established.

      The authors should consider measures that might support the role of Bcl11b targets in SV recruitment during the depletion of synapses or measurements of the readily releasable pool size that would complement their findings in structural studies.

      We fully agree that functional measurements of the readily releasable pool (RRP) size would be a valuable addition to the reported redistribution of SV in structural studies. We have, in fact, attempted to use high-frequency stimulus trains in both field and single-cell recordings (details on single-cell experiments are described in the response to point 8) to evaluate potential differences in RRP size between the control and Bcl11b KO (Figure for reviewers 2a and b). Under both recording conditions we see a trend towards lower values of the intersection between a regression line of late responses and the y-axis. This could be taken as an indication of slightly smaller RRP size in Bcl11b mutant animals compared to controls. However, due to several technical reasons we are extremely cautious about drawing such far-reaching conclusions based on these data. At most, they suffice to conclude that the availability of release-ready vesicles in the KO is likely not dramatically smaller than in the control.

      The primary issue with using high-frequency stimulus trains for RRP measurements at MFS is the particularly low initial release probability (Pr) at these synapses. This means that a large number of stimulations is required to deplete the RRP. As the RRP is constantly replenished, it remains unclear when steady state responses are reached (reviewed by Kaeser and Regehr, 2017). This is clearly visible in our single-cell recordings (Author response image 2b), which were additionally complicated by prominent asynchronous release at later stages of the stimulus train and by a large variability in the shapes of cumulative amplitude curves between cells. In contrast, while the cumulative amplitude curves for field potential recordings do reach a steady state (Author response image 2a), field potential recordings in this context are not a reliable substitute for single cell or, in the case of MFB, singlebouton recordings. Postsynaptic cells in field potential recordings are not clamped, meaning that the massive release of glutamate due to continuous stimulation depolarizes the postsynaptic cells and reduces the driving force for Na+, irrespective of depletion of the RRP. This is supported by the fact that we consistently observed a recovery of fEPSP amplitudes later in the trains where RRP had presumably been maximally depleted. In summary, high-frequency stimulus trains at the field potential level are not a valid and established technique for estimating RRP size at MFS.

      Specialized laboratories have used highly advanced techniques, such as paired recordings between individual MFB and postsynaptic CA3 pyramidal cells, to estimate the RRP size of MFB (Vandael et al., 2020). These approaches are outside the scope of our present study which, while elucidating functional changes following Bcl11b depletion and C1ql2 rescue, does not aim to provide a high-end biophysical analysis of the presynaptic mechanisms involved.

      Author response image 2.

      Estimation of RRP size using high-frequency stimulus trains at mossy fiber-CA3 synapses. a Results from field potential recordings. Cumulative fEPSP amplitude in response to a train of 40 stimuli at 100 Hz. All subsequent peak amplitudes were normalized to the amplitude of the first peak. Data points corresponding to putative steady state responses were fit with linear regression (RRP size is indirectly reflected by the intersection of the regression line with the yaxis). Control+EGFP, 6 slices from 5 mice; Bcl11b cKO+EGFP, 6 slices from 3 mice. b Results from single-cell recordings. Cumulative EPSC amplitude in response to a train of 15 stimuli at 50 Hz. The last four stimuli were fit with linear regression. Control, 5 cells from 4 mice; Bcl11b cKO, 3 cells from 3 mice. Note the shallow onset of response amplitudes and the subsequent frequency potentiation. Due to the resulting increase in slope at higher stimulus numbers, intersection with the y-axis occurs at negative values. The differences shown were not found to be statistically significant; unpaired t-test or Mann-Whitney U-test.

      Bcl11b KO reduces the number of synapses, yet the I-O curve reported in Supp Fig 2 is not changed. How is that possible? This should be explained.

      We agree with reviewer #2– this apparent discrepancy has indeed struck us as a counterintuitive result. It might be that synapses that are preferentially eliminated in Bcl11b cKO are predominantly silent or have weak coupling strength, such that their loss has only a minimal effect on basal synaptic transmission. Although perplexing, the result is fully supported by our single-cell data which shows no significant differences in MF EPSC amplitudes recorded from CA3 pyramidal cells between controls and Bcl11b mutants (Author response image 3; please see the response below for details and also our response to Reviewer #1 question 2).

      Matsuda et al DOI: 10.1016/j.neuron.2016.04.001 previously reported that C1ql2 organizes MF synapses by aligning postsynaptic kainate receptors with presynaptic elements. As this may have consequences for the functional properties of MF synapses including their plasticity, the authors should report whether they see deficient postsynaptic glutamate receptor signaling in the Bcl11b KO and rescue in the C1ql2 re-expression.

      We agree that the study by Matsuda et al. is of key importance for our present work. Although MF LTP is governed by presynaptic mechanisms and we previously did not see differences in short-term plasticity between the control and Bcl11b cKO (De Bruyckere et al., 2018), the clustering of postsynaptic kainate receptors by C1ql2 is indeed an important detail that could potentially alter synaptic signaling at MFS in Bcl11b KO. We, therefore, re-analyzed previously recorded single-cell data by performing a kinetic analysis on MF EPSCs recorded from CA3 pyramidal cells in control and Bcl11b cKO mice (Figure for reviewers 3a) to evaluate postsynaptic AMPA and kainate receptor responses in both conditions. We took advantage of the fact that AMPA receptors deactivate roughly 10 times faster than kainate receptors, allowing the contributions of the two receptors to mossy fiber EPSCs to be separated (Castillo et al., 1997 and reviewed by Lerma, 2003). We fit the decay phase of the second (larger) EPSC evoked by paired-pulse stimulation with a double exponential function, yielding a fast and a slow component, which roughly correspond to the fractional currents evoked by AMPA and kainate receptors, respectively. Analysis of both fast and slow time constants and the corresponding fractional amplitudes revealed no significant differences between controls and Bcl11b mutants (Figure for reviewers 3e-h), indicating that both AMPA and kainate receptor signaling is unaffected by the ablation of C1ql2 following Bcl11b KO.

      Importantly, MF EPSC amplitudes evoked by the first and the second pulse (Author response image 3b), paired-pulse facilitation (Author response image 3c) and failure rates (Author response image 3d) were all comparable between controls and Bcl11b mutants. These results further corroborate our observations from field recordings that basal synaptic transmission at MFS is unaltered by Bcl11b KO.

      We note that the results from single cell recordings regarding basal synaptic transmission merely confirm the observations from field potential recordings, and that the attempted measurement of RRP size at the single cell level was not successful. Thus, our single-cell data do not add new information about the mechanisms underlying the effects of Bcl11b-deficiency and we therefore decided not to report these data in the manuscript.

      Author response image 3.

      Basal synaptic transmission at mossy fiber-CA3 synapses is unaltered in Bcl11b cKO mice. a Representative average trace (20 sweeps) recorded from CA3 pyramidal cells in control and Bcl11b cKO mice at minimal stimulation conditions, showing EPSCs in response to paired-pulse stimulation (PPS) at an interstimulus interval of 40 ms. The signal is almost entirely blocked by the application of 2 μM DCG-IV (red). b Quantification of MF EPSC amplitudes in response to PPS for both the first and the second pulse. c Ratio between the amplitude of the second over the first EPSC. d Percentage of stimulation events resulting in no detectable EPSCs for the first pulse. Events <5 pA were considered as noise. e Fast decay time constant obtained by fitting the average second EPSC with the following double exponential function: I(t)=Afaste−t/τfast+Aslowe−t/τslow+C, where I is the recorded current amplitude after time t, Afast and Aslow represent fractional current amplitudes decaying with the fast (τfast) and slow (τslow) time constant, respectively, and C is the offset. Starting from the peak of the EPSC, the first 200 ms of the decaying trace were used for fitting. f Fractional current amplitude decaying with the fast time constant. g-h Slow decay time constant and fractional current amplitude decaying with the slow time constant. For all figures: Control, 8 cells from 4 mice; Bcl11b cKO, 8 cells from 6 mice. All data are presented as means, error bars indicate SEM. None of the differences shown were found to be statistically significant; Mann-Whitney U-test for nonnormally and unpaired t-test for normally distributed data.

      Reviewer #3 (Public Review):

      Overall, this is a strong manuscript that uses multiple current techniques to provide specific mechanistic insight into prior discoveries of the contributions of the Bcl11b transcription factor to mossy fiber synapses of dentate gyrus granule cells. The authors employ an adult deletion of Bcl11b via Tamoxifen-inducible Cre and use immunohistochemical, electron microscopy, and electrophysiological studies of synaptic plasticity, together with viral rescue of C1ql2, a direct transcriptional target of Bcl11b or Nrxn3, to construct a molecular cascade downstream of Bcl11b for DG mossy fiber synapse development. They find that C1ql2 re-expression in Bcl11b cKOs can rescue the synaptic vesicle docking phenotype and the impairments in MF-LTP of these mutants. They also show that C1ql2 knockdown in DG neurons can phenocopy the vesicle docking and plasticity phenotypes of the Bcl11b cKO. They also use artificial synapse formation assays to suggest that C1ql2 functions together with a specific Nrxn3 splice isoform in mediating MF axon development, extending these data with a C1ql2-K262E mutant that purports to specifically disrupt interactions with Nrxn3. All of the molecules involved in this cascade are disease-associated and this study provides an excellent blueprint for uncovering downstream mediators of transcription factor disruption. Together this makes this work of great interest to the field. Strengths are the sophisticated use of viral replacement and multi-level phenotypic analysis while weaknesses include the linkage of C1ql2 with a specific Nrxn3 splice variant in mediating these effects.

      Here is an appraisal of the main claims and conclusions:

      1) C1ql2 is a downstream target of Bcl11b which mediates the synaptic vesicle recruitment and synaptic plasticity phenotypes seen in these cKOs. This is supported by the clear rescue phenotypes of synapse anatomy (Fig.2) and MF synaptic plasticity (Fig.3). One weakness here is the absence of a control assessing over-expression phenotypes of C1ql2. It's clear from Fig.1D that viral rescue is often greater than WT expression (totally expected). In the case where you are trying to suppress a LoF phenotype, it is important to make sure that enhanced expression of C1ql2 in a WT background does not cause your rescue phenotype. A strong overexpression phenotype in WT would weaken the claim that C1ql2 is the main mediator of the Bcl11b phenotype for MF synapse phenotypes.

      As suggested by reviewer #3, we carried out C1ql2 over-expression experiments in control animals. We show that the over-expression of C1ql2 in the DG of control animals had no effect on the synaptic vesicle organization in the proximity of MFS. This further supports that the observed effect upon rescue of C1ql2 expression in Bcl11b cKOs is due to the physiological function of C1ql2 and not a result of the artificial overexpression. These data are now included in supplementary figure 2g-j and are described in detail in the results part of the revised manuscript. Please also see response to point 3 of reviewer #2.

      2) Knockdown of C1ql2 via 4 shRNAs is sufficient to produce the synaptic vesicle recruitment and MFLTP phenotypes. This is supported by clear effects in the shRNA-C1ql2 groups as compared to nonsense-EGFP controls. One concern (particularly given the use of 4 distinct shRNAs) is the potential for off-target effects, which is best controlled for by a rescue experiment with RNA insensitive C1ql2 cDNA as opposed to nonsense sequences, which may not elicit the same off-target effects.

      We agree with reviewer #3 that the usage of shRNAs could potentially create unexpected off-target effects and that the introduction of a shRNA-insensitive C1ql2 in parallel to the expression on the shRNA cassette would be a very effective control experiment. However, the suggested experiment would require an additional 6 months (2 months for AAV production, 2-3 months from animal injection to sacrifice and 1-2 months for EM imaging/analysis and LTP measurements) and a high number of additional animals (minimum 8 for EM and 8 for LTP measurements). We note here, that before the production of the shRNA-C1ql2 and the shRNA-NS, the individual sequences were systematically checked for off-target bindings on the murine exome with up to two mismatches and presented with no other target except the proposed (C1ql2 for shRNA-C1ql2 and no target for shRNA-NS). Taking into consideration our in-silico analysis, we feel that the interpretation of our findings is valid without this (very reasonable) additional control experiment.

      3) C1ql2 interacts with Nrxn3(25b+) to facilitate MF terminal SV clustering. This claim is theoretically supported by the HEK cell artificial synapse formation assay (Fig.5), the inability of the K262-C1ql2 mutation to rescue the Bcl11b phenotype (Fig.6), and the altered localization of C1ql2 in the Nrxn1-3 deletion mice (Fig.7). Each of these lines of experimental evidence has caveats that should be acknowledged and addressed. Given the hypothesis that C1ql2 and Nrxn3b(25b) are expressed in DG neurons and work together, the heterologous co-culture experiment seems strange. Up till now, the authors are looking at pre-synaptic function of C1ql2 since they are re-expressing it in DGNs. The phenotypes they are seeing are also pre-synaptic and/or consistent with pre-synaptic dysfunction. In Fig.5, they are testing whether C1ql2 can induce pre-synaptic differentiation in trans, i.e. theoretically being released from the 293 cells "post-synaptically". But the post-synaptic ligands (Nlgn1 and and GluKs) are not present in the 293 cells, so a heterologous synapse assay doesn't really make sense here. The effect that the authors are seeing likely reflects the fact that C1ql2 and Nrxn3 do bind to each other, so C1ql2 is acting as an artificial post-synaptic ligand, in that it can cluster Nrxn3 which in turn clusters synaptic vesicles. But this does not test the model that the authors propose (i.e. C1ql2 and Nrxn3 are both expressed in MF terminals). Perhaps a heterologous assay where GluK2 is put into HEK cells and the C1ql2 and Nrxn3 are simultaneously or individually manipulated in DG neurons?

      C1ql2 is expressed by DG neurons and is then secreted in the MFS synaptic cleft, while Nrxn3, that is also expressed by DG neurons, is anchored at the presynaptic side. In our work we used the well established co-culture system assay and cultured HEK293 cells secreting C1ql2 (an IgK secretion sequence was inserted at the N-terminus of C1ql2) together with hippocampal neurons expressing Nrxn3(25b+). We used the HEK293 cells as a delivery system of secreted C1ql2 to the neurons to create regions of high concentration of C1ql2. By interfering with the C1ql2-Nrxn3 interaction in this system either by expression of the non-binding mutant C1ql2 variant in the HEK cells or by manipulating Nrxn expression in the neurons, we could show that C1ql2 binding to Nrxn3(25b+) is necessary for the accumulation of vGlut1. However, we did not examine and do not claim within our manuscript that the interaction between C1ql2 and Nrxn3(25b+) induces presynaptic differentiation. Our experiment only aimed to analyze the ability of C1ql2 to cluster SV through interaction with Nrxn3. Moreover, by not expressing potential postsynaptic interaction partners of C1ql2 in our system, we could show that C1ql2 controls SV recruitment through a purely presynaptic mechanism. Co-culturing GluK2-expressing HEK cells with simultaneous manipulation of C1ql2 and/or Nrxn3 in neurons would not allow us to appropriately answer our scientific question, but rather focus on the potential synaptogenic function of the Nrxn3/C1ql2/GluK2 complex and the role of the postsynaptic ligand in it. Thus, we feel that the proposed experiment, while very interesting in characterization of additional putative functions of C1ql2, may not provide additional information for the point we were addressing. In the revised manuscript we tried to make the aim and methodological approach of this set of experiments more clear.

      4) K262-C1ql2 mutation blocks the normal rescue through a Nrxn3(25b) mechanism (Fig.6). The strength of this experiment rests upon the specificity of this mutation for disrupting Nrxn3b binding (presynaptic) as opposed to any of the known postsynaptic C1ql2 ligands such as GluK2. While this is not relevant for interpreting the heterologous assay (Fig.5), it is relevant for the in vivo phenotypes in Fig.6. Similar approaches as employed in this paper can test whether binding to other known postsynaptic targets is altered by this point mutation.

      It has been previously shown that C1ql2 together with C1ql3 recruit postsynaptic GluK2 at the MFS. However, loss of just C1ql2 did not affect the recruitment of GluK2, which was disrupted only upon loss of both C1ql2 and C1ql3 (Matsuda et al., 2018). In our study we demonstrate a purely presynaptic function of C1ql2 through Nrxn3 in the synaptic vesicle recruitment. This function is independent of C1ql3, as C1ql3 expression is unchanged in all of our models and its over-expression did not compensate for C1ql2 functions (Fig. 2, 3a-c). Our in vitro experiments also reveal that C1ql2 can recruit both Nrxn3 and vGlut1 in the absence of any known postsynaptic C1ql2 partner (KARs and BAI3; Fig.5; please also see response above). Furthermore, we have now performed a kinetic analysis on single-cell data which we had previously collected to evaluate postsynaptic AMPA and kainate receptor responses in both the control and Bcl11b KO. Our analysis reveals no significant differences in postsynaptic current kinetics, making it unlikely that AMPA and kainate receptor signaling is altered upon the loss of C1ql2 following Bcl11b cKO (Author response image 3e-h; please also see our response to reviewer #2 point 8). Thus, we have no experimental evidence supporting the idea that a loss of interaction between C1ql2.K262E and GluK2 would interfere with the examined phenotype. However, to exclude that the K262E mutation disrupts interaction between C1ql2 and GluK2, we performed co-immunoprecipitation from protein lysate of HEK293 cells expressing GluK2myc-flag and GFP-C1ql2 or GluK2-myc-flag and GFP-K262E and could show that both C1ql2 and K262E had GluK2 bound when precipitated. These data are included in supplementary figure 5k of the revised manuscript.

      5) Altered localization of C1ql2 in Nrxn1-3 cKOs. These data are presented to suggest that Nrx3(25b) is important for localizing C1ql2 to the SL of CA3. Weaknesses of this data include both the lack of Nrxn specificity in the triple a/b KOs as well as the profound effects of Nrxn LoF on the total levels of C1ql2 protein. Some measure that isn't biased by this large difference in C1ql2 levels should be attempted (something like in Fig.1F).

      We acknowledge that the lack of specificity in the Nrxn123 model makes it difficult to interpret our data. We have now examined the mRNA levels of Nrxn1 and Nrxn2 upon stereotaxic injection of Cre in the DG of Nrxn123flox/flox animals and found that Nrxn1 was only mildly reduced. At the same time Nrxn2 showed a tendency for reduction that was not significant (data included in supplementary figure 6a of revised manuscript). Only Nrxn3 expression was strongly suppressed. Of course, this does not exclude that the mild reduction of Nrxn1 and Nrxn2 interferes with the C1ql2 localization at the MFS. We further examined the mRNA levels of C1ql2 in control and Nrxn123 mutants to ensure that the observed changes in C1ql2 protein levels at the MFS are not due to reduced mRNA expression and found no changes (data are included in supplementary figure 6b of the revised manuscript), suggesting that overall protein C1ql2 expression is normal.

      The reduced C1ql2 fluorescence intensity at the MFS was first observed when non-binding C1ql2 variant K262E was introduced to Bcl11b cKO mice that lack endogenous C1ql2 (Fig.6). In these experiments, we found that despite the overall high protein levels of C1ql2.K262E in the hippocampus (Fig. 6c), its fluorescence intensity at the SL was significantly reduced compared to WT C1ql2 (Fig. 6d-e). The remaining signal of the C1ql2.K262E at the SL was equally distributed and in a punctate form, similar to WT C1ql2. Together, this suggests that loss of C1ql2-Nrxn3 interaction interferes with the localization of C1ql2 at the MFS, but not with the expression of C1ql2. Of course, this does not exclude that other mechanisms are involved in the synaptic localization of C1ql2, beyond the interaction with Nrxn3, as both the mutant C1ql2 in Bcl11b cKO and the endogenous C1ql2 in Nrxn123 cKOs show residual immunofluorescence at the SL. Further studies are required to determine how C1ql2-Nrxn3 interaction regulates C1ql2 localization at the MFS.

      Reviewer #1 (Recommendations For The Authors):

      In addition to addressing the comments below, this study would benefit significantly from providing insight and discussion into the relevant potential postsynaptic signaling components controlled exclusively by C1ql2 (postsynaptic kainate receptors and the BAI family of proteins).

      We have now performed a kinetic analysis on single-cell data that we had previously collected to evaluate postsynaptic AMPA and kainate receptor responses in both the control and Bcl11b cKO. Our analysis reveals no significant differences in postsynaptic current kinetics, making it unlikely that AMPA and kainate receptor signaling differ between controls and upon the loss of C1ql2 following Bcl11b cKO (Author response image 3e-h; please also see our response to Reviewer #2 point 8). This agrees with previous findings that C1ql2 regulates postsynaptic GluK2 recruitment together with C1ql3 and only loss of both C1ql2 and C1ql3 results in a disruption of KAR signaling (Matsuda et al., 2018). In our study we demonstrate a purely presynaptic function of C1ql2 through Nrxn3 in the synaptic vesicle recruitment. This function is independent of C1ql3, as C1ql3 expression is unchanged in all of our models and its over-expression did not compensate for C1ql2 functions (Fig. 2, 3a-c). Our in vitro experiments also reveal that C1ql2 can recruit both Nrxn3 and vGlut1 in the absence of any known postsynaptic C1ql2 partner (KARs and BAI3; Fig.5; please also see our response to reviewer #3 point 4 above). We believe that further studies are needed to fully understand both the pre- and the postsynaptic functions of C1ql2. Because the focus of this manuscript was on the role of the C1ql2-Nrxn3 interaction and our investigation on postsynaptic functions of C1ql2 was incomplete, we did not include our findings on postsynaptic current kinetics in our revised manuscript. However, we increased the discussion on the known postsynaptic partners of C1ql2 in the revised manuscript to increase the interpretability of our results.

      Major Comments:

      The authors demonstrate that the ultrastructural properties of presynaptic boutons are altered after Bcl11b KO and C1ql2 KD. However, whether C1ql2 functions as part of a tripartite complex and the identity of the postsynaptic receptor (BAI, KAR) should be examined.

      Matsuda and colleagues have nicely demonstrated in their 2016 (Neuron) study that C1ql2 is part of a tripartite complex with presynaptic Nrxn3 and postsynaptic KARs. Moreover, they demonstrated that C1ql2, together with C1ql3, recruit postsynaptic KARs at the MFS, while the KO of just C1ql2 did not affect the KAR localization. In our study we demonstrate a purely presynaptic function of C1ql2 through Nrxn3 in the synaptic vesicle recruitment. This function is independent of C1ql3, as C1ql3 expression is unchanged in all of our models and its over-expression did not compensate for C1ql2 functions (Fig. 2, 3a-c). Our in vitro experiments also reveal that C1ql2 is able to recruit both Nrxn3 and vGlut1 in the absence of any known postsynaptic C1ql2 partner (Fig. 5; please also see our response to reviewer #3 point 4 above). Moreover, we were able to show that the SV recruitment depends on C1ql2 interaction with Nrxn3 through the expression of a non-binding C1ql2 (Fig. 6) that retains the ability to interact with GluK2 (supplementary figure 5k of revised manuscript) or by KO of Nrxns (Fig. 7). Furthermore, we have now performed a kinetic analysis on single-cell data which we had previously collected to evaluate postsynaptic AMPA and kainate receptor responses in both the control and Bcl11b cKO. Our analysis reveals no significant differences in postsynaptic current kinetics, making it unlikely that AMPA and kainate receptor signaling differ between controls and Bcl11b mutants (Author response image 3e-h; please also see our response to Reviewer #2 question 8). Together, we have no experimental evidence so far that would support that the postsynaptic partners of C1ql2 are involved in the observed phenotype. While it would be very interesting to characterize the postsynaptic partners of C1ql2 in depth, we feel this would be beyond the scope of the present study.

      Figure 1f: For a more comprehensive understanding of the Bcl11b KO phenotype and the potential role for C1ql2 on MF synapse number, a complete quantification of vGlut1 and Homer1 for all conditions (Supplement Figure 2e) should be included in the main text.

      In our study we focused on the role of C1ql2 in the structural and functional integrity of the MFS downstream of Bcl11b. Bcl11b ablation leads to several phenotypes in the MFS that have been thoroughly described in our previous study (De Bruyckere et al., 2018). As expected, re-expression of C1ql2 only partially rescued these phenotypes, with full recovery of the SV recruitment (Fig. 2) and of the LTP (Fig. 3), but had no effect on the reduced numbers of MFS nor the structural complexity of the MFB created by the Bcl11b KO (supplementary figure 2d-f of revised manuscript). We understand that including the quantification of vGlut1 and Homer1 co-localization in the main figures would help with a better understanding of the Bcl11b mutant phenotype. However, in our manuscript we investigate C1ql2 as an effector of Bcl11b and thus we focus on its functions in SV recruitment and LTP. As we did not find a link between C1ql2 and the number of MFS/MFB upon re-expression of C1ql2 in Bcl11b cKO or now also in C1ql2 KD (see response to comment #4 below), we believe it is more suitable to present these data in the supplement.

      Figure 3/4: Given the striking reduction in the numbers of synapses (Supplement Figure 2e) and docked vesicles (Figure 2d) in the Bcl11b KO and C1ql2 KD (Figure 4e-f), it is extremely surprising that basal synaptic transmission is unaffected (Supplement Figure 2g). The authors should determine the EPSP input-output relationship following C1ql2 KD and measure EPSPs following trains of stimuli at various high frequencies.

      We fully acknowledge that this is an unexpected result. It is, however, well feasible that the modest displacement of SV fails to noticeably influence basal synaptic transmission. This would be the case, for example, if only a low number of vesicles are released by single stimuli, in line with the very low initial Pr at MFS. In contrast, the reduction in synapse numbers in the Bcl11b mutant might indeed be expected to reflect in the input-output relationship. It is possible, however, that synapses that are preferentially eliminated in Bcl11b cKO are predominantly silent or have weak coupling strength, such that their loss has only a minimal effect on basal synaptic transmission. Finally, we cannot exclude compensatory mechanisms (homeostatic plasticity) at the remaining synapses. A detailed analysis of these potential mechanisms would be a whole project in its own right.

      As additional information, we can say that the largely unchanged input-output-relation in Bcl11b cKO is also present in the single-cell level data (Author response image 3; details on single-cell experiments are described in the response to Reviewer #2 point 8).

      As suggested by the reviewer, we have now additionally analyzed the input-output relationship following C1ql2 KD and again did not observe any significant difference between control and KD animals. We have incorporated the respective input-output curves into the revised manuscript under Supplementary figure 3c-d.

      Figure 4: Does C1ql2 shRNA also reduce the number of MFBs? This should be tested to further identify C1ql2-dependent and independent functions.

      As requested by reviewer #1 we quantified the number of MFBs upon C1ql2 KD. We show that C1ql2 KD in WT animals does not alter the number of MFBs. The data are presented in supplementary figure 4d of the revised manuscript. Re-expression of C1ql2 in Bcl11b cKO did not rescue the loss of MFS created by the Bcl11b mutation. Moreover, C1ql2 re-expression did not rescue the complexity of the MFB ultrastructure perturbed by the Bcl11b ablation. Together, this suggests that Bcl11b regulates MFs maintenance through additional C1ql2-independent pathways. In our previously published work (De Bruyckere et al., 2018) we identified and discussed in detail several candidate genes such as Sema5b, Ptgs2, Pdyn and Penk as putative effectors of Bcl11b in the structural and functional integrity of MFS (please also see response to reviewer #2- point 1 of public reviews).

      Figure 5: Clarification is required regarding the experimental design of the HEK/Neuron co-culture: 1. C1ql2 is a secreted soluble protein - how is the protein anchored to the HEK cell membrane to recruit Nrxn3(25b+) binding and, subsequently, vGlut1?

      C1ql2 was secreted by the HEK293 cells through an IgK signaling peptide at the N-terminus of C1ql2. The high concentration of C1ql2 close to the secretion site together with the sparse coculturing of the HEK293 cells on the neurons allows for the quantification of accumulation of neuronal proteins. We have now described the experimental conditions in greater detail in the main text module of the revised manuscript

      2) Why are the neurons transfected and not infected? Transfection efficiency of neurons with lipofectamine is usually poor (1-5%; Karra et al., 2010), while infection of neurons with lentiviruses or AAVs encoding cDNAs routinely are >90% efficient. Thus, interpretation of the recruitment assays may be influenced by the density of neurons transfected near a HEK cell.

      We agree with reviewer #1 that viral infection of the neurons would have been a more effective way of expressing our constructs. However, due to safety allowances in the used facility and time limitation at the time of conception of this set of experiments, a lipofectamine transfection was chosen.

      However, as all of our examined groups were handled in the same way and multiple cells from three independent experiments were examined for each experimental set, we believe that possible biases introduced by the transfection efficiency have been eliminated and thus have trust in our interpretation of these results.

      3) Surface labeling of HEK cells for wild-type C1ql2 and K262 C1ql2 would be helpful to assess the trafficking of the mutant.

      We recognize that potential changes to the trafficking of C1ql2 caused by the K262E mutation would be important to characterize, in light of the reduced localization of the mutant protein at the SL in the in vivo experiments (Fig. 6e). In our culture system, C1ql2 and K262E were secreted by the HEK cells through insertion of an IgK signaling peptide at the N-terminus of the myc-tagged C1ql2/K262E. Thus, trafficking analysis on this system would not be informative, as the system is highly artificial compared to the in vivo model. Further studies are needed to characterize C1ql2 trafficking in neurons to understand how C1ql2-Nrxn3 interaction regulates the localization of C1ql2. However, labeling of the myc-tag in C1ql2 or K262E expressing HEK cells of the co-culture model reveals a similar signal for the two proteins (Fig. 5a,c). Nrxn-null mutation in neurons co-cultured with C1ql2-expressing HEK cells disrupted C1ql2 mediated vGlut1 accumulation in the neurons. Selective expression of Nrxn3(25b) in the Nrxn-null neurons restored vGlut1 clustering was (Fig. 5e-f). Together, these data suggest that it is the interaction between C1ql2 and Nrxn3 that drives the accumulation of vGlut1.

      Figure 6: Bcl11b KO should also be included in 6f-h.

      As suggested by reviewer #1, we included the Bcl11b cKO in figures 6f-h and in corresponding supplementary figures 5c-j.

      Figure 7b: What is the abundance of mRNA for Nrxn1 and Nrxn2 as well as the abundance of Nrxns after EGFP-Cre injection into DG?

      We addressed this point raised by reviewer #1 by quantifying the relative mRNA levels of Nrxn1 and Nrxn2 via qPCR upon Nrxn123 mutation induction with EGFP-Cre injection. We have now examined the mRNA levels of Nrxn1 and Nrxn2 upon stereotaxic injection of Cre in the DG of Nrxn123flox/flox animals and found that Nrxn1 was only mildly reduced. At the same time Nrxn2 showed a tendency for reduction that was not significant. The data are presented in supplementary figure 6a of the revised maunscript.

      Minor Comments for readability:

      Synapse score is referred to frequently in the text and should be defined within the text for clarification.

      'n' numbers should be better defined in the figure legends. For example, for protein expression analysis in 1c, n=3. Is this a biological or technical triplicate? For electrophysiology (e.g. 3c), does "n=7" reflect the number of animals or the number of slices? n/N (slices/animals) should be presented.

      Figure 7a: Should the diagrams of the cre viruses be EGFP-Inactive or active Cre and not CRE-EGFP as shown in the diagram?

      Figure 7b: the region used for the inset should be identified in the larger image.

      All minor points have been fixed in the revised manuscript according to the suggestions.

      Reviewer #3 (Recommendations For The Authors):

      -Please describe the 'synapse score' somewhere in the text - it is too prominently featured to not have a clear description of what it is.

      The description of the synapse score has been included in the main text module of the revised manuscript.

      -The claim that Bcl11b controls SV recruitment "specifically" through C1ql2 is a bit stronger than is warranted by the data. Particularly given that C1ql2 is expressed at 2.5X control levels in their rescue experiments. See pt.2

      Please see response to reviewer #3 point 1 of public reviews. To address this, we over-expressed C1ql2 in control animals and found no changes in the synaptic vesicle distribution (supplementary figure 2g-j of revised manuscript). This supports that the observed rescue of synaptic vesicle recruitment by re-expression of C1ql2 is due to its physiological function and not due to the artificially elevated protein levels. Of course, we cannot exclude the possibility that other, C1ql2-independent, mechanisms also contribute to the SV recruitment downstream of Bcl11b. Our data from the C1ql2 rescue, C1ql2 KD, the in vitro experiments and the interruption of C1ql2-Nrxn3 in vivo, strongly suggest C1ql2 to be an important regulator of SV recruitment.

      -Does Bcl11b regulate Nrxn3 expression? Considering the apparent loss of C1ql2 expression in the Nrxn KO mice, this is an important detail.

      We agree with reviewer #3 that this is an important point. We have previously done differential transcriptomics from DG neurons of Bcl11b cKOs compared to controls and did not find Nrxn3 among the differentially expressed genes. To further validate this, we now quantified the Nrxn3 mRNA levels via qPCR in Bcl11b cKOs compared to controls and found no differences. These data are included in supplementary figure 5a of the revised manuscript.

      -It appears that C1ql2 expression is much lower in the Nrxn123 KO mice. Since the authors are trying to test whether Nrxn3 is required for the correct targeting of C1ql2, this is a confounding factor. We can't really tell if what we are seeing is a "mistargeting" of C1ql2, loss of expression, or both. If the authors did a similar analysis to what they did in Figure 1 where they looked at the synaptic localization of C1ql2 (and quantified it) that could provide more evidence to support or refute the "mistargeting" claim.

      Please also see response to reviewer #3 point 5 of public reviews. To exclude that reduction of fluorescence intensity of C1ql2 at the SL in Nrxn123 KO mice is due to loss of C1ql2 expression, we examined the mRNA levels of C1ql2 in control and Nrxn123 mutants and found no changes (data are included in supplementary figure 6b of the revised manuscript), suggesting that C1ql2 gene expression is normal. The reduced C1ql2 fluorescence intensity at the MFS was first observed when non-binding C1ql2 variant K262E was introduced to Bcl11b cKO mice that lack endogenous C1ql2 (Fig.6). In these experiments, we found that despite the overall high protein levels of C1ql2.K262E in the hippocampus (Fig. 6c), its fluorescence intensity at the SL was significantly reduced compared to WT C1ql2 (Fig. 6d-e). The remaining C1ql2.K262E signal in the SL was equally distributed and in a punctate form, similar to WT C1ql2. Together, this indicates that the loss of C1ql2-Nrxn3 interaction interferes with the localization of C1ql2 along the MFS, but not with expression of C1ql2. Of course, this does not exclude that additional mechanisms regulate C1ql2 localization at the synapse, as both the mutant C1ql2 in Bcl11b cKO and the endogenous C1ql2 in Nrxn123 cKO show residual immunofluorescence at the SL.

      We note here that we have not previously quantified the co-localization of C1ql2 with individual synapses. C1ql2 is a secreted molecule that localizes at the MFS synaptic cleft. However, not much is known about the number of MFS that are positive for C1ql2 nor about the mechanisms regulating C1ql2 targeting, transport, and secretion to the MFS. Whether C1ql2 interaction with Nrxn3 is necessary for the protection of C1ql2 from degradation, its surface presentation and transport or stabilization to the synapse is currently unclear. Upon revision of our manuscript, we realized that we might have overstated this particular finding and have now rephrased the specific parts within the results to appropriately describe the observation and have also included a sentence in the discussion referring to the lack of understanding of the mechanism behind this observation.

      -Title of Figure S5 is "Nrxn KO perturbs C1ql2 localization and SV recruitment at the MFS", but there is no data on C1ql2 localization.

      This issue has been fixed in the revised manusript.

      -S5 should be labeled more clearly than just Cre+/-

      This issue has been fixed in the revised manuscript.

      References

      Castillo, P.E., Malenka, R.C., Nicoll, R.A., 1997. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature 388, 182–186. https://doi.org/10.1038/40645

      De Bruyckere, E., Simon, R., Nestel, S., Heimrich, B., Kätzel, D., Egorov, A.V., Liu, P., Jenkins, N.A., Copeland, N.G., Schwegler, H., Draguhn, A., Britsch, S., 2018. Stability and Function of Hippocampal Mossy Fiber Synapses Depend on Bcl11b/Ctip2. Front. Mol. Neurosci. 11. https://doi.org/10.3389/fnmol.2018.00103

      Kaeser, P.S., Regehr, W.G., 2017. The readily releasable pool of synaptic vesicles. Curr. Opin. Neurobiol. 43, 63–70. https://doi.org/10.1016/j.conb.2016.12.012

      Lerma, J., 2003. Roles and rules of kainate receptors in synaptic transmission. Nat. Rev. Neurosci. 4, 481–495. https://doi.org/10.1038/nrn1118

      Orlando, M., Dvorzhak, A., Bruentgens, F., Maglione, M., Rost, B.R., Sigrist, S.J., Breustedt, J., Schmitz, D., 2021. Recruitment of release sites underlies chemical presynaptic potentiation at hippocampal mossy fiber boutons. PLoS Biol. 19, e3001149. https://doi.org/10.1371/journal.pbio.3001149

      Vandael, D., Borges-Merjane, C., Zhang, X., Jonas, P., 2020. Short-Term Plasticity at Hippocampal Mossy Fiber Synapses Is Induced by Natural Activity Patterns and Associated with Vesicle Pool Engram Formation. Neuron 107, 509-521.e7. https://doi.org/10.1016/j.neuron.2020.05.013

    1. Author Response

      The following is the authors’ response to the original reviews.

      We are very grateful to the reviewers for their thoughtful comments on the manuscript and to the editors for their assessment.

      We thank the reviewers for their positive feedback and appreciate that they consider our method a valid addition to previously established systems for generating recombinant RNA viruses.

      To strengthen this point, we have now included additional validation by the rescue of recombinant Chikungunya and Dengue virus from viral RNA directly, using the CLEVER protocol. This strengthens the potential of this method as a reverse genetics platform for positive-stranded viruses in general.

      The supportive data has been amended in the Results section, taken into account in Materials and Methods, and the corresponding supplementary figure (Figure S4) has been added.

      One key point raised by one of the reviewers, a comparison with different systems, could not be addressed in this manuscript as our lab does not at all perform BAC cloning. We currently do not have the necessary expertise to conduct an unbiased side-by-side comparison.

      All other comments were addressed in detail, either by including additional data or through specific clarification in the revised text. We are grateful for the careful review and constructive criticisms raised by the reviewers and feel that the corrections and additions have significantly improved the manuscript.

      We have revised the latest version posted May 30, 2023 on bioRxiv (https://doi.org/10.1101/2023.05.11.540343).

      Reviewer #1:

      Public Review:

      In this manuscript, Kipfer et al describe a method for a fast and accurate SARS-CoV2 rescue and mutagenesis. This work is based on a published method termed ISA (infectious subgenomic amplicons), in which partially overlapping DNA fragments covering the entire viral genome and additional 5' and 3' sequences are transfected into mammalian cell lines. These DNA fragments recombine in the cells, express the full length viral genomic RNA and launch replication and rescue of infectious virus.

      CLEVER, the method described here significantly improves on the ISA method to generate infectious SARS-CoV2, making it widely useful to the virology community.

      Specifically, the strengths of this method are:

      1) The successful use of various cell lines and transfection methods.

      2) Generation of a four-fragment system, which significantly improves the method efficiency due to lower number of required recombination events.

      3) Flexibility in choice of overlapping sequences, making this system more versatile.

      4) The authors demonstrated how this system can be used to introduce point mutations as well as insertion of a tag and deletion of a viral gene.

      5) Fast-tracking generation of infectious virus directly from RNA of clinical isolates by RT-PCR, without the need for cloning the fragments or using synthetic sequences.

      One weakness of the latter point, which is also pointed out by the authors, is that the direct rescue of clinical isolates was not tested for sequence fidelity.

      The manuscript clearly presents the findings, and the proof-of-concept experiments are well designed.

      Overall, this is a very useful method for SARS-CoV2 research. Importantly, it can be applicable to many other viruses, speeding up the response to newly emerging viruses than threaten the public health.

      We thank the reviewer for this positive feedback and the summary of the main points. Nevertheless, we would like to comment on point 5): “the direct rescue of clinical isolates was not tested for sequence fidelity”

      This impression by the reviewer suggests that the data was not sufficient on this point. However, the sequence fidelity after direct rescue from RNA was indeed tested in this study, even on a clonal level (please see: Table S2, or raw NGS data SRX20303605 - SRX20303607). For higher clarity, we added the following sentence to the manuscript:<br /> “Indeed, a slight increase of unintentional mutations was observed when sequencing clonal virus populations rescued from RNA directly”.

      Recommendations for the authors:

      Minor Points:

      1) On page 8, the authors write: "levels correlated very well with the viral phenotype". This sentence is not clear. Please clarify what you mean by "viral phenotype". Do you mean CPE on Vero cells?

      We corrected the sentence to: “(…) staining intensity and patterns correlated very well with the wild-type phenotype.”

      2) Page 9 "sequences were analyzed with a cut-off of 10%. Cutoff of what? please clarify.

      The sentence was rephrased to: “(…)mutations with a relative abundance of >10% in the entire virus population were analyzed”

      3) Page 15: The authors refer to the time required for completion of each step of the process. It would be helpful and informative for the readers to include a panel in figure 4, visualizing the timelines.

      We included a timeline in Figure 4, Panel A.

      4) Materials and methods, first paragraph: Please specify which human samples were collected. Do the authors refer to clinical virus isolates?

      We added the following information to the Materials and Methods section:<br /> “Human serum samples for neutralization assays were collected from SARS-CoV-2 vaccinated anonymous donors (…)”

      Clinical virus isolates (Material and Methods; Virus) were used for control experiments, neutralization assays, or as templates for RT-PCR.

      5) Supplementary figure 4A: The color scheme makes it hard to differentiate between the BA.1 and BA.5 fragments. Please choose colors that are not as similar to each other.

      Colors were adapted for better distinction.

      Reviewer #2:

      Public Review:

      The authors of the manuscript have developed and used cloning-free method. It is not entirely novel (rather it is based on previously described ISA method) but it is clearly efficient and useful complementation to the already existing methods. One of strong points of the approach use by authors is that it is very versatile, i.e. can be used in combination with already existing methods and tools. I find it important as many laboratories have already established their favorite methods to manipulate SARS-CoV-2 genome and are probably unwilling to change their approach entirely. Though authors highlight the benefits of their method these are probably not absolute - other methods may be as efficient or as fast. Still, I find myself thinking that for certain purposes I would like to complement my current approach with elements from authors CLEVER method.

      The work does not contain much novel biological data - which is expected for a paper dedicated to development of new method (or for improving the existing one). It may be kind of shortcoming as it is commonly expected that authors who have developed new methods apply it for discovery of something novel. The work stops on step of rescue the viruses and confirming their biological properties. This part is done very well and represents a strength of the study. The properties of rescued viruses were also studied using NSG methods that revealed high accuracy of the used method, which is very important as the method relies on use of PCR that is known to generate random mistakes and therefore not always method of choice.

      What I found missing is a real head-to-head comparison of the developed system with an existing alternatives, preferably some PCR-free standard methods such as use of BAC clones. There are a lot of comparisons but they are not direct, just data from different studies has been compared. Authors could also be more opened to discuss limitations of the method. One of these seems to be rather low rescue efficiency - 1 rescue event per 11,000 transfected cells. This is much lower compared to infectious plasmid (about 1 event per 100 cells or so) and infectious RNAs (often 1 event per 10 cells, for smaller genomes most of transfected cells become infected). This makes the CLEVER method poorly suitable for generation of large infectious virus libraries and excludes its usage for studies of mutant viruses that harbor strongly attenuating mutations. Many of such mutations may reduce virus genome infectivity by 3-4 orders of magnitude; with current efficiencies the use of CLEVER approach may result in false conclusions (mutant viruses will be classified as non-viable while in reality they are just strongly attenuated).

      We thank reviewer 2 for the careful review of our work and the valuable feedback. We agree that a direct comparison with other (PCR-free) methods such as BAC cloning, could be useful for demonstrating the unique benefits of the CLEVER method. However, as our laboratory does not use any BAC or YAC cloning methods, we could not ensure an unbiased side-byside comparison using different techniques.

      We would like to highlight the avoidance of any yeast/bacterial cloning steps that render the CLEVER protocol significantly faster and easier to handle. A visualization of the key steps that could be skipped using CLEVER in comparison to common reverse genetics methods is given in Figure 6.

      Further, we firmly believe that the benefits of the CLEVER method become especially apparent for large viral genomes such as the one of SARS-CoV-2, where assembly, genome amplification and sequence verification of plasmid DNA are highly inefficient and more timeconsuming than for small viruses like DENV, CHIKV or HIV.

      We agree with the reviewer that the overall transfection and recombination efficiencies observed with CLEVER seemed rather low. Although data on transfection/rescue efficiency is known for many techniques and viruses, we did not find any published data on the reconstitution of SARS-CoV-2 or viruses with similar genome sizes. Therefore, a useful comparator for our observations in relation to other techniques is currently simply missing. We therefore emphasize that the efficiencies of CLEVER were achieved with one of the largest plus-stranded RNA virus genomes, and our data can’t be directly compared to transfection efficiencies of short infectious RNAs.

      On the contrary, it was rather interesting to observe the very high rescue efficiency of infectious virus progeny. During the two years of establishing and validating the CLEVER protocol, we reached success rates for the genome reconstitution after transfection of >95 %. This was even obtained with highly attenuated mutants including rCoV2∆ORF3678 (joint deletion of ORF3a, ORF6, ORF7a, and ORF8) (Liu et al., 2022)(see Author response image 1). We amended this data in response to the reviewers’ comment and as an example of the successful rescue of an attenuated virus from five overlapping genome fragments (fragments A, B, C, D1, and D2∆ORF3678).

      The latter data were not added to the main manuscript since in this case the deletions were introduced using a different method: from the plasmid-based DNA fragment D2∆ORF3678 and not directly from PCR-based mutagenesis.

      Further, CLEVER was used for related substantial manipulations, including the complete deletion of the Envelope gene (E) which led to the creation of a single-cycle virus that may serve as a live, replication-incompetent vaccine candidate (Lett et al., 2023).

      Author response image 1.

      rCoV2∆ORF3678. Detection of intracellular SARS-CoV-2 nucleocapsid protein (N, green) and nuclei (Hoechst, blue) in Vero E6TMPRSS2 cells infected with rCoV2∆ORF3678 by immunocytochemistry. Scalebar is 200 µm in overview and 50 µm in ROI images.

      Recommendations for the authors:

      The work is nicely presented and the method authors has developed is clearly valuable. As indicated in Public review section the work would benefit from direct comparison of CLEVER with that of infectious plasmid (or RNA) based methods; direct comparison of data would be more convincing that indirect one. Authors should also discuss possible limitations of the method - this is helpful for a reader.

      We were not able to perform a direct comparison of CLEVER with other methods (see our statement above).

      We added the following section to the discussion: “Along with the advantages of the CLEVER protocol, limitations must be considered: Interestingly, virus was never rescued after transfecting Vero E6 cells, as has been observed previously (Mélade et al., 2022). Whether this is due to low transfection efficiency or the cell’s inability to recombine remains to be elucidated. Other cell lines not tested within this study will have to be tested for efficient recombination and virus production first. Further, the high sequence integrity of rescued virus is highly dependent on the fidelity of the DNA polymerase used for amplification. The use of other enzymes might negatively influence the sequence integrity of recombinant virus, as it has been observed for the direct rescue from viral RNA using a commercially available onestep RT-PCR kit. Another limitation when performing direct mutagenesis is the synthesis of long oligos to create an overlapping region. Repetitive sequences, for example, can impair synthesis, and self-annealing and hairpin formation increase with prolonged oligos.”

      Some technical corrections of the text would be beneficial. In all past of the text the use of terms applicable only for DNA or RNA is mixed and creates some confusion. For example, authors state that "the human cytomegalovirus promoter (CMV) was cloned upstream of 5' UTR and poly(A) tail, the hepatitis delta ribozyme (HDVr) and the simian virus 40 polyadenylation signal downstream of the 3' UTR". Strictly speaking it is impossible as such a construct would contain dsDNA sequence (CMV promoter) followed by ssRNA (5'UTR, polyA tail and HDV ribozyme) and then again dsDNA (SV40 terminator). So, better to be correct and add "sequences corresponding to", "dsDNA copies of" to the description of RNA elements

      We thank the reviewer for the advice but would like to state that in scientific language it is common to assume that nucleic acid cloning is based on DNA.

      We have corrected the description in the Methods section: “The human cytomegalovirus promoter (CMV) was cloned upstream of the DNA sequence of the viral 5’UTR; herein, the first five nucleotides (ATATT) correspond to the 5’UTR of SARS-CoV. Sequences corresponding to the poly(A) tail (n=35), the hepatitis delta virus ribozyme (HDVr), and the simian virus 40 polyadenylation signal (SV40pA) were cloned immediately downstream of the DNA sequence of the viral 3’UTR.”

      For ease of reading and for consistent terminology, we kept the original spelling in the rest of the manuscript.

      In description of neutralization assay authors have used temperature 34 C for incubation of virus with antibodies as well as for subsequent incubation of infected cells. Why this temperature was used?

      The following sentence was added (Materials and Methods; Cells): “A lower incubation temperature was chosen based on previous studies (V’kovski et al., 2021).”

      References

      Lett MJ, Otte F, Hauser D, Schön J, Kipfer ET, Hoffmann D, Halwe NJ, Ulrich L, Zhang Y, Cmiljanovic V, Wylezich C, Urda L, Lang C, Beer M, Mittelholzer C, Klimkait T. 2023. Single-cycle SARS-CoV-2 vaccine elicits high protection and sterilizing immunity in hamsters. doi:10.1101/2023.05.17.541127

      Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Kurhade C, Plante JA, Bopp NE, Kalveram B, Bukreyev A, Ren P, Wang T, Menachery VD, Plante KS, Xie X, Weaver SC, Shi P-Y. 2022. A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nat Commun 13:4337. doi:10.1038/s41467-022-31930-z

      V’kovski P, Gultom M, Kelly JN, Steiner S, Russeil J, Mangeat B, Cora E, Pezoldt J, Holwerda M, Kratzel A, Laloli L, Wider M, Portmann J, Tran T, Ebert N, Stalder H, Hartmann R, Gardeux V, Alpern D, Deplancke B, Thiel V, Dijkman R. 2021. Disparate temperaturedependent virus–host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium. PLoS Biol 19:e3001158. doi:10.1371/journal.pbio.3001158

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The study addresses how faces and bodies are integrated in two STS face areas revealed by fMRI in the primate brain. It builds upon recordings and analysis of the responses of large populations of neurons to three sets of images, that vary face and body positions. These sets allowed the authors to thoroughly investigate invariance to position on the screen (MC HC), to pose (P1 P2), to rotation (0 45 90 135 180 225 270 315), to inversion, to possible and impossible postures (all vs straight), to the presentation of head and body together or in isolation. By analyzing neuronal responses, they found that different neurons showed preferences for body orientation, head orientation, or the interaction between the two. By using a linear support vector machine classifier, they show that the neuronal population can decode head-body angle presented across orientations, in the anterior aSTS patch (but not middle mSTS patch), except for mirror orientation.

      Strengths:

      These results extend prior work on the role of Anterior STS fundus face area in face-body integration and its invariance to mirror symmetry, with a rigorous set of stimuli revealing the workings of these neuronal populations in processing individuals as a whole, in an important series of carefully designed conditions.

      Minor issues and questions that could be addressed by the authors:

      (1) Methods. While monkeys certainly infer/recognize that individual pictures refer to the same pose with varying orientations based on prior studies (Wang et al.), I am wondering whether in this study monkeys saw a full rotation of each of the monkey poses as a video before seeing the individual pictures of the different orientations, during recordings.

      The monkeys had not been exposed to videos of a rotating monkey pose before the recordings. However, they were reared and housed with other monkeys, providing them with ample experience of monkey poses from different viewpoints.

      (2) Experiment 1. The authors mention that neurons are preselected as face-selective, body-selective, or both-selective. Do the Monkey Sum Index and ANOVA main effects change per Neuron type?

      We have performed a new analysis to assess whether the Monkey Sum Index is related to the response strength for the face versus the body as measured in the Selectivity Test of Experiment 1. To do this we selected face- and body-category selective neurons, as well as neurons responding selectively to both faces and bodies. First, we selected those neurons that responded significantly to either faces, bodies, or the two control object categories, using a split-plot ANOVA for these 40 stimuli. From those neurons, we selected face-selective ones having at least a twofold larger mean net response to faces compared to bodies (faces > 2 * bodies) and the control objects for faces (faces  > 2* objects). Similarly, a body-selective neuron was defined by a twofold larger mean net response to bodies compared to faces and the control objects for bodies. A body-and-face selective neuron was defined as having a twofold larger net response to the faces compared to their control objects, and to bodies compared to their control objects, with the ratio between mean response to bodies and faces being less than twofold. Then, we compared the distribution of the Monkey Sum Index (MSI) for each region (aSTS; mSTS), pose (P1, P2), and centering (head- (HC) or monkey-centered (MC)) condition. Too few body-and-face selective neurons were present in each combination of region, pose, and centering (a maximum of 7) to allow a comparison of their MSI distribution with the other neuron types. The Figure below shows the distribution of the MSI for the different orientation-neuron combinations for the body- and face-selective neurons (same format as in Figure 3a, main text). The number of body-selective neurons, according to the employed criteria, varied from 21 to 29, whereas the number of face-selective neurons ranged from 14 to 24 (pooled across monkeys). The data of the two subjects are shown in a different color and the number of cases for each subject is indicated (n1: number of cases for M1; n2: number of cases for M2). The arrows indicate the medians for the data pooled across the monkey subjects. For the MC condition, the MSI tended to be more negative (i.e. relatively less response to the monkey compared to the sum of the body and face responses) for the face compared to the body cells, but this was significant only for mSTS and P1 (p = 0.043; Wilcoxon rank sum test; tested after averaging the indices per neuron to avoid dependence of indices within a neuron). No consistent, nor significant tendencies were observed for the HC stimuli. This absence of a consistent relationship between MSI and face- versus body-selectivity is in line with the absence of a correlation between the MSI and face- versus body-selectivity using natural images of monkeys in a previous study (Zafirova Y, Bognár A, Vogels R. Configuration-sensitive face-body interactions in primate visual cortex. Prog Neurobiol. 2024 Jan;232:102545).

      We did not perform a similar analysis for the main effects of the two-way ANOVA because the very large majority of neurons showed a significant effect of body orientation and thus no meaningful difference between the two neuron types can be expected.

      Author response image 1.

      (3) I might have missed this information, but the correlation between P1 and P2 seems to not be tested although they carry similar behavioral relevance in terms of where attention is allocated and where the body is facing for each given head-body orientation.

      Indeed, we did not compute this correlation between the responses to the sitting (P1) and standing (P2) pose avatar images. However, as pointed out by the reviewer, one might expect such correlations because of the same head orientations and body-facing directions. Thus, we computed the correlation between the 64 head-body orientation conditions of P1 and P2 for those neurons that were tested with both poses and showed a response for both poses (Split-plot ANOVA). This was performed for the Head-Centered and Monkey-Centered tests of Experiment 1 for each monkey and region. Note that not all neurons were tested with both poses (because of failure to maintain isolation of the single unit in both tests or the monkey stopped working) and not all neurons that were recorded in both tests showed a significant response for both poses, which is not unexpected since these neurons can be pose selective. The distribution of the Pearson correlation coefficients of the neurons with a significant response in both tests is shown in Figure S1. The median correlation coefficient was significantly larger than zero for each region, monkey, and centering condition (outcome of Wilcoxon tests, testing whether the median was different from zero (p1 = p-value for M1; p2: p-value for M2) in Figure), indicating that the effect of head and/or body orientation generalizes across pose. We have noted this now in the Results (page 12) and added the Figure (New Figure S1) in the Suppl. Material.

      (4) Is the invariance for position HC-MC larger in aSTS neurons compared to mSTS neurons, as could be expected from their larger receptive fields?

      Yes, the position tolerance of the interaction of body and head orientation was significantly larger for aSTS compared to mSTS neurons, as we described on pages 11 and 12 of the Results. This is in line with larger receptive fields in aSTS than in mSTS. However, we did not plot receptive fields in the present study.

      (5) L492 "The body-inversion effect likely results from greater exposure to upright than inverted bodies during development". Monkeys display more hanging upside-down behavior than humans, however, does the head appear more tilted in these natural configurations?

      Indeed, infant monkeys do spend some time hanging upside down from their mother's belly. While we lack quantitative data on this behavior, casual observations suggest that even young monkeys spend more time upright. The tilt of the head while hanging upside down can vary, just as it does in standing or sitting monkeys (as when they search for food or orient to other individuals). To our knowledge, no quantitative data exist on the frequency of head tilts in upright versus upside-down monkeys. Therefore, we refrain from further speculation on this interesting point, which warrants more attention.

      (6) Methods in Experiment 1. SVM. How many neurons are sufficient to decode the orientation?

      The number of neurons that are needed to decode the head-body orientation angle depends on which neurons are included, as we show in a novel analysis of the data of Experiment 1. We employed a neuron-dropping analysis, similar to Chiang et al. (Chiang FK, Wallis JD, Rich EL. Cognitive strategies shift information from single neurons to populations in prefrontal cortex. Neuron. 2022 Feb 16;110(4):709-721) to assess the positive (or negative) contribution of each neuron to the decoding performance. We performed cross-validated linear SVM decoding N times, each time leaving out a different neuron (using N-1 neurons; 2000 resamplings of pseudo-population vectors). We then ranked decoding accuracies from highest to lowest, identifying the ‘worst’ (rank 1) to ‘best’ (rank N) neurons. Next, we conducted N decodings, incrementally increasing the number of included neurons from 1 to N, starting with the worst-ranked neuron (rank 1) and sequentially adding the next (rank 2, rank 3, etc.). This analysis focused on zero versus straight angle decoding in the aSTS, as it yielded the highest accuracy. We applied it when training on MC and testing on HC for each pose. Plotting accuracy as a function of the number of included neurons suggested that less than half contributed positively to decoding. We show also the ten “best” neurons for each centering condition and pose. These have a variety of tuning patterns for head and body orientation suggesting that the decoding of head-body orientation angle depends on a population code. Notably, the best-ranked (rank N) neuron alone achieved above-chance accuracy. We have added this interesting and novel result to the Results (page 16) and Suppl. Material (new Figure S3).

      (7) Figure 3D 3E. Could the authors please indicate for each of these neurons whether they show a main effect of face, body, or interaction, as well as their median corrected correlation to get a flavor of these numbers for these examples?

      We have indicated these now in Figure 3.

      (8) Methods and Figure 1A. It could be informative to precise whether the recordings are carried in the lateral part of the STS or in the fundus of the STS both for aSTS and mSTS for comparison to other studies that are using these distinctions (AF, AL, MF, ML).

      In experiment 1, the recording locations were not as medial as the fundus. For experiments 2 and 3, the ventral part of the fundus was included, as described in the Methods. We have added this to the Methods now (page 31).

      Wang, G., Obama, S., Yamashita, W. et al. Prior experience of rotation is not required for recognizing objects seen from different angles. Nat Neurosci 8, 1768-1775 (2005). https://doi-org.insb.bib.cnrs.fr/10.1038/nn1600

      Reviewer #2 (Public review):

      Summary:

      This paper investigates the neuronal encoding of the relationship between head and body orientations in the brain. Specifically, the authors focus on the angular relationship between the head and body by employing virtual avatars. Neuronal responses were recorded electrophysiologically from two fMRI-defined areas in the superior temporal sulcus and analyzed using decoding methods. They found that: (1) anterior STS neurons encode head-body angle configurations; (2) these neurons distinguish aligned and opposite head-body configurations effectively, whereas mirror-symmetric configurations are more difficult to differentiate; and (3) an upside-down inversion diminishes the encoding of head-body angles. These findings advance our understanding of how visual perception of individuals is mediated, providing a fundamental clue as to how the primate brain processes the relationship between head and body - a process that is crucial for social communication.

      Strengths:

      The paper is clearly written, and the experimental design is thoughtfully constructed and detailed. The use of electrophysiological recordings from fMRI-defined areas elucidated the mechanism of head-body angle encoding at the level of local neuronal populations. Multiple experiments, control conditions, and detailed analyses thoroughly examined various factors that could affect the decoding results. The decoding methods effectively and consistently revealed the encoding of head-body angles in the anterior STS neurons. Consequently, this study offers valuable insights into the neuronal mechanisms underlying our capacity to integrate head and body cues for social cognition-a topic that is likely to captivate readers in this field.

      Weaknesses:

      I did not identify any major weaknesses in this paper; I only have a few minor comments and suggestions to enhance clarity and further strengthen the manuscript, as detailed in the Private Recommendations section.

      Reviewer #3 (Public review):

      Summary:

      Zafirova et al. investigated the interaction of head and body orientation in the macaque superior temporal sulcus (STS). Combining fMRI and electrophysiology, they recorded responses of visual neurons to a monkey avatar with varying head and body orientations. They found that STS neurons integrate head and body information in a nonlinear way, showing selectivity for specific combinations of head-body orientations. Head-body configuration angles can be reliably decoded, particularly for neurons in the anterior STS. Furthermore, body inversion resulted in reduced decoding of head-body configuration angles. Compared to previous work that examined face or body alone, this study demonstrates how head and body information are integrated to compute a socially meaningful signal.

      Strengths:

      This work presents an elegant design of visual stimuli, with a monkey avatar of varying head and body orientations, making the analysis and interpretation straightforward. Together with several control experiments, the authors systematically investigated different aspects of head-body integration in the macaque STS. The results and analyses of the paper are mostly convincing.

      Weaknesses:

      (1) Using ANOVA, the authors demonstrate the existence of nonlinear interactions between head and body orientations. While this is a conventional way of identifying nonlinear interactions, it does not specify the exact type of the interaction. Although the computation of the head-body configuration angle requires some nonlinearity, it's unclear whether these interactions actually contribute. Figure 3 shows some example neurons, but a more detailed analysis is needed to reveal the diversity of the interactions. One suggestion would be to examine the relationship between the presence of an interaction and the neural encoding of the configuration angle.

      This is an excellent suggestion. To do this, one needs to identify the neurons that contribute to the decoding of head-body orientation angles. For that, we employed a neuron-dropping analysis, similar to Chiang et al. (Chiang FK, Wallis JD, Rich EL. Cognitive strategies shift information from single neurons to populations in prefrontal cortex. Neuron. 2022 Feb 16;110(4):709-721.) to assess the positive (or negative) contribution of each neuron to the decoding performance. We performed cross-validated linear SVM decoding N times, each time leaving out a different neuron (using N-1 neurons; 2000 resamplings of pseudo-population vectors). We then ranked decoding accuracies from highest to lowest, identifying the ‘worst’ (rank 1) to ‘best’ (rank N) neurons. Next, we conducted N decodings, incrementally increasing the number of included neurons from 1 to N, starting with the worst-ranked neuron (rank 1) and sequentially adding the next (rank 2, rank 3, etc.). This analysis focused on zero versus straight angle decoding in the aSTS, as it yielded the highest accuracy. We applied it when training on MC and testing on HC for each pose. Plotting accuracy as a function of the number of included neurons suggested that less than half contributed positively to decoding (see Figure S3). We examined the tuning for head and body orientation of the 10 “best” neurons (Figure S3). For half or more of those the two-way ANOVA showed a significant interaction. These are indicated by the red color in the Figure. They showed a variety of tuning patterns for head and body orientation, suggesting that the decoding of the head-body orientation angle results from a combination of neurons with different tuning profiles. Based on a suggestion from reviewer 2, we performed for each neuron of experiment 1 a one-way ANOVA with as factor head-body orientation angle. To do that, we combined all 64 trials that had the same head-body orientation angle. The percentage of neurons (required to be responsive in the tested condition) for which this one-way ANOVA was significant was low but larger than the expected 5% (Type 1 error), with a median of 16.5% (range: 3 to 23%) in aSTS and 8% for mSTS (range: 0-19%). However, a higher percentage of the 10 best neurons for each pose (indicated by the star) showed a significant one-way ANOVA for angle (for P1, MC: 50% (95% confidence interval (CI): 19% – 81%); P1, HC: 70% (CI: 35% - 93%); P2, MC: 70% (CI: 35% – 93%); P2: HC: 50% (CI: 19%-81%)). These percentages were significantly higher than expected for a random sample from the population of neurons for each pose-centering combination (expected percentages listed in the same order as above: 16%, 13%, 16%, and 10%; all outside CI). Thus, for at least half of the “best” neurons, the response differed significantly among the head-orientation angles at the single neuron level. Nonetheless, the tuning profiles were diverse, suggesting a populationl code for head-body orientation angle. We have added this interesting and novel result to the Results (page 16) and Suppl. Material (Figure S3).

      (2) Figure 4 of the paper shows a better decoding of the configuration angle in the anterior STS than in the middle STS. This is an interesting result, suggesting a transformation in the neural representation between these two areas. However, some control analyses are needed to further elucidate the nature of this transformation. For example, what about the decoding of head and body orientations - dose absolute orientation information decrease along the hierarchy, accompanying the increase in configuration information?

      We have performed now two additional analyses, one in which we decoded the orientation of the head and another one in which we decoded the orientation of the body. We employed the responses to the avatar of experiment 1, using the same sample of neurons of which we decoded the head-body orientation angle. To decode the head orientation, the trials with identical head orientation, irrespective of their body orientation, were given the same label. For this, we employed only responses in the head-centered condition. To decode the body orientation, the trials with identical body orientation, irrespective of their head orientation, had the same label, and we employed only responses in the body-centered condition. The decoding was performed separately for each pose (P1 and P2) and region. We decoded either the responses of 20 neurons (10 randomly sampled from each monkey for each of the 1000 resamplings), 40 neurons (20 randomly sampled per monkey), or 60 neurons (30 neurons per monkey) since the sample of 60 neurons yielded close to ceiling performance for the body orientation decoding. For each pose, the body orientation decoding was worse for aSTS than for mSTS, although this difference reached significance only for P1 and for the 40 neurons sample of P2 (p < 0.025; two-tailed test; same procedure as employed for testing the significance of the decoding of whole-body orientation for upright versus inverted avatars (Experiment 3))). Face orientation decoding was significantly worse for aSTS compared to mSTS. These results are in line with the previously reported decreased decoding of face orientation in the anterior compared to mid-STS face patches (Meyers EM, Borzello M, Freiwald WA, Tsao D. Intelligent information loss: the coding of facial identity, head pose, and non-face information in the macaque face patch system. J Neurosci. 2015 May 6;35(18):7069-81), and decreased decoding of body orientation in anterior compared to mid-STS body patches (Kumar S, Popivanov ID, Vogels R. Transformation of Visual Representations Across Ventral Stream Body-selective Patches. Cereb Cortex. 2019 Jan 1;29(1):215-229). As mentioned by the reviewer, this contrasts with the decoding of the head-body orientation angle, which increases when moving more anteriorly. We mention this finding now in the Discussion (page 27) and present the new Figure S10 in the Suppl. Material.    

      (3) While this work has characterized the neural integration of head and body information in detail, it's unclear how the neural representation relates to the animal's perception. Behavioural experiments using the same set of stimuli could help address this question, but I agree that these additional experiments may be beyond the scope of the current paper. I think the authors should at least discuss the potential outcomes of such experiments, which can be tested in future studies.

      Unfortunately, we do not have behavioral data. One prediction would be that the discrimination of head-body orientation angle, irrespective of the viewpoint of the avatar, would be more accurate for zero versus straight angles compared to the right versus left angles. We have added this to the Discussion (page 28).

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) P22 L373. It should read Figure S5C instead of S4C.

      Thanks; corrected.

      (2) Figure 7B. All inverted decoding accuracies, although significantly lower than upright decoding accuracies, appear significantly above baseline. Should the title be amended accordingly?

      Thanks for pointing this out. To avoid future misunderstanding we have changed the title to:

      “Integration of head and body orientations in the macaque superior temporal sulcus is stronger for upright bodies”

      (3) Discussion L432-33. "with some neurons being tuned to a particular orientation of both the head and the body". Wouldn't that be visible as a diagonal profile on the normalized net responses in Fig 3D? Or can the Anova evidence such a tuning?

      We meant to say that some neurons were tuned to a particular combination of head and body orientation, like the third aSTS example neuron shown in Figure 3D. We have corrected the sentence.

      Reviewer #2 (Recommendations for the authors):

      Major comment:

      This paper effectively demonstrates that the angular relationship between the head and body can be decoded from population responses in the anterior STS. In other words, these neurons encode information about the head-body angle. However, how exactly do these neurons encode this information? Given that the study employed electrophysiological recordings from a local population of neurons, it might be possible to provide additional data on the response patterns of individual neurons to shed light on the underlying encoding mechanisms.

      Although the paper already presents example response patterns (Figures 3D, E) and shows that STS neurons encode interactions between head and body orientations (Figure 3B), it remains unclear whether the angle difference between the head and body has a systematic effect on neuronal responses. For instance, a description of whether some neurons preferentially encode specific head-body angle differences (e.g., a "45-degree angle neuron"), or additional population analyses such as a one-way ANOVA with angle difference as the main effect (or two-way ANOVA with angle difference as one of the main effect), would be very informative. Such data could offer valuable insights into how individual neurons contribute to the encoding of head-body angle differences-a detail that may also be reflected in the decoding results. Alternatively, it is possible that the encoding of head-body angle is inherently complex and only discernible via decoding methods applied to population activity. Either scenario would provide interesting and useful information to the field.

      We have performed two additional analyses which are relevant to this comment. First, we attempted to relate the tuning for body and head orientation with the decoding of the head-body orientation angle. To do this, one needs to identify the neurons that contribute to the decoding of head-body orientation angles. For that, we employed a neuron-dropping analysis, similar to Chiang et al. (Chiang FK, Wallis JD, Rich EL. Cognitive strategies shift information from single neurons to populations in prefrontal cortex. Neuron. 2022 Feb 16;110(4):709-721.) to assess the positive (or negative) contribution of each neuron to the decoding performance. We performed cross-validated linear SVM decoding N times, each time leaving out a different neuron (using N-1 neurons; 2000 resamplings of pseudo-population vectors). We then ranked decoding accuracies from highest to lowest, identifying the ‘worst’ (rank 1) to ‘best’ (rank N) neurons. Next, we conducted N decodings, incrementally increasing the number of included neurons from 1 to N, starting with the worst-ranked neuron (rank 1) and sequentially adding the next (rank 2, rank 3, etc.). This analysis focused on zero versus straight angle decoding in the aSTS, as it yielded the highest accuracy. We applied it when training on MC and testing on HC for each pose. Plotting accuracy as a function of the number of included neurons suggested that less than half contributed positively to decoding (see Figure S3). We examined the tuning for head and body orientation of the 10 “best” neurons (Figure S3). For half or more of those the two-way ANOVA showed a significant interaction. These are indicated by the red color in the Figure. They showed a variety of tuning patterns for head and body orientation, suggesting that the decoding of the head-body orientation angle results from a combination of neurons with different tuning profiles.

      Second, we have followed the suggestion of the reviewer to perform for each neuron of experiment 1 a one-way ANOVA with as factor head-body orientation angle. To do that, we combined all 64 trials that had the same head-body orientation angle. The percentage of neurons (required to be responsive in the tested condition) for which this one-way ANOVA was significant is shown in the Tables below for each region, separately for each pose (P1, P2), centering condition (MC = monkey-centered; HC = head-centered) and monkey subject (M1, M2). The percentages were low but larger than the expected 5% (Type 1 error), with a median of 16.5% (range: 3 to 23%) in aSTS and 8% for mSTS (range: 0-19%).

      Author response table 1.

      Interestingly, a higher percentage of the 10 best neurons for each pose (indicated by the star in the Figure above) showed a significant one-way ANOVA for angle (for P1, MC: 50% (95% confidence interval (CI): 19% – 81%); P1, HC: 70% (CI: 35% - 93%); P2, MC: 70% (CI: 35% – 93%); P2: HC: 50% (CI: 19%-81%)). These percentages were significantly higher than expected for a random sample from the population of neurons for each pose-centering combination (expected percentages listed in the same order as above: 16%, 13%, 16%, and 10%; all outside CI). Thus, for at least half of the “best” neurons, the response differed significantly among the head-orientation angles at the single neuron level. Nonetheless, the tuning profiles were quite diverse, suggesting population coding of head-body orientation angle. We have added this interesting and novel result to the Results (page 16) and Suppl. Material (Figure S3).    

      Minor comments:

      (1) Figure 4A, Fourth Row Example (Zero Angle vs. Straight Angle, Bottom of the P2 Examples): The order of the example stimuli might be incorrect- the 0{degree sign} head with 180{degree sign} body stimulus (leftmost) might be swapped with the 180{degree sign} head with 0{degree sign} body stimulus (5th from the left). While this ordering may be acceptable, please double-check whether it reflects the authors' intended arrangement.

      We have changed the order of the two stimuli in Figure 4A, following the suggestion of the reviewer.

      (2) Page 12, Lines 192-194: The text states, "Interestingly, some neurons (e.g. Figure 3D) were tuned to a particular combination of a head and body irrespective of centering." However, Figure 3D displays data for a total of 10 neurons. Could you please specify which of these neurons are being referred to in this context?

      The wording was not optimal. We meant to say that some neurons were tuned to a particular combination of head and body orientation, like the third aSTS example neuron of Figure 3D. We have rephrased the sentence and clarified which example neuron we referred to.

      (3) Page 28, Lines 470-471: The text states, "We observed no difference in response strength between anatomically possible and impossible configurations." Please clarify which data were compared for response strength, as I could not locate the corresponding analyses.

      The anatomically possible and impossible configurations differ in the head-body orientation angle. However, as we reported before in the Results, there was no effect of head-body orientation angle on mean response strength across poses (Friedman ANOVA; all p-values for both poses and centerings > 0.1). We have clarified this now in the Discussion (page 28).

      (4) Pages 40-43, Decoding Analyses: In experiments 2 and 3, were the decoding analyses performed on simultaneously recorded neurons? If so, such analyses might leverage trial-by-trial correlations and thus avoid confounds from trial-to-trial variability. In contrast, experiment 1, which used single-shank electrodes, would lack this temporal information. Please clarify how trial numbers were assigned to neurons in each experiment and how this assignment may have influenced the decoding performance.

      For the decoding analyses of experiments 2 and 3, we combined data from different daily penetrations, with only units from the same penetration being recorded simultaneously. In the decoding analyses of each experiment, the trials were assigned randomly to the pseudo-population vectors, shuffling on each resampling the trial order per neuron. This shuffling abolishes noise correlations in the analysis of each experiment.

      (5) Page 41, Lines 792-802: The authors state that "To assess the significance of the differences in classification scores between pairs of angles ... we computed the difference in classification score between the two pairs for each resampling and the percentile of 0 difference corresponded to the p-value." In a two-sided test under the null hypothesis of no difference between the distributions, the conventional approach would be to compute the p-value as the proportion of resampled differences that are as extreme or more extreme than the observed difference. Since a zero difference might be relatively rare, relying solely on its percentile could potentially misrepresent the tail probabilities relevant to a two-sided test. Could you clarify how their method addresses this issue?

      This test is based on the computation of the distribution of the difference between classification accuracies across resamplings. This is similar to the computation of the confidence interval of a  difference. Thus, we assess whether the theoretical zero value (= no difference; = null hypothesis) is outside the 2.5 and 97.5 percentile interval of the computed distribution of the empirically observed differences. We clarified now in the Methods (page 41) that for a two-tailed test the computed p-value (the percentile of the zero value) should be smaller than 0.025.

      (6) Page 43, Lines 829-834: The manuscript explains: "The mean of 10 classification accuracies (i.e., of 10 resamplings) was employed to obtain a distribution (n=100) of the differences in classification accuracy ... The reported standard deviations of the classification accuracies are computed using also the means of 10 resamplings." I am unfamiliar with this type of analysis and am unclear about the rationale for calculating distributions and standard deviations based on the means of 10 resamplings rather than using the original distribution of classification accuracies. This resampling procedure appears to yield a narrower distribution and smaller standard deviations than the original data. Could you please justify this approach?

      The logic of the analysis is to reduce the noise in the data, by averaging across 10 randomly selected resamplings, but still keeping a sufficient number of data (100 values) for a test.

      Reviewer #3 (Recommendations for the authors):

      (1) Some sentences are too long and difficult to parse. For example, in line 177: "the correlations between the responses to the 64 head-body orientation conditions of the two centerings for the neuron and pose combinations showing significant head-body interactions for the two centerings were similar to those observed for the whole population."

      We have modified this sentence: For neuron and pose combinations with significant head-body interactions in both centerings, the correlations between responses to the 64 head-body orientation conditions were similar to those observed in the whole population.

      (2) The authors argue in line 485: "in our study, a search bias cannot explain the body-inversion effect since we selected responsive units using both upright and inverted images." However, the body-selective patches were localized using upright images, correct?

      The monkey-selective patches were localized using upright images indeed. However, we recorded in experiment 3 (and 2) also outside the localized patches (as we noted before in the Methods:  “In experiments 2 and 3 we recorded from a wider region, which overlapped with the two monkey patches and the recording locations of experiment 1”). Furthermore, the preference for upright monkey images is not an all-or-nothing phenomenon: most units still responded to inverted monkeys. Also, we believe it is likely that the mean responses to the inverted bodies in the monkey patches, defined by upright bodies versus objects, would be larger than those to objects and we would be surprised to learn that there is a patch selective for inverted bodies that we would have missed with our localizer.

      (3) Typo: line 447, "this independent"->"is independent"?

      Corrected.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Review:

      Reviewer #1:

      Summary:

      The Roco proteins are a family of GTPases characterized by the conserved presence of an ROC-COR tandem domain. How GTP binding alters the structure and activity of Roco proteins remains unclear. In this study, Galicia C et al. took advantage of conformationspecific nanobodies to trap CtRoco, a bacterial Roco, in an active monomeric state and determined its high-resolution structure by cryo-EM. This study, in combination with the previous inactive dimeric CtRoco, revealed the molecular basis of CtRoco activation through GTP-binding and dimer-to-monomer transition.

      Strengths:

      The reviewer is impressed by the authors' deep understanding of the CtRoco protein. Capturing Roco proteins in a GTP-bound state is a major breakthrough in the mechanistic understanding of the activation mechanism of Roco proteins and shows similarity with the activation mechanism of LRRK2, a key molecule in Parkinson's disease. Furthermore, the methodology the authors used in this manuscript - using conformation-specific nanobodies to trap the active conformation, which is otherwise flexible and resistant to single-particle average - is highly valuable and inspiring.

      Weakness:

      Though written with good clarity, the paper will benefit from some clarifications.

      (1) The angular distribution of particles for the 3D reconstructions should be provided (Figure 1 - Sup. 1 & Sup. 2).

      Figure 1 – Figure supplements 1 and 2 now contain particle distribution plots.

      (2) The B-factors for protein and ligand of the model, Map sharpening factor, and molprobity score should be provided (Table 1).

      Table 1 now contains B-factors and molprobity scores.

      The map used to interpret the model was post-processed by density modification, and therefore no data concerning sharpening factors are provided in the output.

      (3) A supplemental Figure to Figure 2B, illustrating how a0-helix interacts with COR-A&LRR before and after GTP binding in atomic details, will be helpful for the readers to understand the critical role of a0-helix during CtRoco activation.

      This is now illustrated in the new Figure 2 – Figure Supplement 1.

      (4) For the following statement, "On the other hand, only relatively small changes are observed in the orientation of the Roc a3 helix. This helix, which was previously suggested to be an important element in the activation of LRRK2 (Kalogeropulou et al., 2022), is located at the interface of the Roc and CORB domains and harbors the residues H554 and Y558, orthologous to the LRRK2 PD mutation sites N1337 and R1441, respectively." It is not surprising the a3-helix of the ROC domain only has small changes when the ROC domain is aligned (Figure 2E). However, in the study by Zhu et al (DOI: 10.1126/science.adi9926), it was shown that a3-helix has a "see-saw" motion when the COR-B domain is aligned. Is this motion conserved in CtRoco from inactive to active state?

      We indeed describe the conformational changes from the perspective of the Roc domain. When using the COR-B domain for structural alignment, a rotational movement of Roc (including a “seesaw”-like movement of the α3-helix helix around His554) with respect to COR-B is correspondingly observed.

      This is now added to Figure 2E. Additionally, the text was adapted to:

      “Interestingly, this rotational movement of CORB seems to use the H554-Y558-Y804 triad on the interface of Roc and CORB as a pivot point (Figure 2E). Mutation of either of the corresponding residues in LRRK2 (N1437, R1441, Y1699, respectively) is associated with PD and leads to LRRK2 activation. Residues H554 and Y558 are located on the Roc a3 helix, which was previously suggested to be an important element in the activation of LRRK2 (Kalogeropulou et al., 2022). Indeed, while the orientation of the a3 helix with respect to the rest of the Roc domain only undergoes small changes upon GTPgS binding, it can be observed that this helix undergoes a “seesaw-like” movement with respect to the CORB domain. A similar rearrangement was previously also observed for Rab29-mediated activation of human LRRK2 (Störmer et al., 2023; Zhu et al., 2022).”

      (5) A supplemental figure showing the positions of and distances between NbRoco1 K91 and Roc K443, K583, and K611 would help the following statement. "Also multiple crosslinks between the Nbs and CtRoco, as well as between both nanobodies were found. ... NbRoco1-K69 also forms crosslinks with two lysines within the Roc domain (K583 and K611), and NbRoco1-K91 is crosslinked to K583".

      A figure displaying these crosslinks is now provided as Figure 4–figure supplement 1. However, in interpreting these crosslinks it should be taken into consideration that the additive length of the DSSO spacer and the lysine side chains leads to a theoretical upper limit of ∼26 Å for the distance between the α carbon atoms of cross-linked lysines (and even a cut-off distance of 35 Å when taking into account protein dynamics).

      (6) It would be informative to show the position of CtRoco-L487 in the NF and GTP-bound state and comment on why this mutation favors GTP hydrolysis.

      L487 is located in Switch 1, which is a critical region for nucleotide binding and hydrolysis. Unfortunately, most probably due to flexibility, the Switch 1 region could not be entirely modeled (in neither nucleotide state). Since L487 is located on the edge of the interpretable portion of the Switch 1 in both structures (see Author response image 1 below), any interpretation regarding the role of this residue would be highly speculative.

      Author response image 1.

      The following text was added to the Results section:

      “Also the Switch 1 loop could not be fully modeled in our structure, presumably indicating some flexibility in this region despite the presence of a GTP analogue. Interestingly, the Switch 1 loop harbors the site of the PD-analogous L487A mutation that leads to a stabilization of the CtRoco dimer with a concomitant decrease in GTPase activity (Deyaert et al., 2019). Unfortunately, an exact interpretation of this effect of the L487A mutation is hampered by the lack of a well resolved Switch 1 loop.”

      Reviewer #2:

      Summary

      The manuscript by Galicia et al describes the structure of the bacterial GTPyS-bound CtRoco protein in the presence of nanobodies. The major relevance of this study is in the fact that the CtRoco protein is a homolog of the human LRRK2 protein with mutations that are associated with Parkinson's disease. The structure and activation mechanisms of these proteins are very complex and not well understood. Especially lacking is a structure of the protein in the GTP-bound state. Previously the authors have shown that two conformational nanobodies can be used to bring/stabilize the protein in a monomerGTPyS-bound state. In this manuscript, the authors use these nanobodies to obtain the GTPyS-bound structure and importantly discuss their results in the context of the mammalian LRRK2 activation mechanism and mutations leading to Parkinson's disease. The work is well performed and clearly described. In general, the conclusions on the structure are reasonable and well-discussed in the context of the LRRK2 activation mechanism.

      Strengths:

      The strong points are the innovative use of nanobodies to stabilize the otherwise flexible protein and the new GTPyS-bound structure that helps enormously in understanding the activation cycle of these proteins.

      Weakness:

      The strong point of the use of nanobodies is also a potential weak point; these nanobodies may have induced some conformational changes in a part of the protein that will not be present in a GTPyS-bound protein in the absence of nanobodies.

      Two major points need further attention.

      (1) Several parts of the protein are very flexible during the monomer-dimer activity cycle. This flexibility is crucial for protein function, but obviously hampers structure resolution. Forced experiments to reduce flexibility may allow better structure resolution, but at the same time may impede the activation cycle. Therefore, careful experiments and interpretation are very critical for this type of work. This especially relates to the influence of the nanobodies on the structure that may not occur during the "normal" monomerdimer activation cycle in the absence of the nanobodies (see also point 2). So what is the evidence that the nanobody-bound GTPyS-bound state is biochemically a reliable representative of the "normal" GTP-bound state in the absence of nanobodies, and therefore the obtained structure can be confidentially used to interpret the activation mechanism as done in the manuscript.

      See below for an answer to remark 1 and 2.

      (2) The obtained structure with two nanobodies reveals that the nanobodies NbRoco1 and NbRoco2 bind to parts of the protein by which a dimer is impossible, respectively to a0helix of the linker between Roc-COR and LRR, and to the cavity of the LRR that in the dimer binds to the dimerizing domain CORB. It is likely the open monomer GTP-bound structure is recognized by the nanobodies in the camelid, suggesting that overall the open monomer structure is a true GTP-bound state. However, it is also likely that the binding energy of the nanobody is used to stabilize the monomer structure. It is not automatically obvious that in the details the obtained nonobody-Roco-GTPyS structure will be identical to the "normal" Roco-GTPyS structure. What is the influence of nanobody-binding on the conformation of the domains where they bind; the binding energy may be used to stabilize a conformation that is not present in the absence of the nanobody. For instance, NbRoco1 binds to the a0 helix of the linker; what is here the "normal" active state of the Roco protein, and is e.g. the angle between RocCOR and LRR also rotated by 135 degrees? Furthermore, nanobody NbRoco2 in the LRR domain is expected to stabilize the LRR domain; it may allow a position of the LRR domain relative to the rest of the protein that is not present without nanobody in the LRR domain. I am convinced that the observed open structure is a correct representation of the active state, but many important details have to be supported by e,g, their CX-MS experiments, and in the end probably need confirmation by more structures of other active Roco proteins or confirmation by a more dynamic sampling of the active states by e.g. molecular dynamics or NMR.

      Recently, nanobodies have increasingly been used successfully to obtain structural insights in protein conformational states (reviewed in Uchański et al, Curr. Opin. Struc. Biol. 2020). As reviewer # 2 points out, the concern is sometimes raised that antibodies could distort a protein into non-native conformations. Here, it is important to note that the nanobodies were raised by immunizing a llama with the fully native CtRoco protein bound to a non-hydrolysable GTP analogue, after which the nanobodies were selected by phage display using the same fully native and functional form of the protein. As clearly explained in Manglik et al. Annu Rev Pharmacol Toxicol. 2017, the probability of an in vivo matured nanobody inducing a non-native conformation of the antigen is low, although it is possible that it selects a high-energy, low-population conformation of a dynamic protein. Immature B cells require engagement of displayed antibodies with antigen to proliferate and differentiate during clonal selection. Antibodies that induce non-native conformations of the antigen pay a substantial energetic penalty in this process, and B cell clones displaying such antibodies will have a significantly lower probability of proliferation and differentiation into mature antibody-secreting B lymphocytes. Hence, many recent experiments and observation give credence to the notion that nanobodies bind antigens primarily by conformational selection and not induced fit (e.g. Smirnova et al. PNAS 2015).

      Extrapolated to the case of CtRoco, which is clearly very flexible in its GTP-bound form, this means that the nanobodies are able to trap and stabilize one conformational state that is representative of the “active state” ensemble of the protein. In this respect, it is clear from our experiments (XL-MS, affinity and effect on GTPase activity) that the effects of NbRoco1 and NbRoco2 are additive (or even cooperative), meaning that both nanobodies recognize different features of the same CtRoco “active state”. Correspondingly, the monomeric, elongated “open” conformation is also observed in the structure of CtRoco bound to NbRoco1 only (Figure1 - supplement 2), albeit that this structure still displays more flexibility. The monomerization and conformational changes that we observe and describe in the current paper at high resolution are also in very good agreement with earlier observations for CtRoco in the GTP-bound form in absence of any nanobodies, including negative stain EM (Deyaert et al. Nature Commun, 2017), hydrogen-deuterium exchange experiments (Deyaert et al. Biochem. J. 2019) and native MS (Leemans et al. Biochem J. 2020).

      In the revised manuscript we added the following text to the discussion:

      “To decrease this flexibility, we have now used two previously developed conformationspecific nanobodies (NbRoco1 and NbRoco2) to stabilize the protein in the GTP-state (Leemans et al., 2020), allowing us to solve its structure using cryo-EM (Figure 1). Recently, Nbs have successfully been used to obtain structural insights in the conformational states of a number of highly dynamic proteins (Uchański et al, 2020). These studies established that Nbs bind antigens primarily by conformational selection rather than by induced fit (Manglik et al., 2017; Smirnova et al.,2015). Since NbRoco1 and NbRoco2 were generated by immunization with fully native CtRoco bound to a nonhydrolysable GTP analogue, and subsequently selected by phase display using the same functional protein, it is thus safe to assume that these Nbs bind to and stabilize a relevant conformation that is present within the “active” CtRoco conformational space (Leemans et al., 2020). Moreover, our current structures are also in very good agreement with previous biochemical studies and data from HDX-MS and negative stain EM (Deyaert et al., 2019; Deyaert, Wauters, et al., 2017).”

      Recommendations for the authors:

      Reviewer #1:

      (1) Figure 2C: please label the residues with meshes (switch 2).

      Labels have been added to figure 2C.

      (2) A supplemental figure for the following statement will be helpful "A remarkable feature of the CtRoco dimer structure was the dimer-stabilized orientation of the P-loop, which would hamper direct nucleotide binding on the dimer. Correspondingly, in the current structure, the P-loop changes orientation, allowing GTPgS to bind, although the EM map does not allow unambiguous placement of the entire P-loop. Surprisingly, also the Switch 1 loop could not be fully modeled, which could indicate some flexibility in this region despite the presence of a GTP analog".

      An additional Figure 2–figure supplement 2 has been added to illustrate this.

      (3) A supplemental figure for the following statement will be helpful "A final important observation in the Roc domain concerns the very C-terminal part of Switch 2 (residues 520 to 533), which could not be modeled in our GTP bound structure due to flexibility, while in the nucleotide-free dimer structure this region is structured and located at the interface of the Roc domain with the LRR-Roc linker and CORA. In this way, the conformational changes induced by GTPgS binding could be relayed via the Switch 2 toward the LRR and CORA domains, and vice versa."

      An additional Figure 2–figure supplement 2 has been added to illustrate this.

      (4) A structural comparison of each domain (LRR, ROC, COR) between NF and GTP-bound states will be greatly useful to understand statements in the manuscript, such as "In addition to the Cterminal dimerization part of CORB that becomes unstructured, also other large conformational changes are observed in the CORA and CORB domains of CtRoco upon GTPgS binding."

      We would like to clarify that with this statement we refer to changes in the relative orientation of the domains between the nucleotide-free and GTPgS-bound states, rather than to conformational changes within each domain. These changes in relative orientation are illustrated in Figure 2 and the associated Figure supplements.

      (5) The statement "to a lesser extent, also between CDR1 and the LRR-Roc linker" is not clearlyillustrated in Figure 3B.

      The reviewer is correct, and we now also show CDR1 in Figure 3B.

      (6) Extra panels can be added in Figure 1 Sup. 4 to illustrate the following statement "In the density map NbRoco2 can easily be identified and placed on the concave side of the LRR domain... Nterminal and C-terminal b-strands interacting with the very C-terminal repeat of the LRR".

      We belief the density map corresponding to NbRoco2 is clearly shown in Figure 1 – supplement 4A. A reference to this figure panel is now added to the main text.

      (7) "In the presence of both Nbs, the hydrolysis rate was increased 4-fold compared to CtRocoL487A alone and 2-fold compared to CtRoco-L487A in the presence of NbRoco1 only, again illustrating a collaboration between the Nbs (Figure 5C)" Here, is it 6-fold instead of 4-fold?

      The reviewer is correct. We changed this accordingly in the manuscript.

      Reviewer #2:

      (1) At many places in the manuscript the lack of structural details is explained by the assumed local flexibility of the protein. This may be true for many cases (such as linker regions), but is probably not always correct; several other explanations are possible to get no local structural details.

      See our answer to point 2, below.

      (2) At several other places in the manuscript the high flexibility is used to explain the lack of structural details (so the reasoning is reversed compared to point 1); this would require that a priori it is known that that the region is flexible and therefore no structure can be expected. An example is found mid-page 8: "A final important observation in the Roc domain concerns the very C-terminal part of Switch 2 (residues 520 to 533), which could not be modeled in our GTP bound structure due to flexibility, while in the nucleotide-free dimer structure this region is structured and located at the interface of the Roc domain with the LRR-Roc linker and CORA." As written there must be a reference to experiments showing the "due to flexibility"

      The reviewer is correct that additional factors might affect the interpretability of the map, such as the small size of the regions used for the focused refinements (around 50 kDa each) or a preferential distribution of orientation of the particles in the grid. Particle distribution plots are now shown in Figure 1 – Figure supplements 1 and 2. However, due to the intrinsic flexible nature of the Switch 1 and Switch 2 regions, we assume this flexibility to be the major cause of lack of features in the EM maps, especially since some of the neighboring regions display well-resolved maps.

      Nevertheless, in the manuscript we reworded our statements to be more careful. For example, on page 8:

      “Also the Switch 1 loop could not be fully modeled in our structure, presumably indicating some flexibility in this region despite the presence of a GTP analogue.”

      “… potentially due to flexibility of this region in the new position of the Switch 2…”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer 1:

      Weaknesses:

      The authors do not discuss based on genomic information; the genomes of the cichlids from the three lakes have been decoded and are therefore available. However, indeed, the species in Lake Tanganyika and Lake Malawi/Victoria are genetically distant from each other, so a comparative genome analysis would not have yielded the results presented here. I recommend adding such a discussion to the Discussion.

      We appreciate your comment. We added the discussion regarding the genomic aspect of parallel evolution.

      Line 386-393: “From a genomic perspective, several studies have investigated the genetic basis of hypertrophied lip cichlids (Masonick et al., 2023; Nakamura et al., 2021). Importantly, some Wnt pathway-related genes (tcf4 and daam2) and ECM-related genes (postna, col12a1a, and col12a1b) have been found to be under positive selection in cichlids with hypertrophied lips of Lake Victoria (see Nakamura et al., 2021 Table S3). For future research, examining whether these genes are under selection in other lakes is crucial to understand the genetic mechanisms underlying the parallel evolution of hypertrophied lips.”

      Minor comments:

      Line 30, the Wnt --> the genes in Wnt

      We appreciate your comment. According to the comment, we corrected the sentence.

      Line 30: “the Wnt signaling pathway” -> “the genes in Wnt signaling pathway”

      Line 42-44, "It is considered that the same direction of natural selection drives phenotypic changes among species since it is unlikely that these complex phenotypes have been acquired repeatedly just by neutral evolution". How about "Since it is unlikely that such a complex phenotype was acquired repeatedly by neutral evolution alone, the same direction of natural selection among species is likely to drive the parallel phenotypic change."?

      We agree with your suggestion and correct the sentence of our manuscript.

      Line 42-44: “It is considered that the same direction of natural selection drives phenotypic changes among species since it is unlikely that these complex phenotypes have been acquired repeatedly just by neutral evolution”

      “Since it is unlikely that such a complex phenotype was acquired repeatedly by neutral evolution alone, the same direction of natural selection among species is likely to drive the parallel phenotypic change”

      Line 60, polygenic --> likely to be polygenic

      We appreciate your comment. Indeed, it is better to weaken the wording.

      Line 60: “most traits are polygenic” -> “most traits are likely to be polygenic”

      Line 91, the Wnt --> the genes in Wnt

      We appreciate your correction. Last paragraph of introduction has been corrected according to the suggestion of Reviewer 2 (Q1).

      Line 230, NovaSeq --> Illumina NovaSeq

      We appreciate your correction.

      Line 222: “NovaSeq 6000” -> “Illumina NovaSeq 6000”

      Line 231 "mRNA Library Prep Kit". Please add a company name.

      We appreciate your correction. We added company’s information.

      Line 223: “a TruSeq stranded mRNA Library Prep Kit.” -> “a TruSeq stranded mRNA Library Prep Kit (Illumina)”

      Line 267, as for the tip of hypertrophied lips, could you add and point out which part is the tip?

      We dissected hypertrophied lips in two half anterior and half posterior. We added the sentence in the materials and methods section.

      Line 156-158: “The lips of H. chilotes were analyzed separately for the base and tip.” -> “The lips of H. chilotes were dissected in two half anterior (tip) and half posterior (base), which are analyzed separately.”

      Line 272, "133 proteins upregulated and 5 proteins downregulated" in hypertrophied lip or normal lip?

      We appreciate your correction. We added the sentence as follows.

      Line 264: “133 proteins upregulated and 5 proteins downregulated”

      “133 proteins upregulated and 5 proteins downregulated in the hypertrophied lip”

      Line 274, "hypertrophied lips" means tip of hypertrophied lips?

      We appreciate your correction. We corrected the sentence as follows.

      Line 266: “hypertrophied lips are abundant” -> “tip of hypertrophied lips is abundant”

      Line 277, Did you perform multiple testing correction for statistical significance?

      We appreciate your comment about multiple testing corrections. We did not apply multiple testing corrections in our “exploratory” analysis of proteomics not to miss biologically important candidates in a limited sample size (n=3). We calculated the multiple corrected p-value in the Benjamini Hochberg method (Author response image 1, right). The result suggested that almost the same proteoglycans and its related proteins as we focused on are highly accumulated in the hypertrophied lips in milder conditions (significance level of 0.1).

      Author response image 1.

      Thus, our main conclusions remain unchanged even with correction applied, however, the overall balance of the volcano plot is not visually appealing (Author response image 1, right).

      It is important to note that we selected the Top 20 proteins based on fold change rather than statistical significance. In addition, our proteomic findings show consistency with our histological and transcriptome data, providing the biological validation from various aspects. While we understand the potential benefits of multiple testing correction, our current approach without multiple testing still offers valuable and fair data to propose hypothesis on the molecular mechanisms of lip hypertrophy in cichlids. Therefore, we want to use original figure without multiple testing. We greatly appreciate the understanding of the reviewer.

      Line 349-351, "The results of the enrichment analysis suggested that the genes that were categorized into both canonical and non-canonical Wnt signaling pathways, were highly expressed in the hypertrophied lips of juvenile and adult cichlids."

      The wnt category was enriched by analyzing the highly expressed genes, so isn't it natural that the wnt category is highly expressed?

      Did you mean to say as in the following sentence?

      "Enrichment of genes categorized in the canonical and noncanonical Wnt signaling pathways suggested that high expression of genes in the Wnt signaling pathway is likely to be involved in the hypertrophied lips of juvenile and adult fish."

      Thank you for your comments. We corrected our manuscript as follows.

      Line 341-344: “The results of the enrichment analysis suggested that the genes that were categorized into both canonical and non-canonical Wnt signaling pathways, were highly expressed in the hypertrophied lips of juvenile and adult cichlids.”

      “As a result of enrichment analysis, DEGs were categorized in the canonical and noncanonical Wnt signaling pathways, suggesting that high expression of genes in the Wnt signaling pathway is likely to be involved in the hypertrophied lips of juvenile and adult fish.”

      Line 403-404, "several other pathways may be involved in the development of hypertrophied lips". Do you have any evidence?

      We appreciate your comment regarding possible evidence for the involvement of multiple pathways in hypertrophied lip development. Our statement was based on two main points:

      (1) While we highlighted the Wnt pathway because this pathway is known to increase proteoglycan expression, we cannot exclude the possibility of the involvement of other pathways. For instance, our enrichment analysis in adult cichlids identified VEGF-related pathways, which could contribute to lip hypertrophy by increasing vascularization and nutrient supply to the lip tissue.

      (2) Previous quantitative trait locus (QTL) analysis by Henning et al. (2017) concluded that lip hypertrophy is likely influenced by numerous loci with small additive effects. This indicates that lip hypertrophy is a complex phenotype consisted of multiple genetic factors, some which probably correspond to different molecular pathways.

      Given these points, we draw a conclusion that emphasize the importance of Wnt pathway while also recognizing the potential cooperative interaction of multiple pathways in developing lip hypertrophy. Without confusing the two statements, we corrected our manuscript as follows.

      Line 398-412: “We uncovered the apparent relationships between hypertrophied lips and the expression profiles of ECM proteins, in particularly proteoglycans. The trends for the overall expression of ECM-related genes were similar across hypertrophied lip species, but we rarely observed a specific gene that was commonly expressed at high or low levels in all three examples of hypertrophied lips across all East African Great Lakes. Furthermore, although we focused primarily on the relationship between the Wnt signaling pathway and lip hypertrophy, several other pathways may be involved in the development of hypertrophied lips. These findings imply that although enlargement of proteoglycan-rich loose connective tissue is common in hypertrophied lips, the developmental pathways to accomplish this are diverse in each lake.”

      “We uncovered the apparent relationships between hypertrophied lips and the expression profiles of ECM proteins, in particularly proteoglycans. The trends for the overall expression of ECM-related genes were similar across hypertrophied lip species, but we rarely observed a specific gene that was commonly expressed at high or low levels in all three examples of hypertrophied lips across all East African Great Lakes. Furthermore, although we focused primarily on the relationship between the Wnt signaling pathway and lip hypertrophy, several other pathways may be involved in the development of hypertrophied lips. For example, our enrichment analysis in adult cichlids identified VEGF-related pathways, which could contribute to lip hypertrophy by increasing vascularization and nutrient supply to the lip tissue. In addition, previous quantitative trait locus (QTL) analysis by Henning et al. (2017) concluded that lip hypertrophy is likely influenced by numerous loci with small additive effects. These lines of data imply that although enlargement of proteoglycan-rich loose connective tissue is common in hypertrophied lips, the developmental pathways to accomplish this are diverse in each lake.”

      Reviewer 2:

      Minor comments:

      Last paragraph of Introduction: Remove the results of this study.

      We appreciate your suggestion. We remove the specialized results from the last paragraph.

      “In this study, we comprehensively compared the hypertrophied lips of cichlids across all East African Great Lakes using histology, proteomics, and transcriptomics. Histological and proteomic analyses revealed a distinct microstructure of hypertrophied lips compared to normal lips, and primary candidate proteins were identified. Transcriptome analysis at different developmental stages showed that the genes in Wnt signaling pathway was highly expressed in cichlids with hypertrophied lips at both the juvenile and adult stages. It is noteworthy that the distinct expression profiles observed in the proteome and transcriptome analyses of hypertrophied lips were similar among cichlids from each of the East African Great Lakes. The present study, which integrates comprehensive analyses for cichlids from all East African Great Lakes, provides insight for a better understanding of the molecular basis of a typical example of parallel evolution.”

      Line 87-91: “In this study, we comprehensively compared the hypertrophied and normal lips of cichlids across all East African Great Lakes at various biological levels using histology, proteomics, and transcriptomics. As a result, we showed that a novel key pathway commonly involved in the formation of hypertrophied lips, providing insight into a better understanding of the molecular basis of a typical example of parallel evolution.”

      Line 156: Italicize the scientific names.

      We appreciate your correction.

      Line 148: “M. zebra and O. niloticus” -> “M. zebra and O. niloticus

      Line 261: Remove the period after "Victoria."

      We appreciate your correction.

      Line 253: “Lake Victoria. (Figure 1; Figure S2).” -> “Lake Victoria (Figure 1; Figure S2).”

      Line 416: Remove the period after "tissue."

      We appreciate your correction.

      Line 420: “tissue. (A,B)” -> “tissue (A,B)”

      Line 646: Probably "the anterior side to the left."

      We apologize for our mistake. As you commented, the anterior side is left. We corrected our manuscript as follows.

      Line 648: “the anterior side to the right” -> “the anterior side to the left”

      Fig. S2: Based on Fig. 1, the VG stained area appears larger in the Hypertrophied lip species; however, it is the opposite in Fig. S2.

      We appreciate your comments. This is because we calculated the ratio of the VG-stained area to the whole lip area. While the absolute VG-stained area is larger in hypertrophied lips, the proportion of the VG-stained area relative to the total lip area is smaller. This correction using entire area allows us to simply compare the degree of lip hypertrophy among species.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1

      Public Review

      Summary:

      (1) This work describes a simple mechanical model of worm locomotion, using a series of rigid segments connected by damped torsional springs and immersed in a viscous fluid.

      (2) It uses this model to simulate forward crawling movement, as well as omega turns.

      Strengths:

      (3) The primary strength is in applying a biomechanical model to omega-turn behaviors.

      (4) The biomechanics of nematode turning behaviors are relatively less well described and understood than forward crawling.

      (5) The model itself may be a useful implementation to other researchers, particularly owing to its simplicity.

      Weaknesses:

      (6) The strength of the model presented in this work relative to prior approaches is not well supported, and in general, the paper would be improved with a better description of the broader context of existing modeling literature related to undulatory locomotion.

      (7) This paper claims to improve on previous approaches to taking body shapes as inputs.

      (8) However, the sole nematode model cited aims to do something different, and arguably more significant, which is to use experimentally derived parameters to model both the neural circuits that induce locomotion as well as the biomechanics and to subsequently compare the model to experimental data.

      (9) Other modeling approaches do take experimental body kinematics as inputs and use them to produce force fields, however, they are not cited or discussed.

      (10) Finally, the overall novelty of the approach is questionable.

      (11) A functionally similar approach was developed in 2012 to describe worm locomotion in lattices (Majmudar, 2012, Roy. Soc. Int.), which is not discussed and would provide an interesting comparison and needed context.

      9-11: The paper you recommended and our manuscript have some similarities and differences.

      Similarities

      Firstly, the components constituting the worm are similar in both models. ElegansBot models the worm as a chain of n rods, while the study by Majmudar et al. (2012) models it as a chain of n beads. Each bead in the Majmudar et al. model has a directional vector, making it very similar to ElegansBot's rod. However, there's a notable difference: in the Majmudar et al. model, each bead has an area for detecting contact between the obstacle and the bead, while in ElegansBot, the rod does not feature such an area.

      Secondly, the types of forces and torques acting on the components constituting the worm are similar. Each rod in ElegansBot receives frictional force, muscle force, and joint force. Each bead in the Majmudar et al. model receives a constraint force, viscous force, and a repulsive force from obstacles. Each rod in ElegansBot receives frictional torque, muscle torque, and joint torque. Each bead in the Majmudar et al. model receives elastic torque, constraint torque, drive torque, and viscous torque. The Majmudar et al. model's constraint force and torque are similar to ElegansBot's joint force and torque in that they prevent two connected components of the worm from separating. The Majmudar et al. model's viscous force and torque are similar to ElegansBot's frictional force and torque in that they are forces exchanged between the worm and its surrounding environment (ground surface). The Majmudar et al. model's drive torque is similar to ElegansBot's muscle force and muscle torque as a cause of the worm's motion. However, unlike ElegansBot, the Majmudar et al. model did not consider the force generating the drive torque, and there are differences in how each force and torque is calculated. This will be discussed in more detail below.

      Differences

      Firstly, the medium in which the worm locomotes is different. ElegansBot is a model describing motion in a homogeneous medium like agar or water without obstacles, while the Majmudar et al. model describes motion in water with circular obstacles fixed at each lattice point. This is because the purposes of the models are different. ElegansBot analyzes locomotion patterns based on the friction coefficient, while the Majmudar et al. model analyzes locomotion patterns based on the characteristics of the obstacle lattice, such as the distance between obstacles. Also, for this reason, the Majmudar et al. model's bead, unlike ElegansBot's rod, receives a repulsive force from obstacles.

      Secondly, the specific methods of calculating similar types of forces differ. ElegansBot calculates joint forces by substituting frictional forces, muscle forces, frictional torques, and muscle torques into an equation derived from differentiating a boundary condition equation twice over time, where two neighboring rods always meet at one point. This involves determining the process through which various forces and torques are transmitted across the worm. Specifically, it entails calculating how the frictional forces and torques, as well as the muscle forces and torques acting on each rod, are distributed throughout the entire length of the worm. In contrast, The Majmudar et al. model uses Lagrange multipliers method based on a boundary condition that the curve length determined by each bead's tangential angle does not change, to calculate the constraint force and torque before calculating the drive torque and viscous force. This implies that the Majmudar et al. model did not consider the mechanism by which the drive torque and viscous force received by one bead are distributed throughout the worm. ElegansBot's rod receives an anisotropic Stokes frictional force from the ground surface, while the Majmudar et al. model considered the frictional force according to the Navier-Stokes equation for incompressible fluid, assuming the fluid velocity at the bead's location as the bead's velocity.

      Thirdly, unlike the Majmudar et al. model, ElegansBot considers the inertia of the worm components. Therefore, ElegansBot can simulate regardless of how low or high the ground surface's friction coefficient is. the Majmudar et al. model is not like this.

      (12) The idea of applying biomechanical models to describe omega turns in C. elegans is a good one, however, the kinematic basis of the model as used in this paper (the authors do note that the control angle could be connected to a neural model, but don't do so in this work) limits the generation of neuromechanical control hypotheses.

      8, 12: We do not agree with the claim that ElegansBot could limit other researchers in generating neuromechanical control hypotheses. The term θ_("ctrl" ,i)^((t) ) used in our model is designed to be replaceable with neuromechanical control in the future.

      (13) The model may provide insights into the biomechanics of such behaviors, however, the results described are very minimal and are purely qualitative.

      (14-1) Overall, direct comparisons to the experiments are lacking or unclear.

      14-1: If you look at the text explaining Fig. 2 and 5 (Fig. 2 and 4 in old version), it directly compares the velocity, wave-number, and period as numerical indicators representing the behavior of the worm, between the experiment and ElegansBot.

      (14-2) Furthermore, the paper claims the value of the model is to produce the force fields from a given body shape, but the force fields from omega turns are only pictured qualitatively.

      13, 14-2: We gratefully accept the point that our analysis of the omega-turn is qualitative. Therefore, we have conducted additional quantitative analysis on the omega-turn and inserted the results into the new Fig. 4. We have considered the term 'Force field' as referring to the force vector received by each rod. We have created numerical indicators representing various behaviors of the worm and included them in the revised manuscript.

      (15) No comparison is made to other behaviors (the force experienced during crawling relative to turning for example might be interesting to consider) and the dependence of the behavior on the model parameters is not explored (for example, how does the omega turn change as the drag coefficients are changed).

      Thank you for the great idea. To compare behaviors, first, a clear criterion for distinguishing behaviors is needed. Therefore, we have created a new mathematical definition for behavior classification in the revised manuscript (“Defining Behavioral Categories” in Method). After that, we compared the force and power (energy consuming rate) between each forward locomotion, backward locomotion, and omega-turn (Fig. 4). And in the revised manuscript, we newly analyzed how the turning behavior changes with variations in the friction coefficients in Figs. S4-S7.

      (16) If the purpose of this paper is to recapitulate the swim-to-crawl transition with a simple model, and then apply the model to new behaviors, a more detailed analysis of the behavior of the model variables and their dependence on the variables would make for a stronger result.

      In our revised manuscript, we have quantitatively analyzed the changes occurring in turning behavior from water to agar, and the results are presented in Figs. S9 and S10.

      (17) In some sense, because the model takes kinematics as an input and uses previously established techniques to model mechanics, it is unsurprising that it can reproduce experimentally observed kinematics, however, the forces calculated and the variation of parameters could be of interest.

      (18) Relatedly, a justification of why the drag coefficients had to be changed by a factor of 100 should be explored.

      (19) Plate conditions are difficult to replicate and the rheology of plates likely depends on a number of factors, but is for example, changes in hydration level likely to produce a 100-fold change in drag? or something more interesting/subtle within the model producing the discrepancy?

      18, 19: As mentioned in the paper, we do not know if the friction coefficients in the study of Boyle et al. (2012) and the friction coefficients in the experiment of Stephens et al. (2016) are the same. In our revised manuscript, we have explored more in detail the effects of the friction coefficient's scale factor, and explained why we chose a scale factor of 1/100 (“Proper Selection of Friction Coefficients” in Supplementary Information). In summary, we analyzed the changes in trajectory due to scaling of the friction coefficient, and chose the scale factor 1/100 as it allowed ElegansBot to accurately reproduce the worm's trajectory while also being close to the friction coefficients in the Boyle et al. paper.

      (20) Finally, the language used to distinguish different modeling approaches was often unclear.

      (21) For example, it was unclear in what sense the model presented in Boyle, 2012 was a "kinetic model" and in many situations, it appeared that the term kinematic might have been more appropriate. Thank you for the feedback. As you pointed it out, we have corrected that part to 'kinematic' in the revised manuscript.

      (22) Other phrases like "frictional forces caused by the tension of its muscles" were unclear at first glance, and might benefit from revision and more canonical usage of terms.

      We agree that the expression may not be immediately clear. This is due to the word limit for the abstract (the abstract of eLife VOR should be under 200 words, and our paper's abstract is 198 words), which forced us to convey the causality in a limited number of words. Therefore, although we will not change the abstract, the expression in question means that the muscle tension, which is the cause of the worm's locomotion, ultimately generates the frictional force between the worm and the ground surface.

      Recommendations For The Authors

      (23) As I stated in my public review, I think the paper could be made much stronger if a more detailed exploration of turning mechanics was presented.

      (24) Relatedly, rather than restricting the analysis to individual videos of turning behaviors, I wonder if a parameterized model of the turning kinematics would be fruitful to study, to try to understand how different turning gaits might be more or less energetically favorable.

      We thank the reviewer once again for their suggestion. Thanks to their proposal, we were able to conduct additional quantitative analysis on turning behavior.

      Reviewer #2

      Public Review

      Summary:

      (1) Developing a mechanical model of C. elegans is difficult to do from basic principles because it moves at a low (but not very small) Reynolds number, is itself visco-elastic, and often is measured moving at a solid/liquid interface.

      (2) The ElegansBot is a good first step at a kinetic model that reproduces a wide range of C. elegans motiliy behavior.

      Strengths: (3) The model is general due to its simplicity and likely useful for various undulatory movements.

      (4) The model reproduces experimental movement data using realistic physical parameters (e.g. drags, forces, etc).

      (5) The model is predictive (semi?) as shown in the liquid-to-solid gait transition.

      (6) The model is straightforward in implementation and so likely is adaptable to modification and addition of control circuits.

      Weaknesses:

      (7) Since the inputs to the model are the actual shape changes in time, parameterized as angles (or curvature), the ability of the model to reproduce a realistic facsimile of C. elegans motion is not really a huge surprise. (8) The authors do not include some important physical parameters in the model and should explain in the text these assumptions.

      (9. 1) The cuticle stiffness is significant and has been measured [1].

      (10. 2) The body of C. elegans is under high hydrostatic pressure which adds an additional stiffness [2].

      (11. 3) The visco-elasticity of C. elegans body has been measured. [3]

      Thank you for asking. The stiffness of C. elegans is an important consideration. We took this into account when creating ElegansBot, but did not explain it in the paper. The detailed explanation is as follows. C. elegans indeed has stiffness due to its cuticle and internal pressure. This stiffness is treated as a passive elastic force (elastic force term of lateral passive body force) in the paper of Boyle et al. (2012). However, the maximum spring constant of the passive elastic force is 1/20 of the maximum spring constant of the active elastic force. If we consider this fact in our model, the elastic term of the muscle torque is as follows: ( is the active torque elasticity coefficient, is the passive torque elasticity coefficient)

      where

      Therefore, there is no need to describe the active and passive terms separately in

      Furthermore, since , assuming , then and .

      (12) There is only a very brief mention of proprioception.

      (13) The lack of inclusion of proprioception in the model should be mentioned and referenced in more detail in my opinion.

      As you emphasized, proprioception is an important aspect in the study of C. elegans' locomotion. In our paper, its importance is briefly introduced with a sentence each in the introduction and discussion. However, our research is a model about the process of the creation of body motion originated from muscle forces, and it does not model the sensory system that senses body posture. Therefore, there is no mention of using proprioception in our paper's results section. What is mentioned in the discussion is that ElegansBot can be applied as the kinetic body model part in a combination model of a kinetic body model and a neuronal circuit model that receives proprioception as a sensory signal.

      (14) These are just suggested references.

      (15) There may be more relevant ones available.

      The papers you provided contain specific information about the Young's modulus of the C. elegans body. The first paper (Rahimi et al., 2022) measured the Young's modulus of the cuticle after chemically isolating it from C. elegans, while the second paper (Park et al., 2007) and third paper (Backholm et al., 2013) measured the elasticity and Young's modulus of C. elegans without separating the cuticle. Based on the Young's modulus provided in each paper (although the second and third papers did not measure stiffness in the longitudinal direction), we derived the elastic coefficient (assuming a worm radius of 25 μm, cuticle thickness of 0.5 μm, and 1/25 of longitudinal length of the cuticle of 40 μm). The range was quite broad, from 9.82ⅹ1011 μg/sec2 (from the first paper) to 2.16 ⅹ 108 μg / sec2 (from the third paper). Although the elastic coefficient value in our paper falls within this range, since the range of the elastic coefficient is wide, we think we can modify the elastic coefficient in our paper and will be able to reapply our model if more accurate values become known in the future.

      Reviewer #3

      Public Review

      Summary:

      (1) A mechanical model is used with input force patterns to generate output curvature patterns, corresponding to a number of different locomotion behaviors in C. elegans

      Strengths:

      (2) The use of a mechanical model to study a variety of locomotor sequences and the grounding in empirical data are strengths.

      (3) The matching of speeds (though qualitative and shown only on agar) is a strength.

      Weaknesses:

      (4) What is the relation between input and output data?

      ElegansBot takes the worm's body control angle as the input, and produces trajectory and force of each segment of the worm as the output.

      (5) How does the input-output relation depend on the parameters of the model?

      If 'parameter' is understood as vertical and horizontal friction coefficients, then the explanation for this can be found in Fig. 5 (Fig. 4 in the old version).

      (6) What biological questions are addressed and can significant model predictions be made?

      Equation of motion deciphering locomotion of C. elegans including turning behaviors which were relatively less well understood.

      Recommendations For The Authors

      (7) The novelty and significance of the paper should be clarified.

      We have added quantitative analyses of turning behavior in the revised manuscript, and we hope this will be helpful to you.

      (8) Previously much more detailed models have been published, as compared to this one.

      We hope the reviewer can point out any previous model that we may have missed.

      (9) The mechanics here are simplified (e.g. no information about dorsal/ventral innervation but only a bending angle) setting limitations on the capacity for model predictiveness.

      (10) Such limitations should be discussed.

      We view the difference between dorsal/ventral innervation and bending angle not as a matter of simplification, but rather as a reflection of the hierarchy that our model implements. Our model does not consider dorsal/ventral innervation, but it uses the bending angle to reproduce behavior in various input and frictional environments, which signifies the strong predictiveness of ElegansBot (Figure 2, 3, 5 (2, 3, 4 in the old version)). Moreover, if the midline of C. elegans is incompressible, then modeling by dividing into dorsal/ventral, as opposed to modeling solely with the bending angle, does not increase the degree of freedom of the worm model, and therefore does not increase its predictiveness.

      (11) The aims of the paper and results need to be supported quantitatively and analyzed through parameter sweeps and intervention.

      We have conducted additional quantitative analyses on turning behavior as suggested by Reviewer #1 (Fig. 4, S4-S7, S9, and S10).

      (12) The methods are given only in broad brushstrokes, and need to be much more clear (and ideally sharing all code).

      We have thoroughly detailed every aspect of this research, from deriving the physical constants of C. elegans, agar, and water to developing the formulas and proofs necessary for operating ElegansBot and its applications. This comprehensive information is all presented in the Results, Methods, and Supplementary Information sections, as well as in the source code. Moreover, we have already ensured that our research can be easily reproduced by providing detailed explanations and by making ElegansBot accessible through public software databases (PyPI, GitHub). To further aid in its application and understanding, especially for those less familiar with the subject, we have also included minimal code as examples in the database. This code is designed to simplify the process of reproducing the results of the paper, thereby making our research more accessible and understandable. Therefore, we believe that readers will easily gain significant assistance from the extensive information we have provided. Should readers require further help, they can always contact us, and we will be readily available to offer support.

      (13) The supporting figures and movies need to include a detailed analysis to evidence the claims.

      We have conducted and provided additional quantitative analyses on turning behavior as suggested by Reviewer #1 (Fig. 4, S4-S7, S9, and S10).

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this manuscript, Chen et al. used cryo-ET and in vitro reconstituted system to demonstrate that the autoinhibited form of LRRK2 can also assemble into filaments that wrap around the microtubule, although the filaments are typically shorter and less regular compared to the previously reported active-LRRK2 filaments. The structure revealed a new interface involving the N-terminal repeats that were disordered in the previous active-LRRK2 filament structure. The autoinhibited-LRRK2 filament also has different helical parameters compared to the active form.

      Strengths:

      The structure obtained in this study is the highest resolution of LRRK2 filaments done by subtomogram averaging, representing a major technical advance compared to the previous Cell paper from the same group. Overall, I think the data are well presented with beautiful graphic rendering, and valuable insights can be gained from this structural study.

      Weaknesses:

      (1) There are only three main figures, together with 9 supplemental figures. The authors may consider breaking the currently overwhelming Figures 1 and 3 into smaller figures and moving some of the supplemental figures to the main figure, e.g., Figure S7.

      (2) The key analysis of this manuscript is to compare the current structure with the previous active-LRRK2 filament structure. Currently, such a comparison is buried in Figure 3H. It should be part of Figure 1.

      We thank the reviewer for this suggestion. As suggested, we have rearranged the figures, split Figure 1 and 3 into smaller Figures, and moved the comparison analysis in Figure 3H to the new Figure 1. Specifically, the old Figure 1 is separated into two figures, introducing the model-building process and describing the two symmetric axes. The old Figure 3 is also separated into two small figures, describing the geometric analysis and model comparison, respectively.

      Reviewer #2 (Public review):

      The authors of this paper have done much pioneering work to decipher and understand LRRK2 structure and function, to uncover the mechanism by which LRRK2 binds to microtubules, and to study the roles that this may play in biology. Their previous data demonstrated that LRRK2 in the active conformation (pathogenic mutation or Type I inhibitor complex) bound to microtubule filaments in an ordered helical arrangement. This they showed induced a "roadblock" in the microtubule impacting vesicular trafficking. The authors have postulated that this is a potentially serious flaw with Type 1 inhibitors and that companies should consider generating Type 2 inhibitors in which the LRRK2 is trapped in the inactive conformation. Indeed the authors have published much data that LRRK2 complexed to Type 2 inhibitors does not seem to associate with microtubules and cause roadblocks in parallel experiments to those undertaken with type 1 inhibitors published above.

      In the current study, the authors have undertaken an in vitro reconstitution of microtubule-bound filaments of LRRK2 in the inactive conformation, which surprisingly revealed that inactive LRRK2 can also interact with microtubules in its auto-inhibited state. The authors' data shows that while the same interphases are seen with both the active LRRK2 and inactive microtubule bound forms of LRRK2, they identified a new interphase that involves the WD40-ARM-ANK- domains that reportedly contributes to the ability of the inactive form of LRRK2 to bind to microtubule filaments. The structures of the inactive LRRK2 complexed to microtubules are of medium resolution and do not allow visualisation of side chains.

      This study is extremely well-written and the figures are incredibly clear and well-presented. The finding that LRRK2 in the inactive autoinhibited form can be associated with microtubules is an important observation that merits further investigation. This new observation makes an important contribution to the literature and builds upon the pioneering research that this team of researchers has contributed to the LRRK2 fields. However, in my opinion, there is still significant work that could be considered to further investigate this question and understand the physiological significance of this observation.

      We thank the reviewer for the positive comments and we agree that more work can be done next to understand the physiological significance of the autoinhibited LRRK2 in cellular environments. We are actively working on understanding how the stability of autoinhibited full-length LRRK2 is regulated, especially how the transfer between autoinhibited and active forms of LRRK2 can happen. Our in situ data (Watabane et al. 2020) indicates that overexpressed hyperactive PD-mutant LRRK2 mainly adopts its active-like conformation in cells. Thus, learning how the state transfer occurs will allow us to target autoinhibited LRRK2 specifically and efficiently in cells and study its structure and function in physiological conditions.

      Reviewer #3 (Public review):

      Summary:

      The manuscript by Chen et al examines the structure of the inactive LRRK2 bound to microtubules using cryo-EM tomography. Mutations in this protein have been shown to be linked to Parkinson's Disease. It is already shown that the active-like conformation of LRRK2 binds to the MT lattice, but this investigation shows that full-length LRRk2 can oligomerize on MTs in its autoinhibited state with different helical parameters than were observed with the active-like state. The structural studies suggest that the autoinhibited state is less stable on MTs.

      Strengths:

      The protein of interest is very important biomedically and a novel conformational binding to microtubules in the proposed.

      Weaknesses:

      (1) The structures are all low resolution.

      We thank the reviewer for the comments on both the strengths and weaknesses of the manuscript. We agree with the reviewer that higher resolution would provide more information about how LRRK2 interacts with microtubules and oligomerizes in its autoinhibited form. However, with the current resolution, our model-building benefited significantly from the published high-resolution models and the alpha-fold predictions. We used cryo-ET and subtomogram analysis to solve the structure because this filament is less regular than the right-handed active LRRK2 filament, preventing us from using conventional single-particle analysis. As highlighted by reviewer 1, being able to push the resolution to sub-nanometer is an important advance reflecting state-of-the-art subtomogram analysis, especially for a heterogeneous sample.  Notably, the microtubule reconstruction reached higher resolution, comparable to our previous single-particle studies on LRRK2-RCKW (Snead and Matyszewski et al.), confirming the data quality.

      (2) There are no measurements of the affinity of the various LRRK2 molecules (with and without inhibitors) to microtubules. This should be addressed through biochemical sedimentation assay.

      We thank the reviewer for the suggestion and we agree that learning the binding affinity between LRRK2 and microtubules would be informative. We attempted to purify the LRRK2 with mutants on the WD40:ARM/ANK interface we identified in the manuscript.. Unfortunately, either LRRK2 or LRRK2<sup>I2020T</sup> with N-terminal mutants (R521A/F573A/E854K), the yield and purity of the final samples are significantly worse than our routine LRRK2 prep. Our chromatography and gel electrophoresis results indicate that proteins are degrading during purification.

      Author response image 1.

      While we have attached the results here, and it would be interesting to investigate why N-terminal mutations destabilize LRRK2, we anticipate that significant efforts would be required for further experiments, which we respectfully consider outside of the scope of this manuscript. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) In Figure S9, the graphic definition of "chain length" in panel A is misleading. The authors can simply note in the figure legend that "chain length is the number of asymmetric units in a continuous chain".

      We thank the reviewer for the suggestion. The updated figure and legend have incorporated the changes.

      (2) In Figure S7B, the conformation changes of the 'G-loop' and the 'DYG' motifs are not so convincing at the current resolution.

      We thank the reviewer for pointing it out. We agree that our model resolution is not high enough to support the unbiased observation of the conformation changes of the key kinase motifs. In the revised manuscript, we avoided emphasizing the comparison between the two models. Instead, we state that for both the MLi-2 bound map and the GZD-824 bound map, the corresponding published high-resolution models fit into each kinase map, but the MLi-2 bound model doesn’t fit as well in the GZD-824 bound map, with a correlation value dropped from 0.44 to 0.4, supporting our statement that “full-length LRRK2 bound to microtubules is in its autoinhibited state in our reconstituted system”.

      Reviewer #2 (Recommendations for the authors):

      (1) Are there any cellular experiments that could be done to demonstrate that inactive LRRK2 associates with microtubules in cells?

      We thank the reviewer for pointing out this direction for future studies. We are studying the physiological significance of the autoinhibited LRRK2 in cells, but haven’t yet been successful at demonstrating physiological binding to microtubules. Further, as noted in our response to reviewer #3, we are also actively working on understanding how the stability of autoinhibited full-length LRRK2 is regulated, especially how the transfer between autoinhibited and active forms of LRRK2 can happen. Our in situ data (Watabane et al. 2020) indicates that hyperactive PD-mutant overexpressed LRRK2 mainly adopts its active-like conformation in cells. Thus, learning how the state transfer occurs will allow us to target autoinhibited LRRK2 specifically and efficiently in cells and study its structure and function in physiological conditions.

      (2) Previous work that the authors and others have undertaken has suggested that only LRRK2 in its active conformation can associate with microtubule filaments and the authors have shown that this leads to a roadblock in vesicular transport only when LRRK2 is complexed with Type 1 but not Type 2 inhibitors. There seems to be some discrepancy here that is not addressed in the paper as based on the current results one would also expect LRRK2 bound to Type 2 inhibitors to induce roadblocks in microtubule filaments. How can this be explained?

      We thank the reviewer for raising this important question. Taking all of our published data together, we believe that LRRK2 can introduce roadblocks with Type 1 inhibitor bound in the active-like conformation, where N-terminus LRRK2 domains are flexible and don’t block the kinase active site. In other words, full-length LRRK2 can form roadblocks when it behaves more like the truncated LRRK2<sup>RCKW</sup> variant. The autoinhibited LRRK2 forms shorter and less stable oligomers on microtubules, making it harder to block transport. Consistent with this, our in situ LRRK2-microtubule structure was observed in cells where LRRK2 is in an active-like conformation, and the LRRK2 N-terminus appeared to be flexible and away from the microtubule when forming right-handed filaments.

      (3) Does the finding that inactive LRRK2 only binds to microtubules as a short filament, explain the differences between the inactive and active forms of LRRK2 binding to microtubules and causing roadblocks?

      We thank the reviewer for discussing this point with us and asking the question. As we replied in the previous comment, the reviewer’s conclusion explains how the roadblock phenomenon occurs only under certain circumstances. We expanded our discussion to add the following and address the question:

      “Notably, we previously demonstrated that active‐like LRRK2, when bound to a Type I inhibitor, can form roadblocks that impair vesicular transport. Since autoinhibited LRRK2 assembles into shorter, less stable oligomers on microtubules, we anticipate it will exert reduced road‐blocking effects in cells, regardless of the inhibitor bound.”

      (4) Could the authors undertake further characterization of the new WD40-ARM-ANK interphase that they have identified? Is this important for the binding of the autoinhibited mutant? Could mutants be made in this interphase to see if this prevents the autoinhibited but not the active conformation of LRRK2 binding to microtubules?

      We thank the reviewer for the comment. As mentioned in our response to Reviewer #2, public comment #2, we attempted to purify the LRRK2 with mutants on the WD40:ARM/ANK interface we identified in the manuscript multiple times. Unfortunately, either LRRK2 or LRRK2<sup>I2020T</sup> with N-terminal mutants (R521A/F573A/E854K), the yield and purity of the final samples are significantly worse than our routine LRRK2 prep. Our chromatography and gel electrophoresis results indicate that proteins are degrading during purification.

      (5) The authors identify several disease-relevant missense mutations that appear to lie within the novel interphase that the authors have characterised in this study. Although this is discussed in the Discussion, some experimental data demonstrating how these missense mutations impact the ability of inactive LRRK2 to bind to microtubule filaments in the presence or absence of Type 1 and Type 2 compounds could provide further experimental data that emphasises the physiological importance of the results presented in this study.

      We thank the reviewer for discussing this interesting direction. The disease-relevant missense mutations can have a direct or indirect impact on the binding of autoinhibited LRRK2 to microtubules, and we agree that it would be interesting to test it out in the future. However, we anticipate that significant effort would be required for further experiments. Alas, our funding for this project ended suddenly and we want to report our results to the community.

      (6) For the data that is shown in Figure 1, could the authors explain how this differs from results in previous papers of the authors showing that the active form of LRRK2 binds microtubules? How does the binding observed here differ from that observed in the previous studies? To a non-specialist reader, the data looks fairly like what has previously been reported.

      We thank the reviewer for asking the question. As mentioned in the response to the public review, the detailed comparison between the data and the previous papers is described in Figure 3, and we agree that it is helpful to incorporate this information in Figure 1. In the revised manuscript, we have incorporated the comparison panel in Figure 1.

      (7) The finding that the autoinhibited LRRK2 forms short and sparse oligomers on microtubules raises the question of how physiological this observation is. Having some data that suggests that this is physiologically relevant would boost the impact of this study.

      We agree with the reviewer on this comment. As discussed in the response to the first comment from the reviewer, we have not been able to assess the physiological relevance of LRRK2 binding to microtubules in either active or inactive state, but continue to pursue this line of research. We are aware and regret that this lessens the impact of this work.

      (8) For the more general reader the authors could potentially better highlight why the key finding in this paper is important.

      We thank the reviewer for the suggestion. To further address the significance of the key findings, especially how it can open up more possibilities for inhibitor-based drug development, we expand our discussion section to include the following:

      “Understanding how Type I and Type II inhibitors’ binding to LRRK2 affects its mechanism is vital to the design of inhibitor-based PD drug development strategies. Our findings revealed that different LRRK2 kinase inhibitors bind to autoinhibited LRRK2 similarly either in solution or on microtubules. Furthermore, the observation of autoinhibited LRRK2 forming short, less stable oligomers on microtubules opens new possibilities to inhibit LRRK2 activity in PD patients. A Type I inhibitor specifically targeting autoinhibited LRRK2 may alleviate the effect of LRRK2 roadblocks on microtubules. Alternatively, a promising strategy of LRRK2 inhibitor design can focus on the stabilization of allosteric N-terminus blocking on the kinase domain, which favors the formation of autoinhibited LRRK2 oligomers on microtubules and causes fewer side effects.”

      Reviewer #3 (Recommendations for the authors):

      In the third paragraph of the introduction, expand on whether type-1 inhibitors which "capture kinases in a closed, "active-like" conformation still inhibit the kinase activity.

      We thank the reviewer for the request to expand this paragraph. We added the following explanation for better understanding in the third paragraph:

      “Type-I inhibitors bind to the ATP binding site and target the kinase in its ‘active-like' conformation, inhibiting its kinase activity.”

    1. Author Response

      The following is the authors’ response to the original reviews.

      We thank the reviewers for truly valuable advice and comments. We have made multiple corrections and revisions to the original pre-print accordingly per the following comments:

      1. Pro1153Leu is extremely common in the general population (allele frequency in gnomAD is 0.5). Further discussion is warranted to justify the possibility that this variant contributes to a phenotype documented in 1.5-3% of the population. Is it possible that this variant is tagging other rare SNPs in the COL11A1 locus, and could any of the existing exome sequencing data be mined for rare nonsynonymous variants?

      One possible avenue for future work is to return to any existing exome sequencing data to query for rare variants at the COL11A1 locus. This should be possible for the USA MO case-control cohort. Any rare nonsynonymous variants identified should then be subjected to mutational burden testing, ideally after functional testing to diminish any noise introduced by rare benign variants in both cases and controls. If there is a significant association of rare variation in AIS cases, then they should consider returning to the other cohorts for targeted COL11A1 gene sequencing or whole exome sequencing (whichever approach is easier/less expensive) to demonstrate replication of the association.

      Response: Regarding the genetic association of the common COL11A1 variant rs3753841 (p.(Pro1335Leu)), we do not propose that it is the sole risk variant contributing to the association signal we detected and have clarified this in the manuscript. We concluded that it was worthy of functional testing for reasons described here. Although there were several common variants in the discovery GWAS within and around COL11A1, none were significantly associated with AIS and none were in linkage disequilibrium (R2>0.6) with the top SNP rs3753841. We next reviewed rare (MAF<=0.01) coding variants within the COL11A1 LD region of the associated SNP (rs3753841) in 625 available exomes representing 46% of the 1,358 cases from the discovery cohort. The LD block was defined using Haploview based on the 1KG_CEU population. Within the ~41 KB LD region (chr1:103365089- 103406616, GRCh37) we found three rare missense mutations in 6 unrelated individuals, Table below. Two of them (NM_080629.2:c.G4093A:p.A1365T; NM_080629.2:c.G3394A:p.G1132S), from two individuals, are predicted to be deleterious based on CADD and GERP scores and are plausible AIS risk candidates. At this rate we could expect to find only 4-5 individuals with linked rare coding variants in the total cohort of 1,358 which collectively are unlikely to explain the overall association signal we detected. Of course, there also could be deep intronic variants contributing to the association that we would not detect by our methods. However, given this scenario, the relatively high predicted deleteriousness of rs3753841 (CADD= 25.7; GERP=5.75), and its occurrence in a GlyX-Y triplet repeat, we hypothesized that this variant itself could be a risk allele worthy of further investigation.

      Author response table 1.

      We also appreciate the reviewer’s suggestion to perform a rare variant burden analysis of COL11A1. We did conduct pilot gene-based analysis in 4534 European ancestry exomes including 797 of our own AIS cases and 3737 controls and tested the burden of rare variants in COL11A1. SKATO P value was not significant (COL11A1_P=0.18), but this could due to lack of power and/or background from rare benign variants that could be screened out using the functional testing we have developed.

      1. COL11A1 p.Pro1335Leu is pursued as a direct candidate susceptibility locus, but the functional validation involves both: (a) a complementation assay in mouse GPCs, Figure 5; and (b) cultured rib cartilage cells from Col11a1-Ad5 Cre mice (Figure 4). Please address the following:

      2A. Is Pro1335Leu a loss of function, gain of function, or dominant negative variant? Further rationale for modeling this change in a Col11a1 loss of function cell line would be helpful.

      Response: Regarding functional testing, by knockdown/knockout cell culture experiments, we showed for the first time that Col11a1 negatively regulates Mmp3 expression in cartilage chondrocytes, an AIS-relevant tissue. We then tested the effect of overexpressing the human wt or variant COL11A1 by lentiviral transduction in SV40-transformed chondrocyte cultures. We deleted endogenous mouse Col11a1 by Cre recombination to remove the background of its strong suppressive effects on Mmp3 expression. We acknowledge that Col11a1 missense mutations could confer gain of function or dominant negative effects that would not be revealed in this assay. However as indicated in our original manuscript we have noted that spinal deformity is described in the cho/cho mouse, a Col11a1 loss of function mutant. We also note the recent publication by Rebello et al. showing that missense mutations in Col11a2 associated with congenital scoliosis fail to rescue a vertebral malformation phenotype in a zebrafish col11a2 KO line. Although the connection between AIS and vertebral malformations is not altogether clear, we surmise that loss of the components of collagen type XI disrupt spinal development. in vivo experiments in vertebrate model systems are needed to fully establish the consequences and genetic mechanisms by which COL11A1 variants contribute to an AIS phenotype.

      2B. Expression appears to be augmented compared WT in Fig 5B, but there is no direct comparison of WT with variant.

      Response: Expression of the mutant (from the lentiviral expression vector) is increased compared to mutant. We observed this effect in repeated experiments. Sequencing confirmed that the mutant and wildtype constructs differed only at the position of the rs3753841 SNP. At this time, we cannot explain the difference in expression levels. Nonetheless, even when the variant COL11A1 is relatively overexpressed it fails to suppress MMP3 expression as observed for the wildtype form.

      2C. How do the authors know that their complementation data in Figure 5 are specific? Repetition of this experiment with an alternative common nonsynonymous variant in COL11A1 (such as rs1676486) would be helpful as a comparison with the expectation that it would be similar to WT.

      Response: We agree that testing an allelic series throughout COL11A1 could be informative, but we have shifted our resources toward in vivo experiments that we believe will ultimately be more informative for deciphering the mechanistic role of COL11A1 in MMP3 regulation and spine deformity.

      2D. The y-axes of histograms in panel A need attention and clarification. What is meant by power? Do you mean fold change?

      Response: Power is directly comparable to fold change but allows comparison of absolute expression levels between different genes.

      2E. Figure 5: how many technical and biological replicates? Confirm that these are stated throughout the figures.

      Response: Thank you for pointing out this oversight. This information has been added throughout.

      1. Figure 2: What does the gross anatomy of the IVD look like? Could the authors address this by showing an H&E of an adjacent section of the Fig. 2 A panels?

      Response: Panel 2 shows H&E staining. Perhaps the reviewer is referring to the WT and Pax1 KO images in Figure 3? We have now added H&E staining of WT and Pax1 KO IVD as supplemental Figure 3E to clarify the IVD anatomy.

      1. Page 9: "Cells within the IVD were negative for Pax1 staining ..." There seems to be specific PAX1 expression in many cells within the IVD, which is concerning if this is indeed a supposed null allele of Pax1. This data seems to support that the allele is not null.

      Response: We have now added updated images for the COL11A1 and PAX1 staining to include negative controls in which we omitted primary antibodies. As can be seen, there is faint autofluorescence in the PAX1 negative control that appears to explain the “specific staining” referred to by the reviewer. These images confirm that the allele is truly a null.

      1. There is currently a lack of evidence supporting the claim that "Col11a1 is positively regulated by Pax1 in mouse spine and tail". Therefore, it is necessary to conduct further research to determine the direct regulatory role of Pax1 on Col11a1.

      Response: We agree with the reviewer and have clarified that Pax1 may have either a direct or indirect role in Col11a1 regulation.

      1. There is no data linking loss of COL11A1 function and spine defects in the mouse model. Furthermore, due to the absence of P1335L point mutant mice, it cannot be confirmed whether P1335L can actually cause AIS, and the pathogenicity of this mutation cannot be directly verified. These limitations need to be clearly stated and discussed. A Col11a1 mouse mutant called chondroysplasia (cho), was shown to be perinatal lethal with severe endochondral defects (https://pubmed.ncbi.nlm.nih.gov/4100752/). This information may help contextualize this study.

      Response: We partially agree with the reviewer. Spine defects are reported in the cho mouse (for example, please see reference 36 Hafez et al). We appreciate the suggestion to cite the original Seegmiller et al 1971 reference and have added it to the manuscript.

      1. A recent article (PMID37462524) reported mutations in COL11A2 associated with AIS and functionally tested in zebrafish. That study should be cited and discussed as it is directly relevant for this manuscript.

      Response: We agree with the reviewer that this study provides important information supporting loss of function I type XI collagen in spinal deformity. Language to this effect has been added to the manuscript and this study is now cited in the paper.

      1. Please reconcile the following result on page 10 of the results: "Interestingly, the AISassociated gene Adgrg6 was amongst the most significantly dysregulated genes in the RNA-seq analysis (Figure 3c). By qRT-PCR analysis, expression of Col11a1, Adgrg6, and Sox6 were significantly reduced in female and male Pax1-/- mice compared to wild-type mice (Figure 3d-g)." In Figure 3f, the downregulation of Adgrg6 appears to be modest so how can it possibly be highlighted as one of the most significantly downregulated transcripts in the RNAseq data?

      Response: By “significant” we were referring to the P-value significance in RNAseq analysis, not in absolute change in expression. This language was clearly confusing, and we have removed it from the manuscript.

      1. It is incorrect to refer to the primary cell culture work as growth plate chondrocytes (GPCs), instead, these are primary costal chondrocyte cultures. These primary cultures have a mixture of chondrocytes at differing levels of differentiation, which may change differentiation status during the culturing on plastic. In sum, these cells are at best chondrocytes, and not specifically growth plate chondrocytes. This needs to be corrected in the abstract and throughout the manuscript. Moreover, on page 11 these cells are referred to as costal cartilage, which is confusing to the reader.

      Response: Thank you for pointing out these inconsistencies. We have changed the manuscript to say “costal chondrocytes” throughout.

      Minor points

      • On 10 of the Results: "These data support a mechanistic link between Pax1 and Col11a1, and the AIS-associated genes Gpr126 and Sox6, in affected tissue of the developing tail." qRT-PCR validation of Sox6, although significant, appears to be very modestly downregulated in KO. Please soften this statement in the text.

      Response: We have softened this statement.

      • Have you got any information about how the immortalized (SV40) costal cartilage affected chondrogenic differentiation? The expression of SV40 seemed to stimulate Mmp13 expression. Do these cells still make cartilage nodules? Some feedback on this process and how it affects the nature of the culture what be appreciated.

      Response: The “+ or –“ in Figure 5 refers to Ad5-cre. Each experiment was performed in SV40-immortalized costal chondrocytes. We have removed SV40 from the figure and have clarified the legend to say “qRT-PCR of human COL11A1 and endogenous mouse Mmp3 in SV40 immortalized mouse costal chondrocytes transduced with the lentiviral vector only (lanes 1,2), human WT COL11A1 (lane 3), or COL11A1P1335L. Otherwise we absolutely agree that understanding Mmp13 regulation during chondrocyte differentiation is important. We plan to study this using in vivo systems.

      • Figure 1: is the average Odds ratio, can this be stated in the figure legend?

      Response: We are not sure what is being asked here. The “combined odds ratio” is calculated as a weighted average of the log of the odds.

      • A more consistent use of established nomenclature for mouse versus human genes and proteins is needed.

      Human:GENE/PROTEIN

      Mouse: Gene/PROTEIN

      Response: Thank you for pointing this out. The nomenclature has been corrected throughtout the manuscript.

      • There is no Figure 5c, but a reference to results in the main text. Please reconcile. -There is no Figure 5-figure supplement 5a, but there is a reference to it in the main text. Please reconcile.

      Response: Figure references have been corrected.

      • Please indicate dilutions of all antibodies used when listed in the methods.

      Response: Antibody dilutions have been added where missing.

      • On page 25, there is a partial sentence missing information in the Histologic methods; "#S36964 Invitrogen, CA, USA)). All images were taken..."

      Response: We apologize for the error. It has been removed.

      • Table 1: please define all acronyms, including cohort names.

      Response: We apologize for the oversight. The legend to the Table has been updated with definitions of all acronyms.

      • Figure 2: Indicate that blue staining is DAPI in panel B. Clarify that "-ab" as an abbreviation is primary antibody negative.

      Response: A color code for DAPI and COL11A! staining has been added and “-ab” is now defined.

      • Page 4: ADGRG6 (also known as GPR126)...the authors set this up for ADGRG6 but then use GPR126 in the manuscript, which is confusing. For clarity, please use the gene name Adgrg6 consistently, rather than alternating with Gpr126.

      Response: Thank you for pointing this out. GPR126 has now been changed to ADGRG6 thoughout the manuscript.

      • REF 4: Richards, B.S., Sucato, D.J., Johnston C.E. Scoliosis, (Elsevier, 2020). Is this a book, can you provide more clarity in the Reference listing?

      Response: Thank you for pointing this out. This reference has been corrected.

      • While isolation was addressed, the methods for culturing Rat cartilage endplate and costal chondrocytes are poorly described and should be given more text.

      Response: Details about the cartilage endplate and costal chondrocyte isolation and culture have been added to the Methods.

      • Page 11: 1st paragraph, last sentence "These results suggest that Mmp3 expression"... this sentence needs attention. As written, I am not clear what the authors are trying to say.

      Response: This sentence has been clarified and now reads “These results suggest that Mmp3 expression is negatively regulated by Col11a1 in mouse costal chondrocytes.”

      • Page 13: line 4 from the bottom, "ECM-clearing"? This is confusing do you mean ECM degrading?

      Response: Yes and thank you. We have changed to “ECM-degrading”.

      • Please use version numbers for RefSeq IDs: e.g. NM_080629.3 instead of NM_080629 Response: This change has been made in the revised manuscript.

      • It would be helpful for readers if the ethnicity of the discovery case cohort was clearly stated as European ancestry in the Results main text.

      Response: “European ancestry” has been added at first description of the discovery cohort in the manuscript.

      • Avoid using the term "mutation" and use "variant" instead.

      Response: Thank you for pointing this out. “Variant” is now used throughout the manuscript.

      • Define error bars for all bar charts throughout and include individual data points overlaid onto bars.

      Response: Thank you. Error bars are now clarified in the Figure legends.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reply to reviewer comments:

      (1) Given the interpretations of this study hinge on the specificity of the antibodies used in immune fluorescence, the authors should provide full western-blot images of all their antibodies in supplementary information. 

      The commercial antibodies have been validated by the provider. 

      Additionally, we did our own tests. Of note is that proper validation of any antibody is only possible by using a knockout mouse for each protein analyzed (i.e. for pPKA wt vs. pka ko mice). This is not possible, because we do not have all these knock-out strains. However, specific proteins like pPKA, pCAMKII, and pCAMKIV are known to be increased by a light pulse. We show by western blot that pPKA (Fig. 2a, b) and pCamKII (Fig. S2a, b) are increased in wt animals mirroring what we observed in the immunofluorescence. These results suggest that the signal is specific to these antibodies. We provide a full panel of western blots, including the other proteins studied by immunofluorescence such as pCamKIV, pCREB, CaV 3.1, and pDARP32 and show that they detect a protein of the expected size. Full Western-blots mentioned in the manuscript are shown in Supplementary Figure 7. Below are additional validations of antibodies used in the immunofluorescence experiments.

      Author response image 1.

      Author response image 2.

      (2) The explanation in the results section surrounding Fig. 4 seems to be specific for the representative trace rather than the group. Specifically, does the following statement apply to all the replicates?  " A Ca2+ transient was observed right before the light was given at ZT14 (Fig. 4b), which showed the same magnitude as those observed during and after the light stimulus". 

      If not this should be corrected.  

      We have replaced now Fig. 4b with an average trace of all experiments. The individual traces can be seen in supplementary figure 4d.

      (3) Are lines 236 -244 and figure 5A/B demonstrating shCDK5 being similar to no-calcium or EGTA conditions at the level of CREB not contradicting Figure 3 which argues that the reason behind the increase in CAMK-phosphorylation and pCREB following shCDK5 is increased basal calcium? If this is the case then why does removing the external calcium phenocopy shCDK5 in these cells? The authors need to clarify this and give an explanation. 

      (4) The authors should explain why they see an equivalent level (or more) of CREB activation, 5 minutes following forskolin activation in Ca2+-free condition (apparent in the case of shCDK5 and EGTA) in the FRET assay. Does this not imply PKA is the most likely candidate mediating this reaction at this stage? Given this interaction has been demonstrated in multiple (other) experiments including in vitro isolated enzyme experiments involving CREB and PKA (E.G. fig 6A in PMID: 2900470) an absence of p-PKA pulldown is not sufficient to justify the non-involvement of PKA (PMID: 22583753). This statement needs support in the form of positive data or acknowledging the limitations in the text (conditions, single technique, etc). 

      (5) The authors should better explain the fret pairs used in the experiments involving ICAP for the reader's benefit - a reduction in fluorescence as a function of CREB activation is non-intuitive.

      We answer all three questions (3-5) together since they belong to the same concept.

      (1) How FRET works.

      The Forster resonance energy transfer (FRET) technique is widely used to investigate molecular interactions between proteins such as CREB: CBP in living cells. We used a sensor called ICAP (an Indicator of CREB Activation due to Phosphorylation) published by Friedrich and colleagues in 2010

      (https://doi.org/10.1074/jbc.M110.124545). The sensor is composed of three different elements: 1) the KID domain of CREB containing the Ser-133, which is phosphorylated upon forskolin induction in our experimental setup, 2) the KIX domain of CBP, which is responsible for the dimerization with phospho-CREB and 3) a short linker that separates the KID with the KIX domain. KID is flanked by a cyan fluorescent protein (CFP), while KIX is flanked by a yellow fluorescent protein (YFP). When KID is not phosphorylated, the ICAP conformation allows CFP - stimulated by blue UV light - to transfer energy to YFP, producing FRET resulting in yellow light emission. Therefore, the ratiometric analysis FRET/CFP shows FRET > CFP. After a stimulus (forskolin), the serine-133 in KID is phosphorylated and KID can bind to KIX. The dimerization separates CFP from YFP, resulting in decreased FRET and increased CFP-dependent blue light emission (see Author response image 3 below). Therefore, the ratiometric analysis FRET/CFP shows FRET<CFP over time (usually within 20’ after the forskolin stimulus).

      Author response image 3.

      FRET model. On the left is a schematic representation of how ICAP works. On the right, an example of the quantified FRET decrease associated with increased KID: KIX interaction.

      (2) The ‘apparent’ contradiction between Figure 5A and Fig 3.

      As mentioned before, the chosen FRET method is ratiometric, meaning that a relative FRET signal in fluorescence is measured compared to the baseline (absence of forskolin, assay buffer). The FRET experiment can only tell whether there is a change in the phosphorylation state of KID during the live imaging comparing the baseline to the period after the forskolin treatment. The result produces a delta [ (time after forskolin)(baseline)]. The higher the delta, the more KID is phosphorylated after forskolin treatment. If KID phosphorylation is not increased compared to the baseline, the FRET signal tends to return to the baseline with a reduced delta [ (time after forskolin)-(baseline)]. Therefore, the experiment does not tell at the quantitative level the amount of KID (CREB domain) phosphorylation before the stimulus. It only tells whether after the stimulus the phosphorylation is increased producing or not a delta. This means that the lack of delta can be caused by: A) high KID phosphorylation in the baseline which does not further increase after the forskolin stimulus; B) very low KID phosphorylation in the baseline which does not increase after the forskolin stimulus. In Fig. 5A, wt cells (orange trace, lines, and double arrow) show a higher delta compared to the ko cells (blue trace, lines, and double arrow). The result indicated that the phosphorylation of CREB (KID domain) is increased after the forskolin stimulus only in the wt. To that extent, the results are in line with the experiment that we show in Figure 3. Indeed, the increased delta in CREB phosphorylation is observed only in the scramble animals, where it is lost in the ko (the blue double arrow indicates the delta in the scramble). 

      Author response image 4.

      (3) The FRET signal within 3 minutes after forskolin stimulation

      The signal mentioned by the reviewers at 5’ is an artifact given by the light diffraction promoted by the addition of Forskolin in DMSO which propagates through the plate. The same effect is observed in the only DMSO treatment (Fig.S5). Therefore, it needs not to be taken into account. The amplitude of this signal in this window of time is due to many independent variables (buffer composition, cell shape, room temperature, pipetting), therefore it is not possible to speculate any consideration about it. We never consider this time window for describing our results.

      Author response image 5.

      (4) Role of PKA and considerations about experiments performed in Fig. 5a and b

      To answer the question about the role of PKA, we believe it is a pivotal player. Our results indicate that PKA might promote CaV3.1, the entrance of calcium, and therefore, CAM Kinase pathway activation leading to CREB phosphorylation (Fig. 5). However, if the calcium is depleted, even a channel activation mediated by PKA cannot propagate the signal. For that reason, when we deplete calcium in wt cells as we do in the experiment performed in Figure 5B the activation of PKA alone cannot promote the CREB phosphorylation associated with a reduction of the FRET signal. As mentioned before, the FRET method gives a binary answer. It means either a higher or lower delta comparing time after forskolin to baseline. It cannot give stoichiometric info about the level of calcium and/or phosphorylation in the baseline. To that extent, the FRET experiment in Figure 5A cannot be connected to the experiment in Figure 5B. The method is the same, but the scientific questions are different. In Figure 5A we demonstrate that CDK5 plays a role in the PKA activation pathway. In Figure 5B we demonstrate that the general pathway needs calcium.

      We modified the text accordingly.

      (6) The presentation of the data in Figure 6 seems to be divergent from the rest of the data presentations. Please make it more consistent and also provide more explanations. Specifically, the authors suggest increased P-CREB nuclear localization (and an increase in phosphorylated PKA/CAMK) following shCDK5. Won't this lead to an increase in Per1, Dec1, cFos, and Sik1 basally (pre-light pulse)?

      We followed the reviewer's suggestion and present data in Figure 6 as done before in the manuscript. The reviewers should also consider our papers published before (Brenna et al., 2019; Brenna et al., 2021). In these papers, we demonstrate two important concepts that are in line with this manuscript. First, the lack of CDK5 promotes PER2 degradation and lack of nuclear translocation (Brenna et al., 2019). Second, PER2 plays a scaffold role in promoting the formation of the CREB transcriptional complex involved in the regulation of the expression of light-dependent genes (Brenna et al., 2021). Therefore, the take-home message here is that even if a lack of Cdk5 promotes a higher basal level of CREB phosphorylation, it also promotes PER2 degradation. Therefore, without PER2, the CREB-dependent gene expression is reduced. For this reason, we say that CDK5 gates phase shift (via PKA-CAM Kinases-CREB axis) of the circadian clock (via PER2).

      (7) The authors should discuss why calcium-sensitive phosphatases such as PP2A (PMID: 23752926) or calcineurin (PMID: 10217279) are not considered candidates for dephosphorylation of DARPP32 as these are described previously (CDK5) and conditions of increased calcium as seen here would favour these enzymes. The phospho-T75 data are supportive, but such additional discussion could be important given the past demonstrations.

      We thank the reviewers for the great insight. The pathway that promotes the T75 phosphorylation/dephosphorylation indeed includes many players as calcineurin and PPA2A. We mention this in the discussion now as follows:

      However, phosphatases such as PP2A and calcineurin, which de-phosphorylate DARPP32 including the Cdk5 phosphorylation site, may be involved in this process as well (Girault and Nairn, 2021). Upon light treatment and increase of Ca2+ these phosphatases would dephosphorylate DARPP32 and thereby inactivate it, leading to PKA activation. This process may occur in parallel to the Cdk5 regulation of DARPP32 contributing to a sustained activation of the light signaling pathway via PKA activation.

      (8) additional details on the knock-downs would be helpful: 

      - the relative amount of reduction in gene expression upon shRNA treatment should be provided  - How was the exact viral delivery and reduction in shRNA-induced knock-down confirmed for the individual animals?  

      The validation of Cdk5 knockdown was widely performed in the previous paper (Brenna et al., 2019, Fig2-Fig supp1, and Fig3-Fig suppl2). We used the same mice. We confirmed the goodness of the silencing also in the supp figure 1A of the current paper.

      (9) The authors only focus on male mice. This is rather incomplete, as it leaves away an important half of biological reality. Testing relevant aspects of the work in female mice would close this significant gap and also increase the number of biological replicates, which can still be considered relatively low. 

      We thank the reviewers for the suggestion. We injected female mice and performed the Ashoff type-II light pulse experiment at ZT14 and observe the same phenotype as for male mice. This is stated now in the paper and the data are shown in supplemental figure 1 e-f.

      (10) Given the roles of CdK5 in circadian clock period length regulation, but also light-induced phase delays, it would be interesting for a broader audience to discuss possible expectations of CdK5's roles, e.g. 

      (a) How will other circadian parameters, eg. activity bouts (numbers, length, activity onset/ offset) be affected? 

      (b) How does that relate to sleep, sleep phases? 

      (c) What is the expected impact on other physiological rhythms, eg food intake, cortisol levels? 

      (d) What are the expected effects on circadian oscillation of gene expression in other brain regions, organs? 

      We thank the reviewers for the observations. 

      a) The activity was discussed in the previous paper (Brenna et al. 2019). ShCdk5 mice show a reduced activity in both DD and LD 12:12 compared to wt, mirroring the Per2 brdm phenotype (Figure- Suppl3, with the difference mostly observed at night time (Figure 2-suppl4).

      We also demonstrate in Suppl Fig1 b, c of the current paper that light pulse does not affect the period length either in scramble mice or in sh Cdk5.

      b) We performed preliminary experiments with SCN shCdk5 knock-down animals and compared them to scr control mice using the Piezo sleep system. Total sleep was not different, however during the dark phase shCdk5 animals tended to sleep a bit more, similar to the neuronal Per2 KO animals (Wendrich et al., 2023 https://doi.org/10.3390/clockssleep5020017 ). After sleep-deprivation no differences were observed between shCdk5 and scr animals. This was comparable to the neuronal Per2 KO animals that also showed no phenotype after sleep deprivation.

      c) and d) We did not investigate food intake, cortisol, or other parameters involving peripheral clocks. We did not investigate the gene expression in other brain regions because the SCN is the main brain region involved in the regulation of the circadian clock phase shift. However future studies will address these questions.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review): 

      Summary: 

      Campbell et al investigated the effects of light on the human brain, in particular the subcortical part of the hypothalamus during auditory cognitive tasks. The mechanisms and neuronal circuits underlying light effects in non-image forming responses are so far mostly studied in rodents but are not easily translated in humans. Therefore, this is a fundamental study aiming to establish the impact light illuminance has on the subcortical structures using the high-resolution 7T fMRI. The authors found that parts of the hypothalamus are differently responding to illuminance. In particular, they found that the activity of the posterior hypothalamus increases while the activity of the anterior and ventral parts of the hypothalamus decreases under high illuminance. The authors also report that the performance of the 2-back executive task was significantly better in higher illuminance conditions. However, it seems that the activity of the posterior hypothalamus subpart is negatively related to the performance of the executive task, implying that it is unlikely that this part of the hypothalamus is directly involved in the positive impact of light on performance observed. Interestingly, the activity of the posterior hypothalamus was, however, associated with an increased behavioural response to emotional stimuli. This suggests that the role of this posterior part of the hypothalamus is not as simple regarding light effects on cognitive and emotional responses. This study is a fundamental step towards our better understanding of the mechanisms underlying light effects on cognition and consequently optimising lighting standards. 

      Strengths: 

      While it is still impossible to distinguish individual hypothalamic nuclei, even with the highresolution fMRI, the authors split the hypothalamus into five areas encompassing five groups of hypothalamic nuclei. This allowed them to reveal that different parts of the hypothalamus respond differently to an increase in illuminance. They found that higher illuminance increased the activity of the posterior part of the hypothalamus encompassing the MB and parts of the LH and TMN, while decreasing the activity of the anterior parts encompassing the SCN and another part of TMN. These findings are somewhat in line with studies in animals. It was shown that parts of the hypothalamus such as SCN, LH, and PVN receive direct retinal input in particular from ipRGCs. Also, acute chemogenetic activation of ipRGCs was shown to induce activation of LH and also increased arousal in mice. 

      Weaknesses: 

      While the light characteristics are well documented and EDI calculated for all of the photoreceptors, it is not very clear why these irradiances and spectra were chosen. It would be helpful if the authors explained the logic behind the four chosen light conditions tested. Also, the lights chosen have cone-opic EDI values in a high correlation with the melanopic EDI, therefore we can't distinguish if the effects seen here are driven by melanopsin and/or other photoreceptors. In order to provide a more mechanistic insight into the light-driven effects on cognition ideally one would use a silent substitution approach to distinguish between different photoreceptors. This may be something to consider when designing the follow-up studies. 

      Reviewer #1 (Recommendations For The Authors): 

      (1) As suggested in the public review more information regarding the reasons behind the chosen light condition is needed. 

      While the light characteristics are well documented and EDI calculated for all of the photoreceptors, it is not very clear why these irradiances and spectra were chosen. It would be helpful if the authors explained the logic behind the four chosen light conditions tested. Also, the lights chosen have cone-opic EDI values in a high correlation with the melanopic EDI, therefore we can't distinguish if the effects seen here are driven by melanopsin or cone opsins. In order to provide a more mechanistic insight into the light-driven effects on cognition ideally one would use a silent substitution approach to distinguish between different photoreceptors. 

      (2) In support of this work, it was shown in mice that acute activation of ipRGCs using chemogenetics induces c-fos in some of the hypothalamic brain areas discussed here including LH (Milosavljevic et al, 2016 Curr Biol). Another study to consider including in the discussion is by Sonoda et al 2020 Science, in which the authors showed that a subset of ipRGCs release GABA. 

      (3) Figure 1 looks squashed, especially the axes. Also, Figure 2 looks somewhat blurry. I would suggest that the authors edit the figures to correct this.

      We thank the reviewer for their positive comments and agree with the weaknesses they pointed out. 

      (1) The explanation regarding the choice of the illuminance is now included in the revised manuscript (PAGE 17): “Blue-enriched light illuminances were set according to the technical characteristics of the light source and to keep the overall photon flux similar to prior 3T MRI studies of our team (between ~1012 and 1014 ph/cm²/s) (Vandewalle et al., 2010, 2011). The orange light was introduced as a control visual stimulation for potential secondary whole-brain analyses. For the present region of interest analyses, we discarded colour differences between the light conditions and only considered illuminance as indexed by mel EDI lux. This constitutes a limitation of our study as it does not allow attributing the findings to a particular photoreceptor class.”

      The revised discussion makes clear that these choices limit the interpretation about the photoreceptors involved (PAGES 12-13): “We based our rationale and part of our interpretations on ipRGC projections, which have been demonstrated in rodents to channel the NIF biological impact of light and incorporate the inputs from rods and cones with their intrinsic photosensitivity into a light signal that can impact the brain (Güler et al., 2008; Tri & Do, 2019). Given the polychromatic nature of the light we used, classical photoreceptors and their projections to visual brain areas are, however, very likely to have directly or indirectly contributed to the modulation by light of the regional activity of the hypothalamus.”

      The discussion also points out the promises of silent substitution (PAGE 13): “Future human studies could isolate the contribution of each photoreceptor class to the impact of light on cognitive brain functions by manipulating prior light history (Chellappa et al., 2014) or through the use of silent substitutions between metameric light exposures (Viénot et al., 2012)”.

      (2) We now refer to the studies by Milosavljevic et al. and Sonoda et al. 

      PAGE 9: “Our data may therefore be compatible with an increase in orexin release by the LH with increasing illuminance. In line with this assumption, chemoactivation of ipRGCs lead to increase c-fos production, a marker of cellular activation, over several nuclei of the hypothalamus, including the lateral hypothalamus (Milosavljevic et al., 2016). If this initial effect of light we observe over the posterior part of the hypothalamus was maintained over a longer period of exposure, this would stimulate cognition and maintain or increase alertness (Campbell et al., 2023) and may also be part of the mechanisms through which daytime light increases the amplitude in circadian variations of several physiological features (BanoOtalora et al., 2021; Dijk et al., 2012).”

      PAGE 10: “Chemoactivation of ipRGCs in rodents led to an increase activity of the SCN, over the inferior anterior hypothalamus, but had no impact on the activity of the VLPO, over the superior anterior hypothalamus (Milosavljevic et al., 2016). How our findings fit with these fine-grained observations and whether there are species-specific differences in the responses to light over the different part of the hypothalamus remains to be established.”

      PAGE 10: “In terms of chemical communication, these changes in activity could be the results of an inhibitory signal from a subclass of ipRGCs, potentially through the release aminobutyric acid (GABA), as a rodent study found that a subset of ipRGCs release GABA at brain targets including the SCN (and intergeniculate leaflet and ventral lateral geniculate nucleus), leading to a reduction in the ability of light to affect pupil size and circadian photoentrainment (Sonoda et al., 2020). Whatever the signalling of ipRGC, our finding over the anterior hypothalamus could correspond to a modification of GABA signalling of the SCN which has been reported to have excitatory properties, such that the BOLD signal changes we report may correspond to a reduction in excitation arising in part from the SCN (Albers et al., 2017).”

      (3) Figures 1 and 2 were modified. We hope their quality is now satisfactory. We are willing to provide separate figures prior to publication of the Version of Record.

      Reviewer #2 (Public Review): 

      Summary 

      The interplay between environmental factors and cognitive performance has been a focal point of neuroscientific research, with illuminance emerging as a significant variable of interest. The hypothalamus, a brain region integral to regulating circadian rhythms, sleep, and alertness, has been posited to mediate the effects of light exposure on cognitive functions. Previous studies have illuminated the role of the hypothalamus in orchestrating bodily responses to light, implicating specific neural pathways such as the orexin and histamine systems, which are crucial for maintaining wakefulness and processing environmental cues. Despite advancements in our understanding, the specific mechanisms through which varying levels of light exposure influence hypothalamic activity and, in turn, cognitive performance, remain inadequately explored. This gap in knowledge underscores the need for high-resolution investigations that can dissect the nuanced impacts of illuminance on different hypothalamic regions. Utilizing state-of-the-art 7 Tesla functional magnetic resonance imaging (fMRI), the present study aims to elucidate the differential effects of light on the hypothalamic dynamics and establish a link between regional hypothalamic activity and cognitive outcomes in healthy young adults. By shedding light on these complex interactions, this research endeavours to contribute to the foundational knowledge necessary for developing innovative therapeutic strategies aimed at enhancing cognitive function through environmental modulation. 

      Strengths: 

      (1) Considerable Sample Size and Detailed Analysis: The study leverages a robust sample size and conducts a thorough analysis of hypothalamic dynamics, which enhances the reliability and depth of the findings. 

      (2) Use of High-Resolution Imaging: Utilizing 7 Tesla fMRI to analyze brain activity during cognitive tasks offers high-resolution insights into the differential effects of illuminance on hypothalamic activity, showcasing the methodological rigor of the study. 

      (3) Novel Insights into Illuminance Effects: The manuscript reveals new understandings of how different regions of the hypothalamus respond to varying illuminance levels, contributing valuable knowledge to the field. 

      (4) Exploration of Potential Therapeutic Applications: Discussing the potential therapeutic applications of light modulation based on the findings suggests practical implications and future research directions. 

      Weaknesses: 

      (1) Foundation for Claims about Orexin and Histamine Systems: The manuscript needs to provide a clearer theoretical or empirical foundation for claims regarding the impact of light on the orexin and histamine systems in the abstract. 

      (2) Inclusion of Cortical Correlates: While focused on the hypothalamus, the manuscript may benefit from discussing the role of cortical activation in cognitive performance, suggesting an opportunity to expand the scope of the manuscript. 

      (3) Details of Light Exposure Control: More detailed information about how light exposure was controlled and standardized is needed to ensure the replicability and validity of the experimental conditions. 

      (4) Rationale Behind Different Exposure Protocols: To clarify methodological choices, the manuscript should include more in-depth reasoning behind using different protocols of light exposure for executive and emotional tasks. 

      Reviewer #2 (Recommendations For The Authors): 

      Attention to English language precision and correction of typographical errors, such as "hypothalamic nuclei" instead of "hypothalamus nuclei," is necessary for enhancing the manuscript.

      We thank the reviewer for recognising the interest and strength of our study.

      (1) As detailed in the discussion, we do believe orexin and histamine are excellent candidates for mediating the results we report. As also pointing out, however, we are in no position to know which neurons, nuclei, neurotransmitter and neuromodulator underlie the results. The last sentence of the abstract (PAGE 2) was therefore removed as we agree the statement was too strong. We carefully reconsider the discussion and believe that no such overstatement was present.

      (2) Hypothalamus nuclei are connected to multiple cortical (and subcortical) structures. The relevance of these projections will vary with the cognitive task considered. In addition, we have not yet considered the cortex in our analyses such that truly integrating cortical structures appears premature. 

      We nevertheless added the following short statement (PAGE 11): “Subcortical structures, and particularly those receiving direct retinal projections, including those of the hypothalamus, are likely to receive light illuminance signal first before passing on the light modulation to the cortical regions involved in the ongoing cognitive process (Campbell et al., 2023).”

      (3) We now include the following as part of the method section (PAGES 16-17): “Illuminance and spectra could not be directly measured within the MRI scanner due to the ferromagnetic nature of measurement systems. The coil of the MRI and the light stand, together with the lighting system were therefore placed outside of the MR room to reproduce the experimental conditions of the in a completely dark room. A sensor was placed 2 cm away from the mirror of the coil that is mounted at eye level, i.e. where the eye of the first author of the paper would be positioned, to measure illuminance and spectra. The procedure was repeated 4 times for illuminance and twice for spectra and measurements were averaged. This procedure does not take into account interindividual variation in head size and orbit shape such that the reported illuminance levels may have varied slightly across subjects. The relative differences between illuminance are, however, very unlikely to vary substantially across participants such that statistics consisting of tests for the impact of relative differences in illuminance were not affected. The detailed values reported in Supplementary Table 2 were computed combining spectra and illuminance using the excel calculator associated with a published work (Lucas et al., 2014).”

      (4) The explanation regarding the choice of the illuminance is now included in the revised manuscript (PAGE 17): “Blue-enriched light illuminances were set according to the technical characteristics of the light source and to keep the overall photon flux similar to prior 3T MRI studies of our team (between ~1012 and 1014 ph/cm²/s) (Vandewalle et al., 2010, 2011). The orange light was introduced as a control visual stimulation for potential secondary whole-brain analyses. For the present region of interest analyses, we discarded colour differences between the light conditions and only considered illuminance as indexed by mel EDI lux. This constitutes a limitation of our study as it does not allow attributing the findings to a particular photoreceptor class.”

      (5) The manuscript was thoroughly rechecked, and we hope to have spotted all typos and language errors.

      Reviewer #3 (Public Review): 

      Summary: 

      Campbell and colleagues use a combination of high-resolution fMRI, cognitive tasks, and different intensities of light illumination to test the hypothesis that the intensity of illumination differentially impacts hypothalamic substructures that, in turn, promote alterations in arousal that affect cognitive and affective performance. The authors find evidence in support of a posterior-to-anterior gradient of increased blood flow in the hypothalamus during task performance that they later relate to performance on two different tasks. The results provide an enticing link between light levels, hypothalamic activity, and cognitive/affective function, however, clarification of some methodological choices will help to improve confidence in the findings. 

      Strengths: 

      * The authors' focus on the hypothalamus and its relationship to light intensity is an important and understudied question in neuroscience. 

      Weaknesses: 

      (1) I found it challenging to relate the authors' hypotheses, which I found to be quite compelling, to the apparatus used to test the hypotheses - namely, the use of orange light vs. different light intensities; and the specific choice of the executive and emotional tasks, which differed in key features (e.g., block-related vs. event-related designs) that were orthogonal to the psychological constructs being challenged in each task. 

      (4) Given the small size of the hypothalamus and the irregular size of the hypothalamic parcels, I wondered whether a more data-driven examination of the hypothalamic time series would have provided a more parsimonious test of their hypothesis. 

      Reviewer #3 (Recommendations For The Authors): 

      (1) The authors may wish to explain the importance of the orange light condition in the early section of the results -- i.e., when they first present the task structure. As it stands, I don't have a good appreciation of why the orange light was included -- was it a control condition? And if the differences between the light conditions (e.g., the narrow- vs. wide-band of light) were indeed ignored by focussing on the illuminance levels, are there any potential issues that the authors could then mitigate against with further experiments/analyses? 

      (2) Are there other explanations for why illuminance levels might improve cognitive performance? For instance, the capacity to more easily perceive the stimuli in an experiment could plausibly make it easier to complete a given task. If this is the case, can the authors conceptualise a way to rule out this hypothesis? 

      (3) Did the authors control for the differences in the number of voxels in each hypothalamic subregion? Or perhaps consider estimating the variance across voxels within the larger parcels, to determine whether the mean time series was comparable to the time series of the smaller parcels? 

      (4) An alternative strategy that would mitigate against the differences in the size of hypothalamic parcels would be to conduct analyses on the hypothalamus without parcellation, but instead using dimensionality reduction techniques to observe the natural spread of responses across the hypothalamus. From the authors' results, my intuition is that these analyses will lead to similar conclusions, albeit without any of the potential issues with respect to differently-sized parcels. 

      We thank the reviewer for acknowledging the originality and interest of our study. We agree that some methodological choices needed more explanation. We will address the weaknesses they pointed out as follows:

      (1) The explanation regarding the choice of the illuminance is now included in the revised manuscript (PAGE 17): “Blue-enriched light illuminances were set according to the technical characteristics of the light source and to keep the overall photon flux similar to prior 3T MRI studies of our team (between ~1012 and 1014 ph/cm²/s) (Vandewalle et al., 2010, 2011). The orange light was introduced as a control visual stimulation for potential secondary whole-brain analyses. For the present region of interest analyses, we discarded colour differences between the light conditions and only considered illuminance as indexed by mel EDI lux. This constitutes a limitation of our study as it does not allow attributing the findings to a particular photoreceptor class.”

      The revised discussion makes clear that these choices limit the interpretation about the photoreceptors involved (PAGE 12-13): “We based our rationale and part of our interpretations on ipRGC projections, which have been demonstrated in rodents to channel the NIF biological impact of light and incorporate the inputs from rods and cones with their intrinsic photosensitivity into a light signal that can impact the brain (Güler et al., 2008; Tri & Do, 2019). Given the polychromatic nature of the light we used, classical photoreceptors and their projections to visual brain areas are, however, very likely to have directly or indirectly contributed to the modulation by light of the regional activity of the hypothalamus.”

      We further mention that (PAGE 13): “Furthermore, we cannot exclude that colour and/or spectral differences between the orange and 3 blue-enriched light conditions may have contributed to our findings. Research in rodent model demonstrated that variation in the spectral composition of light was perceived by the suprachiasmatic nucleus to set circadian timing (Walmsley et al., 2015). No such demonstration has, however, been reported yet for the acute impact of light on alertness, attention, cognition or affective state.”

      Regarding the choice of tasks, we added the following the method section (PAGE 18): “Prior work of our team showed that the n-back task and emotional task included in the present protocol were successful probes to demonstrate that light illuminance modulates cognitive activity, including within subcortical structures (though resolution did not allow precise isolation of nuclei or subparts) (e.g. (Vandewalle et al., 2007, 2010)). When taking the step of ultra-high-field imaging, we therefore opted for these tasks as our goal was to show that illuminance affects brain activity across cognitive domains while not testing for task-specific aspects of these domains.”

      We further added to the discussion (PAGE 8): “The pattern of light-induced changes was consistent across an executive and an emotional task which consisted of block and an event-related fMRI design, respectively. This suggests that a robust anterior-posterior gradient of activity modulation by illuminance is present in hypothalamus across cognitive domains.”

      (2) We are unsure what the reviewer refers to when he states that the experiment could make it easier to perceive a stimulus. Aside from the fact that illuminance can increase alertness and attention such that a stimulus may be better or more easily perceived/processed, we do not see how blocks of ambient light, i.e. a long-lasting visual stimulus, may render auditory stimulation (letters or pseudo-words in the present) easier to perceive. To our knowledge multimodal or cross-modal integration has been robustly demonstrated for short visual/auditory cues that would precede or accompany auditory/visual stimulation. 

      We are willing to clarify this issue in the text if we receive additional explanation from the reviewer.

      (3) We added subpart size as covariate in the analyses (instead of subpart number) and it did not affect the output of the statistical analyses (Author response table 1). 

      For completeness, we further computed standard deviation of the activity estimates of the voxels within each parcel for the main analysis of the n-back tasks and found a main effect of subpart (Author response table 2) indicating that the variability of the estimates varied across subparts. Post hoc contrast and the display included in Author response image1 show however that the difference were not related to subpart size per see. It is in fact the largest subpart (subpart 4) that shows the largest variability while one of the smallest subpart (subpart 2) shows the lowest variability. Though it may have contributed, it is therefore unlikely to explain our findings. We consider the analyses reported in (Author response table 1 and 2 and (Author response image 1 as very technical and did not include it in the supplementary material for conciseness. If the reviewer judges it essential, we can reconsider our decision.  

      While computing these analyses, we realized that there were errors in the table 1 reporting the statistical outcomes of the main analyses of the emotional task. The main statistical outputs remain the same except for a nominal main effect of the task (emotional vs. neutral) and the fact that post hoc show a consistent difference between the posterior subpart (subpart 3) and all the other subparts, rather than all the other subparts except for the difference with superior tubular hypothalamus subpart: p-corrected = 0.09. We apologise for this slight error and were unable to isolate its origin. It does not modify the rest of the analyses (which were also rechecked) and the interpretations. 

      Author response table 1.

      Recomputations of the main GLMMs using subpart sizes rather than subpart numbers as covariate of interest.

      Author response image 1.

      Activity estimate variability per hypothalamus subpart and subpart size.  

      Author response table 2.

      Difference in activity estimate standard deviation between hypothalamus subparts during the n-back task.

      Outputs of the generalized linear mixed model (GLMM) with subject as the random factor (intercept and slope), and task and subpart as repeated measures (ar(1) autocorrelation).

      * The corrected p-value for multiple comparisons over 2 tests is p < 0.025.

      # Refer to Fig.2A for correspondence of subpart numbers

      The text referring to Table 1 was modified accordingly (PAGE 5): “A nominal main effect of the task was detected for the emotional task [p = 0.049; Table 1] but not for the n-back task. For both tasks, there was no significant main effect for any of the other covariates and post hoc analyses showed that the index of the illuminance impact was consistently different in the posterior hypothalamus subpart compared to the other subparts [pcorrected ≤ 0.05]”.

      (4) We agree that a data driven approach could have constituted an alternative means to tests our hypothesis. We opted for an approach that we mastered best, while still allowing to conclusively test for regional differences in activity across the hypothalamus. Examination of time series of the very same data we used will mainly confirm the results of our analyses – an anterior-posterior gradient in the impact of illuminance - while it may yield slight differences in the boarders of the subparts of the hypothalamus undergoing decreased or increased activity with increasing illuminance. While the suggested approach may have been envisaged if we had been facing negative results (i.e. no differences between subparts, potentially because subparts would not reflect functional differences in response to illuminance change), it would constitute a circular confirmation of our main findings (i.e. using the same data). While we truly appreciate the suggestion, we do not consider that it would constitute a more parsimonious test of our hypothesis, now that we successfully applied GLM/parcellation and GLMM approaches.

      We added the following statement to the discussion to take this comment into account (PAGE 12): “Future research may consider data-driven analyses of hypothalamus voxels time series as an alternative to the parcellation approach we adopted here. This may refine the delineation of the subparts of the hypothalamus undergoing decreased or increased activity with increasing illuminance.”

      Response references

      Albers, H. E., Walton, J. C., Gamble, K. L., McNeill, J. K., & Hummer, D. L. (2017). The dynamics of GABA signaling: Revelations from the circadian pacemaker in the suprachiasmatic nucleus. Frontiers in Neuroendocrinology, 44, 35–82. https://doi.org/10.1016/J.YFRNE.2016.11.003

      Bano-Otalora, B., Martial, F., Harding, C., Bechtold, D. A., Allen, A. E., Brown, T. M., Belle, M. D. C., & Lucas, R. J. (2021). Bright daytime light enhances circadian amplitude in a diurnal

      mammal. Proceedings of the National Academy of Sciences of the United States of America, 118(22), e2100094118. https://doi.org/10.1073/PNAS.2100094118/SUPPL_FILE/PNAS.2100094118.SAPP.PDF

      Campbell, I., Sharifpour, R., & Vandewalle, G. (2023). Light as a Modulator of Non-Image-Forming Brain Functions Positive and Negative Impacts of Increasing Light Availability. Clocks & Sleep, 5(1), 116. https://doi.org/10.3390/CLOCKSSLEEP5010012

      Chellappa, S. L., Ly, J. Q. M., Meyer, C., Balteau, E., Degueldre, C., Luxen, A., Phillips, C., Cooper, H. M., & Vandewalle, G. (2014). Photic memory for executive brain responses. Proceedings of the National Academy of Sciences of the United States of America, 111(16), 6087–6091. https://doi.org/10.1073/pnas.1320005111

      Dijk, D. J., Duffy, J. F., Silva, E. J., Shanahan, T. L., Boivin, D. B., & Czeisler, C. A. (2012). Amplitude reduction and phase shifts of melatonin, cortisol and other circadian rhythms after a gradual advance of sleep and light exposure in humans. PloS One, 7(2). https://doi.org/10.1371/JOURNAL.PONE.0030037

      Güler, A. D., Ecker, J. L., Lall, G. S., Haq, S., Altimus, C. M., Liao, H. W., Barnard, A. R., Cahill, H., Badea, T. C., Zhao, H., Hankins, M. W., Berson, D. M., Lucas, R. J., Yau, K. W., & Hattar, S. (2008). Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature, 453(7191), 102–105. https://doi.org/10.1038/nature06829

      Lucas, R. J., Peirson, S. N., Berson, D. M., Brown, T. M., Cooper, H. M., Czeisler, C. A., Figueiro, M. G., Gamlin, P. D., Lockley, S. W., O’Hagan, J. B., Price, L. L. A., Provencio, I., Skene, D. J., & Brainard, G. C. (2014). Measuring and using light in the melanopsin age. Trends in Neurosciences, 37(1), 1–9. https://doi.org/10.1016/j.tins.2013.10.004

      Milosavljevic, N., Cehajic-Kapetanovic, J., Procyk, C. A., & Lucas, R. J. (2016). Chemogenetic Activation of Melanopsin Retinal Ganglion Cells Induces Signatures of Arousal and/or Anxiety in Mice. Current Biology, 26(17), 2358–2363. https://doi.org/10.1016/j.cub.2016.06.057

      Sonoda, T., Li, J. Y., Hayes, N. W., Chan, J. C., Okabe, Y., Belin, S., Nawabi, H., & Schmidt, T. M. (2020). A noncanonical inhibitory circuit dampens behavioral sensitivity to light. Science (New York, N.Y.), 368(6490), 527–531. https://doi.org/10.1126/SCIENCE.AAY3152

      Tri, M., & Do, H. (2019). Melanopsin and the Intrinsically Photosensitive Retinal Ganglion Cells: Biophysics to Behavior. Neuron, 104, 205–226. https://doi.org/10.1016/j.neuron.2019.07.016

      Vandewalle, G., Hébert, M., Beaulieu, C., Richard, L., Daneault, V., Garon, M. Lou, Leblanc, J., Grandjean, D., Maquet, P., Schwartz, S., Dumont, M., Doyon, J., & Carrier, J. (2011). Abnormal hypothalamic response to light in seasonal affective disorder. Biological Psychiatry, 70(10), 954–961. https://doi.org/10.1016/j.biopsych.2011.06.022

      Vandewalle, G., Schmidt, C., Albouy, G., Sterpenich, V., Darsaud, A., Rauchs, G., Berken, P. Y., Balteau, E., Dagueldre, C., Luxen, A., Maquet, P., & Dijk, D. J. (2007). Brain responses to violet, blue, and green monochromatic light exposures in humans: Prominent role of blue light and the brainstem. PLoS ONE, 2(11), e1247. https://doi.org/10.1371/journal.pone.0001247

      Vandewalle, G., Schwartz, S., Grandjean, D., Wuillaume, C., Balteau, E., Degueldre, C., Schabus, M., Phillips, C., Luxen, A., Dijk, D. J., & Maquet, P. (2010). Spectral quality of light modulates emotional brain responses in humans. Proceedings of the National Academy of Sciences of the United States of America, 107(45), 19549–19554. https://doi.org/10.1073/pnas.1010180107

      Viénot, F., Brettel, H., Dang, T.-V., & Le Rohellec, J. (2012). Domain of metamers exciting intrinsically photosensitive retinal ganglion cells (ipRGCs) and rods. Journal of the Optical Society of America A, 29(2), A366. https://doi.org/10.1364/josaa.29.00a366

      Walmsley, L., Hanna, L., Mouland, J., Martial, F., West, A., Smedley, A. R., Bechtold, D. A., Webb, A. R., Lucas, R. J., & Brown, T. M. (2015). Colour As a Signal for Entraining the Mammalian Circadian Clock. PLOS Biology, 13(4), e1002127. https://doi.org/10.1371/journal.pbio.1002127

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The aim of this paper is to describe a novel method for genetic labelling of animals or cell populations, using a system of DNA/RNA barcodes.

      Strengths:

      • The author's attempt at providing a straightforward method for multiplexing Drosophila samples prior to scRNA-seq is commendable. The perspective of being able to load multiple samples on a 10X Chromium without antibody labelling is appealing.

      • The authors are generally honest about potential issues in their method, and areas that would benefit from future improvement.

      • The article reads well. Graphs and figures are clear and easy to understand.

      We thank the reviewer for these positive comments.

      Weaknesses:

      • The usefulness of TaG-EM for phototaxis, egg laying or fecundity experiments is questionable. The behaviours presented here are all easily quantifiable, either manually or using automated image-based quantification, even when they include a relatively large number of groups and replicates. Despite their claims (e.g., L311-313), the authors do not present any real evidence about the cost- or time-effectiveness of their method in comparison to existing quantification methods.

      While the behaviors that were quantified in the original manuscript were indeed relatively easy to quantify through other methods, they nonetheless demonstrated that sequencing-based TaG-EM measurements faithfully recapitulated manual behavioral measurements. In response to the reviewer’s comment, we have added additional experiments that demonstrate the utility of TaG-EM-based behavioral quantification in the context of a more labor-intensive phenotypic assay (measuring gut motility via food transit times in Drosophila larvae, Figure 4, Supplemental Figure 7). We found that food transit times in the presence and absence of caffeine are subtly different and that, as with larger effect size behaviors, TaG-EM data recapitulates the results of the manual assay. This experiment demonstrates both that TaG-EM can be used to streamline labor-intensive behavioral assays (we have included an estimate of the savings in hands-on labor for this assay by using a multiplexed sequencing approach, Supplemental Figure 8) and that TaG-EM can quantify small differences between experimental groups. We also note in the discussion that an additional benefit of TaGEM-based behavioral assays is that the observed is blinded as to the experimental conditions as they are intermingled in a single multiplexed assay. We have added the following text to the paper describing these experiments.

      Results:

      “Quantifying food transit time in the larval gut using TaG-EM

      Gut motility defects underlie a number of functional gastrointestinal disorders in humans (Keller et al., 2018). To study gut motility in Drosophila, we have developed an assay based on the time it takes a food bolus to transit the larval gut (Figure 4A), similar to approaches that have been employed for studying the role of the microbiome in human gut motility (Asnicar et al., 2021). Third instar larvae were starved for 90 minutes and then fed food containing a blue dye. After 60 minutes, larvae in which a blue bolus of food was visible were transferred to plates containing non-dyed food, and food transit (indicated by loss of the blue food bolus) was scored every 30 minutes for five hours (Supplemental Figure 7). 

      Because this assay is highly labor-intensive and requires hands-on effort for the entire five-hour observation period, there is a limit on how many conditions or replicates can be scored in one session (~8 plates maximum). Thus, we decided to test whether food transit could be quantified in a more streamlined and scalable fashion by using TaG-EM (Figure 4B). Using the manual assay, we observed that while caffeinecontaining food is aversive to larvae, the presence of caffeine reduces transit time through the gut (Figure 4C, Supplemental Figure 7). This is consistent with previous observations in adult flies that bitter compounds (including caffeine) activate enteric neurons via serotonin-mediated signaling and promote gut motility (Yao and Scott, 2022). We tested whether TaG-EM could be used to measure the effect of caffeine on food transit time in larvae. As with prior behavioral tests, the TaG-EM data recapitulated the results seen in the manual assay (Figure 4D). Conducting the transit assay via TaGEM enables several labor-saving steps. First, rather than counting the number of larvae with and without a food bolus at each time point, one simply needs to transfer nonbolus-containing larvae to a collection tube. Second, because the TaG-EM lines are genetically barcoded, all the conditions can be tested at once on a single plate, removing the need to separately count each replicate of each experimental condition. This reduces the hands-on time for the assay to just a few minutes per hour.  A summary of the anticipated cost and labor savings for the TaG-EM-based food transit assay is shown in Supplemental Figure 8.”

      Discussion:

      “While the utility of TaG-EM barcode-based quantification will vary based on the number of conditions being analyzed and the ease of quantifying the behavior or phenotype by other means, we demonstrate that TaG-EM can be employed to cost-effectively streamline labor-intensive assays and to quantify phenotypes with small effect sizes (Figure 4, Supplemental Figure 8). An additional benefit of multiplexed TaG-EM behavioral measurements is that the experimental conditions are effectively blinded as the multiplexed conditions are intermingled in a single assay.”

      Methods:

      “Larval gut motility experiments

      Preparing Yeast Food Plates

      Yeast agar plates were prepared by making a solution containing 20% Red Star Active Dry Yeast 32oz (Red Star Yeast) and 2.4% Agar Powder/Flakes (Fisher) and a separate solution containing 20% Glucose (Sigma-Aldrich). Both mixtures were autoclaved with a 45-minute liquid cycle and then transferred to a water bath at 55ºC. After cooling to 55ºC, the solutions were combined and mixed, and approximately 5 mL of the combined solution was transferred into 100 x 15 mm petri dishes (VWR) in a PCR hood or contamination-free area. For blue-dyed yeast food plates, 0.4% Blue Food Color (McCormick) was added to the yeast solution. For the caffeine assays, 300 µL of a solution of 100 mM 99% pure caffeine (Sigma-Aldrich) was pipetted onto the blue-dyed yeast plate and allowed to absorb into the food during the 90-minute starvation period.

      Manual Gut Motility Assay

      Third instar Drosophila larvae were transferred to empty conical tubes that had been misted with water to prevent the larvae from drying out. After a 90-minute starvation period the larvae were moved from the conical to a blue-dyed yeast plate with or without caffeine and allowed to feed for 60 minutes. Following the feeding period, the larvae were transferred to an undyed yeast plate. Larvae were scored for the presence or absence of a food bolus every 30 minutes over a 5-hour period. Up to 8 experimental replicates/conditions were scored simultaneously. 

      TaG-EM Gut Motility Assay

      Third instar larvae were starved and fed blue dye-containing food with or without caffeine as described above. An equal number of larvae from each experimental condition/replicate were transferred to an undyed yeast plate. During the 5-hour observation period, larvae were examined every 30 minutes and larvae lacking a food bolus were transferred to a microcentrifuge tube labeled for the timepoint. Any larvae that died during the experiment were placed in a separate microcentrifuge tube and any larvae that failed to pass the food bolus were transferred to a microcentrifuge tube at the end of the experiment. DNA was extracted from the larvae in each tube and TaG-EM barcode libraries were prepared and sequenced as described above.”

      • Behavioural assays presented in this article have clear outcomes, with large effect sizes, and therefore do not really challenge the efficiency of TaG-EM. By showing a Tmaze in Fig 1B, the authors suggest that their method could be used to quantify more complex behaviours. Not exploring this possibility in this manuscript seems like a missed opportunity.

      See the response to the previous point.

      • Experiments in Figs S3 and S6 suggest that some tags have a detrimental effect on certain behaviours or on GFP expression. Whereas the authors rightly acknowledge these issues, they do not investigate their causes. Unfortunately, this question the overall suitability of TaG-EM, as other barcodes may also affect certain aspects of the animal's physiology or behaviour. Revising barcode design will be crucial to make sure that sequences with potential regulatory function are excluded.

      We have determined that the barcode (BC#8) that had no detectable Gal4induced gene expression in Figure S6 (now Supplemental Figure 9) has a deletion in the GFP coding region that ablates GFP function. Interestingly, the expressed TaG-EM barcode transcript is still detectable in single cell sequencing experiments, but obviously this line cannot be used for cell enrichment (at least based solely on GFP expression from the TaG-EM construct). While it is unclear how this line came to have a lesion in the GFP gene, we have subsequently generated >150 additional TaG-EM stocks and we have tested the GFP expression of these newly established stocks by crossing them to Mhc-Gal4. All of the additional stocks had GFP expression in the expected pattern, indicating that the BC#8 construct is an outlier with respect to inducibility of GFP. We have added the following text to the results section to address this point:

      “No GFP expression was visible for TaG-EM barcode number 8, which upon molecular characterization had an 853 bp deletion within the GFP coding region (data not shown). We generated and tested GFP expression of an additional 156 TaG-EM barcode lines (Alegria et al., 2024), by crossing them to Mhc-Gal4 and observing expression in the adult thorax. All 156 additional TaG-EM lines had robust GFP expression (data not shown).”

      It is certainly the case that future improvements to the construct design may be necessary or desirable and that back-crossing could likely be used to alleviate line-toline differences for specific phenotypes, we also address this point in the discussion with the following text:

      “We excluded this poor performing barcode line from the fecundity tests, however, backcrossing is often used to bring reagents into a consistent genetic background for behavioral experiments and could also potentially be used to address behavior-specific issues with specific TaG-EM lines. In addition, other strategies such as averaging across multiple barcode lines or permutation of barcode assignment across replicates could also mitigate such deficiencies.”

      • For their single-cell experiments, the authors have used the 10X Genomics method, which relies on sequencing just a short segment of each transcript (usually 50-250bp - unknown for this study as read length information was not provided) to enable its identification, with the matching paired-end read providing cell barcode and UMI information (Macosko et al., 2015). With average fragment length after tagmentation usually ranging from 300-700bp, a large number of GFP reads will likely not include the 14bp TaG-EM barcode. 

      The 10x Genomics 3’ workflows that were used for sequencing TaG-EM samples reads the cell barcode and UMI in read one and the expressed RNA sequence in read two. We sequenced the samples shown in Figure 5 in the initial manuscript using a run configuration that generated 150 bp for read two. The TaG-EM barcodes are located just upstream of the poly-adenylation sites (based on the sequencing data, we observe two different poly-A sites and the TaG-EM barcode is located 35 and 60 bp upstream of these sites). Based on the location of the TaG-EM barcodes,150 bp reads is sufficient to see the barcode in any GFP-associated read (when using the 3’ gene expression workflow). In addition to detecting the expression of the TaG-EM barcodes in the 10x Genomics gene expression library, it is possible to make a separate library that enriches the barcode sequence (similar to hashtag or CITE-Seq feature barcode libraries). We have added experimental data where we successfully performed an enrichment of the TaG-EM barcodes and sequenced this as a separate hashtag library (Supplemental Figure 18). We have added text to the results describing this work and also included a detailed information in the methods for performing TaG-EM barcode enrichment during 10x library prep. 

      Results:

      “In antibody-conjugated oligo cell hashing approaches, sparsity of barcode representation is overcome by spiking in an additional primer at the cDNA amplification step and amplifying the hashtag oligo by PCR. We employed a similar approach to attempt to enrich for TaG-EM barcodes in an additional library sequenced separately from the 10x Genomics gene expression library. Our initial attempts at barcode enrichment using spike-in and enrichment primers corresponding to the TaG-EM PCR handle were unsuccessful (Supplemental Figure 18). However, we subsequently optimized the TaG-EM barcode enrichment by 1) using a longer spike-in primer that more closely matches the annealing temperature used during the 10x Genomics cDNA creation step, and 2) using a nested PCR approach to amplify the cell-barcode and unique molecular identifier (UMI)-labeled TaG-EM barcodes (Supplemental Figure 18). Using the enriched library, TaG-EM barcodes were detected in nearly 100% of the cells at high sequencing depths (Supplemental Figure 19). However, although we used a polymerase that has been engineered to have high processivity and that has been shown to reduce the formation of chimeric reads in other contexts (Gohl et al., 2016), it is possible that PCR chimeras could lead to unreliable detection events for some cells. Indeed, many cells had a mixture of barcodes detected with low counts and single or low numbers of associated UMIS. To assess the reliability of detection, we analyzed the correlation between barcodes detected in the gene expression library and the enriched TaG-EM barcode library as a function of the purity of TaG-EM barcode detection for each cell (the percentage of the most abundant detected TaG-EM barcode, Supplemental Figure 19). For TaG-EM barcode detections where the most abundance barcode was a high percentage of the total barcode reads detected (~75%-99.99%), there was a high correlation between the barcode detected in the gene expression library and the enriched TaG-EM barcode library. Below this threshold, the correlation was substantially reduced. 

      In the enriched library, we identified 26.8% of cells with a TaG-EM barcode reliably detected, a very modest improvement over the gene expression library alone (23.96%), indicating that at least for this experiment, the main constraint is sufficient expression of the TaG-EM barcode and not detection. To identify TaG-EM barcodes in the combined data set, we counted a positive detection as any barcode either identified in the gene expression library or any barcode identified in the enriched library with a purity of >75%. In the case of conflicting barcode calls, we assigned the barcode that was detected directly in the gene expression library. This increased the total fraction of cells where a barcode was identified to approximately 37% (Figure 6B).”

      Methods:

      “The resulting pool was prepared for sequencing following the 10x Genomics Single Cell 3’ protocol (version CG000315 Rev C), At step 2.2 of the protocol, cDNA amplification, 1 µl of TaG-EM spike-in primer (10 µM) was added to the reaction to amplify cDNA with the TaG-EM barcode. Gene expression cDNA and TaG-EM cDNA were separated using a double-sided SPRIselect (Beckman Coulter) bead clean up following 10x Genomics Single Cell 3’ Feature Barcode protocol, step 2.3 (version CG000317 Rev E). The gene expression cDNA was created into a library following the CG000315 Rev C protocol starting at section 3. Custom nested primers were used for enrichment of TaG-EM barcodes after cDNA creation using PCR.  The following primers were tested (see Supplemental Figure 18):

      UMGC_IL_TaGEM_SpikeIn_v1:

      GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCTTCCAACAACCGGAAGT*G*A UMGC_IL_TaGEM_SpikeIn_v2:

      GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGCAGCTTATAACTTCCAACAACCGGAAGT*G*A

      UMGC_IL_TaGEM_SpikeIn_v3:

      TGTGCTCTTCCGATCTGCAGCTTATAACTTCCAACAACCGGAAGT*G*A D701_TaGEM:

      CAAGCAGAAGACGGCATACGAGATCGAGTAATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGCAGC*T*T

      SI PCR Primer:

      AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC*T*C

      UMGC_IL_DoubleNest:

      GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGCAGCTTATAACTTCCAACAACCGG*A*A

      P5: AATGATACGGCGACCACCGA

      D701:

      GATCGGAAGAGCACACGTCTGAACTCCAGTCACATTACTCGATCTCGTATGCCGTCTTCTGCTTG

      D702:

      GATCGGAAGAGCACACGTCTGAACTCCAGTCACTCCGGAGAATCTCGTATGCCGTCTTCTGCTTG

      After multiple optimization trials, the following steps yielded ~96% on-target reads for the TaG-EM library (Supplemental Figure 18, note that for the enriched barcode data shown in Figure 6 and Supplemental Figure 19, a similar amplification protocol was used TaG-EM barcodes were amplified from the gene expression library cDNA and not the SPRI-selected barcode pool). TaG-EM cDNA was amplified with the following PCR reaction: 5 µl purified TaG-EM cDNA, 50 µl 2x KAPA HiFi ReadyMix (Roche), 2.5 µl UMGC_IL_DoubleNest primer (10 µM), 2.5 µl SI_PCR primer (10 µM), and 40 µl nuclease-free water. The reaction was amplified using the following cycling conditions: 98ºC for 2 minutes, followed by 15 cycles of 98ºC for 20 seconds, 63ºC for 30 seconds, 72ºC for 20 seconds, followed by 72ºC for 5 minutes. After the first PCR, the amplified cDNA was purified with a 1.2x SPRIselect (Beckman Coulter) bead cleanup with 80% ethanol washes and eluted into 40 µL of nuclease-water. A second round of PCR was run with following reaction: 5 µl purified TaG-EM cDNA, 50 µl 2x KAPA HiFi ReadyMix (Roche), 2.5 µl D702 primer (10 µM), 2.5 µl p5 Primer (10 µM), and 40 µl nuclease-free water. The reaction was amplified using the following cycling conditions: 98ºC for 2 minutes, followed by 10 cycles of 98ºC for 20 seconds, 63ºC for 30 seconds, 72ºC for 20 seconds, followed by 72ºC for 5 minutes. After the second PCR, the amplified cDNA was purified with a 1.2x SPRIselect (Beckman Coulter) bead cleanup with 80% ethanol washes and eluted into 40uL of nuclease-water. The resulting 3’ gene expression library and TaG-EM enrichment library were sequenced together following Scenario 1 of the BioLegend “Total-Seq-A Antibodies and Cell Hashing with 10x Single Cell 3’ Reagents Kit v3 or v3.1” protocol. Additional sequencing of the enriched TaG-EM library also done following Scenario 2 from the same protocol.” 

      When a given cell barcode is not associated with any TaG-EM barcode, then demultiplexing is impossible. This is a major problem, which is particularly visible in Figs 5 and S13. In 5F, BC4 is only detected in a couple of dozen cells, even though the Jon99Ciii marker of enterocytes is present in a much larger population (Fig 5C). Therefore, in this particular case, TaG-EM fails to detect most of the GFP-expressing cells. 

      Figure 5 in the original manuscript represented data from an experiment in which there were eight different TaG-EM barcoded samples present, including four replicates of the pan-midgut driver (each of which included enterocyte populations). One would not expect the BC4 enterocyte driver expression to be observed in all of the Jon99Ciii cells, since the majority of the GFP+ cells shown in the UMAP plot were likely derived from and are labeled by the pan-midgut driver-associated barcodes. Thus, the design and presentation of this particular experiment (in particular, the presence of eight distinct samples in the data set) is making the detection of the TaG-EM barcodes look sparser than it actually is. We have added a panel in both Figure 6B and Supplemental Figure 17B that shows the overall detection of barcodes in the enriched barcode library and gene expression library or the gene expression library only, respectively, for this experiment.

      However, the reviewer’s overall point regarding barcode detection is still valid in that if we consider all eight barcodes, we only see TaG-EM barcode labeling associated with about a quarter of all the cells in this gene expression library, or about 37% of cells when we include the enriched TaG-EM barcode library. While improving barcode detection will improve the yield and is necessary for some applications (such as robust detection of multiplets), we would argue that even at the current level of success this approach has significant utility. First, if one’s goal is to unambiguously label a cell cluster and trace it to a defined cell population in vivo, sparse labeling may be sufficient. Second, demultiplexing is still possible (as we demonstrate) but involves a trade off in yield (not every cell is recovered and there is some extra sequencing cost as some sequenced cells cannot be assigned to a barcode). 

      Similarly, in S13, most cells should express one of the four barcodes, however many of them (maybe up to half - this should be quantified) do not. Therefore, the claim (L277278) that "the pan-midgut driver were broadly distributed across the cell clusters" is misleading. Moreover, the hypothesis that "low expressing driver lines may result in particularly sparse labelling" (L331-333) is at least partially wrong, as Fig S13 shows that the same Gal4 driver can lead to very different levels of barcode coverage.

      As described above, since this experiment included eight different TaG-EM barcodes expressed by five different drivers, the expectation is that only about half of the cells in Figure S13 (now Figure S20) should express a TaG-EM barcode. It is not clear why BC2 is underrepresented in terms of the number of cells labeled and BC7 is overrepresented. We agree with the reviewer that this should be described more accurately in the paper and that it does impact our interpretation related to driver strength and barcode detection. We have revised this sentence in the discussion and also added additional text in the results describing the within driver variability seen in this experiment.

      Results text:

      “As expected, the barcodes expressed by the pan-midgut driver were broadly distributed across the cell clusters (Supplemental Figure 20). However, the number of cells recovered varied significantly among the four pan-midgut driver associated barcodes.”

      Discussion text:

      “It is likely that the strength of the Gal4 driver contributes to the labeling density. However, we also observed variable recovery of TaG-EM barcodes that were all driven by the same pan-midgut Gal4 driver (Supplemental Figure 20).”

      • Comparisons between TaG-EM and other, simpler methods for labelling individual cell populations are missing. For example, how would TaG-EM compare with expression of different fluorescent reporters, or a strategy based on the brainbow/flybow principle?

      The advantage of TaG-EM is that an arbitrarily large number of DNA barcodes can be used (contingent upon the availability of transgenic lines – we described 20 barcoded lines in our initial manuscript and we have now extended this collection to over 170 lines), while the number of distinguishable FPs is much lower. Brainbow/Flybow uses combinatorial expression of different FPs, but because this combinatorial expression is stochastic, tracing a single cell transcriptome to a defined cell population in vivo based on the FP signature of a Brainbow animal would likely not be possible (and would almost certainly be impossible at scale).

      • FACS data is missing throughout the paper. The authors should include data from their comparative flow cytometry experiment of TaG-EM cells with or without additional hexameric GFP, as well as FSC/SSC and fluorescence scatter plots for the FACS steps that they performed prior to scRNA-seq, at least in supplementary figures.

      We have added Supplemental Figures with the FACS data for all of the single cell sequencing data presented in the manuscript (Supplemental Figures 12 and 14).

      • The authors should show the whole data described in L229, including the cluster that they chose to delete. At least, they should provide more information about how many cells were removed. In any case, the fact that their data still contains a large number of debris and dead cells despite sorting out PI negative cells with FACS and filtering low abundance barcodes with Cellranger is concerning.

      This description was referring to the unprocessed Cellranger output (not filtered for low abundance barcodes). Prior to filtering for cell barcodes with high mitochondria or rRNA (or other processing in Seurat/Scanpy), we saw two clusters, one with low UMI counts and enrichment of mitochondrial genes (see Cellranger report below). 

      Author response image 1.

      These cell barcodes were removed by downstream quality filtering and the remaining cells showed expression of expected intestinal stem cell and enteroblast marker genes.

      Overall, although a method for genetic tagging cell populations prior to multiplexing in single-cell experiments would be extremely useful, the method presented here is inadequate. However, despite all the weaknesses listed above, the idea of barcodes expressed specifically in cells of interest deserves more consideration. If the authors manage to improve their design to resolve the major issues and demonstrate the benefits of their method more clearly, then TaG-EM could become an interesting option for certain applications.

      We thank the reviewer for this comment and hope that the above responses and additional experiments and data that we have added have helped to alleviate the noted weaknesses.

      Reviewer #2 (Public Review):

      In this manuscript, Mendana et al developed a multiplexing method - Targeted Genetically-Encoded Multiplexing or TaG-EM - by inserting a DNA barcode upstream of the polyadenylation site in a Gal4-inducible UAS-GFP construct. This Multiplexing method can be used for population-scale behavioral measurements or can potentially be used in single-cell sequencing experiments to pool flies from different populations. The authors created 20 distinctly barcoded fly lines. First, TaG-EM was used to measure phototaxis and oviposition behaviors. Then, TaG-EM was applied to the fly gut cell types to demonstrate its applications in single-cell RNA-seq for cell type annotation and cell origin retrieving.

      This TaG-EM system can be useful for multiplexed behavioral studies from nextgeneration sequencing (NGS) of pooled samples and for Transcriptomic Studies. I don't have major concerns for the first application, but I think the scRNA-seq part has several major issues and needs to be further optimized.

      Major concerns:

      (1) It seems the barcode detection rate is low according to Fig S9 and Fig 5F, J and N. Could the authors evaluate the detection rate? If the detection rate is too low, it can cause problems when it is used to decode cell types.

      See responses to Reviewer #1 on this topic above.  

      (2) Unsuccessful amplification of TaG-EM barcodes: The authors attempted to amplify the TaG-EM barcodes in parallel to the gene expression library preparation but encountered difficulties, as the resulting sequencing reads were predominantly offtarget. This unsuccessful amplification raises concerns about the reliability and feasibility of this amplification approach, which could affect the detection and analysis of the TaG-EM barcodes in future experiments.

      As noted above, we have now established a successful amplification protocol for the TaG-EM barcodes. This data is shown in Figure 6, and Supplemental Figures 18-19 and we have included a detailed information in the methods for performing TaG-EM barcode enrichment during 10x library prep. We have also included code in the paper’s Github repository for assigning TaG-EM barcodes from the enriched library to the associated 10x Genomics cell barcodes.

      (3) For Fig 5, the singe-cell clusters are not annotated. It is not clear what cell types are corresponding to which clusters. So, it is difficult to evaluate the accuracy of the assignment of barcodes.

      We have added annotation information for the cell clusters based on expression of cell-type-specific marker genes (Figure 6A, Supplemental Figures 16-17).

      (4) The scRNA-seq UMAP in Fig 5 is a bit strange to me. The fly gut epithelium contains only a few major cell types, including ISC, EB, EC, and EE. However, the authors showed 38 clusters in fig 5B. It is true that some cell types, like EE (Guo et al., 2019, Cell Reports), have sub-populations, but I don't expect they will form these many subtypes. There are many peripheral small clusters that are not shown in other gut scRNAseq studies (Hung et al., 2020; Li et al., 2022 Fly Cell Atlas; Lu et al., 2023 Aging Fly Cell Atlas). I suggest the authors try different data-processing methods to validate their clustering result.

      For all of the single cell experiments, after doublet and ambient RNA removal (as suggested below), we have reclustered the datasets and evaluated different resolutions using Clustree. As the Reviewer points out, there are different EE subtypes, as well as regionalized expression differences in EC and other cell populations, so more than four clusters are expected (an analysis of the adult midgut identified 22 distinct cell types). With this revised analysis our results more closely match the cell populations observed in other studies (though it should be noted that the referenced studies largely focus on the adult and not the larval stage).  

      (5) Different gut drivers, PMC-, PC-, EB-, EC-, and EE-GAL4, were used. The authors should carefully characterize these GAL4 expression in larval guts and validate sequencing data. For example, does the ratio of each cell type in Fig 5B reflect the in vivo cell type ratio? The authors used cell-type markers mostly based on the knowledge from adult guts, but there are significant morphological and cell ratio differences between larval and adult guts (e.g., Mathur...Ohlstein, 2010 Science).

      We have characterized the PC driver which is highlighted in Supplemental Figure 13, and the EC and EE drivers which are highlighted in Figure 6G-N in detail in larval guts and have added this data to the paper (Supplemental Figure 21). The EB driver was not characterized histologically as EB-specific antibodies are not currently available. The PMG-Gal4 line exhibits strong expression throughout the larval gut (Figure 5B and barcodes are recovered from essentially all of the larval gut cell clusters using this driver (Supplemental Figure 20). We don’t necessarily expect the ratios of cells observed in the scRNA-Seq data to reflect the ratios typically observed in the gut as we performed pooled flow sorting on a multiplexed set of eight genotypes and driver expression levels, flow sorting, and possibly other processing steps could all influence the relative abundance of different cell types. However, detailed characterization of these driver lines did reveal spatial expression patterns that help explain aspects of the scRNA-Seq data. We have also added the following text to the paper to further describe the characterization of the drivers:

      Results:

      “Detailed characterization of the EC-Gal4 line indicated that although this line labeled a high percentage of enterocytes, expression was restricted to an area at the anterior and middle of the midgut, with gaps between these regions and at the posterior (Supplemental Figure 21). This could explain the absence of subsets of enterocytes, such as those labeled by betaTry, which exhibits regional expression in R2 of the adult midgut (Buchon et al., 2013).”

      “Detailed characterization of the EE-Gal4 driver line indicated that ~80-85% of Prospero-positive enteroendocrine cells are labeled in the anterior and middle of the larval midgut, with a lower percentage (~65%) of Prospero-positive cells labeled in the posterior midgut (Supplemental Figure 21). As with the enterocyte labeling, and consistent with the Gal4 driver expression pattern, the EE-Gal4 expressed TaG-EM barcode 9 did not label all classes of enteroendocrine cells and other clusters of presumptive enteroendocrine cells expressing other neuropeptides such as Orcokinin, AstA, and AstC, or neuropeptide receptors such as CCHa2 (not shown) were also observed.”

      Methods:

      “Dissection and immunostaining

      Midguts from third instar larvae of driver lines crossed to UAS-GFP.nls or UAS-mCherry were dissected in 1xPBS and fixed with 4% paraformaldehyde (PFA) overnight at 4ºC. Fixed samples were washed with 0.1% PBTx (1xPBS + 0.1% Triton X-100) three times for 10 minutes each and blocked in PBTxGS (0.1% PBTx + 3% Normal Goat Serum) for 2–4 hours at RT. After blocking, midguts were incubated in primary antibody solution overnight at 4ºC. The next day samples were washed with 0.1% PBTx three times for 20 minutes each and were incubated in secondary antibody solution for 2–3 hours at RT (protected from light) followed by three washes with 0.1% PBTx for 20 minutes each. One µg/ml DAPI solution prepared in 0.1% PBTx was added to the sample and incubated for 10 minutes followed by washing with 0.1% PBTx three times for 10 minutes each. Finally, samples were mounted on a slide glass with 70% glycerol and imaged using a Nikon AX R confocal microscope. Confocal images were processed using Fiji software. 

      The primary antibodies used were rabbit anti-GFP (A6455,1:1000 Invitrogen), mouse anti-mCherry (3A11, 1:20 DSHB), mouse anti-Prospero (MR1A, 1:50 DSHB) and mouse anti-Pdm1 (Nub 2D4, 1:30 DSHB). The secondary antibodies used were goat antimouse and goat anti-rabbit IgG conjugated to Alexa 647 and Alexa 488 (1:200) (Invitrogen), respectively. Five larval gut specimens per Gal4 line were dissected and examined.”

      (6) Doublets are removed based on the co-expression of two barcodes in Fig 5A. However, there are also other possible doublets, for example, from the same barcode cells or when one cell doesn't have detectable barcode. Did the authors try other computational approaches to remove doublets, like DoubleFinder (McGinnis et al., 2019) and Scrublet (Wolock et al., 2019)?

      We have included DoubleFinder-based doublet removal in our data analysis pipeline. This is now described in the methods (see below).

      (7) Did the authors remove ambient RNA which is a common issue for scRNA-seq experiments?

      We have also used DecontX to remove ambient RNA. This is now described in the methods:

      “Datasets were first mapped and analyzed using the Cell Ranger analysis pipeline (10x Genomics). A custom Drosophila genome reference was made by combining the BDGP.28 reference genome assembly and Ensembl gene annotations. Custom gene definitions for each of the TaG-EM barcodes were added to the fasta genome file and .gtf gene annotation file. A Cell Ranger reference package was generated with the Cell Ranger mkref command. Subsequent single-cell data analysis was performed using the R package Seurat (Satija et al., 2015). Cells expressing less than 200 genes and genes expressed in fewer than three cells were filtered from the expression matrix. Next, percent mitochondrial reads, percent ribosomal reads cells counts, and cell features were graphed to determine optimal filtering parameters. DecontX (Yang et al., 2020) was used to identify empty droplets, to evaluate ambient RNA contamination, and to remove empty cells and cells with high ambient RNA expression. DoubletFinder (McGinnis et al., 2019) to identify droplet multiplets and remove cells classified as multiplets. Clustree (Zappia and Oshlack, 2018) was used to visualize different clustering resolutions and to determine the optimal clustering resolution for downstream analysis. Finally, SingleR (Aran et al., 2019) was used for automated cell annotation with a gut single-cell reference from the Fly Cell Atlas (Li et al., 2022). The dataset was manually annotated using the expression patterns of marker genes known to be associated with cell types of interest. To correlate TaG-EM barcodes with cell IDs in the enriched TaG-EM barcode library, a custom Python script was used (TaGEM_barcode_Cell_barcode_correlation.py), which is available via Github: https://github.com/darylgohl/TaG-EM.”

      (8) Why does TaG-EM barcode #4, driven by EC-GAL4, not label other classes of enterocyte cells such as betaTry+ positive ECs (Figures 5D-E)? similarly, why does TaG-EM barcode #9, driven by EE-GAL4, not label all EEs? Again, it is difficult to evaluate this part without proper data processing and accurate cell type annotation.

      As noted in the response to a comment by Reviewer #1 above, part of this apparent sparsity of labeling is due to the way that this experiment was designed and visualized. We have added a new Figure panel in both Figure 6B and Supplemental Figure 17B that shows the overall detection of barcodes in the enriched barcode library and gene expression library or the gene expression library only, respectively, to better illustrate the efficacy of barcode detection. See also the response to point 5 above. Both the lack of labelling of betaTry+ ECs and subsets of EEs is consistent with the expression patterns of the EC-Gal4 and EE-Gal4 drivers.

      (9) For Figure 2, when the authors tested different combinations of groups with various numbers of barcodes. They found remarkable consistency for the even groups. Once the numbers start to increase to 64, barcode abundance becomes highly variable (range of 12-18% for both male and female). I think this would be problematic because the differences seen in two groups for example may be due to the barcode selection rather than an actual biologically meaningful difference.

      While there is some barcode-to-barcode variability for different amplification conditions, the magnitude of this variation is relatively consistent across the conditions tested. We looked at the coefficient of variation for the evenly pooled barcodes or for the staggered barcodes pooled at different relative levels. While the absolute magnitude of the variation is higher for the highly abundant barcodes in the staggered conditions, the CVs for these conditions (0.186 for female flies and for 0.163 male flies) were only slightly above the mean CV (0.125) for all conditions (see Supplemental Figure 3):

      We have added this analysis as Supplemental Figure 3 and added the following text to the paper:(

      “The coefficients of variation were largely consistent for groups of TaG-EM barcodes pooled evenly or at different levels within the staggered pools (Supplemental Figure 3).”

      (10) Barcode #14 cannot be reliably detected in oviposition experiment. This suggests that the BC 14 fly line might have additional mutations in the attp2 chromosome arm that affects this behavior. Perhaps other barcode lines also have unknown mutations and would cause issues for other untested behaviors. One possible solution is to backcross all 20 lines with the same genetic background wild-type flies for >7 generations to make all these lines to have the same (or very similar) genetic background. This strategy is common for aging and behavior assays.

      See response to Reviewer #1 above on this topic.

      Reviewer #3 (Public Review):

      The work addresses challenges in linking anatomical information to transcriptomic data in single-cell sequencing. It proposes a method called Targeted Genetically-Encoded Multiplexing (TaG-EM), which uses genetic barcoding in Drosophila to label specific cell populations in vivo. By inserting a DNA barcode near the polyadenylation site in a UASGFP construct, cells of interest can be identified during single-cell sequencing. TaG-EM enables various applications, including cell type identification, multiplet droplet detection, and barcoding experimental parameters. The study demonstrates that TaGEM barcodes can be decoded using next-generation sequencing for large-scale behavioral measurements. Overall, the results are solid in supporting the claims and will be useful for a broader fly community. I have only a few comments below:

      We thank the reviewer for these positive comments.

      Specific comments:

      (1) The authors mentioned that the results of structure pool tests in Fig. 2 showed a high level of quantitative accuracy in detecting the TaG-EM barcode abundance. Although the data were generally consistent with the input values in most cases, there were some obvious exceptions such as barcode 1 (under-represented) and barcodes 15, 20 (overrepresented). It would be great if the authors could comment on these and provide a guideline for choosing the appropriate barcode lines when implementing this TaG-EM method.

      See the response to point 9 from Reviewer 2. Although there seem to be some systematic differences in barcode amplification, the coefficient of variation was relatively consistent across all of the barcode combinations and relative input levels that we examined. Our recommendation (described in the text) is to average across 3-4 independent barcodes (which yielded a R2 values of >0.99 with expected abundance in the structured pooled tests).  

      (2) In Supplemental Figure 6, the authors showed GFP antibody staining data with 20 different TaG-EM barcode lines. The variability in GFP antibody staining results among these different TaG-EM barcode lines concerns the use of these TaG-EM barcode lines for sequencing followed by FACS sorting of native GFP. I expected the native GFP expression would be weaker and much more variable than the GFP antibody staining results shown in Supplemental Figure 6. If this is the case, variation of tissue-specific expression of TaG-EM barcode lines will likely be a confounding factor.

      Aside from barcode 8, which had a mutation in the GFP coding sequence, we did not see significant variability in expression levels either in the wing disc. Subtle differences seen in this figure most likely result from differences in larval staging. Similar consistent native (unstained) GFP expression of the TaG-EM constructs was seen in crosses with Mhc-Gal4 (described above). 

      (3) As the authors mentioned in the manuscript, multiple barcodes for one experimental condition would be a better experimental design. Could the authors suggest a recommended number of barcodes for each experiential condition? 3? 4? Or more? 

      See response to Reviewer #3, point number 1 above.

      (3b) Also, it would be great if the authors could provide a short discussion on the cost of such TaG-EM method. For example, for the phototaxis assay, if it is much more expensive to perform TaG-EM as compared to manually scoring the preference index by videotaping, what would be the practical considerations or benefits of doing TaG-EM over manual scoring?

      While this will vary depending on the assay and the scale at which one is conducting experiments, we have added an analysis of labor savings for the larval gut motility assay (Supplemental Figure 8). We have also added the following text to the Discussion describing some of the trade-offs to consider in assessing the potential benefit of incorporating TaG-EM into behavioral measurements:

      “While the utility of TaG-EM barcode-based quantification will vary based on the number of conditions being analyzed and the ease of quantifying the behavior or phenotype by other means, we demonstrate that TaG-EM can be employed to cost-effectively streamline labor-intensive assays and to quantify phenotypes with small effect sizes (Figure 4, Supplemental Figure 8).”

      Recommendations for the authors:  

      While recognising the potential of the TaG-EM methodology, we had a few major concerns that the authors might want to consider addressing:

      As stated above, we are grateful to the reviewers and editor for their thoughtful comments. We have addressed many of the points below in our responses above, so we will briefly respond to these points and where relevant direct the reader to comments above.

      (1) We were concerned about the efficacy of TaG-EM in assessing more complex behaviours than oviposition and phototaxis. We note that Barcode #14 cannot be reliably detected in oviposition experiment. This suggests that the BC 14 fly line might have additional mutations in the attp2 chromosome arm that affects this behavior. Perhaps other barcode lines also have unknown mutations and would cause issues for other untested behaviors. One possible solution is to back-cross all 20 lines with the same genetic background wild-type flies for >7 generations to make all these lines to have the same (or very similar) genetic background. This strategy is common for aging and behavior assays.

      See response to Reviewer #1 and Reviewer #2, item 10, above.

      (2) We were unable to assess the drop-out rates of the TaG-EM barcode from the sequencing. The barcode detection rate is low (Fig S9 and Fig 5F, J and N). This would be a considerable drawback (relating to both experimental design and cost), if a large proportion of the cells could not be assigned an identity.

      See comments above addressing this point.

      (3) The effectiveness of TaG-EM scRNA-seq on the larvae gut is not very effective - the cells are not well annotated, the barcodes seem not to have labelled expected cell types (ECs and EEs), and there is no validation of the Gal4 drivers in vivo.

      See previous comments. We have addressed specific comments above on data processing and annotation, included a visualization of the overall effectiveness of labeling, added a protocol and data on enriched TaG-EM barcode libraries, and have added detailed characterization of the Gal4 drivers in the larval gut (Figure 6, Supplemental Figures 17-21).

      (4) A formal assessment of the cost-effectiveness would be an important consideration in broad uptake of the methodology.

      While this is difficult to do in a comprehensive manner given the breadth of potential applications, we have included estimates of labor savings for one of the behavioral assays that we tested (Supplemental Figure 8). We have also included a discussion of some of the factors that would make TaG-EM useful or cost-effective to apply for behavioral assays (see response to Reviewer #3, comment 3b, above). We have also added the following text to the discussion to address the cost considerations in applying TaG-EM for scRNA-Seq:

      “For single cell RNA-Seq experiments, the cost savings of multiplexing is roughly the cost of a run divided by the number of independent lines multiplexed, plus labor savings by also being able to multiplex upstream flow cytometry, minus loss of unbarcoded cells. Our experiments indicated that for the specific drivers we tested TaG-EM barcodes are detected in around one quarter of the cells if relying on endogenous expression in the gene expression library, though this fraction was higher (~37%) if sequencing an enriched TaG-EM barcode library in parallel (Figure 6, Supplemental Figures 18-19).”

      (5) Similarly, a formal assessment of the effect of the insertion on the variability in GFP expression and the behaviour needs to be documented.

      See responses to Reviewer #1, Reviewer #2, item 9, and Reviewer #3, item 2 above.

      Reviewer #1 (Recommendations For The Authors):

      (in no particular order of importance)

      • L84-85: the authors should either expand, or remove this statement. Indeed, lack of replicates is only true if one ignores that each cell in an atlas is indeed a replicate. Therefore, depending on the approach or question, this statement is inaccurate.

      This sentence was meant to refer to experiments where different experimental conditions are being compared and not to more descriptive studies such as cell atlases. We have revised this sentence to clarify.

      “Outside of descriptive studies, these costs are also a barrier to including replicates to assess biological variability; consequently, a lack of biological replicates derived from independent samples is a common shortcoming of single-cell sequencing experiments.”

      • L103-104: this sentence is unclear.

      We have revised this sentence as follows:

      “Genetically barcoded fly lines can also be used to enable highly multiplexed behavioral assays which can be read out using high throughput sequencing.”

      • In Fig S1 it is unclear why there are more than 20 different sequences in panel B where the text and panel A only mention the generation of 20 distinct constructs. This should be better explained.

      The following text was added to the Figure legend to explain this discrepancy:

      “Because the TaG-EM barcode constructs were injected as a pool of 29 purified plasmids, some of the transgenic lines had inserts of the same construct. In total 20 unique lines were recovered from this round of injection.”

      • It would be interesting to compare the efficiency of TaG-EM driven doublet removal (Fig 5A) with standard doublet-removing software (e.g., DoubletFinder, McGinnis et al., 2019).

      We have done this comparison, which is now shown in Supplemental Figure 15.

      • I would encourage the authors to check whether barcode representation in Fig S13  can be correlated to average library size, as one would expect libraries with shorter reads to be more likely to include the 14-bp barcode and therefore more accurately recapitulate TaG-EM barcode expression.

      These are not independent sequencing libraries, but rather data from barcodes that were multiplexed in a single flow sort, 10x droplet capture, and sequencing library. Thus, there must be some other variable that explains the differential recovery of these barcodes.

      • Fig 4A should appear earlier in the paper.

      We have moved Figure 4A from the previous manuscript (a schematic showing the detailed design of the TaG-EM construct) to Figure 1A in the revised version.

      Reviewer #2 (Recommendations For The Authors):

      Minor:

      (1) There is a typo for Fig S13 figure legends: BC1, BC1, BC3... should be BC1, BC2, BC3.

      Fixed.

      Reviewer #3 (Recommendations For The Authors):

      Comments to authors:

      (1) It would be great if the authors could provide an additional explanation on how these 29 barcode sequences were determined.

      Response: This information is in the Methods section. For the original cloned plasmids:

      “Expected construct size was verified by diagnostic digest with _Eco_RI and _Apa_LI. DNA concentration was determined using a Quant-iT PicoGreen dsDNA assay (Thermo Fisher Scientific) and the randomer barcode for each of the constructs was determined by Sanger sequencing using the following primers:

      SV40_post_R: GCCAGATCGATCCAGACATGA

      SV40_5F: CTCCCCCTGAACCTGAAACA”

      For transgenic flies, after DNA extraction and PCR enrichment (details also in the Methods section):

      “The barcode sequence for each of the independent transgenic lines was determined by Sanger sequencing using the SV40_5F and SV40_PostR primers.”

      (2) Why did the authors choose myr-GFP as the backbone instead of nls-GFP if the downstream application is to perform sequencing?

      We initially chose myr::GFP as we planned to conduct single cell and not single nucleus sequencing and myr::GFP has the advantage of labeling cell membranes which could facilitate the characterization or confirmation of cell type-specific expression, particularly in the nervous system. However, we have considered making a version of the TaG-EM construct with a nuclear targeted GFP (thereby enabling “NucEM”). In the Discussion, we mention this possibility as well as the possibility of using a second nuclear-GFP construct in conjunction with TaG-EM lines is nuclear enrichment is desired:

      “In addition, while the original TaG-EM lines were made using a membrane-localized myr::GFP construct, variants that express GFP in other cell compartments such as the cytoplasm or nucleus could be constructed to enable increased expression levels or purification of nuclei. Nuclear labeling could also be achieved by co-expressing a nuclear GFP construct with existing TaG-EM lines in analogy to the use of hexameric GFP described above.”

      Minor comments:

      (1) Line 193, Supplemental Figure 4 should be Supplemental Figure 5

      Fixed.

      (2) Scale bars should be added in Figure 4, Supplemental Figures 6, 7, and 8A.

      We have added scale bars to these figures and also included scale bars in additional Supplemental Figures detailing characterization of the gut driver lines.

      (3) Were Figure 4C and Supplemental Figure 7 data stained with a GFP antibody?

      No, this is endogenous GFP signal. This is now noted in the Figure legends.

      (4) Line 220, specify the three barcode lines (lines #7, 8, 9) in the text. 

      Added this information.

      Same for Lines 251-254. Line 258, which 8 barcode Gal4 line combinations?

      (5) Line 994, typo: (BC1, BC1, BC3, and BC7)-> (BC1, BC2, BC3, and BC7)

      Fixed.

      (6) Figure 5 F, J and N, add EC-Gal4, EB-Gal4, and EE-Gal4 above each panel to improve readability.

      We have added labels of the cell type being targeted (leftmost panels), the barcode, and the marker gene name to Figure 6 C-N.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Public Reviews: 

      Reviewer #1 Comments on revisions: 

      The authors have addressed my concerns so I am fine with revision in principle.

      Thank you for taking the time to review our work and for your thoughtful feedback. We’re glad to hear that your concerns have been addressed.

      Reviewer #2 Comments on revisions:

      The authors have addressed many of the concerns raised in the initial review and provided alternative analytical approaches to address the relevant questions in this revision. Some of these are useful; however, they have not fully addressed one critical point. 

      In my original critique, I noted that the maternal KO might not be suitable as a control, given that there is no significant phenotypic difference between the maternal-only KO and the maternal-zygotic KO. While we did not dispute the molecular differences presented in Figure 2, so how the authors conclude in the Response "embryos with a maternal KO or zygotic heterozygous KO of Oct4 or Sox2 show no noticeable ... molecular difference (Figure 2-figure supplement 4A)"? The authors should recheck whether this is a typographical error or a valid statement. 

      Additionally, I recommend the removal of phrases such as "absolutely priority" and "pivotal" throughout the manuscript, as these terms are overly assertive without sufficient supporting evidence.

      We sincerely appreciate the reviewer’s feedback and would like to take this opportunity to provide further clarification, as there might have been a misunderstanding.

      We respectfully disagree with the reviewer’s statement that “there is no significant phenotypic difference between the maternal-only KO and the maternal-zygotic KO.” Based on privious publications, there is clear evidence that maternal-zygotic KO embryos exhibit significant defects: they fail to form a healthy primitive endoderm, are unable to give rise to embryonic stem cells (ESCs) in vitro, and die shortly after implantation (Frum et al., Dev Cell 2013; Wu et al., Nat Cell Biol 2013; Le Bin et al., Development 2014; Wicklow et al., PLoS Genet 2014). In contrast, maternal-only KO embryos develop as healthy as wild-type (WT) embryos and do not display any of these phenotypic abnormalities. We believe that this distinction validates our use of maternal KO embryos as proper controls in our experiments. 

      To address the reviewer’s concerns and ensure clarity, we have also revised the following statement in the manuscript.

      Original manuscript: “Mouse embryos with a maternal KO or zygotic heterozygous KO of either factor show no noticeable phenotype or molecular difference (Figure 2-figure supplement 4A) (Avilion et al., 2003; Frum et al., 2013; Kehler et al, 2004; Nichols et al., 1998; Wicklow et al., 2014; Wu et al., 2013).” 

      Revised manuscript: “Maternal KO embryos (circles in Figure 2—figure supplement 4A) clustered together with wildtype embryos (triangles and squares) in the PCA analysis, consistent with previous studies reporting no observable phenotype in maternal KO embryos (Avilion et al., 2003; Frum et al., 2013; Kehler et al, 2004; Nichols et al., 1998; Wicklow et al., 2014; Wu et al., 2013).”

      While we acknowledge the potential for using maternal-only KO controls to underestimate differences between control and KO samples, we believe this approach does not introduce false positives in our RNA-seq and ATAC-seq experiments, only the possibility of more conservative conclusions. This minimizes the risk of overestimating the molecular impact.

      We appreciate the reviewer’s recommendation regarding the use of overly assertive terms. Upon careful review of the manuscript and response letter, we could not find instances of the term “absolutely priority.” However, we do use the term “pivotal” and would prefer to retain it as we believe it accurately reflects the importance of the findings presented in our manuscript.

      Thank you for your thoughtful comments and suggestions! We hope this response clarifies our rationale and addresses the concerns.

      ---

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review)

      Summary:

      Numerous mechanism and structural studies reported the cooperative role of Oct4 and Sox2 during the establishment of pluripotency during reprogramming. Due to the difficulty in sample collection and RNA-seq with low-number cells, the precise mechanisms remain in early embryos. This manuscript reported the role of OCT4 and SOX2 in mouse early embryos using knockout models with low-input ATAC-seq and RNA-seq. Compared to the control, chromatin accessibility and transcriptome were affected when Oct4 and Sox2 were deleted in early ICM. Specifically, decreased ATAC-seq peaks showed enrichment of Motifs of TF such as OCT, SOX, and OCT-SOX, indicating their importance during early development. Moreover, by deep analysis of ATAC-seq and RNA-seq data, they found Oct4 and Sox2 target enhancer to activate their downstream genes. In addition, they also uncovered the role of OS during development from the morula to ICM, which provided the scientific community with a more comprehensive understanding.

      Strengths:

      On the whole, the manuscript is innovative, and the conclusions of this paper are mostly well supported by data, however, there are some issues that need to be addressed.

      Weaknesses:

      Major Points:

      (1) In Figure 1, a more detailed description of the knockout strategy should be provided to clarify itself. The knockout strategy in Fig1 is somewhat obscure, such as how is OCT4 inactivated in Oct4mKO2 heterozygotes. As shown in Figure 1, the exon of OCT4 is not deleted, and its promoter is not destroyed. Therefore, how does OCT4 inactivate to form heterozygotes?

      Thank you for helping clarify this. We will add a detailed description of the knockout strategy in the legends for Figure 1A and 1B, as shown below. Note that the same strategy was used by Nichols et al (Cell, 1998).

      Figure 1A. Schemes of mKO2-labeled Oct4 KO (Oct4<sup>mKO2</sup>) and Oct4<sup>flox</sup> alleles. In the Oct4<sup>mKO2</sup> allele, a PGK-pac∆tk-P2A-mKO2-pA cassette was inserted 3.6 kb upstream of the Oct4 transcription start site (TSS) and a promoter-less FRT-SA-IRES-hph-P2A-Venus-pA cassette was inserted into Oct4 intron 1. The inclusion of a stop codon followed by three sets of polyadenylation signal sequences (pA) after the Venus cassette ensures both transcriptional and translational termination, effectively blocking the expression of Oct4 exons 2–5.

      Figure 1B. Schemes of EGFP-labeled Sox2 KO (Sox2<sup>EGFP</sup>) and Sox2 <sup>flox</sup> alleles. In the Sox2 Sox2<sup>EGFP</sup> allele, the 5’ untranslated region (UTR), coding sequence and a portion of the 3’ UTR of Sox2 were deleted and replaced with a PGK-EGFP-pA cassette. Notably, 1,023 bp of the Sox2 3’UTR remain intact.

      (2) Is ZP3-Cre expressed in the zygotes? Is there any residual protein?

      This is indeed a very important issue. Here is why we think we are on the safe side. ZP3 is specifically expressed in growing oocytes, thus making ZP3-Cre a widely used tool for deleting maternally inherited alleles. When we crossed Oct4<sup>flox/flox</sup>; ZP3-Cre<sup>-</sup>_females with _Oct4<sup>flox/flox</sup>; ZP3-Cre<sup>+</sup> males, we got ZP3-Cre<sup>+</sup> Oct4<sup>flox/flox</sup> but no Oct4<sup> flox/∆</sup> or Oct4<sup> ∆/∆</sup> pups, suggesting that the paternally inherited ZP3-Cre allele is not functionally active in zygotes, which is consistent with reports from other researchers (e.g. Frum, et al., Dev Cell 2013; Wu, et al., Nat Cell Biol 2013).

      (3) What motifs are enriched in the rising ATAC-seq peaks after knocking out of OCT4 and SOX2?

      The enriched motifs in the rising ATAC-seq peaking in Oct4 KO and Sox2 KO ICMs are the GATA, TEAD, EOMES and KLF motifs, as shown in Figure 4A and Figure supplement 7.

      (4) The ordinate of Fig4c is lost.

      Thank you for pointing this out. The y-axis is average normalized signals (reads per million-normalized pileup signals). We will add it in the revised version.

      (5) Signals of H3K4me1, H3K27ac, and so on are usually used to define enhancers, and the loci of enhancers vary greatly in different cells. In the manuscript, the authors defined ATAC-seq peaks far from the TSS as enhancers. The definition in this manuscript is not strictly an enhancer.

      Thank you for this insightful comment. We analyzed the published H3K27ac ChIP-seq data of mouse ICM at 94-96 h post hCG (B. Liu, et al., Nat Cell Biol 2024) to assess the enrichment of H3K27ac around our ATAC-seq peaks. Unfortunately, the data quality is poor, e.g., inconsistent across replicates (Author response image 1A), and shows little enrichment around the well-defined enhancers (Author response image 1B). Nevertheless, as we admit not all the distal ATAC-seq peaks or open chromatin regions are enhancers, we have replaced “enhancers” with “open chromatin regions”, “ATAC-seq peaks” or “putative enhancers”.

      Author response image 1.

      Analysis of the published H3K27ac ChIP-seq dataset of mouse ICM at 94-96 h post hCG (B. Liu, et al., Nat Cell Biol 2024). A. ChIP-seq profiles of H3K27ac over the decreased, unchanged and increased ATAC-seq peaks in our Oct4-KO late ICMs. To exclude spurious peaks, only strong unchanged peaks (57,512 out of 142,096) were used in the analysis. B. IGV tracks displaying ATAC-seq and H3K27ac ChIP-seq profiles around Dppa3 and Oct4. Red boxes mark the known OCT-SOX enhancers.

      (6) If Oct4 and Sox2 truly activate sap 30 and Uhrf 1, what effect does interfere with both genes have on gene expression and chromatin accessibility?

      This is indeed an interesting question. Unfortunately, we have not conducted this specific experiment, so we do not have direct results. However, Sap30 is a key component of the mSin3A corepressor complex, while Uhrf1 regulates the establishment and maintenance of DNA methylation. Both proteins are known to function as repressors. Therefore, we hypothesize that interfering with these two genes could alleviate repression of some genes, such as trophectoderm markers, similar to what we have observed in Oct4 KO and Sox2 KO ICMs.

      Reviewer #2 (Public review):

      In this manuscript, Hou et al. investigate the interplay between OCT4 and SOX2 in driving the pluripotent state during early embryonic lineage development. Using knockout (KO) embryos, the authors specifically analyze the transcriptome and chromatin state within the ICM-to-EPI developmental trajectory. They emphasize the critical role of OCT4 and the supportive function of SOX2, along with other factors, in promoting embryonic fate. Although the paper presents high-quality data, several key claims are not well-supported, and direct evidence is generally lacking.

      Major Points:

      (1) Although the authors claim that both maternal KO and maternal KO/zygotic hetero KO mice develop normally, the molecular changes in these groups appear overestimated. A wildtype control is recommended for a more robust comparison. (a complementary comment from the reviewer: “Both maternal KO and maternal-zygotic KO in this study exhibited phenotypic consistency but molecular disparity. Specifically, both KO and control groups could develop normally; however, their chromatin landscapes and transcriptomic profiles showed different. This raises the question of whether the molecular differences are real. We suggest that inclusion of a completely wild-type control group would make the comparison more robust.”)

      Thank you for your feedback as this point was obviously not clear in the manuscript. Here is our explanation: Mouse embryos with a maternal KO or zygotic heterozygous KO of Oct4 or Sox2 show no noticeable phenotype or molecular difference (Figure 2-figure supplement 4A) (Avilion et al., 2003; Frum et al., 2013; Kehler et al, 2004; Nichols et al., 1998; Wicklow et al., 2014; Wu et al., 2013). We have clarified this point in the revised manuscript.

      (2) The authors assert that OCT4 and SOX2 activate the pluripotent network via the OCT-SOX enhancer. However, the definition of this enhancer is based solely on proximity to TSSs, which is a rough approximation. Canonical enhancers are typically located in intronic and intergenic regions and marked by H3K4me1 or H3K27ac. Re-analyzing enhancer regions with these standards could be beneficial. Additionally, the definitions of "close to" or "near" in lines 183-184 are unclear and not defined in the legends or methods.

      Thank you for this insightful and helpful comment. As stated in the response to Reviewer #1’s point (5), we have replaced “enhancers” with “open chromatin regions”, “ATAC-seq peaks” or “putative enhancers”.

      The definition of "close to" or "near" in lines 183-184 is in the legend of Figure 2E and Methods. In the GSEA analysis, Ensembl protein-coding genes with TSSs located within 10 kb of ATAC-seq peak centers were included, so that some of the intronic ATAC-seq peaks were taken into consideration. We have also added the information in the main text of the revised manuscript.

      (3) There is no evidence that the decreased peaks/enhancers could be the direct targets of Oct4 and Sox2 throughout this manuscript. Figures 2 and 4 show only minimal peak annotations related to OCT and SOX motifs, and there is a lack of chromatin IP data. Therefore, claims about direct targets are not substantiated and should be appropriately revised.

      Yes indeed, you have a point. In Figure Supplement 3C, we analyzed the published Sox2 CUT&RUN data from E4.5 ICMs (Li et al., Science, 2023), which demonstrates that the reduced ATAC-seq peaks in our Sox2 KO ICMs are enriched with the Sox2 CUT&RUN signals. Unfortunately, we did not to find similar published data for Oct4 in embryos. We have removed the statement indicating that these are the direct targets in the revised manuscript.

      (4) Lines 143-146 lack direct data to support the claim. Actually, the main difference in cluster 1, 11 and 3, 8, 14 is whether the peak contains OCT-SOX motif. However, the reviewer cannot get any information of peaks activated by OCT4 rather than SOX2 in cluster 1, 11.

      Thank you for the comment that we hope we can clarify.

      Lines 143-146 are: “Notably, the peaks activated by Oct4 but not by Sox2 in the ICM tended to be already open at the morula stage (Figure 2B, clusters 1 and 11), whereas those dependent on both Oct4 and Sox2 became open in the ICM (Figure 2B, clusters 3, 8 and 14).”

      We agree with you that clusters 3/8/14 are more enriched in OCT-SOX motifs than clusters 1/11. However, this is consistent with our observation that accessibility of peaks in clusters 1 and 11 relies mainly on Oct4, while accessibility in clusters 3, 8, 14 depends on both Oct4 and Sox2. But maybe the term “activate” is misleading. We have rephrased the text as below:

      “Notably, compared to the peaks that depend on Oct4 but not Sox2 (Figure 2B, clusters 1 and 11), those reliant on both Oct4 and Sox2 show greater enrichment of the OCT-SOX motif (Figure 2B, clusters 3, 8 and 14). The former group was generally already open in the morula, while the latter group only became open in the ICM. “

      Minor Points:

      (1) Lines 153-159: The figure panel does not show obvious enrichment of SOX2 signals or significant differences in H3K27ac signals across clusters, thus not supporting the claim.

      We hope to be able to explain this.

      Line 153-159 refer to two datasets:  Figure Supplement 3C and 3D.

      In Figure Supplement 3C, the average plots above the heatmaps show that the decreased ATAC-seq peaks (the indigo lines) have higher enrichment with Sox2 CUT&RUN signals than the increased or unchanged peaks (the yellow and light blue lines, respectively).

      In Figure Supplement 3D, the average plots indicate that H3K27ac signals around the center of the decreased ATAC-seq peaks (the indigo line) show higher enrichment compared to the unaltered and decreased groups (the light blue and yellow lines, respectively). Notably, H3K27ac enrichment appears slightly offset from the central nucleosome-free regions.

      (2) Lines 189-190: The term "identify" is overstated for the integrative analysis of RNA-seq and ATAC-seq, which typically helps infer TF targets rather than definitively identifying them.

      You are right. We have replaced “identify” with “infer” in the revised manuscript.

      (3) The Discussion is lengthy and should be condensed.

      We have shortened the discussion in the revised manuscript.

    1. Author Response

      Review 1:

      Major concerns that need to be addressed:

      Investigate the effects of Malat1 on the clearance of Listeria or LCMV.

      In our prior publication (Gagnon et al, Cell Reports) we showed that miR-15/16 deficiency in T cells does not affect the clearance of LCMV, and that transferred memory T cells formed in these mice can function normally to clear a secondary infection with Listeria expressing the LCMV gp33 peptide. However, the size of the memory pool was clearly changed, as was the programming of memory cells. Here, we show that disrupting miR15/16 binding to MALAT1 induces a reciprocal phenotype, validating a biological function for this RNA:RNA interaction. We employed these systems because they are widely used to reveal key aspects of T cell memory, but both infections are readily cleared by the host. These changes in the memory response likely play a limiting role in some biological context(s), and we agree that further investigation to uncover such situations would further validate the importance of this RNA circuit.

      Demonstrate that Malat1 shuttles to the cytosol, this will strengthen the conclusions that Malat1 sponges miR15/16.

      The location of miR-15/16 interaction with Malat1 is an interesting area for future study. Many prior studies have shown clearly that Malat1 is primarily located in the nucleus, but since T cells express such a large excess of this lncRNA, even the remaining fraction detected in the cytosol may be sufficient to “sponge” a significant amount of miR-15/16. Alternatively, these molecules may interact in the nucleus, or during mitosis. As the reviewer suggests, Malat1 may shuttle between compartments, raising the intriguing possibility that it could not only “sponge” but “drag” miR-15/16 away from its targets into the nucleus. A proper analysis of the mechanism of ceRNA function is beyond the scope of this paper, but we do believe that this circuit may be an especially good one for further study.

      Through flow cytometry or immunoblot analyses, investigate the effects of Malat1-miR15/16 on genes listed in table 3. This would add credence to the sequencing and CLIP data.

      We thank the reviewer for bringing to our attention the manuscript’s overemphasis on the former Table 3 gene set, which represented just a few of the hundreds of genes for which our data provide evidence for miR-15/16 binding and inhibition of expression. We have removed this table to avoid the appearance of suggesting an oversimplified model for how miR-15/16 regulate T cell responses, and replaced it with a short description of two targets (Pik3r1 and Mapk8) that link the roles of miR-15/16 in T cell activation and tumor suppression. Like transcription factors, miRNAs function as network regulators of gene expression, gaining biological power through their ability to coregulate many genes with convergent effects on cell behavior. In the case of miR-15/16, our published data, reinforced by the data in this manuscript, indicates that the relevant target network is very large, and that even very small changes in the expression of these targets is sufficient to alter the fate of antigen-responsive T cells in the setting of acute infection.

      This comment also raises the important issue of target validation, which is often difficult, since the effect size for each miRNA target is small (typically 10-30%, sometimes reaching 50% reduction). The expected effect of Malat1 inhibition of miR-15/16 is some fraction of that. Nevertheless, in Figure 3 and Figure 7, we validated two direct targets (CD28 and Bcl2) using flow cytometry, a technique that facilitates precise sampling of protein expression on a large number of individual cells.

      Minor concerns:

      The discussion is too broad and does not address the limitations of the study.

      We added a sentence to acknowledge the limitation regarding small effect sizes and the shortcomings of the acute infection models used in this study:

      “The magnitude of this effect was modest in acute LCMV and Listeria infection, two models that feature robust pathogen clearance, allowing assessment of memory T cells in the absence of chronic antigen persistence. Further work is needed to assess other settings in which Malat1:miR-15/16 interaction may have a bigger impact on the outcome of immune responses.”

      Reviewer 2:

      1) Given the lack of an effect on microRNA or Malat1 levels following the genetic modification is it possible that Malat1 is actually not directly bound by the miRNA? Could the knock-out of the miRNA could induce Ago2 loss on Malat1 by indirect mechanisms? If there is any room for doubt about a direct interaction the authors should at least mention discuss.

      There is very little room for doubt about the direct interaction between miR-15/16 and Malat1. The AHC data we report indicates that the loss of Ago2 binding to the mutant Malat1 occurs predominantly at the site containing the miR-15/16 binding site of interest. This suggests that the mutation we created does not affect global Ago2 levels or occupancy across the rest of the transcript. Further, the miR-15/16 KO data directly support this result, showing that miR-15/16 is necessary for Ago2 binding at that site. If loss of miR15/16 resulted in a non-specific indirect loss of binding to Malat1, we would expect that other binding events would be affected as well, which we do not observe.

      In the Results, the authors write: "miR-15/16 has not been previously shown to interact with Malat1", but they should cite/discuss: MALAT1 regulates the transcriptional and translational levels of proto-oncogene RUNX2 in colorectal cancer metastasis, Qing Ji et al, 2019.

      We thank the reviewer for bringing this study to our attention, and we have cited it in our updated version of the manuscript. While the interaction between miR-15/16 and Malat1 has been shown before, our study represents a significant step beyond this study in two important ways: The rigorous biochemical mapping of the miR-15/16:Malat1 interaction site, and direct evidence for the role of a miR:lncRNA interaction in an in vivo physiological phenotype.

      2) The authors write: "Only a few studies demonstrate sequence dependent function of lncRNAs (Elguindy and Mendell, 2021; Kleaveland et al., 2018; Lee et al., 1999)". But this seems more common that the statement implies (see for example this review: https://www.sciencedirect.com/science/article/pii/S002228361200896 0#s0065).Moreover, SNPs in lncRNAs are associated with pathologies (see for example: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306726/, where also SNPs in Malat1 are presented). The authors could acknowledge this and by reformulating their sentence and citing these.

      A large number of studies uncovered lncRNA functions without identifying RNA sequences that are responsible for that activity, but evidence for sequence-specific effects remain rare. We thank the reviewer for providing direction to additional sequence-specific studies and we have now cited several of them in the updated version of the introduction:

      “Studies demonstrating sequence dependent function of lncRNAs are comparatively rare (Carrieri et al., 2012; Elguindy and Mendell, 2021; Faghihi et al., 2008; Gong and Maquat, 2011; Kleaveland et al., 2018; Lee et al., 1999; Yoon et al., 2012).”

      In particular, association of important SNPs with lncRNA loci is an exciting motivator in the study of lncRNAs and can be informative in the dissection of lncRNA function. For Malat1 in the linked Minotti et al publication, we do not believe the SNPs referenced represent indications of sequence-specific transcript function. The SNPs identified for Malat1 are rs1194338, rs4102217, and rs591291. In the UCSC genome browser screenshot in Author response image 1, you can see that all of these SNPs are upstream of Malat1 and in regions of extremely dense H3K27Ac, suggesting enhancer function. These SNPs do not represent sequence specific function of the Malat1 transcript, but rather more likely genomic sequence regulation of Malat1 (or nearby gene) expression.

      Author response image 1.

      • Figure 2H: In the figure legend, could the authors clarify what they mean by "same conditions as in F"?

      We have updated the figure legend for clarity.

      • Figure 3 panel labels B, C, D don't match figure.

      We have corrected this and provided an updated figure.

      • Figure 4 D, E, F: Can the authors comment more about why in their opinion early activation genes are not significantly decreased in Malat1 scr/scr?

      Figure 4A shows that interrupting Malat1 interaction with miR-15/16 does affect the early induction of the immediate early gene CD69. Even miR-15/16 deficiency did not affect Nur77 expression, indicating that Malat1 and miR-15/16 regulate specific cues and signaling pathways involved in T cell activation. In particular, the transcriptomic analysis led us to focus on effects on costimulation-induced genes (Figure 3). Figure panels 4D, E, and F show the production of cytokines, including IL-2, which has been well documented to be responsive to CD28 signaling and clearly did so in our experiments. These data show a consistent increase in miR-15/16-deficient T cells, despite considerable noise in the assay. The trend toward reduced IL-2 in Malatscr/scr T cells is of smaller magnitude, as expected, and not statistically significant. Repeating this assay to obtain a better p value doesn’t seem warranted. However, we did independently observe decreased IL-2 production in Malatscr/scr T cells in an ex vivo cytokine capture assay (Figure 7F-G).

    1. Author response:

      The following is the authors’ response to the original reviews

      We thank the reviewers for their careful review of our manuscript and the constructive comments. We have addressed the majority of comments with either new experiments, analyses, and/or text revisions. A summary of the major changes is listed below, followed by our point-by-point responses to the reviewer comments.

      Major changes:

      (1) We sought to gain insight into the potential mechanistic cause of the increased intrinsic excitability of Cntnap2<sup>-/-</sup> dSPNs. Given that Kv1.1 and 1.2 potassium channels are known to interact with Caspr2 (the protein encoded by Cntnap2), we hypothesized that altered number, location, and/or function of these channels may underlie the excitability change in these cells. To investigate this, we performed new analyses of the initial dataset to assess action potential (AP) properties known to be impacted by potassium channel function. Indeed, we found that AP frequency was increased, and rheobase current, AP latency and AP threshold were decreased in Cntnap2<sup>-/-</sup> dSPNs, suggestive of altered Kv1.2 function. These data are in the new Supplemental Fig. 4. We also performed new electrophysiology experiments in which we pharmacologically blocked Kv1.1 and 1.2 to assess whether the effects of blocking these channels would be occluded in Cntnap2<sup>-/-</sup> dSPNs. We found that 1) WT dSPNs responded to blockade of Kv1.1/1.2 channels by increasing their excitability but Cntnap2<sup>-/-</sup> dSPNs did not and 2) Kv1.1/1.2 channels were more important contributors to the excitability of dSPNs compared to iSPNs. These new data are presented in the revised Fig. 4 and Supplemental. Figs. 5 and 6.

      (2) We performed additional experiments to assess excitatory synaptic properties, specifically AMPA/NMDA receptor ratio. This has been added to Fig. 1.

      (3) We performed more rigorous statistical analyses of the initial physiology datasets to align with the statistics performed for the revision experiments. This applies to Fig. 1, Fig. 2, Fig. 3, Fig. 5, and Supp. Fig. 2.

      (4) In the discussion section, we now highlight potential limitations of the study and further discuss the variable impact that Cntnap2 loss has on different cell types and brain regions.  

      Reviewer #1 (Public Review):

      Summary:

      Cording et al. investigated how deletion of CNTNAP2, a gene associated with autism spectrum disorder, alters corticostriatal engagement and behavior. Specifically, the authors present slice electrophysiology data showing that striatal projection neurons (SPNs) are more readily driven to fire action potentials in response to stimulation of corticostriatal afferents, and this is due to increases in SPN intrinsic excitability rather than changes in excitatory or inhibitory synaptic inputs. The authors show that CNTNAP2 mice display repetitive behaviors, enhanced motor learning, and cognitive inflexibility. Overall the authors' conclusions are supported by their data, but a few claims could use some more evidence to be convincing.

      Strengths:

      The use of multiple behavioral techniques, both traditional and cutting-edge machine learning-based analyses, provides a powerful means of assessing repetitive behaviors and behavioral transitions/rigidity.

      Characterization of both excitatory and inhibitory synaptic responses in slice electrophysiology experiments offers a broad survey of the synaptic alterations that may lead to increased corticostriatal engagement of SPNs.

      Weaknesses:

      (1) The authors conclude that increased cortical engagement of SPNs is due to changes in SPN intrinsic excitability rather than synaptic strength (either excitatory or inhibitory). One weakness is that only AMPA receptor-mediated responses were measured. Though the holding potential used for experiments in Figure 1FI wasn't clear, recordings were presumably performed at a hyperpolarized potential that limits NMDA receptormediated responses. Because the input-output experiments used to conclude that corticostriatal engagement of SPNs is elevated (Figure 1B-E) were conducted in the current clamp, it is possible that enhanced NMDA receptor engagement contributed to increased SPN responses to cortical stimulation. Confirming that NMDA receptor-mediated EPSC components are not altered would strengthen the main conclusion.

      The reviewer is correct, the initial optically-evoked EPSC assessments were performed at a hyperpolarized potential (-70mV), thus measuring primarily AMPAR-mediated currents. We agree that assessing potential changes in the NMDAR-mediated EPSC component is important and we have completed new experiments to assess this. We find no differences in NMDAR-mediated EPSCs assessed at +40mV or the AMPA:NMDA ratio.

      These results have been added to Fig. 1. An expanded analysis of these results is shown in Author response image 1. We note that the previous AMPAR-mediated EPSC results have been replicated in this additional experiment, again showing no change in Cntnap2<sup>-/-</sup> SPNs. 

      Author response image 1.

      AMPA and NMDA receptor-mediated EPSCs are unchanged in Cntnap2<sup>-/-</sup> SPNs. (A) Quantification (mean ± SEM) of AMPA:NMDA ratio per cell for Cntnap2<sup>+/+</sup> and Cntnap2<sup>-/-</sup> dSPNs, p=0.9537, MannWhitney test. (B) dSPN AMPA current per cell, p=0.6172, Mann-Whitney test. (C) dSPN NMDA current per cell, p=0.6009, Mann-Whitney test. (D) dSPN AMPA:NMDA ratio averaged by animal, p=0.8413, Mann-Whitney test. (E) dSPN AMPA current averaged by animal, p>0.9999, Mann-Whitney test. (F) dSPN NMDA current averaged by animal, p=0.6905, Mann-Whitney test. (G) Quantification (mean ± SEM) of AMPA:NMDA ratio per cell for Cntnap2<sup>+/+</sup> and Cntnap2<sup>-/-</sup> iSPNs, p=0.4104, Mann-Whitney test. (H) iSPN AMPA current per cell, p=0.9010, Mann-Whitney test. (I) iSPN NMDA current per cell, p=0.9512, two-tailed unpaired t test. (J) iSPN AMPA:NMDA averaged by animal, p=0.3095, Mann-Whitney test. (K) iSPN AMPA current averaged by animal, p=>0.9999, Mann-Whitney test. (L) iSPN NMDA current averaged by animal, p=0.8413, MannWhitney test. All values were recorded using 20% blue light intensity. For dSPNs: Cntnap2<sup>+/+</sup> n=22 cells from 5 mice, Cntnap2<sup>-/-</sup> n=22 cells from 5 mice. For iSPNs: Cntnap2<sup>+/+</sup> n=21 cells from 5 mice, Cntnap2<sup>-/-</sup>n=21 cells from 5 mice.

      (2) Data clearly show that SPN intrinsic excitability is increased in knockout mice. Given that CNTNAP2 has been linked to potassium channel regulation, it would be helpful to show and quantify additional related electrophysiology data such as negative IV curve responses and action potential hyperpolarization.

      We appreciate this suggestion. As indicated by the reviewer, Caspr2, has previously been shown to control the clustering of Kv1-family potassium channels in axons isolated from optic nerve and corpus callosum (PMIDs: 10624965, 12963709, 29300891). In particular, Caspr2 is known to associate directly with Kv1.2 (PMID: 29300891). To assess a potential contribution of Kv1.2 to the excitability phenotype, we performed additional analyses of our original dataset to quantify AP properties known to be impacted by changes in Kv1.2 function (i.e. latency to fire and AP threshold, new Supp. Fig. 4). We identified several changes in Cntnap2<sup>-/-</sup> dSPNs resembling those that occur in wild-type cells when Kv1.2 is blocked (i.e. reduced threshold and reduced latency to fire, Supp. Fig. 4). 

      We then performed a pharmacological experiment, blocking Kv1.2 using α-dendrotoxin (α-DTX) while recording intrinsic excitability to assess whether the effects of this drug on dSPN excitability were occluded in Cntnap2<sup>-/-</sup> cells. Indeed, we found that while blocking Kv1.2 in wild-type dSPNs significantly reduced threshold and increased intrinsic excitability, these effects were not seen in Cntnap2<sup>-/-</sup> dSPNs (new Fig. 4). We believe that this suggests an altered contribution of Kv1.2 to the intrinsic excitability of mutant dSPNs, owing to a change in the clustering, number, or function of these channels. Therefore, loss-of-function of Kv1.2 is a likely explanation for the enhanced intrinsic excitability of Cntnap2<sup>-/-</sup> dSPNs. Interestingly, we found that α-DTX had only subtle effects on iSPNs (Cntnap2 WT or mutant), suggesting a lesser contribution of this channel in controlling the excitability of indirect pathway cells. This finding can account for the relatively stronger effect of Cntnap2 loss on dSPN physiology. The results of these new experiments and analyses are presented in the new Fig. 4, Supp. Fig. 5 and Supp. Fig. 6. 

      (3) As it stands, the reported changes in dorsolateral striatum SPN excitability are only correlative with reported changes in repetitive behaviors, motor learning, and cognitive flexibility.

      We agree that we have not identified a causative relationship between the change in dorsolateral dSPN excitability and the behaviors that we measured in Cntnap2<sup>-/-</sup> mice. That said, in a previous study, we showed that selective deletion of the autism spectrum disorder (ASD) risk gene Tsc1 from dorsal striatal dSPNs resulted in increased corticostriatal drive and this was sufficient to increase rotarod motor learning (PMID: 34380034). Therefore, while we have not demonstrated causality in this study, we hypothesize that changes in dSPN excitability are likely to contribute to the behavioral phenotypes observed in Cntnap2<sup>-/-</sup> mice. 

      Reviewer #2 (Public Review):

      Summary:

      This is an important study characterizing striatal dysfunction and behavioral deficits in Cntnap2<sup>-/-</sup> mice. There is growing evidence suggesting that striatal dysfunction underlies core symptoms of ASD but the specific cellular and circuit level abnormalities disrupted by different risk genes remain unclear. This study addresses how the deletion of Cntnap2 affects the intrinsic properties and synaptic connectivity of striatal spiny projection neurons (SPN) of the direct (dSPN) and indirect (iSPN) pathways. Using Thy1-ChR2 mice and optogenetics the authors found increased firing of both types of SPNs in response to cortical afferent stimulation. However, there was no significant difference in the amplitude of optically-evoked excitatory postsynaptic currents (EPSCs) or spine density between Cntnap2<sup>-/-</sup> and WT SPNs, suggesting that the increased corticostriatal coupling might be due to changes in intrinsic excitability. Indeed, the authors found Cntnap2<sup>-/-</sup> SPNs, particularly dSPNs, exhibited higher intrinsic excitability, reduced rheobase current, and increased membrane resistance compared to WT SPNs. The enhanced spiking probability in Cntnap2<sup>-/-</sup> SPNs is not due to reduced inhibition. Despite previous reports of decreased parvalbumin-expressing (PV) interneurons in various brain regions of Cntnap2<sup>-/-</sup> mice, the number and function (IPSC amplitude and intrinsic excitability) of these interneurons in the striatum were comparable to WT controls.

      This study also includes a comprehensive behavioral analysis of striatal-related behaviors. Cntnap2<sup>-/-</sup> mice demonstrated increased repetitive behaviors (RRBs), including more grooming bouts, increased marble burying, and increased nose poking in the holeboard assay. MoSeq analysis of behavior further showed signs of altered grooming behaviors and sequencing of behavioral syllables. Cntnap2<sup>-/-</sup> mice also displayed cognitive inflexibility in a four-choice odor-based reversal learning assay. While they performed similarly to WT controls during acquisition and recall phases, they required significantly more trials to learn a new odor-reward association during reversal, consistent with potential deficits in corticostriatal function.

      Strengths:

      This study provides significant contributions to the field. The finding of altered SPN excitability, the detailed characterization of striatal inhibition, and the comprehensive behavioral analysis are novel and valuable to understanding the pathophysiology of Cntnap2<sup>-/-</sup> mice.

      Weaknesses:

      (1) The approach based on Thy-ChR2 mice has the advantage of overcoming issues caused by injection efficiency and targeting variability. However, the spread of oEPSC amplitudes across mice shown in panels of Figure 1 G/I is very high with almost one order of magnitude difference between some mice. Given this is one of the most important points of the study it will be important to further analyze and discuss what this variability might be due to. Typically, in acute slice recordings, the within-animal variability is larger than the variability across animals. From the sample sizes reported it seems the authors sampled a large number of animals, but with a relatively low number of neurons per animal (per condition). Could this be one of the reasons for this variability?

      We agree with the reviewer that the variability in these experiments is quite large. We have replicated these experiments in the process of performing AMPA:NMDA ratio recordings (see above response to Reviewer 1’s comment). We again find no differences in AMPAR-mediated EPSC amplitude between WT and mutant SPNs (Author response image 2). Notably, these experiments also demonstrate a large amount of variability. In the original dataset, a small number of cells were collected from each animal (~1-3 cells/mouse). However, the variability remains in the new dataset, in which more cells were collected from each animal (~4-6 cells/mouse). We find both withinanimal and between-animal variability, as can be seen in Author response image 2 (recordings made from the same animal are color-coordinated). Potential sources of variability in this experiment include: 1) variable expression of ChR2 per mouse, 2) variable innervation of ChR2-expressing terminals onto any given recorded cell, and/or 3) differences in prior plasticity state between cells (i.e. some neurons may have recently undergone corticostriatal LTP or LTD). 

      Author response image 2.

      Optically-evoked AMPAR EPSCs exhibit within- and between-animal variability. (A) Quantification of EPSC amplitude evoked in dSPNs at different light intensities from the original dataset, plotted by cell (line represents the mean, dots/squares represent average EPSC amplitude for each recorded cell). Cntnap2<sup>+/+</sup> n=17 cells from 8 mice, Cntnap2<sup>-/-</sup> n=13 cells from 5 mice. Repeated measures two-way ANOVA p values are shown; g x s F (2, 56) = 0.3879, geno F (1, 28) = 0.8098, stim F (1.047, 29.32) = 76.56. (B) Quantification of EPSC amplitude evoked in dSPNs, averaged by mouse (line represents the mean, dots/squares represent average EPSC amplitude for each mouse). Cntnap2<sup>+/+</sup> n=8 mice, Cntnap2<sup>-/-</sup> n=5 mice. Repeated measures two-way ANOVA p values are shown; g x s F (2, 22) = 0.2154, geno F (1, 11) = 0.2585, stim F (1.053, 11.58) = 49.68. (C) Quantification of EPSC amplitude in dSPNs from the revision dataset, plotted by cell (line represents the mean, dots/squares represent average EPSC amplitude for each recorded cell). Cntnap2<sup>+/+</sup> n=22 cells from 5 mice, Cntnap2<sup>-/-</sup> n=22 cells from 5 mice. Repeated measures two-way ANOVA p values are shown; g x s F (2, 84) = 0.01885, geno F (1, 42) = 0.002732, stim F (1.863, 78.26) = 20.93. (D) Quantification of EPSC amplitude in dSPNs from the revision dataset, averaged by mouse (line represents the mean, dots/squares represent average EPSC amplitude for each mouse). Cntnap2<sup>+/+</sup> n=5 mice, Cntnap2<sup>-/-</sup> n=5 mice. Repeated measures two-way ANOVA p values are shown; g x s F (2, 16) = 0.06288, geno F (1, 8) = 0.006548, stim F (1.585, 12.68) = 16.97. (E) Quantification of EPSC amplitude evoked in iSPNs from the original dataset, plotted by cell (line represents the mean, dots/squares represent average EPSC amplitude for each recorded cell). Cntnap2<sup>+/+</sup> n=13 cells from 6 mice, Cntnap2<sup>-/-</sup> n=11 cells from 5 mice. Repeated measures two-way ANOVA p values are shown; g x s F (2, 44) = 0.9414, geno F (1, 22) = 1.333, stim F (1.099, 24.18) = 52.26. (F) Quantification of EPSC amplitude evoked in iSPNs from original dataset, averaged by mouse (line represents the mean, dots/squares represent average EPSC amplitude for each mouse). Cntnap2<sup>+/+</sup> n=6 mice, Cntnap2<sup>-/-</sup> n=5 mice. Repeated measures two-way ANOVA p values are shown; g x s F (2, 18) = 0.4428, geno F (1, 9) = 0.5635, stim F (1.095, 9.851) = 23.82. (G) Quantification of EPSC amplitude evoked in iSPNs from the revision dataset, plotted by cell (line represents the mean, dots/squares represent average EPSC amplitude for each recorded cell). Cntnap2<sup>+/+</sup> n=21 cells from 5 mice, Cntnap2<sup>-/-</sup> n=21 cells from 5 mice. Repeated measures two-way ANOVA p values are shown; g x s F (2, 80) = 0.04134, geno F (1, 40) = 0.007025, stim F (1.208, 48.31) = 102.9. (H) Quantification of EPSC amplitude evoked in iSPNs from the revision dataset, averaged by mouse (line represents the mean, dots/squares represent average EPSC amplitude for each mouse). Cntnap2<sup>+/+</sup> n=5 mice, Cntnap2<sup>-/-</sup> n=5 mice. Repeated measures two-way ANOVA p values are shown; g x s F (2, 16) = 0.001865, geno F (1, 8) = 0.1004, stim F (1.179, 9.433) = 61.31.

      (2) This is particularly important because the analysis of corticostriatal evoked APs in panels C and E is performed on pooled data without considering the variability in evoked current amplitudes across animals shown in G and I. Were the neurons in panels C/E recorded from the same mice as shown in G/I? If so, it would be informative to regress AP firing data (say at 20% LED) to the average oEPSC amplitude recorded on those mice at the same light intensity. However, if the low number of neurons recorded per mouse is due to technical limitations, then increasing the sample size of these experiments would strengthen the study.

      We appreciate this point; however, the evoked AP experiment and the evoked EPSC experiment were performed on different mice, so it is not possible to correlate the data across experiments. While the evoked AP experiments were performed using potassium-based internal, we used a cesium-based internal to measure AMPAR-mediated EPSCs to more accurately detect synaptic currents. We note that the evoked AP experiments share a similar amount of variability as the evoked EPSC experiments, again possibly owing to variable expression of channelrhodopsin per mouse, variable innervation of ChR2-positive terminals onto individual cells, and/or differences in prior plasticity status between cells.  

      (3) On a similar note, there is no discussion of why iSPNs also show increased corticostriatal evoked firing in Figure 1E, despite the difference in intrinsic excitability shown in Figure 3. This suggests other potential mechanisms that might underlie altered corticostriatal responses. Given the role of Caspr2 in clustering K channels in axons, altered presynaptic function or excitability could also contribute to this phenotype, but potential changes in PPR have not been explored in this study.

      We have now performed more rigorous statistics on the data in Fig. 1 (repeated measures two-way ANOVA) such that the difference in corticostriatal evoked firing in Cntnap2<sup>-/-</sup> iSPNs no longer reaches statistical significance. This is consistent with the modest but statistically non-significant effect of Cntnap2 loss on iSPN intrinsic excitability. We agree with the reviewer that presynaptic alterations could potentially contribute to the changes in cortically-driven action potentials, especially as this experiment was performed without any synaptic blockers present, and Cntnap2 is deleted from all cells. That said, if changes in presynaptic release probability accounted for the increased corticostriatal drive, we would expect to see differences in cortically-evoked EPSCs onto SPNs. 

      While we can’t rule out the possibility of pre-synaptic changes, a straightforward explanation for our findings is that loss or alteration of Kv1.2 channel function is responsible for the increased excitability of Cntnap2<sup>-/-</sup> dSPNs, resulting in enhanced spiking in response to cortical input. Given the fact that Kv1.2 channels appear less important for regulating iSPN excitability (see new Fig. 4 and Supp. Fig. 6), this can explain the greater impact of Cntnap2 loss on dSPN physiology.

      (4) Male and female SPNs have different intrinsic properties but the number and/or balance of M/F mice used for each experiment is not reported.

      We agree that this is an important consideration. Author response table 1 provides the sex breakdown for the intrinsic excitability experiments. While we did not explicitly power the experiments to test for sex differences, Author response image 3 shows the data separated by sex and genotype for the intrinsic excitability experiments. Within genotype, we find no significant differences between males and females, except for Cntnap2<sup>-/-</sup> iSPNs which showed a significant interaction between sex and current step (Author response image 3F). Interestingly, while present in both sexes, the excitability shift of Cntnap2<sup>-/-</sup> dSPNs may be slightly more pronounced in females compared to males (Author response image 3C and D). However, this result would require further validation with a greater sample size.

      Author response table 1.

      Numbers of male and female mice used for the intrinsic excitability experiments.

      Author response image 3.

      Enhanced excitability of Cntnap2<sup>-/-</sup> dSPNs is present in both males and females. (A) Quantification (mean ± SEM) of the number of APs evoked in dSPNs in Cntnap2<sup>+/+</sup> males and females at different current step amplitudes. Cntnap2<sup>+/+</sup> males n=12 cells from 4 mice, Cntnap2<sup>+/+</sup> females n=8 cells from 4 mice. Repeated measures two-way ANOVA p values are shown; s x c F (28, 560) = 0.8992, sex F (1, 20) = 0.3754, current F (1.279, 25.57) = 56.85. (B) Quantification (mean ± SEM) of the number of APs evoked in dSPNs in Cntnap2<sup>-/-</sup> males and females at different current step amplitudes. Cntnap2<sup>-/-</sup> males n=12 cells from 4 mice, Cntnap2<sup>-/-</sup> females n=11 cells from 4 mice. Repeated measures two-way ANOVA p values are shown; s x c F (28, 588) = 0.6752, sex F (1, 21) = 0.04534, current F (2.198, 46.15) = 78.89. (C) Quantification (mean ± SEM) of the number of APs evoked in dSPNs in Cntnap2<sup>+/+</sup> males and Cntnap2<sup>-/-</sup> males at different current step amplitudes. Cntnap2<sup>+/+</sup> males n=12 cells from 4 mice, Cntnap2<sup>-/-</sup> males n=12 cells from 4 mice. Repeated measures two-way ANOVA p values are shown; g x c F (28, 672) = 2.233, geno F (1, 24) = 3.746, current F (1.708, 40.98) = 79.82. (D) Quantification (mean ± SEM) of the number of APs evoked in dSPNs in Cntnap2<sup>+/+</sup> females and Cntnap2<sup>-/-</sup> females at different current step amplitudes. Cntnap2<sup>+/+</sup> females n=8 cells from 4 mice, Cntnap2<sup>-/-</sup> females n=11 cells from 4 mice. Repeated measures two-way ANOVA p values are shown; g x c F (28, 476) = 1.547, geno F (1, 17) = 5.912, current F (1.892, 32.17) = 58.76. (E) Quantification (mean ± SEM) of the number of APs evoked in iSPNs in Cntnap2<sup>+/+</sup> males and females at different current step amplitudes. Cntnap2<sup>+/+</sup> males n=10 cells from 4 mice, Cntnap2<sup>+/+</sup> females n=12 cells from 4 mice. Repeated measures two-way ANOVA p values are shown; s x c F (28, 560) = 1.236, sex F (1, 20) = 1.074, current F (2.217, 44.34) = 179.6. (F) Quantification (mean ± SEM) of the number of APs evoked in iSPNs in Cntnap2<sup>-/-</sup> males and females at different current step amplitudes. Cntnap2<sup>-/-</sup> males n=12 cells from 4 mice, Cntnap2<sup>-/-</sup> females n=9 cells from 4 mice. Repeated measures two-way ANOVA p values are shown; s x c F (28, 532) = 2.513, sex F (1, 19) = 2.639, current F (1.858, 35.31) = 152.5. (G) Quantification (mean ± SEM) of the number of APs evoked in iSPNs in Cntnap2<sup>+/+</sup> males and Cntnap2<sup>-/-</sup> males at different current step amplitudes. Cntnap2<sup>+/+</sup> males n=10 cells from 4 mice, Cntnap2<sup>-/-</sup> males n=12 cells from 4 mice. Repeated measures twoway ANOVA p values are shown; g x c F (28, 560) = 0.4723, geno F (1, 20) = 0.5675, current F (2.423, 48.47) = 301.7. (H) Quantification (mean ± SEM) of the number of APs evoked in iSPNs in Cntnap2<sup>+/+</sup> females and Cntnap2<sup>-/-</sup> females at different current step amplitudes. Cntnap2<sup>+/+</sup> females n=12 cells from 4 mice, Cntnap2<sup>-/-</sup> females n=9 cells from 4 mice. Repeated measures two-way ANOVA p values are shown; g x c F (28, 532) = 1.655, geno F (1, 19) = 0.2322, current F (2.081, 39.55) = 99.45.

      (5) There is no mention of how membrane resistance was calculated, and no I/V plots are shown.

      Passive properties were calculated from the average of five -5 mV, 100 ms long test pulse steps applied at the beginning of every experiment. Membrane resistance was calculated from the double exponential curve fit. This has now been added to the methods section.

      (6) It would be interesting to see which behavior transitions most contribute to the decrease in entropy. Are these caused by repeated or perseverative grooming bouts? Or is this inflexibility also observed across other behaviors? The transition map in Figure S5 shows the overall number of syllables and transitions but not their sequence during behavior. Can this be analyzed by calculating the ratio of individual 𝑢𝑖 × 𝑝𝑖,𝑗 × log2 𝑝𝑖,𝑗 factors across genotypes?

      We thank the reviewer for raising an insightful question. Here we use a finite state Markov chain model to describe the syllable transitions in animal behavior. To quantify the randomness in the system, we calculated the entropy of the Markov chain (see methods section). The reviewer suggested calculating the partial entropy of the transition matrix, which would allow us to estimate the contribution of a subset of states to the entropy of the whole system, given by the equation:

      The partial equation can indeed quantify the stochasticity, or “flexibility” in our context, of the sub-system containing only a subset of the behavior syllables. However, there are two main limitations to this approach:

      (1) The partial entropy fails to account for the transitions connecting the subset with the rest of the states in the system

      (2) The stationary distribution may not reflect the actual probabilities in the isolated sub-system S.

      Consequently, the partial entropy cannot be directly interpreted as the fraction of contributions from specific syllable pairs or sub-system to the entropy of the whole system. To be more specific, while a significant difference between the same sub-system in WT and KO groups could indicate that the sub-system contributes significantly to the difference of overall entropy, a non-significant result does not mean that the sub-system does not contribute to overall entropy difference, as interactions between the sub-system and other notconsidered states are not accounted for.

      Author response image 4.

      Grooming syllables contribute to some but not all differences in syllable transitions in Cntnap2<sup>-/-</sup> mice. We calculated the entropy of each syllable pair using 𝑢𝑖 × 𝑝𝑖,𝑗 × log2 𝑝𝑖,𝑗 for every syllable pair and every animal. We then statistically tested the difference between genotypes for each syllable pair using Mann-Whitney tests. This plot displays those adjusted p-values for each syllable pair between WT and KO groups. The significant p-values suggest that the transitions to syllables 24 and 25 are different between genotypes (note that these correspond to grooming syllables, see Fig. 5N). However, since the overall entropy is a summation of every pair, it is difficult to conclude that syllables 24 and 25 are the sole contributors to the different entropy we observed.

      Reviewer #3 (Public Review):

      Summary:

      The authors analyzed Cntnap2 KO mice to determine whether loss of the ASD risk gene CNTNAP2 alters the dorsal striatum's function.

      Strengths:

      The results demonstrate that loss of Cntnap2 results in increased excitability of striatal projection neurons (SPNs) and altered striatal-dependent behaviors, such as repetitive, inflexible behaviors. Unlike other brain areas and cell types, synaptic inputs onto SPNs were normal in Cntnap2 KO mice. The experiments are welldesigned, and the results support the authors' conclusions.

      Weaknesses:

      The mechanism underlying SPN hyperexcitability was not explored, and it is unclear whether this cellular phenotype alone can account for the behavioral alterations in Cntnap2 KO mice. No clear explanation emerges for the variable phenotype in different brain areas and cell types.

      We agree that identifying the mechanism by which Cntnap2 loss affects intrinsic excitability is interesting and important. We have added experiments to address this and conclude that the improper clustering, number, or function of Kv1.2 channels in Cntnap2<sup>-/-</sup> dSPNs is likely responsible for their increased excitability. These channels are known to be clustered/organized in part by Caspr2 (PMIDs: 10624965, 12963709, 29300891), and Kv1.2 channels are known to play an important role in regulating excitability in SPNs (PMIDs: 13679409, 32075716). In the case of dSPNs, blocking these channels with α-DTX significantly increased the excitability of WT cells (as has been previously reported); however, this effect was occluded in mutant cells, perhaps owing to a decreased contribution of Kv1.2 channels to excitability in Cntnap2<sup>-/-</sup> dSPNs. In addition, we found that blockade of these channels with α-DTX only modestly affected the excitability of iSPNs. Therefore, this can explain why loss of Cntnap2 more strongly affects the excitability of dSPNs. Please see new Fig. 4, Supp. Fig. 5 and Supp. Fig. 6 for these new data. 

      We agree with the reviewer that we have not identified a causative relationship between the change in dSPN excitability and the behavioral alterations in Cntnap2<sup>-/-</sup> mice. This is a limitation of the study. 

      It is interesting to speculate on the root of the varying impacts to excitability that occur across different brain regions and cell types in Cntnap2<sup>-/-</sup> mice. Increased excitability, as we see in dSPNs, has been identified in cerebellar Purkinje cells and L2/3 pyramidal neurons in somatosensory cortex in the context of Cntnap2 loss (PMIDs: 34593517, 30679017, 36793543). However, other cell types in Cntnap2<sup>-/-</sup> mice have exhibited no change in excitability (mPFC, L2/3 pyramidal neurons, PMID: 31141683) or hypoexcitability (subset of L5/6 pyramidal neurons, PMID: 29112191). While all of these cell types express Kv1.2 channels, they fundamentally vary in their intrinsic properties, owing to the role that other ion channels play in membrane excitability. As a result, loss of Cntnap2 is expected to have a variable effect on excitability depending on the cell type and the complement of other ion channels that are present. In addition, an initial change in excitability may drive secondary, potentially compensatory, changes in other channels that lead to a different excitability state. These changes are also expected to be cell type-specific. We do note that both of the cell types that show increased excitability in the context of Cntnap2 loss have been shown to exhibit an α-DTX-sensitive Kv1 channel current, such that application of α-DTX results in increased firing of these cells (cerebellar Purkinje cells; PMIDs: 17087603, 16210348 and L2/3 pyramidal neurons in somatosensory cortex; PMID: 17215507). These findings are consistent with our results in Cntnap2<sup>-/-</sup> dSPNs. 

      Reviewer #1 (Recommendations For The Authors):

      More thorough analysis of some of the manually quantified behaviors would be helpful. For example, only the grooming bout number was presented- what about the duration of bouts and total time grooming? Similarly, for the open field the number of center entries was reported but what about the total time in the center?

      We have quantified the time spent grooming and total time spent in the center during the open field test from our original data (Author response image 5). These data were not originally included in the manuscript because they were recorded for only a subset of the total animals. For each of these measures we find trend level changes, which are consistent with the primary measures reported in the main manuscript. 

      Author response image 5.

      Time in center and time spent grooming trend towards an increase in Cntnap2<sup>-/-</sup> mice.  (A) Quantification (mean ± SEM) of total time spent in the center of the open field during a 60 minute test, p=0.0656, Mann-Whitney test. (B) Time spent grooming during the first 20 minutes of the open field test, p=0.0611, Mann-Whitney test. For both measurements, Cntnap2<sup>+/+</sup> n=18 mice, Cntnap2<sup>-/-</sup> n=19 mice.

      Reviewer #3 (Recommendations For The Authors):

      What accounts for the hyperexcitability observed in Cntnap2-deficient SPNs? The authors noted that excitability is reportedly increased, reduced, or unchanged in different brain areas. What accounts for this disparity? Is it about the subcellular localization of Kv1 channels? The authors may want to test this possibility experimentally. At least, they may want to test whether Kv1 channels are mislocalized in SPNs.

      We agree that this is an important point, and we have performed additional experiments to address this. We find that the Kv1.2 blocker a-DTX significantly increases the excitability of WT dSPNs but not Cntnap2<sup>-/-</sup> dSPNs. This suggests that the mechanism underlying dSPN hyperexcitability in Cntnap2 mutants is the improper clustering, number, or function of Kv1.2 channels. These channels are known to be clustered and organized in part by Caspr2 (PMIDs: 10624965, 12963709, 29300891) and have been shown to play an important role in regulating the excitability of SPNs (PMIDs: 13679409, 32075716). Interestingly, we find that a-DTX has less of an effect on the excitability of iSPNs, which may account for the greater impact of Cntnap2 loss on dSPNs. Please see new Fig. 4, Supp. Fig. 5 and Supp. Fig. 6 for these added data and analyses. 

      Please see above response to Reviewer #3 for our speculation on the variable impact of Cntnap2 loss on different cell types and brain regions. 

      We agree with the reviewer that assessing potential differences in subcellular localization of Kv1 channels in our model would bolster the conclusion that these channels are mislocalized in the Cntnap2<sup>-/-</sup> striatum. We piloted these experiments using immunohistochemistry to stain for Kv1.1 and 1.2 but found that without very high-resolution imaging, it would be challenging to accurately quantify Kv1 puncta in a cell type-specific manner. We instead chose to investigate the functional contribution of Kv1 channels to the dSPN hyperexcitability phenotype through the a-DTX experiments outlined above. α-DTX strongly inhibits Kv1.2 channels, but also Kv1.1 channels to some extent (PMIDs: 12042352, 13679409). We find that the effects of a-DTX on SPN excitability are occluded in Cntnap2<sup>-/-</sup> dSPNs; therefore, we conclude that Kv1.2 (and possibly Kv1.1) channels have reduced function in these cells. Further work will be needed to determine if this is a result of channel mislocalization or another type of alteration. 

      The authors did not detect synaptic changes in Cntnap-deficient SPNs. This important observation should be briefly discussed in the context of previous work in other brain regions and cell types. For example, some studies reported structural and functional changes at excitatory synapses. The variable impact on synapses suggests distinct compensatory mechanisms in different brain areas.

      Given the prior literature showing effects of Cntnap2 loss on synapses in other brain regions, we were surprised that striatal synapses were not impacted in our model. We agree with the reviewer that the variable changes in synaptic properties across brain regions in Cntnap2 mutant mice is likely a result of distinct compensatory changes in these regions. Differences may also arise depending on whether the synaptic changes originate from the post-synaptic cell or from pre-synaptic changes. An interesting direction for future studies would be to explore the developmental trajectory of excitability and synaptic changes to determine which may be initial perturbations versus those that are secondary and potentially compensatory.

      Line 138: "synaptic excitability". How is this term defined? Consider "synaptic changes" instead.

      “Synaptic excitability” was used to mean a change in the number and/or function of glutamate receptors. We have now changed this term to “excitatory synaptic changes.”

      Consider a short paragraph to highlight some limitations of this study. For example, it is unclear whether SPN hyperexcitability results from a compensatory change in Cntnap2 KO mice and whether the behavioral phenotype is solely due to this cellular phenotype. The study focuses on cortical projections onto SPNs, but these cells receive inputs from other brain areas that were not explored. Lastly, no clear explanation emerges for the variable phenotype in different brain areas and cell types.

      We thank the reviewer for this suggestion and have added several paragraphs to the discussion highlighting some limitations of this study.

      We hypothesize that the dSPN hyperexcitability in Cntnap2<sup>-/-</sup> mice is a primary change, due to the direct relationship between Caspr2 and Kv1.2 channels. The results of our -DTX experiments suggest that the function and/or contribution of these channels to excitability is altered in Cntnap2<sup>-/-</sup> dSPNs. However, it is possible that there are additional changes in dSPNs that occur as a result of Cntnap2 loss and contribute to the hyperexcitability of these cells. Rather surprisingly, we don’t find evidence for altered excitatory (specifically from cortical inputs) or inhibitory synaptic function, suggesting lack of engagement of homeostatic mechanisms at the synaptic level.

      We have not yet determined whether there is a causative relationship between the change in dSPN excitability and the behavioral alterations in Cntnap2<sup>-/-</sup> mice. This is a limitation of the current study. In our discussion section, we highlight that the dSPN changes we observe in dorsolateral striatum (DLS) are known to be sufficient to enhance rotarod learning in other mouse models and thus supports a connection between this cellular change and behavior. For the other behaviors we measured, we acknowledge that both DLS and other striatal or extra-striatal brain regions have been implicated in these behaviors, and therefore less of a direct connection can be made. 

      In terms of the inputs, we focused on cortical inputs given their known role in mediating motor and habit learning (PMID: 15242609, 16237445, 19198605). Notably, corticostriatal synapses have been shown to be altered across a variety of mouse models with mutations in ASD risk genes and therefore may be a point of convergence for disparate genetic insults (PMID: 31758607). We agree that the striatum receives inputs from a variety of brain regions, notably the thalamus, which we did not explore in this study. This would be an interesting area for future studies.

      Finally, it is difficult to speculate on the root of the varying impacts to excitability that occur across different brain regions and cell types in Cntnap2<sup>-/-</sup> mice. Please see above response to Reviewer #3 for some speculation on this point in regard to the potential involvement of Kv1.2 in the excitability changes in various Cntnap2<sup>-/-</sup> cell types. To expand upon this, it is known that ASD-associated mutations can have varying impacts on cell function even across similar cell types within a given brain region – we have seen this between dSPNs and iSPNs (this study, PMIDs: 34380034, 39358043), as have other groups studying ASD risk gene mutations in striatum (PMID: 24995986). This differential impact of the same mutation on intrinsic and/or synaptic physiology across cell types has been identified in other brain regions as well (PMID: 22884327, 26601124). Differences in transcriptional programs, protein expression, neuronal morphology, synaptic inputs and plasticity state make up a non-exhaustive set of variables that will impact the physiological function of a neuron, both in terms of the direct but also indirect consequences of an ASD risk gene mutation. To better address this important question, future studies would benefit from a systematic approach to assessing physiological changes in a given ASD mouse model, both across development and across brain regions.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Thank you for the detailed and constructive reviews. We revised the paper accordingly, and a point-by-point reply appears below. The main changes are:

      • An extended discussion section that places our work in context with other related developments in theory and modeling.

      • A new results section that demonstrates a substantial improvement in performance from a non-linear activation function. This led to addition of a co-author.

      • The mathematical proof that the resolvent of the adjacency matrix leads to the shortest path distances has been moved to a separate article, available as a preprint and attached to this resubmission. This allows us to present that work in the context of graph theory, and focus the present paper on neural modeling.

      Reviewer #1 (Public Review):

      This paper presents a highly compelling and novel hypothesis for how the brain could generate signals to guide navigation towards remembered goals. Under this hypothesis, which the authors call "Endotaxis", the brain co-opts its ancient ability to navigate up odor gradients (chemotaxis) by generating a "virtual odor" that grows stronger the closer the animal is to a goal location. This idea is compelling from an evolutionary perspective and a mechanistic perspective. The paper is well-written and delightful to read.

      The authors develop a detailed model of how the brain may perform "Endotaxis", using a variety of interconnected cell types (point, map, and goal cells) to inform the chemotaxis system. They tested the ability of this model to navigate in several state spaces, representing both physical mazes and abstract cognitive tasks. The Endotaxis model performed reasonably well across different environments and different types of goals.

      The authors further tested the model using parameter sweeps and discovered a critical level of network gain, beyond which task performance drops. This critical level approximately matched analytical derivations.

      My main concern with this paper is that the analysis of the critical gain value (gamma_c) is incomplete, making the implications of these analyses unclear. There are several different reasonable ways in which the Endotaxis map cell representations might be normalized, which I suspect may lead to different results. Specifically, the recurrent connections between map cells may either be an adjacency matrix, or a normalized transition matrix. In the current submission, the recurrent connections are an unnormalized adjacency matrix. In a previous preprint version of the Endotaxis manuscript, the recurrent connections between the map cells were learned using Oja's rule, which results in a normalized state-transition matrix (see "Appendix 5: Endotaxis model and the successor representation" in "Neural learning rules for generating flexible predictions and computing the successor representation", your reference 17). The authors state "In summary, this sensitivity analysis shows that the optimal parameter set for endotaxis does depend on the environment". Is this statement, and the other conclusions of the sensitivity analysis, still true if the learned recurrent connections are a properly normalized state-transition matrix?

      Yes, this is an interesting topic. In v.1 of our bioRxiv preprint we used Oja’s rule for learning, which will converge on a map connectivity that reflects the transition probabilities. The matrix M becomes a left-normalized or right-normalized stochastic matrix, depending on whether one uses the pre-synaptic or the post-synaptic version of Oja’s rule. This is explained well in Appendix 5 of Fang 2023.

      In the present version of the model we use a rule that learns the adjacency matrix A, not the transition matrix T. The motivation is that we want to explain instances of oneshot learning, where an agent acquires a route after traversing it just once. For example, we had found experimentally that mice can execute a complex homing route on the first attempt.

      An agent can establish whether two nodes are connected (adjacency) the very first time it travels from one node to the other. Whereas it can evaluate the transition probability for that link only after trying this and all the other available links on multiple occasions. Hence the normalization terms in Oja’s rule, or in the rule used by Fang 2023, all involve some time-averaging over multiple visits to the same node. This implements a gradual learning process over many experiences, rather than a one-shot acquisition on the first experience.

      Still one may ask whether there are advantages to learning the transition matrix rather than the adjacency matrix. We looked into this with the following results:

      • The result that (1/γ − A)−1 is monotonically related to the graph distances D in the limit of small γ (a proof now moved to the Meister 2023 preprint) , holds also for the transition matrix T. The proof follows the same steps. So in the small gain limit, the navigation model would work with T as well.

      • If one uses the transition matrix to compute the network output (1/γ − T)-1 then the critical gain value is γc = 1. It is well known that the largest eigenvalue of any Markov transition matrix is 1, and the critical gain γc is the inverse of that. This result is independent of the graph. So this offers the promise that the network could use the same gain parameter γ regardless of the environment.

      • In practice, however, the goal signal turned out to be less robust when based on T than when based on A. We illustrate this with the attached Author response image 1. This replicates the analysis in Figure 3 of the manuscript, using the transition matrix instead of the adjacency matrix. Some observations:

      • Panel B: The goal signal follows an exponential dependence on graph distance much more robustly for the model with A than with T. This holds even for small gain values where the exponential decay is steep.

      • Panel C: As one raises the gain closer to the critical value, the goal signal based on T scatters much more than when based on A.

      • Panels D, E: Navigation based on A works better than based on T. For example, using the highest practical gain value, and a readout noise of ϵ = 0.01, navigation based on T has a range of only 8 steps on this graph, whereas navigation based on A ranges over 12 steps, the full size of this graph.

      We have added a section “Choice of learning rule” to explain this. The Author response image 1 is part of the code notebook on Github.

      Author response image 1.

      Overall, this paper provides a very compelling model for how neural circuits may have evolved the ability to navigate towards remembered goals, using ancient chemotaxis circuits.

      This framework will likely be very important for understanding how the hippocampus (and other memory/navigation-related circuits) interfaces with other processes in the brain, giving rise to memory-guided behavior.

      Reviewer #2 (Public Review):

      The manuscript presents a computational model of how an organism might learn a map of the structure of its environment and the location of valuable resources through synaptic plasticity, and how this map could subsequently be used for goal-directed navigation.

      The model is composed of 'map cells', which learn the structure of the environment in their recurrent connections, and 'goal-cell' which stores the location of valued resources with respect to the map cell population. Each map cell corresponds to a particular location in the environment due to receiving external excitatory input at this location. The synaptic plasticity rule between map cells potentiates synapses when activity above a specified threshold at the pre-synaptic neuron is followed by above-threshold activity at the post-synaptic neuron. The threshold is set such that map neurons are only driven above this plasticity threshold by the external excitatory input, causing synapses to only be potentiated between a pair of map neurons when the organism moves directly between the locations they represent. This causes the weight matrix between the map neurons to learn the adjacency for the graph of locations in the environment, i.e. after learning the synaptic weight matrix matches the environment's adjacency matrix. Recurrent activity in the map neuron population then causes a bump of activity centred on the current location, which drops off exponentially with the diffusion distance on the graph. Each goal cell receives input from the map cells, and also from a 'resource cell' whose activity indicates the presence or absence of a given values resource at the current location. Synaptic plasticity potentiates map-cell to goal-cell synapses in proportion to the activity of the map cells at time points when the resource cell is active. This causes goal cell activity to increase when the activity of the map cell population is similar to the activity where the resource was obtained. The upshot of all this is that after learning the activity of goal cells decreases exponentially with the diffusion distance from the corresponding goal location. The organism can therefore navigate to a given goal by doing gradient ascent on the activity of the corresponding goal cell. The process of evaluating these gradients and using them to select actions is not modelled explicitly, but the authors point to the similarity of this mechanism to chemotaxis (ascending a gradient of odour concentration to reach the odour source), and the widespread capacity for chemotaxis in the animal kingdom, to argue for its biological plausibility.

      The ideas are interesting and the presentation in the manuscript is generally clear. The two principle limitations of the manuscript are: i) Many of the ideas that the model implements have been explored in previous work. ii) The mapping of the circuit model onto real biological systems is pretty speculative, particularly with respect to the cerebellum.

      Regarding the novelty of the work, the idea of flexibly navigating to goals by descending distance gradients dates back to at least Kaelbling (Learning to achieve goals, IJCAI, 1993), and is closely related to both the successor representation (cited in manuscript) and Linear Markov Decision Processes (LMDPs) (Piray and Daw, 2021, https://doi.org/ 10.1038/s41467-021-25123-3, Todorov, 2009 https://doi.org/10.1073/pnas.0710743106). The specific proposal of navigating to goals by doing gradient descent on diffusion distances, computed as powers of the adjacency matrix, is explored in Baram et al. 2018 (https://doi.org/10.1101/421461), and the idea that recurrent neural networks whose weights are the adjacency matrix can compute diffusion distances are explored in Fang et al. 2022 (https://doi.org/10.1101/2022.05.18.492543). Similar ideas about route planning using the spread of recurrent activity are also explored in Corneil and Gerstner (2015, cited in manuscript). Further exploration of this space of ideas is no bad thing, but it is important to be clear where prior literature has proposed closely related ideas.

      We have added a discussion section on “Theories and models of spatial learning” with a survey of ideas in this domain and how they come together in the Endotaxis model.

      Regarding whether the proposed circuit model might plausibly map onto a real biological system, I will focus on the mammalian brain as I don't know the relevant insect literature. It was not completely clear to me how the authors think their model corresponds to mammalian brain circuits. When they initially discuss brain circuits they point to the cerebellum as a plausible candidate structure (lines 520-546). Though the correspondence between cerebellar and model cell types is not very clearly outlined, my understanding is they propose that cerebellar granule cells are the 'map-cells' and Purkinje cells are the 'goal-cells'. I'm no cerebellum expert, but my understanding is that the granule cells do not have recurrent excitatory connections needed by the map cells. I am also not aware of reports of place-field-like firing in these cell populations that would be predicted by this correspondence. If the authors think the cerebellum is the substrate for the proposed mechanism they should clearly outline the proposed correspondence between cerebellar and model cell types and support the argument with reference to the circuit architecture, firing properties, lesion studies, etc.

      On further thought we agree that the cerebellum-like circuits are not a plausible substrate for the endotaxis algorithm. The anatomy looks compelling, but plasticity at the synapse is anti-hebbian, and - as the reviewer points out - there is little evidence for recurrence among the inputs. We changed the discussion text accordingly.

      The authors also discuss the possibility that the hippocampal formation might implement the proposed model, though confusingly they state 'we do not presume that endotaxis is localized to that structure' (line 564).

      We have removed that confusing bit of text.

      A correspondence with the hippocampus appears more plausible than the cerebellum, given the spatial tuning properties of hippocampal cells, and the profound effect of lesions on navigation behaviours. When discussing the possible relationship of the model to hippocampal circuits it would be useful to address internally generated sequential activity in the hippocampus. During active navigation, and when animals exhibit vicarious trial and error at decision points, internally generated sequential activity of hippocampal place cells appears to explore different possible routes ahead of the animal (Kay et al. 2020, https://doi.org/10.1016/j.cell.2020.01.014, Reddish 2016, https:// doi.org/10.1038/nrn.2015.30). Given the emphasis the model places on sampling possible future locations to evaluate goal-distance gradients, this seems highly relevant.

      In our model, the possible future locations are sampled in real life, with the agent moving there or at least in that direction, e.g. via VTE movements. In this simple form the model has no provision for internal planning, and the animal never learns any specific route sequence. One can envision extending such a model with some form of sequence learning that would then support an internal planning mechanism. We mention this in the revised discussion section, along with citation of these relevant articles.

      Also, given the strong emphasis the authors place on the relationship of their model to chemotaxis/odour-guided navigation, it would be useful to discuss brain circuits involved in chemotaxis, and whether/how these circuits relate to those involved in goal-directed navigation, and the proposed model.

      The neural basis of goal-directed navigation is probably best understood in the insect brain. There the locomotor decisions seem to be initiated in the central complex, whose circuitry is getting revealed by the fly connectome projects. This area receives input from diverse sensory areas that deliver the signal on which the decisions are based. That includes the mushroom body, which we argue has the anatomical structure to implement the endotaxis algorithm. It remains a mystery how the insect chooses a particular goal for pursuit via its decisions. It could be revealing to force a change in goals (the mode switch in the endotaxis circuit) while recording from brain areas like the central complex. Our discussion now elaborates on this.

      Finally, it would be useful to clarify two aspects of the behaviour of the proposed algorithm:

      1) When discussing the relationship of the model to the successor representation (lines 620-627), the authors emphasise that learning in the model is independent of the policy followed by the agent during learning, while the successor representation is policy dependent. The policy independence of the model is achieved by making the synapses between map cells binary (0 or 1 weight) and setting them to 1 following a single transition between two locations. This makes the model unsuitable for learning the structure of graphs with probabilistic transitions, e.g. it would not behave adaptively in the widely used two-step task (Daw et al. 2011, https://doi.org/10.1016/ j.neuron.2011.02.027) as it would fail to differentiate between common and rare transitions. This limitation should be made clear and is particularly relevant to claims that the model can handle cognitive tasks in general. It is also worth noting that there are algorithms that are closely related to the successor representation, but which learn about the structure of the environment independent of the subjects policy, e.g. the work of Kaelbling which learns shortest path distances, and the default representation in the work of Piray and Daw (both referenced above). Both these approaches handle probabilistic transition structures.

      Yes. Our problem statement assumes that the environment is a graph with fixed edge weights. The revised text mentions this and other assumptions in a new section “Choice of learning rule”.

      2) As the model evaluates distances using powers of adjacency matrix, the resulting distances are diffusion distances not shortest path distances. Though diffusion and shortest path distances are usually closely correlated, they can differ systematically for some graphs (see Baram et al. ci:ted above).

      The recurrent network of map cells implements a specific function of the adjacency matrix, namely the resolvent (Eqn 7). We have a mathematical proof that this function delivers the shortest graph distances exactly, in the limit of small gain (γ in Eqn 7), and that this holds true for all graphs. For practical navigation in the presence of noise, one needs to raise the gain to something finite. Figure 3 analyzes how this affects deviations from the shortest graph distance, and how nonetheless the model still supports effective navigation over a surprising range. The mathematical details of the proof and further exploration of the resolvent distance at finite gain have been moved to a separate article, which is cited from here, and attached to the submission. The preprint by Baram et al. is cited in that article.

      Reviewer #3 (Public Review):

      This paper argues that it has developed an algorithm conceptually related to chemotaxis that provides a general mechanism for goal-directed behaviour in a biologically plausible neural form.

      The method depends on substantial simplifying assumptions. The simulated animal effectively moves through an environment consisting of discrete locations and can reliably detect when it is in each location. Whenever it moves from one location to an adjacent location, it perfectly learns the connectivity between these two locations (changes the value in an adjacency matrix to 1). This creates a graph of connections that reflects the explored environment. In this graph, the current location gets input activation and this spreads to all connected nodes multiplied by a constant decay (adjusted to the branching number of the graph) so that as the number of connection steps increases the activation decreases. Some locations will be marked as goals through experiencing a resource of a specific identity there, and subsequently will be activated by an amount proportional to their distance in the graph from the current location, i.e., their activation will increase if the agent moves a step closer and decrease if it moves a step further away. Hence by making such exploratory movements, the animal can decide which way to move to obtain a specified goal.

      I note here that it was not clear what purpose, other than increasing the effective range of activation, is served by having the goal input weights set based on the activation levels when the goal is obtained. As demonstrated in the homing behaviour, it is sufficient to just have a goal connected to a single location for the mechanism to work (i.e., the activation at that location increases if the animal takes a step closer to it); and as demonstrated by adding a new graph connection, goal activation is immediately altered in an appropriate way to exploit a new shortcut, without the goal weights corresponding to this graph change needing to be relearnt.

      As the reviewer states, allowing a graded strengthening of multiple synapses from the map cells increases the effective range of the goal signal. We have now confirmed this in simulations. For example, in the analysis of Fig 3E, a single goal synapse enables perfect navigation only over a range of 7 steps, whereas the distributed goal synapses allow perfect navigation over the full 12 steps. This analysis is included in the code notebook on Github.

      Given the abstractions introduced, it is clear that the biological task here has been reduced to the general problem of calculating the shortest path in a graph. That is, no real-world complications such as how to reliably recognise the same location when deciding that a new node should be introduced for a new location, or how to reliably execute movements between locations are addressed. Noise is only introduced as a 1% variability in the goal signal. It is therefore surprising that the main text provides almost no discussion of the conceptual relationship of this work to decades of previous work in calculating the shortest path in graphs, including a wide range of neural- and hardwarebased algorithms, many of which have been presented in the context of brain circuits.

      The connection to this work is briefly made in appendix A.1, where it is argued that the shortest path distance between two nodes in a directed graph can be calculated from equation 15, which depends only on the adjacency matrix and the decay parameter (provided the latter falls below a given value). It is not clear from the presentation whether this is a novel result. No direct reference is given for the derivation so I assume it is novel. But if this is a previously unknown solution to the general problem it deserves to be much more strongly featured and either way it needs to be appropriately set in the context of previous work.

      As far as we know this proposal for computing all-pairs-shortest-path is novel. We could not find it in textbooks or an extended literature search. We have discussed it with two graph theorist colleagues, who could not recall seeing it before, although the proof of the relationship is elementary. Inspired by the present reviewer comment, we chose to publish the result in a separate article that can focus on the mathematics and place it in the appropriate context of prior work in graph theory. For related work in the area of neural modeling please see our revised discussion section.

      Once this principle is grasped, the added value of the simulated results is somewhat limited. These show: 1) in practical terms, the spreading signal travels further for a smaller decay but becomes erratic as the decay parameter (map neuron gain) approaches its theoretical upper bound and decreases below noise levels beyond a certain distance. Both follow the theory. 2) that different graph structures can be acquired and used to approach goal locations (not surprising) .3) that simultaneous learning and exploitation of the graph only minimally affects the performance over starting with perfect knowledge of the graph. 4) that the parameters interact in expected ways. It might have been more impactful to explore whether the parameters could be dynamically tuned, based on the overall graph activity.

      This is a good summary of our simulation results, but we differ in the assessment of their value. In our experience, simulations can easily demolish an idea that seemed wonderful before exposure to numerical reality. For example, it is well known that one can build a neural integrator from a recurrent network that has feedback gain of exactly 1. In practical simulations, though, these networks tend to be fickle and unstable, and require unrealistically accurate tuning of the feedback gain. In our case, the theory predicts that there is a limited range of gains that should work, below the critical value, but large enough to avoid excessive decay of the signal. Simulation was needed to test what this practical range was, and we were pleasantly surprised that it is not ridiculously small, with robust navigation over a 10-20% range. Similarly, we did not predict that the same parameters would allow for effective acquisition of a new graph, learning of targets within the graph, and shortest-route navigation to those targets, without requiring any change in the operation of the network.

      Perhaps the most biologically interesting aspect of the work is to demonstrate the effectiveness, for flexible behaviour, of keeping separate the latent learning of environmental structure and the association of specific environmental states to goals or values. This contrasts (as the authors discuss) with the standard reinforcement learning approach, for example, that tries to learn the value of states that lead to reward. Examples of flexibility include the homing behaviour (a goal state is learned before any of the map is learned) and the patrolling behaviour (a goal cell that monitors all states for how recently they were visited). It is also interesting to link the mechanism of exploration of neighbouring states to observed scanning behaviours in navigating animals.

      The mapping to brain circuits is less convincing. Specifically, for the analogy to the mushroom body, it is not clear what connectivity (in the MB) is supposed to underlie the graph structure which is crucial to the whole concept. Is it assumed that Kenyon cell connections perform the activation spreading function and that these connections are sufficiently adaptable to rapidly learn the adjacency matrix? Is there any evidence for this?

      Yes, there is good evidence for recurrent synapses among Kenyon cells (map cells in the model), and for reward-gated synaptic plasticity at the synapses onto mushroom body output cells (goal cells in our model). We have expanded this material in the discussion section. Whether those functions are sufficient to learn the structure of a spatial environment has not been explored; we hope our paper might give an impetus, and are exploring behavioral experiments on flies with colleagues.

      As discussed above, the possibility that an algorithm like 'endotaxis' could explain how the rodent place cell system could support trajectory planning has already been explored in previous work so it is not clear what additional insight is gained from the current model.

      Please see our revised discussion section on “theories and models of spatial learning”. In short, some ingredients of the model have appeared in prior work, but we believe that the present formulation offers an unexpectedly simple end-to-end solution for all components of navigation: exploration, target learning, and goal seeking.

      Reviewer #1 (Recommendations For The Authors):

      Major concern:

      See the public review. How do the results change depending on whether the recurrent connections between map cells are an adjacency matrix vs. a properly normalized statetransition matrix? I'm especially asking about results related to critical gain (gamma_c), and the dependence of the optimal parameter values on the environment.

      Please see our response above including the attached reviewer figure.

      Minor concerns:

      It is not always clear when the learning rule is symmetric vs asymmetric (undirected vs directed graph), and it seems to switch back and forth. For example, line 127 refers to a directed graph; Fig 2B and the intro describe symmetric Hebbian learning. Most (all?) of the simulations use the symmetric rule. Please make sure it's clear.

      For simplicity we now use a symmetric rule throughout, as is appropriate for undirected graphs. We mention that a directed learning rule could be used to learn directed graphs. See the section on “choice of learning rule”. M_ij is not defined when it's first introduced (eq 4). Consider labeling the M's and the G's in Fig 2.

      Done.

      The network gain factor (gamma, eq 4) is distributed over both external and recurrent inputs (v = gamma(u + Mv)), instead of local to the recurrent weights like in the Successor Representation. This notational choice is obviously up to the authors. I raise slight concern for two reasons -- first, distributing gamma may affect some of the parameter sweep results (see major concern), and second, it may be confusing in light of how gamma is used in the SR literature (see reviewer's paper for the derivation of how SR is computed by an RNN with gain gamma).

      In our model, gamma represents the (linear) activation function of the map neuron, from synaptic input to firing output. Because the synaptic input comes from point cells and also from other map cells, the gain factor is applied to both. See for example the Dayan & Abbott book Eqn 7.11, which at steady state becomes our Eqn 4. In the formalism of Fang 2023 (Eqn 2), the factor γ is only applied to the recurrent synaptic input J ⋅ f, but somehow not to the place cell input ϕ. Biophysically, one could imagine applying the variable gain only to the recurrent synapses and not the feed-forward ones. Instead we prefer to think of it as modulating the gain of the neurons, rather than the synapses. The SR literature follows conventions from the early reinforcement learning papers, which were unconstrained by thinking about neurons and synapses. We have added a footnote pointing the reader to the uses of γ in different papers.

      In eq 13, and simulations, noise is added to the output only, not to the activity of recurrently connected neurons. It is possible this underestimates the impact of noise since the same magnitude of noise in the recurrent network (map cells) could have a compounded effect on the output.

      Certainly. The equivalent output noise represents the cumulative effect of noise everywhere in the network. We argue that a cumulative effect of 1% is reasonable given the overall ability of animals at stimulus discrimination, which is also limited by noise everywhere in the network. This has been clarified in the text.

      Fig 3 E, F, it looks like the navigated distance may be capped. I ask because the error bars for graph distance = 12 are so small/nonexistent. If it's capped, this should be in the legend.

      Correct. 12 is the largest distance on this graph. This has been added to the caption.

      Fig 3D legend, what does "navigation failed" mean? These results are not shown.

      On those occasions the agent gets trapped at a local maximum of the goal signal other than the intended goal. We have removed that line as it is not needed to interpret the data.

      Line 446, typo (Lateron).

      Fixed.

      Line 475, I'm a bit confused by the discussion of birds and bats. Bird behavior in the real world does involve discrete paths between points. Even if they theoretically could fly between any points, there are costs to doing so, and in practice, they often choose discrete favorite paths. It is definitely plausible that animals that can fly could also employ Endotaxis, so it is confusing to suggest they don't have the right behavior for Endotaxis, especially given the focus on fruit flies later in the discussion.

      Good points, we removed that remark. Regarding fruit flies, they handle much important business while walking, such as tracking a mate, fighting rivals over food, finding a good oviposition site.

      Section 9.3, I'm a bit confused by the discussion of cerebellum-like structures, because I don't think they have as dense recurrent connections as needed for the map cells in Endotaxis. Are you suggesting they are analogous to the output part of Endotaxis only, not the whole thing?

      Please see our reply in the public review. We have removed this discussion of cerebellar circuits.

      Line 541, "After sufficient exploration...", clarify that this is describing learning of just the output synapses, not the recurrent connections between map cells?

      We have revised this entire section on the arthropod mushroom body.

      In lines 551-556, the discussion is confusing and possibly not consistent with current literature. How can a simulation prove that synapses in the hippocampus are only strengthened among immediately adjacent place fields? I'd suggest either removing this discussion or adding further clarification. More broadly, the connection between Endotaxis and the hippocampus is very compelling. This might also be a good point to bring up BTSP (though you do already bring it up later).

      As suggested, we removed this section.

      Line 621 "The successor representation (at least as currently discussed) is designed to improve learning under a particular policy" That's not actually accurate. Ref 17 (reviewer's manuscript, cited here) is not policy-specific, and instead just learns the transition statistics experienced by the animal, using a biologically plausible learning rule that is very similar to the Endotaxis map cell learning rule (see our Appendix 5, comparing to Endotaxis, though that was referencing the previous version of the Endotaxis preprint where Oja's rule was used).

      We have edited this section in the discussion and removed the reference to policyspecific successor representations.

      Line 636 "Endotaxis is always on" ... this was not clear earlier in the paper (e.g. line 268, and the separation of different algorithms, and "while learning do" in Algorithm 2).

      The learning rules are suspended during some simulations so we can better measure the effects of different parts of endotaxis, in particular learning vs navigating. There is no interference between these two functions, and an agent benefits from having the learning rules on all the time. The text now clarifies this in the relevant sections.

      Section 9.6, I like the idea of tracing different connected functions. But when you say "that could lead to the mode switch"... I'm a bit confused about what is meant here. A mode switch doesn't need to happen in a different brain area/network, because winnertake-all could be implemented by mutual inhibition between the different goal units.

      This is an interesting suggestion for the high-level control algorithm. A Lorenzian view is that the animal’s choice of mode depends on internal states or drives, such as thirst vs hunger, that compete with each other. In that picture the goal cells represent options to be pursued, whereas the choice among the options occurs separately. But one could imagine that the arbitrage between drives happens through a competition at the level of goal cells: For example the consumption of water could lead to adaptation of the water cell, such that it loses out in the winner-take-all competition, the food cell takes over, and the mouse now navigates towards food. In this closed-loop picture, the animal doesn’t have to “know” what it wants at any given time, it just wants the right thing. This could eliminate the homunculus entirely! Of course this is all a bit speculative. We have edited the closing comments in a way that leaves open this possibility.

      Line 697-704, I need more step-by-step explanation/derivation.

      We now derive the properties of E step by step starting from Eqn (14). The proof that leads to Eqn 14 is now in a separate article (available as a preprint and attached to this submission).

      Reviewer #3 (Recommendations For The Authors):

      • Please include discussion and comparison to previous work of graph-based trajectory planning using spreading activation from the current node and/or the goal node. Here is a (far from comprehensive) list of papers that present similar algorithms:

      Glasius, R., Komoda, A., & Gielen, S. C. (1996). A biologically inspired neural net for trajectory formation and obstacle avoidance. Biological Cybernetics, 74(6), 511-520.

      Gaussier, P., Revel, A., Banquet, J. P., & Babeau, V. (2002). From view cells and place cells to cognitive map learning: processing stages of the hippocampal system. Biological cybernetics, 86(1), 15-28.

      Gorchetchnikov A, Hasselmo ME. A biophysical implementation of a bidirectional graph search algorithm to solve multiple goal navigation tasks. Connection Science. 2005;17(1-2):145-166

      Martinet, L. E., Sheynikhovich, D., Benchenane, K., & Arleo, A. (2011). Spatial learning and action planning in a prefrontal cortical network model. PLoS computational biology, 7(5), e1002045.

      Ponulak, F., & Hopfield, J. J. (2013). Rapid, parallel path planning by propagating wavefronts of spiking neural activity. Frontiers in computational neuroscience, 7, 98.

      Khajeh-Alijani, A., Urbanczik, R., & Senn, W. (2015). Scale-free navigational planning by neuronal traveling waves. PloS one, 10(7), e0127269.

      Adamatzky, A. (2017). Physical maze solvers. All twelve prototypes implement 1961 Lee algorithm. In Emergent computation (pp. 489-504). Springer, Cham.

      Please see our reply to the public review above, and the new discussion section on “Theories and models of spatial learning”, which cites most of these papers among others.

      • Please explain, if it is the case, why the goal cell learning (other than a direct link between the goal and the corresponding map location) and calculation of the overlapping 'goal signal' is necessary, or at least advantageous.

      Please see our reply in the public review above.

      • Map cells are initially introduced (line 84) as getting input from "only one or a few point cells". The rest of the paper seems to assume only one. Does it work when this is 'a few'? Does it matter that 'a few' is an option?

      We simplified the text here to “only one point cell”. A map cell with input from two distant locations creates problems. After learning the map synapses from adjacencies in the environment, the model now “believes” that those two locations are connected. This distorts the graph on which the graph distances are computed and introduces errors in the resulting goal signals. One can elaborate the present toy model with a much larger population of map cells that might convey more robustness, but that is beyond our current scope.

      • (line 539 on) Please explain what feature in the mushroom body (or other cerebellumlike) circuits is proposed to correspond to the learning of connections in the adjacency matrix in the model.

      Please see our response to this critique in the public review above. In the mushroom body, the Kenyon cells exhibit sparse responses and are recurrently connected. These would correspond to map cells in Endotaxis. For vertebrate cerebellum-like circuits, the correspondence is less compelling, and we have removed this topic from the discussion.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Lu et. al. proposed here a direct role of LPS in inducing hepatic fat accumulation and that the metabolism of LPS therefore can mitigate fatty liver injury. With an Acyloxyacyl hydrolase whole-body KO mice, they demonstrated that Acyloxyacyl hydrolase deletion resulted in higher hepatic fat accumulation over 8 months of high glucose/high fructose diet. Previous literature has found that hepatocyte TLR4 (which is a main receptor for binding LPS) KO reduced fatty liver in the MAFLD model, and this paper complements this by showing that degradation/metabolism of LPS can also reduce fatty liver. This result proposed a very interesting mechanism and the translational implications of utilizing Acyloxyacyl hydrolase to decrease LPS exposure are intriguing.

      The strengths of the present study include that they raised a very simplistic mechanism with LPS that is of interest in many diseases. The phenotype shown in the study is strong. The mechanism proposed by the findings is generally well supported.

      There are also several shortcomings in the findings of this study. As AOAH is a whole-body KO, the source production of AOAH in MAFLD is unclear. Although the authors used published single-cell RNA-seq data and flow-isolated liver cells, physiologically LPS degradation could occur in the blood or the liver. The authors linked LPS to hepatocyte fatty acid oxidation via SREBP1. The mechanism is not explored in great depth. Is this signaling TLR4? In this model, LPS could activate macrophages and mediate the worsening of hepatocyte fatty liver injury via the paracrine effect instead of directly signaling to hepatocytes, thus it is not clear that this is a strictly hepatocyte LPS effect. It would also be very interesting to see if administration of the AOAH enzyme orally could mitigate MAFLD injury. Overall, this work will add to the current understanding of the gut-liver axis and development of MAFLD and will be of interest to many readers.

      We thank the reviewers for their important questions and comments.

      In previous studies we found that AOAH is expressed in Kupffer cells and dendritic cells cells (Shao et al., 2007). Single-cell RNAseq analysis of mouse livers by others has found AOAH in Kupffer cells, monocytes, NK cells and ILC1 cells (Remmerie et al.,2020). We also analyzed human liver single-cell RNAseq data and found that AOAH is expressed in monocytes, macrophages, resident and circulating NK cells, and some T cells (Ramachandran et al., 2019) (Please see new Figure 3E). Using clodronate-liposomes to deplete Kupffer cells we found that hepatic AOAH mRNA diminished and nSREBP1 increased (Please see new Figure 5D). These results suggest that Kupffer cells are the major source of AOAH in the liver and that LPS needs to be inactivated in the liver to prevent hepatocyte lipid accumulation.

      Using primary hepatocyte culture, we found that LPS can stimulate hepatocytes directly to induce mTOR activation and SREBP1 activation (new Figure 6E). Adding purified Kupffer cells to the hepatocyte culture did not further increase SREBP1 activation. These results suggest that LPS may directly stimulate hepatocyte to accumulate fat, at least in vitro.

      Both TLR4 and caspase 11 are reported to play important roles in MASLD development (Sharifnia et al., 2015; Zhu et al., 2021). We have crossed Aoah<sup>-/-</sup> mice with TLR4<sup>-/-</sup> mice and found that Aoah<sup>-/-</sup>TLR4<sup>-/-</sup> and Aoah<sup>-/-</sup> mice had similarly severe MASLD. This is probably because TLR4 is required for gut homeostasis (Rakoff-Nahoum et al., 2004); in TLR4 whole-body KO mice compromised gut homeostasis may result in more severe MASLD. By specifically deleting TLR4 on hepatocytes, Yu et al found that NASH-induced fibrosis was mitigated (Yu et al., 2021). In future studies we therefore would need to specifically delete TLR4 in hepatocytes to test whether excessive gut-derived LPS in Aoah<sup>-/-</sup> mice stimulates hepatic TLR4 to induce more severe MASLD. We would also test whether Caspase 11 is required for hepatic fat accumulation in Aoah<sup>-/-</sup> mice.

      It is intriguing to test whether providing exogenous AOAH may mitigate MASLD. We will use an AAV expressing AOAH to test this idea.

      Reviewer #2 (Public review):

      The authors of this article investigated the impact of the host enzyme AOAH on the progression of MASLD in mice. To achieve this, they utilized whole-body Aoah<sup>-/-</sup> mice. The authors demonstrated that AOAH reduced LPS-induced lipid accumulation in the liver, probably by decreasing the expression and activation of SREBP1. In addition, AOAH reduced hepatic inflammation and minimized tissue damage.

      However, this paper is descriptive without a clear mechanistic study. Another major limitation is the use of whole-body KO mice so the cellular source of the enzyme remains undefined. Moreover, since LPS-mediated SREBP1 regulation or LPS-mediated MASLD progression is already documented, the role of AOAH in SREBP1-dependent lipid accumulation and MASLD progression is largely expected.

      Specific comments:

      (1) The overall human relevance of the current study remains unclear.

      It is a good point. We have studied human relevance and show the results in Figure 3E. AOAH expression increased in the hepatic macrophages and monocytes of MASLD patients.

      (2) Is AOAH secreted from macrophages or other immune cells? Are there any other functions of AOAH within the cells?

      AOAH can be secreted from kidney proximal tubule cells and the released AOAH can be taken up by cells that do not express AOAH (Feulner et al., 2004). AOAH can also deacylate oxidized phospholipids, DAMP molecules (Zou et al., 2021).

      (3) Due to using whole-body KO mice, the role of AOAH in specific cell types was unclear in this study, which is one of the major limitations of this study. The authors should at least conduct in vitro experiments using a co-culture system of hepatocytes and Kupffer cells (or other immune cells) isolated from WT or Aoah<sup>-/-</sup> mice.

      Thanks for the suggestion.

      Using clodronate-liposomes, we depleted Kupffer cells and found that hepatic AOAH mRNA diminished and nSREBP1 increased in the liver (Please see new Figure 5D). These results confirm that Kupffer cells are the major source of AOAH in the liver and LPS needs to be inactivated in the liver to prevent hepatocyte lipid accumulation.  Using primary hepatocyte culture, we found that LPS can stimulate hepatocytes directly to induce mTOR activation and SREBP1 activation (new Figure 6E).  These results suggest that LPS may directly stimulate hepatocytes to accumulate fat, at least in vitro.

      (4) It has been well-known that intestinal tight junction permeability is increased by LPS or inflammatory cytokines. However, in Figure 3E, intestinal permeability is comparable between the groups in both diet groups. The authors should discuss more about this result. In addition, intestinal junctional protein should be determined by Western blot and IHC (or IF) to further confirm this finding.

      We have stained ZO-1 (Please see Author response image 1, ZO-1- green fluorescence) in Aoah<sup>+/+</sup> and Aoah<sup>-/-</sup> mouse colonic sections. We did not see a big difference between the two strains of mice.

      Author response image 1.

      Feeding a high fat diet in our mouse facility for 28 weeks has led to increased gut permeability, but there was no difference between Aoah<sup>+/+</sup> and Aoah<sup>-/-</sup>mice. Thus, the more severe MASLD in Aoah<sup>-/-</sup> mice is mainly caused by elevated bioactive LPS instead of increased LPS translocation from the intestine to the liver.

      (5) In Figure 6, the LPS i.g. Aoah<sup>-/-</sup> group is missing. This group should be included to better interpret the results.

      Please see new Figure 6. When we orally gavaged Aoah<sup>-/-</sup> mice with LPS, fecal LPS levels did not increase further. Their liver SREBP1 did not increase further while the SREBP1 target gene expression increased when compared with Aoah<sup>-/-</sup> mice i.g. PBS.

      (6) The term NAFLD has been suggested to be changed to MASLD as the novel nomenclature according to the guidelines of AASLD and EASL.

      Thanks for the suggestion. We have changed NAFLD to MASLD.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Consider using MAFLD rather than NAFLD.

      Thanks for the suggestion. We have changed NAFLD to MASLD.

      References

      Feulner, J.A., M. Lu, J.M. Shelton, M. Zhang, J.A. Richardson, and R.S. Munford. 2004. Identification of acyloxyacyl hydrolase, a lipopolysaccharide-detoxifying enzyme, in the murine urinary tract. Infection and immunity 72:3171-3178.

      Zou, B., M. Goodwin, D. Saleem, W. Jiang, J. Tang, Y. Chu, R.S. Munford, and M. Lu. 2021. A highly conserved host lipase deacylates oxidized phospholipids and ameliorates acute lung injury in mice. eLife 10:

    1. Author Response

      The following is the authors’ response to the current reviews.

      Comment 1: The descriptions about body weights should be matched.

      Regrettably, we did not monitor the body weights throughout the study. We have now revised the description clarifying the confusions. Importantly we evaluated the weights of the muscle (EDL and soleus) and heart tissues in 8-month-old mice (Fig. 1A).

      Comment 2: Quantitative data for figures.

      As stated in the manuscript, the presented images are representatives of at least three mice per genotype. However, assessing specific measurements such as cell sizes, diameters, or mitochondria sizes in histological tissue sections and electron microscopical fields is not feasible due to practical limitations. Unfortunately, we do not have access to specialized software for such analyses. While semi-quantification of Western blot bands is possible, implementing this for all Western blots in the manuscript would result in a substantial increase in the number of bar graphics. Below are Western blots from additional two pairs of mice used in all figures.

      Comment 3: Confusions about “total mitochondrial content”.

      The mitochondria content in cells was assessed by quantitatively comparing the DNA level of the mitochondrial gene cytochrome B to that of the nuclear gene 18S using quantitative PCR. This method is commonly used to determine the relative number of mitochondria in cells. However, we have revised and provided a clearer description in the figure legend to avoid any potential confusion.

      Comment 4: Suggestions on further analyses of PGC1-alpha and TFAM. LC3-I and -II.

      We evaluated LC3-I/II levels in PTPMT1 knockout muscles, and our findings did not indicate any signs of increased autophagic activity (Supplementary Figure S3). We will examine PGC1-alph and TFAM levels in our future studies. It is worth noting that in our previous RNA-seq analyses of PTPMT1 knockout hematopoietic cells, we did not observe any significant alterations in the expression levels of these two genes.

      Comment 5: Description on fibrotic lesions.

      Quantifying fibrotic areas poses a significant challenge. Therefore, we were only able to describe this finding.

      Comment 6: Fig 6 is not well organized and aligned.

      In response to your suggestion, we have reorganized this figure accordingly. Panels C, D, and E display mitochondrial OCR data derived from three biological replicates/genotype. We feel that these changes are sufficient to demonstrate the differences in substrate utilization between PTPMT1 knockout and control mitochondria.

      Comment 7: Descriptions on glucose oxidation and glycolysis in different types of muscle fibers are confusing

      We have followed the suggestions and revised the descriptions accordingly.

      Comment 8: A discussion about lactate utilization in cardiomyocytes would be helpful.

      Following this suggestion, we have now added a brief discussion.

      Comment 9: “Cropped” images were used in Fig 10.

      The images shown in Fig. 10 were not cropped images. In order to efficiently use the tissue and mitochondrial lysates, the Western blot membranes were intentionally cut into smaller fragments based on the molecular weights of the proteins to be detected. These smaller membrane sections were then employed for individual Western blotting purposes.

      Minor comment 1: The order of Fig 1 panels should be reorganized.

      Following this suggestion, we have now reorganized this figure.

      Minor comment 2: Suggestion for an Echocardiograph result table.

      These analyses were carried out by trained personnel at the Emory Animal Physiology Core. The data presented in our manuscript was provided by them. It is important to note that no additional parameters were measured beyond the data provided by the Core.

      Minor comment 3: Is ROS production increased in PTPMT1 knockout muscle cells?

      Yes, PTPMT1 knockout tissues showed elevated overall cellular ROS levels even at 3 months (Figure 6I).

      Minor comment 4: Typo in S10 legend.

      The typo has been corrected.


      The following is the authors’ response to the original reviews.

      Comment 1: The effects of PTPMT1 on the skeletal muscle and heart might be an embryonic defect. They might be mediated by significantly reduced mTOR signaling

      We acknowledge the valid point made by this reviewer. While both CKMM-Cre and Myh6Cre express Cre during the embryonic stage, we did not observe any developmental defects in skeletal muscle-specific (PTPMT1fl/fl/CKMM-Cre) or heart-specific (PTPMT1fl/fl/Myh6-Cre) knockout mice. These knockout mice appeared indistinguishable from their WT littermates until the age of 3-4 months.

      Morphologically, the skeletal muscle and heart dissected from these mice showed no abnormalities. Additionally, mitochondria isolated from these tissues did not exhibit any morphological/structural defects. Undoubtedly, the late-onset phenotypes observed in the knockout mice over time was attributed to the metabolic defects arising from the loss of PTPMT1 in the embryos. Although PTPMT1 knockout muscle cells and cardiomyocytes initially maintained energy homeostasis through enhanced fatty acid and glutamate oxidation, along with metabolic adaptations or activation of alternative energy-producing pathways in the first few months, they eventually encountered substantial energy deficits. This was attributed to the subsequent occurrence of oxidative stress and mitochondrial damage. In response to this valuable feedback, we have included a brief discussion in the manuscript's discussion section to address this point.

      As mentioned in the manuscript, the late-onset phenotypes observed in our study were likely a result of subsequent damages induced by prolonged metabolic substrate shift and lipid accumulation within the cells. We agree with the reviewer that decreased mTOR activities may also contribute to these late effects, and have included a brief discussion in the discussion section.

      Comment 2: Why are the effects of the loss of PTPMT1 similar in the skeletal muscle and heart.

      The depletion of PTPMT1 yields similar effects in both tissue types; however, the manifestations occur earlier in the skeletal muscle. Although mitochondria in the skeletal muscle and heart have distinct preferences for energy sources, prolonged forced utilization of fatty acids caused by PTPMT1 depletion eventually leads to lipid accumulation and cellular damage (lipotoxicity) in both tissue types. This phenomenon underscores the importance of maintaining a balance in substrate utilization to prevent adverse effects on cellular health in the skeletal muscle and heart.

      Comment 3: AMPK is activated in PTPMT1 knockout cardiomyocytes; this should have cardioprotective effects.

      AMPK can be activated through various mechanisms. In our study, AMPK activation occurs in response to energetic stress in late-stage PTPMT1 knockout tissues that displayed significantly reduced ATP levels, aligning with its role as a bioenergetic stress sensor. It is possible that AMPK activation alone was insufficient to overcome the secondary damages induced by the prolonged metabolic switch from carbohydrate metabolism to fatty acid metabolism.

      Comment 4: Knockout skeletal muscles and hearts had lipid accumulation; why were knockout mice smaller than controls? Are there any changes in white fat, core temperature or browning of fat? Rescue experiments should be considered to prove that lipid accumulation is the cause of death in the knockout mice.

      We believe that the lipid accumulation observed in muscle cells and cardiomyocytes of the knockout mice does not necessarily imply that these tissue-specific knockout mice would be heavier or have increased body fat. We appreciate the suggestions regarding energy expenditure tests and rescue experiments. We will certainly consider incorporating these experiments into our future study.

      As stated in the manuscript, we did not observe any morphological changes in white or brown fat tissues in the adipocyte-specific PTPMT1 knockout mice. Furthermore, we assessed body temperature and its response to a cold environment (4°C), and no differences were detected between the knockout mice and the control mice.

      Comment 5: Are there sex differences in muscle and heart phenotypes in the tissue specific knockout mice?

      We did not observe significant differences in phenotypes between male and female knockout mice.

      Comment 6: What happens to UCP2 activity in PTPMT1 deleted cells and what is its function in mediating AMPK and/mTOR regulation.

      Currently, there is a lack of direct methods available to measure UCP2 activity. The relationship between UCP2 and the regulation of AMPK and mTOR has not been extensively investigated.

      Comment 7: What is the effect of PTPMT1 deletion on cardiolipin synthesis?

      PTPMT1 has been implicated in both facilitating mitochondrial utilization of pyruvate and participating in the synthesis of cardiolipin. To investigate the impact of PTPMT1 knockout on cardiolipin levels, we plan to establish a mass spectrometry assay for the quantitative analysis of cardiolipin in knockout mitochondria. Completing these experiments might require a considerable amount of time. Nonetheless, we extensively addressed this point in the discussion section.

      Minor concerns:

      Comment 8: The title needs more specificity.

      As suggested, we have revised the title to "Loss of PTPMT1 restricts mitochondrial utilization of carbohydrates and induces muscle atrophy and heart failure in tissue-specific knockout mice".

      Comment 9: Heart and skeletal muscle weights in Fig 1A should be normalized against tibia length.

      Unfortunately, we did not perform normalization in this study. However, we appreciate the suggestion and will incorporate it into our future studies. It is important to note that the lengths of tibias in the knockout mice were only marginally shorter.

      Comment 10: Low magnification and longitudinal section of the muscle should be shown in Fig 1B and 2A.

      The histological images provide supporting evidence for the conclusion, despite not being optimal in quality. We acknowledge the suggested improvements and assure you that we will integrate them into our future studies. It is crucial to emphasize that each conclusion in this study was derived from multiple experimental designs, rather than solely relying on morphological changes.

      Comment 11: Fig 1F is mislabeled as 1G.

      We have conducted a thorough review and can confidently confirm that the labeling is correct.

      Comment 12: Fig 2F and 6B should be quantified.

      As indicated in the manuscript, the images presented are representatives of at least three mice per genotype. While semi-quantification of Western blot bands is possible, implementing this for all Western blots in the manuscript would result in a substantial increase in the number of bar graphics. Below are Western blot images from additional two pairs of mice included in Fig. 2F and Fig. 6B. Furthermore, Western blot images from two additional pairs of mice in other figures are also provided below.

      Author response image 1

      Western blotting data from additional two pairs of mice in Fig. 2F.

      Author response image 2

      Western blotting data from additional two pairs of mice in Fig. 6B.

      Author response image 3

      Western blotting data from additional two pairs of mice in Supplementary Fig. 2G.

      Author response image 4

      Western blotting data from additional two pairs of mice in Supplementary Fig. 3A.

      Author response image 5

      Western blotting data from additional two pairs of mice in Supplementary Fig. 3C.

      Author response image 6

      Western blotting data from additional two pairs of mice in Supplementary Fig. 3D.

      Author response image 7

      Western blotting data from additional two pairs of mice in Supplementary Fig. 4F.

      Author response image 8

      Western blotting data from additional two pairs of mice in

      Author response image 9

      Western blotting data from additional two pairs of mice in Supplementary Fig. 7C.

      Comment 13: Knockout mice should be placed on HFD or keto diet to test for the effects of PTPMT1 depletion.

      We appreciate this thoughtful suggestion. We will certainly incorporate this suggestion into our future studies, expanding beyond the scope of the current initial report.

      Comment 14: Suggestions on Fig 4A.

      Please see our response to Comment 10.

      Comment 15: Suggestions for improving echocardiographs.

      These analyses were conducted by trained personnel at the Emory Animal Physiology Core. The data presented in our manuscript was provided by them. We appreciate bringing the issues to our attention, and we will inform them accordingly.

      Comment 16: Comment on Fig 5B.

      The tissues were sectioned at comparable, if not identical, levels. WT and PTPMT1 knockout heart sections look dramatically different because of the dilated myopathy observed in the knockout hearts.

      Comment 17: Comment on Fig 5C.

      We believe the cell death occurred predominantly in cardiomyocytes.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Gating of Kv10 channels is unique because it involves coupling between non-domain swapped voltage sensing domains, a domain-swapped cytoplasmic ring assembly formed by the N- and C-termini, and the pore domain. Recent structural data suggests that activation of the voltage sensing domain relieves a steric hindrance to pore opening, but the contribution of the cytoplasmic domain to gating is still not well understood. This aspect is of particular importance because proteins like calmodulin interact with the cytoplasmic domain to regulate channel activity. The effects of calmodulin (CaM) in WT and mutant channels with disrupted cytoplasmic gating ring assemblies are contradictory, resulting in inhibition or activation, respectively. The underlying mechanism for these discrepancies is not understood. In the present manuscript, Reham Abdelaziz and collaborators use electrophysiology, biochemistry and mathematical modeling to describe how mutations and deletions that disrupt inter-subunit interactions at the cytoplasmic gating ring assembly affect Kv10.1 channel gating and modulation by CaM. In the revised manuscript, additional information is provided to allow readers to identify within the Kv10.1 channel structure the location of E600R, one of the key channel mutants analyzed in this study. However, the mechanistic role of the cytoplasmic domains that this study focuses on, as well as the location of the ΔPASCap deletion and other perturbations investigated in the study remain difficult to visualize without additional graphical information. This can make it challenging for readers to connect the findings presented in the study with a structural mechanism of channel function.

      The authors focused mainly on two structural perturbations that disrupt interactions within the cytoplasmic domain, the E600R mutant and the ΔPASCap deletion. By expressing mutants in oocytes and recording currents using Two Electrode Voltage-Clamp (TEV), it is found that both ΔPASCap and E600R mutants have biphasic conductance-voltage (G-V) relations and exhibit activation and deactivation kinetics with multiple voltage-dependent components. Importantly, the mutant-specific component in the G-V relations is observed at negative voltages where WT channels remain closed. The authors argue that the biphasic behavior in the G-V relations is unlikely to result from two different populations of channels in the oocytes, because they found that the relative amplitude between the two components in the G-V relations was highly reproducible across individual oocytes that otherwise tend to show high variability in expression levels. Instead, the G-V relations for all mutant channels could be well described by an equation that considers two open states O1 and O2, and a transition between them; O1 appeared to be unaffected by any of the structural manipulations tested (i.e. E600R, ΔPASCap, and other deletions) whereas the parameters for O2 and the transition between the two open states were different between constructs. The O1 state is not observed in WT channels and is hypothesized to be associated with voltage sensor activation. O2 represents the open state that is normally observed in WT channels and is speculated to be associated with conformational changes within the cytoplasmic gating ring that follow voltage sensor activation, which could explain why the mutations and deletions disrupting cytoplasmic interactions affect primarily O2. 

      Severing the covalent link between the voltage sensor and pore reduced O1 occupancy in one of the deletion constructs. Although this observation is consistent with the hypothesis that voltage-sensor activation drives entry into O1, this result is not conclusive. Structural as well as functional data has established that the coupling of the voltage sensor and pore does not entirely rely on the S4-S5 covalent linker between the sensor and the pore, and thus the severed construct could still retain coupling through other mechanisms, which is consistent with the prominent voltage dependence that is observed. If both states O1 and O2 require voltage sensor activation, it is unclear why the severed construct would affect state O1 primarily, as suggested in the manuscript, as opposed to decreasing occupancy of both open states. In line with this argument, the presence of Mg2+ in the extracellular solution affected both O1 and O2. This finding suggests that entry into both O1 and O2 requires voltage-sensor activation because Mg2+ ions are known to stabilize the voltage sensor in its most deactivated conformations. 

      We agree with the reviewer that access to both states requires a conformational change in the voltage sensor. This was stated in our revised article: “In contrast, to enter O2, all subunits must complete both voltage sensor transitions and the collective gating ring transition.” We interpret the two gating steps as sequential; the effective rotation of the intracellular ring would happen only once the sensor is in its fully activated position.

      We also agree that the S4-S5 segment cannot be the only interaction mechanism, as we demonstrated in our earlier work (Lörinczi et al., 2015; Tomczak et al., 2017).  

      Activation towards and closure from O1 is slow, whereas channels close rapidly from O2. A rapid alternating pulse protocol was used to take advantage of the difference in activation and deactivation kinetics between the two open components in the mutants and thus drive an increasing number of channels towards state O1. Currents activated by the alternating protocol reached larger amplitudes than those elicited by a long depolarization to the same voltage. This finding is interpreted as an indication that O1 has a larger macroscopic conductance than O2. In the revised manuscript, the authors performed single-channel recordings to determine why O1 and O2 have different macroscopic conductance. The results show that at voltages where the state O1 predominates, channels exhibited longer open times and overall higher open probability, whereas at more depolarized voltages where occupancy of O2 increases, channels exhibited more flickery gating behavior and decreased open probability. These results are informative but not conclusive because additional details about how experiments were conducted, and group data analysis are missing. Importantly, results showing inhibition of single ΔPASCap channels by a Kv10-specific inhibitor are mentioned but not shown or quantitated - these data are essential to establish that the new O1 conductance indeed represents Kv10 channel activity.

      We observed the activity of a channel compatible with Kv10.1 ΔPAS-Cap (long openings at low-moderate potentials, very short flickery activity at strong depolarizations) in 12 patches from oocytes obtained from different frog operations over a period of two and a half months once the experimental conditions could be established. As stated in the text, we did not proceed to generate amplitude histograms because we could not resolve clear single-channel events at strong depolarizations. Astemizole abolished the activity and (remarkably) strongly reduced the noise in traces at strong depolarizations, which we interpret as partially caused by flicker openings.

      Author response image 1.

      We include two example recordings of Astemizole application (100µM) on two different patches. Both recordings are performed at -60 mV (to decrease the likelihood that the channel visits O2) with 100 mM internal and 60 mM external K+. In both cases, the traces in Astemizole are presented in red.

      It is shown that conditioning pulses to very negative voltages result in mutant channel currents that are larger and activate more slowly than those elicited at the same voltage but starting from less negative conditioning pulses. In voltage-activated curves, O1 occupancy is shown to be favored by increasingly negative conditioning voltages. This is interpreted as indicating that O1 is primarily accessed from deeply closed states in which voltage sensors are in their most deactivated position. Consistently, a mutation that destabilizes these deactivated states is shown to largely suppress the first component in voltage-activation curves for both ΔPASCap and E600R channels.

      The authors then address the role of the hidden O1 state in channel regulation by calmodulation. Stimulating calcium entry into oocytes with ionomycin and thapsigarging, assumed to enhance CaM-dependent modulation, resulted in preferential potentiation of the first component in ΔPASCap and E600R channels. This potentiation was attenuated by including an additional mutation that disfavors deeply closed states. Together, these results are interpreted as an indication that calcium-CaM preferentially stabilizes deeply closed states from which O1 can be readily accessed in mutant channels, thus favoring current activation. In WT channels lacking a conducting O1 state, CaM stabilizes deeply closed states and is therefore inhibitory. It is found that the potentiation of ΔPASCap and E600R by CaM is more strongly attenuated by mutations in the channel that are assumed to disrupt interaction with the C-terminal lobe of CaM than mutations assumed to affect interaction with the N-terminal lobe. These results are intriguing but difficult to interpret in mechanistic terms. The strong effect that calcium-CaM had on the occupancy of the O1 state in the mutants raises the possibility that O1 can be only observed in channels that are constitutively associated with CaM. To address this, a biochemical pull-down assay was carried out to establish that only a small fraction of channels are associated with CaM under baseline conditions. These CaM experiments are potentially very interesting and could have wide physiological relevance. However, the approach utilized to activate CaM is indirect and could result in additional nonspecific effects on the oocytes that could affect the results.

      Finally, a mathematical model is proposed consisting of two layers involving two activation steps for the voltage sensor, and one conformational change in the cytoplasmic gating ring - completion of both sets of conformational changes is required to access state O2, but accessing state O1 only requires completion of the first voltage-sensor activation step in the four subunits. The model qualitatively reproduces most major findings on the mutants. Although the model used is highly symmetric and appears simple, the mathematical form used for the rate constants in the model adds a layer of complexity to the model that makes mechanistic interpretations difficult. In addition, many transitions that from a mechanistic standpoint should not depend on voltage were assigned a voltage dependence in the model. These limitations diminish the overall usefulness of the model which is prominently presented in the manuscript. The most important mechanistic assumptions in the model are not addressed experimentally, such as the proposition that entry into O1 depends on the opening of the transmembrane pore gate, whereas entry into O2 involves gating ring transitions - it is unclear why O2 would require further gating ring transitions to conduct ions given that the gating ring can already support permeation by O1 without any additional conformational changes.

      In essence, we agree with the reviewer; we already have addressed these points in our revised article:

      Regarding the voltage dependence we write “the κ/λ transition could reasonably be expected to be voltage independent because we related it to ring reconfiguration, a process that should occur as a consequence of a prior VSD transition. We have made some attempts to treat this transition as voltage independent but state-specific with upper-layer bias for states on the right and lower-layer bias for states on the left. This is in principle possible, as can already be gleaned from the similar voltage ranges of the left-right transition (α/β) and the κL/λ transition. However, this approach leads to a much larger number of free, less well constrained kinetic parameters and drastically complicated the parameter search. ” As you can see, we also formulated a strategy to free the model of the potentially spurious voltage dependence and (in bold here) explained why we did not follow this route in this study. 

      Regarding the need for gating ring transitions after O1, we wrote, “Thus, the underlying gating events can be separated into two steps: The first gating step involves only the voltage sensor without engaging the ring and leads to a pre-open state, which is non-conducting in the WT but conducting in our mutants. The second gating event operates at higher depolarizations, involves a change in the ring, and leads to an open state both in WT and in the mutants. ” 

      We interpret your statements such that you expect the conducting state to remain available once O1 is reached. However, the experimental evidence speaks against that the pore availability remains regardless of the further gating steps beyond O1. The description of model construction is informative here: “... we could exclude many possible [sites at which O1 connects to closed states] because the attachment site must be sufficiently far away from the conventional open state [O2]. Otherwise, the transition from "O1 preferred" to "O2 preferred" via a few closed intermediate states is very gradual and never produces the biphasic GV curves [that we observed]. ” 

      In other words, voltage-dependent gating steps beyond the state that offers access to O1 appear to close the pore, after it was open. That might occur because only then (for states in which at least one voltage sensor exceeded the intermediate position) the ring is fixed in a particular state until all sensors completed activation. In the WT, closing the pore in deactivated states might rely on an interaction that is absent in the mutant because, at least in HERG: “the interaction between the PAS domain and the C-terminus is more stable in closed than in open KV11.1 (HERG) channels, and a single chain antibody binding to the interface between PAS domain and CNBHD can access its epitope in open but not in closed channels, strongly supporting a change in conformation of the ring during gating ”

      Reviewer #3 (Public Review):

      In the present manuscript, Abdelaziz and colleagues interrogate the gating mechanisms of Kv10.1, an important voltage-gated K+ channel in cell cycle and cancer physiology. At the molecular level, Kv10.1 is regulated by voltage and Ca-CaM. Structures solved using CryoEM for Kv10.1 as well as other members of the KCNH family (Kv11 and Kv12) show channels that do not contain a structured S4-S5 linker imposing therefore a non-domain swapped architecture in the transmembrane region. However, the cytoplasmatic N- and C- terminal domains interact in a domain swapped manner forming a gating ring. The N-terminal domain (PAS domain) of one subunit is located close to the intracellular side of the voltage sensor domain and interacts with the C-terminal domain (CNBHD domain) of the neighbor subunit. Mutations in the intracellular domains has a profound effect in the channel gating. The complex network of interactions between the voltage-sensor and the intracellular domains makes the PAS domain a particularly interesting domain of the channel to study as responsible for the coupling between the voltage sensor domains and the intracellular gating ring.

      The coupling between the voltage-sensor domain and the gating ring is not fully understood and the authors aim to shed light into the details of this mechanism. In order to do that, they use well established techniques such as site-directed mutagenesis, electrophysiology, biochemistry and mathematical modeling. In the present work, the authors propose a two open state model that arises from functional experiments after introducing a deletion on the PAS domain (ΔPAS Cap) or a point mutation (E600R) in the CNBHD domain. The authors measure a bi-phasic G-V curve with these mutations and assign each phase as two different open states, one of them not visible on the WT and only unveiled after introducing the mutations.

      The hypothesis proposed by the authors could change the current paradigm in the current understanding for Kv10.1 and it is quite extraordinary; therefore, it requires extraordinary evidence to support it.

      STRENGTHS: The authors use adequate techniques such as electrophysiology and sitedirected mutagenesis to address the gating changes introduced by the molecular manipulations. They also use appropriate mathematical modeling to build a Markov model and identify the mechanism behind the gating changes.

      WEAKNESSES: The results presented by the authors do not fully support their conclusions since they could have alternative explanations. The authors base their primary hypothesis on the bi-phasic behavior of a calculated G-V curve that do not match the tail behavior, the experimental conditions used in the present manuscript introduce uncertainties, weakening their conclusions and complicating the interpretation of the results. Therefore, their experimental conditions need to be revisited. 

      We respectfully disagree. We think that your suggestions for alternative explanations are addressed in the current version of the article. We will rebut them once more below, but we feel the need to point out that our arguments are already laid out in the revised article.

      I have some concerns related to the following points:

      (1) Biphasic gating behavior

      The authors use the TEVC technique in oocytes extracted surgically from Xenopus Leavis frogs. The method is well established and is adequate to address ion channel behavior. The experiments are performed in chloride-based solutions which present a handicap when measuring outward rectifying currents at very depolarizing potentials due to the presence of calcium activated chloride channel expressed endogenously in the oocytes; these channels will open and rectify chloride intracellularly adding to the outward rectifying traces during the test pulse. The authors calculate their G-V curves from the test pulse steady-state current instead of using the tail currents. The conductance measurements are normally taken from the 'tail current' because tails are measured at a fix voltage hence maintaining the driving force constant. 

      We respectfully disagree. In contrast to other channels, like HERG, a common practice for Kv10 is not to use tail currents. It is long known that in this channel, tail currents and test-pulse steady-state currents can appear to be at odds because the channels deactivate extremely rapidly, at the border of temporal resolution of the measurements and with intricate waveforms. This complicates the estimation of the instantaneous tail current. Therefore, the outward current is commonly used to estimate conductance (Terlau et al., 1996; Schönherr et al., 1999; Schönherr et al., 2002; Whicher and MacKinnon, 2019), while the latter authors also use the extreme of the tail for some mutants.

      Due to their activation at very negative voltage, the reversal potential in our mutants can be measured directly; we are, therefore, more confident with this approach. Nevertheless, we have determined the initial tail current in some experiments. The behavior of these is very similar to the average that we present in Figure 1. The biphasic behavior is unequivocally present.

      Author response image 2.

      Calculating the conductance from the traces should not be a problem, however, in the present manuscript, the traces and the tail currents do not agree. 

      The referee’s observation is perfectly in line with the long-standing experience of several labs working with KV10: tail current amplitudes in KV10 appear to be out of proportion for the WT open state (O2). Importantly, this is due to the rapid closure, which is not present in O1. As a consequence, the initial amplitude of tail currents from O1 are easier to estimate correctly, and they are much more obvious in the graphs. Taken together, these differences between O1 and O2 explain the misconception the reviewer describes next.

      The tail traces shown in Fig1E do not show an increasing current amplitude in the voltage range from +50mV to +120mV, they seem to have reached a 'saturation state', suggesting that the traces from the test pulse contain an inward chloride current contamination. 

      As stated in the text and indicated in Author response image 3, the tail currents In Figure 1E increase in amplitude between +50 and +120 mV, as can be seen in the examples below from different experiments (+50 is presented in black, +120 in red). As stated above, the increase is not as evident as in traces from other mutants because the predominance of O2 also implies a much faster deactivation.

      Author response image 3. 

      We are aware that Ca2+-activated Cl- currents can represent a problem when interpreting electrophysiological data in oocytes. In fact, we show in Supplement 1 to Figure 8 that this can be the case during the Ca2+-CaM experiments, where the increase in Ca2+ would certainly augment Cl- contribution to the outward current. This is why we performed these experiments in Cl--free solutions. As we show in Figure 8, the biphasic behavior was also present in those experiments. 

      Importantly, Cl- free bath solutions would not correct contamination during the tail, since this would correspond to Cl- exiting the oocyte. Yet, if there would be contamination of the outward currents by Cl-, one would expect it to increase with larger depolarizations as the typical Ca2+activated Cl- current in oocytes does. As the reviewer states, this does not seem to be the case.

      In addition, this second component identified by the authors as a second open state appears after +50mV and seems to never saturate. The normalization to the maximum current level during the test pulse, exaggerates this second component on the calculated G-V curve. 

      We agree that this second component continues to increase; the reviewer brought this up in the first review, and we have already addressed this in our reply and in the discussion of the revised version: “This flicker block might also offer an explanation for a feature of the mutant channels, that is not explained in the current model version: the continued increase in current amplitude, hundreds of milliseconds into a strong depolarization (Supp. 4 to Fig. 9). If the relative stability of O2 and C2 continued to change throughout depolarization, such a current creep-up could be reproduced. However, this would require either the introduction of further layers of On ↔Cn states, or a non-Markovian modification of the model’s time evolution.” With non-Markovian, we mean a Langevin-type diffusive process. 

      It's worth noticing that the ΔPASCap mutant experiments on Fig 5 in Mes based solutions do not show that second component on the G-V.

      For the readers of this conversation, we would like to clarify that the reviewer likely refers to experiments shown in Fig. 5 of the initial submission but shown in Fig. 6 of the revised version (“Hyperpolarization promotes access to a large conductance, slowly activating open state.” Fig. 5 deals with single channels). We agree that these data look different, but this is because the voltage protocols are completely different (compare Fig. 6A (fixed test pulse, varied prepulse) and Fig. 2A (varied test pulse, fixed pre-pulse). Therefore, no biphasic behavior is expected. 

      Because these results are the foundation for their two open state hypotheses, I will strongly suggest the authors to repeat all their Chloride-based experiments in Mes-based solutions to eliminate the undesired chloride contribution to the mutants current and clarify the contribution of the mutations to the Kv10.1 gating.

      In summary, we respectfully disagree with all concerns raised in point (1). Our detailed arguments rebutting them are given above, but there is a more high-level concern about this entire exchange: the referee casts doubt on observations that are not new. Several labs have reported for a group of mutant KCNH channels: non-monotonic voltage dependence of activation (see, e.g., Fig. 6D in Zhao et al., 2017), multi-phasic tail currents (see e.g. Fig. 4A in Whicher and MacKinnon, 2019, in CHO cells where Cl- contamination is not a concern), and activation by high [Ca2+]i (Lörinczi et al., 2016). Our study replicates those observations and hypothesizes that the existence of an additional conducting state can alone explain all previously unexplained observations. We highlight the potency of this hypothesis with a Markov model that qualitatively reproduces all phenomena. We not only factually disagree with the individual points raised, but we also think that they don't touch on the core of our contribution

      (2) Two step gating mechanism.

      The authors interpret the results obtained with the ΔPASCap and the E600R as two step gating mechanisms containing two open states (O1 and O2) and assign them to the voltage sensor movement and gating ring rotation respectively. It is not clear, however how the authors assign the two open states.

      The results show how the first component is conserved amongst mutations; however, the second one is not. The authors attribute the second component, hence the second open state to the movement of the gating ring. This scenario seems unlikely since there is a clear voltagedependence of the second component that will suggest an implication of a voltage-sensing current.

      We do not suggest that the gating ring motion is not voltage dependent. We would like to point out that voltage dependence can be conveyed by voltage sensor coupling to the ring; this is the widely accepted theory of how the ring can be involved. Should the reviewer mean it in a narrow sense, that the model should be constructed such that all voltage-dependent steps occur before and independently of ring reconfiguration and that only then an additional step that reflects the (voltage-independent) reconfiguration solely, we would like to point the reviewer to the article, where we write: “the κ/λ transition could reasonably be expected to be voltage independent because we related it to ring reconfiguration, a process that should occur as a consequence of a prior VSD transition. We have made some attempts to treat this transition as voltage independent but state-specific with upper-layer bias for states on the right and lower-layer bias for states on the left. This is in principle possible, as can already be gleaned from the similar voltage ranges of the left-right transition (α/β) and the κL/λ transition. However, this approach leads to a much larger number of free, less well constrained kinetic parameters and drastically complicated the parameter search. ” As you can see, we also formulated a strategy to free the model from the potentially spurious voltage dependence and (in bold here) explained why we did not follow this route in this study. 

      The split channel experiment is interesting but needs more explanation. I assume the authors expressed the 2 parts of the split channel (1-341 and 342-end), however Tomczak et al showed in 2017 how the split presents a constitutively activated function with inward currents that are not visible here, this point needs clarification.

      As stated in the panel heading, the figure legend, and the main text, we did not use 1-341 and 342-end as done in Tomczak et al. Instead, “we compared the behavior of ∆2-10 and ∆210.L341Split,”. Evidently, the additional deletion (2-10) causes a shift in activation that explains the difference you point out. However, as we do not compare L341Split and ∆210.L341Split but ∆2-10 and ∆2-10.L341Split, our conclusion remains that “As predicted, compared to ∆2-10, ∆2-10.L341Split showed a significant reduction in the first component of the biphasic GV (Fig. 2C, D).” Remarkably, the behavior of the ∆3-9 L341Split described in Whicher and MacKinnon, 2019 (Figure 5) matches that of our ∆2-10 L341Split, which we think reinforces our case.

      Moreover, the authors assume that the mutations introduced uncover a new open state, however the traces presented for the mutations suggest that other explanations are possible. Other gating mechanisms like inactivation from the closed state, can be introduced by the mutations. The traces presented for ΔPASCap but specially E600R present clear 'hooked tails', a direct indicator of a populations of inactive channels during the test pulse that recover from inactivation upon repolarization (Tristani-Firouzi M, Sanguinetti MC. J Physiol. 1998). 

      There is a possibility that we are debating nomenclature here. In response to the suggestion that all our observations could be explained by inactivation, we attempted a disambiguation of terms in the reply and the article. As the argument is brought up again without reference to our clarification attempts, we will try to be more explicit here:

      If, starting from deeply deactivated states, an open state is reached first, and then, following further activation steps, closed states are reached, this might be termed “inactivation”. In such a reading, our model features many inactivated states. The shortest version of such a model is C-O-I. It is for instance used by Raman and Bean (2001; DOI: 10.1016/S00063495(01)76052-3) to explain NaV gating in Purkinje neurons. If “inactivation” is meant in the sense that a gating transition exists, which is orthogonal to an activation/deactivation axis, and that after this orthogonal transition, an open state cannot be reached anymore, then all of the upper floor in our model is inactivated with respect to the open state O1. Finally, the state C2 is an inactivated state to O2. In this view, “inactivation” explains the observed phenomena. 

      However, we must disagree if the referee means that a parsimonious explanation exists in which a single conducting state is the only source for all observed currents.   

      There is a high-level reason: we found a single assumption that explains three different phenomena, while the inactivation hypothesis with one conducting state cannot explain one of them (the increase of the first component under raised CaM). But there is also a low-level reason: the tails in Tristani-Firouzi and Sanguinetti 1998 are fundamentally different from what we report herein in that they lack a third component. Thus, those tails are consistent with recovery from inactivation through a single open state, while a three-component tail is not. In the framework of a Markov model, the time constants of transitions from and to a given state (say O2), cannot change unless the voltage changes. During the tail current, the voltage does not change, yet we observe: 

      i) a rapid decrease with a time constant of at most a few milliseconds (Fig 9 S2, 1-> 2),  ii) a slow increase in current, peaking after approximately 25 milliseconds and iii) a relaxation to zero current with a time constant of >50 ms. 

      According to the reviewer’s suggestion, these processes on three timescales should all be explained by depopulating and repopulating the same open state while all rates are constant. There might well be a complicated multi-level state diagram with a single open state with different variants, like (open and open inactivated) that could produce triphasic tails with these properties if the system had not reached a steady state distribution at the end of the test pulse. It cannot, however, achieve it from an equilibrated system, and certainly, it cannot at the same time produce “biphasic activation” and “activation by CaM”. 

      The results presented by the authors can be alternatively explained with a change in the equilibrium between the close to inactivated/recovery from inactivation to the open state. 

      Again, we disagree. The model construction explains in detail that the transition from the first to the second phase is not gradual. Shifting equilibria cannot reproduce this. We have extensively tested that idea and can exclude this possibility.

      Finally, the authors state that they do not detect "cumulative inactivation after repeated depolarization" but that is considering inactivation only from the open state and ignoring the possibility of the existence of close state inactivation or, that like in hERG, that the channel inactivates faster that what it activates (Smith PL, Yellen G. J Gen Physiol. 2002). 

      We respectfully disagree. We explicitly model an open state that inactivates faster (O2->C2) than it activates. Once more, this is stated in the revised article, which we point to for details. Again, this alternative mechanism does not have the potential to explain all three effects. As discussed above about the chloride contamination concerns, this inactivation hypothesis was mentioned in the first review round and, therefore, addressed in our reply and the revised article. We also explained that “inactivation” has no specific meaning in Markov models. In the absence of O1, all transitions towards the lower layer are effectively “inactivation from closed states”, because they make access to the only remaining open state less likely”. But this is semantics. What is relevant is that no network of states around a single open state can reproduce the three effets in a more parsimonious way than the assumption of the second open state does.

      (3) Single channel conductance.

      The single channels experiments are a great way to assess the different conductance of single channel openings, unfortunately the authors cannot measure accurately different conductances for the two proposed open states. The Markov Model built by the authors, disagrees with their interpretation of the experimental results assigning the exact same conductance to the two modeled open states. To interpret the mutant data, it is needed to add data with the WT for comparison and in presence of specific blockers. 

      We respectfully disagree. As previously shown, the conductance of the flickering wild-type open state is very difficult to resolve. Our recordings do not show that the two states have different single-channel conductances, and therefore the model assumes identical singlechannel conductance. 

      The important point is that the single-channel recordings clearly show two different gating modes associated with the voltage ranges in which we predict the two open states. One has a smaller macroscopic current due to rapid flickering (aka “inactivation”). These recordings are another proof of the existence of two open states because the two gating modes occur.  Wild-type data can be found in Bauer and Schwarz, (2001, doi:10.1007/s00232-001-0031-3) or Pardo et al., (1998, doi:10.1083/jcb.143.3.767) for comparison.

      We appreciate the effort editors and reviewers invested in assessing the revised manuscript. Yet, we think that the demanded revision of experimental conditions and quantification methods contradicts the commonly accepted practice for KV10 channels. Some of the reviewer comments are skeptical about the biphasic behavior, which is an established and replicated finding for many mutants and by many researchers. The alternative explanations for these disbelieved findings are either “semantics” or cannot quantitatively explain the measurements. Therefore, only the demand for more explanations and unprecedented resolution in singlechannel recordings remains. We share these sentiments.

      ———— The following is the authors’ response to the original reviews.

      (1) The authors must show that the second open state is not just an artifact of endogenous activity but represents the activity of the same EAG channels. I suggest that the authors repeat these experiments in Mes-based solutions. 

      (2) Along the same lines, it is necessary to show that these currents can be blocked using known EAG channel blockers such as astemizole. Ultimately, it will be important to demonstrate using single-channel analysis that these do represent two distinct open states separated by a closed state. 

      We have addressed these concerns using several approaches. The most substantial change is the addition of single-channel recordings on ΔPASCap. In those experiments, we could provide evidence of the two types of events in the same patch, and the presence of an outward current at -60 mV, 50 mV below the equilibrium potential for chloride. The channels were never detected in uninjected oocytes, and Astemizole silenced the activity in patches containing multiple channels. These observations, together with the maintenance of the biphasic behavior that we interpret as evidence of the presence of O1 in methanesulfonate-based solutions, strongly suggest that both O1 and O2 obey the expression of KV10.1 mutants.

      (3) Currents should be measured by increasing the pulse lengths as needed in order to obtain the true steady-state G-V curves. 

      We agree that the endpoint of activation is ill-defined in the cases where a steady-state is not reached. This does indeed hamper quantitative statements about the relative amplitude of the two components. However, while the overall shape does change, its position (voltage dependence) would not be affected by this shortcoming. The data, therefore, supports the claim of the “existence of mutant-specific O1 and its equal voltage dependence across mutants.”

      (4) A more clear and thorough description should be provided for how the observations with the mutant channels apply to the behavior of WT channels. How exactly does state O1 relate to WT behavior, and how exactly do the parameters of the mathematical model differ between WT and mutants? How can this be interpreted at a structural level? What could be the structural mechanism through which ΔPASCap and E600R enable conduction through O1? It seems contradictory that O1 would be associated exclusively with voltage-sensor activation and not gating ring transitions, and yet the mutations that enable cation access through O1 localize at the gating ring - this needs to be better clarified. 

      We have undertaken a thorough rewriting of all sections to clarify the structural correlates that may explain the behavior of the mutants. In brief, we propose that when all four voltage sensors move towards the extracellular side, the intracellular ring maintains the permeation path closed until it rotates. If the ring is altered, this “lock” is incompetent, and permeation can be detected (page 34). By fixing the position of the ring, calmodulin would preclude permeation in the WT and promote the population of O1 in the mutants.

      (5) Rather than the t80% risetime, exponential fits should be performed to assess the kinetics of activation. 

      We agree that the assessment of kinetics by a t80% is not ideal. We originally refrained from exponential fits because they introduce other issues when used for processes that are not truly exponential (as is the case here). We had planned to perform exponential fits in this revised version, but because the activation process is not exponential, the time constants we could provide would not be accurate, and the result would remain qualitative as it is now. In the experiments where we did perform the fits (Fig. 3), the values obtained support the statement made. 

      (6) It is argued based on the G-V relations in Figure 2A that none of the mutations or deletions introduced have a major effect on state O1 properties, but rather affect state O2. However, the occupancy of state O2 is undetermined because activation curves do not reach saturation. It would be interesting to explore the fitting parameters on Fig.2B further to test whether the data on Fig 2A can indeed only be described by fits in which the parameters for O1 remain unchanged between constructs. 

      We agree that the absolute occupancy of O2 cannot be properly determined if a steady state is not reached. This is, however, a feature of the channel. During very long depolarizations in WT, the current visually appears to reach a plateau, but a closer look reveals that the current keeps increasing after very long depolarizations (up to 10 seconds; see, e.g., Fig. 1B in Garg et al., 2013, Mol Pharmacol 83, 805-813. DOI: 10.1124/mol.112.084384). Interestingly, although the model presented here does not account for this behavior, we propose changes in the model that could. “If the relative stability of O2 and C2 continued to change throughout the depolarization such a current creep-up could be reproduced. However, this would require either the introduction of further layers of On↔Cn states or a non-Markovian modification of the model’s evolution.” Page 34.

      (7) The authors interpret the results obtained with the mutants DPASCAP and E600R -tested before by Lorinczi et al. 2016, to disrupt the interactions between the PASCap and cNBHD domains- as a two-step gating mechanism with two open states. All the results obtained with the E600R mutant and DPASCap could also be explained by inactivation/recovery from inactivation behavior and a change in the equilibrium between the closed states closed/inactivated states and open states. Moreover, the small tails between +90 to +120 mV suggest channels accumulate in an inactive state (Fig 1E). It is not convincing that the two open-state model is the mechanism underlying the mutant's behavior.  

      We respectfully disagree with the notion that a single open state can provide a plausible explanation for "All the results obtained with the E600R mutant and DPASCap". We think that our new single channel results settle the question, but even without this direct evidence, a quantitative assessment of the triphasic tail currents all but excludes the possibility of a single open state. We agree that it is, in principle, possible to obtain some form of a multiphasic tail with a single open state using the scheme suggested in this comment: at the end of the test pulse, a large fraction of the channels must be accumulated in inactive states, and a few are in the open state. The hyperpolarization to -100mV then induces a rapid depopulation of the open state, followed by slower replenishments from the inactive state. Exactly this process occurs in our model, when C2 empties through O2 (Supp. 5 to Fig 9, E600R model variant). However, this alone is highly unlikely to quantitatively explain the measured tail currents, because of the drastically different time scales of the initial current decay (submillisecond to at most a few milliseconds lifetime) and the much slower transient increase in current (several tens of milliseconds) and the final decay with time constants of >100 ms (see for instance data in Fig. 1 E for E600R +50 to +120mV test pulse). To sustain the substantial magnitude of slowly decaying current by slow replenishment of an open state with a lifetime of 1 ms requires vast amounts of inactivated channels. A rough estimation based on the current integral of the initial decay and the current integral of the slowly decaying current suggests that at the end of the test pulse, the ratio inactivated/open channels would have to be 500 to 1500 for this mechanism to quantitatively explain the observed tail currents. To put this in perspective: This would suggest that without inactivation all the expressed channels in an oocyte would provide 6 mA current during the +100 mV test pulse. While theoretically possible, we consider this a less likely explanation than a second open state.

      (8) Different models should be evaluated to establish whether the results in Figure 4 can also be explained by a model in which states O1 and O2 have the same conductance. It would be desirable if the conductance of both states were experimentally determined - noise analysis could be applied to estimate the conductance of both states. 

      In the modified model, O1 and O2 have the same single-channel conductance. The small conductance combined with the fast flickering did not allow an accurate determination, but we can state that there is no evidence that the single-channel conductance of the states is different.

      (9) Although not included, it looks like the model predicts some "conventional inactivation" This can be appreciated in Fig 8, and in the traces at -60mV. Interestingly, the traces obtained in the absence of Cl- also undergo slow inactivation, or 'conventional inactivation' as referred to by the authors. Please revise the following statement "Conventional inactivation was never detected in any mutants after repeated or prolonged depolarization. In the absence of inactivation, the pre-pulse dependent current increase at +40 mV could be related to changes in the relative occupancy of the open states". 

      We have carefully edited the manuscript to address this concern. The use of the term inactivation admittedly represents a challenge. We agree that the state that results from the flickering block (C2) could be defined as “inactivated” because it is preceded by an open state. Yet, in that case, the intermediate states that the channel travels between O1 and O2 would also be sensu stricto “inactivated”, but only in the mutants. We have made this clear in page 17.

      Recommendations for improving the writing and presentation.

      (1) Methods section: Please state the reversal potential calculated for the solution used. It looks like the authors used an Instantaneous I-V curve method to calculate the reversal potential; if that's correct, please show the I-V and the traces together with the protocol used. 

      We have provided the calculated reversal potentials for excised patches. We cannot predict the reversal potential in whole oocytes because we have no control over the intracellular solution. The reversal potential was determined in the mutants through the current at the end of the stimulus because the mutants produced measurable inward currents. The differences in reversal potential were not significant among mutants.

      Pulse protocols have been added to the figures.

      (2) Figure 1 suggestion: Combine the two panels in panel D and move the F panel up so the figure gets aligned in the lower end.

      Thank you, this has been done.

      (3) Please clarify the rationale for using the E600R-specific mutant. I assume it is based on the Lorinzci et al. 2016 effect and how this is similar to the DPASCap phenotype, or is it due to the impact of this mutation in the interactions between the N-term and the cNBHD? 

      We have explained the rationale for the use of E600R explicitly on page 6.

      (4) Fig S1A is not present in the current version of the manuscript. Include a cartoon as well as a structural figure clearly depicting the perturbations introduced by E600R, ΔPASCap, and the other deletions that are tested. Additional structural information supporting the discussion would also be helpful to establish clearer mechanistic links between the experimental observations described here and the observed conformational changes between states in Kv10 channel structures. 

      We have corrected this omission, thank you for pointing it out.

      (5) It would be informative to see the traces corresponding to the I-V shown in Fig 7 A and B at the same indicated time points (0, 60, 150, and 300s). Did the authors monitor the Ca2+ signal rise after the I&T treatment to see if it coincides with the peak in the 60s? 

      In Figure 7 (now Figure 8) we used voltage ramps instead of discrete I-V protocols because of the long time required for recording the latter. This is stated on page 19. Ca2+ was monitored through Cl- current after ionomycin/thapsigargin. The duration of the Ca2+ increase was reproducible among oocytes and in good agreement with the changes observed in the biphasic behavior of the mutants (Supplement 1 to Figure 8).

      (6) Fig 4. Please state in the legend what the different color traces correspond to in E600R and DPASCap. Is there a reason to change the interpulse on DPASCap to -20mV and not allow this mutant to close? Please state. How do the authors decide the 10 ms interval for the experiments in Fig 2? 

      Thank you for pointing this out, we have added the description. We have explained why we use a different protocol for ΔPASCap and the reason for using 10 ms interval (we believe the referee means Figure 4) on page 12.  

      (7) Fig. 5. Since the pre-pulse is supposed to be 5s, but the time scale doesn't correspond with a pre-pulse of 5 s before the test pulse to +40mV. Has the pre-pulse been trimmed for representation purposes? If so, please state. 

      The pre-pulse was 5s, but as the reviewer correctly supposed, the trace is trimmed to keep the +40 mV stimulus visible. This has now been clearly stated in the legend.

      (8) The mutant L322H is located within the S4 helix according to the Kv10.1 structure (PDB 5K7L), not in the 'S3-S4 linker'; please correct. 

      This has been done, thank you.

      The introduction of this mutant should also shift the voltage dependence toward more hyperpolarizing potentials (around 30mV, according to Schoenherr et al. 1999). It looks like that shift is present within the first component of the G-V. Still, since the max amplitude from the second component could be contaminated by endogenous Cl- currents, this effect is minimized. Repeating these experiments in the no Cl- solutions will help clarify this point and see the effect of the DPASCap and E600R in the background of a mutation that accelerates the transitions between the closed states (see Major comment 1). Did the authors record L322H alone for control purposes? 

      We have decided not to measure L322H alone or repeat the measurements in Cl--free solutions because we do not see a way to use the quantitative assessment of the voltage dependence of L322H and the L322H-variants of the eag domain mutants. Like in our answer to main point 3, we base our arguments not on the precise voltage dependence of the second component but on the shape of the G-V curves instead, specifically the consistent appearance of the first component and the local conductance minimum between the first and second components. After the introduction of L322H the first component is essentially absent.

      We think that the measurements of the L322H mutants cannot be interpreted as a hyperpolarizing shift in the first component. The peak of the first conductance component occurs around -20 mV in ΔPASCap and E600R (Fig. 7 C, D). After a -30mV shift, in L322H+DPASCap and L322H+E600R, this first peak would still be detected within the voltage range in our experiments, but it is not. A contamination of the second component would have little impact on this observation, which is why we refrain from the suggested measurements.  

      (9) The authors differentiate between an O1 vs. O2 state with different conductances, and maybe I missed it, but there's no quantitative distinction between the components; how are they different?

      Please see the response to the main comments 1 and 2. This has been addressed in singlechannel recordings.

      (10) Please state the voltage protocols, holding voltages, and the solutions (K+ concentration and Cl-presence/absence) used for the experiments presented in the legends on the figures. Hence, it's easier to interpret the experiments presented. 

      Thank you, this has been done.

      (11) The authors state on page 7 that "with further depolarizations, the conductance initially declined to rise again in response to strong depolarizations. This finding matches the changes in amplitude of the tail currents, which, therefore, probably reflect a true change in conductance" However, the tails in the strong voltage range (+50 to +120 mV) for the E600R mutant argue against this result. Please review.

      The increase in the amplitude of the tail current is also present in E600R, but the relative increase is smaller. We have decided against rescaling these traces because the Figure is already rather complex. We indicated this fact with a smaller arrow and clarified it in the text (page 8).

      (12) The authors mention that the threshold of activation for the WT is around -20mV; however, the foot of the G-V is more around -30 or -40mV. Please revise. 

      Thank you. We have done this. 

      (13) The authors state on page 9 that the 'second component occurs at progressively more depolarized potentials for increasingly larger N-terminal deletions" However E600R mutant that conserves the N-terminal intact has a shift as pronounced as the DPASCap and larger than the D2-10. How do the authors interpret this result? 

      We have corrected this statement in page 10 : “…the second component occurs at progressively more depolarized potentials for increasingly larger N-terminal deletions and when the structure of the ring is altered through disruption of the interaction between N- and C-termini (E600R)”.

      (14) The equation defined to fit the G-Vs, can also be used to describe the WT currents. If the O1 is conserved and present in the WT, this equation should also fit the WT data properly. The 1-W component shown could also be interpreted as an inactivating component that, in the WT, shifts the voltage-dependence of activation towards depolarizing potentials and is not visible. Still, the mutants do show it as if the transition from closed-inactivated states is controlled by interactions in the gating ring, and disturbing them does affect the transitions to the open state. 

      Out of the two open states in the mutant, O2 is the one that shares properties with the WT (e.g. it is inaccessible during Ca2+-CaM binding) while O1 is the open state with the voltage dependence that is conserved across the mutants. We, therefore, believe that this question is based on a mix-up of the two open states. We appreciate the core of the question: does the pattern in the mutants’ G-V curves find a continuation in the WT channel? 

      Firstly, the component that is conserved among mutants does not lead to current in the WT because the corresponding open state (O1) is not observed in WT. However, the gating event represented by this component should also occur in WT and –given its apparent insensitivity to eag domain mutations–  this gating step should occur in WT with the same voltage dependence as in all the mutants. This means that this first component sets a hard boundary for the most hyperpolarized G-V curve we can expect in the WT, based on our mutant measurements. Secondly, the second component shows a regular progression across mutants: The more intact the eag domain is, the more hyperpolarized the Vhalf values of transition term (1-W) and O2 activation. In Δ2-10, the transition term already almost coincides with O1 activation (estimated Vhalf values of -33.57 and -33.47 mV). A further shift of (1-W) in the WT is implausible because, if O1 activation is coupled to the earliest VSD displacement, the transition should not occur before O1 activation. Still, the second component might shift to more hyperpolarized values in the WT, depending on the impact of amino acids 2 to 10 on the second VSD transition.

      In summary, in WT the G-V should not be more hyperpolarized than the first component of the mutants, and the (1-W)-component probably corresponds to the Δ2-10 (1-W)-component. In WT the second component should be no more depolarized than the second component of Δ2-10. The WT G-V (Fig.1B) meets all these predictions derived from the pattern in the mutant GVs: When we use Eq. 4 to fit the WT G-V with A1=0 (O1 is not present in WT) and the parameters of the transition term (1-W)  fixed to the values attained in Δ2-10, we obtain a fit for the O2 component with Vhalf\=+21mV. This value nicely falls into the succession of Vhalf values for Δeag, ΔPASCap, and Δ2-10 (+103mV,+80mV,+52mV) and, at the same time, it is not more hyperpolarized than the conserved first component (Vhalf -34mV). Our measurements therefore support that the O2 component in the mutants corresponds to the single open state in the WT. 

      (15) Page 15, the authors state that 'The changes in amplitude and kinetics in response to rising intracellular Ca2+ support our hypothesis that Ca-CaM stabilized O1, possibly by driving the channels to deep closed states (Fig 5 and 6)' (pg 15). This statement seems contradictory; I can't quite follow the rationale since Ca2+ potentiates the current (Fig 7), and the addition of the L322H mutant in Fig 7 makes the shift of the first component to negative potentials visible.

      Please check the rationale for this section. 

      We have explained this more explicitly in the discussion (page 32). “Because access to O1 occurs from deep closed states, this could be explained by an increased occupancy of such deactivated states in response to CaM binding. This appears to be the case since CaM induces a biphasic behavior in the mutant channels that show reduced access to deep closed states; thus, L322H mutants behave like the parental variants in the presence of Ca2+-CaM. This implies a mechanistic explanation for the effect of Ca2+-CaM on WT since favoring entry into deep closed states would result in a decrease in current amplitude in the absence of (a permeable) O1”.

      Also, Figs 5 and 6 seem miscited here. 

      Thank you, we have corrected this.

      (16) For Figure 5, it would be helpful if each of the current traces corresponding to a particular voltage had a different color. That way, it will be easier to see how the initial holding voltage modulates current. 

      We have considered this suggestion, and we agree that it would make it easier to follow. Yet, since we have identified the mutants with different colors, it would be inconsistent if we used another color palette for this Figure. Supplement 3 to Figure 9 shows the differences in a clearer way.

      (17) Add zero-current levels to all current traces.

      We have done this.

      (18) The mathematical model should be described better. Particularly, the states from which O1 can be accessed should be described more clearly, as well as whether the model considers any direct connectivity between states O1 and O2. The origin of the voltage-dependence for transitions that do not involve voltage-sensor movements should be discussed. Also, it separation of kappa into kappa-l and kappa-r should be described. 

      We have extensively rewritten the description of the mathematical model to address these concerns.

      (19) Page 4, "reveals a pre-open state in which the transmembrane regions of the channel are compatible with ion permeation, but is still a nonconducting state". Also, page 27, "renders a hydrophobic constriction wider than 8 Å, enough to allow K+ flow, but still corresponds to a non-conducting state". These sentences are confusing - how can the regions be compatible with ion permeation, and still not be conducting? Is cation conductance precluded by a change in the filter, or elsewhere? How is it established that it represents a non-conducting state? 

      We have rephrased to clarify this apparent inconsistence. Page 4: “(…) in which the transmembrane regions of the channel are compatible with ion permeation (the permeation path is dilated, like in open states) but the intracellular gate is still in the same conformation as in closed states (Zhang et al., 2023).” Page 31: “The presence of an intact intracellular ring would preclude ionic flow in the WT, and its alteration would explain the permeability of this state in the mutants.”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      The authors use electrophysiological and behavioral measurements to examine how animals could reliably determine odor intensity/concentration across repeated experiences. Because stimulus repetition leads to short-term adaptation evidenced by reduced overall firing rates in the antennal lobe and firing rates are otherwise concentration-dependent, there could be an ambiguity in sensory coding between reduced concentration or more recent experience. This would have a negative impact on the animal's ability to generate adaptive behavioral responses that depend on odor intensities. The authors conclude that changes in concentration alter the constituent neurons contributing to the neural population response, whereas adaptation maintains the 'activated ensemble' but with scaled firing rates. This provides a neural coding account of the ability to distinguish odor concentrations even after extended experience. Additional analyses attempt to distinguish hypothesized circuit mechanisms for adaptation but are inconclusive. A larger point that runs through the manuscript is that overall spiking activity has an inconsistent relationship with behavior and that the structure of population activity may be the more appropriate feature to consider.

      To my knowledge, the dissociation of effects of odor concentration and adaptation on olfactory system population codes was not previously demonstrated. This is a significant contribution that improves on any simple model based on overall spiking activity. The primary result is most strikingly supported by visualization of a principal components analysis in Figure 4. However, there are some weaknesses in the data and analyses that limit confidence in the overall conclusions.

      We thank the reviewer for evaluating our work and highlighting its strengths and deficiencies. We have revised the manuscript with expanded behavioral datasets and additional analyses that we believe convincingly support our conclusion. 

      (1) Behavioral work interpreted to demonstrate discrimination of different odor concentrations yields inconsistent results. Only two of the four odorants follow the pattern that is emphasized in the text (Figure 1F). Though it's a priori unlikely that animals are incapable of distinguishing odor concentrations at any stage in adaptation, the evidence presented is not sufficient to reach this conclusion.

      We have expanded our dataset and now show that the behavioral response is significantly different for high and low concentration exposures of the same odorant. This was observed for all four odorants in our study (refer to Revised Fig. 1F).

      (2) While conclusions center on concepts related to the combination of activated neurons or the "active ensemble", this specific level of description is not directly demonstrated in any part of the results. We see individual neural responses and dimensional reduction analyses, but we are unable to assess to what extent the activated ensemble is maintained across experience.

      We have done several additional analyses (see provisional response). Notably, we have corroborated our dimensionality reduction and correlation analysis results with a quantitative classification analysis that convincingly demonstrates that odor identity and intensity of the odorant can be decoded from the ensemble neural activity, and this could be achieved in an adaptation-invariant fashion (refer to Revised Supplementary Fig. 4). 

      (3) There is little information about the variance or statistical strength of results described at the population level. While the PCA presents a compelling picture, the central point that concentration changes and adaptation alter population responses across separable dimensions is not demonstrated quantitatively. The correlation analysis that might partially address this question is presented to be visually interpreted with no additional testing.

      We have included a plot that compares the odor-evoked responses across all neurons (mean ± variance) at both intensity levels for each odorant (Revised Supplementary Fig. 5). This plot clearly shows how the ensemble neural activity profile varies with odor intensity and how these response patterns are robustly maintained across trials. 

      (4) Results are often presented separately for each odor stimulus or for separate datasets including two odor stimuli. An effort should be made to characterize patterns of results across all odor stimuli and their statistical reliability. This concern arises throughout all data presentations.

      We had to incorporate a 15-minute window between presentations of odorants to reset adaptation. Due to this, we were unable to extracellularly record from all four odorants at two intensities from a single experiment (~ 3.5 hours of recording for just 2 odorants at two intensities with one odorant at higher intensity repeated at the end; Fig. 2a). Therefore, we recorded two datasets. Each dataset captured the responses of ~80 PNs to two odorants at two intensities, one odorant at the higher concentration repeated at the end of the experiment to show repeatability of changes due to adaptation. 

      (5) The relevance of the inconclusive analysis of inferred adaptation mechanisms in Figure 2d-f and the single experiment including a complex mixture in Figure 7 to the motivating questions for this study are unclear.

      Figure 2d-f has been revised. While we agree that the adaptation mechanisms are not fully clear, there is a trend that the most active PNs are the neurons that change the most across trials. This change and the response in the first trial are negatively correlated, indicating that vesicle depletion could be an important contributor to the observed results. However, neurons that adapt strongly at higher intensities are not the ones that adapt at lower intensities. This complicates the understanding of how neural responses vary with intensities and the adaptation that happens due to repetition. This has been highlighted in the revised manuscript. 

      Regarding Figure 7, we wanted to examine the odor-specificity of the changes that happen due to repeated encounters of an odorant. Specifically, wondered if the neural response reduction and behavioral enhancements were a global, non-specific state change in the olfactory system brought about by the repetition of any odorant, or are the observed neural and behavioral response changes odor-specific.

      (6) Throughout the description of the results, typical standards for statistical reporting (sample size, error bars, etc.) are not followed. This prevents readers from assessing effect sizes and undermines the ability to assign a confidence to any particular conclusion.

      We have revised the manuscript to fix these issues and included sample size and error bars in our plots.  

      Reviewer #2 (Public Review):

      Summary:

      The authors' main goal was to evaluate how both behavioral responses to odor, and their early sensory representations are modified by repeated exposure to odor, asking whether the process of adaptation is equivalent to reducing the concentration of an odor. They open with behavioral experiments that actually establish that repeated odor presentation increases the likelihood of evoking a behavioral response in their experimental subjects - locusts. They then examine neural activity patterns at the second layer of the olfactory circuit. At the population level, repeated odor exposure reduces total spike counts, but at the level of individual cells there seems to be no consistent guiding principle that describes the adaptation-related changes, and therefore no single mechanism could be identified.

      Both population vector analysis and pattern correlation analysis indicate that odor intensity information is preserved through the adaptation process. They make the closely related point that responses to an odor in the adapted state are distinct from responses to lower concentration of the same odor. These analyses are appropriate, but the point could be strengthened by explicitly using some type of classification analysis to quantify the adaptation effects. e.g. a confusion matrix might show if there is a gradual shift in odor representations, or whether there are trials where representations change abruptly.

      Strengths:

      One strength is that the work has both behavioral read-out of odor perception and electrophysiological characterization of the sensory inputs and how both change over repeated stimulus presentations. It is particularly interesting that behavioral responses increase while neuronal responses generally decrease. Although the behavioral effect could occur fully downstream of the sensory responses the authors measure, at least those sensory responses retain the core features needed to drive behavior despite being highly adapted.

      Weaknesses:

      Ultimately no clear conceptual framework arises to understand how PN responses change during adaptation. Neither the mechanism (vesicle depletion versus changes in lateral inhibition) nor even a qualitative description of those changes. Perhaps this is because much of the analysis is focused on the entire population response, while perhaps different mechanisms operate on different cells making it difficult to understand things at the single PN level.

      From the x-axis scale in Fig 2e,f it appeared to me that they do not observe many strong PN responses to these stimuli, everything being < 10 spikes/sec. So perhaps a clearer effect would be observed if they managed to find the stronger responding PNs than captured in this dataset.

      We thank the reviewer for his/her evaluation of our work. Indeed, our work does not clarify the mechanism that underlies the adaptation over trials, and how this mechanism accounts for adaptation that is observed at two different intensities of the same odorant. However, as we highlight in the revised manuscript, there is some evidence for the vesicle depletion hypothesis. For the plots shown in Fig. 2, the firing rates were calculated after averaging across time bins and trials. Hence, the lower firing rates. The peak firing rates of the most active neurons are ~100 Hz. So, we are certain that we are collecting responses from a representative ensemble of neurons in this circuit.

      Reviewer #3 (Public Review):

      Summary:

      How does the brain distinguish stimulus intensity reduction from response reductions due to adaptation? Ling et al study whether and how the locust olfactory system encodes stimulus intensity and repetition differently. They show that these stimulus manipulations have distinguishable effects on population dynamics.

      Strengths:

      (1) Provides a potential strategy with which the brain can distinguish intensity decrease from adaptation. -- while both conditions reduce overall spike counts, intensity decrease can also changes which neurons are activated and adaptation only changes the response magnitude without changing the active ensemble.

      (2) By interleaving a non-repeated odor, they show that these changes are odor-specific and not a non-specific effect.

      (3) Describes how proboscis orientation response (POR) changes with stimulus repetition., Unlike the spike counts, POR increases in probability with stimulus. The data portray the variability across subjects in a clear way.

      We thank the reviewer for the summary and for highlighting the strengths of our work.

      Weaknesses:

      (1) Behavior

      a. While the "learning curve" of the POR is nicely described, the behavior itself receives very little description. What are the kinematics of the movement, and do these vary with repetition? Is the POR all-or-nothing or does it vary trial to trial?

      The behavioral responses were monitored in unconditioned/untrained locusts. Hence, these are innate responses to the odorants. These innate responses are usually brief and occur after the onset of the stimulus. However, there is variability across locusts and trials (refer Revised Supplementary Fig. 1). When the same odorant is conditioned with food reward, the POR responses become more stereotyped and occur rapidly within a few hundred milliseconds. 

      Author response image 1.

      POR response dynamics in a conditioned locust. The palps were painted in this case (left panel), and the distance between the palps was tracked as a function of time (right panel).

      b. What are the reaction times? This can constrain what time window is relevant in the neural responses. E.g., if the reaction time is 500 ms, then only the first 500 ms of the ensemble response deserves close scrutiny. Later spikes cannot contribute.

      This is an interesting point. We had done this analysis for conditioned POR responses. For innate POR, as we noted earlier, there is variability across locusts. Many responses occur rapidly after odor onset (<1 s), while some responses do occur later during odor presentation and in some cases after odor termination. It is important to note that these dynamical aspects of the POR response, while super interesting, should occur at a much faster time scale compared to the adaptation that we are reporting across trials or repeated encounters of an odorant.

      c. The behavioral methods are lacking some key information. While references are given to previous work, the reader should not be obligated to look at other papers to answer basic questions: how was the response measured? Video tracking? Hand scored?

      We agree and apologize for the oversight. We have revised the methods and added a video to show the POR responses. Videos were hand-scored. 

      d. Can we be sure that this is an odor response? Although airflow out of the olfactometer is ongoing throughout the experiment, opening and closing valves usually creates pressure jumps that are likely to activate mechanosensors in the antennae.

      Interesting. We have added a new Supplementary Fig. 2 that shows that the POR to even presentations of paraffin oil (solvent; control) is negligible.  This should confirm that the POR is a behavioral response to the odorant. 

      Furthermore, all other potential confounds identified by the reviewer are present for every odorant and every concentration presented.  However, the POR varies in an odor-identity and intensity-specific manner. 

      e. What is the baseline rate of PORs in the absence of stimuli?

      Almost zero. 

      f. What can you say about the purpose of the POR? I lack an intuition for why a fly would wiggle the maxillary palps. This is a question that is probably impossible to answer definitively, but even a speculative explanation would help the reader better understand.

      The locusts use these finger-like maxillary palps to grab a grass blade while eating. Hence, we believe that this might be a preparatory response to feeding. We have noted that the PORs are elicited more by food-related odorants. Hence, we think it is a measure of odor appetitiveness. This has been added to the manuscript. 

      (2) Physiology

      a. Does stimulus repetition affect "spontaneous" activity (i.e., firing in the interstimulus interval? To study this question, in Figures 2b and c, it would be valuable to display more of the prestimulus period, and a quantification of the stability or lability of the inter-stimulus activity.

      Done. Yes, the spontaneous activity does appear to change in an odor-specific manner. We have done some detailed analysis of the same in this preprint:

      Ling D, Moss EH, Smith CL, Kroeger R, Reimer J, Raman B, Arenkiel BR. Conserved neural dynamics and computations across species in olfaction. bioRxiv [Preprint]. 2023 Apr 24:2023.04.24.538157. doi: 10.1101/2023.04.24.538157. PMID: 37162844; PMCID: PMC10168254

      b. When does the response change stabilize? While the authors compare repetition 1 to repetition 25, from the rasters it appears that the changes have largely stabilized after the 3rd or 4th repetition. In Figure 5, there is a clear difference between repetition 1-3 or so and the rest. Are successive repetitions more similar than more temporally-separated repetitions (e.g., is rep 13 more similar to 14 than to 17?). I was not able to judge this based on the dendrograms of Figure 5. If the responses do stabilize at it appears, it would be more informative to focus on the dynamics of the first few repetitions.

      The reviewer makes an astute observation. Yes, the changes in firing rates are larger in the first three trials (Fig. 3c). The ensemble activity patterns, though, are relatively stable across all trials as indicated by the PCA plots and classification analysis results.

      Author response image 2.

      Correlation as a function of trial number. All correlations were made with respect to the odor-evoked responses in the last odor trial of hex(H) and bza(H).

      c. How do temporal dynamics change? Locust PNs have richly varied temporal dynamics, but how these may be affected is not clear. The across-population average is poorly suited to capture this feature of the activity. For example, the PNs often have an early transient response, and these appear to be timed differently across the population. These structures will be obscured in a cross population average. Looking at the rasters, it looks like the initial transient changes its timing (e.g., PN40 responses move earlier; PN33 responses move later.). Quantification of latency to first spike after stimulus may make a useful measure of the dynamics.

      As noted earlier, to keep our story simple in this manuscript, we have only focused on the variations across trials (i.e., much slower response dynamics). We did this as we are not recording neural and behavioral responses from the same locust. We plan to do this and directly compare the neural and behavioral dynamics in the same locust.

      d.How legitimate is the link between POR and physiology? While their changes can show a nice correlation, the fact the data were taken from separate animals makes them less compelling than they would be otherwise. How feasible is it to capture POR and physiology in the same prep?

      This would be most helpful, but I suspect may be too technically challenging to be within scope.

      The antennal lobe activity in the input about the volatile chemicals encountered by the locust. The POR is a behavioral output. Hence, we believe that examining the correlation between the olfactory system's input and output is a valid approach. However, we have only compared the mean trends in neural and behavioral datasets, and dynamics on a much slower timescale. We are currently developing the capability to record neural responses in behaving animals. This turned out to be a bit more challenging than we had envisioned. We plan to do fine-grained comparisons of the neural and behavioral dynamics, recommended by this reviewer, in those preparations.

      Further, we will also be able to examine whether the variability in behavioral responses could be predicted from neural activity changes in that prep.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public review):

      Weaknesses:  

      (1) The heatmaps (for example, Figure 3A, B) are challenging to read and interpret due to their size. Is there a way to alter the visualization to improve interpretability? Perhaps coloring the heatmap by general anatomical region could help? We feel that these heatmaps are critical to the utility of the registration strategy, and hence, clear visualization is necessary. 

      We thank the reviewers for this point on aesthetic improvement, and we agree that clearer visualization of our correlation heatmaps is important. To address this point, we have incorporated the capability of grouping “child” subregions in anatomical order by their more general “parent” region into the package function, plot_correlation_heatmaps(). Parent regions will be can now be plotted as smaller sub-facets in the heatmaps. We have also rearranged our figures to fit enlarged heatmaps in Figures 3-5, and Supplementary Figure 10 for easier visualization. 

      (2) Additional context in the Introduction on the use of immediate early genes to label ensembles of neurons that are specifically activated during the various behavioral manipulations would enable the manuscript and methodology to be better appreciated by a broad audience. 

      We thank the reviewers for this suggestion and have revised the first part of our Introduction to reflect the broader use and appeal of immediate early genes (IEGs) for studying neural changes underlying behavior.

      (3) The authors mention that their segmentation strategies are optimized for the particular staining pattern exhibited by each reporter and demonstrate that the manually annotated cell counts match the automated analysis. They mention that alternative strategies are compatible, but don't show this data. 

      We thank the reviewers for this comment. We also appreciate that integration with alternative strategies is a major point of interest to readers, given that others may be interested in compatibility with our analysis and software package, rather than completely revising their own pre-existing pipelines. 

      Generally, we have validated the ability to import datasets generated from completely different workflows for segmentation and registration. We have since released documentation on our package website with step-by-step instructions on how to do so (https://mjin1812.github.io/SMARTTR/articles/Part5.ImportingExternalDatasets). We believe this tutorial is a major entry point to taking advantage of our analysis package, without adopting our entire workflow.

      This specific point on segmentation refers to the import_segmentation_custom()function in the package. As there is currently not a standard cell segmentation export format adopted by the field, this function still requires some data wrangling into an import format saved as a .txt file. However, we chose not to visually demonstrate this capability in the paper for a few reasons.  

      i) A figure showing the broad testing of many different segmentation algorithms, (e.g., Cellpose, Vaa3d, Trainable Weka Segmentation) would better demonstrate the efficacy of segmentation of these alternative approaches, which have already been well-documented. However, demonstrating importation compatibility is more of a demonstration of API interface, which is better shown in website documentation and tutorial notebooks.

      ii) Additionally, showing importation with one well-established segmentation approach is still a demonstration of a single use case. There would be a major burden-of-proof in establishing importation compatibility with all potential alternative platforms, their specific export formats, which may be slightly different depending on post-processing choices, and the needs of the experimenters (e.g., exporting one versus many channels, having different naming conventions, having different export formats). For example, output from Cellpose can take the form of a NumPy file (_seg.npy file), a .png, or Native ImageJ ROI archive output, and users can have chosen up to four channels. Until the field adopts a standardized file format, one flexible enough to account for all the variables of experimental interest, we currently believe it is more efficient to advise external groups on how to transform their specific data to be compatible with our generic import function.  

      (4) The authors provided highly detailed information for their segmentation strategy, but the same level of detail was not provided for the registration algorithms. Additional details would help users achieve optimal alignment.

      We apologize for this lack of detail. The registration strategy depends upon the WholeBrain (Fürth et al., 2018) package for registration to the Allen Mouse Common Coordinate Framework. While this strategy has been published and documented elsewhere, we have substantially revised our methods section on the registration process to better incorporate details of this approach.

      (5) The authors illustrate registration to the Allen atlas. Can they comment on whether the algorithm is compatible with other atlases or with alternative sectioning planes (horizontal/sagittal)? 

      Since the current registration workflow integrates WholeBrain (Fürth et al., 2018), any limitations of WholeBrain apply to our approach, which means limited support for registering non-coronal sectioning planes and reliance on the Allen Mouse Atlas (Dong, 2008). However, network analysis and plotting functions are currently compatible with the Allen Mouse Brain Atlas and the Kim Unified Mouse Brain Atlas version (2019) (Chon et al., 2019). Therefore, current limitations in registration do not preclude the usefulness of the SMARTTR software in generating valuable insights from network analysis of externally imported datasets. 

      There are a number of alternative workflows, such as the QUINT workflow (Yates et al., 2019), that support multiple different mouse atlases, and registration of arbitrarily sectioned angles. We have plans to support and a facilitate an entry point for this workflow in a future iteration of SMARTTR, but believe it is of benefit to the wider community to release and support SMARTTR in its current state.

      (6) Supplemental Figures S10-13 do not have a legend panel to define the bar graphs. 

      We apologize for this omission and have fixed our legends in our resubmission. Our supplement figure orders have changed and the corresponding figures are now Supplemental Figures S11-14.

      (7) When images in a z-stack were collapsed, was this a max intensity projection or average? Assuming this question is in regards to our manual cell counting validation approach, the zstacks were collapsed as a maximum intensity projection.  

      Reviewer #2 (Public review): 

      Weaknesses: 

      (1) While I was able to install the SMARTR package, after trying for the better part of one hour, I could not install the "mjin1812/wholebrain" R package as instructed in OSF. I also could not find a function to load an example dataset to easily test SMARTR. So, unfortunately, I was unable to test out any of the packages for myself. Along with the currently broken "tractatus/wholebrain" package, this is a good example of why I would strongly encourage the authors to publish SMARTR on either Bioconductor or CRAN in the future. The high standards set by Bioc/CRAN will ensure that SMARTR is able to be easily installed and used across major operating systems for the long term. 

      We greatly thank the reviewer for pointing out this weakness; long-term maintenance of this package is certainly a mutual goal. Loading an .RDATA file is accomplished by either doubleclicking directly on the file in a directory window, after specifying this file type should be opened in RStudio or by using the load() function, (e.g., load("directory/example.RData")). We have now explicitly outlined these directions in the online documentation. 

      Moreover, we have recently submitted our package to CRAN and are currently working on revisions following comments. This has required a package rebranding to “SMARTTR”, as there were naming conflicts with a previously archived repository on CRAN. Currently, SMARTTR is not dependent on the WholeBrain package, which remains optional for the registration portion of our workflow. Ultimately, this independence will allow us to maintain the analysis and visualization portion of the package independently.

      In the meantime, we have fully revised our installation instructions (https://mjin1812.github.io/SMARTTR/articles/SMARTTR). SMARTTR is now downloadable from a CRAN-like repository as a bundled .tar.gz file, which should ease the burden of installation significantly. Installation has been verified on a number of different versions of R on different platforms. Again, we hope these changes are sufficient and improve the process of installation. 

      (2) The package is quite large (several thousand lines include comments and space). While impressive, this does inherently make the package more difficult to maintain - and the authors currently have not included any unit tests. The authors should add unit tests to cover a large percentage of the package to ensure code stability. 

      We have added unit testing to improve the reliability of our package. Unit tests now cover over 71% of our source code base and are available for evaluation on our github website (https://github.com/mjin1812/SMARTTR). We focused on coverage of the most front-facing functions. We appreciate this feedback, which has ultimately enhanced the longevity of our software.

      (3) Why do the authors choose to perform image segmentation outside of the SMARTTR package using ImageJ macros? Leading segmentation algorithms such as CellPose and StarMap have well-documented APIs that would be easy to wrap in R. They would likely be faster as well. As noted in the discussion, making SMARTTR a one-stop shop for multi-ensemble analyses would be more appealing to a user. 

      We appreciate this feedback. We believe parts of our response to Reviewer 1, Comment 3, are relevant to this point. Interfaces for CellPose and ClusterMap (which processes in situ transcriptomic approaches, like STARmap) are both in python, and currently there are ways to call python from within R (https://rstudio.github.io/reticulate/index.html). We will certainly explore incorporating these APIs from R. However, we would anticipate this capability is more similar to “translation” between programming languages, but would not currently preclude users from the issue of needing some familiarity with the capabilities of these python packages, and thus with python syntax.

      (4) Given the small number of observations for correlation analyses (n=6 per group), Pearson correlations would be highly susceptible to outliers. The authors chose to deal with potential outliers by dropping any subject per region that was> 2 SDs from the group mean. Another way to get at this would be using Spearman correlation. How do these analyses change if you use Spearman correlation instead of Pearson? It would be a valuable addition for the author to include Spearman correlations as an option in SMARTTR. 

      We thank reviewers for this suggestion and we have updated our code base to include the possibility for using Spearman’s correlation coefficient as opposed to Pearson’s correlation coefficient for heatmaps in the get_correlations() function. Users can now use the `method` parameter, set to either “pearson” or “spearman” and results will propagate throughout the rest of the analysis using these results.

      Below, in Author response image 1 we show a visual comparison of the correlation heat maps for active eYFP<sup>+</sup> ensembles in the CT and IS groups using both Pearson and Spearman correlations. We see a strongly qualitative similarity between the heat maps. Of course, since the statistical assumptions underlying the relationship between variables using Pearson correlation (linear) vs Spearman correlation (monotonic) are different, users should take this into account when interpreting results using different approaches.

      Author response image 1.

      Pearson and Spearmen regional correlations of eYFP+ ensembles activity in the CT and IS groups.

      (5) I see the authors have incorporated the ability to adjust p-values in many of the analysis functions (and recommend the BH procedure) but did not use adjusted p-values for any of the analyses in the manuscript. Why is this? This is particularly relevant for the differential correlation analyses between groups (Figures 3P and 4P). Based on the un-adjusted pvalues, I assume few if any data points will still be significant after adjusting. While it's logical to highlight the regional correlations that strongly change between groups, the authors should caution which correlations are "significant" without adjusting for multiple comparisons. As this package now makes this analysis easily usable for all researchers, the authors should also provide better explanations for when and why to use adjusted p-values in the online documentation for new users. 

      We appreciate the feedback note that our dataset is presented as a more demonstrative and exploratory resource for readers and, as such, we accept a high tolerance for false positives, while decreasing risk of missing possible interesting findings. As noted by Reviewer #2, it is still “logical to highlight the regional correlations that strongly change between groups.” We have clarified in our methods that we chose to present uncorrected p-values when speaking of significance. 

      We have also removed any previous recommendations for preferred methods for multiple comparisons adjustment in our function documentations, as some previous documentation was outdated. Moreover, the standard multiple comparisons adjustment approaches assume complete independence between tests, whereas this assumption is violated in our differential correlational analysis (i.e., a region with one significantly altered connection is more likely than another to have another significantly altered connection).

      Ultimately, the decision to correct for multiple comparisons with standard FDR, and choice of significance threshold, should still be informed by standard statistical theory and user-defined tolerance for inclusion of false-positives and missing of false-negatives. This will be influenced by factors, such as the nature and purpose of the study, and quality of the dataset.  

      (6) The package was developed in R3.6.3. This is several years and one major version behind the current R version (4.4.3). Have the authors tested if this package runs on modern R versions? If not, this could be a significant hurdle for potential users. 

      We thank reviewers for pointing out concerns regarding versioning. We have since updated our installation approach for SMARTTR, which is compatible with versions of R >= 3.6 and has been tested on Mac ARM-based (Apple silicon) architecture (R v4.4.2), and Windows 10 (R v3.6.3, v4.5.0 [devel]). 

      The recommendation for users to install R 3.6.3 is primarily for those interested in using our full workflow, which requires installation of the WholeBrain package, which is currently a suggested package. We anticipate updating and supporting the visualization and network analysis capabilities, whilst maintaining previous versioning for the full workflow presented in this paper.  

      (7) In the methods section: "Networks were constructed using igraph and tidygraph packages." - As this is a core functionality of the package, it would be informative to specify the exact package versions, functions, and parameters for network construction. 

      We thank reviewers for pointing out the necessity for these details for code reproducibility. We have since clarified our language in the manuscript on the exact functions we use in our analysis and package versions, which we also fully document in our online tutorial. Additionally. We have printed our package development and analysis environment online at https://mjin1812.github.io/SMARTTR/articles/Part7.Development.

      (8) On page 11, "Next, we examined the cross-correlations in IEG expression across brain regions, as strong co-activation or opposing activation can signify functional connectivity between two regions" - cross-correlation is a specific analysis in signal processing. To avoid confusion, the authors should simply change this to "correlations". 

      We thank the reviewer for pointing out this potentially confusing phrasing. We have changed all instances of “cross-correlation” to “correlation”.

      (9) Panels Q-V are missing in Figure 5 caption. 

      We thank the reviewer for pointing out this oversight. We have now fixed this in our revision.

      References

      Chon, U., Vanselow, D. J., Cheng, K. C., & Kim, Y. (2019). Enhanced and unified anatomical labeling for a common mouse brain atlas. Nature Communications, 10(1), 5067. https://doi.org/10.1038/s41467-019-13057-w

      Dong, H. W. (2008). The Allen reference atlas: A digital color brain atlas of the C57Bl/6J male mouse (pp. ix, 366). John Wiley & Sons Inc.

      Fürth, D., Vaissière, T., Tzortzi, O., Xuan, Y., Märtin, A., Lazaridis, I., Spigolon, G., Fisone, G., Tomer, R., Deisseroth, K., Carlén, M., Miller, C. A., Rumbaugh, G., & Meletis, K. (2018). An interactive framework for whole-brain maps at cellular resolution. Nature Neuroscience, 21(1), 139–149. https://doi.org/10.1038/s41593-017-0027-7

      Yates, S. C., Groeneboom, N. E., Coello, C., Lichtenthaler, S. F., Kuhn, P.-H., Demuth, H.-U., Hartlage-Rübsamen, M., Roßner, S., Leergaard, T., Kreshuk, A., Puchades, M. A., & Bjaalie, J. G. (2019). QUINT: Workflow for Quantification and Spatial Analysis of Features in Histological Images From Rodent Brain. Frontiers in Neuroinformatics, 13. https://www.frontiersin.org/articles/10.3389/fninf.2019.00075

    1. Author Response

      The following is the authors’ response to the original reviews.

      eLife assessment

      This important work by Park et al. introduces an open-top two-photon light sheet microscopy (OT-TP-LSM) for lesser invasive evaluation of intraoperative 3D pathology. The authors provide convincing evidence for the effectiveness of this technique in investigating various human cancer cells. The paper needs some minor corrections and has the potential to be of broad interest to biologists and, specifically, pathologists utilizing 3D optical microscopy.

      We would like to thank the editor for the positive general comment. We revised the manuscript by addressing the reviewers' comments.

      Public Reviews:

      Reviewer1

      Summary:

      A2. This manuscript presents the development of a new microscope method termed "open-top two-photon light sheet microscopy (OT-TP-LSM)". While the key aspects of the new approach (open-top LSM and Two-photon microscopy) have been demonstrated separately, this is the first system of integrating the two. The integration provides better imaging depth than a single-photon excitation OT-LSM.

      Strengths:

      The use of liquid prism to minimize the aberration induced by index mismatching is interesting and potentially helpful to other researchers in the field.

      • The use of propidium iodide (PI) provided a deeper imaging depth.

      Weaknesses:

      Details are lacking on imaging time, data size, the processing time to generate large-area en face images, and inference time to generate pseudo H&E images. This makes it difficult to assess how applicable the new microscope approach might be in various pathology applications.

      B2. We would like to thank the reviewer for the critical and positive comments. We agree with the reviewer that detailed information such as processing time is missing.

      The imaging time and data size were estimated per 1cm2 area and they were 7 min and 318 GB (= (7 × 60) s × 400 fps × (1850 × 512 × 2) byte) for each channel, respectively. The time for processing en-face images was relatively long by taking ~1.7 s Gb−1 after loading the image dataset at ~6.8 s Gb−1 in the current setting and needs to be shortened for intraoperative application. The time for converting OT-TP-LSM images of 512 x 512 pixels into virtual H&E staining images was 160 ms. This study was to address the current limitation of 3D pathology such as imaging depth and to develop the image processing to generate virtual H&E images. Further development such as speeding up the image processing would be needed. We added missing information and included some discussion on limitations of the new system and further development for intraoperative applications.

      C1-1. Revised manuscript, Discussion, pages 14-15 and lines 320-328

      Although OT-TP-LSM enabled high-speed 3D imaging, the post-processing time of the OT-TP-LSM image datasets was relatively long due to the large data size, sequential processing of dual channel images, and manual stitching. The long post-processing time needs to be resolved for intraoperative applications. To speed up processing, these processing steps can be performed using field-programmable gate array (FPGA)-based data acquisition with graphics processing unit (GPU)-based computing. The processing time can be further reduced by coding the algorithm in a C++-based environment. Furthermore, ImageJ-based software such as the Bigstitcher plugin can be used for automatic 3D image processing [44].

      C1-2. Revised manuscript, Materials and methods, Image acquisition and post-processing, page 17 and lines 390-398

      Image acquisition and post-processing

      Raw image datasets from dual sCMOS cameras were acquired and processed on a workstation with 128 Gb RAM and a 2 TB SSD drive. The imaging time and data size per 1cm2 area with 400 fps was 7 min and 318 GB (= (7 × 60) s × 400 fps × (1850 × 512 × 2) byte) for each channel, respectively. The raw image strip was sheared at 45° with respect to the sample surface, and a custom image processing algorithm was used to transform the image data in the XYZ coordinate. The processing for en-face image was conducted in MATLAB and took ~1.7 s Gb−1 after loading the image dataset at ~6.8 s Gb−1 in the current laboratory setting. Mosaic images were generated by joining the image strips manually.

      C1-3. Revised manuscript, Materials and methods, Virtual H&E staining of OT-TP-LSM via deep learning network, page 18 and lines 414-418

      The CycleGAN training and testing were performed using a Nvidia GeForce RTX 3090 with 24 GB RAM. The network was implemented using Python version 3.8.0 on a desktop computer with a Core i7-12700K CPU@3.61 GHz and 64 GB RAM, running Anaconda (version 22.9.0). The inference time for converting OT-TP-LSM patch image into virtual H&E patch image was measured as 160 ms.

      Reviewer 2

      Summary:

      A2. In this manuscript, the authors developed an open-top two-photon light sheet microscopy (OT-TP-LSM) that enables high-throughput and high-depth investigation of 3D cell structures. The data presented here shows that OT-T-LSM could be a complementary technique to traditional imaging workflows of human cancer cells.

      Strengths:

      High-speed and high-depth imaging of human cells in an open-top configuration is the main strength of the presented study. An extended depth of field of 180 µm in 0.9 µm thickness was achieved together with an acquisition of 0.24 mm2/s. This was confirmed by 3D visualization of human cancer cells in the skin, pancreas, and prostate.

      Weaknesses:

      The complementary aspect of the presented technique in human pathological samples is not convincingly presented. The traditional hematoxylin and eosin (H&E) staining is a well-established and widely used technique to detect human cancer cells. What would be the benefit of 3D cell visualization in an OT-TP-LSM microscope for cancer detection in addition to H&E staining?

      B2. We would like to thank the reviewer for the critical and positive comments. 3D pathology has been a long-standing research direction. The current pathology is 2D by examining H&E histology slides which were generated by thin sectioning biopsied and surgical specimens at different depths. The reliability of the pathological diagnosis suffers from under sampling of specimens. Although 3D pathology is possible by serial thin-sectioning, imaging, and then combining the images in 3D, it is not practice for clinical use due to the required labor and time.

      We demonstrated the advantages of OT-TP-LSM in various human cancer tissues. The relatively high imaging depths of OT-TP-LSM enabled the nondestructive visualization of detailed 3D cell structures with high contrast and without distortion and allowed a distinction between cancer and normal cell structures as well as the detection of cancer invasiveness within tissues. We revised the manuscript to explain the benefits of 3D pathology with OT-TP-LSM.

      C2-1. Revised manuscript, Results, 3D OT-TP-LSM imaging of human skin cancers, pages 8-9 and lines 176-180

      Using 3D visualization, normal glandular structures in the dermis were distinguished from BCC tumor nests (Video 1). Both eccrine and sebaceous glands could appear similar to BCC nests in 2D images at certain depths. Hence, nondestructive 3D visualization of cell structures would be important for distinguishing them, serving as a complement to the traditional 2D H&E images.

      C2-2. Revised manuscript, Results, 3D OT-TP-LSM imaging of human pancreatic cancers, pages 10-11 and lines 222-232

      Magnified images of ROI 1 (PDAC) at two different depths showed irregularly shaped glands with sharp angles and 3D structural complexity including unstable bridging structure inside (Figure 4B). An irregular and distorted architecture amidst desmoplastic stroma is one of the important diagnostic factors for PDAC [35]. The cancer glands exhibited disorganized cancer cell arrangement with nuclear membrane distortion. Magnified images of ROI 2 showed both nonneoplastic ducts and cancer glands in different cell arrangements (Figure 4C). The nonneoplastic ducts showed single-layered epithelium with small, evenly distributed cells expressing relatively high nuclear fluorescence. Cancer glands, on the other hand, had disorganized and multilayered structure with large nuclei. OT-TP-LSM visualized the 3D invasiveness of cancer glands within tissues nondestructively, which could not be identified from limited 2D information.

      C2-3. Revised manuscript, Results, 3D OT-TP-LSM imaging of human prostatic cancers, page 11 and lines 251-252

      OT-TP-LSM provided histological 3D information equivalent to that of the H&E stained image without the need for sectioning.

      C2-4. Revised manuscript, Discussion, page 12 and lines 274-276

      OT-TP-LSM was developed for the rapid and precise nondestructive 3D pathological examination of excised tissue specimens during both biopsy and surgery, as a compliment to traditional 2D H&E pathology by visualizing 3D cell structures.

      C2-5. Revised manuscript, Discussion, page 13 and lines 284-288

      The relatively high imaging depths of OT-TP-LSM enabled the nondestructive visualization of detailed 3D cell structures with high contrast and without distortion and allowed a distinction between cancer and normal cell structures as well as the detection of cancer invasiveness within tissues. These have been challenging with 2D histological images.

      Reviewer #2 (Recommendations For The Authors):

      I would suggest the following points to the authors to enhance the readability of the manuscript and to provide a strong narrative to explain their findings:

      A3. Line 54: For the non-expert readers, please provide more background information about the histopathology before introducing the hematoxylin and eosin staining.

      B3. We would like to thank the reviewer for the comment. As suggested by the reviewer, we added information about the current standard method of histopathological examination and its limitations.

      C3. Revised manuscript, introduction, page 4 and lines 56-64 Precise intraoperative cancer diagnosis is crucial for achieving optimal patient outcomes by enabling complete tumor removal. The standard method is the microscopic cellular examination of surgically excised specimens following various processing steps, including thin sectioning and hematoxylin and eosin (H&E) cell staining. However, this examination method is laborious and time-consuming. Furthermore, it has inherent artifacts that disturb accurate diagnosis, including tissue loss, limited two-dimensional (2D) information, and sampling error [1]. High-speed three-dimensional (3D) optical microscopy, which can visualize cellular structures without thin sectioning, holds promise for nondestructive 3D pathological examination as a complement of 2D pathology limitation [1-4].

      A4. Line 66 and 71: Please briefly introduce the cited studies to give some information about the previous studies. This will help to reader to understand the innovative aspects of your study.

      B4. We would like to thank the reviewer for the comment. As suggested by the reviewer, we added a brief introduction about the cited studies.

      C4. Revised manuscript, introduction, pages 4-5 and lines 71-82

      As a deep tissue imaging method, two-photon microscopy (TPM) has been used in both biological and optical biopsy studies [17-19]. TPM is based on nonlinear two-photon excitation of fluorophores and achieves high imaging depths down to a few hundred micrometers by using long excitation wavelengths, which reduce light scattering. Moreover, TPM provides additional intrinsic second harmonic generation (SHG) contrast for visualizing collagen fibers within the extracellular matrix (ECM). This feature proved advantageous for high-contrast imaging of cancer tissue and microenvironmental analysis [20-22]. However, TPM has low imaging speeds due to point scanning-based imaging. To address this limitation, two-photon LSM (TP-LSM) techniques were developed for high-speed imaging [23-27]. Although TP-LSM facilitated rapid 3D imaging of cancer cells and zebrafish, its applications were limited to small samples and biological studies due to geometric limitations.

      A5. Line 72: Please mention the importance and benefit of having an open-top configuration. I think this is one of the key aspects that provide a high imaging depth in OT-LP-LSM.

      B5. We would like to thank the reviewer for the comment. Conventional LSM techniques including TP-LSM have a configuration in which the illumination objective is oriented in the horizontal plane and imaging is performed with orthogonally arranged objectives. However, this geometry limited lateral sample size physically and it is unsuitable to image centimeter-scale large tissue. Therefore, we developed OT-TP-LSM for 3D large tissue examination. High imaging depths were achieved with long excitation wavelengths and long emission wavelengths of fluorophores. The open-top configuration does not contribute to the improvement of imaging depth. We revised the manuscript to explain the need for open-top configuration.

      C5. Revised manuscript, introduction, page 5 and lines 82-86

      Conventional TP-LSM had a configuration of a horizontally oriented illumination objective and a vertically oriented imaging objective. This geometry imposed limitations on the sample size, rendering it unsuitable for the examination of centimeter-scale specimens. TP-LSM with open-top configuration is needed for 3D histological examination.

      A6. Line 78: It would be nice to clearly quantify the imaging depth here.

      B6. We would like to thank the reviewer for the comment. Although we considered entering the quantitative imaging depth of OT-TP-LSM in the introduction section, we decided that it would be appropriate to present the quantitative imaging depth in the Results section and discuss it in the Discussion section.

      A7. Line 146: Please clearly explain the reason why the upper layers are not resolved.

      B7. We would like to thank the reviewer for the comment and we are sorry for the missing information. The skin epidermis has various cell layers and superficial layers are composed of less rounded and flat cells with relatively small cytoplasm. Therefore, cells in that layer could be difficult to resolve with the current system resolution because there is little space between nuclei. Additionally, strong autofluorescence signal in the stratum corneum could be the reason for preventing visualization of the cells in the superficial layer. We revised the manuscript to explain the reasons in detail.

      C7. Revised manuscript, Results, 3D OT-TP-LSM imaging of human skin cancers, page 8 and lines 159-163

      Keratinocytes in the basal layer were relatively large and individually resolved, while those in the upper layers were unresolved and appeared as a band. It could be attributed to the upper layers being comprised of flat cells with relatively small cytoplasm, resulting in little space between nuclei. Additionally, strong autofluorescence signal in the stratum corneum might prevent visualization of the cells in the superficial layer.

      A8. Line 253: Please explain the importance of visualization of 3D cell structures in cancer pathology. I think this should be stated clearly throughout the text as it is the key component of OT-LP-LSM to complement the traditional H&E staining. Also, referring to the non-destructive manner of your technique would help to emphasize this point.

      B8. We would like to thank the reviewer for the comment. As answered in A2, the current H&E histological examination has inherent limitations due to limited 2D information and sampling errors. To resolve this, OT-TP-LSM was developed for the visualization of 3D cell structures nondestructively as a complement to traditional slide-based 2D pathology. We demonstrated the advantages of OT-TP-LSM in various human cancer tissues. The relatively high imaging depths of OT-TP-LSM enabled the nondestructive visualization of detailed 3D cell structures with high contrast and without distortion and allowed a distinction between cancer and normal cell structures as well as the detection of cancer invasiveness within tissues. We revised the manuscript to explain the benefits of 3D pathology with OT-TP-LSM.

      C8. Please refer to the answer in C2-1 – C2-5.

      A9. Figures: Please clearly mark the cancer regions in the images as indicated in Figure 5. It will help the reader to easily compare the healthy and invaded tissue parts.

      B9. We would like to thank the reviewer for the comment. We confirmed that the cancer area is not marked in Figure 4 of the pancreatic cancer tissue. We modified Figure 4 to mark the cancer region. Additionally, Figure 2 of the skin cancer tissue was also modified in this regard.

      C9. Modified Figure 2 and Figure 4.

      Author response image 1.

      Author response image 2.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1:

      This research used cell-based signaling assay and Gaussian-accelerated molecular dynamics (GaMD) to study peptide-mediated signaling activation of Polycystin-1 (PC1), which is responsible for the majority of autosomal dominant polycystic kidney disease (ADPKD) cases. Synthetic peptides of various lengths derived from the N-terminal portion of the PC1 C-terminal fragment (CTF) were applied to HEK293T cells transfected with stalkless mouse CTF expression construct. It was shown that peptides including the first 7, 9, and 17 residues of the N-terminal portion could activate signaling to the NFAT reporter. To further understand the underlying mechanism, docking and peptide-GaMD simulations of peptides composed of the first 9, 17, and 21 residues from the N-terminal portion of the human PC1 CTF were performed. These simulations revealed the correlation between peptide-CTF binding and PC1 CTF activation characterized by the close contact (salt bridge interaction) between residues R3848 and E4078. Finally, a Potts statistical model was inferred from diverged PC1 homologs to identify strong/conserved interacting pairs within PC1 CTF, some of which are highly relevant to the findings from the peptide GaMD simulations. The peptide binding pockets identified in the GaMD simulations may serve as novel targets for the design of therapeutic approaches for treating ADPKD.

      We greatly appreciate the reviewer’s encouraging and positive comments. The reviewer’ specific comments are addressed pointwise below and changes to the text will be highlighted in yellow in the revised manuscript.

      (1) The GaMD simulations all include exogenous peptides, thus lacking a control where no such peptide is present (and only stalkless CTF). An earlier study (PNAS 2022 Vol. 119 No. 19 e2113786119) covered this already, but it should be mentioned here that there was no observation of close/activation for the stalkless CTF.

      We appreciate the reviewer’s concern about the lack of a control where no exogenous peptide is present. As suggested by the reviewer, we are adding more details about the study on the stalkless CTF as a control in the Introduction of the revised manuscript. 

      (2) Although 5 independent trajectories were generated for each peptide, the authors did not provide sufficient details regarding the convergence of the simulation. This leaves some uncertainties in their results. Given that the binding poses changed relative to the starting docked poses for all three peptides, it is possible that some other binding pockets and/or poses were not explored.

      We appreciate the reviewer’s comment regarding the convergence of the simulation results. This is clarified in the revised manuscript as: 

      “We have calculated free energy profiles of individual simulations for each system, including the p9, p17, and p21, as shown below (Figs. S5, S6 and S8). For the p9 peptide, the “Bound” lowenergy state was consistently identified in the 2D free energy profile of each individual simulation (Fig. S5). For the p17 peptide, Pep-GaMD simulations were able to refine the peptide conformation from the "Unbound” to the "Intermediate” and “Bound” states in Sim1 and Sim5, while the peptide reached only the "Intermediate” state in the other three simulations (Fig. S6). For the p21 peptide, Pep-GaMD was able to refine the peptide docking conformation to the

      "Bound” state in all the five individual simulations (Fig. S8).”

      “It is important to note that the free energy profiles calculated from GaMD simulations of PC1 CTF were not fully converged since certain variations were observed among the individual simulations. Nevertheless, these calculations allowed us to identify representative low-energy binding conformations of the peptides.”

      (3) The free energy profiles (Figures 2 to 4) based on the selected coordinates provide important information regarding binding and CTF conformational change. However, it is a coarsegrained representation and complementary analysis such as RDFs, and/or contact maps between the peptide and CTF residues might be helpful to understand the details of their interactions. These details are currently only available in the text. 

      Following the reviewer's suggestion, we have now included a set of protein contact maps showing contacts between the peptides and the TOP domain for each peptide in the representative "Bound” state in revised Supplementary Information (Fig. S4). The contact maps serve to visualize the list of contacts mentioned in the main text. This will be clarified in the revised manuscript.

      (4) The use of a stalkless CTF is necessary for studying the functions of the exogenous peptides. However, the biological relevance of the stalkless CTF to ADPKD was not clearly explained, if any.

      We appreciate the reviewer’s comment. As correctly assessed by the reviewer, the stalkless CTF is not a biological form of PC1 observed in ADPKD, but rather was used as the simplest or least complex system in which the activities and binding of exogenous peptides could be studied. However, in ADPKD, there are numerous missense mutations reported within the GPCR autoproteolysis-inducing (GAIN) domain that have been shown to prevent or inhibit cleavage at the GPCR-coupled proteolysis site (GPS). Loss of PC1 GPS cleavage, which is known to cause ADPKD, would retain or sequester the stalk tethered agonist within the interior of the GAIN domain, which would presumably interfere with interactions between stalk tethered agonist residues and the remainder of the CTF. Furthermore, there are 10 single nucleotide polymorphisms reported within the stalk sequence (ADPKD Variant Database; https://pkdb.mayo.edu/welcome), most of which we have found to significantly reduce CTF-mediated activation of the NFAT reporter (Magenheimer BS, et al., Constitutive signaling by the C-terminal fragment of polycystin1 is mediated by a tethered peptide agonist; bioRxiv 2021.08.05.455255). In particular, the ADPKD-associated G3052R stalk mutation that was analyzed along with the stalkless CTF by GaMD simulations (Pawnikar et al, PNAS, 2022) has the same reduction in activity as the stalkless CTF in the cellular signaling reporter assays and the same loss of closed conformation interactions in GaMD analyses. As such, we believe the stalkless CTF has biological relevance from the aspect that it mimics the deficiency in signaling activation observed for PC1 CTF stalk mutants. This is clarified in the revised manuscript in the Introduction, page 5, “constructs encoding a stalkless PC1 CTF (a nonbiological mutant of PC1 with deletion of the first 21 N-terminal residues of CTF) and three ADPKD-associated…”) and near the beginning of the Discussion, page 16, where the biological relevance of studying the stalkless CTF is explained

      (5) The authors might want to clarify if a stalkless CTF is commonly seen in ADPKD, or if it is just a construct used for this study.

      The stalkless CTF is not a biological form of PC1, but rather a construct used for this study. This was clarified in the revised manuscript (see response above).

      (6) (Pages 7-8) "...we generated expression constructs of mouse (m) PC1 consisting of the CD5 signal peptide sequence fused in frame with the stalk sequence of mCTF ...". What is the CD5 signal peptide sequence here? What is its use?

      The CD5 signal peptide sequence is “MPMGSLQPLATLYLLGMLVASVLG” from the T cell surface glycoprotein, CD5. Since the N-terminus of PC1 CTF is derived from a posttranslational, autocatalytic, endoproteolytic cleavage event, this isoform is already membraneembedded and therefore lacks its endogenous signal peptide. The CD5 signal peptide coding sequence is added to the PC1 CTF expression constructs in order to ensure translation and insertion of the encoded protein at the endoplasmic reticulum. Additional details were added to the Experimental Procedures, page 2 of Supporting Information.

      (7) (Page 8) "All peptides were appended with a C-terminal, 7-residue hydrophilic sequence (GGKKKKK) to increase solubility". How did the authors make sure that this sequence has no influence on the signaling? 

      To determine the possible effect of the hydrophilic GGKKKKK sequence on signaling, we had a ‘solubility tag’ peptide (LGGKKKKK) synthesized and purified by GenScript. It was necessary to add an N-terminal Leu residue to the 7-residue hydrophilic tag sequence in order for the highly hydrophilic peptide to be recovered. Effect of treatment with the solubility tag peptide on activation of the NFAT reporter was assessed for both empty vector- and ∆stalkCTF-transfected cells in 3 separate signaling experiments (see figure below). Each experiment also included a negative control treatment (no peptide/culture medium only addition) and a positive control treatment (stalk peptide p17). The p17 peptide we had available was derived from the stalk sequence of human PC1 that differs from the mouse PC1 sequence at residues 15 and 17, which are two poorly conserved positions within the stalk sequence (see Reviewer 2, Response 3). In the first experiment with the solubility tag and human p17 peptides (B in figure below), we inadvertently used the empty expression vector and ∆stalkCTF expression construct from mouse PC1. After realizing our error, we then performed 2 additional signaling experiments (C and D in figure below) with the ‘correct’ human ∆stalkCTF expression construct and empty vector. In the revised manuscript, we have provided the results from each of the 3 experiments as Fig. S2 (below).

      (8) (Page 9) "Using a computational model of the ΔStalk PC1 CTF developed previously". The authors might want to expand here a little to give a short review about the structure preparation.

      We appreciate the reviewer’s suggestion regarding the addition of details for structure preparation for Stalkless CTF. We have added these details in section “Docking and Pep-GaMD simulations of peptide agonist binding to stalkless PC1 CTF” on Page 10 in the revised manuscript:  “The cryo-EM structure of human PC1-PC2 complex (PDB: 6A70) was used to build the computational model for WT PC1 CTF. As the protein had several missing regions including the Stalk and several loops, homology modeling of the missing regions was done using I-TASSER web server. Using the WT PC1 CTF model, computational model for ΔStalk was generated by deleting the first 21 residues (3049-3069) of the WT PC1 and using the structure for stalkless CTF, we successfully docked the p9, p17 and p21 stalk peptides with HPEPDOCK.  The peptides all bound to the TOP domain and the interface between the TOP domain and extracellular loop 1 (ECL1) of CTF.”

      (9) How was "contact" defined when counting the number of contacts used in the 2D PMFs (Figures 2-4). Response: We appreciate the reviewer’s comment regarding the definition of the number of contacts used in the 2D PMFs. This has been clarified in the revised manuscript as: “The number of contacts is calculated between any atom pairs within 4 Å distance of the peptide and extracellular domains of PC1 protein.”

      (10) How was the ranking of GaMD clusters done? It looks from Figure 3A that the "intermediate" state is more favorable compared to the "bound" state, but it was claimed in the text the "bound" state was ranked 1st. 

      Thanks to the reviewer for this comment. It has been clarified in the revised

      Supplementary Information: “Three independent Pep-GaMD simulations were combined to perform structural clustering using the hierarchical agglomerative clustering algorithm in CPPTRAJ. A 3 Å RMSD cutoff was used for each peptide system. PyReweighting was then applied to calculate the original free energy values of each peptide structural cluster with a cutoff of 500 frames. The structural clusters were finally ranked according to the reweighted free energy values.” And in the revised main text: “It is important to note that the free energy profiles calculated from GaMD simulations of PC1 CTF were not fully converged since certain variations were observed among the individual simulations. The free energy values of 2D PMF minima shown in Figure 3A could differ from those in the 1D PMF minima of peptide structural clusters, especially with the usage of distinct reaction coordinates. Nevertheless, these calculations allowed us to identify representative low-energy binding conformations of the peptides.”

      (11) When mentioning residue pair distances, such as in the sentence "The distance between the TOP domain residue R3848 and PL residue E4078 was 3.8 Å (Fig. 4D)" on page 12, it should be clarified if these distances are average distance, or a statistical error can be given.

      We appreciate the reviewer’s comment regarding the TOP Domain and PL distance between residues R3848-E4078. This has been clarified on page 14 in the revised manuscript as:

      “The distance between the TOP domain residue R3848 and PL residue E4078 was 3.8 Å. The distance was extracted from the top-ranked structural cluster of the p21 bound to the ΔStalk CTF, corresponding to the “Closed/Active” low-energy conformational state. (Fig. 4E)”.

      (12) More analysis of the GaMD can be performed. For example, the authors observed a single "bound" state for p21, but there must be some flexibility in the peptide and the protein itself. The authors might want to consider adding some plots illustrating the flexibility of the peptide residues (for example, a RMSD plot). Contact maps can also be added to visualize the results currently discussed in the text. 

      We thank the reviewer for their constructive suggestions. To characterize flexibility of the peptide and protein in the revised manuscript, we have added plots of the TOP-PL interaction distance between residues R3848-E4078 in PC1, the radius of gyration (Rg) of p21 and root-mean square deviation (RMSD) of p21 relative to the starting HPEPDOCK conformation of the peptide in the new Fig. S7. The peptide-protein contact map has also been added in the new Fig. S4.

      (13) (Page 7) In the sentence `...sampled the "Closed/Active" low-energy state relative to the large number of Stalk-TOP contacts`, I suggest using "related to" instead of "relative to"

      We thank the reviewer for the comment, and we have replaced "relative to" to “related to” in the following sentence `...sampled the "Closed/Active" low-energy state relative to the large number of Stalk-TOP contacts`

      (14) (Page 7) In the sentence `Our previous study utilized expression constructs of human PC1 CTF, however, in order to prepare for ...`, "PC1 CTF, however," -> "PC1 CTF. However,"

      We thank the reviewer for the comment, and we have replaced "PC1 CTF, however," to "PC1 CTF. However," in the following sentence `Our previous study utilized expression constructs of human PC1 CTF, however, in order to prepare for ...`.

      Reviewer 2:

      The autosomal dominant polycystic kidney disease (ADPKD) is a major form of polycystic kidney disease (PKD). To provide better treatment and avoid side effects associated with currently available options, the authors investigated an interesting GPCR, polycystin-1 (PC1), as a potential therapeutic target. In vitro and in silico studies were combined to identify peptide agonists for PC1 and to elucidate their roles in PC1 signaling. Overall, regarding the significance of the findings, this work described valuable peptide agonists for PC1 and the combined in vitro and in silico approach can be useful to study a complex system like PC1. However, the strength of the evidence is incomplete, as more experiments are needed as controls to validate the computational observations. The work appears premature.

      We greatly appreciate the reviewer’s encouraging and positive comments. The reviewer’ specific comments are addressed pointwise below and changes to the text will be highlighted in yellow in the revised manuscript.

      (1) The therapeutic potential of PC1 peptide agonists is unclear in the introduction. For example, while the FDA-approved drug Jynarque was mentioned, the text was misleading as it sounded like Jynarque targeted PC1. In fact, it targets another GPCR, the vasopressin receptor 2 (V2). A clear comparison of targeting PC1 over V2 pathways and their therapeutic relevance can help the readers better understand the importance of this work. Importantly, a clear background on the relationship between PC1 agonism and treatments for ADPKD is necessary.

      We understand the confusion that was caused by the brevity of our introductory paragraph and will clarify the differences in therapeutic targeting between Jynarque and our PC1 stalk-derived peptides in the revised manuscript. We will also expound on the rationale for targeting PC1 agonism as a therapeutic approach for ADPKD versus Jynarque. For example: It is known that ADPKD disease severity is dependent on the functional levels of PC1. Jynarque is a small molecule antagonist of the arginine vasopressin receptor 2, V2R, whose signaling, and production of cAMP has been shown to be increased in ADPKD. As this drug targets one of the downstream aberrant pathways, it is only capable of slowing disease progression and has numerous undesirable side effects. We reasoned that a therapeutic agent capable of stimulating and thus augmenting PC1 signaling function would be a safer, cyst initiation-proximal treatment capable of preventing cyst formation with few side effects.

      (2) PC1 is a complex membrane protein, and most figures focus on the peptide-binding site. For general readers (or readers that did not read the previous PNAS publication), it is hard to imagine the overall structure and understand where the key interactions (e.g., R3848-E4078) are in the protein and how peptide binding affects locally and globally. I suggest enhancing the illustrations.

      We thank the reviewer for the constructive comment on adding more illustrations for the PC1 protein to understand the overall structure and the location of the key interaction R3848E4078. We have included these suggestions and modified the main figures in the revised manuscript.  

      (3) The authors used the mouse construct for the cellular assays and the peptide designs in preparation for future in vivo assays. This is helpful in understanding biology, but the relevance of drug discovery is weakened. Related to Point 1, the therapeutic potential of PC1 peptide agonist is largely missing.

      The therapeutic potential of a PC1 peptide agonist is addressed in response #1 above. As mentioned in the manuscript and recognized by the reviewer, the cellular signaling assays were performed with the mouse PC1 CTF expression construct and with peptides based on the mouse PC1 stalk sequence for future, pre-clinical studies, while the peptide binding studies were performed with the human PC1 stalk sequence. We feel the relevance for drug discovery is not significantly weakened for a number of reasons: 1) as shown in Fig. 1A, the stalk sequence is highly conserved between mouse and human PC1, specifically there are only 2 residue differences present within peptides p17 and p21. One of the differences is a ‘semi-conservative’ Gln-Arg substitution at peptide residue 15, while the second difference is a conservative Ile-Val substitution at peptide residue 17; 2) we have found that an Arg to Cys mutation within the mouse PC1 CTF stalk has the same effect on signaling as the corresponding human Gln to Cys ADPKD-associated mutation which was analyzed in Pawnikar et al., 2022; and 3) both peptide residues 15 and 17 represent highly variable positions within the PC1 stalk as shown in the sequence logo (below) of the stalk sequence from 16 vertebrate species; and 4) while addressing the potential effect of the hydrophilic solubility tag on stalk peptide-mediated rescue of CTF∆stalk signaling (see Reviewer 1 comments, point #7), we utilized the ‘human’ version of p17 as a positive control and tested its activation with both mouse and human CTF∆stalk expression constructs and found that human p17 peptide was also capable of stimulating the mouse CTF∆stalk protein (Fig. S2).

      Author response image 1.

      (4) More control experiments are needed. For example, a 7-residue hydrophilic sequence (GGKKKKK) is attached to the peptide design to increase solubility. This 7-residue peptide should be tested for PC1 activation as a control. Second, there is no justification for why the peptide design must begin with residue T3041. Can other segments of the stalk also be agonists?

      As mentioned above for Reviewer 1, the hydrophilic peptide has been synthesized and tested for activation of signaling by the stalkless CTF in the revised manuscript as Fig. S2. The design of peptides that begin with residue T3041 of mouse PC1 CTF is modeled on numerous similar studies for the family of adhesion GPCRs. Optimization of the binding and activity of the PC1 peptide agonist will be investigated in future studies and could include such parameters as whether the peptide must include the first residue and whether subsegments of the stalk are also agonists, however, we feel these questions are beyond the scope of this initial report.

      (5) There are some major concerns about the simulations: The GaMD simulations showed different binding sites of p-21, p-17, and p-9, and the results report the simulated conformations as "active conformational states". However, these are only computational findings without structural biology or mutagenesis data to validate. Further, neither docking nor the simulation data can explain the peptide SAR. Finally, it will be interesting if the authors can use docking or GaMD and explain why some peptide designs (like P11-P15) are less active (as control simulations).

      The reviewer brings up an important observation regarding differences in binding sites between peptides p9, p17 and p21. We will include discussion of this observation and our interpretations to the revised manuscript. While the present study is focused on identification of initial peptides that are able to activate the PC1 CTF, we shall include further mutation experiments and simulations, peptide SAR and optimization of the lead peptides in future studies. This has been clarified in the revised manuscript.

      (6) Additional experiments for the controls and for validating the simulations. Additional simulations to explain the SAR.

      We appreciate the reviewer’s comment for additional experiments for the controls and additional simulations to explain the SAR. For future studies, we shall include further mutation experiments and simulations, peptide SAR and optimization of the lead peptides.

      (7) What is the selectivity of the peptides between PC1 and PC2?

      We have not tested the selectivity of the peptides for PC1 versus PC2 primarily because transfection of PC2 does not activate the NFAT reporter. However, it is possible that co-transfection of PC2 with the PC1 CTF could alter stalk peptide binding. This will be important to consider in future studies.

      Reviewer 3:

      The authors demonstrate the activation of Polycystin-1 (PC1), a G-protein coupled receptor, using small peptides derived from its original agonist, the stalk TA protein. In the experimental part of the study, the authors performed cellular assays to check the peptide-induced reactivation of a mutant form of PC1 which does not contain the stalk agonist. The experimental data is supported by computational studies using state-of-the-art Gaussian accelerated Molecular Dynamics (GaMD) and bioinformatics analysis based on sequence covariance. The computer simulations revealed the mechanistic details of the binding of the said peptides with the mutant PC1 protein and discovered different bound, unbound, and intermediate conformations depending on the peptide size and sequence. The use of reliable and well-established molecular simulation algorithms and the physiological relevance of this protein autosomal dominant polycystic kidney disease (ADPKD) make this work particularly valuable.

      We greatly appreciate the reviewer’s encouraging and positive comments. The reviewer’ specific comments are addressed pointwise below and changes to the text will be highlighted in yellow in the revised manuscript.

      (1) No control has been used for the computational (GaMD) study as the authors only report the free energy surface for 3 highly agonistic peptides but for none of the other peptides that did not induce an agonistic effect. Therefore, in the current version, the reliability of the computational results is not foolproof.

      We appreciate the reviewer’s concern about the lack of control with the other peptides that did not induce an agonistic effect. To address the reviewer’s concern, we have included more details on the study of the stalkless CTF and the solubility tag peptide (Fig. S2) as controls in the revised manuscript.

      (2) All discussions about the residue level interactions focused only on geometric aspects (distance, angle, etc) but not the thermodynamic aspect (e.g. residue-wise interaction energy). Considering they perform a biased simulation; the lack of interaction energy analysis only provides a qualitative picture of the mechanism.

      As mentioned by the reviewer, we have added MM/PBSA analysis results in the revised manuscript and SI.

      Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) analysis was performed to calculate the binding free energies of peptides p9, p17 and p21 to PC1 CTF. The analysis was performed using the trajectory in which the peptide was bound to the receptor. In MM/PBSA, the binding free energy of the ligand (L) to the receptor (R) to form the complex (RL) is calculated as:

      where GRL is the Gibbs free energy of the complex RL, GR is the Gibbs free energy of the molecule R in its unbound state and GL is the Gibbs free energy of the molecule L in its unbound state, respectively. 

      𝛥𝐺𝑏𝑖𝑛𝑑 can be divided into contributions of different interactions as:

      in which

      where ΔEMM , ΔGsol , 𝞓H and −TΔS are the changes in the gas-phase molecular mechanics (MM) energy, solvation free energy, enthalpy and conformational entropy upon ligand binding, respectively. ΔEMM includes the changes in the internal energies ΔEint (bond, angle and dihedral energies), electrostatic energies ΔEelec , and the van der Waals energies ΔEvdW. ΔGsol is the sum of the electrostatic solvation energy ΔGPB/GB (polar contribution) and the nonpolar contribution ΔGSA between the solute and the continuum solvent. The polar contribution is calculated using either the Poisson Boltzmann (PB) or Generalized Born (GB) model, while the nonpolar energy is usually estimated using the solvent-accessible surface area (SASA) where 𝞬 is surface tension coefficient and b is the constant offset. The change in conformational entropy −TΔS is usually calculated by normal-mode analysis on a set of conformational snapshots taken from MD simulations. However, due to the large computational cost, changes in the conformational entropy are usually neglected as we were concerned more on relative binding free energies of the similar peptide ligands.

      MM/PBSA analysis was performed using the gmx_MMPBSA software with the following command line:

      gmx_MMPBSA -O -i mmpbsa.in -cs com.tpr -ci index.ndx -cg 1 13 -ct com_traj.xtc -cp topol.top -o FINAL_RESULTS_MMPBSA.dat -eo FINAL_RESULTS_MMPBSA.csv Input file for running MM/PBSA analysis:

      &general

      sys_name="Prot-Pep-CHARMM",

      startframe=1, endframe=200, # In gmx_MMPBSA v1.5.0 we have added a new PB radii set named charmm_radii. 

      # This radii set should be used only with systems prepared with CHARMM force fields. 

      # Uncomment the line below to use charmm_radii set

      # PBRadii=7,

      /

      &pb

      # radiopt=0 is recommended which means using radii from the prmtop file for both the PB calculation and for the NP

      # calculation

      istrng=0.15, fillratio=4.0, radiopt=0

      The relative rank of the overall peptide binding free energies (Table S1) was consistent with the experimental signaling data, i.e., p21>p9>p17, for which p21 showed the largest binding free energy value of binding (-40.29±6.94 kcal/mol).

      (3) It is not mentioned clearly whether the reader should interpret the free energy landscapes quantitatively or qualitatively. Considering no error analysis or convergence plots are reported for the GaMD free energy surfaces, it may be assumed the results are qualitative. The readers should consider this caveat and not try to quantitatively reproduce these free energy landscapes with other comparable techniques.

      We appreciate the reviewer’s comment whether the free energy landscapes should be interpreted quantitatively or qualitatively. The presented free energy landscapes could be considered semi-quantitative since the simulations are not fully converged. This will be clarified in the revised manuscript as: “It is important to note that the free energy profiles calculated from GaMD simulations of PC1 CTF were not fully converged since certain variations were observed among the individual simulations. Nevertheless, these calculations allowed us to identify representative low-energy binding conformations of the peptides.”

      (4) Energy decomposition analysis similar to the following paper (https://pubs.acs.org/doi/10.1021/bi201856m) should be provided to understand the residue level enthalpic contribution in the peptide-protein interaction.

      As mentioned by the reviewer, we have performed residue-wise interaction energy analysis and included the analysis results in the revised manuscript and SI.

      Residue-wise interaction energy analysis was performed on peptides p9, p17 and p21 using the trajectory in which the peptide was bound to the PC1 CTF using the gmx_MMPBSA software with the following command line:

      gmx_MMPBSA -O -i mmpbsa.in -cs com.tpr -ct com_traj.xtc -ci index.ndx -cg 3 4 -cp topol.top -o FINAL_RESULTS_MMPBSA.dat -eo FINAL_RESULTS_MMPBSA.csv -do FINAL_DECOMP_MMPBSA.dat -deo FINAL_DECOMP_MMPBSA.csv

      Input file for running residue-wise energy decomposition analysis:

      &general

      sys_name="Decomposition", startframe=1, endframe=200,

      # forcefields="leaprc.protein.ff14SB"

      /

      &gb

      igb=5, saltcon=0.150,

      /

      # make sure to include at least one residue from both the receptor #and peptide in the print_res mask of the &decomp section.

      # this requirement is automatically fulfilled when using the within keyword.

      # http://archive.ambermd.org/201308/0075.html

      &decomp

      idecomp=2, dec_verbose=3, print_res="A/854-862 A/1-853”,

      /

      Residue-wise energy decomposition analysis allowed us to identify key residues that contributed the most to the peptide binding energies. These included residues T1 and V9 in p9 (Table S2), residues T1, R15 and V17 in p17 (Table S3), and residues P10, P11, P19 and P21 in p21 and residue W3726 in the PC1 CTF (Table S4). The energetic contributions of these residues apparently correlated to the sequence coevolution predicted from the Potts model.

      (5) To showcase the reliability of the computational approach, the authors should perform the MD simulation studies with one peptide that did not show any significant agonistic effect in the experiment. This will work as a control for the computational protocol and will demonstrate the utility of the pep-GaMD simulation in this work.

      We appreciate the reviewer’s concern about the lack of control with the other peptides that did not induce an agonistic effect. It is difficult for us to add more MD simulations on the other peptides, due to student leave after PhD graduation. But to address the reviewer’s concern, we have included more details on the study of the stalkless CTF as a control in the revised manuscript.

      (6) To assess the accuracy of the computational results the authors should mention (either in the main text or SI) whether the reported free energy surfaces were the average of the five simulations or computed from one simulation. In the latter case, free energy surfaces computed from the other four simulations should be provided in the SI. In addition, how many binding unbinding events have been observed in each simulation should be mentioned.

      We appreciate the reviewer’s comment regarding convergence of the simulation free energy surfaces. In response to Reviewer 1, we have calculated free energy profiles of individual simulations for each system, including the p9, p17, and p21 (Figs. S5, S6 and S8). 

      “We have calculated free energy profiles of individual simulations for each system, including the p9, p17, and p21 (Figs. S5, S6 and S8). For the p9 peptide, the “Bound” low-energy state was consistently identified in the 2D free energy profile of each individual simulation (Fig. S5). For the p17 peptide, Pep-GaMD simulations were able to refine the peptide conformation from the "Unbound” to the "Intermediate” and “Bound” states in Sim1 and Sim5, while the peptide reached only the "Intermediate” state in the other three simulations (Fig. S6). For the p21 peptide, PepGaMD was able to refine the peptide docking conformation to the "Bound” state in all the five individual simulations (Fig. S8).”

      “It is important to note that the free energy profiles calculated from GaMD simulations of PC1 CTF were not fully converged since certain variations were observed among the individual simulations. Nevertheless, these calculations allowed us to identify representative low-energy binding conformations of the peptides.”

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This is a useful report of a spatially-extended model to study the complex interactions between immune cells, fibroblasts, and cancer cells, providing insights into how fibroblast activation can influence tumor progression. The model opens up new possibilities for studying fibroblast-driven effects in diverse settings, which is crucial for understanding potential tumor microenvironment manipulations that could enhance immunotherapy efficacy. While the results presented are solid and follow logically from the model’s assumptions, some of these assumptions may require further validation, as they appear to oversimplify certain aspects in light of complex experimental findings, system geometry, and general principles of active matter research.

      We thank the editor for recognizing the usefulness of our work. This work does not aim to precisely describe the complexity of the tumor microenvironment in lung cancer, but rather to classify and rigorously calibrate a minimum number of parameters to the clinical data we collect and generate, and reproduce the global structures of the microenvironment. We identify different scenarios, and show how they depend on the local interactions within this framework. Although we started in the first version with coalescence in the main text and anisotropic geometry in the supporting information, we realized that we needed to provide more directions to better show how our model can be extended. Thus, in Section III-4 we added an analysis of a microenvironment with blood vessels, and showed how to introduce anisotropic friction as a function of fiber orientation, as well as active stress, paving the way for further studies, that would make our model more complex. However, in a first step, it is crucial to start with a limited number of parameters that can be rigorously determined, and this is how this first work was conceived.

      Public Reviews:

      Reviewer #1 (Public review):

      The authors present an important work where they model some of the complex interactions between immune cells, fibroblasts and cancer cells. The model takes into account the increased ECM production of cancer-associated fibroblasts. These fibres trap the cancer but also protect it from immune system cells. In this way, these fibroblasts’ actions both promote and hinder cancer growth. By exploring different scenarios, the authors can model different cancer fates depending on the parameters regulating cancer cells, immune system cells and fibroblasts. In this way, the model explores non-trivial scenarios. An important weakness of this study is that, though it is inspired by NSCLC tumors, it is restricted to modelling circular tumor lesions and does not explore the formation of ramified tumors, as in NSCLC. In this way, is only a general model and it is not clear how it can be adapted to simulate more realistic tumor morphologies.

      We thank the reviewer for highligting the importance of our work. We acknowledge that although we provided anisotropic geometries and the study of the coalescence in the first version, more effort was needed to provide tools to extend our formalism to non-ideal cases. This is now added as Section III-4, where we analyze the impact of blood vessels, and the anisotropic friction due to the nematic order for the fibers; this nematic order can also be used to introduce active nematic stress.

      Reviewer #2 (Public review):

      Summary:

      The authors develop a computational model (and a simplified version thereof) to treat an extremely important issue regarding tumor growth. Specifically, it has been argued that fibroblasts have the ability to support tumor growth by creating physical conditions in the tumor microenvironment that prevent the relevant immune cells from entering into contact with, and ultimately killing, the cancer cells. This inhibition is referred to as immune exclusion. The computational approach follows standard procedures in the formulation of models for mixtures of different material species, adapted to the problem at hand by making a variety of assumptions as to the activity of different types of fibroblasts, namely ”normal” versus ”cancer-associated”. The model itself is relatively complex, but the authors do a convincing job of analyzing possible behaviors and attempting to relate these to experimental observations.

      Strengths:

      As mentioned, the authors do an excellent job of analyzing the behavior of their model both in its full form (which includes spatial variation of the concentrations of the different cellular species) and in its simplified mean field form. The model itself is formulated based on established physical principles, although the extent to which some of these principles apply to active biological systems is not clear (see Weaknesses). The results of the model do offer some significant insights into the critical factors which determine how fibroblasts might affect tumor growth; these insights could lead to new experimental ways of unraveling these complex sets of issues and enhancing immunotherapy.

      We thank the referee for this summary and for recognizing the strengths of our paper.

      Weaknesses:

      Models of the form being studied here rely on a large number of assumptions regarding cellular behavior. Some of these seemed questionable, based on what we have learned about active systems. The problem of T cell infiltration as well as the patterning of the extracellular matrix (ECM) by fibroblasts necessarily involve understanding cell motion and cell interactions due e.g. to cell signaling. Adopting an approach based purely on physical systems driven by free energies alone does not consider the special role that active processes can play, both in motility itself and in the type of self-organization that can occur due to these cell-cell interactions. This to me is the primary weakness of this paper.

      We thank the referee for this important comment, that allows us to clarify this important point. Although biological materials are out of equilibrium, their behavior often resembles that dictated by thermodynamics. Hence the usefulness of constructing a free energy, in terms of these variables. In a first approach to decipher the complex interactions and describe the different and sometimes non-trivial outcomes in this system that involves many components, we must start by minimizing the number of parameters, and identifying those complex processes, that control the evolution of the system. The free energy that we build on this biological system contains therefore out-of-equilibrium processes that can be approximated by a ”close to equilibrium” description. Our approach is a classical one in statistical physics of active systems, namely in the effort to construct an equivalent free-energy for out-of-equilibrium systems. This allows to gain a clearer insight into those complex processes.

      We have added a sentence in the main text, section III.1, to clarify this point:

      “Building a free-energy density for a biological material is justified, because, although biological materials are out of equilibrium, their behavior often resembles that dictated by thermodynamics. It is therefore useful to write a free energy in terms of state variables.”

      Nevertheless, we recognize that we should have provided more tools for using our formalism by making it active. This is why we introduced the nematic order in the fibers in Section III-4. This nematic order can be used to introduce active stress, and we have cited previous works by some of us see [?, ?, ?] as references for building active processes out of it.

      We must also note that cell signaling has been introduced a minima in our system for providing the cue for the arrival of T-cells and NAFs from the boundaries. However, we found that although we had evoked the other role of the chemicals in the transformation from NAFs to CAFs in the text, details were not well explained. We have therefore corrected and added some explanations in the introduction of section III, and III.1, III.2.

      A separate weakness concerns the assumption that fibroblasts affect T cell behavior primarily by just making a more dense ECM. There are a number of papers in the cancer literature (see, for some examples, Carstens, J., Correa de Sampaio, P., Yang, D. et al. Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. Nat Commun 8, 15095 (2017);Sun, Xiujie, Bogang Wu, Huai-Chin Chiang, Hui Deng, Xiaowen Zhang, Wei Xiong, Junquan Liu et al. ” Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion.” Nature 599, no. 7886 (2021): 673-678) that seem to indicate that density alone is not a sufficient indicator of T cell behavior. Instead, the organization of the ECM (for example, its anisotropy) could be playing a much more essential role than is given credit for here. This possibility is hinted at in the Discussion section but deserves much more emphasis.

      The referee is right in his comment, and we thank him for raising this issue. We have therefore introduced the anisotropic orientation of the fibers, which induces an anisotropic friction in a new section III-4. In addition, the references pointed out were included in this section. However, although the anisotropy strongly influences the fate of the tumor when the fibers are oriented perpendicular to the surface of the cancer nest, it is less effective when the fibroblasts are oriented in the direction of surface of the cancer nest. In the latter case, which is often the case before cancer cells reshape the tumor microenvironment, the matrix density should correlate with the friction.

      Finally, the mixed version of the model is, from a general perspective, not very different from many other published models treating the ecology of the tumor microenvironment (for a survey, see Arabameri A, Asemani D, Hadjati J (2018), A structural methodology for modeling immune-tumor interactions including pro-and anti-tumor factors for clinical applications. Math Biosci 304:48-61). There are even papers in this literature that specifically investigate effects due to allowing cancer cells to instigate changes in other cells from being tumor-inhibiting to tumor-promoting. This feature occurs not only for fibroblasts but also for example for macrophages which can change their polarization from M1 to M2. There needed to be some more detailed comparison with this existing literature.

      The referee is right that the first part of our approach, namely the dynamical system may be common in this kind of system, and it needs to be mentioned. So we added the following sentence in the discussion: ”This is in line with several similar mathematical models, that study through this lens the inhibition/activation of the immune system by cancer cells either by means of compartmental nonlinear models similar to our dynamical system, for instance regarding macrophage recruitment and cytokine signaling {arabameri2018structural} {li2019computational}, or mixture models {fotso2024mixture}. We combine the two approaches in order to rigorosly derive the parameters of the model and gain insights from both.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The authors should address the following points:

      Major issues

      (1) The shape of tumors simulated differs immensely from the observed tumors in Fig. 2. Here, the tumor is constituted by irregular domains, not dissimilar from domains in phase separating mixtures. The domains simulated are circular. Since the authors are using the space dependent model to model the increase in tumor cells with time in the different scenarios (immune-desert, immune-excluded, immune inflamed), it should explain how non-spherical tumor structures can be observed in these scenarios. The authors introduce tumor coalescence in page 28, however, it is not expected that the structures observed in Fig 2 are the result from different tumors merging and coalescing, because that would result from an unlikely large number of initial mutation events in the same region of the tissue. The authors should explain what mechanisms present in the model can lead to non-spherical forms.

      We agree with the reviewer that real tumors are rarely round contrary to what our numerics suggests. In fact, only the last figure of our paper in the supporting information was more appropriate for such a discussion. We are now adding discussions and new figures to better illustrate our spatial model, see Figure 6 and section III-4. The in situ geometry of tumors depends on the shape of the host organ, the diffusive (chemical) or advected species such as T cells and fibroblasts, and on the nutrients. Thus, in our case, only cancer cells are produced locally, but during growth the tumor is strongly constrained by the microenvironment, and thus the geometry of the domain we model in the numerics and its boundary conditions. This is also true for the chemicals responsible for growth, cellular advection and phenotypic transformation. Their concentration depends on a convection-diffusion equation and boundary conditions. For a tumor in situ, such as in the lung, the available space is a constraint that will dominate the final geometry of the tumor nests. We do not think that coalescence is controlled by mutational events, but most likely by the search for space necessary for growth. Compared to the first version, we add new figures (Figure 6) that show that the geometry of the organ, as well as the localization of blood vessels, are a cause of the irregularity of the tumor shapes. We also introduce orientational order, which as suggested in section III-4, can induce anisotropic friction and stresses, as well as anisotropic growth. We cite (Ackermann, Joseph, and Martine Ben Amar. ”Onsager’s variational principle in proliferating biological tissues, in the presence of activity and anisotropy.” The European Physical Journal Plus 138.12 (2023): 1103.) where we described active stresses and coupling related to anisotropic growth.

      (2) According to the authors, the model presented in equations (1) and onwards simulates the evolution of the fraction of tumor cells in the tissue. However the fraction of tumor cells, for example, depends itself on the variation of other cell types. For example, if fibroblasts were to proliferate with rate alpha, even without tumor cells proliferating, the fraction of tumor cells in the mixture should decrease as alpha times the tumor cells fraction. These terms are missing. The equations do not describe the evolution of the cells’ fractions but of the amount of cells of each type, normalised by the total carrying capacity of non-normal cells in the tissue. The text should be rewritten accordingly.

      We agree with the referee: our definition of cell density was not precise enough and may appear misleading. In the paragraph II1, we more explictly introduce the word mass fraction which is the correct physical quantity to introduce into the spatial model.

      ”All these cells have the same mass density and the sum of their mass fraction satisfies the relationship S = C + T + F<sub>NA</sub> + F<sub>A</sub> = 1-N, where N is a healthy non active component as healthy cells, for example.”

      It is less intuitive than ”number of cells per unit volume” but necessary for the following (III)

      (3) The authors start by calculating fixed points of different versions of the dynamical system without spatial dependence. They should explain what is the relevance of these fixed points: in a real situation, where the concentration of tumor fibroblasts and T-cells depend on position, in which conditions are these fixed points relevant?

      The referee is right and we will clarify this point: the dynamic analysis is a help for understanding and predicting the scenario occurring in the system. After all the steps of paragraph 2.2, we are faced with 11 independent parameters only for the dynamical system and without the parameters generated by the space modeling itself. Our estimation concerns only lung cancer. These parameters do not appear in the literature. The parameters introduced in Sec. III which are more related to physical interactions such as friction, cell-cell adhesion, etc. can be found in the literature or can be estimated and thus measured in in vitro experiments (see Ackermann and Ben Amar, EPJP 2023, P. Benaroch, J. Nikolic et al. 2024, biorxiv). So what are the fixed points for: they help to get the right numbers for spatial analysis. To recover special features of cancer evolution, we need a model, but also correct estimates of the data in a code that is quite technical and heavy, with each simulation taking a certain amount of time. For users who only need rough predictions, the analysis in section 2 is sufficient.

      It is also important to note that the global result depends only on the source terms, and on the boundary conditions. This can be illustrated with a simple example: Consider the governing equation for the density of a component with velocity v and source term:

      Integrating the equation over a fixed volume V of surface S gives:

      . This integrated equation can then be approximated by the dynamical system that we write. Thus, while the dynamical system does not give any information about the local structure of the system, it may be indicative of its global outcome.

      (4)   In page 15, the authors identify that α<sub>NA</sub> is proportional to δ𝝐<sup>4</sup>. However, in equation (7), they replace α<sub>NA</sub> by δ𝝐<sup>4</sup> without the proportionality constant. This should be corrected.

      Thank you for your remark. This typo is now corrected.

      (5) The tumor cell movement should be much slower than the T-cells. Here, the authors assign a similar friction coefficient for the cancer cells and T-cells, for example. However, in lung cancer tumor cells are epithelial, and adhere to each other in the tissue. Their movement is very restricted by the basement membranes and by cell-cell adhesion. Immune cells and T-cells on the other hand move rapidly throughout the stroma. It is a gross simplification to not consider the low epitelial tissue mobility in the context of lung cancer.

      It is possible to assume different friction coe cients for each phase pair. This has been done in a previous publication, Ackermann et al., Physics report 2021. It is also possible to play with the cell-cell adhesion in the energy density and on the diffusion coe cient introduced in the Flory-Higgins free energy. Cell-cell adhesion is taken into account in the energy, and this makes the tumor a more dense phase, while T-cells can move towards cancer cells to which they are attracted. In the last part of the paper, we show the role of an anisotropic friction due to a nematic order for activated fibroblasts and all the other cells

      (6) What is the biological mechanism by which the T-cells form a colony with a surface tension? In the phase-field model, the authors have a surface tension assigned to the cancer cells, T-cells and fibroblasts. Can the authors justify biologically why do they consider these surface tensions?

      The fact that T-cells form a colony is due to the accumulation of T-cells at the outer boundary of the tumor, as they are attracted to it but cannot penetrate due to the strong cell-cell adhesion of the tumor cells in the nest. Adding a gradient square is standard in continuous models to limit the sharp variations. In a continuous approach, the gradient square contribution limits the sharp variations in cell density which are not physical.

      Minor issues

      (a) Page 6 (end), characterisation of the fibre barrier produced by CAFs missing: what is the fibre density, how it can hinder the spread of cancer and T-cell motility? Is it so dense that it prevents ameboid movement? Can cells move through it using matrix degradation proteins?

      The fiber density corresponds to the fibrous organic extracellular matrix secreted by cancer-associated fibroblasts. In desmotic (highly fibrous tumors such as PDAC or NSCLC), this extracellular matrix deposited around the tumor forms a physical barrier around the tumor nest, preventing both cell migration and capillary and immune cells penetration. In these cases, the fibrous belt actually prevents ameboid movement and cells must deform significantly to migrate. The role of this barrier was particularly demonstrated in the reference (Grout, John A., et al. ”Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors.” Cancer Discovery 12.11 (2022): 2606-2625.). In later stages of cancer, the tumor may adapt and develop strategies to metastasize, such as matrix degradation. This matrix can be oriented, organized or disordered. To build a minimal model, we first considered an isotropic friction and also an anisotropic friction of the nematic belt, due to the activated fibroblasts. In the case of T-cells, as mentioned in section I.1, it is true that the biological literature also considers a phenotypic transformation of the T cells by the activated fibroblasts: this concerns both their proliferative capacities, antigen recognition and also their cytotoxic function. To better document the different mechanisms, we add the following publication: Cancer associated fibroblasts-an impediment to effective anti-cancer T cell immunity, by Koppensteiner, Lilian and Mathieson, Layla and O’Connor, Richard A and Akram, Ahsan R, Frontiers in immunology (2022).

      However, our goal is to build a minimal model and to characterize and quantify the physical process in which CAFs are involved, namely the role of a physical barrier, that has been documented, as documented above.

      (b) Page 19 (Fig 3), in the figure legend it is written ”resting fibroblasts”, should be ”non-activated fibroblasts”.

      The referee is right: it will be better to write non-activated fibroblasts. This is now changed in the main text.

      (c) Page 21 (equation), what is dΩ? It is dr?

      We thank the referee for raising this point. The text was indeed ambiguous as sometimes dΩ was replaced by dr. To be clearer, all the elements of volume are now noted dV , and the element of surface of the system are noted dS.

      In the article the units are in italic and should be in roman.

      Thank you for raising this point. It has been corrected.

      (d) Page 25 (beginning section III.3), the authors mention that the simulation is 2D, however, the simulation has radial symmetry. A 1D simulation in radial coordinates could simulate a 3D spherical system. Is the simulation of this section equivalent to a 1D radial simulation (in 2D)?

      The referee is right that in radial symmetry, a 1d equation may be written. We therefore present numerics with irregular shapes of the tumor nest in order to make the system fully 2d.

      (e) Page 26 (Fig 4). Legends inside the plots of plates A, B, C and D are not clear. Colorbar range of plates A and D is different. Would facilitate if the ranges were the same.

      The referee is right: the surface plots presented in figure 4 would be easier to compare with the same colorbar range for the legends. In fact, as the referee noted, figures in A, B and C have the same legends, while figure in D has a different one. This is due to the fact that D represents the case of the immune-inflamed tumor where the cancer mass fraction is quite vanishing, resulting in values that are of 3 orders of magnitude lower than those present in A, B and C. Therefore, they would disappear if the colorbar range were equal to the others.We insist more on the change of scale in the legend of Figure 4, in the new version.

      (f) Page 29 (Fig 5), would facilitate if the order of immune-desert, immune-excluded, immune-inflamed was maintained throughout the document. In this figure the immune-inflamed case appears first.

      We agree with the reviewer that following the same order in which the different cases are presented throughout the manuscript would be helpful in comparing the different figures. Therefore, we have modified Figure 5.

      (g) Page 31, the authors indicate that pharmacodynamics and pharmacokinetics are highly dependent on tumour spatial structure. Can they provide examples and citations?

      In the discussion, we have added references concerning pharmacodynamics.

      (h) Page 33 (Fig Sup2), would facilitate if the order of immune-desert, immune-excluded, immune-inflamed was maintained throughout the document. ±±

      We thank the reviewer for pointing this out, the order of the different scenarios in Fig Sup 2 has now been changed.

      Reviewer #2 (Recommendations for the authors):

      Major points

      (1) Following on from the discussion in the public review, I feel that there are a number of critical issues that need to be addressed regarding modeling assumptions. I would like to understand why the authors believe it is possible to use a free energy-driven model of the microenvironment when many of the processes relevant for their study have an undeniably ”active media” flavor.

      The referee is right that processes in biology are active processes. However, it is a classical approach to model physical interactions between biological components with a free-energy, especially cell adhesion, as they often lead to quasi-stationary equilibrium-like patterns. The free-energy approach has also the advantage to derive straight-forwardly complex phenomena involving many components. Activity can indeed be introduced in such a framework, if we know that the fibroblasts transform into myo-fibroblasts, see for example our previous publication Ackermann and Ben Amar, EPJP 2023. However, in the interest of simplification and reduction of the number of free parameters, we have not not considered further complication of the model here, as a minimal model allows to distinguish the main processes that occur. Nevertheless, introducing more precisely activity, in the nematic approach already achieved for the friction, is a natural continuation of our work: See the new Section III-4, where we introduce the nematic order, and we indicate that active nematic stresses can be written from it.

      Next, I don’t understand the assumption that T cells do not proliferate once they detect neoantigens on the cancer cells; activation of T cells usually causes them to become more proliferative.

      We thank the referee for this question. The T-cell fraction has two origins: proliferation of T-cells in situ in the stroma or inside tumor nest or external arrival from the sources that we privilege. We recognize that a full analysis of the tumor-microenvironment would require to consider proliferation near the tumor, as many more other processes which is do able but requires the knowledge of more biological date. In addition, besides, the proliferation of T-cells will be equivalent to increase the killing abilities of T-cells and these two effect overlapp in our approach.

      In order to clarify this point, we modify the following sentence in Section II.2:

      “Although proliferation of cytotoxic T-cells has been observed, we do not consider explicitly proliferation in our study as we focus on their ability to infiltrate the tumor.”

      Rather, we consider that T-cells proliferate outside the domain boundaries, so that this proliferation is included in the boundary source contributions.

      Finally, the issue of whether the density of fibers is sufficient to understand the role of fibroblasts is not at all settled. There should be a full discussion of this issue including mentioning of the Nature paper (cited in the public review) that argues that orientation (and not density) is the key to the role of fibers, as well as the earlier cited work of Kalluri and collaborators on the role of ECM density in pancreatic cancer.

      We thank the referee for this remark. As we wrote above in the response to the public review, we introduced significant additions that aim to tackle this question in the article.

      (2) The authors present a picture of a tumor cell with fibroblasts apparently arrayed circumferentially around the tumor boundary and therefore blocking infiltration. This type of tumor structure has been seen before, for example in ”On the mechanism of long-range orientational order of fibroblasts.” Proceedings of the National Academy of Sciences 114, no. 34 (2017): 8974-8979, which should be cited. More importantly, in that paper the argument is made that positive feedback between fibroblasts and ECM geometry can cause structures like this to form. If this is indeed what is occurring, this would indicate the crucial importance of a mechanism beyond what is contained in the current model. This issue should therefore be discussed within this paper. This issue is of course connected to the previous point regarding the role of ECM structure beyond density.

      We completely agree that the interplay between the fibroblast layer and the tumor shapes the tumor boundary. One of the authors has worked recently on this precise topic (Aging and freezing of active nematic dynamics of cancer-associated fibroblasts by fibronectin matrix remodeling, C Jacques, J Ackermann, S Bell, C Hallopeau, CP Gonzalez, ... bioRxiv, 2023.11. 22.568216, Ordering, spontaneous flows and aging in active fluids depositing tracks S Bell, J Ackermann, A Maitra, R Voituriez arXiv preprint arXiv:2409.05195). Since the fibroblast layer is an active material, it contributes to an anisotropic stress that can be introduced into the model. Our first strategy was to present the simplest modeling in order to focus on the most important interactions as cell-cell adhesion and cell-tissue adhesion. However, we recognize that those questions should be discussed in the text, and we discuss it in the new section III-4

      Minor points

      There are also a number of more minor points to consider:

      (1) Since the parameter is taken to be O(1), why exactly does it matter how the other parameters scale with it?

      It is very important to compare the order of magnitude of the other parameters once the selected parameter of order O(1) is really the driving parameter of the coupling. It gives a first picture of the main interactions that has to consider.

      (2) I didn’t understand the relevance of referring specifically to IL 6 among many other possibly relevant signals, as is currently done on page 7.

      This corresponds to studies aiming to correlate lung cancer risks and the concentration of interleukin, mostly IL6 and IL8 (McKeown, D. J., et al. ”The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer.” British journal of cancer 91.12 (2004): 1993-1995.,Brenner, Darren R., et al. ”Inflammatory cytokines and lung cancer risk in 3 prospective studies.” American journal of epidemiology 185.2 (2017): 86-95. ) but in the absence of very detailed biological information, the modeling and its results are not modified if other chemicals intervene..We slightly modeified the following phrase in section I.1:

      “In particular, in the family of inflammatory proteins, also called cytokines, Interlukin-6 (IL6) and (IL8) seem, among others to stimulate the infiltration of CD8<sup>+</sup>.

      (3) The authors need to mention the possibility of T-cell chemotaxis to the tumor being ”self-amplified” in the T cell system, as put forth in Galeano Nin˜o, Jorge Luis, Sophie V. Pageon, Szun S. Tay, Feyza Colakoglu, Daryan Kempe, Jack Hywood, Jessica K. Mazalo et al. ”Cytotoxic T cells swarm by homotypic chemokine signalling.” eLife 9 (2020): e56554. This might again reveal a needed extension of the current modelling strategy.

      We thank the referee for his/her comment on the self-amplification of T-cell population in the stroma and we mention the indicated reference in our paper. This auto-chemoatactic process which induces a dynamic of more e cient recruitment towards the tumor, may be important for immunotherapy. To have more e cient T-cell arriving at the site of the tumor, will lead a better issue for the patient, if the swarming organization is maintained in a desmoplastic nematic stroma.

      (4) It is not obvious to me that in sub figures 3F and 3H the tumor is enroute to being totally eradicated, as is stated in the text. The blue lines seemed to asymptote at non-zero population values.

      Looking at sub-figures 3F and 3H, we stated in the main text that the tumor is eradicated as the representative population approaches a 0 value fraction, or at least decays around the 0 (0.01/0.05 to be more precise). This is even more evident when compared with the other cases where the tumor mass fraction reaches values of a higher order (up to 0.6), thus leading us to dinstinguish between these different scenarios.

      (5) The description of the interaction of cells with fibers as being increased friction might be misleading, as the real effect could be actual trapping in the network (as opposed to just slowing down the motion).

      We thank the referee for this question as it allow us to make an important distinction. Indeed, what the referee describes seems to correspond to a discrete event, namely a cell trapped in a network. However, coarse-graining the dynamics to the continuous modeling seems to us as leading to an effective friction between the two phases. Moreover, we also now introduced an anisotropic friction which can represent a trapping. The velocities are not only directed around the tumor but can also be oriented towards the tumor, so that eventually the friction along the radius mimics a trapping (see Fig.4 on top). We have introduced this anisotropic friction via a nematic model, see the appendix.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Authors showed the presence of Mtb in human liver biopsy samples of TB patient and reported that chronic infection of Mtb causes immune-metabolic dysregulation. Authors showed that Mtb replicates in hepatocytes in a lipid rich environment created by up regulating transcription factor PPARγ. Authors also reported that Mtb protects itself from anti-TB drugs by inducing drug metabolising enzymes.

      Strengths:

      It has been shown that Mtb induces storage of triacylglycerol in macrophages by induction of WNT6/ACC2 which helps in its replication and intracellular survival, however, creation of favorable replicative niche in hepatocytes by Mtb is not reported. It is known that Mtb infect macrophages and induces formation of lipid-laden foamy macrophages which eventually causes tissue destruction in TB patient. In a recent article it has been reported that "A terpene nucleoside from M. tuberculosis induces lysosomal lipid storage in foamy macrophages" that shows how Mtb manipulates host defense mechanisms for its survival. In this manuscript, authors reported the enhancement of lipid droplets in Mtb infected hepatocytes and convincingly showed that fatty acid synthesis and triacylglycerol formation is important for growth of Mtb in hepatocytes. Authors also showed the molecular mechanism for accumulation of lipid and showed that the transcription factor associated with lipid biogenesis, PPARγ and adipogenic genes were upregulated in Mtb infected cells.

      The comparison of gene expression data between macrophages and hepatocytes by authors is important which indicates that Mtb modulates different pathways in different cell type as in macrophages it is related to immune response whereas, in hepatocytes it is related to metabolic pathways.

      Authors also reported that Mtb residing in hepatocytes showed drug tolerance phenotype due to up regulation of enzymes involved in drug metabolism and showed that cytochrome P450 monooxygenase that metabolize rifampicin and NAT2 gene responsible for N-acetylation of isoniazid were up regulated in Mtb infected cells.

      Weaknesses:

      There are reports of hepatic tuberculosis in pulmonary TB patients especially in immune-compromised patients, therefore finding granuloma in human liver biopsy samples is not surprising.

      Mtb infected hepatic cells showed induced DME and NAT and this could lead to enhanced metabolism of drug by hepatic cells as a result Mtb in side HepG2 cells get exposed to reduced drug concentration and show higher tolerance to drug. Authors mentioned that " hepatocyte resident Mtb may display higher tolerance to rifampicin". In my opinion higher tolerance to drug is possible only when DME of Mtb inside is up regulated or target is modified. Although, in the end authors mentioned that drug tolerance phenotype can be better attributed to host intrinsic factors rather than Mtb efflux pumps. It may be better if Drug tolerant phenotype section can be rewritten to clarify the facts.

      In the revised manuscript, by immune-staining authors convincingly showed that hepatocytes are a favourable niche for replication of MTb.

      Authors have rewritten the drug tolerant phenotype section which reads better.

      Overall, this paper has new and important information on how MTb establishes a favourable niche for growth in hepatocytes and creates a drug tolerant environment.

      We thank the reviewer for the through and insightful review.

      Reviewer #2 (Public review):

      The manuscript by Sarkar et al has demonstrated the infection of liver cells/hepatocytes with Mtb and the significance of liver cells in the replication of Mtb by reprogramming lipid metabolism during tuberculosis. Besides, the present study shows that similar to Mtb infection of macrophages (reviewed in Chen et al., 2024; Toobian et al., 2021), Mtb infects liver cells but with a greater multiplication owing to consumption of enhanced lipid resources mediated by PPARg that could be cleared by its inhibitors. The strength of the study lies in clinical evaluation of the presence of Mtb in human autopsied liver samples from individuals with miliary tuberculosis and presence of a clear granuloma-like structure. The interesting observation is of granuloma-like structure in liver which prompts further investigations in the field.

      The modulation of lipid synthesis during Mtb infection, such as PPARg upregulation, appears generic to different cell types including both liver cells and macrophage cells. It is also known that infection affect PPARγ expression and activity in hepatocytes. It is also known that this can lead to lipid droplet accumulation in the liver and the development of fatty liver disease (as shown for HCV). This study is in similar line for M.tb infection. As liver is the main site for lipid regulation, the availability of lipid resources is greater and higher is the replication rate. In short, the observations from the study confirm the earlier studies with these additional cell types. It is known that higher the lipid content, greater are Lipid Droplet-positive Mtb and higher is the drug resistance (Mekonnen et al., 2021). The DMEs of liver cells add further to the phenotype.

      Comments on revised version:

      The authors noted that even in experiments where mice were infected with lower CFUs, the presence of Mtb colonies could still be detected in the liver. It would be beneficial to include some experimental data related to this in the supplementary information, as it could provide valuable insights for the research field.

      We thank the reviewer for the in depth evaluation of our manuscript and as suggested we will include the data where Mtb was detected in the liver at low CFUs

      Reviewer #3 (Public review):

      In this revised manuscript, the authors explore how Mtb can infect hepatocytes and create a favorable niche associated with upregulation of the transcription factor PPARγ which presumably allows the bacteria to scavenge lipids from lipid droplets in host cells and upregulate drug-metabolizing enzymes to protect against its elimination. In response to the review, the authors have performed some additional immunostaining of hepatocytes, added more detail to figure legends, added experiments somewhat showing improved colocalization and staining, clarified several points and paragraphs, and updated the referenced literature and discussion.

      The current manuscript provides evidence that human miliary TB patients have infection of hepatocytes with Mtb, with evidence that the bacteria survive at least partially through upregulation of PPARγ, which significantly changes the lipid milieu of the cells. There is also an examination of transcriptomics and lipid metabolism in response to Mtb infection, as well as drug tolerance of Mtb inside hepatocytes. The current manuscript is an improvement over the previous one.

      However, although the manuscript is improved, tissue immunophenotyping of the various cells in the liver remains weak and unconvincing. This is truly a missed opportunity and lessens the rigor of the central findings and conclusions. As pointed out by another reviewer, literature has described different fates of Mtb in the liver. Given the tissue available to the authors, carefully dissecting the various cells that the bacteria are in (esp. hepatocytes versus Kupffer cells) is critical. The authors use only 2 generic markers and do not distinguish among cell types within the tissue slices. A review of the literature shows a variety of both human and mouse antibody markers. In fact, a liver atlas based on immunophenotyping has been published. Likewise, the authors comment on liver granulomas, but this is not justified without immunophenotyping.

      We would like to thank the reviewer for the in-depth and detailed suggestions. We would like to clarify that the primary aim of our study was to determine the localization of Mtb within hepatocytes and the downstream biological consequences. To this end, we employed two well-established and widely validated markers (ASPGR 1 and albumin) that are consistently used to identify hepatocytes in both human and murine liver tissue. While we acknowledge the broader potential of comprehensive immunophenotyping, our focused approach was designed to specifically address the question of hepatocyte involvement, which the selected markers effectively support, which was further reiterated by the Reviewer 1.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      In my opinion this paper contains important information and no further information is required for this manuscript.

      We thank the reviewer for the insightful comments

      Reviewer #2 (Recommendations for the authors):

      The authors noted that even in experiments where mice were infected with lower CFUs, the presence of Mtb colonies could still be detected in the liver. It would be beneficial to include some experimental data related to this in the supplementary information, as it could provide valuable insights for the research field.

      As suggested,  we will include the data with the low CFUs in the updated manuscript.

      Reviewer #3 (Recommendations for the authors):

      • Line 340, the fact that PPARγ inhibition decreases bacterial load should not be surprising, as the authors cite several papers where this is already shown.

      • Line 379, the increased tolerance of Mtb to drugs in hepatocytes is only significant at the lower 2 concentrations, not at 5 ug/mL.

      • Fig S4F-H, the y axis is inappropriately not set to zero on the lower limit.

      • Fig S9B, the Y-axis states "relative" CFU, but there is no indication what the bars are normalized to, and the numbers are much more typical of standard CFU values. Was the "Relative" part left in by mistake?

      • Double check the ending of the figure legend for Figure S10 and S11.

      • Line 352, phenomenom [sic] is misspelled.

      • On re-read, several sentences throughout this manuscript need improvement regarding structure and grammar. I suggest careful editorial review.

      We thank the reviewer for pointing out the issues and these will be carefully modified in the next version.


      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors showed the presence of Mtb in human liver biopsy samples of TB patients and reported that chronic infection of Mtb causes immune-metabolic dysregulation. Authors showed that Mtb replicates in hepatocytes in a lipid rich environment created by up regulating transcription factor PPARγ. Authors also reported that Mtb protects itself from anti-TB drugs by inducing drug metabolising enzymes.

      Strengths:

      It has been shown that Mtb induces storage of triacylglycerol in macrophages by induction of WNT6/ACC2 which helps in its replication and intracellular survival, however, creation of favorable replicative niche in hepatocytes by Mtb is not reported. It is known that Mtb infects macrophages and induces formation of lipid-laden foamy macrophages which eventually causes tissue destruction in TB patients. In a recent article it has been reported that "A terpene nucleoside from M. tuberculosis induces lysosomal lipid storage in foamy macrophages" that shows how Mtb manipulates host defense mechanisms for its survival. In this manuscript, authors reported the enhancement of lipid droplets in Mtb infected hepatocytes and convincingly showed that fatty acid synthesis and triacylglycerol formation is important for growth of Mtb in hepatocytes. The authors also showed the molecular mechanism for accumulation of lipid and showed that the transcription factor associated with lipid biogenesis, PPARγ and adipogenic genes were upregulated in Mtb infected cells.

      The comparison of gene expression data between macrophages and hepatocytes by authors is important which indicates that Mtb modulates different pathways in different cell type as in macrophages it is related to immune response whereas, in hepatocytes it is related to metabolic pathways.

      Authors also reported that Mtb residing in hepatocytes showed drug tolerance phenotype due to up regulation of enzymes involved in drug metabolism and showed that cytochrome P450 monooxygenase that metabolize rifampicin and NAT2 gene responsible for N-acetylation of isoniazid were up regulated in Mtb infected cells.

      We thank the reviewer for the positive feedback and for highlighting the strengths of our study.

      Weaknesses:

      There are reports of hepatic tuberculosis in pulmonary TB patients especially in immune-compromised patients, therefore finding granuloma in human liver biopsy samples is not surprising.

      Mtb infected hepatic cells showed induced DME and NAT and this could lead to enhanced metabolism of drug by hepatic cells as a result Mtb in side HepG2 cells get exposed to reduced drug concentration and show higher tolerance to drug. The authors mentioned that " hepatocyte resident Mtb may display higher tolerance to rifampicin". In my opinion higher tolerance to drugs is possible only when DME of Mtb inside is up regulated or the target is modified. Although, in the end authors mentioned that drug tolerance phenotype can be better attributed to host intrinsic factors rather than Mtb efflux pumps. It may be better if the Drug tolerant phenotype section can be rewritten to clarify the facts.

      We agree that several case studies regarding liver infection in pulmonary TB patients have been reported in the literature, however this report is the first comprehensive study that establishes hepatocytes to be a favourable niche for Mtb survival and growth.

      Drug tolerance is a phenomenon that is exhibited by the bacteria and during hostpathogen interactions, can be influenced by both intrinsic (bacterial) and extrinsic (host-mediated) factors. Multiple examples of tolerance being attributed to host driven factors can be found in literature (PMID 32546788, PMID: 28659799, PMID: 32846197). Our studies demonstrate that Mtb infected hepatocytes create a drug tolerant environment by modulating the expression of Drug modifying enzymes (DMEs) in the hepatocytes.

      As suggested by the reviewer we will rewrite the drug tolerant phenotype section.

      Reviewer #2 (Public review):

      The manuscript by Sarkar et al has demonstrated the infection of liver cells/hepatocytes with Mtb and the significance of liver cells in the replication of Mtb by reprogramming lipid metabolism during tuberculosis. Besides, the present study shows that similar to Mtb infection of macrophages (reviewed in Chen et al., 2024; Toobian et al., 2021), Mtb infects liver cells but with a greater multiplication owing to consumption of enhanced lipid resources mediated by PPARg that could be cleared by its inhibitors. The strength of the study lies in the clinical evaluation of the presence of Mtb in human autopsied liver samples from individuals with miliary tuberculosis and the presence of a clear granuloma-like structure. The interesting observation is of granuloma-like structure in liver which prompts further investigations in the field.

      The modulation of lipid synthesis during Mtb infection, such as PPARg upregulation, appears generic to different cell types including both liver cells and macrophage cells. It is also known that infection affect PPARγ expression and activity in hepatocytes. It is also known that this can lead to lipid droplet accumulation in the liver and the development of fatty liver disease (as shown for HCV). This study is in a similar line for M.tb infection. As the liver is the main site for lipid regulation, the availability of lipid resources is greater and higher is the replication rate. In short, the observations from the study confirm the earlier studies with these additional cell types. It is known that higher the lipid content, the greater are Lipid Droplet-positive Mtb and higher is the drug resistance (Mekonnen et al., 2021). The DMEs of liver cells add further to the phenotype.

      We thank the reviewer for emphasizing on the strengths of our study and how it can lead to further investigations in the field.

      Reviewer #3 (Public review):

      This manuscript by Sarkar et al. examines the infection of the liver and hepatocytes during M. tuberculosis infection. They demonstrate that aerosol infection of mice and guinea pigs leads to appreciable infection of the liver as well as the lung. Transcriptomic analysis of HepG2 cells showed differential regulation of metabolic pathways including fatty acid metabolic processing. Hepatocyte infection is assisted by fatty acid synthesis in the liver and inhibiting this caused reduced Mtb growth. The nuclear receptor PPARg was upregulated by Mtb infection and inhibition or agonism of its activity caused a reduction or increase in Mtb growth, respectively, supporting data published elsewhere about the role of PPARg in lung macrophage Mtb infection. Finally, the authors show that Mtb infection of hepatocytes can cause upregulation of enzymes that metabolize antibiotics, resulting in increased tolerance of these drugs by Mtb in the liver.

      Overall, this is an interesting paper on an area of TB research where we lack understanding. However, some additions to the experiments and figures are needed to improve the rigor of the paper and further support the findings. Most importantly, although the authors show that Mtb can infect hepatocytes in vitro, they fail to describe how bacteria get from the lungs to the liver in an aerosolized infection. They also claim that "PPARg activation resulting in lipid droplets formation by Mtb might be a mechanism of prolonging survival within hepatocytes" but do not show a direct interaction between PPARg activation and lipid droplet formation and lipid metabolism, only that PPARg promotes Mtb growth. Thus, the correlations with PPARg appear to be there but causation, implied in the abstract and discussion, is not proven.

      The human photomicrographs are important and overall, well done (lung and liver from the same individuals is excellent). However, in lines 120-121, the authors comment on the absence of studies on the precise involvement of different cells in the liver. In this study there is no attempt to immunophenotype the nature of the cells harboring Mtb in these samples (esp. hepatocytes). Proving that hepatocytes specifically harbor the bacteria in these human samples would add significant rigor to the conclusions made.

      We thank the reviewer for nicely summarizing our manuscript.

      Our study establishes the involvement of liver and hepatocytes in pulmonary TB infection in mice. Understanding the mechanism of bacterial dissemination from the lung to the liver in aerosol infections demands a detailed separate study.

      Figure 6E and 6F shows how PPARγ agonist and antagonist modulate (increase and decrease respectively) bacterial growth in hepatocytes (further supported by the CFU data in Supplementary Figure 9B). Again, the number of lipid droplets in hepatocytes increase and decrease with the treatment of PPARγ agonist and antagonist respectively as shown in Figure 6G and 6H. Collectively, these studies provide strong evidence that PPARγ activation leads to more lipid droplets that support better Mtb growth.

      We thank the reviewer for finding our human photomicrographs convincing. In the manuscript, we provide evidence for the direct involvement of the hepatocytes (and liver) in Mtb infection. We have performed detailed immunophenotyping of hepatocyte cells in the mice model with ASPGR1 (asialoglycoprotein receptor 1) and in the revised version of record, we have further stained the infected hepatocytes with anti-albumin antibody.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      In my opinion drug tolerant phenotype section should be rewritten for better clarification. The manuscript contains important information about hepatic tuberculosis which are not reported yet.

      We have rewritten the drug tolerant phenotype section for better clarity.

      We appreciate the reviewer’s comments regarding important information about hepatic tuberculosis

      Reviewer #2 (Recommendations for the authors):

      The following are some observations and comments on the manuscript.

      (1) The study delves into the mechanisms related to hepatic TB/miliary TB; however, the introduction and discussion only describe and discuss the data in the context of pulmonary TB giving a sense that the mandate of the MS is the exploration of the role of liver cells in pulmonary TB. There appears a gap in the connection of findings from the Miliary TB to the pulmonary TB. A discussion of the conversion of pulmonary TB to extrapulmonary /hepatic TB in the light of the findings may be helpful.

      We have modified the discussion section to include possible mechanisms that convert pulmonary TB to hepatic TB in the light of findings. Briefly, Pulmonary tuberculosis (TB) can lead to miliary TB probably through hematogenous dissemination, where Mtb spreads from the infected lungs into blood vessels either from a primary lung focus, reactivated TB or caseous necrosis.  Once in blood vessels, the bacteria seed multiple organs, forming tiny granulomas, characteristic of miliary TB. The liver involvement could be either through direct hematogenous spread or extrusion from nearby infected lymph nodes, leading to hepatic TB, which presents with granulomas and liver dysfunction. This spread underscores the severity of untreated pulmonary TB and the need for early intervention. Our in vivo infection data clearly shows that pulmonary infection of Mtb in mice and guinea pigs can steadily leads to significant infection of the liver and metabolic abnormalities in the liver. The study further highlights the need for systemic studies to better understand the route and mode of dissemination from lungs to liver for better pathophysiological understanding of the disease and creating new therapeutic targets.  

      (2) The authors show the presence of Mtb in the liver autopsies of miliary tuberculosis patients. It is well known that Mtb disseminates during the late stages to several organs and liver is a major site (Sharma et al. 2005; 10.1016/S1473-3099(05)70163-8). Other clinical observations also point to the fact that although Mtb infects liver cells, it is cleared (Thandi et al., 2018, https://doi.org/10.4049/jimmunol.200.Supp.173.20). As the samples are from miliary TB, it is expected that the bacterial load must have been very high before spreading to blood. It is known that once in blood, M.tb is expected to spread to various organs, especially highly vascular ones. Were any other tissues (especially with high vasculature) stained and verified? If yes, add to the supplementary data or discuss.

      Other tissues were not collected and stained during this study. Studies are currently underway to understand whether other vasculated organs also harbour Mtb or not. Besides several studies have shown that Mtb can infect a wide range of organs like brain, kidney, bone marrow, etc (PMID: 33142108, PMID: 28046053, PMID: 34269789) during miliary conditions.

      (3) It is not evident from this paper if hepatic infiltration occurs in pulmonary TB patients? It may therefore be important to discuss the status of liver infections in the primary pulmonary infection.

      Based on the available data from human biopsied liver samples, there is an indication of liver involvement in systemic tuberculosis (TB). However, to gain a more comprehensive understanding of hepatic infiltration in pulmonary TB patients, it is essential to conduct well-organized clinical studies. These studies should specifically target pulmonary TB patients and explore the extent and nature of liver involvement in these individuals (discussion). As suggested by the reviewer it is in the discussion

      (4) Similarly, in the mice model, M.tb was shown to localize to liver when aerosolic infection was given. Were any other tissues, such as kidney, bone marrow etc, checked? Is it because of the high dose of M.tb against the standard challenge dose of 50-100 CFU? Further, since the study in the mouse model is to mimic a miliary tuberculosis of liver, did the dissemination occur via bloodstream and if mycobacteremia could be observed in infected mice.

      Currently studies are underway to understand the involvement of other organs like kidney, brain, bone marrow, in aerosol infection mice model and how dissemination occurs in those distant organs.

      The focus of the current study was to understand the role of liver in systemic tuberculosis with emphasis on hepatocytes as a key cell type to be infected. We have also conducted the experiments with lower CFUs and could detect the presence of Mtb colonies in liver, so we do not think that the infection of liver is dependent on the dose of infection.

      (5) There are studies in mouse model which infer that liver carried the lowest bacterial burden, was cleared the fastest, and it is established that as compared to sites persistently seeded by M. tuberculosis, in the liver the bacteria rarely infect cell types other than professional phagocytes. As the observations in this study are contrasting, the discussion section should include a critical comparative analysis to justify why in the conditions used in the study, the hepatocytes and not Kupffer cells are infected. Other than the morphological description to indicate M.tb infection of hepatocytes in the liver section (fig 1E), it will be good to show localization of M.tb specifically to hepatocytes by using hepatocyte specific marker. Unlike as reported, why was a clearance of M.tb not observed even after 10 weeks (figure 2B).

      While some studies show that Mtb from the liver is cleared fast but there are several other studies that report Liver harbours Mtb even after 10 weeks postinfection (PMID: 22359543, PMID: 21533158, PMID: 29242198). We have consistently observed Mtb infection of liver post week 10 in our infection model. 

      We have performed detailed immunophenotyping of hepatocyte cells in the mice model with ASPGR1 (asialoglycoprotein receptor 1) and in the revised version of record, we have further stained the isolated hepatocytes with anti-albumin antibody (albumin is a robust marker of hepatocyte identity) and have showed the presence of Mtb in it. The data has been included in the revised manuscript (Fig 2J)

      (6) While the result section mentions that "individuals with miliary tuberculosis' (line 107), the legend of Figure 1 writes 'Presence of Mtb in human pulmonary tuberculosis patients'. This is confusing. Clarify

      We thank the reviewer for pointing it out, we have changed the figure legends to miliary tuberculosis as most of the liver biopsy samples were obtained from military tuberculosis patients. 

      (7) Supplementary Figure 2D: Corresponding control panel (uninfected) should be added, which will also verify the specificity of Ag85b. As it is known that Ag85B is secreted out from the bacteria and hence the detected signals may not confirm that Mtb is in hepatocytes. Ag85B per bacterium decreases by almost 10,000-fold at later stages of infection because of secretion (Ernst JD, Cornelius A, et al 2019 mBio). In Supl figure 2D, Ag85b signal seems to be present everywhere inside the cells. Hence, it is important that the control panel be added.

      We have included a control image below which shows no staining of Ag85B in the uninfected sample.While we acknowledge with the reviewer’s comment, but Ag85B has been consistently used as a marker for Mtb presence in multiple studies. Nargan et al., uses Ag85B based staining to characterize infection both pulmonary and EPTB samples (PMID: 38880068). Jain et al., uses Ag85B to characterize Mtb infection of Mesenchymal stem cell in lung biopsy samples of pulmonary TB patients (PMID: 32546788)

      Author response image 1.

      Ag85B staining in uninfected mice shows no signals

      (8) The kinetics experiments in Figure 3D-3G should have used time laps microscopy of a few of the infected cells or it should be represented in CFU. If we consider the doubling time of H37Rv is about 22h to 24h, the data showing that MFI increases dramatically from 5 HPI to 120 HPI, gives an impression that the bacterial number inside the cells increased more than its doubling time.

      We have added the modified plot. As suggested, the CFU of Mtb within HepG2, PHCs, THP-1, RAW 264.7 and BMDMs have been included in the revised version (Supplementary Figure 4 D-H)

      (9) What is the effect of C45 and T863 on Mtb growth invitro? The effect of C45 and T863 on Mtb growth invitro should be shown to be ruled out. The representative image in Figure 5F is DMSO or C45 treated cells panel? Please specify it.

      As per the reviewer’s suggestion we have seen the effect of C45 (30 µM) and T863 (25 µM) on Mtb growth in vitro and did not find any difference in the growth kinetics. The representative image in Figure 5F is DMSO treated cells.

      Author response image 2.

      Growth kinetics of Mtb in 7H9 medium with DMSO, C75 and T863

      (10) Supplementary Figure 6B: Correct the Y-axis label from mRNA levels to Fold change (normalised to control). Please do similar changes wherever required.

      We have made the necessary changes as per the suggestion of the reviewer.

      (11) Figure 7B and 7C: How was the normalization performed? Is the data normalized to the number of bacteria that entered the specific cell type or was normalized at 48hrs with respect to DMSO? DMSO alone data should be shown.

      In the drug tolerance assays, we have calculated the ratio of the bacterial burden in hepatocytes treated with drugs compared to hepatocytes treated with DMSO. The infection was given for 48 hours post which the infected cells were treated with the mentioned concentrations of isoniazid and rifampicin for 24 hours. CFU enumeration was conducted after this 24 hour. Figure 7A gives a schematic of the experimental set up.

      % Tolerant Bacterial population= [A/B X 100] % where A is the CFU of Mtb from infected hepatocytes treated with drug and B is the CFU of Mtb infected cells treated with DMSO.Thus the effect of MOI is negated.

      To provide further credence to the CFU data, we have analysed these studies using microscopic studies as well, where no cell death was observed under the conditions. Mouse BMDMs were as a macrophage control. We have calculated the % tolerance as ratio by measuring the mean fluorescent intensity of GFP-Mtb per hepatocyte treated with drug to MFI of GFP-Mtb per hepatocyte treated with DMSO (control). More than 20 fields, each consisting of more than 4 infected cells have been used for analysis providing additional evidence of less killing of Mtb in hepatocytes compared to BMDMs with anti-TB drugs. All these details are included in the manuscript.

      (12) While authors have shown the changes in mRNA levels of CYP3A4, CYP3A43, NAT2, the protein or activities of some of these should be measured to verify the effect.

      Currently studies are underway to understand the activities of the key proteins involved in isoniazid and rifampicin metabolism and will be published as a separate manuscript.

      Reviewer #3 (Recommendations for the authors):

      Additional comments are:

      • Figure 2D, the 20X and 40X magnifications do not look appreciably different in size. Please double-check that the correct images were used.

      We thank the reviewer for pointing it out, we havecorrected it in the revised version.

      • Lines 162-164: The authors state almost 100% purity. However, the contour plot in 2F appears to show 2 cell populations. Figure 2G is missing a legend of which colors correspond to which staining (and again there appears to be highly variable staining).

      We agree with the reviewer that there are two contours observed in Figure 2F. Although both the contours are positive for ASPGR1 protein, but the level of expression of the ASPGR1 protein is variable. The corresponding confocal image (Nucleus stained by DAPI and ASPGR1 stained with ASPGR1 antibody with Alexa fluor 555 conjugated secondary antibody) also indicates a variable staining of isolated primary hepatocytes, where some cells give a stronger intensity signal than the other cells, further visually confirming our statement. Moreover, several studies show differential expression of ASPGR1 protein in hepatocyte like cells (PMID: 27143754)

      To further clarify and be more specific with respect to the identity of the hepatocytes, we have stained primary hepatocytes from infected mouse livers with Albumin antibody (a stable marker for hepatocytes) and Ag85B (2J)

      Multiple figures throughout the manuscript, including this one, would benefit from the use of arrows to depict what is described in the legend and text more clearly, and the use of higher power insets to better define cell architecture. Finally, some images appear blurry to the eye. Improvements are needed throughout.

      As per the suggestion, we have modified the figures and figure legends for better clarity.

      • Lines 153-155. Albumin, AST and GGT appear to be significantly up at week 8, contradicting the statement that there is no change until week 10.

      We thank the reviewer for poiting it out and  have made suitable changes in the write up

      • Lines 203-205: The authors state earlier that bacteria survive in macrophage phagosomes. Do the authors know the niche for bacteria in hepatocytes that enable them to continue to grow? Transcriptome data from HepG2 cells suggest perhaps a phagosomal pathway?

      We thank the reviewer for this insightful question. As rightly pointed out by the reviewer, transcription data indeed suggests changes in several important pathways like macroautophagy, golgi vesicular transport and vacuolar transport, which can affect the subcellular localisation of Mtb within hepatocytes. High resolution microscopic studies with respect to the subcellular localisation of labelled Mtb within Primary hepatocytes, HepG2 and THP-1 has been conducted and the % colocalization within different intra-cellular compartments have been measured. The image of colocalization of labelled Mtb within PHCs is shown below along with the % colocalization within various compartments in PHCs, HepG2 and THP-1 is added. 

      Author response image 3.

      Colocalisation of Mtb-GFP with various intra-cellular markers within PHCs.

      Author response image 4.

      Percentage Colocalisation of Mtb-GFP with various intra-cellular markers within PHCs, HepG2 and THP-1.

      • Validation of some critical genes found in the HepG2 cells should be done by qRTPCR in primary hepatocytes.

      qRT-PCR analysis of some of the key genes in HepG2 have been validated in primary hepatocytes at 24 hours post infection. Majority of the genes show a similar trend.

      Author response image 5.

      Gene expression analysis of the mentioned genes in Mtb infected PHCs as compared to the uninfected control.

      • Lines 259-260: The authors state a high degree of co-localization. The photomicrograph of a single cell in Fig. 5D is not convincing. I'm not even sure that they are really in the same subcellular compartment. Co-localization stated in Fig. S8B is also not convincing as shown.

      The image currently shown in figure 3D is a maximum intensity projection image of multiple z-stacks encompassing the entire cell.

      We agree with the reviewer with respect to figure Fig S8B and will modify the text and the figure legend accordingly.

      Copywriting edits:

      • It is difficult to see individual gene names in Figures 4D and 4E. A higher resolution or larger font would be appreciated for the reader.

      An excel file with the top differentially regulated genes at both 0 hours post infection and 48 hours post infection has been added.

      • Figure 5A has a shadow on the top right image.

      We have changed the image in the revised manuscript

      • Figure 5E is difficult to read the labels on the axes; it would be better in general to make the labels separately instead of relying on the graphing software, since these labels can get stretched when the size of the graph is modified.

      We agree with the reviewer and have made necessary changes.

      • Line 163: should be "percent" and not "perfect."

      We thank the reviewer for pointing it out and have corrected it

      • Line 190: is missing a period at the end of the sentence "...for further experiments"

      We thank the reviewer for pointing it out and have corrected it

      • Line 332: should be "hepatocytes" instead of "hepatoctyte" [sic]

      We thank the reviewer for pointing it out and have corrected it

    1. Author response:

      Reviewer #1 (Public Review):

      Summary:

      Li et al investigated how adjuvants such as MPLA and CpG influence antigen presentation at the level of the Antigen-presenting cell and MHCII : peptide interaction. They found that the use of MPLA or CpG influences the exogenous peptide repertoire presented by MHC II molecules. Additionally, their observations included the finding that peptides with low-stability peptide:MHC interactions yielded more robust CD4+ T cell responses in mice. These phenomena were illustrated specifically for 2 pattern recognition receptor activating adjuvants. This work represents a step forward for how adjuvants program CD4+ Th responses and provides further evidence regarding the expected mechanisms of PRR adjuvants in enhancing CD4+ T cell responses in the setting of vaccination.

      Strengths:

      The authors use a variety of systems to analyze this question. Initial observations were collected in an H pylori model of vaccination with a demonstration of immunodominance differences simply by adjuvant type, followed by analysis of MHC:peptide as well as proteomic analysis with comparison by adjuvant group. Their analysis returns to peptide immunization and analysis of strength of relative CD4+ T cell responses, through calculation of IC:50 values and strength of binding. This is a comprehensive work. The logical sequence of experiments makes sense and follows an unexpected observation through to trying to understand that process further with peptide immunization and its impact on Th responses. This work will premise further studies into the mechanisms of adjuvants on T cells.

      Weaknesses:

      Comment 1. While MDP has a different manner of interaction as an adjuvant compared to CpG and MPLA, it is unclear why MDP has a different impact on peptide presentation and it should be further investigated, or at minimum highlighted in the discussion as an area that requires further investigation.

      Thank you for the suggestion. We investigated the reasons for the different effects of MDP on peptide presentation compared with those of CpG and MPLA. We found that the expression of some proteins involved in antigen processing and presentation, such as CTSS, H2-DM, Ifi30, and CD74, was substantially lower in the MDP-treated group than in the CpG- and MPLA-treated groups. To further confirm whether these proteins play a key role during adjuvant modification of peptide presentation, we knocked down them using shRNA and then performed immunopeptidomics. The original mass spectra and peptide spectrum matches have been deposited in the public proteomics repository iProX (https://www.iprox.cn/page/home.html) under accession number IPX0007611000. Unfortunately, the expected results for peptide presentation repertoires were not observed. Thus, we hypothesized that the different effects of MDP on peptide presentation might not result from differences in protein expression. We cannot exclude the possibility that some other proteins that may be important in this process were overlooked. We are still working on the mechanisms and do not have an exact conclusion. Thus, we did not present related data in this manuscript.

      The related statements were added in the Discussion section on page 13, lines 292–299: “In this study, we found that the peptide repertoires presented by APCs were significantly affected by the adjuvants CpG and MPLA, but not MDP. All three adjuvants belong to the PRR ligand adjuvant family. CpG and MPLA bind to TLRs and MDP is recognized by NOD2. Although the receptors are different, many common molecules are involved both in TLR and NLD pathway activation. Unfortunately, we did not demonstrate why the MDP had different impacts on peptide presentation compared with other adjuvants. Further investigation is required to clarify the mechanism by which MPLA, CpG, and MDP adjuvants modulate the presentation of peptides with different stabilities.”

      Comment 2. It is alluded by the authors that TLR activating adjuvants mediate selective, low affinity, exogenous peptide binding onto MHC class II molecules. However, this was not demonstrated to be related specifically to TLR binding. I wonder if some work with TLR deficient mice (TLR 4KO for example) could evaluate this phenomenon more specifically.

      Thank you for the suggestion. This is an important point that was overlooked in this study. Based on published research on the mechanisms of PRR adjuvants, CpG and MPLA, we believe that the effect of CpG and MPLA on APCs-selective epitope presentation needs to be bound to the corresponding receptor, although we did not give a definitive conclusion in the manuscript.

      To confirm the TLR-activating adjuvants affecting peptides presented on MHC molecules specifically through TLR binding, we have used CRISPR-cas9 to knock out TLR4 and TLR9 of A20 cells and repeated the experiments, as suggested. We chose TLR4- and TLR9- knockout A20 cell lines instead of TLR-deficient mice because a large number of APCs are required for immunopeptidomics. Moreover, the data observed in this study were based on the A20 cell line. However, these experiments are time-consuming. Unfortunately, we were unable to provide timely data. In addition, we believe that elucidating the downstream molecular mechanisms of TLR activation is necessary, as mentioned in comment 1. All these data will be combined and reported in our upcoming publications.

      Comment 3. It is unclear to me if this observation is H pylori model/antigen-specific. It may have been nice to characterize the phenomenon with a different set of antigens as supplemental. Lastly, it is unclear if the peptide immunization experiment reveals a clear pattern related to high and low-stability peptides among the peptides analyzed.

      Q1: It is unclear to me if this observation is H. pylori model/antigen-specific. It may have been nice to characterize the phenomenon with a different set of antigens as supplemental.

      Thank you for the comment. To confirm the effect of the adjuvant on the exogenous peptide repertoire presented by MHC II molecules, a set of antigens from another bacterium, Pseudomonas aeruginosa, was used, and the experiments were repeated. The A20 cells were treated with CpG and pulsed with Pseudomonas aeruginosa antigens. Twelve hours later, MHC-II–peptide complexes were immunoprecipitated, and immunopeptidomics were performed. The data are shown below (Author response image 1). Information on the MHC-peptides from Pseudomonas aeruginosa is given in the Supplementary Table named “Table S3 Response to comment3”. A total of 713 and 205 bacterial peptides were identified in the PBS and CpG groups (Author response image 1A). The number of exogenous peptides in the CpG-treated group was significantly lower than that in the PBS-treated control group (Author response image 1B). A total of 568 bacterial peptides were presented only in the PBS group; 60 bacterial peptides were presented in the CpG-treated group, and 145 bacterial peptides were presented in both groups (Author response image 1C). We then analyzed the MHC-binding stability of the peptides present in the adjuvant-treated group and that of the peptide-deficient after adjuvant stimulation using the IEDB website. We found that the IC50 of the peptides in the adjuvant-treated group were much higher than those of the deficient peptides, which indicated that the peptides presented in the CpG-treated groups have lower binding stability for MHC-II (Author response image 1D). These results indicate that CpG adjuvant affects the presentation of exogenous peptides with high binding stability, which is consistent with the data reported in our manuscript. Using another set of antigens, we confirmed that our observations were not H. pylori model- or antigen-specific.

      Author response image 1.

      MHC-II peptidome measurements in adjuvant-treated APCs pulsed with Pseudomonas aeruginosa antigens. (A) Total number of bacterial peptides identified in the PBS- and CpG-treated groups. (B) The number and length distribution of bacterial peptides in different groups were compared. (C) Venn diagrams showing the distribution of bacterial peptides in different groups. (D) IC50 of the presented, deficient, and co-presented peptides post-adjuvant stimulation from immunopeptidome binding to H2-IA and H2-IE were predicted using the IEDB website. High IC50 means low binding stability. *p<0.05, **p<0.01.

      Q2: Lastly, it is unclear if the peptide immunization experiment reveals a clear pattern related to high and low-stability peptides among the peptides analyzed.

      In this study, we used a peptide immunization experiment to evaluate the responses induced by the screened peptides with different stabilities. In addition to this method, tetramer staining and ELISA have been used to assess epitope-specific T-cell proliferation and cytokine secretion. Among these, tetramer staining is often used in studies involving model antigens. However, as many peptides were screened in our study, synthesizing a sufficient number of tetramers was difficult. However, we believe that the experimental data obtained in this study support the conclusion. Nevertheless, we agree that more methods applied will make the pattern more clearly.

      Reviewer #2 (Public Review):

      Adjuvants boost antigen-specific immune responses to vaccines. However, whether adjuvants modulate the epitope immunodominance and the mechanisms involved in adjuvant's effect on antigen processing and presentation are not fully characterized. In this manuscript, Li et al report that immunodominant epitopes recognized by antigen-specific T cells are altered by adjuvants.

      Using MPLA, CpG, and MDP adjuvants and H. pylori antigens, the authors screened the dominant epitopes of Th1 responses in mice post-vaccination with different adjuvants and found that adjuvants altered antigen-specific CD4+ T cell immunodominant epitope hierarchy. They show that adjuvants, MPLA and CpG especially, modulate the peptide repertoires presented on the surface of APCs. Surprisingly, adjuvant favored the presentation of low-stability peptides rather than high-stability peptides by APCs. As a result, the low stability peptide presented in adjuvant groups elicits T cell response effectively.

      Thanks a lot for your comments.

      Reviewer #1 (Recommendations For The Authors):

      Recommendation 1. Figure 6: The peptides considered low affinity- it would be helpful to specify from which adjuvant they were collected from. When they are pooled it is unclear if we are analyzing peptides collected from adjuvanting with any of the three adjuvants studied.

      Thank you for the suggestion. The related description in Figure 6 has been modified in the revised manuscript. Data for the peptides identified from the adjuvants MPLA- and CpG-treated groups are shown separately.

      Recommendation 2. It is unclear to me why the A20 cell line is less preferred to the J774 line for the immunopeptidome analysis - can the authors expand on this?

      We apologize for not clearly explaining this in the original manuscript. In fact, the A20 cell line is better than J774A.1 cell line for immunopeptidomics experiments. Compared to J774A.1 cells, more MHC-II peptides were obtained from a smaller number of A20 cells using immunopeptidomics. At the beginning of this study, we chose the J774A.1 cell line as it is a macrophage cell line. J774A.1 cells (up to 5×108) were pulsed with the antigens, and MHC-II–peptide complexes were eluted from the cell surface for immunopeptidomics. Unfortunately, only a few hundred peptides from the host were detected and no exogenous peptides were detected. Next, we tested the A20 cell line. In total, 108 A20 cells were used in this study. More than 3500 host peptides and approximately 50 exogenous peptides have been identified. These data indicate that the A20 cell line was better.

      To investigate the reasons for this, we detected MHC-II expression on cell surfaces using FACS. Our purpose was to elute peptides from MHC–peptide complexes present on the cell surface. Low MHC expression resulted in the elution of a few peptides. We found the MFI of MHC-II molecules on J774A.1 cell is about 500; however, the MFI of MHC-II molecules on A20 cells is more than 300,000. These data indicate that MHC-II expression on A20 cells was much higher than that on J774A.1 cells. J774A.1 cell is a macrophage cell line. Macrophages have excellent antigen phagocytic capabilities; however, their ability to present antigens is relatively weak. MHC molecules on the macrophage cell surface can be upregulated in the stimulation of some cytokines, for example, IFN-γ. In this study, we used adjuvants as stimulators and did not want to use additional cytokine stimulators. Thus, J774A.1 cells were not used in the present study.

      The related statements are reflected on page 6 lines 120–128 “We also selected another H-2d cell J774A.1, a macrophage cell line, for immunopeptidome analysis in this study. Briefly, 5×108 J774A.1 cells were used for immunopeptidomics. Moreover, fewer than 350 peptides were observed at a peptide spectrum match (PSM) level of < 1.0% false discovery rate (FDR). However, more than 5500 peptides were detected in 108 A20 cells at FDR < 1.0% (Figure S2A). CD86 and MHC-II molecule expression on J774A.1 cells was substantially lower than that on A20 cells (Figure S2B). Low MHC-II expression on J774A.1 cells could be the reason for the lack of peptides identified by LC–MS/MS. Thus, A20 cells instead of J774A.1 cells were used for the subsequent experiments.”

      Recommendation 3. Lines 172-177, can more details be provided about the whole proteome analysis? The plots are shown for relative representation of protein expression to PBS, but it is unclear to me what examples of these proteins are (IFN pathway, Ubiquitination pathway). Could these be confirmed by protein expression analyses in supplemental?

      Thank you for the suggestion. In this study, we conducted whole proteome analysis to investigate changes in protein expression across different pathways in the adjuvant groups. Through KEGG enrichment analysis, we compared the differential expression of MHC presentation pathway proteins (such as H2-M, Ifi30, CD74, CTSS, proteasome, and peptidase subunits) between the PBS- and adjuvant-treated groups using our proteome data. In addition, we focused on IFN and ubiquitination pathways that play crucial roles in antigen presentation modification and immune response. The proteins and their relative expression in these pathways are shown in Figure S4B. Details regarding the protein names and expressions are provided in Supplemental Table S2 of the revised manuscript.

      The original statements in the results “Then, we analyzed the whole proteome data to determine whether the proteins involved in antigen presentation and processing were altered. We found that proteins involved in antigen processing, peptidase function, ubiquitination pathway, and interferon (IFN) signaling were altered post adjuvants treatment, especially in MPLA and CpG groups (Figure 5C; Figure S4B and S4C). These data suggest that adjuvants MPLA and CpG may affect the antigen processing of APCs, resulting in fewer peptides presentation.” This has been revised on page 8 lines 172–182 as “We then investigated whole-proteome data to determine the evidence of adjuvant modification of antigen presentation. We focused on the proteins involved in antigen processing, peptidase function, ubiquitination pathway, and IFN signaling. The ubiquitination pathway and IFN signaling play crucial roles in the modification of antigen presentation and immune responses. Through KEGG enrichment analysis, we found that many proteins involved in antigen processing, peptidase function, ubiquitination pathways, and IFN signaling were altered after adjuvant treatment, particularly in the MPLA- and CpG-treated groups (Figure 5C; Figure S4B). The expression of each protein is shown in Figure S4C and Supplementary Table 2. These data suggest that MPLA and CpG adjuvants may affect the antigen processing of APCs, resulting in fewer peptide presentations.”

      Recommendation 4. Lines 212-218: I think there needs to be more discussion of interpretation here. Only one of the low-stability peptides required low concentrations for CD4+ T cell responses in vitro. What about the other peptides in the analysis? Perhaps if the data is taken together there is not a clear pattern?

      Thank you for the comment. In this study, epitope-specific CD4+ T-cells were expanded in vitro from the spleens of peptide-pool-immunized mice. T-cell responses to individual peptides were detected using ICS and FACS. Only one peptide, recA #23, with low binding stability, and one high-stability peptide, ureA #2, induced effective T-cell responses. Peptide ureA #3 with high stability induces low Th1 responses. The other peptides cannot induce CD4+ T-cell secreting IFN-γ (Data are shown in Author response image 2). Thus, we compared the strength of IFN-γ responses induced by these three peptides at a set of low concentrations. Data for other peptides without any response could not be taken together.

      Author response image 2.

      The expanded CD4+T cells from peptides immunized mice were screened for their response to the peptides in an ICS assay.

      In this study, we used a peptide pool containing four low-stability peptides to vaccinate mice; however, only one peptide induced an effective CD4+ T-cell response. We speculate that the possible reasons are as follows. First, the number of peptides used for vaccination is too small. Only four low-stability peptides were synthesized and used to immunize mice. Three of these could not induce an effective T-cell response, possibly because of their low immunogenicity. If more peptides are synthesized and used, more peptides that induce T-cell responses may be observed. Second, epitope-specific T-cell responses are variable. Responses to the subdominant peptides can be inhibited by the dominant peptide. The subdominant peptide can become dominant by changing the peptide dose or in the absence of the dominant peptide. Thus, we believe that responses to the other three peptides may be detected if mice are immunized with a peptide pool that does not contain a response epitope.

      The corresponding statements have been added to the Discussion section on page 13 lines 287–291 as “Unfortunately, only one peptide, recA #23, with low binding stability and induced significant Th1 responses, was identified in this study. To further confirm that low-stability peptides can induce stronger and higher TCR-affinity antigen-specific T-cell clonotype responses than high-stability peptides, further studies should monitor more peptides with different stabilities.”

      Recommendation 5. There are some areas where additional editing to text would be beneficial due to grammar (eg lines 122-126; line 116, etc).

      The manuscript has been edited by a professional language editing company.

      Reviewer #2 (Recommendations For The Authors):

      Recommendation 1. It is interesting that there was no difference in IFNg responses induced by different adjuvants.

      Thank you for the comment. Possible reasons for the lack of difference in IFN-γ responses could be as follows. First, all adjuvants used in this study have been confirmed to effectively induce Th1 responses. Second, in this study, IFN-γ responses were examined using expanded antigen-specific T cells in vitro. The in vitro cell expansion efficiency may have affected these results.

      Recommendation 2. The data to support the claim that changes in exogenous peptide presentation among adjuvant groups were not due to differences in antigen phagocytosis is insufficient.

      Thank you for the comment. In this study, proteomics of A20 cells pulsed with antigens in different adjuvant-treated groups were used to determine exogenous antigens phagocytosed by cells. In addition, we used fluorescein isothiocyanate (FITC)-labeled OVA to pulse APCs and detected antigen phagocytosis by APCs after treatment with different adjuvants. The MFI of FITC was detected by FACS at different time points. The data are shown below (Author response image 3). No obvious differences in FITC MFI were detected after adjuvant stimulation, indicating that antigen phagocytosis among the adjuvant groups was almost the same.

      A20 cells, used as APCs, are the B-cell line. Antigen recognition and phagocytosis by B-cells depends on the B-cell receptor (BCR) on the cell surface. The ability of BCRs to bind to different antigens varies, leading to significant differences in the phagocytosis of different antigens by B-cells. Therefore, detecting the phagocytosis of a single antigen may not reflect the overall phagocytic state of the B-cells. Thus, in this study, we used proteomics to detect exogenous proteins in B-cells pulsed with H. pylori antigens, which contain thousands of components, to evaluate their overall phagocytic capacity. Only the proteomic data are presented in our manuscript.

      Author response image 3.

      Antigen phagocytosis of A20 cells were measured using FITC-labeled OVA. (A) A20 cells were pulsed with FITC-labeled OVA. MFI of FITC was measured after 1 h. (B) MFI of FITC was examined post the stimulation of adjuvants at different time points.

      Recommendation 3. It is not clear how MPLA, CpG, and MDP adjuvants modulate the presentation of low vs high stability peptides.

      Thank you for pointing this out. We acknowledge that we did not clarify the mechanisms by which adjuvants affect the stability of the peptide presentations of APCs.

      We performed experiments to detect the expression of proteins involved in antigen processing and presentation in the different adjuvant-treated groups. Furthermore, shRNAs were used to knock down the expression of key molecules. Immunopeptidomics was used to detect peptide presentation. Unfortunately, the expected results for peptide presentation repertoires were not observed. We are still working on the mechanisms.

      Please also see our response to comment 1 of reviewer 1

      The related statements were added in the Discussion section on page 13, lines 292–299: “In this study, we found that the peptide repertoires presented by APCs were significantly affected by the adjuvants CpG and MPLA, but not MDP. All three adjuvants belong to the PRR ligand adjuvant family. CpG and MPLA bind to TLRs and MDP is recognized by NOD2. Although the receptors are different, many common molecules are involved both in TLR and NLD pathway activation.  Unfortunately, we did not demonstrate why the MDP had different impacts on peptide presentation compared with other adjuvants. Further investigation is required to clarify the mechanism by which MPLA, CpG, and MDP adjuvants modulate the presentation of peptides with different stabilities.”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Valk and Engert et al. examined the potential relations between three different mental training modules, hippocampal structure and functional connectivity, and cortisol levels over a 9-month period. They found that among the three types of mental training: Presence (attention and introspective awareness), Affect (socio-emotional - compassion and prosocial motivation), and Perspective (socio-cognitive - metacognition and perspective taking) modules; Affect training most consistently related to changes in hippocampal structure and function - specifically, CA1-3 subfields of the hippocampus. Moreover, decreases in diurnal cortisol correlated to bilateral increases in volume, and decreases in diurnal and chronic cortisol left CA1-3 functional connectivity. Chronic cortisol levels also related to right CA4/DG volume and left subiculum function. The authors demonstrate that mindfulness training programs impact hippocampus and are a potential avenue for stress interventions, a potential avenue to improve health. The data contribute to the literature on plasticity of hippocampal subfields during adulthood, the impact of mental training interventions on the brain, and the link between CA1-3 and both short- and long-term stress changes. Additional clarification and extension of the methods is needed to strengthen the authors' conclusions.

      We thank the Reviewer for their positive evaluation and summary of our findings and work. We made additional changes as suggested by the Reviewer and hope this clarified any open points.

      (1) The authors thoughtfully approached the study of hippocampal subfields, utilizing a method designed for T1w images that outperformed Freesurfer 5.3 and that produced comparable results to an earlier version of ASHS. However, given the use of normalized T1-weighted images to delineate hippocampal subfield volume, some caution may be warranted (Wisse et al. 2020). While the authors note the assessment of quality control processes, the difficulty in ensuring valid measurement is an ongoing conversation in the literature. This also extends to the impact of functional co-registration using segmentations. I appreciate the inclusion of Table 5 in documenting reasons for missing data across subjects. Providing additional details on the distribution of quality ratings across subfields would help contextualize the results and ensure there is equal quality of segmentations across subfields.

      We thank the Reviewer for bringing up this point. In the current work, we assessed the overall segmentation of all six subfields per individual. Thus, unfortunately, we have no data of quality of segmentation of individual subfields beyond our holistic assessment. Indeed, registration of hippocampal subfields remains a challenge and we have further highlighted this limitation in the Discussion of the current work.

      “It is of note that the current work relies on a segmentation approach of hippocampal subfields including projection to MNI template space, an implicit correction for total brain volume through the use of a stereotaxic reference frame. Some caution for this method may be warranted, as complex hippocampal anatomy can in some cases lead to over- as well as underestimation of subfield volumes, as well as subfield boundaries may not always be clearly demarcated (1). Future work, studying the hippocampal surface at higher granularity, for example though unfolding the hippocampal sheet (2-5), may further help with both alignment and identification of not only subfield-specific change but also alterations as a function of the hippocampal long axis, a key dimension of hippocampal structural and functional variation that was not assessed in the current work (6, 7).”

      (2) Given the consistent pattern of finding results with CA1-3, in contrast to other subfields, it would help to know if the effects of the different training modules on subfields differed from each other statistically (i.e., not just that one is significant, and one is not) to provide an additional context of the strength of results focused on Affect training and CA1-3 (for example, those shown in Figure 3).

      Our work investigated i) whether the effects of the individual Training Modules differed from each other statistically. We found that the Affect Training Module showed increases in CA1-3 volume, and that these increases remained when testing effects relative to changes in this subfield following Perspective training and in retest controls. Moreover, in CA1-3 we found changes in functional connectivity when comparing the Affect to Perspective training Module. These changes were only present in this contrast, but not significant in each of the Training Modules per se. To test for specificity, we additionally evaluated whether subfield-specific changes were present above and beyond changes in the other ipsilateral hippocampal subfields. Relative to other subfields, right CA1-3 showed increases in the Affect vs Perspective contrast (left: t-value: 2.298, p=0.022, Q>0.1; right: t-value: 3.045, p=0.0025, Q=0.015). No other subfield showed significant changes. We now include this statement in the revised Results and Supplementary Tables.

      “Moreover, associations between CA1-3 and Affect, relative to Perspective, seemed to go largely above and beyond changes in the other subfields (left: t-value: 2.298, p=0.022, Q>0.1; right: t-value: 3.045, p=0.0025, Q=0.015, see further Supplementary File 1h).”

      Author response table 1.

      Subfield-specific changes following the Training Modules, controlling for the other two ipsilateral subfields

      Reviewer #1 (Recommendations For The Authors):

      (1) In Figure 1, using different colors for subfields versus the modules (yellow, red, green) would help as it could lead the reader to try to draw connections between the two when it is namely a depiction of the delineations.

      As suggested, we updated Figure 1 accordingly and present the subfields in different shades of purple for clarity. Please find the updated figure below.

      Author response image 1.

      (2) In the Results, it was at times hard to follow when Affect off Perspective where the focus of the results. Perhaps the authors could restructure or add additional context for clarity.

      We are happy to clarify. For the first analysis on Module-specific changes in hippocampal subfield volume, we compared effects across Training Modules. Here, main contrasts were ran between subjects: Presence vs active control and within subjects: Affect versus Perspective. In additional secondary contrasts, we studied training effects vs retest control. After observing consistent increases in bilateral CA1-3 following Affect, in the following analysis, we evaluated 1) intrinsic functional networks in main and supplementary contrasts and 2) diurnal cortisol measures within the Training modules only and all three Training Modules combined, and also adopted 3) a multivariate approach (PLS) (see comments Reviewer 2). We now also report effects of cortisol change on structural and functional subfield change in Presence and Perspective, for additional completeness and clarity.

      “To study whether there was any training module-specific change in hippocampal subfield volumes following mental training, we compared training effects between all three Training Modules (Presence, Affect, and Perspective). Main contrasts were: Presence vs Active control (between subjects) and Affect vs Perspective (within subjects). Supplementary comparisons were made vs retest controls and within training groups.”

      “Overall, for all hippocampal subfields, findings associated with volume increases in CA1-3 fol-lowing the Affect training were most consistent across timepoints and contrasts (Supplementary File 1a-f).”

      “Subsequently, we studied whether hippocampal CA1-3 would show corresponding changes in intrinsic function following the Affect mental training.”

      “In particular, the moderately consistent CA1-3 volume increases following Affect training were complemented with differential functional connectivity alterations of this subfield when comparing Affect to Perspective training”

      “Last, we probed whether group-level changes in hippocampal subfield CA1-3 volume would correlate with individual-level changes in diurnal cortisol indices (Presence: n= 86; Affect: n=92; Perspective: n=81), given that the hippocampal formation is a nexus of the HPA-axis (8). We took a two-step approach. First, we studied associations between cortisol and subfield change, particularly focusing on the Affect module and CA1-3 volume based on increases in CA1-3 volume identified in our group-level analysis.”

      “We observed that increases in bilateral CA1-3 following Affect showed a negative association with change in total diurnal cortisol output […]”

      “We did not observe alterations in CA1-3 volume in relation to change in cortisol markers in Presence or Perspective. Yet, for Presence, we observed association between slope and LCA4/DG change (t=-2.89, p=0.005, q=0.03), (Supplementary File 1uv).”

      “In case of intrinsic function, we also did not observe alterations in CA1-3 in relation to change in cortisol markers in Presence or Perspective, nor in other subfields (Supplementary File 1wx).”

      Author response table 2.

      Correlating change in subfield volume and diurnal cortisol indices in Presence. Main focus was on CA1-3 based on volumetric observations and are highlighted in bold.

      Author response table 3.

      Correlating change in subfield volume and diurnal cortisol indices in Perspective. Main focus was on CA1-3 based on volumetric observations and are highlighted in bold.

      Author response table 4.

      Association between stress-markers and within functional network sub-regions in Affect and Perspective.

      Author response table 5.

      Correlating change in subfield function and diurnal cortisol indices in Presence. Main focus was on CA1-3 based on volumetric observations and are highlighted in bold. For these multiple comparisons (FDRq, corrected for two subfields) values are reported if uncorrected p values are below p<.05.

      Author response table 6.

      Correlating change in subfield function and diurnal cortisol indices in Perspective. Main focus was on CA1-3 based on volumetric observations and are highlighted in bold. For these multiple comparisons (FDRq, corrected for two subfields) values are reported if uncorrected p values are below p<.05.

      (3) In the Methods, the authors note that corrections for multiple comparisons were used where needed, throughout the manuscript there is some switching between corrected and uncorrected p-values. At times, this made it difficult to follow in terms of when these corrections were needed.

      For clarity, we added explicit multiple comparisons information a) in main and supplementary results, and b) wherever extra information was needed. Also, we only included main contrasts in Table 1-3 to avoid confusion and moved the information on changes in SUB and CA4/DG to the Supplementary tables.

      (4) Typically, when correcting for intracranial volume the purpose is the ensure that sexual dimorphism in the size of the brain is accounted for. I would recommend the authors assess whether sex differences are accounted for by the MNI normalization approach taken. In the reading of the original Methods paper for the patch-based algorithm used, ICV was used to transform to MNI152 space. It would help to have additional information on how the normalization was done in the current study in order to draw comparisons to other findings in the literature.

      We are happy to further clarify. In the current work, we used the same approach as in the original paper. Volumes were linearly registered to the MNI template using FSL flirt. We now provided this additional information in the revised methods.

      “Hippocampal volumes were estimated based on T1w data that were linearly registered to MNI152 using FSL flirt (http://www.fmrib.ox.ac.uk/fsl/), such that intracranial volume was implicitly controlled for.”

      We agree with the Reviewer that sex differences may still be present, and investigated this. At baseline, sex differences were found in all subfields in the left hemisphere, and right CA4/DG (FDRq<0.05). Regressing out ICV resolved remaining sex differences. We then evaluated whether main results of volumetric subfield change were impacted by ICV differences. Differences between Affect and Perspective remained stable. We have now added this additional analysis in the Supplementary Materials.

      “Although stereotaxic normalization to MNI space would in theory account for global sex differences in intra-cranial volume, we still observed sex differences in various subfield volumes at baseline. Yet, accounting for ICV did not impact our main results suggesting changes in CA1-3 following Affect were robust to sex differences in overall brain volume (Supplementary File1j).”

      Author response table 7.

      Sex differences (female versus male) in hippocampal subfield volumes.

      Reviewer #2 (Public Review):

      In this study, Valk, Engert et al. investigated effects of stress-reducing behavioral intervention on hippocampal structure and function across different conditions of mental training and in relation to diurnal and chronic cortisol levels. The authors provide convincing multimodal evidence of a link between hippocampal integrity and stress regulation, showing changes in both volume and intrinsic functional connectivity, as measured by resting-state fMRI, in hippocampal subfield CA1-3 after socio-affective training as compared to training in a socio-cognitive module. In particular, increased CA1-3 volume following socio-affective training overlapped with increased functional connectivity to medial prefrontal cortex, and reductions in cortisol. The conclusions of this paper are well supported by the data, although some aspects of the data analysis would benefit from being clarified and extended.

      A main strength of the study is the rigorous design of the behavioral intervention, including test-retest cohorts, an active control group, and a previously established training paradigm, contributing to an overall high quality of included data. Similarly, systematic quality checking of hippocampal subfield segmentations contributes to a reliable foundation for structural and functional investigations.

      We thank the Reviewer for the thoughtful summary and appreciation of our work, as well as requests for further clarification and analyses. We addressed each of them in a point by point fashion below.

      Another strength of the study is the multimodal data, including both structural and functional markers of hippocampal integrity as well as both diurnal and chronic estimates of cortisol levels.

      (1) However, the included analyses are not optimally suited for elucidating multivariate interrelationships between these measures. Instead, effects of training on structure and function, and their links to cortisol, are largely characterized separately from each other. This results in the overall interpretation of results, and conclusions, being dependent on a large number of separate associations. Adopting multivariate approaches would better target the question of whether there is cortisol-related structural and functional plasticity in the hippocampus after mental training aimed at reducing stress.

      We thank the Reviewer for this suggestion. Indeed, our project combined different univariate analyses to uncover the association between hippocampal subfield structure, function, and cortisol markers. While systematic, a downside of this approach is indeed that interpretation of our results depend on a large number of analyses. To further explore the question whether there is cortisol-related structural and functional plasticity in the hippocampus, we followed the Reviewer’s suggestion and additionally adopted a multivariate partial least squares (PLS) model. We ran two complementary models. One focusing on the bilateral CA1-3, as this region showed increases in volume following Affect training and differential change between Affect and Perspective training in our resting state analyses and one model including all subfields. Both models included all stress markers. We found that both models could significantly relate stress markers to brain measures, and that in particular Affect showed strong associations with significant the latent markers. Both analyses showed inverse effects of structure and function in relation to stress markers and both slope and AUC changes showed strongest loadings. We now include these analyses the revised manuscript.

      Abstract

      “Of note, using a multivariate approach we found that other subfields, showing no group-level changes, also contributed to alterations in cortisol levels, suggesting circuit-level alterations within the hippocampal formation.”

      Methods

      “Partial least squares analysis

      To assess potential relationships between cortisol change and hippocampal subfield volume and functional change, we performed a partial least squares analysis (PLS) (9, 10). PLS is a multivariate associative model that to optimizes the covariance between two matrices, by generating latent components (LCs), which are optimal linear combinations of the original matrices (9, 10). In our study, we utilized PLS to analyze the relationships between change in volume and intrinsic function of hippocampal subfields and diurnal cortisol measures. Here we included all Training Modules and regressed out effects of age, sex, and random effects of subject on the brain measures before conducting the PLS analysis. The PLS process involves data normalization within training groups, cross-covariance, and singular value decomposition. Subsequently, subfield and behavioral scores are computed, and permutation testing (1000 iterations) is conducted to evaluate the significance of each latent factor solution (FDR corrected). We report then the correlation of the individual hippocampal and cortisol markers with the latent factors. To estimate confidence intervals for these correlations, we applied a bootstrapping procedure that generated 100 samples with replacement from subjects’ RSFC and behavioral data.”

      Results

      “Last, to further explore the question whether there is concordant cortisol-related structural and functional plasticity in the hippocampus we adopted a multivariate partial least square approach, with 1000 permutations to account for stability (9, 10) and bootstrapping (100 times) with replacement. We ran two complementary models including all Training Modules whilst regressing out age, sex and random effects of subject. First, we focused on the bilateral CA1-3, as this region showed increases in volume following Affect training and differential change between Affect and Perspective training in our resting state analyses. In the second model included structural and functional data of all subfields. Both models included all stress markers. We found that both models could identify significant associations between cortisol stress markers and hippocampal plasticity (FDRq<0.05), and that in particular Affect showed strongest associations with the latent markers for CA1-3 (Table 5). Both analyses showed inverse effects of subfield structure and function in relation to stress markers and both slope and AUC changes showed strongest associations with the latent factor.”

      Author response table 8.

      Multivariate PLS analyses linking cortisol markers to hippocampal subfield volume and function.

      Discussion

      “Last, performing multivariate analysis, we again observed associations between CA1-3 volume and function plasticity and stress change, strongest in Affect. Yet combining all subfields in a single model indicated that other subfields also link to stress alterations, indicating that ultimately circuit-level alterations within the hippocampal formation relate to latent changes in diurnal stress markers across Training Modules.”

      “This interpretation is also supported by our multivariate observations.”

      “In line with our observations in univariate analysis, we found multivariate associations between hippocampal subfield volume, intrinsic function and cortisol markers. Again, the contribution of volume and intrinsic function was inverse. This may possibly relate to the averaging procedure of the functional networks. Combined, outcomes of our univariate and multivariate analyses point to an association between change in hippocampal subfields and stress markers, and that these changes, at the level of the individual, ultimately reflect complex interactions within and across hippocampal subfields and may capture different aspects of diurnal stress. Future work may more comprehensively study the plasticity of the hippocampal structure, and link this to intrinsic functional change and cortisol to gain full insights in the specificity and system-level interplay across subfields, for example using more detailed hippocampal models (3). Incorporating further multivariate, computational, models is needed to further unpack and investigate the complex and nuanced association between hippocampal structure and function, in particular in relation to subfield plasticity and short and long-term stress markers.”

      “…based on univariate analysis. Our multivariate analysis further nuanced this observation, but again pointed to an overall association between hippocampal subfield changes and cortisol changes, but this time more at a systems level.”

      “Lastly, our multivariate analyses also point to a circuit level understanding of latent diurnal stress scores.”

      Author response image 2.

      Multivariate associations between changes in structure and function of hippocampal subfield volume and markers of stress change in Affect. A) Multivariate associations between bilateral CA1-3 volume and intrinsic function and stress markers. Left: Scatter of loadings, colored by Training Module; Right upper: individual correlations of stress markers; Right lower: individual correlation of subfields; B). Multivariate associations between all subfields’ volume and intrinsic function and stress markers. Left: Scatter of loadings, colored by Training Module; Right upper: individual correlations of stress markers; Right lower: individual correlation of subfields.

      (2) The authors emphasize a link between hippocampal subfield CA1-3 and stress regulation, and indeed, multiple lines of evidence converge to highlight a most consistent role of CA1-3. There are, however, some aspects of the results that limit the robustness of this conclusion. First, formal comparisons between subfields are incomplete, making it difficult to judge whether the CA1-3, to a greater degree than other subfields, display effects of training.

      We thank the Reviewer for this comment. To further test for specificity, we additionally evaluated subfield-specific changes relative to other subfields for our main contrasts (Presence versus Active Control and Affect versus Perspective). Relative to other subfields, right CA1-3 showed increases in the Affect vs Perspective contrast (left: t-value: 2.298, p=0.022, Q>0.1; right: t-value: 3.045, p=0.0025, Q=0.015); no other subfield showed significant changes. We now include this statement in Results and Supplementary Tables.

      “Moreover, associations between CA1-3 and Affect, relative to Perspective, seemed to go largely above and beyond changes in the other subfields (left: t-value: 2.298, p=0.022, Q>0.1; right: t-value: 3.045, p=0.0025, Q=0.015, see further Supplementary File 1h).”

      Author response table 9.

      Subfield-specific changes following the Training Modules, controlling for the other two ipsilateral subfields

      (3) Relatedly, it would be of interest to assess whether changes in CA1-3 make a significant contribution to explaining the link between hippocampal integrity and cortisol, as compared to structure and functional connectivity of the whole hippocampus.

      We thank the Reviewer for this comment. Please see the PLS analysis performed above (R2Q1). Indeed, not only CA1-3 but also other subfields seem to show a relationship with cortisol, in line with circuit level accounts on stress regulation and hippocampal circuit alterations (8, 11-15).

      (4) Second, both structural and functional effects (although functional to a greater degree), were most pronounced in the specific comparison of "Affect" and "Perspective" training conditions, possibly limiting the study's ability to inform general principles of hippocampal stress-regulation.

      We agree with the Reviewer that the association between stress and hippocampal plasticity, on the one hand, and mental training and hippocampal plasticity, on the other hand, make it not very straightforward to inform general principles on hippocampal stress regulation. However, as underscored in the discussion, in previous work we could also link mental training to stress reductions(16-18). We hope that the additional analyses and explanations further explain the multilevel insights of the current work, on the one hand using group-level analysis to investigate and illustrate the association between mental training and hippocampal subfield volume and intrinsic function, and on the other hand using individual level analysis to unpack the association between cortisol change and hippocampal subfield change.

      Reviewer #2 (Recommendations For The Authors):

      (1) In the Results, the description of how the hippocampal subfields' functional networks were defined would benefit from some clarification. It is also somewhat unclear what is meant by (on page 10): "Evaluating functional connectivity changes, we found that connectivity of the right CA1-3 functional network showed differential changes when comparing Affect training to Perspective training (2.420, p=0.016, FDRq=0.032, Cohens D =0.289), but not versus retest control (Table 1 and Supplementary Table 8-14)." Were there significant changes in CA1-3 FC following both training conditions (but these differed from each other)? A description of what this difference reflected would increase the reader's understanding.

      We are happy to clarify. We included information of change of individual modules in the Supplementary materials, Supplementary Table 1 and 2, 9 and 10. Changes for functional connectivity were largely due to the differences in Modules, but did not show strong effects in one Module alone. We now include information on Affect and Perspective un-contrasted change in the main results text:

      “… which could be attributed to decreases in right CA1-3 mean FC following Perspective (t=-2.012, p=0.045, M:-0.024, std: 0.081, CI [-0.041 -0.006]), but not Affect (t=1.691, p=0.092, M: 0.010, std: 0.098, CI [-0.01 0.031]); changes were not present when comparing Affect training versus retest control (Table 1 and Supplementary File 1k-q).”

      (2) As described in the Public Review, the lack of multivariate assessments may risk selling the data short. Including analyses of concomitant functional and structural changes, in relation to cortisol, seems like an approach better adapted to characterize meaningful interrelationships between these measures.

      We thank the Reviewer for suggesting multivariate assessments. To understand the interrelation between behavioral intervention, hippocampal plasticity, and cortisol changes, the current work first evaluates a simpler operationalization of the relationship between hippocampal subfield structure and volume, and cortisol as a function of mental training. Thus, given the complex nature of the study, we initially opted for a model where we assess structural and functional changes independently, with structural changes as the basis of our investigations. Now we have also included a multivariate approach (PLS) to further test the association between hippocampal subfields and cortisol markers, please see our additions to the manuscript above. We now highlighted multivariate associations in the Discussion as well, and suggest this as an important next step for more detailed, future investigations.

      “Incorporating further multivariate, computational, models is needed to further unpack and investigate the complex and nuanced association between hippocampal structure and function, in particular in relation to subfield plasticity and short and long-term stress markers.”

      (3) A minor comment regards the Figures. Some main effects should be visualized in a clearer manner. For instance, the scatterplots in Figure 1, panel D. Also, some of the current headings within the figures could be made more intuitive to the reader.

      We thank the Reviewer for this comment. To improve clarity, we updated figure headings. For Figure 1D, the challenge is that the data are quite scattered and we aimed to visualize our observations in a naturalistic way. Therefore, we added additional y-axis information to further clarify the figures. Creating more overlap or differentiation would make other elements of the figure less clear, hence we remained with the current set-up detailing the intra- and inter-individual alterations of the current model.

      (1) Wisse LEM, Chetelat G, Daugherty AM, de Flores R, la Joie R, Mueller SG, et al. (2021): Hippocampal subfield volumetry from structural isotropic 1 mm(3) MRI scans: A note of caution. Hum Brain Mapp. 42:539-550.

      (2) DeKraker J, Kohler S, Khan AR (2021): Surface-based hippocampal subfield segmentation. Trends Neurosci. 44:856-863.

      (3) DeKraker J, Haast RAM, Yousif MD, Karat B, Lau JC, Kohler S, et al. (2022): Automated hippocampal unfolding for morphometry and subfield segmentation with HippUnfold. Elife. 11.

      (4) Vos de Wael R, Lariviere S, Caldairou B, Hong SJ, Margulies DS, Jefferies E, et al. (2018): Anatomical and microstructural determinants of hippocampal subfield functional connectome embedding. Proc Natl Acad Sci U S A. 115:10154-10159.

      (5) Bernhardt BC, Bernasconi A, Liu M, Hong SJ, Caldairou B, Goubran M, et al. (2016): The spectrum of structural and functional imaging abnormalities in temporal lobe epilepsy. Ann Neurol. 80:142-153.

      (6) Vogel JW, La Joie R, Grothe MJ, Diaz-Papkovich A, Doyle A, Vachon-Presseau E, et al. (2020): A molecular gradient along the longitudinal axis of the human hippocampus informs large-scale behavioral systems. Nat Commun. 11:960.

      (7) Genon S, Bernhardt BC, La Joie R, Amunts K, Eickhoff SB (2021): The many dimensions of human hippocampal organization and (dys)function. Trends Neurosci. 44:977-989.

      (8) McEwen BS (1999): Stress and hippocampal plasticity. Annu Rev Neurosci. 22:105-122.

      (9) Kebets V, Holmes AJ, Orban C, Tang S, Li J, Sun N, et al. (2019): Somatosensory-Motor Dysconnectivity Spans Multiple Transdiagnostic Dimensions of Psychopathology. Biol Psychiatry. 86:779-791.

      (10) McIntosh AR, Lobaugh NJ (2004): Partial least squares analysis of neuroimaging data: applications and advances. Neuroimage. 23 Suppl 1:S250-263.

      (11) Paquola C, Benkarim O, DeKraker J, Lariviere S, Frassle S, Royer J, et al. (2020): Convergence of cortical types and functional motifs in the human mesiotemporal lobe. Elife. 9.

      (12) DeKraker J, Ferko KM, Lau JC, Kohler S, Khan AR (2018): Unfolding the hippocampus: An intrinsic coordinate system for subfield segmentations and quantitative mapping. Neuroimage. 167:408-418.

      (13) McEwen BS, Nasca C, Gray JD (2016): Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex. Neuropsychopharmacology. 41:3-23.

      (14) Sapolsky RM (2000): Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 57:925-935.

      (15) Jacobson L, Sapolsky R (1991): The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev. 12:118-134.

      (16) Engert V, Hoehne K, Singer T (2023): Specific reduction in the cortisol awakening response after socio-affective mental training. Mindfulness.

      (17) Puhlmann LMC, Vrticka P, Linz R, Stalder T, Kirschbaum C, Engert V, et al. (2021): Contemplative Mental Training Reduces Hair Glucocorticoid Levels in a Randomized Clinical Trial. Psychosom Med. 83:894-905.

      (18) Engert V, Kok BE, Papassotiriou I, Chrousos GP, Singer T (2017): Specific reduction in cortisol stress reactivity after social but not attention-based mental training. Sci Adv. 3:e1700495.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews: 

      Reviewer #1 (Public review): 

      Summary: 

      Govindan and Conrad use a genome-wide CRISPR screen to identify genes regulating retention of intron 4 in OGT, leveraging an intron retention reporter system previously described (PMID: 35895270). Their OGT intron 4 reporter reliably responds to O-GlcNAc levels, mirroring the endogenous splicing event. Through a genome-wide CRISPR knockout library, they uncover a range of splicing-related genes, including multiple core spliceosome components, acting as negative regulators of OGT intron 4 retention. They choose to follow up on SFSWAP, a largely understudied splicing regulator shown to undergo rapid phosphorylation in response to O-GlcNAc level changes (PMID: 32329777). RNA-sequencing reveals that SFSWAP depletion not only promotes OGT intron 4 splicing but also broadly induces exon inclusion and intron splicing, affecting decoy exon usage. While this study offers interesting insights into intron retention and O-GlcNAc signaling regulation, the RNA sequencing experiments lack the essential controls needed to provide full confidence to the authors' conclusions. 

      Strengths: 

      (1) This study presents an elegant genetic screening approach to identify regulators of intron retention, uncovering core spliceosome genes as unexpected positive regulators of intron retention. 

      (2) The work proposes a novel functional role for SFSWAP in splicing regulation, suggesting that it acts as a negative regulator of splicing and cassette exon inclusion, which contrasts with expected SR-related protein functions. 

      (3) The authors suggest an intriguing model where SFSWAP, along with other spliceosome proteins, promotes intron retention by associating with decoy exons. 

      We thank the reviewer for recognizing and detailing the strengths of our manuscript. 

      Weaknesses: 

      (1) The conclusions on SFSWAP impact on alternative splicing are based on cells treated with two pooled siRNAs for five days. This extended incubation time without independent siRNA treatments raises concerns about off-target effects and indirect effects from secondary gene expression changes, potentially limiting confidence in direct SFSWAP-dependent splicing regulation. Rescue experiments and shorter siRNA-treatment incubation times could address these issues. 

      We repeated our SFSWAP knockdown analysis and analyzed both OGT e4-e5 junction splicing and SFSWAP transcript levels by RT-qPCR (now included in Sup. Fig. S4) from day 2 to day 5 post siRNA treatment. We observed that the time point at which OGT intron 4 removal increases (day 2) coincides with the time at which SFSWAP transcript levels start decrease, consistent with a direct effect of SFSWAP knockdown on OGT intron 4 splicing. Moreover, the effect of SFSWAP knockdown on OGT intron 4 splicing peaks between day 4-5, supporting our use of these longer time points to cast a wide net for SFSWAP targets.

      (2) The mechanistic role of SFSWAP in splicing would benefit from further exploration. Key questions remain, such as whether SFSWAP directly binds RNA, specifically the introns and exons (including the decoy exons) it appears to regulate. Furthermore, given that SFSWAP phosphorylation is influenced by changes in O-GlcNAc signaling, it would be interesting to investigate this relationship further. While generating specific phosphomutants may not yield definitive insights due to redundancy and also beyond the scope of the study, the authors could examine whether distinct SFSWAP domains, such as the SR and SURP domains, which likely overlap with phosphorylation sites, are necessary for regulating OGT intron 4 splicing. 

      We absolutely agree with the reviewer that the current work stops short of a detailed mechanistic study, and we have made every attempt to be circumspect in our interpretations to reflect that limitation. In addition, we are very interested in delving more deeply into the mechanistic aspects of this regulation. In fact, we have initiated many of the experiments suggested by the reviewer (and more), but in each case, rigorous interpretable results will require a minimum another year’s time. 

      For example, we have used crosslinking and biotin labeling techniques (using previously available reagents from Eclipsebio) to test whether SFSWAP binds RNA. The results were negative, but the lack of strong SFSWAP antibodies required that we use a transiently expressed myc-tagged SFSWAP. Therefore, this negative result could be an artifact of the exogenous expression and/or tagging. Given the difficulties of “proving the negative”, considerably more work will be required to substantiate this finding. As another example, we intend to develop a complementation assay as suggested. For an essential gene, the ideal complementation system employs a degron system, and we have spent months attempting to generate a homozygous AID-tagged SFSWAP. Unfortunately, we so far have only found heterozygotes. Of course, this could be because the tag interferes with function, the insert was not efficiently incorporated by homologous repair, or that we simply haven’t yet screened a sufficient number of clones. We’re confident that these technical issues that can be addressed, but they will take a significant amount of time to resolve. While we would ideally define a mechanism, we think that the data reported here outlining functions for SFSWAP in splicing represent a body of work sufficient for publication. 

      (3) Data presentation could be improved (specific suggestions are included in the recommendations section). Furthermore, Excel tables with gene expression and splicing analysis results should be provided as supplementary datasheets. Finally, a more detailed explanation of statistical analyses is necessary in certain sections. 

      We have addressed all specific suggestions as detailed in the recommendations below.

      Reviewer #2 (Public review): 

      Summary: 

      The paper describes an effort to identify the factors responsible for intron retention and alternate exon splicing in a complex system known to be regulated by the O-GlcNAc cycling system. The CRISPR/Cas9 system was used to identify potential factors. The bioinformatic analysis is sophisticated and compelling. The conclusions are of general interest and advance the field significantly. 

      Strengths: 

      (1) Exhaustive analysis of potential splicing factors in an unbiased screen. 

      (2) Extensive genome wide bioinformatic analysis. 

      (3) Thoughtful discussion and literature survey. 

      We thank the reviewer for recognizing and detailing the strengths of our manuscript. 

      Weaknesses: 

      (1) No firm evidence linking SFSWAP to an O-GlcNAc specific mechanism. 

      We couldn’t agree more with this critique. Indeed, our intention at the outset for the screen was to find an O-GlcNAc sensor linking OGT splicing with O-GlcNAc levels. As often occurs with high-throughput screens, we didn’t find exactly what we were looking for, but the screen nonetheless pointed us to interesting biology. Prompted by our screen, we describe new insights into the function of SFSWAP a relatively uncharacterized essential gene. Currently, we are testing other candidates from our screen, and we are performing additional studies to identify potential O-GlcNAc sensors.  

      (2) Resulting model leaves many unanswered questions. 

      We agree (see Reviewer 1, point 2 response).  

      Reviewer #3 (Public review): 

      Summary: 

      The major novel finding in this study is that SFSWAP, a splicing factor containing an RS domain but no canonical RNA binding domain, functions as a negative regulator of splicing. More specifically, it promotes retention of specific introns in a wide variety of transcripts including transcripts from the OGT gene previously studied by the Conrad lab. The balance between OGT intron retention and OGT complete splicing is an important regulator of O-GlcNAc expression levels in cells. 

      Strengths: 

      An elegant CRISPR knockout screen employed a GFP reporter, in which GFP is efficiently expressed only when the OGT retained intron is removed (so that the transcript will be exported from the nucleus to allow for translation of GFP). Factors whose CRISPR knockdown causes decreased intron retention therefore increase GFP, and can be identified by sequencing RNA of GFP-sorted cells. SFSWAP was thus convincingly identified as a negative regulator of OGT retained intron splicing. More focused studies of OGT intron retention indicate that it may function by regulating a decoy exon previously identified in the intron, and that this may extend to other transcripts with decoy exons. 

      We thank the reviewer for recognizing the strengths of our manuscript. 

      Weaknesses: 

      The mechanism by which SFSWAP represses retained introns is unclear, although some data suggests it can operate (in OGT) at the level of a recently reported decoy exon within that intron.

      Interesting/appropriate speculation about possible mechanisms are provided and will likely be the subject of future studies. 

      We completely agree that this is a limitation of the current study (see above). Now that we have a better understanding of SFSWAP functions, we will continue to explore SFSWAP mechanisms as suggested. 

      Overall the study is well done and carefully described but some figures and some experiments should be described in more detail. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors): 

      (1) Clarify and add missing statistical details across the figures. For example, Figure S2 lacks statistical comparisons, and in Figures 4A and 4C the tests applied should be specified in the legend. 

      We have added appropriate statistical analysis wherever missing and edited figure legends to specify the tests used.

      (2) The authors are strongly encouraged to provide detailed tables of gene expression and alternative splicing analyses from RNA-Seq experiments (e.g., edgeR, rMATS, Whippet, and MAJIQ), as this would enhance transparency and facilitate data interpretation. 

      We have added tables for gene expression and alternate splicing analysis as suggested (Suppl. tables 3-

      6).

      (3) Although the legend sometimes indicates differently (e.g., Figure 3b, 5a, 5c, etc), the volcano plots showing the splicing changes do not contain a cutoff for marginally differential percent spliced in or intron retention values. 

      The legends have been edited to reflect the correct statistical and/or PSI cutoffs.

      (4) For consistency, use a consistent volcano plot format across all relevant figures (Figures 3b, 5a-c, S3, S4, S7, and S8), including cutoffs for differential splicing and the total count of up- and down-regulated events. 

      Due to different statistical frameworks and calculations employed by different alternate splicing pipelines, we could not use the same cutoffs for different pipelines.  However, we have now indicated the number of up- and down-regulated events for consistency among the volcano plots.

      (5) What is the overlap of differentially regulated events between the different analytical methodologies applied? 

      We analyzed the degree of overlap between the three pipelines used in the paper using a Venn diagram (added to Suppl. Fig. S7). However, as widely reported in literature (e.g., Olofsson et al., 2023; Biochem Biophys Res Commun. 2023; doi: 10.1016/j.bbrc.2023.02.053.), the degree of overlap between pipelines is quite low.

      (6) To further substantiate your conclusions, additional validations of RNA-Seq splicing data, ideally visualized on an agarose gel, would be valuable, especially for exons and introns regulated by SFSWAP, and particularly for OGT decoy exons in Figure 4c. 

      We have not included these experiments as we focused on other critiques for this resubmission. Because the RNA-seq, RT-PCR and RT-qPCR data all align, we are confident that the products we are seeing are correctly identified and orthogonally validated (Figs 2d, 4a, 4b, and 4c).  

      (7) It would be more informative if the CRISPR screen data were presented in a format where both the adjusted p-value and LFC values of the hits are presented. Perhaps a volcano plot? 

      We have now included these graphs in revised Supplementary Figure S2. 

      (8) In Figure 2d, a cartoon showing primer binding sites for each panel could aid interpretation, particularly in explaining the unexpected simultaneous increase in OGT mRNA and intron retention upon SFSWAP knockdown. 

      We have added a cartoon showing primer binding sites similar to that shown in Fig. 4a.

      (9) Page 9, line 1, states that SFSWAP autoregulates its expression by controlling intron retention. Including a Sashimi plot would provide visual support for this claim. 

      The data suggesting that SFSWAP autoregulates its own transcript abundance were reported in Zachar et al. (1994), not from our own studies. Validation of those data with our RNA-seq data is confounded by the fact that we are using siRNAs to knockdown the SFSWAP RNA at the transcript level (Fig. S15). 

      (10) In the legend of Figure S2 the authors state that negative results are inconclusive because RNA knockdowns are not verified by western blotting or qRT-PCR. This is correct, but the reviewer would also argue that the positive results are also inconclusive as they are not supported by a rescue experiment to confirm that the effect is not due to off-target effects. 

      This is a fair point with respect to the siRNA experiments on their own. However, the CRISPR screen was performed with sgRNAs, and MAGeCK RRA scores are high only for those genes that have multiple sgRNAs that up-regulate the gene. Examination of the SFSWAP sgRNAs individually shows that three of four SFSWAP sgRNAs had false discovery rates ≤10<sup>-42</sup> for GFP upregulation. Thus, the siRNAs provide an additional orthogonal approach. It seems unlikely that the siRNAs, and three independent sgRNAs will have the same off-target results. Thus, these combined observations support the conclusion that SFSWAP loss leads to decreased OGT intron retention.  

      (11) For clarity in Figure 3a, consider using differential % spliced in or intron retention bar plots with directionality (positive and negative axis) and labeling siSFSWAP as the primary condition. 

      (12) Consider presenting Figure 5D as a box plot with a Wilcoxon test for statistical comparison. 

      For both points 11 and 12, we have tried the graphs as the reviewer suggested. While these were good suggestions, in both cases we felt that the original plots ended up presenting a clearer presentation of the data (see Author response image 1).

      Author response image 1.

      (13) Please expand the Methods section to detail the Whippet and MAJIQ analyses. 

      We have expanded the methods section to include additional details of the alternate splicing analysis.

      (14) Include coordinates for the four possible OGT decoy exon combinations analyzed in the Methods section. 

      We have added the coordinates of all four decoy forms in the methods section.  

      (15) A section on SFSWAP mass spectrometry is listed in Methods but is missing from the manuscript. 

      This section has now been removed.

      Reviewer #2 (Recommendations for the authors): 

      This is an excellent contribution. The paper describes an effort to identify the factors responsible for intron retention and alternate exon splicing in a complex system known to be regulated by the O-GlcNAc cycling system. The CRISPR/Cas9 system was used to identify potential factors. The bioinformatic analysis is sophisticated and compelling. The conclusions are of general interest and advance the field significantly. 

      Some specific recommendations. 

      (1) The plots in Figure 3 describing SI and ES events are confusing to this reader. Perhaps the violin plot is not the best way to visualize these events. The same holds true for the histograms in the lower panel of Figure 3. Not sure what to make of these plots. 

      For Figure 3b, we include both scatter and violin plots to represent the same data in two distinct ways. For Figure 3d, we agree that these are not the simplest plots to understand, and we have spent significant time trying to come up with a better way of displaying these trends in GC content as they relate to SE and RI events. Unfortunately, we were unable to identify a clearer way to present these data. 

      (2) The model (Figure 6) is very useful but confusing. The legend and the Figure itself are somewhat inconsistent. The bottom line of the figure is apparent but I fear that the authors are trying to convey a more complete model than is apparent from this figure. Please revise. 

      We have simplified the figure from the previous submission. As mentioned above, we admit that mechanistic details remain unknown. However, we have tried to generate a model that reflects our data, adds some speculative elements to be tested in the future, but remains as simple as possible. We are not quite sure what the reviewer was referring to as “somewhat inconsistent”, but we have attempted to clarify the model in the revised Discussion and Figure legend.  

      (3) It is unclear how normalization of the RNA seq experiments was performed (eg. Figure S5 and 6).  

      The normalization differences in Fig. S5 and S6 (now Fig S8 and S9) were due to scaling differences during the use of rmats2sashimiplot software. We have now replaced Fig. S5 to reflect correctly scaled images.

      I am enthusiastic about the manuscript and feel that with some clarification it will be an important contribution. 

      Thank you for these positive comments about our study!

      Reviewer #3 (Recommendations for the authors): 

      (1) In Figure 1f, it is clear that siRNA-mediated knockdown of OGT greatly increases spliced RNA as the cells attempt to compensate by more efficient intron removal (three left lanes). However, there is no discussion of the various treatments with TG or OSMI. Might quantitation of these lanes not also show the desired effects of TG and OSMI on spliced transcript levels? 

      The strong effect of OGT knockdown masks the (comparatively modest) effects of subsequent inhibitor treatments on the reporter RNA. We have edited the results section to clarify this.

      (2) In Figure 2c, why is the size difference between spliced RNA and intron-retained RNA so different in the GFP-probed gel (right) compared with the OGT-probed gel (left)? Even recognizing that the GFP probe is directed against reporter transcripts, and the OGT probe (I think) is directed against endogenous OGT transcripts, shouldn't the difference between spliced and unspliced bands be the same, i.e., +/- the intron 4 sequence. Also, why does the GFP probe detect the unspliced transcript so poorly? 

      The fully spliced endogenous OGT mRNA is ~5.5 kb while the fully spliced reporter is only ~1.6kb, so the difference in size (the apparent shift relative to the mRNA) is quite different. Moreover, the two panels in Fig 2c are not precisely scaled to one another, so direct comparisons cannot be made. 

      The intron retained isoform does not accumulate to high levels in this reporter, a phenotype that we also observed with our GFP reporter designed to probe the regulation of the MAT2A retained intron (Scarborough et al., 2021). We are not certain about the reason for these observations, but suspect that the reporter RNA’s retained intron isoforms are less stable in the nucleus than their endogenous counterparts. Alternatively, the lack of splicing may affect 3´ processing of the transcripts so that they do not accumulate to the high levels observed for the wild-type genes. 

      (3) Please provide more information about the RNA-seq experiments. How many replicates were performed under each of the various conditions? The methods section says three replicates were performed for the UPF1/TG experiments; was this also true for the SFSWAP experiments?  

      All RNA-seq experiments were performed in biological triplicates. We have edited the methods section to clarify this.

      (4) Relatedly, the several IGV screenshots shown in Figure 3C presumably represent the triplicate RNA seq experiments. In part D, how many experiments does the data represent? Is it a compilation of three experiments? 

      Fig. 3d is derived from alternate splicing analysis performed on three biological replicates. We have added the number of replicates (n=3) on the figure to clarify this. We have also noted that the three IGV tracks represent biological replicates in the Figure legend for 3c.  

      (5) Please provide more details regarding the qRT-PCR experiments. 

      We have provided the positions of primer sets used for RT-qPCR analysis and cartoon depictions of target sites below the data wherever appropriate.

      (6) In the discussion of decoy exon function (in the Discussion section), several relevant observations are cited to support a model in which decoy exons promote assembly of splicing factors. One might also cite the finding that eCLIP profiling has found enriched binding of U2AF1 and U2AF2 at the 5' splice site region of decoy exons (reference 16). 

      Excellent point. This has now been added to the Discussion. 

      Minor corrections / clarifications: 

      (1) In the Figure 2A legend, CRISPR is misspelled. 

      Corrected.

      (2) In the discussion, the phrase "indirectly inhibits splicing of exons 4 and 5, but promoting stable unproductive assembly of the spliceosome", the word "but" should probably be "by". 

      Corrected.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The paper develops a phase method to obtain the excitatory and inhibitory afferents to certain neuron populations in the brainstem. The inferred contributions are then compared to the results of voltage clamp and current clamp experiments measuring the synaptic contributions to post-I, aug-E, and ramp-I neurons.

      Strengths:

      The electrophysiology part of the paper is sound and reports novel features with respect to earlier work by JC Smith et al 2012, Paton et al 2022 (and others) who have mapped circuits of the respiratory central pattern generator. Measurements on ramp-I neurons, late-I neurons, and two types of post-I neurons in Figure 2 besides measurements of synaptic inputs to these neurons in Figure 5 are to my knowledge new.

      Weaknesses:

      The phase method for inferring synaptic conductances fails to convince. The method rests on many layers of assumptions and the inferred connections in Figure 4 remain speculative. 

      We hope that the additional method justifications now incorporated in the manuscript will make our method more convincing and change this reviewer’s opinion.

      To be convincing, such a method ought to be tested first on a model CPG with known connectivity to assess how good it is at inferring known connections back from the analysis of spatio-temporal oscillations. 

      We respectfully disagree with this critique. Existing respiratory CPG models are based on a conductance-based formalism. Since the neurons recorded using our approach are typically hyperpolarized, in the model at the corresponding values of the membrane potential, all voltage-gated channels will be deactivated. Therefore, the current balance equation used in this study will closely align with the descriptions used in these models. This alignment will result in a near-exact correspondence between the synaptic conductance values inferred by our method and their model counterparts. However, we believe that such a demonstration, while predetermined to be successful, would not be convincing for a computationally savvy audience.

      For biological data, once the network connectivity has been inferred as claimed, the straightforward validation is to reconstruct the experimental oscillations (Figure 2) noting that Rybak et al (Rybak, Paton Schwaber J. Neurophysiol. 77, 1994 (1997)) have already derived models for the respiratory neurons.

      Running such simulations is beyond the scope of this paper, which focuses on our methods for extracting synaptic conductances during network activity cycles from intracellular recordings. However, the existing, largely speculative, respiratory CPG models can be validated against the "ground truth" of the inferences we present here. To illustrate how our circuit connection motifs elaborate on existing respiratory CPG models, we have now included a combinatorial connectivity model in the manuscript derived from the connectivity motifs in the supplemental figures (Figure 4 Supplemental Figure 1) with comparisons to the model schematic utilized by Rybak, Smith et al. in simulation studies to simulate a rhythmic three-phase respiratory pattern. There are conserved mechanistically important connectivity features between these schematics that it is possible to suggest that our more elaborate connectivity scheme would almost certainly generate the three-phase patterns of neuronal firing and network rhythmic activity.

      The transformation from time to phase space, unlike in the Kuramoto model, is not justified here (Line 94) and is wrong. The underpinning idea that "the synaptic conductances depend on the cycle phase and not on time explicitly" is flawed because synapses have characteristic decay times and delays to response which remain fixed when the period of network oscillations increases. Synaptic properties depend on time and not on phase in the network. 

      The primary assumption of our method is that all variables within the system are periodic functions of time. Therefore, the inputs to the recorded neuron, at minimum, are fully defined by the oscillation's phase. While the transduction of the input into postsynaptic conductance may have its own time dependence, the characteristic timescale of synaptic dynamics (10-20 ms, as suggested by the reviewer) is much smaller than the period of network oscillations. This is certainly true for the test system we are using. This valid assumption of our method is now further clarified in the revised manuscript.

      One major consequence relevant to the present identification of excitatory or inhibitory behaviour, is that it cannot account for change in the behaviour of inhibitory synapses - from inhibitory to excitatory action - when the inhibitory decay time becomes commensurable to the period of network oscillations (Wang & Buzsaki Journal of Neuroscience 16, 6402 (1996), van Vreeswijk et al. J. Comp. Neuroscience 1,313 (1994), Borgers and Kopell Neural Comput. 15, 2003). 

      Our method focuses on recovering synaptic conductances rather than directly measuring presynaptic inputs. The conversion of presynaptic inputs (spike trains) into postsynaptic conductances involves its own time scales. This can lead to complex dynamical effects when synaptic delay or decay times are comparable to the oscillation period. In such cases, although our conductance calculation remains accurate, we might misinterpret the phase of the presynaptic input, as it may not align with the phase of the postsynaptic conductance peak. However, this discrepancy is not significant for applications where the synaptic delay/decay times are considerably shorter than the oscillation period.

      In addition, even small delays in the inhibitory synapse response relative to the pre-synaptic action potential also produce in-phase synchronization (Chauhan et al., Sci. Rep. 8, 11431 (2018); Borgers and Kopell, Neural Comput. 15, 509 (2003)). 

      The reviewer is referring to a phenomenon involving interspike synchronization that generates oscillations with very short periods, comparable to synaptic delay times. Our technique, in contrast, is designed for systems of asynchronously firing neurons forming functional populations whose oscillations emerge on a much longer time scale or are driven by periodic stimuli (e.g., sensory input) with a period much longer than the interspike intervals of individual neurons. The time scale difference we are addressing in our test system is two orders of magnitude.

      The present assumptions are way too simplistic because you cannot account for these commensurability effects with a single parameter like the network phase. There is therefore little confidence that this model can reliably distinguish excitatory from inhibitory synapses when their dynamic properties are not properly taken into account.

      As we explained in our previous responses, in our test system, we can reliably resolve post-synaptic conductance variations at 1/100th of the oscillation period. This is due to a >100X time scale difference between the oscillation period and the synaptic/membrane decay time constants. The efficiency of our method in other systems may vary depending on the relationship between the membrane time constant and the oscillation period. The text now provides a clearer discussion of the method's resolution.

      To interpret post-synaptic conductance profiles in terms of presynaptic inputs (e.g., to reconstruct connectivity), one should consider the input-to-conductance transduction processes.We did not aim to provide a general solution for this step in our paper (hence the title) as these processes may differ for different neurotransmitter systems and involve individual dynamics. However, in our test system, as discussed, the oscillation period is much longer than the synaptic decay times of the fast-acting neurotransmitters involved (i.e., glutamate, glycine, and GABA). This means that the possible phase difference between presynaptic neuronal activity and the corresponding postsynaptic conductances is negligible. This allows for a straightforward interpretation of conductance profiles in terms of the functional connectivity of the network. In other systems, the situation may, of course, be different and additional efforts for inferring the presynaptic activity from postsynaptic conductance profiles may be necessary.

      Line 82, Equation 1 makes extremely crude assumptions that the displacement current (CdV/dt) is negligible and that the ion channel currents are all negligible. Vm(t) is also not defined. The assumption that the activation/inactivation times of all ion channels are small compared to the 10-20ms decay time of synaptic currents is not true in general. Same for the displacement current. The leak conductance is typically g~0.05-0.09ms/cm^2 while C~1uF/cm^2. Therefore the ratio C/g leak is in the 10-20ms range - the same as the typical docking neurotransmitter time in synapses.

      We have explicitly included capacitive current in the model formulation and described the time scale separation requirement that justifies our approach. Additionally, we now explain within the text that the current injection protocol involves hyperpolarizing the recorded neuron to ensure voltage-dependent currents remain deactivated during the recording. The remarkable linearity of the current-voltage relationships observed in the vast majority of recorded neurons provides post-hoc evidence supporting this assumption. For further details, please refer to our responses to Reviewer 2 and Figure 1 Supplemental Figure 1 as an example.

      Models of brainstem CPG circuits have been known to exist for decades: JC Smith et al 2012, Paton et al 2022, Bellingham Clin. Exp. Pharm. And Physiol. 25, 847 (1998); Rubin et al., J. Neurophysiol. 101, 2146 (2009) among others. The present paper does not discuss existing knowledge on respiratory networks and gives the impression of reinventing the wheel from scratch. How will this paper add to existing knowledge?

      We appreciate this comment, and in fact, in the original submitted version of this manuscript, we discussed existing knowledge of respiratory networks, but there was editorial concern that this material was above and beyond the technical aspects that we were trying to convey and therefore may detract from the paper as a technical submission. To strike a balance, we have re-incorporated some of this material in abbreviated form into the Discussion section “Implications of reconstructed synaptic conductance profiles for respiratory functional circuit architecture”.

      Reviewer #2 (Public review):

      Summary:

      By measuring intracellular changes in membrane voltage from a single neuron of the medulla the authors describe a method for determining the balance of excitatory and inhibitory synaptic drive onto a single neuron within this important brain region.

      Strengths:

      This approach could be valuable in describing the microcircuits that generate rhythms within this respiratory control centre. This method could more generally be used to enable microcircuits to be studied without the need for time-consuming anatomical tracing or other more involved electrophysiological techniques.

      Weaknesses:

      This approach involves assuming the reversal potential that is associated with the different permeant ions that underlie the excitation and inhibition as well as the application of Ohms law to estimate the contribution of excitation and inhibitory conductance. My first concern is that this approach relies on a linear I-V relationship between the measured voltage and the estimated reversal potential. However, open rectification is a feature of any I-V relationship generated by asymmetric distributions of ions (see the GHK current equation) and will therefore be a particular issue for the inhibition resulting from asymmetrical Cl- ion gradients across GABA-A receptors. The mixed cation conductance that underlies most synaptic excitation will also generate a non-linear I-V relationship due to the inward rectification associated with the polyamine block of AMPA receptors. Could the authors please speculate what impact these non-linearities could have on results obtained using their approach?

      In our Figure 1 Supplemental Figure 1, we illustrated that I-V relationships for each particular phase of the cycle (except for transitions between inspiration and expiration where our error estimates are greatest) are remarkably linear. 

      In Author response iamge 1 we compare the I-V dependence for Cl- as predicted by the GHK equation and its linear approximation using constant conductance and the Cl- Nernst potential. One can see that in the typical range of voltages used (shown by solid black vertical lines), the linear approximation appears quite adequate.

      Author response image 1.

      This approach has similarities to earlier studies undertaken in the visual cortex that estimated the excitatory and inhibitory synaptic conductance changes that contributed to membrane voltage changes during receptive field stimulation. However, these approaches also involved the recording of transmembrane current changes during visual stimulation that were undertaken in voltage-clamp at various command voltages to estimate the underlying conductance changes. Molkov et al have attempted to essentially deconvolve the underlying conductance changes without this information and I am concerned that this simply may not be possible. 

      This was why we compared the results of our reconstructions applied to current- and voltage-clamp recordings from the same neurons and we found, as illustrated, that the synaptic conductance profiles are qualitatively identical with both techniques.

      The current balance equation (1) cited in this study is based on the parallel conductance model developed by Hodgkin & Huxley. However, one key element of the HH equations is the inclusion of an estimate of the capacitive current generated due to the change in voltage across the membrane capacitance. I would always consider this to be the most important motivation for the development of the voltage-clamp technique in the 1930's. Indeed, without subtraction of the membrane capacitance, it is not possible to isolate the transmembrane current in the way that previous studies have done. In the current study, I feel it is important that the voltage change due to capacitive currents is taken into consideration in some way before the contribution of the underlying conductance changes are inferred.

      We have incorporated the capacitive current into the initial model formulation and established explicit requirements for time scale separation. These requirements justify the application of our method. Specifically, the membrane time constant (C/g ~ 10ms in our test system) must be substantially shorter than the period of network oscillations (T ~ 2s in our test system). Under this condition, aggregate variations in synaptic conductances can be considered slow, allowing us to treat membrane voltage as being in instantaneous equilibrium. This defines the time resolution of our method. Please refer to our responses to Reviewer 1 and the revised manuscript text for a more detailed explanation.

      Studies using acute slicing preparations to examine circuit effects have often been limited to the study of small microcircuits - especially feedforward and feedback interneuron circuits. It is widely accepted that any information gained from this approach will always be compromised by the absence of patterned afferent input from outside the brain region being studied. In this study, descending control from the Pons and the neocortex will not be contributing much to the synaptic drive and ascending information from respiratory muscles will also be absent completely. This may not have been such a major concern if this study was limited to demonstrating the feasibility of a methodological approach. However, this limitation does need to be considered when using an approach of this type to speculate on the prevalence of specific circuit motifs within the medulla (Figure 4). Therefore, I would argue that some discussion of this limitation should be included in this manuscript.

      Our experimental brainstem-spinal cord in situ preparation does include important inputs from the pons that are necessary to generate the 3-phase respiratory pattern (e.g., Smith et al. (2013). Brainstem respiratory networks: building blocks and microcircuits. Trends Neurosci, 36(3), 152-162), but we agree that other inputs such as from midbrain and cortex as well as important peripheral afferents are absent, and we have now noted this limitation in the text at the end of the new section “Implications of reconstructed synaptic conductance profiles for respiratory functional circuit architecture“. We show specific circuit motifs simply to illustrate how our readout of synaptic conductances from single neurons and the information on the main neuronal activity patterns in our experimental preparation can be interpreted. We thought that it would be useful to illustrate and interpret inferred connectivity motifs as an output of our methodological approach. As we now discuss in the section “Implications of reconstructed synaptic conductance profiles for respiratory functional circuit architecture” in response to Reviewer #1, our circuit motifs are consistent with some sets of connections that have been speculated in the literature, but they also provide some novel information about connectivity that we have been able to infer for respiratory circuits from the complex sets of synaptic conductances indicated by our approach. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Major comments:

      (1) My recommendation is to clarify how each neuron population was identified. Individual populations are very hard to identify based on morphology alone in brain slices such as Supplemental Figure 1. I assume the authors identified each population based on their phase difference relative to the inspiratory pulse in the phrenic nerve. This ought to be clarified. 

      Neuronal populations were classified based on their firing patterns within the respiratory cycle. Immunohistochemistry was only used for post-hoc identification of the transmitter phenotype in select neurons. Specifically, recorded neurons were categorized according to the phase range of the respiratory cycle in which they fired and their firing pattern during that range. For example, neurons firing during inspiration (synchronously with the phrenic nerve) with a progressively increasing firing rate were classified as ramp-I, etc., as illustrated in the figure depicting phase-dependent firing patterns. This classification is detailed in the "Firing patterns of respiratory interneurons" sub-section.

      It would also be beneficial to discuss the benefits and limitations of using this preparation relative to brainstem slices and in-vivo preparations (e.g. Moraes et al. J. Physiol. 599, 3237 (2021)) for measuring live network activity.

      We provided the reference to an important recent review (Paton et al. 2022, Advancing respiratory-cardiovascular physiology with the working heart-brainstem preparation over 25 years. J Physiol, 600(9), 2049-2075) on the benefits and limitations of using the in situ rodent brainstem-spinal cord preparation employed in our study. 

      (2) The background on inference methods is similarly thin. The works in line 47 are mainly experimental characterizations of excitatory and inhibitory cells. Techniques for estimating network conductances/parameters ought to be covered. One reference that comes to mind: Armstrong, E. Statistical data assimilation for estimating electrophysiology simultaneously with connectivity within a biological neuronal network. Physical Review E 101, 012415, 2020.

      Our technique is not intended to estimate synaptic connections between neurons from paired recordings. Instead, we calculate the dynamics of inhibitory and excitatory synaptic conductances that result from many concurrent synaptic inputs representing aggregate activities of the functionally interacting populations. The previous studies that we cited are the ones that have direct or indirect relation to this paradigm. 

      (3) How the "patterns of synaptic conductances" in phase diagrams imply the network connectivity (l.244) is not clear. Are the patterns of "activity patterns" depicted in Figure 2 the only neuron populations driving the postsynaptic neurons in Figure 4? 

      Figure 2 shows all of the basic firing patterns that we have recorded in our experimental preparation. So, yes, assuming that all periodic inputs in this network originate from within the network, those 6 populations are the main sources of the corresponding patterns.

      The methodology for constructing the networks is unclear, 

      This is explained in detail in the section "Synaptic Conductances and Functional Connectome of Respiratory Interneurons". Specifically, when a neuron with a given firing pattern (and thus belonging to a corresponding population, e.g., pre-I/I) exhibits excitatory or inhibitory conductance during a particular phase of the respiratory cycle (e.g., inhibition during the first half of expiration, as in Figure 3A1), we infer that the population with the same firing pattern receives input from a population with an activity pattern matching the postsynaptic conductance profile (e.g., the pre-I/I population receives post-I inhibition, as in Figure 4A1).

      yet 6 lines later (l.251) the narrative jumps to the conclusion that "the information on inhibitory transmitter phenotypes...indeed corroborates that subsets of the presynaptic neurons are inhibitory" and further "conductance profiles, which gives additional confidence in the correlation between pre-synaptic firing patterns and likely post-synaptic interactions". The method also blends in empirical information from immune labelling. It is unclear what method can actually infer on its own.

      The functional connections that we were able to infer implied that neurons with specific firing patterns (e.g., post-I neurons) must include neurons with specific transmitter phenotypes (e.g., inhibitory). Immune labeling results were used to show that there are indeed neurons having corresponding firing patterns and neurotransmitter phenotypes. It has nothing to do with the inference method. It just shows that our assumption about various inhibitory inputs originating from within the network is plausible.

      (4) Figure 3 - why does the Early-I population which is connected by the same mutually inhibitory links as Post-I and Aug-E within the respiratory CPG have the opposite conductance activation sequence as post-I and aug-E. Namely, it receives excitatory input at phases 0,1,2 when post-I and aug-E receive inhibitory input?

      We added the section “Implications of reconstructed synaptic conductance profiles for respiratory functional circuit architecture” discussing the correspondence and inconsistencies between our findings and existing respiratory CPG models (see Figure 4 Supplemenntal Figure 1). For this specific question, phase 0, 1 and 2 represent the same phase of the respiratory cycle corresponding to a transition from expiration to inspiration. According to the Rybak et al. models, the early-I population receives excitation from the pre-I/I population which is active at the E-I transition and throughout the entire inspiratory phase of the cycle. This is largely consistent with our findings shown in Figure 3. Also, according to Rybak et al., post-I and aug-E populations are inhibited by early-I neurons, which is also consistent with inspiratory inhibition in all examples of these neurons that we show in Figure 3. As noted in other responses to the reviewers’ comments, we have now discussed in the “Implications of reconstructed synaptic conductance profiles for respiratory functional circuit architecture” which covers some comparisons to previously inferred connectivity in the respiratory network.

      Minor comments:

      (1) l.39 - The terminology "patterns of inhibitory and excitatory synaptic conductances" used throughout the manuscript (l.66, 241, 244, 259...) is vague.

      We defined this terminology in the updated version.

      (2) Figure 1 what is the integration time of the moving median in Figure 1a?

      0.1s. Now included in the figure legend.

      (3) L.128 "rhythmic inspiratory neuron" which one is this post-I, aug-E, early-I?

      This example demonstrates a pre-I/I firing pattern, as the neuron begins firing slightly before the phrenic burst and continues throughout inspiration (as defined by phrenic nerve activity). However, this is merely an arbitrary example used to illustrate the methodology. The actual firing pattern of the recorded neuron is not considered in any way for synaptic conductance inference.

      (4) Figure 3 What the panel labelling means A1, B1, A2, etc. is not disclosed in the caption.

      These labels are used in the text to refer to specific examples. Now it is explained in the caption that the letter corresponds to the firing phenotype indicated on the top of each column and the digit refers to the example number.

      (5) L.129/ L.133 - the diagram of the medulla in Supplementary Figure 1 ought to be inserted early on in the main text when introducing the respiratory CPG, phrenic and vagal signals.

      This is a good suggestion and we have linked this figure specifically to Figure 2 as Figure 2 Supplemental Figure 1 in the main text to better orient readers.

      (6) L. 457 - Reference needed on reversal potentials.

      We report what we observed, so it is unclear what reference the reviewer means.

    1. Author Response:

      The following is the authors' response to the original reviews.

      Reply to Public Reviews:

      Reply to Reviewer #1:

      This is a carefully performed and well-documented study to indicate that the FUS protein interacts with the GGGGCC repeat sequence in Drosophila fly models, and the mechanism appears to include modulating the repeat structure and mitigating RAN translation. They suggest FUS, as well as a number of other G-quadruplex binding RNA proteins, are RNA chaperones, meaning they can alter the structure of the expanded repeat sequence to modulate its biological activities.

      Response: We would like to thank the reviewer for her/his time for evaluating our manuscript. We are very happy to see the reviewer for highly appreciating our manuscript.

      1. Overall this is a nicely done study with nice quantitation. It remains somewhat unclear from the data and discussions in exactly what way the authors mean that FUS is an RNA chaperone: is FUS changing the structure of the repeat or does FUS binding prevent it from folding into alternative in vivo structure?

      Response: We appreciate the reviewer’s constructive comments. Indeed, we showed that FUS changes the higher-order structures of GGGGCC [G4C2] repeat RNA in vitro, and that FUS suppresses G4C2 RNA foci formation in vivo. According to the established definition of RNA chaperone, RNA chaperones are proteins changing the structures of misfolded RNAs without ATP use, resulting in the maintenance of proper RNAs folding (Rajkowitsich et al., 2007). Thus, we consider that FUS is classified into RNA chaperone. To clarify these interpretations, we revised the manuscript as follows.

      (1) On page 10, line 215-219, the sentence “These results were in good agreement with our previous study on SCA31 showing the suppressive effects of FUS and other RBPs on RNA foci formation of UGGAA repeat RNA as RNA chaperones …” was changed to “These results were in good agreement with … RNA foci formation of UGGAA repeat RNA through altering RNA structures and preventing aggregation of misfolded repeat RNA as RNA chaperones …”.

      (2) On page 17, line 363-366, the sentence “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure, as evident by CD and NMR analyses (Figure 5), suggesting its functional role as an RNA chaperone.” was changed to “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure as evident by CD and NMR analyses (Figure 5, Figure 5—figure supplement 2), and suppresses RNA foci formation in vivo (Figures 3A and 3B), suggesting its functional role as an RNA chaperone.”

      Reply to Reviewer #2:

      Fuijino et al. provide interesting data describing the RNA-binding protein, FUS, for its ability to bind the RNA produced from the hexanucleotide repeat expansion of GGGGCC (G4C2). This binding correlates with reductions in the production of toxic dipeptides and reductions in toxic phenotypes seen in (G4C2)30+ expressing Drosophila. Both FUS and G4C2 repeats of >25 are associated with ALS/FTD spectrum disorders. Thus, these data are important for increasing our understanding of potential interactions between multiple disease genes. However, further validation of some aspects of the provided data is needed, especially the expression data.

      Response: We would like to thank the reviewer for her/his time for evaluating our manuscript and also for her/his important comments that helped to strengthen our manuscript.

      Some points to consider when reading the work:

      1. The broadly expressed GMR-GAL4 driver leads to variable tissue loss in different genotypes, potentially confounding downstream analyses dependent on viable tissue/mRNA levels.

      Response: We thank the reviewer for this constructive comment. In the RT-qPCR experiments (Figures 1E, 3C, 4G, 6D and Figure 1—figure supplement 1C), the amounts of G4C2 repeat transcripts were normalized to those of gal4 transcripts expressed in the same tissue, to avoid potential confounding derived from the difference in tissue viability between genotypes, as the reviewer pointed out. To clarify this process, we have made the following change to the revised manuscript.

      (1) On page 30, line 548-550, the sentence “The amounts of G4C2 repeat transcripts were normalized to those of gal4 transcripts in the same sample” was changed to “The amounts of G4C2 repeat transcripts were normalized to those of gal4 transcripts expressed in the same tissue to avoid potential confounding derived from the difference in tissue viability between genotypes”.

      2. The relationship between FUS and foci formation is unclear and should be interpreted carefully.

      Response: We appreciate the reviewer’s important comment. We apologize for the lack of clarity. We showed the relationship between FUS and RNA foci formation in our C9-ALS/FTD fly, that is, FUS suppresses RNA foci formation (Figures 3A and 3B), and knockdown of endogenous caz, a Drosophila homologue of FUS, enhanced it conversely (Figures 4E and 4F). We consider that FUS suppresses RNA foci formation through altering RNA structures and preventing aggregation of misfolded G4C2 repeat RNA as an RNA chaperone. To clarify these interpretations, we revised the manuscript as follows.

      (1) On page 10, line 215-219, the sentence “These results were in good agreement with our previous study on SCA31 showing the suppressive effects of FUS and other RBPs on RNA foci formation of UGGAA repeat RNA as RNA chaperones …” was changed to “These results were in good agreement with … RNA foci formation of UGGAA repeat RNA through altering RNA structures and preventing aggregation of misfolded repeat RNA as RNA chaperones …”.

      (2) On page 17, line 363-366, the sentence “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure, as evident by CD and NMR analyses (Figure 5), suggesting its functional role as an RNA chaperone.” was changed to “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure as evident by CD and NMR analyses (Figure 5, Figure 5—figure supplement 2), and suppresses RNA foci formation in vivo (Figures 3A and 3B), suggesting its functional role as an RNA chaperone.”

      Reply to Reviewer #3:

      In this manuscript Fujino and colleagues used C9-ALS/FTD fly models to demonstrate that FUS modulates the structure of (G4C2) repeat RNA as an RNA chaperone, and regulates RAN translation, resulting in the suppression of neurodegeneration in C9-ALS/FTD. They also confirmed that FUS preferentially binds to and modulates the G-quadruplex structure of (G4C2) repeat RNA, followed by the suppression of RAN translation. The potential significance of these findings is high since C9ORF72 repeat expansion is the most common genetic cause of ALS/FTD, especially in Caucasian populations and the DPR proteins have been considered the major cause of the neurodegenerations.

      Response: We would like to thank the reviewer for her/his time for evaluating our manuscript. We are grateful to the reviewer for the insightful comments, which were very helpful for us to improve the manuscript.

      1. While the effect of RBP as an RNA chaperone on (G4C2) repeat expansion is supposed to be dose-dependent according to (G4C2)n RNA expression, the first experiment of the screening for RBPs in C9-ALS/FTD flies lacks this concept. It is uncertain if the RBPs of the groups "suppression (weak)" and "no effect" were less or no ability of RNA chaperone or if the expression of the RBP was not sufficient, and if the RBPs of the group "enhancement" exacerbated the toxicity derived from (G4C2)89 RNA or the expression of the RBP was excessive. The optimal dose of any RBPs that bind to (G4C2) repeats may be able to neutralize the toxicity without the reduction of (G4C2)n RNA.

      Response: We appreciate the reviewer’s constructive comments. We employed the site-directed transgenesis for the establishment of RBP fly lines, to ensure the equivalent expression levels of the inserted transgenes. We also evaluated the toxic effects of overexpressed RBPs themselves by crossbreeding with control EGFP flies, showing in Figure 1A. To clarify them, we have made the following changes to the revised manuscript.

      (1) On page 8, line 166-168, the sentence “The variation in the effects of these G4C2 repeat-binding RBPs on G4C2 repeat-induced toxicity may be due to their different binding affinities to G4C2 repeat RNA, and their different roles in RNA metabolism.” was changed to “The variation in the effects of these G4C2 repeat-binding RBPs on G4C2 repeat-induced toxicity may be due to their different binding affinities to G4C2 repeat RNA, and the different toxicity of overexpressed RBPs themselves.”.

      (2) On page 29, line 519-522, the sentence “By employing site-specific transgenesis using the pUASTattB vector, each transgene was inserted into the same locus of the genome, and was expected to be expressed at the equivalent levels.” was added.

      2. In relation to issue 1, the rescue effect of FUS on the fly expressing (G4C2)89 (FUS-4) in Figure 4-figure supplement 1 seems weaker than the other flies expressing both FUS and (G4C2)89 in Figure 1 and Figure 1-figure supplement 2. The expression level of both FUS protein and (G4C2)89 RNA in each line is important from the viewpoint of therapeutic strategy for C9-ALS/FTD.

      Response: We appreciate the reviewer’s important comment. The FUS-4 transgene is expected to be expressed at the equivalent level to the FUS-3 transgene, since they are inserted into the same locus of the genome by the site-directed transgenesis. Thus, we suppose that the weaker suppressive effect of FUS-4 coexpression on G4C2 repeat-induced eye degeneration can be attributed to the C-terminal FLAG tag that is fused to FUS protein expressed in FUS-4 fly line. Since the caz fly expresses caz protein also fused to FLAG tag at the C-terminus, we used this FUS-4 fly line to directly compare the effect of caz on G4C2 repeat-induced toxicity to that of FUS.

      3. While hallmarks of C9ORF72 are the presence of DPRs and the repeat-containing RNA foci, the loss of function of C9ORF72 is also considered to somehow contribute to neurodegeneration. It is unclear if FUS reduces not only the DPRs but also the protein expression of C9ORF72 itself.

      Response: We thank the reviewer for this comment. We agree that not only DPRs, but also toxic repeat RNA and the loss-of-function of C9ORF72 jointly contribute to the pathomechanisms of C9-ALS/FTD. Since Drosophila has no homolog corresponding to the human C9orf72 gene, the effect of FUS on C9orf72 expression cannot be assessed. Our fly models are useful for evaluating gain-of-toxic pathomechanisms such as RNA foci formation and RAN translation, and the association between FUS and loss-of function of C9ORF72 is beyond the scope of this study.

      4. In Figure 5E-F, it cannot be distinguished whether FUS binds to GGGGCC repeats or the 5' flanking region. The same experiment should be done by using FUS-RRMmut to elucidate whether FUS binding is the major mechanism for this translational control. Authors should show that FUS binding to long GGGGCC repeats is important for RAN translation.

      Response: We would like to thank the reviewer for these insightful comments. Following the reviewer’s suggestion, we perform in vitro translation assay again using FUS-RRMmut, which loses the binding ability to G4C2 repeat RNA as evident by the filter binding assay (Figure 5A), instead of BSA. The results are shown in the figures of Western blot analysis below. The addition of FUS to the translation system suppressed the expression levels of GA-Myc efficiently, whereas that of FUS-RRMmut did not. FUS decreased the expression level of GA-Myc at as low as 10nM, and nearly eliminated RAN translation activity at 100nM. At 400nM, FUS-RRMmut weakly suppressed the GA-Myc expression levels probably because of the residual RNA-binding activity. These results suggest that FUS suppresses RAN translation in vitro through direct interactions with G4C2 repeat RNA.

      Unfortunately, RAN translation from short G4C2 repeat RNA was not investigated in our translation system, although the previous study reported the low efficacy of RAN translation from short G4C2 repeat RNA (Green et al., 2017).

      Author response image 1.

      (A) Western blot analysis of the GA-Myc protein in the samples from in vitro translation. (B) Quantification of the GA-Myc protein levels.

      We have made the following changes to the revised manuscript.

      (1) Figure 5F was replaced to new Figures 5F and 5G.

      (2) On page 14-15, line 326-330, the sentence “Notably, the addition of FUS to this system decreased the expression level of GA-Myc in a dose-dependent manner, whereas the addition of the control bovine serum albumin (BSA) did not (Figure 5F).” was changed to “Notably, upon the addition to this translation system, FUS suppressed RAN translation efficiently, whereas FUS-RRMmut did not. FUS decreased the expression levels of GA-Myc at as low as 10nM, and nearly eliminated RAN translation activity at 100nM. At 400nM, FUS-RRMmut weakly suppressed the GA-Myc expression levels probably because of the residual RNA-binding activity (Figure 5F and 5G).”.

      (3) On page 15, line 330-332, the sentence “Taken together, these results indicate that FUS suppresses RAN translation from G4C2 repeat RNA in vitro as an RNA chaperone.” was changed to “Taken together, these results indicate that FUS suppresses RAN translation in vitro through direct interactions with G4C2 repeat RNA as an RNA chaperone.”.

      (4) On page 37, line 720-723, the sentence “For preparation of the FUS protein, the human FUS (WT) gene flanked at the 5¢ end with an Nde_I recognition site and at the 3¢ end with a _Xho_I recognition site was amplified by PCR from pUAST-_FUS.” was changed to “For preparation of the FUS proteins, the human FUS (WT) and FUS-RRMmut genes flanked at the 5¢ end with an Nde_I recognition site and at the 3¢ end with a _Xho_I recognition site was amplified by PCR from pUAST-_FUS and pUAST- FUS-RRMmut, respectively.”.

      (5) On page 41, line 816-819, the sentence “FUS or BSA at each concentration (10, 100, and 1,000 nM) was added for translation in the lysate.” was changed to “FUS or FUS-RRMmut at each concentration (10, 100, 200, 400, and 1,000 nM) was preincubated with mRNA for 10 min to facilitate the interaction between FUS protein and G4C2 repeat RNA, and added for translation in the lysate.”.

      5. It is not possible to conclude, as the authors have, that G-quadruplex-targeting RBPs are generally important for RAN translation (Figure 6), without showing whether RBPs that do not affect (G4C2)89 RNA levels lead to decreased DPR protein level or RNA foci.

      Response: We appreciate the reviewer’s critical comment. Following the suggestion by the reviewer, we evaluate the effect of these G-quadruplex-targeting RBPs on RAN translation. We additionally performed immunohistochemistry of the eye imaginal discs of fly larvae expressing (G4C2)89 and these G-quadruplex-targeting RBPs. As shown in the figures of immunohistochemistry below, we found that coexpression of EWSR1, DDX3X, DDX5, and DDX17 significantly decreased the number of poly(GA) aggregates. The results suggest that these G-quadruplex-targeting RBPs regulate RAN translation as well as FUS.

      Author response image 2.

      (A) Immunohistochemistry of poly(GA) in the eye imaginal discs of fly larvae expressing (G4C2)89 and the indicated G-quadruplex-targeting RBPs. (B) Quantification of the number of poly(GA) aggregates.

      We have made the following changes to the revised manuscript.

      (1) Figures 6E and 6F were added.

      (2) On page 6-7, line 135-137, the sentence “In addition, other G-quadruplex-targeting RBPs also suppressed G4C2 repeat-induced toxicity in our C9-ALS/FTD flies.” was changed to “In addition, other G-quadruplex-targeting RBPs also suppressed RAN translation and G4C2 repeat-induced toxicity in our C9-ALS/FTD flies.”.

      (3) On page 15, line 344-346, the sentence “As expected, these RBPs also decreased the number of poly(GA) aggregates in the eye imaginal discs (Figures 6E and 6F).” was added.

      (4) On page 15, line 346-347, the sentence “Their effects on G4C2 repeat-induced toxicity and repeat RNA expression were consistent with those of FUS.” was changed to “Their effects on G4C2 repeat-induced toxicity, repeat RNA expression, and RAN translation were consistent with those of FUS.”

      (5) On page 16, line 355-357, the sentence “Thus, some G-quadruplex-targeting RBPs regulate G4C2 repeat-induced toxicity by binding to and possibly by modulating the G-quadruplex structure of G4C2 repeat RNA.” was changed to “Thus, some G-quadruplex-targeting RBPs regulate RAN translation and G4C2 repeat-induced toxicity by binding to and possibly by modulating the G-quadruplex structure of G4C2 repeat RNA.”

      (6) On page 19, line 417-421, the sentence “We further found that G-quadruplex-targeting RNA helicases, including DDX3X, DDX5, and DDX17, which are known to bind to G4C2 repeat RNA (Cooper-Knock et al., 2014; Haeusler et al., 2014; Mori et al., 2013a; Xu et al., 2013), also alleviate G4C2 repeat-induced toxicity without altering the expression levels of G4C2 repeat RNA in our Drosophila models.” was changed to “We further found that G-quadruplex-targeting RNA helicases, … ,also suppress RAN translation and G4C2 repeat-induced toxicity without altering the expression levels of G4C2 repeat RNA in our Drosophila models.”.

      Reply to Recommendations For The Authors:

      1) It is not clear from the start that the flies they generated with the repeat have an artificial vs human intronic sequence ahead of the repeat. It would be nice if they presented somewhere the entire sequence of the insert. The reason being that it seems they also tested flies with the human intronic sequence, and the effect may not be as strong (line 234). In any case, in the future, with a new understanding of RAN translation, it would be nice to compare different transgenes, and so as much transparency as possible would be helpful regarding sequences. Can they include these data?

      Response: We thank the editors and reviewers for this comment. We apologize for the lack of clarity. We used artificially synthesized G4C2 repeat sequences when generating constructs for (G4C2)n transgenic flies, so these constructs do not contain human intronic sequence ahead of the G4C2 repeat in the C9orf72 gene, as explained in the Materials and Methods section. To clarify the difference between our C9-ALS/FTD fly models and LDS-(G4C2)44GR-GFP fly model (Goodman et al., 2019), we have made the following change to the revised manuscript.

      (1) Schema of the LDS-(G4C2)44GR-GFP construct was presented in Figure 3—figure supplement 1.

      Furthermore, to maintain transparency of the study, we have provided the entire sequence of the insert as the following source file.

      (2) The artificial sequences inserted in the pUAST vector for generation of the (G4C2)n flies were presented in Figure 1—figure supplement 1—source data 1.

      2) It is really nice how they quantitated everything and showed individual data points.

      Response: We thank the editors and reviewers for appreciating our data analysis method. All individual data points and statistical analyses are summarized in source data files.

      3) So when they call FUS an RNA chaperone, are they simply meaning it is changing the structure of the repeat, or could it just be interacting with the repeat to coat the repeat and prevent it from folding into whatever in vivo structures? Can they speculate on why some RNA chaperones lead to presumed decay of the repeat and others do not? Can they discuss these points in the discussion? Detailed mechanistic understanding of RNA chaperones that ultimately promote decay of the repeat might be of highly significant therapeutic benefit.

      Response: We appreciate these critical comments. Indeed, we showed that FUS changes the higher-order structures of G4C2 repeat RNA in vitro, and that FUS suppresses G4C2 RNA foci formation. According to the established definition of RNA chaperone, RNA chaperones are proteins changing the structures of misfolded RNAs without ATP use, resulting in the maintenance of proper RNAs folding (Rajkowitsich et al., 2007). Thus, we consider that FUS is classified into RNA chaperone. To clarify these interpretations, we revised the manuscript as follows.

      (1) On page 10, line 215-219, the sentence “These results were in good agreement with our previous study on SCA31 showing the suppressive effects of FUS and other RBPs on RNA foci formation of UGGAA repeat RNA as RNA chaperones …” was changed to “These results were in good agreement with … RNA foci formation of UGGAA repeat RNA through altering RNA structures and preventing aggregation of misfolded repeat RNA as RNA chaperones …”.

      (2) On page 17, line 363-366, the sentence “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure, as evident by CD and NMR analyses (Figure 5), suggesting its functional role as an RNA chaperone.” was changed to “FUS directly binds to G4C2 repeat RNA and modulates its G-quadruplex structure as evident by CD and NMR analyses (Figure 5, Figure 5—figure supplement 2), and suppresses RNA foci formation in vivo (Figures 3A and 3B), suggesting its functional role as an RNA chaperone.”

      Besides these RNA chaperones, we observed the expression of IGF2BP1, hnRNPA2B1, DHX9, and DHX36 decreased G4C2 repeat RNA expression levels. In addition, we recently reported that hnRNPA3 reduces G4C2 repeat RNA expression levels, leading to the suppression of neurodegeneration in C9-ALS/FTD fly models (Taminato et al., 2023). We speculate these RBPs could be involved in RNA decay pathways as components of the P-body or interactors with the RNA deadenylation machinery (Tran et al., 2004; Katahira et al., 2008; Geissler et al., 2016; Hubstenberger et al., 2017), possibly contributing to the reduced expression levels of G4C2 repeat RNA. To clarify these interpretations, we revised the manuscript as follows.

      (3) On page 18, line 392-398, the sentences “Similarly, we recently reported that hnRNPA3 reduces G4C2 repeat RNA expression levels, leading to the suppression of neurodegeneration in C9-ALS/FTD fly models (Taminato et al., 2023). Interestingly, these RBPs have been reported to be involved in RNA decay pathways as components of the P-body or interactors with the RNA deadenylation machinery (Tran et al., 2004; Katahira et al., 2008; Geissler et al., 2016; Hubstenberger et al., 2017), possibly contributing to the reduced expression levels of G4C2 repeat RNA.” was added.

      4) What is the level of the G4C2 repeat when they knock down caz? Is it possible that knockdown impacts the expression level of the repeat? Can they show this (or did they and I miss it)?

      Response: We thank the editors and reviewers for this comment. The expression levels of G4C2 repeat RNA in (G4C2)89 flies were not altered by the knockdown of caz, as shown in Figure 4G.

      5) A puzzling point is that FUS is supposed to be nuclear, so where is FUS in the brain in their lines? They suggest it modulates RAN translation, and presumably, that is in the cytoplasm. Is FUS when overexpressed now in part in the cytoplasm? Is the repeat dragging it into the cytoplasm? Can they address this in the discussion? If FUS is never found in vivo in the cytoplasm, then it raises the point that the impact they find of FUS on RAN translation might not reflect an in vivo situation with normal levels of FUS.

      Response: We appreciate these important comments. We agree with the editors and reviewers that FUS is mainly localized in the nucleus. However, FUS is known as a nucleocytoplasmic shuttling RBP that can transport RNA into the cytoplasm. Indeed, FUS is reported to facilitate transport of actin-stabilizing protein mRNAs to function in the cytoplasm (Fujii et al., 2005). Thus, we consider that FUS binds to G4C2 repeat RNA in the cytoplasm and suppresses RAN translation in this study.

      6) When they are using 2 copies of the driver and repeat, are they also using 2 copies of FUS? These are quite high levels of transgenes.

      Response: We thank the editors and reviewers for this comment. We used only 1 copy of FUS when using 2 copies of GMR-Gal4 driver. Full genotypes of the fly lines used in all experiments are described in Supplementary file 1.

      7) In Figure5-S1, FUS colocalizing with (G4C2)RNA is not clear. High-magnification images are recommended.

      Response: We appreciate this constructive comment on the figure. Following the suggestion, high-magnification images are added in Figure 5—figure supplement 1.

      8) I also suggest that the last sentence of the Discussion be revised as follows: Thus, our findings contribute not only to the elucidation of C9-ALS/FTD, but also to the elucidation of the repeat-associated pathogenic mechanisms underlying a broader range of neurodegenerative and neuropsychiatric disorders than previously thought, and it will advance the development of potential therapies for these diseases.

      Response: We appreciate this recommendation. We have made the following change based on the suggested sentence.

      (1) On page 20-21, line 455-459, “Thus, our findings contribute not only towards the elucidation of repeat-associated pathogenic mechanisms underlying a wider range of neuropsychiatric diseases than previously thought, but also towards the development of potential therapies for these diseases.” was changed to “Thus, our findings contribute to the elucidation of the repeat-associated pathogenic mechanisms underlying not only C9-ALS/FTD, but also a broader range of neuromuscular and neuropsychiatric diseases than previously thought, and will advance the development of potential therapies for these diseases.”.

      Authors’ comment on previous eLife assessment:

      We thank the editors and reviewers for appreciating our study. We mainly evaluated the function of human FUS protein on RAN translation and G4C2 repeat-induced toxicity using Drosophila expressing human FUS in vivo, and the recombinant human FUS protein in vitro. To validate that FUS functions as an endogenous regulator of RAN translation, we additionally evaluated the function of Drosophila caz protein as well. We are afraid that the first sentence of the eLife assessment, that is, “This important study demonstrates that the Drosophila FUS protein, the human homolog of which is implicated in amyotrophic lateral sclerosis (ALS) and related conditions, …” is somewhat misleading. We would be happy if you modify this sentence like “This important study demonstrates that the human FUS protein, which is implicated in amyotrophic lateral sclerosis (ALS) and related conditions, …”.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1:

      (1) Figure 2 and related text: it would be useful to explain more explicitly what is meant by "neurogenic" and "non-neurogenic" models. I presume that the total number of neurons in non-neurogenic models is lower than in neurogenic models because no new neurons are added. It would be useful to plot the number of GCs as a function of timesteps.

      We have clarified the distinction between neurogenic and non-neurogenic models in the text (Lines 142-145), explicitly noting that in non-neurogenic models, no new GCs are added, resulting in a lower total neuron count over time. In response to the reviewer’s suggestion, we generated a plot showing the number of GCs over time (see below). Because the neurogenic model exhibits a simple linear increase, we found this plot not especially informative for inclusion in the manuscript. However, we agree with the reviewer’s later comments that similar plots are useful for interpreting specific results, and we have included those where appropriate.

      Author response image 1.

      Number of GCs over time for neurogenic (solid line) and non-neurogenic (dotted line) networks

      (2) Figure 2F, G: memory declines dramatically when the number of GCs at enrichment onset increases beyond an optimum. Why?

      We have explained the reasoning more thoroughly in the text (Lines 174-177) and added a new supplemental figure to support this reasoning (Figure S2). As the number of GCs increases, the network becomes overly inhibited and the response of abGCs to the stimuli decreases (Fig S2A). This leads to a smaller population of GCs being able to integrate with the stimulus (Fig S2B) which is expected given the activity-dependent plasticity rule. Moreover, it can be seen in Fig S2C that for networks with increasing size, the GCs that do learn only connect to MCs that are driven strongest by the stimuli until they struggle to connect to any MCs at all.

      In principle, a homeostatic mechanism like synaptic scaling could reduce activity to restore balance, but such a mechanism would also likely disrupt existing memories. Alternatively, we suggest activity-dependent apoptosis as a superior homeostatic mechanism because it leads to a stable level of activity without substantially erasing existing memories.

      (3) The paragraph describing synaptic connectivity of abGCs (related to Figure 2H) is confusing. What is the directionality of synapses considered here: mitral-to-granule, or granule-to-mitral? The text is opaque here. Connectivity matrix in Figure 2H: who is presynaptic, who is postsynaptic? If I understand correctly, these questions are actually irrelevant because all mitralgranule synapses in the network are reciprocal. This should be pointed out explicitly in the figure legend. Generally: the fact that the network is fully reciprocal (if I understand correctly) is very important but not stated with sufficient emphasis. It should be stated very explicitly in the text that connectivity matrices are fully reciprocal, and an equation clarifying this point should be included in Methods.

      (6) Connectivity matrix: to what degree was connectivity between mitral and granule cells reciprocal (fraction of connections in either direction that were paired with a connection in the opposite direction between the same cell pair)? Was connectivity shaped by experience (enrichment) reciprocal?

      (7) Directly related to the above: it would be useful to show the disynaptic connectivity matrix between mitral cells and analyze its symmetry. For the symmetric component, it should then be analyzed what fraction of this can be attributed to the reciprocal synapses, and what fraction is contributed by connectivity via different granule cells. This should then be compared to models with biologically realistic fractions of reciprocal connections. Is the model proposed here consistent with a biologically realistic fraction of reciprocal synapses between mitral-granule cell pairs?

      We appreciate these insightful and detailed comments. We agree that the assumption that MC-GC synapses were fully reciprocal was not clearly stated. We now explicitly state this in the main text (lines 90-94, 369-370, Figure 2 caption) and methods (line 561), emphasize its importance. As the reviewer points out, this is a simplifying assumption and does not fully reflect the biology because not all synapses are reciprocal in the true system. We also note that our synaptic plasticity model does not break the reciprocity assumption: all connections added or pruned during learning remain reciprocal. As a result, the disynaptic connectivity matrix (Bottom panel below, MCs sorted by stimulus as shown in the top panel) is always symmetric.

      We have now made these statements explicit in the main text and in the methods. Regarding functional consequences of this assumption, earlier work by our group has examined the impact of the degree of reciprocity of MC-GC synapses in a similar OB model (Chow, Wick & Riecke, Plos Comp Bio 2012). The study examined three different changes in reciprocity by (1) redirecting a fraction of the inhibitory connections of each GC to randomly chosen MCs instead of the MCs that drive that GC, (2) allowing heterogeneity in reciprocal weights so that there is no relationship between the strength of the MC -> GC synapse and the GC -> MC synapse, (3) reducing the level of self-inhibition a MC receives from the GCs that it excites. The model was found to be quite robust to each of these manipulations, suggesting that our present model likely remains functionally relevant even if biological reciprocity is partial. We reference this work now in the discussion, lines 490-492.

      Author response image 2.

      Disynaptic connectivity. Top: MC activity in response to the two stimuli, sorted by MC selectivity. Bottom: Disynaptic connectivity matrix (diagonal subtracted).

      (4) How were mitral cells sorted in Figure 2H? This needs to be explained.

      (5) Directly related to the point above: the text mentions that synaptic connectivity between GCs of the "learning cluster" and mitral cells (which direction?) is increased for mitral cells responding by enrichment odors, but this is not shown in the figure. This statement suggests that mitral cells sorted to the bottom of the y-axis respond more strongly to enrichment odors, but the information is not given directly. Please provide more information to back up your statements.

      Indeed as the reviewer inferred, MCs in Figure 2H were sorted so that those that receive the strongest stimulation from the odor were at the bottom of the y-axis. We have clarified this in the Figure 2 caption and added a subplot to Figure 2H showing the average MC input to make this more explicit.

      (8) Apoptosis (Figure 4 and related text): paragraph 231ff is somewhat difficult to comprehend because the "number" of enrichments should really be the "frequency" of enrichments. In Figure 4, it is not mentioned explicitly that each enrichment is with different random new odors.

      We agree that the term “number” of enrichments was imprecise and have revised the text to refer instead to the frequency of enrichment events (Lines 255-267). We also clarified that in Figure 4, each enrichment corresponds to a different set of randomly sampled odors, and we now state this explicitly in both the Figure 4 legend and main text (Lines 260-261).

      (9) Apoptosis: apoptosis improves memory but the underlying reason remains opaque. A simple prediction of the data in Figure 4D and 4E is that the number of GCs in 4E. It would be helpful to show this. Furthermore, an obvious question that arises is whether a higher frequency of enrichments improves memories because the total number of granule cells is kept low, or because granule cells are removed specifically based on their activity (or both). This could be addressed easily by artificially removing a random subset of granule cells in a simulation such as 4E to match granule cell numbers to the case in 4D.

      Apoptosis improves learning is because it reduces the total inhibition in the network by removing GCs and thus prevents deficits in learning that occur in Fig. 2G as GCs accumulate in the network. As the reviewer inferred, the number of GCs in Figure 4D is lower than in 4E and this is now clarified in the text. This difference was shown implicitly in Supplementary Figure S4D (previously S3D), but we now explicitly reference this plot to support this point as well (Line 266).

      As the reviewer notes, there is a question in whether increased enrichment frequency improves memory because it limits the total number of GCs, or because apoptosis selectively removes GCs based on their activity, or both. Our model supports both mechanisms. Importantly, simply reducing GC numbers through random deletion will degrade existing memories: random removal erodes memory representations encoded by those GCs. In contrast, our age and activity dependent apoptosis rule targets a specific cohort of adult-born GCs. This selective removal minimizes damage to existing memories encoded by GCs outside of this cohort while keeping GC numbers within a regime that supports robust learning (as shown in Figure 2G).

      However, we note that if enrichment frequency becomes too high, even recent memories can be lost due to premature pruning of GCs that have not yet stabilized their synaptic connections. This tradeoff has been shown experimentally (Forest et al., Nat Comm 2019) which we reproduce in our model (Figure S4).

      (10) Text related to Figure 5: "Learning flexibility...approached a steady state when the growth of the network started to saturate". Please show the growth (better: size) of the network (total number of GCs) for these simulations (and other panels in Figure 5). It would also be useful to show the total number of GCs in other figures (e.g. Figure 4; see above).

      We have now added a supplementary figure (Figure S6) that shows the total number of GCs over time for the simulations presented. This confirms that the network size approaches a steady state around the same time that learning flexibility begins to plateau, as noted in the original text (now line 275), and highlights the large number of GCs without apoptosis as well as the slightly reduced number of GCs in the permanent encoding model (line 312).

      (11) As much as I appreciate the comprehensive discussion of the results in a broader context, I feel that the discussion can be somewhat shortened. The section on lateral inhibition is not fully valid given that synaptic connectivity is reciprocal. I also feel that much of the final section (Model assumptions and outlook) can be dropped (except for the last paragraph), not because anything is irrelevant, but because these points have been made, onen repeatedly, in the text above.

      We agree that the discussion could be streamlined and have revised the manuscript accordingly. Specifically, we have shortened the section on lateral inhibition and clarified that the OB relies predominantly on reciprocal connectivity (Line 370). We also agree that parts of the final section were repetitive and have removed these. However, to address comments by Reviewer 3, we also expanded on some of the model assumptions. We thank the reviewer for helping us improve the clarity and focus of the manuscript.

      (12) Figure 5: bolding every 5th curve is confusing.

      We have adjusted our figure accordingly.

      (13) "...we biased the dendritic field...": it would be helpful to explain the idea of a "dendritic field" in a bit more detail prior to this sentence.

      We have now noted that GC’s "dendritic field" refers to the subset of MCs with which it is capable of forming synaptic connections when we initially describe the model (Line 97).

      Reviewer #3:

      (1) The authors find that a network with age-dependent synaptic plasticity outperforms one with constant age-independent plasticity and that having more GC per se is not sufficient to explain this effect. In addition, having an initial higher excitability of GCs leads to increased performance. To what degree the increased excitability of abGCs is conceptually necessarily independent of them having higher synaptic plasticity rates / fast synapses?

      We thank the reviewer for this question, as the difference between excitability and plasticity rate in memory formation is something we intended to highlight in this study. We have updated the (Lines 157-198) to clarify this.

      At the cellular level, a neuron's excitability and its rate of synaptic plasticity are mechanistically distinct: excitability is governed by factors such as ion channel expression or membrane resistance, whereas plasticity rates are influenced by molecular pathways involved in synapse and dendritic spine formation and remodeling. While these are independent properties, they are functionally coupled: most synaptic plasticity rules are activity-dependent, so greater excitability can increase the likelihood of plasticity being induced but does not itself guarantee learning.

      Our model reflects this distinction. Increased excitability biases which neurons become activated and thus eligible to undergo plasticity, but actual learning still depends on the plasticity rate itself. This can be seen by comparing the model constant plasticity and excitability (solid blue and green curves in Figure 2C) to the model with only transient excitability (solid blue and green lines in Figure 2E). In both cases, the strength and duration of the memory remain limited by the plasticity rate. We note additionally that, in this network, neurons compete to learn new stimuli: as GCs start to learn, they suppress MC activity through recurrent inhibition which suppresses learning in other GCs who otherwise would have been in position to learn the odor. As a result there is not a significant increase in the overall number of neurons recruited to learn (Figure 2J). In a different network architecture, such as a feedforward network, we would not expect this to be the case; greater excitability in a population of neurons would likely increase the memory by increasing the number of neurons recruited to learn. Transiently enhanced excitability biases which neurons join the memory engram (Figure 2J), but the extent and rate of learning still depend on the plasticity rates themselves. We did note in the original text (now lines 284-286) that this bias in recruitment subtly increases memory stability, but the extent is not great. In principle, a model can be engineered to rely on transiently increased excitability to encode memories in orthogonal subpopulations of neurons and that this could resolve the flexibility-stability dilemma. However, in that case, the number of memories that can be stored within a short time would be bounded by the size of this subpopulation such that even if a large number of odors are presented, mature GCs cannot become part of the engram and the network would likely fail to learn the stimuli. However, when this was tested experimentally (Forest et al. Cereb Cor. 2020), it was found that mature GCs participated in the engram when the number of odors was sufficiently high. Our results are consistent with these experiments: for complex odor environments, neonatal GCs, which are mature during odor exposure, and abGCs both participate in the engrams.

      Author response image 3.

      Simulating learning in more complex odor environments. Top: enrichment consisted of three odor pairs presented sequentially in a random order. Bottom: enrichment consisted of five odor pairs. Left: discriminability of the odor pairs over time. Middle: connectivity between MCs (sorted by odor selectivity) and GCs (sorted by age). In both cases AbGCs develop a clear connectivity structure. In more complex environments neonatal GCs also start to develop a clear connectivity structure. Right: combined engram membership across all stimuli by GC age.

      In sum, transiently increased excitability alone will not make learning any faster, so a fast learning system must have a high plasticity rate. If this plasticity rate stays high, then memories stored in these neurons, even if no longer highly excitable, will be vulnerable as the neurons can still be driven above their plasticity threshold by moderately interfering stimuli and will thus be quickly forgotten. Conversely, if the reviewer is wondering if a greater increase in the plasticity rate of new neurons can compensate for a lack of excitability, this is not the case: if a newborn neuron is not sufficiently driven by the stimulus it will not learn regardless of how high its plasticity rate is.

      (2) The authors do not mention previous theoretical work on the specificity of mitral to granule cell interactions from several groups (Koulakov & Rinberg - Neuron, 2011; Gilra & Bhalla, PLoSOne, 2015; Grabska-Bawinska...Mainen, Pouget, Latham, Nat. Neurosci. 2017; Tootoonian, Schaefer, Latham, PLoS Comput. Biol., 2022), nor work on the relevance of top-down feedback from the olfactory cortex on the abGC during odor discrimination tasks (Wu & Komiyama, Sci. Adv. 2020), or of top-down regulation from the olfactory cortex on regulating the activity of the mitral/tuned cells in task engaged mice (Lindeman et al., PLoS Comput. Biol., 2024), or in naïve mice that encounter odorants (in the absence of specific context; Boyd, et al., Cell Rep, 2015; Otazu et al., Neuron 2015, Chae et al., Neuron, 2022). In particular, the presence of rich topdown control of granule cell activity (including of abGCs) puts into question the plausibility of one of the opening statements of the authors with respect to relying solely on local circuit mechanisms to solve the flexibility-stability dilemma. I think the discussion of this work is important in order to put into context the idea of specific interactions between the abGCs and the mitral cells.

      We thank the reviewer for these detailed and thorough comments, and whole-heartedly agree that it is important to discuss the listed studies in order to contextualize our work through the broader lens of how information is processed in the OB. We have expanded our discussion to further acknowledge and integrate insight from previous theoretical and experimental work cited by the reviewer. (Lines 361-366, 493-550)

      Regarding the importance of top-down feedback, we of course recognize that in practice cortical inputs play a critical role in abGC survival and synaptic integration. However, its nature is not quite clear and is likely variable across behavioral seungs. In the paradigm that we study in the manuscript, there is likely no key reward value or contextual signal that is relayed to the OB. One plausible interpretation is that in this task, cortical feedback provides a random, variable baseline excitatory drive to GCs. This would likely be consistent with many of the listed studies, e.g.

      (1) Glomerular layer targeting of feedback would be explicitly unrelated to glomerular odor specificity, as in Boyd et al.

      (2) GC activity would decrease if these cortical inputs were silenced, resulting in stronger MC responses as in Otazu et al., Chae et al.

      (3) Silencing PCx during learning would prevent GCs from reaching activity-dependent plasticity thresholds, resulting in decreased spine density as in Wu & Komiyama.

      Likewise activating PCx would lead to increased spine density.

      In this interpretation, the effect of top-down input could be captured implicitly by adjusting model parameters such as activity or plasticity thresholds. For the purposes of our study, we opted to neglect these inputs in favor of model simplicity.

      Critically, even if top-down inputs play a substantially larger role, by perhaps even going as far as providing signals to abGCs to modulate their development, the core solution to the flexibility-stability dilemma that we describe stays local: we predict that the memory persists in the same network in which it was formed.

      (3) To what the degree of specific connectivity reflects a specific stimulus configuration, and is a good proxy for determining the stimulus discriminability and memory capacity in terms of temporal activity patterns (difference in latency/phase with respect to the respiration cycle, etc.) which may account to a substantial fraction of ability to discriminate between stimuli? The authors mention in the discussion that this is, indeed, an upper bound and specific connectivity is necessary for different temporal activity patterns, but a further expansion on this topic would help in understanding the limitations of the model.

      We thank the reviewer for raising this important point. Indeed, there have been several recent experimental studies indicating that much of the information needed for olfactory discrimination is encoded in the temporal activity patterns of mitral and tuned cells. Our model does not explicitly simulate these dynamics. It was for this reason that we defined memory in terms of the learned structure of the network rather than by firing rate activity. This is motivated by the idea that learned patterns of connectivity constrain the space of neural activity the network can support, and thus shape stimulus responses. We now make this limitation more explicit in the discussion and clarify that the specific MC–GC connectivity we analyze should be seen as a structural substrate that constrains the possible temporal transformations the network could support (Lines 492-506).

      (4) Reward or reward prediction error signals are not considered in the model. They however are ubiquitous in nature and likely to be encountered and shape the connectivity and activity patterns of the abGC-mitral cell network. Including a discussion of how the model may be adjusted to incorporate reward/error signals would strengthen the manuscript.

      We appreciate the reviewer’s suggestion and agree that reward and reward prediction error signals are critical components of many learning paradigms. We deliberately chose not to model associative learning, reward signals or top-down neuromodulation in this work. Our goal is to investigate the role of adult neurogenesis in a regime where its contribution has been shown to be experimentally necessary. Specifically, we focused on an unsupervised perceptual learning paradigm where adult neurogenesis is required for successful odor discrimination (Moreno et al. PNAS, 2008). In contrast, when the same odors are used in a rewarded learning paradigm, performance remains intact even when adult neurogenesis is ablated (Imayoshi et al., Nat. Neuro., 2008). This dissociation suggests that neurogenesis is dispensable in contexts where reward can guide learning. As such, we argue that isolating the contribution of local circuit dynamics in an unsupervised setting is critical to understanding what neurogenesis is uniquely enabling, especially given the evolutionary cost of maintaining it.

      We agree that extending this work to incorporate reward-driven plasticity or neuromodulatory influences would be a valuable direction for future research. In particular, it could help clarify how different learning paradigms engage distinct abGC cohorts (e.g., Mandairon et al., eLife 2018; Wu & Komiyama, Sci. Adv. 2020), and how task structure shapes memory allocation and engram composition. We have incorporated this into the discussion regarding extending our model to include top down feedback (lines 539-553).

      Specific comments

      (1) Lines 84-86; 507-509; Eq(3): Sensory input is defined by a basal parameter of MCs spontaneous activity (Sspontaneus) and the odor stimuli input (Siodor) but is not clear from the main text or methods how sensory inputs (glomerular patterns) were modeled

      We now clarify in the Methods section "Stimulus model" how the sensory inputs were modeled. Specifically, odor-evoked inputs to mitral cells (Siodor) were generated either as Gaussian profiles across the mitral cell population (Figs. 2,3) or as sparser random patterns (Figs. 4,5). In Figures 2 and 3, the denser Gaussian stimuli require more GCs to learn the odors, aiding in visualization of the connectivity matrix (Figure 2H) and abGC recruitment plots (Figure 2I,J; Figure 3C,E). However, real olfactory stimuli activate a sparse set of MCs, so in Figures 4 and 5 where we address learning of many stimuli, we utilize sparser, binary, stimuli delivered to only 10% of MCs, in range of experimental data (Wachowiak and Cohen, Neuron, 2001). The fact that the stimuli are binary, however, is not realistic and leads to denser representations. This leads to a worst-case scenario for the model as denser memory representations are easier to overwrite. These points has been added explicitly to the Methods section "Stimulus model" to improve clarity.

      (2) Lines 118-122: The used perceptual learning task explanation is done only in the context of the discriminability of similar artificial stimuli using the Fisher discriminant and "Memory" metric. A detailed description of the logic of the perceptual learning task methods and objective, taking into account Comment 1, would help to better understand the model.

      We thank the reviewer for pointing out had not adequately described the task and have updated the main text (lines 125-132) and included a new methods section "Perceptual learning task" to describe it more explicitly. The experiments that inspired the simulation followed an ecological model of discrimination learning (Moreno et al. PNAS 2009): For one hour a day over a ten day "enrichment period", two tea balls containing similar but distinct odors were suspended from the lid of each mouse's home cage. The mice engaged with the stimuli under self-directed conditions, therefore learning through natural experience. As a result the mice use olfactory information to discriminate between the similar stimuli, a skill potentially relevant for navigation or social behaviors.

      In our simulations, we model these experiments as follows. During the enrichment period, the model is stimulated with a randomly selected stimulus chosen from a set of two similar stimuli, corresponding to a mouse choosing to sniff one of the tea balls. During enrichment, in between these bouts of "sniffing", the model only receives spontaneous activity, reflecting the temporal sparsity of sensory input even over the enrichment period. Outside of enrichment, the model again receives only spontaneous input.

      (3) Rapid re-learning of forgotten odor pair is enabled by sensory-dependent dendritic elaboration of neurons that initially encoded the odors and the observed re-learning would occur even if neurogenesis was blocked following the first enrichment and even though the initial learning did require neurogenesis. When this would ever occur in nature? The re-learning of an odor period? Why is this highlighted in the study?

      We believe that this sort of learning is certainly relevant in nature. To clarify: by “learning,” we do not refer to the memory of an entire “odor period”, but simply an altered mapping of specific stimuli. Therefore, forgeung could occur if these specific stimuli are absent from the environment for a period of time, and re-learning would occur when these stimuli are re-encountered. Natural odor environments are highly dynamic, as environmental conditions and social contexts change over time. The odors an animal encounters also depend strongly on its own behavior; as it explores different environments, it may be exposed to particular odors intermittently: it could encounter them in one location, then not return to that location for some time before returning again.

      Such natural variability in odor exposure makes the ability to forget and re-learn especially valuable, allowing the animal to prioritize relevant information while maintaining flexibility. To this end, we show in Figure 5G that the synaptic forgetting of odors is beneficial to the performance of the model because it reduces interference in the network. Therefore we highlight that re-learning enabled by adult neurogenesis is a highly efficient strategy for memory storage and retrieval, which is why he emphasize it in this study.

      (4) Figure 2A: I understand that the ages shown at the bottom of the colored boxes represent the GC age. If so, find a better way to express that to avoid confusing 'GC ages' from the days shown in the perceptual learning task description (Figure 2B).

      We have updated the text in the figure to disambiguate the two and refer to the “days” shown in the perceptual learning task description now as “time relative to enrichment”

      (5) Figure 2B: Clarify how the two-dimensional arrays are arranged to represent the patterns shown. Does each point of the array represent one neuron? If so, are these neurons re-arranged to help the readers visually differentiate patterns A and B? Are the patterns of activity of MCs in the model spatially and temporally sparse as observed in experimental work?

      In Figure 2B, each point in the two-dimensional array represents the activity of a single mitral cell. The layout is purely for visualization—neurons are re-arranged to make the differences between odor patterns A and B visually apparent. This ordering does not reflect anatomical position or model architecture. We revised the Figure 2 caption to say this explicitly.

      Regarding spatial sparseness, as we mentioned in the response to the reviewer’s comment (1), the activity of mitral cells in response to odors is spatially sparse in the model. Regarding temporal sparseness, while the model is not spiking and does not include temporal dynamics within the timescale of the breath, however, odor input is delivered in discrete, odorspecific epochs interleaved with periods of no input, which leads to temporally structured activity patterns. This information has been made explicit in the new methods sections "Stimulus model" and "Perceptual learning task"

      (6) Figure 3C and Line 189: potential confusion between the color code mentioned in the legend for the enrichment and developing periods.

      It appeared to be a confusion in the text and has been corrected (Lines 212-213).

      (7) Figure 5F: For clarity, this would benefit from replacing the bold line with areas in the plot to depict the enrichment periods.

      We agree that replacing the bolded line segments with shaded areas is more clear and have updated the figure accordingly, and appreciate the reviewer's suggestion to clarify the figure.

      (8) Lines 380, 416: Potential role of cortical feedback and or neuromodulation depending on behavioral relevance or permanent exposure? Later mentioned in Lines 467 - 474.

      We have updated the text to acknowledge the role of potential cortical feedback and neuromodulation, now in lines 403-407.

    1. Author Response

      The following is the authors’ response to the current reviews.

      Response to Reviewer Comments:

      We thank the editors and reviewers for their careful consideration of our revised manuscript. Reviewers 2 and 3 indicated that their previous comments had been satisfactorily addressed by our revisions. Reviewer 1 raised several points and our point by point responses can be found below.

      Reviewer #1 (Recommendations For The Authors):

      1) Please clarify the terminology of spontaneous recovery in your study.

      According to Rescorla RA 2004 ( http://www.learnmem.org/cgi/doi/10.1101/lm.77504.), he defines spontaneous recovery as "with the passage of time following nonreinforcement, there is some "spontaneous recovery" of the initially learned behavior. ". So in this study, I thought Test2 is spontaneous recovery while the Test1 is extinction test as most studies do. But authors seem to define spontaneous recovery from the last trial of Extinction3 to the first trial of Test1, which is confusing to me.

      We agree with the reviewer (and Rescorla, 2004) that spontaneous recovery is defined as the return of the initially learned behaviour after the passage of time. In our study, Test 1 is conducted 24-hours after the final extinction session (Extinction 3) and in our view, the return of responding following that 24-hour delay can be considered spontaneous recovery. Rescorla (2004 and elsewhere) also points out that the magnitude of spontaneous recovery may be greater with larger delays between extinction and testing. This in part motivated our second test 7 days following the last extinction session with optogenetic manipulation. We did not find evidence of greater spontaneous recovery in the test 7 days later, however, the additional extinction trials in Test 1 may have reduced the opportunity to detect such an effect.

      2) Why are E6-8 plots of Offset group in Figure 3E and F different?

      We apologise for this error and have corrected it. This was an artifact of an older version of the figure before final exclusions. The E6-8 data is now the same for panels 2E and 2F.

      3) Related to 2, Please clarify what type of data they are in Figure3E,F Figure5H, and I . If it's average, please add error bars. Also, it's hard to see the statistical significance at the current figure style.

      The data in these panels are the mean lever presses per trial as labeled on the y-axis of the figures. In our view, in this instance, error bars (or lines and other markers of significance) detract from the visual clarity of the figure. The statistical approach and outcomes are included in the figure legend and when presented alongside the figure in the final version of the paper should directly clarify these points.

      Reviewer #2 (Recommendations For The Authors):

      The authors have addressed my previous comments to my satisfaction.

      Reviewer #3 (Recommendations For The Authors):

      The authors have adequately addressed each of the points raised in my original review. The paper will make a nice contribution to the field.


      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations For The Authors):

      • It would be interesting if the authors would do calcium imaging or electrophysiology from LCNA neurons during appetitive extinction.

      Indeed these are interesting ideas. We have plans to pursue them but ongoing work is not yet ready for publication.

      • LC-NA neuronal responses during the omission period seem to be important for appetitive extinction as described in the manuscript (Park et al., 2013; Sara et al., 1994; Su & Cohen 2022). It would be nice to activate/inactivate LC-NA neurons during the omission period.

      Optogenetic manipulation was given for the duration of the stimulus (20 seconds; when reward should be expected contingent upon performance of the instrumental response). We believe the reviewer is suggesting briefer manipulation only at the precise time the pellet would have been expected but omitted. If so, the implementation of that is complex because animals were trained on random ratio schedules and so when exactly the pellet(s) was earned was variable and so when precisely the animal experiences “omission” is difficult to know with better temporal specificity than used in the current experiments. But we agree with the reviewer that now we see that there is an effect of LC manipulation, in future studies we could alter the behavioral task so that the timing of reward is consistent (e.g., train the animals with fixed ratio schedules or continuous reinforcement, or use a Pavlovian paradigm) where a reasonable assertion about when the outcome should occur, and thus when its absence would be detected, can be made and then manipulation given at that time to address this point.

      • Does LC-NA optoinhibition affect the expression of the conditioned response (the lever presses at early trials of Extinction 1)? It's hard to see this from the average of all trials.

      The eNpHR group responded numerically less overall during extinction. This effect appears greatest in the first extinction session, but fails to reach statistical significance [F(1,15)= 3.512, p=0.081]. Likewise, analysis of the trial by trial data for the first extinction session failed to reveal any group differences [F(1,15)= 3.512, p=0.081] or interaction [trial x group; F(1,15)=0.550, p=0.470].

      Comparison of responding in the first trial also failed to reveal group differences [F(1.15)=1.209, p=0.289]. Thus while there is a trend in the data, this is not borne out by the statistical analysis, even in early trials of the session.

      • While the authors manipulate global LC-NA neurons, many people find the heterogeneous populations in the LC. It would be great if the authors could identify the subpopulation responsible for appetitive extinction.

      We agree that it would be exciting to test whether and identify which subpopulation(s) of cells or pathway(s) are responsible for appetitive extinction. While related work has found that discrete populations of LC neurons mediate different behaviours and states, and may even have opposing effects, our initial goal was to determine whether the LC was involved in appetitive extinction learning. These are certainly ideas we hope to pursue in future work.

      Minor:

      • Why do the authors choose 10Hz stimulation?

      The stimulation parameters were based on previously published work. We have added these citations to the manuscript.

      Quinlan MAL, Strong VM, Skinner DM, Martin GM, Harley CW, Walling SG. Locus Coeruleus Optogenetic Light Activation Induces Long-Term Potentiation of Perforant Path Population Spike Amplitude in Rat Dentate Gyrus. Front Syst Neurosci. 2019 Jan 9;12:67. doi: 10.3389/fnsys.2018.00067. PMID: 30687027; PMCID: PMC6333706.

      Glennon E, Carcea I, Martins ARO, Multani J, Shehu I, Svirsky MA, Froemke RC. Locus coeruleus activation accelerates perceptual learning. Brain Res. 2019 Apr 15;1709:39-49. doi: 10.1016/j.brainres.2018.05.048. Epub 2018 May 31. PMID: 29859972; PMCID: PMC6274624.

      Vazey EM, Moorman DE, Aston-Jones G. Phasic locus coeruleus activity regulates cortical encoding of salience information. Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9439-E9448. doi: 10.1073/pnas.1803716115. Epub 2018 Sep 19. PMID: 30232259; PMCID: PMC6176602.

      • The authors should describe the behavior task before explaining Fig1e-g results.

      We agree that introducing the task earlier would improve clarity and have added a brief summary of the task at the beginning of the results section (before reference to Figure 1) and point the reader to the schematics that summarize training for each experiment (Figures 2A and 4D).

      NOTE R2 includes specific comments in their Public review. We have considered those as their recommendations and address them here.

      1) In such discrimination training, Pavlovian (CS-Food) and instrumental (LeverPress-Food) contingencies are intermixed. It would therefore be very interesting if the authors provided evidence of other behavioural responses (e.g. magazine visits) during extinction training and tests.

      In a discriminated operant procedure, the DS (e.g. clicker) indicates when the instrumental response will be reinforced (e.g., lever-pressing is reinforced only when the stimulus is present, and not when the stimulus is absent). This is distinct from something like a Pavlovianinstrumental transfer procedure and so we wish to just clarify that there is no Pavlovian phase where the stimuli are directly paired with food. After a successful lever-press the rat must enter the magazine to collect the food, but food is only delivered contingency upon lever-pressing and so magazine entries here are not a clear indicator of Pavlovian learning as they may be in other paradigms.

      Nonetheless, we have compiled magazine entry data which although not fully independent of the lever-press response in this paradigm, still tells us something about the animals’ expectation regarding reward delivery.

      For the ChR2 experiment, largely paralleling the results seen in the lever-press data, there were no group differences in magazine responses at the end of training [F(2,40)=2.442, p=0.100].

      Responding decreased across days of extinction (when optogenetic stimulation was given) [F(2, 80)=38.070, p<0.001], but there was no effect of group [F(2,40)=0.801, p=0.456] and no interaction between day and group [F(4,40)=1.461, p=0.222]. Although a similar pattern is seen in the test data, group differences were not statistically different in the first [F(2,40)=2.352, p=0.108] or second [F(2,40)=1.900, p=0.166] tests, perhaps because magazine responses were quite low. Thus, overall, magazine data do not present a different picture than lever-pressing, but because of the lack of statistical effects during testing, we have chosen not to include these data in the manuscript.

      For the eNpHR experiment, again a similar pattern to lever-pressing was seen. There were no group differences at the end of acquisition [F(1,15)=0.290, p=0.598]. Responding decreased across days of extinction [F(2, 30)=4.775, p=0.016] but there was no main effect of group [F(1,15)=1.188, p=0.293], and no interaction between extinction and group [F(2,30)=0.070, p=0.932]. There were no group differences in the number of magazine entries in Test 1 [F(1,15)=1.378, p=0.259] or Test 2 [F(1,15)=0.319, p=0.580].

      Author response image 1.

      Author response image 2.

      2) In Figure 1, the authors show the behavioural data of the different groups of control animals which were later collapsed in a single control group. It would be very nice if the authors could provide the data for each step of the discrimination training.

      We are a little confused by this comment. Figure 1, panels E, F, and G show the different control groups at the end of training, for each day of extinction (when manipulations occurred) and for each test, respectively. It’s not clear if there is an additional step the reviewer is interested in? We note neural manipulation only occurred during extinction sessions.

      We chose to compare the control groups initially, and finding no differences, to collapse them for subsequent analyses as this simplifies the statistical analysis substantially; when group differences are found, each of the subgroups has to be investigated (including the different controls means there are 5 groups instead of 3). It doesn’t change the story because we tested that there were not differences between controls before collapsing them, but collapsing the controls makes the presentation of the statistical data much shorter and easier to follow.

      3) Inspection of Figures 2C & 2D shows that responding in control animals is about the same at test 2 as at the end of extinction training. Therefore, could the authors provide evidence for spontaneous recovery in control animals? This is of importance given that the main conclusion of the authors is that LC stimulation during extinction training led to an increased expression of extinction memory as expressed by reduced spontaneous recovery.

      To address this we have added analyses of trial data, specifically comparison of the final 3 trials of extinction to the subsequent three trials of each test. These analyses are included on page 5 of the manuscript and additional data figures can be found as panels 2E and 2F and pasted below.

      What we observe in the trial data for controls is an increase in responding from the end of extinction to the beginning of each test, thus demonstrating spontaneous recovery. Importantly, responding in the ChR2 group does not increase from the end of extinction to the beginning of the test, illustrating that LC stimulation during extinction prevents spontaneous recovery.

      Comparison of the final three trials of Extinction to the three trials of Test 1:

      Author response image 3.

      Comparison of the final three trials of Extinction to the three trials of Test 2:

      Author response image 4.

      Halorhodopsin Experiment Tests 1 and 2, respectively.

      Author response image 5.

      4) Current evidence suggests that there are differences in LC/NA system functioning between males and females. Could the authors provide details about the allocation of male and female animals in each group?

      More females had surgical complications (excess bleeding) than males resulting in the following allocations; control group; 14 males and 8 females; ChR2 group 8 males and 7 females; offset 6 males.

      In our dataset, we did not detect sex differences in training [no main effect of sex: F(1,38)=1.097, p=0.302, sex x group interaction: F(1,38)= 1.825, p=0.185], extinction [no effect of sex; F(1,38)=0.370, p=0.547; no sex x extinction interaction: F(2,76)=0.701, p=0.499 ; no sex x extinction x group interaction: F(2,76)=2.223, p=0.115] or testing [Test 1 no effect of sex: F(1,38)=1.734, =0.196; no sex x group interaction: F(1,38)=0.009, p=0.924; Test 2 no effect of sex: F(1,38)=0.661, p=0.421; no sex x group interaction: F(1,38)=0.566, p=0.456].

      5) The histology section in both experiments looks a bit unsatisfying. Could the authors provide more details about the number of counted cells and also their distribution along the anteroposterior extent of the LC. Could the authors also take into account the sex in such an analysis?

      The antero-posterior coordinates used for cell counts and calculation of % infection rates were between -9.68 and -10.04 (Paxinos and Watson, 2007, 6th Edition) as infection rates were most consistent in this region and it was well-positioned relative to the optic probe although TH and mCherry positive cells were observed both rostral and caudal to this area. For each animal, an average of ~116+/- 25 TH-positive LC neurons as determined by DAPI and GFP positive cells were identified. Viral expression was identified by colocalized mCherry staining. Animals that did not have viral expression in the LC were not included in the experimental groups. We have added these details to the histology results on page 4.

      Males and females showed very similar infection rates (Males, 74%; Females, 72%). While sex differences, such as total number of LC cells or total LC volume have been reported (Guillamon, A. et al. 2005), Garcia-Falgueras et al. (2005) reported no differences in LC volume or number of LC neurons between male and female Long-Evans rats. So while differences may exist in the LC of Long-Evans rats, the cell counts here were comparable between groups (males, 103 +/- 27; females, 129 +/- 17; t-test, p>0.05).

      References:

      1) Garcia-Falgueras, A., Pinos, H., Collado, P., Pasaro, E., Fernandez, R., Segovia, S., & Guillamon, A. (2005). The expression of brain sexual dimorphism in artificial selection of rat strains. Brain Research, 1052(2), 130–138. https://doi.org/10.1016/j.brainres.2005.05.066

      2) Guillamon, A., De Bias, M. R., & Segovia, S. (1988). Effects of sex steroids on the of the locus coeruleus in the rat. Developmental Brain Research, 40, 306–310.

      Reviewer #3 (Recommendations For The Authors):

      MAJOR

      1) It is worth noting that responding in Group ChR2 decreased from Extinction 3 to Test 1, while responding in the other two groups appears to have remained the same. This suggests that there was no spontaneous recovery of responding in the controls; and, as such, something more must be said about the basis of the between-group differences in responding at test. This is particularly important as each extinction session involved eight presentations of the to-betested stimulus, whereas the test itself consisted of just three stimulus presentations. Hence, comparing the mean levels of performance to the stimulus across its extinction and testing overestimates the true magnitude of spontaneous recovery, which is simply not clear in the results of this study. That is, it is not clear that there is any spontaneous recovery at all and, therefore, that the basis of the difference between Group ChR2 and controls at test is in terms of spontaneous recovery.

      The reviewer is correct that there were a different number of trials in extinction vs. test sessions making direct comparison difficult and displaying the data as averages of the test session does not demonstrate spontaneous recovery per se. To address this we have added analyses of trial data and comparison of the final 3 trials of extinction to the subsequent three trials of each test. These analyses are included on page 5 and 6 of the manuscript and additional data figures can be found as panels 2E and 2F and 4 H and I, and pasted below.<br /> What we observe in the trial data for controls is an increase in responding from the end of extinction to the beginning of each test, thus demonstrating spontaneous recovery. Importantly, responding in the ChR2 group does not increase from the end of extinction to the beginning of the test, illustrating that LC stimulation during extinction prevents spontaneous recovery.

      Comparison of the final three trials of Extinction to the three trials of Test 1:

      Author response image 6.

      Comparison of the final three trials of Extinction to the three trials of Test 2:

      Author response image 7.

      Halorhodopsin Experiment Tests 1 and 2, respectively.

      Author response image 8.

      2a) Did the manipulations have any effect on the rates of lever-pressing outside of the stimulus?

      We did not detect any effect of the optogenetic manipulations on rates of lever pressing outside of the stimulus. This is demonstrated in the pre-CS intervals collected on stimulation days (i.e., extinction sessions) where we see similar response rates between controls and the ChR2 and Offset groups as shown below. There was no effect of group [F(2,40)=0.156, 0.856] or group x extinction day interaction [F(2,40)=0.146, p=0.865].

      Author response image 9.

      2b) Did the manipulations have any effect on rates of magazine entry either during or after the stimulus?

      For the ChR2 experiment, there were no group differences in magazine responses at the end of training [F(2,40)=2.442, p=0.100]. Responding decreased across days of extinction (when optogenetic stimulation was given) [F(2, 80)=38.070, p<0.001], but there was no effect of group [F(2,40)=0.801, p=0.456] and no interaction between day and group [F(4,40)=1.461, p=0.222]. Although a similar pattern is seen in the test data, group differences were not statistically different in the first [F(2,40)=2.352, p=0.108] or second [F(2,40)=1.900, p=0.166] tests, perhaps because magazine responses were quite low. Thus, overall, magazine data do not present a different picture than lever-pressing, but because of the lack of statistical effects during testing, we have chosen not to include these data in the manuscript.

      For the eNpHR experiment, again a similar pattern to lever-pressing was seen. There were no group differences at the end of acquisition [F(1,15)=0.290, p=0.598]. Responding decreased across days of extinction [F(2, 30)=4.775, p=0.016] but there was no main effect of group [F(1,15)=1.188, p=0.293], and no interaction between extinction and group [F(2,30)=0.070, p=0.932]. There were no group differences in the number of magazine entries in Test 1 [F(1,15)=1.378, p=0.259] or Test 2 [F(1,15)=0.319, p=0.580].

      Author response image 10.

      Author response image 11.

      2c) Did the manipulations affect the coupling of lever-press and magazine entry responses? I imagine that, after training, the lever-press and magazine entry responses are coupled: rats only visit the magazine after having made a lever-press response (or some number of leverpress responses). Stimulating the LC clearly had no acute effect on the performance of the lever-press response. If it also had no effect on the total number of magazine entries performed during the stimulus, it would be interesting to know whether the coupling of lever-presses and magazine entries had been disturbed in any way. One could assess this by looking at the jointdistribution of lever-presses (or runs of lever-presses) and magazine visits in each extinction session, or across the three sessions of extinction. As a proxy for this, one could look at the average latency to enter the magazine following a lever-press response (or run of leverpresses). Any differences here between the Controls and Group ChR2 would be informative with respect to the effects of the LC manipulations: that is, the results shown in Figure indicate that stimulating the LC has no acute effects on lever-pressing but protects against something like spontaneous recovery; whereas the results shown in Figure 4 indicate that inhibiting the LC facilitates the loss of responding across extinction without protecting against spontaneous recovery. The additional data/analyses suggested here would indicate whether LC stimulation had any acute effects on responding that might explain the protection from spontaneous recovery; and whether LC inhibition specifically reduced lever-pressing across extinction or whether it had equivalent effects on rates of magazine entry.

      Lever-press and magazine response data were collected trial by trial but not with the temporal resolution required for the analyses suggested by the reviewer. We do not have timestamps for magazine entries nor latency data. We can collect this type of data in future studies. At the session or trial level, magazine entries generally correspond to lever-pressing; being trained on ratio schedules, and from informal observation, rats will do several lever-presses and then check the magazine. Rates of each decrease across extinction (magazine data included in response to comment 2b. above). Optogenetic manipulation appeared to have no immediate effect on either response during extinction.

      ROCEDURAL

      1) Why were there three discriminative stimuli in acquisition: a light, white noise, and clicker?

      This was done to be consistent with and apply parameters similar to previous, related studies (Rescorla, 2006; Janak & Corbit, 2011) and to allow comparison to potential future studies that may involve stimulus compounds etc. (requiring training of multiple stimuli).

      2) Why were some rats extinguished to the noise while others were extinguished to the clicker? Were the effects of LC stimulation/inhibition dependent on the identity of the extinguished stimulus?

      Because the animals were trained with multiple stimuli, it allowed us some ability to choose amongst those stimuli to best balance response rates across groups before the key manipulations. The effects of LC manipulation did not differ between animals based on the identity of the extinguished stimulus.

      3) Did the acute effects of LC inhibition on extinction vary as a function of the stimulus identity?

      No

      4) Was the ITI in extinction the same as that in acquisition?

      Yes, the ITI was the same for acquisition and extinction sessions (variable, averaging to 90 seconds). We have added a sentence to the methods (p. 11) to reflect this.

      5) For Group Offset, when was the photo-stimulation applied in relation to the extinguished stimulus: was it immediately upon offset of the stimulus or at a later point in the ITI?

      The group label “Offset” was used to be consistent with Umaetsu et al. (2017) that delivered stimulation 50-70s after a trial. SImilarly, we mean it as discontinuous with the stimulus, not at the termination of the stimulus. We have revised the description of this group on page 11 to clarify the timing of the photostimulation as follows:

      “Animals in the Offset group (and relevant controls) underwent identical training with the exception that stimulation in extinction sessions occurred in the middle of the variable length ITI (45s after stimulus termination, on average).”

      MINOR

      1) "Such recovery phenomena undermine the success of extinction-based therapies..."

      ***Perhaps a different phrasing is needed here: "These phenomena show that extinction-based therapies are not always effective in suppressing an already-established response..."

      We have revised this sentence in line with the reviewer’s suggestion:

      “These phenomena mean that extinction-based therapies are not always successful in suppressing previously-established behaviours” (first paragraph of the introduction).

      2) Typo in para 1 of results: "F(2,19)=0.0.352"

      Thank you for finding this typo. It has been corrected. (p.4)

      3) "As another example of modular functional organization, no improvements to strategy setshifting following global LC stimulation, but improvements were observed when LC terminals in the medial prefrontal cortex were targeted (Cope et al., 2019)." ***This sentence is missing a "there were" before "no improvements".

      Thank you for finding this error. It has been corrected. (p.8)

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      In this manuscript, Butkovic et al. perform a genome-wide association (GWA) study on Arabidopsis thaliana inoculated with the natural pathogen turnip mosaic virus (TuMV) in laboratory conditions, with the aim to identify genetic associations with virus infection-related parameters. For this purpose, they use a large panel of A. thaliana inbred lines and two strains of TuMV, one naïve and one pre-adapted through experimental evolution. A strong association is found between a region in chromosome 2 (1.5 Mb) and the risk of systemic necrosis upon viral infection, although the causative gene remains to be pinpointed.

      This project is a remarkable tour de force, but the conclusions that can be reached from the results obtained are unfortunately underwhelming. Some aspects of the work could be clarified, and presentation modified, to help the reader.

      (Recommendations For The Authors):

      • It is important to note that viral accumulation and symptom development do not necessarily correlate, and that only the former is a proxy for "virus performance". These concepts need to be clear throughout the text, so as not to mislead the reader.

      This has been explained better in line 118-120, “Virus performance has been removed.

      • Sadly, only indirect measures of the viral infection (symptoms) are used, and not viral accumulation. It is important to note that viral accumulation and symptom development do not necessarily correlate and that only the former is a proxy for "virus performance". These concepts need to be clear throughout the text, so as not to mislead the reader. The mention of "virus performance" in line 143 is therefore not appropriate, nor is the reference to viral replication and movement in the Discussion section.

      "Virus performance" was removed. Also, the reference to viral replication and movement in the Discussion section has been removed.

      Now we mention: “We did not measure viral accumulation, but note this is significantly correlated with intensity of symptoms within the Col-0 line (Corrêa et al. 2020), although it is not clear if this correlation occurs in all lines.”

      • Since symptoms are at the center of the screen, images representing the different scores in the arbitrary scales should ideally be shown.

      Different Arabidopsis lines would look different and this could mislead a reader not familiar with the lines. In order to make a representation of our criteria to stablish the symptoms, we believe that a schematic representation is clearer to interpret. Here are some pictures of different lines showing variating symptoms:

      Author response image 1.

      • Statistical analyses could be added to the figures, to ease interpretation of the data presented.

      Statistical analysis can be found in methods. We prefer to keep the figure legend as short as possible.

      • The authors could include a table with the summary of the phenotypes measured in the panel of screened lines (mean values, range across the panel, heritability, etc.).

      These data are plotted in Fig. 1. We believe that repeating this information in tabular form would not contribute to the main message of the work. Phenotype data and the code to reproduce figure 1 are available at GitHub (as stated in Data Availability), anyone interested can freely explore the phenotypes of the screened lines.

      • The definition of the association peak found in chromosome 2 could be explained further: is the whole region (1.5 Mb) in linkage disequilibrium? How many genes are found within this interval, and how were the five strong candidates the authors mention in line 161 selected? It is also not clear which are these 5 candidates, apart from AT2G14080 and DRP3B - and among those in Table 1 (which, by the way, is cited only in the Discussion and not in the Results section)? Why were AT2G14080 and DRP3B in particular chosen?

      We have replaced Table 1 with an updated Table S1 listing all genes found within the range of significant SNPs for each peak. We now highlight a subset of these genes as candidate genes if they have functions related to disease resistance or defence, and mentioned them explicitly in the text (lines 173-179. We have explicitly described how this table was constructed in the methods (lines 525-538).

      • Concerning the validation of the association found in chromosome 2 (line 169 and onward): the two approaches followed cannot be considered independent validations; wouldn't using independent accessions, or an independent population (generated by the cross between two parental lines, showing contrasting phenotypes, for example) have been more convincing?

      We aim to compare the hypothesis that the association is due to a causal locus to the null hypothesis that the observed association is a fluke due to, for example, the small number of lines showing necrosis. If this null hypothesis is true then we would not expect to see the association if we run the experiment again using the same lines. An alternative hypothesis is that the genotype at the QTL and disease phenotypes are not directly causally linked, but are both correlated with some other factor, such as another QTL, or maternal effects. We agree that an independent sample would be required to exclude the latter hypothesis, but argue that the former is the more pertinent. We have edited the text to be explicit about the hypothesis we are testing, and altered the language to shift the focus from ‘validation’ to ‘confirming the robustness’ of the association (line 182).

      • Regarding the identification of the transposon element in the genomic region of AT2G14080: is the complementation of the knock-out mutant with the two alleles (presence/absence of the transposon) possible to confirm its potential role in the observed phenotype?

      This could be feasible but we cannot do it as none of the researchers can continue this project.

      • On the comparison between naïve and evolved viral strains: is the evolved TuMV more virulent in those accessions closer to Col-0?

      This is not something we have looked at but would certainly be an interesting follow-up investigation.

      • The Copia-element polymorphism is identified in an intron; the potential functional consequences of this insertion could be discussed. In the example the authors provide, the transposable element is inserted into the protein-coding sequence instead.

      We now state explicitly that such insertions are expected to influence expression; beyond that we can only speculate. We have removed the reference to the insertion in the coding sequence.

      • The authors state in line 398 that "susceptibility is unquestionably deleterious" - is this really the case? Are the authors considering susceptibility as the capacity to be infected, or to develop symptoms? Viral infections in nature are frequently asymptomatic, and plant viruses can confer tolerance to other stresses.

      We have tone down the expression and clarify our wording: “Given that potyvirus outbreaks are common in nature (Pagán et al., 2010) and susceptibility to symptomatic infection can be deleterious”

      Additional minor comments:

      • In Table 1, Wu et al., 2018 should refer to DRP2A and 2B, not 3B.

      We have removed Table 1 altogether.

      • Line 126: a 23% increase in symptom severity is mentioned, but how is this calculated, considering that severity is measured in four different categories?

      This is the change in mean severity of symptoms between the two categories.

      • Figure 1F: "...symptoms"

      Fixed.

      • Line 179: "...suggesting an antiviral role..."

      Changed.

      • Lines 288-300: This paragraph does not fit into the narrative and could be omitted.

      It has been removed and some of the info moved to the last paragraph of the Intro, when the two TuMV variants were presented.

      • Lines 335-337: The rationale here is unclear since DRP2B will also be in the background - wouldn't DRPB2B and 3B be functionally redundant in the viral infection?

      Our results suggest that DRPB3B is redundant with DRPB2B for the ancestral virus but not for the evolved viral strain. We speculate that the evolved viral isolate may have acquired the capacity to recruit DRPB3B for its replication and hence it produces less symptoms when the plant protein is missing.

      We have spotted a mistake that may have add to the confusion. Originally the text said “In contrast, loss of function of DRP3B decreased symptoms relative to those in Col-0 in response to the ancestral, but not the evolved virus”. The correct statement is “In contrast, loss of function of DRP3B decreased symptoms relative to those in Col-0 in response to the evolved, but not the ancestral virus.”  

      Reviewer #2 (Public Review):

      The manuscript presents a valuable investigation of genetic associations related to plant resistance against the turnip mosaic virus (TuMV) using Arabidopsis thaliana as a model. The study infects over 1,000 A. thaliana inbred lines with both ancestral and evolved TuMV and assesses four disease-related traits: infectivity, disease progress, symptom severity, and necrosis. The findings reveal that plants infected with the evolved TuMV strain generally exhibited more severe disease symptoms than those infected with the ancestral strain. However, there was considerable variation among plant lines, highlighting the complexity of plant-virus interactions.

      A major genetic locus on chromosome 2 was identified, strongly associated with symptom severity and necrosis. This region contained several candidate genes involved in plant defense against viruses. The study also identified additional genetic loci associated with necrosis, some common to both viral isolates and others specific to individual isolates. Structural variations, including transposable element insertions, were observed in the genomic region linked to disease traits.

      Surprisingly, the minor allele associated with increased disease symptoms was geographically widespread among the studied plant lines, contrary to typical expectations of natural selection limiting the spread of deleterious alleles. Overall, this research provides valuable insights into the genetic basis of plant responses to TuMV, highlighting the complexity of these interactions and suggesting potential avenues for improving crop resilience against viral infections.

      Overall, the manuscript is well-written, and the data are generally high-quality. The study is generally well-executed and contributes to our understanding of plant-virus interactions. I suggest that the authors consider the following points in future versions of this manuscript:

      1. Major allele and minor allele definition: When these two concepts are mentioned in the figure, there is no clear definition of the two words in the text. Especially for major alleles, there is no clear definition in the whole text. It is recommended that the author further elaborate on these two concepts so that readers can more easily understand the text and figures.

      We agree that the distinction between major/minor alleles and major/minor associations in our previous manuscript may have been confusing. In the current manuscript we now define the minor allele at a locus as the less-common allele in the population (line 167). We have removed references to major/minor associations, and instead refer to strong/weak associations.

      1. Possible confusion caused by three words (Major focus / Major association and major allele): Because there is no explanation of the major allele in the text, it may cause readers to be confused with these two places in the text when trying to interpret the meaning of major allele: major locus (line 149)/ the major association with disease phenotypes (line 183).

      See our response to the previous comment.

      1. Discussion: The authors could provide a more detailed discussion of how the research findings might inform crop protection strategies or breeding programs.

      We would prefer to restrain speculating about future applications in breeding programs.

      (Recommendations For The Authors):

      1. Stacked bar chart for the Fig 1F. It is recommended that the author use the form of a stacked bar chart to display the results of Fig 1F. On the one hand, it can fit in with the format of Fig 1D/E/G, on the other hand, it can also display the content more clearly.

      We think the results are easier to interpret without the stacked bar chart.

      1. Language Clarity: While there are no apparent spelling errors, some sentences could be rewritten for greater clarity, especially when explaining the results in Figure 1 and Figure 2.

      We have reviewed these sections and attempted to improve clarity where that seemed appropriate.

      There are some possibilities to explore in the future. For example: clarity of mechanisms for the future. While the study identifies genetic associations, it lacks an in-depth exploration of the underlying molecular mechanisms. Elaborating on the mechanistic aspects would enhance the scientific rigor and practical applicability of the findings.

      Yes, digging into the molecular mechanisms is an ongoing task and will be published elsewhere. It was out of the scope of this already dense manuscript.  

      Reviewer #3 (Public Review):

      Summary of Work

      This paper conducts the largest GWAS study of A. thaliana in response to a viral infection. The paper identifies a 1.5 MB region in the chromosome associated with disease, including SNPs, structural variation, and transposon insertions. Studies further validate the association experimentally with a separate experimental infection procedure with several lines and specific T-DNA mutants. Finally, the paper presents a geographic analysis of the minor disease allele and the major association. The major take-home message of the paper is that structural variants and not only SNPs are important changes associated with disease susceptibility. The manuscript also makes a strong case for negative frequency-dependent selection maintaining a disease susceptibility locus at low frequency.

      Strengths and Weaknesses

      A major strength of this manuscript is the large sample sizes, careful experimental design, and rigor in the follow-up experiments. For instance, mentioning non-infected controls and using methods to determine if geographic locus associations were due to chance. The strong result of a GWAS-detected locus is impressive given the complex interaction between plant genotypes and strains noted in the results. In addition to the follow-up experiments, the geographic analysis added important context and broadened the scope of the study beyond typical lab-based GWAS studies. I find very few weaknesses in this manuscript.

      Support of Conclusions

      The support for the conclusions is exceptional. This is due to the massive amount of evidence for each statement and also due to the careful consideration of alternative explanations for the data.

      Significance of Work

      This manuscript will be of great significance in plant disease research, both for its findings and its experimental approach. The study has very important implications for genetic associations with disease beyond plants.

      (Recommendations For The Authors):

      Line 41 - Rephrase, not clear "being the magnitude and sign of the difference dependent on the degree of adaptation of the viral isolate to A. thaliana."

      Now it reads: “When inoculated with TuMV, loss-of-function mutant plants of this gene exhibited different symptoms than wild-type plants, where the scale of the difference and the direction of change between the symptomatology of mutant and wild-type plants depends on the degree of adaptation of the viral isolate to A. thaliana.”

      Line 236 - typo should read: "and 21-fold"

      Changed.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer 1:

      I would suggest that the authors focus on what I think is the main goal of the work, namely, to consider the whole cell contour when characterizing cell shape instead of only some points on the contour. A reference to the connection with Minkowski tensors and the biologically relevant mathematical consequences of this connection would suffice; a detailed definition of the Minkowski tensors does not seem to be necessary. Especially because you do not really use them. You could use the analysis of the simulation data to explain what the γ<sub>p</sub> miss and for which statements they would be sufficient.

      We argue that the explanation of Minkowski tensors is helpful and should remain in the Methods and materials section. There are two reasons: First, our argumentation relays on the robustness and stability properties of Minkowski tensors. Introducing q<sub>p</sub> without the connection to Minkowski tensors would not allow us to make these statements. Second, Minkowski tensors seem not well known in the community, otherwise measures like γ<sub>p</sub> would not have been introduced. Furthermore, readers not interested in the technical details could skip this part of the manuscript and directly go to the Results section. Concerning the questions, what the γ<sub>p</sub> miss and for which statements they would be sufficient, the answer from a purly mathematical point of view is rather simple: As γ<sub>p</sub> does not share robustness and stability it should not be used in any case! The provided results on computational and experimental data demonstrate the consequences of using such measures. In case of the proposed nematic-hexatic transition in Armengol-Collade et al. (2023) the consequence is severe, as this transition is specific only to the used method but not to the underlying physics. A second aspect which we now further highlight is the influence of approximating a cell by a polygon. We demonstrate that this approximation is responsible for a strong hexatic order on the cellular scale in the considered MDCK data from Armengol-Collade et al. (2023).

      It is not clear to me what we should learn about the two tissue models by using q<sub>2</sub> and q<sub>6</sub> to quantify cell shape. Can you clearly formulate one or more conclusions?

      What we can learn from the research is a dependence of q<sub>p</sub> on model parameters in the two tissue models is

      increases with higher activity or deformability

      decreases with higher activity or deformability.

      Furthermore, q<sub>2</sub> and q<sub>6</sub> are independent and describe distinct properties. Using these models as a basis to coarse-grain and derive continuous models on the tissue scale, these results indicate that more general p-atic liquid crystal theories should be used and the simplest nematic liquid crystal theories might not be sufficient.

      The experimental data and their analysis does not seem to add anything to the work. Do you report only data from independent measurements, or did you consider all images of a monolayer?

      As we now also analyze experimental data from Armengol-Collado et al. (2023) which confirm our findings on independency of q<sub>2</sub> and q<sub>6</sub> and also confirm that the proposed nematic-hexatic transition is only specific to the use of γ<sub>p</sub> for characterizing the shape, additional experimental data are indeed no longer needed. We, therefore, skip the detailed analysis of this data and only keep the results in Fig 1 and Fig 2 and the corresponding figures in the appendix as illustrating examples.

      L13: ”P-atic liquid crystal theories offer new perspectives on how cells self-organize (...)” This is a difficult entry, because the average reader of eLife might not be familiar with p-atic liquid crystals.

      We agree that p-atic liquid crystals might not be familiar to the average reader. For this reason we introduce orientational order in the introduction with examples demonstrating that not only nematic, but also tetratic and hexatic order have been identified in tissue and introduce the different symmetries. Furthermore, we provide examples for p-atic liquid crystals from other fields and various references. In the conclusion, we also cite models for p-atic liquid crystal theories. Even if the average reader is not familiar with these theories, it should become evident that nematic order might not be sufficient to describe tissue as other symmetries are present as well.

      L32: ”nematic” needs to be introduced.

      Nematic order is already explained as rotational order with 180° degrees. The references cited discuss nematic liquid crystals in the context of morphological changes in tissue. We therefore only added a standard text book as reference for liquid crystal theories and refrain introducing it in more detail in the manuscript.

      Figure 1: Why do you show the data for q<sub>3</sub>, q<sub>4</sub>, and q<sub>5</sub>, which you do not really consider in this manuscript? Same for Figure 2. Why not combine the two figures? Furthermore, you show q<sub>p</sub> without having defined them yet.

      We consider all p \= 2,3,4,5,6, but focus on p = 2,6 in the main text and p = 3,4,5 in the appendix. Figures 1 and 2 essentially only introduce the subject and help to relate p-atic order to cell shapes and introduce the methodology to analyze the data. Our conclusion is that all p can be important and should be considered in continuous descriptions of tissue.

      Equation 1: The notation is confusing: the domain of integration (C or ∂C) also appears as the variable you integrate.

      The equation is correct. The variable of integration is 1 or H and the domain of integration is C (cell) or ∂C (cell contour).

      L68: ”a snapshot of the considered monolayer of wild-type MDCK cells”. Did you analyse only one monolayer? Please, provide information about the number of monolayers that were imaged and how many cell shapes were analyzed.

      We have analyzed one monolayer and have added the missing information.

      L86: ”field-specific prefactors” I do not understand what is meant by these.

      Different communities, e.g. physics, mathematics, cosmology, .... use different prefactors in the definition. We have removed this statement.

      L89: ”Hadwiger’s characterization theorem”. What is this?

      This mathematical result is important to claim robustness and stability, it can be found in the cited reference.

      L104: ”the essential property is the continuity”. Essential for what?

      Essential ”for our purpose” to characterize the shape of cells by a robust method.

      L120: ”the theory also guarantees robust description of p-atic orientation for p = 3,4,5,6,...” I do not understand what you mean.

      The previous examples only consider p \= 2. However, the cited theoretical results also hold for p = 3,4,5,6,..

      Equations (5) and (6): You define ψ<sub>p</sub>(C) twice. Are the definitions equivalent? Why do you need both?

      This is not a different definition, equation (6) is a reformulation which is more useful for our purpose. But we indeed define ϑ<sub>p</sub> twice. We now use a new symbol to distinguish ϑ<sub>p</sub> in Equation 7 and 9.

      Figure 4: ”The visualization uses rotationally-symmetric direction fields (known as p-RoSy fields in computer graphics (Vaxman et al., 2016)).” I guess that you have used these fields already in Figure 1, so why introduce them only now?

      We have moved this comment to Figure 1.

      Figure 6: Using a few discrete values cannot illustrate continuity. Also, the ”jump” in γ<sub>p</sub> results from deleting a vertex, so I doubt that this is a fair comparison. Still, I think that it is important to point out to the reader that the value γ<sub>p</sub> depends on the number of vertices (here, I allow that two edges connected by a vertex are aligned).

      We adjusted the caption to make our point more clear. The last image is a triangle and according to the definition of γ<sub>p</sub> is, therefore, described by only three vertices. So, it is indeed a fair comparison. The reviewer is right that the value of γ<sub>p</sub> has a strong dependency of the number of used vertices, this is exactly the point that we are trying to make with this figure. Also, adding vertices artificially to make γ<sub>p</sub> continuous leads to more problems, as the values for γ<sub>p</sub> change if we change the number of vertices. But an equilateral triangle should be recognized as an equilateral triangle, no matter if there is an artificial fourth vertex or not. The triangle in our picture and the triangle that the reviewer mentioned (so our triangle with an artificial fourth vertex) both have the shape of an equilateral triangle, yet for one it is |γ<sub>3</sub>| = 1.0 and for the other one it is |γ<sub>3</sub>| = 0.935.

      While we agree on the reviewers statement about continuity, we did not modify the sentence, as the meaning should be clear.

      L160: The definition of the center of mass is incorrect as it is not that of an extended object whose contour is defined by a polygon, but only of the set of vertices. In Figure 6 you write ”the choice of the center of mass highly influences the value of γ<sub>p</sub>” - is there really a choice of the center of mass? I thought that it was uniquely defined.

      We here only repeat the definition from Armengol-Collado et al. (2023) in order to be able to directly compare our analyses with the results presented therein. We adjusted the caption to be more clear.

      L166: What is the weighting you refer to in Equation 9?

      We apologize, the reference is to Equation 8. We have modified this.

      L312: ”Quantifying orientational order in biological tissues can be realized by Minkowsky tensors”. As mentioned above, you do not really use them, but use Equation (7), which can be defined without reference to Minkowski tensors.

      Eq. (7) is part of the irreducible representations of the Minkowsky tensor. Therefore the sentence is correct.

      L318: I do not quite understand the link between being able (or not) to compare q<sub>p</sub>’s for different values of p and the interpretability of q<sub>2</sub> and q<sub>6</sub>. Also, since you introduce q<sub>p</sub>, how can the question about their comparability be a recurrent challenge? Finally, would you agree that even though a comparison between the absolute values of q<sub>2</sub> and q<sub>6</sub> is inappropriate, one can still meaningfully compare relative changes as a parameter is changed or when comparing cells in different conditions?

      We have modified the sentence. Furthermore we agree that one can still meaningfully compare relative changes as a parameter is changed, as we do. However, our claim that q<sub>2</sub> and q<sub>6</sub> are independent, does not allow to conclude any kind of nematic-hexatic phase transition. We have now provided further evidence using the published data of Armengol-Collado et al. (2023), which unequivocally supports this statement. We would also like to remark that the detection of a phase-transition requires a single order parameter, which cannot exist as q<sub>2</sub> and q<sub>6</sub> are independent.

      We have further explained this in the main text.

      Figure 7: The axes are not labeled.

      We added the labels.

      L359: ”q<sub>2</sub> and q<sub>6</sub> values cluster tightly”, L362 ”q<sub>2</sub> and q<sub>6</sub> values become highly scattered” Please, quantify.

      We kept these formulations but have added statistical measures to these qualitative descriptions, see Supplementary Figures to Fig 7 for the distance correlation and the P-values of the distance correlation. These data support our claim of independence.

      L362: ”each q<sub>2</sub> value spans a broad range of q<sub>6</sub> values and vice versa, demonstrating their independence”. Please, use a quantitative test of statistical independence.

      We have added statistical information by using the distance correlation and statistical tests, see Supplementary Figures to Fig 7. Similar results are obtained for the Pearson correlation and corresponding tests. However, they are not included as the distance correlation is more general.

      L371: Please, define Q<sub>2</sub> and Q<sub>6</sub> in the main text.

      We have now added the definition to the Materials and methods section.

      L420: A reference seems to be missing.

      Thanks for pointing this out. This was a formatting error, we only wanted to cite Balasubramaniam et al. (2021).

      L425: ”strong dependence of cell shape on cell density”. But q<sub>6</sub> seems to be rather independent of density, see Figure 11. Also, what do you mean by ”strong”? Can you quantify?

      The dependency of the cell shape on the cell density is shown in detail in (Eckert et al., 2023). Furthermore, to describe the cell shape the values for all p are needed. So the change in q<sub>2</sub> already indicates a change in the overall cell shape even as q<sub>6</sub> is barely changing. As we excluded these experimental results now in favor of the experimental data also used in Armengol-Collado et al. (2023), we did not add further evaluations regarding cell density.

      L453 ”These divergences [nonmonotonic dependence of γ<sub>p</sub> on activity or deformability] highlight the limitations of γ<sub>p</sub> in capturing consistent patterns”. I am not sure to follow your argument here.

      Besides the quantitative differences seen in comparing Fig. 1 and Fig 2 with the corresponding figures in the appendix, these results show qualitative differences. Using a method which is not robust and not continuous leads to qualitative different results. The nonmonotonic dependence of γ<sub>p</sub> is specific to the method but not to the underlying physics.

      Appendix 3 - Figure 20: It is not clear how to compare this figure to Figure 3e of Armengol-Collado et al 2023. Please, provide more details.

      Appendix 3 - Figure 20 (Appendix 3 - Figure 25 in the revised version) and Figure 3e in Armengol-Collado et al. (2023) cannot be directly compared. Fig 3e shows results of experiments and multiphase field simulations for one parameter stetting and Fig 20 results of the active vertex model for various parameter settings. But both are considered using γ<sub>p</sub> and Γ<sub>p</sub>. We have added these computation, see Fig. 13, which indeed reproduces the results from Fig 3e. We refrain from considering corresponding plots to Fig 20 for the multiphase field model, as this first requires computing the vertices and no additional information can be expected.

      Reviewer 2:

      The manuscript lacks statistical information. The following should be addressed: How often have the experiments been performed? How many monolayers have been analyzed? How many time steps have been considered and in what duration? How many cells have been included in the analysis? What are the p-values to determine if q<sub>p</sub>’s (Figure 2, panel a) and γ<sub>p</sub>’s (Appendix 3-Figure 17, panel a) are significantly different? Same figures: How many cells and experiments have been considered here? Figure 11: What is the density of cells for each condition? Please provide the corresponding values. How significant are the differences? How many times has the experiment been repeated? Figure 12: Due to cell proliferation, the cell density changes over time. Does this need to be taken into account?

      We agree, our information have only been qualitative. We have added the missing information. Especially we added statistical information by using the distance correlation and statistical tests, see Supplementary Figures to Fig. 7. Similar results are obtained for the Pearson correlation and corresponding tests (not included). As we excluded the experimental results previously shown in Figure 11 and Figure 12, in the revised version in favor of the experimental data that is already published in Armengol-Collado et al. (2023), we did not add further statistics regarding this. We added the number of frames and cells in the text.

      The image analysis part of the Method section states that time-series were xy-drift corrected, and cells were tracked. However, the manuscript does not contain results of dynamical data, timedependent analyses, or discussions of how q<sub>p</sub> changes over time. The authors mention that the fluidity of the tissue was confirmed by the MSD, neighbor number variance, and the self-intermediate scattering function, but none of the results are shown in the manuscript. I would like to ask the authors to provide the results and related content in the Method section.

      We have modified the description and removed all parts related to dynamical data. Due to the heavy overload of images in the manuscript we refrain from providing all the results for the phase diagram to distinguish solid and fluid phase. These measures have been provided previously for the considered modeling approaches and provide here only a side remark. Our results do not depend on an exact localization of a solid-fluid phase boundary.

      Additional information is missing in the Image analysis part of the Method section. Could the authors provide the information on the image analysis steps between obtaining the segmented image and inputting the parameters for the Minkowski tensor? This should include how the normal vectors have been determined and whether this has been done for all pixels along the contour.

      We added further details in the section Extraction of the contour in Experimental setup in Methods and Materials and also provide the code to compute q<sub>p</sub> for segmented images.

      The authors have analyzed low-resolution phase contrast images acquired with a 10x objective to experimentally support their introduced Minkowski tensors. This may have decreased the resolution of the cell boundary detection and its curvature. I strongly suggest imaging the tissue with higher magnification (40x or 63x) and/or fluorescent markers to visualize the cell boundaries in high quality. This would allow the authors to distinguish between circles and circle-like shapes (lines 432-434) and to further investigate differences between MDCK wild-type and MDCK E-cad KO cells.

      We agree that higher resolution of the images would be beneficial. However, we are convinced that this will not influence our findings. Instead of performing the experiments with higher magnification or using fluorescent markers, we have considered the experimental data from Armengol-Collado et al. (2023) to support our results.

      The authors have coarse-grained the shape function, Γ<sub>p</sub>, and have chosen the active vertex model (Appendix 3-Figure 20) for comparison with the Minkowski tensors, Q<sub>p</sub> (Appendix 2 Figure 13). In both figures, the hexatic-nematic crossover does not occur. Armengol-Collado et al. have previously reported that the Voronoi model failed to achieve the hexatic-nematic crossover and argued that this is due to the artificial enhancement of the polygon’s hexagonality, leading to high hexatic order at the tissue scale. Since the authors have used the Voronoi-tailing method (line 196), I would like to ask the authors to compare the multiphase field models for Γ<sub>p</sub> andQ<sub>p</sub> instead.

      We would like to mention that we do not consider a Voronoi model but an active vertex model. A Voronoi model is only used for initialization. Both models are certainly related but not identical and claims for a Voronoi model do not need to hold for an active vertex model. The suggested comparison for the multi phasefield model is not an easy task as it requires to compute the vertices from the phase field variables. There are gaps between cells and a reliable algorithm to identify the vertices is a task on its own. We, therefore, refrain from doing these calculations. Instead, we have used the experimental data from Armengol-Collado et al. (2023) for which the polygonal information are provided, see Figure 11. Especially for p \= 6, strong differences can be seen by comparing the PDF obtained by the full shape and the polygonal shape. Indeed, the strong hexatic order at the cellular scale is only a consequence of the approximation by polygons. With this result analysing the multi phasefield data by γ<sub>p</sub> does not add any new information as this first requires an approximation by polygons.

      The authors show the q<sub>p</sub> distributions for the experimental systems (Figure 2, Figure 11). For completeness, I would like to ask the authors to also coarse-grain q<sub>p</sub> and γ<sub>p</sub> of the experimental data as shown for the computational models in Appendix 2 - Figure 13 and Appendix 2 - Figure 14. It would be interesting to see if the hexatic-nematic crossover appears. I would recommend that the authors avoid using the Voronoi tailing of the experimental system, as this may fail to obtain the crossover as explained in (5) above. Instead, I suggest using the real vertex positions for γ<sub>p</sub>, which can be obtained from the segmented images.

      It remains open what is meant by ”the real vertex positions for γ<sub>p</sub>, which can be obtained from the segmented images”. Segmenting the images leads to smooth contours, partly even with gaps between cells. As the magnitude of γ<sub>p</sub> depends on the number of points used in the calculation it is not meaningful to use all points of the contour for calculating γ<sub>p</sub>, as this would lead to artificially low values for |γ<sub>p</sub>|. Identifying the vertex positions for an approximating polygon is an issue of its own and the consequence of this approximation is already mentioned above. For a comparison we therefore added the experimental data from Armengol-Collado et al (2023) and used the provided vertex positions to compute q<sub>p</sub> and γ<sub>p</sub> as well as the raw data and performed the segmentation and used these data to compute q<sub>p</sub>. See Figure 11. These results confirm our findings and show that the proposed nematic-hexatic phase transition is specific to γ<sub>p</sub> to characterize shape.

      In order to show that shape descriptors like the shape function, γ<sub>p</sub>, introduced by Armengol-Collado et al., ’fail to capture the nuance of irregular shapes’ (line 445), the authors have compared γ<sub>p</sub> with the Minkowski tensors, q<sub>p</sub>, using the same dataset (Figure 1 with Appendix 3 - Figure 16, Figure 2 with Appendix 3 - Figure 17, and Figure 4 with Appendix 3 - Figure 15 Appendix 3). I agree that γ<sub>p</sub> and q<sub>p</sub> are different, not showing identical values. However, I see no evidence in these figures that q<sub>p</sub> describes the symmetry of a cell better than γ<sub>p</sub>, since the values are similar and vary quite similarly between different p-atic orders. What is the quantitative difference that shows the failure of the shape function to capture the nuance of irregular shapes?

      The statement already follows from the mathematical properties of robustness and stability, which is illustrated in Fig. 6. The mentioned comparisons for simulation and experimental data only demonstrate that the lack of robustness and stability of γ<sub>p</sub> also leads to different results if applied to averages of cell measures. The differences are twofold, first the approximation of cells by polygons leads to different results, and second even for polygons different results follow, as only one approach is continuous and the other not. This has strong consequences for the proposed nematic-hexatic phase transition if coarse-grained. Our added results for the experimental data from Armengo-Collado et al. (2023) show that this behavior is not a physical feature but only specific to the use of γ<sub>p</sub>.

      The authors claim that the Minkowski tensors provide a ’reliable framework’ and that this framework ’opens new pathways for understanding the role of orientational symmetries in tissue mechanics and development’ (line 78-79). However, the p-atic orders in the experimental systems peak at very low orders of q<sub>p</sub> < 0.3, which may not allow conclusions about (non-)dominant orientational symmetry(ies) of cells. Can this framework be applied to experimental systems? Since the Minkowski tensors display the independence of the hexatic and nematic symmetry, the variations of cell shapes in experimental systems are too strong to provide any additional results (line 437), as stated by the authors, and no crossover was found, while the crossover was reported by Armengol-Collado et al., what new pathways can be opened to study tissues?

      We have added a comparison with experimental data from Armengol-Collado et al. (2023) and demonstrate that the proposed nematic-hexatic transition is only specific to the use of γ<sub>p</sub> for characterizing the shape. So our results first of all essentially close the ”pathway for understanding the role of orientational symmetries in tissue mechanics and development”, which was proposed on this nematic-hexatic transition. On the other side, even if q<sub>p</sub> peaks at relatively low values, the results demonstrate independence of the measures for different p’s, for two different modeling approaches and two different sets of experimental data. This motivates to consider p-atic order for different p simultaneously. Such theories of ”multi”-p-atic liquid crystals, as proposed in the conclusions, are the mentioned new pathways.

      In principle, the introduced Minkowski tensors integrate the orientation of the normal vectors (Equation 6) and consider the perimeter of the contour (Equation 1). Do the tensors distinguish between convex and concave curvature since both are present in tissues? Does a square with 4 concave and a square with 4 convex edges (same curvature) have the same q<sub>p</sub> values?

      For the specific situation of a square with 4 concave or 4 convex edges even p would lead to the same orientation and the same value for q<sub>p</sub>, as even p have a 180 degree symmetry. Odd p would result in the same value for q<sub>p</sub> but in a different orientation ϑ<sub>p</sub>. In more general cases, e.g. shapes with concave and convex edges, no general statements can be made. In general the theoretical results on stability of q<sub>p</sub> only hold for convex shapes. However, as discussed in Methods and materials the known counterexamples for concave shapes are not relevant for cell shapes.

      In lines 169-172 and Figure 6, the authors report a jump in γ<sub>p</sub>. Why has the fourth vertex in the last image been removed? The vertices are essential for the calculation of γ<sub>p</sub>. If the fourth vertex is not removed, the following values result: γ<sub>3</sub> = 0.935 and γ<sub>4</sub> = 0.474, which leads to changes of the same order of magnitude as those of q<sub>p</sub>. I think it is therefore not the choice of the center of mass that ’heavily influences the value of γ<sub>p</sub>’, but the removal of the fourth vertex.

      We adjusted the caption to make our point more clear. The last image is a triangle and according to the definition of γ<sub>p</sub> is therefore described by only three vertices. The reviewer is right that the value of γ<sub>p</sub> has a strong dependency of the number of used vertices, this is exactly the point that we are trying to make with this figure. An equilateral triangle should be recognized as an equilateral triangle, no matter if there is an artificial fourth vertex or not. The triangle in our picture and the triangle that the reviewer described (so our triangle with an artificial fourth vertex) both have the shape of an equilateral triangle, yet for one |γ<sub>3</sub>| = 1.0 and for the other one it is |γ<sub>3</sub>| = 0.935. This can be seen even more clearly if even more artificial vertices on the outline of the equilateral triangle are added, which will decrease |γ<sub>3</sub>| even more. Furthermore, we think there was a misunderstanding regarding our statement about the center of mass. The general problem of γ<sub>p</sub> - so the dependence of the values on the number of vertices - is independent of the calculation of the center of mass. The exact values of γ<sub>p</sub> on the other hand depend on the choice of this. We follow Armengol-Collado et al. (2023) and use the mean of all vertex coordinates as center of mass. If the reviewer would use the center of mass of the equilateral triangle and do the same calculations the resulting values for γ<sub>p</sub> would be different. This is what we meant with ’heavily influences the value of γ<sub>p</sub>’.

      In Appendix 3 - Figure 18, the authors show that the shape function, γ<sub>6</sub>, exhibits a non-monotonic trend as a function of activity and deformability. I have no objection to this statement. However, I would like to ask the authors to check the values for γ<sub>6</sub>. In the bottom-left corner, for example, γ<sub>6</sub> = 0.55. This value seems very low to me. In Appendix 3-Figure 20, |Q<sub>6</sub>| for R/Rcell = 2 is already in this range, while |Q<sub>6</sub>| for R/Rcell = 1 (not shown), corresponding to γ<sub>6</sub>, must be even higher. Also, the parameters p<sub>6</sub> = 3.5 and v<sub>0</sub> = 0.1 should result in a nearly hexagonal lattice, which should be captured with high γ<sub>6</sub> values. I would expect γ<sub>6</sub> to be in the same range as q<sub>6</sub>.

      Many thanks for pointing this out. There are two different points addressed in this question: The first is if |Γ<sub>p</sub>| is too high. We checked the values, |Γ<sub>p</sub>| = 0.5075 for R/R<sub>cell</sub> = 2, so it is lower than = 0.58. The second question is why γ<sub>p</sub> and q<sub>p</sub> are not in the same value range. You are right that for a perfectly hexagonal lattice both should give the same value, namely = = 1.0. However, even at p<sub>6</sub> = 3.5 and v<sub>0</sub> = 0.1 this is not a perfectly hexagonal lattice anymore and how fast the values of q<sub>6</sub> and |γ<sub>6</sub>| drop if we move away from a perfect hexagon scales differently. As q<sub>p</sub> is stable and only changes slightly for slight changes in the shape it makes sense, that q<sub>p</sub> is still close to 1.0 . We included an image, see below, of one time step in said parameter to showcase that cells do not form a perfect hexagonal lattice anymore.

      Reviewer 3:

      Could the authors show why and how this method could bring new information which were missing so far in the understanding of morphogenesis in vitro and in vivo with the current quantification?

      The introduction provides examples of how orientational order and its topological defects can be linked to morphological changes in tissues. The orientational order emerges from the shape of the cells. Most commonly nematic order has been considered, but more recently also hexatic order and even a nematic-hexactic crossover on larger scales. This suggests a mechanical mechanism for morphogenesis, like a phase transition from hexatic to nematic, which would have consequences on the evolution of shape. We demonstrate that the measures q<sub>2</sub> and q<sub>6</sub> are independent. Furthermore the proposed nematic-hexatic transition is only specific to the use of γ<sub>p</sub> for characterizing the shape and coarse-graining of the associated order. These measures are not robust and therefore should not be used. Results for the robust measures q<sub>p</sub> suggest to consider all p for a coarse-grained theory to model morphological changes in tissues.

      Could authors show quantitative comparisons between available methods with the same sets of data and highlight pros and cons?

      Author response image 1.

      Screenshot from p<sub>6</sub> = 3.5 and v<sub>0</sub> = 0.1

      In addition to what was already done for the simulation data we have added data from Armengol-Collado et al. (2023) and compared the results for q<sub>p</sub> and Q<sub>p<sub> and γ<sub>p</sub> and Γ<sub>p</sub>. The theoretical results and the illustrating example in Fig. 6 already show that there are no pros for γ<sub>p</sub>. Other methods belong to the class of bond-order methods and measure neighbor relations instead of shape. We already comment that these methods are inappropriate to classify shape, see Methods and materials, last sentence and Mickel et al. (2013) for a detailed discussion why these methods are not robust.

      Instead of using phase contrast images, which exhibit curved cell-cell contours, could authors use data with E-cadherin staining instead - as used in many epithelial studies in vitro and in vivo? Could they show both images for wild type and for the E-cadherin KO cell lines with fluorescent readout?

      We are convinced that our results do not depend on the way to visualize the cell contours. Furthermore the images do not provide additional information. To further strengthen the experimental part of the manuscript, we instead analyzed data from Armengol-Collado et al. (2023).

      They confirm our findings.

      The authors acknowledge differences in density between cell lines p. 13 so this calls for new experiments with solid readouts and analysis using comparable experimental conditions.

      Additionally, we analyzed data from Armengol-Collado et al. (2023) which confirm our findings. Our results are now supported by two different modeling approaches and two different experimental settings. Because of redundancy we removed the original experimental data from the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this manuscript, the authors employed direct RNA sequencing with nanopores, enhanced by 5' end adaptor ligation, to comprehensively interrogate the human transcriptome at singlemolecule and nucleotide resolution. They conclude that cellular stress induces prevalent 5' end RNA decay that is coupled to translation and ribosome occupancy. Contrary to the literature, they found that, unlike typical RNA decay models in normal conditions, stress-induced RNA decay is dependent on XRN1 but does not depend on the removal of the poly(A) tail. The findings presented are interesting but a substantial amount of work is needed to fully establish these paradigm-shifting findings.

      Strengths:

      These are paradigm-shifting observations using cutting-edge technologies.

      Weaknesses:

      The conclusions do not appear to be fully supported by the data presented.

      Our response to the reviewer comments is provided at the end of this document in the section "Recommendations For The Authors"

      Reviewer #2 (Public Review):

      In the manuscript "Full-length direct RNA sequencing uncovers stress-granule dependent RNA decay upon cellular stress", Dar, Malla, and colleagues use direct RNA sequencing on nanopores to characterize the transcriptome after arsenite and oxidative stress. They observe a population of transcripts that are shortened during stress. The authors hypothesize that this shortening is mediated by the 5'-3' exonuclease XRN1, as XRN1 knockdown results in longer transcripts. Interestingly, the authors do not observe a polyA-tail shortening, which is typically thought to precede decapping and XRN1-mediated transcript decay. Finally, the authors use G3BP1 knockout cells to demonstrate that stress granule formation is required for the observed transcript shortening.

      The manuscript contains intriguing findings of interest to the mRNA decay community. That said, it appears that the authors at times overinterpret the data they get from a handful of direct RNA sequencing experiments. To bolster some of the statements additional experiments might be desirable.

      A selection of comments:

      (1) Considering that the authors compare the effects of stress, stress granule formation, and XRN1 loss on transcriptome profiles, it would be desirable to use a single-cell system (and validated in a few more). Most of the direct RNAseq is performed in HeLa cells, but the experiments showing that stress granule formation is required come from U2OS cells, while short RNAseq data showing loss of coverage on mRNA 5'ends is reanalyzed from HEK293 cells. It may be plausible that the same pathways operate in all those cells, but it is not rigorously demonstrated.

      We agree with the reviewer that performing all experiments in a single cell system would be desirable. Presently, our core findings on 5’ RNA shortening are all performed in HeLa cells: the identification of 5’ RNA shortening, the reliance of shortening through XRN1 silencing, suppression of shortening by translation inhibition, and now the relationship between 5’ shortening and deadenylation/decapping through experiments described further below. Our use of other cell lines is primarily to show that 5’ shortening is a general phenomenon, and we have now done this for U20S cells, HEK293 cells, and primary 3T3 cells from mouse. 

      Regarding stress granule formation, we are unfortunately restricted by the lack of available wellcharacterized resources. The DDG3BP1/2 U2OS is a well characterized cell line that has been extensively used for stress granule-related experiments. We have therefore opted to use it and performed experiments to verify both the occurrence of stress-induced RNA shortening as well as the rescue in the absence of stress granules. The reproducibility and breadth of the cell lines used in our analysis makes us confident on the generality of our findings.

      (2) An interesting finding of the manuscript is that polyA tail shortening is not observed prior to transcript shortening. The authors would need to demonstrate that their approach is capable of detecting shortened polyA tails. Using polyA purified RNA to look at the status of polyA tail length may not be ideal (as avidity to oligodT beads may increase with polyA tail length and therefore the authors bias themselves to longer tails anyway). At the very least, the use of positive controls would be desirable; e.g. knockdown of CCR4/NOT.

      We thank the reviewer for their comment. Previous studies, using in vitro transcribed RNA molecules, have shown that direct RNA sequencing can capture and quantify poly(A) tails of varying lengths (Krause et al. 2019). Specifically, a range of 10 to 150 nt has been tested and a high concordance between known and dRNA-Seq determined values was observed. Both tailfindR and nanopolish (used in this work) showed high poly(A) tail estimation accuracy.

      Regardless, we agree with the reviewer that our method depends on poly(A) tail capture and thus may be incomplete for fully quantifying poly(A) length changes. We therefore opted to replace these data and instead follow this and other reviewers’ suggestions and perform experiments following knockdown of CCR4/NOT using cells expressing a catalytically inactive CNOT8 (CNOT8*) dominant negative mutant (Chang et al. 2019). Our new data show that stress-induced 5’ end decay is indeed not dependent on prior removal of the poly(A) tail. Specifically, we find that transcript shortening is still observed upon oxidative stress in cells expressing CNOT8* compared to control cells. We present these new results in Fig. 3 and Sup. Fig 3. 

      (3) The authors use a strategy of ligating an adapter to 5' phosphorylated RNA (presumably the breakdown fragments) to be able to distinguish true mRNA fragments from artifacts of abortive nanopore sequencing. This is a fantastic approach to curating a clean dataset. Unfortunately, the authors don't appear to go through with discarding fragments that are not adapter-ligated (presumably to increase the depth of analysis; they do offer Figure 1e that shows similar changes in transcript length for fragments with adapter, compared to Figure 1d). It would be good to know how many reads in total had the adapter. Furthermore, it would be good to know what percentage of reads without adapters are products of abortive sequencing. What percentage of reads had 5'OH ends (could be answered by ligating a different adapter to kinasetreated transcripts). More read curation would also be desirable when building the metagene analysis - why do the authors include every 3'end of sequenced reads (their RNA purification scheme requires a polyA tail, so non-polyadenylated fragments are recovered in a nonquantitative manner and should be discarded).

      We thank the reviewer for appreciating our approach. The reviewer is correct that we do not discard reads that are not adapter-ligated. As the reviewer correctly mentions this is to increase the sequencing depth. We have found that the ligation efficiency is very low, ~1-2 % of total reads (now in Sup. Table. 1), across all libraries, and so the percentage of REL5-ligated reads does not directly infer the total amount of non-artifactual 5’ ends. Instead, we use these REL5ligated reads as a subset of our data for which we have extremely high confidence in the true 5’end. Our results show that non-ligated reads display the same length distribution as ligated ones, and that the results are reproducible regardless of read selection (e.g. Fig. 1c, e, Sup. Fig. 1k, l, Fig. 3b, c). This strong concordance between REL5-ligated and non-ligated reads suggests that our conclusions on 5’ end shortening are not substantially influenced by abortive sequencing or other artefactual creation of 5’ shortening. We have modified the text to clarify these points and have added plots using only ligated molecules for relevant figures that this was not previously done (Sup. Fig 1l, 3c)

      We agree with the reviewer that non-polyadenylated reads could be discarded from metagene analysis and we have performed this change in the revised version. Our conclusions following removal of non-polyadenylated reads remain unchanged (Sup. Fig. 1g).

      (4) The authors should come to a clear conclusion about what "transcript shortening" means. Is it exonucleolytic shortening from the 5'end? They cannot say much about the 3'ends anyway (see above). Or are we talking about endonucleolytic cuts leaving 5'P that then can be attached by XRN1 (again, what is the ratio of 5'P and 5'OH fragments; also, what is the ratio of shortened to full-length RNA)?

      We thank the reviewer for their suggestion. We have performed additional experiments to investigate the role of deadenylation and decapping by expressing dominant negative forms of the NOT8 deadenylase (NOT8*) and DCP2 decapping (DCP2*) enzyme in HeLa cells. Our results show that neither expression of NOT8* nor DCP2* can inhibit stress-induced transcript shortening following arsenite treatment (Fig. 3e-f). These new data suggest that neither deadenylation nor decapping are required for stress-induced RNA decay. Instead, our data are more compatible with endonucleolytic cleavage as the most likely mechanism for stressinduced RNA decay. We have incorporated these results in the text and present them in Fig. 3 and Sup. Fig. 3.

      (5) The authors should clearly explain how they think the transcript shortening comes about. They claim it does not need polyA shortening, but then do not explain where the XRN1 substrate comes from. Does their effect require decapping? Or endonucleolytic attacks?

      Please also refer to our answer to the previous comment (#4). Collectively, our results from a) the dominant negative expression of NOT8* and DCP2* that show no effect on stress-induced shortening and b) the rescue of transcript length upon translation initiation inhibition, indicate a potential endonucleolytic mechanism as a mediator of stress-induced RNA decay. However, we believe that extensive, further studies currently beyond the scope of this work, will be required to discover the nuclease and to dissect the exact molecular mechanisms that define the 5' ends of mRNAs upon stress-induced decay. We now discuss these points in the discussion.

      (6) XRN1 KD results in lengthened transcripts. That is not surprising as XRN1 is an exonuclease - and XRN1 does not merely rescue arsenite stress-mediated transcript shortening, but results in a dramatic transcript lengthening.

      The reviewer raises an intriguing point. Additional analysis of data has showed that in fact, in unstressed cells, XRN1 KD leads to modestly significant reduction in overall transcript length (Fig. 3b, c). This could possibly be the result of an accumulation of intermediate cleavage products normally expected to be degraded by XRN1 as previously described (Pelechano, Wei, and Steinmetz 2015; Ibrahim et al. 2018).

      Instead, we find that under stress, XRN1 KD shows an almost identical transcript length distribution to unstressed cells and significantly higher than siCTRL stressed cells (Fig. 3b, c). These results indicate that in the absence of XRN1, stress-induced decay is largely abolished. As the reviewer correctly points out, this seems to affect the majority of RNAs which we believe is evidence of the general lack of specificity in the mechanism. Nevertheless, we find that transcripts that are the primary substrates to stress-induced shortening are substantially more lengthened than all other transcripts (Fig. 3e). This indicates that transcripts primarily affected by stress-induced decay are also lengthened the most in the absence of XRN1 and at an even higher level than expected by general XRN1 KD effects.

      Reviewer #3 (Public Review):

      The work by Dar et al. examines RNA metabolism under cellular stress, focusing on stressgranule-dependent RNA decay. It employs direct RNA sequencing with a Nanopore-based method, revealing that cellular stress induces prevalent 5' end RNA decay that is coupled to translation and ribosome occupancy but is independent of the shortening of the poly(A) tail. This decay, however, is dependent on XRN1 and enriched in the stress granule transcriptome. Notably, inhibiting stress granule formation in G3BP1/2-null cells restores the RNA length to the same level as wild-type. It suppresses stress-induced decay, identifying RNA decay as a critical determinant of RNA metabolism during cellular stress and highlighting its dependence on stress-granule formation.

      This is an exciting and novel discovery. I am not an expert in sequencing technologies or sequencing data analysis, so I will limit my comments purely to biology and not technical points. The PI is a leader in applying innovative sequencing methods to studying mRNA decay.

      One aspect that appeared overlooked is that poly(A) tail shortening per se does lead to decapping. It is shortening below a certain threshold of 8-10 As that triggers decapping. Therefore, I found the conclusion that poly(A) tail shortening is not required for stress-induced decay to be somewhat premature. For a robust test of this hypothesis, the authors should consider performing their analysis in conditions where CNOT7/8 is knocked down with siRNA.

      We agree with the reviewer. We have now performed experiments in cells expressing a well characterized catalytically inactive dominant negative NOT8 isoform (NOT8*) (Chang et al.

      2019). Our new data show that stress-induced decay still occurs in cells expressing NOT8*.

      These results confirm our findings that stress-induced decay does not require deadenylation. We present these new results in Fig. 3 and Sup. Fig. 3. 

      Similarly, as XRN1 requires decapping to take place, it necessitates the experiment where a dominant-negative DCP2 mutant is over-expressed.

      We agree with the reviewer and have performed this experiment as requested. Expression of a dominant negative DCP2 (DCP2*) isoform (Loh, Jonas, and Izaurralde 2013) in HeLa cells showed that decapping is also not required for stress-induced decay. We present these new results in Fig. 3 and Sup. Fig. 3.

      Are G3BP1/2 stress granules required for stress-induced decay or simply sites for storage? This part seems unclear. A very worthwhile test here would be to assess in XRN1-null background.

      We thank the reviewer for their comment. Our data show that stress-induced decay is not observed in DDG3BP1/2 U2OS cells, unable to form stress granules (Fig. 6). This result suggests that G3BP1/2 SGs are either a) required for 5’ RNA shortening or b) preserve partially fragmented RNAs that would otherwise be rapidly degraded. We find the second option unlikely for two reasons. First, even if the fragments were rapidly degraded, we would still expect to find evidence of their presence in our data. However, Fig. 6f shows that the length distribution of DDG3BP1/2 U2OS cells, with and without arsenite, are almost identical, thus arguing against the presence of such a pool of rapidly degrading RNAs. Second, if these RNAs were protected by SGs, then they would be expected to be downregulated in the absence of SGs in DDG3BP1/2 U2OS cells treated with arsenite. Our results contradict this hypothesis as no association is found between the level of downregulation in arsenite-treated DDG3BP1/2 U2OS cells and the observed stress-induced fragmentation in WT. Collectively our results point towards G3BP1/2 stress granules being required for stress-induced decay. We have expanded on these points in the manuscript to clarify.

      Finally, the authors speculate that the mechanism of stress-induced decay may have evolved to relieve translational load during stress. But why degrade the 5' end when removing the cap may be sufficient? This returns to the question of assessing the role of decapping in this mechanism.

      The reviewer raises a very interesting point. Our new results, following expression of dominant negative DCP2, show that stress-induced decay does not require decapping. It is therefore plausible that a stress-induced co-translational mechanism cleaves mRNAs endonucleolyticaly to reduce the translational load. Such a mechanism would have many functional benefits as it would acutely reduce the translational load, degrade non-essential RNAs, preserve energy and release ribosomes for translation of the stress response program. We have expanded the discussion to mention these points.

      Recommendations for the authors:

      Reviewing Editor (Recommendations For The Authors):

      As you can see from the comments, although the reviewers appreciate the novelty of your findings, there was a consensus opinion from all reviewers that the authors overinterpreted their data, since they only have one assay and did not fully analyze it, as laid out in one of the reviewer's critiques. Some orthogonal validation of the "groundbreaking" claims is necessary. Examination of the effects of upstream events in 5'-to-3' decay, namely deadenylation, and decapping, would be necessary for a better understanding of the phenomena the authors describe. Many tools and approaches for studying this are described well in the literature (CNOT7-KD, dominant negative DCP2 E148Q, XRN1-null cell lines), so it is well within the authors' reach. Overall, while some of the evidence presented is novel and solid, for some of the claims there is only incomplete evidence.

      We thank the reviewers and the editor for their comments and suggestions. We have performed several additional experiments to further support our conclusions. We have notably investigated the role of deadenylation and decapping in the stress-induced decay by expressing dominant negative NOT8 and DCP2, respectively, as suggested. Our results show that neither deadenylation nor decapping is necessary for stress-induced transcript shortening, suggesting an endonucleolytic event. We believe that these additional experiments strengthen the main conclusions of our work. 

      Reviewer #1 (Recommendations For The Authors):

      Major comments:

      (1) The experiments were conducted in two unrelated cell lines, HeLa and U2OS. The authors should determine if the 5'end RNA decay in response to stress is also observed in normal human cells such as normal human diploid fibroblasts. Furthermore, it would be important to know if this mechanism is conserved between human and mouse cells. This can be tested in mouse embryonic fibroblasts.

      We thank the reviewer for their suggestion. We have now also performed experiments in the mouse embryonic fibroblast NIH 3T3 cell line. Our new results confirm that stress-induced 5’ end RNA decay is also observed in this primary cell line and is conserved between human and mouse (Sup. Fig. 1k, I). 

      (2) The authors state that they monitored cell viability up to 24 hours after Arsenite treatment, but the data is shown up to 240 min (Suppl. 1a). Also, the Y-axis label of this Figure is "Active cells (%)". This should be changed to "Live cells (%)" if this is what they are referring to.

      We thank the reviewer for identifying this mistake. Cell viability was monitored up to 4 hours after arsenite treatment. We have corrected the text and modified the figure according to the reviewer’s suggestion.

      (3) Based on direct Nanopore-based RNA-seq the authors surprisingly found that RNAs in oxidative stress were globally shorter than unstressed cells. Since Nanopore-based RNA-seq will not detect RNAs that lack a poly A-tail, are they not missing out on RNAs that have already started getting degraded due to the loss of a poly A-tail? Also, I am not sure if they used a spikein control which would be critical to claim global changes in RNA expression.

      We agree with the reviewer that our strategy does not capture RNA molecules without a poly(A) tail. Nevertheless, our data do identify shortening upon stress at the 5’ end of RNAs that include poly(A) tails. We considered this as direct evidence that decay at the 5’ end does not require prior removal of the poly(A) tail. Otherwise, these molecules would not have been captured and observed. Indeed, our newly added data from cells expressing a well characterized catalytically inactive dominant negative NOT8 isoform (Chang et al. 2019) show that stress-induced decay occurs even upon silencing of the CCR4-NOT deadenylation complex. We present these results in Fig. 3 and Sup. Fig 3.

      We would like to clarify that in our results we did not use a spike-in control and thus refrain from claiming global changes in RNA expression. Instead, we compare relative ratios of groups of molecules within libraries that are internally normalized, we perform correlative comparisons that are invariant to normalization and we perform differential gene expression using established normalization schemes such as DESeq2 (Love, Huber, and Anders 2014). 

      (4) Many graphs are confusing and inconsistent. For example, samples for Nanopore RNA-seq were prepared in triplicates. Biological or technical? The schematic in Figure 1a shows ISRIB but it appears from Figure 4 onwards. It is missing in the Figure 1 results and the Figure legend. The X-axis labels of many graphs are confusing. For example, Supplementary Figure 1d, 1e, 1g and 1h. It says transcript length but are these nucleotides? P-values are missing from many of these graphs. For some graphs, the authors compared Unstressed vs Arsenite (Figure 1), but in other panels they state No Ars vs 0.5 mM Ars (Fig. 3a) or Control vs Ars (Figure 5c). Likewise, in Figure 1b, Expression change (log2) is unstressed vs Arsenite or Arsenite vs unstressed?

      We thank the reviewer identifying these inconsistencies in the presentation of our results. The replicates for nanopore RNA-seq experiments were biological. We have now clarified this point in the text. Furthermore, we have removed “ISRIB” from Fig. 1a to avoid any confusion. We have also made our labelling across all figures more consistent using ‘unstressed’ for NO arsenite treatment vs “arsenite” or ‘+ Ars’ for arsenite treatment. 

      (5) The authors transfected cells with siCTRL or siXRN1 using electroporation and treated the cells 72 hours after transfection. Since XRN1 is an essential gene, it would be important to determine the viability of cells 72 hours after transfection. Along these lines, in Figure 3b, it would be important to determine the effect of XRN1 knockdown in unstressed cells. Currently, there are only 3 comparisons in Figure 3b - unstressed, siCTRL + Ars and siXRN1 + Ars, and this is insufficient to conclude the effects of XRN1 knockdown in the presence of Arsenite.

      We thank the reviewer for their suggestion. We have updated Fig. 3b and the text to show the requested conditions: siCTRL and siXRN1 with and without arsenite. While XRN2 is an essential gene for many organisms, XRN1 is not essential in mammalian cells and no increased cell death has been reported for XRN1-KO or –KD cells (Brothers et al. 2023). We have also tested different concentration (up to 40 nM) of siRNA and monitored the cells up to five days after transfection without observing any cell toxicity, as previously reported.

      (6) More broadly, the whole study is somewhat descriptive. The biological effect of 5'end mRNA shortening on gene expression is unclear. There is no data indicating how these changes in RNA lengths impact protein expression. Global quantitative proteomics would be critical to determine this.

      We thank the reviewer for their suggestion. To address this concern we have performed additional experiments using cells expressing catalytically inactive forms of NOT8 (Chang et al. 2019) and DCP2 (Loh, Jonas, and Izaurralde 2013) to inhibit deadenylation and decapping.

      These experiments provide additional mechanistic details for 5’ shortening and suggest endonucleolytic cleavage as a critical step (Fig. 3 and Sup. Fig. 3). We agree that it would be interesting to study the fate of these shortened transcripts notably regarding translation. However, given the complexity of the expected proteome changes also following global translation arrest under stress (Harding et al., 2003; Pakos-Zebrucka et al., 2016), we think that this work is beyond the scope of this manuscript and will be the subject of future studies. 

      Minor comments:

      (1) Some of the affected RNAs can be validated in HeLa and other cell lines.

      We thank the reviewer for their suggestion. We have performed RT-qPCR on 3 different mRNAs that present 5’ shortening upon oxidative stress using different primers located along the mRNA. We hypothesized that the closer the primer set is located to the 5’ end, the less abundant the corresponding region would be for arsenite-treated compared to untreated cells. Our results show indeed that the measured level of these mRNAs depends on the location of the primer sets used for the qPCR, the closer to the 5’end it is, the less abundant the mRNA is upon oxidative stress compared to control cells. We present these data as well as a schematic representing the positions of the primers in Sup. Fig. 2d. 

      (2) The authors should check whether XRN1 also co-localizes in SGs.

      We thank the reviewer for their suggestion. We have performed immunofluorescence on U2OS and HeLa upon oxidative stress and did not observe a co-localization of XRN1 with TIA-1, a marker of stress granules (see below). These results are consistent with (Kedersha et al. 2005) that have shown that XRN1 mainly co-localizes to processing bodies and are very weakly detectable in SGs in DU145 cells. We think that this result is beyond the scope of this study and thus decided to only include it for the reviewers.

      Author response image 1.

      Representative immunofluorescence merged image of HeLa (left panel) and U2OS (right panel) cells treated with sodium arsenite and labelled with anti-TIA1 (red), anti-XRN1 (green) antibodies and DAPI (blue). Scale bar 50 µm.

      (3) XRN1 should be knocked down with more than one siRNA.

      We thank the reviewer for this suggestion. Our results show that our XRN1 KD specifically rescues the length of the most shortened mRNAs (Fig. 3e). This is a highly specific effect that makes us confident it is not mediated by non-specific siRNA binding; thus, we do not consider it necessary to repeat the experiment.

      (4) There are typos in the text regarding Figure 6d, e, and f. Also, Supplementary Figure 4a.

      We thank the reviewer for identifying these mistakes. We have corrected the typos. 

      Reviewer #3 (Recommendations For The Authors):

      The authors should consider testing their hypotheses by arresting the decay pathway using the approaches I mentioned previously. As it stands, some conclusions are somewhat speculative.

      We have replied to the reviewer comments in the public review section. 

      References:

      • Brothers, William R., Farah Ali, Sam Kajjo, and Marc R. Fabian. 2023. “The EDC4-XRN1 Interaction Controls P-Body Dynamics to Link MRNA Decapping with Decay.” The EMBO Journal, August, e113933.

      • Chang, Chung-Te, Sowndarya Muthukumar, Ramona Weber, Yevgen Levdansky, Ying Chen, Dipankar Bhandari, Catia Igreja, Lara Wohlbold, Eugene Valkov, and Elisa Izaurralde. 2019. “A Low-Complexity Region in Human XRN1 Directly Recruits Deadenylation and Decapping Factors in 5’-3’ Messenger RNA Decay.” Nucleic Acids Research 47 (17): 9282–95.

      • Harding, Heather P., Yuhong Zhang, Huiquing Zeng, Isabel Novoa, Phoebe D. Lu, Marcella Calfon, Navid Sadri, et al. 2003. “An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress.” Molecular Cell 11 (3): 619–33.

      • Ibrahim, Fadia, Manolis Maragkakis, Panagiotis Alexiou, and Zissimos Mourelatos. 2018. “Ribothrypsis, a Novel Process of Canonical MRNA Decay, Mediates Ribosome-Phased MRNA Endonucleolysis.” Nature Structural & Molecular Biology 25 (4): 302–10.

      • Kedersha, Nancy, Georg Stoecklin, Maranatha Ayodele, Patrick Yacono, Jens Lykke-Andersen, Marvin J. Fritzler, Donalyn Scheuner, Randal J. Kaufman, David E. Golan, and Paul Anderson. 2005. “Stress Granules and Processing Bodies Are Dynamically Linked Sites of MRNP Remodeling.” The Journal of Cell Biology 169 (6): 871–84.

      • Krause, Maximilian, Adnan M. Niazi, Kornel Labun, Yamila N. Torres Cleuren, Florian S. Müller, and Eivind Valen. 2019. “Tailfindr: Alignment-Free Poly(A) Length Measurement for Oxford Nanopore RNA and DNA Sequencing.” RNA  25 (10): 1229–41.

      • Loh, Belinda, Stefanie Jonas, and Elisa Izaurralde. 2013. “The SMG5-SMG7 Heterodimer Directly Recruits the CCR4-NOT Deadenylase Complex to MRNAs Containing Nonsense Codons via Interaction with POP2.” Genes & Development 27 (19): 2125–38.

      • Love, Michael I., Wolfgang Huber, and Simon Anders. 2014. “Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data with DESeq2.” Genome Biology 15 (12): 550.

      • Pakos-Zebrucka, Karolina, Izabela Koryga, Katarzyna Mnich, Mila Ljujic, Afshin Samali, and Adrienne M. Gorman. 2016. “The Integrated Stress Response.” EMBO Reports 17 (10): 1374–95.

      • Pelechano, Vicent, Wu Wei, and Lars M. Steinmetz. 2015. “Widespread Co-Translational RNA Decay Reveals Ribosome Dynamics.” Cell 161 (6): 1400–1412.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Strengths:

      The three experiments are well designed and the various conditions are well controlled. The rationale of the study is clear, and the manuscript is pleasant to read. The analysis choices are easy to follow, and mostly appropriate.

      We are grateful to the reviewer’s thoughtful comments.

      Weaknesses:

      I only have one potential worry. The analysis for gait tracking (1 Hz) in Experiment 2 (Figures 3a/b) starts by computing a congruency effect (A/V stimulation congruent (same frequency) versus A/V incongruent (V at 1 Hz, A at either 0.6 or 1.4 Hz), separately for the Upright and Inverted conditions. Then, this congruency effect is contrasted between Upright and Inverted, in essence computing an interaction score (Congruent/Incongruent X Upright/Inverted). Then, the channels in which this interaction score is significant (by cluster-based permutation test; Figure 3a) are subselected for further analysis. This further analysis is shown in Figure 3b and described in lines 195-202. Critically, the further analysis exactly mirrors the selection criteria, i.e. it is aimed at testing the effect of Congruent/Incongruent and Upright/Inverted. This is colloquially known as "double dipping", the same contrast is used for selection (of channels, in this case) as for later statistical testing. This should be avoided, since in this case even random noise might result in a significant effect. To strengthen the evidence, either the authors could use a selection contrast that is orthogonal to the subsequent statistical test, or they could skip either the preselection step or the subsequent test. (It could be argued that the test in Figure 3b and related text is not needed to make the point - that same point is already made by the cluster-based permutation test.)

      Thanks for the helpful suggestions. In Experiment 2, to investigate whether the multisensory integration effect was specialized for biological motion perception, we contrasted the congruency effect between the upright and inverted conditions to search for clusters showing a significant interaction effect. We performed further analyses based on neural responses from this cluster to examine whether the congruency effect was significant in the upright and the inverted conditions, respectively, following the logic of post hoc comparisons after identifying an interaction effect. However, we agree with the reviewer that comparing the congruency effects between the upright and inverted conditions again based on data from this cluster was redundant and resulted in doubledipping. Therefore, we have removed this comparison from the main text and optimized the way to present our results in the revised Fig. 3).

      Related to the above: the test for the three-way interaction (lines 211-216) is reported as "marginally significant", with a p-value of 0.087. This is not very strong evidence.

      As shown in Fig.3b & e, the magnitude of amplitude differs between the gaitcycle frequency (mean = 0.008, SD = 0.038) and the step-cycle frequency (mean = 0.052; SD =0.056), which might influence the statistical results of the interaction effect. To reduce such influence, we converted the amplitude data at each frequency condition into Z-scores, separately. The repeated-measures ANOVA analysis on these normalized amplitude data revealed a significant three-way interaction (F (1,23) = 7.501, p = 0.012, ƞ<sub>p</sub><sup>2</sup> \= 0.246). We have updated the results in the revised manuscript (lines 218-225).

      Reviewer #1 (Recommendations For The Authors):

      -  Which variable caused one data point to be classified as outlier? (line 221).

      The outlier is a participant whose audiovisual congruency effect (Upright – Inverted) in neural responses at the frequency of interest exceeds 3 SD from the group mean. It is marked by a red diamond in Author response 2. Before removing the data, the correlation between the AQ score and the congruency effect is r \= -0.396, p \= 0.055. For comparison, the results after removing the outlier are shown in Fig. 3c of the revised manuscript. We have added more information about the variable causing the outlier in the revised manuscript (lines 231-232).

      Author response image 1.

      The correlation between AQ score and congruency effect

      -  The authors cite Maris & Oostenveld (2007) in line 415 as the main reference for the FieldTrip toolbox, but the correct reference here is different, see https://www.fieldtriptoolbox.org/faq/how_should_i_refer_to_fieldtrip_in_my_p ublication/

      Thank you for pointing out this issue. Citation corrected.

      -  The authors could consider giving some more background on the additive vs superadditive distinction in the Introduction, which may increase the impact; as it stands the reader might not know why this is particularly interesting. Summarize some of the takeaways of the Stevenson et al. (2014) review in this respect.

      Thanks for the suggestion and we have added the following relevant information in the Introduction (lines 80-90):

      “Moreover, we adopted an additive model to classify multisensory integration based on the AV vs A+V comparison. This model assumes independence between inputs from each sensory modality and distinguishes among sub-additive (AV < A+V), additive (AV = A+V), and super-additive (AV > A+V) response modes (see a review by Stevenson et al., 2014). The additive mode represents a linear combination between two modalities. In contrast, the super-additive and subadditive modes indicate non-linear interaction processing, either with potentiated neural activation to facilitate the perception or detection of nearthreshold signals (super-additive) or a deactivation mechanism to minimize the processing of redundant information cross-modally (sub-additive) (Laurienti et al., 2005; Metzger et al., 2020; Stanford et al., 2005; Wright et al., 2003).”

      Reviewer #2 (Public Review):

      Strengths:

      The manuscript is well-written, with a concise and clear writing style. The visual presentation is largely clear. The study involves multiple experiments with different participant groups. Each experiment involves specific considered changes to the experimental paradigm that both replicate the previous experiment's finding yet extend it in a relevant manner.

      We thank the reviewer for the valuable feedback.

      Weaknesses:

      The manuscript interprets the neural findings using mechanistic and cognitive claims that are not justified by the presented analyses and results.

      First, entrainment and cortical tracking are both invoked in this manuscript, sometimes interchangeably so, but it is becoming the standard of the field to recognize their separate evidential requirements. Namely, step and gate cycles are striking perceptual or cognitive events that are expected to produce event-related potentials (ERPs). The regular presentation of these events in the paradigm will naturally evoke a series of ERPs that leave a trace in the power spectrum at stimulation rates even if no oscillations are at play. Thus, the findings should not be interpreted from an entrainment framework except if it is contextualized as speculation, or if additional analyses or experiments are carried out to support the assumption that oscillations are present. Even if oscillations are shown to be present, it is then a further question whether the oscillations are causally relevant toward the integration of biological motion and for the orchestration of cognitive processes.

      Second, if only a cortical tracking account is adopted, it is not clear why the demonstration of supra-additivity in spectral amplitude is cognitively or behaviorally relevant. Namely, the fact that frequency-specific neural responses to the [audio & visual] condition are stronger than those to [audio] and [visual] combined does not mean this has implications for behavioral performance. While the correlation to autism traits could suggest some relation to behavior and is interesting in its own right, this correlation is a highly indirect way of assessing behavioral relevance. It would be helpful to test the relevance of supra-additive cortical tracking on a behavioral task directly related to the processing of biological motion to justify the claim that inputs are being integrated with the service of behavior. Under either framework, cortical tracking or entrainment, the causal relevance of neural findings toward cognition is lacking.

      Overall, I believe this study finds neural correlates of biological motion, and it is possible that such neural correlates relate to behaviorally relevant neural mechanisms, but based on the current task and associated analyses this has not been shown.

      Thanks for raising the important concerns regarding the interpretation of our results within the entrainment or the cortical tracking frame. A strict neural entrainment account emphasizes the alignment of endogenous neural oscillations with external rhythms, rather than a mere regular repetition of stimulus-evoked responses. However, it is challenging to fully dissociate these components, given that rhythmic stimulation can shape intrinsic neural oscillations, resulting in an intricate interplay between endogenous neural oscillations and stimulus-evoked responses (Duecker et al., 2024; Herrmann et al., 2016; Hosseinian et al., 2021). Therefore, some research, including the current study, use the term “entrainment” to refer to the alignment of brain activity to rhythmic stimulation in a broader context, without isolating the intrinsic oscillations and evoked responses (e.g., Ding et al., 2016; Nozaradan et al., 2012; Obleser & Kayser, 2019). Nevertheless, we agree with the reviewer that since the current results did not examine or provide direct evidence for endogenous oscillations, it is better to contextualize the oscillation view as speculations. Hence, we have replaced most of the expressions about “entrainment” with a more general term “tracking” in the revised manuscript (as well as in the title of the manuscript). We only briefly mentioned the entrainment account in the Discussion to facilitate comparison with the literature (lines 307-312).

      Regarding the relevance between neural findings and cognition or behavioral performance, the first supporting evidence comes from the inversion effect in Experiment 2. For the neural responses at gait-cycle frequency, we observed a significantly enhanced audiovisual congruency effect in the upright condition compared with the inverted condition. Inversion disrupts the distinctive kinematic features of biological motion (e.g., gravity-compatible ballistic movements) and significantly impairs biological motion processing, but it does not change the basic visual properties of the stimuli, including the rhythmic signals generated by low-level motion cues. Therefore, the inversion effect has long been regarded as an indicator of the specificity of biological motion processing in numerous behavioral and neuroimaging studies (Bardi et al., 2014; Grossman & Blake, 2001; Shen, Lu, Yuan, et al., 2023; Simion et al., 2008; Troje & Westhoff, 2006; Vallortigara & Regolin, 2006; Wang et al., 2014; Wang & Jiang, 2012; Wang et al., 2022). Here, our finding of the cortical tracking of higher-order rhythmic structures (gait cycles) present in the upright but not in the inverted condition suggests that this cortical tracking effect can not be explained by ERPs evoked by regular onsets of rhythmic events. Rather, it is closely linked with the specialized cognitive processing of biological motion. Furthermore, we found that the BM-specific cortical tracking effect at gait-cycle frequency (rather than the non-selective tracking effect at step-cycle frequency) correlates with observers’ autistic traits, indicating its functional relevance to social cognition. These findings convergingly suggest that the cortical tracking effect that we currently observed engages cognitively relevant neural mechanisms. In addition, our recent behavioral study showed that listening to frequency-congruent footstep sounds, compared with incongruent sounds, enhanced the visual search for human walkers but not for non-biological motion stimuli containing the same rhythmic signals (Shen, Lu, Wang, et al., 2023). These results suggest that audiovisual correspondence specifically enhances the perceptual and attentional processing of biological motion. Future research could examine whether the cortical tracking of rhythmic structures plays a functional role in this process, which may shed more light on the behavioral relevance of the cortical tracking effect to biological motion perception. We have incorporated the above information into the Discussion (lines 268-293).

      Reviewer #2 (Recommendations For The Authors):

      In Figure 1c, it could be helpful to add the word "static" in the illustration for the auditory condition so that readers understand without reading the subtext that it is a static image without biological motion.

      Suggestion taken.

      In the Discussion, I believe it is important to justify an oscillation and entrainment account, or if it cannot be justified based on the current results and analyses (which is my opinion), it could be helpful to explicitly frame it as speculation.

      We agree with the reviewer. For more clarification, please refer to our response to the public review.

      L335, I did not understand this sentence - a reformulation would be helpful.

      The point-light stimuli were created by capturing the motion of a walking actor (Vanrie & Verfaillie, 2004). The global motion of the walking sequences was eliminated so that the point-light walker looks like walking on a treadmill without translational motion. We have reformulated the sentence as follows: “The point-light walker was presented at the center of the screen without translational motion.”

      The results in Figure 2a and 2d are derived by performing a t-test between the amplitude at the frequency of gait and step cycles and zero. Comparison against amplitude of zero is too liberal; the possibility for a Type-I error is inflated because even EEG data with only noise will not have amplitudes of zero at all frequencies. A better baseline (H0) is either the 1/frequency trend in the power spectrum derived using methods like FOOOF (https://fooof-tools.github.io/fooof/) or by performing non-parametric shuffling based methods (https://doi.org/10.1016/j.jneumeth.2007.03.024).

      In our data analysis, instead of performing the t-test between raw amplitude with zero, we compared the normalized amplitude at each frequency bin (by subtracting the average amplitude measured at the neighboring frequency bins from the original amplitude data) against zero. Such analysis is equal to contrasting the raw amplitude to its neighboring frequency bins, allowing us to test whether the neural response in each frequency bin showed a significant enhancement compared with its neighbors. The multiple comparisons on each frequency bin were controlled by false discovery rate (FDR) correction, reducing the Type-I error. Such analysis procedures help reduce (though not totally remove) the influence of the 1/f trend and have been widely used in this field (Cirelli et al., 2016; Henry & Obleser, 2012; Lenc et al., 2018; Nozaradan et al., 2012; Peter et al., 2023).

      To further verify our findings, we adopted the reviewer’s suggestion and created a baseline by performing a non-parametric shuffling-based analysis. More specifically, to establish the statistical significance of amplitude peaks, we carried out a surrogate analysis on each condition. For each participant, a single control surrogate dataset was derived from their actual dataset by jittering the onset of each step-cycle relative to the actual original onset by a randomly selected integer value ranging between − 490–490 ms. This procedure removed the consistent relationship between the EEG signal and the stimuli while preserving each epoch’s general timing within the exposure period. Then, epochs were extracted based on surrogate stimuli onset, and amplitude was computed across frequencies through FFT under a null model of non-entrainment (Moreau et al., 2022). This entire procedure was performed 100 times, producing a surrogate amplitude distribution of 100 group-averaged values for each condition. If the observed amplitude values at the frequency of interest exceeded the value corresponding to the 95th percentile of the surrogate distribution (p < .05) within a given condition (e.g., AV), the amplitude peak was considered significant (Batterink, 2020). As shown in Author response image 2, the statistical results from these analyses are similar to those reported in the manuscript, confirming the significant amplitude peaks at the frequencies of interest.

      Author response image 2.

      Non-parametric analysis for spectral peak. The dotted lines represent the random data based on shuffling analysis. The solid lines represent the observed data in measured EEG signals. All conditions induced significant peaks at step-cycle frequency and its harmonic, while only the AV condition induced a significant peak at gait-cycle frequency.

      Reviewer #3 (Public Review):

      Strengths:

      The main strengths of the paper relate to the conceptualization of BM and the way it is operationalized in the experimental design and analyses. The use of entrainment, and the tracking of different, nested aspects of BM result in seemingly clean data that demonstrate the basic pattern. The first experiments essentially provide the basic utility of the methodological innovation and the second experiment further hones in on the relevant interpretation of the findings by the inclusion of better control stimuli sets.

      Another strength of the work is that it includes at a conceptual level two replications.

      We appreciate the reviewer for the comprehensive review and positive comments.

      Weaknesses:

      The statistical analysis is misleading and inadequate at times. The inclusion of the autism trait is not foreshadowed and adequately motivated and is likely underpowered. Finally, a broader discussion over other nested frequencies that might reside in the point-light walker stimuli would also be important to fully interpret the different peaks in the spectra.

      (1) Regarding the nested frequency peaks in the spectra, we did observe multiple significant amplitude peaks at 1f (1/0.83 Hz), 2f (2/1.67 Hz), and 4f (4/3.33 Hz) relative to the gait-cycle frequency (Fig. 2 a&d). To further test the functional roles of the neural activity at different frequencies, we analyzed the audiovisual integration modes at each frequency. Note that we collapsed the data from Experiments 1a & 1b in the analysis as they yielded similar results. Overall, results show a similar additive audiovisual integration mode at 2f and 4f and a super-additive integration mode only at 1f (Figure S1), suggesting that the cortical tracking effects at 2f and 4f may be functionally linked but independent of that at 1f. We have reported the detailed results in the Supplementary Information.

      (2) For the reviewer’s other concerns about statistical analysis and autism traits, please refer to our responses below to the Recommendations for the authors.

      Reviewer #3 (Recommendations For The Authors):

      The description of the analyses performed for experiment 2 comes across as double dipping. Congruency effects for BM and non-BM motion (inverted) were compared using cluster-based statistics. Then identified clusters informed an averaging of signals which then were subjected to a paired comparison. At this point, it is no surprise that these paired comparisons are highly significant seeing that the channels were selected based on a cluster analysis of the same exact contrast. This approach should be avoided.

      In the analysis of the repeated measures ANOVA reporting a trend as marginally significant is misleading. Reporting the statistical results whilst indicating that those do not reach significance is the appropriate way to communicate this finding. Other statistics can be used in order to provide the likelihood of those findings supporting H1 or H0 if the authors would like to state something more precise (Bayesian).

      Thanks for the comments. We have addressed these two points in our response to the public review of Reviewer #1.

      The authors perform a correlation along "autistic trait" scores in an individual differences approach. Individual differences are typically investigated in larger samples (>n=40). In addition, the range of AQ scores seems limited to mostly average or lower-than-average AQs (barring a couple). These points make the conclusions on the possible role of BM in the autistic phenotype very tentative. I would recommend acknowledging this.

      An alternative analysis approach that might better suit the smaller sample size is a comparison between high and low AQ participants, defined based on a median split.

      Many thanks for the suggestion. We agree with the reviewer that the sample size (n = 24) in the current study is not large for exploring the correlation between BM and autistic traits. The narrow range of AQ scores was due to the fact that all participants were non-clinical populations and we did not pre-select participants by AQ scores. To further confirm our findings, we adopted your suggestion to compare the BM-specific cortical tracking effect (i.e., audiovisual congruency effect (Upright - Inverted)) between high and low AQ participants split by the median AQ score (20) of this sample. Similar to correlation analysis, one outlier, whose audiovisual congruency effect (Upright – Inverted) in neural responses at 1 Hz exceeds 3 SD from the group mean, was removed from the following analysis. As shown in Figure S3, at 1 Hz, participants with low AQ showed a greater cortical tracking effect compared with high AQ participants (t (21) = 2.127, p \= 0.045). At 2 Hz, low and high AQ participants showed comparable neural responses (t (22) = 0.946, p \= 0.354). These results are in line with the correlation analysis, providing further support to the functional relevance between social cognition and cortical tracking of biological motion as well as its dissociation at the two temporal scales. We have added these results to the main text (lines 238-244) and the supplementary information.

      Writing

      The narrative could be better unfolded and studies better motivated. The transition from basic science research on BM to possibly delineating a mechanistic understanding of autism was a surprise at the end of the intro. Once the authors consider the suggestions and comments above it would be good to have this detail and motivation more obviously foreshadowed in the text.

      Thanks for the great suggestion and we have provided an introduction about how audiovisual BM processing links with social cognition and ASD in the first paragraph of the revised manuscript (lines 46-56). In particular, integrating multisensory BM cues is foundational for perceiving and attending to other people and developing further social interaction. However, such ability is usually compromised in people with social deficits, such as individuals with autism spectrum disorder (ASD) (Feldman et al., 2018), and even in non-clinical populations with high autistic traits (Ujiie et al., 2015). These behavioral findings underline the close relationship between multisensory BM processing and one’s social cognitive capability, motivating us to further explore this issue at the neural level in the current study. We have also modified the relevant content in the last paragraph of the Introduction (lines 100-108), briefly mentioning the methods that we used to investigate this issue.

      The use of terminology related to neural oscillations which are entraining to the BM seems to suggest that the rhythmic tracking inevitably stems from the shaping of existing intrinsic dynamics of the brain. I am not sure this is necessarily the case. I would therefore adopt a more concrete jargon for the description of the entrainment seen in this study. If a discussion over internal dynamics shaped by external stimuli should be invoked, it should be done explicitly with appropriate references (but in my opinion, it isn't quite required).

      Please refer to our response to a similar point raised in the public review of Reviewer #2.

      References

      Bardi, L., Regolin, L., & Simion, F. (2014). The First Time Ever I Saw Your Feet: Inversion Effect in Newborns’ Sensitivity to Biological Motion. Developmental Psychology, 50. https://doi.org/10.1037/a0034678

      Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The autism-spectrum quotient (AQ): Evidence from Asperger syndrome/highfunctioning autism, males and females, scientists and mathematicians. Journal of Autism and Developmental Disorders, 31(1), 5–17. https://doi.org/10.1023/a:1005653411471

      Batterink, L. (2020). Syllables in Sync Form a Link: Neural Phase-locking Reflects Word Knowledge during Language Learning. Journal of Cognitive Neuroscience, 32(9), 1735–1748. https://doi.org/10.1162/jocn_a_01581

      Cirelli, L. K., Spinelli, C., Nozaradan, S., & Trainor, L. J. (2016). Measuring Neural Entrainment to Beat and Meter in Infants: Effects of Music Background. Frontiers in Neuroscience, 10. https://doi.org/10.3389/fnins.2016.00229

      Ding, N., Melloni, L., Zhang, H., Tian, X., & Poeppel, D. (2016). Cortical tracking of hierarchical linguistic structures in connected speech. Nature Neuroscience, 19(1), 158–164. https://doi.org/10.1038/nn.4186

      Duecker, K., Doelling, K. B., Breska, A., Coffey, E. B. J., Sivarao, D. V., & Zoefel, B. (2024). Challenges and approaches in the study of neural entrainment. Journal of Neuroscience, 44(40). https://doi.org/10.1523/JNEUROSCI.1234-24.2024

      Falck-Ytter, T., Nyström, P., Gredebäck, G., Gliga, T., Bölte, S., & the EASE team. (2018). Reduced orienting to audiovisual synchrony in infancy predicts autism diagnosis at 3 years of age. Journal of Child Psychology and Psychiatry, 59(8), 872–880. https://doi.org/10.1111/jcpp.12863

      Feldman, J. I., Dunham, K., Cassidy, M., Wallace, M. T., Liu, Y., & Woynaroski, T. G. (2018). Audiovisual multisensory integration in individuals with autism spectrum disorder: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 95, 220–234. https://doi.org/10.1016/j.neubiorev.2018.09.020

      Grossman, E. D., & Blake, R. (2001). Brain activity evoked by inverted and imagined biological motion. Vision Research, 41(10), 1475–1482. https://doi.org/10.1016/S0042-6989(00)00317-5

      Henry, M. J., & Obleser, J. (2012). Frequency modulation entrains slow neural oscillations and optimizes human listening behavior. Proceedings of the National Academy of Sciences, 109(49), 20095–20100. https://doi.org/10.1073/pnas.1213390109

      Herrmann, C. S., Murray, M. M., Ionta, S., Hutt, A., & Lefebvre, J. (2016). Shaping Intrinsic Neural Oscillations with Periodic Stimulation. Journal of Neuroscience, 36(19), 5328–5337. https://doi.org/10.1523/JNEUROSCI.0236-16.2016

      Hosseinian, T., Yavari, F., Biagi, M. C., Kuo, M.-F., Ruffini, G., Nitsche, M. A., & Jamil, A. (2021). External induction and stabilization of brain oscillations in the human. Brain Stimulation, 14(3), 579–587. https://doi.org/10.1016/j.brs.2021.03.011

      Klin, A., Lin, D. J., Gorrindo, P., Ramsay, G., & Jones, W. (2009). Two-year-olds with autism orient to non-social contingencies rather than biological motion. Nature, 459(7244), 257–261. https://doi.org/10.1038/nature07868

      Laurienti, P. J., Perrault, T. J., Stanford, T. R., Wallace, M. T., & Stein, B. E. (2005). On the use of superadditivity as a metric for characterizing multisensory integration in functional neuroimaging studies. Experimental Brain Research, 166(3), 289–297. https://doi.org/10.1007/s00221-005-2370-2

      Lenc, T., Keller, P. E., Varlet, M., & Nozaradan, S. (2018). Neural tracking of the musical beat is enhanced by low-frequency sounds. Proceedings of the National Academy of Sciences, 115(32), 8221–8226. https://doi.org/10.1073/pnas.1801421115

      Metzger, B. A., Magnotti, J. F., Wang, Z., Nesbitt, E., Karas, P. J., Yoshor, D., & Beauchamp, M. S. (2020). Responses to Visual Speech in Human Posterior Superior Temporal Gyrus Examined with iEEG Deconvolution. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 40(36), 6938–6948. https://doi.org/10.1523/JNEUROSCI.0279-20.2020

      Moreau, C. N., Joanisse, M. F., Mulgrew, J., & Batterink, L. J. (2022). No statistical learning advantage in children over adults: Evidence from behaviour and neural entrainment. Developmental Cognitive Neuroscience, 57, 101154. https://doi.org/10.1016/j.dcn.2022.101154

      Nozaradan, S., Peretz, I., & Mouraux, A. (2012). Selective Neuronal Entrainment to the Beat and Meter Embedded in a Musical Rhythm. Journal of Neuroscience, 32(49), 17572–17581. https://doi.org/10.1523/JNEUROSCI.3203-12.2012

      Obleser, J., & Kayser, C. (2019). Neural Entrainment and Attentional Selection in the Listening Brain. Trends in Cognitive Sciences, 23(11), 913–926. https://doi.org/10.1016/j.tics.2019.08.004

      Peter, V., Goswami, U., Burnham, D., & Kalashnikova, M. (2023). Impaired neural entrainment to low frequency amplitude modulations in English-speaking children with dyslexia or dyslexia and DLD. Brain and Language, 236, 105217. https://doi.org/10.1016/j.bandl.2022.105217

      Shen, L., Lu, X., Wang, Y., & Jiang, Y. (2023). Audiovisual correspondence facilitates the visual search for biological motion. Psychonomic Bulletin & Review, 30(6), 2272–2281. https://doi.org/10.3758/s13423-023-02308-z

      Shen, L., Lu, X., Yuan, X., Hu, R., Wang, Y., & Jiang, Y. (2023). Cortical encoding of rhythmic kinematic structures in biological motion. NeuroImage, 268, 119893. https://doi.org/10.1016/j.neuroimage.2023.119893

      Simion, F., Regolin, L., & Bulf, H. (2008). A predisposition for biological motion in the newborn baby. Proceedings of the National Academy of Sciences, 105(2), 809–813. https://doi.org/10.1073/pnas.0707021105

      Stanford, T. R., Quessy, S., & Stein, B. E. (2005). Evaluating the Operations Underlying Multisensory Integration in the Cat Superior Colliculus. Journal of Neuroscience, 25(28), 6499–6508. https://doi.org/10.1523/JNEUROSCI.5095-04.2005

      Stevenson, R. A., Ghose, D., Fister, J. K., Sarko, D. K., Altieri, N. A., Nidiffer, A. R., Kurela, L. R., Siemann, J. K., James, T. W., & Wallace, M. T. (2014). Identifying and Quantifying Multisensory Integration: A Tutorial Review. Brain Topography, 27(6), 707–730. https://doi.org/10.1007/s10548-014-0365-7

      Troje, N. F., & Westhoff, C. (2006). The Inversion Effect in Biological Motion Perception: Evidence for a “Life Detector”? Current Biology, 16(8), 821–824. https://doi.org/10.1016/j.cub.2006.03.022

      Ujiie, Y., Asai, T., & Wakabayashi, A. (2015). The relationship between level of autistic traits and local bias in the context of the McGurk effect. Frontiers in Psychology, 6. https://doi.org/10.3389/fpsyg.2015.00891

      Vallortigara, G., & Regolin, L. (2006). Gravity bias in the interpretation of biological motion by inexperienced chicks. Current Biology, 16(8), R279–R280. https://doi.org/10.1016/j.cub.2006.03.052

      Vanrie, J., & Verfaillie, K. (2004). Perception of biological motion: A stimulus set of human point-light actions. Behavior Research Methods, Instruments, & Computers, 36(4), 625–629. https://doi.org/10.3758/BF03206542

      Wang, L., & Jiang, Y. (2012). Life motion signals lengthen perceived temporal duration. Proceedings of the National Academy of Sciences of the United States of America, 109(11), E673-677. https://doi.org/10.1073/pnas.1115515109

      Wang, L., Yang, X., Shi, J., & Jiang, Y. (2014). The feet have it: Local biological motion cues trigger reflexive attentional orienting in the brain. NeuroImage, 84, 217–224. https://doi.org/10.1016/j.neuroimage.2013.08.041

      Wang, Y., Zhang, X., Wang, C., Huang, W., Xu, Q., Liu, D., Zhou, W., Chen, S., & Jiang, Y. (2022). Modulation of biological motion perception in humans by gravity. Nature Communications, 13(1), Article 1. https://doi.org/10.1038/s41467-022-30347-y

      Wright, T. M., Pelphrey, K. A., Allison, T., McKeown, M. J., & McCarthy, G. (2003). Polysensory Interactions along Lateral Temporal Regions Evoked by Audiovisual Speech. Cerebral Cortex, 13(10), 1034–1043. https://doi.org/10.1093/cercor/13.10.1034

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public review):

      Summary:

      The manuscript discusses the role of phosphorylated ubiquitin (pUb) by PINK1 kinase in neurodegenerative diseases. It reveals that elevated levels of pUb are observed in aged human brains and those affected by Parkinson's disease (PD), as well as in Alzheimer's disease (AD), aging, and ischemic injury. The study shows that increased pUb impairs proteasomal degradation, leading to protein aggregation and neurodegeneration. The authors also demonstrate that PINK1 knockout can mitigate protein aggregation in aging and ischemic mouse brains, as well as in cells treated with a proteasome inhibitor. While this study provided some interesting data, several important points should be addressed before being further considered.

      Strengths:

      (1) Reveals a novel pathological mechanism of neurodegeneration mediated by pUb, providing a new perspective on understanding neurodegenerative diseases.

      (2) The study covers not only a single disease model but also various neurodegenerative diseases such as Alzheimer's disease, aging, and ischemic injury, enhancing the breadth and applicability of the research findings.

      Weaknesses:

      (1) PINK1 has been reported as a kinase capable of phosphorylating Ubiquitin, hence the expected outcome of increased p-Ub levels upon PINK1 overexpression. Figures 5E-F do not demonstrate a significant increase in Ub levels upon overexpression of PINK1 alone, whereas the evident increase in Ub expression upon overexpression of S65A is apparent. Therefore, the notion that increased Ub phosphorylation leads to protein aggregation in mouse hippocampal neurons is not yet convincingly supported.

      Indeed, overexpression of sPINK1 alone resulted in minimal changes in Ub levels in the soluble fraction (Figure 5E), which is expected given that the soluble Ub pool remains relatively stable and buffered. However, sPINK1* overexpression led to a marked increase in Ub levels in the insoluble fraction, indicative of increased protein aggregation (Figure 5F). The molecular weight distribution of Ub in the insoluble fraction was predominantly below 70 kDa, suggesting that phosphorylation inhibits Ub chain elongation.

      To further validate this mechanism, we utilized the Ub/S65A mutant to antagonize Ub phosphorylation and observed a significant reduction in the intensity of aggregated bands at low molecular weights, indicating restored proteasomal activity. The observed increase in Ub levels in the soluble fraction upon Ub/S65A overexpression is likely due to enhanced ubiquitination driven by elevated Ub-S65A, and notably, Ub/S65A was also detectable using an antibody against wild-type Ub.

      Consistent with these findings, overexpression of Ub/S65E resulted in a further increase in Ub levels in the insoluble fraction, with intensified low molecular weight bands. The effect was even more pronounced than that observed with sPINK1 transfection, likely resulting from the complete phosphorylation mimicry achieved by Ub/S65E, compared to the relatively low levels of phosphorylation by PINK1.

      These findings collectively support the conclusion that sPINK1 promotes protein aggregation via Ub phosphorylation. We have updated the Results and Discussion sections to more clearly present the data and explain the various controls.

      (2) The specificity of PINK1 and p-Ub antibodies requires further validation, as a series of literature indicate that the expression of the PINK1 protein is relatively low and difficult to detect under physiological conditions.

      We acknowledge the challenges in achieving high specificity with commercially available and customgenerated antibodies targeting PINK1 and pUb, particularly given their low endogenous expression under physiological conditions. However, in our study, we observed robust immunofluorescent staining for PINK1 (Figures 1A, 1C, and 1G) and pUb (Figures 1B, 1D, and 1G) in human brain samples from Alzheimer's disease (AD) patients, as well as in mouse models of AD and cerebral ischemia. The clear visualization can be partly attributed to the pathological upregulation of PINK1 and pUb under disease conditions. Importantly, the images from pink1<sup>-/-</sup> mice exhibit much weaker staining.

      Additionally, we detected a significant elevation in the pUb levels in aged mouse brains compared to younger ones (Figures 1E and 1F). In contrast, pink1<sup>-/-</sup> mice showed no change in pUb levels with aging, despite some background signals, demonstrating that pUb accumulation during aging is PINK1dependent. Collectively, these results support the specificity of the antibodies used in detecting pathophysiological changes in PINK1 and pUb levels.

      For cultured cells, pink1<sup>-/-</sup> cells served as a negative control for both PINK1 (Figures 2B and 2C) and pUb (Figures 2D and 2E). While the pUb Western blot exhibited some nonspecific background, pUb levels in pink1<sup>-/-</sup> cells remained unchanged across all MG132 treatment conditions (Figures 2D and 2E), further attesting the usability of the antibodies in conjunction with appropriated controls.

      We have updated the manuscript with higher-resolution images; individual image files have been uploaded separately.

      (3) In Figure 6, relying solely on Western blot staining and Golgi staining under high magnification is insufficient to prove the impact of PINK1 overexpression on neuronal integrity and cognitive function. The authors should supplement their findings with immunostaining results for MAP2 or NeuN to demonstrate whether neuronal cells are affected.

      We included NeuN immunofluorescent staining at 10, 30, and 70 days post transfection in Figure 5— figure supplement 2. The results clearly demonstrate a significant loss of NeuN-positive cells in the hippocampus following Ub/S65E overexpression, while no apparent reduction was observed with sPINK1 transfection alone. 

      We have also quantified MAP2 protein levels via Western blotting and examined morphology of neuronal dendrite and synaptic structure using Golgi staining. These analyses revealed a significant reduction in MAP2 levels and synaptic damage upon sPINK1 or Ub/S65E overexpression (Figures 6F and 6H), consistent with the proteomics analysis (Figure 5—figure supplementary 5). Notably, these detrimental effects could be rescued by co-expression of Ub/S65A, reinforcing the role of pUb in mediating these structural changes.

      Together, our findings from NeuN immunostaining, MAP2 protein analysis, proteomics analysis, and Golgi staining provide strong evidence for the impact of PINK1 overexpression and pUb elevation on neuronal integrity and synaptic structure.

      (4) The authors should provide more detailed figure captions to facilitate the understanding of the results depicted in the figures.

      Figure captions have been updated with more details incorporated in the revised manuscript.

      (5) While the study proposes that pUb promotes neurodegeneration by affecting proteasomal function, the specific molecular mechanisms and signaling pathways remain to be elucidated.

      The molecular mechanisms and signaling pathways through which pUb promotes neurodegeneration are likely multifaceted and interconnected. Our findings suggest that mitochondrial dysfunction plays a central role following sPINK1* overexpression. This is supported by (1) an observed increase in full-length PINK1, indicative of impaired mitochondrial quality control, and (2) proteomic data showing enhanced mitophagy at 30 days post-transfection, followed by substantial mitochondrial injuries at 70 days post-transfection (Figure 5—figure supplement 5 and Supplementary Data). The progressive mitochondrial damage caused by protein aggregates would exacerbate neuronal injury and degeneration.

      Additionally, reduced proteasomal activity may lead to the accumulation of inhibitory proteins that are normally degraded by the ubiquitin-proteasome system. Our proteomics analysis identified a >50fold increase in CamK2n1 (UniProt ID: Q6QWF9), an endogenous inhibitor of CaMKII activation, following sPINK1* overexpression. The accumulation of CamK2n1 suppresses CaMKII activation, thereby inhibiting the CREB signaling pathway (Figure 7), which is essential for synaptic plasticity and neuronal survival. This disruption can further contribute to neurodegenerative processes.

      Thus, our findings underscore the complexity of pUb-mediated neurodegeneration and call for further investigation into downstream consequences.

      Reviewer #1 (Recommendations for the authors):

      Suggestions for improved or additional experiments, data or analyses.

      We have performed additional experiments to investigate how the impairment of ubiquitinproteasomal activity contributes to neurodegeneration. Specifically, we investigated CamK2n1, an endogenous inhibitor of CaMKII, which is normally degraded by the proteasome to allow CaMKII activation. Our proteomics analysis revealed a significant (>50-fold) elevation of CamKI2n1 following sPINK1 overexpression (Figure 5—figure supplement 5 and Supplementary Data).

      To validate this mechanism, we conducted immunofluorescence and Western blot analyses, demonstrating reduced levels of phosphorylated CaMKII (pCaMKII) and phosphorylated CREB (pCREB), as well as reduced levels of downstream proteins such as BDNF and ERK. These results have been incorporated into the revised manuscript (Figure 7).

      As the proteasome is crucial in maintaining proteostasis, its dysregulation would trigger neurodegeneration through multiple pathways, contributing to a broad cascade of pathological events.

      Reviewer #2 (Public review):

      Summary:

      The manuscript makes the claim that pUb is elevated in a number of degenerative conditions including Alzheimer's Disease and cerebral ischemia. Some of this is based on antibody staining which is poorly controlled and difficult to accept at this point. They confirm previous results that a cytosolic form of PINK1 accumulates following proteasome inhibition and that this can be active. Accumulation of pUb is proposed to interfere with proteostasis through inhibition of the proteasome. Much of the data relies on over-expression and there is little support for this reflecting physiological mechanisms.

      Weaknesses:

      The manuscript is poorly written. I appreciate this may be difficult in a non-native tongue, but felt that many of the problems are organizational. Less data of higher quality, better controls and incision would be preferable. Overall the referencing of past work is lamentable. Methods are also very poor and difficult to follow.

      Until technical issues are addressed I think this would represent an unreliable contribution to the field.

      (1) Antibody specificity and detection under pathological conditions

      We recognize the limitations of commercially available antibodies for detecting PINK1 and pUb. Nevertheless, our findings reveal a significant elevation in PINK1 and pUb levels under pathological conditions, such as Alzheimer's disease (AD) and ischemia. Additionally, we observed an increase in pUb level during brain aging, further demonstrating its relevance and a potentially causative role for this special pathological condition. Similarly, elevated pUb levels were observed for cultured cells following pharmacological treatment or oxygen-glucose deprivation (OGD).

      In contrast, in pink1<sup>-/-</sup> mice and HEK293 cells used as negative controls, PINK1 and pUb levels remained consistently low. Therefore, the observed elevation of PINK1 and pUb are associated with special pathological conditions, rather than an antibody-detection anomaly.

      (2) Overexpression as a model for pathological conditions

      To investigate whether the inhibitory effects of sPINK1 on the ubiquitin-proteasome system (UPS) depend on its kinase activity, we employed a kinase-dead version of sPINK1* as a negative control. Given that PINK1 targets multiple substrates, we also investigated whether its effects on UPS inhibition were specifically mediated by ubiquitin phosphorylation. To this end, we used Ub/S65A (a phospho-null mutant) to block Ub phosphorylation by sPINK1, and Ub/S65E (a phospho-mimetic mutant) to mimic phosphorylated Ub. These well-defined controls ensured the robustness of our conclusions.

      Although overexpression does not perfectly replicate physiological conditions, it provides a valuable model for studying pathological scenarios such as neurodegeneration and brain aging, where pUb levels are elevated. For example, we observed a 30.4% increase in pUb levels in aged mouse brains compared to young brains (Figure 1F). Similarly, in our sPINK1 overexpression model, pUb levels increased by 43.8% and 59.9% at 30- and 70-days post-transfection, respectively, compared to controls (Figures 5A and 5C). Notably, co-expression of sPINK1* with Ub/S65A almost entirely prevented sPINK1* accumulation (Figure 5B), indicating that an active UPS can efficiently degrade this otherwise stable variant of sPINK1.

      Together, our findings demonstrate that sPINK1 accumulation inhibits UPS activity, an effect that can be reversed by the phospho-null Ub mutant. The overexpression model mimics pathological conditions and provides valuable insights into pUb-mediated proteasomal dysfunction.

      (3) Organization of the manuscript

      Following your suggestion, we have restructured the manuscript to present the key findings in a more logical and cohesive sequence:

      (a) Evidence for elevated PINK1 and pUb levels across a broad spectrum of pathological and neurodegenerative conditions;

      (b) The effects of pUb elevation in cultured cells, focusing on the proteasome;

      (c) Mechanistic insights into how pUb elevation inhibits proteasomal activity;

      (d) The absence of PINK1 and pUb alleviates protein aggregation;

      (e) Evidence for the causative relationship between elevated pUb levels and proteasomal inhibition;

      (f) Demonstration that pUb elevation directly contributes to neuronal degeneration;

      (g) Give an additional evidence to explain the mechanism of neuronal degeneration post sPINK1* over-expression. The downstream effects of elevated CamK2n1, an inhibitor of CaMKII, resulting from proteasomal inhibition.

      This reorganization should ensure a clear and progressive narrative, and enhance the overall coherence and impact of the revised manuscript.

      (4) Revisions to writing, referencing, and methodology

      We have made a great effort to enhance the clarity and flow of the manuscript, including the addition of references to appropriately acknowledge prior work. We have also expanded the Methods section with additional details to improve readability and ensure reproducibility. We believe these revisions effectively address the concerns raised and strengthen the overall quality of the manuscript.

      Reviewer #2 (Recommendations for the authors):

      Figure 1: PINK1 is a poorly expressed protein and difficult to detect by Western blot let alone by immunofluorescence. I have direct experience of the antibody used in this study and do not consider it reliable. There are much cleaner reagents out there, although they still have many challenges. The minimal requirement here is for the PINK1 antibody staining to be compared in wild-type and knockout mice. One would also expect to see a mitochondrial staining which would require higher magnification to be definitive, but it does not look like it to me. This is a key foundational figure and is unreliable. The pUb antibody also has a high background, see for example figure 2E.

      Under physiological conditions, PINK1 and pUb levels are indeed low, making their detection challenging. However, under pathological conditions, their expression is significantly elevated, correlating with disease severity. Given the limitations of available reagents, using appropriate controls is a standard approach in biological research.

      Nevertheless, we observed robust immunofluorescent staining for PINK1 (Figures 1A, 1C, and 1G) and pUb (Figures 1B, 1D, and 1G) in human brain samples from Alzheimer’s disease (AD) patients and mouse models of AD and cerebral ischemia. Compared to healthy controls, the significant elevation of PINK1 and pUb under these pathological conditions accounts for their clear visualization. To validate antibody specificity, we have included images from pink1<sup>-/-</sup> mice as negative controls (Figure 1C and 1D, third panel).

      Furthermore, we analyzed pUb levels in both young and aged mice, using pink1<sup>-/-</sup> mice as controls.

      Our results revealed a significant increase in pUb levels in aged wild-type mice (Figures 1E and 1F), In contrast, pink1<sup>-/-</sup> mice exhibited relatively low pUb levels, with no notable change between young and aged groups. These findings reinforce the conclusion that pUb accumulation during aging is dependent on PINK1.Furthermore, we analyzed pUb levels in both young and aged mice, using pink1<sup>-/-</sup> mice as controls.

      For HEK293 cells, pink1<sup>-/-</sup> cells were used as a negative control for assessing PINK1 (Figures 2B and 2C) and pUb levels (Figures 2D and 2E). While the pUb Western blot did show some nonspecific background, as you have noted, pUb levels significantly increased following MG132 treatment of the wildtype cells. In contrast, no such increase was observed in pink1<sup>-/-</sup> cells (Figure 2D and 2E). These results further validate the reliability of our findings.

      Regarding mitochondrial staining, we recognize that PINK1 localization can vary depending on the pathological context. For example, in Alzheimer’s disease, PINK1 exhibits relatively high nuclear staining, while in cerebral ischemia and brain aging, it is predominantly cytoplasmic and punctate. In contrast, in young, healthy mouse brains, PINK1 is more uniformly distributed. The observed elevation in pUb levels could arise from mitochondrial PINK1 or soluble sPINK1 in the cytoplasm, and it remains unclear whether nuclear PINK1 contributes to pUb accumulation. Investigating the role of PINK1 in different forms and subcellular localizations will be an important avenue for future research.

      To enhance clarity, we have updated our images and replaced them with higher-resolution versions in the revised manuscript.

      Please also confirm that the GAPDH loading controls represent the same gels, to my eye they do not match.

      We have reviewed all the bands, and confirmed that the GAPDH loading controls correspond to the same gels. For different gels, we use separate GAPDH loading controls. There are two experimental scenarios to consider:

      (1) When there is a large difference in molecular weight between target proteins, we cut the gel into sections and incubate each section with different antibodies separately.

      (2) When the molecular weight difference is small and cutting is not feasible, we first probe the membrane with one antibody, strip it, and then re-incubate the membrane with a second antibody.

      These approaches ensure accurate and reliable detection of target proteins with various molecular weights relative to GAPDH.

      1H. Ponceau.

      We have corrected the spelling.

      Figure 2 many elements are confirmation of work already reported and this must be made clearer in the text. 

      Indeed, the elevation of sPINK1 and pUb upon proteasomal inhibition has been previously reported, and these studies have been acknowledged (Gao, et al, 2016; Dantuma, et al, 2000). In the present study, we expand on these findings by conducting a detailed analysis of the time- and concentrationdependent effects of MG132 on sPINK1 and pUb levels, establishing a causative relationship between pUb accumulation and proteasomal inhibition. Furthermore, we demonstrate that sPINK1 overexpression and MG132-induced proteasomal inhibition exhibit no additive effect, indicating that both converge on the same pathway, resulting in the impairment of proteasomal activity.

      It has been established that ubiquitin phosphorylation inhibits Ub chain elongation (Wauer, et al, 2015). However, our study provides novel insights by identifying an additional mechanism: phosphorylated Ub also interferes with the noncovalent interactions between Ub chain and Ub receptors in the proteasome, which further contributes to the impairment of UPS function.

      The PINK1 kinase-dead mutant construction (Figure 2F) and the use of Ub-GFP as a proteasomal substrate were based on established methodologies, which have been appropriately cited in the manuscript (Beilina, etal 2005 for KD sPINK1; Yamano, et al for endogenous PINK1; Samant, et al, 2018 and Dantuma, et al, 2000 for Ub-GFP probe). Similarly, our use of puromycin and BALA treatments follows previously reported protocols (Gao, et al, 2016), which allowed us to dissect the relative contributions of sPINK1* overexpression to proteasomal vs. autophagic dysfunction.

      As you have noted, our study has built upon prior findings while introducing new mechanistic insights into sPINK1 and pUb-mediated proteasomal dysfunction.

      2C 24h MG132 not recommended, most cells are dead by then.

      We used MG132 treatment for 24 hours to evaluate the time-course effects of proteasomal inhibition on PINK1 and pUb levels in HEK293 cells (Figures 2C and 2E). We did observe some decrease in both PINK1 and pUb levels at 24 hours compared to 12 hours, which may result from some extend of cell death at the longer treatment duration.

      In SH-SY5Y cells, we collected cells at 24 hours after MG132 administration (Figure 5—figure supplementary 1). Though protein aggregation was evident in these cells, we did not observe pronounced cell death under these conditions, justifying our treatment.

      Our findings are consistent with previous studies demonstrating that MG132 at 5 µM for 24 hours effectively induces proteasomal inhibition without substantial cytotoxicity. For example, studies using human esophageal squamous cancer cells have reported that this treatment condition inhibits cell proliferation while maintaining cell viability, with cell viability >70% after 24-hour treatment with 5 µM MG132 (Int J Mol Med 33: 1083-1088, 2014). 

      MG132 has been commonly used at concentrations ranging from 5 to 50 µM for durations of 1 to 24 hours, as stated at the vendor’s website (https://www.cellsignal.com/products/activatorsinhibitors/mg-132/2194).

      2I what is BALA do they mean bafilomycin. This is a v-ATPase inhibitor, not just an autophagy inhibitor.

      We appreciate the reviewer’s comment regarding the use of BALA in Figure 2I. To clarify, BALA refers to bafilomycin A1, a well-established v-ATPase inhibitor that blocks lysosomal acidification. While bafilomycin A1 is commonly used as an autophagy inhibitor, its primary mechanism involves inhibiting lysosomal function, which is critical for autophagosome-lysosome fusion and subsequent degradation of autophagic cargo.

      In our study, we used bafilomycin A1 in conjunction with puromycin to dissect the relative contributions of sPINK1 overexpression on proteasomal and autophagic activities. Puromycin induces protein misfolding and aggregation, causing stress on both degradation pathways. By inhibiting lysosomal function with bafilomycin A1 and blocking the protein degradation load at various stages, we can tell the relative contributions of autophagy and UPS pathways.

      We acknowledge that bafilomycin A1’s effects extend beyond autophagy, as it also inhibits v-ATPase activity. However, its inhibition of lysosomal degradation is integral to distinguishing autophagy’s contribution under the experimental conditions, and BALA treatment has been used in extensively in previous studies (Mauvezin and Neufeld, 2015). 

      We have further clarified this treatment in the revised manuscript.

      Figure 3. Legend or text needs to be more explicit about how chains have been produced. From what I can gather from methods only a single E2 has been trialed. Authors should use at least one of the criteria used by Wauer et al. (2014) to confirm the stoichiometry of phosphorylation. The concept that pUb can interfere with E2 discharging is not new, but not universal across E2s.

      We have cited in the manuscript that PINK1-mediated ubiquitin phosphorylation can interfere with ubiquitin chain elongation for certain E2 enzymes (Wauer et al., 2015). 

      To clarify, the focus of our current work is on how elevation of Ub phosphorylation impacts UPS activity, rather than exploring the broader effects of Ub phosphorylation on Ub chain elongation. For this reason, we have used the standard E2 that is well-established for generating K48-linked polyUb chain (Pickart CM, 2005). Moreover, our findings go further and by demonstrate that phosphorylated K48-linked polyubiquitin exhibits weaker non-covalent interactions with proteasomal ubiquitin receptors. This dual effect—on both covalent chain elongation and non-covalent interactions— contributes to the observed reduction in ubiquitin-proteasome activity, a novel aspect of our study.

      To address the reviewer’s concerns, we have added details in the Methods section and figure legends regarding the generation of ubiquitin chains. Specifically, we used ubiquitin-activating enzyme E1 (UniProt ID: P22314) and ubiquitin-conjugating enzyme E2-25K (UniProt ID: P61086) to generate K48-linked ubiquitin chains. 

      Our ESI-MS analysis showed that only 1–2 phosphoryl groups were incorporated into the K48-linked tetra-ubiquitin chains (Figure 3—figure supplement 2). This is consistent with our in vivo findings, where pUb levels increased by 30.4% in aged mouse brains compared to young brains (Figure 1F). Notably, even sub-stoichiometric phosphorylation onto the K48-linked ubiquitin chain significantly weakens the non-covalent interactions with the proteasome (Figures 3E and 3H).

      Figure 4. I could find no definition of the insoluble fraction, nor details on how it is prepared.

      The insoluble fraction primarily contains proteins that are aggregated or associated with hydrophobic interactions and cannot be solubilized by RIPA buffer. We have provided more details in the Methods of the revised manuscript about how the insoluble fraction was prepared. Our approach was based on established protocols for fractionating soluble and insoluble proteins from brain tissues (Wirths, 2017). Here is an outline of the procedure, which enables the separation and subsequent analysis of distinct protein populations:

      • Lysis and preparation of soluble fraction: Cells and brain tissues were lysed using RIPA buffer (Beyotime Biotechnology, cat# P0013B) containing protease (P1005) and phosphatase inhibitors (P1081) on ice for 30 minutes, with gentle vortexing every 10 minutes. Brain samples were homogenized using a precooled TissuePrep instrument (TP-24, Gering Instrument Company). Lysates were centrifuged at 12,000 rpm for 30 minutes at 4°C. The supernatant was collected as the soluble protein fraction.

      • Preparation of insoluble fraction: The pellet was resuspended in 20 µl of SDS buffer (2% SDS, 50 mM Tris-HCl, pH 7.5) and subjected to ultrasonic pyrolysis at 4°C for 8 cycles (10 seconds ultrasound, 30 seconds interval). The samples were then centrifuged at 12,000 rpm for 30 minutes at 4°C. The supernatant obtained after this step was designated as the insoluble protein fraction.

      • Protein quantification: Protein concentrations for both soluble and insoluble fractions were determined using the BCA Protein Assay Kit (Beyotime Biotechnology, cat# P0009).

      Figure 5. What is the transfection efficiency? How many folds is sPINK1 over-expressed? Typically, a neuron will have only a few hundred copies of PINK1 at the basal state. How much mutant ubiquitin is expressed relative to wild type, seeing the free ubiquitin signals on the gels might be helpful here, but they seem to have been cut off. 

      We appreciate the reviewer's insightful comments regarding transfection efficiency, the extent of sPINK1 overexpression, and the expression levels of mutant ubiquitin relative to wild-type ubiquitin. Below, we provide detailed responses to each point:

      Transfection Efficiency: Our immunofluorescent staining for NeuN, a neuronal marker, demonstrated that over 90% of NeuN-positive cells were co-localized with GFP (Figure 5—figure supplement 2), indicating a high transfection efficiency in our neuronal cultures.

      Extent of sPINK1 Overexpression: Quantifying the exact fold increase of sPINK1 upon overexpression is inherently difficult due to its low basal expression under physiological conditions, making the relative increase difficult to measure (small denominator effect). However, our Western blot analysis shows that ischemic events can cause a substantial elevation of PINK1 levels, including both full-length and cleaved forms (Figure 1H). This suggests that our overexpression model recapitulates the pathological increase in PINK1, making it a relevant system for studying disease mechanisms.

      From Figure 5B, it is evident that sPINK1 levels differ significantly between neurons overexpressing sPINK1 alone and those co-expressing sPINK1 + Ub/S65A (70 days post-transfection). Overexpression of sPINK1 alone results in multiple PINK1 bands, consistent with sPINK1, endogenous PINK1 (induced by mitochondrial damage), and ubiquitinated sPINK1. In comparison, co-expressing Ub/S65A leads to faint PINK1 bands, suggesting that in the presence of a functionally restored proteasome, overexpressed sPINK1 is rapidly degraded. Therefore, actual accumulation of sPINK1 depends on proteasomal activity, and the “over-expressed” PINK1 level can be comparable to levels observed under native, pathological conditions.

      Expression Levels of Mutant Ubiquitin Relative to Wild-Type: Assessing the expression levels of mutant versus wild-type ubiquitin is indeed valuable. In Figure 5E, we observed a 38.9% increase in high-molecular-weight ubiquitin conjugates in the soluble fraction when comparing the sPINK1+Ub/S65A group to the control. This increase suggests that mutant ubiquitin is actively incorporated into polyubiquitin chains.

      Regarding free monomeric ubiquitin, its low abundance and rapid incorporation into polyubiquitin chains make it difficult to visualize in Western blots. Additionally, its low molecular weight and lower antibody binding valency further reduce its visibility.

      General: a number of effects are shown following over-expression but no case is made that these levels of pUb are ever attained physiologically. I am very unconvinced by these findings and think the manuscript needs to be improved at multiple levels before being added to the record.

      We understand the reviewer’s concerns regarding the relevance of pUb levels observed in our overexpression model. To clarify, our study is not focused on physiological levels of pUb, but rather on pathologically elevated levels, which have been documented in various neurodegenerative conditions. While overexpression is not a perfect replication of pathological states, it provides a valuable tool to investigate mechanisms that become relevant under disease conditions. Moreover, we have taken steps to ensure the validity of our findings and to address potential limitations associated with overexpression models:

      Pathological Relevance: Besides several reported literatures, we observed significant increases in PINK1 and pUb levels in human brain samples from Alzheimer's disease (AD) patients, as well as in mouse models of AD, cerebral ischemia (including mouse middle cerebral artery occlusion ischemic model and oxygen glucose deprivation cell model), and aging (e.g., Figures 1E, 1F, and 1H). All these data show that pUb levels are elevated under pathological conditions. Our overexpression model mimics these pathological scenarios by recreating the high levels of pUb, which lead to the impairment of proteasomal activity and subsequent disruption of proteostasis.

      Use of Robust Controls: To ensure the reliability of our results and interpretations, we employed multiple controls for our experiments. We have used pink1<sup>-/-</sup> mice and cells to confirm that pUb accumulation is PINK1-dependent (Figures 1C and 2C). We have also included kinase-dead sPINK1 mutant and Ub/S65A phospho-null mutants to negate/counteract the specific roles of PINK1 activity and pUb in proteasomal dysfunction. On the other hand, we have used Ub/S65E for phosphomimetic mutant, corresponding to a 100% Ub phosphorylation.

      Importantly, we have compared sPINK1 overexpression with both baseline and disease-mimicking conditions, thus to ensure that the observed effects are consistent with pathological changes. Furthermore, our findings are supported by complementary evidences from human brain samples, model animals, cell cultures, and molecular assays. Integrating the different controls and various approaches, we have provided mechanistic insights into how elevated pUb levels causes proteasomal impairment and contributes to neurodegeneration.

      Our findings elucidate how elevated pUb level contributes to the disruption of proteostasis in neurodegenerative conditions. While overexpression may have limitations, it remains a powerful tool for dissecting pathological mechanisms and testing hypotheses. Our results align with and expand upon previous studies suggesting pUb as a biomarker of neurodegeneration (Hou, et al, 2018; Fiesel, et al, 2015), and provide mechanistic insights into how elevated pUb and sPINK1 drive a viscous feedforward cycle, ultimately leading to proteasomal dysfunction and neurodegeneration. 

      We hope these clarifications highlight the relevance and rigor of our study, and welcome additional suggestions to improve the manuscript.

      Reviewer #3 (Public review):

      Summary:

      This study aims to explore the role of phosphorylated ubiquitin (pUb) in proteostasis and its impact on neurodegeneration. By employing a combination of molecular, cellular, and in vivo approaches, the authors demonstrate that elevated pUb levels contribute to both protective and neurotoxic effects, depending on the context. The research integrates proteasomal inhibition, mitochondrial dysfunction, and protein aggregation, providing new insights into the pathology of neurodegenerative diseases.

      Strengths:

      - The integration of proteomics, molecular biology, and animal models provides comprehensive insights.

      - The use of phospho-null and phospho-mimetic ubiquitin mutants elegantly demonstrates the dual effects of pUb.

      - Data on behavioral changes and cognitive impairments establish a clear link between cellular mechanisms and functional outcomes.

      Weaknesses:

      - While the study discusses the reciprocal relationship between proteasomal inhibition and pUb elevation, causality remains partially inferred.

      It has been well-established that protein aggregates, particularly neurodegenerative fibrils, can impair proteasomal activity (McDade, et al., 2024; Kinger, et al., 2024; Tseng, et al., 2008). Other contributing factors, including ATP depletion, reduced proteasome component expression, and covalent modifications of proteasomal subunits, can also lead to declined proteasomal function. Additionally, mitochondrial injury serves as an important source of elevated PINK1 and pUb levels. Recent studies have demonstrated that efficient mitophagy is essential to prevent pUb accumulation, whereas partial mitophagy failure results in elevated PINK1 levels (Chin, et al, 2023; Pollock, et al. 2024).

      While pathological conditions can impair proteasomal function and slow sPINK1 degradation, leading to its accumulation, our results demonstrate that overexpression of sPINK1 or PINK1 can initiate this cycle as well. Once this cycle is initiated, it becomes self-perpetuating, as sPINK1 and pUb accumulation progressively impair proteasomal function, leading to more protein aggregates and mitochondrial damages.

      Importantly, we show that co-expression of Ub/S65A effectively rescues cells from this cycle, which further illustrates the pivotal role of pUb in driving proteasomal inhibition and the causality between pUb elevation and proteasomal inhibition. At the animal level, pink1 knockout prevents protein aggregation under aging and cerebral ischemia conditions (Figures 1E and 1G). 

      Together, by controlling at protein, cell, and animal levels, our findings support this self-reinforcing and self-amplifying cycle of pUb elevation, proteasomal inhibition, protein aggregation, mitochondrial damage, and ultimately, neurodegeneration.

      - The role of alternative pathways, such as autophagy, in compensating for proteasomal dysfunction is underexplored.

      Indeed, previous studies have shown that elevated sPINK1 can enhance autophagy (Gao, et al., 2016,), potentially compensating for impaired UPS function. One mechanism involves PINK1mediated phosphorylation of p62, which enhances autophagic activity.

      In our study, we observed increased autophagic activity upon sPINK1 overexpression, as shown in Figure 2I (middle panel, without BALA). This increase in autophagy may facilitate the degradation of ubiquitinated proteins induced by puromycin, partially mitigating proteasomal dysfunction. This compensation might also explain why protein aggregation, though statistically significant, increased only slightly at 70 days post-sPINK1 transfection (Figure 5F). Additionally, we detected a mild but statistically insignificant increase in LC3II levels in the hippocampus of mouse brains at 70 days postsPINK1 transfection (Figure 5—figure supplement 6), further supporting the notion of autophagy activation.

      However, while autophagy may provide some compensation, its effect is likely limited. The UPS and autophagy serve distinct roles in protein degradation:

      • Autophagy is a bulk degradation pathway, primarily targeting damaged organelles, intracellular pathogens, and protein aggregates, often in a non-selective manner.

      • The UPS, in contrast, is highly selective, degrading short-lived regulatory proteins, misfolded proteins, and proteins tagged for degradation via ubiquitination.

      Thus, while sPINK1 overexpression enhances autophagy-mediated degradation, it simultaneously impairs UPS-mediated degradation. This suggests that autophagy partially compensates for proteasomal dysfunction but is insufficient to counterbalance the UPS's selective degradation function. We have incorporated additional discussion in the revised manuscript.

      - The immunofluorescence images in Figure 1A-D lack clarity and transparency. It is not clear whether the images represent human brain tissue, mouse brain tissue, or cultured cells. Additionally, the DAPI staining is not well-defined, making it difficult to discern cell nuclei or staging. To address these issues, lower-magnification images that clearly show the brain region should be provided, along with improved DAPI staining for better visualization. Furthermore, the Results section and Figure legends should explicitly indicate which brain region is being presented. These concerns raise questions about the reliability of the reported pUb levels in AD, which is a critical aspect of the study's findings.

      We have taken steps to address the concerns regarding clarity and transparency in Figure 1A-D. We have already addressed the source of tissues at the left of each images. For example, we have written “human brain with AD” at the left side of Figure 1A, and “mouse brains with AD” at the left side of Figure 1C.

      Briefly, the human brain samples in Figure 1 originate from the cingulate gyrus of Alzheimer’s disease (AD) patients. Our analysis revealed that PINK1 is primarily localized within cell bodies, whereas pUb is more abundant around Aβ plaques, likely in nerve terminals. For the mouse brain samples, we have now explicitly indicated in the figure legends and Results section that the images represent the neocortex of APP/PS1 mice, a mouse model relevant to AD pathology, as well as the corresponding regions in wild-type and pink1<sup>-/-</sup> mice. We have ensured that the brain regions and sources are clearly stated throughout the manuscript.

      Regarding image clarity, we have uploaded higher-resolution versions of the images in the revised manuscript to improve visualization of key features, including DAPI staining. We believe these revisions enhance the reliability and interpretability of our findings, particularly in relation to the reported pUb levels in AD. 

      - Figure 4B should also indicate which brain region is being presented.

      The images were taken for layer III-IV in the neocortex of mouse brains. We have included this information in the figure legend of the revised manuscript.

      Reviewer #3 (Recommendations for the authors):

      - Expand on the potential compensatory role of autophagy in response to proteasomal dysfunction.

      Upon proteasomal inhibition, cells may activate autophagy as an alternative pathway of degradation to help clear damaged or misfolded proteins. Autophagy is a bulk degradation process that targets long-lived proteins, damaged organelles, and aggregated proteins for lysosomal degradation. While this pathway can provide some compensation, it is distinct from the ubiquitin-proteasome system (UPS), which specializes in the selective degradation of short-lived regulatory proteins and misfolded proteins.

      In our study, we observed increased autophagic activity following sPINK1 overexpression (Figure 2J, middle panel, without BALA) and a slight, though statistically insignificant, increase in LC3II levels in the hippocampus of mouse brains at 70 days post-sPINK1 transfection (Figure 5—figure supplement 6). These findings suggest that autophagy is indeed upregulated as a compensatory response to proteasomal dysfunction, potentially facilitating the degradation of aggregated ubiquitinated proteins. Additionally, gene set enrichment analysis (GSEA) revealed similar enrichment of autophagy pathways at 30 and 70 days post-sPINK1 overexpression (Figure 5—figure supplement 5).

      However, the compensatory capacity of autophagy is likely limited. While autophagy can reduce protein aggregation, it is an inherently non-selective process and cannot fully replace the targeted functions of the UPS. Moreover, as we illustrate in Figure 7 of the revised manuscript, UPS is essential for degrading specific regulatory and inhibitory proteins and plays a critical role in cellular proteostasis, particularly in signaling regulation, cell cycle control, and stress responses.

      Together, while autophagy activation provides some degree of compensation, it cannot fully restore cellular proteostasis. The interplay between these two degradation pathways is an important area for future investigation. For the present study, our focus is on how pUb elevations impact proteasomal activity and elicits downstream effects.

      We have incorporated these additional discussions on this topic in the revised manuscript.

      - Simplify the discussion of complex mechanisms to improve accessibility for readers.

      We have revised the Discussion to present the mechanisms in a more coherent and accessible manner, ensuring clarity for a broader readership. These revisions should make the discussion more intuitive while preserving the depth of our findings.

      - Statistical analyses could benefit from clarifying how technical replicates and biological replicates were accounted for across experiments.

      We have clarified our statistical analysis in the Methods section and figure legends, explicitly detailing how many biological replicates were accounted for across experiments. These revisions should enhance transparency and clarity, ensuring that our findings are robust and reproducible.

      - The image in Figure 3D is too small to distinguish any signals. A larger and clearer image should be presented.

      We have expanded the images in Figure 3D. Additionally, we have replaced figures with version of better resolutions throughout the manuscript.

      - NeuN expression in Figure 4B differs between wildtype and pink-/- mice. Additional validation is needed to determine whether pink-/- enhances NeuN expression.

      The difference in NeuN immunofluorescence intensity between wild-type and pink1<sup>-/-</sup> mice in Figure 4B may simply result from variations in image acquisition rather than an actual difference in NeuN expression.

      Our single nuclei RNA-seq analyses of wild-type and pink1<sup>-/-</sup> mice at 3 and 18 months of age reveal no significant differences in NeuN expression at the transcript level (data provided below). This confirms that the observed variation in fluorescence intensity is unlikely to reflect an authentic upregulation of NeuN expression. Thus, factors like the concentration of antibody, image exposure and processing may contribute to differences in staining intensity.

      Author response image 1.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      This paper examines the role of MLCK (myosin light chain kinase) and MLCP (myosin light chain phosphatase) in axon regeneration. Using loss-of-function approaches based on small molecule inhibitors and siRNA knockdown, the authors explore axon regeneration in cell culture and in animal models. Their evidence shows that MLCK activity facilitates axon extension/regeneration, while MLCP prevents it.

      Major concern:

      A global inconsistency in the conclusions of the authors is evident when trying to understand the role of NMII in axon growth and to understand the present results in light of previous reports by the authors and many others on the role of NMII in axon extension. The discussion of the matter fails to acknowledge a vast literature on how NMII activity is regulated. The authors study enzymes responsible for the phosphorylation and dephosphorylation of NMII, referring to something that is strongly proven elsewhere, that phosphorylation activates NMII and dephosphorylation deactivates it. The authors mention their own previous evidence using inhibitors of NMII ATPase activity (blebbistatin, Bleb for short) and inhibitors of a kinase that phosphorylates NMII (ROCK), highlighting that Bleb increases axon growth. Since Bleb inhibits the ATPase activity of NMII, it follows that NMII is in itself an inhibitor of axon growth, and hence when NMII is inhibited, the inhibition on axon growth is relieved, and axonal growth takes place (REF1). It is known that NMII exists in an inactive folded state, and ser19 phosphorylation (by MLCK or ROCK) extends the protein, allowing NMII filament formation, ATPase activity, and force generation on actin filaments (REF2). From this, it is derived that if MLCK is inhibited, then there is no NMII phosphorylation, and hence no NMII activity, and, according to their previous work, this should promote axon growth. On the contrary, the authors show the opposite effect: in the lack of phospho-MLC, authors show axon growth inhibition.

      We thank the Reviewer for taking time to review our manuscript, and we really appreciated the comments from the reviewer. We have tried our best to revise the manuscript to address all the comments raised by the Reviewer.

      Reporting evidence challenging previous conclusions is common business in scientific endeavors, but the problem with the current manuscript is that it fails to point to and appropriately discuss this contradiction. Instead, the authors refer to the fact that MLCK and Bleb inhibit NMII in different steps of the activation process. While this is true, this explanation does not solve the contradiction. There are many options to accommodate the information, but it is not the purpose of this revision to provide them. Since the manuscript is focused solely on phosphorylation states of MLC and axon extension, the claims are simply at odds with the current literature, and this important finding, if true, is not properly discussed.

      Thank you for reviewer's very good comments. As suggested by Reviewer, we discuss more detail it in our revised manuscripts (line 357-368; line 373-374).

      What follows is a discussion of the merits and limitations of different claims of the manuscript in light of the evidence presented.

      (1) Using western blot and immunohistochemical analyses, authors first show that MLCK expression is increased in DRG sensory neurons following peripheral axotomy, concomitant to an increase in MLC phosphorylation, suggesting a causal effect (Figure 1). The authors claim that it is common that axon growth-promoting genes are upregulated. It would have been interesting at this point to study in this scenario the regulation of MLCP, which is a main subject in this work, and expect its downregulation.

      We thank the Reviewer for taking time to review our manuscript, and we really appreciated the positive comments from the Reviewer.

      (2) Using DRG cultures and sciatic nerve crush in the context of MLCK inhibition and down-regulation, authors conclude that MLCK activity is required for mammalian peripheral axon regeneration both in vitro and in vivo (Figure 2).

      The in vitro evidence is of standard methods and convincing. However, here, as well as in all other experiments using siRNAs, it is not clear what the control is about (the identity of the plasmids and sequences, if any).

      We used the pCMV–EGFP–N3 as control, and the pCMV–EGFP–N3 plasmid was from Clontech, Inc. (line 114-115).   

      Related to this, it is not helpful to show the same exact picture as a control example in Figures 2 and 3 (panels J and E, respectively). Either because they should not have received the same control treatment, or simply because it raises concern that there are no other control examples worth showing. In these images, it is not also clear where and how the crush site is determined in the GFP channel. This is of major importance since the axonal length is measured from the presumed crush site. Apart from providing further details in the text, the authors should include convincing images.

      Thank you so much for your comments. We changed the control example in Figure 3J. For sciatic nerve regeneration experiments, the sciatic nerve was exposed at the sciatic notch by a small incision 2 days after the in vivo electroporation. The nerve was then crushed, and the crush site was marked with a 11-0 nylon epineural suture. After surgeries, the wound was closed, and the mice were allowed to recover. Three days after the sciatic nerve crush, the whole sciatic nerves from the perfused animals were dissected out and postfixed overnight in 4% PFA at 4°C. Before whole-mount flattening, it was confirmed that the place of epineural suture matched the injury site, and experiments were included in the analysis only when the crush site was clearly identifiable. Using whole mounted tissue, all identifiable EGFP-labeled axons in the sciatic nerve were manually traced from the crush site to the distal growth cone to measure the length of axon regeneration. (line 159-164).

      (3) The authors then examined the role of the phosphatase MLCP in axon growth during regeneration. The authors first use a known MLCP blocker, phorbol 12,13-dibutyrate (PDBu), to show that is able to increase the levels of p-MLC, with a concomitant increase in the extent of axon regrowth of DRG neurons, both in permissive as well as non-permissive. The authors repeat the experiments using the knockdown of MYPT1, a key component of the MLC-phosphatase, and again can observe a growth-promoting effect (Figure 3).

      The authors further show evidence for the growth-enhancing effect in vivo, in nerve crush experiments. The evidence in vivo deserves more evidence and experimental details (see comment 2). Some key weaknesses of the data were mentioned previously (unclear RNAi controls and duplication of shown images), but in this case, it is also not clear if there is a change only in the extent of growth, or also in the number of axons that are able to regenerate.

      Thank you so much for your comments. We used same control as in vitro experiments (the pCMV– EGFP–N3 plasmid was from Clontech, Inc), and we also changed the control image in Figure 3J. For in vivo axon regeneration experiments, we measured the lengths of all identifiable EGFP-labelled axons in the sciatic nerve from the crush site to the distal axonal ends. The number of EGFP labeled regenerating axons were actually determined by the electroporation rate of EGFP, which is similar, but not identical, in different mice. Thus, our data only can show the differences in axon lengths among different experimental conditions. Such approach has been used in many of our previously published papers (e.g. Saijilafu et al. Nature Communications, 2011, Saijilafu et al. Nature Communications, 2013). (line 152-153).

      (4) In the next set of experiments (presented in Figure 4) authors extend the previous observations in primary cultures from the CNS. For that, they use cortical and hippocampal cultures, and pharmacological and genetic loss-of-function using the above-mentioned strategies. The expected results were obtained in both CNS neurons: inhibition or knockdown of the kinase decreases axon growth, whereas inhibition or knockdown of the phosphatase increases growth. A main weakness in this set is that it is not indicated when (at what day in vitro, DIV) the treatments are performed. This is important to correctly interpret the results, since in the first days in vitro these neurons follow well-characterized stages of development, with characteristic cellular events with relevance to what is being evaluated. Importantly, this would be of value to understand whether the treatments affect axonal specification and/or axonal extension. Although these events are correlated, they imply a different set of molecular events.

      The treatments were started from the initial of cell culture period, and this procedure may affect axon specification as the Reviewer point out. However, we mainly focused on axon length in our experiments, thus, for quantification of axon length, neurons with processes longer than twice the diameter of cell bodies were photographed, and the longest axon of each neuron was measured. We revised the manuscript as suggested by the reviewer (line 143-145).

      The title of this section is misleading: line 241 "MLCK/MLCP activity regulated axon growth in the embryonic CNS"... the title (and the conclusion) implies that the experiments were performed in situ, looking at axons in the developing brain. The most accurate title and conclusion should mention that the evidence was collected in CNS primary cultures derived from embryos.

      We have revised the manuscript as suggested by the reviewer (line 251).

      (5) Performing nerve crush injury in CNS nerves (optic nerve and spinal cord), and the local application of PBDu, the author shows contrasting results (Figure 5). In the ON nerve, they can see axons extending beyond the lesion site due to PBDu. On the contrary, the authors fail to observe so in the corticospinal tract present in the spinal cord. The authors fail to discuss this matter in detail. Also, they accommodate the interpretation of the evidence in light of a process known as axon retraction, and its prevention by MLCP inhibition. Since the whole paper is on axon extension, and it is known that mechanistically axon retraction is not merely the opposite of axon extension, the claim needs far more evidence.

      Thank you so much for your comments. Compared to optic nerve axons, corticospinal tract axons exhibit a reduced intrinsic axon growth capability. Consequently, we observed that PBDu stimulates optic nerve axon regeneration. However, unfortunately, we did not detect any enhancement in corticospinal tract axons beyond the injury site in SCI following the inhibition of myosin light chain phosphatase (MLCP) with PBDu.

      In panel 5F and the supplementary data, the authors mention the occurrence of retraction bulbs, but the images are too small to support the claim, and it is not clear how these numbers were normalized to the number of axons labeled in each condition.

      Thank you so much for your comments. In this study, we used a similar method from Ertürk et al. (2007) to quantify the retraction bulb. Both maximum width of the enlarged distal tip of the axon and the width of its immediately adjacent axon shaft was measured. Then, the ratio of these two widths was then calculated. An axonal tip was considered as a retraction bulb if its tip/shaft ratio exceeded 4. Averages number of retraction bulb were calculated from 3 sections in every mice for each group (n=5). (line 187-191).

      [Ref] Ertürk A, Hellal F, Enes J, and Bradke F (2007). Disorganized microtubules underlie the formation of retraction bulbs and the failure of axonal regeneration. J. Neurosci 27, 9169–9180. [PubMed:17715353].

      (6) The author combines MLCK and MLCP inhibitors with Bleb, trying to verify if both pairs of inhibitors act on the same target/pathway (Figure 6). The rationale is wrong for at least two reasons.<br /> a- Because both lines of evidence point to contrasting actions of NMII on axon growth, one approach could never "rescue" the other.

      If MLCK regulates axon growth through the activation of Myosin, the inhibitory effect of ML-7 (an MLCK inhibitor) on axon growth might be influenced by Bleb, a NMII inhibitor. However, our findings reveal that the combination of Bleb and ML-7 does not alter the rate of axon outgrowth compared to ML-7 alone. This suggests that the roles of ML-7 and Bleb in axon growth are independent. It means MLCK may regulates axon growth independent of NMII activity.

      b. Because the approaches target different steps on NMII activation, one could never "prevent" or rescue the other. For example, for Bleb to provide a phenotype, it should find any p-MLC, because it is only that form of MLC that is capable of inhibiting its ATPase site. In light of this, it is not surprising that Bleb is unable to exert any action in a situation where there is no p-MLC (ML-7, which by inhibiting the kinase drives the levels of p-MLC to zero, Figure 4A). Hence, the results are not possible to validate in the current general interpretation of the authors. (See 'major concern').

      The reported mechanism of blebbistatin is not through competition with the ATP binding site of myosin. Instead, it selectively binds to the ATPase intermediate state associated with ADP and inorganic phosphate, which decelerates the phosphate release. Importantly, blebbistatin does not impede myosin's interaction with actin or the ATP-triggered disassociation of actomyosin. It rather inhibits the myosin head when it forms a product complex with a reduced affinity for actin. This indicates that blebbistatin functions by stabilizing a particular myosin intermediate state that is independent of the phosphorylation status of myosin light chain (MLC).

      [Ref] Kovács M, Tóth J et al. Mechanism of blebbistatin inhibition of myosin II. J Biol Chem. 2004 Aug 20;279(34):35557-63. doi: 10.1074/jbc.M405319200.

      (7) In Figure 7, the authors argue that the scheme of replating and using ML7 before or after replating is evidence for a local cytoskeletal action of the drug. However, an alternative simpler explanation is that the drug acts acutely on its target, and that, as such, does not "survive" the replating procedure. Hence, the conclusion raised by the evidence shown is not supported.

      In our study, we meticulously assessed the neuronal survival rates across various experimental groups. The findings indicate no significant variation in survival rates among the groups. This suggests that the drug treatment exerts no discernible influence on cell viability but primarily modulates axonal elongation."

      Author response image 1.

      (8) In Figure 8, the authors show that the inhibitory treatments on MLCK and MLCP (ML7 and PRBu) alter the morphology of growth cones. However, it is not clear how this is correlated with axon growth. The authors also mention in various parts of the text that a local change in the growth cone is evidence for a local action/activity of the drug or enzyme. However, the local change<->local action is not a logical truth. It can well be that MLCK and MLCP activity trigger molecular events that ultimately have an effect elsewhere, and by looking at "elsewhere" one observes of course a local effect but is not because the direct action of MLCK or MLCP are localized. To prove true localized effects there are numerous efforts that can be made, starting from live imaging, fluorescent sensors, and compartmentalized cultures, just to mention a few.

      About the relationship between growth cone size and its growth rate, the previous published literatures found that a fast-growing axon tended to have small growth cones (Mason C. et al. 1997). A recent study on Aplysia further supports this by noting that growth cones enlarge significantly when axonal elongation halts (Miller and Suter, 2018). Consistent with these findings, our data indicate that inhibiting MLCP with PDBu treatment leads to a reduction in growth cone size, which in turn promotes axon regeneration.

      [Ref] Mason CA, Wang LC. Growth cone form is behavior-specific and, consequently, position-specific along the retinal axon pathway. J Neurosci. 1997; 13:1086–1100. [PubMed: 8994063]

      [Ref] Miller KE, Suter DM. An Integrated Cytoskeletal Model of Neurite Outgrowth. Front Cell Neurosci. 2018 Nov 26;12:447. doi: 10.3389/fncel.2018.00447. eCollection 2018.

      References:

      (1) Eun-Mi Hur 1, In Hong Yang, Deok-Ho Kim, Justin Byun, Saijilafu, Wen-Lin Xu, Philip R Nicovich, Raymond Cheong, Andre Levchenko, Nitish Thakor, Feng-Quan Zhou. 2011. Engineering neuronal growth cones to promote axon regeneration over inhibitory molecules. Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5057-62. doi: 10.1073/pnas.1011258108.

      (2) Garrido-Casado M, Asensio-Juárez G, Talayero VC, Vicente-Manzanares M. 2024. Engines of change: Nonmuscle myosin II in mechanobiology. Curr Opin Cell Biol. 2024 Apr;87:102344. doi: 10.1016/j.ceb.2024.102344.

      (3) Karen A Newell-Litwa 1, Rick Horwitz 2, Marcelo L Lamers. 2015. Non-muscle myosin II in disease: mechanisms and therapeutic opportunities. Dis Model Mech. 2015 Dec;8(12):1495-515. doi: 10.1242/dmm.022103.

      Reviewer #2 (Public review):

      Summary:

      Saijilafu et al. demonstrate that MLCK/MLCP proteins promote axonal regeneration in both the central nervous system (CNS) and peripheral nervous system (PNS) using primary cultures of adult DRG neurons, hippocampal and cortical neurons, as well as in vivo experiments involving sciatic nerve injury, spinal cord injury, and optic nerve crush. The authors show that axon regrowth is possible across different contexts through genetic and pharmacological manipulation of these proteins. Additionally, they propose that MLCK/MLCP may regulate F-actin reorganization in the growth cone, which is significant as it suggests a novel strategy for promoting axonal regeneration.

      Strengths:

      This manuscript presents a comprehensive array of experimental models, addressing the biological question in a broad manner. Particularly noteworthy is the use of multiple in vivo models, which significantly strengthens the overall validity of the study.

      We thank the Reviewer for taking time to review our manuscript, and we really appreciated the positive comments from the Reviewer.

      Weaknesses:

      The following aspects apply:

      (1) The manuscript initially references prior research by the authors suggesting that NMII inhibition enhances axonal growth and that MLCK activates NMII. However, the study introduces a contradiction by demonstrating that MLCK inhibition (via ML-7 or siMLCK) inhibits axonal growth. This inconsistency is not adequately addressed or discussed in the manuscript.

      Thank you for reviewer's very good comments. As suggested by Reviewer, we discuss more detail it in our revised manuscripts (line 357-368; line373-374).

      (2) While the study proposes that MLCK/MLCP regulates F-actin redistribution in the growth cone, the mechanism is not explored in depth. The only figure showing how pharmacological manipulation affects the growth cone suggests that not only F-actin but also the microtubule cytoskeleton might be affected, indicating that the mechanism may not be specific. A deeper exploration of this relationship in DRG neurons, in addition to cortical neurons, as shown in the study, would be beneficial.

      Thank you for your insightful suggestion. However, our study primarily focuses on actin and myosin dynamics in the context of axonal elongation, as indicated by our direct observations in growing dorsal root ganglia (DRGs). Athamneh et al. (2017) elegantly demonstrated that the bulk movement of microtubules (MTs), rather than their assembly, predominantly drives MT advance during axonal elongation. Consequently, our manuscript concentrates on the actomyosin system, which is central to our findings. While the role of MTs in axonal growth is indeed significant and fascinating, the data we present is predominantly concerned with the actomyosin mechanism.

      [Ref] Athamneh, A. I. M. et al. Neurite elongation is highly correlated with bulk forward translocation of microtubules. Scientific Reports 7, (2017).

      (3) In the sciatic nerve injury experiments, it would be crucial to include additional controls that clearly demonstrate that siMYPT1 treatment increases MLCP in the L4-L5 ganglia. Additionally, although the manuscript mentions quantifying axons expressing EGFP, the Materials and Methods section only discusses siMYPT1 electroporation, which could lead to confusion.

      Thank you for your suggestion. However, due to the unavailability of a suitable commercial MLCP antibody, we were unable to directly detect MLCP expression. Instead, we assessed the phosphorylation level of myosin light chain (MLC) as a proxy to indicate that siMYPT1 transfection effectively downregulates MLCP activity in L4/5 dorsal root ganglia (DRG). This approach was taken to ensure the integrity of our findings despite the limitations in antibody availability.

      About the electroporation method section, we have now included detailed information about the control plasmid used in our experiments to ensure a clear understanding of our experimental setup and to validate our results. A 1 μl solution containing indicated siRNAs together with the plasmid encoding EGFP (pCMV–EGFP–N3) was then microinjected into the L4–L5 DRG….. (line 152-153).

      (4) In some panels, it is difficult to differentiate the somas from the background (Figures 3, 4, 7). In conditions where images with shorter axonal lengths are represented, it is unclear whether this is due to fewer cells or reduced axonal growth (Figures 2, 4, 6).

      In the original submission, there was some loss of image quality while converting the TIFF to PDF. We improved the quality of images in our revised manuscripts.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      There are a number of typos and language errors that should be thoroughly revised. For example, line 219: "It is well known that the opposite role of MLCK and MLCP to regulate the MLC phosphorylation status". The term "opposite role" is vague. Using "opposite roles" and specifying that they are in regulating MLC phosphorylation status clarifies the relationship between MLCK and MLCP. Also, the original phrase "to regulate" was not correctly integrated into the sentence. Rephrasing it to "in regulating" makes the role of MLCK and MLCP clearer.

      We have revised the manuscript as suggested by the reviewer (line 229).

      In the same line, there is a high number of panels that are not referred to in the text or references for panels that have another letter. Just to mention a few:

      - line 199: "(Figure 1F, G)", → BUT figure 1 contains no G panel.

      We have revised the manuscript as suggested by the reviewer (line 209).

      - line 203: "The results showed that ML-7 administration led to a significant reduction in MLC phosphorylation levels (Figure 2A, B) and impaired axonal growth in sensory neurons (Figure 2C, D). → BUT panel C is related to A and B, and only D and E show impaired axonal growth.

      We have revised the manuscript as suggested by the reviewer (line 214; line 215; line 217; line 219 ).

      Reviewer #2 (Recommendations for the authors):

      (1) Improving the quality of the images would significantly strengthen the results presented.

      In the original submission, there was some loss of image quality while converting the TIFF to PDF. We improved the quality of images in our revised manuscripts.

      (2) The representative images of controls do not always show the same number of cells or axonal growth (e.g., Figure 4).

      We have changed some images as suggested by the reviewer.

      (3) The text has citation errors when referring to the figure labels.

      Upon thorough review, we have carefully examined our manuscript and have made the necessary corrections to address the identified errors. We appreciate the opportunity to enhance the quality of our work and believe that these revisions have significantly improved the clarity of our manuscript.

      (4) What happens to MLCK levels when MLCP activity is inhibited in the optic nerve?

      Upon analyzing our experimental data, we observed no significant alterations in the protein levels of MLCK when the activity of MLCP was inhibited. This finding suggests that the regulatory mechanisms governing MLCK expression may not be directly influenced by short-term MLCP inhibition. It is plausible that the duration of the inhibition period was insufficient to elicit a detectable change in MLCK expression levels.

      (5) The text in line 266: "In contrast, local PBS administration at the injury site or intravitreal PDBu injection induced little axon regeneration beyond the injury site (Figure 5 A-C)." However, this is not reflected in the figure.

      In our revised manuscript, we have provided a more precise description of our findings: In contrast, local PBS administration at the injury site or intravitreal PDBu injection did not significantly enhance axon regeneration beyond the injury site (Figure 5 A-C). This observation suggests that the only treatment employed in the injury site (the inhibition of MLCP activity within the growth cone) effective promote axonal growth. (line 276-279).

      (6) Line 287: The phrase "Consistent with our previous study" requires a citation to support it.

      We added the reference paper; Consistent with our previous study 1, the inhibition of myosin II activity with 25 μM blebbistatin markedly promoted axonal growth (Figure 6A, B). (line 298)

      (7) Line 333: The paper cited by Yu P et al. (2012) does not mention MLCK or p-MLC, so it appears to be misquoted.

      Thank you for comments. We rechecked this cited paper and confirmed that the author provided the western data C in the supplementary figure 1, it showed that Bleb did not alter the phosphorylation status of MLC.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Dong et al here have studied the impact of the small Ras-like GTPase Rab10 on the exocytosis of dense core vesicles (DVC), which are important mediators of neuropeptide signaling in the brain. They use optical imaging to show that lentiviral depletion of Rab10 in mouse hippocampal neurons in culture independent of the established defects in neurite outgrowth hamper DCV exocytosis. They further demonstrate that such defects are paralleled by changes in ER morphology and defective ER-based calcium buffering as well as reduced ribosomal protein expression in Rab10-depleted neurons. Re-expression of Rab10 or supplementation of exogenous L-leucine to restore defective neuronal protein synthesis rescues impaired DCV secretion. Based on these results they propose that Rab10 regulates DCV release by maintaining ER calcium homeostasis and neuronal protein synthesis.

      Strengths:

      This work provides interesting and potentially important new insights into the connection between ER function and the regulated secretion of neuropeptides via DCVs. The authors combine advanced optical imaging with light and electron microscopy, biochemistry, and proteomics approaches to thoroughly assess the effects of Rab10 knockdown at the cellular level in primary neurons. The proteomic dataset provided may be valuable in facilitating future studies regarding Rab10 function. This work will thus be of interest to neuroscientists and cell biologists.

      We appreciate the positive evaluation of our manuscript.

      Weaknesses:

      While the main conclusions of this study are comparably well supported by the data, I see three major weaknesses:

      (1) For some of the data the statistical basis for analysis remains unclear. I.e. is the statistical assessment based on N= number of experiments or n = number of synapses, images, fields of view etc.? As the latter cannot be considered independent biological replicates, they should not form the basis of statistical testing.

      This is an important point and we agree that multiple samples from the same biological replicate are not independent observations. We reanalyzed all nested data using a linear mixed model and indicated this in the Methods section and the relevant figure legends (Brunner et al., 2022). In brief, biological replicates (individual neuronal cultures) were used as a linear predictor. Outliers were identified and excluded using the ROUT method in GraphPad. A fixed linear regression model was then fitted to the data using the lm() function in R. A one-way anova (analysis of variance) was used to assess whether including the experimental group as a second linear predictor (formula = y ~ Group + Culture) statistically improved the fit of a model without group information (formula = y ~ 1 + Culture). Post-hoc analysis was performed using the emmeans() function with Tukey’s adjustment when more than two experimental groups were present. Importantly, our conclusions remain unchanged.

      (2) As it stands the paper reports on three partially independent phenotypic observations, the causal interrelationship of which remains unclear. Based on prior studies (e.g. Mercan et al 2013 Mol Cell Biol; Graves et al JBC 1997) it is conceivable that defective ER-based calcium signaling and the observed reduction in protein synthesis are causally related. For example, ER calcium release is known to promote pS6K1 phosphorylation, a major upstream regulator of protein synthesis and ribosome biogenesis. Conversely, L-leucine supplementation is known to trigger calcium release from ER stores via IP3Rs. Given the reported impact of Rab10 on axonal transport of autophagosomes and, possibly, lysosomes via JIP3/4 or other mediators (see e.g. Cason and Holzbaur JCB 2023) and the fact that mTORC1, the alleged target of leucine supplementation, is located on lysosomes, which in turn form membrane contacts with the ER, it seems worth analyzing whether the various phenotypes observed are linked at the level of mTORC1 signaling.

      This is great suggestion that could indeed further clarify the potential interplay between ER-based Ca2+ signaling and protein synthesis. To address this, we assessed the phosphorylation level of pS6K1 in control and Rab10 knockdown (KD) neurons with or without leucine treatment. These data are included in the new Figure 8—figure supplement 1 in the revised manuscript. Our results indicate that pS6K1 phosphorylation was not upregulated in Rab10 KD neurons, suggesting that the level of mTORC1 signaling is not different between wild-type or KD neurons. Furthermore, leucine treatment increased the pS6K1 phosphorylation level, as expected, but this effect was similar in both groups. Hence, we conclude that differences in mTORC1 signaling induced by Rab10 loss is not a major factor in the observed impairment in protein synthesis.

      Author response image 1.

      Rab10 depletion does not upregulate mTORC1 pathway. (A)Typical immunoblot showing pS6K1 levels in each condition. (B) Quantification of relative pS6K1 levels in each condition. All Data are plotted as mean±s.e.m. (C) Control, Control + Leu: N = 2, n = 2, Rab10 KD, Rab10 KD + Leu: N = 2, n = 4.

      (3) The claimed lack of effect of Rab10 depletion on SV exocytosis is solely based on very strong train stimulation with 200 Aps, a condition not very well suited to analyze defects in SV fusion. The conclusion that Rab10 loss does not impact SV fusion thus seems premature.

      We agree that 200 APs stimulation might be too strong to detect specific effects on evoked synaptic vesicle release, although this stimulation pattern is an established pattern in hundreds of studies (Emperador-Melero et al., 2018; Granseth et al., 2006; Ivanova et al., 2021; Kwon and Chapman, 2011; Reshetniak et al., 2020). We have toned down our conclusions and clarified in the revised manuscript that Rab10 is dispensable for SV exocytosis evoked by intense stimulations. The corresponding statements in the text have been modified accordingly (p. 5, l. 98, 124) and in figure legend (p. 17, 490).

      Reviewer #2 (Public Review):

      Summary:<br /> In this paper, the authors assess the function of Rab10 in dense core vesicle (DCV) exocytosis using RNAi and cultured neurons. The author provides evidence that their knockdown (KD) is effective and provides evidence that DCV is compromised. They also perform proteomic analysis to identify potential pathways that are affected upon KD of Rab10 that may be involved in DCV release. Upon focusing on ER morphology and protein synthesis, the authors conclude that defects in protein synthesis and ER Ca2+ homeostasis contributes to the DVC release defect upon Rab10 KD. The authors claim that Rab10 is not involved in synaptic vesicle (SV) release and membrane homeostasis in mature neurons.

      Strengths:

      The data related to Rab10's role in DCV release seems to be strong and carried out with rigor. While the paper lacks in vivo evidence that this gene is indeed involved in DCV in a living mammalian organism, I feel the cellular studies have value. The identification of ER defect in Rab10 manipulation is not truly novel but it is a good conformation of studies performed in other systems. The finding that DCV release defect and protein synthesis defect seen upon Rab10 KD can be significantly suppressed by Leucine supplementation is also a strength of this work.

      We appreciate the positive evaluation of our manuscript.

      Weaknesses:

      The data showing Rab10 is NOT involved in SV exocytosis seems a bit weak to me. Since the proteomic analysis revealed so many proteins that are involved in SV exo/encodytosis to be affected upon Rab10, it is a bit strange that they didn't see an obvious defect. Perhaps this could have been because of the protocol that the authors used to trigger SV release (I am not an E-phys expert but perhaps this could have been a 'sledge-hammer' manipulation that may mask any subtle defects)? Perhaps the authors can claim that DCV is more sensitive to Rab10 KD than SV, but I am not sure whether the authors should make a strong claim about Rab10 not being important for SV exocytosis.

      We agree that 200 APs stimulation might be too strong to see specific effects on evoked synaptic vesicle release, although this stimulation pattern is an established pattern in hundreds of studies. We have toned down our conclusions and clarified in the revised manuscript that Rab10 is dispensable for SV exocytosis evoked by intense stimulations. The corresponding statements in the text have been modified accordingly (p. 5, l. 98, 124) and in figure legend (p. 17, 490).

      Also, the authors mention "Rab10 does not regulate membrane homeostasis in mature neurons" but I feel this is an overstatement. Since the authors only performed KD experiments, not knock-out (KO) experiments, I believe they should not make any conclusion about it not being required, especially since there is some level of Rab10 present in their cells. If they want to make these claims, I believe the authors will need to perform conditional KO experiments, which are not performed in this study.

      This is a valid point. We have changed the statement to “membrane homeostasis in mature neurons was unaffected by Rab10 knockdown” (p. 13, l.376-377).

      Finally, the authors show that protein synthesis and ER Ca2+ defects seem to contribute to the defect but they do not discuss the relationship between the two defects. If the authors treat the Rab10 KD cells with both ionomycin and Leucine, do they get a full rescue? Or is one defect upstream of the other (e.g. can they see rescue of ER morphology upon Leucine treatment)? While this is not critical for the conclusions of the paper, several additional experiments could be performed to clarify their model, especially considering there is no clear model that explains how Rab10, protein synthesis, ER homeostasis, and Ca2+ are related to DCV (but not SV) exocytosis.

      This is an important point and a great suggestion. We have now tested the rescue effects of leucine treatment on ER morphology, as suggested. These data are included in the new Figure 8—figure supplement 2 in the revised manuscript. Our results indicate that the same dose of leucine that rescues DCV fusion and protein translation failed to rescue ER morphology. Hence, the defects in ER morphology appear to be independent of the impaired protein translation.

      Author response image 2.

      Leucine supplementation does not rescue ER morphological deficiency in Rab10 KD neurons. (A) Typical examples showing the KDEL signals in each condition. (B) Quantification of RTN4 intensity in MAP2-positive dendrites. (C) The ratio of neuritic to somatic RTN4 intensity (N/S). All Data are plotted as mean±s.e.m. (B, C) Control: N = 3, n = 10; Rab10 KD: N = 3, n = 11; Rab10 KD + Leu: N = 3; n = 11. A one-way ANOVA tested the significance of adding experimental group as a predictor. **** = p<0.0001, ns = not significant.

      Reviewer #3 (Public Review):

      In the submitted manuscript, Dong and colleagues set out to dissect the role of the Rab10 small GTPase on the intracellular trafficking and exocytosis of dense core vesicles (DCVs). While the authors have already shown that Rab3 plays a central role in the exocytosis of DVC in mammalian neurons, the roles of several other Rab-members have been identified genetically, but their precise mechanism of action in mammalian neurons remains unclear. In this study, the authors use a carefully designed and thoroughly executed series of experiments, including live-cell imaging, functional calcium-imaging, proteomics, and electron microscopy, to identify that DCV secretion upon Rab10 depletion in adult neurons is primarily a result of dysregulated protein synthesis and, to a lesser extent, disrupted intracellular calcium buffering. Given that the full deletion of Rab10 has a deleterious effect on neurons and that Rab10 has a major role in axonal development, the authors cautiously employed the knock-down strategy from 7 DIV, to focus on the functional impact of Rab10 in mature neurons. The experiments in this study were meticulously conducted, incorporating essential controls and thoughtful considerations, ensuring rigorous and comprehensive results.

      We are grateful for the positive evaluation of our manuscript.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      The work by Dong et al provides interesting and potentially important new insights into the connection between ER function and the regulated secretion of neuropeptides via DCVs. I suggest that the authors address the following points experimentally to increase the impact of this potentially important study.

      Major points:

      (1) As alluded to above, for some of the data the statistical basis for analysis remains unclear (examples are Figures 1C-F, J,K; Figure 2 1B-D,I-K; Figure 2 - Supplement 1D-F; Figure 2 - Supplement 2J,K, etc). I.e. is the statistical assessment based on N = number of experiments or n = number of synapses, images, fields of view etc.? As the latter cannot be considered independent biological replicates, they should not form the basis of statistical testing. The Ms misses also misses a dedicated paragraph on statistics in the methods section.

      See reply to reviewer 1 above. We fully agree and solved this point.

      (2) A main weakness of the paper is the missing connection between neuronal protein synthesis, and the observed structural and signaling defects at the level of the ER. I suggest that the authors analyze mTORC1 signaling in Rab10 depleted neurons and under rescue conditions (+Leu or re-expression of Rab10) as ribosome biogenesis is a major downstream target of mTORC1 and mTORC1 activity is related to lysosome position, which may be affected upon rab10 loss -either directly or via effects on the ER that forms tight contacts with lysosomes.

      See reply to reviewer 1 above. We agreed and followed up experimentally.

      (3) Related to the above: Does overexpression of SERCA2 restore normal DCV exocytosis in Rab10-depleted neurons? This would help to distinguish whether calcium storage and release at the level of the ER indeed contribute to the exocytosis defect.

      This is an important point and a great suggestion. We have now tested the rescue effects of overexpression of SERCA2 on DCV fusion. These data are included in the new Figure 8—figure supplement 3 in the revised manuscript. SERCA2 OE failed to rescue the DCV fusion defects in Rab10 KD neurons.

      Author response image 3.

      Overexpression of SERCA2 does not rescue DCV fusion deficits in Rab10 KD neurons. (A) Typical examples showing the SERCA2 signals in each condition. (B) Cumulative plot of DCV fusion events per cell. (C) Summary graph of DCV fusion events per cell. (A) Total number of DCVs (total pool) per neuron, measured as the number of NPY-pHluorin puncta upon NH4Cl perfusion. (B) Fraction of NPY-pHluorin-labeled DCVs fusing during stimulation. All Data are plotted as mean±s.e.m. (C-E) Control: N = 2, n = 10; Rab10 KD: N = 2, n = 13; SERCA2 OE: N = 2; n = 15. A one-way ANOVA tested the significance of adding experimental group as a predictor. *** = p<0.001, ** = p<0.01, ns = not significant.

      (4) The claimed lack of effect of Rab10 depletion on SV exocytosis is solely based on very strong train stimulation with 200 Aps, a condition not very well suited to analyze defects in SV fusion. The conclusion that Rab10 loss does not impact SV fusion thus seems premature. The authors should conduct additional experiments under conditions of single or few Aps (e.g. 4 or 10 Aps) to really assess whether or not Rab10 depletion alters SV exocytosis at the level of pHluorin analysis in cultured neurons.

      See reply to reviewer 2 above. Agreed to and made textual adjustments to solve this

      (5) Related to the above: I am puzzled by the data shown in Figure 1H-J: From the pHluorin traces shown I would estimate a tau value of about 20-30 s (e.g. decay to 1/e = 37% of the peak value). The bar graph in Figure 1K claims 3-4 s, clearly clashing with the data shown. Were these experiments conducted at RT (where expected tau values are in the range of 30s) or at 37{degree sign}C (one would expect taus of around 10 s in this case for Syp-pH)? I ask the authors to carefully check and possibly re-analyze their datasets.

      This is indeed a mistake. We thank the reviewer for flagging this miscalculation. Our original Matlab script used for calculating the tau value contained an error and the datasets were normalized twice by mistake. We now reanalyzed the data and the corresponding figures and texts have been updated. Our conclusion that Rab10 KD does not affect SV endocytosis remains unchanged since the difference in tau between the control (28.5 s) and Rab10 KD (32.8 s) suffered from the same systematic error and were/are not significantly different.

      (6) How many times was the proteomics experiment shown in Figure 3 conducted? I noticed that the data in panel H missed statistical analysis and error bars. Given the typical variation in these experiments, I suggest to only include data for proteins identified in at least 3 out of 4 experimental replicates.

      We agree that this information has not been clear. We have now explained replication in the Methods section (p. 42, l. 879-885). In brief, the proteomics experiment presented in Fig 3 was conducted with two independent cultures (‘biological replicates’), hence, formally only two independent observations. For each biological replicate, we performed four technical replicates. For our analysis, we only included peptides that were consistently detected across all samples (not only three as this reviewer suggests). Proteins in Panel H are ER-related proteins that are significantly different from control neurons with an adjusted FDR ≤ 0.01 and Log2 fold change ≥ 0.56. The primary purpose of our proteomics experiments was to generate hypotheses and guide subsequent experiments and the main findings were corroborated by other experiments presented in the manuscript.

      Minor:

      (7) Figure 2 - supplement 3 and Figure 4 - supplement 3 are only mentioned in the discussion. The authors should consider referring to these data in the results section.

      This is a valid point. We have now added a new statement “Moreover, only 10% of DCVs co-transport with Rab10” in the Results (p. 6-7, l. 162-164).

      (8) Where is the pHluorin data shown in Figure 1 bleach-corrected? If so, this should be stated somewhere in the Ms. Moreover, the timing of the NH4Cl pulse should be indicated in the scheme in panel I.

      We thank the reviewer for pointing these omissions out. We have now included information about the timing of NH4Cl pulse in panel I. We did not do bleach-correction for the pHluorin data shown in Figure 1. It has been shown that pHluorin is very stable with a bleaching rate in the alkaline state of 0.06% per second and 0.0024% per second in the quenched state (Balaji and Ryan, 2007). Indeed, we did not observe obvious photobleaching in the first 30s during our imaging as indicated by the average trace of pHluorin intensity in panel I.

      (9) Page 3/ lines 59-60: "...strongest inhibition of neuropeptide accumulation...". What is probably meant is "...strongest inhibition of neuropeptide release".

      We agree this statement is unclear. Sasidharan et al used a coelomocyte uptake assay as an indirect readout for DCV release. The ‘strongest inhibition of neuropeptide accumulation’ in coelomocytes in Rab10 mutant indicates DCV fusion deficits. We have now replaced the text with “Rab10 deficiency produces the strongest inhibition of neuropeptide release in C. elegans” to make it more clear.

      Reviewer #3 (Recommendations For The Authors):

      I strongly recommend the publishing of this study as a VOR with minor comments directed to the authors.

      (1) In Figure 4, the authors should include examples of tubular ER at the synapse, especially as this is an interesting point discussed in ln 226-229. Are there noticeable changes in the ER-mitochondria contacts at the synaptic boutons?

      We agree that examples of tubular ER at the synapse would improve the manuscript. We have now replaced the Figure 4A with such examples. We found it challenging to quantify ER-mitochondria contacts based on the electron microscopy (EM) images we currently have. The ER-mitochondria contact sites are quite rare in the cross-sections of our samples, making it difficult to perform a reliable quantitative analysis.

      (2) The limited impairment of calcium-ion homeostasis in Rab10 KD neurons is very interesting. Would the overexpression of Rab10T23N mimic the effect of a KD scenario? Is there a separation of function for Rab10 in calcium homeostasis vs. the regulation of protein synthesis?

      This is an interesting possibility. We tested this and expressed Rab10T23N in a new series of experiments. These data are presented as a new Figure 5 in the revised manuscript (p. 29). We observed that Ca2+ refilling after caffeine treatment was delayed to a similar extent in Rab10T23N-expressing and Rab10 KD neurons. While impaired Ca2+ homeostasis may affect protein synthesis through ER stress or mTORC1 activation, our findings indicate otherwise in Rab10 KD neurons. First, ATF4 levels, a marker of ER stress, were unaffected in Rab10 KD neurons. This indicates that any ER stress present is minimal or insufficient to significantly impact protein synthesis through this pathway. Second, we did not observe significant changes in mTORC1 activation in Rab10 KD neurons as indicated by a normal pS6K1 phosphorylation (see above). Based on these observations, we conclude that Rab10's roles in calcium homeostasis and protein synthesis are most likely separate.

      (3) The authors indicate that the internal release of calcium ions from the ER has no effect on DCV trafficking and fusion without showing the data. It is important to include this data as the major impact of the study is the dissecting of the calcium effects in mammalian neurons from the previous studies in invertebrates.

      We agree this is an important aspect in our reasoning. We are submitting the related manuscript on internal calcium stores to BioRVix. The link will be added to the consolidated version of our manuscript

      (4) The distinction between Rab3 and Rab10 co-trafficking on DCVs should be reported in the Results (currently, Figure 2 - supplement 3 is only mentioned in the Discussion) as it helps to understand the effects on DCV fusion.

      We agree. We now added a new statement “Moreover, only 10% of DCVs co-transport with Rab10” in the Results (p. 6, l. 162-163).

      Reference:

      Balaji, J., Ryan, T.A., 2007. Single-vesicle imaging reveals that synaptic vesicle exocytosis and endocytosis are coupled by a single stochastic mode. Proceedings of the National Academy of Sciences 104, 20576–20581. https://doi.org/10.1073/pnas.0707574105

      Brunner, J.W., Lammertse, H.C.A., Berkel, A.A. van, Koopmans, F., Li, K.W., Smit, A.B., Toonen, R.F., Verhage, M., Sluis, S. van der, 2022. Power and optimal study design in iPSC-based brain disease modelling. Molecular Psychiatry 28, 1545. https://doi.org/10.1038/s41380-022-01866-3

      Emperador-Melero, J., Huson, V., van Weering, J., Bollmann, C., Fischer von Mollard, G., Toonen, R.F., Verhage, M., 2018. Vti1a/b regulate synaptic vesicle and dense core vesicle secretion via protein sorting at the Golgi. Nat Commun 9, 3421. https://doi.org/10.1038/s41467-018-05699-z

      Granseth, B., Odermatt, B., Royle, S.J., Lagnado, L., 2006. Clathrin-Mediated Endocytosis Is the Dominant Mechanism of Vesicle Retrieval at Hippocampal Synapses. Neuron 51, 773–786. https://doi.org/10.1016/j.neuron.2006.08.029

      Ivanova, D., Dobson, K.L., Gajbhiye, A., Davenport, E.C., Hacker, D., Ultanir, S.K., Trost, M., Cousin, M.A., 2021. Control of synaptic vesicle release probability via VAMP4 targeting to endolysosomes. Science Advances 7, eabf3873. https://doi.org/10.1126/sciadv.abf3873

      Kwon, S.E., Chapman, E.R., 2011. Synaptophysin Regulates the Kinetics of Synaptic Vesicle Endocytosis in Central Neurons. Neuron 70, 847–854. https://doi.org/10.1016/j.neuron.2011.04.001

      Reshetniak, S., Fernández-Busnadiego, R., Müller, M., Rizzoli, S.O., Tetzlaff, C., 2020. Quantitative Synaptic Biology: A Perspective on Techniques, Numbers and Expectations. International Journal of Molecular Sciences 21, 7298. https://doi.org/10.3390/ijms21197298

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      This valuable work analyzes how specialized cells in the auditory cells, known as the octopus cells, can detect coincidences in their inputs at the submillisecond time scale. While previous work indicated that these cells receive no inhibitory inputs, the present study unambiguously demonstrates that these cells receive inhibitory glycinergic inputs. The physiologic impact of these inputs needs to be studied further. It remains incomplete at present but could be made solid by addressing caveats related to similar sizes of excitatory postsynaptic potentials and spikes in the octopus neurons.

      We apologize for not explicitly describing our experimental methods and analyses procedures that ensure the discrimination between action potentials and EPSPs. This has been addressed in responses to reviewer comments and amended in the manuscript.

      Reviewer #1 (Public Review):

      Kreeger and colleagues have explored the balance of excitation and inhibition in the cochlear nucleus octopus cells of mice using morphological, electrophysiological, and computational methods. On the surface, the conclusion, that synaptic inhibition is present, does not seem like a leap. However, the octopus cells have been in the past portrayed as devoid of inhibition. This view was supported by the seeming lack of glycinergic fibers in the octopus cell area and the lack of apparent IPSPs. Here, Kreeger et al. used beautiful immunohistochemical and mouse genetic methods to quantify the inhibitory and excitatory boutons over the complete surface of individual octopus cells and further analyzed the proportions of the different subtypes of spiral ganglion cell inputs. I think the analysis stands as one of the most complete descriptions of any neuron, leaving little doubt about the presence of glycinergic boutons.

      Kreeger et al then examined inhibition physiologically, but here I felt that the study was incomplete. Specifically, no attempt was made to assess the actual, biological values of synaptic conductance for AMPAR and GlyR. Thus, we don't really know how potent the GlyR could be in mediating inhibition. Here are some numbered comments:

      (1) "EPSPs" were evoked either optogenetically or with electrical stimulation. The resulting depolarizations are interpreted to be EPSPs. However previous studies from Oertel show that octopus cells have tiny spikes, and distinguishing them from EPSPs is tricky. No mention is made here about how or whether that was done. Thus, the analysis of EPSP amplitude is ambiguous.

      We agree that large EPSPs can be difficult to distinguish from an octopus cell’s short spikes during experiments. During analysis, we distinguished spikes from EPSPs by generating phase plots, which allow us to visualize the first derivative of the voltage trace on the y-axis and the value of the voltage on the x-axis at each moment in time. In the example shown below, four depolarizing events were electrically evoked in an octopus cell (panel A). The largest of these events (shown in orange in panels B-D) has an amplitude of ~9mV and could be a small spike. The first derivative of the voltage (panel C) reveals a bi-phasic response in the larger orange trace, where during the rising phase (mV/ms > 0) of the EPSP there is a second, sharper rising phase for the spike. Like more traditionally sized action potentials, phase plots for octopus cell spikes also reveal a sharp change in the rate of voltage change over time (Author response image 1 panel D, ✱) after the rising action of the EPSP begins to slow. EPSPs (shown in blue in panels B-D) lack the deflection in the phase plot. Not all cases were as unambiguous as this example. Therefore, our analysis only included subthreshold stimulation that unambiguously evoked EPSPs, not spikes. A brief description of this analysis has been added to the methods text (lines 625-627) and we have noted in the results section that both ChR2-evoked and electrically-evoked stimulation can produce small action potentials, which were excluded from analysis (lines 156-158).

      Author response image 1.

      (2) For this and later analysis, a voltage clamp of synaptic inputs would have been a simple alternative to avoid contaminating spikes or shunts by background or voltage-gated conductances. Yet only the current clamp was employed. I can understand that the authors might feel that the voltage clamp is 'flawed' because of the failure to clamp dendrites. But that may have been a good price to pay in this case. The authors should have at least justified their choice of method and detailed its caveats.

      We agree that data collected using voltage-clamp would have eliminated the confound of short action potentials and avoided the influence of voltage-gated conductances. The large-diameter, and comparatively simple dendritic trees of octopus cells make them good morphological candidates for reliable voltage clamp. However, as suggested, we were concerned that the abundance of channels open at the neuron’s resting potential would make it difficult to sufficiently clamp dendrites. Ultimately, given the low input resistances of octopus cells and the fast kinetics of excitatory inputs, we determined that bad voltage clamp conditions were likely to result in unclamped synaptic events with unpredicted distortions in kinetics and attenuation (To et al. 2022; PMID: 34480986; DOI: 10.1016/j.neuroscience.2021.08.024). We therefore chose to focus our efforts on current-clamp.

      Beyond the limits of both current-clamp and voltage-clamp, we chose to leave all conductances that influence EPSP dendritic propagation intact because our model demonstrates that active Kv and leak conductances shape and attenuate synaptic inputs as they travel through the dendritic tree (Supp. Fig. 4F-G). The addition of voltage-clamp recordings would not impact the conclusions we make about EPSP summation at the soma. Future studies will need to focus on a dendrite-centric view of local excitatory and inhibitory summation. For dendrite-centric experiments, dendritic voltage-clamp recordings are well suited to answer that set of questions.

      (3) The modeling raised several concerns. First, there is little presentation of assumptions, and of course, a model is entirely about its assumptions. For example, what excitatory conductance amplitudes were used? The same for inhibitory conductance? How were these values arrived at? The authors note that EPSGs and IPSGs had peaks at 0.3 and 3 ms. On what basis were these numbers obtained? The model's conclusions entirely depend on these values, and no measurements were made here that could have provided them. Parenthetical reference is made to Figure S5 where a range of values are tested, but with little explanation or justification.

      We apologize for not providing this information. We used our octopus neuron model to fit both EPSP and IPSP parameters to match experimental data. We have expanded the methods to include final values for the conductances (lines 649-651), which were adjusted to match experimental values seen in current-clamp recordings. We have also expanded the results section to describe each of the parameters we tuned (lines 203-222). An example of these adjustments is illustrated in Fig. 4F where the magnitude of inhibitory potentials at different conductances (100nS and 1nS) was compared to experimental data over a range of octopus cell input resistance conditions. Kinetic parameters were determined by aligning modeled PSPs to the rise times and full width at half maximum (FWHM) measurements from experiments under control and Kv block conditions. The experimental data for EPSPs and IPSPs that was used to fit the model is shown in Author response image 2 below.

      Author response image 2.

      (4) In experiments that combined E and I stimulation, what exactly were time courses of the conductance changes, and how 'synchronous' were they, given the different methods to evoke them? (had the authors done voltage clamp they would know the answers).

      We chose to focus data collection on voltage changes at the soma under physiological conditions to better understand how excitation and inhibition integrate at the somatic compartment. Our conclusions in the combined E and I stimulation experiments require the resting membrane properties of octopus cells to be intact to make physiologically-relevant conclusions. Our current-clamp data includes the critical impact of leak, Kv, and HCN conductances on this computation. Reliable voltage-clamp would necessitate the removal of the Kv and HCN conductances that shape PSP magnitude, shape, and speed. Because it was not necessary to measure the conductances and kinetics of specific channels, we chose to use current-clamp.

      Evoked IPSPs and EPSPs had cell-to-cell variability in their latencies to onset. Somatically-recorded optically-evoked inhibition under pharmacological conditions that changed cable properties had onset latencies between 2.5 and 4.3ms; electrically-evoked excitation under control conditions had latencies between 0.8 and 1.4ms. To overcome cell-to-cell timing variabilities, we presented a shuffled set of stimulation pairings that had a 3ms range of timings with 200µs intervals. As the evoked excitation and inhibition become more ‘synchronous’, the impact on EPSP magnitude and timing is greatest. Data presented in this paper was for the stimulation pairings that evokes a maximal shift in EPSP timing. On average, this occurred when the optical stimulation began ~1.2ms before electrical stimulation. Stimulation pairing times ranged between a 0ms offset and a 1.8ms offset at the extremes. An example of the shuffled stimulation pairings is shown in Author response image 3 below, and we have included information about the shuffled stimulus in the methods (lines 627-630)

      Author response image 3.

      (5) Figure 4G is confusing to me. Its point, according to the text, is to show that changes in membrane properties induced by a block of Kv and HCN channels would not be expected to alter the amplitudes of EPSCs and IPSCs across the dendritic expanse. Now we are talking about currents (not shunting effects), and the presumption is that the blockers would alter the resting potential and thus the driving force for the currents. But what was the measured membrane potential change in the blockers? Surely that was documented. To me, the bigger concern (stated in the text) is whether the blockers altered exocytosis, and thus the increase in IPSP amplitude in blockers is due BOTH to loss of shunting and increase in presynaptic spike width. Added to this is that 4AP will reduce the spike threshold, thus allowing more ChR2-expressing axons to reach the threshold. Figure 4G does not address this point.

      These are valuable points that motivated us to improve the clarity of this figure and the corresponding text. We discussed two separate points in this paragraph and were not clear. Our intention with Figure 4G was to address concerns that using pharmacological blockers changes driving forces and may confound the measured change in magnitude of postsynaptic potentials. Membrane potentials hyperpolarized by approximately 8-10 mV after application of blockers. We corrected for this effect by adding a holding current to depolarize the neuron to its baseline resting potential. Text in the results (lines 187-190) and figure legends have been changed to clarify these points.

      We also removed any discussion of presynaptic effects from this portion of the text because our description was incomplete and we did not directly collect data related to these claims. We originally wrote, “While blocking Kv and HCN allowed us to reveal IPSPs at the soma, 4-AP increases the duration of the already unphysiological ChR2-evoked presynaptic action potential (Jackman et al., 2014; DOI: 10.1523/jneurosci.4694-13.2014), resulting in altered release probabilities and synaptic properties, amongst other caveats (Mathie et al., 1998; DOI: 10.1016/S0306-3623(97)00034-7)”. Ultimately, effects on exocytosis, presynaptic excitability, or release probability are only relevant for the experiments presented in Figure 4. Figure 4 serves as evidence that synaptic release of glycine elicits strychnine-sensitive inhibitory postsynaptic potentials in octopus cells. Concerns of presynaptic effects do not carry over to the data presented in Figure 5, as Kv and HCN were not blocked in these experiments. Therefore, we have removed this portion of the text.

      (6) Figure 5F is striking as the key piece of biological data that shows that inhibition does reduce the amplitude of "EPSPs" in octopus cells. Given the other uncertainties mentioned, I wondered if it makes sense as an example of shunting inhibition. Specifically, what are the relative synaptic conductances, and would you predict a 25% reduction given the actual (not modeled) values?

      We agree that both shunting and hyperpolarizing inhibition could play a role in the measured EPSP changes. Because we focused data collection on voltage changes at the soma under physiological conditions, we cannot calculate the relative synaptic conductances. Together, our experimental current-clamp results paired with estimates from the model provide compelling evidence for the change we observe in EPSPs. Regardless, the relative weights of the synaptic conductances is a very interesting question, but this information is not necessary to answer the questions posed in this study, namely the impact of dendritic inhibition on the arrival of EPSPs in the soma.

      (7) Some of the supplemental figures, like 4 and 5, are hardly mentioned. Few will glean anything from them unless the authors direct attention to them and explain them better. In general, the readers would benefit from more complete explanations of what was done.

      We apologize for not fully discussing these figures in the results text. We have fully expanded the results section to detail the experiments and results presented in the supplement (lines 203-238).

      Reviewer #2 (Public Review):

      Summary:

      Kreeger et.al provided mechanistic evidence for flexible coincidence detection of auditory nerve synaptic inputs by octopus cells in the mouse cochlear nucleus. The octopus cells are specialized neurons that can fire repetitively at very high rates (> 800 Hz in vivo), yield responses dominated by the onset of sound for simple stimuli, and integrate auditory nerve inputs over a wide frequency span. Previously, it was thought that octopus cells received little inhibitory input, and their integration of auditory input depended principally on temporally precise coincidence detection of excitatory auditory nerve inputs, coupled with a low input resistance established by high levels of expression of certain potassium channels and hyperpolarization-activated channels.

      In this study, the authors used a combination of numerous genetic mouse models to characterize synaptic inputs and enable optogenetic stimulation of subsets of afferents, fluorescent microscopy, detailed reconstructions of the location of inhibitory synapses on the soma and dendrites of octopus cells, and computational modeling, to explore the importance of inhibitory inputs to the cells. They determined through assessment of excitatory and inhibitory synaptic densities that spiral ganglion neuron synapses are densest on the soma and proximal dendrite, while glycinergic inhibitory synaptic density is greater on the dendrites compared to the soma of octopus cells. Using different genetic lines, the authors further elucidated that the majority of excitatory synapses on the octopus cells are from type 1a spiral ganglion neurons, which have low response thresholds and high rates of spontaneous activity. In the second half of the paper, the authors employed electrophysiology to uncover the physiological response of octopus cells to excitatory and inhibitory inputs. Using a combination of pharmacological blockers in vitro cellular and computational modeling, the authors conclude that glycine in fact evokes IPSPs in octopus cells; these IPSPs are largely shunted by the high membrane conductance of the cells under normal conditions and thus were not clearly evident in prior studies. Pharmacological experiments point towards a specific glycine receptor subunit composition. Lastly, Kreeger et. al demonstrated with in vitro recordings and computational modeling that octopus cell inhibition modulates the amplitude and timing of dendritic spiral ganglion inputs to octopus cells, allowing for flexible coincidence detection.

      Strengths:

      The work combines a number of approaches and complementary observations to characterize the spatial patterns of excitatory and inhibitory synaptic input, and the type of auditory nerve input to the octopus cells. The combination of multiple mouse lines enables a better understanding of and helps to define, the pattern of synaptic convergence onto these cells. The electrophysiology provides excellent functional evidence for the presence of the inhibitory inputs, and the modeling helps to interpret the likely functional role of inhibition. The work is technically well done and adds an interesting dimension related to the processing of sound by these neurons. The paper is overall well written, the experimental tests are well-motivated and easy to follow. The discussion is reasonable and touches on both the potential implications of the work as well as some caveats.

      Weaknesses:

      While the conclusions presented by the authors are solid, a prominent question remains regarding the source of the glycinergic input onto octopus cells. In the discussion, the authors claim that there is no evidence for D-stellate, L-stellate, and tuberculoventral cell (all local inhibitory neurons of the ventral and dorsal cochlear nucleus) connections to octopus cells, and cite the relevant literature. An experimental approach will be necessary to properly rule out (or rule in) these cell types and others that may arise from other auditory brainstem nuclei. Understanding which cells provide the inhibitory input will be an essential step in clarifying its roles in the processing of sound by octopus cells.

      We are glad that the reviewer agrees with the conclusions we have made and is interested in learning more about how these findings impact sound processing. We agree that defining the source of inhibition will dramatically shape our understanding of the computation octopus cells are making. However, this is not an easy task, given the small size of the octopus cell area, and will involve considerable additional work. Since the overall findings do not depend on knowing the source of inhibition, we have instead re-written the discussion to clarify the lack of evidence for intrinsic inhibitory inputs to octopus cells, in addition to presenting likely candidates. As genetic profiles of cochlear nucleus and other auditory brainstem neurons become available, we intend to make and utilize genetic mouse models to answer questions like this.

      The authors showed that type 1a SGNs are the most abundant inputs to octopus cells via microscopy. However, in Figure 3 they compare optical stimulation of all classes of ANFs, then compare this against stimulation of type 1b/c ANFs. While a difference in the paired-pulse ratio (and therefore, likely release probability) can be inferred by the difference between Foxg1-ChR2 and Ntng1-ChR2, it would have been preferable to have specific data with selective stimulation of type 1a neurons.

      We agree that complete genetic access to only the Ia population would have been the preferable approach, but we did not have an appropriate line when beginning these experiments. Because our results did not suggest a meaningful difference between the populations, we did not pursue further investigation once a line was available.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Besides the points mentioned in the main review:

      Minor

      (1) I really like the graphics and the immunohistological presentation.

      (2) Lines 316-319 say that octopus cells lack things like back-propagating spikes and dendritic Ca spikes. How do you know this?

      This statement was intended to be a summary of suggestions from the literature and lacked references and context as written. We have rewritten this section and clarified that our hypothesis was formed from data found in the literature (lines 334-337).

      (3) Spectrograms of Figure 6A...where were these data obtained?

      We recorded and visualized human-generated rhythmic tapping and high-frequency squeaking sounds using Audacity. The visualizations of rhythmic tapping and imitated vocalizations are meant to show two different types of multi-frequency stimuli we hypothesize would result in somatic summation within an octopus cell’s spike integration window, despite differences in timing. We rewrote the figure legend to explain more clearly what is shown and how it relates to the model in Figure 6.

      (4) 'on-path' and 'off-path' seem like jargon that may not be clear to the average reader.

      Thank you for pointing out our use of unapproachable jargon. We have replaced the term from the figure with “proximal” and “distal” inhibition. In the main text, we now describe on-path and off-path together as the effect of location of dendritic inhibition on somatically recorded EPSPs.

      (5) The paper could benefit from a table of modeled values.

      We have added specific details about the modelling in the text and clarified which modeled values were referenced from previous computational models and which were tuned to fit experimental data. Since most values were taken from a referenced publication, we did not add a table and instead point readers towards that source.

      (6) Figure S4A-C what currents were delivered to the modeled cells?

      The model cells were injected with a -0.8 nA DC current for 300 ms in current clamp mode. This information has been added to the figure legend.

      (7) In that figure "scaling factors" scale exactly which channels?

      Scaling factor is used to scale low-voltage activated K<sup>+</sup> (ḡ<sub>KLT</sub>), high threshold K<sup>+</sup> (ḡ<sub>KHT</sub>), fast transient K<sup>+</sup> (ḡ<sub>KA</sub>), hyperpolarization-activated cyclic nucleotide-gated HCN (ḡ<sub>h</sub>) but not fast Na<sup>+</sup> (ḡ<sub>Na</sub>) and leak K<sup>+</sup> (ḡ<sub>leak</sub>). This information has been added to the text (lines 205-208 and 646-653).

      (8) In performing and modeling Kv/HCN block, do you know how complete the level of the block is?

      Since we cannot assess how complete the level of block is, we have changed the language in the text to clarify that we are reducing Kv and HCN channel conductance to the degree needed to increase resistance of the neuron (line 185).

      (9) More on this Figure S4. It is hardly referred to in the text except to say that it supports that blocking the Kv/HCN channels will enhance the IPSP. Given how large the figure is, can you offer more of a conclusion than that? Also, in the synaptic model in that figure, the IPSCs are presumably happening in current-clamp conditions, and the reduction in amplitude of the IPSC (as opposed to the increase in IPSP) is due to hyperpolarization. Can you simply state that so readers can track what this figure is showing? Other similar things: what is a transfer impedance? How is it measured? What do we take from the analysis?

      We have elaborated on our description of both Supp. Fig. 4 and Supp. Fig. 5 in the results section of the text (lines 203-238).

      (10) Figure S5 also needs a better explanation. E.g., in C-D, what does 'average' mean? The gray is an SD of this average? You modeled a range of values...but which ones are physiological? To me, this is a key point.

      We have elaborated on our description of both Supp. Fig. 4 and Supp. Fig. 5 in the results section of the text (lines 203-238).

      Reviewer #2 (Recommendations For The Authors):

      General:

      The images and 3-D reconstructions are visually stunning, but they are not colorblind-friendly and in some cases, hard to distinguish. This shows up particularly in the green and blue colors used in Figure 1. Also, better representative images could be used for Figure 1B.

      Thank you for pointing out that blue and green were difficult to distinguish in Figure 1H. We have outlined the green inhibitory puncta in this image to make them more distinguishable. We have also increased the resolution of the image in Figure 1B for better clarity. All other colors are selected from Wong, 2011 (PMID: 21850730; DOI: https://doi.org/10.1038/nmeth.1618).

      Supplemental Figure 1D: The low-power view is good to have, but the CN is too small and the image appears a bit noisy. An inset showing the CN on a larger scale (higher resolution image?) would be more convincing. In this image, I see what appear to be cells in the DCN labeled, which calls into question the purity of the source of optogenetic synaptic activation. It is also difficult to tell whether there are other cells labeled in the VCN. Such inputs would still be minor, but it would be good to be very clear about the expression pattern.

      To offer more information about the activity of the Ntng1<sup>Cre</sup> line in other regions of the auditory system, we increased the resolution of the image included in Supp. Fig. 1D and have also included an additional image (Supp. Fig. 1E) of a coronal section of the cochlear nucleus complex with Ntng1-tdT labelling. This image provides additional context for the cells labeled in the DCN. The text in the figure legend has been changed to clarify that some cells in the DCN were labeled (lines 118-120).

      We agree that in the Ntng1<sup>Cre</sup> experiments, there is the possibility of minor contamination from excitatory cells that express ChR2 outside of the spiral ganglion. This is also true for our Foxg1<sup>Cre</sup> and Foxg1<sup>Flp</sup> experiments, because these lines label cortical cells in addition to cochlear cells. However, we do not observe direct descending inputs from the cortex into the PVCN, making contamination from other Foxg1<sup>Cre</sup>-positive neurons unlikely. While non-cochlear inputs from the Ntng1<sup>Cre</sup> line are possible, evidence from both lines gives us confidence that we are not capturing inputs to octopus cells outside the cochlea. Central axons from Type I spiral ganglion neurons have VGLUT1+ synaptic terminals. When comparing the overlap between VGLUT1+ terminals and Foxg1-tdT labelling, we see full coverage. That is, all VGLUT+ terminals on octopus cells are co-labelled by Foxg1<sup>Cre</sup>-mediated expression of tdTomato. An example image is shown below. Here, an octopus cell soma is labeled with blue fluorescent Nissl stain and inputs to the cochlear nucleus complex are labeled with Foxg1<sup>Cre</sup>-dependent tdTomato (Foxg1-tdT; magenta). We have also immunolabeled for VGLUT1 puncta in green. This eliminates the possibility that VGLUT+ cells from outside the cochlea and cortex are sources of excitation to octopus cells.

      Author response image 4.

      Further, we have looked at expression of Ntng1-tdT and Foxg1-EYFP together in the octopus cell area.  An example image is shown below. All Ntng1-tdT+ fibers (magenta) are also Foxg1-EYFP+ (green), suggesting that all Ntng1<sup>Cre</sup>-targeted inputs to octopus cells are a part of the Foxg1<sup>Cre</sup>-targeted input population, which are very likely to only be from the cochlea. We have expanded the results section to include information about the overlap in expression driven by the Ntng1<sup>Cre</sup> and Foxg1<sup>Flp</sup> lines.

      Author response image 5.

      Supplemental Figure 2 G: These are a bit hard to read. Perhaps use a different image, or provide a reference outline drawing telling us what is what.

      We have used a different image with a Thy1-YFP labeled octopus cell for clarity.

      In some places, the term "SGN" is used when referencing the axons and terminals within the CN, and without some context, this was occasionally confusing (SGN would seem to refer to the cell bodies). In some places in the text, it may be preferable to separate SGN, auditory nerve fibers (ANFs), and terminals, as entities for clarity.

      In order to make the study accessible to a broad neuroscience audience, we refer to the neurons of the spiral ganglion and their central axon projections using one name. We understand why, for those well acquainted with the auditory periphery, condensing terminology may feel awkward. However, for those readers unfamiliar with the anatomy of the cochlea and auditory nerve, we feel that the use of “SGN central axon” makes it clear that the “auditory nerve fibers” come from neurons in the spiral ganglion. This is clarified in the first paragraph of the introduction (lines 29-31) and in the methods (line 533).

      Specific: Numbers refer to the line numbers on the manuscript.

      L29-31: Cochlear nucleus neurons are more general in their responses than this sentence indicates. While we can all agree that they are specialized to carry (or improve upon) the representation of these specific features of sound, they also respond more generally to sounds that might not have specific information in any of these domains. They are not silos of neural computation, and their outputs become mixed and "re-represented" well before they reach the auditory cortex. Octopus cells are no exception to this. I suggest striking most of the first paragraph, and instead using the first sentence to lead into the second paragraph, and putting the last sentence (of the current first paragraph) at the end of the second (now first) paragraph.

      We agree with this assessment and have made major changes to the introduction in line with these suggestions.

      L33-46: A number of points in this paragraph need references (exp. line 41).

      We agree and have added references accordingly.

      L43: Not sure what is meant by "fire at the onset of the sound, breaking it up into its frequency components"?

      We changed this text as part of a major reworking of the introduction.

      L47-66: Again more citations are needed (at the end of sentence at line 55, probably moving some of the citations from the next sentence up).

      We agree and have added references accordingly.

      L51: The consistent orientation of octopus cell dendrites across the ANFs has been claimed in the literature (as mentioned here), but there are some (perhaps problematic - plane of sectioning?) counterexamples from the older Golgi-stained images, and even amongst intracellularly stained cells (for example see Reccio-Spinoza and Rhode, 2020). This is important with regards to the broader hypothesis regarding traveling-wave compensation (e.g., McGinley et al; but also many others); if the cells are not all in the appropriate orientation then such compensation may be problematic. Likewise, the data from Lu et al., 2022, points towards a range of sensitivity to frequency-swept stimuli, some of which work in opposition to the traveling wave compensation hypothesis. It would seem that with the Thy1 mice, you have an opportunity to clarify the orientation. Figures 1A and 2A show a consistent dendritic orientation, assuming that these drawings are reconstructions of the cells as they were actually oriented in the tissue. Can you either comment on this or provide clearer evidence?

      We are happy to offer more information about the appearances of octopus cells in our preparations. In our hands, sparsely labeled octopus cells in Thy1-YFP-H mice show consistent dendritic orientation when visualized in a 15 degree parasaggital plane, with the most diversity apparent in cells with somas located more dorsally in the octopus cell area. We hypothesize that this is due to the limited area through which the central projections of spiral ganglion neurons (i.e. ANFs) must pass through before they enter the dorsal cochlear nucleus and continue their tonotopic organization in that area.

      A caveat to studies without physiological or genetic identification of octopus cells is the assumption that all neurons in the octopus cell area are octopus cells. We find, especially along the borders of the octopus cell area, that stellate cells can be seen amongst octopus cells. Because stellate cell dendrites are not oriented like octopus cell dendrites, any stellate cells misidentified as octopus cells would appear to have poorly-oriented dendrites. This may explain why some studies report this finding. In addition, it can be difficult to assess tonotopic organization because of the 3D trajectory of tightly bundled axons, which is not capturable by a single section plane. Although a parasaggital plane of sectioning captures the tonotopic axis in one part of the octopus cell area, that same plane may be perpendicular at the opposing end.

      L67: canonical -> exceptional.

      Thank you for the suggestion. We have made this change in the introduction.

      L127: This paragraph was confusing on first reading. I don't think Supplemental Figure 1D shows the restricted pattern of expression very clearly. The "restricted to SGNs" might be better as "restricted to auditory nerve fibers" (except in the DCN, where there seem to be some scattered small cells?). A higher magnification image of the CN, but lower magnification than in panel E, would be helpful here.

      To avoid confusion, we have re-written this paragraph (lines 117-127) and included a higher magnification image of the CN in a revised Supp. Fig. 1.

      L168: Here, perhaps say ANFs instead of SGNs.

      As above, we have decided to describe ANFs as SGN central axons to make the anatomy more accessible to people unfamiliar with cochlear anatomy.

      L201-204: The IPSPs are surprisingly slow (Figures 5B, C), especially given the speed of the EPSPs/EPSCs in these cells. This is reminiscent of the asymmetry between EPSC and IPSC kinetics in bushy cells (Xie and Manis, 2014). The kinetics used in the model (3 ms; mentioned on line 624) however seem a bit arbitrary and no data is provided for the selection of that value. Were there any direct measurements of the IPSC kinetics (all of the traces in the paper are in the current clamp) that were used to justify this value?

      The kinetics of the somatically-recorded IPSPs are subject to the effects of our pharmacological manipulations. EPSPs measured at the soma under control conditions are small amplitude and rapid. With pharmacological reduction of HCN and Kv channels, EPSPs are larger and slower (please see figure in response to a similar question posed by Reviewer #1). We expect that this change also occurs with the IPSP kinetics under pharmacological conditions. Our justification of kinetics has been expanded and justified in the methods section (lines 641-661).

      L594: Technically, this is a -11 mV junction potential, but thanks for including the information.

      We have corrected this in the text (line 618). Thank you for the close reading of all experimental and methodological details.

      L595: The estimated power of the LED illumination at the focal plane should be measured and indicated here.

      We measured the power of the LED illumination at the focal plane using a PM100D Compact Power and Energy Meter Console (Thorlabs), a S120C Photodiode Power Sensor (Thorlabs), and a 1000µm diameter Circular Precision Pinhole (Thorlabs). Light intensity at the focal plane ranged between 1.9 and 4.1mW/mm<sup>2</sup>, corresponding to 6% and 10% intensity on the Colibri5 system. We have reported these measurements in the results section (Lines 621-622).

      L609: One concern about the model is that the integration time of 25 microseconds is rather close to the relative shifts in latency. While I doubt it will make a difference (except in the number), it may be worth verifying (spot checks, at least) that running the model with a 5 or 10-microsecond step yields a similar pattern of latency shifts (e.g., Supplementary Figure 5, Figure 5).

      Also, it is not clear what temperature the model was executed at (I would presume 35C); this needs to be given, and channel Q10's listed.

      We realize that additional information is needed to fully understand the model and have added this to the results and the methods. The synaptic mechanism (.mod) files were obtained from Manis and Campagnola (2018) (PMID: 29331233; DOI: https://doi.org/10.1016/j.heares.2017.12.017). Q10 (3) and temperature (22°C) were also matched to parameters from Manis and Campagnola (2018). Because temperature is a critical factor for channel kinetics, we verified that our primary results remain consistent under conditions using a temperature of 35°C and a time step of 5µs, depicted below. Panel A illustrates the increase in IPSP as a function of glycine conductance under Kv+HCN block conditions at 35°C. As at 22°C, an increase in IPSP magnitude is absent in the control condition at 35°C. Panels B and C provide a direct comparison between the initial (i.e. 22°C) and suggested (i.e. 35°C) simulation conditions. Again we found that temperature does not have a major impact on the amplitude of IPSPs. Thus, results at 35°C do not change the conclusions we make from the model.

      Author response image 6.

      The nominal conductance densities should at least be provided in a table (supplemental, in addition to including them in the deposited code). The method for "optimization" of the conductance densities to match the experimental recordings needs to be described; the parameter space can be quite large in a model such as this. The McGinley reference needs a number.

      We added a more thorough description of modeling parameters and justification of choices in the methods section of the text (lines 641-661). We have also added a reference number to the McGinley 2012 reference in the text.

      I think this is required by the journal:

      The model code, test results, and simulation results should be deposited in a public resource (Github would be preferable, but dryad, Zenodo, or Figshare could work), and the URL/doi for the resource provided in the manuscript. This includes the morphology swc/hoc file. The code should be in a form, and with a description, that readily allows an interested party with appropriate skills to download it and run it to generate the figures.

      We will upload the code and all associated simulation files to the ModelDB repository upon publication.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Response to Reviewer #1:

      Thank you for the careful reading and the positive evaluation of our manuscript. As you mentioned, the present study tried to address the question of how the lost genomic functions could be compensated by evolutionary adaptation, indicating the potential mechanism of "constructive" rather than "destructive" evolution. Thank you for the instructive comments that helped us to improve the manuscript. We sincerely hope the revised manuscript and the following point-to-point response meet your concerns.

      • Line 80 "Growth Fitness" is this growth rate?

      Yes. The sentence was revised as follows.

      (L87-88) “The results demonstrated that most evolved populations (Evos) showed improved growth rates, in which eight out of nine Evos were highly significant (Fig. 1B, upper).”

      • Line 94 a more nuanced understanding of r/K selection theory, allows for trade-ups between R and K, as well as trade-offs. This may explain why you did not see a trade-off between growth and carrying capacity in this study. See this paper https://doi.org/10.1038/s41396-023-01543-5. Overall, your evos lineages evolved higher growth rates and lower carrying capacity (Figures 1B, C, E). If selection was driving the evolution of higher growth rates, it may have been that there was no selective pressure to maintain high carrying capacity. This means that the evolutionary change you observed in carrying capacity may have been neutral "drift" of the carrying capacity trait, during selection for growth rate, not because of a trade-off between R and K. This is especially likely since carrying capacity declined during evolution. Unless the authors have convincing evidence for a tradeoff, I suggest they remove this claim.

      • Line 96 the authors introduce a previous result where they use colony size to measure growth rate, this finding needs to be properly introduced and explained so that we can understand the context of the conclusion.

      • Line 97 This sentence "the collapse of the trade-off law likely resulted from genome reduction." I am not sure how the authors can draw this conclusion, what is the evidence supporting that the genome size reduction causes the breakdown of the tradeoff between R and K (if there was a tradeoff)?

      Thank you for the reference information and the thoughtful comments. The recommended paper was newly cited, and the description of the trade-off collapse was deleted. Accordingly, the corresponding paragraph was rewritten as follows.

      (L100-115) “Intriguingly, a positive correlation was observed between the growth fitness and the carrying capacity of the Evos (Fig. 1D). It was somehow consistent with the positive correlations between the colony growth rate and the colony size of a genome-reduced strain 11 and between the growth rates and the saturated population size of an assortment of genome reduced strains 13. Nevertheless, the negative correlation between growth rate and carrying capacity, known as the r/K selection30,31 was often observed as the trade-off relationship between r and K in the evolution and ecology studies 32 33,34. As the r/K trade-off was proposed to balance the cellular metabolism that resulted from the cost of enzymes involved 34, the deleted genes might play a role in maintaining the metabolism balance for the r/K correlation. On the other hand, the experimental evolution (i.e., serial transfer) was strictly performed within the exponential growth phase; thus, the evolutionary selection was supposed to be driven by the growth rate without selective pressure to maintain the carrying capacity. The declined carrying capacity might have been its neutral "drift" but not a trade-off to the growth rate. Independent and parallel experimental evolution of the reduced genomes selecting either r or K is required to clarify the actual mechanisms.”

      • Line 103 Genome mutations. The authors claim that there are no mutations in parallel but I see that there is a 1199 base pair deletion in eight of the nine evo strains (Table S3). I would like the author to mention this and I'm actually curious about why the authors don't consider this parallel evolution.

      Thank you for your careful reading. According to your comment, we added a brief description of the 1199-bp deletion detected in the Evos as follows.

      (L119-122) “The number of mutations largely varied among the nine Evos, from two to 13, and no common mutation was detected in all nine Evos (Table S3). A 1,199-bp deletion of insH was frequently found in the Evos (Table S3, highlighted), which well agreed with its function as a transposable sequence.”

      • Line 297 Please describe the media in full here - this is an important detail for the evolution experiment. Very frustrating to go to reference 13 and find another reference, but no details of the method. Looked online for the M63 growth media and the carbon source is not specified. This is critical for working out what selection pressures might have driven the genetic and transcriptional changes that you have measured. For example, the parallel genetic change in 8/9 populations is a deletion of insH and tdcD (according to Table S3). This is acetate kinase, essential for the final step in the overflow metabolism of glucose into acetate. If you have a very low glucose concentration, then it could be that there was selection to avoid fermentation and devote all the pyruvate that results from glycolysis into the TCA cycle (which is more efficient than fermentation in terms of ATP produced per pyruvate).

      Sorry for the missing information on the medium composition, which was additionally described in the Materials and Methods. The glucose concentration in M63 was 22 mM, which was supposed to be enough for bacterial growth. Thank you for your intriguing thinking about linking the medium component to the genome mutation-mediated metabolic changes. As there was no experimental result regarding the biological function of gene mutation in the present study, please allow us to address this issue in our future work.

      (L334-337) “In brief, the medium contains 62 mM dipotassium hydrogen phosphate, 39 mM potassium dihydrogen phosphate, 15 mM ammonium sulfate, 15 μM thiamine hydrochloride, 1.8 μM Iron (II) sulfate, 0.2 mM magnesium sulfate, and 22 mM glucose.”

      • Line 115. I do not understand this argument "They seemed highly related to essentiality, as 11 out of 49 mutated genes were essential (Table S3)." Is this a significant enrichment compared to the expectation, i.e. the number of essential genes in the genome? This enrichment needs to be tested with a Hypergeometric test or something similar.

      • Also, "As the essential genes were known to be more conserved than nonessential ones, the high frequency of the mutations fixed in the essential genes suggested the mutation in essentiality for fitness increase was the evolutionary strategy for reduced genome." I do not think that there is enough evidence to support this claim, and it should be removed.

      Sorry for the unclear description. Yes, the mutations were significantly enriched in the essential genes (11 out of 45 genes) compared to the essential genes in the whole genome (286 out of 3290 genes). The improper description linking the mutation in essential genes to the fitness increase was removed, and an additional explanation on the ratio of essential genes was newly supplied as follows.

      (L139-143) “The ratio of essential genes in the mutated genes was significantly higher than in the total genes (286 out of 3290 genes, Chi-square test p=0.008). As the essential genes were determined according to the growth35 and were known to be more conserved than nonessential ones 36,37, the high frequency of the mutations fixed in the essential genes was highly intriguing and reasonable.”

      • Line 124 Regarding the mutation simulations, I do not understand how the observed data were compared to the simulated data, and how conclusions were drawn. Can the authors please explain the motivation for carrying out this analysis, and clearly explain the conclusions?

      Random simulation was additionally explained in the Materials and Methods and the conclusion of the random simulation was revised in the Results, as follows.

      (L392-401) “The mutation simulation was performed with Python in the following steps. A total of 65 mutations were randomly generated on the reduced genome, and the distances from the mutated genomic locations to the nearest genomic scars caused by genome reduction were calculated. Subsequently, Welch's t-test was performed to evaluate whether the distances calculated from the random mutations were significantly longer or shorter than those calculated from the mutations that occurred in Evos. The random simulation, distance calculation, and statistic test were performed 1,000 times, which resulted in 1,000 p values. Finally, the mean of p values (μp) was calculated, and a 95% reliable region was applied. It was used to evaluate whether the 65 mutations in the Evos were significantly close to the genomic scars, i.e., the locational bias.”

      (L148-157) “Random simulation was performed to verify whether there was any bias or hotspot in the genomic location for mutation accumulation due to the genome reduction. A total of 65 mutations were randomly generated on the reduced genome (Fig. 2B), and the genomic distances from the mutations to the nearest genome reduction-mediated scars were calculated. Welch's t-test was performed to evaluate whether the genomic distances calculated from random mutations significantly differed from those from the mutations accumulated in the Evos. As the mean of p values (1,000 times of random simulations) was insignificant (Fig. 2C, μp > 0.05), the mutations fixed on the reduced genome were either closer or farther to the genomic scars, indicating there was no locational bias for mutation accumulation caused by genome reduction.”

      • Line 140 The authors should give some background here - explain the idea underlying chromosomal periodicity of the transcriptome, to help the reader understand this analysis.

      • Line 142 Here and elsewhere, when referring to a method, do not just give the citation, but also refer to the methods section or relevant supplementary material.

      The analytical process (references and methods) was described in the Materials and Methods, and the reason we performed the chromosomal periodicity was added in the Results as follows.

      (L165-172) “As the E. coli chromosome was structured, whether the genome reduction caused the changes in its architecture, which led to the differentiated transcriptome reorganization in the Evos, was investigated. The chromosomal periodicity of gene expression was analyzed to determine the structural feature of genome-wide pattern, as previously described 28,38. The analytical results showed that the transcriptomes of all Evos presented a common six-period with statistical significance, equivalent to those of the wild-type and ancestral reduced genomes (Fig. 3A, Table S4).”

      • Line 151 "The expression levels of the mutated genes were higher than those of the remaining genes (Figure 3B)"- did this depend on the type of mutation? There were quite a few early stops in genes, were these also more likely to be expressed? And how about the transcriptional regulators, can you see evidence of their downstream impact?

      Sorry, we didn't investigate the detailed regulatory mechanisms of 49 mutated genes, which was supposed to be out of the scope of the present study. Fig. 3B was the statistical comparison between 3225 and 49 genes. It didn't mean that all mutated genes expressed higher than the others. The following sentences were added to address your concern.

      (L181-185) “As the regulatory mechanisms or the gene functions were supposed to be disturbed by the mutations, the expression levels of individual genes might have been either up- or down-regulated. Nevertheless, the overall expression levels of all mutated genes tended to be increased. One of the reasons was assumed to be the mutation essentiality, which remained to be experimentally verified.”

      • Line 199 onward. The authors used WGCNA to analyze the gene expression data of evolved organisms. They identified distinct gene modules in the reduced genome, and through further analysis, they found that specific modules were strongly associated with key biological traits like growth fitness, gene expression changes, and mutation rates. Did the authors expect that there was variation in mutation rate across their populations? Is variation from 3-16 mutations that they observed beyond the expectation for the wt mutation rate? The genetic causes of mutation rate variation are well understood, but I could not see any dinB, mutT,Y, rad, or pol genes among the discovered mutations. I would like the authors to justify the claim that there was mutation rate variation in the evolved populations.

      Thank you for the intriguing thinking. We don't think the mutation rates were significantly varied across the nine populations, as no mutation occurred in the MMR genes, as you noticed. Our previous study showed that the spontaneous mutation rate of the reduced genome was higher than that of the wild-type genome (Nishimura et al., 2017, mBio). As nonsynonymous mutations were not detected in all nine Evos, the spontaneous mutation rate couldn't be calculated (because it should be evaluated according to the ratio of nonsynonymous and synonymous single-nucleotide substitutions in molecular evolution). Therefore, discussing the mutation rate in the present study was unavailable. The following sentence was added for a better understanding of the gene modules.

      (L242-245) “These modules M2, M10 and M16 might be considered as the hotspots for the genes responsible for growth fitness, transcriptional reorganization, and mutation accumulation of the reduced genome in evolution, respectively.”

      • Line 254 I get the idea of all roads leading to Rome, which is very fitting. However, describing the various evolutionary strategies and homeostatic and variable consequence does not sound correct - although I am not sure exactly what is meant here. Looking at Figure 7, I will call strategy I "parallel evolution", that is following the same or similar genetic pathways to adaptation and strategy ii I would call divergent evolution. I am not sure what strategy iii is. I don't want the authors to use the terms parallel and divergent if that's not what they mean. My request here would be that the authors clearly describe these strategies, but then show how their results fit in with the results, and if possible, fit with the naming conventions, of evolutionary biology.

      Thank you for your kind consideration and excellent suggestion. It's our pleasure to adopt your idea in tour study. The evolutionary strategies were renamed according to your recommendation. Both the main text and Fig. 7 were revised as follows.

      (L285-293) “Common mutations22,44 or identical genetic functions45 were reported in the experimental evolution with different reduced genomes, commonly known as parallel evolution (Fig. 7, i). In addition, as not all mutations contribute to the evolved fitness 22,45, another strategy for varied phenotypes was known as divergent evolution (Fig. 7, ii). The present study accentuated the variety of mutations fixed during evolution. Considering the high essentiality of the mutated genes (Table S3), most or all mutations were assumed to benefit the fitness increase, partially demonstrated previously 20. Nevertheless, the evolved transcriptomes presented a homeostatic architecture, revealing the divergent to convergent evolutionary strategy (Fig. 7, iii).”

      Author response image 1.

      • Line 327 Growth rates/fitness. I don't think this should be called growth fitness- a rate is being calculated. I would like the authors to explain how the times were chosen - do the three points have to be during the log phase? Can you also explain what you mean by choosing three ri that have the largest mean and minor variance?

      Sorry for the confusing term usage. The fitness assay was changed to the growth assay. Choosing three ri that have the largest mean and minor variance was to avoid the occasional large values (blue circle), as shown in the following figure. In addition, the details of the growth analysis can be found at https://doi.org/10.3791/56197 (ref. 59), where the video of experimental manipulation, protocol, and data analysis is deposited. The following sentence was added in accordance.

      Author response image 2.

      (L369-371) “The growth rate was determined as the average of three consecutive ri, showing the largest mean and minor variance to avoid the unreliable calculation caused by the occasionally occurring values. The details of the experimental and analytical processes can be found at https://doi.org/10.3791/56197.”

      • Line 403 Chromosomal periodicity analysis. The windows chosen for smoothing (100kb) seem big. Large windows make sense for some things - for example looking at how transcription relates to DNA replication timing, which is a whole-genome scale trend. However, here the authors are looking for the differences after evolution, which will be local trends dependent on specific genes and transcription factors. 100kb of the genome would carry on the order of one hundred genes and might be too coarse-grained to see differences between evos lineages.

      Thank you for the advice. We agree that the present analysis focused on the global trend of gene expression. Varying the sizes may lead to different patterns. Additional analysis was performed according to your comment. The results showed that changes in window size (1, 10, 50, 100, and 200 kb) didn't alter the periodicity of the reduced genome, which agreed with the previous study on a different reduced genome MDS42 of a conserved periodicity (Ying et al., 2013, BMC Genomics). The following sentence was added in the Materials and Methods.

      (L460-461) “Note that altering the moving average did not change the max peak.”

      • Figures - the figures look great. Figure 7 needs a legend.

      Thank you. The following legend was added.

      (L774-777) “Three evolutionary strategies are proposed. Pink and blue arrowed lines indicate experimental evolution and genome reduction, respectively. The size of the open cycles represents the genome size. Black and grey indicate the ancestor and evolved genomes, respectively.”

      Response to Reviewer #2:

      Thank you for reviewing our manuscript and for your fruitful comments. We agree that our study leaned towards elaborating observed findings rather than explaining the detailed biological mechanisms. We focused on the genome-wide biological features rather than the specific biological functions. The underlying mechanisms indeed remained unknown, leaving the questions as you commented. We didn't perform the fitness assay on reconstituted (single and combinatorial) mutants because the research purpose was not to clarify the regulatory or metabolic mechanisms. It's why the RNA-Seq analysis provided the findings on genome-wide patterns and chromosomal view, which were supposed to be biologically valuable. We did understand your comments and complaints that the conclusions were biologically meaningless, as ALE studies that found the specific gene regulation or improved pathway was the preferred story in common, which was not the flow of the present study.

      For this reason, our revision may not address all these concerns. Considering your comments, we tried our best to revise the manuscript. The changes made were highlighted. We sincerely hope the revision and the following point-to-point response are acceptable.

      Major remarks:

      (1) The authors outlined the significance of ALE in genome-reduced organisms and important findings from published literature throughout the Introduction section. The description in L65-69, which I believe pertains to the motivation of this study, seems vague and insufficient to convey the novelty or necessity of this study i.e. it is difficult to grasp what aspects of genome-reduced biology that this manuscript intends to focus/find/address.

      Sorry for the unclear writing. The sentences were rewritten for clarity as follows.

      (L64-70) “Although the reduced growth rate caused by genome reduction could be recovered by experimental evolution, it remains unclear whether such an evolutionary improvement in growth fitness was a general feature of the reduced genome and how the genome-wide changes occurred to match the growth fitness increase. In the present study, we performed the experimental evolution with a reduced genome in multiple lineages and analyzed the evolutionary changes of the genome and transcriptome.”

      (2) What is the rationale behind the lineage selection described in Figure S1 legend "Only one of the four overnight cultures in the exponential growth phase (OD600 = 0.01~0.1) was chosen for the following serial transfer, highlighted in red."?

      The four wells (cultures of different initial cell concentrations) were measured every day, and only the well that showed OD600=0.01~0.1 (red) was transferred with four different dilution rates (e.g., 10, 100, 1000, and 10000 dilution rates). It resulted in four wells of different initial cell concentrations. Multiple dilutions promised that at least one of the wells would show the OD600 within the range of 0.01 to 0.1 after the overnight culture. They were then used for the next serial transfer. Fig. S1 provides the details of the experimental records. The experimental evolution was strictly controlled within the exponential phase, quite different from the commonly conducted ALE that transferred a single culture in a fixed dilution rate. Serial transfer with multiple dilution rates was previously applied in our evolution experiments and well described in Nishimura et al., 2017, mBio; Lu et al., 2022, Comm Biol; Kurokawa et al., 2022, Front Microbiol, etc. The following sentence was added in the Materials and Methods.

      (L344-345) “Multiple dilutions changing in order promised at least one of the wells within the exponential growth phase after the overnight culture.”

      (3) The measured growth rate of the end-point 'F2 lineage' shown in Figure S2 seemed comparable to the rest of the lineages (A1 to H2), but the growth rate of 'F2' illustrated in Figure 1B indicates otherwise (L83-84). What is the reason for the incongruence between the two datasets?

      Sorry for the unclear description. The growth rates shown in Fig. S2 were obtained during the evolution experiment using the daily transfer's initial and final OD600 values. The growth rates shown in Fig. 1B were obtained from the final population (Evos) growth assay and calculated from the growth curves (biological replication, N=4). Fig. 1B shows the precisely evaluated growth rates, and Fig. S2 shows the evolutionary changes in growth rates. Accordingly, the following sentence was added to the Results.

      (L84-87) “As the growth increases were calculated according to the initial and final records, the exponential growth rates of the ancestor and evolved populations were obtained according to the growth curves for a precise evaluation of the evolutionary changes in growth.”

      (4) Are the differences in growth rate statistically significant in Figure 1B?

      Eight out of nine Evos were significant, except F2. The sentences were rewritten and associated with the revised Fig. 1B, indicating significance.

      (L87-90) “The results demonstrated that most evolved populations (Evos) showed improved growth rates, in which eight out of nine Evos were highly significant (Fig. 1B, upper). However, the magnitudes of growth improvement were considerably varied, and the evolutionary dynamics of the nine lineages were somehow divergent (Fig. S2).”

      (5) The evolved lineages showed a decrease in their maximal optical densities (OD600) compared to the ancestral strain (L85-86). ALE could accompany changes in cell size and morphologies, (doi: 10.1038/s41586-023-06288-x; 10.1128/AEM.01120-17), which may render OD600 relatively inaccurate for cell density comparison. I suggest using CFU/mL metrics for the sake of a fair comparison between Anc and Evo.

      The methods evaluating the carrying capacity (i.e., cell density, population size, etc.) do not change the results. Even using CFU is unfair for the living cells that can not form colonies and unfair if the cell size changes. Optical density (OD600) provides us with the temporal changes of cell growth in a 15-minute interval, which results in an exact evaluation of the growth rate in the exponential phase. CFU is poor at recording the temporal changes of population changes, which tend to result in an inappropriate growth rate. Taken together, we believe that our method was reasonable and reliable. We hope you can accept the different way of study.

      (6) Please provide evidence in support of the statement in L115-119. i.e. statistical analysis supporting that the observed ratio of essential genes in the mutant pool is not random.

      The statistic test was performed, and the following sentence was added.

      (L139-141) “The ratio of essential genes in the mutated genes was significantly higher than in the total genes (286 out of 3290 genes, Chi-square test p=0.008).”

      (7) The assumption that "mutation abundance would correlate to fitness improvement" described in L120-122: "The large variety in genome mutations and no correlation of mutation abundance to fitness improvement strongly suggested that no mutations were specifically responsible or crucially essential for recovering the growth rate of the reduced genome" is not easy to digest, in the sense that (i) the effect of multiple beneficial mutations are not necessarily summative, but are riddled with various epistatic interactions (doi: 10.1016/j.mec.2023.e00227); (ii) neutral hitchhikers are of common presence (you could easily find reference on this one); (iii) hypermutators that accumulate greater number of mutations in a given time are not always the eventual winners in competition games (doi: 10.1126/science.1056421). In this sense, the notion that "mutation abundance correlates to fitness improvement" in L120-122 seems flawed (for your perusal, doi: 10.1186/gb-2009-10-10-r118).

      Sorry for the improper description and confusing writing, and thank you for the fruitful knowledge on molecular evolution. The sentence was deleted, and the following one was added.

      (L145-146) “Nevertheless, it was unclear whether and how these mutations were explicitly responsible for recovering the growth rate of the reduced genome.”

      (8) Could it be possible that the large variation in genome mutations in independent lineages results from a highly rugged fitness landscape characterized by multiple fitness optima (doi: 10.1073/pnas.1507916112)? If this is the case, I disagree with the notion in L121-122 "that no mutations were specifically responsible or crucially essential" It does seem to me that, for example, the mutations in evo A2 are specifically responsible and essential for the fitness improvement of evo A2 in the evolutionary condition (M63 medium). Fitness assessment of individual (or combinatorial) mutants reconstituted in the Ancestral background would be a bonus.

      Thank you for the intriguing thinking. The sentence was deleted. Please allow us to adapt your comment to the manuscript as follows.

      (L143-145) “The large variety of genome mutations fixed in the independent lineages might result from a highly rugged fitness landscape 38.”

      (9) L121-122: "...no mutations were specifically responsible or crucially essential for recovering the growth rate of the reduced genome". Strictly speaking, the authors should provide a reference case of wild-type E. coli ALE in order to reach definitive conclusions that the observed mutation events are exclusive to the genome-reduced strain. It is strongly recommended that the authors perform comparative analysis with an ALEed non-genome-reduced control for a more definitive characterization of the evolutionary biology in a genome-reduced organism, as it was done for "JCVI-syn3.0B vs non-minimal M. mycoides" (doi: 10.1038/s41586-023-06288-x) and "E. coli eMS57 vs MG1655" (doi: 10.1038/s41467-019-08888-6).

      The improper description was deleted in response to comments 7 and 8. The mentioned references were cited in the manuscript (refs 21 and 23). Thank you for the experimental advice. We are sorry that the comparison of wild-type and reduced genomes was not in the scope of the present study and will probably be reported soon in our future work.

      (10) L146-148: "The homeostatic periodicity was consistent with our previous findings that the chromosomal periodicity of the transcriptome was independent of genomic or environmental variation" A Previous study also suggested that the amplitudes of the periodic transcriptomes were significantly correlated with the growth rates (doi: 10.1093/dnares/dsaa018). Growth rates of 8/9 Evos were higher compared to Anc, while that of Evo F2 remained similar. Please comment on the changes in amplitudes of the periodic transcriptomes between Anc and each Evo.

      Thank you for the suggestion. The correlation between the growth rates and the amplitudes of chromosomal periodicity was statistically insignificant (p>0.05). It might be a result of the limited data points. Compared with the only nine data points in the present study, the previous study analyzed hundreds of transcriptomes associated with the corresponding growth rates, which are suitable for statistical evaluation. In addition, the changes in growth rates were more significant in the previous study than in the present study, which might influence the significance. It's why we did not discuss the periodic amplitude.

      (11) Please elaborate on L159-161: "It strongly suggested the essentiality mutation for homeostatic transcriptome architecture happened in the reduced genome.".

      Sorry for the improper description. The sentence was rewritten as follows.

      (L191-193) “The essentiality of the mutations might have participated in maintaining the homeostatic transcriptome architecture of the reduced genome.”

      (12) Is FPKM a valid metric for between-sample comparison? The growing consensus in the community adopts Transcripts Per Kilobase Million (TPM) for comparing gene expression levels between different samples (Figure 3B; L372-379).

      Sorry for the unclear description. The FPKM indicated here was globally normalized, statistically equivalent to TPM. The following sentence was added to the Materials and Methods.

      (L421-422) “The resulting normalized FPKM values were statistically equivalent to TPM.”

      (13) Please provide % mapped frequency of mutations in Table S3.

      They were all 100%. The partially fixed mutations were excluded in the present study. The following sentence was added to the caption of Table S3.

      (Supplementary file, p 9) “Note that the entire population held the mutations, i.e., 100% frequency in DNA sequencing.”

      (14) To my knowledge, M63 medium contains glucose and glycerol as carbon sources. The manuscript would benefit from discussing the elements that impose selection pressure in the M63 culture condition.

      Sorry for the missing information on M63, which contains 22 mM glucose as the only carbon source. The medium composition was added in the Materials and Methods, as follows.

      (L334-337) “In brief, the medium contains 62 mM dipotassium hydrogen phosphate, 39 mM potassium dihydrogen phosphate, 15 mM ammonium sulfate, 15 μM thiamine hydrochloride, 1.8 μM Iron (II) sulfate, 0.2 mM magnesium sulfate, and 22 mM glucose.”

      (15) The RNA-Seq datasets for Evo strains seemed equally heterogenous, just as their mutation profiles. However, the missing element in their analysis is the directionality of gene expression changes. I wonder what sort of biological significance can be derived from grouping expression changes based solely on DEGs, without considering the magnitude and the direction (up- and down-regulation) of changes? RNA-seq analysis in its current form seems superficial to derive biologically meaningful interpretations.

      We agree that most studies often discuss the direction of transcriptional changes. The present study aimed to capture a global view of the magnitude of transcriptome reorganization. Thus, the analyses focused on the overall features, such as the abundance of DEGs, instead of the details of the changes, e.g., the up- and down-regulation of DEGs. The biological meaning of the DEGs' overview was how significantly the genome-wide gene expression fluctuated, which might be short of an in-depth view of individual gene expression. The following sentence was added to indicate the limitation of the present analysis.

      (L199-202) “Instead of an in-depth survey on the directional changes of the DEGs, the abundance and functional enrichment of DEGs were investigated to achieve an overview of how significant the genome-wide fluctuation in gene expression, which ignored the details of individual genes.”

      Minor remarks

      (1) L41: brackets italicized "(E. coli)".

      It was fixed as follows.

      (L40) “… Escherichia coli (E. coli) cells …”

      (2) Figure S1. It is suggested that the x-axis of ALE monitor be set to 'generations' or 'cumulative generations', rather than 'days'.

      Thank you for the suggestion. Fig. S1 describes the experimental procedure, so the" day" was used. Fig. S2 presents the evolutionary process, so the "generation" was used, as you recommended here.

      (3) I found it difficult to digest through L61-64. Although it is not within the job scope of reviewers to comment on the language style, I must point out that the manuscript would benefit from professional language editing services.

      Sorry for the unclear writing. The sentences were revised as follows.

      (L60-64) “Previous studies have identified conserved features in transcriptome reorganization, despite significant disruption to gene expression patterns resulting from either genome reduction or experimental evolution 27-29. The findings indicated that experimental evolution might reinstate growth rates that have been disrupted by genome reduction to maintain homeostasis in growing cells.”

      (4) Duplicate references (No. 21, 42).

      Sorry for the mistake. It was fixed (leaving ref. 21).

      (5) Inconsistency in L105-106: "from two to 13".

      "From two to 13" was adopted from the language editing. It was changed as follows.

      (L119) “… from 2 to 13, …”

      Response to Reviewer #3:

      Thank you for reviewing our manuscript and for the helpful comments, which improved the strength of the manuscript. The recommended statistical analyses essentially supported the statement in the manuscript were performed, and those supposed to be the new results in the scope of further studies remained unconducted. The changes made in the revision were highlighted. We sincerely hope the revised manuscript and the following point-to-point response meet your concerns. You will find all your suggested statistic tests in our future work that report an extensive study on the experimental evolution of an assortment of reduced genomes.

      (1) Line 106 - "As 36 out of 45 SNPs were nonsynonymous, the mutated genes might benefit the fitness increase." This argument can be strengthened. For example, the null expectation of nonsynonymous SNPs should be discussed. Is the number of observed nonsynonymous SNPs significantly higher than the expected one?

      (2) Line 107 - "In addition, the abundance of mutations was unlikely to be related to the magnitude of fitness increase." Instead of just listing examples, a regression analysis can be added.

      Yes, it's significant. Random mutations lead to ~33% of nonsynonymous SNP in a rough estimation. Additionally, the regression is unreliable because there's no statistical significance between the number of mutations and the magnitude of fitness increase. Accordingly, the corresponding sentences were revised with additional statistical tests.

      (L123-129) “As 36 out of 45 SNPs were nonsynonymous, which was highly significant compared to random mutations (p < 0.01), the mutated genes might benefit fitness increase. In addition, the abundance of mutations was unlikely to be related to the magnitude of fitness increase. There was no significant correlation between the number of mutations and the growth rate in a statistical view (p > 0.1). Even from an individual close-up viewpoint, the abundance of mutations poorly explained the fitness increase.”

      (3) Line 114 - "They seemed highly related to essentiality, as 11 out of 49 mutated genes were essential (Table S3)." Here, the information mentioned in line 153 ("the ratio of essential to all genes (302 out of 3,290) in the reduced genome.") can be used. Then a statistical test for a contingency table can be used.

      (4) Line 117 - "the high frequency of the mutations fixed in the essential genes suggested the mutation in essentiality for fitness increase was the evolutionary strategy for reduced genome." What is the expected number of fixed mutations in essential genes vs non-essential genes? Is the observed number statistically significantly higher?

      Sorry for the improper and insufficient information on the essential genes. Yes, it's significant. The statistical test was additionally performed. The corresponding part was revised as follows.

      (L134-146) “They seemed highly related to essentiality7 (https://shigen.nig.ac.jp/ecoli/pec/genes.jsp), as 11 out of 49 mutated genes were essential (Table S3). Although the essentiality of genes might differ between the wild-type and reduced genomes, the experimentally determined 302 essential genes in the wild-type E. coli strain were used for the analysis, of which 286 were annotated in the reduced genome. The ratio of essential genes in the mutated genes was significantly higher than in the total genes (286 out of 3290 genes, Chi-square test p=0.008). As the essential genes were determined according to the growth35 and were known to be more conserved than nonessential ones 36,37, the high frequency of the mutations fixed in the essential genes was highly intriguing and reasonable. The large variety of genome mutations fixed in the independent lineages might result from a highly rugged fitness landscape 38. Nevertheless, it was unclear whether and how these mutations were explicitly responsible for recovering the growth rate of the reduced genome.”

      (5) The authors mentioned no overlapping in the single mutation level. Is that statistically significant? The authors can bring up what the no-overlap probability is given that there are in total x number of fixed mutations observed (either theory or simulation is good).

      Sorry, we feel confused about this comment. It's unclear to us why it needs to be statistically simulated. Firstly, the mutations were experimentally observed. The result that no overlapped mutated genes were detected was an Experimental Fact but not a Computational Prediction. We feel sorry that you may over-interpret our finding as an evolutionary rule, which always requires testing its reliability statistically. We didn't conclude that the evolution had no overlapped mutations. Secondly, considering 65 times random mutations happened to a ~3.9 Mb sequence, the statistical test was meaningful only if the experimental results found the overlapped mutations. It is interesting how often the random mutations cause the overlapped mutations in parallel evolutionary lineages while increasing the evolutionary lineages, which seems to be out of the scope of the present study. We are happy to include the analysis in our ongoing study on the experimental evolution of reduced genomes.

      (6) The authors mentioned no overlapping in the single mutation level. How about at the genetic level? Some fixed mutations occur in the same coding gene. Is there any gene with a significantly enriched number of mutations?

      No mutations were fixed in the same gene of biological function, as shown in Table S3. If we say the coding region, the only exception is the IS sequences, well known as the transposable sequences without genetic function. The following description was added.

      (L119-122) “The number of mutations largely varied among the nine Evos, from 2 to 13, and no common mutation was detected in all nine Evos (Table S3). A 1,199-bp deletion of insH was frequently found in the Evos (Table S3, highlighted), which well agreed with its function as a transposable sequence.”

      (7) Line 151-156- It seems like the authors argue that the expression level differences can be just explained by the percentage of essential genes that get fixed mutations. One further step for the argument could be to compare the expression level of essential genes with vs without fixed mutations. Also, the authors can compare the expression level of non-essential genes with vs without fixed mutations. And the authors can report whether the differences in expression level became insignificant after the control of the essentiality.

      It's our pleasure that the essentiality intrigued you. Thank you for the analytical suggestion, which is exciting and valuable for our studies. As only 11 essential genes were detected here and "Mutation in essentiality" was an indication but not the conclusion of the present study, we would like to apply the recommended analysis to the datasets of our ongoing study to demonstrate this statement. Thank you again for your fruitful analytical advice.

      (8) Line 169- "The number of DEGs partially overlapped among the Evos declined significantly along with the increased lineages of Evos (Figure 4B). " There is a lack of statistical significance here while the word "significantly" is used. One statistical test that can be done is to use re-sampling/simulation to generate a null expectation of the overlapping numbers given the DEGs for each Evo line and the total number of genes in the genome. The observed number can then be compared to the distribution of the simulated numbers.

      Sorry for the inappropriate usage of the term. Whether it's statistically significant didn't matter here. The word "significant" was deleted as follows.

      (L205--206) “The number of DEGs partially overlapped among the Evos declined along with the increased lineages of Evos (Fig. 4B).”

      (9) Line 177-179- "In comparison,1,226 DEGs were induced by genome reduction. The common DEGs 177 of genome reduction and evolution varied from 168 to 540, fewer than half of the DEGs 178 responsible for genome reduction in all Evos" Is the overlapping number significantly lower than the expectation? The hypergeometric test can be used for testing the overlap between two gene sets.

      There's no expectation for how many DEGs were reasonable. Not all numbers experimentally obtained are required to be statistically meaningful, which is commonly essential in computational and data science.

      (10) The authors should give more information about the ancestral line used at the beginning of experimental evolution. I guess it is one of the KHK collection lines, but I can not find more details. There are many genome-reduced lines. Why is this certain one picked?

      Sorry for the insufficient information on the reduced genome used for the experimental evolution. The following descriptions were added in the Results and the Materials and Methods, respectively.

      (L75-79) “The E. coli strain carrying a reduced genome, derived from the wild-type genome W3110, showed a significant decline in its growth rate in the minimal medium compared to the wild-type strain 13. To improve the genome reduction-mediated decreased growth rate, the serial transfer of the genome-reduced strain was performed with multiple dilution rates to keep the bacterial growth within the exponential phase (Fig. S1), as described 17,20.”

      (L331-334) “The reduced genome has been constructed by multiple deletions of large genomic fragments 58, which led to an approximately 21% smaller size than its parent wild-type genome W3110.”

      (11) How was the saturated density in Figure 1 actually determined? In particular, the fitness assay of growth curves is 48h. But it seems like the experimental evolution is done for ~24 h cycles. If the Evos never experienced a situation like a stationary phase between 24-48h, and if the author reported the saturated density 48 h in Figure 1, the explanation of the lower saturated density can be just relaxation from selection and may have nothing to do with the increase of growth rate.

      Sorry for the unclear description. Yes, you are right. The evolution was performed within the exponential growth phase (keeping cell division constant), which means the Evos never experienced the stationary phase (saturation). The final evolved populations were subjected to the growth assay to obtain the entire growth curves for calculating the growth rate and the saturated density. Whether the decreased saturated density and the increased growth rate were in a trade-off relationship remained unclear. The corresponding paragraph was revised as follows.

      (L100-115) “Intriguingly, a positive correlation was observed between the growth fitness and the carrying capacity of the Evos (Fig. 1D). It was somehow consistent with the positive correlations between the colony growth rate and the colony size of a genome-reduced strain 11 and between the growth rates and the saturated population size of an assortment of genome reduced strains 13. Nevertheless, the negative correlation between growth rate and carrying capacity, known as the r/K selection30,31 was often observed as the trade-off relationship between r and K in the evolution and ecology studies 32 33,34. As the r/K trade-off was proposed to balance the cellular metabolism that resulted from the cost of enzymes involved 34, the deleted genes might play a role in maintaining the metabolism balance for the r/K correlation. On the other hand, the experimental evolution (i.e., serial transfer) was strictly performed within the exponential growth phase; thus, the evolutionary selection was supposed to be driven by the growth rate without selective pressure to maintain the carrying capacity. The declined carrying capacity might have been its neutral "drift" but not a trade-off to the growth rate. Independent and parallel experimental evolution of the reduced genomes selecting either r or K is required to clarify the actual mechanisms.”

      (12) What annotation of essentiality was used in this paper? In particular, the essentiality can be different in the reduced genome background compared to the WT background.

      Sorry for the unclear definition of the essential genes. They are strictly limited to the 302 essential genes experimentally determined in the wild-type E coli strain. Detailed information can be found at the following website: https://shigen.nig.ac.jp/ecoli/pec/genes.jsp. We agree that the essentiality could differ between the WT and reduced genomes. Identifying the essential genes in the reduced genome will be an exhaustedly vast work. The information on the essential genes defined in the present study was added as follows.

      (L134-139) “They seemed highly related to essentiality7 (https://shigen.nig.ac.jp/ecoli/pec/genes.jsp), as 11 out of 49 mutated genes were essential (Table S3). Although the essentiality of genes might differ between the wild-type and reduced genomes, the experimentally determined 302 essential genes in the wild-type E. coli strain were used for the analysis, of which 286 were annotated in the reduced genome.”

      (13) The fixed mutations in essential genes are probably not rarely observed in experimental evolution. For example, fixed mutations related to RNA polymerase can be frequently seen when evolving to stressful environments. I think the author can discuss this more and elaborate more on whether they think these mutations in essential genes are important in adaptation or not.

      Thank you for your careful reading and the suggestion. As you mentioned, we noticed that the mutations in RNA polymerases (rpoA, rpoB, and rpoD) were identified in three Evos. As they were not shared across all Evos, we didn't discuss the contribution of these mutations to evolution. Instead of the individual functions of the mutated essential gene functions, we focused on the enriched gene functions related to the transcriptome reorganization because they were the common feature observed across all Evos and linked to the whole metabolic or regulatory pathways, which are supposed to be more biologically reasonable and interpretable. The following sentence was added to clarify our thinking.

      (L268-273) “In particular, mutations in the essential genes, such as RNA polymerases (rpoA, rpoB, rpoD) identified in three Evos (Table S3), were supposed to participate in the global regulation for improved growth. Nevertheless, the considerable variation in the fixed mutations without overlaps among the nine Evos (Table 1) implied no common mutagenetic strategy for the evolutionary improvement of growth fitness.”

      (14) In experimental evolution to new environments, several previous literature also show that long-term experimental evolution in transcriptome is not consistent or even reverts the short-term response; short-term responses were just rather considered as an emergency plan. They seem to echo what the authors found in this manuscript. I think the author can refer to some of those studies more and make a more throughput discussion on short-term vs long-term responses in evolution.

      Thank you for the advice. It's unclear to us what the short-term and long-term responses referred to mentioned in this comment. The "Response" is usually used as the phenotypic or transcriptional changes within a few hours after environmental fluctuation, generally non-genetic (no mutation). In comparison, long-term or short-term experimental "Evolution" is associated with genetic changes (mutations). Concerning the Evolution (not the Response), the long-term experimental evolution (>10,000 generations) was performed only with the wild-type genome, and the short-term experimental evolution (500~2,000 generations) was more often conducted with both wild-type and reduced genomes, to our knowledge. Previous landmark studies have intensively discussed comparing the wild-type and reduced genomes. Our study was restricted to the reduced genome, which was constructed differently from those reduced genomes used in the reported studies. The experimental evolution of the reduced genomes has been performed in the presence of additional additives, e.g., antibiotics, alternative carbon sources, etc. That is, neither the genomic backgrounds nor the evolutionary conditions were comparable. Comparison of nothing common seems to be unproductive. We sincerely hope the recommended topics can be applied in our future work.

      Some minor suggestions

      • Figures S3 & Table S2 need an explanation of the abbreviations of gene categories.

      Sorry for the missing information. Figure S3 and Table S3 were revised to include the names of gene categories. The figure was pasted followingly for a quick reference.

      Author response image 3.

      • I hope the authors can re-consider the title; "Diversity for commonality" does not make much sense to me. For example, it can be simply just "Diversity and commonality."

      Thank you for the suggestion. The title was simplified as follows.

      (L1) “Experimental evolution for the recovery of growth loss due to genome reduction.”

      • It is not easy for me to locate and distinguish the RNA-seq vs DNA-seq files in DRA013662 at DDBJ. Could you make some notes on what RNA-seq actually are, vs what DNA-seq files actually are?

      Sorry for the mistakes in the DRA number of DNA-seq. DNA-seq and RNA-seq were deposited separately with the accession IDs of DRA013661 and DRA013662, respectively. The following correction was made in the revision.

      (L382-383) “The raw datasets of DNA-seq were deposited in the DDBJ Sequence Read Archive under the accession number DRA013661.”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In their manuscript, Yu et al. describe the chemotactic gradient formation for CCL5 bound to - i.e. released from - glycosaminoglycans. The authors provide evidence for phase separation as the driving mechanism behind chemotactic gradient formation. A conclusion towards a general principle behind the finding cannot be drawn since the work focuses on one chemokine only, which is particularly prone to glycan-induced oligomerisation.

      Strengths:

      The principle of phase separation as a driving force behind and thus as an analytical tool for investigating protein interactions with strongly charged biomolecules was originally introduced for protein-nucleic acid interactions. Yu et al. have applied this in their work for the first time for chemokine-heparan sulfate interactions. This opens a novel way to investigate chemokine-glycosaminoglycan interactions in general.

      Response: Thanks for the encouragement of the reviewer.

      Weaknesses:

      As mentioned above, one of the weaknesses of the current work is the exemplification of the phase separation principle by applying it only to CCL5-heparan sulfate interactions. CCL5 is known to form higher oligomers/aggregates in the presence of glycosaminoglycans, much more than other chemokines. It would therefore have been very interesting to see, if similar results in vitro, in situ, and in vivo could have been obtained by other chemokines of the same class (e.g. CCL2) or another class (like CXCL8).

      Response: We share the reviewer’s opinion that to investigate more molecules/cytokines that interact with heparan sulfate in the system should be of interesting. We expect that researchers in the field will adapt the concept to continue the studies on additional molecules. Nevertheless, our earlier study has demonstrated that bFGF was enriched to its receptor and triggered signaling transduction through phase separation with heparan sulfate (PMID: 35236856; doi: 10.1038/s41467-022-28765-z), which supports the concept that phase separation with heparan sulfate on the cell surface may be a common mechanism for heparan sulfate binding proteins. The comment of the reviewer that phase separation is related to oligomerization is demonstrated in (Figure 1—figure supplement 2C and D), showing that the more easily aggregated mutant, A22K-CCL5, does not undergo phase separation.

      In addition, the authors have used variously labelled CCL5 (like with the organic dye Cy3 or with EGFP) for various reasons (detection and immobilisation). In the view of this reviewer, it would have been necessary to show that all the labelled chemokines yield identical/similar molecular characteristics as the unlabelled wildtype chemokine (such as heparan sulfate binding and chemotaxis). It is well known that labelling proteins either by chemical tags or by fusion to GFPs can lead to manifestly different molecular and functional characteristics.

      Response: We agree with the reviewer that labeling may lead to altered property of a protein, thus, we have compared chemotactic activity of CCL5 and CCL5-EGFP (Figure 2—figure supplement 1). To further verify this, we performed additional experiment to compare chemotactic activity between CCL5 and Cy3-CCL5 (see Author response image 1). For the convenience of readers, we have combined the original Figure 2—figure supplement 1 with the new data (Figure R1), which replaced original Figure 2—figure supplement 1.

      Author response image 1.

      Chemotactic function of CCL5-EGFP and CCL5-Cy3. Cy3-Labeled CCL5 has similar activity as CCL5, 50 nM CCL5 or CCL5-Cy3 were added to the lower chamber of the Transwell. THP-1 cells were added to upper chambers. Data are mean ± s.d. n=3. P values were determined by unpaired two-tailed t-tests. NS, Not Significant.

      Reviewer #2 (Public Review):

      Although the study by Xiaolin Yu et al is largely limited to in vitro data, the results of this study convincingly improve our current understanding of leukocyte migration.

      (1) The conclusions of the paper are mostly supported by the data although some clarification is warranted concerning the exact CCL5 forms (without or with a fluorescent label or His-tag) and amounts/concentrations that were used in the individual experiments. This is important since it is known that modification of CCL5 at the N-terminus affects the interactions of CCL5 with the GPCRs CCR1, CCR3, and CCR5 and random labeling using monosuccinimidyl esters (as done by the authors with Cy-3) is targeting lysines. Since lysines are important for the GAG-binding properties of CCL5, knowledge of the number and location of the Cy-3 labels on CCL5 is important information for the interpretation of the experimental results with the fluorescently labeled CCL5. Was the His-tag attached to the N- or C-terminus of CCL5? Indicate this for each individual experiment and consider/discuss also potential effects of the modifications on CCL5 in the results and discussion sections.

      Response: We agree with the reviewer that labeling may lead to altered property of a protein, thus, we have compared chemotactic activity of CCL5 and CCL5-EGFP (Figure 2—figure supplement 1). To further verify this, we performed additional experiment to compare chemotactic activity between CCL5 and Cy3-CCL5 (see Author response image 1). For the convenience of readers, we have combined the original Figure 2—figure supplement 1 with the new data (Author response image 1), which replaced original Figure 2—figure supplement 1.

      The His-tag is attached to the C-terminus of CCL5, in consideration of the potential impact on the N-terminus.

      (2) In general, the authors appear to use high concentrations of CCL5 in their experiments. The reason for this is not clear. Is it because of the effects of the labels on the activity of the protein? In most biological tests (e.g. chemotaxis assays), unmodified CCL5 is active already at low nM concentrations.

      Response: We agree with the reviewer that the CCL5 concentrations used in our experiments were higher than reported chemotaxis assays and also higher than physiological levels in normal human plasma. In fact, we have performed experiments with lower concentration of CCL5, where the effect of LLPS was not seen though the chemotactic activity of the cytokine was detected. Thus, LLPS-associated chemotactic activity may represent a scenario of acute inflammatory condition when the inflammatory cytokines can increase significantly.

      (3) For the statistical analyses of the results, the authors use t-tests. Was it confirmed that data follow a normal distribution prior to using the t-test? If not a non-parametric test should be used and it may affect the conclusions of some experiments.

      Response: We thank the reviewer for pointing out this issue. As shown in Author response table 1, The Shapiro-Wilk normality test showed that only two control groups (CCL5 and 44AANA47-CCL5+CHO K1) in Figure 3 did not conform to the normal distribution. The error was caused by using microculture to count and calculate when there were very few cells in the microculture. For these two groups, we re-counted 100 μL culture medium to calculate the number of cells. The results were consistent with the positive distribution and significantly different from the experimental group (Author response image 3). The original data for the number of cells chemoattractant by 500 nM CCL5 was revised from 0, 247, 247 to 247, 123, 370 and 500 nM 44AANA47 +CHO-K1 was revised from 1111, 1111, 98 to 740, 494, 617. The revised data does not affect the conclusion.

      Author response table 1.

      Table R1 Shapiro-Wilk test results of statistical data in the manuscript

      Author response image 3.

      Quantification of THP-1collected from the lower chamber. Data are mean ± s.d. n=3. P values were determined by unpaired two-tailed t-tests.

      Recommendations for the authors:

      Reviewer #1:

      See the weaknesses section of the Public Review. In addition, the authors should discuss the X-ray structure of CCL5 in complex with a heparin disaccharide in comparison with their docked structure of CCL5 and a heparin tetrasaccharide.

      Response: Our study, in fact, is strongly influenced by the report (Shaw, Johnson et al., 2004) that heparin disaccharide interaction with CCL5, which is highlighted in the text (page5, line100-102).

      Reviewer #2:

      (1) Clearly indicate in the results section and figure legends (also for the supplementary figures) which form and concentration of CCL5 is used.

      Response: The relevant missing information is indicated across the manuscript.

      (2) Clearly indicate which GAG was used. Was it heparin or heparan sulfate and what was the length (e.g. average molecular mass if known) or source (company?)?

      Response: Relevant information is added in the section “Materials and Methods.

      (3) Line 181: What do you mean exactly with "tiny amounts"?

      Response: “tiny amounts” means 400 transfected cells. This is described in the section of Materials and Methods. It is now also indicated in the text and legend to the figure.

      (4) Lines 216-217: This is a very general statement without a link to the presented data. No combination of chemokines is used, in vivo testing is limited (and I agree very difficult). You may consider deleting this sentence (certainly as an opening sentence for the Discussion).

      Response: We appreciate very much for the thoughtful suggestion of the reviewer. This sentence is deleted in the revised manuscript.

      (5) Why was 5h used for the in vitro chemotaxis assay? This is extremely long for an assay with THP-1 cells.

      Response: We apologize for the unclear description. The 5 hr includes 1 hr pre- incubation of CCL5 with the cells enable to form phase separation. After transferring the cells into the upper chamber, the actual chemotactic assay was 4 hr. This is clarified in the Materials and Methods section and the legend to each figure.

      (6) Define "Sec" in Sec-CCL5-EGFP and "Dil" in the legend of Figure 4.

      Response: The Sec-CCL5-EGFP should be “CCL5-EGFP’’, which has now been corrected. Dil is a cell membrane red fluorescent probe, which is now defined.

      (7) Why are different cell concentrations used in the experiment described in Figure 5?

      Response: The samples were from three volunteers who exhibited substantially different concentrations of cells in the blood. The experiment was designed using same amount of blood, so we did not normalize the number of the cell used for the experiment. Regardless of the difference in cell numbers, all three samples showed the same trend.

      (8) Check the text for some typos: examples are on line 83 "ratio of CCL5"; line 142 "established cell lines"; line 196 "peripheral blood mononuclear cells"; line 224 "to mediate"; line 226 "bind"; line 247 "to form a gradient"; line 248 "of the glycocalyx"; line 343 and 346 "tetrasaccharide"; line 409-410 "wild-type"; line 543 "on the surface of CHO-K1 and CHO-677"; line 568 "white".

      Response: Thanks for the careful reading. The typo errors are corrected and Manuscript was carefully read by colleagues.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer 1 (Public Review):

      1. The name of the new method "inter-haplotype distance" is more confusing than helpful, as the haplotype information is not critical for implementing this method. First, the mutation spectrum is aggregated genome-wide regardless of the haplotypes where the mutations are found. Second, the only critical haplotype information is that at the focal site (i.e., the locus that is tested for association): individuals are aggregated together when they belong to the same "haplotype group" at the focal site. However, for the classification step, haplotype information is not really necessary: individuals can be grouped based on their genotypes at the given locus (e.g., AA vs AB). As the authors mentioned, this method can be potentially applied to other mutation datasets, where haplotype information may well be unavailable. I hope the authors can reconsider the name and remove the term "haplotype" (perhaps something like "inter-genotype distance"?) to avoid giving the wrong impression that haplotype information is critical for applying this method.

      We appreciate the reviewer's concern about the name of our method. The reviewer is correct that haplotype information is not critical for our method to work, and as a result we've decided to simply rename the approach to "aggregate mutation spectrum distance" (abbreviated AMSD). For simplicity, we refer to the method as IHD throughout our responses to reviewers, but the revised manuscript now refers to AMSD.

      1. The biggest advantage of the IHD method over QTL mapping is alleviation of the multiple testing burden, as one comparison tests for any changes in the mutation spectrum, including simultaneous, small changes in the relative abundance of multiple mutation types. Based on this, the authors claim that IHD is more powerful to detect a mutator allele that affects multiple mutation types. Although logically plausible, it is unclear under what quantitative conditions IHD can actually have greater power over QTL. It will be helpful to support this claim by providing some simulation results.

      This comment prompted us to do a more detailed comparison of IHD vs. QTL power under conditions that are more similar to those observed in the BXD cohort. While preparing the original manuscript, we assumed that IHD might have greater power than QTL mapping in a population like the BXDs because some recombinant inbred lines have accumulated many more germline mutations than others (see Figure 1 in Sasani et al. 2022, Nature). In a quantitative trait locus scan (say, for the fraction of C>A mutations in each line) each BXD's mutation data would be weighted equally, even if a variable number of mutations was used to generate the phenotype point estimate in each line.

      To address this, we performed a new series of simulations in which the average number of mutations per haplotype was allowed to vary. At the low end, some BXDs accumulated as few as 100 total germline mutations, while others have accumulated as many as 2,000. Thus, instead of simulating a mean number of mutations on each simulated haplotype, we allowed the mean number of mutations per haplotype to vary from N to 20N. By simulating a variable count of mutations on each haplotype, we could more easily test the benefits of comparing aggregate, rather than individual, mutation spectra between BXDs.

      In these updated simulations, we find that IHD routinely outperforms QTL mapping under a range of parameter choices (see Author Response image 1). Since IHD aggregates the mutation spectra of all haplotypes with either B or D alleles at each locus in the genome, the method is much less sensitive to individual haplotypes with low mutation counts. We include a mention of these updated simulations on lines 135-138 and describe the updated simulations in greater detail in the Materials and Methods (lines 705-715).

      Author response image 1.

      Power of IHD and QTL mapping on simulated haplotypes with variable counts of mutations. We simulated germline mutations on the specified number of haplotypes (as described in the manuscript) but allowed the total number of mutations per haplotype to vary by a factor of 20.

      1. The flip side of this advantage of IHD is that, when a significant association is detected, it is not immediately clear which mutation type is driving the signal. Related to this, it is unclear how the authors reached the point that "...the C>A mutator phenotype associated with the locus on chromosome 6", when they only detected significant IHD signal at rs46276051 (on Chr6), when conditioning on D genotypes at the rs27509845 (on Chr4) and no significant signal for any 1-mer mutation type by traditional mapping. The authors need to explain how they deduced that C>A mutation is the major source of the signal. In addition, beyond C>A mutations, can mutation types other than C>A contribute to the IHD signal at rs46276051? More generally, I hope the authors can provide some guidelines on how to narrow a significant IHD signal to specific candidate mutation type(s) affected, which will make the method more useful to other researchers.

      We thank the reviewer for pointing out this gap in our logic. We omitted specific instructions for narrowing down an IHD signal to specific mutation type(s) for a few reasons. First, this can be addressed using mutational signature analysis methods that are in widespread use. For example, upon identifying one or more candidate mutator loci, we can enter the mutation spectra of samples with each possible mutator genotype into a program (e.g., SigProfilerExtractor) to determine which combinations of mutation types occur proportionally more often in the genomes that harbor mutators (see Figure 3c in our manuscript). A second approach for narrowing down an IHD signal, highlighted in Figure 3a (and now described in the text of the Results section at lines 256-261), is to simply test which mutation type proportion(s) differ significantly between groups of samples with and without a candidate mutator (for example, with a Chi-square test of independence for each mutation type).

      Although this second approach incurs a multiple testing burden, the burden is offset somewhat by using IHD to identify mutator loci, rather than performing association tests for every possible mutation type to begin with. Although Figure 3a only shows the significant difference in C>A fraction among BXDs with different mutator locus genotypes, Figure 3-figure supplement 1 shows the complete set of 1-mer spectrum comparisons. It is possible that this second approach would not prove very useful in the case of a mutator with a “flat” signature (i.e., a mutator that slightly perturbs the rates of many different mutation types), but in our case it clearly shows which mutation type is affected.

      1. To account for differential relatedness between the inbred lines, the authors regressed the cosine distance between the two aggregate mutation spectra on the genome-wide genetic similarity and took the residual as the adjusted test metric. What is the value of the slope from this regression? If significantly non-zero, this would support a polygenic architecture of the mutation spectrum phenotype, which could be interesting. If not, is this adjustment really necessary? In addition, is the intercept assumed to be zero for this regression, and does such an assumption matter? I would appreciate seeing a supplemental figure on this regression.

      The reviewer raises a good question. We find that the slope of the "distance vs. genetic similarity" regression is significantly non-zero, though the slope estimate itself is small. A plot of cosine distance vs. genome-wide genetic similarity (using all BXDs) is shown below in Author response image 2:

      Author response image 2.

      Relationship between cosine distance and genetic similarity in the BXDs. As described in the Materials and Methods, we computed two values at each marker in the BXDs: 1) the cosine distance between the aggregate mutation spectra of BXDs with either B or D genotypes at the marker, and 2) the correlation between genome-wide D allele frequencies in BXDs with either B or D genotypes at the marker. We then regressed these two values across all genome-wide markers.

      This result indicates that if two groups of BXDs (one with D genotypes and one with B genotypes at a given locus) are more genetically similar, their mutation spectra are also more similar. Since the regression slope estimate is significantly non-zero (p < 2.2e-16), we believe that it's still worth using residuals as opposed to raw cosine distance values. This result also suggests that there may be a polygenic effect on the mutation spectrum in the BXDs.

      We have also generated a plot showing the cosine distance between the mutation spectra of every possible pair of BXDs, regressed against the genetic similarity between each of those pairs (Author Response image 3). Here, the potential polygenic effects on mutation spectra similarity are perhaps more obvious.

      Author response image 3.

      Pairwise cosine distance between BXD mutation spectra as a function of genetic similarity. We computed two values for every possible pair of n = 117 BXDs: 1) the cosine distance between the samples' individual 1-mer mutation spectra and 2) the correlation coefficient between the samples' genome-wide counts of D alleles.

      Private Comments

      1. It will also be useful to see how the power of IHD and QTL mapping depend on the allele frequency of the mutator allele and the sample size, as mutator alleles are likely rare or semi-rare in natural populations (such as the human de novo mutation dataset that the authors mentioned).

      This is another good suggestion. In general, we'd expect the power of both IHD and QTL mapping to decrease as a function of mutator allele frequency. At the same time, we note that the power of these scans should mostly depend on the absolute number of carriers of the mutator allele and less on its frequency. In the BXD mouse study design, we observe high frequency mutators but also a relatively small sample size of just over 100 individuals. In natural human populations, mutator frequencies might be orders of magnitude smaller, but sample sizes may be orders of magnitude larger, especially as new cohorts of human genomes are routinely being sequenced. So, we expect to have similar power to detect a mutator segregating at, say, 0.5% frequency in a cohort of 20,000 individuals, as we would to detect a mutator segregating at 50% frequency in a dataset of 200 individuals.

      To more formally address the reviewer's concern, we performed a series of simulations in which we simulated a population of 100 haplotypes. We assigned the same average number of mutations to each haplotype but allowed the allele frequency of the mutator allele to vary between 0.1, 0.25, and 0.5. The results of these simulations are shown in Author response image 4 and reveal that AMSD tends to have greater power than QTL mapping at lower mutator allele frequencies. We now mention these simulations in the text at lines 135-138 and include the simulation results in Figure 1-figure supplement 4.

      Author response image 4.

      Power of AMSD and QTL mapping on simulated haplotypes with variable marker allele frequencies. We simulated germline mutations on the specified number of haplotypes (as described in the manuscript), but simulated genotypes at the mutator allele such that "A" alleles were at the specified allele frequency.

      1. In the Methods section of "testing for epistasis between the two mutator loci", it will be helpful to explicitly lay out the model and assumptions in mathematical formulae, in addition to the R scripts. For example, are the two loci considered independent when their effects on mutation rate is multiplicative or additive? Given the R scripts provided, it seems that the two loci are assumed to have multiplicative effects on the mutation rate, and that the mutation count follows a Poisson distribution with mean being the mutation rate times ADJ_AGE (i.e., the mutation opportunity times the number of generations of an inbred line). However, this is not easily understandable for readers who are not familiar with R language. In addition, I hope the authors can be more specific when discussing the epistatic interaction between the two loci by explicitly saying "synergistic effects beyond multiplicative effects on the C>A mutation rate".

      The reviewer raises a good point about the clarity of our descriptions of tests for epistasis. We have now added a more detailed description of these tests in the section of the Materials and Methods beginning at line 875. We have also added a statement to the text at lines 289-291: “the combined effects of D genotypes at both loci exceed the sum of marginal effects of D genotypes at either locus alone.” We hope that this will help clarify the results of our tests for statistical epistasis.

      Reviewer 2 (Public Review):

      1. The main limitation of the approach is that it is difficult to see how it might be applied beyond the context of mutation accumulation experiments using recombinant inbred lines. This is because the signal it detects, and hence its power, is based on the number of extra accumulated mutations linked to (i.e. on the same chromosome as) the mutator allele. In germline mutation studies of wild populations the number of generations involved (and hence the total number of mutations) is typically small, or else the mutator allele becomes unlinked from the mutations it has caused (due to recombination), or is lost from the population altogether (due to chance or perhaps selection against its deleterious consequences).

      The reviewer is correct that as it currently exists, IHD is mostly limited to applications in recombinant inbred lines (RILs) like the BXDs. This is due to the fact that IHD assumes that each diploid sample harbors one of two possible genotypes at a particular locus and ignores the possibility of heterozygous genotypes for simplicity. In natural, outbreeding populations, this assumption will obviously not hold. However, as we plan to further iterate on and improve the IHD method, we hope that it will be applicable to a wider variety of experimental systems in the future. We have added additional caveats about the applicability of our method to other systems in the text at lines 545-550.

      Private Comments

      1. On p. 8, perhaps I've misunderstood but it's not clear in what way the SVs identified were relevant to the samples used in this dataset - were the founder strains assembled? Is there any chance that additional SVs were present, e.g. de novo early in the accumulation line?

      Our description of this structural variation resource could have been clearer. The referenced SVs were identified in Ferraj et al. (2023) by generating high-quality long read assemblies of inbred laboratory mice. Both DBA/2J and C57BL/6J (the founder strains for the BXD resource) were included in the Ferraj et al. SV callset. We have clarified our description of the callset at lines 247-248.

      It is certainly possible that individual BXD lines have accumulated de novo structural variants during inbreeding. However, these "private" SVs are unlikely to produce a strong IHD association signal (via linkage to one of the ~7,000 markers) at either the chromosome 4 or chromosome 6 locus, since we only tested markers that were at approximately 50% D allele frequency among the BXDs.

      1. On p. 13, comparing the IHD and QTL approaches, regarding the advantage of the former in that it detects the combined effect of multiple k-mer mutation types, would it not be straightforward to aggregate counts for different types in a QTL setting as well?

      The mutation spectrum is a multi-dimensional phenotype (6-dimensional if using the 1-mer spectrum, 96-dimensional if using the 3-mer spectrum, etc.). Most QTL mapping methods use linear models to test for associations between genotypes and a 1-dimensional phenotype (e.g., body weight, litter size). In the past, we used QTL mapping to test for associations between genotypes and a single element of the mutation spectrum (e.g., the rate of C>A mutations), but there isn't a straightforward way to aggregate or collapse the mutation spectrum into a 1dimensional phenotype that retains the information contained within the full 1-mer or 3-mer spectrum. For that reason, we developed the "aggregate mutation spectrum" approach, as it preserves information about the complete mutation spectrum in each group of strains.

      The reviewer is correct that we could also aggregate counts of different mutation types to, say, perform a QTL scan for the load of a specific mutational signature. For example, we could first perform standard mutational signature analysis on our dataset and then test for QTLs associated with each signature that is discovered. However, this approach would not solve the second problem that our method is designed to solve: the appropriate weighting of samples based on how many mutations they contain.

      1. pp. 15-16: In the discussion of how you account for relatedness between strains, I found the second explanation (on p. 16) much clearer. It would be interesting to know how much variance was typically accounted for by this regression?

      As shown in the response to Reviewer 1, genotype similarity between genotype groups (i.e., those with either D or B genotypes at a marker) generally explains a small amount of variance in the cosine distance between those groups (R2 ~= 0.007). However, since the slope term in that regression is significantly non-zero, correcting for this relationship should still improve our power relative to using raw cosine distance values that are slightly confounded by this relationship.

      1. Similarly, in the section on Applying the IHD method to the BXDs (pp. 18-19), I think this description was very useful, and some or all of this description of the experiment (and how the DNMs in it arise) could profitably be moved to the introduction.

      We appreciate the reviewer’s feedback about the details of the BXD cohort. Overall, we feel the description of the BXDs in the Introduction (at lines 65-73) is sufficient to introduce the cohort, though we now add some additional detail about variability in BXD inbreeding duration (at lines 89-93) to the Introduction as well, since it is quite relevant to some of the new simulation results presented in the manuscript.

      1. A really minor one, not sure if this is for the journal or the authors, but it would be much better to include both page and line numbers in any version of an article for review. My pdf had neither!

      We apologize for the lack of page/line numbers in the submitted PDF. We have now added line numbers to the revised version of the manuscript.

      Reviewer 3 (Public Review):

      1. Under simulated scenarios, the authors' new IHD method is not appreciably more powerful than conventional QTL mapping methods. While this does not diminish the rigor or novelty of the authors findings, it does temper enthusiasm for the IHD method's potential to uncover new mutators in other populations or datasets. Further, adaptation of this methodology to other datasets, including human trios or multigenerational families, will require some modification, which could present a barrier to broader community uptake. Notably, BXD mice are (mostly) inbred, justifying the authors consideration of just two genotype states at each locus, but this decision prevents out-of-the-box application to outbred populations and human genomic datasets. Lastly, some details of the IHD method are not clearly spelled out in the paper. In particular, it is unclear whether differences in BXD strain relatedness due to the breeding epoch structure are fully accounted for in permutations. The method's name - inter-haplotype distance - is also somewhat misleading, as it seems to imply that de novo mutations are aggregated at the scale of sub-chromosomal haplotype blocks, rather than across the whole genome.

      The reviewer raises very fair concerns. As mentioned in response to a question from Reviewer 1, we performed additional simulation experiments that demonstrate the improved power of IHD (as compared to QTL mapping) in situations where mutation counts are variable across haplotypes or when mutator alleles are present at allele frequencies <50% (see Author response image 2 and 3, as well as new supplements to Figure 1 in the manuscript). However, the reviewer is correct that the IHD method is not applicable to collections of outbred individuals (that is, individuals with both heterozygous and homozygous genotypes), which will limit its current applications to datasets other than recombinant inbred lines. We have added a mention of these limitations to the Results at lines 138-141 and the Discussion at lines 545-550, but plan to iterate on the IHD method and introduce new features that enable its application to other datasets. We have also explicitly stated that we account for breeding epochs in our permutation tests in the Materials and Methods at lines 670-671. Both Reviewer 1 and Reviewer 3 raised concerns about the name of our method, and we have therefore changed “inter-haplotype distance” to “aggregate mutation spectrum distance” throughout the manuscript.

      1. Nominating candidates within the chr6 mutator locus requires an approach for defining a credible interval and excluding/including specific genes within that interval as candidates. Sasani et al. delimit their focal window to 5Mb on either side of the SNP with the most extreme P-value in their IHD scan. This strategy suffers from several weaknesses. First, no justification for using 10 Mb window, as opposed to, e.g., a 5 Mb window or a window size delimited by a specific threshold of P-value drop, is given, rendering the approach rather ad hoc. Second, within their focal 10Mb window, the authors prioritize genes with annotated functions in DNA repair that harbor protein coding variants between the B6 and D2 founder strains. While the logic for focusing on known DNA repair genes is sensible, this locus also houses an appreciable number of genes that are not functionally annotated, but could, conceivably, perform relevant biological roles. These genes should not be excluded outright, especially if they are expressed in the germline. Further, the vast majority of functional SNPs are non-coding, (including the likely causal variant at the chr4 mutator previously identified in the BXD population). Thus, the author's decision to focus most heavily on coding variants is not well-justified. Sasani et al. dedicate considerable speculation in the manuscript to the likely identity of the causal variant, ultimately favoring the conclusion that the causal variant is a predicted deleterious missense variant in Mbd4. However, using a 5Mb window centered on the peak IHD scan SNP, rather than a 10Mb window, Mbd4 would be excluded. Further, SNP functional prediction accuracy is modest [e.g., PMID 28511696], and exclusion of the missense variant in Ogg1 due its benign prediction is potentially premature, especially given the wealth of functional data implicating Ogg1 in C>A mutations in house mice. Finally, the DNA repair gene closest to the peak IHD SNP is Rad18, which the authors largely exclude as a candidate.

      We agree that the use of a 10 Mb window, rather than an empirically derived confidence interval, is a bit arbitrary and ad hoc. To address this concern, we have implemented a bootstrap resampling approach (Visscher et al. 1996, Genetics) to define confidence intervals surrounding IHD peaks. We have added a description of the approach to the Materials and Methods at lines 609-622, but a brief description follows. In each of N trials (here, N = 10,000), we take a bootstrap sample of the BXD phenotype and genotype data with replacement. We then perform an IHD scan on the chromosome of interest using the bootstrap sample and record the position of the marker with the largest cosine distance value (i.e., the "peak" marker). After N trials, we calculate the 90% confidence interval of bootstrapped peak marker locations; in other words, we identify the locations of two genotyped markers, between which 90% of all bootstrap trials produced an IHD peak. We note that bootstrap confidence intervals can exhibit poor "coverage" (a measure of how often the confidence intervals include the "true" QTL location) in QTL mapping studies (see Manichaikul et al. 2006, Genetics), but feel that the bootstrap is more reasonable than simply defining an ad hoc interval around an IHD peak.

      The new 90% confidence interval surrounding the IHD peak on chromosome 6 is larger than the original (ad hoc) 10 Mbp window, now extending from around 95 Mbp to 114 Mbp. Notably, the new empirical confidence interval excludes Mbd4. We have accordingly updated our Results and Discussion sections to acknowledge the fact that Mbd4 no longer resides within the confidence interval surrounding the IHD peak on chromosome 6 and have added additional descriptions of genes that are now implicated by the 90% confidence interval. Given the uncertainties associated with using bootstrap confidence intervals, we have retained a brief discussion of the evidence supporting Mbd4 in the Discussion but focus primarily on Ogg1 as the most plausible candidate.

      The reviewer raises a valid concern about our treatment of non-DNA repair genes within the interval surrounding the peak on chromosome 6. We have added more careful language to the text at lines 219-223 to acknowledge the fact that non-annotated genes in the confidence interval surrounding the chromosome 6 peak may play a role in the epistatic interaction we observed.

      The reviewer also raises a reasonable concern about our discussions of both Mbd4 and Ogg1 as candidate genes in the Discussion. Since Mbd4 does not reside within the new empirical bootstrap confidence interval on chromosome 6 and given the strong prior evidence that Ogg1 is involved in C>A mutator phenotypes (and is in the same gene network as Mutyh), we have reframed the Discussion to focus on Ogg1 as the most plausible candidate gene (see lines 357360).

      Using the GeneNetwork resource, we also more carefully explored the potential effects of noncoding variants on the C>A mutator phenotype we observed on chromosome 6. We have updated the Results at lines 240-246 and the Discussion at line 439-447 to provide more evidence for regulatory variants that may contribute to the C>A mutator phenotype. Specifically, we discovered a number of strong-effect cis-eQTLs for Ogg1 in a number of tissues, at which D genotypes are associated with decreased Ogg1 expression. Given new evidence that the original mutator locus we discovered on chromosome 4 harbors an intronic mobile element insertion that significantly affects Mutyh expression (see Ferraj et al. 2023, Cell Genomics), it is certainly possible that the mutator phenotype associated with genotypes on chromosome 6 may also be mediated by regulatory, rather than coding, variation.

      1. Additionally, some claims in the paper are not well-supported by the author's data. For example, in the Discussion, the authors assert that "multiple mutator alleles have spontaneously arisen during the evolutionary history of inbred laboratory mice" and that "... mutational pressure can cause mutation rates to rise in just a few generations of relaxed selection in captivity". However, these statements are undercut by data in this paper and the authors' prior publication demonstrating that a number of candidate variants are segregating in natural mouse populations. These variants almost certainly did not emerge de novo in laboratory colonies, but were inherited from their wild mouse ancestors. Further, the wild mouse population genomic dataset used by the authors falls far short of comprehensively sampling wild mouse diversity; variants in laboratory populations could derive from unsampled wild populations.

      The reviewer raises a good point. In our previous publication (Sasani et al. 2022, Nature), we hypothesized that Mutyh mutator alleles had arisen in wild, outbreeding populations of Mus musculus, and later became fixed in inbred strains like DBA/2J and C57BL/6J. However, in the current manuscript, we included a statement about mutator alleles "spontaneously arising during the evolutionary history of inbred laboratory mice" to reflect new evidence (from Ferraj et al. 2023, Cell Genomics) that the mutator allele we originally identified in Mutyh may not be wild derived after all. Instead, Ferraj et al. suggest that the C>A mutator phenotype we originally identified is caused by an intronic mobile element insertion (MEI) that is present in DBA/2J and a handful of other inbred laboratory strains. Although this MEI may have originally occurred in a wild population of mice, we wanted to acknowledge the possibility that both the original Mutyh mutator allele, as well as the new mutator allele(s) we discovered in this manuscript, could have arisen during the production and inbreeding of inbred laboratory lines. We have also added language to the Discussion at lines 325-327 to acknowledge that the 67 wild mice we analyzed do not comprise a comprehensive picture of the genetic diversity present in wild-derived samples.

      We have added additional language to the Discussion at lines 349-357 in which we acknowledge that the chromosome 6 mutator allele might have originated in either laboratory or wild mice and elaborate on the possibility that mutator alleles with deleterious fitness consequences may be more likely to persist in inbred laboratory colonies.

      1. Finally, the implications of a discovering a mutator whose expression is potentially conditional on the genotype at a second locus are not raised in the Discussion. While not a weakness per se, this omission is perceived to be a missed opportunity to emphasize what, to this reviewer, is one of the most exciting impacts of this work. The potential background dependence of mutator expression could partially shelter it from the action of selection, allowing the allele persist in populations. This finding bears on theoretical models of mutation rate evolution and may have important implications for efforts to map additional mutator loci. It seems unfortunate to not elevate these points.

      We agree and have added additional discussion of the possibility that the C>A mutator phenotypes in the BXDs are a result of interactions between the expression of two DNA repair genes in the same base-excision network to the Discussion section at lines 447-449.

      Private comments

      1. The criteria used to determine or specify haplotype size are not specified in the manuscript. I mention this above but reiterate here as this was a big point of confusion for me when reading the paper. Haplotype length is important consideration for overall power and for proper extension of this method to other systems/populations.

      We may not have been clear enough in our description of our method, and as suggested by Reviewer 1, the name "inter-haplotype distance" may also have been a source of confusion. At a given marker, we compute the aggregate mutation spectrum in BXDs with either B or D genotypes using all genome-wide de novo mutations observed in those BXDs. Since the BXDs were inbred for many generations, we expect that almost all de novo germline mutations observed in an RIL are in near-perfect linkage with the informative genotypes used for distance scans. Thus, the "haplotypes" used in the inter-haplotype distance scans are essentially the lengths of entire genomes.

      1. Results, first paragraph, final sentence. I found the language here confusing. I don't understand how one can compute the cosine distance at single markers, as stated. I'm assuming cosine distance is computed from variants residing on haplotypes delimited by some defined window surrounding the focal marker?

      As discussed above, we aggregate all genome-wide de novo mutations in each group of BXDs at a given marker, rather than only considering DNMs within a particular window surrounding the marker. The approach is discussed in greater detail in the caption of Figure 1.

      1. Nominating candidates for the chr6 locus, Table 1. It would be worth confirming that the three prioritized candidates (Setmar, Ogg1, and Mbd4) all show germline expression.

      Using the Mouse Genome Informatics online resource, we confirmed that all prioritized candidate genes (now including Setmar and Ogg1, but not Mbd4) are expressed in the male and female gonads, and mention this in the Results at lines 228 and 233-234.

      1. Does the chr6 peak on the C>A LOD plot (Figure 2- figure supplement 1) overlap the same peak identified in the IHD scan? And, does this peak rise to significance when using alpha = 0.05? Given that the goal of these QTL scans is to identify loci that interact with the C>A mutator on chr4, it is reasonable to hypothesize that the mutation impact of epistatic loci will also be restricted to C>A mutations. Therefore, I am not fully convinced that the conservative alpha = 0.05/7 threshold is necessary.

      The chromosome 6 peak in Figure 2-figure supplement 1 does, in fact, overlap the peak marker we identified on chromosome 6 using IHD. One reason we decided to use a more conservative alpha of (0.05 / 7) is that we wanted these results to be analogous to the ones we performed in a previous paper (Sasani et al. 2022, Nature), in which we first identified the mutator locus on chromosome 4. However, the C>A peak does not rise to genome-wide significance if we use a less conservative alpha value of 0.05 (see Author response image 5). As discussed in our response to Reviewer 1, we find that QTL mapping is not as powerful as IHD when haplotypes have accumulated variable numbers of germline mutations (as in the BXDs), which likely explains the fact that the peak on chromosome 6 is not genome-wide significant using QTL mapping.

      Author response image 5.

      QTL scan for the fraction of C>A mutations in BXDs harboring D alleles at the locus near Myth QTL scan was performed at a genome-wide significance alpha of 0.05, rather than 0.05/7.

      1. Is there significant LD between the IHD peaks on chr6 and chr4 across the BXD? If so, it could suggest that the signal is driven by cryptic population structure that is not fully accounted for in the author's regression based approach. If not, this point may merit an explicit mention in the text as an additional validation for the authenticity of the chr6 mutator finding.

      This is a good question. We used the scikit-allel Python package to calculate linkage disequilibrium (LD) between all pairs of genotyped markers in the BXD cohort, and found that the two peak loci (on chromosomes 4 and 6) exhibit weak LD (r2 = 4e-5). We have added a mention of this to the main text of the Results at lines 212-213. That being said, we do not think the chromosome 6 mutator association (or the apparent epistasis between the alleles on chromosomes 4 and 6) could be driven by cryptic population structure. Unlike in human GWAS and other association studies in natural populations, there is no heterogeneity in the environmental exposures experienced by different BXD subpopulations. In humans, population structure can create spurious associations (e.g., between height and variants that are in LD and are most common in Northern Europe), but this requires the existence of a phenotypic gradient caused by genetic or environmental heterogeneity that is not likely to exist in the context of inbred laboratory mice that are all the progeny of the same two founder strains.

      1. Discussion, last sentence of the "Possible causal alleles..." section: I don't understand how the absence of the Mariner-family domain leads the authors to this conclusion. Setmar is involved in NHEJ, which to my knowledge is not a repair process that is expected to have a specific C>A mutation bias. I think this is grounds enough for ruling out its potential contributions, in favor of focusing on other candidates, (e.g., Mbd4 and Ogg1).

      The reviewer raises a good point. Our main reason for mentioning the absence of the Marinerfamily domain is that even if NHEJ were responsible for the C>A mutator phenotype, it likely wouldn't be possible for Setmar to participate in NHEJ without the domain. However, the reviewer is correct that NHEJ is not expected to cause a C>A mutation bias, and we have added a mention of this to the text as well at lines 379-382.

      1. Discussion, second to last paragraph of section "Mbd4 may buffer...": The authors speculate that reduced activity of Mbd4 could modulate rates of apoptosis in response to DNA damage. This leads to the prediction that mice with mutator alleles at both Mutyh and Mbd4 should exhibit higher overall mutation rates compared to mice with other genotypes. This possibility could be tested with the authors' data.

      The reviewer raises a good question. As mentioned above, however, we implemented a new approach to calculate confidence intervals surrounding distance peaks and found that this empirical approach (rather than the ad hoc 10-Mbp window approach we used previously) excluded Mbd4 from the credible interval. Although we still mention Mbd4 as a possible candidate (since it still resides within the 10 Mbp window), we have refactored the Discussion section to focus primarily on the evidence for Ogg1 as a candidate gene on chromosome 6.

      In any case, we do not observe that mice with mutator alleles at both the chromosome 4 and chromosome 6 loci have higher overall mutation rates compared to mice with other genotype combinations. This may not be terribly surprising, however, since C>A mutations only comprise about 10% of all possible mutations. Thus, given the variance in other 1-mer mutation counts, even a substantial increase in the C>A mutation rate might not have a detectable effect on the overall mutation rate. Indeed, in our original paper describing the Mutyh mutator allele (Sasani et al. 2022, Nature), we did not identify any QTL for the overall mutation rate in the BXDs and found that mice with the chromosome 4 mutator allele only exhibited a 1.11X increase in their overall mutation rates relative to mice without the mutator allele.

      1. Methods, "Accounting for BXD population structure": An "epoch-aware" permutation strategy is described here, but it is not clear when (and whether) this strategy is used to determine significance of IHD P-values.

      We have added a more explicit mention of this to the Methods section at lines 670-671, as we do, in fact, use the epoch-aware permutation strategy when calculating empirical distance thresholds.

      1. The simulation scheme employed for power calculations is highly specific to the BXD population. This is not a weakness, and perfectly appropriate to the study population used here. However, it does limit the transferability of the power analyses presented in this manuscript to other populations. This limitation may merit an explicit cautionary mention to readers who may aspire to port the IHD method over to their study system.

      This is true. Our simulation strategy is relatively simple and makes a number of assumptions about the simulated population of haplotypes (allele frequencies normally distributed around 0.5, expected rates of each mutation type, etc.). In response to concerns from Reviewer 1, we performed an updated series of simulations in which we varied some of these parameters (mutator allele frequencies, mean numbers of mutations on haplotypes, etc.). However, we have added a mention of the simulation approach's limitations and specificity to the BXDs to the text at lines 545-550.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Yun et al. examined the molecular and neuronal underpinnings of changes in Drosophila female reproductive behaviors in response to social cues. Specifically, the authors measure the ejaculate-holding period, which is the amount of time females retain male ejaculate after mating (typically 90 min in flies). They find that female fruit flies, Drosophila melanogaster, display shorter holding periods in the presence of a native male or male-associated cues, including 2-Methyltetracosane (2MC) and 7-Tricosene (7-T). They further show that 2MC functions through Or47b olfactory receptor neurons (ORNs) and the Or47b channel, while 7-T functions through ppk23 expressing neurons. Interestingly, their data also indicates that two other olfactory ligands for Or47b (methyl laurate and palmitoleic acid) do not have the same effects on the ejaculate-holding period. By performing a series of behavioral and imaging experiments, the authors reveal that an increase in cAMP activity in pC1 neurons is required for this shortening of the ejaculate-holding period and may be involved in the likelihood of remating. This work lays the foundation for future studies on sexual plasticity in female Drosophila.

      The conclusions of this paper are mostly supported by the data, but aspects of the lines used for individual pC1 subtypes and visual contributions as well as the statistical analysis need to be clarified.

      (1) The pC1 subtypes (a - e) are delineated based on their morphology and connectivity. While the morphology of these neurons is distinct, they do share a resemblance that can be difficult to discern depending on the imaging performed. Additionally, genetic lines attempting to label individual neurons can easily be contaminated by low-level expression in off-target neurons in the brain or ventral nerve cord (VNC), which could contribute to behavioral changes following optogenetic manipulations. In Figures 5C - D, the authors generated and used new lines for labeling pC1a and pC1b+c. The line for pC1b+c was imaged as part of another recent study (https://doi.org/10.1073/pnas.2310841121). However, similar additional images of the pC1a line (i.e. 40x magnification and VNC expression) would be helpful in order to validate its specificity.

      We have included the high-resolution images of the expression of the pC1a-split-Gal4 driver in the brain and the VNC in the new figures S6A and S6B.

      (2) The author's experiments examining olfactory and gustatory contributions to the holding period were well controlled and described. However, the experiments in Figure 1D examining visual contributions were not sufficiently convincing as the line used (w1118) has previously been shown to be visually impaired (Wehner et al., 1969; Kalmus 1948). Using another wild-type line would have improved the authors' claims.

      It is evident that w1118 flies are visually impaired and are able to receive a limited amount of visual information in dim red light. Nevertheless, they are able to exhibit MIES phenotypes, which further supports the dispensability of visual information in MIES. In a 2024 study, Doubovetzky et al. (1) found that MIES in ninaB mutant females, which have defects in visual sensation, was not altered. This further corroborates our assertion that vision is likely to be of lesser importance than olfaction in MIES.

      (3) When comparisons between more than 2 groups are shown as in Figures 1E, 3D, and 5E, the comparisons being made were not clear. Adding in the results of a nonparametric multiple comparisons test would help for the interpretation of these results.

      We have revised figures 1E, 3D, 5E and the accompanying legends as suggested.

      Reviewer #2 (Public Review):

      The work by Yun et al. explores an important question related to post-copulatory sexual selection and sperm competition: Can females actively influence the outcome of insemination by a particular male by modulating the storage and ejection of transferred sperm in response to contextual sensory stimuli? The present work is exemplary for how the Drosophila model can give detailed insight into the basic mechanism of sexual plasticity, addressing the underlying neuronal circuits on a genetic, molecular, and cellular level.

      Using the Drosophila model, the authors show that the presence of other males or mated females after mating shortens the ejaculate-holding period (EHP) of a female, i.e. the time she takes until she ejects the mating plug and unstored sperm. Through a series of thorough and systematic experiments involving the manipulation of olfactory and chemo-gustatory neurons and genes in combination with exposure to defined pheromones, they uncover two pheromones and their sensory cells for this behavior. Exposure to the male-specific pheromone 2MC shortens EHP via female Or47b olfactory neurons, and the contact pheromone 7-T, present in males and on mated females, does so via ppk23 expressing gustatory foreleg neurons. Both compounds increase cAMP levels in a specific subset of central brain receptivity circuit neurons, the pC1b,c neurons. By employing an optogenetically controlled adenyl cyclase, the authors show that increased cAMP levels in pC1b and c neurons increase their excitability upon male pheromone exposure, decrease female EHP, and increase the remating rate. This provides convincing evidence for the role of pC1b,c neurons in integrating information about the social environment and mediating not only virgin but also mated female post-copulatory mate choice.

      Understanding context and state-dependent sexual behavior is of fundamental interest. Mate behavior is highly context-dependent. In animals subjected to sperm competition, the complexities of optimal mate choice have attracted a long history of sophisticated modelling in the framework of game theory. These models are in stark contrast to how little we understand so far about the biological and neurophysiological mechanisms of how females implement post-copulatory or so-called "cryptic" mate choice and bias sperm usage when mating multiple times.

      The strength of the paper is decrypting "cryptic" mate choice, i.e. the clear identification of physiological mechanisms and proximal causes for female post-copulatory mate choice. The discovery of peripheral chemosensory nodes and neurophysiological mechanisms in central circuit nodes will provide a fruitful starting point to fully map the circuits for female receptivity and mate choice during the whole gamut of female life history.

      We appreciate the positive response to our work.

      Recommendations for the authors:

      Reviewing Editor (Recommendations For The Authors):

      While appreciating the quality of the work the reviewers had a few key concerns that would greatly improve the manuscript. These are:

      (1) In some cases the specific statistical analyses are not clear. Could the authors please clarify what comparisons were made and the specific tests used?

      We have clarified the comparisons made in the multiple comparison analysis and specified the tests used in figures 1E, 3D, 5E.

      (2) Could the authors please include data that verify the expression patterns of their new reagent for pC1a, which will be useful for the community?

      Figure S6 was revised to include the expression of the pC1a-split-Gal4 gene in the brain (Fig. S6A) and the VNC (Fig. S6B).

      (3) A figure summarising their findings in the context of known circuitry will be useful.

      A new Figure 7 has been prepared, which provides a summary of our findings.

      (4) The SAG data are interesting. Do the authors wish to consider moving it to the main text or removing it if too preliminary?

      The supplementary figure 10 and related discussions in the discussion section have been removed.

      In the revised version of this manuscript, we present new evidence that the Or47b gene is required for 2MC-induced cAMP elevation in pC1 neurons, but not for 7T-induced one (see Fig. 5F). This observation supports that Or47b is a receptor for 2MC.

      The following paragraph was inserted at line 248 to provide a detailed description of the new findings: "To further test the role of Or47b in 2MC detection, we generated Or47b-deficient females with pC1 neurons expressing the CRE-luciferase reporter. Females with one copy of the wild-type Or47b allele, which served as the control group, showed robust CRE-luciferase reporter activity in response to either 2MC or 7-T. In contrast, Or47b-deficient females showed robust CRE-luciferase activity in response to to 7-T, but little activity in response to 2MC. This observation suggests that the odorant receptor Or47b plays an essential role in the selective detection of 2MC (Fig. 5F).”

      In addition, the following sentence was inserted at line 308 in the discussion section: “In this study, we provide compelling evidence that 2MC induces cAMP elevation in pC1 neurons and EHP shortening via both the Or47b receptor and Or47b ORNs, suggesting that 2MC functions as an odorant ligand for Or47b.”

      Relative CRE-luciferase reporter activity of pC1 neurons in females of the indicated genotypes, incubated with a piece of filter paper perfumed with solvent vehicle control or the indicated pheromones immediately after mating. The CRE-luciferase reporter activity of pC1 neurons of Or47b-deficient females (Or47b2/2 or Or47b3/3) was observed to increase in response to 7-T but not to 2MC. To calculate the relative luciferase activity, the average luminescence unit values of the female incubated with the vehicle are set to 100%. Mann-Whitney Test (n.s. p > 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). Gray circles indicate the relative luciferase activity (%) of individual females, and the mean ± SEM of data is presented.

      Reviewer #1 (Recommendations For The Authors):

      (1) There was a discrepancy between the text and the figures. Based on the asterisks above the data in Figure S5A, the data supports only 150 ng of 7-T shortening the ejaculation holding period. However, the text states that (line 190) "150 or 375 ng of 7-T significantly shortened EHP." It would be helpful if the authors clarified this discrepancy.

      The sentence has been revised and now reads as follows: ‘150 ng of 7-T significantly shortened EHP’.

      (2) Based on the current organization of the text, it was not clear how 2MC was identified and its concentrations were known to be physiologically relevant. It would be helpful if the authors could expand on this in lines 178 - 179.

      The following sentences were inserted into the revised version of the manuscript at line 178: The EHP was therefore measured in females incubated in a small mating chamber containing a piece of filter paper perfumed with male CHCs, including 2-methylhexacosane, 2-methyldocosane, 5-methyltricosane, 7-methyltricosane, 10Z-heneicosene, 9Z-heneicosene, and 2MC at various concentrations (not shown). Among these, 2MC at 750 ng was the only one that significantly reduced EHP (Fig. 3A; Fig. S4). 2MC was mainly found in males, but not in virgin females (30). Notably, it is present in D. melanogaster, D. simulans, D. sechellia, and D. erecta, but not in D. yakuba (30, 60).

      (3) The inset pie chart image illustrating MIES in Figure 1A was difficult to interpret. It would be helpful if the authors used a different method for representing this (i.e. a timeline).

      Figure 1A was revised as suggested.

      (4) In lines 121 - 122, the authors state that the females are exposed to "actively courting naive wild type Canton S males." This was difficult to understand and might be improved by removing "actively courting."

      Revised as suggested.

      Reviewer #2 (Recommendations For The Authors):

      (1) Summary figure

      The story is quite comprehensive and contains a lot of detail regarding the interaction of signaling pathways, internal state, and sensory stimuli. I believe a schematic summary figure bringing together all findings could be very helpful and would make it much easier to understand the discussion!

      Figure 7 has been prepared, which provides a summary of the findings and an explanation of the current working model.

      (2) Figure S10/effect on SAG activation of EHP

      At the moment, the quite interesting and relevant result that SAG activation shortens EHP shown in Figure S10 is only referred to in the discussion. Maybe move this to the results and give it a bit more attention? Actually, I believe this is a very exciting finding that could also be the basis for some more interesting speculations about physiological relevance. Since SAG is silenced upon seminal fluid/sex peptide exposure after mating, a mating with failed SAG silencing (i.e. unusually high post-mating SAG activity) could indicate to the female that there was low or failed sex peptide/seminal fluid transfer. In such a case it would be probably advantageous for the female to decrease EHP and quickly remate, as females need the "beneficial" effects of seminal fluid on ovulation and physiology adaptation. SAG could therefore represent another arm of sensing male quality- here not via external pheromones, but internally, via sensing male sex peptide levels.

      If this is a bit preliminary and rather suited to start a new study, Figure S10 could also be removed from the current manuscript.

      Figure S10 and associated text were removed in the revised version of the manuscript.

      (3) PhotoAC experiments in pC1b,c: the authors find that raising cAMP levels in pC1b,c leads to a decrease in EHP. They argue that increased cAMP levels lead to higher excitability of pC1b,c. This implies that the activity of pC1b,c promotes mating plug ejection. I assume the authors have also tried activating pC1b,c directly by optogenetic cation channels? What is the outcome of this? If different from elevating cAMP levels: why so?

      We employed CsChrimson, a red light-sensitive channelrhodopsin, to investigate the effect of optogenetic activation of each pC1 subset on EHP. Optogenetic activation of pC1a, pC1d, or pC1e had little effect on EHP; however, optogenetic activation of pC1b, c significantly increased EHP. This observation was puzzling because optogenetic silencing of the same neurons also increased EHP. In this experiment, females expressing CsChrimson were exposed to red light for the entire period of EHP measurement. Therefore, we suspect that prolonged activation of pC1b and pC1c neurons depleted their neurotransmitter pool, resulting in a silencing effect, but this requires further testing.

      Author response image 1.

      The prolonged optogenetic activation of pC1b, c neurons increases EHP, mimicking silencing of pC1b, c neurons. Females of the indicated genotypes were cultured on food with or without all-trans-retinal (ATR). The ΔEHP is calculated by subtracting the mean of the reference EHP of females cultured in control ATR- food from the EHP of individual females in comparison. The female genotypes are as follows: (A) 71G01-GAL4/UAS-CsChrimson, (B) pC1a-split-Gal4/UAS-CsChrimson, (C) pC1b,c-split-Gal4/UAS-CsChrimson, (D) pC1d-split-Gal4/UAS-CsChrimson, and (E) pC1e-split-Gal4/UAS-CsChrimson. Gray circles indicate the ΔEHP of individual females, and the mean ± SEM of data is presented. Mann-Whitney Test (n.s. p > 0.05; *p <0.05; ****p < 0.0001). Numbers below the horizontal bar represent the mean of the EHP differences between the indicated treatments.

      (4) Text edits

      In general, the manuscript is very well-written, clear, and easy to follow. I recommend small edits of the text and correction of typos in some places:

      l.92: "Drosophila females seem to signal the social sexual context through sperm ejection." This sentence could give the impression that the main function of sperm ejection was to signal to conspecifics. I recommend reformulating to leave it open if ejected sperm is a signal or rather a simple cue. e.g. :"There is evidence that Drosophila females detect the social sexual context through sperm ejected by other females."

      Thanks for the good suggestion. It has been revised as suggested. In addition, we have also made additional changes to the text to correct typos.

      l.97: "transcriptional factor" > "transcription factor"

      Revised as suggested. See lines 77, 98, and 201.

      l.101: "There are Dsx positive 14 pC1 neurons in each brain hemisphere of the brain," > "There are 14 Dsx positive pC1 neurons in each brain hemisphere,"

      Revised as suggested, it now reads " There are 14 Dsx-positive pC1 neurons in each hemisphere of the brain, ...".

      l.160: ", even up to 1440 ng" > ", even when applied at concentrations as high as 1440 ng"

      Revised as suggested.

      l.168: "females with male oenocytes significantly shortens EHP" >"females with male oenocytes significantly shorten EHP"

      Revised as suggested.

      l.181: "it was restored when Orco expression is reinstated" >"it was restored when Orco expression was reinstated"

      Revised as suggested. See line 186.

      l.196: "MIES is almost completely abolished" >"MIES was almost completely abolished"

      Revised as suggested. See line 201.

      l.202: "a sexually dimorphic transcriptional factor gene" >"the sexually determination transcription factor gene" or "the sex specifically spliced transcription factor gene". The gene itself is not dimorphic!

      Revised as suggested, lines 208-210 now read "The same study found that Dh44 receptor neurons involved in EHP regulation also express doublesex (dsx), which encodes sexually dimorphic transcription factors."

      l.211: "to silenced" > "to silence"

      Revised as suggested. See line 216.

      l.229: "females that selectively produce the CRE-Luciferase reporter gene" >"females that selectively express CRE-Luciferase reporter"

      Revised as suggested. See line 234.

      l.271: "neurons. expedite" > delete dot

      Revised as suggested. See line 284.

      l.287: "Furthermore, our study has uncovered the conserved neural circuitry that processes male courtship cues and governs mating decisions play an important role in regulating this behavior." > grammar: "our study has uncovered that the conserved neural circuitry that processes male courtship cues and governs mating decisions plays an important role in regulating this behavior." Also: the meaning of "conserved" is not fully clear to me here: conserved in regards to other Drosophila species? Or do the authors mean: general functional similarity with mouse sexual circuitry?

      The sentence (lines 299-301) has been revised for clarity to read "In addition, our study has revealed that the neural circuit that processes male courtship cues and controls mating decisions plays an important role in regulating this behavior. This fly circuit has recently been proposed to be homologous to VMHvl in the mouse brain (45, 46).”

      l.311: "lipid drolet" > "lipid droplets"

      Revised as suggested. See line 325.

      l.316 and in several instances in the following, including Figure 5 caption (l.723) : "cAMP activity" > "cAMP levels" or "increased cAMP levels"

      Revised as suggested.

      l.323: "in hemibrain" > ", as seen in the hemibrain connectome dataset"

      Revised as suggested. See line 337.

      l.326: "increased cAMP levels causes pC1b,c neurons" > "increased cAMP levels cause pC1b,c neurons"

      Revised as suggested. See line 340.

      l.329: "removement" > "removal" or "ejection"

      Revised as suggested, it now reads "the removal of the mating plug". See line 343.

      l. 330: "This observation well aligns" > "The observation aligns well"

      Revised as suggested. See line 345.

      l. 398: Behavior assays: It would be good to describe how mating plug ejection was identified- by eye? Under the microscope/UV light?

      The following sentence has been added to the behavioral assays section at lines 425-426: The sperm ejection scene, in which the female expels a white sac containing sperm and the mating plug through the vulva, has been directly observed by eye in recorded video footage.

      l.685, Figure legend 2: "thermal activation" > "thermogenetic activation"

      Revised as suggested. See line 430.

      Reference:

      (1) Doubovetzky, N., Kohlmeier, P., Bal, S., & Billeter, J. C. (2023). Cryptic female choice in response to male pheromones in Drosophila melanogaster. bioRxiv, 2023-12.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      This valuable study uses a novel experimental design to elegantly demonstrate how we exploit stimulus structure to overcome working memory capacity limits. While the behavioural evidence is convincing, the neural evidence is incomplete, as it only provides partial support for the proposed information compression mechanism. This study will be of interest to cognitive neuroscientists studying structure learning and memory.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Huang and Luo investigated whether regularities between stimulus features can be exploited to facilitate the encoding of each set of stimuli in visual working memory, improving performance. They recorded both behavioural and neural (EEG) data from human participants during a sequential delayed response task involving three items with two properties: location and colour. In the key condition ('aligned trajectory'), the distance between locations of successively presented stimuli was identical to their 'distance' in colour space, permitting a compression strategy of encoding only the location and colour of the first stimulus and the relative distance of the second and third stimulus (as opposed to remembering 3 locations and 3 colours, this would only require remembering 1 location, 1 colour, and 2 distances). Participants recalled the location and colour of each item after a delay.

      Consistent with the compression account, participants' location and colour recall errors were correlated and were overall lower compared to a non-compressible condition ('misaligned trajectory'). Multivariate analysis of the neural data permitted decoding of the locations and colours during encoding. Crucially, the relative distance could also be decoded - a necessary ingredient for the compression strategy.

      Strengths:

      The main strength of this study is a novel experimental design that elegantly demonstrates how we exploit stimulus structure to overcome working memory capacity limits. The behavioural results are robust and support the main hypothesis of compressed encoding across a number of analyses. The simple and well-controlled design is suited to neuroimaging studies and paves the way for investigating the neural basis of how environmental structure is detected and represented in memory. Prior studies on this topic have primarily studied behaviour only (e.g., Brady & Tenenbaum, 2013).

      Thanks for the positive comments and excellent summary.

      Weaknesses:

      The main weakness of the study is that the EEG results do not make a clear case for compression or demonstrate its neural basis. If the main aim of this strategy is to improve memory maintenance, it seems that it should be employed during the encoding phase. From then on, the neural representation in memory should be in the compressed format. The only positive evidence for this occurs in the late encoding phase (the re-activation of decoding of the distance between items 1 and 2, Fig. 5A), but the link to behaviour seems fairly weak (p=0.068).

      Thanks for raising this important concern. The reviewer is correct that in principle subjects should employ the compression strategy during the encoding phase when sequence stimuli are presented, yet our results show that the 1-2 trajectory could only be decoded during the late encoding phase.

      Meanwhile, subjects could not get enough information to form the compressed strategy for the location and color sequences until the appearance of the 3rd item. Specifically, based on the first two items, the 1st and 2nd item, they only learn whether the 1st-2nd trajectories are congruent between location and color features. However, they could not predict whether it would also apply to the incoming 2nd-3rd trajectory. This is exactly what we found in neural decoding results. The 1st-2nd trajectory could be decoded after the 2nd item presentation, and the 2nd-3rd trajectory appears after the 3rd item onset. Most critically, the 1st-2nd trajectory is reactivated after the 3rd item but only for alignment condition, implicating formation of the full-sequence compression strategy wherein the previously formed 1st-2nd trajectory is reactivated to be connected to the 2nd-3rd trajectory.

      Regarding the difference between higher- and lower-correlation groups, previously we used the time window based on the overall 2nd-3rd neural reactivations, which might not be sensitive to reactivation strength. We now re-chose the time window based on the higher-correlation group (bootstrap test, p = 0.037, two sides).

      Results have been updated (Figure 5; Results, Page 16). Interpretations about the formation of compression strategy during encoding phase have been added to Results (Page 15-16) and Discussion (Page 18).

      Stronger evidence would be showing decoding of the compressed code during memory maintenance or recall, but this is not presented. On the contrary, during location recall (after the majority of memory maintenance is already over), colour decoding re-emerges, but in the un-compressed item-by-item code (Fig. 4B). The authors suggest that compression is consolidated at this point, but its utility at this late stage is not obvious.

      Thank you for the important question we apologize for omitting previously - neural evidence for the compressive account.

      The reason we did not perform neural decoding during maintenance is that previous EEG/MEG studies including our own failed to reveal robust and sustained time-resolved memory decoding during this period. This is posited to arise from “activity-silent” WM states, wherein memories are not necessarily retained in sustained firing but silently stored within connection weights of WM networks (Stokes, Trends Cogn. Sci., 2015; Rose, Curr Dir Psychol Sci, 2020). Our previous work showed that by transiently perturbing the 'activity-silent' WM using a retrocue or neutral impulse, memories could be reactivated and robustly decoded from neural activities (Huang et al., eLife, 2021). However, due to the lack of transient events during retention in the current design, we do not expect robust decoding results during maintenance. As shown below (AB), this is indeed what we have observed, i.e., no robust neural decoding of trajectories during retention.

      We further used alpha-band (8-11 Hz) neural activities, which have been shown to carry WM information (de Vries et al., Trends Cogn. Sci, 2020; Foster et al., Curr. Biol, 2016; Fukuda et al., J. Neurophysiol, 2016; Sutterer et al., PLOS Biol., 2019) to perform decoding analysis of compression trajectories during maintenance. As shown below, the alpha-band decoding results are indeed stronger than raw activities. Importantly, as shown below (CD), the aligned condition indeed showed significant and long-lasting decoding of compression trajectories (1st-2nd, 2nd-3rd) during retention, while the misaligned condition only showed decoding at the beginning (GH), which might be due to the non-specific offset response of the 3rd item. The results, although not as clear as those during encoding and recalling periods, support the reviewer’s hypothesis that the compressive strategy, if exploited, would be demonstrated during both encoding and maintenance periods. New results and related discussion have been added (Page 16, Supplementary Figure 4).

      With regards to the observed item-by-item color replay during location recall, the reviewer was concerned that this was not consistent with the compressive account, given the lack of trajectory decoding.

      First, item sequences stored in compressive formats need to be converted to sequences during serial recall. In other words, even though color and location sequences are retained in a compressive format (i.e., common 1st-2nd, 2nd-3rd trajectories) throughout the encoding and retention phases, they should be transferred to two sequences as outputs. This is exactly why we performed decoding analysis on individual color and location items rather than trajectories.

      Second and most importantly, we observed serial replay of color sequences when recalling locations. In our view, these results constitute strong evidence for common structure, since the spontaneous color replay during location recall for aligned condition highlights the close bound between color and location sequences stored in WM. In fact, item-by-item serial replay has been well acknowledged as a critical neural index of cognitive maps, not only for spatial navigation but also for higher-order tasks (e.g., Liu et al., Cell, 2019; Liu et al., Science, 2021). Therefore, spontaneous color sequence replay during location sequence recall supports their shared underlying cognitive map.

      Finally, spontaneous serial replay is also correlated with the reactivation of compressive trajectories during encoding (Supplementary Figure 3). This further indicates that serial replay during recalling is associated with memory reorganization formed during encoding.

      Taken together, we posit that memories need to be converted to sequences as outputs, which leads to serial reactivations during recalling. Importantly, the observed spontaneous replay of color sequences for the aligned condition provides strong evidence supporting the associations between color and location sequences in WM.

      We have now added relevant interpretations and discussions (Page 11&13).

      Reviewer #2 (Public Review):

      Summary:

      In this study, the authors wanted to test if using a shared relational structure by a sequence of colors in locations can be leveraged to reorganize and compress information.

      Strength:

      They applied machine learning to EEG data to decode the neural mechanism of reinstatement of visual stimuli at recall. They were able to show that when the location of colors is congruent with the semantically expected location (for example, green is closer to blue-green than purple) the related color information is reinstated at the probed location. This reinstatement was not present when the location and color were not semantically congruent (meaning that x displacement in color ring location did not displace colors in the color space to the same extent) and semantic knowledge of color relationship could not be used for reducing the working memory load or to benefit encoding and retrieval in short term memory.

      Weakness:

      The experiment and results did not address any reorganization of information or neural mechanism of working memory (that would be during the gap between encoding and retrieval).

      We apologize for not presenting clear neural evidence for memory reorganization, particularly neural decoding during WM maintenance and retrieval, in the previous version. As below, we explain why the findings provide converging neural evidence for WM reorganization based on a shared cognitive map.

      First, during the encoding phase when location and color sequences are serially presented, our results reveal reactivation of the 1st-2nd trajectories upon the onset of the 3rd item when location and color sequences are aligned with each other. The reactivation of 1st-2nd trajectory right after the emergence of 2nd-3rd trajectory for aligned but not for misaligned sequences strongly supports WM reorganization, since only stimulus sequences that could be compressed based on shared trajectories (aligned condition) show the co-occurrence of 1st-2nd and 2nd-3rd trajectories. Moreover, the relevance of 1st-2nd reactivation to behavioral measurements of color-location reorganization (i.e., behavioral trajectory correlation, Figure 5D) further indicates its link to WM reorganization.

      Second, the reason we originally did not perform neural decoding during maintenance is that previous EEG/MEG studies including our own failed to reveal robust and sustained time-resolved memory decoding during this period. This is posited to arise from “activity-silent” WM states, wherein memories are not necessarily retained in sustained firing but silently stored within connection weights of WM networks (Stokes, Trends Cogn. Sci., 2015; Wolff et al., Nat. Neurosci, 2017; Rose et al., Curr Dir Psychol Sci, 2020). Our previous work showed that by transiently perturbing the 'activity-silent' WM using a retrocue or neutral impulse, memories could be reactivated and robustly decoded from neural activities (Huang et al., eLife, 2021). However, due to the lack of transient events during retention in the current design, we do not expect robust decoding results during maintenance. As shown in Supplementary Figure 4(AB), this is indeed what we have observed, i.e., no robust neural decoding of trajectories during retention.

      We then used alpha-band (8-11 Hz) neural activities, which have been found to carry WM information (de Vries et al., Trends Cogn. Sci, 2020; Foster et al., Curr. Biol, 2016; Fukuda et al., J. Neurophysiol, 2016; Sutterer et al., PLOS Biol., 2019) to perform decoding analysis of compression trajectories during maintenance. As shown below, the alpha-band decoding results are indeed stronger than raw activities. Importantly, as shown in Supplementary Figure 4(CD), the aligned condition indeed showed significant and long-lasting decoding of compression trajectories (1st-2nd, 2nd-3rd) during retention, while the misaligned condition only showed decoding at the beginning (GH), which might be due to the non-specific offset response of the 3rd item. The results, although not as clear as those during encoding and recalling periods, thus also support WM reorganization.

      Finally, during the recalling period, we observed automatic serial replay of color sequences when recalling locations. In our view, these results constitute strong evidence for common structure, since the spontaneous color replay during location recall for aligned condition highlights the close bound between color and location sequences stored in WM. In fact, item-by-item serial replay has been well acknowledged as a critical neural index of cognitive maps, not only for spatial navigation but also for higher-order tasks (e.g., Liu et al., Cell, 2019; Liu et al., Science, 2021). Therefore, spontaneous replay of color sequence during location recall supports their shared underlying cognitive map. Moreover, the spontaneous serial replay is correlated with the reactivation of compressive trajectories during encoding (Supplementary Figure 3). This further indicates that serial replay during recalling is associated with memory reorganization formed during encoding.

      Taken together, we have added updated results about the maintenance period (Page 16, Supplementary Figure 4) and included clarifications and interpretations about why the findings during the encoding and retrieval periods support the WM reorganization view (Page 15-16).

      There was also a lack of evidence to rule out that the current observation can be addressed by schematic abstraction instead of the utilization of a cognitive map.

      The likely impact of the initial submission of the study would be in the utility of the methods that would be helpful for studying a sequence of stimuli at recall. The paper was discussed in a narrow and focused context, referring to limited studies on cognitive maps and replay. The bigger picture and long history of studying encoding and retrieval of schema-congruent and schema-incongruent events is not discussed.

      We agree with the reviewer that cognitive map referred here could be understood as schematic abstraction. Cognitive map refers to the internal representation of spatial relations in a specific environment (Tolman 1948). Schematic abstraction denotes a more broad range of circumstances, whereby the gist or structure of multiple environments or episodes can be integrated (Bartlett, 1932; Farzanfar et al., Nat. Rev. Neurosci, 2023).

      In other words, schema refers to highly abstract framework of prior knowledge that captures common patterns across related experiences, which does not necessarily occur in a spatial framework as cognitive maps do. Meanwhile, in the current design, we specifically manipulate the consistency of spatial trajectory distance between color and location sequences. Therefore, we would argue that cognitive map is a more conservative and appropriate term to frame our findings.

      Relevant discussions have been added (Page 3&19).

      We apologize for the lack of more generalized discussion and have added schema-related literatures. Thanks for the suggestion.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) Do time-frequency-domain data (e.g., alpha-band power) in the delay provide evidence for delay-period decoding of trajectory lengths? This might strengthen the case for compression.

      Thanks for the suggestion. We now performed decoding analysis of the delay period based on alpha-band power. As shown in supplementary figure 4, both the 1st-2nd and 2nd-3rd trajectories could be decoded for the aligned condition.

      Added in supplementary figure 4 and Page 16.  

      (2) Do participants erroneously apply the compression strategy in the misaligned condition? This would not show up in the trajectory error correlation analysis, but might be visible when examining correlations between raw trajectory lengths.

      Thanks for raising this interesting suggestion. To test the hypothesis, we chose a typical misaligned condition where 1st-2nd trajectory distances are same between location and color sequences, while the 2nd-3rd trajectory distances are different between the two features.

      In this case, participants might exploit the compression strategy for the first two items and erroneously apply the strategy to the 3rd item. If so, we would expect better memory performance for the first two items but worse memory for the 3rd item, compared to the rest of misaligned trials. As shown below, the 1st-2nd aligned trials showed marginally significant higher performance than misaligned trials for the first two items (t(32) = 1.907, p = 0.066, Cohen’s d = 0.332) . Unfortunately, we did not find significant worse performance for the 3rd item between the two conditions (t(32) = -0.4847, p = 0.631, Cohen’s d = -0.084). We observed significant interactions between the last two items and the alignment effect (t(32) = 2.082, p = 0.045, Cohen’s d = 0.362), indicating a trend of applying wrong compression strategy to the 3nd item.

      Author response image 1.

      (3a) Some more detail on some of the methods might help readers. For instance, did trajectories always move in a clockwise direction? Could the direction reverse on the third item? If not, did this induce a response bias? Could such a bias possibly account for the trajectory error correlations

      Sorry for the unclear statement. For individual trial, both the color and location features of the three items are randomly selected from nine possible values without any constraint about the directions. That is to say, the trajectories can move in a clockwise or anticlockwise direction, and the direction can also reverse on the third item in some trials. Thus, we think the current design can actually help us to reduce the influence of response bias. Taking a step back, if trajectory error correlations are due to response bias, we should expect consistent significant correlation for all conditions, instead of only observing significant correlation for 1st-2nd and 2nd-3rd trajectories but not for 1st-3rd trajectory and only in aligned trajectory condition but not in misaligned condition. Therefore, we think the trajectory error correlations cannot be simply explained by response bias.

      Details have been added (Page 23).

      (3b) Is the colour wheel always oriented the same way for a participant? If so, given there are only nine colors, it seems possible that colors are mapped to locations and remembered in a location code instead. This does not seem to be a problem in principle for the behavioural findings, but might change the interpretation of what is being decoded from the EEG. If this is a possibility then this might be acknowledged.

      The color wheel is always oriented the same way for each participant. We agree with the reviewer that it is possible that participants tend to map colors to locations and remembered in a location code. We don’t have sufficient evidence to rule out this possibility. One possible way could be running another experiment with varied color wheel during response period. Meanwhile, we would like to point out that the underlying logic of the current design is based on the facts that thinking spatially is intuitive and spatial metaphors like “location” and “distance” is commonly used to describe world, e.g., the well-known mental number line (Dehaene et al., JEP: General, 1993). Therefore, we expected participants to associate or integrate location and color maps based on trajectory distance.

      The reviewer is correct that the color decoding would reflect spatial location rather than the genuine color feature. This is actually the point of the experimental design, whereby two irrelevant features could be possibly combined within a common cognitive map. Without the realignment of the two feature maps defined in space, subjects could not at all form the strategy to compress the two sequences. In other words, decoding of color sequences could be understood as neural representation of a series of corresponding locations along the ring that are independent of the physical locations of the items.

      Interpretations and clarifications have been added (Page 23&26).

      (4) Does the discretisation of the stimulus distribution (to only 9 possible locations) make the compression strategy easier to use? If the features had been continuously distributed across the location/colour circle, would participants still pick up on and use the shared trajectory structure?

      Thanks for the question. Without further data, it’s hard to say whether the discretization of the stimulus distribution would make the compression strategy easier to use or not, compared to continuous distribution. Both outcomes seem possible. On the one hand, discrete stimulus distribution would result in discrete trajectory distribution, which helps participants to realize the common trajectory strategy. On the other hand, discrete stimulus distribution would result in category or label representation, which may weaken the effectiveness of structure compression strategy. We postulate that our findings could be generalized to continuous trajectories in a cognitive map within certain resolution.

      (5a) Minor point: I disagree that avoiding the same points for location and colour for a given item allows them to be independently decoded. I would argue the contrary - this kind of constraint should create a small anti-correlation that in principle could lead to spurious decoding of one variable (although this seems unlikely here).

      We appreciate the concern. As mentioned above, with discrete stimulus distribution (9 possible values for both color and location domains), it is quite possible that a fraction of trials would share same values in location and color. Therefore, the neural decoding for one domain might be confounded by another domain. To dissociate their neural representations, we imposed constraints that color and location could not occupy the same value for a given item.

      We agree that this kind of constraint might create a small anti-correlation, even though it is not observed here. Future studies using continuous stimulus distribution would reduce the correlation or anti-correlation between stimuli.

      (5b) Very minor point: 1,000 permutations for significance testing seems on the low side. Since some of the p-values are close to 0.05 it may be worth running more permutations.

      Thanks for this suggestion. We got similar results using 1000 or 10000 permutations.

      (6) Missing reference: H. H. Li et al., 2021 (line 213) seems not to be on the list of references.

      Sorry for the mistake. Added.

      Reviewer #2 (Recommendations For The Authors):

      The study aimed to discuss the working memory mechanism, instead, it seems to be focused on the encoding and recall strategies after a short while, I recommend updating the manuscript to refer to the relevant cognitive mechanism.

      There was a strong voice on the effect of using the cognitive map in working memory, without any tests on if indeed a cognitive map was used (for example the novel link between stimuli and how a cognitive map can be used to infer shortcuts). Was the participant required to have any mental map beyond the schema of the shown color ring?

      In the current experiment, to discuss if the effect is driven by utilizing a cognitive map or schematic abstraction of color-relatedness, further analysis is required to possibly assess the effects of schema on neural activity and behavior. Namely,<br /> (1) Was there any reinstatement of schematically congruent (expected) colors that were probed by location 1, at locations 2 and 3 in the MAT condition?

      Thanks for pointing out this possibility. However, we don’t think there will be stable color expectations given location information under the MAT condition. First, as the trajectory distance varied on a trial-by-trial basis, no prior common trajectory knowledge could be used to make inference about the current stimuli in individual trial. Second, the starting points for color and location (1st item) were randomly and independently selected, such that color sequence could not be predicted based on the location sequence for both aligned and misaligned conditions.

      (2) Given that response time can be a behavioral marker of schematic conflict, was the response time faster for congruent than incongruent conditions?

      Thanks for this question. Unfortunately, due to the experimental design, the response time could not be used as a behavioral marker to infer mental conflicts, since participants were not required to respond as fast as possible. Instead, they took their own pace to reproduce sequences without time limit. They could even take a short break before submitting their response to initiate the next trial.

      (3) In case you cannot rule out that utilizing schema is the cognitive mechanism that supports working memory performance (the behavior), please add the classical literature (on the memory of schematically congruent and incongruent events) to the discussion.

      Thanks for this suggestion and we have added relevant literatures now (Page 3&19).

      (4) On page 6, 'common structure in the cognitive map' is the schema, isn't it?

      Correct. Based on our understanding, ‘common structure in the cognitive map’ is a spatial schema.

      (5) In Figure 2 EFG, would you please use a mixed effect model or show evidence that all participants demonstrated a correlation between the location trajectory error and color trajectory error?

      Thanks for the suggestion. We have added the mixed effect model results, which are consistent with Figure 2EFG (AT: 1st-2nd trajectory, β = 0.071, t = 4.215, p < 0.001; 2nd-3rd trajectory, β = 0.077, t = 3.570, p < 0.001; 1st-3rd trajectory, β = 0.019, t = 1.118, p = 0.264; MAT: 1st-2nd trajectory, β = 0.031, t = 1.572, p = 0.116; 2nd-3rd trajectory, β = 0.002, t = 0.128 , p = 0.898; 1st-3rd trajectory, β = -0.017, t = -1.024, p = 0.306).

      In general, doesn't such correlation just show that good participants/trials were good (some did well in the study and some did poorly throughout?)

      We don’t think the trajectory error correlation results just reveal that some participants did well and some participants did poorly. If that is the case, we shouldn’t observe significant correlation in Figure 2D, where we first run correlation for each participant and then test correlation significance at group level. Indeed, trajectory error correlation between color and location domains characterizes the consistent changes between the two domains.

      It is worth to note that the correlation was estimated with signed trajectory errors in color and location domains, which meant that we indeed cared about whether the errors in the two domains were consistently varied in the same direction, i.e., whether longer trajectory memory compared to the actual trajectory in location domain would predict longer trajectory memory in color domain.

      Moreover, as shown in Figure 2EFG, by dividing trials into 4 bins according to the location trajectory error for each participant and pooling the data across participants, we observed 4 clusters along x-axis (location trajectory error). This suggests that participants’ memory performance is rather consistent instead of being extremely good or bad. Besides, if trajectory error correlation is due to different overall memory performance between participants, we should observe significant trajectory error correlations both in AT and MAT conditions, instead of only under AT condition and for 1st-2nd and 2nd-3rd trajectories but not for 1st-3rd trajectory.

      In Figure 2 G, is the marginal error just too big to be sensitive? I am not sure what we are learning here, please clarify.

      Sorry for the confusion. To examine this possibility, we excluded errors which are beyond 2.5 * σ, and still observed non-significant 1st-3rd trajectory error correlation between color and location domains (r = 0.119, p = 0.167).

      The 1st-3rd trajectory showed nonsignificant behavioral correlation and neural representation, which suggests that the current sequential memory task would encourage participants to organize all information by relying more on the adjacent items and their distance. Thus, we think the 1st-3rd trajectory would serve as a control trajectory, which helps us not only exclude other possible explanation (e.g., systematic response bias), but also validate current findings both in behavioral and neural level.

      Results and statements (Page 10-11) added now.

      Author response image 2.

      (6) Regarding the first lines on page 11, did you do qualitative research to know if less information was encoded in congruent conditions?

      The current experimental design is inspired by the mental compression of spatial sequence studies from Dehaene’s lab (Amalric er al., 2017; Roumi et al., 2021), in which they propose that human brain compresses spatial sequence using an abstract language and formalize minimal description length of a sequence as the “language-of-thought complexity.” Based on this evidence, we think less information is required to describe congruent condition compared to incongruent condition. This idea is supported by better memory performance for congruent condition. Unfortunately, we couldn’t manage to quantify how less information was encoded in congruent condition.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      In this work, the authors examine the mechanism of action of MOTS-c and its impact on monocyte-derived macrophages. In the first part of the study, they show that MOTS-c acts as a host defense peptide with direct antibacterial activity. In the second part of the study, the authors aim to demonstrate that MOTS-c influences monocyte differentiation into macrophages via transcriptional regulation.

      Major strengths.

      Methods used to study the bactericidal activity of MOTS-c are appropriate and the results are convincing.

      Major weaknesses.

      Methods used to study the impact on monocyte differentiation are inappropriate and the conclusions are not supported by the data shown. A major issue is the use of the THP-1 cell line, a transformed monocytic line which does not mimic physiological monocyte biology. In particular, THP-1 differentiation is induced by PMA, which is a completely artificial system and conclusions from this approach cannot be generalized to monocyte differentiation. The authors would need to perform this series of experiments using freshly isolated monocytes, either from mouse or human. The read-out used for macrophage differentiation (adherence to plastic) is also not very robust, and the authors would need to analyze other parameters such as cell surface markers. It is also not clear whether MOTS-c could act in a cell-intrinsic fashion, as the authors have exposed cells to exogenous MOTS-c in all their experiments. The authors did not perform complementary experiments using MOTS-c deficient monocytes. The authors have also analyzed the transcriptomic changes induced by MOTS-c exposure in macrophages derived from young or old mice. While the results are potentially interesting, the differences observed seem independent from MOTS-c and mainly related to age, therefore the conclusions from this figure are not clear. Another concern is the reproducibility of the experiments, as the authors do not indicate the number of biological replicates analyzed nor the number of independent experiments performed.

      In this study, we employed the THP-1 cell line as a proof-of-principle to elucidate the existence of a firstin-class mitochondrial-encoded host defense peptide. This peptide is expressed in monocytes and serves dual functions: i) direct targeting of bacteria, and ii) regulation of monocyte differentiation. It is noteworthy that THP-1 cells differentiated by PMA have been widely utilized as a model for monocyte differentiation by numerous research groups.  While we acknowledge the significance of utilizing primary monocytes to fully comprehend the translational implications of our findings, conducting a complete replication of our experiments in primary monocytes falls beyond the scope of this study. However, we have conducted several pivotal experiments in primary monocytes, including:  

      i) Demonstration of the induction of endogenous MOTS-c in primary human monocytes during differentiation by M-CSF (Fig 3A).

      ii) Observation of an increased number of adhered monocytes during monocyte differentiation following MOTS-c treatment (Fig 5A).

      iii) Examination of the transcriptional regulation in mouse primary bone marrow-derived macrophages (BMDMs) by MOTS-c, seven days after a single treatment at the onset of differentiation (Fig 6).

      In addition to assessing adherence to plastic, we performed RNA-seq of THP-1 cells during early differentiation with MOTS-c as a measure of accelerated differentiation (Fig 4). The positive correlation between the effects of PMA and PMA+MOTS-c suggests that MOTS-c accelerates the transcriptional changes that occur during differentiation (Fig 4G). We consider this method a more comprehensive evaluation of differentiation as it encompasses the expression of thousands of genes rather than relying on a limited selection of cell surface markers. Future investigations should explore additional indicators of differentiation, including potential epigenetic effects of MOTS-c.

      Our findings indicate that endogenous MOTS-c is induced during monocyte stimulation and translocates into the nucleus (Figs 3-4), implying a cell-intrinsic role for MOTS-c during monocyte differentiation. Although examining MOTS-c deficient monocytes would offer valuable insights, technical limitations currently hinder the production of such monocytes due to the mitochondrial genomic encoding of MOTSc within the 12S rRNA.

      Furthermore, our study reveals that MOTS-c alters gene expression in macrophages similarly across age and sex groups. This observation, illustrated in Fig 6E where the fold changes in clusters 5 and 6 in response to MOTS-c were consistent across all groups, suggests that MOTS-c modulates macrophage gene expression in an age-related manner. We postulate this to be an adaptive response to age-related alterations in the monocyte and macrophage microenvironment.

      The number of biological replicates performed for each experiment is indicated.

      The different parts of the manuscript do not appear well connected and it is not clear what the main message from the manuscript would be. The physiological relevance of this study is also unclear.

      The main message of our manuscript is that the mitochondrial genome encodes for a previously unknown host defense peptide that has physiological roles in modulating immune responses during infection and during aging. We have edited the ‘introduction’ to clarify this.

      Reviewer #2 (Public Review):

      The research study presented by Rice et al. set out to further profile the host defense properties of the mitochondrial protein MOTS-c. To do this they studied i. the potential antimicrobial effects of MOTS-c on common bacterial pathogens E.coli and MRSA, ii. the effects of MOTS-c on the stimulation and differentiation of monocytes into macrophages. This is a well performed study that utilizes relevant methods and cell types to base their conclusions on. However, there appear to be a few weaknesses to the current study that hold it back from more broad application.

      Comment 1: From reading the manuscript methods and results, it is unclear exactly what the synthetic MOTS-c source is. Therefore it is hard to determine whether there may be any impurities in the production of this synthetic protein that may interfere with the results presented throughout the manuscript. Though, the data presented in Supplemental Figure 4F, where E.coli expressing intracellular MOTS-c inhibited bacterial growth certainly support MOTS-c specific effects. Similarly with the experiments showing endogenous MOTS-c levels rising in stimulation and differentiated macrophages (Figure 3).

      We have edited our manuscript to include the source and purity of our synthetic MOTS-c peptide. The MOTS-c peptide used was synthesized by New England Peptides (now Biosynth) with a purity >95% by mass spectrometry.

      Comment 2: It is interesting that the mice receiving bacteria coupled with MOTS-c lost about 10% of their body weight. It would have been interesting to demonstrate the cause of this weight loss since the effect appears to be separate from mere PAMPs as shown by using heat-killed MRSA in Supplemental Figure 5. Was inflammation changed? Is this due to changes in systemic metabolism? Would have been interesting to have seen CRP levels or circulating liver enzymes.

      As suggested, we repeated this experiment to include both the heat-killed and MOTS-c-MRSA groups in the same controlled experiment for comparison (Fig 2; see below). Blood was collected from these mice for evaluation of cytokine levels and markers of organ damage. While only 1/6 controls survived, all MOTSc and heat-killed MRSA-treated mice survived. However, compared to the heat-killed group, the MOTS-cMRSA group lost more weight and had a higher inflammatory profile, but still significantly less than in the control group. We hypothesize that this is due to only partial killing of MRSA by MOTS-c, as suggested by the CFU plated after overnight incubation, leading to a non-lethal infection in these mice. Others have shown that in this peritonitis model, α-hemolysin production by live MRSA is a key factor in toxicity, rather than PAMP-induced shock (PMID: 8975909; 22802349), which is consistent with the absence of death following heat-killed MRSA inoculation.

      Despite these concerns, the data are well suited to answering their research question, and they open up the door to studying how mitochondrial peptides like MOTS-c could have roles outside of the mitochondria.

      Reviewer #1 (Recommendations For The Authors):

      Suggestions for improvement

      (1) The authors need to indicate in each legend the number of biological replicates analyzed and the number of independent experiments performed. This is essential.

      We have included the number of biological replicates analyzed.

      (2) The authors need to repeat the key experiments using freshly isolated monocytes, either human or mouse. THP-1 cells are abnormal cells and findings from these cells cannot be generalized to monocytes. For instance, in Figures 3A and B, it is clear that the kinetics of MOTS-c expression are different between THP-1 cells and human blood monocytes.

      The kinetics of THP-1 cells compared to human monocytes are slightly different, as expected by using different cells and different differentiation cues (M-CSF vs PMA). However, our findings collectively demonstrate the same effect, that each stimulus transiently induces the expression of MOTS-c within 24 hours in monocytes.

      In Figure 3A, the authors should show what happens in the absence of MCSF. Is MOTS-c expression upregulated by culture alone?

      There is some degree of baseline expression of MOTS-c in a resting state, and MOTS-c expression is significantly increased upon stimulation. This expression may be higher in primary monocytes than THP-1 cells, given that these monocytes are inevitably stressed by being removed from the native environment and put through the purification process.

      (3) In Figure 4A, a control for cytoplasmic contamination in the nuclear fraction is missing.

      We now include GAPDH detection in the nuclear fraction.  

      Author response image 1.

      (4) The RNA-seq analysis shown in Figure 4 is not very informative. What genes are differentially expressed? The authors should provide a list of these genes as supplementary information and highlight some key genes in the figure and text.

      The complete list of these genes is provided in Tables S1 and S2. We chose not to highlight specific genes in this paper due to the lack of sufficient evidence identifying any particular genes as key factors at this time.

      (5) In Figure 5A, a control is missing: the authors should treat the monocytes with the same volume of 'vehicle' (presumably it is water).

      In all experiments with MOTS-c treatment, the controls were treated with the same volume of vehicle (water). We have edited legends to state this.

      (6) In Figure 6, the differences observed seem independent on MOTS-c. The conclusions from this figure are overstated and need to be rephrased and clarified.

      MOTS-c shifted gene expression in macrophages in a similar manner regardless of age and sex, as shown in Fig 6E where the fold changes in clusters 5 and 6 in response to MOTS-c were similar in all groups. Independently, aging alone increases the expression of these same genes related to antigen presentation and interferon signaling, suggesting that MOTS-c shifts macrophage gene expression in an age-related manner – the expression of antigen presentation and interferon-related genes have been shown to be highly age-related (PMID: 36040389, 32669714, 36622281, 31754020). We hypothesize this to be an adaptive response to age-related changes in the monocyte and macrophage microenvironment.

      (7) Adherence to plastic is not a robust read-out for monocyte differentiation into macrophages. The authors need to examine other parameters, for instance characteristic cell surface markers for macrophages.

      As a read-out of accelerated differentiation, in addition to adherence to plastic we performed RNA-seq of THP-1 cells during early differentiation with MOTS-c (Fig 4). The positive correlation between the effects of PMA and effects of PMA+MOTS-c suggest MOTS-c is accelerating the transcriptional changes that occur during differentiation (Fig 4G). We believe this to be a more robust assessment of differentiation as it relies on the expression of thousands of genes rather than a limited selection of cell surface markers. Further studies are needed to assess other read-outs of differentiation, including possible epigenetic effects of MOTS-c.

      (8) It is not clear whether MOTS-c could have a cell-intrinsic effect in monocytes. The results should be strengthened by examining the differentiation of monocytes deficient for MOTS-c (without addition of exogenous MOTS-c).

      We have shown that endogenous MOTS-c is induced during monocyte stimulation and translocates into the nucleus (Figs 3-4), suggesting that MOTS-c does have a cell-intrinsic role during monocyte differentiation.

      While having MOTS-c deficient monocytes would certainly be insightful, because MOTS-c is encoded within the mitochondrial genome in the 12S rRNA there are currently technical limitations in producing these monocytes.

      Other points

      (1) The paper would benefit from a more extended discussion to understand the physiological relevance of these findings. What cells would release MOTS-c in vivo, and how would that affect monocytes ? Is there a cell-intrinsic of MOTS-c in monocytes, and if so what would be the signals inducing its expression during differentiation ? These aspects should be discussed by the authors so that the readers can understand their views.

      We thank the reviewer for their suggestion and have edited the discussion in our revised manuscript.  

      MOTS-c has been detected in various tissue and cell types, including the liver, muscle, T cells, monocytes/macrophages, and epithelial cells. This aligns with MOTS-c being referred to in literature as a cytokine, which are typically expressed by a broad range of cell types. Consistent with this, we also propose that MOTS-c would be expressed in cells known to express HDPs.

      We hypothesize that MOTS-c acts in both a cell-intrinsic and extrinsic manner in vivo, consistent with known HDPs, to both target bacteria directly and modulate immune cell responses. In vitro, M-CSF, PMA, LPS, and IFNγ each induced MOTS-c expression. In vivo, monocytes respond to a range of stimuli that influence their differentiation, and these stimuli may induce MOTS-c as well. We have previously published that MOTS-c acts primarily under conditions of cell stress, such as nutrient deprivation and oxidative stress, to help restore homeostasis. While MOTS-c did regulate macrophage gene expression in resting “M0-like” macrophages, we hypothesize that the physiological role of MOTS-c is to regulate cell adaptation to stress, therefore the context under which monocytes differentiate will be an important factor determining the functional effects of MOTS-c. In future studies, we plan to test whether the immuno-modulatory effects of MOTS-c are dependent on the environment during differentiation.

      (2) Scale bar appear to be missing from Figure 1G.

      We apologize for the poor resolution of the scale bar. We have made it easily recognizable in the revised figure.  

      (3) It is not very clear what is shown in Figure S2. The authors should better explain what the images represent.

      Figure S2 is related to Figure 1D and Figure S1. In this experiment, E. coli, S. typhimurium, and P. aeruginosa cultures were treated with MOTS-c (100uM). We observed that only E. coli aggregated immediately, while

      S. typhimurium and P. aeruginosa did not show aggregation. This suggests that MOTS-c exhibits specificity in targeting certain types of bacteria, although the underlying basis of this specificity is currently unknown.  

      We have revised the legend as follows: 'MOTS-c exhibits specificity in bacterial targeting. MOTS-c (100 μM) treatment causes immediate aggregation of E. coli but not S. typhimurium or P. aeruginosa (n=6). Representative image shown. See Figure 1D'.

      Reviewer #2 (Recommendations For The Authors):

      This is a beautifully executed study and a well written manuscript. I generally don't have much critical feedback to give based on my reading. The only recommendation I have to improve the completeness of the data would be in relation to Figure 5E and F. The metabolic phenotype of LPS stimulated monocytes/macrophages is more typically the Warburg effect where oxidative phosphorylation is reduced (as you show with a lowered OCR), but with a concomitant elevation in lactate production. It would have been nice to see either i. the ECAR levels from your seahorse data, or ii. separate lactate measurements on your supernatants. This would go a long way to further explaining the phenotype described in the figure.

      We greatly appreciate the reviewer's positive feedback. The data provided below are ECAR measurements obtained from the Seahorse assay. However, it's important to note that the assays were originally designed for OCR measurement (e.g. buffered media unsuitable for ECAR measurements, use of mitochondrial complex inhibitors, etc.), thus rendering the ECAR data unreliable for accurately assessing glycolysis. Consequently, while we share this data with the reviewer, we believe it is inappropriate to include it in the manuscript (hence omitted in the original submission).

      Author response image 2.

      Furthermore, we are currently engaged in a separate manuscript focusing on elucidating the immunometabolic mechanisms of MOTS-c in macrophages. We intend for this manuscript to stand alone, providing a comprehensive exploration of metabolic pathways, including a detailed untargeted metabolomics map spanning multiple time-points.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      The authors sought to test whether anterior insular cortex neurons increase or decrease firing during fear behavior and freezing, bi-directionally control fear via separate, anatomically defined outputs. Using a fairly simple behavior where mice were exposed to tone-shock pairings, they found roughly equal populations that do indeed either increase or decrease firing during freezing. Next, they sought to test whether these distinct populations may also have distinct outputs. Using retrograde tracers they found that the anterior insular cortex contains non-overlapping neurons which project to the mediodorsal thalamus or amygdala. Mediodorsal thalamus-projecting neurons tended to cluster in deep cortical layers while amygdala-projecting neurons were primarily in more superficial layers. Stimulation of insula-thalamus projection decreased freezing behavior, and stimulation of insula-amygdala projections increased fear behavior. Given that the neurons that increased firing were located in deep layers, that thalamus projections occurred in deep layers, and that stimulation of insula-thalamus neurons decreased freezing, the authors concluded that the increased firing neurons may be thalamus projections. Similarly, given that decreased-firing neurons tended to occur in more superficial layers, that insula-amygdala projections were primarily superficial, and that insula-amygdala stimulation increased freezing behavior, authors concluded that the decreased firing cells may be amygdala projections. The study has several strengths though also some caveats.

      Strengths:

      The potential link between physiological activity, anatomy, and behavior is well laid out and is an interesting question. The activity contrast between the units that increase/decrease firing during freezing is clear.

      It is nice to see the recording of extracellular spiking activity, which provides a clear measure of neural output, whereas similar studies often use bulk calcium imaging, a signal that rarely matches real neural activity even when anatomy suggests it might (see London et al 2018 J Neuro - there are increased/decreased spiking striatal populations, but both D1 and D2 striatal neurons increase bulk calcium).

      Weaknesses:

      The link between spiking, anatomy, and behavior requires assumptions/inferences: the anatomically/genetically defined neurons which had distinct outputs and opposite behavioral effects can only be assumed the increased/decreased spiking neurons, based on the rough area of the cortical layer they were recorded.

      Yes, we are aware that we could not provide a direct link between spiking, anatomy and behavior. We have specifically noted this in the discussion section and added a possible experiment that could be carried out to provide a more direct link in a future study.

      [Lines 371-375] We would like to provide a more direct evidence between the neuronal response types and projection patterns in future studies by electrophysiologically identifying freezing-excited and freezing-inhibited aIC neurons and testing whether those neurons activates to optogenetic activation of amygdala or medial thalamus projecting aIC neurons.

      The behavior would require more control to fully support claims about the associative nature of the fear response (see Trott et al 2022 eLife) - freezing, in this case, could just as well be nonassociative. In a similar vein, fixed intertrial intervals, though common practice in the fear literature, pose a problem for neurophysiological studies. The first is that animals learn the timing of events, and the second is that neural activity is dynamic and changes over time. Thus it is very difficult to determine whether changes in neural activity are due to learning about the tone-shock contingency, timing of the task, simply occur because of time and independently of external events, or some combination of the above.

      Trott et al. (2022) stated that "...freezing was the purest reflection of associative learning." The nonassociative processes mentioned in the study were related to running and darting behaviors, which the authors argue are suppressed by associative learning. Moreover, considerable evidence from immediate postshock freezing and immediate postshock context shift studies all indicate that the freezing response is an associative (and not nonassociative) response (Fanselow, 1980 and 1986; and Landeira-Fernandez et al., 2006). Thus, our animals' freezing response to the tone CS presentation in a novel context, following three tone CS-footshock US pairings, most likely reflects associative learning. 

      Concerning the issue of fixed inter-trial intervals (ITIs), which are standard in fear conditioning studies, particularly those with few CS-US paired trials, we acknowledge the challenge in interpreting the neural correlates of behavior. However, the ITIs in our extinction study was variable and we still found neural activities that had significant correlation with freezing. The results of our extinction study, carried out with variable it is, suggest that the aIC neural activity changes measured in this study is likely due to freezing behavior associated with fear learning, not due to learning the contingencies of fixed ITIs.

      Reviewer #2 (Public Review):

      In this study, the authors aim to understand how neurons in the anterior insular cortex (insula) modulate fear behaviors. They report that the activity of a subpopulation of insula neurons is positively correlated with freezing behaviors, while the activity of another subpopulation of neurons is negatively correlated to the same freezing episodes. They then used optogenetics and showed that activation of anterior insula excitatory neurons during tones predicting a footshock increases the amount of freezing outside the tone presentation, while optogenetic inhibition had no effect. Finally, they found that two neuronal projections of the anterior insula, one to the amygdala and another to the medial thalamus, are increasing and decreasing freezing behaviors respectively. While the study contains interesting and timely findings for our understanding of the mechanisms underlying fear, some points remain to be addressed.

      We are thankful for the detailed and constructive comments by the reviewer and addressed the points. Specifically, we included possible limitations of using only male mice in the study, included two more studies about the insula as references, specified the L-ratio and isolated distance used in our study, added the ratio of putative-excitatory and putative-inhibitory neurons obtained from our study, changed the terms used to describe neuronal activity changes (freezing-excited and freezing-inhibited cells), added new analysis (Figure 2H), rearranged Figure 2 for clarity, added new histology images, and added atlas maps with viral expressions (three figure supplements).

      Reviewer #1 (Recommendations For The Authors):

      - I would suggest keeping the same y-axis for all figures that display the same data type - Figure 5D, for example.

      Thank you for the detailed suggestion. We corrected the y-axis that display the same data type to be the same for all figures.

      - In the methods, it says 30s bins were used for neural analysis (line 435). I cannot imagine doing this, and looking at the other figures, it does not look like this is the case so could you please clarify what bins, averages, etc were used for neural and behavioral analysis?

      Bin size for neural analysis varied; 30s, 5s, 1s bins were used depending on the analysis. We corrected this and specified what time bin was used for which figure in the methods.

      Bin size for neural and freezing behavior was 30s and we also added this to the methods.

      - I would not make any claims about the fear response here being associative/conditional. This would require a control group that received an equal number of tone and shock exposures, whether explicitly unpaired or random.

      The unpaired fear conditioning paradigm, unpaired tone and shock, suggested by the reviewer is well characterized not to induce fear behavior by CS (Moita et al., 2003 and Kochli et al., 2015). In addition, considerable evidence from immediate post-shock freezing and immediate post-shock context shift studies all indicate that the freezing response is an associative (and not nonassociative) response (Fanselow, 1980 and 1986; and Landeira-Fernandez et al., 2006). Thus, our animals' freezing response to the tone CS presentation in a novel context, following three tone CS-footshock US pairings, most likely reflects associative learning.

      - I appreciate the discussion about requiring some inference to conclude that anatomically defined neurons are the physiologically defined ones. This is a caveat that is fully disclosed, however, I might suggest adding to the discussion that future experiments could address this by tagging insula-thalamus or insula-amygdala neurons with antidromic (opto or even plain old electric!) stimulation. These experiments are tricky to perform, of course, but this would be required to fully close all the links between behavior, physiology, and anatomy.

      As suggested, we have included that, in a future study, we would like to elucidate a more direct link between physiology, anatomy and behaviors by optogenetically tagging the insula-thalamus/insula-amygdala neurons and identifying whether it may be a positive or a negative cell (now named the freezing-excited and freezing-inhibited cells, respectively) in the discussion.

      [Lines 371-375] We would like to provide a more direct evidence between the neuronal response types and projection patterns in future studies by electrophysiologically identifying freezing-excited and freezing-inhibited aIC neurons and testing whether those neurons activates to optogenetic activation of amygdala or medial thalamus projecting aIC neurons.

      Reviewer #2 (Recommendations For The Authors):

      Major comments:

      (1) As all experiments have been performed only in male mice, the authors need to clearly state this limit in the introduction, abstract, and title of the manuscript.

      With increasing number of readers becoming interested in the biological sex used in preclinical studies, we also feel that it should be mentioned in the beginning of the manuscript. As suggested, we explicitly wrote that we only used male mice in the title, abstract, and introduction. In addition, we discussed possible limitations of only using male mice in the discussion section as follows:

      [Lines 381-386] Another factor to consider is that we have only used male mice in this study. Although many studies report that there is no biological sex difference in cued fear conditioning (42), the main experimental paradigm used in this study, it does not mean that the underlying brain circuit mechanism would also be similar. The bidirectional fear modulation by aIC→medial thalamus or the aIC→amygdala projections may be different in female mice, as some studies report reduced cued fear extinction in females (42).

      (2) The authors are missing important publications reporting findings on the insular cortex in fear and anxiety. For example, the authors should cite studies showing that anterior insula VIP+ interneurons inhibition reduces fear memory retrieval (Ramos-Prats et al., 2022) and that posterior insula neurons are a state-dependent regulator of fear (Klein et al., 2021). Also, regarding the anterior insula to basolateral amygdala projection (aIC-BLA), the author should include recent work showing that this population encodes both negative valence and anxiogenic spaces (Nicolas et al., 2023). 

      We appreciate the detailed suggestions and we added appropriate publications in the discussion section. The anterior insula VIP+ interneuron study (Ramos-Prats et al., 2022) is interesting, but based on the evidence provided in the paper, we felt that the role of aIC VIP+ interneuron in fear conditioning is low. VIP+ interneurons in the aIC seem to be important in coding sensory stimuli, however, it’s relevance to conditioned stimuli seems to be low; overall VIP intracellular calcium activity to CS was low and did not differ between acquisition and retrieval. Also, inhibition of VIP did not influence fear acquisition. VIP inhibition during fear acquisition did reduce fear retrieval (CS only, no light stimulation), but this does not necessarily mean that VIP activity will be involved in fear memory storage or retrieval, especially because intracellular calcium activity of VIP+ neurons was low during fear conditioning and retrieval.

      Studies by Klein et al. (2021) and Nicolas et al. (2023) are integrated in the discussion section as follows.

      [Lines 297-301] Group activity of neurons in the pIC measured with fiberphotometry, interestingly, exhibited fear state dependent activity changes—decreased activity with high fear behavior and increased activity with lower fear behavior (29)—suggesting that group activity of the pIC may be involves in maintain appropriate level of fear behavior.

      [Lines 316-319] Another distinction between the aIC and pIC may be related with anxiety, as a recent study showed that group activity of aIC neurons, but not that of the pIC, increased when mice explored anxiogenic space (open arms in an elevated plus maze, center of an open field box) (32).

      (3) The authors should specify how many neurons they excluded after controlling the L-ratio and isolation distance. It is also important to specify the percentage of putative excitatory and inhibitory interneurons recorded among the 11 mice based on their classification (the number of putative inhibitory interneurons in Figure 1D seems too low to be accurate).

      We use manual cluster cutting and only cut clusters that are visually well isolated. So we hardly have any neurons that are excluded after controlling for L-ratio and isolation distance. The criterion we used was L-ratio<0.3 and isolation distance>15, and we specified this in the methods as follows.

      [Lines 454-458] We only used well-isolated units (L-ratio<0.3, isolation distance>15) that were confirmed to be recorded in the aIC (conditioned group: n = 116 neurons, 11 mice; control group: n = 14 neurons, 3 mice) for the analysis (46). The mean of units used in our analysis are as follows: L-ratio = 0.09 ± 0.012, isolation distance = 44.97 ± 5.26 (expressed as mean ± standard deviation).

      As suggested, we also specified the percentage of putative excitatory and inhibitory interneurons recorded from our study in the results and methods section. The relative percentage of putative excitatory and inhibitory interneurons were similar for both the conditioned and the control groups (conditioned putative-excitatory: 93.1%, putative-inhibitory: 6.9%; control putative-excitatory: 92.9%, putative-inhibitory: 7.1%). Although the number of putative-interneurons isolated from our recordings is low that is what we obtained. Putative inhibitory neurons, probably because of their relatively smaller size, has a tendency to be underrepresented than the putative excitatory cells.

      [Lines 83-87] Of the recorded neurons, we analyzed the activity of 108 putative pyramidal neurons (93% of total isolated neurons) from 11 mice, which were distinguished from putative interneurons (n = 8 cells, 7% of total isolated neurons) based on the characteristics of their recorded action potentials (Figure 1D; see methods for details).

      [Lines 464-467] The percentage of putative excitatory neurons and putative inhibitory interneurons obtained from both groups were similar (conditioned putative-excitatory: 93.1%, putative-inhibitory: 6.9%; control putative-excitatory: 92.9%, putative-inhibitory: 7.1%).

      (4) While the use of correlation of single-unit firing frequency with freezing is interesting, classically, studies analyze the firing in comparison to the auditory cues. If the authors want to keep the correlation analysis with freezing, rather than correlations to the cues, they should rename the cells as "freezing excited" and "freezing inhibited" cells instead of positive and negative cells.

      As suggested, we used the terms “freezing-excited” and “freezing-inhibited” cells instead of positive and negative cells.

      (5) To improve clarity, Figure 2 should be reorganized to start with the representative examples before including the average of population data. Thus Panel D should be the first one. The authors should also consider including the trace of the firing rate of these representative units over time, on top of the freezing trace, as well as Pearson's r and p values for both of them. Then, the next panels should be ordered as follows: F, G, H, C, A, B, I, and finally E.

      We have rearranged Figure 2 based on the suggestions.

      (6) It is unclear why the freezing response in Figure 2 is different in current panels F, G, and H. Please clarify this point.

      It was because the freezing behaviors of slightly different population of animals were averaged. Some animals did not have positive/negative (or both) cells and only the behavior of animals with the specified cell-type were used for calculating the mean freezing response. With rearrangement of Figure 2, now we do not have plots with juxtaposed mean neuronal response-types and behavior.

      (7) Even though the peak of tone-induced firing rate change between negative and positive cells is 10s later for positive cells, the conclusion that this 'difference suggests differential circuits may regulate the activities of different neuron types in response to fear' is overstating the observation. This statement should be rephrased. Indeed, it could be the same circuits that are regulated by different inputs (glutamatergic, GABA, or neuromodulatory inputs).

      We agree and delete the statement from the manuscript.

      (8) The authors mention they did not find tone onset nor tone offset-induced responses of anterior insula neurons. It would be helpful to represent this finding in a Figure, especially, which were the criteria for a cell to be tone onset or tone offset responding.

      We added how tone-onset and tone-offset were analyzed in the methods section and added a plot of the analysis in Figure 2H.

      (9) Based on the spread of the viral expression shown in Figure 3B, it appears that the authors are activating/inhibiting insula neurons in the GI layer, whereas single-unit recordings report the electrodes were located in DI, AID, and AIV layers. The authors should provide histology maps of the viral spread for ChR2, NpHR3, and eYFP expression.

      Thank you for the excellent suggestion. Now the histological sample in Figure 3B is a sample with expression in the GI/DI/AID layers and it also has an image taken at higher resolution (x40) to show that viral vectors are expressed inside neurons. We also added histological maps with overlay of viral expression patterns of the ChR2, eYFP, and NpHR3 groups in Figure 3—figure supplement 1.

      (10) In Figure 5B, the distribution of terminals expressing ChR2 appears much denser in CM than in MD. This should be quantified across mice and if consistent with the representative image, the authors should refer to aIC-CM rather than aIC-MD terminals.

      Overall, we referred to the connection as aIC-medial thalamus, which collectively includes both the CM and the MD. Microscopes we have cannot determine whether terminals end at the CM or MD, but the aIC projections seems to pass through the CM to reach the MD. The Allen Brain Institute’s Mouse brain connectivity map (https://connectivity.brain-map.org/projection/experiment/272737914) of a B6 mouse, the mouse strain we used in our study, with tracers injected in similar location as our study also supports our speculation and shows that aIC neuronal projections terminate more in the MD than in the CM. In addition, the power of light delivered for optogenetic manipulation is greatly reduced over distance, and therefore, the MD projecting terminals which is closer to the optic fiber will be more likely to be activated than the CM projecting terminals. However, since we could not determine whether the aIC terminate at the CM or the MD, we collectively referred to the connection as the aIC-medial thalamus throughout the manuscript.

      Author response image 1.

      (11) Histological verifications for each in vivo electrophysiology, optogenetic, and tracing experiments need to include a representative image of the implantation/injection site, as well as a 40x zoom-in image focusing on the cell bodies or terminals right below the optic fiber (for optogenetic experiments). Moreover, an atlas map including all injection locations with the spread of the virus and fiber placement should be added in the Supplement Figures for each experiment (see Figure S1 Klein et al., 2021). Similarly, the authors need to add a representation of the spread of the retrograde tracers for each mouse used for this tracing experiment.

      As suggested, we added a histology sample showing electrode recording location for in-vivo electrophysiology in Figure 1 and added atlas maps for the optogenetic and tracing experiments in supplementary figures. We also provide a 40x zoom-in image of the expression pattern for the optogenetic experiments (Figure 3B).

      (12) To target anterior insula neurons, authors mention coordinates that do not reach the insula on the Paxinos atlas (AP: +1.2 mm, ML: -3.4 mm, DV: -1.8 mm). If the DV was taken from the brain surface, this has to be specified, and if the other coordinates are from Bregma, this also needs to be specified. Finally, the authors cite a review from Maren & Fanselow (1996), for the anterior insula coordinates, but it remains unclear why.

      AP and ML coordinates are measurement made in reference to the bregma. DV was calculated from the brain surface. We specified these in the Methods. We did not cite a review from Maren & Fenselow for the aIC coordinates.

      Minor comments:

      (1) A schematic of the microdrive and tetrodes, including the distance of each tetrode would also be helpful.

      We used a handcrafted Microdrives with four tetrodes. Since they were handcrafted, the relative orientation of the tetrodes varies and tetrode recording locations has to be verified histologically. We, however, made sure that the distance between tetrodes to be more than 200 μm apart so that distinct single-units will be obtained from different tetrodes. We added this to the methods as follows.

      [Lines 430-431] The distance between the tetrodes were greater than 200 μm to ensure that distinct single-units will be obtained from different tetrodes.

      (2) Figure 2E: representation of the baseline firing (3-min period before the tone presentation) is missing.

      Figure 2E is the 3 min period before tone presentation

      (3) Figure 2: Averages Pearson's correlation r and p values should be stated on panels F, G, and H (positive cell r = 0.81, P < 0.05; negative cell r = -0.68, P < 0.05).

      They were all originally stated in the figures. But with reorganization of Figure 2, we now have a plot of the Pearson’s Correlation with r and p values in Figure 2F.

      (4) Figure 2I: Representation of the absolute value of the normalized firing is highly confusing. Indeed, as the 'negative cells' are inhibited to freezing, firing should be represented as normalized, and negative for the inhibited cells.

      To avoid confusion, we did not take an absolute value of the “negative cells”, which are now called the “freezing-inhibited cells”.

      (5) Figure 4E (retrograde tracing): representation of individual values is missing.

      Figure 4E now has individual values.

      References:

      London, T. D., Licholai, J. A., Szczot, I., Ali, M. A., LeBlanc, K. H., Fobbs, W. C., & Kravitz, A. V. (2018). Coordinated ramping of dorsal striatal pathways preceding food approach and consumption. Journal of Neuroscience, 38(14), 3547-3558.

      Trott, J. M., Hoffman, A. N., Zhuravka, I., & Fanselow, M. S. (2022). Conditional and unconditional components of aversively motivated freezing, flight and darting in mice. Elife, 11, e75663.

      Fanselow, M. S. (1980). Conditional and unconditional components of post-shock freezing. The Pavlovian journal of biological science: Official Journal of the Pavlovian, 15(4), 177-182.

      Fanselow, M. S. (1986). Associative vs topographical accounts of the immediate shock-freezing deficit in rats: implications for the response selection rules governing species-specific defensive reactions. Learning and Motivation, 17(1), 16-39.

      Landeira-Fernandez, J., DeCola, J. P., Kim, J. J., & Fanselow, M. S. (2006). Immediate shock deficit in fear conditioning: effects of shock manipulations. Behavioral neuroscience, 120(4), 873.

      Moita, M. A., Rosis, S., Zhou, Y., LeDoux, J. E., & Blair, H. T. (2003). Hippocampal place cells acquire location-specific responses to the conditioned stimulus during auditory fear conditioning. Neuron, 37(3), 485-497.

      Kochli, D. E., Thompson, E. C., Fricke, E. A., Postle, A. F., & Quinn, J. J. (2015). The amygdala is critical for trace, delay, and contextual fear conditioning. Learning & memory, 22(2), 92-100.

      Ramos-Prats, A., Paradiso, E., Castaldi, F., Sadeghi, M., Mir, M. Y., Hörtnagl, H., ... & Ferraguti, F. (2022). VIP-expressing interneurons in the anterior insular cortex contribute to sensory processing to regulate adaptive behavior. Cell Reports, 39(9).

      Klein, A. S., Dolensek, N., Weiand, C., & Gogolla, N. (2021). Fear balance is maintained by bodily feedback to the insular cortex in mice. Science, 374(6570), 1010-1015.

      Nicolas, C., Ju, A., Wu, Y., Eldirdiri, H., Delcasso, S., Couderc, Y., ... & Beyeler, A. (2023). Linking emotional valence and anxiety in a mouse insula-amygdala circuit. Nature Communications, 14(1), 5073.

      Maren, S., & Fanselow, M. S. (1996). The amygdala and fear conditioning : Has the nut been cracked? Neuron, 16(2), 237‑240. https://doi.org/10.1016/s0896-6273(00)80041-0

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This work by Ding et al uses agent-based simulations to explore the role of the structure of molecular motor myosin filaments in force generation in cytoskeletal structures. The focus of the study is on disordered actin bundles which can occur in the cell cytoskeleton and have also been investigated with in vitro purified protein experiments.

      Strengths:

      The key finding is that cooperative effects between multiple myosin filaments can enhance both total force and the efficiency of force generation (force per myosin). These trends were possible to obtain only because the detailed structure of the motor filaments with multiple heads is represented in the model.

      We appreciate your comments about the strength of our study. 

      Weaknesses:

      It is not clearly described what scientific/biological questions about cellular force production the work answers. There should be more discussion of how their simulation results compare with existing experiments or can be tested in future experiments.

      Please see our response to the comment (1) below.

      The model assumptions and scientific context need to be described better.

      We apologize for the insufficient descriptions about the model and the scientific context. We revised the manuscript to better explain model assumptions and scientific context as described in our responses below.

      The network contractility seems to be a mere appendix to the bundle contractility which is presented in much more detail.

      Please see our response to the comment (6) below.

      Reviewer #1 (Recommendations for the authors):

      (1) It is not clearly described what scientific/biological questions about cellular force production the work answers. There should be more discussion of how their simulation results compare with existing experiments, or can be tested in future experiments. The authors do briefly mention Reference 4 where different myosin isoforms were used, but it is not clear that these experiments support the scalings predicted in this work in Figures 3-6. Also, the experiments in Ref. 4 apparently did not involve passive crosslinkers (ACPs) which are key in this study.

      Thank you for the comment. In the 5th paragraph of the discussion section of the original manuscript, we applied our findings to understand how structural differences between ventral stress fibers and actin arcs could affect force generation. In addition, at the end of the discussion section, we mentioned that experiments with artificially-made myosin thick filaments could be used for verifying our results. 

      The experiments in Ref. 4 were only ones that we could directly compare our results with. In previous study, actomyosin bundles were experimentally created with ACPs (K.L. Weirich et al., Biophys J, 2021, 120: 1957-1970), but the motions of myosin thick filaments were only quantities measured in the experiments. In general, measuring forces generated by in vitro actomyosin bundles is very challenging. This is why the predictions from our model are particularly valuable for understanding the force generation of actomyosin structures. 

      (2) The architecture of the bundles seems to be prescribed by hand in these simulations. Several well-known stochastic aspects of the dynamics of actin and actin-binding proteins are not included in the model. For example, there is no remodeling of the actin structures through actin polymerization and depolymerization, or crosslink (ACP) binding and unbinding. Can the authors comment on why these effects could be neglected for the questions they want to address?

      Thank you for the comment. We previously showed that the force generation process in actomyosin networks and bundles is affected by actin dynamics (Q. Yu et al., Biophys J, 2018, 115: 2003-2013) and the unbinding of ACPs (T. Kim, Biomech Model Mechanobiol, 2015, 14(2): 345-355 and W. Jung et al., Comput Part Mech, 2015, 2(4): 317-327). 

      However, we did not include the actin dynamics and the ACP unbinding in the current study to clearly understand the effects of the structural properties of thick filaments on the force generation process. We have learned that the stochastic behaviors of cytoskeletal components lead to noisier results, which requires us to run a much larger number of simulations to obtain statistically convincing data. We added the following paragraph in the discussion section of the revised manuscript:

      “Although this study focused mainly on parameters related to motor structures, we expect that other parameters would affect the force generation process. For example, as we showed before, a decrease in ACP density would reduce forces by deteriorating connectivity between filaments. With very low ACP density, some of neighboring motors may not have ACPs between them, thus adding up their forces as shown in Fig. 2. However, such low ACP density may not maintain the structure of bundles or cross-linked networks well. In addition, the force-dependent unbinding of ACPs could change the spatial distribution of ACPs during force generation. If they behave as a slip bond which unbinds more frequently with higher forces, ACPs may not stay between two motors for long time due to high tension. Then, forces generated by two motors may have a higher chance to add up. By contrast, if they behave as a catch bond which unbinds less frequently with larger forces, more ACPs will be recruited between two motors, reducing a chance to add up

      forces. The length of actin filaments is unlikely to affect the force generation process significantly unless filaments are very short. Additionally, as we showed before, actin turnover would reduce forces by competing with motor activities, change connectivity between filaments over time, and prevent motors from being stalled for long time, all of which could affect force generation.”

      (3) The present study is confined to the fixed density of motors and ACPs. However, these can be easily varied in in vitro experiments. Works such as Reference 4 show an optimum in contractility vs myosin concentration. Myosins act not only to slide actin filaments but also crosslink them.

      Can the authors vary myosin concentration to demonstrate such effects in their model?

      As the reviewer pointed out, there is a belief that myosin thick filaments can serve as crosslinkers as well. However, unless there are a fraction of dead myosins (which remain bound on filaments without walking) or myosins dwell at the barbed ends filaments for very long time, it looks very hard for bundles or networks to generate large forces. A former experiment showed that active myosins increases the viscosity of actin networks, not elasticity (D. Humphrey et al., Nature, 2002, 416: 413-416) Computer simulations with reasonable assumptions did not show significant force generation without cross-linkers. We have tested systems with a large number of motors and a few cross-linkers in previous studies (T. Kim, Biomech Model Mechanobiol, 2015, 14(2): 345-355 and W. Jung et al., Comput Part Mech, 2015, 2(4): 317-327). We observed that large force/stress was generated momentarily, but it was relaxed very fast. It is expected that there will be similar outcomes if we try such conditions in the current study.

      (4) Why is there a (factor of 1.5-2) discrepancy in the measured (Ftot) and estimated (Fest) force values in Figure 4-6? How can the authors improve their scaling arguments to capture this? What about the estimated efficiency?

      Thank you for the comment. Indeed, there was a discrepancy between the actual and estimated forces. When the estimated force was calculated, we used the z positions of motors without consideration of the actual bundle geometry with multiple filaments. For example, if two motors are located on the opposite sides of the bundle (i.e., if they are located far from each other in x or y direction), forces generated by them may not counterbalance each other. Then, the estimated force can be smaller than the actual force because counterbalance between motors can be overcounted. The original manuscript had the following sentences to clarify this point: “F</sub>est</sub> was generally smaller than F<sub>tot</sub> because this analysis does not account for actual bundle geometry consisting of multiple F-actins; if two motors are located far from each other in x or y direction, they may not counterbalance or add up forces. Nevertheless, we found that F<sub>est</sub> captures the overall dependence of F<sub>tot</sub> on parameters well.”

      (5) Several choices of parameter values used in the simulations are not clear:

      a) Why consider F actin of 140 nm specifically? Actin can come in a range of lengths. How do their results depend upon the length scale of actin?

      It seems that there is a misunderstanding. 140 nm is the equilibrium length of one actin segment in our model. The actual F-actin consists of multiple actin segments. The length of Factin was 9 μm in bundle simulations and 10 μm (average) in network simulations. We expect that the general tendency of our results would not change with different filament length. However, if filament length becomes too short, the force generation process would be impaired due to lack of connectivity between filaments. 

      b) Similarly, very specific values of myosin backbone length (42 nm), number of myosin heads (8), number of arms (24), and Actin Cross-linking Proteins (ACPs). What informs these values and how will the results change if they are different? It is not especially clear how an "Arm" differs from "heads" and what kind of coarse-graining is involved.

      In the “model overview” section of the original manuscript, we mentioned the following to clarify the definitions of motor arms and motor heads: 

      “To mimic the structure of bipolar filaments, each motor has a backbone, consisting of serially linked segments, and two arms on each endpoint of the backbone segments that represent 8 myosin heads (N<sub>h</sub> = 8).”

      We devised this coarse-graining scheme of myosin thick filaments in our previous work (T. Kim, Biomech Model Mechanobiol, 2015, 14(5): 1143-1155). Through extensive tests, we showed that force generation and motor behaviors are largely independent of coarse-graining level. In other words, a motor with the same value of N<sub>h</sub>N<sub>a</sub> leads to similar outcomes regardless of the value of N<sub>a</sub>. However, in a bundle with multiple filaments, each motor has a sufficient number of arms to ensure simultaneous interactions with those filaments. This is why we decided to useN<sub>h</sub> = 8 and N<sub>a</sub> = 24. 

      To match the length of thick filaments and the total number of heads (N<sub>h</sub>N<sub>a</sub>) in the model with real myosin thick filaments, we have used 42 nm for each backbone length. Varying this length is equivalent to a variation in L<sub>sp</sub> that we did for Fig. 6.

      We used high ACP density to ensure connections between all neighboring pairs of actin filaments. We already showed how the presence of ACPs affects the force generation process in Fig. 2 using two actin filaments. It is expected that a variation of ACP density would affect our results to some extent. Since the main focus of the current study is the structural properties of motors, we did not explore the effects of ACP density. I hope that the reviewer would understand our intention. 

      (6) The manuscript focuses on disordered bundles with only one figure on networks. However, actin fibers also ubiquitously exist as disordered networks, and it is important to explore in more detail the contractile forces in such network arrangements.

      We appreciate the comment. Because we plan to delve into the effects of motor structures on the force generation in networks as a follow-up study, we showed the minimal results in the current study to prove the generality of our findings. I hope that the reviewer would understand our intention and plan.

      It is not described very clearly how these networks were generated.

      We apologize for lack of explanation about how the networks were generated. We added the following section in Supplementary Text of the revised manuscript:

      “Network assembly

      Unlike F-actin in bundle simulations, F-actin in network simulations is formed by stochastic processes as in our previous studies. The formation of F-actin is initiated from a nucleation event with a constant rate constant, k<sub>n,A</sub>, with the appearance of one cylindrical segment in a random position with a random orientation perpendicular to the z direction. The polymerization of F-actin is simulated by adding cylindrical segments at the barbed end of existing filaments with a rate constant, k<sub>p,A</sub>. The ratio of k<sub>n,A</sub>to k<sub>p,A</sub> is adjusted to result in the average filament length of ~10 μm. The rest of the assembly process is identical to that described in the main text.”

      Crosslinked biopolymers like actin typically form disordered elastic networks with their coordination number below rigidity percolation threshold (z=4 in 2D), see for example review by Broedersz and Mackintosh Rev. Mod, Phys. 2013. Such networks should exist in the bendingdominated regime, where bending forces play a vital role in force propagation. Was that observed in the simulations? Why or why not?

      We appreciate the comment. We are aware of the bending-dominated regime and indeed showed the importance of the bending stiffness of actin filaments at low shear strain level in our previous work (T. Kim et al., PLOS Comput Biol, 2009, 5(7): e1000439). In case of active networks with motors, such a bending-dominated regime has not been observed without external shear strain. Instead, buckling of actin filaments was found to be essential for breaking symmetry between tensile and compressive forces developed by motor activities. We have shown that the free contraction of networks is inhibited if filament bending stiffness is increased substantially (J. Li et al., Soft Matter, 2017, 13: 3213-3220 and T. Bidone et al., PLOS Comput Biol, 2017, 13(1): e1005277). We expect that contractile forces generated by bundles or networks will be reduced significantly if we highly increase bending stiffness. However, considering the focus of the current study is on the structural properties of motors, we did not perform such simulations. 

      (7) It would be interesting to see the simulated predictions of the bundle or network contraction dynamics. This can be done by changing to free boundary conditions so that the bundle can contract.

      Thank you for the suggestion. We have previously investigated the free contraction of actomyosin networks with different motor density and ACP density (J Li et al., Soft Matter, 2017, 13: 3213). We observed that the rate of network contraction was higher with more motors and ACPs. However, we did not test the effects of the structural properties of thick filaments in the previous study. We plan to investigate the effects in future studies because the focus of the current study is the force generation process. Please note that in the discussion section of the original manuscript, we mentioned the following:

      “Although we focused on force generation, the contractile behaviors of actomyosin structures (i.e., a decrease in length) have also been of great interest. Our model can be used to study such contractile behaviors by deactivating the periodic boundary condition and removing connection between one end of bundle/network and a domain boundary as done previously [20]. To achieve higher contractile speed with the same total number of myosin heads, the existence of multiple contractile units would be better as suggested in a previous work [4]. This means that there is a trade-off between force generation and contractile speed. Previous studies also showed that the contractile speed of networks is proportional to motor density [18, 43, 51]. We may be able to use our model to systematically investigate how the contractile speed is regulated by parameters that we tested in this study, including the number, distribution, length, and structure of motors.”

      Minor suggestions for improvement:

      (1) What are the vertical markers in Figures 1E and F? They should be labelled. if they are crosslinkers, it is not clear why the color is different from Figure 1A and B.

      We believe that the reviewer meant Figs. 2E, F. Those vertical lines are indeed ACPs (crosslinkers). We changed the color of ACPs in Fig. 1A and Fig. 2B-D to purple to be consistent. In addition, we changed the colors of two filaments in Figs. 2B-D slightly to be consistent with Fig. 2E.

      (2) To help understanding, please include a figure showing how forces are measured.

      We added Fig. S1 in the revised manuscript to explain how the bundle force is calculated.

      (3) It should be possible to extend the scaling arguments to predict what is the crossover myosin density (N_M) in Figure 4a at which the efficiency changes from going as 1/N_M to saturating. 

      As the reviewer might have observed, the slope of the efficiency in Fig. 4A gradually changes, rather than showing a sharp transition. Thus, it is hard to define one crossover myosin density. 

      Similarly, what are the slopes in Figure 6a-b?

      We drew the reference lines in those two plots. Unfortunately, we do not have explanations about the origin of these slopes.

      (4) Some more explanation for the observed values should be added. Figure 4: Why does efficiency plateau at a value close to 0.8 in (A)? 

      We assume that the reviewer meant the plateau of η close to 0.08, not 0.8. Our speculation for the origin of this plateau value is related to L<sub>M</sub> (= 462 nm under the reference condition). Ideally, ~43 motors are required to cover the entire length of the bundle (= 20 μm). Under this condition, η is ~0.023. Although this is not 0.08, we believe that these two values are related to each other. For example, if we increase L<sub>M</sub>, this plateau level would increase. We added the following sentences in the result section of the revised manuscript:

      “The plateau level of η at ~0.08 is related to the minimum number of motors required for saturating an entire bundle, implying that the plateau level would be higher if each motor is longer.”

      Figure 5: Overlapping between motors seems to increase the total force applied by them because of cooperative effects. However, it is not abundantly clear why that should peak at a value of f = 0.06.

      As shown in Fig. 5B, smaller f always results in higher F<sub>tot</sub> due to higher level of cooperative overlap. The minimum value of f we tested in this study was 0.06, so F<sub>tot</sub> was maximal at f = 0.06.

      (5) Why is the network force expected to scale approximately as sqrt(N_M)? Is it because of the 2D geometry where the number of motors along the x or y-direction scale as sqrt(N_M)?

      We initially thought that the weaker dependence of the total force on N<sub>M</sub> was related to the random orientations of motors. However, if the network is fully saturated with motors, the inclusion of more motors will increase forces in both x and y directions almost linearly, resulting in the direct proportionality of F<sub>tot</sub> to N<sub>M</sub>. Our new hypothesis for weaker dependence is consistent with the reviewer’s speculation; the network is not fully saturated even with 1000 motors, so the entire regime shown in Fig. 7B corresponds to that with N<sub>M</sub> < 100 in Fig. 4A where similar weaker dependence on N<sub>M</sub> was observed. We added the following sentence in the result section of the revised manuscript to clarify this point:

      “the average number of motors in each direction which can experience the cooperative overlap would be ~. Maximal N<sub>M</sub> tested with the network was ~2,500, so the dependence of F<sub>tot</sub> on N<sub>M</sub> with the network is similar to that with N<sub>M</sub> < ~50 with the bundle (Fig. 4A).”

      (6) Figures 6 D and A: Figure 6D suggests that there is a more full overlap in the cases where there was a longer bare zone or larger spacing between motor arms. However, the quantification of the total force in A shows that the force is highest for the case where LM was increased by increasing the number of arms. Why do the authors think that is? I would expect from the explanation in Fig 6D that the Lsp and Lbz would be higher than Na in Fig 6A.

      Fig. 6D shows a difference in the level of the cooperative overlap () between two motors. As the reviewer pointed out, the case with more arms shows the lowest , resulting in the lowest as we showed in Fig. S2B. However, as show in in Eq. 7, the total force is a function of both N<sub>a</sub> and . Thus, due to higher N<sub>a</sub> and lower , the force in the case with different N<sub>a</sub> can be similar to that in the case with different L<sub>bz</sub>. In the original manuscript, we had the following sentence to explain how the force can be similar between the two cases: 

      “Thus, was higher (Fig. S2B, blue), resulting in higher F<sub>tot</sub> and η despite smaller N<sub>a</sub>.”

      Reviewer #2 (Public review):

      Summary:

      In this study, the authors use a mechanical model to investigate how the geometry and deformations of myosin II filaments influence their force generation. They introduce a force generation efficiency that is defined as the ratio of the total generated force and the maximal force that the motors can generate. By changing the architecture of the myosin II filaments, they study the force generation efficiency in different systems: two filaments, a disorganized bundle, and a 2D network. In the simple two-filament systems, they found that in the presence of actin crosslinking proteins motors cannot add up their force because of steric hindrances. In the disorganized bundle, the authors identified a critical overlap of motors for cooperative force generation. This overlap is also influenced by the arrangement of the motor on the filaments and influenced by the length of the bare zone between the motor heads.

      Strengths:

      The strength of the study is the identification of organizational principles in myosin II filaments that influence force generation. It provides a complementary mechanistic perspective on the operation of these motor filaments. The force generation efficiency and the cooperative overlap number are quantitative ways to characterize the force generation of molecular motors in clusters and between filaments. These quantities and their conceptual implications are most likely also applicable in other systems.

      Thank you for the comments about the strength of our study. 

      Weaknesses:

      The detailed model that the authors present relies on over 20 numerical parameters that are listed in the supplement. Because of this vast amount of parameters, it is not clear how general the findings are. On the other hand, it was not obvious how specific the model is to myosin II, meaning how well it can describe experimental findings or make measurable predictions. The model seems to be quantitative, but the interpretation and connection to real experiments are rather qualitative in my point of view.

      As the reviewer mentioned, all agent-based computational models for simulating the actin cytoskeleton are inevitably involved with such a large number of parameters. Some of the parameter values are not known well, so we have tuned our parameter values carefully by comparing our results with experimental observations in our previous studies since 2009.We were aware of the importance of rigorous representation of unbinding and walking rates of myosin motors, so we implemented the parallel cluster model, which can predict those rates with consideration of the mechanochemical rates of myosin II, into our model. Thus, we are convincing that our motors represent myosin II.

      In our manuscript, our results were compared with prior observations in Ref. 4 (Thoresen et al., Biophys J, 2013) several times. In particular, larger force generation with more myosin heads per thick filament was consistent between the experiment and our simulations. 

      Our study can make various predictions. First, our study explains why non-muscle myosin II in stress fibers shows focal distributions rather than uniform distributions; if they stay closely, they can generate much larger forces in the stress fibers via the cooperative overlap. Our study also predicts a difference between bipolar structures (found in skeletal muscle myosins and nonmuscle myosins) and side polar structures (found in smooth muscle myosins) in terms of the likelihood of the cooperative overlap. As shown below, myosin filaments with the bipolar structure can add up their forces better than those with the side polar structure when their overlap level is the same.

      Author response image 1.

       

      It was often difficult for me to follow what parameters were changed and what parameters were set to what numerical values when inspecting the curve shown in the figures. The manuscript could be more specific by explicitly giving numbers. For example, in the caption for Figure 6, instead of saying "is varied by changing the number of motor arms, the bare zone length, the spacing between motor arms", the authors could be more specific and give the ranges: "is varied by changing the number of motor arms form ... to .., the bare zone length from .. to..., and the spacing between motor arms from .. to ..".

      This unspecificity is also reflected in the text: "We ran simulations with a variation in either L<sub>sp</sub> or L<sub>bz</sub>" What is the range of this variation? "WhenL<sub>M</sub> was similar" similar to what? "despite different N<sub>M</sub>." What are the different values for N<sub>M</sub>? These are only a few examples that show that the text could be way more specific and quantitative instead of qualitative descriptions.

      We appreciate the comment. In the revised manuscript, we specified the range of the variation in each parameter.

      In the text, after equation (2) the authors discuss assumptions about the binding of the motor to the actin filament. I think these model-related assumptions and explanations should be discussed not in the results section but rather in the "model overview" section.

      Thank you for pointing this out. In the original manuscript, we described all the details of the model in Supplementary Material. We feel that the assumptions about interactions between motors and actin filaments are too detailed information to be included in the model overview section.

      The lines with different colors in Figure 2A are not explained. What systems and parameters do they represent?

      The different colors used in Fig. 2A were used for distinguishing 20 cases. We added the explanation about the colors in the figure caption in the revised manuscript.

      Reviewer #2 (Recommendations for the authors):

      To guarantee the reproducibility of the results, I recommend that the authors publish their simulation code on GitHub.

      We appreciate the reviewer’s suggestion. Following the suggestion, we prepared and posted the code on GitHub as mentioned in the Data Availability of the revised manuscript: The source code of our model is available on GitHub: https://github.com/ktyman2/ThickFilament”

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer 1 (Public review):

      Weaknesses: The interpretation is somewhat model-dependent, and it is unclear if the interpretation is unique. For example, it is unclear if the heterogeneous release probability among sites, silent sites, can explain the results. N estimates out of variance-mean analysis for example may be limited by the availability of postsynaptic receptors.

      To address this criticism, we have added a paragraph in the Discussion outlining the main assumptions underlying our work and how possible deviations from these assumptions may have affected our conclusions. This new paragraph is titled ' Assumptions behind our analysis, and possible limitations of our conclusions'.

      Reviewer 1, Recommendations to Authors:

      Without molecular evidence or anatomical evidence, the model and conclusions may remain as a postulate at this stage. This can be discussed carefully. Also, the study looks a bit narrow regarding the scope, only dealing with RS-DS model vs TS-LS model. Maybe, the authors pick up a bit more qualitative findings that directly support RS-DS model.

      To address these issues, another paragraph has been added to the Discussion titled 'Functional evidence in favor of the RS/DS model at PF-MLI synapses, and remaining uncertainties on the molecular composition and morphological arrangement of docking sites'.

      Minor: Fukaya et al. studied not cerebellar mossy fiber synapses.

      We apologize for this error, which has now been rectified.

      Reviewer 2 (Public review):

      It remains unclear how generalizable the findings are to other types of synapses.

      We agree with the Reviewer: this is a limitation of our study. In the Discussion we have a paragraph titled 'Maximum RRP size for other synaptic types' where we discuss this point. As we say in this paragraph, central synapses are clearly diverse, and the level of applicability of our results across preparations will depend on our ability to extend SV counting to various types of brain synapses. For the moment SV counting has been applied to only two types of synapses: PF-MLI synapses and hMF-IN synapses. We are encouraged by the fact that the simple synapse study by Tanaka et al. (2021), carried out at hMF-IN synapses, offers another example where the ratio between RRP size and N is larger than 1.

      Recommendations to Authors,

      Minor comments:

      The manuscript is at times difficult to read or reads like a review. The introduction could be shortened to concisely outline the motivation and premises for the study. The results and methods sections should not contain excessive interpretation and discussion. Although very informative, it distracts from the simple principal message.

      To address these criticisms, we have shortened the Introduction and parts of the Results section. These changes have resulted in a presentation of Results that is shorter and more focused on data and simulations than in the previous version. Nevertheless, readers need to be informed of ongoing research on docking sites and the principles of sequential models to understand the usefulness of our work. For this reason, we have maintained a theoretical section at the beginning of Results.

      The rationale for the choice of synapse and experimental conditions remains unclear until the discussion. This needs to be clearly addressed at the beginning, in the introduction, or in the results. In particular, the extracellular calcium concentration and the addition of 4-AP to the recording solution should be addressed in the results.

      The reason to choose the PF-MLI synapse is now indicated at the end of the Introduction. The rationale underlying our choice of experimental conditions including the extracellular calcium concentration and the addition of 4-AP is now briefly explained in the beginning the second section of Results (titled 'Maximizing RRP size and its release during AP trains'), and more extensively in the Methods section (as in the previous version of the manuscript).

      Potential confounds of the approach should be discussed (e.g. could a broadened AP in 4-AP alter synchronicity of release, i.e. desynchronization of release, especially during trains. That could be complemented with information on the EPSC kinetics (rise, decay) under different experimental conditions, as well as during train stimulation. How could presynaptic calcium concentration and time course in 4-AP impact the conclusions?

      To study the effects of 4-AP on AP broadening we have performed a new analysis of EPSC latencies in control and in 4-AP. In both cases the first latencies were independent of i. In 4-AP, first latencies displayed a small right shift of 0.2 ms (see additional figure below). This indicates that 4-AP does broaden the AP waveform, but that the extent of this broadening is limited. This new information has been added in the Methods of the revised manuscript.

      As suspected by the Reviewer, the latency distribution changes as a function of i and in the presence of 4-AP. Consistent with earlier findings (Miki et al., 2018), the proportion of 2-step release (with longer latencies) augments as a function of i both in control and in 4-AP. We also find that the value of the fast time constant of the latency distribution,τf, is larger in 4-AP than in control. This last result probably indicates a longer presynaptic calcium entry in 4-AP.

      In the revised version, we describe these results in the Methods section, in a new paragraph titled 'Changes in latency distributions as a function of i and of experimental conditions'.

      While the latency distributions change as a function of i and as a function of experimental conditions, this does not affect our conclusions, because these conclusions are based on the summed number of release events after each AP (or in other words, on the integral of the latency distributions).

      The kinetics of mEPSCs (risetime and decay time) are unchanged by 4-AP or by PTP. Consequently, in a given experiment, we used the same template to perform our deconvolution analysis for all conditions that were examined (starting with 3 mM Cao up to 200 Hz). This information has now been added in Methods.

      Following an AP stimulation, the amount of calcium entry in the presence of 4-AP is presumably much larger than in control. TEA, a weaker K channel blocker than 4-AP at PF-MLI synapses, elicits a marked increase in calcium entry (Malagon et al., 2020). This suggests an even larger increase with 4-AP, even though this has not been directly confirmed in the present work. The enhanced calcium entry translates in an increase in the parameters pr, r and s of our model. The important thing for our study is to increase pr and r as much as possible to promote the emptying of the RRP during trains. Knowing the exact amount of calcium entry and its relation to pr /r increase is not essential for this purpose. Likewise, whether r (and/or s) increase as a function of i is of little practical importance since much of the RRP is emptied already after the second stimulation, at least in the most extreme case (200 Hz stimulation).

      The applicability of this model to other synapses needs to be addressed more thoroughly. This synapse, under physiological conditions, has a very low Pr, and the experimental conditions have to be adjusted dramatically to achieve a high-Pr. How applicable are the conclusions to high-Pr synapses and/or synapses that operate in a multivesicular release regime? Although that might be difficult to test experimentally it should be addressed in the discussion.

      The applicability issue to other synapses has been addressed above, in response to the public comments of the same Reviewer.

      As the Reviewer points out, the PF-MLI synapse has a small P value under physiological conditions. One can speculate that synapses that exhibit a higher P value may have a higher docking site occupancy than PF-MLI synapses. This feature would increase their chance of having a ratio of RRP size over N larger than 1, as it occurs in PF-MLI synapses in high docking occupancy conditions. A sentence making this point has been added to the paragraph titled 'Maximum RRP size for other synaptic types' in the revised manuscript.

      Author response image 1.

      Latency histograms for s1 in control and in the presence of 4-AP. After normalization, the averaged latency histogram in 4-AP displays an additional delay of 0.2 ms, and a slowing of the time constant τf from 0.47 ms to 0.70 ms.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Su et al propose the existence of two mechanisms repressing SBF activity during entry into meiosis in budding yeast. First, a decrease in Swi4 protein levels by a LUTI-dependent mechanism where Ime1 would act closing a negative feedback loop. Second, the sustained presence of Whi5 would contribute to maintaining SBF inhibited under sporulation conditions. The article is clearly written and the experimental approaches used are adequate to the aims of this work. The results obtained are in line with the conclusions reached by the authors but, in my view, they could also be explained by the existing literature and, hence, would not represent a major advance in the field of meiosis regulation.

      We respectfully disagree with the reviewer about their comment that this work can be explained by the existing literature. First, while SWI4LUTI has been previously identified in meiotic cells along with ~ 380 LUTIs, the biological purpose of these alternative mRNA isoforms and their effect on cellular physiology still remain largely unknown. Our manuscript clarifies this gap in understanding for SWI4LUTI. Loss of SWI4LUTI contributes to dysregulation of meiotic entry and does so by failing to properly repress the known inhibitors of meiotic entry, the CLNs. Furthermore, even though Cln1 and Cln2 have been previously shown to antagonize meiosis, the mechanisms that restrict their activity was unclear prior to our study.

      We recognize work done by others demonstrating Whi5-dependent repression of SBF during mitotic G1/S transition (De Bruin et al., 2004; Costanzo et al., 2004). We further examined Whi5’s involvement during meiotic entry and found that it acts in conjunction with the LUTI-based mechanism to restrict SBF activity. Combined loss of both mechanisms results in the increased expression of G1 cyclins, decreased expression of early meiotic genes, and a delay in meiotic entry (Figure 6). Neither mechanism was previously known to regulate meiotic entry. Our study not only adds to our broader understanding of gene regulation during meiosis but also raises additional questions regarding how LUTIs regulate gene expression and function.

      Regarding the first mechanism, Fig 1 shows that Swi4 decreases very little after 1-2h in sporulation medium, whereas G1-cyclin expression is strongly repressed very rapidly under these conditions (panel D and work by others). This fact dampens the functional relevance of Swi4 downregulation as a causal agent of G1 cyclin repression.

      Reviewer 1 expresses concern for the observation that by 2 h in sporulation media there is a 32% decrease in Swi4-3V5 protein abundance compared to 0 h in SPO. This is consistent with the range of protein level decrease typically accomplished by LUTI-based gene regulation (Chen et al., 2017; Chia et al., 2017; Tresenrider et al., 2021), and while it is a modest reduction, it is consistent across replicates. Furthermore, we don’t make the argument that reduction in Swi4 levels alone is the sole regulator of G1 cyclin levels. In fact, we report that in addition to Swi4 downregulation, Whi5 also functions to restrict SBF activity during meiotic entry, thereby ensuring G1 cyclin repression.

      In addition, the LUTI-deficient SWI4 mutant does not cause any noticeable relief in CLN2 repression, arguing against the relevance of this mechanism in the repression of G1-cyclin transcription during entry into meiosis. The authors propose a second mechanism where Whi5 would maintain SBF inactive under sporulation conditions. The role of Whi5 as a negative regulator of the SBF regulon is well known. On the other hand, the double WHI5-AA SWI4-dLUTI mutant does not upregulate CLN2, the G1 cyclin with the strongest negative effect on sporulation, raising serious doubts on the functional relevance of this backup mechanism during entry into meiosis.

      Due to replicate variance, CLN2 did not make the cut by our mRNA-seq data analysis as a significant hit. To address reviewer 1’s final point we opted for the “gold standard” of reverse transcription coupled with qPCR to measure CLN2 transcript levels in the double mutant ∆LUTI; WHI5-AA and the wild-type control. This revealed that CLN2 levels were significantly increased in the double mutant compared to wild type at 2 h in SPO (Author Response Image 1, *, p = 0.0288, two-tailed t-test).

      Author response image 1.

      Wild type (UB22199) and ∆LUTI;WHI5-AA (UB25428) cells were collected to perform RT-qPCR for CLN2 transcript abundance. Transcript abundance was quantified using primer sets specific for each respective gene from three technical replicates for each biological replicate. Quantification was performed in reference to PFY1 and then normalized to wild-type control. FC = fold change. Experiments were performed twice using biological replicates, mean value plotted with range. Differences in wild type versus ∆LUTI; WHI5-AA transcript levels compared with a two-tailed t-test (*, p = 0.0288)

      Reviewer #2 (Public Review):

      Summary:

      The manuscript highlights a mechanistic insight into meiotic initiation in budding yeast. In this study, the authors addressed a genetic link between mitotic cell cycle regulator SBF (the Swi4-Swi6 complex) and a meiosis inducing regulator Ime1 in the context of meiotic initiation. The authors' comprehensive analyses with cytology, imaging, RNA-seq using mutant strains lead the authors to conclude that Swi4 levels regulates Ime1-Ume6 interaction to activate expression of early meiosis genes for meiotic initiation. The major findings in this paper are that (1) the higher level of Swi4, a subunit of SBF transcription factor for mitotic cell cycle regulation, is the limiting factor for mitosis-to-meiosis transition; (2) G1 cyclins (Cln1, Cln2), that are expressed under SBF, inhibit Ime1-Ume6 interaction under overexpression of SWI4, which consequently leads to downregulation of early meiosis genes; (3) expression of SWI4 is regulated by LUTI-based transcription in the SWI4 locus that impedes expression of canonical SWI4 transcripts; (4) expression of SWI4 LUTI is likely negatively regulated by Ime1; (5) Action of Swi4 is negatively regulated by Whi5 (homologous to Rb)-mediated inhibition of SBF, which is required for meiotic initiation. Thus, the authors proposed that meiotic initiation is regulated under the balance of mitotic cell cycle regulator SBF and meiosis-specific transcription factor Ime1.

      Strengths:

      The most significant implication in their paper is that meiotic initiation is regulated under the balance of mitotic cell cycle regulator and meiosis-specific transcription factor. This finding will provide a mechanistic insight in initiation of meiosis not only into the budding yeast also into mammals. The manuscript is overall well written, logically presented and raises several insights into meiotic initiation in budding yeast. Therefore, the manuscript should be open for the field. I would like to raise the following concerns, though they are not mandatory to address. However, it would strengthen their claims if the authors could technically address and revise the manuscript by putting more comprehensive discussion.

      Weaknesses:

      The authors showed that increased expression of the SBF targets, and reciprocal decrease in expression of meiotic genes upon SWI4 overexpression at 2 h in SPO (Figure 2F). However, IME1 was not found as a DEG in Supplemental Table 1. Meanwhile, IME1 transcript level was decreased at 2 h SPO condition in pATG8-CLN2 cells in Fig S4C.

      Now this reviewer still wonders with confusion whether expression of IME1 transcripts per se is directly or in directly suppressed under SBF-activated gene expression program at 2 h SPO in pATG8-SWI4 and pATG8-CLN2 cells. This reviewer wonders how Fig S4C data reconciles with the model summarized in Fig 6F.

      One interpretation could be that persistent overexpression of G1 cyclin caused active mitotic cell cycle, and consequently delayed exit from mitotic cell cycle, which may have given rise to an apparent reduction of cell population that was expressing IME1. For readers to better understand, it would be better to explain comprehensively this issue in the main text.

      We believe there was an oversight here. In supplemental table 1, IME1 expression is reported as significantly decreased. The volcano plot shown below also highlights this change (Author response image 2).

      Author response image 2.

      Volcano plot of DE-Seq2 analysis for ∆LUTI;WHI5-AA versus wild type. Dashed line indicates padj (p value) = 0.05. Analysis was performed using mRNA-seq from two biological replicates. Wild type (UB22199) and ∆LUTI;WHI5-AA (UB25428) cells were collected at 2 h in SPO. SBF targets (pink) (Iyer et al., 2001) and early meiotic genes (blue) defined by (Brar et al., 2012). Darker pink or darker blue, labeled dots are well studied targets in either gene set list.

      The % of cells with nuclear Ime1 was much reduced in pATG8-CLN2 cells (Fig 2B) than in pATG8-SWI4 cells (Fig 4C). Is the Ime1 protein level comparable or different between pATG8-CLN2 strain and pATG8-SWI4 strain? Since it is difficult to compare the quantifications of Ime1 levels in Fig S1D and Fig S4B, it would be better to comparably show the Ime1 protein levels in pATG8-CLN2 and pATG8-SWI4 strains.

      Further, it is uncertain how pATG8-CLN2 cells mimics the phenotype of pATG8-SWI4 cells in terms of meiotic entry. It would be nice if the authors could show RNA-seq of pATG8-CLN2/WT and/or quantification of the % of cells that enter meiosis in pATG8-CLN2.

      Analyzing bulk Ime1 protein levels across a population of cells (Author response image 3) reveals that overexpression of CLN2 causes a more severe decrease in Ime1 levels than overexpression of SWI4. This is consistent with our observation that pATG8-CLN2 has a more severe impact on meiotic entry than pATG8-SWI4. The higher CLN2 levels (Author response image 4) likely accounts for the observed difference in severity of phenotype between the two mutants.

      Author response image 3.

      Samples from strain wild type (UB22199), pATG8-SWI4 (UB2226), pATG8-CLN2 (UB25959) and were collected between 0-4 hours (h) in sporulation medium (SPO) and immunoblots were performed using α-GFP. Hxk2 was used a loading control.

      Author response image 4.

      Wild type (UB22199), pATG8-SWI4 (UB2226), pATG8-CLN2 (UB25959) cells were collected to perform RT-qPCR for CLN2 transcript abundance. Quantification was performed in reference to PFY1 and then normalized to wild-type control. FC = fold change.

      The authors stated that reduced Ime1-Ume6 interaction is a primary cause of meiotic entry defect by CLN2 overexpression (Line 320-322, Fig 4J-L). This data is convincing. However, the authors also showed that GFP-Ime1 protein level was decreased compared to WT in pATG8-CLN2 cells by WB (Fig S4A).

      Compared to wild type, pATG8-CLN2 cells have lower levels of Ime1. Consequently, reviewer 2 suggests that this reduction may be responsible for the observed meiotic defect. However, we tested this possibility and found it not to be the primary cause of the meiotic defect in pATG8-CLN2 cells. As shown in Figure S4A, when IME1 was overexpressed from the pCUP1 promoter, Ime1 protein levels were similar between wild-type and pATG8-CLN2 cells. Despite this similarity, we still observed a decrease in nuclear Ime1 (Figure 4F) and no rescue in sporulation (Figure 4A). Therefore, the reduction in Ime1 protein levels alone cannot explain the meiotic defect caused by CLN2 overexpression.

      Further, GFP-Ime1 signals were overall undetectable through nuclei and cytosol in pATG8-CLN2 cells (Fig 4B), and accordingly cells with nuclear Ime1 were reduced (Fig 4C). Although the authors raised a possibility that the meiotic entry defect in the pATG8-CLN2 mutant arises from downregulation of IME1 expression (Line 282-283), causal relationship between meiotic entry defect and CLN2 overexpression is still not clear.

      As reviewer 2 comments, we initially considered the possibility that meiotic entry defect induced by CLN2 overexpression could be attributed to decreased IME1 expression. However, in the following paragraph in the manuscript, we demonstrate equalizing IME1 transcript levels using the pCUP1-IME1 allele does not rescue the meiotic defect caused by CLN2 overexpression. Consequently, we conclude that the decrease in IME1 transcript levels alone cannot explain the meiotic defect caused by increased CLN2 levels.

      Is the Ime1 protein level reduced in the pATG8-CLN2;UME6-⍺GFP strain compared to WT? It would be better to comparably show the Ime1 protein levels in the pATG8-CLN2 strain and the pATG8-CLN2;UME6-⍺GFP strain by WB. Also, it would be nice if the authors could show quantification of the % of cells that enter meiosis in the pATG8-CLN2;UME6-⍺GFP strain to see how and whether artificial tethering of Ime1 to Ume6 rescued normal meiosis program rather than simply showing % sporulation in Fig4A.

      We do not agree with the suggestion to compare the pATG8-CLN2;UME6-⍺GFP with wild type as the kinetics of meiosis is rather different. The more appropriate comparison is UME6-⍺GFP and pATG8-CLN2;UME6-⍺GFP which shows GFP-Ime1 bulk protein levels are slightly lower (Author response image 5). However, when we use a more sensitive measurement of meiotic entry through the nuclear accumulation of Ime1 in single cells, as illustrated in Figure 4L, it becomes evident that the Ume6-Ime1 tether is capable of restoring nuclear Ime1 levels, even in the presence of CLN2 overexpression. Given that these cells exhibited wild type levels of nuclear Ime1 and underwent sporulation after 24 hours, we make the fair assumption that they have successfully initiated the meiotic program.

      Author response image 5.

      Wild type (UB22199), pATG8-SWI4 (UB35106), UME6-⍺GFP (UB35300), and UME6-⍺GFP; pATG8-CLN2 (UB35177) cells collected between 0-3 hours (h) in sporulation medium (SPO) and immunoblots were performed using α-GFP. Hxk2 was used a loading control

      The authors showed Ume6 binding at the SWI4LUTI promoter (Figure 5K). However, since Ume6 forms a repressive form with Rpd3 and Sin3a and binds to target genes independently of Ime1, Ume6 binding at the SWI4LUTI promoter bind does not necessarily represent Ime1-Ume6 binding there. Instead, it would be better to show Ime1 ChIP-seq at the SWI4LUTI promoter.

      We agree with reviewer 2 that Ime1 ChIP would be the ideal measurement. Unfortunately, this has proved to be technically challenging. To address this limitation, we utilized a published Ume6 ChIP-seq dataset along with a published UME6-T99N RNA-seq dataset. Cells carrying the UME6-T99N allele are unable to induce the expression of early meiotic transcripts due to lack of Ime1 binding to Ume6 (Bowdish et al., 1995). Accordingly, RNA-seq analysis should reveal whether or not the LUTIs identified by Ume6 ChIP are indeed regulated by Ime1-Ume6 during meiosis. For SWI4LUTI, this is exactly what we observe. Not only is there Ume6 binding at the SWI4LUTI promoter (Figure 5K), but there is also a significant decrease in SWI4LUTI expression in UME6-T99N cells under meiotic conditions (Figure S5). Based on these data, we conclude that the Ime1-Ume6 complex is responsible for regulating SWI4LUTI expression during meiosis.

      The authors showed ∆LUTI mutant and WHI5-AA mutant did not significantly change the expression of SBF targets nor early meiotic genes relative to wildtype (Figure 6A, C). Accordingly, they concluded that LUTI- or Whi5-based repression of SBF alone was not sufficient to cause a delay in meiotic entry (Line451-452), and perturbation of both pathways led to a significant delay in meiotic entry (Figure 6E). This reviewer wonders whether Ime1 expression level and nuclear localization of Ime1 was normal in ∆LUTI mutant and WHI5-AA mutant.

      Based on our observations in Figure 4, Ime1 protein and expression levels were not reliable indicators of meiotic entry. Consequently, we opted for a more downstream and functionally relevant measure of meiotic entry, which involved time-lapse fluorescence imaging of Rec8, an Ime1 target.

      Reviewer #1 (Recommendations For The Authors):

      The authors would like to mention previous work showing that G1-cyclin overexpression decreases the expression and nuclear accumulation of Ime1 (Colomina et al 1999 EMBO J 18:320). In this work, the interaction between Ime1 and Ume6 had been found to be resistant to G1-cyclin expression, arguing against a direct effect on the recruitment of Ime1 at meiotic promoters. Alternatively, differences in the experimental approaches used could be discussed to explain this apparent discrepancy.

      To clarify, in the paper that reviewer 1 is referring to (Colomina et al., 1999), the authors determine that the interaction between Ime1 and Ume6 is regulated by the presence of a non-fermentable carbon source. Additional work by others reveals that Ime1 undergoes phosphorylation by the protein kinases Rim11 and Rim15, promoting its nuclear localization and enabling interaction with Ume6 (Vidan and Mitchell, 1997; Pnueli et al., 2004; Malathi et al., 1999, 1997). Furthermore, both Rim11 and Rim15 kinase activities are inhibited by the presence of glucose via the PKA pathway (Pedruzzi et al., 2003; Rubin-Bejerano et al., 2004; Vidan and Mitchell, 1997). Accordingly, the elimination of cyclins in the presence of a non-fermentable carbon source (glucose) in (Colomina et al., 1999) is unlikely to result in an interaction between Ime1 and Ume6, as Rim11 and Rim15 remain repressed. Removal of cyclins in acetate does not further increase Ime1-Ume6 interaction leading the authors to conclude that G1 cyclins do not block Ime1 function through its interaction with Ume6. This work however uses loss of function (removal of G1 cyclins) to study the G1 cyclins’ effect on Ime1-Ume6 interaction while using timepoints that are well beyond meiotic entry. Additionally, Ime1-Ume6 interaction is being tested using yeast-two hybrid analysis with just the proposed interaction domain of Ime1 (amino acids 270-360). Therefore, the interpretation that G1 cyclins are dispensable for regulating the interaction between Ime1 and Ume6 is unclear from this work alone.

      There are many differences that can explain the discrepancy between our work and (Colomina et al., 1999). Our work uses increased expression of cyclins during meiotic entry. Additionally, in our study, we collected timepoints to measure meiotic entry (2 h in SPO) and sporulation (gamete formation) efficiency (24 h in SPO). Finally, we are using the endogenous, full length Ime1. These differences could very well explain the discrepancy with previous work. Lastly, in our discussion we acknowledge the lack of CDK consensus phosphorylation sites on Ime1. Therefore, it is most likely that G1 cyclins are not directly phosphorylating Ime1 and that other factors like Rim11 and Rim15 could be direct targets of the G1 cyclins, considering their involvement in the phosphorylation of Ime1-Ume6, as well as their role in regulating Ime1 localization and its interaction with Ume6. We have included these points in the revised manuscript (lines 547-551).

      Reviewer #2 (Recommendations For The Authors):

      This reviewer thinks that the findings in this paper are of general interest to meiosis field and help understanding the mechanism of meiotic initiation in mammals. The way of the current manuscript seems to be written for limited budding yeast scientists, and should not limited to the interest by the budding yeast scientists. Thus, it would be better to discuss more about what is known about the mechanism of initiation of meiosis not only in budding yeast but also in other species to share their finding to more broad scientists using other organisms.

      We appreciate reviewer 2’s comment and have added more discussion about the parallels between yeast and mammalian systems in meiotic initiation (lines 613-624).

      Reviewer #3 (Recommendations For The Authors):

      The effect of overexpression of Swi4 is tested for MI and MII (Fig1F): this is a very indirect readout of meiotic entry. The authors could present Rec8 localization (Fig2I) at this stage. However, this is still a superficial description of the meiotic phenotype: is the phenotype only a delay or is the meiotic prophase altered. It is specifically important to analyse this in more detail to answer whether the overexpression of Swi4 leads to an identical phenotype to the one of CLN2. Also the comparison between overexpression of Swi4 and Cln2 is difficult to evaluate: what is the level of CLN2 when SwI4 is overexpressed compared to CLN2 overexpression. The percentage of nuclear Ime1 is 50% vs 5% when Swi4 or Cln2 are overexpressed. What is the interpretation? What are the levels of Ime1? (Y axis of quantifications not comparable, see also comment for Fig5F,H)

      CLN2 is expressed at a much higher level in pATG8-CLN2 cells relative to pATG8-SWI4 (Author Response Image 4). Therefore, we don’t expect identical phenotypes, but rather a more severe deficiency in meiotic entry upon CLN2 overexpression. The key experiment that establishes causality between SWI4 and CLNs is reported in Figure 3, where deletion of either CLN1 or CLN2 rescues the meiotic entry delay exerted by SWI4 overexpression.

      Fig3EF: What is the phenotype of Cln1 and Cln2 without overexpression of Swi4?

      Meiotic entry is not faster in cln1∆ or cln2∆ cells compared to wild-type. We included these data in Supplemental Figure 3 and made the relevant changes in the manuscript (lines 257-261).

      Fig4F: Need a control with CLN2 overexpression only.

      A control with only CLN2 overexpression (pATG8-CLN2) is not appropriate since these meiotic time course experiments are synchronized using the pCUP1-IME1 allele. It would be a misleading comparison since the two meiosis would have different kinetics. Figure 4F reports that despite similar IME1 transcript levels and Ime1 protein levels, CLN2 overexpressing cells still have reduced nuclear Ime1. Since side-by-side comparison of pATG8-CLN2 and pCUP1-IME1 is not possible, we chose to measure sporulation efficiency at 24 h in Figure 4A. These data together suggest that elevated IME1 transcript and protein levels cannot rescue the defects associated with increased CLN2 expression.

      Fig5E: in wild type, by Northern blot, Swi4canon level is increasing during meiosis, not decreasing?, whereas protein level is decreasing, what is the interpretation?

      Northern data is less quantitative than smFISH, which show that SWI4canon transcript levels are significantly lower in meiosis compared to vegetative cells (Figure 5D). We also note that the Northern blot data were acquired from unsynchronized meiotic cells and could have additional limitations based on the population-based nature of the assay. Finally, additional analysis of a transcript leader sequencing (TL-seq) dataset from synchronized cells (Tresenrider et al., 2021) further confirms the decrease in SWI4canon transcript levels upon meiotic entry. (Author response image 6).

      Author response image 6.

      TL-seq data from (Tresenrider et al. 2021) visualized on IGV at the SWI4 locus. Two timepoints are plotted including premeiotic before IME1 induction (pink) and meiotic prophase or after IME1 induction (blue).

      Fig5F, H. This quantification needs duplicates for validation.

      Replicates are submitted for every blot in this paper to eLIFE.It can be found in the shared Dropbox folder to the editors (named Raw-blots-for-eLIFE).

      Fig5F, H. Why are the wild type values so different?

      The immunoblotting done between Figure 5F and Figure 5H are on separate blots and therefore should not be compared. Additionally, these values are not absolute measurements of wild type values of Swi4-3V5 and therefore we should not expect them to be the same. Any comparisons done of relative amounts of Swi4-3V5 are always done on the same blot and normalized to a loading control, hexokinase.

      FigS5: What is the effect of the Ume6-T99N on Swi4 protein level and on meiotic entry? Is the backup mechanism proposed active?

      We haven’t measured Swi4 protein levels in the UME6-T99N background but given that this mutation is known to disrupt the interaction between Ime1 and Ume6, we expect a similar trend to that reported in Figure 5I (pCUP1-IME1 uninduced).

      What is the evidence that Swi4/6 is a E2F homolog? What is the homology at the protein level?

      While there is no sequence homology between SBF and E2F there is remarkable similarity between metazoans and yeast in terms of the regulation of the G1/S transition (reviewed in Bertoli et al., 2013). E2F and SBF are both repressed before the G1/S transition by the inhibitors Rb and Whi5, respectfully (Costanzo et al., 2004; De Bruin et al., 2004; Hasan et al., 2014). During G1/S transition, a cyclin dependent kinase phosphorylates and inactivates these inhibitors. We have carefully edited our language in the manuscript to “functional homology” instead of just “homology”.

      FigS3 is missing

      Each supplemental figure was matched to its corresponding main figure. In the original submission, we didn’t have Figure S3. However, the revised manuscript now contains FigS3.

      Bertoli, C., J.M. Skotheim, and R.A.M. De Bruin. 2013. Control of cell cycle transcription during G1 and S phases. Nat. Rev. Mol. Cell Biol. 14:518–528. doi:10.1038/nrm3629.

      Bowdish, K.S., H.E. Yuan, and A.P. Mitchell. 1995. Positive control of yeast meiotic genes by the negative regulator UME6. Mol. Cell. Biol. 15:2955–2961. doi:10.1128/mcb.15.6.2955.

      Brar, G.A., M. Yassour, N. Friedman, A. Regev, N.T. Ingolia, and J.S. Weissman. 2012. High-Resolution View of the Yeast Meiotic Program Revealed by Ribosome Profiling. Science (80-. ). 335:552–558. doi:10.1126/science.1215110.

      De Bruin, R.A.M., W.H. McDonald, T.I. Kalashnikova, J. Yates, and C. Wittenberg. 2004. Cln3 activates G1-specific transcription via phosphorylation of the SBF bound repressor Whi5. Cell. 117:887–898. doi:10.1016/j.cell.2004.05.025.

      Chen, J., A. Tresenrider, M. Chia, D.T. McSwiggen, G. Spedale, V. Jorgensen, H. Liao, F.J. Van Werven, and E. Ünal. 2017. Kinetochore inactivation by expression of a repressive mRNA. Elife. 6:1–31. doi:10.7554/eLife.27417.

      Chia, M., A. Tresenrider, J. Chen, G. Spedale, V. Jorgensen, E. Ünal, and F.J. van Werven. 2017. Transcription of a 5’ extended mRNA isoform directs dynamic chromatin changes and interference of a downstream promoter. Elife. 6:1–23. doi:10.7554/eLife.27420.

      Colomina, N., E. Garí, C. Gallego, E. Herrero, and M. Aldea. 1999. G1cyclins block the Ime1 pathway to make mitosis and meiosis incompatible in budding yeast. EMBO J. 18:320–329. doi:10.1093/emboj/18.2.320.

      Costanzo, M., J.L. Nishikawa, X. Tang, J.S. Millman, O. Schub, K. Breitkreuz, D. Dewar, I. Rupes, B. Andrews, and M. Tyers. 2004. CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast. Cell. 117:899–913. doi:10.1016/j.cell.2004.05.024.

      Hasan, M., S. Brocca, E. Sacco, M. Spinelli, P. Elena, L. Matteo, A. Lilia, and M. Vanoni. 2014. A comparative study of Whi5 and retinoblastoma proteins : from sequence and structure analysis to intracellular networks. 4:1–24. doi:10.3389/fphys.2013.00315.

      Iyer, V.R., C.E. Horak, P.O. Brown, D. Botstein, V.R. Iyer, M. Snyder, and C.S. Scafe. 2001. Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature. 409:533–538. doi:10.1038/35054095.

      Malathi, K., Y. Xiao, and A.P. Mitchell. 1997. Interaction of yeast repressor-activator protein Ume6p with glycogen synthase kinase 3 homolog Rim11p. Mol. Cell. Biol. 17:7230–7236. doi:10.1128/mcb.17.12.7230.

      Malathi, K., Y. Xiao, and A.P. Mitchell. 1999. Catalytic roles of yeast GSK3β/shaggy homolog Rim11p in meiotic activation. Genetics. 153:1145–1152. doi:10.1093/genetics/153.3.1145.

      Pedruzzi, I., F. Dubouloz, E. Cameroni, V. Wanke, J. Roosen, J. Winderickx, and C. De Virgilio. 2003. TOR and PKA Signaling Pathways Converge on the Protein Kinase Rim15 to Control Entry into G0. Mol. Cell. 12:1607–1613. doi:10.1016/S1097-2765(03)00485-4.

      Pnueli, L., I. Edry, M. Cohen, and Y. Kassir. 2004. Glucose and Nitrogen Regulate the Switch from Histone Deacetylation to Acetylation for Expression of Early Meiosis-Specific Genes in Budding Yeast. Mol. Cell. Biol. 24:5197–5208. doi:10.1128/mcb.24.12.5197-5208.2004.

      Rubin-Bejerano, I., S. Sagee, O. Friedman, L. Pnueli, and Y. Kassir. 2004. The In Vivo Activity of Ime1, the Key Transcriptional Activator of Meiosis-Specific Genes in Saccharomyces cerevisiae, Is Inhibited by the Cyclic AMP/Protein Kinase A Signal Pathway through the Glycogen Synthase Kinase 3- Homolog Rim11. Mol. Cell. Biol. 24:6967–6979. doi:10.1128/mcb.24.16.6967-6979.2004.

      Tresenrider, A., K. Morse, V. Jorgensen, M. Chia, H. Liao, F.J. van Werven, and E. Ünal. 2021. Integrated genomic analysis reveals key features of long undecoded transcript isoform-based gene repression. Mol. Cell. 81:2231-2245.e11. doi:10.1016/j.molcel.2021.03.013.

      Vidan, S., and A.P. Mitchell. 1997. Stimulation of yeast meiotic gene expression by the glucose-repressible protein kinase Rim15p. Mol. Cell. Biol. 17:2688–2697. doi:10.1128/mcb.17.5.2688.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This study by Wang et al. identifies a new type of deacetylase, CobQ, in Aeromonas hydrophila. Notably, the identification of this deacetylase reveals a lack of homology with eukaryotic counterparts, thus underscoring its unique evolutionary trajectory within the bacterial domain.

      Strengths:

      The manuscript convincingly illustrates CobQ's deacetylase activity through robust in vitro experiments, establishing its distinctiveness from known prokaryotic deacetylases. Additionally, the authors elucidate CobQ's potential cooperation with other deacetylases in vivo to regulate bacterial cellular processes. Furthermore, the study highlights CobQ's significance in the regulation of acetylation within prokaryotic cells.

      Weaknesses:

      While the manuscript is generally well-structured, some clarification and some minor corrections are needed.

      Reviewer #2 (Public Review):

      In recent years, lots of researchers have tried to explore the existence of new acetyltransferase and deacetylase by using specific antibody enrichment technologies and high-resolution mass spectrometry. This study adds to this effort. The authors studied a novel Zn2+- and NAD+-independent KDAC protein, AhCobQ, in Aeromonas hydrophila. They studied the biological function of AhCobQ by using a biochemistry method and used MS identification technology to confirm it. The results extend our understanding of the regulatory mechanism of bacterial lysine acetylation modifications. However, I find their conclusion to be a little speculative, and unfortunately, it also doesn't totally support the conclusion that the authors provided. In addition, regarding the figure arrangement, lots of the supplementary figures are not mentioned, and tables are not all placed in context.

      Major concerns:

      - In the opinion of this reviewer, is a little arbitrary to come to the title "Aeromonas hydrophila CobQ is a new type of NAD+- and Zn2+-independent protein lysine deacetylase in prokaryotes." This should be modified to delete the "in the prokaryotes", unless the authors get new or more evidence in the other prokaryotes for the existence of the AhCobQ.

      Thanks for your suggestions. " in the prokaryotes " has been deleted in the revised manuscript.

      - I was confused about the arrangement of the supplementary results. There are no citations for Figures S9-S19.

      Thank you very much for your suggestion. We have made revisions and highlighted in the undated manuscript.

      - No data are included for Tables S1-S6.;

      Dear reviewer, sorry to confuse you. We have included the Supplementary Tables in the undated manuscript.

      - The load control is not all integrated. All of the load controls with whole PAGE gel or whole membrane western blot results should be provided. Without these whole results, it is not convincing to come to the conclusion that the authors have.

      Dear reviewer, thanks for your suggestion. We have meticulously incorporated the complete PVDF membranes from our Western blot experiments into Supplementary Material 1. Furthermore, we have included the Coomassie Blue R-350 staining outcomes of these PVDF membranes, post-Western blot detection, as a loading control in accordance with the protocol outlined in the reference by Charlotte et al. (Journal of Proteome Research, 2011, 10:1416–1419).

      - The materials & methods section should be thoroughly reviewed. It is unclear to me what exactly the authors are describing in the method. All the experimental designs and protocols should be described in detail, including growth conditions, assay conditions, purification conditions, etc.

      Dear reviewer, thanks for your valuable comments. We have carefully reviewed the entire manuscript and made revisions, highlighted in red.

      - Relevant information should be included about the experiments performed in the figure legends, such as experimental conditions, replicates, etc. Often it is not clear what was done based on the figure legend description.

      Thank you very much for your suggestion. We have made revisions and highlighted in red.

      Reviewer #3 (Public Review):

      Summary:

      This study reports on a novel NAD+ and Zn2+-independent protein lysine deacetylase (KDAC) in Aeromonas hydrophila, termed AhCobQ (AHA_1389). This protein is annotated as a CobQ/CobB/MinD/ParA family protein and does not show similarity with known NAD+-dependent or Zn2+-dependent KDACs. The authors show that AhCobQ has NAD+ and Zn2+-independent deacetylase activity with acetylated BSA by western blot and MS analyses. They also provide evidence that the 195-245 aa region of AhCobQ is responsible for the deacetylase activity, which is conserved in some marine prokaryotes and has no similarity with eukaryotic proteins. They identified target proteins of AhCobQ deacetylase by proteomic analysis and verified the deacetylase activity using site-specific acetyllysine-incorporated target proteins. Finally, they show that AhCobQ activates isocitrate dehydrogenase by deacetylation at K388.

      Strengths:

      The finding of a new type of KDAC has a valuable impact on the field of protein acetylation. The characters (NAD+ and Zn2+-independent deacetylase activity in an unknown domain) shown in this study are very unexpected.

      Weaknesses:

      (1) As the characters of AhCobQ are very unexpected, to convince readers, MSMS data would be needed to exactly detect deacetylation at the target site in deacetylase activity assays. The authors show the MSMS data in assays with acetylated BSA, but other assays only rely on western blot.

      (2) They prepared site-specific Kac proteins and used them in deacetylase activity assays. The incorporation of acetyllysine at the target site needs to be confirmed by MSMS and shown as supplementary data.

      (3) The authors imply that the 195-245 aa region of AhCobQ may represent a new domain responsible for deacetylase activity. The feature of the region would be of interest but is not sufficiently described in Figure 5. The amino acid sequence alignments with representative proteins with conserved residues would be informative. It would be also informative if the modeled structure predicted by AlphaFold is shown and the structural similarity with known deacetylases is discussed.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) The protein molecules of AhCobB and AhCobQ are greater than 45 kDa. But the gene sequences don't seem to match. Please explain.

      We are sorry to confuse you. The vector used for the purification of CobB and CobQ in the manuscript is pET-32a, which carries the TrxA fusion protein and is approximately 20kDa in size. Therefore, the final molecular weight of recombinant AhCobB and AhCobQ is 48.3(28.3+ ~20kDa) and 49.8 (29.8+ ~20kDa), respectively.

      (2) Figure 7: The gels look very smeary. Please explain.

      Dear esteemed reviewer, in our study, we have meticulously crafted recombinant site-specific Kac proteins utilizing an innovative two-plasmid system, grounded on the seminal work published in Nature Chemical Biology (2017, 13(12): 1253-1260), which introduced the genetic encoding of Nᵋ-acetyllysine into recombinant proteins. However, we have encountered a prevalent challenge—the occurrence of protein truncation due to premature translation termination at the reassigned codon. This phenomenon not only diminishes protein yields, as highlighted in ChemBioChem (2017, 18(20): 1973-1983), but also plagues many recombinant proteins with a troublesome backdrop in Western Blot (WB) outcomes.

      Despite our rigorous approach, involving at least two independent repetitions for WB analysis of site-specific Kac proteins, yielding consistent results, we acknowledge that the overall quality of these WB assays remains suboptimal. This variability is inherently tied to the intrinsic properties of the target proteins themselves. Illustratively, the WB outcomes for proteins such as ENO and ICD exhibit notable differences in quality across biological replicates, emphasizing the complexity and nuances involved in this process.

      Thus, while our methodology remains robust and reproducible, we are mindful of the limitations imposed by the nature of the proteins under investigation and strive to continually refine our approaches to mitigate these challenges.

      (3) To ensure that the phenotype shown in Figure 1 is not due to polar effects, results of supplementing complementary strains should be provided.

      Thank you for your suggestion. We have constructed a complement strain and tested the bacterial migration ability. As shown in the Figure S1, the complement strain does not affect the physiological phenotype mentioned above.

      (4) The caption to Figure 8 includes * and *** to indicate significance levels, but only *** appears in the picture.

      Thank you for your suggestion. It has been modified and highlighted in red.

      (5) Has the mechanistic role of lysine 388 in ICD been characterized?

      Thank you for your invaluable professional insights. Indeed, the acetylation sites of ICD have been established to exert a significant influence on its enzymatic activity. Sumana Venkat et al., in their seminal work published in the Journal of Molecular Biology (2018, 430(13): 1901-1911), convincingly demonstrated that the acetylation of specific lysine residues—K100, K230, K55, and K350—in ICD proteins from E. coli serves as a negative regulatory mechanism for enzyme activity. Intriguingly, the functional implications of the Kac modification on K387 (corresponding to the K388 site in ICD from A. hydrophila ATCC 7966, as featured in this manuscript) remain an uncharted territory.

      Our experimental endeavors have illuminated that the K388 site of ICD in A. hydrophila holds the potential to modulate enzymatic activity and is under the regulatory influence of AhCobQ.

      (6) The format of the references is not uniform enough, for example, some journal names are abbreviated, and some are not, please check and correct.

      Thank you for your suggestion. It has been modified and highlighted in red.

      (7) Page 23, line 13, gene not expressed in italics, please correct.

      Thank you for your suggestion. It has been modified and highlighted in red.

      (8) Figure S8 does not appear to match the gene size.

      We are sorry to confuse you. The vector used for the purification of recombinant protein in the manuscript is pET-32a, which carries the TrxA fusion protein and is approximately 20kDa in size. Therefore, the final molecular weight of recombinant protein is 25.5(5.5+ ~20kDa).

      (9) The format of the two figures in Figure S10 is not uniform.

      Thank you for your suggestion. It has been modified and highlighted in red.

      Reviewer #2 (Recommendations For The Authors):

      Minor concerns:

      L147, L177 - Please arrange the results as they are shown in the content sequentially. For example, rename Figure S2 with Figure S1.

      Thank you for your suggestion. It has been modified and highlighted in red.

      L174 Figure 2D - There is no big change in the acetylation between the wild type and ahcobQ mutant from Figure 2D, but the ahcobB mutant is.

      I am extremely grateful for your insightful comment. As clearly depicted in the right panel of Figure 2D, the overall Kac protein levels in both the ahcobQ and ahcobB knockout strains exhibit a marked elevation compared to the wild-type strain, despite equivalent loading of total cellular proteins (the left panel of Figure 2D). Notably, this increase is particularly pronounced among proteins with a molecular weight below 35 kDa. We wholeheartedly concur with your perspective that the deletion of ahcobB leads to a more substantial enhancement in Kac protein levels, suggesting CobB may play a pivotal role in regulating a broader spectrum of acetylated proteins or Kac sites. This hypothesis is further strengthened by subsequent mass spectrometry analyses, which lend additional credence to our shared understanding.

      L174-187, L795 - Please show the whole membrane (or PAGE gel) of the loading control of CobB, and CobQ, except for the Kac-BSA.

      Dear esteemed reviewer, we have thoroughly revised our submission to include the full western blot (WB) membrane for all figures and supplementary figures within the updated Supplementary Material 1. Additionally, we would like to clarify a few crucial points to ensure transparency and accuracy.

      Firstly, in Figure 2D, we present WB results solely pertaining to whole-cell samples from cobB or cobQ mutant strains. Consequently, these findings do not directly correlate with recombinant CobB or CobQ proteins.

      Secondly, the objective of Figure 2 is to validate the lysine deacetylase activity of AhCobQ protein through a qualitative, rather than quantitative, experimental approach. Hence, the crucial loading control lies in the amount of Kac-BSA, rather than CobB or CobQ. Prior to conducting the in vitro deacetylase assay, we ensured equal protein concentrations of purified CobB or CobQ using BCA assay, adhering to the protocol's specified deacetylase-to-Kac-BSA loading ratio of 1:5. However, this ratio renders the deacetylase (CobB or CobQ) undetectable on Coomassie Blue R-350-stained blots or WB membranes (as detailed in the whole WB membrane in Supplementary Material 1).

      To reinforce our observations, we reiterated the analysis of protein samples by subjecting them once again to SDS-PAGE, maintaining the same loading quantity as utilized in the preceding western blotting experiment shown in Figure 2E. As Author response image 1 clearly illustrates, the CobB/CobQ bands are indeed discernible, albeit they exhibit significantly fainter intensities when compared to the Kac-BSA bands. Notably, upon reviewing the full strained PVDF membrane presented in Supplementary Material 1, we find that the CobB/CobQ bands are not readily visible. This observation can be attributed to the potential loss of proteins during the transfer process from SDS-PAGE to the PVDF membrane.

      Author response image 1.

      The SDS-PAGE gel displayed the loading amounts of Kac-BSA and CobB/CobQ.

      Furthermore, recognizing the potential for confusion given the similar molecular weights of CobB (257aa) and CobQ (264aa, excluding fusion tags), we conducted a comparative analysis of deacetylase activity between His-tagged and GST-fused recombinant CobQ proteins. Encouragingly, both variants exhibited deacetylase activity (as presented in Figure S5 of the revised manuscript), thereby excluding any influence from nonspecific proteins that might have contaminated the purification process.

      We hope these clarifications and additions to our submission address your concerns and enhance the overall quality of our work. Thank you for your valuable time and consideration.

      - Could you provide the raw data of these anti-acetylation western blot results?

      Thank you very much for your suggestion. The raw results have been uploaded in the supplementary materials.

      - According to the loading control, the protein quantity of BSA is very big, however, why is the acetylation of Kac-BSA relatively low? Is it consistent between the western blot and loading control?

      Thank you very much for your suggestion, first of all, all the western blot and loading control in the manuscript are the same membrane, and the specific method is described in "Western blot". Therefore, there is no possibility that the western blot and loading control do not correspond. Secondly, not every site of BSA has acetylation modifications, and the amount of modifications at each site is also different, so there will be a large amount of protein but a small amount of acetylation.

      Figure 2C - Could the Dot blot experiment be described in detail in the Methods part?

      Thank you for your suggestion. It has been added and highlighted in red.

      Figure 2C&2D - Please provide the anti-acetylation antibody information.

      Thank you for your suggestion. It has been added and highlighted in red.

      Figure 2E - It is confusing why the acetylation of Kac-BSA is higher than adding NAD+ with CobB? But only CobB can deacetylate the Kac-BSA without NAD+?

      We are sorry to confuse you. The information in the figure is incorrect. For somehow, we provided the uncorrected version, and we have revised it in the undated manuscript.

      Figure 2F - The control of this experiment should include the NAM, CobB, and NAM+CobB. Similar to 2E, it also should include NAD, CobB, and NAD+CobB, respectively. Same with 2H.

      We are sorry to confuse you. The intent of Figure 2F is to further confirm that AhCobQ is different from AhCobQ and can remove the acetylation modification of BSA without relying on NAD+, so NAD+ was added to this group of experiments. We have revised the manuscript to add details about the experiments.

      L178 Figure S1C - One question about the protein AhAcuC. From the PCR results, it is larger than ahcobB and ahcobQ, however, why is the protein AhAcuC smaller than them?

      We are sorry to confuse you. The images in the original manuscript may have had some errors in protein size due to different PAGE gels. We have re-run the gels and replaced them in the manuscript in the Supplementary Figure S3 in revised manuscript.

      - All the proteins are expressed and purified from E.coli BL21(DE3). How did you avoid the pollution of the deacetylase from the E.coli? There is no control over it in your experiment. Without this control, it is not easy to come to the conclusion that the deacetylation is from the AhCobQ but not from the pollution from the protein purification.

      In response to your inquiry, we have conducted a meticulous comparative analysis of the deacetylase activity exhibited by both His-tagged and GST-fused recombinant AhCobQ proteins. Reassuringly, our findings reveal that both variants possess robust deacetylase activity, as clearly demonstrated in Figure S5 of the revised manuscript. Furthermore, to ensure the rigor of our experiments, we employed GST protein purified from E.coli strains as a negative control in Figure S8. The Western blot (WB) results conclusively demonstrate that GST protein alone lacks deacetylase activity, thereby reinforcing the authenticity of our findings and effectively mitigating any concerns regarding potential interference from nonspecific proteins during the purification process.

      L190 - Could you provide the raw data for Table S1?

      Thank you very much for your suggestion. The raw MS data were deposited in the public ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD038735 or IPX0005366000(iProx database). We also uploaded the analysis results in Table S1 and Supplementary material 2.

      - I am not an expert on MS. I have one question about the MS results. Why there is no peak for the CobB or CobQ as they add to the reaction system?

      Thank you for your insightful question. To clarify, the Kac peptides identified from Kac-BSA, as presented in Table S1, were meticulously selected for the purpose of enhancing their display and facilitating interpretation. The comprehensive raw mass spectrometry (MS) data, along with detailed analytical outcomes, have been diligently deposited within the ProteomeXchange Consortium, specifically through the PRIDE partner repository, under the dataset identifier PXD038735 or alternatively accessible via the iProx database under IPX0005366000. The analysis results also included in the Table S1 and Supplementary material 2.

      Furthermore, it is crucial to note that in this study, we utilized Bovine serum albumin (BSA) as the foundational database for our MS searches. Consequently, the absence of CobB or CobQ proteins in our MS results stems from the inherent focus on BSA and the specific experimental design, which did not encompass the detection of these particular proteins.

      We appreciate your attention to these details and hope this clarification addresses your query.

      L189-L206 - Based on the results here, the function of CobB and CobQ overlaps on the same STDKac peptides.

      Dear esteemed reviewer, our mass spectrometry (MS) analysis has revealed an intriguing finding: CobB and CobQ indeed function on the same STDKac peptide, suggesting a potential collaboration among distinct deacetylases in regulating protein function. This observation is further corroborated by our subsequent quantitative Kac proteomics results, which were obtained from three deacetylase mutants. These results underscore the possibility that CobB, CobQ, and AcuC possess both unique and overlapping protein substrates, reinforcing our hypothesis that multiple deacetylases work in concert to modulate protein activity.

      - Do you assay the Km and Kcat about the CobQ by using Kac-BAS as the substrate by comparing with AhCobB?

      Dear reviewer, thanks for your professional suggestion. In accordance with your guidance, we diligently attempted to analyze the Km or Kcat values of CobQ during its incubation with the substrate Kac-BSA using LC-MS/MS, repeating the process twice. However, to our disappointment, our current experimental platform has been unable to detect any discernible metabolites. We suspect that this may stem from operational proficiency challenges, as even our positive control experiment involving CobB incubation has failed to yield satisfactory results.

      Given our uncertainty regarding the root cause of these issues, coupled with the suggestion from experts that the LC column might be a contributing factor except for skill, we have decided against repeating the experiments at this juncture. Nonetheless, we would like to assure you that we have rigorously validated the deacetylase activity of CobQ proteins through mass spectrometry, as detailed in our manuscript.

      Furthermore, I am delighted to share that our preliminary findings have sparked interest among other research teams. In fact, one such group, upon reading our preprint, has independently tested the activity of CobQ and uncovered an additional intriguing function. We are actively exploring the possibility of collaborating with this team to delve deeper into the research and, hopefully, in the future, conduct a more refined analysis of the Km and Kcat of CobQ.

      L214- Same question with Figures 2E-2H. Could you provide the whole page gel about the loading control? I want to know the quantity of the AhCobQ in this experiment except for the Kac-BSA. To tell the truth, the quantity of BSA is too much in the deacetylation reaction system to be able to tell its deacetylation activity in vitro.

      Thank you very much for your suggestion. The raw data has been uploaded in the supplementary materials and the clarification is similar with above mentioned.

      L217 - There might be a wrong citation of Figure S2 here.

      Thank you for your suggestion. It has been corrected.

      L244-250, Figure 6A - Are there 47, not 46 Kac proteins?

      Thank you for your suggestion. It has been corrected.

      - Are there nineteen, not nine increased Kac peptides common between the ΔahcobQ and ΔahacuC strains?

      Thank you for your suggestion. It has been corrected.

      - Are there ten, not six increased Kac peptides common between the ΔahcobQ and ΔahcobB strains?

      Thank you for your suggestion. It has been corrected.

      - Are there 69, not 65 increased Kac peptides common between the ΔahcobB and ΔahacuC strains?

      Thank you for your suggestion. It has been corrected.

      - Where is the raw data for Table S2?

      Thank you very much for your suggestion. The raw data has been uploaded in the supplementary materials.

      Figure 6B - Are there 52, not 51 Kac peptides?

      Thank you for your suggestion. It has been corrected.

      L272 - Why do you choose these 11 target proteins? There is no description of this background in the context.

      We have opted to prioritize these proteins for subsequent validation, as their Kac levels exhibit a notable upregulation in the ΔahcobQ strain, potentially indicating their role as protein substrates for AhCobQ. We will incorporate this clarification into the revised manuscript to ensure clarity and comprehensiveness.

      L277 - Figure S6 - Please show the whole PAGE gel about the loading control.

      Dear esteemed reviewer, we sincerely apologize for any confusion our previous presentation may have caused. We would like to clarify that the bottom panel of Figure S6 depicts a Coomassie Blue R-350 stained whole PVDF membrane, rather than a PAGE gel, as may have been mistakenly inferred. To facilitate a comprehensive understanding, we have included the entire stained PVDF membranes in Supplementary Material 1.

      As we have previously elaborated, the recombinant His-tagged or GST-fused AhCobQ proteins were not as discernible on the PVDF membrane due to a relatively lower loading amount compared to that of Kac-BSA.

      -There might be a wrong citation in Figure S6. As you mentioned in the context, you expressed and purified 11 proteins and then tested their acetylation background.

      Thank you for your suggestion. It has been corrected.

      L280 - Figure S7 -The label of the Figure should be modified for the ATP.

      Thank you for your suggestion. It has been modified.

      - How did you do the experiment for 0h of ATP? There is no description of it in the Methods.

      Thank you for your suggestion. It has been added.

      - Please show the whole PAGE gel about the loading control.

      Thank you very much for your suggestion. The whole PAGE gel has been uploaded in the supplementary materials.

      L282 - Figure 7 - Please show the whole PAGE gel about the loading control.

      Dear esteemed reviewer, we sincerely apologize for any confusion our previous presentation may have caused. We would like to clarify that the bottom panel of Figure S6 depicts a Coomassie Blue R-350 stained whole PVDF membrane, rather than a PAGE gel, as may have been mistakenly inferred. To facilitate a comprehensive understanding, we have included the entire stained PVDF membranes in Supplementary Material 1.

      - Please adjust the font size of "A" and "B".

      Thank you for your suggestion. It has been adjusted.

      Figure 7A - The anti-acetylation Western blot here does not look good. All the western blots here should be re-done.

      Dear reviewer, the recombinant site-specific Kac proteins were constructed by two-plasmid system based on genetically encoding Nᵋ-acetyllysine in recombinant proteins in this study (Nature chemical biology, 2017, 13(12): 1253-1260). However, a common problem experienced is protein truncation arising from translation termination at the reassigned codon, lowering protein yields (ChemBioChem, 2017, 18(20): 1973-1983), and leading to a dirty background of WB results in many recombinant proteins. Although we did perform at least two times independent repeats for site-specific Kac protein WB and got similar results, the WB quality of site-specific Kac proteins are general poor and that depend on the properties of target proteins. For example, the WB results of ENO and ICD can display considerable qualities in different biological repeats.

      - Why did you choose the PAGE gel but not the anti-His Western blot as the loading control?

      Thank you very much for your suggestion. Labeling antibodies is a very effective loading control. However, in order to ensure the accuracy of the data, both the experimental data and loading control in this manuscript are required to be reflected on the same membrane. If His tags are used, the membrane will be washed repeatedly for secondary color development. Based on the fact that acetylation modification is already difficult for color development, this will greatly affect the quality of the results presented. Meanwhile, while ensuring consistent protein levels, we believe that changes in acetylation modifications can also explain the issue. Therefore, you choose the PAGE gel but not the anti-His Western blot as the loading control.

      L278 - Where are the results of the site-specific lysine acetylation of the target protein by using two-plasmid-based system of genetically encoded Nε-acetyllysine. Usually, there will be a shift when it is full acetylated by compared with the wild-type protein.

      Sorry for the confusion caused. As the size of the acetyl group is only about 40.6Da, which is thousands of times smaller than the size of the protein, the changes in size of the protein before and after modification cannot be seen with the naked eye.

      L287 - Where is Figure 7C?

      We are sorry to confuse you. It has been corrected.

      - Here the citation might be Figure 7A but not Figure 7B.

      Thank you for your suggestion. It has been corrected.

      L290 - It is difficult to read here, please rearrange this Figure S8. There is no useful label.

      Thank you for your suggestion. It has been corrected.

      - The citation of Figure S8 is wrong.

      Thank you for your suggestion. It has been corrected.

      - For Figure S8, please add the label on the figure. And add anti-GST western blot as well. Because the GST is about 26KD, why are the purified recombinant truncated proteins (GST-fusion) so small?

      Sorry for the inconvenience caused. The truncated fragment used for recombinant purification in Figure S8 is very small, and when converted to protein, it is approximately between 1-5kDa. Therefore, the resulting protein is also very small.

      - Why there are two Figure S8 in the supplemental materials?

      We are sorry to confuse you. It has been corrected.

      L293 - Where is Figure 7D?

      We are sorry to confuse you. It has been corrected.

      L297-313 - Please provide the MS result of the ICDK388?

      Author response image 2.

      The mass spectrum of Kac modification on ICD protein at K388 site.

      Dear reviewer, we are pleased to present the mass spectrum data pertaining to the Kac modification at the K388 site of the ICD protein in Δ_ahcobQ_ strain in Figure2 in this responding letter. It is important to clarify that, while we have not directly validated the Kac status of site-specific lysine acetylation at the recombinant ICD K388 site through mass spectrometry (MS) in this particular study, we have strong reasons to believe in its specificity.

      Firstly, our confidence stems from the well-established and rigorously validated two-plasmid system methodology for site-directed acetylation modification. This approach has been successfully employed in modifying diverse and specific sites across various proteins, as evidenced by the pioneering work of David et al. in Nature Chemical Biology (2017, 13(12), 1253-1260).

      Secondly, we have taken meticulous measures to ensure the accuracy and reliability of our findings. This includes double-checking our PCR primers and DNA sequencing for the genetic code expansion technology employed. Furthermore, we have included control experiments utilizing proteins that were not subjected to site-directed acetylation (ICD), as detailed in Figure 8A in revised manuscript, thereby providing an additional layer of validation and reinforcing the robustness of our results.

      We believe that these two lines of evidence, combined with our rigorous experimental design and execution, provide a solid foundation for our conclusion regarding the specific acetylation of the K388 site in ICD.

      - Please provide the whole PAGE gel of loading control. Or other anti-His results?

      Dear esteemed reviewer, we sincerely apologize for any confusion our previous presentation may have caused. We would like to clarify that the bottom panel of Figure S6 depicts a Coomassie Blue R-350 stained whole PVDF membrane, rather than a PAGE gel, as may have been mistakenly inferred. To facilitate a comprehensive understanding, we have included the entire stained PVDF membranes in Supplementary Material 1.

      - Do you have site-specific antibody of ICDK388? It should be better to identify the ICDK388 with site-specific anti-acetylation antibody.

      Thank you for your insightful suggestion. We fully concur that a site-specific antibody targeting ICDK388 would be an optimal tool to elucidate the impact of CobQ on the acetylation status (Kac) of this protein. Unfortunately, we are currently without such an antibody due to the intricate and time-consuming process of its production, which also requires rigorous validation to ensure specificity. Furthermore, the cost associated with its development is considerable.

      To address this limitation, in the present manuscript, we have innovatively employed a two-plasmid system for site-directed acetylation modification of ICDK388. This method, which has been extensively validated and utilized in modifying diverse specific sites (David et al., Nature Chemical Biology, 2017, 13(12), 1253-1260), allowed us to precisely manipulate the acetylation status of our target protein. Additionally, we incorporated control experiments using proteins that were not subjected to site-directed acetylation, as depicted in Figure 8A in revised manuscript, thereby reinforcing the robustness and reliability of our findings.

      - Please give some background information about K388 site of ICD in the context.

      Thank you for your suggestion. It has been added.

      L484 - Could you provide the reference for this assay method "Protein deacetylation assay in vitro"?

      Thank you for your suggestion. The work published in science 327, 1004 (2010) and Nat. Protoc.5, 1583-1595.

      L490 - There is no detailed information about the growh condition for the quantitative acetylome analysis. Without these information, the proportion of the Kac peptides doesn't make any sense.

      Thank you for your suggestion. It has been added.

      L531 - Insert one line before the paragraph of Western blot.

      Thank you for your suggestion. It has been inserted.

      Reviewer #3 (Recommendations For The Authors):

      Tables S1 and S2 are missing. I could not fully understand the manuscript without them.

      We are sorry to confuse you.The data has been uploaded in the supplementary materials.

      Line 130. The gene IDs of AhCobB and AhAcuC should be presented.

      Thank you for your suggestion. It has been presented.

      Line 285. What is different between ArcA and ArcA-2? Please clarify.

      Thank you for your suggestion. ArcA is aerobic respiration control protein ArcA, gene name AHA_3026 (https://www.uniprot.org/uniprotkb/A0KMM9/entry). ArcA-2 is arginine deiminase, which gene name is AHA_4093  (https://www.uniprot.org/uniprotkb/A0KQG6/entry). Therefore, they are different proteins according to Uniport annotation.

      Line 303. 8further, a bug?

      We are sorry to confuse you. It has been corrected.

      Line 412-416. The related papers on ICD acetylation in E. coli should be cited.

      We are sorry to confuse you. It has been added.

      Line 478. Not in vivo but in vitro?

      Sorry to confuse you. It should be in vitro. We have revised in the updated manuscript.

      Figure 3C and 3D. The image resolution is bad. The figures should be improved so that readers to know easily that Kac is exactly incorporated at the target site.

      Thank you for your suggestion. It has been corrected.

      Figure 4B. The amino acid residues of the whole AhCobB should be 1-264 aa.

      Thank you for your suggestion. It has been corrected.

      Figure 8. It would be better to use the same colors between panels C and D. It should be shown the significance between ICD-Kac388 and ICD-Kac388+AhCobB to support the authors' conclusion that AhCobQ activates ICD by deacetylation at K388.

      Thank you for your suggestion. It has been adjusted.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer 1

      “The exact levels of inhibition, excitation, and neuromodulatory inputs to neural networks are unknown. Therefore, the work is based on fine-tuned measures that are indirectly based on experimental results. However, obtaining such physiological information is challenging and currently impossible. From a computational perspective it is a challenge that in theory can be solved. Thus, although we have no ground-truth evidence, this framework can provide compelling evidence for all hypothesis testing research and potentially solve this physiological problem with the use of computers.”

      Response: We agree with the reviewer. This work was intended to determine the feasibility of reverse engineering motor unit firing patterns, using neuron models with a high degree realism. Given the results support this feasibility, our model and technique will therefore serve to construct new hypotheses as well as testing them.

      • Common input structure lines 115

      I agree with the following concepts, but I would specify that there is not only one dominant common input. It has been shown that there are multiple common inputs to the same motor nuclei (e.g., the two inputs are orthogonal and are shared with a subset of the active motoneurons) particularly for agonist motoneuron pools of synergistic muscles. On the hand muscles the authors are correct that there is only one dominant common input. Moreover, there is also some animal work suggesting that common inputs is just an epiphenomenon. This is completely in contradiction to what we observe in-vivo in the firing patterns of motor units, but perhaps worth mentioning and discussing.

      Response: Thanks for emphasizing this point. We have cited a recent reference discussing the important issue of common drive and the possibility of more than one source. Our simulations assume the net form of the excitatory input to all motoneurons in the pool is the same, except for noise. This net form (which produces the linear CST output in each case) essentially represents the sum of all inputs, both descending and sensory. Our results show the same over pattern as human data, i.e. that all motor unit firing patterns have similar trajectories (again allowing for the impact of noise). Future studies will consider separating excitatory inputs into different sources.

      It is interesting that the authors mention suprathreshold rate modulation. Could the authors just discuss more on how the model would respond to a simulated suprathreshold current for all simulated motoneurons (i.e., like the ones generated during a suprathreshold-injected current or voluntary maximal feedforward movement?)

      Response: Thank you for this point. Our use of the term “suprathreshold” was not applied correctly. We meant “suprathreshold” to refer to amount of input above the recruitment threshold. We have decided to remove this term so now the sentence “…so less is available for rate modulation…”.

      194 a full point is missing.

      Response: We addressed the error.

      204-231 and 232-259, these two paragraphs have been copied twice.

      Response: We addressed the error.

      Line 475 typo

      Response: We addressed the error.

      591 It would be interesting to add the me it takes a standard computer with known specs and a super computer to run over one batch of simulation (i.e., how long one of the 6,300,000 simulation takes).

      Response: Each simulation took about 20 minutes of real me. Assuming a standard computer with 16 processor cores using a similar microarchitecture as Bebop (Intel Broadwell architecture), the standard computer could run 16 simulations at a me (one simulation assigned per core). This would take the standard computer about 15 years to complete all 6.3M simulations.

      594 I don't understand why there are 6M simulations, could the authors provide more info on the combinations and why there are 6M simulations.

      Response: The 6M simulations are the total number of simulations that were performed for this work. A detailed explanation can be found in section: “Machine learning inference of motor pool characteristics” at line 591. Briefly, there were 315,000 simulations of a pool of 20 motoneurons (20 x 315,000 = 6.3 million). The 315,000 simulations was required to run all possible combinations of 15 patens of inhibition, 5 of neuromodulation, 7 of distribution of excitatory inputs and 30 different repeats of synaptic noise with different seeds. In addition, there were 20 iterations for each of these combinations to generate a linear CST output (as illustrated in Fig. 3). 15 x5 x 7 x 30 x 20=315,000.

      In several simulations it seems that there was a lot of fine-tuning of inputs to match the measured motor unit firing pattern. Have the authors ever considered a fully black-box AI approach? If they think is interesting maybe it could spice up the discussion.

      Response: We agree that AI has potential for reverse engineering the whole system and we are looking into adding it to future version of this algorithm as an alternative. We started with a simple but powerful grid search to enhance our understanding of the interaction between inputs, neuron properties and outputs.

      Reviewer 2

      Comment 1:

      “First, I believe that the relation between individual motor neuron behavioral characteristics (delta F, brace height etc.) and the motor neuron input properties can be illustrated more clearly. Although this is explained in the text, I believe that this is not optimally supported by figures. Figure 6 to some extent shows this, but figures 8 and 9 as well as Table 1 shows primarily the goodness of fit rather than the actual fit.”

      Response: We agree with the reviewer that showing the relationship between the motor neuron behavioral characteristics (delta F, brace height etc.) and the motor neuron input properties would be a great addition to the manuscript. Because the regression models have multiple dimensions (7 inputs and 3 outputs) it is difficult to show the relationship in a static image. We thought it best to show the goodness of fit even though it is more abstract and less intuitive. We added a supplemental diagram to Figure 8 to show the structure of the reverse engineered model that was fit (see Figure 8D).

      Author response image 1.

      Figure 8. Residual plots showing the goodness of fit of the different predicted values: (A) Inhibition, (B) Neuromodulation and (C) excitatory Weight Rao. The summary plots are for the models showing highest 𝑅𝑅2 results in Table 1. The predicted values are calculated using the features extracted from the firing rates (see Figure 7, section Machine learning inference of motor pool characteristics and Regression using motoneuron outputs to predict input organization). Diagram (D) shows the multidimensionality of the RE models (see Model fits) which have 7 feature inputs (see Feature Extraction) predicting 3 outputs (Inhibition, Neuromodulation and Weight Rao).

      Comment 2:

      “Second, I would have expected the discussion to have addressed specifically the question of which of the two primary schemes (pushpull, balanced) is the most prevalent. This is the main research question of the study, but it is to some degree le unanswered. Now that the authors have identified the relation between the characteristics of motor neuron behaviors (which has been reported in many previous studies), why not exploit this finding by summarizing the results of previous studies (at least a few representative ones) and discuss the most likely underlying input scheme? Is there a consistent trend towards one of the schemes, or are both strategies commonly used?”

      Response: We agree with the reviewer that our discussion should have addressed which of the two primary schemes – push-pull or balanced – is the most prevalent. At first glance, the upper right of Figure 6 looks the most realistic when compared to real data. We thus would expect that the push-pull scheme to dominate for the given task.

      We added a brief section (Push-Pull vs Balance Motor Command) in the discussion to address the reviewer’s comments. This section is not exhaustive but frames the debate using relevant literature. We are also now preparing to deploy these techniques on real data.

      Comment 3:

      In addition, it seems striking to me that highly non-linear excitation profiles are necessary to obtain a linear CST ramp in many model configurations. Although somewhat speculative, one may expect that an approximately linear relation is desired for robust and intuitive motor control. It seems to me that humans generally have a good ability to accurately grade the magnitude of the motor output, which implies that either a non-linear relation has been learnt (complex task), or that the central nervous system can generally rely on a somewhat linear relation between the neural drive to the muscle and the output (simpler task).

      Response: We agree with the reviewer, and we were surprised by these results. Our motoneuron pool is equipped with persistent inward currents (PICs) which are nonlinear. Therefore, for the motoneuron to produce a linear output the central nervous system would have to incorporate these nonlinearities into its commands.

      Following this reasoning, it could be interesting to report also for which input scheme, the excitation profile is most linear. I understand that this is not the primary aim of the study, but it may be an interesting way to elaborate on the finding that in many cases non-linear excitation profiles were needed to produce the linear ramp.

      This is a very interesting point. The most realistic firing patterns – with respect to human data – are found in the parameter regions in the upper right in Figure 6, which in fact produce the most nonlinear input (see push-pull pattern in Figure 4C). However, in future studies we hope to separate the total motor command illustrated here into descending and feedback commands. This may result in a more linear descending drive.

    1. Author Response

      The following is the authors’ response to the original reviews.

      eLife assessment

      The study provides valuable insights into allosteric regulation of BTK, a non-receptor protein kinase, challenging previous models. Using a variety of biophysical and functional techniques, the paper presents evidence that the N-terminal PH-TH domain of BTK exists in a conformational ensemble surrounding a compact SH3-SH2-kinase core, that the BTK kinase domain can form partially active dimers, and that the PH domain can form a novel inhibitory interface after SH2/SH3 disengagement. Overall the presented evidence is solid, but the EM results may be over-interpreted and the work would benefit from additional functional validation.

      We made every effort in our descriptions of the cryoEM data presented for full-length BTK to not overinterpret the results. In essence this is not an ideal EM target but given the failure by us and others to capture the full-length multi-domain protein crystallographically, we decided that the albeit low resolution cryoEM data are useful to the field.

      Reviewer #1 (Public Review):

      The manuscript by Lin et al describes a wide biophysical survey of the molecular mechanisms underlying full-length BTK regulation. This is a continuation of this lab's excellent work on deciphering the myriad levels of regulation of BTKs downstream of their activation by plasma membrane localised receptors.

      The manuscript uses a synergy of cryo EM, HDX-MS and mutational analysis to delve into the role of how the accessory domains modify the activity of the kinase domain. The manuscript essentially has three main novel insights into BTK regulation.

      1) Cryo EM and SAXS show that the PHTH region is dynamic compared to the conserved Src module.

      2) A 2nd generation tethered PH-kinase construct crystal of BTK reveals a unique orientation of the PH domain relative to the kinase domain, that is different from previous structures.

      3) A new structure of the kinase domain dimer shows how trans-phosphorylation can be achieved.

      Excitingly these structural works allow for the generation of a model of how BTK can act as a strict coincidence sensor for both activated BCR complex as well as PIP3 before it obtains full activity. To my eye the most exciting result of this work is describing how the PH domain can inhibit activity once the SH3/SH2 domain is disengaged, allowing for an additional level of regulatory control.

      I have very few experimental concerns as the methods and figures are well-described and clear. As the authors are potentially saying that the previously solved PH domain-kinase interface is artefactual, additional evidence strengthening their model would be helpful to resolve any possible controversies.

      We do not argue that the previously solved PH domain-kinase interface is artefactual. Instead we point out that the PH/kinase interface identified in the prior structure is incompatible with the contacts between the SH3 and kinase domains in autoinhibited BTK. This then leads us to the suggestion that a PH/kinase inhibitory interaction may instead occur upon dissociation of the SH3-SH2 cassette from the kinase domain. Our data support that model. Moreover, our data suggest the PHTH domain is dynamic, likely not settling in to one particular autoinhibitory state. Thus, it is possible the previously solved PH/kinase structure exists within the conformational ensemble of a range PH/kinase domain interactions. In an effort to clarify our think we added two sentences to the Discussion (pg. 19).

      Reviewer #2 (Public Review):

      In this study, multiple biophysical techniques were employed to investigate the activation mechanism of BTK, a multi-domain non-receptor protein kinase. Previous studies have elucidated the inhibitory effects of the SH3 and SH2 domains on the kinase and the potential activation mechanism involving the membranebound PIP3 inducing transient dimerization of the PH-TH domain, which binds to lipids.

      The primary focus of the present study was on three new constructs: a full-length BTK construct, a construct where the PH-TH domain is connected to the kinase domain, and a construct featuring a kinase domain with a phosphomimetic at the autophosphorylation site Y551. The authors aimed to provide new insights into the autoinhibition and allosteric control of BTK.

      The study reports that SAXS analysis of the full-length BTK protein construct, along with cryoEM visualization of the PH-TH domain, supports a model in which the N-terminal PH-TH domain exists in a conformational ensemble surrounding a compact/autoinhibited SH3-SH2-kinase core. This finding is interesting because it contradicts previous models proposing that each globular domain is tightly packed within the core.

      Furthermore, the authors present a model for an inhibitory interaction between the N-lobe of the kinase and the PH-TH domain. This model is based on a study using a tethered complex with a longer tether than a previously reported construct where the PH-TH domain was tightly attached to the kinase domain (ref 5). The authors argue that the new structure is relevant. However, this assertion requires further explanation and discussion, particularly considering that the functional assays used to assess the impact of mutating residues within the PH-TH/kinase domain contradict the results of the previous study (ref 5).

      In our hands BTK activity is not significantly affected by mutation of just two residues, R133 and Y134. It is somewhat difficult to compare the previously reported activity assay for the same BTK mutant (Wang et al. ref 5, Figure 4D) with the data we report here. For unexplained reasons, the time scale for the quantitative assay in the previous work is truncated to 50 munutes for the R133/Y134 mutant data compared to 120 minutes for all of the other activity data reported in that figure. In our data, if we qualitatively examine the differences in a representative progress curve at 50 minutes between WT and the double R133/Y134 mutant (see Figure 6a, dark blue and pink traces) one might conclude that the R133/Y134 mutation is activating BTK. However, when we calculate the average kinase activity rate ± standard error for three independent experiments we find that the difference between WT and the double R133/Y134 mutant is not significant (see Figure 6b and c). Thus, instead of making any assertions about the previously published data we are trying to be as rigoruous as possible in presentation and interpretation of our own data.

      In addition, throughout the manuscript we tried to be very careful in our discussion of our data and that published previously, to avoid conclusive statements about the previously described interface. Afterall, one of our overriding conclusions is that the N-terminal region of BTK is highly dynamic. See response to reviewer 1 above.

      Additionally, the study presents the structure of the kinase domain with swapped activation loops in a dimeric form, representing a previously unseen structure along the trans-phosphorylation pathway. This structure holds potential relevance. To better understand its significance, employing a structure/function approach like the one described for the PH-TH/kinase domain interface would be beneficial.

      We completely agree with this comment and are pursuing such studies now.

      Overall, this study contributes to our understanding of the activation mechanism of BTK and sheds light on the autoinhibition and allosteric control of this protein kinase. It presents new structural insights and proposes novel models that challenge previous understandings. However, further investigation and discussion would significantly strengthen the study.

      As indicated we are pursuing further investigation and felt that the body of work presented here is sufficient for a single manuscript.

      Reviewer #3 (Public Review):

      Yin-wei Lin et al set out to visualize the inactive conformation of full-length Bruton's Tyrosine Kinase (BTK), a molecule that has evaded high-resolution structural studies in its full-length form to this date. An open question in the field is how the Pleckstrin Homology-Tec Homology (PHTH) domain inhibits BTK activity, with multiple competing models in the field. The authors used a complimentary set of biophysical techniques combined with well-thought-out stabilizing mutations to obtain structural insights into BTK regulation in its full-length form. They were able to crystallize the full-length construct of BTK but unfortunately, the PHTH was not resolved yielding a structure similar to that previously obtained in the field. The investigation of the same construct by SAXS yielded an elongated structural model, consistent with previous SAXS studies. Using cryo-EM the authors obtained a low-resolution model for the FL BTK with a loosely connected density assigned to the dynamic PHTH around the compact SH2-SH3-Kinase Domain (KD) core. To gain further molecular insights into PHTH-KD interactions the authors followed a previously reported strategy and generated a fusion of PHTH-KD with a longer linker, yielding a crystal structure with a novel PHTH-KD interface which they tested in biochemical assays. Lastly, Yin-wei Lin et al crystallized the BTK KD in a novel partially active state in a "face-to-face" dimer with kinases exchanging the activation loops, although partially disordered, being theoretically perfectly positioned for transphosphorylation. Overall this presents a valiant effort to gain molecular insights into what clearly is a dynamic regulatory motif on BTK and is a valuable addition to the field.

      However, this work can be improved by considering these points:

      1) The cryo-EM reconstructions are potentially over-interpreted. The reported resolution for all of the analyzed reconstructions is better than 8Å, at which point helices should be recognized as well-resolved structural elements. In the current view/depiction of the cryo-EM maps/models it is hard to see such structural features and it would be great if the authors could include a panel showing maps at higher thresholds to show correspondence between the helices in the kinase C lobe and the cryo-EM maps. Otherwise, the overall positioning of the models within the cryo-EM maps is hard to evaluate and may very well be wrong. (Fig 4, S2).

      First, we fully recognize the model is low-resolution and we are careful in our discussion of the cryo-EM data to use language that acknowledges the limitations of the model. Nevertheless, this is the model we have (specific data processing points are discussed below).

      The resolution numbers are from the Fourier Shell Correlation (FSC) curve given by Cryosaprc at the end of refinement. We do acknowledge the reviewer’s comments that the resolution could be over estimated in that calculation, but our main focus is to show that the overall domain arrangement of the autoinhibited BTK core (Src-module) fits into the reconstructions.

      We tested visualizing the maps at higher threshold, but the secondary structures of the reconstructions were still not well resolved. We do realize that with the current reconstructions, we do not have the structural details to correctly orientate and fit individual domains; this is why we chose to simply fit the available crystal structure of the autoinhibited BTK SH3-SH2-kinase core into the maps.

      2) With the above in mind, if the maps are not at the point where helices are well resolved, it may be beneficial to low-pass filter the maps to a more conservative resolution for fitting, analysis, and representation. (Fig 4, S2).

      Using low-pass filtered maps at 10Å or unsharpened maps, the fitting of the BTK model and map do not change significantly.

      3) It would be valuable to get a quantitative metric on the model/map fitting for the cryo-EM work. One good package for this is Situs which provides cross-correlation values for the top orthogonal fits, without user input for initial fitting. This would again increase confidence in the correctness of model positioning on the map. (Fig 4, S2).

      Thank you for this suggestion. We tested the colores feature (Exhaustive One-At-A-Time 6D Search) in Situs to perform model to map fitting without user input as the reviewer suggested. The highest ranked fitting is identical to what we presented in the manuscript. Following are the cross-corelation numbers calculated from “Fit-in-map” tool in chimera and from “collage” function in Situs. We now indicate this step in the caption to Figure 4.

      Author response table 1.

      4) It would be great to see 2D class averages from the particles contributing to each of the 3D classes. Theoretically, a clear bright "blob" (hypothesized to be the PHTH domain) should be observable in the 2D class averages. In the current 2D class averages that region is unconvincingly weak. (Fig 4, S2).

      We attempted to improve both 2D and 3D reconstructitions by feeding the particles from each 3D class through many cycles of 2D classification and selection to exclude ‘bad’ paritcles, but neither the 2D class averages nor 3D reconstructions could be improved.

      We agree the feature that appears in the 2D class averages is weak. The BTK protein is only 77kD in size and is highly dynamic and flexible. Thus, in reality this is not an ideal system for cryo-EM. As well, the PHTH domain itself is quite small and NMR data, acquired in the context of a different project, provides evidence that the isolated PHTH domain is dynamic in solution (NMR linewidths vary throughout the protein suggesting intermediate exchange). Nevertheless, given the inability to capture the PHTH domain in crystal structures of full-llength BTK we reasoned that cryo-EM could provide some insight. In the future we anticipate building on these data to include inhibitory binding partners of BTK; however such an effort is beyond the scope of the current work.

      5) It seems like there was quite a large circular mask applied during 2D classification. Are authors confident that the weak density attributed to the PHTH domain is not neighboring particles making their way into the extraction box? It would be great if the authors would trim their particle stack with a very stringent interparticle distance cutoff (or report the cutoff in the manuscript if already done so) to minimize this possibility.

      We initially picked particles using a small radius (100 Å), and stringently selected 2D classes with particles that contained only density aligning to the core SH3-SH2-kinase domains. We found, however, that 3D ab initio reconstruction always resulted in an additional density located at different positions around the larger core density. The structure of a single BTK PHTH domain fits into that additional remote density. Given the additional density that consistently appeared in 3D reconstructions, we went back and picked particles using a larger circular mask (200 A). Subsequent 2D classification and 3D reconstruction from this analysis gave similar results and are presented in the manuscript.

      Regardless of the mask radius, we used stringent conditions for particle picking and checked for the presence of duplicates. An interparticle distance cutoff of 0.1 to 0.5 times the particle diameter was used and resulted in fewer number of particles, but the presence of the extended density remains. We also made use of template picking (2D class averages) to repick the particles and found no significant difference in the number of particles or quality of 2D classifications.

      6) The cryo-EM processing may benefit from more stringent particle picking. The authors picked over 2M particles from 750 micrographs which likely represents very heavy overpicking. I would encourage the authors to re-pick the micrographs with 2D class averages and use more stringent metrics to reduce the overpicking. This may result in higher-resolution reconstructions. (Fig 4, S2).

      This was an effort to maximize the number of particles extracted. After multiple rounds of 2D classification and selection to exclude empty and junk particles, the final number of particles selected for 3D ab-initio reconstructions were only 68,788, and only ~20K particles for each 3D reconstruction. Thus, we are not concerned that we overpicked particles. This approach is described in Supp Figure S2.

      7) The Dmax from SAXS for the Full Length BTK is at 190Å. It would be great if the authors could make a cartoon of what domain arrangement may satisfy this distance, as it is quite extended for such a small particle. Can the authors rule out dimerization at SAXS concentrations? (Fig 1).

      SAXS data for full-length, wild-type BTK has been previously published (Márquez et al, 2003 EMBO J. (2003) 22:4616-4624). Our data for WT BTK are consistent with that published previously (and we have cited this previous work). In that work, the authors attribute the ~200 Å Dmax value to an elongated BTK conformation where the domains of BTK are arranged in a linear fashion (a figure showing this domain arragement is provided by Marquez et al. precluding the need for such a cartoon here).

      In the present work we take advantage of targeted mutations to stabilize the autoinhibted SH2-SH2-kinase core and the Dmax value that we report for this more autoinhibited version of full-length BTK (FL 4P1F) is ~150Å. Notwithstanding low resolution in both SAXS and cryoEM, it is notable that superposition of the cryoEM models in Figure 4c & d gives a distance of ~150Å between the PHTH domains from the two models.

      Finally, we cannot completely rule out that a small fraction of full length BTK is forming dimers. However, in our experience purifying and working with this protein, we find that purified and concentrated monomeric fulllength Btk proteins (as high as 15mg/ml) are quite stable and remain monomeric and free of aggregation even after sitting at 4°C for more than a week. Here the BTK SAXS data were collected within 24 hours after the samples were thawed.

      8) In Figure S1 (C) it seems that the curves are just scattering curves with Guinier plots in the inserts, but are labeled as Guinier plots in the legend. The Guinier plots for some samples (FL 4P1F) show signs of aggregation, which may complicate the analysis, it could be beneficial to redo.

      We thank the reviewer for pointing out our mistake in presention of the SAXS data. We have now replaced plots in Figure S1c with the correct scattering profiles for each construct with the Guinier insets shown. We revised the label of this panel to “Scattering profile and Guinier plots (insets)”.

      In addition, we re-processed the FL 4P1F data by performing buffer subtraction (using a different buffer alone scattering dataset (also collected during original data acquisition)). The data quality after reprocessing were significantly improved (see new scattering profiles and Guinier plots for full-length BTK in Supplementary Figure S1). Protein stability (see above) and the current data quality therefore suggest that aggregation is not complicating the SAXS analysis.

      9) Have the authors verified that the activation loop mutations that they introduce do not disrupt the PHTH binding as they previously reported an activation loop on BTK to interact with PHTH, an interaction they do not see here? If so, a citation would be helpful in the text. If not, testing this would strengthen the paper.

      The same activation loop mutations were included in the constructs used in the previous solution studies of the PHTH/kinase domain interaction by NMR and HDX (see ref [11]). We clarify this point in the methods section. As well, all but one of the sequence changes introduced into the activation loop are at positions at the ‘base’ of the activation loop and therefore are not surface exposed. Only one amino acid change is on the exposed part of the activation loop (V555T).

      10) Can the authors comment on the surfaces which are accessible and inaccessible to the PHTH in the crystal (Fig 3E)? The fact that PHTH doesn't adopt a stable conformation in the solvent channel to some degree indicates that the accessible interaction surfaces are not suitable for PHTH interactions, as the "effective concentration" of the PHTH would be quite high. Are these surfaces consistent with the cryo-EM analysis?

      This is an excellent point and we did state the following in describing the crystallization results:

      “the crystallography results are consistent with a flexible N-terminal PHTH domain with the caveat that the domain swapped dimer organization might limit native autoinhibitory contacts between the PHTH and SH3SH2-kinase regions.”

      In the domain swapped dimer seen in the crystal, a symmetry related molecule does partially block the Ghelix region of the kinase domain while the activation loop and C-helix in the N-lobe remain accessible. Our previous solution studies (ref [11]) pointed to the G helix as part of the interaction interface in addition to the activation loop and part of the N-lobe. We have now modified the sentence above to more clearly describe which parts of the kinase domain are inaccessible in the crystal and the possible ramifications of the steric environment on PHTH domain mobility in the crystal (see pg. 10). That said, all of our previous HDX data shows little protection in the PHTH domain in full-length BTK (mapping of the PHTH/kinase interaction was only possible in trans using excess PHTH domain) and so our data can be best summarized by concluding that the PHTH domain visits a number of conformational states and makes transient contacts with various regions of the kinase domain (dependent upon whether the SH3-SH2 region is engaged or not). This is similar to the ‘fuzzy’ intramolecular contacts described for the N-terminal region of the SRC family. Like the SRC family, BTK (and other TEC kinases) contain a long disordered linker between the N-terminal region and the compact SH3-SH2-kinase core.

      11) For the novel active state dimer of the Kinase Domain it would be great to see some functional validation of the dimerization interface. It is structurally certainly quite suggestive, but without such experiments the functional significance is unclear. If appropriate mutations have been published previously a citation would be helpful.

      We completely agree. We scoured the literature and our own facuntional assay results over many years but the appropriate mutations to test the functional significance of the kinase domain dimer have not been reported or previously studied in our lab. We are therefore actively pursuing this line of investigation now.

      Reviewer #1 (Recommendations For The Authors):

      I have the following proposed experiments/analysis that should help.

      1) To better validate the putative PH-kinase interface seen, the authors should try some alphafold multimer / rosettaTTFold modelling of just the PHTH module with the kinase domain. The advantage of this is that it will test how conserved over evolution the potential interface is, and will help to decipher discrepancies between the two structures. This may end up being similar to what is seen in Akt (in this case the alphafold prediction does not match the allosteric inhibitor structure, or the nanobody bound structure), but this could help provide additional insight into how the PH domain interacts.

      We have applied alphafold to this system. The PHTH-kinase fusion sequence was fed to Alphafold and the separate PHTH and kinase domains to Aphafold multimer. The results provide a range of ‘complexes’ none of which recapitulate the PHTH/kinase interface reported here or that reported by Wang et al in previous work. Three of five results from Alphafold Multimer place the PHTH domain on the activation loop face of the kinase domain consistent with the previous solution data pointing to a similar regulatory interface. This is interesting but our experience in applying alphafold to dynamic confromationally heterogeneous systems is that the results need to be considered with caution. For that reason we did not include any of the alphafold predictions in the manuscript.

      Evolutionary conservation is discussed further in the next section:

      2) Could the authors provide a detailed evolutionarily analysis of the binding surface between the PHTH and kinase domains and include this in Fig5, this also would help interpret the likelihood of this interface.

      This is an excellent question and we have in fact previously published a detailed evolutionary analysis of the BTK kinase domain in collaboration with Kannan Natarajan (see Amatya et al., PNAS, 2019, [ref 11]). In that work we found that evolutionarily conserved residues on the kinase domain map to the activation loop face, supporting the solution data that the PHTH interacts with the kinase domain across the activation loop face. That work predated alphafold but it is interesting that, to the exent that alphafold predicts anything, it seems to converge on the PHTH domain containg the activation loop face.

      In the context of our current work, and this question from the reviewer, we re-examined the evolutionary anlysis carried out previously and find that BTK (or TEC family) specific residues on the kinase domain do not appear at the newly identified PHTH/kinase interface we report here. We could speculate that since the ‘back’ of the kinase domain N-lobe interacts with multiple binding partners (SH3, SH2-linker and PHTH) evolutionary pressures may have resulted in a certain degree of plasticity to allow recognition of multiple binding partners.

      Evolutionary analysis of the BTK PH domain was also carried out previously and shows that the conserved sites map to the phospholipid binding pocket of the PH domain. The analysis did not include TH domain residues. Since we find the TH domain contributes to the PHTH/kinase interface in our crystal structure, we do not have the data at this time to do a thourough anaylsis but we appreciate this comment and can address this in furture work with collaborators.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the reviewers and editors for their careful read of our paper, and appreciate the thoughtful comments.

      Both reviewers agreed that our work had several major strengths: the large dataset collected in collaboration across ten labs, the streamlined processing pipelines, the release of code repositories, the multi-task neural network, and that we definitively determined that electrode placement is an important source of variability between datasets.

      However, a number of key potential improvements were noted: the reviewers felt that a more standard model-based characterization of single neuron responses would benefit our reproducibility analysis, that more detail was needed about the number of cells, sessions, and animals, and that more information was needed to allow users to deploy the RIGOR standards and to understand their relationship to other metrics in the field.

      We agree with these suggestions and have implemented many major updates in our revised manuscript. Some highlights include:

      (1)  A new regression analysis that specifies the response profile of each neuron, allowing a comparison of how similar these are across labs and areas (See Figure 7 in the new section, “Single neuron coefficients from a regression-based analysis are rep oducible across labs”);

      (2) A new decoding analysis (See Figure 9 in the section, “Decodability of task variables is consistent across labs, but varies by brain region”);

      (3) A new RIGOR notebook to ease useability;

      (4) A wealth of additional information about the cells, animals and sessions in each figure;

      (5) Many new additional figure panels in the main text and supplementary material to clarify the specific points raised by the reviewers.

      Again, we are grateful to the reviewers and editors for their helpful comments, which have significantly improved the work. We are hopeful that the many revisions we have implemented will be sufficient to change the “incomplete” designation that was originally assigned to the manuscript.

      Reviewer #1 (Public review):

      Summary:

      The authors explore a large-scale electrophysiological dataset collected in 10 labs while mice performed the same behavioral task, and aim to establish guidelines to aid reproducibility of results collected across labs. They introduce a series of metrics for quality control of electrophysiological data and show that histological verification of recording sites is important for interpreting findings across labs and should be reported in addition to planned coordinates. Furthermore, the authors suggest that although basic electrophysiology features were comparable across labs, task modulation of single neurons can be variable, particularly for some brain regions. The authors then use a multi-task neural network model to examine how neural dynamics relate to multiple interacting task- and experimenter-related variables, and find that lab-specific differences contribute little to the variance observed. Therefore, analysis approaches that account for correlated behavioral variables are important for establishing reproducible results when working with electrophysiological data from animals performing decision-making tasks. This paper is very well-motivated and needed. However, what is missing is a direct comparison of task modulation of neurons across labs using standard analysis practice in the fields, such as generalized linear model (GLM). This can potentially clarify how much behavioral variance contributes to the neural variance across labs; and more accurately estimate the scale of the issues of reproducibility in behavioral systems neuroscience, where conclusions often depend on these standard analysis methods.

      We fully agree that a comparison of task-modulation across labs is essential. To address this, we have performed two new analyses and added new corresponding figures to the main text (Figures 7 and 9). As the reviewer hoped, this analysis did indeed clarify how much behavioral variance contributes to the variance across labs. Critically, these analyses suggested that our results were more robust to reproducibility than the more traditional analyses would indicate.

      Additional details are provided below (See detailed response to R1P1b).

      Strengths:

      (1) This is a well-motivated paper that addresses the critical question of reproducibility in behavioural systems neuroscience. The authors should be commended for their efforts.

      (2) A key strength of this study comes from the large dataset collected in collaboration across ten labs. This allows the authors to assess lab-to-lab reproducibility of electrophysiological data in mice performing the same decision-making task.

      (3) The authors' attempt to streamline preprocessing pipelines and quality metrics is highly relevant in a field that is collecting increasingly large-scale datasets where automation of these steps is increasingly needed.

      (4) Another major strength is the release of code repositories to streamline preprocessing pipelines across labs collecting electrophysiological data.

      (5) Finally, the application of MTNN for characterizing functional modulation of neurons, although not yet widely used in systems neuroscience, seems to have several advantages over traditional methods.

      Thanks very much for noting these strengths of our work.

      Weaknesses:

      (1) In several places the assumptions about standard practices in the field, including preprocessing and analyses of electrophysiology data, seem to be inaccurately presented:

      a) The estimation of how much the histologically verified recording location differs from the intended recording location is valuable information. Importantly, this paper provides citable evidence for why that is important. However, histological verification of recording sites is standard practice in the field, even if not all studies report them. Although we appreciate the authors' effort to further motivate this practice, the current description in the paper may give readers outside the field a false impression of the level of rigor in the field.

      We agree that labs typically do perform histological verification. Still, our methods offer a substantial improvement over standard practice, and this was critical in allowing us to identify errors in targeting. For instance, we used new software, LASAGNA, which is an innovation over the traditional, more informal approach to localizing recording sites. Second, the requirement that two independent reviewers concur on each proposed location for a recording site is also an improvement over standard practice. Importantly, these reviewers use electrophysiological features to more precisely localize electrodes, when needed, which is an improvement over many labs. Finally, most labs use standard 2D atlases to identify recording location (a traditional approach); our use of a 3D atlas and a modern image registration pipeline has improved the accuracy of identifying the true placement of probes in 3D space.

      Importantly, we don’t necessarily advocate that all labs adopt our pipeline; indeed, this would be infeasible for many labs. Instead, our hope is that the variability in probe trajectory that we uncovered will be taken into account in future studies. Here are 3 example ways in which that could happen. First, groups hoping to target a small area for an experiment might elect to use a larger cohort than previously planned, knowing that some insertions will miss their target. Second, our observation that some targeting error arose because experimenters had to move probes due to blood vessels will impact future surgeries: when an experimenter realizes that a blood vessel is in the way, they might still re-position the probe, but they can also adjust its trajectory (e.g., changing the angle) knowing that even little nudges to avoid blood vessels can have a large impact on the resulting insertion trajectory. Third, our observation of a 7 degree deviation between stereotaxic coordinates and Allen Institute coordinates can be used for future trajectory planning steps to improve accuracy of placement. Uncovering this deviation required many insertions and our standardized pipeline, but now that it is known, it can be easily corrected without needing such a pipeline.

      We thank the reviewer for bringing up this issue and have added new text (and modified existing text) in the Discussion to highlight the innovations we introduced that allowed us to carefully quantify probe trajectory across labs (lines 500 - 515):

      “Our ability to detect targeting error benefited from an automated histological pipeline combined with alignment and tracing that required agreement between multiple users, an approach that greatly exceeds the histological analyses done by most individual labs. Our approach, which enables scalability and standardization across labs while minimizing subjective variability, revealed that much of the variance in targeting was due to the probe entry positions at the brain surface, which were randomly displaced across the dataset. … Detecting this offset relied on a large cohort size and an automated histological pipeline, but now that we have identified the offset, it can be easily accounted for by any lab. Specifically, probe angles must be carefully computed from the CCF, as the CCF and stereotaxic coordinate systems do not define the same coronal plane angle. Minimizing variance in probe targeting is another important element in increasing reproducibility, as slight deviations in probe entry position and angle can lead to samples from different populations of neurons. Collecting structural MRI data in advance of implantation could reduce targeting error, although this is infeasible for most labs. A more feasible solution is to rely on stereotaxic coordinates but account for the inevitable off-target measurements by increasing cohort sizes and adjusting probe angles when blood vessels obscure the desired location.”

      b) When identifying which and how neurons encode particular aspects of stimuli or behaviour in behaving animals (when variables are correlated by the nature of the animals behaviour), it has become the standard in behavioral systems neuroscience to use GLMs - indeed many labs participating in the IBL also has a long history of doing this (e.g., Steinmetz et al., 2019; Musall et al., 2023; Orsolic et al., 2021; Park et al., 2014). The reproducibility of results when using GLMs is never explicitly shown, but the supplementary figures to Figure 7 indicate that results may be reproducible across labs when using GLMs (as it has similar prediction performance to the MTNN). This should be introduced as the first analysis method used in a new dedicated figure (i.e., following Figure 3 and showing results of analyses similar to what was shown for the MTNN in Figure 7). This will help put into perspective the degree of reproducibility issues the field is facing when analyzing with appropriate and common methods. The authors can then go on to show how simpler approaches (currently in Figures 4 and 5) - not accounting for a lot of uncontrolled variabilities when working with behaving animals - may cause reproducibility issues.

      We fully agree with the reviewer's suggestion. We have addressed their concern by implementing a Reduced-Rank Regression (RRR) model, which builds upon and extends the principles of Generalized Linear Models (GLMs). The RRR model retains the core regression framework of GLMs while introducing shared, trainable temporal bases across neurons, enhancing the model’s capacity to capture the structure in neural activity (Posani, Wang, et al., bioRxiv, 2024). Importantly, Posani, Wang et al compared the predictive performance of GLMs vs the RRR model, and found that the RRR model provided (slightly) improved performance, so we chose the RRR approach here.

      We highlight this analysis in a new section (lines 350-377) titled, “Single neuron coefficients from a regression-based analysis are reproducible across labs”. This section includes an entirely new Figure (Fig. 7), where this new analysis felt most appropriate, since it is closer in spirit to the MTNN analysis that follows (rather than as a new Figure 3, as the reviewer suggested). As the reviewer hoped, this analysis provides some reassurance that including many variables when characterizing neural activity furnishes results with improved reproducibility. We now state this in the Results and the Discussion (line 456-457), highlighting that these analyses complement the more traditional selectivity analyses, and that using both methods together can be informative.

      When the authors introduce a neural network approach (i.e. MTNN) as an alternative to the analyses in Figures 4 and 5, they suggest: 'generalized linear models (GLMs) are likely too inflexible to capture the nonlinear contributions that many of these variables, including lab identity and spatial positions of neurons, might make to neural activity'). This is despite the comparison between MTNN and GLM prediction performance (Supplement 1 to Figure 7) showing that the MTNN is only slightly better at predicting neural activity compared to standard GLMs. The introduction of new models to capture neural variability is always welcome, but the conclusion that standard analyses in the field are not reproducible can be unfair unless directly compared to GLMs.

      In essence, it is really useful to demonstrate how different analysis methods and preprocessing approaches affect reproducibility. But the authors should highlight what is actually standard in the field, and then provide suggestions to improve from there.

      Thanks again for these comments. We have also edited the MTNN section slightly to accommodate the addition of the previous new RRR section (line 401-402).

      (2) The authors attempt to establish a series of new quality control metrics for the inclusion of recordings and single units. This is much needed, with the goal to standardize unit inclusion across labs that bypasses the manual process while keeping the nuances from manual curation. However, the authors should benchmark these metrics to other automated metrics and to manual curation, which is still a gold standard in the field. The authors did this for whole-session assessment but not for individual clusters. If the authors can find metrics that capture agreed-upon manual cluster labels, without the need for manual intervention, that would be extremely helpful for the field.

      We thank the reviewer for their insightful suggestions regarding benchmarking our quality control metrics against manual curation and other automated methods at the level of individual clusters. We are indeed, as the reviewer notes, publishing results from spike sorting outputs that have been automatically but not manually verified on a neuron-by-neuron basis. To get to the point where we trust these results to be of publishable quality, we manually reviewed hundreds of recordings and thousands of neurons, refining both the preprocessing pipeline and the single-unit quality metrics along the way. All clusters, both those passing QCs and those not passing QCs, are available to review with detailed plots and quantifications at https://viz.internationalbrainlab.org/app (turn on “show advanced metrics” in the upper right, and navigate to the plots furthest down the page, which are at the individual unit level). We would emphasize that these metrics are definitely imperfect (and fully-automated spike sorting remains a work in progress), but so is manual clustering. Our fully automated approach has the advantage of being fully reproducible, which is absolutely critical for the analyses in the present paper. Indeed, if we had actually done manual clustering or curation, one would wonder whether our results were actually reproducible independently. Nevertheless, it is not part of the present manuscript’s objectives to validate or defend these specific choices for automated metrics, which have been described in detail elsewhere (see our Spike Sorting whitepaper, https://figshare.com/articles/online_resource/Spike_sorting_pipeline_for_the_International_Brain_La boratory/19705522?file=49783080). It would be a valuable exercise to thoroughly compare these metrics against a careful, large, manually-curated set, but doing this properly would be a paper in itself and is beyond the scope of the current paper. We also acknowledge that our analyses studying reproducibility across labs could, in principle, result in more or less reproducibility under a different choice of metrics, which we now describe in the Discussion (line 469-470)”:

      “Another significant limitation of the analysis presented here is that we have not been able to assess the extent to which other choices of quality metrics and inclusion criteria might have led to greater or lesser reproducibility.”

      (3) With the goal of improving reproducibility and providing new guidelines for standard practice for data analysis, the authors should report of n of cells, sessions, and animals used in plots and analyses throughout the paper to aid both understanding of the variability in the plots - but also to set a good example.

      We wholeheartedly agree and have added the number of cells, mice and sessions for each figure. This information is included as new tabs in our quality control spreadsheet (https://docs.google.com/spreadsheets/d/1_bJLDG0HNLFx3SOb4GxLxL52H4R2uPRcpUlIw6n4 n-E/). This is referred to in line 158-159 (as well as its original location on line 554 in the section, “Quality control and data inclusion”).

      Other general comments:

      (1) In the discussion (line 383) the authors conclude: 'This is reassuring, but points to the need for large sample sizes of neurons to overcome the inherent variability of single neuron recording'. - Based on what is presented in this paper we would rather say that their results suggest that appropriate analytical choices are needed to ensure reproducibility, rather than large datasets - and they need to show whether using standard GLMs actually allows for reproducible results.

      Thanks. The new GLM-style RRR analysis in Figure 7, following the reviewer’s suggestion, does indeed indicate improved reproducibility across labs. As described above, we see this new analysis as complementary to more traditional analyses of neural selectivity and argue that the two can be used together. The new text (line 461) states:

      “This is reassuring, and points to the need for appropriate analytical choices to ensure reproducibility.”

      (2) A general assumption in the across-lab reproducibility questions in the paper relies on intralab variability vs across-lab variability. An alternative measure that may better reflect experimental noise is across-researcher variability, as well as the amount of experimenter experience (if the latter is a factor, it could suggest researchers may need more training before collecting data for publication). The authors state in the discussion that this is not possible. But maybe certain measures can be used to assess this (e.g. years of conducting surgeries/ephys recordings etc)?

      We agree that understanding experimenter-to-experimenter variability would be very interesting and indeed we had hoped to do this analysis for some time. The problem is that typically, each lab employed one trainee to conduct all the data collection. This prevents us from comparing outcomes from two different experimenters in the same lab. There are exceptions to this, such as the Churchland lab in which 3 personnel (two postdocs and a technician) collected the data. However, even this fortuitous situation did not lend itself well to assessing experimenter-to-experimenter variation: the Churchland lab moved from Cold Spring Harbor to UCLA during the data collection period, which might have caused variability that is totally independent of experimenter (e.g., different animal facilities). Further, once at UCLA, the postdoc and technician worked closely together- alternating roles in animal training, surgery and electrophysiology. We believe that the text in our current Discussion (line 465-468) accurately characterizes the situation:

      “Our experimental design precludes an analysis of whether the reproducibility we observed was driven by person-to-person standardization or lab-to-lab standardization. Most likely, both factors contributed: all lab personnel received standardized instructions for how to implant head bars and train animals, which likely reduced personnel-driven differences.”

      Quantifying the level of experience of each experimenter is an appealing idea and we share the reviewer’s curiosity about its impact on data quality. Unfortunately, quantifying experience is tricky. For instance, years of conducting surgeries is not an unambiguously determinable number. Would we count an experimenter who did surgery every day for a year as having the same experience as an experimenter who did surgery once/month for a year? Would we count a surgeon with expertise in other areas (e.g., windows for imaging) in the same way as surgeons with expertise in ephys-specific surgeries? Because of the ambiguities, we leave this analysis to be the subject of future work; this is now stated in the Discussion (line 476).

      (3) Figure 3b and c: Are these plots before or after the probe depth has been adjusted based on physiological features such as the LFP power? In other words, is the IBL electrophysiological alignment toolbox used here and is the reliability of location before using physiological criteria or after? Beyond clarification, showing both before and after would help the readers to understand how much the additional alignment based on electrophysiological features adjusts probe location. It would also be informative if they sorted these penetrations by which penetrations were closest to the planned trajectory after histological verification.

      The plots in Figure 3b and 3c reflect data after the probe depth has been adjusted based on electrophysiological features. This adjustment incorporates criteria such as LFP power and spiking activity to refine the trajectory and ensure precise alignment with anatomical landmarks. The trajectories have also been reviewed and confirmed by two independent reviewers. We have clarified this in line 180 and in the caption of Figure 3.

      To address this concern, we have added a new panel c in Figure 3 supplementary 1 (also shown below) that shows the LFP features along the probes prior to using the IBL alignment toolbox. We hope the reviewer agrees that a comparison of panels (a) and (c) below make clear the improvement afforded by our alignment tools.

      In Figure 3 and Figure 3 supplementary 1, as suggested, we have also now sorted the probes by those that were closest to the planned trajectory. This way of visualizing the data makes it clear that as the distance from the planned trajectory increases, the power spectral density in the hippocampal regions becomes less pronounced and the number of probes that have a large portion of the channels localized to VISa/am, LP and PO decreases. We have added text to the caption to describe this. We thank the reviewer for this suggestion and agree that it will help readers to understand how much the additional alignment (based on electrophysiological features) adjusts probe location.

      (4) In Figures 4 and 6: If the authors use a 0.05 threshold (alpha) and a cell simply has to be significant on 1/6 tests to be considered task modulated, that means that they have a false positive rate of ~30% (0.05*6=0.3). We ran a simple simulation looking for significant units (from random null distribution) from these criteria which shows that out of 100.000 units, 26500 units would come out significant (false error rate: 26.5%). That is very high (and unlikely to be accepted in most papers), and therefore not surprising that the fraction of task-modulated units across labs is highly variable. This high false error rate may also have implications for the investigation of the spatial position of task-modulated units (as effects of the spatial position may drown in falsely labelled 'task-modulated' cells).

      Thank you for this concern. The different tests were kept separate, so we did not consider a neuron modulated if it was significant in only one out of six tests, but instead we asked whether a neuron was modulated according to test one, whether it was modulated according to test two, etc., and performed further analyses separately for each test. Thus, we are only vulnerable to the ‘typical’ false positive rate of 0.05 for any given test. We made this clearer in the text (lines 232-236) and hope that the 5% false positive rate seems more acceptable.

      (5) The authors state from Figure 5b that the majority of cells could be well described by 2 PCs. The distribution of R2 across neurons is almost uniform, so depending on what R2 value one considers a 'good' description, that is the fraction of 'good' cells. Furthermore, movement onset has now been well-established to be affecting cells widely and in large fractions, so while this analysis may work for something with global influence - like movement - more sparsely encoded variables (as many are in the brain) may not be well approximated with this suggestion. The authors could expand this analysis into other epochs like activity around stimulus presentation, to better understand how this type of analysis reproduces across labs for features that have a less global influence.

      We thank the reviewer for the suggestion and fully agree that the window used in our original analysis would tend to favor movement-driven neurons. To address this, we repeated the analysis, this time using a window centered around stimulus onset (from -0.5 s prior to stimulus onset until 0.1 s after stimulus onset). As the reviewer suspected, far fewer neurons were active in this window and consequently far fewer were modelled well by the first two PCs, as shown in Author response image 1b (below). Similar to our original analysis using the post-movement window, we found mixed results for the stimulus-centered window across labs. Interestingly, regional differences were weaker in this new analysis compared to the original analysis of the post-movement window. We have added a sentence to the results describing this. Because the results are similar to the post-movement window main figure, we would prefer to restrict the new analysis only to this point-by-point response, in the hopes of streamlining the paper.

      Author response image 1.

      PCA analysis applied to a stimulus-aligned window ([-0.5, 0.1] sec relative to stim onset). Figure conventions as in main text Fig 5. Results are comparable to the post-movement window analysis, however regional differences are weaker here, possibly because fewer cells were active in the pre-movement window. We added panel j here and in the main figure, showing cell-number-controlled results. I.e. for each test, the minimum neuron number of the compared classes was sampled from all classes (say labs in a region), this sampling was repeated 1000 times and p-values combined via Fisher’s method, overall resulting in much fewer significant differences across laboratories and, independently, regions.

      (6) Additionally, in Figure 5i: could the finding that one can only distinguish labs when taking cells from all regions, simply be a result of a different number of cells recorded in each region for each lab? It makes more sense to focus on the lab/area pairing as the authors also do, but not to make their main conclusion from it. If the authors wish to do the comparison across regions, they will need to correct for the number of cells recorded in each region for each lab. In general, it was a struggle to fully understand the purpose of Figure 5. While population analysis and dimensionality reduction are commonplace, this seems to be a very unusual use of it.

      We agree that controlling for varying cell numbers is a valuable addition to this analysis. We added panel j in Fig. 5 showing cell-number-controlled test results of panel i. I.e. for a given statistical comparison, we sample the lowest number of cells of compared classes from the others, do the test, and repeat this sampling 1000 times, before combining the p-values using Fisher’s method. This cell-number controlled version of the tests resulted in clearly fewer significant differences across distributions - seen similarly for the pre-movement window shown in j in Author response image 1. We hope this clarified our aim to illustrate that low-dimensional embedding of cells’ trial-averaged activity can show how regional differences compare with laboratory differences.

      As a complementary statistical analysis to the shown KS tests, we fitted a linear-mixed-effects model (statsmodels.formula.api mixedlm), to the first and second PC for both activity windows (“Move”: [-0.5,1] first movement aligned; “Stim”: [-0.5,0.1] stimulus onset aligned), independently. Author response image 2 (in this rebuttal only) is broadly in line with the KS results, showing more regional than lab influences on the distributions of first PCs for the post-movement window.

      Author response image 2:

      Linear mixed effects model results for two PCs and two activity windows. For the post-movement window (“Move”), regional influences are significant (red color in plots) for all but one region while only one lab has a significant model coefficient for PC1. For PC2 more labs and three regions have significant coefficients. For the pre-movement window (“Stim”) one region for PC1 or PC2 has significant coefficients. The variance due to session id was smaller than all other effects (“eids Var”). “Intercept” shows the expected value of the response variable (PC1, PC2) before accounting for any fixed or random effects. All p-values were grouped as one hypothesis family and corrected for multiple comparisons via Benjamini-Hochberg.

      (7) In the discussion the authors state: " Indeed this approach is a more effective and streamlined way of doing it, but it is questionable whether it 'exceeds' what is done in many labs.

      Classically, scientists trace each probe manually with light microscopy and designate each area based on anatomical landmarks identified with nissl or dapi stains together with gross landmarks. When not automated with 2-PI serial tomography and anatomically aligned to a standard atlas, this is a less effective process, but it is not clear that it is less precise, especially in studies before neuropixels where active electrodes were located in a much smaller area. While more effective, transforming into a common atlas does make additional assumptions about warping the brain into the standard atlas - especially in cases where the brain has been damaged/lesioned. Readers can appreciate the effectiveness and streamlining provided by these new tools without the need to invalidate previous approaches.

      We thank the reviewer for highlighting the effectiveness of manual tracing methods used traditionally. Our intention in the statement was not to invalidate the precision or value of these classical methods but rather to emphasize the scalability and streamlining offered by our pipeline. We have revised the language to more accurately reflect this (line 500-504):

      “Our ability to detect targeting error benefited from an automated histological pipeline combined with alignment and tracing that required agreement between multiple users, an approach that greatly exceeds the histological analyses done by most individual labs. Our approach, which enables scalability and standardization across labs while minimizing subjective variability, revealed that much of the variance in targeting was due to the probe entry positions at the brain surface, which were randomly displaced across the dataset.”

      (8) What about across-lab population-level representation of task variables, such as in the coding direction for stimulus or choice? Is the general decodability of task variables from the population comparable across labs?

      Excellent question, thanks! We have added the new section “Decodability of task variables is consistent across labs, but varies by brain region” (line 423-448) and Figure 9 in the revised manuscript to address this question. In short, yes, the general decodability of task variables from the population is comparable across labs, providing additional reassurance of reproducibility.

      Reviewer #2 (Public review):

      Summary:

      The authors sought to evaluate whether observations made in separate individual laboratories are reproducible when they use standardized procedures and quality control measures. This is a key question for the field. If ten systems neuroscience labs try very hard to do the exact same experiment and analyses, do they get the same core results? If the answer is no, this is very bad news for everyone else! Fortunately, they were able to reproduce most of their experimental findings across all labs. Despite attempting to target the same brain areas in each recording, variability in electrode targeting was a source of some differences between datasets.

      Major Comments:

      The paper had two principal goals:

      (1) to assess reproducibility between labs on a carefully coordinated experiment

      (2) distill the knowledge learned into a set of standards that can be applied across the field.

      The manuscript made progress towards both of these goals but leaves room for improvement.

      (1) The first goal of the study was to perform exactly the same experiment and analyses across 10 different labs and see if you got the same results. The rationale for doing this was to test how reproducible large-scale rodent systems neuroscience experiments really are. In this, the study did a great job showing that when a consortium of labs went to great lengths to do everything the same, even decoding algorithms could not discern laboratory identity was not clearly from looking at the raw data. However, the amount of coordination between the labs was so great that these findings are hard to generalize to the situation where similar (or conflicting!) results are generated by two labs working independently.

      Importantly, the study found that electrode placement (and thus likely also errors inherent to the electrode placement reconstruction pipeline) was a key source of variability between datasets. To remedy this, they implemented a very sophisticated electrode reconstruction pipeline (involving two-photon tomography and multiple blinded data validators) in just one lab-and all brains were sliced and reconstructed in this one location. This is a fantastic approach for ensuring similar results within the IBL collaboration, but makes it unclear how much variance would have been observed if each lab had attempted to reconstruct their probe trajectories themselves using a mix of histology techniques from conventional brain slicing, to light sheet microscopy, to MRI imaging.

      This approach also raises a few questions. The use of standard procedures, pipelines, etc. is a great goal, but most labs are trying to do something unique with their setup. Bigger picture, shouldn't highly "significant" biological findings akin to the discovery of place cells or grid cells, be so clear and robust that they can be identified with different recording modalities and analysis pipelines?

      We agree, and hope that this work may help readers understand what effect sizes may be considered “clear and robust” from datasets like these. We certainly support the reviewer’s point that multiple approaches and modalities can help to confirm any biological findings, but we would contend that a clear understanding of the capabilities and limitations of each approach is valuable, and we hope that our paper helps to achieve this.

      Related to this, how many labs outside of the IBL collaboration have implemented the IBL pipeline for their own purposes? In what aspects do these other labs find it challenging to reproduce the approaches presented in the paper? If labs were supposed to perform this same experiment, but without coordinating directly, how much more variance between labs would have been seen? Obviously investigating these topics is beyond the scope of this paper. The current manuscript is well-written and clear as is, and I think it is a valuable contribution to the field. However, some additional discussion of these issues would be helpful.

      We thank the reviewer for raising this important issue. We know of at least 13 labs that have implemented the behavioral task software and hardware that we published in eLife in 2021, and we expect that over the next several years labs will also implement these analysis pipelines (note that it is considerably cheaper and faster to implement software pipelines than hardware). In particular, a major goal of the staff in the coming years is to continue and improve the support for pipeline deployment and use. However, our goal in this work, which we have aimed to state more clearly in the revised manuscript, was not so much to advocate that others adopt our pipeline, but instead to use our standardized approach as a means of assessing reproducibility under the best of circumstances (see lines 48-52): “A high level of reproducibility of results across laboratories when procedures are carefully matched is a prerequisite to reproducibility in the more common scenario in which two investigators approach the same high-level question with slightly different experimental protocols.”

      Further, a number of our findings are relevant to other labs regardless of whether they implement our exact pipeline, a modified version of our pipeline, or something else entirely. For example, we found probe targeting to be a large source of variability. Our ability to detect targeting error benefited from an automated histological pipeline combined with alignment and tracing that required agreement between multiple users, but now that we have identified the offset, it can be easily accounted for by any lab. Specifically, probe angles must be carefully computed from the CCF, as the CCF and stereotaxic coordinate systems do not define the same coronal plane angle. Relatedly, we found that slight deviations in probe entry position can lead to samples from different populations of neurons. Although this took large cohort sizes to discover, knowledge of this discovery means that future experiments can plan for larger cohort sizes to allow for off-target trajectories, and can re-compute probe angle when the presence of blood vessels necessitates moving probes slightly. These points are now highlighted in the Discussion (lines 500-515).

      Second, the proportion of responsive neurons (a quantity often used to determine that a particular area subserves a particular function), sometimes failed to reproduce across labs. For example, for movement-driven activity in PO, UCLA reported an average change of 0 spikes/s, while CCU reported a large and consistent change (Figure 4d, right most panel, compare orange vs. yellow traces). This argues that neuron-to-neuron variability means that comparisons across labs require large cohort sizes. A small number of outlier neurons in a session can heavily bias responses. We anticipate that this problem will be remedied as tools for large scale neural recordings become more widely used. Indeed, the use of 4-shank instead of single-shank Neuropixels (as we used here) would have greatly enhanced the number of PO neurons we measured in each session. We have added new text to Results explaining this (lines 264-268):

      “We anticipate that the feasibility of even larger scale recordings will make lab-to-lab comparisons easier in future experiments; multi-shank probes could be especially beneficial for cortical recordings, which tend to be the most vulnerable to low cell counts since the cortex is thin and is the most superficial structure in the brain and thus the most vulnerable to damage. Analyses that characterize responses to multiple parameters are another possible solution (See Figure 7).”

      (2) The second goal of the study was to present a set of data curation standards (RIGOR) that could be applied widely across the field. This is a great idea, but its implementation needs to be improved if adoption outside of the IBL is to be expected. Here are three issues:

      (a) The GitHub repo for this project (https://github.com/int-brain-lab/paper-reproducible-ephys/) is nicely documented if the reader's goal is to reproduce the figures in the manuscript. Consequently, the code for producing the RIGOR statistics seems mostly designed for re-computing statistics on the existing IBL-formatted datasets. There doesn't appear to be any clear documentation about how to run it on arbitrary outputs from a spike sorter (i.e. the inputs to Phy).

      We agree that clear documentation is key for others to adopt our standards. To address this, we have added a section at the end of the README of the repository that links to a jupyter notebook (https://github.com/int-brain-lab/paper-reproducible-ephys/blob/master/RIGOR_script.ipynb) that runs the RIGOR metrics on a user’s own spike sorted dataset. The notebook also contains a tutorial that walks through how to visually assess the quality of the raw and spike sorted data, and computes the noise level metrics on the raw data as well as the single cell metrics on the spike sorted data.

      (b) Other sets of spike sorting metrics that are more easily computed for labs that are not using the IBL pipeline already exist (e.g. "quality_metrics" from the Allen Institute ecephys pipeline [https://github.com/AllenInstitute/ecephys_spike_sorting/blob/main/ecephys_spike_sorting/m odules/quality_metrics/README.md] and the similar module in the Spike Interface package [https://spikeinterface.readthedocs.io/en/latest/modules/qualitymetrics.html]). The manuscript does not compare these approaches to those proposed here, but some of the same statistics already exist (amplitude cutoff, median spike amplitude, refractory period violation).

      There is a long history of researchers providing analysis algorithms and code for spike sorting quality metrics, and we agree that the Allen Institute’s ecephys code and the Spike Interface package are the current options most widely used (but see also, for example, Fabre et al. https://github.com/Julie-Fabre/bombcell). Our primary goal in the present work is not to advocate for a particular implementation of any quality metrics (or any spike sorting algorithm, for that matter), but instead to assess reproducibility of results, given one specific choice of spike sorting algorithm and quality metrics. That is why, in our comparison of yield across datasets (Fig 1F), we downloaded the raw data from those comparison datasets and re-ran them under our single fixed pipeline, to establish a fair standard of comparison. A full comparison of the analyses presented here under different choices of quality metrics and spike sorting algorithms would undoubtedly be interesting and useful for the field - however, we consider it to be beyond the scope of the present work. It is therefore an important assumption of our work that the result would not differ materially under a different choice of sorting algorithm and quality metrics. We have added text to the Discussion to clarify this limitation:

      “Another significant limitation of the analysis presented here is that we have not been able to assess the extent to which other choices of quality metrics and inclusion criteria might have led to greater or lesser reproducibility.”

      That said, we still intend for external users to be able to easily run our pipelines and quality metrics.

      (c) Some of the RIGOR criteria are qualitative and must be visually assessed manually. Conceptually, these features make sense to include as metrics to examine, but would ideally be applied in a standardized way across the field. The manuscript doesn't appear to contain a detailed protocol for how to assess these features. A procedure for how to apply these criteria for curating non-IBL data (or for implementing an automated classifier) would be helpful.

      We agree. To address this, we have provided a notebook that runs the RIGOR metrics on a user’s own dataset, and contains a tutorial on how to interpret the resulting plots and metrics (https://github.com/int-brain-lab/paper-reproducible-ephys/blob/master/RIGOR_script.ipynb).

      Within this notebook there is a section focused on visually assessing the quality of both the raw data and the spike sorted data. The code in this section can be used to generate plots, such as raw data snippets or the raster map of the spiking activity, which are typically used to visually assess the quality of the data. In Figure 1 Supplement 2 we have provided examples of such plots that show different types of artifactual activity that should be inspected.

      Other Comments:

      (1) How did the authors select the metrics they would use to evaluate reproducibility? Was this selection made before doing the study?

      Our metrics were selected on the basis of our experience and expertise with extracellular electrophysiology. For example: some of us previously published on epileptiform activity and its characteristics in some mice (Steinmetz et al. 2017), so we included detection of that type of artifact here; and, some of us previously published detailed investigations of instability in extracellular electrophysiological recordings and methods for correcting them (Steinmetz et al. 2021, Windolf et al. 2024), so we included assessment of that property here. These metrics therefore represent our best expert knowledge about the kinds of quality issues that can affect this type of dataset, but it is certainly possible that future investigators will discover and characterize other quality issues.

      The selection of metrics was primarily performed before the study (we used these assessments internally before embarking on the extensive quantifications reported here), and in cases where we refined them further during the course of preparing this work, it was done without reference to statistical results on reproducibility but instead on the basis of manual inspection of data quality and metric performance.

      (2) Was reproducibility within-lab dependent on experimenter identity?

      We thank the reviewer for this question. We have addressed it in our response to R1 General comment 2, as follows:

      We agree that understanding experimenter-to-experimenter variability would be very interesting and indeed we had hoped to do this analysis for some time. The problem is that typically, each lab employed one trainee to conduct all the data collection. This prevents us from comparing outcomes from two different experimenters in the same lab. There are exceptions to this, such as the Churchland lab in which 3 personnel (two postdocs and a technician) collected the data. However, even this fortuitous situation did not lend itself well to assessing experimenter-to-experimenter variation: the Churchland lab moved from Cold Spring Harbor to UCLA during the data collection period, which might have caused variability that is totally independent of experimenter (e.g., different animal facilities). Further, once at UCLA, the postdoc and technician worked closely together- alternating roles in animal training, surgery and electrophysiology. We believe that the text in our current Discussion (line 465-468) accurately characterizes the situation:

      “Our experimental design precludes an analysis of whether the reproducibility we observed was driven by person-to-person standardization or lab-to-lab standardization. Most likely, both factors contributed: all lab personnel received standardized instructions for how to implant head bars and train animals, which likely reduced personnel-driven differences.”

      Quantifying the level of experience of each experimenter is an appealing idea and we share the reviewer’s curiosity about its impact on data quality. Unfortunately, quantifying experience is tricky. For instance, years of conducting surgeries is not an unambiguously determinable number. Would we count an experimenter who did surgery every day for a year as having the same experience as an experimenter who did surgery once/month for a year? Would we count a surgeon with expertise in other areas (e.g., windows for imaging) in the same way as surgeons with expertise in ephys-specific surgeries? Because of the ambiguities, we leave this analysis to be the subject of future work; this is now stated in the Discussion (line 476).

      (3) They note that UCLA and UW datasets tended to miss deeper brain region targets (lines 185-188) - they do not speculate why these labs show systematic differences. Were they not following standardized procedures?

      Thank you for raising this point. All researchers across labs were indeed following standardised procedures. We note that our statistical analysis of probe targeting coordinates and angles did not reveal a significant effect of lab identity on targeting error, even though we noted the large number of mis-targeted recordings in UCLA and UW to help draw attention to the appropriate feature in the figure. Given that these differences were not statistically significant, we can see how it was misleading to call out these two labs specifically. While the overall probe placement surface error and angle error both show no such systematic difference, the magnitude of surface error showed a non-significant tendency to be higher for samples in UCLA & UW, which, compounded with the direction of probe angle error, caused these probe insertions to land in a final location outside LP & PO.

      This shows how subtle differences in probe placement & angle accuracy can lead to compounded inaccuracies at the probe tip, especially when targeting deep brain regions, even when following standard procedures. We believe this is driven partly by the accuracy limit or resolution of the stereotaxic system, along with slight deviations in probe angle, occurring during the setup of the stereotaxic coordinate system during these recordings.

      We have updated the relevant text in lines 187-190 as follows, to clarify:

      “Several trajectories missed their targets in deeper brain regions (LP, PO), as indicated by gray blocks, despite the lack of significant lab-dependent effects in targeting as reported above. These off-target trajectories tended to have both a large displacement from the target insertion coordinates and a probe angle that unfavorably drew the insertions away from thalamic nuclei (Figure 2f).”

      (4) The authors suggest that geometrical variance (difference between planned and final identified probe position acquired from reconstructed histology) in probe placement at the brain surface is driven by inaccuracies in defining the stereotaxic coordinate system, including discrepancies between skull landmarks and the underlying brain structures. In this case, the use of skull landmarks (e.g. bregma) to determine locations of brain structures might be unreliable and provide an error of ~360 microns. While it is known that there is indeed variance in the position between skull landmarks and brain areas in different animals, the quantification of this error is a useful value for the field.

      We thank the reviewer for their thoughtful comment and are glad that they found the quantification of variance useful for the field.

      (5) Why are the thalamic recording results particularly hard to reproduce? Does the anatomy of the thalamus simply make it more sensitive to small errors in probe positioning relative to the other recorded areas?

      We thank the reviewer for raising this interesting question. We believe that they are referring to Figure 4: indeed when we analyzed the distribution of firing rate modulations, we saw some failures of reproducibility in area PO (bottom panel, Figure 4h). However, the thalamic nuclei were not, in other analyses, more vulnerable to failures in reproducibility. For example, in the top panel of Figure 4h, VisAM shows failures of reproducibility for modulation by the visual stimulus. In Fig. 5i, area CA1 showed a failure of reproducibility. We fear that the figure legend title in the previous version (which referred to the thalamus specifically) was misleading, and we have revised this. The new title is, “Neural activity is modulated during decision-making in five neural structures and is variable between laboratories.” This new text more accurately reflects that there were a number of small, idiosyncratic failures of reproducibility, but that these were not restricted to a specific structure. The new analysis requested by R1 (now in Figure 7) provides further reassurance of overall reproducibility, including in the thalamus (see Fig. 7a, right panels; lab identity could not be decoded from single neuron metrics, even in the thalamus).

      Reviewer #1 (Recommendations for the authors):

      (1) Figure font sizes and formatting are variable across panels and figures. Please streamline the presentation of results.

      Thank you for your feedback. We have remade all figures with the same standardized font sizes and formatting.

      (2) Please correct the noncontinuous color scales in Figures 3b and 3d.

      Thank you for pointing this out, we fixed the color bar.

      (3) In Figures 5d and g, the error bars are described as: 'Error bands are standard deviation across cells normalised by the square root of the number of sessions in the region'. How does one interpret this error? It seems to be related to the standard error of the mean (std/sqrt(n)) but instead of using the n from which the standard deviation is calculated (in this case across cells), the authors use the number of sessions as n. If they took the standard deviation across sessions this would be the sem across sessions, and interpretable (as sem*1.96 is the 95% parametric confidence interval of the mean). Please justify why these error bands are used here and how they can be interpreted - it also seems like it is the only time these types of error bands are used.

      We agree and for clarity use standard error across cells now, as the error bars do not change dramatically either way.

      (4) It is difficult to understand what is plotted in Figures 5e,h, please unpack this further and clarify.

      Thank you for pointing this out. We have added additional explanation in the figure caption (See caption for Figure 5c) to explain the KS test.

      (5) In lines 198-201 the authors state that they were worried that Bonferroni correction with 5 criteria would be too lenient, and therefore used 0.01 as alpha. I am unsure whether the authors mean that they are correcting for multiple comparisons across features or areas. Either way, 0.01 alpha is exactly what a Bonferroni corrected alpha would be when correcting for either 5 features or 5 areas: 0.05/5=0.01. Or do they mean they apply the Bonferroni correction to the new 0.01 alpha: i.e., 0.01/5=0.002? Please clarify.

      Thank you, that was indeed written confusingly. We considered all tests and regions as whole, so 7 tests * 5 regions = 35 tests, which would result in a very strong Bonferroni correction. Indeed, if one considers the different tests individually, the correction we apply from 0.05 to 0.01 can be considered as correcting for the number of regions, which we now highlight better. We apply no further corrections of any kind to our alpha=0.01. We clarified this in the manuscript in all relevant places (lines 205-208, 246, 297-298, and 726-727).

      (6) Did the authors take into account how many times a probe was used/how clean the probe was before each recording. Was this streamlined between labs? This can have an effect on yield and quality of recording.

      We appreciate the reviewer highlighting the potential impact of probe use and cleanliness on recording quality and yield. While we did not track the number of times each probe was used, we ensured that all probes were cleaned thoroughly after each use using a standardized cleaning protocol (Section 16: Cleaning the electrode after data acquisition in Appendix 2: IBL protocol for electrophysiology recording using Neuropixels probe). We acknowledge that tracking the specific usage history of each probe could provide additional insights, but unfortunately we did not track this information for this project. In prior work the re-usability of probes has been quantified, showing insignificant degradation with use (e.g. Extended Data Fig 7d from Jun et al. 2017).

      (7) Figure 3, Supplement1: DY_013 missed DG entirely? Was this included in the analysis?

      Thank you for this question. We believe the reviewer is referring to the lack of a prominent high-amplitude LFP band in this mouse, and lack of high-quality sorted units in that region. Despite this, our histology did localize the recording trajectory to DG. This recording did pass our quality control criteria overall, as indicated by the green label, and was used in relevant analyses.

      The lack of normal LFP features and neuron yield might reflect the range of biological variability (several other sessions also have relatively weak DG LFP and yield, though DY_013 is the weakest), or could reflect some damage to the tissue, for example as caused by local bleeding. Because we could not conclusively identify the source of this observation, we did not exclude it.

      (8) Given that the authors argue for using the MTNN over GLMs, it would be useful to know exactly how much better the MTNN is at predicting activity in the held-out dataset (shown in Figure 7, Supplement 1). It looks like a very small increase in prediction performance between MTNN and GLMs, is it significantly different?

      The average variance explained on the held-out dataset, as shown in Figure 8–Figure Supplement 1 Panel B, is 0.065 for the GLMs and 0.071 for the MTNN. As the reviewer correctly noted, this difference is not significant. However, one of the key advantages of the MTNN over GLMs lies in its flexibility to easily incorporate covariates, such as electrophysiological characteristics or session/lab IDs, directly into the analysis. This feature is particularly valuable for assessing effect sizes and understanding the contributions of various factors.

      (9) In line 723: why is the threshold for mean firing rate for a unit to be included in the MTNN results so high (>5Hz), and how does it perform on units with lower firing rates?      

      We thank the reviewer for pointing this out. The threshold for including units with a mean firing rate above 5 Hz was set because most units with firing rates below this threshold were silent in many trials, and reducing the number of units helped keep the MTNN training time reasonable. Based on this comment, we ran the MTNN experiments including all units with firing rates above 1 Hz, and the results remained consistent with our previous conclusions (Figure 8). Crucially, the leave-one-out analysis consistently showed that lab and session IDs had effect sizes close to zero, indicating that both within-lab and between-lab random effects are small and comparable.

      Reviewer #2 (Recommendations for the authors):

      (1) Most of the more major issues were already listed in the above comments. The strongest recommendation for additional work would be to improve the description and implementation of the RIGOR statistics such that non-IBL labs that might use Neuropixels probes but not use the entire IBL pipeline might be able to apply the RIGOR framework to their own data.

      We thank the reviewer for highlighting the importance of making the RIGOR statistics more accessible to a broader audience. We agree that improving the description and implementation of the RIGOR framework is essential for facilitation of non-IBL labs using Neuropixels probes. To address this we created a jupyter notebook with step-by-step guidance that is not dependent on the IBL pipeline. This tool (https://github.com/int-brain-lab/paper-reproducible-ephys/blob/develop/RIGOR_script.ipynb) is publicly available through the repository, accompanied by example datasets and usage tutorials.

      (2) Table 1: How are qualitative features like "drift" defined? Some quantitative statistics like "presence ratio" (the fraction of the dataset where spikes are present) already exist in packages like ecephys_spike_sorting. Who measured these qualitative features? What are the best practices for doing these qualitative analyses?

      At the probe level, we compute the estimate of the relative motion of the electrodes to the brain tissue at multiple depths along the electrode. We overlay the drift estimation over a raster plot to detect sharp displacements as a function of time. Quantitatively, the drift is the cumulative absolute electrode motion estimated during spike sorting (µm). We clarified the corresponding text in Table 1.

      The qualitative assessments were carried out by IBL staff and experimentalists. We have now provided code to run the RIGOR metrics along with an embedded tutorial, to complement the supplemental figures we have shown about qualitative metric interpretation.

      (3) Table 1: What are the units for the LFP derivative?

      We thank the reviewer for noting that the unit was missing. The unit (decibel per unit of space) is now in the table.

      (4) Table 1: For "amplitude cutoff", the table says that "each neuron must pass a metric". What is the metric?

      We have revised the table to include this information. This metric was designed to detect potential issues in amplitude distributions caused by thresholding during deconvolution, which could result in missed spikes. There are quantitative thresholds on the distribution of the low tail of the amplitude histogram relative to the high tail, and on the relative magnitude of the bins in the low tail. We now reference the methods text from the table, which includes a more extended description and gives the specific threshold numbers. Also, the metric and thresholds are more easily understood with graphical assistance; see the IBL Spike Sorting Whitepaper for this (Fig. 17 in that document and nearby text; https://doi.org/10.6084/m9.figshare.19705522.v4). This reference is now also cited in the text.

      (5) Figure 2: In panel A, the brain images look corrupted.

      Thanks; in the revised version we have changed the filetype to improve the quality of the panel image.

      (6) Figure 7: In panel D, make R2 into R^2 (with a superscript)

      Panel D y-axis label has been revised to include superscript (note that this figure is now Figure 8).

      Works Cited

      Julie M.J. Fabre, Enny H. van Beest, Andrew J. Peters, Matteo Carandini, and Kenneth D. Harris. Bombcell: automated curation and cell classification of spike-sorted electrophysiology data, July 2023. URL https://doi.org/10.5281/zenodo.8172822.

      James J. Jun, Nicholas A. Steinmetz, Joshua H. Siegle, Daniel J. Denman, Marius Bauza, Brian Barbarits, Albert K. Lee, Costas A. Anastassiou, Alexandru Andrei, C¸ a˘gatayAydın, Mladen Barbic, Timothy J. Blanche, Vincent Bonin, Jo˜ao Couto, Barundeb Dutta, Sergey L. Gratiy, Diego A. Gutnisky, Michael H¨ausser, Bill Karsh, Peter Ledochowitsch, Carolina Mora Lopez, Catalin Mitelut, Silke Musa, Michael Okun, Marius Pachitariu, Jan Putzeys, P. Dylan Rich, Cyrille Rossant, Wei-lung Sun, Karel Svoboda, Matteo Carandini, Kenneth D. Harris, Christof Koch, John O’Keefe, and Timothy D.Harris. Fully integrated silicon probes for high-density recording of neural activity.Nature, 551(7679):232–236, Nov 2017. ISSN 1476-4687. doi: 10.1038/nature24636. URL https://doi.org/10.1038/nature24636.

      Simon Musall, Xiaonan R. Sun, Hemanth Mohan, Xu An, Steven Gluf, Shu-Jing Li, Rhonda Drewes, Emma Cravo, Irene Lenzi, Chaoqun Yin, Bj¨orn M. Kampa, and Anne K. Churchland. Pyramidal cell types drive functionally distinct cortical activity patterns during decision-making. Nature Neuroscience, 26(3):495– 505, Mar 2023. ISSN 1546-1726. doi: 10.1038/s41593-022-01245-9. URL https://doi.org/10.1038/s41593-022-01245-9.

      Ivana Orsolic, Maxime Rio, Thomas D Mrsic-Flogel, and Petr Znamenskiy. Mesoscale cortical dynamics reflect the interaction of sensory evidence and temporal expectation during perceptual decision-making. Neuron, 109(11):1861–1875.e10, April 2021. Hyeong-Dong Park, St´ephanie Correia, Antoine Ducorps, and Catherine Tallon-Baudry.Spontaneous fluctuations in neural responses to heartbeats predict visual detection.Nature Neuroscience, 17(4):612–618, Apr 2014. ISSN 1546-1726. doi: 10.1038/nn.3671. URL https://doi.org/10.1038/nn.3671.

      Lorenzo Posani, Shuqi Wang, Samuel Muscinelli, Liam Paninski, and Stefano Fusi. Rarely categorical, always high-dimensional: how the neural code changes along the cortical hierarchy. bioRxiv, 2024. doi: 10.1101/2024.11.15.623878. URL https://www.biorxiv.org/content/early/2024/12/09/2024.11.15.623878.

      Nicholas A. Steinmetz, Christina Buetfering, Jerome Lecoq, Christian R. Lee, Andrew J. Peters, Elina A. K. Jacobs, Philip Coen, Douglas R. Ollerenshaw, Matthew T. Valley, Saskia E. J. de Vries, Marina Garrett, Jun Zhuang, Peter A. Groblewski, Sahar Manavi, Jesse Miles, Casey White, Eric Lee, Fiona Griffin, Joshua D. Larkin, Kate Roll, Sissy Cross, Thuyanh V. Nguyen, Rachael Larsen, Julie Pendergraft, Tanya Daigle, Bosiljka Tasic, Carol L. Thompson, Jack Waters, Shawn Olsen, David J. Margolis, Hongkui Zeng, Michael Hausser, Matteo Carandini, and Kenneth D. Harris. Aberrant cortical activity in multiple gcamp6-expressing transgenic mouse lines. eNeuro, 4(5), 2017. doi: 10.1523/ENEURO.0207-17.2017. URL https://www.eneuro.org/content/4/5/ENEURO.0207-17.2017.

      Nicholas A. Steinmetz, Peter Zatka-Haas, Matteo Carandini, and Kenneth D. Harris. Distributed coding of choice, action and engagement across the mouse brain. Nature, 576(7786):266–273, Dec 2019. ISSN 1476-4687. doi: 10.1038/s41586-019-1787-x. URL https://doi.org/10.1038/s41586-019-1787-x.

      Nicholas A. Steinmetz, Cagatay Aydin, Anna Lebedeva, Michael Okun, Marius Pachitariu, Marius Bauza, Maxime Beau, Jai Bhagat, Claudia B¨ohm, Martijn Broux, Susu Chen, Jennifer Colonell, Richard J. Gardner, Bill Karsh, Fabian Kloosterman, Dimitar Kostadinov, Carolina Mora-Lopez, John O’Callaghan, Junchol Park, Jan Putzeys, Britton Sauerbrei, Rik J. J. van Daal, Abraham Z. Vollan, Shiwei Wang, Marleen Welkenhuysen, Zhiwen Ye, Joshua T. Dudman, Barundeb Dutta, Adam W. Hantman,Kenneth D. Harris, Albert K. Lee, Edvard I. Moser, John O’Keefe, Alfonso Renart, Karel Svoboda, Michael H¨ausser, Sebastian Haesler, Matteo Carandini, and Timothy D. Harris. Neuropixels 2.0: A miniaturized high-density probe for stable, long-term brain recordings. Science, 372(6539):eabf4588, 2021. doi: 10.1126/science.abf4588.URL https://www.science.org/doi/abs/10.1126/science.abf4588.

      Charlie Windolf, Han Yu, Angelique C. Paulk, Domokos Mesz´ena, William Mu˜noz, Julien Boussard, Richard Hardstone, Irene Caprara, Mohsen Jamali, Yoav Kfir, Duo Xu, Jason E. Chung, Kristin K. Sellers, Zhiwen Ye, Jordan Shaker, Anna Lebedeva, Manu Raghavan, Eric Trautmann, Max Melin, Jo˜ao Couto, Samuel Garcia, Brian Coughlin, Csaba Horv´ath, Rich´ard Fi´ath, Istv´an Ulbert, J. Anthony Movshon, Michael N. Shadlen, Mark M. Churchland, Anne K. Churchland, Nicholas A. Steinmetz, Edward F. Chang, Jeffrey S. Schweitzer, Ziv M. Williams, Sydney S. Cash, Liam Paninski, and Erdem Varol. Dredge: robust motion correction for high-density extracellular recordings across species. bioRxiv, 2023. doi: 10.1101/2023.10.24.563768. URL https://www.biorxiv.org/content/early/2023/10/29/2023.10.24.563768.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      This study extends the previous interesting work of this group to address the potentially differential control of movement and posture. Their earlier work explored a broad range of data to make the case for a downstream neural integrator hypothesized to convert descending velocity movement commands into postural holding commands. Included in that data were observations from people with hemiparesis due to stroke. The current study uses similar data but pushes into a different, but closely related direction, suggesting that these data may address the independence of these two fundamental components of motor control. I find the logic laid out in the second sentence of the abstract ("The paretic arm after stroke is notable for abnormalities both at rest and during movement, thus it provides an opportunity to address the relationships between control of reaching, stopping, and stabilizing") less than compelling, but the study does make some interesting observations. Foremost among them, is the relation between the resting force postural bias and the effect of force perturbations during the target hold periods, but not during movement. While this interesting observation is consistent with the central mechanism the authors suggest, it seems hard to me to rule out other mechanisms, including peripheral ones. 

      Response 1.1. Thank you for your comments, which we address in detail below and in our response to Recommendations to the authors (see pp. 15-19 of this letter). We would first like to clarify the motivation behind our use of a stroke population to understand the interactions between the control of reaching in and holding. We agree that this idea can be laid out in a more compelling way.

      The fact that stroke patients usually display issues with their control of both reaching and holding, allows for within-individual comparisons of those two modes of control. Further, the magnitude of abnormalities is relatively large, making it easier to measure, compare and investigate effects. And, importantly, these two modes of control can be differentially affected after stroke (also pointed out by Reviewer 2, point 4 in Comments to the Authors). Finally, this kind of work – examining interactions between positive signs of stroke (such as abnormal posture or synergy) vs. negative signs (such as loss of motor control) – needs to be done in humans, as positive signs are relatively absent even in primates (Tower, 1940).

      We have changed our abstract (changes shown below in red), and our intro (expanding the second paragraph, lines 75-76), to lay out our motivation more clearly.

      From the abstract:

      “The paretic arm after stroke exhibits different abnormalities during rest vs. movement, providing an opportunity to ask whether control of these behaviors is independently affected in stroke. “

      On the other hand, the relation between force bias and the well-recognized flexor synergy seems rather self-evident, and I don't see that these results add much to that story.

      Response 1.2. While it seems natural that these biases would be the resting expression of abnormal flexor synergies (given their directionality towards the body, as shown in Figures 2-3, and the other similarities we demonstrate in Figure 8), we do not believe it is self-evident. These biases are measured at rest, with the patient passively moved and held still, whereas abnormal synergies emerge when the patient actively tries to move. The lack of relationship we find between these resting force biases and active movement underlines that the relation between force bias and flexor synergy should not be taken as self-evident, making it worthwhile to examine it (as we motivate in lines 589-596 and show in Figure 8).

      The paradox here is that, in spite of a relationship between force bias and flexor synergy (itself manifesting during attempted movement), there seems to be no relationship between force bias and direct measures of active movement (Figures 5,6). This is the paradox that inspired our conceptual model (Figure 9) and inspires to further investigate the factors under which these two systems are intermingled or kept separate. We thus find it to be a helpful element in the story.

      I am also struck by what seems to be a contradiction between the conclusions of the current and former studies: "These findings in stroke suggest that moving and holding still are functionally separable modes of control" and "the commands that hold the arm and finger at a target location depend on the mathematical integration of the commands that moved the limb to that location." The former study is mentioned here only in passing, in a single phrase in the discussion, with no consideration of the relation between the two studies. This is odd and should be addressed. 

      Response 1.3. While these two sets of findings are not contradictory, we understand how they can appear as such without providing context. We now discuss the relationship between our present study and the previous one more directly (lines 66-70 and 663-669 of the revised manuscript).

      The previous study examined how the control of movement informs the control of holding after the movement was over; the current study examines whether abnormalities in holding measured at rest with the movement leading to the rest position being passive. There are thus two important distinctions:

      First, directionality of potential effects: here we examine the effect of (abnormalities in) holding control upon movement, but the 2020 study (Albert et al., 2020) examines the effects of movement upon holding control. Stroke patient data in the 2020 study showed that, under CST damage, while the reach controller is disrupted, the hold controller can continue to integrate the malformed reach commands faithfully. In line with this, we proposed a model where the postural controller system sits downstream of the moving controller (Figure 7G in the 2020 paper). We thus did not claim, in 2020, that integration of movement commands is the only way to do determine posture control, as we stated explicitly back then, e.g. (emphasis ours):

      “Equations (1) and (2) describe how the integration of move activity may relate to changes in hold commands, but does not specify the hold command at the target.”

      In short, finding no effect of holding abnormalities upon movement (present finding) does not mean there is no potential effect of movement upon holding (2020 finding). This is something we had alluded to in the Discussion but not clarified, which we do now (see edits at the end of our response to this point).

      Second, active vs. passive movement: here, we measure holding control at rest (Experiment 1). The 2020 study shows that endpoint forces reflect the integration of learned dynamics exerted during active movement that led to the endpoint position. However, in Experiment 1, there is no active reaching to integrate, as the robot passively moves the arm to the held position. Thus, resting postural forces measured in Experiment 1 could not reflect the integration of reach commands that led to each rest position.  

      Thus, the two sets of findings are not contradictory. Taking our current and 2020 findings together suggests that active holding control would comprise would reflect both the integration of movement control that led to assuming the held position, plus the force biases measured at rest.

      Hence our decision to describe these two systems as functionally separable: while these systems can interact, the effects of post-stroke malfunctions in each can be independent depending on the function and conditions at hand. This does not make this a limited finding: being able to dissociate post-stroke impairment based on each of these two modes of control may inform rehabilitation, and also importantly, understanding the conditions in which these two modes of control become separable can substantially advance our understanding of both how different stroke signs interact with each other and how motor control is assembled in the healthy motor system. Figure 9 illustrates our conceptual model behind this and may serve as a blueprint to further dissect these circuits in the future.

      We discuss these issues briefly in lines 663-669 in our Discussion section, reproduced below for convenience:

      “It should be noted, however, that having distinct neural circuits for reaching and holding does not rule out interactions between them. For example, we recently demonstrated how arm holding control reflects the integration of motor commands driving the preceding active movement that led to the hold position, in both healthy participants and patients with hemiparesis (Albert et al., 2020). However, in that paper, we did not claim that this integration is the only source of holding control. Indeed, in Experiment 1 of the current study, we used passive movement to bring the arm to each probed position, which means that the postural biases could not be the result of integration of motor commands.” 

      And, we have adjusted our Introduction to provide pertinent context regarding our 2020 work (first paragraph, lines 66-70 of the updated manuscript).

      A minor wording concern I had is that the term "holding still" is frequently hard to parse. A couple of examples: "These findings in stroke suggest that moving and holding still are functionally separable modes of control." This example is easily read, "moving and holding [continue to be] functionally separable". Another: "...active reaching and holding still in the same workspace, " could be "...active reaching and holding [are] still in the same workspace." Simply "holding", "posture" or "posture maintenance" would all be better options.

      Response 1.4. Thank you for your suggestion. Following your comment, we have abbreviated this term to simply “holding”, both on the title and throughout the text.

      Reviewer #2 (Public Review):

      Summary: 

      Here the authors address the idea that postural and movement control are differentially impacted with stroke. Specifically, they examined whether resting postural forces influenced several metrics of sensorimotor control (e.g., initial reach angle, maximum lateral hand deviation following a perturbation, etc.) during movement or posture. The authors found that resting postural forces influenced control only following the posture perturbation for the paretic arm of stroke patients, but not during movement. They also found that resting postural forces were greater when the arm was unsupported, which correlated with abnormal synergies (as assessed by the Fugl-Meyer). The authors suggest that these findings can be explained by the idea that the neural circuitry associated with posture is relatively more impacted by stroke than the neural circuitry associated with movement. They also propose a conceptual model that differentially weights the reticulospinal tract (RST) and corticospinal tract (CST) to explain greater relative impairments with posture control relative to movement control, due to abnormal synergies, in those with stroke.

      Strengths: 

      The strength of the paper is that they clearly demonstrate with the posture task (i.e., active holding against a load) that the resting postural forces influence subsequent control (i.e., the path to stabilize, time to stabilize, max. deviation) following a sudden perturbation (i.e., suddenly removal of the load). Further, they can explain their findings with a conceptual model, which is depicted in Figure 9. 

      Weaknesses: 

      Current weaknesses and potential concerns relate to i) not displaying or reporting the results of healthy controls and non-paretic arm in Experiment 2 and ii) large differences in force perturbation waveforms between movement (sudden onset) and posture (sudden release), which could potentially influence the results and or interpretation. 

      Response 2.0. Thank you for your assessment, and for pointing out ways to improve our paper. We address the weakness and potential concerns in detail below.

      Larger concerns

      (1) Additional analyses to further support the interpretation. In Experiment 1 the authors present the results for the paretic arm, non-paretic arm, and controls. However, in Experiment 2 for several key analyses, they only report summary statistics for the paretic arm (Figure 5D-I; Figure 6D-E; Figure 7F). It is understood that the controls have much smaller resting postural force biases, but they are still present (Figure 3B). It would strengthen the position of the paper to show that controls and the non-paretic arm are not influenced by resting postural force biases during movement and particularly during posture, while acknowledging the caveat that the resting positional forces are smaller in these groups. It is recommended that the authors report and display the results shown in Figure 5D-I; Figure 6D-E; Figure 7F for the controls and non-paretic arm. If these results are all null, the authors could alternatively place these results in an additional supplementary. 

      Response 2.1a. Thank you for your recommendations. We agree both on the value of these analyses and the caveat associated with them: these resting postural force biases are substantially smaller for the non-paretic and control data (for example, the magnitude of resting biases in the supported condition is 2.8±0.4N for the paretic data, but only 1.8±0.4N and 1.3±0.2N for the non-paretic and control data, respectively; the difference is even greater in the unsupported condition, though this is not the one being compared to Experiment 2).

      We now conduct a comprehensive series of supplementary analyses, including the examination of non-paretic and control data for all three components of Experiment 2 (unperturbed reaches; pulse perturbations; and active holding control). These are mentioned in the Results (lines 422-424, 512513, and 574-574 of the revised manuscript) and illustrated in the supplementary materials: Supplementary Figures S5-1, S6-1, and S7-1 contain the main analyses (comparisons of instances with the most extreme resting biases for each individual) for the unperturbed reach analysis, pulse perturbation analysis, and active holding control analysis, respectively.

      We find that non-paretic and control data do not display effects of resting biases upon unperturbed reaching control (Figure S5-1) or control against a pulse perturbation early during movement (Figure S6-1) – as is the case with the paretic data. Non-paretic and control data do not display evidence of influence of their resting force biases upon active holding control either (Figure S7-1), unlike the paretic data. For the non-paretic data, however, these influences are nominally towards the same direction as in the paretic data. Given that resting biases are substantially weaker for the non-paretic case, it is possible a similar relationship exists but requires increased statistical power to discern. Moreover, it is possible that the effect of resting biases is non-linear, with small biases effectively kept under check so that their impact upon active holding control is even less than a linearly scaled version of the impact of the stronger, paretic-side biases. This can be the subject of future work.

      Please also note that, following your recommendation (Recommendations to the Authors, point 2.1), we have conducted secondary analyses which estimate sensitivity to resting bias using all datapoints, validating our main analyses; these analyses were also performed for control and non-paretic data, with similar results (Response 2.A.1).

      Further, the results could be further boosted by reporting/displaying additional analyses. In Figure 6D the authors performed a correlation analysis. Can they also display the same analysis for initial deviation and endpoint deviation for the data shown in Figure 5D-F & 5G-I, as well for 7F for the path to stabilization, time to stabilization, and max deviation? This will also create consistency in the analyses performed for each dependent variable across the paper.

      Response 2.1b. Here, we set to test whether resting biases affect movement. It is best to do this using a within-individual comparison design, rather than using across-individual correlations: while correlation analyses can in general be informative, they obscure within-individual effects which are the main comparisons of interest in our study. Consider a participant with strong resting bias towards one direction, tested on opposing perturbations; averaging these responses for each individual would mostly cancel out any effects of resting biases. Even if we were to align responses to the direction of the perturbation before averaging, the power of correlation analyses may be diluted by inter-individual differences in other factors, such as overall stiffness.

      Thus, our analysis design was instead focused on examining the differential effects of resting posture biases within each individual’s data. We compared the most extreme opposing/aligned or clockwise/counter-clockwise instances within each individual, specifically to assess these differential effects. In our revised version, we have further reinforced these analyses to include all data rather than the most extreme instances (see response 2.A.1.a to the Reviewer’s recommendation to the authors) where we performed correlations of within-individual resting posture vs. the corresponding dependent variables and compared the resulting slopes. 

      The across-individual correlation analyses add little to that for the reasons we outlined above. At the same time, it is possible they can be helpful in e.g. illustrating across-individual variability. We thus now include across-individual correlation analyses for all dependent variables, but, given their limited value, only in the supplementary material. This also means that, for consistency, we moved the correlation analysis in Figure 6 to the corresponding supplementary figure as well (Figure S6-3).

      In addition, following the Reviewer’s comment about consistency in the analyses performed for each dependent variable across the paper, we added within-individual comparisons for settling time following the pulse perturbations (Figure 6D, right).

      (2) Inconsistency in perturbations that would differentially impact muscle and limb states during movement and posture. It is well known that differences in muscle state (activation / preloaded, muscle fiber length and velocity) and limb state (position and velocity) impact sensorimotor control (Pruszynski, J. A., & Scott, S. H. (2012). Experimental brain research, 218, 341-359.). Of course, it is appreciated that it is not possible to completely control all states when comparing movement and posture (i.e., muscle and limb velocity). However, using different perturbations differentially impacts muscle and limb states. Within this paper, the authors used very different force waveforms for movement perturbations (i.e., 12 N peak, bell-shaped, 0.7ms duration -> sudden force onset to push the limb; Figure 6A) and posture perturbations (i.e., 6N, 2s ramp up -> 3s hold -> sudden force release that resulted in limb movement; Figure 4) that would differentially impact muscle (and limb) states. Preloaded muscle (as in the posture perturbation) has a very different response compared to muscle that has little preload (as in the movement perturbations, where muscles that would resist a sudden lateral perturbation would likely be less activated since they are not contributing to the forward movement). Would the results hold if the same perturbation had been used for both posture and movement (e.g., 12 N pulse for both experiments)? It is recommended that the authors comment and discuss in the paper why they chose different perturbations and how that might impact the results. 

      Response 2.2a. We agree that it can be impossible to completely control all states when comparing movement and posture. We would also like to stress that these perturbations were not designed so that responses are directly compared to each other (though of course there is an indirect comparison in the sense that we show influence of biases in one type of perturbation but not the other). Instead, Experiment 2 tried to implement a probe optimized for each motor control modality (moving vs. holding). However, the Reviewer has a point that the potential impact of differences between the perturbations is important to discuss in the paper.

      The Reviewer points out two potentially interesting differences between the two perturbations. First, the magnitude (6N for the posture perturbation vs. 12N for the pulse perturbation); second, the presence of background load in the posture perturbation, in contrast to the pulse perturbation.

      For the movement perturbation, we used a 12-N, 70ms pulse. This perturbation and scaled versions have been tested before in both control and patient populations (Smith et al., 2000; Fine and Thoroughman, 2006). For the holding perturbation, we used a background load to ensure that active holding control is engaged, and the duration of the probe (holding for about 5s) made using a stronger perturbation impractical –maintaining a background load at, say, 12N for that long could lead to increased fatigue.

      The question raised by the Reviewer, whether the findings would be the same if the same, 12-N pulse were used to probe both moving and holding control, is interesting to investigate. We would expect the same qualitative findings (i.e. there would still be a connection between resting posture and active holding control when the latter were probed with a 12N pulse). Recent work provides more specific insight into what to expect. Our posture perturbation task is similar to the Unload Task in (Lowrey et al., 2019), whereby a background torque is released, whereas our pulse perturbation is more similar to their Load Task, whereby a torque is imposed against no background load (though it is a step perturbation rather than a pulse). Lowrey et al., 2019 find that their Unload task is harder than the Load task, with 2x the fraction of patient trials classified as failed (with failure defined as task performance being outside of the 95% confidence interval for controls), though there are still clear effects for the Load task. 

      This suggests that the potential effects of using a pulse-like perturbation to probe posture control would likely be weaker in magnitude, all other things being equal. At the same time, however, the Load and Unload tasks in Lowrey et al., 2019 were perturbations of the same magnitude; it is thus also likely that the reduction in effect would be mitigated, or reversed, by the fact that we would be using a 12N instead of a 6N perturbation.

      A relevant consequence of the Lowrey et al., 2019 findings is that the Unload paradigm is superior in its ability to detect impairment in static, posture perturbations, and thus provides a better signal to detect potential relationships with resting posture biases. This is not surprising, as a background load further engages the control of active holding, which what we were trying to probe in the first place.

      But then why not use the same paradigm (preloading and release) for movement? There are two main reasons. First, requiring a background load throughout the experiment is unfeasible due to fatigue. Second, for the holding perturbation, we wanted to ensure that the postural control system is meaningfully engaged when the perturbation hits, hence we picked the background load. Were we to impose the same during moving – i.e. impose a lateral background load on the movement - we could be engaging posture control on top of movement control. This preloading would reduce the degree to which the pulse probe isolates movement control, and lead to intrusion of the posture control system in the movement task by design. This relates to what the Reviewer proposes in the comment below: preloading may result in postural biases i.e. engage posture control; see below where we argue this interpretation is within the scope of our conceptual model rather a counter to it.

      We now explain the rationale behind our perturbation design in the Methods section (lines 211-220).

      Relatedly, an alternative interpretation of the results is that preloading muscle for stroke patients, whether by supporting the weight of one's arm (experiment 1) or statically resisting a load prior to force release (experiment 2), leads to a greater postural force bias that can subsequently influence control. It is recommended that the authors comment on this. 

      Response 2.2b. We find this interpretation valid, but we do not see how it meaningfully differs from the framework we propose. We already state that the RST may be tailored for both posture/holding control and the production of large forces (which would include muscle preloading):

      “Thus, the accumulated evidence suggests that the RST could control posture and large force production in the upper limb.“ (lines 698-699 in the current version)

      “the RST, in contrast, is weighted more towards slower postural control and generation of large isometric forces” (lines 724-726 in the current version)

      And, we discuss other conditions where the RST is involved in large force production, such as power grip, and how these interact with the role of the RST in posture/holding control (lines 758-768 in the current version).

      To better explain our model, we now provide the two examples mentioned by the reviewer along with our description of the proposed role for the RST (lines 726-727):

      “…the RST, in contrast, is weighted more towards slower postural control and generation of large isometric forces (such as vertical forces for arm support, or horizontal forces for holding the arm still against a background load like in our posture/release perturbation trials).”

      We note, however, that we find resting posture abnormalities even in the presence of arm support, suggesting the involvement of the RST in holding control even when the forces involved (and the need to preload the muscle) are small.

      Reviewer #3 (Public Review): 

      The authors attempt to dissociate differences in resting vs active vs perturbed movement biases in people with motor deficits resulting from stroke. The analysis of movement utilizes techniques that are similar to previous motor control in both humans and non-human primates, to assess impairments related to sensorimotor injuries. In this regard, the authors provide additional support to the extensive literature describing movement abnormalities in patients with hemiparesis both at rest and during active movement. The authors describe their intention to separate out the contribution of holding still at a position vs active movement as a demonstration that these two aspects of motor control are controlled by two separate control regimes.

      Strengths: 

      (1) The authors utilize a device that is the same or similar to devices previously used to investigate motor control of movement in normal and impaired conditions in humans and non-human primates. This allows comparisons to existing motor control studies. 

      (2) Experiment 1 demonstrates resting flexion biases both in supported and unsupported forelimb conditions. These biases show a correlated relationship with FM-UE scores, suggesting that the degree of motor impairment and the degree of resting bias are related.

      (3) The stroke patient participant population had a wide range of both levels of impairment and time since stroke, including both sub-acute and chronic cases allowing the results to be compared across impairment levels.

      The authors describe several results from their study: 1. Postural biases were systematically toward the body (flexion) and increased with distance from the body (when the arm was more extended) and were stronger when the arm was unsupported. 2. These postural biases were correlated with FM-UE score. 3. They found no evidence of postural biases impacting movement, even when that movement was perturbed. 4. When holding a position at the end of a movement, if the position was perturbed opposite of the direction of bias, movement back to the target was improved compared to the perturbation in the direction of bias. Taken together, the authors suggest that there are at least two separate motor controls for tasks at rest versus with motion. Further, the authors propose that these results indicate that there is an imbalance between cortical control of movement (through the corticospinal tracts) and postural control (through the reticulospinal tract).

      Response 3.1. Thank you for pointing out some of the strengths of our work and summarizing our findings. A minor clarification we would like to make, related to (3), is that, while our study did enroll two patients towards the end of the subacute stage (2-3 months), the rest of the population were at the chronic stage, at one year and beyond. We thus find it very unlikely that time after stroke was the primary driver of differences in impairment in the population we studied.

      There are several weaknesses related to the interpretation of the results:

      In Experiment 1, the participants are instructed to keep their limbs in a passive position after being moved. The authors show that, in the impaired limb, these resting biases are significantly higher when the limb is unsupported and increase when the arm is moved to a more extended position.

      When supported by the air sled, the arm is in a purely passive position, not requiring the same antigravity response so will have less RST but also less CST involvement. While the unsupported task invokes more involvement of the reticulospinal tract (RST), it likely also has significantly higher CST involvement due to the increased difficulty and novelty of the task.

      If there were an imbalance in CST regulating RST as proposed by the authors, the bias should be higher in the supported condition as there should be relatively less CST activation/involvement/ modulation leading to less moderating input onto the RST and introducing postural biases. In the unsupported condition, there is likely more CST involvement, potentially leading to an increased modulatory effect on RST. If the proportion of CST involvement significantly outweighs the RST activation in the unsupported task, then it isn't obvious that there is a clear differentiation of motor control. As the degree of resting force bias and FM-UE score are correlated, an argument could be made that they are both measuring the impairment of the CST unrelated to any RST output. If it is purely the balance of CST integrity compared to RST, then the degree of bias should have been the same in both conditions. In this idea of controller vs modulator, it is unclear when this switch occurs or how to weigh individual contributions of CST vs. extrapyramidal tracts. Further, it isn't clear why less modulation on the RST would lead only to abnormal flexion.

      Response 3.2. Our model posits two mechanisms by which CST impairment would lead to increased RST involvement. The first – which is the one discussed by the Reviewer here - is a direct one, whereby weaker modulation of the RST by the CST leads to increased RST involvement. The second is an indirect one, whereby the incapacity of CST to drive sufficient motor output to deal with tasks eventually leads to increased RST drive.

      The reviewer suggests it is likely that the unsupported task demands increased activation through both the CST and the RST. If that were the case, however, it would exaggerate the effects of CST/RST imbalance after stroke compared to healthy motor control: if task conditions (lack of support) required higher CST involvement, then CST damage would have an even larger effect. In turn, this would lead to even higher RST involvement and further diminishing the ability of CST to moderate RST. Thus, RST-driven biases would be higher in the unsupported condition.

      And, given that the CST itself is damaged and has to deal with an even-increased RST activation, we would not expect that the proportion of CST involvement would outweigh RST activation, but the opposite. In fact, a series of relatively recent findings suggest just this. For example,

      • Zaaimi et al., 2012  showed that unilateral CST lesions in monkeys lead to significant increases in the excitability of the contralesional RST (Zaaimi et al., 2012). Interestingly, this effect was present in flexors but not extensors, potentially explaining why less modulation and/or overactivation of the RST would primarily lead to abnormal flexion. 

      • McPherson et al. (further discussed in point 2.A.23, by Reviewer 2 – Recommendations to the Authors) showed that, after stroke, contralesional activity (which would include the ipsilateral RST) increases relative to ipsilesional activity (which would include the contralateral CST)

      (McPherson et al., 2018). The same study also provides evidence that FM-UE may primarily reflect RST-driven impairment. The ipsilateral(RST)/contralateral(CST) balance, expressed as a laterality index, correlated with FM-UE, with lower FM-UE for indices indicating higher RST involvement. (Interestingly, the slope of this relationship was steeper when the laterality of brain activation patterns was examined under tasks with less arm support, mirroring the steeper FM-UE vs resting bias slope when arm support is absent, as shown in our Figure 8).

      • Wilkins et al., 2020 (Wilkins et al., 2020) found that providing less support (i.e. requiring increased shoulder abduction) increases ipsilateral activation (representing RST) relative to contralateral activation (representing CST).

      This resting bias could be explained by an imbalance in the activation of flexors vs extensors which follows the results that this bias is larger as the arm is extended further, and/or in a disconnect in sensory integration that is overcome during active movement. Neither would necessitate separate motor control for holding vs active movement. 

      Response 3.3. We do not think that either of these points necessarily argue against our model. First, the resting biases we observe are clearly pointed towards increased flexion, and can thus be seen as the outcome of an imbalance in the activation of flexors vs. extensors at rest. This imbalance between flexors/extensors can also be explained by the CST/RST imbalance posited by our conceptual model: in their study of CST lesions in the monkey, Zaaimi et al., 2012 found increased RST activation for flexors but not extensors, suggesting that RST over-involvement may specifically lead to flexor abnormalities (Zaaimi et al., 2012). Second, overcoming a disconnect in sensory integration may be one way the motor system switches between separate controllers; how this switch happens is not examined by our conceptual model.

      In Experiment 2, the participants are actively moving to and holding at targets for all trials while being supported by the air sled. Even with the support, the paretic participants all showed start- and endpoint force biases around the movement despite not showing systematic deviations in force direction during active movement start or stop. There could be several factors that limit systematic deviations in force direction. The most obvious is that the measured biases are significantly higher when the limb is unsupported and by testing with a supported limb the authors are artificially limiting any effect of the bias.

      Response 3.4. We do expect, in line with what the reviewer suggests, that any potential effects would be stronger in the unsupported condition. The decision to test active motor control with arm support was done as running the same Experiment 2 would pose challenges, particularly with our most impaired patients, given the duration of Experiment 2 (~2 hours, about 1 hour with each arm) and the expected fatigue that would ensue.

      However, a key characteristic of our comparisons is that we are comparing Experiment 2 active control data under arm support, against Experiment 1 resting bias data also under arm support. While Experiment 1 measured biases without arm support as well, these are not used for this comparison. And, while resting biases are weaker with arm support, they are still clear and significant; yet they do not lead to detectable changes in active movement.

      At the same time, we do not rule out that, if we were to repeat Experiment 2 without arm support, we could find some systematic deviation in the direction of resting bias in movement control. Our conceptual model, in fact, suggests that this may be the case, as we described in lines 618-620 of our original manuscript. The idea here is that, when arm support is not provided, the increased strength requirements lead to increased drive through the RST, to the point that posture control (and its abnormalities) spills into movement control (Figure 9). We now better clarify this position in our Discussion (lines 744-750):

      “The interesting implication of this conceptual model is that synergies are in fact postural abnormalities that spill over into active movement when the CST can no longer modulate the increased RST activation that occurs when weight support is removed (i.e. resting biases may influence active reaching in absence of weight support). Supporting this idea, a study found increased ipsilateral activity (which primarily represents activation via the descending ipsilateral RST (Zaaimi et al., 2012)) when the paretic arm had reduced support compared to full support (McPherson et al., 2018).”

      It is also possible that significant adaptation or plasticity with the CST or rubrospinal tracts could give rise to motor output that already accounts for any intrinsic resting bias.  

      Response 3.5. This kind of adaptation – regardless of the tracts potentially involved – is an issue we examined in our experiment. As we talk about in our Results (lines 458-460 in the updated manuscript), with most of our patient population in the chronic stage, it could be likely that their motor system adapted to those biases to the point that movement planning took them into account, thereby limiting their effect. This motivated us to examine responses to unpredictable perturbations during movement (Figure 6) where we still find lack of an obvious effect of resting biases upon reaching control. We thus believe that our findings are not explained by this kind of adaptation, though we agree it would be of great interest for future work to compare resting biases and reaching control in acute vs. chronic stroke populations to examine the degree to which stroke patients adapt to these biases as they recover.

      In any case, the results from the reaching phase of Experiment 2 do not definitively show that directional biases are not present during active reaching, just that the authors were unable to detect them with their design. The authors do acknowledge the limitations in this design (a 2D constrained task) in explaining motor impairment in 3D unconstrained tasks. 

      Response 3.6. It is, of course, an inherent limitation of a negative finding is that it cannot be proven. What we show here is that, there is no hint of intrusion of resting posture abnormalities upon active movement in spite of these resting posture abnormalities being substantial and clearly demonstrated even under arm support. To allow for the maximum bandwidth to detect any such effects, we specifically chose to compare the most extreme instances (resting bias-wise) for each individual, and yet we did not find any relationship between biases and active reaching.

      This suggests that, even if these biases could be in some form present during active movement, their effect would be minimal and thus limited in meaningfully explaining post-stroke impairment in active movement under arm support.

      Note that, as we already discuss, our conceptual model (Figure 9) suggests that the degree to which directional biases would be present in active reaching may be influenced by arm support (or the specific movements examined – hence our limitation in not examining 3D movement). Thus we do not claim that this independence is absolute. Examples include the last line of the passage quoted right above, and the summary statement of our Discussion quoted below (lines 639-641):

      “…which raises the possibility that the observed dissociation of movement and posture control for planar weight-supported movements may break down for unsupported 3D arm movements.”

      Finally, we now more explicitly acknowledge that abnormal resting biases may influence active movement in the absence of arm support (see Response 3.4).

      It would have been useful, in Experiment 2, to use FM-UE scores (and time from injury) as a factor to determine the relationship between movement and rest biases. Using a GLMM would have allowed a similar comparison to Experiment 1 of how impairment level is related to static perturbation responses. While not a surrogate for imaging tractography data showing a degree of CST involvement in stroke, FM-UE may serve as an appropriate proxy so that this perturbation at hold responses may be put into context relative to impairment.

      Response 3.7. Here the Reviewer suggests we use FM-UE scores as a proxy for CST integrity. We do not think this analysis would be particularly helpful in our case for a number of reasons:

      First, while FM-UE is a general measure of post-stroke impairment, it was designed to track - among other things - the emergence and resolution of abnormal synergies, a sign assumed to result from abnormally high RST outflow (McPherson et al., 2018; McPherson and Dewald, 2022). In line with this, the FM-UE scales with EMG-based measures of synergy abnormality (Bourbonnais et al., 1989). Impairments in dexterity, a sign associated with damage to the CST (Lawrence and Kuypers, 1968; Porter and Lemon, 1995; Duque et al., 2003), dissociate with synergy abnormalities when compared under arm support as we do here (Levin, 1996; Hadjiosif et al., 2022). This means that FM-UE would be a stronger proxy for RST activity and thus not a direct proxy for CST integrity particularly when one wants to dissociate RST-specific vs. CST-specific abnormalities. In fact, as we discuss in Response 3.2 above, there is a number of studies supporting this idea: for example, Zaaimi et al., 2012 show that relative RST activation – the balance between ipsilateral excitability, primarily reflecting RST, and contralateral excitability, primarily reflecting the CST, scales with FM-UE (Zaaimi et al., 2012).

      Second, this kind of analysis would obscure within-individual effects, since FM-UE scores are, of course, assigned to each individual. This is the same issue as doing across-individual correlation analyses in general (see response 2.1b).Strong resting force bias would have opposite effects on opposing perturbations, averaging across subjects would occlude these effects.

      Third, while FM-UE is a good measure of synergy abnormality, weakness alone could also give an abnormal FM-UE (Avni et al., 2024).

      The Reviewer also suggests we use time from injury for this analysis. Time from injury can indeed potentially be an important factor. However, this analysis would not be appropriate for our dataset, since the effective variation in recovery stage within our population is limited: our sample is essentially chronic (only two patients were examined within the subacute stage – at 2 and 3 months after stroke - with everybody else examined more than a year after stroke) with the “positive” elements of their phenotype (and FM-UE itself) essentially plateaued (Twitchell, 1951; Cortes et al., 2017). We thus would not expect to see any meaningful effects of time from injury within our population. It would be an excellent question for future work to investigate both resting biases and their relationship to reaching in acute/subacute patients, and examine whether the trajectory of resting biases (both emergence and abatement due to recovery) follows the one for abnormal synergies.

      It is not clear that even in the static perturbation trials that the hold (and subsequent move from perturbation) is being driven by reticulospinal projections. Given a task where ~20% of the trials are going to be perturbed, there is likely a significant amount of anticipatory or preparatory signaling from the CST. How does this balance with any proposed contribution that the RST may have with increased grip?

      Response 3.8. We included our response to this as part of Response 3.2. In brief, while we cannot rule out that these tasks may recruit increased CST signaling, this would tend to increase, rather than reduce, the effects of post-stroke impairment: the requirement for increased signaling from a CST that is damaged would magnify the effects of this damage, in turn leading to increased recruitment of other tracts, such as the RST.

      In general, the weakness of the interpretation of the results with respect to the CST/RST framework is that it is necessary to ascribe relative contributions of different tracts to different phases of movement and hold using limited or indirect measures. Barring any quantification of this data during these tasks, different investigators are likely to assess these contributions in different ways and proportions limiting the framework's utility.

      Response 3.9. We believe that our Reponses 3.2-3.6 put our findings in fair perspective, and the edits undertaken based on the Reviewer’s comments have clarified our position as to how the dissociation between holding and moving control may break down. We do agree, however, that our framework would be strengthened by the use of direct measures of CST/RST connectivity in future research. We present our conceptual model as a comprehensive explanation of our findings and how they blend with current hypotheses regarding the role of these two tracts in motor control after stroke.  As such, it provides a blueprint towards future research that more directly measures or modulates CST and RST involvement, using tools such as tractography or non-invasive brain stimulation.

      Recommendations for the authors:   

      Reviewer #1 (Recommendations For The Authors):

      L226 “…of this issue, we repeated the analysis of Figure 7F (a) by excluding these four patients…”.  Should this be three, based on the previous sentence? 

      Response 1.A.1. Thank you for pointing this typo, which is now corrected. The analysis in question (Figure S1 in the original submission, now re-numbered as Figure S7-4), excluded the three patients mentioned in the previous sentence.

      L254 “…the hand was held in a more distal position. The postural force biases were strongest when…”  Could this be "extended" rather than distal? See my later comment about the inadequate description of targets.

      Response 1.A.2. The reviewer is correct that, the arm will tend to be more extended in the distal targets. However, since these positions were defined in extrinsic coordinates, we think the terms distal/proximal are also appropriate. In either case, we now clarify these definitions in the text (see Response 1.A.3 below).

      L263 “…contained both distal and proximal targets, and, importantly, they were also the movement…”.  Distal/proximal targets were never described as part of the task. 

      Response 1.A.3. We improved our description by (i) changing the wording above to “represented positions both distal and proximal to the body,”, (ii) doing the same in our Methods (line 175) and (iii) indicating distal/proximal targets in Figure 3A (bottom right of panel A).

      L378 “…the pulse perturbation. We hypothesized that, should resting postural forces play a role, they…”  L379 “…would tend to reduce the effect of the pulse if they were in the opposite direction, and…”  Not really obvious why. A reduction in the displacement caused by a force pulse might be caused by different stiffness or viscosity, but not by a linear, time-invariant force bias. This situation is different from that of "moving the arm through a high-postural bias area vs. a low-postural bias area" where it would encounter time- (actually spatially) varying forces and varying amounts of displacement. Clarify the logic if this is a critical point.

      Response 1.A.4. We thank the Reviewer for highlighting this point of potential confusion. We now clarify that these postural bias forces are neuromuscular in origin (Kanade-Mehta et al., 2023), and likely result from an expression of abnormal synergy, at least under static conditions. In this case, we hypothesized that force pulses acting against the gradient of the postural bias field would act to stretch the already active muscles, which would lead to a further increase in postural resistance due to inherent length-tension properties of active muscle. By contrast, force pulses acting along the gradient of the postural bias field would act to shorten the same active muscles, which would lead to a reduction in postural resistance. The data did not support this in the case of force pulses imposed during movement. We note, however, that similar effects would affect responses to static perturbations as well, wherein we do find an effect of resting biases. We now better explain this reasoning (lines 479482).

      L466 “resting postural force). In short, our perturbations revealed that resting flexor biases switched  467 on after movement was over, providing evidence for separate control between moving” and 

      L468 “holding still.”

      I do not think the authors have presented clear evidence that forces, "switch on", implying the switch to a different controller which they posit. This could as easily be a nonlinear or time-varying property of a single controller (admittedly, the latter possibility overlaps broadly with their idea of distinct, interacting controllers). An example that the authors are certainly aware of is that of muscle "thixotropy" a purely peripheral mechanism due to the dynamics of crossbridge cycling that causes resting muscle to be stiffer than moving muscle, changing with a time constant of ~1-2 seconds. Neither this particular example nor changing levels of contraction (more likely during the unpredictable force perturbations) would be in the direction to explain the main observation here -- a point perhaps worth making, together with the stretch reflex comments. 

      Response 1.A.5. Thank you for this perspective. Indeed, it might be that “switching on” represents a shift along a nonlinear property of the same controller: in the extreme, if this nonlinearity is a step (on/off) function, this single controller would be functionally identical to two separate controllers. We thus cannot tell if these controllers are distinct in the strict sense. What we argue here is that, no matter the underlying controller architecture - two distinct controllers or two distinct modes of the same controller - is that the control of reaching vs. holding can be functionally separable even after stroke. In line with this idea, we used a more nuanced phrasing (e.g. “separable functional modes for moving vs. holding”) throughout our manuscript, and we have now edited out a mention of “separate controllers” to be consistent with this.

      Moreover, thank you for pointing out the example of thixotropy, showing how peripheral mechanisms could interact with central control. As you point out, this effect would not explain the main observation here: in fact, if stiffness were substantially higher during rest or holding (instead of moving) that would reduce the impact of the static perturbation, making it harder to detect any effects of resting biases compared to the moving perturbation case.

      L480 “…during movement (Sukal et al., 2007). Yet, Experiment 2 found no relationship between resting…” L481”… postural force biases and active movement control. To further investigate this apparent…”  The methods of the two studies seem fairly similar, but this question warrants a more careful comparison. How did the size of the two workspaces compare? What about the magnitude of the exerted forces? The movement condition in this study was done with the limb entirely supported. Under that condition, the Sukal study also found fairly small effects of the range of motion.

      Response 1.A.6. Sukal et al., 2007 did not directly measure exerted forces, but instead compared the active range of motion under different loading conditions. They used the extent of reach area to quantify the effect of abnormal synergies, with a more extended active range of motion signifying reduced effect of abnormal synergies. As the Reviewer points out, Sukal et al. found fairly small effects of synergies upon the range of motion when arm support was provided (the reach area for the paretic side was found to be about 85% of the nonparetic side under full arm support, though they were statistically significantly different, Figure 5 of their paper). They found increasing effect of synergies as arm support was reduced: on average, the reach area when participants had to fully support the arm was less than 50% the reach area when full arm support was given (comparing the 0% vs. 100% active support conditions [i.e. 100% vs. 0% external support] in their Figure 5). As we discuss in our paper, this effect of arm support upon synergy mirrors the one we found for resting postures.

      To compare our workspace with the one in Sukal et al., we overlaid our workspace (the array of positions for which the posture biases were measured, for a typical participant from Experiment 1) on the one they used as shown in their Figure 4. Note that their figure only shows an example participant, and thus our ability to compare is limited by the fact that each participant can vary widely in terms of their impairment, and assumptions had to be made to prepare this overlay (e.g. that (0,0) represents the position of the right acromion point). 

      For this example, and our assumptions, our workspace was smaller, with the main points of interest (red dots, the movement start/end points used for Experiment 2) within the Sukal et al. workspace. That our workspace is smaller is not surprising, given that the area in Sukal et al. represents the limit of what can be reached, and thus motor control *has* to be examined in a subset of that area.

      Author response image 1.

      Comparing the two study methodologies, however, suggests an advantage of measuring resting biases in terms of sensitivity and granularity: first, resting biases can be clearly detected even under arm support (something we point out in our Discussion, lines 715-717); second, they can measure abnormalities at any point in the workspace, rather than a binary within/without the reach area. The resting bias approach may thus be a more potent tool to probe the shared bias/synergy mechanisms we propose here.

      Figure 2 

      Needs color code. 

      The red dots could be bigger.

      Response 1.A.7. We have increased the size of the red dots and added a color code to explain the levels illustrated by the contours. We also expanded our caption to better explain this illustration.

      Figure 3

      Labeling is confusing. Drop the colored words (from both A and B), and stick to the color legend. Consider using open and filled symbols (and bars) to represent arm support or lack thereof. The different colored ovals are very hard to distinguish.

      Response 1.A.8. We find these recommendations improve the readability of Figure 3 and we have thus adopted them - see updated Figure 3.

      Figure 4

      Not terribly necessary.  

      Response 1.A.9. While this figure is indeed redundant based our descriptions in the text, we kept it as we believe it can be useful in clarifying the different stages of movement we examine.

      Figure 5 

      Tiny blue and green arrows are impossible to distinguish. 

      Although the general idea is clear, E and H are not terribly intuitive.  Add distance scale bars for D-I. 

      Response 1.A.10. For improved contrast, we now use red and blue (also in line with comment below regarding Figure 7), and switched to brighter colors in general. To make E and H more intuitive and easier to follow, we expanded the on-panel legend. Thank you for pointing out that distance scale bars are missing; we have now added them (panels EFHI).

      Figure 6 

      Panel E inset is too small. 

      Response 1.A.11. We have now moved the inset to the right and enlarged it.

      Figure 7 

      Green and blue colors are not good. 

      Response 1.A.12. For improved contrast, we now use red and blue.

      Figure 8 

      Delete or move to supplement? 

      Response 1.A.13. We respectfully disagree. While the relationships on these data are also captured by the ANOVA, we believe these scatter plots offer a better overview of the relationships between force biases and FM-UE across different conditions.

      Really minor

      L113 “…participants' lower arm was supported using a custom-made air-sled (Figure 1C). Above the  participant's…” 

      Response 1.A.14. We put the apostrophe after the s so to refer to participants in general (plural).

      L117 ”…subject-produced forces on the handle were recorder using a 6-axis force transducer.”  recorded 

      Response 1.A.14. Thank you for pointing out this error which we have now corrected.

      L136 “…2013), Experiment 1 assessed resting postural forces by passively moving participants to>…”  The experiment did not move the participant. 

      Response 1.A.15. We now fix this issue: “by having the robot passively move…”

      L248 “…experiment blocks: two with each arm, with or without arm weight support (provided by an air experimental…”

      Response 1.A.16. We have now corrected this.

      L364 “…responses to mid-movement perturbations. In 1/3 of randomly selected reaching movements…”  Obviously, you mean 1/3 of all movements: "One-third of the reaching movements were chosen randomly"  

      Response 1.A.17. We now clarify: “In 1/3 of reaching movements in Experiment 2, chosen randomly”. Also please note our response to Reviewer 2, point 10: we now report the exact number of trials for which each kind of perturbation was present.

      L609 “Damage to the CST after stroke reduces its moderating influence upon the RST (Figure 9,…”  "its" refers to the subject, "Damage", not "CST".

      Response 1.A.18. We have changed this to “Post-stroke damage to the CST reduces the moderating influence the CST has upon the RST”.

      Reviewer #2 (Recommendations For The Authors):

      (1) Throughout, the authors cleverly selected the most opposed and most aligned resting postural force biases to perform a within-subject analysis. However, this approach excludes a lot of data. The authors could perform an additional within-subject analysis. For each participant they could correlate lateral resting posture force bias to each dependent variable, utilizing all the trials of a participant. 

      Response 2.A.1a. Thank you for your appreciating our analysis design, and suggesting additional analyses. We focused our within-subject analysis design on the most extreme instances, as we believe that this approach would offer the best opportunity to detect any potential effects of resting biases. We reasoned that, since resting biases tend to be relatively small for most locations in the workspace, taking all biases into account would inject a disproportionate amount of noise in our analysis, which would in turn diminish our ability to detect any potential relationships. This could be because small biases lead to small effects but also small biases may themselves be more likely to reflect measurement noise in the first place. Note that our study talks about separability of active reaching from resting abnormalities based on lack of relationships between the two. While one cannot definitely prove a negative, it is also important to take the approach that maximizes the ability to detect any such relationship if there were one. We believe taking the most extreme instances fulfills that role.

      However, as the Reviewer points out, this approach also excludes a substantial amount of data. We agree that our findings could be further strengthened by exploring additional within-subject analyses that utilize all trials. Thus, following the reviewer’s suggestion, we estimated the sensitivity of each dependent variable to lateral resting posture force bias. Specifically, we estimated the slope of this relationship for each individual (separately for paretic and non-paretic data) using linear regression, and assessed whether the average slope is significant for each group (paretic data, non-paretic data, and control data).

      This secondary analysis replicated our main findings: lack of relationship between posture biases and active reaching control (both for unperturbed and perturbed movement), and a significant relationship between posture biases and active holding control. In addition, in line with main point 2.1 by the reviewer, we performed the same analyses for non-paretic and control data. While there are no definitive conclusions to be made for these cases (as was likely, given that the resting force biases are smaller, as also pointed out by the Reviewer in 2.1) these data are worthy of discussion, with potentially interesting insights (for example, there are hints that the connection between resting biases and active holding control is present in the non-paretic arm as well, and may be explored in future research).

      We have included these analyses in the supplementary materials, and we point to them in the main text. Specifically:

      First, in line with our main analyses in Figure 5, we find no effect (the average slope is insignificant) for start and endpoint biases upon the corresponding reaching angles. This is now mentioned in lines 425-434 of the Results, and illustrated in Figure S5-2. There was a lack of effect for the non-paretic and control data as well.

      Second, in line with our main analyses in Figure 6, we find no effect of start biases upon responses to the pulse (Figure S6-2, mentioned in lines 513-517 of the Results). As above, there was no effect of non-paretic or control data either.

      And, finally, in line with our main analysis in Figure 7, we find an effect of resting biases upon performance for the static perturbation (Figure S7-2, mentioned in lines 578-586 of the Results). Interestingly, there is a suggestion that resting biases may affect static perturbation responses in the non-paretic data as well based on the relationship between posture bias and maximum deviation, but not the other two metrics. Given the lack of consistency of resting bias effects for all three different dependent variables examined, however, our current data are thus unable to give a definite answer as to whether there is the connection between resting biases and active holding control is also present in the non-paretic side. Our hypothesis is that, since resting abnormalities and their effects are the pathological over-manifestations of mechanisms inherent in the motor system in general, then such a relationship would exist. Answering this question, however, would require an experiment design better tailored to detect relationships in the non-paretic arm, where resting biases are weaker.

      We thank the Reviewer for their suggestions and believe that these additional analyses provide a more complete picture of the data, and their consistency with our main results reinforces the message of the paper.

      Then, they can report the percentage of participants that display significant correlations separately for the paretic, nonparetic, and control arms. 

      Response 2.A.1b. We note that, even in cases where the average slope (across individuals) is significant, the individual slopes themselves are usually not significant, likely due to the large amount of noise for datapoints corresponding to weak resting biases. To further examine this, we performed additional analyses whereby we examined slopes by (a) pooling all participant data together (centered separately for each individual), and then (b) took a further step to normalize each participant’s data not only by centering but by also adjusting by each individual’s variability along each axis (i.e. assess the slope between z-scores of resting bias vs. z-scores of each dependent variable). These two analyses confirmed our finding that resting biases interacted with active motor control, with significant slopes between resting biases and outcome variables. (a) Pooling all data together: path to stabilization: p = 0.032; time to stabilization: p = 1.4x10-5; maximum deviation: p = 0.021. (b) Pooling and normalizing: path to stabilization: p = 0.0013; time to stabilization: p = 8.6x10-6; maximum deviation: p = 0.00056. The latter analysis showed even stronger connection between resting bias and active holding control, probably due to better accounting for differences in the range of resting biases across participants). For simplicity, however, we only provide the across-individual slope comparisons in the paper.

      (2) An important aspect of all the analyses is that they rely heavily on estimates of the resting postural force bias. How stable are these resting postural force biases at the individual level? The authors could assess this by reporting within-subject variance for both the magnitude and direction of the resting postural force bias.

      Response 2.A.2. Thank you for your suggestion. We now assess the individual-level variance in error across measurements for patients’ paretic data using an ANOVA: the variance that remains after all other factors (same probe location; same arm support condition; same participant) are taken into account. We found that individual level measurement variance explained a mere 9.0% of total variance for resting bias magnitude. (We note that the same figure was 20.2% for the non-paretic data, in line with the weaker average biases which would be more susceptible to noise). We now note this in the Methods, as part of the new subsection “Stability of resting posture bias measurements in Experiment 1” (lines 266-273).

      (3) Does resting postural force bias influence hand movement immediately following force release from the postural perturbation? This could be assessed before any volitional responses by examining the velocity of the hand during the first 50 ms following the postural perturbation.

      Response 2.A.3. The influence seems fairly rapid, within the first 100ms as shown to the right. Here we plot hand deviation in the direction of the perturbation for the most-opposed (red) vs. most-aligned (blue) instances to examine when these curves become different. The bottom plots show the difference between these two, whereas shading indicates SEM (note that these curves are referenced to the average deviation in the last 0.5 s before force release). The rightmost plots zoom in to make it easier to see how responses to the most opposed vs. most aligned instances diverge.

      To detect the earliest post-perturbation timepoint for which this effect was significant, we performed paired t-tests at each timestep, and found that the two responses were systematically statistically different 95ms after perturbation onset onwards. For reference, the same method detected a response at 25ms for the most aligned instances and 40ms for the most opposed instances.

      We have now added Supplementary Figure S7-4 with short commentary in the Supplementary Materials.

      (4) Abstract. lines 7-9. At a glance (and when reading the manuscript linearly) this sentence is unclear. If the paretic arm is compromised across rest and movement, how does that afford the opportunity to address the relationship between reaching, stopping, and stabilizing when all could be impacted? It might be useful to specify that these factors may impacted differently relative to one another with stroke, providing an opportunity to better understand the differences between movement and postural control. 

      Response 2.A.4. Thank you for pointing out this issue (also related to Reviewer 1’s point – Response 1.1). We have changed this to more clearly reflect our reasoning and highlight that the issue is that stroke can differentially impact reaching vs. holding, copied below:

      “The paretic arm after stroke exhibits different abnormalities during rest vs. movement, providing an opportunity to ask whether control of these behaviors is independently affected in stroke.”

      (5) Line 27. It is perhaps more appropriate to say conceptual model than simply 'model'.  

      Response 2.A.5. Thank you for your suggestion, which we have adopted throughout the manuscript.

      (6) Line 122-125. Figure 1A caption. The authors should specify that resting posture force biases occur when the limb or hand is physically constrained in a specific position. 

      Response 2.A.6. Thank you for pointing this out – we have clarified the caption:

      “If one were to physically constrain the hand in a position away from the resting posture, the torques involved in each component of the abnormal resting posture translate to a force on the hand (blue arrow);”

      (7) Line 147. Why was the order not randomized or counterbalanced? 

      Response 2.A.7. We prioritized paretic data, as the primary analyses and comparisons in our paper involved resting posture biases and active movement with the paretic arm. We note that our primary analyses, which rely on paretic-paretic comparisons, would not be affected by paretic vs. non-paretic ordering effects. However, ordering effects could potentially affect comparisons between paretic and non-paretic data. We now note the reasoning behind the absence of counterbalancing, and mention the potential limitation in interpreting paretic to non-paretic comparisons in lines 124-129 of the Methods.

      (8) Line 172. 12N is the peak force of the pulse?

      Response 2.A.8. The reviewer is correct; we have clarified our description (line 463 in the updated manuscript):

      “a 70 ms bell-shaped force pulse which was 12N at its peak”

      (9) Line 175. What is a clockwise pulse? Was the force vector rotating in direction over time so that it was always acting orthogonally to the movement, or did it always act leftwards or rightwards?

      Response 2.A.9. The force vector was not rotating in direction over time. Here, we used clockwise/counterclockwise to indicate rightwards/leftwards with respect to the ideal movement direction – the line from start position to target (which is what we understand the Reviewer means by “always act rightwards or leftwards”). We have clarified the text to indicate this (lines 193-195):

      …was applied by the robot lateral to the ideal movement direction (i.e. the direction formed between the center of the start position and the center of the target) after participants reached 2cm away from the starting position (Smith and Shadmehr, 2005; Fine and Thoroughman, 2006).

      (10) Lines 177-182. It might be useful to explicitly mention the frequency of each of the perturbations, just for ease of the reader. 

      Response 2.A.10. We have added this information to our Methods (lines 206-210):

      Thus, in summary, each 96-movement block consisted of 64 unperturbed movements and 32 movements perturbed with a force pulse (16 clockwise, and 16 counter-clockwise). For 20 out of the 96 movements in each block, the hold period was extended to test the hold perturbation (4 trials for each of the 5 target locations, each one of the 4 trials testing one perturbation direction as shown in Figure 7C).

      (11) Line 191. Lines 188-190. It would be useful to see a sample of several of these force traces over time (0-5s) that were used to make the average for a position. That would give insight into the stability of the forces of a participant for one of the postures. These traces could be shown in Figure 2.

      Response 2.A.11. Thank you for your suggestion. We have added these panels to Figure 1, (as Figure 2 was already large). Each panel illustrates the three measurements taken at similar positions (closest to midline, distal from the body) and the same condition (paretic arm, with arm support given) for one participant (same participants as in Figure 2). Solid lines indicate the force on the x-axis (positive values indicate forces towards the left), whereas dashed lines indicate the force on the y-axis (positive values indicate forces towards the body). The shaded area indicates the part averaged in order to estimate the resting bias, illustrating how resting biases were relatively stable by the 2s mark. Note that these examples include one trial (blue traces in the third panel) which was rejected following visual inspection as described in Materials and Methods – Data Exclusion Criteria (“trials where forces appeared unstable and/or there was movement during the robot hold period”). We find this helpful as this illustrates (and motivates) one component of our methodology. 

      (12) Line 196. Figure 1D (not 1E).  

      Response 2.A.12. Thank you for catching this error, which we have now corrected.

      (13) Line 215: The authors mentioned similar results. Were there any different results that impacted interpretation? Some evidence of this, similar to and in addition to Supplementary 1, would be helpful. 

      Response 2.A.13. We repeated our analyses without these exclusion criteria, with no impact to the interpretation. We now include versions of the main outcome panels from Figures 5, 6, and 7 in the supplementary materials calculated without this outlier exclusion (Figures S5-E, S6-E, and S7-E, respectively). 

      (14) Line 231: Perhaps better to explicitly state the furthest three positions are being across as the distal targets for the ANOVA. 

      Response 2.A.14. Thank you for your suggestion. We now explicitly clarify this in line 276:

      “distal targets [furthest three positions] vs. proximal targets [closest two positions]”

      (15) Figure 3B, lines 265. Clearly, these are different, but the authors should report statistics. 

      Response 2.A.15. We now report these numbers (lines 339-346 of the revised manuscript, which also include statistics related to bias direction as described in 2.A.17 below).

      (16) Figure 2 should have a heat map scale.  

      Response 2.A.16. We have now added this (also Response 1.A.7), including an explanation of what the heat map represents in the caption.

      (17) Figure 3C: It would be useful to quantify and plot the direction of the resting force bias vector. 

      Response 2.A.17. Thank you for your suggestion. We have expanded Figure 3 to include the average direction of the resting force bias vector (note the readjustment of colors following Reviewer 1’s comment: striped bars indicate No Support data, and full bars indicate Support data, with the colors being the same). The direction of the force bias vector, however, may not be very informative in cases where the magnitude is small (and the signal-to-noise ratio is small), whereas averaging the direction of the force bias vector across different positions for one participant may average out systematic variations in this direction across different locations. Nevertheless, the average direction appears generally towards the body (around -90°, or 6 o’clock) even in the non-paretic and control data (though the noise – as suggested by the size of the errorbars – is much higher in the latter cases, especially when the arm is supported). This is a (weak) suggestion that these resting biases may be present, though much subdued, in the nonparetic limb and healthy individuals; further work will be needed to elucidate this.

      (18) Line 428. It is not significantly longer compared to controls. Can the authors slightly revise this sentence?

      Response 2.A.18. We have revised this sentence (lines 529-532):

      Patients showed impaired capacity to resist and recover from this perturbation (the abrupt release of the imposed force). The time to stabilization for the paretic side (0.94±0.05s) was longer compared to the non-paretic side (0.79±0.03s, p = 0.024) and controls (0.78±0.06s, though this was statistically marginal, p = 0.061) as shown in Figure 7E, left.

      (19) Line 541. It is unclear how these data support the idea of three distinct controllers. Can the authors please clarify? 

      Response 2.A.19. Here, we compared our findings to previous ideas about distinct controllers, and discuss a potential fusion of these ideas with ours. Specifically, we find that holding is distinct from both initial reaching and coming to a stop. Previous work argues that initial reaching and coming to a stop are themselves distinct (Ghez et al., 2007; Jayasinghe et al., 2022). Combining these two sets of arguments, we arrive at the possibility of three distinct controllers. 

      (20) It would be useful if the authors provided a definition of synergy, as well as distinguishing between muscle and movement synergies. 

      Response 2.A.20. We now provide this in lines 591-594:

      Here, “synergies” refer to abnormal co-activation patterns across joints that manifest as the patient tries to move – for example, the elbow involuntarily flexing as the patient tries to abduct their shoulder (Twitchell, 1951; Brunnstrom, 1966). 

      (21) Line 592-593. The wording of this sentence could be improved. 

      Response 2.A.21. We have switched this sentence to active voice for more clarity:

      Thus, while full weight support reduces both resting flexor biases and movement-related flexor synergies, this reduction seems more complete for synergies rather than resting biases.

      (22) Figure 9. In the left column, it should read normal synergies and normal resting posture.  

      Response 2.A.22. We intentionally used the same terminology, as the idea behind our conceptual model is that these patterns, which manifest as well-recognized abnormal synergies and abnormal resting postures in stroke, may be present in the healthy motor system as well, but kept in check by CST moderating the RST. At the same time, we recognize that, by definition, synergies and posture in controls are the “normal” reference point against which “abnormal” synergies and posture are defined after stroke. To clarify this issue, we thus decided to forgo the use of the terms “abnormal” in the figure, and instead refer to “synergistic movement ” and “synergistic resting posture”.

      (23) Figure 9. With stroke, is RST upregulated, a decreased influence of CST, or both? All seem plausible.

      Response 2.A.23a. We believe both can be happening. From previous work (e.g. McPherson et al., 2018) it seems safe to say that RST upregulation is the case, whereas one would also expect a decreased CST influence due to its damage due to the stroke. The relative weight of these influences would be interesting to elucidate in future work.

      I have not read the paper, but did McPherson et al., 2018 test these different hypotheses?  

      Response 2.A.23b. The main point of McPherson et al., 2018 is that increased synergy expression is due to increased RST involvement, rather than reduced CST influence. However, McPherson et al. do not show separate increases/reductions in RST/CST activity; they show that contralesional activity relative to ipsilesional activity is increased (using a laterality index). While it does seem that RST is upregulated in this case, this does not exclude the possibility that CST influence is reduced as well.

      We also noticed that the citation itself, while mentioned in the text, was missing from the bibliography. This is now fixed.

      For Figure 9, McPherson is cited as they provide evidence for the idea that RST involvement increases when arm support is decreased. This evidence is both direct (e.g. in their Figure 3 where they show that “Stroke participants exhibited increased activity in the contralesional (R) hemisphere as SABD loading increased” [i.e. arm support was reduced]) and indirect: they connect synergies to RST involvement, and also show increased synergies with reduced arm support (also shown multiple times previously). Both these arguments suggest that arm support reduces RST involvement. We have clarified the relevant sentence:

      The interesting implication of this conceptual model is that synergies are in fact postural abnormalities that spill over into active movement when the CST can no longer modulate the increased RST activation that occurs when weight support is removed. Supporting this idea, McPherson et al. found increased ipsilateral activity (which primarily represents activation via the descending RST (Zaaimi et al., 2012)) when the paretic arm had reduced support compared to full support (McPherson et al., 2018).

      Reviewer #3 (Recommendations For The Authors):

      For Experiment 2, it is not immediately clear how the within-subject values are being pooled and compared across the different conditions. For instance, in the static perturbation trials, there are four blocks with 20 perturbation trials per block per arm (80 total per arm) with each location and direction once per block. For each participant, the comparison is between the location/direction that was most opposed (although this doesn't look accurately represented in Fig 7F). Therefore, the within-subject comparison is 4 trials per participant? Were these values averaged or pooled? It is a little odd that the SD for all the within-subjects trials are identical or nearly identical across conditions especially when looking at the example patient data in 7B and 7F.  

      Response 3.A.1. For static perturbation trials, the within-subject comparison involves 8 trials per participant: 4 trials corresponding to the perturbation direction/position combination with resting bias most opposed to the perturbation, and 4 trials corresponding to the perturbation direction/position combination with resting bias most aligned with the perturbation. These values were averaged for each individual. We have expanded our methods to make this part of our data analysis clear (lines 284-296) for all types of comparisons (unperturbed movement, pulse perturbation, static perturbations – now referred to as “release perturbation”).

      The across-subject SDs for the average resting forces for each one of these two conditions, shown in Figure 7F are indeed identical. This is due to how these two instances (most aligned vs. most resistive) were selected: because the perturbation directions come in pairs that exactly oppose each other (Figure 7B), if one were to select the position with the most opposing resting bias, that would mean that the combination with same position and the oppositely-directed perturbation would be the one with the most assistive resting bias. Hence the resting biases selected for the most opposing/assistive instances would be equal in magnitude and opposite to each other for each participant, as illustrated in Figure 7F, whereby the most-opposed bias for each individual is exactly opposite to the corresponding most-aligned bias for the same individual. We have added a brief commentary about this on the caption (lines 551-554), reproduced below:

      Note how the most-opposed resting bias for each patient is equal and opposite to the their mostaligned resting bias. This is because the same resting bias, when projected along the direction of two oppositely-directed perturbations (illustrated in C), it would oppose one with the same magnitude it would align with the other.

      Importantly, following suggestions by Reviewer 2 (see point 2.A.1), we now provide supplementary analyses that use the entirety of the relevant data, rather than the most extreme instances, which provide evidence supporting our main findings (Figures S5-2, S6-2, and S7-2).

      The printed colors in Figure 3 are very muddled and hard to read/interpret, especially in panel A. 

      Response 3.A.2. Thank you for pointing out this issue, also raised by Reviewer 1. We have adjusted the colors to be more distinct from each other and look clear both in print and on-screen, making use of dashed lines and stripes rather than different shades.

      I think it would improve readability and interpretation if Figure 8 and the results related to FM-UE were contained within the description of results for Experiment 1.

      Response 3.A.3. Thank you for this suggestion. This is actually a debate we had among ourselves earlier, and we can see merits to either ordering. It is very arguable that moving Figure 8 and the FMUE results within the rest of Experiment 1 may improve readability somewhat. However, we believe that presenting these results at the end better serves to illustrate the apparent paradox between the lack of direct connection between resting biases and active movement on one hand, and the relationship between resting biases and abnormal synergies on the other. We believe that this better sets the stage to present our conceptual model, which explains this paradox based on the role arm support plays in modulating the expression of both resting biases and abnormal synergies.

      Additional changes/corrections not outlined above

      Figure 1D displayed a right arm, but showed a target array (red dots) for a left arm paradigm. We now flip the target array shown for consistency.

      We corrected Figure 6C, which accidentally used an earlier definition of settling time which was based on lateral stabilization throughout the entire movement, rather focus on the period immediately following the pulse. The intended definition of settling time (as we had described in the Methods, lines 204-206 of original submission) focuses on lateral corrections specific to the pulse (rather than corrections when the participant approaches the endpoint) and better matches the one for settling time for the release (static) perturbation trials. Note that this change did not affect the (lack of) relationship between settling time and resting force bias, both across individuals (correlation plots now in Figure S6-1) and within individuals (now shown in the right part of panel 6D). Also in panel C, an error in the scaling for the maximum lateral deviation in the pulse direction (right side of the panel) is also now corrected.

      In addition, we made minor edits throughout the text to improve readability.

      References

      Albert ST, Hadjiosif AM, Jang J, Zimnik AJ, Soteropoulos DS, Baker SN, Churchland MM, Krakauer JW, Shadmehr R (2020) Postural control of arm and fingers through integration of movement commands. Elife 9:e52507.

      Avni I, Arac A, Binyamin-Netser R, Kramer S, Krakauer JW, Shmuelof L (2024) The Kinematics of 3D Arm Movements in Sub-Acute Stroke: Impaired Inter-Joint Coordination is Attributable to Both Weakness and Flexor Synergy Intrusion. Neurorehabil Neural Repair 38:646–658.

      Bourbonnais D, VANDEN NOVEN S, Carey KM, Rymer WZ (1989) Abnormal spatial patterns of elbow muscle activation in hemiparetic human subjects. Brain 112:85–102.

      Brunnstrom S (1966) Motor testing procedures in hemiplegia: based on sequential recovery stages. Phys Ther 46:357–375.

      Cortes JC, Goldsmith J, Harran MD, Xu J, Kim N, Schambra HM, Luft AR, Celnik P, Krakauer JW,

      Kitago T (2017) A Short and Distinct Time Window for Recovery of Arm Motor Control Early After Stroke Revealed With a Global Measure of Trajectory Kinematics. Neurorehabil Neural Repair 31:552–560.

      Duque J, Thonnard J, Vandermeeren Y, Sébire G, Cosnard G, Olivier E (2003) Correlation between impaired dexterity and corticospinal tract dysgenesis in congenital hemiplegia. Brain 126:732–747.

      Fine MS, Thoroughman KA (2006) Motor Adaptation to Single Force Pulses: Sensitive to Direction but Insensitive to Within-Movement Pulse Placement and Magnitude. J Neurophysiol 96:710–720.

      Ghez C, Scheidt R, Heijink H (2007) Different Learned Coordinate Frames for Planning Trajectories and Final Positions in Reaching. J Neurophysiol 98:3614–3626.

      Hadjiosif AM, Branscheidt M, Anaya MA, Runnalls KD, Keller J, Bastian AJ, Celnik PA, Krakauer JW (2022) Dissociation between abnormal motor synergies and impaired reaching dexterity after stroke. J Neurophysiol 127:856–868.

      Jayasinghe SA, Scheidt RA, Sainburg RL (2022) Neural Control of Stopping and Stabilizing the Arm. Front Integr Neurosci 16.

      Kanade-Mehta P, Bengtson M, Stoeckmann T, McGuire J, Ghez C, Scheidt RA (2023) Spatial mapping of posture-dependent resistance to passive displacement of the hypertonic arm post-stroke. J NeuroEngineering Rehabil 20:163.

      Lawrence DG, Kuypers HG (1968) The functional organization of the motor system in the monkey: II. The effects of lesions of the descending brain-stem pathways. Brain 91:15–36.

      Levin MF (1996) Interjoint coordination during pointing movements is disrupted in spastic hemiparesis. Brain 119:281–293.

      Lowrey CR, Bourke TC, Bagg SD, Dukelow SP, Scott SH (2019) A postural unloading task to assess fast corrective responses in the upper limb following stroke. J NeuroEngineering Rehabil 16:1–17.

      McPherson JG, Chen A, Ellis MD, Yao J, Heckman C, Dewald JP (2018) Progressive recruitment of contralesional cortico-reticulospinal pathways drives motor impairment post stroke. J Physiol 596:1211–1225.

      McPherson LM, Dewald JP (2022) Abnormal synergies and associated reactions post-hemiparetic stroke reflect muscle activation patterns of brainstem motor pathways. Front Neurol 13:934670.

      Porter R, Lemon R (1995) Corticospinal function and voluntary movement. Oxford University Press.

      Smith MA, Brandt J, Shadmehr R (2000) Motor disorder in Huntington’s disease begins as a dysfunction in error feedback control. Nature 403:544.

      Smith MA, Shadmehr R (2005) Intact ability to learn internal models of arm dynamics in Huntington’s disease but not cerebellar degeneration. J Neurophysiol 93:2809–2821.

      Tower SS (1940) Pyramidal lesion in the monkey. Brain 63:36–90.

      Twitchell TE (1951) The restoration of motor function following hemiplegia in man. Brain 74:443–480.

      Wilkins KB, Yao J, Owen M, Karbasforoushan H, Carmona C, Dewald JP (2020) Limited capacity for ipsilateral secondary motor areas to support hand function post-stroke. J Physiol 598:2153– 2167.

      Zaaimi B, Edgley SA, Soteropoulos DS, Baker SN (2012) Changes in descending motor pathway connectivity after corticospinal tract lesion in macaque monkey. Brain 135:2277–2289.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      In their manuscript, Gerlevik et al. performed an integrative analysis of clinical, genetic and transcriptomic data to identify MDS subgroups with distinct outcomes. The study was based on the building of an "immunoscore" and then combined with genotype and clinical data to analyze patient outcomes using multi-omics factor analysis. 

      Strengths: Integrative analysis of RNA-seq, genotyping and clinical data 

      Weaknesses: Validation of the bioinformatic pipeline is incomplete 

      Major comments: 

      (1) This study considered two RNA-seq data sets publicly available and generated in two distinct laboratories. Are they comparable in terms of RNA-seq technique: polyA versus rRNA depletion, paired-end sequencing, fragment length? 

      We want to reemphasize that the main point of this study is not to compare the BMMNC with the HSPC cohort. These datasets are not comparable because they were

      collected from different cell types, and we should not expect them to be matched. We just analysed them in parallel to check how much HSPCs contribute to the molecular signatures we see in BMMNC samples. However, we agree with the reviewer that similar RNA-seq experimental techniques should be employed to control for confounding factors. Here is the information that we found for HSPC and BMMNC RNA-seq studies:

      HSPC RNA-seq cohort: Total RNA was extracted using TRIzol (Thermo Scientific), and Sequencing was performed on an Illumina HiSeq4000 with 100-bp paired-end reads.

      BMMNC RNA-seq cohort: The RNA was extracted with TRIzol reagent (Thermo Scientific). RNA-sequencing libraries were prepared from poly(A)-selected RNA and were sequenced using Illumina HiSeq 2000 or 2500 platform with 100-bp paired-end reads. 

      The only difference between the two cohorts is that one cohort includes total RNAs, whereas the other has polyA-selected RNAs. Since the gene set signatures use the expression of proteincoding genes, which all have polyA tails and are included in total RNA libraries, the analysis will not be affected by total vs. polyA-selected RNA-seq techniques. 

      (2) Data quality control (figure 1): the authors must show in a graph whether the features (dimensions) of factor 1 were available for each BMMNC and CD34+ samples.  

      By features of Factor 1, we think the reviewer means the features with high weights for Factor 1 in BMMNC and CD34+ samples. Figure 2c-d clearly illustrates the important features and their associations with Factor 1 for all samples in both cohorts. The samples are the columns of the two heatmaps.

      (3) How to validate the importance of "immunoscore"? If GSEA of RNA-seq data was performed in the entire cohort, in the SF3B1-mutated samples or SRSF2-mutated samples (instead of patients having a high versus low level of factor 1 shown in Sup Fig. 4), what would be the ranking of Hallmarks or Reactome inflammatory terms among the others? 

      Our GSEA analysis was an attempt to validate the importance of our identified factors. As described in the paper, Factor 1 represents a combination of immunology scores (or  “immunoscores”) in CD34+ cohort. Applying GSEA, we identified upregulation of inflammation related pathways, chemokines, and Neutrophils in patients having high (4th quartile) versus low (1st quartile) levels of Factor 1. Interestingly, sorting patients by Factor 1 resulted in similar pattern based on gene signature scores (Figure 2d).    

      To show that Factor1 generated by MOFA is important and different from known MDS categories such as SF3B1 and SRSF2 mutants, we performed GSEA in SF3B1-mutated vs. SF3B1-WT samples and SRSF2-mutated vs. SRSF2-WT samples in the CD34+ cohort. As shown in Author response image 1, we did not see the upregulation of inflammation and interferon pathways in SF3B1 and SRSF2 mutant MDS.

      Author response image 1.

      GSEA showed no upregulation of inflammation and interferon pathways for SF3B1 and SRSF2 mutant in CD34+ cohort.  

      (4) To decipher cell-type composition of BMMNC and CD34+ samples, the authors used van Galen's data (2019; supplementary table 3). Cell composition is expressed as the proportion of each cell population among the others. Surprisingly, the authors found that the promonocytelike score was increased in SF3B1-mutated samples and not in SRSF2-mutated samples, which are frequently co-mutated with TET2 and associated with a CMML-like phenotype. Is there a risk of bias if bone marrow subpopulations such as megakaryocytic-erythroid progenitors or early erythroid precursors are not considered? 

      We thank the reviewer for their insightful comment about CMML and the high prevalence of SRSF2 mutation (> 45%) in CMML cases. Using single-cell RNA sequencing and high-parameter flow cytometry, Ferrall-Fairbanks et al. (DOI: 10.1158/2643-3230.BCD-21-0217) recently showed that CMML can be classified into three differentiation trajectories: monocytic, megakaryocyte-erythroid progenitor (MEP), and normal-like. One hallmark of monocytic-biased trajectory was the enrichment of inflammatory granulocyte–macrophage progenitor (GMP)-like cells, which we observed through our analysis for SRSF2 mutants (Figure 6a).

      Unfortunately,  van Galen's data does not provide any gene set for MEP, and there is no singlecell RNA-seq atlas for MDS to employ to calculate the MEP score. Also, we compared the Promono-like and GMP-like gene sets from van Galen's data, and we could not find any overlap, meaning that Promono-like is not specific enough to capture the signatures coming from the more differentiated progenitors such as GMPs. Therefore, as described in the paper, we focused on GMP-like rather than Promono-like.

      (5) Figures 2a and 2b indicated that the nature of retrotransposons identified in BMMNC and CD34+ was dicerent. ERVs were not detected in CD34+ cells. Are ERVs not reactivated in CD34+ cells? Is there a bias in the sequencing or bioinformatic method?  

      As described above, the two cohorts' sequencing methods, read length, etc., are identical.

      CD34+ RNA-seq is total RNA-seq that includes both polyA and non-polyA RTE transcripts.

      Therefore, the chance of bias and missing RTE signatures in CD34+ cohort is very low. L1 and Alu, which are shared between the two cohorts, are the two RTE families that are still active and make new insertions in humans. Our interpretation is that ERV activation in BM is associated with immune cells. As shown by Au et al. (DOI: 10.1016/j.ccell.2021.10.001), several ERV loci had expression in purified immune cell subsets in renal cell carcinoma samples, potentially explaining ERV upregulation in tumours responding to treatment as those biopsies had increased tumour infiltration.

      (6) What is the impact of factor 1 on survival? Is it dicerent between BMMNC and CD34+ cells considering the distinct composition of factor 1 in CD34+ and BMMNC? 

      As shown in Table 1, Factor 1 in the BMMNC cohort is associated with overall survival (P-val < 0.05) when we did multivariate analysis but not univariate analysis. We did not observe any association between Factor 1 and event-free survival in the BMMNC cohort. Also, The 10 factors identified by MOFA in BM CD34+ cohort did not show any significance associated with MDS overall survival (Supplementary Table 5). 

      (7) In Figure 1e, genotype contributed to the variance of in the CD34+ cell analyses more importantly than in the BMMNC. Because the patients are dicerent in the two cohorts, dicerences in the variance could be explained either by a greater variability of the type of mutations in CD34 or an increased frequency of poor prognosis mutations in CD34+ compared to BMMNC. The genotyping data must be shown.  

      The genotype has already been reported in Supplementary Table 2. In fact, the number of inspected genes was much higher in the BMMNC cohort (17 genes) compared to the CD34+ cohort (3 genes). Therefore, we have more significant variability of the type of mutations in the BMMNC cohort compared to the CD34+ cohort. For the CD34+ cohort, we only had mutations for three spliceosome genes, where most cases (n=28) were SF3B1 mutants with good prognosis. We think that the result makes sense because the less genetic variability, the more homogenous groups and the more chance that one factor or a group of factors can explain the genetic variance.   

      (8) Fig. 2a-b: Features with high weight are shown for each factor. For factor 9, features seemed to have a low weight (Fig. 1b and 1c). However, factor 9 was predictive of EFS and OS in the BMMNC cohort. What are the features driving the prognostic value of factor 9? 

      As shown in Figure 3b, The main features are RTE expression from LTR:ERV1, SINE:MIR, and SINE:Alu family.  

      (9) The authors also provided microarray analyses of CD34+ cell. It could be interesting to test more broadly the correlation between features identified by RNA-seq or microarrays. 

      The microarray data did not come with any genetic information or clinical data except survival information. Therefore, we could not apply MOFA on Microarray data. However, we did generate gene signature scores from Microarray data and investigated the relationship between inflammatory chemokines and cytokines, and IFN-I signature scores with MDS survival (Figure 3c and 4c).    

      (10) The authors should discuss the relevance of immunosenescence features in the context of SRSF2 mutation and extend the discussion to the interest of their pipeline for patient diagnosis and follow up under treatments. 

      We have added the below text to the discussion:

      Recent studies have shown that the expression of programmed death-ligand 1 (PD-L1) protein is significantly elevated in senescent cells (DOIs: 10.1128/mcb.00171-22, 10.1172/JCI156250, 10.1038/s41586-022-05388-4). Increased PD-L1 protein levels protect senescent cells from being cleared by cytotoxic immune cells that express the PD-1 checkpoint receptor. In fact, activation of the PD-1 receptor inhibits the cytotoxic capabilities of CD8 + T and NK cells, increasing immunosenescence.   

      Notably, patients with MDS who possess particular somatic mutations, such as those in the TP53, ASXL1, SETBP1, TET2, SRSF2, and RUNX1 genes, have an increased propensity to react favourably to PD-1/PD-L1 inhibitors (DOIs: 10.1111/bjh.17689, https://doi.org/10.1182/blood2020-141100) confirming that many cellular and molecular mechanisms, known to promote cellular senescence, including alteration of splicing machinery, are crucial stimulators of the expression of PD-L1 protein. Interestingly, in our analysis, we also observed a correlation between the senescence gene signature score and the expression of the PD-L1 gene in CD34+ cells (Supplementary Figure 7), supporting the previous findings linking PD-L1 gene expression to cellular senescence.

      The immunology and ageing features extracted from the MDS transcriptomic data used in our analysis pipeline can enhance the conventional risk-scoring systems for MDS by providing new insights into this disease, particularly in the context of inflammation and ageing. For some patients, the clinical and genetic features may remain relatively the same until follow-up. Still, the transcriptomic features might differ considerably from the baseline diagnosis, affecting the course of treatment.    

      Reviewer #2 (Public Review): 

      The authors performed a Multi-Omics Factor Analysis (MOFA) on analysis of two published MDS patient cohorts-1 from bone marrow mononuclear cells (BMMNCs) and CD34 cells (ref 17) and another from CD34+ cells (ref 15) --with three data modalities (clinical, genotype, and transcriptomics). Seven different views, including immune profile, inflammation/aging, Retrotransposon (RTE) expression, and cell-type composition, were derived from these modalities to attempt to identify the latent factors with significant impact on MDS prognosis. 

      SF3B1 was found to be the only mutation among 13 mutations in the BMMNC cohort that indicated a significant association with high inflammation. This trend was also observed to a lesser extent in the CD34+ cohort. The MOFA factor representing inflammation showed a good prognosis for MDS patients with high inflammation. In contrast, SRSF2 mutant cases showed a granulocyte-monocyte progenitor (GMP) pattern and high levels of senescence, immunosenescence, and malignant myeloid cells, consistent with their poor prognosis. Also, MOFA identified RTE expression as a risk factor for MDS. They proposed that this work showed the efficacy of their integrative approach to assess MDS prognostic risk that 'goes beyond all the scoring systems described thus far for MDS'. 

      Several issues need clarification and response: 

      (1) The authors do not provide adequate known clinical and molecular information which demonstrates prognostic risk of their sample cohorts in order to determine whether their data and approach 'goes 'beyond all the scoring systems described thus far for MDS'. For example, what data have the authors that their features provide prognostic data independent of the prior known factors related to prognosis (eg, marrow blasts, mutational, cytogenetic features, ring sideroblasts, IPSS-R, IPSS-M, MDA-SS)? 

      We agree with the reviewer that we did not generate a new cumulative risk score and compare it with the conventional risk scores for MDS. However, we identified individual MOFA factors, which are risk or protective factors for MDS, based on survival analysis in the BMMNC cohort. One reason that we did not generate our independent, cumulative score and compare it with other scores was that we did not receive any conventional risk score for the BMMNC cohort. However, we had access to all the clinical and genetic variables from the BMMNC cohort (except for three patients) that were required to calculate IPSS-R; hence, we calculated the IPSS-R in our resubmission for the BMMNC cohort. We made three IPSS-R risk categories by combining low and very low as low risk, and high and very high as high risk, and keeping intermediate as intermediate risk. Our survival analysis of these three categories showed a clear match between IPSS-R score and MDS survival (Author response image 2a).

      We then investigated the relationship between factors 2, 4, and 9 from MOFA with three IPSS-R risk groups.  Integration of IPSS-R risk groups with factor values confirmed the finding in the manuscript that Factors 4 and 9 generally exert a protective influence over the MDS risk, whilst higher levels of Factor 2 predict a high-risk MDS (Author response image 2b). However, we see so many outliers in all three factors, indicating that some patients were assigned to the wrong IPSS-R categories because IPSS-R calculation is based on clinical and genetic variables and does not include the transcriptomics data for coding and non-coding genomic regions. 

      Author response image 2.

      Comparison of IPSS-R risk categories and MOFA risk and protective factors.

      (2) A major issue in analyzing this paper relates to the specific patient composition from whom the samples and data were obtained. The cells from the Shiozawa paper (ref 17) is comprised of a substantial number of CMML patients. Thus, what evidence have the authors that much of the data from the BMMNCs from these patients and mutant SRSF2 related predominantly to their monocytic dicerentiation state?  

      We thank the reviewer for the insightful comment about the monocytic differentiation state of CMML and SRSF2 mutant cases. The BMMNC cohort has 11 CMML and 17 SRSF2 mutant cases, of which six are shared between the two groups. We have divided the patients into four groups: CMML only, SRSF2 mutant only, CCML and SRSF2 mutant, and others. We have generated boxplots for all cellular composition gene signature scores for these groups and compared the scores between these groups. As explained above, Ferrall-Fairbanks et al. (DOI: 10.1158/2643-3230.BCD-21-0217) recently showed that CMML can be classified into three differentiation trajectories: monocytic, megakaryocyte-erythroid progenitor (MEP), and normal-like. One hallmark of monocytic-biased trajectory was the enrichment of inflammatory granulocyte–macrophage progenitor (GMP)-like cells, which we observed through our analysis for the CMML cases with SRSF2 mutation (Author response image 3.).

      Author response image 3.

      Cellular composition gene signature scores for CMML and SRSF2 mutant versus other cases. CMML cases with SRSF2 mutation show a significant higher level of GMP and GMP-like scores compared to other MDS cases.  

      (3) In addition, as the majority of patients in the Shiozawa paper have ring sideroblasts (n=59), thus potentially skewing the data toward consideration mainly of these patients, for whom better outcomes are well known.  

      We disagree with the reviewer. We used 94 BMMNC samples from Shiozawa’s paper, of which 19 cases had Refractory Anemia with Ring Sideroblasts (RARS), 4 cases had Refractory Anemia with Ring Sideroblasts and thrombocytosis (RARS-T), and 5 cases had Refractory cytopenia with multilineage dysplasia and ring sideroblasts (RCMD-RS). In total, we had 28 cases (~30%) with Ring Sideroblasts (RS), which are not large enough to skew the data.

      (4) Further, regarding this patient subset, what evidence have the authors that the importance of the SF3B1 mutation was merely related to the preponderance of sideroblastic patients from whom the samples were analyzed? 

      We had 34 SF3B1 mutant cases, of which 25 had Ring Sideroblasts (RS). The total number of cases with RS in the BMMNC cohort was 28. Therefore, the BMMNC cohort is not an RSdominant cohort, and RS cases did not include all SF3B1 mutants. Furthermore, it was recently shown by Ochi et al. (DOI: 10.1038/s41598-022-18921-2) that RS is a consequence of SF3B1K700E mutation, and it is not a cause to affect the SF3B1 importance.

      (5) An Erratum was reported for the Shiozawa paper (Shiozawa Y, Malcovati L, Gallì A, et al. Gene expression and risk of leukemic transformation in myelodysplasia. Blood. 2018 Aug 23;132(8):869-875. doi: 10.1182/blood-2018-07-863134) that resulted from a coding error in the construction of the logistic regression model for subgroup prediction based on the gene expression profiles of BMMNCs. This coding error was identified after the publication of the article. The authors should indicate the ecect this error may have had on the data they now report.  

      Thank you for bringing this important issue to our attention. The error resulted from a mistake in the construction of the logistic regression model for subgroup prediction based on the gene expression profiles of BMMNCs. However, this issue does not affect our result because we analysed the expression data from scratch and generated our own gene signature scores. Also, the error has no impact on the genetics and clinical information that we received from the authors.

      (6) What information have the authors as to whether the dicering RTE findings were not predominantly related to the dicerentiation state of the cell population analyzed (ie higher in BM MNCs vs CD34, Fig 1)? What control data have the authors regarding these values from normal (non-malignant) cell populations? 

      As described above, L1 and Alu, the two RTE families shared between the two cohorts, are still active and make new insertions in humans (Figure 2.a-b). Our interpretation is that ERV activation in BM is associated with immune cells. This interpretation is further supported by the findings of Au et al. (DOI: 10.1016/j.ccell.2021.10.001), where several ERV loci had expression in purified immune cell subsets in renal cell carcinoma samples. 

      Unfortunately, none of these two cohorts had normal (non-malignant) cell populations. We think that the MOFA unbiased way of modelling the heterogeneity is su@icient to capture the RTE derepressed phenotype of a subset of MDS cases compared to others, and we do not need normal cases to further support the finding. 

      (7) The statement in the Discussion regarding the ecects of SRSF2 mutation is speculative and should be avoided. Many other somatic gene mutations have known stronger ecects on prognosis for MDS. 

      One aim of this study is to identify specific immune signatures associated with SRSF2 and SF3B1 mutations, which are highly prevalent in MDS. Although other mutations, such as TP53, may have a stronger correlation with poor survival, numerous studies have demonstrated a clear link between SRSF2 mutations and poor prognosis.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations For The Authors):

      1) Line 99-100 The authors claimed that IQCH is a novel IQ motif-containing protein, which is essential for spermiogenesis and fertilization. However, it is not clear if the currently published paper named an ancient testis-specific IQ motif containing H gene that regulates specific transcript isoform expression during spermatogenesis.

      Response: Thanks to the reviewer’s comment. Yes, IQCH is the ancient testis-specific IQ motif containing H gene. According to the reviewer’s suggestion, we have revised the statement “Here, we revealed a testis-specific IQ motif containing H gene, IQCH, which is essential for spermiogenesis and fertilization” in Introduction part of revised manuscript.

      2) Line 154-159 Immunofluorescence staining for the marker of the acrosome (peanut agglutinin: PNA) as well as the mitochondrial marker (Transcription Factor A, Mitochondrial: TFAM) was performed to confirm the deficiency of the acrosomes and mitochondria in the proband's spermatozoa. It seems that the spermatozoa acrosomes and mitochondria were severely defective in the proband. The authors should indicate IQCH's role in mitochondrial and acrosome function and IQCH's role in mitochondrial and acrosome function these points by explaining how IQCH is related to mitochondrial and acrosome deficiency. In addition to staining, other functional analyses should be performed to strengthen the claim of acrosome and mitochondrial defects.

      Response: We appreciate the reviewer's valuable suggestion. Indeed, in our study, the results of multiomics analysis on WT and Iqch KO testes, including LC-MS/MS analysis, proteomic analysis, and RNA-seq analysis, found a potential role of IQCH in mitochondrial and acrosome function. GO analysis of these analysis indicated a significant enrichment in mitochondrial and acrosomal functions, including acrosomal vesicle, acrosome assembly, vesicle fusion with Golgi apparatus, mitochondrion organization, mitochondrial matrix, and so on. Among the enriched molecules, in particular, HNRNPK mainly expresses at Golgi phase and Cap phase (Biggiogera et al. 1993). ANXA7 is a calcium-dependent phospholipid-binding protein that is a negative regulator of mitochondrial apoptosis (Du et al. 2015). Loss of SLC25A4 results in mitochondrial energy metabolism defects in mice (Graham et al. 1997). Furthermore, we confirmed that IQCH interacted with HNRNPK, ANXA7, and SLC25A4 through Co-IP, and exhibited downregulation in the sperm of the Iqch KO mice by immunofluorescence and western blotting. Moreover, IQCH can bind to HNRPAB, which could influence the mRNAs level of Catsper-family, such as Catsper1, Catsper2, and Catsper3, which are crucial for acrosome development (Jin ZR et al). In addition, we also detected HNRPAB binding to Dnhd1, which affects mitochondria development (Tan C et al). Therefore, in addition to staining, the other functional analyses also have provided the evidence of acrosome and mitochondrial defects caused by IQCH absence.

      3) Line 180-182 IQCH knockout mice were generated. It is not clear why Mut-IQCH mice were not generated to be consistent with the human sequencing data.

      Response: Thanks for reviewer’s comments. To understand IQCH's impact on fecundity in mice, we employed CRISPR-Cas9 to generate mice encoding the orthologous variant of IQCH387+1_387+10del detected in humans. Regrettably, due to sequence complexity, the designed sgRNA's specificity and efficiency were low, hindering successful Iqch knock-in mouse construction. Considering IQCH387+1_387+10del results in absent expression, we pursued Iqch knockout mice to explore IQCH's role in spermatogenesis.

      4) Line 241.Figure 5A Gene Ontology (GO) analysis of the IQCH-bound proteins revealed a particular enrichment in fertilization, sperm axoneme assembly, mitochondrial organization, calcium channel, and RNA processing. But these GO functions are not shown in Figure 5A. The entire Figure 5 should be revised to enhance readability.

      Response: We sincerely apologize for the oversight. These GO functions were indeed identified during the analysis of IQCH-bound proteins. Regrettably, we unintentionally omitted these GO functions when creating the plots. We have revised the plots in Figure 5 in revised manuscript to enhance readability.

      5) Line 242 "33 ribosomal proteins were identified (Fig. 5B), indicating that IQCH might be involved in protein synthesis". The authors should perform an analysis to support the claim of protein synthesis defects.

      Response: Thanks to reviewer’s suggestions. Initially, we have supplemented Co-IP experiments to confirm the interaction between IQCH and three ribosomal proteins (RPL4, RPS3, and RPS7), chosen from a pool of 33 ribosomal proteins based on different protein scores (Figure R1). In addition, the proteomic analysis revealed 807 upregulated proteins and 1,186 downregulated proteins in KO mice compared to WT mice. We confirmed the key downregulated proteins by western blotting and immunofluorescence staining in the previous manuscript. These results indicated that IQCH might interact with ribosomal proteins to regulate protein expression. Naturally, the regulation of protein synthesis by IQCH requires further experiments for confirmation in future studies.

      Author response image 1.

      The interaction between IQCH and ribosomal proteins. Co-IP assays confirmed that IQCH interacted with RPL4, RPS3, and RPS7 in WT mouse sperm.

      6) Line 244 The authors mentioned too many GO functions without focus.

      Response: Following reviewer’s suggestions, we have simplified IQCH-associated GO functions in the revised manuscript.

      7) Figure 6, there are no negative controls in all co-IP experiments. Band sizes are not marked. Thus, all data can't be evaluated. This also raises concern about whether the LC-MS/MS experiment to identify IQCH interacting protein was well-controlled? All co-IP experiments were poorly designed to draw any conclusion.

      Response: Thanks to reviewer’s comments. We have supplemented negative controls in all Co-IP experiments and provided band sizes in Figure 6 in revised manuscript.

      8) The authors mentioned that IQCH can bind to CaM. But they didn't detect CaM protein in Figure 5. Did the LC-MS/MS experiment really work?

      Response: Thanks to reviewer’s comments. We detected the interaction of CaM protein with IQCH in the LC-MS/MS experiment analysis, which has been submitted as new Data S1 in the revised manuscript. We also confirmed their binding in mouse sperm by Co-IP experiment and immunofluorescence staining, which results were shown in Figure 6 and Figure S10 in the previous study.

      9) Figure 6D. Because IQCH is lost in Iqch KO sperm, what is the point of showing in the Co-IP assay that CaM does not bind to IQCH in Iqch KO sperm?

      Response: Following reviewer’s suggestions, we have deleted the results of Co-IP assay that CaM could not bind to IQCH in Iqch KO sperm.

      10) Figure 6E. The Co-IP assay does not support the authors' claim that the decreased expression of HNRPAB was due to the reduced binding of IQCH and CaM by the knockout of IQCH or CaM.

      Response: Thanks to reviewer’s expert comments. Indeed, the results of Figure 6E confirmed the interaction of IQCH and CaM in K562 cells, and also showed that the expression of HNRPAB was reduced when IQCH or CaM was knocked down, suggesting that IQCH or CaM might regulate HNRPAB expression. While in Figure 6F, the downregulation of HNRPAB caused by knocking down IQCH (or CaM) cannot be rescued when overexpressed CaM (or IQCH), indicating that CaM (or IQCH) cannot mediate HNRPAB expression alone. Therefore, the reduced expression of HNRPAB in Figure 6E might result from the weakened interaction between IQCH and CaM, but not a superficial downregulation of IQCH or CaM expression. To avoid the confusion, we have modified the relevant description in the revied manuscript.

      Reviewer #2 (Recommendations For The Authors):

      Major comments:

      1) Lines 117 and 129: Please provide the reference number (NM_xxx.x) for the IQCH isoform that was used to interpret this variant. This is key information. Also, please provide the predicted truncation consequence caused by this splicing variant to IQCH protein.

      Response: Thanks to reviewer’s suggestions. We have added reference number (NM_0010317152) of IQCH in manuscript. We employed splice site prediction tools, such as SpliceAI, RDDC, and varSEAK, to assess the expression consequences of this IQCH splicing variant. These tools couldn't anticipate the outcome of this splicing variant. However, the results of minigene splicing assay showed that the IQCH c.387+1_387+10del resulted in degradation of IQCH.

      2) Figure 1A: The deleted sequence indicated by the red box does not match IQCH c.387+1_387+10del. Please show a plot of the exon-intron boundary under the Sanger sequencing results of the WT allele.

      Response: Thanks to reviewer’s suggestions. We are sorry for the use of non-standard descriptions about the results of Sanger sequencing. According to the HGVS nomenclature (Figure R2), we have modified the red box to match IQCH c.387+1_387+10del and have added the exon-intron boundary in Figure 1A accordingly.

      Author response image 2.

      HGVS nomenclature description of the IQCH variant. The picture showed a detailed HGVS nomenclature description of IQCH c.387+1_387+10del.

      Minor comments:

      a) Manuscript title: It is suggested to change the title to "IQCH regulates spermatogenesis by interacting with CaM to promote the expression of RNA-binding proteins".

      Response: According to reviewer’s suggestions, we have modified the title as “IQCH regulates spermatogenesis by interacting with CaM to promote the expression of RNA-binding proteins”.

      b) Line 116: Please introduce the abbreviation WES. Also, please introduce the other abbreviations (such as WT, SEM, TEM, etc.) the first time they appear.

      Response: Thanks to reviewer’s suggestions. We have provided the full explanations for all abbreviations upon their initial appearance.

      c) Line 140, "Nonfunctional IQCH": Due to "the lack of IQCH expression" in Line 137, should "Nonfunctional IQCH" be changed into "IQCH deficiency"?

      Response: Thanks for reviewer’s the detailed review. We have modified this title in Results part of the revised manuscript as followed: “IQCH deficiency leads to sperm with cracked axoneme structures accompanied by defects in the acrosome and mitochondria”

      d) The information on the following references is incomplete: Sechi et al., Tian et al., Wang et al., and Xu et al. Please provide issue/page/article numbers.

      Response: We are sorry for our oversight. We have provided the missing issue/page/article numbers for the references.

      e) The title of Figure 1: Please emphasize that the male infertile-associated variant is "homozygous".

      Response: Thanks to reviewer’s suggestions. We have revised the title of Figure 1 to emphasize the homozygous variant as follows: “Identification of a homozygous splicing mutation in IQCH in a consanguineous family with male infertility”.

      f) Table 1: Please provide the reference paper for the normal values. Response: We appreciate the reviewer's detailed checks. We have provided the reference paper for the normal values in Table 1.

      g) Figure 5F is distorted. Please make sure that it is a perfect circle.

      Response: Thanks to reviewer’s suggestions. We have revised both the graphical representation and layout of Figure 5 in revised manuscript to make sure the readability.

      Reviewer #3 (Recommendations For The Authors):

      While the writing is generally clear, there are multiple examples of where the writing could be improved for clarity.

      1) While some terms are defined throughout the manuscript, many abbreviations are not defined upon their first mention, such as WES, RT-PCR, TYH, HTF, KSOM, KEGG, RIPA, PMSE, SDS-PAGE, H&L, and HRP.

      Response: Thanks to reviewer’s suggestions. We have provided the full explanations for all abbreviations upon their initial appearance.

      2) On line 44, the claim that spermatogenesis is the "most complex biological process" is rather subjective and hard to support with concrete data.

      Response: Thanks to reviewer’s suggestions. We have modified this description in the Introduction section as follow: “Spermatogenesis is one of the most complex biological process in male organisms and functions to produce mature spermatozoa from spermatogonia in three phases: (i) spermatocytogenesis (mitosis), (ii) meiosis, and (iii) spermiogenesis.”

      3) On line 54, I think the authors meant "heterogeneous," not "heterologous."

      Response: Thanks to reviewer’s comment. We have changed “heterologous” into “heterogeneous”.

      4) On line 156, I think the authors meant "deficiency," not "deficient."

      Response: Thanks to reviewer’s comment. We are sorry to make this mistake. We have made the correction in the revised version of the manuscript.

      5) On line 300, K562 cells are mentioned, but neither in the Methods nor the Results are any details about the biological origin of these cells (or rationale for their use other than co-expression of IQCH and CaM) provided.

      Response: Thanks to reviewer’s suggestion. K562 cell line is a human leukemia cell line and is enriched in the expression of IQCH and CaM, we thus opted to use this cell line for an easier knockdown of IQCH and CaM. We have supplemented the details about the biological origin of these cells in Method section of revised manuscript.

      6) For the Results section describing Figure 6H, it would be nice to provide some explanation of the results of ICHQ overexpression alone relative to control situations and not just relative to the delta-IQ version or relative to simultaneous CaM manipulation.

      Response: According to the reviewer’s suggestion, we have supplemented the co-transfection of control and CaM plasmids in HEK293T cells, and the results showed that the expression of HNRPAB in cells co-transfected with control and CaM plasmids was similar to that of co-transfected with IQCH (△IQ) /CaM plasmids, but was lower than that in the cells overexpressing the WT-IQCH and CaM plasmids, confirming the nonfunction of IQCH (△IQ) plasmids. We have shown the results in Figure 6H in the revised manuscript.

      7) The sentence on lines 352-354 is confusing.

      Response: We apologize for any confusion caused by the sentence in question. We have revisited the sentence and made appropriate revisions to enhance its clarity as follows: “Our findings suggest that the fertilization function is the main action of IQ motif-containing proteins, while each specific IQ motif-containing protein also has its own distinct role in spermatogenesis.”

      8) The use of "employee" on line 371 is awkward and not very scientific.

      Response: Thanks to reviewer’s comment. We have changed “employee” in to “downstream effector protein” on line 376

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      This study provides an important cell atlas of the gill of the mussel Gigantidas platifrons using a single nucleus RNA-seq dataset, a resource for the community of scientists studying deep sea physiology and metabolism and intracellular host-symbiont relationships. The work, which offers solid insights into cellular responses to starvation stress and molecular mechanisms behind deep-sea chemosymbiosis, is of relevance to scientists interested in host-symbiont relationships across ecosystems.

      Public Reviews:

      Reviewer #1 (Public Review):

      Wang et al have constructed a comprehensive single nucleus atlas for the gills of the deep sea Bathymodioline mussels, which possess intracellular symbionts that provide a key source of carbon and allow them to live in these extreme environments. They provide annotations of the different cell states within the gills, shedding light on how multiple cell types cooperate to give rise to the emergent functions of the composite tissues and the gills as a whole. They pay special attention to characterizing the bacteriocyte cell populations and identifying sets of genes that may play a role in their interaction with the symbiotes.

      Wang et al sample mussels from 3 different environments: animals from their native methane-rich environment, animals transplanted to a methane-poor environment to induce starvation, and animals that have been starved in the methane-poor environment and then moved back to the methane-rich environment. They demonstrated that starvation had the biggest impact on bacteriocyte transcriptomes. They hypothesize that the upregulation of genes associated with lysosomal digestion leads to the digestion of the intracellular symbiont during starvation, while the non-starved and reacclimated groups more readily harvest the nutrients from symbiotes without destroying them.

      Strengths:

      This paper makes available a high-quality dataset that is of interest to many disciplines of biology. The unique qualities of this non-model organism and the collection of conditions sampled make it of special interest to those studying deep sea adaptation, the impact of environmental perturbation on Bathymodioline mussels populations, and intracellular symbiotes. The authors do an excellent job of making all their data and analysis available, making this not only an important dataset but a readily accessible and understandable one.

      The authors also use a diverse array of tools to explore their data. For example, the quality of the data is augmented by the use of in situ hybridizations to validate cluster identity and KEGG analysis provides key insights into how the transcriptomes of bacteriocytes change.

      The authors also do a great job of providing diagrams and schematics to help orient non-mussel experts, thereby widening the audience of the paper.

      Thank the reviewer for the valuable feedback on our study. We are grateful that the reviewers found our work to be interesting and we appreciate their thorough evaluation of our research. Their constructive comments will be considered as we continue to develop and improve our study.

      Weaknesses:

      One of the main weaknesses of this paper is the lack of coherence between the images and the text, with some parts of the figures never being referenced in the body of the text. This makes it difficult for the reader to interpret how they fit in with the author's discussion and assess confidence in their analysis and interpretation of data. This is especially apparent in the cluster annotation section of the paper.

      We appreciate the feedback and suggestions provided by the reviewer, and we have revised our manuscript to make it more accessible to general audiences.

      Another concern is the linking of the transcriptomic shifts associated with starvation with changes in interactions with the symbiotes. Without examining and comparing the symbiote population between the different samples, it cannot be concluded that the transcriptomic shifts correlate with a shift to the 'milking' pathway and not other environmental factors. Without comparing the symbiote abundance between samples, it is difficult to disentangle changes in cell state that are due to their changing interactions with the symbiotes from other environmental factors.

      We are grateful for the valuable feedback and suggestions provided by the reviewer. Our keen interest lies in understanding symbiont responses, particularly at the single-cell level. However, it's worth noting that existing commercial single-cell RNA-seq technologies rely on oligo dT priming for reverse transcription and barcoding, thus omitting bacterial gene expression information from our dataset. We hope that advancements in technology will soon enable us to perform an integrated analysis encompassing both host and symbiont gene expression.

      Additionally, conclusions in this area are further complicated by using only snRNA-seq to study intracellular processes. This is limiting since cytoplasmic mRNA is excluded and only nuclear reads are sequenced after the organisms have had several days to acclimate to their environment and major transcriptomic shifts have occurred.

      We appreciate the comments shared by the reviewer and agree that scRNA-seq provides more comprehensive transcriptional information by targeting the entire mRNA of the cell. However, we would like to highlight that snRNA-seq has some unique advantages over scRNA-seq. Notably, snRNA-seq allows for simple snap-freezing of collected samples, facilitating easier storage, particularly for samples obtained during field trips involving deep-sea animals and other ecologically significant non-model animal samples. Additionally, unlike scRNA-seq, snRNA-seq eliminates the need for tissue dissociation, which often involves prolonged enzymatic treatment of deep-sea animal tissue/cells under atmospheric pressure. This process can potentially lead to the loss of sensitive cells or alterations in gene expression. Moreover, snRNA-seq procedures disregard the size and shape of animal cells, rendering it a superior technology for constructing the cell atlas of animal tissues. Consequently, we assert that snRNA-seq offers flexibility and represents a suitable choice for the research objects of our current research.

      Reviewer #2 (Public Review):

      Wang, He et al. shed insight into the molecular mechanisms of deep-sea chemosymbiosis at the single-cell level. They do so by producing a comprehensive cell atlas of the gill of Gigantidas platifrons, a chemosymbiotic mussel that dominates the deep-sea ecosystem. They uncover novel cell types and find that the gene expression of bacteriocytes, the symbiont-hosting cells, supports two hypotheses of host-symbiont interactions: the "farming" pathway, where symbionts are directly digested, and the "milking" pathway, where nutrients released by the symbionts are used by the host. They perform an in situ transplantation experiment in the deep sea and reveal transitional changes in gene expression that support a model where starvation stress induces bacteriocytes to "farm" their symbionts, while recovery leads to the restoration of the "farming" and "milking" pathways.

      A major strength of this study includes the successful application of advanced single-nucleus techniques to a non-model, deep-sea organism that remains challenging to sample. I also applaud the authors for performing an in situ transplantation experiment in a deep-sea environment. From gene expression profiles, the authors deftly provide a rich functional description of G. platifrons cell types that is well-contextualized within the unique biology of chemosymbiosis. These findings offer significant insight into the molecular mechanisms of deep-sea host-symbiont ecology, and will serve as a valuable resource for future studies into the striking biology of G. platifrons.

      The authors' conclusions are generally well-supported by their results. However, I recognize that the difficulty of obtaining deep-sea specimens may have impacted experimental design. In this area, I would appreciate more in-depth discussion of these impacts when interpreting the data.

      Thank the reviewer for their valuable feedback on our study. We're grateful that the reviewers found our work interesting, and we appreciate their thorough evaluation of our research. We'll consider their constructive comments as we continue to develop and improve our study.

      Because cells from multiple individuals were combined before sequencing, the in situ transplantation experiment lacks clear biological replicates. This may potentially result in technical variation (ie. batch effects) confounding biological variation, directly impacting the interpretation of observed changes between the Fanmao, Reconstitution, and Starvation conditions. It is notable that Fanmao cells were much more sparsely sampled. It appears that fewer cells were sequenced, resulting in the Starvation and Reconstitution conditions having 2-3x more cells after doublet filtering. It is not clear whether this is due to a technical factor impacting sequencing or whether these numbers are the result of the unique biology of Fanmao cells. Furthermore, from Table S19 it appears that while 98% of Fanmao cells survived doublet filtering, only ~40% and ~70% survived for the Starvation and Reconstitution conditions respectively, suggesting some kind of distinction in quality or approach.

      There is a pronounced divergence in the relative proportions of cells per cell type cluster in Fanmao compared to Reconstitution and Starvation (Fig. S11). This is potentially a very interesting finding, but it is difficult to know if these differences are the expected biological outcome of the experiment or the fact that Fanmao cells are much more sparsely sampled. The study also finds notable differences in gene expression between Fanmao and the other two conditions- a key finding is that bacteriocytes had the largest Fanmao-vs-starvation distance (Fig. 6B). But it is also notable that for every cell type, one or both comparisons against Fanmao produced greater distances than comparisons between Starvation and Reconstitution (Fig. 6B). Again, it is difficult to interpret whether Fanmao's distinctiveness from the other two conditions is underlain by fascinating biology or technical batch effects. Without biological replicates, it remains challenging to disentangle the two.

      As highlighted by the reviewer, our experimental design involves pooling multiple biological samples within a single treatment state before sequencing. We acknowledge the concern regarding the absence of distinct biological replicates and the potential impact of batch effects on result interpretation. While we recognize the merit of conducting multiple sequencing runs for a single treatment to provide genuine biological replicates, we contend that batch effects may not exert a strong influence on the observed patterns.

      In addition, we applied a bootstrap sampling algorithm to assess whether the gene expression patterns within a cluster are more similar than those between clusters. This algorithm involves selecting a portion of cells per cluster and examining whether this subset remains distinguishable from other clusters. Our assumption was that if different samples exhibited distinct expression patterns due to batch effect, the co-assignment probabilities of a cluster would be very low. This expectation was not met in our data, as illustrated in Fig. S2. The lack of significantly low co-assignment probabilities within clusters suggests that batch effects may not exert a strong influence on our results.

      Indeed, we acknowledge a noticeable shift in the expression patterns of certain cell types, such as the bacteriocyte. However, this is not universally applicable across all cell types. For instance, the UMAP figure in Fig. 6A illustrates a substantial overlap among basal membrane cell 2 from Fanmao, Starvation, and Reconstitution treatments, and the centroid distances between the three treatments are subtle, as depicted in Fig. 6B. This consistent pattern is also observed in DEPC, smooth muscle cells, and the food groove ciliary cells.

      The reviewer also noted variations in the number of cells per treatment. Specifically, Fanmao sequencing yielded fewer than 10 thousand cells, whereas the other two treatments produced 2-3 times more cells after quality control (QC). It is highly probable that the technician loaded different quantities of cells into the machine for single-nucleus sequencing—a not uncommon occurrence in this methodology. While loading more cells may increase the likelihood of doublets, it is crucial to emphasize that this should not significantly impact the expression patterns post-QC. It's worth noting that overloading samples has been employed as a strategic approach to capture rare cell types, as discussed in a previous study (reference: 10.1126/science.aay0267).

      The reviewer highlighted the discrepancy in cell survival rates during the 'doublet filtering' process, with 98% of Fanmao cells surviving compared to approximately 40% and 70% for the Starvation and Reconstitution conditions, respectively. It's important to clarify that the reported percentages reflect the survival of cells through a multi-step QC process employing various filtering strategies.

      Post-doublet removal, we filtered out cells with <100 or >2500 genes and <100 or >6000 unique molecular identifiers (UMIs). Additionally, genes with <10 UMIs in each data matrix were excluded. The observed differences in survival rates for Starvation and Reconstitution cells can be attributed to the total volume of data generated in Illumina sequencing. Specifically, we sequenced approximately 91 GB of data for Fanmao, ~196 GB for Starvation, and ~249 GB for Reconstitution. As a result, the qualified data obtained for Starvation and Reconstitution conditions was only about twice that of Fanmao due to the limited data volume.

      The reviewer also observed a divergence in the relative proportions of cells per cell type cluster in Fanmao compared to Reconstitution and Starvation, as depicted in Fig. S1. This discrepancy may hold true biological significance, presenting a potentially intriguing finding. However, our discussion on this pattern was rather brief, as we acknowledge that the observed differences could be influenced by the sample preparation process for dissection and digestion. It is crucial to consider that cutting a slightly different area during dissection may result in variations in the proportion of cells obtained. While we recognize the potential impact of this factor, we do not think that the sparsity of sampling alone could significantly affect the relative proportions of cells per cell type.

      In conclusion, we acknowledge the reviewer's suggestion that sequencing multiple individual samples per treatment condition would have been ideal, rather than pooling them together. However, the homogenous distribution observed in UMAP and the consistent results obtained from bootstrap sampling suggest that the impact of batch effects on our analyses is likely not substantial. Additionally, based on our understanding, the smaller number of cells in the Fanmao sample should not have any significant effect on the resulting different proportion of cells or the expression patterns per each cluster.

      Reviewer #3 (Public Review):

      Wang et al. explored the unique biology of the deep-sea mussel Gigantidas platifrons to understand the fundamental principles of animal-symbiont relationships. They used single-nucleus RNA sequencing and validation and visualization of many of the important cellular and molecular players that allow these organisms to survive in the deep sea. They demonstrate that a diversity of cell types that support the structure and function of the gill including bacteriocytes, specialized epithelial cells that host sulfur-oxidizing or methane-oxidizing symbionts as well as a suite of other cell types including supportive cells, ciliary, and smooth muscle cells. By performing experiments of transplanting mussels from one habitat which is rich in methane to methane-limited environments, the authors showed that starved mussels may consume endosymbionts versus in methane-rich environments upregulated genes involved in glutamate synthesis. These data add to the growing body of literature that organisms control their endosymbionts in response to environmental change.

      The conclusions of the data are well supported. The authors adapted a technique that would have been technically impossible in their field environment by preserving the tissue and then performing nuclear isolation after the fact. The use of single-nucleus sequencing opens the possibility of new cellular and molecular biology that is not possible to study in the field. Additionally, the in-situ data (both WISH and FISH) are high-quality and easy to interpret. The use of cell-type-specific markers along with a symbiont-specific probe was effective. Finally, the SEM and TEM were used convincingly for specific purposes in the case of showing the cilia that may support water movement.

      We appreciate the valuable feedback provided by the reviewer on our study. It is encouraging to know that our work was found to be interesting and that they conducted a thorough evaluation of our research. We will take their constructive comments into account as we strive to develop and enhance our study. Thank the reviewer for all the input.

      The one particular area for clarification and improvement surrounds the concept of a proliferative progenitor population within the gill. The authors imply that three types of proliferative cells within gills have long been known, but their study may be the first to recover molecular markers for these putative populations. The markers the authors present for gill posterior end budding zone cells (PEBZCs) and dorsal end proliferation cells (DEPCs) are not intuitively associated with cell proliferation and some additional exploration of the data could be performed to strengthen the argument that these are indeed proliferative cells. The authors do utilize a trajectory analysis tool called Slingshot which they claim may suggest that PEBZCs could be the origin of all gill epithelial cells, however, one of the assumptions of this analysis is that differentiated cells are developed from the same precursor PEBZC population.

      However, these conclusions do not detract from the overall significance of the work of identifying the relationship between symbionts and bacteriocytes and how these host bacteriocytes modulate their gene expression in response to environmental change. It will be interesting to see how similar or different these data are across animal phyla. For instance, the work of symbiosis in cnidarians may converge on similar principles or there may be independent ways in which organisms have been able to solve these problems.

      We are grateful for the valuable comments and suggestions provided by the reviewer. All suggestions have been carefully considered, and the manuscript has been revised accordingly. We particularly value the reviewer's insights regarding the characterization of the G. platifrons gill proliferative cell populations. In a separate research endeavor, we have conducted experiments utilizing both cell division and cell proliferation markers on these proliferative cell populations. While these results are not incorporated into the current manuscript, we would be delighted to share our preliminary findings with the reviewer. Our preliminary results indicate that the proliferative cell populations exhibit positivity for cell proliferation markers and contain a significant number of mitotic cells..

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Further experiments are needed to link the changes in transcriptomes of Bathymodioline mussels in the different environmental conditions to changes in their interactions with symbiotes. For example, quantifying the abundance and comparing the morphology of symbiotes between the environmental conditions would lend much support for shifting between milking and farming strategies. Without analyzing the symbiotes and comparing them across populations, it is difficult to comment on the mechanisms of interactions between symbiotes and the hosts. Without this analysis, this data is better suited towards comments about the general effect of environmental perturbation and stress on gene expression in these mussels.

      We appreciate the reviewer’s comments. We are also very curious about the symbiont responses, especially at the single-cell level. However, all the current commercial single-cell RNA-seq technologies are based on oligo dT priming for reverse transcription and barcoding. Therefore, the bacterial gene expression information is omitted from our dataset. Hopefully, with the development of technology, we could conduct an integrated analysis of both host and symbiont gene expression soon.

      Additionally, clarification is needed on which types of symbiotes are being looked at. Are they MOX or SOX populations? Are they homogenous? What are the concentrations of sulfur at the sampled sites?

      We thank you for your valuable comments and suggestions. Gigantidas platifrons harbors a MOX endosymbiont population characterized by a single 16S rRNA phylotype. We apologize for any confusion resulting from our previous wording. To clarify, we have revised lines 57-59 of our introduction

      In the text and images, consider using standardized gene names and leaving out the genome coordinates. This would greatly help with readability. Also, be careful to properly follow gene naming and formatting conventions (ie italicizing gene names and symbols).

      We appreciate the reviewer’s insightful comments. In model animals, gene nomenclature often stems from forward genetic approaches, such as the identification of loss-of-function mutants. These gene names, along with their protein products, typically correspond to unique genome coordinates. Conversely, in non-model invertebrates (e.g., Gigantidas platifrons of present study), gene prediction relies on a combination of bioinformatics methods, including de novo prediction, homolog-based prediction, and transcriptomics mapping. Subsequently, the genes are annotated by identifying their best homologs in well-characterized databases. Given that different genes may encode proteins with similar annotated functions, we chose to include both the gene ID (genome coordinates) and the gene name in our manuscript. This dual labeling approach ensures that our audience receives accurate and comprehensive information regarding gene identification and annotation.

      Additionally, extending KEGG analysis to the atlas annotation section could help strengthen the confidence of annotations. For example, when identifying bacteriocyte populations, the functional categories of individual marker genes (lysosomal proteases, lysosomal traffic regulators, etc) are used to justify the annotation. Presenting KEGG support that these functional categories are upregulated in this population relative to others would help further support how you characterize this cluster by showing it's not just a few specific genes that are enriched in this cell group, but rather an overall functionality.

      We appreciate the valuable suggestion provided by the reviewer. Indeed, incorporating KEGG analysis into the atlas annotation section could further enhance the confidence in our annotations. However, in our study, we encountered some limitations that impeded us from conducting a comprehensive KEGG enrichment analysis.

      Firstly, the number of differentially expressed genes (DEGs) that we identified for certain cell populations was relatively small, making it challenging to meet the threshold required for meaningful KEGG enrichment analysis. For instance, among the 97 marker genes identified for the Bacteriocyte cluster, only two genes, Bpl_scaf_59648-4.5 (lysosomal alpha-glucosidase-like) and Bpl_scaf_52809-1.6 (lysosomal-trafficking regulator-like isoform X1), were identified as lysosomal genes. To generate reliable KEGG enrichments, a larger number of genes is typically required.

      Secondly, single-nucleus sequencing, as employed in our study, tends to yield a relatively smaller number of genes per cell compared to bulk RNA sequencing. This limited gene yield can make it challenging to achieve sufficient gene representation for rigorous KEGG enrichment analysis.

      Furthermore, many genes in the genome still lack comprehensive annotation, both in terms of KEGG and GO annotations. In our dataset, out of the 33,584 genes obtained through single-nuclei sequencing, 26,514 genes have NO KEGG annotation, and 25,087 genes have NO GO annotation. This lack of annotations further restricts the comprehensive application of KEGG analysis in our study.

      The claim that VEPCs are symbiote free is not demonstrated. Additional double in situs are needed to show that markers of this cell type localize in regions free of symbiotes.

      We appreciate your comments and suggestions. In Figure 5B, our results demonstrate that the bacteriocytes (green fluorescent signal) are distant from the VEPCs, which are located around the tip of the gill filaments (close to the food groove). We have revised our Figure 5B to make it clear.

      Additionally, it does not seem like trajectory analysis is appropriate for these sampling conditions. Generally, to create trajectories confidently, more closely sampled time points are needed to sufficiently parse out the changes in expression. More justification is needed for the use of this type of analysis here and a discussion of the limitations should be mentioned, especially when discussing the hypotheses relating to PEBZCs, VEPCs, and DEPCs.

      We greatly appreciate your thoughtful commentary. It is important to acknowledge that in the context of a developmental study, incorporating more closely spaced time points indeed holds great value. In our ongoing project investigating mouse development, for instance, we have implemented time points at 24-hour intervals. However, in the case of deep-sea adult animals, we hypothesized a slower transcriptional shift in such extreme environment, which led us to opt for a time interval of 3-7 days. Examining the differential expression profiles among the three treatments, we observed that most cell types exhibited minimal changes in their expression profiles. For the cell types strongly impacted by in situ transplantation, their expression profiles per cell type still exhibited highly overlap in the UMAP analysis (Figure 6a), thus enabling meaningful comparisons. Nevertheless, we recognize that our sampling strategy may not be flawless. Additionally, the challenging nature of conducting in situ transplantation in 1000-meter depths limited the number of sampling occasions available to us. We sincerely appreciate your input and understanding.

      Finally, more detail should be added on the computational methods used in this paper. For example, the single-cell genomics analysis protocol should be expanded on so that readers unfamiliar with BD single-cell genomics handbooks could replicate the analysis. More detail is also needed on what criteria and cutoffs were used to calculate marker genes. Also, please be careful to cite the algorithms and software packages mentioned in the text.

      Acknowledged, thank you for highlighting this. In essence, the workflow closely resembles that of the 10x Genomics workflow (despite the use of a different software, i.e., Cell Ranger). We better explain the workflow below, and also noting that this information may no longer be relevant for newer users of BD or individuals who are not acquainted with BD, given that the workflow underwent a complete overhaul in the summer of 2023.

      References to lines

      Line 32: typo "..uncovered unknown tissue heterogeny" should read "uncovering" or "and uncovered")

      Overall abstract could include more detail of findings (ex: what are the "shifts in cell state" in line 36 that were observed)

      We apologize for the mistakes, and have revised the manuscript accordingly.

      Line 60: missing comma "...gill filament structure, but also"

      We apologize for the mistakes, and have revised the manuscript accordingly.

      Line 62-63: further discussion here, or in the relevant sections of the specific genes identified in the referenced bulk RNA-seq project could help strengthen confidence in annotation

      We appreciate the comment, and have revised the manuscript accordingly.

      Line 112: what bootstrapping strategy? Applied to what?

      This is a bootstrap sampling algorithm to assess the robustness of each cell cluster developed in a recent biorxiv paper. (Singh, P. & Zhai, Y. Deciphering Hematopoiesis at single cell level through the lens of reduced dimensions. bioRxiv, 2022.2006.2007.495099 (2022). https://doi.org:10.1101/2022.06.07.495099)

      Lines 127-129: What figures demonstrate the location of the inter lamina cells? Are there in situs that show this?

      We apologize for any errors; the referencing of figures in the manuscript has been revised for clarity

      Lines 185-190: does literature support these as markers of SMCs? Are they known smooth muscle markers in other systems?

      We characterized the SMCs by the expression of LDL-associated protein, angiotensin-converting enzyme-like protein, and the "molecular spring" titin-like protein, all of which are commonly found in human vascular smooth muscle cells. Based on this analysis, we hypothesize that these cells belong to the smooth muscle cell category.

      Line 201: What is meant by "regulatory roles"?

      In this context, we are discussing the expression of genes encoding regulatory proteins, such as SOX transcription factors and secreted-frizzled proteins.

      Line 211: which markers disappeared? What in situs show this?

      We apologize for the mistakes, and have revised the manuscript accordingly.

      Line 211: typo, "role" → "roll"

      We apologize for the mistakes, and have revised the manuscript accordingly.

      Line 214: what are these "hallmark genes"

      We apologize for the mistakes, here we are referring to the genes listed in figure 4B. We have revised the manuscript accordingly.

      Line 220: are there meristem-like cells in metazoans? If so, this would be preferable to a comparison with plants.

      In this context, we are discussing the morphological characteristics of gill proliferative cell populations found in filibranch bivalves. These populations, namely PEPC, VEPC, and DEPC, consist of cells exhibiting morphological traits akin to those of plant cambial-zone meristem cells. These cells typically display small, round shapes with a high nucleus-to-plasma ratio. We acknowledge that while these terms are utilized in bivalve studies (citations below), they lack the robust support seen in model systems backed by molecular biology evidences. The present snRNA-seq data, however, may offer valuable cell markers for future comprehensive investigations.

      Leibson, N. L. & Movchan, O. T. Cambial zones in gills of Bivalvia. Mar. Biol. 31, 175-180 (1975). https://doi.org:10.1007/BF00391629

      Wentrup, C., Wendeberg, A., Schimak, M., Borowski, C. & Dubilier, N. Forever competent: deep-sea bivalves are colonized by their chemosynthetic symbionts throughout their lifetime. Environ. Microbiol. 16, 3699-3713 (2014). https://doi.org:10.1111/1462-2920.12597

      Cannuel, R., Beninger, P. G., McCombie, H. & Boudry, P. Gill Development and its functional and evolutionary implications in the blue mussel Mytilus edulis (Bivalvia: Mytilidae). Biol. Bull. 217, 173-188 (2009). https://doi.org:10.1086/BBLv217n2p173

      Line 335: what is slingshot trajectory analysis? Does this differ from the pseudotime analysis?

      Slingshot is an algorithm that uses the principal graph of the cells to infer trajectories. It models trajectories as curves on the principal graph, capturing the progression and transitions between different cellular states.

      Both Slingshot and pseudotime aim to infer cellular trajectories. Slingshot focuses on capturing branching patterns which is fully compatible with the graph generated using dimensionality reduction such as UMAP and PHATE, while pseudotime analysis aims to order cells along a continuous trajectory. It does not rely on dimensionality reduction graphs. We used both in the MS for different purposes.

      Line 241: introduce FISH methodology earlier in the paper, when in situ images are first referenced

      We appreciate the comment, and have revised the manuscript accordingly.

      Line 246-249: can you quantify the decrease in signal or calculate the concentration of symbiotes in the cells? Was 5C imaged whole? This can impact the fluorescent intensity in tissues of different thicknesses.

      We appreciate your comment. In Figure 5C, most of the typical gill filament region is visible (the ventral tip of the gill filament, and the mid part of the gill filament) except for the dorsal end. The gill filament of bathymodioline mussels exhibits a simple structure: a single layer of bacteriocytes grow on the basal membrane. Consequently, the gill slices have a fairly uniform thickness (with two layers of bacteriocytes and one layer of interlamina cells in between), minimizing any potential impact on fluorescent intensity. As of now, detailed quantification of intracellular symbionts may necessitate continuous TEM or ultra-resolution confocal sections to 3D reconstruct the bacteriocytes, which may exceed the scope of the current study. Therefore, fluorescent intensity remains the only method available to us for estimating bacterial density/distribution across the gill filament.

      Line 249: What is meant by 'environmental gradient?'

      Here we are refereeing the gases need for symbiont’s chemosynthesis. We have revised the manuscript to make it clear.

      Lines 255-256: Were the results shown in the TEM images previously known? Not clear what novel information is conveyed in images Fig 5 C and D

      In the Fig 5 C and D, we’ve delivered a high-quality SEM TEM image of a typical bacteriocyte, showcasing its morphology and subcellular machinery with clarity. These electron microscopy images offer the audience a comprehensive introduction to the cellular function of bacteriocytes. Additionally, they serve as supportive evidence for the bacteriocytes' snRNA-seq data.

      Line 295-296: Can you elaborate on what types of solute carrier genes have been shown to be involved with symbioses?

      We appreciate the comment, and have revised the manuscript accordingly. The putative functions of the solute carriers could be found in Figure 5I.

      Line 297-301: Which genes from the bulk RNA-seq study? Adding more detail and references in cluster annotation would help readers better understand the justifications.

      We appreciate the comment, and have revised the manuscript accordingly.

      Line 316 -322: Can you provide the values of the distances?

      We also provide values in the main text, in addition to the Fig6b. We also provide a supplementary Table (Supplementary Table S19).

      Line 328: What are the gene expression patterns?

      We observed genes that are up- and down-regulated in Starvation and reconstitution.

      LIne 334-337: A visualization of the different expression levels of the specific genes in clusters between sites might be helpful to demonstrate the degree of difference between sites.

      We have prepared a new supplementary file showing the different expression levels.

      Line 337: Citation needed

      We appreciate the comment. Here, we hypothesize the cellular responds based on the gene’s function and their expression patterns.

      Line 402-403: Cannot determine lineages from data presented. Need lineage tracing over time to determine this

      We acknowledge the necessity of conducting lineage tracing over time to validate this hypothesis. Nonetheless, in practical terms, it is difficult to obtain samples for testing this. Perhaps, it is easier to use their shallow sea relatives to test this hypothesis. However, in practice, it is very difficult.

      413-414: What are the "cell-type specific responses to environmental change"? It could be interesting to present these results in the "results and discussion" section

      These results are shown in Supplementary Figure S8.

      Line 419-424: Sampling details might go better earlier on in the paper, when the sampling scheme is introduced.

      We appreciate the comments. Here, we are discussing the limitations of our current study, not sampling details.

      Line 552: What type of sequencing? Paired end? How long?

      We conducted 150bp paired-end sequencing.

      556-563: More detail here would be useful to readers not familiar with the BD guide. Also be careful to cite the software used in analysis!

      The provided guide and handbook elucidate the intricacies of gene name preparation, data alignment to the genome, and the generation of an expression matrix. It is worth mentioning that we relied upon outdated versions of the aforementioned resources during our data analysis phase, as they were the only ones accessible to us at the time. However, we have since become aware of a newer pipeline available this year, rendering the information presented here of limited significance to other researchers utilizing BD.

      Many thanks for your kind reminding. We have now included a reference for STAR. All other software was cited accordingly. There are no scholarly papers or publications to refer to for the BD pipeline that we can cite.

      Line 577-578: How was the number of clusters determined? What is meant by "manually combine the clusters?" If cells were clustered by hand, more detail on the method is needed, as well as direct discussion and justification in the body of the paper.

      It would be more appropriate to emphasize the determination of cell types rather than clusters. The clusters were identified using a clustering function, as mentioned in the manuscript. It's important to note that the clustering function (in our case, the FindClusters function of Seurat) provides a general overview based on diffuse gene expression. Technically speaking, there is no guarantee that one cluster corresponds to a single cell type. Therefore, it is crucial to manually inspect the clustering results to assign clusters to the appropriate cell types. In some cases, multiple clusters may be assigned to the same cell type, while in other cases, a single cluster may need to be further subdivided into two or more cell types or sub-cell types, depending on the specific circumstances.

      For studies conducted on model species such as humans or mice, highly and specifically expressed genes within each cluster can be compared to known marker genes of cell types mentioned in previous publications, which generally suffices for annotation purposes. However, in the case of non-model species like Bathymodioline mussels, there is often limited information available about marker genes, making it challenging to confidently assign clusters to specific cell types. In such situations, in situ hybridisation proves to be incredibly valuable. In our study, WISH was employed to visualise the expression and morphology of marker genes within clusters. When WISH revealed the expression of marker genes from a cluster in a specific type of cell, we classified that cluster as a genuine cell type. Moreover, if WISH demonstrated uniform expression of marker genes from different clusters in the same cell, we assigned both clusters to the same cell type.

      We expanded the description of the strategy in the Method section.

      LIne 690-692: When slices were used, what part of the gill were they taken from?

      We sectioned the gill around the mid part which could represent the mature bacteriocytes.

      References to figures:

      General

      Please split the fluorescent images into different channels with an additional composite. It is difficult to see some of the expression patterns. It would also make it accessible to colorblind readers.

      We appreciate the comments and suggestions from the reviewer. We have converted our figures to CMYK colour which will help the colorblind audiences to read our paper.

      Please provide the number of replicates for each in situ and what proportion of those displayed the presented pattern.

      We appreciate the reviewer’s comments. We have explained in the material and methods part of the manuscript.

      Figure 2.C' is a fantastic summary and really helps the non-mussel audience understand the results. Adding schematics like this to Figures 3-5 would be helpful as well.

      We value the reviewer's comments. We propose that Figures 3K, 4C, and 5A-D could offer similar schematic explanations to assist the audience.

      Figure 2:

      Figures 2.C-F, 2.C', 2.H-J are not referenced in the text. Adding in discussions of them would help strengthen your discussions on the cluster annotation

      We appreciate the reviewer's comments. We have revise the manuscript accordingly.

      In 2.B. 6 genes are highlighted in red and said to be shown in in situs, but only 5 are shown.

      We apology for the mistake. We didn’t include the result 20639-0.0 WISH in present study. We have changed the label to black.

      Figure 3:

      FIg 2C-E not mentioned.

      We appreciate the reviewer's comments. We have revise the manuscript accordingly.

      In 3.B 8 genes are highlighted in red and said to be shown in in situs. Only 6 are.

      The result of the WISH were provided in Supplementary Figures S4 and S5.

      FIgure 3.K is not referenced in the legend.

      We appreciate the comment, and have revised the manuscript accordingly.

      Figure 4:

      In Figure D, it might be helpful to indicate the growth direction.

      We appreciate the comment, and have revised the manuscript accordingly by adding an arrow in panel D to indicate growth direction.

      4F: A double in situ with the symbiote marker is needed to demonstrate the nucleolin-like positive cells are symbiote free.

      We appreciate the comment. The symbiont free region could be found in Figure 5A.

      Figure 5:

      In 5.A, quantification of symbiote concentration would help support your conclusion that they are denser around the edges.

      We appreciate the comment, as we mentioned above, detailed quantification of intracellular symbionts may necessitate continuous TEM or ultra-resolution confocal sections to 3D reconstruct the bacteriocytes, which may exceed the scope of the current study. Therefore, fluorescent intensity remains the only method available to us for estimating bacterial density/distribution across the gill filament.

      In 5.D, the annotation is not clear. Adding arrows like in 5.C would be helpful.

      We appreciate the comment, and have revised the manuscript accordingly.

      A few genes in 5.F are not mentioned in the paper body when listing other genes. Mentioning them would help provide more support for your clustering.

      We appreciate the comment, and have revised the manuscript accordingly.

      Is 5.I meant to be color coded with the gene groups from 5.F? Color Coding the gene names, rather than organelles or cellular structures might portray this better and help visually strengthen the link between the diagram and your dot plot.

      We appreciate the suggestions. We've experimented with color-coding the gene names, but some colors are less discernible against a white background.

      Figure 6:

      6.B Is there a better way to visualize this data? The color coding is confusing given the pairwise distances. Maybe heatmaps?

      We attempted a heatmap, as shown in the figure below. However, all co-authors agree that a bar plot provides clearer visualization compared to the heatmap. We agree that the color scheme maya be confusing because they use the same color as for individual treatment. So we change the colors.

      Author response image 1.

      Figure 6.D: Why is the fanmao sample divided in the middle?

      Fig6C show that single-cell trajectories include branches. The branches occur because cells execute alternative gene expression programs. Thus, in Fig 6D, we show changes for genes that are significantly branch dependent in both lineages at the same time. Specifically, in cluster 2, the genes are upregulated during starvation but downregulated during reconstitution. Conversely, genes in cluster 1 are downregulated during starvation but upregulated during reconstitution. It's of note that Fig 6D displays only a small subset of significantly branch-dependent genes.

      FIgure 6.D: Can you visualize the expression in the same format as in figures 2-5?

      We appreciate the comments from the reviewer. As far as we know, this heatmap are the best format to demonstrate this type of gene expression profile.

      Supplementary Figure S2:

      Please provide a key for the cell type abbreviations

      We appreciate the comment, and have added the abbreviations of cell types accordingly.

      Supplementary Figures S4 and S5:

      What part of the larger images are the subsetted image taken from?

      We appreciate the comment, these images were taken from the ventral tip and mid of the gill slices, respectively. We have revised the figure legends to make it clear.

      Supplemental Figure S7:

      If clusters 1 and 2 show genes up and downregulated during starvation, what do clusters 4 and 3 represent?

      Cluster 1: Genes that are obviously upregulated during Starvation, and downregulated during reconstitution; luster4: genes are downregulated during reconstitution but not obviously upregulated during Starvation.

      Cluster 2 show genes upregulated during reconstitution, and cluster 3 obviously downregulated during Starvation.

      Author response table 1.

      Supplemental Figure S8:

      This is a really interesting figure that I think shows some of the results really well! Maybe consider moving it to the main figures of the paper?

      We appreciate the comments and suggestions. We concur with the reviewer on the significance of the results presented. However, consider the length of this manuscript, we have prioritized the inclusion of the most pertinent information in the main figures. Supplementary materials containing additional figures and details on the genes involved in these pathways are provided for interested readers.

      Supplemental Figure S11:

      Switching the axes might make this image easier for the reader to interpret. Additionally, calculating the normalized contribution of each sample to each cluster could help quantify the extent to which bacteriocytes are reduced when starving.

      Thank you for the insightful suggestion, which we have implemented as detailed below. We acknowledge the importance of understanding the changes in bacteriocyte proportions across different treatments. However, it's crucial to note that the percentage of cells per treatment is highly influenced by factors such as the location of digestion and sequencing, as previously mentioned.

      Author response image 2.

      Reviewer #2 (Recommendations For The Authors):

      The following are minor recommendations for the text and figures that may help with clarity:

      Fig. 3K: This figure describes water flow induced by different ciliary cells. It is not clear what the color of the arrows corresponds to, as they do not match the UMAP (i.e. the red arrow) and this is not indicated in the legend. Are these colours meant to indicate the different ciliary cell types? If so it would be helpful to include this in the legend.

      We appreciate the reviewer's comments and suggestions. The arrows indicate the water flow that might be agitated by the certain types of cilium. We have revised our figure and figure legends to make it clear.

      Line 369: The incorrect gene identifier is given for the mitochondrial trifunctional enzyme. This gene identifier is identical to the one given in line 366, which describes long-chain-fatty-acid-ligase ACSBG2-like (Bpl_scaf_28862-1.5).

      We appreciate the reviewer's comments and suggestions. We have revised our manuscript accordingly.

      Line 554: The Bioproject accession number (PRJNA779258) does not appear to lead to an existing page in any database.

      We appreciate the reviewer's comments and suggestions. We have released this Bioproject to the public.

      Line 597-598: it would be helpful to know the specific number of cells that the three sample types were downsampled to, and the number of cells remaining in each cluster, as this can affect the statistical interpretation of differential expression analyses.

      The number of cells per cluster in our analysis ranged from 766 to 14633. To mitigate potential bias introduced by varying cell numbers, we implemented downsampling, restricting the number of cells per cluster to no more than 3500. This was done to ensure that the differences between clusters remained less than 5 times. We experimented with several downsampling strategies, exploring cell limits of 4500 and 2500, and consistently observed similar patterns across these variations.

      Data and code availability:

      The supplementary tables and supplementary data S1 appear to be the final output of the differential expression analyses. Including the raw data (e.g. reads) and/or intermediate data objects (e.g. count matrices, R objects), in addition to the code used to perform the analyses, may be very helpful for replication and downstream use of this dataset. As mentioned above, the Bioproject accession number appears to be incorrect.

      We appreciate the reviewer's comments and suggestions. Regarding our sequencing data, we have deposited all relevant information with the National Center for Biotechnology Information (NCBI) under Bioproject PRJNA779258. Additionally, we have requested the release of the Bioproject. Furthermore, as part of this round of revision, we have included the count matrices for reference.

      Reviewer #3 (Recommendations For The Authors):

      As noted in the public review, my only major concerns are around the treatment of progenitor cell populations. I am sympathetic to the challenges of these experiments but suggest a few possible avenues to the authors.

      First, there could be some demonstration that these cells in G. platifrons are indeed proliferative, using EdU incorporation labeling or a conserved epitope such as the phosphorylation of serine 10 in histone 3. It appears in Mytilus galloprovincialis that proliferating cell nuclear antigen (PCNA) and phospho-histone H3 have previously been used as good markers for proliferative cells (Maiorova and Odintsova 2016). The use of any of these markers along with the cell type markers the authors recover for PEBZCs for example would greatly strengthen the argument that these are proliferative cells.

      If performing these experiments would not be currently possible, the authors could use some computation approaches to strengthen their arguments. Based on conserved cell cycle markers and the use of Cell-Cycle feature analysis in Seurat could the authors provide evidence that these progenitors occupy the G2/M phase at a greater percentage than other cells? Other than the physical position of the cells is there much that suggests that these are proliferative? While I am more convinced by markers in VEPCs the markers for PEBZCs and DEPCs are not particularly compelling.

      While I do not think the major findings of the paper hinge on this, comments such as "the PBEZCs gave rise to new bacteriocytes that allowed symbiont colonization" should be taken with care. It is not clear that the PBEZCs are proliferative and there does not seem to be any direct evidence that PBEZCs (or DEPCs or VEPCS for that manner) are the progenitor cells through any sort of labeling or co-expression studies.

      We appreciate the comments and suggestions from the reviewer. We have considered all the suggestions and have revised the manuscript accordingly. We especially appreciate the reviewer’s suggestions about the characterisations of the G. platifrons gill proliferative cell populations. In a separate research project, we have tested both cell division and cell proliferation markers on the proliferation cell populations. Though we are not able to include these results in the current manuscript, we are happy to share our preliminary results with the reviewer. Our results demonstrate the proliferative cell populations, particularly the VEPCs, are cell proliferation marker positive, and contains high amount of mitotic cells.

      Author response image 3.

      Finally, there is a body of literature that has examined cell proliferation and zones of proliferation in mussels (such as Piquet, B., Lallier, F.H., André, C. et al. Regionalized cell proliferation in the symbiont-bearing gill of the hydrothermal vent mussel Bathymodiolus azoricus. Symbiosis 2020) or other organisms (such as Bird, A. M., von Dassow, G., & Maslakova, S. A. How the pilidium larva grows. EvoDevo. 2014) that could be discussed.

      We appreciate the comments and suggestions from the reviewer. We have considered all the suggestions and have revised the manuscript accordingly (line 226-229).

      Minor comments also include:

      Consider changing the orientation of diagrams in Figure 2C' in relationship to Figure 2C and 2D-K.

      We appreciate the comments and suggestions from the reviewer. The Figure 2 has been reorganized.

      For the diagram in Figure 3K, please clarify if the arrows drawn for the direction of inter lamina water flow is based on gene expression, SEM, or some previous study.

      We are grateful for the reviewer's valuable feedback and suggestions. The arrows in the figure indicate the direction of water flow that could be affected by specific types of cilium. Our prediction is based on both gene expression and SEM results. To further clarify this point, we have revised the figure legend of Fig. 3.

      Please include a label for the clusters in Figure 5E for consistency.

      We have revised our Figure 5E to keep our figures consistent.

      Please include a note in the Materials and Methods for Monocle analysis in Figure 6.

      We conducted Monocle analyses using Monocle2 and Monocle 3 in R environment. We have revised our material and methods with further information of Figure 6.

      In Supplement 2, the first column is labeled PEBC while the first row is labeled PEBZ versus all other rows and columns have corresponding names. I am guessing this is a typo and not different clusters?

      We appreciate the great effort of the reviewer in reviewing our manuscript. We have corrected the typo in the revised version.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      1. The most important concern that I have refers to the FDTD simulations to characterize the ZMW, as shown in Appendix 2, Figure 4. So far, the explanations given in the caption of Figure 4 are confusing and misleading: the authors should provide more detailed explanations on how the simulations were performed and the actual definition of the parameters used. In particular:

      a. lines 1330-1332: it is not clear to me how the fluorescence lifetime can be calculated from the detected signal S (z), and why they are horizontal, i.e., no z dependence? Which lifetimes are the authors referring to?

      b. lines 1333-1335: Where do these values come from? And how do they relate to panels D & E? From what I can see in these panels the lifetimes are highly dependent on z and show the expected reduction of lifetime inside the nanostructures.

      c. lines 1336-1337: Why the quantum yield of the dyes outside the ZMW differs from those reported in the literature? In particular the changes of quantum yield and lifetime for Alexa 488 are very large (also mentioned in the corresponding part of Materials & Methods but not explained in any detail).

      We thank the Reviewer for his detailed questions on the FDTD simulations. We have now added the missing equation related to the computation of signal-averaged fluorescence lifetimes from the FDTD simulations. Specifically to the three points raised:

      a) The fluorescence lifetime is indeed not calculated from the detected signal S(z), but from the radiative and non-radiative rates in the presence of the ZMW as given in eq. 9-10. However, we use the detected signal S(z) to compute the average fluorescence lifetime over the whole z-profile of the simulation box, which we relate to the experimentally measured fluorescence lifetimes as given in Appendix 7, Figure 1. We have now added the equation to compute the signal-weighted fluorescence lifetimes, which we denote as <𝜏>S , in eq. 13 in the methods. To clarify this point, we have added the symbol <𝜏>S to the plots in Appendix 2, Figure 4 D-E and Appendix 7, Figure 1 C-D.

      b) The estimated lifetimes were obtained as the signal-weighted average over the lifetime profiles, (<𝜏>S) as given in the new eq. 13. All plotted quantities, i.e., the detection efficiency η, quantum yield ϕ, detected signal S(z), and fluorescence lifetime, are computed from the radiative and loss rates obtained from the FDTD simulation according to eqs. 8-11. To make this clearer, we have now added the new Appendix 2 – Figure 5 which shows the z-profiles of the quantities (radiative and loss rates) used to derive the experimental observables.

      c) There are multiple reasons for the differences of the quantum yields of the two analytes used in this study compared to the literature values. For cyanine dyes such as Alexa647, it is well known that steric restriction (as e.g. caused by conjugation to a biomolecule) can lead to an increase of the quantum yield and fluorescence lifetime. We observe a minor increase of the fluorescence lifetime for Alexa647 from the literature value of 1.17 ns to a value of 1.37 ns when attached to Kap95, which is indicative of this effect. In the submitted manuscript, this was discussed in the methods in lines 936-938 (lines 938-945 in the revised manuscript). For the dye Alexa488, which is used to label the BSA protein, this effect is absent. Instead, we observe (as the Reviewer correctly notes) a quite drastic reduction of the fluorescence lifetime compared to the unconjugated dye from 4 ns to 2.3 ns. In cases where a single cysteine is labeled on a protein, such a drastic reduction of the quantum yield usually indicates the presence of a quenching moiety in proximity of the labeling site, such as tryptophane, which acts via the photo-induced electron transfer mechanism. Indeed, BSA contains two tryptophanes that could be responsible for the low quantum yield of the conjugated dyes. The situation is complicated by the fact that BSA contains 35 cysteines that can potentially be labeled (although 34 are involved in disulfide bridges). The labeled BSA was obtained commercially and the manufacturer lists the degree of labeling as ~6 dye molecules per protein, with a relative quantum yield of 0.2 compared to the standard fluorescein. This corresponds to an absolute quantum yield of ~0.16, which is low compared to the literature value for Alexa488 of ~0.8.

      Based on the measured fluorescence lifetime, we estimate a quantum yield of 0.46, which is higher than the photometrically obtained value of 0.16 reported by the manufacturer. Fully quenched, nonfluorescent dyes will not contribute to the lifetime measurement but are detected in the photometric quantum yield estimates. The difference between the lifetime and photometric based quantum yield estimates thus suggest that part of the fluorophores are almost fully quenched. While it is unknown where the dyes are attached to the protein, the low quantum yield could be indicative of dye-dye interactions via pi-pi stacking, which can often lead to non-fluorescent dimers. This is supported by the fact that the manufacturer reports color differences between batches of labeled protein, which indicate spectral shifts of the absorption spectrum when dye-dye adducts are formed by π-π stacking. We have now added a short discussion of this effect in lines 938-941. We note that the conclusions drawn on the quenching effect of the metal nanostructure remain valid despite the drastic reduction of the quantum yield for Alexa488, which leads to a further quantum yield reduction of the partly quenched reference state.

      2) A second important concern refers to Figure 3: Why is there so much variability on the burst intensities reported on panels C, D? They should correspond to single molecule translocation events and thus all having comparable intensity values. In particular, the data shown for BSA in panel D is highly puzzling, since it not only reflects a reduced number of bursts (which is the main finding) but also very low intensity values, suggesting a high degree of quenching of the fluorophore being proximal to the metal on the exit side of the pore. In fact, the count rates for BSA on the uncoated pore range form 50-100kcounts/s, while on the coated pores thy barely reach 30 kcounts/s, a clear indication of quenching. Importantly, and in direct relation to this, could the authors exclude the possibility that the low event rates measured on BSA are largely due to quenching of the dye by getting entangled in the Nsp mesh just underneath the pore but in close contact to the metal?

      The Reviewer raises a valid concern, but further analysis shows that this is unproblematic. Notably, the burst intensities are in fact not reduced, in contrast to the visual impression obtained from the time traces shown in the figure. The time trace of the BSA intensity is visually dominated by high-intensity bursts which mask the low-intensity bursts in the plot. In contrast, in Figure 3 the reduced number of BSA events results in a sparser distribution of the intensity spikes, which allows low-intensity events to be seen. Different to the visual inspection, the spike-detection algorithm does not exhibit any bias in terms of the duration or the number of photons of the detected events between the different conditions for both BSA and Kap95, as shown in the new Appendix 7 – Figure 1. Using FCS analysis it can be tested whether the event duration varies between the different conditions shown in Figure 3 C-D. This did not show a significant difference in the estimated diffusion time for BSA (Appendix 7 – Figure 1 C,D). Contrary to the suggestion of the Reviewer, we also do not observe any indication of quenching by the metal between uncoated and Nsp1-coated pores for BSA. Such quenching should result in differences of the fluorescence lifetimes, which however is not evident in our experimental data (Appendix 7 – Figure 1 F).

      3) Line 91: I suggest the authors remove the word "multiplexed" detection since it is misleading. Essentially the authors report on a two-color excitation/detection scheme which is far from being really multiplexing.

      We have changed the word to “simultaneous” now and hope this avoids further confusion.

      4) Line 121: why are the ZMW fabricated with palladium? Aluminum is the gold-standard to reduce light transmissivity. An explanation for the choice of this material would be appreciated by the community.

      In a previous study (Klughammer and Dekker, Nanotechnology, 2021), we established that palladium can have distinct advantages compared to other ZMW metals such as aluminum and gold, most prominently, an increased chemical stability and reduced photoluminescence. For this study, we chose palladium over aluminum as it allowed the use of simple thiol chemistry for surface modification. In the beginning of the project, we experimented with aluminum pores as well. We consistently found that the pores got closed after measuring their ionic conductance in chlorine-containing solutions such as KCl or PBS. This problem was avoided by choosing palladium.

      5) Lines 281-282: This statement is somewhat misleading, since it reads such that the molecules stay longer inside the pore. However, if I understand correctly, these results suggest that Kap95 stays closer to the metal on the exit side. This is because measurements are being performed on the exit side of the pore as the excitation field inside the pore is quite negligible.

      We thank the Reviewer for this comment and have clarified the text in lines 290-292 as suggested to: “(…) this indicates that, on the exit side, Kap95 diffuses closer to the pore walls compared to BSA due to interactions with the Nsp1 mesh”

      6) Lines 319-320: Although the MD simulations agree with the statement being written here, the variability could be also due to the fact that the proteins could interact in a rather heterogenous manner with the Nsp mesh on the exit side of the pore, transiently trapping molecules that then would stay longer and/or closer to the metal altering the emission rate of the fluorophores. Could the authors comment on this?

      The variation mentioned in the text refers to a pore-to-pore variation and thus needs to be due to a structural difference between individual pores. This effect would also need to be stable for the full course of an experiment, typically hours. We did not find any structural changes in the fluorescence lifetimes measured on individual pores such as suggested by the Reviewer. We think that the suggested mechanism would show up as distinct clusters in Appendix 7 – Figure 1 E,F where we found no trace of such a change to happen. If we understand correctly, the Reviewer suggests a mechanism, not based on changes in the Nup layer density, that would lead to a varying amount of trapping of proteins close to the surface. Such a behavior should show up in the diffusion time of each pore ( Appendix 7 – figure 1 C,D), where we however find no trace of such an effect.

      7) Lines 493-498: These claims are actually not supported by the experimental data shown in this contribution: a) No direct comparison in terms of signal-to-noise ratio between fluorescence-based and conductance-based readouts has been provided in the ms. b) I would change the word multiplexed by simultaneous since it is highly misleading. c) The results shown are performed sequentially and thus low throughput. d) Finally, the use of unlabeled components is dubious since the detection schemes relies on fluorescence and thus requiring labeling.

      We thank the Reviewer for pointing this out.

      a) We have now added a section in appendix 3 that discusses the signal-to-noise ratios. In brief, there are three observations that led us to conclude that ZMWs provide beneficial capabilities to resolve individual events from the background:

      1. The signal-to-background ratio was determined to be 67±53 for our ZMW data of Kap95 which is an order of magnitude higher compared to the ~5.6 value for a conductance-based readout.

      2. The detection efficiency for ZMWs is independent of the Kap95 occupancy within the pore. This is different from conductance based approaches that have reduced capability to resolve individual Kap95 translocations at high concentrations.

      3. The fraction of detected translocations is much higher for ZMWs than for conductance-based data (where lots of translocations occur undetected) and matches closer to the theoretical predictions.

      b) We have changed the wording accordingly.

      c) We agree with the Reviewer that our method is still low throughput. However, the throughput is markedly increased compared to previous conductance-based nanopore measurements. This is because we can test many (here up to 8, but potentially many more) pores per chip in one experiment, whereas conductance-based readouts are limited to a single pore. We have now changed the wording to “increased throughput” in line 507 to avoid confusion.

      d) We agree that only labeled components can be studied directly with our methods. However, the effect of unlabeled analytes can be assessed indirectly without any perturbation of the detection scheme due to the specificity of the fluorescent labeling. This is distinct from previous nanopore approaches using a conductance-based readout that lack specificity. In our study, we have for example used this advantage of our approach to access event rates at high concentrations (1000nM Kap95, 500nM BSA) and large pore diameters by reducing the fraction of labeled analyte in the sample. Finally, the dependence of the BSA leakage rate as a function of the concentration of Kap95 (Figure 6) relies on a specific readout of BSA events in the presence of large amounts of Kap95, which would be impossible in conductance-based experiments.

      8) Line 769: specify the NA of the objective. Using a very long working distance would also affect the detection efficiency. Have the authors considered the NA of the objective on the simulations of the detection efficiency? This information should be included and it is important as the authors are detecting single molecule events.

      We used an NA of 1.1 for the simulation of the Gaussian excitation field in the FDTD simulations, corresponding to the NA of the objective lens used in the experiments and as specified in the methods. The Reviewer is correct that the NA also affects the absolute detection efficiency of the fluorescence signal due to the finite opening angle of the collection cone of ~56˚. In our evaluation of the simulations, we have neglected this effect for simplicity, because the finite collection efficiency of the objective lens represents only an additional constant factor that does not depend on the parameters of the simulated system, such as the pore diameter. Instead, we focused solely the effect of the ZMW and defined the detection efficiency purely based on the fraction of the signal that is emitted towards the detection side and can potentially be detected in the experiment, which also provides the benefit that the discussed numbers are independent of the experimental setup used.

      To clarify this, we have now made this clearer in the method text on lines 917-920.

      9) Line 831: I guess that 1160ps is a mistake, right?

      This is not a mistake. We performed a tail fit of the fluorescence decay curves, meaning that the initial rise of the decay was excluded from the fit. The initial part of the fluorescence decay is dominated by the instrument response function (IRF) of the system, with an approximate width of ~500 ps. To minimize the influence of the IRF on the tail fit, we excluded the first ~1 ns of the fluorescence decay.

      10) Lines 913-917: Why are the quantum yield of Alexa 488 and lifetime so much reduced as compared to the published values in literature?

      See answer to point 1. We have added a short discussion at lines 938-941 where we speculate that the reduced quantum yield is most likely caused by dye-dye interactions due to the high degree of labeling of ~6 dyes per protein.

      11) Lines 1503-1509: The predicted lifetimes with the Nsp-1 coating have not been shown in Appendix 2 - Figure 4. How have they been estimated?

      We have not performed predictions of fluorescence lifetimes in the presence of an Nsp1 coating. Predictions of the fluorescence lifetime in the absence of the Nsp1 coating were obtained by assuming a uniform occupancy of the molecules over the simulation box. A prediction of the fluorescence lifetimes in the presence of the Nsp1 coating would require a precise knowledge of the spatial distribution of analytes, which depends, among other factors, on the extension of the Nsp1 brushes and the interaction strengths with the FG repeats. While simulations provide some insights on this, we consider a quantitative comparison of predicted and measured fluorescence lifetimes in the presence of the Nsp1 coating beyond the scope of the present study.

      12) Lines 1534-1539: I disagree with this comment, since the measurements reported here have been performed outside the nano-holes, and thus the argument of Kap95 translocating along the edges of the pore and being responsible for the reduced lifetime does not make sense to me.

      In accordance with our answer to point 5 above, we have now changed the interpretation to the proximity of Kap95 to the metal surface on the exit side, rather than speculating on the path that the protein takes through the pore (lines 1662-1664), as follows:

      “This indicates that, in the presence of Nsp1, Kap95 molecules diffuse closer to or spend more time in proximity of the metal nanoaperture on the exit side.”

      Reviewer #2:

      (Numbers indicate the line number.)

      48: should cite more recent work: Timney et al. 2016 Popken et al 2015

      59: should cite Zilman et al 2007, Zilman et al 2010

      62: should cite Zilman et al 2010

      We thank the Reviewer for the suggestions and have added them to the manuscript now.

      65: one should be careful in making statements that the "slow" phase is immobile, as it likely rapidly exchanging NTRs with the "fast" phase.

      We have removed this description and replaced it by “This 'slow phase' exhibits a reduced mobility due to the high affinity of NTRs to the FG-Nup mesh.” to avoid misunderstanding.

      67: Schleicher 2014 does not provide evidence of dedicated channels

      We agree with the Reviewer and therefore moved the reference to an earlier position in the sentence.

      74-75: must cite work by Lusk & Lin et al on origami nanochannels

      We thank the Reviewer for this suggestion. We have now added a reference to the nanotraps of Shen et al. 2021, JACS, in line 75. In addition, we now also refer to Shen et al. 2023, NSMB, in the discussion where viral transport is discussed.

      77: Probably Jovanovic- Talisman (2009)?

      We thank the Reviewer for pointing out this typo.

      93; should cite Auger&Montel et al, PRL 2014

      We thank the Reviewer for pointing out this reference. To give proper credit to previous ZMW, we have now incorporated a sentence in lines 100-102 citing this reference.

      111-112: there appears to be some internal inconsistency between this interpretation and the BSA transport mostly taking place through the "central hole" (as seems to be implied by Equation (3). Probably it should be specified explicitly that the "central hole" in large channels is a "void".

      We thank the Reviewer for this suggestion and have added a clarifying sentence.

      115-177: This competition was studied in Jovanovic-Talisman 2009 and theoretically analysed in Zilman et al Plos Comp Biol 2010. The differences in the results and the interpretation should be discussed.

      We agree, therefore it is discussed in the discussion section (around line 594) and now added the reference to Zilman et al.

      Figure 2 Caption: "A constant flow..." - is it clear that is flow does not generate hydrodynamic flow through the pore?

      The Reviewer raises an important point. Indeed, the pressure difference over the membrane generates a hydrodynamic flow through the pore that leads to a reduction of the event rate compared to when no pressure is applied. However, as all experiments were performed under identical pressures, one can expect a proportional reduction of the absolute event rates due to the hydrodynamic flow against the concentration gradient. In other words, this will not affect the conclusions drawn on the selectivity, as it is defined as a ratio of event rates.

      We have now added additional data on the influence of the hydrodynamic flow on the translocation rate in Appendix 3 – Figure 2, where we have measured the signal of free fluorophores at high concentration on the exit side of the pore as a function of the applied pressure. The data show a linear dependence of the signal reduction on the applied pressure. At the pressure values used for the experiments of 50 mbar, we see a ~5% reduction compared to the absence of pressure, implying that the reported absolute event rates are underestimated only by ~5%. Additionally we have added such data for Kap95 translocations that shows a similar effect (however less consistent). Measuring the event rate at zero flow is difficult, since this leads to an accumulation of fluorophores on the detection side.

      Figure 3: it would help to add how long is each translocation, and what is the lower detection limit. A short explanation of why the method detects actual translocations would be good

      With our method, unfortunately, we can not assess the duration of a translocation event since we only see the particle as it exists the pore. Instead, the measured event duration is determined by the time it takes for the particle to diffuse out of the laser focus. This is confirmed by FCS analysis of translocation events that show the same order of magnitude of diffusion times as for free diffusion (Appendix 7 – Figure 1 C,D) in contrast to a massively reduced diffusion time within a nanopore. In Figure 2D we show the detection efficiency at different locations around the ZMW as obtained from FDTD simulations and discuss the light blocking. This clearly shows that the big majority of the fluorescence signal comes from the laser illuminated side and therefore only particles that translocated through the ZMW are detected as presented between lines 170-190. In Yang et al. 2023, bioRxiv (https://doi.org/10.1101/2023.06.26.546504) a more detailed discussion about the optical properties of Pd nanopores is given.

      This point also explains why we see actual translocations: since the light is blocked by the ZMW, fluorophores can only be detected after they have translocated. On parts of the membrane without pores and upstream the amount of spikes found in a timetrace was found to be negligibly small. Additionally, if a significant part of the signal would be contributed by leaking fluorescence from the dark top side, there should no difference in BSA event rate found between small open and Nsp1 pores which we did not observe.

      With respect to the lower detection limit for events: In the burst search algorithm we require a false positive level rate of lower than 1 event in 100. Additionally, as described in Klughammer and Dekker, Nanotechnology (2021), we apply an empirical filtering to remove low signal to noise ratio events that contain less than 5 detected photons per event or a too low event rate. From the event detection algorithm there is no lower limit set on the duration of an event. Such a limit is then set by the instrument and the maximum frequency it which it can detect photons. This time is below 1μs. Practically we don’t find events shorter than 10μs as can be seen in the distribution of events where also the detection limits can be estimated (Appendix 7 – figure 1 A and B.)

      Equation (1): this is true only for passive diffusion without interactions (see eg Hoogenboom et al Physics Reports 2021 for review). Using it for pores with interactions would predict, for instance, that the inhibition of the BSA translocation comes from the decrease in D which is not correct.

      We agree with the Reviewer that this equation would not reproduce the measured data in a numerically correct way. We included it to justify why we subsequently fit a quadratic function to the data. As we write in line 260 we only used the quadratic equation “as a guide to the eye and for numerical comparison” and specifically don’t claim that this fully describes the translocation process. In this quadratic function, we introduced a scaling factor α that can be fitted to the data and thus incorporates deviations from the model. In appendix 5 we added a more elaborate way to fit the data including a confinement-based reduction of the diffusion coefficient (although not incorporating interactions). Given the variations of the measured translocation rates, the data is equally well described by both the simple and the more complex model function.

      Equation (1): This is not entirely exact, because the concentration at the entrance to the pore is lower than the bulk concentration, which might introduce corrections

      We agree with the Reviewer and have added that the concentration difference Δc is measured at the pore entrance and exit, and this may be lower than the bulk concentration. As described in our reaction to the Reviewer’s previous comment, equation (1) only serves as a justification to use the quadratic dependence and any deviations in Δc are absorbed into the prefactor α in equation (2).

      Equation (3): I don't understand how this is consistent with the further discussion of BSA translocation. Clearly BSA can translocate through the pore even if the crossection is covered by the FG nups (through the "voids" presumably?).

      The Reviewer raises an important point here. Equation 3 can only be used for a pore radius r > rprot + b. b was determined to be 11.5 nm and rprot is 3.4 nm for BSA, thus it needs to be that r > 15 nm. We would like to stress, however, that b does not directly give a height of a rigid Nsp1 ring but is related to the configuration of the Nsp1 inside the pore. Equation (3) (and equation (2)) were chosen because even these simple equations could fit the experimentally measured translocation rates well, and not because they would accurately model the setup in the pore. As we found from the simulations, the BSA translocations at low pore diameters presumably happen through transient openings of the mesh. The dynamics leading to the stochastic opening of voids on average leads to the observed translocation rate.

      296-297: is it also consistent with the simulations?

      We compare the experimentally and simulated b values in lines 387-388 and obtained b=9.9 ± 0.1 nm from the simulations (as obtained from fitting the translocation rates and not from measuring the extension of the Nsp1 molecules) and 11.5 ± 0.4 nm from the experiments – which we find in good agreement.

      331: has it been established that the FG nups equilibrate on the microsecond scale?

      As an example, we have analyzed the simulation trajectory of the most dense nanopore (diameter = 40 nm, grafting = 1/200 nm2). In Author response image 1 we show for each of the Nsp1-proteins how the radius of gyration (Rg) changes in time over the full trajectory (2 μs + 5 μs). As expected, the Rg values reached the average equilibrium values very well within 2 μs simulation time, showing that the FG-Nups indeed equilibrate on the (sub)microsecond scale.

      Author response image 1.

      334-347: the details of the method should be explained explicitly in the supplementary (how exactly voids distributions are estimated and the PMF are calculated etc)

      The void analysis was performed with the software obtained from the paper of Winogradoff et al. In our Methods we provide an overview of how this software calculates the void probability maps and how these are converted into PMFs. For a more detailed description of how exactly the analysis algorithm is implemented in the software, we refer the reader to the original work. The analysis codes with the input files that were used in this manuscript have been made public ( https://doi.org/10.4121/22059227.v1 ) along with the manuscript.

      Equation (4) is only an approximation (which works fine for high barriers but not the low ones). Please provide citations/derivation.

      To our knowledge, the Arrhenius relation is a valid approximation for our nanopore simulations. We are unaware of the fact that it should not work for low barriers and cannot find mention of this in the literature. It would be helpful if the Reviewer can point us to relevant literature.

      Figure 4: how was transport rate for Kaps calculated?

      As mentioned in lines 388-391, we assumed that the Kap95 translocation rate through Nsp1-coated pores is equal to that for open pores, as we did not observe any significant hindrance of Kap95 translocation by the Nsp1 mesh in the experiment (Figure 4 A,C).

      378: It's a bit strange to present the selectivity ratio as prediction of the model when only BSA translocation rate was simulated (indirectly).

      We agree with the Reviewer that ideally we should also simulate the Kap95 translocation rate to obtain an accurate selectivity measure of the simulated nanopores. However, as the experiments showed very similar Kap95 translocation rates for open pores and Nsp1-coated pores, we believe it is reasonable to take the Kap95 rates for open and Nsp1-pores to be equal.

      Figure 5C and lines 397: I am a bit confused how is this consistent with Figure 4D?

      Figure 5C and figure 4D both display the same experimental data, where 4D only focuses on a low diameter regime. In relation to line 397 (now 407), the Nsp1 mesh within the 60-nm pore dynamically switches between closed configurations and configurations with an open channel. When taking the temporal average of these configurations, we find that the translocation rate is higher than for a closed pore but lower than for a fully open pore. The stochastic opening and closing of the Nup mesh results in the continuous increase of the translocation rates with increasing diameter, which is in contrast to a step-wise increase that would be expected from an instantaneous collapse of the Nsp1 mesh at a certain pore diameter.

      428-439: Please discuss the differences from Jovanovic-Talisman 2009.

      How our results for a Kap95 induced change of the BSA translocation rate are related to previous literature is discussed extensively in the lines 598-620.

      440: How many Kaps are in the pore at different concentrations?

      This is a very interesting question that we were, unfortunately, not able to answer within the scope of this project. With our fluorescent based methods we could not determine this number because the excitation light does not reach well into the nanopore.

      In our previous work on Nsp1-coated SiN nanopores using conductance measurements, we quantified the drop in conductance at increasing concentrations of Kap95 (Fragasso et al., 2023, NanoResearch, http://dx.doi.org/10.1007/s12274-022-4647-1). From this, we estimated that on average ~20 Kap95 molecules are present in a pore with a diameter of 55 nm at a bulk concentration of 2 µM. In these experiments, however, the height of the pore was only ~20 nm, which is much lower compared to 100 nm long channel used here, and the grafting density of 1 per 21 nm2 was high compared to the grafting density here of 1 per 300 nm2. Assuming that the Kap95 occupancy scales linearly with the number of binding sites (FG repeats) in the vicinity of the pore, and hence the amount of Nsp1 molecules bound to the pore, we would expect approximately ~7 Kap95 molecules in a pore of similar diameter under saturating (> 1 µM) concentrations.

      On the other hand, the simulations showed that the density of Nsp1 within the pore is equal to the density within the 20-nm thick SiN pores (line 380). For the longer channel and lower grafting density used here, Nsp1 was also more constrained to the pore compared to thinner pores used in previous studies (Fragasso et al., 2023, NanoResearch), where the grafted protein spilled out from the nanopores. Thus assuming that the Kap95 occupancy depends on the protein density in the pore volume rather than the total protein amount grafted to the pore walls, we would estimate a number of 100 Kap95 molecules per pore.

      These varying numbers already show that we cannot accurately provide an estimate of the Kap95 occupancy within the pore from our data due to limitations of the ZMW approach.

      445: how is this related to the BSA translocation increase?

      For the calculation of the selectivity ratio, we assumed the normalized Kap95 translocation rate to be independent of the Kap95 concentration. Hence, the observed trends of the selectivity ratios at different concentrations of Kap95, as shown in Figure 6 D, are solely due to a change in the BSA translocation rate at different concentrations of Kap95, as given in Figure 6 B,C.

      462-481: it's a bit confusing how this interfaces with the "void" analysis ( see my previous comments)

      We agree that the phenomenological descriptions in terms of transient openings (small, dynamic voids) that for larger pores become a constantly opened channel (a single large, static void) might cause some confusion to the reader. In the last part of the results, we aimed to relate the loss of the BSA rate to a change of the Nsp1 mesh. We acknowledge that the model of a rim of Nsp1 and an open center described in Figure 5F is highly simplifying . We now explain this in the revised paper at lines 483-486 by referring to an effective layer thickness which holds true under the simplifying assumption of a central transport channel.

      Figure 6D: I think the illustration of the effect of kaps on the brush is somewhat misleading: at low pore diameters, it is possible that the opposite happens: the kaps concentrate the polymers towards the center of the pore. It should be also made clear that there are no kaps in simulations (if I understand correctly?)

      Indeed, at small pore diameters we think it would be possible to observe what the Reviewer describes. The illustration should only indicate what we think is happening for large pore diameters where we observed the opening of a central channel. To avoid confusion, we now shifted the sketches to panel G where the effective layer thickness is discussed.

      Indeed, as stated in lines 331-340 no Kap95 or BSA molecules were present in the simulations. We have now clarified this point in lines 872-876.

      518: Please provide more explanation on the role of hydrodynamics pressure.

      We have now performed additional experiments and quantified the effect of the pressure to be a ~5% reduction of the event rates, as described in the answer to a previous question above.  

      Reviewer #3 (Recommendations For The Authors):

      No experiments have been performed with the Ran-Mix regeneration system. It would be beneficial to add Ran-Mix to the trans compartment and see how this would affect Kap95 translocation events frequency and passive cargo diffusion. As the authors note in their outlook, this setup offers an advantage in using Ran-Mix and thus could also be considered here or in a future follow-up study.

      We thank the Reviewer for this suggestion. We think, however, that it is beyond the scope of this paper and an interesting subject for a follow-up study.

    1. Author Response

      The following is the authors’ response to the original reviews.

      eLife assessment

      This study and associated data is compelling, novel, important, and well-carried out. The study demonstrates a novel finding that different chemotherapeutic agents can induce nucleolar stress, which manifests with varying cellular and molecular characteristics. The study also proposes a mechanism for how a novel type of nucleolar stress driven by CDK inhibitors may be regulated. The study sheds light on the importance of nucleolar stress in defining the on-target and offtarget effects of chemotherapy in normal and cancer cells.

      We are thankful to the reviewers and the editor for their feedback and thorough assessment of our work. Our responses to the comments and suggestions are below.

      Reviewer #1 (Public Review):

      The study titled "Distinct states of nucleolar stress induced by anti-cancer drugs" by Potapova and colleagues demonstrates that different chemotherapeutic agents can induce nucleolar stress, which manifests with varying cellular and molecular characteristics. The study also proposes a mechanism for how a novel type of nucleolar stress driven by CDK inhibitors may be regulated. As a reviewer, I appreciate the unbiased screening approach and I am enthusiastic about the novel insights into cell biology and the implications for cancer research and treatment. The study has several significant strengths: i) it highlights the understudied role of nucleolar stress in the on- and off-target effects of chemotherapy; ii) it defines novel molecular and cellular characteristics of the different types of nucleolar stress phenotypes; iii) it proposes novel modes of action for well-known drugs. However, there are several important points that should be addressed:

      • The rationale behind choosing RPE cells for the screen is unclear. It might be more informative to use cancer cells to study the effects of chemotherapeutic agents. Alternatively, were RPE cells selected to evaluate the side effects of these agents on normal cells? Clarifying these points in the introduction and discussion would guide the reader.

      RPE1, a non-cancer-derived cell line, was chosen for this study to evaluate the effects of anticancer drugs on normal nucleolar function, with the underlying premise that nucleolar stress in normal cells can contribute to non-specific toxicity. This clarification is added to the introduction. Another factor that played in selecting a normal cell line for the drug screen and subsequent experiments was the spectrum of known and unknown genetic and metabolic alterations present in various cancer cell lines. These variables are often unique to a particular cancer cell line and may or may not impact nucleolar proteome and function. Therefore, the nucleolar stress response can be influenced by the spectrum of alterations inherent to each cancer. Our primary focus was to determine the impact of these drugs under normal conditions.

      That said, the selected hits of main drug classes were validated in a panel of cell lines that included two other hTERT lines (BJ5TA and CHON-002) and two cancer lines (DLD1 and HCT116). In cancer cells starting nucleolar normality scores were lower than in hTERT cells, suggesting that genetic and metabolic changes in these cells may indeed affect nucleolar morphology. Nonetheless, all drugs from a panel of selected hits from different target classes validated in both cancer cell lines (Fig. 2F).

      • Figure 2F indicates that DLD1 and HCT116 cells are less sensitive to nucleolar changes induced by several inhibitors, including CDK inhibitors. It would be crucial to correlate these differences with cell viability. Are these differences due to cell-type sensitivity or variations in intracellular drug levels? Assessing cell viability and intracellular drug concentration for the same drugs and cells would provide valuable insights.

      One of the reasons for the reduced magnitude of the effects of selected drugs in DLD1 and HCT116 cells is their lower baseline normality scores compared to hTERT cells (now shown in Sup. Fig. 1B-C). Other potential factors include proteomic and metabolic shifts and alterations in signaling pathways that control ribosome production. The less-likely possibility of variations in intracellular drug levels cannot be excluded, but measuring this for every compound in every cell line was not feasible in this study. These limitations are now noted in the results section.

      Regarding the point about viability - our initial screen output, in addition to normality scores, included cell count (cumulative count of cells in all imaged fields), which serves as a proxy for viability. By this measure, all hit compounds in our screen were cytostatic or cytotoxic in RPE1 cells (Fig. 2C). The impact of these drugs on the viability of cancer cells that can have various degrees of addiction to ribosome biogenesis merits a separate study of a large cancer cell line panel.

      • Have the authors interpreted nucleolar stress as the primary cause of cell death induced by these drugs? When cells treated with CDK inhibitors exhibit the dissociated nucleoli phenotype, is this effect reversible? Is this phenotype indicative of cell death commitment? Conducting a washout experiment to measure the recovery of nucleolar function and cell viability would address these questions.

      Whether nucleolar toxicity is the primary cause of cytotoxicity for a given chemotherapy drug is an incisive and thought-provoking question. Our screen did not discern whether the cytotoxic effects of our hits were due to inhibition of their intended targets, their impact on the nucleolus, or a combined effect. This point is now mentioned in the results section. Regarding the reversibility of the nucleolar disassembly phenotype seen in CDK inhibitors –in the case of flavopiridol, which is a reversible CDK inhibitor, we demonstrated that nucleoli re-assembled within 4-6 hours after the drug was washed out. An example of this is shown in Sup. Figure 3 and in Video 5. For these experiments, cells were pretreated with the drug for 5 hours, not long enough to cause cell death.

      • The correlation between the loss of Treacle phosphorylation and nucleolar stress upon CDK inhibition is intriguing. However, it remains unclear how these two events are related. Would Treacle knockdown yield the same nucleolar phenotype as CDK inhibition? Moreover, would point mutations that abolish Treacle phosphorylation prevent its interaction with Pol-I? Experiments addressing these questions would enhance our understanding of the correlation/causation between Treacle phosphorylation and the effects of CDK inhibition on nucleolar stress.

      We agree that the Treacle finding is interesting and warrants further investigation. In our attempts to knock down Treacle with siRNA, its protein levels were reduced by no more than 50%, which was not sufficient to cause a strong nucleolar stress response. Therefore, these data were not incorporated into the manuscript. However, in our view, Treacle is unlikely to be the only nucleolar CDK substrate whose dephosphorylation is causing the “bare scaffold” phenotype caused by the transcriptional CDK inhibitors. Our phospho-proteomics studies identified multiple nucleolar CDK substrates with established roles in the formation of the nucleolus. For instance, the granular component protein Ki-67 was also dephosphorylated on multiple sites and dispersed throughout the nucleus (shown in Sup. Fig 4). Given that CDKs typically phosphorylate many substrates that can have multiple phosphorylation sites, identifying a sole protein or phosphorylation site responsible for nucleolar disassembly may be an unattainable target.

      Overall, this study is significant and novel as it sheds light on the importance of nucleolar stress in defining the on-target and off-target effects of chemotherapy in normal and cancer cells.

      Thank you, we appreciate the positive and constructive assessment of our study.

      Reviewer #2 (Public Review):

      This is an interesting study with high-quality imaging and quantitative data. The authors devise a robust quantitative parameter that is easily applicable to any experimental system. The drug screen data can potentially be helpful to the wider community studying nucleolar architecture and the effects of chemotherapy drugs. Additionally, the authors find Treacle phosphorylation as a potential link between CDK9 inhibition, rDNA transcription, and nucleolar stress. Therefore I think this would be of broad interest to researchers studying transcription, CDKs, nucleolus, and chemotherapy drug mechanisms. However, the study has several weaknesses in its current form as outlined below.

      1) Overall the study seems to suffer from a lack of focus. At first, it feels like a descriptive study aimed at characterizing the effect of chemotherapy drugs on the nucleolar state. But then the authors dive into the mechanism of CDK inhibition and then suddenly switch to studying biophysical properties of nucleolus using NPM1. Figure 6 does not enhance the story in any way; on the contrary, the findings from Fig. 6 are inconclusive and therefore could lead to some confusion.

      This study was specifically designed to examine a broad range of chemotherapy drugs. The newly created nucleolar normality score enabled us to measure nucleolar stress precisely and in high throughput. Our primary objective was to find drugs that disrupt the normal nucleolar morphology and then study in-depth the most interesting and novel hits. We have made revisions to emphasize that these are the primary focal points of the manuscript.

      As context, we were motivated to explore the biophysical properties of the nucleolus because they are thought to underlie its formation and function, which also suggested a potential predictive value for modeling nucleolar responses to drug treatments. For this, we edited the RPE1 cell line by endogenously tagging NPM1, a granular component protein that behaves in line with the phase-separation paradigm in vitro and when over-expressed. We fully expected to confirm that its behavior in vivo would be consistent with LLPS, but instead found that even in an untreated scenario, the dynamics of endogenous NPM1 could not be fully explained by the phase separation theory (Fig. 6 A-C). Our message is that accurately predicting drug responses using the nucleolar normality score as a readout, based on our current understanding of the biophysical forces governing nucleolar assembly, is unworkable. For instance, normality scores decrease and NPM1 dynamics increase radically when CDKs are inhibited, without changes in NPM1 concentration or concentrations of other protein components (Fig.6 E-H). These observations are important because they highlight our gaps in understanding the relative contribution of phase separation versus active assembly in nucleolar formation. We believe that these observations are worth sharing with the scientific community.

      2) The justification for pursuing CDK inhibitors is not clear. Some of the top hits in the screen were mTOR, PI3K, HSP90, Topoisomerases, but the authors fail to properly justify why they chose CDKi over other inhibitors.

      We decided to focus on CDK inhibitors for several reasons. First, their effects were completely new and unexpected, suggesting the existence of an unknown mechanism regulating nucleolar structure and function. In addition, CDK inhibitors caused a very strong and distinct nucleolar stress phenotype with the lowest normality scores that merited its own term, the “bare scaffold” phenotype. One more reason for pursuing CDK-inhibiting drugs was their high rate of failure in clinics because of the intense and hard-to-explain toxicity. We suspect that this toxicity may be due at least in part to their profound effect on nucleolar organization and ribosome production throughout the body. We stated this rationale more explicitly in the manuscript.

      3) In addition to poor justification, it seems like a very superficial attempt at deciphering the mechanism of CDK9imediated nucleolar stress. I think the most interesting part of the study is the link between CDK9, Pol I transcription, and nucleolar stress. But the data presented is not entirely convincing. There are several important controls missing as detailed below.

      We agree with the reviewer that follow-up studies of CDK9, Pol I, and nucleolar stress connection are important long-term goals. However, the primary objective of this study was to ascertain the scope of anticancer agents that can cause nucleolar stress and the establishment of nucleolar stress categories. This is an important advance and could serve as the foundation for a standalone in-depth study or multiple studies. We have included the complete screen, proteomics, and phospho-proteomics results (Sup. Tables 1, 2, and 3), which will enable other investigators to mine the screen information based on their specific interests. Furthermore, we have made multiple text revisions to clarify rationale and interpretation, and incorporated additional data that strengthen the manuscript.

      4) The authors did not test if inhibition of CDK7 and/or CDK12 also induces nucleolar stress. CDK7 and CDK12 are also major kinases of RNAPII CTD, just like CDK9. Importantly, there are well-established inhibitors against both these kinases. It is not clear from the text whether these inhibitors were included in the screen library.

      Our anticancer compound library contained CDK7 inhibitor THZ1⦁2HCL, and it was a hit at both 1 and 10 uM concentrations (Sup. Table 1). However, its nucleolar stress phenotype was morphologically distinct from CDK9 inhibitors, resembling the stress caps phenotype instead of the bare scaffold phenotype. We did not pursue CDK7 because of its two hard-to-separate functions: in addition to its role as an RNAPII CTD kinase, it also acts as a CDK-activating kinase (CAK) by promoting the associations of multiple CDKs with their cyclin partners. This dual role of CDK7 makes the interpretation of THZ1-induced nucleolar stress phenotype difficult because it could be attributed to either or both of these functions. Moreover, it was reported to cause DNA damage, which may explain why it causes stress caps. An image depicting nucleolar stress phenotype caused by THZ1⦁2HCL is provided in Author response image 1.

      Author response image 1.

      Control and THZ1 - treated RPE1 cells, images from screen plates.

      We are not aware of specific inhibitors of CDK12, as they also reportedly inhibit CDK13. None of the CDK12/CDK13 inhibitors were present in our library, therefore we can neither confirm nor exclude the possible involvement of these kinases in regulating nucleolar structure. Many other existing CDK inhibitors were absent from our library. Our work highlights the importance of assessing their potential to induce nucleolar stress and offers an approach for this assessment.

      5) In Figure 4E, the authors show that Pol I is reduced in nucleolus/on rDNA. The authors should include an orthogonal method like chromatin fractionation and/or ChIP

      We acknowledge the reviewer’s request for additional validation of reduced occupancy of rDNA by Pol I.<br /> Nucleolar chromatin fractionation in cells treated with CDK inhibitors is unlikely to work due to nearly complete nucleolar disassembly. Chromatin immunoprecipitation would require finding and validating a suitable ChIP-grade antibody. Moreover, the evaluation of repetitive regions by ChIP is non-trivial and error-prone. To help address this request and further confirm the POLR1A immunofluorescence results in 4E, we included additional immunofluorescence data obtained with a different POLR1A antibody (Sup. Fig. 3D), and the results were similar.

      6) In Fig. 5D, in vitro kinase lacks important controls. The authors should include S to A mutants of Treacle S1299A/S1301A to demonstrate that CDK9 phosphorylates these two residues specifically.

      7) To support their model, the authors should test if overexpression of Treacle mutants S1299A/S1301A can partially phenocopy the nucleolar stress seen upon CDK9 inhibition. This would considerably strengthen the author's claim that reduced Treacle phosphorylation leads to Pol I disassociation from rDNA and consequently leads to nucleolar stress.

      8) Additionally, it would be interesting if S1299D/S1301D mutants could partially rescue CDK9 inhibition.

      Points (6-8):

      We reiterate that transcriptional CDKs target multiple nucleolar proteins, and the observed phenotype might be due to the combined effects of de-phosphorylation of multiple substrates. We concur that deconstructing the role of Treacle phosphorylation sites is very interesting and warrants further in-depth studies. The phospho-proteomics enrichment method, while an effective first-pass strategy, might not capture 100% of the phosphorylated sites. Treacle is a phospho-protein with an abundance of serine and threonine residues. It could potentially have been selectively dephosphorylated on more sites than were detected by this method. Therefore, the suggested mutations may not be the exclusive contributors responsible for the functional phenotype. Additionally, overexpressing Treacle impairs the viability of RPE1 cells, complicating the interpretation of experiments involving overexpression of both wild-type and mutant proteins. A conceivable strategy would involve generating phosphomimetic and non-phosphorylatable mutants by gene editing, studying their interactions by biochemical approaches, and determining their impact on nucleolar function, but this may take years of additional work. We hope that our work will inspire further studies that explore Treacle phosphorylation and other functions of transcriptional CDKs in nucleolar formation.

      Thank you for the thoughtful review and suggestions.

      Reviewer #2 (Recommendations For The Authors):

      1) The manuscript could be re-organized to focus on 'CDK9-Treacle-Pol I-nucleolar stress' as the central part of the story.

      While we acknowledge this suggestion, it's important to emphasize that the primary focus of this manuscript is on the identification of anticancer drugs that induce nucleolar stress and the establishment of nucleolar stress categories.

      2) Include a "no ATP" control in the in vitro kinase assay and indicate molecular sizes.

      We provided an additional kinase assay (Sup. Fig. 4B) that includes no ATP control lanes and a fragment of a Coomassie blue stained gel showing molecular weight markers. No ATP control assays (lanes 4 and 5) were blank as expected. Molecular weight markers were added to all other kinase assays based on the known sizes of isolated Pol II holoenzyme subunits Rbp1 (191 kDa) and Rbp2 (138 kDa).

      3) For in vitro phosphorylation, please provide an explanation for using CDK9/cyclin K instead of Cyclin T1 which is the predominant cyclin for CDK9

      Recombinant CDK9/cyclin K complex was used for in vitro kinase assays for a technical reason: CDK9/cyclin T obtained from the same vendor appeared to be low quality, as it showed only minimal activity toward our positive control, the isolated Pol II complex. The kinase assays using recombinant CDK9/cyclin T in parallel with CDK9/cyclin K are now presented it Sup. Fig. 4B. The first two assays in this experiment contained Pol II as a substrate, and it is evident that Pol II was phosphorylated much stronger by CDK9/cyclin K than CDK9/cyclin T (comparing lane 1 vs lane 2). Therefore, the lack of detectable Treacle phosphorylation by CDK9/Cyclin T (lane 7), in contrast to strong phosphorylation by CDK9/cyclin K (lane 6), was likely attributable to poor reagent quality rather than physiological differences. We can conclude that CDK9/cyclin K reliably phosphorylates Treacle in vitro, but CDK9/cyclin T kinase assays were inconclusive.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      This important study presents a novel pipeline for the large-scale genomic prediction of members of the non-ribosomal peptide group of pyoverdines based on a dataset from nearly 2000 Pseudomonas genomes. The advance presented in this study is largely based on solid evidence, although some main claims are only incompletely supported. This study on bacterial siderophores has broad theoretical and practical implications beyond a singular subfield.

      Thank you for the supportive and encouraging words. We appreciate the editor’s and reviewers’ careful and professional assessment of this manuscript. The reviewers’ scrutiny has helped us to improve the presentation and discussion of our work. We have now carefully revised the manuscript following their instructive suggestions and comments. Please find below our detailed responses (marked in blue) to each of the comments.

      Public Reviews:

      Reviewer #1 (Public Review):

      The manuscript introduces a bioinformatic pipeline designed to enhance the structure prediction of pyoverdines, revealing an extensive and previously overlooked diversity in siderophores and receptors. Utilizing a combination of feature sequence and phylogenetic approaches, the method aims to address the challenging task of predicting structures based on dispersed gene clusters, particularly relevant for pyoverdines.

      Predicting structures based on gene clusters is still challenging, especially pyoverdines as the gene clusters are often spread to different locations in the genome. An improved method would indeed be highly useful, and the diversity of pyoverdine gene clusters and receptors identified is impressive.

      However, so far the method basically aligns the structural genes and domains involved in pyoverdine biosynthesis and then predicts A domain specificity to predict the encoded compounds. Both methods are not particularly new as they are included in other tools such as PRISM (10.1093/nar/gkx320) or Sandpuma (https://doi.org/10.1093/bioinformatics/btx400) among others. The study claims superiority in A domain prediction compared to existing tools, yet the support is currently limited, relying on a comparison solely with AntiSMASH. A more extensive and systematic comparison with other tools is needed.  

      Thanks for pointing this out. In the revised manuscript, we have included a comprehensive comparative analysis, in which we compared our pipeline to six different commonly used methods, including NP.searcher, PRISM4, AdenPredictor, SeMPI2, SANDPUMA, antiSMASH5 (see Supplementary_table 6 for details, and lines 281-286). These approaches either consist of a single specific algorithm or integrate several methods. Our approach performs best (see table below), demonstrating a clear improvement over previous tool. The improvements are due to several methodological differences inherent to our approach. Additionally, while exploring existing prediction tools, we found that some had not been maintained for years. For instance, we were unable to access NRPSsp (www.nrpssp.com) and NRPSpredictor2 (http://nrps.informatik.uni-tuebingen.de/). Below, we briefly explain these differences, particularly in relation to PRISM and SANDPUMA, as highlighted by the reviewer. 

      Author response table 1.

      PRISM annotates biosynthetic gene clusters (BGC) and reconstructs the linear structures of NRPS synthetases, with this function depending on proper annotations of open reading frames. This pipeline can have difficulties in assembling the linear structure into a final product. In our approach, we found that the annotations of NRPS gene are frequently truncated because of sequencing errors and annotation issues. Our method fixes this problem through rescanning all possible reading frames of the BGC to rebuild complete pyoverdine synthetase genes. 

      Sandpum and our approach are based on similar ideas (using the prediCAT algorithm) to predict A domain substrates, namely by using the closest reference A domain annotated. However, our method uses a self-adaptive feature extraction step to reduce the co-founding influence of phylogeny. This small adjustment significantly improves the performance of our approach and even works well for small training sets (101 experimentally validated A domains with our approach as opposed to 494 A domains used by Sandpuma from MIBiG).

      Additionally, in contradiction to the authors' claims, the method's applicability seems constrained to well-known and widely distributed gene clusters. The absence of predictions for new amino acids raises concerns about its generalizability to NRPS beyond the studied cases.

      We thank the reviewers for this comment. We acknowledge that our method cannot directly predict new amino acids. Nevertheless, for several reasons we believe that our approach is not constrained and can be widely applied in the future.

      First, our method can identify A domains that select new unknown amino acid substrates. In fact, three of the four unresolved cases in our experimental verification analysis (Fig. 3d) represent new amino acids. Obviously, experimental verification is required to characterize the unknown substrate. Once verified, the new A domains and their substrates can expand the reference dataset, allowing targeted improvement of our phylogeny-focused prediction technique. We now discuss this aspect in lines 634-645.

      Second, despite that the overall substrate diversity in NRPS is high across the microbial kingdom, our analysis suggests that the number of amino acids used for a specific group of secondary metabolites quickly reaches a saturation point. The discovery rate of new amino acids was 1.7% for our experimental Pseudomonas data set (Fig. 3d). The discovery rate of new amino acids was even 0.0 % for the Burkholderiales data set. This suggests that as the database expands, the discovery rate of novel amino acid substrates is expected to drop rapidly.

      Third, we acknowledge that the inability to predict the substrates of unknown domains is a common limitation among all knowledge-guided learning algorithms, including ours. However, we have made significant improvements in prediction accuracy. As the database grows, we expect the rate of unknown substrates to decrease, and the prediction accuracy to increase.

      The manuscript lacks clarity on how the alignment of structural genes operates when dealing with multiple NRPS gene clusters on different genome contigs. How would the alignment of each BGC work?

      We thank the reviewers for this comment. The pyoverdine molecules consist of a conserved fluorescent chromophore (Flu) and a peptide chain (Pep), both synthesized by NRPS enzymes. In most instances (over 90%), Flu and Pep are produced by two separate biosynthetic gene clusters (BGCs). In these cases, we merge the two BGCs by positioning Flu at the head and Pep at the tail. For the remaining less than 10%, there are two scenarios: 1. Flu and Pep are located on the same BGC, which eliminates any issues with BGC alignment. 2. In very rare cases, Flu and Pep are synthesized by three BGCs. Here, Flu is still synthesized by one BGC at the head, while Pep is produced by two BGCs. We put the BGC containing the Thioesterase (TE) domain as the tail and the BGC not containing the TE domain in the middle.

      (see lines 165-169).

      Another critical concern is that a main challenge in NRPS structure prediction is not the backbone prediction but rather the prediction of tailoring reactions, which is not addressed in the manuscript at all, and this limitation extensively restricts the applicability of the method.

      While we thank the reviewer for this comment, we only partly agree with it. Peptide backbone predictions are still a significant challenge. This challenge is clearly visible in our new analysis comparing prediction accuracies of different pipelines, such as antiSMASH5, PRISM4, AdenPredictor, SeMPI2, NP.searcher, Sandpuma. Unresolved and wrong substrate predictions are still common, highlighting the importance of our contribution in developing a new approach with improved high accuracy. 

      However, we agree with the reviewer that our current algorithm does not predict tailoring reactions (now discussed on lines 680-685). Although tailoring reactions are important for predicting the final NRPS product structure, none of the other existing pipelines address this issue either, and it remains a challenge for future work. For our study, it is important to note that the specificity of pyoverdines is primarily determined by the backbone composition, whereas tailoring reactions seem to play a minor role.

      The manuscript presents a potentially highly useful bioinformatic pipeline for pyoverdine structure prediction, showcasing a commendable exploration of siderophore diversity. However, some of the claims made remain unsubstantiated. Overall, while the study holds promise, further validation and refinement are required to fulfill its potential impact on the field of bioinformatic structure prediction.

      Thank you for the supportive and encouraging words. We deeply appreciate your constructive comments and suggestions. 

      Reviewer #2 (Public Review):

      Pyoverdines, siderophores produced by many Pseudomonads, are one of the most diverse groups of specialized metabolites and are frequently used as model systems. Thousands of Pseudomonas genomes are available, but large-scale analyses of pyoverdines are hampered by the biosynthetic gene clusters (BGCs) being spread across multiple genomic loci and existing tools' inability to accurately predict amino acid substrates of the biosynthetic adenylation (A) domains. The authors present a bioinformatics pipeline that identifies pyoverdine BGCs and predicts the A domain substrates with high accuracy. They tackled a second challenging problem by developing an algorithm to differentiate between outer membrane receptor selectivity for pyoverdines versus other siderophores and substrates. The authors applied their dataset to thousands of Pseudomonas strains, producing the first comprehensive overview of pyoverdines and their receptors and predicting many new structural variants.

      The A domain substrate prediction is impressive, including the correction of entries in the MIBiG database. Their high accuracy came from a relatively small training dataset of A domains from 13 pyoverdine BGCs. The authors acknowledge that this small dataset does not include all substrates, and correctly point out that new sequence/structure pairs can be added to the training set to refine the prediction algorithm. 

      The authors could have been more comprehensive in finding their training set data. For instance, the authors claim that histidine "had not been previously documented in pyoverdines", but the sequenced strain P. entomophila L48, incorporates His (10.1007/s10534-009-9247-y). 

      Thank you for highlighting this issue. We agree that stating histidine has not been reported before in pyoverdine was incorrect. We have reviewed the full text and made the necessary corrections.

      The primary reason for excluding the sequenced strains P. syringae 1448a (10.1186/14712180-11-218) and P. entomophila L48 (10.1007/s10534-009-9247-y) from the training set is that the pyoverdine structures of these strains were not determined solely through experimental methods. In these works, the pyoverdine structures were predicted based on the synthetic gene sequence using bioinformatical analysis, followed by structural analysis experiments based on this predicted structure. We found that pre-prediction probably has introduced biases into downstream analyses. Specifically, in the case of Pseudomonas entomophila L48, we discovered inaccuracies in the annotation of certain domains (see figures below). For example, the third A domain of the peptide chain in P. entomophila L48 pyoverdine was initially annotated with Dab specificity. However, upon closer examination, it appears to differ significantly from other Dab references (top) or Dab from our experimentally validated (right) domains (left panel in the figure below). By analyzing the interface (I) domain (10.1073/pnas.1903161116) in its predicted site, we suggested that it should actually recognize OHHis. The OHAsp domain of P. entomophila L48 reported in the paper is actually close in sequence similarity to the OHAsp domain (left panel in the figure below), while the Ala domain reported is more similar to the Ser domain (right panel in the figure below). For these reasons, we did not include this supervised pyoverdine structure analysis strain in the training set data.

      Author response image 1.

      The workflow cannot differentiate between different variants of Asp and OHOrn, and it's not clear if this is a limitation of the workflow, the training data, or both. 

      Thanks for pointing this out. It is generally challenging to differentiate between variants of the same amino acid (for all the algorithms existing to date). In this sense, it is a limitation of our but also of all other workflows. Nonetheless, we wish to stress that we observed feature sequence divergence (using the A motif4-5 region), which helped us to separate some (but not all) of the Asp and Orn variants. For example, separations between Asp-variants are distinct (left panel in the figure below). To be on the conservative side, we only differentiated between OHAsp and Asp for our predictions, but also differentiation between DOHAsp and OHAsp would be possible. In the case of Orn-variants, there was a clear separation between Orn and the OHOrn variants (right panel). In contrast, it was difficult to differentiate between the subgroups of OHOrn variants. We believe that no A domain prediction tool will be able to solve this issue. Instead, it would be important to include information on substrate-modifying enzymes in future approaches.

      Author response image 2.

      The prediction workflow holds up well in Burkholderiales A domains, however, they fail to mention in the main text that they achieved these numbers by adding more A domains to their training set.

      We thank the reviewers for this comment. We apologize for not having mentioned the training data set in the main text, while we described it in detail in the methods section (lines 714-732). We now provided more details on the analysis procedure in the main text (lines 307313). Important to note is that we did not add more A domains to the training data set but built up a new independent data set for Burkholderiales. The aim was to mirror the analysis we performed for pyoverdines with a completely new data set, featuring 124 A domains for training and 178 A domains as test set.

      To validate their predictions, they elucidated structures of several new pyoverdines, and their predictions performed well. However, the authors did not include their MS/MS data, making it impossible to validate their structures. In general, the biggest limitation of the submitted manuscript is the near-empty methods section, which does not include any experimental details for the 20 strains or details of the annotation pipeline (such as "Phydist" and "Syndist"). The source code also does not contain the requisite information to replicate the results or re-use the pipeline, such as the antiSMASH version and required flags. That said, skimming through the source code and data (kindly provided upon request) suggests that the workflow itself is sound and a clear improvement over existing tools for pyoverdine BGC annotation.

      Thank you for highlighting these issues. We agree that the methods section is short. This is because the entire paper is a step-by-step methodological introduction to our pipeline. We have now carefully revised the main text to add the information requested by the reviewer. Moreover, we have included a supplementary file with the MS/MS data of the experimentally analyzed pyoverdine structures. Finally, we further include a link to a one-click online notebook that can be used to replicate the annotation and substrate prediction results See: https://drive.google.com/drive/folders/1JsfyPUGDTFo8BDDZk8JLSvKry8emzMhr?usp=drive_ link , following a more detail explanation on code.

      Predicting outer membrane receptor specificity is likewise a challenging problem and the authors have made a promising achievement by finding specific gene regions that differentiate the pyoverdine receptor FpvA from FpvB and other receptor families. Their predictions were not tested experimentally, but the finding that only predicted FpvA receptors were proximate to the biosynthesis genes lends credence to the predictive power of the workflow. The authors find predicted pyoverdine receptors across an impressive 468 genera, an exciting finding for expanding the role of pyoverdines as public goods beyond Pseudomonas. However, whether or not these receptors can recognize pyoverdines (and if so, which structures!) remains to be investigated.

      Thank you for the supportive and encouraging words. The bioinformatic analysis and experimental testing of pyoverdine-receptor matching is complicated and it is not part of this paper. We treated it in a separate manuscript in which we developed an experimentally verified co-evolution algorithm that matches pyoverdines to receptors. With this algorithm, we can identify self-receptors (i.e. receptors used to take up the self-produced pyoverdine), and therefore establish pyoverdine sharing and interaction networks across strains in communities.

      Please see DOI:10.1101/2023.11.05.565711 for details.

      In all, the authors have assembled a rich dataset that will enable large-scale comparative genomic analyses. This dataset could be used by a variety of researchers, including those studying natural product evolution, public good eco/evo dynamics, and NRPS engineering.

      Thank you for the supportive and encouraging words. We are grateful for the reviewers’ instructive suggestions and comments.

      Reviewer #3 (Public Review):

      Summary:

      Secondary metabolites are produced by numerous microorganisms and have important ecological functions. A major problem is that neither the function of a secondary metabolite enzyme nor the resulting metabolite can be precisely predicted from gene sequence data.

      In the current paper, the authors addressed this highly relevant question.

      The authors developed a bioinformatic pipeline to reconstruct the complete secondary metabolism pathway of pyoverdines, a class of iron-scavenging siderophores produced by Pseudomonas spp. These secondary metabolites are biosynthesized by a series of nonribosomal peptide synthetases and require a specific receptor (FpvA) for uptake. The authors combined knowledge-guided learning with phylogeny-based methods to predict with high accuracy encoding NRPSs, substrate specificity of A domains, pyoverdine derivatives, and receptors. After validation, the authors tested their pipeline with sequence data from 1664 phylogenetically distinct Pseudomonas strains and were able to determine 18,292 enzymatic A domains involved in pyoverdine synthesis, reliably predicted 97.8% of their substrates, identified 188 different pyoverdine molecule structures and 4547 FpvA receptor variants belonging to 94 distinct groups. All the results and predictions were clearly superior to predictions that are based on antiSMASH. Novel pyoverdine structures were elucidated experimentally by UHPLC-HR-MS/MS.

      To assess the extendibility of the pipeline, the authors chose Burkholderiales as a test case which led to the results that the pipeline consistently maintains high prediction accuracy within Burkholderiales of 83% which was higher than for antiSMASH (67%).

      Together, the authors concluded that supervised learning based on a few known compounds produced by species from the same genus probably outperforms generalized prediction algorithms trained on many products from a diverse set of microbes for NRPS substrate predictions. As a result, they also show that both pyoverdine and receptor diversity have been vastly underestimated.

      Strengths:

      The authors developed a very useful bioinformatic pipeline with high accuracy for secondary metabolites, at least for pyoverdines. The pipelines have several advantages compared to existing pipelines like the extensively used antiSMASH program, e.g. it can be applied to draft genomes, shows reduced erroneous gene predictions, etc. The accuracy was impressively demonstrated by the discovery of novel pyoverdines whose structures were experimentally substantiated by UHPLC-HR-MS/MS.

      The manuscript is very well written, and the data and the description of the generation of pipelines are easy to follow.

      Weaknesses:

      The only major comment I have is the uncertainty of whether the pipeline can be applied to more complex non-ribosomal peptides. In the current study, the authors only applied their pipeline to a very narrow field, i.e., pyoverdines of Pseudomonas and Burkholderia strains.

      Thanks for your positive and encouraging comment. Regarding your only major comment, we think that the design concept of our pipeline has the potential to be applied to more complex non-ribosomal peptides. Currently, our method is tailored to accurately predict the structural composition of the Pseudomonas siderophore pyoverdine (see also response 3). A key point emphasized in our article is the importance of considering phylogeny in developing substrate prediction algorithms for A domains. Currently, the main challenge in advancing these algorithms is the limited availability of data on A domains and their corresponding substrates. However, with the future accumulation of more reference data, we are confident that the design principles of our method will enable precise predictions of the structural compositions of all products synthesized by non-ribosomal peptide synthetases (see our discussions in lines 634-

      645). 

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      I believe that the manuscript would benefit from focusing solely on the task of improving pyoverdine predictions. This aspect alone is significant, and robustly supporting this claim would strengthen the manuscript. The diversity analysis provided is valuable and would undoubtedly benefit the scientific community. However, additional systematic comparisons with other methods are necessary. Furthermore, clarification of certain terms, such as 'featurebased' (e.g., whether it refers to NRPS domains or CDS), would enhance clarity.

      Thank you for the supportive and encouraging words. We followed the reviewer’s suggestion and now provide the requested method comparison, see also response 2 for details. Furthermore, we have carefully checked the main text to clarify terms whenever needed. Specifically, we now define the terms “feature sequence” and “feature sequence distance” in lines 227-229.  

      Additionally, several minor points could be improved upon:

      In line 85, clarification is needed on how pyoverdine genes were identified.

      Thank you for your thorough review. In the introduction section, we provided a brief overview of our work, while the detailed methodology is outlined in the results section on lines 160-174.

      In line 382, it would be helpful to know the source of the sequences.

      We agree and have now carefully revised the manuscript following your suggestions (lines 403-405).

      Line 392 could be explained more clearly. Does it mean that the authors used an hmm search to search pHMMs against each reference sequence?

      Thanks for your comment. Yes, we used an hmm search to search pHMMs against each reference sequence. We have now revised the manuscript to improve explanations (lines 413-418).

      Reviewer #2 (Recommendations For The Authors):

      The authors state they "elucidated the chemical structure of the 20 pyoverdines using culturebased methods combined with UHPLC-HR-MS/MS", so I was alarmed to see that KR and LB already published several of those structures in the cited paper. I hope that this "double dipping" will be fixed in a revision process.

      Thank you for pointing this out. We agree that we have not explained clearly enough what steps were conducted in this study and which data were used from a previous paper (https://doi.org/10.1007/s00216-022-03907-w). The genomes of the 20 strains used for the verification analysis (Fig. 3d) were sequenced as part of this study (access code now provided). 14 out of the 20 pyoverdine structures were elucidated with UHPLC-HR-MS/MS in this study. For 6 out of the 20 pyoverdines, we had structural information already at hand from the previous paper. We have now clarified these details in our manuscript (lines 276-280). 

      Thank you for providing the source code and data, and I hope that the final non-redundant dataset will be uploaded to Zenodo or another repository. Please deposit the 20 newlysequenced genomes to GenBank or another public repository. Please also show the UHPLC-

      HR-MS/MS data, preferably in the form of raw data uploaded to GNPS.

      We have followed the reviewer’s advice and deposited our data:

      - The sequences of the 20 newly sequenced strains are available on ENA accession PRJEB76792.

      - The MS/MS plots of the 14 newly analyzed pyoverdines are shown in the Supplementary Materials.

      - We provide a one-click online notebook to allow readers to replicate the pyoverdine cluster annotation and substrate prediction of the 20 experimentally analyzed strains.

      I suggest adding "at least" or a similar qualifier when the 73 variants are mentioned unless the literature search was truly exhaustive. What were the criteria for inclusion of the 13 strains in Table S2? For instance, sequenced strains P. syringae 1448a (10.1186/1471-2180-11-218) and P. entomophila L48 (10.1007/s10534-009-9247-y) were not included.

      Thank you for your comment. We have now carefully revised the manuscript following your suggestions (lines 291-295). Regarding the criteria for including the 13 strains in Table S2, we aimed to select strains with the high credibility for inclusion in the training set data. The primary reason for excluding the two strains from the training set is that their siderophore structures were analyzed through supervised experiments. We wanted to avoid any form of biases that bioinformatic pre-predictions could introduce to downstream analyses (see Response 13 for details).

      OHAsp in pyoverdines has been reported to arise from hydroxylation of Asp after it's already been activated by the A domain (10.1073/pnas.1903161116). Was there a clear difference between A domains that lead to Asp and OHAsp? Conversely, acetylation and formylation of OHOrn occur before adenylation. Can your workflow be used to differentiate cOHOrn, fOHOrn, and AcOHOrn, which are currently difficult to predict through genome mining?

      Thank you for these considerations. We treated these aspects in our response 8.  

      Throughout, define non-proteinogenic AA substrate abbreviations (ex: Rsc, Dab).

      Revised as per suggestion (lines 329-333).

      Additional line comments:

      189: Mention PhyloPhlAn in the main text.

      Revised as per suggestion (lines 189).

      191: Define these filtering/selection criteria.

      Thanks for your comment, we have added the criteria in the main text (line 196 and line 198). 

      309, 620: An A domain presumably loading histidine is present in sequenced strain P. entomophila L48 (10.1007/s10534-009-9247-y). Please also clarify that Val has previously been seen in a pyoverdine (it is in Table S1) albeit not sequenced.

      We have clarified these aspects as per suggestion (lines 314-315 and line 630).

      310: The pipeline can "highlight" new substrates, but not identify them.

      Revised as per suggestion (line 295).

      354: Please clarify "13 amino acid substrates form the core of all the 188 pyoverdine structures", considering that 279 A domain substrates couldn't be predicted.

      Thanks for your comments. We have now clarified “our analysis found that 13 amino acids form the main structural substrates of all the 188 pyoverdine structures.” (lines

      360-363)

      630: "discovered" implies that there is experimental evidence. I suggest something like "here we predicted 151 putatively new variants".

      Revised as per suggestion (line 648).

      Reviewer #3 (Recommendations For The Authors):

      Weakness:

      The only major comment I have is the uncertainty of whether the pipeline can be applied to more complex non-ribosomal peptides. In the current study, the authors only applied their pipeline to a very narrow field, i.e., pyoverdines of Pseudomonas and Burkholderia strains

      Thanks for your comment. Please see our Responses 3+13 above, where we treat this concern in detail. Moreover, we discussed the possibility of extension to other groups of secondary metabolites in our discussion. We believe that we deliver a balanced view on the applicability of our approach and the next steps to be taken.  

      Please comment on this aspect.

      Minor:

      (1)  When you speak about "synthesis" it is rather biosynthesis. Synthesis is chemical synthesis.

      Please replace all instances of the word synthesis with biosynthesis.

      Revised as per suggestion.

      (2)  Line 188: synthetase is rather synthetases

      Revised as per suggestion (line 191).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      Point 1: While the manuscript is methodologically sound, the following aspects of image acquisition and data analysis need to be clarified to ensure replicability and reproducibility. The authors state that the sample is a "population-derived adult lifespan sample", the lack of demographic information makes it impossible to know if the sample is truly representative. Though this may seem inconsequential, education may impact both cognitive performance and functional activation patterns. Moreover, the authors do not report race/ethnicity in the manuscript. This information is essential to ensure representativeness in the sample. It is imperative that barriers to study participation within minoritized groups are addressed to ensure rigor and reproducibility of findings.

      First, the section Methods-Participants has been updated to refer readers to a prior article where the sample’s demographics are broken down into nine decile age groups (see Wu et al. 2023 Table 1), including information about their education levels. Secondly, we have updated the Data Availability section text to indicate that all Cam-CAN IDs are included in the available OSF datasets, allowing anyone to verify additional participant demographics described in the Cam-CAN protocol article (Shafto et al., 2014). Third, we have updated the Participants section text to refer to another prior study that reported on the representativeness of the Cam-CAN sample indicating that at least some elements of the sample have been independently deemed as representative (e.g., Sex).

      Page-24

      “A healthy population-derived adult lifespan human sample (N = 223; ages approximately uniformly distributed from 19 - 87 years; females = 112; 50.2%) was collected as part of the Cam-CAN study (Stage 3 cohort; Shafto et al., 2014). Participants were fluent English speakers in good physical and mental health, based on the Cam-CAN cohort’s exclusion criteria which includes poor mini mental state examination, ineligibility for MRI and medical, psychiatric, hearing or visual problems. Throughout analyses, age is defined at the Home Interview (Stage 1; Shafto et al., 2014). The study was approved by the Cambridgeshire 2 (now East of England–Cambridge Central) Research Ethics Committee and participants provided informed written consent. Further demographic information of the sample is reported in Wu et al. (2023) and is openly available (see section Data Availability) with a recent report indicating the representativeness of the sample across sexes (Green et al., 2018).”

      Page-30

      “Raw and minimally pre-processed MRI (i.e., from automatic analysis; Taylor et al., 2017) and behavioural data are available by submitting a data request to Cam-CAN (https://camcan-archive.mrc-cbu.cam.ac.uk/dataaccess/). The univariate and multivariate ROI data, and behavioural data, can be downloaded from the Open Science Framework, which includes Cam-CAN participant identifiers allowing the retrieval of any additional demographic data (https://osf.io/v7kmh), while the analysis code is available on GitHub.”

      Point 2: For the whole-brain analysis in which the ROIs were derived, the authors used a threshold-free cluster enhancement (TFCE; Smith & Nichols 2009). The methodological paper cited suggests that individuals' TCFE image should still be corrected for multiple comparisons using the following: "to correct for multiple comparisons, one [...] has to build up the null distribution (across permutations of the input data) of the maximum (across voxels) TFCE score, and then test the actual TFCE image against that. Once the 95th percentile in the null distribution is found then the TFCE image is simply thresholded at this level to give inference at the p < 0.05 (corrected) level." (Smith & Nichols, 2009). Although the authors mention that clusters were estimated using 2000 permutations, there is no mention of the TFCE image itself being thresholded. While this would impact the overall size of the ROIs used in the study, the remaining analyses are methodologically sound.

      We have updated the text to detail the t=1.97 (i.e., p = .05) threshold we applied before interpretation of the resultant TFCE images to the section: Experimental Design & Statistical Analysis. This threshold value can also be verified in the analytics code that is referenced on GitHub from the section Data Availability within the requisite toolbox functions: https://github.com/kamentsvetanov/CommonalityAnalysis/blob/main/code/ca_vba_tfce_threshold.m#L24 and https://github.com/kamentsvetanov/CommonalityAnalysis/blob/main/code/external/ca_matlab_tfce_transform.m

      Page-30

      “For whole-brain voxelwise analyses, clusters were estimated using threshold-free cluster enhancement (TFCE; Smith & Nichols 2009) with 2000 permutations and the resulting images were thresholded at a t-statistic of 1.97 before interpretation.”

      Point 3: The authors should consider moving the ROI section to results. The way the manuscript currently reads, the ROIs seem to be derived a priori as opposed to being derived from activation maps in the current study.

      After consideration of this point, we have decided to leave the methodological details regarding the definition of ROIs in the methods, to maintain the focus of the Results section. However, we have improved signposting in the results section to highlight that the ROIs were derived from the overlapped activation maps.

      Page-8

      “Crucially, two areas of the brain showed spatially-overlapping positive effects of age and performance, which is suggestive of an age-related compensatory response (Figure 2A yellow intersection). These were in bilateral cuneal cortex (Figure 2B magenta) and bilateral frontal cortex (Figure 2B brown), the latter incorporating parts of the middle frontal gyri and anterior cingulate. Therefore, based on traditional univariate analyses, these are two candidate regions for age-related functional compensation (Cabeza et al. 2013; 2018). Accordingly, we defined regions of interest within these two regions using the overlap activation maps (see section: ROIs) to be used for subsequent univariate and multivariate analysis.”

      Point 4: The manuscript can be strengthened by explaining why the authors chose a greedy search algorithm over a dynamic Bayesian model.

      The text is updated to refer to appropriateness of the computationally efficient greedy search implementation, due to the size of the fMRI cohort dataset.

      Page-28

      “The pattern weights specifying the mapping of data features to the target variable are optimized with a greedy search algorithm using a standard variational scheme (Friston et al., 2007) which was particularly appropriate given the large dataset.”

      Reviewer #2:

      Point 1: However, it might have been nice to see an analysis of a more crystallised intelligence task included too, as a contrast since this is an area that does not demonstrate such a decline (and perhaps continues to improve over aging).

      We (Samu et al., 2017) have previously investigated, but failed to find, univariate evidence for functional compensation in this cohort’s performance on a sentence comprehension task that is more closely aligned to a measure of crystallised intelligence. Based on the additional previous studies where we have applied these types of univariate and multivariate criteria of functional compensation (Morcom & Henson, 2018; Knights et al., 2021), we have consistently observed that the uni-/multivariate effects are in the same direction. Therefore, we would not initially expect a different conclusion here, where the univariate and multivariate effects suggest different outcomes. Notably, the univariate analysis approach in Samu et al. (2017) did differ from focusing on the age x behaviour interaction term here, so it could still be worth future investigation, but it does seem less likely that evidence of compensation would be observed than for fluid intelligence. However, as the Reviewer suggests, such a task may make another good contrast to show evidence against the existence of functional compensation (as in Morcom & Henson, 2018; Knights et al., 2021).

      Point 2: Figure 1B: Consider adding coefficients describing relationships to plots.

      Annotations of the coefficients have been added to Figure 1B:

      Point 3: Figure 2C. The scale of the axis for RSFA-Scales cuneal cortex ROI activations should be the same as the other 3 plots.

      Figure axes are updated such that ROIs are on matching scales, according to whether data were RSFA-scaled or not.

      Point 4: Figure 2C. Adding in the age ranges for each of the three groups following the tertile split may be informative to the reader.

      The age group tertile definition used for Figure 2C visualisations is now added to the Figure description.

      Page-10

      “Figure 2. Univariate analysis. (A) Whole-brain effects of age and performance. Age (green) and performance (red) positively predicted unique aspects of increased task activation, with their spatial overlap (yellow) being overlaid on a template MNI brain, using p < 0.05 TFCE. (B) Intersection ROIs. A bilateral cuneal (magenta) and frontal cortex (brown) ROI were defined from voxels that showed a positive and unique effect of both age and performance (yellow map in Figure 2A). (C) ROI Activation. Activation (raw = left; RSFA-scaled = right) is plotted against behavioural performance based on a tertile split between three age groups (19-44, 45-63 & 64-87 years).”

      Reviewer #3:

      Point 1: [Public Review] 1) I don't quite follow the argumentation that compensatory recruitment would need to show via non-redundant information carried by any given non-MDN region (cf. p14). Wouldn't the fact that a non-MDN region carries task-related information be sufficient to infer that it is involved in the task and, if activated increasingly with increasing age, that its stronger recruitment reflects compensation, rather than inefficiency or dedifferentiation? Put differently, wouldn't "more of the same" in an additional region suffice to qualify as compensation, as compared to the "additional information in an additional region" requirement set by the authors? As a consequence, in my honest opinion, showing that decoding task difficulty from non-MDN ROIs works better with higher age would already count as evidence for compensation, rather than asking for age-related increases in decoding boosts obtained from adding such ROIs. It would be interesting to see whether the arguably redundant frontal ROI would satisfy this less demanding criterion. At any rate, it seems useful to show whether the difference in log evidence for the real vs. shuffled models is also related to age.

      We agree with the logic for conducting a weaker assessment of functional compensation whereby a brain region does not necessarily have to provide a unique contribution beyond that of the ordinarily activated task-relevant network. However, although non-unique recruitment is predicted by a compensation theory, it can also be explained by a nonspecific mechanism that recruits multiple regions in tandem. In contrast, unique additional recruitment is compatible with compensation but not with nonspecific recruitment. In this article, and those prior (Morcom & Henson, 2018; Knights et al. 2021), we have also deliberately avoided using the specific kind of analysis proposed (i.e., testing for an effect of age on differential log evidence) because these would involve applying statistical tests directly to the log evidence, a variable that is already a statistical test output.

      Nevertheless, temporarily putting these caveats aside, we did run the suggested test. Results from multiple regression showed that using log evidence from frontal cortex models still did not meet this less demanding criterion for functional compensation as there was an effect of age in the opposite direction to that expected by functional compensation: there was a significant negative effect of age (t(218) = -7.95, p = < .001) indicating that as age increased, the difference in log evidence decreased. This effect is visualised below for transparency, but we preferred not to add this information to the article because we do not wish to encourage using this kind of analysis for the reason mentioned above. Thus, although our main multivariate test of interest is stringent, the additional step of mapping log evidence back to the boost-likelihood categories (e.g., boost vs. no difference to model performance) lends itself to the more appropriate logistic regression statistical approach.

      Author response image 1.

      Negative effect of age on MVB log evidence model outcomes for frontal cortex.

      A different approach that could be taken to assess a more lenient definition of functional compensation would be to analyse the effects of age on the spread of multivariate responses predicting task difficulty (i.e., standard deviation of fitted MVB voxel weights; also see Morcom & Henson, 2018; Knights et al., 2021) specifically from models that only include the candidate ‘compensation’ ROIs.

      Accordingly, these analyses and their discussion have been added to the article. To summarise, these analyses showed that (1) the frontal cortex still did not show evidence of functional compensation (i.e., a negative effect of age like in Morcom & Henson, 2018) and (2) no effect of age on the cuneal ROI, implying that the original model comparison approach (i.e., Figure 2C in the manuscript now) can provide more sensitivity for detecting evidence of functional compensation (perhaps because of the importance of including task-relevant network responses when building decoding models).

      Page-15

      “As a final analysis, we also tested a more lenient definition of functional compensation, whereby the multivariate contribution from the “compensation ROI” does not necessarily need to be above and beyond that of the task-relevant network (Morcom & Henson, 2018; Knights et al., 2021). To do this, we again assessed whether age was associated with an increase in the spread (standard deviation) of the weights over voxels, for smaller models containing only the cuneal or frontal ROI. This tested whether increased age led to more voxels carrying substantial information about task difficulty, a pattern predicted by functional compensation (but also consistent with non-specific additional recruitment). In this case, the results of this test did not support functional compensation, as there was no effect detected for the cuneal cortex and even a negative effect of age for the frontal cortex where the spread of the information across voxels was lower for older age (Figure 3C; Table 2).”

      Page-21

      “The age- and performance-related activation in our frontal region satisfied the traditional univariate criteria for functional compensation, but our multivariate (MVB) model comparison analysis showed that additional multivariate information beyond that in the MDN was absent in this region, which is inconsistent with the strongest definition of compensation. In fact, the results from the spread analysis showed that as age increased, this frontal area processed less, rather than more, multivariate information about the cognitive outcome (Figure 3C) as previously observed in two (memory) tasks for a comparable ROI within the same Cam-CAN cohort (Morcom & Henson, 2018).”

      Page-24

      “This said, univariate criteria for functional compensation will continue to play a role in hypothesis testing. For instance, the over-additive interaction observed in the cuneal cortex - where the increase in activity with better performance is more pronounced in older adults - offers stronger evidence of compensation compared to the simple additive effect of age and performance observed in the frontal cortex (Figure 2C). So far, the two studies that have combined these rigorous univariate, behavioral and multivariate approaches to assess functional compensation (i.e., Knights et al., 2021; the present study) have generally found converging evidence regardless of the method used. However, it is important to note that the MVB approach uniquely shifts the focus from individual differences to the specific task-related information that compensatory neural activations are assumed to carry and provides a specific test of region- (or network-) unique information. With further studies, it may also be that multivariate approaches prove more sensitive for detecting compensation effects than when using mean responses over voxels (e.g., Friston et al., 1995) particularly since over-additive effects are challenging to observe because compensatory effects are typically ‘partial’ and do not fully restore function (for review see Scheller et al., 2014; Morcom & Johnson, 2015). Within the multivariate analysis options themselves, it is also interesting to highlight that the stringent MVB boost likelihood analysis could detect functional compensation unlike the more lenient analysis focusing on the spread of MVB voxel weights. This suggests the importance of including task-relevant network responses when building decoding models to assess compensation.”

      Page-32

      “Alongside the MVB boost analysis, we also included an additional measure using the spread (standard deviation) of voxel classification weights (Morcom & Henson, 2018). This measure indexes the absolute amplitude of voxel contributions to the task, reflecting the degree to which multiple voxels carry substantial task-related information. When related to age this can serve as a multivariate index of information distribution, unlike univariate analyses. However, it is worth highlighting that even if an ROI shows an effect of age on this spread measure, such an effect could instead be explained by a non-specific mechanism that represents the same information in tandem across multiple regions (rather than reflecting compensation) as seen previously (Knights et al., 2021; also see Morcom & Johnson, 2015). Thus, it is the MVB boost analysis that is the most compelling assessment of functional compensation because it can directly detect novel information representation.”

      Point 2: [Public Review] 2) Relatedly, does the observed boost in decoding by adding the cuneal ROI (in older adults) really reflect "additional, non-redundant" information carried by this ROI? Or could it be that this boost is just a statistical phenomenon that is obtained because the cuneus just happens to show a more clear-cut, less noisy difference in hard vs. easy task activation patterns than does the MDN (which itself may suffer from increased neural inefficiency in older age), and thus the cuneaus improves decoding performance without containing additional (novel) pieces of information (but just more reliable ones)? If so, the compensation account could still be maintained by reference to the less demanding rationale for what constitutes compensation laid out above.

      We agree that this is a possibility and have added this as an additional explanation to the Discussion. We have also discussed why we think it is a less likely possibility, but do concede that it cannot be ruled out currently.

      Page-20

      “Another possibility is that the age-related increases in fMRI activations (for hard versus easy) in one or both of our ROIs do not reflect greater fMRI signal for hard problems in older than younger people, but rather lower fMRI signal for easy problems in the older. Without a third baseline condition, we cannot distinguish these two possibilities in our data. However, a reduced “baseline” level of fMRI signal (e.g., for easy problems) in older people is consistent with other studies showing an age-related decline in baseline perfusion levels, coupled with preserved capacity of cerebrovascular reactivity to meet metabolic demands of neuronal activity at higher cognitive load  (Calautti et al., 2001; Jennings et al., 2005). Though age-related decline in baseline perfusion occurs in the cuneal cortex (Tsvetanov et al., 2021), the brain regions showing modulation of behaviourally-relevant Cattell fMRI activity by perfusion levels did not include the cuneal cortex (Wu et al., 2023). This suggests that the compensatory effects in the cuneus are unlikely to be explained by age-related hypo-perfusion, consistent with the minimal effect here of adjusting for RSFA (Figure 2C).

      One final possibility is whether the observed boost in decoding from adding the cuneal ROI simply reflects less noisy task-related information (i.e., a better signal-to-noise ratio (SNR)) than the MDN and, consequently, the boosted decoding is the result of more resilient patterns of information (rather than the representation of additional information) based on a steeper age-related decline of SNR in the MDN. Overall then, as none of the explanations above agree with all aspects of the results, to functionally explain the role of the cuneal cortex in this task would require further investigation.”

      Point 3: [Public Review] 3) On page 21, the authors state that "...traditional univariate criteria alone are not sufficient for identifying functional compensation." To me, this conclusion is quite bold as I'd think that this depends on the unvariate criterion used. For instance, it could be argued that compensation should be more clearly indicated by an over additive interaction as observed for the relationship of cuneal activity with age and performance (i.e., the activity increase with better performance becomes stronger with age), rather than by an additive effect of age and performance as observed for the prefrontal ROI (see Fig. 2C). In any case, I'd appreciate it if the authors discussed this issue and the relationship between univariate and multivariate results in more detail (e.g. how many differences in sensitivity between the two approaches have contributed), in particular since the sophisticated multivariate approach used here is not widely established in the field yet.

      We have now considered this point further in a section of the Discussion (which is merged with points 1 & 2 above) about the relevance and distinction of univariate / multivariate criteria for functional compensation. As described in text below, whilst we agree that univariate / behavioural approaches have a role in testing functional compensation, we still view the MVB boost analysis to be a particularly compelling approach for assessing this theory.

      Page-22

      “This said, univariate criteria for functional compensation will continue to play a role in hypothesis testing. For instance, the over-additive interaction observed in the cuneal cortex - where the increase in activity with better performance is more pronounced in older adults - offers evidence of compensation compared to the simple additive effect of age and performance observed in the frontal cortex (Figure 2C). However, the conclusions that can be drawn from age-related differences in cross-sectional associations of brain and behaviour are limited, mainly because individual performance differences are largely lifespan-stable (see Lindenberger et al., 2011; Morcom & Johnson, 2015). So far, the two studies that have combined these univariate-behavioral and multivariate approaches to assess functional compensation (i.e., Knights et al., 2021; the present study) have generally found converging evidence regardless of the method used. However, it is important to note that the MVB approach uniquely shifts the focus from individual differences to the specific task-related information that compensatory neural activations are assumed to carry. With further studies, it may also be that multivariate approaches prove more sensitive for detecting compensation effects than when using mean responses over voxels (e.g., Friston et al., 1995) particularly since over-additive effects are challenging to observe because compensatory effects are typically ‘partial’ and do not fully restore function. Within the multivariate analysis options themselves, it is also interesting to highlight that the stringent MVB boost likelihood analysis could detect functional compensation unlike the more lenient analysis focusing on the spread of MVB voxel weights. This suggests the importance of including task-relevant network responses when building decoding models to asses compensation.”

      Point 4: [Public Review] 4) As to the exclusion of poorly performing participants (see p24): If only based on the absolute number of errors, wouldn't you miss those who worked (overly) slowly but made few errors (possibly because of adjusting their speed-accuracy tradeoff)? Wouldn't it be reasonable to define a criterion based on the same performance measure (correct - incorrect) as used in the main behavioural analyses?

      This is a good point, though if we were to exclude participants using a chance level exclusion rate based on the formulae used for measuring behavioural performance, this removes identical subjects to those originally excluded. Based on this, the text has been updated to reflect this more parsimonious approach for defining exclusion criteria.

      Page-25

      “In a block design, participants completed eight 30-second blocks which contained a series of puzzles from one of two difficulty levels (i.e., four hard and four easy blocks completed in an alternating block order; Figure 1A). The fixed block time allowed participants to attempt as many trials as possible. Therefore, to balance speed and accuracy, behavioural performance was measured by subtracting the number of incorrect from correct trials and averaging over the hard and easy blocks independently (i.e., ((hard correct - hard incorrect) + (easy correct - easy incorrect))/2; Samu et al., 2017). For assessing reliability and validity, behavioural performance (total number of puzzles correct) was also collected from the same participants during a full version of the Cattell task (Scale 2 Form A) administered outside the scanner at Stage 2 of the Cam-CAN study (Shafto et al., 2014). Both the in- and out-of-scanner measures were z-scored. We excluded participants (N = 28; 17 females) who performed at chance level ((correct + incorrect) / incorrect < 0.5) on the fMRI task, leading to the same subset as reported in Samu et al. (2017).”

      Point 5: [Public Review] 5) Did the authors consider testing for negative relationships between performance and brain activity, given that there is some literature arguing that neural efficiency (i.e. less activation) is the hallmark of high intelligence (i.e. high performance levels in the Cattell task)? If that were true, at least for some regions, the set of ROIs putatively carrying task-related information could be expanded beyond that examined here. If no such regions were found, it would provide some evidence bearing on the neural efficiency hypothesis.

      No, we did not test for negative relationships between performance and brain activity in this study. However, In Wu et al. (2023) we did specifically test for this and neither of the relevant results reported in section 3.3.1 (i.e., unique relationship between activity and performance) nor section 3.3.2 (i.e., age-related relationship between activity and performance) showed the queried direction of effects. Note that the negative effect in section 3.3.2 (Age U Performance) is a more unique suppression effect representing a positive relationship between performance and activity where this becomes stronger as age is added to the model.

      Point 6: [Recommendations for the authors] 1) Page 26: It is not quite clear how the authors made sure their age and performance covariates functioned as independent regressors in the univariate group-level GLM, given the correlation between age and performance (i.e. shared variance).

      We included age and performance as covariates (of the age x performance effect of interest) by simply including these as independent regressors in the group-level GLM design matrix in addition to the interaction term (i.e., activity ~ age*performance + covariates equivalent to activity ~ age:performance + age + performance + covariates; Wilkinson & Roger 1973 notation), allowing us to examine the unique variance explained by each predictor (Table 1 and Table 2) and to control for their shared variance.

      We should note that while the GLM approach we used accounts for unique and shared effects, it does not explicitly report shared effects in its standard output. To directly examine shared variance, one would need to employ commonality analysis. For reference, results from a commonality analysis on this task have been previously reported in Wu et al. (2023).

      Prompted by this point, we have made some further minor improvements to help ensure our methodological steps are reproducible, as highlighted below.

      Page-30

      “Continuous age and behavioural performance variables were standardised and treated as linear predictors in multiple regression throughout the behavioural (Figure 1B), wholebrain voxelwise (Figure 1C/2A), univariate (Table 1; Figure 1B/2B) and MVB (Table 2; Figure 3) analyses. Throughout, sex was included as a covariate. The models, including interaction terms, can be described, according to Wilkinson & Roger’s (1973) notation, as activity ~ age * performance + covariates (which is equivalent to activity ~ age:performance + age + performance + covariates), allowing us to examine the unique variance explained by each predictor (Table 1) and to control for their shared variance. For whole-brain voxelwise analyses, clusters were estimated using threshold-free cluster enhancement (TFCE; Smith & Nichols 2009) with 2000 permutations and the resulting images were thresholded at a t-statistic of 1.97 before interpretation. Bonferroni correction was applied to a standard alpha = 0.05 based on the two ROIs (cuneal and frontal) that were examined. For Bayes Factors, interpretation criteria norms were drawn from Jarosz & Wiley (2014).”

      Point 7: [Recommendations for the authors] 2) Figure 3: I suggest changing the subheading in panel B to "Joint vs. MDN-only Model," in line with the wording in the main text.

      The subheading of Figure 3B is updated as suggested to `Joint vs. MDN-only Model`.

      Point 8: [Recommendations for the authors] 3) In Figures 1C and 2A, MNI z coordinates should be added to the section views. The appreciation of Figure 2B could be enhanced by adding some rendering with a saggital (medial and/or lateral) view.

      The slice mosaics in Figure 1C and 2A are now updated with each slice’s MNI Z coordinates and mentioned in the figure descriptions.

      Point 9: [Recommendations for the authors] 4) Page 7 (l. 135): What exactly is meant by "lateral occipital temporal cortex"?

      The text is updated to specify the anatomical landmarks that were used for guidance when referring to activation within the lateral occipital temporal cortex, based on ROI criteria definitions used in Knights, Mansfield et al. (2021):

      Page-7 Line-135:

      “Additional activation was observed bilaterally in the inferior/ventral and lateral occipital temporal cortex (i.e., a cluster around the lateral occipital sulcus that extended anteriorly beyond the anterior occipital sulcus), likely due to the visual nature of the task.”

      Point 10: [Recommendations for the authors] 5) On p18ff. (ll. 259-318) the authors discuss in quite some detail how the age-related decoding boost seen with the cuneus ROI can be functionally explained, but it seems like none of the explanations agrees with all aspects of the results. While this is not a major problem for the paper, it may be advisable if this part of the discussion ends with a clearer statement that this issue is not fully solved yet and provides material for future research.

      A more direct sentence has been added to make it clear that future investigation will be needed to explain the role of the cuneal cortex here.

      Page-20 Line-322:

      “Another possibility is that the age-related increases in fMRI activations (for hard versus easy) in one or both of our ROIs do not reflect greater fMRI signal for hard problems in older than younger people, but rather lower fMRI signal for easy problems in the older. Without a third baseline condition, we cannot distinguish these two possibilities in our data. However, a reduced “baseline” level of fMRI signal (e.g., for easy problems) in older people is consistent with other studies showing an age-related decline in baseline perfusion levels, coupled with preserved capacity of cerebrovascular reactivity to meet metabolic demands of neuronal activity at higher cognitive load  (Calautti et al., 2001; Jennings et al., 2005). Though age-related decline in baseline perfusion occurs in the cuneal cortex (Tsvetanov et al., 2021), the brain regions showing modulation of behaviourally-relevant Cattell fMRI activity by perfusion levels did not include the cuneal cortex (Wu et al., 2021). This suggests that the compensatory effects in the cuneus are unlikely to be explained by age-related hypo-perfusion, consistent with the minimal effect here of adjusting for RSFA (Figure 2C). Overall then, as none of the explanations above agree with all aspects of the results, to functionally explain the role of the cuneal cortex in this task will require further investigation.”

      Point 11: [Recommendations for the authors] 6) The threshold choice for Bayesian log evidence (> 3) should be motivated in some more detail, rather than just pointing to a book reference, as there is no established convention in the field, the choice may depend on the type of data and/or analysis, and a sizeable part of the readership may not be deeply familiar with the particular Bayesian approach used here.

      Text is updated to further clarify our motivation for using the log evidence BF>3 criterion:

      Page-29

      “The outcome measure was the log evidence for each model (Morcom & Henson, 2018; Knights et al., 2021). To test whether activity from an ROI is compensatory, we used an ordinal boost measure (Morcom & Henson, 2018; Knights et al., 2021) to assess the contribution of that ROI for the decoding of task-relevant information (Figure 3B). Specifically, Bayesian model comparison assessed whether a model that contains activity patterns from a compensatory ROI and the MDN (i.e., a joint model) boosted the prediction of task-relevant information relative to a model containing the MDN only. The compensatory hypothesis predicts that the likelihood of a boost to model decoding will increase with older age. The dependent measure, for each participant, was a categorical recoding of the relative model evidence to indicate the outcome of the model comparison. The three possible outcomes were: a boost to model evidence for the joint vs. MDN-only model (difference in log evidence > 3), ambiguous evidence for the two models (difference in log evidence between -3 to 3), or a reduction in evidence for the joint vs. MDN-only model (difference in log evidence < -3).These values were selected because a log difference of three corresponds to a Bayes Factor of 20, which is generally considered strong evidence (Lee & Wagenmakers, 2014). Further, with uniform priors, this chosen criterion (Bayes Factor > 3) corresponds to a p-value of p<~.05 (since the natural logarithm of 20 equals three, as evidence for the alternative hypothesis).”

      Point 12: [Recommendations for the authors] 7) Adding page numbers would be helpful.

      Page numbers have been added to the manuscript file – apologies for this oversight.

      References

      Green, E., Bennett, H., Brayne, C., & Matthews, F. E. (2018). Exploring patterns of response across the lifespan: The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study. BMC Public Health18, 1-7.

      Knights, E., Mansfield, C., Tonin, D., Saada, J., Smith, F. W., & Rossit, S. (2021). Hand-selective visual regions represent how to grasp 3D tools: brain decoding during real actions. Journal of Neuroscience41(24), 5263-5273.

      Samu, D., Campbell, K. L., Tsvetanov, K. A., Shafto, M. A., & Tyler, L. K. (2017). Preserved cognitive functions with age are determined by domain-dependent shifts in network responsivity. Nature communications, 8(1), 14743.

      Shafto, M. A., Tyler, L. K., Dixon, M., Taylor, J. R., Rowe, J. B., Cusack, R., ... & Cam-CAN. (2014). The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing. BMC neurology14, 1-25.

      Wu, S., Tyler, L. K., Henson, R. N., Rowe, J. B., & Tsvetanov, K. A. (2023). Cerebral blood flow predicts multiple demand network activity and fluid intelligence across the adult lifespan. Neurobiology of aging121, 1-14.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Reviewer):

      It is not clear from the analysis presented in the paper how persistent those environmentally induced changes, do they remain with the bats till the end of their lives.

      Currently, the long-term effects of enrichment on the bats remain uncertain. Preliminary results suggest that these differences may persist throughout the bats’ lifetimes; however, further data analysis is ongoing to determine the extent of these effects. We also addressed now at the manuscript discussion

      Reviewer #2 (Public Reviewer):

      (1) Assessing personality metrics and the indoor paradigm: While I applaud this effort and think the metrics used are justified, I see a few issues in the results as they are currently presented:

      (a) [Major] I am somewhat concerned that here, the foraging box paradigm is being used for two somewhat conflicting purposes: (1) assessing innate personality and (2) measuring changes in personality as a result of experience. If the indoor foraging task is indeed meant to measure and reflect both at the same time, then perhaps this can be made more explicit throughout the manuscript. In this circumstance, I think the authors could place more emphasis on the fact that the task, at later trials/measurements, begins to take on the character of a "composite" measure of personality and experience.

      Personality traits should generally be stable over time, but personality can also somewhat change with experience. We used the foraging box to assess individual personality, but we also examined the assumption that what we are measuring is a proxy of personality and hence is stable over time. We now clarify this in the manuscript. 

      (b) [Major] Although you only refer to results obtained in trials 1 and 2 when trying to estimate "innate personality" effects, I am a little worried that the paradigm used to measure personality, i.e. the stable components of behavior, is itself affected by other factors such as age (in the case of activity, Fig. 1C3, S1C1-2), the environment (see data re trial 3), and experience outdoors (see data re trials 4/5).

      We found that boldness was the most consistent trait, showing persistence between trials 1 to 5, i.e., 144 days apart on average. We thus also used Boldness as the primary parameter for assessing the effects of personality on the outdoors behavior. While we evaluated other traits for completeness, boldness was the only one that consistently met the criteria for personality, which is why we focused on it in our analyses. The other traits which were not stable over time could be used to assess the effects of experience on behavior

      Ideally, a study that aims to disentangle the role of predisposition from early-life experience would have a metric for predisposition that is relatively unchanging for individuals, which can stand as a baseline against a separate metric that reflects behavioral differences accumulated as a result of experience.

      I would find it more convincing that the foraging box paradigm can be used to measure personality if it could be shown that young bats' behavior was consistent across retests in the box paradigm prior to any environmental exposure across many baseline trials (i.e. more than 2), and that these "initial settings" were constant for individuals. I think it would be important to show that personality is consistent across baseline trials 1 and 2. This could be done, for example, by reproducing the plots in Fig. 1C1-3 while plotting trial 1 against trial 2. (I would note here that if a significant, positive correlation were to be found (as I would expect) between the measures across trial 1 and 2, it is likely that we would see the "habituation effect" the authors refer to expressed as a steep positive slope on the correlation line (indicating that bold individuals on trial 1 are much bolder on trial 2).)

      We agree and thus used boldness which was found to be stable over five trials (three of which were without external experience). We note that if Boldness as we measured it increased over time, the differences between individuals remained similar and this is what is expected from personality traits measured in the same paradigm several times (after the animal acquires experience).  

      (c) Related to the previous point, it was not clear to me why the data from trial 2 (the second baseline trial) was not presented in the main body of the paper, and only data from trial 1 was used as a baseline.

      We added a main figure, showing the correlation between the two baseline trials

      In the supplementary figure and table, you show that the bats tended to exhibit more boldness and exploratory behavior, but fewer actions, in trial 2 as compared with trial 1. You explain that this may be due to habituation to the experimental setup, however, the precise motivation for excluding data from trial 2 from the primary analyses is not stated. I would strongly encourage the authors to include a comparison of the data between the baseline trials in their primary analysis (see above), combine the information from these trials to form a composite baseline against which further analyses are performed, or further justify the exclusion of data as a baseline.

      We had no intention of excluding data from baseline 2. As we have shown several times before (e.g., Harten, 2021) bats’ boldness as we measure it in the box experiment increases over sessions performed nearby in time. This means that trial 2’s boldness was higher than that of trial 1 and trial 3 which made the data less suitable for a Linear model. Moreover, our measurement of boldness is capped (with a maximum of 1) again making it less suitable for a Linear model. However, following the reviewer’s question we now ran all analyses with trial 2’s data included and not only that the results remained the same, some of the models fit better (based on the AIC criterion). We added this information to the revised manuscript.  

      (2) Comparison of indoor behavioral measures and outdoor behavioral measures Regarding the final point in the results, correlation between indoor personality on Trial 4 and outdoor foraging behavior: It is not entirely clear to me what is being tested (neither the details of the tests nor the data or a figure are plotted). Given some of the strong trends in the data - namely, (1) how strongly early environment seems to affect outdoor behavior, (2) how strongly outdoor experience affects boldness, measured on indoor behavior (Fig. 1D) - I am not convinced that there is no relationship, as is stated here, between indoor and outdoor behavior. If this conclusion is made purely on the basis of a p-value, I would suggest revisiting this analysis.

      We agree that the relationship between indoor personality measures and outdoor foraging behavior is of great interest and had expected to find some correspondence between the two. To test this, we conducted multiple GLM analyses using the different indoor behavioral traits as predictors of outdoor behaviors. These analyses did not reveal any significant correlations. We also performed a separate analysis using PC1 (derived from the indoor behavioral variables) as a predictor, and again found no significant associations with outdoor behavior.

      We were indeed surprised by this outcome. It is possible that the behavioral traits we assessed indoors (boldness, exploration, and activity) do not fully capture the dimensions of behavior that are most relevant to foraging in the wild. For example, traits such as neophobia or decisionmaking under risk, which we did not assess directly, may have had stronger predictive value for outdoor behavior. We now highlight this point more clearly in the Discussion and acknowledge the possibility that alternative or additional personality traits might have revealed meaningful relationships.

      (3) Use of statistics/points regarding the generalized linear models While I think the implementation of the GLMM models is correct, I am not certain that the interpretation of the GLMM results is entirely correct for cases where multivariate regression has been performed (Tables 4s and S1, and possibly Table 3). (You do not present the exact equation they used for each model (this would be a helpful addition to the methods), therefore it is somewhat difficult to evaluate if the following critique properly applies, however...)

      The "estimate" for a fixed effect in a regression table gives the difference in the outcome variable for a 1 unit increase in the predictor variable (in the case of numeric predictors) or for each successive "level" or treatment (in the case of categorical variables), compared to the baseline, the intercept, which reflects the value of the outcome variable given by the combination of the first value/level of all predictors. Therefore, for example, in Table 4a - Time spend outside: the estimate for Bat sex: male indicates (I believe) the difference in time spent outside for an enriched male vs. an enriched female, not, as the authors seem to aim to explain, the effect of sex overall. Note that the interpretation of the first entry, Environmental condition: impoverished, is correct. I refer the authors to the section "Multiple treatments and interactions" on p. 11 of this guide to evaluating contrasts in G/LMMS: https://bbolker.github.io/mixedmodelsmisc/notes/contrasts.pdf

      We are not certain we fully understand the comment; however, if our understanding is correct, we respectfully disagree. A GLM analysis without interaction terms—as conducted in our study—functions as a multiple linear regression, wherein each factor's estimate reflects its individual effect on the dependent variable. For example in the case of sex, it examines he effect of sex on the tie spent out independently of enrichment. An interaction term would be needed to test sex*enrichment. We have added the models’ formula, and we hope this clarifies our approach

      Reviewer #1 (Recommendations for the authors):

      I would recommend the following:

      (1) As video tracking and behavioral analysis softwares are wide spread, it would be great to see this applied to the bat behavior indoor to answer questions like how does the bat velocity or heading or acceleration correlate with the behavioral measures boldness , activity or exploration? In the same gist, can one infer boldness, activity or exploration from measured bat velocity or other parameters? I think this will further make the indoor behavior more quantitative.

      In a tent of the size used in our study, bats’ flight behavior tends to be highly stereotypical: they typically perch on the wall, take off, circle the tent—sometimes multiple times—and then either land or not, and enter or not. Flight velocity is largely determined by individual maneuverability and the physical constraints of the space; thus, precise tracking is unlikely to provide further insight into boldness. In contrast, decision-making behaviors—such as whether to land or enter—more accurately reflect personality traits, as we have shown previously (Harten et al., 2018). Moreover, accurate 3D tracking in such an environment is possible but definitely not easy due to the many blind-spots resulting from the cameras being inside the 3D volume.  Nonetheless, we quantified flight activity and assessed its correlation with the other behavioral axes. As it was highly correlated with general activity, we did not include it as an independent parameter in the main analysis. However, in response to the reviewer’s suggestion, we now present this analysis in the Supplementary Materials.

      (2) It is not clear whether the bats come from the same genetic background. they might be but it is not mentioned in the methods under the experimental subjects.

      We have shown in the past that there is no familial relations in a randomly caught sample of bats in the colony where we usually work (Harten et al., 2018). The bats were caught in three, not related wild colonies. The text referring to the table was clarified in the revised manuscript

      (3) It will be great to include the author's thoughts about mechanisms underlying those environmentally induced changes in behavior in the discussion section along with how this will affect the bats' social foraging abilities. Another question that comes to mind is whether growing up with a large number of bats constitute an enriched environment in itself.

      We agree that this could count as an enrichment, and we thus ensured similar group sizes in both groups for this reason. We clarify this in the revised manuscript. 

      We have elaborated on the underlying mechanisms in the discussion, focusing on how they contribute to behavioral changes.

      Reviewer #2 (Recommendations for the authors):

      (1) Outdoor foraging behavior

      If I understand correctly, the data you display in Fig. 3A is only from the 2nd to 3rd weeks of exploration, i.e. just before the first post-exploration trial.

      What does the data look like for the second outdoor exploration data, i.e. before the final trial?

      Is there a specific reason why these measures were only computed on the GPS data from the 3rd week outside? If so, can this sampling of the data be motivated or briefly addressed (in the methods and wherever else necessary)?

      In order to allow a comparison between individuals, we had to restrict ourself to a period we had data from many individuals (some dissapeared later on).

      Following the reviewer suggestion – we added a supplemenry figure including days 21-26

      I would find it important and of great interest to see movement maps for more animals, as these give very rich information that is not entirely captured by the three proxies of outdoor activity.

      Are these four exemplary animals sampled from both seasons?

      Did you check to see if there were any overall differences in outdoor foraging behavior as a function of the season in which the bats were captured?

      Yes, the samples represent individuals from both tested years. This was clarified, and additional examples were included in a supplementary figure.

      Variable of time spent outdoors: You mention that you did not include the nights that the bat spent in the colony in these calculations. Did you also look to see if 'the number of nights when the bats left the colony' predicted the bat's earlier enrichment treatment? This could also be interesting to consider.

      In response to the reviewer’s comment, we conducted an additional analysis to test whether the proportion of nights each bat spent foraging outside the roost was predicted by its earlier environmental condition (enriched vs. impoverished). We also examined whether sex or age influenced this variable. This analysis showed no significant effect of environmental condition, sex, or age on the proportion of nights spent foraging outside the roost

      [Following on point 3 in public review...]

      When wishing to discuss the effect/significance of predictors overall, it is common to present the modelling results as an analysis of variance table. See, for example, the two-way anova section (p. 182) in the book Practical Regression and ANOVA using R: https://cran.r-project.org/doc/contrib/Faraway-PRA.pdf

      I think the output of passing the model object to an "anova" yields the table that you may be looking for, where the variance accounted for by a predictor is given overall, and not just relative to the first level of all predictors. Naturally, this information can be used in combination with the information provided by the raw model output presented in the paper.

      I assume you have done this analysis in R, but am not sure, as the statistical software used is not mentioned. There are several packages in R that allow users to quickly plot the graphical interaction of the parameters they use in models, which aids in interpreting results. It would be good to check results of model fitting in this manner.

      Relatedly, I was unable to locate the data and code for this paper using the DOI provided. Neither searching the internet using the doi nor entering the doi on the Mendeley Data website returned the right results. I tried searching Mendeley Data using the senior author's last name, but the most recent entry does not appear to be from this paper. https://data.mendeley.com/datasets/fr48bmnhxj/1

      We thank the reviewer for the helpful comment. The analysis was indeed conducted in MATLAB, and this has now been clarified in the manuscript. We have also revised the result tables to improve clarity and included the exact formulas used for each model. Regarding the data availability, the reviewer is correct — the dataset had not yet been published at the time of submission. It is now available at the provided DOI link.

      ### Suggestions and questions for the present paper, grouped thematically:

      [Major] Expansion and development of results: I thought there were many interesting and suggestive points in this data that could be expanded upon. I mention some of these here. While the authors of course do not need to implement all of these suggestions, I think the paper would benefit from a more substantial presentation of this rich data set:

      (a) Individual differences as such are not emphasized in the paper so much, as the analyses, particularly those expressed as boxplots, are grouped. The scatter plots in Figure 1 give the richest insight into how individual behavior changes throughout the course of the experiment. I would advocate for the authors to show additional comparisons using such scatter plots (perhaps in the supplementary, if needed).

      We thank the reviewer and added scatter plots to figure 2

      (b) In the second paragraph of the results, the authors introduce the concept of a pareto front and that of personality archetypes (lines 101-107). I found this very interesting, but these concepts were never reiterated upon later in the results or in the discussion. In fact, at many points, I found myself curious as to how the three indoor measures of personality might be combined to form a composite measure of personality (and likewise for outdoor measures). Have you tried to combine measures into a composite and tried to measure whether this composite metric provides any additional insight into these phenomena? For example, what if you mapped the starting position of each bat as a point in a three-dimensional space, given by the three personality measures, and then evaluated their trajectory through this space with measurements taken at later trials. Could innate personality be interpreted as the starting vector in this space (measured across the two baseline trials)? 

      Following the reviewer’s (justified) curiosity we ran a PCA analysis on the behavioral data from trials 1 and 5 and found that there is a significant correlation between the individual scores on PC1. This can be thought of as a measurement that takes both boldness and exploration into account (the weight of activity was very low). We added this information to the revised manuscript and also use this new behavioral parameter as a predisposition in the models (instead of exploration and activity). 

      Could environmental exposure be quantified as a warping of the trajectory through this space? Finally, could outdoor experience also be incorporated to evaluate how an individual arrives at its final measurement of personality combined with experience (trial 5)?

      The paper currently tries to explain outdoors behavior given personality and not vice versa. While this is a very interesting suggestion, we feel that adding this analysis would make the premise of the paper less clear and since the paper is already somewhat complex, we prefer to leave this analysis for a future study. 

      Examining the 3D trajectories of the individuals through the personality space did not reveal any immediate clear pattern (triangles mark the first trial and colours depict the environmental treatment) – 

      Author response image 1.

      Related to this point: I think the strongest part of the paper is the result showing that bats exposed to enriched environments explore farther, more often, and over larger distances than bats that were raised in an impoverished environment.

      We completely agree and tried to further emphasize this  

      (c) While these results of the outdoor GPS tracking are very clear, I wish that more information were extracted from the tracking data, which is incredibly rich and certainly can be used to derive many interest parameters beyond those that the authors have shown here. Examples might include: distance travelled (as opposed to estimated km2 or farthest point), a metric of navigational ability (how much "dead reckoning" the animal engages in). I even wonder if the areas or landmarks visited by the enriched bats might be found to be more complex, challenging, or richer by some measure.

      This study was a first step, aiming to establish a connection between early exposure and outdoors foraging

      We agree that there are many more analyses that can be done and indeed that ones related to navigation capabilities are missing. We are still collecting data on these bats and hope to present a more advanced analysis with a time span of years. 

      (d) Related to the above point: I find it very interesting that in 3 of the 4 bats for which you show exemplary movement data (Fig. 3, panels B and C), they appear to travel to the farthest distances and cover the most ground early on, and become more "conservative" in their flight paths on later evenings. This point is not explored in the discussion, nor related to earlier measurements.

      During the first months of exploration, bats will occasionally perform long exploratory flights in between bouts of shorter flights where they return to nearby familiar trees. This behavior can be seen in more detail in Harten et al Science 2020. We are currently quantifying this more carefully for another study. 

      (e) Finally, my points about the possible strength of a composite measure of the three personality metrics is related to my concern about one of the conclusions, which is that innate personality does not have an effect on outdoor foraging behavior. I think the manner in which this was tested statistically is likely to bias the results against finding such a result given that personality metrics are used to predict outdoor behaviors in an individual manner (6 models in total, each examining a single comparison of predisposition to outdoor behavior), while both indoor personality metrics (Fig 1B) and outdoor behaviors appear to be correlated with each other (Table 5).

      Are there other analyses you have performed that are not presented in the paper and that have led you to conclude that there is no relationship here?

      We agree with the reviewer, that our findings do not exclude an effect of innate personality on foraging but only suggest no such affect for the parameter we measured. That said, we did expect to find an effect of boldness because this parameter has been shown to differentiate much between groups (Harten et al., 2018), and to correlate with other parameters of behavior. We were therefore surprised to find no significant effects, as we had anticipated observing some differences.

      Following the reviewer’s previous comment we now also tested another predisposition parameter – the PC1 score and also found that it did not explain foraging. 

      (f) Personality measured before and after early environmental exposure (related to point (a) above): I find it interesting that the positive correlation in boldness between baseline and post-enrichment or baseline and post-release suggests that the individuals that were the most bold remained bold (and likewise for less adventurous individuals). The correlation for activity, too, still suggests that more active individuals early in life are likely to remain very active after enrichment, even accounting for the fact that activity is confounded with age.

      Perhaps you could place some emphasis on the fact that the initial variation between individuals also appears to be relatively stable over repeated trials. You might also consider measuring this directly (population variance over successive trials; relationship of population variance on indoor measures vs. outdoor measures...)

      Yes – this is a main point of interest. We further emphasize that in the revised manuscript 

      (g) Effect of indoor behavior following early experience on outdoor behavior: You evaluate the effect of predisposition (measured on baseline trial 1) and environmental condition on measures of outdoor activity (Table 4). I wonder if you also tried using indoor behavioral measures measured on the post-enrichment trial 3 to predict outdoor foraging behavior.

      Assuming that these measures are in fact reflecting a combination of predisposition and accumulated experience, then measurements at this closer time point may tell you how the combination of innate traits and early acquired experience affect behavior in the wild.

      We appreciate the reviewer’s insightful suggestion to test whether indoor behavior from post-enrichment Trial 3, reflecting both innate traits and experience, predicts outdoor foraging behavior. We conducted this analysis, but found that the boldness in Trial 3 did not significantly predict any of the outdoor activity measures.

      (2) [Minor] Age/development: While the authors discuss the effect of their manipulations on behavioral measures, they do not much discuss the effect of age.

      I think it would be important to include at some point a mention of the developmental stages of Rousettus, giving labels to certain age ranges, e.g. pup, juvenile, adult, and to provide more context about the stages at which bats were tested in the discussion. Presently, age is only really mentioned as an explanation for declining activity levels, but I wonder if it might also have an influence on boldness.

      It would also be very elegant for figures where age is given in days, to additional label then with these stages.

      All bats were juveniles during the trials (approximately 4 to 8 months old), so they could not be divided into distinct age groups. To assess the effect of age, it was included as a predictor (in days) in the GLM analysis.

      (3) [Major] Effect of early experience and outdoor experience on the indoor task: In the paragraph on lines 278-285, you argue that the effect of seeing earlyenriched bats exhibit more boldness in trial 5 was likely due to post-sampling bias...

      I tend to disagree with this conclusion. I actually find this result both interesting and intuitive - that bats that were exposed to an enriched environment and have had experience in the wild, show much bolder activity on a familiar indoor foraging test (i.e. outside experience has made the animals bolder than before) (Fig 1, lines 159-161, Fig. S1). I did not notice this possibility mentioned in the discussion of the results.

      I also do not fully understand this argument. Could you please explain further?

      We accept the reviewer's comment and updated the manuscript (lines 336346) explaining the two hypotheses more clearly and arguing that it is difficult to tell them apart with the current data.

      [Minor] You also say that "this difference... can be seen in Figure 2 when examining only the bats that had remained until the last trial (Figure 2A2)." Do you mean supplementary Figure S1 A2? In fact, I am entirely unclear on what data is plotted in the supplementary Figure S1 and what differentiates the two columns of figures and the two models presented in the supplementary table. Did you plot data similar to that in Figure 2, with only bats that were present for all trials, but not show this data?

      There was a mistake: what was previously referred to as 2A2 is actually S2 A2.

      On the right side—only among the individuals with GPS data—the change is already evident at Baseline 2, where only the bolder individuals remain. If you have suggestions for a better analysis approach, we would be happy to hear them.

      ### Minor points

      General points regarding figures:

      For Figures 2 and 3A1-3 (as well as Fig. S1): Authors must show the raw data points over the box plots. It is very difficult to interpret the data and conclusions without being able to see the true distribution.

      Done

      For all figures showing grouped individual data, please annotate all panels or sets of boxplots with the number of bats whose data entered into each, as it is a little difficult to keep track of the changing sample sizes across experimental stages.

      To enhance transparency, we have added individual data points to all boxplots, allowing visual estimation of sample sizes across experimental stages. While numerical annotations are not included on the figures, the exact number of bats contributing to each group is provided in the Methods section (Table 8), ensuring this information is readily accessible to readers.In response to the reviewer’s request, we have updated all relevant figures to display individual data points within each boxplot. This addition makes it easier to track changes in sample size across different experimental stages.

      Unless I've missed the reason behind differences in axis labelling across the figures, it seems that trials are not always referred to consistently. E.g. Fig. 1 labels say "Trial 1 (baseline)" and fig. 2 labels say "Baseline 1 0 days." I'm not entirely sure if these correspond to exactly the same data. If so, perhaps the labels can be made uniform. I think the descriptive ones (Baseline 1, Postenrichment...) may be more helpful to the reader than providing the trial number (Trial 1, etc....).

      Done

      Figure 1:

      Very good Fig. 1A and 1B.

      For panels C1-3 & D, I think it would make it easier for the reader if the personality measure labels were placed at the top of each panel, e.g. "Boldness (entrance proportion)". The double axis labels are not only harder to read, they are also redundant, as the personality measure label repeats on both axes.

      Done

      Panel C1: For the first panel in this sequence, I think it would be elegant to include an annotation in the figure that indicates what the datapoints lying on either side of the dashed line means, i.e. "bolder after enrichment treatment" in the upper left corner, and "bolder before enrichment treatment" in the bottom right corner.

      Panel C2: It appears as though many of the data points in this panel overlap, and it appears to me that the blue data points in particular are overlaid by the orange ones. I am guessing this happens because proportion values based on entrances to only 6 boxes end up giving a more "discrete" looking distribution. I wonder if you can find a way to allow all the data to be visible by, e.g., jittering the data slightly; if there is rounding being done to the proportions, perhaps don't round them so that minute differences will allow them to escape the overlap; or possibly split the panel by enrichment treatment.

      Caption for C1-3: it may be helpful to mention the correlation line color scheme: "enriched (blue lines), the impoverished (orange lines)". The caption also says positive correlations were found for "both environments together," but this correlation line is not shown. Perhaps mention "(not shown)" or show line. Please rephrase the sentence "Dashed line represents the Y=X line." for more transparency and clarity. I understand you mean an "equality" or "unity" line, but perhaps you can explicitly state the information that this line provides, something like e.g. "Dashed line indicates equal values measured on both trials."

      We added the line for a reference, the caption was corrected

      Figure 3:

      Panels B1-C2: I would suggest giving these panels supertitles that indicate that B panels are enriched, C panels are impoverished, and that each panel is data from a different individual.

      The legend was corrected to be more clear about the figure

      General points regarding tables:

      Please revisit tables for formatting and typos, particularly in Table 4. Please also revise table captions for clarity. E.g. "first exploration as predisposition" to "Exploration (Baseline 1)" or similar

      Done

      Supplementary Tables and Figure: these are missing captions and explanations.

      The missing parts were adddad and corrected

      Points of clarification/style:

      It would seem to me more logical to present the results shown in Table 3 before those in Table 2, given that the primary in-lab manipulation is discussed with relation to Table 3, and the analysis in Table 2 is discussed rather as a limitation (though I believe this result can be expanded upon further, see above).

      For the activity metric, I would suggest showing this data as actions/hour instead of actions/minute. I think it is much more intuitive to consider, for example, that a bat makes 2 actions every hour, than that it makes 0.002 actions per minute.

      Done

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The authors present a model for multisensory correlation detection that is based on the neurobiologically plausible Hassenstein Reichardt detector. It modifies their previously reported model (Parise & Ernst, 2016) in two ways: a bandpass (rather than lowpass) filter is initially applied and the filtered signals are then squared. The study shows that this model can account for synchrony judgement, temporal order judgement, etc in two new data sets (acquired in this study) and a range of previous data sets.

      Strengths:

      (1) The model goes beyond descriptive models such as cumulative Gaussians for TOJ and differences in cumulative Gaussians for SJ tasks by providing a mechanism that builds on the neurobiologically plausible Hassenstein-Reichardt detector.

      (2) This modified model can account for results from two new experiments that focus on the detection of correlated transients and frequency doubling. The model also accounts for several behavioural results from experiments including stochastic sequences of A/V events and sine wave modulations.

      Additional thoughts:

      (1) The model introduces two changes: bandpass filtering and squaring of the inputs. The authors emphasize that these changes allow the model to focus selectively on transient rather than sustained channels. But shouldn't the two changes be introduced separately? Transients may also be detected for signed signals.

      We updated the original model because our new psychophysical evidence demonstrates the fundamental role of unsigned transient for multisensory perception. While the original model received input from sustained unimodal channels (low-pass filters), the new version receives input from unsigned unimodal transient channels. Transient channels are normally modelled through bandpass filters (to remove the DC and high-frequency signal components) and squaring (to remove the sign). While these may appear as two separate changes in the model, they are, in fact, a single one: the substitution of sustained with unsigned transient channels (for a similar approach, see Stigliani et al. 2017, PNAS). Either change alone would not be sufficient to implement a transient channel that accounts for the present results.

      That said, we were also concerned with introducing too many changes in the model at once. Indeed, we simply modelled the unimodal transient channels as a single band-pass filter followed by squaring. This is already a stripped-down version of the unsigned transient detectors proposed by Adelson and Bergen in their classic Motion Energy model. The original model consisted of two biphasic temporal filters 90 degrees out of phase (i.e., quadrature filters), whose output is later combined. While a simpler implementation of the transient channels was sufficient in the present study, the full model may be necessary for other classes of stimuli (including speech, Parise, 2024, BiorXiv). Therefore, for completeness, we now include in the Supplementary Information a formal description of the full model, and validate it by simulating our two novel psychophysical studies. See Supplementary Information “The quadrature MCD model” section and Supplementary Figure S8.

      (2) Because the model is applied only to rather simple artificial signals, it remains unclear to what extent it can account for AV correlation detection for naturalistic signals. In particular, speech appears to rely on correlation detection of signed signals. Can this modified model account for SJ or TOJ judgments for naturalistic signals?

      It can. In a recent series of studies we have demonstrated that a population of spatially-tuned MCD units can account for audiovisual correlation detection for naturalistic stimuli, including speech (e.g. the McGurk Illusion). Once again, unsigned transients were sufficient to replicate a variety of previous findings. We have now extended the discussion to cover this recent research: Parise, C. V. (2024). Spatiotemporal models for multisensory integration. bioRxiv, 2023-12.

      Even Nidiffer et al. (2018) which is explicitly modelled by the authors report a significant difference in performance for correlated and anti-correlated signals. This seems to disagree with the results of study 1 reported in the current paper and the model's predictions. How can these contradicting results be explained? If the brain detects correlation on signed and unsigned signals, is a more complex mechanism needed to arbitrate between those two?

      We believe the reviewer here refers to our Experiment 2 (where, like Nidiffer at al. (2018) we used periodic stimuli, not Experiment 1, which consists of step stimuli). We were also puzzled by the difference between our Experiment 2 and Nidiffer et al. (2018): we induced frequency doubling, Nidiffer did not. Based on quantitative simulations, we concluded that this difference could be attributed to the fact that while Nidiffer included on each trial an intensity ramp in their periodic audiovisual stimuli, we did not. As a result, when considering the ramp (unlike in Nidiffer’s analyses), all audiovisual signals used by Nidiffer were positively correlated (irrespective of frequency and phase offset), while our signals in Experiment 2 were sometimes correlated and other times not (depending on the phase offset). This important simulation is included in Supplementary Figure S7; we also have now updated the text to better highlight the role of the pedestal in determining the direction of the correlation.

      (3) The number of parameters seems quite comparable for the authors' model and descriptive models (e.g. PSF models). This is because time constants require refitting (at least for some experimental data sets) and the correlation values need to be passed through a response mode (i.e. probit function) to account for behavioural data. It remains unclear how the brain adjusts the time constants to different sensory signals.

      This is a deep question. For simplicity, here the temporal constants were fitted to the empirical psychometric functions. To avoid overfitting, whenever possible we fitted such parameters over some training datasets, while trying to predict others. However, in some cases, it was necessary to fit the temporal constants to specific datasets. This may suggest that the temporal tuning of those units is not crystalised to some pre-defined values, but is adjusted based on recent perceptual history (e.g., the sequence of trials and stimuli participants are exposed to during the various experiments).

      For transparency, here we show how varying the tuning of the temporal constants of the filters affects the goodness of fit of our new psychophysical experiments (Supplementary Figure S8). As it can be readily appreciated, the relative temporal tuning of the unimodal transient detector was critical, though their absolute values could vary over a range of about 15 to over 100ms. The tuning of the low-pass filters of the correlation detector (not shown here) displayed much lower temporal sensitivity over a range between 0.1s to over 1s.

      This simulation shows the impact of temporal tuning in our simulations, however, the question remains as to how such a tuning gets selected in the first place. An appealing explanation relies on natural scene statistics: units are temporally tuned to the most common audiovisual stimuli. Although our current empirical evidence does not allow us to quantitatively address this question, in previous simulations (see Parise & Ernst, 2016, Supplementary Figure 8), by analogy with visual motion adaptation, we show how the temporal constants of our model can dynamically adjust and adapt to recent perceptual history. We hope these new and previous simulations address the question about the nature of the temporal tuning of the MCD units.

      (4) Fujisaki and Nishida (2005, 2006) proposed mechanisms for AV correlation detection based on the Hassenstein-Reichardt motion detector (though not formalized as a computational model).

      This is correct, Fujisaki and Nishida (2005, 2007) also hypothesized that AV synchrony could be detected using a mechanism analogous to motion detection. Interestingly, however, they ruled out such a hypothesis, as their “data do not support the existence of specialized low-level audio-visual synchrony detectors”. Yet, along with our previous work (Parise & Ernst, 2016, where we explicitly modelled the experiments of Fujisaki and Nishida), the present simulations quantitatively demonstrate that a low-level AV synchrony detector is instead sufficient to account for audiovisual synchrony perception and correlation detection. We now credit Fujusaki and Nishida in the modelling section for proposing that AV synchrony can be detected by a cross-correlator.

      Finally, we believe the reviewer is referring to the 2005 and 2007 studies of Fujisaki and Nishida (not 2006); here are the full references of the two articles we are referring to:

      Fujisaki, W., & Nishida, S. Y. (2005). Temporal frequency characteristics of synchrony–asynchrony discrimination of audio-visual signals. Experimental Brain Research, 166, 455-464.

      Fujisaki, W., & Nishida, S. Y. (2007). Feature-based processing of audio-visual synchrony perception revealed by random pulse trains. Vision Research, 47(8), 1075-1093.

      Reviewer #2 (Public Review):

      Summary:

      This is an interesting and well-written manuscript that seeks to detail the performance of two human psychophysical experiments designed to look at the relative contributions of transient and sustained components of a multisensory (i.e., audiovisual) stimulus to their integration. The work is framed within the context of a model previously developed by the authors and is now somewhat revised to better incorporate the experimental findings. The major takeaway from the paper is that transient signals carry the vast majority of the information related to the integration of auditory and visual cues, and that the Multisensory Correlation Detector (MCD) model not only captures the results of the current study but is also highly effective in capturing the results of prior studies focused on temporal and causal judgments.

      Strengths:

      Overall the experimental design is sound and the analyses are well performed. The extension of the MCD model to better capture transients makes a great deal of sense in the current context, and it is very nice to see the model applied to a variety of previous studies.

      Weaknesses:

      My one major issue with the paper revolves around its significance. In the context of a temporal task(s), is it in any way surprising that the important information is carried by stimulus transients? Stated a bit differently, isn't all of the important information needed to solve the task embedded in the temporal dimension? I think the authors need to better address this issue to punch up the significance of their work.

      In hindsight, it may appear unsurprising that transient signals carry most information for audiovisual integration. Yet, so somewhat unexpectedly, this has never been investigated using perhaps the most diagnostic psychophysical tools for perceived crossmodal timing; namely temporal order and simultaneity judgments–along with carefully designed experiments with quantitative predictions for the effect of either channel. The fact that the results conform to intuitive expectations further supports the value of the present work: grounding empirically with what is intuitively expected. This offers solid psychophysical evidence that one can build on for future advancements. Importantly, developing a model that builds on our new results and uses the same parameters to predict a variety of classic experiments in the field, further supports the current approach.

      If “significance” is intended as shaking previous intuitions or theories, then no: this is not a significant contribution. If instead, by significance we intend to build a solid empirical and theoretical ground for future work, then we believe this study is not significant, it is foundational. We hope that this work's significance is better captured in our discussion.

      On a side note, there is an intriguing factor around transient vs. sustained channels: what matters is the amount of change, not the absolute stimulus intensity. Previous studies, for example, have suggested a positive cross modal mapping between auditory loudness and visual lightness or brightness [Odegaard et al., 2004]. This study, conversely, challenges this view and demonstrates that what matters for multisensory integration in time is not the intensity of a stimulus, but changes thereof.

      In a more minor comment, I think there also needs to be a bit more effort into articulating the biological plausibility/potential instantiations of this sustained versus transient dichotomy. As written, the paper suggests that these are different "channels" in sensory systems, when in reality many neurons (and neural circuits) carry both on the same lines.

      The reviewer is right, in our original manuscript we glossed over this aspect. We have now expanded the introduction to discuss their anatomical basis. However, we are not assuming any strict dichotomy between transient and sustained channels; rather, our results and simulations demonstrate that transient information is sufficient to account for audiovisual temporal integration.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) Related to point 2 of the public review, can the authors provide additional results showing that the model can also account for naturalistic signals and more complex stochastic signals?

      While working on this manuscript, we were also working in parallel on a project related to audiovisual integration of naturalistic signals. A pre-print is available online [Parise, 2024, BiorXiv], and the related study is now discussed in the conclusions.

      (2) As noted in the public review, Fujisaki and Nishida (2005, 2006) already proposed mechanisms for AV correlation detection based on the Hassenstein-Reichardt motion detector. Their work should be referenced and discussed.

      We have now acknowledged the contribution of Fujisaki and Nishida in the modelling section, when we first introduce the link between our model and the Hassenstein-Reichardt detectors.

      (3) Experimental parameters: Was the phase shift manipulated in blocks? If yes, what about temporal recalibration?

      To minimise the effect of temporal recalibration, the order of trials in our experiments was randomised. Nonetheless, we can directly assess potential short-term recalibration effects by plotting our psychophysical responses against both the current SOA, and that of the previous trials. The resulting (raw) psychometric surfaces below are averaged across observers (and conditions for Experiment 1). In all our experiments, responses are obviously dependent on the current SOA (x-axis). However, the SOA of the previous trials (y-axis) does not seem to meaningfully affect simultaneity and temporal order judgments. The psychometric curves above the heatmaps represent the average psychometric functions (marginalized over the SOA of the previous trial).

      All in all, the present analyses demonstrate negligible temporal recalibration across trials, likely induced by a random sequence of lags or phase shifts. Therefore, when estimating the temporal constants of the model, it seems reasonable to ignore the potential effects of temporal recalibration. To avoid increasing the complexity of the present manuscript, we would prefer not to include the present analyses in the revised version.

      Author response image 1.

      Effect of previous trial. Psychometric surfaces for Experiments 1 and 2 plotted against the lag in the current vs. the previous trial. While psychophysical responses are strongly modulated by the lag in the last trial (horizontal axis), they are relatively unaffected by the lag in the previous trial (vertical axis).

      (4) The model predicts no differences for experiment 1 and this is what is empirically observed. Can the authors support these null results with Bayes factors?

      This is a good suggestion: we have now included a Bayesian repeated measures ANOVA to the analyses of Experiment 1. As expected, these analyses provide further, though mild evidence in support for the null hypothesis (See Table S2). For completeness, the new Bayesian analyses are presented alongside the previous frequentist ones in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The authors aim to consider the effects of phonotactics on the effectiveness of memory reactivation during sleep. They have created artificial words that are either typical or atypical and showed that reactivation improves memory for the latter but not the former.

      Comment 1:

      Strengths:

      This is an interesting design and a creative way of manipulating memory strength and typicality. In addition, the spectral analysis on both the wakefulness data and the sleep data is well done. The article is clearly written and provides a relevant and comprehensive of the literature and of how the results contribute to it.

      We thank the reviewer for his/her positive evaluation of our manuscript. 

      Comment 2:

      Weaknesses:

      (1) Unlike most research involving artificial language or language in general, the task engaged in this manuscript did not require (or test) learning of meaning or translation. Instead, the artificial words were arbitrarily categorised and memory was tested for that categorisation. This somewhat limits the interpretation of the results as they pertain to language science, and qualifies comparisons with other language-related sleep studies that the manuscript builds on.

      We thank the reviewer for this comment. We agree that we did not test for meaning or translation but used a categorization task in which we trained subjects to discriminate artificial words according to their reward associations (rewarded vs. non-rewarded). Previous language studies (Batterink et al., 2014; Batterink and Paller, 2017; Reber, 1967) used artificial words to investigate implicit learning of hidden grammar rules. Here, the language researchers studied generalization of the previously learned grammar knowledge by testing subject’s ability to categorize correctly a novel set of artificial words into rule-congruent versus rule-incongruent words. These differences to our study design might limit the comparability between the results of previous language studies of artificial grammar learning and our findings. We discussed now this aspect as a limitation of our novel paradigm. 

      We added the following sentences to the discussion on p.14, ll. 481-488:

      Based on our paradigm, we investigated categorization learning of artificial words according to their reward associations (rewarded vs. unrewarded) and did not studied aspects of generalization learning of artificial grammar rules (Batterink et al., 2014; Batterink and Paller, 2017; Reber, 1967). This difference might limit the comparability between these previous language-related studies and our findings. However, the usage of artificial words with distinct phonotactical properties provided a successful way to manipulate learning difficulty and to investigate word properties on TMR, whereas our reward categorization learning paradigm had the advantage to increase the relevance of the word learnings due to incentives.    

      Comment 3:

      (2) The details of the behavioural task are hard to understand as described in the manuscript. Specifically, I wasn't able to understand when words were to be responded to with the left or right button. What were the instructions? Were half of the words randomly paired with left and half with right and then half of each rewarded and half unrewarded? Or was the task to know if a word was rewarded or not and right/left responses reflected the participants' guesses as to the reward (yes/no)? Please explain this fully in the methods, but also briefly in the caption to Figure 1 (e.g., panel C) and in the Results section.

      We thank the reviewer for this comment and added additional sentences into the document to provide additional explanations. We instructed the participants to respond to each word by left- and right-hand button presses, whereas one button means the word is rewarded and the other button means the word is unrewarded. The assignment of left- and right-hand button presses to their meanings (rewarded versus unrewarded) differed across subjects. In the beginning, they had to guess. Then over trial repetitions with feedback at the end of each trial, they learned to respond correctly according to the rewarded/unrewarded associations of the words.        

      We added the following sentences to the results section on p.5, ll. 161-168: 

      As a two alternative forced-choice task, we assigned left- and right-hand button presses to the rewarded and the unrewarded word category, counterbalanced across subjects. We instructed the participants to respond to each word by left- or right-hand button presses, whereas one button means the word is rewarded (gain of money points) and the other button means the word is unrewarded (avoid the loss of money points). In the beginning, they had to guess. By three presentations of each word in randomized order and by feedback at the end of each trial, they learned to respond correctly according to the rewarded/unrewarded associations of the words (Fig. 1c). 

      We added the following sentences to the caption of Figure 1 on p.6, ll. 188-194:

      As a two alternative forced-choice task, responses of left- and right-hand button presses were assigned to the rewarded and the unrewarded word category, respectively. The participants were instructed to respond to each word by left- or right-hand button presses, whereas one button means the word is rewarded (gain of money points) and the other button means the word is unrewarded (avoid the loss of money points). d) Feedback matrix with the four answer types (hits: rewarded and correct; CR, correct rejections: unrewarded and correct; misses: rewarded and incorrect; FA, false alarms: unrewarded and incorrect) regarding to response and reward assignment of the word.

      We added the following sentences to the methods on p.19, ll. 687-692:  

      As a two alternative forced-choice task, we assigned left- and right-hand button presses to the rewarded and the unrewarded word category, counterbalanced across subjects. We instructed the participants to respond to each word by left- or right-hand button presses, whereas one button means the word is rewarded (gain of money points) and the other button means the word is unrewarded (avoid the loss of money points).

      Comment 4:  

      (3) Relatedly, it is unclear how reward or lack thereof would translate cleanly into a categorisation of hits/misses/correct rejections/false alarms, as explained in the text and shown in Figure 1D. If the item was of the non-rewarded class and the participant got it correct, they avoided loss. Why would that be considered a correct rejection, as the text suggests? It is no less of a hit than the rewarded-correct, it's just the trial was set up in a way that limits gains. This seems to mix together signal detection nomenclature (in which reward is uniform and there are two options, one of which is correct and one isn't) and loss-aversion types of studies (in which reward is different for two types of stimuli, but for each type you can have H/M/CR/FA separably). Again, it might all stem from me not understanding the task, but at the very least this required extended explanations. Once the authors address this, they should also update Fig 1D. This complexity makes the results relatively hard to interpret and the merit of the manuscript hard to access. Unless there are strong hypotheses about reward's impact on memory (which, as far as I can see, are not at the core of the paper), there should be no difference in the manner in which the currently labelled "hits" and "CR" are deemed - both are correct memories. Treating them differently may have implications on the d', which is the main memory measure in the paper, and possibly on measures of decision bias that are used as well.

      We thank the reviewer for this comment giving us the opportunity to clarify. As explained in the previous comment, for our two alternative forced-choice task, we instructed the participants to press one button when they were thinking the presented word is rewarded and the other button, when they were thinking the word is unrewarded. Based on this instruction, we applied the signal detection theory (SDT), because the subjects had the task to detect when reward was present or to reject when reward was absent. Therefore, we considered correct responses of words of the rewarded category as hits and words of the unrewarded category as correct rejections (see Table below). However, the reviewer is correct because in addition to false alarms, we punished here the incorrect responses by subtraction of money points to control for alternative task strategies of the participants instead of reward association learning of words. We agree that further explanation/argumentation to introduce our nomenclature is necessary.  

      Author response table 1.

      We adjusted the results section on p.5, ll. 169-177:

      To obtain a measurement of discrimination memory with respect to the potential influence of the response bias, we applied the signal detection theory (Green and Swets, 1966). Because, we instructed the participants to respond to each word by left- or right-hand button presses and that one button means reward is present whereas the other button means reward is absent, we considered correct responses of words of the rewarded category as hits and words of the unrewarded category as correct rejections. Accordingly, we assigned the responses with regard to the reward associations of the words to the following four response types: hits (rewarded, correct); correct rejections (unrewarded, correct); misses (rewarded, incorrect); and false alarms (unrewarded, incorrect). Dependent on responses, subjects received money points (Fig. 1d). 

      Comment 5:

      (4) The study starts off with a sample size of N=39 but excludes 17 participants for some crucial analyses. This is a high number, and it's not entirely clear from the text whether exclusion criteria were pre-registered or decided upon before looking at the data. Having said that, some criteria seem very reasonable (e.g., excluding participants who were not fully exposed to words during sleep). It would still be helpful to see that the trend remains when including all participants who had sufficient exposure during sleep. Also, please carefully mention for each analysis what the N was.

      Our study was not pre-registered. Including all the subjects independent of low prememory performance, but with respect to a decent number of reactivations (> 160 reactivations, every word at least 2 times), resulted in a new dataset with 15 and 13 participants of the high- and low-PP cueing condition, respectively. Here, statistical analyses revealed no significant overnight change anymore in memory performance in the high-PP cueing condition (Δ memory (d'): t(14) = 1.67, p = 0.12), whereas the increase of the bias in decision making towards risk avoidance still remained significant (Δ bias (c-criterion): t(14) = 3.36, p = 0.005).

      We modified and added the following sentences to the discussion on p.13, ll. 456-458:

      Our study has limitations due to a small sample size and between-subject comparisons. The criteria of data analyses were not pre-registered and the p-values of our behavior analyses were not corrected for multiple comparisons.

      Comment 6:             

      (5) Relatedly, the final N is low for a between-subjects study (N=11 per group). This is adequately mentioned as a limitation, but since it does qualify the results, it seemed important to mention it in the public review.

      We agree with the reviewer that the small sample size and the between subject comparisons represent major limitations of our study. Accordingly, we now discussed these limitations in more detail by adding alternative explanations and further suggestions for future research to overcome these limitations.        

      We added the following sentences to the discussion about the limitations on p.14, ll. 465-488: 

      To control for potential confounders despite the influence of difficulty in word learning on TMR, we compared parameters of sleep, the pre-sleep memory performance and the vigilance shortly before the post-sleep memory test, revealing no significant group differences (see Table S1 and S2). Nevertheless, we cannot rule out that other individual trait factors differed between the groups, such as the individual susceptibility to TMR. To rule out these alternative explanations based on individual factors, we suggest for future research to replicate our study by conducting a within-subject design with cueing of subsets of previously learned low- and high-PP words providing all conditions within the same individuals as shown in other TMR studies (Cairney et al., 2018; Schreiner and Rasch, 2015).

      Comment 7:

      (6) The linguistic statistics used for establishing the artificial words are all based on American English, and are therefore in misalignment with the spoken language of the participants (which was German). The authors should address this limitation and discuss possible differences between the languages. Also, if the authors checked whether participants were fluent in English they should report these results and possibly consider them in their analyses. In all fairness, the behavioural effects presented in Figure 2A are convincing, providing a valuable manipulation test.

      We thank the reviewer pointing to the misalignment between the German-speaking participants and the used artificial words based on American English. Further, we did not assessed the English language capability of the participants to control it as a potential confounder, whereas comparative control analyses revealed no significant differences between the both cueing groups in pre-sleep memory performance (see Table S1). 

      We now discussed these comments as limitations on p.14, ll. 473-481: 

      Further, we used artificial words based on American English in combination with German speaking participants, whereas language differences of pronunciation and phoneme structures might affect word perception and memory processing (Bohn and Best, 2012). On the other hand, both languages are considered to have the same language family (Eberhard et al., 2019) and the phonological distance between English and German is quite short compared for example to Korean (Luef and Resnik, 2023). Thus, major common phonological characteristics across both languages are still preserved. In addition, our behavior analyses revealed robust word discrimination learning and distinct memory performance according to different levels of phonotactic probabilities providing evidence of successful experimental manipulation. 

      Comment 8:

      (7) With regard to the higher probability of nested spindles for the high- vs low-PP cueing conditions, the authors should try and explore whether what the results show is a general increase for spindles altogether (as has been reported in the past to be correlated with TMR benefit and sleep more generally) or a specific increase in nested spindles (with no significant change in the absolute numbers of post-cue spindles). In both cases, the results would be interesting, but differentiating the two is necessary in order to make the claim that nesting is what increased rather than spindle density altogether, regardless of the SW phase.

      We conducted additional analyses based on detected sleep spindles to provide additional data according to this question. 

      We added the following section to the supplementary data on pp. 31-32, ll. 1007-1045:  

      After conducting a sleep spindle detection (frequency range of 12-16Hz, see methods for details), we compared the sleep spindle density between the TMR conditions of high- and lowPP showing no significant difference (see Fig. S8a and Table S9). Next, we subdivided the detected sleep spindles into coupled and uncoupled sleep spindles with the previously detected slow waves (SW; analyses of Fig. 4). Sleep spindles were defined as coupled when their amplitude peak occurred during the SW up-state phase (0.3 to 0.8s time-locked to the SW troughs). A two-way mixed design ANOVA on the amplitude size of the sleep spindles with the cueing group as a between-subject factor (high-PP-cued vs. low-PP-cued) and SW-coupling as a within-subject factor (coupled vs. uncoupled) showed a significant interaction effect (cueing group × SW-coupling: F(1,20) = 4.51, p = 0.046, η2 = 0.18), a significant main effect of SW-coupling (F(1,20) = 85.02, p < 0.001, η2 = 0.81), and a trend of significance of the main effect of the cueing group (F(1,20) = 3.54, p = 0.08). Post-hoc unpaired t-tests revealed a significant higher amplitude size of the coupled sleep spindles of the cueing group of high- compared to low-PP (t(20) = 2.13, p = 0.046, Cohen’s d = 0.91; Fig. S8b) and no significant group difference of the uncoupled sleep spindles (t(20) = 1.62, p = 0.12). An additional comparison of the amount of coupled sleep spindles between the cueing groups revealed no significant difference (see Table S9). 

      Here, we found that detected sleep spindles coupled to the SW up-state phase occurred with higher amplitude after TMR presentations of the high-PP words in comparison to the low-PP words, whereas the sleep spindle density and the amount of sleep spindles coupled to the SW up-state phase did not differed between the cueing conditions.     

      We added the following sentences to the methods on pp. 22-23, ll. 822-839:  

      Sleep spindle analyses 

      We detected fast sleep spindles by band-pass filtering (12-16Hz) the signal of the Pz electrode during the auditory cueing trials in the time windows of -2 to 8s according to stimulus onsets. The amplitude threshold was calculated individually for each subject as 1.25 standard deviations (SDs) from the mean. The beginning and end times of the sleep spindles were then defined as the points at which the amplitude fell below 0.75 SDs before and after the detected sleep spindle. Only sleep spindles with a duration of 0.5-3 s were included in subsequent analyses. 

      To compare the sleep spindle densities between the different cueing conditions of high- and low-PP, we computed the grand average sleep spindle density distribution in number per trial with a bin size of 0.5s from -0.5 to 6s time-locked to stimulus onset in each condition (see Fig. S8a and Table S9).     

      Based on the detected slow waves and sleep spindles, we defined coupling events when the positive amplitude peak of a detected sleep spindle was occurring during the slow wave upstate phase in a time window of 0.3 to 0.8s according to the trough of a slow wave. 

      We computed the averaged amplitude size of each detected sleep spindle by calculating the mean of the absolute amplitude values of all negative and positive peaks within a detected sleep spindle (see Fig. S8b).

      We added the following sentences to the results on p.10, ll. 338-343:  

      By conducting an additional analyses based on detection of fast sleep spindles (12-16Hz; see methods), we confirmed that fast sleep spindles during the SW up-states (from 0.3 to 0.8s after the SW trough) occurred with significantly higher amplitude after the cueing presentation of high- compared to low-PP words, whereas parameters of sleep spindle density and the amount sleep spindles coupled to the SW up-state did not differed between the cueing conditions (see Fig. S8 and Table S9).       

      Reviewer #2 (Public Review):

      Summary:

      The work by Klaassen & Rasch investigates the influence of word learning difficulty on sleepassociated consolidation and reactivation. They elicited reactivation during sleep by applying targeted memory reactivation (TMR) and manipulated word learning difficulty by creating words more similar (easy) or more dissimilar (difficult) to our language. In one group of participants, they applied TMR of easy words and in another group of participants, they applied TMR of difficult words (between-subjects design). They showed that TMR leads to higher memory benefits in the easy compared to the difficult word group. On a neural level, they showed an increase in spindle power (in the up-state of an evoked response) when easy words were presented during sleep.

      Comment 9:

      Strengths:

      The authors investigate a research question relevant to the field, that is, which experiences are actually consolidated during sleep. To address this question, they developed an innovative task and manipulated difficulty in an elegant way.

      Overall, the paper is clearly structured, and results and methods are described in an understandable way. The analysis approach is solid.

      We thank the reviewer for his/her positive evaluation of our manuscript.

      Weaknesses:

      Comment 10:

      (1) Sample size

      For a between-subjects design, the sample size is too small (N = 22). The main finding (also found in the title "Difficulty in artificial word learning impacts targeted memory reactivation") is based on an independent samples t-test with 11 participants/group.

      The authors explicitly mention the small sample size and the between-subjects design as a limitation in their discussion. Nevertheless, making meaningful inferences based on studies with such a small sample size is difficult, if not impossible.

      We agree with the reviewer that the small sample size and the between subject comparisons represent major limitations of our study. Accordingly, we now discussed these limitations in more detail by adding alternative explanations and further suggestions for future research to overcome these limitations.        

      We added the following sentences to the discussion about the limitations on p.14, ll. 465-473: 

      To control for potential confounders despite the influence of difficulty in word learning on TMR, we compared parameters of sleep, the pre-sleep memory performance and the vigilance shortly before the post-sleep memory test, revealing no significant group differences (see Table

      S1 and S2). Nevertheless, we cannot rule out that other individual trait factors differed between the groups, such as the individual susceptibility to TMR. To rule out these alternative explanations based on individual factors, we suggest for future research to replicate our study by conducting a within-subject design with cueing of subsets of previously learned low- and high-PP words providing all conditions within the same individuals as shown in other TMR studies (Cairney et al., 2018; Schreiner and Rasch, 2015).

      Comment 11:

      (2) Choice of task

      though the task itself is innovative, there would have been tasks better suited to address the research question. The main disadvantage the task and the operationalisation of memory performance (d') have is that single-trial performance cannot be calculated. Consequently, choosing individual items for TMR is not possible.

      Additionally, TMR of low vs. high difficulty is conducted between subjects (and independently of pre-sleep memory performance) which is a consequence of the task design.

      The motivation for why this task has been used is missing in the paper.

      We used a reward task combined with TMR because previous studies revealed beneficial effects of reward related information on sleep dependent memory consolidation and reactivation (Asfestani et al., 2020; Fischer and Born, 2009; Lansink et al., 2009; Sterpenich et al., 2021). In addition, we wanted to increase the motivation of the participants, as they could receive additional monetary compensation according to their learning and memory task performances. Furthermore, we designed the task, with the overall possibility to translate this task to operant conditioning in rats (see research proposal: https://data.snf.ch/grants/grant/168602). However, the task turned out to be too difficult to translate to rats, whereas we developed a different learning paradigm for the animal study (Klaassen et al., 2021) of this cross-species research project.       

      We added the following sentence to the introduction on p.4, ll. 134-137:

      To consider the beneficial effect of reward related information on sleep dependent memory consolidation and reactivation (Asfestani et al., 2020; Fischer and Born, 2009; Lansink et al., 2009; Sterpenich et al., 2021), we trained healthy young participants to categorize these words into rewarded and unrewarded words to gain and to avoid losses of money points.  

      Reviewer #3 (Public Review):

      Summary:

      In this study, the authors investigated the effects of targeted memory reactivation (TMR) during sleep on memory retention for artificial words with varying levels of phonotactical similarity to real words. The authors report that the high phonotactic probability (PP) words showed a more pronounced EEG alpha decrease during encoding and were more easily learned than the low PP words. Following TMR during sleep, participants who had been cued with the high PP TMR, remembered those words better than 0, whilst no such difference was found in the other conditions. Accordingly, the authors report higher EEG spindle band power during slow-wave up-states for the high PP as compared to low PP TMR trials. Overall, the authors conclude that artificial words that are easier to learn, benefit more from TMR than those which are difficult to learn.

      Comment 12 & 13:

      Strengths:

      (1) The authors have carefully designed the artificial stimuli to investigate the effectiveness of TMR on words that are easy to learn and difficult to learn due to their levels of similarity with prior wordsound knowledge. Their approach of varying the level of phonotactic probability enables them to have better control over phonotactical familiarity than in a natural language and are thus able to disentangle which properties of word learning contribute to TMR success.

      (2) The use of EEG during wakeful encoding and sleep TMR sheds new light on the neural correlates of high PP vs. low PP both during wakeful encoding and cue-induced retrieval during sleep.

      We thank the reviewer for his/her positive evaluation of our manuscript.

      Weaknesses:

      Comment 14:

      (1) The present analyses are based on a small sample and comparisons between participants. Considering that the TMR benefits are based on changes in memory categorization between participants, it could be argued that the individuals in the high PP group were more susceptible to TMR than those in the low PP group for reasons other than the phonotactic probabilities of the stimuli (e.g., these individuals might be more attentive to sounds in the environment during sleep). While the authors acknowledge the small sample size and between-subjects comparison as a limitation, a discussion of an alternative interpretation of the data is missing.

      We agree with the reviewer that the small sample size and the between subject comparisons represent major limitations of our study. We thank the reviewer for this helpful comment and now discussed these limitations in more detail by adding alternative explanations and further suggestions for future research to overcome these limitations.

      We added the following sentences to the discussion on p.14, ll. 465-473: 

      To control for potential confounders despite the influence of difficulty in word learning on TMR, we compared parameters of sleep, the pre-sleep memory performance and the vigilance shortly before the post-sleep memory test, revealing no significant group differences (see Table S1 and S2). Nevertheless, we cannot rule out that other individual trait factors differed between the groups, such as the individual susceptibility to TMR. To rule out these alternative explanations based on individual factors, we suggest for future research to replicate our study by conducting a within-subject design with cueing of subsets of previously learned low- and high-PP words providing all conditions within the same individuals as shown in other TMR studies (Cairney et al., 2018; Schreiner and Rasch, 2015).

      Comment 15:

      (2) While the one-tailed comparison between the high PP condition and 0 is significant, the ANOVA comparing the four conditions (between subjects: cued/non-cued, within-subjects: high/low PP) does not show a significant effect. With a non-significant interaction, I would consider it statistically inappropriate to conduct post-hoc tests comparing the conditions against each other. Furthermore, it is unclear whether the p-values reported for the t-tests have been corrected for multiple comparisons. Thus, these findings should be interpreted with caution.

      We thank the reviewer for this comment giving us the opportunity to correct our analyses and clarify with additional description. Indeed, we investigated at first overnight changes in behavior performance within the four conditions, conducting t-tests against 0 of Δ-values of d' and c-criterion. Whereas for all our statistical analyses the p-value was set at p < 0.05 for two-tailed testing, we did not corrected the p-value of our behavior analyses for multiple comparisons. To investigate subsequently differences between conditions, we conducted additional ANOVAs. We agree with the reviewer that without significant of results of the ANOVA, post-hoc analyses should not be conducted. Taken in account as well the recommendation of reviewer 1, we included now only post-hoc pairwise comparisons when the interaction effect of the ANOVA revealed at least a trend of significance (p < 0.1). 

      We removed the following post-hoc analyses from the results section on p.9, ll. 291-295: 

      Additional post-hoc pairwise comparisons revealed a significant difference between the highPP cued and low-PP uncued (high-PP cued vs. low-PP uncued: t(10) = 2.43, p = 0.04), and no difference to other conditions (high-PP cued vs.: high-PP uncued t(20) = 1.28, p = 0.22; lowPP cued t(20) = 1.57, p = 0.13).  

      Further, we mentioned the lack of correction for multiple comparisons as a limitation of our results in the discussion on p.13, ll. 456-458:  

      The criteria of data analyses were not pre-registered and the p-values of our behavior analyses were not corrected for multiple comparisons.

      We added the following sentences to the methods p.23, ll. 842-849:

      To analyze overnight changes of sleep behavioral data within TMR conditions, we conducted at first dependent sample t-tests against 0 of Δ-values (post-sleep test minus pre-sleep test) of d' and c-criterion (see Fig. 3). Two-way mixed design ANOVAs were computed to compare Δvalues between TMR conditions. After confirming at least a trend of significance (p < 0.1) for the interaction effect, we conducted post-hoc pairwise comparisons by independent and dependent sample t-tests. For all behavior statistical analyses, the p-value was set at p < 0.05 for two-tailed testing. A p-value < 0.1 and > 0.05 was reported as a trend of significance.

      Comment 16:

      (3) With the assumption that the artificial words in the study have different levels of phonotactic similarity to prior word-sound knowledge, it was surprising to find that the phonotactic probabilities were calculated based on an American English lexicon whilst the participants were German speakers. While it may be the case that the between-language lexicons overlap, it would be reassuring to see some evidence of this, as the level of phonotactic probability is a key manipulation in the study.

      We thank the reviewer pointing to the misalignment between the German-speaking participants and the used artificial words based on American English. In line with this recommendation, we added a more outlined argumentation to the manuscript about the assumption of our study that major common phonetic characteristics across both languages are still preserved.       

      We now discussed these aspects on p.14, ll. 473-481:

      Further, we used artificial words based on American English in combination with German speaking participants, whereas language differences of pronunciation and phoneme structures might affect word perception and memory processing (Bohn and Best, 2012). On the other hand, both languages are considered to have the same language family (Eberhard et al., 2019) and the phonological distance between English and German is quite short compared for example to Korean (Luef and Resnik, 2023). Thus, major common phonological characteristics across both languages are still preserved. In addition, our behavior analyses revealed robust word discrimination learning and distinct memory performance according to different levels of phonotactic probabilities providing evidence of successful experimental manipulation. 

      Comment 17:

      (4) Another manipulation in the study is that participants learn whether the words are linked to a monetary reward or not, however, the rationale for this manipulation is unclear. For instance, it is unclear whether the authors expect the reward to interact with the TMR effects.

      We used a reward task combined with TMR because previous studies revealed beneficial effects of reward related information on sleep dependent memory consolidation and reactivation (Asfestani et al., 2020; Fischer and Born, 2009; Lansink et al., 2009; Sterpenich et al., 2021). In addition, we wanted to increase the motivation of the participants, as they could receive additional monetary compensation according to their learning and memory task performances. Furthermore, we designed the task, with the overall possibility to translate this task to operant conditioning in rats (see research proposal: https://data.snf.ch/grants/grant/168602). However, the task turned out to be too difficult to translate to rats, whereas we developed a different learning paradigm for the animal study (Klaassen et al., 2021) of this cross-species research project.       

      We added the following sentence to the introduction on p.4, ll. 134-137:

      To consider the beneficial effect of reward related information on sleep dependent memory consolidation and reactivation (Asfestani et al., 2020; Fischer and Born, 2009; Lansink et al., 2009; Sterpenich et al., 2021), we trained healthy young participants to categorize these words into rewarded and unrewarded words to gain and to avoid losses of money points.  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Comment 18:

      (1) Please clearly define all linguistics terms - and most importantly the term "phonotactics" - at first use.

      We thank the reviewer for this recommendation and we added the definition of phonotactics and further reduced the diversity of linguistic terms to improve readability. 

      We added the following sentences to the beginning of the introduction on p.3, ll. 72-76:

      One critical characteristic of similarity to pre-existing knowledge in auditory word processing is its speech sound (phoneme) pattern. In phonology as the field of language specific phoneme structures, phonotactics determines the constraints of word phoneme composition of a specific language.

      Comment 19:

      (2) Some critical details about the methods should be included in the Results section to make it comprehensible. For example, the way the crucial differences between G1-4 words should be addressed in the Results, not only in Figure 1.

      According to the recommendation, we added this information to the results section.  We added the following sentences to the results section on p.4, ll. 145-154:

      To study the impact of difficulty in word learning on TMR, we developed a novel learning paradigm. We formed four sets of artificial words (40 words per set; see Table S3 and S4) consisting of different sequences of two vowels and two consonants. Here, we subdivided the alphabet into two groups of consonants (C1: b, c, d, f, g, h, j, k, l, m; C2: n, p, q, r, s, t, v, w, x, z) and vowels (V1: a, e, I; V2: o, u, y). Four-letter-words were created by selecting letters from the vowel and consonant groups according to four different sequences (G1:C1, V1, V2, C2; G2: C1, V1, C2, V2; G3: V1, C1, C2, V2; G4: V1, C1, V2, C2; Fig. 1a; see methods for further details). Comparison analyses between the sets revealed significant differences in phonotactic probability (PP; Fig. 1b; unpaired t-tests: G1 / G2 > G3 / G4, p < 0.005, values of Cohen’s d > 0.71).

      Comment 20

      (3) Was scoring done both online and then verified offline? If so, please note that.

      We included now this information.  

      We adjusted the method section on p.21, ll. 765-769:   

      The sleep stages of NREM 1 to 3 (N1 to N3), wake, and REM sleep were scored offline and manually according to the criteria of the American Academy of Sleep Medicine (AASM) by visual inspection of the signals of the frontal, central, and occipital electrodes over 30s epochs (Iber et al., 2007). Based on offline scoring, we confirmed TMR exposure during N2 and N3 and no significant differences (p-values > 0.05) of sleep parameters between the cueing groups (see Table S2).  

      Comment 21:

      (4) In Figure 2, please arrange the panel letters in an easier-to-read way (e.g., label upper right panel b with a different letter).

      Now we rearranged the panel letters according to the recommendation.

      We adjusted Figure 2 on p.8, ll. 242-258:     

      Comment 22

      (5) In the first paragraph on TMR effects, please note which memory measure you are comparing (i.e., d').

      We added this information according to the recommendation.  

      We adjusted the sentence of the results on p.8, ll. 260-263:

      To examine whether TMR during sleep impacts memory consolidation of discrimination learning with respect to learning difficulty, we calculated the overnight changes by subtracting the pre- from the post-sleep memory performance based on d'-values of the reactivated sequences (cued) and non-reactivated sequences (uncued).

      Comment 23:

      (6) Please show the pre-sleep and post-sleep test scores for both word categories (not only the delta). It may be best to show this as another data point in Fig 2a, but it may be helpful to also see this split between cued and uncued.

      We added the pre-sleep and post-sleep test scores with the individual data points as an additional figure. 

      We added the following figure to the supplementary data on p.28, ll. 936-940:  

      Comment 24:

      (7) In the sentence "An additional two-way mixed design ANOVA on the same values with cueing as a between-subject factor (cued vs. uncued) ...", a more exact phrasing for the last parentheses would probably be "(high-PP-Cued vs Low-PP-Cued)". Both groups were cued.

      We thank the reviewer pointing this out. According to the recommendation, we corrected the descriptions of the two-way mixed design ANOVAs. In addition, we detected a mistake of wrong assignments of the conditions to ANOVAs and corrected the reported values.   

      We adjusted the sentences and corrected the values on p.9, ll. 271-275 and ll. 289-291: 

      An additional two-way mixed design ANOVA on the same values with the factor cueing (cued vs. uncued) as a within-subject factor and group as a between-subject factor revealed trends of significance (p < 0.1) for the interaction (cueing × group: F(1,20) = 3.47, p = 0.08) and the main effect of group (F(1,20) = 3.28, p = 0.09). The main effect of cueing was not significant (F(1,20) = 0.58, p = 0.46).

      An ANOVA on c-criterion changes showed no significant effects (interaction cueing × group: F(1,20) = 2.66, p = 0.12; main effect cueing  F(1,20) = 2.08, p = 0.17; main effect group F(1,20) = 0.38, p = 0.55).

      Comment 25:

      (8) In the same ANOVA, please mention that there is a trend toward an interaction effect. If there wasn't one, the post-hoc comparison would be unwarranted. Please consider noting other p<0.1 pvalues as a trend as well, for consistency.

      Regarding this recommendation, we included now only post-hoc pairwise comparisons after confirming at least a trend toward an interaction effect of these ANOVAs and reported consistently a p-value < 0.1 and > 0.05 as a trend of significance.

      We added the following sentences to the methods p.23, ll. 844-849:

      Two-way mixed design ANOVAs were computed to compare Δ-values between TMR conditions. After confirming at least a trend of significance (p < 0.1) for the interaction effect, we conducted post-hoc pairwise comparisons by independent and dependent sample t-tests. For all behavior statistical analyses, the p-value was set at p < 0.05 for two-tailed testing. A p-value < 0.1 and > 0.05 was reported as a trend of significance.

      We removed the following post-hoc analyses from the results section on p.9, ll. 291-295: 

      Additional post-hoc pairwise comparisons revealed a significant difference between the highPP cued and low-PP uncued (high-PP cued vs. low-PP uncued: t(10) = 2.43, p = 0.04), and no difference to other conditions (high-PP cued vs.: high-PP uncued t(20) = 1.28, p = 0.22; lowPP cued t(20) = 1.57, p = 0.13).          

      Comment 26:      

      (9) Please consider adding an analysis correlating spindle power with memory benefit across participants. Even if it is non-significant, it is important to report given that some studies have found such a relationship.

      According to this recommendation, we conducted an additional correlation analyses.

      We added the following sentences to the manuscript into the results (pp. 10-11, ll. 346-349), the discussion (p.12, ll. 413-417), and the methods (p.23, ll. 864-867):   

      Whereas we found a significant group difference in spindle power nested during SW up-states,   conducting further whole sample (n = 22) correlation analyses between the individual spindle power values of the significant cluster and the overnight changes of behavior measurements revealed no significant correlations (Δ d': r = 0.16, p = 0.48; Δ c-criterion: r = 0.19, p = 0.40).

      In addition to our result of the significant group difference, we failed to find significant correlations between SW nested spindle power values and overnight changes in behavior measurements, whereas previous studies reported associations of SW and spindle activities during sleep with the integration of new memories in pre-existing knowledge networks (Tamminen et al., 2013, 2010).

      By using the same extracted power values (0.3 to 0.8s; 11-14Hz; Pz, P3, P4, O2, P7) per subject, we performed whole sample (n = 22) Pearson correlation analyses between these power values and the overnight changes of behavior measurements of the cued condition (Δ d' and Δ ccriterion).

      Reviewer #2 (Recommendations For The Authors):

      (1) Choice of task

      Comment 27:      

      In general, I find your task well-designed and novel. In light of your research question, however, I wonder why you chose this task. When you outlined the research question in the introduction, I expected a task similar to Schreiner et al. (2015). For example, participants have to associate high PP words with each other and low PP words. The advantage here would be that you could test the benefits of TMR in a within-subjects design (for example, cueing half of the remembered high and half of the remembered low PP words).

      Please see our previous response at comment 14.    

      Comment 28:

      Why did you decide to introduce a reward manipulation?

      Please see our previous response at comment 11.    

      Comment 29:

      Why did you do the cueing on a category level (cueing all high PP or all low PP words instead of single word cueing or instead of cueing 20 reward high-PP, 20 unrewarded high-PP plus 20 reward low-PP and 20 unrewarded low-PP)? Both alternatives would have provided you the option to run your statistics within participants.

      Please see our previous response at comment 14.    

      Comment 30:

      (2) Between-subjects design and small sample size.

      Why did you decide on a between-subjects design that severely reduces your power?

      Why did you just collect 22 participants with such a design? Were there any reasons for this small sample size? Honestly, I think publishing a TMR study with healthy participants and such a small sample size (11 participants for some comparisons) is not advisable.

      Please see our previous response at comment 14.

      Comment 31:

      (3) Encoding performance.

      Is d' significantly above 0 in the first repetition round? I would assume that the distinction between rewarded and non-rewarded words is just possible after the first round of feedback.

      Indeed, conducting t-tests against 0 revealed significantly increased d'-values in the first repetition round (2nd presentation) in both PP conditions (high-PP: 0.85 ± 0.09, t(32) = 9.17, p < 0.001; low-PP: 0.62 ± 0.09, t(32) = 6.83, p < 0.001).  

      Comment 32:

      (4) Encoding response options

      If you want to you could make it more explicit what exactly the response options are. I assume that one button means a word has a high reward and the other button means a word has a low reward. Making it explicit increases the understanding of the results section.

      Please see our previous response at comment 3.

      Comment 33:           

      (5) Alpha desynchronisation.

      Relative change

      Why did you subtract alpha power during the 1st presentation from alpha power during 2nd and 3rd presentation? You baseline-corrected already and individually included the 1st, 2nd, and 3rd repetition in your behavioural analysis.

      Based on this analysis, we aimed to examine the relative change in alpha power between PP-conditions of memory-relevant word repetitions. Therefore, to extract memory relevant changes of EEG activities, the first word presentation of naive stimulus processing could serve as a more representative baseline condition covering the time-window of interest of 0.7 to 1.9 s after the stimulus onset compared to a baseline condition before stimulus onset (-1 to -0.1s). 

      To explain the rational of the analyses with the baseline condition more clearly, we added this information to the results section on p.7, ll. 222-226: 

      We obtained the changes in power values by subtracting the first from the second and third presentation for the high- and low-PP condition, respectively. Here, the first word presentation of naive stimulus processing served us with a more representative baseline condition covering the time-window of interest of 0.7 to 1.9 s after the stimulus onset to examine relevant changes of encoding.  

      Comment 34:

      (6) Alpha desynchronisation as a neural correlate of encoding depth & difficulty?

      "In addition to the behavior results, these EEG results indicate differences between PP conditions in desynchronization of alpha oscillations, as an assumed neural correlate of encoding depth. In addition to the behavior results, these EEG results indicate differences between PP conditions in desynchronization of alpha oscillations, as an assumed neural correlate of encoding depth."

      Given that the low-PP words are more difficult to learn, I was expecting to see higher alpha desynchronisation in the low-PP relative to the high-PP words. Could you outline in a bit more detail how your findings fit into the literature (e.g., Simon Hanslmayr did a lot of work on this)?

      I would also advise you to add citations e.g., after your sentence in the quote above ("as an assumed neural correlate of encoding depth").

      We thank the reviewer for the recommendation giving us the opportunity to discuss in more detail how our results relate to previous findings. 

      We added additional sentences to the discussion on p.13, ll. 441-455:    

      Additional studies linked alpha desynchronization to cognitive effort and cognitive load (Proskovec et al., 2019; Zhu et al., 2021). So, one could assume to observe higher alpha desynchronization in the more difficult to learn condition of low-PP compared to high-PP. On the other hand numerous studies investigating oscillatory correlates of learning and memory showed that alpha desynchronization is associated with memory across different tasks, modalities and experimental phases of encoding and retrieval (Griffiths et al., 2016, 2021, 2019a, 2019b; Hanslmayr et al., 2009; Michelmann et al., 2016). Strikingly, Griffith and colleagues (Griffiths et al., 2019a) revealed by simultaneous EEG-fMRI recordings a negative correlation between the occurrence of patterns of stimulus-specific information detected by fMRI and cortical alpha/beta suppression. Here, the authors suggested that a decrease of alpha/beta oscillations might represent the neuronal mechanism of unmasking the task-critical signal by simultaneous suppression of task-irrelevant neuronal activities to promote information processing. Following this interpretation, we assume that over the course of learning elevated memory processing of the easier to learn stimuli is associated with enhanced information processing and thus accompanied by higher cortical alpha desynchronization in comparison of the more difficult to learn stimuli.

      In addition, we added the mentioned quote on p.7, ll. 239-240:

      In addition to the behavior results, these EEG results indicate differences between PP conditions in desynchronization of alpha oscillations, as an assumed neural correlate of encoding depth (Griffiths et al., 2021; Hanslmayr et al., 2009).

      Comment 35:

      (7) Exclusion criterion.

      Why did you use a d' > 0.9 as a criterion for data inclusion?

      This criterion ensured that each included subject had at least in one PP-condition a d' > 1.05 of pre-sleep memory performance, which corresponds to a general accuracy rate of 70%. 

      Accordingly, we adjusted these sentences of the method section on p.19, ll. 677-680: 

      Data were excluded from subjects who did not reach the minimal learning performance of d' > 1.05 during the pre-sleep memory test in at least one of the two PP conditions, whereas this threshold value corresponds to accuracy rates of 70% (n = 5). In addition, we excluded one subject who showed a negative d' in one PP condition of the pre-sleep memory test (n = 1). 

      Comment 36:

      (8) Coherence of wording.

      When you talk about your dependent variable (d') you sometimes use sensitivity. I would stick to one term.

      We replaced the word sensitivity with d'.    

      (9) Criterion

      Comment 37:

      Why do you refer to a change in criterion (Figure 3b, axis labels) as a change in memory? Do you think the criterion says something about memory?

      We corrected the axis label of Figure 3b and deleted here the word memory.

      Comment 38:

      Additionally, why did you analyse the effect of TMR on the criterion? Do you expect the criterion to change due to sleep-dependent memory consolidation? This section would benefit from more explanation. Personally, I am very interested in your thoughts and your hypothesis (if you had one, if not that is also fine but then, make it explicit that it was an exploratory analysis).

      By conducting exploratory analyses of overnight changes of the c-criterion measurements, we aimed to examine the bias of decision-making to provide comprehensive data according to the framework of the signal detection theory. Regarding the previous literature showing mainly beneficial effects of sleep on learning and memory, we focused with our hypothesis on d' and explored additionally the c-criterion.

      Despite our task design with gains/hits of +10 money points and losses/FAs of -8 (instead of -10), the subjects showed already during the pre-sleep memory task significant biases towards loss avoidance in both PP conditions (t-tests against 0: high-PP: 0.44 ± 0.07, t(21) = 5.63, p < 0.001; low-PP: 0.47 ± 0.09, t(21) = 5.51, p < 0.001). As already reported in the preprint, we found an additional significant increase of c-criterion by TMR solely for the high-PP words (see Fig. 3b). Even by integrating subjects with poor pre-sleep memory performance (high-PP-cueing group: n = 15; low-PP-cueing group: n = 13), t-tests against 0 revealed a significant increase of the high-PP cueing condition (t(14) = 3.36, p = 0.005) and no significant overnight changes in the other conditions (high-PP uncued: t(12) = 1.39, p = 0.19; low-PP cued: t(12) = 1.47, p = 0.17; low-PP uncued: t(14) = -0.20, p = 0.84). These exploratory findings on c-criterion suggest potential applications of TMR to affect decision-making biases in combination with reward learning.      

      We revised the manuscript mentioning the exploratory character of the c-criterion analyses of the results on p.9, ll. 282-283 and of the discussion on p.12, ll. 400-402:  

      We examined next as an exploratory analysis whether TMR conditions influence biases in decision-making.

      By conducting an additional exploratory analysis, we observed a significant change of the decision bias in the cueing condition of the easy to learn words and no overnight changes in the other conditions.

      Comment 39:

      (10) You detected SWs in the time range of 0-6 sec post sound stimulation. How was the distribution of all detected SW down-states in this time range? (You could plot a histogram for this.)

      We illustrated now the detected SWs in the time range of 0 to 6 s after stimulus onset. 

      We added a histogram to the supplementary section on p.30, ll. 982-986:  

      Reviewer #3 (Recommendations For The Authors):

      Comment 40:

      (1) In line with the weakness outlined above, I would recommend including a discussion of how the between-subject comparison and small sample size could affect the results and provide alternative interpretations.

      Please see our previous response at comment 14.

      Comment 41:

      (2) Regarding my point about statistical comparisons, I would recommend that the authors follow best practice guidelines for post-hoc tests and multiple comparisons. In Figures 3a and b, I would also recommend removing the stars indicating significance from the post-hoc tests (if this is what they reflect). Perhaps this link will be useful: https://www.statology.org/anova-post-hoc-tests/

      Please see our previous response at comment 15.    

      Comment 42:

      (3) Furthermore, to address any doubts about the possible phonotactic probability differences between languages, I would recommend that the authors show whether the languages overlap, the level of English fluency in the German-speaking participants, and/or another way of reassuring that this is unlikely to have affected the results.

      Please see our previous response at comment 7.    

      Comment 43:

      (4) In the introduction, I would recommend that the authors outline a clear rationale for the reward/no reward manipulation.

      Please see our previous response at comment 11.    

      Comment 44:

      (5) Figure 1c: Please include what response options participants had, e.g., 'rewarded/not rewarded'. This would make the type of categorization clearer to the reader.

      Please see our previous response at comment 3.

      Comment 45:

      (6) It is unclear whether the additional ANOVA conducted on the time and frequency of the identified clusters included all channels or only the channels contributing to the cluster. Consider clarifying this in the relevant methods and results. Furthermore, I would recommend labelling this as a posthoc test as this analysis was guided by an initial peak at the data and the timings, frequencies, and channels of interest were not selected a-priori.

      We thank the reviewer for this recommendation and labelled the additional repeatedmeasure ANOVA as a post-hoc test. Further, we mentioned the used channels (Pz and Cz) for this analyses.

      We adjusted the results section on p.7, ll. 230-233 and the methods section on p.23, ll. 858-860:            

      A post-hoc repeated-measure ANOVA on alpha power changes (merged over Pz and Cz electrodes) with PP (high vs. low) and presentations (2 to 3) as within-subjects factors revealed a main effect of PP (F(1,32) = 5.42, p = 0.03, η2 = 0.15), and a significant interaction (F(1,32)  = 7.38, p = 0.01, η2 = 0.19; Fig. 2e).

      After confirming the existence of a significant cluster, we conducted an additional post-hoc repeated-measure ANOVA with averaged values of the identified time and frequency range of interest and merged over the Pz and Cz electrodes (see Fig. 2e).

      Comment 46:

      (7) Figure 3: To better illustrate within- vs. between-subjects comparisons and promote transparency, please add individual points and lines between the within-subjects conditions.

      According to this recommendation, we changed Figure 3 to add the individual data points by lines.  

      We modified Figure 3 on p.9, ll. 299-303:  

      Comment 47:

      (8) For the SW density time-bin analyses, please include statistics for all comparisons (i.e., through 0 s to 3 s) and say whether these were corrected for multiple comparisons.

      According to this recommendation, we included now statistics for all comparisons. 

      We added table S6 table to the supplementary data on p.29, l.962:     

      Comment 48:

      (9) Consider reporting effect sizes.

      We thank the reviewer for this recommendation and we added now effect sizes of significant results. 

      Comment 49:

      (10) For transparency and replicability, consider including a list of the four stimulus sets including their phoneme and biphone probabilities.

      We included a list of the four stimulus sets with their phoneme and biphone probabilities  

      We added table S3 and table S4 to the supplementary data on pp. 26-27:       

      References

      Asfestani MA, Brechtmann V, Santiago J, Peter A, Born J, Feld GB. 2020. Consolidation of Reward Memory during Sleep Does Not Require Dopaminergic Activation. J Cogn Neurosci 32:1688– 1703. doi:10.1162/JOCN_A_01585

      Batterink LJ, Oudiette D, Reber PJ, Paller KA. 2014. Sleep facilitates learning a new linguistic rule.

      Neuropsychologia 65:169–79. doi:10.1016/j.neuropsychologia.2014.10.024

      Batterink LJ, Paller KA. 2017. Sleep-based memory processing facilitates grammatical generalization: Evidence from targeted memory reactivation. Brain Lang 167:83–93. doi:10.1016/J.BANDL.2015.09.003

      Bohn OS, Best CT. 2012. Native-language phonetic and phonological influences on perception of American English approximants by Danish and German listeners. J Phon 40:109–128. doi:10.1016/J.WOCN.2011.08.002

      Cairney SA, Guttesen A á. V, El Marj N, Staresina BP. 2018. Memory Consolidation Is Linked to Spindle-Mediated Information Processing during Sleep. Curr Biol 28:948-954.e4. doi:10.1016/j.cub.2018.01.087

      Eberhard DM, Simons GF, Fennig CD. 2019. Ethnologue: Languages of the world . SIL International. Online version: http://www.ethnologue.com.

      Fischer S, Born J. 2009. Anticipated reward enhances offline learning during sleep. J Exp Psychol Learn Mem Cogn 35:1586–1593. doi:10.1037/A0017256

      Green DM, Swets JA. 1966. Signal detection theory and psychophysics., Signal detection theory and psychophysics. Oxford,  England: John Wiley.

      Griffiths B, Mazaheri A, Debener S, Hanslmayr S. 2016. Brain oscillations track the formation of episodic memories in the real world. Neuroimage 143:256–266. doi:10.1016/j.neuroimage.2016.09.021

      Griffiths BJ, Martín-Buro MC, Staresina BP, Hanslmayr S, Staudigl T. 2021. Alpha/beta power decreases during episodic memory formation predict the magnitude of alpha/beta power decreases during subsequent retrieval. Neuropsychologia 153. doi:10.1016/j.neuropsychologia.2021.107755

      Griffiths BJ, Mayhew SD, Mullinger KJ, Jorge J, Charest I, Wimber M, Hanslmayr S. 2019a. Alpha/beta power decreases track the fidelity of stimulus specific information. Elife 8. doi:10.7554/eLife.49562

      Griffiths BJ, Parish G, Roux F, Michelmann S, van der Plas M, Kolibius LD, Chelvarajah R, Rollings DT, Sawlani V, Hamer H, Gollwitzer S, Kreiselmeyer G, Staresina B, Wimber M, Hanslmayr S. 2019b. Directional coupling of slow and fast hippocampal gamma with neocortical alpha/beta oscillations in human episodic memory. Proc Natl Acad Sci U S A 116:21834–21842. doi:10.1073/pnas.1914180116

      Hanslmayr S, Spitzer B, Bäuml K-H. 2009. Brain oscillations dissociate between semantic and nonsemantic encoding of episodic memories. Cereb Cortex 19:1631–40. doi:10.1093/cercor/bhn197

      Iber C, Ancoli‐Israel S, Chesson AL, Quan SF. 2007. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Westchester, IL: American Academy of Sleep Medicine.

      Klaassen AL, Heiniger A, Sánchez PV, Harvey MA, Rainer G. 2021. Ventral pallidum regulates the default mode network, controlling transitions between internally and externally guided behavior. Proc Natl Acad Sci U S A 118:1–10. doi:10.1073/pnas.2103642118

      Lansink CS, Goltstein PM, Lankelma J V., McNaughton BL, Pennartz CMA. 2009. Hippocampus leads ventral striatum in replay of place-reward information. PLoS Biol 7. doi:10.1371/JOURNAL.PBIO.1000173

      Luef EM, Resnik P. 2023. Phonotactic Probabilities and Sub-syllabic Segmentation in Language

      Learning. Theory Pract Second Lang Acquis 9:1–31. doi:10.31261/TAPSLA.12468

      Michelmann S, Bowman H, Hanslmayr S. 2016. The Temporal Signature of Memories: Identification of a General Mechanism for Dynamic Memory Replay in Humans. PLoS Biol 14:e1002528. doi:10.1371/journal.pbio.1002528

      Proskovec AL, Heinrichs-Graham E, Wilson TW. 2019. Load Modulates the Alpha and Beta Oscillatory Dynamics Serving Verbal Working Memory. Neuroimage 184:256. doi:10.1016/J.NEUROIMAGE.2018.09.022

      Reber AS. 1967. Implicit learning of artificial grammars. J Verbal Learning Verbal Behav 6:855–863.

      doi:10.1016/S0022-5371(67)80149-X

      Schreiner T, Rasch B. 2015. Boosting vocabulary learning by verbal cueing during sleep. Cereb Cortex 25:4169–4179. doi:10.1093/cercor/bhu139

      Sterpenich V, van Schie MKM, Catsiyannis M, Ramyead A, Perrig S, Yang H-D, Van De Ville D, Schwartz S. 2021. Reward biases spontaneous neural reactivation during sleep. Nat Commun 2021 121 12:1–11. doi:10.1038/s41467-021-24357-5

      Tamminen J, Lambon Ralph MA, Lewis PA. 2013. The role of sleep spindles and slow-wave activity in integrating new information in semantic memory. J Neurosci 33:15376–15381. doi:10.1523/JNEUROSCI.5093-12.2013

      Tamminen J, Payne JD, Stickgold R, Wamsley EJ, Gaskell MG. 2010. Sleep spindle activity is associated with the integration of new memories and existing knowledge. J Neurosci 30:14356–60. doi:10.1523/JNEUROSCI.3028-10.2010

      Zhu Y, Wang Q, Zhang L. 2021. Study of EEG characteristics while solving scientific problems with different mental effort. Sci Rep 11. doi:10.1038/S41598-021-03321-9

    1. Author Response

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      In this study, the researchers aimed to investigate the cellular landscape and cell-cell interactions in cavernous tissues under diabetic conditions, specifically focusing on erectile dysfunction (ED). They employed single-cell RNA sequencing to analyze gene expression patterns in various cell types within the cavernous tissues of diabetic individuals. The researchers identified decreased expression of genes associated with collagen or extracellular matrix organization and angiogenesis in several cell types, including fibroblasts, chondrocytes, myofibroblasts, valve-related lymphatic endothelial cells, and pericytes. They also discovered a newly identified marker, LBH, that distinguishes pericytes from smooth muscle cells in mouse and human cavernous tissues. Furthermore, the study revealed that pericytes play a role in angiogenesis, adhesion, and migration by communicating with other cell types within the corpus cavernosum. However, these interactions were found to be significantly reduced under diabetic conditions. The study also investigated the role of LBH and its interactions with other proteins (CRYAB and VIM) in maintaining pericyte function and highlighted their potential involvement in regulating neurovascular regeneration. Overall, the manuscript is well-written and the study provides novel insights into the pathogenesis of ED in patients with diabetes and identifies potential therapeutic targets for further investigation.

      Reviewer #2 (Public Review):

      Summary: In this manuscript, the authors performed single cell RNA-sequencing of cells from the penises of healthy and diabetes mellitus model (STZ injection-based) mice, identified Lbh as a marker of penis pericytes, and report that penis-specific overexpression of Lbh is sufficient to rescue erectile function in diabetic animals. In public human single cell RNA-sea datasets, the authors report that LBH is similarly specific to pericytes and down regulated in diabetic patients. Additionally, the authors report discovery of CRYAB and VIM1 as protein interacting partners with LBH.

      The authors contributions are of interest to the erectile dysfunction community and their Lbh overexpression experiments are especially interesting and well-conducted. However, claims in the manuscript regarding the specificity of Lbh as a pericyte marker, the mechanism by which Lbh overexpression rescues erectile function, cell-cell interactions impaired by diabetes, and protein-interaction partners require qualification or further evidence to justify.

      Major claims and evidence:

      1) Marker gene specificity and quantification: One of the authors' major contributions is the identification of Lbh as a marker of pericytes in their data. The authors present qualitative evidence for this marker gene relationship, but it is unclear from the data presented if Lbh is truly a specific marker gene for the pericyte lineage (either based on gene expression or IF presented in Fig. 2D, E). Prior results (see Tabula Muris Consortium, 2018) suggest that Lbh is widely expressed in non-pericyte cell types, so the claims presented in the manuscript may be overly broad. Even if Lbh is not a globally specific marker, the authors' subsequent intervention experiments argue that it is still an important gene worth studying.

      Answer: We appreciate this comment. In our scRNAseq data for the mouse cavernosum tissues, previously known markers such as Rgs5, Pdgfrb, Cspg4, Kcnj8, Higd1b, and Cox4i2 were found to be expressed not exclusively in pericytes, while Lbh exhibited specific expression patterns in pericytes (Fig. 2 and Supplementary Fig. 5). LBH expression was easily distinguishable from α-SMA, not only in mouse cavernosum but also in dorsal artery and dorsal vein tissues within penile tissues. This distinctive expression pattern of LBH was also observed in the human cavernous pericytes (Fig. 5). Then, we examined Lbh expression patterns in various mouse tissues using the mouse single-cell atlas (Tabula Muris), although endothelial and pericyte clusters were not subclustered in most tissues from Tabula Muris. To identify pericytes, we relied on the expression pattern of known marker genes (Pecam1 for endothelial cells, Rgs5, Pdgfrb, and Cspg4 for pericytes). Lbh was expressed in pericytes of the bladder, heart and aorta, kidney, and trachea but not as specifically in penile pericytes (Supplementary Fig. 6A-D). However, it is worth noting that other known pericyte markers were also did not exhibit exclusive expression in pericytes across all the tissues we analyzed. Therefore, in certain tissues, particularly in mouse penile tissues, Lbh may be a valuable marker in conjunction with other established pericyte marker genes for distinguishing pericytes.

      2) Cell-cell communication and regulon activity changes in the diabetic penis: The authors present cell-cell communication analysis and TF regulon analysis in Fig 3 and report differential activities in healthy and DM mice. These results are certainly interesting, however, no statistical analyses are performed to justify claimed changes in the disease state and no validations are performed. It is therefore challenging to interpret these results, and the relevant claims do not seem well supported.

      Answer: In response to these helpful suggestions, we calculated statistical significance and performed experimental validation. CellphoneDB permutes the cluster labels of all cells 1000 times and calculates the mean(mean(molecule 1 in cluster X), mean(molecule 2 in cluster Y)) at each time for each interaction pair, for each pairwise comparison between two cell types. We only considered interactions in which the difference in means calculated by these permutations were greater than 0.25-fold between diabetes and normal. Also, we considered that the interactions with P-value < 0.05 were significant.

      To assess differential regulon activities of transcription factor (SCENIC) between diabetic and normal pericytes, we utilized a generalized linear model with scaled activity scores for each cell as input. These scaled regulon activity values for angiogenesis-related TFs exhibited differences between diabetic and normal pericytes. The results of the generalized linear model revealed that Klf5, Egr1, and Junb were TFs with significantly altered regulon activities in diabetic pericytes. Experimental data indicated that the expression level of Lmo2, Junb, Elk1, and Hoxd10 was higher (Hoxd10) or lower (Lmo2, Junb, Elk1) in diabetic pericytes compared to normal pericytes (Supplementary Fig. 9). We have added the scaled regulon activity values and statistical significance in Fig. 3E.

      3) Rescue of ED by Lbh overexpression: This is a striking and very interesting result that warrants attention. By simple overexpression of the pericyte marker gene Lbh, the authors report rescue of erectile function in diabetic animals. While mechanistic details are lacking, the phenomenon appears to have a large effect size and the experiments appear sophisticated and well conducted. If anything, the authors appear to underplay the magnitude of this result.

      Answer: We appreciate this comment. Therefore, we have added relevant clarification in the revised manuscript discussion section to emphasize the importance of LBH overexpression on rescuing ED as follows: “To test our hypothesis, we utilized the diabetes-induced ED mouse model, commonly employed in various studies focusing on microvascular complications associated with type 1 diabetes. We observed that the overexpression of LBH in diabetic mice led to the restoration of reduced erectile function by enhancing neurovascular regeneration. However, this study primarily demonstrated the observed phenomenon without delving into the detailed mechanisms. Nonetheless, these results of LBH on erections provide us with new strategies for treating ED and should be of considerable concern.” (Please see revised ‘Discussion’)

      4) Mechanistic claims for rescue of ED by Lbh overexpression: The authors claim that cell type-specific effects on MPCs are responsible for the rescue of erectile function induced by Lbh overexpression. This causal claim is unsupported by the data, which only show that Lbh overexpression influences MPC performance. In vivo, it's likely that Lbh is being over expressed by diverse cell types, any of which could be the causal driver of ED rescue. In fact, the authors report rescue of cell type abundance in endothelial cells and neuronal cells. Therefore, it cannot be concluded that MPC effects alone or in principal are responsible for ED rescue.

      Answer: We agree with these claims. Therefore, we have added relevant clarifications in the discussion section of the revised manuscript. Our findings suggest that LBH can affect the function of cavernous pericytes, although we cannot definitively specify which particular cavernous cell types are affected by the overexpressed LBH, whether it be cavernous endothelial cells, smooth muscle cells, or others. Subsequent research will be required to conduct more comprehensive mechanistic investigations, such as in vitro studies using cavernous endothelial cells, smooth muscle cells, and fibroblasts to address these knowledge gaps. (Please see revised ‘Discussion’)

      5) Protein interaction data: The authors claim that CRYAB and VIM1 are novel interacting partners of LBH. However, the evidence presented (2 blots in Fig. 6A,B) lack the relevant controls. It is possible that CRYAB and VIM1 are cross-reactive with the anti-LBH antibody or were not washed out completely. The abundance of bands on the Coomassie stain in Fig. 6A suggests that either event is plausible. Therefore, the evidence presented is insufficient to support the claim that CRYAB and VIM1 are protein interacting partners of LBH.

      Answer: We agree with these claims. Therefore, we have added the relevant controls(Input) and performed Co-IP (IP: CRYAB or VIM, WB: LBH) to demonstrate CRYAB and VIM1 are not simply cross-reactive antigens to their LBH antibody. Our results show that we can detect the expression of CRYAB and VIM after LBH IP, and we also detect the expression of LBH after CRYAB and VIM IP. In addition, it can be seen from our results that the binding of LBH to VIM is higher than that of CRYAB. Regardless, these results indicate that the binding of CRYAB or VIM to LBH is not a random phenomenon. (Please see revised ‘Result’ and ‘Figure 6B’)

      Impact: These data will trigger interest in Lbh as a target gene within the erectile dysfunction community.

      Reviewer #3 (Public Review):

      Bae et al. described the key roles of pericytes in cavernous tissues in diabetic erectile dysfunction using both mouse and human single-cell transcriptomic analysis. Erectile dysfunction (ED) is caused by dysfunction of the cavernous tissue and affects a significant proportion of men aged 40-70. The most common treatment for ED is phosphodiesterase 5 inhibitors; however, these are less effective in patients with diabetic ED. Therefore, there is an unmet need for a better understanding of the cavernous microenvironment, cell-cell communications in patients with diabetic ED, and the development of new therapeutic treatments to improve the quality of life.

      Pericytes are mesenchymal-derived mural cells that directly interact with capillary endothelial cells (ECs). They play a vital role in the pathogenesis of erectile function as their interactions with ECs are essential for penile erection. Loss of pericytes has been associated with diabetic retinopathy, cancer, and Alzheimer's disease and has been investigated in relation to the permeability of cavernous blood vessels and neurovascular regeneration in the authors' previous studies. This manuscript explores the mechanisms underlying the effect of diabetes on pericyte dysfunction in ED. Additionally, the cellular landscape of cavernous tissues and cell type-specific transcriptional changes were carefully examined using both mouse and human single-cell RNA sequencing in diabetic ED. The novelty of this work lies in the identification of a newly identified pericyte (PC)-specific marker, LBH, in mouse and human cavernous tissues, which distinguishes pericytes from smooth muscle cells. LBH not only serves as a cavernous pericyte marker, but its expression level is also reduced in diabetic conditions. The LBH-interacting proteins (Cryab and Vim) were further identified in mouse cavernous pericytes, indicating that these signaling interactions are critical for maintaining normal pericyte function. Overall, this study demonstrates the novel marker of pericytes and highlights the critical role of pericytes in diabetic ED.

      Reviewer #1 (Recommendations For The Authors):

      1) The methods are poorly written. It lacks specific information on the sample size, experimental design, and data analysis methods employed. The absence of these crucial details makes it difficult to evaluate the robustness and reliability of the findings.

      Answer: We agree with the reviewer’s suggestion, now we revised the methods of our manuscript, and added detailed information or references. For sample size we have added detailed information in Figure legend (Please see revised ‘Method’ , Figure Legend, and Supplementary information.)

      2) The cell number in the scRNA-seq analysis is small (~12000) and some minor cell types are probably underrepresented. It is not clear whether the authors pooled the cells from different mice as one sample, or replicates in different groups have been included. It will be helpful to label different samples in the UMAP. The authors should repeat the experiments with more replicates to increase the cell number and validate the findings.

      Answer: We understand the reviewer's concern, but due to the small size of mouse penile tissue, we had to pool 5 corpus cavernosum tissues for each group (using pooled samples) for scRNA-seq analysis. Moreover, owing to the unique nature of mouse penile tissue, which is highly resistant, it posed challenges for the dissolution and isolation of single cells using conventional single-cell separation methods. Consequently, we had to increase the concentration of the enzyme to finally obtain 12,894 cells. Rather than conducting a repetitive scRNAseq analysis on the same mouse model, we validated our findings in human cavernous single-cell transcriptome data. This analysis allowed us to confirm the presence of pericyte in human corpus cavernosum, specific expression of LBH in human cavernous pericytes, and the identification of relevant GO terms associated with pericyte functions (Figure 5). We have add these information in ‘Method’ (Please see revised ‘Method’).

      3) Functional studies are lacking to justify how manipulating LBH expression or its interacting proteins might lead to effective therapeutic approaches for diabetic ED.

      Answer: We have performed the functional study to evaluate LBH expression might lead to effective therapeutic approaches for diabetic ED as showed in Figure 4G. Assessment of intracavernous pressure (ICP) is the most representative test for evaluating erectile function. Therefore, we modulated LBH expression in the penis of diabetic mice and assessed the erectile function of the mice by intracavernous pressure. However, we have not performed ICP studies and relative in vitro studies (migration, survival experiment) to assess whether LBH-interacting proteins have the same effect.

      4) Although the abstract identifies novel targets for potential interventions, such as LBH and its interacting proteins, the clinical relevance of these findings remains uncertain. The authors should include a discussion regarding the translation of these discoveries into therapeutic strategies or their potential impact on patients with diabetes and ED.

      Answer: We appreciate the reviewer's suggestion and have added a discussion as per the reviewer’s recommendation (Please see revised ‘Discussion’).

      5) While the study highlights the importance of pericytes in penile erection, it fails to mention the broader context of other cell types involved in the pathogenesis of ED. Neglecting to discuss potential contributions from endothelial cells, smooth muscle cells, or neural elements limits the comprehensive understanding of the cellular interactions underlying diabetic ED.

      Answer: We agree with the reviewer's suggestion and have added a discussion regarding the significance of other cell populations in penile tissues, such as endothelial cells, smooth muscle cells fibroblasts, and neural elements, along with the rationale for our focus on pericytes. (Please see revised ‘Discussion’).

      Reviewer #2 (Recommendations For The Authors):

      We congratulate the authors on an interesting study. We were especially excited to see their Lbh overexpression results. However, we felt other claims in the paper could benefit from additional investigation, analysis, and statistical rigor. We have provided a set of suggestions for improvement below.

      Major points:

      1) Pericyte marker gene proposal: See public review for commentary on the following suggested experiments. The authors should perform binary classification analysis using Lbh and report the performance of this gene as a marker (e.g. using the area under the receiver operating characteristic, accuracy, precision and recall). Further, they should consider performing this analysis for all other genes in their data to determine whether Lbh is the best marker gene.

      Answer: We appreciate this comment. AUC scores of Rgs5, Pln, Ednra, Npylr, Atp1b2, and Gpc3 for ability of a binary classifier to distinguish between pericyte and the other cell types in mouse penile tissues were measured by using FindMarkers function. Rgs5 had the highest AUC, but Rgs5 was also expressed in SMCs in our data. Pln, Ednra, Gpc3, and Npy1r also seemed to be candidate markers, but the literature search excluded these genes as they are also expressed in the SMCs of other tissues or different cell types. The AUC score of Lbh was over 0.7, and expression in SMC was not identified in previous studies, and ultimately, we experimentally identified that Lbh is penis pericyte specific. We have added this to the manuscript.

      Author response table 1.

      Robust differential expression analysis should also be performed for this gene (if not all) and the statistics should be reported, given known issues with the statistical approach used by the authors for differential expression (see: Squair 2021, 10.1038/s41467-021-25960-2). The authors' should also report the number of cells involved in these comparisons, as the number of pericytes in the data (Fig 1B) appears quite small.

      Answer: We appreciate this comment. We used “MAST” to identify differentially expressed genes. This test is often used to find DEGs in single-cell RNA data. However, because the pseudobulk method has advantages over the single cell DEG method (Squair 2021, 10.1038/s41467-021-25960-2), we additionally performed DEG analysis with DESeq2 to confirm whether Lbh can distinguish pericytes from other cell types in the penile. As a result, even when tested with DESeq2, Lbh expression was significantly higher in pericytes than in other cell types in penile (adjusted p-value = 2.694475e-07 in Pericyte vs SMC, adjusted P-value = 3.700118e-58 in Pericyte vs the other cell types). Mouse penile tissue is small in size, and the number of pericytes in mouse penile tissue is relatively smaller compared to fibroblasts and chondrocytes. In our mouse penile scRNAseq data, the number of pericytes is as follows: normal: 58, diabetes: 116. Despite the limited number of cells, we were able to establish statistical significance in our analyses.

      Immunostaining results in Fig. 2D, E should likewise be quantified. At present, it's unclear that LBH and aSMA are mutually exclusive as claimed. The authors should also investigate Lbh expression in public single cell genomics data, rather than performing candidate gene literature searches. For example, the Tabula Muris suggests Lbh is expressed widely outside pericytes.

      Answer: For Figure 2D and E, the aim of these analyses was to assess the distribution of LBH and other cellular markers to see if they overlap and if they can be distinguished. We think that some of the overlapping staining in the tissue may be caused by multilayered cellular structures, so staining within cells would be more convincing. Therefore, we quantified the percentage of LBH- or α-SMA-expressed pericytes and relative expression in smooth muscle cells in cell staining (Supplementary Fig. 5E). We found that only 3% of smooth muscle cells expressed LBH, 67% of mouse cavernous pericytes (MCPs) expressed α-SMA, and more than 97% of MCPs expressed LBH. Therefore, these results may illustrate the specific expression of LBH in MCPs. These information was added as ‘Supplementary Fig. 5E’ (Please see revised ‘Supplementary information’). We also examined Lbh expression patterns in various mouse tissues using the public mouse single-cell atlas (Tabula Muris), and provided a detailed response in reviewer 2’s public review 1.

      Even if Lbh is not the best marker, the authors' intervention experiment still motivates study of the gene, but these analyses would help contextualize the result for readers.

      2) Statistical anslyses for cell-cell communication and TF regulon analysis: See public review for context on these comments. The authors should perform statistical tests to evaluate the significance of differences detected for each of these analysis. For example, generalized linear models can be used to assess the significance of TF regulon activity scores from SCENIC, and permutation tests can be used to measure the significance of cell-cell interaction score changes. Without these statistical tests, it's challenging for a reader to interpret whether the results reported are meaningful or within the realm of experimental noise.

      Answer: We appreciate this comment. We calculated statistical significance TF regulon analyses as suggested by the reviewer and described a detailed statistical calculation method for cell-cell communication. We provided a detailed response in reviewer 2’s public review 2.

      3) Mechanism of ED rescue by Lbh overexpression: To support this claim, the authors would need to perform an experiment where Lbh is over expressed specifically in MPCs (using e.g. a specific promoter on their LTV construct, or a transgenic line with a cell type-specific Cre-Lox system). Absent these data, the claim should be removed.

      Answer: We agree with the reviewer's suggestion and we have reworked the claim that ‘LBH overexpression is affected by pericytes during ED recovery’ and have added relevant clarification in the Discussion section to clearly state that LBH overexpression may affect many cavernosum cells, such as cavernous endothelial cells, smooth muscle cells, fibroblasts, and pericytes (Please see revised ‘Result’ and ‘Discussion’)

      4) Protein interaction claims: This experiment would require that the authors perform a similar pull-down with LBH KO cells and or a reciprocal Co-IP (e.g. IP: CRYAB or VIM1, WB: LBH) to demonstrate CRYAB and VIM1 are not simply cross-reactive antigens to their LBH antibody. Further, these experiments appear to only have a single replicate for each condition. The authors should either remove associated claims, or perform a Co-IP experiment with the relevant controls with sufficient replication.

      Answer: We agree with the claims. Therefore, we have included the necessary controls (Input) and performed Co-IP (IP: CRYAB or VIM1, WB: LBH) to demonstrate that CRYAB and VIM1 are not simply cross-reactive antigens to their LBH antibody. Our results show that we can detect the expression of CRYAB and VIM after LBH IP, and we also detect the expression of LBH after CRYAB and VIM IP. In addition, it can be seen from our results that the binding of LBH to VIM is higher than that of CRYAB. Regardless, these results indicate that the binding of CRYAB or VIM to LBH is not a random phenomenon. Additionally, all IP experiments were replicated at least three times. (Please see revised ‘Result’ and ‘Figure 6B’)

      Minor Points:

      • The reference "especially in men" on line 56 seems odd given that only males can experience penile erectile dysfunction.

      Answer: We agree with the reviewer's suggestion and have removed the description 'especially male' (Please see revised ‘Introduction’)

      • Line 109, it's unclear what genes showed altered expression in Schwann cells.

      Answer: We apologize for the confusion. There was no significant differentially expressed genes between normal and diabetes in Schwann cells. We revised this part in the manuscript. (Schwann cells showed an increased expression compared to normal cells in diabetes, though not significant. In Schwann cells, there were no significant DEGs between diabetic and normal cells.)

      • It would be helpful for readers to see an analysis of the cell types that are transduced in the Lbh overexpression experiment in vivo. At present, some pericyte specificity is implied, but not demonstrated.

      Answer: We appreciate this comment. Our findings suggest that LBH can affect the function of cavernous pericytes, although we cannot definitively conclude which specific-cavernous cell types are affected by the overexpressed LBH, whether it be cavernous endothelial cells, smooth muscle cells, or others. Subsequent research will be required to conduct more comprehensive mechanistic investigations, such as in vitro studies using cavernous endothelial cells, smooth muscle cells, and fibroblasts to address these knowledge gaps. These were also mentioned in the manuscript.

      • To improve clarity and enhance readability, define abbreviations before their initial usage in the text. For instance, in the second paragraph of the Introduction, the abbreviation 'ECs' is used without prior definition. It can be inferred that it is referring to endothelial cells, mentioned in parentheses in the subsequent sentence.

      Answer: We agree with the reviewer's suggestion to expand acronyms and ensure that all acronyms are defined in the revised manuscript before they are used for the first time in the text (Please see revised Manuscript).

      • It is important to include relevant references that align with the content being discussed. For example, in the Introduction, pericytes are described as being involved in various processes such as angiogenesis, vasoconstriction, and permeability. The text refers to a single reverence, a review by Gerhardt and Besholtz, which primarily focuses on pericyte's role in regulating angiogenesis. Adding additional sources, such as the review by Bergers and Song (Neuro Oncol., 2005) is recommended.

      Answer: We agree with the reviewer's suggestion, and have added the reference as reviewer recommended (Please see revised Manuscript and reference).

      • Figure 3E: it is stated that a panel of 53 angiogenesis factors were tested, it is stated that only MMP3 showed increased expression. However, various unlabeled spots appear to show changed expression patterns. It would be helpful to show a summary graph with the relative intensities of the full array of factors tested.

      Answer: We agree with the reviewer’s suggestion, now we showed all spots density in angiogenesis array as Supplementary Table 1. The condition of the spots we selected was that the expression density was at least above 1500, and the change ratio was greater than 1.2. (Please see revised ‘Supplementary information’)

      Reviewer #3 (Recommendations For The Authors):

      Detailed statistical power calculation

      Data availability statement( were both mouse and human scRNA deposited in GEO with a taken and when will they be released to the public?)

      Answer: Human scRNA data have been deposited in GEO under accession number GSE206528. Our mouse scRNA dataset has been uploaded to KoNA and is available for download (https://www.kobic.re.kr/kona/review?encrypt_url=amlod2FucGFya3xLQUQyMzAxMDEz)

      Major concerns about this work

      1) The single cell RNAseq data collected for mouse diabetic ED(Fig 1B), FB are the most abundant cell population compared to PC, EC, SMC and other clusters. The rationale for studying FB clusters (in Figure 1, D-F) instead of PC cluster is unclear. Which cluster DEG did the authors annotate for Fig 1G-H?

      Answer: We understand the reviewer's suggestion and confusion. Although other major cell populations in penile tissue such as smooth muscle cells, endothelial cell, and fibroblasts have been extensively studied, pericytes have mainly been investigated in the context of the central nervous system (CNS). For example, in the CNS, pericytes are involved in maintaining the integrity of the brain's blood-brain barrier (BBB) [PMID: 27916653], regulating blood flow at capillary junctions [PMID: 33051294], and promoting neuroinflammatory processes [PMID: 31316352], whose dysfunction is considered an important factor in the progression of vascular diseases such as Alzheimer's disease [PMID: 24946075]. But little is known about the role of pericytes in penile tissue [PMID: 35865945; PMID: 36009395; PMID: 26044953]. In order to explore the role of pericytes in repairing the corpus cavernosum vascular and neural tissues damaged by DM, we focused on pericytes, which are multipotent perivascular cells that contribute to the generation and repair of various tissues in response to injury. Although recent studies have shown that pericytes are involved in physiological mechanisms of erection, little is known about their detailed mechanisms. We have also added this rationale in discussion.

      Single cell level study has not been conducted in mouse penile tissues. Therefore, before delving into pericytes, we aimed to identify overall transcriptome differences between normal and diabetic conditions in mouse penile tissues. We presented the analyses of FB, which make up the largest proportion among the cell types in the mouse penis, in Fig. 1D-F. The analysis of other cell types is provided in Supplementary Fig. 1-4. Fig. 1G-H are GO terms for Fibroblasts clusters. We added this information in the figure.

      2) Fig 2 is the critical data to show Lbh is a cavernous PC specific marker. More PC violin plots to identify PC cluster such as Cspg4, Kcnj8, Higd1b, Cox4i2 and more SMC violin plots to identify SMC cluster such as Acta2, Myh11, Tagln, Actg2 should be used for inclusion and exclusion of PC( the same concern applied to human scRNAseq in Fig 5B).

      Answer: We appreciate this comment. We examined the expression of other marker genes of pericytes and SMCs. Although some marker genes were rarely expressed in the mouse penis data (Kcnj8, Higd1b), the expression of marker genes tended to be relatively high in each cluster. The expression of Cspg4 and Cox4i2 was higher in pericytes than in SMCs, while the expression of Acta2, Myh11,and Tagln was higher in SMCs than in pericytes. Actag2 was specifically expressed in SMCs. Through the gene set enrichment test as well as the expression of known cell type marker genes, we identified that the annotation of pericyte and SMC was appropriate (Fig. 2B and Fig. 5C). We added the violin plots of these marker genes in Supplementary Fig. 5.

      Author response image 1.

      (Mouse)

      In human penis data, ACTA2 and MYH11 were expressed in SMCs, pericytes, and myofibroblasts, as in the previous paper [PMID: 35879305]. Among pericyte markers, the number of cells expressing KCNJ8 and HIGD1B was small. The cluster we annotated as pericyte was double positive for pericyte markers CSPG4 and COX4I2. ACTG2, a marker for SMC, was expressed more highly in SMC than in pericytes and myofibroblasts. As in the mouse penis data, we identified that the annotation of each cell type was appropriate through the gene set enrichment test in the human penis data. We added the violin plots of CSPG4, COX4I2, and ACTG2 in Supplementary Fig. 11.

      Author response image 2.

      (Human)

      When exploring Lbh expression levels in "Database of gene expression in adult mouse brain and lung vascular and perivascular cells" from https://betsholtzlab.org/VascularSingleCells/database.html, Lbh is not uniquely expressed in PC, suggesting its tissue-specific expression level. This difference should be discussed in the Discussion section.

      Answer: We appreciate this valuable comment. For the answer to this comment, we extensively analyzed Lbh expression patterns in various mouse tissues using the public mouse single-cell atlas (Tabula Muris) as also suggested by Reviewer 2. Please see our detailed response in reviewer 2’s public review 1.

      3) In prior studies on PC morphology and location (PMID: 21839917), they reside in capillaries (diameter less than 10um) or distal vessels (diameter less than 25um) and have oval cell body and long processes. Due to the non-specificity of Pdgfrb, SMC are positive for Pdgfrb staining (this has been shown in many publications that SMC are Pdgfrb+; unfortunately, NG2 antibody also stains for both PC and SMC). Therefore, the LBH immunostaining (in Fig 2D and 2E of large-sized vessels) are very likely for SMC identity, not PC. PC should be in close contact with CD31+ ECs in healthy conditions. The LBH immunostaining of PC in both mouse and human tissues (Fig 4) must be replaced and better characterized.

      Answer: We agree with the reviewer's suggestion. As it is widely known, peicytes are primarily located in capillaries, where they surround endothelial cells of blood vessels. However, recent discoveries have identified cells with pericyte-like characteristics in the walls of large blood vessels, challenging the traditional concept [PMID: 27268036]. In our study, we observed minimal overlap in staining between LBH and α-SMA, suggesting that the cells expressing LBH were not smooth muscle cells but possibly pericyte-like cells in large vessels. In small vessels within the bladder, kidney, and even the aorta, we found LBH-expressing cells surrounding CD31-expressing vessels, consistent with the known characteristics of pericytes. Further research is needed to comprehend the differences in LBH expression and its characteristics in both large and small blood vessels. We have added discussions and references for this issue (Please see revised ‘Discussion’ and ‘Reference’)

      4) How do mouse cavernous pericytes isolate? How is purity?

      Answer: As the reviewer points out, we isolated mouse spongiform pericytes following our and other previously published methods. We used pigment epithelium-derived factor (PEDF), which removes non-pericytic cells [PMID: 30929324, 23493068]. Although there are no purity study results such as FACS, other staining results thoroughly support the notion that this method yields pericytes with a notably high level of purity. (Please see ‘Method’ section).

      5) Can mouse scRNAseq cell-cell communication in Fig 3 be reproducible in human scRNAseq cell-cell communication? The results in human ED are more clinically significant than in mouse data.

      Answer: In human scRNAseq data, the difference between angiogenesis-related interactions between normal and diabetes was not as significant as that in mouse data. Because the cell type composition of the human and mouse penis is not completely identical, there are limitations in comparing cell-cell interactions. However, in the human penis data, some interactions related to angiogenesis between pericytes and other cell types were decreased in diabetes compared to normal (boxed parts).

      Author response image 3.

      6) Fibroblasts also express Vim. Murine PC VIM/CRYAB( should be written as Vim/Cryab as mouse proteins) direct interaction with Lbh is unclear from Lbh IP as Fig 6A red boxes showed a wide range of sizes. Where is the band for Lbh? Do human PC LBH interact with VIM/CRYAB?

      Answer: We agree with the reviewer's comment. VIM is a type III intermediate filament protein expressed in many cell types. We have added the relevant controls (Input) and performed Co-IP (IP: CRYAB or VIM, WB: LBH) to demonstrate CRYAB and VIM are not simply cross-reactive antigens to their LBH antibody. In western blot study, the LBH band was expressed between 35 kDa-48 kDa. From Figure 6A, we detected CRYAB in band 1 and VIM in bands 2 and 3. This may be due to the formation of dimers or multimers by VIM. We did not use human PCs for IP studies because IP requires large amounts of protein, making IP studies using human pericyte challenging. Nevertheless, the interaction between LBH and CRYAB in humans has been reported through fluorescent resonance energy transfer assay and affinity chromatography technology assay [PMID:34000384, PMID:20587334].

      7) In Fig 6H and I, why does CRYAB expression significantly reduce in vitro and in vivo under diabetic conditions, whereas VIM expression significantly increases?

      Answer: As the reviewer pointed out, and we have discussed on this issue in the manuscript, CRYAB is known to promote angiogenesis. Diabetes reduces CRYAB expression, so angiogenesis may be impaired. Furthermore, since VIM is a multifunctional protein, it interacts with several other proteins with multiple functions under various pathophysiological conditions. There are many relevant literatures showing that VIM expression is increased under diabetic conditions [PMID: 28348116 and PMID: 32557212]. And VIM deficiency protects against obesity and insulin resistance in patients with type 2 diabetes. Therefore, we hypothesize that exogenous LBH may have the ability to bind to the increased VIM in diabetic conditions and inactivate the effects of VIM. Thereby achieving the protective effect. This needs to be proved in further studies.

      8) The therapeutic strategies targeting (Lbh-Cryab-Vim) on mouse diabetic ED model is not investigated and need to be further validated and discussed.

      Answer: As the reviewers pointed out, in this study, we did not evaluate the targeted therapeutic strategy for LBH-CRYAB-VIM in a mouse diabetic ED model. We only identified the binding potential of these three proteins. Evaluation of this treatment strategy requires further study. For example, we can employ shRNA lentivirus, either alone or in combination, to downregulate CRYABexpression [PMID: 31612679] in normal mice, utilize a lentiviral vector CMV-GFP-puro-vimentin to overexpress Vimentin [PMID: 36912679], and then treat it with LBH to evaluate whether the LBH effect still exists (in vivo erectile function study and in vitro angiogenesis assay). We include this information in the Discussion section as a limitation of this study (Please see revised ‘Discussion’).

      9) The Discussion of current knowledge of pericytes in diabetic ED and other diseases and the significance of this study as well as clinical implications, should be expanded.

      Answer: As the reviewers pointed out, we have expanded the current knowledge of pericytes in diabetic ED and other diseases (CNS disease) and clinical implications as follows: “Although other major cell populations in penile tissue such as smooth muscle cells, endothelial cell, and fibroblasts have been extensively studied, pericytes have mainly been investigated in the context of the central nervous system (CNS). For example, in the CNS, pericytes are involved in maintaining the integrity of the brain's blood-brain barrier (BBB), regulating blood flow at capillary junctions, and promoting neuroinflammatory processes, whose dysfunction is considered an important factor in the progression of vascular diseases such as Alzheimer's disease. But little is known about the role of pericytes in penile tissue.” (Please see revised ‘Discussion’).

      10) How many clinical samples were used? How many times did each experiment repeat?

      Answer: As the reviewers pointed out, the clinical samples’ information was added in ‘method’ section. A total four human samples were used in this study (‘human corpus cavernosum tissues were obtained from two patients with congenital penile curvature (59-year-old and 47-year-old) who had normal erectile function during reconstructive penile surgery and two patients with diabetic ED (69-year-old and 56-year-old) during penile prosthesis implantation.’). For in vivo study, we quantified four different fields from human samples.

      Minor concerns

      1) Fig 1A, why normal mouse's body size is the same as DM?

      Answer: As the reviewer pointed out, in Figure 1A, while the size of normal mice and DM mice may not appear significantly different, there are indeed notable difference in body weight and size. The normal mice body weigh we used was about 30 grams, while DM mice body weigh was generally less than 24 grams. We found that we missed information on physiological and metabolic parameters from in vivo studies (ICP function study). Therefore, we have added it in Supplementary Table 2 (Please see revised ‘Supplementary information’)

      2) The label and negative, and positive controls for Fig 6B are missing.

      Answer: We thank for pointing out this. We have added the relevant controls (Input) and performed Co-IP (IP: CRYAB or VIM1, WB: LBH) to demonstrate CRYAB and VIM1 are not simply cross-reactive antigens to their LBH antibody and all IP was replicated for at least 3 times. (Please see revised ‘Result’ and ‘Figure 6B’)

      3) The limitation of this study and future work should be discussed.

      Answer: As the reviewer pointed out, we have added the limitation of this study and future direction in the discussion section (Please see revised ‘Discussion’).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The authors report an fMRI investigation of the neural mechanisms by which selective attention allows capacity-limited perceptual systems to preferentially represent task-relevant visual stimuli. Specifically, they examine competitive interactions between two simultaneously-presented items from different categories, to reveal how task-directed attention to one of them modulates the activity of brain regions that respond to both. The specific hypothesis is that attention will bias responses to be more like those elicited by the relevant object presented on its own, and further that this modulation will be stronger for more dissimilar stimulus pairs. This pattern was confirmed in univariate analyses that measured the mass response of a priori regions of interest, as well as multivariate analyses that considered the patterns of evoked activity within the same regions. The authors follow these neuroimaging results with a simulation study that favours a "tuning" mechanism of attention (enhanced responses to highly effective stimuli, and suppression for ineffective stimuli) to explain this pattern.

      Strengths:

      The manuscript clearly articulates a core issue in the cognitive neuroscience of attention, namely the need to understand how limited perceptual systems cope with complex environments in the service of the observer's goals. The use of a priori regions of interest, and the inclusion of both univariate and multivariate analyses as well as a simple model, are further strengths. The authors carefully derive clear indices of attentional effects (for both univariate and multivariate analyses) which makes explication of their findings easy to follow.

      Weaknesses:

      There are some relatively minor weaknesses in presentation, where the motivation behind some of the procedural decisions could be clearer. There are some apparently paradoxical findings reported -- namely, cases in which the univariate response to pairs of stimuli is greater than to the preferred stimulus alone -- that are not addressed. It is possible that some of the main findings may be attributable to range effects: notwithstanding the paradox just noted, it seems that a floor effect should minimise the range of possible attentional modulation of the responses to two highly similar stimuli. One possible limitation of the modelled results is that they do not reveal any attentional modulation at all under the assumptions of the gain model, for any pair of conditions, implying that as implemented the model may not be correctly capturing the assumptions of that hypothesis.

      We thank the reviewer for the constructive comments. In response, in the current version of the manuscript we have improved the presentation. We further discuss how the response in paired conditions is in some cases higher than the response to the preferred stimulus in this letter. For this, we provide a vector illustration, and a supplementary figure of the sum of weights to show that the weights of isolated-stimulus responses for each category pair are not bound to the similarity of the two isolated responses.

      Regarding the simulation results, we have clarified that the univariate effect of attention is not the attentional modulation itself, but the change in the amount of attentional modulation in the two paired conditions. We provide an explanation for this in this letter below, and have changed the term “attentional modulation” to “univariate shift” in the manuscript to avoid the confusion.

      Reviewer #2 (Public Review):

      Summary:

      In an fMRI study requiring participants to attend to one or another object category, either when the object was presented in isolation or with another object superimposed, the authors compared measured univariate and multivariate activation from object-selective and early visual cortex to predictions derived from response gain and tuning sharpening models. They observed a consistent result across higher-level visual cortex that more-divergent responses to isolated stimuli from category pairs predicted a greater modulation by attention when attending to a single stimulus from the category pair presented simultaneously, and argue via simulations that this must be explained by tuning sharpening for object categories.

      Strengths:

      - Interesting experiment design & approach - testing how category similarity impacts neural modulations induced by attention is an important question, and the experimental approach is principled and clever.

      - Examination of both univariate and multivariate signals is an important analysis strategy.

      - The acquired dataset will be useful for future modeling studies.

      Weaknesses:

      - The experimental design does not allow for a neutral 'baseline' estimate of neural responses to stimulus categories absent attention (e.g., attend fixation), nor of the combination of the stimulus categories. This seems critical for interpreting results (e.g., how should readers understand univariate results like that plotted in Fig. 4C-D, where the univariate response is greater for 2 stimuli than one, but the analyses are based on a shift between each extreme activation level?).

      We are happy to clarify our research rationale. We aimed to compare responses in paired conditions when the stimuli were kept constant while varying the attentional target. After we showed that the change in the attentional target resulted in a response change , we compared the amount of this response change to different stimulus category pairs to investigate the effect of representation similarity between the target and the distractor on the response modulation caused by attentional shift. While an estimate of the neural responses in the absence of attention might be useful for other modeling studies, it would not provide us with more information than the current data to answer the question of this study.

      Regarding the univariate results in Fig. 4C-D (and other equivalent ROI results in the revised version) and our analyses, we did not impose any limit on the estimated weights of the two isolated responses in the paired response and thus the sum of the two weights could be any number. We however see that the naming of “weighted average”, which implies a sum of weights being capped at one, has been misleading . We have now changed the name of this model to “linear combination” to avoid confusion

      Previous studies (Reddy et al., 2009, Doostani et al., 2023) using a similar approach have shown a related results pattern: the response to multiple stimuli is higher than the average, but lower than the sum of the isolated responses, which is exactly what our results suggest. We have added discussion on this topic in the Results section in lines 409-413 for clarification:

      “Note that the response in paired conditions can be higher or lower than the response to the isolated more preferred stimulus (condition Mat), depending on the voxel response to the two presented stimuli, as previously reported (Doostani et al. 2023). This is consistent with previous studies reporting the response to multiple stimuli to be higher than the average, but lower than the sum of the response to isolated stimuli (Reddy et al. 2009).”

      We are not sure what the reviewer means by “each extreme activation level”. Our analyses are based on all four conditions. The two isolated conditions are used to calculate the distance measures and the two paired conditions are used for calculating the shift index. Please note that either the isolated or the paired conditions could show the highest response and we seeboth cases in our data. For example, as shown in Figure 4A in EBA, the isolated Body condition and the paired BodyatCar condition show the highest activation levels for the Body-Car pair, whereas in Figure 4C, the two paired conditions (BodyatCat and BodyCatat) elicit the highest response.

      - Related, simulations assume there exists some non-attended baseline state of each individual object representation, yet this isn't measured, and the way it's inferred to drive the simulations isn't clearly described.

      We agree that the simulations assume a non-attended baseline state, and that we did not measure that state empirically. We needed this non-attended response in the simulations to test which attention mechanism led to the observed results. Thus, we generated the non-attended response using the data reported in previous neural studies of object recognition and attention in the visual cortex (Ni et al., 2012, Bao and Tsao, 2018). Note that the simulations are checking for the profile of the modulations based on category distance. Thus, they do not need to exactly match the real isolated responses in order to show the effect of gain and tuning shift on the results. We include the clarification and the range of neural responses and attention parameters used in the simulations in the revised manuscript in lines 327-333:

      “To examine which attentional mechanism leads to the effects observed in the empirical data, we generated the neural response to unattended object stimuli as a baseline response in the absence of attention, using the data reported by neural studies of object recognition in the visual cortex (Ni et al., 2012, Bao and Tsao, 2018). Then, using an attention parameter for each neuron and different attentional mechanisms, we simulated the response of each neuron to the different task conditions in our experiment. Finally, we assessed the population response by averaging neural responses.”

      - Some of the simulation results seem to be algebraic (univariate; Fig. 7; multivariate, gain model; Fig. 8)

      This is correct. We have used algebraic equations for the effect of attention on neural responses in the simulations. In fact, thinking about the two models of gain and tuning shift leads to the algebraic equations, which in turn logically leads to the observed results, if no noise is added to the data. The simulations are helpful for visualizing these logical conclusions. Also, after assigning different noise levels to each condition for each neuron, the results are not algebraic anymore which is shown in updated Figure 7 and Figure 8.

      - Cross-validation does not seem to be employed - strong/weak categories seem to be assigned based on the same data used for computing DVs of interest - to minimize the potential for circularity in analyses, it would be better to define preferred categories using separate data from that used to quantify - perhaps using a cross-validation scheme? This appears to be implemented in Reddy et al. (2009), a paper implementing a similar multivariate method and cited by the authors (their ref 6).

      Thank you for pointing out the missing details about how we used cross-validation. In the univariate analysis, we did use cross validation, defining preferred categories and calculating category distance on one half of the data and calculating the univariate shift on the other half of the data. Similarly, we employed cross-validation for the multivariate analysis by using one half of the data to calculate the multivariate distance between category pairs, and the other half of the data to calculate the weight shift for each category pair. We have now added this methodological information in the revised manuscript.

      - Multivariate distance metric - why is correlation/cosine similarity used instead of something like Euclidean or Mahalanobis distance? Correlation/cosine similarity is scale-invariant, so changes in the magnitude of the vector would not change distance, despite this likely being an important data attribute to consider.

      Since we are considering response patterns as vectors in each ROI, there is no major difference between the two measures for similarity. Using euclidean distance as a measure of distance (i.e. inverse of similarity) we observed the same relationship between weight shift and category euclidean distance. There was a positive correlation between weight shift and the euclidean category distance in all ROIs ( ps < 0.01, ts > 2.9) except for V1 (p = 0.5, t = 0.66). We include this information in the revised manuscript in the Results section lines 513-515:

      “We also calculated category distance based on the euclidean distance between response patterns of category pairs and observed a similarly positive correlation between the weight shift and the euclidean category distance in all ROIs (ps < 0.01, ts >2.9) except V1 ( p = 0.5, t = 0.66).”

      - Details about simulations implemented (and their algebraic results in some cases) make it challenging to interpret or understand these results. E.g., the noise properties of the simulated data aren't disclosed, nor are precise (or approximate) values used for simulating attentional modulations.

      We clarify that the average response to each category was based on previous neurophysiology studies (Ni et al., 2012, Bao and Tsao, 2018). The attentional parameter was also chosen based on previous neurophysiology (Ni et al., 2012) and human fMRI (Doostani et al., 2023) studies of visual attention by randomly assigning a value in the range from 1 to 10. We have included the details in the Methods section in lines 357-366:

      “We simulated the action of the response gain model and the tuning sharpening model using numerical simulations. We composed a neural population of 4⨯105 neurons in equal proportions body-, car-, cat- or house-selective. Each neuron also responded to object categories other than its preferred category, but to a lesser degree and with variation. We chose neural responses to each stimulus from a normal distribution with the mean of 30 spikes/s and standard deviation of 10 and each neuron was randomly assigned an attention factor in the range between 1 and 10 using a uniform distribution. These values are comparable with the values reported in neural studies of attention and object recognition in the ventral visual cortex (Ni et al. 2012, Bao and Tsao 2018). We also added poisson noise to the response of each neuron (Britten et al. 1993), assigned randomly for each condition of each neuron.”

      - Eye movements do not seem to be controlled nor measured. Could it be possible that some stimulus pairs result in more discriminable patterns of eye movements? Could this be ruled out by some aspect of the results?

      Subjects were instructed to direct their gaze towards the fixation point. Given the variation in the pose and orientation of the stimuli, it is unlikely that eye movements would help with the task. Eye movements have been controlled in previous experiments with individual stimulus presentation (Xu and Vaziri-Pashkam, 2019) and across attentional tasks in which colored dots were superimposed on the stimuli (Vaziri-Pashkam and Xu, 2017) and no significant difference for eye movement across categories or conditions was observed. As such, we do not think that eye movements would play a role in the results we are observing here.

      - A central, and untested/verified, assumption is that the multivariate activation pattern associated with 2 overlapping stimuli (with one attended) can be modeled as a weighted combination of the activation pattern associated with the individual stimuli. There are hints in the univariate data (e.g., Fig. 4C; 4D) that this might not be justified, which somewhat calls into question the interpretability of the multivariate results.

      If the reviewer is referring to the higher response in the paired compared to the isolated conditions, as explained above, we have not forced any limit on the sum of the estimated weights to equal 1 or 2. Therefore, our model is an estimation of a linear combination of the two multivariate patterns in the isolated conditions. In fact, Leila Reddy et al. (reference 6) reported that while the combination is closer to a weighted average than to a weighted sum, the sum of the weights are on average larger than 1. In Figure 4C and 4D the responses in the paired conditions are higher than either of the isolated-condition responses. This suggests that the weights for the linear combination of isolated responses in the multivariate analysis should add up to larger than one. This is what we find in our results. We have added a supplementary figure to Figure 6, depicting the sum of weights for different category pairs in all ROIs. The figure illustrates that in each ROI, the sum of weights are greater than 1 for some category pairs. It is however noteworthy that we normalized the weights in each condition by the sum of weights to calculate the weight shift in our analysis. The amount of the weight shift was therefore not affected by the absolute value of the weights.

      - Throughout the manuscript, the authors consistently refer to "tuning sharpening", an idea that's almost always used to reference changes in the width of tuning curves for specific feature dimensions (e.g., motion direction; hue; orientation; spatial position). Here, the authors are assaying tuning to the category (across exemplars of the category). The link between these concepts could be strengthened to improve the clarity of the manuscript.

      The reviewer brings up an excellent point. Whereas tuning curves have been extensively used for feature dimensions such as stimulus orientation or motion direction, here, we used the term to describe the variation in a neuron’s response to different object stimuli.

      With a finite set of object categories, as is the case in the current study, the neural response in object space is discrete, rather than a continuous curve illustrated for features such as stimulus orientation. However, since more preferred and less preferred features (objects in this case) can still be defined, we illustrated the neural response using a hypothetical curve in object space in Figure 3 to show how it relates with other stimulus features. Therefore, here, tuning sharpening refers to the fact that the response to the more preferred object categories has been enhanced while the response to the less preferred stimulus categories is suppressed.

      We clarify this point in the revised manuscript in the Discussion section lines 649-659:

      “While tuning curves are commonly used for feature dimensions such as stimulus orientation or motion direction, here, we used the term to describe the variation in a neuron’s response to different object stimuli. With a finite set of object categories, as is the case in the current study, the neural response in object space is discrete, rather than a continuous curve illustrated for features such as stimulus orientation. The neuron might have tuning for a particular feature such as curvature or spikiness (Bao et al., 2020) that is present to different degrees in our object stimuli in a continuous way, but we are not measuring this directly. Nevertheless, since more preferred and less preferred features (objects in this case) can still be defined, we illustrate the neural response using a hypothetical curve in object space. As such, here, tuning sharpening refers to the fact that the response to the more preferred object categories has been enhanced while the response to the less preferred stimulus categories is suppressed.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      a. The authors should address the apparent paradox noted above (and report whether it is seen in other regions of interest as well). On what model would the response to any pair of stimuli exceed that of the response to the preferred stimulus alone? This implies some kind of Gestalt interaction whereby the combined pair generates a percept that is even more effective for the voxels in question than the "most preferred" one?

      The response to a pair of stimuli can exceed the response to each of the stimuli presented in isolation if the voxel is responsive to both stimuli and as long as the voxel has not reached its saturation level. This phenomenon has been reported in many previous studies (Zoccolan et al., 2005, Reddy et al., 2009, Ni et al., 2012, Doostani et al., 2023) and can be modeled using a linear combination model which does not limit the weights of the isolated responses to equal 1 (Doostani et al., 2023). Note that the “most preferred” stimulus does not necessarily saturate the voxel response, thus the response to two stimuli could be more effective based on voxel responsiveness to the second stimulus.

      As for the current study, the labels “more preferred” and “less preferred” are only relatively defined (as explained in the Methods section), meaning that the more preferred stimulus is not necessarily the most preferred stimulus for the voxels. Furthermore, the presented stimuli are semi-transparent and presented with low-contrast, which moves the responses further away from the saturation level. Based on reported evidence for multiple-stimulus responses, responses to single stimuli are in many cases sublinearly added to yield the multiple-stimulus response (Zoccolan et al., 2005, Reddy et al., 2009, Doostani et al., 2023). This means that the multiple-stimulus response is lower than the sum of the isolated responses and not lower than each of the isolated responses. Therefore, it is not paradoxical to observe higher responses in paired conditions compared to the isolated conditions. We observe similar results in other ROIs, which we provide as supplementary figures to Figure 4 in the revised manuscript.

      We address this observation and similar reports in previous studies in the Results section of the revised manuscript in lines 409-413:

      “Note that the response in paired conditions can be higher or lower than the response to the isolated more preferred stimulus (condition Mat), depending on the voxel preference for the two presented stimuli, as previously reported (Doostani et al., 2023). This is consistent with previous studies reporting the response to multiple stimuli to be higher than the average, but lower than the sum of the response to isolated stimuli (Reddy et al., 2009).”

      b. Paradox aside, I wondered to what extent the results are in part explained by range limits. Take two categories that evoke a highly similar response (either mean over a full ROI, or in the multivariate sense). That imposes a range limit such that attentional modulation, if it works the way we think it does, could only move responses within that narrow range. In contrast, the starting point for two highly dissimilar categories leaves room in principle for more modulation.

      We do not believe that the results can be explained by range limits because responses in paired conditions are not limited by the isolated responses, as can be observed in Figure 4. However, to rule out the possibility of the similarity between responses in isolated conditions affecting the range within which responses in paired conditions can change, we turned to the multivariate analysis. We used the weight shift measure as the change in the weight of each stimulus with the change in the attentional target. In this method, no matter how close the two isolated vectors are, the response to the pair could still have a whole range of different weights of the isolated responses. We have plotted an example illustration of two-dimensional vectors for better clarification. Here, the vectors Vxat and Vyat denote the responses to the isolated x and y stimuli, respectively, and the vector Pxaty denotes the response to the paired condition in which stimulus x is attended. The weights a1 and a2 are illustrated in the figure, which are equal to regression coefficients if we solve the equation Pxaty \= [a1 a2] [x y]’. While the weight values depend on the amplitude of and the angle between the three vectors, they are not limited by a lower angle between Vxat and Vyat.

      We have updated Figure 2 in the manuscript to avoid the confusion. We have also added a figure including the sum of weights for different category pairs in different regions, showing that the sum of weights are not dependent on the similarity between the two stimuli. The conclusions based on the weight shift are therefore not confounded by the similarity between the two stimuli.

      c. Finally, related to the previous point, while including V1 is a good control, I wonder if it is getting a "fair" test here, because the range of responses to the four categories in this region, in terms of (dis)similarity, seems compressed relative to the other categories.

      We believe that V1 is getting a fair test because the single-subject range of category distance in V1 is similar to LO, as can be observed Author response image 1_:_

      Author response image 1.

      Range of category distance in each ROI averaged across participants

      The reason that V1 is showing a more compressed distance range on the average plot is that the category distance in V1 is not consistent among participants. Although the average plots are shown in Figure 5 and Figure 6, we tested statistical significance in each ROI based on single-subject correlation coefficients.

      Please also note that a more compressed range of dissimilarity does not necessarily lead to a less strong effect of category distance on the effect of attention. For instance, while LO shows a more compressed dissimilarity range for the presented categories compared to the other object selective regions, it shows the highest correlation between weight shift and category distance. Furthermore, as illustrated in Figure 5, no significant correlation is observed between univariate shift and category distance in V1, even though the range of the univariate distance in V1 is similar to LO and pFs, where we observed a significant correlation between category distance and univariate shift.

      d. In general, the manuscript does a very good job explaining the methods of the study in a way that would allow replication. In some places, the authors could be clearer about the reasoning behind those methodological choices. For example: - How was the sample size determined?

      Estimating conservatively based on the smallest amount of attentional modulation we observed in a previous study (Doostani et al., 2023), we chose a medium effect size (0.3). For a power of 0.8, the minimum number of participants should be 16. We have added the explanation to the Methods section in lines 78-81:

      “We estimated the number of participants conservatively based on the smallest amount of attentional modulation observed in our previous study (Doostani et al., 2023). For a medium effect size of 0.3 and a power of 0.8, we needed a minimum number of 16 participants.”

      - Why did the authors choose those four categories? What was the evidence that would suggest these would span the range of similarities needed here?

      We chose these four categories based on a previous behavioral study reporting the average reaction time of participants when detecting a target from one category among distractors from another category (Xu and Vaziri-Pashkam, 2019). Ideally the experiment should include as many object categories as possible. However, since we were limited by the duration of the experiment, the number of conditions had to be controlled, leading to a maximum of 4 object categories. We chose two animate and two inanimate object categories to include categories that are more similar and more different based on previous behavioral results (Xu and Vaziri-Pashkam, 2019). We included body and house categories because they are both among the categories to which highly responsive regions exist in the cortex. We chose the two remaining categories based on their similarity to body and house stimuli. In this way, for each category there was another category that elicited similar cortical responses, and two categories that elicited different responses. While we acknowledge that the chosen categories do not fully span the range of similarities, they provide an observable variety of similarities in different ROIs which we find acceptable for the purposes of our study.

      We include this information in the Methods section of the revised manuscript in lines 89-94:

      “We included body and house categories because there are regions in the brain that are highly responsive and unresponsive to each of these categories, which provided us with a range of responsiveness in the visual cortex. We chose the two remaining categories based on previous behavioral results to include categories that provided us with a range of similarities (Xu and Vaziri-Pashkam, 2019). Thus, for each category there was a range of responsiveness in the brain and a range of similarity with the other categories.”

      - Why did the authors present the stimuli at the same location? This procedure has been adopted in previous studies, but of course, it does also move the stimulus situation away from the real-world examples of cluttered scenes that motivate the Introduction.

      We presented the stimuli at the same location because we aimed to study the mechanism of object-based attention and this experimental design helped us isolate it from spatial attention. We do not think that our design moves the stimulus situation away from real-world examples in such a way that our results are not generalizable. We include real-world instances, as well as a discussion on this point, in the Discussion section of the revised manuscript, in lines 611-620:

      “Although examples of superimposed cluttered stimuli are not very common in everyday life, they still do occur in certain situations, for example reading text on the cellphone screen in the presence of reflection and glare on the screen or looking at the street through a patterned window. Such instances recruit object-based attention which was the aim of this study, whereas in more common cases in which attended and unattended objects occupy different locations in space, both space-based and object-based attention may work together to resolve the competition between different stimuli. Here we chose to move away from usual everyday scenarios to study the effect of object-based attention in isolation. Future studies can reveal the effect of target-distractor similarity, i.e. proximity in space, on space-based attention and how the effects caused by object-based and space-based attention interact.”

      - While I'm not concerned about this (all relevant comparisons were within-participants) was there an initial attempt to compare data quality from the two different scanners?

      We compared the SNR values of the two groups of participants and observed no significant difference between these values (ps > 0.34, ts < 0.97). We have added this information to the Methods section.

      Regarding the observed effect, we performed a t-test between the results of the participants from the two scanners. For the univariate results, the observed correlation between univariate attentional modulation and category distance was not significantly different for participants of the two scanners in any ROIs (ps > 0.07 , ts < 1.9). For the multivariate results, the observed correlation between the weight shift and multivariate category distance was not significantly different in any ROIs (ps > 0.48 , ts < 0.71) except for V1 (p-value = 0.015 , t-value = 2.75).

      We include a sentence about the comparison of the SNR values in the preprocessing section in the revised manuscript.

      e. There are a couple of analysis steps that could be applied to the existing data that might strengthen the findings. For one, the authors have adopted a liberal criterion of p < 0.001 uncorrected to include voxels within each ROI. Why, and to what extent is the general pattern of findings robust over more selective thresholds? Also, there are additional regions that are selective for bodies (fusiform body area) and scenes (occipital place area and retrosplenial cortex). Including these areas might provide more diversity of selectivity patterns (e.g. different responses to non-preferred categories) that would provide further tests of the hypothesis.

      We selected this threshold to allow for selection of a reasonable number of voxels in each hemisphere across all participants. To check whether the effect is robust over more selective thresholds, we exemplarily redefined the left EBA region using p < 0.0001 and p < 0.00001 and observed that the weight shift effect remained equivalent. We have made a note of this analysis in the Results section. As for the additional regions suggested by the reviewer, we chose not to include them because they could not be consistently defined in both hemispheres of all participants. Please note that the current ROIs also show different responses to non-preferred categories (e.g. in LO and pFs). We include this information in the Methods section in lines 206-207:

      “We selected this threshold to allow for selection of a reasonable number of voxels in each hemisphere across all participants.”

      And in the Results section in lines 509-512:

      “We performed the analysis including only voxels that had a significantly positive GLM coefficient across the runs and observed the same results. Moreover, to check whether the effect is robust over more selective thresholds for ROI definition, we redefined the left EBA region with p < 0.0001 and p < 0.00001 criteria. We observed a similar weight shift effect for both criteria.”

      f. One point the authors might address is the potential effect of blocking the paired conditions. If I understood right, the irrelevant item in each paired display was from the same category throughout a block. To what extent might this knowledge shape the way participants attend to the task-relevant item (e.g. by highlighting to them certain spatial frequencies or contours that might be useful in making that particular pairwise distinction)? In other words, are there theoretical reasons to expect different effects if the irrelevant category is not predictable?

      We believe that the participants’ knowledge about the distractor does not significantly affect our results because our results are in agreement with previous behavioral data (Cohen et al., 2014, Xu and Vaziri-Pashkam, 2019), in which the distractor could not be predicted. These reports suggest there is a theoretical reason to expect similar effects if the participants could not predict the distractor. To directly test this, one would need to perform an fMRI experiment using an event-related design, an interesting venue for future research.

      We have made a note of this point in the Discussion section of the revised manuscript in lines 621-626:

      “Please note that we used a blocked design in which the target and distractor categories could be predicted across each block. While it is possible that the current design has led to an enhancement of the observed effect, previous behavioral data (Cohen et al., 2014, Xu and Vaziri-Pashkam, 2019) have reported the same effect in experiments in which the distractor was not predictable. To study the effect of predictability on fMRI responses, however, an event-related design is more appropriate, an interesting venue for future fMRI studies.”

      g. The authors could provide behavioural data as a function of the specific category pairs. There is a clear prediction here about which pairs should be more or less difficult.

      We provide the behavioral data as a supplementary figure to Figure 1 in the revised manuscript. We however do not see differences in behavior for the different category paris. This is so because our fMRI task was designed in a way to make sure the participants could properly attend to the target for all conditions. The task was rather easy across all conditions and due to the ceiling effect, there was no significant difference between behavioral performance for different category pairs. However, the effect of category pair on behavior has been previously tested and reported in a visual search paradigm with the same categories (Xu and Vaziri-Pashkam, 2019), which was in fact the basis for our choice of categories in this study (as explained in response to point “d” above).

      h. Figure 4 shows data for EBA in detail; it would be helpful to have a similar presentation of the data for the other ROIs as well.

      We provide data for all ROIs as figure supplements 1-4 to Figure 4 in the revised manuscript.

      i. For the pFs and LOC ROIs, it would be helpful to have an indication of what proportion of voxels was most/least responsive to each of the four categories. Was this a relatively even balance, or generally favouring one of the categories?

      In LO, the proportion of voxels most responsive to each of the four categories was relatively even for Body (31%) and House (32%) stimuli, which was higher than the proportion of Car- and Cat-preferring voxels (18% and 19%, respectively). In pFs, 40% of the voxels were house-selective, while the proportion was relatively even for voxels most responsive to bodies, cars, and houses with 21%, 17%, and 22% of the voxels, respectively. We include the percentage of voxels most responsive to each of the four categories in each ROI as Appendix 1-table 1.

      j. Were the stimuli in the localisers the same as in the main experiment?

      No, we used different sets of stimuli for the localizers and the main experiment. We have added the information in line 146 of the Methods section.

      Reviewer #2 (Recommendations For The Authors):

      (1) Why are specific ROIs chosen? Perhaps some discussion motivating these choices, and addressing the possible overlap between these and retinotopic regions (based on other studies, or atlases - Wang et al, 2015) would be useful.

      Considering that we used object categories, we decided to look at general object-selective regions (LO, pFS) as well as regions that are highly selective for specific categories (EBA, PPA). We also looked at the primary visual cortex as a control region. We have added this clarification in the Methods section lines 128-133:

      “Considering that we used object categories, we investigated five different regions of interest (ROIs): the object-selective areas lateral occipital cortex (LO) and posterior fusiform (pFs) as general object-selective regions, the body-selective extrastriate body area (EBA) and the scene-selective parahippocampal place area (PPA) as regions that are highly selective for specific categories, and the primary visual cortex (V1) as a control region. We chose these regions because they could all be consistently defined in both hemispheres of all participants and included a large number of voxels.”

      (2) The authors should consider including data on the relative prevalence of voxels preferring each category for each ROI (and/or the mean activation level across voxels for each category for each ROI). If some ROIs have very few voxels preferring some categories, there's a chance the observed results are a bit noisy when sorting based on those categories (e.g., if a ROI has essentially no response to a given pair of categories, then there's not likely to be much attentional modulation detectable, because the ROI isn't driven by those categories to begin with).

      We thank the reviewer for the insightful comment.

      We include the percentage of voxels most responsive to each of the four categories in each ROI in the Appendix ( Appendix 1-table 1, please see the answer to point “i” of the first reviewer).

      We also provide a table of average activity across voxels for each category in all ROIs as Appendix 1-table 2.

      As shown in the table, voxels show positive activity for all categories in all ROIs except for PPA, where voxels show no response to body and cat stimuli. This might explain why we observed a marginally significant correlation between weight shift and category distance in PPA only. As the reviewer mentions, since this region does not respond to body and cat stimuli, we do not observe a significant change in response due to the shift in attention for some pairs. We include the table in the Appendix and add the explanation to the Results section of the revised manuscript in lines 506-508:

      _“_Less significant results in PPA might arise from the fact that PPA shows no response to body and cat stimuli and little response to car stimuli (Appendix 1-table 2). Therefore, it is not possible to observe the effect of attention for all category pairs.”

      a. Related - would it make sense to screen voxels for inclusion in analysis based on above-basely activation for one or both of the categories? [could, for example, imagine you're accidentally measuring from the motor cortex - you'd be able to perform this analysis, but it would be largely nonsensical because there's no established response to the stimuli in either isolated or combined states].

      We performed all the analyses including only voxels that had a significantly positive GLM coefficient across the runs and the results remained the same. We have added the explanation in the Results section in line 509-510.

      (3) Behavioral performance is compared against chance level, but it doesn't seem that 50% is chance for the detection task. The authors write on page 4 that the 1-back repetition occurred between 2-3 times per block, so it doesn't seem to be the case that each stimulus had a 50% chance of being a repetition of the previous one.

      We apologize for the mistake in our report. We have reported the detection rate for the target-present trials (2-3 per block), not the behavioral performance across all trials. We have modified the sentence in the Results section.

      (4) Authors mention that the stimuli are identical for 2-stimulus trials where each category is attended (for a given pair) - but the cue is different, and the cue appears as a centrally-fixated word for 1 s. Is this incorporated into the GLM? I can't imagine this would have much impact, but the strict statement that the goals of the participant are the only thing differentiating trials with otherwise-identical stimuli isn't quite true.

      The word cue was not incorporated as a separate predictor into the GLM. As the reviewer notes, the signals related to the cue and stimuli are mixed. But given that the cues are brief and in the form of words rather than images, they are unlikely to have an effect on the response in the regions of interest.

      To be more accurate, we have included the clarification in the Methods section in lines 181-182:

      “We did not enter the cue to the GLM as a predictor. The obtained voxel-wise coefficients for each condition are thus related to the cue and the stimuli presented in that condition.”

      And in the Results section in lines 425-428 :

      “It is important to note that since the cue was not separately modeled in the GLM, the signals related to the cue and the stimuli were mixed. However, given that the cues were brief and presented in the form of words, they are unlikely to have an effect on the responses observed in the higher-level ROIs.”

      (5) Eq 5: I expected there to be some comparison of a and b directly as ratios (e.g., a_1 > b_1, as shown in Fig. 2). The equations used here should be walked through more carefully - it's very hard to understand what this analysis is actually accomplishing. I'm not sure I follow the explanation of relative weights given by the authors, nor how that maps onto the delta_W quantity in Equation 5.

      We provide a direct comparison of a and b, as well as a more thorough clarification of the analysis, in the Methods section in lines 274-276:

      “We first projected the paired vector on the plane defined by the isolated vectors (Figure 2A) and then determined the weight of each isolated vector in the projected vector (Figure 2B).”

      And in lines 286-297:

      “A higher a1 compared to a2 indicates that the paired response pattern is more similar to Vxat compared to Vyat, and vice versa. For instance, if we calculate the weights of the Body and Car stimuli in the paired response related to the simultaneous presentation of both stimuli, we can write in the LO region: VBodyatCar \= 0.81 VBody + 0.31 VCar, VBodyCarat \= 0.43 VBody + 0.68 VCar. Note that these weights are averaged across participants. As can be observed, in the presence of both body and car stimuli, the weight of each stimulus is higher when attended compared to the case when it is unattended. In other words, when attention shifts from body to car stimuli, the weight of the isolated body response (VBody) decreases in the paired response. We can therefore observe that the response in the paired condition is more similar to the isolated body response pattern when body stimuli are attended and more similar to the isolated car response pattern when car stimuli are attended.”

      And lines 303-306:

      “As shown here, even when body stimuli are attended, the effect of the unattended car stimuli is still present in the response, shown in the weight of the isolated car response (0.31). However, this weight increases when attention shifts towards car stimuli (0.68 in the attended case).”

      We also provide more detailed clarification for the 𝛥w and the relative weights in lines 309-324:

      “To examine whether this increase in the weight of the attended stimulus was constant or depended on the similarity of the two stimuli in cortical representation, we defined the weight shift as the multivariate effect of attention:

      𝛥w = a1/(a1+a2) – b1/(b1+b2)                                                                                          (5)

      Here, a1, a2, b1,and b2 are the weights of the isolated responses, estimated using Equation 4. We calculate the weight of the isolated x response once when attention is directed towards x (a1), and a second time when attention is directed towards y (b1). In each case, we calculate the relative weight of the isolated x in the paired response by dividing the weight of the isolated x by the sum of weights of x and y (a1+a2 when attention is directed towards x, and b1+b2 when attention is directed towards y). We then define the weight shift, Δw, as the change in the relative weight of the isolated x response in the paired response when attention shifts from x to y. A higher Δw for a category pair indicates that attention is more efficient in removing the effect of the unattended stimulus in the pair. We used relative weights as a normalized measure to compensate for the difference in the sum of weights for different category pairs. Thus, using the normalized measure, we calculated the share of each stimulus in the paired response. For instance, considering the Body-Car pair, the share of the body stimulus in the paired response was equal to 0.72 and 0.38, when body stimuli were attended and unattended, respectively. We then calculated the change in the share of each stimulus caused by the shift in attention using a simple subtraction ( Equation 5: Δw=0.34 for the above example of the Body-Car pair in LO) and used this measure to compare between different pairs.”

      We hope that this clarification makes it easier to understand the multivariate analysis and the weight shift calculation in Equation 5.

      We additionally provide the values of the weights (a1, b1, a2, and b2 ) for each category pair averaged across participants as Appendix 1 -table 4.

      (6) For multivariate analyses (Fig. 6A-E), x axis is normalized (pattern distance based on Pearson correlation), while the delta_W does not seem to be similarly normalized.

      We calculated ΔW by dividing the weights in each condition by the sum of weights in that condition. Thus, we use relative weights which are always in the range of 0 to 1, and ΔW is thus always in the range of -1 to 1. This means that both axes are normalized. Note that even if one axis were not normalized, the relationship between the independent and the dependent variables would remain the same despite the change in the range of the axis.

      (7) Simulating additional scenarios like attention to both categories just increasing the mean response would be helpful - is this how one would capture results like those shown in some panels of Fig. 4?

      We did not have a condition in which participants were asked to attend to both categories. Therefore it was not useful for our simulations to include such a scenario. Please also note that the goal of our simulations is not to capture the exact amount of attentional modulation, but to investigate the effect of target-distractor similarity on the change in attentional modulation (univariate shift and weight shift).

      As for the results in some panels of Figure 4, we have explained the reason underlying higher responses in paired conditions compared to isolated conditions) in response to the “weaknesses” section of the second reviewer. We hope that these points satisfy the reviewer’s concern regarding the results in Figure 4 and our simulations.

      (8) Lines 271-276 - the "latter" and "former" are backwards here I think.

      We believe that the sentence was correct, but confusing.. We have rephrased the sentence to avoid the confusion in lines 371-376 of the revised manuscript:

      “We modeled two neural populations: a general object-selective population in which each voxel shows preference to a particular category and voxels with different preferences are mixed in with each other (similar to LO and pFS), and a category-selective population in which all voxels have a similar preference for a particular category (similar to EBA and PPA).”

      (9) Line 314 - "body-car" pair is mentioned twice in describing the non-significant result in PPA ROI.

      Thank you for catching the typo. We have changed the second Body-Car to Body-Cat.

      (10) Fig. 5 and Fig. 6 - I was expecting to see a plot that demonstrated variability across subjects rather than across category pairs. Would it be possible to show the distribution of each pair's datapoints across subjects, perhaps by coloring all (e.g.) body-car datapoints one color, all body-cat datapoints another, etc? This would also help readers better understand how category preferences (which differ across ROIs) impact the results.

      We demonstrated variability across category pairs rather than subjects because we aimed to investigate how the variation in the similarity between categories (i.e. category distance) affected the univariate and multivariate effects of attention. The variability across subjects is reflected in the error bars in the bar plots of Figure 5 and Figure 6.

      Here we show the distribution of each category pair’s data points across subjects by using a different color for each pair:

      Author response image 2.

      Univariate shift versus category distance including single-subject data points in all ROIs.

      Author response image 3.

      Weight shift versus category distance including single-subject data points in all ROIs.

      As can be observed in the figures, category preference has little impact on the results. Rather, the similarity in the preference (in the univariate case) or the response pattern (in the multivariate case) to the two presented categories is what impacts the amount of the univariate shift and the weight shift, respectively. For instance, in EBA we observe a low amount of attentional shift both for the Body-Cat pair, with two stimuli for which the ROI is highly selective, and the Car-House pair, including stimuli to which the region shows little response. A similar pattern is observed in the object-selective regions LO and pFs which show high responses to all stimulus categories.

      We believe that the figures including the data points related to all subjects are not strongly informative. However, we agree that using different colors for each category pair helps the readers better understand that category preference has little impact on the results in different ROIs. We therefore present the colored version of Figure 5 and Figure 6 in the revised manuscript, with a different color for each category pair.

      (11) Fig. 5 and Fig. 6 use R^2 as a dependent variable across participants to conclude a positive relationship. While the positive relationship is clear in the scatterplots, which depict averages across participants for each category pair, it could still be the case that there are a substantial number of participants with negative (but predictive, thus high positive R^2) slopes. For completeness and transparency, the authors should illustrate the average slope or regression coefficient for each of these analyses.

      We concluded the positive relationship and calculated the significance in Figure 5 and Figure 6 using the correlation r rather than r.^2 This is why the result was not significantly positive in V1. We acknowledge that the use of r-squared in the bar plot leads to confusion. We have therefore changed the bar plots to show the correlation coefficient instead of the r-squared. Furthermore, we have added a table of the correlation coefficient for all participants in all ROIs for the univariate and weight shift analyses supplemental to Figure 5 and Figure 6, respectively.

      (12) No statement about data or analysis code availability is provided

      Thanks for pointing this out. The fMRI data is available on OSF. We have added a statement about it in the Data Availability section of the revised manuscript in line 669.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer#1:

      Comment #1: It is unclear how the fraction of NK cell populations is quantified in the spatial-seq datasets. Figures display spatial data with expression scores, but the method for calculating the score and determining NK cell presence in tumor tissue is ambiguous. Clarification is needed on whether the identification relied solely on visual inspection or if quantitative analyses using other criteria were conducted.

      Thank you for your questions. We removed the background and made the accordingly modifications according to your demand. We used the AddModuleScore function in Seurat to quantify the main immune subpopulations in spatial-seq using the gene sets identified in single-cell-seq. Additionally, the tumor and non-tumor region was identified by immunohistochemistry as well as cell clusters in spatial-seq, it is rough that we can't quantify the NK cell presence in each region precisely. The consolation is that the differences of NK cell presence in tumor and non-tumor region is observable by visual inspection. The methodology has been supplemented in the revised manuscript (line 190-193).

      Comment #2: The authors do not provide a clear definition of "resting" NK cells. It remains unclear whether they refer to a senescent state or a non-matured NK cell population. Furthermore, the criteria used to define resting and activated cells based on the expression of KIR2DL4, GPR183, GRP171, CD69, IFNG, GZMK, TTC38, CD160, and PLEKNF1 in Figure 4 are not well-defined. The expression patterns of these genes in Figure 4D are not distinct, and it is unclear which combination of genes was used to classify the populations. Clarification is needed on whether the presence of GZMK alone defines resting NK cells, or if the presence of any of the described genes (GZMK, TTC38, or CD160) is sufficient. Additionally, the method used for this classification, whether visual or algorithm-based, should be described.

      Thank you for your question. The resting and activated NK cells was defined by the preferential expression of the described resting genes (AZU, BPI, CAMP, CD160,CD2, CDHR1, CEACAM8, DEFA4, ELANE, GFI1, GZMK, KLRC4, MGAM, MS4A3, NME8, PLEKHF1, TEP1, TRBC1, TTC38, ZNF135) and activated NK genes (APOBEC3G, APOL6, CCL4, CCND2, CD69, CDK6, CSF2, DPP4, FASLG, GPR171, GPR18, GRAP2, IFNG, KIR2DL4, KIR2DS4, LTA, LTB, NCR3, OSM, PTGER2, SOCS1, TNFSF14) in CIBERSORT. Actually, these marker genes were not specifically expressed in a single NK cells subset. On the other hand, combined with further flow cytometric analysis verification, the resting NK cell tend to be a decidual-like NK cells and tumor- infiltrated NK cells with higher expression of CD9, CD49a and PD-1.

      Comment #3: Criteria used to define high or low NK cell presence/infiltration in Figure 5 are not described in the main text or figure legend. Since, the claim that the presence of the resting or activated NK cells predicts cancer prognosis is based on this figure, this needs to be clearly described.

      Thank you for your questions. The activated and resting NK cell percentage in TCGA and GSE29623 was determined by CIBERSORT. Additionally, the infiltration of activated and resting NK cell was also determined by the AddModuleScore function using the gene sets of activated and resting NK cell identified in single-cell-seq, the differences of activated and resting NK cell presence in tumor and non-tumor region is also determined by visual inspection. We have amended in the main text and figure legend in the revised manuscript.

      Comment #4: The absence of FMO controls for KIR2DL4 or GZMK and the lack of increase in GZMK expression during co-culture with tumour lines raises concerns since GZMK was used as a defining feature of resting NK cells.

      Thank you for your questions. We did a new batch of flow experiments and FMO controls of all the markers used in the experiments were set up to define the precise positive gate locations.

      Author response image 1.

      The positive gate locations of CD56, GZMK, KIR2DL4, CD9, CD49a, PD-1 defined according to the FMO control.

      Comment #5: All the co-cultures were performed with tumour cell line only and no healthy cells, such as human foreskin fibroblasts, were used as control. In the absence of a non-tumour cell line, it is very difficult to draw any conclusions. Furthermore, to claim that resting or activated NK cells are responsible for tumour migration or proliferation, it is important to at least isolate resting and activated NK cells ex vivo and culture with tumour lines, instead of NK cell lines.

      Thank you for your questions. According to your suggestion, NK cells were co-cultured with human foreskin fibroblasts, the phenotype was identified by Flow cytometry. When co-cultured with HFF in direct contact (CN group), NK cells were also tending towards tissue infiltration state (high expression of CD9). However, the domestication effect is significantly reduced compared to co-culturing with tumor cells. Additionally, unlike supernatant of CNS group (NK and HCT were in contact) from NK and HCT co-culture system could significantly increase the migration of fresh HCT, fresh HCT underwent a limited increase (no statistical significance was found) in migration when cultured in the supernatant from the co-culture system in which NK and HFF were in contact (CNS group), but not when co-cultures were performed in the cell supernatant (SNS group) and fresh medium (MNS group). Finally, we tried to isolate resting and activated NK cells from fresh colon cancer surgical specimen. Unfortunately, the NK cells were too few to perform further functional experiments such as migration and proliferation.

      Author response image 2.

      Phenotype switch of NK cells in different co-cultured system and the corresponding NK cell-mediated effect on cell migration of fresh colon cancer cell (HCT-116). A-B: NK cells underwent phenotype switch (high expression of CD9) when cocultured with HCT and HFF, the phenotype switch was more obvious when co-cultured with HCT. CN: NK cells cocultured with HCT/HFF; SN: NK cells cocultured with supernatant of HCT/HFF; MN: NK cells cocultured in fresh medium. C-E: Transwell assay showed the only tumor co-cultured NK mediated the inductive effect on cell migration of colon cancer cell (HCT-116). CNS: Colon cancer cells were cultured in the supernatant from co-culture system that NK and HCT/HFF were cultured in direct contact; SNS: Colon cancer cells were cultured in the supernatant from co-culture system that NK cocultured with supernatant of HCT/HFF; MNS: Colon cancer cells were cultured in the fresh medium.

      Comment #6: It seems that flow cytometric analyses and GZMK and KIR2DL4 staining were performed without cell permeabilization. Could authors confirm if this is accurate, or if they performed intracellular staining instead?

      Thank you for your questions. For GZMK, which known as the secretory protein, flow cytometric analyses were performed both with (Fig.3) and without cell fixation and permeabilization, no significant differences were found among each group. The difference is that GZMK was nearly all negative without fixation and permeabilization while it is all positive with fixation and permeabilization. Conditions of flow cytometry analyses for GZMK may need further optimization or GZMK may not be a suitable flow cytometric marker for resting NK cells. On the other hand, for membrane protein such as CD56, CD9, CD49a, KIR2DL4, PD-1, staining was performed without cell permeabilization.

      Author response image 3.

      Phenotype switch (CD56+, GZMK+) of NK cells was analyzed by FACS after fixation and permeabilization in different co-cultured groups. CN: NK cells cocultured with colon cancer cells; SN: NK cells cocultured with supernatant of cancer cells; MN: NK cells cocultured in fresh medium.

      Comment #7: The identity of the published datasets used for analysis is not provided, and references are not cited in the results section.

      Thank you for your questions. We are sorry for the neglect of our previous work. We have added the information in the revised manuscript (section of Materials and Methods) (Line 123-128).

      Comment #8: References are difficult to locate, as the main text follows APA style while the reference section is organized numerically with no clear order.

      Thank you for your questions. We have modified the format of the references in the revised manuscript.

      Comment #9: Figure 3 shows volcano plots showing DEG genes between tumor and healthy tissue NK cells are not described clearly, and authors did not discuss the significance of these genes, highlighted in the plot.

      Thank you for your questions. Volcano plots of Figure 3 showed the DEGs between colon cancer with metastasis and without metastasis in TCGA database. We focused on the genes which were enriched in the pathway of “Natural killer cell mediated cytotoxicity” and found nearly all the genes enriched in the pathway were down-regulated in the colon cancer with metastasis. We have modified the description in the result section and added the description of importance of these genes in the discussion section in the revise manuscript (Line 322-326).

      Comment #10: The meaning of "M0" and "M1" in Figures 5A and 5B is unclear and should be defined in the text.

      Thank you for your questions. "M0" and "M1" in Figure 5A and 5B means “colon cancer without metastasis” and “colon cancer with metastasis”, respectively. We have modified in the revise manuscript (Line 350-354).

      Comment #11: Terms such as "dynamic remodelling of NK cells" and "landscape of NK cells" are used without explanation, necessitating clarification of their meaning.

      Thank you for your questions. We have modified in the revise manuscript (Line 331-334).

      Comment #12: In vitro assays are described vaguely, making it difficult for readers to understand. More clarity is needed in describing these assays.

      Thank you for your questions. We have added clarification in the revise manuscript (Line 205-211).

      Reviewer #2:

      Comment #1: This manuscript investigates the role of the abundant NK cells that are observed in colon cancer liver metastasis using sequencing and spatial approaches in an effort to clarify the pro and anti-tumorigenic properties of NK cells. This descriptive study characterises different categories of NK cells in tumor and tumor-adjacent tissues and some correlations. An attempt has been made using pseudotime trajectory analysis but no models around how these NK cells might be regulated are provided.

      Thank you for your questions. The single-cell sequencing data enrolled in this study are CD45 positive immune cells and do not involve tumor cells, cellular communication analysis between NK cells and tumor cells cannot be conducted. The change process of NK can only be predicted through pseudotime trajectory analysis. Our hypothesis is that tumor cells domesticate NK cells into a tumor- infiltrated NK cells through direct contact, and flow cytometry experiments have also confirmed that tumor cells can only have such domestication through direct contact with NK cells (with prominent high expression of CD9). However, the detailed mechanism remained unclear.

      Comment #2: A small number of patients are analyzed in this study. The descriptive gene markers, while interesting, need to be further validated to understand how strong this analysis might be and its potential application.

      Thank you for your questions. The sample size included in this study is indeed a bit small, which is also a limitation of our study. However, this is the only large sample single-cell sequencing dataset could be found that includes primary colon cancer tissues, paired paratumor normal colon tissues, paired liver metastatic cancer tissue, and paired paratumor normal liver tissues. We will expand the sample size to further verify the current conclusion in subsequent experiments. In addition, the marker genes of different NK groups used in this study refer to the CIBERSORT's classification of activated NK cells and resting NK cells, which is a widely recognized indicator. We will verify the expression and clinical application value of the screened genes in tissues in subsequent studies.

      Comment #3: Figure 1C and other figures throughout the paper. It is not clear how marker genes were selected.

      Thank you for your questions. The marker genes displayed in the Figure.3C were the highly variable genes of each cell group as well as the marker genes of each immune cells, such as T cells (CD3D, CD3E), NK cells (NKG7, KLRD1), monocytes (LYZ, S100A8, S100A9), B cells (CD79A), plasma cells (JCHAIN, IGHA1, IGHA2), Neutrophils (CXCL8, FCGR3B).

      Comment #4: Figure 1E. P and T have not been defined. Lines should not connect the datasets as they are independent assessments.

      Thank you for your questions. P and T means paratumor normal tissues and tumor tissues, respectively. Which have been added in the caption of Figure 1E. Additionally, the single cell sequencing samples included in the study were paired, with primary colon cancer tissues, paired normal tissues adjacent to colon cancer, paired liver metastatic cancer tissue, and paired normal liver tissues from 20 colon cancer patients with liver metastasis, paired test analysis was thus performed.

      Comment #5: Figure 2C. It is unclear what ST-P1 means. This is not a particularly informative figure.

      Thank you for your questions. We are sorry that it was our annotation error. Actually, it is the spatial transcriptome of the primary colon cancer tissue and liver metastasis tissue of four patients. We have made the modifications in the revised manuscript.

      Comment #6: Multiple figures - abbreviations are used but not provided in the legend. They occur in the text but are not directly related to the figures where they are used to label axes or groups.

      Thank you for your questions. We have rechecked and made corresponding modifications in the revised manuscript.

      Comment #6: Patients: it is not clear what other drugs patients have been exposed to or basic data (sex, age, underlying conditions etc)

      Thank you for your questions. The baseline data of the patient of SC dataset and ST dataset were showed in the Table.1 and Table.2 followed, respectively. They were not presented before as no patients characteristics related analysis was performed in the current study.

      Author response table 1.

      The baseline data of patient from single cell sequencing database.

      Author response table 2.

      The baseline data of patient from spatial transcriptome database.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      In this manuscript, the authors investigated the dynamics of a neural network model characterized by sparsely connected clusters of neuronal ensembles. They found that such a network could intrinsically generate sequence preplay and place maps, with properties like those observed in the real-world data. Strengths of the study include the computational model and data analysis supporting the hippocampal network mechanisms underlying sequence preplay of future experiences and place maps.

      Previous models of replay or theta sequences focused on circuit plasticity and usually required a pre-existing place map input from the external environment via upstream structures. However, those models failed to explain how networks support rapid sequential coding of novel environments or simply transferred the question to the upstream structure. On the contrary, the current proposed model required minimal spatial inputs and was aimed at elucidating how a preconfigured structure gave rise to preplay, thereby facilitating the sequential encoding of future novel environments.

      In this model, the fundamental units for spatial representation were clusters within the network. Sequential representation was achieved through the balance of cluster isolation and their partial overlap. Isolation resulted in a self-reinforced assembly representation, ensuring stable spatial coding. On the other hand, overlap-induced activation transitions across clusters, enabling sequential coding.

      This study is important when considering that previous models mainly focused on plasticity and experience-related learning, while this model provided us with insights into how network architecture could support rapid sequential coding with large capacity, upon which learning could occur efficiently with modest modification via plasticity.

      I found this research very inspiring and, below, I provide some comments aimed at improving the manuscript. Some of these comments may extend beyond the scope of the current study, but I believe they raise important questions that should be addressed in this line of research.

      (1) The expression 'randomly clustered networks' needs to be explained in more detail given that in its current form risks to indicate that the network might be randomly organized (i.e., not organized). In particular, a clustered network with future functionality based on its current clustering is not random but rather pre-configured into those clusters. What the authors likely meant to say, while using the said expression in the title and text, is that clustering is not induced by an experience in the environment, which will only be later mapped using those clusters. While this organization might indeed appear as randomly clustered when referenced to a future novel experience, it might be non-random when referenced to the prior (unaccounted) activity of the network. Related to this, network organization based on similar yet distinct experiences (e.g., on parallel linear tracks as in Liu, Sibille, Dragoi, Neuron 2021) could explain/configure, in part, the hippocampal CA1 network organization that would appear otherwise 'randomly clustered' when referenced to a future novel experience.

      As suggested by the reviewer, we have revised the text to clarify that the random clustering is random with respect to any future, novel environment (lines 111-114 and 710-712).

      Lines 111-114: “To reconcile these experimental results, we propose a model of intrinsic sequence generation based on randomly clustered recurrent connectivity, wherein place cells are connected within multiple overlapping clusters that are random with respect to any future, novel environment.”

      Lines 710-712: “Our results suggest that the preexisting hippocampal dynamics supporting preplay may reflect general properties arising from randomly clustered connectivity, where the randomness is with respect to any future, novel experience.”

      The cause of clustering could be prior experiences (e.g. Bourjaily and Miller, 2011) or developmental programming (e.g. Perin et al., 2011; Druckmann et al., 2014; Huszar et al., 2022), and we have modified lines 116 and 714-718 to state this.

      Lines 116: Added citation of “Perin et al., 2011”

      Lines 714-718: “Synaptic plasticity in the recurrent connections of CA3 may primarily serve to reinforce and stabilize intrinsic dynamics, which could be established through a combination of developmental programming (Perin et al., 2011; Druckmann et al., 2014; Huszar et al., 2022) and past experiences (Bourjaily and Miller, 2011), rather than creating spatial maps de novo.”

      We thank the reviewer for suggesting that the results of Liu et al., 2021 strengthen the support for our modeling motivations. We agree, and we now cite their finding that the hippocampal representations of novel environments emerged rapidly but were initially generic and showed greater discriminability from other environments with repeated experience in the environment (lines 130-134).

      Lines 130-134: “Further, such preexisting clusters may help explain the correlations that have been found in otherwise seemingly random remapping (Kinsky et al., 2018; Whittington et al., 2020) and support the rapid hippocampal representations of novel environments that are initially generic and become refined with experience (Liu et al., 2021).”

      (2) The authors should elaborate more on how the said 'randomly clustered networks' generate beyond chance-level preplay. Specifically, why was there preplay stronger than the time-bin shuffle? There are at least two potential explanations:

      (1) When the activation of clusters lasts for several decoding time bins, temporal shuffle breaks the continuity of one cluster's activation, thus leading to less sequential decoding results. In that case, the preplay might mainly outperform the shuffle when there are fewer clusters activating in a PBE. For example, activation of two clusters must be sequential (either A to B or B to A), while time bin shuffle could lead to non-sequential activations such as a-b-a-b-a-b where a and b are components of A and B;

      (2) There is a preferred connection between clusters based on the size of overlap across clusters. For example, if pair A-B and B-C have stronger overlap than A-C, then cluster sequences A-B-C and C-B-A are more likely to occur than others (such as A-C-B) across brain states. In that case, authors should present the distribution of overlap across clusters, and whether the sequences during run and sleep match the magnitude of overlap. During run simulation in the model, as clusters randomly receive a weak location cue bias, the activation sequence might not exactly match the overlap of clusters due to the external drive. In that case, the strength of location cue bias (4% in the current setup) could change the balance between the internal drive and external drive of the representation. How does that parameter influence the preplay incidence or quality?

      Explanation 1 is correct: Our cluster-activation analyses (Figure 5) showed that the parameter values that generate preplay correspond to the parameter regions that support sustained cluster activity over multiple decoding time bins, which led us to the conclusion of the reviewer’s first proposed explanation.

      We have now added additional analyses supporting the conclusion that cluster-wise activity is the main driver of preplay rather than individual cell-identity (Figures 6 and 7). In Figure 6 we show that cluster-identity alone is sufficient to produce significant preplay by performing decoding after shuffling cell identity within clusters, and in Figure 7 we show that this result holds true when considering the sequence of spiking activity within population bursts rather than the spatial decoding.

      Lines 495-515: The pattern of preplay significance across the parameter grid in Figure 4f shows that preplay only occurs with modest cluster overlap, and the results of Figure 5 show that this corresponds to the parameter region that supports transient, isolated cluster-activation. This raises the question of whether cluster-identity is sufficient to explain preplay. To test this, we took the sleep simulation population burst events from the fiducial parameter set and performed decoding after shuffling cell identity in three different ways. We found that when the identity of all cells within a network are randomly permuted the resulting median preplay correlation shift is centered about zero (t-test 95% confidence interval, -0.2018 to 0.0012) and preplay is not significant (distribution of p-values is consistent with a uniform distribution over 0 to 1, chi-square goodness-of-fit test p=0.4436, chi-square statistic=2.68; Figure 6a). However, performing decoding after randomly shuffling cell identity between cells that share membership in a cluster does result in statistically significant preplay for all shuffle replicates, although the magnitude of the median correlation shift is reduced for all shuffle replicates (Figure 6b). The shuffle in Figure 6b does not fully preserve cell’s cluster identity because a cell that is in multiple clusters may be shuffled with a cell in either a single cluster or with a cell in multiple clusters that are not identical. Performing decoding after doing within-cluster shuffling of only cells that are in a single cluster results in preplay statistics that are not statistically different from the unshuffled statistics (t-test relative to median shift of un-shuffled decoding, p=0.1724, 95% confidence interval of -0.0028 to 0.0150 relative to the reference value; Figure 6c). Together these results demonstrate that cluster-identity is sufficient to produce preplay.

      Lines 531-551: While cluster-identity is sufficient to produce preplay (Figure 6b), the shuffle of Figure 6c is incomplete in that cells belonging to more than one cluster are not shuffled. Together, these two shuffles leave room for the possibility that individual cell-identity may contribute to the production of preplay. It might be the case that some cells fire earlier than others, both on the track and within events. To test the contribution of individual cells to preplay, we calculated for all cells in all networks of the fiducial parameter point their mean relative spike rank and tested if this is correlated with the location of their mean place field density on the track (Figure 7). We find that there is no relationship between a cell’s mean relative within-event spike rank and its mean place field density on the track (Figure 7a). This is the case when the relative rank is calculated over the entire network (Figure 7, “Within-network”) and when the relative rank is calculated only with respect to cells with the same cluster membership (Figure 7, “Within-cluster”). However, because preplay events can proceed in either track direction, averaging over all events would average out the sequence order of these two opposite directions. We performed the same correlation but after reversing the spike order for events with a negative slope in the decoded trajectory (Figure 7b). To test the significance of this correlation, we performed a bootstrap significance test by comparing the slope of the linear regression to the slope that results when performing the same analysis after shuffling cell identities in the same manner as in Figure 6. We found that the linear regression slope is greater than expected relative to all three shuffling methods for both the within-network mean relative rank correlation (Figure 6c) and the within-cluster mean relative rank correlation (Figure 6d).

      Lines 980-1000:

      “Cell identity shuffled decoding

      We performed Bayesian decoding on the fiducial parameter set after shuffling cell identities in three different manners (Figures 6 and 7). To shuffle cells in a cluster-independent manner (“Across-network shuffle”), we randomly shuffled the identity of cells during the sleep simulations. To shuffle cells within clusters (“Within-cluster shuffle”), we randomly shuffled cell identity only between cells that shared membership in at least one cluster. To shuffle cells within only single clusters (“Within-single-cluster shuffle”), we shuffled cells in the same manner as the within-cluster shuffle but excluded any cells from the shuffle that were in multiple clusters.

      To test for a correlation between spike rank during sleep PBEs and the order of place fields on the track (Figure 7), we calculated for each excitatory cell in each network of the fiducial parameter set its mean relative spike rank and correlated that with the location of its mean place field density on the track (Figure 7a). To account for event directionality, we calculated the mean relative rank after inverting the rank within events that had a negatively sloped decoded trajectory (Figure 7b). We calculated mean relative rank for each cell relative to all cells in the network (“Within-network mean relative rank”) and relative to only cells that shared cluster membership with the cell (“Within-cluster mean relative rank”). We then compared the slope of the linear regression between mean relative rank and place field location against the slope that results when applying the same analysis to each of the three methods of cell identify shuffles for both the within-network regression (Figure 7c) and the within-cluster regression (Figure 7d).”

      We also now show that the sequence of cluster-activation in events with 3 active clusters does not match the sequence of cluster biases on the track above chance levels and that events with fewer active clusters have the largest increase in median weighted decode correlation (Figure 5—figure supplement 1), showing that the reviewer’s second explanation is not the case.

      Lines 466-477: “The results of Figure 5 suggest that cluster-wise activation may be crucial to preplay. One possibility is that the random overlap of clusters in the network spontaneously produces biases in sequences of cluster activation which can be mapped onto any given environment. To test this, we looked at the pattern of cluster activations within events. We found that sequences of three active clusters were not more likely to match the track sequence than chance (Figure 5—figure supplement 1a). This suggests that preplay is not dependent on a particular biased pattern in the sequence of cluster activation. We then we asked if the number of clusters that were active influenced preplay quality. We split the preplay events by the number of clusters that were active during each event and found that the median preplay shift relative to shuffled events with the same number of active clusters decreased with the number of active clusters (Spearman’s rank correlation, p=0.0019, =-0.13; Figure 5—figure supplement 1b).”

      Lines 1025-1044:

      “Active cluster analysis

      To quantify cluster activation (figure 5), we calculated the population rate for each cluster individually as the mean firing rate of all excitatory cells belonging to the cluster smoothed with a Gaussian kernel (15 ms standard deviation). A cluster was defined as ‘active’ if at any point its population rate exceeded twice that of any other cluster during a PBE. The active clusters’ duration of activation was defined as the duration for which it was the most active cluster.

      To test whether the sequence of activation in events with three active clusters matched the sequence of place fields on the track, we performed a bootstrap significance test (Figure 5—figure supplement 1). For all events from the fiducial parameter set that had three active clusters, we calculated the fraction in which the sequence of the active clusters matched the sequence of the clusters’ left vs right bias on the track in either direction. We then compared this fraction to the distribution expected from randomly sampling sequences of three clusters without replacement.

      To determine if there was a relationship between the number of active clusters within an event and it’s preplay quality we performed a Spearman’s rank correlation between the number of active clusters and the normalized absolute weighted correlation across all events at the fiducial parameter set. The absolute weighted correlations were z-scored based on the absolute weighted correlations of the time-bin shuffled events that had the same number of active clusters.”

      We also now add control simulations showing that without the cluster-dependent bias the population burst events no longer significantly decode as preplay (Figure 4—figure supplement 4e).

      (3) The manuscript is focused on presenting that a randomly clustered network can generate preplay and place maps with properties similar to experimental observations. An equally interesting question is how preplay supports spatial coding. If preplay is an intrinsic dynamic feature of this network, then it would be good to study whether this network outperforms other networks (randomly connected or ring lattice) in terms of spatial coding (encoding speed, encoding capacity, tuning stability, tuning quality, etc.)

      We agree that this is an interesting future direction, but we see it as outside the scope of the current work. There are two interesting avenues of future work: 1) Our current model does not include any plasticity mechanisms, but a future model could study the effects of synaptic plasticity during preplay on long-term network dynamics, and 2) Our current model does not include alternative approaches to constructing the recurrent network, but future studies could systematically compare the spatial coding properties of alternative types of recurrent networks.

      (4) The manuscript mentions the small-world connectivity several times, but the concept still appears too abstract and how the small-world index (SWI) contributes to place fields or preplay is not sufficiently discussed.

      For a more general audience in the field of neuroscience, it would be helpful to include example graphs with high and low SWI. For example, you can show a ring lattice graph and indicate that there are long paths between points at opposite sides of the ring; show randomly connected graphs indicating there are no local clustered structures, and show clustered graphs with several hubs establishing long-range connections to reduce pair-wise distance.

      How this SWI contributes to preplay is also not clear. Figure 6 showed preplay is correlated with SWI, but maybe the correlation is caused by both of them being correlated with cluster participation. The balance between cluster overlap and cluster isolation is well discussed. In the Discussion, the authors mention "...Such a balance in cluster overlap produces networks with small-world characteristics (Watts and Strogatz, 1998) as quantified by a small-world index..." (Lines 560-561). I believe the statement is not entirely appropriate, a network similar to ring lattice can still have the balance of cluster isolation and cluster overlap, while it will have small SWI due to a long path across some node pairs. Both cluster structure and long-range connection could contribute to SWI. The authors only discuss the necessity of cluster structure, but why is the long-range connection important should also be discussed. I guess long-range connection could make the network more flexible (clusters are closer to each other) and thus increase the potential repertoire.

      We agree that the manuscript would benefit from a more concrete explanation of the small-world index. We have added a figure illustrating different types of networks and their corresponding SWI (Figure 1—figure supplement 1) and a corresponding description in the main text (lines 228-234).

      Lines 228-234: “A ring lattice network (Figure 1—figure supplement 1a) exhibits high clustering but long path lengths between nodes on opposite sides of the ring. In contrast, a randomly connected network (Figure 1—figure supplement 1c) has short path lengths but lacks local clustered structure. A network with small world structure, such as a Watts-Strogatz network (Watts and Strogatz, 1998) or our randomly clustered model (Figure 1—figure supplement 1b), combines both clustered connectivity and short path lengths. In our clustered networks, for a fixed connection probability the SWI increases with more clusters and lower cluster participation…”

      We note that while our most successful clustered networks are indeed those with small-world characteristics, there are other ways of producing small-world networks which may not show good place fields or preplay. We have modified lines 690-692 to clarify that that statement is specific to our model.

      Lines 690-692: “In our clustered network structure, such a balance in cluster overlap produces networks with small-world characteristics (Watts and Strogatz, 1998) as quantified by a small-world index (SWI, Figure 1g; Neal, 2015; Neal, 2017).”

      (5) What drives PBE during sleep? Seems like the main difference between sleep and run states is the magnitude of excitatory and inhibitory inputs controlled by scaling factors. If there are bursts (PBE) in sleep, do you also observe those during run? Does the network automatically generate PBE in a regime of strong excitation and weak inhibition (neural bifurcation)?

      During sleep simulations, the PBEs are spontaneously generated by the recurrent connections in the network. The constant-rate Poisson inputs drive low-rate stochastic spiking in the recurrent network, which then randomly generates population events when there is sufficient internal activity to transiently drive additional spiking within the network.

      During run simulations, the spatially-tuned inputs drive greater activity in a subset of the cells at a given point on the track, which in turn suppress the other excitatory cells through the feedback inhibition.

      We have added a brief explanation of this in the text in lines 281-284.

      Lines 281-284: “During simulated sleep, sparse, stochastic spiking spontaneously generates sufficient excitement within the recurrent network to produce population burst events resembling preplay (Figure 2d-f)”

      (6) Is the concept of 'cluster' similar to 'assemblies', as in Peyrache et al, 2010; Farooq et al, 2019? Does a classic assembly analysis during run reveal cluster structures?

      Our clusters correspond to functional assemblies in that cells that share a cluster membership have more-similar place fields and are more likely to reactivate together during population burst events. In the figure to the right, we show for an example network at the fiducial parameter set the Pearson correlation between all pairs of place fields split by whether the cells share membership in a cluster (blue) or do not (red).

      Author response image 1.

      We expect an assembly analysis would identify assemblies similarly to the experimental data, but we see this additional analysis as a future direction. We have added a description of this correspondence in the text at lines 134-137.

      Lines 134-137: “Such clustered connectivity likely underlies the functional assemblies that have been observed in hippocampus, wherein groups of recorded cells have correlated activity that can be identified through independent component analysis (Peyrache et al., 2010; Farooq et al., 2019).”

      (7) Can the capacity of the clustered network to express preplay for multiple distinct future experiences be estimated in relation to current network activity, as in Dragoi and Tonegawa, PNAS 2013?

      We agree this is an interesting opportunity to compare the results of our model to what has been previously found experimentally. We report here preliminary results supporting this as an interesting future direction.

      Author response image 2.

      We performed a similar analysis to that reported in Figure 3C of Dragoi and Tonegawa, 2013. We determined the statistical significance of each event individually for each of the two environments by testing whether the decoded event’s absolute weighted correlation exceeded that 99th percentile of the corresponding shuffle events. We then fit a linear regression to the fraction of events that were significant for each of the two tracks and that were significant to either of the two tracks (left panel of above figure). We then estimated the track capacity as the number of tracks at the point where the linear regression reached 100% of the network capacity. We find that applying this analysis to our fiducial parameter set returns an estimate of ~8.6 tracks (Dragoi and Tonegawa, 2013, found ~15 tracks).

      We performed this same analysis for each parameter point in our main parameter grid (right panel of above figure). The parameter region that produces significant preplay (Figure 4f) corresponds to the region that has a track capacity of approximately 8-25 tracks. In the parameter grid region that does not produce preplay, the estimated track capacity approaches the high values that this analysis would produce when applied to events that are significant only at the false-positive rate. This analysis is based on the assumption that each preplay event would significantly correspond to at least one future event. Interesting interpretation issues arise when applying this analysis to parameter regions that do not produce statistically significant preplay, which we leave to future directions to address.

      We note two differences between our analysis here and that in Dragoi and Tonegawa, 2013. First, their track capacity analysis was performed on spike sequences rather than decoded spatial sequences, which is the focus of our manuscript. Second, they recorded rats exploring three novel tracks, while in our manuscript we only simulated two novel tracks, which reduces the accuracy of our linear extrapolation of track capacity.

      Reviewer #2 (Public Review):

      Summary:

      The authors show that a spiking network model with clustered neurons produces intrinsic spike sequences when driven with a ramping input, which are recapitulated in the absence of input. This behavior is only seen for some network parameters (neuron cluster participation and number of clusters in the network), which correspond to those that produce a small world network. By changing the strength of ramping input to each network cluster, the network can show different sequences.

      Strengths:

      A strength of the paper is the direct comparison between the properties of the model and neural data.

      Weaknesses:

      My main critiques of the paper relate to the form of the input to the network.

      First, because the input is the same across trials (i.e. all traversals are the same duration/velocity), there is no ability to distinguish a representation of space from a representation of time elapsed since the beginning of the trial. The authors should test what happens e.g. with traversals in which the animal travels at different speeds, and in which the animal's speed is not constant across the entire track, and then confirm that the resulting tuning curves are a better representation of position or duration.

      We thank the reviewer for pointing out this important limitation. We see extensive testing of the time vs space coding properties of this network as a future direction, but we have performed simulations that demonstrate the robustness of place field coding to variations in traversal speeds and added the results as a supplemental figure (Figure 3—figure supplement 1).

      Lines 332-336: “To verify that our simulated place cells were more strongly coding for spatial location than for elapsed time, we performed simulations with additional track traversals at different speeds and compared the resulting place fields and time fields in the same cells. We find that there is significantly greater place information than time information (Figure 3—figure supplement 1).

      Lines 835-841: “To compare coding for place vs time, we performed repeated simulations for the same networks at the fiducial parameter point with 1.0x and 2.0x of the original track traversal speed. We then combined all trials for both speed conditions to calculate both place fields and time fields for each cell from the same linear track traversal simulations. The place fields were calculated as described below (average firing rate within each of the fifty 2-cm long spatial bins across the track) and the time fields were similarly calculated but for fifty 40-ms time bins across the initial two seconds of all track traversals.”

      Second, it's unclear how much the results depend on the choice of a one-dimensional environment with ramping input. While this is an elegant idealization that allows the authors to explore the representation and replay properties of their model, it is a strong and highly non-physiological constraint. The authors should verify that their results do not depend on this idealization. Specifically, I would suggest the authors also test the spatial coding properties of their network in 2-dimensional environments, and with different kinds of input that have a range of degrees of spatial tuning and physiological plausibility. A method for systematically producing input with varying degrees of spatial tuning in both 1D and 2D environments has been previously used in (Fang et al 2023, eLife, see Figures 4 and 5), which could be readily adapted for the current study; and behaviorally plausible trajectories in 2D can be produced using the RatInABox package (George et al 2022, bioRxiv), which can also generate e.g. grid cell-like activity that could be used as physiologically plausible input to the network.

      We agree that testing the robustness of our results to variations in feedforward input is important. We have added new simulation results (Figure 4—figure supplement 4) showing that the existence of preplay in our model is robust to variations in the form of input.

      Testing the model in a 2D environment is an interesting future direction, but we see it as outside the scope of the current work. To our knowledge there are no experimental findings of preplay in 2D environments, but this presents an interesting opportunity for future modeling studies.

      Lines 413-420: To test the robustness of our results to variations in input types, we simulated alternative forms of spatially modulated feedforward inputs. We found that with no parameter tuning or further modifications to the network, the model generates robust preplay with variations on the spatial inputs, including inputs of three linearly varying cues (Figure 4—figure supplement 4a) and two stepped cues (Figure 4—figure supplement 4b-c). The network is impaired in its ability to produce preplay with binary step location cues (Figure 4—figure supplement 4d), when there is no cluster bias (Figure 4—figure supplement 4e), and at greater values of cluster participation (Figure 4—figure supplement 4f).

      Finally, I was left wondering how the cells' spatial tuning relates to their cluster membership, and how the capacity of the network (number of different environments/locations that can be represented) relates to the number of clusters. It seems that if clusters of cells tend to code for nearby locations in the environment (as predicted by the results of Figure 5), then the number of encodable locations would be limited (by the number of clusters). Further, there should be a strong tendency for cells in the same cluster to encode overlapping locations in different environments, which is not seen in experimental data.

      Thank you for making this important point and giving us the opportunity to clarify. We do find that subsets of cells with identical cluster membership have correlated place fields, but as we show in Figure 9b (original Figure 7b) the network place map as a whole shows low remapping correlations across environments, which is consistent with experimental data (Hampson et al., 1996; Pavlides, et al., 2019).

      Our model includes a relatively small number of cells and clusters compared to CA3, and with a more realistic number of clusters, the level of correlation across network place maps should reduce even further in our model network. The reason for a low level of correlation in the model is because cluster membership is combinatorial, whereby cells that share membership in one cluster can also belong to separate/distinct other clusters, rendering their activity less correlated than might be anticipated.

      We have added text at lines 627-630 clarifying these points.

      Lines 628-631: “Cells that share membership in a cluster will have some amount of correlation in their remapping due to the cluster-dependent cue bias, which is consistent with experimental results (Hampson et al., 1996; Pavlides et al., 2019), but the combinatorial nature of cluster membership renders the overall place field map correlations low (Figure 9b).”

      Reviewer #3 (Public Review):

      Summary:

      This work offers a novel perspective on the question of how hippocampal networks can adaptively generate different spatial maps and replays/preplays of the corresponding place cells, without any such maps pre-existing in the network architecture or its inputs. Unlike previous modeling attempts, the authors do not pre-tune their model neurons to any particular place fields. Instead, they build a random, moderately-clustered network of excitatory (and some inhibitory) cells, similar to CA3 architecture. By simulating spatial exploration through border-cell-like synaptic inputs, the model generates place cells for different "environments" without the need to reconfigure its synaptic connectivity or introduce plasticity. By simulating sleep-like random synaptic inputs, the model generates sequential activations of cells, mimicking preplays. These "preplays" require small-world connectivity, so that weakly connected cell clusters are activated in sequence. Using a set of electrophysiological recordings from CA1, the authors confirm that the modeled place cells and replays share many features with real ones. In summary, the model demonstrates that spontaneous activity within a small-world structured network can generate place cells and replays without the need for pre-configured maps.

      Strengths:

      This work addresses an important question in hippocampal dynamics. Namely, how can hippocampal networks quickly generate new place cells when a novel environment is introduced? And how can these place cells preplay their sequences even before the environment is experienced? Previous models required pre-existing spatial representations to be artificially introduced, limiting their adaptability to new environments. Other models depended on synaptic plasticity rules which made remapping slower than what is seen in recordings. This modeling work proposes that quickly-adaptive intrinsic spiking sequences (preplays) and spatially tuned spiking (place cells) can be generated in a network through randomly clustered recurrent connectivity and border-cell inputs, avoiding the need for pre-set spatial maps or plasticity rules. The proposal that small-world architecture is key for place cells and preplays to adapt to new spatial environments is novel and of potential interest to the computational and experimental community.

      The authors do a good job of thoroughly examining some of the features of their model, with a strong focus on excitatory cell connectivity. Perhaps the most valuable conclusion is that replays require the successive activation of different cell clusters. Small-world architecture is the optimal regime for such a controlled succession of activated clusters.

      The use of pre-existing electrophysiological data adds particular value to the model. The authors convincingly show that the simulated place cells and preplay events share many important features with those recorded in CA1 (though CA3 ones are similar).

      Weaknesses:

      To generate place cell-like activity during a simulated traversal of a linear environment, the authors drive the network with a combination of linearly increasing/decreasing synaptic inputs, mimicking border cell-like inputs. These inputs presumably stem from the entorhinal cortex (though this is not discussed). The authors do not explore how the model would behave when these inputs are replaced by or combined with grid cell inputs which would be more physiologically realistic.

      We chose the linearly varying spatial inputs as the minimal model of providing spatial input to the network so that we could focus on the dynamics of the recurrent connections. We agree our results will be strengthened by testing alternative types of border-like input. We show in Figure 4—figure supplement 4that our preplay results are robust to several variations in the location-cue inputs. However, given that a sub-goal of our model was to show that place fields could arise in locations at which no neurons receive a peak in external input, whereas combining input from multiple grid cells produces peaked place-field like input, adding grid cell input (and the many other types of potential hippocampal input) is beyond the scope of the paper.

      Even though the authors claim that no spatially-tuned information is needed for the model to generate place cells, there is a small location-cue bias added to the cells, depending on the cluster(s) they belong to. Even though this input is relatively weak, it could potentially be driving the sequential activation of clusters and therefore the preplays and place cells. In that case, the claim for non-spatially tuned inputs seems weak. This detail is hidden in the Methods section and not discussed further. How does the model behave without this added bias input?

      We apologize for a lack of clarity if we have caused confusion about the type of inputs and if we implied an absence of spatially-tuned information in the network. In order for place fields to appear the network must receive spatial information, which we model as linearly-varying cues and illustrate in Figure 1b and describe in the caption (original lines 156-157), Results (original lines 189-190 & 497-499), and Methods (original lines 671-683). Such input is not place-field like, as the small bias to any cell linearly decreases from one boundary of the track or the other.

      The cluster-dependent bias, which is also described in the same lines (Figure 1 caption (original lines 156-157), Results (original lines 189-190 & 497-499), and Methods (original lines 671-683)), only affects the strength of the spatial cues that are present during simulated run periods. Crucially, this cluster-dependent bias is absent during sleep simulations when preplay occurs, which is why preplay can equally correlate with place field sequences in any context.

      We have modified the text (lines 207-210, 218, and 824-827) to clarify these points. We have also added results from a control simulation (Figure 4—figure supplement 4e) showing that preplay is not generated in the absence of the cluster-dependent bias.

      Lines 207-210: “This bias causes cells that share cluster memberships to have more similar place fields during the simulated run period, but, crucially, this bias is not present during sleep simulations so that there is no environment-specific information present when the network generates preplay.”

      Lines 218: “Second, to incorporate cluster-dependent correlations in place fields, a small…”

      Lines 824-827: “The addition of this bias produced correlations in cells’ spatial tunings based on cluster membership, but, importantly, this bias was not present during the sleep simulations, and it did not lead to high correlations of place-field maps between environments (Figure 9b).”

      Unlike excitation, inhibition is modeled in a very uniform way (uniform connection probability with all E cells, no I-I connections, no border-cell inputs). This goes against a long literature on the precise coordination of multiple inhibitory subnetworks, with different interneuron subtypes playing different roles (e.g. output-suppressing perisomatic inhibition vs input-gating dendritic inhibition). Even though no model is meant to capture every detail of a real neuronal circuit, expanding on the role of inhibition in this clustered architecture would greatly strengthen this work.

      This is an interesting future direction, but we see it as outside the scope of our current work. While inhibitory microcircuits are certainly important physiologically, we focus here on a minimal model that produces the desired place cell activity and preplay, as measured in excitatory cells. We have added a brief discussion of this to the manuscript.

      Lines 733-739: “Additionally, the in vivo microcircuitry of CA3 is complex and includes aspects such as nonlinear dendritic computations and a variety of inhibitory cell types (Rebola et al., 2017). This microcircuitry is crucial for explaining certain aspects of hippocampal function, such as ripple and gamma oscillogenesis (Ramirez-Villegas et al., 2017), but here we have focused on a minimal model that is sufficient to produce place cell spiking activity that is consistent with experimentally measured place field and preplay statistics.”

      For the modeling insights to be physiologically plausible, it is important to show that CA3 connectivity (which the model mimics) shares the proposed small-world architecture. The authors discuss the existence of this architecture in various brain regions but not in CA3, which is traditionally thought of and modeled as a random or fully connected recurrent excitatory network. A thorough discussion of CA3 connectivity would strengthen this work.

      We agree this is an important point that is missing, and we have modified lines 114-116 to address the clustered connectivity reported in CA3.

      Lines 114-116: “Such clustering is a common motif across the brain, including the CA3 region of the hippocampus (Guzman et al., 2016) as well as cortex (Song et al., 2005), …”

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) Based on Figure 3, the place fields are not uniformly distributed in the maze. Meanwhile, based on Figure 1b and Methods, the total input seems to be uniform across the maze. Why does the uniform total external input lead to nonuniform network activities?

      While the total input to the network is constant across the maze, the input to any individual cell can peak only at either end of the track. All excitatory cells receive input from both the left-cue and the right-cue with different input strengths. By chance and due to the cluster-dependent bias some cells will have stronger input from one cue than the other and will therefore be more likely to have a place field toward that side of the track. However, no cell receives a peak of input in the center of the track. We have modified lines 141-143 to clarify this.

      Lines 141-143: “While the total input to the network is constant as a function of position, each cell only receives a peak in its spatially linearly varying feedforward input at one end of the track.”

      (2) I find these sentences confusing: "...we expected that the set of spiking events that significantly decode to linear trajectories in one environment (Figure 4) should decode with a similar fidelity in another environment..." (Lines 513-515) and "As expected... but not with the place fields of trajectories from different environments (Figure 7c)" (Line 517-520). What is the expectation for cross-environment decoding? Should they be similar or different? Also, in Figure 7c, the example is not fully convincing. In the figure caption, it states that decoding is significant in the top row but not in the bottom row, but they look similar across rows.

      Original lines 513-515 refer to the entire set of events, while original lines 517-520 refer to one example event. The sleep events are simulated without any track-specific information present, so the degree to which preplay occurs when decoding based on the place fields of a specific future track should be independent of any particular track when considering the entire set of decoded PBEs, as shown in Figure 9d (original Figure 7). However, because there is strong remapping across tracks (Figure 9b), an individual event that shows a strong decoded trajectory based on the place fields of one track (Figure 9c, top row) should show chance levels of a decoded trajectory when decoded with the place fields of an alternative track (Figure 9c, bottom row).

      We have revised lines 643-650 for clarity, and we have added statistics for the events shown in Figure 9c.

      Lines 644-651: “Since the place field map correlations are high for trajectories on the same track and near zero for trajectories on different tracks, any individual event would be expected to have similar decoded trajectories when decoding based on the place fields from different trajectories in the same environment and dissimilar decoded trajectories when decoding based on place fields from different environments. A given event with a strong decoded trajectory based on the place fields of one environment would then be expected to have a weaker decoded trajectory when decoded with place fields from an alternative environment (Figure 9c).

      Lines 604-608: “(c) An example event with a statistically significant trajectory when decoded with place fields from Env. 1 left (absolute correlation at the 99th percentile of time-bin shuffles) but not when decoded with place fields of the other trajectories (78th, 45th, and 63rd percentiles, for Env. 1 right, Env. 2 left, and Env. 2 right, respectively). shows a significant trajectory when it is decoded with place fields from one environment (top row), but not when it is decoded with place fields from another environment (bottom row). “

      (3) In Methods, the equation at line 610, E in the last term should be E_ext.

      We modeled the feedforward inputs as excitatory connections with the same reversal potential as the recurrent excitatory connections, so  is the proper value.

      (4) Equation line 617 states that conductances follow exponential decay, but the initial conductances of g_I.g_E and g_SRA are not specified.

      We have added a description of the initial values in lines 760-764.

      Lines 760-764: “Initial feed-forward input conductances were set to values approximating their steady-state values by randomly selecting values from a Gaussian with a mean of   and a standard deviation of . Initial values of the recurrent conductances and the SRA conductance were set to zero.”

      (5) In the parameter table below line 647, W_E-E, W_E-I, and W_I-E are not described in the text.

      We have clarified in lines 757-760 that the step increase in conductance corresponds to these parameter values.

      Lines 757-760: “A step increase in conductance occurs at the time of each spike by an amount corresponding to the connection strength for each synapse ( for E-to-E connections, for E-to-I connections, and  for I-to-E connections), or by  for .”

      (6) On line 660, "...Each environment and the sleep session had unique context cue input weights...". Does that mean that within a sleep session, the network received the same context input? How strongly are the sleep dynamics driven by that context input rather than by intrinsic dynamics? Usually, sleep activity is high dimensional, what would happen if the input during sleep is more stochastic?

      Yes, within a sleep session each network receives a single set of context inputs, which are implemented as independent Poisson spike trains (so being independent, in small time-windows the dimensionality is equal to the number of neurons). The effects of any particular set of sleep context cue inputs should be minor, since the standard deviation of the input weights, , is small. Further, because the preplay analysis is performed across many networks at each parameter point, the observation of preplay is independent of any particular realization of either the recurrent network or the sleep context inputs.

      Further exploring the effects of more biophysically realistic neural dynamics during simulated sleep is an interesting future direction.

      (7) One bracket is missing in the denominator in line 831.

      We have fixed this error.

      Line 1005: “)” -> “()”

      Reviewer #2 (Recommendations For The Authors):

      - I would suggest the authors cite Chenkov et al 2017, PLOS Comp Bio, in which "replay" sequences were produced in clustered networks, and discuss how their work differs.

      We have included a contrast of our model to that of Chenkov et al., 2017 in lines 73-78.

      Lines 73-78: “Related to replay models based on place-field distance-dependent connectivity is the broader class of synfire-chain-like models. In these models, neurons (or clusters of neurons) are connected in a 1-dimensional feed-forward manner (Diesmann et al., 1999; Chenkov et al., 2017). The classic idea of a synfire-chain has been extended to included recurrent connections, such as by Chenkov et al., 2017, however such models still rely on an underlying 1-dimensional sequence of activity propagation.”

      - Figure legend 2e says "replay", should be "preplay".

      We have fixed this error.

      Line 255: “(e) Example preplay event…”

      - How much does the context cue affect the result? e.g. Is sleep notably different with different sleep context cues?

      As discussed above in our response to Reviewer 1, the context cue weights have a small standard deviation, , which means that differences in the effects of different realizations of the context inputs are small. Different sets of context cues will cause cells to have slightly higher or lower spiking rates during sleep simulations, but because there is no correlation between the sleep context cue and the place field simulations there should be no effect on preplay quality.

      - Figure 4 should include a control with a single cluster.

      We thank the reviewer for this suggestion and have added additional control simulations.

      In our model, the recurrent structure of a network with a single cluster is equivalent to a cluster-less random network. Additionally, any network where cluster participation equals the number of clusters is equivalent to a cluster-less random network, since all neurons belong to all clusters and can therefore potentially connect to any other neuron. Such a condition corresponds to a diagonal boundary where the number of clusters equals the cluster participation, which occurs at higher values of cluster participation than we had shown in our primary parameter grid.

      We now include simulation results that extend to this boundary, corresponding to cluster-less networks (Figure 4—figure supplement 4f). Networks at these parameter points do not show preplay. See our earlier response for the new text associated with Figure 4—figure supplement 4.

      - The results of Figure 4 are very noisy. I would recommend increasing the sampling, both in terms of the number of population events in each condition and the number of conditions.

      We have run simulations for longer durations (300 seconds) and with more networks (20) to produce more accurate empirical values for the statistics calculated across the parameter grids in Figures 3 and 4. Our additional simulations (Figure 4—figure supplement 4) provide support that the parameter region of preplay significance is reliable.

      Lines 831-833: “For the parameter grids in Figures 3 and 4 we simulated 20 networks with 300 s long sleep sessions in order to get more precise empirical estimates of the simulation statistics.”

      - It's not entirely clear what's different between the analysis described in lines 334-353, and the preplay analysis in Figure 2. In general, the description of this result was difficult to follow, as it included a lot of text that would be better served in the methods.

      In Figure 2 we first introduce the Bayesian decoding method, but it is not until Figure 4 that the shuffle-based significance testing is first introduced. We have simplified the description of the shuffle comparison in lines 371-375 and now refer the reader to the methods for details.

      Lines 371-375: “We find significant preplay in both our reference experimental data set (Shin et al., 2019; Figure 4a, b; see Figure 4—figure supplement 1 for example events) and our model (Figure 4c, d) when analyzed by the same methods as Farooq et al., 2019, wherein the significance of preplay is determined relative to time-bin shuffled events (see Methods). For each detected event we calculated its absolute weighted correlation. We then generated 100 time-bin shuffles of each event, and for each shuffle recalculated the absolute weighted correlation to generate a null distribution of absolute weighted correlations.”

      - Many of the figures have low text resolution (e.g. Figure 6).

      We have now fixed this.

      - How does the clustered small world network compare to e.g. a small world ring network as used in Watts and Strogatz 1998?

      As described in our above response to Reviewer 1's fourth point, we have added a supplementary figure (Figure 1—figure supplement 1, with corresponding text) comparing our model with the Watts-Strogatz model.

      Reviewer #3 (Recommendations For The Authors):

      Figure 5 would benefit from a plot of the overlap of activated clusters per event.

      In our cluster activation analysis in Figure 5, we defined a cluster as “active” if at any point in the event its population rate was twice that of any other clusters’. We used this definition—which permits no overlap of activated clusters—rather than a definition based on a z-scoring of the rate, because we determined that preplay required periods of spiking dominated by individual clusters.

      Author response image 3.

      The choice of such a definition is supported by our observation that most spiking activity within an event is dominated by whichever cluster is most active at each point in time. In the left panel of the above figure we show the distribution of the average fraction of spikes within each event that came from the most active cluster at each point in time. The right panel shows the distribution of the average across time within each event of the ratio of the population activity rate of the most active cluster to the second most active cluster. The data for both panels comes from all events at the fiducial parameter set.

      Author response image 4.

      Rather than overlapping at a given moment in time, clusters might have overlap in their probability of being active at some point within an event. We do find that there is a small but significant correlation in cluster co-activation. For each network we calculated the activation correlation across events for each pair of clusters (example network show in the left panel). We compared the distribution of resulting absolute correlations against the values that results after shuffling the correlations between cluster activations (right panel, all correlations for all networks from the fiducial parameter point).

      Figures 4e/f are referred to as 4c/d in the text (pg 14).

      We have fixed this error.

      Lines 400-412: “4c” -> “4e” and “4d” -> “4f”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      The Notch signaling pathway plays an important role in many developmental and disease processes. Although well-studied there remain many puzzling aspects. One is the fact that as well as activating the receptor through trans-activation, the transmembrane ligands can interact with receptors present in the same cell. These cis-interactions are usually inhibitory, but in some cases, as in the assays used here, they may also be activating. With a total of 6 ligands and 4 receptors, there is potentially a wide array of possible outcomes when different combinations are co-expressed in vivo. Here the authors set out to make a systematic analysis of the qualitative and quantitative differences in the signaling output from different receptor-ligand combinations, generating sets of "signaling" (ligand expressing) and "receiving" (receptor +/- ligand expressing cells).

      The readout of pathway activity is transcriptional, relying on the fusion of GAL4 in the intracellular part of the receptor. Positive ligand interactions result in the proteolytic release of Gal4 that turns on the expression of H2B-citrine. As an indicator of ligand and receptor expression levels, they are linked via TA to H2B mCherry and H2B mTurq expression respectively. The authors also manipulate the expression of the glycosyltransferase Lunatic-Fringe (LFng) that modifies the EGF repeats in the extracellular domains impacting their interactions. The testing of multiple ligand-receptor combinations at varying expression levels is a tour de force, with over 50 stable cell lines generated, and yields valuable insights although as a whole, the results are quite complex.

      Strengths:

      Taking a reductionist approach to testing systematically differences in the signaling strength, binding strength, and cis-interactions from the different ligands in the context of the Notch1 and Notch 2 receptors (they justify well the choice of players to test via this approach) produces a baseline understanding of the different properties and leads to some unexpected and interesting findings. Notably:

      -                Jag1 ligand expressing cells failed to activate Notch1 receptor although were capable of activating Notch2. Conversely, Jag2 cells elicited the strongest activation of both receptors. The results with

      Jag1 are surprising also because it exhibits some of the strongest binding to plate-bound ligands. The failure to activate Notch1 has major functional significance and it will be important in the future to understand the mechanistic basis.

      -                Jagged ligands have the strongest cis-inhibitory effects and the receptors differ in their sensitivity to cis-inhibition by Dll ligands. These observations are in keeping with earlier in vivo and cell culture studies. More referencing of those would better place the work in context but it nicely supports and extends previous studies that were conducted in different ways.

      -                Responses to most trans-activating ligands showed a degree of ultrasensitivity but this was not the case for cis-interactions where effects were more linear. This has implications for the way the two mechanisms operate and for how the signaling levels will be impacted by ligand expression levels.

      -                Qualitatively similar results are obtained in a second cell line, suggesting they reflect fundamental properties of the ligands/receptors.

      We appreciate the positive and constructive feedback.

      Weaknesses:

      One weakness is that the methods used to quantify the expression of ligands and receptors rely on the co-translation of tagged nuclear H2B proteins. These may not accurately capture surface levels/correctly modified transmembrane proteins. In general, the multiple conditions tested partly compensate for the concerns - for example, as Jag1 cells do activate Notch2 even if they do not activate Notch1 some Jag1 must be getting to the surface. But even with Notch2, Jag1 activities are on the lower side, making it important to clarify, especially given the different outcomes with the plated ligands. Similarly, is the fact that all ligands "signalled strongest to Notch2" an inherent property or due to differences in surface levels of Notch 2 compared to Notch1? The results would be considerably strengthened by calibration of the ligand/receptor levels (and ideally their sub-cellular localizations). Assessing the membrane protein levels would be relatively straightforward to perform on some of the basic conditions because their ligand constructs contain Flag tags, making it plausible to relate surface protein to H2B, and there are antibodies available for Notch1 and Notch2.

      We agree that mCherry fluorescence does not provide a direct readout of active surface ligand levels. As the reviewer points out, the ability of Jag1 to activate Notch2 demonstrates that expressed Jag1 is competent for signaling. Further, in some cases, Jag1-Notch2 activation can be comparable to Dll1-Notch2 activation (Figure 2A). Following the reviewer’s suggestion, we performed a Western blot for multiple expression levels for each of three surface ligands (Dll1, Dll4, Jag1) (Figure 2—figure supplement 2). This blot revealed a signal for surface expression of Jag1. Interpretation is complicated by the expected dependence of the efficiency of surface protein purification on the number of primary amines in the protein, which varies among these ligands, and qualitatively correlates with the staining intensity. While this makes quantitative interpretation difficult, this result further supports the notion that Jag1 is present on the cell surface. Finally, we note that high signaling activity need not, in general, directly correlate with surface expression levels. In fact, one study showed an example in which increased ligand activity occurred with decreased basal ligand surface levels (Antfolk et al., 2017). While one would ideally like to know all parameters of the system, including surface protein levels, rates of recycling, etc. the perspective taken here is that the net effect of these many post-translational processing steps can be subsumed into the overall relationship between the expression of the protein (which, in our case, is read out by the co-translational reporter) and its activity, which is relevant for the behavior of developmental circuits, among other systems. To address this comment, we now explicitly mention the limitation of mCherry as a proxy for surface protein, and add a reference to previous work highlighting the relationship between surface levels and ligand activity.

      In terms of the dependence of signaling on Notch levels, the metric of signaling activity used here is explicitly normalized by the mTurquoise co-translational reporter of Notch expression to account for differences in receptor expression across receiver clones. We have added a new figure to show the variation in expression (Figure 1—figure supplement 1A) and to demonstrate this normalization (Figure 1—figure supplement 5). Having said that, as the reviewer correctly points out, we cannot directly address the dependence on surface receptor levels with mTurquoise alone. To address this comment, we have added a figure that shows cotranslational and surface receptor expression for a subset of our receiver clones (Figure 1—figure supplement 1B). Although antibody binding strengths may vary, it appears unlikely that higher surface levels could explain most ligands’ preferential activation of Notch2 over Notch1, since Notch2 levels were lower than Notch1 levels in both surface expression and cotranslational expression.

      Cis-activation as a mode of signaling has only emerged from these synthetic cell culture assays raising questions about its physiological relevance. Cis-activation is only seen at the higher ligand (Dll1, Dll4) levels, how physiological are the expression levels of the ligands/receptors in these assays? Is it likely that this would make a major contribution in vivo? Is it possible that the cells convert themselves into "signaling" and "receiving" sub-populations within the culture by post-translational mechanism? Again some analysis of the ligand/receptors in the cultures would be a valuable addition to show whether or not there are major heterogeneities.

      The cis-activation results in this paper are, as the reviewer points out, conducted in synthetic cell culture assays. Cis-activation is observed across a large dynamic range of ligand expression, possibly including non-physiologically high levels. However, our previous work (Nandagopal et al, eLife 2019) showed that cis-activation does not require over-expression, as it occurred in unmodified Caco-2 and NMuMG cells with their endogenous ligand and receptor expression levels. As shown here in Figure 4B, cis-activation for Notch2 increases monotonically and is substantial even at intermediate ligand concentrations. In other cases, cis-activation is maximal at intermediate concentrations. We agree that the in vivo role remains unclear, and is difficult to determine due to the typical close contacts among cells in tissues. Therefore, these assays do not speak to in vivo relevance. Note that we can, however, rule out the possibility of trans signaling between well-mixed cell populations at these densities (Figure 4A).

      It is hard to appreciate how much cell-to-cell variability in the "output" there is. For example, low "outputs" could arise from fewer cells becoming activated or from all cells being activated less. As presented, only the latter is considered. That may be already evident in their data, but not easy for the reader to distinguish from the way they are presented. For example, in many of the graphs, data have been processed through multiple steps of normalization. Some discussion/consideration of this point is needed.

      We agree that in different experiments changes in a mean response can reflect changes in fraction of activated cells, or level of activation or some combination of both. In this work, most assays were conducted by flow cytometry, which provides a full distribution of cellular responses. We provided distributions for some experiments in the supplementary figures (i.e., Figure 4—figure supplement 1, and Figure 5—figure supplement 4). The sheer number of experiments and samples prevents us from displaying all underlying histograms. Therefore, we have provided all flow data sets in an extensive archive that is publicly available on data.caltech.edu (https://doi.org/10.22002/gjjkn-wrj28).

      Impact:

      Overall, cataloging the outcomes from the different ligand-receptor combinations, both in cis and trans, yields a valuable baseline for those investigating their functional roles in different contexts. There is still a long way to go before it will be possible to make a predictive model for outcomes based on expression levels, but this work gives an idea about the landscape and the complexities. This is especially important now that signaling relationships are frequently hypothesized based on single-cell transcriptomic data. The results presented here demonstrate that the relationships are not straightforward when multiple players are involved.

      We appreciate this concise impact summary, and agree with its conclusions.

      Reviewer #2 (Public Review):

      Summary:

      In this manuscript, the authors extend their previous studies on trans-activation, cis-inhibition (PMID: 25255098), and cis-activation (PMID: 30628888) of the Notch pathway. Here they create a large number of cell lines using CHO-K1 and C2C12 cells expressing either Notch1-Gal4 or Notch2-Gal4 receptors which express a fluorescent protein upon receptor activation (receiver cells). For cis-inhibition and cis-activation assays, these cells were engineered to express one of the four canonical Notch ligands (Dll1, Dll4, Jag1, Jag2) under tetracycline control. Some of the receiver cells were also transfected with a Lunatic fringe (Lfng) plasmid to produce cells with a range of Lfng expression levels. Sender cells expressing all of the canonical ligands were also produced. Cells were mixed in a variety of co-culture assays to highlight trans-activation, cis-activation, and cis-inhibition. All four ligands were able to trans-activate Notch1 and Notch 2, except Jag1 did not transactivate Notch1. Lfng enhanced trans-activation of both Notch receptors by Dll1 and Dll2, and inhibited Notch1 activation by Jag2 and Notch2 activation by both Jag 1 and Jag2. Cis-expression of all four ligands was predominantly inhibitory, but Dll1 and Dll4 showed strong cis-activation of Notch2. Interestingly, cis-ligands preferentially inhibited trans-activation by the same ligand, with varying effects on other trans-ligands.

      Strengths:

      This represents the most comprehensive and rigorous analysis of the effects of canonical ligands on cis- and trans-activation, and cis-inhibition, of Notch1 and Notch2 in the presence or absence of Lfng so far. Studying cis-inhibition and cis-activation is difficult in vivo due to the presence of multiple Notch ligands and receptors (and Fringes) that often occur in single cells. The methods described here are a step towards generating cells expressing more complex arrays of ligands, receptors, and Fringes to better mimic in vivo effects on Notch function.

      In addition, the fact that their transactivation results with most ligands on Notch1 and 2 in the presence or absence of Lfng were largely consistent with previous publications provides confidence that the author's assays are working properly.

      We appreciate the thoughtful comments and feedback.

      Weaknesses:

      It was unusual that the engineered CHO cells expressing Notch1-Gal4 were not activated at all by co-culture with Jag1-expressing CHO cells. Many previous reports have shown that Jag1 can activate Notch1 in co-culture assays, including when Notch1 was expressed in CHO cells. Interestingly, when the authors used Jag1-Fc in a plate coating assay, it did activate Notch1 and could be inhibited by the expression of Lfng.

      In our assays, we do in fact also see some signaling of Jag1 to Notch1, especially when dLfng is coexpressed (Figure 2—figure supplement 4, formerly Figure 2—figure supplement 3). While these levels are lower than those observed for other ligand-receptor combinations, they are significantly elevated compared to baseline. In specific natural contexts, it will be important to determine whether the weak but non-zero Jag1-Notch1 signaling acts negatively to suppress signaling from other ligands, or provides weak but potentially functionally important levels of signaling. Evidence for both modes exists in the literature. To address this, we have expanded the discussion of Jag1-Notch1 signaling and added references to other work on Jag1-Notch1 signaling to the Discussion section.

      The cell surface level of the ligands was determined by flow cytometry of a co-translated fluorescent protein. Some calibration of the actual cell surface levels with the fluorescent protein would strengthen the results.

      This issue was also raised by Reviewers #1 and #3. Please see responses to Reviewer #1, above.

      Reviewer #3 (Public Review):

      Summary:

      This manuscript reports a comprehensive analysis of Notch-Delta/Jagged signaling inclusive of the human Notch1 and Notch2 receptors and DLL1, DLL4, JAG1, and JAG2 ligands. Measurements

      encompassed signaling activity for ligand trans-activation, cis-activation, cis-inhibition, and activity modulation by Lfng. The most striking observations of the study are that JAG1 has no detectable activity as a Notch1 ligand when presented on a cell (though it does have activity when immobilized on a surface), even though it is an effective cis-inhibitor of Notch1 signaling by other ligands, and that DLL1 and DLL4 exhibit cis-activating activity for Notch1 and especially for Notch2. Notwithstanding the artificiality of the system and some of its shortcomings, the results should nevertheless be a valuable resource for the Notch signaling community.

      Strengths:

      (1)  The work is systematic and comprehensive, addressing questions that are of importance to the community of researchers investigating mammalian Notch proteins, their activation by ligands, and the modulation of ligand activity by LFng.

      (2)  A quantitative and thorough analysis of the data is presented.

      Weaknesses:

      (1) The manuscript is primarily descriptive and does not delve into the underlying, mechanistic origin or source of the different ligand activities.

      We agree that the goals of this paper were largely to discover the range of signaling modes that occur. A mechanistic analysis would be beyond the scope of this work, but we agree it is an important next step.

      (2) The amount of ligand or receptor expressed is inferred from the flow cytometry signal of a co-translated fluorescent protein-histone fusion, and is not directly measured. The work would be more compelling if the amount of ligand present on the cell surface were directly measured with anti-ligand antibodies, rather than inferred from measurements of the fluorescent protein-histone fusion.

      This issue was also raised by Reviewers #1 and #2. Please see responses to Reviewer #1, above.

      (3) It would be helpful to see plots of the raw activity data before transformation and normalization, because the plots present data after several processing steps, and it is not clear how the processed data relate to the original values determined in each measurement.

      We included examples showing how raw data is processed in Figure 4—figure supplement 1 and Figure 5—figure supplement 4. The sheer number of experiments precludes including similar figures for all data sets. However, all raw and processed data and data analysis code is publicly available at (https://doi.org/10.22002/gjjkn-wrj28).

      (4) The authors use sparse plating of engineered cells with parental (no ligand or receptor-expressing cell to measure cis activation). However, the cells divide within the cultured period of 22-24 h and can potentially trans-activate each other.

      If measured cis-activation signal arises solely from trans-activation, then the measured cis-activation signal per cell should increase with cell density, since trans-activation per cell does depend on cell density (Figure 4A). However, for the strongest cis-activators (Dll1- and Dll4-Notch2), signaling magnitude is similar when these cells are cultured sparsely or at confluence, which would otherwise allow efficient trans signaling (Figure 5A). Thus, for Dll1- and Dll4-Notch2 receivers, total signaling strength per cell depends little or not at all on the opportunity to signal intercellularly. Moreover, cis-activation signal for the Dll1- and Dll4-Notch2 combinations exceeded the maximum trans-signaling levels we could achieve for the same receivers when cis-ligand was suppressed (Figure 4B). These results argue that cis interactions dominate signaling in this context. However, we have not ruled out the possibility that trans-signaling between sister cells after division contributes to the comparatively weak cis-activation observed for Notch1 receivers.

      Reviewer #1 (Recommendations For The Authors):

      As outlined in the public review, there is a question of whether the nuclear H2B accurately reflects the surface levels of the transmembrane proteins (ligand and receptor). Clearly, it would not be feasible to check levels in all of the experimental conditions, but some baseline conditions should be analyzed.

      We addressed this above.

      Reviewer #2 (Recommendations For The Authors):

      (1)  As mentioned above, it was unusual that Jag1 did not activate Notch1 in co-culture assays, but did activate Notch1 in plate-coating assays. The authors should add some text to the Discussion to explain why they think this is happening in their engineered cells. One possibility is that the CHO cells express Manic fringe (Mfng) which is known to reduce Jag1-Notch1 activation. Data for Mfng levels in CHO cells were not included in Supplemental Table 2. Knocking down all three Fringes in CHO cells might increase Jag1-Notch1 activation.

      This is already addressed in a sentence in the results: “Strikingly, while Jag1 sender cells failed to activate Notch1 receivers above background (Figure 2D), plate-bound Jag1-ext-Fc activated Notch1 only ~3-fold less efficiently than it activated Notch2 (Figure 3B-D). This suggests that the natural endocytic activation mechanism, or potential differences in tertiary structure between the expressed and recombinant Jag1 extracellular domains, could play roles in preventing Jag1-Notch1 signaling in coculture.” Regarding the point about Mfng, we added a note to Supplementary Table about other CHO-K1 expression data.

      (2) Figure 1-supplemental figure 1: Both the Notch1-Jag1 and Notch1-Jag2 cells show high expression of Jag1 in low 4epi, but any higher concentration reduces to control levels. How much of a problem is this for interpreting your data?

      This was not the ideal behavior, but by binning cells by co-translational reporters for ligand expression, we were able to obtain enough cells in intermediate bins. (Note: Figure 1—figure supplement 1 is now Figure 1—figure supplement 2.)

      (3)  Figure 1C legend: Are these stably-expressing cells or Tet-off cells? Please state in legend.

      The figure legend has been updated.

      (4)  Figure 1E: How long is the knockdown of Rfng and Lfng effective? Does it affect the expression of Lfng later?

      siRNA effects generally last for at least 72-96 hours, so we do not anticipate this being an issue.

      (5) Page 9: "Lfng significantly decreased trans-activation of both receptors by Jag1 (>2.5-fold)". If there is no Jag1-Notch1 activation, how can Lfng decrease trans-activation?

      We added a note in the main text to clarify that while Jag1-Notch1 signaling is relatively low, it can still be detectably decreased.

      (6) Figure 4A legend: Please define what "2.5k ea senders and Rec" means. In the text, it says "To focus on cis-interactions alone, we then cultured receiver cells at low density, amid an excess of wildtype CHO-K1 cells" (page 14).

      This was clarified in the text.

      (7)  Page 14: "By contrast, Notch2 was cis-activated by both Dll1 and Dll4, to levels exceeding those produced by trans-activation by high-Dll1 senders (Figure 4B, lower left)." Where is the trans-activation data? 4B, lower right?

      We updated this reference in the main text.

      (8)  Page 16: "For Notch2-Dll1 and Notch2-Dll4, single cell reporter activities correlated with cis-ligand expression, regardless of whether cells were pre-induced at a high or low culture density (Figure 4D)." It appears that Notch2-Dll1 has lower Notch activation at sparse culture than confluent.

      We agree that the level signaling is lower in sparse compared to confluent on average. This is explained by the sensitivity of the Tet-OFF promoter to culture density (Figure 4—figure supplement 2). However, the key point of this experiment is the positive correlation, which is consistent with cis-activation, and inconsistent with the pre-generation of NEXT hypothesis diagrammed in Figure 4C, which would not be expected to produce such a correlation.

      (9a) For the creation of the C2C12-Nkd cells: Has genomic sequencing been done to confirm editing of Notch2 and Jag1 loci?

      We confirmed the knockdown but did not do genomic sequencing.

      (9b) The gel in Figure 7-Supplement 1C is not adequate for showing loss of Jag1. It should be repeated.

      In this case, we have only the single gel. We added a note in figure legend that no duplicate was performed.

      (10) Figure 7A: Which Fringes are expressed in C2C12 cells? You should provide a rationale for knocking down just Rfng.

      Figure 7—figure supplement 1A shows the levels of expression in C2C12. Note that Mfng is not highlighted because its levels were undetectable.

      (11) Figure 7-Supplement 1D: This is confusing. Notch2 levels are not reduced in the left panel, and Notch1 and Notch2 levels are not reduced in the right panel?

      C2C12-Nkd cells exhibit reduced levels of Notch1 and Notch3. This can be seen in Figure 7—figure supplement 1A. Panel D presents the results of additional siRNA knockdown, performed to prevent subsequent up-regulation of Notch1 and Notch3 during the assay. These knockdown results were variable, as shown. The Notch2 siRNA knockdown was not essential for these experiments, but performed despite very low levels of Notch2 to begin with. In the revision, we have added this note to the Methods.

      Reviewer #3 (Recommendations For The Authors):

      (1) The results section of the manuscript is very dense and difficult to follow, as are the figure legends.

      We appreciate the criticism, and regret that it is not easier to read in its current form.

      (2) The authors could emphasize areas of concordance with published results (where available) to place their artificial, engineered system into a better biological context. Are there any examples of studies in whole organisms where cis-activation plays a role?

      We are not aware of examples of cis-activation in whole organisms at this point.

      (3) How do the authors rationalize the different responses of Notch1 to cell-presented Jag1 as opposed to immobilized Jag1, where its signal strength is second in rank order on a molar basis?

      This comment was addressed above in response to the first recommendation from Reviewer #2.

      It is also difficult to understand Figure 2_—_figure Supplement 3B, in which it appears that Jag1 induces a Notch1 reporter response when LFng is knocked down (dLfng), and how those data relate to the inactive response to Jag1 shown in the main figures.

      The issue here is a difference of normalization. Figure 2A in the main text is normalized to the sender expression level, i.e. relative signaling strength. By contrast, Figure 2—figure supplement 4B (previously Figure 2—figure supplement 3B) shows absolute signaling activity, which can appear higher because it does not normalize for ligand expression. For Jag1-Notch1 signaling in particular, substantial signaling required very high levels of Jag1. We have added a new figure to demonstrate these two types of normalization (Figure 2—figure supplement 1A).

      See the Authr response image 1 below for a direct comparison of these two normalization modes using data from both Figure 2A and Figure 2—figure supplement 4B. Note how the Jag1-Notch1 signaling activities that are nonzero in the top plot go to zero in the bottom plot as a result of normalizing the values to ligand expression.

      Author response image 1. Comparison of normalization modes in Figure 2A and Figure 2—figure supplement 4B (formerly 3B). Normalized trans-activation signaling activities for different ligand-receptor combinations (with dLfng only), either with further normalization to ligand expression (bottom row) or without further normalization (top row). Normalized signaling activity is defined as reporter activity (mCitrine, A.U.) divided by cotranslational receptor expression (mTurq2, A.U.), normalized to the strongest biological replicate-averaged signaling activity across all ligand-receptor-Lfng combinations in this experiment. Saturated data points, defined here as those with normalized signaling activity over 0.75 in both dLfng and Lfng conditions, were excluded. Colors indicate the identity of the trans-ligand expressed by cocultured sender cells. Error bars denote bootstrapped 95% confidence intervals (Methods), in this case sampled from the number of biological replicates given in the legend—n1 (for Notch1) or n2 (for Notch2). See Methods and Figure 2A caption for more details. Note that the only difference between this figure and the new Figure 2—figure supplement 1A is that this figure additionally includes the Jag1-high data from Figure 2—figure supplement 4B.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #1 (Public review):

      Summary:

      In this manuscript, Herrmannova et al explore changes in translation upon individual depletion of three subunits of the eIF3 complex (d, e and h) in mammalian cells. The authors provide a detailed analysis of regulated transcripts, followed by validation by RT-qPCR and/or Western blot of targets of interest, as well as GO and KKEG pathway analysis. The authors confirm prior observations that eIF3, despite being a general translation initiation factor, functions in mRNA-specific regulation, and that eIF3 is important for translation re-initiation. They show that global effects of eIF3e and eIF3d depletion on translation and cell growth are concordant. Their results support and extend previous reports suggesting that both factors control translation of 5'TOP mRNAs. Interestingly, they identify MAPK pathway components as a group of targets coordinately regulated by eIF3 d/e. The authors also discuss discrepancies with other reports analyzing eIF3e function.

      Strengths:

      Altogether, a solid analysis of eIF3 d/e/h-mediated translation regulation of specific transcripts. The data will be useful for scientists working in the Translation field.

      Weaknesses:

      The authors could have explored in more detail some of their novel observations, as well as their impact on cell behavior.

      The manuscript has improved with the new corrections. I appreciate the authors' attention to the minor comments, which have been fully solved. The authors have not, however, provided additional experimental evidence that uORF-mediated translation of Raf-1 mRNA depends on an intact eIF3 complex, nor have they addressed the consequences of such regulation for cell physiology. While I understand that this is a subject of follow-up research, the authors could have at least included their explanations/ speculations regarding major comments 2-4, which in my opinion could have been useful for the reader.

      Our explanations/speculations regarding major comments 2 and 3 were included in the Discussion. We apologize for this misunderstanding as we thought that we were supposed to explain our ideas only in the responses. We did not discuss the comment 4, however, as we are really not sure what is the true effect and did not want to go into wild speculations in our manuscript. We thank this reviewer for his insightful comments and understanding.


      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations For The Authors):

      Major comments:

      (1) The authors report the potential translational regulation of Raf kinase by re-initiation. It would be interesting to show that Raf is indeed regulated by uORF-mediated translation, and that this is dependent on an intact eIF3 complex. Analyzing the potential consequences of Raf1 regulation for cancer cell proliferation or apoptosis would be a plus.

      We agree that this is an interesting and likely possibility. In fact, another clue that translation of Raf1 is regulated by uORFs comes from Bohlen et al. 2023 (PMID: 36869665) where they showed that RAF1 translation is dependent on PRRC2 proteins (that promote leaky scanning through these uORFs). We noted in the discussion that our results from eIF3d/e/hKD and the PRRC2A/B/CKD partly overlap. It is a subject of our follow-up research to investigate whether eIF3 and PRRC2 co-operate together to regulate translation of this important mRNA. 

      (2) The authors show that eIF3 d/e -but not 3h- has an effect on cell proliferation. First, this indicates that proliferation does not fully correlate with eIF3 integrity. Depletion of eIF3d does not affect the integrity of eIF3, yet the effects on proliferation are similar to those of eIF3e. What is the possibility that changes in proliferation reflect functions of eIF3d outside the eIF3 complex? What could be the real consequences of disturbing eIF3 integrity for the mammalian cell? Please, discuss.

      Yes, proliferation does not fully correlate with eIF3 integrity. Downregulation of eIF3 subunits that lead to disintegration of eIF3 YLC core (a, b, c, g, i) have more detrimental effect on growth and translation than downregulation of the peripheral subunits (e, k, l, f, h, m). Our previous studies (Wagner et al. 2016, PMID: 27924037 and Herrmannová et al. 2020, PMID: 31863585) indicate that the YLC core of eIF3 can partially support translation even without its peripheral subunits. In this respect eIF3d (as a peripheral subunit) is an amazing exception, suggesting it may have some specialized function(s). Whether this function resides outside of the eIF3 complex or not we do not know, but do not think so. Mainly because in the absence of eIF3e – its interaction partner, eIF3d gets rapidly degraded. Therefore, it is not very likely that eIF3d exists alone outside of eIF3 complex with moonlighting functions elsewhere. We think that eIF3d, as a head-interacting subunit close to an important head ribosomal protein RACK1 (a landing pad for regulatory proteins), is a target of signaling pathways, which may make it important for translation of specific mRNAs. In support is these thoughts, eIF3d (in the context of entire eIF3) together with DAP5 were shown to promote translation by an alternate capdependent (eIF4F-independent) mechanism (Lee et al. 2016, PMID: 27462815; de la Parra et al. 2018, PMID:30076308). In addition, the eIF3d function (also in the context of entire eIF3) was proved to be regulated by stress-triggered phosphorylation (Lamper et al. 2020, PMID: 33184215). 

      (3) Figure 6D: Surprisingly, reduced levels of ERK1/2 upon eIF3d/e-KD are compensated by increased phosphorylation of ERK1/2 and net activation of c-Jun. Please comment on the functional consequences of buffering mechanisms that the cell deploys in order to counteract compromised eIF3 function. Why would the cell activate precisely the MAPK pathway to compensate for a compromised eIF3 function?

      This we do not know. We can only speculate that when translation is compromised, cells try to counteract it in two ways: 1) they produce more ribosomes to increase translational rates and 2) activate MAPK signaling to send pro-growth signals, which can in the end further boost ribosome biogenesis.

      (4) Regarding DAP-sensitive transcripts, can the authors discuss in more detail the role of eIF3d in alternative cap-dependent translation versus re-initiation? Are these transcripts being translated by a canonical cap- and uORF-dependent mechanism or by an alternative capdependent mechanism?

      This is indeed not an easy question. On one hand, it was shown that DAP5 facilitates translation re-initiation after uORF translation in a canonical cap-dependent manner. This mechanism is essential for translation of the main coding sequence (CDS) in mRNAs with structured 5' leaders and multiple uORFs. (Weber et al. 2022, PMID: 36473845; David et al., 2022, PMID: 35961752). On the other hand, DAP5 was proposed to promote alternative, eIF4F-independent but cap-dependent translation, as it can substitute the function of the eIF4F complex in cooperation with eIF3d (de la Parra et al., 2018, PMID: 30076308; Volta et al., 2021 34848685). Overall, these observations paint a very complex picture for us to propose a clear scenario of what is going on between these two proteins on individual mRNAs. We speculate that both mechanisms are taking place and that the specific mechanism of translation initiation differs for differently arranged mRNAs.

      Minor comments:

      (5) Figure S2C: why is there a strong reduction of the stop codon peak for 3d and 3h KDs?

      We have checked the Ribowaltz profiles of all replicates (in the Supplementary data we are showing only a representative replicate I) and the stop codon peak differs a lot among the replicates. We think that this way of plotting was optimized for calculation and visualization of P-sites and triplet periodicity and thus is not suitable for this type of comparison among samples. Therefore, we have performed our own analysis where the 5’ ends of reads are used instead of P-sites and triplicates are averaged and normalized to CDS (see below please), so that all samples can be compared directly in one plot (same as Fig. S13A but for stop codon). We can see that the stop codon peak really differs and is the smallest for eIF3hKD. However, these changes are in the range of 20% and we are not sure about their biological significance. We therefore refrain from drawing any conclusions. In general, reduced stop codon peak may signal faster termination or increased stop codon readthrough, but the latter should be accompanied by an increased ribosome density in the 3’UTR, which is not the case. A defect in termination efficiency would be manifested by an increased stop codon peak, instead.

      Author response image 1.

       

      (6) Figures 5 and S8: Adding a vertical line at 'zero' in all cumulative plots will help the reader understand the author's interpretation of the data. 

      We have added a dashed grey vertical line at zero as requested. However, for interpretation of these plots, the reader should focus on the colored curve and whether it is shifted in respect to the grey curve (background) or not. Shift to the right indicates increased expression, while shift to the left indicates decreased expression. The reported p-value then indicates the statistical significance of the shift.

      (7) The entire Figure 2 are controls that can go to Supplementary Material. The clustering of Figure S3B could be shown in the main Figure, as it is a very easy read-out of the consistent effects of the KDs of the different eIF3 subunits under analysis.

      We have moved the entire Figure 2 to Supplementary Material as suggested (the original panels can be found as Supplementary Figures 1B, 1C and 3A). Figure S3B is now the main Figure 2E. 

      (8) There are 3 replicates for Ribo-Seq and four for RNA-Seq. Were these not carried out in parallel, as it is usually done in Ribo-seq experiments? Why is there an extra replicate for RNASeq?

      Yes, the three replicates were carried out in parallel. We have decided to add the fourth replicate in RNA-Seq to increase the data robustness as the RNA-Seq is used for normalization of FP to calculate the TE, which was our main analyzed metrics in this article. We had the option to add the fourth replicate as we originally prepared five biological replicates for all samples, but after performing the control experiments, we selected only the 3 best replicates for the Ribo-Seq library preparation and sequencing.  

      (9) Please, add another sheet in Table S2 with the names of all genes that change only at the translation (RPF) levels.

      As requested, we have added three extra sheets (one for each downregulation) for differential FP with Padjusted <0.05 in the Spreadsheet S2. We also provide a complete unfiltered differential expression data (sheet named “all data”), so that readers can filter out any relevant data based on their interest.

      (10) Page 5, bottom: ' ...we showed that the expression of all 12 eIF3 subunits is interconnected such that perturbance of the expression of one subunit results in the down-regulation of entire modules...'. This is not true for eIF3d, as shown in Fig1B and mentioned in Results.

      This reviewer is correct. By this generalized statement, we were trying to summarize our previous results from Wagner et al., 2014, PMID: 24912683; Wagner et al.,2016, PMID: 27924037 and Herrmannova et al.,2020, PMID: 31863585. The eIF3d downregulation is the only exception that does not affect expression of any other eIF3 subunit. Therefore, we have rewritten this paragraph accordingly: “We recently reported a comprehensive in vivo analysis of the modular dynamics of the human eIF3 complex (Wagner et al, 2020; Wagner et al, 2014; Wagner et al., 2016). Using a systematic individual downregulation strategy, we showed that the expression of all 12 eIF3 subunits is interconnected such that perturbance of the expression of one subunit results in the down-regulation of entire modules leading to the formation of partial eIF3 subcomplexes with limited functionality (Herrmannova et al, 2020). eIF3d is the only exception in this respect, as its downregulation does not influence expression of any other eIF3 subunit.”

      (11) Page 10, bottom: ' The PCA plot and hierarchical clustering... These results suggest that eIF3h depletion impacts the translatome differentially than depletion of eIF3e or eIF3d.' This is already obvious in the polysome profiles of Figure S2C.

      We agree that this result is surely not surprising given the polysome profile and growth phenotype analyses of eIF3hKD. But still, we think that the PCA plot and hierarchical clustering results represent valuable controls. Nonetheless, we rephrased this section to note that this result agrees with the polysome profiles analysis: “The PCA plot and hierarchical clustering (Figure 2A and Supplementary Figure 4A) showed clustering of the samples into two main groups: Ribo-Seq and RNA-seq, and also into two subgroups; NT and eIF3hKD samples clustered on one side and eIF3eKD and eIF3dKD samples on the other. These results suggest that the eIF3h depletion has a much milder impact on the translatome than depletion of eIF3e or eIF3d, which agrees with the growth phenotype and polysome profile analyses (Supplementary Figure 1A and 1D).”

      (12) Page 12: ' As for the eIF3dKD "unique upregulated" DTEGs, we identified one interesting and unique KEGG pathway, the ABC transporters (Supplementary Figure 5A, in green).' This sentence is confusing, as there are more pathways that are significant in this group, so it is unclear why the authors consider it 'unique'.

      The eIF3dKD “unique upregulated” group comprises genes with increased TE only in eIF3dKD but not in eIF3eKD or eIF3hKD (500 genes, Fig 2G). All these 500 genes were examined for enrichment in the KEGG pathways, and the top 10 significant pathways were reported (Fig S6A). However, 8 out of these 10 pathways were also significantly enriched in other gene groups examined (e.g. eIF3d/eIF3e common). Therefore, the two remaining pathways (“ABC transporters” and “Other types of O-glycan biosynthesis”) are truly unique for eIF3dKD. We wanted to highlight the ABC transporters group in particular because we find it rather interesting (for the reasons mentioned in the article). We have corrected the sentence in question to avoid confusion: “Among the eIF3dKD “unique upregulated” DTEGs, we identified one interesting KEGG pathway, the ABC transporters, which did not show up in other gene groups (Supplementary Figure 6A, in green). A total of 12 different ABC transporters had elevated TE (9 of them are unique to eIF3dKD, while 3 were also found in eIF3eKD), 6 of which (ABCC1-5, ABCC10) belong to the C subfamily, known to confer multidrug resistance with alternative designation as multidrug resistance protein (MRP1-5, MRP7) (Sodani et al, 2012).

      Interestingly, all six of these ABCC transporters were upregulated solely at the translational level (Supplementary Spreadsheet S2).”    

      (13) Note typo ('Various') in Figure 4A.

      Corrected

      (14) The introduction could be shortened.

      This is a very subjective requirement. In fact, when this manuscript was reviewed in NAR, we were asked by two reviewers to expand it substantially. Because a number of various research topics come together in this work, e.g. translational regulation, the eIF3 structure and function, MAPK/ERK signaling, we are convinced that all of them demand a comprehensive introduction for non-experts in each of these topics. Therefore, with all due respect to this reviewer, we did not ultimately shorten it.

      Reviewer #2 (Recommendations For The Authors):

      - In Figure 2, it would be useful to know why eIF3d is destabilized by eIF3e knockdown - is it protein degradation and why do the eIF3d/e knockdowns not more completely phenocopy each other when there is the same reduction to eIF3d as in the eIF3d knockdown sample?

      Yes, we do think that protein degradation lies behind the eIF3d destabilization in the eIF3eKD, but we have not yet directly demonstrated this. However, we have shown that eIF3d mRNA levels are not altered in eIF3eKD and that Ribo-Seq data indicate no change in TE or FP for eIF3d-encoding mRNA in eIF3eKD. Nonetheless, it is important to note (and we discuss it in the article) that eIF3d levels in eIF3dKD are lower than eIF3d levels in eIF3eKD (please see Supplementary Figure 1C). In fact, we believe that this is one of the main reasons for the eIF3d/e knockdowns differences.

      - The western blots in Figures 4 and 6 show modest changes to target protein levels and would be strengthened by quantification.

      We have added the quantifications as requested by this reviewer and the reviewer 3.

      - For Figure 4, this figure would be strengthened by experiments showing if the increase in ribosomal protein levels is correlated with actual changes to ribosome biogenesis.

      As suggested, we performed polysome profiling in the presence of EDTA to monitor changes in the 60S/40S ratio, indicating a potential imbalance in the biogenesis of individual ribosome subunits. We found that it was not affected (Figure 3G). In addition, we performed the same experiment, normalizing all samples to the same number of cells (cells were carefully counted before lysis). In this way, we confirmed that eIF3dKD and eIF3eKD cells indeed contain a significantly increased number of ribosomes, in agreement with the western blot analysis (Figure 3H).

      - In Figure 6, there needs to be a nuclear loading control.

      This experiment was repeated with Lamin B1 used as a nuclear loading control – it is now shown as Fig. 5F.

      - For Figure 8, these findings would be strengthened using luciferase reporter assays where the various RNA determinants are experimentally tested. Similarly, 5′ TOP RNA reporters would have been appreciated in Figure 4.

      This is indeed a logical continuation of our work, which represents the current work in progress of one of the PhD students. We apologize, but we consider this time- and resource-demanding analysis out of scope of this article.

      Reviewer #3 (Recommendations For The Authors):

      (1) Within the many effects observed, it is mentioned that eIF3d is known to be overexpressed while eIF3e is underexpressed in many cancers, but knockdown of either subunit decreases MDM2 levels, which would be expected to increase P53 activity and decrease tumor cell transformation. In contrast, they also report that 3e/3d knockdown dramatically increases levels of cJUN, presumably due to increased MAPK activity, and is expected to increase protumor gene expression. Additional discussion is needed to clarify the significance of the findings, which are a bit confusing.

      This is indeed true. However, considering the complexity of eIF3, the largest initiation factor among all, as well as the broad portfolio of its functions, it is perhaps not so surprising that the observed effects are complex and may seem even contradictory in respect to cancer. To acknowledge that, we expanded the corresponding part of discussion as follows: “Here, we demonstrate that alterations in the eIF3 subunit stoichiometry and/or eIF3 subcomplexes have distinct effects on the translatome; for example, they affect factors that play a prominent (either positive or negative) role in cancer biology (e.g., MDM2 and cJUN), but the resulting impact is unclear so far. Considering the complex interactions between these factors as well as the complexity of the eIF3 complex per se, future studies are required to delineate the specific oncogenic and tumor suppressive pathways that play a predominant role in mediating the effects of perturbations in the eIF3 complex in the context of neoplasia.”

      (2) There are places in the text where the authors refer to changes in transcriptional control when RNA levels differ, but transcription versus RNA turnover wasn't tested, e.g. page 16 and Figure S10, qPCR does not confirm "transcriptional upregulation in all three knockdowns" and page 19 "despite apparent compensatory mechanisms that increase their transcription."

      This is indeed true, the sentences in question were corrected. The term “increased mRNA levels” was used instead of transcriptional upregulation (increased mRNA stabilization is also possible).

      (3) Similarly, the authors suggest that steady-state LARP1 protein levels are unaffected based on ribosome footprint counts (page 21). It is incorrect to assume this, because ribosome footprints can be elevated due to stalling on RNA that isn't being translated and doesn't yield more protein, and because levels of translated RNA/synthesized proteins do not always reflect steady-state protein levels, especially in mutants that could affect lysosome levels and protein turnover. Also page 12, 1st paragraph suggests protein production is down when ribosome footprints are changed.

      Yes, we are well-aware of this known limitation of Ribo-seq analysis. Therefore, the steadystate protein levels of our key hits were verified by western blotting. In addition, we have removed the sentence about LARP1 because it was based on Ribo-Seq data only without experimental evaluation of the steady-state LARP1 protein levels.

      (4) The translation buffering effect is not clear in some Figures, e.g. S6, S8, 8A, and B. The authors show a scheme for translationally buffered RNAs being clustered in the upper right and lower left quadrants in S4H (translation up with transcript level down and v.v.), but in the FP versus RNA plots, the non-TOP RNAs and 4E-P-regulated RNAs don't show this behavior, and appear to show a similar distribution to the global changes. Some of the right panels in these figures show modest shifts, but it's not clear how these were determined to be significant. More information is needed to clarify, or a different presentation, such as displaying the RNA subsets in the left panels with heat map coloring to reveal whether RNAs show the buffered translation pattern defined in purple in Figure S4H, or by reporting a statistical parameter or number of RNAs that show behavior out of total for significance. Currently the conclusion that these RNAs are translationally buffered seems subjective since there are clearly many RNAs that don't show changes, or show translation-only or RNA-only changes.

      We would like to clarify that S4H does not indicate a necessity for changes in FPs in the buffered subsets. Although opposing changes in total mRNA and FPs are classified as buffering, often we also consider the scenario where there are changes to the total mRNA levels not accompanied by changes in ribosome association.

      In figure S6, the scatterplots indicate a high density of genes shifted towards negative fold changes on the x-axis (total mRNA). This is also reflected in the empirical cumulative distribution functions (ecdfs) for the log2 fold changes in total mRNA in the far right panels of A and B, and the lack of changes in log2 fold change for FPs (middle panels). Similarly, in figure S8, the scatterplots indicate a density of genes shifted towards positive fold changes on the x-axis for total mRNA. The ecdfs also demonstrate that there is a significant directional shift in log2 fold changes in the total mRNA that is not present to a similar degree in the FPs, consistent with translational offsetting. It is rightly pointed out that not all genes in these sets follow the same pattern of regulation. We have revised the title of Supplementary Figure S6 (now S7) to reflect this. However, we would like to emphasize that these figures are not intended to communicate that all genes within these sets of interest are regulated in the same manner, but rather that when considered as a whole, the predominant effect seen is that of translational offsetting (directional shifts in the log2 fold change distribution of total mRNA that are not accompanied by similar shifts in FP mRNA log2 fold changes).

      The significance of these differences was determined by comparing the ecdfs of the log2 fold changes for the genes belonging to a particular set (e.g. non-TOP mTOR-sensitive, p-eIF4E-sensitive) against all other expressed genes (background) using a Wilcoxan rank sum test. This allows identification of significant shifts in the distributions that have a clear directionality (if there is an overall increase, or decrease in fold changes of FPs or total mRNA compared to background). If log2 fold changes are different from background, but without a clear directionality (equally likely to be increased or decreased), the test will not yield a significant result. This approach allows assessment of the overall behavior of gene signatures within a given dataset in a manner that is completely threshold-independent, such that it does not rely on classification of genes into different regulatory categories (translation only, buffering, etc.) based on significance or fold-change cut-offs (as in S4H). Therefore, we believe that this unbiased approach is well-suited for identifying cases when there are many genes that follow similar patterns of regulation within a given dataset.

      (5) Page 10-"These results suggest that eIF3h depletion impacts the translatome differentially than depletion of eIF3e or eIF3d" ...These results suggest that eIF3h has less impact on the translatome, not that it does so differently. If it were changing translation by a different mechanism, I would not expect it to cluster with control.

      This sentence was rewritten as follows: “The PCA plot and hierarchical clustering (Figure 2A and Supplementary Figure 4A) showed clustering of the samples into two main groups: RiboSeq and RNA-seq, and also into two subgroups; NT and eIF3hKD samples clustered on one side and eIF3eKD and eIF3dKD samples on the other. These results suggest that the eIF3h depletion has a much milder impact on the translatome than depletion of eIF3e or eIF3d, which agrees with the growth phenotype and polysome profile analyses (Supplementary Figure 1A and 1D).”

      Other minor issues:

      (1) There are some typos: Figure 2 leves, Figure 4 variou,

      Corrected.

      (2) Figure 3, font for genes on volcano plot too small

      Yes, maybe, however the resolution of this image is high enough to enlarge a certain part of it at will. In our opinion, a larger font would take up too much space, which would reduce the informativeness of this graph.

      (3) Figure S5, highlighting isn't defined.

      The figure legend for S5A (now S6A) states: “Less significant terms ranking 11 and below are in grey. Terms specifically discussed in the main text are highlighted in green.” Perhaps it was overlooked by this reviewer.

      (4) At several points the authors refer to "the MAPK signaling pathway", suggesting there is a single MAPK that is affected, e.g in the title, page 3, and other places when it seems they mean "MAPK signaling pathways" since several MAPK pathways appear to be affected.

      We apologize for any terminological inaccuracies. There are indeed several MAPK pathways operating in cells. In our study, we focused mainly on the MAPK/ERK pathway. The confusion probably stems from the fact that the corresponding term in the KEGG pathway database is labeled "MAPK signaling pathway" and this term, although singular, includes all MAPK pathways. We have carefully reviewed the entire article and have corrected the term used accordingly to either: 1) MAPK pathways in general, 2) the MAPK/ERK pathway for this particular pathway, or 3) "MAPK signaling pathway", where the KEGG term is meant.

      (5) Some eIF3 subunit RNAs have TOP motifs. One might expect 3e and 3h levels to change as a function of 3d knockdown due to TOP motifs but this is not observed. Can the authors speculate why the eIF3 subunit levels don't change but other TOP RNAs show TE changes? Is this true for other translation factors, or just for eIF3, or just for these subunits? Could the Western blot be out of linear range for the antibody or is there feedback affecting eIF3 levels differently than the other TOP RNAs, or a protein turnover mechanism to maintain eIF3 levels?

      This is indeed a very interesting question. In addition to the mRNAs encoding ribosomal proteins, we examined all TOP mRNAs and added an additional sheet to the S2 supplemental spreadsheet with all TOP RNAs listed in (Philippe et al., 2020, PMID: 32094190). According to our Ribo-Seq data, we could expect to see increased protein levels of eIF3a and eIF3f in eIF3dKD and eIF3eKD, but this is not the case, as judged from extensive western blot analysis performed in (Wagner et. al 2016, PMID: 27924037). Indeed, we cannot rule out the involvement of a compensatory mechanism monitoring and maintaining the levels of eIF3 subunits at steady-state – increasing or decreasing them if necessary, which could depend on the TOP motif-mediated regulation. However, we think that in our KDs, all non-targeted subunits that lose their direct binding partner in eIF3 due to siRNA treatment become rapidly degraded. For example, co-downregulation of subunits d, k and l in eIF3eKD is very likely caused by protein degradation as a result of a loss of their direct binding partner – eIF3e. Since we showed that the yeast eIF3 complex assembles co-translationally (Wagner et. al 2020, PMID: 32589964), and there is no reason to think that mammalian eIF3 differs in this regard, our working hypothesis is that free subunits that are not promptly incorporated into the eIF3 complex are rapidly degraded, and the presence or absence of the TOP motif in the 5’ UTR of their mRNAs has no effect. As for the other TOP mRNAs, translation factors eEF1B2, eEF1D, eEF1G, eEF2 have significantly increased FPs in both eIF3dKD and eIF3eKD, but we did not check their protein levels by western blotting to conclude anything specific.

    1. Author response:

      The following is the authors’ response to the original reviews.

      The detailed, thorough critique provided by the three reviewers is very much appreciated. We believe the manuscript is greatly improved by the changes we have made based on those reviews. The major changes are described below, followed by a point by point response.

      Major Changes:

      (1) We revised our model (old Fig. 10; new Fig. 9) to keep the explanation focused on the data shown in the current study. Specifically, references to GTP/GDP states of Rab3A and changes in the presynaptic quantum have been removed and the mechanisms depicted are confined to pre- or post-synaptic Rab3A participating in either controlling release of a trophic factor that regulates surface GluA2 receptors (pre- or postsynaptic) or directly affecting fusion of GluA2-receptor containing vesicles (postsynaptic).

      (2) We replaced all cumulative density function plots and ratio plots, based on multiple quantile samples per cell, with box plots of cell means. This affects new Figures 1, 2, 3, 5, 6, 7 and 8. All references to “scaling,” “divergent scaling,” or “uniform scaling,” have been removed. New p values for comparison of means are provided above every box plot in Figures 1, 2, 3, 5, 6, 7 and 8. The number of cultures is provided in the figure legends.

      (3) We have added frequency to Figures 1, 2 and 8. Frequency values overall are more variable, and the effect of activity blockade less robust, than for mEPSC amplitudes. We have added text indicating that the increase in frequency after activity blockade was significant in neurons from cultures prepared from WT in the Rab3A+/- colony but not cultures prepared from KO mice (Results, lines 143 to 147, new Fig. 1G. H). The TTX-induced increase in frequency was significant in the NASPM experiments before NASPM, but not after NASPM (Results, lines 231 to 233, new Fig. 3, also cultures from WT in Rab3A+/- colony). The homeostatic plasticity effect on frequency did not reach significance in WT on WT glia cultures or

      WT on KO glia cultures, possibly due to the variability of frequency, combined with smaller sample sizes (Results, lines 400 to 403, new Fig. 8). In the cultures prepared from WT mice in the Rab3A+/Ebd colony, there was a trend towards higher frequency after TTX that did not reach statistical significance, and in cultures prepared from mutant mice, the p value was large, suggesting disruption of the effect, which appears to be due to an increase in frequency in untreated cultures, similar to the behavior of mEPSC amplitudes in neurons from mutant mice (Results, lines 161-167). In sum, the effect of activity on frequency requires Rab3A and Ca2+-permeable receptors, and is mimicked by the presence of the Rab3A Earlybird mutant. We have also added a discussion of these results (Discussion, lines 427-435). 

      (4) In the revised manuscript we have added analysis of VGLUT1 levels for the same synaptic sites that we previously analyzed GluA2 levels, and these data are described in Results, lines 344 to 371, and appear in new Table 2. In contrast to previous studies, we did not find any evidence for an increase in VGLUT1 levels after activity blockade. We reviewed those studies to determine whether there might be differences in the experimental details that could explain the lack of effect we observed. In (De Gois et al., 2005), the authors measured mRNA and performed western blots to show increases in VGLUT1 after TTX treatment in older rat cortical cultures (DIV 19). The study performs immunofluorescence imaging of VGLUT1 but only after bicuculline treatment (it decreases), not after TTX treatment. In (Wilson et al.,

      2005), the hippocampal cultures are treated with AP5, not TTX, and the VGLUT1 levels in immunofluorescence images are reported relative to synapsin I. That the type of activity blockade matters is illustrated by the failure of Wilson and colleagues to observe a consistent increase in VGLUT1/Synapsin ratio in cultures treated with AMPA receptor blockade (NBQX; supplementary information). These points have been added to the Discussion, lines 436 to 447.)

      Reviewer #1:

      (1) (model…is not supported by the data), (2) (The analysis of mEPSC data using quantile sampling…), (3) (…statistical analysis of CDFs suffers from n-inflation…), (4) (How does recording noise and the mEPSC amplitude threshold affect “divergent scaling?”) (5) (…justification for the line fits of the ratio data…), (7) (A comparison of p-values between conditions….) and (10) (Was VGLUT intensity altered in the stainings presented in the manuscript?)

      The major changes we made, described above, address Reviewer #1’s points. The remaining points are addressed below.

      (6) TTX application induces a significant increase in mEPSC amplitude in Rab3A-/- mice in two out of three data sets (Figs. 1 and 9). Hence, the major conclusion that Rab3A is required for homeostatic scaling is only partially supported by the data. 

      The p values based on CDF comparisons were problematic, but the point we were making is that they were much larger for amplitudes measured in cultures prepared from Rab3A-/- mice (Fig. 1, p = 0.04) compared to those from cultures prepared from Rab3A+/+ mice (Fig. 1, p = 4.6 * 10-4). Now that we are comparing means, there are no significant TTX-induced effects on mEPSC amplitudes for Rab3A-/- data. However, acknowledging that some increase after activity blockade remains, we describe homeostatic plasticity as being impaired or not significant, rather than abolished, by loss of Rab3A, (Abstract, lines 37 to 39; Results, lines 141 to 143; Discussion, lines 415 to 418).

      (8) There is a significant increase in baseline mEPSC amplitude in Rab3AEbd/Ebd (15 pA) vs. Rab3AEbd/+ (11 pA) cultures, but not in Rab3A-/- (13.6 pA) vs. Rab3A+/- (13.9 pA). Although the nature of scaling was different between Rab3AEbd/Ebd vs. Rab3AEbd/+ and Rab3AEbd/Ebd with vs. without TTX, the question arises whether the increase in mEPSC amplitude in Rab3AEbd/Ebd is Rab3A dependent. Could a Rab3A independent mechanism occlude scaling?

      The Reviewer is concerned that the increase in mEPSC amplitude in the presence of the Rab3A point mutant may be through a ‘non-Rab3A’ mechanism (a concern raised by the lack of such effect in cultures from the Rab3A-/- mice), and secondly, that the already large mEPSC cannot be further increased by the homeostatic plasticity mechanism. It must always be considered that a mutant with an altered genetic sequence may bind to novel partners, causing activities that would not be either facilitated or inhibited by the original molecule. We have added this caveat to Results, lines 180 to 186 We added that a number of other manipulations, implicating individual molecules in the homeostatic mechanism, have caused an increase in mEPSC amplitude at baseline, potentially nonspecifically occluding the ability of activity blockade to induce a further increase (Results lines 186 to 189). Still, it is a strong coincidence that the novel activity of the mutant Rab3A would affect mEPSC amplitude, the same characteristic that is affected by activity blockade in a Rab3A dependent manner, a point which we added to Results, lines 189 to 191.

      (9) Figure 4: NASPM appears to have a stronger effect on mEPSC frequency in the TTX condition vs. control (-40% vs -15%). A larger sample size might be necessary to draw definitive conclusions on the contribution of Ca2+-permeable AMPARs.

      Our results, even with the modest sample size of 11 cells, are clear: NASPM does not disrupt the effect of TTX treatment on mEPSC amplitude (new Fig. 3A). It also looks like there is a greater magnitude effect of NAPSM on frequency in TTX-treated cells; we note this, but point out that nevertheless, these mEPSCs are not contributing to the increase in mEPSC amplitude (Results, lines 238-241). 

      (11) The change in GluA2 area or fluorescence intensity upon TTX treatment in controls is modest. How does the GluA2 integral change?

      We had reported that GluA2 area showed the most prominent increase following activity blockade, with intensity changing very little. When we examined the integral, it closely matched the change in area. We have added the values for integral to new Fig. 5 D, H; new Fig. 6 A-C; new Fig. 7 A-C and new Table 1 (for GluA2) and new Table 2 (for VGLUT1). These results are described in the text in the following places: Results, lines 289-292; 298-299; 311-319; 328-324). For VGLUT1, both area and intensity changed modestly, and the integral appeared to be a combination of the two, being higher in magnitude and resulting in smaller p values than either area or intensity (Results, lines 344-348; 353-359; new Table 2).

      (12) The quantitative comparison between physiology and microscopy data is problematic. The authors report a mismatch in ratio values between the smallest mEPSC amplitudes and the smallest GluA2 receptor cluster sizes (l. 464; Figure 8). Is this comparison affected by the fluorescence intensity threshold? What was the rationale for a threshold of 400 a.u. or 450 a.u.? How does this threshold compare to the mEPSC threshold of 3 pA.

      This concern is partially addressed by no longer comparing the rank ordered mEPSC amplitudes with the rank ordered GluA2 receptor characteristics. We had used multiple thresholds in the event that an experiment was not analyzable with the chosen threshold (this in fact happened for VGLUT1, see end of this paragraph). We created box plots of the mean GluA2 receptor cluster size, intensity and integral, for experiments in which we used all three thresholds, to determine if the effect of activity blockade was different depending on which threshold was applied, and found that there was no obvious difference in the results (Author response image 1). Nevertheless, since there is no need to use a different threshold for any of the 6 experiments (3 WT and 3KO), for new Figures 5, 6 and 7 we used the same threshold for all data, 450; described in Methods, lines 746 to 749. For VGLUT1 levels, it was necessary to use a different threshold for Rab3A+/+ Culture #1 (400), but a threshold of 200 for the other five experiments (Methods, lines 751-757). The VGLUT1 immunofluorescent sites in Culture #1 had higher levels overall, and the low threshold caused the entire AOI to be counted as the synapse, which clearly included background levels outside of the synaptic site. Conversely, to use a threshold of 400 on the other experiments meant that the synaptic site found by the automated measurement tool was much smaller that what was visible by eye. In our judgement it would have been meaningless to adhere to a single threshold for VGLUT1 data.

      Author response image 1.

      Using different thresholds does not substantially alter GluA2 receptor cluster size data. A) Rab3A+/+ Culture #1, size data for three different thresholds, depicted above each graph. B) Rab3A+/+ Culture #2, size data for three different thresholds, depicted above each graph. Note scale bar in A is different from B, to highlight differences for different thresholds. (Culture #3 was only analyzed with 450 threshold).

      The conclusion that an increase in AMPAR levels is not fully responsible for the observed mEPSC increase is mainly based on the rank-order analysis of GluA2 intensity, yielding a slope of ~0.9. There are several points to consider here: (i) GluA2 fluorescence intensity did increase on average, as did GluA2 cluster size.

      (ii) The increase in GluA2 cluster size is very similar to the increase in mEPSC amplitude (each approx. 1820%). (iii) Are there any reports that fluorescence intensity values are linearly reporting mEPSC amplitudes (in this system)? Antibody labelling efficiency, and false negatives of mEPSC recordings may influence the results. The latter was already noted by the authors.

      Our comparison between mEPSC amplitude and GluA2 receptor cluster characteristics has been reexamined in the revised version using means rather than rank-ordered data in rank-order plots or ratio plots. Importantly, all of these methods revealed that in one out of three WT cultures (Culture #3) GluA2 receptor cluster size (old Fig. 8, old Table 1; new Fig. 6, new Table 1), intensity and integral (new Fig. 6, new Table 1) values decreased following activity blockade while in the same culture, mEPSC amplitudes increased. It is based on this lack of correspondence that we conclude that increases in mEPSC amplitude are not fully explained by increases in GluA2 receptors, and suggest there may be other contributors. These points are made in the Abstract (lines 108-110); Results (lines 319 to 326; 330337; 341-343) and the Discussion (lines 472 to 474). To our knowledge, there are not any reports that quantitatively compare receptor levels (area, intensity or integrals) to mEPSC amplitudes in the same cultures. We examined the comparisons very closely for 5 studies that used TTX to block activity and examined receptor levels using confocal imaging at identified synapses (Hou et al., 2008; Ibata et al., 2008; Jakawich et al., 2010a; Xu and Pozzo-Miller, 2017; Dubes et al., 2022). We were specifically looking for whether the receptor data were more variable than the mEPSC amplitude data, as we found. However, for 4 of the studies, sample sizes were very different so that we cannot simply compare the p values. Below is a table of the comparisons.

      Author response table 1.

      In Xu 2017 the sample sizes are close enough that we feel comfortable concluding that the receptor data were slightly more variable (p < 0.05) than mEPSC data (p<0.01) but recognize that it is speculative to say our finding has been confirmed. A discussion of these articles is in Discussion, lines 456-474.

      (iv) It is not entirely clear if their imaging experiments will sample from all synapses. Other AMPAR subtypes than GluA2 could contribute, as could kainite or NMDA receptors.

      While our imaging data only examined GluA2, we used the application of NASPM to demonstrate Ca2+permeable receptors did not contribute quantitatively to the increase in mEPSC amplitude following TTX treatment. Since GluA3 and GluA4 are also Ca2+-permeable, the findings in new Figure 3 (old Fig. 4) likely rule out these receptors as well.  There are also reports that Kainate receptors are Ca2+-permeable and blocked by NASPM (Koike et al., 1997; Sun et al., 2009), suggesting the NASPM experiment also rules out the contribution of Kainate receptors. Finally, given our recording conditions, which included normal magnesium levels in the extracellular solution as well as TTX to block action-potential evoked synaptic transmission, NMDA receptors would not be available to contribute currents to our recordings due to block by magnesium ions at resting Vm. These points have been added to the Methods section, lines 617 to 677 (NMDA); 687-694 (Ca2+-permeable AMPA receptors and Kainate receptors).

      Furthermore, the statement “complete lack of correspondence of TTX/CON ratios” is not supported by the data presented (l. 515ff). First, under the assumption that no scaling occurs in Rab3A-/-, the TTX/CON ratios show a 20-30% change, which indicates the variation of this readout. Second, the two examples shown in Figure 8 for Rab3A+/+ are actually quite similar (culture #1 and #2, particularly when ignoring the leftmost section of the data, which is heavily affected by the raw values approaching zero.

      We are no longer presenting ratio plots in the revised manuscript, so we do not base our conclusion that mEPSC amplitude data is not always corresponding to GluA2 receptor data on the difference in behavior of TTX/CON ratio values, but only on the difference in direction of the TTX effect in one out of three cultures. We agree with the reviewer that the ratio plots are much more sensitive to differences between control and treated values than the rank order plot, and we feel these differences are important, for example, there is still a homeostatic increase in the Rab3A-/- cultures, and the effect is still divergent rather than uniform. But the comparison of ratio data will be presented elsewhere.

      (13) Figure 7A: TTX CDF was shifted to smaller mEPSC amplitude values in Rab3A-/- cultures. How can this be explained?

      While this result is most obvious in CDF plots, we still observe a trend towards smaller mEPSC amplitudes after TTX treatment in two of three individual cultures prepared from Rab3A-/- mice when comparing means (new Fig. 7, Table 1) which did not reach statistical significance for the pooled data (new Fig. 5, new Table 1). There was not any evidence of this decrease in the larger data set (new Fig. 1) nor for Rab3A-/- neurons on Rab3A+/+ glia (new Fig. 8). Given that this effect is not consistent, we did not comment on it in the revised manuscript. It may be that there is a non-Rab3A-dependent mechanism that results in a decrease in mEPSC amplitude after activity blockade, which normally pulls down the magnitude of the activity-dependent increase typically observed. But studying this second component would be difficult given its magnitude and inconsistent presentation.

      Reviewer #1 (Recommendations For the Authors):

      (1) Abstract, last sentence: The conclusion of the present manuscript should be primarily based on the results presented. At present, it is mainly based on a previous publication by the authors.

      We have revised the last sentence to reflect actual findings of the current study (Abstract, lines 47 to 49).

      (2) Line 55: “neurodevelopmental”

      This phrase has been removed.

      (3) Line 56: “AMPAergic” should be replaced by AMPAR-mediated

      This sentence was removed when all references to “scaling” were removed; no other instances of “AMPAergic” are present.

      (4) Figure 9: The use of BioRender should be disclosed in the Figure Legend.

      We used BioRender in new Figures 3, 7 and 8, and now acknowledge BioRender in those figure legends.

      (5) Figure legends and results: The number of cultures should be indicated for each comparison.

      Number of cultures has been added to the figure legends.

      (6) Line 289: A comparison of p-values between conditions does not allow any meaningful conclusions.

      Agreed, therefore we have removed CDFs and the KS test comparison p values. All comparisons in the revised manuscript are for cell means.

      (7) Line 623ff: The argument referring to NMJ data is weak, given that different types of receptors are involved.

      We still think it is valid to point out that Rab3A is required for the increase in mEPC at the NMJ but that ACh receptors do not increase (Discussion, lines 522 to 525). We are not saying that postsynaptic receptors do not contribute in cortical cultures, only that there could be another Rab3A-dependent mechanism that also affects mEPSC amplitude.

      (8) Plotting data points outside of the ranges should be avoided (e.g., Fig. 2Giii, 7F).

      These two figures are no longer present in the revised manuscript. In revising figures, we made sure no other plots have data points outside of the ranges.

      (9) The rationale for investigating Rab3AEbd/Ebd remains elusive and should be described.

      A rationale for investigating Rab3AEbd/Ebd is that if the results are similar to the KO, it strengthens the evidence for Rab3A being involved in homeostatic synaptic plasticity. In addition, since its phenotype of early awakening was stronger than that demonstrated in Rab3A KO mice (Kapfhamer et al., 2002), it was possible we would see a more robust effect. These points have been added to the Results, lines 118 to 126.

      (10) Figures 3 and 4, as well as Figure 5 and 6 could be merged.

      In the revised version, Figure 3 has been eliminated since its main point was a difference in scaling behavior. Figure 4 has been expanded to include a model of how NASPM could reduce frequency (new Fig. 3.) Images of the pyramidal cell body have been added to Figure 5 (new Fig. 4), and Figure 6 has been completely revised and now includes pooled data for both Rab3A+/+ and Rab3A-/- cultures, for mEPSC amplitude, GluA2 receptor cluster size, intensity and integral.

      (11) Figure 5: The legend refers to MAP2, but this is not indicated in the figure.

      MAP2 has now been added to the labels for each image and described in the figure legend (new Fig. 4).

      Reviewer #2:

      Technical concerns:

      (1) The culture condition is questionable. The authors saw no NMDAR current present during spontaneous recordings, which is worrisome since NMDARs should be active in cultures with normal network activity (Watt et al., 2000; Sutton et al., 2006). It is important to ensure there is enough spiking activity before doing any activity manipulation. Similarly it is also unknown whether spiking activity is normal in Rab3AKO/Ebd neurons.

      In the studies cited by the reviewer, NMDA currents were detected under experimental conditions in which magnesium was removed. In our recordings, we have normal magnesium (1.3 mM) and also TTX, which prevents the necessary depolarization to allow inward current through NMDA receptors. This point has been added to our Methods, lines 674 to 677. We acknowledge we do not know the level of spiking in cultures prepared from Rab3A+/+, Rab3A-/- or Rab3A_Ebd/Ebd_ mice. Given the similar mEPSC amplitude for untreated cultures from WT and KO studies, we think it unlikely that activity was low in the latter, but it remains a possibility for untreated cultures from Rab3A_Ebd/Ebd_ mice, where mEPSC amplitude was increased. These points are added to the Methods, lines 615 to 622.

      (2) Selection of mEPSC events is not conducted in an unbiased manner. Manually selecting events is insufficient for cumulative distribution analysis, where small biases could skew the entire distribution. Since the authors claim their ratio plot is a better method to detect the uniformity of scaling than the well-established rank-order plot, it is important to use an unbiased population to substantiate this claim.

      We no longer include any cumulative distributions or ratio plot analysis in the revised version. We have added the following text to Methods, lines 703 to 720:

      “MiniAnalysis selects many false positives with the automated feature when a small threshold amplitude value is employed, due to random fluctuations in noise, so manual re-evaluation of the automated process is necessary to eliminate false positives. If the threshold value is set high, there are few false positives but small amplitude events that visually are clearly mEPSCs are missed, and manual re-evaluation is necessary to add back false negatives or the population ends up biased towards large mEPSC amplitudes. As soon as there is a manual step, bias is introduced. Interestingly, a manual reevaluation step was applied in a recent study that describes their process as ‘unbiased (Wu et al., 2020). In sum, we do not believe it is currently possible to perform a completely unbiased detection process. A fully manual detection process means that the same criterion (“does this look like an mEPSC?”) is applied to all events, not just the false positives, or the false negatives, which prevents the bias from being primarily at one end or the other of the range of mEPSC amplitudes. It is important to note that when performing the MiniAnalysis process, the researcher did not know whether a record was from an untreated cell or a TTX-treated cell.”

      (3) Immunohistochemistry data analysis is problematic. The authors only labeled dendrites without doing cell-fills to look at morphology, so it is questionable how they differentiate branches from pyramidal neurons and interneurons. Since glutamatergic synapse on these two types of neuron scale in the opposite directions, it is crucial to show that only pyramidal neurons are included for analysis.

      We identified neurons with a pyramidal shape and a prominent primary dendrite at 60x magnification without the zoom feature. This should have been made clear in the description of imaging. We have added an image of the two selected cells to our figure of dendrites (old Fig. 5, new Fig. 4), and described this process in the Methods, lines 736 to 739, and Results, lines 246 to 253. Given the morphology of the neurons selected it is highly unlikely that the dendrites we analyzed came from interneurons.

      Conceptual Concerns

      The only novel finding here is the implicated role for Rab3A in synaptic scaling, but insights into mechanisms behind this observation are lacking. The authors claim that Rab3A likely regulates scaling from the presynaptic side, yet there is no direct evidence from data presented. In its current form, this study’s contribution to the field is very limited.

      We have demonstrated that loss of Rab3A and expression of a Rab3A point mutant disrupt homeostatic plasticity of mEPSC amplitudes, and that in the absence of Rab3A, the increase in GluA2 receptors at synaptic sites is abolished. Further, we show that this effect cannot be through release of a factor, like TNFα, from astrocytes. In the new version, we add the finding that VGLUT1 is not increased after activity blockade, ruling out this presynaptic factor as a contributor to homeostatic increases in mEPSC amplitude. We show for the first time by examining mEPSC amplitudes and GluA2 receptors in the same cultures that the increases in GluA2 receptors are not as consistent as the increases in mEPSC amplitude, suggesting the possibility of another contributor to homeostatic increases in mEPSC amplitude. We first proposed this idea in our previous study of Rab3A-dependent homeostatic increases in mEPC amplitudes at the mouse neuromuscular junction. In sum, we dispute that there is only one novel finding and that we have no insights into mechanism. We acknowledge that we have no direct evidence for regulation from the presynaptic side, and have removed this claim from the revised manuscript. We have retained the Discussion of potential mechanisms affecting the presynaptic quantum and evidence that Rab3A is implicated in these mechanisms (vesicle size, fusion pore kinetics; Discussion, lines 537 to 563). One way to directly show that the amount of transmitter released for an mEPSC has been modified after activity blockade is to demonstrate that a fast off-rate antagonist has become less effective at inhibiting mEPSCs (because the increased glutamate released out competes it; see (Liu et al., 1999) and (Wilson et al., 2005) for example experiments). This set of experiments is underway but will take more time than originally expected, because we are finding surprisingly large decreases in frequency, possibly the result of mEPSCs with very low glutamate concentration that are completely inhibited by the dose used. Once mEPSCs are lost, it is difficult to compare the mEPSC amplitude before and after application of the antagonist. Therefore we intend to include this experiment in a future report, once we determine the reason for the frequency reduction, or, can find a dose where this does not occur.

      (1) Their major argument for this is that homeostatic effects on mEPSC amplitudes and GluA2 cluster sizes do not match. This is inconsistent with reports from multiple labs showing that upscaling of mEPSC amplitude and GluA2 accumulation occur side by side during scaling (Ibata et al., 2008; Pozo et al., 2012; Tan et al., 2015; Silva et al., 2019). Further, because the acquisition and quantification methods for mEPSC recordings and immunohistochemistry imaging are entirely different (each with its own limitations in signal detection), it is not convincing that the lack of proportional changes must signify a presynaptic component.

      Within the analyses in the revised manuscript, which are now based only on comparison of cell/dendrite means, we find a very good match in the magnitude of increase for the pooled data of mEPSC amplitudes and GluA2 receptor cluster sizes (+19.7% and +20.0% respectively; new Table 1). However, when looking at individual cultures, we had one of three WT cultures in which mEPSC amplitude increased 17.2% but GluA2 cluster size decreased 9.5%. This result suggests that while activity blockade does lead to an increase in GluA2 receptors after activity blockade, the effect is more variable than that for mEPSC amplitude. We went back to published studies to see if this has been previously observed, but found that it was difficult to compare because the sample sizes were different for the two characteristics (see Author response table 1). We included these particular 5 studies because they use the same treatment (TTX), examine receptors using imaging of identified synaptic sites, and record mEPSCs in their cultures (although the authors do not indicate that imaging and recordings are done simultaneously on the same cultures.) Only one of the studies listed by the Reviewer is in our group (Ibata et al., 2008). The study by (Tan et al., 2015) uses western blots to measure receptors; the study by (Silva et al., 2019) blocks activity using a combination of AMPA and NMDA receptor blockers; the study by (Pozo et al., 2012) correlates mEPSC amplitude changes with imaging but not in response to activity blockade, instead for changing the expression of GluA2. While it may seem like splitting hairs to reject studies that use other treatment protocols, there is ample evidence that the mechanisms of homeostatic plasticity depend on how activity was altered, see the following studies for several examples of this (Sutton et al., 2006; Soden and Chen, 2010; Fong et al., 2015). A discussion of the 5 articles we selected is in the revised manuscript, Discussion, lines 456 to 474. In sum, we provide evidence that activity blockade is associated with an overall increase in GluA2 receptors; what we propose is that this increase, being more variable, does not fully explain the increase in mEPSC amplitude. However, we acknowledge that the disparity could be explained by the differences in limitations of the two methods (Discussion, lines 469-472).

      (2) The authors also speculate in the discussion that presynaptic Rab3A could be interacting with retrograde BDNF signaling to regulate postsynaptic AMPARs. Without data showing Rab3A-dependent presynaptic changes after TTX treatment, this argument is not compelling. In this retrograde pathway, BDNF is synthesized in and released from dendrites (Jakawich et al., 2010b; Thapliyal et al., 2022), and it is entirely possible for postsynaptic Rab3A to interfere with this process cell-autonomously.

      We have added the information that Rab3A could control BDNF from the postsynaptic cell and included the two references provided by the reviewer, Discussion, lines 517 to 518. We have added new evidence, recently published, that the Rab3 family has been shown to regulate targeting of EGF receptors to rafts (among other plasma membrane molecules), with Rab3A itself clearly present in nonneuronal cells (Diaz-Rohrer et al., 2023) (added to Discussion, lines 509 to 515).

      (3) The authors propose that a change in AMPAR subunit composition from GluA2-containing ones to GluA1 homomers may account for the distinct changes in mEPSC amplitudes and GluA2 clusters. However, their data from the NASPM wash-in experiments clearly show that the GluA1 homomer contributions have not changed before and after TTX treatment.

      We have revised this section in the Discussion, lines 534 to 536, to clarify that any change due to GluA1 homomers should have been detectable by a greater ability of NASPM to reverse the TTX-induced increase.

      Reviewer #2 (Recommendations for the Authors):

      For authors to have more convincing arguments in general, they will need to clarify/improve certain details in their data collection by addressing the above technical concerns. Additionally, the authors should design experiments to test whether Rab3A regulates scaling from pre- or post-synaptic site. For example, they could sparsely knock out Rab3A in WT neurons to test the postsynaptic possibility. On the other hand, their argument for a presynaptic role would be much more compelling if they could show whether there are clear functional changes such as in vesicle sizes and release probability in the presynaptic terminal of Rab3AKO neurons.

      An important next step is to identify whether Rab3A is acting pre- or post-synaptically (Discussion, lines 572 to 573), but these experiments will be undertaken in the future. It would not add much to simply show vesicle size is altered in the KO (and we do not necessarily expect this since mEPSC amplitude is normal in the KO). It will be very difficult to establish that vesicle size is changing with activity blockade and that this change is prevented in the Rab3A KO, because we are looking for a ~25% increase in vesicle volume, which would correspond to a ~7.5% increase in diameter. Finally, we do not believe demonstrating changes in release probability tell us anything about a presynaptic role for Rab3A in regulating the size of the presynaptic quantum.

      Reviewer #3 (Public Review)

      Weaknesses: However, the rather strong conclusions on the dissociation of AMPAR trafficking and synaptic response are made from somewhat weaker data. The key issue is the GluA2 immunostaining in comparison with the mEPSC recordings. Their imaging method involves only assessing puncta clearly associated with a MAP2 labeled dendrite. This is a small subset of synapses, judging from the sample micrographs (Fig. 5). To my knowledge, this is a new and unvalidated approach that could represent a particular subset of synapses not representative of the synapses contributing to the mEPSC change (they are also sampling different neurons for the two measurements; an additional unknown detail is how far from the cell body were the analyzed dendrites for immunostaining.) While the authors acknowledge that a sampling issue could explain the data, they still use this data to draw strong conclusions about the lack of AMPAR trafficking contribution to the mEPSC amplitude change. This apparent difference may be a methodological issue rather than a biological one, and at this point it is impossible to differentiate these. It will unfortunately be difficult to validate their approach. Perhaps if they were to drive NMDAdependent LTD or chemLTP, and show alignment of the imaging and ephys, that would help. More helpful would be recordings and imaging from the same neurons but this is challenging. Sampling from identified synapses would of course be ideal, perhaps from 2P uncaging combined with SEP-labeled AMPARs, but this is more challenging still. But without data to validate the method, it seems unwarranted to make such strong conclusions such as that AMPAR trafficking does not underlie the increase in mEPSC amplitude, given the previous data supporting such a model.

      In the new version, we soften our conclusion regarding the mismatch between GluA2 receptor levels and mEPSC amplitudes, now only stating that receptors may not be the sole contributor to the TTX effect on mEPSC amplitude (Discussion, lines 472 to 474). With our analysis in the new version focusing on comparisons of cell means, the GluA2 receptor cluster size and the mEPSC amplitude data match well in magnitude for the data pooled across the 3 matched cultures (20.0% and 19.7%, respectively, see new Table 1). However, in one of the three cultures the direction of change for GluA2 receptors is opposite that of mEPSC amplitudes (Table 1, Culture #3, -9.5% vs +17.2%, respectively).

      It is unlikely that the lack of matching of homeostatic plasticity in one culture, but very good matching in two other cultures, can be explained by an unvalidated focus on puncta associated with MAP2 positive dendrites. We chose to restrict analysis of synaptic GluA2 receptors to the primary dendrite in order to reduce variability, reasoning that we are always measuring synapses for an excitatory pyramidal neuron, synapses that are relatively close to the cell body, on the consistently identifiable primary dendrite. We measured how far this was for the two cells depicted in old Figure 5 (new Fig. 4). Because we always used the 5X zoom window which is a set length, and positioned it within ~10 microns of the cell body, these cells give a ball park estimate for the usual distances. For the untreated cell, the average distance from the cell body was 38.5 ± 2.8 µm; for the TTX-treated cell, it was 42.4 ± 3.2 µm (p = 0.35, KruskalWallis test). We have added these values to the Results, lines 270 to 274.

      We did not mean to propose that AMPA receptor levels do not contribute at all to mEPSC amplitude, and we acknowledge there are clear cases where the two characteristics change in parallel (for example, in the study cited by Reviewer #2, (Pozo et al., 2012), increases in GluA2 receptors due to exogenous expression are closely matched by increases in mEPSC amplitudes.) What our matched culture experiments demonstrate is that in the case of TTX treatment, both GluA2 receptors and mEPSC amplitudes increase on average, but sometimes mEPSC amplitudes can increase in the absence of an increase in GluA2 receptors (Culture #3, Rab3A+/+ cultures), and sometimes mEPSC amplitudes do not increase even though GluA2 receptor levels do increase (Culture #3, Rab3A-/- cultures). Therefore, it would not add anything to our argument to examine receptors and mEPSCs in NMDA-dependent LTP, a different plasticity paradigm in which changes in receptors and mEPSCs may more closely align. It has been demonstrated that mEPSCs of widely varying amplitude can be recorded from a single synaptic site (Liu and Tsien, 1995), so we would need to measure a large sample of individual synapse recordings to detect a modest shift in average values due to activity blockade. In addition, it would be essential to express fluorescent AMPA receptors in order to correlate receptor levels in the same cells we record from (or at the same synapses). And yet, even after these heroics, one is still left with the issue that the two methods, electrophysiology and fluorescent imaging, have distinct limitations and sources of variability that may obscure any true quantitative correlation.

      Other questions arise from the NASPM experiments, used to justify looking at GluA2 (and not GluA1) in the immunostaining. First, there is a frequency effect that is quite unclear in origin. One would expect NASPM to merely block some fraction of the post-synaptic current, and not affect pre-synaptic release or block whole synapses. It is also unclear why the authors argue this proves that NASPM was at an effective concentration (lines 399-400). Further, the amplitude data show a strong trend towards smaller amplitude. The p value for both control and TTX neurons was 0.08 – it is very difficult to argue that there is no effect. And the decrease is larger in the TTX neurons. Considering the strong claims for a presynaptic locus and the use of this data to justify only looking at GluA2 by immunostaining, these data do not offer much support of the conclusions. Between the sampling issues and perhaps looking at the wrong GluA subunit, it seems premature to argue that trafficking is not a contributor to the mEPSC amplitude change, especially given the substantial support for that hypothesis. Further, even if trafficking is not the major contributor, there could be shifts in conductance (perhaps due to regulation of auxiliary subunits) that does not necessitate a pre-synaptic locus. While the authors are free to hypothesize such a mechanism, it would be prudent to acknowledge other options and explanations.

      We have created a model cartoon to explain how NASPM could reduce mEPSC frequency (new Fig. 3D). mEPSCs that arise from a synaptic site that has only Ca2+-permeable AMPA receptors will be completely blocked by NASPM, if the NASPM concentration is maximal. The reason we conclude that we have sufficient NASPM reaching the cells is that the frequency is decreased, as expected if there are synaptic sites with only Ca2+-permeable AMPA receptors. We previously were not clear that there is an effect of NASPM on mEPSC amplitude, although it did not reach statistical significance (new Fig. 3B). Where there is no effect is on the TTX-induced increase in mEPSC amplitude, which remains after the acute NASPM application (new Fig. 3A). We have revised the description of these findings in Results, lines 220 to 241. In reviewing the literature further, we could find no previous studies demonstrating an increase in conductance in GluA2 or Ca2+-impermeable receptors, only in GluA1 homomers. In other words, any conductance change would have been due to a change in GluA1 homomers, and should have been visible as a disruption of the homeostatic plasticity by NASPM application. We have added text to Results, lines 211 to 217; 236-241; Discussion, lines 420 to 422; 526-536 and Methods, lines 685 to 695 regarding this point.

      The frequency data are missing from the paper, with the exception of the NASPM dataset. The mEPSC frequencies should be reported for all experiments, particularly given that Rab3A is generally viewed as a pre-synaptic protein regulating release. Also, in the NASPM experiments, the average frequency is much higher in the TTX treated cultures. Is this statistically above control values?

      This comment is addressed by the major change #3, above.

      Unaddressed issues that would greatly increase the impact of the paper:

      (1) Is Rab3A activity pre-synaptically, post-synaptically or both. The authors provide good evidence that Rab3A is acting within neurons and not astrocytes. But where is it acting (pre or post) would aid substantially in understanding its role (and particularly the hypothesized and somewhat novel idea that the amount of glutamate released per vesicle is altered in HSP). They could use sparse knockdown of Rab3A, or simply mix cultures from KO and WT mice (with appropriate tags/labels). The general view in the field has been that HSP is regulated post-synaptically via regulation of AMPAR trafficking, and considerable evidence supports this view. The more support for their suggestion of a pre-synaptic site of control, the better.

      This is similar to the request of Reviewer #2, Recommendations to the Authors. An important next step is to identify whether Rab3A is working pre- or postsynaptically. However, it is possible that it is acting pre-synaptically to anterogradely regulate trafficking of AMPAR, as we have depicted in our model, new Fig. 9. To demonstrate that the presynaptic quantum is being altered, we would need to show that vesicle size is increased, or the amount of transmitter being released during an mEPSC is increased after activity blockade. To that end, we are currently performing experiments using a fast off-rate antagonist. As described above in response to Reviewer #2’s Conceptual Concerns, we find dramatic decreases in frequency not explained by the 30-60% inhibition observed for the largest amplitude mEPSCs, which suggests the possibility that small mEPSCs are more sensitive than large mEPSCs and therefore may have less transmitter. Due to these complexities and the delay while we test other antagonists to see if the effect is specific to fast-off rate antagonists, we are not including these results here.

      (2) Rab3A is also found at inhibitory synapses. It would be very informative to know if HSP at inhibitory synapses is similarly affected. This is particularly relevant as at inhibitory synapses, one expects a removal of GABARs and/or a decrease of GABA-packaging in vesicles (ie the opposite of whatever is happening at excitatory synapses.). If both processes are regulated by Rab3A, this might suggest a role for this protein more upstream in the signaling, an effect only at excitatory synapses would argue for a more specific role just at these synapses.

      It will be important to determine if homeostatic synaptic plasticity at inhibitory synapses on excitatory neurons is sensitive to Rab3A deletion, especially in light of the fact that unlike many of the other molecules implicated in homeostatic increases in mEPSCS, Rab3A is not a molecule known to be selective for glutamate receptor trafficking (in contrast to Arc/Arg3.1 or GRIP1, for example). Such a study would warrant its own publication.

      Reviewer #3 (Recommendations for the Authors):

      There are a number of minor points or suggestions for the authors:

      Is RIM1 part of this pathway (or expected to be)? Some discussion of this would be nice.

      RIM, Rab3-interacting molecule, has been implicated at the drosophila neuromuscular junction in a presynaptic form of homeostatic synaptic plasticity in which evoked release is increased after block of postsynaptic receptors (Muller et al., 2012), a plasticity that also requires Rab3-GAP (Muller et al., 2011). To our knowledge there is no evidence that RIM is involved in the homeostatic plasticity of mEPSC amplitude after activity blockade by TTX. The Rim1a KO does not have a change in mEPSC amplitude relative to WT (Calakos et al., 2004), but that is not unexpected given the normal mEPSC amplitude in neurons from cultures prepared from Rab3A-/- mice in the current study. It would be interesting to look at homeostatic plasticity in cortical cultures prepared from Rim1a or other RIM deletion mice, but we have not added these points to the revised manuscript since there are a number of directions one could go in attempting to define the molecular pathway and we feel it is more important to discuss the potential location of action and physiological mechanisms.

      Is the Earlybird mutation a GOF? More information about this mutation would help.

      We have added a description of how the Earlybird mutation was identified, in a screen for rest:activity mutants (Results, lines 118 to 123). Rab3A Earlybird mice have a shortened circadian period, shifting their wake cycle earlier and earlier. When Rab3A deletion mice were tested in the same activity raster plot measurements, the shift was smaller than that for the Earlybird mutant, suggesting the possibility that it is a dominant negative mutation.

      The high K used in the NASPM experiments seems a bit unusual. Have the authors done high K/no drug controls to see if this affects the synapses in any way?

      We used the high K based on previous studies that indicated the blocking effect of the Ca2+-permeable receptor blockers was use dependent (Herlitze et al., 1993; Iino et al., 1996; Koike et al., 1997). We reasoned that a modest depolarization would increase the frequency of AMPA receptor mEPSCs and allow access of the NASPM.  We have added this point to the Methods, lines 695 to 708. 

      The NASPM experiments do not show that GluA1 does not contribute (line 401), only that GluA1 homomers are not contributing (much – see above). GluA1/A2 heteromers are quite likely involved. Also, the SEM is missing from the WT pre/post NASPM data.

      Imaging of GluA2-positive sites will not distinguish between GluA2 homomers and GluA2-GluA1 heteromers, so we have added this clarification to Results, lines 242 to 246. We have remade the NASPM pre-post line plots so that the mean values and error bars are more visible (new Fig. 3B, C).

      It seems odd to speculate based on non-significant findings (line 650-1), with lower significance (p = 0.11) than findings being dismissed in the paper (NASPM on mEPSC amplitude; p = 0.08).

      We did not mean to dismiss the effect of NASPM on mEPSC amplitude (new Fig. 3B), rather, we dismiss the effect of NASPM on the homeostatic increase in mEPSC amplitude caused by TTX treatment (new Fig. 3A). We have emphasized this distinction in Results, lines 223 to 225, and Discussion, lines 420 to 422, as well as adding that the stronger effect of NASPM on frequency after TTX treatment suggests an activity-dependent increase in the number of synapses expressing only Ca2+ permeable homomers (Results, lines 236 to 241; Discussion, lines 431 to 435).

      Fig. 4 could be labeled better (to make it clear that B is amplitude and C is freq from the same cells).

      Fig. 4 has been revised—now the amplitude and frequency plots from the same condition (new Fig. 3, B, C; CON or TTX) are in a vertical line and the figure legend states that the frequency data are from the same cells as in Fig. 3A.

      The raw amplitude data seems a bit hidden in the inset panels – I would suggest these data are at least as important as the cumulative distributions in the main panel. Maybe re-organizing the figures would help.

      We have removed all cumulative distributions, rank order plots, and ratio plots. The box plots are now full size in new Figures 1, 2, 5, 6, 7 and 8.

      I’m not sure I would argue in the paper that 12 cells a day is a limiting issue for experiments. It doesn’t add anything and doesn’t seem like that high a barrier. It is fine to just say it is difficult and therefore there is a limited amount of data meeting the criteria.

      We have removed the comment regarding difficulty.

      Calakos N, Schoch S, Sudhof TC, Malenka RC (2004) Multiple roles for the active zone protein RIM1alpha in late stages of neurotransmitter release. Neuron 42:889-896.

      De Gois S, Schafer MK, Defamie N, Chen C, Ricci A, Weihe E, Varoqui H, Erickson JD (2005) Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits. J Neurosci 25:7121-7133.

      Diaz-Rohrer B, Castello-Serrano I, Chan SH, Wang HY, Shurer CR, Levental KR, Levental I (2023) Rab3 mediates a pathway for endocytic sorting and plasma membrane recycling of ordered microdomains. Proc Natl Acad Sci U S A 120:e2207461120.

      Dubes S, Soula A, Benquet S, Tessier B, Poujol C, Favereaux A, Thoumine O, Letellier M (2022) miR-124dependent tagging of synapses by synaptopodin enables input-specific homeostatic plasticity. EMBO J 41:e109012.

      Fong MF, Newman JP, Potter SM, Wenner P (2015) Upward synaptic scaling is dependent on neurotransmission rather than spiking. Nat Commun 6:6339.

      Herlitze S, Raditsch M, Ruppersberg JP, Jahn W, Monyer H, Schoepfer R, Witzemann V (1993) Argiotoxin detects molecular differences in AMPA receptor channels. Neuron 10:1131-1140.

      Hou Q, Zhang D, Jarzylo L, Huganir RL, Man HY (2008) Homeostatic regulation of AMPA receptor expression at single hippocampal synapses. Proc Natl Acad Sci U S A 105:775-780.

      Ibata K, Sun Q, Turrigiano GG (2008) Rapid synaptic scaling induced by changes in postsynaptic firing. Neuron 57:819-826.

      Iino M, Koike M, Isa T, Ozawa S (1996) Voltage-dependent blockage of Ca(2+)-permeable AMPA receptors by joro spider toxin in cultured rat hippocampal neurones. J Physiol 496 ( Pt 2):431437.

      Jakawich SK, Neely RM, Djakovic SN, Patrick GN, Sutton MA (2010a) An essential postsynaptic role for the ubiquitin proteasome system in slow homeostatic synaptic plasticity in cultured hippocampal neurons. Neuroscience 171:1016-1031.

      Jakawich SK, Nasser HB, Strong MJ, McCartney AJ, Perez AS, Rakesh N, Carruthers CJ, Sutton MA (2010b) Local presynaptic activity gates homeostatic changes in presynaptic function driven by dendritic BDNF synthesis. Neuron 68:1143-1158.

      Kapfhamer D, Valladares O, Sun Y, Nolan PM, Rux JJ, Arnold SE, Veasey SC, Bucan M (2002) Mutations in Rab3a alter circadian period and homeostatic response to sleep loss in the mouse. Nat Genet 32:290-295.

      Koike M, Iino M, Ozawa S (1997) Blocking effect of 1-naphthyl acetyl spermine on Ca(2+)-permeable AMPA receptors in cultured rat hippocampal neurons. Neurosci Res 29:27-36.

      Liu G, Tsien RW (1995) Properties of synaptic transmission at single hippocampal synaptic boutons. Nature 375:404-408.

      Liu G, Choi S, Tsien RW (1999) Variability of neurotransmitter concentration and nonsaturation of postsynaptic AMPA receptors at synapses in hippocampal cultures and slices. Neuron 22:395409.

      Muller M, Pym EC, Tong A, Davis GW (2011) Rab3-GAP controls the progression of synaptic homeostasis at a late stage of vesicle release. Neuron 69:749-762.

      Muller M, Liu KS, Sigrist SJ, Davis GW (2012) RIM controls homeostatic plasticity through modulation of the readily-releasable vesicle pool. J Neurosci 32:16574-16585.

      Pozo K, Cingolani LA, Bassani S, Laurent F, Passafaro M, Goda Y (2012) beta3 integrin interacts directly with GluA2 AMPA receptor subunit and regulates AMPA receptor expression in hippocampal neurons. Proc Natl Acad Sci U S A 109:1323-1328.

      Silva MM, Rodrigues B, Fernandes J, Santos SD, Carreto L, Santos MAS, Pinheiro P, Carvalho AL (2019) MicroRNA-186-5p controls GluA2 surface expression and synaptic scaling in hippocampal neurons. Proc Natl Acad Sci U S A 116:5727-5736.

      Soden ME, Chen L (2010) Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid. J Neurosci 30:16910-16921.

      Sun HY, Bartley AF, Dobrunz LE (2009) Calcium-permeable presynaptic kainate receptors involved in excitatory short-term facilitation onto somatostatin interneurons during natural stimulus patterns. J Neurophysiol 101:1043-1055.

      Sutton MA, Ito HT, Cressy P, Kempf C, Woo JC, Schuman EM (2006) Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis. Cell 125:785-799.

      Tan HL, Queenan BN, Huganir RL (2015) GRIP1 is required for homeostatic regulation of AMPAR trafficking. Proc Natl Acad Sci U S A 112:10026-10031.

      Thapliyal S, Arendt KL, Lau AG, Chen L (2022) Retinoic acid-gated BDNF synthesis in neuronal dendrites drives presynaptic homeostatic plasticity. Elife 11.

      Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG, Erickson JD, Liu G (2005) Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J Neurosci 25:62216234.

      Wu YK, Hengen KB, Turrigiano GG, Gjorgjieva J (2020) Homeostatic mechanisms regulate distinct aspects of cortical circuit dynamics. Proc Natl Acad Sci U S A 117:24514-24525.

      Xu X, Pozzo-Miller L (2017) EEA1 restores homeostatic synaptic plasticity in hippocampal neurons from Rett syndrome mice. J Physiol 595:5699-5712.

    1. Author Response

      The following is the authors’ response to the original reviews.

      eLife assessment

      This important study enhances our understanding of the effects of landscape context on grassland plant diversity and biomass. Notably, the authors use a well-designed field sampling method to separate the effects of habitat loss and fragmentation per se. Most of the data and analyses provide solid support for the findings that habitat loss weakens the positive relationship between grassland plant richness and biomass.

      Response: Thanks very much for organizing the review of the manuscript. We are grateful to you for the recognition. We have carefully analyzed all comments of the editors and reviewers and revised our manuscript to address them. All comments and recommendations are helpfully and constructive for improving our manuscript. We have described in detail our response to each of comment below.

      In addition to the reviewers' assessments, we have the following comments on your paper.

      (1) Some of the results are not consistent between figures. The relationships between overall species richness and fragmentation per se are not consistent between Figs. 3 and 5. The relationships between aboveground biomass and habitat loss are not consistent between Figs. 4 and 5. How shall we interpret these inconsistent results?

      Response: Thanks for your insightful comments. The reason for these inconsistencies is that the linear regression model did not take into account the complex causal relationships (including direct and indirect effects) among the different influencing factors. The results in Figures 3 and 4 just represent the pairwise relationship pattern and relative importance, respectively. The causal effects of habitat loss and fragmentation per se on plant richness and above-ground biomass should be interpreted based on the structural equation model results (Figure 6). We have revised the data analysis to clear these inconsistent results. Line 225-228

      In the revised manuscript, we have added the interpretation for these inconsistent results. The inconsistent effects between Figures 3 and 6 suggest that fragmentation per se actually had a positive effect on plant richness after accounting for the effects of habitat loss and environmental factors simultaneously.

      The inconsistent effects between Figures 4 and 6 are because the effects of habitat loss and fragmentation per se on above-ground biomass were mainly mediated by plant richness and environmental factors, which had no significant direct effect (Figure 6). Thus, habitat loss and fragmentation per se showed no significant relative effects on above-ground biomass after controlling the effects of plant richness and environmental factors (Figure 4).

      (2) One of the fragmentation indices, mean patch area metric, seems to be more appropriate as a measure of habitat loss, because it represents "a decrease in grassland patch area in the landscape".

      Response: Thanks for your insightful comments. We apologize for causing this confusion. The mean patch area metric in our study represents the mean size of grassland patches in the landscape for a given grassland amount. Previous studies have often used the mean patch metric as a measure of fragmentation, which can reflect the processes of local extinction in the landscape (Fahrig, 2003; Fletcher et al., 2018). We have revised the definition of the mean patch area metric and added its ecological implication in the revised manuscript to clarify this confusion.

      (3) It is important to show both the mean and 95% CI (or standard error) of the slope coefficients regarding to Figs. 3 and 6.

      Response: Thanks for your suggestions. We have added the 95% confidence intervals to the Figure 3 and Figure 6 in the revised manuscript.

      (4) It would be great to clarify what patch-level and landscape-level studies are in lines 302-306. Note that this study assesses the effects of landscape context on patch-level variables (i.e., plot-based plant richness and plot-based grassland biomass) rather than landscape-level variables (i.e., the average or total amount of biomass in a landscape).

      Response: Thanks for your insightful comment. We agree with your point that our study investigated the effect of fragmented landscape context (habitat loss and fragmentation per se) on plot-based plant richness and plot-based above-ground biomass rather than landscape-level variables.

      Therefore, we no longer discussed the differences between the patch-level and landscape-level studies here, instead focusing on the different ecological impacts of habitat loss and fragmentation per se in the revised manuscript.

      Line 369-374:

      “Although habitat loss and fragmentation per se are generally highly associated in natural landscapes, they are distinct ecological processes that determine decisions on effective conservation strategies (Fahrig, 2017; Valente et al., 2023). Our study evaluated the effects of habitat loss and fragmentation per se on grassland plant diversity and above-ground productivity in the context of fragmented landscapes in the agro-pastoral ecotone of northern China, with our results showing the effects of these two facets to not be consistent.”

      (5) One possible way to avoid the confusion between "habitat fragmentation" and "fragmentation per se" could be to say "habitat loss and fragmentation per se" when you intend to express "habitat fragmentation".

      Response: Thanks for your constructive suggestions. To avoid this confusion, we no longer mention habitat fragmentation in the revised manuscript but instead express it as habitat loss and fragmentation per se.

      Reviewer #1 (Public Review):

      This is a well-designed study that explores the BEF relationships in fragmented landscapes. Although there are massive studies on BEF relationships, most of them were conducted at local scales, few considered the impacts of landscape variables. This study used a large dataset to specifically address this question and found that habitat loss weakened the BEF relationships. Overall, this manuscript is clearly written and has important implications for BEF studies as well as for ecosystem restoration.

      Response: We are grateful to you for the recognition and constructive comments. All the comments and suggestions are very constructive for improving this manuscript. We have carefully revised the manuscript following your suggestions. All changes are marked in red font in the revised manuscript.

      My only concern is that the authors should clearly define habitat loss and fragmentation. Habitat loss and fragmentation are often associated, but they are different terms. The authors consider habitat loss a component of habitat fragmentation, which is not reasonable. Please see my specific comments below.

      Response: We agree with your point. In the revised manuscript, we no longer consider habitat loss and fragmentation per se as two facets of habitat fragmentation. We have clearly defined habitat loss and fragmentation per se and explicitly evaluated their relative effects on plant richness, above-ground biomass, and the BEF relationship.

      Reviewer #1 (Recommendations For The Authors):

      Title: It is more proper to say habitat loss, rather than habitat fragmentation.

      Response: Thanks for your suggestion. We have revised the title to “Habitat loss weakens the positive relationship between grassland plant richness and above-ground biomass”

      Line 22, remove "Anthropogenic", this paper is not specifically discussing habitat fragmentation driven by humans.

      Response: Thanks for your suggestion. We have removed the “Anthropogenic” from this sentence.

      Line 26, revise to "we investigated the effects of habitat loss and fragmentation per se on plant richness... in grassland communities by using a structural equation model".

      Response: Thanks for your suggestion. We have revised this sentence.

      Line 25-28:

      “Based on 130 landscapes identified by a stratified random sampling in the agro-pastoral ecotone of northern China, we investigated the effects of landscape context (habitat loss and fragmentation per se) on plant richness, above-ground biomass, and the relationship between them in grassland communities using a structural equation model.”

      Line 58-60, habitat fragmentation generally involves habitat loss, but habitat loss is independent of habitat fragmentation, it is not a facet of habitat fragmentation.

      Response: Thanks for your insightful comment. We have no longer considered habitat loss and fragmentation per se as two facets of habitat fragmentation. In the revised manuscript, we consider habitat loss and fragmentation as two different processes in fragmented landscapes.

      Line 65-67, this sentence is not very relevant to this paragraph and can be deleted.

      Response: Thanks for your suggestion. We have deleted this sentence from the paragraph.

      Line 87-90, these references are mainly based on microorganisms, are there any references based on plants? These references are more relevant to this study. In addition, this is a key mechanism mentioned in this study, this section needs to be strengthened with more evidence and further exploration.

      Response: Thanks for your comment and suggestion. Thanks for your comment and suggestion. We have added some references based on plants here to strengthen the evidence and mechanism of habitat specialisation determines the BEF relationship.

      Line 89-95:

      “In communities, specialists with specialised niches in resource use may contribute complementary roles to ecosystem functioning, whereas generalists with unspecialised in resource use may contribute redundant roles to ecosystem functioning due to overlapping niches (Dehling et al., 2021; Denelle et al., 2020; Gravel et al., 2011; Wilsey et al., 2023). Therefore, communities composed of specialists should have a higher niche complementarity effect in maintaining ecosystem functions and a more significant BEF relationship than communities composed of generalists.”

      Denelle, P., Violle, C., DivGrass, C., Munoz, F. 2020. Generalist plants are more competitive and more functionally similar to each other than specialist plants: insights from network analyses. Journal of Biogeography 47: 1922-1933.

      Dehling, D.M., Bender, I.M.A., Blendinger, P.G., Böhning-Gaese, K., Muñoz, M.C., Neuschulz, E.L., Quitián, M., Saavedra, F., Santillán, V., Schleuning, M., Stouffer, D.B. 2021. Specialists and generalists fulfil important and complementary functional roles in ecological processes. Functional Ecology 35: 1810-1821.

      Wilsey, B., Martin, L., Xu, X., Isbell, F., Polley, H.W. 2023. Biodiversity: Net primary productivity relationships are eliminated by invasive species dominance. Ecology Letters.

      Line 129-130, Although you can use habitat loss in the discussion or the introduction, here preferably use habitat amount or habitat area, rather than habitat loss in this case. Habitat loss represents changes in habitat area, but the remaining grasslands could be the case of natural succession or other processes, rather than loss of natural habitat.

      Response: Thanks for your insightful comment. We agree with your point. In the revised manuscript, we have explicitly stated that habitat loss was represented by the loss of grassland amount in the landscape.

      Since the remaining grassland fragments in this region were mainly caused by grassland loss due to human activities such as cropland expansion (Chen et al., 2019; Yang et al., 2020), we used the percentage of non-grassland cover in the landscape to represent habitat loss in our study.

      Line 132-135:

      “Habitat loss was represented by the loss of grassland amount in the landscape. As the remaining grassland fragments in this region were mainly caused by grassland loss due to human activities such as cropland expansion (Chen et al., 2019; Yang et al., 2020), the percentage of non-grassland cover in the landscape was used in our study to represent habitat loss.”

      Lines 245-246, please also give more details of the statistical results, such as n, r value et al in the text.

      Response: Thanks for your suggestion. We have added the details of the statistical results in the revised manuscript.

      Line 283-290:

      “Habitat loss was significantly negatively correlated with overall species richness (R = -0.21, p < 0.05, Figure 3a) and grassland specialist richness (R = -0.41, p < 0.01, Figure 3a), but positively correlated with weed richness (R = 0.31, p < 0.01, Figure 3a). Fragmentation per se was not significantly correlated with overall species richness and grassland specialist richness, but was significantly positively correlated with weed richness (R = 0.26, p < 0.01, Figure 3b). Habitat loss (R = -0.39, p < 0.01, Figure 3c) and fragmentation per se (R = -0.26, p < 0.01, Figure 3d) were both significantly negatively correlated with above-ground biomass.”

      Fig. 5, is there any relationship between habitat amount and fragmentation per se in this study?

      Response: Thanks for your insightful comment. We have considered a causal relationship between habitat loss and fragmentation per se in the structural equation model. We have discussed this relationship in the revised manuscript.

      Line 290-293, how about the BEF relationships with different fragmentation levels? I may have missed something somewhere, but it was not shown here.

      Response: Thanks for your insightful comment. We have added the BEF relationships with different fragmentation per se levels here.

      Line 323-340:

      “The linear regression models showed that habitat loss had a significant positive modulating effect on the positive relationship between plant richness and above-ground biomass, and fragmentation per se had no significant modulating effect (Figure 5). The positive relationship between plant richness and above-ground biomass weakened with increasing levels of habitat loss, strengthened and then weakened with increasing levels of fragmentation per se.

      Author response image 1.

      Relationships between grassland plant richness and above-ground biomass at different levels of habitat loss and fragmentation per se from 130 landscapes in the Tabu River Basin, a typical agro-pastoral ecotone of northern China: (a) high habitat loss and low fragmentation per se, (b) high habitat loss and moderate fragmentation per se, (c) high habitat loss and high fragmentation per se, (d) moderate habitat loss and low fragmentation per se, (e) moderate habitat loss and moderate fragmentation per se, (f) moderate habitat loss and high fragmentation per se, (g) low habitat loss and low fragmentation per se, (h) low habitat loss and moderate fragmentation per se. The R2 values in each panel are from linear regression models. The n in each panel is the number of surveying sites used in the linear regression models. The blue solid and dashed trend lines represent the significant and not significant effects, respectively. The shaded area around the trend line represents the 95% confidence interval. * represent significance at the 0.05 level. ** represent significance at the 0.01 level.”

      Discussion

      The Discussion (Section 4.2) needs to be revised and focused on your key findings, it is habitat loss, not fragmentation per se, that weakens the BEF relationships.

      Response: Thanks for your insightful comment and suggestion. In the revised manuscript, we have rephrased the Discussion (Section 4.2) to mainly discuss the inconsistent effects of habitat loss and fragmentation per se on the BEF relationship.

      Line 414-416:

      “4.2 Habitat loss rather than fragmentation per se weakened the magnitude of the positive relationship between plant diversity and ecosystem function”

      The R2 in the results are low (e.g., Fig. 3), please also mention other variables that might influence the observed pattern in the Discussion, such as soil and topography, though I understand it is difficult to collect such data in this study.

      Response: Thanks for your insightful comment and suggestion. We agree with you and reviewer 3 that the impact of environmental factors should also be considered.

      Therefore, we have considered two environmental factors related to water and temperature (soil water content and land surface temperature) in the analysis and discussed their impacts on plant diversity and above-ground biomass in the revised manuscript.

      Lines 344-345, its relative importance was stronger in the intact landscape than that of the fragmented landscape?

      Response: We apologize for making this confusion. We have rephrased this sentence.

      Line 422-426:

      “Our study found grassland plant diversity showed a stronger positive impact on above-ground productivity than landscape context and environmental factors. This result is consistent with findings by Duffy et al. (2017) in natural ecosystems, indicating grassland plant diversity has an important role in maintaining grassland ecosystem functions in the fragmented landscapes of the agro-pastoral ecotone of northern China.”

      Reviewer #2 (Public Review):

      Summary:

      In this manuscript, Yan et al. assess the effect of two facets of habitat fragmentation (i.e., habitat loss and habitat fragmentation per se) on biodiversity, ecosystem function, and the biodiversity-ecosystem function (BEF) relationship in grasslands of an agro-pastoral ecotone landscape in northern China. The authors use stratified random sampling to select 130 study sites located within 500m-radius landscapes varying along gradients of habitat loss and habitat fragmentation per se. In these study sites, the authors measure grassland specialist and generalist plant richness via field surveys, as well as above-ground biomass by harvesting and dry-weighting the grass communities in each 3 x 1m2 plots of the 130 study sites. The authors find that habitat loss and fragmentation per se have different effects on biodiversity, ecosystem function and the BEF relationship: whereas habitat loss was associated with a decrease in plant richness, fragmentation per se was not; and whereas fragmentation per se was associated with a decrease in above-ground biomass, habitat loss was not. Finally, habitat loss, but not fragmentation per se was linked to a decrease in the magnitude of the positive biodiversity-ecosystem functioning relationship, by reducing the percentage of grassland specialists in the community.

      Strengths:

      This study by Yan et al. is an exceptionally well-designed, well-written, clear and concise study shedding light on a longstanding, important question in landscape ecology and biodiversity-ecosystem functioning research. Via a stratified random sampling approach (cf. also "quasi-experimental design" Butsic et al. 2017), Yan et al. create an ideal set of study sites, where habitat loss and habitat fragmentation per se (usually highly correlated) are decorrelated and hence, separate effects of each of these facets on biodiversity and ecosystem function can be assessed statistically in "real-world" (and not experimental, cf. Duffy et al. 2017) communities. The authors use adequate and well-described methods to investigate their questions. The findings of this study add important empirical evidence from real-world grassland ecosystems that help to advance our theoretical understanding of landscape-moderation of biodiversity effects and provide important guidelines for conservation management.

      Weaknesses:

      I found only a few minor issues, mostly unclear descriptions in the study that could be revised for more clarity.

      Response: Thanks very much for your review of the manuscript. We are grateful to you for the recognition. All the comments and suggestions are very insightful and constructive for improving this manuscript. We have carefully studied the literature you recommend and revised the manuscript carefully following your suggestions. All changes are marked in red font in the revised manuscript.

      Reviewer #2 (Recommendations For The Authors):

      Specific comments

      (1) Some aspects of the Methods section were not entirely clear to me, could you revise them for more clarity?

      (a) Whereas you describe 4 main facets of fragmentation per se that are used to create the PC1 as a measure of overall fragmentation per se, it looks as if this PC1 is mainly driven by 3 facets only (ED, PD and AREA_MN), and patch isolation (nearest neighbour distance, ENN) having a relatively low loading on PC1 (Figure A1). I think it would be good to discuss this fact and the consequences of it, that your definition of fragmentation is focused more on edge density, patch density and mean patch area, and less on patch isolation in your Discussion section?

      Response: Thanks for your insightful comment and suggestion. We agree with your point. We have discussed this fact and its implications for understanding the effects of fragmentation per se in our study.

      Line 384-389:

      “However, it is important to stress that the observed positive effect of fragmentation per se does not imply that increasing the isolation of grassland patches would promote biodiversity, as the metric of fragmentation per se used in our study was more related to patch density, edge density and mean patch area while relatively less related to patch isolation (Appendix Table A1). The potential threats from isolation still need to be carefully considered in the conservation of biodiversity in fragmented landscapes (Haddad et al., 2015).”

      (b) Also, from your PCA in Figure A1, it seems that positive values of PC1 mean "low fragmentation", whereas high values of PC1 mean "high fragmentation", however, in Figure A2, the inverse is shown (low values of PC1 = low fragmentation, high values of PC1 = high fragmentation). Could you clarify in the Methods section, if you scaled or normalized the PC1 to match this directionality?

      Response: We apologize for making this confusion. In order to be consistent with the direction of change in fragmentation per se, we took the inverse of the PC1 as a single fragmentation per se index, which was positively correlated with patch density, edge density, mean nearest-neighbor distance metric, and negatively with mean patch area (Appendix Figure A1 and Table A1). We have clarified this point in the Method section.

      Line 160-163:

      “We took the inverse of the PC1 as a single fragmentation per se index, which was positively correlated with patch density, edge density, mean nearest-neighbor distance metric, and negatively with mean patch area (Appendix Figure A1 and Table A1).”

      (c) On line 155 you describe that you selected at least 20 landscapes using stratified sampling from each of the eight groups of habitat amount and fragmentation combination. Could you clarify: 1) did you randomly sample within these groups with a minimum distance condition or was it a non-random selection according to other criteria? (I think you could move the "To prevent overlapping landscapes..." sentence up here to the description of the landscape selection process) 2) Why did you write "at least 20 landscapes" - were there in some cases more or less landscapes selected? 130 study landscapes divided by 8 groups only gives you 16.25, hence, at least for some groups there were less than 20 landscapes? Could you describe your final dataset in more detail, i.e. the number of landscapes per group and potential repercussions for your analysis?

      Response: Thanks for your insightful comments. In the revised manuscript, we have rephrased the method to provide more detail for the sampling landscape selection.

      (1) Line 169-172

      We randomly selected at least 20 grassland landscapes with a minimum distance condition using stratified sampling from each of the remaining eight grassland types as alternative sites for field surveys. The minimum distance between each landscape was at least 1000 m to prevent overlapping landscapes and potential spatial autocorrelation.

      (2) Line 184-191

      The reason for selecting at least 20 grassland landscapes of each type in this study was to ensure enough alternative sites for the field survey. This is because the habitat type of some selected sites was not the natural grasslands, such as abandoned agricultural land. Some of the selected sites may not be permitted for field surveys.

      Thus, we finally established 130 sites in the field survey. The types of the 130 sites were: 19 high-moderate, 14 high-low, 19 moderate-high, 16 moderate-moderate, 18 moderate-low, 16 low-high, 17 low-moderate, 11 low-low habitat amount and fragmentation per se.

      (d) On line 166, you describe that you established 130 sites of 30 m by 30 m - I assume they were located (more or less) exactly in the centre of the selected 500 m - radius landscapes? Were they established so that they were fully covered with grassland? And more importantly, how did you establish the 10 m by 10 m areas and the 1 m2 plots within the 30 m by 30 m sites? Did you divide the 30 m by 30 m areas into three rectangles of 10 m by 10 m and then randomly established 1 m2 plots? Were the 1 m2 plots always fully covered with grassland/was there a minimum distance to edge criterion? Please describe with more detail how you established the 1 m2 study sites, and how many there were per landscape.

      Response: Thanks for your insightful comments. In the revised manuscript, we have provided more detailed information on how to set up 130 sites of 30 m by 30 m and three plots of 1 m by 1 m.

      (1) As these 130 sites were selected based on the calculation of the moving window, they were located (more or less) exactly in the centre of the 500-m radius buffer.

      (2) These sites were fully covered with grassland because their size (30 m by 30 m) was the same as the size of the grassland cell (30 m by 30 m) used in the calculation of the moving window.

      (3) We randomly set up three 1 m * 1 m plots in a flat topographic area at the 10 m * 10 m centre of each site. Thus, there was a minimum distance of 10 m to the edge for each 1 m * 1 m plot.

      (4) There are three 1 m * 1 m plots per landscape.

      Line 182-191:

      “Based on the alternative sites selected above, we established 130 sites (30 m * 30 m) between late July to mid-August 2020 in the Tabu River Basin in Siziwang Banner, Inner Mongolia Autonomous Region (Figure 1). The types of the 130 sites were: 19 high-moderate, 14 high-low, 19 moderate-high, 16 moderate-moderate, 18 moderate-low, 16 low-high, 17 low-moderate, 11 low-low habitat amount and fragmentation per se. In order to exclude the impact of historical agricultural activities, the habitat type of the established sites was natural grasslands with regional vegetation characteristics. Each site was not abandoned agricultural land, and there was no sign of agricultural reclamation.

      At the 10 m * 10 m center of each site, we randomly set up three 1 m * 1 m plots in a flat topographic area to investigate grassland vascular plant diversity and above-ground productivity.”

      (e) Line 171: could you explain what you mean by reclaimed?

      Response: Thanks for your comment. The “reclaimed” means that historical agricultural activities. We have rephrased this sentence to make it more explicit.

      Line 186-189:

      “In order to exclude the impact of historical agricultural activities, the habitat type of the established sites was natural grasslands with regional vegetation characteristics. Each site was not abandoned agricultural land, and there was no sign of agricultural reclamation.”

      (f) Line 188 ff.: Hence your measure of productivity is average-above ground biomass per 1 m2. I think it would add clarity if you highlighted this more explicitly.

      Response: Thanks for your suggestion. We have highlighted that the productivity in our study was the average above-ground biomass per 1 m * 1 m plots in each site.

      Line 215-217:

      “For each site, we calculated the mean vascular plant richness of the three 1 m * 1 m plots, representing the vascular plant diversity, and mean above-ground biomass of the three 1 m * 1 m plots, representing the above-ground productivity.”

      (2) All figures are clear and well-designed!

      (a) Just as a suggestion: in Figures 3 and 6, you could maybe add the standard errors of the mean as well?

      Response: Thanks for your suggestion. In the revised manuscript, we have added the standard errors of the mean in Figures 3 and 6.

      (b) Figure 4: Could you please clarify: Which models were the optimal models on which these model-averaged standardized parameter estimates were based on? And hence, the optimal models contained all 4 predictors (otherwise, no standardized parameter estimate could be calculated)? Or do these model-averaged parameters take into account all possible models (and not only the optimal ones)?

      Response: Thanks for your suggestion. We selected the four optimal models based on the AICc value to calculate the model-averaged standardized parameter estimates. The four optimal models contained all predictors in Figure 4. We have added the four optimal models in Appendix Table A3.

      Appendix:

      Author response table 1.

      Four optimal models of landscape context, environment factors, and plant diversity affecting above-ground biomass.

      Note: AGB: above-ground biomass; HL: habitat loss; FPS: fragmentation per se; SWT: soil water content; LST: land surface temperature; GSR: grassland specialist richness; WR: weed richness; **: significance at the 0.01 level.”

      (c) Please add in all Figures (i.e., Figures 4, 5 and 6, Figure 6 per "high, moderate and low-class") the number of study units the analyses were based on.

      Response: Thanks for your suggestion. In the revised manuscript, we have added the number of study units the analyses were based on in all Figures.

      (d) Figure 6: I think it would be more consistent to add a second plot where the BEF-relationship is shown for low, moderate and high levels of habitat fragmentation per se. Could you also add a clearer description in the Methods and/or Results section of how you assessed if habitat amount or fragmentation per se affected the BEF-relationship? I.e. based on the significance of the interaction term (habitat amount x species richness) in a linear model?

      Response: Thanks for your insightful comment and suggestion. We have added a second plot in Figure 5 to show the BEF relationship at low, moderate and high levels of fragmentation per se.

      Line 328-340:

      Author response image 2.

      Relationships between grassland plant richness and above-ground biomass at different levels of habitat loss and fragmentation per se from 130 landscapes in the Tabu River Basin, a typical agro-pastoral ecotone of northern China: (a) high habitat loss and low fragmentation per se, (b) high habitat loss and moderate fragmentation per se, (c) high habitat loss and high fragmentation per se, (d) moderate habitat loss and low fragmentation per se, (e) moderate habitat loss and moderate fragmentation per se, (f) moderate habitat loss and high fragmentation per se, (g) low habitat loss and low fragmentation per se, (h) low habitat loss and moderate fragmentation per se. The R2 values in each panel are from linear regression models. The n in each panel is the number of surveying sites used in the linear regression models. The blue solid and dashed trend lines represent the significant and not significant effects, respectively. The shaded area around the trend line represents the 95% confidence interval. * represent significance at the 0.05 level. ** represent significance at the 0.01 level.”

      We determined whether habitat loss and fragmentation per se moderated the BEF relationship by testing the significance of their interaction term with plant richness. We have added a clearer description in the Methods section of the revised manuscript.

      Line 245-250:

      “We then assessed the significance of interaction terms between habitat loss and fragmentation per se and plant richness in the linear regression models to evaluate whether they modulate the relationship between plant richness and above-ground biomass. Further, we used a piecewise structural equation model to investigate the specific pathways in which habitat loss and fragmentation per se modulate the relationship between plant richness and above-ground biomass.”

      (3) While reading your manuscript, I missed a discussion on the potential non-linear effects of habitat amount and fragmentation per se. In your study, it seems that the effects of habitat amount and fragmentation per se on biodiversity and ecosystem function are quite linear, which contrasts previous research highlighting that intermediate levels of fragmentation/heterogeneity could maximise spatial asynchrony, biodiversity and ecosystem function (e.g. Redon et al. 2014, Thompson & Gonzalez 2016, Tscharntke et al. 2012, Wilcox et al. 2017). I think it would add depth to your study if you discussed your finding of linear effects of habitat amount and fragmentation on biodiversity, ecosystem functioning and BEF. For example:

      Response: Thanks for your constructive suggestions. We have carefully studied the literature (e.g. Redon et al. 2014, Thompson & Gonzalez 2016, Tscharntke et al. 2012, Wilcox et al. 2017), which highlights that intermediate levels of fragmentation/heterogeneity could maximise spatial asynchrony, biodiversity and ecosystem function.

      In the revised manuscript, we have added the discussion about the linear positive effects of fragmentation on plant diversity and above-ground productivity and discussed possible reasons for this linear effect.

      Line 402-413:

      “In our study, a possible mechanism for the positive impacts of fragmentation per se on plant diversity and above-ground productivity (indirect positive impact via plant diversity) is that fragmentation per se increases the habitat heterogeneity in the landscape, which can promote biodiversity through spatial asynchrony and spatial insurance effects (Tscharntke et al., 2012). Previous studies indicated that heterogeneity typically has nonlinear effects on biodiversity and ecosystem function, as moderate heterogeneity can maximise spatial asynchrony (Redon et al., 2014; Wilcox et al., 2017). However, our study did not observe nonlinear patterns between fragmentation per se and plant diversity and above-ground productivity. This may be due to the low spatial heterogeneity of this area as a result of agricultural intensification (Benton et al., 2003; Chen et al., 2019). The gradient of fragmentation per se in our study may not cover the optimal heterogeneity levels for maximising plant diversity and above-ground productivity (Thompson and Gonzalez, 2016).”

      Meanwhile, we also discussed the nonlinear pattern of the BEF relationship with increasing levels of fragmentation per se to add depth to the discussion.

      Line 442-451:

      “In addition, our study found that the BEF relationship showed a nonlinear pattern with increasing levels of fragmentation per se. For a given level of habitat loss, the positive BEF relationship was strongest at moderate fragmentation per se level and became neutral at high fragmentation per se level. This can be explained by the increased spatial asynchrony at moderate fragmentation per se level, which can promote niche complementary among species in the community and thus strengthen the BEF relationship (Gonzalez et al., 2020; Thompson and Gonzalez, 2016; Tscharntke et al., 2012). The neutral BEF relationship at high fragmentation per se level may be due to edge effects enhancing environmental filtering, thereby leading to functional redundancy among species and decoupling the BEF relationship (Fetzer et al., 2015; Hu et al., 2016; Zambrano et al., 2019).”

      (a) Line 74-75: I was wondering if you also thought of spatial insurance effects or spatial asynchrony effects that can emerge with habitat fragmentation, which could lead to increased ecosystem functioning as well? (refs. above).

      Response: Thanks for your constructive suggestions. In the revised manuscript, we have explicitly considered the spatial insurance effect or spatial asynchrony as the important mechanism for fragmentation per se to increase plant diversity, ecosystem function, and the BEF relationship.

      Line 74-77:

      “In theory, habitat loss and fragmentation per se can regulate ecosystem function and the BEF relationship by altering species composition, interactions, and spatial asynchrony regardless of changes in species richness (Liu et al., 2018; Thompson and Gonzalez, 2016; Tscharntke et al., 2012).”

      Line 402-408:

      “In our study, a possible mechanism for the positive impacts of fragmentation per se on plant diversity and above-ground productivity (indirect positive impact via plant diversity) is that fragmentation per se increases the habitat heterogeneity in the landscape, which can promote biodiversity through spatial asynchrony and spatial insurance effects (Tscharntke et al., 2012). Previous studies indicated that heterogeneity typically has nonlinear effects on biodiversity and ecosystem function, as moderate heterogeneity can maximise spatial asynchrony (Redon et al., 2014; Wilcox et al., 2017).”

      Line 442-451:

      “In addition, our study found that the BEF relationship showed a nonlinear pattern with increasing levels of fragmentation per se. For a given level of habitat loss, the positive BEF relationship was strongest at moderate fragmentation per se level and became neutral at high fragmentation per se level. This can be explained by the increased spatial asynchrony at moderate fragmentation per se level, which can promote niche complementary among species in the community and thus strengthen the BEF relationship (Gonzalez et al., 2020; Thompson and Gonzalez, 2016; Tscharntke et al., 2012). The neutral BEF relationship at high fragmentation per se level may be due to edge effects enhancing environmental filtering, thereby leading to functional redundancy among species and decoupling the BEF relationship (Fetzer et al., 2015; Hu et al., 2016; Zambrano et al., 2019).”

      (b) I was wondering, if this result of linear effects could also be the result of a fragmentation gradient that does not cover the whole range of potential values? Maybe it would be good to compare the gradient in habitat fragmentation in your study with a theoretical minimum maximum/considering that there might be an optimal medium degree of fragmentation.

      Response: Thanks for your insightful comment. We agree with your point that the linear effect of fragmentation per se in our study may be due to the fact that the gradient of fragmentation per se in this region may not cover the optimal heterogeneity levels for maximising spatial asynchrony. This is mainly because the agricultural intensification in the agro-pastoral ecotone of northern China could lead to lower spatial heterogeneity in this region. We have explicitly discussed this point in the revised manuscript.

      Line 406-413:

      “Previous studies indicated that heterogeneity typically has nonlinear effects on biodiversity and ecosystem function, as moderate heterogeneity can maximise spatial asynchrony (Redon et al., 2014; Wilcox et al., 2017). However, our study did not observe nonlinear patterns between fragmentation per se and plant diversity and above-ground productivity. This may be due to the low spatial heterogeneity of this area as a result of agricultural intensification (Benton et al., 2003; Chen et al., 2019). The gradient of fragmentation per se in our study may not cover the optimal heterogeneity levels for maximising plant diversity and above-ground productivity (Thompson and Gonzalez, 2016).”

      (4) Some additional suggestions:

      (a) Line 3: Maybe add "via reducing the percentage of grassland specialists in the community"?

      Response: Thanks for your suggestion. We have revised this sentence.

      Line 19:

      “Habitat loss can weaken the positive BEF relationship via reducing the percentage of grassland specialists in the community”

      (b) Lines 46-48: Maybe add "but see: Duffy, J.E., Godwin, C.M. & Cardinale, B.J. (2017). Biodiversity effects in the wild are common and as strong as key drivers of productivity. Nature."

      Response: Thanks for your suggestion. We have added this reference here.

      Line 47-49:

      “When research expands from experiments to natural systems, however, BEF relationships remain unclear in the natural assembled communities, with significant context dependency (Hagan et al., 2021; van der Plas, 2019; but see Duffy et al., 2017).”

      (c) Lines 82-87 and lines 90-93: Hence, your study actually is in contrast to these findings, i.e., fragmented landscapes do not necessarily have a lower fraction of grassland specialists? If yes, could you highlight this more explicitly?

      Response: Thanks for your insightful comment. We have explicitly highlighted this point in the revised manuscript.

      Line 434-439:

      “Meanwhile, our study demonstrates that habitat loss, rather than fragmentation per se, can decrease the degree of habitat specialisation by leading to the replacement of specialists by generalists in the community, thus weakening the BEF relationship. This is mainly because fragmentation per se did not decrease the grassland specialist richness in this region, whereas habitat loss decreased the grassland specialist richness and led to the invasion of more weeds from the surrounding farmland into the grassland community (Yan et al., 2022; Yan et al., 2023).”

      (d) Line 360: Could you add some examples of these multiple ecosystem functions you refer to?

      Response: Thanks for your suggestion. We have added some examples of these multiple ecosystem functions here.

      Line 456-457:

      “Therefore, future studies are needed to focus on multiple ecosystem functions, such as below-ground productivity, litter decomposition, soil carbon stocks, etc.”

      Reviewer #3 (Public Review):

      Summary:

      The authors aim to solve how landscape context impacts the community BEF relationship. They found habitat loss and fragmentation per se have inconsistent effects on biodiversity and ecosystem function. Habitat loss rather than fragmentation per se can weaken the positive BEF relationship by decreasing the degree of habitat specialization of the community.

      Strengths:

      The authors provide a good background, and they have a good grasp of habitat fragmentation and BEF literature. A major strength of this study is separating the impacts of habitat loss and fragmentation per se using the convincing design selection of landscapes with different combinations of habitat amount and fragmentation per se. Another strength is considering the role of specialists and generalists in shaping the BEF relationship.

      Response: We are grateful to you for the recognition and constructive comments. All the comments and suggestions are very constructive for improving this manuscript. We have carefully revised the manuscript following your suggestions. All changes are marked in red font in the revised manuscript.

      Weaknesses:

      (1) The authors used five fragmentation metrics in their study. However, the choice of these fragmentation metrics was not well justified. The ecological significance of each fragmentation metric needs to be differentiated clearly. Also, these fragmentation metrics may be highly correlated with each other and redundant. I suggest author test the collinearity of these fragmentation metrics for influencing biodiversity and ecosystem function.

      Response: Thanks for your constructive suggestion. The fragmentation metrics used in our study represent the different processes of breaking apart of habitat in the landscape, which are widely used by previous studies (Fahrig, 2003; Fahrig, 2017). In the revised manuscript, we have provided more detailed information about the ecological significance of these fragmentation indices.

      Line 142-148:

      “The patch density metric reflects the breaking apart of habitat in the landscape, which is a direct reflection of the definition of fragmentation per se (Fahrig et al., 2019). The edge density metric reflects the magnitude of the edge effect caused by fragmentation (Fahrig, 2017). The mean patch area metric and the mean nearest-neighbor distance metric are associated with the area and distance effects of island biogeography, respectively, reflecting the processes of local extinction and dispersal of species in the landscape (Fletcher et al., 2018).”

      Meanwhile, we have calculated the variance inflation factors (VIF) for each fragmentation metric to assess their collinearity. The VIF of these fragmentation metrics were all less than four, suggesting no significant multicollinearity for influencing biodiversity and ecosystem function.

      Author response table 2.

      Variance inflation factors of habitat loss and fragmentation per se indices for influencing plant richness and above-ground biomass.

      (2) I found the local environmental factors were not considered in the study. As the author mentioned in the manuscript, temperature and water also have important impacts on biodiversity and ecosystem function in the natural ecosystem. I suggest authors include the environmental factors in the data analysis to control their potential impact, especially the structural equation model.

      Response: Thanks for your constructive suggestion. We agree with you that environmental factors should be considered in our study. In the revised manuscript, we have integrated two environmental factors related to water and temperature (soil water content and land surface temperature) into the data analysis to control their potential impact. The main results and conclusions of the revised manuscript are consistent with those of the previous manuscript.

      Reviewer #3 (Recommendations For The Authors):

      (1) L60-63. The necessity to distinguish between habitat loss and fragmentation per se is not clearly stated. More information about biodiversity conservation strategies can be given here.

      Response: Thanks for your suggestion. In the revised manuscript, we have provided more evidence about the importance of distinguishing between habitat loss and fragmentation per se for biodiversity conservation.

      Line 62-67:

      “Habitat loss is often considered the major near-term threat to the biodiversity of terrestrial ecosystems (Chase et al., 2020; Haddad et al., 2015), while the impact of fragmentation per se remains debated (Fletcher Jr et al., 2023; Miller-Rushing et al., 2019). Thus, habitat loss and fragmentation per se may have inconsistent ecological consequences and should be considered simultaneously to establish effective conservation strategies in fragmented landscapes (Fahrig et al., 2019; Fletcher et al., 2018; Miller-Rushing et al., 2019).”

      (2) L73-77. The two sentences are hard to follow. Please rephrase to improve the logic. And I don't understand the "however" here. There is no twist.

      Response: Thanks for your suggestion. We have rephrased the two sentences to improve their logic.

      Line 74-79:

      “In theory, habitat loss and fragmentation per se can regulate ecosystem function and the BEF relationship by altering species composition, interactions, and spatial asynchrony regardless of changes in species richness (Liu et al., 2018; Thompson and Gonzalez, 2016; Tscharntke et al., 2012). This is because species in communities are not ecologically equivalent and may respond differently to habitat loss and fragmentation per se, and contribute unequally to ecosystem function (Devictor et al., 2008; Wardle and Zackrisson, 2005).”

      (3) L97. Are grasslands really the largest terrestrial ecosystem? Isn't it the forest?

      Response: We apologize for making this confusion. We have rephrased this sentence here.

      Line 101-104:

      “Grasslands have received considerably less attention, despite being one of the largest terrestrial ecosystems, and suffering severe fragmentation due to human activities, such as agricultural reclamation and urbanisation (Fardila et al., 2017).”

      (4) Fig.1, whether the four sample plots presented in panel b are from panel a. Please add the scale bar in panel b.

      Response: Thanks for your comment. The four sample plots presented in panel b are from panel a in Figure 1. We have also added the scale bar in panel b.

      (5) L105. This statement is too specific. Please remove and consider merging this paragraph with the next.

      Response: Thanks for your suggestion. We have removed this sentence and merged this paragraph with the next.

      (6) L157. The accuracy and kappa value of the supervised classification should be given.

      Response: Thanks for your suggestion. We have added the accuracy and kappa value of the supervised classification in the revised manuscript.

      Line 176-177:

      “The overall classification accuracy was 84.3 %, and the kappa coefficient was 0.81.”

      (7) I would recommend the authors provide the list of generalists and specialists surveyed in the supplementary. Readers may not be familiar with the plant species composition in this area.

      Response: Thanks for your suggestion. We agree with your point. We have provided the list of generalists and specialists surveyed in the Appendix Table A4.

      Line 282-283:

      “A total of 130 vascular plant species were identified in our study sites, including 91 grassland specialists and 39 weeds (Appendix Table A4).”

      (8) Fig.4, it is better to add the results of variation partition to present the relative contribution of habitat fragmentation, environmental factors, and plant diversity.

      Response: Thanks for your suggestion. We have integrated the landscape context, environmental factors, and plant diversity into the multi-model averaging analysis and redraw Figure 4 to present their relative importance for above-ground biomass.

      Line 313-319:

      Author response image 3.

      Standardised parameter estimates and 95% confidence intervals for landscape context, plant diversity, and environmental factors affecting above-ground biomass from 130 landscapes in the Tabu River Basin, a typical agro-pastoral ecotone of northern China. Standardised estimates and 95% confidence intervals are calculated by the multi-model averaging method based on the four optimal models affecting above-ground biomass (Appendix Table A3). ** represent significance at the 0.01 level.

      (9) Please redraw Fig.2 and Fig.5 to integrate the environmental factors. Add the R-square to Fig 5.

      Response: Thanks for your suggestion. We have integrated two environmental factors into the structural equation model and redraw Figure 2 and Figure 5 in the revised manuscript. And we have added the R-square to the Figure 5.

      (10) L354. The authors should be careful to claim that habitat loss could reduce the importance of plant diversity to ecosystem function. This pattern observed may depend on the type of ecosystem function studied.

      Response: Thanks for your suggestion. We have avoided this claim in the revised manuscript and explicitly discussed the importance of simultaneously focusing on multiple ecosystem functions, such as below-ground productivity, litter decomposition, soil carbon stocks, etc.

      Line 454-457:

      “This inconsistency can be explained by trade-offs between different ecosystem functions that may differ in their response to fragmentation per se (Banks-Leite et al., 2020). Therefore, future studies are needed to focus on multiple ecosystem functions, such as below-ground productivity, litter decomposition, soil carbon stocks, etc.”

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment This valuable paper reports a theoretical framework and methodology for identifying Cancer Driving Nucleotides (CDNs), primarily based on single nucleotide variant (SNV) frequencies. A variety of solid approaches indicate that a mutation recurring three or more times is more likely to reflect selection rather than being the consequence of a mutation hotspot. The method is rigorously quantitative, though the requirement for larger datasets to fully identify all CDNs remains a noted limitation. The work will be of broad interest to cancer geneticists and evolutionary biologists. 

      The key criticism “the requirement for larger datasets to fully identify all CDNs remains a noted limitation” that is also found in both reviews. We have clarified the issue in the main text, the relevant parts, from which are copied below. The response below also addresses many comments in the reviews. In addition, Discussion of eLife-RP-RA-2024-99341 has been substantially expanded to answer the questions of Reviewer 2.

      We shall answer the boldface comment in three ways. First, it can be answered using GENIE data. Fig. 7 of the main text (eLife-RP-RA-2024-99340) shows that, when n increases from ~ 1000 to ~ 9,000, the numbers of discovered CDNs increase by 3 – 5 fold, most of which come from the two-hit class. Hence, the power of discovering more CDNs with larger datasets is evident. By extrapolation, a sample size of 100,000 should be able to yield 90% of all CDNs, as calculated here. (Fig. 7 also addresses the queries of whether we have used datasets other than TCGA. We indeed have used all public data, including GENIE and COSMIC.) 

      Second, the power of discovering more cancer driver genes by our theory is evident even without using larger datasets. Table 3 of the companion study (eLife-RP-RA-2024-99341) shows that, averaged across cancer types, the conventional method would identify 45 CDGs while the CDN method tallies 258 CDGs. The power of the CDN method is demonstrated. This is because the conventional approach has to identify CDGs (cancer driver genes) in order to identify the CDNs they carry. However, many CDNs occur in non-CDGs and are thus missed by the conventional approach. In Supplementary File S2, we have included a full list of CDNs discovered in our study, along with population allele frequency annotations from gnomAD. The distribution patterns of these CDNs across different cancer types show their pan-cancer properties as further explored in the companion paper.

      Third, while many, or even most CDNs occur in non-CDGs and are thus missed, the conventional approach also includes non-CDN mutations in CDGs. This is illustrated in Fig. 5 of the companion study (eLife-RP-RA-2024-99341) that shows the adverse effect of misidentifications of CDNs by the conventional approach. In that analysis, the gene-targeting therapy is effective if the patient has the CDN mutations on EGFR, but the effect is reversed if the EGFR mutations are non-CDN mutations.

      Reviewer #1 (Public Review):

      The authors developed a rigorous methodology for identifying all Cancer Driving Nucleotides (CDNs) by leveraging the concept of massively repeated evolution in cancer. By focusing on mutations that recur frequently in pan-cancer, they aimed to differentiate between true driver mutations and neutral mutations, ultimately enhancing the understanding of the mutational landscape that drives tumorigenesis. Their goal was to call a comprehensive catalogue of CDNs to inform more effective targeted therapies and address issues such as drug resistance.

      Strengths

      (1) The authors introduced a concept of using massively repeated evolution to identify CDNs. This approach recognizes that advantageous mutations recur frequently (at least 3 times) across cancer patients, providing a lens to identify true cancer drivers.

      (2) The theory showed the feasibility of identifying almost all CDNs if the number of sequenced patients increases to 100,000 for each cancer type.

      Weaknesses

      (1) The methodology remains theoretical and no novel true driver mutations were identified in this study.

      We now address the weakness criticism, which is gratefully received.

      The second part of the criticism (no novel true driver mutations were identified in this study) has been answered in the long responses to eLife assessment above. The first part “The methodology remains theoretical” is somewhat unclear. It might be the lead to the second part. However, just in case, we interpret the word “theoretical” to mean “the lack of experimental proof” and answer below.

      As Reviewer #1 noted, a common limitation of theoretical and statistical analyses of cancer drivers is the need to validate their selective advantage through in vitro or in vivo functional testing. This concern is echoed by both reviewers in the companion paper (eLife-RP-RA-2024-99341), prompting us to consider the methodology for functional testing of potential cancer drivers. An intuitive approach would involve introducing putative driver mutations into normal cells and observing phenotypic transformation in vitro and in vivo. In a recent stepwise-edited human melanoma model, Hodis et al. demonstrated that disease-relevant phenotypes depend on the “correct” combinations of multiple driver mutations (Hodis et al. 2022). Other high-throughput strategies can be broadly categorized into two approaches: (1) introducing candidate driver mutations into pre-malignant model systems that already harbor a canonical mutant driver (Drost and Clevers 2018; Grzeskowiak et al. 2018; Michels et al. 2020) and (2) introducing candidate driver mutations into growth factor-dependent cell models and assessing their impact on resulting fitness (Bailey et al. 2018; Ng et al. 2018). The underlying assumption of these strategies is that the fitness outcomes of candidate driver mutations are influenced by pre-existing driver mutations and the specific pathways or cancer hallmarks being investigated. This confines the functional test of potential cancer driver mutations to conventional cancer pathways. A comprehensive identification of CDNs is therefore crucial to overcome these limitations. In conjunction with other driver signal detection methods, our study aims to provide a more comprehensive profile of driver mutations, thereby enabling the functional testing of drivers involved in non-conventional cancer evolution pathways.

      (2) Different cancer types have unique mutational landscapes. The methodology, while robust, might face challenges in uniformly identifying CDNs across various cancers with distinct genetic and epigenetic contexts.

      We appreciate the comment. Indeed, different cancer types should have different genetic and epigenetic landscapes. In that case, one may have expected CDNs to be poorly shared among cancer types. However, as reported in Fig. 4 of the companion study, the sharing of CDNs across cancer types is far more common than the sharing of CDGs (Cancer Driving Genes). We suggest that CDNs have a much higher resolution than CDGs, whereby the signals are diluted by non-driver mutations. In other words, despite that the mutational landscape may be cancer-type specific, the pan-cancer selective pressure may be sufficiently high to permit the detection of CDN sharing among cancer types.

      Below, we shall respond in greater details. Epigenetic factors, such as chromatin states, methylation/acetylation levels, and replication timing, can provide valuable insights when analyzing mutational landscapes at a regional scale (Stamatoyannopoulos et al. 2009; Lawrence et al. 2013; Makova and Hardison 2015; Baylin and Jones 2016; Alexandrov et al. 2020; Abascal et al. 2021; Sherman et al. 2022). However, at the site-specific level, the effectiveness of these covariates in predicting mutational landscapes depends on their integration into a detailed model. Overemphasizing these covariates could lead to false negatives for known driver mutations (Hess et al. 2019; Elliott and Larsson 2021). In figure 3B of the main text, we illustrate the discrepancy between the mutation rate predictions from Dig and empirical observation. Ideally, no covariates would be needed under extensive sample sizes, where each mutable genomic sites would have sufficient mutations to yield a statistic significance and consequently, synonymous mutations would be sufficient for the characterization of mutational landscape. In this sense, the integration of mutational covariates represents a compromise under current sample size. In our study, the effect of unique mutational landscapes is captured by E(u), the mean mutation rate for each cancer type. We further accounted for the variability of site-level mutability using a gamma distribution. The primary goal of our study is to determine the upper limit of mutation recurrences under mutational mechanisms only. While selection force acts blindly to genomic features, mutational hotspots should exhibit common characteristics determined by their underlying mechanisms. In the main text, we attempted to identify such shared features among CDNs. Until these mutational mechanisms are fully understood, CDNs should be considered as potential driver mutations.

      (3) L223, the statement "In other words, the sequences surrounding the high-recurrence sites appear rather random.". Since it was a pan-cancer analysis, the unique patterns of each cancer type could be strongly diluted in the pan-cancer data.

      We now state that the analyses of mutation characteristic have been applied to the individual cancer types and did not find any pattern that deviates from randomness. Nevertheless, it may be argued that, with the exception of those with sufficiently large sample sizes such as lung and breast cancers, most datasets do not have the power to reject the null hypothesis. To alleviate this concern, we applied the ResNet and LSTM/GRU methods for the discovery of potential mutation motifs within each cancer type. All methods are more powerful than the one used but the results are the same – no cancer type yields a mutation pattern that can reject the null hypothesis of randomness (see below).

      As a positive control, we used these methods for the discovery of splicing sites of human exons. When aligned up with splicing site situated in the center (position 51 in the following plot), the sequence motif would look like:

      Author response image 1.

      5-prime

      Author response image 2.

      3-prime

      However, To account for the potential influence of distance from the mutant site in motif analysis, we randomly shuffled the splicing sites within a specified window around the alignment center, and their sequence logo now looks like:

      Author response image 3.

      5-prime shuffled

      Author response image 4.

      3-prime shuffled

      Author response image 5.

      random sequences from coding regions

      The classification results of the shuffled 5-prime (donner), 3-prime (acceptor) and random sequences from coding regions (Random CDS) are presented in the Author response table 1 (The accuracy for the aligned results, which is approximately 99%, is not shown here).

      Author response table 1.

      With the positive results from these positive controls (splicing site motifs) validating our methodology, we applied the same model structure to the train and test of potential mutational motifs of CDN sites. All models achieved approximately 50% accuracy in CDN motif analysis, suggesting that the sequence contexts surrounding CDN sites are not significantly different from other coding regions of the genome. This further implies that the recurrence of mutations at CDN sites is more likely driven by selection rather than mutational mechanisms.

      Note that this preliminary analysis may be limited by insufficient training data for CDN sites. Future studies will require larger sample sizes and more sophisticated models to address these limitations.

      (4) To solidify the findings, the results need to be replicated in an independent dataset.

      Figure 7 validates our CDN findings using the GENIE dataset, which primarily consists of targeted sequencing data from various panels. By focusing on the same genomic regions sequenced by GENIE, we observed a 3-5 fold increase in the number of discovered CDNs as sample size increased from approximately 1000 to 9000. Moreover, the majority of CDNs identified in TCGA were confirmed as CDNs in GENIE.

      (5) The key scripts and the list of key results (i.e., CDN sites with i{greater than or equal to}3) need to be shared to enable replication, validation, and further research. So far, only CDN sites with i{greater than or equal to}20 have been shared.

      We have now updated the “Data Availability” section in the main text, the corresponding scripts for key results are available on Gitlab at: https://gitlab.com/ultramicroevo/cdn_v1.

      (6) The versions of data used in this study are not clearly detailed, such as the specific version of gnomAD and the version and date of TCGA data downloaded from the GDC Data Portal.

      The versions of data sources have now been updated in the revised manuscript.

      Recommendations For The Authors:

      (1) L119, states "22.7 million nonsynonymous sites," but Table 1 lists the number as 22,540,623 (22.5 million). This discrepancy needs to be addressed for consistency.<br /> (2) Figure 2B, there is an unexplained drop in the line at i = 6 and 7 (from 83 to 45). Clarification is needed on why this drop occurs.<br /> (3) Figure 3A, for the CNS type, data for recurrence at 8 and 9 are missing. An explanation should be provided for this absence.<br /> (4) L201, the title refers to "100-mers," but L218 mentions "101-mers." This inconsistency needs to be corrected to ensure clarity and accuracy.<br /> (5) Figures 6 and 7 currently lack titles. Titles should be added to these figures to improve readability.

      Thanks. All corrections have been incorporated into the revised manuscript.

      Reviewer #2 (Public Review):<br /> Summary:<br /> The authors propose that cancer-driver mutations can be identified by Cancer Driving Nucleotides (CDNs). CDNs are defined as SNVs that occur frequently in genes. There are many ways to define cancer driver mutations, and the strengths and weaknesses are the reliance on statistics to define them.<br /> Strengths:<br /> There are many well-known approaches and studies that have already identified many canonical driver mutations. A potential strength is that mutation frequencies may be able to identify as yet unrecognized driver mutations. They use a previously developed method to estimate mutation hotspots across the genome (Dig, Sherman et al 2022). This publication has already used cancer sequence data to infer driver mutations based on higher-than-expected mutation frequencies. The advance here is to further illustrate that recurrent mutations (estimated at 3 or more mutations (CDNs) at the same base) are more likely to be the result of selection for a driver mutation (Figure 3). Further analysis indicates that mutation sequence context (Figure 4) or mutation mechanisms (Figure 5) are unlikely to be major causes for recurrent point mutations. Finally, they calculate (Figure 6) that most driver mutations identifiable by the CDN approach could be identified with about 100,000 to one million tumor coding genomes.<br /> Weaknesses:<br /> The manuscript does provide specific examples where recurrent mutations identify known driver mutations but do not identify "new" candidate driver mutations. Driver mutation validation is difficult and at least clinically, frequency (ie observed in multiple other cancer samples) is indeed commonly used to judge if an SNV has driver potential. The method would miss alternative ways to trigger driver alterations (translocations, indels, epigenetic, CNVs). Nevertheless, the value of the manuscript is its quantitative analysis of why mutation frequencies can identify cancer driver mutations.

      Recommendations For The Authors<br /> Whereas the analysis of driver mutations in WES has been extensive, the application of the method to WGS data (ie the noncoding regions) would provide new information.

      We appreciate that Reviewer #2 has suggested the potential application of our method to noncoding regions. Currently, the background mutation model is based on the site level mutations in coding regions, which hinders its direct applications in other mutation types such as CNVs, translocations and indels. We acknowledge that the proportion of patients with driver event involving CNV (73%) is comparable to that of coding point mutations (76%) as reported in the PCAWG analysis (Fig. 2A from Campbell et al., 2020). In future studies, we will attempt to establish a CNV-based background mutation rate model to identify positive selection signals driving tumorigenesis.

      References

      Abascal F, Harvey LMR, Mitchell E, Lawson ARJ, Lensing SV, Ellis P, Russell AJC, Alcantara RE, Baez-Ortega A, Wang Y, et al. 2021. Somatic mutation landscapes at single-molecule resolution. Nature:1–6.

      Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, Boot A, Covington KR, Gordenin DA, Bergstrom EN, et al. 2020. The repertoire of mutational signatures in human cancer. Nature 578:94–101.

      Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, et al. 2018. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell 173:371-385.e18.

      Baylin SB, Jones PA. 2016. Epigenetic Determinants of Cancer. Cold Spring Harb Perspect Biol 8:a019505.

      Campbell PJ, Getz G, Korbel JO, Stuart JM, Jennings JL, Stein LD, Perry MD, Nahal-Bose HK, Ouellette BFF, Li CH, et al. 2020. Pan-cancer analysis of whole genomes. Nature 578:82–93.

      Drost J, Clevers H. 2018. Organoids in cancer research. Nat Rev Cancer 18:407–418.

      Elliott K, Larsson E. 2021. Non-coding driver mutations in human cancer. Nat Rev Cancer 21:500–509.

      Grzeskowiak CL, Kundu ST, Mo X, Ivanov AA, Zagorodna O, Lu H, Chapple RH, Tsang YH, Moreno D, Mosqueda M, et al. 2018. In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer. Nat Commun 9:2732.

      Hess JM, Bernards A, Kim J, Miller M, Taylor-Weiner A, Haradhvala NJ, Lawrence MS, Getz G. 2019. Passenger Hotspot Mutations in Cancer. Cancer Cell 36:288-301.e14.

      Hodis E, Triglia ET, Kwon JYH, Biancalani T, Zakka LR, Parkar S, Hütter J-C, Buffoni L, Delorey TM, Phillips D, et al. 2022. Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironment. Science 376:eabi8175.

      Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, et al. 2013. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499:214–218.

      Makova KD, Hardison RC. 2015. The effects of chromatin organization on variation in mutation rates in the genome. Nat Rev Genet 16:213–223.

      Michels BE, Mosa MH, Streibl BI, Zhan T, Menche C, Abou-El-Ardat K, Darvishi T, Członka E, Wagner S, Winter J, et al. 2020. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids. Cell Stem Cell 26:782-792.e7.

      Ng PK-S, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana VH, Tran R, et al. 2018. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell 33:450-462.e10.

      Sherman MA, Yaari AU, Priebe O, Dietlein F, Loh P-R, Berger B. 2022. Genome-wide mapping of somatic mutation rates uncovers drivers of cancer. Nat Biotechnol 40:1634–1643.

      Stamatoyannopoulos JA, Adzhubei I, Thurman RE, Kryukov GV, Mirkin SM, Sunyaev SR. 2009. Human mutation rate associated with DNA replication timing. Nat Genet 41:393–395.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews: 

      Reviewer #1 (Public review): 

      Summary:  

      Wang et al. investigate sexual dimorphic changes in the transcriptome of aged humans. This study relies upon analysis of the Genotype-Tissue Expression dataset that includes 54 tissues from human donors. The authors investigate 17,000 transcriptomes from 35 tissues to investigate the effect of age and sex on transcriptomic variation, including the analysis of alternative splicing. Alternative splicing is becoming more appreciated as an influence in the aging process, but how it is affected by sexual dimorphism is still largely unclear. The authors investigated multiple tissues but ended up distilling brain tissue down to four separate regions: decision, hormone, memory, and movement. Building upon prior work, the authors used an analysis method called principal component-based signal-to-variation ratio (pcSVR) to quantify differences between sex or age by considering data dispersion. This method also considers differentially expressed genes and alternative splicing events. 

      Strengths:  

      (1) The authors investigate sexual dimorphism on gene expression and alternative splicing events with age in multiple tissues from a large publicly available data set that allows for reanalysis. 

      (2) Furthermore, the authors take into account the ethnic background of donors. Identification of agingmodulating genes could be useful for the reanalysis of prior data sets. 

      Weaknesses:  

      The models built off of the GTEx dataset should be tested in another data set (ex. Alzheimer's disease) where there are functional changes that can be correlated. Gene-length-dependent transcription decline, which occurs with age and disease, should also be investigated in this data set for potential sexual dimorphism. 

      We appreciate the reviewer’s constructive feedback and acknowledgment of the strengths of our study. The detailed results are included in the ‘Recommendations for the authors’ from the editorial office. Below we summarize our feedback that address the concerns of this reviewer:

      (1) Independent Alzheimer’s disease (AD) datasets:

      We acknowledge the importance of validating our models beyond GTEx to assess their generalizability aging to Alzheimer’s disease. While GTEx provides valuable transcriptomic data across multiple tissues, it lacks direct functional assessments linked to disease states. We have already analyzed RNA-seq data from ROSMAP and GEO in Figure 4, focusing on sex-biased gene expression and splicing changes between aging and AD.  The results showed a male-biased association with Alzheimer’s disease at AS resolution, indicating that the AS changes during aging could contribute more to AD in males than females. We added a highlight to this analysis in the manuscript (Pages 6-7).

      (2) Sexual dimorphism in Gene-Length-Dependent Transcription Decline (GLTD) 

      We appreciate the reviewer’s suggestion to explore gene-length-dependent transcription decline (GLTD), which has been implicated in both aging and disease. As the reviewer suggested, our analysis revealed that GLTD exhibits sex-biased patterns in different tissues, aligning with recent literature on sex-dimorphic transcriptional aging. Our findings also revealed that longer genes with greater transcriptional decline are enriched in AD-related pathways. We have incorporated this new analysis in the ‘Recommendations for the authors’ in Author response image 5-6 and expanded the discussion of the biological relevance. 

      Reviewer #2 (Public review): 

      Summary: 

      In this manuscript, Wang et al analyze ~17,000 transcriptomes from 35 human tissues from the GTEx database and address transcriptomic variations due to age and sex. They identified both gene expression changes as well as alternative splicing events that differ among sexes. Using breakpoint analysis, the authors find sex dimorphic shifts begin with declining sex hormone levels with males being affected more than females. This is an important pan-tissue transcriptomic study exploring age and sex-dependent changes although not the first one. 

      Strengths:  

      (1) The authors use sophisticated modeling and statistics for differential, correlational, and predictive analysis. 

      (2) The authors consider important variables such as genetic background, ethnicity, sampling bias, sample sizes, detected genes, etc. 

      (3) This is likely the first study to evaluate alternative splicing changes with age and sex at a pan-tissue scale. 

      (4) Sex dimorphism with age is an important topic and is thoroughly analyzed in this study.  Weaknesses:  

      (1) The findings have not been independently validated in a separate cohort or through experiments. Only selective splicing factor regulation has been verified in other studies. 

      (2) It seems the authors have not considered PMI or manner of death as a variable in their analysis. 

      (3) The manuscript is very dense and sometimes difficult to follow due to many different types of analyses and correlations. 

      (4) Short-read data can detect and quantify alternative splicing events with only moderate confidence and therefore the generalizability of these findings remains to be experimentally validated. 

      We appreciate the thorough review and thoughtful feedback. We have addressed the reviewer’s concerns and added clarification. The detailed results are included in Recommendations for the authors. Here are the summaries.

      (1) Challenge of independent validation in separate cohorts

      • The GTEx dataset includes the most comprehensive transcriptome resource for studying population-level differences in age and sex across tissues, particularly including large-scale brain samples. This provides a unique opportunity to analyze sex-dimorphic aging and the relevance of age-associated diseases.  Several technical issues, including cell type heterogeneity, postmortem artifacts, as well as sequencing biases, lead to technical challenges in different cohorts.

      • As the reviewer mentioned, we analyzed transcriptomic data from Shen et al. (2024) and compared them with GTEx results (Author response image 2). Limited overlap in differentially expressed genes again highlighted the challenges in cross-dataset validation due to the differences in cell composition and data processing (peripheral blood mononuclear cells (PBMCs) vs whole blood). 

      • Due to the limited human brain transcriptome data covering different age and sex groups, we found mouse hippocampus datasets from Mass spectrometry (MS), including young and old, as well as female and male groups.  The results validated the expression of splicing factors in brain (Author response image 9). This cross-species consistency supports the robustness of our findings in human brain aging.

      (2) Effects of Postmortem Interval, Manner of Death, and Time of Death

      • We agree that the sample collections could introduce confounding effects. To address this, we calculated the correlations between the confounding factors with Postmortem Interval (PMI), Manner of Death (DTHMNNR), or Time of Death (DTHTIME and DTHSEASON). We observed strong correlations in some surrogate variables in most tissues, indicating that those factors could be well-regressed during our analysis (Recommendations for the authors, Figure S4 and R8). 

      • In addition, we re-evaluated our analyses while incorporating PMI as a covariate in our models. Our results align with our initial findings (Author response image 1), suggesting that age- and sex-dependent transcriptomic changes are not strongly confounded by PMI and confirming that our model has controlled PMI. These results are detailed in ‘Recommendations for the authors’ and included in Figure S4C-E with the description in text, Page 5. 

      (3) Readability of manuscript and flow of analyses

      • In summary, our study first examined global alternative splicing (AS) and gene expression (GE) across all tissues before focusing on specific regions for deeper insights. To improve clarity, we have made the following revisions:

      • Add clearer statements when transitioning between all-tissue and brain-specific analyses (Page 6-7).

      • Modify the subtitle of Results to highlight all-tissue vs. brain analyses (Page 6).

      • These refinements could enhance the manuscript’s structure, making the flow of analysis and conclusions more intuitive for readers.

      (4) Limitations of short-read RNA-seq for splicing analysis

      • Short-read RNA-seq provides only moderate confidence in detecting and quantifying full-length isoforms. However, its higher sequencing depth makes it more suitable for quantifying changes in alternative splicing (AS) events.

      • Our analysis focused on splicing event-level quantification, applying stringent filters and using our GPU-based tool, which showed strong concordance with RT-PCR and other pipelines. Therefore, we also cited and included the updated Paean manuscript that benchmarks its performance in AS analysis.

      Reviewer #3 (Public review): 

      Summary:  

      In this study, Wang et al utilized the available GTEx data to compile a comprehensive analysis that attempt to reveal aging-related sex-dimorphic gene expression as well as alternative splicing changes in humans. 

      The key conclusions based on their analysis are that. 

      (1) extensive sex-dimorphisms during aging with distinct patterns of change in gene expression and alternative splicing (AS), and 

      (2) the male-biased age-associated AS events have a stronger association with Alzheimer's disease, and  (3) the female-biased events are often regulated by several sex-biased splicing factors that may be controlled by estrogen receptors. They further performed break-point analysis and revealed that in males there are two main breakpoints around ages 35 and 50, while in females, there is only one breakpoint at 45. 

      Strengths:  

      This study sets an ambitious goal, leveraging the extensive GTEx dataset to investigate aging-related, sexdimorphic gene expression and alternative splicing changes in humans. The research addresses a significant question, as our understanding of sex-dimorphic gene expression in the context of human aging is still in its early stages. Advancing our knowledge of these molecular changes is vital for identifying therapeutic targets for age-related diseases and extending the human health span. The study is highly comprehensive, and the authors are commendable for their attempted thorough analysis of both gene expression and alternative splicing - an area often overlooked in similar studies. 

      We thank this reviewer for the insightful review and recognition of our study's significance.  We agree with the reviewer on how to examine sex-dimorphic gene expression and alternative splicing in aging by using the GTEx dataset.  This is indeed an essential aspect of developing potential therapeutic targets for agerelated diseases to promote human health span.

      Weaknesses:  

      Due to the inherent noise within the GTEx dataset - which includes numerous variables beyond aging and sex - there are significant technical concerns surrounding this study. Additionally, the lack of crossvalidation with independent, existing data raises questions about whether the observed gene expression changes genuinely reflect those associated with human aging. For instance, the break-point analysis in this study identifies two major breakpoints in males around ages 35 and 50, and one breakpoint in females at age 45; however, these findings contradict a recent multi-omics longitudinal study involving 108 participants aged 25 to 75 years, where breakpoint at 44 and 60 years was observed in both male and females (Shen et al, 2024). These issues cast doubt on the robustness of the study's conclusions. Specific concerns are outlined below: 

      References: 

      Ferreira PG, Muñoz-Aguirre M, Reverter F, Sá Godinho CP, Sousa A, Amadoz A, Sodaei R, Hidalgo MR, Pervouchine D, Carbonell-Caballero J et al (2018) The effects of death and post-mortem cold ischemia on human tissue transcriptomes. Nature Communications 9: 490. 

      Shen X, Wang C, Zhou X, Zhou W, Hornburg D, Wu S, Snyder MP (2024) Nonlinear dynamics of multiomics profiles during human aging. Nature Aging. 

      Wucher V, Sodaei R, Amador R, Irimia M, Guigó R (2023) Day-night and seasonal variation of human gene expression across tissues. PLOS Biology 21: e3001986. 

      (1) The primary method used in this study is linear regression, incorporating age, sex, and age-by-sex interactions as covariates, alongside other confounding factors (such as ethnicity) as unknown variables. However, the analysis overlooks two critical known variables in the GTEx dataset: time of death (TOD) and postmortem interval (PMI). Both TOD and PMI are recorded for each sample and account for substantial variance in gene expression profiles. A recent study by Wucher et al.(Wucher et al, 2023) demonstrated the powerful impact of TOD on gene expression by using it to reconstruct human circadian and even circannual datasets. Similarly, Ferreira et al. (Ferreira et al, 2018) highlighted PMI's influence on gene expression patterns. Without properly adjusting for these two variables, confidence in the study's conclusions remains limited at best. 

      We appreciate the reviewer for raising this important point regarding the impact of post-mortem interval (PMI) and time of death (TOD) on gene expression, including the death seasons (DTHSEASON) and daytime (DTHTIME). To address this point, we carefully evaluated whether our linear model controlled for these factors as potential confounders. 

      Our results showed that PMI and TOD significantly correlated with the estimated covariates in most tissues, suggesting that their effects could be effectively regressed out using our model (Figure S4).  As the reviewers and editors suggested, we have now included this correlation analysis in the updated Figure S4C-E and the text in the Results section, citing relevant literature [1,2] (Page 5). 

      Author response image 1.

      The results of differential gene expression analysis with vs without the inclusion of PMI correction as a known covariate. The scatter plots show the correlations of significance levels (pvalues, left panel) and effect sizes (coefficients, right panel) of sex (A) and age (B). Whole-blood tissue is used as an example.

       

      In addition, we did the differential analysis that incorporated PMI as a covariate in the regression models and re-evaluated the age- and sex-related transcriptomic changes. Using WholeBlood gene expression as an example, our revised analysis shows that the inclusion of PMI in the covariates has minimal impact on the significance levels and effects of sex and age (i.e., p-values and coefficients, respectively), indicating that our findings are robust using confounding factors (Author response image 1). 

      (2) To demonstrate that their analysis is robust and that the covariates TOD and PMI are otherwise negligible - the authors should cross-validate their findings with independent datasets to confirm that the identified gene expression changes are reproducible for some tissues. For instance, the recent study by Shen et al. (Shen et al., 2024) in Nature Aging offers an excellent dataset for cross-validation, particularly for blood samples. Comparing the GTEx-derived results with this longitudinal transcriptome dataset would enable verification of gene expression changes at both the individual gene and pathway levels. Without such validation, confidence in the study's conclusions remains limited. 

      We thank the reviewer for the insightful suggestion regarding cross-validation with independent datasets. We understand that validating findings across datasets is crucial for ensuring robustness. As the reviewers suggested, we see whether there are some shared findings in the GTEx data with the study by Shen et al. (2024) in Nature Aging. However, after performing comparisons with our GTEx results in whole blood tissue, we found that the overlaps of differentially expressed genes are limited (Fig. 3). In our results, we found a large proportion of age-associated genes in the GTEx data, whereas just 54 genes are age-associated from Shen et al.’s PBMC data. 3 in 7 genes are differentially expressed in both datasets (Fig. 3A). Additionally, we performed the functional enrichment analysis on the GTEx-specific age-associated genes.

      We observed a strong enrichment in the biological pathways related to neutrophil functions and innate immune responses, which are specific to the cell compositions in whole blood rather than PBMC (Fig. 3B).

      Author response image 2.

      The comparison between the gene expression of whole blood tissue from GTEx and PBMCs from Shen et al. (A) The bar plot shows the number of age (left panel) or sex-associated  (right panel) genes in the two datasets. The grey bars highlight the proportion of overlapped genes in both datasets. (B) The top 10 significantly enriched biological processes in the GTEx-specific age-associated genes. The color bar shows the number of age-associated genes in specific pathways.

      These discrepancies highlighted the crucial factors in cross-dataset comparison:

      • Cell compositions: GTEx used whole blood, which contains all blood components, including neutrophils and erythrocytes, whereas PBMCs contain lymphocytes and monocytes. Under the influence of granulocytes and red blood cells in whole blood, the gene expression profiles between these two datasets are different.

      • Biological functions: Whole blood includes both innate and adaptive immune components; thus, aging-related gene expression changes in whole blood may include a broader systemic response than those in PBMCs. This difference in biological context contributes to the observed variation in the differentially expressed genes, as demonstrated by our functional enrichment analysis (Fig. 3B). 

      • Sequencing biases and data processing: The two datasets were generated using different RNAseq processing pipelines, including distinct normalization, batch correction, and quantification methodologies. These technical differences may introduce systematic variations that complicate direct cross-validation.

      Due to these fundamental problems, a direct one-to-one validation between the two datasets is challenging. We understand the importance of independent dataset validation and appreciate the reviewer’s suggestion. However, future studies could be performed more precisely if comparable whole-blood-based datasets are available. In addition, GTEx data provides nearly thousands of samples in whole blood, which is a largescale, comprehensive, and clinically relevant dataset for studying aging-related changes, particularly in innate immunity and inflammation, which are not well captured in PBMCs.

      (3) As a demonstration of the lack of such validation, in the Shen et al. study (Shen et al., 2024), breakpoints at 44 and 60 years were observed in both males and females, while this study identifies two major breakpoints in males around ages 35 and 50, and one breakpoint in females at age 45. What caused this discrepancy? 

      We thank the reviewer and the editors for both coming up with the non-linear multi-omic aging patterns observed by Shen et al.  They observed two prominent crests around the ages of 45 and 60 from omics data.

      Similarly, we also identified two breakpoints in our analysis, with some differences in specific age breakpoints. These could be the result of sample preparation methods and breakpoint definition. These responses are also included in the editor’s recommendations.

      Definition of breakpoints vs crests:

      • Crests represent age-related molecular changes at each time point across the human lifespan. They indicate the number of molecules that are differentially expressed during aging (q < 0.05), without considering individual expression levels.

      • Our breakpoints, in contrast, are identified after filtering the chronological trends using the Autoregressive Integrated Moving Average (ARIMA) model. We calculated the rate of change at each age point using the smooth approach and sliding windows. Breakpoints are defined as local maxima where the distance to the nearest minimum, relative to the global maximum. We indeed found some local wide peaks around 60 in some tissues, shown in Figure S10, however, we excluded these due to our strict cutoffs to remove noise.

      Differences and similarities between sequenced tissues: 

      • Whole-blood vs PBMC: In the GTEx RNA-seq data used in our study, whole blood samples from donors were sequenced, whereas their study used PBMCs. Whole blood contains all blood components, including red blood cells, platelets, granulocytes (e.g., neutrophils), lymphocytes, and monocytes, while PBMCs represent a subset of white blood cells, primarily consisting of lymphocytes (T cells, B cells, NK cells) and monocytes, excluding granulocytes and erythrocytes. As we mentioned in the previous responses, the gene expression changes observed in whole blood capture the contributions of neutrophils and other granulocytes, which are neglected in the PBMC profile (also shown in Figure S11C). 

      • For the shared tissues in two studies – skin, we looked at the non-linear changes during aging and found the same two breakpoints: 43 and 58. 

      Novelties in our study:

      • Whole blood can serve as a readily accessible resource for testing age-related disease biomarkers without cell separation, making it more practical for clinical applications.

      • Our analysis was performed on females and males, respectively. The main object of our analysis is to compare the differences in aging rates between sexes. Our results reveal clear sex-specific differences across multiple human tissues. Therefore, the identified breakpoints may differ when sex effects are not taken into account, highlighting the specificity of our analysis. 

      • Additionally, our breakpoints are integrated across multiple tissues. Our results showed that there is a large diversity of aging patterns in different tissues.

      As the reviewers and editors suggested, we have added the following statements to clarify this distinction in the Discussion section: ‘Our analysis observed the non-linear aging patterns with two breakpoints, which is consistent with recent findings, with differences in specific age points due to sex differences as well as tissue diversities 3.’ (Page 14), and ‘These breakpoints could represent key junctures in the aging process that align with the non-linear patterns of aging and disease progression.’ (Page 15)

      (4) Although the alternative splicing analysis is intriguing, the authors did not differentiate between splicing events that alter the protein-coding sequence and those that do not. Many splicing changes occurring in the 5' UTR and 3' UTR regions do not impact protein coding, so it is essential to filter these out and focus specifically on alternative splicing events that can modify protein-coding sequences. 

      The reviewer raises an important point. In our study, we included the AS events in protein-coding genes to gain a comprehensive understanding of sex-biased age-associated splicing. As the reviewer suggested, focusing on coding-sequence-altering events is particularly relevant to protein function. To address this, we performed an additional analysis to specifically annotate sBASEs occurring within the coding sequence (defeined as CDS-altering sBASEs) and reanalyzed their functional pathways and AD-associations (Author response image 3).  

      Our analysis revealed that most of the sBASEs are relevant to protein-coding sequences (CDS) across multiple tissues (Author response image 3A).  We then confirmed our findings using CDS-altering sBASEs. We found that those sBASEs in brain regions were significantly enriched in pathways related to amyloid-beta formation and actin filament organization (Author response image 3B). Notably, male-biased sBASEs in decision-related brain regions were particularly associated with dendrite development and regulation of cell morphogenesis, highlighting the sex-specific roles of sBASEs in brain functions. Additionally, we performed a random forest classification using only CDS-altering sBASEs in AD datasets (Author response image 3C-D), again confirming the malebiased association between aging and AD.

      Overall, we found that most of the identified sBASEs could modify protein-coding sequences, and our main conclusions remain consistent even after filtering out non-coding events. 

      Nevertheless, in addition to AS events that impact protein sequences, alternative splicing in untranslated regions (UTRs) also plays a critical regulatory role. Splicing events in the 5′ UTR can influence translation efficiency by modifying upstream open reading frames (uORFs) or RNA secondary structures, while splicing in the 3′UTR can affect mRNA stability, localization, and translation by altering microRNA binding sites and RNA-binding protein interactions. Given these functional implications, we believe that UTR-targeted AS events should also be considered to supplement the understanding of post-transcriptional gene regulation in future research.

      Author response image 3.

      The distribution and functional relevance of sBASEs with coding effects. (A) The number of sBASEs and CDS-altering sBASEs across multiple tissues. The deeper bars show the number of sBASEs whose alternative splice sites are located at protein-coding regions. (B) GO biological pathways in each sex and brain region. Heatmap shows the sex-specific pathways that are significantly enriched by CDS-altering sBASEs in more than 2 brain regions and sex. (C) Correlation between ADassociated and age-associated AS changes across the CDS-altering sBASEs that alter protein-coding sequences in females and males. (D) Performances of sex-stratified models predicted by CDS-altering sBASEs in 100 iterations using the random forest approach

      (5) One of the study's main conclusions - that "male-biased age-associated AS events have a stronger association with Alzheimer's disease" - is not supported by the data presented in Figure 4A, which shows an association with "regulation of amyloid precursor formation" only in female, not male, alternative splicing genes. Additionally, the gene ontology term "Alzheimer's disease" is absent from the unbiased GO analysis in Figure S6. These discrepancies suggest that the focus on Alzheimer's disease may reflect selective data interpretation rather than results driven by an unbiased analysis. 

      We thank the reviewer for this point. In our functional analysis, we identified distinct biological processes enriched in female- and male-biased AS genes, such as the regulation of amyloid precursor formation in females and structural constituents of the cytoskeleton in males. However, Alzheimer’s disease (AD) is a complex neurodegenerative disorder with multiple pathological mechanisms beyond amyloid-beta (Aβ) formation, many of which are strongly age-related in both sexes. This complexity motivates us to explore novel relationships between splicing and AD in distinct sexes.

      Although Figure 4A shows the enrichment of “regulation of amyloid precursor formation” in female-biased AS events, this does not contradict the broader enrichment of AD-related processes in male-biased AS events. Our disease ontology analysis supports this finding, as male-biased age-associated AS events are enriched in neurodegenerative diseases, including cognitive disorders. Additionally, we considered not only individual GO terms but also the disease-associated transcriptomic signatures from AD-related datasets, which collectively indicate a stronger association in males. 

      Regarding Figure S6 mentioned by the reviewer, the GO term “Alzheimer’s disease” is not explicitly listed in the heatmap because we filtered the pathways that are consistently enriched in multiple tissues. As noted in the figure legend, we only displayed sex-specific GO terms that were significant in at least 15 tissues. Then, since the brain is highly affected by age-related processes and neurological conditions show sex differences, the sex-biased AS events could help explain differential susceptibility to age-related cognitive decline and neurodegeneration. That’s why we chose the brain data for detailed analysis.

      To improve clarity, we have revised the text to describe the purpose of our analysis in brain rather than other tissues (Page 6-7). We appreciate the reviewer’s feedback, and we will consider additional analyses to further explore the sex-biased AS as well as disease risk in other tissues.

      (6) The experimental data presented in Figures 5E - I merely demonstrate that estrogen receptor regulates the expression of two splicing factors, SRSF1 and SRSF7, in an estradiol-dependent manner. However, this finding does not support the notion that this regulation actually contributes to sex-dimorphic alternative splicing changes during human aging. Notably, the authors do not provide evidence that SRSF1 and SRSF7 expression changes actually occur in a sex-dependent manner with human aging (in a manner similar to TIA1). As such, this experimental dataset is disconnected from the main focus of the study and does not substantiate the conclusions on sex-dimorphic splicing during human aging. The authors performed RNAseq in wild-type and ER mutant cells, and they should perform a comprehensive analysis of ER-dependent alternative splicing and compare the results with the GTEx data. It should be straightforward. 

      Thanks for the reviewer’s feedback. The main purpose of the analyses in Figures 5E-I was to explore which factors affect the sex-biased expression of splicing factors during aging and substantially regulate alternative splicing (AS). To address the reviewer’s concerns, we have included additional analysis and explained the challenge of linking estrogen receptor (ER)-regulated splicing factors to sex-dimorphic AS changes during human aging in specific human cell types. 

      • As suggested by the reviewer, we first examined the expression changes of SRSF1 and SRSF7 during aging in males and females, like TIA1 in decision-related brain regions (Fig. 5I).

      • Secondly, the regulation is based on a highly complex regulatory network involving multiple splicing factors and cell heterogeneity. Due to these complexities, we did not overlap ER-dependent AS changes with sBASEs from GTEx datasets directly. As far as the reviewer is concerned, we supplemented the AS analysis in the GSE89888 dataset (Fig. 5H) and identified the estrogenregulated AS events mediated by ESR1. We found that ~6% (26/396) of female-specific ageassociated AS events were regulated by ESR1, of which 6 sBASEs can be regulated by femalebiased splicing factors. The low overlaps could be represented by the limited coverage of different RNA-seq datasets and cell types used across these analyses. Notably, the results indicated that only a fraction of AS could be directly accounted for by estrogen via ESR1, suggesting the complexity of transcriptional and splicing regulatory networks during aging. 

      • Meanwhile, we downloaded independent experimental datasets to discover the regulation by our candidate splicing factors. Due to SRSF1 is identified as a potential regulator of sex-biased splicing, we analyzed RNA-seq data with SRSF1 knock-down (KD) glioblastoma cell lines (U87MG and U251), a type of brain cancer formed from astrocytes that support nerve cells 4.  As a result, we indeed found that some sBASEs are regulated by SRSF1 during aging through this experiment using brain cell lines (Author response image 4). Together, these results suggested that some of the SF-RNA regulatory relationships can be observed in another cellular system, further supporting our findings. 

      Due to the limitations of cell-based models and the complexity in the splicing regulatory network, it is challenging to directly validate aging regulation, particularly between different sexes, based on ER treatments in vivo. However, our findings still provide valuable mechanistic insights into ER-regulated splicing factors, implying their potential role in sex-biased aging.

      Author response image 4.

      SRSF1 regulations on specific sBASEs using SRSF1 knock-down RNA-seq data in GBM cells. Three examples are shown to be regulated during aging with significant changes between SRSF1 KD vs control in U251 and U87MG cell lines. The splicing diagrams are shown below.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors): 

      The authors found that alternative splicing was affected by both sex and age across many tissues, with gene expression differences affected by both parameters only present in some tissues. This trend was consistent when the effects of sex chromosomes were subtracted from the analysis. The effect of aging on differential gene expression and alternative splicing was more prevalent in male than female samples. For analysis purposes, young subjects were deemed to be anyone under 40, and old subjects were over 60 years old. The authors then investigated if specific genes or alternative splicing events were responsible for these effects. Some candidate genes or splicing events were identified but there was little overlap between tissues, suggesting no universal gene or event as a driver of aging. Surrogate variables like the ethnic backgrounds of donors were also investigated. Ultimately the authors found that alternative splicing events showed a stronger sexual dimorphic effect with age than did differential gene expression and that at least for the brain, alternative splicing changes showed a bias for Alzheimer's disease in male samples. This was highlighted by examples of exon skipping in SCL43A2 and FAM107A in males that were associated respectively with plaques and tangles. 

      The authors go on to identify sexual dimorphic differences in splicing factors in particular brain regions during age. Finally, the authors performed analysis for aging-modulated genes, identifying nearly 1000 across the tissues, nearly 70% of which are sex-specific. Their work suggests that further analysis of these aging-modulated genes could be differentially modulating the transcriptome based on sex. The work is novel and interesting, especially investigating sexual dimorphism in alternative splicing. However, the work is still preliminary, and these assumptions need to be applied to other data sets beyond GTEx for validation as well as some other phenomena that need to be considered. I recommend major revisions to address the points below. 

      (1) At the beginning of the results section, the authors state that the brain is stratified into four functional regions. It would be useful to explicitly state those four regions in the text at that point. 

      We agree that specifying these regions early in the text will improve clarity and provide the reader with a clear understanding of the analysis. As the reviewer’s suggestion, we revised the Results section (Page 3) to explicitly state the four functional brain regions as follows: ‘Due to data sparseness, the brain tissues were recombined into four functional regions (table S1), including hormone- or emotion-related region, movement-related region, memory-related region, and decision-related region (See Methods).’. This ensures that the regions are clearly defined before the subsequent analysis is presented. 

      (2) The manuscript becomes a bit confusing when the authors shift from all the tissues as a whole specifically to the brain and then back to the larger tissue set to make assumptions. This can be a bit confusing and should be better delineated.

      We thank the reviewer and editor for the feedback regarding the transitions between the analysis of all tissues and the brain-specific analysis. In our study, we first conducted a broad analysis of alternative splicing (AS) and gene expression (GE) across all tissues. For the AS analyses, we did sBASEs analysis in all tissues and then focused on specific tissue (i.e., brain) whose splicing changes are functionally enriched with age-related diseases.  For the GE analyses, we also analyzed the aging rate across tissues and identified the tissue-specific/shared patterns. 

      We agree that the shifts of the tissues for AS and GE may cause some confusion, and have made the following revisions to delineate why we focused on different tissues for distinct analyses:

      • We have added clear statements to better delineate when we shift focus from the analysis of all tissues to the region-specific analysis and vice versa. For instance, in the Results section (Page 67), we include a transitional phrase: ‘Having established patterns across all tissues, we now turn to a more focused analysis to investigate tissue-specific alternative splicing changes.’

      • To improve the overall structure, we have reorganized the Results section, adding distinct subheadings for the analysis of all tissues and the brain (Page 6), which should make the transition between these sections smoother and more intuitive for the reader.

      We believe that these revisions will make the manuscript’s structure clearer and allow the reader to better follow the flow of the analysis and the subsequent conclusions.

      (3) Gene-length-dependent transcription decline (GLTD) is another phenomenon that occurs with aging and is known to be associated with Alzheimer's disease [PMID38519330]. The authors should make some statement if this is present in their dataset and if any sexual dimorphism in tissues is present. 

      We thank the editors and reviewers for bringing up the possible connection of gene-length-dependent transcription decline (GLTD), which was reported to be associated with both aging and Alzheimer’s disease (AD). We appreciate the reviewer’s suggestion and have addressed whether GLTD is present in our dataset and whether any sex differences are observed in this context.

      We evaluated GLTD using the correlation between gene length with age-associated changes (i.e., the coefficients of the ‘age’ term in the linear regression model) in GTEx data. We did observe strong evidence of GLTD, particularly in the brain, heart, muscle, pancreas, spleen, skin, muscle, etc (Author response image 5A). In brain, we performed the functional enrichment analysis on the genes with Foldchange > 2 and length > 10<sup>5</sup> bp (Author response image 5B). We found that these extremely long genes are significantly relevant to synapse and neuron functions. These findings align with previous studies showing that GLTD can occur with aging in the tissues that are relevant to Alzheimer’s disease, cardiovascular diseases, and common failures of metabolism (e.g., diabetes) [5,6]. Additionally, it was not a ubiquitous phenomenon across all tissues. The correlations could be positive in tissues like adipose and artery.  These findings suggested the GLTD could be varied and tissuespecific in its manifestation during aging. 

      Author response image 5.

      (A) The correlation between gene length and age-associated changes across GTEx tissues in human samples. The correlation tests are evaluated using Spearman’s approach. The color bar indicates the -log10 transformed p-values in the correlation test. (B) The results of GO enrichment analysis using the genes with Foldchange > 2 and length > 10<sup>5</sup> bp. The parent terms calculated by ‘rrvgo’ with a similarity threshold of 0.9 are shown.

      Regarding sexual dimorphism, we conducted this analysis in females and males, respectively (Author response image 6). We found GLTD exists in both females and males in most tissues, such as brain, whole blood, muscle, etc, consistent with the previous results without considering the sex groups. Interestingly, we observed sexbiased patterns in certain tissues. In particular, the left ventricle, pancreas, and hippocampus showed notable male-biased patterns in the degree of transcriptional decline with gene length, whereas skin, liver, small intestine, and esophagus showed that in females. These findings suggest that GLTD could be relevant to aging and age-related diseases; the levels of expression and sexual dimorphism may vary depending on the tissue type. We hope this clarification addresses the reviewer’s concern and provides a more comprehensive understanding of the GLTD and sex differences observed in our dataset. 

      Author response image 6.

      The correlation between gene length and age-associated changes across tissues in females and males, respectively. The correlation tests are evaluated using the Spearman’s approach. The red dots indicate the significant correlations in females, while the navy dots show those in males.

      (4) Because the majority of this work has been performed in the GTEx dataset, applying this analysis to another publicly available dataset would be useful validation. For instance, the authors have interesting findings in the brain and correlations to Alzheimer's disease. Analysis of an existing RNAseq dataset from Alzheimer's disease patients and controls (with functional outcomes) would provide more evidence beyond the preliminary findings from GTEx. 

      We appreciate the reviewer’s suggestion on the validation of our findings by applying our analysis to independent RNA-seq datasets from Alzheimer’s disease patients. 

      • We have used two Alzheimer’s disease datasets, GEO and ROSMAP, to investigate the correlation between aging and Alzheimer’s disease (AD) and included these analyses in our study (Fig. 4B-C and Figure S8C).

      • In the Results section (Page 7), we have presented the results of this validation, where we identified correlations between sex-biased aging-related splicing changes and AD-related changes. These findings support the conclusions from the GTEx dataset and further strengthen the relevance of our results to AD.

      As suggested, we have updated the manuscript to more explicitly highlight this validation in the Discussion section (Page 12), noting: ‘We further validated our findings using Alzheimer’s disease dataset, ROSMAP, where we observed consistent correlations between aging-related splicing changes and Alzheimer’s disease-related changes, providing additional evidence for the robustness of our results.’ 

      Reviewer #2 (Recommendations for the authors): 

      (1) In the text (Introduction and Discussion), the authors mention analyzing 54 tissues, the abstract states 35 tissues, Table S1 lists 48, and Figure 2A-B shows 33. Could the authors please clarify exactly how many tissues they used? I am also confused by the sample numbers in Table S1. For example: for adiposesubcutaneous tissue, the total number of females is listed as 218 but the sum of young and old females is only 110. Does this mean some samples were excluded? What is the exclusion criterion? 

      We thank the reviewers and editors for pointing out the discrepancies regarding the number of tissues analyzed and the sample numbers in Table S1. We appreciate the opportunity to clarify these points:

      Number of tissues analyzed:

      • We downloaded and analyzed 17,382 samples in 54 tissues from GTEx in total (31 tissues and 13 brain regions), as mentioned in the Results, Methods, and Discussion sections. Table S1 lists 48 tissues (31 tissues, 13 brain regions, and 4 merged brain regions), which include a refined classification of the tissues we analyzed, accounting for the variations in brain region categorization in the dataset.

      • The discrepancy also arises from the different sample size cutoffs in specific analyses. For pcSVR analysis (Figure 2A-B), we did the subsampling for the permutation analysis for certain key findings, so we filtered a subset of 33 tissues (29 tissues and 4 merged brain regions), which included at least 3 samples in each age group in females or males. 

      • To resolve this, we have clarified the total number of tissues analyzed and aligned the numbers across the manuscript. In the revised manuscript, we now explicitly state in both the Abstract and Methods sections that 54 tissues were analyzed in the context of this study. We added a note in Methods to clarify that 35 tissues are 31 tissues and 4 merged brain regions (Page 16). In Figure 2A-B, we clarified that the 33 tissues are filtered due to the usage in this analysis (Page 17).

      Sample numbers in Table S1:

      • Regarding the sample sizes of age groups, the discrepancy occurred due to the classification of the age groups. We classify the samples into three: Young, Middle, and Old, as mentioned in the Results section (Page 4). 

      • Additionally, we excluded the sample sizes in 13 single brain regions. We aligned the total tissue number to 35 with our texts.

      We hope this resolves the confusion regarding the number of tissues and the sample sizes used in the analysis. These clarifications have been incorporated into the revised manuscript to ensure consistency.

      (2) Was post-mortem interval (PMI) or manner of death considered in the model? For example, traumatic death may have major consequences on gene expression. Similarly, a few tissues have low sample numbers, for example, kidney cortex and brain. The pooling of brain samples is explained and the kidney cortex is excluded, so why is it listed in Table S1? 

      Thank you for raising this important point regarding the potential impact of post-mortem interval (PMI) and manner of death (DTHMNNR) on gene expression. We carefully considered both factors as potential confounders in our analysis. 

      Specifically, to evaluate their impacts, we calculated the correlations between the coefficients of PMI or manner of death, with the confounding factors. Our results showed that PMI and DTHMNNR are significantly correlated with the covariates in most tissues, suggesting that their effects could be effectively regressed in our model (Figure S4). As we have mentioned in Figure S4 and Author response image 1, we conducted a differential analysis that incorporated PMI as a covariate in the regression models and re-evaluated the age- and sex-related transcriptomic changes to address this concern. The high correlations showed the minor effect size of PMI when including the covariates in the model. As suggested by the reviewers and editors, we have now included this correlation analysis in Figure S4C-E and updated the text in the results section (Page 5).

      Additionally, as the responses above, Table S1 provides the general sample sizes of all GTEx tissues without filtering. We have modified the table to include a total of 35 tissues, including 31 non-brain tissues and 4 brain regions.

      (3) It might be important to show a simple visual of cohort details such as age ranges, sexes, ethnicities, PMIs, etc. 

      To address this, we added summary figures to illustrate the distributions of key demographic variables, including age, sex, BMI, ethnicity, post-mortem intervals (PMIs), and manner of death (DTHMNNR) (Author response image 7 and Author response image 8). This will provide readers with a clearer overview of the dataset composition and potential covariates affecting the analysis. 

      Author response image 7.

      Age (left panel), BMI (Body Mass Index) (middle panel), and PMI (Post-Mortem Interval) (right panel) distribution in GTEx v8 cohort.

      Author response image 8.

      Sex (left panel), ethnicity (middle panel), and manner of death (DTHMNNR) (right panel) distribution in GTEx v8 cohort.

      (4) Since this study is highly correlative, it is impossible to determine if the findings hold true without an independent cohort validation or experimental validation. They used the ROSMAP cohort for AD samples, and some splicing factors regulation but the generalizability to the age and sex effects have not been independently tested.

      The reviewer raises an important point regarding the independent validation of sex- and age-associated splicing changes associated with AD. We used GTEx primarily because it includes approximately 17,000 RNA-seq samples across multiple human tissues, making it the most comprehensive public resource for studying population-level differences in age and sex. In particular, its large-scale brain samples provide a unique opportunity to analyze transcriptomic changes in sex-dimorphic aging.

      We understand the reviewer’s concern that our findings are mainly supported by correlative evidence, which could be affected by dataset-specific biases. However, there are several technical issues in crossvalidation with transcriptomes across different datasets, including limited comparability due to cell type heterogeneity, postmortem artifacts, and sequencing biases.

      Specifically, GTEx data is bulk RNA-seq that does not capture cell-type-specific transcriptomic changes. Given the cellular complexity of the brain and other tissues, observed differences in gene expression and splicing may be influenced by shifts in cellular composition rather than intrinsic transcriptional regulation. For example, we compared our results from GTEx whole blood with the analysis using an external dataset from Peripheral Blood Mononuclear Cells (PBMCs) provided by Shen et al. (2024) [3] (Author response image 2).  We observed limited overlap in differentially expressed genes between these datasets (probably because the whole blood contains diverse immune cell populations), highlighting the challenges in cross-dataset validation due to differences in tissue composition and sample processing.

      Therefore, we applied surrogate variable analysis (SVA) to minimize technical and biological confounders. This approach helped reduce biases from genetic background to hidden batch effects, including postmortem artifacts, sequencing biases (Figure S4), and other covariates. This approach could help us identify whether sex-biased splicing events are biologically meaningful rather than technical artifacts.  

      In addition, to address the reviewer’s concern on the splicing factor regulation, we managed to find a dataset in decision-related brain regions. Due to the limitation of human brain data covering different age and sex groups, we used mouse hippocampus datasets, including young and old, as well as female and male groups [7].  The analysis of protein levels from MS data identified sex-biased age-associated splicing factors, including Srsf1 and Srsf7.  We found that the changes are consistent with the findings from GTEx (Author response image 9), aligning with our sex-biased splicing factor expression during aging in the same region of the human brain. This cross-species consistency supports the robustness of our findings in human brain aging.

      Author response image 9.

      Protein levels of some male-specific splicing factors in human hippocampus quantified using MS data. The Y-axis shows the protein intensity. Different facets mean different sample batch sets. The yellow boxes indicate the protein levels in the young group, while the brown boxes indicate those in the old group.

      In summary, despite the inherent limitations of RNA-seq studies in sex- and age-related transcriptomics, we have made our best efforts to address these concerns through comparisons with external datasets, statistical corrections, and validation using proteomic data. We appreciate the reviewer’s feedback and include additional discussion on these points (Page 13). 

      (5) Are AS predictions from short-read data accurate enough to make the predictions the authors report? 

      The reviewer is correct that the short-read sequencing has inherent limitations in reconstructing full-length isoforms.  However, the higher sequencing depth for short reads makes it a better choice in quantifying the relative change of each AS event across different conditions.  As a result, short-read data are extensively used in the splicing field to quantitatively measure the AS changes.  For this reason, we focused on the levels of alternative splicing events, rather than the quantification of full-length isoforms.  We used a series of stringent filters in our analyses to increase the reliability of our results.

      Specifically, we filtered the read counts of the junction read counts (JC) of most differential AS events that were higher than 10, as mentioned in the Methods section. Also, we used our GPU-based gene expression quantification tool, Paean, which performed better in cross-validation with quantitative RT-PCR results. The results of Paean are consistent with other pipelines. We cited an updated version of Paean that included the comparison with other tools in analyzing AS for consistency.  The manuscript on the new Paean version is being reviewed in another journal, and we included the PDF of that manuscript (Fig. 3 in the Paean manuscript) in the revised documents. 

      (6) Along the same lines, the finding that male age-related AS events are linked to Alzheimer's disease somewhat contradicts epidemiological studies that show that even after adjusting for age, women still have a greater risk of developing Alzheimer's than men. The authors show a significant overlap with AD GE events in females but don't explain the discrepancy. 

      We appreciate the editor’s comment regarding these discrepancies with the epidemiological studies. Previous studies suggested that the disease manifestations of Alzheimer’s Disease (AD) showed sex differences in AD phenotypes, including cognitive decline and brain atrophy [8].  The analyses on the sex/age effect of AD are indeed pretty complex, depending on the molecular criteria (GE or AS vs epidemiological data) in distinct studies, probably due to the difficulty in capturing how environmental exposures interact with biological pathways.  We hope to bring up three related points regarding this concern, which were also discussed in the revised manuscript. 

      • As we have mentioned in the Discussion section, an early study investigated the relationship between age, sex, and cognitive function in a large cohort of 17,127 UK Biobank participants [9]. Their study highlighted more apparent age-related changes in cognitive function among men, suggesting a potential vulnerability of men to cognitive decline with age.  Their main conclusion is consistent with our findings. 

      • While men and women can both suffer from Alzheimer's disease, women are more likely to be diagnosed, possibly due to longer lifespans and potential differences in brain structure or other factors. Although women exhibit a higher overall risk of AD, they may also have distinct molecular compensatory mechanisms that influence disease progression. 

      • To avoid the age effect, in our AD datasets, including ROSMAP, we filtered the samples over 90 years old to match the number of both sexes and the age distribution between the AD and control groups. Our analysis avoided the age biases in comparing AD and control, suggesting the crucial roles of sBASEs in AD during male aging.

      Moreover, for gene expression (GE), we showed distinct patterns of AD-related genes in females with AS. These two molecular processes do not necessarily have the same functional impact. AS changes may precede or contribute to disease onset in different ways compared to GE alterations. Our study came up with the underlying mechanisms linking cognitive disorders and alternative splicing (AS) at a higher molecular resolution.   

      (7) Could the authors explain which sBASE subset they used for their random forest prediction model and what was the rationale? 

      We are sorry for missing the details in selecting sBASEs (sex-biased age-associated splicing events) for the random forest prediction model. We specifically used sBASEs that exhibited specific sex-biased changes in splicing associated with aging. This subset of sBASEs was chosen in terms of those that could also be detected in the ROSMAP AD dataset due to different sequencing depths or technical biases across datasets. These sBASEs were further input to a prediction model with the feature selection algorithm RFE, and then evaluated their contributions. In the revised manuscript, we added the details of this selection in the Methods (Page 7).

      (8) The breakpoint analysis is particularly interesting. Can this be speculated to correlate with the recent non-linear multi-omic aging patterns observed by Shen et al in Nature Aging? 

      Thank you for highlighting the interesting aspects of our breakpoint analysis and suggesting its potential correlation with the non-linear aging patterns observed by Shen et al. 

      Shen et al. observed two prominent crests around the ages of 45 and 60 using omics data. Similarly, we also identified the non-linear aging patterns with two breakpoints in our analysis. However, there are some notable differences in specific breakpoints between these two studies, resulting from the breakpoint definition, as well as the sample preparations. According to the response in Author response image 2, the differences come from the following aspects:

      The definition of breakpoints vs crests:

      • Crests represent age-related molecular changes at each time point across the human lifespan. They indicate the number of molecules that are differentially expressed during aging (q < 0.05), without considering individual expression levels.

      • Our breakpoints, in contrast, are identified after filtering the chronological trends based on the expression levels and calculating the rate of change at each age point using sliding windows. Breakpoints are defined as local maxima where the distance to the nearest minimum, relative to the global maximum, exceeds 10%. We indeed found some local wide peaks around 60 in some tissues, shown in Figure S10, however, we excluded these due to our strict cutoffs.

      The sequenced biosamples: 

      • Whole-blood vs Peripheral Blood Mononuclear Cells (PBMC): As mentioned in previous responses, in GTEx, whole blood samples from donors were sequenced, whereas their study used PBMCs. Whole blood contains all blood components, including red blood cells, platelets, granulocytes (e.g., neutrophils), lymphocytes, and monocytes, while PBMCs only represent a subset of white blood cells, primarily consisting of lymphocytes (T cells, B cells, NK cells) and monocytes, excluding granulocytes and erythrocytes. Gene expression changes observed in whole blood capture the contributions from neutrophils and other granulocytes, which are absent in PBMC analyses (as shown in Figure S11C and Author response image 2). Additionally, whole blood can serve as a readily accessible biomarker source for testing age-related diseases without the need for cell separation, making it a more practical option for clinical applications.

      • For both studies, we share a tissue, which is skin, we looked at the non-linear changes during aging and found the same two breakpoints: 43 and 58. 

      Sex-specific analysis in females and males:

      • The main object of our analysis is to compare the differences in aging rates between sexes. Notably, the identified breakpoints may differ when sex effects are not taken into account, highlighting the importance of analyzing males and females separately.

      We have added the following statements to further clarify this connection: ‘Our analysis observed the nonlinear aging patterns with two breakpoints, which is consistent with recent findings (Nature Aging, 2024), with differences in specific age points due to the sex differences as well as tissue diversities.’ (Page 14), and ‘These breakpoints could represent key junctures in the aging process that align with the non-linear patterns of aging and disease progression.’ (Page 15)

      (9) Minor - the authors should refer to figures in the Discussion. They do so in some cases but this needs to be more extensive. 

      Thank you for pointing this out. In response, we have reviewed the Discussion section and added references to relevant figures where appropriate. In the section discussing the discrepancies between the profiles of GE vs. AS, we now refer to Figure 3 to highlight the earlier onset of different transcriptomic resolutions (Page 12); When describing the sex-specific age-associated AS changes and their associations with Alzheimer’s disease, we have added references to Figure 4 (Page 12); In the discussion of estrogen-mediated regulation of splicing factors, we have referred to Figure 5A, which detail the construction of RBP-RNA regulatory network integrating muti-dimensional data obtained through several orthogonal state-of-the-art approaches (Page 14).

      Reference:

      (1) Ferreira, P.G. et al. The effects of death and post-mortem cold ischemia on human tissue transcriptomes. Nature communications 9, 490 (2018).

      (2) Wucher, V., Sodaei, R., Amador, R., Irimia, M. & Guigó, R. Day-night and seasonal variation of human gene expression across tissues. PLoS Biology 21, e3001986 (2023).

      (3) Shen, X. et al. Nonlinear dynamics of multi-omics profiles during human aging. Nature aging, 116 (2024).

      (4) Zhou, X. et al. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B. The Journal of clinical investigation 129, 676-693 (2019).

      (5) Soheili-Nezhad, S., Ibáñez-Solé, O., Izeta, A., Hoeijmakers, J.H. & Stoeger, T. Time is ticking faster for long genes in aging. Trends in Genetics 40, 299-312 (2024).

      (6) Brouillette, M. Gene length could be a critical factor in the aging of the genome. Proceedings of the National Academy of Sciences 121, e2416630121 (2024).

      (7) Keele, G.R. et al. Global and tissue-specific aging effects on murine proteomes. Cell reports 42(2023).

      (8) Ferretti, M.T. et al. Sex differences in Alzheimer disease—the gateway to precision medicine. Nature Reviews Neurology 14, 457-469 (2018).

      (9) Foo, H. et al. Age-and sex-related topological organization of human brain functional networks and their relationship to cognition. Frontiers in aging neuroscience 13, 758817 (2021).

    1. Author Response

      The following is the authors’ response to the original reviews.

      eLife assessment

      The work is a useful contribution towards understanding the role of archaeal and plant D-aminoacyl-tRNA deacylase 2 (DTD2) in deacylation and detoxification of D-Tyr-tRNATyr modified by various aldehydes produced as metabolic byproducts in plants. It integrates convincing results from both in vitro and in vivo experiments to address the long-standing puzzle of why plants outperform bacteria in handling reactive aldehydes and suggests a new strategy for stress-tolerant crops. The impact of the paper is limited by the fact that only one modified D-aminoacyl tRNA was examined, in lack of evidence that plant eEF1A mimics EF-Tu in protecting L-aminoacyl tRNAs from modification, and in failure to measure accumulation of toxic D-aminoacyl tRNAs or impairment of translation in plant cells lacking DTD2.

      We have now addressed all the drawbacks as follows:

      ‘only one modified D-aminoacyl tRNA was examined’

      We wish to clarify that only D-Leu (Yeast), D-Asp (Bacteria, Yeast), D-Tyr (Bacteria, Cyanobacteria, Yeast) and D-Trp (Bacteria) show toxicity in vivo in the absence of known DTD (Soutourina J. et al., JBC, 2000; Soutourina O. et al., JBC, 2004; Wydau S. et al., JBC, 2009) and D-Tyr-tRNATyr is used as a model substrate to test the DTD activity in the field because of the conserved toxicity of D-Tyr in various organisms. DTD2 has been shown to recycle D-Asp-tRNAAsp and D-Tyr-tRNATyr with the same efficiency both in vitro and in vivo (Wydau S. et al., NAR, 2007) and it also recycles acetaldehyde-modified D-Phe-tRNAPhe and D-Tyr-tRNATyr in vitro as shown in our earlier work (Mazeed M. et al., Science Advances, 2021). We have earlier shown that DTD1, another conserved chiral proofreader across bacteria and eukaryotes, acts via a side chain independent mechanism (Ahmad S. et al., eLife, 2013). To check the biochemical activity of DTD2 on D-Trp-tRNATrp, we have now done the D-Trp, D-Tyr and D-Asp toxicity rescue experiments by expressing the archaeal DTD2 in dtd null E. coli cells. We found that DTD2 could rescue the D-Trp toxicity with equal efficiency like D-Tyr and D-Asp (Figure: 1). Considering the action on multiple side chains with different chemistry and size, it can be proposed with reasonable confidence that DTD2 also operates based on a side chain independent manner.

      Author response image 1.

      DTD2 recycles multiple D-aa-tRNAs with different side chain chemistry and size. Growth of wildtype (WT), dtd null strain (∆dtd), and Pyrococcus horikoshii DTD2 (PhoDTD2) complemented ∆dtd strains of E. coli K12 cells with 500 µM IPTG along with A) no D-amino acids, B) 2.5 mM D-tyrosine, C) 30 mM D-aspartate and D) 5 mM D-tryptophan.

      ‘lack of evidence that plant eEF1A mimics EF-Tu in protecting L-aminoacyl tRNAs from modification’

      To understand the role of plant eEF1A in protecting L-aa-tRNAs from aldehyde modification, we have done a thorough sequence and structural analysis. We analysed the aa-tRNA bound elongation factor structure from bacteria (PDB ids: 1TTT) and found that the side chain of amino acid in the amino acid binding site of EF-Tu is projected outside (Figure: 2A; 3A). In addition, the amino group of amino acid is tightly selected by the main chain atoms of elongation factor thereby lacking a space for aldehydes to enter and then modify the L-aa-tRNAs and Gly-tRNAs (Figure: 2B; 3B). Modelling of D-amino acid (D-phenylalanine and smallest chiral amino acid, D-alanine) in the same site shows serious clashes with main chain atoms of EF-Tu, indicating D-chiral rejection during aa-tRNA binding by elongation factor (Figure: 2C-E). Next, we superimposed the tRNA bound mammalian eEF-1A cryoEM structure (PDB id: 5LZS) with bacterial structure to understand the structural differences in terms of tRNA binding and found that elongation factor binds tRNA in a similar way (Figure: 3C-D). Modelling of D-alanine in the amino acid binding site of eEF-1A shows serious clashes with main chain atoms, indicating a general theme of D-chiral rejection during aa-tRNA binding by elongation factor (Figure: 2F; 3E). Structure-based sequence alignment of elongation factor from bacteria, archaea and eukaryotes (both plants and mammals) shows a strict conservation of amino acid binding site (Figure: 2G). This suggests that eEF-1A will mimic EF-Tu in protecting L-aa-tRNAs from reactive aldehydes. Minor differences near the amino acid side chain binding site (as indicated in Wolfson and Knight, FEBS Letters, 2005) might induce the amino acid specific binding differences (Figure: 3F). However, those changes will have no influence when the D-chiral amino acid enters the pocket, as the whole side chain would clash with the active site. We have now included this sequence and structural conservation analysis in our revised manuscript (in text: line no 107-129; Figure: 2 and S2). Overall, our structural analysis suggests a conserved mode of aa-tRNA selection by elongation factor across life forms and therefore, our biochemical results with bacterial elongation factor Tu (EF-Tu) reflect the protective role of elongation factor in general across species.

      Author response image 2.

      Elongation factor enantio-selects L-aa-tRNAs through D-chiral rejection mechanism. A) Surface representation showing the cocrystal structure of EF-Tu with L-Phe-tRNAPhe. Zoomed-in image showing the binding of L-phenylalanine with side chain projected outside of binding site of EF-Tu (PDB id: 1TTT). B) Zoomed-in image of amino acid binding site of EF-Tu bound with L-phenylalanine showing the selection of amino group of amino acid through main chain atoms (PDB id: 1TTT). C) Modelling of D-phenylalanine in the amino acid binding site of EF-Tu shows severe clashes with main chain atoms of EF-Tu. Modelling of smallest chiral amino acid, alanine, in the amino acid binding site of EF-Tu shows D) no clashes with L-alanine and E) clashes with D-alanine. F) Modelling of D-alanine in the amino acid binding site of eEF-1A shows clashes with main chain atoms. (*Represents modelled molecule). G) Structure-based sequence alignment of elongation factor from bacteria, archaea and eukaryotes (both plants and animals) showing conserved amino acid binding site residues. (Key residues are marked with red star).

      Author response image 3.

      Elongation factor protects L-aa-tRNAs from aldehyde modification. A) Cartoon representation showing the cocrystal structure of EF-Tu with L-Phe-tRNAPhe (PDB id: 1TTT). B) Zoomed-in image of amino acid binding site of EF-Tu bound with L-phenylalanine (PDB id: 1TTT). C) Cartoon representation showing the cryoEM structure of eEF-1A with tRNAPhe (PDB id: 5LZS). D) Image showing the overlap of EF-Tu:L-Phe-tRNAPhe crystal structure and eEF-1A:tRNAPhe cryoEM structure (r.m.s.d. of 1.44 Å over 292 Cα atoms). E) Zoomed-in image of amino acid binding site of eEF-1A with modelled L-alanine (PDB id: 5ZLS). (*Modelled) F) Overlap showing the amino acid binding site residues of EF-Tu and eEF-1A. (EF-Tu residues are marked in black and eEF-1A residues are marked in red).

      ‘failure to measure accumulation of toxic D-aminoacyl tRNAs or impairment of translation in plant cells lacking DTD2’

      We agree that measuring the accumulation of D-aa-tRNA adducts from plant cells lacking DTD2 is important. We tried to characterise the same with dtd2 mutant plants extensively through Northern blotting as well as mass spectrometry. However, due to the lack of information about the tissue getting affected (root or shoot), identity of aa-tRNA as well as location of aa-tRNA (cytosol or organellar), we are so far unsuccessful in identifying them from plants. Efforts are still underway to identify them from plant system lacking DTD2. However, we have used a bacterial surrogate system, E. coli, as used earlier in Mazeed M. et al., Science Advances, 2021 to show the accumulation of D-aa-tRNA adducts in the absence of dtd. We could identify the accumulation of both formaldehyde and MG modified D-aa-tRNA adducts via mass spectrometry (Figure: 4). These results are now included in the revised manuscript (in line no: 190-197 and Figure: S5).

      Author response image 4.

      Loss of DTD results in accumulation of modified D-aminoacyl adducts on tRNAs in E. coli. Mass spectrometry analysis showing the accumulation of aldehyde modified D-Tyr-tRNATyr in A) Δdtd E. coli, B) formaldehyde and D-tyrosine treated Δdtd E. coli, and C) MG and D-tyrosine treated Δdtd E. coli. ESI-MS based tandem fragmentation analysis for unmodified and aldehyde modified D-Tyr-tRNATyr in D) Δdtd E. coli, E) and F) formaldehyde and D-tyrosine treated Δdtd E. coli, G) and H) MG and D-tyrosine treated Δdtd E. coli.

      Response to Public Reviews:

      We are grateful for the reviewers’ positive feedback and their comments and suggestions on this manuscript. Reviewer 1 has indicated two weaknesses and Reviewer 2 has none. We have now addressed all the concerns of the Reviewers.

      Reviewer #1 (Public Review):

      Summary:

      This work is an extension of the authors' earlier work published in Sci Adv in 2001, wherein the authors showed that DTD2 deacylates N-ethyl-D-aminoacyl-tRNAs arising from acetaldehyde toxicity. The authors in this study, investigate the role of archaeal/plant DTD2 in the deacylation/detoxification of D-Tyr-tRNATyr modified by multiple other aldehydes and methylglyoxal (produced by plants). Importantly, the authors take their biochemical observations to plants, to show that deletion of DTD2 gene from a model plant (Arabidopsis thaliana) makes them sensitive to the aldehyde supplementation in the media especially in the presence of D-Tyr. These conclusions are further supported by the observation that the model plant shows increased tolerance to the aldehyde stress when DTD2 is overproduced from the CaMV 35S promoter. The authors propose a model for the role of DTD2 in the evolution of land plants. Finally, the authors suggest that the transgenic crops carrying DTD2 may offer a strategy for stress-tolerant crop development. Overall, the authors present a convincing story, and the data are supportive of the central theme of the story.

      We are happy that reviewer found our work convincing and would like to thank the reviewer for finding our data supportive to the central theme of the manuscript.

      Strengths:

      Data are novel and they provide a new perspective on the role of DTD2, and propose possible use of the DTD2 lines in crop improvement.

      We are happy for this positive comment on the manuscript.

      Weaknesses:

      (a) Data obtained from a single aminoacyl-tRNA (D-Tyr-tRNATyr) have been generalized to imply that what is relevant to this model substrate is true for all other D-aa-tRNAs (term modified aa-tRNAs has been used synonymously with the modified Tyr-tRNATyr). This is not a risk-free extrapolation. For example, the authors see that DTD2 removes modified D-Tyr from tRNATyr in a chain-length dependent manner of the modifier. Why do the authors believe that the length of the amino acid side chain will not matter in the activity of DTD2?

      We thank the reviewer for bringing up this important point. As mentioned above, we wish to clarify that only half of the aminoacyl-tRNA synthetases are known to charge D-amino acids and only D-Leu (Yeast), D-Asp (Bacteria, Yeast), D-Tyr (Bacteria, Cyanobacteria, Yeast) and D-Trp (Bacteria) show toxicity in vivo in the absence of known DTD (Soutourina J. et al., JBC, 2000; Soutourina O. et al., JBC, 2004; Wydau S. et al., JBC, 2009). D-Tyr-tRNATyr is used as a model substrate to test the DTD activity in the field because of the conserved toxicity of D-Tyr in various organisms. DTD2 has been shown to recycle D-Asp-tRNAAsp and D-Tyr-tRNATyr with the same efficiency both in vitro and in vivo (Wydau S. et al., NAR, 2007). Moreover, we have previously shown that it recycles acetaldehyde-modified D-Phe-tRNAPhe and D-Tyr-tRNATyr in vitro as shown in our earlier work (Mazeed M. et al., Science Advances, 2021). We have earlier shown that DTD1, another conserved chiral proofreader across bacteria and eukaryotes, acts via a side chain independent mechanism (Ahmad S. et al., eLife, 2013). To check the biochemical activity of DTD2 on D-Trp-tRNATrp, we have now done the D-Trp, D-Tyr and D-Asp toxicity rescue experiments by expressing the archaeal DTD2 in dtd null E. coli cells. We found that DTD2 could rescue the D-Trp toxicity with equal efficiency like D-Tyr and D-Asp (Figure 1). Considering the action on multiple side chains with different chemistry and size, it can be proposed with reasonable confidence that DTD2 also operates based on a side chain independent manner.

      (b) While the use of EFTu supports that the ternary complex formation by the elongation factor can resist modifications of L-Tyr-tRNATyr by the aldehydes or other agents, in the context of the present work on the role of DTD2 in plants, one would want to see the data using eEF1alpha. This is particularly relevant because there are likely to be differences in the way EFTu and eEF1alpha may protect aminoacyl-tRNAs (for example see description in the latter half of the article by Wolfson and Knight 2005, FEBS Letters 579, 3467-3472).

      We thank the reviewer for bringing up this important point. As mentioned above, to understand the role of plant eEF1A in protecting L-aa-tRNAs from aldehyde modification, we have done a thorough sequence and structural analysis. We analysed the aa-tRNA bound elongation factor structure from bacteria (PDB ids: 1TTT) and found that the side chain of amino acid in the amino acid binding site of EF-Tu is projected outside (Figure: 2A; 3A). In addition, the amino group of amino acid is tightly selected by the main chain atoms of elongation factor thereby lacking a space for aldehydes to enter and then modify the L-aa-tRNAs and Gly-tRNAs (Figure: 2B; 3B). Modelling of D-amino acid (D-phenylalanine and smallest chiral amino acid, D-alanine) in the same site shows serious clashes with main chain atoms of EF-Tu, indicating D-chiral rejection during aa-tRNA binding by elongation factor (Figure: 2C-E). Next, we superimposed the tRNA bound mammalian eEF-1A cryoEM structure (PDB id: 5LZS) with bacterial structure to understand the structural differences in terms of tRNA binding and found that elongation factor binds tRNA in a similar way (Figure: 3C-D). Modelling of D-alanine in the amino acid binding site of eEF-1A shows serious clashes with main chain atoms, indicating a general theme of D-chiral rejection during aa-tRNA binding by elongation factor (Figure: 2F; 3E). Structure-based sequence alignment of elongation factor from bacteria, archaea and eukaryotes (both plants and mammals) shows a strict conservation of amino acid binding site (Figure: 2G). Minor differences near the amino acid side chain binding site (as indicated in Wolfson and Knight, FEBS Letters, 2005) might induce the amino acid specific binding differences (Figure: 3F). However, those changes will have no influence when the D-chiral amino acid enters the pocket, as the whole side chain would clash with the active site. We have now included this sequence and structural conservation analysis in our revised manuscript (in text: line no 107-129; Figure: 2 and S2). Overall, our structural analysis suggests a conserved mode of aa-tRNA selection by elongation factor across life forms and therefore, our biochemical results with bacterial elongation factor Tu (EF-Tu) reflect the protective role of elongation factor in general across species.

      Reviewer #2 (Public Review):

      In bacteria and mammals, metabolically generated aldehydes become toxic at high concentrations because they irreversibly modify the free amino group of various essential biological macromolecules. However, these aldehydes can be present in extremely high amounts in archaea and plants without causing major toxic side effects. This fact suggests that archaea and plants have evolved specialized mechanisms to prevent the harmful effects of aldehyde accumulation.

      In this study, the authors show that the plant enzyme DTD2, originating from archaea, functions as a D-aminoacyl-tRNA deacylase. This enzyme effectively removes stable D-aminoacyl adducts from tRNAs, enabling these molecules to be recycled for translation. Furthermore, they demonstrate that DTD2 serves as a broad detoxifier for various aldehydes in vivo, extending its function beyond acetaldehyde, as previously believed. Notably, the absence of DTD2 makes plants more susceptible to reactive aldehydes, while its overexpression offers protection against them. These findings underscore the physiological significance of this enzyme.

      We thank the reviewer for the positive comments the manuscript.

      Response to recommendation to authors:

      Reviewer #1 (Recommendations For The Authors):

      I enjoyed reading the manuscript entitled, "Archaeal origin translation proofreader imparts multi aldehyde stress tolerance to land plants" from the Sankaranarayanan lab. This work is an extension of their earlier work published in Sci Adv in 2001, wherein they showed that DTD2 deacylates N-ethyl-D-aminoacyl-tRNAs arising from acetaldehyde toxicity. Now, the authors of this study (Kumar et al.) investigate the role of archaeal/plant DTD2 in the deacylation/detoxification of D-Tyr-tRNATyr modified by multiple other aldehydes and methylglyoxal (which are produced during metabolic reactions in plants). Importantly, the authors take their biochemical observations to plants, to show that deletion of DTD2 gene from a model plant (Arabidopsis thaliana) makes them sensitive to the aldehyde supplementation in the media especially in the presence of D-Tyr. These conclusions are further supported by the observation that the model plant shows increased tolerance to the aldehyde stress when DTD2 is overproduced from the CaMV 35S promoter. The authors propose a model for the role of DTD2 in the evolution of land plants. Finally, the authors suggest that the transgenic crops carrying DTD2 may offer a strategy for stress-tolerant crop development. Overall, the authors present a convincing story, and the data are supportive of the central theme of the story.

      We are happy that reviewer enjoyed our manuscript and found our work convincing. We would also like to thank reviewer for finding our data supportive to the central theme of the manuscript.

      I have the following observations that require the authors' attention.

      1) The title of the manuscript will be more appropriate if revised to, "Archaeal origin translation proofreader, DTD2, imparts multialdehyde stress tolerance to land plants".

      Both the reviewer’s suggested to change the title. We have now changed the title based on reviewer 2 suggestion.

      2) Abstract (line 19): change, "physiologically abundantly produced" to "physiologically produced".

      As per the reviewer’s suggestion, we have now changed it to "physiologically produced".

      3) Introduction (line 50): delete, 'extremely'.

      We have removed the word 'extremely' from the Introduction.

      4) Line 79: change, "can be utilized" to "may be explored".

      We have changed "can be utilized" to "may be explored" as suggested by the reviewers.

      5) Results in general:

      (a) Data obtained from a single aminoacyl-tRNA (D-Tyr-tRNATyr) have been generalized to imply that what is relevant to this model substrate is true for all other D-aa-tRNAs (term modified aa-tRNAs has been used synonymously with the modified D-Tyr-tRNATyr). This is a risky extrapolation. For example, the authors see that DTD2 removes modified D-Tyr from tRNATyr in a chain-length dependent manner of the modifier. Why do the authors believe that the length of the amino acid side chain will not matter in the activity of DTD2?

      We thank the reviewer for bringing up this important point. As mentioned above, we wish to clarify that only half of the aminoacyl-tRNA synthetases are known to charge D-amino acids and only D-Leu (Yeast), D-Asp (Bacteria, Yeast), D-Tyr (Bacteria, Cyanobacteria, Yeast) and D-Trp (Bacteria) show toxicity in vivo in the absence of known DTD (Soutourina J. et al., JBC, 2000; Soutourina O. et al., JBC, 2004; Wydau S. et al., JBC, 2009). D-Tyr-tRNATyr is used as a model substrate to test the DTD activity in the field because of the conserved toxicity of D-Tyr in various organisms. DTD2 has been shown to recycle D-Asp-tRNAAsp and D-Tyr-tRNATyr with the same efficiency both in vitro and in vivo (Wydau S. et al., NAR, 2007). Moreover, we have previously shown that it recycles acetaldehyde-modified D-Phe-tRNAPhe and D-Tyr-tRNATyr in vitro as shown in our earlier work (Mazeed M. et al., Science Advances, 2021). We have earlier shown that DTD1, another conserved chiral proofreader across bacteria and eukaryotes, acts via a side chain independent mechanism (Ahmad S. et al., eLife, 2013). To check the biochemical activity of DTD2 on D-Trp-tRNATrp, we have now done the D-Trp, D-Tyr and D-Asp toxicity rescue experiments by expressing the archaeal DTD2 in dtd null E. coli cells. We found that DTD2 could rescue the D-Trp toxicity with equal efficiency like D-Tyr and D-Asp (Figure 1). Considering the action on multiple side chains with different chemistry and size, it can be proposed with reasonable confidence that DTD2 also operates based on a side chain independent manner.

      (b) Interestingly, the authors do suggest (in the Materials and Methods section) that the experiments were performed with Phe-tRNAPhe as well as Ala-tRNAAla. If what is stated in Materials and Methods is correct, these data should be included to generalize the observations.

      We regret for the confusing statement. We wish to clarify that L- and D-Tyr-tRNATyr were used for checking the TLC-based aldehyde modification, EF-Tu based protection assays and deacylation assays, D-Phe-tRNAPhe was used to characterise aldehyde-based modification by mass spectrometry and L-Ala-tRNAAla was used to check the modification propensity of multiple aldehydes. We used multiple aa-tRNAs to emphasize that aldehyde-based modifications are aspecific towards the identity of aa-tRNAs. All the data obtained with respective aa-tRNAs are included in manuscript.

      (c) While the use of EFTu supports that the ternary complex formation by the elongation factor can resist modifications of L-Tyr-tRNATyr by the aldehydes or other agents, in the context of the present work on the role of DTD2 in plants, one would want to see the data using eEF1alpha. This is particularly relevant because there are likely to be differences in the way EFTu and eEF1alpha may protect aminoacyl-tRNAs (for example see description in the latter half of the article by Wolfson and Knight 2005, FEBS Letters 579, 3467-3472).

      We thank the reviewer for bringing up this important point. As mentioned above, to understand the role of plant eEF1A in protecting L-aa-tRNAs from aldehyde modification, we have done a thorough sequence and structural analysis. We analysed the aa-tRNA bound elongation factor structure from bacteria (PDB ids: 1TTT) and found that the side chain of amino acid in the amino acid binding site of EF-Tu is projected outside (Figure: 2A; 3A). In addition, the amino group of amino acid is tightly selected by the main chain atoms of elongation factor thereby lacking a space for aldehydes to enter and then modify the L-aa-tRNAs and Gly-tRNAs (Figure: 2B; 3B). Modelling of D-amino acid (D-phenylalanine and smallest chiral amino acid, D-alanine) in the same site shows serious clashes with main chain atoms of EF-Tu, indicating D-chiral rejection during aa-tRNA binding by elongation factor (Figure: 2C-E). Next, we superimposed the tRNA bound mammalian eEF-1A cryoEM structure (PDB id: 5LZS) with bacterial structure to understand the structural differences in terms of tRNA binding and found that elongation factor binds tRNA in a similar way (Figure: 3C-D). Modelling of D-alanine in the amino acid binding site of eEF-1A shows serious clashes with main chain atoms, indicating a general theme of D-chiral rejection during aa-tRNA binding by elongation factor (Figure: 2F; 3E). Structure-based sequence alignment of elongation factor from bacteria, archaea and eukaryotes (both plants and mammals) shows a strict conservation of amino acid binding site (Figure: 2G). Minor differences near the amino acid side chain binding site (as indicated in Wolfson and Knight, FEBS Letters, 2005) might induce the amino acid specific binding differences (Figure: 3F). However, those changes will have no influence when the D-chiral amino acid enters the pocket, as the whole side chain would clash with the active site. We have now included this sequence and structural conservation analysis in our revised manuscript (in text: line no 107-129; Figure: 2 and S2). Overall, our structural analysis suggests a conserved mode of aa-tRNA selection by elongation factor across life forms and therefore, our biochemical results with bacterial elongation factor Tu (EF-Tu) reflect the protective role of elongation factor in general across species.

      6) Results (line 89): Figure: 1C-G (not B-G).

      As correctly pointed out by the reviewer(s), we have changed it to Figure: 1C-G.

      7) Results (line 91): Figure: S1B-G (not C-G).

      We wish to clarify that this is correct.

      8) Line 97: change, "propionaldehyde" to "propionaldehyde (Figure: 1H)".

      As per the reviewer’s suggestion, we have now changed, "propionaldehyde" to "propionaldehyde (Figure: 1H)".

      9) Line 124: The statement, "DTD2 cleaved all modified D-aa-tRNAs at 50 pM to 500 nM range (Figure: 2A_D)" is not consistent with the data presented. For example, Figure 2D does not show any significant cleavage. Figure S2A-B also does not show cleavage.

      We thank the reviewers for pointing this out. We have changed the sentence to “DTD2 cleaved majority of aldehyde modified D-aa-tRNAs at 50 pM to 500 nM range".

      10) Line 131: Cleavage observed in Fig. S2E is inconsistent with the generalized statement on DTD1.

      We wish to clarify that the minimal activity seen in Fig. S2E is inconsistent with the general trend of DTD1’s biochemical activity seen on modified D-aa-tRNAs. In addition, we have earlier shown that D-aa-tRNA fits snugly in the active site of DTD1 (Ahmad S. et al., eLife, 2013) whereas the modified D-aa-tRNA cannot bind due to the space constrains in the active site of DTD1 (Mazeed M. et al., Science Advances, 2021). Therefore, this minimal activity could be a result of technical error during this biochemical experiment and could be considered as no activity.

      11) Lines 129-133: Citations of many figure panels particularly in the supplementary figures are inconsistent with generalized statements. This section requires a major rewrite or rearrangement of the figure panels (in case the statements are correct).

      We thank the reviewers for bringing forth this point and we have accordingly modified the statement into “DTD2 from archaea recycled short chain aldehyde-modified D-aa-tRNA adducts as expected (Figure: 3E-G) and, like DTD2 from plants, it did not act on aldehyde-modified D-aa-tRNAs longer than three chains (Figure: 3H; S3C-D; S4G-L)”.

      12) Line 142: I don't believe one can call PTH a proofreader. Its job is to recycle tRNAs from peptidyl-tRNAs.

      We thank the reviewers for pointing out this very important point. This is now corrected.

      13). Line 145: change, "DTD2 can exert its protection for" to "DTD2 may exert protection from".

      As per the reviewer’s suggestion, we have now changed"DTD2 can exert its protection for" to "DTD2 may exert protection from".

      14) Line 148: change, "a homozygous line (Figure: 3A) and checked for" to "homozygous lines (Figure: 3A) and checked them for".

      As per the reviewer’s suggestion, we have now changed, "a homozygous line (Figure: 3A) and checked for" to "homozygous lines (Figure: 3A) and checked them for".

      15) Line 148: Change, the sentence beginning with dtd2 as follows. Similar to earlier results30-32, dtd2-/- (dtd2 hereafter) plants were susceptible to ethanol (Figure: S4A) confirming the non-functionality DTD2 gene in dtd2 plants.

      As per the reviewer’s suggestion, we have now changed the sentence accordingly.

      16) Line 161: change, "linked" to "associated".

      As per the reviewer’s suggestion, we have now changed "linked" to "associated".

      17) Lines 173-176: It would be interesting to know how well the DTD2 OE lines do in comparison to the other known transgenic lines developed with, for example, ADH, ALDH, or AOX lines. Any ideas would help appreciate the observation with DTD2 OE lines!

      We greatly appreciate the reviewer’s suggestion. We have not done any comparison experiment with any transgenic lines so far. However, it can be potentially done in further studies with DTD2 OE lines.

      18) Line 194: change, "necessary" with "present".

      As per the reviewer’s suggestion, we have now changed "necessary" with "present".

      19) Line 210: what is meant by 'huge'? Would 'significant' sound better?

      As per the reviewer’s suggestion, we have now changed "huge" with "significant".

      20) Lines 239-243: This needs to be rephrased. Isn't alpha carbonyl of the carboxyl group that makes ester bond with the -CCA end of the tRNA required for DTD2 activity as well? Are you referring to the carbonyl group in the moiety that modifies the alpha-amino group? Please clarify. The cited reference (no. 64) of Atherly does not talk about it.

      We regret for the confusing statement. To clarify, we were referencing to the carbonyl carbon of the modification post amino group of the amino acid in aa-tRNAs (Figure: 5). We have now included a figure (Figure: S4Q of revised manuscript) to show the comparison of the carbonyl group for the better clarity. The cited reference Atherly A. G., Nature, 1978 shows the activity of PTH on peptidyl-tRNAs and peptidyl-tRNAs possess carbonyl carbon at alpha position post amino group of amino acid in L-aa-tRNAs.

      Author response image 5.

      Figure showing the difference in the position of carbonyl carbon in acetonyl and acetyl modification on aa-tRNAs.

      21) Line 261: thrive (not thrives).

      As per the reviewer’s suggestion, we have now changed it to thrive.

      22) In Fig3A: second last lane, it should be dtd-/-:: AtDTDH150A (not dtd-/-:: AtDTDH150A).

      We thank the reviewers for pointing out this, we have corrected it.

      23). Materials and methods: Please clarify which experiments used tRNAPhe, tRNAAla, PheRS, etc. Also, please carefully check all other details provided in this section.

      As per the reviewer’s suggestion, we would like to provide a table below explaining the use of different substrates as well as enzymes in our experiments.

      Author response table 1.

      24) Figure legends (many places): p values higher than 0.05 (not less than) are denoted as ns.

      We thank the reviewers for pointing out this. We have corrected it.

      Reviewer #2 (Recommendations For The Authors):

      I have only minor comments for the authors:

      Title: I would replace "Archeal origin translation proofreader" with " A translation proofreader of archeal origin"

      As per the reviewer’s suggestion, we have now changed the title.

      Abstract: This section could benefit from some rewriting. For instance, at the outset, the initial logical connection between the first and second sentences of the abstract is somewhat unclear. At the very least, I would suggest swapping their order to enhance the narrative flow. Later in the text, the term "chiral proofreading systems" is introduced; however, it is only in a subsequent sentence that these systems are explained to be responsible for removing stable D-aminoacyl adducts from tRNA. Providing an immediate explanation of these systems would enhance the reader's comprehension. The authors switch from the past participle tense to the present tense towards the end of the text. I would recommend that they choose one tense for consistency. In the final sentence, I would suggest toning down the statement and replacing "can be used" with "could be explored." (https://www.nature.com/articles/d41586-023-02895-w). The same comment applies to the introduction, line 79.

      As per the reviewer’s suggestion, we have now changed the abstract appropriately.

      General note: Conventionally, the use of italics is reserved for the specific species "Arabidopsis thaliana," while the broader genus "Arabidopsis" is not italicized.

      We acknowledge the reviewer for this pertinent suggestion. This is now corrected in revised version of our manuscript.

      General note: I would advise the authors against employing bold characters in conjunction with colors in the figures.

      We thank the reviewer for this suggestion. We have now changed it appropriately in revised version of our manuscript.

      Figure 1A: I recommend including the concentrations of the various aldehydes used in the experiment within the figure legend. While this information is available in the materials and methods section, it would be beneficial to have it readily accessible when analyzing the figure.

      As per the reviewer’s suggestion, we have now included the concentrations in figure legend.

      Figure 1I, J: some error bars are invisible.

      We thank the reviewers for pointing out this, we have corrected it.

      Figure 2M: The table could be simplified by removing aldehydes for which it was not feasible to demonstrate activity. The letter "M" within the cell labeled "aldehydes" appears to be a typographical error, presumably indicating the figure panel.

      As per the reviewer’s suggestion, we have now changed this appropriately.

      Figure 3: For consistency with the other panels in the figure, I recommend including an additional panel to display the graph depicting the impact of MG on germination.

      As per the reviewer’s suggestion, we have now changed this appropriately.

      Figure 4: Considering that only one plant is presented, it would be beneficial to visualize the data distribution for the other plants used in this experiment, similar to what the authors have done in panel A of the same figure.

      We thank the reviewer for bringing up this point. We wish to clarify that we have done experiment with multiple plants. However, for the sake of clarity, we have included the representative images. Moreover, we have included the quantitative data for multiple plants in Figure 3C-G.

      Figure 5E: The authors may consider presenting a chronological order of events as they believe they occurred during evolution.

      We thank the reviewer for the suggestion. However, it is very difficult to pinpoint the chronology of the events. Aldehydes are lethal for systems due to their hyper reactivity and systems would require immediate solutions to survive. Therefore, we think that both problem (toxic aldehyde production) and its solution (expansion of aldehyde metabolising repertoire and recruitment of archaeal DTD2) might have appeared simultaneously.

      Figure 6: The model appears somewhat crowded, which may affect its clarity and ease of interpretation. The authors might also consider dividing the legend sentence into two separate sentences for better readability.

      As per the reviewer’s suggestion, we have now changed this appropriately.

      Line 149: I recommend explicitly stating that ethanol metabolism produces acetaldehyde. This clarification will help the general reader immediately understand why DTD2 mutant plants are sensitive to ethanol.

      As per the reviewer’s suggestion, we have now changed this appropriately.

      Line 289: there is a typographical error, "promotor" instead of the correct term "promoter.".

      We thank the referee for pointing out this, we have now corrected it.

      Figure S5: The root morphology of DTD2 OE plants appears to exhibit some differences compared to the WT, even in the absence of a high concentration of aldehydes. It would be valuable if the authors could comment on these observed differences unless they have already done so, and I may have overlooked it.

      We thank the referee for pointing out this. We do see minor differences in root morphology, but they are more pronounced with aldehyde treatments. The reason for this phenotype remains elusive and we are trying to understand the role of DTD2 in root development in detail in further studies.

      Some Curiosity Questions (not mandatory for manuscript acceptance):

      1) Do DTD2 OE plants display an earlier flowering phenotype than wild-type Col-0?

      We have not done detailed phenotyping of DTD2 OE plants. However, our preliminary observations suggest no differences in flowering pattern as compared to wild-type Col-0.

      2) What is the current understanding of the endogenous regulation of DTD2?

      We have not done detailed analysis to understand the endogenous regulation of DTD2.

      3) Could the protective phenotype of DTD2 OE plants in the presence of aldehydes be attributed to additional functions of this enzyme beyond the removal of stable D-aminoacyl adducts from tRNAs?

      Based on the available evidence regarding the biochemical activity and in vivo phenotypes of DTD2, it appears that removal of stable D-aminoacyl adducts from tRNA is key for the protective phenotype of DTD2 OE.

      A Suggestion for Future Research (not required for manuscript acceptance):

      The authors could explore the possibility of overexpressing DTD2 in pyruvate decarboxylase transgenic plants and assess whether this strategy enhances flood tolerance without incurring a growth penalty under normal growth conditions.

      We thank the referee for this interesting suggestion for future research. We will surely keep this in mind while exploring the flood tolerance potential of DTD2 OE plants.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Major change:

      All three of our reviewers raised the possibility that changes in movement during the time spent at the center ports could have contributed to changes in SWR rates. Analyses to address this possibility, based on the examination of trials with high and low speeds, were originally included in the supplement but we did not sufficiently highlight and explain these results. To rectify this, we have moved these results into a new main Figure 3 and now include a paragraph describing our interpretation of these results (page 9). We also include a more detailed description of the subjects’ behavior during port times – namely, that all subjects must remain quite stationary while at the reward ports in order to keep their nose in a specific position which keeps the port triggered. As a result, all subjects maintain head speeds well below our typical speed threshold for immobility while at the ports. This leads us to predict that any feedback based on periods of immobility alone (as requested by Reviewer 3) would show results very similar to our Control cohort and would not alter SWR rates seen during neurofeedback trials.

      Minor changes:

      (1) Reviewer 1 observed our that reported statistics appeared to be missing an interaction term showing that neurofeedback differentially affected the SWR rate/count pre- and postreward. We apologize for a lack of clarity here: we fit pre- and post-reward times with separate linear mixed effects models, so this interaction term is neither expected nor defined in our model. We have added a sentence clarifying this aspect of our LME approach in the Methods section: “Each model is designed to compare samples from all trials of the control group to samples from neurofeedback and delay trials from the neurofeedback cohort for a specific time period (for instance, pre-reward-delivery at the center ports).” Combining both times in the same model would require adding an additional hierarchical level in order to preserve the pairing of the pre- and post-reward time period for each trial, which we are concerned would complicate the formulation and interpretation of the model. However, the reviewer raises a good point that the comparison between these two time periods reveals an additional difference between the trial types: SWR rate remains relatively consistent between the pre- and post-reward periods during neurofeedback trials, while delay and control trials show a clear increase in SWR rate between the two time periods. To visualize and quantify this effect, we calculated the difference in SWR rates between the two time periods and now include this plot as Supplementary Figure 2F, which is referenced in page 8 of the main text.

      (2) Reviewer 2 found our original title, “Neurofeedback training can modulate task-relevant memory replay in rats” to be misleading and suggestive of a manipulation to memory content. We are in complete agreement with the Reviewer in that our manipulation does not alter replay content, so to be more specific and accurate, we have changed our title to their suggestion “Neurofeedback training can modulate task-relevant memory replay rate in rats” accordingly.

      (3) Reviewer 2 also requested that we include analyses quantifying baseline SWR rates for each of our experimental subjects. Although we initially considered reporting our results in measures of change relative to each individual animal’s baseline, we decided against this approach for several reasons.

      First, it is important to clarify that we extensively train the animals on the task prior to implant, so we do not have access to a truly naïve, pre-behavior baseline SWR rate for any of our subjects. However, because the pre-implant training is conducted consistently between our neurofeedback and our control cohort, we have no reason to believe that the behavioral training prior to implant would introduce differences in SWR rate between the cohorts. Indeed, we find no difference in post-reward SWR rate (or SWR rate at the home well) when we quantify the first 250 trials of post-implant behavior for each subject (see panel A below). Note that we cannot compare the pre-reward SWR rate at this point, because it is influenced by the task structure which guarantees at least one SWR in each neurofeedback trial pre-reward.

      Further, we do find that SWR rate is quite consistent over many days of task performance in the control cohort (show for the post-reward period in panel B below). This suggests that comparing the post-neurofeedback training SWR rates for the neurofeedback cohort to SWR rates throughout the training for the control cohort is not likely to be confounded by differing amounts of training experience. This is supported by our analyses in Figure 2 which show no differences in SWR rate between the two cohorts when considering pre- and post-reward times combined.

      Author response image 1.

      (A) SWR rate calculated during the post-reward period at the center port for the first 250 trials of postimplant behavior for each animal. Trials of all types are included (ie both neurofeedback trials and delay trials for the manipulation cohort). Groupwise comparison p=0.192. (B) Mean SWR rate during the post-reward period at the center port for each behavioral training epoch shows no systematic change over time across subjects within the control cohort.

      Finally, within each cohort, we found the overall SWR rates to be quite consistent across animals. If each subject in the neurofeedback cohort had shown dramatically different SWR rates at the beginning of neurofeedback training, we would have needed to express the effect of neurofeedback training relative to baseline for each animal. However, since the range of SWR rates were highly comparable, we felt that it was more accessible, and easier to place our results within the context of the literature, by expressing our results as simple SWR rates themselves rather than measures of relative change. Within the neurofeedback cohort, comparing neurofeedback to delay trials is inherently matched for baseline SWR rate since these comparisons are made within the same animal.

      (4) Finally, Reviewer 2 raises the possibility that older animals or those with cognitive deficits might respond to neurofeedback differently. We entirely agree with this possibility, and note this in our Discussion section: “Since the neurofeedback paradigm depends on the occurrence of at least a low endogenous rate of SWR occurrence, it would be important to implement neurofeedback training as a relatively early interventional strategy prior to extensive neurodegeneration, and training may take longer in aged or impaired subjects.”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this study, Yue et al. re-processed publicly available DNA methylation data (published in 2012 and 2017 from the Meissner lab) from pre- and post-implantation mouse embryos. Against the global wave of genome-wide reduction of DNA methylation occurring during pre-implantation development, they detected a slight increase (~1% on average) of DNA methylation at gene promoter regions during the transition from 8-cell to blastocyst stage. They claim that many such promoters are located in the X chromosome. Subsequently, they knocked down Dnmt3b (presumably because of its upregulation during the transition from the 8-cell to blastocyst stage) and detected the aberrant patterning of H3K27me3 in the mutant female embryos. Based on this observation, they claim that imprinted X-chromosome inactivation is impaired in the Dnmt3b-Kd pre-implantation embryos. Finally, they propose a model where such an increase of DNA methylation together with H3K27me3 regulates imprinted X-chromosome inactivation in the pre-implantation embryos. While their observation is of potential interest, the current version of the work fails to provide enough evidence to support their conclusions. Below are suggestions and comments on the manuscript.

      Major issues:

      (1) Sex of the embryos of the genome-wide bisulfite-sequencing data

      The authors re-analyzed publicly available genome-wide DNA methylation data from the Meissner lab published in 2012 and 2017. The former used reduced representation bisulfite sequencing (RRBS) and the latter used whole-genome bisulfite sequencing (WGBS). Based mainly on the RRBS data, Yue et al. detected de novo DNA methylated promoters during the transition from 8-cell to blastocyst against the global wave of genome-wide DNA demethylation. They claim that such promoter regions are enriched at the "inactive" X chromosome. However, it would be difficult to discuss DNA methylation at inactive X-chromosomes as the RRBS data were derived from a mixture of male and female embryos. It would also be notable that the increase of DNA methylation at these promoter regions is ~1% on average. Such a slight increase in DNA methylation during pre-implantation development could also be due to the developmental variations between the embryos or between the sexes of embryos.

      Thanks so much for your insightful comments. Whether de novo DNA methylation occurs in a sex-dimorphic manner would be of significance for our study. Based on your comments, we have added a reanalysis based on a publicly available single cell multi-omics sequencing (COOL-seq) data of mouse early embryos (Guo et al., 2017). The results showed that both male and female embryonic cells gain DNA methylation during the transition from the 8-cell to ICM (Figure 1—figure supplement 1C-D; Lines 112-115 in the revised manuscript).

      With regards to the increase in the promoter region, many previous studies have revealed that promoter and overlapping CGI regions, especially high CpG promoters, always showed low levels of DNA methylation (Auclair et al., 2014; Borgel et al., 2010; Dahlet et al., 2020). The relatively lower basal levels make the increase seem relatively slight. Thus, we added relevant statements to clarify this information and rewritten the sentences in the revised manuscript (Lines 116-118, 125-127 in the revised manuscript).

      In addition, using the single cell COOL-seq data, we also specifically reanalyzed the DNA methylation changes on the X chromosome in female embryos. The X chromosome showed a more notable increase than that on autosomes, and the female X chromosome showed a higher DNA methylation level than that of the male (Figure 3—figure supplement 2A-B; Lines 203-206 in the revised manuscript).

      Thanks again for your insightful and constructive comments that significantly strengthen our evidence. We have added these results in the revised manuscript.

      (2) Imprinted X-chromosome inactivation and evaluation of H3K27me3 (related to Figures 2C, D; 3F; Figure2-supplement 2 F, G; Figure3-supplement 3G)

      Based on the slight change in the H3K27me3 signals in the Dnmt3b-Kd blastocysts, the authors claim that imprinted X-chromosome inactivation is impaired in the mutant embryo. It would be not easy to reach this conclusion from such a rough analysis of H3K27me3 presented in Figure 2C, D. Rigorous quantification/evaluation of the H3K27me3 signals in the Dnmt3b-Kd embryos should be considered. Additional evidence for the impairment of H3K27me3 in the mutant embryos should also be provided (expression of a subset of X-linked genes by RNA-FISH or RT-PCR etc.). Though technically challenging, high-resolution genome-wide approach such as ChIP-seq of H3K27me3 in the Dnmt3b-kd female embryos (with traceable SNPs between maternal and paternal X chromosome to distinguish inactive and active X-chromosome) could more precisely evaluate regions that lose H3K27me3 in the X-chromosome (de novo DNA methylated promoters from 8-cell to blastocyst, for example).

      Thanks so much for your insightful comments that make our results more convincing. The H3K27me3 domain is a classic marker for establishment of XCI by achieving X chromosome wide heterochromatinization of transcriptional depression (Chow and Heard, 2009; Heard et al., 2004; Huynh and Lee, 2005). Thus, in the present study, we have performed immunostaining for H3K27me3 domains to evaluate the iXCI status in the blastocysts, as previously reported (Fukuda et al., 2014; Gontan et al., 2018; Inoue et al., 2010; Tan et al., 2016). Base on your comments, we have added another statistical method to quantify the establishment of iXCI, i.e. the percentage of H3K27me3-positive and -negative cells to total trophoblast cells in female blastocysts subject to Dnmt3b knockdown or not. The result also indicated that Dnmt3b knockdown led to a significant loss of H3K27me3 domains from total trophoblast cells. Similarly, new data based on statistical analyses of total trophoblast cells, has also been added in the results of Dnmt3b knockout and 5-aza-dC (Figure 3F; Figure 3—figure supplement 3D, H in the revised manuscript).

      To clarify the significance and reliability of detecting H3K27me3 domains, we have added a schematic diagram depicting the process of iXCI initiation and establishment, as well as the experimental design and work flows, to make our results easier to be understood (Figure 3C in the revised manuscript).

      In addition, we agree with your comments that additional evidence will benefit the conclusion. Thus, we have reanalyzed the RNA-seq and H3K27me3 CHIP-seq data in extraembryonic ectoderm (ExE) of E6.5 single embryos that underwent Dnm3a/3b knockout because preimplantation iXCI status maintains extraembryonic cells (Chen et al., 2019; Galupa and Heard, 2015; Schulz and Heard, 2013). The results showed that Dnmt knockout-induced chromosome-wide loss of DNA methylation led to a nearly complete loss of H3k27me3 on paternal X chromosome (specifically inactivated in iXCI), along with a notable transcriptional upregulation cross the chromosome. By contrast, these changes cannot be not observed on maternal X chromosome.

      We have added this result in the revised manuscript (Lines 253-261; Figure 3—figure supplement 4A in the revised manuscript).

      (3) Analysis of the developmental potential of Dnmt3b-kd embryos

      While the authors claim that Dnmt3b-mediated de novo DNA methylation plays an important role in imprinted X-chromosome inactivation, it remains unclear whether the analysis presented in Figure 4 is derived from "female" embryos. This analysis seemed confusing as the authors claim that de novo DNA methylation in the promoter regions during the transition from 8-cell to blastocyst regulates imprinted X-chromosome inactivation, but this should not happen in the male embryos. Was the impairment of embryonic proliferation and differentiation observed in both male and female embryos? Or is this specific to the female embryos? We think that the sex of the embryos would be critical for the analysis presented in Figure 4.

      Thanks so much for your constructive comments to make our results smoother and clearer. The Figure 4 mainly presents the developmental role of minor de novo methylation based on the integrated analysis of DNA methylation and gene expression dynamics from the 8-cell to ICM. Because our data indicated that both male and female embryos undergo minor de novo methylation (Figure 1—figure supplement 1C-D in the revised manuscript). This section mainly focused on genome wide and general changes, but not on sex dimorphic consequence.

      To avoid the possible confusion, we have reorganized the RESULTS AND DISCUSSION section and presented this section as Figure 2 in the revised manuscript, before the chromosomal distribution analysis and subsequent detection relevant to iXCI.

      Reviewer #2 (Public Review):

      Summary:

      Here, Yue et al. set out to determine if the low DNMT3B expression that is observed prior to de novo DNA methylation (before the blastocyst stage) has a function. Re-analyzing existing DNA methylation data from Smith et al. (2012) they find a small DNA methylation gain over a subset of promoters and gene bodies, occurring between the 8-cell and blastocyst stages, and refer to this as "minor de novo DNA methylation". They attempt to assess the relevance/functionality of this minor DNA methylation gain, and report reduced H3K27me3 in Dnmt3b knockdown (KD) trophoblast cells that normally undergo imprinted X-chromosome inactivation (iXCI) before the blastocyst stage. In addition, they assess the proliferation, differentiation, metabolic function, implantation rate, and live birth rate of Dnmt3b KD blastocysts.

      Strengths:

      Working with early embryos is technically demanding, making the well-designed experiments from this manuscript useful to the epigenetics community. Particularly, the DNMT3B expression and 5-mC staining at different embryonic stages.

      Thanks for your positive evaluation, we have revised manuscript based on your comments, and the items need to be addressed in detail are explained in the point-by-point response to each comment.

      Weaknesses:

      - Throughout the manuscript, please represent DNA methylation changes as delta DNA methylation instead of fold change.

      Thanks so much for your constructive comments. We have represented DNA methylation changes as “ΔDNA methylation” (Figure 2—figure supplement 1A; Figure 3—figure supplement 1A; Figure 3—figure supplement 3I in the revised manuscript).

      - Detailed methods on the re-analysis of the DNA methylation data from Smith et al. 2012 are missing from the materials and methods section. Was a minimum coverage threshold used?

      Thanks so much for your reminder. We have added relevant statements and provided the detail of the coverage criteria in the subsection of Bioinformatics analysis in the Materials and methods section as follows: RRBS data of mouse embryos (2-cell embryos, 4-cell embryos, 8-cell embryos, ICM, and E6.5 embryos) were downloaded from the published article by Smith et al (Smith et al., 2012) (accession number: GSE34864). The methylation level was calculated as the number of “methylated” reads (reporting as C), divided by the total number of “methylated” and “unmethylated” read, which reporting as C or T. The genomic region information was downloaded from the mm9 Repeat Masker. As described in the published article, promoters were defined as 1 kb up- and downstream of the TSS and classified into high-density CpG promoter (HCP), intermediate-density CpG promoter (ICP) and low-density CpG promoter (LCP). Only CpG sites with at least fivefold coverage were included in the methylation analysis. We have added relevant information in the revised manuscript (Lines 462-470 in the revised manuscript).

      - Detailed methods on the establishment and validation of Dnmt3b KO blastocysts and 5-aza-dC treated blastocysts are missing (related to Figure 2).

      Thanks so much for your detailed reminder. In the present study, we used a well-established Dnmt3b-deficient mouse model (Okano et al., 1999) to validate the role of minor de novo DNA methylation in iXCI establishment. Heterozygous Dnmt3b<sup>+/-</sup> mice that carry one mutant locus of Dnmt3b, were obtained from the Mutant Mouse Resource & Research Centers (MMRRC, NIH). Homozygous embryos were obtained by intercrossing Dnmt3b<sup>+/-</sup> male and female mice. Genotyping assays of collected embryos was performed by PCR using primers that were designed based on the gene targeting strategy following the MMRRC genotyping protocol (https://www.med.unc.edu/mmrrc/genotyping-protocols/mmrrc-center-protocol-29886/). We have provided the detailed methods in the revised manuscript (Lines 350-354; 391-393 in the revised manuscript). In addition, we added a schematic diagram depicting the processes of embryo collection and detection (Figure 3—figure supplement 3A in the revised manuscript).

      Similarly, we have provided relevant details of 5-aza-dC supplementation in the revised manuscript (Lines 412-415 in the revised manuscript) and added a schematic diagram depicting the details of experimental design and processes (Figure 3—figure supplement 3E in the revised manuscript).

      - Detailed methods on the re-analysis of the ChIPseq data from Liu et al. 2016 are missing from the materials and methods section.

      Thank you for pointing this out. The bigwig files of H3K27me3 ChIP-seq data were downloaded from the published article by Liu et al (Liu et al., 2016)(accession number: GSE73952). These signal tracks were generated using the MACS2 (v2.0.10.20131216) pileup function and normalized to 1 million reads for visualization, as described in the original publication. We have added relevant information to the MATERIALS AND METHODS section in the revised manuscript (Lines 474-479 in the revised manuscript).

      - Some of the data represented in bar graphs does not look convincing/significant. Maybe this data can be better represented differently, such as in box plots or violin plots, which would better represent the data.

      Thanks so much for your comments that improve our result presentation, relevant results have been changed into box plots in the revised manuscript (Figure 3E; Figure 3—figure supplement 3C; Figure 3—figure supplement 3G in the revised manuscript). In addition, to strengthen our evidence, we have added alternative statistical method to quantify the establishment of iXCI, i.e. the percentage of H3K27me3-positive and -negative cells to total trophoblast cells in female blastocysts subject to Dnmt3b knockdown or not. (Figure 3F; Figure 3—figure supplement 3D, H in the revised manuscript).

      - The relevance and rationale for experiments using 5-aza-dC treatment is unclear.

      Thanks so much for reminding us to make our results more informative and convincing. 5-aza-dC is a well-established global DNA hypomethylating agent that efficiently inhibit the activity of all DNMTs, and thus has been frequently used to study the maintenance of DNA methylation and de novo DNA methylation (Maslov et al., 2012; Oka et al., 2005).

      In our study, to validate the function of minor de novo DNA methylation in iXCI, we take advantage of 5-aza-dC-induced DNMT inhibition, which allows us, despite its inhibitory effect common to various DNMTs, to transiently treat embryos specifically during the window of minor de novo DNA methylation (from the 8-cell to blastocyst stage). We have added these statements, as well as a schematic diagram depicting the experimental design, in the revised manuscript to make our experiments more rational and easier to be understood (Lines 183-188; Figure 3—figure supplement 3E in the revised manuscript).

      References

      Auclair, G., Guibert, S., Bender, A. and Weber, M. (2014). Ontogeny of CpG island methylation and specificity of DNMT3 methyltransferases during embryonic development in the mouse. Genome Biol. 15, 545.

      Borgel, J., Guibert, S., Li, Y., Chiba, H., Schubeler, D., Sasaki, H., Forne, T. and Weber, M. (2010). Targets and dynamics of promoter DNA methylation during early mouse development. Nat. Genet. 42, 1093-1100.

      Chen, Z., Yin, Q., Inoue, A., Zhang, C. and Zhang, Y. (2019). Allelic H3K27me3 to allelic DNA methylation switch maintains noncanonical imprinting in extraembryonic cells. Sci Adv 5, eaay7246.

      Chow, J. and Heard, E. (2009). X inactivation and the complexities of silencing a sex chromosome. Curr. Opin. Cell Biol. 21, 359-366.

      Dahlet, T., Argueso Lleida, A., Al Adhami, H., Dumas, M., Bender, A., Ngondo, R. P., Tanguy, M., Vallet, J., Auclair, G., Bardet, A. F., et al. (2020). Genome-wide analysis in the mouse embryo reveals the importance of DNA methylation for transcription integrity. Nat Commun 11, 3153.

      Fukuda, A., Tomikawa, J., Miura, T., Hata, K., Nakabayashi, K., Eggan, K., Akutsu, H. and Umezawa, A. (2014). The role of maternal-specific H3K9me3 modification in establishing imprinted X-chromosome inactivation and embryogenesis in mice. Nat Commun 5, 5464.

      Galupa, R. and Heard, E. (2015). X-chromosome inactivation: new insights into cis and trans regulation. Curr. Opin. Genet. Dev. 31, 57-66.

      Gontan, C., Mira-Bontenbal, H., Magaraki, A., Dupont, C., Barakat, T. S., Rentmeester, E., Demmers, J. and Gribnau, J. (2018). REX1 is the critical target of RNF12 in imprinted X chromosome inactivation in mice. Nat Commun 9, 4752.

      Guo, F., Li, L., Li, J., Wu, X., Hu, B., Zhu, P., Wen, L. and Tang, F. (2017). Single-cell multi-omics sequencing of mouse early embryos and embryonic stem cells. Cell Res. 27, 967-988.

      Heard, E., Chaumeil, J., Masui, O. and Okamoto, I. (2004). Mammalian X-chromosome inactivation: an epigenetics paradigm. Cold Spring Harb. Symp. Quant. Biol. 69, 89-102.

      Huynh, K. D. and Lee, J. T. (2005). X-chromosome inactivation: a hypothesis linking ontogeny and phylogeny. Nat. Rev. Genet. 6, 410-418.

      Inoue, K., Kohda, T., Sugimoto, M., Sado, T., Ogonuki, N., Matoba, S., Shiura, H., Ikeda, R., Mochida, K., Fujii, T., et al. (2010). Impeding Xist expression from the active X chromosome improves mouse somatic cell nuclear transfer. Science 330, 496-499.

      Liu, X. Y., Wang, C. F., Liu, W. Q., Li, J. Y., Li, C., Kou, X. C., Chen, J. Y., Zhao, Y. H., Gao, H. B., Wang, H., et al. (2016). Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos. Nature 537, 558-562.

      Maslov, A. Y., Lee, M., Gundry, M., Gravina, S., Strogonova, N., Tazearslan, C., Bendebury, A., Suh, Y. and Vijg, J. (2012). 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1. Oncogene 31, 5172-5179.

      Oka, M., Meacham, A. M., Hamazaki, T., Rodic, N., Chang, L. J. and Terada, N. (2005). De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine. Oncogene 24, 3091-3099.

      Okano, M., Bell, D. W., Haber, D. A. and Li, E. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257.

      Schulz, E. G. and Heard, E. (2013). Role and control of X chromosome dosage in mammalian development. Curr. Opin. Genet. Dev. 23, 109-115.

      Smith, Z. D., Chan, M. M., Mikkelsen, T. S., Gu, H. C., Gnirke, A., Regev, A. and Meissner, A. (2012). A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 484, 339-344.

      Tan, K., An, L., Miao, K., Ren, L., Hou, Z., Tao, L., Zhang, Z., Wang, X., Xia, W., Liu, J., et al. (2016). Impaired imprinted X chromosome inactivation is responsible for the skewed sex ratio following in vitro fertilization. Proc. Natl. Acad. Sci. U. S. A. 113, 3197-3202.

      Reviewer #1 (Recommendations For The Authors):

      Title

      It would be hard to understand what "co"-regulates means. Does this mean DNA methylation and H3K27me3 co-regulate imprinted X- X-chromosome inactivation? If so, the title can be reworded.

      Thanks for your insightful comments, the title has been corrected into “A wave of minor de novo DNA methylation initiates in mouse 8-cell embryos and co-regulates imprinted X- chromosome inactivation with H3K27me3” (Line 2 in the revised manuscript).

      Text

      (1) As DNA methylation analysis is a primary part of this study, how they processed DNA methylation data can be added to the "Bioinformatics analysis" in the MATERIALS AND METHODS section.

      Thanks for your kind reminder. We have added relevant information in the Materials and methods section in the revised manuscript (Lines 462-474 in the revised manuscript).

      (2) It seems that recent literature has not been cited in the manuscript. Specifically, none of the papers after 2018 were cited. Recent relevant papers should also be cited throughout the manuscript.

      Thanks so much for your reminder. We have added more recent literature to update the relevant information, such as the evidence supporting the causal role between DNA methylation and XCI (Lines 225-228, 264-265 in the revised manuscript); the concurrent enrichment of DNA methylation and H3K27me3 in genes subject to XCI (Lines 301-303 in the revised manuscript); the dominant role of de novo methylation in X chromosome (Lines 253-256 in the revised manuscript), etc.

      (3) Line 56: The first report that describes the dynamics of DNMT3B expression in pre-implantation embryonic development (Hirasawa et al., 2007) is missing. This paper should be cited.

      Sorry for our carelessness, we have added relevant references and rewritten the sentence in the revised manuscript (Lines 56-57 in the revised manuscript). I think you meant the report by Hirasawa et al in 2008, in which presented expression and subcellular localization of Dnmt3a and Dnmt3b in mouse oocytes and preimplantation embryos.

      (4) Line 98: It would be good to mention that the data were derived from reduced representation bisulfite sequencing as the authors used whole-genome bisulfite sequencing data from the same research group as well.

      Thanks for your kind reminder. As you have suggested, we have added the description in the revised manuscript to emphasize that these data were derived from reduced representation bisulfite sequencing, while another data were derived from whole-genome bisulfite sequencing, respectively. (Lines 98-99, 111 in the revised manuscript).

      (5) Line 101: We first... "the preferential target of DNMT3B (Auclair et al., 2014; Borgel et al., 2010)". More recent literature (Baubec et al., 2016, Duymich et al., 2016, for example) showed that the preferential target of DNMT3B is not a promoter but a gene body. This sentence should be reworded.

      Thanks so much for your detailed reminder. As you have pointed out, “preferential target” seems to be an inaccurate statement. Besides of promoters, gene bodies and other elements also undergo de novo DNA methylation (Auclair et al., 2014; Dahlet et al., 2020; Duymich et al., 2016).

      We have rewritten the sentence as follows in the revised manuscript: “Promoter regions are important target sites of DNMT3B (Choi et al., 2011). The acquisition of DNA methylation in promoters, especially in intermediate and low CpG promoters, during implantation is largely dependent on DNMT3B and plays an important role in regulating developmental genes (Auclair et al., 2014; Borgel et al., 2010; Dahlet et al., 2020). Thus, among genomic regions that may undergo de novo DNA methylation, we initially focused our analysis on DNA methylation dynamics of promoters...” (Lines 100-106 in the revised manuscript)

      (6) Lines 108-109: It would be good to mention that these data were derived from whole-genome bisulfite sequencing.

      Thanks for your kind reminder. As aforementioned, we have added a description in the revised manuscript to distinguish between data derived from reduced representation bisulfite sequencing and whole-genome bisulfite sequencing (Lines 98-99, 111 in the revised manuscript).

      (7) Line 141: rXCI should be defined.

      Thanks for your kind reminder. We have added full descriptions and more necessary information about iXCI and rXCI, to make our statements clearer and easier to be understood (Lines 210-213 in the revised manuscript). In addition, we carefully checked the relevant descriptions throughout the manuscript, and each abbreviation (such as “ICM”) has been defined at its first occurrence. Additionally, we have replaced abbreviations that appears only once in the manuscript with their full terms (Lines 122, 212 in the revised manuscript).

      (8) Lines 145-149: The role of DNA methylation for imprinted X-inactivation has already been reported (Chiba et al., 2008). The relevant sentences should be reworded.

      Thanks so much for reminding us the important earlier literature that explores the relationship between DNA methylation and XCI. However, the primary aim and hypothesis of the study by Chiba et al. are different from those of our study. Chiba et al focused on whether DNA methylation is the imprinting mark responsible for monoallelic expression of Xist (the initiation event of iXCI), while our study focused on the role of DNA methylation in achieving X chromosomal heterochromatinization (the late event of iXCI).

      In detail, the study by Chiba et al. mainly focused on exploring why Xist is specifically expressed from paternal allele and iXCI occurs specifically on the paternal X chromosome in mouse preimplantation embryos. Because Previous studies have suggested that genomic imprinting of Xist is established during oogenesis (Oikawa et al., 2014; Tada et al., 2000), Chiba et al. wanted to test whether the DNA methylation imprinting established during oogenesis is responsible for the monoallelic expression of Xist in preimpantaiton embryos. Analyses of DNA methyltransferase maternal knockout embryos revealed that oocyte DNA methylation is dispensable for Xist imprinting (Chiba et al., 2008). Follow-up study by Inoue et al. identified a broad H3K27me3 enrichment within the Xist 5’region established during oocyte growth and persists through preimplantation development, as the imprinting mark of Xist (Inoue et al., 2017). These series of studies are very important and allows us to understand the mechanism underlying paternal allele-specific iXCI in mouse preimplantation embryos and extraembryonic tissues.

      However, the hypothesis is different in our study. Based on the finding of minor de novo DNA methylation and its preferential distribution on the X chromosome, we have speculated that the minor de novo methylation, which occurs from the 8-cell to blastocyst stage, may participate in achieving X chromosomal heterochromatinization. Although DNA methylation is essential for maintaining X chromosome-wide transcriptional silence of rXCI, its role in iXCI remains controversial and it is even plausibly thought that DNA methylation is not required for achieving iXCI because preimplantation embryos undergo global and massive DNA demethylation.

      We have reorganized this paragraph, relevant statements have been added to make the background and discussion clearer and easier to be understood. (Lines 217-234 in the revised manuscript)

      (9) Lines 164-165: Information regarding Dnmt3b KO is missing. Did the authors generate an original KO line or use an already published one? It should be explicitly stated.

      Thank you so much for your kind reminder. The Dnmt3b heterozygous mice were obtained from the Mutant Mouse Resource & Research Centers (MMRRC), and Dnmt3b knockout (KO) embryos were generated by mating Dnmt3b heterozygous females with heterozygous males. The genotyping of Dnmt3b KO embryos was performed by PCR following the MMRRC genotyping protocol (https://www.med.unc.edu/mmrrc/genotyping-protocols/mmrrc-center-protocol-29886/). The relevant information has been added to the MATERIALS AND METHODS section in the revised manuscript (Lines 350-354; 391-393 in the revised manuscript).

      (10) Line 165: chemical-induced inhibition of DNMT3B. As 5-aza-dC also blocks DNMT3A and DNMT1, this sentence should be reworded.

      Thank you for your valuable comments. 5-aza-dC is a well-established global DNA hypomethylating agent that efficiently inhibit the activity of all DNMTs, and has been frequently used to study the maintenance of DNA methylation and de novo DNA methylation (Maslov et al., 2012; Oka et al., 2005). Thus, despite its inhibitory effect common to various DNMTs, chemical-induced inhibition of DNMTs has the advantage of allowing us to transiently treated embryos specifically during the window of minor de novo DNA methylation (the 8-cell to blastocyst stage). We have rewritten the relevant sentences in the revised manuscript (Lines 183-188 in the revised manuscript).

      (11) Lines 171-174: "The role of de novo methylation in iXCI...". This possibility was already tested in the previous study from the Sasaki lab (Chiba et al., 2008).

      As mentioned above, the primary aim and hypothesis of the study by Chiba et al. are different from those of our study. Chiba et al. mainly focused on exploring why Xist is specifically expressed from paternal allele and iXCI occurs specifically on the paternal X chromosome in mouse preimplantation embryos, so they tested whether the DNA methylation imprinting established during oogenesis is responsible for this monoallelic expression of Xist in preimplantation embryos (the initiation event of iXCI).

      By contrast, based on the finding of minor de novo DNA methylation and its preferential distribution on X chromosome, our study has speculated that the minor de novo DNA methylation, which occurs from the 8-cell to blastocyst stage, may participate in achieving X chromosomal heterochromatinization (the late event of iXCI).

      Thanks so much for reminding us this important literature, to make our discussion more informative. We have reorganized this paragraph by rewriting or adding relevant statements to make the background and discussion clearer and easier to be understood (Lines 217-231 in the revised manuscript). In addition, to avoid repeated statement and make our discussion more concise, we have removed the similar sentences at the end of this paragraph.

      (12) Lines 198-200: "Given DNA methylation...". These citations mention a general relationship between DNA methylation and H3K27me3 in cells in culture. As I believe the authors focus on X-chromosome inactivation in the female embryos, more relevant papers that discuss the order of the events for the establishment of H3K27me3 and DNA methylation in the inactive X-chromosome can be cited.

      Thanks so much for your comment to improve our discussion. It has been thought that during the late phase of rXCI in fully differentiated cells, gene silencing is achieved by PRC2 complex-induced H3K27me3, and then is further stably maintained by the redundant action of multiple layers of epigenetic modifications, including DNA methylation, to reach the maximum level of chromatin compaction (Chow and Heard, 2009; Heard et al., 2004; Pintacuda and Cerase, 2015). In line with this, a recent multifaceted analysis showed that DNA methylation and H3K27me3 are concurrently enriched in genes subject to XCI (Balaton and Brown, 2021). We have added these statements in the revised manuscript (Lines 295-303 in the revised manuscript).

      (13) Line 241: As 5-aza-dC blocks both de novo and maintenance DNA methylation, this sentence should be reworded.

      Thank you for your kind reminder. As you have mentioned above, 5-aza-dC is a well-established global DNA hypomethylating agent that efficiently inhibit the activity of all DNMTs, and has been frequently used to study the maintenance of DNA methylation and de novo DNA methylation (Maslov et al., 2012; Oka et al., 2005). Thus, despite its inhibitory effect common to various DNMTs, chemical-induced inhibition of DNMTs has the advantage of allowing us to transiently treated embryos specifically during the window of minor de novo DNA methylation (the 8-cell to blastocyst stage). We have rewritten the relevant sentences in the revised manuscript (Lines 183-188 in the revised manuscript).

      Figures

      (1) Figure 1C, D: Do the rows in C and D show the corresponding genes?

      Figure 1C and D represent the DNA methylation changes of promoters (C) and gene bodies (D) respectively, during the transition from the 8-cell to blastocyst stage. Two data were analyzed independently, and rows did not show the corresponding genes. Since we have focused on the minor de novo methylation in promoter regions, to avoid confusion, the results of the gene body have been removed from the revised manuscript.

      (2) Figure 1G: Yy2 promoter gained DNA methylation during the transition from 8-cell to the blastocyst stage. Is this a representative locus for the de novo methylated promoters that are shown in Figure 1F where an increase of DNA methylation is about ~1% on average? Another representative locus could be shown instead of this gene promoter.

      Thanks so much for you detailed reminder. The inconsistency between the global methylation change and bisulfite sequencing analysis of Yy2, may be due to the details of methodologies, such C-T conversion efficiency, the number of picked colonies, etc. Since we have confirmed the presence of minor de novo DNA methylation using different publicly available data, to avoid ambiguity, we have removed this result in revised manuscript.

      (3) Figures 2C and 3A: It would be helpful to mention what the arrowheads mean.

      Thanks so much for you detailed reminder. In Figure 2C, the arrowhead indicates the H3k27me3 domain and the blank arrowhead indicates the blastomere without the H3k27me3 domain. In Figure 3A, the arrowhead indicates Xist RNA domain and the blank arrowhead indicates the blastomere without Xist RNA domain. We have added the information in the revised manuscript (Lines 736-738, 747-749 in the revised manuscript).

      (4) Figure 3-figure supplement 2B: It would be hard to see whether H3K27me3 is enriched at the promoter regions of presented genes. It would be helpful to show the values for the Y-axis as in panel A.

      Thanks for your helpful reminder. We have added the scales to the figure to improve the result presentation (Figure 4—figure supplement 2B in the revised manuscript).

      (5) Figure 4-figure supplement 2: 5-aza-dC blocks not only the activity of DNMT3B but also DNMT1, and DNMT3A (all these DNMTs are expressed during pre-implantation embryos, see Hirasawa et al., 2007). This part can be omitted from the manuscript.

      Thanks for your insightful comments. As you have mentioned above, the relevance and rationale for experiments using 5-aza-dC treatment should be clarified. 5-aza-dC is a well-established global DNA hypomethylating agent that efficiently inhibit the activity of all DNMTs, and thus has been frequently used to study the maintenance of DNA methylation and de novo DNA methylation (Maslov et al., 2012; Oka et al., 2005).

      In our study, to validate the function of minor de novo DNA methylation in iXCI and blastocyst development, we take advantage of 5-aza-dC-induced DNMT inhibition, which allows us to transiently treated embryos specifically during the window of minor de novo DNA methylation (the 8-cell to blastocyst stage), despite its non-specificity to various DNMTs.

      Based on these considerations, we hope to retain this result, and wish to get your understanding.

      We have added these statements in the revised manuscript to make our experiments more rational and easier to be understood (Lines 183-188 in the revised manuscript) and added a schematic diagram depicting the experimental design (Figure 3—figure supplement 3E in the revised manuscript).

      Reviewer #2 (Recommendations For The Authors):

      Recommendations/concerns in the text:

      - Line 106, it is unclear what is meant by "in line with this"? Gene body DNA methylation is a characteristic of active transcription, so why would a gain in DNA methylation at promoters be in line with a gain in DNA methylation over gene bodies?

      Thank you so much for your comments that pointed out our ambiguous statement. We meant both the promoter and gene body regions, albeit accounting for small proportions, gain DNA methylation during the transition from the 8-cell to blastocyst stage. Based on the comment by Reviewer#1, since we have focused on the minor de novo methylation in promoter regions, to avoid confusion, the results of the gene body have been removed from the revised manuscript.

      - Line 111 & 114, can 6% DNA methylation really be considered "relatively hypermethylated" compared to 3% DNA methylation that is referred to as "more hypomethylated"?

      We apologize for our unclear and ambiguous statements. Here we focused on the promoter regions. Many previous studies have revealed that compared with gene bodies and other genome elements, promoter and overlapping CGI regions, especially high CpG promoters, always showed low levels of DNA methylation. We have added relevant statements to clarify this information, and rewritten the sentences in the revised manuscript (Lines 100-106, 116-118, 121, 124 in the revised manuscript).

      - Line 124, there are a number of processes identified, why only mention one in the text? Suggest changing writing to be more accurate, indicating what was included for the GO analysis and using the words "enriched for ... processes". Saying it may be linked to a process is an overstatement and not supported by further experiments/data.

      Thank you so much for your detailed comments that make our results more informative. We have checked the relevant description and addressed your suggestions as follows: By performing gene ontology enrichment analysis of genes that undergo minor or major de novo DNA methylation respectively, we noticed that besides of many important basic processes common to two waves of de novo DNA methylation, genes subject to minor de novo DNA methylation were enriched in processes such as organic substance transport, chromosome organization, and cell fate specification (Lines 129-134 in the revised manuscript).

      - Lines 149 - 152: sentence/message unclear.

      We apologize for the ambiguous description. We have corrected the relevant descriptions as follows: To identify the biological function of minor de novo DNA methylation in iXCI, we knocked down Dnmt3b in preimplantation embryos by microinjecting Dnmt3b siRNA into zygotes (Lines 234-236 in the revised manuscript).

      - Lines 162-164: the data in Figure 2C/D does not support this statement, as it does not show H3K27me3 loss specifically at the inactive X-chromosome.

      Thanks so much for your insightful comments. Despite the global enrichment of H3K27me3, the H3K27me3 domain detected by immunostaining is a classic marker for establishment of XCI by achieving X chromosome wide heterochromatinization of transcriptional depression (Chow and Heard, 2009; Heard et al., 2004; Huynh and Lee, 2005). Thus, we have used immunostaining for H3K27me3 domains to evaluate the iXCI establishment in the blastocysts, as previously reported (Fukuda et al., 2014; Gontan et al., 2018; Inoue et al., 2010; Tan et al., 2016). To make our results more convincing, we have added another statistical method to quantify the establishment of iXCI, i.e., the percentage of H3K27me3-positive and -negative trophoblast cells to total trophoblast cells in female blastocysts subject to Dnmt3b knockdown or not.

      In addition, we have added a schematic diagram depicting the process of iXCI initiation and establishment, as well as the experimental design and work flows, to make the result easier to be understood.

      In addition, we agree with your comments that additional evidence will benefit the conclusion. To strengthen the evidence, and test whether DNA methylation loss leads to a prolonged effect on iXCI, we have reanalyzed the RNA-seq and H3K27me3 CHIP-seq data in extraembryonic ectoderm (ExE) of E6.5 single embryos that underwent Dnm3a/3b knockout because preimplantation iXCI status maintains extraembryonic cells (Chen et al., 2019; Galupa and Heard, 2015; Schulz and Heard, 2013). The results showed that chromosome-wide loss of DNA methylation led to a nearly complete loss of H3k27me3 on paternal (specifically inactivated in iXCI), along with a notable transcriptional upregulation cross the chromosome. By contrast, these changes cannot be not observed on maternal X chromosome. (Lines 253-261; Figure 3—figure supplement 4A in the revised manuscript)

      - Lines 169-174: sentence/message unclear.

      As aforementioned, we have reorganized this paragraph by rewriting or adding relevant statements relevant to the DNA methylation and XCI, to make the background and discussion clearer and easier to be understood (Lines 217-234 in the revised manuscript). In addition, to avoid repeated statement and make our discussion more concise, we have removed the similar sentences at the end of this paragraph.

      - Lines 177-179: this statement is too bold. The data does not support "direct evidence".

      Thank you for your detailed reminder. We have rewritten the sentence to avoid confusion and overstatement (Lines 262-268 in the revised manuscript).

      - Line 198: these are not all enzymes, but could be referred to as chromatin modifiers.

      We apologize for the ambiguous description. As you suggested, we have corrected “enzymes” to “chromatin modifiers” (Lines 284, 287 in the revised manuscript).

      - Line 199: this statement is not correct in all contexts. There are many studies showing antagonism between DNA methylation and H3K27me3.

      Thanks so much for you careful reviewing. As you have pointed out, the relationship of DNA methylation and H3K27me3 are divergent and largely controversial among studies. Under certain circumstances, DNA methylation shows antagonistic effect to H3K27me3 at promoters, via excluding the binding of PRC2 (the main complex responsible for H3K27me3 deposition) components to their targets (Bartke et al., 2010; Jermann et al., 2014), while other studies have presented alternative evidence that PRC2 (the main complex responsible for H3K27me3 deposition) and DNA methylation cooperate to achieve silencing (Hagarman et al., 2013; Vire et al., 2006). Thus, it has been thought that the relationship between DNA and methylation and histone modifications is complex, possibly in a cell-type and/or genomic region-specific manner. Both antagonism and coordination can be observed in different regulatory elements in mouse ES cells (King et al., 2016).

      We apologize our incomplete statement because we mainly focused on their synergistic relationship. We have refined this section by rewriting relevant sentences and adding necessary statements (Lines 288-303 in the revised manuscript).

      - Lines 228-230: the developmental significance of DNA methylation homeostasis is already well-established. Please reference relevant papers showing this here.

      Thank you for this helpful suggestion. We have reorganized this section. Relevant references that highlight the developmental significance of DNA methylation homeostasis have added. The sentence has been rewritten and moved to the end of this paragraph, in the revised manuscript (Lines 159-161 in the revised manuscript).

      - Line 238: an explanation/rationale for looking at energy metabolism is lacking.

      Thank you for your comments to make our results earlier to be understood. The detection of energy metabolism is mainly based on the integrated analysis of DNA methylation and gene expression from the 8-cell embryos to ICM, to test the potential short-and long-term developmental consequences of minor de novo DNA methylation. Bioinformatic analysis suggested that many basic processes, such as cell differentiation, cell cycle and metabolic regulation, may be regulated by minor de novo DNA methylation. Among the enriched genes, several are related energy metabolism. In addition, because energy metabolism is crucial for supporting embryo differentiation and development, and oxidative phosphorylation (OXPHOS) metabolism is highly activated during the blastocyst stage (Zhao et al., 2021), we next examined the energy metabolism, particularly OXPHOS activity, of Dnmt3b-KD embryos. We have refined the section by rewritten relevant sentence and added necessary statements (Lines 175-179 in the revised manuscript).

      - Lines 246-248: Looking at the data in Figure 2 figure supplement 2, this statement is simply not true with regards to DNMT3B protein, and also global DNA methylation level is reduced in the Dnmt3b KD blastocyst, which could lead to defective major de novo DNA methylation.

      Thanks for your careful reviewing, we have rewritten the sentence to make our statement more accurate and avoid overstatement (Lines 188-190 in the revised manuscript).

      Recommendations/concerns relating to figures:

      Figure 1:

      - Of all genic promoters, how many were included in the analysis (contained sufficient coverage)? What cut-off/thresholds were used to consider DNA methylation gain at a promoter?

      Thanks for your comments. In total, 11662 promoters were analyzed. Given that promoter methylation is generally at low level, particularly at the 8-cell stage at which minor de novo methylation is just initiated. The relatively lower basal levels make the increase before the blastocyst, seem considerably slight. To capture the slight changes, we have used the relaxed threshold based on ΔDNA methylation. Only CpG sites with at least fivefold coverage were included in the methylation analysis based on data from Smith et al. (Smith et al., 2012)., ΔDNA methylation greater or less than 0 was defined as gain or loss of DNA methylation. We have added this information in the revised manuscript (Lines 462-470 in the revised manuscript).

      - Does an average methylation level of 0.02 represent 2% DNA methylation? Presuming yes, is the average 1.5% DNA methylation gain at promoters real? And meaningful? Especially compared to the gain in DNA methylation that takes place between ICM and E6.5 (Figure 1 Figure Supplement 1 D)

      As you have pointed out, an average methylation level of 0.02 represent 2% DNA methylation. As aforementioned, promoters exhibited an average of 1.5% DNA methylation gain during the transition from 8-cell stage to ICM. The slight increase may be mainly due to the relatively lower basal levels. As you expected, compared with the comprehensive de novo DNA methylation during implantation, preimplantation de novo methylation occurs more slightly, at a small proportion of promoter regions, so designated it as minor de novo DNA methylation. It should be also mentioned that a proportion of these promoters continue to gain massive DNA methylation during implantation. We have refined the relevant sentences to provide more detailed information of our results (Lines 125-127 in the revised manuscript).

      - Why is there a focus on promoters (which are not the preferential target of DNMT3B)?

      Thanks so much for your detailed reminder. As you have pointed out, “preferential target” seems to be an inaccurate statement. besides of promoters, gene bodies and other elements also undergo de novo DNA methylation (Auclair et al., 2014; Dahlet et al., 2020; Duymich et al., 2016). We have focused on the promoter regions based on the following considerations: (1) Promoter regions are important target sites of DNMT3B (Choi et al., 2011); (2) The acquisition of DNA methylation in promoters, especially in intermediate and low CpG promoters, during implantation is largely dependent on DNMT3B and plays an important role in regulating developmental genes (Auclair et al., 2014; Borgel et al., 2010; Dahlet et al., 2020). We have rewritten the relevant sentence in the revised manuscript (Lines 100-106 in the revised manuscript).

      - Figure 1H shows that promoters that gain DNA methylation during the "minor de novo DNA methylation" continue to gain DNA methylation during "de novo DNA methylation". Is the ~1.5% DNA methylation gain just the slow start of the main de novo DNA methylation wave?

      Your comments is very helpful to improve the description of our results. In the present study, our analysis indicated that a small proportion of promoters initially gain methylation during the transition from the 8-cell to ICM. The finding challenges current knowledge: (1) de novo DNA methylation occurs during implantation, by which globally hypomethylated blastocysts acquire genome-wide DNA methylation (Borgel et al., 2010; Dahlet et al., 2020; Smith et al., 2012); (2) during preimplantation development, embryos undergo massive and global DNA demethylation.

      To distinguish the current knowledge of the timing and dynamics of DNA methylation during the early development, we have designated our finding during the transition from the 8-cell to blastocyst stage, as minor de novo DNA methylation.

      We agree with your notion that among the promoters undergoing minor de novo methylation, most of them continue to gain DNA methylation during implantation, as revealed in Fig. 1F. We have added refine the relevant statement in revised manuscript (Lines 125-127 in the revised manuscript).

      - The GO analysis performed for Figure 1H, what was used as input? Promoters of genes that gain DNA methylation as identified in 1C?

      Thank you for your comments. For the GO analysis shown in Figure 1H, we used genes with promoter regions that gained or lost DNA methylation during the transition from the 8-cell to ICM respectively (identified in Figure 1C, as input), respectively. This information has been clarified in the revised manuscript to ensure accuracy (Lines 129-134 in the revised manuscript).

      - Figure 1 figure supplement 1, is there only a fold change as threshold or also a calculated significance (eg. p-value/FDR)?

      Thanks for your valuable comments. Considering the relatively low DNA methylation levels at promoter regions, and the slightly changes occurring during the preimplantation embryo development, we used the relaxed threshold based on ΔDNA methylation. Only CpG sites with at least fivefold coverage were included in the methylation analysis based on data from Smith et al. (Smith et al., 2012), ΔDNA methylation greater or less than 0 was defined as gain or loss of DNA methylation. We have replaced relevant figures and added this information in the revised manuscript (Figure 1—figure supplement 1D-E; Lines 125-127 in the revised manuscript).

      - To confirm DNMT3B is responsible for the DNA methylation gain: DNMT3B KD/KO followed by promoter DNA methylation analysis to confirm the promoters that gain DNA methylation between 8 cell and ICM don't gain DNA methylation in the absence of DNMT3B.

      We agree with your comments that additional evidence will benefit the conclusion. To strengthen the evidence, we have reanalyzed the RNA-seq and H3K27me3 CHIP-seq data in extraembryonic ectoderm (ExE) of E6.5 single embryos that underwent Dnm3a/3b knockout because preimplantation iXCI status maintains extraembryonic cells (Chen et al., 2019; Galupa and Heard, 2015; Schulz and Heard, 2013). The results showed that chromosome-wide loss of DNA methylation led to a nearly complete loss of H3k27me3 on paternal (specifically inactivated in iXCI), which showed a notable transcriptional upregulation cross the chromosome. By contrast, these changes cannot be not observed on maternal X chromosome. We have added this result in the revised manuscript (Lines 253-261; Figure 3—figure supplement 4A in the revised manuscript).

      Figure 2:

      - Figure 2A: label missing for what the numbers on the y-axis represent.

      Thank you for pointing this out. We apologize for the oversight. We have added the label of y-axis in Figure 2A to clarify what the numbers represent, making it easier to be understood (Figure 3A in the revised manuscript).

      - Figure 2B: y-axis is % of methylated promoters compared to all promoters?

      Thank you for your suggestion. The y-axis in Figure 2B indeed represents the percentage of de novo methylated promoters relative to all promoters. As you have suggested, we have clarified this labeling in the revised manuscript (Figure 3B in the revised manuscript).

      - What is the delta DNA methylation gain specifically for X-linked promoters?

      Thanks so much for your reminder. To provide more convincing evidence. We have reanalyzed a single cell COOL-seq data, we also specifically reanalyzed the DNA methylation changes on the X chromosomal promoter in female embryos. The X chromosome showed a more notable increase in the de novo methylated promoters than that on autosomes, and the female X chromosome showed higher DNA methylation levels than that of the male (Figure 3—figure supplement 2A-B; Lines 203-206 in the revised manuscript).

      - Figure 2C: include representative images of separate channels to better see the signal of CDX2 and H3K27me3. Quantification would be better represented with box plots.

      Thank you for your helpful suggestions. We have added separate channel images in the revised manuscript. Additionally, we have adjusted the quantification to be represented as box plots, as you have suggested, to improve the accuracy and interpretability of the data presentation (Figure 3D-F in the revised manuscript).

      - Figure 2C: Does the H3K27me3 signal overlap with the location of the inactive X-chromosome (is there maybe denser DAPI or do IF combined with Xist RNA-FISH)?

      Thanks so much for your insightful comments. Despite the global enrichment of H3K27me3, the H3K27me3 domain detected by immunostaining is a classic marker for establishment of XCI by achieving X chromosome wide heterochromatinization of transcriptional depression (Chow and Heard, 2009; Heard et al., 2004; Huynh and Lee, 2005). Thus, we have used immunostaining for H3K27me3 domains to evaluate the iXCI establishment in the blastocysts, as previously reported (Fukuda et al., 2014; Gontan et al., 2018; Inoue et al., 2010; Tan et al., 2016). We have taken effort to perform co-staining of H3K27me3 IF and Xist FISH, but was hindered by the technical challenge, we wish to get your understanding. However, as we aforementioned, H3K27me3 is a well-accepted maker to clarify the XCI status.

      In addition, to make our results more convincing, we have added an alternative statistical method to quantify the establishment of iXCI, i.e., the percentage of H3K27me3-positive and -negative trophoblast cells to total trophoblast cells in female blastocysts subject to Dnmt3b knockdown or not (Figure 3F; Lines 243-244 in the revised manuscript)

      - Figure 2 figure supplement 2A: relative expression of Dnmt3b?

      Thanks for your detailed reminder. The data represent the relative expression level of Dnmt3b, as noted in the original figure legend. Based on your comments, we have added the gene name in the label of the Y-axis. Similarly, the protein name has been also added to make the results more informative (Figure 2 figure supplement 2A, C, E in the revised manuscript).

      - Figure 2 figure supplement 2B/C: in the text, line 153, it is stated that "Dnmt3b mRNA and protein levels were significantly reduced in morulae, but not in blastocysts compared to those of negative control (NC) group". These figures do not support that statement. The IF images show a loss of DNMT3B in the Dnmt3b KD blastocysts. The IF quantification seems to have fewer datapoints for the blastocyst, and looking at the bar graphs, there seems to be a trend towards reduced DNMT3B in both the morula and blastocyst, which would also explain the reduction in DNA methylation in both stages as shown in Figure 2 figure supplement 2D/E.

      Thanks so much for your careful reviewing that makes our statements more accurate. We have rewritten the sentence in the revised manuscript as follows: Dnmt3b mRNA and protein levels were significantly reduced in morulae, and tended to be lower in blastocysts compared to those of the negative control (NC) group. In addition, we have removed “transient” from the original statement “The transient inhibition of Dnmt3b” (Lines 168-170 in the revised manuscript).

      - Figure 2 figure supplement 2F/G: include representative IF images with separation of all channels and the merged image.

      Thank you for your suggestion. We have added the representative immunofluorescence (IF) images with separate channels and merged image in the revised manuscript (Figure 3—figure supplement 3B, F in the revised manuscript).

      - Figure 2 figure supplement 2H: Instead of showing log2FC in methylation levels, delta methylation would be more informative. Are these genes already inactivated at the 8-cell stage? Or are they active and become inactivated by the gain in DNA methylation? Doing qPCR for these genes, or looking at published RNAseq data would be informative. What happens to the expression of these genes in the Dnmt3b KD?

      Thanks for your suggestions. We have represented DNA methylation changes as “ΔDNA methylation”. During mouse preimplantation development, iXCI is initiated in earlier cleavage female embryos dependent on Xist upregulation around 4-8-cell stage, and then Xist specifically coats paternal X chromosome and finally leads to chromosome-wide silencing via heterochromatinization in early blastocysts. Thus, these non-escaping genes, which are subject to XCI, would not be inactivated at 8-cell stage

      Author response image 1.

      The processes of iXCI initiation and establishment (left panel), and dynamics of total expression levels of X chromosome in male and female preimplantation embryos (right panel, note that X-dosage is balanced between sexes until the early blastocyst stage).

      As you expected, most of these representative non-escaping is downregulated upon the transition of 8-cell to blastocyst stage, consistent with their gain of DNA methylation. Additionally, since preimplantation iXCI status maintains extraembryonic cells (Galupa and Heard, 2015; Schulz and Heard, 2013), we further reanalyzed the published RNA-seq data in extraembryonic ectoderm (ExE) of E6.5 single embryos that underwent DNA methyltransferase knockout (Chen et al., 2019). The results showed that chromosome-wide loss of DNA methylation led to a chromosome-wide transcriptional upregulation, including the locus of these non-escaping genes, on paternal X chromosome. We have added this result in the revised manuscript (Figure 3—figure supplement 3J; Figure 3—figure supplement 4A-B; Lines 253-261 in the revised manuscript).

      Figure 3:

      - Figure 3 figure supplement 1: representative IF image missing.

      Thanks for your kind reminder. We have added the representative IF images in the revised manuscript to provide a clearer illustration of the data (Figure 4—figure supplement 1A in the revised manuscript).

      - Figure 3 figure supplement 2B: scales are missing for the H3K27me3 ChIP-seq data (are the 8-cell and ICM tracks set to the same scale?). It looks like the ICM track is cut off at the top (peaks not fully displayed) and the data looks very sparse. A more informative analysis would be to do peak calling over promoters and compare 8-cell with ICM.

      Thanks for your detailed reminder. We apologize for the missing of scale bars in the H3K27me3 ChIP-seq data. The 8-cell and ICM tracks were set to the same scale, and we have now added scales to the figure in the revised manuscript to improve the result presentation. As you have speculated, the visual effect of the flatted peak is not caused by track cutting off, but rather by zooming into a specific region in the extended IGV files.

      These results are based on the reanalysis of publicly available data of pooled embryos, which just provided suggestive but not direct evidence to support the role of DNA methylation in promoting X-linked H3K27me3 enrichment in iXCI.

      To provide more convincing evidence. we have reanalyzed the RNA-seq and H3K27me3 CHIP-seq data in extraembryonic ectoderm (ExE) of E6.5 female embryos that underwent Dnmt3a/3b knockout because preimplantation iXCI status maintains extraembryonic cells (Chen et al., 2019; Galupa and Heard, 2015; Schulz and Heard, 2013). The results showed that Dnmt knockout led to a nearly complete loss of H3k27me3 on paternal (specifically inactivated in iXCI), which showed a notable transcriptional upregulation cross the chromosome. By contrast, these changes cannot be not observed on maternal X chromosome (Figure 3—figure supplement 4 in the revised manuscript). We have added these results in the revised manuscript.

      - Figure 3E: Given all tested proteins give a positive signal, it would have been good to include a negative control chromatin protein that is known to not interact with DNMT3B. Given both PRC2 and DNMT3B are chromatin-binding proteins, can the signal be a result of close proximity instead of a direct interaction?

      In the present study, to test the interaction between DNMT3B and PRC2 core components, we have used in situ proximity ligation assay (PLA), an increasingly popular technique for detecting the close proximity of two proteins in fixed samples using two primary antibodies (Alsemarz et al., 2018).

      Author response image 2.

      Schematic diagram of the principle of the in situ PLA.

      Compared with classical co-Immunoprecipitation (Co-IP) method, in situ PLA has advantages in (1) detecting low input samples or proteins expressed at low levels, which is extremely difficult using Co-IP; (2) providing in situ or subcellular information of protein-protein interaction. However, it should be noted that the maximal distance allowing this reaction is 40 nm, which is not quite small enough to demonstrate a physical interaction between the two antigens, but sufficient to support a very close “proximity”.

      In our study, in situ PLA, including the experimental design of negative control, was performed in the accordance with the manufacturer’s instruction of Duolink® In Situ Red Starter Kit (MilliporeSigma): “Technical negative controls included incubation with each primary antibody separately and no primary antibody”. We have refined the relevant sentence in the revised manuscript (Lines 308-310 in the revised manuscript)

      - Figure 3G: It would have been good to include a negative control, and DNase/benzonase to exclude DNA/RNA-mediated protein interaction.

      - (Of note, there have been previous studies reporting an interaction between PRC2 and DNMT3B in other cell types, such as in Weigert et al. 2023, but unfortunately, they don't seem to use DNase/benzonase either).

      The Co-IP analysis of DNMT3B and PRC2 core components in differentiated female ES cells was presented as additional supportive evidence. Because the Co-IP analysis is extremely difficult for preimplantation embryos, we have used in situ PLA to detect their interaction. However, the maximal distance allowing in situ PLA reaction is 40 nm, which is not quite small enough to demonstrate a physical interaction (Alsemarz et al., 2018). Thus, we have added a Co-IP analysis using differentiated female ES cells, in which rXCI occurs upon the differentiation.

      Based on this consideration of the importance and contribution of this result, we have moved this result from the main figure, to the supplemental figure (Figure 4—figure supplement 3H in the revised manuscript).

      - Figure 3 figure supplement 3G: what were the ESCs differentiated into? Did the Dnmt3b KO or Dnmt3a/b DKO show any differentiation defect?

      The mouse ESC line PGK12.1 was a well-established ex vivo model of rXCI. Under the standard culture condition, PGK12.1 is normally fated to neuroectodermal commitment.

      Author response image 3.

      Immunostaining of NESTIN, a neuroectodermal stem cell marker molecule, and NANOG in undifferentiated and differentiated PGK12.1 ESCs respectively.

      No differentiation defects have been observed in either Dnmt3b KO or Dnmt3a/3b DKO ESCs in our study. Dnmt KO/DKO/TKO ES cell lines have been successfully used as the model of interaction of DNA methylation and H3K27me3 deposition (King et al., 2016).

      Figure 4:

      - Figure 4B: Is there an explanation for seeing similar total cell numbers in Figure 4B, but showing decreased proliferation in Figure 4A?

      Thank you for your insightful comments. The EdU cell proliferation assays labels cells during the S phase of cell cycle, as the 5-ethynyl 2´-deoxyuridine (EdU) is incorporated into newly synthesized DNA. This labeling identifies cells undergoing DNA synthesis, but these cells may not have completed mitosis at the time of detection. As a result, the total cell number may not immediately reflect the decrease in proliferation observed in the treated group. To address this point, we have rewritten the sentences in the revised manuscript (Lines 174-175 in the revised manuscript).

      References

      Alsemarz, A., Lasko, P. and Fagotto, F. J. B. (2018). Limited significance of the in situ proximity ligation assay. bioRxiv, 411355.

      Auclair, G., Guibert, S., Bender, A. and Weber, M. (2014). Ontogeny of CpG island methylation and specificity of DNMT3 methyltransferases during embryonic development in the mouse. Genome Biol. 15, 545.

      Balaton, B. P. and Brown, C. J. (2021). Contribution of genetic and epigenetic changes to escape from X-chromosome inactivation. Epigenetics Chromatin 14, 30.

      Bartke, T., Vermeulen, M., Xhemalce, B., Robson, S. C., Mann, M. and Kouzarides, T. (2010). Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 143, 470-484.

      Borgel, J., Guibert, S., Li, Y., Chiba, H., Schubeler, D., Sasaki, H., Forne, T. and Weber, M. (2010). Targets and dynamics of promoter DNA methylation during early mouse development. Nat. Genet. 42, 1093-1100.

      Chen, Z., Yin, Q., Inoue, A., Zhang, C. and Zhang, Y. (2019). Allelic H3K27me3 to allelic DNA methylation switch maintains noncanonical imprinting in extraembryonic cells. Sci Adv 5, eaay7246.

      Chiba, H., Hirasawa, R., Kaneda, M., Amakawa, Y., Li, E., Sado, T. and Sasaki, H. (2008). De novo DNA methylation independent establishment of maternal imprint on X chromosome in mouse oocytes. Genesis 46, 768-774.

      Choi, S. H., Heo, K., Byun, H. M., An, W., Lu, W. and Yang, A. S. (2011). Identification of preferential target sites for human DNA methyltransferases. Nucleic Acids Res. 39, 104-118.

      Chow, J. and Heard, E. (2009). X inactivation and the complexities of silencing a sex chromosome. Curr. Opin. Cell Biol. 21, 359-366.

      Dahlet, T., Argueso Lleida, A., Al Adhami, H., Dumas, M., Bender, A., Ngondo, R. P., Tanguy, M., Vallet, J., Auclair, G., Bardet, A. F., et al. (2020). Genome-wide analysis in the mouse embryo reveals the importance of DNA methylation for transcription integrity. Nat Commun 11, 3153.

      Duymich, C. E., Charlet, J., Yang, X. J., Jones, P. A. and Liang, G. N. (2016). DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells. Nat Commun 7, 11453.

      Fukuda, A., Tomikawa, J., Miura, T., Hata, K., Nakabayashi, K., Eggan, K., Akutsu, H. and Umezawa, A. (2014). The role of maternal-specific H3K9me3 modification in establishing imprinted X-chromosome inactivation and embryogenesis in mice. Nat Commun 5, 5464.

      Galupa, R. and Heard, E. (2015). X-chromosome inactivation: new insights into cis and trans regulation. Curr. Opin. Genet. Dev. 31, 57-66.

      Gontan, C., Mira-Bontenbal, H., Magaraki, A., Dupont, C., Barakat, T. S., Rentmeester, E., Demmers, J. and Gribnau, J. (2018). REX1 is the critical target of RNF12 in imprinted X chromosome inactivation in mice. Nat Commun 9, 4752.

      Hagarman, J. A., Motley, M. P., Kristjansdottir, K. and Soloway, P. D. (2013). Coordinate regulation of DNA methylation and H3K27me3 in mouse embryonic stem cells. PLoS One 8, e53880.

      Heard, E., Chaumeil, J., Masui, O. and Okamoto, I. (2004). Mammalian X-chromosome inactivation: an epigenetics paradigm. Cold Spring Harb. Symp. Quant. Biol. 69, 89-102.

      Huynh, K. D. and Lee, J. T. (2005). X-chromosome inactivation: a hypothesis linking ontogeny and phylogeny. Nat. Rev. Genet. 6, 410-418.

      Inoue, A., Jiang, L., Lu, F. and Zhang, Y. (2017). Genomic imprinting of Xist by maternal H3K27me3. Genes Dev. 31, 1927-1932.

      Inoue, K., Kohda, T., Sugimoto, M., Sado, T., Ogonuki, N., Matoba, S., Shiura, H., Ikeda, R., Mochida, K., Fujii, T., et al. (2010). Impeding Xist expression from the active X chromosome improves mouse somatic cell nuclear transfer. Science 330, 496-499.

      Jermann, P., Hoerner, L., Burger, L. and Schubeler, D. (2014). Short sequences can efficiently recruit histone H3 lysine 27 trimethylation in the absence of enhancer activity and DNA methylation. Proc. Natl. Acad. Sci. U. S. A. 111, E3415-3421.

      King, A. D., Huang, K., Rubbi, L., Liu, S., Wang, C. Y., Wang, Y., Pellegrini, M. and Fan, G. (2016). Reversible Regulation of Promoter and Enhancer Histone Landscape by DNA Methylation in Mouse Embryonic Stem Cells. Cell Rep. 17, 289-302.

      Maslov, A. Y., Lee, M., Gundry, M., Gravina, S., Strogonova, N., Tazearslan, C., Bendebury, A., Suh, Y. and Vijg, J. (2012). 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1. Oncogene 31, 5172-5179.

      Oikawa, M., Inoue, K., Shiura, H., Matoba, S., Kamimura, S., Hirose, M., Mekada, K., Yoshiki, A., Tanaka, S., Abe, K., et al. (2014). Understanding the X chromosome inactivation cycle in mice: a comprehensive view provided by nuclear transfer. Epigenetics-Us 9, 204-211.

      Oka, M., Meacham, A. M., Hamazaki, T., Rodic, N., Chang, L. J. and Terada, N. (2005). De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine. Oncogene 24, 3091-3099.

      Pintacuda, G. and Cerase, A. (2015). X Inactivation Lessons from Differentiating Mouse Embryonic Stem Cells. Stem Cell Rev Rep 11, 699-705.

      Schulz, E. G. and Heard, E. (2013). Role and control of X chromosome dosage in mammalian development. Curr. Opin. Genet. Dev. 23, 109-115.

      Smith, Z. D., Chan, M. M., Mikkelsen, T. S., Gu, H. C., Gnirke, A., Regev, A. and Meissner, A. (2012). A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 484, 339-344.

      Tada, T., Obata, Y., Tada, M., Goto, Y., Nakatsuji, N., Tan, S., Kono, T. and Takagi, N. (2000). Imprint switching for non-random X-chromosome inactivation during mouse oocyte growth. Development 127, 3101-3105.

      Tan, K., An, L., Miao, K., Ren, L., Hou, Z., Tao, L., Zhang, Z., Wang, X., Xia, W., Liu, J., et al. (2016). Impaired imprinted X chromosome inactivation is responsible for the skewed sex ratio following in vitro fertilization. Proc. Natl. Acad. Sci. U. S. A. 113, 3197-3202.

      Vire, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J. M., et al. (2006). The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874.

      Zhao, J., Yao, K., Yu, H., Zhang, L., Xu, Y., Chen, L., Sun, Z., Zhu, Y., Zhang, C., Qian, Y., et al. (2021). Metabolic remodelling during early mouse embryo development. Nat Metab 3, 1372-1384.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1

      (1) In the "Introduction" section, an important aspect that requires attention pertains to the discussion surrounding the heterodimerization of CXCR4 and CCR5. Notably, the manuscript overlooks a recent study (https://doi.org/10.1038/s41467-023-42082-z) elucidating the mechanism underlying the formation of functional dimers within these G protein-coupled receptors (GPCRs)…The inclusion of this study within the manuscript would significantly enrich the contextual framework of the work, offering readers a comprehensive understanding of the current knowledge surrounding the structural dynamics and functional implications of CXCR4 and CCR5 heterodimerization.

      We thank the reviewer for his/her recommendation to enrich the contextual framework of our study. The Nature Communications paper by Di Marino et al. was published after we sent the first version of our manuscript to eLife, and therefore was not included in the discussion. As the reviewer rightly indicates, this paper elucidates the mechanism underlying the formation of functional dimers within CCR5 and CXCR4. Using metadynamics approaches, the authors emphasize the importance of distinct transmembrane regions for dimerization of the two receptors. In particular, CXCR4 shows two low energy dimer structures and the TMVI-TMVII helices are the preferred interfaces involved in the protomer interactions in both cases. Although the study uses in silico techniques, it also includes the molecular binding mechanism of CCR5 and CXCR4 in the membrane environment, as the authors generate a model in which the receptors are immersed in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) phospholipid bilayer with 10% cholesterol. This is an important point in this study, as membrane lipids also interact with membrane proteins, and the lipid composition affects CXCR4 oligomerization (Gardeta S.R. et al. Front. Immunol. 2023). In particular, Di Marino et al. find a cholesterol molecule placed in-between the two CXCR4 protomers where it engages a series of hydrophobic interactions with residues including Leu132, Val214, Leu216 and Phe249. Then, the polar head of cholesterol forms an H-bond with Tyr135 that further stabilizes protomer binding. In our hands, the F249L mutation in CXCR4 reverted the antagonism of AGR1.137, suggesting that the compound binds, among others, this residue. We should, nonetheless, indicate that we analyzed receptor oligomerization and not CXCR4 dimerization, which was the main object of the Di Marino et al. study. It is therefore also plausible that other residues than those described as essential for CXCR4 dimerization might participate in receptor oligomerization. We can speculate that AGR1.137 might affect cholesterol binding to CXCR4 and, therefore, alter dimerization/oligomerization. Additionally, the CXCR4 x-ray structure with PDB code 3ODU (Wu B. et al. Science, 2010) experimentally shows the presence of two fatty acid molecules in contact with both TMV and TMVI. These molecules closely interact with hydrophobic residues in the protein, thereby stabilizing it in a hydrophobic environment. Although more experiments will be needed to clarify the mechanism involved, our results suggest that cholesterol and/or other lipids also play an important role in CXCR4 oligomerization and function, as seen for other GPCRs (Jakubik J. & ElFakahani E.E. Int J Mol Sci. 2021). However, we should also consider that other factors not included in the analysis by Di Marino et al. can also affect CXCR4 oligomerization; for instance, the co-expression of other chemokine receptors and/or other GPCRs that heterodimerize with CXCR4 might affect CXCR4 dynamics at the cell membrane, similar to other membrane proteins such as CD4, which also forms complexes with CXCR4 (Martinez-Muñoz L. et al. Mol. Cell 2018).

      The revised discussion contains references to the study by Di Marino et al. to enrich the contextual framework of our data.

      (2) In "various sections" of the manuscript, there appears to be confusion surrounding the terminology used to refer to antagonists. It is recommended to provide a clearer distinction between allosteric and orthosteric antagonists to enhance reader comprehension. An orthosteric antagonist typically binds to the same site as the endogenous ligand, directly blocking its interaction with the receptor. On the other hand, an allosteric antagonist binds to a site distinct from the orthosteric site, inducing a conformational change in the receptor that inhibits the binding of the endogenous ligand. By explicitly defining the terms "allosteric antagonist" and "orthosteric antagonist" within the manuscript, readers will be better equipped to discern the specific mechanisms discussed in the context of the study.

      The behavior of the compounds described in our manuscript (AGR1.35 and AGR1.137) fits with the definition of allosteric antagonists, as they bind on a site distinct from the orthosteric site, although they only block some ligand-mediated functions and not others. This would mean that they are not formally antagonists and should be not considered as allosteric compounds, as their binding on CXCR4 does not alter CXCL12 binding, although they might affect its affinity. In this sense, our compounds respond much better to the concept of negative allosteric modulators (Gao Z.-G. & Jacobson K.A. Drug Discov. Today Technol. 2013). They act by binding on a site distinct from the orthosteric site and selectively block some downstream signaling pathways but not others induced by the same endogenous agonist.

      To avoid confusion and to clarify the role of the compounds described in this study, we now refer to them as negative allosteric modulators along the manuscript.

      (3) In the Results section, the computational approach employed for "screening small compounds targeting CXCR4, particularly focusing on the inhibition of CXCL12-induced CXCR4 nanoclustering", requires clarification due to several points of incomprehension. The following recommendations aim to address these concerns and enhance the overall clarity of the section:

      (1) Computational Approach and Binding Mode Description: 

      -Explicitly describe the methodology for identifying the pocket/clef area in angstroms (Å) on the CXCR4 protein structure. Include details on how the volume of the cleft enclosed by TMV and TMVI was determined, as this information is not readily apparent in the provided reference (https://doi.org/10.1073/pnas.1601278113).

      The identification of the cleft was based on the observations by Wu et al. (Wu B. et al. Science 2010) who described the presence of bound lipids in the area formed by TMV and VI, and those of Wescott et al. (Wescott M.P. et al. Proc. Natl. Acad. Sci. 2016) on the importance of TMVI in the transmission of conformational changes promoted by CXCL12 on CXCR4 towards the cytoplasmic surface of the receptor to link the binding site with signaling activation. Collectively, these results, and our previous data on the critical role of the N-terminus region of TMVI for CXCR4 oligomerization (Martinez-Muñoz L. et al. Mol. Cell 2018), focused our in silico screening to this region. Once we detected that several compounds bound CXCR4 in this region, the cleavage properties were calculated by subtracting the compound structure. The resulting PDB was analyzed using the PDBsum server (Laskowski R.A. et. al. Protein Sci. 2018). Volume calculations were obtained using the server analyzing surface clefts by SURFNET (Laskowski R. A. J. Mol. Graph. 1995). The theoretical interaction surface between the selected compounds and CXCR4 and the atomic distances between the protein residues and the compounds was calculated using the PISA server (Krissinel E. & Henrick K. J. Mol. Biol. 2007) (Fig. I, only for review purposes). The analysis of the cleft occupied by AGR1.135 showed two independent cavities of 434 Å3 and 1,381 Å3 that were not connected to the orthosteric site. In the case of AGR1.137, the data revealed two distinct clefts of 790 Å3 and 580 Å3 (Fig. I, only for review purposes). These details have been included in the revised manuscript (New Fig. 1A, Supplementary Fig 8A, B).

      (4) Clarify the statement regarding the cleft being "surface exposed for interactions with the plasma membrane," particularly in the context of its embedding within the membrane.

      For GPCRs, transmembrane domains represent binding sites for bioactive lipids that play important functional and physiological roles (Huwiler A. & Zangemeister-Wittke U. Pharmacol. Ther. 2018). The channel between TMV and TMVI connects the orthosteric chemokine binding pocket to the lipid bilayer and is occupied by an oleic acid molecule, according to the CXCR4 structure published in 2010 (Wu B. et al. Science 2010). In addition, the target region contains residues involved in cholesterol (and perhaps other lipids) engagement (Di Marino et al. Nat. Commun. 2023). Taken together, these data support our statement that the cleft supports interactions between CXCR4 molecules and the plasma membrane. 

      Moreover, the data of Di Marino et al. also support that CCR5 and CXCR4 have a symmetric and an asymmetric binding mode. Therefore, either dimeric structure has the possibility to form trimers, tetramers, and even oligomers by using the free binding interface to complex with another protomer. This hypothesis suggests that the interaction of dimers to form oligomers should involve residues distinct from those included in the dimeric conformation.

      The sentence has been modified in the revised manuscript to clarify comprehension.

      (5) Discuss the rationale behind targeting the allosteric binding pocket instead of the orthosteric pocket, outlining potential advantages and disadvantages.

      The advantages and disadvantages of using negative allosteric modulators vs orthosteric antagonists have been now included in the revised discussion. 

      The majority of GPCR-targeted drugs function by binding to the orthosteric site of the receptor, and are agonists, partial agonists, antagonists or inverse agonists. These orthosteric compounds can have off-target effects and poor selectivity due to highly homologous receptor orthosteric sites and to abrogation of spatial and/or temporal endogenous signaling patterns. 

      The alternative is to use allosteric modulators, which can tune the functions associated with the receptors without affecting the orthosteric site. They can be positive, negative or neutral modulators, depending on their effect on the functionality of the receptor (Foster D.J. & Conn P.J. Neuron 2017). For example, the use of a negative allosteric modulator of a chemokine receptor to dampen pathological signaling events, while retaining full signaling for non-pathological activities might limit adverse effects (Kohout T.A.et al. J. Biol. Chem. 2004). In this case, the negative allosteric modulator 873140 blocks CCL3 binding on CCR5 but does not alter CCL5 binding (Watson C. et al. Mol. Pharmacol. 2005). In other cases, allosteric modulators can stabilize a particular receptor conformation and block others. The mechanism of action of the anti-HIV-1, FDAapproved, CCR5 allosteric modulator, maraviroc (Jin J. et al. Sci. Signal. 2018) is attributed to its ability to modulate CCR5 dimer populations and their subsequent subcellular trafficking and localization to the cell membrane (Jin J .et al. Sci. Signal. 2018). Two CCR5 dimeric conformations that are imperative for membrane localization were present in the absence of maraviroc; however, an additional CCR5 dimer conformation was discovered after the addition of maraviroc, and all homodimeric conformations were further stabilized. This finding is consistent with the observation that CCR5 dimers and oligomers inhibit HIV host-cell entry, likely by preventing the HIV-1 co-receptor formation.

      It is well known that GPCRs activate G proteins, but they also recruit additional proteins (e.g., β-arrestins) that induce signaling cascades which, in turn, can direct specific subsets of cellular responses independent of G protein activation (Eichel K. et al. Nature 2018) and are responsible for either therapeutic or adverse effects. Allosteric modulators can thus be used to block these adverse effects without influencing the therapeutic benefits. This was the case in the design of G protein-biased agonists for the kappa opioid receptor, which maintain the desirable antinociceptive and antipruritic effects and eliminate the sedative and dissociative effects in rodent models (Brust T.F. et al. Sci. Signal 2016).

      (6) Provide the PDB ID of the CXCR4 structure used as a template for modeling with SwissModel. Explain the decision to model the structure from the amino acid sequence and suggest an alternative approach, such as utilizing AlphaFold structures and performing classical molecular dynamics with subsequent clustering for the best representative structure.

      The PDB used as a template for modeling CXCR4 was 3ODU. This information was already included in the material and methods section. At the time we performed these analyses, there were several crystallographic structures of CXCR4 in complex with different molecules and peptides deposited at the PDB. None of them included a full construct containing the complete receptor sequence to provide a suitable sample for Xray structure resolution, as the N- and C-terminal ends of CXCR4 are very flexible loops. In addition, the CXCR4 constructs contained T4 lysozyme inserted between helices TMV and TMVI to increase the stability of the protein––a common strategy used to facilitate crystallogenesis of GPCRs (Zou Y. et al. PLoS One 2012). Therefore, we generated a CXCR4 homology model using the SWISS-MODEL server (Waterhouse A. et al. Nucleic Acids Res. 2018). This program reconstructed the loop between TMV and TMVI, a domain particularly important in this study that was not present in any of the crystal structure available in PDB. The model structure was, nonetheless, still incomplete, as it began at P27 and ended at S319 because the terminal ends were not resolved in the crystal structure used as a template. Nevertheless, we considered that these terminal ends were not involved in CXCR4 oligomerization. 

      As Alphafold was not available at the time we initiated this project, we didn’t use it. However, we have now updated our workflow to current methods and predicted the structure of the target using AlphaFold (Jumper J. et al. Nature 2021) and the sequence available under UniProt entry P61073. We prepared the ligands using OpenBabel (O’Boyle N.M. et al., J. Cheminformatics 2011), with a gasteiger charge assignment, and generated 10 conformers for each input ligand using the OpenBabel genetic algorithm. We then prepared the target structure with Openmm, removing all waters and possible heteroatoms, and adding all missing atoms. We next predicted the target binding pockets with fPocket (Le Guilloux V. et al. BMC Bioinformatics 2009), p2rank (Krivak R. & Hoksza, J. Cheminformatics 2018), and AutoDock autosite (Ravindranath P.A. & Sanner M.F. Bioinformatics 2016). We chose only those pockets between TMV and TMVI (see answer to point 3). We merged the results of the three programs into so-called consensus pockets, as two pockets are said to be sufficiently similar if at least 75% of their surfaces are shared (del Hoyo D. et al. J. Chem. Inform. Model. 2023). From the consensus pockets, there was one pocket that was significantly larger than the others and was therefore selected. We then docked the ligand conformers in this pocket using AutoDock GPU (Santos-Martins D. et al. J. Chem. Theory Comput. 2021), LeDock (Liu N & Xu Z., IOP Conf. Ser. Earth Environ. Sci. 2019), and Vina (Eberhardt J. et al. J. Chem. Inf. Model. 2021). The number of dockings varied from 210 to 287 poses. We scored each pose with the Vina score using ODDT (Wójcikowski M. et al. J. Cheminform. 2015). Then, we clustered the different solutions into groups whose maximum RMSD was 1Å. This resulted in 40 clusters, the representative of each cluster was the one with maximum Vina score and confirmed that the selected compounds bound this pocket (Author response image 1). When required, we calculated the binding affinity using Schrodinger’s MM-GBSA procedure (Greenidge P.A. et al. J. Chem. Inf. Model. 2013), in two ways: first, assuming that the ligand and target are fixed; second, with an energy minimization of all the atoms within a distance of 3Å from the ligand. This information has now been included in the revised version of the manuscript.

      Author response image 1.

      AGR1.135 docking in CXCR4 using the updated protocol for ligand docking. Cartoon representation colored in gray with TMV and TMVI shown in blue and pink, respectively. AGR1.135 is shown in stick representation with carbons in yellow, oxygens in red and nitrogens in blue.

      (7) Specify the meaning of "minimal interaction energy" and where (if present) the interaction scores are reported in the text.

      We refer to minimal interaction energy, the best docking score, that is, the best score obtained in our docking studies. These data were not included in the previous manuscript due to space restrictions but are now included in the reviewed manuscript.

      (8) You performed docking studies using GLIDE to identify potential binding sites for the small compounds on the CXCR4 protein. The top-scoring binders were then subjected to further refinement using PELE simulations. However, I realize that a detailed description of the specific binding modes of these compounds was not provided in the text. Please make the description of binding poses more detailed

      Firstly, to assess the reliability of this method, a PELE study was carried out for the control molecule IT1t, which is a small drug-like isothiourea derivative that has been crystallized in complex with CXCR4 (PDB code: 3ODU). IT1t is a CXCR4 antagonist that binds to the CXCL12 binding cavity and inhibits HIV-1 infection (Das D. Antimicrob. Agents Chemother. 2015; Dekkers S. et al. J. Med. Chem. 2023). From the best five trajectories, two of them had clearly better binding energies, and corresponded to almost the same predicted pose of the molecule. Although the predicted binding mode was not exactly the same as the one in the crystal structure, the approximation was very good, giving validation to the approach. Although PELE is a suitable technique to find potential binding sites, the predicted poses must be subsequently refined using docking programs.

      Analyzing the best trajectories for the remaining ligands, at least one of the best-scored poses was always located at the orthosteric binding site of CXCR4. Even though these poses showed good binding energies, they were discarded as the in vitro biological experiments indicated that the compounds were unable to block CXCL12 binding or CXCL12-mediated inhibition of cAMP release or CXCR4 internalization. Collectively, these data indicated that the selected compounds did not behave as orthosteric inhibitors of CXCR4. The CXCL12 binding pocket is the biggest cavity in CXCR4, and so PELE may tend to place the molecules near it. However, all the compounds presented other feasible binding sites with a comparable binding energy.

      AGR1.135 and AGR1.137 showed interesting poses between TMV and TMVI with very good binding energy (-51.4 and -37.2 kcal/mol, respectively). This was precisely the region we had previously selected for the in silico screening, as previously described (see response to point 3).

      AGR1.131 showed two poses with low binding energy that were placed between helices TMI and TMVII (-43.6 kcal/mol) and between helices TMV and TMVI (-39.8 kcal/mol). This compound was unable to affect CXCL12-mediated chemotaxis and was therefore used as an internal negative control as it was selected in the in silico screening with the same criteria as the other compounds but failed to alter any CXCL12-mediated functions. PELE studies nonetheless provided different binding sites for each molecule, which had to be further studied using docking to obtain a more accurate binding mode. In agreement with the previous commentary, we repeated the analysis using AlphaFold and the rest of the procedure described (see our response to point 6) and calculated the binding energies for all the compounds using Schrodinger’s MM-GBSA procedure (Greenidge P.A. et al. J. Chem. Inf. Model. 2013). Calculations were performed in two ways: first, assuming that the ligand and target are fixed; second, with an energy minimization of all the atoms within a distance of 3Å from the ligand. The results using the first method indicated that AGR1.135 and AGR1.137 showed poses between TMV and TMVI with - 56.4 and -62.4 kcal/mol, respectively and AGR1.131 had a pose between TMI and TMVII with -61.6kcal/mol.  In the second method AGR1.135 and AGR1.137 showed poses between TMV and TMVI with -57.9, and -67.6 kcal/mol, respectively, and AGR1.131 of -62.2 kcal/mol between TMI and TMVII.

      This information is now included in the text.

      (9) (2) Experimental Design:-Justify the choice of treating Jurkat cells with a concentration of 50 μM of the selected compound. Consider exploring different concentrations and provide a rationale for the selected dosage. Additionally, clearly identify the type of small compound used in the initial experiment.

      The revised version contains a new panel in Fig. 1B to show a more detailed kinetic analysis with different concentrations (1-100 µM) of the compounds in the Jurkat migration experiments. In all cases, 100 µM nearly completely abrogated cell migration, but in order to reduce the amount of DMSO added to the cells we selected 50 µM for further experiments, as it was the concentration that inhibits 50-75% of ligand-induced cell migration. Regarding the type of small compounds used in the initial experiments, they were compounds included in the library described in reference #24 (Sebastian-Pérez V. et al Med. Biol. Chem. 2017), which contains heterocyclic compounds. We would note that we do not consider AGR1.137 a final compound. We think that there is scope to develop AGR1.137-based second-generation compounds with greater solubility in water, greater specificity or affinity for CXCR4, and to evaluate delivery methods to hopefully increase activity.  

      (10) Avoid reporting details in rounded parentheses within the text; consider relocating such information to the Materials and Methods section or figure captions for improved readability.

      Most of the rounded parentheses within the text have been eliminated in the revised version of the manuscript to improve readability.

      (11) Elaborate on the virtual screening approach using GLIDE software, specifying the targeted site and methodology employed.

      For the virtual screening, we used the Glide module (SP and XP function scoring) included in the Schrödinger software package, utilizing the corresponding 3D target structure and our MBC library (Sebastián-Pérez V et al. J. Chem. Inf. Model. 2017).  The center of the catalytic pocket was selected as the centroid of the grid. In the grid generation, a scaling factor of 1.0 in van der Waals radius scaling and a partial charge cutoff of 0.25 were used. A rescoring of the SP poses of each compound was then performed with the XP scoring function of the Glide. The XP mode in Glide was used in the virtual screening, the ligand sampling was flexible, epik state penalties were added and an energy window of 2.5 kcal/mol was used for ring sampling. In the energy minimization step, the distance-dependent dielectric constant was 4.0 with a maximum number of minimization steps of 100,000. In the clustering, poses were considered as duplicates and discarded if both RMS deviation is less than 0.5 Å and maximum atomic displacement is less than 1.3 Å.

      (12) Provide clarity on the statement that AGR1.131 "theoretically" binds the same motif, explaining the docking procedure used for this determination.

      In the in silico screening, AGR1.131 was one of the 40 selected compounds that showed, according to the PELE analysis (see answer to point 8), a pose with low binding energy (-39.8 kcal/mol) between TMV and TMVI helices, which is the selected area for the screening. It, nonetheless, also showed a best pose placed between helices TM1 and TM7 (-43.7 kcal/mol) using the initial workflow. In conclusion, although AGR1.131 also faced to the TMV-TMVI, the most favorable pose was in the area between TMI and TMVII. In addition, the compound was included in the biological screening, where it did not affect CXCL12-mediated chemotaxis. We thus decided to use it as an internal negative control, as it has a skeleton very similar to AGR1.135 and AGR1.137 and can interact with the TM domains of CXCR4 without promoting biological effects. This statement has been clarified in the revised text.

      (13) Toxicity Testing:

      -Enhance the explanation of the approach to testing the toxicity of the compound in Jurkat cells. Consider incorporating positive controls to strengthen the assessment and clarify the experimental design.

      All the selected compounds in the in silico screening were initially tested for propidium iodide incorporation in treated cells in a toxicity assay, and some of them were discarded for further experiments (e.g., AGR1.103 and VSP3.1).

      Further evaluation of Jurkat cell viability was determined by cell cycle analysis using propidium iodide.  Supplementary Fig. 1B included the percentage of each cell cycle phase, and data indicated no significant differences between the treatments tested. Nevertheless, at the suggestion of the reviewer, and to clarify this issue, positive controls inducing Jurkat cell death (staurosporine and hydrogen peroxide) have also been included in the new Supplementary Fig. 2. The new figure also includes a table showing the percentage of cells in each cell-cycle phase.  

      (14) In the Results section concerning "AGR1.135 and AGR1.137 blocking CXCL12-mediated CXCR4 nanoclustering and dynamics", several points can be improved to enhance clarity and coherence: 1. Specificity of Low Molecular Weight Compounds:  

      -Clearly articulate how AGR1.135 and AGR1.137 specifically target homodimeric CXCR4 and provide an explanation for their lack of impact on heterodimeric CXCR4-CCR5 in that region.

      First of all, we should clarify that when we talk about receptor nanoclustering, oligomers refer to complexes including 3 or more receptors and, therefore, the residues involved in these interactions can differ from those involved in receptor dimerization. Moreover, our FRET experiments did not indicate that the compounds alter receptor dimerization (see new Supplementary Fig. 7). Of note, mutant receptors unable to oligomerize can still form dimers (Martínez-Muñoz L. et al. Mol. Cell 2018; García-Cuesta E.M .et al. Proc. Natl. Acad. Sci. USA 2022). Additionally, we believe that these oligomers can also include other chemokine receptors/proteins expressed at the cell membrane, which we are currently studying using different models and techniques.

      We have results supporting the existence of CCR5/CXCR4 heterodimers (Martínez-Muñoz L et al. Proc. Natl. Acad. Sci. USA 2014), in line with the data published by Di Marino et al. However, in the current study we have not evaluated the impact of the selected compounds on other CXCR4 complexes distinct from CXCR4 oligomers. Our Jurkat cells do not express CCR5 and, therefore, we cannot discuss whether AGR1.137 affects CCR5/CXCR4 heterodimers. The chemokine field is very complex and most receptors can form dimers (homo- and heterodimers) as well as oligomers (Martinez-Muñoz L., et al Pharmacol & Therap. 2011) when co-expressed. To evaluate different receptor combinations in the same experiment is a complex task, as the number of potential combinations between distinct expressed receptors makes the analysis very difficult. We started with CXCR4 as a model, to continue later with other possible CXCR4 complexes. In addition, for the analysis of CCR5/CXCR4 dynamics, it is much better to use dual-TIRF techniques, which allow the simultaneous detection of two distinct molecules coupled to different fluorochromes.

      Regarding the data of Di Marino et al., it is possible that the compounds might also affect heterodimeric conformations of CXCR4. This aspect has also been broached in the revised discussion. We would again note that we evaluated CXCR4 oligomers and not monomers or dimers; this is especially relevant when we compare the residues involved in these processes as they might differ depending on the receptor conformation considered. This issue was also hypothesized by Di Marino et al. (see our response to point 4).

      (15) When referring to "unstimulated" cells, provide a more detailed explanation to elucidate the experimental conditions and cellular state under consideration.

      Unstimulated cells refer to the cells in basal conditions, that is, cells in the absence of CXCL12. For TIRF-M experiments, transiently-transfected Jurkat cells were plated on glass-bottomed microwell dishes coated with fibronectin; these are the unstimulated cells. To observe the effect of the ligand, dishes were coated as above plus CXCL12 (stimulated cells). We have clarified this point in the material and methods section of the revised version.

      (16) 2. Paragraph Organization

      -Reorganize the second paragraph to eliminate redundancy and improve overall flow. A more concise and fluid presentation will facilitate reader comprehension and engagement.

      The second paragraph has been reorganized to improve overall flow.

      (17) Ensure that each paragraph contributes distinct information, avoiding repetition and redundancy.

      We have carefully revised each paragraph of the manuscript to avoid redundancy.

      (18) 3. Claim of Allosteric Antagonism:

      -Exercise caution when asserting that "AGR1.135 and AGR1.137 behave as allosteric antagonists of CXCR4" based on the presented results. Consider rephrasing to reflect that the observed effects suggest the potential allosteric nature of these compounds, acknowledging the need for further investigations and evidence.

      To avoid misinterpretations on the effect of the compounds on CXCR4, as we have commented in our response to point 2, we have substituted the term allosteric inhibitors with negative allosteric modulators, which refer to molecules that act by binding a site distinct from the orthosteric site, and selectively block some downstream signaling pathways, whereas others induced by the same endogenous or orthosteric agonist are unaffected (Gao Z.-G. & Jacobson K.A. Drug Discov. Today Technol. 2013). Our data indicate that the selected small compounds do not block ligand binding or G protein activation or receptor internalization, but inhibit receptor oligomerization and ligand-mediated directed cell migration.

      (19) In the Results section discussing the "incomplete abolition of CXCR4-mediated responses in Jurkat cells by AGR1.135 and AGR1.137", several points can be refined for better clarity and completeness:  1. Inclusion of Positive Controls: 

      -Consider incorporating positive controls in relevant experiments to provide a comparative benchmark for assessing the impact of AGR1.135 and AGR1.137. This addition will strengthen the interpretation of results and enhance the experimental rigor. 

      The in vivo experiments (Fig. 7E,F) used AMD3100, an orthosteric antagonist of CXCR4, as a positive control. We also included AMD3100, as a positive control of inhibition when evaluating the effect of the compounds on CXCL12 binding (Fig. 3, new Supplementary Fig. 3). The revised version of the manuscript also includes the effect of this inhibitor on other relevant CXCL12-mediated responses such as cell migration (Fig. 1B), receptor internalization (Fig. 3A), cAMP production (Fig. 3C), ERK1/2 and AKT phosphorylation (Supplementary Fig. 4), actin polymerization (Fig. 4A), cell polarization (Fig. 4B, C) and cell adhesion (Fig. 4D), to facilitate the interpretation of the results and improve the experimental rigor.

      (20) 2. Clarification of Terminology: 

      -Clarify the term "CXCR4 internalizes" by providing context, perhaps explaining the process of receptor internalization and its relevance to the study.

      We refer to CXCR4 internalization as a CXCL12-mediated endocytosis process that results in reduction of CXCR4 levels on the cell surface. We use CXCR4 internalization in this study with two purposes: First, for CXCR4 and other chemokine receptors, internalization processes are mediated by ligand-induced clathrin vesicles (Venkatesan et al 2003) a process that triggers CXCR4 aggregation in these vesicles. We have previously determined that the oligomers of receptors detected by TIRF-M remain unaltered in cells treated with inhibitors of clathrin vesicle formation and of internalization processes (Martinez-Muñoz L. et al. Mol. Cell 2018). Moreover, we have described a mutant CXCR4 that cannot form oligomers but internalizes normally in response to CXCL12 (Martinez-Muñoz L. et al. Mol. Cell 2018). The observation in this manuscript of normal CXCL12-mediated endocytosis in the presence of the negative allosteric inhibitors of CXCR4 that abrogate receptor oligomerization reinforces the idea that the oligomers detected by TIRF are not related to receptor aggregates involved in endocytosis; Second, receptor internalization is not affected by the allosteric compounds, indicating that they downregulate some CXCL12-mediated signaling events but not others (new Fig. 3).

      All these data have been included in the revised discussion of the manuscript.

      (21) Elaborate on the meaning of "CXCL12 triggers normal CXCR4mut internalization" to enhance reader understanding.

      We have previously described a triple-mutant CXCR4 (K239L/V242A/L246A; CXCR4mut). The mutant residues are located in the N-terminal region of TMVI, close to the cytoplasmic region, thus limiting the CXCR4 pocket described in this study (see our response to point 3). This mutant receptor dimerizes but neither oligomerizes in response to CXCL12 nor supports CXCL12-induced directed cell migration, although it can still trigger some Ca2+ flux and is internalized after ligand activation (Martinez-Muñoz L. et al. Mol. Cell 2018).  We use the behavior of this mutant (CXCR4mut) to show that the CXCR4 oligomers and the complexes involved in internalization processes are not the same and to explain why we evaluated CXCR4 endocytosis in the presence of the negative allosteric modulators.

      As we indicated in a previous answer to the reviewer, these issues have been re-elaborated in the revised version.

      (22) 3. Discrepancy in CXCL12 Concentration:

      -Address the apparent discrepancy between the text stating, "...were stimulated with CXCL12 (50 nM, 37{degree sign}C)," and the figure caption (Fig. 3A) reporting a concentration of 12.5 nM. Rectify this inconsistency and provide an accurate and clear explanation.

      We apologize for this error, which is now corrected in the revised manuscript. With the exception of the cell migration assays in Transwells, where the optimal concentration was established at 12.5 nM, in the remaining experiments the optimal concentration of CXCL12 employed was 50 nM. These concentrations were optimized in previous works of our laboratory using the same type of experiment. We should also remark that in the experiments using lipid bilayers or TIRF-M experiments, CXCL12 is used to coat the plates and therefore it is difficult to determine the real concentration of the ligand that is retained in the surface of the plates after the washing steps performed prior to adding the cells. In addition, we use 100 nM CXCL12 to create the gradient in the chambers used to perform the directed-cell migration experiments.

      (23) 4. Speculation on CXCL12 Binding:

      -Refrain from making speculative statements, such as "These data suggest that none of the antagonists alters CXCL12 binding to CXCR4," unless there is concrete evidence presented up to that point. Clearly outline the results that support this conclusion.

      Figure 3B and Supplementary Figure 3 show CXCL12-ATTO700 binding by flow cytometry in cells pretreated with the negative allosteric modulators. We have also included AMD3100, the orthosteric antagonist, as a control for inhibition. While these experiments showed no major effect of the compounds on CXCL12 binding, we cannot discard small changes in the affinity of the interaction between CXCL12 and CXCR4. In consequence we have re-written these statements.

      (24) 5. Corroboration of Data:

      -Specify where the corroborating data from immunostaining and confocal analysis are reported, ensuring readers can access the relevant information to support the conclusions drawn in this section.

      In agreement with the suggestion of the reviewer, the revised manuscript includes data from immunostaining and confocal analysis to complement Fig. 4B (new Fig. 4C). The revised version also includes some representative videos for the TIRF experiments showed in Figure 2 to clarify readability.

      (25) In the Results section concerning "AGR1.135 and AGR1.137 antagonists and their direct binding to CXCR4", several aspects need clarification and refinement for a more comprehensive and understandable presentation: 1. Workflow Clarification:

      -Clearly articulate the workflow used for assessing the binding of AGR1.135 and AGR1.137 to CXCR4. Address the apparent contradiction between the inability to detect a direct interaction and the utilization of Glide for docking in the TMV-TMVI cleft.

      To address the direct interaction of the compounds with CXCR4, we intentionally avoided the modification of the small compounds with different labels, which could affect their properties. We therefore attempted a fluorescence a spectroscopy strategy to formally prove the ability of the small compounds to bind CXCR4, but this failed because the AGR1.135 is yellow in color, which interfered with the determinations. We also tried a FRET strategy (see new Supplementary Fig. 7) and detected a significant increase in FRET efficiency of CXCR4 homodimers when AGR1.135 was evaluated, but again the yellow color interfered with FRET determinations. Moreover, AGR1.137 did not modify FRET efficiency of CXCR4 dimers. Therefore, we were unable to detect the interaction of the compounds with CXCR4.

      We elected to develop an indirect strategy; in silico, we evaluated the binding-site using docking and molecular dynamics to predict the most promising CXCR4 binding residues involved in the interaction with the selected compounds. Next, we generated point mutant receptors of the predicted residues and re-evaluated the behavior of the allosteric antagonists in a CXCL12-induced cell migration experiment. Obviously, we first discarded those CXCR4 mutants that were not expressed on the cell membrane as well as those that were not functional when activated with CXCL12. Using this strategy, we eliminated the interference due to the physical properties of the compounds and demonstrated that if the antagonism of a compound is reversed in a particular CXCR4 mutant it is because the mutated residue participates or interferes with the interaction between CXCR4 and the compound, thus assuming (albeit indirectly) that the compound binds CXCR4. 

      To select the specific mutations included in the analysis, our strategy was to generate point mutations in residues present in the TMV-TMVI pocket of CXCR4 that were not directly proposed as critical residues involved in chemokine engagement, signal initiation, signal propagation, or G protein-binding, based on the extensive mutational study published by Wescott MP et. al. (Wescott M.P. et. al. Proc. Natl. Acad. Sci. U S A. 2016).

      (26) Provide a cohesive explanation of the transition from docking evaluation to MD analysis, ensuring a transparent representation of the methodology.

      Based on the aim of this work, the workflow shown in Author response image 2, was proposed to predict the binding mode of the selected molecules. Firstly, a CXCR4 model was generated to reconstruct some unresolved parts of the protein structure; then a binding site search using PELE software was performed to identify the most promising binding sites; subsequently, docking studies were performed to refine the binding mode of the molecules; and finally, molecular dynamics simulations were run to determine the most stable poses and predict the residues that we should mutate to test that the compounds interact with CXCR4. 

      Author response image 2.

      Workflow followed to determine the binding mode of the  studied compounds.

      (27) 2. Choice of Software and Techniques:

      -Justify the use of "AMBER14" and the PELE approach, considering  their potential obsolescence.

      These experiments were performed five years ago when the project was initiated. As the reviewer indicates, AMBER14 and PELE approaches might perhaps be considered obsolescent. Thus, we have predicted the structure of the target using AlphaFold (Jumper J. et al, Nature 2021) and the sequence available under UniProt entry P61073. The complete analysis performed (see our response to point 4) confirmed that the compounds bound the selected pocket, as we had originally determined using PELE. These new analyses have been incorporated into the revised manuscript.

      (28)-Discuss the role of the membrane in the receptor-ligand interac7on. Elaborate on how the lipidic double layer may influence the binding of small compounds to GPCRs embedded in the membrane.

      Biological membranes are vital components of living organisms, providing a diffusion barrier that separates cells from the extracellular environment, and compartmentalizing specialized organelles within the cell. In order to maintain the diffusion barrier and to keep it electrochemically sealed, a close interaction of membrane proteins with the lipid bilayer is necessary. It is well known that this is important, as many membrane proteins undergo conformational changes that affect their transmembrane regions and that may regulate their activity, as seen with GPCRs (Daemen F.J. & Bonting S.L., Biophys. Struct. Mech. 1977; Gether U. et al. EMBO J. 1997). The lateral and rotational mobility of membrane lipids supports the sealing function while allowing for the structural rearrangement of membrane proteins, as they can adhere to the surface of integral membrane proteins and flexibly adjust to a changing microenvironment. In the case of the first atomistic structure of CXCR4 (Wu B. et al. Science 2010), it was indicated that for dimers, monomers interact only at the extracellular side of helices V and VI, leaving at least a 4-Å gap between the intracellular regions, which is presumably filled by lipids. In particular, they indicated that the channel between TMV and TMVI that connects the orthosteric chemokine binding pocket to the lipid bilayer is occupied by an oleic acid molecule. Recently, Di Marino et al., analyzing the dimeric structure of CXCR4, found a cholesterol molecule placed in between the two protomers, where it engages a series of hydrophobic interactions with residues located in the area between TMI and TMVI (Leu132, Val214, Leu216, Leu246, and Phe249). The polar head of cholesterol forms an H-bond with Tyr135 that further stabilizes its binding mode. This finding confirms that cholesterol might play an important role in mediating and stabilizing receptor dimerization, as seen in other GPCRs (Pluhackova, K., et al. PLoS Comput. Biol. 2016). In addition, we have previously observed that, independently of the structural changes on CXCR4 triggered by lipids, the local lipid environment also regulates CXCR4 organization, dynamics and function at the cell membrane and modulates chemokine-triggered directed cell migration. Prolonged treatment of T cells with bacterial sphingomyelinase promoted the complete and sustained breakdown of sphingomyelins and the accumulation of the corresponding ceramides, which altered both membrane fluidity and CXCR4 nanoclustering and dynamics. Under these conditions, CXCR4 retained some CXCL12-mediated signaling activity but failed to promote efficient directed cell migration (Gardeta S.R. et al. Front. Immunol. 2022). Collectively, these data demonstrate the key role that lipids play in the stabilization of CXCR4 conformations and in regulating its lateral mobility, influencing their associated functions. These considerations have been included in the revised version of the manuscript. 

      (29) 3. Stable Trajectories and Binding Mode Superimposi7on -Specify the criteria for defining "stable trajectories" to enhance reader understanding

      There could be several ways to describe the stability of a MD simulation, based on the convergence of energies, distances or ligand-target interactions, among others. In this work, we use the expression “stable trajectories” to refer to simulations in which the ligand trajectory converges and the ligand RMSD does not fluctuate more than 0.25Å. This definition is now included in the revised text.

      (30)  Clarify the meaning behind superimposing the two small compounds and ensure that the statement in the figure caption aligns with the information presented in the main text.

      We apologize for the error in the previous Fig. 5A and in its legend. The figure was created by superimposing the protein component of the poses for the two compounds, AGR1.135 and AGR1.137, rather than the compounds themselves. As panel 5A was confusing, we have modified all Fig. 5 in the revised manuscript to improve clarity.

      (31) 4. Volume Analysis and Distances:

      -Provide details on how the volume analysis was computed and how distances were accounted for. Consider adding a figure to illustrate these analyses, aiding reader comprehension.

      The cleft search and analysis were performed using the default settings of SURFNET (Laskowski R.A. J. Mol. Graph. 1995) included in the PDBsum server (Laskowski R.A. et. al. Trends Biochem. Sci. 1997). The first run of the input model for CXCR4 3ODU identified a promising cleft of 870 Å3 in the lower half of the region flanked by TMV and TMVI, highlighting this area as a possible small molecule binding site (Fig. I, only for review purposes). Analysis of the cleft occupied by AGR1.135 showed two independent cavities of 434 Å3 and 1381 Å3 that were not connected to the orthosteric site. The same procedure for AGR1.137 revealed two distinct clefts of 790 Å3 and 580 Å3, respectively (Fig. I, only for review purposes). Analysis of the atomic distances between the protein residues and the compounds was performed using the PISA server. Krissinel E. & Henrick K. J. Mol. Biol. 2007). (Please see our response to point 3 and the corresponding figure).

      (32) 5. Mutant Selection and Relevance:

      -Clarify the rationale behind selecting the CXCR4 mutants used in the study. Consider justifying the choice and exploring the possibility of performing an alanine (ALA) scan for a more comprehensive mutational analysis.  

      The selection of the residues to be mutated along the cleft was first based on their presence in the proposed cleft and the direct interaction of the compounds with them, either by hydrogen bonding or by hydrophobic interactions. Secondly, all mutated residues did not belong to any of the critical residues involved in transmitting the signal generated by the interaction of CXCL12 with the receptor. In any case, mutants producing a non-functional CXCR4 at the cell membrane were discarded after FACS analysis and chemotaxis experiments. Finally, the length and nature of the resulting mutations were designed mainly to occlude the cleft in case of the introduction of long residues such as lysines (I204K, L208K) or to alter hydrophobic interactions by changing the carbon side chain composition of the residues in the cleft. Indeed, we agree that the alanine scan mutation analysis would have been an alternative strategy to evaluate the residues involved in the interactions of the compounds. 

      (33) Reevaluate the statement regarding the relevance of the Y256F muta7on for the binding of AGR1.137. If there is a significant impact on migra7on in the mutant (Fig. 6B), elaborate on the significance in the context of AGR1.137 binding.

      In the revised discussion we provide more detail on the relevance of Y256F mutation for the binding of AGR1.137 as well as for the partial effect of G207I and R235L mutations. The predicted interactions for each compound are depicted in new Fig. 6 C, D after LigPlot+ analysis (Laskowski R.A. & Swindells M.B. J. Chem. Inf. Model. 2011), showing that AGR1.135 interacted directly with the receptor through a hydrogen bond with Y256. When this residue was mutated to F, one of the anchor points for the compound was lost, weakening the potential interaction in the region of the upper anchor point.

      It is not clear how the Y256F mutation will affect the binding of AGR1.137, but other potential contacts cannot be ruled out since that portion of the compound is identical in both AGR1.135 and AGR1.137. This is especially true for its neighboring residues in the alpha helix, F249, L208, as shown in 3ODU structure (Fig. 6D), which are shown to be directly implicated in the interaction of both compounds. Alternatively, we cannot discard that Y256 interacts with other TMs or lipids stabilizing the overall structure, which could reverse the effect of the mutant at a later stage (Author response image 3).

      Author response image 3.

      Cartoon representation of Y256 and its intramolecular interactions in the CXCR4 Xray solved structure 3ODU. TMV helix is colored in blue and TMVI in pink.

      (34) Address the apparent discrepancy in residue involvement between AGR1.135 and AGR1.137, particularly if they share the same binding mode in the same clef.

      AGR1.135 and AGR1.137 exhibit comparable yet distinct binding modes, engaging with CXCR4 within a molecular cavity formed by TMV and TMVI. AGR1.135 binds to CXCR4 through three hydrogen bonds, two on the apical side of the compound that interact with residues TMV-G207 and TMVI-Y256 and one on the basal side that interacts with TMVI-R235 (Fig. 5A). This results in a more extended and rigid conformation when sharing hydrogen bonds, with both TMs occupying a surface area of 400 Å2 and a length of 20 Å in the cleft between TMV and TMVI (Supplementary Fig. 8A). AGR1.137 exhibits a distinct binding profile, interacting with a more internal region of the receptor. This interaction involves the formation of a hydrogen bond with TMIIIV124, which induces a conformational shift in the TMVI helix towards an active conformation (Fig. 5B; Supplementary Fig. 13). Moreover, AGR1.137 may utilize the carboxyl group of V124 in TMIII and overlap with AGR1.135 binding in the cavity, interacting with the other 19 residues dispersed between TMV and VI to create an interaction surface of 370 Å2 along 20 Å (Supplementary Fig. 8B). This is illustrated in the new Fig. 5B. AGR1.137 lacks the phenyl ring present in AGR1.135, resulting in a shorter compound with greater difficulty in reaching the lower part of TMVI where R235 sits. 

      Author response image 4.

      AGR1.135 and AGR1.137 interaction with TMV and TMVI.  The model shows the location of the compounds within the TMV-VI cleft, illustrated by a ribbon and stick representation. The CXCR4 segments of TMV and TMVI are represented in blue and pink ribbons respectively, and side chains for some of the residues defining the cavity are shown in sticks. AGR1.135 and AGR1.137 are shown in stick representation with carbon in yellow, nitrogen in blue, oxygen in red, and fluorine in green. Hydrogen bonds are indicated by dashed black lines, while hydrophobic interactions are shown in green. The figure reproduces the panels A, B of Fig. 5 in the revised manuscript.

      (35) In the Results sec7on regarding "AGR1.137 treatment in a zebrafish xenograf model", the following points can be refined for clarity and completeness: 1. Cell Line Choice for Zebrafish Xenograft Model:

      -Explain the rationale behind the choice of HeLa cells for the zebrafish xenograft model when the previous experiments primarily focused on Jurkat cells. Address any specific biological or experimental considerations that influenced this decision.

      As far as we know, there are no available models of tumors in zebrafish using Jurkat cells. We looked for a tumoral cell system that expresses CXCR4 and could be transplanted into zebrafish. HeLa cells are derived from a human cervical tumor, express a functional CXCR4, and have been previously used for tumorigenesis analyses in zebrafish (Brown H.K. et al. Expert Opin. Drug Discover. 2017; You Y. et al Front. Pharmacol. 2020). These cells grow in the fish and disseminate through the ventral area and can be used to determine primary tumor growth and metastasis. Nonetheless, we first analyzed in vitro the expression of a functional CXCR4 in these cells (Supplementary Fig. 10A), whether AGR1.137 treatment specifically abrogated CXCL12-mediated direct cell migration (Fig. 7A, B), as whether it affected cell proliferation (Supplementary Fig. 10B). As HeLa cells reproduce the in vitro effects detected for the compounds in Jurkat cells, we used this model in zebrafish. These issues were already discussed in the first version of our manuscript. 

      (36) 2. Toxicity Assessment in Zebrafish Embryos: 

      -Clarify the basis for stating that AGR1.137 is not toxic to zebrafish embryos. Consider referencing the Zebrafish Embryo Acute Toxicity Test (ZFET) and provide relevant data on lethal concentration (LC50) and non-lethal toxic phenotypes such as pericardial edema, head and tail necrosis, malformation, brain hemorrhage, or yolk sac edema.

      Tumor growth and metastasis kinetics within the zebrafish model have been extensively evaluated in many publications (White R. et al. Nat. Rev. Cancer. 2013; Astell K.R. and Sieger D. Cold Spring Harb. Perspect. Med. 2020; Chen X. et al. Front. Cell Dev. Biol. 2021; Weiss JM. Et al. eLife 2022; Lindhal G. et al NPJ Precis. Oncol. 2024). Our previous experience using this model shows that tumors start having a more pronounced proliferation and lower degree of apoptosis from day 4 onwards, but we cannot keep the tumor-baring larvae for that long due to ethical reasons and also because we don’t see much scientific benefit of unnecessarily extending the experiments. Anti-proliferative or pro-apoptotic effects of drugs can still be observed within the three days, even if this is then commonly seen as larger reduction (instead of a smaller growth as it is commonly seen in for example mouse tumor models) compared to controls. Initially we characterized the evolution of implanted tumors in our system and how much they metastasize over time in the absence of treatment before to test the compounds (Author response image 5).

      The in vivo experiments were planned to validate efficacious concentrations of the investigated drugs rather than to derive in vivo IC50 or other values, which require testing of multiple doses. We have, however, included an additional concentration to show concentration-dependence and therefore on-target specificity of the drugs in the revised version of the manuscript (data also being elaborated in ongoing experiments). At this stage, we believe that adding the LC50 does not provide interesting new knowledge, and it is standard to only show results from the experimental endpoint (in our case 3 days post implantation). We agree that showing these new data points strengthens the manuscript and facilitates independent evaluation and conclusions to be drawn from the presented data. We have created new graphs where datapoints for each compound dose are shown.  

      Author response image 5.

      Evolution of the tumors and metastasis along the time in the absence of any treatment. HeLa cells were labeled with 8 µg/mL Fast-DiI™ oil and then implanted in the dorsal perivitelline space of 2-days old zebrafish embryos. Tumors were imaged within 2 hours of implantation and re-imaged each 24 h for three days. Changes in tumor size was evaluated as tumor area at day 1, 2 and 3 divided by tumor area at day 0, and metastasis was evaluated as the number of cells disseminated to the caudal hematopoietic plexus at day 1, 2 and 3 divided by the number of cells at day  3.

      Regarding the statement that AGR1.137 was not toxic, this was based on visual inspection of the zebrafish larvae at the end of the experiment, which also revealed a lack of drug-related mortality in these experiments. There are a number of differences in how our experiment was run compared with the standardized ZFET. ZFET evaluates toxicity from 0 hours post-fertilization to 1 or 2 days post-fertilization, whereas here we exposed zebrafish from 2 days post-fertilization to 5 days post-fertilization. The ZFET furthermore requires that the embryos are raised at 26ºC whereas kept the temperature as close as possible to a physiologically relevant temperature for the tumor cells (36ºC). In the ZFET, embryos are incubated in 96-well plates whereas for our studies we required larger wells to be able to manipulate the larvae and avoid well edge-related imaging artefacts, and we therefore used 24-well plates. As such, the ZFET was for various reasons not applicable to our experimental settings. As we were not interested in rigorously determining the LD50 or other toxicity-related measurements, as our focus was instead on efficacy and we found that the targeted dose was tolerated, we did not evaluate multiple doses, including lethal doses of the drug, and are therefore not able to determine an LD50/LC50. We also did not find drug-induced non-lethal toxic phenotypes in this study, and so we cannot elaborate further on such phenotypes other than to simply state that the drug is well tolerated at the given doses. Therefore, the reference to ZFET in the manuscript was eliminated.

      (37) If supplementary information is available, consider providing it for a comprehensive understanding of toxicity assessments. 

      The effective concentration used in the zebrafish study was derived from the in vitro experiments. That being said, and as elaborated in our response to comment 36, we have added data for one additional dose to show the dose-dependent regulation of tumor growth and metastasis. 

      (38) 3. Optimization and Development of AGR1.137: 

      -Justify the need for further optimization and development of AGR1.137 if it has a comparable effect to AMD3100. Explain the specific advantages or improvements that AGR1.137 may offer over AMD3100. 

      AGR1.137 is highly hydrophobic and is very difficult to handle, particularly in in vivo assays; thus, for the negative allosteric modulators to be used clinically, it would be very important to increase their solubility in water. Contrastingly, AMD3100 is a water-soluble compound. Before using the zebrafish model, we performed several experiments in mice using AGR1.137, but the inhibitory results were highly variable, probably due to its hydrophobicity. We also believe that it would be important to increase the affinity of AGR1.137 for CXCR4, as the use of lower concentrations of the negative allosteric modulator would limit potential in vivo side effects of the drug. On the other hand, we are also evaluating distinct administration alternatives, including encapsulation of the compounds in different vehicles. These alternatives may also require modifications of the compounds. 

      AMD3100 is an orthosteric inhibitor and therefore blocks all the signaling cascades triggered by CXCL12. For instance, we observed that AMD3100 treatment blocked CXCL12 binding, cAMP inhibition, calcium flux, cell adhesion and cell migration (Fig. 3, Fig. 4), whereas the effects of AGR1.137 were restricted to CXCL12-mediated directed cell migration. Although AMD3100 was well tolerated by healthy volunteers in a singledose study, it also promoted some mild and reversible events, including white blood cells count elevations and variations of urine calcium just beyond the reported normal range (Hendrix C.W. et al. Antimicrob. Agents Chemother. 2000). To treat viral infections, continuous daily dosing requirements of AMD3100 were impractical due to severe side effects including cardiac arrhythmias (De Clercq E. Front Immunol. 2015). For AMD3100 to be used clinically, it would be critical to control the timing of administration. In addition, side effects after long-term administration have potential problems. Shorter-term usage and lower doses would be fundamental keys to its success in clinical use (Liu T.Y. et al. Exp. Hematol. Oncol. 2016). The use of a negative allosteric modulator that block cell migration but do not affect other signaling pathways triggered by CXCL12 would be, at least in theory, more specific and produce less side effects. These ideas have been incorporated into the revised discussion to reflect potential advantages or improvements that AGR1.137 may offer over AMD3100.

      (39) 4. Discrepancy in AGR1.137 and AMD3100 Effects:

      -Discuss the observed discrepancy where AGR1.137 exhibits similar effects to AMD3100 but only after 48 hours. Provide insights into the temporal dynamics of their actions and potential implications for the experimental design.

      Images and data shown in Fig. 7E, F correspond to days 0 and 3 after HeLa cell implantation (tumorigenesis) and only to day 3 in the case of metastasis data. The revised version contains the effect of two distinct doses of the compounds (10 and 50 µM, for AGR1.135 and AGR1.137 and 1 and 10 µM for AMD3100). 

      (40) In the "Discussion" section, there are several points that require clarifica7on and refinement to enhance the overall coherence and depth of the analysis:  1. Reduction of Side-Effects: 

      -Provide a more detailed explanation of how the identified compounds, specifically AGR1.135 and AGR1.137, contribute to the reduction of side effects. Consider discussing specific mechanisms or characteristics that differentiate these compounds from existing antagonists.

      The sentence indicating that AGR1.135 and AGR1.137 contribute to reduce side effects is entirely speculative, as we have no experimental evidence to support it. We have therefore corrected this in the revised version. The origin of the sentence was that orthosteric antagonists typically bind to the same site as the endogenous ligand, thus blocking its interaction with the receptor. Therefore, orthosteric inhibitors (i.e. AMD3100) block all signaling cascades triggered by the ligand and therefore their functional consequences. However, the compounds described in this project are essentially negative allosteric modulators, that is, they bind to a site distinct from the orthosteric site, inducing a conformational change in the receptor that does not alter the binding of the endogenous ligand, and therefore block some specific receptor-associated functions without altering others. We observed that AGR1.137 blocked receptor oligomerization and directed cell migration whereas CXCL12 still bound CXCR4, triggered calcium mobilization, did not inhibit cAMP release or promoted receptor internalization. This is why we speculated on the limitation of side effects. The statements have been nonetheless revised in the new version of the manuscript.

      (41) 2. Binding Site Clarification:

      -Address the apparent discrepancy between docking the small compounds in a narrow cleft formed by TMV and TMVI helices and the statement that AGR1.131 binds elsewhere. Clarify the rationale behind this assertion

      After the in silico screening, a total of 40 compounds were selected.  These compounds showed distinct degrees of interaction with the cleft formed by TMV and TMVI and even with other potential interaction sites on CXCR4, with the exception of the ligand binding site according to the data described by Wescott et al. (PNAS 2016 113:9928-9933), as this possibility was discarded in the initial approach of the in silico screening. According to PELE analysis, AGR1.131 was one of the 40 selected compounds that showed a pose with low binding energy, -39.8 kcal/mol, between TMV and TMVI helices, that is, it might interact with CXCR4 through the selected area for the screening. It nonetheless also showed a best pose placed between helices TMI and TMVII, -43.7 kcal/mol. In any case, the compound was included in the biological screening, where it was unable to impact CXCL12-mediated chemotaxis (Fig. 1B). We then focused on AGR1.135 and AGR1.137, as showed a higher inhibitory effect on CXCL12-mediated migration, and on AGR1.131 as an internal negative control. AGR1.131 has a skeleton very similar to the other compounds (Fig. 1C) and can interact with the TM domains of CXCR4 without promoting effects. None of the three compounds affected CXCL12 binding, or CXCL12mediated inhibition of cAMP release, or receptor internalization. However, whereas AGR1.135 and AGR1.137, blocked CXCL12-mediated CXCR4 oligomerization and directed cell migration towards CXCL12 gradients, AGR1.131 had no effect in these experiments (Fig. 3, Fig.  4). 

      Next, we performed additional theoretical calculations (PELE, docking, MD) to inspect in detail the potential binding modes of active and inactive molecules. Based on these additional calculations, we identified that whereas AGR1.135 and AGR1.137 showed preferent binding on the molecular pocket between TMV and TMVI, the best pose for AGR1.131 was located between TMI and TMVII, as the initial experiments indicated.  These observations and data have been clarified in the revised discussion. 

      (42) 3. Impact of Chemical Modifications:

      -Discuss the consequences of the distinct chemical groups in AGR1.135, AGR1.137, and AGR1.131, specifically addressing how variations in amine length and chemical nature may influence binding affinity and biological activity. Provide insights into the potential effects of these modifications on cellular responses and the observed outcomes in zebrafish. 

      The main difference between AGR1.131 and the other two compounds is the higher flexibility of AGR1.131 due to the additional CH2 linker, together with the lack of a piperazine ring. The additional CH2 linking the phenyl ring increases the flexibility of AGR1.131 when compared with AGR1.135 and AGR1.137, and the absence of the piperazine ring might be responsible for its lack of activity, as it makes this compound able to bind to CXCR4 (Fig. 1C).

      AGR1.137 was chosen in a second round. The additional presence of the tertiary amine (in the piperazine ring) allows the formation of quaternary ammonium salts in the aqueous medium and its substituents to increase its solubility (Fig 1C). This characteristic might be related to the absence of toxic effects of the compound in the zebrafish model.

      (43) 4. Existence of Distinct CXCR4 Conformational States: 

      -Provide more detailed support for the statement suggesting the "existence of distinct CXCR4 conformational states" responsible for activating different signaling pathways. Consider referencing relevant studies or experiments that support this claim.

      Classical models of GPCR allostery and activation, which describe an equilibrium between a single inactive and a single signaling-competent active conformation, cannot account for the complex pharmacology of these receptors. The emerging view is that GPCRs are highly dynamic proteins, and ligands with varying pharmacological properties differentially modulate the balance between multiple conformations.

      Just as a single photograph from one angle cannot capture all aspects of an object in movement, no one biophysical method can visualize all aspects of GPCR activation. In general, there is a tradeoff between high-resolution information on the entire protein versus dynamic information on limited regions. In the former category, crystal and cryo-electron microscopy (cryoEM) structures have provided comprehensive, atomic-resolution snapshots of scores of GPCRs both in inactive and active conformations, revealing conserved conformational changes associated with activation. However, different GPCRs vary considerably in the magnitude and nature of the conformational changes in the orthosteric ligand-binding site following agonist binding (Venkatakrishnan A.J.V. et al. Nature 2016). Spectroscopic and computational approaches provide complementary information, highlighting the role of conformational dynamics in GPCR activation (Latorraca N.R.V. et al. Chem. Rev 2017). In the absence of agonists, the receptor population is typically dominated by conformations closely related to those observed in inactive-state crystal structures (Manglik A. et al. Cell 2015). While agonist binding drives the receptor population towards conformations similar to those in activestate structures, a mixture of inactive and active conformations remains, reflecting “loose” or incomplete allosteric coupling between the orthosteric and transducer pockets (Dror R.O. et al. Proc. Natl. Acad. Sci. USA 2011). Surprisingly, for some GPCRs, and under some experimental conditions, a substantial fraction of unliganded receptors already reside in an active-like conformation, which may be related to their level of basal or constitutive signaling (Staus D.P. et al. J. Biol. Chem. 2019);  Ye L. et al. Nature 2016).  In our case, the negative allosteric modulators, (Staus DP, et al. J. Biol. Chem 2019); Ye L. et al. Nature 2016) did not alter ligand binding and had only minor effects on specific CXCL12-mediated functions such as inhibition of cAMP release or receptor internalization, among others, but failed to regulate CXCL12-mediated actin dynamics and receptor oligomerization. Collectively, these data suggest that the described compounds alter the active conformation of CXCR4 and therefore support the presence of distinct receptor conformations that explain a partial activation of the signaling cascade.

      All these observations are now included in the revised discussion of the manuscript.

      (44) 5. Equilibrium Shift and Allosteric Ligands: 

      -Clarify the statement about "allosteric ligands shifting the equilibrium to favor a particular receptor conformation". Support this suggestion with references or experimental evidence

      In a previous answer (see our response to point 2), we explain why we define the compounds as negative allosteric modulators. These compounds do not bind the orthosteric binding site or a site distinct from the orthosteric site that alters the ligand-binding site. Their effect should be due to changes in the active conformation of CXCR4, which allow some signaling events whereas others are blocked. Our functional data thus support that through the same receptor the compounds separate distinct receptor-mediated signaling cascades, that is, our data suggest that CXCR4 has a conformational heterogeneity. It is known that GPCRs exhibit more than one “inactive” and “active” conformation, and the endogenous agonists stabilize a mixture of multiple conformations. Biased ligands or allosteric modulators can achieve their distinctive signaling profiles by modulating this distribution of receptor conformations. (Wingler L.M. & Lefkowitz R.J. Trends Cell Biol. 2020). For instance, some analogs of angiotensin II do not appreciably activate Gq signaling (e.g., increases in IP3 and Ca2+) but still induce receptor phosphorylation, internalization, and mitogen-activated protein kinase (MAPK) signaling (Wei H, et al. Proc. Natl. Acad. Sci. USA 2003). Some of these ligands activate Gi and G12 in bioluminescence resonance energy transfer (BRET) experiments (Namkung Y. et al. Sci. Signal. 2018). A similar observation was described in the case of CCR5, where some chemokine analogs promoted G protein subtype-specific signaling bias (Lorenzen E. et al. Sci. Signal 2018). Structural analysis of distinct GPCRs in the presence of different ligands vary considerably in the magnitude and nature of the conformational changes in the orthosteric ligand-binding site following agonist binding (Venkatakrishnan A.J.V. et al. Nature 2016). Yet, these changes modify conserved motifs in the interior of the receptor core and induce common conformational changes in the intracellular site involved in signal transduction. That is, these modifications might be considered distinct receptor conformations. 

      The revised discussion contains some of these interpretations to support our statement about the stabilization of a particular receptor conformation triggered by the negative allosteric modulators. 

      (45) 6. Refinement of Binding Mode: 

      -Clarify the workflow for obtaining the binding mode, particularly the role of GLIDE and PELE. Clearly explain how these software tools were used in tandem to refine the binding mode. 

      The computational sequential workflow applied in this project included, i) Protein model construction, ii) Virtual screening (Glide), iii) PELE, iv) Docking (AutoDock and Glide) and v) Molecular Dynamics (AMBER).

      Glide was applied for the structure-based virtual screening to explore which compounds could fit and interact with the previously selected binding site.

      After the identification of theoretically active compounds (modulators of CXCR4), additional calculations were done to identify a potential binding site. PELE was used in this sense, to study how the compounds could bind in the whole surface of the target (TMV-TMVI). By applying PELE, we avoided biasing the calculation, and we found that the trajectories with better interaction energies identified the cleft between TMV and TMVI as the binding site for AGR1.135 and AGR1.137, and not for AGR1.131. AGR1.131 showed a pose with low binding energy, -39.8 kcal/mol, between TMV and TMVI helices, that is, it might interact with CXCR4 in the selected area for the screening. But it also showed a better pose placed between helices TMI and TMVII, - 43.7 kcal/mol (see our response to point 41). These data have been now confirmed using Schrodinger’s MM-GBSA procedure (see our response to points 6 and 8). In any case, the compound was included in the biological screening, where it was unable to affect CXCL12-mediated chemotaxis (Fig. 1B). Docking and MD simulations were then performed to study and refine the specific binding mode in this cavity. These data were important to choose the mutations on CXCR4 required, to test whether the compounds reversed its behavior. In these experiments we also confirmed that AGR1.131 had a better pose on the TMI-TMVII region. 

      (46) 7. Impact of Compound Differences on CXCR4-F249L mutant: 

      -Provide visual aids, such as figures, and additional experiments to support the statement about differences in the behavior of AGR1.135 and AGR1.137 on cells expressing CXCR4-F249L mutant. Elaborate on the closer interaction suggested between the triazole group of AGR1.137 and the F249 residue

      At the reviewer’s suggestion, Fig. 5 has been modified to incorporate a closer view of the interactions identified and new panels in new Fig. 6 have been added to show in detail the effect of the mutations selected on the structure of the cleft between TMV and TMVI. The main difference between AGR1.135 and AGR1.137 is how the triazole group interacts with F249 and L216 (Author response image 6). In AGR1.137, the three groups are aligned in a parallel organization, which appears to be more effective: This might be due to a better adaptation of this compound to the cleft since there is only one hydrogen bond with V124. In AGR1.135, the compound interacts with the phenyl ring of F249 and has a stronger interaction at the apical edge to stabilize its position in the cleft. However, there is still an additional interaction present. When changing F249

      Author response image 6.

      Cartoon representation of the interaction of CXCR4 F249L mutant with AGR1.135 (A) and AGR1.137 (B). The two most probable conformations of Leucine rotamers are represented in cyan A and B conformations. Van der Waals interactions are depicted in blue cyan dashed lines, hydrogen bonds in black dashed lines. CXCR4 segments of TMV and TMVI are colored in blue and pink, respectively

      to L (Fig. VIIA, B, only for review purposes) and showing the two most likely rotamers resulting from the mutation, it is observed that rotamer B is in close proximity to the compound, which may cause the binding to either displace or adopt an alternative conformation that is easier to bind into the cleft. As previously mentioned, it is likely that AGR1.135 can displace the mutant rotamer and bind into the cleft more easily due to its higher affinity.

      (47) In the "Materials and Methods" section, the computational approach for the "discovery of CXCR4 modulators" requires significant revision and clarification. The following suggestions aim to address the identified issues: 1. Structural Modeling: 

      -Reconsider the use of SWISS-MODEL if there is an available PDB code for the entire CXCR4 structure. Clearly articulate the rationale for choosing one method over the other and explain any limitations associated with the selected approach. 

      The SWISS-model server allows for automated comparative modeling of 3D protein structures that was pioneered in the fields of automated modeling. At the time we started this project. it was the most accurate method to generate reliable 3D protein structure models.

      As explained above, we have now predicted the structure of the target using AlphaFold (Jumper J. et al, Nature 2021) and performed several additional experiments that confirm that the small compounds bind the selected pocket as the original strategy indicated (see our response to point 6). (Fig. II, only for review purposes).

      (48) 2. Parametriza7on of Small Compounds: 

      -Provide a detailed description of the parametrization process for the small compounds used in the study. Specify the force field and parameters employed, considering the obsolescence of AMBER14 and ff14SB. Consider adopting more contemporary force fields and parameterization strategies. 

      When we performed these experiments, some years ago, the force fields applied (ff14SB, AMBER14 used in MD or OPLS2004 in docking with Glide) were well accepted and were gold standards. It is, however, true that the force fields have evolved in the past few years, Moreover, in the case of the MD simulations, to consider the parameters of the ligands that are not contained within the force field, we performed an additional parameterization as a standard methodology. We then generated an Ab initio optimization of the ligand geometry, defining as basis sets B3LYP 6-311+g(d), using Gaussian 09, Revision A.02, and then a single point energy calculation of ESP charges, with HF 6311+g(d) on the optimized structure. As the last step of the parametrization, the antechamber module was used to adapt these charges and additional parameters for MD simulations.

      (49) 3. Treatment of Lipids and Membrane: 

      -Elaborate on how lipids were treated in the system. Clearly describe whether a membrane was included in the simulations and provide details on its composition and structure. Address the role of the membrane in the study and its relevance to the interactions between CXCR4 and small compounds 

      To stabilize CXCR4 and more accurately reproduce the real environment in the MD simulation, the system was embedded in a lipid bilayer using the Membrane Builder tool (Sunhwan J. et al. Biophys. J. 2009) from the CHARMM-GUI server. The membrane was composed of 175 molecules of the fatty acid 1-palmitoyl-2-oleoyl-sn-glycero-3phosphocholine (POPC) in each leaflet. The protein-membrane complex was solvated with TIP3 water molecules. Chloride ions were added up to a concentration of 0.15 M in water, and sodium ions were added to neutralize the system. This information was previously described in detail.

      (50) 4. Molecular Dynamics Protocol: 

      -Provide a more detailed and coherent explanation of the molecular dynamics protocol. Clarify the specific steps, parameters, and conditions used in the simulations. Ensure that the protocol aligns with established best practices in the field.

      Simulations were calculated on an Asus 1151 h170 LVX-GTX-980Ti workstation, with an Intel Core i7-6500 K Processor (12 M Cache, 3.40 GHz) and 16 GB DDR4 2133 MHz RAM, equipped with a Nvidia GeForce GTX 980Ti available for GPU (Graphics Processing Unit) computations. MD simulations were performed using AMBER14 (Case D.A. et al. AMBERT 14, Univ. of California, San Francisco, USA, 2014) with ff14SB (Maier J.A. et al. J. Chem. Theory Comput. 2015) and lipid14 (Dickson C. J. et al. J. Chem. Theory Comput. 2014) force fields in the NPT thermodynamic ensemble (constant pressure and temperature). Minimization was performed using 3500 Steepest Descent steps and 4500 Conjugate Gradient steps three times, firstly considering only hydrogens, next considering only water molecules and ions, and finally minimizing all atoms. Equilibration raises system temperature from 0 to 300 K at a constant volume fixing everything but ions and water molecules. After thermalization, several density equilibration phases were performed. In the production phase, 50 ns MD simulations without position restraints were calculated using a time step of 2 fs. Trajectories of the most interesting poses were extended to 150 ns. All bonds involving hydrogen atoms were constrained with the SHAKE algorithm (Lippert R.A. et al. J. Chem. Phys. 2007). A cutoff of 8 Å was used for the Lennard-Jones interaction and the short-range electrostatic interactions. Berendsen barostat (Berendsen H.J. et al. J. Chem. Phys.  1984) and Langevin thermostat were used to regulate the system pression and temperature, respectively. All trajectories were processed using CPPTRAJ (Roe D.R. & Cheatham III T.E. J. Chem. Theory Comput. 2013) and visualized with VMD (Visual Molecular Dynamics) (Humphrey W. et al. J. Mol. Graphics. 1996). To reduce the complexity of the data, Principal Component Analysis (PCA) was performed on the trajectories using CPPTRAJ.

      (51) Consider updating the molecular dynamics protocol to incorporate more contemporary methodologies, considering advancements in simulation techniques and software.

      In our answer to points 6 and 47, we describe why we use the technology based on Swiss-model and PELE analysis and how we have now used Alphafold and other more contemporary methodologies to confirm that the small compounds bind the selected pocket.

      (52) Figure 1A: 

      •  Consider switching to a cavity representation for CXCL12 to enhance clarity and emphasize the cleft.

      Fig. 1A has been modified to emphasize the cleft.

      (53) Explicitly show the TMV-TMVI cleft in the figure for a more comprehensive visualization. 

      In Fig. 1A we have added an insert to facilitate TMV-TMVI visualization.

      (54) Figure 1B: 

      •  Clearly explain the meaning of the second DMSO barplot to avoid confusion. 

      To clarify this panel, we have modified the figure and the figure legend. Panel B now includes a complete titration of the three compounds analyzed in the manuscript.  The first bar shows cell migration in the absence of both treatment with AMD3100 and stimulation with CXCL12.  The second bar shows migration in response to CXCL12 in the absence of AMD3100. The third bar shows the effect of AMD3100 on CXCL12-induced migration, as a known control of inhibition of migration.  We hope that this new representation of the data results is clearer.

      (55) Figure 1C: 

      •  Provide a clear legend explaining the significance of the green shading on the small compounds. 

      The legend for Fig. 1C has been modified accordingly to the reviewer’s suggestion.

      (56) Figure 2: 

      •  Elaborate on the role of fibronectin in the experiment and explain the specific contribution of CD86-AcGFP.

      The ideal situation for TIRF-M determinations is to employ cells on a physiological substrate complemented with or without chemokines. Fibronectin is a substrate widely used in different studies that allows cell adhesion, mimicking a physiological situation. Jurkat cells express alpha4beta1 and alpha5beta1 integrins that mediate adhesion to fibronectin (Seminario M.C. et al. J. Leuk. Biol. 1999).

      Regarding the use of CD86-AcGFP in TIRF-M experiments. We currently determine the number of receptors in individual trajectories of CXCR4 using, as a reference, the MSI value of CD86-AcGFP that strictly showed a single photobleaching step (Dorsch S. et al. Nat Methods 2009).

      We preferred to use CD86-AcGFP in cells instead of AcGFP on glass, to exclude any potential effect on the different photodynamics exhibited by AcGFP when bound directly to glass. In any case, this issue has been clarified in the revised version.

      (57) Figure 3D: 

      •  Include a plot for the respective band intensity to enhance data presentation 

      The plot showing the band intensity analysis of the experiments shown in Fig. 3D was already included in the original version (see old Supplementary Fig. 3). However, in the revised version, we include these plots in the same figure as panels 3E and 3F.  As a control of inhibition of CXCL12 stimulation, we have also included a new figure (Supplementary Fig. 4) showing the effect of AMD3100 on CXCL12-induced activation of Akt and ERK as analyzed by western blot.

      (58) Consider adding AMD3100 as a control for comparison. 

      In agreement with the reviewer’s suggestion, we have added the effect of AMD3100 in most of the functional experiments performed.

      (59) Figure 4: 

      •  Address the lack of positive controls in Figure 4 and consider their inclusion for a more comprehensive analysis. 

      DMSO bars correspond to the control of the experiment, as they represent the effect of CXCL12 in the absence of any allosteric modulator. As previously described in this point-by-point reply, DMSO bars correspond to the control performed with the solvent with which the small compounds, at maximum concentration, are diluted.  Therefore, they show the effect of the solvent on CXCL12 responses. In any case, and in order to facilitate the comprehension of the figure we have also added the controls in the absence of DMSO to demonstrate that the solvent does not affect CXCL12-mediated functions, together with the effect of the orthosteric inhibitor AMD3100. In addition, we have also included representative images of the effect of the different compounds on CXCL12-induced polarization (Fig. 4C).

      (60) In Figure 4A, carefully assess overlapping error bars and ensure accurate interpreta7on. If necessary, consider alternative representation. 

      We have tried alternative representations of data in Fig. 4A, but in all cases the figure was unclear. We believe that the way we represent the data in the original manuscript is the most clear and appropriate.  Nevertheless, we have now included significance values as a table annexed to the figure, as well as the effect of AMD3100, as a control of inhibition

      (61) Supplementary Figure 1A: 

      •  Improve the clarity of bar plots for better understanding. Consider reordering them from the most significant to the least. 

      This was a good idea, and therefore Supplementary Fig. 1A has been reorganized to improve clarity.

      (62) Supplementary Figure 1C: 

      •  Clarify the rationale behind choosing the 12.5 nM concentration and explain if different concentrations of CXCL12 were tested. 

      In old Supplementary Fig. 1C, we used untreated cells, that is, CXCL12 was not present in the assay.  These experiments were performed to test the potential toxicity of DMSO (solvent) or the negative allosteric modulators on Jurkat cells. The 12.5 nM concentration of CXCL12 mentioned in the figure legend applied only to panels A and B, as indicated in the figure legend. We previously optimized this concentration for Jurkat cells using different concentrations of CXCL12 between 5 and 100 nM.  Nevertheless, we have reorganized old supplementary fig. 1 and clarified the figure legend to avoid misinterpretations (see Supplementary Fig 1A, B and Supplementary Fig. 2A, B).

      (63) Explain the observed reduction in fluorescence intensity for AGR1.135. 

      The cell cycle analysis has been moved from Supplementary Fig. 1C to a new Supplementary Fig. 2.  It now includes the flow cytometry panels to show fluorescence intensity as a function of the number of cells analyzed (Panel 1A) as well as a table (panel B) with the percentage of cells in each phase of the cell cycle. We believe that the apparent reduction in fluorescence that the reviewer observes is mainly due to the number of events analyzed. However, we have changed the flow cytometry panels for others that are more representative and included a table with the mean of the different results. When we determined the percentage of cells in each cell cycle phase, we observed that it looks very similar in all the experimental conditions. That is, none of the compounds affected any of the cell cycle phases. We have also included the effect of H2O2 and staurosporine as control compounds inducing cell death and cell cycle alteration of Jurkat cells.

      (64) Supplementary Table 1: 

      •  Include a column specifying the scoring for each compound to provide a clear reference for readers. 

      To facilitate references to readers, we have now included the inhibitory effect of each compound on Jurkat cell migration in the revised version of this table. 

      (65) Minor Points 

      Page 2 - Abstract: Rephrase the first sentence of the abstract to enhance fluidity. 

      Although the entire manuscript was revised by a professional English editor, we appreciate the valuable comments of this reviewer and we have corrected these issues accordingly.

      (66) Page 2 - Abstract: Explicitly define "CXCR4" as "C-X-C chemokine receptor type 4" the first time it appears.

      We have not used C-X-C chemokine receptor type 4 the first time it appears in the abstract. CXCR4 is an acronym normally accepted to identify this chemokine receptor, and it is used as CXCR4 in many articles published in eLife. However, we introduce the complete name the first time it appears in the introduction.

      (67) Page 2 - Abstract: Explicitly define "CXCL12" as "C-X-C motif chemokine 12" the first time it is mentioned. 

      As we have discussed in the previous response, we have not used C-X-C motif chemokine 12 the first time CXCL12 appears in the abstract, as it is a general acronym normally accepted to identify this specific chemokine, even in eLife papers. However, we introduce the complete name the first time it appears in the introduction section.

      (68) Page 2 - Abstract: Explicitly define "TMV and TMVI" upon its first mention.

      The acronym TM has been defined as “Transmembrane” in the revised version

      (69) Page 2 - Abstract: Review the use of "in silico" in the sentence for accuracy and consider revising if necessary.

      With the term “in silico” we want to refer to those experiments performed on a computer or via computer simulation software. We have carefully reviewed its use in the new version of the manuscript.

      (70) Page 2 - Abstract: Add a comma after "compound" in the sentence, "We identified AGR1.137, a small compound that abolishes...".

      A comma after “compound” has been added in the revised sentence.

      (71) Page 2 - Significance Statement: Rephrase the first sentence of the "Significance Statement" to avoid duplication with the abstract.

      The first sentence of the Significance Statement has been revised to avoid duplication with the abstract. 

      (72) Page 2 - Significance Statement: Break down the lengthy sentence, "Here, we performed in silico analyses..." for better readability. 

      The sentence starting by “Here, we performed in silico analyses…” has been broken down in the revised manuscript.

      (73) Page 2 - Introduction: Replace "Murine studies" with a more specific term for clarity.

      The term “murine studies” is normally used to refer to experimental studies developed in mice. We have nonetheless rephrased the sentence.

      (74) Page 3 - Introduction: Rephrase the sentence for clarity: "Finally, using a zebrafish model, ..."

      The sentence has been now rephrased for clarity.

      (75) Results-AGR1.135 and AGR1.137 block CXCL12-mediated CXCR4 nanoclustering and dynamics: 

      Rephrase the sentence for clarity: "Retreatment with AGR1.135 and AGR1.137, but not with AGR1.131, substantially impaired CXCL12-mediated receptor nanoclustering.”

      The sentence has been rephrased for clarity.

      (76) Results - AGR1.135 and AGR1.137 incompletely abolish CXCR4-mediated responses in Jurkat cells: Clarify the sentence: "In contrast to the effect promoted by AMD3100, a binding-site antagonist of CXCR4..."

      The sentence has been modified for clarity.

      (77) Consider using "orthosteric" instead of "binding-site" antagonist.

      The term orthosteric is now used throughout to refer to a binding site antagonist.

      (78) Discussion: Use the term "in silico" only when necessary.

      We have carefully reviewed the use of “in silico” in the manuscript.

      (79) Discussion: Clarify the sentence: "...not affect neither CXCR2-mediated cell migration...". Confirm if "CXCL12" is intended.

      The sentence refers to the chemokine receptor CXCR2, which binds the chemokine CXCL2. To test the specificity of the compounds for the CXCL12/CXCR4 axis, we evaluated CXCL2-mediated cell migration.  The results indicated that CXCL2/CXCR2 axis was not affected by the negative allosteric modulators, whereas CXCL12-mediated cell migration was blocked.  The sentence has been clarified in the new version of the manuscript.

      (80) Figure 4B: Bold the "B" in the figure label for consistency.

      The “B” in Fig. 4B has been bolded.

      Reviewer #2

      (1) Fig 2. The SPT data is sub-optimal in its presentation as well as analysis. Example images should be shown. The analysis and visualization of the data should be reconsidered for improvements. Graphs with several hundreds, in some conditions over 1000 tracks, per condition are very hard to compare. The same (randomly selected representative set) number of data points should be shown for better visualization. Also, more thorough analyses like MSD or autocorrelation functions are lacking - they would allow enhanced overall representation of the data.

      In agreement with the reviewer’s commentary, we have modified the representation of Fig. 2. We have carefully read the paper published by Lord S.J. and col. (Lord S. J. et al., J. Cell Biol. 2020) and we apply their recommendations for these type of data. We have also included as supplementary material representative videos for the TIRF-M experiments performed to allow readers to visualize the original images. Regarding the MSD analyses, they were developed to determine all D1-4 values. According to the data published by Manzo & García-Parajo (Manzo C. & García-Parajo M.F. Rep.Prog. Phys. 2015) due to the finite trajectory length the MSD curve at large tlag has poor statistics and deviates from linearity. However, the estimation of the Diffusion Coefficient (D1-4) can be obtained by fitting of the short tlag region of the MSD plot giving a more accurate idea of the behavior of particles. In agreement we show D1-4 values and not MSD data. 

      Due to the space restrictions, it is very difficult to include all the figures generated, but, only for review purposes, we included in this point-by-point reply some representative plots of the MSD values as a function of the time from individual trajectories showing different types of motion obtained in our experiments (Author response image 7).

      Author response image 7.

      Representative MSD plots from individual trajectories of CXCR4-AcGFP showing different types of motion: A) confined, B) Brownian/Free, C) direct transport of CXCR4-AcGFP particles diffusing at the cell membrane detected by SPT-TIRF in resting JKCD4 cells.

      Further analysis, such as the classification based on particle motion, has not been included in this article. This classification uses the moment scaling spectrum (MSS), described by Ewers H. et al. 2005 PNAS, and requires particles with longer trajectories (>50 frames). Only for review purposes, we include a figure showing the percentage of the MSS-based particle motion classification for each condition. As expected, most of long particles are confined, with a slight increase in the percentage upon CXCL12 stimulation in all conditions, except in cell treated with AGR1.137 (Author response image 8).

      Author response image 8.

      Effects of the negative allosteric modulators on the Types of Motion of CXCR4. Percentage of single trajectories with different types of motion, classified by MSS (DMSO: 58 particles in 59 cells on FN; 314 in 63 cells on FN+CXCL12; AGR1.131: 102 particles in 71 cells on FN; 258in 69 cells on FN+CXCL12; AGR1.135: 86 particles in 70 cells on FN; 120 in 77 cells on FN+CXCL12; AGR1.137: 47 particles in 66 cells on FN; 74 in 64 cells on FN+CXCL12) n = 3.

      (2) Fig 3. The figure legends have inadequate information on concentrations and incubation times used, both for the compounds and other treatments like CXCL12 and forskolin. For the Western blot data, also the quantification should be added to the main figure. The compounds, particularly AGR1.137 seem to lead to augmented stimulation of pAKT and pERK. This should be discussed

      The Fig. 3 legend has been corrected in the revised manuscript. Fig. 3D now contains representative western blots and the densitometry evaluation of these experiments. As the reviewer indicates, we also detected in the western blot included, augmented stimulation of pAKT and pERK in cells treated with AGR1.137. However, as shown in the densitometry analysis, no significant differences were noted between the data obtained with each compound. As a control of inhibition of CXCL12 stimulation we have included a new Supplementary Fig. 4 showing the effect of AMD3100 on CXCL12-induced activation of Akt and ERK as analyzed by western blot.

      (3) Fig. 4 immunofluorescence data on polarization as well as the flow chamber data lack the representative images of the data. The information on the source of the T cells is missing. Not clear if this experiment was done on bilayers or on static surfaces.

      Representative images for the data shown in Figure 4B have been added in the revised figure (Fig. 4C). The experiments in Fig. 4B were performed on static surfaces. As indicated in the material and methods section, primary T cell blasts were added to fibronectin-coated glass slides and then were stimulated or not with CXCL12 (5 min at 37ºC) prior to fix permeabilize and stain them with Phalloidin. Primary T cell blasts were generated from PBMCs isolated from buffy coats that were activated in vitro with IL-2 and PHA as indicated in the material and methods section.

      (4) The data largely lacks titration of different concentrations of the compounds. How were the effective concentration and treatment times determined? What happens at higher concentrations? It is important to show, for instance, if the CXCR12 binding gets inhibited at higher concentrations. most experiments were performed with 50 uM, but HeLa cell data with 100 uM. Why and how was this determined? 

      The revised version contains a new panel in Fig. 1B to show a more detailed kinetic analysis with different concentrations (1-100 µM) of the compounds in the migration experiments using Jurkat cells. We choose 50 µM for further studies as it was the concentration that inhibits 50-75% of the ligand induced cell migration. 

      We have also included the effect of two doses of the compounds (10 and 50 µM) in the zebrafish model as well as AMD3100 (1 and 10 µM) as control (new Fig. 7D, E).  Tumors were imaged within 2 hours of implantation and tumor-baring embryos were treated with either vehicle (DMSO) alone, AGR1.131 or AGR1.137 at 10 and 50 µM or AMD3100 at 1 and 10 µM for three days, followed by re-imaging.

      Regarding the amount of CXCL12 used in these experiments, with the exception of cell migration assays in Transwells, where the optimal concentration was established at 12.5 nM, in all the other experiments the optimal concentration of CXCL12 employed was 50 nM. In the case of the directional cell migration assays, we use 100 nM to create the chemokine gradient in the device. These concentrations have been optimized in previous works of our laboratory using these types of experiments. It should also be noted that in the experiments using lipid bilayers or TIRF-M experiments, CXCL12 is used to coat the plates and therefore it is difficult to determine the real concentration that is retained in the surface after the washing steps performed prior adding the cells.

      (5) The authors state that they could not detect direct binding of the compounds and the CXCR14. It should be reported what approaches were tried and discussed why this was not possible. 

      We attempted a fluorescence spectroscopy strategy to formally prove the ability of AGR1.135 to bind CXCR4, but this strategy failed because the compound has a yellow color that interfered with the determinations. We also tried a FRET strategy (see supplementary Fig. 7) and detected a significant increase in FRET efficiency of CXCR4 homodimers in cells treated with AGR1.135; this effect was due to the yellow color of this compound that interferes with FRET determinations. In the same assays, AGR1.137 did not modify FRET efficiency for CXCR4 homodimers and therefore we cannot assume that AGR1.137 binds on CXCR4. All these data have been considered in the revised discussion.

      (6) The proliferation data in Supplementary Figure 1 lacks controls that affect proliferation and indication of different cell cycle stages. What is the conclusion of this data? More information on the effects of the drug to cell viability would be important.

      Toxicity in Jurkat cells was first determined by propidium iodide incorporation. Some compounds (i.e., AGR1.103 and VSP3.1) were discarded from further analysis as they were toxic for cells. In a deeper analysis of cell toxicity, even if these compounds did not kill the cells, we checked whether they could alter the cell cycle of the cells. New Supplementary Fig. 2 includes a table (panel B) with the percentage of cells in each cell cycle phase, and no differences between any of the treatments tested were detected. 

      Nevertheless, to clarify this issue the revised version of the figure also includes H2O2 and staurosporine stimuli to induce cell death and cell cycle alterations as controls of these assays.

      (7) The flow data in Supplementary Figure 2 should be statistically analysed. 

      Bar graphs corresponding to the old Supplementary Fig. 2 (new Supplementary Fig. 3) are shown in Fig. 3B. We have also incorporated the corresponding statistical analysis to this figure. 

      (8) In general, the authors should revise the figure legends to ensure that critical details are added. 

      We have carefully revised all the figure legends in the new version of the manuscript.

      (9) Bar plots are very poor in showing the heterogeneity of the data. Individual data points should be shown whenever feasible. Superplot-type of representation is strongly advised (https://doi.org/10.1083/jcb.202001064).

      We have carefully read the paper published by Lord S.J. and col. (Lord S. J. et al., J. Cell Biol. 2020) and we apply their recommendations for our TIRF-M data (see revised Fig.  2).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations For The Authors): 

      - The title may not reflect the key finding of the paper. It is well established in the field that the disaggregation process is sensitive to perturbations of the levels of the disaggregating factors.

      We have changed the title to better reflect the major finding of the work, the importance of the NEF during the initiation of disaggregation. The new title is: Early Steps of Protein Disaggregation by Hsp70 Chaperone and Class B J-Domain Proteins are Shaped by Hsp110.

      - Abstract:

      Please note that the phrases "stimulation is much limited with class A JDPs", "limited destabilization of the chaperone complex improves disaggregation", and "tuned proportion between the co-chaperones" are hard to understand. Only after having read the manuscript are the meanings of these phrases accessible.

      The phrases in the abstract were changed (page 1, lines 10-14).

      - The subheading "Sse1 improves aggregate modification by Hsp70" on p. 7 is unclear. What is measured is a decrease in aggregate size dependent on Hsp70-JDP as well as Sse1.

      The subheading was changed to include more precise information, into “Sse1 leads to Hsp70-depenent reduction of aggregate size”.

      - The subheading "Biphasic effects of Sse1 on the Hsp70 disaggregation activity" does not describe the finding clearly; "Biphasic effects" is a term that is hard to understand.

      To avoid phrases that can be understood in many ways, we have changed the subheading into “Hormetic effects of Sse1 in Hsp70 disaggregation activity”

      - p.5, last line. Hsp110 typo The typos have been corrected.

      Reviewer #2 (Recommendations For The Authors):

      (1) The article emphasises multiple times the importance of stoichiometry between the (co-)chaperones. Most figures would benefit from an indication of the used stoichiometry (or all absolute concentrations) to support the points made about the stoichiometry, especially the figures showing titrations of Sse1, Sse1-2, and Sis1 (Fig. 3D, 3E, 4A-C, S2B, S5F, S6A-E).

      The information of protein concentrations has been included in all figure captions.

      (2) The manuscript includes a summary model. While this model is a plausible hypothesis of the mechanism of disaggregation by Hsp70, in particular when viewed with previous data (Wyszkowski et al., 2021), it focuses rather heavily on the potential remodeling of clients by Hsp70, which is not the primary focus of the data presented in this manuscript. More emphasis could be put on the JDP class/ functional specificity observed.

      The model has been changed according to the Reviewer’s comments to better reflect the findings presented in the manuscript (Figure 5).

      (3) The methods section is very brief. I recommend including additional details about reaction conditions (temperature, buffer compositions, protein concentrations) even when previously reported elsewhere to improve the readability of the manuscript. Details regarding the DLS experiments performed are missing.

      More detailed information on the experimental conditions has been added to the Methods section, as well as to figure legends.

      (4) Many experiments incorporate BLI to assess the effect of NEFs on the binding of the Hsp70 and JDP to aggregates. Although appropriate controls are included (no ATP, Hsp70, and JDP only), a control with only Hsp70 and the NEF would be useful to determine to which extent the NEF itself alters the thickness of the (Hsp70-bound) aggregate biolayer.

      The suggested controls were added (Figure 1—figure supplement 1 G) and discussed in the manuscript (page 5, lines 23-24).

      Reviewer #3 (Recommendations For The Authors):

      - The refolding assay makes use of Luciferase denatured in 5 M GdnHCl. These conditions lead to a spontaneous refolding yield of 20% (Figure 3C), which is very high and limits conclusions on the effect of Hsp110 but also JDPs on the refolding process. Typically this assay uses 6 M GdnHCl for Luciferase denaturation and under these conditions, spontaneous refolding of Luciferase is hardly observed (e.g. Laufen et al. PNAS 1999). The authors are therefore asked to repeat key experiments using altered (6M) GdnHCl concentrations.

      We based our experiments assessing luciferase refolding on the publication by Imamoglu et al. (2020), in which the authors, using 5 M GdnHCl for luciferase denaturation, demonstrated that spontaneous and chaperone-assisted luciferase refolding strongly depends on luciferase concentration. In this work, a similar degree of luciferase refolding was reported for the same final luciferase concentration (100 nM) as we used in our experiments (Figure 1—figure supplement 1D). As an additional control, we compared the effects of 5 M and 6 M of GdnHCl during denaturation on luciferase refolding under the same conditions (100 nM, 25 °C, 2 h) and we observed no significant differences (Author response image 1).

      Author response image 1.

      Chaperone-assisted folding of luciferase after denaturation at 5 M or 6 M GdnHCl. Luciferase was denatured in 5 M or 6 M GdnHCl according to the protocol in the Materials and Methods section. Luminescence was monitored alone or after incubation with Luminescence was monitored alone or after incubation with Ssa1-Sis1 or Ssa1-Ydj1. Chaperones were used at 1 µM concentration. Luciferase activity was measured after 2 hours and normalized to the activity of the native protein. Error bars indicate SD from three repeats.

      - Figure 1B: The authors are asked to provide binding curves for Ssa1/Sse1 (no Sis1) and Sis1/Sse1 (no Ssa1) as controls. Particularly the latter combination is required as direct cooperation between Hsp110 and JDPs has been suggested in the literature (Mattoo et al., JBC 2013).

      We performed the suggested BLI experiment, and the results are presented in the new Figure 1—figure supplement 1 G (page 5, lines 23-24).

      - Figure 1B (and other figure parts showing BLI data): it is unclear how often the BLI experiments have been performed. This should be stated in the figure legend. Can the authors add SDs to the respective curves?

      We added detailed information about the number of replicates to the figure legends. SD bars were added to the BLI results shown in Figures1-4, apart from the results of titrations, for which, for the sake of clarity, the three replicates are represented in the plots on the right (Figure 3D). In the case of less than 3 repeats of the results presented in the Supplementary Figures, the remaining repeats are added to the provided Source Data file, information about which has been added to the captions of the respective figures. 

      - The observation that Hsp110 can interrupt Hsp70 interaction with JDPs is intriguing. Do the authors envision JDP displacement from the aggregate? If so this could be shown in BLI experiments by monitoring the release of fluorescently labeled Sis1 (similar to labeled Ssa1, Fig. S3C). Or will the released JDP immediately rebind to another binding site on the aggregate? The authors should at least discuss the diverse scenarios as they are relevant to the mechanism of protein disaggregation.

      The proposed experiment is challenging due to the transient nature of Sis1 binding to aggregate and high background observed with the method using the fluorescently labelled proteins. The aspect of chaperone’s re-binding after their release by Hsp110 proposed by the reviewer has been introduced into the Discussion section (pages 12/13, lines 25-4). We speculate that Hsp110 might release an Hsp70 molecule as well as a JDP molecule that had been bound to the aggregate through Hsp70 (Figure 5).  

      - Figure 2B: Ssa1/Sis1/Sse1 strongly decreases the size of Luciferase-GFP aggregates. Yet this activity only allows for limited refolding of aggregated Luciferase and the reaction stays largely dependent on Hsp104. How do the authors envision the role of the hexameric disaggregase in this process? Does it act exclusively on small-sized aggregates after Hsp110-dependent fragmentation?

      A question of the Hsp104 activity with the Hsp70-processed aggregates is indeed intriguing and we agree that it should have been discussed more thoroughly. We added to the manuscript the results of the reactivation of luciferase-GFP with and without Hsp104 to emphasize the role of Hsp104 in the active protein recovery (Figure 2—figure supplement 1A) (page 7, lines 24-27). We propose that aggregate fragmentation by Hsp70-JDPB-Hsp110 increases the effective aggregate surface, at which Hsp104 might become engaged. We do not think that Hsp104 acts only on small aggregates, it might be just more effective, when the number of exposed polypeptides is larger. In the cell, where Hsp104 binds to aggregates of various sizes, protein aggregates apparently also need to undergo such Hsp110-boosted pre-processing by Hsp70, based on the finding that Sse1 is not necessary for Hsp104 recruitment to aggregates, but it is required for Hsp104-dependent disaggregation (Kaimal et al., 2017). We have added a comment on this problem to the Discussion section (pages 11/12, lines 33-4) .

      - Page 9: The authors state that the Sse1-2 variant is nearly as effective as Sse1 Wt in stimulating substrate dissociation and refer to published work (Polier et al., 2008). It is unclear how the variant should have Wtlike activity in triggering substrate release although its activity in catalyzing nucleotide exchange is reduced to 5% (both activities are coupled). The observation that high Sse1-2 concentrations do not inhibit protein disaggregation does not necessarily exclude the possibility that high Sse1 WT concentration inhibit the reaction by overstimulating substrate release. The latter possibility should be considered by the authors and added to the discussion section.

      We agree with the Reviewer that the description of the Sse1-2 variant was misleading, as it was lacking the key information, that according to the published data (Polier et al., 2008), it was 10 times higher the concentration of the Sse1-2 variant than Sse1 WT that had a similar nucleotide-exchange activity to the wild type. We have changed the text (page 9, lines 16-22, page 13, lines 26-28) to avoid confusion as well as the model in the Figure 5, to underline the importance of substrate release as the cause of the Hsp110-dependent inhibition.

      - While similar effects are observed for human class A and class B JDP co-chaperones, they are clearly less pronounced. A mechanistic explanation for the difference between yeast and human chaperones is currently missing and the authors are asked to elaborate on this aspect.

      There are indeed clear differences between the human and yeasts systems, especially regarding the dependence on the NEF. Hsc70 has been reported to have a lower rate of ADP release (Dragovic et al., 2006) and thus might rely more on Hsp110 than its yeast ortholog. For the same reason, the strong Hsc70 stimulation by Hsp105 is also observed with class A JDP. We have added a comment on these effects in the Discussion section (page 12, lines 17-21).

      Minor points

      - Figure S1C (right): the disaggregation rate (%GFP/h) is somewhat misleading/confusing as a value of more than 150%/h is determined in the presence of the complete disaggregation system while only approx. 60% GFP is indeed refolded by the system (Figure S1C, left). Showing the rate as %GFP/min seems more rational.

      We changed the units according to the Reviewer’s comment (Figure 1—figure supplement 1A, C).

      - Figure S5B: Only a single data point is shown for Ssa1/Sis1/Sse1.

      We changed the figure to include datapoints from all three repeats (Figure 3—figure supplement 1 B).

      - There are several typos throughout the manuscript. A more careful proofreading is recommended

      We have corrected the typos.

      Reviewer #1 (Public Review):

      The experiments differ somewhat in regard to the aggregated protein used. For example, in Figure 1A, FFL is used with only limited reactivation (10% reactivated at the last timepoint and the curve is flattening), while in Figure 2B FFL-EGFP is used to monitor microscopically what appears to be complete disaggregation. Does FFL-EGFP behave the same as FFL in assays such as the one in Figure 1A or are there major differences that may impact how the data should be interpreted?

      We added the results of Luc-GFP reactivation (Figure 2—figure supplement 1 B) (discussed on page 7, lines 24-27 of the manuscipt) which agree with the results obtain with Luciferase as a substrate (Figure 1—figure supplement 1 B). They clearly show that the Ssa1-Sis1-Sse1-dependent decrease in aggregate size is not associated with the recovery of active protein.

      Reviewer #2 (Public Review):

      Experimental data concerning the class A JDPs should be interpreted with caution. These experiments show very small reactivation activities for luciferase in the range of 0-1% without the addition of Hsp104 and 0-15% with the addition of Hsp104. Moreover, since the assay is based on the recovery of luciferase activity, it conflates two chaperone activities, namely disaggregation and refolding. It is possible that the small degree of reactivation observed for the class A JDP reflects a minor subpopulation of the aggregated species that is particularly easy to disaggregate/refold and may thus not be representative of bulk behaviour.

      The disaggregation by the Hsp70 system can be enhanced by the addition of small heat shock proteins at the step of substrate aggregation (Rampelt et al., 2012). However, sHsps compete with Hsp70 for binding to the aggregate (Żwirowski et al., 2017) and for that reason we decided not to include sHsps in the experiments presented in the manuscript, as it would introduce another level of complexity. However, as a control, we performed the disaggregation assay with Hsp70 with Ydj1 using luciferase aggregates formed in the presence or absence of sHsp (Author response image 2). In 1 h, the Hsp70 system without Hsp104 yielded 5% of recovered luciferase activity and the system with Hsp104, 23% compared to the native. The impact of Sse1 on Ssa1-Ydj1 and Ssa1-Ydj1-Hsp104 was similar as for luciferase aggregates formed without sHsps (Figure 1A, Figure 1—figure supplement 1 B). Furthermore, according to the Reviewer’s comment, we have changed the Figure 5 to underscore the more prominent role of class A JDPs in the final protein folding than in disaggregation.

      Author response image 2.

      Disaggregaton of heat-aggregated luciferase – impact of sHsps. Luciferase (2 μM) was denatured with (blue) or without (red) Hsp26 (20 μM) at 45 ̊C for 15 min in the buffer A (Materials and Methods). Upon 100-fold dilution with the buffer A, supplemented wih 5 mM ATP, 2 mM DTT, 1.2 μM creatine kinase, 20 mM creatine phosphate, chaperones indicated in the legend were added to the final concentration of 1 μM, except for Sse1, concentration of which was 0.1 μM. Shown is luciferase activity measured after 1 h of incubation at 25 °C, normalized to the activity of native luciferase.

      Reviewer #3 (Public Review):

      Enhanced recruitment of Hsp70 in the presence of Hsp110 was shown for amyloid fibrils before (Beton et al., EMBO J 2022) and should be acknowledged. 

      We have added the suggested citation with a respective comment (page 11, lines 20-21).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      This paper details a study of endothelial cell vessel formation during zebrafish development. The results focus on the role of aquaporins, which mediate the flow of water across the cell membrane, leading to cell movement. The authors show that actin and water flow together drive endothelial cell migration and vessel formation. If any of these two elements are perturbed, there are observed defects in vessels. Overall, the paper significantly improves our understanding of cell migration during morphogenesis in organisms.

      Strengths:

      The data are extensive and are of high quality. There is a good amount of quantification with convincing statistical significance. The overall conclusion is justified given the evidence.

      Weaknesses:

      There are two weaknesses, which if addressed, would improve the paper.

      (1) The paper focuses on aquaporins, which while mediates water flow, cannot drive directional water flow. If the osmotic engine model is correct, then ion channels such as NHE1 are the driving force for water flow. Indeed this water is shown in previous studies. Moreover, NHE1 can drive water intake because the export of H+ leads to increased HCO3 due to the reaction between CO2+H2O, which increases the cytoplasmic osmolarity (see Li, Zhou and Sun, Frontiers in Cell Dev. Bio. 2021). If NHE cannot be easily perturbed in zebrafish, it might be of interest to perturb Cl channels such as SWELL1, which was recently shown to work together with NHE (see Zhang, et al, Nat. Comm. 2022).

      (2) In some places the discussion seems a little confusing where the text goes from hydrostatic pressure to osmotic gradient. It might improve the paper if some background is given. For example, mention water flow follows osmotic gradients, which will build up hydrostatic pressure. The osmotic gradients across the membrane are generated by active ion exchangers. This point is often confused in literature and somewhere in the intro, this could be made clearer.

      Reviewer #1 (Recommendations For The Authors):

      (1) The paper focuses on aquaporins, which while mediating water flow, cannot drive directional water flow. If the osmotic engine model is correct, then ion channels such as NHE1 are the driving force for water flow. Indeed this water is shown in previous studies. Moreover, NHE1 can drive water intake because the export of H+ leads to increased HCO3 due to the reaction between CO2+H2O, which increases the cytoplasmic osmolarity (see Li, Zhou and Sun, Frontiers in Cell Dev. Bio. 2021). If NHE cannot be easily perturbed in zebrafish, it might be of interest to perturb Cl channels such as SWELL1, which was recently shown to work together with NHE (see Zhang, et al, Nat. Comm. 2022).

      We thank Reviewer #1 for this very important comment and the suggestion to examine the function of ion channels in establishing an osmotic gradient to drive directional flow. We have taken on board the reviewer’s suggestion and examined the expression of NHE1 and SWELL1 in endothelial cells using published scRNAseq of 24 hpf ECs (Gurung et al, 2022, Sci. Rep.). We found that slc9a1a, slc9a6a, slc9a7, slc9a8, lrrc8aa and lrrc8ab are expressed in different endothelial subtypes. To examine the function of NHE1 and SWELL1 in endothelial cell migration, we used the pharmacological compounds, 5-(N-ethyl-Nisopropyl)amiloride (EIPA) and DCPIB, respectively. While we were unable to observe an ISV phenotype after EIPA treatment at 5, 10 and 50µM, we were able to observe impaired ISV formation after DCPIB treatment that was very similar to that observed in Aquaporin mutants. We were very encouraged by these results and proceeded to perform more detailed experiments whose results have yielded a new figure (Figure 6) and are described and discussed in lines 266 to 289 and 396 to 407, respectively, in the revised manuscript.

      (2) In some places the discussion seems a little confusing where the text goes from hydrostatic pressure to osmotic gradient. It might improve the paper if some background is given. For example, mention water flow follows osmotic gradients, which will build up hydrostatic pressure. The osmotic gradients across the membrane are generated by active ion exchangers. This point is often confused in literature and somewhere in the intro, this could be made clearer.

      Thank you for pointing out the deficiency in explaining how osmotic gradients drive water flow to build up hydrostatic pressure. We have clarified this in lines 50, 53 - 54 and 385.

      The two recommendations listed above would improve the paper. They are however not mandatory. The paper would be acceptable with some clarifying rewrites. I am not an expert on zebrafish genetics, so it might be difficult to perturb ion channels in this model organism. Have the authors tried to perturb ion channels in these cells?

      We hope that our attempts at addressing Reviewer’s 1 comments are satisfactory and sufficient to clarify the concerns outlined.

      Reviewer #2 (Public Review):

      Summary:

      Directional migration is an integral aspect of sprouting angiogenesis and requires a cell to change its shape and sense a chemotactic or growth factor stimulus. Kondrychyn I. et al. provide data that indicate a requirement for zebrafish aquaporins 1 and 8, in cellular water inflow and sprouting angiogenesis. Zebrafish mutants lacking aqp1a.1 and aqp8a.1 have significantly lower tip cell volume and migration velocity, which delays vascular development. Inhibition of actin formation and filopodia dynamics further aggravates this phenotype. The link between water inflow, hydrostatic pressure, and actin dynamics driving endothelial cell sprouting and migration during angiogenesis is highly novel.

      Strengths:

      The zebrafish genetics, microscopy imaging, and measurements performed are of very high quality. The study data and interpretations are very well-presented in this manuscript.

      Weaknesses:

      Some of the mechanobiology findings and interpretations could be strengthened by more advanced measurements and experimental manipulations. Also, a better comparison and integration of the authors' findings, with other previously published findings in mice and zebrafish would strengthen the paper.

      We thank Reviewer #2 for the critique that the paper can be strengthened by more advanced measurements and experimental manipulations. One of the technical challenges that we face is how to visualize and measure water flow directly in the zebrafish. We have therefore taken indirect approaches to assess water abundance in endothelial cells in vivo. One approach was to measure the diffusion of GEM nanoparticles in tip cell cytoplasm in wildtype and Aquaporin mutants, but results were inconclusive. The second was to measure the volume of tip cells, which should reflect water in/outflow. As the second approach produced clear and robust differences between wildtype ECs, ECs lacking Aqp1a.1 and Aqp8a.1 and ECs overexpressing Aqp1a.1 (revised Fig. 5), we decided to present these data in this manuscript.

      We have also taken Reviewer 2 advice to better incorporate previously published data in our discussion (see below and lines 374 to 383 of the revised manuscript).

      Reviewer #2 (Recommendations For The Authors):

      I have a few comments that the authors may address to further improve their manuscript analysis, quality, and impact.

      Major comments:

      (1) Citation and discussion of published literature

      The authors have failed to cite and discuss recently published results on the role of aqp1a.1 and aqp8a.1 in ISV formation and caliber in zebrafish (Chen C et al. Cardiovascular Research 2024). That study showed a similar impairment of ISV formation when aqp1a.1 is absent but demonstrated a stronger phenotype on ISV morphology in the absence of aqp8a.1 than the current manuscript by Kondrychyn I et al. Furthermore, Chen C et al show an overall decrease in ISV diameter in single aquaporin mutants suggesting that the cell volume of all ECs in an ISV is affected equally. Given this published data, are ISV diameters affected in single and double mutants in the current study by Kondrochyn I et al? An overall effect on ISVs would suggest that aquaporin-mediated cell volume changes are not an inherent feature of endothelial tip cells. The authors need to analyse/compare and discuss all differences and similarities of their findings to what has been published recently.

      We apologise for having failed and discussed the recently published paper by Chen et al. This has been corrected and discussed in lines 374 to 383.

      In the paper by Chen et al, the authors describe a role of Aqp1a.1 and Aqp8a.1 in regulating ISV diameter (ISV diameter was analysed at 48 hpf) but they did not examine the earlier stages of sprouting angiogenesis between 20 to 30 hpf, which is the focus of our study. We therefore cannot directly compare the ISV phenotypes with theirs. Nevertheless, we recognise that there are differences in ISV phenotypes from 2 dpf. For example, they did not observe incompletely formed or missing ISVs at 2 and 3 dpf, which we clearly observe in our study. This could be explained by differences in the mutations generated. In Chen et al., the sgRNA used targeted the end of exon 2 that resulted in the generation of a 169 amino acid truncated aqp1a.1 protein. However, in our approach, our sgRNA targeted exon 1 of the gene that resulted in a truncated aqp1a.1 protein that is 76 amino acid long. As for the aqp8a.1 zebrafish mutant that we generated, our sgRNA targeted exon 1 of the gene that resulted in a truncated protein that is 73 amino acids long. In Chen et al., the authors did not generate an aqp8a.1 mutant but instead used a crispant approach, which leads to genetic mosaicism and high experimental variability.

      Following the reviewer’s suggestion, we have now measured the diameters of arterial ISVs (aISVs) and venous ISVs (vISVs) in aqp1a.1<sup>-/-</sup>, aqp8a.1<sup>-/-</sup> and aqp1a.1<sup>-/-</sup>;aqp8a.1<sup>-/-</sup> zebrafish. In our lab, we always make a distinction between aISVs and vISVs are their diameters are significantly different from each other. The results are in Fig S11A. While we corroborate a decrease in diameter in both aISVs and vISVs in single aqp1a.1<sup>-/-</sup> and double aqp1a.1<sup>-/-</sup>;aqp8a.1<sup>-/-</sup>.zebrafish, we observed a slight increase in diameter in both aISVs and vISVs in aqp8a.1<sup>-/-</sup> zebrafish at 2 dpf. We also measured the diameter of aISV and vISV in Tg(fli1ep:aqp1a.1-mEmerald) and Tg(fli1ep:aqp8a.1-mEmerald) zebrafish at 2 dpf (Fig S11B) and unlike in Chen et al., we could not detect a difference in the diameter between control and aqp1a.1- or aqp8a.1-overexpressing endothelial cells.

      We also would also like to point out that, because ISVs are incompletely formed or are missing in aqp1a.1<sup>-/-</sup>;aqp8a.1<sup>-/-</sup> zebrafish (Fig. 3G – L), blood flow is most likely altered in the zebrafish trunk of these mutants, and this can have a secondary effect on blood vessel calibre or diameter. In fact, we often observed wider ISVs adjacent to unperfused ISVs (Fig. 3J) as more blood flow enters the lumenized ISV. Therefore, to determine the cell autonomous function of Aquaporin in mediating cell volume changes in vessel diameter regulation, one would need to perform cell transplantation experiments where we would measure the volume of single aqp1a.1<sup>-/-</sup>;aqp8a.1<sup>-/-</sup> endothelial cells in wildtype embryos with normal blood flow. As this is beyond the scope of the present study, we have not done this experiment during the revision process.

      (2) Expression of aqp1a.1 and aqp8a.1

      The quantification shown in Figure 1G shows a relative abundance of expression between tip and stalk cells. However, it seems aqp8a.1 is almost never detected in most tip cells. The authors could show in addition, the % of Tip and stalk cells with detectable expression of the 2 aquaporins. It seems aqp8a1 is really weakly or not expressed in the initial stages. Ofcourse the protein may have a different dynamic from the RNA.

      We would like to clarify that aqp8a.1 mRNA is not detected in tip cells of newly formed ISVs at 20hpf. At 22 hpf, it is expressed in both tip cells (22 out of 23 tip cells analysed) and stalk cells of ISVs at 22hpf. This is clarified in lines 107 - 109. We also include below a graph showing that although aqp8a.1 mRNA is expressed in tip cells, its expression is higher in stalk cells.

      Author response image 1.

      Could the authors show endogenously expressed or tagged protein by antibody staining? The analysis of the Tg(fli1ep:aqp8a.1-mEmerald)rk31 zebrafish line is a good complement, but unfortunately, it does not reveal the localization of the endogenously expressed protein. Do the authors have any data supporting that the endogenously expressed aqp8a.1 protein is present in sprouting tip cells?

      We tested several antibodies against AQP1 (Alpha Diagnostic International, AQP11-A; ThermoFisher Scientific, MA1-20214; Alomone Labs, AQP-001) and AQP8 (Sigma Aldrich, SAB 1403559; Alpha Diagnostic International, AQP81-A; Almone Labs, AQP-008) but unfortunately none worked. As such, we do not have data demonstrating endogenous expression and localisation of Aqp1a.1 and Aqp8a.1 proteins in endothelial cells.

      Could the authors perform F0 CRISPR/Cas9 mediated knockin of a small tag (i.e. HA epitope) in zebrafish and read the endogenous protein localization with anti-HA Ab?

      CRISPR/Cas9 mediated in-frame knock-in of a tag into a genomic locus is a technical challenge that our lab has not established. We therefore cannot do this experiment within the revision period.

      Given the double mutant phenotypic data shown, is aqp8a.1 expression upregulated and perhaps more important in aqp1a.1 mutants?

      In our analysis of aqp1a.1 homozygous zebrafish, there is a slight down_regulation in _aqp8a.1 expression (Fig. S5C). Because the loss of Aqp1a.1 leads to a stronger impairment in ISV formation than the loss of Aqp8a.1 (see Fig. S6F, G, I and J), we believe that Aqp1a.1 has a stronger function than Aqp8a.1 in EC migration during sprouting angiogenesis.

      Regarding the regulation of expression by the Vegfr inhibitor Ki8751, does this inhibitor affect Vegfr/ERK signalling in zebrafish and the sprouting of ISVs significantly?

      ki8751 has been demonstrated to inhibit ERK signalling in tip cells in the zebrafish by Costa et al., 2016 in Nature Cell Biology. In our experiments, treatment with 5 µM ki8751 for 6 hours from 20 hpf also inhibited sprouting of ISVs.

      The data presented suggest that tip cells overexpressing aqp1a.1-mEmerald (Figure 2C) need more than 6 times longer to migrate the same distance as tip cells expressing aqp8a.1mEmerald (Figure 2D). How does this compare with cells expressing only Emerald? A similar time difference can be seen in Movie S1 and Movie S2. Is it just a coincidence? Could aqp8a.1, when expressed at similar levels than aqp1a, be more functional and induce faster cell migration? These experiments were interpreted only for the localization of the proteins, but not for the potential role of the overexpressed proteins on function. Chen C et al. Cardiovascular Research 2024 also has some Aqp overexpression data.

      The still images prepared for Fig. 2 C and D were selected to illustrate the localization of Aqp1a.1-mEmerald and Aqp8a.1-mEmerald at the leading edge of migrating tip cells. We did not notice that the tip cell overexpressing Aqp1a.1-mEmerald (Figure 2C) needed more than 6 times longer to migrate the same distance as the tip cell expressing aqp8a.1-mEmerald (Figure 2D), which the reviewer astutely detected. To ascertain whether there is a difference in migration speed between Aqp1a.1-mEmerald and Aqp8a.1-mEmerald overexpressing endothelial cells, we measured tip cell migration velocity of three ISVs from Tg(fli1ep:aqp1a.1-mEmerald) and Tg(fli1ep:aqp8a.1-mEmerald) zebrafish during the period of ISV formation (24 to 29 hpf) using the Manual Tracking plugin in Fiji. As shown in the graph, there is no significant difference in the migration speed of ECs overexpressing Aqp1a.1-mEmerald and Aqp8a.1-mEmerald, suggesting that Aqp8a.1-overexpressing cells migrate at a similar rate as Aqp1a.1-overexpressing cells. As we have not generated a Tg(fli1ep:mEmerald) zebrafish line, we are unable to determine whether endothelial cells migrate faster in Tg(fli1ep:aqp1a.1mEmerald) and Tg(fli1ep:aqp8a.1-mEmerald) zebrafish compared to endothelial cell expressing only mEmerald. As for the observation that tip cells overexpressing aqp1a.1mEmerald (Figure 2C) need more than 6 times longer to migrate the same distance as tip cells expressing aqp8a.1-mEmerald, we can only surmise that it is coincidental that the images selected “showed” faster migration of one ISV from Tg(fli1ep:aqp8a.1-mEmerald) zebrafish. We do not know whether the Aqp1a.1 and Aqp8a.1 are overexpressed to the same levels in Tg(fli1ep:aqp1a.1mEmerald) and Tg(fli1ep:aqp8a.1-mEmerald) zebrafish.

      We would also like to point out that when we analysed the lengths of ISVs at 28 hpf in aqp1a.1<sup>-/-</sup> and aqp8a.1<sup>-/-</sup> zebrafish, ISVs were shorter in aqp1a.1<sup>-/-</sup> zebrafish compared to aqp8a.1<sup>-/-</sup> zebrafish (Fig. S6 F to J). These results indicate that the loss of Aqp1a.1 function causes slower migration than the loss of aqp8a.1 function, and suggest that Aqp1a.1 induces faster endothelial cell migration that Aqp8a.1.

      Author response image 2.

      The data on Aqps expression after the Notch inhibitor DBZ seems unnecessary, and is at the moment not properly discussed. It is also against what is set in the field. aqp8a.1 levels seem to increase only 24h after DBZ, not at 6h, and still authors conclude that Notch activation inhibits aqp8a.1 expression (Line 138-139). In the field, Notch is considered to be more active in stalk cells, where aqp8a.1 expression seems higher (not lower). Maybe the analysis of tip vs stalk cell markers in the scRNAseq data, and their correlation with Hes1/Hey1/Hey2 and aqp1 vs aqp8 mRNA levels will be more clear than just showing qRT-PCR data after DBZ.

      As our scRNAseq data did not include ECs from earlier during development when ISVs are developing, we have analysed of scRNAseq data of 24 hpf endothelial cells published by Gurung et al, 2022 in Scientific Reports during the revision of this manuscript. However, we are unable to detect separate clusters of tip and stalk cells. As such, we are unable to correlate hes1/hey1/hey2 expression (which would be higher in stalk cells) with that of aqp1a.1/aqp8a.1. Also, we have decided to remove the DBZ-treatment results from our manuscript as we agree with the two reviewers that they are unnecessary.

      The paper would also benefit from some more analysis and interpretation of available scRNAseq data in development/injury/disease/angiogenesis models (zebrafish, mice or humans) for the aquaporin genes characterized here. To potentially raise a broader interest at the start of the paper.

      We thank the reviewer for suggesting examining aquaporin genes in other angiogenesis/disease/regeneration models to expand the scope of aquaporin function. We will do this in future studies.

      (3) Role of aqp1a.1 and aqp8a.1 on cytoplasmic volume changes and related phenotypes

      In Figure 5 the authors show that Aqp1/Aqp8 mutant endothelial tip cells have a lower cytoplasmic volume than tip cells from wildtype fish. If aquaporin-mediated water inflow occurs locally at the leading edge of endothelial tip cells (Figure 2, line 314-318), why doesn't cytoplasmic volume expand specifically only at that location (as shown in immune cells by Boer et al. 2023)? Can the observed reduction in cytoplasmic volume simply be a side-effect of impaired filopodia formation (Figure 4F-I)?

      We believe that water influx not only expands filopodia but also the leading front of tip cells (see bracket region in Fig. 4D), where Aqp1a.1-mEmerald/Aqp8a.1-mEmerald accumulate (Fig. 2), to generate an elongated protrusion and forward expansion of the tip cell. The decrease in cytoplasmic volume observed in the aqp1a.1;aqp8a.1 double mutant zebrafish is a result of decreased formation of these elongated protrusions at the leading front of migration tip cells as shown in Fig. 4E (compare to Fig. 4D), not from just a decrease in filopodia number. In fact, in the method used to quantify cell volume, mEmerald/EGFP localization is limited to the cytoplasm and does not label filopodia well (compare mEmerald/EGFP in green with membrane tagged-mCherry in Fig. 5A - C). The volume measured therefore reflects cytoplasmic volume of the tip cell, not filopodia volume.

      Do the authors have data on cytoplasmic volume changes of endothelial tip cells in latrunculin B treated fish? The images in Figures 6 A,B suggest that there is a difference in cell volume upon lat b treatment only.

      No, unfortunately we have not performed single cell labelling and measurement of tip cells in Latrunculin B-treated embryos. We can speculate that as there is a decrease in actindriven membrane protrusions in this experiment, one would also expect a decrease in cell volume as the reviewer has observed.

      (4) Combined loss of aquaporins and actin-based force generation.

      Lines 331-332 " we show that hydrostatic pressure is the driving force for EC migration in the absence of actin-based force generation"....better leave it more open and stick to the data. The authors show that aquaporin-mediated water inflow partially compensates for the loss of actin-based force generation in cell migration. Not that it is the key driving/rescuing force in the absence of actin-based force.

      We have changed it to “we show that hydrostatic pressure can generate force for EC migration in the absence of actin-based force generation” in line 348.

      (5) Aquaporins and their role in EC proliferation

      In the study by Phnk LK et al. 2013, the authors have shown that proliferation is not affected when actin polymerization or filopodia formation is inhibited. However, in the current manuscript by Kondrychyn I. et al. this has not been analysed carefully. In Movie S4 the authors indicate by arrows tip cells that fail to invade the zebrafish trunk demonstrating a severe defect of sprouting initiation in these mutants. Yet, when only looking at ISVs that reach the dorsal side in Movie S4, it appears that they are comprised of fewer EC nuclei/ISV than the ISVs in Movie S3. At the beginning of DLAV formation, most ISVs in control Movie S3 consist of 3-4 EC nuclei, while in double mutants Movie S4 it appears to be only 2-3 EC nuclei. At the end of the Movie S4, one ISV on the left side even appears to consist of only a single EC when touching the dorsal roof. The authors provide convincing data on how the absence of aquaporin channels affects sprouting initiation and migration speed, resulting in severe delay in ISV formation. However, the authors should also analyse EC proliferation, as it may also be affected in these mutants, and may also contribute to the observed phenotype. We know that effects on cell migration may indirectly change the number of cells and proliferation at the ISVs, but this has not been carefully analysed in this paper.

      We thank the reviewer for highlighting the lack of information on EC number and division in the aquaporin mutants. We have now quantified EC number in ISVs that are fully formed (i.e. connecting the DA or PCV to the DLAV) at 2 and 3 dpf and the results are displayed in Figure S10A and B. At 2 dpf, there is a slight but significant reduction in EC number in both aISVs and vISVs in aqp1a.1<sup>-/-</sup> zebrafish and an even greater reduction in the double aqp1a. aqp1a.1<sup>/-</sup>;aqp8a.1<sup>-/-</sup> zebrafish. No significant change in EC number was observed in aqp8a.1<sup>-/-</sup> zebrafish. EC number was also significantly decreased at 3 dpf for aqp1a.1<sup>-/-</sup>, aqp8a.1<sup>-/-</sup> and aqp1a.1<sup>-/-</sup>;aqp8a.1<sup>-/-</sup> zebrafish. The decreased in EC number per ISV may therefore contribute to the observed phenotype.

      We have also quantified the number of cell divisions during sprouting angiogenesis (from 21 to 30 hpf) to assess whether the lack of Aquaporin function affects EC proliferation. This analysis shows that there is no significant difference in the number of mitotic events between aqp1a.1<sup>+/-</sup>; aqp8a.1<sup>+/-</sup> and aqp1a.1<sup>-/-</sup>;aqp8a.1<sup>-/-</sup> zebrafish (Figure S10 C), suggesting that the reduction in EC number is not caused by a decrease in EC proliferation.

      These new data are reported on lines 198 to 205 of the manuscript.

      Minor comments:

      - Figure 3K data seems not to be necessary and even partially misleading after seeing Figure 3E. Fig. 3E represents the true strength of the phenotype in the different mutants.

      Figure 3K has been removed from Figure 3.

      - Typo Figure 3L (VII should be VI).

      Thank you for spotting this typo. VII has been changed to VI.

      - Line 242: The word "required" is too strong because there is vessel formation without Aqps in endothelial cells.

      This has been changed to “ …Aqp1a.1 and Aqp8a.1 regulate sprouting angiogenesis…” (lines 238 - 239).

      - From Figure S2, the doublets cluster should be removed.

      We have performed a new analysis of 24 hpf, 34hpf and 3 dpf endothelial cells scRNAseq data (the previous analysis did not consist of 24 hpf endothelial cells). The doublets cluster is not included in the UMAP analysis.

      - Better indicate the fluorescence markers/alleles/transgenes used for imaging in Figures 6A-D.

      The transgenic lines used for this experiment are now indicated in the figure (this figure is now Figure 7).

      Reviewer #3 (Public Review):

      Summary:

      Kondrychyn and colleagues describe the contribution of two Aquaporins Aqp1a.1 and Aqp8a.1 towards angiogenic sprouting in the zebrafish embryo. By whole-mount in situ hybridization, RNAscope, and scRNA-seq, they show that both genes are expressed in endothelial cells in partly overlapping spatiotemporal patterns. Pharmacological inhibition experiments indicate a requirement for VEGR2 signaling (but not Notch) in transcriptional activation.

      To assess the role of both genes during vascular development the authors generate genetic mutations. While homozygous single mutants appear normal, aqp1a.1;aqp8a.1 double mutants exhibit defects in EC sprouting and ISV formation.

      At the cellular level, the aquaporin mutants display a reduction of filopodia in number and length. Furthermore, a reduction in cell volume is observed indicating a defect in water uptake.

      The authors conclude, that polarized water uptake mediated by aquaporins is required for the initiation of endothelial sprouting and (tip) cell migration during ISV formation. They further propose that water influx increases hydrostatic pressure within the cells which may facilitate actin polymerization and formation membrane protrusions.

      Strengths:

      The authors provide a detailed analysis of Aqp1a.1 and Aqp8a.1 during blood vessel formation in vivo, using zebrafish intersomitic vessels as a model. State-of-the-art imaging demonstrates an essential role in aquaporins in different aspects of endothelial cell activation and migration during angiogenesis.

      Weaknesses:

      With respect to the connection between Aqp1/8 and actin polymerization/filopodia formation, the evidence appears preliminary and the authors' interpretation is guided by evidence from other experimental systems.

      Reviewer #3 (Recommendations For The Authors):

      Figure 1 H, J:

      The differential response of aqp1/-8 to ki8751 vs DBZ after 6h treatment is quite obvious. Why do the authors show the effect after 24h? The effect is more likely than not indirect.

      We agree with the reviewer and we have now removed 24 hour Ki8751 treatment and all DBZ treatments from Figure 1.

      Figure 2:

      According to the authors' model anterior localization of Aqp1 protein is critical. The authors perform transient injections to mosaically express Aqp fusion proteins using an endothelial (fli1) promoter. For the interpretation, it would be helpful to also show the mCherry-CAAX channel in separate panels. From the images, it is not possible to discern how many cells we are looking at. In particular the movie in panel D may show two cells at the tip of the sprout. A marker labelling cell-cell junctions would help. Furthermore, the authors are using a strong exogenous promoter, thus potentially overexpressing the fusion protein, which may lead to mislocalization. For Aqp1a.1 an antibody has been published to work in zebrafish (e.g. Kwong et al., Plos1, 2013).

      We would like to clarify that we generated transgenic lines - Tg(fli1ep:aqp1a.1-mEmerald) and Tg(fli1ep:aqp8a.1-mEmerald) - to visualize the localization of Aqp1a.1 and Aqp8a.1 in endothelial cells, and the images displayed in Fig. 2 are from the transgenic lines (not transient, mosaic expression).

      To aid visualization and interpretation, we have now added mCherry-CAAX only channel to accompany the Aqp1a.1/Aqp8a.1-mEmerald channel in Fig. 2A and B. To discern how many cells there are in the ISVs at this stage, we have crossed Tg(fli1ep:aqp1a.1-mEmerald) and Tg(fli1ep:aqp8a.1-mEmerald) zebrafish to TgKI(tjp1a-tdTomato)<sup>pd1224</sup> (Levic et al., 2021) to visualize ZO1 at cell-cell junction. However, because tjp1-tdTomato is expressed in all cell types including the skin that lies just above the ISV and the signal in ECs in ISVs is very weak at 22 to 25 hpf, it was very difficult to obtain good quality images that can properly delineate cell boundaries to determine the number of cells in the ISVs at this early stage. Instead, we have annotated endothelial cell boundaries based on more intense mCherryCAAX fluorescence at cell-cell borders, and from the mosaic expression of mCherryCAAX that is intrinsic to the  Tg(kdrl:ras-mCherry)<sup>s916</sup> zebrafish line.

      In Fig. 2D, there are two endothelial cells in the ISV during the period shown but there is only 1 cell occupying the tip cell position i.e. there is one tip cell in this ISV. Unlike the mouse retina where it has been demonstrated that two endothelial cells can occupy the tip cell position side-by-side (Pelton et al., 2014), this is usually not observed in zebrafish ISVs. This is demonstrated in Movie S3, where it is clear that one nucleus (belonging to the tip cell) occupies the tip of the growing ISV. The accumulation of intracellular membranes is often observed in tip cells that may serve as a reservoir of membranes for the generation of membrane protrusions at the leading edge of tip cells.

      We agree that by generating transgenic Tg(fli1ep:aqp1a.1-mEmerald) and Tg(fli1ep:aqp8a.1mEmerald) zebrafish, Aqp1a.1 and Aqp8a.1 are overexpressed that may affect their localization. The eel anti-Aqp1a.1 antibody used in (Kwong et la., 2013) was a gift from Dr. Gordon Cramb, Univ. of St Andrews, Scotland and it was first published in 2001. This antibody is not available commercially. Instead, we have tried to several other antibodies against AQP1 (Alpha Diagnostic International , AQP11-A; ThermoFisher Scientific, MA120214; Alomone Labs, AQP-001) and AQP8 (Sigma Aldrich, SAB 1403559; Alpha Diagnostic International, AQP81-A; Almone Labs, AQP-008) but unfortunately none worked. As such, we cannot compare localization of Aqp1a.1-mEmerald and Aqp8a.1-mEmerald with the endogenous proteins.

      Figure 3:

      E: the quantification is difficult to read. Wouldn't it be better to set the y-axis in % of the DV axis? (see also Figure S6).

      We would like to show the absolute length of the ISVs, and to illustrate that the ISV length decreases from anterior to posterior of the zebrafish trunk. We have increased the size of Fig. 3E to enable easier reading of the bars.

      K: This quantification appears arbitrary.

      We have removed this panel from Figure 3.

      G-J: The magenta channel is difficult to see. Is the lifeact-mCherry mosaic? In panel J there appears to be a nucleus between the sprout and the DLAV. It would be helpful to crop the contralateral side of the image.

      No, the Tg(fli1:Lifeact-mCherry) line is not mosaic. The “missing” vessels are not because of mosaicism in transgene but because of truncated ISVs that is a phenotype of loss Aquaporin function. We have changed the magenta channel to grey and hope that by doing so, the reviewer will be able to see the shape of the blood vessels more clearly. We would like to leave the contralateral side in the images, as it shows that the defective vessel is only on one side of body. Furthermore, when we tried to remove it (reducing the number of Z-stacks) neighbour ISV looks incomplete because the embryos were not mounted flat. To clarify what the nucleus between the sprout and the DLAV is, we have indicated that it is that of the contralateral ISV.

      L: I do not quite understand the significance of the different classes of phenotypes. Do the authors propose different morphogenetic events or contexts of how these differences come about?

      Here, we report the different types of ISV phenotypes that we observe in 3 dpf aqp1a.1<sup>-/-</sup>; aqp8a.1<sup>-/-</sup> zebrafish (Fig. 3 and Fig. S7). As demonstrated in Fig. 4, most of the phenotypes can be explained by the delayed emergence of tip cells from the dorsal aorta and slower tip cell migration. However, in some instances, we also observed retraction of tip cells (Movie S4) and failure of tip cells to emerge from the dorsal aorta or endothelial cell death (see attached figure on page 14), which can give rise to the Class II phenotype. In the dominant class I phenotype (in contrast to class II), secondary sprouting from the posterior cardinal vein is unaffected, and the secondary sprout migrates dorsally passing the level of horizontal myoseptum but cannot complete the formation of vISV (it stops beneath the spinal cord). The Class III phenotype appears to result from a failure of the secondary sprout to fuse with the regressed primary ISV. In the Class IV phenotype, the ventral EC does not maintain a connection to the dorsal aorta. We did not examine how Class III and IV phenotypes arise in detail in this current study.

      Author response image 3.

      Figure 4:

      This figure nicely demonstrates the defects in cell behavior in aqp mutants.

      In panel F it would be helpful to show the single channels as well as the merge.

      We have now added single channels for PLCd1PH and Lifeact signal in panels F and G.

      In Figure 1 the authors argue that the reduction of Aqp1/8 by VEGFR2 inhibition may account for part of that phenotype. In turn, the aqp phenotype seems to resemble incomplete VEGFR2 inhibition. The authors should check whether expression Aqp1Emerald can partially rescue ki8751 inhibition.

      To address the reviewer’s comment, we have treated Tg(fli1ep:Aqp1-Emerald) embryos with ki8751 from 20 hpf for 6 hours but we were unable to observe a rescue in sprouting. It could be because VEGFR2 inhibition also affects other downstream signalling pathways that also control cell migration as well as proliferation.

      Based on previous studies (Loitto et al.; Papadopoulus et al.) the authors propose that also in ISVs aquaporin-mediated water influx may promote actin polymerization and thereby filopodia formation. However, while the effect on filopodia number and length is well demonstrated, the underlying cause is less clear. For example, filopodia formation could be affected by reduced cell polarization. This can be tested by using a transgenic golgi marker (Kwon et al., 2016).

      We have examined tip cell polarity of wildtype, aqp1a.1<sup>-/-</sup> and  aqp8a. 1<sup>-/-</sup> embryos at 24-26 hpf by analysing Golgi position relative to the nucleus. We were unable to analyze polarity in  aqp1a.1<sup>rk28/rk28</sup>; aqp8a.1<sup>rk29/rk29</sup> embryos as they exist in an mCherry-containing transgenic zebrafish line (the Golgi marker is also tagged to mCherry). The results show that tip cell polarity is similar, if not more polarised, in aqp1a.1<sup>-/-</sup> and  aqp8a. 1<sup>-/-</sup> embryos when compared to wildtype embryos (Fig. S10D). This new data is discussed in lines 234 to 237.

      Figure 5:

      Panel D should be part of Figure 4.

      Panel 5D is now in panel J of Figure 4 and described in lines 231 and 235.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      People can perform a wide variety of different tasks, and a long-standing question in cognitive neuroscience is how the properties of different tasks are represented in the brain. The authors develop an interesting task that mixes two different sources of difficulty, and find that the brain appears to represent this mixture on a continuum, in the prefrontal areas involved in resolving task difficulty. While these results are interesting and in several ways compelling, they overlap with previous findings and rely on novel statistical analyses that may require further validation.

      Strengths

      1) The authors present an interesting and novel task for combining the contributions of stimulus-stimulus and stimulus-response conflict. While this mixture has been measured in the multi-source interference task (MSIT), this task provides a more graded mixture between these two sources of difficulty

      2) The authors do a good job triangulating regions that encoding conflict similarity, looking for the conjunction across several different measures of conflict encoding

      3) The authors quantify several salient alternative hypothesis and systematically distinguish their core results from these alternatives

      4) The question that the authors tackle is of central theoretical importance to cognitive control, and they make an interesting an interesting contribution to this question

      We would like to thank the reviewer for the positive evaluation of our manuscript and the constructive comments and suggestions. Your feedback has been invaluable in our efforts to enhance the accessibility of our manuscript and strengthen our findings. In response to your suggestion, we reanalyzed our data using the approach proposed by Chen et al.’s (2017, NeuroImage) and applied stricter multiple comparison correction thresholds in our reporting. This reanalysis largely replicated our previous results, thereby reinforcing the robustness of our findings. We also have examined several alternative models and results supported the integration of the spatial Stroop and Simon conflicts within the cognitive space. In addition, we enriched the theoretical framework of our manuscript by connecting the cognitive space with other important theories such as the “Expected Value of Control” theory. We have incorporated your feedback, revisions and additional analyses into the manuscript. As a result, we firmly believe that these changes have significantly improved the quality of our work. We have provided detailed responses to your comments below.

      1) It's not entirely clear what the current task can measure that is not known from the MSIT, such as the additive influence of conflict sources in Fu et al. (2022), Science. More could be done to distinguish the benefits of this task from MSIT.

      We agree that the MSIT task incorporates Simon and Eriksen Flanker conflict tasks and can efficiently detect the additivity of conflict effects across orthogonal tasks. Like the MSIT, our task incorporates Simon with spatial Stroop conflicts and can test the same idea. For example, a previous study from our lab (Li et al., 2014) used the combined spatial Stroop-Simon condition with the arrows displayed on diagonal corners and found evidence for the additive hypothesis. However, the MSIT cannot be used to test whether/how different conflicts are parametrically represented in a low-dimensional space, a question that is important to address the debate of domain-general and domain-specific cognitive control.

      To this end, our current study adopted the spatial Stroop-Simon task for the unique purpose of parametrically modulating conflict similarity. As far as we know, there is no way to define the similarity between the combined Simon_Flanker conflict condition and the Simon/Flanker conditions in the MSIT. In contrast, with the spatial Stroop-Simon paradigm, we can define the similarity with the cosine of the angle difference across the two conditions in question.

      We have added the following texts in the discussion part to emphasize the 51 difference between our paradigm and other studies.

      "The use of an experimental paradigm that permits parametric manipulation of conflict similarity provides a way to systematically investigate the organization of cognitive control, as well as its influence on adaptive behaviors. This approach extends traditional paradigms, such as the multi-source interference task (Fu et al., 2022), color Stroop-Simon task (Liu et al., 2010) and similar paradigms that do not afford a quantifiable metric of conflict source similarity."

      References:

      Li, Q., Nan, W., Wang, K., & Liu, X. (2014). Independent processing of stimulus-stimulus and stimulus-response conflicts. PloS One, 9(2), e89249.

      2) The evidence from this previous work for mixtures between different conflict sources make the framing of 'infinite possible types of conflict' feel like a strawman. The authors cite classic work (e.g., Kornblum et al., 1990) that develops a typology for conflict which is far from infinite, and I think few people would argue that every possible source of difficulty will have to be learned separately. Such an issue is addressed in theories like 'Expected Value of Control', where optimization of control policies can address unique combinations of task demands.

      The notion that there might be infinite conflicts arises when we consider the quantitative feature of cognitive control. If each combination of the Stroop-Simon combination is regarded as a conflict condition, there would be infinite combinations, and it is our major goal to investigate how these infinite conflict conditions are represented effectively in a space with finite dimensions. We agree that it is unnecessary to dissociate each of these conflict conditions into a unique conflict type, since they may not differ substantially. However, we argue that understanding variant conflicts within a purely categorical framework (e.g., Simon and Flanker conflict in MSIT) is insufficient, especially because it leads to dichotomic conclusions that do not capture how combinations of conflicts are organized in the brain, as our study addresses.

      There could be different perspectives on how our cognitive control system flexibly encodes and resolves multiple conflicts. The cognitive space assumption we held provides a principle by which we can represent multiple conflicts in a lower dimensional space efficiently. While the “Expected Value of Control” theory addresses when and how much cognitive control to apply based on control demand, the “cognitive space” view seeks to explain how the conflict, which defines cognitive control demand, is encoded in the brain. Thus, we argue that these two lines of work are different yet complementary. The geometry of cognitive space of conflict can benefit the adjustment of cognitive control for upcoming conflicts. For example, our brain may evaluate the similarity/distance (and thus cost) between the consecutive conflict conditions, and selects the path with best cost-benefit tradeoff to switch from one state to another. This idea is conceptually similar to a recent study by Grahek et al. (2022) demonstrating that more frequently switching states were encoded as closer together than less frequently switching states in a “drift-threshold” space.

      Nevertheless, Grahek et al (2022) investigated how cognitive control changes based on the expected value of control theory within the same conflict, whereas our study aims to examine organization of different conflict.

      We have added the implications of cognitive space view in the discussion to indicate the potential values of our finding to understand the EVC account and the difference between the two theories.

      “Previous researchers have proposed an “expected value of control (EVC)” theory, which posits that the brain can evaluate the cost and benefit associated with executing control for a demanding task, such as the conflict task, and specify the optimal control strength (Shenhav et al., 2013). For instance, Grahek et al. (2022) found that more frequently switching goals when doing a Stroop task were achieved by adjusting smaller control intensity. Our work complements the EVC theory by further investigating the neural representation of different conflict conditions and how these representations can be evaluated to facilitate conflict resolution. We found that different conflict conditions can be efficiently represented in a cognitive space encoded by the right dlPFC, and participants with stronger cognitive space representation have also adjusted their conflict control to a greater extent based on the conflict similarity (Fig 4C). The finding suggests that the cognitive space organization of conflicts guides cognitive control to adjust behavior. Previous studies have shown that participants may adopt different strategies to represent a task, with the model-based strategies benefitting goal-related behaviors more than the model-free strategies (Rmus et al., 2022). Similarly, we propose that cognitive space could serve as a mental model to assist fast learning and efficient organization of cognitive control settings. Specifically, the cognitive space representation may provide a principle for how our brain evaluates the expected cost of switching and the benefit of generalization between states and selects the path with the best cost-benefit tradeoff (Abrahamse et al., 2016; Shenhav et al., 2013). The proximity between two states in cognitive space could reflect both the expected cognitive demand required to transition and the useful mechanisms to adapt from. The closer the two conditions are in cognitive space, the lower the expected switching cost and the higher the generalizability when transitioning between them. With the organization of a cognitive space, a new conflict can be quickly assigned a location in the cognitive space, which will facilitate the development of cognitive control settings for this conflict by interpolating nearby conflicts and/or projecting the location to axes representing different cognitive control processes, thus leading to a stronger CSE when following a more similar conflict condition. On the other hand, without a cognitive space, there would be no measure of similarity between conflicts on different trials, hence limiting the ability of fast learning of cognitive control setting from similar trials.”

      Reference:

      Grahek, I., Leng, X., Fahey, M. P., Yee, D., & Shenhav, A. Empirical and Computational Evidence for Reconfiguration Costs During Within-Task Adjustments in Cognitive Control. CogSci.

      3) Wouldn't a region that represented each conflict source separately still show the same pattern of results? The degree of Stroop vs Simon conflict is perfectly negatively correlated across conditions, so wouldn't a region that just tracks Stoop conflict show these RSA patterns? The authors show that overall congruency is not represented in DLPFC (which is surprising), but they don't break it down by whether this is due to Stroop or Simon congruency (I'm not sure their task allows for this).

      To estimate the unique contributions of the spatial Stroop and Simon conflicts, we performed a model-comparison analysis. We constructed a Stroop-Only model and a Simon-Only model, with each conflict type projected onto the Stroop (vertical) axis or Simon (horizontal) axis, respectively. The similarity between any two conflict types was defined using the Jaccard similarity index (Jaccard, P., 1901), that is, their intersection divided by their union. By replacing the cognitive spacebased conflict similarity regressor with the Stroop-Only and Simon-Only regressors, we calculated their BICs. Results showed that the BIC was larger for Stroop-Only (5377122) and Simon-Only (5377096) than for the Cognitive-Space model (5377094). An additional Stroop+Simon model, including both Stroop-Only and Simon-Only regressors, also showed a poorer model fitting (BIC = 5377118) than the Cognitive-Space model. Considering that the pattern of conflict representations is more manifested when the conflict is present (i.e., on incongruent trials) than not (i.e., on congruent trials), we also conducted the model comparison using the incongruent trials only. Results showed that Stroop-Only (1344128), Simon-Only (1344120), and Stroop+Simon (1344157) models all showed higher BIC values than the CognitiveSpace model (1344104). These results indicate that the right 8C encodes an integrated cognitive space for resolving Stroop and Simon conflicts. Therefore, we believe the cognitive space has incorporated both dimensions. We added these additional analyses and results to the revised manuscript.

      “To examine if the right 8C specifically encodes the cognitive space rather than the domain-general or domain-specific organizations, we tested several additional models (see Methods). Model comparison showed a lower BIC in the Cognitive-Space model (BIC = 5377094) than the Domain-General (BIC = 537127) or Domain-Specific (BIC = 537127) models. Further analysis showed the dimensionality of the representation in the right 8C was 1.19, suggesting the cognitive space was close to 1D. We also tested if the observed conflict similarity effect was driven solely by spatial Stroop or Simon conflicts, and found larger BICs for the models only including the Stroop similarity (i.e., the Stroop-Only model, BIC = 5377122) or Simon similarity (i.e., the Simon-Only model, BIC = 5377096). An additional Stroop+Simon model, including both StroopOnly and Simon-Only regressors, also showed a worse model fitting (BIC = 5377118). Moreover, we replicated the results with only incongruent trials, considering that the pattern of conflict representations is more manifested when the conflict is present (i.e., on incongruent trials) than not (i.e., on congruent trials). We found a poorer fitting in Domain-general (BIC = 1344129), Domain-Specific (BIC = 1344129), Stroop-Only (BIC = 1344128), Simon-Only (BIC = 1344120), and Stroop+Simon (BIC = 1344157) models than the Cognitive-Space model (BIC = 1344104). These results indicate that the right 8C encodes an integrated cognitive space for resolving Stroop and Simon conflicts. The more detailed model comparison results are listed in Table 2.”

      We reason that we did not observe an overall congruency effect in the RSA results is because our definition of congruency here differed from traditional definitions (i.e., contrast between incongruent and congruent conditions). In the congruency regressor of our RSA model, we defined representational similarity as 1 if calculated between two incongruent, or two congruent trials, and 0 if between incongruent and congruent trials. Thus, our definition of the congruency regressor reflects whether multivariate patterns differ between incongruent and congruent trials, rather than whether activity strengths differ. Indeed, we did observe the latter form of congruency effects, with stronger univariate activities in pre-SMA for incongruent versus congruent conditions. We have added this in the Note S6 (“The multivariate representations of conflict type and orientation are different from the congruency effect”):

      “Neither did we observe a multivariate congruency effect (i.e., the pattern difference between incongruent and congruent conditions compared to that within each condition) in the right 8C or any other regions. Note the definition of congruency here differed from traditional definitions (i.e., contrast between activity strength of incongruent and congruent conditions), with which we found stronger univariate activities in pre-SMA for incongruent versus congruent conditions.”

      We could not determine whether the null effect of the congruency regressor was due to Stroop or Simon congruency alone, because congruency levels of the two types always covary. On all trials of the compound conditions (Conf 2-4), whenever the Stroop dimension was incongruent, the Simon dimension was also incongruent, and vice versa for the congruent condition. Thus, the contribution of spatial Stroop or Simon alone to the congruency effect could not be tested using compound conditions. Although we have pure spatial Stroop or Simon conditions, within-Stroop and withinSimon trial pairs constituted only 8% of cells in the representational similarity matrix. This was insufficient to determine whether the null congruency effect was due to solely Stroop or Simon.

      Overall, with the added analysis we found that the data in the right 8C area supports conflict representations that are organized based on both Simon and spatial Stroop conflict. Although the current experimental design does not allow us to identify whether the null effect of the congruency regressor was driven by either conflict or both, we clarified that the congruency regressor did not test the 205 conventional congruency effect and the null finding does not contradict previous 206 research.

      Reference:

      Jaccard, P. (1901). Étude comparative de la distribution florale dans une portion des Alpes et des Jura. Bull Soc Vaudoise Sci Nat(37), 547-579.

      4) The authors use a novel form of RSA that concatenates patterns across conditions, runs and subjects into a giant RSA matrix, which is then used for linear mixed effects analysis. This appears to be necessary because conflict type and visual orientation are perfectly confounded within the subject (although, if I understand, the conflict type x congruence interaction wouldn't have the same concern about visual confounds, which shouldn't depend on congruence). This is an interesting approach but should be better justified, preferably with simulations validating the sensitivity and specificity of this method and comparing it to more standard methods.

      The confound exists for both the conflict type and the conflict type × congruence interaction in our design, since both incongruent and congruent conditions include stimuli from the full orientation space. For example, for the spatial Stroop type, the congruent condition could be either an up arrow at the top or a down arrow at the bottom. Similarly, the incongruent condition could be either an up arrow at the bottom or a down arrow at the top. Therefore, both the congruent and incongruent conditions are perfectly confounded with the orientation.

      We reanalyzed the data using the well-documented approach by Chen et al. (2017, Neuroimage), as suggested by the reviewer. The new analysis replicated our previously reported results (Fig. 4-5, S4-S7). As Chen et al (2017) has provided abundant simulations to validate this approach, we did not run any further simulations.

      5) A chief concern is that the same pattern contributes to many entries in the DV, which has been addressed in previous work using row-wise and column-wise random effects (Chen et al., 2017, Neuroimage). It would also be informative to know whether the results hold up to removing within-run similarity, which can bias similarity measures (Walther et al., 2016, Neuroimage).

      Thank you for the comment. In our revised manuscript, we followed your suggestion and adopted the approach proposed by Chen et al. (2017). Specifically, we included both the upper and lower triangle of the representational similarity matrix (excluding the diagonal). Moreover, we also removed all the within-subject similarity (thus also excluding the within-run similarity as suggested by Walther et al. (2016)) to minimize the bias of the potentially strong within-subject similarity. In addition, we added both the row-wise and column-wise random effects to capture the dependence of cells within each column and each row, respectively (Chen et al., 2017).

      Results from this approach largely replicated our previous results. The right 8C again showed significant conflict similarity representation, with greater representational strength in incongruent than congruent condition, and positively correlated to behavioral performance. The orientation effect was also identified in the visual (e.g., right V1) and oculomotor (e.g., left FEF) regions.

      We have revised the methodology and the results in the revised manuscript:

      "Representational similarity analysis (RSA).

      For each cortical region, we calculated the Pearson’s correlations between fMRI activity patterns for each run and each subject, yielding a 1400 (20 conditions × 2 runs × 35 participants) × 1400 RSM. The correlations were calculated in a cross297 voxel manner using the fMRI activation maps obtained from GLM3 described in the previous section. We excluded within-subject cells from the RSM (thus also excluding the within-run similarity as suggested by Walther et al., (2016)), and the remaining cells were converted into a vector, which was then z-transformed and submitted to a linear mixed effect model as the dependent variable. The linear mixed effect model also included regressors of conflict similarity and orientation similarity. Importantly, conflict similarity was based on how Simon and spatial Stroop conflict are combined and hence was calculated by first rotating all subject’s stimulus location to the top right and bottom-left quadrants, whereas orientation was calculated using original stimulus locations. As a result, the regressors representing conflict similarity and orientation similarity were de-correlated. Similarity between two conditions was measured as the cosine value of the angular difference. Other regressors included a target similarity regressor (i.e., whether the arrow directions were identical), a response similarity regressor (i.e., whether the correct responses were identical); a spatial Stroop distractor regressor (i.e., vertical distance between two stimulus locations); a Simon distractor regressor (i.e., horizontal distance between two stimulus locations). Additionally, we also included a regressor denoting the similarity of Group (i.e., whether two conditions are within the same subject group, according to the stimulus-response mapping). We also added two regressors including ROI316 mean fMRI activations for each condition of the pair to remove the possible uni-voxel influence on the RSM. A last term was the intercept. To control the artefact due to dependence of the correlation pairs sharing the same subject, we included crossed random effects (i.e., row-wise and column-wise random effects) for the intercept, conflict similarity, orientation and the group factors (G. Chen et al., 2017)."

      Reference:

      Walther, A., Nili, H., Ejaz, N., Alink, A., Kriegeskorte, N., & Diedrichsen, J. (2016). Reliability of dissimilarity measures for multi-voxel pattern analysis. Neuroimage, 137, 188-200. doi:10.1016/j.neuroimage.2015.12.012

      6) Another concern is the extent to which across-subject similarity will only capture consistent patterns across people, making this analysis very similar to a traditional univariate analysis (and unlike the traditional use of RSA to capture subject-specific patterns).

      With proper normalization, we assume voxels across different subjects should show some consistent localizations, although individual differences can be high. J. Chen et al. (2017) has demonstrated that consistent multi-voxel activation patterns exist across individuals. Previous studies have also successfully applied cross-subject RSA (see review by Freund et al, 2021) and cross-subject decoding approaches (e.g., Jiang et al., 2016; Tusche et al., 2016), so we believe cross-subject RSA should be feasible to capture distributed activation patterns shared at the group level. We added this argument in the revised manuscript:

      "Previous studies (e.g., J. Chen et al., 2017) have demonstrated that consistent multivoxel activation patterns exist across individuals, and successful applications of cross-subject RSA (see review by Freund, Etzel, et al., 2021) and cross-subject decoding approaches (Jiang et al., 2016; Tusche et al., 2016) have also been reported."

      In the revised manuscript, we also tested whether the representation in right 8C held for within-subject data. We reasoned that the conflict similarity effects identified by cross-subject RSA should be replicable in within-subject data, although the latter is not able to dissociate the conflict similarity effect from the orientation effect. We performed similar RSA for within-subject RSMs, excluding the within-run cells. We replaced the perfectly confounded factors of conflict similarity and orientation with a common factor called similarity_orientation. Other confounding factor pairs were addressed similarly. Results showed a significant effect of similarity_orientation, t(13993) = 3.270, p = .0005, 1-tailed. Given the specific representation of conflict similarity identified by the cross-subject RSA, we believe that the within-subject data of right 8C probably showed similar conflict similarity modulation effects as the cross-subject data, although future research that orthogonalizes conflict type and orientation is needed to fully answer this question. We added this result in the revised section Note S7.

      "Note S7. The cross-subject RSA captures similar effects with the within-subject RSA Considering the variability in voxel-level functional localizations among individuals, one may question whether the cross-subject RSA results were biased by the consistent multi-voxel patterns across subjects, distinct from the more commonly utilized withinsubject RSA. We reasoned that the cross-subject RSA should have captured similar effects as the within-subject RSA if we observe the conflict similarity effect in right 8C with the latter analysis. Therefore, we tested whether the representation in right 8C held for within-subject data. Specifically, we performed similar RSA for withinsubject RSMs, excluding the within-run cells. We replaced the perfectly confounded factors of conflict similarity and orientation with a common factor called similarity_orientation. Other confounding factor pairs (i.e., target versus response, and Stroop distractor versus Simon distractor) were addressed similarly. Results showed a significant effect of similarity_orientation, t(13993) = 3.270, p = .0005, 1tailed. Given the specific representation of conflict similarity identified by the crosssubject RSA, the within-subject data of right 8C may show similar conflict similarity modulation effects as the cross-subject data. Further research is needed to fully dissociate the representation of conflict and the representation of visual features such as orientation."

      Reference:

      Chen, J., Leong, Y. C., Honey, C. J., Yong, C. H., Norman, K. A., & Hasson, U. (2017). Shared memories reveal shared structure in neural activity across individuals. Nature Neuroscience, 20(1), 115-125.

      Freund, M. C., Etzel, J. A., & Braver, T. S. (2021). Neural Coding of Cognitive Control: The Representational Similarity Analysis Approach. Trends in Cognitive Sciences, 25(7), 622-638.

      Jiang, J., Summerfield, C., & Egner, T. (2016). Visual Prediction Error Spreads Across Object Features in Human Visual Cortex. J Neurosci, 36(50), 12746-12763.

      Tusche, A., Bockler, A., Kanske, P., Trautwein, F. M., & Singer, T. (2016). Decoding the Charitable Brain: Empathy, Perspective Taking, and Attention Shifts Differentially Predict Altruistic Giving. Journal of Neuroscience, 36(17), 4719-4732.

      7) Finally, the authors should confirm all their results are robust to less liberal methods of multiplicity correction. For univariate analysis, they should report the effects from the standard p < .001 cluster forming threshold for univariate analysis (or TFCE). For multivariate analyses, FDR can be quite liberal. The authors should consider whether their mixed-effects analyses allow for group-level randomization, and consider (relatively powerful) Max-Stat randomization tests (Nichols & Holmes, 2002, Hum Brain Mapp).

      In our revised manuscript, we have corrected the univariate results using the probabilistic TFCE (pTFCE) approach by Spisak et al. (2019). This approach estimates the conditional probability of cluster extent based on Bayes’ rule. Specifically, we applied pTFCE on our univariate results (i.e., the z-maps of our contrasts). This returned enhanced Z-score maps, which were then thresholded based on simulated cluster size thresholds using 3dClustSim. A cluster-forming threshold of p < .001 was employed. Results showed only the pre-SMA was activated in the incongruent > congruent contrast, and right IPS and right dmPFC were activated in the linear Simon modulation effect. Further tests also showed these regions were not correlated with the behavioral performance, uncorrected ps >.28. These results largely replicated our previous results. We have revised the method and results accordingly.

      Methods:

      "Results were corrected with the probabilistic threshold-free cluster enhancement(pTFCE) and then thresholded by 3dClustSim function in AFNI (Cox & Hyde, 1997) with voxel-wise p < .001 and cluster-wize p < .05, both 1-tailed."

      Results:

      "In the fMRI analysis, we first replicated the classic congruency effect by searching for brain regions showing higher univariate activation in incongruent than congruent conditions (GLM1, see Methods). Consistent with the literature (Botvinick et al., 2004; Fu et al., 2022), this effect was observed in the pre-supplementary motor area (preSMA) (Fig. 3, Table S1). We then tested the encoding of conflict type as a cognitive space by identifying brain regions with activation levels parametrically covarying with the coordinates (i.e., axial angle relative to the horizontal axis) in the hypothesized cognitive space. As shown in Fig. 1B, change in the angle corresponds to change in spatial Stroop and Simon conflicts in opposite directions. Accordingly, we found the right inferior parietal sulcus (IPS) and the right dorsomedial prefrontal cortex (dmPFC) displayed positive correlation between fMRI activation and the Simon conflict (Fig. 3, Fig. S3, Table S1)."

      We appreciate the reviewer’s suggestion to apply the Max-Stat randomization tests (Nichols & Holmes, 2002) for the multivariate analyses. However, the representational similarity matrix was too large (1400×1400) to be tested with a balanced randomization approach (i.e., the Max-Stat), due to (1) running even 1000 times for all ROIs cost very long time; (2) the distribution generated from normal times of randomization (e.g., 5000 iterations) would probably be unbalanced, since the full range of possible samples that could be generated by a complete randomization is not adequately represented. Instead, we adopted a very strict Bonferroni correction p < 0.0001/360 when reporting the regression results from RSA. Notebally, Chen et al (2017) has shown that their approach could control the FDR at an acceptable level.

      Reference:

      Spisák, T., Spisák, Z., Zunhammer, M., Bingel, U., Smith, S., Nichols, T., & Kincses,T. (2019). Probabilistic TFCE: A generalized combination of cluster size and voxel intensity to increase statistical power. NeuroImage, 185, 12-26.

      Chen, G., Taylor, P. A., Shin, Y.-W., Reynolds, R. C., & Cox, R. W. J. N. (2017). Untangling the relatedness among correlations, Part II: Inter-subject correlation group analysis through linear mixed-effects modeling. 147, 825-840.

      Minor concerns:

      8) I appreciate the authors wanting to present the conditions in a theory-agnostic way, but the framing of 5 conflict types was confusing. I think framing the conditions as a mixture of 2 conflict types (Stroop and Simon) makes more sense, especially given the previous work on MSIT.

      We have renamed the Type1-5 as spatial Stroop, StHSmL, StMSmM, StLSmH, and Simon conditions, respectively. H, L, and M indicate high, low andmedium similarity with the corresponding conflict, respectively. This is alsoconsistent with the naming of our previous work (Yang et al., 2021).

      Reference:

      Yang, G., Xu, H., Li, Z., Nan, W., Wu, H., Li, Q., & Liu, X. (2021). The congruency sequence effect is modulated by the similarity of conflicts. Journal of Experimental Psychology: Learning, Memory, and Cognition, 47(10), 1705-1719.

      9) It would be helpful to have more scaffolding for the key conflict & orientation analyses. A schematic in the main text that outlines these contrasts would be very helpful (e.g. similar to S4).

      We have inserted Figure 7 in the revised manuscript. In this figure, we plotted the schematic of the difference between the conflict similarity 467 and orientation regressors according to their cross-group representational similarity 468 matrices.

      10) Figure 4D could be clearer, both in labeling and figure caption. 'Modeled similarity' could be relabelled to something more informative, like 'conflict type (or mixture) similarity'. Alternatively, it would be helpful to show a summary RDM for region r-8C. For example, breaking it down by just conflict type and congruence.

      We have relabeled the x-axis to “Conflict type similarity” and y-axis to “Neural similarity” for Figure 4D in the revised manuscript.

      We have also added a summary RSM figure in Fig. S5 to show the different similarity patterns between incongruent and congruent conditions.

      11) It may be helpful to connect your work to how people have discussed multiple forms of conflict monitoring and control with respect to target and distractor features e.g., Lindsay & Jacoby, 1994, JEP:HPP; Mante, Sussillo et al., 2013, Nature; Soutschek et al., 2015, JoCN; Jackson et al., 2021, Comm Bio; Ritz & Shenhav, 2022, bioRxiv

      We have added an analysis to examine how cognitive control modulates target and distractor representation. To this end, we selected the left V4, a visual region showing joint representation of target, Stroop distractor and Simon distractor, as the region of interest. We tested whether these representation strengths differed between incongruent and congruent conditions, finding the representation of target was stronger and representations of both distractors were weaker in the incongruent condition. This suggests that cognitive control modulates the stimuli in both directions. We added the results in Note S10 and Fig. S8, and also added discussion of it in “Methodological implications”.

      “Note S10. Cognitive control enhances target representation and suppresses distractor representation Using the separability of confounding factors afforded by the cross-subject RSA, we examined how representations of targets and distractors are modulated by cognitive control. The key assumption is that exerting cognitive control may enhance target representation and suppress distractor representation. We hypothesized that stimuli are represented in visual areas, so we chose a visual ROI from the main RSA results showing joint representation of target, spatial Stroop distractor and Simon distractor (p < .005, 1-tail, uncorrected). Only the left V4 met this criterion. We then tested representations with models similar to the main text for incongruent only trials, congruent only trials, and the incongruent – congruent contrast. The contrast model additionally used interaction between the congruency and target, Stroop distractor and Simon distractor terms. Results showed that in the incongruent condition, when we employ more cognitive control, the target representation was enhanced (t(237990) = 2.59, p = .029, Bonferroni corrected) and both spatial Stroop (t(237990) = –4.18, p < .001, Bonferroni corrected) and Simon (t(237990) = –3.14, p = .005, Bonferroni corrected) distractor representations were suppressed (Fig. S8). These are consistent with the idea that the top-down control modulates the stimuli in both directions (Polk et al., 2008; Ritz & Shenhav, 2022).”

      Discussion:

      “Moreover, the cross-subject RSA provides high sensitivity to the variables of interest and the ability to separate confounding factors. For instance, in addition to dissociating conflict type from orientation, we dissociated target from response, and spatial Stroop distractor from Simon distractor. We further showed cognitive control can both enhance the target representation and suppress the distractor representation (Note S10, Fig. S8), which is in line with previous studies (Polk et al., 2008; Ritz & Shenhav, 2022)."

      12) For future work, I would recommend placing stimuli along the whole circumference, to orthogonalize Stroop and Simon conflict within-subject.

      We thank the reviewer for this highly helpful suggestion. Expanding the 547 conflict conditions to a full conflict space and replicating our current results could 548 provide stronger evidence for the cognitive space view.

      In the revised manuscript, we added this as a possible future design:

      “A possible improvement to our current design would be to include left, right, up, and down arrows presented in a grid formation across four spatially separate quadrants, with each arrow mapped to its own response button. However, one potential confounding factor would be that these conditions have different levels of difficulty (i.e., different magnitude of conflict), which may affect the CSE results and their representational similarity."

      Reviewer #2:

      Summary, general appraisal

      This study examines the construct of "cognitive spaces" as they relate to neural coding schemes present in response conflict tasks. The authors utilize a novel paradigm, in which subjects must map the direction of a vertically oriented arrow to either a left or right response. Different types of conflict (spatial Stroop, Simon) are parametrically manipulated by varying the spatial location of the arrow (a taskirrelevant feature). The vertical eccentricity of the arrow either agrees or conflicts with the arrow's direction (spatial Stroop), while the horizontal eccentricity of the arrow agrees or conflicts with the side of the response (Simon). A neural coding model is postulated in which the stimuli are embedded in a cognitive space, organized by distances that depend only on the similarity of congruency types (i.e., where conditions with similar relative proportions of spatial-Stroop versus Simon congruency are represented with similar activity patterns). The authors conduct a behavioral and fMRI study to provide evidence for such a representational coding scheme. The behavioral findings replicate the authors' prior work in demonstrating that conflict-related cognitive control adjustments (the congruency sequence effect) shows strong modulation as a function of the similarity between conflict types. With the fMRI neural activity data, the authors report univariate analyses that identified activation in left prefrontal and dorsomedial frontal cortex modulated by the amount of Stroop or Simon conflict present, and multivariate representational similarity analyses (RSA) that identified right lateral prefrontal activity encoding conflict similarity and correlated with the behavioral effects of conflict similarity.

      This study tackles an important question regarding how distinct types of conflict, which have been previously shown to elicit independent forms of cognitive control adjustments, might be encoded in the brain within a computationally efficient representational format. The ideas postulated by the authors are interesting ones and the utilized methods are rigorous.

      We would like to express our sincere appreciation for the reviewer’s positive evaluation of our manuscript and the constructive comments and suggestions. Through careful consideration of your feedback, we have endeavored to make our manuscript more accessible to readers and further strengthened our findings. In response to your suggestion, we reanalyzed our data with the approach proposed by Chen et al.’s (2017, NeuroImage). This reanalysis largely replicated our previous results, reinforcing the validity of our findings. Additionally, we conducted tests with several alternative models and found that the cognitive space hypothesis best aligns with our observed data. We have incorporated these revisions and additional analyses into the manuscript based on your valuable feedback. As a result, we believe that these changes and additional analyses have significantly enhanced the quality of our manuscript. We have provided detailed responses to your comments below.

      However, the study has critical limitations that are due to a lack of clarity regarding theoretical hypotheses, serious confounds in the experimental design, and a highly non-standard (and problematic) approach to RSA. Without addressing these issues it is hard to evaluate the contribution of the authors findings to the computational cognitive neuroscience literature.

      1) The primary theoretical question and its implications are unclear. The paper would greatly benefit from more clearly specifying potential alternative hypotheses and discussing their implications. Consider, for example, the case of parallel conflict monitors. Say that these conflict monitors are separately tuned for Stroop and Simon conflict, and are located within adjacent patches of cortex that are both contained within a single cortical parcel (e.g., as defined by the Glasser atlas used by the authors for analyses). If RSA was conducted on the responses of such a parcel to this task, it seems highly likely that an activation similarity matrix would be observed that is quite similar (if not identical) to the hypothesized one displayed in Figure 1. Yet it would seem like the authors are arguing that the "cognitive space" representation is qualitatively and conceptually distinct from the "parallel monitor" coding scheme. Thus, it seems that the task and analytic approach is not sufficient to disambiguate these different types of coding schemes or neural architectures.

      The authors also discuss a fully domain-general conflict monitor, in which different forms of conflict are encoded within a single dimension. Yet this alternative hypothesis is also not explicitly tested nor discussed in detail. It seems that the experiment was designed to orthogonalize the "domain-general" model from the "cognitive space" model, by attempting to keep the overall conflict uniform across the different stimuli (i.e., in the design, the level of Stroop congruency parametrically trades off with the level of Simon congruency). But in the behavioral results (Fig. S1), the interference effects were found to peak when both Stroop and Simon congruency are present (i.e., Conf 3 and 4), suggesting that the "domain-general" model may not be orthogonal to the "cognitive space" model. One of the key advantages of RSA is that it provides the ability to explicitly formulate, test and compare different coding models to determine which best accounts for the pattern of data. Thus, it would seem critical for the authors to set up the design and analyses so that an explicit model comparison analysis could be conducted, contrasting the domain-general, domain-specific, and cognitive space accounts.

      We appreciate the reviewer pointing out the need to formally test alternative models. In the revised manuscript, we have added and compared a few alternative models, finding the Cognitive-Space model (the one with graded conflict similarity levels as we reported) provided the best fit to our data. Specifically, we tested the following five models against the Cognitive-Space model:

      (1) Domain-General model. This model treats each conflict type as equivalent, so each two conflict types only differ in the magnitude of their conflict. Therefore, we defined the domain-general matrix as the difference in their effects indexed by the group-averaged RT in Experiment 2. Then the z-scored model vector was sign-flipped to reflect similarity instead of distance. This model showed non-significant conflict type effects (t(951989) = 0.92, p = .179) and poorer fit (BIC = 5377126) than the Cognitive-Space model (BIC = 5377094).

      (2) Domain-Specific model. This model treats each conflict type differently, so we used a diagonal matrix, with within-conflict type similarities being 1 and all crossconflict type similarities being 0. This model also showed non-significant effects (t(951989) = 0.84, p = .201) and poorer fit (BIC = 5377127) than the Cognitive-Space model.

      (3) Stroop-Only model. This model assumes that the right 8C only encodes the spatial Stroop conflict. We projected each conflict type to the Stroop (vertical) axis and calculated the similarity between any two conflict types as the Jaccard similarity index (Jaccard, 1901), that is, their intersection divided by their union. This model also showed non-significant effects (t(951989) = 0.20, p = .423) and poorer fit (BIC = 5377122) than the Cognitive-Space model.

      (4) Simon-Only model. This model assumes that the right 8C only encodes the Simon conflict. We projected each conflict type to the Simon (horizontal) axis and calculated the similarity like the Stroop-Only model. This model showed significant effects (t(951989) = 4.19, p < .001) but still quantitatively poorer fit (BIC = 5377096) than the Cognitive-Space model.

      (5) Stroop+Simon model. This model assumes the spatial Stroop and Simon conflicts are parallelly encoded in the brain, similar to the "parallel monitor" hypothesis suggested by the reviewer. It includes both Stroop-Only and Simon-Only regressors. This model showed nonsignificant effect for the Stroop regressor (t(951988) = 0.06, p = .478) and significant effect for the Simon regressor (t(951988) = 3.30, p < .001), but poorer fit (BIC = 5377118) than the Cognitive-Space model.

      “Moreover, we replicated these results with only incongruent trials (i.e., when conflict is present), considering that the pattern of conflict representations is more manifested when the conflict is present (i.e., on incongruent trials) than not (i.e., on congruent trials). We found a poorer fitting in Domain-general (BIC = 1344129), Domain-Specific (BIC = 1344129), Stroop-Only (BIC = 1344128), Simon-Only (BIC = 1344120), and Stroop+Simon (BIC = 1344157) models than the Cognitive-Space model (BIC = 1344104).”

      In summary, these results indicate that the right 8C encodes an integrated cognitive space for resolving Stroop and Simon conflicts. We added the above results to the revised manuscript.

      The above analysis approach was added to the method “Model comparison and representational dimensionality”, and the results were added to the “Multivariate patterns of the right dlPFC encodes the conflict similarity” in the revised manuscript.

      Methods:

      “Model comparison and representational dimensionality To estimate if the right 8C specifically encodes the cognitive space, rather than the domain-general or domain-specific structures, we conducted two more RSAs. We replaced the cognitive space-based conflict similarity matrix in the RSA we reported above (hereafter referred to as the Cognitive-Space model) with one of the alternative model matrices, with all other regressors equal. The domain-general model treats each conflict type as equivalent, so each two conflict types only differ in the magnitude of their conflict. Therefore, we defined the domain-general matrix as the difference in their congruency effects indexed by the group-averaged RT in Experiment 2. Then the zscored model vector was sign-flipped to reflect similarity instead of distance. The domain-specific model treats each conflict type differently, so we used a diagonal matrix, with within-conflict type similarities being 1 and all cross-conflict type similarities being 0.

      Moreover, to examine if the cognitive space is driven solely by the Stroop or Simon conflicts, we tested a spatial Stroop-Only (hereafter referred to as “Stroop-Only”) and a Simon-Only model, with each conflict type projected onto the spatial Stroop (vertical) axis or Simon (horizontal) axis, respectively. The similarity between any two conflict types was defined using the Jaccard similarity index (Jaccard, 1901), that is, their intersection divided by their union. We also included a model assuming the Stroop and Simon dimensions are independently represented in the brain, adding up the StroopOnly and Simon-Only regressors (hereafter referred to as the Stroop+Simon model). We conducted similar RSAs as reported above, replacing the original conflict similarity regressor with the Strrop-Only, Simon-Only, or both regressors (for the Stroop+Simon model), and then calculated their Bayesian information criterions (BICs).”

      Results:

      “To examine if the right 8C specifically encodes the cognitive space rather than the domain-general or domain-specific organizations, we tested several additional models (see Methods). Model comparison showed a lower BIC in the Cognitive-Space model (BIC = 5377094) than the Domain-General (BIC = 537127) or Domain-Specific (BIC = 537127) models. Further analysis showed the dimensionality of the representation in the right 8C was 1.19, suggesting the cognitive space was close to 1D. We also tested if the observed conflict similarity effect was driven solely by spatial Stroop or Simon conflicts, and found larger BICs for the models only including the Stroop similarity (i.e., the Stroop-Only model, BIC = 5377122) or Simon similarity (i.e., the Simon-Only model, BIC = 5377096). An additional Stroop+Simon model, including both StroopOnly and Simon-Only regressors, also showed a worse model fitting (BIC = 5377118). Moreover, we replicated the results with only incongruent trials, considering that the pattern of conflict representations is more manifested when the conflict is present (i.e., on incongruent trials) than not (i.e., on congruent trials). We found a poorer fitting in Domain-general (BIC = 1344129), Domain-Specific (BIC = 1344129), Stroop-Only (BIC = 1344128), Simon-Only (BIC = 1344120), and Stroop+Simon (BIC = 1344157) models than the Cognitive-Space model (BIC = 1344104). These results indicate that the right 8C encodes an integrated cognitive space for resolving Stroop and Simon conflicts. The more detailed model comparison results are listed in Table 2.”

      Reference:

      Jaccard, P. (1901). Étude comparative de la distribution florale dans une portion des Alpes et des Jura. Bull Soc Vaudoise Sci Nat(37), 547-579.

      2a) Relatedly, the reasoning for the use of the term "cognitive space" is unclear. The mere presence of graded coding for two types of conflict seems to be a low bar for referring to neural activity patterns as encoding a "cognitive space". It is discussed that cognitive spaces/maps allow for flexibility through inference and generalization. But no links were made between these cognitive abilities and the observed representational structure.

      In the revised manuscript, we have clarified that we tested a specific prediction of the cognitive space hypothesis: the geometry of the cognitive space predicts that more similar conflict types will have more similar neural representations,leading to the CSE and RSA patterns tested in this study. These results add to the literature by providing empirical evidence on how different conflict types are encoded in the brain. We agree that this study is not a comprehensive test of the cognitive space hypothesis. Thus, in the revised manuscript we explicitly clarified that this study is a test of the geometry of the cognitive space hypothesis.

      Critically, the cognitive space view holds that the representations of different abstract information are organized continuously and the representational geometry in the cognitive space are determined by the similarity among the represented information (Bellmund et al., 2018).

      "The present study aimed to test the geometry of cognitive space in conflict representation. Specifically, we hypothesize that different types of conflict are represented as points in a cognitive space. Importantly, the distance between the points, which reflects the geometry of the cognitive space, scales with the difference in the sources of the conflicts being represented by the points."

      We have also discussed the limitation of the results and stressed the need for more research to fully test the cognitive space hypothesis.

      “Additionally, our study is not a comprehensive test of the cognitive space hypothesis but aimed primarily to provide original evidence for the geometry of cognitive space in representing conflict information in cognitive control. Future research should examine other aspects of the cognitive space such as its dimensionality, its applicability to other conflict tasks such as Eriksen Flanker task, and its relevance to other cognitive abilities, such as cognitive flexibility and learning.

      2b) Additionally, no explicit tests of generality (e.g., via cross-condition generalization) were provided.

      To examine the generality of cognitive space across conditions, we conducted a leave-one-out prediction analysis. We used the behavioral data from Experiment 1 for this test, due to its larger amount of data than Experiment 2. Specifically, we removed data from one of the five similarity levels (as illustrated by the θs in Fig. 1C) and used the remaining data to perform the same mixed-effect model as reported in the main text (i.e., the two-stage analysis). This yielded one pair of beta coefficients including the similarity regressor and the intercept for each subject, with which we predicted the CSE for the removed similarity level for each subject. We repeated this process for each similarity level once. The predicted results were highly correlated with the original data, with r = .87 for the RT and r = .84 for the ER, ps < .001. We have added this analysis and result to the “Conflict type 706 similarity modulated behavioral congruency sequence effect (CSE)” section.

      “Moreover, to test the continuity and generalizability of the similarity modulation, we conducted a leave-one-out prediction analysis. Specifically, we removed data from one of the five similarity levels (as illustrated by the θs in Fig. 1C) and used the remaining data to perform the same mixed-effect model (i.e., the two-stage analysis). This yielded one pair of beta coefficients including the similarity regressor and the intercept for each subject, with which we predicted the CSE for the removed similarity level for each subject. We repeated this process for each similarity level once. The predicted results were highly correlated with the original data, with r = .87 for the RT and r = .84 for the ER, ps < .001."

      2c) Finally, although the design elicits strong CSE effects, it seems somewhat awkward to consider CSE behavioral patterns as a reflection of the kind of abilities supported by a cognitive map (if this is indeed the implication that was intended). In fact, CSE effects are well-modeled by simpler "model-free" associative learning processes, that do not require elaborate representations of abstract structures.

      We argue the conflict similarity modulation of CSEs we observed cannot be explained by the “model-free” stimulus-driven associative learning process. This mainly refers to the feature integration account proposed by Hommel et al. (2004), which explains poorer performance in CI and IC trials (compared with CC and II trials) with the partial repetition cost caused by the breaking of stimulus-response binding. Although we cannot remove its influence on the within-type trials (similarity level 5, θ = 0), it should not affect the cross-type trials (similarity level 1-4, θ = 90°, 67.5°, 45° and 22.5°, respectively), because the CC, CI, IC, II trials had equal probabilities of partially repeated and fully switched trials (see the Author response image 1 for an example of trials across Conf 1 and Conf 3 conditions). Thus, feature integration cannot explain the gradual CSE decrease from similarity level 1 to 4, which sufficiently reproduce the full effect, as suggested by the leave-one-out prediction analysis mentioned above. We thus conclude that the similarity modulation of CSE cannot be explained by the stimulus-driven associative learning.

      Author response image 1.

      Notably, however, our findings are aligned with an associative learning account of cognitive control (Abrahamse et al., 2016), which extends association learning from stimulus/response level to cognitive control. In other words, abstract cognitive control state can be learned and generalized like other sensorimotor features. This view explicitly proposes that “transfer occurs to the extent that two tasks overlap”, a hypothesis directly supported by our CSE results (see also Yang et al., 2021). Extending this, our fMRI results provide the neural basis of how cognitive control can generalize through a representation of cognitive space. The cognitive space view complements associative learning account by providing a fundamental principle for the learning and generalization of control states. Given the widespread application of CSE as indicator of cognitive control generalization (Braem et al., 2014), we believe that it can be recognized as a kind of ability supported by the cognitive space. This was further supported by the brain-behavioral correlation: stronger encoding of cognitive space was associated with greater bias of trial-wise behavioral adjustment by the consecutive conflict similarity.

      We have incorporated these ideas into the discussion:

      “Similarly, we propose that cognitive space could serve as a mental model to assist fast learning and efficient organization of cognitive control settings. Specifically, the cognitive space representation may provide a principle for how our brain evaluates the expected cost of switching and the benefit of generalization between states and selects the path with the best cost-benefit tradeoff (Abrahamse et al., 2016; Shenhav et al., 2013). The proximity between two states in cognitive space could reflect both the expected cognitive demand required to transition and the useful mechanisms to adapt from. The closer the two conditions are in cognitive space, the lower the expected switching cost and the higher the generalizability when transitioning between them. With the organization of a cognitive space, a new conflict can be quickly assigned a location in the cognitive space, which will facilitate the development of cognitive control settings for this conflict by interpolating nearby conflicts and/or projecting the location to axes representing different cognitive control processes, thus leading to a stronger CSE when following a more similar conflict condition.”

      References:

      Hommel, B., Proctor, R. W., & Vu, K. P. (2004). A feature-integration account of sequential effects in the Simon task. Psychological Research, 68(1), 1-17. Abrahamse, E., Braem, S., Notebaert, W., & Verguts, T. (2016). Grounding cognitive control in associative learning. Psychological Bulletin, 142(7), 693-728.

      Yang, G., Xu, H., Li, Z., Nan, W., Wu, H., Li, Q., & Liu, X. (2021). The congruency sequence effect is modulated by the similarity of conflicts. Journal of 770 Experimental Psychology: Learning, Memory, and Cognition, 47(10), 1705-1719.

      Braem, S., Abrahamse, E. L., Duthoo, W., & Notebaert, W. (2014). What determines the specificity of conflict adaptation? A review, critical analysis, and proposed synthesis. Frontiers in Psychology, 5, 1134.

      3) More generally, it seems problematic that Stroop and Simon conflict in the paradigm parametrically trade-off against each other. A more powerful design would have de-confounded Stroop and Simon conflict so that each could be separately estimation via (potentially orthogonal) conflict axes. Additionally, incorporating more varied stimulus sets, locations, or responses might have enabled various tests of generality, as implied by a cognitive space account.

      We thank the reviewer for these valuable suggestions. We argue that the current design is adequate to test the prediction that more similar conflict types have more similar neural representations. That said, we agree that further examination using more powerful experimental designs are needed to fully test the cognitive space account of cognitive control. We also agree that employing more varied stimulus sets,locations and responses would further extend our findings. We have included this as a future research direction in the revised manuscript.

      We have revised our discussion about the limitation as:

      “A few limitations of this study need to be noted. To parametrically manipulate the conflict similarity levels, we adopted the spatial Stroop-Simon paradigm that enables parametrical combinations of spatial Stroop and Simon conflicts. However, since this paradigm is a two-alternative forced choice design, the behavioral CSE is not a pure measure of adjusted control but could be partly confounded by bottom-up factors such as feature integration (Hommel et al., 2004). Future studies may replicate our findings with a multiple-choice design (including more varied stimulus sets, locations and responses) with confound-free trial sequences (Braem et al., 2019). Another limitation is that in our design, the spatial Stroop and Simon effects are highly anticorrelated. This constraint may make the five conflict types represented in a unidimensional space (e.g., a circle) embedded in a 2D space. Future studies may test the 2D cognitive space with fully independent conditions. A possible improvement to our current design would be to include left, right, up, and down arrows presented in a grid formation across four spatially separate quadrants, with each arrow mapped to its own response button. However, one potential confounding factor would be that these conditions have different levels of difficulty (i.e., different magnitude of conflict), which may affect the CSE results and their representational similarity.”

      4) Serious confounds in the design render the results difficult to interpret. As much prior neuroimaging and behavioral work has established, "conflict" per se is perniciously correlated with many conceptually different variables. Consequently, it is very difficult to distinguish these confounding variables within aggregate measures of neural activity like fMRI. For example, conflict is confounded with increased time-on-task with longer RT, as well as conflict-driven increases in coding of other task variables (e.g., task-set related coding; e.g., Ebitz et al. 2020 bioRxiv). Even when using much higher resolution invasive measures than fMRI (i.e., eCoG), researchers have rightly been wary of making strong conclusions about explicit encoding of conflict (Tang et al, 2019; eLife). As such, the researchers would do well to be quite cautious and conservative in their analytic approach and interpretation of results.

      We acknowledge the findings showing that encoding of conflicts may not be easily detected in the brain. However, recent studies have shown that the representational similarity analysis can effectively detect representations of conflict tasks (e.g., the color Stroop) using factorial designs (Freund et al., 2021a; 2021b).

      In our analysis, we are aware of the potential impact of time-on-task (e.g., RT) on univariate activation levels and subsequent RSA patterns. To address this issue, we added univariate fMRI activation levels as nuisance regressors to the RSA. To de confound conflict from other factors such as orientation of stimuli related to the center of the screen, we also applied the cross-subject RSA approach. Furthermore, we were cautious about determining regions that encoded conflict control. We set three strict criteria: (1) Regions must show a conflict similarity modulation effect; (2) regions must show higher representational strength in the incongruent condition compared with the congruent condition; and (3) regions must correlate with behavioral performance. With these criteria, we believe that the results we reported are already conservative. We would be happy to implement any additional criteria the reviewer recommends.

      Reference:

      Freund, M. C., Etzel, J. A., & Braver, T. S. (2021a). Neural Coding of Cognitive Control: The Representational Similarity Analysis Approach. Trends in Cognitive Sciences, 25(7), 622-638.

      Freund, M. C., Bugg, J. M., & Braver, T. S. (2021b). A Representational Similarity 823 Analysis of Cognitive Control during Color-Word Stroop. Journal of 824 Neuroscience, 41(35), 7388-7402.

      5) This issue is most critical in the interpretation of the fMRI results as reflecting encoding of conflict types. A key limitation of the design, that is acknowledged by the authors is that conflict is fully confounded within-subject by spatial orientation. Indeed, the limited set of stimulus-response mappings also cast doubt on the underlying factors that give rise to the CSE modulations observed by the authors in their behavioral results. The CSE modulations are so strong - going from a complete absence of current x previous trial-type interaction in the cos(90) case all the way to a complete elimination of any current trial conflict when the prior trial was incongruent in the cos(0) case - that they cause suspicion that they are actually driven by conflict-related control adjustments rather than sequential dependencies in the stimulus-response mappings that can be associatively learned.

      Unlike the fMRI data, we cannot tease apart the effects of conflict similarity and orientation in a similar manner as the cross-subject RSA for behavioral CSEs. However, we have a few reasons that the orientation and other bottom-up factors should not be the factors driving the similarity modulation effect.

      First, we did not find any correlation between the regions showing orientation effects and behavioral CSEs. This suggests that orientation does not directly contribute to the CSE modulation.

      Second, if the CSE modulation is purely driven by the association learning of the stimulus-response mapping, we should observe a stronger modulation effect after more extensive training. However, our results do not support this prediction. Using data from Experiment 1, we found that the modulation effect remained constant across the three sessions (see Note S3).

      “Note S3. Modulation of conflict similarity on behavioral CSEs does not change across time We tested if the conflict similarity modulation on the CSE is susceptible to training. We collected the data of Experiment 1 across three sessions, thus it is possible to examine if the conflict similarity modulation effect changes across time. To this end, we added conflict similarity, session and their interaction into a mixed-effect linear model, in which the session was set as a categorical variable. With a post-hoc analysis of variance (ANOVA), we calculated the statistical significance of the interaction term. This approach was applied to both the RT and ER. Results showed no interaction effect in either RT, F(2,1479) = 1.025, p = .359, or ER, F(2,1479) = 0.789, p = .455. This result suggests that the modulation effect does not change across time. “

      Third, the observed similarity modulation on the CSE, particularly for similarity levels 1-4, should not be attributed to the stimulus-response associations, such as feature integration, as have been addressed in response to comment 2.c.

      Finally, other bottom-up factors, such as the spatial location proximity did not drive the CSE modulation results, which we have addressed in the original manuscript in Note S2.

      "Note S2. Modulation of conflict similarity on behavioral CSEs cannot be explained by the physical proximity

      In our design, the conflict similarity might be confounded by the physical proximity between stimulus (i.e., the arrow) of two consecutive trials. That is, when arrows of the two trials appear at the same quadrant, a higher conflict similarity also indicates a higher physical proximity (Fig. 1A). Although the opposite is true if arrows of the two trials appear at different quadrants, it is possible the behavioral effects can be biased by the within quadrant trials. To examine if the physical distance has confounded the conflict similarity modulation effect, we conducted an additional analysis.

      We defined the physical angular difference across two trials as the difference of their polar angles relative to the origin. Therefore, the physical angular difference could vary from 0 to 180°. For each CSE conditions (i.e., CC, CI, IC and II), we grouped the trials based on their physical angular distances, and then averaged trials with the same previous by current conflict type transition but different orders (e.g., StHSmL−StLSmH and StLSmH−StHSmL) within each subject. The data were submitted to a mixed-effect model with the conflict similarity, physical proximity (i.e., the opposite of the physical angular difference) as fixed-effect predictors, and subject and CSE condition as random effects. Results showed significant conflict similarity modulation effects in both Experiment 1 (RT: β = 0.09 ± 0.01, t(7812) = 13.74, p < .001, ηp2 = .025; 875 ER: β = 0.09 ± 0.01, t(7812) = 7.66, p < .001, ηp2 = .018) and Experiment 2 (RT: β = 876 0.21 ± 0.02, t(3956) = 9.88, p < .001, ηp2 = .043; ER: β = 0.20 ± 0.03, t(4201) = 6.11, 877 p < .001, ηp2 = .038). Thus, the observed modulation of conflict similarity on behavioral 878 CSEs cannot be explained by physical proximity."

      6) To their credit, the authors recognize this confound, and attempt to address it analytically through the use of a between-subject RSA approach. Yet the solution is itself problematic, because it doesn't actually deconfound conflict from orientation. In particular, the RSA model assumes that whatever components of neural activity encode orientation produce this encoding within the same voxellevel patterns of activity in each subject. If they are not (which is of course likely), then orthogonalization of these variables will be incomplete. Similar issues underlie the interpretation target/response and distractor coding. Given these issues, perhaps zooming out to a larger spatial scale for the between-subject RSA might be warranted. Perhaps whole-brain at the voxel level with a high degree of smoothing, or even whole-brain at the parcel level (averaging per parcel). For this purpose, Schaefer atlas parcels might be more useful than Glasser, as they more strongly reflect functional divisions (e.g., motor strip is split into mouth/hand divisions; visual cortex is split into central/peripheral visual field divisions). Similarly, given the lateralization of stimuli, if a within-parcel RSA is going to be used, it seems quite sensible to pool voxels across hemispheres (so effectively using 180 parcels instead of 360).

      Doing RSA at the whole-brain level is an interesting idea. However, it does not allow the identification of specific brain regions representing the cognitive space. Additionally, increasing the spatial scale would include more voxels that are not involved in representing the information of interest and may increase the noise level of data. Given these concerns, we did not conduct the whole-brain level RSA.

      We agree that smoothing data can decrease cross-subject variance in voxel distribution and may increase the signal-noise ratio. We reanalyzed the results for the right 8C region using RSA on smoothed beta maps (6-mm FWHM Gaussian kernel). This yielded a significant conflict similarity effect, t(951989) = 5.55, p < .0001, replicating the results on unsmoothed data (t(951989) = 5.60, p < .0001). Therefore, we retained the results from unsmoothed data in the main text, and added the results based on smoothed data to the supplementary material (Note S9).

      “Note S9. The cross-subject pattern similarity is robust against individual differences Due to individual differences, the multivoxel patterns extracted from the same brain mask may not reflect exactly the same brain region for each subject. To reduce the influence of individual difference, we conducted the same cross-subject RSA using data smoothed with a 6-mm FWHM Gaussian kernel. Results showed a significant conflict similarity effect, t(951989) = 5.55, p < .0001, replicating the results on unsmoothed data (t(951989) = 5.60, p < .0001). “

      We also used the bilateral 8C area as a single mask and conducted the same RSA. We found a significant conflict type similarity effect, t(951989) = 4.36, p < .0001. However, the left 8C alone showed no such representation, t(951989) = 0.38, p = .351, consistent with the right lateralized representation of cognitive space we reported in Note S8. Therefore, we used ROIs from each hemisphere separately.

      “Note S8. The lateralization of conflict type representation

      We observed the right 8C but not the left 8C represented the conflict type similarity. A further test is to show if there is a lateralization. We tested several regions of the left dlPFC, including the i6-8, 8Av, 8C, p9-46v, 46, 9-46d, a9-46v (Freund, Bugg, et al., 2021). We found that none of these regions show the representation of conflict type, all uncorrected ps > .35. These results indicate that the conflict type is specifically represented in the right dlPFC. “

      We have also discussed the lateralization in the manuscript:

      “In addition, we found no such representation in the left dlPFC (Note S8), indicating a possible lateralization. Previous studies showed that the left dlPFC was related to the expectancy-related attentional set up-regulation, while the right dlPFC was related to the online adjustment of control (Friehs et al., 2020; Vanderhasselt et al., 2009), which is consistent with our findings. Moreover, the right PFC also represents a composition of single rules (Reverberi et al., 2012), which may explain how the spatial Stroop and Simon types can be jointly encoded in a single space.”

      7) The strength of the results is difficult to interpret due to the non-standard analysis method. The use of a mixed-level modeling approach to summarize the empirical similarity matrix is an interesting idea, but nevertheless is highly non-standard within RSA neuroimaging methods. More importantly, the way in which it was implemented makes it potentially vulnerable to a high degree of inaccuracy or bias. In this case, this bias is likely to be overly optimistic (high false positive rate). No numerical or formal defense was provided for this mixed-level model approach. As a result, the use of this method seems quite problematic, as it renders the strength of the observed results difficult to interpret. Instead, the authors are encouraged using a previously published method of conducting inference with between-subject RSA, such as the bootstrapping methods illustrated in Kragel et al. (2018; Nat Neurosci), or in potentially adopting one of the Chen et al. methods mentioned above, that have been extensively explored in terms of statistical properties.

      No numerical or formal defense was provided for this mixed-level model approach. As a result, the use of this method seems quite problematic, as it renders the strength of the observed results difficult to interpret. Instead, the authors are encouraged using a previously published method of conducting inference with between-subject RSA, such as the bootstrapping methods illustrated in Kragel et al. (2018; Nat Neurosci), or in potentially adopting one of the Chen et al. methods mentioned above, that have been extensively explored in terms of statistical properties.

      In our revised manuscript, we have adopted the approach proposed by Chen et al. (2017). Specifically, we included both the upper and lower triangle of the representational similarity matrix (excluding the diagonal). Moreover, we also removed all the within-subject similarity (thus also excluding the within-run similarity) to minimize the bias of the potentially strong within-subject similarity (note we also analyzed the within-subject data and found significant effects for the similarity modulation, though this effect cannot be attributed to the conflict similarity or orientation alone. We added this part in Note S7, see below). In addition, we added both the row-wise and column-wise random effects to capture the dependence of cells within each column/row (Chen et al., 2017). We have revised the method part as:

      “We excluded within-subject cells from the RSM (thus also excluding the withinrun similarity as suggested by Walther et al., (2016)), and the remaining cells were converted into a vector, which was then z-transformed and submitted to a linear mixed effect model as the dependent variable. The linear mixed effect model also included regressors of conflict similarity and orientation similarity. Importantly, conflict similarity was based on how Simon and spatial Stroop conflicts are combined and hence was calculated by first rotating all subject’s stimulus location to the topright and bottom-left quadrants, whereas orientation was calculated using original stimulus locations. As a result, the regressors representing conflict similarity and orientation similarity were de-correlated. Similarity between two conditions was measured as the cosine value of the angular difference. Other regressors included a target similarity regressor (i.e., whether the arrow directions were identical), a response similarity regressor (i.e., whether the correct responses were identical); a spatial Stroop distractor regressor (i.e., vertical distance between two stimulus locations); a Simon distractor regressor (i.e., horizontal distance between two stimulus locations). Additionally, we also included a regressor denoting the similarity of Group (i.e., whether two conditions are within the same subject group, according to the stimulus-response mapping). We also added two regressors including ROImean fMRI activations for each condition of the pair to remove the possible uni-voxel influence on the RSM. A last term was the intercept. To control the artefact due to dependence of the correlation pairs sharing the same subject, we included crossed random effects (i.e., row-wise and column-wise random effects) for the intercept, conflict similarity, orientation and the group factors (G. Chen et al., 2017).”

      Results from this approach highly replicated our original results. Specifically, we found the right 8C again showed a strong conflict similarity effect, a higher representational strength in the incongruent condition compared to the congruent condition, and a significant correlation with the behavioral CSE. The orientation effect was also identified in the visual (e.g., right V1) and oculomotor (e.g., left FEF) regions.

      We revised the results accordingly:

      For the conflict type effect:

      “The first criterion revealed several cortical regions encoding the conflict similarity, including the Brodmann 8C area (a subregion of dlPFC(Glasser et al., 2016)) and a47r in the right hemisphere, and the superior frontal language (SFL) area, 6r, 7Am, 24dd, and ventromedial visual area 1 (VMV1) areas in the left hemisphere (Bonferroni corrected ps < 0.0001, one-tailed, Fig. 4A). We next tested whether these regions were related to cognitive control by comparing the strength of conflict similarity effect between incongruent and congruent conditions (criterion 2). Results revealed that the left SFL, left VMV1, and right 8C met this criterion, Bonferroni corrected ps < .05, one-tailed, suggesting that the representation of conflict type was strengthened when conflict was present (e.g., Fig. 4D). The intersubject brain-behavioral correlation analysis (criterion 3) showed that the strength of conflict similarity effect on RSM scaled with the modulation of conflict similarity on the CSE (slope in Fig. S2C) in right 8C (r = .52, Bonferroni corrected p = .002, onetailed, Fig. 4C, Table 1) but not in the left SFL and VMV1 (all Bonferroni corrected ps > .05, one-tailed). “

      For the orientation effect:

      “We observed increasing fMRI representational similarity between trials with more similar orientations of stimulus location in the occipital cortex, such as right V1, right V2, right V4, and right lateral occipital 2 (LO2) areas (Bonferroni corrected ps < 0.0001). We also found the same effect in the oculomotor related region, i.e., the left 997 frontal eye field (FEF), and other regions including the right 5m, left 31pv and right parietal area F (PF) (Fig. 5A). Then we tested if any of these brain regions were related to the conflict representation by comparing their encoding strength between incongruent and congruent conditions. Results showed that the right V1, right V2, left FEF, and right PF encoded stronger orientation effect in the incongruent than the congruent condition, Bonferroni corrected ps < .05, one-tailed (Table1, Fig. 5B). We then tested if any of these regions was related to the behavioral performance, and results showed that none of them positively correlated with the behavioral conflict similarity modulation effect, all uncorrected ps > .45, one-tailed. Thus all regions are consistent with the criterion 3.”

      “Note S7. The cross-subject RSA captures similar effects with the within-subject RSA Considering the variability in voxel-level functional localizations among individuals, one may question whether the cross-subject RSA results were biased by the consistent multi-voxel patterns across subjects, distinct from the more commonly utilized withinsubject RSA. We reasoned that the cross-subject RSA should have captured similar effects as the within-subject RSA if we observe the conflict similarity effect in right 8C with the latter analysis. Therefore, we tested whether the representation in right 8C held for within-subject data. Specifically, we performed similar RSA for withinsubject RSMs, excluding the within-run cells. We replaced the perfectly confounded factors of conflict similarity and orientation with a common factor called similarity_orientation. Other confounding factor pairs (i.e., target versus response, and Stroop distractor versus Simon distractor) were addressed similarly. Results showed a significant effect of similarity_orientation, t(13993) = 3.270, p = .0005, 1tailed. Given the specific representation of conflict similarity identified by the crosssubject RSA, the within-subject data of right 8C may show similar conflict similarity modulation effects as the cross-subject data. Further research is needed to fully dissociate the representation of conflict and the representation of visual features such as orientation.”

      8) Another potential source of bias is in treating the subject-level random effect coefficients (as predicted by the mixed-level model) as independent samples from a random variable (in the t-tests). The more standard method for inference would be to use test statistics derived from the mixed-model fixed effects, as those have degrees of freedom calculations that are calibrated based on statistical theory.

      In our revised manuscript, we reported the statistical p values calculated from the mixed-effect models. Note that because we used the Chen et al. (2017) method, which includes data from the symmetric matrix, we corrected the degrees of freedom and estimated the true p values based on the t statistics of model results. For the I versus C comparison results, we calculated the p values by combining I and C RSMs into a larger model and then adding the condition type, as well as the interaction between the regressors of interest (conflict similarity and orientation) and the condition type. We made the statistical inference based on the interaction effect.

      We have revised the corresponding methods as:

      “The statistical significance of these beta estimates was based on the outputs of the mixed-effect model estimated with the “fitlme” function in Matlab 2022a. Since symmetric cells from the RSM matrix were included in the mixed-effect model, we adjusted the t and p values with the true degree of freedom, which is half of the cells included minus the number of fixed regressors. Multiple comparison correction was applied with the Bonferroni approach across all cortical regions at the p < 0.0001 level. To test if the representation strengths are different between congruent and incongruent conditions, we also conducted the RSA using only congruent (RDM_C) and incongruent (RDM_I) trials separately. The contrast analysis was achieved by an additional model with both RDM_C and RDM_I included, adding the congruency and the interaction between conflict type (and orientation) and congruency as both fixed and random factors. The difference between incongruent and congruent representations was indicated by a significant interaction effect.”

      Reviewer #3:

      Yang and colleagues investigated whether information on two task-irrelevant features that induce response conflict is represented in a common cognitive space. To test this, the authors used a task that combines the spatial Stroop conflict and the Simon effect. This task reliably produces a beautiful graded congruency sequence effect (CSE), where the cost of congruency is reduced after incongruent trials. The authors measured fMRI to identify brain regions that represent the graded similarity of conflict types, the congruency of responses, and the visual features that induce conflicts.

      Using several theory-driven exclusion criteria, the authors identified the right dlPFC (right 8C), which shows 1) stronger encoding of graded similarity of conflicts in incongruent trials and 2) a positive correlation between the strength of conflict similarity type and the CSE on behavior. The dlPFC has been shown to be important for cognitive control tasks. As the dlPFC did not show a univariate parametric modulation based on the higher or lower component of one type of conflict (e.g., having more spatial Stroop conflict or less Simon conflict), it implies that dissimilarity of conflicts is represented by a linear increase or decrease of neural responses. Therefore, the similarity of conflict is represented in multivariate neural responses that combine two sources of conflict.

      The strength of the current approach lies in the clear effect of parametric modulation of conflict similarity across different conflict types. The authors employed a clever cross-subject RSA that counterbalanced and isolated the targeted effect of conflict similarity, decorrelating orientation similarity of stimulus positions that would otherwise be correlated with conflict similarity. A pattern of neural response seems to exist that maps different types of conflict, where each type is defined by the parametric gradation of the yoked spatial Stroop conflict and the Simon conflict on a similarity scale. The similarity of patterns increases in incongruent trials and is correlated with CSE modulation of behavior.

      We would like to thank the reviewer for the positive evaluation of our manuscript and for providing constructive comments. By addressing these comments, we believe that we have made our manuscript more accessible for the readers while also strengthening our findings. In particular, we have tested a few alternative models and confirmed that the cognitive space hypothesis best fits the data. We have also demonstrated the geometric properties of the cognitive space by examining the continuity and dimensionality of the space, further supporting our main arguments. We have incorporated revisions and additional analyses to the manuscript based on your feedback. Overall, we believe that these changes and additional analyses have significantly improved the manuscript. Please find our detailed responses below.

      However, several potential caveats need to be considered.

      1) One caveat to consider is that the main claim of recruitment of an organized "cognitive space" for conflict representation is solely supported by the exclusion criteria mentioned earlier. To further support the involvement of organized space in conflict representation, other pieces of evidence need to be considered. One approach could be to test the accuracy of out-of-sample predictions to examine the continuity of the space, as commonly done in studies on representational spaces of sensory information. Another possible approach could involve rigorously testing the geometric properties of space, rather than fitting RSM to all conflict types. For instance, in Fig 6, both the organized and domain-specific cognitive maps would similarly represent the similarity of conflict types expressed in Fig1c (as evident from the preserved order of conflict types). The RSM suggests a low-dimensional embedding of conflict similarity, but the underlying dimension remains unclear.

      Following the reviewer’s first suggestion, we conducted a leave-one-out prediction approach to examine the continuity of the cognitive space. We used the behavioral data from Experiment 1 for this test, due to its larger amount of data than Experiment 2. Specifically, we removed data from one of the five similarity levels (as illustrated by the θs in Fig. 1C) and used the remaining data to perform the same mixed-effect model as reported in the main text (i.e., the two-stage analysis). This yielded one pair of beta coefficients including the similarity regressor and the intercept for each subject, with which we predicted the CSE for the removed similarity level at subject level. We repeated this process for each similarity level once. The predicted results were highly correlated with the original data, with r = .87 for the RT and r = .84 for the ER, ps < .001. We have added this analysis and result to the “Conflict type similarity modulated behavioral congruency sequence effect (CSE)” 1079 section:

      “Moreover, to test the continuity and generalizability of the similarity modulation, we conducted a leave-one-out prediction analysis. We used the behavioral data from Experiment 1 for this test, due to its larger amount of data than Experiment 2. Specifically, we removed data from one of the five similarity levels (as illustrated by the θs in Fig. 1C) and used the remaining data to perform the same mixed-effect model (i.e., the two-stage analysis). This yielded one pair of beta coefficients including the similarity regressor and the intercept for each subject, with which we predicted the CSE for the removed similarity level for each subject. We repeated this process for each similarity level once. The predicted results were highly correlated with the original data, with r = .87 for the RT and r = .84 for the ER, ps < .001.”

      To estimate if the domain-specific model could explain the results we observed in right 8C, we conducted a model-comparison analysis. The domain-specific model treats each conflict type differently, so we used a diagonal matrix, with within-conflict type similarities being 1 and all cross-conflict type similarities being 0. This model showed non-significant effects (t(951989) = 0.84, p = .201) and poorer fit (BIC = 5377127) than the cognitive space model (t(951989) = 5.60, p = 1.1×10−8, BIC = 5377094). We also compared other alternative models and found the cognitive space model best fitted the data. We have included these results in the revised manuscript:

      “To examine if the right 8C specifically encodes the cognitive space rather than the domain-general or domain-specific organizations, we tested several additional models (see Methods). Model comparison showed a lower BIC in the Cognitive-Space model (BIC = 5377094) than the Domain-General (BIC = 537127) or Domain-Specific (BIC = 537127) models. Further analysis showed the dimensionality of the representation in the right 8C was 1.19, suggesting the cognitive space was close to 1D. We also tested if the observed conflict similarity effect was driven solely by spatial Stroop or Simon conflicts, and found larger BICs for the models only including the Stroop similarity (i.e., the Stroop-Only model, BIC = 5377122) or Simon similarity (i.e., the Simon-Only model, BIC = 5377096). An additional Stroop+Simon model, including both StroopOnly and Simon-Only regressors, also showed a worse model fitting (BIC = 5377118). Moreover, we replicated the results with only incongruent trials, considering that the pattern of conflict representations is more manifested when the conflict is present (i.e., on incongruent trials) than not (i.e., on congruent trials). We found a poorer fitting in Domain-general (BIC = 1344129), Domain-Specific (BIC = 1344129), Stroop-Only (BIC = 1344128), Simon-Only (BIC = 1344120), and Stroop+Simon (BIC = 1344157) models than the Cognitive-Space model (BIC = 1344104). These results indicate that the right 8C encodes an integrated cognitive space for resolving Stroop and Simon conflicts. The more detailed model comparison results are listed in Table 2.”

      We also estimated the dimensionality of the right 8C with the averaged RSM and found the dimensionality of the cognitive space was ~ 1.19, very close to a 1D space. This result is consistent with our experimental design, as the only manipulated variable is the angular distance between conflict types. We have added these results and the methods to the revised manuscript.

      Results:

      “Further analysis showed the dimensionality of the representation in the right 8C was 1.19, suggesting the cognitive space was close to 1D.”

      Methods:

      “To better capture the dimensionality of the representational space, we estimated its dimensionality using the participation ratio (Ito & Murray, 2023). Since we excluded the within-subject cells from the whole RSM, the whole RSM is an incomplete matrix and could not be used. To resolve this issue, we averaged the cells corresponding to each pair of conflict types to obtain an averaged 5×5 RSM matrix, similar to the matrix shown in Fig. 1C. We then estimated the participation ratio using the formula:

      where λi is the eigenvalue of the RSM and m is the number of eigenvalues.

      2) Another important factor to consider is how learning within the confined task space, which always negatively correlates the two types of conflicts within each subject, may have influenced the current results. Is statistical dependence of conflict information necessary to use the organized cognitive space to represent conflicts from multiple sources? Answering this question would require a paradigm that can adjust multiple sources of conflicts parametrically and independently. Investigating such dependencies is crucial in order to better understand the adaptive utility of the observed cognitive space of conflict similarity.

      As the central goal of our design was to test the geometry of neural representations of conflict, we manipulated the conflict similarity. The anticorrelated Simon and spatial Stroop conflict aimed to make the overall magnitude of conflict similar among different conflict types. We agree that with the current design the likely cognitive space is not a full 2D space with Simon and spatial Stroop being two dimensions. Instead, the likely cognitive space is a subspace (e.g., a circle) embedded in the 2D space, due to the constraint of anticorrelated Simon and spatial Stroop conflict across conflict types. Nevertheless, the subspace can also be used to test the geometry that similar conflict types share similar neural representations.

      To test the full 2D cognitive space, a possible revision of our current design is to have multiple hybrid conditions (like Type 2-4) that cover the whole space. For instance, imagine arrow locations in the first quadrant space. We could have a 3×3 design with 9 conflict conditions, where their horizontal/vertical coordinates could be one of the combinations of 0, 0.5 and 1. This way, the spatial Stroop and Simon conditions would be independent of each other. Notably, however, one potential confounding factor would be that these conditions have different levels of difficulty (i.e., different magnitude of conflict), which may affect the CSE results and their representational similarity.<br /> We have added the above limitations and future designs to the revised 1156 manuscript.

      “Another limitation is that in our design, the spatial Stroop and Simon effects are highly anticorrelated. This constraint may make the five conflict types represented in a unidimensional space (e.g., a circle) embedded in a 2D space. Future studies may test the 2D cognitive space with fully independent conditions. A possible improvement to our current design would be to include left, right, up, and down arrows presented in a grid formation across four spatially separate quadrants, with each arrow mapped to its own response button. However, one potential confounding factor would be that these conditions have different levels of difficulty (i.e., different magnitude of conflict), which may affect the CSE results and their representational similarity.”

      Major comments:

      3) The RSM result (and the absence of univariate effect) seem to be a good first step to claim the use of cognitive space of conflict. Yet, the presence of an organized (unidimensional; Fig. 6) and continuous cognitive space should be further tested and backed up.

      We thank the reviewer for recognizing the methods and results of our current work. Indeed, the utilization of a parametric design and RSA to examine organization of neural representations is a widely embraced methodology in the field of cognitive neuroscience (e.g., Freund et al., 2021; Ritz et al., 2022). Our current study aimed primarily to provide original evidence for whether similar conflicts are represented similarly in the brain, which reflects the geometry of conflict representations (i.e., the structure of differences between conflict representations). We have used multiple criteria to back up the findings by showing the representation is sensitive to the presence of conflict and has behavioral relevance.

      We agree that the cognitive space account of cognitive control requires further validation. Therefore, in the revised manuscript, we have added several additional tests to strengthen the evidence supporting the organized cognitive space representation. Firstly, we tested five alternative models (Domain-General, Domain Specific, Stroop-Only, Simon-Only and Stroop+Simon models), and found that the Cognitive-Space model best fitted our data. Secondly, we explicitly calculated the dimensionality of the representation and observed a low dimensionality (1.19D). We have added these results to the “Multivariate patterns of the right dlPFC encodes the conflict similarity” section in the revised manuscript (see also the response to Comment 1).

      Furthermore, we utilized data from Experiment 1 to demonstrate the continuity of the cognitive space by showing its ability to predict out-of-sample data. We have included this result to the “Conflict type similarity modulated behavioral congruency sequence effect (CSE)” section in the revised manuscript:

      “Moreover, to test the continuity and generalizability of the similarity modulation, we conducted a leave-one-out prediction analysis. We used the behavioral data from Experiment 1 for this test, due to its larger amount of data than Experiment 2. Specifically, we removed data from one of the five similarity levels (as illustrated by the θs in Fig. 1C) and used the remaining data to perform the same mixed-effect model (i.e., the two-stage analysis). This yielded one pair of beta coefficients including the similarity regressor and the intercept for each subject, with which we predicted the CSE for the removed similarity level for each subject. We repeated this process for each similarity level once. The predicted results were highly correlated with the original data, with r = .87 for the RT and r = .84 for the ER, ps < .001.”

      References:

      Freund, M. C., Bugg, J. M., & Braver, T. S. (2021). A Representational Similarity Analysis of Cognitive Control during Color-Word Stroop. Journal of Neuroscience, 41(35), 7388-7402.

      Ritz, H., & Shenhav, A. (2022). Humans reconfigure target and distractor processing to address distinct task demands. bioRxiv. doi:10.1101/2021.09.08.459546

      4) Is the conflict similarity effect not driven by either coding of the weak to strong gradient of the spatial Stroop conflict or the Simon conflict? For example, would simply identifying brain regions that selectively tuned to the Simon conflict continuously enough to create a graded similarity in Fig. C.

      We recognize that our current design and analyzing approach cannot fully exclude the possibility that the current results are driven solely by either Stroop or Simon conflicts, since their gradients are correlated to the conflict similarity gradient we defined. To estimate their unique contributions, we performed a model-comparison analysis. We constructed a Stroop-Only model and a Simon-Only model, with each conflict type projected onto the Stroop (vertical) axis or Simon (horizontal) axis, respectively. The similarity between any two conflict types was defined using the Jaccard similarity index (Jaccard, P., 1901), that is, their intersection divided by their union. By replacing the cognitive space-based conflict similarity regressor with the Stroop-Only and Simon-Only regressors, we calculated their BICs. Results showed that the BIC was larger for Stroop-Only (5377122) and Simon-Only (5377096) than for the cognitive space model (5377094). An additional Stroop+Simon model, including both Stroop-Only and Simon-Only regressors, also 1220 showed a poorer model fitting (BIC = 5377118) than the cognitive space model.

      Moreover, we replicated the results with only incongruent trials. We found a poorer fitting in Stroop-Only (BIC = 1344128), Simon-Only (BIC = 1344120), and Stroop+Simon (BIC = 1344157) models than the Cognitive-Space model (BIC = 1344104). These results indicate that the right 8C encodes an integrated cognitive space for resolving Stroop and Simon conflicts. Therefore, we believe the cognitive space has incorporated both dimensions. We added these additional analyses and results to the revised manuscript (see also the response to the above Comment 1).

      5) Is encoding of conflict similarity in the unidimensional organized space driven by specific requirements of the task or is this a general control strategy? Specifically, is the recruitment of organized space something specific to the task that people are trained to work with stimuli that negatively correlate the spatial Stroop conflict and the Simon conflict?

      We argue that this encoding is a general control strategy. In our task design, we asked the participants to respond to the target arrow and ignore the location that appeared randomly for them. So, they were not trained to deal with the stimuli in any certain way. We also found the conflict similarity modulation on CSE did not change with more training (We added this result in Note S3), indicating that the cognitive space did not depend on strategies that could be learned through training.

      “Note S3. Modulation of conflict similarity on behavioral CSEs does not change across time We tested if the conflict similarity modulation on the CSE is susceptible to training. We collected the data of Experiment 1 across three sessions, thus it is possible to examine if the conflict similarity modulation effect changes across time. To this end, we added conflict similarity, session and their interaction into a mixed-effect linear model, in which the session was set as a categorical variable. With a post-hoc analysis of variance (ANOVA), we calculated the statistical significance of the interaction term.

      This approach was applied to both the RT and ER. Results showed no interaction effect in either RT, F(2,1479) = 1.025, p = .359, or ER, F(2,1479) = 0.789, p = .455. This result suggests that the modulation effect does not change across time."

      Instead, the cognitive space should be determined by the intrinsic similarity structure of the task design. A previous study (Freitas et al., 2015) has found that the CSE across different versions of spatial Stroop and flanker tasks was stronger than that across either of the two conflicts and Simon. In their designs, the stimulus similarity was controlled at the same level, so the difference in CSE was only attributable to the similar dimensional overlap between Stroop and flanker tasks, in contrast to the Simon task. Furthermore, recent studies showed that the cognitive space generally exists to represent structured latent states (e.g., Vaidya et al., 2022), mental strategy cost (Grahek et al., 2022), and social hierarchies (Park et al., 2020). Therefore, we argue that cognitive space is likely a universal strategy that can be applied to different scenarios.

      We added this argument in the discussion:

      “Although the spatial orientation information in our design could be helpful to the construction of cognitive space, the cognitive space itself was independent of the stimulus-level representation of the task. We found the conflict similarity modulation on CSE did not change with more training (see Note S3), indicating that the cognitive space did not depend on strategies that could be learned through training. Instead, the cognitive space should be determined by the intrinsic similarity structure of the task design. For example, a previous study (Freitas et al, 2015) has found that the CSE across different versions of spatial Stroop and flanker tasks was stronger than that across either of the two conflicts and Simon. In their designs, the stimulus similarity was controlled at the same level, so the difference in CSE was only attributable to the similar dimensional overlap between Stroop and flanker tasks, in contrast to the Simon task. Furthermore, recent studies showed that the cognitive space generally exists to represent structured latent states (e.g., Vaidya et al., 2022), mental strategy cost (Grahek et al., 2022), and social hierarchies (Park et al., 2020). Therefore, cognitive space is likely a universal strategy that can be applied to different scenarios."

      Reference:

      Freitas, A. L., & Clark, S. L. (2015). Generality and specificity in cognitive control: conflict adaptation within and across selective-attention tasks but not across selective-attention and Simon tasks. Psychological Research, 79(1), 143-162.

      Vaidya, A. R., Jones, H. M., Castillo, J., & Badre, D. (2021). Neural representation of 1280 abstract task structure during generalization. Elife, 10, 1-26.

      Grahek, I., Leng, X., Fahey, M. P., Yee, D., & Shenhav, A. Empirical and 1282 Computational Evidence for Reconfiguration Costs During Within-Task 1283 Adjustments in Cognitive Control. CogSci.

      Park, S. A., Miller, D. S., Nili, H., Ranganath, C., & Boorman, E. D. (2020). Map 1285 Making: Constructing, Combining, and Inferring on Abstract Cognitive Maps. 1286 Neuron, 107(6), 1226-1238 e1228. doi:10.1016/j.neuron.2020.06.030

      6) The observed pattern seems to suggest that there is conflict similarity space that is defined by the combination of the conflict similarity (i.e., the strength of conflicts) and the sources of conflict (i.e., the Simon vs the spatial Stroop). What are the rational reasons to separate conflicts of different sources (beyond detecting incongruence)? And how are they used for better conflict resolutions?

      The necessity of separating conflicts of different sources lies in that the spatial Stroop and the Simon effects are resolved with different mechanisms. The behavioral congruency effects of a combined conflict from two different sources were shown to be the summation of the two conflict sources (Liu et al., 2010), suggesting that the conflicts are resolved independently. Moreover, previous studies have shown that different sources of conflict are resolved with different brain regions (Egner, 2008; Li et al., 2017), and at different processing stages (Wang et al., 2013). Therefore, when multiple sources of conflict occur simultaneously or sequentially, it should be more efficient to resolve the conflict by identifying the sources.

      We have added this argument to the revised manuscript:

      “The rationale behind defining conflict similarity based on combinations of different conflict sources, such as spatial-Stroop and Simon, stems from the evidence that these sources undergo independent processing (Egner, 2008; Li et al., 2014; Liu et al., 2010; Wang et al., 2014). Identifying these distinct sources is critical in efficiently resolving potentially infinite conflicts."

      Reference:

      Egner, T. (2008). Multiple conflict-driven control mechanisms in the human brain. Trends in Cognitive Sciences, 12(10), 374-380.

      Li, Q., Yang, G., Li, Z., Qi, Y., Cole, M. W., & Liu, X. (2017). Conflict detection and 1307 resolution rely on a combination of common and distinct cognitive control networks. Neuroscience and Biobehavioral Reviews, 83, 123-131.

      Wang, K., Li, Q., Zheng, Y., Wang, H., & Liu, X. (2014). Temporal and spectral 1310 profiles of stimulus-stimulus and stimulus-response conflict processing. NeuroImage, 89, 280-288.

      Liu, X., Park, Y., Gu, X., & Fan, J. (2010). Dimensional overlap accounts for independence and integration of stimulus-response compatibility effects. Attention, Perception, & Psychophysics, 72(6), 1710-1720.

      7) The congruency effect is larger in conflict type 2, 3, 4 consistently compared to conflict 1 and 5. Are these expected under the hypothesis of unified cognitive space of conflict similarity? Is the pattern of similarity modeled in RSA?

      Yes, this is expected. The spatial Stroop and Simon effects have been shown to be additive and independent (Li et al., 2014). Therefore, the congruency effects of conflict type 2, 3 and 4 would be the weighted sum of the spatial Stroop and Simon effects. The weights can be defined by the sine and cosine of the polar angle.

      For instance, in Type 2, wy = sin(67.5°) and wx = cos(67.5°). The sum of the two 1321 weight values (i.e., 1.31) is larger than 1, leading to a larger congruency effect than 1322 the pure spatial Stroop (Conf 1) and Simon (Conf 5) conditions.

      Note that this hypothesis underlies the Stroop+Simon model, which assumes the Stroop and Simon dimensions are independently represented in the brain and drive the behavior in an additive fashion. Moreover, the observed difference of behavioral congruency effects may have reflected the variance in the Domain-General model, which treats all conflict types as equivalent, with the only difference between each two conflict types in the magnitude of their conflict. Therefore, we did not model the behavioral congruency effects as a covariance regressor in the major RSA. Instead, we conducted a model comparison analysis by comparing these models and the Cognitive-Space model. Results showed worse model fitting of both the Domain-general and Stroop+Simon models. Specially, the regressor of congruency effect difference in the Domain-General model was not significant (p = .575), which also suggests that the higher congruency effect in conflict type 2, 3 and 4 should not influence the Cognitive-Space model results. We have added these methods and results to the revised manuscript (see also our response to Comment 1):

      Methods:

      “Model comparison and representational dimensionality

      To estimate if the right 8C specifically encodes the cognitive space, rather than the domain-general or domain-specific structures, we conducted two more RSAs. We replaced the cognitive space-based conflict similarity matrix in the RSA we reported above (hereafter referred to as the Cognitive-Space model) with one of the alternative model matrices, with all other regressors equal. The domain-general model treats each conflict type as equivalent, so each two conflict types only differ in the magnitude of their conflict. Therefore, we defined the domain-general matrix as the difference in their congruency effects indexed by the group-averaged RT in Experiment 2. Then the z scored model vector was sign-flipped to reflect similarity instead of distance. The domain-specific model treats each conflict type differently, so we used a diagonal matrix, with within-conflict type similarities being 1 and all cross-conflict type similarities being 0.

      Moreover, to examine if the cognitive space is driven solely by the Stroop or Simon conflicts, we tested a spatial Stroop-Only (hereafter referred to as “Stroop-Only”) and a Simon-Only model, with each conflict type projected onto the spatial Stroop (vertical) axis or Simon (horizontal) axis, respectively. The similarity between any two conflict types was defined using the Jaccard similarity index (Jaccard, 1901), that is, their intersection divided by their union. We also included a model assuming the Stroop and Simon dimensions are independently represented in the brain, adding up the Stroop Only and Simon-Only regressors. We conducted similar RSAs as reported above, replacing the original conflict similarity regressor with the Strrop-Only, Simon-Only, or both regressors, and then calculated their Bayesian information criterions (BICs)."

      Reference:

      Li, Q., Nan, W., Wang, K., & Liu, X. (2014). Independent processing of stimulus stimulus and stimulus-response conflicts. PloS One, 9(2), e89249.

      8) Please clarify the observed patterns of CSE effects in relation to the hypothesis of common cognitive space of conflict. In particular, right 8C shows that the patterns become dissimilar in incongruent trials compared to congruent trials. How does this direction of the effect fit to the common unidimensional cognitive space account? And how does such a representation contribute to the CES effects?

      The behavioral CSE patterns provide initial evidence for the cognitive space hypothesis. Previous studies have debated whether cognitive control relies on domain-general or domain-specific representations, with much evidence gathered from behavioral CSE patterns. A significant CSE across two conflict conditions typically suggests domain-general representations of cognitive control, while an absence of CSE suggests domain-specific representations. The cognitive space view proposes that conflict representations are neither purely domain-general nor purely domain-specific, but rather exist on a continuum. This view predicts that the CSE across two conflict conditions should depend on the representational distance between them within this cognitive space. Our finding that CSE values systematically vary with conflict similarity level support this hypothesis. We have added this point in the discussion of the revised manuscript:

      “Previous research on this topic often adopts a binary manipulation of conflict(Braem et al., 2014) (i.e., each domain only has one conflict type) and gathered evidence for the domain-general/specific view with presence/absence of CSE, respectively. Here, we parametrically manipulated the similarity of conflict types and found the CSE systematically vary with conflict similarity level, demonstrating that cognitive control is neither purely domain-general nor purely domain-specific, but can be reconciled as a cognitive space(Bellmund et al., 2018) (Fig. 6, middle).

      Fig. 4D was plotted to show the steeper slope of the conflict similarity effect for incongruent versus congruent conditions. Note the y-aixs displays z-scored Pearson correlation values, so the grand mean of each condition was 0. The values for the first two similarity levels (level 1 and 2) were lower for incongruent than congruent conditions, seemingly indicating lower average similarity. However, this was not the case. The five similarity levels contained different numbers of data points (see Fig. 1C), so levels 4 and 5 should be weighted more heavily than levels 1 and 2. When comparing the grand mean of raw Pearson correlation values, the incongruent condition (0.0053) showed a tendency toward higher similarity than the congruent condition (0.0040), t(475998) = 1.41, p = .079. We have also plotted another version of Fig. 4D in Fig. S5, in which the raw Pearson correlation values were used.

      The greater representation of conflict type in incongruent condition compared to congruent condition (as evidenced by a steeper slope) suggests that the conflict representation was driven by the incongruent condition. This is probably due to the stronger involvement of cognitive control in incongruent condition (than congruent condition), which in turn leads to more distinct patterns across different conflict types. This is consistent with the fact that the congruent condition is typically a baseline, where any conflict related effects should be weaker.

      The representation of cognitive space may contribute to the CSE as a mental model. This model allows our brain to evaluate the cost and benefit associated with transitioning between different conflict conditions. When two consecutive trials are characterized by more similar conflict types, their representations in the cognitive space will be closer, resulting in a less costly transition. As a consequence, stronger CSEs are observed. We revised the corresponding discussion part as:

      “Similarly, we propose that cognitive space could serve as a mental model to assist fast learning and efficient organization of cognitive control settings. Specifically, the cognitive space representation may provide a principle for how our brain evaluates the expected cost of switching and the benefit of generalization between states and selects the path with the best cost-benefit tradeoff (Abrahamse et al., 2016; Shenhav et al., 2013). The proximity between two states in cognitive space could reflect both the expected cognitive demand required to transition and the useful mechanisms to adapt from. The closer the two conditions are in cognitive space, the lower the expected switching cost and the higher the generalizability when transitioning between them. With the organization of a cognitive space, a new conflict can be quickly assigned a location in the cognitive space, which will facilitate the development of cognitive control settings for this conflict by interpolating nearby conflicts and/or projecting the location to axes representing different cognitive control processes, thus leading to a stronger CSE when following a more similar conflict condition.”

      Minor comments:

      9) Some of the labels of figure axes are unclear (e.g., Fig4C) about what they represent.

      In Fig. 4C, the x-axis label is “neural representational strength”, which refers to the beta coefficient of the conflict type effect computed from the main RSA, denoting the strength of the conflict type representation in neural patterns. The y-axis label is “behavioral representational strength”, which refers to the beta coefficient obtained from the behavioral linear model using conflict similarity to predict the CSE in Experiment 2; it reflects how strong the conflict similarity modulates the behavioral 1440 CSE. We apologize for any confusion from the brief axis labels. We have added expanded descriptions to the figure caption of Fig. 4C.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1:

      One concern is regarding the experimental task design. Currently, only subjective reports of interoceptive intensity are taken into account, the addition of objective behavioural measures would have given additional value to the study and its impact. 

      To address this comment, we calculated interoceptive accuracy during the cardiorespiratory perturbation (isoproterenol) task according to our previous methods (e.g., Khalsa et al 2009 Int J Psychophys, Khalsa et al, 2015 IJED, Khalsa et al 2020 Psychophys, Hassanpour et al, 2018 NPP, Teed et al 2022 JAMA Psych). Thus, we quantified interoceptive accuracy as the cross-correlation between heart rate and real-time cardiorespiratory perception; specifically, the zero-lag cross-correlation between the heart rate and dial rating time series, and the maximum cross-correlation between these time series while allowing for different temporal delays (or lags). As expected, we found a dose-related increase in interoceptive accuracy from the 0.5mcg moderate perturbation dose (for which neuroimaging maps were not included in the current study) to the 2.0mcg high perturbation dose: zero-lag cross-correlations of 0.25 and 0.61, maximum cross-correlations of 0.41 and 0.73, for 0.5mcg and 2.0mcg doses, respectively, when averaged across all participants in the current study. Taking a closer examination at just the 2.0mcg dose, there were no group differences in zero-lag cross-correlation (t89\=-0.68, p=0.50) or maximum cross-correlation (t87\=-1.0, p=0.32) (depicted below, panel A). Furthermore, there were no associations between either of these interoceptive accuracy measures and the magnitude of activation within bilateral dysgranular convergent regions (F1\= 0.27 and 0.01, p=0.61 and 0.91, for the main effect of percent signal change on max and zero-lag cross-correlations, respectively; depicted below, panel B). When considering the significant correlation between the right insula signal intensity and subjective dial ratings, this lack of association with interoceptive accuracy suggests that the right dysgranular convergent insula was preferentially tracking the magnitude estimation rather than accuracy facet of interoceptive awareness during cardiorespiratory perturbation. Notably, during the saline placebo infusion, there were no systematic changes in heart rate and thus no systematic change in dial rating, precluding the calculation of the cross-correlation as a measure of interoceptive accuracy.

      In reviewing these findings, we did not feel that the results add meaningful information to our interpretation of convergence, and accordingly we have chosen not to include it in the manuscript.

      Author response image 1.

      (A) Interoceptive accuracy during 2.0mcg isoproterenol perturbation, as measured by the maximum (left panel) and zero-lag (right panel) cross-correlation between the time series of heart rate and perceptual dial rating. There were no differences between groups. (B) There were no associations between interoceptive accuracy ratings and signal intensity within the convergence dysgranular insula during the Peak period of 2.0mcg perturbation. 

      This brings me to my second concern. The authors mostly refer to their own previous work, without highlighting other methods used in the field. Some tasks measure interoceptive accuracy or other behavioural outcomes, instead of merely subjective intensity. Expanding the scientific context would aid the understanding and integration of this study with the rest of the field. 

      Given our focus on the neural basis of bottom-up perturbations of interoception, we found it relevant to reference previous studies from our lab, as we built directly upon these previous findings to inform the hypotheses and design of the current experiment, but we can appreciate to provide a broader view of the literature. To expand the contextual frame, we have cited two fMRI meta-analyses of cardiac and gastrointestinal interoception (line 101). There are few studies that have used comparable perturbation approaches during neuroimaging in clinical populations, although we have referenced an exemplar study from the respiratory domain by Harrison et al (2021) in the discussion (line 612). In considering this comment more carefully, we felt that expanding the context further to other task-based methods or behavioral outcomes would shift the focus beyond our emphasis on the insular cortex and top-down/bottom-up convergence, though we have previously discussed and integrated such approaches (e.g., Khalsa & Lapidus, 2016 Front Psych, Khalsa et al, 2018 Biol Psychiatry CNNI, Khalsa et al 2022, Curr Psych Rep).

      Lastly, the suggestions for future research lack substance compared to the richness of the discussion. I recommend a slight revision of the introduction/discussion. There is text in the discussion (explanatory or illuminating) which is better suited to the introduction. 

      When discussing our study limitations (beginning line 732), we offer numerous areas for future research including different preprocessing pipelines, more sophisticated analysis techniques (such as multivariate pattern analysis) that would allow for individual-level inferences regarding convergent patterns of activation within the insula. However, we have revised the last sentence of our limitations paragraph (line 757), and have added more specificity regarding future approaches examining insular and whole-brain interoceptive signal flow.

      Reviewer 2:

      (1) The interpretation of the resting-state data is not quite as clear-cut as the task-based data - as presented currently, changes could potentially represent fluctuations over time rather than following interoception specifically. In contrast, much stronger conclusions can be drawn from the authors' task-based data. …I was also unsure about the interpretation of the resting state analysis (Figure 5), as there was no control condition without interoceptive tasks, meaning any change could represent a change over time that differed between groups and not necessarily a change from pre- to post-interoception. Relatedly I wondered if the authors had calculated the test-retest reliability of the resting state data (e.g. intraclass correlation coefficients for the whole-brain functional connective of convergent dysgranular insula subregions and left middle frontal gyrus before vs. after the tasks), as it would be generally useful for the field to know its stability. 

      We have acknowledged the lack of a control condition in the isoproterenol task (note that the VIA task contained an exteroceptive trial that was included in the brain image contrast analysis). We have also provided further justification for our approach in both the Methods (see the first paragraph “fMRI resting state analysis” subsection) and Results (see the last paragraph of the “Convergence analysis” subsection). We cannot estimate test-retest reliability from the current dataset, given that we do not have resting state scans separated by a similar time frame without the performance of the interoceptive tasks in between (this is now clarified in line 346).

      (2) The transdiagnostic sample could be better characterised in terms of diagnostic information, and was almost entirely female; it is also unclear what the effect of psychotropic medications may have been on the results given the effects of (e.g.) serotonergic medication on the BOLD signal. …Table 1 would be substantially improved by a fuller clinical characterisation of the specific sample included in the analysis - the diagnostic acronyms included in the table caption are not used in the table itself at present and would be an excellent addition, describing, for example, the demographics and symptom scores of patients meeting criteria for MDD, GAD, and AN (and perhaps those meeting criteria for more than 1). Similarly, additional information about the specific medications patients (or controls?) were taking in this study would be welcome (given the potential influences of common medications (e.g. antidepressants) on neurovascular coupling). 

      We have expanded Table 1 to include more specific diagnostic information for the transdiagnostic ADE group (GAD, MDD, and/or AN, as well as other psychiatric diagnoses). We have also included medication use.  

      Finally, Figures 7c and 7d would be greatly improved by showing individual data points if possible, and there may be a typo in the caption 'The cardiac group reported higher cardiac intensity ratings in the ADE group'.

      We have adjusted Figure 7c and 7d to include individual data points, as we agree that this provides greater transparency to the data itself. We have also fixed the typo in the figure caption.

      (3) As the authors point out, there may have been task-specific preprocessing/analysis differences that influenced results, for example, due to physiological correction in one but not both tasks. Although I note this is mentioned in the limitations, it was not clear to me why physiological noise was removed from the ISO task and whether it would be possible to do the same in the VIA task, which could be important for the most robust comparison of the two. 

      In this study, we intentionally chose different task-specific preprocessing pipelines so we could ensure that our results were not simply due to new ways of handling the data. This would allow us to evaluate evidence of replicating the previous group-level findings of insular activation that informed the current approach and hypotheses. We agree that a harmonized approach is also merited, and in a subsequent project using this dataset, we have matched preprocessing pipelines for a connectivity-based analysis, to best facilitate comparison across tasks. We look forward to sharing those results with the scientific community in due time.

      Reviewer 3:

      Maybe I missed it (and my apologies in case I did), but there were a few instances where it was not entirely clear whether differential effects (say between groups or conditions) were compared directly, as would be required. One example is l. 459 ff: The authors report the interesting lateralisation effect for the two interception tasks and say it was absent in the exteroceptive VIA task. As a reader, it would be great to know whether that finding (effect in one condition but not in the other) is meaningful, i.e. whether the direct comparison becomes statistically significant. … The same applies to later comparisons, for example, the correlations reported in l. 465 ff (do these differ from one another?) as well as the FC patterns reported in l. 476 ff - again, there is a specific increase in the ADE group (but not in the HC), but is this between-group difference statistically meaningful? 

      Thank you for these questions. We have added greater detail in the Results section in order to increase clarity regarding which statistical comparisons support which conclusions. Generally, we limited our comparisons to the effect of group, as comparing ADE vs. HC individuals was of primary interest, and in some cases also the effect of hemisphere and epoch. However, we did not perform exhaustive comparisons for all measures, in the interest of keeping the focus of our multi-level multi-task analysis on the hypothesis-driven questions specifically related to convergence of top-down and bottom-up processing.

      Regarding the comment asking if we could compare the lateralization effect directly across task conditions (i.e., is there a greater difference between hemispheres in the ISO task compared to VIA?): unfortunately, directly comparing signal intensity across tasks is not possible because the isoproterenol infusion induces physiological changes that can cause some dose-related signal reduction (we have attempted to address this in the past, e.g., Hassanpour et al, 2018 HumBrMapp). Consequently, our conclusions about spatial localization of top-down and bottom-up convergence are limited to group-level comparisons based on binary activation.

      (2) A second 'major' relates to the intensity ratings (l. 530 ff). I found it very interesting that the ADE group reported higher cardiac, but lower exteroceptive intensity ratings during the VIA task. I understand the authors' approach to collapse within the ADE group, but it would be great to know which subgroup of patients drives this differential effect. It could be the case that the cardiac effect is predominantly present in the anxiety group, while the lower exteroceptive ratings are driven by the depression patients. Even if that were not the case, it would be highly instructive to understand the rating pattern within the anxiety group in greater detail. Do these patients 'just' selectively upregulate interoception, or is there even a perceived downregulation of exteroceptive signalling? 

      We have depicted these data below for reviewers’ reference, showing individual responses for each group (HC and ADE; panel A), as well as the ADE individuals separated by primary diagnosis (GAD = generalized anxiety disorder, n=24; AN = anorexia nervosa, n=16; MDD = major depressive disorder, n=6; panel B). When tested via linear regression, we found no differences in ratings across ADE subgroups (rating ~ subgroup * condition, F3\=1.71, p=0.16 for main effect of subgroup). However, several factors should be considered in interpreting this result: first, all subgroups are small, particularly the MDD sample. Second, while these diagnostic labels refer to the most prominent symptom expression of each patient, every clinical participant in the study had a co-morbid disorder. Therefore, it is not possible to isolate disorder-specific pathology from our multi-diagnostic sample, and for this reason we refrained from including the subgroup-specific data in the manuscript.

      Author response image 2.

      (A) Post-trial ratings during the Visceral Interoceptive attention task, for reference. This is also shown in Figure 7D. (B) The same post-trial ratings in (A), but with the ADE group separated by primary diagnoses. Importantly, although assigned to one diagnostic category on the basis of most prominent symptom expression, most patients had one or more comorbidities across disorders. GAD = Generalized Anxiety Disorder. MDD = major depressive disorder. AN = anorexia nervosa. HC = healthy comparison.

      l. 86: 'Conscious experience' of what, precisely? During the first round of reading, I was wondering about the extent to which consciousness as a general concept will play a role, which could be misleading. 

      We have changed it to “conscious experience of the inner body” in the text. The current study is limited in scope to the neurobiology of conscious perceptions of the inner body, not consciousness as a general phenomenon. We hope this distinction is now clear.

      l.115: Particularly given the focus on predictive processing, I was wondering whether the (slightly outdated) spotlight metaphor is really needed here. 

      While not perfect, we believe it is still valid to metaphorically reference goal-directed attention towards the body as an “attentional spotlight”. Given the concern, we have minimized the focus on this metaphor, and the sentence now reads as follows:

      “Extending beyond these model-based influences are goal-directed activities (also described previously as the ‘attentional spotlight’ effect ((Brefczynski and DeYoe 1999)), whereby focusing voluntary attention towards certain environmental signals not only alters their conscious experience but selectively enhances neural activity in the responsive area of cortex.”

      l. 129 ff: The sentence has three instances of 'and' in it, most likely a typo. 

      We have fixed this in the text.

      l. 245: What do these ratings correspond to, i.e. what was the precise question/instruction? 

      The instructions for subjective ratings in each task are mentioned in the Methods (line 223 for ISO task, line 249 for the VIA task), and we have added more detail regarding the scale used to collect subjective intensity ratings.

      l. 322: Could you provide the equation of the LMEM in the main text? It would be interesting to know e.g. whether participants/patients were included as a random effect. 

      We have provided this equation in the Methods (line 326).

      l. 418 ff: I was confused about the statistical approach here. Why use separate t-tests instead of e.g. another LMEM which would adequately model task and condition factors? 

      We did not use t-tests, but instead used linear regression to look at differences in agranular PSC across groups, hemispheres, and epochs, as well as potential associations between PSC and trait measures. We have adjusted the wording in this Methods paragraph (line 418) to help clarity.

      l. 425: As a general comment, it would be great to provide the underlying scripts openly through GitHub, OSF, ... 

      We agree with this comment, and our main analysis scripts have been posted on our OSF as an addition to the original preregistration of this work (https://osf.io/6nxa3/).

      l. 443: For consistency, please report the degrees of freedom for the X² test.

      l. 454: ... and the F statistic would require two degrees of freedom (only the second is reported).

      l. 523: The t value is reported without degrees of freedom here (but has them in other instances).

      l. 540: Typo ('were showed').

      We have reported degrees of freedom for all statistics.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer 1:

      (1) In general, the representation of target and distractor processing is a bit of a reach. Target processing is represented by SSVEP amplitude, which is most likely going to be related to the contrast of the dots, as opposed to representing coherent motion energy, which is the actual target. These may well be linked (e.g., greater attention to the coherent motion task might increase SSVEP amplitude), but I would call it a limitation of the interpretation. Decoding accuracy of emotional content makes sense as a measure of distractor processing, and the supplementary analysis comparing target SSVEP amplitude to distractor decoding accuracy is duly noted.

      We agree with the reviewer. The SSVEP amplitude of the target at the whole trial level indeed reflected the combined effect of the stimulus parameters (e.g., contrast of the moving dots) as well as attention. However, the time course of the target SSVEP amplitude within a trial, derived from the moving window analysis, reflected the temporal fluctuations of target processing, since the stimulus parameters remained the same during the trial. We now make this clearer in the revised manuscript.

      (2) Comparing SSVEP amplitude to emotional category decoding accuracy feels a bit like comparing apples with oranges. They have different units and scales and probably reflect different neural processes. Is the result the authors find not a little surprising in this context? This relationship does predict performance and is thus intriguing, but I think this methodological aspect needs to be discussed further. For example, is the phase relationship with behaviour a result of a complex interaction between different levels of processing (fundamental contrast vs higher order emotional processing)?

      Traditionally, the SSVEP amplitude at the distractor frequency is used to quantify distractor processing. Given that the target SSVEP amplitude is stronger than that of the distractor, it is possible that the distractor SSVEP amplitude is contaminated by the target SSVEP amplitude due to spectral power leakage; see Figure S4 for a demonstration of this. Because of this issue we therefore introduced the use of decoding accuracy as an index of distractor processing. The lack of correlation between the distractor SSVEP amplitude and the distractor decoding accuracy, although it is kind of like comparing apples with oranges as pointed out by the reviewer, serves the purpose of showing that these two measures are not co-varying, and the use of decoding accuracy is free from the influence of the distractor SSVEP amplitude which is influenced by the target SSVEP amplitude. Also, to address the apples-vs-oranges issue, the correlation was computed on normalized time series, in which a z-score time series replaced the original time series so that the correlated variables are dimensionless. Regarding the question of assessing the relation between behavior and different levels of processing, we do not have means to address it, given that we are not able to empirically separate the effects of stimulus parameters versus attention.

      Reviewer 2:

      (1) Incomplete Evidence for Rhythmicity at 1 Hz: The central claim of 1 Hz rhythmic sampling is insufficiently validated. The windowing procedure (0.5s windows with 0.25s step) inherently restricts frequency resolution, potentially biasing toward low-frequency components like 1 Hz. Testing different window durations or providing controls would significantly strengthen this claim.

      We appreciate the reviewer’s insightful suggestion. In response, we tested different windowing parameters, e.g., 0.1s sliding window with a 0.05s step size. Figure S5 demonstrates that the strength of both target and distractor processing fluctuates around ~1 Hz, both at the individual and group levels. Additionally, Figures S6(A) and S6(B) show that the relative phase between target and distractor processing time series exhibits a uniform distribution across subjects. In terms of the relation between relative phase and behavior, Figure S6(C) illustrates two representative cases: a high-performing subject with 84.34% task accuracy exhibited a relative phase of 0.9483π (closer to π), while a low-performing subject with 30.95% accuracy showed a phase of 0.29π close to 0). At the group level, a significant positive correlation between relative phase and task performance was found (r = 0.6343, p = 0.0004), as shown in Figure S6(D). All these results, aligning closely with our original findings (0.5s window length and 0.25s step size), suggest that the conclusions are not dependent on windowing parameters. We discuss these results in the revised manuscript.

      To further validate our findings, we also employed the Hilbert transform to extract amplitude envelopes of the target and distractor signals on a time-point-by-time-point basis, providing a window-free estimate of signal strength (Figures R3 and R4). The results remain consistent with both the original findings and the new sliding window analyses (Figure S6). Specifically, Figure S7 reveals ~1 Hz fluctuations in target and distractor processing at both individual and group levels. Figures S8(A) and S8(B) confirm a uniform distribution of the relative phase across subjects. In Figure S8(C), the relative phase was 0.9567π for a high-performing subject (84.34% accuracy) and 0.2247π for a low-performing subject (28.57% accuracy). At the group level, a significant positive correlation was again observed between relative phase and task performance (r = 0.4020, p = 0.0376), as shown in Figure S8(D).

      (2) No-Distractor Control Condition: The study lacks a baseline or control condition without distractors. This makes it difficult to determine whether the distractor-related decoding signals or the 1 Hz effect reflect genuine distractor processing or more general task dynamics.

      The lack of a no-distractor control condition is certainly a limitation and will be acknowledged as such in the revised manuscript. However, given that our decoding results are between two different classes of distractors, we are confident that they reflect distractor processing.

      (3) Decoding Near Chance Levels: The pairwise decoding accuracies for distractor categories hover close to chance (~55%), raising concerns about robustness. While statistically above chance, the small effect sizes need careful interpretation, particularly when linked to behavior.

      This is an important point. To test robustness, we have implemented a random permutation procedure in which trial labels were randomly shuffled to construct a nullhypothesis distribution for decoding accuracy. We then compared the decoding accuracy from the actual data to this distribution. Figure S9 shows the results based on 1,000 permutations. For each of the three pairwise classifications—pleasant vs. neutral, unpleasant vs. neutral, and pleasant vs. unpleasant—as well as the three-way classification, the actual decoding accuracies fall far outside the null-hypothesis distribution (p < 0.001), and the effect size in all four cases is extremely large. These findings indicate that the observed decoding accuracies are statistically significant and robust in terms of both statistical inference and effect size.

      (4) No Clear Correlation Between SSVEP and Behavior: Neither target nor distractor signal strength (SSVEP amplitude) correlates with behavioral accuracy. The study instead relies heavily on relative phase, which - while interesting - may benefit from additional converging evidence.

      We felt that what the reviewer pointed out is actually the main point of our study, namely, it is not the target or distractor strength over the whole trial that matters for behavior, it is their temporal relationship within the trial that matters for behavior. This reveals a novel neuroscience principle that has not been reported in the past. We have stressed this point further in the revised manuscript.

      (5) Phase-analysis: phase analysis is performed between different types of signals hindering their interpretability (time-resolved SSVEP amplitude and time-resolved decoding accuracy).

      The time-resolved SSVEP amplitude is used to index the temporal dynamics of target processing whereas the time-resolved decoding accuracy is used to index the temporal dynamics of distractor processing. As such, they can be compared, using relative phase for example, to examine how temporal relations between the two types of processes impact behavior. This said, we do recognize the reviewer’s concern that these two processes are indexed by two different types of signals. We thus normalized each time course using zscoring, making them dimensionless, and then computed the temporal relations between them.

      Appraisal of Aims and Conclusions:

      The authors largely achieved their stated goal of assessing rhythmic sampling of distractors. However, the conclusions drawn - particularly regarding the presence of 1 Hz rhythmicity - rest on analytical choices that should be scrutinized further. While the observed phaseperformance relationship is interesting and potentially impactful, the lack of stronger and convergent evidence on the frequency component itself reduces confidence in the broader conclusions.

      Impact and Utility to the Field:

      If validated, the findings will advance our understanding of attentional dynamics and competition in complex visual environments. Demonstrating that ignored distractors can be rhythmically sampled at similar frequencies to targets has implications for models of attention and cognitive control. However, the methodological limitations currently constrain the paper's impact.

      Thanks for these comments and positive assessment of our work’s potential implications and impact. As indicated above, in the revision process, we have carried out a number of additional analyses, some suggested by the reviewers, and the results of the additional analyses, now included in the Supplementary Materials, served to further validate the main findings and strengthen our conclusions.

      Additional Context and Considerations:

      (1) The use of EEG-fMRI is mentioned but not leveraged. If BOLD data were collected, even exploratory fMRI analyses (e.g., distractor modulation in visual cortex) could provide valuable converging evidence.

      Indeed, leveraging fMRI data in EEG studies would be very beneficial, as has been demonstrated in our previous work. However, given that this study concerns the temporal relationship between target and distractor processing, it is felt that fMRI data, which is known to possess low temporal resolution, has limited potential to contribute. We will be exploring this rich dataset in other ways in the future, where we will be integrating the two modalities for more insights that are not possible with either modality used alone.

      Author response image 1.

      Appyling moving window analysis (0.02s window duration and 0.01 step size) to a different EEG-fMRI dataset. (A) The amplitude time series of the 4.29 Hz component and the Fourier spectrum. (B) The group level Fourier spectrum. At both individual and group level, no 1 Hz modulation is observed, suggesting that the 1 Hz modulation observed in our data is not introduced by the artifact removal procedure.

      (2) In turn, removal of fMRI artifacts might introduce biases or alter the data. For instance, the authors might consider investigating potential fMRI artifact harmonics around 1 Hz to address concerns regarding induced spectral components.

      We have done extensive work in the area of simultaneous EEG-fMRI and have not encountered artifacts with a 1Hz rhythmicity. Our scanner artifact removal procedure is very standardized. As such, it stands to reason that if the 1Hz rhythmicity observed here results from the artifact removal process, it should also be present in other datasets where the same preprocessing steps were implemented. We tested this using another EEG-fMRI dataset (Rajan et al., 2019) . Author response image 1 shows that the EEG power time series of the new dataset doesn't have 1 Hz rhythmicity, whether at the individual level or at the group level, suggesting that the 1 Hz rhythmicity reported in the manuscript is not coming from the removal of the scanner artifacts, but instead reflects true rhythmic sampling of stimulus information. Also, the fact that the temporal relations between target processing and distractor processing at 1Hz impact behavior is another indication that the 1Hz rhythmicity is a neuroscientific effect, not an artifact.

      References

      Rajan, A., Siegel, S. N., Liu, Y., Bengson, J., Mangun, G. R., & Ding, M. (2019). Theta Oscillations Index Frontal Decision-Making and Mediate Reciprocal Frontal–Parietal Interactions in Willed Attention. Cerebral Cortex, 29(7), 2832–2843. https://doi.org/10.1093/cercor/bhy149

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      This report contains two parts. In the first part, several experiments were carried out to show that CsoR binds to CheA, inhibits CheA phosphorylation, and impairs P. putida chemotaxis. The second part provides some evidence that CsoR is a copper-binding protein, binds to CheA in a copper-dependent manner, and regulates P. putida response to copper, a chemorepellent. Based on these results, a working model is proposed to describe how CsoR coordinates chemotaxis and resistance to copper in P. putida. While the second part of the study is relatively solid, there are some major concerns about the first part.

      Critiques:

      (1) The rigor from prior research is not clear. In addition to talking about other bacterial chemotaxis, the Introduction should briefly summarize previous work on P. putida chemotaxis and copper resistance.

      We summarized previous results on P. putida copper resistance and added those results to the introduction section of the revised manuscript. As for chemotaxis, most studies in P. putida focused on the sensing/responding of the bacteria to different chemical compounds and the methyl-accepting chemotaxis proteins (MCPs) involved in the sensing, which is not relevant to the main content of this study. The component of the chemotaxis system in P. putida is similar to that in E. coli, and the signaling mechanism is presumably similar.

      (2) The rationale for identifying those CheA-binding proteins is vague. CheA has been extensively studied and its functional domains (P1 to P5) have been well characterized. Compared to its counterparts from other bacteria, does P. putida CheA contain a unique motif or domain? Does CsoR bind to other bacterial CheAs or only to P. putida CheA?

      The original purpose of the pull-down assay was to detect the interaction between CheA and c-di-GMP metabolizing enzymes, which was another project. However, we ignored that most c-di-GMP metabolizing enzymes were membrane proteins, and we made a mistake by using whole-cell lysate in the pull-down experiment. Thus, we failed to identify c-di-GMP metabolizing enzymes in “target” proteins of the pull-down assay. However, we found several novel “target” proteins in the pull-down assay. We wondered about the function of these proteins and the physiological roles of the interaction between CheA and these proteins, which was the primary purpose of this study. Although the function of CheA has been well characterized, most previous results focused on the role of CheA in chemotaxis, and its role in other bacterial processes was poorly studied. To extend our knowledge about CheA, we analyzed the results of the pull-down assay and decided to test the interaction between CheA and identified proteins, as well as the physiological roles of the interaction.

      BLAST results showed that the CheA of P. putida shared 41.12% sequence similarity with the CheA of E. coli, and the CheA of P. putida had a similar domain pattern to those CheAs from other bacteria. To test whether  CsoR<sub>P. putida</sub> interacted with CheA from other bacteria, we performed a BTH assay to investigate the interaction between  CsoR<sub>P. putida</sub> and eight CheAs, including CheA from E. coli, CheA from A. caldus, CheA from B. diazoefficiens, CheA from B. subtilis, CheA from L. monocytogenes, CheA from P. fluorescens, CheA from P. syringae, and CheA from P. stutzeri. As shown in the following Fig. 1,  CsoR<sub>P. putida</sub> could interact with CheA from A. caldus, B. subtilis, L. monocytogenes, P. fluorescens, P. syringae, and P. stutzeri. Besides, among these strains, cheA and csoR coexist in A. caldus, B. diazoefficiens, B. subtilis, L. monocytogenes, P. fluorescens, P. syringae, and P. stutzeri. We previously tested the interaction of the two proteins from these bacterial species. The results showed that the CheA-CsoR interaction existed between proteins from A. caldus, B. subtilis, P. syringae, and P. stutzeri (Fig. 7 in the manuscript). However, CheA and CsoR from B. diazoefficiens, L. monocytogenes, and P. fluorescens showed no apparent interaction (Fig. 7 in the manuscript). These results suggested that unique amino acid sequences in the two proteins might be required to achieve interaction.

      (3) Line 133-136, "Collectively, using pull-down, BTH, and BiFC assays, we identified 16 new CheA-interacting proteins in P. putida." It is surprising that so many proteins were identified but none of them were chemotaxis proteins, in particular those known to interact with CheA, such as CheW, CheY and CheZ, which raises a concern about the specificity of these methods. BTH and BiFC often give false-positive results and thus should be substantiated by other approaches such as co-IP, surface plasmon resonance (SPR), or isothermal titration calorimetry (ITC) along with mutagenesis studies.

      The response regulator CheY and the phosphatase CheZ (two proteins known to be associated with CheA) were identified in the pull-down assay (Table S1), and the two proteins showed high Log<sub>2</sub>(fold change) values, indicating that they were obtained in the pull-down assay with high amount in the experimental group and low amount in the control group. Our study aimed to identify new CheA-interacting proteins; thus, the two proteins (CheY and CheZ) were not included in subsequent investigations. The CheA-interacting proteins were initially obtained through an in vitro assay (pull-down), followed by an in vivo assay (BTH and BiFC) to test the interaction further. Only proteins that showed positive results in all three assays were considered trustworthy CheA-interacting proteins and kept for further study.

      (4) Line 147-149, "Fig. 2a, five strains (WT+pcsoR, WT+pispG, WT+pnfuA, WT+pphaD, and WT+pPP_1644) displayed smaller colony than the control strain (WT+pVec), indicating a weaker chemotaxis ability in these five strains." If copper is a chemorepellent, these strains should swim away from high concentrations of copper; thus, the sizes of colonies couldn't be used to measure this response. In the cited reference (reference 29), bacterial response to phenol was measured using a response index (RI).

      Except for CsoR, the rest of the CheA-interacting proteins had no direct connection with copper and were involved in different processes (Table S1). A reasonable speculation is that these proteins involved in different processes can integrate signals from specific processes into chemotaxis by regulating CheA autophosphorylation, leading to better regulation of chemotaxis according to intracellular physiological state. We used semisolid nutrient agar plates to test and compare bacterial chemotaxis ability. In a fixed attractant/repellent gradient, chemokine, such as copper, can lead to two subpopulations traveling at different speeds, with the slower one being held back by the chemokinetic drift. In the case of semisolid plate migration, bacteria with chemotaxis ability formed large colonies by generating their gradient by consuming nutrients/producing toxic metabolic waste and following attractant/repellent gradients leading outward from the colony origin (Cremer et al., 2019. Nature 575:658–663). The observation of successive sharp circular bands (rings) progressing outward from the inoculation point was taken to confirm the chemotaxis genotype, and mutants without chemotaxis spread out uniformly and formed a small colony (Wolfe and Berg, PNAS. 1989, 86:6973-6977). In our experiment, we were unsure about the signals/chemokines of each target protein, so we could not design a fixed attractant/repellent gradient. Besides, all target proteins interacted with CheA, which is a crucial factor in chemotaxis, and we assume that these proteins would affect chemotaxis under overexpression conditions. Thus, we used semisolid nutrient plates to test and compare bacterial chemotaxis ability.

      (5) Figures 2 and 3 show both CsoR and PhaD bind to CheA and inhibit CheA autophosphorylation. Do these two proteins share any sequence or structural similarity? Does PhaD also bind to copper? Otherwise, it is difficult to understand these results.

      Thanks a lot. This is an enlightening comment. CsoR is a protein with a size of 10.8 kDa, and PhaD is 23.1 kDa. Because of the difference in size, we took it for granted that the two proteins were not similar. We recently compared their sequence on NCBI BLAST. Although both CsoR and PhaD are transcriptional regulators and interact with CheA, they have no significant sequence similarity. In terms of protein structure, we predicted their structures using AlphaFold. The results showed that CsoR consisted of three α-helixes and PhaD consisted of nine α-helixes (new Fig. S5a and S5b in the manuscript). We further compared their structure using Pymol but found no significant similarity between the two proteins (new Fig. S5c in the manuscript).

      PhaD is a TetR family transcriptional regulator located adjacent to the genes involved in PHA biosynthesis, and it behaves as a carbon source-dependent activator of the pha cluster related to polyhydroxyalkanoates (PHAs) biosynthesis (de Eugenio et al., Environ Microbiol. 2010, 12:1591-1603; Tarazona et al., Environ Microbiol. 2020, 22:3922-3936). Bacterial PHAs are isotactic polymers synthesized under unfavorable growth conditions in the presence of excess carbon sources. PHAs are critical in central metabolism, acting as dynamic carbon reservoirs and reducing equivalents (Gregory et al., Trends Mol Med. 2022, 28:331-342). The interaction between PhaD and CheA leads us to speculate that there might be some connection between PHA synthesis and bacterial chemotaxis. For example, chemotaxis helps bacteria move towards specific carbon sources that favor PHA synthesis, and the interaction between PhaD and CheA weakens chemotaxis, causing bacteria to linger in areas rich in these carbon sources. This is an interesting hypothesis worth testing in the future.

      (6) Line 195-196, "CsoR/PhaD had no apparent influence on the phosphate transfer between CheA and CheY". CheA controls bacterial chemotaxis through CheY phosphorylation. If this is true, how do CsoR and PhaD affect chemotaxis?

      During the autophosphorylation assay, CheA was mixed with CsoR/PhaD and incubated for about 10 min before adding [<sup>32</sup>P]ATP[γP]. Thus, the effect of CsoR/PhaD on CheA autophosphorylation happened through the assay, and a significant inhibition effect was observed in the final result. Regarding transphosphorylation, CheA was mixed with ATP and incubated for about 30 min, at which time the autophosphorylation of CheA happened. Then, CsoR/PhaD and CheY were added to the phosphorylated CheA to investigate transphosphorylation. CsoR and PhaD affected chemotaxis via inhibiting CheA autophosphorylation, which was a crucial step in chemotaxis signaling, and the decrease in CheA autophosphorylation caused decreased chemotaxis.

      (7) Figure 3 shows that CsoR/PhaD bind to CheA through P1, P3, and P4. This result is intriguing. All CheA proteins contain these three domains. If this is true, CsoR/PhaD should bind to other bacterial CheAs too. That said, this experiment is premature and needs to be confirmed by other approaches.

      As replied to comment (2) above, we performed a BTH assay to investigate whether  CsoR<sub>P. putida</sub> interacts with CheA from other bacterial species. The results revealed that  CsoR<sub>P. putida</sub> interacted with CheA from A. caldus, B. subtilis, L. monocytogenes, P. fluorescens, P. syringae, and P. stutzeri, but not with CheA from E. coli and B. diazoefficiens. This result suggested that CheA-CsoR interaction required specific/unique amino acid sequence patterns in the two proteins, and similar domain composition alone was insufficient.

      (8) Figure 5, does PhaD contain these three residues (C40, H65, and C69)? If not, how does PhaD inhibit CheA autophosphorylation and chemotactic response to copper?

      No, there is no significant sequence similarity between PhaD and CsoR, and PhaD contains none of the three residues of CsoR (C40, H65, and C69). The size of the two proteins is also quite different (CsoR 10.8 kDa, PhaD 23.1 kDa). The structure alignment also revealed no apparent similarity between the predicted structures of PhaD and CsoR (new Fig. S5c in the manuscript). Nevertheless, CsoR and PhaD interacted with CheA through its P1, P3, and P4 domains. It is interesting how the two proteins interacted with CheA, but we currently have no answer.

      (9) Does deletion of cosR or cheA have any impact on P. putida resistance to high concentrations of copper?

      No, deletion of cosR/cheA had no noticeable impact on P. putida's resistance to high concentrations of copper. We performed a growth assay to test the effect of CsoR and CheA on copper resistance under both liquid and solid medium conditions. The copper concentration was set at 0, 200, 500, 1000 μM. With the increase of copper concentration, the growth of bacteria was gradually inhibited, but the growth trends of csoR mutant, cheA mutant, and complementary strains were similar to that of the wild-type strain (new Fig. S6b and S6c in the manuscript). We speculated that this might be attributed to CsoR being a repressor and inhibiting gene expression in the absence of copper. When copper existed, the inhibitory effect of CsoR was relieved, which is the same as that in the csoR mutant. Besides, although deletion of cosR led to a slight increase (about 1.3-fold) in the expression of copper resistance genes (Fig. 4b in the manuscript), its effect on gene expression was much weaker than its homologous protein in other bacterial species. In M. tuberculosis, B. subtilis, C. glutamicum, L. monocytogenes, and S. aureus, deletion of csoR resulted in an about 10-fold increase in the expression of target genes in the absence of copper. This difference might be attributed to several vital regulators that activated the expression of copper-resistance genes in response to copper in P. putida, such as CueR and CopR (Adaikkalam and Swarup, Microbiology. 2002, 148:2857-2867; Hofmann et al., Int J Mol Sci, 2021, 22:2050; Quintana et al., J Biol Chem, 2017, 292:15691-15704). CueR positively regulated the expression of cueA, encoding a copper-transporting P1-type ATPase that played a crucial role in copper resistance. CopR was essential for expressing several genes implicated in cytoplasmic copper homeostasis, such as copA-II, copB-II, and cusA. The existence of these positive regulators makes the function of CosR a secondary or even dispensable insurance in the expression of copper-resistance genes. Consistent with this, there is no CosR homolog in P. aeruginosa, and copper homeostasis is mainly controlled by CueR and CopR.

      Reviewer #2 (Public Review):

      This manuscript focuses on the apparent involvement of a proposed copper-responsive regulator in the chemotactic response of Pseudomonas putida to Cu(II), a chemorepellent. Broadly, this area is of interest because it could provide insight into how soil microbes mitigate metal stress. Additionally, copper has some historical agricultural use as an antimicrobial, thus can accumulate in soil. The manuscript bases its conclusions on an in vitro screen to identify interacting partners of CheA, an essential kinase in the P. putida chemotaxis-signaling pathway. Much of the subsequent analysis focuses on a regulator of the CsoR/RcnR family (PP_2969).

      Weaknesses:

      The data presented in this work does not support the model (Figure 8). In particular, PP_2969 is linked to Ni/Co resistance, not Cu resistance. Further, it is not clear how the putative new interactions with CheA would be integrated into diverse responses to various chemoattract/repellents. These two comments are justified below.

      Thanks a lot for all these comments. Before designing experiments to explore the function of PP_2969, we found three clues: (i) its sequence showed 38% similarity to the copper-responsive regulator CsoR of M. tuberculosis, and the three conserved amino acids essential for copper-binding were conserved in PP_2969; (ii) it located next to a Ni<sup>2+</sup>/Co<sup>2+</sup> transporter (PP_2968) on the genome; (iii) a previous report revealed that PP_2969 (also named MreA) expression increased during metal stress, and overexpression of PP_2969 in P. putida and E. coli led to metal accumulation (Zn, Cd, and Cr) (Lunavat et al., Curr Microbiol. 2022, 79:142). These clues indicate that the function of PP_2969 is related to metal-binding, but it remains to be explored which metal(s) PP_2969 binds to. Thus, we played MST assay to test the interaction between PP_2969 and metals, including copper (Cu<sup>2+</sup>), zinc (Zn<sup>2+</sup>), nickel (Ni<sup>2+</sup>), cobalt (Co<sup>2+</sup>), cadmium (Cd<sup>2+</sup>), and magnesium (Mg<sup>2+</sup>). The result showed that PP_2969 was bound to three metal ions (Cu<sup>2+</sup>, Zn<sup>2+</sup>, Ni<sup>2+</sup>), and the binding to Cu<sup>2+</sup> was the strongest. Besides, the EMSA assay revealed that Cu<sup>2+</sup>/Ni<sup>2+</sup>/Zn<sup>2+</sup> inhibited the interaction between PP_2969 and promoter DNA, and Cu<sup>2+</sup> showed the most substantial inhibitory effect at the same concentration. These results suggested that PP_2969 was mainly bound to Cu<sup>2+</sup>, followed by Zn<sup>2+</sup> and Ni<sup>2+</sup>. To further test whether PP_2969 functioned as a metal-responsive repressor and which metal resistance was related to its target gene, we constructed a PP_2969 deletion mutant and complementary strain and performed a qPCR assay to compare the expression of metal resistance-related genes. 14 metal-resistant-related genes were chosen as targets. The results showed that PP_2969 deletion led to a weak but significant increase (about 1.3-fold) in expression of 10 genes, including three copper-resistance genes (copA-I, copA-II, and copB-II), one nickel-resistance gene (nikB), two cadmium-resistance genes (cadA-I and cadA-III), one cobalt-resistance gene (cbtA), and three multiple metal-resistance genes (czcC-I, czcB-II, and PP_0026) (Fig. 4b, Fig. S5a in the manuscript). Meanwhile, complementation with a multicopy plasmid containing the PP_2969 gene decreased the gene expression in Δ_PP_2969_. Although PP_2969 regulated the expression of multiple metal resistance genes, it showed the most robust binding to Cu<sup>2+</sup>. Thus, we considered its primary function as a Cu<sup>2+</sup>-responsive regulator.

      As for the second comment, “How would the putative new interactions with CheA be integrated into diverse responses to various chemoattract/repellents?”, We have some speculations based on our results and previous reports. For example, PP_2969 interacted with CheA and decreased its autophosphorylation activity, and copper inhibited the interaction between CheA and PP_2969. In the absence of copper, PP_2969 binds to promoters to inhibit the expression of copper resistance genes, and it also binds to CheA to inhibit its autophosphorylation, resulting in lower chemotaxis. When the bacteria move to an area of high copper concentration, PP_2969 binds to copper and falls off the DNA promoter, leading to higher expression of copper resistance genes. Meanwhile, copper-binding of PP_2969 decreases its interaction with CheA, increasing CheA autophosphorylation promoting chemotaxis, and bacteria swim away from the high copper concentration. Another attractive target protein is PhaD, a TetR family transcriptional regulator located adjacent to the genes involved in PHA biosynthesis, and it behaves as a carbon source-dependent activator of the pha cluster related to polyhydroxyalkanoates (PHAs) biosynthesis (de Eugenio et al., Environ Microbiol. 2010, 12:1591-1603; Tarazona et al., Environ Microbiol. 2020, 22:3922-3936). Bacterial PHAs are isotactic polymers synthesized under unfavorable growth conditions in the presence of excess carbon sources. PHAs are critical in central metabolism, acting as dynamic carbon reservoirs and reducing equivalents (Gregory et al., Trends Mol Med. 2022, 28:331-342). The interaction between PhaD and CheA leads us to speculate that there might be some connection between PHA synthesis and bacterial chemotaxis. For example, chemotaxis helps bacteria move towards particular carbon sources that favor PHA synthesis; the regulator PhaD activates the genes related to PHA synthesis. Meanwhile, the interaction between PhaD and CheA weakens chemotaxis, causing bacteria to linger in areas rich in these carbon sources. Collectively, we speculate that by interacting with CheA and modulating its autophosphorylation, target proteins such as CsoR/PhaD integrate signals from their original process pathway into chemotaxis signaling.

      PP_2969

      (1) The authors present a sequence alignment (Figure S5) that is the sole basis for their initial assignment of this ORF as a CsoR protein. There is a conservation of the primary coordinating ligands (highlighted with asterisks) known to be involved in Cu(I) binding to CsoR (ref 31). There are some key differences, though, in residues immediately adjacent to the conserved Cys (the preceding Ala, which is Tyr in the other sequences). The effect of these changes may be significant in a physiological context.

      We constructed a point mutation in PP_2969 by replacing the Ala residue before the conserved Cys with a Tyr (CsoR<sub>A39Y</sub>) and then analyzed the effect of this mutation on CsoR. As shown in Author response image 1a, CsoR<sub>A39Y</sub> showed similar promoter-binding ability as the wild-type CsoR and the presence of Cu<sup>2+</sup> abolished the interaction between CsoR<sub>A39Y</sub> and DNA, suggesting that the A39 residue in PP_2969 was not essential for the DNA-binding and Cu<sup>2+</sup>-binding abilities. Besides, CsoR<sub>A39Y</sub> interacted with CheA as the wild-type CsoR did (Author response image 1b), indicating that the Ala39 residue was not required to interact with CheA.

      The CsoR from B. subtilis has a Tyr before the conserved Cys, which is the same as other sequences, and the BTH result showed that interaction existed between CsoR and CheA from B. subtilis (Fig. 7 in the manuscript).

      Author response image 1.

      The effect of CsoR point mutation (CsoR<sub>A39Y</sub>) on the DNA-binding and Cu<sup>2+</sup>-binding abilities of CsoR. (a) Analysis for interactions between CsoR/CsoR<sub>A39Y</sub> and copA-I promoter DNA using EMSA. The concentrations of CsoR/CsoR<sub>A39Y</sub> and Cu<sup>2+</sup> added in each lane are shown above the gel. Free DNA and protein-DNA complexes are indicated. (b) The interaction between CsoR/CsoR<sub>A39Y</sub> and CheA was tested by BTH. Blue indicates protein-protein interaction in the colony after 60 h of incubation, while white indicates no protein-protein interaction. CK+ represents positive control, and CK- represents negative control.

      (2) The gene immediately downstream of PP_2969 is homologous to E. coli RcnA, a demonstrated Ni/Co efflux protein, suggesting that P2969 may be Ni or Co responsive. Indeed PP_2970 has previously been reported as Ni/Co responsive (J. Bact 2009 doi:10.1128/JB.00465-09). The host cytosol plays a critical role in determining metal response, in addition to the protein, which can explain the divergence from the metal response expected from the alignment.

      Correction: The gene immediately upstream (not downstream) of PP_2969 (the ID is PP_2968, not PP_2970) is homologous to E. coli RcnA, a demonstrated Ni/Co efflux protein. The previous JBact study (J. Bact 2009 doi:10.1128/JB.00465-09) named PP_2968 as MrdH, and mrdH disruption led to sensitivity to cadmium, zinc, nickel, and cobalt, but not copper. Their results also revealed that MrdH was a broad-spectrum metal efflux transporter with a substrate range including Cd<sup>2+</sup>, Zn<sup>2+</sup>, and Ni<sup>2+</sup>. However, the role of MrdH in Cu<sup>2+</sup> efflux was not tested. Commonly, metal efflux transporter has a broad substrate spectrum, allowing transporters to influence bacterial resistance to a variety of metals (Munkelt et al., J Bacteriol. 2004, 186:8036-8043; Grass et al., J Bacteriol. 2005, 187:1604-1611; Nies et al., J Ind Microbiol. 1995, 14:186-199; Kelley et al., Metallomics. 2021, 13:mfaa002). Our results showed that PP_2969 bound to Cu<sup>2+</sup>, Zn<sup>2+</sup>, and Ni<sup>2+</sup> under our experimental conditions, and CsoR regulated the expression of genes related to Cu<sup>2+</sup>, Zn<sup>2+</sup>, and Ni<sup>2+</sup> resistance, indicating that CsoR was involved in resistance to these metals. But the binding of CsoR to Cu<sup>2+</sup> was the strongest, and Cu<sup>2+</sup> showed the most substantial inhibitory effect on CsoR-DNA interaction. Thus, we considered its primary function as a Cu<sup>2+</sup>-responsive regulator.

      (3) The previous JBact study also explains the lack of an effect (Figure 5b) of deleting PP_2969 on copper-efflux gene expression (copA-I, copA-II, and copB-II) as these are regulated by CueR not PP_2969 consistent with the previous report. Deletion of CsoR/RcnR family regulator will result in constitutive expression of the relevant efflux/detoxification gene, at a level generally equivalent to the de-repression observed in the presence of the signal.

      We performed qPCR to test the effect of PP_2969 on gene expression, and we chose 14 target genes, including copper-resistance genes, nickel-resistance genes, zinc-resistance genes, cadmium-resistance genes, and cobalt-resistance genes. The results showed that PP_2969 deletion led to a weak but significant increase (about 1.3-fold) in the expression of 10 genes (Fig. 4b, new Fig. S5a in the manuscript), and complementation with a multicopy plasmid containing PP_2969 gene decreased the gene expression in Δ_PP_2969_. We were confused about these results. Why was the effect of PP_2969 on gene expression so weak? Did we pick the wrong target genes? In other bacteria, deletion of csoR led to an about ten-fold increase in gene expression, generally equivalent to the de-repression observed in the presence of metal. Thus, to further identify target genes, we performed RNA-seq to compare the gene expression in WT and Δ_PP_2969_ without copper. The result surprised us because no gene expression levels changed more than two-fold (data not shown). This result might be attributed to several vital regulators that activated the expression of metal-resistance genes in response to metal in P. putida, such as CueR and CopR (Adaikkalam and Swarup, Microbiology. 2002, 148:2857-2867; Hofmann et al., Int J Mol Sci, 2021, 22:2050; Quintana et al., J Biol Chem, 2017, 292:15691-15704). CueR positively regulated the expression of cueA, encoding a copper-transporting P1-type ATPase that played a crucial role in copper resistance. CopR was essential for expressing several genes implicated in cytoplasmic copper homeostasis, such as copA-II, copB-II, and cusA. The existence of these positive regulators might make the function of CosR a secondary or even dispensable insurance in the expression of copper-resistance genes. Consistent with this, there is no CosR homolog in P. aeruginosa, and copper homeostasis is mainly controlled by CueR and CopR.

      (4) Further, CsoR proteins are Cu(I) responsive so measuring Cu(II) binding affinity is not physiologically relevant (Figures 5a and S5b). The affinities of demonstrated CsoR proteins are 10-18 M and these values are determined by competition assay. The MTS assay and resulting affinities are not physiologically relevant.

      Thank you for this enlightening comment. This question also confused us during our experiment. The first study on CsoR from Mycobacterium tuberculosis showed that CsoR bound a single-monomer mole equivalent of Cu(I) to form a trigonally coordinated complex, and that was a convincing result from protein structure analysis (Liu et al., Nat Chem Biol. 2007, 3:60-68). They further revealed that the presence of Cu(I) in the EMSA assay abolished the DNA-binding ability of CsoR, but the impact of Cu(II) was not tested. Besides, their results also showed that adding CuCl<sub>2</sub> in the medium induced the expression of the cso operon involved in copper resistance. Perhaps Cu(II) converted to Cu(I) and then bound to CsoR in bacterial cells. Later studies in diverse bacterial species (including Listeria monocytogenes, Corynebacterium glutamicum, Deinococcus radiodurans, and Thermus thermophilus) showed that in vitro assays with Cu(II) abolished the DNA-binding ability of CsoR, indicating that CsoR bound to both Cu (I) and Cu(II) (Corbett et al., Mol Microbiol. 2011, 81:457-472; Teramoto et al., Biosci Biotechnol Biochem. 2012, 76:1952-1958; Zhao et al., Mol Biosyst. 2014, 10:2607-2616; Sakamoto et al., Microbiology. 2010, 156:1993-2005). Here, our results from in vitro assays (MST and EMSA) showed that CsoR bound to Cu(II) and Cu(II) affected the interaction between CsoR and promoter DNA. Compounds containing Cu(I) are poorly soluble in water and easily oxidized by Cu(II). DTT can reduce Cu(II) to Cu(I) (Krzel et al., J Inorg Biochem. 2001, 84:77-88). To test whether Cu(I) bound to CsoR and affected its DNA-binding ability, we recently performed an EMSA assay with the addition of CuCl<sub>2</sub>/DTT/CuCl<sub>2</sub>+DTT. As shown in Fig. 4d, the addition of DTT (0.1 and 1 mM) decreased CsoR-DNA interaction in the presence of 0.2 mM CuCl<sub>2</sub>, while the addition of DTT alone had no apparent influence on CsoR-DNA interaction, indicating that DTT enhanced the inhibition of CuCl<sub>2</sub> on CsoR-DNA interaction, and the Cu(I) converted from Cu(II) by DTT had stronger inhibitory effect than Cu(II) on CsoR-DNA interaction. Together, these results suggested that CsoR bound to Cu(I) more strongly than it bound to Cu(II). We have added these results to the new version of manuscript.

      (5) The DNA-binding assays are carried out at protein concentrations well above physiological ranges (Figures 5c and d, and S5c, d). The weak binding will in part result from using DNA sequences upstream of the copA genes and not from PP_2970.

      We performed the vitro DNA-binding assay several times, and the lowest CsoR concentration used to obtain a shifted band was about 3 μM, and a higher concentration (15 μM) caused total DNA binding. Thus, we used the concentration of 15 and 20 μM to test the effect of metal on protein-DNA interaction in the assay. We also realized that these concentrations were above physiological ranges. We considered that the in vitro DNA-binding assay was only a mimic of the in vivo process, and the extracellular physiological conditions in EMSA might restrict the activity of CsoR. Besides, we recently performed EMSA to investigate the interaction between CsoR and its own promoter (csoRpro). As shown in Author response image 2, CsoR bound to csoRpro with a similar intensity to that it bound to copA-Ipro. Thus, the weak binding was not caused by the promoter used in the assay. 

      Author response image 2.

      The binding of CsoR to its own promoter (csoRpro) and copA-I promoter (copA-1pro) in EMSA. The concentrations of CsoR added in each lane are shown above the gel. Free DNA and CsoR-DNA complex are indicated.

      CheA interactions

      (1) There is no consideration given to the likely physiological relevance of the new interacting partners for CheA.

      Thank you for this comment. The initial purpose of this research was to identify new CheA-interacting proteins to broaden our knowledge of CheA and bacterial chemotaxis. Thus, we are currently focusing on the effect of the interaction on CheA and chemotaxis and trying to find the link between different processes and bacterial chemotaxis. We infer that the interaction between these new interacting partners and CheA can integrate signals from different pathways into the chemotaxis signaling pathway so that bacteria can better sense and adapt to different environments. Besides, the other role of the interaction, which is the influence of CheA on these new interacting partners, is also an exciting question that remains to be answered. Among the 16 new CheA-interacting proteins, five showed significant influence on chemotaxis, and the remaining 11 proteins had no obvious impact on chemotaxis (Fig. 2a in the manuscript). CsoR and PhaD inhibited CheA autophosphorylation, and here we focused on the effect of CsoR on chemotaxis. We also investigated the impact of CheA on CsoR, such as gene regulation and copper resistance. However, the results showed that CheA had no obvious influence on these functions of CsoR. The interactions between CheA and these proteins may be physiologically biased, with some interactions affecting the function of CheA and others mainly affecting the function of partners. Future studies on the function of these new CheA-interacting proteins and the role of CheA in regulating their functions would further expand our knowledge of CheA.

      (2) How much CheA is present in the cell (copies) and how many copies of other proteins are present? How would specific responses involving individual interacting partners be possible with such a heterogenous pool of putative CheA-complexes in a cell? For PP_2969, the affinity reported (Figure 5A) may lay at the upper end of the CsoR concentration range (for example, CueR in Salmonella is present at ~40 nM).

      Thank you for this insightful comment. We don’t know the copy number of CheA and other proteins in the cell. We were also initially surprised and felt skeptical about the reliability of CheA interaction with so many proteins. CheA interacts with CheY, CheW, and CheB in the classical chemotaxis pathway. This study found 16 new CheA-interacting proteins using pull-down assay and subsequent analysis. Moreover, in another unpublished result, we found that CheA interacted with eight c-di-GMP-metabolizing proteins, and CheA transferred the phosphate group to one of them. Together, it seemed that CheA could interact with at least 27 proteins. With such a heterogeneous pool of CheA-complexes, performing a specific response seemed difficult. However, several previous studies have reported the example of one protein interacting with dozens of proteins. For example, the c-di-GMP effector LapD in Pseudomonas fluorescens and Pseudomonas putida can interact with a dozen different c-di-GMP-metabolizing proteins (Giacalone et al., mBio. 2018, 9:e01254-18; Nie et al., Mol Microbiol. 2024, 121:1-17.) In Escherichia coli, a subset of DGCs and PDEs operated as central interaction hubs in a larger “supermodule” by interacting with dozens of proteins (Sarenko et al., mBio. 2017, 8:e01639-17). We infer that the expression of different CheA-interacting proteins might happen at different growth stages or under different conditions, and their interaction with CheA under that stage/condition changed bacterial chemotaxis or the process in which the target protein was involved.

      (3) The two-hybrid system experiment uses a long growth time (60 h) before analysis. Even low LacZ activity levels will generate a blue color, depending upon growth medium (see doi: 10.1016/0076-6879(91)04011-c). It is also not clear how Miller units can be accurately or precisely determined from a solid plate assay (the reference cited describes a protocol for liquid culture).

      We didn’t observe a blue color on the colony after 60 h growth on a plate under our experimental conditions. The BTH experiment was described as follows: After transforming the two plasmids into E. coli BTH101 cells, the plates containing transformants were placed at 28° for 48 h, at which time the colonies of the transformants were big enough to be picked up and incubated in a liquid medium for 24 h at 28°. Then, 5 μL of the culture was spotted onto an LB agar plate supplemented with antibiotics, X-gal, and IPTG and incubated for 60 h at 28° before taking the photos. After the photos were taken, the bacteria on the plate were scraped off and resuspended with buffer, and then the LacZ activity of the bacteria was tested. According to our experience, culture at 28°(lower than 30°) is a critical condition, and we have not observed false positives in BTH assays under this condition.

      Reviewer #1 (Recommendations For The Authors):

      In addition to genetic and biochemical approaches, structural studies should be conducted to elucidate the molecular interaction between CheA and CsoR with/without copper.

      It would be more logical to first establish the role of CsoR in copper regulation and chemotaxis (the second part of this report) and then investigate its underpinning mechanism (the first part).

      Thank you for these recommendations. Structural analysis can reveal more details about the molecular mechanism of CheA-CsoR interaction, but we currently don’t have sufficient experimental conditions for such structural analysis.

      As for the presentation logic of the results, we wrote the manuscript following the sequence of experiments. Firstly, screening of CheA interacting proteins (pull-down assay) was conducted, and then the influence of interacting proteins on the chemotaxis of strains and CheA autophosphorylation activity was detected. Based on these results, we obtained two proteins, CsoR and PhaD, and decided to go deeper into the function of CsoR and its effect on chemotaxis. We considered that this writing logic reflected our research design better and could also lay a foundation for future exploration of the functions of other interacting proteins and the physiological significance of interactions.

      Reviewer #2 (Recommendations For The Authors):

      A huge amount of effort has gone into this work.

      It would be good to see at least one of the newly identified interactions turn out to be physiologically relevant.

      The experimental tools appear to be available to do this, but it is critical to consider how these tools can lead to attempts to prove rather than test and possibly refute a model or hypothesis. In particular, please consider some of the comments about the physiological relevance of affinities when generating models.

      Thank you for these recommendations. Our study aimed to screen new interacting proteins of CheA and explore how new interacting proteins affect CheA activity and bacterial chemotaxis, thereby broadening our understanding of chemotaxis. However, the impact of each protein-protein interaction has two sides: the influence of A to B and B to A. During experimental design, we focused more on the influence of identified interacting proteins on CheA function and chemotaxis but paid less attention to the function of interacting proteins and the influence of the interaction on their function. Moreover, our study found that the influence of protein-protein interaction was biased. In the interaction between CsoR and CheA, CsoR mainly affected the function of CheA and then affected the chemotaxis, while CheA had no significant effect on the function of CsoR. This might be attributed to the weak effect of CsoR in regulating metal resistance in P. putida, and we speculated that this interaction was more about favoring the sensing and avoiding metal stress. In addition, we planned to explore the interaction between CheA and another interacting protein (PhaD) in the future, reveal the effect of the interaction on PhaD function (regulation of PHAS synthesis in bacteria), and explore the effect of the interaction on CheA function and chemotaxis, to find out whether the association existed between PHAS anabolism and bacterial chemotaxis. Besides, for those proteins that did not have significant effects on CheA autophosphorylation and bacterial chemotaxis, we speculated that CheA might affect their function/activity through interactions, which meant that the physiological effects of the interaction mainly reflected through the interacting protein rather than CheA. These are speculations that need to be tested by experiments.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public review):

      Summary:

      Rossi et al. asked whether gait adaptation is solely a matter of slow perceptual realignment or if it also involves fast/flexible stimulus-response mapping mechanisms. To test this, they conducted a series of split-belt treadmill experiments with ramped perturbations, revealing behavior indicative of a flexible, automatic stimulus-response mapping mechanism.

      Strengths:

      (1) The study includes a perceptual test of leg speed, which correlates with the perceptual realignment component of motor aftereffects. This indicates that there are motor performances that are not accounted for by perceptual re-alignment.

      (2) They study incorporates qualitatively distinct, hypothesis-driven models of adaptation and proposes a new framework that integrates these various mechanisms.

      Weaknesses:

      (1) The study could benefit from considering other alternative models. As the authors noted in their discussion, while the descriptive models explain some patterns of behaviour/aftereffects, they don't currently account for how these mechanisms influence the initial learning process itself.

      (1a) For example, the pattern of gait asymmetric might differ for perceptual realignment (a smooth, gradual process), structural learning (more erratic, involving hypothesis testing/reasoning to understand the perturbation, see (Tsay et al. 2024) for a recent review on Reasoning), and stimulus-response mapping (possibly through a reinforcement based trial-and-error approach). If not formally doing a model comparison, the manuscript might benefit from clearly laying out the behavioural predictions for how these different processes shape initial learning.

      (1b) Related to the above, the authors noted that the absence of difference during initial learning suggests that the differences in Experiment 2 in the ramp-up phase are driven by two distinct processes: structural learning and memory-based processes. If the assumptions about initial learning are not clear, this logic of this conclusion is hard to follow.

      Thank you for this insightful comment. We agree that considering alternative models and clarifying their potential contributions to the initial learning process would enhance the manuscript. We performed additional analyses and revised the text to outline how the mechanisms of adaptation in our study align with the framework described by Tsay et al. (2024) regarding the initial learning process and other features of adaptation.

      First, we referenced the Tsay et al. framework in the Introduction and Discussion to highlight parallels between their description of implicit adaptation and our forward model recalibration mechanism (producing motor changes and perceptual realignment). Specifically, the features defining recalibration in our study – gradual, trial-by-trial adjustments, rigid learning that leads to aftereffects, and limited contribution to generalization – align with those described by Tsay et al.

      Second, we used the description provided by Tsay et al. to test the presence of explicit strategies in our study. We specifically test for the criteria of reportability and intentionality, corroborating the finding that our stimulus response mapping mechanism differs from explicit strategies.

      “A recent framework for motor learning by Tsay et al. defines explicit strategies as motor plans that are both intentional and reportable (Tsay et al., 2024). Within this framework, Tsay et al. clarify that "intentional" means participants deliberately perform the motor plan, while "reportable" means they are able to clearly articulate it.” (Experiment 2 Results, lines 515-518).

      “…the motor adjustments reported by participants consistently fail to meet the criteria for explicit strategies as outlined by Tsay et al.: reportability and intentionality (Tsay et al., 2024).” (Discussion, lines 657-660).

      Third, we interpreted the operation of stimulus-response mapping within the Tsay theoretical framework for the three stages of motor learning: 1) “reasoning” to acquire new action–outcome relationships, 2) “refinement” of the motor action parameters, and 3) “retrieval” of learnt motor actions based on contextual cues. We note that the definition of these stages closely aligns with our definition for stimulus response mapping mechanisms. Moreover, according to Tsay’s definition, both implicit and explicit learning mechanisms can involve similar reasoning and retrieval processes. This shared operational basis may explain why our stimulus-response mapping mechanism exhibits some characteristics associated with explicit strategies, such as flexibility and generalizability.

      We performed a new analysis to evaluate Tsay’s framework predictions that, if walking adaptation includes a stimulus-response mapping mechanism following these three stages of motor learning, the learning process would initially be erratic and would then stabilize as learning progresses. We assessed within-participant residual variance in step length asymmetry around a double exponential model fit during adaptation, testing the prediction that this variability would decrease between the start and end of adaptation. Experiment 1 results confirmed this prediction, showing that a significant reduction in variability as adaptation progressed.

      “We finally tested whether the pattern of motor variability during adaptation aligns with predictions for learning new  stimulus response maps. In contrast to recalibration, mapping mechanisms are predicted to be highly  variable  and  erratic  during  early learning, and stabilize as learning progresses (Tsay et al., 2024). Consistent with these predictions,  the  step  length  asymmetry residual  variance  (around  a  double exponential  fit)  decreased  significantly between the start and end of adaptation (residual variance at start minus end of adaptation = 0.005 [0.004, 0.007], mean [CI]; SI Appendix, Fig. S3). These control analyses corroborate the hypothesis that the “no aftereffects” region of the Ramp Down reflects the operation of a mapping mechanism.”

      (Experiment 1 Results, lines 187-194; Methods, lines 1040-1050).

      Moreover, Experiment 2 results demonstrated that the pattern of variability (its magnitude and decay in adaptation) did not differ between participants using memory-based versus structure-based stimulus-response mapping mechanisms. These findings suggest that both types of mapping operate accordingly to Tsay’s stages of motor learning.

      “Furthermore, the pattern of step length asymmetry variability was similar between the subgroups (structure – memory difference in residual variance relative to double exponential during initial adaptation = -0.0052 [0.0161, 0.0044], adaptation plateau = -0.0007 [-0.0021, 0.0003], difference in variance decay = -0.0045 [-0.0155, 0.0052], mean [CI]; SI Appendix, Fig. S16). This confirms that the distinct performance clusters in the Ramp Up & Down task are not driven by natural variations in learning ability, such as differences in learning speed or variability. Rather, these findings indicate that the subgroups employ different types of mapping mechanisms, which perform similarly during initial learning but differ fundamentally in how they encode, retrieve, and generalize relationships between perturbations and Δ motor outputs.” (Experiment 2 Results, lines 503-511).

      “Both memory- and structure-based operations of mapping align with Tsay et al.’s framework for motor learning: first, action–outcome relationships are learned through exploration; second, motor control policies are refined to optimize rewards or costs, such as reducing error; and finally, learned mappings or policies are retrieved based on contextual cues (Tsay et al., 2024). Consistent with the proposed stages of exploration followed by refinement, we found that motor behavior during adaptation was initially erratic but became less variable at later stages of learning. Similarly, consistent with the retrieval stage, the generalization observed in the ramp tasks indicates that learned motor outputs are flexibly retrieved based on belt speed cues.” (Discussion, lines 701-708).

      Finally, we addressed the prediction outlined by Tsay et al. that repeated exposure to perturbations attenuates the magnitude of forward model recalibration, with savings being driven by stimulus-response mapping mechanisms. While we could not directly test savings for the primary perturbation used during adaptation, we were able to indirectly evaluate savings for a different perturbation through analyses of our control experiments combined with previous results from Leech et al. (Leech et al., 2018). Specifically, we examined how motor aftereffects and perceptual realignment evolved across repeated iterations of the speed-matching task post-adaptation in Ascending groups. Each task began with the right leg stationary and the left leg moving at 0.5 m/s – a configuration corresponding to a perturbation of -0.5 m/s, which is opposite in direction to the adaptation perturbation. By analyzing repeated exposures to this -0.5 m/s perturbation across iterations, we gained insights into the learning dynamics associated with this perturbation and the effect of repeated exposures on motor aftereffects and perceptual realignment. Consistent with predictions from Tsay et al., our results combined with Leech et al. demonstrate that, with repeated exposures to the same perturbation, perceptual realignment decays while the contribution of stimulus-response mapping to aftereffect savings is enhanced. We present this analysis and interpretation in Control Experiments Results, lines 429-442; Figure 8B; Table S7; and Discussion lines 709-753.

      (1c) The authors could also test a variant of the dual-rate state-space model with two perceptual realignment processes where the constraints on retention and learning rate are relaxed. This model would be a stronger test for two perceptual re-alignment processes: one that is flexible and another that is rigid, without mandating that one be fast learning and fast forgetting, and the other be slow learning and slow forgetting.

      We tested multiple variants of the suggested models, and confirmed that they cannot capture the motor behavior observed in our Ramp Down task. We include Author response image 1 with the models fits, Author response table 1 with the BIC statistics, and the models equations below. Only the recalibration + mapping model captures the matching-then-divergent behavior of the Δ motor output, corroborating our interpretation that state-space based models cannot capture the mapping mechanism (see Discussion, “Implications for models of adaptation”). Furthermore, all models fit the data significantly worse than the recalibration+mapping model according to the BIC statistic.

      Model fits:

      Author response image 1.

      Statistical results:

      Author response table 1.

      Model definitions:

      • DualStateRelaxed: same equations as the original Dual State, but no constraints dictating the relative relationship between the parameters

      • DualStateRelaxedV2: same equations as the original Dual State, but no constraints dictating the relative relationship between the parameters, and “loose” parameter bounds (parameters can take values between -10 to 10).

      • PremoOriginalRelaxed: PReMo with two states (see below), no constraints dictating the relative relationship between the parameters

      • PremoOriginalRelaxed: PReMo with two states (see below), no constraints dictating the relative relationship between the parameters, and “loose” parameter bounds (parameters can take values between -10 to 10).

      PReMo with two states – the remaining equations are the same as the original PReMo (see Methods):

      (2) The authors claim that stimulus-response mapping operates outside of explicit/deliberate control. While this could be true, the survey questions may have limitations that could be more clearly acknowledged.

      (2a) Specifically, asking participants at the end of the experiments to recall their strategies may suffer from memory biases (e.g., participants may be biased by recent events, and forget about the explicit strategies early in the experiment), be susceptible to the framing of the questions (e.g., participants not being sure what the experimenter is asking and how to verbalize their own strategy), and moreover, not clear what is the category of explicit strategies one might enact here which dictates what might be considered "relevant" and "accurate".

      (2b) The concept of perceptual realignment also suggests that participants are somewhat aware of the treadmill's changing conditions; therefore, as a thought experiment, if the authors have asked participants throughout/during the experiment whether they are trying different strategies, would they predict that some behaviour is under deliberate control?

      We have expanded the discussion to explicitly acknowledge that our testing methodology for assessing explicit strategies may have limitations, recognizing the factors mentioned by the reviewer. Moreover, as mentioned in response to comment (1), we leveraged the framework from Tsay et al., 2024 and its definition of explicit strategies to ensure a robust and consistent approach in interpreting the survey responses.

      We revised the Experiment 2 Results section, lines 515-518, to specify that we are evaluating the presence of explicit strategies according to the criteria of intentionality and reportability:

      “A recent framework for motor learning by Tsay et al. defines explicit strategies as motor plans that are both intentional and reportable (Tsay et al., 2024). Within this framework, Tsay et al. clarify that "intentional" means participants deliberately perform the motor plan, while "reportable" means they are able to clearly articulate it.”

      We then reorganized the Discussion to include a separate section “Mapping operates independently of explicit control”, lines 646-661, where we discuss limitations of the survey methodology and interpretation of the results according to Tsay et al., 2024:

      “Here, we show that explicit strategies are not systematically used to adapt step length asymmetry and Δ motor output: the participants in our study either did not know what they did, reported changes that did not actually occur or would not lead symmetry. Only one person reported “leaning” on the left (slow) leg for as much time as possible, which is a relevant but incomplete description for how to walk with symmetry. Four reports mentioned pressure or weight, which may indirectly influence symmetry (Hirata et al., 2019; Lauzière et al., 2014), but they were vague and conflicting (e.g., “making heavy steps on the right foot” or “put more weight on my left foot”). All other responses were null, explicitly wrong or irrelevant, or overly generic, like wanting to “stay upright” and “not fall down”. We acknowledge that our testing methodology has limitations. First, it may introduce biases related to memory recall or framing of the questionnaire. Second, while it focuses on participants' intentional use of explicit strategies to control walking, it does not rule out the possibility of passive awareness of motor adjustments or treadmill configurations. Despite these limitations, the motor adjustments reported by participants consistently fail to meet the criteria for explicit strategies as outlined by Tsay et al.: reportability and intentionality (Tsay et al., 2024). Together with existing literature, this supports the interpretation that stimulus response mapping operates automatically.”

      We also made the following addition to the “Limitations” section of the Discussion (lines 917-919):

      “While mapping differs from explicit strategies as they are currently defined, we still lack a comprehensive framework to capture the varying levels and nuanced characteristics of intentionality and awareness of different mechanisms (Tsay et al., 2024).”

      We finally note that “Unlike explicit strategies, which are rapidly acquired and diminish over time, this mapping mechanism exhibits prolonged learning beyond 15 minutes, with a rate comparable to recalibration” (Discussion, lines 632-634).

      (3) The distinction between structural and memory-based differences in the two subgroups was based on the notion that memory-based strategies increase asymmetry. However, an alternative explanation could be that unfamiliar perturbations, due to the ramping up, trigger a surprise signal that leads to greater asymmetry due to reactive corrections to prevent one's fall - not because participants are generalizing from previously learned representations (e.g., (Iturralde & Torres-Oviedo, 2019)).

      We agree that reactive corrections could contribute to the walking pattern in response to split-belt perturbations, as detailed by Iturralde & Torres-Oviedo, 2019. We also acknowledge that reactive corrections are rapid, flexible, feedback-driven, and automatic – characteristics that make them appear similar to stimulus-response mapping. However, a detailed evaluation of our results suggests that the behaviors observed in the ramp tasks cannot be fully explained by reactive corrections. Reactive corrections occur almost immediately, quickly adjusting the walking pattern to reduce error and improve stability. This excludes the possibility that what we identified as stimulusresponse mapping could instead be reactive corrections, because the stimulus-response mapping observed in our study is acquired slowly at a rate comparable to recalibration. It also excludes the possibility that the increased asymmetry in the Ramp Up & Down could be due to reactive corrections, because these would operate alongside mapping to help reduce asymmetry rather than exacerbate it.

      We made substantial revisions to the Discussion and included the section “Stimulus-response mapping is flexible but requires learning” to explain this interpretation (lines 595-622):

      “The mapping mechanism observed in our study aligns with the corrective responses described by Iturralde and Torres-Oviedo, which operate relative to a recalibrated "new normal" rather than relying solely on environmental cues (Iturralde and Torres-Oviedo, 2019). Accordingly, our findings suggest a tandem architecture: forward model recalibration adjusts the nervous system's "normal state," while stimulus-response mapping computes motor adjustments relative to this "new normal." This architecture explains the sharp transition from flexible to rigid motor adjustments observed in our Ramp Down task. The transition occurs at the configuration perceived as "equal speeds" (~0.5 m/s speed difference) because this corresponds to the recalibrated “new normal”.

      In the first half of the Ramp Down, participants adequately modulated their walking pattern to accommodate the gradually diminishing perturbation, achieving symmetric step lengths. Due to the recalibrated “new normal”, perturbations within this range are perceived as congruent with the direction of adaptation but reduced in magnitude. This allows the mapping mechanism to flexibly modulate the walking pattern by using motor adjustments previously learned during adaptation. Importantly, the rapid duration of the Ramp Down task rules out the possibility that the observed modulation may instead reflect washout, as confirmed by the fact the aftereffects measured post-Ramp-Down were comparable to previous work (Kambic et al., 2023; Reisman et al., 2005).

      In the second half of the Ramp Down, aftereffects emerged as participants failed to accommodate perturbations smaller than the recalibrated “new normal”. These perturbations were perceived as opposite to the adaptation perturbation and, therefore, novel. Accordingly, the mapping mechanism responded as it would to a newly introduced perturbation, rather than leveraging previously learned adjustments (Iturralde and Torres-Oviedo, 2019). Due to the rapid nature of the Ramp Down, the mapping mechanism lacked sufficient time to learn the novel motor adjustments required for these perturbations – a process that typically takes several minutes, as shown by our baseline ramp tasks and control experiments. As mapping-related learning was negligible, the rigid recalibration adjustments dominated during this phase. Consequently, the walking pattern did not change to accommodate the gradually diminishing perturbation, leading to the emergence of aftereffects.”

      (4) Further contextualization: Recognizing the differences in dependent variables (reaching position vs. leg speed/symmetry in walking), could the Proprioceptive/Perceptual Re-alignment model also apply to gait adaptation (Tsay et al., 2022; Zhang et al., 2024)? Recent reaching studies show a similar link between perception and action during motor adaptation (Tsay et al., 2021) and have proposed a model aligning with the authors' correlations between perception and action. The core signal driving implicit adaptation is the discrepancy between perceived and desired limb position, integrating forward model predictions with proprioceptive/visual feedback.

      We appreciate the reviewer’s suggestion and agree that the Proprioceptive Re-alignment model (PReMo) and Perceptual Error Adaptation model (PEA), offer valuable insights into the relationship between perception and motor adaptation. To explore whether these frameworks apply to gait adaptation, we conducted an extensive modeling analysis. This is shown in Figure 5 and Supplementary Figures S7-S8, and is detailed in the text of Experiment 1 Results section “Modelling analysis for perceptual realignment” (lines 327–375), Methods section “Proprioceptive re-alignment model (PReMo)” (lines 1181-1221), Methods section “Perceptual Error Adaptation model (PEA)” (lines 1222-1247), Methods section “Perceptuomotor recalibration + mapping (PM-ReMap)” (lines 1248-1286), and SI Appendix section “Evaluation and development of perceptual models.” (lines 99-237).

      First, we evaluated how PReMo and PEA models fitted our Ramp Down data. We translated the original variables to walking adaptation variables using a conceptual equivalence explained by one of the features explored by Tsay et al. (2022). Specifically, the manuscript provides guidance on extending the PReMo model from visuomotor adaptation in response to visual-proprioceptive discrepancies, to force-field adaptation in response to mechanical perturbations – which share conceptual similarities with split-belt treadmill perturbations. The manuscript also discusses that, if vision is removed, the proprioceptive shift decays back to zero according to a decay parameter. This description entails that proprioceptive shift cannot increase or develop in the absence of vision. We applied the models to split-belt adaptation in accordance with this information, as described in the SI Appendix: “PReMo variables equivalents for walking adaptation”. As reported in Experiment 1 Results “Modelling analysis for perceptual realignment” (lines 327–375) and Figure 5, neither PReMo nor PEA adequately captured the key features of our Ramp Down data: “The models could not capture the matching-then-divergent behavior of Δ motor output, performing significantly worse than the recalibration + mapping model (PReMo minus recalibration+mapping BIC difference = 24.591 [16.483, 32.037], PEA minus recalibration+mapping BIC difference = 6.834 [1.779, 12.130], mean [CI]). Furthermore, they could not capture the perceptual realignment and instead predicted that the right leg would feel faster than the left throughout the entire Ramp Down”.

      Second, we used simulations to confirm that PReMo and PEA cannot account for the perceptual realignment observed in our study, and to understand why. At adaptation plateau, PReMo predicts that perceived and actual step length asymmetry converge, as shown in Fig. S7A, top, and as detailed in the SI Appendix “Original PReMo simulations”. We found that this is because PReMo assumes that perceptual realignment arises specifically from mismatches between different sensory modalities. This assumption works for paradigms that introduce an actual mismatch between sensory modalities, such as visuomotor adaptation paradigms with a mismatch between vision and proprioception. This assumption also works for paradigms that indirectly introduce a mismatch between integrated sensory information from different sensory modalities. In force-field adaptation, both proprioceptive and visual inputs are present and realistic, but when these inputs are integrated with sensory predictions, the resulting integrated visual estimate is mismatched compared to the integrated proprioceptive estimate. In contrast, the assumption that perceptual realignment arises from sensory modalities mismatches does not work for paradigms that involve a single sensory modality. Split-belt adaptation only involves proprioception as no visual feedback is given, and perceptual realignment arises from discrepancies between predicted and actual motor outcomes, rather than between integrated sensory modalities.

      To overcome this limitation, we reinterpreted the variables of the PReMo model, while keeping the original equations, to account for realignment driven by mismatches of the same nature as the perturbation driving adaptation. As reported in the SI Appendix “Iterative simulations for the development of PM-ReMap”, the simulation (Fig. S7A, middle row) “showed perceptual realignment at adaptation plateau, addressing a limitation of the original model. However, it failed to account for the Ramp Down perceptual results, inaccurately predicting that belt speeds feel equal when they are actually equal (Fig. S7A, middle row, perceived perturbation decays alongside actual perturbation and converge to zero at the end of the Ramp Down). […] This occurs because, under the retained PReMo equations, β<sub>p</sub> and β<sub>v</sub> change immediately and are proportional to the difference between and on each trial, so that they ramp down to zero in parallel with the perturbation”.

      We also noted that the simulations of the original and reinterpreted PReMo models could also not support the operation of the mapping mechanism observed in the Ramp Down (Fig. S7B). We describe that “This occurs because the overall motor output x<sub>p</sub>, which includes both recalibration and mapping mechanisms, changes gradually according to the learning rate 𝐾. Consequently, changes in 𝐺 take many trials to be fully reflected in x<sub>p</sub>. Hence, we found complementary limitations where PReMo assumes perceptual realignment changes immediately while mapping adjustments develop gradually – but the opposite is true in our data”.

      We therefore modified the PReMo equations and developed a new model, called perceptuomotor recalibration + mapping (PM-ReMap) that addresses these limitations and is able to capture our Ramp Down motor and perceptual results. As described in the SI Appendix “Iterative simulations for the development of PM-ReMap”, “we introduced an update equation for β<sub>p</sub> so that it changes gradually trial-by-trial according to the learning rate 𝐾. We then removed the learning rate from the update equation for x<sub>p</sub> so that it integrates two distinct types of changes: 1) the gradual changes in driven by β<sub>p</sub> and representing the recalibration mechanism, and 2) the immediate changes in 𝐺 – representing the mapping mechanism”. The final equations of the PM-ReMap model are as follows:

      As reported in Experiment 1 Results, “Modelling analysis for perceptual realignment”, and as shown in Fig. 5C, “the PM-ReMap model captured the Δ motor output in the Ramp Down with performance comparable to that of the recalibration + mapping model (BIC difference = 2.381 [-0.739, 5.147], mean [CI]). It also captured perceptual realignment, predicting that some intermediate belt speed difference in the Ramp Down is perceived as “equal speeds” (, Fig. 5C)”. We also found that the estimated aligned with the empirical measurement of the PSE in the Ramp Down both at group and individual level: “At group level, was comparable to the upper bound of compensation<sub>perceptual</sub> (difference = -7 [-15, 1]%, mean [CI]), but significantly larger than the lower bound (difference = 19 [8, 31]%, mean [CI]). Furthermore, we found a significant correlation between individual participants’ and their upper bound of compensation<sub>perceptual</sub> (r=0.63, p=0.003), but not their lower bound (r=0.30, p=0.203). Both sets of results are consistent with those observed for the recalibration + mapping model”.

      Based on these findings, we summarize that PM-ReMap “extends the recalibration + mapping model by incorporating the ability to account for forgetting – typical of state space models – while still effectively capturing both recalibration and mapping mechanisms. However, performance of the PM-ReMap model does not exceed that of the simpler recalibration + mapping model, suggesting that forgetting and unlearning do not have a substantial impact on the Ramp Down”.

      Reviewer #2 (Public review):

      Recent findings in the field of motor learning have pointed to the combined action of multiple mechanisms that potentially contribute to changes in motor output during adaptation. A nearly ubiquitous motor learning process occurs via the trial-by-trial compensation of motor errors, often attributed to cerebellar-dependent updating. This error-based learning process is slow and largely unconscious. Additional learning processes that are rapid (e.g., explicit strategy-based compensation) have been described in discrete movements like goal-directed reaching adaptation. However, the role of rapid motor updating during continuous movements such as walking has been either under-explored or inconsistent with those found during the adaptation of discrete movements. Indeed, previous results have largely discounted the role of explicit strategy-based mechanisms for locomotor learning. In the current manuscript, Rossi et al. provide convincing evidence for a previously unknown rapid updating mechanism for locomotor adaptation. Unlike the now well-studied explicit strategies employed during reaching movements, the authors demonstrate that this stimulus-response mapping process is largely unconscious. The authors show that in approximately half of subjects, the mapping process appears to be memory-based while the remainder of subjects appear to perform structural learning of the task design. The participants that learned using a structural approach had the capability to rapidly generalize to previously unexplored regions of the perturbation space.

      One result that will likely be particularly important to the field of motor learning is the authors' quite convincing correlation between the magnitude of proprioceptive recalibration and the magnitude error-based updating. This result beautifully parallels results in other motor learning tasks and appears to provide a robust marker for the magnitude of the mapping process (by means of subtracting off the contribution of error-based motor learning). This is a fascinating result with implications for the motor learning field well beyond the current study.

      A major strength of this manuscript is the large sample size across experiments and the extent of replication performed by the authors in multiple control experiments.

      Finally, I commend the authors on extending their original observations via Experiment 2. While it seems that participants use a range of mapping mechanisms (or indeed a combination of multiple mapping mechanisms), future experiments may be able to tease apart why some subjects use memory versus structural mapping. A future ability to push subjects to learn structurally-based mapping rules has the potential to inform rehabilitation strategies.

      Overall, the manuscript is well written, the results are clear, and the data and analyses are convincing. The manuscript's weaknesses are minor, mostly related to the presentation of the results and modeling.

      Weaknesses:

      The overall weaknesses in the manuscript are minor and can likely be addressed with textual changes.

      (1) A key aspect of the experimental design is the speed of the "ramp down" following the adaptation period. If the ramp-down is too slow, then no after-effects would be expected even in the alternative recalibration-only/errorbased only hypothesis. How did the authors determine the appropriate rate of ramp-down? Do alternative choices of ramp-down rates result in step length asymmetry measures that are consistent with the mapping hypothesis?

      We thank the reviewer for their insightful comment regarding the rate of the Ramp Down following the adaptation period and its potential impact on aftereffects under different hypotheses. We added a detailed explanation for how we determined the Ramp Down design, including analyses of previous work, to the SI Appendix, “Ramp Down design”, lines 22-98. We also describe the primary points in the main Methods section, “Ramp Tasks”, lines 978-991:

      As described in SI Appendix, “Ramp Down design”, the Ramp Down task was specifically designed to measure the pattern of aftereffects in a way that ensured reliable and robust measurements with sufficient resolution across speeds, and that minimized washout to prevent confounding the results. To balance time constraints with a measurement resolution adequate for capturing perceptual realignment, we used 0.05 m/s speed decrements, matching the perceptual sensitivity estimated from our re-analysis of the baseline data from Leech et al. (Leech et al., 2018a). To obtain robust motor aftereffect measurements, we collected three strides at each speed condition, as averaging over three strides represents the minimum standard for consistent and reliable aftereffect estimates in split-belt adaptation (typically used in catch trials) (Leech et al., 2018a; Rossi et al., 2019; Vazquez et al., 2015). To minimize unwanted washout by forgetting and/or unlearning, we did not pause the treadmill between adaptation and the post-adaptation ramp tasks, and ensured the Ramp Down was relatively quick, lasting approximately 80 seconds on average. Of note, the Ramp Down design ensures that even in cases of partial forgetting, the emergence pattern of aftereffects remains consistent with the underlying hypotheses.

      In the SI Appendix, we explain that, while we did not test longer ramp-down durations directly, previous data suggest that durations of up to at least 4.5 minutes would yield step length asymmetry measures consistent with our results and the mapping hypothesis. Additionally, our control experiments replicated the behavior observed in the Ramp Down using speed match tasks lasting only 30 seconds, further supporting the robustness of our findings across varying durations.

      (2) Overall, the modeling as presented in Figure 3 (Equation 1-3) is a bit convoluted. To my mind, it would be far more useful if the authors reworked Equations 1-3 and Figure 3 (with potential changes to Figure 2) so that the motor output (u) is related to the stride rather than the magnitude of the perturbation. There should be an equation relating the forward model recalibration (i.e., Equation 1) to the fraction of the motor error on a given stride, something akin to u(k+1) = r * (u(k) - p(k)). This formulation is easier to understand and commonplace in other motor learning tasks (and likely what the authors actually fit given the Smith & Shadmehr citation and the derivations in the Supplemental Materials). Such a change would require that Figure 3's independent axes be changed to "stride," but this has the benefit of complementing the presentation that is already in Figure 5.

      We reworked these equations (now numbered 4-6, lines 207-209) so that the motor output u is related to stride k as suggested by the reviewer:

      We changed Figure 2 and Figure 3 accordingly, adding a “stride” x-axis to the Ramp Down data figure.

      Reviewer #2 (Recommendations for the authors):

      I think that some changes to the text/ordering could improve the manuscript's readability. In particular:

      (1) My feeling is that much of the equations presented in the Methods section should be moved to the Results section. Particularly Equations 9-11. The introduction of these motor measures should likely precede Figure 1, as their definitions form the crux of Figure 1 and the subsequent analyses.

      (2) It is unclear to me why many of the analyses and discussion points have been relegated to Supplemental Material. I would significantly revise the manuscript to move much of the content from Supplemental Material to the Methods and Discussion (where appropriate). Even the Todorov and Herzfeld models can likely simply be referenced in the text without a need for their full description in the Supplemental material - as their implementations appear to this reviewer as consistent with those presented in the respective papers. Beyond the Supplementary Tables, my feeling is that nearly all of the content in Supplemental can either be simply cited (e.g. alternative model implementations) or directly incorporated into the main manuscript without compromising the readability of the manuscript.

      We reorganized the manuscript and SI Appendix substantially, moving content to the Results or other main text section. The changes included those recommended by the reviewer:

      • We moved the equations describing step length asymmetry, perturbation, and Δ motor output (originally numbered Eq. 9-11) to the Results section (Experiment 1, “Motor paradigm and hypothesis”, lines 131-133, now numbered Eq. 1-3).

      • We moved Supplementary Methods to the main Methods section

      • We moved the most relevant content of the Supplementary Discussion to the main Discussion, and removed the less relevant content altogether.

      • We moved the methods describing walking-adaptation specific implementation of the Todorov and Herzfeld models to the main Methods section and removed the portions that were identical to the original implementation.

      • We moved the control experiments to the main text (main Results and Methods sections).

      • We removed the SI Appendix section “Experiment 1 mechanisms characteristics”

      Reviewer #3 (Public review):

      Summary:

      In this work, Rossi et al. use a novel split-belt treadmill learning task to reveal distinct sub-components of gait adaptation. The task involved following a standard adaptation phase with a "ramp-down" phase that helped them dissociate implicit recalibration and more deliberate SR map learning. Combined with modeling and re-analysis of previous studies, the authors show multiple lines of evidence that both processes run simultaneously, with implicit learning saturating based on intrinsic learning constraints and SR learning showing sensitivity to a "perceptual" error. These results offer a parallel with work in reaching adaptation showing both explicit and implicit processes contributing to behavior; however, in the case of gait adaptation the deliberate learning component does not appear to be strategic but is instead a more implicit SR learning processes.

      Strengths:

      (1) The task design is very clever and the "ramp down" phase offers a novel way to attempt to dissociate competing models of multiple processes in gait adaptation.

      (2) The analyses are thorough, as is the re-analysis of multiple previous data sets.

      (3) The querying of perception of the different relative belt speeds is a very nice addition, allowing the authors to connect different learning components with error perception.

      (4) The conceptual framework is compelling, highlighting parallels with work in reaching but also emphasizing differences, especially w/r/t SR learning versus strategic behaviors. Thus the discovery of an SR learning process in gait adaptation would be both novel and also help conjoin different siloed subfields of motor learning research.

      Weaknesses:

      (1) The behavior in the ramp-down phase does indeed appear to support multiple learning processes. However, I may have missed something, but I have a fundamental worry about the specific modeling and framing of the "SR" learning process. If I correctly understand, the SR process learns by adjusting to perceived L/R belt speed differences (Figure 7). What is bugging me is why that process would not cause the SR system to still learn something in the later parts of the ramp-down phase when the perceived speed differences flip (Figure 4). I do believe this "blunted learning" is what the SR component is actually modeled with, given this quote in the caption to Figure 7: "When the perturbation is perceived to be opposite than adaptation, even if it is not, mapping is zero and the Δ motor output is constant, reflecting recalibration adjustments only." It seems a priori odd and perhaps a little arbitrary to me that a SR learning system would just stop working (go to zero) just because the perception flipped sign. Or for that matter "generalize" to a ramp-up (i.e., just learn a new SR mapping just like the system did at the beginning of the first perturbation). What am I missing that justifies this key assumption? Or is the model doing something else? (if so that should be more clearly described).

      We concur that this point was confusing, and we performed additional analyses and revised the text to improve clarity. Specifically, we clarify that the stimulus-response mapping does indeed still learn in the second portion of the Ramp Down, when the perceived speed differences flip. However, learning by the mapping mechanism proceeds slowly – at a rate comparable to that of forward model recalibration, taking several minutes. The duration of the task is relatively short, so that learning by the mapping mechanism is limited. We schematize the learning to be zero as an approximation. We have now included an additional modelling analysis (as part of our expanded perceptual modelling analyses), which shows there is no significant improvement in modelling performance when accounting for forgetting of recalibration or learning in the opposite direction by mapping in the second half of the ramp down, supporting this approximation. We explain this and other revisions in detail below.

      We include a Discussion section “Stimulus-response mapping is flexible but requires learning” where we improve our explanation of the operation of the mapping mechanism in the Ramp Down by leveraging the framework proposed by Iturralde and Torres-Oviedo, 2019. The section first explains that mapping operates relative to a new equilibrium corresponding to the current forward model calibration (lines 595-603):

      “The mapping mechanism observed in our study aligns with the corrective responses described by Iturralde and Torres-Oviedo, which operate relative to a recalibrated "new normal" rather than relying solely on environmental cues (Iturralde and Torres-Oviedo, 2019). Accordingly, our findings suggest a tandem architecture: forward model recalibration adjusts the nervous system's "normal state," while stimulus-response mapping computes motor adjustments relative to this "new normal." This architecture explains the sharp transition from flexible to rigid motor adjustments observed in our Ramp Down task. The transition occurs at the configuration perceived as "equal speeds" (~0.5 m/s speed difference) because this corresponds to the recalibrated “new normal”.”

      The following paragraph (lines 604-611) explain how this concept reflects in the first half of the Ramp Down:

      “In the first half of the Ramp Down, participants adequately modulated their walking pattern to accommodate the gradually diminishing perturbation, achieving symmetric step lengths. Due to the recalibrated “new normal”, perturbations within this range are perceived as congruent with the direction of adaptation but reduced in magnitude. This allows the mapping mechanism to flexibly modulate the walking pattern by using motor adjustments previously learned during adaptation. Importantly, the rapid duration of the Ramp Down task rules out the possibility that the observed modulation may instead reflect washout, as confirmed by the fact the aftereffects measured post-Ramp-Down were comparable to previous work (Kambic et al., 2023; Reisman et al., 2005).”

      The last paragraph (lines 612–622) explain the second half of the Ramp Down in light of the equilibrium concept and of the slow learning rate of mapping:

      “In the second half of the Ramp Down, aftereffects emerged as participants failed to accommodate perturbations smaller than the recalibrated “new normal”. These perturbations were perceived as opposite to the adaptation perturbation and, therefore, novel. Accordingly, the mapping mechanism responded as it would to a newly introduced perturbation, rather than leveraging previously learned adjustments (Iturralde and TorresOviedo, 2019). Due to the rapid nature of the Ramp Down, the mapping mechanism lacked sufficient time to learn the novel motor adjustments required for these perturbations – a process that typically takes several minutes, as shown by our baseline ramp tasks and control experiments. As mapping-related learning was negligible, the rigid recalibration adjustments dominated during this phase. Consequently, the walking pattern did not change to accommodate the gradually diminishing perturbation, leading to the emergence of aftereffects.”

      We also revised the Discussion section “Mapping operates as memory-based in some people, structure-based in others”, to clarify the processes of interpolation and extrapolation (lines 689-700). This revision helps explain why mapping may generalize to a ramp-up faster than learning a perturbation perceived in the opposite direction (when considered together with the explanation that mapping operates relative to the new recalibrated equilibrium) In the former case (generalize to a ramp-up), a structure-based mapping can use the extrapolation computation: it leverages previous knowledge of which gait parameters should be modified and how – e.g., modulating the positioning our right foot to be more forward on the treadmill – but must extrapolate the specific parameter values – e.g., how more far forward. In the latter case (learning a perturbation perceived in the opposite direction), even a structure-based mapping would need to figure out what gait parameters to change completely anew – e.g., modulating the positioning of the foot in the opposite way, to be less forward, requires a different set of control policies.

      We mentioned above that this illustration of the mapping mechanism relies on the assumption that the additional learning of the mapping mechanism in the second half of the Ramp Down is negligible. As part of our revisions for the “Modelling analysis for perceptual realignment”, we developed a new model – the perceptuomotor recalibration + mapping model (PM-ReMap) that extends the recalibration + mapping model by accounting for the possibility that Δ motor output is not constant in the second half of the Ramp Down (main points are at lines 355-275, and Figure 5; see response to Reviewer #1 (Public review), Comment 4, for a detailed explanation). We find that performance of the PM-ReMap model does not exceed that of the simpler recalibration + mapping model, suggesting that the Δ motor output does not change substantially in the second half of the Ramp Down. Note that, if the Δ motor output decayed in this phase, it could be due to forgetting or unlearning of the recalibration mechanism, or also it could be due to the mapping mechanism learning in the opposite direction than it did in adaptation. In the Results section, we focused on describing recalibration forgetting/unlearning for simplicity. However, in the Discussion section “Mapping may underly savings upon re-exposure to the same or different perturbation”, we explain in detail how the motor aftereffects also depend on the mapping mechanism learning in the opposite direction, as corroborated by our Control experiments and previous work. Therefore, the finding that the PM-ReMap model performance does not exceed that of the simpler recalibration + mapping model suggest that both effects – recalibration forgetting/unlearning and opposite-direction-learning of mapping – are not significant, nor is their combined effect on the Δ motor output.

      (2) A more minor point, but given the sample size it is hard to be convinced about the individual difference analysis for structure learning (Figure 5). How clear is it that these two groups of subjects are fully separable and not on a continuum? The lack of clusters in another data set seems like a somewhat less than convincing control here.

      We performed an additional analysis – a silhouette analysis – to confirm the presence of these clusters in our data (Methods, lines 1070-1072). The results, reported in Experiment 2 Results, lines 487-490, confirmed that there is strong evidence for the presence of these clusters:

      “A silhouette analysis confirmed strong evidence for these clusters: the average silhouette score was 0.90, with 19 of 20 participants scoring above 0.7 – considered strong evidence – and one scoring between 0.5 and 0.7 – considered reasonable evidence (Dalmaijer et al., 2022; Kaufman and Rousseeuw, 1990; Rousseeuw, 1987).”

      Reviewer #3 (Recommendations for the authors):

      (1) I think there is far too much content pushed into the supplement. The other models and full model comparison should be in the main text, as should the re-analysis of previous data sets. Also, key discussion points should not be in the supplement either.

      We reorganized the manuscript and SI Appendix substantially, including the changes recommended by the reviewer. Please refer to our response to “Reviewer #2 - Recommendations for the authors” for a detailed explanation.

      (2) Line 649: in reaching the calibration system does respond to different error sizes; why not here?

      We apologize for the confusion. Similar to reaching adaptation, the recalibration in walking adaptation also scales based on the error size experienced in adaptation. What we meant to convey is that, once a calibration has been acquired in adaptation, the recalibration process is rigid in that it can only change gradually. So if we jump the perturbation to a different value, the original calibration is transiently used until the system has the time to recalibrate again. For example, if we jump abruptly from the adaptation perturbation to a perturbation of zero in postadaptation, the adaptation calibration persists resulting in aftereffects.

      We revised the manuscript to clarity these points. First, we explicitly report that forward model recalibration scales based on the error size experienced in adaptation:

      “We next compared Medium Descend and Small Abrupt (1m/s or 0.4m/s perturbation), and found that recalibration contributed significantly more for the smaller perturbation (larger compensation<sub>perceptual</sub> / compensation<sub>motor-total</sub> in Small Abrupt than Medium Descend, Fig. 8A middle and Table S6).” (Control experiments Results, lines 422-425)

      “the mapping described here shares some characteristics with explicit mechanisms, such as flexibility and modulation by error size” (Discussion, lines 630-631)

      Additionally, we leverage the framework proposed by Tsay et al., 2024, to improve our explanation of the characteristics of the different learning mechanisms. Please refer to our response to “Reviewer #1 (Public review)”, Comment (1).

      (3) It would be nice to see bar graphs showing model comparison results for each individual subject in the main text, and to see how many subjects are best fit by the SR+calibration model.

      We included the recommended bar graphs to Figure 3 and Figure 5.

      (4) Why exactly does the "perturbation" in Figure 3 have error bars?

      In walking adaptation, the perturbation that participants experienced is closely dictated by the treadmill belt speeds, but not exactly, because participants are free to move their feet as they like, so that their ankle movement may not always match the treadmill belts exactly. Therefore, we record the perturbation that is actually experienced by each participant’s feet using markers. We then display the mean and standard error of this perturbation.

      We moved the equation describing the perturbation measure from the Methods to the Experiment 1 Results (lines 131-133, Eq. 1-3). We believe this change will help the reader understand the measures depicted.

    1. Author Response

      The following is the authors’ response to the original reviews.

      eLife assessment

      This valuable work provides a near-complete description of the mechanosensory bristles on the Drosophila melanogaster head and the anatomy and projection patterns of the bristle mechanosensory neurons that innervate them. The data presented are solid. The study has generated numerous invaluable resources for the community that will be of interest to neuroscientists in the field of circuits and behaviour, particularly those interested in mechanosensation and behavioural sequence generation.

      We express our gratitude to the Reviewers for their valuable suggestions, which significantly enhanced the manuscript. The revisions were undertaken, not with the expectation of acceptance, but rather driven by our sincere belief that these revisions would enhance the manuscript's impact for future readers.

      Public Reviews:

      Reviewer #1 (Public Review):

      Sensory neurons of the mechanosensory bristles on the head of the fly project to the sub esophageal ganglion (SEZ). In this manuscript, the authors have built on a large body of previous work to comprehensively classify and quantify the head bristles. They broadly identify the nerves that various bristles use to project to the SEZ and describe their region-specific innervation in the SEZ. They use dye-fills, clonal labelling, and electron microscopic reconstructions to describe in detail the phenomenon of somatotopy - conserved peripheral representations within the central brain - within the innervation of these neurons. In the process they develop novel tools to access subsets of these neurons. They use these to demostrate that groups of bristles in different parts of the head control different aspects of the grooming sequence.

      Reviewer #2 (Public Review):

      The authors combine genetic tools, dye fills and connectome analysis techniques to generate a "first-of-its-kind", near complete, synaptic resolution map of the head bristle neurons of Drosophila. While some of the BMN anatomy was already known based on previous work by the authors and other researchers, this is the first time a near complete map has been created for the head BMNs at electron microscopy resolution.

      Strengths:

      (1) The authors cleverly use techniques that allow moving back and forth between periphery (head bristle location) and brain, as well as moving between light microscopy and electron microscopy data. This allows them to first characterize the pathways taken by different head BMNs to project to the brain and also characterize anatomical differences among individual neurons at the level of morphology and connectivity.

      (2) The work is very comprehensive and results in a near complete map of all I’m head BMNs.

      (3) Authors also complement this anatomical characterization with a first-level functional analysis using optogenetic activation of BMNs that results in expected directed grooming behavior.

      Weaknesses:

      (1) The clustering analysis is compelling but cluster numbers seem to be arbitrarily chosen instead of by using some informed metrics.

      We made revisions to the manuscript that address this concern. Please see our response to “recommendations for authors” for a description of these revisions.

      (2) It could help provide context if authors revealed some of the important downstream pathways that could explain optogenetics behavioral phenotypes and previously shown hierarchical organization of grooming sequences.

      We made revisions to the manuscript that address this recommendation. Please see our response to “recommendations for authors” for a description of these revisions.

      (3) In contrast to the rigorous quantitative analysis of the anatomical data, the behavioral data is analyzed using much more subjective methods. While I do not think it is necessary to perform a rigorous analysis of behaviors in this anatomy focused manuscript, the conclusions based on behavioral analysis should be treated as speculative in the current form e.g. calling "nodding + backward walking" as an avoidance response is not justified as it currently stands. Strong optogenetic activation could lead to sudden postural changes that due to purely biomechanical constraints could lead to a couple of backward steps as seen in the example videos. Moreover since the quantification is manual, it is not clear what the analyst interprets as backward walking or nodding. Interpretation is also concerning because controls show backward walking (although in fewer instances based on subjective quantification).

      While unbiased machine vision-based methods would nicely complement the present work, this type of analysis is not yet working to distinguish between different head grooming movements. Therefore, we are currently limited to manual annotation for our behavioral analysis. That said, we do not believe that our manual annotation is subjective. The grooming movements that we examine in this work are distinguishable from each other through frame-by-frame manual annotation of video at 30 fps. Our annotation of the grooming and backward motions performed by flies are based on previous publications that established a controlled vocabulary defining each movement (Hampel et al., 2020a, 2017, 2015; Seeds et al., 2014). In this work, we added head nodding to this controlled vocabulary that is described in the Materials and methods. We have added additional text to the third paragraph of the Material and methods section entitled “Behavioral analysis procedures” that we hope better describes our behavioral analysis. This description now reads:

      Head nodding was annotated when the fly tilted its head downward by any amount until it returned its head back in its original position. This movement often occurred in repeated cycles. Therefore, the “start” was scored at the onset of the first forward movement and the “stop” when the head returned to its original position on the last nod.

      We do not make any firm conclusions about the head movements (nodding) and backwards motions. We refer to nodding as a descriptive term that would allow the reader to better understand what the behavior looks like. We make no firm conclusions about any behavioral functional role that either the nodding or the backward motions might have, with the exception of nodding in the context of grooming. We only suggest that the behaviors appear to be avoidance responses. Furthermore, backward walking was not mentioned. Instead we refer to backward motions. We are only reporting our annotations of these movements that do occur, and are significantly different from controls. We speculate that these could be avoidance responses based on support from the literature. Future studies will be required to understand whether these movements serve real behavioral roles.

      Summary:

      The authors end up generating a near-complete map of head BMNs that will serve as a long-standing resource to the Drosophila research community. This will directly shape future experiments aimed at modeling or functionally analyzing the head grooming circuit to understand how somatotopy guides behaviors.

      Reviewer #3 (Public Review):

      Eichler et al. set out to map the locations of the mechanosensory bristles on the fly head, examine the axonal morphology of the bristle mechanosensory neurons (BMNs) that innervate them, and match these to electron microscopy reconstructions of the same BMNs in a previously published EM volume of the female adult fly brain. They used BMN synaptic connectivity information to create clusters of BMNs that they show occupy different regions of the subesophageal zone brain region and use optogenetic activation of subsets of BMNs to support the claim that the morphological projections and connectivity of defined groups of BMNs are consistent with the parallel model for behavioral sequence generation.

      The authors have beautifully cataloged the mechanosensory bristles and the projection paths and patterns of the corresponding BMN axons in the brain using detailed and painstaking methods. The result is a neuroanatomy resource that will be an important community resource. To match BMNs reconstructed in an electron microscopy volume of the adult fly brain, the authors matched clustered reconstructed BMNs with light-level BMN classes using a variety of methods, but evidence for matching is only summarized and not demonstrated in a way that allows the reader to evaluate the strength of the evidence. The authors then switch from morphology-based categorization to non-BMN connectivity as a clustering method, which they claim demonstrates that BMNs form a somatotopic map in the brain. This map is not easily appreciated, and although contralateral projections in some populations are clear, the distinct projection zones that are mentioned by the authors are not readily apparent. Because of the extensive morphological overlap between connectivity-based clusters, it is not clear that small projection differences at the projection level are what determines the post-synaptic connectivity of a given BMN cluster or their functional role during behavior. The claim the somatotopic organization of BMN projections is preserved among their postsynaptic partners to form parallel sensory pathways is not supported by the result that different connectivity clusters still have high cosine similarity in a number of cases (i.e. Clusters 1 and 3, or Clusters 1 and 2). Finally, the authors use tools that were generated during the light-level characterization of BMN projections to show that specifically activating BMNs that innervate different areas of the head triggers different grooming behaviors. In one case, activation of a single population of sensory bristles (lnOm) triggers two different behaviors, both eye and dorsal head grooming. This result does not seem consistent with the parallel model, which suggests that these behaviors should be mutually exclusive and rely on parallel downstream circuitry.

      We made revisions to the manuscript that address this recommendation. Please see our response to “recommendations for authors” for a description of these revisions.

      This work will have a positive impact on the field by contributing a complete accounting of the mechanosensory bristles of the fruit fly head, describing the brain projection patterns of the BMNs that innervate them, and linking them to BMN sensory projections in an electron microscopy volume of the adult fly brain. It will also have a positive impact on the field by providing genetic tools to help functionally subdivide the contributions of different BMN populations to circuit computations and behavior. This contribution will pave the way for further mechanistic study of central circuits that subserve grooming circuits.

      Recommendations for the authors:

      All three reviewers appreciated the work presented in this manuscript. There were also a few overlapping concerns that were raised that are summarised below, should the authors wish to address them:

      Somatotopy: We recommend that the authors describe the extent of prior knowledge in more detail to highlight their contribution better.

      We made revisions that better highlight the extent of prior knowledge about somatotopy. We describe how previous studies showed bristle mechanosensory neurons in insects are somatotopically organized, but these studies were not comprehensive descriptions of complete somatotopic maps for the head or body. To our knowledge, our study provides the first comprehensive and synaptic resolution somatotopic map of a head for any animal. This sets the stage for the complete definition of the interface between somatotopically-organized mechanosensory neurons and postsynaptic circuits, which has broad implications for future studies on aimed grooming, and mechanosensation in general. Below we itemize revisions to the Introduction, Discussion, and Figures to provide a clearer statement of the significance of our study as it relates to somatotopy.

      (1) Newly added Figure 1 – figure supplement 1 more explicitly grounds the study in somatotopy, providing a working model of the organization of the circuit pathways that produce the grooming sequence. This model features somatotopy as shown in Figure 1 – figure supplement 1C.

      (2) Figure 1 – figure supplement 1 is incorporated into the Introduction in the second, third, and fourth paragraphs, the first paragraph of the Results section titled “Somatotopically-organized parallel BMN pathways”, and the second and third paragraphs of the last Discussion section titled “Parallel circuit architecture underlying the grooming sequence”.

      (3) We added text to the end of the fourth paragraph of the Introduction that now reads: “In this model, parallel-projecting mechanosensory neurons that respond to stimuli at specific locations on the head or body could connect with somatotopically-organized parallel circuits that elicit grooming of those locations (Figure 1 – figure supplement 1A-C). The previous discovery of a mechanosensory-connected circuit that elicits aimed grooming of the antennae provides evidence of this organization (Hampel 2015). However, the extent to which distinct circuits elicit grooming of other locations is unknown, in part, because the somatotopic projections of the mechanosensory neurons have not been comprehensively defined for the head or body.”

      (4) There is a Discussion section that further explains the extent of prior knowledge and our contributions on somatotopy that is titled “A synaptic resolution somatotopic map of the head BMNs”. Additionally, the previous version of this section had a paragraph on the broader implications of our work as it relates to somatotopy across species. In light of the reviewer comments, we decided to make this paragraph into its own Discussion section to better highlight the broader significance of our work. This section is titled “First synaptic resolution somatotopic map of the head”.

      The somatotopy isn't overtly obvious - perhaps they could try mapping presynaptic sites and provide landmarks to improve visualisation.

      We made the following revisions to better highlight the head BMN somatotopy. One point of confusion from the previous manuscript version stemmed from us not explicitly defining the somatotopic organization that we observed. There seemed to be confusion that we were defining the head somatotopy based only on the small projection differences among BMNs from neighboring head locations. While we believe that these small differences indeed correspond to somatotopy, we failed to highlight that there are overt differences in the brain projections of BMNs from distant locations on the head. For example, Figure 5B (right panel) shows the distinct projections between the LabNv (brown) and AntNv (blue) BMNs that innervate bristles on the ventral and dorsal head, respectively. Thus, BMN types innervating neighboring bristles show overlapping projections with small projection differences, whereas those innervating distant bristles show non overlapping projections into distinct zones.

      Our analysis of postsynaptic connectivity similarity also shows somatotopic organization among the BMN postsynaptic partners, as BMN types innervating the same or neighboring bristle populations show high connectivity similarity (Figure 8, old Figure 7). Below we highlight major revisions to the text and Figures that hopefully better reveal the head somatotopy.

      (1) In the last paragraph of the Introduction we added text that explicitly frames the experiments in terms of somatotopic organization: “This reveals somatotopic organization, where BMNs innervating neighboring bristles project to the same zones in the CNS while those innervating distant bristles project to distinct zones. Analysis of the BMN postsynaptic connectome reveals that neighboring BMNs show higher connectivity similarity than distant BMNs, providing evidence of somatotopically organized postsynaptic circuit pathways.”

      (2) We mention an example of overt somatotopy from Figure 5 in the Results section titled “EM-based reconstruction of the head BMN projections in a full adult brain”. The text reads “For example, BMNs from the Eye- and LabNv have distinct ventral and anterior projections, respectively. This shows how the BMNs are somatotopically organized, as their distinct projections correspond to different bristle locations on the head (Figure 5B,C).”

      (3) In new Figure 8 (part of old Figure 7), we modified panels that correspond to the cosine similarity analysis of postsynaptic connectivity. The major revision was to plot the cosine similarity clusters onto the head bristles so that the bristles are now colored based on their clusters (C). This shows how neighboring BMNs cluster together, and therefore show similar postsynaptic connectivity. We believe that this provides a nice visualization of somatotopic organization in BMN postsynaptic connectivity. We also added the clustering dendrogram as recommended by Reviewer #2 (Figure 8A).

      (4) In new Figure 8, we added new panels (D-F) that summarize our anatomical and connectomic analysis showing different somatotopic features of the head BMNs. Different BMN types innervate bristles at neighboring and distant proximities (D). BMNs that innervate neighboring bristles project into overlapping zones (E, example of reconstructed BM-Fr and -Ant neurons with non-overlapping BM-MaPa neurons) and show postsynaptic connectivity similarity (F, example connectivity map of three BM types on cosine similarity data).

      (5) To accompany the new Figure 8D-F panels, we added a paragraph to summarize the different somatotopic features of the head BMNs that were identified based on our anatomical and connectomic analysis. This is the last paragraph in the Results section titled “Somatotopically-organized parallel BMN pathways”:

      Our results reveal head bristle proximity-based organization among the BMN projections and their postsynaptic partners to form parallel mechanosensory pathways. BMNs innervating neighboring bristles project into overlapping zones in the SEZ, whereas those innervating distant bristles project to distinct zones (example of BM-Fr, -Ant, and -MaPa neurons shown in Figure 8D,E). Cosine similarity analysis of BMN postsynaptic connectivity revealed that BMNs innervating the same bristle populations (same types) have the highest connectivity similarity. Figure 8F shows example parallel connections for BM-Fr, -Ant, and -MaPa neurons (vertical arrows), where the edge width indicates the number of synapses from each BMN type to their major postsynaptic partners. Additionally, BMNs innervating neighboring bristle populations showed postsynaptic connectivity similarity, while BMNs innervating distant bristles show little or none. For example, BM-Fr and -Ant neurons have connections to common postsynaptic partners, whereas BM-MaPa neurons show only weak connections with the main postsynaptic partners of BM-Fr or -Ant neurons (Figure 8F, connections under 5% of total BMN output omitted). These results suggest that BMN somatotopy could have different possible levels of head spatial resolution, from specific bristle populations (e.g. Ant bristles), to general head areas (e.g. dorsal head bristles).

      We also refer to Figure 8D-F to illustrate the different somatotopic features in the Discussion. These references can be found in the following Discussion sections titled “A synaptic resolution somatotopic map of the head BMNs (fourth paragraph)”, and “Parallel circuit architecture underlying the grooming sequence (second paragraph)”.

      (6) In addition to improving the Figures, we provide additional tools that enable readers to explore the BMN somatotopy in a more interactive way. That is, we provide 5 different FlyWire.ai links in the manuscript Results section that enable 3D visualization of the different reconstructed BMNs (e.g. FlyWire.ai link 1).

      Note: In working on old Figure 7 to address this Reviewer suggestion, we also reordered panels A-E. We believe that this was a more logical ordering than in the previous draft. These panels are now the only data shown in Figure 7, as the cosine similarity analysis is now in Figure 8. We hope that splitting these panels into two Figures will improve manuscript readability.

      Light EM Mapping: A better description of methods by which this mapping was done would be helpful. Perhaps the authors could provide a few example parallel representations of the EM and light images in the main figure would help the reader better appreciate the strength of their approach.

      We have done as the Reviewers suggested and added panels to Figure 6 that show examples of the LM and EM image matching (Figure 6A,B). We added two examples that used different methods for labeling the LM imaged BMNs, including MCFO labeling of an individual BM-InOc neuron and driver line labeling of a major portion of BM-InOm neurons using InOmBMN-LexA. These panels are referred to in the first paragraph of the Results section titled “Matching the reconstructed head BMNs with their bristles”. Note that examples for all LM/EM matched BMN types are shown in Figure 6 – figure supplement 2.

      We had provided Figure 6 – figure supplement 2 in the reviewed manuscript that shows all the above requested “parallel representations of the EM and light images”. However, the Reviewer critiques made us realize that the purpose of this figure supplement was not clearly indicated. Therefore, we have revised Figure 6 – figure supplement 2 and its legend to make its purpose clearer. First, we changed the legend title to better highlight its purpose. The legend is now titled: “Matching EM reconstructed BMN projections with light microscopy (LM) imaged BMNs that innervate specific bristles”. Second, we added label designations to the figure panel rows that highlight the LM and EM comparisons. That is, the rows for light microscopy images of BMNs are indicated with LM and the rows for EM reconstructed BMN images are labeled with EM. Reviewer #3 had indicated that it was not clear what labeling methods were used to visualize the LM imaged BM-InOm neurons in Figure 6 – figure supplement 2N. Therefore, we added text to the figure and the legend to better highlight the different methods used. Panels A and B were also cropped to accommodate the above mentioned revisions.

      The manuscript also provides an extensive Materials and methods section that describes the different lines of evidence that were used to assign the reconstructed BMNs as specific types. We changed the title to better highlight the purpose of this methods section to “Matching EM reconstructed BMN projections with light microscopy imaged BMNs that innervate specific bristles”. The evidence used to support the assignment of the different BMN types is also summarized in Figure 6 – figure supplement 3.

      Parallel circuit model: The authors motivate their study with this. We're recommending that they define expectations of such circuitry, its alternatives (including implications for downstream pathways), and behavior before they present their results. We're also recommending that they interpret their behavioural results in the context of these circuits.

      Our primary motivation for doing the experiments described in this manuscript was to help define the neural circuit architecture underlying the parallel model that drives the Drosophila grooming sequence. This manuscript provides a comprehensive assessment of the first layer of this circuit architecture. A byproduct of this work is a contribution that offers immediate utility and significance to the Drosophila connectomics community. Namely, the description of the majority of mechanosensory neurons on the head, with their annotation in the recently released whole brain connectome dataset (FlyWire.ai). In writing this manuscript, we tried to balance both of these things, which was difficult to write. We very much appreciate the Reviewers' comments that have highlighted points of confusion in our original draft. We hope that the revised draft is now clearer and more logically presented. We have made revisions to the text and provided a new figure supplement (Figure 1 - figure supplement 1) and new panels in Figure 8. Below we highlight the major revisions.

      (1) The Introduction was revised to more explicitly ground the study in the parallel model, while also removing details that were not pertinent to the experiments presented in the manuscript.

      The first paragraph introduces different features of the parallel model. To better focus the reader on the parts of the model that were being assessed in the manuscript, we removed the following sentences: “Performance order is established by an activity gradient among parallel circuits where earlier actions have the highest activity and later actions have the lowest. A winner-take-all network selects the action with the highest activity and suppresses the others. The selected action is performed and then terminated to allow a new round of competition and selection of the next action.” Note that these sentences are included in the third and fourth paragraphs of the last Discussion section titled “Parallel circuit architecture underlying the grooming sequence”.

      The first paragraph of the Introduction now introduces a bigger picture view of the model that emphasizes the two main features: 1) a parallel circuit architecture that ensures all mutually exclusive actions to be performed in sequence are simultaneously readied and competing for output, and 2) hierarchical suppression among the parallel circuits, where earlier actions suppress later actions.

      (2) Newly added Figure 1 – figure supplement 1 provides a working model of grooming (Reviewer # 1 suggestion). We now more strongly emphasize that the study aimed to define the parallel neural circuit architecture underlying the grooming sequence, focusing on the mechanosensory layer of this architecture. In particular, we refer to the new Figure 1 – figure supplement 1 that has been added to better convey the hypothesized grooming neural circuit architecture. Figure 1 – figure supplement 1 is incorporated into the Introduction (paragraphs two, three, and four), Results section titled “Somatotopically-organized parallel BMN pathways (first paragraph)”, and last Discussion section titled “Parallel circuit architecture underlying the grooming sequence (second and third paragraphs)”.

      (3) New panels in Figure 8 update the model of parallel circuit organization as it relates to somatotopy (D-F). These panels show the parallel circuits hypothesized by the model, but also indicate convergence, with different possible levels of head resolution for these circuits. We describe above where these panels are referenced in the text.

      (4) We added a new paragraph in the last Discussion section titled “Parallel circuit architecture underlying the grooming sequence” that better incorporates the results from this manuscript into the working model of grooming. This paragraph is shown below.

      Here we define the parallel architecture of BMN types that elicit the head grooming sequence that starts with the eyes and proceeds to other locations, such as the antennae and ventral head. The different BMN types are hypothesized to connect with parallel circuits that elicit grooming of specific locations (described above and shown in Figure 1 – figure supplement 1A,C). Indeed, we identify distinct projections and connectivity among BMNs innervating distant bristles on the head, providing evidence supporting this parallel architecture (Figure 8D-F). However, we also find partially overlapping projections and connectivity among BMNs innervating neighboring bristles. Further, optogenetic activation of BMNs at specific head locations elicits grooming of both those locations and neighboring locations (Figure 9). These findings raise questions about the resolution of the parallel architecture underlying grooming. Are BMN types connected with distinct postsynaptic circuits that elicit aimed grooming of their corresponding bristle populations (e.g. Ant bristles)? Or are neighboring BMN types that innervate bristles in particular head areas connected with circuits that elicit grooming of those areas (e.g. dorsal or ventral head)? Future studies of the BMN postsynaptic circuits will be required to define the resolution of the parallel pathways that elicit aimed grooming.

      Aside from this summary of major concerns, the detailed recommendations are attached below.

      Reviewer #1 (Recommendations For The Authors):

      I appreciate the quality and exhaustive body of work presented in this manuscript. I have a few comments that the authors may want to consider:

      (1) The authors motivate this study by posing that it would allow them to uncover whether the complex grooming behaviour of flies followed a parallel model of circuit function. It would have been nice to have been introduced to what the alternative model might be and what each would mean for organisation of the circuit architecture. Some guiding schematics would go a long way in illustrating this point. Modifying the discussion along these lines would also be helpful.

      We made several revisions to the manuscript that address this recommendation. Among these revisions, we added Figure 1 – figure supplement 1 that includes a working model for grooming. Please see above for a description of these revisions.

      (2) The authors mention the body of work that has mapped head bristles and described somatotopy. It would be useful to discuss in more detail what these studies have shown and highlight where the gaps are that their study fills.

      We made several revisions to the manuscript that address this recommendation. Please see above for a description of these revisions.

      (3) The dye-fills and reconstructions that are single colour could use a boundary to demarcate the SEZ. This would help in orienting the reader.

      We agree with Reviewer #1 that Figure 4 and its supplements could use some indicator that would orient the reader with respect to the dye filled or stochastically labeled neurons. The images are of the entire SEZ in the ventral brain, and in the case of some panels, the background staining enables visualization of the brain (e.g. Figure 4H,M,N. To help orient the reader in this region, we added a dotted line to indicate the approximate SEZ midline. This also enables the reader to more clearly see which of the BMN types cross the midline.

      Midline visual guides were added for Figure 4, Figure 4 – figure supplement 2, Figure 4 – figure supplement 3, Figure 4 – figure supplement 4, Figure 4 – figure supplement 5, Figure 4 – figure supplement 6, Figure 4 – figure supplement 7, Figure 4 – figure supplement 8, Figure 6 – figure supplement 2.

      (4) The comparison between the EM and the fills/clones are not obvious. And particularly because they are not directly determined, it would be nice to have the EM reconstruction alongside the dye-fills. This would work very nicely in the supplementary figure with the multiple fills of the same bristles. I think this would really drive home the point.

      We made several revisions to the manuscript that address this recommendation. Please see above for a description of these revisions.

      (5) Are there unnoticed black error-bars floating around in many of the gray-scale images?

      The black bars were masking white scale bars in the images. We have removed the black bars and remade the images without scale bars. This was done for the following Figures: Figure 4, Figure 4 – figure supplement 2, Figure 4 – figure supplement 3, Figure 4 – figure supplement 4, Figure 4 – figure supplement 5, Figure 4 – figure supplement 6, Figure 4 – figure supplement 7, Figure 4 – figure supplement 8, Figure 6 – figure supplement 2.

      Reviewer #2 (Recommendations For The Authors):

      (1) The only point in the paper I found myself going back and forth between methods/supp and text was when authors discuss about the clustering. I think it would help the reader if a few sentences about cosine clustering used for connectivity based clustering were included in the main text. Also, for NBLAST hierarchical clustering, it would help if some informed metrics could be used for defining cluster numbers (e.g. Braun et al, 2010 PLOS ONE shows how Ward linkage cost could be used for hierarchical clustering).

      Depending on where the cut height is placed on the dendrogram for cosine similarity of BMNs, different features of the BMN type postsynaptic connectivity are captured. As the number of clusters is increased (lower cut height), clustering is mainly among BMNs of the same type, showing that these BMNs have the highest connectivity similarity. As the number of clusters is reduced (higher cut height), BMNs innervating neighboring bristles on the head are clustered, revealing three general clusters corresponding to the dorsal, ventral, and posterior head. This reveals somatotopy based clustering among same and neighboring BMN types. The cut height shown in Figure 8 and Figure 8 – figure supplement 2 was chosen because it highlighted both of these features.

      The NBLAST clustering shows similar results to the connectivity based clustering with respect to neighboring and distant BMN types. As the number of clusters increases BMNs of the same type are clustered, and these types can be further subdivided into morphologically distinct subtypes. As the number of clusters is reduced, the clustering captures neighboring BMNs. Thus, neighboring BMN types showed high morphology similarity (and proximity) with each other, and low similarity with distant BMN types.

      Please see our responses to a Reviewer #3 critique below for further description of the clustering results.

      On the same lines it would help if the clustering dendrograms were included in the main figure.

      We thank Reviewer #2 for this comment. We have added the dendrogram to Figure 8A, a change that we feel makes this Figure much easier to understand.

      (2) It could help provide intuition if the authors revealed some of the downstream targets and their implication in explaining the behavioral phenotypes.

      While this will be the subject of at least two forthcoming manuscripts, we have added text to the present manuscript that provides insight into BMN postsynaptic targets. Our previous work (Hampel et al. 2015) described a mechanosensory connected neural circuit that elicits grooming of the antennae. While this previous study demonstrated that the Johnston’s organ mechanosensory neurons are synaptically and functionally connected with this circuit, our preliminary analysis indicates that it is also connected with BM-Ant neurons. We hypothesize that there are additional such circuits that are responsible for eliciting grooming of other head locations.

      To better highlight potential downstream targets in the manuscript, we now mention the antennal circuit in the Introduction. This text reads: In this model, parallel-projecting mechanosensory neurons that respond to stimuli at specific locations on the head or body could connect with somatotopically-organized parallel circuits that elicit grooming of those locations (Figure 1 – figure supplement 1A-C). The previous discovery of a mechanosensory-connected circuit that elicits aimed grooming of the antennae provides evidence of this organization (Hampel 2015). However, the extent to which distinct circuits elicit grooming of other locations is unknown, in part, because the somatotopic projections of the mechanosensory neurons have not been comprehensively defined for the head or body.

      There is also text in the Discussion that addresses this Reviewer comment. It describes the antennal circuit and mentions the possibility that other similar circuits may exist. This can be found in the third paragraph of the section titled “Circuits that elicit aimed grooming of specific head locations”.

      (3) Authors find that opto activation of BMNs leads to grooming of targeted as well as neighboring areas. Is there any sequence observed here? i.e. first clean targeted area and then clean neighboring area? I wonder if the answer to this is something as simple as common post-synaptic targets which is essentially reducing the resolution of the BMN sensory map. Some more speculation on this interesting result could be helpful.

      We appreciate and agree with this point from Reviewer #2, and have tried to better emphasize the possible implications for grooming that the overlapping projections and connectivity among BMNs innervating neighboring bristles may have. This is now better addressed in the Results and Discussion sections. Below we highlight where this is addressed:

      (1) In the second paragraph of the Results section titled “Activation of subsets of head BMNs elicits aimed grooming of specific locations” we added text that suggests the possibility that grooming of the stimulated and neighboring locations could be due to the overlapping projections and connectivity. This text reads: This suggested that head BMNs elicit aimed grooming of their corresponding bristle locations, but also neighboring locations. This result is consistent with our anatomical and connectomic data indicating that BMNs innervating neighboring bristles show overlapping projections and postsynaptic connectivity similarity (see Discussion).

      (2) In the fourth paragraph of the Discussion section titled “A synaptic resolution somatotopic map of the head BMNs”, we added a sentence to the end of the fourth paragraph that alludes to further discussion of this topic. This sentence reads: This overlap may have implications for aimed grooming behavior. For example, neighboring BMNs could connect with common neural circuits to elicit grooming of overlapping locations (discussed more below).

      (3) In the fourth paragraph of the Discussion section titled “Circuits that elicit aimed grooming of specific head locations” there is a paragraph that mentions the possibility of mechanosensory convergence onto common postsynaptic circuits to promote grooming of the stimulated area, along with neighboring areas. This paragraph is below.

      We find that activation of specific BMN types elicits both aimed grooming of their corresponding bristle locations and neighboring locations. This suggests overlap in the locations that are groomed with the activation of different BMN types. Such overlap provides a means of cleaning the area surrounding the stimulus location. Interestingly, our NBLAST and cosine similarity analysis indicates that neighboring BMNs project into overlapping zones in the SEZ and show common postsynaptic connectivity. Thus, we hypothesize that neighboring BMNs connect with common neural circuits (e.g. antennal grooming circuit) to elicit overlapping aimed grooming of common head locations.

      (4) In the new second paragraph of the Discussion section titled “Parallel circuit architecture underlying the grooming sequence” we further discuss the issue of the BMN “sensory map. This paragraph is below.

      Here we define the parallel architecture of BMN types that elicit the head grooming sequence that starts with the eyes and proceeds to other locations, such as the antennae and ventral head. The different BMN types are hypothesized to connect with parallel circuits that elicit grooming of specific locations (described above and shown in Figure 1 – figure supplement 1A,C). Indeed, we identify distinct projections and connectivity among BMNs innervating distant bristles on the head, providing evidence supporting this parallel architecture (Figure 8D-F). However, we also find partially overlapping projections and connectivity among BMNs innervating neighboring bristles. Further, optogenetic activation of BMNs at specific head locations elicits grooming of both those locations and neighboring locations (Figure 9). These findings raise questions about the resolution of the parallel architecture underlying grooming. Are BMN types connected with distinct postsynaptic circuits that elicit aimed grooming of their corresponding bristle populations (e.g. Ant bristles)? Or are neighboring BMN types that innervate bristles in particular head areas connected with circuits that elicit grooming of those areas (e.g. dorsal or ventral head)? Future studies of the BMN postsynaptic circuits will be required to define the resolution of the parallel pathways that elicit aimed grooming.

      (4) If authors were to include a summary table that shows all known attributes about BMN type as columns that could be very useful as a resource to the community. Table columns could include attributes like "bristle name", "nerve tract", "FlyWire IDs of all segments corresponding to the bristle class". "split-Gal4 line or known enhancer" , etc.

      We provided a table that includes much of this information after the manuscript had already gone out for review. We regret that this was not available. This is now provided as Supplementary file 3. This table provides the following information for each reconstructed BMN: BMN name, bristle type, nerve, flywire ID, flywire coordinates, NBLAST cluster (cut height 1), NBLAST cluster (cut height 5), and cosine cluster (cut height 4.5). Note that the driver line enhancers for targeting specific BMN types are shown in Figure 3I.

      Specific Points:

      Figure 4C-V:

      • I find it a bit difficult to distinguish ipsi- from contra-lateral projections. Maybe indicate the midline as a thin, stippled line?

      We thank the Reviewer #2 for this suggestion. We have now added lines in the panels in Figure 4C-V to indicate the approximate location of the midline. We also added lines to the Figure 4 – figure supplements as described above.

      I think this Fig reference is wrong "the red-light stimulus also elicited backward motions with control flies (Figure 6B,C, control, black trace, Video 5)." should be Fig 8B,C

      We have fixed this error.

      Reviewer #3 (Recommendations For The Authors):

      Introduction:

      Motivating this study in terms of understanding the neural mechanisms that execute the parallel model seems to overstate what you will achieve with the current study. If you want to motivate it this way, I suggest focusing on the grooming sequence of the head along (eyes, antennae, proboscis).

      We made several revisions to the manuscript that address this recommendation. Please see above for a description of these revisions. Please note that many of the revisions focus on the head grooming sequence. We also made minor revisions to the Introduction that further emphasize the focus on head grooming.

      Results:

      Figure 1. Please indicate that this is a male fly in either the figure title or in the figure itself.

      We added a male symbol to Figure 1A.

      Figure 3. Panel J is referenced in the main body text and in the figure caption, but there is no Fig 3J.

      Panel J is shown in the upper right corner of Figure 3. We realize that the placement of this panel is not ideal, but this was the only place that we could fit it. Additionally, the panel works nicely at that location to better enable comparison with panel C. We have revised the text in the Figure 3 legend to better highlight the location of this Figure panel: “Shown in the upper right corner of the figure are the aligned expression patterns of InOmBMN-LexA (red), dBMN-spGAL4 (green), and TasteBMN-spGAL4 (brown).”

      We also added text to a sentence in the results section entitled “Head BMNs project into discrete zones in the ventral brain” that indicates the panel location. This text reads: To further visualize the spatial relationships between these projections, we computationally aligned the expression patterns of the different driver lines into the same brain space (Figure 3J, upper right corner).

      Matching the BMNs to EM reconstructions: why cut the dendrogram at H=5? Would be better to determine cluster number using an unbiased method.

      To match the morphologically distinct EM reconstructed BMNs to their specific bristles, we relied on different lines of evidence, including NBLAST results (discussed more below), dye fill/stochastic labeling/driver line labeling matches, published morphology, nerve projection, bristle number, proximity to other BMNs, and postsynaptic connectivity (summarized in Figure 6 – figure supplement 3). The following Materials and methods section provides a detailed description of the evidence used to assign each BMN type in “Matching EM reconstructed BMN projections with light microscopy imaged BMNs that innervate specific bristles”. In many cases, BMN type could be assigned with confidence solely based on morphological comparisons with our light level data (e.g. dye fills), in conjunction with bristle counts to indicate an expected number of BMNs showing similar morphology. Thus, the LM/EM matches and NBLAST clustering were largely complementary.

      The EM reconstructed BMNs were matched as particular BMN types, in part based on examination of the NBLAST data at different cut heights. NBLAST clustering of the BMNs revealed general trends at higher and lower cut heights (Figure 6 – figure supplement 1A, Supplementary file 3). The lowest cut heights included mostly BMNs of the same type innervating the same bristle populations, and smaller clusters that subdivided into morphologically distinct subtypes (see Supplementary file 3 for clusters produced at cut height 1). This revealed that BMNs of the same type tended to show the highest morphological similarity with each other, but they also showed intratype morphological diversity. Higher cut heights produced clusters of BMNs innervating neighboring bristles populations (e.g. ventral head BMNs), showing high morphological similarity among neighboring BMN types.

      We selected the cut height 5 shown in Figure 6 – figure supplement 1A,B because it captures examples of both same and neighboring type clustering. For example, it captures a cluster of mostly BM-Taste neurons (Cluster 16), and neighboring BMN types, including those from the dorsal head (Cluster 14) or ventral head (Cluster 15).

      Based on reviewer comments, we realized that the way we wrote the BMN matching section in the Results indicated more reliance on the NBLAST clustering than what was actually necessary, distorting the way we actually matched the BMNs. Therefore, we softend the first couple of sentences to place less emphasis on the importance of the NBLAST. We also indicated that the readers can find the resulting clusters at different cut heights, referring to Figure 6 – figure supplement 1A and Supplementary file 3. The first two sentences of the first paragraph in the Results section titled “Matching the reconstructed head BMNs with their bristles” now read:

      The reconstructed BMN projections were next matched with their specific bristle populations. The projections were clustered based on morphological similarity using the NBLAST algorithm (example clustering at cut height 5 shown in Figure 6 – figure supplement 1A,B, Supplementary file 3, FlyWire.ai link 2) (Costa et al., 2016). Clusters could be assigned as BMN types based on their similarity to light microscopy images of BMNs known to innervate specific bristles.

      The number of reconstructed BMNs is remarkably similar to what is expected based on bristle counts for each group except for lnOm. Why do you think there is such a large discrepancy there?

      We believe that there is a discrepancy between the number of reconstructed BM-InOm neurons and the number expected based on InOm bristle counts because these bristle counts were based on few flies and these numbers appear to be variable. We did not further investigate the numbers of InOm bristles in this manuscript because we only needed an estimate of their numbers, given that there is over an order of magnitude difference in the eye bristles versus any other head bristle population. Therefore, we could relatively easily conclude that the head BMNs were related to the InOm bristles, based on their sheer numbers and their morphology.

      Figure 6 - figure supplement 2N, please describe these panels better. Main text says the upper image is from lnOmBMN-LexA, but the figure legend doesn't agree.

      We have added text to the figure legend that now makes the contents of panel 2N clear to the reader. Further, we now indicate in the figure legend for each panel, the method used to obtain the labeled neurons (i.e. fill, MCFO, driver), to avoid similar confusion for the other panels.

      Figure 6 - figure supplement 4D. How frequently is there a mismatch between the number of BMNs for a given type across hemispheres?

      Although the full reconstruction of the BMNs on both sides of the brain was beyond the scope of this work, the BMNs on both sides have since been reconstructed and annotated (Schlegal et al. 2023). We plan to provide more analysis of BMNs on both sides of the brain in a forthcoming manuscript. However, the BMN numbers tend to show agreement on both sides of the brain. The table below shows a comparison between the two sides:

      Author response table 1.

      Figures 6 and 7. It would be helpful to include a reference brain in all panels that show cluster morphology. Without landmarks there is nothing to anchor the eye to allow the reader to see the described differences in BMN projection zones and patterns.

      While we apologize for not making this specific change, we have made revisions to other parts of the manuscript to better highlight the somatotopic organization among the BMNs (revisions described above). Please note that we now provide FlyWire.ai publicly available links that enable readers to view the BMN projections in 3D. They can also toggle a brain mesh on and off to provide spatial reference.

      "BMN somatotopic map": It would be helpful to show or describe in more detail what the unique branch morphology for each zone is. It is quite difficult to appreciate, as the groups also have a lot of overlap. Would the unique regions that the BMN groups innervate be easier to see if you plotted presynaptic sites by group? I am left unsure about whether there is a somatotopic map here.

      We made several revisions to the manuscript that address this recommendation. Please see above for a description of these revisions. Please note that we did not examine the fine branch morphological differences between BMN types having overlapping projections. Showing these differences would require more extensive anatomical analysis that is beyond the scope of this work. For showing definitive somatotopy, we focused on the overt differences between BMNs innervating bristles at distant locations on the head.

      Overall the strict adherence to the parallel model impacts the interpretation of the data. It would be helpful for the authors to discuss which aspects of the current study are consistent with the parallel model and which results are not consistent.

      We made several revisions to the manuscript that address this recommendation. Please see above for a description of these revisions.

      Discussion:

      "Circuits that elicit aimed grooming of specific head locations": In the previous paragraph you mention "BMN types innervating neighboring bristle populations have overlapping projections into zones that correspond roughly to the dorsal, ventral, and posterior head. The overlap is likely functionally significant, as cosine similarity analysis revealed that neighboring head BMN types have common postsynaptic partners. However, overlap between neighboring BMN types is only partial, as they show differing projections and postsynaptic connectivity." Then in this paragraph, you say, "How do the parallel-projecting head BMNs interface with postsynaptic neural circuits to elicit aimed grooming of specific head locations? Different evidence supports the hypothesis that the BMNs connect with parallel circuits that each elicit a different aimed grooming movement (Seeds et al., 2014)." The overlapping postsynaptic BMN connectivity seems in conflict with the claim that the circuits are parallel.

      We apologize for this confusion. We now better describe this apparent discrepancy between our results and the parallel model of grooming behavior. We made several revisions to the manuscript that address this recommendation. Please see above for a description of these revisions.

      We have made additional changes to the manuscript:

      (1) We added Supplementary file 2 that includes links for downloading the image stacks used to generate panels in Figure 1, Figure 2, Figure 3, Figure 4, and figure supplements for these figures. These image stacks are stored in the Brain Image Library (BIL). Rows in the spreadsheet correspond to each image stack. Columns provide information about each stack including: figure panels that each image stack contributed to, image stack title, DOI for each stack (link provides metadata for each stack and file download link), image stack file name, genotype of imaged fly, and information about image stack. References to this file have been made at different locations throughout the text and Figure legends. We also added a section on the BIL data in the Materials and methods entitled “Light microscopy image stack storage and availability”. Old Supplementary file 2 has been renamed Supplementary file 3.

      (2) We added a new reference for FlyWire.ai (Dorkenwald et al. 2023) that was posted as a preprint during the revision of this manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      In the manuscript titled "Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation" by Lu et al, the authors show that Vangl2, a planner cell polarity component, plays a direct role in autophagic degradation of NFkB-p65 by facilitating its ubiquitination via PDLIM2 and subsequent recognition and autophagic targeting via the autophagy adaptor protein NDP52. Conceptually it is a wonderful study with excellent execution of experiments and controls. The concerns with the manuscript are mainly on two counts - First issue is the kinetics of p65 regulation reported here, which does not fit into the kinetics of the mechanism proposed here, i.e., Vangl2-mediated ubiquitination followed by autophagic degradation of p65. The second issue is more technical- an absolute lack of quantitative analyses. The authors rely mostly on visual qualitative interpretation to assess an increase or decrease in associations between partner molecules throughout the study. While the overall mechanism is interesting, the authors should address these concerns as highlighted below:

      Major points:

      (1) Kinetics of p65 regulation by Vangl2: As mentioned above, authors report that LPS stimulation leads to higher IKK and p65 activation in the absence of Vangl2. The mechanism of action authors subsequently work out is that- Vangl2 helps recruit E3 ligase PDLIM to p65, which causes K63 ubiquitination, which is recognised by NDP52 for autophagic targeting. Curiously, peak p65 activation is achieved within 30 minutes of LPS stimulation. The time scale of all other assays is way longer. It is not clear that in WT cells, p65 could be targeted to autophagic degradation in Vangl2 dependent manner within 30 minutes. The HA-Myc-Flag-based overexpression and Co-IP studies do confirm the interactions as proposed. However, they do not prove that this mechanism was responsible for the Vangl2-mediated modulation of p65 activation upon LPS stimulation. Moreover, the Vangl2 KO line also shows increased IKK activation. The authors do not show the cause behind increased IKK activation, which in itself can trigger increased p65 phosphorylation.

      We thank the reviewer for this valuable suggestion.

      Indeed, we agreed with the reviewer that peak p65 activation is achieved within 30 minutes of LPS stimulation in vitro, and p65 could not be targeted to autophagic degradation in a Vangl2 dependent manner within 30 minutes. Given that the protein and mRNA levels of Vangl2 were elevated at 3-6 h of LPS stimulation (Fig. S1 C-E), we extended the stimulation time scale in the revised manuscript. The data (Fig. 2A-D in the revised manuscript) demonstrated that IKK phosphorylation was enhanced in Vangl2 KO myeloid cells during the early phase (within 3 h) of LPS stimulation, but not for the prolonged period of LPS stimulation. The underlying mechanism may be complex. Only p65 phosphorylation was continuously enhanced after long-term LPS stimulation in Vangl2 KO cells, compared to WT cells. Furthermore, the overexpression of Vangl2 in A549 cells also demonstrated a reduction of phosphorylation and total endogenous p65 (Fig. 2 I, J in the revised manuscript). These findings were corroborated by overexpression and Co-IP experiments, which collectively indicated that Vangl2 regulates the stability of p65 by promoting its interaction with NDP52 and autophagic degradation. (Page 7; Line 183-185).  

      (2) The other major concern is regarding the lack of quantitative assessments. For Co-IP experiments, I can understand it is qualitative observation. However, when the authors infer that there is an increase or decrease in the association through co-IP immunoblots, it should also be quantified, especially since the differences are quite marginal and could be easily misinterpreted.

      We are grateful to the reviewer for this suggestion. The quantitative analysis has been updated in the revised version.

      (3) Figure 4E and F: It is evident that inhibiting Autolysosome (CQ or BafA1) or autophagy (3MA) led to the recovery of p65 levels and inducing autophagy by Rapamycin led to faster decay in p65 levels. Did the authors also note/explore the possibility that Vangl2 itself may be degraded via the autophagy pathway? IB of WCL upon CQ/BAF/3MA or upon Rapa treatment does indicate the same. If true, how would that impact the dynamics of p65 activation?

      We thank the reviewer for this question. Previous studies have shown that Vangl2 is primarily degraded by the proteasome pathway, rather than by the autolysosomal pathway (doi: 10.1126/sciadv.abg2099; doi: 10.1038/s41598-019-39642-z). In our experiments, Vangl2 recruits E3 ligase PDLIM2 to enhance K63-linked ubiquitination on p65, which serves as a recognition signal for cargo receptor NDP52-mediated selective autophagic degradation. Vangl2 facilitated the interaction between p65 and NDP52, yet itself did not undergo significant autophagic degradation.

      (4) Autophagic targeting of p65 should also be shown through alternate evidence, like microscopy etc., in the LPS-stimulated WT cells.

      We thank the reviewer for this suggestion. We have added the data (co-localization of p65 and LC3 was detected by immunofluorescence) in the revised version (Fig. S4 H in the revised manuscript). (Page 9, lines 267-268)

      Reviewer #2 (Public Review):

      Vangl2, a core planar cell polarity protein involved in Wnt/PCP signaling, mediates cell proliferation, differentiation, homeostasis, and cell migration. Vangl2 malfunctioning has been linked to various human ailments, including autoimmune and neoplastic disorders. Interestingly, Vangl2 was shown to interact with the autophagy regulator p62, and indeed, autophagic degradation limits the activity of inflammatory mediators such as p65/NF-κB. However, if Vangl2, per se, contributes to restraining aberrant p65/NF-kB activity remains unclear.

      In this manuscript, Lu et al. describe that Vangl2 expression is upregulated in human sepsis-associated PBMCs and that Vangl2 mitigates experimental sepsis in mice by negatively regulating p65/NF-κB signaling in myeloid cells. Vangl2 recruits the E3 ubiquitin ligase PDLIM2 to promote K63-linked poly-ubiquitination of p65. Vangl2 also facilitates the recognition of ubiquitinated p65 by the cargo receptor NDP52. These molecular processes cause selective autophagic degradation of p65. Indeed, abrogation of PDLIM2 or NDP52 functions rescued p65 from autophagic degradation, leading to extended p65/NF-κB activity.

      As such, the manuscript presents a substantial body of interesting work and a novel mechanism of NF-κB control. If found true, the proposed mechanism may expand therapeutic opportunities for inflammatory diseases. However, the current draft has significant weaknesses that need to be addressed.

      We appreciate the reviewer’s comments on our manuscript, and we have further improved the manuscript as suggested.

      Specific comments

      (1) Vangl2 deficiency did not cause a discernible increase in the cellular level of total endogenous p65 (Fig 2A and Fig 2B) but accumulated also phosphorylated IKK.

      Even Fig 4D reveals that Vangl2 exerts a rather modest effect on the total p65 level and the figure does not provide any standard error for the quantified data. Therefore, these results do not fully support the proposed model (Figure 7) - this is a significant draw back. Instead, these data provoke an alternate hypothesis that Vangl2 could be specifically mediating autophagic removal of phosphorylated IKK and phosphorylated IKK, leading to exacerbated inflammatory NF-κB response in Vangl2-deficient cells. One may need to use phosphorylation-defective mutants of p65, at least in the over-expression experiments, to dissect between these possibilities.

      We appreciate the reviewer’s comments on our manuscript, and we have further improved the manuscript as suggested.

      (1) Indeed, we agreed with the reviewer that Vangl2 deficiency did not cause a discernible increase in the cellular level of total p65 after a short time of LPS stimulation in vitro, and p65 could not be targeted to autophagic degradation in a Vangl2 dependent manner within 30 minutes. Given that the protein and mRNA levels of Vangl2 were elevated at 3-6 h of LPS stimulation (Fig. S1 C-E), we extended the stimulation time scale in the revised manuscript. The data (Fig. 2A-D in the revised manuscript) demonstrated that IKK phosphorylation was enhanced in Vangl2 KO myeloid cells during the early phase (within 3 h) of LPS stimulation, but not for the prolonged period of LPS stimulation. The underlying mechanism may be complex. Only phosphorylation of p65 and total endogenous p65 was continuously enhanced after long-term LPS stimulation in Vangl2 KO cells, compared to WT cells. Furthermore, the overexpression of Vangl2 in A549 cells also demonstrated a reduction of phosphorylation and total endogenous p65 (Fig. 2 I, J in the revised manuscript). These findings were corroborated by overexpression and Co-IP experiments, which collectively indicated that Vangl2 regulates the stability of p65 by promoting its interaction with NDP52 and autophagic degradation. (Page 7; Line 183-185).  

      (2) Similarly, the stimulation time scale in Fig 4D was extended, and it was demonstrated that p65 was more stable in Vangl2-deficient cells.

      3) Moreover, we constructed phosphorylation-defective mutants of p65 (S536A), and found that Vangl2 could also promote the degradation of the p65 phosphorylation mutants (Fig. S4 A, B in the revised manuscript). Thus, Vangl2 promote the degradation of the basal/unphosphorylated p65. (Page 8, lines 237-240)

      (2) Fig 1A: The data indicates the presence of two subgroups within the sepsis cohort - one with high Vangl2 expressions and the other with relatively normal Vangl2 expression. Was there any difference with respect to NF-κB target inflammatory gene expressions between these subgroups?

      As suggested, we conducted an analysis of NF-kB target inflammatory gene expressions between the high and relatively low Vangl2 expression groups in sepsis patients. The results showed that the serum of the high Vangl2 expression group exhibited lower levels of IL-6, WBC, and CRP than the low Vangl2 expression group, which suggested an inverse correlation between Vangl2 and the inflammatory response (Fig. S1 A in the revised manuscript) (Page 5, lines 126-128).

      (3) The effect of Vangl2 deficiency was rather modest in the neutrophil. Could it be that Vangl2 mediates its effect mostly in macrophages?

      As showed in Fig. S1C-E, the induction of Vangl2 by LPS stimulation is more rapid in macrophages than in neutrophils. This may contribute to its dominant effect in macrophages. Consequently, we primarily focused our investigation on the role of Vangl2 in macrophages.

      (4) Fig 1D and Figure 1E: Data for unstimulated Vangl2 cells should be provided. Also, the source of the IL-1β primary antibody has not been mentioned.

      Thank you for the suggestion. We have updated the data for unstimulated cells in the revised manuscript (Fig. 1 D, E in the revised manuscript). Also, IL-1β primary antibody was purchased from Cell Signaling Technology and the information has been included in the Materials and Methods section (Table S1).

      (5) The relevance and the requirement of RNA-seq analysis are not clear in the present draft. Figure 1E already reveals upregulation of the signature NF-κB target inflammatory genes upon Vangl2 deficiency.

      We agreed with the reviewer that the data presented in Figure 1E demonstrated the upregulation of the signature NF-kB target inflammatory genes upon Vangl2 deficiency in a murine model of LPS induced sepsis. Subsequently, we proceeded to investigate the mechanism by which Vangl2 regulates NF-kB target inflammatory genes at the cellular level in Figure 2. To this end, we performed RNA-seq analysis to screen signal pathways involved in LPS-induced septic shock by comparing LPS-stimulated BMDMs from Vangl2ΔM and WT mice, and identified that TNF signaling pathway and cytokine-cytokine receptor interaction were found to be significantly enriched in Vangl2ΔM BMDMs upon LPS stimulation. This analysis provides further evidence that Vangl2 plays a role in regulating NF-kB signaling pathways and the release of related inflammatory cytokines.

      (6) Fig 2A reveals an increased accumulation of phosphorylated p65 and IKK in Vangl2-deficient macrophages upon LPS stimulation within 30 minutes. However, Vangl2 accumulates at around 60 minutes post-stimulation in WT cells. Similar results were obtained for neutrophils (Fig 2B). There appears to be a temporal disconnect between Vangl2 and phosphorylated p65 accumulation - this must be clarified.

      This concern has been addressed above (see response to questions 1 from reviewer #2). 

      (7) Figure 2E and 2F do not have untreated controls. Presentations in Fig 2E may be improved to more clearly depict IL6 and TNF data, preferably with separate Y-axes.

      Thank you for the suggestion. We have added untreated controls and separated Y-axes for IL-6 and TNF data in the revised manuscript (Fig. 2 E, F in the revised manuscript).

      (8) Line 219: "strongly with IKKα, p65 and MyD88, and weak" - should be revised.

      We have improved the manuscript as suggested in the revised manuscript (Page 7; Line 203).

      (9) It is not clear why IKKβ was excluded from interaction studies in Fig S3G.

      We added the Co-IP experiment and showed that HA-tagged Vangl2 only interacted with Flag-tagged p65, but not with Flag-tagged IKKb in 293T cells (Fig S3H). Furthermore, endogenous co-IP immunoblot analyses showed that Vangl2 did not associate with IKKb (Fig. S3I)

      (10) Fig 3F- In the text, authors mentioned that Vangl2 strongly associates with p65 upon LPS stimulation in BMDM. However, no controls, including input or another p65-interacting protein, were used.

      As reviewer suggested, we have added input and positive control (IkBa) in this experiment (Fig. 3F in the revised manuscript). The results demonstrated that the interaction between p65 and IkBa was attenuated, although the total IkBa did not undergo significant degradation over long-term course of LPS stimulation.

      (11) Figure 4D - Authors claim that Vangl2-deficient BMDMs stabilized the expression of endogenous p65 after LPS treatment. However, p65 levels were particularly constitutively elevated in knockout cells, and LPS signaling did not cause any further upregulation. This again indicates the role of Vangl2 in the basal state. The authors need to explain this and revise the test accordingly.

      Thank you for the reviewer's comments. We repeated the experiment to ascertain whether Vangl2 could stabilize the expression of endogenous p65 before and after LPS treatment. It was found that, due to the extremely low expression of Vangl2 in WT cells in the absence of stimulation, there was no observable difference on the basal level of p65 between WT and Vangl2DM cells. However, upon prolonged LPS stimulation, Vangl2 expression was induced, resulting in p65 degradation in WT cells. In contrast, p65 protein was more stable in Vangl2 deficient cells after LPS stimulation (Fig. 4D in the revised manuscript).

      Reviewer #3 (Public Review):

      Lu et al. describe Vangl2 as a negative regulator of inflammation in myeloid cells. The primary mechanism appears to be through binding p65 and promoting its degradation, albeit in an unusual autolysosome/autophagy dependent manner. Overall, the findings are novel and the crosstalk of PCP pathway protein Vangl2 with NF-kappaB is of interest. …….Regardless, Vangl2 as a negative regulator of NF-kappaB is an important finding. There are, however, some concerns about methodology and statistics that need to be addressed.

      Thank you for your comments on our manuscript, and we have further improved the manuscript as suggested.

      (1) Whether PCP is anyway relevant or if this is a PCP-independent function of Vangl2 is not directly explored (the later appears more likely from the manuscript/discussion). PCP pathways intersect often with developmentally important pathways such as WNT, HH/GLI, Fat-Dachsous and even mechanical tension. It might be of importance to investigate whether Vangl2-dependent NF-kappaB is influenced by developmental pathways.

      Thank you for the reviewer's insightful comments. Our study revealed that Vangl2 recruits the E3 ubiquitin ligase PDLIM2 to facilitate K63-linked ubiquitination of p65, which is subsequently recognized by autophagy receptor NDP52 and then promotes the autophagic degradation of p65. Our findings by using autophagy inhibitors and autophagic-deficient cells indicate that Vangl2 regulates NF-kB signaling through a selective autophagic pathway, rather than affecting the PCP pathway, WNT, HH/GLI, Fat-Dachsous or even mechanical tension. Moreover, a discussion section has been added to the revised version. (Page 12, lines 377-393)

      (2) Are Vangl2 phosphorylations (S5, S82 and S84) in anyway necessary for the observed effects on NF-kappaB or would a phospho-mutant (alanine substitution mutant) Vangl2 phenocopy WT Vangl2 for regulation of NF-kappaB?

      As suggested, we generated phospho-mutants of Vangl2 (S82/84A) and observed that Vangl2 (S82/84A) could still facilitate the degradation of p65 (Fig. S4 B in the revised manuscript), suggesting that Vangl2 regulates the NF-kB pathway independently of its phosphorylation.

      (3) Another area to strengthen might be with regards to specificity of cell types where this phenomenon may be observed. LPS treatment in mice resulted in Vangl2 upregulation in spleen and lymph nodes, but not in lung and liver. What explains the specificity of organ/cell-type Vangl2 upregulation and its consequences observed here? Why is NF-kappaB signaling not more broadly or even ubiquitously affected in all cell types in a Vangl2-dependent manner, rather than being restricted to macrophages, neutrophils and peritoneal macrophages, or, for that matter, in spleen and LN and not liver and lung? After all, one may think that the PCP proteins, as well as NF-kappaB, are ubiquitous.

      Thank you for the reviewer's comments.

      (1) LPS is an important mediator to trigger sepsis with excessive immune activation. As is well known, the spleen and lymph nodes are important peripheral immune organs, where immune cells (e.g., macrophages) are abundant and respond sensitively to LPS stimulation. Nevertheless, immune cells represent a minor fraction of the lungs and liver. Consequently, Vangl2 represents a pivotal regulator of immune function, exhibiting a more pronounced increase in the immune organs and cells.

      2) Induction of Vangl2 expression by LPS stimulation is cell specific. Given that different cells exhibit varying protein abundances, the molecular events involved may also differ. Moreover, we observed high Vangl2 expression in the liver at the basal state (Author response image 1), whereas it was not induced after 12 h of LPS stimulation. Therefore, the functional role of Vangl2 exhibits significant phenotype in macrophages and neutrophils/spleen and LN, rather than in liver or lung cells.

      Author response image 1.

      Vangl2 showed no significant changes in the liver after LPS treatment. Mice (n≥3) were treated with LPS (30 mg/kg, i.p.). Livers were collected at 12 h after LPS treatment. Immunoblot analysis of Vangl2.

      Recommendations For The Authors:

      Reviewer #1 (Recommendations For The Authors):

      General points:

      Figure 4G- panels appear mislabeled. Pl correct.

      We have corrected this mislabeling as you suggested.

      The dynamics of Vangl2 interaction with p65 and autophagy adaptors is not clear/apparent. For example, Vangl2 expression destabilises p65 levels (as in Fig. 4), but in Fig. 5, it seems there is no decline in the p65 protein level, and a large fraction of it coprecipitates with NDP52.

      We appreciate the reviewer’s comments. In the co-IP assay, we used the lysosomal inhibitor CQ to inhibit p65 degradation to observe the interaction between p65 and NDP52 or Vangl2.

      Fig 5E- I would expect p65 levels to be lower in WT cells than Vangl2 KO cells. But as such, there is no difference between the two.

      We appreciate the reviewer’s comments. We repeated the experiments and updated the data. Firstly, Vangl2 was not induced in WT cells in the absence of LPS stimulation, thus there was no difference in p65 expression between the two groups at the basal level. Secondly, we used CQ/Baf-A1 to inhibit the degradation of Vangl2 in the co-IP assay to observe the interaction between p65 and other molecule.

      Reviewer #2 (Recommendations For The Authors):

      A few points that can be looked at and revised.

      (1) Quantification of the presented data is needed for Fig 4D and Fig 4E.

      We added the quantification analysis as suggested.  

      (2) The labeling of Fig 4G should be scrutinized.

      We have corrected this mislabeling as you suggested.

      (3) Fig 6B and Fig 6C should be explained in the result section more elaborately.

      We thank the reviewer for the suggestion, and we have rephrased this sentence to better describe the results. (Page 10, lines 306-313)

      (4) Line 85: "Vangl2 mediated downstream of Toll-like or interleukin (IL)-1" - unclear.

      We appreciate the reviewer’s comments on our manuscript, and we have further improved the manuscript as suggested in the revised manuscript. (Page 3, lines 68)

      (5) Line 181: "mice. Differentially expression analysis" - this should be revised.

      We appreciate the reviewer’s comments on our manuscript, and we have further improved the manuscript as suggested in the revised manuscript. (Page 11, lines 323)

      (6) Line 261-264- CHX-chase assay showed the degradation rate of p65 in Vangl2-deficient BMDM was slower compared with WT cells. However, Vangl2 is not induced in WT BMDMs upon CHX treatment (Fig. S4B).

      We appreciate the reviewer’s comments on our manuscript, and we have further improved the manuscript as suggested in the revised manuscript (Fig. S4D).

      (7) Finally, some editing to provide data only critical for the conclusions could improve the ease of reading.

      We have further improved the manuscript as suggested in the revised manuscript.

      Reviewer #3 (Recommendations For The Authors):

      Comments (general, please address at least in Discussion. Some experimental data, for example the role, if any, of Vangl2 phosphorylations will be very useful):

      (1) It might be interesting to explore whether there are any potential effects of developmental pathways on the observed effect mediated by Vangl2 or if the effects are entirely a PCP-independent function of Vangl2. Please see above public review.

      Thank you for the reviewer's insightful comments. Our study revealed that Vangl2 recruits the E3 ubiquitin ligase PDLIM2 to facilitate K63-linked ubiquitination of p65, which is subsequently recognized by autophagy receptor NDP52 and then promotes the autophagic degradation of p65. Our findings by using autophagy inhibitors and autophagic-deficient cells indicate that Vangl2 regulates NF-kB signaling through a selective autophagic pathway, rather than affecting the PCP pathway, WNT, HH/GLI, Fat-Dachsous or even mechanical tension. Furthermore, we generated phospho-mutants of Vangl2 (S82/84A) and observed that Vangl2 (S82/84A) could still facilitate the degradation of p65 (Fig. S4 B), suggesting that Vangl2 regulates the NF-kB pathway independently of its phosphorylation. In addition, a discussion section has been added to the revised version. (Page 12, lines 377-393)

      (2) What explains the specificity of organ/cell-type Vangl2 upregulation and its consequences observed here? Why is NF-kappaB signaling not more broadly or even ubiquitously affected in all cell types in a Vangl2-dependent manner, rather than being restricted to macrophages, neutrophils and peritoneal macrophages, or, for that matter, in spleen and LN and not liver and lung? Afterall, one may think that the PCP proteins, as well as NF-kappaB, are ubiquitous.

      Thank you for the reviewer's comments. A similar question has been addressed above (refer to the response to question 3 of reviewer 3).

      (3) Another specificity-related question that comes to mind is whether the Vangl2 function in autolysomal/autophagic degradation is restricted to p65 as the exclusive substrate? The cytosolic targeting of p65 as opposed to the more well-known nuclear-targeting is interesting.

      Our previous finding demonstrated that Vangl2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation (doi: 10.1126/sciadv.adg2339), thereby indicating that p65 is not the sole substrate for Vangl2. However, in the NF-kB pathway, p65 is a specific substrate for Vangl2. Moreover, our findings indicate that the interaction between Vangl2 and p65 occurs predominantly in the cytoplasm, rather than in the nucleus (Fig. S4 C).

      (4) Pharmacological approach is used to tease apart autolysosome versus proteasome pathway. What is the physiological importance of autophagic degradation? It is interesting to note that Vangl2 was already previously implicated in degrading LAMP-2A and increasing chaperon-mediated autophagy (CMA)-lysosome numbers (PMID: 34214490).

      Previous literature has domonstrated that Vangl2 can inhibit CMA degradation (PMID: 34214490). However, in our study, we found that Vangl2 can promote the selective autophagic degradation of p65. It is important to note that CMA degradation and selective autophagic degradation are two distinct degradation modes, which is not contradictory.

      (5) Are these phenotypes discernable in heterozygotes or only when ablated in homozygosity? Any phenotypes recapitulated in the looptail heterozygote mice?

      We found that these phenotypes discernable only in homozygosity.

      (6) What is the conservation of the Vangl2 p65-interaction site between Vangl2 and Vangl1? PDLIM2 recruitment between Vangl2 and Vangl1?

      We appreciate the reviewer’s comments on our manuscript. Previous studies have shown that human Vangl1 and Vangl2 exhibit only 72% identity and exhibit distinct functional properties (doi: 10.1530/ERC-14-0141).Thus, the interaction of Vangl2 with p65 and PDLIM2 recruitment may not necessarily occur in Vangl1.

      Comments (specific to experiments and data analyses. Please address the following):

      (7) The patient population used in Fig 1 is not described in the Methods. This is a critical omission. Were age, sex etc. controlled for between healthy and disease? How was the diagnosis made? What times during sepsis were the samples collected? As presented, this data is impossible to evaluate and interpret.

      We appreciate the reviewer’s comments on our manuscript, and we have further improved the manuscript as suggested in the revised supplement materials. (Supplementary information, Page 12, lines 146-147)

      (8) In general, the statistical method should be described for each experiment presented in the figures. Comparisons should not be made only at the time point with maximal difference (such as in Fig 1F or Fig 2C, but at all time points using appropriate statistical methods). The sample size should also be included to allow determination appropriateness of parametric or non-parametric tests.

      We appreciate the reviewer’s comments on our manuscript, and we have further improved the manuscript as suggested in the revised manuscript (Figures 1F and 2C).

      (9) PCP pathways can activate p62/SQSTM1 or JNK via RhoA. JNK activation should be tested experimentally.

      According to the reviewer's comments, we further examined the effect of Vangl2 on the JNK pathway. The results showed that Vangl2 did not affect the JNK pathway (Author response image 2). This suggests that Vangl2 functions independently of the PCP pathway.

      Author response image 2.

      Vangl2 did not affect the JNK pathway. WT and Vangl2-deficient (n≥3) BMDMs were stimulated with LPS (100 ng/ml) for the indicated times. Immunoblot analysis of total and phosphorylated JNK.

      (10) Why are different cells such as A549, HEK293, CHO, 293T, THP-1 used during the studies for different experiments? Consistency would improve rigor. At least, logical explanation driving the cell type of choice for each experiment should be included in the manuscript. Nonetheless, one aspect of using a panel of cell lines indicate that the effect of Vangl2 on NF-kappa B is pleiotropic.

      We are grateful to the reviewer for their comments on our manuscript. A549, HEK293, CHO, and 293T cells are commonly utilized in protein-protein interaction studies. The selection of cell lines for overexpression (exogenous) experiment is dependent on their transfection efficiency and the ability to express TLR4 (the receptor for LPS). Additionally, we conducted endogenous experiments by using THP-1 and BMDMs, which are human macrophage cell lines and murine primary macrophages, respectively. Moreover, we generated Vangl2f/f lyz-cre mice by specifically knocking out Vangl2 in myeloid cells, and investigated the effect of Vangl2 on NF-kB signaling in vivo.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The manuscript describes the crystal structures of Streptococcus pneumoniae NOXs. Crystals were obtained for the wild-type and mutant dehydrogenase domain, as well as for the full-length protein comprising the membrane domain. The manuscript further carefully studies the enzyme's kinetics and substrate-specificity properties. Streptococcus pneumoniae NOX is a non-regulated enzyme, and therefore, its structure should provide a view of the NOX active conformation. The structural and biochemical data are discussed on this ground.

      Strengths:

      This is very solid work. The protein chemistry and biochemical analysis are well executed and carefully described. Similarly, the crystallography must be appreciated given the difficulty of obtaining good enzyme preparations and the flexibility of the protein. Even if solved at medium resolution, the crystal structure of the full-length protein conveys relevant information. The manuscript nicely shows that the domain rotations are unlikely to be the main mechanistic element of NOX regulation. It rather appears that the NADPH-binding conformation is pivotal to enzyme activation. The paper extensively refers to the previous literature and analyses the structures comprehensively with a comparison to previously reported structures of eukaryotic and prokaryotic NOXs.

      We thank the referee for these very nice comments about our work.

      Weaknesses:

      The manuscript is not always very clear with regard to the analysis of NADPH binding. The last section describes a "crevice" featured by the NADPH-binding sites in NOXs. It remains unclear whether this element corresponds to the different conformations of the protein C-terminal residues or more extensive structural differences. This point must be clarified.

      We agree with the referee that our terminology was not very clear. Responding to your comment helped us to improve our explanation: we have changed the text to emphasize the differences we observe in the distances between the FAD binding groove and the entire NADPH binding groove, which includes conserved NADPH-contacting motifs as well as the critical aromatic.

      A second less convincing point concerns the nature of the electron acceptor. The manuscript states that this NOX might not physiologically act as a ROS producer. A question then immediately arises: Is this protein an iron reductase?

      Can the authors better discuss or provide more data about this point?

      The referee has a legitimate point, which was also our first idea. In the initial work on SpNOX, where we discovered bacterial NOX enzymes (see Hajjar et al 2017 in mBio), we evaluated its possible role as an iron reductase. There we showed that SpNOX can reduce CytC directly; however, while some reduction of Fe3+-NTA complex (used classically in ferric reductase activity assay) occurred, this reduction was inhibitable by SOD and occurred indirectly by the superoxide produced, so therefore not a true iron reductase activity. This represents a mixed situation of direct and indirect reduction of an iron-containing acceptor that appears to preclude physiological iron reductase activity since it appears that the protein component of CytC allows it to interact with SpNOX. As these questions had been already addressed in a previous paper, we did not add anything here and we prefer to underline this possibility of another acceptor and to leave this question open for future works.

      Reviewer #2 (Public Review):

      The authors describe the structure of the S. pneumoniae Nox protein (SpNOX). This is a first. The relevance of it to the structure and function of eukaryotic Noxes is discussed in depth.

      Strengths and Weaknesses

      One of the strengths of this work is the effort put into preparing a pure and functionally active SpNOX preparation. The protein was expressed in E. coli and the purification and optimization of its thermostability and activity are described in detail, involving salt concentration, glycerol concentration, and pH.

      This reviewer was surprised by the fact that the purification protocol in the eLife paper differs from those in the mBio and Biophys. J. papers by the absence of the detergent lauryl maltose neopentyl glycol (LMNG). LMNG is only present in the activity assay at a low concentration (0.003%; molar data should be given; by my calculation, this corresponds to 30 μM).

      We regret this misunderstanding: our description was not clear enough. As the referee points out, in previous papers we purified the full length SpNOX with the detergent LMNG. In the current paper, we described only the protocol for SpNOX DH domain variant, a soluble cytoplasmic domain. We have now modified the text to clarify the difference between the purification of fulllength SpNOX variants, which were performed with detergent as cited in Vermot et al 2020, and the purification of DH domains, which are soluble and thus did not require detergent in the purification.

      In light of the presence of lipids in cryo-EM-solved structures of DUOX and NOX2, it is surprising that the authors did not use reconstitution of the purified SpNOX in phospholipid (nanodisk?). The issue is made more complicated by the statement on p. 18 of "structures solved in detergent like ours" when no use of detergent in the solubilization and purification of SpNOX is mentioned in the Methods section (p. 21-22).

      As stated above, detergent used to purify the full-length version of SpNOX. We did in fact perform some preliminary tests of reconstitution in nanodiscs. Different trials of negative staining studies showed heterogeneous size of SpNOX in nanodiscs and the initial images were not promising. Furthermore, in parallel, we had positive results in crystallography relatively quickly with protein in detergent. We thus focused on refining the crystals, which was a fairly long and mobilizing task; we decided to allocate time and resources to the promising avenue and did not further pursue nanodiscs.

      We did not go in theCryo-EM direction because the small size of the protein was initially believed to be a significant barrier to successful Cryo-EM. Perhaps we could have pursued this avenue: while our manuscript here was submitted to eLife, another group deposited a preprint in BioRxiv using CryoEM to solve the structure of SpNOX (see comment below). This structure was solved in detergent so even in this CryEM structure there is no information on the potential roles of lipids as asked by the referee.

      In this revised version, we have added a comment, in the last paragraph, in reference to the additional data available today thanks to the other structures generated by this other group (Murphy's group).

      Can the authors provide information on whether E. coli BL21 is sufficiently equipped for the heme synthesis required for the expression of the TM domain of SpNOX. Was supplementation with δaminolevulinic acid used

      The production of His-SpNox in E.coli C41(DE3) is without any δ-aminolevulinic acid supplementation. Supplementation was tested but no change was observed regarding the heme content (UV/Visible spectra) so we settled on the purification described by Vermot et al 2020. Initially, for the mBio paper (Haajar et al 2017), we performed heme titrations which gave stoichiometry between 1.35 to 1.5 heme/protein, indicating 2 hemes (these data were not shown). In the end in this work we observed two hemes in the crystal structure, thus confirming that E.coli, at least for this protein, did not need supplementation with δ-aminolevulinic acid .

      The 3 papers on SpNOX present more than convincing evidence that SpNOX is a legitimate Nox that can serve as a legitimate model for eukaryotic Noxes (cyanide resistance, inhibition by DPI, absolute FAD dependence, and NADPH/NADH as the donor or electrons to FAD). It is also understood that the physiological role of SpNOX in S. pneumoniae is unknown and that the fact that it can reduce molecular oxygen may be an experimental situation that does not occur in vivo.

      I am, however, linguistically confused by the statement that "SpNOX requires "supplemental" FAD". Noxes have FAD bound non-covalently and this is the reason that, starting from the key finding of Babior on NOX2 back in 1977 to the present, FAD has to be added to in vitro systems to compensate for the loss of FAD in the course of the purification of the enzyme from natural sources or expression in a bacterial host. I wonder whether this makes FAD more of a cosubstrate than a prosthetic group unless what the authors intend to state is that SpNOX is not a genuine flavoprotein.

      We believe there is some confusion between SpNOX – the full length transmembran protein -- and SpNOXDH -- the cytosolic domain only. The sentence pinpointed by the referee was in fact “The strict requirement of FAD addition for SpNOXDH activity suggests that the flavin behaves as a cosubstrate”. This statement was about the isolated cytosolic domain that does not contain the TM part of the protein.

      We agree that in WT NOX enzymes (including SpNOX) FAD is held within the enzyme structure and thus can be considered, by definition, as a prosthetic group. This is supported by the nanomolar affinity for FAD of SpNOX. We did not intend to say that NOX and SpNOX are not genuine flavoproteins.

      On the other hand, when isolated, the affinity of DH domain for flavins drops to the µM level. This µM level of affinity does not allow stable maintenance of the flavin in the active site as illustrated by the spectra of Figure 3. This is instead the typical affinity of a substrate or a co-substrate (similar to that of substrate NADPH) that can be exchangeable and diffuse in and out of the active site. The DH domain recognizes and reduces flavins but, as a consequence of its lower affinity, will release to its environment free reduced flavins. Thus the isolated DH behaves as a flavin reductase that uses flavin as substrate. Such enzymes have already been well described (and some of them are of the FNR family). Such enzymes, using flavin as substrate, typically have affinity for flavin in the µM range and share with the SpNOX DH binding properties centered on the isoalloxazine ring only.

      We understand that, in the text, to switch from the SpNOX to the SpNOX DH and for FAD from a prosthetic group to a diffusible co-substrate can be confusing. So, to make it clearer, we modified the following sentences and added references to “some flavin reductases characterization” that could provide support for the reader.

      “The strict requirement of FAD addition for SpNOXDH activity and its µM level of affinity suggests that the flavin behaves as a co-substrate rather than a prosthetic group. As an isolated domain, SpNOXDH may work as a flavin reductase enzyme (Gaudu et al, 1994; Fieschi et al 1995; Nivière et al 1996), ..”

      We hope that it will help.

      I am also puzzled by the statement that SpNOX "does not require the addition of Cyt c to sustain superoxide production". Researchers with a Cartesian background should differentiate between cause and effect. Cyt c serves merely as an electron acceptor from superoxide made by SpNOX but superoxide production and NADPH oxidation occur independently of the presence of added Cyt c.

      Thanks to the referee for pointing out this poor wording. We agree and have amended the text to clarify what we originally meant. It is now:

      “SpNOXDH requires supplemental FAD to sustain both superoxide production, which can be observed in the presence of Cyt c (Figure 2A), and NADPH oxidation, which can be observed in the absence of Cyt c (Figure 2B).”

      The ability of the DH domain of SpNOX (SpNOXDH) to produce superoxide is surprising to this reviewer.The result is based on the inhibition of Cyt c reduction by added superoxide dismutase (SOD) by 40%. In all eukaryotic Noxes superoxide is produced by the one-electron reduction of molecular oxygen by electrons originating from the distal heme, having passed from reduced FAD via two hemes. The proposal that superoxide is generated by direct transfer of electrons from FAD to oxygen deserves a more in-depth discussion and relies too heavily on the inhibitory effect of SOD. A control experiment with inactivated SOD should have been done (SOD is notoriously heat resistant and inactivation might require autoclaving).

      The initial reports of a NOX DH-domain-only construct (that of human Nox4) producing superoxide are cited in the text. Moreover, natural flavin reductases are known to produce superoxide due to the release of free reduced flavin in the medium.

      As explain above, FAD in full length SpNox is a relay for the electrons from NADPH to heme and is internal to the protein and thus devoted to this specific task.

      In the case of SpNOX DH, its flavin reductase behavior leads to the release in the medium of free reduced flavin as a nonspecific diffusible electron carrier. It has been already demonstrated that such free reduced flavin can efficiently reduce soluble O2 and be a source of superoxide.

      This has been particularly well documented in (Gaudu et al, 1994. J.Biol.Chem). We have added this reference to the text (see the modified sentence in a reply, 2 comments above).

      Furthermore, we want to point to the referee that the link between flavin and superoxide production here is not only based on the inhibition by SOD. When we added the flavin inhibitor DPI we observed no more superoxide production from the DH domain (Figure 2C). This supports the role of free-reduced flavin in both the production of superoxide and also part of direct cyt C reduction as observed.

      An unasked and unanswered question is that, since under aerobic conditions, both direct Cyt c reduction (60%) and superoxide production (40%) occur, what are the electron paths responsible for the two phenomena occurring simultaneously?

      We thank the referee for dedication to a clear understanding of the mechanism used by the SpNOXDH construct. It pushes us to develop a clear description of the mechanism at work here for the readers. Please find below a proposal mechanism describing the electron transfer from NAD(P)H to free flavin that can, as diffusible species, then reduce non-specifically either the O2 or the Cyt.C encountered.

      Author response image 1.

      However, it is important to remember that this is not physiological, and rather the result of using a DH domain isolated from the TM of SpNOX. Nonetheless, it shows that the DH domain is fully functional for NAD(P)H as well as the hydride transfer.

      This reviewer had difficulty in following the argument that the fact that the kcat of SpNOX and SpNOXDH are similar supports the thesis that the rate of enzyme activation is dependent on hydride transfer from nicotinamide to FAD.

      We have amended the text to clarify this point. If the reaction rate is not affected by the presence or absence of the hemes in the TM domain, this inevitably implies that the rate is NOT limited by the electron transfer to the heme, and ultimately to O2, from the FAD, and thus the hydride transfer step that oxidizes the FAD must be the rate limiting step.

      The section dealing with mutating F397 is a key part of the paper. There is a proper reference to the work of the Karplus group on plant FNRs (Deng et al). However, later work, addressing comparison with NOX2, should be cited (Kean et al., FEBS J., 284, 3302-3319, 2017). Also, work from the Dinauer group on the minimal effect of mutating or deleting the C-terminal F570 in NOX2 on superoxide production should be cited (Zhen et al., J. Biol. Chem. 273, 6575-6581, 1998).

      We thank the reviewer for pointing out our unintended omission of these important works; we have amended the text and added the citations.

      It is not clear why mutating F397 to W (both residues having aromatic side chains) would stabilize FAD binding.

      In a few words, trp’s double ring can establish larger and stronger vanderWaals contact with the isoalloxazine ring than the phe sidechain. Our discussion regarding this point is extensive in the structural section where we compare the structures with F and W in this position. At this time we do not think it is necessary to add anything to the text.

      Also, what is meant by "locking the two subdomains of the DH domain"? What subdomains are meant?

      The two subdomains are the NADPH-binding domain and the FAD-binding domain, which we define on p 11 (“SpNOXDH presents a typical fold of the FNR superfamily of reductase domain containing two sub-domains, the FAD-binding domain (FBD) and an NADPH-binding domain (NBD) “) and which are labeled in Fig. 4. By “locking” we meant to convey immobilizing them into a specific conformation; we have amended the text to clarify this point.

      Methodological details on crystallization (p. 11) should be delegated to the Methodology section. How many readers are aware that SAD means "Single Wavelength Anomalous Diffraction" or know what is the role of sodium bromide?

      We have amended the text to emphasize the intended point, which is the different origins of the two DH structures: the de novo structure was possible through co crystallization with bromide, and the molecular replacement structure used the de novo structure as a model.

      The data on the structure of SpNOX are supportive of a model of Nox activation that is "dissident" relative to the models offered for DUOX and NOX2 activation. These latter models suggested that the movement of the DH domain versus the TM domain was related to conversion from the resting to the activated state. The findings reported in this paper show that, unexpectedly, the domain orientation in SpNOX (constitutively active!) is much closer to that of resting NOX2. One of the criteria associated with the activated state in Noxes was the reduction of the distance between FAD and the proximal heme. The authors report that, paradoxically, this distance is larger in the constitutively active SpNOX (9.2 Å) than that in resting state NOX2 (7.6 Å) and the distance in Ca2+-activated DUOX is even larger (10.2 Å).

      A point made by the authors is the questioning of the paradigm that activation of Noxes requires DH domain motion.

      Instead, the authors introduce the term "tensing", within the DH domain, from a "relaxed" to a more rigid conformation. I believe that this proposal requires a somewhat clearer elaboration

      It is clear that the distance between the FAD and NADPH shown in the Duox and Nox2 structures is too large for the chemical reaction of hydride transfer. Wu et al used the terms ‘tense’ and ‘relaxed’ to describe conformations of the DH domain corresponding to ‘short distance’ and ‘longer distance’, respectively, between the two ligand binding sites. We quoted this terminology and have amended the text to clarify that we envision a motion of the NBD relative to the FBD, as distinct from a larger motion of the whole DH domain relative to the TM domain.

      The statement on p. 18, in connection to the phospholipid environment of Noxes, that the structure of SpNOX was "solved in detergent" is puzzling since the method of SpNOX preparation and purification does not mention the use of a detergent. As mentioned before, this absence of detergent in the present report was surprising because LMNG was used in the methods described in the mBio and Biophys. J. papers. The only mention of LMNG in the present paper was as an addition at a concentration of 0.003% in the activity assay buffers.

      Please see our response to similar points above. Detergent was present for the solubilization of the full-length SpNOX.

      The Conclusions section contains a proposal for the mechanism of conversion of NOX2 from the resting to the activated state. The inclusion of this discussion is welcome but the structural information on the constitutively active SpNOX can, unfortunately, contribute little to solving this important problem. The work of the Lambeth group, back in 1999 (cited as Nisimoto et al.), on the role of p67-phox in regulating hydride transfer from NADPH to FAD in NOX2 may indeed turn out to have been prophetic. However, only solving the structure of the assembled NOX2 complex will provide the much-awaited answer. The heterodimerization of NOX2 with p22-phox, the regulation of NOX2 by four cytosolic components, and the still present uncertainty about whether p67-phox is indeed the final distal component that converts NOX2 to the activated state make this a formidable task.

      The work of the Fieschi group on SpNOX is important and relevant but the absence of external regulation, the absence of p22-phox, and the uncertainty about the target molecule make it a rather questionable model for eukaryotic Noxes. The information on the role of the C-terminal Phe is of special value although its extension to the mechanism of eukaryotic Nox activation proved, so far, to be elusive.

      We really thank the referee for the positive comments on our work and the deep interest shown by this careful evaluation.

      We understand the arguments of the referee regarding the relevance of our work here to eukaryotic NOX, but we do not share the reservations expressed. While human NOXes need interactions with other proteins or have EF-hand or other domains that control them, SpNOX corresponds exactly to the minimal core common to any NOX isoform. In fact, because SpNOX has only this conserved core, it is unique in that it can work as a constitutively active NOX without protein-protein interactions or regulatory domains. Thus the fundamentals of electron transfer mechanisms of NOX enzyme are present in SpNOX.

      There might be some differences in the internal organization from isoform to isoform (as regarding the relative DH domain vs TM domain orientation) but considering the similarity between NOX2 and SpNOX topology we are rather confident that the SpNOX structure will turn out to be a reasonable model of the activated NOX2 structure. History will tell.

      In any case, this work on SpNOX allowed us to highlight hydride transfer as the limiting step and also to highlight some structural differences that could be at the source of the regulation in eukaryotic NOX. In itself, we think this is a significant contribution to the field.

      We warmly thank both referees for their constructive remarks and their help in the improvement of this manuscript.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      • The manuscript states that the flavin "behaves" like a co-substrate and thereby reports on the Km for the flavins. I feel that this terminology might be confusing. The flavin is unchanged after the reaction, and what matters is the enzyme's affinity for the flavin and the flavin concentration needed to saturate the enzyme (to have it in the fully holo form).

      See above -- answering many questions from referee2, we have extensively commented on that point (substrate, cofactor, affinity, etc..) and made some adjustments in the text to clarify. We hope it is now satisfactory.

      • I could not find the methodological description of the experiments performed to measure the Km for the flavins, and the legend of Figure S4 does not help in this regard. I think that the data (left panels of S4) should be interpreted as binding curves with associated Kd values.

      We have changed the text to clarify the method used to measure Km for flavins.

      • A related point is that the manuscript refers to Km as an "affinity". This is inappropriate and should be avoided, as the Km is not the Kd.

      We agree with the referee that the Km is not the Kd. However, under the appropriate conditions, to which our experiments conform, Km is accepted as a relevant approximation of affinity (Srinisivan, FEBS Journal, v 289 pp 6086-6098 2022). We have added a sentence to clarify this point and cite this reference in the text.

      • The environment around the putative oxygen site should be shown. The text indicates that "the residues characteristic of the O2 reducing center in eukaryotic FRD domains of NOX and DUOX enzymes are not conserved in SpNOX." How does the site look? This point relates to the more general comment above on the oxidizing substrate used by this bacterial NOX.

      This is a really interesting point that contains many potential biological developments for future studies of this prokaryotic family of NOX enzymes. While we were submitting this work to eLife for evaluation, another group (Murphy's lab) filed a pre-publication in BioRXiv, in which they also solved the structure of SpNOX but this time by CryoEM with an unexpected level of resolution for such a small protein (their paper is not yet published but probably under peer review somewhere). In their work, they made a special effort to identify the O2 reducing center (bacterial NOX sequences alignment, mutation studies, …) They were not able to localize such a site with accuracy. There is also other complementary data between their work and ours. So, we will add a paragraph at the end of the discussion to comment on this parallel work and to emphasize on the complementarity of their studies and what it brings to the final understanding of this enzyme.

      • The section "A Close-up View of NOX's NAD(P)H Binding Domains vs the FNR Gold Standard" should be clarified.

      I found it difficult to understand. Is the different conformation of Phe397 creating the crevice? Could NADPH be modeled in NOX2 and DUOX in the same conformation observed in FNR and modeled in the bacterial NOX? Or would there be clashes, implying the necessity of larger conformational changes to bring the nicotinamide closer to the FAD?

      Please see responses above on this point; we have amended the text to clarify. In a few words, we propose that activation in the eukaryotic enzymes would entail NBD subdomain (containing NADPH site) towards the FBD subdomain (containing FAD) through an internal motion within the DH domain. Doing so, they would approach the DH domain topology of SpNOX, which models an active state.

      Reviewer #2 (Recommendations For The Authors):

      On p. 6, second line, it should be (Figure 1C and 1D). Space is missing between C and "and".

      On p. 9, in Figure 3, the labeling A and B are missing. Also, the legend of part B does not correspond to the actual graph colors. Thus, the tracing of F397W is red and not grey as indicated in the legend.

      Corrected. Thank you

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review): 

      Summary: 

      In this work, the authors examine the activity and function of D1 and D2 MSNs in dorsomedial striatum (DMS) during an interval timing task. In this task, animals must first nose poke into a cued port on the left or right; if not rewarded after 6 seconds, they must switch to the other port. Critically, this task thus requires animals to estimate if at least 6 seconds have passed after the first nose poke - this is the key aspect of the task focused on here. After verifying that animals reliably estimate the passage of 6 seconds by leaving on average after 9 seconds, the authors examine striatal activity during this interval. They report that D1-MSNs tend to decrease activity, while D2-MSNs increase activity, throughout this interval. They suggest that this activity follows a drift-diffusion model, in which activity increases (or decreases) to a threshold after which a decision (to leave) is made. The authors next report that optogenetically inhibiting D1 or D2 MSNs, or pharmacologically blocking D1 and D2 receptors, increased the average wait time of the animals to 10 seconds on average. This suggests that both D1 and D2 neurons contribute to the estimate of time, with a decrease in their activity corresponding to a decrease in the rate of

      'drift' in their drift-diffusion model. Lastly, the authors examine MSN activity while pharmacologically inhibiting D1 or D2 receptors. The authors observe most recorded MSNs neurons decrease their activity over the interval, with the rate decreasing with D1/D2 receptor inhibition. 

      Major strengths: 

      The study employs a wide range of techniques - including animal behavioral training, electrophysiology, optogenetic manipulation, pharmacological manipulations, and computational modeling. The behavioral task used by the authors is quite interesting and a nice way to probe interval timing in rodents. The question posed by the authors - how striatal activity contributes to interval timing - is of importance to the field and has been the focus of many studies and labs; thus, this paper can meaningfully contribute to that conversation. The data within the paper is presented very clearly, and the authors have done a nice job presenting the data in a transparent manner (e.g., showing individual cells and animals). Overall, the manuscript is relatively easy to read and clear, with sufficient detail given in most places regarding the experimental paradigm or analyses used. 

      We are glad our main points came through to the reviewer.  

      Major weaknesses: 

      I perceive two major weaknesses. The first is the impact or contextualization of their results in terms of the results of the field more broadly. More specifically, it was not clear to me how the authors are interpreting the striatal activity in the context of what others have observed during interval timing tasks. In other words - what was the hypothesis going into this experiment? Does observing increasing/decreasing activity in D2 versus D1 support one model of interval timing over another, or does it further support a more specific idea of how DMS contributes to interval timing? Or was the main question that we didn't know if D2 or D1 neurons had differential activity during interval timing? 

      This is a helpful comment. Our hypothesis is that D1 and D2 MSNs had similar patterns of activity.  Our rationale is prior behavioral work from our group describing that blocking striatal D1 and D2 dopamine receptors had similar behavioral effects on interval timing (De Corte et al., 2019; Stutt et al., 2023), We rewrote our introduction with this idea in mind (Line 89)

      “We and others have found that striatal MSNs encode time across multiple intervals by time-dependent ramping activity or monotonic changes in firing rate across a temporal interval (Emmons et al., 2017; Gouvea et al., 2015; Mello et al., 2015; Wang et al., 2018). However, the respective roles of D2-MSNs and D1-MSNs are unknown. Past work has shown that disrupting either D2-dopamine receptors (D2) or D1-dopamine receptors (D1) powerfully impairs interval timing by increasing estimates of elapsed time (Drew et al., 2007; Meck, 2006). Similar behavioral effects were found with systemic (Stutt et al., 2024) or local dorsomedial striatal D2 or D1 disruption (De Corte et al., 2019a). These data lead to the hypothesis that D2 MSNs and D1 MSNs have similar patterns of ramping activity across a temporal interval. 

      We tested this hypothesis with a combination of optogenetics, neuronal ensemble recording, computational modeling, and behavioral pharmacology. We use a well-described mouse-optimized interval timing task (Balci et al., 2008; Bruce et al., 2021; Larson et al., 2022; Stutt et al., 2024; Tosun et al., 2016; Weber et al., 2023). Strikingly, optogenetic tagging of D2-MSNs and D1-MSNs revealed distinct neuronal dynamics, with D2-MSNs tending to increase firing over an interval and D1-MSNs tending to decrease firing over the same interval, similar to opposing movement dynamics (Cruz et al., 2022; Kravitz et al., 2010; Tecuapetla et al., 2016). MSN dynamics helped construct and constrain a four-parameter drift-diffusion computational model of interval timing, which predicted that disrupting either D2MSNs or D1-MSNs would increase interval timing response times. Accordingly, we found that optogenetic inhibition of either D2-MSNs or D1-MSNs increased interval timing response times. Furthermore, pharmacological blockade of either D2- or D1receptors also increased response times and degraded trial-by-trial temporal decoding from MSN ensembles. Thus, D2-MSNs and D1-MSNs have opposing temporal dynamics yet disrupting either MSN type produced similar effects on behavior. These data demonstrate how striatal pathways play complementary roles in elementary cognitive operations and are highly relevant for understanding the pathophysiology of human diseases and therapies targeting the striatum.”

      In the second, I felt that some of the conclusions suggested by the authors don't seem entirely supported by the data they present, or the data presented suggests a slightly more complicated story. Below I provide additional detail on some of these instances. 

      Regarding the results presented in Figures 2 and 3: 

      I am not sure the PC analysis adds much to the interpretation, and potentially unnecessarily complicates things. In particular, running PCA on a matrix of noisy data that is smoothed with a Gaussian will often return PCs similar to what is observed by the authors, with the first PC being a line up/down, the 2nd PC being a parabola that is up/down, etc. Thus, I'm not sure that there is much to be interpreted by the specific shape of the PCs here. 

      We are glad the reviewer raised this point. First, regarding the components in noisy data, what the reviewer says is correct, but usually, the variance explained by PC1 is small. This is the reason we include scree plots in our PC analysis (Fig 3B and Fig 6G). When we compare our PC1s to variance explained in random data, our PC1 variance is always stronger. We have now included this in our manuscript:

      First, we generated random data and examined how much variance PC1 might generate. 

      We added this to the methods (Line 634)

      “The variance of PC1 was empirically compared against data generated from 1000 iterations of data from random timestamps with identical bins and kernel density estimates. Average plots were shown with Gaussian smoothing for plotting purposes only.”

      These data suggested that our PC1 was stronger than that observed in random data (Line 183):

      “PCA identified time-dependent ramping activity as PC1 (Fig 3A), a key temporal signal that explained 54% of variance among tagged MSNs (Fig 3B; variance for PC1 p = 0.009 vs 46 (44-49)% variance for PC1 derived from random data; Narayanan, 2016).”

      And in the pharmacology data (Line 367):

      “The first component (PC1), which explained 54% of neuronal variance, exhibited “time-dependent ramping”, or monotonic changes over the 6 second interval immediately after trial start (Fig 6F-G; variance for PC1 p = 0.001 vs 46 (45-47)% variance in random data; Narayanan, 2016).”

      Second, we note that we have used this analysis extensively in the past, and PC1 has always been identified as a linear ramping in our work and in work by others (Line 179):

      “Work by our group and others has uniformly identified PC1 as a linear component among corticostriatal neuronal ensembles during interval timing (Bruce et al., 2021; Emmons et al., 2020, 2019, 2017; Kim et al., 2017a; Narayanan et al., 2013; Narayanan and Laubach, 2009; Parker et al., 2014; Wang et al., 2018).”

      Third, we find that PC1 is highly correlated to the GLM slope (Line 205):

      “Trial-by-trial GLM slope was correlated with PC1 scores in Fig 3A-C (PC1 scores vs. GLM slope r = -0.60, p = 10-8).”

      Fourth, our goal was not to heavily interpret PC1 – but to compare D1 vs. D2 MSNs, or compare population responses to D2/D1 pharmacology. We have now made this clear in introducing PCA analyses in the results (Line 177):

      “To quantify differences in D2-MSNs vs D1-MSNs, we turned to principal component analysis (PCA), a data-driven tool to capture the diversity of neuronal activity (Kim et al., 2017a).”

      Finally, despite these arguments the reviewer’s point is well taken. Accordingly, we have removed all analyses of PC2 from the manuscript which may have been overly interpretative. 

      We have now removed language that interpreted the components, and we now find the discussion of PC1 much more data-driven. We have also removed much of the advanced PC analysis in Figure S9. Given our extensive past work using this exact analysis of PC1, we think PCA adds a considerable amount to our manuscript justified as the reviewer suggested. 

      I think an alternative analysis that might be both easier and more informative is to compute the slope of the activity of each neuron across the 6 seconds. This would allow the authors to quantify how many neurons increase or decrease their activity much like what is shown in Figure 2.  

      We agree – we now do exactly this analysis in Figure 3D. We now clarify this in detail, using the reviewer’s language to the methods (Line 648):

      “To measure time-related ramping over the first 6 seconds of the interval, we used trial-by-trial generalized linear models (GLMs) at the individual neuron level in which the response variable was firing rate and the predictor variable was time in the interval or nosepoke rate (Shimazaki and Shinomoto, 2007). For each neuron, it’s time-related “ramping” slope was derived from the GLM fit of firing rate vs time in the interval, for all trials per neuron. All GLMs were run at a trial-by-trial level to avoid effects of trial averaging (Latimer et al., 2015) as in our past work (Bruce et al., 2021; Emmons et al., 2017; Kim et al., 2017b).”

      And to the results (Line 194):

      “To interrogate these dynamics at a trial-by-trial level, we calculated the linear slope of D2-MSN and D1-MSN activity over the first 6 seconds of each trial using generalized linear modeling (GLM) of effects of time in the interval vs trial-by-trial firing rate (Latimer et al., 2015).”

      Relatedly, it seems that the data shown in Figure 2D *doesn't* support the authors' main claim regarding D2/D1 MSNs increasing/decreasing their activity, as the trial-by-trial slope is near 0 for both cell types. 

      This likely refers to Figure 3D. The reviewer is correct that the changes in slope are small and near 0. Our goal was to show that D2-MSN and D1-MSN slopes were distinct – rather than increasing and decreasing. We have added this to the abstract (Line 46)

      “We found that D2-MSNs and D1-MSNs exhibited distinct dynamics over temporal intervals as quantified by principal component analyses and trial-by-trial generalized linear models.”

      We have clarified this idea in our hypothesis (Line 96):

      “These data led to the hypothesis that D2 MSNs and D1 MSNs have similar patterns of ramping activity across a temporal interval.”

      We have added this idea to the results (Line 194)

      “To interrogate these dynamics at a trial-by-trial level, we calculated the linear slope of D2-MSN and D1-MSN activity over the first 6 seconds of each trial using generalized linear modeling (GLM) of effects of time in the interval vs trial-by-trial firing rate (Latimer et al., 2015). Nosepokes were included as a regressor for movement. GLM analysis also demonstrated that D2-MSNs had significantly different slopes (-0.01 spikes/second (-0.10 – 0.10)), which were distinct from D1MSNs (-0.20 (-0.47– -0.06; Fig 3D; F = 8.9, p = 0.004 accounting for variance between mice (Fig S3B); Cohen’s d = 0.8; power = 0.98; no reliable effect of sex (F = 0.02, p = 0.88) or switching direction (F = 1.72, p = 0.19)). We found that D2-MSNs and D1-MSNs had significantly different slopes even when excluding outliers (4 outliers excluded outside of 95% confidence intervals; F = 7.51, p = 0.008 accounting for variance between mice) and when the interval was defined as the time between trial start and the switch response on a trial-by-trial basis for each neuron (F = 4.3, p = 0.04 accounting for variance between mice). Trial-by-trial GLM slope was correlated with PC1 scores in Fig 3A-C (PC1 scores vs. GLM slope r = -0.60, p = 108). These data demonstrate that D2-MSNs and D1-MSNs had distinct slopes of firing rate across the interval and were consistent with analyses of average activity and PC1, which exhibited time-related ramping.”

      And Line 215:

      “In summary, we used optogenetic tagging to record from D2-MSNs and D1-MSNs during interval timing. Analyses of average activity, PC1, and trial-by-trial firingrate slopes over the interval provide convergent evidence that D2-MSNs and D1MSNs had distinct and opposing dynamics during interval timing. These data provide insight into temporal processing by striatal MSNs.”

      And in the discussion (Line 415):

      “We describe how striatal MSNs work together in complementary ways to encode an elementary cognitive process, interval timing. Strikingly, optogenetic tagging showed that D2-MSNs and D1-MSNs had distinct dynamics during interval timing. “

      We have now included a new plot with box plots to make the differences in Figure 3D clear

      Other reviewers requested additional qualitative descriptions of our data, and we have referred to increases / decreases in this context. 

      Regarding the results in Figure 4: 

      The authors suggest that their data is consistent with a drift-diffusion model. However, it is unclear how well the output from the model fits the activity from neurons the authors recorded. Relatedly, it is unclear how the parameters were chosen for the D1/D2 versions of this model. I think that an alternate approach that would answer these questions is to fit the model to each cell, and then examine the best-fit parameters, as well as the ability of the model to predict activity on trials held out from the fitting process. This would provide a more rigorous method to identify the best parameters and would directly quantify how well the model captures the data. 

      We are glad the reviewer raised these points. Our goal was to use neuronal activity to fit behavioral activity, not the reverse. While we understand the reviewer’s point, we note that one behavioral output (switch time) can be encoded by many patterns of neuronal activity; thus, we are not sure we can use the model developed for behavior to fit diverse neuronal activity, or an ensemble of neurons. We have made this clear in the manuscript (Line 251):

      “Our model aimed to fit statistical properties of mouse behavioral responses while incorporating MSN network dynamics. However, the model does not attempt to fit individual neurons’ activity, because our model predicts a single behavioral parameter – switch time – that can be caused by the aggregation of diverse neuronal activity.”

      To attempt to do something close to what the reviewer suggested, we attempted to predict behavior directly from neuronal ensembles.  We have now made this clear in the methods on Line 682):

      “Analysis and modeling of mouse MSN-ensemble recordings. Our preliminary analysis found that, for sufficiently large number of neurons (𝑵 > 𝟏𝟏), each recorded ensemble of MSNs on a trial-by-trial basis could predict when mice would respond. We took the following approach: First, for each MSN, we convolved its trial-by-trial spike train 𝑺𝒑𝒌(𝒕) with a 1-second exponential kernel 𝑲(𝒕) = 𝒘 𝒆-𝒕/𝒘 if 𝒕 > 𝟎 and 𝑲(𝒕) = 𝟎 if 𝒕 ≤ 𝟎 (Zhou et al., 2018; here 𝒘 = 𝟏 𝒔). Therefore, the smoothed, convolved spiking activity of neuron 𝒋 (𝒋 = 𝟏, 𝟐, … 𝑵),

      tracks and accumulates the most recent (one second, in average) firing-rate history of the 𝒋-th MSN, up to moment 𝒕. We hypothesized that the ensemble activity

      (𝒙𝟏(𝒕), 𝒙𝟐(𝒕), … , 𝒙𝑵(𝒕)), weighted with some weights 𝜷𝒋 , could predict the trial switch time 𝒕∗ by considering the sum

      and the sigmoid 

      that approximates the firing rate of an output unit. Here parameter 𝒌   indicates how fast 𝒙(𝒕) crosses the threshold 0.5 coming from below (if 𝒌 > 𝟎) or coming from above (if 𝒌 < 𝟎) and relates the weights 𝜷𝒋 to the unknowns 𝜷H𝒋 \= 𝜷𝒋/𝒌 and 𝜷H𝟎 \= −𝟎. 𝟓/𝒌. Next, we ran a logistic fit for every trial for a given mouse over the spike count predictor matrix 7𝒙𝟏(𝒕), 𝒙𝟐(𝒕), … , 𝒙𝑵(𝒕)9 from the mouse MSN recorded ensemble, and observed value 𝒕∗, estimating the coefficients 𝜷H𝟎 and 𝜷H𝒋, and so, implicitly, the weights 𝜷𝒋. From there, we compute the predicted switch time 𝒕∗𝒑𝒓𝒆𝒅 by condition 𝒙(𝒕) = 𝟎. 𝟓. Accuracy was quantified comparing the predicted accuracy within a 1 second window to switch time on a trial-by-trial basis (Fig S4).

      And in the results (Line 254): 

      We first analyzed trial-based aggregated activity of MSN recordings from each mouse (𝒙𝒋(𝒕)) where 𝒋 = 𝟏, … , 𝑵 neurons. For D2-MSN or D1-MSN ensembles of 𝑵 > 𝟏𝟏, we found linear combinations of their neuronal activities, with some 𝜷𝒋 coefficients,

      that could predict the trial-by-trial switch response times (accuracy > 90%, Fig S4; compared with < 20% accuracy for Poisson-generated spikes of same trial-average firing rate). The predicted switch time 𝒕∗𝒑𝒓𝒆𝒅 was defined by the time when the weighted ensemble activity 𝒙(𝒕) first reached the value 𝒙) = 0.5. Finally, we built DDMs to account for this opposing trend (increasing vs decreasing) of MSN dynamics and for ensemble threshold behavior defining 𝒕∗𝒑𝒓𝒆𝒅; see the resulting model (Equations 1-3) and its simulations (Figure 4A-B).”

      And we have added a new figure, Figure S4, that demonstrates these trial-by-trial predictions of switch response times.  

      Note that we have included predictions from shuffled data similar to what the reviewer suggested based on shuffled data. Predictions are derived from neuronal ensembles on that trial; thus we could not apply a leave-one-out approach to trial-by-trial predictions.

      These models are highly predictive for larger ensembles and poorly predictive for smaller ensembles.  We think this model adds to the manuscript and we are glad the reviewer suggested it. 

      Relatedly, looking at the raw data in Figure 2, it seems that many neurons either fire at the beginning or end of the interval, with more neurons firing at the end, and more firing at the beginning, for D2/D1 neurons respectively. Thus, it's not clear to me whether the drift-diffusion model is a good model of activity. Or, perhaps the model is supposed to be related to the aggregate activity of all D1/D2 neurons? (If so, this should be made more explicit. The comment about fitting the model directly to the data also still stands).  

      Our model was inspired by the aggregate activity.  We have now made this clear in the results (Line 227): 

      “Our data demonstrate that D2-MSNs and D1-MSNs have opposite activity patterns. However, past computational models of interval timing have relied on drift-diffusion dynamics with a positive slope that accumulates evidence over time (Nguyen et al., 2020; Simen et al., 2011). To reconcile how these MSNs might complement to effect temporal control of action, we constructed a four-parameter drift-diffusion model (DDM). Our goal was to construct a DDM inspired by average differences in D2MSNs and D1-MSNs that predicted switch-response time behavior.”

      Further, it's unclear to me how, or why, the authors changed the specific parameters they used to model the optogenetic manipulation. Were these parameters chosen because they fit the manipulation data? This I don't think is in itself an issue, but perhaps should be clearly stated, because otherwise it sounds a bit odd given the parameter changes are so specific. It is also not clear to me why the noise in the diffusion process would be expected to change with increased inhibition. 

      We have clarified that our parameters were chosen to best fit behavior (Line 266):

      “The model’s parameters were chosen to fit the distribution of switch-response times:

      𝑭 = 𝟏, 𝒃 = 𝟎. 𝟓𝟐 (so 𝑻 = 𝟎. 𝟖𝟕), 𝑫 = 𝟎. 𝟏𝟑𝟓, 𝝈 = 𝟎. 𝟎𝟓𝟐 for intact D2-MSNs (Fig 4A, in black); and  𝑭 = 𝟎, 𝒃 = 𝟎. 𝟒𝟖 (so 𝑻 = 𝟎. 𝟏𝟑), 𝑫 = 𝟎. 𝟏𝟒𝟏, 𝝈 = 𝟎. 𝟎𝟓𝟐 for intact D1-MSNs (Fig 4B, in black).”

      Furthermore, we have clarified the approach to noise in the results (Line 247):  

      “The drift, together with noise 𝝃(𝒕) (of zero mean and strength 𝝈), leads to fluctuating accumulation which eventually crosses a threshold 𝑻 (see Equation 3; Fig 4A-B).”

      And Line 279: 

      “The results were obtained by simultaneously decreasing the drift rate D  (equivalent to lengthening the neurons’ integration time constant) and lowering the level of network noise 𝝈: D = 𝟎. 𝟏𝟐𝟗, 𝝈 = 𝟎. 𝟎𝟒𝟑 for D2-MSNs in Fig 4A (in red; changes in noise had to accompany changes in drift rate to preserve switch response time variance); and 𝑫 = 𝟎. 𝟏𝟐𝟐, 𝝈 = 𝟎. 𝟎𝟒𝟑  for D1-MSNs in Fig 4B (in blue). The model predicted that disrupting either D2-MSNs or D1-MSNs would increase switch response times (Fig 4C and Fig 4D) and would shift MSN dynamics.”

      Regarding the results in Figure 6: 

      My comments regarding the interpretation of PCs in Figure 2 apply here as well. In addition, I am not sure that examining PC2 adds much here, given that the authors didn't examine such nonlinear changes earlier in the paper. 

      We agree – we removed PC2 for these reasons. We have also noted that the primary reason for PC1 was to compare results of D2/D1 blockade (Line 362):

      “We noticed differences in MSN activity across the interval with D2 blockade and D1 blockade at the individual MSN level (Fig 6B-D) as well as at the population level (Fig 6E). We used PCA to quantify effects of D2 blockade or D1 blockade (Bruce et al., 2021; Emmons et al., 2017; Kim et al., 2017a). We constructed principal components (PC) from z-scored peri-event time histograms of firing rate from saline, D2 blockade, and D1 blockade sessions for all mice together. The first component (PC1), which explained 54% of neuronal variance, exhibited “timedependent ramping”, or monotonic changes over the 6 second interval immediately after trial start (Fig 6F-G; variance for PC1 p = 0.001 vs 46 (45-47)% variance in random data; Narayanan, 2016).”

      As noted above, PC1 does not explain this level of variance in noisy data.

      We also reworked Figure 6 to make the effects of D2 and D1 blockade more apparent by moving the matched sorting to the main figure: 

      A larger concern though that seems potentially at odds with the authors' interpretation is that there seems to be very little change in the firing pattern after D1 or D2 blockade. I see that in Figure 6F the authors suggest that many cells slope down (and thus, presumably, they are recoding more D1 cells), and that this change in slope is decreased, but this effect is not apparent in Figure 6C, and Figure 6B shows an example of a cell that seems to fire in the opposite direction (increase activity). I think it would help to show some (more) individual examples that demonstrate the summary effect shown by the authors, and perhaps the authors can comment on the robustness (or the variability) of this result. 

      These are important suggestions, we changed our analysis to better capture the variability and main effects in the data, exactly as the reviewer suggested. First, we now included 3 individual raster examples, exactly as the reviewer suggested

      As the reviewer suggested, we wanted to compare variability for *all* MSNs. We sorted the same MSNs across saline, D2 blockade, and D1 blockade sessions. We detailed these sorting details in the methods (Line 618):

      “Single-unit recordings were made using a multi-electrode recording system (Open

      Ephys, Atlanta, GA). After the experiments, Plexon Offline Sorter (Plexon, Dallas, TX), was used to remove artifacts. Principal component analysis (PCA) and waveform shape were used for spike sorting. Single units were defined as those 1) having a consistent waveform shape, 2) being a separable cluster in PCA space, and 3) having a consistent refractory period of at least 2 milliseconds in interspike interval histograms. The same MSNs were sorted across saline, D2 blockade, and D1 blockade sessions by loading all sessions simultaneously in Offline Sorter and sorted using the preceding criteria. MSNs had to have consistent firing in all sessions to be included. Sorting integrity across sessions was quantified by comparing waveform similarity via correlation coefficients between sessions.”

      To confirm that we were able to track neurons across sessions, we quantified waveform similarity (Line 353):

      “We analyzed 99 MSNs in sessions with saline, D2 blockade, and D1 blockade. We matched MSNs across sessions based on waveform and interspike intervals; waveforms were highly similar across sessions (correlation coefficient between matched MSN waveforms: saline vs D2 blockade r = 1.00 (0.99 – 1.00 rank sum vs correlations in unmatched waveforms p = 3x10-44; waveforms; saline vs D1 blockade r = 1.00 (1.00 – 1.00), rank sum vs correlations in unmatched waveforms p = 4x10-50). There were no consistent changes in MSN average firing rate with D2 blockade or D1 blockade (F = 1.1, p = 0.30 accounting for variance between MSNs; saline: 5.2 (3.3 – 8.6) Hz; D2 blockade 5.1 (2.7 – 8.0) Hz; F = 2.2, p = 0.14; D1 blockade 4.9 (2.4 – 7.8) Hz).”

      As noted above, this enabled us to compare activity for the same MSNs across sessions in a new Figure 6 (previously, this analysis had been in Figure S9), and used PCA to quantify this variability.

      By tracking neurons across saline, D2 blockade, and D1 blockade, readers can see all the variability in MSNs. We added these data to the results (Line 362):  

      “We noticed differences in MSN activity across the interval with D2 blockade and D1 blockade at the individual MSN level (Fig 6B-D) as well as at the population level (Fig 6E). We used PCA to quantify effects of D2 blockade or D1 blockade (Bruce et al., 2021; Emmons et al., 2017; Kim et al., 2017a). We constructed principal components (PC) from z-scored peri-event time histograms of firing rate from saline, D2 blockade, and D1 blockade sessions for all mice together. The first component (PC1), which explained 54% of neuronal variance, exhibited “timedependent ramping”, or monotonic changes over the 6 second interval immediately after trial start (Fig 6F-G; variance for PC1 p = 0.001 vs 46 (45-47)% variance in random data; Narayanan, 2016). Interestingly, PC1 scores shifted with D2 blockade (Fig 6F; PC1 scores for D2 blockade: -0.6 (-3.8 – 4.7) vs saline: -2.3 (-4.2 – 3.2), F = 5.1, p = 0.03 accounting for variance between MSNs; no reliable effect of sex (F = 0.2, p = 0.63) or switching direction (F = 2.8, p = 0.10)). PC1 scores also shifted with D1 blockade (Fig 6F; PC1 scores for D1 blockade: -0.0 (-3.9 – 4.5), F = 5.8, p = 0.02 accounting for variance between MSNs; no reliable effect of sex (F = 0.0, p = 0.93) or switching direction (F = 0.9, p = 0.34)). There were no reliable differences in PC1 scores between D2 and D1 blockade. Furthermore, PC1 was distinct even when sessions were sorted independently and assumed to be fully statistically independent (Figure S10; D2 blockade vs saline: F = 5.8, p = 0.02; D1 blockade vs saline: F = 4.9, p = 0.03; all analyses accounting for variance between mice). Higher components explained less variance and were not reliably different between saline and D2 blockade or D1 blockade. Taken together, this data-driven analysis shows that D2 and D1 blockade produced similar shifts in MSN population dynamics represented by PC1. When combined with the major contributions of D1/D2 MSNs to PC1 (Fig 3C) these findings indicate that pharmacological D2 blockade and D1 blockade disrupt ramping-related activity in the striatum.”

      Finally, we included the data in which sessions were sorted independently and assumed to be fully statistically independent in a new Figure S10.

      And in the results (Line 376): 

      “Furthermore, PC1 was distinct even when sessions were sorted independently and assumed to be fully statistically independent (Figure S10; D2 blockade vs saline: F = 5.8, p = 0.02; D1 blockade vs saline: F = 4.9, p = 0.03; all analyses accounting for variance between mice). Higher components explained less variance and were not reliably different between saline and D2 blockade or D1 blockade.”

      These changes strengthen the manuscript and better show the main effects and variability of the data. 

      Regarding the results in Figure 7: 

      I am overall a bit confused about what the authors are trying to claim here. In Figure 7, they present data suggesting that D1 or D2 blockade disrupts their ability to decode time in the interval of interest (0-6 seconds). However, in the final paragraph of the results, the authors seem to say that by using another technique, they didn't see any significant change in decoding accuracy after D1 or D2 blockade. What do the authors make of this? 

      This was very unclear. The second classifier was predicting response time, but it was confusing, and we removed it. 

      Impact: 

      The task and data presented by the authors are very intriguing, and there are many groups interested in how striatal activity contributes to the neural perception of time. The authors perform a wide variety of experiments and analysis to examine how DMS activity influences time perception during an interval-timing task, allowing for insight into this process. However, the significance of the key finding - that D2/D1 activity increases/ decreases with time - remains somewhat ambiguous to me. This arises from a lack of clarity regarding the initial hypothesis and the implications of this finding for advancing our understanding of striatal functions. 

      As noted above, we clarified our hypothesis and implications, and strengthened several aspects of the data as suggested by this reviewer.  

      Reviewer #2 (Public Review): 

      Summary: 

      In the present study, the authors investigated the neural coding mechanisms for D1- and D2expressing striatal direct and indirect pathway MSNs in interval timing by using multiple strategies. They concluded that D2-MSNs and D1-MSNs have opposing temporal dynamics yet disrupting either type produced similar effects on behavior, indicating the complementary roles of D1- and D2- MSNs in cognitive processing. However, the data was incomplete to fully support this major finding. One major reason is the heterogenetic responses within the D1-or D2MSN populations. In addition, there are additional concerns about the statistical methods used. For example, the majority of the statistical tests are based on the number of neurons, but not the number of mice. It appears that the statistical difference was due to the large sample size they used (n=32 D2-MSNs and n=41 D1-MSNs), but different neurons recorded in the same mouse cannot be treated as independent samples; they should use independent mouse-based statistical analysis. 

      Strengths: 

      The authors used multiple approaches including awake mice behavior training, optogeneticassistant cell-type specific recording, optogenetic or pharmacological manipulation, neural computation, and modeling to study neuronal coding for interval timing. 

      We appreciate the reviewer’s careful read recognizing the breadth of our approach.  

      Weaknesses: 

      (1) More detailed behavior results should be shown, including the rate of the success switches, and how long it takes to wait in the second nose poke to get a reward. For line 512 and the Figure 1 legend, the reviewer is not clear about the reward delivery. The methods appear to state that the mouse had to wait for 18s, then make nose pokes at the second port to get the reward. What happens if the mouse made the second nose poke before 18 seconds, but then exited? Would the mouse still get the reward at 18 seconds? Similarly, what happens if the mice made the third or more nosepokes within 18 seconds? It is important to clarify because, according to the method described, if the mice made a second nose poke before 18 seconds, this already counted as the mouse making the "switch." Lastly, what if the mice exited before 6s in the first nosepoke? 

      We completely agree. We have now completely revised Figure 1 to include many of these task details.

      We have clarified remaining details in the methods (Line 548):

      “Interval timing switch task. We used a mouse-optimized operant interval timing task described in detail previously (Balci et al., 2008; Bruce et al., 2021; Tosun et al., 2016; Weber et al., 2023). Briefly, mice were trained in sound-attenuating operant chambers, with two front nosepokes flanking either side of a food hopper on the front wall, and a third nosepoke located at the center of the back wall. The chamber was positioned below an 8-kHz, 72-dB speaker (Fig 1A; MedAssociates, St. Albans, VT). Mice were 85% food restricted and motivated with 20 mg sucrose pellets (BioServ, Flemington, NJ). Mice were initially trained to receive rewards during fixed ratio nosepoke response trials. Nosepoke entry and exit were captured by infrared beams. After shaping, mice were trained in the “switch” interval timing task. Mice self-initiated trials at the back nosepoke, after which tone and nosepoke lights were illuminated simultaneously. Cues were identical on all trial types and lasted the entire duration of the trial (6 or 18 seconds). On 50% of trials, mice were rewarded for a nosepoke after 6 seconds at the designated first ‘front’ nosepoke; these trials were not analyzed. On the remaining 50% of trials, mice were rewarded for nosepoking first at the ‘first’ nosepoke location and then switching to the ‘second’ nosepoke location; the reward was delivered for initial nosepokes at the second nosepoke location after 18 seconds when preceded by a nosepoke at the first nosepoke location.  Multiple nosepokes at each nosepokes were allowed. Early responses at the first or second nosepoke were not reinforced. Initial responses at the second nosepoke rather than the first nosepoke, alternating between nosepokes, going back to the first nosepoke after the second nosepoke were rare after initial training. Error trials included trials where animals responded only at the first or second nosepoke and were also not reinforced. We did not analyze error trials as they were often too few to analyze; these were analyzed at length in our prior work (Bruce et al., 2021).

      Switch response time was defined as the moment animals departed the first nosepoke before arriving at the second nosepoke. Critically, switch responses are a time-based decision guided by temporal control of action because mice switch nosepokes only if nosepokes at the first location did not receive a reward after 6 seconds. That is, mice estimate if more than 6 seconds have elapsed without receiving a reward to decide to switch responses. Mice learn this task quickly (3-4 weeks), and error trials in which an animal nosepokes in the wrong order or does not nosepoke are relatively rare and discarded. Consequently, we focused on these switch response times as the key metric for temporal control of action. Traversal time was defined as the duration between first nosepoke exit and second nosepoke entry and is distinct from switch response time when animals departed the first nosepoke. Nosepoke duration was defined as the time between first nosepoke entry and exit for the switch response times only. Trials were self-initiated, but there was an intertrial interval with a geometric mean of 30 seconds between trials.”

      And in the results on Line 131: 

      “We investigated cognitive processing in the striatum using a well-described mouseoptimized interval timing task which requires mice to respond by switching between two nosepokes after a 6-second interval (Fig 1A; see Methods; (Balci et al., 2008; Bruce et al., 2021; Larson et al., 2022; Tosun et al., 2016; Weber et al., 2023)). In this task, mice initiate trials by responding at a back nosepoke, which triggers auditory and visual cues for the duration of the trial. On 50% of trials, mice were rewarded for nosepoking after 6 seconds at the designated ‘first’ front nosepoke; these trials were not analyzed. On the remaining 50% of trials, mice were rewarded for nosepoking at the ‘first’ nosepoke and then switching to the ‘second’ nosepoke; initial nosepokes at the second nosepoke after 18 seconds triggered reward when preceded by a first nosepoke. The first nosepokes occurred before switching responses and the second nosepokes occurred much later in the interval in anticipation of reward delivery at 18 seconds (Fig 1B-D). During the task, movement velocity peaked before 6 seconds as mice traveled to the front nosepoke (Fig 1E).

      We focused on the switch response time, defined as the moment mice exited the first nosepoke before entering the second nosepoke. Switch responses are a timebased decision guided by temporal control of action because mice switch nosepokes only if nosepoking at the first nosepokes does not lead to a reward after 6 seconds (Fig 1B-E). Switch responses are guided by internal estimates of time because no external cue indicates when to switch from the first to the second nosepoke (Balci et al., 2008; Bruce et al., 2021; Tosun et al., 2016; Weber et al., 2023). We defined the first 6 seconds after trial start as the ‘interval’, because during this epoch mice are estimating whether 6 seconds have elapsed and if they need to switch responses. In 30 mice, switch response times were 9.3 seconds (8.4 – 9.7; median (IQR)); see Table 1 for a summary of mice, experiments, trials, and sessions). We studied dorsomedial striatal D2-MSNs and D1-MSNs using a combination of optogenetics and neuronal ensemble recordings in 9 transgenic mice (4 D2-Cre mice switch response time 9.7 (7.0 – 10.3) seconds; 5 D1-Cre mice switch response time 8.2 (7.7 – 8.7) seconds; rank sum p = 0.73; Table 1).”

      (2) There are a lot of time parameters in this behavior task, the description of those time parameters is mentioned in several parts, in the figure legend, supplementary figure legend, and methods, but was not defined clearly in the main text. It is inconvenient, sometimes, confusing for the readers. The authors should make a schematic diagram to illustrate the major parameters and describe them clearly in the main text. 

      We agree. We have clarified this in a new schematic, shading the interval in gray:   

      And in the results on line 131:

      “We focused on the switch response time, defined as the moment mice exited the first nosepoke before entering the second nosepoke. Switch responses are a time-based decision guided by temporal control of action because mice switch nosepokes only if nosepoking at the first nosepokes does not lead to a reward after 6 seconds (Fig 1BE). Switch responses are guided by internal estimates of time because no external cue indicates when to switch from the first to the second nosepoke (Balci et al., 2008; Bruce et al., 2021; Tosun et al., 2016; Weber et al., 2023). We defined the first 6 seconds after trial start as the ‘interval’, because during this epoch mice are estimating whether 6 seconds have elapsed and if they need to switch responses. In 30 mice, switch response times were 9.3 seconds (8.4 – 9.7; median (IQR)); see Table 1 for a summary of mice, experiments, trials, and sessions). We studied dorsomedial striatal D2-MSNs and D1-MSNs using a combination of optogenetics and neuronal ensemble recordings in 9 transgenic mice (4 D2-Cre mice switch response time 9.7

      (7.0 – 10.3) seconds; 5 D1-Cre mice switch response time 8.2 (7.7 – 8.7) seconds; rank sum p = 0.73; Table 1).”

      (3) In Line 508, the reviewer suggests the authors pay attention to those trials without "switch". It would be valuable to compare the MSN activity between those trials with or without a "switch". 

      This is a great suggestion. We analyzed such error trials and MSN activity in Figure 6 of Bruce et al., 2021. However, this manuscript was not designed to analyze errors, as they are rare beyond initial training (Bruce et al., 2021 focused on early training), and too inconsistent to permit robust analysis. This was added to the methods on Line 567:

      “Early responses at the first or second nosepoke were not reinforced. Initial responses at the second nosepoke rather than the first nosepoke, alternating between nosepokes, going back to the first nosepoke after the second nosepoke were rare after initial training. Error trials included trials where animals responded only at the first or second nosepoke and were also not reinforced. We did not analyze error trials as they were often too few to analyze; these were analyzed at length in our prior work (Bruce et al., 2021).”

      (4) The definition of interval is not very clear. It appears that the authors used a 6-second interval in analyzing the data in Figure 2 and Figure 3. But from my understanding, the interval should be the time from time "0" to the "switch", when the mice start to exit from the first nose poke. 

      We have now defined it explicitly in the schematic: 

      Incidentally, this reviewer asked us to analyze a longer epoch – this analysis beautifully justifies our focus on the first 6 seconds (now in Figure S2).

      We focus on the first six seconds as there are few nosepokes and switch responses during this epoch; however, we consider the reviewer’s definition and analyze the epoch the reviewer suggests from 0 to the switch in analyses below. 

      (5) For Figure 2 C-F, the authors only recorded 32 D2-MSNs in 4 mice, and 41 D1-MSNs in 5 mice. The sample size is too small compared to the sample size usually used in the field. In addition to the small sample size, the single-cell activity exhibited heterogeneity, which created potential issues. 

      We are glad the reviewer raised these points. First, our tagging dataset is relatively standard for optogenetic tagging. Second, we now include Cohen’s d for both PC and slope results for all optogenetic tagging analysis, which demonstrate that we have adequate statistical power and medium-to-large effect sizes (Line 186): 

      “In line with population averages from Fig 2G&H, D2-MSNs and D1-MSNs had opposite patterns of activity with negative PC1 scores for D2-MSNs and positive PC1 scores for D1-MSNs (Fig 3C; PC1 for D2-MSNs: -3.4 (-4.6 – 2.5); PC1 for D1MSNs: 2.8 (-2.8 – 4.9); F = 8.8, p = 0.004 accounting for variance between mice (Fig S3A); Cohen’s d = 0.7; power = 0.80; no reliable effect of sex (F = 0.44, p = 0.51) or switching direction (F = 1.73, p = 0.19)).”

      And Line 197:

      “GLM analysis also demonstrated that D2-MSNs had significantly different slopes (0.01 spikes/second (-0.10 – 0.10)), which were distinct from D1-MSNs (-0.20 (-0.47– 0.06; Fig 3D; F = 8.9, p = 0.004 accounting for variance between mice (Fig S3B); Cohen’s d = 0.8; power = 0.98; no reliable effect of sex (F = 0.02, p = 0.88) or switching direction (F = 1.72, p = 0.19)).”

      We added boxplots to Figure 3, which better highlight differences in these distributions.

      However, the reviewer’s point is well-taken, and we have added a caveat to the discussion exactly as the reviewer suggested (Line 496):

      “Second, although we had adequate statistical power and medium-to-large effect sizes, optogenetic tagging is low-yield, and it is possible that recording more of these neurons would afford greater opportunity to identify more robust results and alternative coding schemes, such as neuronal synchrony.”

      For both D1 and D2 MSNs, the authors tried to make conclusions on the "trend" of increasing in D2-MSNs and decreasing in D1-MSNs populations, respectively, during the interval. However, such a conclusion is not sufficiently supported by the data presented. It looks like the single-cell activity patterns can be separated into groups: one is a decreasing activity group, one is an increasing activity group and a small group for on and off response. Because of the small sample size, the author should pay attention to the variance across different mice (which needs to be clearly presented in the manuscript), instead of pooling data together and analyzing the mean activity. 

      We were not clear – we now do exactly as the reviewer suggested. We are not pooling any data – instead – as we state on line 620 - we are using linear-mixed effects models to account for mouse-specific and neuron-specific variance. This approach was developed with our statistics core for exactly the reasons the reviewer suggested (see letter). We state this explicitly in the methods (Line 704):

      “Statistics. All data and statistical approaches were reviewed by the Biostatistics,

      Epidemiology, and Research Design Core (BERD) at the Institute for Clinical and Translational Sciences (ICTS) at the University of Iowa. All code and data are made available at http://narayanan.lab.uiowa.edu/article/datasets. We used the median to measure central tendency and the interquartile range to measure spread. We used Wilcoxon nonparametric tests to compare behavior between experimental conditions and Cohen’s d to calculate effect size. Analyses of putative single-unit activity and basic physiological properties were carried out using custom routines for MATLAB.

      For all neuronal analyses, variability between animals was accounted for using generalized linear-mixed effects models and incorporating a random effect for each mouse into the model, which allows us to account for inherent between-mouse variability. We used fitglme in MATLAB and verified main effects using lmer in R. We accounted for variability between MSNs in pharmacological datasets in which we could match MSNs between saline, D2 blockade, and D1 blockade. P values < 0.05 were interpreted as significant.”

      We have now stated in the results that we are explicitly accounting for variance between mice (Line 186): 

      “In line with population averages from Fig 2G&H, D2-MSNs and D1-MSNs had opposite patterns of activity with negative PC1 scores for D2-MSNs and positive PC1 scores for D1-MSNs (Fig 3C; PC1 for D2-MSNs: -3.4 (-4.6 – 2.5); PC1 for D1MSNs: 2.8 (-2.8 – 4.9); F = 8.8, p = 0.004 accounting for variance between mice (Fig S3A); Cohen’s d = 0.7; power = 0.80; no reliable effect of sex (F = 0.44, p = 0.51) or switching direction (F = 1.73, p = 0.19)).”

      And on Line 197:

      “GLM analysis also demonstrated that D2-MSNs had significantly different slopes (0.01 spikes/second (-0.10 – 0.10)), which were distinct from D1-MSNs (-0.20 (-0.47– 0.06; Fig 3D; F = 8.9, p = 0.004 accounting for variance between mice (Fig S3B); Cohen’s d = 0.8; power = 0.98; no reliable effect of sex (F = 0.02, p = 0.88) or switching direction (F = 1.72, p = 0.19)).”

      All statistics in the manuscript now explicitly account for variance between mice. 

      This is the approach that was recommended by our the Biostatistics, Epidemiology, and

      Research Design Core (BERD) at the Institute for Clinical and Translational Sciences (ICTS) at the University of Iowa, who reviews all of our work.

      We note that these Cohen d values usually interpret as medium or large. 

      We performed statistical power calculations and include these to aid readers’ interpretation. These are all >0.8. 

      Finally, the reviewer uses the word ‘trend’. We define p values <0.05 as significant in the methods, and do not interpret trends (on line 717): 

      “P values < 0.05 were interpreted as significant.”

      And, we have now plotted values for each mouse in a new Figure S3.

      As noted in the figure legend, mouse-specific effects were analyzed using linear models that account for between-mouse variability, as discussed with our statisticians. However, the reviewer’s point is well taken, and we have added this idea to the discussion as suggested (Line 496):

      “Second, although we had adequate statistical power and medium-to-large effect sizes, optogenetic tagging is low-yield, and it is possible that recording more of these neurons would afford greater opportunity to identify more robust results and alternative coding schemes, such as neuronal synchrony.”

      (6) For Figure 2, from the activity in E and F, it seems that the activity already rose before the trial started, the authors should add some longer baseline data before time zero for clarification and comparison and show the timing of the actual start of the activity with the corresponding behavior. What behavior states are the mice in when initiating the activity? 

      This is a key point. First, we are not certain what state the animal is in until they initiate trials at the back nosepoke (“Start”). Therefore, we cannot analyze this epoch.  

      However, we can show neuronal activity during a longer epoch exactly as the reviewer suggested. Although there are modulations, the biggest difference between D2 and D1 MSNs is during the 0-6 second interval. This analysis supports our focus on the 0-6 second interval. We have included this as a new Figure S2.

      (7) The authors were focused on the "switch " behavior in the task, but they used an arbitrary 6s time window to analyze the activity, and tried to correlate the decreasing or increasing activities of MSNs to the neural coding for time. A better way to analyze is to sort the activity according to the "switch" time, from short to long intervals. This way, the authors could see and analyze whether the activity of D1 or D2 MSNs really codes for the different length of interval, instead of finding a correlation between average activity trends and the arbitrary 6s time window. 

      This is a great suggestion. We did exactly this and adjusted our linear models on a trialby-trial basis to account for time between the start of the interval and the switch. This is now added to the methods (line 656): 

      “We performed additional sensitivity analysis excluding outliers and measuring firing rate from the start of the interval to the time of the switch response on a trialby-trial level for each neuron.”

      And to the results (Line 201):

      “We found that D2-MSNs and D1-MSNs had a significantly different slope even when excluding outliers (4 outliers excluded outside of 95% confidence intervals; F=7.51, p=0.008 accounting for variance between mice) and when the interval was defined as the time between trial start and the switch response on a trial-by-trial basis for each neuron (F=4.3, p=0.04 accounting for variance between mice).”

      We now state our justification for focusing on the first 6 seconds of the interval (Line 134)

      “Switch responses are guided by internal estimates of time and temporal control of action because no external cue indicates when to switch from the first to the second nosepoke (Balci et al., 2008; Bruce et al., 2021; Tosun et al., 2016; Weber et al., 2023). We defined the first 6 seconds after trial start as the ‘interval’, because during this epoch mice are estimating whether 6 seconds have elapsed and if they need to switch responses.”

      As noted previously, epoch is now justified by Figure S2E.

      And we note that this focus minimizes motor confounds (Line 511):

      “Four lines of evidence argue that our findings cannot be directly explained by motor confounds: 1) D2-MSNs and D1-MSNs diverge between 0-6 seconds after trial start well before the first nosepoke (Fig S2), 2) our GLM accounted for nosepokes and nosepoke-related βs were similar between D2-MSNs and D1-MSNs, 3) optogenetic disruption of dorsomedial D2-MSNs and D1-MSNs did not change task-specific movements despite reliable changes in switch response time, and 4) ramping dynamics were quite distinct from movement dynamics. Furthermore, disrupting D2-MSNs and D1-MSNs did not change the number of rewards animals received, implying that these disruptions did not grossly affect motivation. Still, future work combining motion tracking with neuronal ensemble recording and optogenetics and including bisection tasks may further unravel timing vs. movement in MSN dynamics (Robbe, 2023).”

      We are glad the reviewer suggested this analysis as it strengthens our manuscript.  

      Reviewer #3 (Public Review): 

      Summary: 

      The cognitive striatum, also known as the dorsomedial striatum, receives input from brain regions involved in high-level cognition and plays a crucial role in processing cognitive information. However, despite its importance, the extent to which different projection pathways of the striatum contribute to this information processing remains unclear. In this paper, Bruce et al. conducted a study using a range of causal and correlational techniques to investigate how these pathways collectively contribute to interval timing in mice. Their results were consistent with previous research, showing that the direct and indirect striatal pathways perform opposing roles in processing elapsed time. Based on their findings, the authors proposed a revised computational model in which two separate accumulators track evidence for elapsed time in opposing directions. These results have significant implications for understanding the neural mechanisms underlying cognitive impairment in neurological and psychiatric disorders, as disruptions in the balance between direct and indirect pathway activity are commonly observed in such conditions. 

      Strengths: 

      The authors employed a well-established approach to study interval timing and employed optogenetic tagging to observe the behavior of specific cell types in the striatum. Additionally, the authors utilized two complementary techniques to assess the impact of manipulating the activity of these pathways on behavior. Finally, the authors utilized their experimental findings to enhance the theoretical comprehension of interval timing using a computational model. 

      We are grateful for the reviewer’s consideration of our work and for recognizing the strengths of our approach.  

      Weaknesses: 

      The behavioral task used in this study is best suited for investigating elapsed time perception, rather than interval timing. Timing bisection tasks are often employed to study interval timing in humans and animals.

      This is a key point, and the reviewer is correct. We use our task because of its’ translational validity; as far as we know, temporal bisection tasks have been used less often in human disease and in rodent models. We have included a new paragraph describing this in the discussion (Line 472):

      “Because interval timing is reliably disrupted in human diseases of the striatum such as Huntington’s disease, Parkinson’s disease, and schizophrenia (Hinton et al., 2007; Singh et al., 2021; Ward et al., 2011), these results have relevance to human disease. Our task version has been used extensively to study interval timing in mice and humans (Balci et al., 2008; Bruce et al., 2021; Stutt et al., 2024; Tosun et al., 2016; Weber et al., 2023). However, temporal bisection tasks, in which animals hold during a temporal cue and respond at different locations depending on cue length, have advantages in studying how animals time an interval because animals are not moving while estimating cue duration (Paton and Buonomano, 2018; Robbe, 2023; Soares et al., 2016). Our interval timing task version – in which mice switch between two response nosepokes to indicate their interval estimate has elapsed – has been used extensively in rodent models of neurodegenerative disease (Larson et al., 2022; Weber et al., 2024, 2023; Zhang et al., 2021), as well as in humans (Stutt et al., 2024). Furthermore, because many therapeutics targeting dopamine receptors are used clinically, these findings help describe how dopaminergic drugs might affect cognitive function and dysfunction. Future studies of D2-MSNs and D1-MSNs in temporal bisection and other timing tasks may further clarify the relative roles of D2- and D1-MSNs in interval timing and time estimation.”

      Furthermore, we have modified the use of the definition of interval timing in the abstract, introduction, and results to reflect the reviewers comment. For instance, in the abstract (Line 43):

      “We studied dorsomedial striatal cognitive processing during interval timing, an elementary cognitive task that requires mice to estimate intervals of several seconds and involves working memory for temporal rules as well as attention to the passage of time.”

      However, we think it is important to use the term ‘interval timing’ as it links to past work by our group and others.   

      The main results from unit recording (opposing slopes of D1/D2 cell firing rate, as shown in Figure 3D) appear to be very sensitive to a couple of outlier cells, and the predictive power of ensemble recording seems to be only slightly above chance levels. 

      This is a key point raised by other reviewers as well. We have now included measures of statistical power (as we interpret the reviewer’s comment of predictive power), effect size, and perform additional sensitivity analyses (Line 187): 

      “PC1 scores for D1-MSNs (Fig 3C; PC1 for D2-MSNs: -3.4 (-4.6 – 2.5); PC1 for D1MSNs: 2.8 (-4.9 – -2.8); F=8.8, p = 0.004 accounting for variance between mice (Fig S3A);  Cohen’s d = 0.7; power = 0.80; no reliable effect of sex (F=1.9, p=0.17) or switching direction (F=0.1, p=0.75)).”

      And on Line 197:

      “GLM analysis also demonstrated that D2-MSNs had significantly different slopes (0.01 spikes/second (-0.10 – 0.10)), which were distinct from D1-MSNs (-0.20 (-0.45– 0.06; Fig 3D; F=8.9, p = 0.004 accounting for variance between mice (Fig S3B); Cohen’s d = 0.8; power = 0.98).  We found that D2-MSNs and D1-MSNs had a significantly different slope even when excluding outliers (4 outliers excluded outside of 95% confidence intervals; F=7.51, p=0.008 accounting for variance between mice) and when the interval was defined as the time between trial start and the switch response on a trial-by-trial basis for each neuron (F=4.3, p=0.04 accounting for variance between mice).”

      These are medium-to-large Cohen’s d results, and we have adequate statistical power. These results are not easily explained by chance. 

      We also added boxplots, which highlight the differences in distribution.

      Finally, we note that our conclusions are drawn from many convergent analyses (on Line 216): 

      “Analyses of average activity, PC1, and trial-by-trial firing-rate slopes over the interval provide convergent evidence that D2-MSNs and D1-MSNs had distinct and opposing dynamics during interval timing.”

      In the optogenetic experiment, the laser was kept on for too long (18 seconds) at high power (12 mW). This has been shown to cause adverse effects on population activity (for example, through heating the tissue) that are not necessarily related to their function during the task epochs. 

      This is an important point. We are well aware of heating effects with optogenetics and other potential confounds. For the exact reasons noted by the reviewer, we had opsinnegative controls – where the laser was on for the exact same amount of time (18 seconds) and at the same power (12 mW)– in Figure S5. We have now better highlighted these controls in the methods (Line 598):

      “In animals injected with optogenetic viruses, optical inhibition was delivered via bilateral patch cables for the entire trial duration of 18 seconds via 589-nm laser light at 12 mW power on 50% of randomly assigned trials. We performed control experiments in mice without opsins using identical laser parameters in D2-cre or D1-cre mice (Fig S6).”

      And in results (Line 298):

      “Importantly, we found no reliable effects for D2-MSNs with opsin-negative controls (Fig S6).”

      And Line 306): 

      “As with D2-MSNs, we found no reliable effects with opsin-negative controls in D1MSNs (Fig S6).”

      We have highlighted these data in Figure S6: 

      Furthermore, the effect of optogenetic inhibition is similar to pharmacological effects in this manuscript and in our prior work (De Corte et al., 2019; Stutt et al., 2024) on line 459): 

      “Past pharmacological work from our group and others has shown that disrupting D2- or D1-MSNs slows timing (De Corte et al., 2019b; Drew et al., 2007, 2003; Stutt et al., 2024), in line with pharmacological and optogenetic results in this manuscript.”

      And in the discussion section on Line 488: 

      “Our approach has several limitations. First, systemic drug injections block D2- and D1-receptors in many different brain regions, including the frontal cortex, which is involved in interval timing (Kim et al., 2017a). D2 blockade or D1 blockade may have complex effects, including corticostriatal or network effects that contribute to changes in D2-MSN or D1-MSN ensemble activity. We note that optogenetic inhibition of D2-MSNs and D1-MSNs produces similar effects to pharmacology in Figure 5.”

      Given the systemic delivery of pharmacological interventions, it is difficult to conclude that the effects are specific to the dorsomedial striatum. Future studies should use the local infusion of drugs into the dorsomedial striatum. 

      This is a great point - we did this experiment in De Corte et al, 2019 with local drug infusions. This earlier study was the departure point for this experiment. We now point this out in the introduction (Line 92): 

      “Past work has shown that disrupting either D2-dopamine receptors (D2) or D1dopamine receptors (D1) powerfully impairs interval timing by increasing estimates of elapsed time (Drew et al., 2007; Meck, 2006). Similar behavioral effects were found with systemic (Stutt et al., 2024) or local dorsomedial striatal D2 or D1 disruption (De Corte et al., 2019a). These data lead to the hypothesis that D2 MSNs and D1 MSNs have similar patterns of ramping activity across a temporal interval.”

      However, the reviewer makes a great point - and we will develop this in our future work (Line 485): 

      “Future studies might extend our work combining local pharmacology with neuronal ensemble recording.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Just a few minor notes: 

      (1) Figures 2C and D should have error bars. 

      We agree.  We added error bars to these figures and other rasters as recommended.  

      (2) Figures 2G and H seem to be smoothed - how was this done? 

      We added these details.

      (3) It is unclear what the 'neural network machine learning classifier' mentioned in lines 193-199 adds if the data relevant to this analysis isn't presented. I would potentially include this. 

      We agree. This analysis was confusing and not relevant to our main points; consequently, we removed it.  

      Reviewer #2 (Recommendations For The Authors): 

      Major: 

      (1)  For Figure 2, the description of the main results in (C-F) in the main text is too brief and is not clear. 

      We have added to and clarified this text (Line 147)

      “Striatal neuronal populations are largely composed of MSNs expressing D2dopamine or D1-dopamine receptors. We optogenetically tagged D2-MSNs and D1MSNs by implanting optrodes in the dorsomedial striatum and conditionally expressing channelrhodopsin (ChR2; Fig S1) in 4 D2-Cre (2 female) and 5 D1-Cre transgenic mice (2 female). This approach expressed ChR2 in D2-MSNs or D1MSNs, respectively (Fig 2A-B; Kim et al., 2017a). We identified D2-MSNs or D1MSNs by their response to brief pulses of 473 nm light; neurons that fired within 5 milliseconds were considered optically tagged putative D2-MSNs (Fig S1B-C). We tagged 32 putative D2-MSNs and 41 putative D1-MSNs in a single recording session during interval timing. There were no consistent differences in overall firing rate between D2-MSNs and D1-MSNs (D2-MSNs: 3.4 (1.4 – 7.2) Hz; D1-MSNs 5.2 (3.1 – 8.6) Hz; F = 2.7, p = 0.11 accounting for variance between mice). Peri-event rasters and histograms from a tagged putative D2-MSN (Fig 2C) and from a tagged putative D1-MSN (Fig 2D) demonstrate prominent modulations for the first 6 seconds of the interval after trial start. Z-scores of average peri-event time histograms (PETHs) from 0 to 6 seconds after trial start for each putative D2-MSN are shown in Fig 2E and for each putative D1-MSN in Fig 2F. These PETHs revealed that for the 6-second interval immediately after trial start, many putative D2-MSN neurons appeared to ramp up while many putative D1-MSNs appeared to ramp down. For 32 putative D2-MSNs average PETH activity increased over the 6second interval immediately after trial start, whereas for 41 putative D1-MSNs, average PETH activity decreased. These differences resulted in distinct activity early in the interval (0-1 seconds; F = 6.0, p = 0.02 accounting for variance between mice), but not late in the interval (5-6 seconds; F = 1.9, p = 0.17 accounting for variance between mice) between D2-MSNs and D1-MSNs. Examination of a longer interval of 10 seconds before to 18 seconds after trial start revealed the greatest separation in D2-MSN and D1-MSN dynamics during the 6-second interval after trial start (Fig S2). Strikingly, these data suggest that D2-MSNs and D1-MSNs might display opposite dynamics during interval timing.”

      (2)  For Figure3 

      (A)  Is the PC1 calculated from all MSNs of all mice (4 D2, 5 D1 mice)? 

      We clarified this (Line 182):

      “We analyzed PCA calculated from all D2-MSNs and D1-MSNs PETHs over the 6second interval immediately after trial start.”

      And for pharmacology (Line 362): 

      “We noticed differences in MSN activity across the interval with D2 blockade and D1 blockade at the individual MSN level (Fig 6B-D) as well as at the population level (Fig 6E). We used PCA to quantify effects of D2 blockade or D1 blockade (Bruce et al., 2021; Emmons et al., 2017; Kim et al., 2017a). We constructed principal components (PC) from z-scored peri-event time histograms of firing rate from saline, D2 blockade, and D1 blockade sessions for all mice together.”

      (B)  The authors should perform PCA on single mouse data, and add the plot and error bar. 

      This is a great idea. We have now included this as a new Figure S3:   

      (C)  As mentioned before, both D2-or D1- MSNs can be divided into three groups, it is not appropriate to put them together as each MSN is not an independent variable, the authors should do the statistics based on the individual mouse, and do the parametric or non-parametric comparison, and plot N (number of mice) based error bars. 

      We have done exactly this using a linear mixed effects model, as recommend by our statistics core. They have explicitly suggested that this is the best approach to these data (see letter). We have also included measures of statistical power and effect size (Line 704):  

      “All data and statistical approaches were reviewed by the Biostatistics, Epidemiology, and Research Design Core (BERD) at the Institute for Clinical and Translational Sciences (ICTS) at the University of Iowa. All code and data are made available at http://narayanan.lab.uiowa.edu/article/datasets. We used the median to measure central tendency and the interquartile range to measure spread. We used Wilcoxon nonparametric tests to compare behavior between experimental conditions and Cohen’s d to calculate effect size. Analyses of putative single-unit activity and basic physiological properties were carried out using custom routines for MATLAB.

      For all neuronal analyses, variability between animals was accounted for using generalized linear-mixed effects models and incorporating a random effect for each mouse into the model, which allows to account for inherent between-mouse variability. We used fitglme in MATLAB and verified main effects using lmer in R. We accounted for variability between MSNs in pharmacological datasets in which we could match MSNs between saline, D2 blockade, and D1 blockade. P values < 0.05 were interpreted as significant.”

      We have now included measures of ‘power’ (which we interpret to be statistical), effect size, and perform additional sensitivity analyses (Line 187): 

      “PC1 scores for D1-MSNs (Fig 3C; PC1 for D2-MSNs: -3.4 (-4.6 – 2.5); PC1 for D1MSNs: 2.8 (-4.9 – -2.8); F=8.8, p = 0.004 accounting for variance between mice (Fig S3A); Cohen’s d = 0.7; power = 0.80; no reliable effect of sex (F=1.9, p=0.17) or switching direction (F=0.1, p=0.75)).”

      And Line 197:

      “GLM analysis also demonstrated that D2-MSNs had significantly different slopes (0.01 spikes/second (-0.10 – 0.10)), which were distinct from D1-MSNs (-0.20 (-0.45– 0.06; Fig 3D; F=8.9, p = 0.004 accounting for variance between mice (Fig S3B); Cohen’s d = 0.8; power = 0.98).  We found that D2-MSNs and D1-MSNs had a significantly different slope even when excluding outliers (4 outliers excluded outside of 95% confidence intervals; F=7.51, p=0.008 accounting for variance between mice) and when the interval was defined as the time between trial start and the switch response on a trial-by-trial bases for each neuron (F=4.3, p=0.04 accounting for variance between mice).”

      These are medium-to-large Cohen’s d results, and we have adequate statistical power. These results are not easily explained by chance. 

      We also added boxplots, which highlight the differences in distributions.

      (3) For results in Figure 5 and Figure S7, according to Figure 1 legend, lines 4 to 5, the response times were defined as the moment mice exit the first nose poke (on the left) to respond at the second nose poke; and according to method session (line 522), "switch" traversal time was defined as the duration between first nose poke exit and second nose poke entry. It seems that response time is the switch traversal time, they should be the same, but in Figures B and D, the response time showed a clear difference between the laser off and on groups, while in Figures S7 C, and G, there were no differences between laser off and on group for switch traversal time. Please reconcile these inconsistencies. 

      We were not clear. We now clarify – switch responses are the moment when mice depart the first nosepoke, whereas traversal time is the time between departing the first nosepoke and arriving at the second nosepoke. We have reworked our figures to make this clear.

      And in the methods (Line 570):

      “Switch response time was defined as the moment animals departed the first nosepoke before arriving at the second nosepoke. Critically, switch responses are a time-based decision guided by temporal control of action because mice switch nosepokes only if nosepokes at the first location did not receive a reward after 6 seconds. That is, mice estimate if more than 6 seconds have elapsed without receiving a reward to decide to switch responses. Mice learn this task quickly (3-4 weeks), and error trials in which an animal nosepokes in the wrong order or does not nosepoke are relatively rare and discarded. Consequently, we focused on these switch response times as the key metric for temporal control of action. Traversal time was defined as the duration between first nosepoke exit and second nosepoke entry and is distinct from switch response time when animals departed the first nosepoke. Nosepoke duration was defined as the time between first nosepoke entry and exit for the switch response times only. Trials were self-initiated, but there was an intertrial interval with a geometric mean of 30 seconds between trials.”

      And in Figure S8, we have added graphics and clarified the legend.

      (4) The first nose poke and second nose poke are very close, why did it take so long to move from the first nose poke to the second nose poke, even though the mouse already made the decision to switch? Please see Figure S1A, it took less than 6s from the back nose poke to the first nose poke, but it took more than 6s (up to 12s) from the first nose poke to the second nose poke, what were the mice's behavior during this period? 

      This is a key detail. There is no temporal urgency as only the initial nosepoke after 18 seconds leads to reward. In other words, making a second nosepoke prior to 18 seconds is not rewarded and, in well-trained animals, is wasted effort. We have added these details to the methods (Line 124):

      “On the remaining 50% of trials, mice were rewarded for nosepoking at the ‘first’ nosepoke and then switching to the ‘second’ nosepoke; initial nosepokes at the second nosepoke after 18 seconds triggered reward when preceded by a first nosepoke. The first nosepokes occurred before switching responses and the second nosepokes occurred much later in the interval in anticipation of reward delivery at 18 seconds (Fig 1B-D). During the task, movement velocity peaked before 6 seconds as mice traveled to the front nosepoke (Fig 1E).”

      And in Figure 1, as described in detail above. 

      (5) How many trials did mice perform in one day? How many recordings/day for how many days were performed? 

      These are key details that we have now added to Table 1.

      We have added the number of recording sessions to the methods (Line 603): 

      “For optogenetic tagging, putative D1- and D2-MSNs were optically identified via 473-nm photostimulation. Units with mean post-stimulation spike latencies of ≤5 milliseconds and a stimulated-to-unstimulated waveform correlation ratio of >0.9 were classified as putative D2-MSNs or D1-MSNs (Ryan et al., 2018; Shin et al., 2018). Only one recording session was performed for each animal per day, and one recording session was included from each animal.”

      And Line 606: 

      “Only one recording session was performed for each animal per day, and one recording session was included from saline, D2 blockade, and D1 blockade sessions.”

      (6) For results in Figure 5, the authors should analyze the speed for the laser on and off group, since the dorsomedial striatum was reported to be related to control of speed (Yttri, Eric A., and Joshua T. Dudman. "Opponent and bidirectional control of movement velocity in the basal ganglia." Nature 533.7603 (2016): 402-406.). 

      We have some initial DeepLabCut data and have included it in a new Figure 1E.

      B) DeepLabCut tracking of position during the interval timing revealed that mice moved quickly after trial start and then velocity was relatively constant throughout the trial

      We measure movement speed using nosepoke duration and traversal time, which can give some measure of movement velocity.

      In Yttri and Dudman, the mice are head-fixed and moving a joystick, whereas our mice are freely moving. However, we have now included the lack of motor control as a major limitation (Line 510): 

      “Finally, movement and motivation contribute to MSN dynamics (Robbe, 2023). Four lines of evidence argue that our findings cannot be directly explained by motor confounds: 1) D2-MSNs and D1-MSNs diverge between 0-6 seconds after trial start well before the first nosepoke (Fig S2), 2) our GLM accounted for nosepokes and nosepoke-related βs were similar between D2-MSNs and D1-MSNs, 3) optogenetic disruption of dorsomedial D2-MSNs and D1-MSNs did not change task-specific movements despite reliable changes in switch response time, and 4) ramping dynamics were quite distinct from movement dynamics. Furthermore, disrupting D2-MSNs and D1-MSNs did not change the number of rewards animals received, implying that these disruptions did not grossly affect motivation. Still, future work combining motion tracking with neuronal ensemble recording and optogenetics and including bisection tasks may further unravel timing vs. movement in MSN dynamics (Robbe, 2023).”

      (7)  Figure S3 (C, E, and F), statistics should be done based on N (number of mice), not on the number of recorded neurons.  

      We have removed this section, and all other statistics in the paper properly account for mouse-specific variance, as noted above.

      (8)  Figure S1 

      (A) Are these the results from all mice superposed together, or from one mouse on one given day? How many of the trials' data were superposed?

      We included these details in a new Figure 1.

      (B, C) How many trials were included? 

      (D) How many days did these data cover? 

      We have included a new Table 1 with these important details.

      We have noted that only 1 recording session / mouse was included in analysis (Line 606):

      “Only one recording session was performed for each animal per day, and one recording session was included from each animal.”

      And Line 614: 

      “Only one recording session was performed for each animal per day, and one recording session was included from saline, D2 blockade, and D1 blockade sessions.”

      (9) Figure S2 

      (A) Can the authors add coordinates of the brain according to the mouse brain atlas or, alternatively, show it using a coronal section? 

      Great idea – added to Figure S2 legend: 

      “Figure S1: A) Recording locations in the dorsomedial striatum (targeting AP +0.4, ML -1.4, DV -2.7). Electrode reconstructions for D2-Cre (red), D1-Cre (blue), and wild-type mice (green). Only the left striatum was implanted with electrodes in all animals.”

      We have also added it to Figure S5 legend: 

      “Figure S5: Fiber optic locations from A) an opsin-expressing mouse with mCherrytagged halorhodopsin and bilateral fiber optics, and B) across 10 D2-Cre mice (red) and 6 D1-cre mice (blue) with fiber optics (targeting AP +0.9, ML +/-1.3, DV –2.5).”

      (C) Why did the waveform of laser and no laser seem the same? 

      The optogenetically tagged spike waveforms are highly similar, indicating that optogenetically-triggered spikes are like other spikes. That is the main point – optogenetically stimulating the neuron does not change the waveform. We have added this detail to the legend of S1: 

      “Inset on bottom right – waveforms from laser trials (red) and trials without laser (blue).  Across 73 tagged neurons, waveform correlation coefficients for laser trials vs. trials without laser was r = 0.97 (0.92-0.99). These data demonstrate that optogenetically triggered spikes are similar to non-optogenetically triggered spikes.”

      (10)  Figure S7, what was the laser power used in this experiment? Have the authors tried different laser powers? 

      We have now clarified the laser power on line 598: 

      “In animals injected with optogenetic viruses, optical inhibition was delivered via bilateral patch cables for the entire trial duration of 18 seconds via 589-nm laser light at 12 mW power on 50% of randomly assigned trials.”

      And for Figure S6 (was S7 previously): 

      We did not try other laser powers; our parameters were chosen a priori based on our past work.  

      (11)  In Figure S9, what method was used to sort the neurons? 

      We now clarify in the methods (Line 617): 

      “Electrophysiology. Single-unit recordings were made using a multi-electrode recording system (Open Ephys, Atlanta, GA). After the experiments, Plexon Offline Sorter (Plexon, Dallas, TX), was used to remove artifacts. Principal component analysis (PCA) and waveform shape were used for spike sorting. Single units were defined as those 1) having a consistent waveform shape, 2) being a separable cluster in PCA space, and 3) having a consistent refractory period of at least 2 milliseconds in interspike interval histograms.  The same MSNs were sorted across saline, D2 blockade, and D1 blockade sessions by loading all sessions simultaneously in Offline Sorter and sorted using the preceding criteria. MSNs had to have consistent firing in all sessions to be included. Sorting integrity across sessions was quantified by comparing waveform similarity via R2 between sessions.”

      And in the results (Line 353):

      “We analyzed 99 MSNs in sessions with saline, D2 blockade, and D1 blockade. We matched MSNs across sessions based on waveform and interspike intervals; waveforms were highly similar across sessions (correlation coefficient between matched MSN waveforms: saline vs D2 blockade r = 1.00 (0.99 – 1.00 rank sum vs correlations in unmatched waveforms p = 3x10-44; waveforms; saline vs D1 blockade r = 1.00 (1.00 – 1.00), rank sum vs correlations in unmatched waveforms p = 4x10-50). There were no consistent changes in MSN average firing rate with D2 blockade or D1 blockade (F = 1.1, p = 0.30 accounting for variance between MSNs; saline: 5.2 (3.3 – 8.6) Hz; D2 blockade 5.1 (2.7 – 8.0) Hz; F = 2.2, p = 0.14; D1 blockade 4.9 (2.4 – 7.8) Hz).”

      (C-F) statistics should be done based on the number of mice, not on the number of recorded neurons. 

      We agree, all experiments are now quantified using linear mixed effects models which formally accounts for variance contributed across animals, as discussed at length earlier in the review and with statistical experts at the University of Iowa.

      (12) For results in Figure 6, did the authors do cell-type specific recording on D1 or D2 MSNs using optogenetic tagging? As the D1- or D2- MSNs account for ~50% of all MSNs, the inhibition of a considerable amount of neurons was not observed. The authors should discuss the relation between the results from optogenetic inhibition of D1- or D2- MSNs and pharmacological disruption of D1 or D2 dopamine receptors. 

      This is a great point. First, we did not combine cell-type specific recordings with tagging as it was difficult to get enough trials for analysis in a single session in the tagging experiments, and pharmacological interventions can further decrease performance.  However, we have made our results in Figure 6 much more focused.

      We have discussed the relationship between these data in the results (Line 380): 

      “This data-driven analysis shows that D2 and D1 blockade produced similar shifts in MSN population dynamics represented by PC1.  When combined with major contributions of D1/D2 MSNs to PC1 (Fig 3C) these findings show that pharmacologically disrupting D2 or D1 MSNs can disrupt ramping-related activity in the striatum.”

      And in the discussion (Line 417): 

      “Strikingly, optogenetic tagging showed that D2-MSNs and D1-MSNs had distinct dynamics during interval timing. MSN dynamics helped construct and constrain a four-parameter drift-diffusion model in which D2- and D1-MSN spiking accumulated temporal evidence. This model predicted that disrupting either D2MSNs or D1-MSNs would increase response times. Accordingly, we found that optogenetically or pharmacologically disrupting striatal D2-MSNs or D1-MSNs increased response times without affecting task-specific movements. Disrupting D2MSNs or D1-MSNs shifted MSN temporal dynamics and degraded MSN temporal encoding. These data, when combined with our model predictions, demonstrate that D2-MSNs and D1-MSNs contribute temporal evidence to controlling actions in time.”

      And: 

      “D2-MSNs and D1-MSNs play complementary roles in movement. For instance, stimulating D1-MSNs facilitates movement, whereas stimulating D2-MSNs impairs movement (Kravitz et al., 2010). Both populations have been shown to have complementary patterns of activity during movements (Tecuapetla et al., 2016), with MSNs firing at different phases of action initiation and selection. Further dissection of action selection programs reveals that opposing patterns of activation among D2MSNs and D1-MSNs suppress and guide actions, respectively, in the dorsolateral striatum (Cruz et al., 2022). A particular advantage of interval timing is that it captures a cognitive behavior within a single dimension — time. When projected along the temporal dimension, it was surprising that D2-MSNs and D1-MSNs had opposing patterns of activity. Past pharmacological work from our group and others have shown that disrupting D2 or D1 MSNs slows timing (De Corte et al., 2019; Drew et al., 2007, 2003; Stutt et al., 2023), in line with pharmacological and optogenetic results in this manuscript. Computational modeling predicted that disrupting either D2-MSNs or D1-MSNs increased self-reported estimates of time, which was supported by both optogenetic and pharmacological experiments. Notably, these disruptions are distinct from increased timing variability reported with administrations of amphetamine, ventral tegmental area dopamine neuron lesions, and rodent models of neurodegenerative disease (Balci et al., 2008; Gür et al., 2020, 2019; Larson et al., 2022; Weber et al., 2023). Furthermore, our current data demonstrate that disrupting either D2-MSN or D1-MSN activity shifted MSN dynamics and degraded temporal encoding, supporting prior work (De Corte et al., 2019; Drew et al., 2007, 2003; Stutt et al., 2023). Our recording experiments do not identify where a possible response threshold T is instantiated, but downstream basal ganglia structures may have a key role in setting response thresholds (Toda et al., 2017).”

      (13) For Figure 2, what is the error region for G and H? Is there a statistically significant difference between the start (e.g., 0-1 s) and the end (e.g., 5-6 s) time? 

      G and H are standard error, which we have now clarified.

      And on Line 166: 

      “These differences resulted in distinct activity early in the interval (0-1 seconds; F = 6.0, p = 0.02 accounting for variance between mice), but not late in the interval (5-6 seconds; F = 1.9, p = 0.17 accounting for variance between mice) between D2-MSNs and D1-MSNs.”

      Minor: 

      (1)  Figure 2 legend showed the wrong label "Peri-event raster C) from a D2-MSN (red) and E) from a D1-MSN (blue). It should be (D). 

      Fixed, thank you.  

      (2)  Figure 2. Missing legend for (E) and (F).  

      Fixed, thank you.  

      (3)  Line 423: mistyped "\" 

      Fixed, thank you.  

      Reviewer #3 (Recommendations For The Authors): 

      -  To clarify that complementary means opposing in this context, I suggest changing the title. 

      This is a helpful suggestion. We have changed it exactly as the reviewer suggested: 

      “Complementary opposing D2-MSNs and D1-MSNs dynamics during interval timing”

      -  I recommend adding a supplementary figure to demonstrate all the nose pokes in all trials in a given session. The current figures make it hard to assess the specifics of the behavior. For example, what happens if, in a long-interval trial, the mouse pokes in the second nose poke before 6 seconds? Is that behavior punished? Do they keep alternating between the nose poke or do they stick to one nose poke? 

      We agree. We think this is a main point, and we have now redesigned Figure 1 to describe these details: 

      And added these details to the methods (Line 548): 

      “Interval timing switch task. We used a mouse-optimized operant interval timing task described in detail previously (Balci et al., 2008; Bruce et al., 2021; Tosun et al., 2016; Weber et al., 2023). Briefly, mice were trained in sound-attenuating operant chambers, with two front nosepokes flanking either side of a food hopper on the front wall, and a third nosepoke located at the center of the back wall. The chamber was positioned below an 8-kHz, 72-dB speaker (Fig 1A; MedAssociates, St. Albans, VT). Mice were 85% food restricted and motivated with 20 mg sucrose pellets (BioServ, Flemington, NJ). Mice were initially trained to receive rewards during fixed ratio nosepoke response trials. Nosepoke entry and exit were captured by infrared beams. After shaping, mice were trained in the “switch” interval timing task. Mice self-initiated trials at the back nosepoke, after which tone and nosepoke lights were illuminated simultaneously. Cues were identical on all trial types and lasted the entire duration of the trial (6 or 18 seconds). On 50% of trials, mice were rewarded for a nosepoke after 6 seconds at the designated first ‘front’ nosepoke; these trials were not analyzed. On the remaining 50% of trials, mice were rewarded for nosepoking first at the ‘first’ nosepoke location and then switching to the ‘second’ nosepoke location; the reward was delivered for initial nosepokes at the second nosepoke location after 18 seconds when preceded by a nosepoke at the first nosepoke location.  Multiple nosepokes at each nosepokes were allowed. Early responses at the first or second nosepoke were not reinforced. Initial responses at the second nosepoke rather than the first nosepoke, alternating between nosepokes, going back to the first nosepoke after the second nosepoke were rare after initial training. Error trials included trials where animals responded only at the first or second nosepoke and were also not reinforced. We did not analyze error trials as they were often too few to analyze; these were analyzed at length in our prior work (Bruce et al., 2021).”

      -  Figures 2E and 2F suggest that some D1 cells ramp up during the first 6 seconds, while others ramp down. The same is more or less true for D2s. I wonder if the analysis will lose its significance if the two outlier D1s are excluded from Figure 3D. 

      This is a great idea suggested by multiple reviewers. We repeated this analysis with outliers removed. We used a data-driven approach to remove outliers (Line 656): 

      “We performed additional sensitivity analysis excluding outliers outside of 95% confidence intervals and measuring firing rate from the start of the interval to the time of the switch response on a trial-by-trial level for each neuron.”

      And described these data in the results (Line 201): 

      “We found that D2-MSNs and D1-MSNs had a significantly different slope even when excluding outliers (4 outliers excluded outside of 95% confidence intervals; F=7.51, p=0.008 accounting for variance between mice) and when the interval was defined as the time between trial start and the switch response on a trial-by-trial basis for each neuron (F=4.3, p=0.04 accounting for variance between mice).”

      Finally, we removed the outliers the reviewers alluded to – two D1 MSNs – and found similar results (F=6.59, p=0.01 for main effect of D2 vs. D1 MSNs controlling for between-mouse variability). We elected to include the more data driven approach based on 95% confidence intervals.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This useful study examined the associations of a healthy lifestyle with comprehensive and organ-specific biological ages defined using common blood biomarkers and body measures. Its large sample size, longitudinal design, and robust statistical analysis provide solid support for the findings, which will be of interest to epidemiologists and clinicians.

      Thank you very much for your thoughtful review of our manuscript. Your valuable comments have greatly helped us improve our manuscript. We have carefully considered all the comments and suggestions made by the reviewers and have revised them to address each point. Below, we provide detailed responses to each of the reviewers' comments. Please note that the line numbers mentioned in the following responses correspond to the line numbers in the clean version of the manuscript.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This study was to examine the associations of a healthy lifestyle with comprehensive and organ-specific biological ages. It emphasized the importance of lifestyle factors in biological ages, which were defined using common blood biomarkers and body measures.

      Strengths:

      The data were from a large cohort study and defined comprehensive and six-specified biological ages.

      Weaknesses:

      (1) Since only 8.5% of participants from the CMEC (China Multi-Ethnic Cohort Study) were included in the study, has any section bias happened?

      Thank you for your valuable question. We understand the concern regarding the potential selection bias due to only 8.5% of participants being included in the study. The baseline survey of China Multi-Ethnic Cohort Study (CMEC) employed a rigorous multi-stage stratified cluster sampling method and the repeat survey reevaluated approximately 10% of baseline participants through community-based cluster random sampling. Therefore, the sample of the repeat survey is representative. The second reason for the loss of sample size was the availability of biomarkers for BA calculation. We have compared characteristic of the overall population, the population included in and excluded from this study. Most characteristics were similar, but participants included in this study showed better in some health-related variables, one potential reason is healthier individuals were more likely to complete the follow-up survey. In conclusion, we believe that the impact of selection bias is limited.

      Author response table 1.

      Baseline characteristics of participants included and not included in the study

      BA, biological age; BMI, body mass index; CVD, cardiovascular disease; HLI, healthy lifestyle indicator.

      1 Data are presented as median (25th, 75th percentile) for continuous variables and count (percentage) for categorical variables.

      2 For HLI, "healthy" corresponds to a score of 4-5.

      3 Information on each validated BA has been reported. BA acceleration is the difference between each BA and CA in the same survey.

      (2) The authors should specify the efficiency of FFQ. How can FFQ genuinely reflect the actual intake? Moreover, how was the aMED calculated?

      Thank you for the comments and questions. We appreciate the opportunity to clarify these aspects of our study. For the first question, we evaluated the FFQ's reproducibility and validity by conducting repeated FFQs and 24-hour dietary recalls at the baseline survey. Intraclass correlation coefficients (ICC) for reproducibility ranged from 0.15 for fresh vegetables to 0.67 for alcohol, while deattenuated Spearman rank correlations for validity ranged from 0.10 for soybean products to 0.66 for rice. More details are provided in our previous study (Lancet Reg Health West Pac, 2021). We have added the corresponding content in both the main text and the supplementary materials.

      Methods, Page 8, lines 145-146: “The FFQ's reproducibility and validity were evaluated by conducting repeated FFQs and 24-hour dietary recalls.”

      Supplementary methods, Dietary assessment: “We evaluated the FFQ's reproducibility and validity by conducting repeated FFQs and 24-hour dietary recalls. Intraclass correlation coefficients for reproducibility ranged from 0.15 for fresh vegetables to 0.67 for alcohol, while deattenuated Spearman rank correlations for validity ranged from 0.10 for soybean products to 0.66 for rice.”

      For the second question, we apologize for any confusion. To avoid taking up too much space in the main text, we decided not to include the detailed aMED calculation (as described in Circulation, 2009) there and instead placed it in the supplementary materials:

      “Our calculated aMED score incorporates eight components: vegetables, legumes, fruits, whole grains, fish, the ratio of monounsaturated fatty acids (MUFA) to saturated fatty acids (SFA), red and processed meats, and alcohol. Each component's consumption was divided into sex-specific quintiles. Scores ranging from 1 to 5 were assigned based on quintile rankings to each component, except for red and processed meats and alcohol, for which the scoring was inverted. The alcohol criteria for the aMED was defined as moderate consumption. Since the healthy lifestyle index (HLI) already contained a drinking component, we removed the drinking item in the aMED, which had a score range of 7-35 with a higher score reflecting better adherence to the overall Mediterranean dietary pattern. We defined individuals with aMED scores ≥ population median as healthy diets.”

      Reference:

      (1) Xiao X, Qin Z, Lv X, Dai Y, Ciren Z, Yangla Y, et al. Dietary patterns and cardiometabolic risks in diverse less-developed ethnic minority regions: results from the China Multi-Ethnic Cohort (CMEC) Study. Lancet Reg Health West Pac. 2021;15:100252. doi: 10.1016/j.lanwpc.2021.100252.

      (2) Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB. Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation. 2009;119(8):1093-100. doi: 10.1161/circulationaha.108.816736.

      (3) HLI (range) and HLI (category) should be clearly defined.

      Thank you for the comment. We have added the definition of HLI (range) and HLI (category) in the methods section:

      Methods P9 lines 165-170: “The HLI was calculated by directly adding up the five lifestyle scores, ranging from 0-5, with a higher score representing an overall healthier lifestyle, denoted as HLI (range) in the following text. We then transformed HLI into a dichotomous variable in this study, denoted as HLI (category), where a score of 4-5 for HLI was considered a healthy lifestyle, and a score of 0-3 was considered an unfavorable lifestyle that could be improved.”

      (4) The comprehensive rationale and each specific BA construction should be clearly defined and discussed. For example, can cardiopulmonary BA be reflected only by using cardiopulmonary status? I do not think so.

      Thank you for the opportunity to clarify. We constructed the comprehensive BA based on all the available biochemical data from the CMEC study, selecting aging-related markers (J Gerontol A Biol Sci Med Sci, 2021), and further construct organ-specific BAs based on these selected biomarkers. The KDM algorithm does not specify biomarker types but requires them to be correlated with chronological age (CA) (Ageing Dev, 2006). Existing studies typically construct BA based on available biomarker, we included 15 biomarkers in this study, which could be considered comprehensive and extensive compared to previous research (J Transl Med. 2023; J Am Heart Assoc. 2024; Nat Cardiovasc Res. 2024). For how the biomarkers for each organ-specific BAs were selected, we categorized biomarkers primarily based on their relevance to the structure and function of each organ system according to the classification in previous studies (Nat Med, 2023; Cell Rep, 2022). Since the biomarkers we used came from clinical-lab data sets, they were categorized based on the clinical interpretation of blood chemistry tests following the methods outlined in the two referenced papers (Nat Med, 2023; Cell Rep, 2022). We only used biomarkers directly related to each specific system to minimize overlap between the indicators used for different BAs, thereby preserving the distinctiveness of organ-specific BAs. We acknowledge the limitations of this approach that a few biomarkers may not fully capture the complete aging process of a system, and certain indicators may be missing due to data constraints. However, the multi-organ BAs we constructed are cost-effective, easy to implement, and have been validated, making them valuable despite the limitations.

      Reference:

      (1) Verschoor CP, Belsky DW, Ma J, Cohen AA, Griffith LE, Raina P. Comparing Biological Age Estimates Using Domain-Specific Measures From the Canadian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci. 2021;76(2):187-94. doi: 10.1093/gerona/glaa151.

      (2) Klemera P, Doubal S. A new approach to the concept and computation of biological age. Mech Ageing Dev. 2006;127(3):240-8. doi: 10.1016/j.mad.2005.10.004

      (3) Zhang R, Wu M, Zhang W, Liu X, Pu J, Wei T, et al. Association between life's essential 8 and biological ageing among US adults. J Transl Med. 2023;21(1):622. doi: 10.1186/s12967-023-04495-8.

      (4) Forrester SN, Baek J, Hou L, Roger V, Kiefe CI. A Comparison of 5 Measures of Accelerated Biological Aging and Their Association With Incident Cardiovascular Disease: The CARDIA Study. J Am Heart Assoc. 2024;13(8):e032847. doi: 10.1161/jaha.123.032847.

      (5) Jiang M, Tian S, Liu S, Wang Y, Guo X, Huang T, Lin X, Belsky DW, Baccarelli AA, Gao X. Accelerated biological aging elevates the risk of cardiometabolic multimorbidity and mortality. Nat Cardiovasc Res. 2024;3(3):332-42. doi: 10.1038/s44161-024-00438-8.

      (6) Tian YE, Cropley V, Maier AB, Lautenschlager NT, Breakspear M, Zalesky A. Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat Med. 2023;29(5):1221-31. doi: 10.1038/s41591-023-02296-6.

      (7) Nie C, Li Y, Li R, Yan Y, Zhang D, Li T, et al. Distinct biological ages of organs and systems identified from a multi-omics study. Cell Rep. 2022;38(10):110459. doi: 10.1016/j.celrep.2022.110459.

      (5) The lifestyle index is defined based on an equal-weight approach, but this does not reflect reality and cannot fully answer the research questions it raises.

      Thank you very much for your valuable suggestion. We used equal weight healthy lifestyle index (HLI) partly to facilitate comparisons with other studies. The equal-weight approach to construct the HLI is commonly used in current research (Bmj, 2021; Diabetes Care. 2022; Arch Gerontol Geriatr. 2022). The equal-weight HLI can demonstrate the average benefit of adopting each additional healthy lifestyle and avoid assumptions about the relative importance of different behaviors, which may vary depending on the population. To further clarify the importance of each lifestyle factor, we conducted quantile G-computation analysis, which can reflect the weight differences between lifestyle factors (PLoS Med, 2020; Clin Epigenetics, 2022).

      Reference:

      (1) Zhang YB, Chen C, Pan XF, Guo J, Li Y, Franco OH, Liu G, Pan A. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. Bmj. 2021;373:n604. doi: 10.1136/bmj.n604.

      (2) Han H, Cao Y, Feng C, Zheng Y, Dhana K, Zhu S, Shang C, Yuan C, Zong G. Association of a Healthy Lifestyle With All-Cause and Cause-Specific Mortality Among Individuals With Type 2 Diabetes: A Prospective Study in UK Biobank. Diabetes Care. 2022;45(2):319-29. doi: 10.2337/dc21-1512.

      (3) Jin S, Li C, Cao X, Chen C, Ye Z, Liu Z. Association of lifestyle with mortality and the mediating role of aging among older adults in China. Arch Gerontol Geriatr. 2022;98:104559. doi: 10.1016/j.archger.2021.104559.

      (4) Chudasama YV, Khunti K, Gillies CL, Dhalwani NN, Davies MJ, Yates T, Zaccardi F. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: A longitudinal cohort study. PLoS Med. 2020;17(9):e1003332. doi: 10.1371/journal.pmed.1003332.

      (5) Kim K, Zheng Y, Joyce BT, Jiang H, Greenland P, Jacobs DR, Jr., et al. Relative contributions of six lifestyle- and health-related exposures to epigenetic aging: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Epigenetics. 2022;14(1):85. doi: 10.1186/s13148-022-01304-9.

      Reviewer #2 (Public Review):

      This interesting study focuses on the association between lifestyle factors and comprehensive and organ-specific biological aging in a multi-ethnic cohort from Southwest China. It stands out for its large sample size, longitudinal design, and robust statistical analysis.

      Some issues deserve clarification to enhance this paper:

      (1) How were the biochemical indicators for organ-specific biological ages chosen, and are these indicators appropriate? Additionally, a more detailed description of the multi-organ biological ages should be provided to help understand the distribution and characteristics of BAs.

      We thank you for raising this point. As explained in our response to the fourth question from the first reviewer, we constructed the comprehensive BA b ased on all the available biochemical data from the CMEC study, selecting aging-related markers (J Gerontol A Biol Sci Med Sci, 2021), and further construct organ-specific BAs based on these selected biomarkers. The KDM algorithm does not specify biomarker types but requires them to be correlated with chronological age (CA) (Ageing Dev, 2006). Existing studies typically construct BA based on available biomarker, we included 15 biomarkers in this study, which could be considered comprehensive and extensive compared to previous research (J Transl Med. 2023; J Am Heart Assoc. 2024; Nat Cardiovasc Res. 2024). For how   the biomarkers for each organ-specific BAs were selected, we categorized biomarkers primarily based on their relevance to the structure and function of each organ system according to the classification in previous studies (Nat Med, 2023; Cell Rep, 2022). Since the biomarkers we used came from clinical-lab data sets, they were categorized based on the clinical interpretation of blood chemistry tests (Nat Med, 2023). We only used biomarkers directly related to each specific system to minimize overlap between the indicators used for different BAs, thereby preserving the distinctiveness of organ-specific BAs.

      We have added a descriptive table for the comprehensive and organ systems BAs in the supplementary materials to provide a more detailed understanding of the distribution and characteristics of BAs:

      Author response table 2.

      Description of BA and BA acceleration1

      BA, biological age

      1 Data are presented as mean (standard deviation).

      (2) The authors categorized the HLI score into a dichotomous variable, which may cause a loss of information. How did the authors address this potential issue?

      Thank you for raising this concern. We categorized each lifestyle factor into a binary variable based on relevant guidelines and studies, which recommend assigning a score of 1 if the guideline or study recommendations are met (Bmj, 2021; J Am Heart Assoc, 2023). While dichotomization may lead to some loss of information, it allows for a clearer interpretation and comparison of adherence to ideal healthy lifestyle behaviors. Another advantage of this treatment is that it allows for easy comparison with other studies. We categorized the HLI score into a dichotomous variable to enhance the practical relevance of the results (J Gerontol A Biol Sci Med Sci, 2021). Additionally, we conducted analyses using the continuous HLI score to ensure that our findings were robust, and the results were consistent with those obtained using the dichotomous HLI.

      Reference:

      (1) Verschoor CP, Belsky DW, Ma J, Cohen AA, Griffith LE, Raina P. Comparing Biological Age Estimates Using Domain-Specific Measures From the Canadian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci. 2021;76(2):187-94. doi: 10.1093/gerona/glaa151.

      (2) Klemera P, Doubal S. A new approach to the concept and computation of biological age. Mech Ageing Dev. 2006;127(3):240-8. doi: 10.1016/j.mad.2005.10.004

      (3) Zhang R, Wu M, Zhang W, Liu X, Pu J, Wei T, et al. Association between life's essential 8 and biological ageing among US adults. J Transl Med. 2023;21(1):622. doi: 10.1186/s12967-023-04495-8.

      (4) Forrester SN, Baek J, Hou L, Roger V, Kiefe CI. A Comparison of 5 Measures of Accelerated Biological Aging and Their Association With Incident Cardiovascular Disease: The CARDIA Study. J Am Heart Assoc. 2024;13(8):e032847. doi: 10.1161/jaha.123.032847.

      (5) Jiang M, Tian S, Liu S, Wang Y, Guo X, Huang T, Lin X, Belsky DW, Baccarelli AA, Gao X. Accelerated biological aging elevates the risk of cardiometabolic multimorbidity and mortality. Nat Cardiovasc Res. 2024;3(3):332-42. doi: 10.1038/s44161-024-00438-8.

      (6) Tian YE, Cropley V, Maier AB, Lautenschlager NT, Breakspear M, Zalesky A. Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat Med. 2023;29(5):1221-31. doi: 10.1038/s41591-023-02296-6.

      (7) Nie C, Li Y, Li R, Yan Y, Zhang D, Li T, et al. Distinct biological ages of organs and systems identified from a multi-omics study. Cell Rep. 2022;38(10):110459. doi: 10.1016/j.celrep.2022.110459.

      (3) Because lifestyle data are self-reported, they may suffer from recall bias. This issue needs to be addressed in the limitations section.

      Thank you for your valuable suggestion. We acknowledge that the use of self-reported lifestyle data in our study may introduce recall bias, potentially affecting the accuracy of the information collected. We have added the following statement to the limitations section of our manuscript:

      Discussion, Page 22, lines 463-464: “Fifth, assessment of lifestyle factors was based on self-reported data collected through questionnaires, which may be subject to recall bias.”

      (4) It should be clarified whether the adjusted CA is the baseline value of CA. Additionally, why did the authors choose models with additional adjustments for time-invariant variables as their primary analysis? This approach does not align with standard FEM analysis (Lines 261-263).

      Thank you for the opportunity to clarify. We have changed the sentence to “baseline CA”. For the second question, in a standard fixed effects model (FEM), only time-varying variables are typically included. However, to enhance the flexibility of our models and account for potential variations in the association of time-invariant variables with CA, as has been commonly done in previous studies, we additionally adjusted for time-invariant variables and the baseline value of CA (BMC Med Res Methodol, 2024; Am J Clin Nutr, 2020). Moreover, sensitivity analyses using the standard FEM were conducted in this study, and robust results were obtained.

      Reference:

      (1) Tang D, Hu Y, Zhang N, Xiao X, Zhao X. Change analysis for intermediate disease markers in nutritional epidemiology: a causal inference perspective. BMC Med Res Methodol. 2024;24(1):49. doi: 10.1186/s12874-024-02167-9.

      (2) Trichia E, Luben R, Khaw KT, Wareham NJ, Imamura F, Forouhi NG. The associations of longitudinal changes in consumption of total and types of dairy products and markers of metabolic risk and adiposity: findings from the European Investigation into Cancer and Nutrition (EPIC)-Norfolk study, United Kingdom. Am J Clin Nutr. 2020;111(5):1018-26. doi: 10.1093/ajcn/nqz335.

      (5) How is the relative contribution calculated in the QGC analysis? The relative contribution of some lifestyle factors is not shown in Figure 2 and the supplementary figures, such as Supplementary Figure 7. These omissions should be explained.

      Thanks for the questions. The QGC obtains causal relationships and estimates weights for each component, which has been widely used in epidemiological research. More details about QGC can be found in the supplementary methods. The reason some results are not displayed is that we assumed all healthy lifestyle changes would have a protective effect on BA acceleration. However, the effect size of some lifestyle factors did not align with this assumption and lacked statistical significance. Because positive and negative weights were calculated separately in QGC, with all positive weights summing to 1 and all negative weights summing to 1, these factors would have had large positive weights. To avoid potential misunderstandings, we chose not to include these results in the figures. We have added explanations to the figure legends where applicable:

      “The blue bars represent results that are statistically significant in the FEM analysis, while the gray bars represent results in the FEM analysis that were not found to be statistically significant and positive weights were not shown.”

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      To enhance this paper, some issues deserve clarification:

      (1) How were the biochemical indicators for organ-specific biological ages chosen, and are these indicators appropriate? Additionally, please provide a more detailed description of the multi-organ biological ages to help understand BAs' the distribution and characteristics.

      (2) The authors categorized the HLI score into a dichotomous variable, which may cause a loss of information. How did the authors address this potential issue?

      (3) Because lifestyle data are self-reported, they may suffer from recall bias. This issue needs to be addressed in the limitations section.

      (4) Lines 261-263: Please clarify if the adjusted CA is the baseline value of CA. Additionally, why did you choose models with additional adjustments for time-invariant variables as your primary analysis? This approach does not align with standard FEM analysis.

      (5) How is the relative contribution calculated in the QGC analysis? The relative contribution of some lifestyle factors is not shown in Figure 2 and the supplementary figures, such as Supplementary Figure 7. Please explain these omissions.

      The above five issues overlap with those raised by Reviewer #2 (Public Review). Please refer to the responses provided earlier.

      Minor revision:

      Line 50: The expression "which factors" should be changed to "which lifestyle factor."

      Thank you for the suggestion. As suggested, we have used “which lifestyle factor” instead.

      Lines 91-92: "Aging exhibits variations across and with individuals" appears to be a clerical error. According to the context, it should be "Aging exhibits variations across and within individuals."

      We thank the reviewer for the correction. We have updated the text to read:

      “Aging exhibits variations across and within individuals.”

      Line 154: The authors mentioned "Considering previous studies" but lacked references. Please add the appropriate citations.

      Thank you for pointing this out. We apologize for the oversight. We have now added the appropriate citations to support the statement "Considering previous studies" in the revised manuscript.

      Lines 170-171: "regular exercise ("12 times/week", "3-5 times/week," or "daily or almost every day")"; the first item in parentheses should be "1-2 times/week"? Please verify and correct if necessary. Additionally, check the entire text carefully to avoid confusion caused by clerical errors.

      Thank you for your careful review. We have changed the sentence to "1-2 times/week." We have thoroughly checked the entire manuscript to ensure that no other clerical errors remain.

      Clarifications for Table 1:

      i. The expression "HLI=0" is difficult to understand. Please provide a more straightforward explanation or rephrase it.

      Thank you for your feedback. We have removed the confusing expression and provided a clearer explanation in the table legend for better understanding:

      “For HLI (category), "healthy" corresponds to a score of 4-5, while "unfavorable" corresponds to a score of 0-3.”

      ii. The baseline age is presented as an integer, but the follow-up age is not. Please clarify this discrepancy.

      Thank you for pointing out this discrepancy. We calculated the precise chronological age based on based on participants' survey dates and birth dates for the biological age calculations. Initially, the table presented age as integers, but we have now updated it to show the precise ages.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1:

      Despite the strengths, multiple analytical decisions have to be explained, justified, or clarified. Also, there is scope to enhance the clarity and coherence of the writing - as it stands, readers will have to go back and forth to search for information. Last, it would be helpful to add line numbers in the manuscript during the revision, as this will help all reviewers to locate the parts we are talking about.

      We thank the reviewer’s suggestions have added the line numbers to the revised manuscript.

      (1) Introduction:

      The introduction is somewhat unmotivated, with key terms/concepts left unexplained until relatively late in the manuscript. One of the main focuses in this work is "hyperaltruistic", but how is this defined? It seems that the authors take the meaning of "willing to pay more to reduce other's pain than their own pain", but is this what the task is measuring? Did participants ever need to PAY something to reduce the other's pain? Note that some previous studies indeed allow participants to pay something to reduce other's pain. And what makes it "HYPER-altruistic" rather than simply "altruistic"?

      As the reviewer noted, we adopted a well-established experimental paradigm to study the context-dependent effect on hyper-altruism. Altruism refers to the fact that people take others’ welfare into account when making decisions that concern both parties. Research paradigms investigating altruistic behavior typically use a social decision task that requires participants to choose between options where their own financial interests are pitted against the welfare of others (FeldmanHall et al., 2015; Hu et al., 2021; Hutcherson et al., 2015; Teoh et al., 2020; Xiong et al., 2020). On the other hand, the hyperaltruistic tendency emphasizes subjects’ higher valuation to other’s pain than their own pain (Crockett et al., 2014, 2015, 2017; Volz et al., 2017). One example for the manifestation of hyperaltruism would be the following scenario: the subject is willing to forgo $2 to reduce others’ pain by 1 unit (social-decision task) and only willing to forgo $1 to reduce the same amount of his/her own pain (self-decision task) (Crockett et al., 2014). On the contrary, if the subjects are willing to forgo less money to reduce others’ suffering in the social decision task than in the self-decision task, then it can be claimed that no hyperaltruism is observed. Therefore, hyperaltruistic preference can only be measured by collecting subjects’ choices in both the self and social decision tasks and comparing the choices in both tasks.

      In our task, as in the studies before ours (Crockett et al., 2014, 2015, 2017; Volz et al., 2017), subjects in each trial were faced with two options with different levels of pain on others and monetary payoffs on themselves. Based on subjects’ choice data, we can infer how much subjects were willing to trade 1 unit of monetary payoff in exchange of reducing others’ pain through the regression analysis (see Figure 1 and methods for the experimental details). We have rewritten the introduction and methods sections to make this point clearer to the audience.  

      Plus, in the intro, the authors mentioned that the "boundary conditions" remain unexplored, but this idea is never touched again. What do boundary conditions mean here in this task? How do the results/data help with finding out the boundary conditions? Can this be discussed within wider literature in the Discussion section?

      Boundary conditions here specifically refer to the variables or decision contexts that determine whether hyperaltruistic behavior can be elicited. Individual personality trait, motivation and social relationship may all be boundary conditions affecting the emergence of hyperaltruistic behavior. In our task, we specifically focused on the valence of the decision context (gain vs. loss) since previous studies only tested the hyperaltruistic preference in the gain context and the introduction of the loss context might bias subjects’ hyperaltruistic behavior through implicit moral framing.

      We have explained the boundary conditions in the revised introduction (Lines 45 ~ 49).

      “However, moral norm is also context dependent: vandalism is clearly against social and moral norms yet vandalism for self-defense is more likely to be ethically and legally justified (the Doctrine of necessity). Therefore, a crucial step is to understand the boundary conditions for hyperaltruism.”

      Last, what motivated the authors to examine the decision context? It comes somewhat out of the blue that the opening paragraph states that "We set out to [...] decision context", but why? Are there other important factors? Why decision context is more important than studying those others?

      We thank the reviewer for the comment. The hyperaltruistic preference was originally demonstrated between conditions where subjects’ personal monetary gain was pitted against others’ pain (social-condition) or against subjects’ own suffering (self-condition) (Crockett et al., 2014). Follow up studies found that subjects also exhibited strong egoistic tendencies if instead subjects needed to harm themselves for other’s benefit in the social condition (by flipping the recipients of monetary gain and electric shocks) (Volz et al., 2017). However, these studies have primarily focused on the gain contexts, neglecting the fact that valence could also be an influential factor in biasing subjects’ behavior (difference between gain and loss processing in humans). It is likely that replacing monetary gains with losses in the money-pain trade-off task might bias subjects’ hyperaltruistic preference due to heightened vigilance or negative emotions in the face of potential loss (such as loss aversion) (Kahneman & Tversky, 1979; Liu et al., 2020; Pachur et al., 2018; Tom et al., 2007; Usher & McClelland, 2004; Yechiam & Hochman, 2013). Another possibility is that gain and loss contexts may elicit different subjective moral perceptions (or internal moral framings) in participants, affecting their hyperaltruistic preferences (Liu et al., 2017; Losecaat Vermeer et al., 2020; Markiewicz & Czupryna, 2018; Wu et al., 2018). In our manuscript, we did not strive to compare which factors might be more important in eliciting hyperaltruistic behavior, but rather to demonstrate the crucial role played by the decision context and to show that the internal moral framing could be the mediating factor in driving subjects’ hyperaltruistic behavior. In fact, we speculate that the egoistic tendencies found in the Volz et al. 2017 study was partly driven by the subjects’ failure to engage the proper internal moral framing in the social condition (harm for self, see Volz et al., 2017 for details).

      (2) Experimental Design:

      (2a) The experiment per se is largely solid, as it followed a previously well-established protocol. But I am curious about how the participants got instructed? Did the experimenter ever mention the word "help" or "harm" to the participants? It would be helpful to include the exact instructions in the SI.

      In the instructions, we avoided words such as “harm”, “help”, or other terms reminding subjects about the moral judgement of the decisions they were about to make. Instead, we presented the options in a neutral and descriptive manner, focusing only on the relevant components (shocks and money). The instructions for all four conditions are shown in supplementary Fig. 9.

      (2b) Relatedly, the experimental details were not quite comprehensive in the main text. Indeed, the Methods come after the main text, but to be able to guide readers to understand what was going on, it would be very helpful if the authors could include some necessary experimental details at the beginning of the Results section.

      We thank the reviewer’s suggestion. We have now provided a brief introduction of the experimental details in the revised results section (Lines 125 ~132).

      “Prior to the money-pain trade-off task, we individually calibrated each subject’s pain threshold using a standard procedure[4–6]. This allowed us to tailor a moderate electric stimulus that corresponded to each subject’s subjective pain intensity. Subjects then engaged in 240 decision trials (60 trials per condition), acting as the “decider” and trading off between monetary gains or losses for themselves and the pain experienced by either themselves or an anonymous “pain receiver” (gain-self, gain-other, loss-self and loss-other, see Supplementary Fig. 8 for the instructions and also see methods for details).”

      (3) Statistical Analysis<br /> (3a) One of the main analyses uses the harm aversion model (Eq1) and the results section keeps referring to one of the key parameters of it (ie, k). However, it is difficult to understand the text without going to the Methods section below. Hence it would be very helpful to repeat the equation also in the main text. A similar idea goes to the delta_m and delta_s terms - it will be very helpful to give a clear meaning of them, as nearly all analyses rely on knowing what they mean.

      We thank the reviewer’s suggestion. We have now added the equation of the harm aversion model and provided more detailed description to the equations in the main text (Lines 150 ~155).

      “We also modeled subjects’ choices using an influential model where subjects’ behavior could be characterized by the harm (electric shock) aversion parameter κ, reflecting the relative weights subjects assigned to ∆m and ∆s, the objective difference in money and shocks between the more and less painful options, respectively (∆V=(1-κ)∆m - κ∆s Eq.1, See Methods for details)[4–6]. Higher κ indicates that higher sensitivity is assigned to ∆s than ∆m and vice versa.”

      (3b) There is one additional parameter gamma (choice consistency) in the model. Did the authors also examine the task-related difference of gamma? This might be important as some studies have shown that the other-oriented choice consistency may differ in different prosocial contexts.

      To examine the task-related difference of choice consistency (γ), we compared the performance of 4 candidate models:

      Model 1 (M1): The choice consistency parameter γ remains constant across shock recipients (self vs. other) and decision contexts (gain vs. loss).

      Model 2 (M2): γ differs between the self- and other-recipient conditions, with γ<sub>self</sub> and γ<sub>other</sub> representing the choice consistency when pain is inflicted on him/her-self or the other-recipient.

      Model 3 (M3): γ differs between the gain and loss conditions, with γ<sub>gain</sub> and γ<sub>loss</sub> representing the choice consistencies in the gain and loss contexts, respectively.

      Model 4 (M4): γ varies across four conditions, with γ<sub>self-gain</sub>, γ<sub>other-gain</sub>, γ<sub>self-loss</sub> and γ<sub>other-loss</sub> capturing the choice consistency in each condition.

      Supplementary Fig. 10 shows, after fitting all the models to subjects’ choice behavioral data, model 1 (M1) performed the best among all the four candidate models in both studies (1 & 2) with the lowest Bayesian Information Criterion (BIC). Therefore, we conclude that factors such as the shock recipients (self vs. other) and decision contexts (gain vs. loss) did not significantly influence subjects’ choice consistency and report model results using the single choice consistency parameter.

      (3c) I am not fully convinced that the authors included two types of models: the harm aversion model and the logistic regression models. Indeed, the models look similar, and the authors have acknowledged that. But I wonder if there is a way to combine them? For example:

      Choice ~ delta_V * context * recipient (*Oxt_v._placebo)

      The calculation of delta_V follows Equation 1.

      Or the conceptual question is, if the authors were interested in the specific and independent contribution of dalta_m and dalta_s to behavior, as their logistic model did, why did the authors examine the harm aversion first, where a parameter k is controlling for the trade-off? One way to find it out is to properly run different models and run model comparisons. In the end, it would be beneficial to only focus on the "winning" model to draw inferences.

      The reviewer raised an excellent point here. According to the logistic regression model, we have:

      Where P is the probability of selecting the less harmful option. Similarly, if we combine Eq.1 (∆V=1-κ)∆m-κ∆s) and Eq.2 ) of the harm aversion model, we have:

      If we ignore the constant term β<sub>0</sub> from the logistic regression model, the harm aversion model is simply a reparameterization of the logistic regression model. The harm aversion model was implemented first to derive the harm aversion parameter (κ), which is an parameter in the range of [0 1] to quantify how subjects value the relative contribution of Δm and Δs between options in their decision processes. Since previous studies used the term κ<sub>other</sub>-κ<sub>self</sub> to define the magnitude of hyperaltruistic preference, we adopted similar approach to compare our results with previous research under the same theoretical framework. However, in order to investigate the independent contribution of Δm and Δs, we will have to take γ into account (we can see that the β<sub>∆m</sub> and β<sub>∆s</sub> in the logistic regression model are not necessarily correlated by nature; however, in the harm aversion model the coefficients (1-κ) and κ is always strictly negatively correlated (see Eq. 1). Only after multiplying γ, the correlation between γ(1-κ) and γκ will vary depending on the specific distribution of γ and κ). In summary, we followed the approach of previous research to estimate harm aversion parameter κ to compare our results with previous studies and to capture the relative influence between Δm and Δs. When we studied the contextual effects (gain vs. loss or placebo vs. control) on subjects’ behavior, we further investigated the contextual effect on how subjects evaluated Δm and Δs, respectively. The two models (logistic regression model and harm aversion model) in our study are mathematically the same and are not competitive candidate models. Instead, they represent different aspects from which our data can be examined.

      We also compared the harm aversion model with and without the constant term β<sub>0</sub> in the choice function. Adding a constant term β<sub>0</sub> the above Equation 2 becomes:

      As the following figure shows, the hyperaltruistic parameters (κ<sub>other</sub>-κ<sub>self</sub>) calculated from the harm aversion model with the constant term (panels A & B) have almost identical patterns as the model without the constant term (panels C & D, i.e. Figs. 2B & 4B in the original manuscript) in both studies.

      Author response image 1.

      Figs. 2B & 4B in the original manuscript) in both studies.

       

      (3d) The interpretation of the main OXT results needs to be more cautious. According to the operationalization, "hyperaltruistic" is the reduction of pain of others (higher % of choosing the less painful option) relative to the self. But relative to the placebo (as baseline), OXT did not increase the % of choosing the less painful option for others, rather, it decreased the % of choosing the less painful option for themselves. In other words, the degree of reducing other's pain is the same under OXT and placebo, but the degree of benefiting self-interest is reduced under OXT. I think this needs to be unpacked, and some of the wording needs to be changed. I am not very familiar with the OXT literature, but I believe it is very important to differentiate whether OXT is doing something on self-oriented actions vs other-oriented actions. Relatedly, for results such as that in Figure 5A, it would be helpful to not only look at the difference but also the actual magnitude of the sensitivity to the shocks, for self and others, under OXT and placebo.

      We thank the reviewer for this thoughtful comment. As the reviewer correctly pointed out, “hyperaltruism” can be defined as “higher % of choosing the less painful option to the others relative to the self”. Closer examination of the results showed that both the degrees of reducing other’s pain as well as reducing their own pain decreased under OXT (Figure 4A). More specifically, our results do not support the claim that “In other words, the degree of reducing others’ pain is the same under OXT and placebo, but the degree of benefiting self-interest is reduced under OXT.” Instead, the results show a significant reduction in the choice of less painful option under OXT treatment for both the self and other conditions (the interaction effect of OXT vs. placebo and self vs. other: F<sub>1.45</sub>= 16.812, P < 0.001, η<sup>2</sup> = 0.272, simple effect OXT vs. placebo in the self- condition: F<sub>1.45</sub>=59.332, P < 0.001, η<sup>2</sup> = 0.569, OXT vs. placebo in the other-condition: F<sub>1.45</sub>= 14.626, P < 0.001, η<sup>2</sup> = 0.245, repeated ANOVA, see Figure 4A).

      We also performed mixed-effect logistic regression analyses where subjects’ choices were regressed against  and  in different valences (gain vs. loss) and recipients (self vs. other) conditions in both studies 1 & 2 (Supplementary Figs. 1 & 6). As we replot supplementary Fig. 6 and panel B (included as Supplementary Fig. 8 in the supplementary materials) in the above figure, we found a significant treatment × ∆<sub>s</sub> (differences in shock magnitude between the more and less painful options) interaction effect β=0.136±0.029P < =0.001, 95% CI=[-0.192, -0.079]), indicating that subject’s sensitivities towards pain were indeed different between the placebo and OXT treatments for both self and other conditions. Furthermore, the significant four-way ∆<sub>s</sub> × treatment (OXT vs. Placebo) × context (gain vs. loss) × recipient (self vs. other) interaction effect (β=0.125±0.053, P=0.018 95% CI=[0.022, 0.228]) in the regression analysis, followed by significant simple effects (In the OXT treatment: ∆<sub>s</sub> × recipient effect in the gain context: F<sub>1.45</sub>= 7.622, P < 0.008, η<sup>2</sup> = 0.145; ∆<sub>s</sub> × recipient effect in the loss context: F<sub>1.45</sub>= 7.966, P 0.007, η<sup>2</sup> = 0.150, suggested that under OXT treatment, participants showed a greater sensitivity toward ∆<sub>s</sub> (see asterisks in the OXT condition in panel B) in the other condition than the self-condition, thus restoring the hyperaltruistic behavior in loss context.

      As the reviewer suggested, OXT’s effect on hyperaltruism does manifest separately on subjects’ harm sensitivities on self- and other-oriented actions. We followed the reviewer’s suggestions and examined the actual magnitude of the sensitivities to shocks for both the self and other treatments (panel B in the figure above). It’s clear that the administration of OXT (compared to the Placebo treatment, panel B in the figure above) significantly reduced participants’ pain sensitivity (treatment × ∆<sub>s</sub>: β=-0.136±0.029, P < 0.001, 95% CI=[-0.192,-0.079]), yet also restored the harm sensitivity patterns in both the gain and loss conditions. These results are included in the supplementary figures (6 & 8) as well as in the main texts.

      Recommendations:

      (1) For Figures 2A-B, it would be great to calculate the correlation separately for gain and loss, as in other figures.

      We speculate that the reviewer is referring to Figures 3A & B. Sorry that we did not present the correlations separately for the gain and loss contexts because the correlation between an individual’s IH (instrumental harm), IB (impartial beneficence) and hyperaltruistic preferences was not significantly modulated by the contextual factors. The interaction effects in both Figs. 3A & B and Supplementary Fig.5 (also see Table S1& S2) are as following: Study1 valence × IH effect: β=0.016±0.022, t<sub>152</sub>=0.726, P=0.469; valence × IB effect: β=0.004±0.031, t<sub>152</sub>=0.115, P=0.908; Study2 placebo condition: valence × IH effect: β=0.018±0.024, t<sub>84</sub>=0.030 P=0.463; valence × IB effect: β=0.051±0.030, t<sub>84</sub>=1.711, P=0.702. We have added these statistics to the main text following the reviewer’s suggestions.

      (2) "by randomly drawing a shock increment integer ∆s (from 1 to 19) such that [...] did not exceed 20 (𝑆+ {less than or equal to} 20)." I am not sure if a random drawing following a uniform distribution can guarantee S is smaller than 20. More details are needed. Same for the monetary magnitude.

      We are sorry for the lack of clarity in the method description. As for the task design, we followed adopted the original design from previous literature (Crockett et al., 2014, 2017). More specifically:

      “Specifically, each trial was determined by a combination of the differences of shocks (Δs, ranging from 1 to 19, with increment of 1) and money (Δm, ranging from ¥0.2 to ¥19.8, with increment of ¥0.2) between the two options, resulting in a total of 19×99=1881 pairs of [Δs, Δm]. for each trial. To ensure the trials were suitable for most subjects, we evenly distributed the desired ratio Δm / (Δs + Δm) between 0.01 and 0.99 across 60 trials for each condition. For each trial, we selected the closest [Δs, Δm] pair from the [Δs, Δm] pool to the specific Δm / (Δs + Δm) ratio, which was then used to determine the actual money and shock amounts of two options. The shock amount (S<sub>less</sub>) for the less painful option was an integer drawn from the discrete uniform distribution [1-19], constraint by S<sub>less</sub> + ∆s < 20. Similarly, the money amount (M<sub>less</sub>) for the less painful option was drawn from a discrete uniform distribution [¥0.2 - ¥19.8], with the constraint of M<sub>less</sub> + ∆m < 20. Once the S<sub>less</sub>and M<sub>less</sub> were selected, the shock (S<sub>more</sub>) and money (M<sub>more</sub>) magnitudes for the more painful option were calculated as: S<sub>more</sub> = S<sub>less</sub> + ∆s, M<sub>more</sub> = M<sub>less</sub> + ∆m”  

      We have added these details to the methods section (Lines 520-533).

      Reviewer #2:

      (1) The theoretical hypothesis needs to be better justified. There are studies addressing the neurobiological mechanism of hyperaltruistic tendency, which the authors unfortunately skipped entirely.

      Also in recommendation #1:

      (1) In the Introduction, the authors claim that "the mechanistic account of the hyperaltruistic phenomenon remains unknown". I think this is too broad of a criticism and does not do justice to prior work that does provide some mechanistic account of this phenomenon. In particular, I was surprised that the authors did not mention at all a relevant fMRI study that investigates the neural mechanism underlying hyperaltruistic tendency (Crockett et al., 2017, Nature Neuroscience). There, the researchers found that individual differences in hyperaltruistic tendency in the same type of moral decision-making task is better explained by reduced neural responses to ill-gotten money (Δm in the Other condition) in the brain reward system, rather than heightened neural responses to others' harm. Moreover, such neural response pattern is related to how an immoral choice would be judged (i.e., blamed) by the community. Since the brain reward system is consistently involved in Oxytocin's role in social cognition and decision-making (e.g., Dolen & Malenka, 2014, Biological Psychiatry), it is important to discuss the hypothesis and results of the present research in the context of this literature.

      We totally agree with the reviewer that the expression “mechanistic account of the hyperaltruistic phenomenon remains unknown” in our original manuscript can be misleading to the audience. Indeed, we were aware of the major findings in the field and cited all the seminal work of hyperaltruism and its related neural mechanism (Crockett et al., 2014, 2015, 2017). We have changed the texts in the introduction to better reflect this point and added further discussion as to how oxytocin might play a role:

      “For example, it was shown that the hyperaltruistic preference modulated neural representations of the profit gained from harming others via the functional connectivity between the lateral prefrontal cortex, a brain area involved in moral norm violation, and profit sensitive brain regions such as the dorsal striatum6.” (Lines 41~45)

      “Oxytocin has been shown to play a critical role in social interactions such as maternal attachment, pair bonding, consociate attachment and aggression in a variety of animal models[42,43]. Humans are endowed with higher cognitive and affective capacities and exhibit far more complex social cognitive patterns[44]. ” (Lines 86~90)

      (2) There are some important inconsistencies between the preregistration and the actual data collection/analysis, which the authors did not justify.

      Also in recommendations:

      (4) It is laudable that the authors pre-registered the procedure and key analysis of the Oxytocin study and determined the sample size beforehand. However, in the preregistration, the authors claimed that they would recruit 30 participants for Experiment 1 and 60 for Experiment 2, without justification. In the paper, they described a "prior power analysis", which deviated from their preregistration. It is OK to deviate from preregistration, but this needs to be explicitly mentioned and addressed (why the deviation occurred, why the reported approach was justifiable, etc.).

      We sincerely appreciate the reviewer’s thorough assessment of our manuscript. In the more exploratory study 1, we found that the loss decision context effectively diminished subjects’ hyperaltruistic preference. Based on this finding, we pre-registered study 2 and hypothesized that: 1) The administration of OXT may salvage subject’s hyperaltruistic preference in the loss context; 2) The administration of OXT may reduce subjects’ sensitivities towards electric shocks (but not necessarily their moral preference), due to the well-established results relating OXT to enhanced empathy for others (Barchi-Ferreira & Osório, 2021; Radke et al., 2013) and the processing of negative stimuli(Evans et al., 2010; Kirsch et al., 2005; Wu et al., 2020); and 3) The OXT effect might be context specific, depending on the particular combination of valence (gain vs. loss) and shock recipient (self vs. other) (Abu-Akel et al., 2015; Kapetaniou et al., 2021; Ma et al., 2015).

      As our results suggested, the administration of OXT indeed restored subjects’ hyperaltruistic preference (confirming hypothesis 1, Figure 4A). Also, OXT decreased subjects’ sensitivities towards electric shocks in both the gain and loss conditions (supplementary Fig. 6 and supplementary Fig. 8), consistent with our second hypothesis. We must admit that our hypothesis 3 was rather vague, since a seminal study clearly demonstrated the context-dependent effect of OXT in human cooperation and conflict depending on the group membership of the subjects (De Dreu et al., 2010, 2020). Although our results partially validated our hypothesis 3 (supplementary Fig. 6), we did not make specific predictions as to the direction and the magnitude of the OXT effect.

      The main inconsistency is related to the sample size. When we carried out study 1, we recruited both male and female subjects. After we identified the context effect on the hyperaltruistic preference, we decided to pre-register and perform study 2 (the OXT study). We originally made a rough estimate of 60 male subjects for study 2. While conducting study 2, we also went through the literature of OXT effect on social behavior and realized that the actual subject number around 45 might be enough to detect the main effect of OXT. Therefore, we settled on the number of 46 (study 2) reported in the manuscript. Correspondingly, we increased the subject number in study 1 to the final number of 80 (40 males) to make sure the subject number is enough to detect a small-to-medium effect, as well as to have a fair comparison between study 1 and 2 (roughly equal number of male subjects). It should be noted that although we only reported all the subjects (male & female) results of study 1 in the manuscript, the main results remain very similar if we only focus on the results of male subjects in study 1 (see the figure below). We believe that these results, together with the placebo treatment group results in study 2 (male only), confirmed the validity of our original finding.

      Author response image 2.

      Author response image 3.

      We have included additional texts (Lines 447 ~ 452) in the Methods section for the discrepancy between the preregistered and actual sample sizes in the revised manuscript:

      “It should be noted that in preregistration we originally planned to recruit 60 male subjects for Study 2 but ended up recruiting 46 male subjects (mean age =  years) based on the sample size reported in previous oxytocin studies[57,69]. Additionally, a power analysis suggested that the sample size > 44 should be enough to detect a small to median effect size of oxytocin (Cohen’s d=0.24, α=0.05, β=0.8) using a 2 × 2 × 2 within-subject design[76].”

      (3) Some of the exploratory analysis seems underpowered (e.g., large multiple regression models with only about 40 participants).

      We thank the reviewer’s comments and appreciate the concern that the sample size would be an issue affecting the results reliability in multiple regression analysis.

      In Fig. 2, the multiple regression analyses were conducted after we observed a valence-dependent effect on hyperaltruism (Fig. 2A) and the regression was constructed accordingly:

      Choice ~ ∆s *context*recipient + ∆m *context*recipient+(1+ ∆s *context*recipient + ∆s*context*recipient | subject)

      Where ∆s and ∆m indicate the shock level and monetary reward difference between the more and loss painful options, context as the monetary valence (gain vs. loss) and recipient as the identity of the shock recipient (self vs. other).

      Since we have 240 trials for each subject and a total of 80 subjects in Study 1, we believe that this is a reasonable regression analysis to perform.

      In Fig. 3, the multiple regression analyses were indeed exploratory. More specifically, we ran 3 multiple linear regressions:

      hyperaltruism~EC*context+IH*context+IB*context

      Relative harm sensitivity~ EC*context+IH*context+IB*context

      Relative money sensitivity~ EC*context+IH*context+IB*context

      Where Hyperaltruism is defined as κ<sub>other</sub> - κ<sub>self</sub>, Relative harm sensitivity as otherβ<sub>∆s</sub> - selfβ<sub>∆s</sub> and Relative monetary sensitivity as otherβ<sub>∆m</sub> - selfβ<sub>∆m</sub>. EC (empathic concern), IH (instrumental harm) and IB (impartial beneficence) were subjects’ scores from corresponding questionnaires.

      For the first regression, we tested whether EC, IH and IB scores were related to hyperaltruism and it should be noted that this was tested on 80 subjects (Study 1). After we identified the effect of IH on hyperaltruism, we ran the following two regressions. The reason we still included IB and EC as predictors in these two regression analyses was to remove potential confounds caused by EC and IB since previous research indicated that IB, IH and EC could be correlated (Kahane et al., 2018).

      In study 2, we performed the following regression analyses again to validate our results (Placebo treatment in study 2 should have similar results as found in study 1).

      Relative harm sensitivity~ EC*context+IH*context+IB*context

      Relative money sensitivity~ EC*context+IH*context+IB*context

      Again, we added IB and EC only to control for the nuance effects by the covariates. As indicated in Fig. 5 C-D, the placebo condition in study 2 replicated our previous findings in study 1 and OXT administration effectively removed the interaction effect between IH and valence (gain vs. loss) on subjects’ relative harm sensitivity.

      To more objectively present our data and results, we have changed the texts in the results section and pointed out that the regression analysis:

      hyperaltruism~EC*context+IH*context+IB*context

      was exploratory (Lines 186-192).

      “We tested how hyperaltruism was related to both IH and IB across decision contexts using an exploratory multiple regression analysis. Moral preference, defined as κ<sub>other</sub> - κ<sub>self</sub>, was negatively associated with IH (β=-0.031±0.011, t<sub>156</sub>=-2.784, P =0.006) but not with IB (β=0.008±0.016, t<sub>156</sub>=0.475, P=0.636) across gain and loss contexts, reflecting a general connection between moral preference and IH (Fig. 3A & B).”

      (4) Inaccurate conceptualization of utilitarian psychology and the questionnaire used to measure it.

      Also in recommendations:

      (2) Throughout the paper, the authors placed lots of weight on individual differences in utilitarian psychology and the Oxford Utilitarianism Scale (OUS). I am not sure this is the best individual difference measure in this context. I don't see a conceptual fit between the psychological construct that OUS reflects, and the key psychological processes underlying the behaviors in the present study. As far as I understand it, the conceptual core of utilitarian psychology that OUS captures is the maximization of greater goods. Neither the Instrumental Harm (IH) component nor the Impartial Beneficence (IB) component reflects a tradeoff between the personal interests of the decision-making agent and a moral principle. The IH component is about the endorsement of harming a smaller number of individuals for the benefit of a larger number of individuals. The IB component is about treating self, close others, and distant others equally. However, the behavioral task used in this study is neither about distributing harm between a smaller number of others and a larger number of others nor about benefiting close or distant others. The fact that IH showed some statistical association with the behavioral tendency in the present data set could be due to the conceptual overlap between IH and an individual's tendency to inflict harm (e.g., psychopathy; Table 7 in Kahane et al., 2018, which the authors cited). I urge the authors to justify more why they believe that conceptually OUS is an appropriate individual difference measure in the present study, and if so, interpret their results in a clearer and justifiable manner (taking into account the potential confound of harm tendency/psychopathy).

      We thank the reviewer for the thoughtful comment and agree that “IH component is about the endorsement of harming a smaller number of individuals for the benefit of a larger number of individuals. The IB component is about treating self, close others, and distant others equally”. As we mentioned in the previous response to the reviewer, we first ran an exploratory multiple linear regression analysis of hyperaltruistic preference (κ<sub>other</sub> - κ<sub>self</sub>) against IB and IH in study 1 based on the hypothesis that the reduction of hyperaltruistic preference in the loss condition might be due to 1) subjects’ altered altitudes between IB and hyperaltruistic preference between the gain and loss conditions, and/or 2) the loss condition changed how the moral norm was perceived and therefore affected the correlation between IH and hyperaltruistic preference. As Fig. 3 shows, we did not find a significant IB effect on hyperaltruistic preference (κ<sub>other</sub> - κ<sub>self</sub>), nor on the relative harm or money sensitivity (supplementary Fig. 3). These results excluded the possibility that subjects with higher IB might treat self and others more equally and therefore show less hyperaltruistic preference. On the other hand, we found a strong correlation between hyperaltruistic preference and IH (Fig. 3A): subjects with higher IH scores showed less hyperaltruistic preference. Since the hyperaltruistic preference (κ<sub>other</sub> - κ<sub>self</sub>) is a compound variable and we further broke it down to subjects’ relative sensitivity to harm and money (other β<sub>∆s</sub> - self β<sub>∆s</sub> and other β<sub>∆m</sub> - self β<sub>∆m</sub>, respectively). The follow up regression analyses revealed that the correlation between subjects’ relative harm sensitivity and IH was altered by the decision contexts (gain vs. loss, Fig. 3C-D). These results are consistent with our hypothesis that for subjects to engage in the utilitarian calculation, they should first realize that there is a moral dilemma (harming others to make monetary gain in the gain condition). When there is less perceived moral conflict (due to the framing of decision context as avoiding loss in the loss condition), the correlation between subjects’ relative harm sensitivity and IH became insignificant (Fig. 3C). It is worth noting that these results were further replicated in the placebo condition of study 2, further indicating the role of OXT is to affect how the decision context is morally framed.

      The reviewer also raised an interesting possibility that the correlation between subject’s behavioral tendency and IH may be confounded by the fact that IH is also correlated with other traits such as psychopathy. Indeed, in the Kahane et al., 2018 paper, the authors showed that IH was associated with subclinical psychopathy in a lay population. Although we only collected and included IB and Empathic concern (EC) scores as control variables and in principle could not rule out the influence of psychopathy, we argue it is unlikely the case. First, psychopaths by definition “only care about their own good” (Kahane et al., 2018). However, subjects in our studies, as well as in previous research, showed greater aversion to harming others (compared to harming themselves) in the gain conditions. This is opposite to the prediction of psychopathy. Even in the loss condition, subjects showed similar levels of aversion to harming others (vs. harming themselves), indicating that our subjects valuated their own and others’ well-being similarly. Second, although there appears to be an association between utilitarian judgement and psychopathy(Glenn et al., 2010; Kahane et al., 2015), the fact that people also possess a form of universal or impartial beneficence in their utilitarian judgements suggest psychopathy alone is not a sufficient variable explaining subjects’ hyperaltruistic behavior.

      We have thus rewritten part of the results to clarify our rationale for using the Oxford Utilitarianism Scale (especially the IH and IB) to establish the relationship between moral traits and subjects’ decision preference (Lines 212-215):

      “Furthermore, our results are consistent with the claim that profiting from inflicting pains on another person (IH) is inherently deemed immoral1. Hyperaltruistic preference, therefore, is likely to be associated with subjects’ IH dispositions.”

      (3) Relatedly, in the Discussion, the authors mentioned "the money-pain trade-off task, similar to the well-known trolley dilemma". I am not sure if this statement is factually accurate because the "well-known trolley dilemma" is about a disinterested third-party weighing between two moral requirements - "greatest good for the greatest number" (utilitarianism) and "do no harm" (Kantian/deontology), not between a moral requirement and one's own monetary interest (which is the focus of the present study). The analogy would be more appropriate if the task required the participants to trade off between, for example, harming one person in exchange for a charitable donation, as a recent study employed (Siegel et al., 2022, A computational account of how individuals resolve the dilemma of dirty money. Scientific reports). I urge the authors to go through their use of "utilitarian/utilitarianism” in the paper and make sure their usage aligns with the definition of the concept and the philosophical implications.

      We thank the reviewer for prompting us to think over the difference between our task and the trolley dilemma. Indeed, the trolley dilemma refers to a disinterested third-party’s decision between two moral requirements, namely, the utilitarianism and deontology. In our study, when the shock recipient was “other”, our task could be interpreted as either the decision between “moral norm of no harm (deontology) and one’s self-interest maximization (utilitarian)”, or a decision between “greatest good for both parties (utilitarian) vs. do no harm (deontology)”, though the latter interpretation typically requires differential weighing of own benefits versus the benefits of others(Fehr & Schmidt, 1999; Saez et al., 2015). In fact, it could be argued that the utilitarianism account applies not only to the third party’s well-being, but also to our own well-being, or to “that of those near or dear to us” (Kahane et al., 2018).

      We acknowledge that there may lack a direct analogy between our task and the trolley dilemma and therefore have deleted the trolley example in the discussion.

      (5) Related to the above point, the sample size of Study 2 was calculated based on the main effect of oxytocin. However, the authors also reported several regression models that seem to me more like exploratory analyses. Their sample size may not be sufficient for these analyses. The authors should: a) explicitly distinguish between their hypothesis-driven analysis and exploratory analysis; b) report achieved power of their analysis.

      We appreciate the reviewer’s thorough reading of our manuscript. Following the reviewer’s suggestions, we have explicitly stated in the revised manuscript which analyses were exploratory, and which were hypothesis driven. Following the reviewer’s request, we added the achieved power into the main texts (Lines 274-279):

      “The effect size (Cohen’s f<sup>2</sup>) for this exploratory analysis was calculated to be 0.491 and 0.379 for the placebo and oxytocin conditions, respectively. The post hoc power analysis with a significance level of α = 0.05, 7 regressors (IH, IB, EC, decision context, IH×context, IB×context, and EC×context), and sample size of N = 46 yielded achieved power of 0.910 (placebo treatment) and 0.808 (oxytocin treatment).”

      (6) Do the authors collect reaction times (RT) information? Did the decision context and oxytocin modulate RT? Based on their procedure, it seems that the authors adopted a speeded response task, therefore the RT may reflect some psychological processes independent of choice. It is also possible (and recommended) that the authors use the drift-diffusion model to quantify latent psychological processes underlying moral decision-making. It would be interesting to see if their manipulations have any impact on those latent psychological processes, in addition to explicit choice, which is the endpoint product of the latent psychological processes. There are some examples of applying DDM to this task, which the authors could refer to if they decide to go down this route (Yu et al, 2021, How peer influence shapes value computation in moral decision-making. Cognition.)

      We did collect the RT information for this experiment. As demonstrated in the figure below, participants exhibited significantly longer RT in the loss context compared to the gain context (Study1: the main effect of decision context: F<sub>1,79</sub>=20.043, P < 0.001, η<sup>2</sup> =0.202; Study2-placebo: F<sub>1.45</sub>=17.177, P < 0.001, η<sup>2</sup> =0.276). In addition to this effect of context, decisions were significantly slower in the other-condition compared to the self-condition

      (Study1: the main effect of recipient: F<sub>1,79</sub>=4.352, P < 0.040, η<sup>2</sup> =0.052; Study2-placebo: F<sub>1,45</sub>=5.601, P < 0.022, η<sup>2</sup> =0.111) which replicates previous research findings (Crockett et al., 2014). However, the differences in response time between recipients was not modulated by decision context (Study1: context × recipient interaction: F<sub>1,79</sub>=1.538, P < 0.219, η<sup>2</sup> =0.019; Study2-placebo: F<sub>1,45</sub>=2.631, P < 0.112, η<sup>2</sup> =0.055). Additionally, the results in the oxytocin study (study 2) revealed no evidence supporting any effect of oxytocin on reaction time. Neither the main effect (treatment: placebo vs. oxytocin) nor the interaction effect of oxytocin on response time was statistically significant (main effect of OXT treatment: F<sub>1,45</sub>=2.380, P < 0.230, η<sup>2</sup> =0.050; treatment × context: F<sub>1,45</sub>=2.075, P < 0.157η<sup>2</sup> =0.044; treatment × recipient: F<sub>1,45</sub>=0.266, P < 0.609, η<sup>2</sup> =0.006; treatment × context × recipient: F<sub>1,45</sub>=2.909, P < 0.095, η<sup>2</sup> =0.061).;

      Author response image 4.

      We also agree that it would be interesting to also investigate how the OXT might impact the dynamics of the decision process using a drift-diffusion model (DDM). However, we have already showed in the original manuscript that the OXT increased subjects’ relative harm sensitivities. If a canonical DDM is adopted here, then such an OXT effect is more likely to correspond to the increased drift rate for the relative harm sensitivity, which we feel still aligns with the current framework in general. In future studies, including further manipulations such as time pressure might be a more comprehensive approach to investigate the effect of OXT on DDM related decision variables such as attribute drift rate, initial bias, decision threshold and attribute synchrony.

      (7) This is just a personal preference, but I would avoid metaphoric language in a scientific paper (e.g., rescue, salvage, obliterate). Plain, neutral English terms can express the same meaning clearly (e.g., restore, vanish, eliminate).

      Again, we thank the reviewer for the suggestion and have since modified the terms.

      Reviewer #3:

      The primary weakness of the paper concerns its framing. Although it purports to be measuring "hyper-altruism" it does not provide evidence to support why any of the behavior being measured is extreme enough to warrant the modifier "hyper" (and indeed throughout I believe the writing tends toward hyperbole, using, e.g., verbs like "obliterate" rather than "reduce"). More seriously, I do not believe that the task constitutes altruism, but rather the decision to engage, or not engage, in instrumental aggression.

      We agree with the reviewer (and reviewer # 2) that plain and clear English should be used to describe our results and have since modified those terms.

      However, the term “hyperaltruism”, which is the main theme of our study, was originally proposed by a seminal paper (Crockett et al., 2014) and has since been widely adopted in related studies (Crockett et al., 2014, 2015, 2017; Volz et al., 2017; Zhan et al., 2020). The term “hyperaltruism” was introduced to emphasize the difference from altruism (Chen et al., 2024; FeldmanHall et al., 2015; Hu et al., 2021; Hutcherson et al., 2015; Lockwood et al., 2017; Xiong et al., 2020). Hyperaltruism does not indicate extreme altruism. Instead, it simply reflects the fact that “we are more willing to sacrifice gains to spare others from harm than to spare ourselves from harm” (Volz et al., 2017). In other words, altruism refers to people’s unselfish regard for or devotion to the welfare of others, and hyperaltruism concerns subject’s own cost-benefit preference as the reference point and highlights the “additional” altruistic preference when considering other’s welfare. For example, in the altruistic experimental design, altruism is characterized by the degree to which subjects take other people’s welfare into account (left panel). However, in a typical hyperaltruism task design (right panel), hyperaltruistic preference is operationally defined as the difference (κ<sub>other</sub> - κ<sub>self</sub>) between the degrees to which subjects value others’ harm (κ<sub>other</sub>) and their own harm (κ<sub>self</sub>).

      Author response image 5.

      I found it surprising that a paradigm that entails deciding to hurt or not hurt someone else for personal benefit (whether acquiring a financial gain or avoiding a loss) would be described as measuring "altruism." Deciding to hurt someone for personal benefit is the definition of instrumental aggression. I did not see that in any of the studies was there a possibility of acting to benefit the other participant in any condition. Altruism is not equivalent to refraining from engaging in instrumental aggression. True altruism would be to accept shocks to the self for the other's benefit (e.g., money).  The interpretation of this task as assessing instrumental aggression is supported by the fact that only the Instrumental Harm subscale of the OUS was associated with outcomes in the task, but not the Impartial Benevolence subscale. By contrast, the IB subscale is the one more consistently associated with altruism (e.g,. Kahane et al 2018; Amormino at al, 2022) I believe it is important for scientific accuracy for the paper, including the title, to be re-written to reflect what it is testing.

      Again, as we mentioned in the previous response, hyperaltruism is a term coined almost a decade ago and has since been widely adopted in the research field. We are afraid that switching such a term would be more likely to cause confusion (instead of clarity) among audience.

      Also, from the utilitarian perspective, the gain or loss (or harm) occurred to someone else is aligned on the same dimension and there is no discontinuity between gains and losses. Therefore, taking actions to avoid someone else’s loss can also be viewed as altruistic behavior, similar to choices increasing other’s welfare (Liu et al., 2020).

      Relatedly: in the introduction I believe it would be important to discuss the non-symmetry of moral obligations related to help/harm--we have obligations not to harm strangers but no obligation to help strangers. This is another reason I do not think the term "hyper altruism" is a good description for this task--given it is typically viewed as morally obligatory not to harm strangers, choosing not to harm them is not "hyper" altruistic (and again, I do not view it as obviously altruism at all).

      We agree with the reviewer’s point that we have the moral obligations not to harm others but no obligation to help strangers (Liu et al., 2020). In fact, this is exactly what we argued in our manuscript: by switching the decision context from gains to losses, subjects were less likely to perceive the decisions as “harming others”. Furthermore, after the administration of OXT, making decisions in both the gain and loss contexts were more perceived by subjects as harming others (Fig. 6A).

      The framing of the role of OT also felt incomplete. In introducing the potential relevance of OT to behavior in this task, it is important to pull in evidence from non-human animals on origins of OT as a hormone selected for its role in maternal care and defense (including defensive aggression). The non-human animal literature regarding the effects of OT is on the whole much more robust and definitive than the human literature. The evidence is abundant that OT motivates the defensive care of offspring of all kinds. My read of the present OT findings is that they increase participants' willingness to refrain from shocking strangers even when incurring a loss (that is, in a context where the participant is weighing harm to themselves versus harm to the other). It will be important to explain why OT would be relevant to refraining from instrumental aggression, again, drawing on the non-human animal literature.

      We thank the reviewer’s comments and agree that the current understanding of the link between our results of OT with animal literature can be at best described as vague and intriguing. Current literature on OT in animal research suggests that the nucleus accumbens (NAc) oxytocin might play the critical role in social cognition and reinforcing social interactions (Dölen et al., 2013; Dölen & Malenka, 2014; Insel, 2010). Though much insight has already been gained from animal studies, in humans, social interactions can take a variety of different forms, and the consociate recognition can also be rather dynamic. For example, male human participants with self-administered OT showed higher trust and cooperation towards in-group members but more defensive aggression towards out-group members (De Dreu et al., 2010). In another human study, participants administered with OT showed more coordinated out-group attack behavior, suggesting that OT might increase in-group efficiency at the cost of harming out-group members (Zhang et al., 2019). It is worth pointing out that in both experiments, the participant’s group membership was artificially assigned, thus highlighting the context-dependent nature of OT effect in humans.

      In our experiment, more complex and higher-level social cognitive processes such as moral framing and moral perception are involved, and OT seems to play an important role in affecting these processes. Therefore, we admit that this study, like the ones mentioned above, is rather hard to find non-human animal counterpart, unfortunately. Instead of relating OT to instrumental aggression, we aimed to provide a parsimonious framework to explain why the “hyperaltruism” disappeared in the loss condition, and, with the OT administration, reappeared in both the gain and loss conditions while also considering the effects of other relevant variables.  

      We concur with the reviewer’s comments about the importance of animal research and have since added the following paragraph into the revised manuscript (Line 86~90) as well as in the discussion:

      “Oxytocin has been shown to play a critical role in social interactions such as maternal attachment, pair bonding, consociate attachment and aggression in a variety of animal models[42,43]. Humans are endowed with higher cognitive and affective capacities and exhibit far more complex social cognitive patterns[44].”

      Another important limitation is the use of only male participants in Study 2. This was not an essential exclusion. It should be clear throughout sections of the manuscript that this study's effects can be generalized only to male participants.

      We thank the reviewer’s comments. Prior research has shown sex differences in oxytocin’s effects (Fischer-Shofty et al., 2013; Hoge et al., 2014; Lynn et al., 2014; Ma et al., 2016; MacDonald, 2013). Furthermore, with the potential confounds of OT effect due to the menstrual cycles and potential pregnancy in female subjects, most human OT studies have only recruited male subjects (Berends et al., 2019; De Dreu et al., 2010; Fischer-Shofty et al., 2010; Ma et al., 2016; Zhang et al., 2019). We have modified our manuscript to emphasize that study 2 only recruited male subjects.

      Recommendations:

      I believe the authors have provided an interesting and valuable dataset related to the willingness to engage in instrumental aggression - this is not the authors' aim, although also an important aim. Future researchers aiming to build on this paper would benefit from it being framed more accurately.

      Thus, I believe the paper must be reframed to accurately describe the nature of the task as assessing instrumental aggression. This is also an important goal, as well-designed laboratory models of instrumental aggression are somewhat lacking.

      Please see our response above that to have better connections with previous research, we believe that the term hyperaltruism might align better with the main theme for this study.

      The research literature on other aggression tasks should also be brought in, as I believe these are more relevant to the present study than research studies on altruism that are primarily donation-type tasks. It should be added to the limitations of how different aggression in a laboratory task such as this one is from real-world immoral forms of aggression. Arguably, aggression in a laboratory task in which all participants are taking part voluntarily under a defined set of rules, and in which aggression constrained by rules is mutual, is similar to aggression in sports, which is not considered immoral. Whether responses in this task would generalize to immoral forms of aggression cannot be determined without linking responses in the task to some real-world outcome.

      We agree with the reviewer that “aggression in a lab task …. is similar to aggression in sports”. Our starting point was to investigate the boundary conditions for the hyperaltruism (though we don’t deny that there is an aggression component in hyperaltruism, given the experiment design we used). In other words, the dependent variable we were interested in was the difference between “other” and “self” aggression, not the aggression itself. Our results showed that by switching the decision context from the monetary gain environment to the loss condition, human participants were willing to bear similar amounts of monetary loss to spare others and themselves from harm. That is, hyperaltruism disappeared in the loss condition. We interpreted this result as the loss condition prompted subjects to adopt a different moral framework (help vs. harm, Fig. 6A) and subjects were less influenced by their instrumental harm personality trait due to the change of moral framework (Fig. 3C). In the following study (study 2), we further tested this hypothesis and verified that the administration of OT indeed increased subjects’ perception of the task as harming others for both gain and loss conditions (Fig. 6A), and such moral perception mediated the relationship between subject’s personality traits (instrumental harm) and their relative harm sensitivities (the difference of aggression between the other- and self-conditions). We believe the moral perception framework and that OT directly modulates moral perception better account for subjects’ context-dependent choices than hypothesizing OT’s context-dependent modulation effects on aggression.

      The language should also be toned down--the use of phrases like "hyper altruism" (without independent evidence to support that designation) and "obliterate" rather than "reduce" or "eliminate" are overly hyperbolic.

      We have changed terms such as “obliterate” and “eliminate” to plain English, as the reviewer suggested.

      Reference

      Abu-Akel, A., Palgi, S., Klein, E., Decety, J., & Shamay-Tsoory, S. (2015). Oxytocin increases empathy to pain when adopting the other- but not the self-perspective. Social Neuroscience, 10(1), 7–15.

      Barchi-Ferreira, A., & Osório, F. (2021). Associations between oxytocin and empathy in humans: A systematic literature review. Psychoneuroendocrinology, 129, 105268.

      Berends, Y. R., Tulen, J. H. M., Wierdsma, A. I., van Pelt, J., Feldman, R., Zagoory-Sharon, O., de Rijke, Y. B., Kushner, S. A., & van Marle, H. J. C. (2019). Intranasal administration of oxytocin decreases task-related aggressive responses in healthy young males. Psychoneuroendocrinology, 106, 147–154.

      Chen, J., Putkinen, V., Seppälä, K., Hirvonen, J., Ioumpa, K., Gazzola, V., Keysers, C., & Nummenmaa, L. (2024). Endogenous opioid receptor system mediates costly altruism in the human brain. Communications Biology, 7(1), 1–11.

      Crockett, M. J., Kurth-Nelson, Z., Siegel, J. Z., Dayan, P., & Dolan, R. J. (2014). Harm to others outweighs harm to self in moral decision making. Proceedings of the National Academy of Sciences of the United States of America, 111(48), 17320–17325.

      Crockett, M. J., Siegel, J. Z., Kurth-Nelson, Z., Dayan, P., & Dolan, R. J. (2017). Moral transgressions corrupt neural representations of value. Nature Neuroscience, 20(6), 879–885.

      Crockett, M. J., Siegel, J. Z., Kurth-Nelson, Z., Ousdal, O. T., Story, G., Frieband, C., Grosse-Rueskamp, J. M., Dayan, P., & Dolan, R. J. (2015). Dissociable Effects of Serotonin and Dopamine on the Valuation of Harm in Moral Decision Making. Current Biology, 25(14), 1852–1859.

      De Dreu, C. K. W., Greer, L. L., Handgraaf, M. J. J., Shalvi, S., Van Kleef, G. A., Baas, M., Ten Velden, F. S., Van Dijk, E., & Feith, S. W. W. (2010). The Neuropeptide Oxytocin Regulates Parochial Altruism in Intergroup Conflict Among Humans. Science, 328(5984), 1408–1411.

      De Dreu, C. K. W., Gross, J., Fariña, A., & Ma, Y. (2020). Group Cooperation, Carrying-Capacity Stress, and Intergroup Conflict. Trends in Cognitive Sciences, 24(9), 760–776.

      Dölen, G., Darvishzadeh, A., Huang, K. W., & Malenka, R. C. (2013). Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature, 501(7466), 179–184.

      Dölen, G., & Malenka, R. C. (2014). The Emerging Role of Nucleus Accumbens Oxytocin in Social Cognition. Biological Psychiatry, 76(5), 354–355.

      Evans, S., Shergill, S. S., & Averbeck, B. B. (2010). Oxytocin Decreases Aversion to Angry Faces in an Associative Learning Task. Neuropsychopharmacology, 35(13), 2502–2509.

      Fehr, E., & Schmidt, K. M. (1999). A Theory of Fairness, Competition, and Cooperation*. The Quarterly Journal of Economics, 114(3), 817–868.

      FeldmanHall, O., Dalgleish, T., Evans, D., & Mobbs, D. (2015). Empathic concern drives costly altruism. Neuroimage, 105, 347–356.

      Fischer-Shofty, M., Levkovitz, Y., & Shamay-Tsoory, S. G. (2013). Oxytocin facilitates accurate perception of competition in men and kinship in women. Social Cognitive and Affective Neuroscience, 8(3), 313–317.

      Fischer-Shofty, M., Shamay-Tsoory, S. G., Harari, H., & Levkovitz, Y. (2010). The effect of intranasal administration of oxytocin on fear recognition. Neuropsychologia, 48(1), 179–184.

      Glenn, A. L., Koleva, S., Iyer, R., Graham, J., & Ditto, P. H. (2010). Moral identity in psychopathy. Judgment and Decision Making, 5(7), 497–505.

      Hoge, E. A., Anderson, E., Lawson, E. A., Bui, E., Fischer, L. E., Khadge, S. D., Barrett, L. F., & Simon, N. M. (2014). Gender moderates the effect of oxytocin on social judgments. Human Psychopharmacology: Clinical and Experimental, 29(3), 299–304.

      Hu, J., Hu, Y., Li, Y., & Zhou, X. (2021). Computational and Neurobiological Substrates of Cost-Benefit Integration in Altruistic Helping Decision. Journal of Neuroscience, 41(15), 3545–3561.

      Hutcherson, C. A., Bushong, B., & Rangel, A. (2015). A Neurocomputational Model of Altruistic Choice and Its Implications. Neuron, 87(2), 451–462.

      Insel, T. R. (2010). The Challenge of Translation in Social Neuroscience: A Review of Oxytocin, Vasopressin, and Affiliative Behavior. Neuron, 65(6), 768–779.

      Kahane, G., Everett, J. A. C., Earp, B. D., Caviola, L., Faber, N. S., Crockett, M. J., & Savulescu, J. (2018). Beyond sacrificial harm: A two-dimensional model of utilitarian psychology. Psychological Review, 125(2), 131–164.

      Kahane, G., Everett, J. A. C., Earp, B. D., Farias, M., & Savulescu, J. (2015). ‘Utilitarian’ judgments in sacrificial moral dilemmas do not reflect impartial concern for the greater good. Cognition, 134, 193–209.

      Kahneman, D., & Tversky, A. (1979). Prospect Theory: An Analysis of Decision under Risk. Econometrica, 47(2), 263.

      Kapetaniou, G. E., Reinhard, M. A., Christian, P., Jobst, A., Tobler, P. N., Padberg, F., & Soutschek, A. (2021). The role of oxytocin in delay of gratification and flexibility in non-social decision making. eLife, 10, e61844.

      Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005). Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans. The Journal of Neuroscience, 25(49), 11489–11493.

      Liu, J., Gu, R., Liao, C., Lu, J., Fang, Y., Xu, P., Luo, Y., & Cui, F. (2020). The Neural Mechanism of the Social Framing Effect: Evidence from fMRI and tDCS Studies. The Journal of Neuroscience, 40(18), 3646–3656.

      Liu, Y., Li, L., Zheng, L., & Guo, X. (2017). Punish the Perpetrator or Compensate the Victim? Gain vs. Loss Context Modulate Third-Party Altruistic Behaviors. Frontiers in Psychology, 8, 2066.

      Lockwood, P. L., Hamonet, M., Zhang, S. H., Ratnavel, A., Salmony, F. U., Husain, M., & Maj, A. (2017). Prosocial apathy for helping others when effort is required. Nature Human Behaviour, 1(7), 131–131.

      Losecaat Vermeer, A. B., Boksem, M. A. S., & Sanfey, A. G. (2020). Third-party decision-making under risk as a function of prior gains and losses. Journal of Economic Psychology, 77, 102206.

      Lynn, S. K., Hoge, E. A., Fischer, L. E., Barrett, L. F., & Simon, N. M. (2014). Gender differences in oxytocin-associated disruption of decision bias during emotion perception. Psychiatry Research, 219(1), 198–203.

      Ma, Y., Liu, Y., Rand, D. G., Heatherton, T. F., & Han, S. (2015). Opposing Oxytocin Effects on Intergroup Cooperative Behavior in Intuitive and Reflective Minds. Neuropsychopharmacology, 40(10), 2379–2387.

      Ma, Y., Shamay-Tsoory, S., Han, S., & Zink, C. F. (2016). Oxytocin and Social Adaptation: Insights from Neuroimaging Studies of Healthy and Clinical Populations. Trends in Cognitive Sciences, 20(2), 133–145.

      MacDonald, K. S. (2013). Sex, Receptors, and Attachment: A Review of Individual Factors Influencing Response to Oxytocin. Frontiers in Neuroscience, 6. 194.

      Markiewicz, Ł., & Czupryna, M. (2018). Cheating: One Common Morality for Gain and Losses, but Two Components of Morality Itself. Journal of Behavior Decision Making. 33(2), 166-179.

      Pachur, T., Schulte-Mecklenbeck, M., Murphy, R. O., & Hertwig, R. (2018). Prospect theory reflects selective allocation of attention. Journal of Experimental Psychology: General, 147(2), 147–169.

      Radke, S., Roelofs, K., & De Bruijn, E. R. A. (2013). Acting on Anger: Social Anxiety Modulates Approach-Avoidance Tendencies After Oxytocin Administration. Psychological Science, 24(8), 1573–1578.

      Saez, I., Zhu, L., Set, E., Kayser, A., & Hsu, M. (2015). Dopamine modulates egalitarian behavior in humans. Current Biology, 25(7), 912–919.

      Teoh, Y. Y., Yao, Z., Cunningham, W. A., & Hutcherson, C. A. (2020). Attentional priorities drive effects of time pressure on altruistic choice. Nature Communications, 11(1), 3534.

      Tom, S. M., Fox, C. R., Trepel, C., & Poldrack, R. A. (2007). The neural basis of loss aversion in decision-making under risk. Science, 315(5811), 515–518.

      Usher, M., & McClelland, J. L. (2004). Loss Aversion and Inhibition in Dynamical Models of Multialternative Choice. Psychological Review, 111(3), 757–769.

      Volz, L. J., Welborn, B. L., Gobel, M. S., Gazzaniga, M. S., & Grafton, S. T. (2017). Harm to self outweighs benefit to others in moral decision making. Proceedings of the National Academy of Sciences of the United States of America, 114(30), 7963–7968.

      Wu, Q., Mao, J., & Li, J. (2020). Oxytocin alters the effect of payoff but not base rate in emotion perception. Psychoneuroendocrinology, 114, 104608.

      Wu, S., Cai, W., & Jin, S. (2018). Gain or non-loss: The message matching effect of regulatory focus on moral judgements of other-orientation lies. International Journal of Psychology, 53(3), 223-227.

      Xiong, W., Gao, X., He, Z., Yu, H., Liu, H., & Zhou, X. (2020). Affective evaluation of others’ altruistic decisions under risk and ambiguity. Neuroimage, 218, 116996.

      Yechiam, E., & Hochman, G. (2013). Losses as modulators of attention: Review and analysis of the unique effects of losses over gains. Psychological Bulletin, 139(2), 497–518.

      Zhan, Y., Xiao, X., Tan, Q., Li, J., Fan, W., Chen, J., & Zhong, Y. (2020). Neural correlations of the influence of self-relevance on moral decision-making involving a trade-off between harm and reward. Psychophysiology, 57(9), e13590.

      Zhang, H., Gross, J., De Dreu, C., & Ma, Y. (2019). Oxytocin promotes coordinated out-group attack during intergroup conflict in humans. eLife, 8, e40698.

    1. Author Response

      The following is the authors’ response to the original reviews.

      eLife assessment

      This important work identifies a previously uncharacterized capacity for songbirds to recover vocal targets even without sensory experience. While the evidence supporting this claim is solid, with innovative experiments exploring vocal plasticity in deafened birds, additional behavioral controls and analyses are necessary to shore up the main claims. If improved, this work has the potential for broad relevance to the fields of vocal and motor learning.

      We were able to address the requests for additional behavioral controls about the balancing of the groups (reviewer 1) and the few individual birds that showed a different behavior (reviewer 2) without collecting any further data. See our detailed replies below.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Zai et al test if songbirds can recover the capacity to sing auditory targets without singing experience or sensory feedback. Past work showed that after the pitch of targeted song syllables is driven outside of birds' preferred target range with external reinforcement, birds revert to baseline (i.e. restore their song to their target). Here the authors tested the extent to which this restoration occurs in muted or deafened birds. If these birds can restore, this would suggest an internal model that allows for sensory-to-motor mapping. If they cannot, this would suggest that learning relies entirely on feedback-dependent mechanisms, e.g. reinforcement learning (RL). The authors find that deafened birds exhibit moderate but significant restoration, consistent with the existence of a previously under-appreciated internal model in songbirds.

      Strengths:

      The experimental approach of studying vocal plasticity in deafened or muted birds is innovative, technically difficult, and perfectly suited for the question of feedback-independent learning. The finding in Figure 4 that deafened birds exhibit subtle but significant plasticity toward restoration of their pre-deafening target is surprising and important for the songbird and vocal learning fields, in general.

      Weaknesses:

      The evidence and analyses related to the directed plasticity in deafened birds are confusing, and the magnitude of the plasticity is far less than the plasticity observed in control birds with intact feedback. The authors acknowledge this difference in a two-system model of vocal plasticity, but one wonders why the feedback-independent model, which could powerfully enhance learning speed, is weak in this songbird system.

      We fully agree with the reviewer. This surprising weakness applies to birds’ inability rather than our approach for characterizing it.

      There remains some confusion about the precise pitch-change methods used to study the deafened birds, including the possibility that a critical cohort of birds was not suitably balanced in a way where deafened birds were tested on their ability to implement both pitch increases and decreases toward target restoration.

      Both deaf groups were balanced: (dLO and WNd) were balanced in that half of the birds (5/10 WNm and 4/8 dLO) shifted their pitch up (thus target restoration corresponded to decreasing pitch) and half of the birds (5/10 WNd and 4/8 dLO) shifted their pitch down (thus target restoration corresponded to increasing pitch), see Methods.

      To clarify the precise pitch-change method used, we added to the methods an explanation about why we used the sensitivity index 𝒅′ in Fig. 4:

      We used sensitivity 𝒅′ relative to the last 2 h of WN/LO instead of NRP because we wanted to detect a pitch change, which is the realm of detection theory, i.e. 𝒅′. Furthermore, by measuring local changes in pitch relative to the last 2 h of WN/LO reinforcement, our measurements are only minimally affected by the amount of reinforcement learning that might have occurred during this 2 h time window — choosing an earlier or longer window would have blended reinforced pitch changes into our estimates. Last but not least, changes in the way in which we normalized 𝒅’ values — dividing by 𝑺𝑩, — or using the NRP relative to the last 2 h of WN/LO did not qualitatively change the results shown in Fig. 4D.

      Reviewer #2 (Public Review):

      Summary:

      This paper investigates the role of motor practice and sensory feedback when a motor action returns to a learned or established baseline. Adult male zebra finches perform a stereotyped, learned vocalization (song). It is possible to shift the pitch of particular syllables away from the learned baseline pitch using contingent white noise reinforcement. When the reinforcement is stopped, birds will return to their baseline over time. During the return, they often sing hundreds of renditions of the song. However, whether motor action, sensory feedback, or both during singing is necessary to return to baseline is unknown.

      Previous work has shown that there is covert learning of the pitch shift. If the output of a song plasticity pathway is blocked during learning, there is no change in pitch during the training. However, as soon as the pathway is unblocked, the pitch immediately shifts to the target location, implying that there is learning of the shift even without performance. Here, they ask whether the return to baseline from such a pitch shift also involves covert or overt learning processes. They perform a series of studies to address these questions, using muting and deafening of birds at different time points. learning.

      Strengths:

      The overall premise is interesting and the use of muting and deafening to manipulate different aspects of motor practice vs. sensory feedback is a solid approach.

      Weaknesses:

      One of the main conclusions, which stems primarily from birds deafened after being pitch-shifted using white noise (WNd) birds in comparison to birds deafened before being pitchshifted with light as a reinforcer (LOd), is that recent auditory experience can drive motor plasticity even when an individual is deprived of such experience. While the lack of shift back to baseline pitch in the LOd birds is convincing, the main conclusion hinges on the responses of just a few WNd individuals who are closer to baseline in the early period. Moreover, only 2 WNd individuals reached baseline in the late period, though neither of these were individuals who were closer to baseline in the early phase. Most individuals remain or return toward the reinforced pitch. These data highlight that while it may be possible for previous auditory experience during reinforcement to drive motor plasticity, the effect is very limited. Importantly, it's not clear if there are other explanations for the changes in these birds, for example, whether there are differences in the number of renditions performed or changes to other aspects of syllable structure that could influence measurements of pitch.

      We thank the reviewer for these detailed observations. We looked into the reviewer’s claim that our main conclusion of revertive pitch changes in deaf birds with target mismatch experience hinges on only few WNd birds in the early period.

      When we remove the three birds that were close to baseline (NRP=0) in the early period, we still get the same trend that WNd birds show revertive changes towards baseline: Early 𝒅’ = −𝟎. 𝟏𝟑, 𝒑 = 𝟎. 𝟐𝟒, tstat = −𝟎.𝟕𝟒, 𝒅𝒇 = 𝟔, 𝑵 = 𝟕 birds, one-sided t-test of H0: 𝒅′ = 𝟎; Late 𝒅’ = −𝟏. 𝟐𝟔, 𝒑 = 𝟎. 𝟎𝟖, tstat = −𝟏.𝟔𝟑, 𝒅𝒇 = 𝟔, 𝑵 = 𝟕 birds, one-sided t-test of H0: 𝒅′ = 𝟎. Furthermore, even without these three birds, bootstrapping the difference between WNd and dC birds shows the same trend in the early period (p=0.22) and a significant reversion in the late period (p<0.001). Thus, the effect of reversion towards baseline in the late period is robustly observed on a population level, even when discounting for three individual birds that the reviewer suspected would be responsible for the effect.

      Moreover, note that there are not two but three WNd individuals that reached baseline in the late period (see Figure 2C, D). One of them was already close to baseline in the early period and another one was already relatively close, too.

      Also, the considerable variability among birds is not surprising, it is to be expected that the variability across deaf birds is large because of their ongoing song degradation that might lead to a drift of pitch over time since deafening.

      Last but not least, see also our multivariate model (below).

      With regards to the “differences in the number of renditions” that could explain pitch changes: Deaf birds sing less after deafening than hearing birds: they sing less during the first 2 hours (early): 87±59 renditions (WNd) and 410±330 renditions (dLO) compared to 616±272 renditions (control birds). Also, WN deaf birds sing only 4300±2300 motif renditions between the early and late period compared to the average of 11000±3400 renditions that hearing control birds produce in the same time period. However, despite these differences, when we provide WNd birds more time to recover, namely 9 days after the early period, they sung on average 12000±6000 renditions, yet their NRP was still significantly different from zero (NRP = 0.37, p=0.007, tstat=3.47, df=9). Thus, even after producing more practice songs, deaf birds do not recover baseline pitch and so the number of songs alone cannot explain why deaf birds do not fully recover pitch. We conclude that auditory experience seems to be necessary to recover song.

      We added this information to the Results.

      In this context, note that the interesting part of our work is not that deaf birds do not fully recover, but that they recover anything at all (“main conclusion”, Fig. 4). The number of songs does not explain why deaf birds with mismatch experience (WNd, singing the least and singing significantly less than control birds, p=2.3*10-6, two-tailed t-test) partially revert song towards baseline, unlike deaf birds without mismatch experience (dLO, singing significantly more than WNd birds, p=0.008, and indistinguishable from control birds, p=0.1). We added this information to the Results section.

      With regards to ‘other aspects of syllable structure’: We did not look into this. Regardless of the outcome of such a hypothetical analysis, whether other syllable features change is irrelevant for our finding that deaf birds do not recover their target song. Nevertheless, note that in Zai et al. 2020 (supplementary Figure 1), we analyzed features other than pitch change in deaf birds. Absolute change in entropy variance was larger in deaf birds than in hearing birds, consistent with the literature on song degradation after deafening (Lombardino and Nottebohm, 2000, Nordeen and Nordeen 2010 and many others). In that paper, we found that only pitch changes consistently along the LO direction. All other features that we looked at (duration, AM, FM and entropy) did not change consistently with the LO contingency. We expect that a similar result would apply for the changes across the recovery period in WNd and dLO birds, i.e., that song degradation can be seen in many features and that pitch is the sole feature that changes consistently with reinforcement (LO/WN) direction.

      While there are examples where the authors perform direct comparisons between particular manipulations and the controls, many of the statistical analyses test whether each group is above or below a threshold (e.g. baseline) separately and then make qualitative comparisons between those groups. Given the variation within the manipulated groups, it seems especially important to determine not just whether these are different from the threshold, but how they compare to the controls. In particular, a full model with time (early, late), treatment (deafened, muted, etc), and individual ID (random variable) would substantially strengthen the analysis.

      We performed a full model of the NRP as the reviewer suggests and it supports our conclusions: Neither muting, deafening nor time without practice between R and E windows have a significant effect on pitch in the E window, but the interaction between deafening and time (late, L) results in a significant pitch change (fixed effect 0.67, p=2*10-6), demonstrating that deaf birds are significantly further away from baseline (NRP=0) than hearing birds in late windows, thereby confirming that birds require auditory feedback to recover a distant pitch target. Importantly, we find a significant fixed effect on pitch in the direction of the target with mismatch experience (fixed effect -0.37, p=0.006), supporting our finding that limited vocal plasticity towards a target is possible even without auditory feedback.

      We included this model as additional analysis to our manuscript.

      The muted birds seem to take longer to return to baseline than controls even after they are unmuted. Presumably, there is some time required to recover from surgery, however, it's unclear whether muting has longer-term effects on syrinx function or the ability to pass air. In particular, it's possible that the birds still haven't recovered by 4 days after unmuting as a consequence of the muting and unmuting procedure or that the lack of recovery is indicative of an additional effect that muting has on pitch recovery. For example, the methods state that muted birds perform some quiet vocalizations. However, if birds also attempt to sing, but just do so silently, perhaps the aberrant somatosensory or other input from singing while muted has additional effects on the ability to regain pitch. It would also be useful to know if there is a relationship between how long they are muted and how quickly they return to baseline.

      We agree, it might be the case that muting has some longer-term effects that could explain why WNm birds did not recover pitch 4 days after unmuting. However, if such an effect exists, it is only weak. Arguing against the idea that a longer muting requires longer recovery, we did not find a correlation between the difference in NRP between early and late and 1. the duration the birds were muted (correlation coefficient = -0.50, p=0.20), and 2. the number of renditions the birds sung between early and late (correlation coefficient = 0.03, p=0.95), and 3. the time since they last sung the target song (last rendition of baseline, correlation coefficient = -0.43, p=0.29). Neither did we find a correlation between the early NRP and the time since the muting surgery (correlation coefficient = 0.26, p=0.53), suggesting that the lack of pitch recovery while muted was not due to a lingering burden of the muting surgery. We added these results to the results section.

      In summary, we used the WNm group to assess whether birds can recover their target pitch in the absence of practice, i.e. whether they recovered pitch in the early time period. Whether or not some long-term effect of the muting/unmuting procedure affects recovery does not impair the main finding we obtained from WNm birds in Figure 1 (that birds do not recover without practice).

      Reviewer #3 (Public Review):

      Summary:

      Zai et al. test whether birds can modify their vocal behavior in a manner consistent with planning. They point out that while some animals are known to be capable of volitional control of vocalizations, it has been unclear if animals are capable of planning vocalizations -that is, modifying vocalizations towards a desired target without the need to learn this modification by practicing and comparing sensory feedback of practiced behavior to the behavioral target. They study zebra finches that have been trained to shift the pitch of song syllables away from their baseline values. It is known that once this training ends, zebra finches have a drive to modify pitch so that it is restored back to its baseline value. They take advantage of this drive to ask whether birds can implement this targeted pitch modification in a manner that looks like planning, by comparing the time course and magnitude of pitch modification in separate groups of birds who have undergone different manipulations of sensory and motor capabilities. A key finding is that birds who are deafened immediately before the onset of this pitch restoration paradigm, but after they have been shifted away from baseline, are able to shift pitch partially back towards their baseline target. In other words, this targeted pitch shift occurs even when birds don't have access to auditory feedback, which argues that this shift is not due to reinforcement-learning-guided practice, but is instead planned based on the difference between an internal representation of the target (baseline pitch) and current behavior (pitch the bird was singing immediately before deafening).

      The authors present additional behavioral studies arguing that this pitch shift requires auditory experience of the song in its state after it has been shifted away from baseline (birds deafened early on, before the initial pitch shift away from baseline, do not exhibit any shift back towards baseline), and that a full shift back to baseline requires auditory feedback. The authors synthesize these results to argue that different mechanisms operate for small shifts (planning, does not need auditory feedback) and large shifts (reinforcement learning, requires auditory feedback).

      We thank the reviewer for this concise summary of our paper. To clarify, we want to point out that we do not make any statement about the learning mechanism birds use to make large shifts to recover their target pitch, i.e. we do not say that large shifts are learned by reinforcement learning requiring auditory feedback. We only show that large shifts require auditory feedback.

      The authors also make a distinction between two kinds of planning: covert-not requiring any motor practice and overt-requiring motor practice but without access to auditory experience from which target mismatch could be computed. They argue that birds plan overtly, based on these deafening experiments as well as an analogous experiment involving temporary muting, which suggests that indeed motor practice is required for pitch shifts.

      Strengths:

      The primary finding (that partially restorative pitch shift occurs even after deafening) rests on strong behavioral evidence. It is less clear to what extent this shift requires practice, since their analysis of pitch after deafening takes the average over within the first two hours of singing. If this shift is already evident in the first few renditions then this would be evidence for covert planning. This analysis might not be feasible without a larger dataset. Similarly, the authors could test whether the first few renditions after recovery from muting already exhibit a shift back toward baseline.

      This work will be a valuable addition to others studying birdsong learning and its neural mechanisms. It documents features of birdsong plasticity that are unexpected in standard models of birdsong learning based on reinforcement and are consistent with an additional, perhaps more cognitive, mechanism involving planning. As the authors point out, perhaps this framework offers a reinterpretation of the neural mechanisms underlying a prior finding of covert pitch learning in songbirds (Charlesworth et al., 2012).

      A strength of this work is the variety and detail in its behavioral studies, combined with sensory and motor manipulations, which on their own form a rich set of observations that are useful behavioral constraints on future studies.

      Weaknesses:

      The argument that pitch modification in deafened birds requires some experience hearing their song in its shifted state prior to deafening (Fig. 4) is solid but has an important caveat. Their argument rests on comparing two experimental conditions: one with and one without auditory experience of shifted pitch. However, these conditions also differ in the pitch training paradigm: the "with experience" condition was performed using white noise training, while the "without experience" condition used "lights off" training (Fig. 4A). It is possible that the differences in the ability for these two groups to restore pitch to baseline reflect the training paradigm, not whether subjects had auditory experience of the pitch shift. Ideally, a control study would use one of the training paradigms for both conditions, which would be "lights off" or electrical stimulation (McGregor et al. 2022), since WN training cannot be performed in deafened birds. This is difficult, in part because the authors previously showed that "lights off" training has different valences for deafened vs. hearing birds (Zai et al. 2020). Realistically, this would be a point to add to in discussion rather than a new experiment.

      We added the following statement to our manuscript:

      It is unlikely that dLO birds’ inability to recover baseline pitch is somehow due to our use of a reinforcer of a non-auditory (visual) modality, since somatosensory stimuli do not prevent reliable target pitch recovery in hearing birds (McGregor et al 2022).

      A minor caveat, perhaps worth noting in the discussion, is that this partial pitch shift after deafening could potentially be attributed to the birds "gaining access to some pitch information via somatosensory stretch and vibration receptors and/or air pressure sensing", as the authors acknowledge earlier in the paper. This does not strongly detract from their findings as it does not explain why they found a difference between the "mismatch experience" and "no mismatch experience groups" (Fig. 4).

      We added the following statement: Our insights were gained in deaf birds and we cannot rule out that deaf birds could gain access to pitch information via somatosensoryproprioceptive sensory modalities. However, such information, even if available, cannot explain the difference between the "mismatch experience” (WNd) and the "no mismatch experience" (dLO) groups, which strengthens our claim that the pitch reversion we observe is a planned change and not merely a rigid motor response (as in simple usedependent forgetting).

      More broadly, it is not clear to me what kind of planning these birds are doing, or even whether the "overt planning" here is consistent with "planning" as usually implied in the literature, which in many cases really means covert planning. The idea of using internal models to compute motor output indeed is planning, but why would this not occur immediately (or in a few renditions), instead of taking tens to hundreds of renditions?

      Indeed, what we call ‘covert planning’ refers to what usually is called ‘planning’ in the literature. Also, there seems to be currently no evidence for spontaneous overt planning in songbirds (which we elicited with deafening). Replay of song-like syringeal muscle activity can be induced by auditory stimuli during sleep (Bush, A., Doppler, J. F., Goller, F., and Mindlin, G. B. (2018), but to our knowledge there are no reports of similar replay in awake, non-singing birds, which would constitute evidence for overt planning.

      We cannot ascertain how fast birds can plan their song changes, but our findings are not in disagreement with fast planning. The smallest time window of analysis we chose is 2h, which sets a lower bound of the time frame within which we can measure pitch changes. Our approach is probably not ideally suited for determining the minimal planning time, because the deafening and muting procedures cause an increase in song variability, which calls for larger pitch sample sizes for statistical testing, and the surgeries themselves cause a prolonged period without singing during which we have no access to the birds’ planned motor output. Note that fast planning is demonstrated by the recent finding of instant imitation in nightingales (Costalunga, Giacomo, et al. 2023) and is evidenced by fast re-pitching upon context changes in Bengalese finches (Veit, L., Tian, L. Y., Monroy Hernandez, C. J., & Brainard, M. S., 2021).

      To resolve confusion, it would be useful to discuss and add references relating "overt" planning to the broader literature on planning, including in the introduction when the concept is introduced.

      Overt and covert planning are terms used in the literature on child development and on adult learning, see (Zajic, Matthew Carl, et al., Overt planning behaviors during writing in school-age children with autism spectrum disorder and attention-deficit/hyperactivity disorder, 2020) and (Abbas zare-ee, Researching Aptitude in a Process-Based Approach to Foreign Language Writing Instruction. Advances in Language and Literary Studies, 2014), and references therein.

      Indeed, muddying the interpretation of this behavior as planning is that there are other explanations for the findings, such as use-dependent forgetting, which the authors acknowledge in the introduction, but don't clearly revisit as a possible explanation of their results. Perhaps this is because the authors equate use-dependent forgetting and overt planning, in which case this could be stated more clearly in the introduction or discussion.

      We do not mean to strictly equate use-dependent forgetting and overt planning, although they can be related, namely when ‘use’ refers to ‘altered use’ as is the case when something about the behavior is missing (e.g. auditory feedback in our study), and the dependence is not just on ‘use’ but also on ‘experience’.

      We added the following sentence to the discussion: We cannot distinguish the overt planning we find from more complex use-and-experience dependent forgetting, since we only probed for recovery of pitch and did not attempt to push birds into planning pitch shifts further away from baseline.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) The single main issue with this paper is in the section related to Figure 4, and the Figure itself - this is the most important part of the paper essential to buttress the claim of covert learning. However, there are several sources of confusion in the text, analyses, and figures. The key result is in Figure 4B, C - and, in the context of Figs 1-3, the data are significant but subtle. That is, as the authors state, the birds are mostly dependent on slow sensory feedback-dependent (possibly RL) mechanisms but there is a small component of target matching that evidences an internal model. One wonders why this capacity is so small - if they had a good internal model they'd be much faster and better at recovering target pitches after distortion-driven deviations even without sensory feedback.

      (1a) The analysis of the WNd and DLO reversions of pitch (related to Fig. 4) uses a d' analysis which is a pivot from the NRP analysis used in the rest of the paper. It is not clear why different analyses are being used here to compute essentially the same measure, i.e. how much did the pitch revert. It's also odd that different results are now obtained - Fig. 4 has a small but significant reversion of pitch in WNd birds but Fig. 2 shows no significant return to baseline.

      We did not test for reversion towards baseline in Fig. 2 and made no statement about whether there is a significant reversion or not. But when we do such a test, we find a significant reversion for WNd birds in the ‘late’ window (NRP=0.5, p=0.02, N=10, tstat=-1.77, two-tailed t-test), which agrees with Figure 4. In the ‘early’ window in Fig. 2, we find only a trend but no reversion (NRP = 0.76, p=0.11, n=10, tstat=-1.76), which contrasts with our findings in Figure 4. However, the discrepancy can be simply explained by the difference in time alignment that we detail in the Materials and Methods. Namely, in Figure 2, we measure pitch relative to the pitch in the morning on the day before, which is not a good measure of ‘reversion’ (since pitch had been reinforced further away during the day), which is why we do not present this analysis in the paper and dedicate a separate analysis in Figure 4 to reversion.

      (1b) Also in Fig. 4 is it the case that, as in the schematic of 4a, ALL birds in these experiments had their pitch pushed up - so that the return to baseline was all down? If this is the case the analysis may be contaminated by a pitch-down bias in deafened birds. This would ideally be tested with a balance of pitch-up and pitch-down birds in the pre-deafening period, and/or analysis of non-targeted harmonic stacks to examine their pitch changes. If non-targeted stacks exhibit pitch-down changes after deafening, then the reversion that forms the key discovery of this paper will be undermined. Please address.

      Both groups in Figure 4 were balanced (same number of birds were shifted their pitch up and down), see response to public review and Methods.

      (1c) After multiple re-reads and consultations with the Methods section I still do not understand the motivation or result for Figure 4E. Please provide clarification of the hypothesis/control being assessed and the outcome.

      Figure 4E does not add an additional result but strengthens our previous findings because we obtain the same result with a different method. The pitch of deaf birds tends to drift after deafening. To discount for this drift and the effect of time elapsed since deafening, we bootstrapped the magnitude of the pitch change in WNd and dLO birds by comparing them to dC birds in matched time windows. We modified the sentence in the results section to clarify this point:

      To discount for the effect of time elapsed since deafening and quantify the change in pitch specifically due to reinforcement, we bootstrapped the difference in 𝒅′ between dLO/WNd birds and a new group of dC birds that were deafened but experienced no prior reinforcement (see methods).

      (1d) Line 215. It's not clear in the text here how the WNd birds experience a pitch mismatch. Please clarify the text that this mismatch was experienced before deafening. This is a critical paragraph to set up the main claims of the paper. Also, it's not clear what is meant by 'fuel their plan'? I can imagine this would simply be a DA-dependent plasticity process in Area X that does not fuel a plan but rather re-wires and HVC timestep to medium spiny neurons whose outputs drive pitch changes - i.e. not a fueled plan but simply an RL-dependent re-mapping in the motor system. Alternatively, a change could result in plasticity in pallial circuits (e.g. auditory to HVC mappings) that are RL independent and invoke an inverse model along the lines of the author's past work (e.g. Ganguli and Hahnlsoer). This issue is taken up in the discussion but the setup here in the results is very confusing about the possible outcomes. This paragraph is vague with respect to the key hypotheses. It's possible that the WNd and DLO groups enable dissection of the two hypotheses above - because the DLO groups would presumably have RL signals but without recovery - but there remains a real lack of clarity over exactly how the authors are interpreting Fig 4 at the mechanistic level.

      WNd birds experience a pitch mismatch because while singing they hear that their pitch differs from baseline pitch, but the same is not true for dLO birds. We simply tested whether this experience makes a difference for reversion and it does. We added ‘before deafening’ to the paragraph and changed the wording of our hypothesis to make it clearer (we reworded ‘fuel their plan’). Mechanistic interpretations we left in the discussion. Without going to details, all we are saying is that birds can only plan to revert motor changes they are aware of in the first place.

      Minor issues

      The songs of deafened birds degrade, at a rate that depends on the bird's age. Younger crystalized birds degrade much faster, presumably because of lower testosterone levels that are associated with increased plasticity and LMAN function. Some background is needed on deafened birds to set up the WNd experiments.

      Despite deafening leading to the degradation of song (Lombardino and Nottebohm, 2000), syllable detection and pitch calculation were still possible in all deaf birds (up to 13-50 days after deafening surgery, age range 90-300 dph, n=44 birds).

      Since pitch shifting was balanced in both deaf bird groups (the same number of birds were up- and down-shifted), systematic changes in pitch post deafening (Lombardino and Nottebohm, 2000) will average out and so would not affect our findings.

      Lines 97-103. The paragraph is unclear and perhaps a call to a SupFig to show the lack of recovery would help. If I understand correctly, the first two birds did not exhibit the normal recovery to baseline if they did not have an opportunity to hear themselves sing without the WN. I am failing to understand this.

      In the early window (first 2 hours after unmuting) birds have not changed their pitch compared to their pitch in the corresponding window at the end of reinforcement (with matching time-of-day). We added ‘immediately after unmuting (early)’ to clarify this statement.

      Lines 68-69. What is the difference between (2) and (3)? Both require sensory representation/target to be mapped to vocal motor output. Please clarify or fuse these concepts.

      We fused the concept and changed the figure and explanation accordingly.

      Line 100. Please name the figure to support the claim.

      We marked the two birds in the Fig. 1H and added a reference in the text.

      Line 109. Is there a way to confirm / test if muted birds attempted to sing?

      Unfortunately, we do not have video recordings to check if there are any signs of singing attempts in muted birds.

      Line 296: Why 'hierarchically 'lower'?

      Lower because without it there is nothing to consolidate, i.e. the higher process can only be effective after the lower but not before. We clarified this point in the text.

      Past work on temporal - CAF (tcaf) by the Olveczky group showed that syllable durations and gaps could be reinforced in a way that does not depend on Area X and, therefore, related to the authors' discussion on the possible mechanisms of sensory-feedback independent recovery, may rely on the same neural substrates that Fig. 4 WNd group uses to recover. Yet the authors find in this paper that tCAF birds did not recover. There seems to be an oddity here - if covert recovery relies on circuits outside the basal ganglia and RL mechanisms, wouldn't t-CAF birds be more likely to recover? This is not a major issue but is a source of confusion related to the authors' interpretations that could be fleshed out.

      This is a good point, we reinvestigated the tCAF birds in the context of Fig 4 where we looked for pitch reversions towards baseline. tCAF birds do also revert towards baseline. We added this information to the supplement. We cannot say anything about the mechanistic reasons for lack of recovery, especially given that we did not look at brain-level mechanisms.

      Reviewer #2 (Recommendations For The Authors):

      The data presentation could be improved. It is difficult to distinguish between the early and late symbols and to distinguish between the colors for the individual lines on the plots or to match them with the points on the group data plots. In addition, because presumably, the points in plots like 2D are for the same individuals, lines connecting those points would be useful rather than trying to figure out which points are the same color.

      We added lines in Fig. 2D connecting the birds in early and late.

      The model illustrations (Fig 1A, Fig 5) are not intuitive and do not help to clarify the different hypotheses or ideas. I think these need to be reworked.

      We revised the model illustrations and hope they improved to clarify the different hypothesis.

      Some of the phrasing is confusing. Especially lines 157-158 and 256-257.

      Lines 157-158: we removed an instance of ‘WNd’, which was out of place.

      Lines 256-257: we rephrased to ‘showing that prior experience of a target mismatch is necessary for pitch reversion independently of auditory feedback’

      Reviewer #3 (Recommendations For The Authors):

      For Fig. 1, the conclusion in the text "Overall, these findings suggest that either motor practice, sensory feedback, or both, are necessary for the recovery of baseline song" is not aligned with the figure header "Recovery of pitch target requires practice".

      We rephrased the conclusion to: Overall, these findings rule out covert planning in muted birds and suggest that motor practice is necessary for recovery of baseline song.

      The use of the term "song experience" can be confusing as to whether it means motor or auditory experience. Perhaps replace it with "singing experience" or "auditory experience" where appropriate.

      We did the requested changes.

      Fig. 1A, and related text, reads as three hypotheses that the authors will test in the paper, but I don't think this turns out to the be the main goal (and if it is, it is not clear their results differentiate between hypotheses 1, 2, and 3). Perhaps reframe as discussion points and have this panel not be so prominent at the start, just to avoid this confusion.

      We modified the illustration in Fig 1A and simplified it. We now only show the 2 hypotheses that we test in the paper.

      Line 275-276, "preceding few hours necessitates auditory feedback, which sets a limit to zebra finches' covert planning ability". Did the authors mean "overt", not covert? Since their study focuses on overt planning.

      Our study focuses on covert planning in figure 1 and overt planning in subsequent figures.

      The purpose of the paragraph starting on line 278 could be more clear. Is the goal to say that overt planning and what has previously been described as use-dependent forgetting are actually the same thing? If not, what is the relationship between overt planning and forgetting? In other words, why should I care about prior work on use-dependent forgetting?

      We moved the paragraph further down where it does not interrupt the narrative. See also our reply to reviewer 3 on use-dependent forgetting.

      Line 294, "...a dependent process enabled by experience of the former...", was not clear what "former" is referring to. In general, this paragraph was difficult to understand. Line 296: Which is the "lower" process?

      We added explanatory parentheses in the text to clarify. We rephrased the sentence to ‘the hierarchically lower process of acquisition or planning as we find is independent of immediate sensory experience.’

      Line 295, the reference to "acquisition" vs. "retention". It is not clear how these two concepts relate to the behavior in this study, and/or the hierarchical processes referenced in the previous sentence. Overall, it is not clear how consolidation is related to the paper's findings.

      We added explanatory parentheses in the text and changed figure 5 to better explain the links.

      Line 305, add a reference to Warren et al. 2011, which I believe was the first study (or one of them) that showed that AFP bias is required for restoring pitch to baseline.

      We are citing Warren et al. 2011 in the sentence:

      Such separation also applies to songbirds. Both reinforcement learning of pitch and recovery of the original pitch baseline depend on the anterior forebrain pathway and its output, the lateral magnocellular nucleus of the anterior nidopallium (LMAN)(1).

      Line 310, "Because LMAN seems capable of executing a motor plan without sensory feedback", is this inferred from this paper (in which case this is an overreach) or is this referencing prior work (if so, which one, and please cite)?

      We changed the wording to ‘It remains to be seen whether LMAN is capable of executing a motor plans without sensory feedback’.

      Line 326, "which makes them well suited for planning song in a manner congruent with experience." I don't fully understand the logic. Can this sentence be clarified?

      We rephrased the sentence and added an explanation as follows: …which makes them well suited for executing song plans within the range of recent experience (i.e., if the song is outside recent experience, it elicits no LMAN response and so does not gain access to planning circuits).

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      In this manuscript, the authors report a molecular mechanism for recruiting syntaixn 17 (Syn17) to the closed autophagosomes through the charge interaction between enriched PI4P and the C-terminal region of Syn17. How to precisely control the location and conformation of proteins is critical for maintaining autophagic flux. Particularly, the recruitment of Syn17 to autophagosomes remains unclear. In this paper, the author describes a simple lipid-protein interaction model beyond previous studies focusing on protein-protein interactions. This represents conceptual advances.

      We would like to thank Reviewer #1 for the positive evaluation of our study.

      Reviewer #2 (Public Review):

      Summary:

      Syntaxin17 (STX17) is a SNARE protein that is recruited to mature (i.e., closed) autophagosomes, but not to immature (i.e., unclosed) ones, and mediates the autophagosome-lysosome fusion. How STX17 recognizes the mature autophagosome is an unresolved interesting question in the autophagy field. Shinoda and colleagues set out to answer this question by focusing on the C-terminal domain of STX17 and found that PI4P is a strong candidate that causes the STX17 recruitment to the autophasome.

      Strengths:

      The main findings are: 1) Rich positive charges in the C-terminal domain of STX17 are sufficient for the recruitment to the mature autophagosome; 2) Fluorescence charge sensors of different strengths suggest that autophagic membranes have negative charges and the charge increases as they mature; 3) Among a battery of fluorescence biosensors, only PI4P-binding biosensors distribute to the mature autophagosome; 4) STX17 bound to isolated autophagosomes is released by treatment with Sac1 phosphatase; 5) By dynamic molecular simulation, STX17 TM is shown to be inserted to a membrane containing PI4P but not to a membrane without it. These results indicate that PI4P is a strong candidate that STX17 binds to in the autophagosome.

      We would like to thank Reviewer #2 for pointing out these strengths.

      Weaknesses:

      • It was not answered whether PI4P is crucial for the STX17 recruitment in cells because manipulation of the PI4P content in autophagic membranes was not successful for unknown reasons.

      As we explained in the initial submission, we tried to deplete PI4P in autophagosomes by multiple methods but did not succeed. In this revised manuscript, we added the result of an experiment using the PI 4-kinase inhibitor NC03 (Figure 4―figure supplement 1), which shows no significant effect on the autophagosomal PI4P level and STX17 recruitment.

      Author response image 1.

      The PI 4-kinase inhibitor NC03 failed to suppress autophagosomal PI4P accumulation and STX17 recruitment. HEK293T cells stably expressing mRuby3–STX17TM (A) or mRuby3–CERT(PHD) (B) and Halotag-LC3 were cultured in starvation medium for 1 h and then treated with and without 10 μM NC03 for 10 min. Representative confocal images are shown. STX17TM- or CERT(PHD)-positive rates of LC3 structures per cell (n > 30 cells) are shown in the graphs. Solid horizontal lines indicate medians, boxes indicate the interquartile ranges (25th to 75th percentiles), and whiskers indicate the 5th to 95th percentiles. Differences were statistically analyzed by Welch’s t-test. Scale bars, 10 μm (main), 1 μm (inset).

      • The molecular simulation study did not show whether PI4P is necessary for the STX17 TM insertion or whether other negatively charged lipids can play a similar role.

      As the reviewer suggested, we performed the molecular dynamics simulation using membranes with phosphatidylinositol, a negatively charged lipid. STX17 TM approached the PI-containing membrane but was not inserted into the membrane within a time scale of 100 ns in simulations of all five structures. This data suggests that PI4P, which is more negatively charged than PI, is required for STX17 insertion. Thus, we have included these data in Figure 5E and F and added the following text to Lines 242–244. “Moreover, if the membrane contained phosphatidylinositol (PI) instead of PI4P, STX17 approached the PI-containing membrane but was not inserted into the membrane (Figure 5E, F, Video 3)."

      Author response image 2.

      (E) An example of a time series of simulated results of STX17TM insertion into a membrane consisting of 70% phosphatidylcholine (PC), 20% phosphatidylethanolamine (PE), and 10% phosphatidylinositol (PI). STX17TM is shown in blue. Phosphorus in PC, PE and PI are indicated by yellow, cyan, and orange, respectively. Short-tailed lipids are represented as green sticks. The time evolution series are shown in Video 3. (F) Time evolution of the z-coordinate of the center of mass (z_cm) of the transmembrane helices of STX17TM in the case of membranes with PI. Five independent simulation results are represented by solid lines of different colors. The gray dashed lines indicate the locations of the lipid heads. A scale bar indicates 5 nm.

      • The question that the authors posed in the beginning, i.e., why is STX17 recruited to the mature (closed) autophagosome but not to immature autophagic membranes, was not answered. The authors speculate that the seemingly gradual increase of negative charges in autophagic membranes is caused by an increase in PI4P. However, this was not supported by the PI4P fluorescence biosensor experiment that showed their distribution to the mature autophagosome only. Here, there are at least two possibilities: 1) The increase of negative charges in immature autophagic membranes is derived from PI4P. However the fluorescence biosensors do not bind there for some reason; for example, they are not sensitive enough to recognize PI4P until it reaches a certain level, or simply, their binding does not occur in a quantitative manner. 2) The negative charge in immature membranes is not derived from PI4P, and PI4P is generated abundantly only after autophagosomes are closed. In either case, it is not easy to explain why STX17 is recruited to the mature autophagosome only. For the first scenario, it is not clear how the PI4P synthesis is regulated so that it reaches a sufficient level only after the membrane closure. In the second case, the mechanism that produces PI4P only after the autophagosome closure needs to be elucidated (so, in this case, the question of the temporal regulation issue remains the same).

      We thank the reviewers for pointing this out. While the probe for weakly negative charges (1K8Q) labeled both immature and mature autophagosomes, the probes for intermediate charges (5K4Q and 3K6Q) and PI4P labeled only mature autophagosomes (Figure 2F, Figure 2–figure supplement 1B). Thus, we think that the autophagosomal membrane rapidly and drastically becomes negatively charged, and at the same time, PI4P is enriched. Although immature membranes may have weak negative charges, we did not examine which lipids contribute to the negative charges. Thus, we have added the following sentences to the Discussion part.

      “Our data of the 1K8Q probe suggest that immature autophagosomal membranes may also have slight negative charges (Figure 2E). Although the source of the negative charge of immature autophagosomes is currently unknown, it may be derived from low levels of PI4P, which is undetectable by the PI4P probes and/or other negatively charged lipids such as PI and PS (Schmitt et al., EMBO Rep, 2022).” (Lines 279–283) “In any case, it would be important to elucidate how PI 4-kinase activity or PI4P synthesis is upregulated during autophagosome maturation.” (Lines 302–303)

      Reviewer #3 (Public Review):

      Summary:

      In this study, the authors set out to address the question of how the SNARE protein Syntaxin 17 senses autophagosome maturation by being recruited to autophagosomal membranes only once autophagosome formation and sealing is complete. The authors discover that the C-terminal region of Syntaxin 17 is essential for its sensing mechanism that involves two transmembrane domains and a positively charged region. The authors discover that the lipid PI4P is highly enriched in mature autophagosomes and that electrostatic interaction with Syntaxin 17's positively charged region with PI4P drives recruitment specifically to mature autophagosomes. The temporal basis for PI4P enrichment and Syntaxin 17 recruitment to ensure that unsealed autophagosomes do not fuse with lysosomes is a very interesting and important discovery. Overall, the data are clear and convincing, with the study providing important mechanistic insights that will be of broad interest to the autophagy field, and also to cell biologists interested in phosphoinositide lipid biology. The author's discovery also provides an opportunity for future research in which Syntaxin 17's c-terminal region could be used to target factors of interest to mature autophagosomes.

      Strengths:

      The study combines clear and convincing cell biology data with in vitro approaches to show how Syntaxin 17 is recruited to mature autophagosomes. The authors take a methodical approach to narrow down the critical regions within Syntaxin 17 required for recruitment and use a variety of biosensors to show that PI4P is enriched on mature autophagosomes.

      We would like to thank Reviewer #3 for the positive comments.

      Weaknesses:

      There are no major weaknesses, overall the work is highly convincing. It would have been beneficial if the authors could have shown whether altering PI4P levels would affect Syntaxin 17 recruitment. However, this is understandably a challenging experiment to undertake and the authors outlined their various attempts to tackle this question.

      We thank Reviewer #3 for pointing this out. Please see our above response to Reviewer #2 (Public Review).

      In addition, clear statements within the figure legends on the number of independent experimental repeats that were conducted for experiments that were quantitated are not currently present in the manuscript.

      As pointed out by Reviewer #3, we have added the number of independent experimental repeats in the figure legends.

      Reviewer #1 (Recommendations For The Authors):

      This paper is well written and all experiments were conducted with a high standard. Several minor issues should be addressed before final publication.

      (1) To further confirm the charge interaction, a charge screening experiment should be performed for Fig. 2A.

      We have asked Reviewer #1 through the editor what this experiment meant and understood that it was to see the effects of high salt concentrations. We monitored the association of GFP-STX17TM with liposomes in the presence or absence of 1 M NaCl and found that it was blocked in a high ionic buffer. This data supports the electrostatic interaction of STX17 with membranes. We have included this data in Figure 2B and added the following sentences to Lines 124–126.

      “The association of STX17TM with PI4P-containing membranes was abolished in the presence of 1 M NaCl (Figure 2B). These data suggest that STX17 can be recruited to negatively charged membranes via electrostatic interaction independent of the specific lipid species.”

      Author response image 3.

      GFP–STX17TM translated in vitro was incubated with rhodamine-labeled liposomes containing 70% PC, 20% PE and 10% PI4P in the presence of 1 M NaCl or 1.2 M sucrose. GFP intensities of liposomes were quantified and shown as in Figure 1C (n > 30).

      (2) The authors claim that "Autophagosomes become negatively charged during maturation", based on experiments using membrane charge probes. Since it's mainly about the membrane, it's better to refine the claim to "The membrane of autophasosomes becomes...", which would be more precise and close to the topic of this paper.

      We would like to thank the reviewer for pointing this out. This point is valid. As recommended, we have collected the phrases “Autophagosomes become negatively charged during maturation” to “The membrane of autophagosomes becomes negatively charged during maturation” (Line 72, 118, 262, 969 (title of Figure2), 1068 (title of Figure2–figure supplyment1)).

      (3) The authors should add more discussion regarding the "specificity" for recruiting Syn17 through the charge interaction. Particularly, how Syn17 could be maintained before the closure of autophagosomes? For the MD simulations in Fig. 5, the current results don't add much to the manuscript. The cell biology experiments have demonstrated the conclusion. The authors could try to find more details about the insertion by analyzing the simulation movies. Do membrane packing defects play a role during the insertion process? A similar analysis was conducted for alpha-synuclein (https://pubmed.ncbi.nlm.nih.gov/33437978/).

      Regarding the mechanism of STX17 maintenance in the cytosol, we do not think that other molecules, such as chaperones, are essential because purified recombinant mGFP-STX17TM used in this study is soluble. However, it does not rule out such a mechanism, which would be a future study.

      In the paper by Liu et al. (PMID: 33437978), small liposomes with diameters of 25–50 nm are used. Therefore, there are packing defects in the highly curved membranes, to which alpha-synuclein helices are inserted in a curvature-dependent manner. On the other hand, autophagosomes are much larger (~1 um in diameter) and almost flat for STX17 molecules, so we think it is unlikely that STX17 recognizes the packing defect.

      Reviewer #2 (Recommendations For The Authors):

      • The two (and other) possibilities with regards to the interpretation of the negative charge/PI4P result in autophagic membranes are hoped to be discussed.

      As mentioned above, we have added the following sentences to the Discussion section. “Our data of the 1K8Q probe suggest that immature autophagosomal membranes may also have slight negative charges (Figure 2E). Although the source of the negative charge of immature autophagosomes is currently unknown, it may be derived from low levels of PI4P, which is undetectable by the PI4P probes and/or other negatively charged lipids such as PI and PS (Schmitt et al., EMBO Rep, 2022).” (Lines 279–283)

      “In any case, it would be important to elucidate how PI 4-kinase activity or PI4P synthesis is upregulated during autophagosome maturation.” (Lines 302–303)

      • Fluorescence biosensors are convenient to give an overview of the intracellular distribution of various lipids, but some of them show false-negative results. For example, evectin-2-PH for PS binds to endosomes but not to the plasma membrane, even though the latter contains abundant PS. With regards to PI4P, some biosensors illuminate both the Golgi and autophagosome, while others do not appear to bind the Golgi. Moreover, fluorescence biosensors for PI(3,5)P2 and PI(3,4)P2, which are also candidates for the STX17 insertion issue, are less reliable than others (e.g., those for PI3P and PI(4,5)P2). These problems need to be considered.

      We agree with Reviewer #2 that fluorescence biosensors are not perfect for detecting specific lipids. Based on the Reviewer’s suggestion, we have included a comment on this in the Discussion section as follows (Lines 265–268).

      “Given the possibility that fluorescence lipid probes may give false-negative results, a more comprehensive biochemical analysis, such as lipidomics analysis of mature autophagosomes, would be imperative to elucidate the potential involvement of other negatively charged lipids.”

      • A negative control for the PI4P biosensor, i.e., a mutant lacking the PI4P binding ability, is better to be tested to confirm the presence of PI4P in autophagosomes.

      We would like to thank the Reviewer for this comment. We conducted the suggested experiment and confirmed that the CERT(PHD)(W33A) mutant, which is deficient for PI4P binding (Sugiki et al., JBC. 2012), was diffusely present in the cytosol and did not localize to STX17-positive autophagosomes. This data supports our conclusion that PI4P is indeed present in autophagosomes. We have included this data in Figure 3–figure supplement 2A and explained it in the text (Lines 164–166).

      Author response image 4.

      Mouse embryonic fibroblasts (MEFs) stably expressing GFP–CERT(PHD)(W33A) and mRuby3–STX17TM were cultured in starvation medium for 1 h. Bars indicate 10 μm (main images) and 1 μm (insets).

      • As a control to the molecular dynamic simulation study, STX17 TM insertion into a membrane containing other negative charge lipids, especially PI, needs to be tested. PI is a negative charge lipid that is likely to exist in autophagic membranes (as suggested by the authors' past study).

      We thank the reviewers for this suggestion. As mentioned above (Reviewer #2, Public Review), we performed the molecular dynamics simulation using membranes containing PI and added the results in Figure 5E and F and Video 3.

      • If the putative role of PI4P could be shown in the cellular context, the authors' conclusion would be much strengthened. I wonder if overexpression of PI4P fluorescence biosensors, especially those that appear to bind to the autophagosome almost exclusively, may suppress the recruitment of STX17 there.

      We would like to thank the Reviewer for asking this question. In MEFs stably overexpressing PI4P probes driven by the CMV promoter, STX17 recruitment was not affected. Thus, simple overexpression of PI4P probes does not appear to be effective in masking PI4P in autophagosomes.

      Another idea is to use an appropriate molecule (e.g., WIPI2, ATG5) and to recruit Sac1 to autophagic membranes by using the FRB-FKBP system or the like. I hope these and other possibilities will be tested to confirm the importance of PI4P in the temporal regulation of STX17 recruitment.

      We tried the FRB-FKBP system using the phosphatase domain of yeast Sac1 fused to FKBP and LC3 fused to FRB, but unfortunately, this system failed to deplete PI4P from the autophagosomal membrane.

      Reviewer #3 (Recommendations For The Authors):

      A few areas for suggested improvement are:

      (1) It would be helpful if the authors could clarify for all figures how many independent experiments were conducted for all experiments, particularly those that have quantitation and statistical analyses.

      As pointed out by Reviewer #3, we have added the number of independent experimental repeats in the figure legends.

      The authors made several attempts to modulate PI4P levels on autophagosomes although understandably this proved to be challenging. A couple of suggestions are provided to address this area:

      (2) Given the reported role of GABARAPs in PI4K2a recruitment and PI4P production on autophagosomes, as well as autophagosome-lysosome fusion (Nguyen et al (2016) J Cell Biol) it would be worthwhile to assess whether GABARAP TKO cells have reduced PI4P and reduced Stx17 recruitment

      According to the Reviewer’s suggestion, we examined the localization of STX17 TM and the PI4P probe CERT(PHD) in ATG8 family (LC3/GABARAP) hexa KO HeLa cells that were established by the Lazarou lab (Nguyen et al., JCB 2016). As in WT cells, STX17 TM and CERT(PHD) were still colocalized with each other in hexa KO cells, suggesting that neither STX17 recruitment nor PI4P enrichment depends on ATG8 family proteins (note: the size of autophagosomes in HeLa cells is smaller than in MEFs, making it difficult to observe autophagosomes as ring-shaped structures). We have included this result in Figure 3–figure supplement 2(F) and explained it in the text (Lines 194–196, 198).

      Author response image 5.

      (F) WT and ATG8 hexa KO HeLa cells stably expressing GFP–STX17TM and transiently expressing mRuby3–CERT(PHD) were cultured in starvation medium. Bars indicate 10 μm (main images) and 1 μm (insets).

      (3) Can the authors try fusing Sac1 to one of the PI4P probes (CERT(PHD)) that were used, or alternatively to the c-terminus of Syntaxin 17? This approach would help to recruit Sac1 only to mature autophagosomes and could therefore prevent the autophagosome formation defect observed when fused to LC3B that targeted Sac1 to autophagosomes as they were forming. Understandably, this approach might seem a bit counterintuitive since the phosphatase is removing PI4P which is what is recruiting it but it could be a viable approach to keep PI4P levels low enough on mature autophagosomes so that Syntaxin 17 is no longer recruited. A Sac1 phosphatase mutant might be needed as a control.

      We would like to thank the Reviewer for these suggestions. We tried the phosphatase domain of yeast Sac1 or human SAC1 fused with STX17TM, but unfortunately, these fusion proteins did not deplete PI4P from autophagosomes.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Review:

      Reviewer #1:

      (1) To support the finding that texture is not represented in a modular fashion, additional possibilities must be considered. These include (a) the effectiveness and specificity of the texture stimulus and control stimuli, (b) further analysis of possible structure in images that may have been missed, and (c) limitations of imaging resolution.

      Thank you for your comments. To address your concerns, we have conducted a new 3T fMRI experiment to demonstrate the effectiveness and specificity of our stimuli, performed further analyses to investigate possible structure of texture-selective activation, and discussed the limitations of imaging resolution.

      (a) To demonstrate the effectiveness and specificity of our stimuli, we conducted a new 3T fMRI experiment in five participants using an experimental design and texture families similar to those in Freeman (2013). Six texture stimuli in the 7T experiment were also included. To assess the effectiveness of each stimulus type, different texture families and their corresponding noise patterns were presented in separate blocks for 24 seconds, at a high presentation rate of 5 frames per second. In Figure S7, all texture families showed significantly stronger activation in V2 compared to their corresponding noise patterns, even for those that ‘appeared’ to have residual texture (e.g., the third texture family). These results demonstrate that our texture vs. noise stimuli were effective in producing texture-selective activations in area V2. Compared to the 7T results, the 3T data showed a notable increase in texture-selective activations in V2, likely due to increased stimulus presentation speed (1.25 vs. 5 frames/second). Future studies should use stimuli with faster presentation speed to validate our results in the 7T experiment.

      (b)Thank you for pointing out the possible structures of texture-selective activations in the peripheral visual field (Figure S1). In further analyses, we also found stronger texture selectivity in more peripheral visual fields (Figure 2D), and there were weak but significant correlations in the texture-noise activation patterns during split-half analysis (Author response image 2). Although this is not strong evidence for columnar organization of naturalistic textures, it suggests a possibility for modular organizations in the peripheral visual field.

      (c) Although our fMRI result at 1-mm isotropic resolution did not show strong evidence for modular processing of naturalistic texture in V2 stripe columns, this does not exclude the possibility that smaller modules exist beyond the current fMRI resolution. We have discussed this possibility in the revised manuscript.

      We hope this response clarifies our findings, and we have revised the conclusions in the manuscript accordingly.

      (2) More in-depth analysis of subject data is needed. The apparent structure in the texture images in peripheral fields of some subjects calls for more detailed analysis. e.g Relationship to eccentricity and the need for a 'modularity index' to quantify the degree of modularity. A possible relationship to eccentricity should also be considered.

      Based on your recommendations, we have performed further analysis and found interesting results regarding the modularity index in relation to eccentricity. As shown in Figure 2D, the texture-selectivity index increased as eccentricity. This may suggest a higher possibility of modular organization for texture representation in the peripheral compared to central visual fields. We have updated our results in Figure 2C, and discussed this possibility in the revised manuscript.

      (3) Given what is known as a modular organization in V4 and V3 (e.g. for color, orientation, curvature), did images reveal these organizations? If so, connectivity analysis would be improved based on such ROIs. This would further strengthen the hierarchical scheme.

      Following your recommendations, we have conducted further analysis to investigate the potential modular organizations in V4 and V3ab. In Figure S9 (Figure S9), vertices that are most responsive to color, disparity and texture were shown in a representative subject. Indeed, texture-selective patches can be found in both V4 and V3ab, along with the color- and disparity-selective patches. We agree with you that there should be pathway-specific connectivity among the same type of functional modules. In the informational connectivity analyses, we already used highly informative voxels by feature selection, which should mainly represent information from the modular organizations in these higher visual areas.

      Reviewer #2:

      (1) In lines 162-163, it is stated that no clear columnar organization exists for naturalistic texture processing in V2. In my opinion, this should be rephrased. As far as I understand, Figure 2B refers to the analysis used to support the conclusion. The left and middle bar plots only show a circular analysis since ROIs were based on the color and disparity contrast used to define thin and thick stripes. The interesting graph is the right plot, which shows no statistically significant overlap of texture processing with thin, thick, and pale stripe ROIs. It should be pointed out that this analysis does not dismiss a columnar organization per se but instead only supports the conclusion of no coincidence with the CO-stripe architecture.

      Thank you for your suggestions. Reviewer #1 also raised a similar concern. We agree that there may be a smaller functional module of textures in area V2 at a finer spatial scale than our fMRI resolution. We have rephrased our conclusions to be more precise.

      (2) In Figure 3, cortical depth-dependent analyses are presented for color, disparity, and texture processing. I acknowledge that the authors took care of venous effects by excluding outlier voxels. However, the GE-BOLD signal at high magnetic fields is still biased to extravascular contributions from around larger veins. Therefore, the highest color selectivity in superficial layers might also result from the bias to draining veins and might not be of neuronal origin. Furthermore, it is interesting that cortical profiles with the highest selectivity in superficial layers show overall higher selectivity across cortical depth. Could the missing increase toward the pial surface in other profiles result from the ROI definition or overall smaller signal changes (effect size) of selected voxels? At least, a more careful interpretation and discussion would be helpful for the reader.

      We agree with you that there will be residual venous effects even after removing voxels containing large veins. However, calculating the selectivity index largely removed the superficial bias (Figure 3). In the revised manuscript, we discussed the limitations of cortical depth-dependent analysis using GE-BOLD fMRI.

      In Line 397-403: “Due to the limitations of the T2*w GE-BOLD signal in its sensitivity to large draining veins (Fracasso et al., 2021; Parkes et al., 2005; Uludag & Havlicek, 2021), the original BOLD responses were strongly biased towards the superficial depth in our data (Figure S8). Compared to GE-BOLD, VASO-CBV and SE-BOLD fMRI techniques have higher spatial specificity but much lower sensitivity (Huber et al., 2019). As shown in a recent study (Qian et al., 2024), using differential BOLD responses in a continuous­­ stimulus design can significantly enhance the laminar specificity of the feature selectivity measures in our results (Figure 3).”

      It is unlikely that the strongest color selectivity index in the superficial depth is a result of stronger signal change or larger effect size in this condition. As shown by the original BOLD responses in Figure S8, all stimulus conditions produced robust activations that strongly biased to the superficial depth. High texture selectivity was also found in V4 and V3ab across cortical depth, which showed a flat laminar profile.

      (3) I was slightly surprised that no retinotopy data was acquired. The ROI definition in the manuscript was based on a retinotopy atlas plus manual stripe segmentation of single columns. Both steps have disadvantages because they neglect individual differences and are based on subjective assessment. A few points might be worth discussing: (1) In lines 467-468, the authors state that V2 was defined based on the extent of stripes. This classical definition of area V2 was questioned by a recent publication (Nasr et al., 2016, J Neurosci, 36, 1841-1857), which showed that stripes might extend into V3. Could this have been a problem in the present analysis, e.g., in the connectivity analysis? (2) The manual segmentation depends on the chosen threshold value, which is inevitably arbitrary. Which value was used?

      A previous study showed that the retinotopic atlas of early visual areas (V1-V3) aligned very well across participants on the standard surface after surface-based registration by the anatomical landmarks (Benson 2018). Thus, the group-averaged atlas should be accurate in defining the boundaries of early visual areas. To directly demonstrate the accuracy of this method, retinotopic data were acquired in five participants in a 3T fMRI experiment. A phase-encoded method was used to define the boundaries of early visual areas (black lines in Author response image 1), which were highly consistent with the Benson atlas.

      Although a few feature-selective stripes may extend into V3, these stripe patterns were mainly represented in V2. Thus, the signal contribution from V3 is likely to be small and should not affect the pattern of results. The activation map threshold for manual segmentation was abs(T)>2. We have clarified this in the revised methods.

      Author response image 1.

      Retinotopic ROIs defined by the Benson atlas (left) and the polar angle map (right) of the representative subject. Black lines denote the boundaries of early visual areas based on the retinotopic map from the subject.

      Benson, N. C., Jamison, K. W., Arcaro, M. J., Vu, A. T., Glasser, M. F., Coalson, T. S., Van Essen, D. C., Yacoub, E., Ugurbil, K., Winawer, J., & Kay, K. (2018). The Human Connectome Project 7 Tesla retinotopy dataset: Description and population receptive field analysis. J Vis, 18(13), 23. https://doi.org/10.1167/18.13.23

      (4) The use of 1-mm isotropic voxels is relatively coarse for cortical depth-dependent analyses, especially in the early visual cortex, which is highly convoluted and has a small cortical thickness. For example, most layer-fMRI studies use a voxel size of around isotropic 0.8 mm, which has half the voxel volume of 1 mm isotropic voxels. With increasing voxel volume, partial volume effects become more pronounced. For example, partial volume with CSF might confound the analysis by introducing pulsatility effects.

      We agree that a 1-mm isotropic voxel is much larger in volume than a 0.8-mm isotropic voxel, but the resolution along the cortical depth is not a big difference. In addition to our study, a previous study showed that fMRI at 1-mm isotropic resolution is capable of resolving cortical depth-dependent signals (Roefs et al., 2024; Shao et al., 2021). We have discussed these issues about fMRI resolution in the revised manuscript.

      In Line 403-408: “Compared to the submillimeter voxels, as used in most laminar fMRI studies, our fMRI resolution at 1-mm isotropic voxel may have a stronger partial volume effect in the cortical depth-dependent analysis. However, consistent with our results, previous studies have also shown that 7T fMRI at 1-mm isotropic resolution can resolve cortical depth-dependent signals in human visual cortex (Roefs et al., 2024; Shao et al., 2021).”

      Shao, X., Guo, F., Shou, Q., Wang, K., Jann, K., Yan, L., Toga, A. W., Zhang, P., & Wang, D. J. J. (2021). Laminar perfusion imaging with zoomed arterial spin labeling at 7 Tesla. NeuroImage, 245, 118724. https://doi.org/10.1016/j.neuroimage.2021.118724

      Roefs, E. C., Schellekens, W., Báez-Yáñez, M. G., Bhogal, A. A., Groen, I. I., van Osch, M. J., ... & Petridou, N. (2024). The Contribution of the Vascular Architecture and Cerebrovascular Reactivity to the BOLD signal Formation across Cortical Depth. Imaging Neuroscience, 2, 1–19.

      (5) The SVM analysis included a feature selection step stated in lines 531-533. Although this step is reasonable for the training of a machine learning classifier, it would be interesting to know if the authors think this step could have reintroduced some bias to draining vein contributions.

      We excluded vertices with extremely large signal change and their corresponding voxels in the gray matter when defining ROIs. The same number of voxels were selected from each cortical depth for the SVM analysis, thus there was no bias in the number of voxels from the superficial layers susceptible to large draining veins.

      Reviewer #3:

      The authors tend to overclaim their results.

      Re: Thank you for your comments. We added more control analyses to strengthen our findings, and gave more appropriate discussion of results.

      Recommendations for the authors:

      Reviewer #1:

      (1) Controls: There is a bit more complexity than is expressed in the introduction. The authors hypothesize that the emergence of computational features such as texture may be reflected in specialized columns. That is, if texture is generated in V2, there may be texture columns (perhaps in the pale stripes of V2); but if generated at a higher level, then no texture columns would be needed. This is a very interesting and fundamental hypothesis. While there may be merit to this hypothesis, the demonstration that color and disparity are modular but not texture falls short of making a compelling argument. At a minimum, the finding that texture is not organized in V2 requires additional controls. (a) To boost the texture signal, additional texture stimuli or a sequence of multiple texture stimuli per trial could be considered. (b) Unfortunately, the comparison noise pattern also seems to contain texture; perhaps a less textured control could be designed. (c) It also appears that some of the texture images in Supplementary Figure S1 contain possible structure, e.g. in more peripheral visual fields. (d) Is it possible that the current imaging resolution is not sufficient for revealing texture domains? (e) Note that 'texture' may be a property that defines surfaces and not contours. Thus, while texture may have orientation content, its function may be associated with the surface processing pathways. A control stimulus might contain oriented elements of a texture stimulus that do not elicit texture percept; such a control might activate pale and/or thick stripes (both of which contain orientation domains), while the texture percept stimulus may activate surface-related bands in V4.

      Thank you for your suggestions. They are extremely helpful in improving our manuscript. For the controls you mentioned in (a-d), we discussed them in the public review that we also attached below.

      (a) and (b): To demonstrate the effectiveness and specificity of our stimuli, we conducted a new 3T fMRI experiment in five participants using an experimental design and texture families similar to those in Freeman (2013). All texture stimuli in the 7T experiment were also included. To assess the effectiveness of each stimulus type, different texture families and their corresponding noise patterns were presented in separate blocks for 24 seconds, at a high presentation rate of 5 frames per second. In Figure S7, all texture families showed significantly stronger activation in V2 compared to their corresponding noise patterns, even for those that ‘appeared’ to have residual texture (e.g., the third texture family). These results suggest that our texture stimuli were effective in producing texture-selective activations in area V2 compared to the noise control. Compared to the 7T results, the 3T data showed a notable increase in texture-selective activations in V2, likely due to the increased stimulus presentation speed (1.25 vs. 5 frames/second). Weak texture activations might preclude the detection of columnar representations in the 7T experiment.

      (c) Thank you for pointing out the possible structures of texture-selective activations in the peripheral visual field (Figure S1). In further analyses, we also found stronger texture selectivity in more peripheral visual fields (Figure 2D), and there were weak but significant correlations in the texture-noise activation patterns during split-half analysis (Author response image 2). Although these are not strong evidence for columnar organization of naturalistic textures, it suggests a possibility for such organizations in the peripheral visual field.

      (d) Although our fMRI result at 1-mm isotropic resolution did not show strong evidence for modular processing of naturalistic texture in V2 stripe columns, this does not exclude the possibility that smaller modules exist beyond the current fMRI resolution. We have discussed these limitations in the revised manuscript.

      We fully agree with your explanation in (e). It fits our data very well. Both texture and control stimuli strongly activated the CO-stripes (Figure 2 and Figure 2D), while modular organizations for texture were found in V4 and V3ab (Figure S9). We have discussed this explanation in the revised manuscript.

      In Line 371-374: “Consistently, our pilot results also revealed modular organizations for textures in V4 and V3ab (Figure S9). These texture-selective organizations may be related to surface representations in these higher order visual areas (Wang et al., 2024).”

      (2) Overly simple description of FF, FB circuitry. The classic anatomical definition of feedforward is output from a 'lower' area, in most cases predominantly arising from superficial layers and projecting to middle layers of a 'higher area' (Felleman and Van Essen 1991). This description holds for V1-to-V2, V2-to-V3, and V2-to-V4. [Note there are also feedforward projections from central 5 degrees of V1-to-V4 (cf. Ungerleider) as well as V3-to-V4.] The definition of feedback can be more varied but is generally considered from cells in superficial and deep layers of 'higher' areas projecting to superficial and deep layers of 'lower' areas. Feedback inputs to V1 heavily innervate Layer 1 and superficial Layer 2, as well as the deep layers. Note that feedback connections from V2 to V1, similar to that from V1 to V2, are functionally specific, i.e. thin-to-blob and pale/thick-to interblob (Federer...Angelucci 2021, Hu...Roe 2022). Thus, current views are moving away from the dogma that feedback is diffuse. Recognition that feedback may be modular introduces new ideas about analysis.

      Thanks for your detailed recommendations. We have expanded the discussion of circuit models of functional connectivity in the introduction. Our model and experiments primarily aim to investigate how higher-level areas provide feedback to the V2 area. While we acknowledge that feedback may indeed be functionally specific, our methodology has some certain advantages: it ensures signal stability and avoids the double-dipping issue. Meanwhile, it also focuses on voxels with high feature selectivity, which may already be included in the modular organizations of early visual areas. In the functional connectivity analysis, we performed feature selection to use the most informative voxels. These voxels with high feature selectivity should already be included in the modular organizations of early visual areas. Identifying functionally specific feedback connections between modular areas will be an important and meaningful work for future research. We have added a discussion of this topic in the revised manuscript.

      In Line 136-138: “Only major connections were shown here. There are also other connections, such as V1 interblobs projecting to thick stripes (Federer et al., 2021; Hu & Roe, 2022; Sincich and Horton, 2005).”

      (3) Imaging superficial layers: Although removal of the top layer of cortical voxels (top 5% of voxels) is a common method for dealing with surface vascular artifact contribution to BOLD signal, it likely removes a portion of the Layer 1&2 feedback signals. Is this why the authors define feedback and deep layer to deep layer? If so, both superficial and deep-layer data in Figure 4 should be explicitly explained and discussed.

      Thank you for pointing this out. We would like to clarify the surface-based method removing vascular artifact. The vertices influenced by large pial veins were first defined on the cortical surface, and then voxels were removed from the entire columns corresponding to these vertices to avoid sampling bias along the cortical depth. Thus, there should be complete data from all cortical depths for the remaining columns. We defined the feedback connectivity from deep layers to deep layers because it represents strong feedback connections according to literature (Markov et al., 2013; Ullman, 1995) and also avoids confounding the feedforward signals from superficial layers.

      Markov, N. T., Vezoli, J., Chameau, P., Falchier, A., Quilodran, R., Huissoud, C., Lamy, C., Misery, P., Giroud, P., Ullman, S., Barone, P., Dehay, C., Knoblauch, K., & Kennedy, H. (2014). Anatomy of hierarchy: feedforward and feedback pathways in macaque visual cortex. The Journal of comparative neurology, 522(1), 225–259. https://doi.org/10.1002/cne.23458

      Ullman S. (1995). Sequence seeking and counter streams: a computational model for bidirectional information flow in the visual cortex. Cerebral cortex, 5(1), 1–11. https://doi.org/10.1093/cercor/5.1.1

      (4) More detail on other subjects in Figure S1. Ten subjects conducted visual fixation and used a bite bar. Imaging data are illustrated in detail from one subject and the remaining subjects are depicted in graphs and in Supplemental Figure S1. Please provide arrowheads in each image to help guide the reader. Some kind of summary or index of modularity would also be helpful.

      Thanks for your suggestions. There are arrowheads in each image in our original manuscript and we have revised Figure S1 for better illustration. Additionally, we have added a table summarizing the number of stripes to provide a clearer overview.

      (5) How are ROIs in V3ab and V4 defined? V2 ROIs were defined (thin, thick, and pale stripe), but V3ab and V4 averaged across the whole area. Why not use the most activated "domains" from V3ab and V4? How does this influence connectivity analysis?

      Thank you for your question. We defined V4 and V3ab on the cortical surface using a retinotopic atlas (Benson 2018), which has been shown to be quite accurate in defining ROIs for the early visual areas. Since all ‘domains’ showed robust BOLD activation to our stimuli, we used voxels from the entire ROI in the depth-dependent analysis. In the functional connectivity analysis, we used the most informative voxels by feature selection, which should already be included in the feature domains.

      Minor:

      English language editing is needed.

      Thank you for your feedback. We have carefully revised the manuscript for clarity and readability.

      Line 31 "its" should be "their".

      Thank you. We have corrected "its" to "their".

      Replace 'representative subject' with 'subject'.

      We have replaced "representative subject" with "subject" in the manuscript.

      Replace 'naturalistic texture' with 'texture'.

      Thank you for your suggestion. The textures used in our experiment were generated based on the algorithm by Portilla and Simoncelli (2000), and the term "naturalistic texture" was used to be consistent with literature. The textures used in our study are different from traditional artificial textures, as they contain higher-order statistical dependencies. Following your recommendations, we have replaced ‘naturalistic texture’ with ‘texture’ in some places in the main text to improve readability.

      Typo: Line 126, Fig 2B should be 1B.

      Thank you. We have corrected "Fig 2B" to "Fig 1B" in Line 128.

      Fig. 2A: point out where are texture domains in anterior V2.

      The texture-selective activations in anterior V2 (corresponds to peripheral visual field) have been highlighted by arrowheads.

      Fig 2B, 3 legend: Round symbols are for each subject?

      Yes, the round symbols in Figures 2B represent data for individual participants. We have revised the legend for clarity.

      Fig. 3: Disparity and texture values do not look different across depth (except may the V2 texture values).

      While the difference in feature selectivity is small across cortical depths, they are highly consistent across participants. We have provided a figure showing the original BOLD responses in the revised manuscript (Figure S8 and Figure S8). Data from individual subjects were also available at Open Science Framework (OSF, https://doi.org/10.17605/OSF.IO/KSXT8 (‘rawBetaValues.mat’ in the data directory)).

      Line 57-59 The statement is not strictly accurate. V1 also has color, orientation, and motion representations.

      Thank you for your feedback. Our statement was intended to convey that M and P information from the geniculate input are transformed into representations of color, orientation, disparity, and motion in the primary visual cortex. We have clarified this point in the revised manuscript.

      In Line 58-60: “In the primary visual cortex (V1), the M and P information from the geniculate input are transformed into higher-level visual representations, such as motion, disparity, color, orientation, etc. (Tootell & Nasr, 2017).”

      Fig. 1B V1 interblobs also project to thick stripes (Sincich and Horton).

      Thank you for the additional information. We appreciate your input. Our figure is intended as a simplified schematic and does not fully represent all the connections. We have discussed this reference in the revised manuscript.

      In Line 136-138: “Only major connections were shown here. There are also other connections, such as V1 interblobs projecting to thick stripes (Federer et al., 2021; Hu & Roe, 2022; Sincich and Horton, 2005).”

      Line 207 "suggesting that both local and feedforward connections are involved in processing color information in area V2." Logic? English?

      Thank you for pointing this out. The superficial layers are involved in local intracortical processing by lateral connections and also send output to higher order visual areas along the feedforward pathway. Thus, the strongest color selectivity in the superficial depth of V2 supports that color information was processed in local neural circuits in area V2 and transmitted to higher order areas along the feedforward pathway. We have revised the manuscript for clarity.

      In Line 241-245: “According to the hierarchical model, the strongest color selectivity in the superficial cortical depth is consistent with the fact that color blobs locate in the superficial layers of V1 (Figure 1B, Felleman & Van Essen, 1991; Hubel & Livingstone, 1987; Nassi & Callaway, 2009). The strongest color selectivity in superficial V2 suggests that both local and feedforward connections are involved in processing color information (Figure 1C).”

      Line 254 "Laminar". Please use "cortical depth" or explicitly state that 'laminar' refers to superficial, middle, and deep as defined by cortical depth.

      Thank you for your suggestion. We have clarified the term "laminar" in the manuscript as referring to superficial, middle, and deep layers as defined by cortical depth.

      In Line 96-99: “To better understand the mesoscale functional organizations and neural circuits of information processing in area V2, the present study investigated laminar (or cortical depth-dependent) and columnar response profiles for color, disparity, and naturalistic texture in human V2 using 7T fMRI at 1-mm isotropic resolution.”

      Fig. S5 Please add a unit of isoluminance.

      Thank you for your suggestion. Supplementary Figure S10A and S10B illustrate the blue-matched luminance levels in RGB index. In our isoluminance experiment, blue was set as the reference color (RGB [0 0 255]) to measure the red and gray isoluminance.

      Line 448-449 To make this rationale clearer, refer to:

      Wang J, Nasr S, Roe AW, Polimeni JR. 2022. Critical factors in achieving fine‐scale functional MRI: Removing sources of inadvertent spatial smoothing. Human Brain Mapping. 43:3311-3331.

      Thank you for your suggestion. We have added this reference to better support the rationale of data analysis.

      Reviewer #2:

      (1) Line 126 should refer to Figure 1B.

      Thank you. We have corrected the reference in the revised manuscript as Figure 1B.

      (2) Even if only one naturalistic texture session was acquired per participant, it might be interesting to see the within-session repeatability by, e.g., splitting the texture runs into two halves.

      Thank you for your suggestion. We performed a split-half correlation analysis for participants who completed 10 runs in the naturalistic texture session. The result from one representative subject was shown in the figure below (for other participants, r = 0.38, 0.38, 0.24, and 0.23, respectively).

      Author response image 2.

      Split-half correlations for the texture-selective activation maps in a representative subject (S01) in V2.

      (3) Unfortunately, Figure S2 only shows the stripe ROIs but not V3ab or V4 ROIs. Including another figure that shows all ROIs in more detail would be interesting.

      Thank you for your suggestion. We have included a figure showing the ROIs for V4 and V3ab (the black dotted lines in Figure S9).

      (4) It would be helpful for the reader to have a more detailed discussion about methodological limitations, including the unspecificity of the GE-BOLD signal (Engel et al., 1997, Cereb Cortex, 7, 181-192; Parkes et al., 2005, MRM, 54, 1465-1472; Fracasso et al., 2021, Prog Neurobiol, 202, 102187) and the used voxel sizes.

      Thank you for your suggestion. We have added a more detailed discussion about the methodological limitations, including the unspecificity of the GE-BOLD signal and the voxel sizes used.

      In Line 397-408: “Due to the limitations of the T2*w GE-BOLD signal in its sensitivity to large draining veins (Fracasso et al., 2021; Parkes et al., 2005; Uludag & Havlicek, 2021), the original BOLD responses were strongly biased towards the superficial depth in our data (Figure S8). Compared to GE-BOLD, VASO-CBV and SE-BOLD fMRI techniques have higher spatial specificity but much lower sensitivity (Huber et al., 2019). As shown in a recent study (Qian et al., 2024), using differential BOLD responses in a continuous¬¬ stimulus design can significantly enhance the laminar specificity of the feature selectivity measures in our results (Figure 3). Compared to the submillimeter voxels, as used in most laminar fMRI studies, our fMRI resolution at 1-mm isotropic voxel may have a stronger partial volume effect in the cortical depth-dependent analysis. However, consistent with our results, previous studies have also shown that 7T fMRI at 1-mm isotropic resolution can resolve cortical depth-dependent signals in human visual cortex (Roefs et al., 2024; Shao et al., 2021).”

      (5) If I understand correctly, different numbers of runs/sessions were acquired for different subjects. It would be good to discuss if this could have impacted the results, e.g., different effect sizes could have biased the manual ROI definition.

      Thank you for your suggestion. Although there were differences in the number of runs/sessions acquired for different subjects, there were at least four runs of data for each experiment, which should be enough to examine the within-subject effect. We have discussed this point in the revised manuscript.

      In Line 481-484: “Although the number of runs were not equal across participants, there were at least four runs (twenty blocks for each stimulus condition) of data in each experiment, which should be sufficient to investigate within-subject effects.”

      (6) It would be good to add the software used for layer definition. Was it Laynii?

      We have provided more details in the revised methods.

      In Line 523-526: “An equi-volume method was used to calculate the relative cortical depth of each voxel to the white matter and pial surface (0: white matter surface, 1: pial surface, Supplementary Figure S11A), using mripy (https://github.com/herrlich10/mripy).”

      (7) It would be interesting to see (at least for one subject) the contrasts of color-selective thin stripes and disparity-selective thick stripes from single sessions to demonstrate the repeatability of measurements.

      Thank you for your suggestion. We have shown the test-retest reliability of the response pattern of color-selective thin stripes and disparity-selective thick stripes in a representative subject in Figure S5.

      (8) By any chance, do the authors also have resting-state data from the same subjects? It would be interesting to see the connectivity analysis between stripes and V3ab, V4 with resting-state data.

      Thank you for your suggestion. Unfortunately, we do not have resting-state data from the same subjects at this time. We agree with you that layer-specific connectivity analysis with resting-state data is very interesting and worth investigating in future studies.

      Reviewer #3:

      (1) For investigating information flow across areas, the authors rely on layer-specific informational connectivity analyses, which is an exciting approach. Covariation in decoding accuracy for a specific dependent variable between the superficial layers of a lower area and the middle layer of a higher area is taken as evidence for feedforward connectivity, whereas FB was defined as the connection between the two deep layers. Yet this method is not assumption-free. For example, the canonical idea (Figure 1C) of FF terminals exclusively arriving in layer 4 and FB terminals exclusively terminating in supra-or infragranular layers is not entirely correct. This is not even the case for area V1 - see for example Kathy Rockland's exquisite tractography studies, showing that even single axons with branches terminating in different layers. Also, feedback signals not only arrive in the deep layers of a lower area. Although these informational connectivity analyses can be suggestive of information flow, this reviewer doubts it can be considered as conclusive evidence. Therefore, the authors should drastically tone down their language in this respect, throughout the text. They present suggestive, not conclusive evidence. To obtain truly conclusive evidence, one likely has to perform laminar electrophysiological recordings simultaneously across multiple areas and infer the directionality of information flow using, for example, granger causality.

      Thank you for pointing out this important issue. In our response to a previous question (Reviewer #1, the 2nd comment), we have discussed other possible connections in addition to the canonical feedforward and feedback pathways. In the revised manuscript, the conclusion has been toned down to properly reflect our findings. However, we would also like to emphasize that our conclusion about laminar circuits was supported by converging lines of evidence. For example, in addition to the depth-dependent connectivity results, the role of feedback circuit in processing texture information was also supported by greater selectivity in V4 than V2, and the strongest deep layer selectivity in V2 (Figure 3C).

      (2) In the same realm, how reproducible are the information connectivity results? In the first part of the study, the authors performed a split-half analyses. This should be also done for Figure 4.

      Thank you for your suggestion. We have performed a split-half analysis for the informational connectivity results. As shown in Author response image 3, the results for the color experiment were robust and reproducible, while the disparity and texture connectivity results were less consistent between the two halves. The results from the second half (Author response image 3, below) are more consistent with the original findings (Figure 4). Overall, the pattern of results were qualitatively similar between the two halves. The inconsistency may be due to the fact that some participants had only four runs of data, which could make the split-half analysis less reliable.

      Author response image 3.

      Split-half analysis of informational connectivity.

      (3) Most of the other layer-specific claims (not the ones about the flow of information) are based on indices. It is unclear which ROIs contributed to these indices. Was it the entire extent of V1, V2, ...? Or only the visually-driven voxels within these areas? How exactly were the voxels selected? For V2, it would make sense to calculate the selectivity indices independently for the disparity and color-selective (putative) thick and (putative) thin stripe compartments, respectively. Adding voxels of non-selective compartments (e.g. putative thick stripe voxels for calculating the color-index; or adding putative thin-strip voxels for calculating the disparity index), will only add noise.

      In the revised manuscript, we have clarified that we selected the entire ROI in the depth-dependent analysis. Since our study does not have an independent functional localizer, using the entire ROI avoids the problem of double dipping. The processing of visual features is not confined solely to specific stripes. We have also provided a more comprehensive explanation of this issue in the discussion section.

      In Line 541-544: “For the cortical depth-dependent analyses in Figure 3, we used all voxels in the retinotopic ROI. Pooling all voxels in the ROI avoids the problem of double-dipping and also increases the signal-to-noise ratio of ROI-averaged BOLD responses.”

      (4) It is apparent from Figure 3, that the indices are largely (though not exclusively) driven by 2 subjects. Therefore, this reviewer wishes to see the raw data in addition to a table for calculating the color, disparity, and texture selectivity indices -along with the number of voxels that contributed to it.

      Thank you for your suggestion. We have provided a figure showing the original BOLD responses (Figure S8 and Figure S8). Data from individual subjects were also available at Open Science Framework (OSF, https://doi.org/10.17605/OSF.IO/KSXT8 (‘rawBetaValues.mat’ in the data directory)).

      Minor:

      (1) I typically find inferences about 'layer fMRI' vastly overstated. We all know that fMRI does not (yet) provide laminar-specific resolution, i.e., whereby meaningful differences in fMRI signals can be extracted from all 6 individual layers of neocortex, without partial volume effects, or without taking into account pre-and postsynaptic contributions of neurons to the fMRI signal (the cell bodies may very well lay in different layers than the dendritic trees etc.), or without taking into account the vascular anatomy, etc. The authors should use the term cortical depth-dependent fMRI throughout the text -as they do in the abstract and intro.

      Thank you for pointing out this important issue. We have now defined the meaning of layer or laminar as “cortical depth-dependent” in the introduction, to be consistent with the terminology in most published papers on this topic.

      (2) 1st sentence abstract: I disagree with this statement. The parallel streams in intermediate-level areas are probably equally well studied as the geniculostriate pathway -already starting with the seminal work of Hubel, Livingstone, and more recently by Angelucci and co-workers who looked in detail at the anatomical and functional interactions across sub-compartments of V1 and V2.

      Thank you for your feedback. In the revised manuscript, we have removed the term "much" from the first sentence of the abstract. Although there have been seminal studies of V2 sub-compartments in monkeys, only a few fMRI studies investigated this issue in humans.

      (3) The authors show inter-session correlations for color and disparity. This reviewer would like to see test-retest images since the explained variance is not terribly good. Also, show the correlation values for the inter-session texture beta values.

      Thank you for your suggestion. We have performed the test-retest reliability analysis of texture-selective patterns in the response to a previous question (Reviewer #2, the 2nd comment, Author response image 2).

      (4) The stripe definitions are threshold dependent. Please clarify whether the reported results are threshold-independent.

      Thank you for your question. To address your concern, we defined the stripe ROIs using different thresholds, and the results remained consistent. Specifically, we ranked the voxels in manually defined stripe ROIs by the color-disparity response. We then defined the lowest 10% as the thick stripe voxels, the highest 10% as thin stripe voxels, and the middle 10% as pale stripe voxels. Additionally, we adjusted the thresholds to 20% and 30% to define the three stripes (with 30% being the least strict threshold). Feature selectivities at different thresholds were shown in Figure S6 (from left to right: 10%, 20%, 30%). Notably, in all threshold conditions, there was no significant difference in texture selectivity across different stripes.

      (5) How were the visual areas defined?

      In the revised manuscript, we have provided a detailed description about methods.

      In Line 531-535: “ROIs were defined on the inflated cortical surface. Surface ROIs for V1, V2, V3ab, and V4 were defined based on the polar angle atlas from the 7T retinotopic dataset of Human Connectome Project (Benson et al., 2014, 2018). Moreover, the boundary of V2 was edited manually based on columnar patterns. All ROIs were constrained to regions where mean activation across all stimulus conditions exceeded 0.”

      (6) "According to the hierarchical model in Figure 1B and 1C, the strongest color selectivity in the superficial cortical depth is consistent with the fact that color blobs mainly locate in the superficial layers of V1, suggesting that both local and feedforward connections are involved in processing color information in area V2." But color-selective activation within V2 could be also consistent with feedback from other areas (some of which were not covered in the present experiments) -the more since most parts of the brain were not covered (i.e. a slab of 4 cm was covered)?

      Thank you for reminding us about this issue. We have discussed the possibility of feedback influence in explanation of the superficial bias of color selectivity in area V2.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews: 

      Reviewer #1 (Public review):

      Summary: 

      Authors benchmarked 5 IBD detection methods (hmmIBD, isoRelate, hap-IBD, phasedIBD, and Refined IBD) in Plasmodium falciparum using simulated and empirical data. Plasmodium falciparum has a mutation rate similar to humans but a much higher recombination rate and lower SNP density. Thus, the authors evaluated how recombination rate and marker density affect IBD segment detection. Next, they performed parameter optimization for Plasmodium falciparum and benchmarked the robustness of downstream analyses (selection detection and Ne inference) using IBD detected by each of the methods. They also tracked the computational efficiency of these methods. The authors work is valuable for the tested species and the analyses presented appear to support their claim that users should be cautious calling IBD when SNP density is low and recombination rate is high. 

      Strengths: 

      The study design was solid. The authors set up their reasoning for using P. falciparum very well. The high recombination rate and similar mutation rate to humans is indeed an interesting case. Further, they chose methods that were developed explicitly for each species. This was a strength of the work, as well as incorporating both simulated and empirical data to support their goal that IBD detection should be benchmarked in P. falciparum

      Weaknesses: 

      The scope of the optimization and application of results from the work are narrow, in that everything is finetuned for Plasmodium. Some of the results were not entirely unexpected for users of any of the tested software that was developed for humans. For example, it is known that Refined IBD is not going to do well with the combination of short IBD segments and low SNP density. Lastly, it appears the authors only did one largescale simulation (there are no reported SDs). 

      We thank the reviewer for highlighting the strengths and weaknesses of the study. 

      First, we would like to highlight that: (1) while we use Plasmodium as a model to investigate the impact of high recombination and low marker density on IBD detection and downstream analyses, our IBD benchmarking framework and strategies are widely applicable to IBD methods development for many sexually recombining species including both Plasmodium and non-Plasmodium species. (2) Although some results are not completely unexpected, such as the impact of low marker density on IBD detection, IBD-based methods have been increasingly used in malaria genomic surveillance research without comprehensive benchmarking for malaria parasites despite the high recombination rate. Due to the lack of benchmarking, researchers use a variety of different IBD callers for malaria research including those that are only benchmarked in human genomes, such as refined-ibd. Our work not only confirmed that low marker density (related to high recombination rate) can affect the accuracy of IBD detection, but also demonstrated the importance of proper parameter optimization and tool prioritization for specific downstream analyses in malaria research. We believe our work significantly contributes to the robustness of IBD segment detection and the enhancement of IBDbased malaria genomic surveillance.

      Second, we agree that there is a lack of clarity regarding simulation replicates and the uncertainty of reported estimates. We have made the following improvements, including (1) running n = 3 full sets of simulations for each analysis purpose, which is in addition to the large sample sizes and chromosomal-level replications already presented in our initial submission, and (2) updating data and figures to reflect the uncertainty at relevant levels (segment level, genome-pair level or simulation set level).   

      Reviewer #2 (Public review):

      Summary: 

      Guo et al. benchmarked and optimized methods for detecting Identity-By-Descent (IBD) segments in Plasmodium falciparum (Pf) genomes, which are characterized by high recombination rates and low marker density. Their goal was to address the limitations of existing IBD detection tools, which were primarily developed for human genomes and do not perform well in the genomic context of highly recombinant genomes. They first analysed various existing IBD callers, such as hmmIBD, isoRelate, hap-IBD, phased-IBD, refinedIBD. They focused on the impact of recombination on the accuracy, which was calculated based on two metrics, the false negative rate and the false positive rate. The results suggest that high recombination rates significantly reduce marker density, leading to higher false negative rates for short IBD segments. This effect compromises the reliability of IBD-based downstream analyses, such as effective population size (Ne) estimation. They showed that the best tool for IBD detection in Pf is hmmIBD, because it has relatively low FN/FP error rates and is less biased for relatedness estimates. However, this method is less computationally efficient. Their suggestion is to optimize human-oriented IBD methods and use hmmIBD only for the estimation of Ne. 

      Strengths: 

      Although I am not an expert on Plasmodium falciparum genetics, I believe the authors have developed a valuable benchmarking framework tailored to the unique genomic characteristics of this species. Their framework enables a thorough evaluation of various IBD detection tools for non-human data, such as high recombination rates and low marker density, addressing a key gap in the field. This study provides a

      comparison of multiple IBD detection methods, including probabilistic approaches (hmmIBD, isoRelate) and IBS-based methods (hap-IBD, Refined IBD, phased IBD). This comprehensive analysis offers researchers valuable guidance on the strengths and limitations of each tool, allowing them to make informed choices based on specific use cases. I think this is important beyond the study of Pf. The authors highlight how optimized IBD detection can help identify signals of positive selection, infer effective population size (Ne), and uncover population structure. They demonstrate the critical importance of tailoring analytical tools to suit the unique characteristics of a species. Moreover, the authors provide practical recommendations, such as employing hmmIBD for quality-sensitive analyses and fine-tuning parameters for tools originally designed for non-P. falciparum datasets before applying them to malaria research. 

      Overall, this study represents a meaningful contribution to both computational biology and malaria genomics, with its findings and recommendations likely to have an impact on the field. 

      Weaknesses: 

      One weakness of the study is the lack of emphasis on the broader importance of studying Plasmodium falciparum as a critical malaria-causing organism. Malaria remains a significant global health challenge, causing hundreds of thousands of deaths annually. The authors could have introduced better the topic, even though I understand this is a methodological paper. While the study provides a thorough technical evaluation of IBD detection methods and their application to Pf, it does not adequately connect these findings to the broader implications for malaria research and control efforts. Additionally, the discussion on malaria and its global impact could have framed the study in a more accessible and compelling way, making the importance of these technical advances clearer to a broader audience, including researchers and policymakers in the fight against malaria. 

      We thank the reviewer for highlighting the need to better contextualize the work and emphasize its relevance to malaria control and elimination efforts. We have edited the introduction and discussion sections to highlight the importance of studying Plasmodium as malaria-causing organisms and why IBD-based analysis is important to malaria researchers and policymakers. We believe the changes will better emphasize the public health relevance of the work and improve clarity for a general audience.  

      We would like to clarify that we are not recommending that researchers “optimize human-oriented IBD methods and use hmmIBD only for the estimation of Ne.” We recommended hmmIBD for Ne analysis; however, hmmIBD can be utilized for other applications, including population structure and selection detection. Thus, we generally recommend using hmmIBD for Plasmodium when phased genotypes are available. To avoid potential misunderstandings, we have revised relevant sentences in the abstract, introduction, and discussion. One reason to consider human-oriented IBD detection methods in Plasmodium research is that hmmIBD currently has limitations in handling large genomic datasets. Our ongoing research focuses on improving hmmIBD to reduce its computational runtime, making it scalable for large Plasmodium wholegenome sequence datasets.

      Recommendations for the authors

      Reviewer #1:

      (1) Additional experiments 

      (i) More simulation replicates would be valuable here. The way that results are presented, it appears as though there are no replicates. Apologies if I am incorrect, but when looking through the authors code the --num_reps defaults to one simulation and there are no SDs reported for any figure. Perhaps the authors are bypass replicates by taking a random sample of lineages? Some clarification here would be great. 

      We agree with the reviewer’s constructive suggestions. We have increased the number of simulation sets to (n = 3) in addition to the existing replicates at the chromosomal level. We did not use a larger n for full sets of simulation replicates for two reasons: (1) full replication is quite computationally intensive (n=3 simulation sets already require a week to run on our computer cluster with hundreds of CPU cores). (2), the results from different simulation sets are highly consistent with each other, likely due to our large sample size (n= 1000 haploid genomes for each parameter combination).  The consistency across simulation sets can be exemplified by the following figures (Author response image 1 and 2) based on simulation sets different from Figures and Supplementary Figures included in the manuscript. 

      Author response image 1.

      Additional simulation sets repeating experiments shown in Fig 2.

      Author response image 2.

      Post-optimization Ne estimates based on three independent simulation sets (Fig 5 shows data simulation set 1).

      In our updated figures, we address the uncertainty of measurements as follows:

      (1) For IBD accuracy based on overlapping IBD segments, we present the mean ± standard deviation (SD) at the segment level (IBD segment false positives and false negatives for each length bin) or genome-pair level (IBD error rates at the genome-wide level). Figures in the revised manuscript show results from one of the three simulation set replicates. The SD of IBD segment accuracy is included in all relevant figures. In the S2 Data file, we chose not to show SDs to avoid text overcrowding in the heatmaps; however, a detailed version, including SD plotting on the heatmap and across three simulation set replicates, is available on our GitHub repository at https://github.com/bguo068/bmibdcaller_simulations/tree/main/simulations/ext_data

      (2) For IBD-based genetic relatedness, the uncertainty is depicted in scatterplots.

      (3) For IBD-based selection signal scans, we provide the mean ± SD of the number of true selection signals and false selection signals. The SD is calculated at the simulation set level (n=3). 

      (4) For IBD network community detection, the mean ± SD of the adjusted Rand index is reported at the simulation set level (n=3). A representative simulation set is randomly chosen for visualization purposes.

      (5) For IBD-based Ne estimates, each simulation set provides confidence intervals via bootstrapping. We found Ne estimates across n=3 simulation sets to be highly consistent and decided to display Ne from one of the simulation sets.

      (6) For the measurement of computational efficiency and memory usage, the mean ± SD was calculated across chromosomes from the same simulation sets.

      We have included a paragraph titled "Replications and Uncertainty of Measures" in the methods section to clarify simulation replications. Additionally, a table of simulation replicates is provided in the new S1 Data file under the sheet named “02_simulation_replicates.”

      (ii) I might also recommend a table or illustrative figure with all the simulation parameters for the readers rather than them having to go to and through a previous paper to get a sense of the tested parameters. 

      We have now generated tables containing full lists of simulation/IBD calling parameters. We have organized the tables into two sections: simulation parameters and IBD calling parameters. For the simulations, we are using three demographic models: the single-population (SP) model, the multiple-population (MP) model, and the human population demography in the UK (UK) model, each with different sets of parameters. Parameters and their values are listed separately for each demographic model (SP, MP and UK). For the IBD calling, we have five different IBD callers, each with different parameters. We have provided lists of the parameters and their values separately for each caller. In total, there are 15 different combinations of 3 demographic models in simulation and five callers in IBD detection (Author response image 3). We provide a table for each of the 15 combinations. We also provide a single large table by concatenating all 15 tables. In the combined table, demographic model-specific or IBD caller-specific parameters are displayed in their own columns, with NA values (empty cells) appearing in rows where these parameters are not applied (see S2 Data file).

      Author response image 3.

      Schematic of combined parameters from simulations and IBD detection (also included in the S2 Data file)

      (2) Recommendations for improving the writing and presentation 

      Overall, the writing was great, especially the introduction. 

      Three thoughts: 

      (i) It would be great if the authors included a few sentences with guidance on the approach one would take if their organism was not human or P. falciparum

      We have updated our discussion with the following statement: “Beyond Plasmodium parasites, there are many other high-recombining organisms such as Apicomplexan species like Theileria, insects like Apis mellifera (honeybee), and fungi like Saccharomyces cerevisiae (Baker's yeast). For these species, our optimized parameters may not be directly applicable, but the benchmarking framework established in this study can be utilized to prioritize and optimize IBD detection methods in a context-specific manner.”

      (ii) I think there was a lot of confusion about the simulations as they were presented between the co-reviewer and I. Clarification on whether there were replicates and how sampling of lineages occurred would be helpful for a reader. 

      We have added a paragraph with heading “Replications and uncertainty of measures” under the method section to clarify simulation replicates.  Please also refer to our response above for more details (Reviewer #1 (1) Additional experiments).

      (iii) Maybe we missed it, but could the authors add a sentence or two about why isoRelate performed so poorly (e.g. lines 206-207) considering it was developed for Plasmodium? This result seems important. 

      IsoRelate assumes non-phased genotypes as input; therefore, even if phased genotypes are provided, the HMM model used in isoRelate (distinct from the hmmIBD model) may not utilize them. Below, we present examples of IBD segments between true sets and inferred sets from both isoRelate and hmmIBD, where many small IBD segments identified by tskibd (ground truth) and hmmIBD (inferred) are not detected by isoRelate (inferred), although isoRelate still captures very long IBD segments. These patterns are also illustrated in Fig. 3 and S3 Fig. We acknowledge that isoRelate may outperform other methods in the context of unphased genotypes. However, we chose not to benchmark IBD calling methods using unphased genotypes in simulations, as the results may be significantly influenced by the quality of genotype phasing for all other IBD detection methods. The characterization of deconvolution methods is beyond the scope of this paper. We have added a paragraph in the discussion to reflect the above explanation.

      Author response image 4.

      Example IBD segments inferred by isoRelate and hmmIBD compared to true IBD segments calculated by tskibd.

      (3) Minor corrections to the text and figures 

      Lines 105-110 feel like introduction because the authors are defining IBD and goals of work 

      We have shortened these sentences and retained only relevant information for transition purposes. 

      Line 121-122 The definition of false positive is incorrect, it appears to be the exact text from false negative 

      We apologize for the typo and have corrected the definition, so that  it is consistent with that in the methods section. 

      Lines 177-180 feels more like discussion than results 

      We have removed this sentence for brevity. 

      Figure 1: 

      Remove plot titles from the figure 

      Write out number in a 

      The legend in b overlaps the data so moving that inset to the right would be helpful 

      We have removed the titles from Figure 1. In Figure 1a, we have changed the format of  the y-axis tick labels from scientific notation to integers.  In Figure 1b, we have adjusted the size and location of the legend so that it does not overlap with the data points.

      Figure 2-3 & S4-5: 

      It was hard to tell the difference between [3-4) and [10-18) because the colors and shapes are similar. It might be worth using a different color or shape for one of them? 

      We have changed the color for the [10-18) group so that the two groups are easier to distinguish.

      Figure 3 & S3-5: 

      Biggest suggestion is that when an axis is logged it should not only be mentioned in the caption but also should be shown in the figure as well. 

      We have updated all relevant figures so that the log scale is noted in the figure captions (legends) as well as in the figures (in the x and/or y axis labels).

      Supplementary Figure S2 

      (i) It would be nice to either combine it with the main text Figure 1 (I don't believe it would be overwhelming) or add in the other two methods for comparison 

      We have now plotted data for all five IBD callers in S1 Fig for better comparison. 

      (ii) the legend overlaps the data so relocating it to the top or bottom would be helpful 

      We have moved the legend to the bottom of the figure to avoid overlap with the data.

      Reviewer #2:

      I don't have any major comments on the paper. It is well-written, although perhaps a bit long and repetitive in some sections. Make sure not to repeat the same concepts too many times. 

      We have consolidated and removed several paragraphs to reduce repetition of the same concepts.

      I am not a methodological developer, but it seems you have addressed several challenges regarding IBD detection in P. falciparum. You have also acknowledged the study's caveats, which I agree with. 

      Thank you for the positive comments.

      Minor comments: 

      -In my opinion, the paper would benefit from including the workflow figure in the main text rather than keeping it in the supplementary materials. This would make it more accessible and useful for readers. 

      We have moved the original S1 Fig to be Fig 1 in the main text.

      -Some of the figures (e.g. Fig. 2, 4) should be larger for better clarity and interpretation. 

      We have updated Fig 2 and Fig 4 (now labeled as Figure 3 and 5) to make them larger for improved clarity and interpretation.

      -While the focus on P. falciparum is understandable, it would have been valuable to include examples of other species and discuss the broader implications of the findings for a broader field. 

      We have updated the third-to-last paragraph to discuss implications for other species, such as Apicomplexan species like Theileria, insects like Apis mellifera (honeybee), and fungi like Saccharomyces cerevisiae (Baker's Yeast). We acknowledge that optimal parameters and tool choices may vary among species due to differences in demographic history and evolutionary parameters. However, we emphasize that the methods outlined are adaptable for prioritizing and optimizing IBD detection methods in a context-specific manner across different species.

      -Figure 6 is somewhat confusing and could use clearer labeling or additional explanation to improve comprehension. 

      We have updated the labels and titles in the figure to improve clarity. We also edited the figure caption for better clarity.

      -Although hmmIBD outperformed other tools in accuracy, its computational inefficiency due to single-threaded execution poses a significant challenge for scaling to large datasets. The trade-off between accuracy and computational cost could be discussed in more detail. 

      We have added a paragraph in the discussion section to highlight the trade-off between accuracy and computation cost. We noted that we are developing an adapted tool to enhance the hmmIBD model and significantly reduce the runtime via parallelizing the IBD inference process.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public Review):

      The authors of this study use electron microscopy and 3D reconstruction techniques to study the morphology of distinct classes of Drosophila sensory neurons *across many neurons of the same class.* This is a comprehensive study attempting to look at nearly all the sensory neurons across multiple sensilla to determine a) how much morphological variability exists between and within neurons of different and similar sensory classes, and 2) identify dendritic features that may have evolved to support particular sensory functions. This study builds upon the authors' previous work, which allowed them to identify and distinguish sensory neuron subtypes in the EM volumes without additional staining so that reconstructed neurons could reliably be placed in the appropriate class. This work is unique in looking at a large number of individual neurons of the same class to determine what is consistent and what is variable about their class-specific morphologies.

      This means that in addition to providing specific structural information about these particular cells, the authors explore broader questions of how much morphological diversity exists between sensory neurons of the same class and how different dendritic morphologies might affect sensory and physiological properties of neurons.

      The authors found that CO2-sensing neurons have an unusual, sheet-like morphology in contrast to the thin branches of odor-sensing neurons. They show that this morphology greatly increases the surface area to volume ratio above what could be achieved by modest branching of thin dendrites, and posit that this might be important for their sensory function, though this was not directly tested in their study. The study is mainly descriptive in nature, but thorough, and provides a nice jumping-off point for future functional studies. One interesting future analysis could be to examine all four cell types within a single sensilla together to see if there are any general correlations that could reveal insights about how morphology is determined and the relative contributions of intrinsic mechanisms vs interactions with neighboring cells. For example, if higher than average branching in one cell type correlated with higher than average branching in another type, if in the same sensilla. This might suggest higher extracellular growth or branching cues within a sensilla. Conversely, if higher branching in one cell type consistently leads to reduced length or branching in another, this might point to dendrite-dendrite interactions between cells undergoing competitive or repulsive interactions to define territories within each sensilla as a major determinant of the variability.

      We thank the reviewer for the insightful comments and appreciation for our study.

      Reviewer #2 (Public Review):

      The manuscript employs serial block‐face electron microscopy (SBEM) and cryofixation to obtain high‐resolution, three‐dimensional reconstructions of Drosophila antennal sensilla containing olfactory receptor neurons (ORNs) that detectCO2. This method has been used previously by the same lab in Gonzales et. al, 2021. (https://elifesciences.org/articles/69896), which had provided an exemplary model by integrating high-resolution EM with electrophysiology and cell-type-specific labeling.

      We thank the reviewer for expressing appreciation for our published study.

      The previous study ended up correlating morphology with activity for multiple olfactory sensillar types. Compared to the 2021 study, this current manuscript appears somewhat incomplete and lacks integration with activity.

      We thank the reviewer for their feedback. However, we would like to clarify that our previous study did not correlate morphology with activity to a greater extent than the current study. Both employed the same cryofixation, SBEM-based approach without recording odor-induced activity, but the focus of the current work is fundamentally different. While the previous study examined multiple sensillum types, the current study concentrates on a single sensillum type to address a distinct biological question regarding morphological heterogeneity. We appreciate the opportunity to clarify this distinction, and we hope that the revised manuscript more clearly conveys the unique scope and contributions of this study.

      In fact older studies have also reported two-dimensional TEM images of the putative CO2 neuron in Drosophila (Shanbhag et al., 1999) and in mosquitoes (McIver and Siemicki, 1975; Lu et al, 2007), and in these instances reported that the dendritic architecture of the CO2 neuron was somewhat different (circular and flattened, lamellated) from other olfactory neurons.

      We thank the reviewer for pointing this out. As noted in both the Introduction and Discussion sections, previous studies—including those cited by the reviewer—suggested that CO2-sensing neurons may have a distinct dendritic morphology. However, those earlier studies lacked the means to definitively link the observed morphology to CO2 neuron identity.

      In contrast, our study assigns neuronal identity based on quantitative morphometric measurements, allowing us to confidently associate the unique dendritic architecture with CO2 neurons. Furthermore, we extend previous observations by providing full 3D reconstructions and nanoscale morphometric analyses, offering a much more comprehensive and definitive characterization of these neurons. We believe this represents a significant advancement over earlier work.

      The authors claim that this approach offers an artifact‐minimized ultrastructural dataset compared to earlier. In this study, not only do they confirm this different morphology but also classify it into distinct subtypes (loosely curled, fully curled, split, and mixed). This detailed morphological categorization was not provided in prior studies (e.g., Shanbhag et al., 1999).

      We thank the reviewer for acknowledging the significance of our study.

      The authors would benefit from providing quantitative thresholds or objective metrics to improve reproducibility and to clarify whether these structural distinctions correlate with distinct functional roles.

      We thank the reviewer for raising this point. However, we would like to clarify that assigning neurons to strict morphological subtypes was not the primary aim of our study. In practice, dendritic architectures can be highly complex, with individual neurons often displaying features characteristic of multiple subtypes. This is precisely why we included a “mixed” subtype category—to acknowledge and capture this morphological heterogeneity rather than impose rigid classification boundaries.

      Our intent in defining subtypes was not to imply discrete functional classes, but rather to highlight the range of morphological variation observed across ab1C neurons. While we agree that exploring potential correlations between structure and function is an important future direction, the current study focuses on characterizing this diversity using 3D reconstruction and morphometric analysis. We hope this clarifies the purpose and scope of our morphological categorization.

      Strengths:

      The study makes a convincing case that ab1C neurons exhibit a unique, flattened dendritic morphology unlike the cylindrical dendrites found in ab1D neurons. This observation extends previous qualitative TEM findings by not only confirming the presence of flattened lamellae in CO₂ neurons but also quantifying key morphometrics such as dendritic length, surface area, and volume, and calculating surface area-to-volume ratios. The enhanced ratios observed in the flattened segments are speculated to be linked to potential advantages in receptor distribution (e.g., Gr21a/Gr63a) and efficient signal propagation.

      We thank the reviewer for appreciating the significance our current study.

      Weaknesses:

      While the manuscript offers valuable ultrastructural insights and reveals previously unappreciated heterogeneity among CO₂-sensing neurons, several issues warrant further investigation in addition to the points made above.

      (1) Although this quantitative approach is robust compared to earlier descriptive reports, its impact is somewhat limited by the absence of direct electrophysiological data to confirm that ultrastructural differences translate into altered neuronal function. A direct comparison or discussion of how the present findings align with the functional data obtained from electrophysiology would strengthen the overall argument.

      We thank the reviewer for this comment. We would like to clarify, however, that our study does not claim that the observed morphological heterogeneity necessarily leads to functional diversity. Rather, we consider this as a possible implication and discuss it as a potential question for future research. This idea is raised only in the Discussion section, and we are carefully not to present functional diversity as a conclusion of our study. Nonetheless, we have reviewed the relevant paragraph to ensure the language remains cautious and does not overstate our interpretation.

      We also acknowledge the significance of directly linking ultrastructural features to neuronal function through electrophysiological recordings. However, at present, it is technically challenging to correlate the nanoscale morphology of individual ORNs with their functional activity, as this would require volume EM imaging of the very same neurons that were recorded via electrophysiology. Currently, there is no dye-labeling method compatible with single-sensillum recording and SBEM sample preparation that allows for unambiguous identification and segmentation of recorded ORNs at the necessary ultrastructural resolution.

      To acknowledge this important limitation, we have added a paragraph in the Discussion section, as suggested, to clarify the current technical barriers and to highlight this as a promising direction for future methodological advances.

      (2) Clarifying the criteria for dendritic subtype classification with quantitative parameters would enhance reproducibility and interpretability. Moreover, incorporating electrophysiological recordings from ab1C neurons would provide compelling evidence linking structure and function, and mapping key receptor proteins through immunolabeling could directly correlate receptor distribution with the observed morphological diversity.

      Please see our response to the comment regarding the technical limitations of directly correlating ultrastructure with electrophysiological data.

      In addition, we would like to address the suggestion of using immunolabeling to map receptor distribution in relation to the 3D EM models. Currently, antibodies against Gr21a or Gr63a (the receptors expressed in ab1C neurons) are not available. Even if such antibodies were available, immunogold labeling for electron microscopy requires harsh detergent treatment to increase antibody permeability, damaging morphological integrity. These treatments would compromise the very morphological detail that our study aims to capture and quantify.

      (3) Even though Cryofixation is claimed to be superior to chemical fixation for generating fewer artifacts, authors need to confirm independently the variation observed in the CO2 neuron morphologies across populations. All types of fixation in TEMs cause some artifacts, as does serial sectioning. Without understanding the error rates or without independent validation with another method, it is hard to have confidence in the conclusions drawn by the authors of the paper.

      We thank the reviewer for raising concerns regarding potential artifacts in morphological analyses. However, we would like to clarify that cryofixation is widely regarded as a gold standard for ultrastructural preservation and minimizing fixation-induced artifacts, as supported by extensive literature. This is why we adopted high-pressure freezing and freeze substitution in our study.

      We have also published a separate methods paper (Tsang et al., eLife, 2018) directly comparing our cryofixation-based protocol with conventional chemical fixation, demonstrating substantial improvements in morphological preservation. This provides strong empirical support for the reliability of our approach.

      Regarding the suggestion to validate observed morphological variation across populations: we note that determining the presence of artifacts requires a known ground truth, which is inherently unavailable as we could not measure the morphometrics of fly olfactory receptor neurons in their native state. In the absence of such a benchmark, we have instead prioritized using the best-available preparation methods and high-resolution imaging to ensure structural integrity.

      Addressing these concerns and integrating additional experiments would significantly bolster the manuscript's completeness and advancement.

      We appreciate the reviewer’s feedback. As discussed in our responses to the specific comments above, certain suggested experiments are currently limited by technical constraints, particularly in the context of high-resolution volume EM for insect tissues enclosed in cuticles.

      Nevertheless, we have carefully addressed the reviewer’s concerns to the fullest extent possible within the scope of this study. We have revised the manuscript to clarify methodological limitations, added new explanatory content where appropriate, and ensured that our interpretations remain well grounded in the data. We hope these revisions strengthen the clarity and completeness of the manuscript.

      Reviewer #3 (Public Review):

      In the current manuscript entitled "Population-level morphological analysis of paired CO2- and odor-sensing olfactory neurons in D. melanogaster via volume electron microscopy", Choy, Charara et al. use volume electron microscopy and sensillum. They aim to investigate the degree of dendritic heterogeneity within a functional class of neurons using ab1Cand ab1D, which they can identify due to the unique feature of ab1 sensilla to house four neurons and the stereotypic location on the third antennal segment. This is a great use of volumetric electron imaging and neuron reconstruction to sample a population of neurons of the same type. Their data convincingly shows that there is dendritic heterogeneity in both investigated populations, and their sample size is sufficient to strongly support this observation. This data proposes that the phenomenon of dendritic heterogeneity is common in the Drosophila olfactory system and will stimulate future investigations into the developmental origin, functional implications, and potential adaptive advantage of this feature.

      Moreover, the authors discovered that there is a difference between CO2- and odour-sensing neurons of which the first show a characteristic flattened and sheet-like structure not observed in other sensory neurons sampled in this and previous studies. They hypothesize that this unique dendritic organization, which increases the surface area to volume ratio, might allow more efficient CO2 sensing by housing higher numbers of CO2 receptors. This is supported by previous attempts to express CO2 sensors in olfactory sensory neurons, which lack this dendritic morphology, resulting in lower CO2 sensitivity compared to endogenous neurons.

      Overall, this detailed morphological description of olfactory sensory neurons' dendrites convincingly shows heterogeneity in two neuron classes with potential functional impacts for odour sensing.

      Strength:

      The volumetric EM imaging and reconstruction approach offers unprecedented details in single cell morphology and compares dendrite heterogeneity across a great fraction of ab1 sensilla. The authors identify specific shapes for ab1C sensilla potentially linked to their unique function in CO2 sensing.

      We thank the reviewer for the insightful comments and appreciation for our study.

      Weaknesses:

      While the morphological description is highly detailed, no attempts are made to link this to odour sensitivity or other properties of the neurons. It would have been exciting to see how altered morphology impacts physiology in these olfactory sensory cells.

      We agree that linking morphological variation to physiological properties, such as odor sensitivity, would be a highly valuable direction for future research. However, the aim of the current study is to provide an in-depth nanoscale characterization based on a substantial proportion of ab1 sensilla, highlighting morphological heterogeneity among homotypic ORNs.

      At present, it is technically challenging to correlate the nanoscale morphology of individual ORNs with their physiological responses, as this would require volume EM imaging of the exact neurons recorded via single-sensillum electrophysiology. Currently, no dye-labeling method exists that is compatible with both single-sensillum recording and the stringent requirements of SBEM sample preparation to allow for unambiguous identification and segmentation of recorded ORNs.

      To acknowledge this important limitation, we have added a paragraph in the Discussion section clarifying the current technical barriers and highlighting this as a promising area for future methodological development. Please also see our responses to the reviewer’s 4th comment below, where we present preliminary experiments examining whether odor sensitivity varies among homotypic ORNs.

      (Please see the following pages for additional responses to the reviewers’ specific comments. These responses are not intended for publication.)

      Reviewer #1 (Recommendations for the authors):

      As this is mainly a descriptive paper I have no suggestions for additional experiments. Minor Text Suggestions:

      (1) The authors might want to include a better description/definition of the fly antennae, olfactory sensilla and their basic structure/makeup, position of the sensory neurons and dendrites within, etc, in the introduction perhaps in cartoon form to help readers that are not familiar (i.e. non-Drosophila readers) with the terminology and basic organization can follow the paper more easily from the start.

      We thank the reviewer for the helpful suggestion to broaden the appeal of our study to a wider readership. In response, we added a new introductory paragraph at the beginning of the Results section, along with illustrations in a new supplementary figure (Figure 1—figure supplement 1). The new paragraph reads as follows.

      “The primary olfactory organ in Drosophila is the antenna, which contains hundreds olfactory sensilla on the surface of its third segment (Figure 1—figure supplement 1A) . Each sensillum typically encapsulates the outer dendrites of two to four ORNs. The outer dendrites are the sites where odorant receptors are expressed, enabling the detection of volatile chemicals. A small portion of the outer dendrites lies beneath the base of the sensillum cuticle. At the ciliary constriction, the outer dendrites connect to the inner dendritic segment, which then links to the soma of each ORN (Figure 1—figure supplement 1B).”

      (2) In Figure 4D, the letter annotations above the graphs are not clearly defined anywhere that I could easily find. Please clarify with different symbols and/or in the figure legend so readers can easily comprehend the stats that are presented.

      We thank the reviewer for raising this point. As suggested, in the revised Figure 4D legend, following the original sentence “Statistical significance is determined by Kruskal-Wallis one-way ANOVA on ranks and denoted by different letters”, we added “For example, labels “a” and “b” indicate a significant difference between groups (P < 0.05), whereas labels with identical or shared letters (e.g., “a” and “a”, “a,b” and “a”, or “a,b” and “b”) indicate no significant difference.”

      Reviewer #3 (Recommendations for the authors):

      There are several aspects that I would like the authors to consider to improve the current manuscript:

      (1) Line 331: "Our analysis highlights how structural scaling in ab1D neurons achieves enhanced sensory capacity while maintaining the biophysical properties of dendrites". This is a strong statement, and not shown by the authors. They speculate about this in the discussion, but I would like them to soften the language here.

      We thank the reviewer for raising this point. As suggested, we have softened the language in the sentence in question. The revised version is as follows.

      “Our analysis suggests that structural scaling in ab1D neurons may enhance sensory capacity while preserving the biophysical properties of dendrites.”

      (2) The Supplementary material is not well presented and is not cited in the manuscript. It is not clear what the individual data files show, where they refer to, etc. Please provide clear labels of all data, cite them at the appropriate location in the manuscript, and make them more accessible to the reader. Also, there are two Videos mentioned in the manuscript that are not included in the submission.

      We thank the reviewer for bringing this to our attention and apologize for the oversight. We appreciate the reviewer’s careful attention to the supplementary materials. We have addressed these issues accordingly: 1) all source data have been consolidated in to a single, clearly labeled Excel file to improve accessibility for readers; this file is now cited at the appropriate locations in the manuscript. 2) The supplementary videos mentioned in the manuscript have also been included in the re-submission.

      (3) In Figure 1B, it is hard to recapitulate the increase in dendritic density in the presented pictures. Could the authors please highlight dendrites in the raw imaging files (e.g. by colour coding as done later in the manuscript). Also, it might be helpful to indicate the measured parameters visually in this Figure (e.g. volume, length, etc.).

      We thank the reviewer for the helpful suggestion. As suggested, we have pseudocolored the dendrites in Figure 1B to enhance visual clarity.

      As noted, the original legend stated that “the sensilla were arranged from left to right in order of increasing dendritic branch counts”. To improve clarity, we have now added the number of dendritic branches above each sensillum to make this information more explicit.

      We hope these changes make the figure more accessible and informative for readers.

      (4) Given the strength of the authors in in vivo physiology and single sensilla recordings, I would be very curious about how the described morphological heterogeneity is reflected in the response properties of ab1Cs and ab1Ds. Can the authors provide data (already existing from their lab) of these two neurons on response heterogeneity? I acknowledge that spike sorting can be very challenging in ab1s, but maybe it is possible to show the range of response sensitivities upon CO2 stimulation in ab1Cs? The authors speculate in the discussion and presented data will only be correlative - however I think it would strengthen the manuscript to have some link to physiology included.

      We thank the reviewer for this insightful comment. We share the same curiosity about response variability among homotypic ORNs, including ab1C and ab1D. Ideally, this question could be addressed by recording from a large proportion of neurons of a given ORN type to assess the response variability within a single antenna. However, due to technical limitations, we are only able to reliably record from 3–4 ab1 sensilla per antennal preparation, representing approximately 8% of the total ab1 population.

      Moreover, our recordings are typically limited to ab1 sensilla located on the posterior-medial side of the antenna, as this region provides the best accessibility for our recording electrode. This spatial constraint may limit our ability to sample the full morphological diversity of ab1C and ab1D neurons.

      Given these limitations, it is technically challenging to rigorously assess physiological variability in ab1C and ab1D responses across the entire ab1 population. Nonetheless, we attempted to address this question using a different sensillum type where a larger proportion of the population is accessible to single-sensillum recording per antennal preparation. Specifically, we focused on ab2 sensilla in the following analysis because we can reliably record from 6 sensilla per antenna, representing approximately 25% of the total ab2 population.

      In the preliminary data presented below, we recorded from 6 ab2A ORNs per antenna across a total of 6 flies. Spike analysis revealed that odor-evoked responses were consistent across individual ab2A neurons (Author response image 1A). When analyzing the dose-response curve for each ORN, we found no statistically significant differences in odor sensitivity, either among ORNs within the same antenna or across different flies (Author response image 1B; two-way ANOVA: P > 0.99 within antennae, P > 0.99 across flies). This is further supported by the closely clustered EC50 values (Author response image 1C). This result suggests that odor sensitivity is largely uniform among homotypic ab2A ORNs.

      Author response image 1.

      Homotypic ab2A ORNs display similar odorant sensitivity. (A) Single-sensillum recording. Raster plots of ab2A/Or59b ORN spike responses. Six ab2A ORNs from the same antenna were recorded per fly. Odor stimulus: methyl acetate (10-6). (B) Dose-response relationships of peak spike responses, normalized to the maximum response of the ORN to facilitate comparison of odor sensitivity. Each curve represents responses from a single ab2A ORN fitted with the Hill equation (n=36 ab2 sensilla from 6 flies). Responses recorded from the same antenna are indicated by the same color. Statistical comparisons between different ab2A ORNs from the same antenna (P > 0.99) or across flies (P > 0.99) were performed by two-way ANOVA. (C) Quantification of individual pEC50 values from (B), defined as -logEC50.

      However, we are hesitant to include this result in the main manuscript for several reasons. First, it does not directly relate to the morphometric analysis of ab1C and ab1D neurons, which is the primary focus of our study. Second, while we were able to record from approximately 25% of the ab2 population, this level of coverage is still limited and potentially subject to sampling bias due to the spatial constraints of the antennal region accessible to the recording electrode.

      At best, our data suggest limited variability in odor sensitivity among the recorded ab2A ORNs. However, we are cautious about generalizing this finding to the entire ab2 population. In light of these considerations, we hope the reviewer can appreciate the technical challenges inherent in addressing what may appear to be a straightforward question.

      For these reasons, we have chosen to include this preliminary result in the response only, rather than in the main manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer 1 (Public Review):

      Summary:

      The authors present a mean-field model that describes the interplay between (protein) aggregation and phase separation. Different classes of interaction complexity and aggregate dimensionality are considered, both in calculations concerning (equilibrium) phase behavior and kinetics of assembly formation.

      Strengths:

      The present work is, although purely theoretical, of high interest to understanding biological processes that occur as a result of a coupling between protein aggregation and phase separation. Of course, such processes are abundant, in the living cell as well as in in-vitro experiments. I appreciate the consideration of aggregates with various dimensionality, as well as the categorization into different ”interaction classes”, together with the mentioning of experimental observations from biology. The model is convincing and underlines the complexity associated with the distribution of proteins across phases and aggregates in the living cell.

      Weaknesses:

      There are a few minor weaknesses.

      Reviewer 2 (Public Review):

      This work deals with a very difficult physical problem: relating the assembly of building blocks on a molecular scale to the appearance of large, macroscopic assemblies. This problem is particularly difficult to treat, because of the large number of units involved, and of the complex way in which these units-monomers-interact with each other and with the solvent. In order to make the problem treatable, the authors recur to a number of approximations: Among these, there is the assumption that the system is spatially homogeneous, i.e., its features are the same in all regions of space. In particular, the homogeneity assumption may not hold in biologically relevant systems such as cells, where the behavior close to the cell membrane may strongly differ from the one in the bulk. As a result, this hypothesis calls for a cautious consideration and interpretation of the results of this work. Another notable simplification introduced by the authors is the assumption that the system can only follow two possible behaviors: In the first, each monomer interacts equally with the solvent; no matter the size of the cluster of which it is part. In the second case, monomers in the bulk of a cluster and monomers at the assembly boundary interact with the solvent in a different way. These two cases are considered not only because they simplify the problem, but also because they are inspired by biologically relevant proteins.

      With these simplifications, the authors trace the phase diagram of the system, characterizing its phases for different fractions of the volume occupied by the monomers and solvent, and for different values of the temperature. The results qualitatively reproduce some features observed in recent experiments, such as an anomalous distribution of cluster sizes below the system saturation threshold, and the gelation of condensed phases above such threshold.

      Reviewer 3 (Public Review):

      Summary:

      The authors combine classical theories of phase separation and self-assembly to establish a framework for explaining the coupling between the two phenomena in the context of protein assemblies and condensates. By starting from a mean-field free energy for monomers and assemblies immersed in solvent and imposing conditions of equilibrium, the authors derive phase diagrams indicating how assemblies partition into different condensed phases as temperature and the total volume fraction of proteins are varied. They find that phase separation can promote assembly within the protein-rich phase, providing a potential mechanism for spatial control of assembly. They extend their theory to account for the possibility of gelation. They also create a theory for the kinetics of self-assembly within phase separated systems, predicting how assembly size distributions change with time within the different phases as well as how the volumes of the different phases change with time.

      Strengths:

      The theoretical framework that the authors present is an interesting marriage of classic theories of phase separation and self-assembly. Its simplicity should make it a powerful general tool for understanding the thermodynamics of assembly coupled to phase separation, and it should provide a useful framework for analyzing experiments on assembly within biomolecular condensates.

      The key advance over previous work is that the authors now account for how self-assembly can change the boundaries of the phase diagram.

      A second interesting point is the explicit theoretical consideration for the possibility that gelation (i.e. self-assembly into a macroscopic aggregate) could account for widely observed solidification of condensates. While this concept has been broadly discussed, to date I have yet to see a rigorous theoretical analysis of the possibility.

      The kinetic theory in sections 5 and 6 is also interesting as it extends on previous work by considering the kinetics of phase separation as well as those of self-assembly.

      Weaknesses:

      A key point the authors make about their theory is that it allows, as opposed to previous research, to study non-dilute limits. It is true that they consider gelation when the 3D assemblies become macroscopic. However, dilute solution theory assumptions seem to be embedded in many aspects of their theory, and it is not always clear where else the non-dilute limits are considered. Is it in the inter-species interaction χij? Why then do they never explore cases for which χij is nonzero in their analysis?

      We explicitly consider that monomers and aggregates are non-dilute with respect to solvent. This is evident in accounting for the mixing entropy of all components, including the solvent. Moreover, we account for interactions among the monomers and the different aggregates with the solvent. We consider the case where each monomeric unit, independent in aggregate it is part of, interacts the same way with the solvent. Please note that this case corresponds to a non-dilute scenario where interactions indeed drive phase separation.

      The connection between this theory and biological systems is described in the introduction but lost along the main text. It would be very helpful to point out, for instance, that the presence of phase separation might induce aggregation of proteins. This point is described formally at the end of Section 3, but a more qualitative connection to biological systems would be very useful here.

      We thank the referee for the useful comment, we now mention this in the introduction (line 80) and point out the biological relevance of assembly formation and localization via the presence of phase separation (lines 268 and 283).

      Building on the previous point, it would be helpful to give an intuitive sense of where the equations derived in the Appendices and presented in the main text come from and to spell out clear physical interpretations of the results. For example, it would be helpful to point out that Eq. 4 is a form of the law of mass action, familiar from introductory chemistry. It would be useful to better explain how the current work extends on existing previous work from these authors as well as others. Along these lines, closely related work by W. Jacobs and B. Rogers [O. Hedge et al. 2023, https://arxiv.org/abs/2301.06134; T. Li et al. 2023, https://arxiv.org/abs/2306.13198] should be cited in the introduction. The results discussed in the first paragraph of Section 3 on assembly size distributions in a homogeneous system are well-known from classic theories of self-assembly. This should be acknowledged and appropriate references should be added; see for instance, Rev. Mod. Phys. 93, 025008 and Statistical Thermodynamics Of Surfaces, Interfaces, And Membranes by Sam Safran. Equation 14 for the kinetic of volume fractions is given with reference to Bauermann et al. 2022, but it should be accompanied by a better intuitive interpretation of its terms in the main text. In particular, how should one understand the third term in this equation? Why does the change in volume impact the change of volume fraction in this way?

      We thank the referee for the suggestions. We have included the missing references, with a particular emphasis on DNA nanostars that inhibit phase separation in DNA liquids in the definition of class II. We added intuitive explanations of the main equations, such as Eqs. (4),(8),(14), (17), and (18). Notice that, according to Mysels, Karol J., J. Chem. Educ., 33, 178 (1956) (https://pubs-acs-org.sire.ub.edu/doi/epdf/10.1021/ed033p178) we refer to (18) as the law of mass action.

      The discussion in the last paragraph of Section 6 should be clarified. How can the total amount of protein in both phases decrease? This would necessarily violate either mass or volume conservation. Also, the discussion of why the volume is non-monotonic in time is not clear.

      A decrease in the total amount of protein in both phases does not violate mass conservation, if the volume of the phases varies accordingly. In particular, the volume of the denser phase should grow. This given, in the case presented the total protein amount in the dense phase decreases, while in the dilute phase increases. For this reason, we revised the paragraph and now explain the results in more detail (see lines starting from 407). The nonmonotonic volume change is indeed a puzzling finding that, as we now state in the manuscript, requires further investigation. Given the lack of analytical approaches available to tackle the complex kinetics in the presence of coexisting phases, we believe that this analysis goes beyond the scope of the present paper.

      Recommendations for the authors

      Reviewer 1 (Recommendations For The Authors):

      Line 96: I feel a mentioning/definition/explanation and perhaps some discussion on the parameter M (limiting aggregate size) would have been in place in the introduction of Equation (1). Furthermore, in the usual interpretation, Flory interaction parameters (symbolized χ) are dimensionless, as, classically, they represent an exchange energy (normalized by kT), defined on a monomeric basis. Here they seem to carry the dimension of energy.

      We thank the reviewer for the observation. We have included a brief comment on M and mentioned that we use χ parameters that carry the dimension of energy such that, varying kBT, we scale at the same time the term containing interaction propensities (χ) and the one containing internal energies (_e_int). See the comment on line 127

      Line 150: The choice of ρi \= i physically implies that a single protein is assumed to have the same as a solvent molecule. This may be a bit of a stretch. This assumption leads to an overestimation of the translational entropy of the aggregates (first term in Equation (1)). Acknowledging that ρ_1 >> ρs_ would give a pronounced desymmetrization of the phase diagram (I suspect).

      Indeed, in the case of monomers only, the assumption leads to a symmetric phase diagram which may be unrealistic. Once assemblies form, however, the phase diagram becomes asymmetric and for this reason we decided to assume ρi \= i, simplifying the theoretical analysis. We have added a clarifying sentence in the manuscript, see line 163

      Furthermore, the pictures in Figure 1a-c suggest the presence of a disordered residue, the degree of swelling of which might affect binding strength (see for instance: https://doi.org/10.3389/fnmol.2022.962526).

      We added a comment on the possible coupling between internal free energies and interaction propensities, such as the swelling mechanism that affects binding sites, and included the reference above (line 215).

      Line 154-156: It’s unclear what is meant with ”an internal bond that keeps each assembly together”. How should this be interpreted on an intuitive physical level?

      We apologise for being unclear. We meant the internal bonds that lead to the formation of assemblies. We have now rephrased this sentence in the main text (lines starting from 169).

      Line 254: The fact that ϕsg is defined below does not mean it does not fall out of the air here. The same holds for the consideration of the limit M →∞. Ideally, the main text should stand on its own, in particular with respect to physical intuitiveness, as well as the necessity and interest of discussion topics. Technical details, derivations and additional information can be in an appendix.

      We agree with the referee and added some physical insights about the limit. We now also state clearly in the main text (line 298) that _ϕ_sg is affected by temperature and the free energy of internal bonds.

      Line 257: ”Since we do not explicitly include the solvent in assembly formation we will consider the gel as a phase without solvent and thus ϕtot \= 1”. I’m not sure if I can agree with this. I would say, a gel, certainly in biological context, almost per definition contains a large fraction of solvent, i.e. here water. The situation ”ϕtot \= 1” would rather be a solid precipitate. Is gelation properly captured by this model?

      We thank the referee for this very relevant observation. We now state in the main text that the model predicts a macroscopic assembly which we call ’the gel phase’, in agreement with previous literature. Then, to clarify, we added the sentence ”Please note that, since we do not explicitly include the solvent in assembly formation (see reaction scheme in Fig.1a), in our model the gel corresponds to a phase without solvent, _ϕ_tot \= 1. To account for biological gels that can be rich in water, our theory can be straightforwardly extended by incorporating the solvent into the reaction scheme.”, see main text line 300.

      Line 268: Shouldn’t ”solvent” be ”solution”? If fsol is given by Equation (1), surely not only the solvent is considered.

      Indeed, this is a typo, and we now use the term ’solution’ instead of ’solvent.’

      Line 273: At this stage, the only information provided in the main text is that ω∞ is ”a constant that does not affect chemical nor phase equilibrium, except in the limit M →∞” (see lines 153-154). This is a little bit too abstract for me. Again, the main text should stand on its own, meaning the reader should not have to rely on an appendix to at least have an intuitive physical understanding of any modeling or input parameter discussed in the main text.

      We thank the reviewer for pointing this out. We now comment on the physical interpretation of ω∞ in the main text, see lines from 320 on.

      Figure 4. appears in Equation (39) but it is not defined.

      We thank the reviewer for pointing this out. We have reshaped appendix 6A, making use of chemical activities and clarified the origin of the rate .

      Line 317. I don’t fully understand the intention of the remark on the model being adaptable for ”primary and secondary nucleation”. How/in what way is this different from association and dissociation? For instance, classical nucleation theory is based on association and dissociation of monomeric units to and from clusters.

      We agree that the kinetic rate coefficients kij (appearing in the association and dissociation rates ∆rij, Eq. 17) in our manuscript already depend on assembly length, see Appendix 6 B, where we now clarified their definition. Please note that, however, that secondary nucleation is a special kind of association, for which the kinetic rate coefficients corresponding to associations of small assemblies, i.e. kij with_i,j_ ≪ M, explicitly depend on the presence of large assemblies with sizes l ≫ 1. In our manuscript, we have not accounted for such a dependence. We now make this aspect clear in the manuscript, see Appendix 6 B.

      Line 321. Why is ∆rij called the ”monomer exchange rate”? In line 318 the same parameter is defined as the ”reaction rate for the formation of a (i+j)-mer”. Why should these be the same?

      We thank the reviewer for spotting this typo.

      Line 323. Why do these calculations use M = 15?

      The exploration of a 15-dimensional phase space is already numerically challenging. We are currently working on a generalization of the numerical scheme to work with larger values of M but, to discuss the fundamental physical principles, we kept M \= 15.

      Reviewer 2 (Recommendations For The Authors):

      The manuscript presents several issues, on both the scientific and presentational level, which need to be carefully addressed. Please find below a list of the points that need to be addressed by the authors, divided into major and minor points. Major issues:

      • A general, major concern about the results in the paper is the homogeneity assumption. I do understand that repeating the whole analysis presented in the manuscript by allowing for spatial inhomogeneities partially goes beyond the scope of this paper. However, the authors should at least discuss how such inhomogeneities may alter the results in a qualitative way, and treat explicitly the presence of inhomogeneity in one prototypical case treated in the manuscript. Namely, what happens if the volume fractions and relative molecular volumes in the free energy (1) depend on space, e.g., ϕiϕi(x)?

      We would like to stress that, in the present paper, we do account for spatial inhomogeneities. Indeed, in the case of phase separation, we consider systems which are divided into two phases, characterized by different values of the assemblies’ volume fractions ϕi. We do, however, consider the system to be homogeneous inside the phases, implying a jump in the value of the volume fraction at the interface between the two phases. In this sense, the analysis we carry out is valid in the thermodynamic limit, where gradients of the volume fractions ϕi(x) within the phases, can be neglected. On the other hand, considering the full spatial problem, i.e. solving the equations for M \= 15 spatially varying fields, would be numerically extremely challenging.

      • The authors’ results relate molecular assembly- a phenomenon at the molecular scale-to phase separation-a mesoscopic or macroscopic phenomenon. The authors should stress the conceptual importance of this connection between scales, and present their results from the perspective of a multi-scale model.

      We thank the reviewer for pointing this out. We now emphasize the multi-scale feature of our model in the introduction (line 80).

      • Starting from Section 1, the reader is not well guided through the sections that follow. The authors should provide an outline of the line of though that they are going to follow in the following sections, and logically connect each section to the next one with a short paragraph at the end of each section. This paragraph should resume what has been addressed in the current section, and the connection with the topic that will be addressed in the next one.

      We agree with the reviewer and have added a transitioning sentence at the end of each paragraph.

      • ’We focus on linear assemblies (d = 1)’: Given the striking differences of the results between d = 1 and d > 1 shown above, the authors should discuss what happens for d > 1 as well.

      • ’In figure Fig. 5a, we show the initial and final equilibrium binodals (black and coloured curve, respectively), for the case of linear assemblies (d = 1) belonging to class 1’: Again, show what happens for d > 1.

      We agree with the reviewer, the kinetics in d > 1 would be definitely interesting. However, in this case, one assembly can become macroscopic (i.e. M must be set to ∞). This requires some substantial modification in the kinetic scheme, like introducing an absorbing boundary condition for monomers ’sucked in’ the gel. We prefer to leave this for future work, and now state it explicitly in the manuscript (line 383).

      • ’This difference arises because, within class 2, monomers in the bulk of an assembly have reduced interaction propensity with respect to the boundary ones. As a consequence, the formation of large clusters shifts the onset of phase separation to higher ϕtot values.’: To prove this argument, the authors should show Fig. 2g and h for d > 1. In fact, by varying d, the effect of the boundary vs. bulk also varies.

      We prefer to discuss the thermodynamics of d > 1 in section 4 on gelation. There we present only a single phase diagram so as not to blow up the discussion on equilibrium too much.

      • ’referring for simplicity to systems belonging to Class 1’: The authors should do the same analysis for Class 2.

      We agree with the reviewer. However, again not to blow up the discussion on equilibrium, we leave it for future work.

      • ’other, implying that the corresponding Flory-Huggins parameter χij vanishes’: Why?

      The explanation based on a lattice model is reported in Appendix 2, and is now more clearly referenced (line 185).

      Minor issues:

      • Eq. (10): Here the authors should explain in the main text, possibly in a simple and intuitive way, why the number of monomers i and the space dimension d enter the righthand side of this equation in this particular way.

      We thank the reviewer for pointing this out. We added the physical origin of the scaling with dimension in Eq. (10) and in Eq. (8), as pointed out by reviewer 3.

      • ’The second and fifth terms of fsol characterize the internal free energies’: What do you mean by ’characterize the internal free energies’? Please clarify.

      As we now state more clearly (lines 114-120), these two contributions include the internal free energies ω_s and _ωi, stemming from the free energy of internal bonds that lead to assembly formation.

      • ’depend on the scaling form of the’: Scaling with respect to what ? Please clarify.

      We have now clarified that the scaling is with respect to the assembly size i.

      • Figure 2 is way too dense: it should be split into two figures, and the legend of each of the two figures should be expanded to properly guide the reader to understand the figures.

      We understand the reviewer’s point of view. To avoid altering the present flow, we decided not to split the figure, but we have included shaded boxes to better guide the reader.

      • ’this is a consequence of the gelation transition’: Please clarify

      • ’and this limitation can be dealt with by introducing explicitly the infinite-sized gel in the free energy’: Why? Please clarify.

      We have now rephrased these sentences, hopefully in a clearer way. We now state: ’We know that this divergence is physical, and is caused by the gelation transition. This limitation can be dealt with by introducing explicitly a term in the free energy that accounts for an infinite-sized assembly (the gel)’, see lines 320-322.

      • Figure 4: Add plots of panels d, e, h and i with log scale on the y axis to make explicit an eventual exponential behavior, and revise the text accordingly

      Not to further complicate Figure 4, we preferred to display the logarithmic plots of the equilibrium distribution in the appendix, see Figure A3-1.

      • ’... an equilibrium distribution which monotonously decreases with assembly size’: It is not the distributions that decreases but the cluster volume fraction, please rephrase.

      We thank the reviewer for pointing this out and have now rephrased this sentence (line 394).

      Reviewer 3 (Recommendations For The Authors):

      I could not obtain the exact form of Eq 29 in App 3, can the authors elaborate on this calculation. App 3: What does it mean binodal agrees well with ϕsg? And doesn’t ϕsg depend on temperature through phi tilde? What temperature is this result for?

      We apologise for the unclear explanation. We now state in detail that Eq. (29) is obtained by plugging the expression of ϕi given in Eq. (24) into Eq. (1), in the main text. The dependence of ϕ<sub>1</sub> on ϕ<sub>tot</sub> is expressed in Eq. (26), and we have omitted linear terms in ϕ<sub>tot</sub>, since they do not affect phase equilibrium (see lines 802-809). Moreover, ϕsg depends indeed on k<sub>B</sub>T. We refer to the comparison between the full curve ϕsg in the k<sub>B</sub>T−ϕ<sub>tot</sub> plane, and the branch of the binodal between the triple point (indicated now with a cross) and ϕ<sub>tot</sub> \= 1. The two curves are close, as expected since both correspond to the boundary between homogeneous mixtures and the gel state, obtained with different methods.

      The references to Figures in the appendices are confusing. Please make it clear whether Figures in the main text or the appendices are being referenced. On a related note, the Appendix figures seem to be placed in appendices whose text describes something else - Appendix 2, Figure 1 should be moved to Appendix 3; Appendix 3, Figure 1 should be moved to Appendix 4; etc.

      We revised the appendix, corrected the figure positions and clarified their references.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #2 (Public Review):

      Making state-of-the-art (super-resolution) microscopy widely available has been the subject of many publications in recent years as correctly referenced in the manuscript. By advocating the ideas of open-microscopy and trying to replace expensive, scientific-grade components such as lasers, cameras, objectives, and stages with cost-effective alternatives, interested researchers nowadays have a number of different frameworks to choose from. In the iteration of the theme presented here, the authors used the existing modular UC2 framework, which consists of 3D printable building blocks, and combined a cheapish laser, detector and x,y,(z) stage with expensive filters/dichroics and a very expensive high-end objective (>15k Euros). This particular choice raises a first technical question, to which extent a standard NA 1.3 oil immersion objective available for <1k would compare to the chosen NA 1.49 one.

      Measurement of the illumination quality (e.g. the spectral purity) of low budget lasers convinced us of the necessity to use spectral filtering. These cannot be replaced with lower budget alternatives, to sill retain the necessary sensitivity to image single molecules. As expected, the high-quality objectives are able to produce high-quality data. Lower budget alternatives (<500 €) to replace the objective have been tried out. Image quality is reduced but key features in fluorescent images can be identified (see figure S1). The usage of a low budget objective for SMLM imaging is possible, but quality benchmarks such as identifying railroad tracks along microtubule profiles is not possible. Their usage is not optimal for applications aiming to visualize single molecules and might find better application in teaching projects.

      The choice of using the UC2 framework has the advantage, that the individual building blocks can be 3D printed, although it should be mentioned that the authors used injection-molded blocks that will have a limited availability if not offered commercially by a third party. The strength of the manuscript is the tight integration of the hardware and the software (namely the implementations of imSwitch as a GUI to control data acquisition, OS SMLM algorithms for fast sub-pixel localisation and access to Napari).

      The injection-molded cubes can be acquired through the OpenUC2 platform. Alternatively, the 3D printable version of the cubes is freely available and just requires the user to have a 3D printer. https://github.com/openUC2/UC2-GIT/tree/master/CAD/CUBE_EmptyTemplate

      The presented experimental data is convincing, demonstrating (1) extended live cell imaging both using bright-field and fluorescence in the incubator, (2) single-particle tracking of quantum dots, and (3) and STORM measurements in cells stained against tubulin. In the following I will raise two aspects that currently limit the clarity and the potential impact of the manuscript.

      First, the manuscript would benefit from further refinement. Elements in Figure 1d/e are not described properly. Figure 2c is not described in the caption. GPI-GFP is not introduced. MMS (moment scaling spectrum) could benefit from a one sentence description of what it actually is. In Figure 6, the size of the STORM and wide-field field of views are vastly different, the distances between the peaks on the tubuli are given in micrometers rather than nanometers. (more in the section on recommendations for the author)

      Second, and this is the main criticism at this point, is that although all the information and data is openly available, it seems very difficult to actually build the setup due to a lack of proper documentation (as of early July 2023).

      1) The bill of materials (https://github.com/openUC2/UC2-STORM-and-Fluorescence#bill-of-material) should provide a link to the commercially available items. Some items are named in German. Maybe split the BoM in commercially available and 3D printable parts (I first missed the option to scroll horizontally).

      2) The links to the XY and Z stage refer to the general overview site of the UC2 project (https://github.com/openUC2/) requiring a deep dive to find the actual information.

      3) Detailed building instructions are unfortunately missing. How to assemble the cubes (pCad files showing exploded views, for example)? Trouble shooting?

      4) Some of the hardware details (e.g. which laser was being used, lenses, etc) should be mentioned in the manuscript (or SI)

      I fully understand that providing such level of detail is very time consuming, but I hope that the authors will be able to address these shortcomings.

      1) The bill of materials has been and will also in future still be improved. The items have been sorted into UC2 printed parts and externally acquired parts. The combination of part name as well as provider enables users to find and acquire the same parts. Additionally, depending on the country where the user is located, different providers of a given part might be advantageous as delivery means and costs might vary.

      2) The Z-stage now has a specific repository with different solutions, offering different solutions with different levels of movement precision. According to the user and their budget, different solutions can be optimal for the endeavor.

      https://github.com/openUC2/UC2-Zstage

      The XY stage now also has a detailed repository, as the motorizing of the stage requires a fair amount of tinkering. The video tutorials and the detailed instructions on stage motorizing should help any user to reproduce the stage shown within this manuscript. https://github.com/openUC2/UC2-Motorized-XY-Table

      3) The updated repository has a short video showing the general assembly of the cubes and the layers. Additionally, figure S2 shows all the pieces that are included in every layer (as a photograph as well as CAD). An exploded view of the complete setup would certainly be a helpful visualization of the complete setup. We however hope that the presented assembly tutorials and documents are sufficient to successfully reproduce the U.C.STORM setup.

      First, we want to thank the reviewers for their effort to help us improving our work. We apologize for any trivial mistakes we had overlooked. Please find below our answers to the very constructive and helpful comments of the editors.  

      Recommendations for the authors:

      Reviewer #1 (Recommendations for The Authors):

      To complement the current data set:

      Figure 2(a & b): Panels i & ii, were chosen on the area where the distribution of the laser appears to be flatter. Can the authors select microtubules from a different section? Otherwise, it is reasonable to also crop the field-of-view along the flatter area (as done in Fig 6).

      Figure 2 was changed to according to the reviewer’s suggestions. The profiles of microtubules from a different section have similar profiles, but the region with best illumination thus best SNR of the profile have been used for the figure.

      Figure 2(c): The current plot shows the gaussian distribution which does not appear to be centered. Instead of a horizontal line, can the authors provide a diagonal profile across the field of view and update the panel below?

      A diagonal cross-section of the illuminated FOV is provided in figure 2 to replace the previous horizontal profile. The pattern seems not to be perfectly radially symmetric, and more light seems to be blocked at the bottom of the illumination pattern compared to the top. A possible improvement can be provided by a fiber-coupled laser, that could provide a more homogeneous illumination while being easier to handle in the assembly process.

      Author response image 1.

      Diagonal cross-section of the illuminated FOV. Pixel-size (104nm) is the same as in figure 2. Intensity has been normalized according to the maximal value.

      Figure 2(d): The system presents a XY drift of ~500nm over the course of a couple of hours. However, is not clear how the focus is being maintained. Can the authors clarify this point and add the axial drift to the plot?

      The axial position of the sample could be maintained over a prolonged period of time without correcting for drift. Measurements where an axial shift was induced by tension pulses in the electronics have been discarded, but the stability of the stage seems to be sufficient to allow for imaging without lateral and axial drift correction. The XY drift measurement displayed in Figure 2(d) can be extended by measuring the σ of the PSF over time. The increase of σ would suggest an axial displacement in relation to the focus plane. In these measurements, a slight axial drift can be seen, the fluorescent beads however can still be localized over the whole course of the measurement.

      A separate experiment was performed, using the same objective on the UC2 setup and on a high-quality setup equipped with a piezo actuator able to move in 10 nm steps. The precise Z steps of the piezo allows to reproducibly swipe through the PSF shape and to give an estimate of the axial displacement of the sample, according to the changes in PSF FWHM (Full Width at Half Maximum). When superimposing the graph with the UC2 measurement of fluorescent beads with the smallest possible Z step, an estimate about the relative axial position of the sample can be provided. The accuracy of the stage however remains limited.

      Author response image 2.

      Drift Figure: a. Drift of fluorescent TS beads on the UC2 setup positioned upon an optical table over a duration of two hours. Beads are localized and resulting displacement in i. and ii. are plotted in the graphs below. The procedure is repeated in b. with the microscope placed on a laboratory bench instead. c. (for the optical table i.) and d. (for the laboratory bench i.) show the variation in the sigma value of the localized beads over the measurement duration. As the sigma values changes when the beads are out of focus, the stability of the setup can be confirmed, as it remains practically unchanged over the measurement duration.

      Author response image 3.

      Z-focus Figure: Estimation of the axial position of TS beads on the UC2 setup. a. The change in PSF FWHM was quantified by acquiring a Z stack of a beads sample. The homebuilt high-quality setup (HQ) was used as a reference, by using the same objective and TS sample. The PSF FWHM on the UC2 setup was measured using the lowest possible axial stage displacement. A Z-position can thus be estimated for single molecules, as displayed in b.

      Addressing the seemingly correlated behavior of the X and Y drift:

      Further measurement show less correlation between drift in X and in Y. Simultaneous motion in X and Y seems to indicate that the stage or the sample is tilted. The collective movement in X and Y seems accentuated by bigger jumps, probably originating from vibrations (as more predominantly shown in the measurements on the laboratory bench compared to the optical table). Tension fluctuations inducing motion of the stage are possible but are highly unlikely to have induced the drift in the displayed measurements.

      Figure 3: Can the authors comment on the effect or otherwise potential effect of the incubator (humidity, condensation etc) may have on the system (e.g., camera, electronics etc)?

      When moving the microscope into the incubator, the first precaution is to check if the used electronics are able to perform at 37° C. Then, placing the microscope inside the incubator can induce condensation of water droplets at the cold interfaces, potentially damaging the electronics or reducing imaging quality. This can be prevented by preheating the microscope in e.g. an incubator without humidity, for a few hours before placing it within the functional incubator. The used incubator should also be checked for air streams (to distribute the CO2), and a direct exposure of the setup to the air stream should be prevented. The usage of a layer of foam material (e.g. Polyurethane) under the microscope helps to reduce possible effects of incubator vibrations on the microscope. The hydrophilic character of PLA makes its usage within the incubator challenging due to its reduced thermal stability. The temperature also inherently reduces the mechanical stability of 3D printed parts. Using a less hydrophilic and more thermally stable plastic, such as ABS, combined with a higher percentage of infill are the empirical solution to this challenge. Further options and designs to improve the usage of the microscope within the incubator are still in developement.

      Figure 5: Can the authors perform single molecule experiments with an alternative tag such as Alexa647?

      The SPT experiments were performed with QDs to make use of their photostability and brightness. The dSTORM experiment suggests that imaging single AF647 molecules with sufficient SNR is possible. The usage of AF647 for SPT is possible but would reduce the accuracy of the localization and shorten the acquired track-lengths, due to the blinking properties of AF647 when illuminated. The tracking experiment with the QDs thus was a proof of concept that the SPT experiments are possible and allow to reproduce the diffusion coefficients published in common literature. The usage of alternative tags can be an interesting extension of the capabilities that users can perform for their applications.

      Figure 6: The authors demonstrate dSTORM of microtubules. It would enhance the paper to also demonstrate 3D imaging (e.g., via cylindrical lens).

      The usage of a cylindrical lens for 3D imaging was not performed yet. The implementation would not be difficult, given the high modularity of the setup in general. The calibration of the PSF shape with astigmatism might however be challenging as the vertical scanning of the Z-stage lacks reliability in its current build. Methods such as biplane imaging might also be difficult to implement, as the halved number of photons in each channel leads to losses in the accuracy of localization. As a future improvement of the setup, the option of providing 3D information with single molecule accuracy is definitely desirable and will be tried out. In the following figure, two concepts for introducing 3D imaging capabilities in the detection layer of the microscope are presented.

      Author response image 4.

      3D concept Figure: Two possible setup modifications to provide axial information when imaging single molecules. a. A cylindrical lens can be placed to induce an asymmetry between the PSF FWHM in x and in y. Every Z position can be identified by two distinct PSF FWHM values in X and Y. b. By splitting the beam in two and defocusing one path, every PSF will have a specific set of values for its FWHM on the two detectors.

      Imaging modalities section: Regarding the use of cling film to diffuse; can the authors comment on the continual use of this approach, including its degradation over time?

      The cling foil was only used as a diffuser for broadening the laser profile. A detailed analysis of the constitution of the foil was not done, as no visible changes could be seen on the illumination pattern and the foil itself. The piece of cling foil is attached to a rotor. Detaching of the cling foil or vibrations originating from the rotor need to be minimized. By keeping the rotation speed to a necessary minimum and attaching the cling foil correctly to the rotor, a usable solution can be created. The low price of the cling foil provides the possibility to exchange the foil on a regular basis, allowing to keep the foil under optimal conditions.

      Author response image 5.

      Profile Figure: By moving a combination of pinhole and photometer to scan through the laser profile with a translational mount, the shape of the laser beam can be estimated. The cling foil plays the same role as a diffuser in other setups.

      Reviewer #2 (Recommendations for The Authors):

      lines

      20, add "," after parts

      110, rotating cling foil?

      112/116, "custom 3D printed" I thought they were injection molded, please finalize

      113, "puzzle pieces" rephrase and they are also barely visible

      119, not clear that the stage is a manual stage that was turned into a motorised one by adding belts

      123-126, detail for SI,

      132, replace Arduino-coded with Arduino-based

      143, add reference to Napari

      146, (black) cardboard seems to be a cheaper and quicker alternative

      153, dichroic

      151-155, reads more like a blog post than a paper (maybe add a section on trouble shooting)

      156, antibody?

      167/189, moderate, please be specific

      194, layer of foam material, specify

      221, add description/reference to GPI. What is that? why is it relevant?

      226: add one sentence description of MMS

      318, add "," after students

      332-334, as mentioned earlier, not clear, you bought a manual stage and connected belts, correct?

      376-377, might be difficult to understand for the layman

      391, what laser was used?

      Figure 1, poor contrast between components, components visible should be named as much as possible, maybe provide the base layer in a different shade. To me, the red and blue labels look like fluorophores.

      Figure 1. looks like d is the excitation layer and not e, please fix.

      Figure 2, caption a-c, figure 1-d!, btw, why is the drift so anti-correlated?

      Figure 6 (line 259) nanometer I guess, not micrometer

      We now incorporated all the above-mentioned changes in the manuscript. Furthermore we added the supplementary Figures as below.

      Author response image 6.

      Basic concept of the UC2 setup: Left: Cubes (green) are connected to one another via puzzle pieces (white). Middle: 3D printed mounts have been designed to adapt various optics (right) to the cube framework. Combined usage of cubes and design of various mounts allows to interface various optics for the assembly.

      Author response image 7.

      Building the UC2 widefield microscope: a. Photograph of the complete setup. b. All pieces necessary to build the setup. A list of the components can be found in the bill of materials. c. Bottom emission layer of the microscope before assembly. d. Emission layer after assembly. Connection between cubes is doubled by using a layer of puzzles on the top and the bottom of the emission layer. e. CAD schematic of the emission layer and the positioning of the optics. f. Middle excitation layer of the microscope before assembly. Beam magnifier and homogenizer have been left out for clarity. g. Excitation layer after assembly is also covered by a puzzle layer. h. CAD schematic of the excitation layer and the positioning of the optics. i. Z-stage photograph and corresponding CAD file. Motor of the stage is embedded within the bottom cube. j. A layer of empty cubes supports the microscope stage. k. At this stage of the assembly, the objective is screwed into the objective holder. l. Finally, the stage is wired to the electronics and can then be mounted on top of the microscope (see a.).

      Author response image 8.

      Measurements performed on the UC2 setup with lower budget objectives. The imaged sample is HeLa cells, stably transfected to express CLC-GFP, then labelled with AF647 through immunostaining. The setup has been kept identical except for the objectives. Scale bar respectively represents 30 µm.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment 

      This study investigates associations between retrotransposon element expression and methylation with age and inflammation, using multiple public datasets. The study is valuable because a systematic analysis of retrotransposon element expression during human aging has been lacking. However, the data provided are incomplete due to the sole reliance on microarray expression data for the core analysis of the paper. 

      Both reviewers found this study to be important. We have selected the microarray datasets of human blood adopted by a comprehensive study of ageing published in a Nature

      Communications manuscript (DOI: doi: 10.1038/ncomms9570). We only included the datasets specifically collected for ageing studies. Therefore, the large RNA-seq cohorts for cancer, cardiovascular, and neurological diseases were not relevant to this study and cannot be included.   

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      Tsai and Seymen et al. investigate associations between RTE expression and methylation and age and inflammation, using multiple public datasets. The concept of the study is in principle interesting, as a systematic analysis of RTE expression during human aging is lacking. 

      We thank the reviewer for the positive comment. 

      Unfortunately, the reliance on expression microarray data, used to perform the core analysis of the paper places much of the study on shaky ground. The findings of the study would not be sufficiently supported until the authors validate them with more suitable methods. 

      In our discussion section in the manuscript, we have clarified that “we are aware of the limitations imposed by using microarray in this study, particularly the low number of intergenic probes in the expression microarray data. Our study can be enriched with the advent of large  RNA-seq cohorts for aging studies in the future.”  However, the application of microarray for RTE expression analysis was introduced previously (DOI: 10.1371/journal.pcbi.1002486) and applied in some highly cited and important publications before (DOI: 10.1038/ncomms1180, DOI: 10.1093/jnci/djr540). In fact, in a manuscript published by Reichmann et al.  (DOI: 10.1371/journal.pcbi.1002486) which was cited 76 times, the authors showed and experimentally verified that cryptic repetitive element probes present in Illumina and Affymetrix gene expression microarray platforms can accurately and sensitively monitor repetitive element expression data. Inspired by this methodological manuscript with reasonable acceptance by other researchers, we trusted that the RTE microarray probes could accurately quantify RTE expression at class and family levels.

      Strengths: 

      This is a very important biological problem. 

      Weaknesses: 

      RNA microarray probes are obviously biased to genes, and thus quantifying transposon analysis based on them seems dubious. Based on how arrays are designed there should at least be partial (perhaps outdated evidence) that the probe sites overlap a protein-coding or non-coding RNA. 

      We disagree with the reviewer that quantifying transposon analysis based on microarray data is dubious. As previously shown by Reichmann et al., the quantification is reliable as long as the probes do not overlap with annotated genes and they are in the correct orientation to detect sense repetitive element transcripts. Reichman et al. identified 1,400 repetitive element probes in version 1.0, version 1.1 and version 2.0 of the Illumina Mouse WG-6 Beadchips by comparing the genomic locations of the probes with the Repeatmasked regions of the mouse genome. We applied the same criteria for Illumina Human HT-12 V3 (29431 probes) and V4 (33963) to identify the RTE-specific probes. 

      The authors state they only used intergenic probes, but based on supplementary files, almost half of RTE probes are not intergenic but intronic (n=106 out of 264). 

      All our identified RTE probes overlap with intergenic regions. However, due to their repetitive natures, some probes overlap with intronic regions, too. We have replaced "intergenic" with "non-coding" in our resubmission to show that they do not overlap with the exons of protein-coding genes. However, we do not rule out the possibility that some of our detected RTE probes might overlap non-coding RNAs. In fact, the border between coding and non-coding genomes has recently become very fuzzy with new annotations of the genome. RTE RNAs can be easily considered as non-coding RNAs if we challenge our traditional junk DNA view. 

      This is further complicated by the fact that not all this small subset of probes is available in all analyzed datasets. For example, 232 probes were used for the MESA dataset but only 80 for the GTP dataset. Thus, RTE expression is quantified with a set of probes which is extremely likely to be highly affected by non-RTE transcripts and that is also different across the studied datasets. Differences in the subsets of probes could very well explain the large differences between datasets in multiple of the analyses performed by the authors, such as in Figure 2a, or 3a. It is nonetheless possible that the quantification of RTE expression performed by the authors is truly interpretable as RTE expression, but this must be validated with more data from RNA-seq. Above all, microarray data should not be the main type of data used in the type of analysis performed by the authors. 

      In this study, we did not compare MESA with GTP etc. We have analysed each dataset separately based on the available data for that dataset. Therefore, sacrificing one analysis because of the lack of information from the other does not make sense. We would do that if we were after comparing different datasets. Moreover, the datasets are not comparable because they were collected from different types of blood samples. 

      Reviewer #2 (Public Review): 

      Summary: 

      Yi-Ting Tsai and colleagues conducted a systematic analysis of the correlation between the expression of retrotransposable elements (RTEs) and aging, using publicly available transcriptional and methylome microarray datasets of blood cells from large human cohorts, as well as single-cell transcriptomics. Although DNA hypomethylation was associated with chronological age across all RTE biotypes, the authors did not find a correlation between the levels of RTE expression and chronological age. However, expression levels of LINEs and LTRs positively correlated with DNA demethylation, and inflammatory and senescence gene signatures, indicative of "biological age". Gene set variation analysis showed that the inflammatory response is enriched in the samples expressing high levels of LINEs and LTRs. In summary, the study demonstrates that RTE expression correlates with "biological" rather than "chronological" aging. 

      Strengths: 

      The question the authors address is both relevant and important to the fields of aging and transposon biology. 

      We thank the reviewer for finding this study relevant and important.

      Weaknesses: 

      The choice of methodology does not fully support the primary claims. Although microarrays can detect certain intergenic transposon sequences, the authors themselves acknowledge in the Discussion section that this method's resolution is limited. More critical considerations, however, should be addressed when interpreting the results. The coverage of transposon sequences by microarrays is not only very limited (232 unique probes) but also predetermined. This implies that any potential age-related overexpression of RTEs located outside of the microarray-associated regions, or of polymorphic intact transposons, may go undetected. Therefore, the authors should be more careful while generalising their conclusions. 

      This is a bioinformatics study, and we have already admitted and discussed the limitations in the discussion section of this manuscript. All technologies have their own limitations, and this should not stop us from shedding light on scientific facts because of inadequate information. In the manuscript, we have discussed that all large and proper ageing studies were performed using microarray technology. Peters et al. (DOI: doi: 10.1038/ncomms9570) adopted all these datasets in their transcriptional landscape of ageing manuscript, which was used in previous studies of ageing as well. Our study essentially applies the Reichmann et al. method to the peripheral blood-related data from the Peters et al. manuscript. Since hypomethylation due to ageing is a well-established and broad epigenetic reprogramming, it is unlikely that only a fraction of RTEs is affected by this phenomenon. Therefore, the subsampling of RTEs should not affect the result so much. Indeed, this is supported in our study by the inverse correlation between DNA methylation and RTE expression for LINE and SINE classes despite having limited numbers of probes for LINE and SINE expressions.    

      Additionally, for some analyses, the authors pool signals from RTEs by class or family, despite the fact that these groups include subfamilies and members with very different properties and harmful potentials. For example, while sequences of older subfamilies might be passively expressed through readthrough transcription, intact members of younger groups could be autonomously reactivated and cause inflammation. The aggregation of signals by the largest group may obscure the potential reactivation of smaller subgroups. I recommend grouping by subfamily or, if not possible due to the low expression scores, by subgroup. For example, all HERV subfamilies are from the ERVL family. 

      We agree with the reviewer that different subfamilies of RTEs play different roles through their activation. However, we will lose our statistical power if we study RTE subfamilies with a few probes. Global epigenetic alteration and derepression of RTEs by ageing have been observed to be genome-wide. While our systematic analysis across RTE classes and families cannot capture alterations in subfamilies due to statistical power, it is still relevant to the research question we are addressing.

      Next, Illumina arrays might not accurately represent the true abundance of TEs due to nonspecific hybridization of genomic transposons. Standard RNA preparations always contain traces of abundant genomic SINEs unless DNA elimination is specifically thorough. The problem of such noise should be addressed. 

      We have checked the RNA isolation step from MESA, GTP, and GARP manuscripts. The total RNA was isolated using the Qiagen mini kit following the manufacturer’s recommendations. The authors of these manuscripts did not mention whether they eliminated genomics DNA, but we assumed they were aware of the DNA contamination and eliminated it based on the manufacturer’s recommendations. We have looked up the literature about nonspecific hybridization of RTEs but could not find any evidence to support this observation. We would appreciate the reviewers providing more evidence about such RTE contaminations.   

      Lastly, scRNAseq was conducted using 10x Genomics technology. However, quantifying transposons in 10x sequencing datasets presents major challenges due to sparse signals. 

      Applying the scTE pipeline (https://www.nature.com/articles/s41467-021-21808-x), we have found that the statical power of quantifying RTE classes (LINE, SINE, and LTR) or  RTE families (L1, L2, All, ERVK, etc.) are as good as each individual gene. However, our proposed method cannot analyse RTE subfamilies, and we did not do that. 

      Smart-seq single-cell technology is better suited to this particular purpose. 

      We agree with the reviewer that Smart-seq provides higher yield than 10x, but there is no Smartseq data available for ageing study.  

      Anyway, it would be more convincing if the authors demonstrated TE expression across different clusters of immune cells using standard scRNAseq UMAP plots instead of boxplots. 

      Since the number of RTE reads per cell is low, showing the expression of RTEs per cell in UMAP may not be the best statistical approach to show the difference between the aged and young groups. This is why we chose to analyse with Pseudobulk and displayed differential expression using boxplot rather than UMAP for each immune cell type. 

      I recommend validating the data by RNAseq, even on small cohorts. Given that the connection between RTE overexpression and inflammation has been previously established, the authors should consider better integrating their observations into the existing knowledge. 

      Please see below. We have analysed RNA-seq data suggested by Reviewer 1 in the Recommendations for the Authors section.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      I can recommend two sizeable human PMBC RNA-seq datasets that the authors could use:

      Marquez et al. 2020 (phs001934.v1.p1, controlled access) and Morandini et al. 2023 (GSE193141, public access). There are likely other suitable datasets that I am not aware of. I would also recommend using identical sets of probes to quantify RTE expression across studies. If certain datasets have too few probes and would thus limit the number of probes available across all studies it might be a good idea to exclude the dataset, especially if the analysis has been supplemented by the additional RNA-seq datasets. 

      Until recently, there was no publicly-available, non-cancerous, large cohort of RNA-seq data for ageing studies. We tried to gain access to the two RNA-seq datasets suggested by reviewer 2: Marquez et al. 2020 (phs001934.v1.p1, controlled access) and Morandini et al. 2023 (GSE193141, public access). 

      Unfortunately, Marquez et al. 2020 data is not accessible because the authors only provide the data for projects related to cardiovascular diseases. However, we did analyse Morandini et al. 2023 data, and we can confirm that no association was observed between any class and family of RTEs with chronological ageing (Author response image 1), which is the second strong piece of evidence supporting the statement in the manuscript. However, as expected, we found a positive correlation between RTE expression and IFN-I signature score (Author response image 2).

      Author response image 1.

      Linear analysis of RTE expression and chronological age.

      Author response image 2.

      Linear analysis of RTE expression and IFN gene signature expression.

      The authors use "biological age" and inflammation as interchangeable concepts, including in the title. Please correct this wording. 

      We have now added a new terminology to the manuscript called “biological age-related (BAR)”, which has been clearly addressed this distinction. We don’t think it is needed to change the title.  

      The authors find correlations between RTE expression and age-associated gene signatures but not chronological age itself. This is puzzling because, as the wording suggests, the expression of these inflammatory pathways is age-associated. If RTE expression correlates with inflammation which itself correlates with age, one might expect RTE expression to also correlate with age. Do the authors see a correlation between various inflammatory gene signatures and chronological age, in the analyzed datasets? If yes, then how would you explain that discrepancy? Moreover, in this case, I would recommend using a linear model, rather than correlation, to separate the effects of chronological age and RTE expression on inflammation (Inflammation et al ~ Age + RTE expression), or equivalent designs.

      As described above, we have now introduced the BAR terminology, which resolves this confusion. We did not find a correlation between RTE expression and chronological age. However, we did identify the correlation between BAR gene signatures and RTE expression.

      To separate the effects of chronological age and RTE expression on BAR gene signature scores, we performed a generalized linear model (GLM) analysis using BAR gene signature scores as response variables and RTE expression and chronological age as predictors (BAR gene signature scores ~ RTE expression + chronological age). Significant association was observed between BAR gene signature scores and RTE expression in the GARP cohort (Author response image 3). However, when chronological age is considered as predictor, we did not identify a correlation between chronological age and BAR gene signatures, indicating that BAR events are not corelated with chronological age (Author response image 3).  

      Author response image 3.

      Generalized linear models (GLM) analysis (BAR gene signature scores ~ RTE expression + chronological age). For each RTE family, we separately performed GLM. Age (RTE family) indicates the chronological age when used in the design formula for that specific RTE family. 

      Some of the gene sets used by the authors have considerable overlap with others and are also not particularly comprehensive. I can recommend this very comprehensive gene set: https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/SAUL_SEN_MAYO.  

      We did not choose to use large gene lists such as the suggested SEN_MAYO list, as we found Singscore struggles to generate reliable scores with sufficient variance when the number of genes increase to more than twenty. Although there is some overlap between inflammation-related genes and cellular senescence genes (e.g., IL6, IL1A, IL1B), it is important to note that each gene list focuses on different aspects of biological aging and should not be dismissed as redundant.

      Minor comments: 

      Overall, several sentences in the manuscript feel somewhat unnatural. I would recommend further proofreading. I will mention some examples:  

      Thank you for your feedback. We have fixed all these issues in the new submission.  

      • One line 34, "like the retroviruses" should be "like retroviruses. There are several other places in the text where "the" is not required. 

      Fixed.

      • On line 86, "to generate the RTE expression". "the" is again not necessary and I would replace "generate" with "quantify". 

      Fixed.

      • On line 86, "we mapped the probe locations to RepeatMasker". RepeatMasker is not a genome. Do you mean you mapped the probe location to a genome annotated by RepeatMasker? The same applies to line 99.  

      Fixed. We changed the sentence to: “To quantify RTE expression, we mapped the microarray probe locations to RTE locations in RepeatMasker to extract the list of noncoding (intergenic or intronic) probes that cover the RTE regions.”

      • Figure 1 contains a typo in the aims section: "evetns" instead of "events".  

      Fixed.

      • On line 495 "filtered out" seems to imply your removed intergenic probes. I assume you mean that you specifically selected intergenic probes. 

      Fixed.

      • Figure 1 nicely summarizes your datasets. Could you add a Figure 1b panel showing how you used RNA arrays to quantify RTE expression? This should include the number of probes for each RTE family, so I suggest merging this with Figure S1.  

      We disagree with the reviewer to merge Figure 1 and Figure S1 because they are addressing two different concepts.  

      Reviewer #2 (Recommendations For The Authors): 

      In Figure 2c, it is unclear what colour scale has been used for age. 

      Thank you for the comment. We have added a legend for age in this figure.

      There are no figure legends for Supplementary Figures 1 to 5 and all figures after Supplementary Figure 8. 

      A new version with legends has been submitted.

      For different datasets used, the choice of "healthy" patients should be more clear and explicit.

      Are asymptomatic patients with autoimmune inflammatory disorders considered as "healthy"? If not only healthy patients' blood is analysed (such as PBMS from primary osteoarthrosis), how inflammatory signatures enrichment discovered in this study may be associated not just with "biological age" but with the disease itself? 

      In our analysis, we did not exclusively study "healthy" individuals, as none of our datasets were initially collected from strictly healthy populations. While the microarray datasets were not specifically collected from people with particular diseases, they were also not screened for asymptomatic conditions. To demonstrate the same pattern in healthier cohorts, we added scRNA-seq analysis of confirmed healthy individuals to our study. However, the focus of this study is not on healthy aging. Instead, it is on biological ageing that includes both healthy and non-healthy ageing.

      We included the GARP (primary osteoarthritis) dataset as it is a cohort of age-related diseases (ARD). While we cannot definitively attribute inflammatory signatures enrichment to biological aging or disease, the observation of such enrichment in a cohort of ARD is worth considering. To make this clearer, we have replaced the term “healthy” with “non-cancerous” for microarray analysis throughout the paper.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Response to reviewers

      We would like to thank the reviewers for their feedback. Below we address their comments and have indicated the associated changes in our point-by-point response (blue: answers, red: changes in manuscript).

      Reviewer #1:

      Overall, the hypotheses and results are clearly presented and supported by high quality figures. The study is presented in a didactic way, making it easy for a broad audience to understand the significance of the results. The study does present some weaknesses that could easily be addressed by the authors.

      We thank the reviewer for appreciating our work and providing useful suggestions for improvement.

      1) First, there are some anatomical inaccuracies: line 129 and fig1C, the authors omit m.dial septum projections to area CA1 (in addition to the entorhinal cortex). Moreover, in addition to CA1, CA3 also provides monosynaptic feedback projections to the medial septum CA3. Finally, an indirect projection from CA1/3 excitatory neurons to the lateral septum, which in turn sends inhibitory projections to the medial septum could be included or mentioned by the authors. This could be of particular relevance to support claims related to effects of neurostimulations, whereby minutious implementation of anatomical data could be key.

      If not updating their model, the authors could add this point to their limitation section, where they already do a good job of mentioning some limitations of using the EC as a sole oscillatory input to CA1.

      We acknowledge that our current model strongly simplifies the interconnections between the medial septum and the hippocampal formation, but including more anatomical details is beyond the scope of this manuscript and would be a topic for future work. Nevertheless, we followed the reviewer’s advice to stress this point in our manuscript. First, we moved a paragraph that was initially in the “methods” section to the “results” section (L.141-150 of the revised manuscript):

      “Biologically, GABAergic neurons from the medial septum project to the EC, CA3, and CA1 fields of the hippocampus (Toth et al., 1993; Hajós et al., 2004; Manseau et al., 2008; Hangya et al., 2009; Unal et al., 2015; Müller and Remy, 2018). Although the respective roles of these different projections are not fully understood, previous computational studies have suggested that the direct projection from the medial septum to CA1 is not essential for the production of theta in CA1 microcircuits (Mysin et al., 2019). Since our modeling of the medial septum is only used to generate a dynamic theta rhythm, we opted for a simplified representation where the medial septum projects only to the EC, which in turn drives the different fields of the hippocampus. In our model, Kuramoto oscillators are therefore connected to the EC neurons and they receive projections from CA1 neurons (see methods for more details).”

      Second, we expanded the corresponding paragraph in the limitation section to discuss this point further (L.398-415 of the revised manuscript):

      “We decided to model septal pacemaker neurons projecting to the EC as the main source of hippocampal theta as reported in multiple experimental studies (Buzsáki, 2002; Buzsáki et al., 2003; Hangya et al., 2009). However, experimental findings and previous models have also proposed that direct septal inputs are not essential for theta generation (Wang, 2002; Colgin et al., 2013; Mysin et al., 2019), but play an important role in phase synchronization of hippocampal neurons. Furthermore, the model does not account for the connections between the lateral and medial septum and the hippocampus (Takeuchi et al., 2021). These connections include the inhibitory projections from the lateral to the medial septum and the monosynaptic projections from the hippocampal CA3 field to the lateral septum. An experimental study has highlighted the importance of the lateral septum in regulating the hippocampal theta rhythm (Bender et al., 2015), an area that has not been included in the model. Specifically, theta-rhythmic optogenetic stimulation of the axonal projections from the lateral septum to the hippocampus was shown to entrain theta oscillations and lead to behavioral changes during exploration in transgenic mice. To account for these discrepancies, our model could be extended by considering more realistic connectivity patterns between the medial / lateral septum and the hippocampal formation, including glutamatergic, cholinergic, and GABAergic reciprocal connections (Müller and Remy, 2018), or by considering multiple sets of oscillators each representing one theta generator.”

      1. The authors test conditions of low theta inputs, which they liken to pathological states (line 112). It is not clear what pathology the authors are referring to, especially since a large amount of 'oscillopathies' in the septohippocampal system are associated with decreased gamma/PAC, but not theta oscillations (e.g. Alzheimer's disease conditions).

      In the manuscript, we referred to “oscillopathies” in a broad sense way as we did not want to overstate the biological implications of the model or the way we modeled pathological states. To our knowledge, several studies have yielded inconsistent results regarding the specific changes in theta or gamma power in Alzheimer’s disease, and the most convincing alteration seems to be the theta-gamma phase-amplitude coupling (PAC) (for review see e.g., Kitchigina, V. F. Alterations of Coherent Theta and Gamma Network Oscillations as an Early Biomarker of Temporal Lobe Epilepsy and Alzheimer’s Disease. Front Integr Neurosci 12, 36 (2018)), as also mentioned by the reviewer.

      In this study, the most straightforward way to reduce theta-gamma PAC was to reduce the amplitude of the oscillators’ gain, which affected theta power, gamma power, and theta-gamma PAC (Figure 5 of the revised manuscript). Affecting their synchronization level (i.e., the order parameter) did not affect any of these variables (Figure 5 – Figure Supplement 4).

      In order to alter theta-gamma PAC without affecting theta or gamma power, we believe that more complex changes should be performed in the model, likely at the level of individual neurons in the hippocampal formation. For example, cholinergic deprivation has been previously used in a multi-compartment model of the hippocampal CA3 to mimic Alzheimer’s disease and to draw functional implications on the slowing of theta oscillations and the storage of new information (Menschik, E. D. & Finkel, L. H. Neuromodulatory control of hippocampal function: towards a model of Alzheimer’s disease. Artif Intell Med 13, 99–121 (1998)).

      This has now been added to the limitations section (L.458-465 of the revised manuscript):

      “Finally, we likened conditions of low theta input to pathological states characteristic of oscillopathies such as Alzheimer’s disease, as these conditions disrupted all aspects of theta-gamma oscillations in our model: theta power, gamma power, and theta-gamma PAC (Figure 5). However, it should be noted that changes in theta or gamma power in these pathologies are often unclear, and that the most consistent alteration that has been reported in Alzheimer’s disease is a reduction of theta-gamma PAC (for review, see Kitchigina, 2018). Future work should explore the effects of cellular alterations intrinsic to the hippocampal formation and their impact on theta-gamma oscillations.”

      1. While relevant for the clinical field, there is overall a missed opportunity to explain many experimental accounts with this novel model. Although to this day, clinical use of DBS is mostly restricted to electrical (and thus cell-type agnostic) stimulation, recent studies focusing on mechanisms of neurostimulations have manipulated specific subtypes in the medial septum and observed effects on hippocampal oscillations (e.g. see Muller & Remy, 2017 for review). Focusing stimulations in CA1 is of course relevant for clinical studies but testing mechanistic hypotheses by focusing stimulation on specific cell types could be highly informative. For instance, could the author reproduce recent optogenetic studies (e.g. Bender et al. 2015 for stimulation of fornix fibers; Etter et al., 2019 & Zutshi et al. 2018 for stimulation of septal inhibitory neurons)? Cell specific manipulations should at least be discussed by the authors.

      We acknowledge the importance of cell-type-specific manipulation in the septo-hippocampal circuitry. However, our model was designed to study neurostimulation protocols that affect the hippocampal formation, not the medial septum, which is why only the hippocampal formation is composed of biophysically realistic (i.e., conductance-based) neuronal models. To replicate the various studies mentioned by the reviewer (which are all very relevant), we would need to implement a biophysical model of the medial septum, which would be an entirely new project.

      Nevertheless, we can use the existing model to replicate optogenetic studies that induced gamma oscillations in excitatory-inhibitory circuits, using either ramped photostimulation targeting excitatory neurons (Adesnik et al., 2010; Akam et al., 2012; Lu et al., 2015), or pulsed stimulation driving inhibitory cells in the gamma range (Cardin et al., 2009; Iaccarino et al., 2016). In fact, such approaches have been demonstrated not just in the hippocampus but also in the neocortex, and represent a hallmark of local excitatory-inhibitory circuits. To account for these experimental results and replicate them, we have added 4 new figures (Figure 2 and its 3 figure supplements) and an extensive section in the results part (L.151-217 of the revised manuscript):

      “From a conceptual point of view, our model is thus composed of excitatory-inhibitory (E-I) circuits connected in series, with a feedback loop going through a population of coupled phase oscillators. In the next sections, we first describe the generation of gamma oscillations by individual E-I circuits (Figure 2), and illustrate their behavior when driven by an oscillatory input such as theta oscillations (Figure 3). We then present a thorough characterization of the effects of theta input and stimulation amplitude on theta-nested gamma oscillations (Figure 4 and Figure 5). Finally, we present some results on the effects of neurostimulation protocols for restoring theta-nested gamma oscillations in pathological states (Figure 6 and Figure 7).

      Generation of gamma oscillations by E-I circuits

      It is well-established that a network of interconnected pyramidal neurons and interneurons can give rise to oscillations in the gamma range, a mechanism termed pyramidal-interneuronal network gamma (PING) (Traub et al., 2004; Onslow et al., 2014; Segneri et al., 2020;). This mechanism has been observed in several optogenetic studies with gradually increasing light intensity (i.e., under a ramp input) affecting multiple different circuits, such as layer 2-3 pyramidal neurons of the mouse somatosensory cortex (Adesnik et al., 2010), the CA3 field of the hippocampus in rat in vitro slices (Akam et al., 2012), and in the non-human primate motor cortex (Lu et al., 2015). In all cases, gamma oscillations emerged above a certain threshold in terms of photostimulation intensity, and the frequency of these oscillations was either stable or slightly increased when increasing the intensity further. We sought to replicate these findings with our elementary E-I circuits composed of single-compartment conductance-based neurons driven by a ramping input current (Figure 2 and Figure S2). As an example, all the results in this section will be shown for an E-I circuit that has similar connectivity parameters as the CA1 field of the hippocampus in our complete model (see section “Hippocampal formation: inputs and connectivity” in the methods).

      For low input currents provided to both neuronal populations, only the highly-excitable interneurons were activated (Figure 2A). For a sufficiently high input current (i.e., a strong input that could overcome the inhibition from the fast-spiking interneurons), the pyramidal neurons started spiking as well. As the amplitude of the input increased, the activity of the both neuronal populations became synchronized in the gamma range, asymptotically reaching a frequency of about 60 Hz (Figure 2A bottom panel). Decoupling the populations led to the abolition of gamma oscillations (Figure 2B), as neuronal activity was determined solely by the intrinsic properties of each cell. Interestingly, when the ramp input was provided solely to the excitatory population, we observed that the activity of the pyramidal neurons preceded the activity of the inhibitory neurons, while still preserving the emergence of gamma oscillations (Figure S2 A). As expected, decoupling the populations also abolished gamma oscillations, with the excitatory neurons spiking a frequency determined by their intrinsic properties and the inhibitory population remaining silent (Figure S2B).

      To further characterize the intrinsic properties of individual inhibitory and excitatory neurons, we derived their input-frequency (I-F) curves, which represent the firing rate of individual neurons in response to a tonic input (Figure S3A). We observed that for certain input amplitudes, the firing rates of both types of neurons was within the gamma range. Interestingly, in the absence of noise, each population could generate by itself gamma oscillations that were purely driven by the input and determined by the intrinsic properties of the neurons (Figure S3B). Adding stochastic Gaussian noise in the membrane potential disrupted these artificial oscillations in decoupled populations (Figure S3C). All subsequent simulations were run with similar noise levels to prevent the emergence of artificial gamma oscillations.

      Another potent way to induce gamma oscillations is to drive fast-spiking inhibitory neurons using pulsed optogenetic stimulation at gamma frequencies, a strategy that has been used both in the neocortex (Cardin et al., 2009) and hippocampal CA1 (Iaccarino et al., 2016). In particular, Cardin and colleagues systematically investigated the effect of driving either excitatory or fast-spiking inhibitory neocortical neurons at frequencies between 10 and 200 Hz (Cardin et al., 2009). They showed that fast-spiking interneurons are preferentially entrained around 40-50 Hz, while excitatory neurons respond better to lower frequencies. To verify the behavior of our model against these experimental data, we simulated pulsed optogenetic stimulation as an intracellular current provided to our reduced model of a single E-I circuit. Stimulation was applied at frequencies between 10 and 200 Hz to excitatory cells only, to inhibitory cells only, or to both at the same time (Figure S4). The population firing rates were used as a proxy for the local field potentials (LFP), and we computed the relative power in a 10-Hz band centered around the stimulation frequency, similarly to the method proposed in (Cardin et al., 2009). When presented with continuous stimulation across a range of frequencies in the gamma range, interneurons showed the greatest degree of gamma power modulation (Figure S4). Furthermore, when the stimulation was delivered to the excitatory population, the relative power around the stimulation frequency dropped significantly in frequencies above 10 Hz, similar to the reported experimental data (Cardin et al., 2009). The main difference between our simulation results and these experimental data is the specific frequencies at which fast-spiking interneurons showed resonance, which was slow gamma around 40 Hz in the mouse barrel cortex and fast gamma around 90 Hz in our model. This could be attributed to several factors, such as differences in the cellular properties between cortical and hippocampal fast-spiking interneurons, or the differences between the size of the populations and their relevant connectivity in the cortex and the hippocampus.”

      Author response image 1.

      Figure 2. Emergence of gamma oscillations in coupled excitatory-inhibitory populations under ramping input to both populations. A. Two coupled populations of excitatory pyramidal neurons (NE = 1000) and inhibitory interneurons (NI = 100) are driven by a ramping current input (0 nA to 1 nA) for 5 s. As the input becomes stronger, oscillations start to emerge (shaded green area), driven by the interactions between excitatory and inhibitory populations. The green inset shows the raster plot (neuronal spikes across time) of the two populations during the green shaded period (red for inhibitory; blue for excitatory). When the input becomes sufficiently strong (shaded magenta area), the populations become highly synchronized and produce oscillations in the gamma range (at approximately 50 Hz). The spectrogram (bottom panel) shows the power of the instantaneous firing rate of the pyramidal population as a function of time and frequency. It reveals the presence of gamma oscillations that emerge around 2s and increase in frequency until 4 s, when they settle at approximately 60 Hz. B. Similar depiction as in panel A. with the pyramidal-interneuronal populations decoupled. The absence of coupling leads to the abolition of gamma oscillations, each cell spiking activity being driven by its own inputs and intrinsic properties.

      Author response image 2.

      Figure S2 (Figure 2 – Figure Supplement 1). Emergence of gamma oscillations in coupled excitatoryinhibitory populations under ramping input to the excitatory population. Similar representation as in Figure 2, but with the input provided only to the excitatory population. All conclusions remain the same. In addition, the inhibitory population does not show any spiking activity in the decoupled case.

      Author response image 3.

      Figure S3 (Figure 2 – Figure Supplement 2). Cell-intrinsic spiking activity in decoupled excitatory and inhibitory populations under ramping input. A. Input-Frequency (I-F) curves for excitatory cells (left panel; pyramidal neurons with ICAN) and inhibitory cells (right panel; interneurons, fast-spiking) used in the model. Above a certain tonic input (around 0.35 nA for excitatory and 0.1 nA for inhibitory neurons), neurons can spike in the gamma range. B. Raster plot showing the spiking activity of excitatory (blue, NE = 1000) and inhibitory (red, NI = 100) neurons in decoupled populations under ramping input (top trace) and in the absence of noise in the membrane potential. Despite random initial conditions across neurons, oscillations emerge in both populations due to the intrinsic properties of the cells, with a frequency that is predicted by the respective I-F curves (panel A.). C. Similar representation as panel B. but with the addition of stochastic noise in the membrane potential of each neuron. The presence of noise disrupts the emergence of oscillations in these decoupled populations.

      Author response image 4.

      Figure S3 (Figure 2 – Figure Supplement 2). Cell-intrinsic spiking activity in decoupled excitatory and inhibitory populations under ramping input. A. Input-Frequency (I-F) curves for excitatory cells (left panel; pyramidal neurons with ICAN) and inhibitory cells (right panel; interneurons, fast-spiking) used in the model. Above a certain tonic input (around 0.35 nA for excitatory and 0.1 nA for inhibitory neurons), neurons can spike in the gamma range. B. Raster plot showing the spiking activity of excitatory (blue, NE = 1000) and inhibitory (red, NI = 100) neurons in decoupled populations under ramping input (top trace) and in the absence of noise in the membrane potential. Despite random initial conditions across neurons, oscillations emerge in both populations due to the intrinsic properties of the cells, with a frequency that is predicted by the respective I-F curves (panel A.). C. Similar representation as panel B. but with the addition of stochastic noise in the membrane potential of each neuron. The presence of noise disrupts the emergence of oscillations in these decoupled populations.

      Beyond these weaknesses, this study has a strong utility for researchers wanting to explore hypotheses in the field of neurostimulations. In particular, I see value in such models for exploring more intricate, phase specific effects of continuous, as well as close loop stimulations which are on the rise in systems neuroscience.

      We thank the reviewer for this appreciation of our work and its future perspectives.

      Recommendations For The Authors:

      Line 144, the authors mention that their MI values are erroneous in absence of additive noise - could this be due to the non-sinusoidal nature of the phase signal recorded, and be fixed by upscaling model size?

      We thank the reviewer for this question and suggestion. The main reason behind the errors in the computation of the MI lies in the complete absence of oscillations at specific frequencies. Filtered signals within specific bands produced a power of 0 (or extremely low values), as seen in the power spectral densities. In such cases, the phase signal was not mathematically defined, but the toolbox we used to compute it still returned a numerical result that was inaccurate (for more details on the computation of the MI see Tort et al., 2010). To mitigate this numerical artefact, we decided to add uniform noise in the computed firing rates. This strategy is illustrated on Figure S6 (Figure 3 – Figure Supplement 2), which we have copied below for reference. Alternative approaches could probably have been used, such as increasing the noise in the membrane potential so that neurons would start spiking with firing rates that show more realistic power spectra, even in the absence of external inputs.

      Author response image 5.

      Figure S6 (Figure 3 – Figure Supplement 2). Quantification of PAC with and without noise. A. Quantifying PAC in the absence of noise produced inaccurate identification of the coupled frequency bands, due to the complete absence of oscillations at some frequencies. All analyses are based on the CA1 firing rates (top traces) during a representative simulation. Power spectral densities of these firing rates (left) indicate that some frequencies have a power of 0. PAC of the excitatory population was assessed using two graphical representations, the polar plot (middle) and comodulogram (right), and quantified using the MI. The comodulogram was calculated by computing the MI across 80% overlapping 1-Hz frequency bands in the theta range and across 90% overlapping 10-Hz frequency bands in the gamma range and subsequently plotted as a heat map. In the absence of noise, a slow theta frequency centered around 5 Hz is found to modulate a broad range of gamma frequencies between 40 and 100 Hz. The value indicated on the comodulogram indicates the average MI in the 3-9 Hz theta range and 40-80 Hz gamma range. As in Figure 2, the polar plot represents the amplitude of gamma oscillations (averaged across all theta cycles) at each phase of theta (theta range: 3-9 Hz, phase indicated as angular coordinate) and for different gamma frequencies (radial coordinate, binned in 1-Hz ranges). B. Adding uniform noise to the firing rate (with an amplitude ranging between 15 and 25% of the maximum firing rate) improved the identification of the coupled frequency bands. In this case, the slower theta frequency centered around 5 Hz modulates a gamma band located between 45 and 75 Hz.

      Reviewer #2:

      The main strength of this model is its use of a fairly physiologically detailed model of the hippocampus. The cells are single-compartment models but do include multiple ion channels and are spatially arranged in accordance with the hippocampal structure. This allows the understanding of how ion channels (possibly modifiable by pharmacological agents) interact with system-level oscillations and neurostimulation. The model also includes all the main hippocampal subfields. The other strength is its attention to an important topic, which may be relevant for dementia treatment or prevention, which few modeling studies have addressed. The work has several weaknesses.

      We thank the reviewer for appreciating our detailed description of the hippocampal formation and the focus on neurostimulation applications that aim at treating oscillopathies, especially dementia.

      1. First, while investigations of hippocampal neurostimulation are important there are few experimental studies from which one could judge the validity of the model findings. All its findings are therefore predictions. It would be much more convincing to first show the model is able to reproduce some measured empirical neurostimulation effect before proceeding to make predictions.

      We acknowledge that the results presented in Figures 4-7 of the revised manuscript cannot be compared to existing experimental data, and are therefore purely predictive. Future experimental work is needed to verify these predictions.

      Yet, we would also like to stress that the motivation behind this project was the inadequacy of previous models of theta-nested gamma oscillations (Onslow et al., 2014; Aussel et al., 2018; Segneri et al., 2020) to account for the mechanism of theta phase reset that occurs during electrical stimulation of the fornix or perforant path (Williams and Givens, 2003). Since we could not use these previous models to study the effects of neurostimulation on theta-nested gamma oscillations, we had to modify them to account for a dynamical theta input, which is the main methodological novelty that is reported in our manuscript (Figures 1 and 3 of the revised manuscript).

      Despite the scarcity of experimental studies that could confirm the full model, we sought to replicate a few experimental findings that employed optogenetic stimulation to induce gamma oscillations in individual excitatory-inhibitory circuits. Although not specific to the hippocampus, these studies have shown that gamma oscillations can be induced using either ramped photostimulation targeting excitatory neurons (Adesnik et al., 2010; Akam et al., 2012; Lu et al., 2015), or pulsed stimulation driving inhibitory cells in the gamma range (Cardin et al., 2009; Iaccarino et al., 2016). To account for these experimental results and replicate them, we have added 4 new figures (Figure 2 and its 3 figure supplements) and an extensive section in the results part (L.141-217 of the revised manuscript). The added section and related figures are indicated in our response to reviewer 1, comment 3 (p 2-7).

      2.1. Second, the model is very specific. Or if its behavior is to be considered general it has not been explained why.

      Although the spatial organization and cellular details of the model are indeed very specific, its general behavior, i.e., the production of theta-nested gamma oscillations and theta phase reset, are common to any excitatory-inhibitory circuit interconnected with Kuramoto oscillators. To illustrate this point, we have generalized our approach to the neural mass model developed by Onslow and colleagues (Onslow ACE, Jones MW, Bogacz R. A Canonical Circuit for Generating Phase-Amplitude Coupling. PLoS ONE. 2014 Aug; 9(8):e102591). These results are represented in a new supplementary figure (Figure3 – Figure Supplement 4), and briefly described in a new paragraph of the results section (L.262-268 of the revised manuscript):

      “Importantly, our approach is generalizable and can be applied to other models producing theta-nested gamma oscillations. For instance, we adapted the neural mass model by Onslow and colleagues (Onslow et al., 2014), replaced the fixed theta input by a set of Kuramoto oscillators, and demonstrated that it could also generate theta phase reset in response to single-pulse stimulation (Figure S8). These results illustrate that the general behavior of our model is not specific to the tuning of individual parameters in the conductancebased neurons, but follows general rules that are captured by the level of abstraction of the Kuramoto formalism.”

      Author response image 6.

      Figure S8 (Figure 3 – Figure Supplement 4). A neural mass model of coupled excitatory and inhibitory neurons driven by Kuramoto oscillators generates theta-nested gamma oscillations and theta phase reset. A. Two coupled neural masses (one excitatory and one inhibitory) driven by Kuramoto oscillators, which represent a dynamical oscillatory drive in the theta range, were used to implement a neural mass equivalent to our conductance-based model represented in Figure 1. Neural masses were modeled using the WilsonCowan formalism, with parameters adapted from Onslow et al. (2014) (𝑊𝐸𝐸 = 4.8, 𝑊𝐸𝐼 = 𝑊𝐼𝐸 = 4, 𝑊𝐼𝐼 = 0). B. The normalized population firing rates exhibit theta-nested gamma oscillations (middle and bottom panels) in response to the dynamic theta rhythm (top panel). A stimulation pulse delivered at the descending phase of the rhythm to both populations (marked by the inverted red triangle) produces a robust theta phase reset, similarly to Figure 3A.

      This simplified model is described in more details in the methods (L.694-710 of the revised manuscript). Additionally, the generation of gamma oscillations by individual excitatory-inhibitory circuits is now described in details in the added section “Generation of gamma oscillations by E-I circuits” (L.159-217 of the revised manuscript), which has already been discussed in our response to reviewer 1, comment 3 (p 2-7).

      2.2. For example, the model shows bistability between quiescence and TNGO, however what aspect of the model underlies this, be it some particular network structure or particular ion channel, for example, is not addressed.

      We thank the reviewer for mentioning this point, which we have now addressed. The “bistable” behavior that we reported occurs for values of the theta input that are just below the threshold to induce selfsustained theta-gamma oscillations (Figure 5 of the revised manuscript, point B). Moreover, the presence of the Calcium-Activated-Nonspecific (CAN) cationic channel, which is expressed by pyramidal neurons in the entorhinal cortex, CA3, and CA1 fields of the hippocampus, is necessary for this behavior to occur. Indeed, abolishing CAN channels in all areas of the model suppresses this behavior. We have now addressed this point in a new supplementary figure (Figure 5 – Figure Supplement 4) and a short description in the text (L.287-303 of the revised manuscript).

      “In the presence of dynamic theta input, the effects of single-pulse stimulation depended both on theta input amplitude and stimulation amplitude, highlighting different regimes of network activity (Figure 5 and Figure S9, Figure S10, Figure S11). For low theta input, theta-nested gamma oscillations were initially absent and could not be induced by stimulation (Figure 5A). At most, the stimulation could only elicit a few bursts of spiking activity that faded away after approximately 250 ms, similar to the rebound of activity seen in the absence of theta drive. For increasing theta input, the network switched to an intermediate regime: upon initialization at a state with no spiking activity, it could be kicked to a state with self-sustained theta-nested gamma oscillations by a single stimulation pulse of sufficiently high amplitude (Figure 5B). This regime existed for a range of septal theta inputs located just below the threshold to induce self-sustained theta-gamma oscillations without additional stimulation, as characterized by the post-stimulation theta power, gamma power, and theta-gamma PAC (Figure 5D). Removing CAN currents from all areas of the model abolished this behavior (Figure S12), which is interesting given the role of this current in the multistability of EC neurons (Egorov et al., 2002; Fransen et al., 2006) and in the intrinsic ability of the hippocampus to generate thetanested gamma oscillations (Giovannini et al., 2017). For the highest theta input, the network became able to spontaneously generate theta-nested gamma oscillations, even when initialized at a state with no spiking activity and without additional neurostimulation (Figure 5C).”

      Author response image 7.

      Figure S12 (Figure 5 – Figure Supplement 4). CAN currents are necessary for the production of selfsustained theta-gamma oscillations in response to single-pulse stimulation. A. Same as Figure 5B. B. Similar simulation as panel A., but without the presence of CAN currents in the EC, CA3 and CA1 fields of the hippocampus. Removing CAN currents from the model abolishes self-sustained theta-nested gamma oscillations in response to a single stimulation pulse (for the parameters represented in Figure 5, point B).

      Furthermore, we realized that the terminology “bistable” may not be justified as we could not perform a systematic bifurcation analysis, which is typically carried out in simpler neural mass models (e.g., Onslow et al., 2014; Segneri et al., 2020). Therefore, we decided to rephrase the sentences about “bistability” to keep a more general terminology. The following sentences were revised:

      L.20-23: “We showed that, for theta inputs just below the threshold to induce self-sustained theta-nested gamma oscillations, a single stimulation pulse could switch the network behavior from non-oscillatory to a state producing sustained oscillations.”

      L.305-309: “Based on the above analyses, we considered two pathological states: one with a moderate theta input (i.e., moderately weak projections from the medial septum to the EC) that allowed the initiation of selfsustained oscillations by single stimulation pulses (Figure 5, point B), and one with a weaker theta input characterized by the complete absence of self-sustained oscillations even following transient stimulation (Figure 5, point A).”

      L.316-317: “In the case of a moderate theta input and in the presence of phase reset, delivering a pulse at either the peak or trough of theta could induce theta-nested gamma oscillations (Figure 6A and 6C).”

      L.353-357: “A very interesting finding concerns the behavior of the model in response to single-pulse stimulation for certain values of the theta amplitude (Figure5). For low theta amplitudes, a single stimulation pulse was capable of switching the network behavior from a state with no spiking activity to one with prominent theta-nested gamma oscillations. Whether such an effect can be induced in vivo in the context of memory processes remains an open question.”

      2.3. Similarly for the various phase reset behaviors that are found.

      We would like to clarify the fact that the observed phase reset curves (reported in Figure 3D) are a direct consequence of the choice of an appropriate phase response function for the Kuramoto oscillators representing the medial septum. This choice is inspired by experimentally measured phase response curves from CA3 neurons. These aspects are described briefly in the introduction and in more details in the methods, as indicated below:

      L.101: “This new hybrid dynamical model could generate both theta-nested gamma oscillations and theta phase reset, following a particular phase response curve (PRC) inspired by experimental literature (Lengyel et al., 2005; Akam et al., 2012; Torben-Nielsen et al., 2010).”

      L.528-537: “Hereafter, we call the term 𝑍(𝜃) the phase response function, to distinguish it from the PRC obtained from experimental data or simulations (see section below "Data Analysis", "Phase Response Curve"). Briefly, the PRC of an oscillatory system indicates the phase delay or advancement that follows a single pulse, as a function of the phase at which this input is delivered. The phase response function 𝑍(𝜃) was chosen to mimic as well as possible experimental PRCs reported in the literature (Lengyel et al., 2005; Kwag and Paulsen, 2009; Akam et al., 2012). These PRCs appear biphasic and show a phase advancement (respectively delay) for stimuli delivered in the ascending (respectively descending) slope of theta. To accurately model this behavior, we used the following equation for the phase response function, where 𝜃𝑝𝑒𝑎𝑘 represents the phase at which the theta rhythm reaches its maximum and the parameter 𝜙𝑜𝑓𝑓𝑠𝑒𝑡 controls the desired phase offset from the peak:

      Author response image 8.

      On the figure below, we illustrate the phase response curves of CA3 neurons measured by Lengyel et al., 2005 (panel A.), and compare it with our simulated phase response curves (panel B.). Note that the conventions for phase advance and phase delay are reversed between the two panels.

      Finally, we would like to acknowledge that the model “is not derived from experimental phase response curves of septal neurons of which there is no direct measurement”, as mentioned by the reviewer in their comment 4 below. Despite the lack of experimental data specific to medial septum neurons, we argue that this phase response function is the only one that mathematically supports the generation of self-sustained theta-nested gamma oscillations in our current model. This statement is illustrated by Figure S7 (Figure 3 – Figure Supplement 3) and is mentioned in the results (L.249-261 of the revised manuscript):

      We modeled this behavior by a specific term (which we called the phase response function) in the general equation of the Kuramoto oscillators (see methods, Equation 1). Importantly, introducing a phase offset in the phase response function disrupted theta-nested gamma oscillations (Figure S7), which suggests that the septohippocampal circuitry must be critically tuned to be able to generate such oscillations. The strength of phase reset could also be adjusted by a gain that was manually tuned. In the presence of the physiological phase response function and of a sufficiently high reset gain, a single stimulation pulse delivered to all excitatory and inhibitory CA1 neurons could reset the phase of theta to a value close to its peaks (Figure 3A). We computed the PRC of our simulated data for different stimulation amplitudes and validated that our neuronal network behaved according to the phase response function set in our Kuramoto oscillators (Figure 3D). It should be noted that including this phase reset mechanism affected the generated theta rhythm even in the absence of stimulation, extending the duration of the theta peak and thereby slowing down the frequency of the generated theta rhythm.

      Author response image 9.

      Figure S7 (Figure 3 – Figure Supplement 3). Network behavior generated by Kuramoto oscillators with nonphysiological phase response functions. Each panel is similar to Figure 3A, but with a different offset added to the phase response function of the Kuramoto oscillators (see methods, Equation 4). The center frequency was set to 6 Hz in all of these simulations. Overall, theta oscillations in these cases are less sinusoidal and show more abrupt phase changes than in the physiological case. A. A phase offset of −𝜋∕2 leads to an overall theta oscillation of 4 Hz, with a second peak following the main theta peak. B. A phase offset of +𝜋∕2 reduces the peak of theta, resetting the rhythm to the middle of the ascending phase. C. A phase offset of 𝜋 or -𝜋 leads to the CA1 output resetting the theta rhythm to the trough of theta.

      2.4. We may wonder whether a different hippocampal model of TNGO, of which there are many published (for example [1-6]) would show the same effect under neurostimulation. This seems very unlikely […]

      [1] Hyafil A, Giraud AL, Fontolan L, Gutkin B. Neural cross-frequency coupling: connecting architectures, mechanisms, and functions. Trends in neurosciences. 2015 Nov 1;38(11):725-40.

      [2] Tort AB, Rotstein HG, Dugladze T, Gloveli T, Kopell NJ. On the formation of gamma-coherent cell assemblies by oriens lacunosum-moleculare interneurons in the hippocampus. Proceedings of the National Academy of Sciences. 2007 Aug 14;104(33):13490-5.

      [3] Neymotin SA, Lazarewicz MT, Sherif M, Contreras D, Finkel LH, Lytton WW. Ketamine disrupts theta modulation of gamma in a computer model of hippocampus. Journal of Neuroscience. 2011 Aug 10;31(32):11733-43.

      [4] Ponzi A, Dura-Bernal S, Migliore M. Theta-gamma phase-amplitude coupling in a hippocampal CA1 microcircuit. PLOS Computational Biology. 2023 Mar 23;19(3):e1010942.

      [5] Bezaire MJ, Raikov I, Burk K, Vyas D, Soltesz I. Interneuronal mechanisms of hippocampal theta oscillations in a full-scale model of the rodent CA1 circuit. Elife. 2016 Dec 23;5:e18566.

      [6] Chatzikalymniou AP, Gumus M, Skinner FK. Linking minimal and detailed models of CA1 microcircuits reveals how theta rhythms emerge and their frequencies controlled. Hippocampus. 2021 Sep;31(9):982-1002.

      The highlighted publications, while very important in their findings regarding theta-gamma phase-amplitude coupling, focused on specific subfields of the hippocampus. In our work, we aimed to develop a model that includes the different anatomical divisions of the hippocampal formation, while still exhibiting theta-nested gamma oscillations, which is why we decided to expand the model by Aussel et al. (2018). Exploring the behavior of all these different hippocampal models under neurostimulation is beyond the scope of the current manuscript.

      Nevertheless, we have added a new figure (Figure 3 – Figure Supplement 4) showing an adaptation of our modeling approach to a generic neural mass model of theta-nested gamma oscillations (Onslow et al., 2014), which illustrates the generalizability of our findings and is described in details in our response to comment 2.1. Moreover, we have further addressed the comments of the reviewers regarding bistability and phase response curves in our responses to comments 2.2 and 2.3.

      Furthermore, we have added references to all 6 of these publications in the revised version of the manuscript:

      L.43-50: Moreover, the modulation of gamma oscillations by the phase of theta oscillations in hippocampal circuits, a phenomenon termed theta-gamma phase-amplitude coupling (PAC), correlates with the efficacy of memory encoding and retrieval (Jensen and Colgin, 2007; Tort et al., 2009; Canolty and Knight, 2010; Axmacher et al., 2010; Fell and Axmacher, 2011; Lisman and Jensen, 2013; Lega et al., 2016). Experimental and computational work on the coupling between oscillatory rhythms has indicated that it originates from different neural architectures and correlates with a range of behavioral and cognitive functions, enabling the long-range synchronization of cortical areas and facilitating multi-item encoding in the context of memory (Hyafil et al., 2015)."

      L.415-426: “In terms of neuronal cell types, we also made an important simplification by considering only basket cells as the main class of inhibitory interneuron in the whole hippocampal formation. However, it should be noted that many other types of interneurons exist in the hippocampus and have been modeled in various works with higher computational complexity (e.g., Bezaire et al., 2016; Chatzikalymniou et al., 2021). Among these various interneurons, oriens-lacunosum moleculare (OLM) neurons in the CA1 field have been shown to play a crucial role in synchronizing the activity of pyramidal neurons at gamma frequencies (Tort et al., 2007), and in generating theta-gamma PAC (e.g., Neymotin et al., 2011; Ponzi et al., 2023). Additionally, these cells may contribute to the formation of specific phase relationships within CA1 neuronal populations, through the integration between inputs from the medial septum, the EC, and CA3 (Mysin et al., 2019). Future work is needed to include more diverse cell types and detailed morphologies modeled through multiple compartments.”

      2.5. […] and indeed the quiescent state itself shown by this model seems quite artificial.

      We would like to clarify the fact that the “quiescent state” mentioned by the reviewer is a simply a state where the theta input is too low to induce theta-nested gamma oscillations. In this regime, neurons are active only due to the noise term in the membrane potential, which was adjusted based on Figure S3 (Figure 2 – Figure Supplement 2, shown below), at the minimal level needed to disrupt artificial synchronization in decoupled populations. For an input of 0 nA, we acknowledge that this network is indeed fully quiescent (i.e., does not show any spiking activity). However, as soon as the input increases, spontaneous spiking activity starts to appear with an average firing rate that depends on the input amplitude and is characterized by the input-frequency curves (panel A.). Please note that adding more noise could eliminate the observed quiescence in the absence of any input, but that it would not affect qualitatively the reported results.

      Author response image 10.

      Figure S3 (Figure 2 – Supplement 2). Cell-intrinsic spiking activity in decoupled excitatory and inhibitory populations under ramping input. A. Input-Frequency (I-F) curves for excitatory cells (left panel; pyramidal neurons with ICAN) and inhibitory cells (right panel; interneurons, fast-spiking) used in the model. Above a certain tonic input (around 0.35 nA for excitatory and 0.1 nA for inhibitory neurons), neurons can spike in the gamma range. B. Raster plot showing the spiking activity of excitatory (blue, NE = 1000) and inhibitory (red, NI = 100) neurons in decoupled populations under ramping input (top trace) and in the absence of noise in the membrane potential. Despite random initial conditions across neurons, oscillations emerge in both populations due to the intrinsic properties of the cells, with a frequency that is predicted by the respective IF curves (panel A.). C. Similar representation as panel B. but with the addition of stochastic noise in the membrane potential of each neuron. The presence of noise disrupts the emergence of oscillations in these decoupled populations.

      2.6. Some indication that particular ion channels, CAN and M are relevant is briefly provided and the work would be much improved by examining this aspect in more detail.

      We thank the reviewer for acknowledging the importance of these ion channels. We have now added a new supplementary figure (Figure 5 – Figure Supplement 4), which is described in more details in our response to comment 2.2 and illustrates the role of the CAN current in the generation of theta-nested gamma oscillations following a single stimulation pulse. Moreover, we would like to stress that the impact of CAN currents in the ability of the hippocampus to generate theta-nested gamma oscillations intrinsically, i.e., in the absence of persistent external input, has already been investigated in details by a previous computational study cited in our manuscript (Giovannini F, Knauer B, Yoshida M, Buhry L. The CAN-In network: A biologically inspired model for self-sustained theta oscillations and memory maintenance in the hippocampus. Hippocampus. 2017 Apr;809 27(4):450–463).

      2.7. In summary, the work would benefit from an intuitive analysis of the basic model ingredients underlying its neurostimulation response properties.

      We thank the reviewer for this suggestion. By addressing the reviewer’s previous comments (reviewer 2, comments 2.1 and 2.2), which overlap partly with the first reviewer (reviewer 1, comment 3), we believe we have improved the manuscript and have provided key information related to the way the model responds to neurostimulation.

      3..) Third, while the model is fairly realistic, considerable important factors are not included and in fact, there are much more detailed hippocampal models out there (for example [5,6]). In particular, it includes only excitatory cells and a single type of inhibitory cell. This is particularly important since there are many models and experimental studies where specific cell types, for example, OLM and VIP cells, are strongly implicated in TNGO.

      [5] Bezaire MJ, Raikov I, Burk K, Vyas D, Soltesz I. Interneuronal mechanisms of hippocampal theta oscillations in a full-scale model of the rodent CA1 circuit. Elife. 2016 Dec 23;5:e18566.

      [6] Chatzikalymniou AP, Gumus M, Skinner FK. Linking minimal and detailed models of CA1 microcircuits reveals how theta rhythms emerge and their frequencies controlled. Hippocampus. 2021 Sep;31(9):982-1002.

      We thank the reviewer for pointing out these interesting avenues for future studies. As indicated in previous responses (reviewer 1, comment 1; reviewer 2, comment 2.4), we have added several paragraphs to discuss these limitations, the rationale behind our simplifications, and potential improvements. In particular, we have added the following paragraphs to discuss our simplifications in terms of connectivity and cell types:

      Anatomical connectivity:

      L.141-150: “Biologically, GABAergic neurons from the medial septum project to the EC, CA3, and CA1 fields of the hippocampus (Toth et al., 1993; Hajós et al., 2004; Manseau et al., 2008; Hangya et al., 2009; Unal et al., 2015; Müller and Remy, 2018). Although the respective roles of these different projections are not fully understood, previous computational studies have suggested that the direct projection from the medial septum to CA1 is not essential for the production of theta in CA1 microcircuits (Mysin et al., 2019). Since our modeling of the medial septum is only used to generate a dynamic theta rhythm, we opted for a simplified representation where the medial septum projects only to the EC, which in turn drives the different subfields of the hippocampus. In our model, Kuramoto oscillators are therefore connected to the EC neurons and they receive projections from CA1 neurons (see methods for more details).”

      Cell types:

      L.415-426: “In terms of neuronal cell types, we also made an important simplification by considering only basket cells as the main class of inhibitory interneuron in the whole hippocampal formation. However, it should be noted that many other types of interneurons exist in the hippocampus and have been modeled in various works with higher computational complexity (e.g., Bezaire et al., 2016; Chatzikalymniou et al., 2021). Among these various interneurons, oriens-lacunosum moleculare (OLM) neurons in the CA1 field have been shown to play a crucial role in synchronizing the activity of pyramidal neurons at gamma frequencies (Tort et al., 2007), and in generating theta-gamma PAC (e.g., Neymotin et al., 2011; Ponzi et al., 2023). Additionally, these cells may contribute to the formation of specific phase relationships within CA1 neuronal populations, through the integration between inputs from the medial septum, the EC, and CA3 (Mysin et al., 2019). Future work is needed to include more diverse cell types and detailed morphologies modeled through multiple compartments.”

      3.2. Other missing ingredients one may think might have a strong impact on model response to neurostimulation (in particular stimulation trains) include the well-known short-term plasticity between different hippocampal cell types and active dendritic properties.

      We agree with the reviewer that plasticity mechanisms are important to include in future work, which we had already mentioned in the limitations section of the manuscript:

      L.436-443: “Importantly, we did not consider learning through synaptic plasticity, even though such mechanisms could drastically modify synaptic conduction for the whole network (Borges et al., 2017). Even more interestingly, the inclusion of spike-timing-dependent plasticity would enable the investigation of stimulation protocols aimed at promoting LTP, such as theta-burst stimulation (Larson et al., 2015). This aspect would be of uttermost importance to make a link with memory encoding and retrieval processes (Axmacher et al., 2006; Tsanov et al., 2009; Jutras et al., 2013) and with neurostimulation studies for memory improvement (Titiz et al., 2017; Solomon et al., 2021).”

      1. Fourth the MS model seems somewhat unsupported. It is modeled as a set of coupled oscillators that synchronize. However, there is also a phase reset mechanism included. This mechanism is important because it underlies several of the phase reset behaviors shown by the full model. However, it is not derived from experimental phase response curves of septal neurons of which there is no direct measurement. The work would benefit from the use of a more biologically validated MS model.

      We would like to confirm that the phase reset mechanism is indeed at the core of using Kuramoto oscillators to model a particular system. For more details about our choice of a phase response function and the obtained results in terms of phase response curves, we refer the reader to our response to comment 2.3.

      Generally speaking, we chose to use Kuramoto oscillators as it is the simplest model that can provide an oscillatory input to another system while including a phase reset mechanism. This set of oscillators was used to replace the fixed sinusoidal wave that represented theta inputs in previous models (Onslow et al., 2014; Aussel et al., 2018; Segneri et al., 2020). Kuramoto oscillators are a well-established model of synchronization in various fields of physics. They have also been used in neuroscience to model the phase reset of collective rhythms (Levnajić et al. 2010), and the effects of DBS on the basal ganglia network in Parkinson’s disease (Tass et al. 2003, Ebert et al. 2014, Weerasinghe et al. 2019).

      More detailed models of the medial septum exist in the literature (e.g., Wang et al. 2002, Hajós et al. 2004) and model the GABAergic effects of the septal projections onto the hippocampal formation. However, it is not trivial to infer the connectivity parameters and the degree of innervation between the hippocampus and the medial septum. Furthermore, the claims made in our study do not necessarily depend on the nature of the projections between the two areas. Therefore, we decided to represent the medial septum in a conceptual way and focus mostly on the effects of these projections rather than replicating them in detail.

      Aussel, Amélie, Laure Buhry, Louise Tyvaert, and Radu Ranta. “A Detailed Anatomical and Mathematical Model of the Hippocampal Formation for the Generation of Sharp-Wave Ripples and Theta-Nested Gamma Oscillations.” Journal of Computational Neuroscience 45, no. 3 (December 2018): 207–21. https://doi.org/10.1007/s10827-018-0704-x.

      Ebert, Martin, Christian Hauptmann, and Peter A. Tass. “Coordinated Reset Stimulation in a Large-Scale Model of the STN-GPe Circuit.” Frontiers in Computational Neuroscience 8 (2014): 154. https://doi.org/10.3389/fncom.2014.00154.

      Hajós, M., W.E. Hoffmann, G. Orbán, T. Kiss, and P. Érdi. “Modulation of Septo-Hippocampal θ Activity by GABAA Receptors: An Experimental and Computational Approach.” Neuroscience 126, no. 3 (January 2004): 599–610. https://doi.org/10.1016/j.neuroscience.2004.03.043.

      Levnajić, Zoran, and Arkady Pikovsky. “Phase Resetting of Collective Rhythm in Ensembles of Oscillators.” Physical Review E 82, no. 5 (November 3, 2010): 056202. https://doi.org/10.1103/PhysRevE.82.056202.

      Onslow, Angela C. E., Matthew W. Jones, and Rafal Bogacz. “A Canonical Circuit for Generating PhaseAmplitude Coupling.” Edited by Adriano B. L. Tort. PLoS ONE 9, no. 8 (August 19, 2014): e102591. https://doi.org/10.1371/journal.pone.0102591.

      Segneri, Marco, Hongjie Bi, Simona Olmi, and Alessandro Torcini. “Theta-Nested Gamma Oscillations in Next Generation Neural Mass Models.” Frontiers in Computational Neuroscience 14 (2020). https://doi.org/10.3389/fncom.2020.00047. T ass, Peter A. “A Model of Desynchronizing Deep Brain Stimulation with a Demand-Controlled Coordinated Reset of Neural Subpopulations.” Biological Cybernetics 89, no. 2 (August 1, 2003): 81–88. https://doi.org/10.1007/s00422-003-0425-7.

      Wang, Xiao-Jing. “Pacemaker Neurons for the Theta Rhythm and Their Synchronization in the Septohippocampal Reciprocal Loop.” Journal of Neurophysiology 87, no. 2 (February 1, 2002): 889–900. https://doi.org/10.1152/jn.00135.2001.

      Weerasinghe, Gihan, Benoit Duchet, Hayriye Cagnan, Peter Brown, Christian Bick, and Rafal Bogacz. “Predicting the Effects of Deep Brain Stimulation Using a Reduced Coupled Oscillator Model.” PLoS Computational Biology 15, no. 8 (August 8, 2019): e1006575. https://doi.org/10.1371/journal.pcbi.1006575.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      Weaknesses:

      (1) The authors themselves propose in their Introduction that the "ECM-associated changes are increasingly perceived as causative, rather than consequential"; however, they have not conducted mechanistic (gain of function/loss of function) studies either in vitro or in vivo from any of their identified targets to truly prove causality. This remains one of the limitations of this study. Thus, future studies should investigate this point in detail. For instance, it would have been intriguing to dissect if knocking out specific genes involved in one specific model or genes common to both would yield distinct phenotypic outcomes.

      We agree with the reviewer that our study does not provide mechanistic verification of the function of identified targets with suggested role in the development and/or resolution of fibrosis. The current study was primarily conducted in order to identify these possible targets with focus on the identification of differences in extracellular matrix deposited in two selected models of liver fibrosis with different modes of action. To conduct further studies using knock-out/in models for verification of causality of proposed targets was at this point well beyond our intention. However, we are fully aware of the potential of identified molecules and further studies to disect their roles in liver diseases are part of future plans.

      (2) The majority of the conclusions are derived primarily from the proteomic analyses. Although well conducted, it would strengthen the study to corroborate some of the major findings by other means such as IHC/IF with the corresponding quantifications and not only representative images.

      We have now provided additional IF images and their quantifications in accordance with the Reviewer’s suggestions to our major MS findings to strenghten the significance of the MS data (see detailed answer below).

      Reviewer #2:

      Weaknesses:

      (1) As it currently stands, the data, whilst extensive, is primarily focussed on the proteomic data which is fairly descriptive and I am not clear on the additional insight gained in their approach that is not already detailed from the extensive transcriptomic studies. The manuscript overall would benefit from some mechanistic functional insight to provide new additional modes of action relevant to fibrosis progression.  

      We agree with the reviewer that our study could initially appear descriptive. However, this characteristics is inherent to most omics studies, which tend to provide hypothesis-free testing of a large number of analytes in order to find a multitude of candidate biomarkers(1). Importantly, we believe our study provides insights that go beyond the scope of previously published transcriptomic analyses.

      Specifically, our work focuses on compartment-specific changes in the liver proteome, with an emphasis on the extracellular matrix (ECM) composition and alterations in protein solubility—features that cannot be captured by transcriptomic studies. The matrisome is more than a structural scaffold; it functions as a reservoir for secreted factors, including growth factors and cytokines, which modulate the local cellular microenvironment. Transition dynamics between the insoluble matrisome and soluble protein pools influence the signaling capabilities and bioavailability of these factors. Moreover, fibrous ECM assemblies directly impact tissue mechanics, providing cells embedded within the matrix with spatially distinct biochemical and biomechanical contexts. The current understanding of matrisome composition in the context of specific liver disease etiologies is limited. Dr. Friedman, in his 2022 review on hepatic fibrosis, highlights the unmet need to elucidate etiology-specific protein signatures of the cirrhotic liver matrisome, which could serve as disease staging or prognostic biomarkers(2). Our study addresses this gap by characterizing the distinct matrisome profiles associated with hepatotoxic- versus cholestasis-driven liver injury. We believe our findings lay the groundwork for identifying etiology-specific biomarkers and potential therapeutic targets for antifibrotic interventions, offering a novel layer of insight beyond what transcriptomic data alone can provide.

      (2) Whilst there is some human data presented it is a minimal analysis without quantification that would imply relevance to disease state. Although studying disease progression in animals is a fundamental aspect of understanding the full physiological response of fibrotic disease, without more human insight makes any analysis difficult to fulfil their suggestion that these targets identified will be of use to treat human disease.

      We thank the reviewer for this comment. Our study primarily focuses on utilizing animal models to explore the fundamental physiological processes underlying the development and resolution of fibrotic liver disease. To address the translational relevance of our findings, we concentrated on clusterin, one of the key target proteins identified during our analysis of the insoluble proteome. Specifically, we investigated its localization in human liver samples, focusing on its association with collagen deposits (Figure 6F). To this end, we analyzed human liver samples of diverse etiologies and varying degrees of fibrotic damage, including samples representing four distinct stages of HCV-induced fibrosis (Figure 6F, lower panel). While this analysis highlights the presence and localization of clusterin in fibrotic deposits, we acknowledge that our study does not include extensive quantification or mechanistic insight into clusterin's role in human liver fibrosis. We believe that the data presented in this manuscript provide a valuable foundation for future investigations into clusterin’s involvement in liver fibrosis across different etiologies. Recognizing the translational importance of this work, we have already initiated a prospective study involving human patients, which aims to conduct a more comprehensive analysis of clusterin's function and its potential as a therapeutic target.

      To further support our findings on clusterin's role in fibrosis development and resolution and to address the reviewer's concern, we quantified clusterin deposits in the available human samples representing four distinct stages of HCV-induced fibrotic disease. Using immunofluorescence (IF) images at a 20x field of view, we measured both clusterin and collagen deposits to illustrate changes in clusterin abundance during fibrosis progression (stages F1–F4) in relation to collagen deposition dynamics. The quantified data have been included for the reviewer's consideration (Figure 1). However, it is important to emphasize that this quantification was conducted on a single human sample per fibrotic stage, which limits the statistical robustness of the analysis. A more comprehensive evaluation involving additional patient samples would be necessary for a more definitive conclusion. For this reason, we propose to include these results solely in our rebuttal letter and to incorporate a more extensive analysis in our intended follow-up study, where larger cohorts will allow for a thorough investigation of clusterin's role in human liver fibrosis.

      Author response image 1.

      Dynamics of clusterin abundance with the development of HCV-induced fibrotic disease in comparison to the changes in collagen deposits. IF images of human liver sections from different stages of chronic HCV infection were immunolabeled for clusterin and collagen 1. Clusterin- and collagenpositive (<sup>+</sup>) areas (as %) from three to eight fields of view (20x objective) were evaluated for each fibrosis stage (F1-F4). 

      (3) Some of the terminology is incorrect while discussing these models of injury used and care should be taken. For example - both models are toxin-induced and I do not think these data have any support that the DDC model has a higher carcinogenic risk. An investigation into the tumour-induced risk would require significant additional models. These types of statements are incorrect and not supported by this study.

      We are grateful to the reviewer for drawing our attention to the incorrect use of the term "toxin-induced". In two instances, where the wording was incorrect, we have corrected the term to hepatotoxin-induced as it was originally intended. While we believe that our proteomic signature data and identified signaling pathways suggest a potential carcinogenic risk associated with the cholestatic, but not the hepatotoxic model, we have toned down the statements on this issue in the article to respect the reviewer's perspective. These changes, which are highlighted in the track changes mode of the article, aim to make the conclusions of the study more precise and thus improve the clarity of our conclusions.

      Reviewer #1 (Recommendations for the authors): 

      (1) In the Discussion, the authors could consider pointing out that one limitation of the study is a lack of mechanistic (gain of function/loss of function) studies either in vitro or in vivo from any of their identified targets to truly prove causality. 

      As noted earlier, we fully agree with both reviewers that a limitation of this study is its descriptive nature, which is an inherent characteristic of omics-based research. In our manuscript, we aimed to "determine compartment-specific proteomic landscapes of liver fibrosis and delineate etiology-specific ECM components," with the overarching goal of providing a foundation for future antifibrotic therapies.

      The insights gained from our study will indeed serve as a critical basis for subsequent research, where we will prioritize mechanistic investigations to elucidate the roles of the identified targets. While we acknowledge the importance of gain- or loss-of-function studies to establish causality, we believe this falls outside the primary scope of the current manuscript. Instead, we envision these mechanistic approaches as key elements of our future research efforts. For this reason, we feel it is not necessary to further expand on this limitation in the current discussion.

      (2) The majority of the conclusions are derived primarily from the proteomic analyses. Although well conducted, it would strengthen the study to corroborate some of the major findings by other means such as IHC/IF with the corresponding quantifications and not only representative images. For example, the IF stainings for ECM1 should also be quantified - ECM1. 

      To strengthen our MS findings on ECM1 expression and to address the reviewer's concern, we have now included quantification of ECM1 using IF staining at selected time points in Figure S7E and we refer to these data in the Results section (p. 12 of the current manuscript). The IF quantification data correspond well to the MS data showing increase in ECM1 expression with fibrosis development and decline with partial fibrosis resolution.

      (3) S1 - it would be important to show Sirius Red images over the time course, especially for CCl4 T4 where fibrosis resolution is occurring. Proteomics data also show this group clusters more closely with control mice and seeing a representative image would add further credibility to this point. 

      Requsted Sirius Red images are now part of the Figure S1B, documenting partial fibrosis resolution and overall parenchyma healing in T4 in both models.

      (4) How comparable are the periods of the two models? 2 weeks in one model may not be the same as 2 weeks in the other depending on the severity of the pathogenesis. 

      We appreciate the reviewer’s comment regarding the comparability of time points between the two models. Indeed, the temporal dynamics of fibrosis development differ between the models employed in our study, and we have carefully considered this aspect to ensure the validity of our comparative analysis. To address this, we started our comparisons at a stage corresponding to the onset of fibrosis in each model. Specifically, quantification of Sirius Red-positive areas, indicative of collagen deposition (Figure S1B), revealed that 2 weeks of DDC treatment produced a comparable extent of fibrosis to that observed after 3 weeks of CCl₄ treatment. This point was designated as the initial fibrosis time point (T1, Figure S1B), from which further treatment was applied to induce more advanced fibrosis. This approach allowed us to standardize the comparison of fibrosis progression between the two models.

      (5) Figure 4A-D - cell-type-specific signatures should be corroborated by actual IHC or IF stainings if possible. HNF4a (hepatocytes), CK19 (cholangiocytes), aSMA (activated fibrogenic HSCs), immune cells (B220, F4/80, Cd11b, CD11c etc).

      We thank the reviewer for this valuable suggestion. To strengthen our analysis, we have now complemented the box plots of cell type-specific signatures derived from the MS data (Figure 4A-D) with immunofluorescence (IF) staining, which has been included in the Supplemental Data (Figure S6). Specifically, we provide representative IF images from control and T1-T4 time points for each model, documenting the changes in abundance with treatment in:

      A) Hepatocytes (HNF4α), activated hepatic stellate cells (αSMA), and cholangiocytes (CK19).

      B) Immune cell populations, including B cells (B220) and macrophages/monocytes/Kupffer cells (F4/80), as these immune cell groups were not only identified in our MS analysis but also have established roles in the selected models(3, 4, 5). 

      The representative images shown in Figure S6 show the dynamics of the cellular populations in each of the models, which correspond well with the MS data (compare Figures 4A-D and S5). These additional data further validate our findings and enhance the robustness of our conclusions.

      References:

      (1) Thiele M, Villesen IF, Niu L, et al. Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases. J Hepatol 2024;81:345-359.

      (2) Friedman SL, Pinzani M. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology 2022;75:473-488.

      (3) Best J, Verhulst S, Syn WK, et al. Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic Cholangiopathies. PLoS One 2016;11:e0162286.

      (4) Aoyama T, Inokuchi S, Brenner DA, et al. CX3CL1-CX3CR1 interaction prevents carbon tetrachlorideinduced liver inflammation and fibrosis in mice. Hepatology 2010;52:1390-400.

      (5) Yang W, Chen L, Zhang J, et al. In-Depth Proteomic Analysis Reveals Phenotypic Diversity of Macrophages in Liver Fibrosis. J Proteome Res 2024;23:5166-5176.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      The current manuscript focuses on the adenine phosphoribosyltransferase (Aprt) and how the lack of its function affects nervous system function. It puts it into the context of Lesch-Nyhan disease, a rare hereditary disease linked to hypoxanthine-guanine phosphoribosyltransferase (HGPRT). Since HGPRT appears absent in Drosophila, the study focuses initially on Aprt and shows that aprt mutants have a decreased life-span and altered uric acid levels (the latter can be attenuated by allopurinol treatment). Moreover, aprt mutants show defects in locomotor reactivity behaviors. A comparable phenotype can be observed when specifically knocking down aprt in dopaminergic cells. Interestingly, also glia-specific knock-down caused a similar behavioral defect, which could not be restored when re-expressing UAS-aprt, while neuronal re-expression did restore the mutant phenotype. Moreover, mutants, pan-neuronal and pan-neuronal plus glia RNAi for aprt caused sleep-defects. Based on immunostainings Dopamine levels are increased; UPLC shows that adenosine levels are reduced and PCR showed in increase of Ent2 levels are increased (but not AdoR). Moreover, aprt mutants display seizure-like behaviors, which can be partly restored by purine feeding (adenosine and N6methyladenosine). Finally, expression of the human HGPRT also causes locomotor defects.

      The authors provide a wide range of genetic experimental data to assess behavior and some molecular assessment on how the defects may emerge. It is clearly written, and the arguments follow the experimental evidence that is provided. The findings provide a new example of how manipulating specific genes in the fruit fly allows the study of fundamental molecular processes that are linked to a human disease.

      We thank the reviewer for his clear understanding and positive assessment of our work.

      Reviewer #2 (Public Review):

      The manuscript by Petitgas et al demonstrates that loss of function for the only enzyme responsible for the purine salvage pathway in fruit-flies reproduces the metabolic and neurologic phenotypes of human patients with Lesch-Nyhan disease (LND). LND is caused by mutations in the enzyme HGPRT, but this enzyme does not exist in fruit-flies, which instead only have Aprt for purine recycling. They demonstrate that mutants lacking the Aprt enzyme accumulate uric acid, which like in humans can be rescued by feeding flies allopurinol, and have decreased longevity, locomotion and sleep impairments and seizures, with striking resemblance to HGPRT loss of function in humans. They demonstrate that both loss of function throughout development or specifically in the adult ubiquitously or in all neurons, or dopaminergic neurons, mushroom body neurons or glia, can reproduce the phenotypes (although knock-down in glia does not affect sleep). They show that the phenotypes can be rescued by over-expressing a wild-type form of the Aprt gene in neurons. They identify a decrease in adenosine levels as the cause underlying these phenotypes, as adenosine is a neurotransmitter functioning via the purinergic adenosine receptor in neurons. In fact, feeding flies throughout development and in the adult with either adenosine or m6A could prevent seizures. They also demonstrate that loss of adenosine caused a secondary up-regulation of ENT nucleoside transporters and of dopamine levels, that could explain the phenotypes of decreased sleep and hyperactivity and night. Finally, they provide the remarkable finding that over-expression of the human mutant HGPRT gene but not its wild-type form in neurons impaired locomotion and induced seizures. This means that the human mutant enzyme does not simply lack enzymatic activity, but it is toxic to neurons in some gain-of-function form. Altogether, these are very important and fundamental findings that convincingly demonstrate the establishment of a Drosophila model for the scientific community to investigate LND, to carry out drug testing screens and find cures.

      We thank the reviewer for his clear understanding and positive assessment of our work.

      The experiments are conducted with great rigour, using appropriate and exhaustive controls, and on the whole the evidence does convincingly or compellingly support the claims. The exception is an instance when authors mention 'data not shown' and here data should either be provided, or claims removed: "feeding flies with adenosine or m6A did not rescue the SING phenotype of Aprt mutants (data not shown)". It is important to show these data (see below).

      As recommended by the reviewer, these results are now shown in the new Figure S15.

      Sleep is used to refer to lack of movement of flies to cross a beam for more than 5 minutes. However, lack of movement does not necessarily mean the flies are asleep, as they could be un-motivated to move (which could reflect abnormal dopamine levels) or engaged in incessant grooming instead. These differences are important for future investigation into the neural circuits affect by LND.

      We agree that the method we used could overestimate sleep duration because flies that don't move do not necessarily sleep either, as it is the case with brain-dopamine deficient flies (Riemensperger et al., PNAS 2011). To address this issue, we have recorded video data showing that after 5 min of inactivity, wild-type and Aprt5 mutant flies are less sensitive to stimulation, indicating that they were indeed asleep. This is now shown in the new Figure S10 and mentioned on page 17, lines 338-339 in the main text. In addition, in this work we report that Aprt mutant flies have a nocturnal insomnia phenotype. Sleep overestimation is not, therefore, an issue that could challenge these results.

      The authors claim that based on BLAST genome searchers, there are no HPRTI (encoding HGPRT) homologues in Drosophila. However, such a claim would require instead structure-based searches that take into account structural conservation despite high sequence divergence, as this may not be detected by regular BLAST.

      To reinforce our conclusions about the lack of homologue of the human HPRT1 gene in Drosophila, we have now added a Results section about the evolution of HGPRT proteins on pages 6-7, lines 122150, and two phylogenetic analyses as new Figures S2 and S3 with more details in legends. We have also carried out structural similarity searches against the RCSB PDB repository. The structural analysis did not identify any relevant similarity with HGPRT 3D structures in Insecta (mentioned lines 146-150). We hope these new analyses address the Reviewer's concerns. Furthermore, as shown in Table S2, no enzymatic HGPRT activity could be detected in extracts of wild-type Drosophila. A protein that would be structurally similar to human HGPRT but with a divergent sequence could not be involved in purine recycling without expressing HGPRT-like activity. In contrast, enzymatic Aprt activity could be easily detected in this organism (Figure S4 and Table S1).

      This work raises important questions that still need resolving. For example, the link between uric acid accumulation, reduced adenosine levels, increased dopamine and behavioural neurologic consequences remain unresolved. It is important that they show that restoring uric acid levels does not rescue locomotion nor seizure phenotypes, as this means that this is not the cause of the neurologic phenotypes.

      We agree with the reviewer about the potential importance of our results and the need to resolve the exact origin of the neurological phenotypes. This would need to be addressed in further studies in our opinion. The fact that allopurinol treatment did not improve the locomotor ability of Aprt5 mutant flies is now shown in Figure 1D, E to emphasize this result. Results showing that allopurinol does not rescue the bang-sensitivity phenotype of Aprt-deficient mutants are shown in Figure S14.

      Instead, their data indicate adenosine deficiency is the cause. However, one weakness is that for the manipulations they test some behaviours but not all. The authors could attempt to improve the link between mechanism and behaviour by testing whether over-expression of Aprt in neurons or glia, throughout development or in the adult, and feeding with adenosine and m6A can rescue each of the behavioural phenotypes handled: lifespan, SING, sleep and seizures. The authors could also attempt to knock-down dopamine levels concomitantly with feeding with adenosine or m6A to see if this rescues the phenotypes of SING and sleep.

      The reviewer is right. However, carrying out all these experiments properly with enough repeats will require about two more years of work. Because of that, they could not be included in the revision of the present article. Here we show that Aprt overexpression in neurons, but not in glia, rescues the SING phenotype of Aprt5 mutants (Figure 2B and 2E). We have also added in the revised article the new result that Aprt overexpression reduces transcript levels of DTH1, which codes for the neural form of the dopamine-synthesizing enzyme tyrosine hydroxylase (new Figure 5F).

      Visualising the neural circuits that express the adenosine receptor could reveal why the deficit in adenosine can affect distinct behaviours differentially, and which neurologic phenotypes are primary and which secondary consequences of the mutations. This would allow them to carry out epistasis analysis by knocking-down AdoR in specific circuits, whilst at the same time feeding Aprt mutants with Adenosine.

      Deciphering the specific circuits involved in the various effects of adenosine would indeed be extremely interesting. Unfortunately very few is currently known about the neural circuits that express AdoR in flies. No antibody is available to detect this receptor in situ and mutated AdoR gene coding for a tagged form of the receptor has not been engineered yet to our knowledge.

      The revelation that the mutant form of human HGPRT has toxic effects is very intriguing and important and it invites the community to investigate this further into the future.

      To conclude, this is a fundamental piece of work that opens the opportunity for the broader scientific community to use Drosophila to investigate LND.

      We sincerely thank the reviewer for his thoughtful and positive comments on our work.

      Reviewer #3 (Public Review):

      The study attempts to develop a Drosophila model for the human disease of LND. The issue here, and the main weakness of this study, is that Drosophila does not express the enzyme, HGPRT, which when mutated causes LND. The authors, instead, mutate the functionally-related Drosophila Aprt enzyme. However, it is unknown whether Aprt is also a structural homologue. Because of this, it will likely not be possible to identify pharmacological compounds that rescue HGPRT activity via a direct interaction (unless modelling predicts high conservation of substrate binding pocket between the two enzymes, etc).

      As stated in our Provisional Responses prior to revision of the Reviewed Preprint, the enzymes APRT and HGPRT are actually known to be functionally and structurally related. We apologize for not providing this information in the original submission. This point is now made clearer in the revised article on page 39, lines 785-792. Indeed, both human APRT and HGPRT belong to the type I PRTases family identified by a conserved phosphoribosyl pyrophosphate (PRPP) binding motif, which is used as a substrate to transfer phosphoribosyl to purines. This binding motif is only found in PRTases from the nucleotide synthesis and salvage pathways (see: Sinha and Smith (2001) Curr Opin Struct Biol 11(6):733-9, doi: 10.1016/s0959-440x(01)00274-3). The purine substrates adenine, hypoxanthine and guanine share the same chemical skeleton and APRT can bind hypoxanthine, indicating that APRT and HGPRT also share similarities in their substrate binding sites (Ozeir et al. (2019) J Biol Chem. 294(32):11980-11991, doi: 10.1074/jbc.RA119.009087). Moreover, Drosophila Aprt and Human APRT are closely related as the amino acid sequences of APRT proteins have been highly conserved throughout evolution (see Figure S5B in our paper).

      An additional weakness is that the study does not identify a molecule that may act as a lead compound for further development for treating LND. Rather, the various rescues reported are selective for only a subset of the disease-associated phenotypes. Thus, whilst informative, this first section of the study does not meet the study ambitions.

      In this study, we identify adenosine and N6-methyladenosine as rescuers of the epileptic behavior in Aprt mutant flies (shown in Figure 7E, F). Interestingly, the same molecules have been found to rescue the viability of fibroblasts and neural stem cells derived from iPSCs of LND patients, in which de novo purine synthesis was prevented (discussed on page 38, lines 747-753). This suggests that the Drosophila model reported here could help to identify new genetic targets and pharmacological compounds capable to rescue HGPRT mutations in humans.

      The second approach adopted is to express a 'humanised mutated' form of HGPRT in Drosophila, which holds more promise for the development of a pharmacological screen. In particular, the locomotor defect is recapitulated but the seizure-like activity, whilst reported as being recapitulated, is debatable. A recovery time of 2.3 seconds is very much less than timings for typical seizure mutants. Nevertheless, the SING behaviour could be sufficient to screen against. However, this is not explored.

      We agree with the reviewer that it would be very interesting to do a pharmacological screen in this second LND model. However, we did not have the possibility to carry out such a screen yet.

      In summary, this is a largely descriptive study reporting the behavioural effects of an Aprt loss-offunction mutation. RNAi KD and rescue expression studies suggest that a mix of neuronal (particularly dopaminergic and possibly adenosinergic signalling pathways) and glia are involved in the behavioural phenotypes affecting locomotion, sleep and seizure. There is insufficient evidence to have confidence that the Arpt fly model will prove valuable for understanding / treating LND.

      Here we report many common phenotypes between the Aprt fly model and the symptoms of LND patients (reduced longevity, locomotor problems, sleep defects, overproduction of uric acid that is rescued by allopurinol treatment…). Moreover, APRT and HGPRT enzymes are both functional and structural homologues, as explained in our answers. We also found that the same drugs can rescue the seizure-like phenotype in Aprt-deficient flies and the viability of LND fibroblasts and neural stem cells, derived from iPSCs of LND patients, in which de novo purine synthesis is prevented (Figure 7E, F). In many respects, our results therefore suggest that Aprt mutant flies could be useful to better understand LND, and potentially to screen for new therapeutic compounds.

      From the Reviewing Editor:

      (1) How are the pathways of purine catabolism different between flies and mammals? How does the absence of HGPRT and presence of only AGPRT affect purine catabolism? When did HGPRT appear in evolution?

      Purine catabolism is quite similar in flies and mammals, except for the lack of urate oxidase in primates, as described in Figure S1. We added words in the revised article about purine anabolism/catabolism pathways lines 123-126 (see below our detailed response to Reviewer 1’s Recommandations). HGPRT is present in Bacteria, Archea and Eukaryota, and nearly all animal phyla. However, BLAST search indicates that HGPRT homologues cannot be found in most insect species, such as Drosophila. To reinforce our conclusions about the lack of homologue of the human HPRT1 gene in Drosophila melanogaster, we have now added a Results section about the evolution of HGPRT proteins on pages 6-7, lines 122-150, and two phylogenetic analyses as new Figures S2 and S3 with details in legends.

      In addition to BLAST a structural based modelling method should be used to establish the loss of HGPRT in Drosophila.

      In agreement with the phylogenetic analyses, we have confirmed that no HGPRT enzymatic activity can be detected in wild-type Drosophila extract (Table S2). To complete these observations, as recommended by reviewer #2, we have carried out 3D structure-based searches in the RCSB Protein Data Bank. This enabled us to compare human HGPRT with all currently available protein structures. W found no Drosophila protein with a divergent sequence showing relevant structural similarity to human HGPRT. In contrast, this search identified proteins similar to human HGPRT in many other species of Eukaryota, Archea and Bacteria. This is now mentioned on page 7, lines 146-150 in the revised article.

      (2) Of the three biochemical changes reported the change in dopamine levels should be validated by other methods given the unreliable nature of IHC.

      As recommended by Reviewer #1, we have added the results of new experiments carried out by RTqPCR and Western blotting, which confirm the effect of Aprt mutation on brain dopamine levels. In addition, we added the consistent result that Aprt overexpression reduces transcript levels of DTH1. The results are shown in the new panels E to H of Figure 5 and mentioned in the text on page 20, lines 385-389.

      (3) As suggested by reviewer 2 it would be helpful to clearly identify which of the three biochemical changes (DA, uric acid, adenosine) are responsible for the numerous behaviours tested. This is important because it is relevant for developing any therapeutic strategy arising from this study.

      We agree that it would be very interesting to decipher the relationship between the different behaviors observed in mutant flies and the biochemical changes (dopamine, uric acid or adenosine). However, this would require a large amount of new experiments and it would probably double the size of our paper, which already includes many original data. In our opinion, such a detailed study should logically be the purpose of another article.

      (4) There is concern regarding the robustness of the seizure data. Reviewer 3 has suggestions on how to address this.

      See our answers to Reviewer 3’s recommendations below.

      (5) Editorial corrections and changes suggested by reviewers 2 and 3 need to be addressed.

      As indicated in our answers, we have taken into account and when possible addressed the corrections and changes suggested by the reviewers.

      (6) It is recommended that the authors tone down the relevance of this model for LND, particularly in the abstract. The focus should be on stating what is actually delivered.

      As recommended by the reviewing editor, and to take in account the reserved comments of reviewer #3, we have toned down our affirmation that our new fly models are relevant for LND in the last sentences of the Abstract and Discussion, and also added a question mark in the subtitle of the Discussion on line 777. As mentioned in our provisional responses to the Public Reviews, we would like to emphasize, however, that reviewers #1 and #2 expressed more confidence than reviewer #3 in the potential usefulness of our work. Reviewer #1 indeed stated that: “The findings provide a new example of how manipulating specific genes in the fruit fly allows the study of fundamental molecular processes that are linked to a human disease”, and reviewer #2 further wrote: "Altogether, these are very important and fundamental findings that convincingly demonstrate the establishment of a Drosophila model for the scientific community to investigate LND, to carry out drug testing screens and find cures”, and added: “To conclude, this is a fundamental piece of work that opens the opportunity for the broader scien2fic community to use Drosophila to inves2gate LND”.

      Reviewer #1 (Recommendations For The Authors):

      • An important prerequisite for the current study is that there appears to be no HGPRT "activity" in Drosophila. It is initially stated that there was previously no "HGPRT activity observed" in two papers form the 70ies. It would be important to corroborate this notion and provide some background on the <br /> /catabolism pathways. How shared or divergent are these pathways between Drosophila and mammals?

      In agreement with the pioneering studies of Becker (1974a, b), we have confirmed in this work that no HGPRT enzymatic activity can be detected in wild-type Drosophila extracts, as mentioned in Results on page 6, lines 127-130 and reported in Table S2. Purine catabolism is quite similar in flies and mammals, except for the lack of urate oxidase in primates, as shown in Figure S1. All the enzymes involved in purine anabolism/catabolim or recycling in humans have been conserved in Drosophila and humans, with the notorious exception of HPRT1.

      If there is no HGPRT gene, but only the APRT ortholog, what would this mean for the metabolites? Our enzymatic assays on Drosophila extracts indicated that hypoxanthine and guanine cannot be recycled into IMP and GMP, respectively, contrary to adenine which can be converted into AMP in flies. In the absence of HGPRT activity, GMP and IMP could be produced by de novo purine synthesis, or, alternatively, synthesized from AMP, which can be converted into IMP by the enzyme AMPD, and then IMP can be converted into GMP by the enzymes IMPDH and GMPS. These metabolic pathways are depicted in Figure S1A.

      Is the lack of HGPRT specific for Drosophila, insects (generally in invertebrates)? I feel clarifying this would provide more insight into the motivation of the experimental approach.

      As suggested by the Reviewer and the Reviewing Editor, we have addressed the evolution of HGPRT proteins more precisely in the revision. We have added a section on this subject in Results on pages 67, lines 122-150, and two phylogenetic analyses as Figures S2 and S3 with details in legends. A phylogenetic analysis was carried out a few years ago by Giorgio Matassi, who is now co-author of this paper. The most striking result was the great impact of horizontal gene transfer in the evolution of HGPRT in Insects (Figures S2 and S3). Our analysis of the phyletic distribution of HGPRT proteins revealed their striking rareness in Insecta, and in particular, their absence in Drosophilidae. The PSIBlast search detected however a significant hit in Drosophila immigrans (accession KAH8256851.1). Yet, this sequence is 100% identical to the HGPRT of the Gammaroteobacterium Serratia marcescens. Indeed, a phylogenetic analysis showed that D. immigrans HGPRT clusters with the Serratia genus (see Figure S3). This can be interpreted either a contamination of the sequenced sample, or as a very recent horizontal gene transfer event. The second scenario is more likely for the corresponding nucleotide sequences differ by 5 synonymous substitutions (out of 534 positions). A powerful approach to try to understand the "origin" of the D. immigrans protein would be to analyze whether horizontal gene transfer has affected its chromosomal neighbours. This approach, proposed previously by G. Matassi (BMC Evol Biol, 2017, 17:2, doi: 10.1186/s12862-016-0850-6), is highly demanding in terms of computing time and would require an ad hoc study. We hope that these new analyses address the Reviewer's concerns.

      • On the mechanistic side on how the behavioral defects may arise, the authors show that dopaminergic neurons (and glia cells) are involved. One interesting finding is that dopamine immunostainings suggest increased dopamine levels. However, immunostainings are notorious for artifacts and do not provide a strong quantitative assessment. I feel it would be helpful to have an alternative technique to corroborate this finding.

      We agree with the reviewer and we added the results of further confirmatory experiments in the four new panels E-H of Figure 5, showing that: 1) the transcript levels of DTH1 (encoding the neuronal isoform of the dopamine-synthesizing enzyme tyrosine hydroxylase in Drosophila) are increased in Aprt5 mutants compared to wild-type flies (new Figure 5E), 2) consistent with this, DTH1 transcript levels were found in contrast to be decreased when Aprt was overexpressed ubiquitously in flies (new Figure 5F), 3) Western blot experiments showed that DTH1 protein levels are also increased in Aprt5 mutant flies compared to controls (new Figure 5G-H).

      Reviewer #2 (Recommendations For The Authors):

      As mentioned in the public review, the behavioural phenotypes of decreased lifespan, SING, sleep and seizures could be tested for all manipulations: feeding with allopurinol, adenosine and m6A, and combining this with knock-down dopamine levels in PAMs or MBs. This could help dissect the relationship between mutations in Aprt and behaviour.

      We thank the reviewer for these suggestions, and, indeed, we would have liked to do all these experiments. However, as mentioned in our responses to the Public Reviews, carrying out these experiments properly with sufficient repeats would require about two more years of work. We have already accumulated a large amount of data, so we have decided to publish our results at this stage in order to make our new fly models available to the scientific community. We are giving careful and due consideration to these experimental proposals and we hope to continue our investigation on this topic in the future.

      It would also be helpful to find out which neurons and glia express AdoR. Perhaps there are already tools available the authors could test or at least check with the scRNAseq Fly Atlas (public Scope database).

      Following the reviewer’s recommendation, we have checked the scRNAseq Fly Atlas for AdoR expression in the brain, compared to that of ple (encoding tyrosine hydroxylase) and Eaat1 (encoding the astrocytic glutamate transporter). As shown in the image below, the results are not very informative. AdoR appears to be expressed in rather widespread subsets of neurons and glial cells, that partly overlap with ple and Eaat1 expression. Further work would be required to identify more precisely the neurons and glial cells expressing AdoR in the brain.

      Author response image 1.

      Page 7, line 161: use of the word 'normalize'. "We tried to normalise uric acid content in flies..." would best to use 'rescue' instead, as normalisation in science has a different meaning.

      We modified this word as suggested.

      Page 9 line 203: 'genomic deficiencies that cover': the genetic term is 'uncover', as a deficiency for a locus reveals a phenotypes, thus it is said 'a gene uncovered by xx deficiency".

      Thank you for this helpful remark. We corrected this in line 221.

      Page 10, lines 206-208: 'allopurinol treatment did not improve the locomotor activity...". These are important observations that should be best presented within the main manuscript Figure 1.

      As recommended, we have transferred the graphs of Figure S5 to new panels D and E of Figure 1.

      Figure 4: please indicate genotypes in the figure, where no information is given that these are UASAprt-RNAi experiments.

      We added the complete genotype in Figure 4G, and also in Figure S12C and D. Thank you for noting that.

      Page 25 line 491: "None of these drugs was able to rescue the SING defects (data not shown)". Either provide the data or remove this claim.

      We have added these data in the new Figure S15.

      Statistical analyses: details are provided in the methods, but the name of test and multiple comparisons corrections should be also provided in the legends.

      Thank you very much for the careful proofreading. This was an oversight and we have added the information in all legends of the revised article.

      Reviewer #3 (Recommendations For The Authors):

      This is a difficult manuscript to appreciate. The abstract and introduction suggest that the study is to identify novel treatments for a human disease (LND) by development of a Drosophila model. Much of the results, however, are focussed to describing the consequences to purine metabolism of the Aprt mutation. To my mind, a rewrite to focus on the latter would be beneficial. The potential applicability to LND would be best restricted to the discussion.

      We apologize for not making our goals clearer. Our purpose was to find out if purine recycling deficiency could lead to metabolic and neurobehavioral disturbances in Drosophila, as it is the case in human LND patients when HGPRT is mutated. Interestingly, we observed that mutation of the only purine recycling enzyme in flies, Aprt, did induce defects in part comparable to that of LND in humans, including overproduction of uric acid that is rescued by allopurinol treatment, reduced longevity, and various neurobehavioral phenotypes including bang-sensitive seizure, sleep defects and locomotor impairments. We also identified adenosine and N6-methyladenosine as rescuers of the epileptic behavior in these mutants. These drugs were also identified as therapeutic candidates in screens based on iPSCs from LND patients. This suggests that Aprt deficiency in Drosophila could be used as a model to better understand this disease and find new therapeutic targets.

      Regardless of the above comment, the concluding sentence of the abstract is inappropriate. This study does not show that Drosophila can be used to identify a cure for LND.

      We agree with the Reviewer that the last sentence of the abstract was too affimative. As also recommended by the reviewing editor, we have modified this sentence in the abstract and other sentences in the text in order to tone down the affirmation that our new fly models are relevant for LND. See our answers to the Reviewing Editor above for details.

      Indeed, I would challenge the premise that screening against a functional, but unknown if structural, homologue (Aprt) will ever provide an exploitable opportunity. To meet this statement, this study needs to identify a treatment that rescues all of the behavioural phenotypes associated with the Aprt mutation, in addition to rescuing the influences of the mis-expression of mutated HGPRT.

      APRT and HGPRT are both functionally and structurally related. Both human APRT and HGPRT belong to the type I PRTases family identified by a conserved phosphoribosyl pyrophosphate (PRPP) binding motif, which is used as a substrate to transfer phosphoribosyl to purines. This binding motif is only found in PRTases from the nucleotide synthesis and salvage pathways (see: Sinha and Smith (2001) Curr Opin Struct Biol 11(6):733-9733-9, doi: 10.1016/s0959-440x(01)00274-3). The purine substrates adenine, hypoxanthine and guanine share the same chemical skeleton and APRT can bind hypoxanthine, indicating that APRT and HGPRT also share similarities in their substrate binding sites (Ozeir et al. (2019) J Biol Chem. 294(32): 11980-11991, doi: 10.1074/jbc.RA119.009087)). This point has been made clearer in the Discussion page 39, in lines 785-792.. Finally, Drosophila Aprt and Human APRT are closely related as the amino acid sequences of APRTs have been highly conserved throughout evolution (shown in Figure S5B).

      With respect to expression of the mutated HGPRT: the short seizure recovery time of 2.3 seconds is not very convincing evidence of a seizure phenotype. This is far below the timings reported for typical BS mutations. Because of this, the authors should run a positive control (e.g. one of the wellestablished BS mutations: parabss, eas or jus) to validate their assay. Moreover, was the seizure induced by the Aprt mutation (17.3 secs - again a low value) rescued by prior exposure to an antiepileptic? Could this behaviour be, instead, related to the SING locomotor phenotype?

      The assay we used to test for bang-sensitivity has been validated in previous articles from different laboratories. We agree that the recovery times we observed were shorter than those of the BS mutations mentioned by the reviewer. However, we could cite another Drosophila BS mutant, porin, that shows similarly short recovery times (2.5 and 6 sec, according to the porin alleles tested, Graham et al. J Biol Chem. 2010, doi: 10.1074/jbc.M109.080317). This is now mentioned on page 36 lines 717-720). In addition, the BS phenotype we observed with Aprt mutants was robust and highly significant compared to control flies (Figure 7). We did not try to rescue this phenotype by exposing the flies to an antiepileptic, but we do not think that it can be related to the SING phenotype. Indeed, providing adenosine or N6-methyladenosine to Aprt5 mutant flies was able to rescue the BS phenotype (Figure 7E, F), but did not rescue the locomotor defects (new Figure S15). Moreover, SING performances of Aprt5 mutant flies at 8 or 30 d a. E. are decreased nearly in almost identical way (Figure 1C), while we observed an effect on BS behavior at 30 d a. E., which implies that the SING and BS behaviors are most likely unrelated.

      Line 731 states that 'Aprt mutants show a typical BS phenotype' - whilst accurate to some extent (e.g. the behaviour depicted in the supp videos), it should be made clear, it should be made clear that the recovery time is uncharacteristically short and thus differs from typical BS mutations.

      We have corrected the sentence in the revised article to mention that (page 36, lines 717-718).

      Line 732 stating that BS phenotype is often linked to neuronal activity - what other links would there be? Even if via glia or other tissues the final effect is via neurons.

      We have modified this sentence (page 36, line 720).

      The introduction and, particularly, the discussion are overly long and, in the case of the latter, repetitive of the results text. Pruning to make the paper more concise would be very beneficial. Removal of the extensive speculation about how DA and adenosine may interact would help in this regard (line 688 onwards). Indeed, in many places the discussion morphs into a review.

      We agree with the reviewer on this point, and have therefore done our best to shorten the Introduction and Discussion, which are now 24% and 21% shorter, respectively, in the revised article compared to the original submission.

      The applicability of using Drosophila Aprt mutations to screen for compounds that may treat LND is predicated on some degree of similarity in either enzyme structure or metabolic pathways. A discussion of how relevant, therefore, studying Aprt is needs to be included. Given the authors insights - where should potential new rugs be targeted to?

      As stated above, we now mention in the article that APRT and HGPRT share similarities in their structure. In addition, the metabolic pathways between humans and Drosophila have been largely conserved (shown in Figure S1B).

    1. Author Response

      The following is the authors’ response to the original reviews.

      Response to review.

      We thank the editors and reviewers for their time in assessing our manuscript. We changed the title to remove the word “all” because we realized that was hyperbolic. Corrections in response to review are in blue text throughout the manuscript document (other minor corrections are not highlighted).

      eLife assessment

      This study presents valuable insights into the evolution of the gasdermin family, making a strong case that a GSDMA-like gasdermin was already present in early land vertebrates and was activated by caspase-1 cleavage. Convincing biochemical evidence is provided that extant avian, reptile, and amphibian GSDMA proteins can still be activated by caspase-1 and upon cleavage induce pyroptosis-like cell death - at least in human cell lines. The caspase-1 cleavage site is only lost in mammals, which use the more recently evolved GSDMD as a caspase-1 cleavable pyroptosis inducer. The presented work will be of considerable interest to scientists working on the evolution of cell death pathways, or on cell death regulation in non-mammalian vertebrates.

      We thank the editor for their time in evaluating our manuscript. We agree with the eLife assessment and with the comments of the reviewers.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The authors start out by doing a time-calibrated gene/species tree analysis of the animal gasdermin family, resulting in a dendrogram showing the relationship of the individual gasdermin subfamilies and suggesting a series of gene duplication events (and gene losses) that lead to the gasdermin distribution in extant species. They observe that the GSDMA proteins from birds, reptiles, and amphibians do not form a clade with the mammalian GSDMAs and notice that the non-mammalian GSDMA proteins share a conserved caspase-1 cleavage motif at the predicted activation site. The authors provide several series of experiments showing that the non-mammalian GSDMA proteins can indeed be activated by caspase-1 and that this activation leads to cell death (in human cells). They also investigate the role of the caspase-1 recognition tetrapeptide for cleavage by caspase-1 and for the pathogen-derived protease SpeB.

      We thank the reviewer for their time in evaluating our manuscript.

      Strengths:

      The evolutionary analysis performed in this manuscript appears to use a broader data basis than what has been used in other published work. An interesting result of this analysis is the suggestion that GSDMA is evolutionarily older than the main mammalian pyroptotic GSDMD, and that birds, reptiles, and amphibians lack GSDMD but use GSDMA for the same purpose. The consequence that bird GSDMA should be activated by an inflammatory caspase (=caspase1) is convincingly supported by the experiments provided in the manuscript.

      We thank the reviewer for their assessment of the manuscript.

      Weaknesses:

      1. As a non-expert in phylogenetic tree reconstruction, I find the tree resulting from the authors' analysis surprising (in particular the polyphyly of GSDMA) and at odds with several other published trees of this family. The differences might be due to differences in the data being used or due to the tree construction method, but no explanation for this discrepancy is provided.

      We agree, and we have modified the text to add more context to explain why our analysis generated a different topology: “In comparison to previously published studies, we used different methods to construct our gasdermin phylogenetic tree, with the result that our tree has a different topology. The topology of our tree is likely to be affected by our increased sampling of gasdermin sequences; we included 1,256 gasdermin sequences in comparison to 300 or 97 sequences used in prior studies. Prior studies used maximum likelihood tree building techniques, whereas we used a more computationally intensive Bayesian method using BEAST with strict molecular clocks that allows us to provide divergence time estimates, which we calibrated using mammal fossil estimated ages. We think that this substantially increased sampling paired with time calibration allow us to produce a more accurate phylogeny of the gasdermin protein family.”

      To explain and further support our method in a more technical manner, in our phylogenetic tree, non-mammal GSDMAs are paralogous to mammals GSDMAs whereas others have found that non-mammal GSDMAs are orthologous to mammal GSDMAs. We obtained moderate support for the non-mammal GSDMA placement with Bayesian posterior 0.42 and with maximum likelihood bootstrap support of 0.96. Angosto-Bazarra et al. has for their placement a Bayesian posterior of 0.66 and maximum likelihood bootstrap support of 0.98. These are good results, but they arise from significantly fewer sequences than are included in our tree. However, in Fig S2 of Angosto-Bazarra et al. the support drops to 0.08. That the posteriors in both are not 1 indicate the presence of phylogenetic conflicts (i.e., a significant fraction of alternative trees), which means that the tree of our study or Angosto-Bazarra could be incorrect. That said, our tree is supported by biological support, and our dataset is substantially larger. To better characterize this node, further sampling with even more species would be required. We exhausted the current available sequences at the time our tree was generated.

      Differences between our study and previous studies:

      Author response table 1.

      1. While the cleavability of bird/reptile GSDMA by caspase-1 is well-supported by several experiments, the role of this cleavage for pyroptotic cell killing is addressed more superficially. One cell viability assay upon overexpression of GSDMA-NTD in human HEK293 cells is shown and one micrograph shows pyroptotic morphology upon expression in HeLa cells. It is not clear why these experiments were limited to human cells…

      We did include one more experiment in human cells which is Figure 4B, in which we express full length chicken GSDMA with dimerizable caspase-1, and show that LDH release requires the cleavage site aspartate, D244. That said, we agree that our use of only human cell lines is a weakness of the paper. We thought that the best way to definitively show the interaction of caspase-1 and GSDMA was to perform experiments in chicken macrophages. Therefore, we generated a custom-raised anti-chicken-GSDMA antibody. Unfortunately, the quality of the antibody was insufficient to detect endogenous GSDMA in chicken bone marrow-derived macrophages. Off target binding prevented the observation of chicken GSDMA bands. We added a section to the discussion acknowledge the need for further studies: “In future studies, the association of bird/amphibian/reptile GSDMA and caspase-1 should be confirmed in native cells from each of these animals.”

      …and why two different cell types were used for the two complementary results.

      In the paper we used 293T cells and HeLa cells as generic cell types that have distinct benefits. In general, we used 293T/17 cells for experiments where high transfection efficiency was most critical, as it is simple to achieve 90% or higher transfection efficiency in this line. However, 293T/17s have poor spreading in culture and thus are not as useful for morphologic studies. 293T/17 cells do display pyroptotic ballooning upon gasdermin activation, however, the images are less pronounced in comparison to other cell types that have more distinct morphology. Therefore, we used HeLa cells for the microscopy experiments because they are more adherent and larger than 293T/17s which make for easier visualization of pyroptotic ballooning. We have added the following statement to the text to make our rationale for the use of different cell line more apparent: “In these experiments, 293T/17s were used for their high transfection efficiency, and HeLas were used for microscopy studies for their larger size and improved adherence.”

      1. The introduction mentions as a motivation for this work our lack of knowledge of how human GSDMA is activated. This is indeed an interesting and pressing question, but it is not really addressed in the manuscript. This is particularly true when believing the authors' dendrogram results that the bird and mammalian GSDMA families do not form a clade.

      As a consequence, the significance of this finding is mostly limited to birds and reptiles.

      Our aspirations were to discover hidden facets of mammal GSDMA by using a molecular evolutionary analysis. bird/amphibian/reptile GSDMA. Although we did not learn the identity of a host protease that activates mammalian GSDMA, we serendipitously discovered the evolutionary history of the association of caspase-1 with the gasdermin family. We think this manuscript provides an important and interesting advance in the field to reveal the process of evolution at work in the gasdermin family, and that the association of caspase-1 with a gasdermin to cause pyroptosis is an unbroken pairing throughout evolution. It is surprising to us that the specific gasdermin partner has changed over time.

      Reviewer #2 (Public Review):

      Summary:

      The authors investigated the molecular evolution of members of the gasdermin (GSDM) family. By adding the evolutionary time axis of animals, they created a new molecular phylogenetic tree different from previous ones. The analyzed result verified that non-mammalian GSDMAs and mammalian GSDMAs have diverged into completely different and separate clades. Furthermore, by biochemical analyses, the authors demonstrated non-mammalian GSDMA proteins are cleaved by the host-encoded caspase-1. They also showed mammalian GSDMAs have lost the cleavage site recognized by caspase-1. Instead, the authors proposed that the newly appeared GSDMD is now cleaved by caspase-1.

      We thank the reviewer for their time in evaluating our manuscript.

      Through this study, we have been able to understand the changes in the molecular evolution of GSDMs, and by presenting the cleavage of GSDMAs through biochemical experiments, we have become able to grasp the comprehensive picture of this family of molecules. However, there are some parts where explanations are insufficient, so supplementary explanations and experiments seem to be necessary.

      Strengths:

      It has a strong impact in advancing ideas into the study of pyroptotic cell death and even inflammatory responses involving caspase-1.

      We thank the reviewer for the critical consideration of the phylogeny presented.

      Weaknesses:

      Based on the position of mammalian GSDMA shown in the molecular phylogenetic tree (Figure 1), it may be difficult to completely agree with the authors' explanation of the evolution of GSDMA.

      1. Focusing on mammalian GSDMA, this group, and mammalian GSDMD diverged into two clades, and before that, GSDMA/D groups and mammalian GSDMC separated into two, more before that, GSDMB, and further before that, non-mammalian GSDMA, when we checked Figure 1. In the molecular phylogenetic tree, it is impossible that GSDMA appears during evolution again. Mammalian GSDMAs are clearly paralogous molecules to non-mammalian GSDMAs in the figure. If they are bona fide orthologous, the mammalian GSDMA group should show a sub-clade in the non-mammalian GSDMA clade. It is better to describe the plausibility of the divergence in the molecular evolution of mammalian GSDMA in the Discussion section.

      We appreciate the reviewer’s careful consideration of our phylogeny. We agree that we did not make this clear enough in the discussion. Indeed, this is a confusing point, and is a critical concept in the paper. This is among our most important findings, so we have added a line addressing this finding to the abstract. We think about these concepts starting from the oldest common ancestor of a group, and then think about how genes duplicate over time. To the discussion we now begin with the following:

      We discovered that GSDMA in amphibians birds and reptiles are paralogs to mammal GSDMA. Surprisingly, the GSDMA genes in both the amphibians/reptiles/birds and mammal groups appear in the exact same locus. Therefore, this GSDMA gene was present in the common ancestor of all these animals. In mammals, this GSDMA duplicated to form GSDMB and GSDMC. Finally, a new gene duplicate, GSDMD, arose in a different chromosomal location. Then this GSDMD gene became a superior target for caspase-1 after developing the exosite. Once GSDMD had evolved, we speculate that the mammalian GSDMA became a pseudogene that was available to evolve a new function. This new function included a new promoter to express mammalian GSDMA primarily in the skin, and perhaps acquisition of a new host protease that has yet to be discovered.

      In further support of the topology of our Bayesian tree in Figure 1, we also performed a maximum likelihood analysis, which also placed the GSDMA genes into similarly distinct clades (Figure 1-S3). Finally, we have biological evidence to support this reasoning, where caspase-1 cleaves non-mammal GSDMAs and also mammal GSDMD (and no longer can cleave mammal GSDMA).

      1. Regarding (1), it is recommended that the authors reconsider the validity of estimates of divergence dates by focusing on mammalian species divergence. Because the validity of this estimation requires a recheck of the molecular phylogenetic tree, including alignment.

      Our reconstructed evolution of gasdermins is consistent with the mammal tree of life. We constrained Bayesian estimation of divergences using soft calibrations from mammal fossil estimated ages. We have included the fossil calibration of mammalian gasdermins to the results section and to our methods.

      1. If GSDMB and/or GSDMC between non-mammalian GSDMA and mammalian GSDMD as shown in the molecular phylogenetic tree would be cleaved by caspase-1, the story of this study becomes clearer. The authors should try that possibility.

      It is known that mammal GSDMB and GSDMC cannot be activated by caspase-1. We propose that GSDMA was cleaved by caspase-1 only in extinct mammals that had not yet associated GSDMD with caspase-1. Such an extinct mammal could have encoded a GSDMA cleaved by caspase-1, a GSDMB cleaved by granzyme A, and GDSMC cleaved by caspase-8. Later, the GSDMA gene was again duplicated to form GSDMD. After GSDMD was targeted by caspase-1, then GSDMA was free to gain its current function in barrier tissues.

      Reviewer #1 (Recommendations For The Authors):

      As a non-expert on phylogenetic tree construction, I found the "time-calibrated maximum clade credibility coalescent tree" hard to digest. I would have liked to see an explanation of how this method is different from what has been used before and why the authors consider it to be better. This is particularly important when considering that the resulting tree shown in Figure 1 is quite different from other published trees of the same family (e.g. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742441 where the GSDMA family appears monophyletic).

      Please see response to Reviewer 1 weaknesses above. Also, we have moved the text “time-calibrated maximum clade credibility coalescent tree” to the figure legend.

      In the bioinformatical analysis of the conserved caspase-1 cleavage motif in bird GSDMA sequences, I would recommend also addressing the residue behind the cleavage site Asp, as this position has an unusually high conservation (mostly Gly) in bird GSDMA.

      This is a great observation. We suspect that this may reflect a need for flexibility in the secondary structure to allow the cleavage site to enter the enzymatic pocket of the caspase. This residue is also similarly enriched in mammal GSDMD, which is also cleaved by caspase-1. We also note high conservation of a P2' proline residue in birds with the FASD tetrapeptide, which could also be important for displaying the tetrapeptide to the caspase.

      This comment prompted us to search the literature for evidence of these residues in caspase-1 substrate preference studies. Remarkably, a P1' glycine and P2` proline are among the most enriched residues in human caspase-1 targets. This supports our hypothesis that caspase-1 cleaves GSDMA in non-mammals. We added the following to the results section: “Additionally, the P1' residue in amphibian, bird and reptile GSDMA was often a glycine, and the P2' residue was often a proline, especially in birds with FASD/FVSD tetrapeptides (Fig. 2B). A small P1' residue is preferred by all caspases. By using a peptide library, glycine has been determined to be the optimal P1' residue for caspase-1 and caspase-4. Further, in a review of the natural substrates of caspase-1, glycine was the second most common P1' residue, and proline was the most common P2' residue. These preferences were not observed for caspase-9.”

      Finally, I would like the authors to at least explain why the cell viability assays were done in 293T cells while the micrographs were done in HeLa cells. Why not show both experiments for both cell types?

      In the paper we used 293T cells and HeLa cells as generic cell types that have distinct benefits. In general, we used 293T/17 cells for experiments where high transfection efficiency was most critical, as it is simple to achieve 90% or higher transfection efficiency in this line. However, 293T cells have poor spreading in culture and thus are not as useful for morphologic studies. 293T/17 cells do display pyroptotic ballooning upon gasdermin activation, however, the images are less pronounced in comparison to other cell types that have more distinct morphology. Therefore, we used HeLa cells for the microscopy experiments because they are more adherent and larger than 293T/17s which make for easier visualization of pyroptotic ballooning. We have added the following statement to the text to make our rationale for the use of different cell line more apparent: “In these experiments, 293T/17s were used for their high transfection efficiency, and HeLas were used for microscopy studies for their larger size and improved adherence.”

      There are a number of minor points related to language and presentation:

      • the expressions "pathogens contaminate the cytosol", "mammals can encode..", "an outsized effect" are unusual and might be rephrased.

      We changed these to:

      “manipulate the host cell, sometimes contaminating the cytosol with pathogen associated molecular patterns, or disrupting aspects of normal cell physiology”,

      “Only mammals encode GSDMC and GSDMD alongside the other four gasdermins.”,

      and

      “greater effect”

      • in line 87 the abbreviation "GSDMEc" is first used without explanation (of the "c").

      This is an important distinction, as GSDMEc proteins were only recently uncovered. To remedy this, we have added the following text following line 87: “This gasdermin was recently identified as an ortholog of GSDMA.

      It was called GSDMEc, following the nomenclature of other duplications of GSDME in bony fish that have been named GSDMEa and GSDMEb.”

      • line 89 grammar problem.

      Corrected

      • line 186ff the sentence "We believe..." does not appear to make sense.

      We revised the text to make this clear, changing the text to now read “We hypothesized that activating pyroptosis using separate gasdermins for caspase-1 and caspase-3 is a useful adaptation and allows for fine-tuning of these separate pathways. In mammals, this separation depends on the activation of GSDMD by caspase-1 and the activation of GSDME by caspase-3.”

      • many figures use pictures rather than text to represent species groups. These pictures are not always intuitive. As an example, in Figure 6 the 'snake' represents amphibians. After reading the text, I understand that these should probably be the caecilian amphibians, but not every reader might know what these critters look like. In Figure 7, I have no idea what the black blob (2nd image from top) is supposed to be.

      In crafting the manuscript, we found the use of text to denote the various species to be cumbersome. The species silhouettes are a standard graphical depiction used in evolutionary biology, which we think aids readability to the figures. For example, in a paper cited in our manuscript, these same silhouettes were used to depict the evolution of GSDMs (https://doi.org/10.3389/fcell.2022.952015 Figure 1A, Figure 3D, Figure 4G). However, we agree that many readers will not know that caecilians are legless amphibians that resemble snakes in their body morphology, but are not close to snakes by phylogeny. We think it is important to use an image of a caecilian amphibian because the more iconic amphibians (frogs, salamanders) do not encode GSDMA. To increase clarity, we have mentioned the morphology of caecilians in the legend of Figure 2, Figure 6, and Figure 7 when caecilican amphibians are first introduced.

      In Figure 2: “Note, that caecilians morphologically are similar to snakes in their lack of legs and elongated body, however, this is an example of convergent evolution as caecilians are amphibians and are thus more closely related to frogs and salamanders than snakes.”

      In Figure 6: “M. unicolor is an amphibian despite sharing morphological similarity to a snake.”

      In Figure 7: “In caecilian amphibians, which are morphologically similar to snakes, birds, and reptiles, GSDMA is cleaved by caspase-1.”

      The black blob is the mollusk Lingula anatina, which unfortunately has an indistinct silhouette. To clarify this, we have added text to label the images in Figure 7.

      Reviewer #2 (Recommendations For The Authors):

      1. Line 214, in "(Fig. 3-S2) Human and mouse ..", it is necessary to type a period.

      2. Line 238, in the subtitle, GSMA should be amended to GSDMA.

      These have both been corrected.

    1. Author Response

      The following is the authors’ response to the original reviews.

      We thank the three reviewers for their positive comments and helpful suggestions. We have addressed the issues raised which have helped to improve the manuscript. Below, we address the specific points with detailed responses.

      Reviewer #1 (Recommendations For The Authors):

      Minor comments

      1) Figure 2 - figure supplement 1. The figure states minimal medium while the legend states rich medium.

      We have corrected the legend as the experiment was done in minimal medium.

      2) Figure 3B - the statements in the text do not seem to match what is in the figure. "Cluster 1 (293 genes, 12 priority unstudied) is enriched for genes showing high expression variability across different conditions (71) and for genes induced during meiotic differentiation (72) and in response to TORC1 inhibitors (29). Cluster 2 (570 genes, 20 priority unstudied) is enriched for phenotypes related to cell mating and sporulation, e.g. 'incomplete cell-wall disassembly at cell fusion site' or 'abnormal shmoo morphology'". These terms (high expression variability, meiotic differentiation, TORC1 inhibitors, cell mating and sporulation/abnormal shmoo morphology" are not seen in the figure.

      As stated in the Results, we have carried out analyses with both Metascape and AnGeLi for functional enrichments in different GO and KEGG pathway terms (Figure 3B; Metascape) and/or among genes from published expression or phenotyping studies (AnGeLi). The enrichments for expression variability, meiotic differentiation, TORC1 inhibitors, and cell mating/sporulation/abnormal shmoo morphology are not based on GO terms but on lists from published expression and phenotyping experiments. We have slightly edited the sentence in the Results to make this clearer.

      3) The authors could consider citing a systematic screen for sporulation in the introduction (PMID: 292590

      We have cited 17 papers for growth screens under different conditions using similar approaches as used by us. Given that we already cite 100 papers, we did not choose to cite numerous other papers reporting screens for more complex phenotypes (cell morphology, mating, meiosis, recombination, etc), which are not directly relevant to our study here.

      Reference PMID: 292590 refers to a 1979 paper in the German Dentist Journal.

      Reviewer #2 (Recommendations For The Authors):

      General comments

      1) The authors use their NET-FF approach to predict GO Biological Process and Molecular Function terms (Figure 4). Why was the Cellular Component ontology not included? In general, gene and protein functional characterization is best described by the Biological Process and Cellular Component ontologies, whereas Molecular Function describes the biochemical activity of a protein. In other words, proteins which share Biological Process and/or Cellular Component annotations often function in the same module, which may not be the case for shared Molecular Function annotations.

      We did not include Cellular Component because in previous benchmarking of our method using CAFA datasets our approach did not perform well at predicting Cellular Component. This aspect is harder to pick up from homology data and protein network data and is generally the toughest challenge in CAFA. In contrast, our predictions of Biological Process and Molecular Function are competitive with other methods. We have now made the reason for omitting Cellular Component clearer in the Methods.

      2) The authors use protein embeddings produced by integrating 6 STRING networks using the deepNF method. One of these networks is the "database" network. According to STRING (https://academic.oup.com/nar/article/47/D1/D607/5198476): "The database channel is based on manually curated interaction records assembled by expert curators, at KEGG, Reactome, BioCyc and Gene Ontology, as well as legacy datasets from PID and BioCarta". If one of the input networks contains information from GO, and then embeddings containing this information are used to predict GO annotations, are the authors not then leaking annotations which could improve downstream GO annotation predictions? It would be valuable to demonstrate to what extent the "database" network is contributing by repeating the GO prediction analyses with this network removed.

      We agree and also pointed out this circularity in the manuscript. We used an independent dataset – phenotype data – to benchmark our method, which showed good performance. Note that this study did not aim to develop a completely new method or improve on deepNF and CATH-FunFams but to integrate and exploit their combined power. For that reason, we wanted to keep as many high-quality curated edges in the STRING network as possible. Combining these independent methods brings synergies from their complementary approaches to facilitate interpretation of gene function.

      Minor comments

      1) Ternary encoding was used as a preprocessing step on the phenotype data before clustering was performed. An explanation of why this encoding was necessary (as opposed to a normalization/standardization approach) would be helpful.

      Ternary encoding was not strictly necessary but provided more nuanced and coherent clusters. Some conditions and mutants were associated with much larger phenotypic responses which disproportionately influenced the clustering. After trying different approaches, we followed the recommendations from the R package microbialPhenotypes (https://github.com/peterwu19881230/microbialPhenotypes), which is now specified in the legend of Fig. 3A. Discretizing the data also helped to compare phenotypes across different types of mutants, and we have applied this approach previously in our phenomics study of non-coding RNA mutants (Rodriguez-Lopez et al. eLife 2022). Moreover, this approach allowed us to generate vectors of phenotypes for calculating phenotypic distances between mutants (including hamming distance or Pearson correlations), which supported the posterior cluster analysis using Cytoscape.

      2) The authors use a validation set to perform early-stopping on the deepNF model. However, it appears that the validation set proteins are then used in downstream analyses anyway: "After training, weights from the epoch with the lowest validation loss were used to generate embeddings for all proteins" (my emphasis). In the case where the model was being used to generalize to new proteins (such as classification), this analysis would not be a valid way to perform hyperparameter tuning (e.g. early-stopping) since the validation set is then used in downstream analyses. However, deepNF is performing an unsupervised, multi- network encoding on all the available datapoints (proteins). In the case where only deepNF loss is being used to tune the hyperparameters, it's not necessary to use a held-out validation set - it is appropriate to use the full set of proteins to do this.

      Our Random Forest consisted of 500 trees with default values for the number of sub- features as √n and partial sampling of 0.7. GO terms were predicted using 5-fold cross- validation. Changing parameters showed that our model was robust to the values of the hyperparameters, so we settled on our initial model.

      3) The NET-FF hyperparameter tuning results should be made available in the supplement.

      We do not think this would be useful for the reason described in the reply above.

      Reviewer #3 (Recommendations For The Authors):

      Major points

      1) Why were the quantitive colony size data converted to -1, 0, and 1?

      It is unclear to me why the authors decided to convert the colony size data to ternary encoding of -1, 0, and 1. The original colony size data seem to be of fairly high precision so that the authors can detect a 5% difference from the wild type. I guess the authors must have tried using the quantitive colony size data for clustering analysis and found the results unsatisfactory. If that is the case, can the authors provide some possible explanations?

      A similar query has been raised by Reviewer 2. Ternary encoding provided more nuanced and coherent clusters. Some conditions and mutants were associated with much larger phenotypic responses which disproportionately influenced the clustering. After trying different approaches, we followed the recommendations from the R package microbialPhenotypes, as now specified in the legend of Fig. 3A. Discretizing the data also helped to compare phenotypes across different types of mutants, and we have applied this approach previously in our phenomics study of non-coding RNA mutants (Rodriguez-Lopez et al. eLife 2022). Moreover, this approach allowed us to generate vectors of phenotypes for calculating phenotypic distances between mutants (including hamming distance or Pearson correlations), which supported the posterior cluster analysis using Cytoscape.

      2) What do 5% difference and 10% difference look like?

      The authors used 5% difference and 10% difference as cutoffs. I am curious whether a 5% difference in colony size is obvious to human eyes. Can the authors show some plate images and label colonies that differ from the wild type by about 5% and 10%? It will help readers understand the thresholds used for determining whether a mutant has a phenotype.

      Showing the original ‘raw’ colonies would not be meaningful because all colony sizes have been grid-corrected as described (Kamrad et al. eLife 2020). The grid correction takes care of three issues: (1) it converts colony size into an easily interpretable value by reporting a ratio relative to wild type; (2) it makes results comparable across different plates/batches; and (3) it corrects for within-plate positional effects which become apparent due to the same wild-type grid strain showing different fitness in different plate positions. But in principle, detecting a 5% difference in colony size by eye would be hard, and multiple measurements are required (>10 repeats) to obtain statistically reliable results. Author response image 1 shows the grid colonies in red frames and numbers at bottom right of colonies indicate the corrected effect sizes. Colony 17-8 (top right) is an example of a colony differing by 5% compared to neighbouring colonies 16-8 and 17-9.

      Author response image 1.

      3) How were the phenotyping conditions chosen?

      I am sure that the authors have put a lot of thoughts into designing the 131 phenotyping conditions. It will benefit the readers if the authors can explain how these conditions were chosen. For example, what literature precedents were considered and which conditions have never been examined before in S. pombe research? For drug treatment conditions, were pilot tests done to choose drug doses based on the growth inhibition effects on the wild type?

      We have used a wide range of different types of conditions that affect diverse processes (see colour legend on top of Fig. 3A). This was based on our previous experience and selection of conditions in large-scale phenotyping of wild strains (Jeffares et al. Nature Genetics 2015) and non-coding RNA mutants (Rodriguez-Lopez et al. eLife 2022). For previously applied conditions (e.g. oxidants), we used literature precedents for the doses, while for other conditions, we used trial and error to adjust the diose such that wild-type cell growth is barely inhibited. For some drugs and stresses, we assayed both low and high doses, in which wild-type cell growth is normal or inhibited, respectively, to uncover both sensitive or resistant mutants.

      Minor points

      1) One of the growth condition is "YES_ethanol_1percent_no_glucose". I am curious how this is possible, as S. pombe cannot use ethanol as a carbon source.

      We assume that the cells contain sufficient internal glucose to fuel growth and division for a few cycles before running out of glucose. Thus, cells showed some residual growth on this medium, but growth is indeed very limited. Nevertheless, we could identify both sensitive and resistant mutants in this condition.

      2) Abstract "over 900 new proteins affected the resistance to oxidative stress". This sentence should be rephrased. Perhaps it is better to say "over 900 proteins were newly implicated in the resistance to oxidative stress".

      Yes, we have edited the sentence as suggested.

      3) Page 4 "S. pombe encodes 641 'unknown' genes (PomBase, status March 2023). " "Among these 643 unknown proteins, many are apparently found only in the fission yeast clade, but 380 are more widely conserved. " Which number is correct, 641 or 643?

      These numbers keep changing slightly. We now consistently use 641, the number from March 2023.

      4) Page 4 "These priority unstudied proteins have not been directly studied in any organism but can be assumed to have pertinent biological roles conserved over 500 million years of evolution. " According to http://timetree.org/, S. pombe and H. sapiens diverged about 1275 million years ago.

      We have now changed ‘over 500 million’ to ‘over 1000 million’, although there are of course different estimates for these times.

      5) "Using these potent wet and dry methods, we obtained 103,520 quantitative phenotype datapoints for 3,492 non-essential genes across 131 diverse conditions."

      I think "quantitative phenotype datapoints" are generated using wet methods, not dry methods. Yes, we have now deleted ‘Using these potent wet and dry methods,’ and start the sentence with ‘We obtained…’

      6) Abstract "We assayed colony-growth phenotypes to measure the fitness of deletion mutants for all 3509 non-essential genes"

      Page 6 "We performed colony-based phenotyping of the deletion mutants for all non- essential S. pombe genes"

      It is not clear to me how the authors can claim that the 3509 non-essential genes correspond to "all non-essential S. pombe genes". The authors should explain how they classify S. pombe genes into essential genes and non-essential genes. The deletion project papers (Kim et al. 2010 and Hayles et al. 2013) provided binary classification for most but not all genes, as there are genes whose deletion mutants were not generated by the deletion project. PomBase does not use a binary classification and there are a number of genes deemed "Gene Deletion Viability: Depends on conditions" by PomBase.

      We used the latest deletion library (Bioneer Version 5) as well as additional deletion mutants published by Kathy Gould and colleagues, which together should capture all non- essential genes. But we agree that non-essentiality is not that clear-cut and context- dependent. So we have deleted ‘all’ in the two sentences highlighted above.

      7) Page 20 "Other clusters contained mostly genes involved in vacuolar/endosomal transport and peroxisome function, along with poorly characterized genes (Figure 6B)."

      This sentence needs rephrasing. Perhaps it is better to say "Cluster 31 and cluster 22 contained respectively mostly genes involved in vacuolar/endosomal transport and peroxisome function, along with poorly characterized genes (Figure 6B)."

      We have edited this sentence to ‘Cluster 31 and Cluster 22 contained mostly genes involved in vacuolar/endosomal transport and peroxisome function, respectively, along with poorly characterized genes (Figure 6B).’

      8) Legend of Figure 2-figure supplement 1A

      "Left: Volcano plot of mutant colony sizes for priority unstudied genes (green) and all other genes (grey) growing in rich medium. " I think "rich medium" should be "minimal medium".

      Yes, we have now corrected this.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this manuscript, the role of orexin receptors in dopamine neurons is studied. Considering the importance of both orexin and dopamine signalling in the brain, with critical roles in arousal and drug seeking, this study is important to understand the anatomical and functional interaction between these two neuromodulators. This work suggests that such interaction is direct and occurs at the level of SN and VTA, via the expression of OX1R-type orexin receptors by dopaminergic neurons.

      Strengths:

      The use of a transgenic line that lacks OX1R in dopamine-transporter-expressing neurons is a strong approach to dissecting the direct role of orexin in modulating dopamine signalling in the brain. The battery of behavioural assays to study this line provides a valuable source of information for researchers interested in the role of orexin-A in animal physiology.

      We thank the reviewer for summarizing the importance and significance of our study. 

      Weaknesses:

      The choice of methods to demonstrate the role of orexin in the activation of dopamine neurons is not justified and the quantification methods are not described with enough detail. The representation of results can be dramatically improved and the data can be statistically analysed with more appropriate methods.

      We have further improved our description of the methods in the revised reviewed preprint, and here in the response letter, we respond point-by-point to ‘Reviewer #1 (Recommendations For The Authors)’ below. 

      Reviewer #2 (Public Review):

      Summary:

      This manuscript examines the expression of orexin receptors in the midbrain - with a focus on dopamine neurons - and uses several fairly sophisticated manipulation techniques to explore the role of this peptide neurotransmitter in reward-related behaviors. Specifically, in situ hybridization is used to show that dopamine neurons predominantly express the orexin receptor 1 subtype and then go on to delete this receptor in dopamine neurons using a transgenic strategy. Ex vivo calcium imaging of midbrain neurons is used to show that in the absence of this receptor orexin is no longer able to excite dopamine neurons of the substantia nigra.

      The authors proceed to use this same model to study the effect of orexin receptor 1 deletion on a series of behavioral tests, namely, novelty-induced locomotion and exploration, anxiety-related behavior, preference for sweet solutions, cocaine-induced conditioned place preference, and energy metabolism. Of these, the most consistent effects are seen in the tests of novelty-induced locomotion and exploration in which the mice with orexin 1 receptor deletion are observed to show greater levels of exploration, relative to wild-type, when placed in a novel environment, an effect that is augmented after icv administration of orexin.

      In the final part of the paper, the authors use PET imaging to compare brain-wide activity patterns in the mutant mice compared to wildtype. They find differences in several areas both under control conditions (i.e., after injection of saline) as well as after injection of orexin. They focus on changes in the dorsal bed nucleus of stria terminalis (dBNST) and the lateral paragigantocellular nucleus (LPGi) and perform analysis of the dopaminergic projections to these areas. They provide anatomical evidence that these regions are innervated by dopamine fibers from the midbrain, are activated by orexin in control, but not mutant mice, and that dopamine receptors are present. Thus, they argue these anatomical data support the hypothesis that behavioral effects of orexin receptor 1 deletion in dopamine neurons are due to changes in dopamine signaling in these areas.

      Strengths:

      Understanding how orexin interacts with the dopamine system is an important question and this paper contains several novel findings along these lines. Specifically:

      (1) The distribution of orexin receptor subtypes in VTA and SN is explored thoroughly.

      (2) Use of the genetic model that knocks out a specific orexin receptor subtype from only dopamine neurons is a useful model and helps to narrow down the behavioral significance of this interaction.

      (3) PET studies showing how central administration of orexin evokes dopamine release across the brain is intriguing, especially since two key areas are pursued - BNST and LPGi - where the dopamine projection is not as well described/understood.

      We thank the reviewer for the careful summary and highlighting the novelty of our study.

      Weaknesses:

      The role of the orexin-dopamine interaction is not explored in enough detail. The manuscript presents several related findings, but the combination of anatomy and manipulation studies does not quite tell a cogent story. Ideally, one would like to see the authors focus on a specific behavioral parameter and show that one of their final target areas (dBNST or LPGi) was responsible or at least correlated with this behavioral readout. In addition, some more discussion on what the results tell us about orexin signaling to dopamine neurons under normal physiological conditions would be very useful. For example, what is the relevance of the orexin-dopamine interaction blunting noveltyinduced locomotion under wildtype conditions?

      We agree that focusing on some orexin-dopamine targeting areas, such as dBNST or LPGi, is important to further reveal the anatomy-behavior links and underlying mechanisms. While we are very interested in further investigations, in the present manuscript we mainly aim to give an overview of the behavioral roles of orexin-dopamine interaction and to propose some promising downstream pathways in a relatively broad and systematical way. 

      We have explained the physiological meanings of our results in more detail in the discussion in the revised reviewed preprint (lines 282-293, 318-332, ). Novelty-induced behavioral response should be at proper levels under normal physiological conditions. The orexin-dopamine interaction blunting novelty-induced locomotion could be important to keep attention on the main task without being distracted too much by other random stimuli in the environment. When this balance is disrupted, behavioral deficit may happen, such as attention deficit and hyperactivity disorder (ADHD).  

      In some places in the Results, insufficient explanation and reporting is provided. For example, when reporting the behavioral effects of the Ox1 deletion in two bottle preference, it is stated that "[mutant] mice showed significant changes..." without stating the direction in which preference was affected.

      For the reward-related behaviors described in this study, we did not find significant changes between [mutant] and control mice. We agree that it will be helpful for readers by describing the behavioral tests in more details. In the revised reviewed preprint, we have described in more detail in the results and Materials and Methods section how the control and [mutant] mice behave to the reward (lines 162-165, 171-181, 526-528).  

      The cocaine CPP results are difficult to interpret because it is unclear whether any of the control mice developed a CPP preference. Therefore, it is difficult to conclude that the knockout animals were unaffected by drug reward learning. Similarly, the sucrose/sucralose preference scores are also difficult to interpret because no test of preference vs. water is performed (although the data appear to show that there is a preference at least at higher concentrations, it has not been tested).

      We described the CPP analysis in the Materials and Methods section (lines 523-528 ) as below: ‘The percentage of time spent in the reward-paired compartment was calculated: 100 x time spent in the compartment / (total time - time spent in the middle area). The CPP score was then analyzed using the calculated percentage of time: 100 x (time on the test day – time on pre-test days)/ time on pre-test days. The pre-test and test days were before and after the conditioning, respectively. Thus, the CPP score above zero indicates that the CPP preference has developed.’ In Figure 2—figure supplement 4 C and F, it was shown that most control and knockout mice had a CPP score above zero. The control and knockout groups both developed a preference and there was no significant difference between the groups. 

      For the sucrose/sucralose preference tests, in Figure 2—figure supplement 4 A and D, we present values as the percentages of sucrose/sucralose consumption in total daily drinking amount (sucrose/sucralose solution + water). Thus, percentages above 50% indicates mice prefer sucrose/sucralose to water. As shown in the figure, male mice only showed weak preference of 0.5% sucrose, compared to water, and under all other tested conditions, the mice showed strong preference of the sweet solution. There was no significant difference between control and knockout mice. 

      We have described this in more details in the Results and Materials and Methods section in the revised reviewed preprint. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) Figure 1, A-I. It is difficult to depict the anatomical subdivision of VTA in Figure 1, panels A and B. It is recommended to add a panel showing a schematic illustration of the SNc and subregions of VTA: PN, PIF, PBP, IF (providing more detail than in Figure 1, panel J). It is also recommended to show lower magnification images (as in Figure 1 - supplement 1), including both hemispheres, and to delineate the outline of the different subregions using curved lines, based on reference atlases (similar to Figure 1, panel I, please include distance from bregma). It would be helpful to indicate in Figure 1 that panel A is a control mouse and panel B is a Ox1RΔDAT mouse and include C-F letters to show corresponding insets. Anatomically, the paraintrafasicular nucleus (PIF) is positioned between the paranigral nucleus (PN) and the parabrachial pigmented nucleus (PBP). The authors have depicted the PIF ventral to the PN in Figure 1 panels A, B, and I. These panels and the quantification of Ox1R/2R positive cells within the different subdivisions need to be corrected accordingly. The image analysis method used to quantify RNAscope fluorescent images is not described in sufficient detail. Please expand this section.

      According to the reviewer’s suggestions, we have refined Figure 1 in the revised reviewed preprint. We are now showing the schematic illustration of the SN and subregions of VTA in panel I, with blue squares to label the regions shown in panels A and B, and the distance from bregma is included. The outlines to delineate SN and the subregions of VTA are adjusted from straight to curved lines based on reference atlases. As suggested, we have also indicated panel A is a control and panel B is a Ox1RΔDAT mouse and included C-F letters to show corresponding insets. We apologize for the mistake about labeling PIF and PN positions in Figure A. We have corrected the labeling of their positions and double checked the quantification accordingly. This does not change our discussion or conclusion since both PIF and PN are the medial part of VTA, where both Ox1R and Ox2R are observed. The description of the image analysis in Matierials and Methods section has been improved (lines 378-385). We decided not to show lower magnification images than in Figure 1—supplement 1 to include both hemispheres, in the interests of clarity and reader-friendliness.  

      (2) Figure 1, J-L. The claim that orexin activates dopaminergic SN and VTA neurons is weakly supported by the data provided. Calcium imaging of SN dopaminergic neurons in control mice suggests a discrete effect of 100 nM orexin-A application compared to baseline. Application of 300 nM shows a slightly bigger effect, but none of these results are statistically analysed. 

      We are surprised by this comment and thank the reviewer for pointing out our apparent lack of clarity in the previous version (lines 96-106 and legend of Figure 1K, L). In more detail, we explain the data analysis in the new version (lines 119-133, 451-465) and the legend of Figure 1K, L and Figure 1-figure supplement 3).

      The main goal of this part of the project was to functionally validate the Ox1R knockout in dopaminergic (DAT-expressing) neurons. This was a prerequisite for the behavioral and PET imaging experiments. We used GCaMP-mediated Ca2+ imaging in acute brain slices to reach this goal. This analysis was performed on the dopaminergic SN neurons, which we used as an "indicator population" because a large number of these neurons express Ox1R, but only a few express Ox2R. 

      The analysis consisted of two parts:

      a) For each neuron, we tested whether it responded to orexin A. At the single cell level, a neuron was considered orexin A-responsive if the change in fluorescence induced by orexin A was three times larger than the standard deviation (3 σ criterion) of the baseline fluorescence, corresponding to a Zscore of 3. We found that 56% of the neurons tested responded to orexin A, while 44% of the neurons did not respond to orexin A (Figure 1L, top). These data agree with the number of Ox1R-expressing neurons (Figure 1J). 

      b) We also determined the orexin A-induced GCaMP fluorescence for each neuron, expressed as a percentage of GCaMP fluorescence induced upon application of high K+ saline. Accordingly, the "population response" of all analyzed neurons was expressed as the mean ± SEM of these responses. The significance of this mean response was tested for each group (control and Ox1R KO) using a onesample t-test. We found a marked and highly significant (p < 0.0001, n = 71) response of control neurons to 100 nM orexin A, while the Ox1R KO neurons did not respond (p = 0.5, n = 86). Note that, as described in a), 44% of the neurons contributing to the mean do not respond to orexin. Thus, the orexin responses of most responders are significantly higher than the mean. This is also evident in the example recordings in Figure 1K and Figure1—figure supplement 3. The orexin A-induced change in fluorescence was increased by increasing the orexin A concentration to 300 nM.

      Note: As mentioned above, the orexin A response was expressed for each neuron individually as a percentage of its high K+saline-induced GCaMP fluorescence. This value is a solid reference point, reflecting the GCaMP fluorescence at maximal voltage-activated Ca2+ influx. Obviously, the Ca2+ concentration at this point is extremely high and not typically reached under physiological conditions. Therefore, as shown in Figure1—figure supplement 3 for completeness, the physiologically relevant responses may appear relatively minor at first glance when presented together in one figure (compare Figure1—figure supplement 3 A and B).

      The authors should provide more evidence of the orexin-induced activation of dopaminergic neurons in the SN to support this claim and investigate whether a similar activation is observed in VTA neurons. 

      Following the reviewer's suggestion, we confirmed orexin A-induced activation of dopaminergic neurons in the mouse SN by using perforated patch clamp recordings (Figure1—figure supplement 2).

      This finding is consistent with previous extracellular in vivo recordings in rats (Liu et al., 2018).

      The activation of dopaminergic neurons in the mouse VTA by orexin A has been shown repeatedly in earlier studies (e.g., Baimel et al., 2017; Korotkova et al., 2003; Tung et al., 2016).

      In addition, Figure 3-Figure Supplement 2 shows that injection of orexin does not induce c-Fos expression in SN and VTA dopaminergic neurons of control and Ox1RΔDAT mice, which further weakens the claim made by the authors.

      Figure 3—Figure Supplement 2 in the original submission is now Figure 3—Figure Supplement 3 in the revised reviewed preprint. It shows low c-Fos expression in SN and VTA dopaminergic neurons, and orexin-induced c-Fos expression was observed in Th-negative cells in SN and VTA. 

      Technically relatively straightforward, Fos analysis is widely (and successfully) used in studies to reveal neuronal activation. However, this approach has limitations, e.g., regarding sensitivity and temporal resolution. Electrophysiological or optical imaging techniques can circumvent these shortcomings. The electrophysiological and Ca2+ imaging studies presented here, along with previous electrophysiological studies by others, clearly show that orexin A acutely and directly stimulates SN and VTA dopaminergic neurons.

      In vivo, the injection of orexin A induced a pronounced c-Fos activity in non-dopaminergic cells of the VTA and SN but not in dopaminergic neurons. This result shows that the detection of c-Fos has worked in principle. Whether the absent c-Fos staining in dopaminergic neurons is due to lack of sensitivity, whether other IEGs would have worked better here, or whether there are other, e.g., cell type-specific reasons for the absence of staining, cannot be determined from the current data.

      (3) Figure 2, I-L. The fact that ICV injection of both saline and orexin causes a sustained increase of locomotion (around 20 minutes in males, and over 30 minutes in females) is problematic and could mask the effects of orexin, particularly in females. It is unclear what panels J and L are showing. To be appropriately analysed, the authors should plot the pre- and post-injection AUC data for all groups and analyse it as a two-way mixed ANOVA, with the within-subjects factor "pre/post injection activity" and between-subjects factor "group". The authors can only warrant a statistically meaningful hyperlocomotor effect in Ox1RΔDAT mice if a significant interaction is found.

      Though mice were habituated to the injection, it still makes sense to see the injection-induced increase in locomotion to some extent. We described in the figure legend that the AUC was calculated for the period after orexin injection, which meant 5 – 90 min in Figure 2 I, K. We have clearly observed significant differences between genotypes and between saline and orexin application, which means the genotype and orexin impact is strong enough to pop up despite of the injection effect. 

      As the reviewer’s suggests, we have now plotted the pre- and post-injection AUC data for all groups and analyzed it as a two-way mixed ANOVA, with the within-subjects factor "pre/post injection activity" and between-subjects factor "group". To match the pre- and post-injection duration, we are now comparing AUC for around 60 min before and after the injection. A significant interaction is found here. Panels I-L are renewed, and the differences induced by Ox1R knockout and orexin confirmed the results shown in the initially submitted manuscript.  

      (4) Figure 3. The literature has robustly shown that one of the main projection areas of VTA and SN dopaminergic neurons is the striatum, in particular its ventral part. It is surprising to see that this region is not affected by the lack of OX1R or by the injection of orexin. How can the authors explain that identified regions with significantly different activity include neighbouring brain structures with heterogenous composition? See for example, in panel A, section bregma 0.62mm, a significant region is seen expanding across the cortex, corpus callosum, and striatum. While the data from PET studies is potentially interesting, it may not be adequate to provide enough resolution to allow examination of the anatomical distribution of orexin-mediated neuronal activation.

      While the striatum is a major projection area of dopaminergic neurons in VTA and SN, the projection and function of Ox1R-positive dopaminergic neurons is not clear. We have improved the description of dopamine function diversity in the revised reviewed preprint (lines 46-58), and it was reported before that the projection-defined dopaminergic populations in the VTA exhibited different responses to orexin A (Baimel et al., 2017). Moreover, the striatum activity is modulated by the indirect effect via other brain regions affected by Ox1R-positive dopaminergic neurons. It is unknown how the striatum activity should change after Ox1R deletion in dopaminergic neurons. We could not rule out the possibility that the striatum is indeed modulated by the Ox1R-positive dopaminergic neurons, though there was only a trend of genotype difference (Ox1RΔDAT vs. ctrl) in the ventral striatum in the section bregma 1.42 mm in Figure 3A. The ICV injection of orexin is potentially acting on Ox1R and Ox2R in the whole brain, so projections from other brain regions to the striatum also affect striatum activity and could have masked the effect of Ox1R-positive dopaminergic neurons. 

      The spatial resolution of the PET data is in the order of ~1 mm^3. As we also explained in the Materials and Methods section, the size of a voxel in the original PET data is 0.4mm x 0.4mm x 0.8 mm. All calculations were performed on this grid. The higher-resolved images shown in Figure 3 are for presentation purposes only inspired by a request of the reviewer who asked us to show this in the Jais et al. 2016 manuscript. To make this clearer we now added the p-map images with the original voxel size to the supplement (Figure 3—figure supplement 1). For the interest in specific brain areas, more precise identification of anatomical sub-regions requires using methods with higher spatial resolution such as staining of brain slices for c-Fos-positive cells as we do in Figure 4.

      PET is a powerful tool to identify global regions of activation/inhibition. In the manuscript, we have described in the results and discussion section that the activity in brain regions with related functions were changed. In panel A, Ox1RΔDAT showed activity increase in MPA, Pir and endopiriform claustrum, which are important for olfactory sensation; spinal trigeminal nucleus, sp5, and IRt, which regulates mastication and sensation of the oral cavity and the surface of the face; SubCV and Gi, which regulates sleeping and motion-related arousal and motivation. In panel B, changes in HDB, MCPO, Pir, DEn, S1, V2L and V1 are related to sensation, and changes in BNST, LPGi and M2 are important for emotion, exploration, and action selection. 

      (5) Figure 4. As in Figure 1, the authors should consider including a schematic illustration of the brain areas that are being analysed using a reference atlas. It is also recommended to provide more details describing the quantification of the images. Without such information, the data is not convincing, in particular, the claim that Ox1R depletion causes a decrease in DRD1 in BNST is unclear. Additional unbiased quantitative approaches could be used to strengthen this point.

      We have added Figure 4—figure supplement 1 as a schematic illustration of the brain areas that were being analyzed using a reference atlas. More details describing the unbiased quantification of the images have been added to Materials and Methods. We have added Figure 4—figure supplement 3, to show DRD1, DRD2 and the merged signal separately.  

      (6) The discussion starts by stating that the main findings of this study are based on RNAscope and optophysiological experiments, however, the latter are not presented anywhere in the manuscript. This sentence (line 192) should be revised. The authors state in line 193 that OX1R is the only orexin receptor in the SN, but they show in Figure 1 that in the SN, 3% of neurons express OX2R and 2% co-express both receptors. 

      We thank the reviewer for the input. We have rephrased the beginning of the discussion to clarify the objectives (lines 238 - 246). In doing so, we changed "optophysiological experiments" and "single orexin receptor" (lines 192 and 193 in the original manuscript) to " Ca2+ imaging experiments" and "main subtype of orexin receptors ", respectively. In this context, it should be noted that Ca2+ imaging is considered an optophysiological method - optophysiology generally refers to techniques that combine optical methods with physiological measurements.

      The results of LPGi and BNST dopamine receptors in control and Ox1RΔDAT mice are poorly discussed. The authors should justify why these two regions were selected for further validation and how these may be related to the behavioural effects found in Ox1RΔDAT regarding exposure to a novel context.

      Ox1RΔDAT mice exhibited increased novelty- and orexin-induced locomotion compared to control mice. After orexin injection, PET imaging shows that the neural activity of BNST and LPGi was lower or higher than in control mice, respectively. We selected BNST and LPGi for further validation because we think their key functional roles in regulating emotion, exploratory behaviors and locomotor speed are related to novelty-induced locomotion. We confirmed changes in neural activity change by c-Fos staining and investigated the expression patterns of dopamine receptors in BNST and LPGi. Our findings suggested that Ox1R deletion in dopaminergic neurons results in the disinhibition of neural activity in LPGi via dopaminergic pathways and the decrease of dopamine-mediated neural activity in BNST. Emotion perception affects the decision of how to respond to the novelty. It is possible that novelty activates the orexin system and Ox1R signaling in dopaminergic neurons promotes emotion perception and inhibits exploration. Of course, further careful investigation is necessary to test this hypothesis in the future experiments. We have improved the rational description and discussion in the

      ‘Results’ and ‘Discussion’ section in the revised reviewed preprint (lines 210-213, 259-270, 293-308). 

      Reviewer #2 (Recommendations For The Authors):

      A major recommendation - if possible - would be to directly show that one or both of the two target areas - dBNST and LPGi - are associated with the behavioral effects caused by the deletion of the orexin receptor 1 in dopamine neurons.

      We completely agree that it would be very valuable to directly show dBNST and LPGi are associated with the behavioral effects caused by the deletion of Ox1R in dopaminergic neurons. While we are very interested in carefully investigating specific orexin-dopamine targeting areas and related neural circuits in the future, in the present manuscript, we mainly aim to give an overview of the behavioral roles of orexin-dopamine interaction and propose some promising downstream pathways. 

      The authors should state if data are corrected for multiple comparisons, e.g., in the PET study of different regions.

      We have included information about the post-hoc tests for all 2-way ANOVA analyses in the submitted manuscript. For the PET study, the p-values in the p-maps were not corrected for multiple comparison, Figure 3—figure supplement 2 shows the raw data of each mouse and the analysis method (t-test). In the revised reviewed preprint, we include the information on the analysis method in the figure legends of Figure 3. 

      We consider that saline and orexin injections mimic the resting and active state of mice, respectively, and would like to study genotype effect under each condition. Doing 2-way ANOVA takes in count the difference between orexin and saline injection, which could mask the genotype effect under a certain condition. Therefore, we decided to perform t-tests for each condition in Figure 3. While we provide readers with full information in Figure 3—figure supplement 2 with the raw data of each individual mouse, below we present the p-maps after multiple comparisons (Sidak’s post hoc test). After multiple comparisons, we could see changes in similar brain regions as in Figure 3, though significant values are reduced by the correction for multiple comparisons, and under orexin-injection condition, we fail to see significantly higher activity around the lateral paragigantocellular nucleus (LPGi), nucleus of the horizontal limb of the diagonal band (HDB) and magnocellular preoptic nucleus (MCPO) in Ox1RΔDAT mice. In order to more precisely identify the anatomical locations, we performed additional experiments to confirm the changes revealed by PET. For example, LPGi is a relatively small region confirmed and identified more precisely by c-Fos immunostaining (Figure 4A, C). 

      Author response image 1.

      PET imaging studies comparing Ox1RΔDAT and control mice, with post-hoc t-test to correct for multiple comparisons. 3D maps of p-values in PET imaging studies comparing Ox1RΔDAT and control mice, after intracerebroventricular (ICV) injection of (A) saline (NS) and (B) orexin A. Control-NS, n = 8; control-orexin, n = 6; Ox1RΔDAT, n = 8. M2, secondary motor cortex; MPA, medial preoptic area; Pir, piriform cortex; IEn, intermediate endopiriform claustrum; DEn, dorsal endopiriform claustrum; VEn, ventral endopiriform claustrum; LSS, lateral stripe of the striatum; BNST, the dorsal bed nucleus of the stria terminalis; S1Sh, primary somatosensory cortex, shoulder region; S1HL, primary somatosensory cortex, hindlimb region; S1BF, primary somatosensory cortex, barrel field; S1Tr, primary somatosensory cortex, trunk region; V1, primary visual cortex; V2L, secondary visual cortex, lateral area; SubCV, subcoeruleus nucleus, ventral part; Gi, gigantocellular reticular nucleus; IRt, intermediate reticular nucleus; sp5, spinal trigeminal tract.

      Provide a rationale for following up on BNST and LPGi and not any of the regions identified in the PET study.

      We thank the reviewer for the careful reading and important input. Ox1RΔDAT mice exhibited increased novelty- and orexin-induced locomotion compared to control mice. After orexin injection, PET imaging shows that the neural activity of BNST and LPGi was lower or higher than control mice, respectively.

      We selected BNST and LPGi for further validation because we think their key functional roles in regulating emotion, exploratory behaviors and locomotor speed are related to novelty-induced locomotion. We confirmed the neural activity change by c-Fos staining and investigated the expression patterns of dopamine receptors in BNST and LPGi. Our findings suggested that Ox1R deletion in dopaminergic neurons results in the disinhibition of neural activity in LPGi via dopaminergic pathways and the decrease of dopamine-mediated neural activity in BNST. Emotion perception affects the decision how to respond to the novelty. It is possible that novelty activates the orexin system and Ox1R signaling in dopaminergic neurons promotes emotion perception and inhibits exploration. Of course, further investigation is necessary to test this hypothesis in future. We have improved the rational description and discussion in the ‘Results’ and ‘Discussion’ section in the revised reviewed preprint (lines 210-213, 259-270, 293-308). 

      Heatmap in Fig. 1K should not have smoothing across the y-axis, individual cells should be discrete.

      We thank the reviewer for bringing this issue to our attention. The data had not been intentionally smoothed (neither across the x-axis nor the y-axis), but it was probably a formatting issue. We have corrected this and separated individual cell traces with lines (Figure 1K, Figure 1—figure supplement 3).

      Dopamine cells are well known to lack Fos expression in most cases. Did the authors consider using another IEG to show neural activation, e.g., pERK?

      We did not use another IEG. The electrophysiological and Ca2+ imaging studies presented here, along with previous electrophysiological studies by others, clearly show that orexin A acutely and directly stimulates SN and VTA dopaminergic neurons. Please see also the response to a related comment of Reviewer 1.

      Consider adding a lower magnification section to anatomical figures to aid the reader in orienting and identifying the location.

      We have added the schematic illustration of SN, VTA, BNST and LPGi in Figure 1I and Figure 4— figure supplement 1. We hope this helps the reader in orienting and identifying the location.  

      Data availability should be stated.

      There are no restrictions on data availability. We have added this section to the revised reviewed preprint.

      Line 50. Some more references both historical and recent could be given to support this statement about the function of dopamine.

      We have improved the description and references to support the statement about dopamine function (lines 46-58). We have cited recent studies and some reviews in the revised reviewed preprint (lines 4658). 

      The PET data (Fig. 3) might be easier to visualize and interpret if a white background was used. In addition, is there a more refined way of presenting the data in Fig 3, S1?

      It is common to present imaging data such as PET and MRI on a black background. We also have already applied this color scheme in multiple publications and would therefore prefer to stick to this color scheme. 

      While Figure 3 is the concise way to present PET data, we aim to show the original individual results of mice in Figure 3—figure supplement 2 and to demonstrate how we performed the statistical analysis. Therefore, we take an example voxel of the respective brain area, perform the t-test, and present the data as bars with individual dots. 

      Line 97. State what type of Ca imaging here, e.g., "we performed Ca imaging in ex vivo slices of VTA and SN".

      As the reviewer suggested, we have specified the type of Ca2+ imaging (line 112).

      Line 165. State which groups this post-mortem analysis was performed on and if any differences were to be found (not expected to find differences in this anatomical tracing experiment but good to report this as both groups were used).

      Postmortem analysis of c-Fos staining revealed low c-Fos expression in dopaminergic neurons in the VTA and SN of Ox1RΔDAT and control mice after ICV injection of saline or orexin A (1 nmol). No obvious changes were observed among the groups. We have improved the description in the revised reviewed preprint (lines 202-208).

      Line 192. What do you mean by optophysiological here? The Ca imaging (which is a fairly small, confirmatory element of the manuscript).

      We have changed ‘optophysiological experiments’ (line 192 in initial submitted manuscript) to ‘calcium imaging experiments’ and rephrased the beginning of the discussion to clarify the objectives (lines 238246).

      The protein level in the diet is substantially higher than in most rodent diets (34% here vs 14-20% in most commercial rodent chows). Please comment on this.

      This diet is for rat and mouse maintenance, purchased from ssniff Spezialdiäten GmbH (product V1554).

      The percentage of calories supplied by protein is affected by the calculation methods. The company calculated with pig equation before and the value was 34% in the old instruction data sheet. They have updated the value to 23% in the new data sheet with calculations by Atwater factors. We thank the reviewer for reminding us and have updated the values in the revised reviewed preprint (lines 314-316). 

      Editor's note:

      Should you choose to revise your manuscript, please include full statistical reporting including exact p-values wherever possible alongside the summary statistics (test statistic and df) and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05.

      We have provided the source data and the statistical reporting for each Figure with the revision

      References

      Baimel, C., Lau, B. K., Qiao, M., & Borgland, S. L. (2017). Projection-target-defined effects of orexin and dynorphin on VTA dopamine neurons. Cell Rep, 18(6), 1346-1355.  https://doi.org/10.1016/j.celrep.2017.01.030

      Korotkova, T. M., Eriksson, K. S., Haas, H. L., & Brown, R. E. (2002). Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept, 104(1-3), 83-89. https://doi.org/10.1016/s0167-0115(01)00323-8 

      Korotkova, T. M., Sergeeva, O. A., Eriksson, K. S., Haas, H. L., & Brown, R. E. (2003). Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci, 23(1), 7-11. https://www.ncbi.nlm.nih.gov/pubmed/12514194

      Liu, C., Xue, Y., Liu, M. F., Wang, Y., Liu, Z. R., Diao, H. L., & Chen, L. (2018). Orexins increase the firing activity of nigral dopaminergic neurons and participate in motor control in rats. J Neurochem, 147(3), 380-394. https://doi.org/10.1111/jnc.14568 

      Tung, L. W., Lu, G. L., Lee, Y. H., Yu, L., Lee, H. J., Leishman, E., Bradshaw, H., Hwang, L. L., Hung, M. S., Mackie, K., Zimmer, A., & Chiou, L. C. (2016). Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons. Nat Commun, 7, 12199. https://doi.org/10.1038/ncomms12199

    1. Author response:

      The following is the authors’ response to the original reviews.

      We would like to thank all of the reviewers for their helpful and the effort they made in reading and evaluating our manuscript. In response to them, we have made major changes to the text and figures and performed substantial new experiments. These new data and changes to the text and figures have substantially strengthened the manuscript. We believe that the manuscript is now very strong in both its impact and scope and we hope that reviewers will find it suitable for publication in eLife

      A point-by-point response to the reviewers' specific comments is provided below.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this report, Yu et al ascribe potential tumor suppressive functions to the non-core regions of RAG1/2 recombinases. Using a well-established BCR-ABL oncogene-driven system, the authors model the development of B cell acute lymphoblastic leukemia in mice and found that RAG mutants lacking non-core regions show accelerated leukemogenesis. They further report that the loss of non-core regions of RAG1/2 increases genomic instability, possibly caused by increased off-target recombination of aberrant RAG-induced breaks. The authors conclude that the non-core regions of RAG1 in particular not only increase the fidelity of VDJ recombination, but may also influence the recombination "range" of off-target joints, and that in the absence of the non-core regions, mutant RAG1/2 (termed cRAGs) catalyze high levels of off-target recombination leading to the development of aggressive leukemia.

      Strengths:

      The authors used a genetically defined oncogene-driven model to study the effect of RAG non-core regions on leukemogenesis. The animal studies were well performed and generally included a good number of mice. Therefore, the finding that cRAG expression led to the development of more aggressive BCR-ABL+ leukemia compared to fRAG is solid.

      Weaknesses:

      In general, I find the mechanistic explanation offered by the authors to explain how the non-core regions of RAG1/2 suppress leukemogenesis to be less convincing. My main concern is that cRAG1 and cRAG2 are overexpressed relative to fRAG1/2. This raises the possibility that the observed increased aggressiveness of cRAG tumors compared to fRAG tumors could be solely due to cRAG1/2 overexpression, rather than any intrinsic differences in the activity of cRAG1/2 vs fRAG1/2; and indeed, the authors allude to this possibility in Fig S8, where it was shown that elevated expression of RAG (i.e. fRAG) correlated with decreased survival in pediatric ALL. Although it doesn't mean the authors' assertions are incorrect, this potential caveat should nevertheless be discussed.

      We appreciate the valuable suggestions from the reviewer. BCR-ABL1+ B-ALL is characterized by halted early B-lineage differentiation. In BCR-ABL1+ B cells, RAG recombinases are highly expressed, leading to the inactivation of genes that encode essential transcription factors for B-lineage differentiation. This results in cells being trapped within the precursor compartment, thereby elevating RAG gene expression. Our interpretation of the data suggests that, in BCR-ABL1+ B-ALL mouse models, the high expression of both cRAG and fRAG and the deletion of the non-core regions influence the precision of RAG targeting within the genome. This causes more genomic damage in cRAG tumors than in fRAG tumors, consequently leading to the observed increased aggressiveness of cRAG tumors compared to fRAG tumors. We discussed the issues on Page 12, lines 295-307 in the revised manuscript.

      Some of the conclusions drawn were not supported by the data.

      (1) I'm not sure that the authors can conclude based on μHC expression that there is a loss of pre-BCR checkpoint in cRAG tumors. In fact, Fig. 2B showed that the differences are not statistically significant overall, and more importantly, μHC expression should be detectable in small pre-B cells (CD43-). This is also corroborated by the authors' analysis of VDJ rearrangements, showing that it has occurred at the H chain locus in cRAG cells.

      We appreciate the insightful comment from the reviewer. Upon reevaluation of the data presented in Fig. 2B, we identified and rectified certain errors. The revised analysis now shows that the differences in μHC expression are statistically significant. This significant expression of μHC in fRAG leukemic cells implies that these cells may progress further in differentiation, potentially acquiring an immune phenotype. These modifications have been incorporated into the manuscript on page 7, lines 153-156 in the revised manuscript.

      (2) The authors found a high degree of polyclonal VDJ rearrangements in fRAG tumor cells but a much more limited oligoclonal VDJ repertoire in cRAG tumors. They concluded that this explains why cRAG tumors are more aggressive because BCR-ABL induced leukemia requires secondary oncogenic hits, resulting in the outgrowth of a few dominant clones (Page 19, lines 381-398). I'm not sure this is necessarily a causal relationship since we don't know if the oligoclonality of cRAG tumors is due to selection based on oncogenic potential or if it may actually reflect a more restricted usage of different VDJ gene segments during rearrangement.

      Thank you for your insightful comments and questions regarding the relationship between the oligoclonality of V(D)J rearrangements and the aggressiveness of cRAG tumors. You raise an important point regarding whether the observed oligoclonality is a result of selective pressure favoring clones with specific oncogenic potential, or if it reflects inherent limitations in V(D)J segment usage during rearrangement in cRAG models. In our study, we observed a marked difference in the V(D)J rearrangement patterns between fRAG and cRAG tumor cells, with cRAG tumors exhibiting a more limited, oligoclonal repertoire. This observation led us to speculate that the aggressive nature of cRAG tumors might be linked to a selective advantage conferred by specific V(D)J rearrangements that cooperate with the BCR-ABL1 oncogene to drive leukemogenesis. However, we acknowledge that our current data do not definitively establish a causal relationship between oligoclonality and tumor aggressiveness. The restricted V(D)J repertoire in cRAG tumors could indeed be due to a more constrained rearrangement process, possibly influenced by the altered expression or function of RAG1/2 in the absence of non-core regions. This could limit the diversity of V(D)J rearrangements, leading to the emergence of a few dominant clones not necessarily because they have greater oncogenic potential, but because of a narrowed field of rearrangement possibilities.

      To address this question more thoroughly, future studies could examine the functional consequences of specific V(D)J rearrangements found in dominant cRAG tumor clones. This could include assessing the oncogenic potential of these rearrangements in isolation and in cooperation with BCR-ABL1, as well as exploring the mechanistic basis for the restricted V(D)J repertoire. Such studies would provide deeper insight into the interplay between RAG-mediated recombination, clonal selection, and leukemogenesis in BCR-ABL1+ B-ALL.

      We appreciate your feedback on this matter and agree that further investigation is required to unravel the precise relationship between V(D)J rearrangement diversity and leukemic progression in cRAG models. We have revised our discussion to reflect these considerations and to clarify the speculative nature of our conclusions regarding the link between oligoclonality and tumor aggressiveness. We added more discussion on this issue on Page 7, lines 166-170 in the revised manuscript.

      (3) What constitutes a cancer gene can be highly context- and tissue-dependent. Given that there is no additional information on how any putative cancer gene was disrupted (e.g., truncation of regulatory or coding regions), it is not possible to infer whether increased off-target cRAG activity really directly contributed to the increased aggressiveness of leukemia.

      We totally agree you raised the issues. In Supplementary Table 3, we have presented data on off-target gene disruptions, specifically in introns, exons, downstream regions, promoters, 3' UTRs, and 5' UTRs. However, this dataset alone does not suffice to conclusively determine whether the increased off-target activity of cRAG directly influences the heightened aggressiveness of leukemia. To bridge this knowledge gap, our future research will extend to include both knockout and overexpression experiments targeting these off-target genes.

      (4) Fig. 6A, it seems that it is really the first four nucleotide (CACA) that determines fRAG binding and the first three (CAC) that determine cRAG binding, as opposed to five for fRAG and four for cRAG, as the author wrote (page 24, lines 493-497).

      We thank the reviewer for the insightful comment. In response, we have revised the text to accurately reflect the nucleotide sequences responsible for RAG binding and cleavage. Specifically, we now clarify that the first four nucleotides (CACA) are crucial for fRAG binding and cleavage, while the initial three nucleotides (CAC) are essential for cRAG binding and cleavage. These updates have been made on page 10, lines 242-245 of the revised manuscript.

      (5) Fig S3B, I don't really see why "significant variations in NHEJ" would necessarily equate "aberrant expression of DNA repair pathways in cRAG leukemic cells". This is purely speculative. Since it has been reported previously that alt-EJ/MMEJ can join off target RAG breaks, do the authors detect high levels of microhomology usage at break points in cRAG tumors?

      We appreciate the reviewer's comment. Currently, we have not observed microhomology usage at breakpoints in cRAG tumors. We plan to address this aspect in a future, more detailed study. Regarding the 'aberrant expression of DNA repair pathways in cRAG leukemic cells, we acknowledge that this is speculative. Therefore, we have carefully rephrased this to 'suggesting a potential aberrant expression of DNA repair pathways in cRAG leukemic cells.' This modification is reflected on page 12, lines 290-291 of the revised manuscript.

      (6) Fig. S7, CDKN2B inhibits CDK4/6 activation by cyclin D, but I don't think it has been shown to regulate CDK6 mRNA expression. The increase in CDK6 mRNA likely just reflects a more proliferative tumor but may have nothing to do with CDKN2B deletion in cRAG1 tumors.

      We fully concur with the reviewer's comment. We have deleted this inappropriate part from the text.

      Insufficient details in some figures. For instance, Fig. 1A, please include statistics in the plot showing a comparison of fRAG vs cRAG1, fRAG vs cRAG2, cRAG1 vs cRAG2. As of now, there's a single p-value (0.0425) stated in the main text and the legend but why is there only one p-value when fRAG is compared to cRAG1 or cRAG2? Similarly, the authors wrote "median survival days 11-26, 10-16, 11-21 days, P < 0.0023-0.0299, Fig. S2B." However, it is difficult for me to figure out what are the numbers referring to. For instance, is 11-26 referring to median survival of fRAG inoculated with three different concentrations of GFP+ leukemic cells or is 11-26 referring to median survival of fRAG, cRAG1, cRAG2 inoculated with 10^5 cells? It would be much clearer if the authors can provide the numbers for each pair-wise comparison, if not in the main text, then at least in the figure legend. In Fig. 5A-B, do the plots depict SVs in cRAG tumors or both cRAG and fRAG cells? Also in Fig. 5, why did 24 SVs give rise to 42 breakpoints, and not 48? Doesn't it take 2 breaks to accomplish rearrangement? In Fig. 6B-C, it is not clear how the recombination sizes were calculated. In the examples shown in Fig. 4, only cRAG1 tumors show intra-chromosomal joins (chr 12), while fRAG and cRAG2 tumors show exclusively inter-chromosomal joins.

      We appreciate the reviewer's feedback and have made the following revisions:

      (1) The text has been adjusted to rectify the previously mentioned error in the figure legends (page 1, lines 5-6).

      (2) We have clarified the intended message in the revised text (page 6, lines 129-130) and the figure legend (page 4-5, lines 107-113) for greater precision.

      (3) Figure 5A-B now presents an overview of all structural variants (SVs) identified in both cRAG and fRAG cells, offering a comprehensive comparison.

      (4) Among the analyzed SVs, 24 generated a total of 48 breakpoints, with 41 occurring within gene bodies and the remaining 7 in adjacent flanking sequences. This informs our exon-intron distribution profile analysis.

      (5) We have defined recombination sizes as ‘the DNA fragment size spanning the two breakpoints’ for clarity (page 10, lines 251-252).

      (6) All off-target recombinations identified in the genome-wide analyses of fRAG, cRAG1, and cRAG2 leukemic cells were determined to be intra-chromosomal joins, highlighting their specific nature within the genomic context.

      Insufficient details on certain reagents/methods. For instance, are the cRAG1/2 mice of the same genetic background as fRAG mice (C57BL/6 WT)? On Page 23, line 481, what is a cancer gene? How are they defined? In Fig. 3C, are the FACS plots gated on intact cells? Since apoptotic cells show high levels of gH2AX, I'm surprised that the fraction of gH2AX+ cells is so much lower in fRAG tumors compared to cRAG tumors. The in vitro VDJ assay shown in Fig 3B is not described in the Method section (although it is described in Fig S5b). Fig. 5A-B, do the plots depict SVs in cRAG tumors or both cRAG and fRAG cells?

      We are grateful for the reviewer's feedback and have incorporated their insights as follows:

      (1) We clarify that both cRAG1/2 and fRAG mice share the same genetic background, specifically the C57BL/6 WT strain, ensuring consistency across experimental models.

      (2) We define a 'cancer gene' as one harboring somatic mutations implicated in cancer. To support our analysis, we refer to the Catalogue Of Somatic Mutations In Cancer (COSMIC) at http://cancer.sanger.ac.uk/cosmic. COSMIC serves as the most extensive repository for understanding the role of somatic mutations in human cancers.

      (3) Upon thorough review of the raw data for γ-H2AX and the fluorescence-activated cell sorting (FACS) plots gated on intact cells, we propose that the observed discrepancies might stem from the limited sensitivity of the γ-H2AX flow cytometry detection method. This insight prompts our commitment to employing more efficient detection methodologies in forthcoming studies.

      (4) Detailed procedures for the in vitro V(D)J recombination assay have been included in the Methods section (page 15, lines 384-388) to enhance the manuscript's comprehensiveness and reproducibility.

      (5) The presented plots offer a comprehensive overview of structural variants (SVs) identified in both cRAG and fRAG cells, providing a holistic view of the genomic landscape across different models.

      Reviewer #3 (Public Review):

      Summary:

      In the manuscript, the authors summarized and introduced the correlation between the non-core regions of RAG1 and RAG2 in BCR-ABL1+acute B lymphoblastic leukemia and off-target recombination which has certain innovative and clinical significance.

      Recommendations For The Authors:

      Reviewer #1 (Recommendations For The Authors):

      I would suggest that the authors tone down some of their conclusions, which are not necessarily supported by their own data. in addition, there are some minor mistakes in figure assembly/presentation. For instance, I believe that the axes labels in Fig. 1E were flipped. BrdU should be on y-axis and 7-AAD on the x-axis. Fig. 3B, the y-axis contains a typo, it should be "CD90.1..." and not "D90.1...". In Fig. 5C, the numbers seem to be flipped, with 93% corresponding to cRAG1 and 100% to cRAG2 (compare with the description on page 23, lines 474-475). Fig. 5C, y-axis, "hybrid" is a typo. Page 3, line 59: The abbreviation of RSS has already been described earlier (p4, line 53).

      We thank the reviewer for these suggestions. We carefully checked the raw data and corrected these mistakes in the revised manuscript.

      Page 3, line 63: "signal" segment (commonly referred to as signal ends), not "signaling" segment.

      We have changed “signaling segment” to “signal ends in the revised manuscript. (page 3, lines 54-55)

      Page 3, lines 64-65: VDJ recombination promotes the development of both B and T cells, and aberrant recombination can cause both B and T cell lymphomas.

      The statement about the role of V(D)J recombination in B and T cell development and its link to lymphomagenesis is grounded in a substantial body of research. Theoretical frameworks and empirical studies delineate how aberrations in the recombination process can lead to genomic instability, potentially triggering oncogenic events. This connection is extensively documented in immunology and oncology literature, illustrating the critical balance between necessary genetic rearrangements for immune diversity and the risk of malignancy when these processes are dysregulated (Thomson, et al.,2020; Mendes, et al.,2014; Onozawa and Aplan,2012).

      Page 4, line 72: "recombinant dispensability" is not a commonly used phrase. Do the authors mean the say that the non-core regions of RAG1/2 are not strictly required for VDJ recombination?

      We thank the reviewers for their insightful suggestion. We have revised the sentence to read, 'Although the non-core regions of RAG1/2 are not essential for V(D)J recombination, the evolutionary conservation of these regions suggests their potential significance in vivo, possibly affecting RAG activity and expression in both quantitative and qualitative manners.' This revision appears on page 3, lines 61-62, in the revised manuscript.

      Fig. 4. It would have been nice to show at least one more cRAG1 tumor circus plot.

      We appreciate the reviewer's comment and concur with the suggestion. In future sequencing experiments, we will consider including additional replicates. However, due to time and financial constraints, the current sequencing effort was limited to a maximum of three replicates.

      Reviewer #3 (Recommendations For The Authors):

      In the manuscript, the authors summarized and introduced the correlation between the non-core regions of RAG1 and RAG2 in BCR-ABL1+acute B lymphoblastic leukemia and off-target recombination which has certain innovative and clinical significance. The following issues need to be addressed by the authors.

      (1) Authors should check and review extensively for improvements to the use of English.

      We thank the reviewer for their comment. With assistance from a native English speaker, we have carefully revised the manuscript to enhance its readability.

      (2) Authors should revise the conclusion so that the above can be clearly reviewed and summarized.

      The conclusion has been partially revised in the revised manuscript.

      (3) The article should state that the experiment was independently repeated three times.

      The experiment was repeated under the same conditions three times and the information has been descripted in Statistics section on page 19, lines 473-475 in the revised manuscript.

      (4) The article will be more convincing if it uses references in the last 5 years.

      We are grateful to the reviewer for their guidance in enhancing our manuscript. We have incorporated additional references from the past five years in the revised version.

      (5) Additional experiments are suggested to elucidate the molecular mechanisms related to off-target recombination.

      We thank the reviewer for this suggestion. In future experiments, we plan to perform ChIP-seq analysis to investigate the relationship between chromatin accessibility and off-target effects, as well as to examine the impact of knocking out and overexpressing off-target genes on cancer development and progression.

      (6) It is suggested to further analyze the effect of the absence of non-core RAG region on the differentiation and development of peripheral B cells in mice by flow analysis and expression of B1 and B2.

      Thank you very much for highlighting this crucial issue. FACS analysis was performed, revealing that leukemia cells in peripheral B cells in mice did not express CD5. The data are presented as follows:

      Author response image 1.

      (7) Fig3A should have three biological replicates and the molecular weight should be labeled on the right side of the strip.

      Thank you for this suggestion. The experiment was independently repeated three times, and the molecular weights have been labeled on the right side of the bands in the revised version

      References:

      Mendes RD, Sarmento LM, Canté-Barrett K, Zuurbier L, Buijs-Gladdines JG, Póvoa V, Smits WK, Abecasis M, Yunes JA, Sonneveld E, Horstmann MA, Pieters R, Barata JT, Meijerink JP. 2014. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events. BLOOD 124:567-578. doi:10.1182/blood-2014-03-562751

      Onozawa M, Aplan PD. 2012. Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy. Genes Chromosomes Cancer 51:525-535. doi:10.1002/gcc.21942

      Thomson DW, Shahrin NH, Wang P, Wadham C, Shanmuganathan N, Scott HS, Dinger ME, Hughes TP, Schreiber AW, Branford S. 2020. Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia. LEUKEMIA 34:2051-2063. doi:10.1038/s41375-020-0751-y

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Zhang et al. demonstrate that CD4<sup>+</sup> single positive (SP) thymocytes, CD4<sup>+</sup> recent thymic emigrants (RTE), and CD4<sup>+</sup> T naive (Tn) cells from Cd11c-p28-flox mice, which lack IL-27p28 selectively in Cd11c+ cells, exhibit a hyper-Th1 phenotype instead of the expected hyper Th2 phenotype. Using IL-27R-deficient mice, the authors confirm that this hyper-Th1 phenotype is due to IL-27 signaling via IL-27R, rather than the effects of monomeric IL-27p28. They also crossed Cd11c-p28-flox mice with autoimmune-prone Aire-deficient mice and showed that both T cell responses and tissue pathology are enhanced, suggesting that SP, RTE, and Tn cells from Cd11c-p28-flox mice are poised to become Th1 cells in response to self-antigens. Regarding mechanism, the authors demonstrate that SP, RTE, and Tn cells from Cd11c-p28-flox mice have reduced DNA methylation at the IFN-g and Tbx21 loci, indicating 'de-repression', along with enhanced histone tri-methylation at H3K4, indicating a 'permissive' transcriptional state. They also find evidence for enhanced STAT1 activity, which is relevant given the well-established role of STAT1 in promoting Th1 responses, and surprising given IL-27 is a potent STAT1 activator. This latter finding suggests that the Th1-inhibiting property of thymic IL-27 may not be due to direct effects on the T cells themselves.

      Strengths:

      Overall the data presented are high quality and the manuscript is well-reasoned and composed. The basic finding - that thymic IL-27 production limits the Th1 potential of SP, RTE, and Tn cells - is both unexpected and well described.

      Weaknesses:

      A credible mechanistic explanation, cellular or molecular, is lacking. The authors convincingly affirm the hyper-Th1 phenotype at epigenetic level but it remains unclear whether the observed changes reflect the capacity of IL-27 to directly elicit epigenetic remodeling in developing thymocytes or knock-on effects from other cell types which, in turn, elicit the epigenetic changes (presumably via cytokines). The authors propose that increased STAT1 activity is a driving force for the epigenetic changes and resultant hyper-Th1 phenotype. That conclusion is logical given the data at hand but the alternative hypothesis - that the hyper-STAT1 response is just a downstream consequence of the hyper-Th1 phenotype - remains equally likely. Thus, while the discovery of a new anti-inflammatory function for IL-27 within the thymus is compelling, further mechanistic studies are needed to advance the finding beyond phenomenology.

      Thank you for your insightful comments and suggestions. We appreciate your feedback and have carefully considered the concerns raised regarding the mechanistic explanation of our findings. To address the issue of whether developing thymocytes are the direct targets of IL-27, we plan to conduct further studies using Cd4-IL-27ra knockout mice or mixed bone marrow chimeras consisting of wildtype and IL-27ra knockout cells. This approach will help us determine if IL-27 directly induces epigenetic remodeling in thymocytes or if the observed effects are secondary to influences from other cell types.

      Regarding the potential autocrine loop contributing to STAT1 hyperactivation, we have performed preliminary experiments by adding IFN-γ antibody to CD4<sup>+</sup> T cell cultures and observed no significant impact on STAT1 phosphorylation. If necessary, we will further investigate this possibility in vivo using Cd4-Ifng and CD11c-p28 double knockout mice.

      The detailed mechanisms underlying STAT1 hyperactivation remain to be elucidated. Recent studies have shown that IL-27p28 can act as an antagonist of gp130-mediated signaling. Structural analyses have also demonstrated that IL-27p28 interacts with EBI3 and the two receptor subunits IL-27Rα and gp130. Given these findings and the similar phenotypes observed in p28 and IL-27ra deficient mice, we speculate that the deficiency of either p28 or IL-27ra may increase the availability of gp130 for signaling by other cytokines. We will focus our future research on gp130-related cytokines to identify potential candidates that could lead to enhanced STAT1 activation in the absence of p28. Alternatively, the release of EBI3 in p28-deficient conditions may promote its interaction with other cytokine subunits. IL-35, which is composed of EBI3 and p35, is of particular interest given the involvement of IL-27Rα in its signaling pathway.

      To narrow down the candidate cytokines, we reanalyzed single-cell RNA sequencing data from CD11c-cre p28<sup>f/f</sup> and wild-type thymocytes (Signal Transduct Target Ther. 2022, DOI: 10.1038/s41392-022-01147-z). Our analysis revealed that thymic dendritic cells (DCs) were categorized into two distinct clusters, with both Il12a (p35, which forms IL-35 with EBI3) and Clcf1 (CLCF1) being upregulated in CD11c-cre p28<sup>f/f</sup> mice. In CD4 single-positive (SP) thymocytes, the expression levels of gp130 and IL-12Rβ2 (the receptor for IL-35) were comparable between knockout and wild-type mice. However, the mRNA levels of Lifr and Cntfr were low in CD4 SP thymocytes.

      Author response image 1.

      Single-cell RNA sequencing data from CD11c-cre p28<sup>f/f</sup> (KO) and wild-type thymocytes (Signal Transduct Target Ther. 2022, DOI: 10.1038/s41392-022-01147-z).

      We have planned to assess the protein levels of IL-35 and CLCF1 in dendritic cells, as well as their respective receptors, to evaluate their effects on STAT1 phosphorylation in CD4<sup>+</sup> thymocytes from both wild-type and p28-deficient mice. Unfortunately, we have encountered challenges with the mouse breeding and anticipate that it will take approximately six months to obtain the appropriate genotype necessary to complete these experiments.

      Reviewer #2 (Public Review):

      Summary:

      Naïve CD4 T cells in CD11c-Cre p28-floxed mice express highly elevated levels of proinflammatory IFNg and the transcription factor T-bet. This phenotype turned out to be imposed by thymic dendritic cells (DCs) during CD4SP T cell development in the thymus [PMID: 23175475]. The current study affirms these observations, first, by developmentally mapping the IFNg dysregulation to newly generated thymic CD4SP cells [PMID: 23175475], second, by demonstrating increased STAT1 activation being associated with increased T-bet expression in CD11c-Cre p28-floxed CD4 T cells [PMID: 36109504], and lastly, by confirming IL-27 as the key cytokine in this process [PMID: 27469302]. The authors further demonstrate that such dysregulated cytokine expression is specific to the Th1 cytokine IFNg, without affecting the expression of the Th2 cytokine IL-4, thus proposing a role for thymic DC-derived p28 in shaping the cytokine response of newly generated CD4 helper T cells. Mechanistically, CD4SP cells of CD11c-Cre p28-floxed mice were found to display epigenetic changes in the Ifng and Tbx21 gene loci that were consistent with increased transcriptional activities of IFNg and T-bet mRNA expression. Moreover, in autoimmune Aire-deficiency settings, CD11c-Cre p28-floxed CD4 T cells still expressed significantly increased amounts of IFNg, exacerbating the autoimmune response and disease severity. Based on these results, the investigators propose a model where thymic DC-derived IL-27 is necessary to suppress IFNg expression by CD4SP cells and thus would impose a Th2-skewed predisposition of newly generated CD4 T cells in the thymus, potentially relevant in autoimmunity.

      Strengths:

      Experiments are well-designed and executed. The conclusions are convincing and supported by the experimental results.

      Weaknesses:

      The premise of the current study is confusing as it tries to use the CD11c-p28 floxed mouse model to explain the Th2-prone immune profile of newly generated CD4SP thymocytes. Instead, it would be more helpful to (1) give full credit to the original study which already described the proinflammatory IFNg+ phenotype of CD4 T cells in CD11c-p28 floxed mice to be mediated by thymic dendritic cells [PMID: 23175475], and then, (2) build on that to explain that this study is aimed to understand the molecular basis of the original finding.

      In its essence, this study mostly rediscovers and reaffirms previously reported findings, but with different tools. While the mapping of epigenetic changes in the IFNg and T-bet gene loci and the STAT1 gene signature in CD4SP cells are interesting, these are expected results, and they only reaffirm what would be assumed from the literature. Thus, there is only incremental gain in new insights and information on the role of DC-derived IL-27 in driving the Th1 phenotype of CD4SP cells in CD11c-p28 floxed mice.

      Thank you for your valuable comments and suggestions. We appreciate your input and have carefully reviewed the concerns raised regarding the premise and novelty of our study.

      Indeed, the current study is built upon the foundational work of Zhang et al. (PMID: 23175475), which first described the proinflammatory IFN-γ<sup>+</sup> phenotype of CD4 T cells in CD11c-p28 floxed mice mediated by thymic dendritic cells. We have cited this study multiple times in our manuscript to acknowledge its significance. Our goal was to expand on this original finding by exploring the functional bias of newly generated CD4<sup>+</sup> T cells, elucidating the mechanisms underlying the hyper-Th1 phenotype in the absence of thymic DC-derived IL-27, and exploring its relevance in pathogenesis of autoimmunity.

      Our study revisits this phenomenon with a focus on the molecular and epigenetic changes that drive the Th1 bias in CD4SP cells. We demonstrated that the deletion of p28 in thymic dendritic cells leads to an unexpected hyperactivation of STAT1, which is associated with epigenetic modifications that favor Th1 differentiation. These findings provide a deeper understanding of the molecular basis behind the original observation of the Th1-skewed phenotype in CD11c-p28 floxed mice.

      However, as you pointed out, there is still a gap in understanding the precise link between p28 deficiency and STAT1 activation. We acknowledge that our study primarily reaffirms previously reported findings with different tools and approaches. While the mapping of epigenetic changes in the IFN-γ and T-bet gene loci and the STAT1 gene signature in CD4SP cells are interesting, they are indeed expected results based on the existing literature. This limits the novelty and incremental gain in new insights provided by our study.

      To address this gap and enhance the novelty of our findings, we plan to conduct further investigations to elucidate the detailed mechanisms connecting p28 deficiency to STAT1 hyperactivation. We will explore potential compensatory pathways or alternative signaling mechanisms that may contribute to the observed epigenetic changes and Th1 bias. Additionally, we will consider the broader impact of IL-27 deficiency on the thymic environment and its downstream effects on CD4<sup>+</sup> T cell differentiation.

      We appreciate your feedback and will work to strengthen the mechanistic underpinnings of our study. We believe that these additional efforts will provide a more comprehensive understanding of the role of DC-derived IL-27 in shaping the Th1 phenotype of CD4SP cells and contribute meaningful insights to the field.

      Altogether, the major issues of this study remain unresolved:

      (1) It is still unclear why the p28-deficiency in thymic dendritic cells would result in increased STAT1 activation in CD4SP cells. Based on their in vitro experiments with blocking anti-IFNg antibodies, the authors conclude that it is unlikely that the constitutive activation of STAT1 would be a secondary effect due to autocrine IFNg production by CD4SP cells. However, this possibility should be further tested with in vivo models, such as Ifng-deficient CD11c-p28 floxed mice. Alternatively, is this an indirect effect by other IFNg producers in the thymus, such as iNKT cells? It is necessary to explain what drives the STAT1 activation in CD11c-p28 floxed CD4SP cells in the first place.

      Thank you for your insightful suggestions. We appreciate your feedback and are committed to addressing the critical questions raised regarding the mechanisms underlying STAT1 activation in CD4SP cells in the context of p28 deficiency in thymic dendritic cells.

      To further investigate the potential autocrine loop for IFN-γ production, we will conduct in vivo studies using Cd4-Ifng and CD11c-p28 double knockout mice. This model will allow us to directly test whether IFN-γ produced by CD4SP cells themselves contributes to the observed STAT1 activation. Additionally, this approach will help exclude the possibility of indirect effects from other IFN-γ-producing cells in the thymus, such as invariant natural killer T (iNKT) cells, as suggested by the reviewer.

      As you correctly pointed out, a key unanswered question is what drives the initial STAT1 activation in CD4SP cells of CD11c-p28 floxed mice. Our current hypothesis is that p28 deficiency enhances the responsiveness of developing thymocytes to STAT1-activating cytokines. This hypothesis is supported by several lines of evidence:

      (1) Functional Antagonism: Recent studies have shown that IL-27p28 can act as an antagonist of gp130-mediated signaling. This suggests that in the absence of p28, the inhibitory effect of IL-27p28 on downstream signaling may be lost, leading to increased sensitivity to other cytokines that activate STAT1.

      (2) Structural Insights: Structural studies have demonstrated that IL-27p28 is centrally positioned within the complex formed with EBI3 and the two receptor subunits IL-27Rα and gp130. This positioning implies that p28 deficiency could disrupt the balance of cytokine signaling pathways involving these components.

      (3)  Phenotypic Similarity: We have observed a similar hyper-Th1 phenotype in mice lacking either p28 or IL-27ra. This similarity suggests that the absence of p28 may lead to increased availability of gp130 for signaling by other cytokines, thereby enhancing STAT1 activation.

      Based on these considerations, we hypothesize that the deficiency of p28 results in a greater availability of gp130 to transduce signals from other cytokines, ultimately leading to enhanced STAT1 activation in CD4SP cells. To identify the specific cytokine(s) responsible for this effect, we will focus on gp130-related cytokines, as outlined in our response to Reviewer 1. This will involve reanalysis of single-cell RNA sequencing data and further experimental validation to pinpoint the candidate cytokines driving the observed STAT1 hyperactivation.

      We are confident that these additional studies will provide a clearer understanding of the mechanisms linking p28 deficiency in thymic dendritic cells to increased STAT1 activation in CD4SP cells. We appreciate your guidance and look forward to sharing our findings.

      (2) It is also unclear whether CD4SP cells are the direct targets of IL-27 p28. The cell-intrinsic effects of IL-27 p28 signaling in CD4SP cells should be assessed and demonstrated, ideally by CD4SP-specific deletion of IL-27Ra, or by establishing bone marrow chimeras of IL-27Ra germline KO mice.

      Thanks for the suggestions. Further studies will be performed to test whether developing thymocytes are the direct targets of IL-27 using Cd4-IL-27ra knockout mice or mixed bone marrow chimeras of wildtype and IL-27ra knockout cells. Unfortunately, we have encountered challenges with the mouse breeding and anticipate that it will take approximately six months to obtain the appropriate genotype necessary to complete these experiments.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) Is the hyper-STAT1 response seen in T cells from Cd11c-p28-flox mice due to increased availability and/or increased responsiveness to STAT1 activating cytokines? Studies, where SP, RTE, and Tn cells are pulsed ex vivo with IL-27 and/or other STAT1-activating cytokines, would address the latter (with STAT1 phosphorylation as the major readout). Given the ability of IL-27 to activate STAT3, this pathway should also be addressed. It would be of interest if STAT1 signaling is selectively impaired, as suggested by the work of Twohig et al. (doi: 10.1038/s41590-019-0350-0.)(which should be cited and discussed).

      Thank you for your insightful suggestions. We appreciate your input and are committed to addressing the critical questions raised regarding the mechanisms underlying the hyper-activation of STAT1 in T cells from Cd11c-p28-flox mice.

      The detailed mechanisms driving the hyper-activation of STAT1 remain to be fully elucidated. Recent studies have shown that IL-27p28 can act as an antagonist of gp130-mediated signaling. Structural analyses have also demonstrated that IL-27p28 interacts with EBI3 and the two receptor subunits IL-27Rα and gp130. Considering these findings and the similar phenotypes observed in p28 and IL-27ra deficient mice, we speculate that the deficiency of either p28 or IL-27ra may increase the availability of gp130 for signaling by other cytokines. This could potentially enhance the responsiveness of developing thymocytes to STAT1-activating cytokines. We will focus our future research on gp130-related cytokines to identify the candidate(s) responsible for the enhanced STAT1 activation in the absence of p28. Alternatively, the release of EBI3 in the absence of p28 may facilitate its coupling with other cytokine subunits. IL-35, which is composed of EBI3 and p35, is of particular interest given the involvement of IL-27Rα in its signaling pathway.

      To narrow down the candidate cytokines, we reanalyzed single-cell RNA sequencing data from CD11c-cre p28<sup>f/f</sup> and wild-type thymocytes (Signal Transduct Target Ther. 2022, DOI: 10.1038/s41392-022-01147-z). Our analysis revealed that thymic dendritic cells (DCs) were categorized into two distinct clusters, with both Il12a (p35, which forms IL-35 with EBI3) and Clcf1 (CLCF1) being upregulated in CD11c-cre p28<sup>f/f</sup> mice. In CD4 single-positive (SP) thymocytes, the expression levels of gp130 and IL-12Rβ2 (the receptor for IL-35) were comparable between knockout and wild-type mice. However, the mRNA levels of Lifr and Cntfr were low in CD4 SP thymocytes.

      Single-cell RNA sequencing data from CD11c-cre p28<sup>f/f</sup> (KO) and wild-type thymocytes (Signal Transduct Target Ther. 2022, DOI: 10.1038/s41392-022-01147-z).

      We have planned to assess the protein levels of IL-35 and CLCF1 in dendritic cells, as well as their respective receptors, to evaluate their effects on STAT1 phosphorylation in CD4<sup>+</sup> thymocytes from both wild-type and p28-deficient mice. Unfortunately, we have encountered challenges with the mouse crosses and anticipate that it will take approximately six months to obtain the appropriate genotype necessary to complete these experiments.

      As you correctly noted, the ability of IL-27 to activate STAT3 signaling is an important consideration. We have carefully examined this pathway in our current study, and our results indicate that neither total nor phosphorylated STAT3 and STAT4 were found to be altered with IL-27p28 ablation (Figure 5B). This suggests that the impact is indeed specific to the STAT1 axis. We will also consider the possibility of selective impairment of STAT1 signaling, as suggested by the work of Twohig et al. (doi: 10.1038/s41590-019-0350-0), which we will cite and discuss in our revised manuscript.

      We appreciate your guidance and will work diligently to address these questions in our future studies. We look forward to sharing our findings and contributing to a deeper understanding of the role of IL-27 in the regulation of STAT1 activation in T cells.

      (2) It may be that the hyper-Th1 phenotype is not due to cell-intrinsic differences in STAT1 signaling (see Major Point 1) but rather, hyper-responsiveness to TCR + Co-stimulation (as provided in the re-stim assays used throughout). This issue is particularly relevant for the ChIP studies where the author notes that, "...we chose to treat the cells with anti-CD3 and anti-CD28 for 3 days prior to the assay". Why not treat these cells ex vivo with STAT1-activating cytokines instead of anti-CD3/CD28? The current methodology makes it impossible to distinguish between enhanced TCR/CD28 and cytokine signaling, and ultimately does not address SP, RTE, and Tn cells (since they are now activated, blasts.).

      Thank you for raising this important point. We appreciate your feedback and fully recognize the limitations of our current methodology, which uses anti-CD3/CD28 stimulation for ChIP experiments. This approach indeed complicates the distinction between enhanced TCR/CD28 signaling and cytokine-mediated STAT1 activation, particularly in the context of SP, RTE, and Tn cells, which become activated blasts under these conditions.

      To address these concerns and provide more precise insights into the mechanisms underlying the hyper-Th1 phenotype, we are revising our experimental strategy. Specifically, we are shifting our focus to directly investigate the role of STAT1-activating cytokines in the absence of p28. Based on our previous analysis and re-evaluation of single-cell RNA sequencing data, we have identified IL-35 and CLCF1 as the most promising candidate cytokines.

      We are now planning to perform ChIP experiments using these cytokines directly, rather than relying on TCR + co-stimulation. This approach will allow us to more accurately evaluate the impact of these cytokines on STAT1 signaling in CD4<sup>+</sup> T cells. By treating cells ex vivo with IL-35 and CLCF1, we aim to elucidate whether the observed hyper-Th1 phenotype is driven by enhanced responsiveness to these cytokines, independent of TCR/CD28 signaling.

      We regret to inform you that we have encountered unforeseen challenges with mouse crosses, which have delayed our progress. As a result, we anticipate a delay of approximately six months to obtain the appropriate genotypes necessary to complete these experiments. We understand the importance of these revisions and are committed to overcoming these challenges to provide a more robust and accurate analysis.

      (3) Studies involving STAT1-deficient mice are necessary (ideally with STAT1 deficiency restricted to the T cell compartment). At a minimum, it must be confirmed that these phenocopy Cd11c-p28-flox mice in terms of SP, RTE, and Tn cells (and their Th1-like character). If a similar hyper-Th1 phenotype is not seen, then the attendant hyper STAT1 response can only be viewed as a red herring.

      Thank you for raising this important consideration. We acknowledge the significance of addressing the role of STAT1 specifically within the T cell compartment to validate the mechanisms underlying the hyper-Th1 phenotype observed in Cd11c-p28-flox mice.

      We agree that studies involving STAT1-deficient mice, particularly with STAT1 deficiency restricted to the T cell compartment, are essential to confirm whether the hyper-Th1 phenotype is directly driven by STAT1 hyperactivation in T cells. Ideally, such studies would help determine if STAT1 deficiency in T cells phenocopies the Cd11c-p28-flox mice, particularly in terms of the SP, RTE, and Tn cells and their Th1-like characteristics.

      Unfortunately, we currently face challenges in obtaining and breeding the appropriate STAT1 conditional knockout mice with T cell-specific deletion. This has limited our ability to conduct these experiments in a timely manner. However, we recognize the importance of these studies and are actively working to secure the necessary resources and models to address this critical question.

      We understand that without these experiments, any conclusions drawn about the role of STAT1 hyperactivation in driving the hyper-Th1 phenotype must be considered with caution. If a similar hyper-Th1 phenotype is not observed in STAT1-deficient T cells, then the hyper-STAT1 response may indeed be a secondary or compensatory effect rather than a primary driver.

      We are committed to pursuing these studies and will prioritize them in our future work. We will keep you informed of our progress and will update the manuscript with the results of these experiments once completed. We appreciate your patience and understanding as we work to address this important aspect of our research.

      (4) The authors mine their RNA-seq data using a STAT1 geneset sourced from studies involving IL-21 as the upstream stimulus. Why was this geneset was chosen? It is true that IL-21 can activate STAT1 but STAT3 is typically viewed as its principal signaling pathway. There are many more appropriate genesets, especially from studies where T cells are cultured with traditional STAT1 stimuli (e.g. IL-27 in Hirahara et al., Immunity 2015 or interferons in Iwata et al., Immunity 2017)doi: 10.1016/j.immuni.2015.04.014, 10.1016/j.immuni.2017.05.005).

      Thank you for your insightful comments. We appreciate your attention to the choice of the STAT1 gene set in our RNA-seq analysis.

      Initially, we selected the STAT1 gene set from a study involving IL-21 stimulation (GSE63204) because IL-21 is known to activate STAT1, despite STAT3 being its principal signaling pathway. However, we acknowledge that this choice may not have been optimal given the context of our study, which focuses on the role of IL-27 and its impact on STAT1 signaling in T cells.

      We agree that gene sets derived from studies using more canonical STAT1 stimuli, such as IL-27 or interferons, would be more relevant for our analysis. In response to your suggestion, we have revised our approach and adopted a gene set from GSE65621, which compares STAT1-/- and wild-type CD4 T cells following IL-27 stimulation. This gene set is more aligned with the focus of our study and provides a more appropriate reference for identifying STAT1-activated genes.

      Our re-analysis revealed that 270 genes (FPKM > 1, log2FC > 2) were downregulated in STAT1-/- cells compared to wild-type cells, which we defined as STAT1-activated genes. Notably, approximately 50% of the upregulated differentially expressed genes (55 out of 137) in our dataset fell into the category of STAT1-activated genes, while none were classified as STAT1-suppressed genes (Figure 4B). Furthermore, Gene Set Enrichment Analysis (GSEA) demonstrated significant enrichment of STAT1-activated genes in the transcriptome of CD4 SP thymocytes from the knockout mice (NES = 1.67, nominal p-value = 10<sup>-16</sup>, Figure 4D).

      These findings support our conclusion that IL-27p28 deficiency leads to enhanced STAT1 activity in CD4 SP thymocytes. We believe that using a more relevant gene set has strengthened our analysis and provided clearer insights into the molecular mechanisms underlying the observed phenotype.

      We have cited the relevant studies (Hirahara et al., Immunity 2015; Iwata et al., Immunity 2017) to provide context for our revised analysis and to acknowledge the importance of canonical STAT1 stimuli in T cell signaling. We appreciate your guidance and are confident that these revisions have improved the robustness and relevance of our findings.

      (5) Given the ability of IL-27 to activate STAT1 in T cells, it is surprising that SP, RTE, and Tn cells from Cd11c-p28-flox mice exhibit more STAT1 signaling than WT controls. If not IL-27, then what is the stimulus for this STAT1 activity? The authors rule out autocrine IFN-g production in vitro (not in vivo) but provide no further insight.

      Thank you for raising this important question. We appreciate your interest in understanding the source of enhanced STAT1 signaling in SP, RTE, and Tn cells from Cd11c-p28-flox mice, especially given the role of IL-27 in activating STAT1 in T cells. As previously discussed, we have identified IL-35 and CLCF1 as the most likely candidate cytokines driving the observed STAT1 activity in the absence of p28. These cytokines are of particular interest due to their potential to activate STAT1 and their relevance in the context of our study.

      To address the question of what drives the enhanced STAT1 signaling, we are planning to perform ChIP experiments using these cytokines directly. This approach will allow us to evaluate their impact on STAT1 signaling more precisely, without relying on TCR + co-stimulation. By treating cells ex vivo with IL-35 and CLCF1, we aim to determine whether these cytokines are responsible for the increased STAT1 activity observed in Cd11c-p28-flox mice.

      We acknowledge that ruling out autocrine IFN-γ production in vitro, as we have done, does not fully address the potential role of IFN-γ in vivo. Therefore, we are also considering additional in vivo experiments to further investigate this possibility. These studies will help us determine whether other sources of IFN-γ or other cytokines contribute to the observed STAT1 hyperactivation. Unfortunately, due to unforeseen challenges with mouse crosses, we anticipate a delay of approximately six months to obtain the appropriate genotypes necessary for these experiments. We are actively working to resolve these challenges and will update the manuscript with the results of these experiments upon completion.

      (6) The RNAseq data affirms that SP, RTE, and Tn cells from Cd11c-p28-flox mice exhibit more STAT1 signaling than WT controls. However, this does little to explain the attendant hyper-Th1 phenotype. Is there evidence that epigenetic machinery is deregulated (to account for changes in DNA. histone methylation)? Were IFN-g and Tbet among these few observed DEG? If so, then this should be highlighted. If not, then the authors must address why not. Are there clues as to why STAT1 signing is exaggerated? Also, the hyper-STAT1 effect should be better described using more rigorous STAT1- and interferon-signature genesets (see the work of Virginia Pascual, Anne O'Garra).

      Thank you for your valuable feedback and suggestions. We appreciate your interest in understanding the mechanisms underlying the hyper-Th1 phenotype observed in Cd11c-p28-flox mice. Below, we address each of your points in detail:

      (1) Epigenetic Regulation:

      We have conducted a thorough analysis of the global levels of key histone modifications, including H3K4me3, H3K9me3, and H3K27me3, as well as the mRNA expression of the enzymes responsible for catalyzing these marks. Our results indicate that there are no significant differences in these histone modifications or the expression of the associated enzymes between Cd11c-p28<sup>f/f</sup> and wildtype mice (Figure 3-figure supplement 1A-C). This suggests that the enhanced STAT1 signaling is not a consequence of broad epigenetic deregulation. Instead, we hypothesize that the observed changes may be driven by more specific molecular mechanisms, such as cytokine signaling pathways.

      (2) IFN-γ and Tbx21 Expression:

      Regarding the expression of Th1-associated genes, our analysis revealed a modest induction of ifng and tbx21 (encoding T-bet) in the CD4SP population following TCR stimulation. However, the baseline expression levels of these genes were quite low in freshly isolated CD4SP cells. Specifically, ifng was undetectable, and tbx21 had an FPKM of 0.29 in wildtype mice compared to 1.05 in Cd11c-p28<sup>f/f</sup> mice. While these findings indicate some upregulation of Th1-associated genes, the overall expression levels remain relatively low, suggesting that additional factors may contribute to the hyper-Th1 phenotype.

      (3) STAT1 Signature Genesets:

      We have revised our analysis to incorporate more rigorous STAT1 and interferon-signature genesets, as suggested. We have adopted gene sets from well-established studies, including those by Virginia Pascual and Anne O'Garra, to provide a more comprehensive and accurate assessment of STAT1 signaling. This approach has enhanced our ability to identify and characterize the genes involved in the STAT1 pathway, providing clearer insights into the exaggerated STAT1 signaling observed in our model.

      We appreciate your guidance and are committed to refining our analysis to provide a more detailed understanding of the mechanisms driving the hyper-Th1 phenotype in Cd11c-p28-flox mice. We will continue to explore the potential roles of cytokines such as IL-35 and CLCF1, as well as other factors that may contribute to the observed changes in STAT1 signaling and Th1 differentiation. We look forward to sharing our updated findings and further discussing these mechanisms in our revised manuscript.

      (7) Is the hyper-Th1 phenotype of SP, RTE, and Tn cells from Cd11c-p28-flox mice unique to the CD4 compartment? Are developing CD8<sup>+</sup> cells similarly prone to increased STAT1 signaling and IFN-g production?

      Thank you for raising this important point. Our data indeed suggests that the hyper-Th1 phenotype observed in SP, RTE, and Tn cells from Cd11c-p28<sup>f/f</sup> mice is unique to the CD4<sup>+</sup> T cell compartment. Specifically, we found that while CD4<sup>+</sup> SP cells from Cd11c-p28<sup>f/f</sup> mice exhibited a significant upregulation in IL-27 receptor expression (both IL27Ra and gp130) compared to wild-type (WT) mice, CD8<sup>+</sup> SP cells from the same genotype showed markedly lower expression of these receptor subunits (Figure 1C in Sci Rep. 2016 Jul 29:6:30448. DOI: 10.1038/srep30448). This finding is further supported by our observation that the phosphorylation levels of STAT1, STAT3, and STAT4, downstream targets of IL-27 signaling, were comparable between CD8 SP cells from Cd11c-p28<sup>f/f</sup> and WT mice (Author response image 1). Additionally, we observed no significant difference in IFN-γ and granzyme B production between naïve CD8 T cells isolated from the lymph nodes of the two genotypes (Author response image 1). Taken together, these results suggest that the enhanced Th1 differentiation and IFN-γ production seen in the CD4<sup>+</sup> T cell population from Cd11c-p28<sup>f/f</sup> mice is not recapitulated in the CD8<sup>+</sup> T cell lineage.

      Author response image 2.

      (A) Intracellular staining was performed with freshly isolated thymocytes from Cd11c-p28<sup>f/f</sup> mice and WT littermates mice using antibodies against phosphorylated STAT1 (Y701), STAT3 (Y705), and STAT4 (Y693). The mean fluorescence intensity (MFI) for CD8 SP from three independent experiments (mean ± SD, n=3). (B) CD8<sup>+</sup> naive T cells were cultured under Th0 conditions for 3 days. The frequency of IFN-γ-, and granzyme B-producing CD8<sup>+</sup> T cells were determined analyzed by intracellular staining. Representative dot plots (left) and quantification (right, mean ± SD, n=6).

      Minor points and questions

      (1) Line 84 - Villarino et al. and Pflanz et al. are mis-referenced. Neither involves Trypanosome studies. The former is on Toxoplasma infection and, thus, should be properly referenced in the following sentence.

      Thank you for pointing out this error. You are correct that the references to Villarino et al. and Pflanz et al. were misapplied in the context of Trypanosome studies. Villarino et al. focuses on Toxoplasma infection, and we appreciate your guidance to ensure accurate citation. We will correct this in the manuscript and properly cite the studies in their appropriate contexts. Thank you for your vigilance in maintaining the accuracy of our references.

      (2) T-bet protein should also be measured by cytometry

      We sincerely thank the reviewer for the valuable suggestion regarding the measurement of T-bet protein levels. In response to this comment, we have performed additional experiments to quantify T-bet protein expression using flow cytometry. The results of these analyses have been incorporated into the revised manuscript as Figure 1F.

      Reviewer #2 (Recommendations For The Authors):

      (1) When new mouse strains are generated in this study, there is no comment on whether there are any changes in the frequency or cell number of CD4 T cells. For instance, in Aire-deficient CD11c-p28 floxed mice, it should be noted whether CD4SP, naïve CD4, and CD4 RTE are all the same in frequency and number compared to their littermate controls. Also, is there any effect on the generation of these thymocytes?

      We sincerely thank the reviewer for raising this important point regarding the potential changes in the frequency and cell numbers of CD4<sup>+</sup> T cells in the newly generated mouse strains. In response to the reviewer’s question, we would like to clarify the following:

      (1) Impact of Aire deficiency on CD4<sup>+</sup> T Cells:

      As previously reported by us and others (Aging Dis. 2019, doi: 10.14336/AD.2018.0608; Science. 2002, doi: 10.1126/science.1075958), Aire deficiency does not significantly alter the overall number or frequency of CD4 single-positive (CD4SP) thymocytes, recent thymic emigrants (RTEs), or naïve CD4<sup>+</sup> T cells. However, it profoundly affects their composition and functional properties, leading to the escape of autoreactive T cells and subsequent autoimmune manifestations.

      (2) Observations in Cd11c-p28<sup>f/f</sup>Aire<sup>-/-</sup> mice:

      In our study, we observed that the number and frequency of CD4<sup>+</sup> T cells in the spleen and lymph nodes were comparable among Cd11c-p28<sup>f/f</sup>, Aire<sup>-/-</sup>, and Cd11c-p28<sup>f/f</sup>Aire<sup>-/-</sup> mice, and WT controls. This suggests that the genetic modifications did not significantly impact the overall development or peripheral maintenance of CD4<sup>+</sup> T cells.

      Author response image 3.

      (3) Challenges in assessing RTEs in double knockout mice:

      To accurately assess RTEs in the double knockout mice, it would be necessary to cross these mice with Rag-GFP reporter mice, which specifically label RTEs. However, breeding the appropriate mouse strain for this analysis would require additional time and resources, which were beyond the scope of the current study.

      (2) There are a couple of typos throughout the manuscript. For example, line 91: IL-27Rα or line 313: phenotype.

      We apologize for the typographical errors. We have carefully reviewed the entire manuscript and corrected all identified mistakes, including those on line 91 (IL-27Rα) and line 305 (phenotype).

      (4) The authors should show each data point on their bar graphs.

      Thank you for the suggestion. We have presented each data point on their bar graphs in the revised manuscript.

      (4) It should be noted from which organs the RTE and the naïve T cells were harvested.

      Thank you for the constructive suggestion. We isolated CD4<sup>+</sup> RTEs and mature naive CD4<sup>+</sup> T cells by sorting GFP<sup>+</sup>CD4<sup>+</sup>CD8<sup>-</sup>CD<sup>-</sup>NK1.1<sup>-</sup> cells (RTEs) and GFP<sup>-</sup>CD4<sup>+</sup>CD8<sup>-</sup>CD<sup>-</sup>CD44<sup>lo</sup> cells (naive T cells) from lymph nodes. This detail has been added to the manuscript on line 475.

    1. Author response:

      The following is the authors’ response to the original reviews

      We thank the expert reviewers for their careful consideration of our manuscript and the feedback to help us strengthen our work. Please find a response to each reviewer’s comments below. We have included the original text from the reviewer in unbolded text and our response, immediately below, in bold text for clarity. 

      Reviewer #1:

      (1) Appetite is controlled, not regulated; please reword throughout.

      The reviewer raises a valid point that we have misused the word “regulate” in certain instances and “control” would be more accurate term. We have made adjustments throughout the manuscript.

      (2) One minor point that would further strengthen the data is a more distinct analysis of receptors that are characteristic of the different populations of neuronal and non-neuronal cells; this part could be improved. 

      We thank the reviewer for this suggestion as we had not directly compared metabolicallyrelevant peptides/receptors between the mouse and rat DVC. We have included a list of selected receptors and neuropeptides expression (see Figure S13) for neuronal cells in mouse and rat. We have included this figure as a new supplement. There are some interesting insights from this data, including the relatively broad expression of Lepr in the rat compared with the mouse and the absence of proglucagon expressing neurons within the rat DVC.  

      Reviewer #2:

      (1) In some of the graphs, the label AP/NTS is used, but DVC would be more appropriate.

      We have reviewed the figures and legends to ensure appropriate use of DVC. We thank the reviewer for bringing this oversight to our attention.  

      (2) Line 124, p7 - Sprague Dawley RATS

      We have changed the text to “Sprague Dawley rats” 

      (3) Line 132, p7 - The phrase "were provided with given access to food" needs grammatical correction.

      We agree the text was poorly written. The sentence has been corrected to: “Wild-type Sprague

      Dawley rats (Charles River) were provided with ad libitum access to food (Purina Lab Diet

      5001) and water in temperature-controlled (22°C) rooms on a 12-hour light-dark cycle with daily health checks.” We have also reviewed the entire manuscript and made additional amendments where necessary.  

      (4) Page 15 - Mention that GFAP is a marker for astrocytes. Additionally, correct the typo "gfrap".

      We have corrected the misspelling of “Gfap” within the text. We appreciate the reviewer’s comment that there is value in communicating to the nonexpert reader that GFAP is a marker for astrocytes, however, as our data and that from other snRNA-Seq studies show that Gfap mRNA only labels a subset of astrocytes, our preference is to refrain from stating this. Our data suggests the sole use of Gfap as an astrocyte marker will not reflect the true astrocyte population.  

      (5) Line 432, p15 - What was the rationale for selecting clusters 23, 26, and 27?

      We chose to perform subclustering on these clusters because they displayed multiple cell identities when surveyed for the 473 marker genes as described in Methods 2.6. In order to separate these, the granularity was increased in them by sub-clustering.

      (6) Line 533, p18 - only 5 out of 34 neurons express GFRAL, which makes the language used a little bit misleading. As per the comment above, I would specify that only a subset (X%) of neurons express GFRAL, and apply the same approach for other markers.

      We thank the reviewer for raising this point. We agree the text, as written, was an oversimplification. We adjusted the text as recommended: that a subset (~15%) express detectable Gfral mRNA but is likely an underrepresentation due to the challenges in detecting lowly expressed transcripts such as Gfral.  

      (7) Line 547, p18 - This statement appears to refer to rat data specifically, rather than rodent data in general.

      The text has been corrected. 

      (8) Section 3.6 - The discussion on meal-related transcriptional programs in the murine DVC does not mention Figure S10A and B.

      We thank the reviewer for the observation. It is true that we do not discuss this figure. Fig10S is the integration of samples in treeArches, a necessary step to build the hierarchy in python so the learning algorithm uses only genes that are related to identity and not treatment, we obtained the same overlap of samples when we used R to assign identities. This figure demonstrates our integration was successful because it is only considering genes that are not-treatment related to establish identities, those which are expressed by cells regardless of their response to any treatment. For the meal-related analysis, we were interested in the genes that are changed by treatment, and this is why the analysis differed. We have included a sentence in the methods to clarify this point that states: " This sample integration was done to ensure that inter-sample variations were removed for the cell identity steps."

      (9) Page 5, citation 10 - the author cited a clinical trial for glucagon and GLP-1 receptor dual agonist survodutide for "DVC neurons' role in appetite and energy balance stems from their role as therapeutic targets for obesity". A more appropriate citation (such as a review) would be preferable.

      We appreciate the suggestion by the reviewer. We have updated our references to reflect a recent manuscript from the Alhadeff group which demonstrates the DVC acts as the target of GLP1-based therapies. We have also included a review as suggested 10.1038/s42255-02200606-9.

      (10) Line 52, p5 - a citation of obesity is needed, as the current ref only pertains to cancer cachexia.

      We have included a reference for obesity.  

      (11) In the discussion, it would be valuable to elaborate on the potential significance of DVCspecific glial cells (perhaps at the end of the second paragraph?).

      We thank the reviewer for this suggestion. Our discovery of a DVC-specific astrocyte transcriptional profile was underrepresented within the discussion. We have attempted to expand this discussion on the suspected roles for these DVC-specific astrocytes. Much of this discussion is based on the distinct localization pattern of Gfap mRNA in the DVC (see Image on Allen Brain ISH) which shows dense signal at the boundary of the AP and NTS. As astrocytes have well established roles in maintaining BBB integrity, it is our speculation that this is a major role of these cells. However, functional studies will be critical to assess the roles of these astrocytes in DVC biology.  

      (12) Line 683, p22 - Consider adding PMID: 38987598 which describes the dissociable GLP-1R circuits.

      We appreciate this recommendation – we have included this reference.  

      (13) The authors suggest that a possible explanation for the discrepancy between snRNA-Seq and in situ hybridization data is that Agrp and Hcrt mRNA reads in snRNA-Seq overwhelmingly mapped to non-coding regions. To what extent could this limitation affect other genes included in the current analyzed 10x datasets?

      As shown by Pool and cols. (https://doi.org/10.1038/s41592-023-02003-w) including intronic reads improves sensitivity and more accurately reflects endogenous gene expression. Therefore, including intronic reads is considered more of a strength than a limitation and is now default in platforms such as CellRanger. While including intronic reads for mapping snRNA-Seq data, we would advise corroboration of snRNA-Seq findings with published literature or detection of coding mRNA or protein. In our case, the detection of hypothalamic neuropeptide via snRNA-Seq data could not be verified by performing in situ hybridizations using probes that detect exons.  Therefore, Hcrt and Agrp having only intronic reads suggest a regulatory (reviewed in https://doi.org/10.3389/fgene.2018.00672) rather than a coding role in the DVC.

      (14) Given the manuscript's focus on feeding and metabolism, I believe a more detailed description and comparison of the transcription profile of known receptors, neurotransmitters, and neuropeptides involved in food intake and energy homeostasis between mice and rats would add value. Adding a curated list of key genes related to feeding regulation would be particularly informative.

      A similar request was made by reviewer #1. Please see the full response above. Briefly, we have performed additional analysis of the mouse and rat DVC data and included this data as an additional supplemental figure (Figure S13).  

      (15) Line 479-482, p17 - It would be helpful if the authors could quantify (e.g., number and/or percentage) the extent of TH and CCK co-expression.

      We have amended the text of the manuscript to include quantification of Cck and Th colocalization.  According to our snRNA-seq data, out of the 764 Th-expressing neurons, 80 coexpress Cck in the mouse (~10%). The Cck-expressing cells are more numerous, 3,821 in total.  

      (16) The number of animals used differs significantly between species, which the authors acknowledge as a limitation in the discussion. Since the authors took advantage of previously published mouse data sets (Ludwig and Dowsett data sets), I wonder if the authors could compare/integrate any rat data set currently available in rats as well to partially address the sample size disparity.

      We agree with the review that our rat database is considerably smaller than our mouse database, making comparisons between rat and mouse DVC challenging. We attempted to increase the size of our rat DVC atlas by incorporating publicly available rat DVC snRNA-Seq data (Reiner et al 2022). However, we found several issues with the quality of this data including low UMIs/cell and gene #/cell. For these reasons, we decided against merging these two datasets. So while relatively small, our rat DVC atlas uses high quality data and serves as a valuable starting point. By introducing TreeArches as a method to relatively easily incorporate new snRNA-Seq data into our own, it is our hope that future studies will do so and thus expand the rat DVC atlas we have built.    

      (17) In the Materials and Methods section, LiCl is mentioned as one of the treatment conditions; however, very little corresponding data are presented or discussed. Please include these results and elaborate on the rationale for selecting LiCl over other anorectic compounds.

      The reviewer is correct, some of the tissues used in this study were from animals treated with LiCl prior to euthanasia. Our intent was to contrast the transcriptional effects induced by LiCl ( an anorectic agent with aversive properties) with refeeding (a naturally rewarding and satiating stimuli). However, upon analyzing the data, we found very few transcriptional changes induced by LiCl. It is unclear to us whether this was a technical failure in the experiment and so did not elaborate on the results.  

      Reviewer #3 (Recommendations for the authors):

      (1) The use of both sexes is indicated in the discussion, but methods and results do not address sex distribution in the investigated groups. Also, the groups could be more clearly described, e.g., the size of the 2 hour refeeding mouse group varies from n=10 to n=5.

      We have clarified the text, in line with the reviewer’s suggestion. There were two cohorts of fasted/ refed mice (n=5 each), so in the manuscript methods it is stated as n=10 because of this. The fasted-only group, which was not refed before euthanasia is a separate group, n=5.

      (2) Page 20, the last sentence needs to be reworded.

      We thank the reviewer for this recommendation. The text has been amended to improve clarity of the sentence. 

      (3) Page 22, lines 691-692 - this sentence needs to be reworded.

      We thank the reviewer for this comment. The offending sentences have been amended.  

      (4) While the authors find transcriptional changes in all neuronal and non-neuronal cell types, which is interesting, the verification of known transcriptional changes (e.g., cFos) is unaddressed. cFos is a common gene upregulated with refeeding that was surprisingly not investigated, even though this should be a strong maker of proper meal-induced neuronal activation in the DMV. This is a missed opportunity either to verify the data set or to highlight important limitations if that had been attempted without success.

      This is a highly salient point made by the reviewer. Including Fos expression serves as an internal validation of our refeeding condition and the absence of Fos mRNA levels from the original manuscript was an oversight on our part. As shown in our volcano plot, between ad libitum fed and refed mice, there are two significantly Fos-associated genes upregulated in the refed group. Therefore, we are confident that the snRNA-Seq analysis accurately captured rapid changes in response to refeeding in the DVC. Only genes differentially expressed (log2 Fold-change >0.5 per group) were considered in the analysis. NS= non-significant.

      Author response image 1.

      (5) The focus on transmitter classification is highlighted, but surprisingly, the well-accepted distinction of GABAergic neurons by Slc32a1 was not used, instead, Gad1 and Gad2 were used as GABAergic markers. While this may be proper for the DMV, given numerous findings that Gad1/2 are not proper markers for GABAergic neurons and often co-expressed in glutamatergic populations, this confound should have been addressed to make a case if and why they would be proper markers in the DMV.

      The reviewer raises an important point. Indeed, there are discrepancies in expression between the Gad1/2 genes and Slc32a1 gene in other data sets. To analyze this within our data set, we examined the mainly GABAergic magnaclass 1 (see Slc32a1 UMAP plot below).  In magnaclass 1, only 5% and 3% of all neurons exclusively express solely Slc32a1 without either Gad1 or Gad2, respectively. In line with the reviewer’s comment, we found that 54% of neurons express either Gad1 or Gad2 but had no detectable Slc32a1. While our failure to detect more cells that co-express Slc32a1 and Gad genes may be partially due to the low expression of Slc32a1, it is also very likely that the DVC, like other brain regions, contains neurons that express the Gad enzymes without co-expression of Slc32a1.  

      This was very much the case with the GLP1 cell cluster, which we identified as the population which had the highest co-expression of excitatory and inhibitory markers. When we refined this analysis to look at expression of excitatory markers with Slc32a1 (and not other inhibitory genes), there was a marked reduction in the proportion of GLP1 neurons meeting this criterion. We find this is mainly due to the GLP1 cells expressing Gad2 (see plots below). We still find that there are some GLP1-expressing neurons that express excitatory markers and Slc32a1 and that the GLP1 neurons have a higher proportion of these co-expressing cells than other cell types.  

      We have extended our results section to reflect this and thank the reviewer for recommending this analysis.  

      Author response image 2.

      Slc32a1 expression across all neurons.  

      Author response image 3.

      Proportion of neurons in all cell identities expressing glutamatergic markers alone (dark green), Slc32a1 alone (light green), both glutamatergic markers and Slc32a1 (purple) or expressing neither Slc32a1 or glutamatergic markers  (grey).  

      Author response image 4.

      Balloon plot of Slc32a1, Gad1 and Gad2 across cell types. The GLP1-expressing neurons express Gad2 but minimal Slc32a1.  

      (6) The Pdgfra IHC as verification is great, but images are not very convincing in distinguishing the 2 (mouse) or 3 (rat) classes of cells. Why not compare Pdgfra and HuC/D co-localization by IHC and snRNAseq data (using the genes for HuC/D) in the mouse and in the rat? That would also clarify how specific HuC/D is for DMV neurons, or if it may also be expressed in non-neuronal populations.

      In agreement with the suggestion by the reviewer, we reanalyzed the snRNA-Seq data to identify the extent of the co-expression of HuC/HuD (i.e. Elavl3 and Elavl4 genes, respectively) in Pdgfra-expressing neurons. The gene expression of the 34 rat neurons belonging to this group are shown in the following heatmap in which each column represents one neuron. As shown, most neurons co-express Pdgfra and either HuC or HuD gene. In addition, we shown the UMAP plots of the rat neurons showing expression of the same genes regardless of the neuronal identity assigned. The Pdgfra neurons are visible in darker blue in the last UMAP plot. It's important to note that HuD is a more specific neuronal marker as shown in the table with the average expression of Elavl3/4 genes, since HuC is expressed by glial cells, specially OPCs and oligodendrocytes. As the HUC/D antibody detects both proteins, this complicates the interpretation of the immunofluorescent staining. While, the snRNA-Seq data suggests these Pdgfra expressing cells are indeed neurons (albeit a rare population), we aim to confirm this in separate studies.  

      Author response image 5.

      Author response image 6.

      Average expression (log-normalized counts) of HuC/D by layer 1 cell identity in the rat cells:

      Author response table 1.

      (7) The importance of sub-clustering for clusters 23, 26, and 27 is not immediately clear. Does this have any relevance to the mouse vs. rat data? Or fed, fast, refeeding data sets? Or is it just to show the depth that can be achieved?

      We appreciate that our justification was not clear within the manuscript. We have clarified our rationale below but briefly, in each case distinct transcriptional profiles were observed, and we pursued this by performing sub-clustering.   

      Cluster 23 was subclustered as it was found to contain both pre-myelinating and a subset of myelinating oligodendrocytes, therefore, to label them effectively in R instead of cell by cell, those subclusters showing pre-myelinating oligodendrocyte markers were instructed to be labeled as such in the dataset. The remaining cells were labeled as mature oligodendrocytes.

      A similar approach was taken for cluster 27 which contained pericytes, endothelial and smooth muscle cells (Figure S5).

      In the case of cluster 26, it was possible to find two subclusters of fibroblasts when mapping markers, so they were sub-clustered to instruct in R to label a group with one identity and the other, with the other identity. Therefore, the sub-clustering was done as an aid to label the different identities found through markers mapping (Table S5) in the first clustering round.

      All labels were transferred from mouse to rat data using treeArches, including those resulting from the sub-clustering of these clusters. Because this was done to establish identity, it should not be relevant for treatment analyses (e.g. fasted, refed) since they are built from markers that don't change by conditions but remain as identity markers. Indeed, our dataset has an even distribution of these subclusters among samples.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      This work investigated the role of CXXC-finger protein 1 (CXXC1) in regulatory T cells. CXXC1-bound genomic regions largely overlap with Foxp3-bound regions and regions with H3K4me3 histone modifications in Treg cells. CXXC1 and Foxp3 interact with each other, as shown by co-immunoprecipitation. Mice with Treg-specific CXXC1 knockout (KO) succumb to lymphoproliferative diseases between 3 to 4 weeks of age, similar to Foxp3 KO mice. Although the immune suppression function of CXXC1 KO Treg is comparable to WT Treg in an in vitro assay, these KO Tregs failed to suppress autoimmune diseases such as EAE and colitis in Treg transfer models in vivo. This is partly due to the diminished survival of the KO Tregs after transfer. CXXC1 KO Tregs do not have an altered DNA methylation pattern; instead, they display weakened H3K4me3 modifications within the broad H3K4me3 domains, which contain a set of Treg signature genes. These results suggest that CXXC1 and Foxp3 collaborate to regulate Treg homeostasis and function by promoting Treg signature gene expression through maintaining H3K4me3 modification.

      Strengths:

      Epigenetic regulation of Treg cells has been a constantly evolving area of research. The current study revealed CXXC1 as a previously unidentified epigenetic regulator of Tregs. The strong phenotype of the knockout mouse supports the critical role CXXC1 plays in Treg cells. Mechanistically, the link between CXXC1 and the maintenance of broad H3K4me3 domains is also a novel finding.

      Weaknesses:

      (1) It is not clear why the authors chose to compare H3K4me3 and H3K27me3 enriched genomic regions. There are other histone modifications associated with transcription activation or repression. Please provide justification.

      Thank you for highlighting this important point. We chose to focus on H3K4me3 and H3K27me3 enriched genomic regions because these histone modifications are well-characterized markers of transcriptional activation and repression, respectively. H3K4me3 is predominantly associated with active promoters, while H3K27me3 marks repressed chromatin states, particularly in the context of gene regulation at promoters. This duality provides a robust framework for investigating the balance between transcriptional activation and repression in Treg cells. While histone acetylation, such as H3K27ac, is linked to enhancer activity and transcriptional elongation, our focus was on promoter-level regulation, where H3K4me3 and H3K27me3 are most relevant. Although other histone modifications could provide additional insights, we chose to focus on these two to maintain clarity and feasibility in our analysis. We have revised the text accordingly; please refer to Page 18, lines 353-356.

      (2) It is not clear what separates Clusters 1 and 3 in Figure 1C. It seems they share the same features.

      We apologize for not clarifying these clusters clearly. Cluster 1 and 3 are both H3K4me3 only group, with H3K4me3 enrichment and gene expression levels being higher in Cluster 1. At first, we divided the promoters into four categories because we wanted to try to classify them into four categories: H3K4me3 only, H3K27me3 only, H3K4me3-H3K27me3 co-occupied, and None. However, in actual classification, we could not distinguish H3K4me3-H3K27me3 co-occupied group. Instead, we had two categories of H3K4me3 only, with cluster 1 having a higher enrichment level for H3K4me3 and gene expression levels.

      (3) The claim, "These observations support the hypothesis that FOXP3 primarily functions as an activator by promoting H3K4me3 deposition in Treg cells." (line 344), seems to be a bit of an overstatement. Foxp3 certainly can promote transcription in ways other than promoting H3K3me3 deposition, and it also can repress gene transcription without affecting H3K27me3 deposition. Therefore, it is not justified to claim that promoting H3K4me3 deposition is Foxp3's primary function.

      Thank you for your insightful feedback. We agree that the statement in line 344 may have overstated the role of FOXP3 in promoting H3K4me3 deposition as its primary function. As you pointed out, FOXP3 is indeed a multifaceted transcription factor that regulates gene expression through various mechanisms. It can promote transcription independent of H3K4me3 deposition, as well as repress transcription without directly influencing H3K27me3 levels.

      To more accurately reflect the broader regulatory functions of FOXP3, we have revised the manuscript. The updated text (Page 19, lines 385-388) now reads:

      "These findings collectively support the conclusion that FOXP3 contributes to transcriptional activation in Treg cells by promoting H3K4me3 deposition at target loci, while also regulating gene expression directly or indirectly through other epigenetic modifications.

      (4) For the in vitro suppression assay in Figure S4C, and the Treg transfer EAE and colitis experiments in Figure 4, the Tregs should be isolated from Cxxc1 fl/fl x Foxp3 cre/wt female heterozygous mice instead of Cxxc1 fl/fl x Foxp3 cre/cre (or cre/Y) mice. Tregs from the homozygous KO mice are already activated by the lymphoproliferative environment and could have vastly different gene expression patterns and homeostatic features compared to resting Tregs. Therefore, it's not a fair comparison between these activated KO Tregs and resting WT Tregs.

      Thank you for raising this insightful point regarding the potential activation status of Treg cells in homozygous knockout mice. To address this concern, we performed additional experiments using Treg cells isolated from Foxp3<sup>Cre/+</sup>Cxxc1<sup>fl/fl</sup> (hereafter referred to as “het-KO”) female mice and their littermate controls, Foxp3<sup>Cre/+</sup>Cxxc1<sup>fl/+</sup> (referred to as “het-WT”) mice.

      The results of these new experiments are now included in the manuscript (Page25, lines 507–509, Figure 6E and Figure S6A-E):

      (1) In the in vitro suppression assay, Treg cells from het-KO mice exhibited reduced suppressive function compared to het-WT Treg cells. This finding underscores the intrinsic defect in Treg cells suppressive capacity attributable to the loss of one Cxxc1 allele.

      (2) In the experimental autoimmune encephalomyelitis (EAE) model, Treg cells isolated from het-KO mice also demonstrated impaired suppressive function.

      (5) The manuscript didn't provide a potential mechanism for how CXXC1 strengthens broad H3K4me3-modified genomic regions. The authors should perform Foxp3 ChIP-seq or Cut-n-Taq with WT and Cxxc1 cKO Tregs to determine whether CXXC1 deletion changes Foxp3's binding pattern in Treg cells.

      Thank you for raising this important point. To address your suggestion, we performed CUT&Tag experiments and found that Cxxc1 deletion does not alter FOXP3 binding patterns in Treg cells. Most FOXP3-bound regions in WT Treg cells were similarly enriched in KO Treg cells, indicating that Cxxc1 deficiency does not impair FOXP3’s DNA-binding ability. These results have been added to the revised manuscript (Page 28, lines 567-575, Figure S8A-B) and are further discussed in the Discussion (Pages 28-29, lines 581-587).

      Reviewer #2 (Public review):

      FOXP3 has been known to form diverse complexes with different transcription factors and enzymes responsible for epigenetic modifications, but how extracellular signals timely regulate FOXP3 complex dynamics remains to be fully understood. Histone H3K4 tri-methylation (H3K4me3) and CXXC finger protein 1 (CXXC1), which is required to regulate H3K4me3, also remain to be fully investigated in Treg cells. Here, Meng et al. performed a comprehensive analysis of H3K4me3 CUT&Tag assay on Treg cells and a comparison of the dataset with the FOXP3 ChIP-seq dataset revealed that FOXP3 could facilitate the regulation of target genes by promoting H3K4me3 deposition.

      Moreover, CXXC1-FOXP3 interaction is required for this regulation. They found that specific knockdown of Cxxc1 in Treg leads to spontaneous severe multi-organ inflammation in mice and that Cxxc1-deficient Treg exhibits enhanced activation and impaired suppression activity. In addition, they have also found that CXXC1 shares several binding sites with FOXP3 especially on Treg signature gene loci, which are necessary for maintaining homeostasis and identity of Treg cells.

      The findings of the current study are pretty intriguing, and it would be great if the authors could fully address the following comments to support these interesting findings.

      Major points:

      (1) There is insufficient evidence in the first part of the Results to support the conclusion that "FOXP3 functions as an activator by promoting H3K4Me3 deposition in Treg cells". The authors should compare the results for H3K4Me3 in FOXP3-negative conventional T cells to demonstrate that at these promoter loci, FOXP3 promotes H3K4Me3 deposition.

      Thank you for this insightful comment. We have already performed additional experiments comparing H3K4Me3 levels between FOXP3-positive Treg cells and FOXP3-negative conventional T cells (Tconv). Please refer to Pages 18, lines 361-368, and Figure 1C and Figure S1C for the results. Our results show that H3K4Me3 abundance is higher at many Treg-specific gene loci in Treg cells compared to Tconv cells. This supports our conclusion that FOXP3 promotes H3K4Me3 deposition at these loci.

      (2) In Figure 3 F&G, the activation status and IFNγ production should be analyzed in Treg cells and Tconv cells separately rather than in total CD4+ T cells. Moreover, are there changes in autoantibodies and IgG and IgE levels in the serum of cKO mice?

      Thank you for your valuable suggestions. In response to your comment, we reanalyzed the data in Figures 3F and 3G to assess the activation status and IFN-γ production in Tconv cells. The updated analysis revealed that Cxxc1 deletion in Treg cells leads to increased activation and IFN-γ production in Tconv cells. Additionally, we corrected the analysis of IL-17A and IL-4 expression, which were upregulated in Tconv cells. These updated results are now included in the revised manuscript (Page 21, lines 429-431, Figure 3I and Figure S3E-F).

      Additionally, we examined autoantibodies and immunoglobulin levels in the serum of Cxxc1 cKO mice. Our data show a significant increase in serum IgG levels, accompanied by elevated IgG autoantibodies, indicating heightened autoimmune responses. In contrast, serum IgE levels remained largely unchanged. The results are detailed in the revised manuscript (Page 21, lines 421-423, Figure 3E and Figure S3B).

      (3) Why did Cxxc1-deficient Treg cells not show impaired suppression than WT Treg during in vitro suppression assay, despite the reduced expression of Treg cell suppression assay -associated markers at the transcriptional level demonstrated in both scRNA-seq and bulk RNA-seq?

      Thank you for your thoughtful comment. The absence of impaired suppression in Cxxc1-deficient Treg cells from homozygous knockout (KO) mice during the in vitro suppression assay, despite the reduced expression of Treg-associated markers at the transcriptional level (as demonstrated by scRNA-seq), can likely be explained by the activated state of these Treg cells. In homozygous KO mice, Treg cells are already activated due to the lymphoproliferative environment, resulting in gene expression patterns that differ from those of resting Treg cells. This pre-activation may obscure the effect of Cxxc1 deletion on their suppressive function in vitro.

      To address this limitation, we used heterozygous Foxp3<sup>Cre/+</sup>Cxxc1<sup>fl/fl</sup> (het-KO) female mice, along with their littermate controls, Foxp3<sup>Cre/+</sup>Cxxc1<sup>fl/+</sup> (het-WT) mice. In these heterozygous mice, we observed an impairment in Treg cell suppressive function in vitro, which was accompanied by the downregulation of several key Treg-associated genes, as confirmed by RNA-Seq analysis.

      These updated findings, based on the use of het-KO mice, are now incorporated into the revised manuscript (Page 25, lines 507–509, Figure 6E).

      (4) Is there a disease in which Cxxc1 is expressed at low levels or absent in Treg cells? Is the same immunodeficiency phenotype present in patients as in mice?

      This is indeed a very meaningful and intriguing question, and we are equally interested in understanding whether low or absent Cxxc1 expression in Treg cells is associated with any human diseases. However, despite an extensive review of the literature and available data, we found no reports linking Cxxc1 deficiency in Treg cells to immunodeficiency phenotypes in patients comparable to those observed in mice.

      Reviewer #3 (Public review):

      In the report entitled "CXXC-finger protein 1 associates with FOXP3 to stabilize homeostasis and suppressive functions of regulatory T cells", the authors demonstrated that Cxxc1-deletion in Treg cells leads to the development of severe inflammatory disease with impaired suppressive function. Mechanistically, CXXC1 interacts with Foxp3 and regulates the expression of key Treg signature genes by modulating H3K4me3 deposition. Their findings are interesting and significant. However, there are several concerns regarding their analysis and conclusions.

      Major concerns:

      (1) Despite cKO mice showing an increase in Treg cells in the lymph nodes and Cxxc1-deficient Treg cells having normal suppressive function, the majority of cKO mice died within a month. What causes cKO mice to die from severe inflammation?

      Considering the results of Figures 4 and 5, a decrease in the Treg cell population due to their reduced proliferative capacity may be one of the causes. It would be informative to analyze the population of tissue Treg cells.

      Thank you for your insightful observation regarding the mortality of cKO mice despite increased Treg cells in lymph nodes and the normal suppressive function of Cxxc1-deficient Treg cells.

      As suggested, we hypothesized that the reduction of tissue-resident Treg cells could be a key factor. Additional experiments revealed a significant decrease in Treg cell populations in the small intestine lamina propria (LPL), liver, and lung of cKO mice. These findings highlight the critical role of tissue-resident Treg cells in preventing systemic inflammation.

      This reduction aligns with Figures 4 and 5, which demonstrate impaired proliferation and survival of Cxxc1-deficient Treg cells. Together, these defects lead to insufficient Treg populations in peripheral tissues, escalating localized inflammation into systemic immune dysregulation and early mortality.

      These additional results have been incorporated into the revised manuscript (Page21, lines 424-427, Figure 3G and Figure S3C).

      (2) In Figure 5B, scRNA-seq analysis indicated that the Mki67+ Treg subset is comparable between WT and Cxxc1-deficient Treg cells. On the other hand, FACS analysis demonstrated that Cxxc1-deficient Treg shows less Ki-67 expression compared to WT in Figure 5I. The authors should explain this discrepancy.

      Thank you for pointing out the apparent discrepancy between the scRNA-seq and FACS analyses regarding Ki-67 expression in Cxxc1-deficient Treg cells.

      In Figure 5B, the scRNA-seq analysis identified the Mki67+ Treg subset as comparable between WT and Cxxc1-deficient Treg cells. This finding reflects the overall proportion of cells expressing Mki67 transcripts within the Treg population. In contrast, the FACS analysis in Figure 5I specifically measures Ki-67 protein levels, revealing reduced expression in Cxxc1-deficient Treg cells compared to WT.

      To resolve this discrepancy, we performed additional analyses of the scRNA-seq data to directly compare the expression levels of Mki67 mRNA between WT and Cxxc1-deficient Treg cells. The results revealed a consistent reduction in Mki67 transcript levels in Cxxc1-deficient Treg cells, aligning with the reduced Ki-67 protein levels observed by FACS.

      These new analyses have been included in the revised manuscript (Author response image 1) to clarify this point and demonstrate consistency between the scRNA-seq and FACS data.

      Author response image 1.

      Violin plots displaying the expression levels of Mki67 in T<sub>reg</sub> cells from Foxp3<sup>cre</sup> and Foxp3<sup>cre</sup>Cxxc1<sup>fl/fl</sup> mice.

      In addition, the authors concluded on line 441 that CXXC1 plays a crucial role in maintaining Treg cell stability. However, there appears to be no data on Treg stability. Which data represent the Treg stability?

      Thank you for your valuable comment. We agree that our wording in line 441 may have been too conclusive. Our data focus on the impact of Cxxc1 deficiency on Treg cell homeostasis and transcriptional regulation, rather than directly measuring Treg cell stability. Specifically, the downregulation of Treg-specific suppressive genes and upregulation of pro-inflammatory markers suggest a shift in Treg cell function, which points to disrupted homeostasis rather than stability.

      We have revised the manuscript to clarify that CXXC1 plays a crucial role in maintaining Treg cell function and homeostasis, rather than stability (Page 24, lines 489-491).

      (3) The authors found that Cxxc1-deficient Treg cells exhibit weaker H3K4me3 signals compared to WT in Figure 7. This result suggests that Cxxc1 regulates H3K4me3 modification via H3K4 methyltransferases in Treg cells. The authors should clarify which H3K4 methyltransferases contribute to the modulation of H3K4me3 deposition by Cxxc1 in Treg cells.

      We appreciate the reviewer’s insightful comment regarding the role of H3K4 methyltransferases in regulating H3K4me3 deposition by CXXC1 in Treg cells.

      CXXC1 has been reported to function as a non-catalytic component of the Set1/COMPASS complex, which includes the H3K4 methyltransferases SETD1A and SETD1B—key enzymes responsible for H3K4 trimethylation(1-4). Based on these findings, we propose that CXXC1 modulates H3K4me3 levels in Treg cells by interacting with and stabilizing the activity of the Set1/COMPASS complex.

      These revisions are further discussed in the Discussion (Page 30-31, lines 624-632).

      Furthermore, it would be important to investigate whether Cxxc1-deletion alters Foxp3 binding to target genes.

      Thank you for raising this important point. To address your suggestion, we performed CUT&Tag experiments and found that Cxxc1 deletion does not alter FOXP3 binding patterns in Treg cells. Most FOXP3-bound regions in WT Treg cells were similarly enriched in KO Treg cells, indicating that Cxxc1 deficiency does not impair FOXP3’s DNA-binding ability. These results have been added to the revised manuscript (Page 28, lines 567-575, Figure S8A-B) and are further discussed in the Discussion (Pages 28-29, lines 581-587).

      (4) In Figure 7, the authors concluded that CXXC1 promotes Treg cell homeostasis and function by preserving the H3K4me3 modification since Cxxc1-deficient Treg cells show lower H3K4me3 densities at the key Treg signature genes. Are these Cxxc1-deficient Treg cells derived from mosaic mice? If Cxxc1-deficient Treg cells are derived from cKO mice, the gene expression and H3K4me3 modification status are inconsistent because scRNA-seq analysis indicated that expression of these Treg signature genes was increased in Cxxc1-deficient Treg cells compared to WT (Figure 5F and G).

      Thank you for your insightful comment. To clarify, the Cxxc1-deficient Treg cells analyzed for H3K4me3 modifications in Figure 7 were derived from Cxxc1 conditional knockout (cKO) mice, not mosaic mice.

      Regarding the apparent inconsistency between reduced H3K4me3 levels and the increased expression of Treg signature genes observed in scRNA-seq analysis (Figure 5F and G), we believe this discrepancy can be attributed to distinct mechanisms regulating gene expression. H3K4me3 is an epigenetic mark that facilitates chromatin accessibility and transcriptional regulation, reflecting upstream chromatin dynamics. However, gene expression levels are influenced by a combination of factors, including transcriptional activators, downstream compensatory mechanisms, and the inflammatory environment in cKO mice.

      The upregulation of Treg signature genes in scRNA-seq data likely reflects an activated or pro-inflammatory state of Cxxc1-deficient Treg cells in response to systemic inflammation, as previously described in the manuscript. This contrasts with the intrinsic reduction in H3K4me3 levels at these loci, indicating a loss of epigenetic regulation by CXXC1.

      To further support this interpretation, RNA-seq analysis of Treg cells from Foxp3<sup>Cre/+</sup> Cxxc1<sup>fl/fl</sup> (“het-KO”) and their littermate Foxp3<sup>Cre/+</sup> Cxxc1<sup>fl/+</sup> (“het-WT”) female mice (Figure S6C) revealed a significant reduction in key Treg signature genes such as Icos, Ctla4, Tnfrsf18, and Nt5e in het-KO Treg cells. These results align with the diminished H3K4me3 modifications observed in cKO Treg cells, further underscoring the role of CXXC1 as an epigenetic regulator.

      In summary, while the gene expression changes observed in scRNA-seq may reflect adaptive responses to inflammation, the reduced H3K4me3 modifications directly highlight the critical role of CXXC1 in maintaining the epigenetic landscape essential for Treg cell homeostasis and function.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      In Figure 7E, the y-axis scale for H3K4me3 peaks at the Ctla4 locus should be consistent between WT and cKO samples.

      We thank the reviewer for pointing out the inconsistency in the y-axis scale for the H3K4me3 peaks at the Ctla4 locus in Figure 7E. We have carefully revised the figure to ensure that the y-axis scale is now consistent between the WT and cKO samples.

      We appreciate the reviewer’s attention to this detail, as it enhances the rigor of the data presentation. Please find the updated Figure 7E in the revised manuscript.

      Reviewer #2 (Recommendations for the authors):

      In lines 455 and 466, the name of Treg signature markers validated by flow cytometry should be written as protein name and capitalized.

      Thank you for pointing this out. We have carefully reviewed lines 455 and 466 and have revised the text to ensure that the Treg signature markers validated by flow cytometry are referred to using their protein names, with proper capitalization.

      Reviewer #3 (Recommendations for the authors):

      (1) On line 431, "Cxxc1-deficient cells" should be Cxxc1-deficient Treg cells".

      We thank the reviewer for highlighting this oversight. On line 431, we have revised "Cxxc1-deficient cells" to "Cxxc1-deficient Treg cells" to provide a more accurate and specific description. We appreciate the reviewer's attention to detail, as this correction improves the precision of our manuscript.

      (2) In Figure 4H, negative values should be removed from the y-axis.

      Thank you for your observation. We have revised Figure 4H to remove the negative values from the y-axis, as requested. This adjustment ensures a more accurate and meaningful representation of the data.

      (3) It is better to provide the lists of overlapping genes in Figure 7C.

      Thank you for your suggestion. We agree that providing the lists of overlapping genes in Figure 7C would enhance the clarity and reproducibility of the results. We have now included the gene lists as supplementary information (Supplementary Table 3) accompanying Figure 7C.

      (1) Lee, J. H. & Skalnik, D. G. CpG-binding protein (CXXC finger protein 1) is a component of the mammalian set1 histone H3-Lys4 methyltransferase complex, the analogue of the yeast Set1/COMPASS complex. Journal of Biological Chemistry 280, 41725-41731, doi:10.1074/jbc.M508312200 (2005).

      (2) Thomson, J. P., Skene, P. J., Selfridge, J., Clouaire, T., Guy, J., Webb, S., Kerr, A. R. W., Deaton, A., Andrews, R., James, K. D., Turner, D. J., Illingworth, R. & Bird, A. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 464, 1082-U1162, doi:10.1038/nature08924 (2010).

      (3) Shilatifard, A. in Annual Review of Biochemistry, Vol 81 Vol. 81 Annual Review of Biochemistry (ed R. D. Kornberg)  65-95 (2012).

      (4) Brown, D. A., Di Cerbo, V., Feldmann, A., Ahn, J., Ito, S., Blackledge, N. P., Nakayama, M., McClellan, M., Dimitrova, E., Turberfield, A. H., Long, H. K., King, H. W., Kriaucionis, S., Schermelleh, L., Kutateladze, T. G., Koseki, H. & Klose, R. J. The SET1 Complex Selects Actively Transcribed Target Genes via Multivalent Interaction with CpG Island Chromatin. Cell Reports 20, 2313-2327, doi:10.1016/j.celrep.2017.08.030 (2017).

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Zhang et al. describe a delicate relationship between Tet2 and FBP1 in the regulation of hepatic gluconeogenesis.

      Strengths:

      The studies are very mechanistic, indicating that this interaction occurs via demethylation of HNF4a. Phosphorylation of HNF4a at ser 313 induced by metformin also controls the interaction between Tet2 and FBP1.

      We are grateful for the reviewer's praise on the manuscript.

      Weaknesses:

      The results are briefly described, and oftentimes, the necessary information is not provided to interpret the data. Similarly, the methods section is not well developed to inform the reader about how these experiments were performed. While the findings are interesting, the results section needs to be better developed to increase confidence in the interpretation of the results.

      Thanks very much for pointing out the shortcomings of the manuscript. We apologize that we did not provide detailed description for some experimental methods and results. Following reviewer’s suggestion, we added the details in method section, including the generation of whole-body Tet2 KO mice and liver-specific Tet2 knockdown mice (AAV8-shTet2), the missing information of reagent, antibody, primer sequences and mutant generation, and the methods of chromatin immunoprecipitation (ChIP) and immunofluorescence. The interpretation of the results was also further developed according to reviewer’s comments.

      Reviewer #2 (Public review):

      Summary:

      This study reveals a novel role of TET2 in regulating gluconeogenesis. It shows that fasting and a high-fat diet increase TET2 expression in mice, and TET2 knockout reduces glucose production. The findings highlight that TET2 positively regulates FBP1, a key enzyme in gluconeogenesis, by interacting with HNF4α to demethylate the FBP1 promoter in response to glucagon. Additionally, metformin reduces FBP1 expression by preventing TET2-HNF4α interaction. This identifies an HNF4α-TET2-FBP1 axis as a potential target for T2D treatment.

      Strengths:

      The authors use several methods in vivo (PTT, GTT, and ITT in fasted and HFD mice; and KO mice) and in vitro (in HepG2 and primary hepatocytes) to support the existence of the HNF4alpha-TET-2-FBP-1 axis in the control of gluconeogenesis. These findings uncovered a previously unknown function of TET2 in gluconeogenesis.

      We are grateful for the reviewer's praise on the manuscript.

      Weaknesses:

      Although the authors provide evidence of an HNF4α-TET2-FBP1 axis in the control of gluconeogenesis, which contributes to the therapeutic effect of metformin on T2D, its role in the pathogenesis of T2D is less clear. The mechanisms by which TET2 is up-regulated by glucagon should be more explored.

      Thanks very much for pointing out the shortcomings of the manuscript. We agree with the reviewer that the manuscript is focused on the function of HNF4α-TET2-FBP1 axis in the control of gluconeogenesis, but not on its role in the pathogenesis of T2D. Following reviewer’s suggestion, we changed the title of the manuscript to “HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetes”. For the mechanisms by which TET2 is up-regulated by glucagon, we examined TET2 mRNA levels at different time points after a single dose of glucagon treatment in HepG2 cells. Interestingly, the results showed that TET2 mRNA levels significantly increased by 6 folds at 30 min and the sustained effect of glucagon on Tet2 mRNA levels persisted for more than 48 hours (refer to Fig. 3E).

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):<br /> The authors indicate that they have overexpressed TET2 in HepG2 cells and primary mouse hepatocytes. The degree of overexpression should be shown. Is this similar to an increase in TET2 with fasting or HFD treatment?

      Thanks for reviewer’s helpful comment. Following reviewer’s suggestion, we examined the protein levels of overexpressed TET2 in HepG2 cells and primary mouse hepatocytes. The results revealed that the degree of TET2 overexpression (refer to Fig. 3J) is similar to the increase of TET2 under fasting or HFD treatment (Fig. 1C, D).

      In Figures 2E-2G, the authors report results in Tet2-KO mice. Information on how these mice were generated is lacking. There is limited information about how Tet2-KO cells were generated, but again, I could not find anything about these mice in the methods section or figure legend. Is this whole-body or liver-specific Tet2-KO? How old were the mice at the time of PTT, GTT, or ITT?

      Were these mice on chow or HFD? Are there any differences in body weight between WT and Tet2-KO mice?

      Thanks for reviewer’s helpful comment. Following reviewer’s suggestion, we provided the detailed information about the Tet2-KO mice, including the mouse generation in methods section. Moreover, the details of Tet2-KO mice used in each figure were clearly described in the figure legend. In this study, two mouse models were employed: whole-body Tet2-KO mice and liver-specific TET2 knockdown mice (AAV8-shTet2). The mice used for PTT, GTT and ITT were 8 weeks old and on HFD. To address reviewer’s concern, we compared the body weight of WT and Tet2-KO mice and results revealed that no significant differences in the body weight between WT and Tet2-KO mice at 8 and 10 weeks old when on a normal chow diet, as depicted in Figure 2I.

      Figures 3A-C shows that 48 hours after glucagon treatment, Tet2 and FBP1 mRNA increased. It's surprising that a single dose of glucagon would have effects that last that long. The peak rise in glucose following glucagon treatment occurs in 30 minutes. How do authors explain such a long effect of glucagon on Tet2 mRNA and protein?

      Thanks for reviewer’s constructive comment. To address reviewer’s concern, we examined the mRNA levels of TET2 and FBP1 at different time points following a single dose of glucagon treatment in HepG2 cells. Interestingly, the results showed that TET2 mRNA levels significantly increased by 6 folds at 30 min and the sustained effect of glucagon on Tet2 mRNA levels persisted for more than 48 hours (refer to Fig. 3E). The detailed mechanism underlying long effect of glucagon on Tet2 mRNA and protein needs further exploration.

      It's interesting that in Figure 3F, Fbp1 and Tet2 mRNA expression correlated positively in both ad libitum and fasting conditions. I would expect that during fed conditions, gluconeogenesis would not be activated and thus would expect no correlation.

      Thanks for reviewer’s constructive comment. According to the results in new Fig. 3H, the mRNA levels of Fbp1 and Tet2 indeed positively correlated in both ad libitum and fasting conditions, while the r value is higher and p value is lower in fasting condition compared to ad libitum. Notably, both the expression levels of Fbp1 and Tet2 increased under fasting treatment, which is consistent with Fig. 1C and Fig. 4K.

      The authors state that "Our results demonstrated that HNF4α recruits TET2 to the FBP1 promoter and activates FBP1 expression through demethylation" What data points out that this is mediated through demethylation?

      Thanks for reviewer’s constructive comment. Following reviewer’s suggestion, we conducted new ChIP experiments. These data demonstrated that HNF4α recruits TET2 to the FBP1 promoter and activates FBP1 expression through demethylation, as showed in Fig. 4F-H.

      For Figures 5B, 4D, and 3L-N y-axes are labeled as fold enrichment. The authors should clearly indicate what was being measured on y-axes.

      Thanks for reviewer’s helpful comment. Following reviewer’s suggestion, we clearly labeled all the y-axes in each figure.

      The authors indicate that metformin increases phosphorylation of Hnf4a at ser 313 Figure 5C. How do we know that ser 313 is involved? Only one antibody is listed for Hnf4a (SAB, 32591).

      Thanks very much for pointing out. We determined the phosphorylation levels of HNF4α at S313 using Anti-HNF4α (phospho S313) (ab78356), we apologize for not labeling it clearly. Now, we made it clear in Fig. 5C and the detailed information of the antibody was added to the method section of “Western Blot and Immunoprecipitation”.

      How did the authors make phosphomimetic mutation (S313D) and phosphoresistant mutation (S313A) of HNF4α? This is not described.

      Thanks very much for pointing out. Following reviewer’s suggestion, the detailed method for making phosphomimetic mutation (S313D) and phosphoresistant mutation (S313A) of HNF4α was added to the method section of “Gene Knockout Cells and Mutagenesis”.

      Reviewer #2 (Recommendations for the authors):

      Major points:

      (1) Other key gluconeogenesis genes (e.g. PEPCK and G6Pase) should have been investigated to demonstrate whether or not the regulation of TET-2 is specific on FBP-1.

      Thanks for reviewer’s helpful comment. Following reviewer’s suggestion, we designed the qPCR to assay other key gluconeogenesis genes, including PEPCK and G6Pase, and the results showed that glucagon treatment had no effect on PEPCK and G6Pase expression (Fig. 3D), suggesting the regulation of TET2 is specific on FBP1.

      (2) The methods are not well defined and more details should be given, for example, to explain how the Tet2 KO mice were generated. Since these animals are not KO liver-specific and TET2 is expressed in a variety of tissues and organs and is predominantly found in hematopoietic cells, including bone marrow and blood cells, the phenotype of these mice should be better characterized.

      Thanks for reviewer’s helpful comment. The Tet2 knockout (Tet2 KO) mice were originally purchased from the Jackson Laboratory (strain No. 023359) and we added the detailed information to method section of “Animal”. According to the previously reported phenotype of Tet2 KO mice, it mainly includes bone marrow, spleen, islet and heart. Specifically, Tet2 KO mice led to an increase of total cell numbers in the bone marrow and spleen (PMID: 21873190), as well as an elevated white blood cell (WBC) count (PMID: 37541212). Additionally, Tet2 KO mice exhibited splenomegaly (PMID: 37541212, PMID: 21723200, PMID: 38773071, PMID: 21723200). And the morphology of the islets (PMID: 34417463), anatomical chamber volumes or ventricular functions (PMID: 38357791) were indistinguishable between the Tet2 KO and wild type (WT) mice.

      (3) An experiment showing the co-localization of TET2 and HNF4α in the mouse liver in fasted mice and/or in HFD-mice would strengthen the data shown in Figure 3.

      Thanks for reviewer’s helpful comment. Following reviewer’s suggestion, the experiments showing the co-localization of TET2 and HNF4α in the mouse liver in fasted mice and FD mice were conducted, as shown in new Fig. 4B and C.

      Minor points:

      (1) Given that the manuscript does not focus on the role of TET2 in the pathogenesis of T2D, its title should be changed.

      hanks for reviewer’s helpful comment. Following reviewer’s suggestion, we changed the title of the manuscript to “HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetes”.

      (2) Please indicate the molecular weight of bands in all figures.

      Thanks for reviewer’s helpful comment. Following reviewer’s suggestion, the molecular weight of bands was indicated in all figures.

      (3) Why do the control values of the y-axis in Figure 1 A and B are so different? Please maintain the same scale in both figures.

      Thanks for reviewer’s helpful comment. Following reviewer’s suggestion, we recalculated and normalized the control value in Fig. 1A to maintain the same scale in both figures.

      (4) In Figure 2F, do the plasma insulin levels have altered in response to GTT in Tet2-KO mice? If so, please show the data and discuss.

      Thanks for reviewer’s helpful comment. Following reviewer’s suggestion, we examined the plasma insulin levels in the process of GTT assay, and the result revealed that Tet2-KO mice showed lower insulin levels after glucose administration, which reflects higher insulin sensitivity, as shown in new Fig. 2H.

      (5) The increase of TET2 hepatic protein levels in response to fasting occur in other tissues and hematopoietic cells?

      Thanks for reviewer’s helpful comment. Following reviewer’s suggestion, we examined Tet2 protein levels under fasting condition in other tissues and hematopoietic cells, and found that fasting also increased Tet2 protein levels in kidney, brain, and hematopoietic cells, but not in heart.

      Author response image 1.

      (6) Please indicate the glucagon concentration and metformin dose in all figures in which they are mentioned.

      Thanks for reviewer’s helpful comment. Following reviewer’s suggestion, the glucagon concentration (20 nM) and metformin concentration (10 mM for HepG2 cell treatment and 300 mg/kg per day for mice treatment) were added in the figure legends, respectively.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      In the current manuscript, the authors use theoretical and analytical tools to examine the possibility of neural projections to engage ensembles of synaptic clusters in active dendrites. The analysis is divided into multiple models that differ in the connectivity parameters, speed of interactions, and identity of the signal (electric vs. second messenger). They first show that random connectivity almost ensures the representation of presynaptic ensembles. As expected, this convergence is much more likely for small group sizes and slow processes, such as calcium dynamics. Conversely, fast signals (spikes and postsynaptic potentials) and large groups are much less likely to recruit spatially clustered inputs. Dendritic nonlinearity in the postsynaptic cells was found to play a highly important role in distinguishing these clustered activation patterns, both when activated simultaneously and in sequence. The authors tackled the difficult issue of noise, showing a beneficiary effect when noise 'happens' to fill in gaps in a sequential pattern but degraded performance at higher background activity levels. Last, the authors simulated selectivity to chemical and electrical signals. While they find that longer sequences are less perturbed by noise, in more realistic activation conditions, the signals are not well resolved in the soma.

      While I think the premise of the manuscript is worth exploring, I have a number of reservations regarding the results.

      (1) In the analysis, the authors made a simplifying assumption that the chemical and electrical processes are independent. However, this is not the case; excitatory inputs to spines often trigger depolarization combined with pronounced calcium influx; this mixed signaling could have dramatic implications on the analysis, particularly if the dendrites are nonlinear (see below)

      We thank the reviewer for pointing out that we were not entirely clear about the strong basis upon which we had built our analyses of nonlinearity. In the previous version we had relied on published work, notably (Bhalla 2017), which does include these nonlinearities. However, we agree it is preferable to unambiguously demonstrate all the reported selectivity properties in a single model with all the nonlinearities discussed. We have now done so. This is now reported in the paper:

      “A single model exhibits multiple forms of nonlinear dendritic selectivity

      We implemented all three forms of selectivity described above, in a single model which included six voltage and calcium-gated ion channels, NMDA, AMPA and GABA receptors, and chemical signaling processes in spines and dendrites. The goal of this was three fold: To show how these nonlinear operations emerge in a mechanistically detailed model, to show that they can coexist, and to show that they are separated in time-scales. We implemented a Y-branched neuron model with additional electrical compartments for the dendritic spines (Methods). This model was closely based on a published detailed chemical-electrical model (Bhalla 2017). We stimulated this model with synaptic input corresponding to the three kinds of spatiotemporal patterns described in figures Figure 8 - Supplement 1 (sequential synaptic activity triggering electrical sequence selectivity), Figure 8 - Supplement 2 (spatially grouped synaptic stimuli leading to local Ca4_CaM activation), and Figure 8 - Supplement 3 (sequential bursts of synaptic activity triggering chemical sequence selectivity). We found that each of these mechanisms show nonlinear selectivity with respect to both synaptic spacing and synaptic weights. Further, these forms of selectivity coexist in the composite model (Figure 8 Supplements 1, 2, 3), separated by the time-scales of the stimulus patterns (~ 100 ms, ~ 1s and ~10s respectively). Thus mixed signaling in active nonlinear dendrites yields selectivity of the same form as we explored in simpler individual models. A more complete analysis of the effect of morphology, branching and channel distributions deserves a separate in-depth analysis, and is outside the scope of the current study.”

      (2) Sequence detection in active dendrites is often simplified to investigating activation in a part of or the entirety of individual branches. However, the authors did not do that for most of their analysis. Instead, they treat the entire dendritic tree as one long branch and count how many inputs form clusters. I fail to see why simplification is required and suspect it can lead to wrong results. For example, two inputs that are mapped to different dendrites in the 'original' morphology but then happen to fall next to each other when the branches are staggered to form the long dendrites would be counted as neighbors.

      We have added the below section within the main text in the section titled “Grouped Convergence of Inputs” to address the effect of branching.

      “End-effects limit convergence zones for highly branched neurons

      Neurons exhibit considerable diversity with respect to their morphologies. How synapses extending across dendritic branch points interact in the context of a synaptic cluster/group, is a topic that needs detailed examination via experimental and modeling approaches. However for the sake of analysis, we present calculations under the assumption that selectivity for grouped inputs might be degraded across branch points.

      Zones beginning close to a branch point might get interrupted. Consider a neuron with B branches. The length of the typical branch would be L/B. As a conservative estimate if we exclude a region of length Z for every branch, the expected number of zones that begin too close to a branch point is

                                                                          [Equation 3]

      For typical pyramidal neurons B~50, so Eend ~ 0.05 for values of Z of ~10 µm. Thus pyramidal neurons will not be much affected by branching effects, Profusely branching neurons like Purkinje cells have B~900 for a total L of ~7800 µm, (McConnell and Berry, 1978), hence Eend ~1 for values of Z of ~10 µm. Thus almost all groups in Purkinje neurons would run into a branch point or terminal. For the case of electrical groups, this estimate would be scaled by a factor of 5 if we consider a zone length of 50 µm. However, it is important to note that these are very conservative estimates, as for clusters of 4-5 inputs, the number of synapses available within a zone are far greater (~100 synapses within 50 µm).”

      (3) The simulations were poorly executed. Figures 5 and 6 show examples but no summary statistics.

      We have included the summary statistics in Figure 5F and Figure 6E. The statistics for both these panels were generated by simulating multiple spatiotemporal combinations of ectopic input in the presence of different stimulus patterns for each sequence length.

      The authors emphasize the importance of nonlinear dendritic interactions, but they do not include them in their analysis of the ectopic signals! I find it to be wholly expected that the effects of dendritic ensembles are not pronounced when the dendrites are linear.

      We would like to clarify that both Figures 5 and 6 already included nonlinearities. In Figure 5, the chemical mechanism involving the bistable switch motif is strongly selective for ordered inputs in a nonlinear manner. A separate panel highlighting this (Panel C) has now been included in Figure 5. This result had been previously shown in Figure 3I of (Bhalla 2017). We have reproduced it in Figure 5C.

      The published electrical model used in Figure 6 also has a nonlinearity which predominantly stems from the interaction of the impedance gradient along the dendrite with the voltage dependence of NMDARs. Check Figure 4C,D of (Branco, Clark, and Häusser 2010).

      To provide a comprehensive analysis of dendritic integration, the authors could simulate more realistic synaptic conductances and voltage-gated channels. They would find much more complicated interactions between inputs on a single site, a sliding temporal and spatial window of nonlinear integration that depends on dendritic morphology, active and passive parameters, and synaptic properties. At different activation levels, the rules of synaptic integration shift to cooperativity between different dendrites and cellular compartments, further complicated by nonlinear interactions between somatic spikes and dendritic events.

      We would like to clarify two points. First, the key goal of our study was to understand the role played by random connectivity in giving rise to clustered computation. In this revision we provide simulations to show the mechanistic basis for the nonlinearities, and then abstracted these out in order to scale the analysis to networks. These nonlinearities were taken as a given, though we elaborated previous work slightly in order to address the question of ectopic inputs. Second, in our original submission we relied on published work for the estimates of dendritic nonlinearities. Previous work from (Poirazi, Brannon, and Mel 2003; Branco, Clark, and Häusser 2010; Bhalla 2017) have already carried out highly detailed realistic simulations, and in some cases including chemical and electrical nonlinearities as the reviewer mentions (Bhalla 2017). Hence we did not feel that this needed to be redone.

      In this resubmission we have addressed the above and two additional concerns, namely whether the different forms of selectivity can coexist in a single model including all these nonlinearities, and whether there is separation of time-scales. The answer is yes to both. The outcome of this is presented in Figure 8 and the associated supplementary figures, and all simulation details are provided on the github repository associated with this paper. A more complete analysis of interaction of multiple nonlinearities in a detailed model is material for further study.

      While it is tempting to extend back-of-the-napkin calculations of how many inputs can recruit nonlinear integration in active dendrites, the biological implementation is very different from this hypothetical. It is important to consider these questions, but I am not convinced that this manuscript adequately addressed the questions it set out to probe, nor does it provide information that was unknown beforehand.

      We developed our analysis systematically, and perhaps the reviewer refers to the first few calculations as back-of-the-napkin. However, the derivation rapidly becomes more complex when we factor in combinatorics and the effect of noise. This derivation is in the supplementary material. Furthermore, the exact form of the combinatorial and noise equations was non-trivial to derive and we worked closely with the connectivity simulations (Figures 2 and 4) to obtain equations which scale across a large parameter space by sampling connectivity for over 100000 neurons and activity over 100 trials for each of these neurons for each network configuration we have tested.

      the biological implementation is very different from this hypothetical.

      We do not quite understand in what respect the reviewer feels that this calculation is very different from the biological implementation. The calculation is about projection patterns. In the discussion we consider at length how our findings of selectivity from random projections may be an effective starting point for more elaborate biological connection rules. We have added the following sentence:

      “We present a first-order analysis of the simplest kind of connectivity rule (random), upon which more elaborate rules such as spatial gradients and activity-dependent wiring may be developed.”

      In case the reviewer was referring to the biological implementation of nonlinear integration, we treat the nonlinear integration in the dendrites as a separate set of simulations, most of which are closely based on published work (Bhalla 2017). We use these in the later sections of the paper to estimate selectivity terms, which inform our final analysis.

      In the revision we have worked to clarify this progression of the analysis. As indicated above, we have also made a composite model of all of the nonlinear dendritic mechanisms, chemical and electrical, which underlie our analysis.

      nor does it provide information that was unknown beforehand.

      We conducted a broad literature survey and to the best of our knowledge these calculations and findings have not been obtained previously. If the reviewer has some specific examples in mind we would be pleased to refer to it.

      Reviewer #2 (Public Review):

      Summary:

      If synaptic input is functionally clustered on dendrites, nonlinear integration could increase the computational power of neural networks. But this requires the right synapses to be located in the right places. This paper aims to address the question of whether such synaptic arrangements could arise by chance (i.e. without special rules for axon guidance or structural plasticity), and could therefore be exploited even in randomly connected networks. This is important, particularly for the dendrites and biological computation communities, where there is a pressing need to integrate decades of work at the single-neuron level with contemporary ideas about network function.

      Using an abstract model where ensembles of neurons project randomly to a postsynaptic population, back-of-envelope calculations are presented that predict the probability of finding clustered synapses and spatiotemporal sequences. Using data-constrained parameters, the authors conclude that clustering and sequences are indeed likely to occur by chance (for large enough ensembles), but require strong dendritic nonlinearities and low background noise to be useful.

      Strengths:

      (1) The back-of-envelope reasoning presented can provide fast and valuable intuition. The authors have also made the effort to connect the model parameters with measured values. Even an approximate understanding of cluster probability can direct theory and experiments towards promising directions, or away from lost causes.

      (2) I found the general approach to be refreshingly transparent and objective. Assumptions are stated clearly about the model and statistics of different circuits. Along with some positive results, many of the computed cluster probabilities are vanishingly small, and noise is found to be quite detrimental in several cases. This is important to know, and I was happy to see the authors take a balanced look at conditions that help/hinder clustering, rather than to just focus on a particular regime that works.

      (3) This paper is also a timely reminder that synaptic clusters and sequences can exist on multiple spatial and temporal scales. The authors present results pertaining to the standard `electrical' regime (~50-100 µm, <50 ms), as well as two modes of chemical signaling (~10 µm, 100-1000 ms). The senior author is indeed an authority on the latter, and the simulations in Figure 5, extending those from Bhalla (2017), are unique in this area. In my view, the role of chemical signaling in neural computation is understudied theoretically, but research will be increasingly important as experimental technologies continue to develop.

      Weaknesses:

      (1) The paper is mostly let down by the presentation. In the current form, some patience is needed to grasp the main questions and results, and it is hard to keep track of the many abbreviations and definitions. A paper like this can be impactful, but the writing needs to be crisp, and the logic of the derivation accessible to non-experts. See, for instance, Stepanyants, Hof & Chklovskii (2002) for a relevant example.

      It would be good to see a restructure that communicates the main points clearly and concisely, perhaps leaving other observations to an optional appendix. For the interested but time-pressed reader, I recommend starting with the last paragraph of the introduction, working through the main derivation on page 7, and writing out the full expression with key parameters exposed. Next, look at Table 1 and Figure 2J to see where different circuits and mechanisms fit in this scheme. Beyond this, the sequence derivation on page 15 and biophysical simulations in Figures 5 and 6 are also highlights.

      We appreciate the reviewers' suggestions. We have tightened the flow of the introduction. We understand that the abbreviations and definitions are challenging and have therefore provided intuitions and summaries of the equations discussed in the main text.

      Clusters calculations

      “Our approach is to ask how likely it is that a given set of inputs lands on a short segment of dendrite, and then scale it up to all segments on the entire dendritic length of the cell.

      Thus, the probability of occurrence of groups that receive connections from each of the M ensembles (PcFMG) is a function of the connection probability (p) between the two layers, the number of neurons in an ensemble (N), the relative zone-length with respect to the total dendritic arbor (Z/L) and the number of ensembles (M).”

      Sequence calculations

      “Here we estimate the likelihood of the first ensemble input arriving anywhere on the dendrite, and ask how likely it is that succeeding inputs of the sequence would arrive within a set spacing.

      Thus, the probability of occurrence of sequences that receive sequential connections (PcPOSS) from each of the M ensembles is a function of the connection probability (p) between the two layers, the number of neurons in an ensemble (N), the relative window size with respect to the total dendritic arbor (Δ/L) and the number of ensembles (M).”

      (2) I wonder if the authors are being overly conservative at times. The result highlighted in the abstract is that 10/100000 postsynaptic neurons are expected to exhibit synaptic clustering. This seems like a very small number, especially if circuits are to rely on such a mechanism. However, this figure assumes the convergence of 3-5 distinct ensembles. Convergence of inputs from just 2 ense mbles would be much more prevalent, but still advantageous computationally. There has been excitement in the field about experiments showing the clustering of synapses encoding even a single feature.

      We agree that short clusters of two inputs would be far more likely. We focused our analysis on clusters with three of more ensembles because of the following reasons:

      (1) The signal to noise in these clusters was very poor as the likelihood of noise clusters is high.

      (2) It is difficult to trigger nonlinearities with very few synaptic inputs.

      (3) At the ensemble sizes we considered (100 for clusters, 1000 for sequences), clusters arising from just two ensembles would result in high probability of occurrence on all neurons in a network (~50% in cortex, see p_CMFG in figures below.). These dense neural representations make it difficult for downstream networks to decode (Foldiak 2003).

      However, in the presence of ensembles containing fewer neurons or when the connection probability between the layers is low, short clusters can result in sparse representations (Figure 2 - Supplement 2). Arguments 1 and 2 hold for short sequences as well.

      (3) The analysis supporting the claim that strong nonlinearities are needed for cluster/sequence detection is unconvincing. In the analysis, different synapse distributions on a single long dendrite are convolved with a sigmoid function and then the sum is taken to reflect the somatic response. In reality, dendritic nonlinearities influence the soma in a complex and dynamic manner. It may be that the abstract approach the authors use captures some of this, but it needs to be validated with simulations to be trusted (in line with previous work, e.g. Poirazi, Brannon & Mel, (2003)).

      We agree that multiple factors might affect the influence of nonlinearities on the soma. The key goal of our study was to understand the role played by random connectivity in giving rise to clustered computation. Since simulating a wide range of connectivity and activity patterns in a detailed biophysical model was computationally expensive, we analyzed the exemplar detailed models for nonlinearity separately (Figures 5, 6, and new figure 8), and then used our abstract models as a proxy for understanding population dynamics. A complete analysis of the role played by morphology, channel kinetics and the effect of branching requires an in-depth study of its own, and some of these questions have already been tackled by (Poirazi, Brannon, and Mel 2003; Branco, Clark, and Häusser 2010; Bhalla 2017). However, in the revision, we have implemented a single model which incorporates the range of ion-channel, synaptic and biochemical signaling nonlinearities which we discuss in the paper (Figure 8, and Figure 8 Supplement 1, 2,3). We use this to demonstrate all three forms of sequence and grouped computation we use in the study, where the only difference is in the stimulus pattern and the separation of time-scales inherent in the stimuli.

      (4) It is unclear whether some of the conclusions would hold in the presence of learning. In the signal-to-noise analysis, all synaptic strengths are assumed equal. But if synapses involved in salient clusters or sequences were potentiated, presumably detection would become easier? Similarly, if presynaptic tuning and/or timing were reorganized through learning, the conditions for synaptic arrangements to be useful could be relaxed. Answering these questions is beyond the scope of the study, but there is a caveat there nonetheless.

      We agree with the reviewer. If synapses receiving connectivity from ensembles had stronger weights, this would make detection easier. Dendritic spikes arising from clustered inputs have been implicated in local cooperative plasticity (Golding, Staff, and Spruston 2002; Losonczy, Makara, and Magee 2008). Further, plasticity related proteins synthesized at a synapse undergoing L-LTP can diffuse to neighboring weakly co-active synapses, and thereby mediate cooperative plasticity (Harvey et al. 2008; Govindarajan, Kelleher, and Tonegawa 2006; Govindarajan et al. 2011). Thus if clusters of synapses were likely to be co-active, they could further engage these local plasticity mechanisms which could potentiate them while not potentiating synapses that are activated by background activity. This would depend on the activity correlation between synapses receiving ensemble inputs within a cluster vs those activated by background activity. We have mentioned some of these ideas in a published opinion paper (Pulikkottil, Somashekar, and Bhalla 2021). In the current study, we wanted to understand whether even in the absence of specialized connection rules, interesting computations could still emerge. Thus, we focused on asking whether clustered or sequential convergence could arise even in a purely randomly connected network, with the most basic set of assumptions. We agree that an analysis of how selectivity evolves with learning would be an interesting topic for further work.

      References

      Bhalla, Upinder S. 2017. “Synaptic Input Sequence Discrimination on Behavioral Timescales Mediated by Reaction-Diffusion Chemistry in Dendrites.” Edited by Frances K Skinner. eLife 6 (April):e25827. https://doi.org/10.7554/eLife.25827.

      Branco, Tiago, Beverley A. Clark, and Michael Häusser. 2010. “Dendritic Discrimination of Temporal Input Sequences in Cortical Neurons.” Science (New York, N.Y.) 329 (5999): 1671–75. https://doi.org/10.1126/science.1189664.

      Foldiak, Peter. 2003. “Sparse Coding in the Primate Cortex.” The Handbook of Brain Theory and Neural Networks. https://research-repository.st-andrews.ac.uk/bitstream/handle/10023/2994/FoldiakSparse HBTNN2e02.pdf?sequence=1.

      Golding, Nace L., Nathan P. Staff, and Nelson Spruston. 2002. “Dendritic Spikes as a Mechanism for Cooperative Long-Term Potentiation.” Nature 418 (6895): 326–31. https://doi.org/10.1038/nature00854.

      Govindarajan, Arvind, Inbal Israely, Shu-Ying Huang, and Susumu Tonegawa. 2011. “The Dendritic Branch Is the Preferred Integrative Unit for Protein Synthesis-Dependent LTP.” Neuron 69 (1): 132–46. https://doi.org/10.1016/j.neuron.2010.12.008.

      Govindarajan, Arvind, Raymond J. Kelleher, and Susumu Tonegawa. 2006. “A Clustered Plasticity Model of Long-Term Memory Engrams.” Nature Reviews Neuroscience 7 (7): 575–83. https://doi.org/10.1038/nrn1937.

      Harvey, Christopher D., Ryohei Yasuda, Haining Zhong, and Karel Svoboda. 2008. “The Spread of Ras Activity Triggered by Activation of a Single Dendritic Spine.” Science (New York, N.Y.) 321 (5885): 136–40. https://doi.org/10.1126/science.1159675.

      Losonczy, Attila, Judit K. Makara, and Jeffrey C. Magee. 2008. “Compartmentalized Dendritic Plasticity and Input Feature Storage in Neurons.” Nature 452 (7186): 436–41. https://doi.org/10.1038/nature06725.

      Poirazi, Panayiota, Terrence Brannon, and Bartlett W. Mel. 2003. “Pyramidal Neuron as Two-Layer Neural Network.” Neuron 37 (6): 989–99. https://doi.org/10.1016/S0896-6273(03)00149-1.

      Pulikkottil, Vinu Varghese, Bhanu Priya Somashekar, and Upinder S. Bhalla.     2021.

      “Computation, Wiring, and Plasticity in Synaptic Clusters.” Current Opinion in Neurobiology, Computational Neuroscience, 70 (October):101–12. https://doi.org/10.1016/j.conb.2021.08.001.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      This useful manuscript reports mechanisms behind the increase in fecundity in response to sub-lethal doses of pesticides in the crop pest, the brown plant hopper. The authors hypothesize that the pesticide works by inducing the JH titer, which through the JH signaling pathway induces egg development. Evidence for this is, however, inadequate.

      We greatly appreciate your valuable comments and constructive suggestions for our work. All in all, the manuscript has been carefully edited and improved following your suggestions. We also provide more evidence to support our statements by conducting new experiments. First, we found that also EB treatment of adult females can stimulate egg-laying. Second, EB treatment in female adults increases the number of mature eggs in the ovary and ovarioles. Third, EB treatment in females enhances the expression of the kr-h1 gene in the whole body of BPH. Finally, EB treatment in female adults increases the JHIII titer, but has no impact on the 20E titer.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Gao et al. have demonstrated that the pesticide emamectin benzoate (EB) treatment of brown planthopper (BPH) leads to increased egg-laying in the insect, which is a common agricultural pest. The authors hypothesize that EB upregulates JH titer resulting in increased fecundity.

      Strengths:

      The finding that a class of pesticide increases the fecundity of brown planthopper is interesting.

      We greatly appreciate your positive comments on our work.

      Weaknesses:

      (1) EB is an allosteric modulator of GluCl. That means EB physically interacts with GluCl initiating a structural change in the cannel protein. Yet the authors' central hypothesis here is about how EB can upregulate the mRNA of GluCl. I do not know whether there is any evidence that an allosteric modulator can function as a transcriptional activator for the same receptor protein. The basic premise of the paper sounds counterintuitive. This is a structural problem and should be addressed by the authors by giving sufficient evidence about such demonstrated mechanisms before.

      Thank you for your question. As the reviewer points out, EB physically interacts with its target protein GluCl and thus affects its downstream signaling pathway. In the manuscript, we reported that EB-treated brown planthoppers display increased expression of GluCl in the adult stage (Fig. 5A). Actually, there are many studies showing that insects treated with insecticides can increase the expression of target genes. For example, the relative expression level of the ryanodine receptor gene of the rice stem borer, Chilo suppressalis was increased 10-fold after treatment with chlorantraniliprole, an insecticide which targets the ryanodine receptor (Peng et al., 2017). Besides this, in Drosophila, starvation (and low insulin) elevates the transcription level of the sNPF and tachykinin receptors (Ko et al., 2015; Root et al., 2011). In brown planthoppers, reduction in mRNA and protein expression of a nicotinic acetylcholine receptor α8 subunit is associated with resistance to imidacloprid (Zhang et al., 2015). RNA interference knockdown of α8 gene decreased the sensitivity of N. lugens to imidacloprid (Zhang et al., 2015). Hence, expression of receptor genes can be regulated by diverse factors including insecticide treatment. In our case, we found that EB can upregulate its target gene GluCl. However, we did not claim that EB functions as transcriptional activator for GluCl, and we still do not know why EB treatment changes the expression of GluCl in the brown planthopper. Considering our experiments are lasting several days, it might be an indirect (or secondary) effect caused by other factors, which change the expression of GluCl gene upon EB action of the channel. One reason is maybe that the allosteric interaction with GluCl by EB makes it dysfunctional and the cellular response is to upregulate the channel/receptor to compensate. We have inserted text on lines 738 - 757 to explain these possibilities.

      (2) I am surprised to see a 4th instar larval application or treatment with EB results in the upregulation of JH in the adult stages. Complicating the results further is the observation that a 4th instar EB application results in an immediate decrease in JH titer. There is a high possibility that this late JH titer increase is an indirect effect.

      Thank you for your question. Treatment with low doses or sublethal doses of insecticides might have a strong and complex impact on insects (Gandara et al., 2024; Gong et al., 2022; Li et al., 2023; Martelli et al., 2022). We kept the 4th instar of brown planthoppers feeding on EB for four days. They will develop to 5th instar after four days treatment, which is the final nymphal stage of BPH. Since the brown planthopper is a hemimetabolous insect, we cannot rule out the possibility that an indirect effect of treatment with EB results in the upregulation of JH in the adult stages. In this new revised manuscript, we investigated the impact of EB treatment in the adult stage. We found that female adults treated with EB also laid more eggs than controls (Figure 1-figure supplement 1A). The following experiments were performed in adults to address how EB treated stimulates egg-laying in adult brown planthopper.

      (1) We found that EB treatment in adults increases the number of mature eggs in ovary (new Figure 2-figure supplement 1). We add this results in lines 234 – 238 and 281-285.

      (2) We measured the JH titer after the female adults had been treated with EB. We found that EB can also increase the JH titer but has no impact on the 20E titer in the female adult (Figure 3-S3A and B). We add this results in lines 351 – 356 and 281-285.

      (3) EB treatment in adults increases the gene expression of JHAMT and Kr-h1 (Figure 3-S3C and D). We add this results in lines 378 – 379, lines 387-390 and lines 457-462.

      (3) The writing quality of the paper needs improvement. Particularly with respect to describing processes and abbreviations. In several instances the authors have not adequately described the processes they have introduced, thus confusing readers.

      Thank you for your suggestion. We have thoroughly revised the paper to improve clarity.

      (4) In the section 'EB promotes ovarian development' the authors have shown that EB treatment results in increased detention of eggs which contradicts their own results which show that EB promotes egg laying. Again, this is a serious contradiction that nullifies their hypothesis.

      Thank you for pointing this out. We revised the figure 2B to show number of mature eggs in the ovary. The number of mature eggs in ovaries of females that fed on EB was higher than in control females. We also show that BPH fed with EB laid more eggs than controls. Thus, our results suggest that EB promotes ovary maturation (and egg production) and also increases egg laying (Figure 1 and Table S1). Thus, we found that EB treatment can increase both the production of eggs and increase egg laying. We add this results in lines 234 – 238.

      (5) Furthermore, the results suggest that oogenesis is not affected by EB application. The authors should devote a section to discussing how they are observing increased egg numbers in EB-treated insects while not impacting Oogenesis.

      Thank you for your suggestions, and apologies for the lack of clarity in our initial explanation. First, we found that EB treatment led to an increase in the number of eggs laid by female brown planthoppers (Figure 1). Through dissection experiments, we observed that EB-treated females had more mature eggs in their ovaries (Figure 2A and B), indicating that the increased egg-laying was due to a larger production of mature eggs in the ovaries after EB treatment. This is now explained on lines 229-238.

      Additionally, since there is no systematic description of oogenesis in the brown planthopper, we were the first to observe the oogenesis process in this species using immunohistochemistry and laser confocal microscopy. Based on the developmental characteristics, we defined the different stages of oogenesis (Figure 2C, Figure 2-figure supplement 2). We did not observe any significant effect of EB treatment on the various stages of oogenesis, indicating that EB treatment does not impair normal egg development (Figure 2D). Instead, the increase in vitellogenin accelerates the production of mature eggs. This is now explained on lines 243-262.

      During the maturation process, eggs require uptake of vitellogenin, and an increase in vitellogenin (Vg) content can accelerate egg maturation, producing more mature eggs. Our molecular data suggest that EB treatment leads to an upregulation of vg expression. Based on these findings, we conclude that the increase in egg-laying caused by EB treatment is due to the upregulation of vg (Figure 3I), which raises vitellogenin content, promoting the uptake of vitellogenin by maturing eggs and resulting in the production of more mature eggs. We have revised the text on lines 389-395 to clarify this point.

      (6) Met is the receptor of JH and to my understanding, remains mostly constant in terms of its mRNA or protein levels throughout various developmental periods in many different insects. Therefore, the presence of JH becomes the major driving factor for physiological events and not the presence of the receptor Met. Here the authors have demonstrated an increase in Met mRNA as a result of EB treatment. Their central hypothesis is that EB increases JH titer to result in enhanced fecundity. JH action will not result in the activation of Met. Although not contradictory to the hypothesis, the increase in mRNA content of Met is contrary to the findings of the JH field thus far.

      Thank you for your comment. Our results showed that EB treatment can mildly increase (about 2-fold) expression of the Met gene in brown planthoppers (Figure 3G). And our data indicated that Met and FAMeT expression levels were not influenced so much by EB compared with kr-h1 and vg (Figure 3H and I). We agree that JH action will not result in the increase of Met. However, we cannot rule out the possibility of other factors (indirect effects), induced by EB treatment that increase the mRNA expression level of Met. One recent paper reported that downregulation of transcription factor CncC will increase met expression in beetles (see Figure 6A in this reference) (Jiang et al., 2023). Many studies have reported that insecticide treatment will activate the CncC gene signaling pathway, which regulates detoxification gene expression (Amezian et al., 2023; Fu et al., 2024; Hu et al., 2021). Hence, it is possible that EB might influence the CncC gene pathway which then induces met expression. This EB effect on met upregulation may be similar to the upregulation of GluCl and some other secondary effects. We have discussed this on lines 725-738.

      (7) As pointed out before, it is hard to rationalize how a 4th instar exposure to EB can result in the upregulation of key genes involved in JH synthesis at the adult stage. The authors must consider providing a plausible explanation and discussion in this regard.

      Thank you for your comments. It must be mentioned that although we exposed the BPH to EB at 4th instar, we make the insect feed on the EB-treated rice plants for four days. After that, the insect will develop into 5<sup>th</sup> instar, the final nymphal stage of brown planthopper. Since brown planthoppers do not have a pupal stage, this might cause the EB presented to the insects last a longer time even in the adult stage. Besides this, we found that EB treatment will increase the weight of adult females (Figure 1-figure supplement 3E and F), which indicates that EB might increase food intake in BPHs that might produce more insulin peptide. Insulin might increase the JH synthesis at the adult stage. In our revised study we also investigate EB impairment in adult BPHs. We found that, similar to the nymphal stage, EB treatment in adult BPHs also increases the egg laying. Furthermore, the JH titer was increased after treatment of BPH with EB in adults. Besides this, GluCl and kr-h1 genes were also up-regulated after EB treatment in the adult stage. We have discussed this on lines 739-746.

      (8) I have strong reservations against such an irrational hypothesis that Met (the receptor for JH) and JH-Met target gene Kr-h1 regulate JH titer (Line 311, Fig 3 supplemental 2D). This would be the first report of such an event on the JH field and therefore must be analysed in depth. I strongly suggest the authors remove such claims from the manuscript without substantiating it.

      Thank you for your suggestions and comments. We have changed our claims in this revised MS. We found that EB treatment can enhance Kr-h1 expression. We have no evidence to support that JH can induce met expression. We have rewritten the manuscript to avoid confusion (see text on lines 725-735).

      (9) Kr-h1 is JH/Met target gene. The authors demonstrate that silencing of Kr-h1 results in inhibition of FAMeT, which is a gene involved in JH synthesis. A feedback loop in JH synthesis is unreported. It is the view of this reviewer that the authors must go ahead with a mechanistic detail of Kr-h1 mediated JH upregulation before this can be concluded. Mere qPCR experiments are not sufficient to substantiate a claim that is completely contrary to the current understanding of the JH signalling pathway.

      Thank you for your suggestions and comments. We agree that only qPCR experiments are not enough to provide this kind of claim. More evidences need to be provided to support this. We have revised the MS to avoid confusion (see text on lines 725-735).

      (10) The authors have performed knockdowns of JHAMT, Met, and Kr-h1 to demonstrate the effect of these factors on fecundity in BPH. Additionally, they have performed rescue experiments with EB application on these knockdown insects (Figure 3K-M). This, I believe, is a very flawed experiment. The authors demonstrate EB works through JHAMT in upregulating JH titer. In the absence of JHAMT, EB application is not expected to rescue the phenotype. But the authors have reported a complete rescue here. In the absence of Met, the receptor of JH, either EB or JH is not expected to rescue the phenotype. But a complete rescue has been reported. These two experimental results contradict their own hypothesis.

      Thank you for your comments. We thought that this rescue is possible since knockdown of the genes is incomplete when using dsRNA injection (and residual gene expression allows for EB action). It is not a total knockout and actually, these genes still have a low level of expression in the dsRNA-injected insects. Since EB can upregulate the expression of JHAMT, Met, and Kr-h1, it is reasonable that EB treatment can rescue the down-regulation effects of these three genes and make fecundity completely rescued. We have clarified this on lines 411-413).

      (11) A significant section of the paper deals with how EB upregulates JH titer. JH is a hormone synthesized in the Corpora Allata. Yet the authors have chosen to use the whole body for all of their experiment. Changes in the whole body for mRNA of those enzymes involved in JH synthesis may not reflect the situation in Corpora Allata. Although working with Corpora Allata is challenging, discarding the abdomen and thorax region and working with the head and neck region of the insect is easily doable. Results from such sampling are always more convincing when it comes to JH synthesis studies.

      Thank you for your suggestions. Because the head is very difficult to separate from the thorax region in brown planthoppers as you can see in Author response image 1. We are now trying to answer how EB regulates JH synthesis using Drosophila as a model.

      Author response image 1.

      The brown planthopper

      (12) The phenomenon reported was specific to BPH and not found in other insects. This limits the implications of the study.

      Thank you for your comments. The brown planthopper is a serious insect pest on rice in Asia. Our findings can guide the use of this insecticide in the field. Besides this, our findings indicated that EB, which targets GluCl can impair the JH titer. Our findings added new implications for how a neuronal system influences the JH signaling pathway. We will further investigate how EB influences JH in the future and will use Drosophila as a model to study the molecular mechanisms.

      (13) Overall, the molecular experiments are very poorly designed and can at best be termed superficial. There are several contradictions within the paper and no discussion or explanation has been provided for that.

      Thank you for your comments. We have revised the paper according to your suggestions and added further explanation of our results in the discussion parts and hope the conclusions are better supported in the new version. We have discussed this on lines 725-746 and 778-799.

      Reviewer #2 (Public Review):

      The brown plant hopper (BPH) is a notorious crop pest and pesticides are the most widespread means of controlling its population. This manuscript shows that in response to sublethal doses of the pesticide (EB), BPH females show enhanced fecundity. This is in keeping with field reports of population resurgence post-pesticide treatment. The authors work out the mechanism behind this increase in fecundity. They show that in response to EB exposure, the expression of its target receptor, GluCl, increases. This, they show, results in an increase in the expression of genes that regulate the synthesis of juvenile hormone (JH) and JH itself, which, in turn, results in enhanced egg-production and egg-laying. Interestingly, these effects of EB exposure are species-specific, as the authors report that other species of plant hoppers either don't show enhanced fecundity or show reduced fecundity. As the authors point out, it is unclear how an increase in GluCl levels could result in increased JH regulatory genes.

      We greatly appreciate your valuable comments and constructive suggestion to our work. We will try to figure out how EB interacts with its molecular target GluCl and then increases JH regulatory genes in the future work using Drosophila as models.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Overall, the molecular experiments are very poorly designed and can at best be termed superficial. There are several contradictions within the paper and no discussion or explanation has been provided for that.

      The authors should consider a thorough revision.

      Thank you for your comments. We have thoroughly revised the paper according to your suggestions and added further experiments and explanations of our results in the discussion parts.

      Reviewer #2 (Recommendations For The Authors):

      It would help the reader to have more schematics along with the figures. The final figure is helpful, but knowing the JH pathway, and where it acts would help with the interpretations as one reads the manuscript and the figures. The pathways represented in 4N or 5J are helpful but could be improved upon for better presentation.

      It would be nice to have some discussion on how the authors think EB exposure results in an increase in GluCl expression, and how that in turn affects the expression of so many genes.

      Thank you for your comments. We have thoroughly revised the paper according to your suggestions and added further experiments and explanations of how we think EB exposure results in an increase in JH titer and other genes in the discussion parts. We have added the test on lines 753-761.

      References

      Amezian, D., Fricaux, T., de Sousa, G., Maiwald, F., Huditz, H.-I., Nauen, R., Le Goff, G., 2023. Investigating the role of the ROS/CncC signaling pathway in the response to xenobiotics in Spodoptera frugiperda using Sf9 cells. Pesticide Biochemistry and Physiology 195, 105563.

      Fu, B., Liang, J., Hu, J., Du, T., Tan, Q., He, C., Wei, X., Gong, P., Yang, J., Liu, S., Huang, M., Gui, L., Liu, K., Zhou, X., Nauen, R., Bass, C., Yang, X., Zhang, Y., 2024. GPCR–MAPK signaling pathways underpin fitness trade-offs in whitefly. Proceedings of the National Academy of Sciences 121, e2402407121.

      Gandara, L., Jacoby, R., Laurent, F., Spatuzzi, M., Vlachopoulos, N., Borst, N.O., Ekmen, G., Potel, C.M., Garrido-Rodriguez, M., Böhmert, A.L., Misunou, N., Bartmanski, B.J., Li, X.C., Kutra, D., Hériché, J.-K., Tischer, C., Zimmermann-Kogadeeva, M., Ingham, V.A., Savitski, M.M., Masson, J.-B., Zimmermann, M., Crocker, J., 2024. Pervasive sublethal effects of agrochemicals on insects at environmentally relevant concentrations. Science 386, 446-453.

      Gong, Y., Cheng, S., Desneux, N., Gao, X., Xiu, X., Wang, F., Hou, M., 2022. Transgenerational hormesis effects of nitenpyram on fitness and insecticide tolerance/resistance of Nilaparvata lugens. Journal of Pest Science.

      Hu, B., Huang, H., Hu, S., Ren, M., Wei, Q., Tian, X., Esmail Abdalla Elzaki, M., Bass, C., Su, J., Reddy Palli, S., 2021. Changes in both trans- and cis-regulatory elements mediate insecticide resistance in a lepidopteron pest, Spodoptera exigua. PLOS Genetics 17, e1009403.

      Jiang, H., Meng, X., Zhang, N., Ge, H., Wei, J., Qian, K., Zheng, Y., Park, Y., Reddy Palli, S., Wang, J., 2023. The pleiotropic AMPK–CncC signaling pathway regulates the trade-off between detoxification and reproduction. Proceedings of the National Academy of Sciences 120, e2214038120.

      Ko, K.I., Root, C.M., Lindsay, S.A., Zaninovich, O.A., Shepherd, A.K., Wasserman, S.A., Kim, S.M., Wang, J.W., 2015. Starvation promotes concerted modulation of appetitive olfactory behavior via parallel neuromodulatory circuits. eLife 4, e08298.

      Li, Z., Wang, Y., Qin, Q., Chen, L., Dang, X., Ma, Z., Zhou, Z., 2023. Imidacloprid disrupts larval molting regulation and nutrient energy metabolism, causing developmental delay in honey bee Apis mellifera. eLife

      Martelli, F., Hernandes, N.H., Zuo, Z., Wang, J., Wong, C.-O., Karagas, N.E., Roessner, U., Rupasinghe, T., Robin, C., Venkatachalam, K., Perry, T., Batterham, P., Bellen, H.J., 2022. Low doses of the organic insecticide spinosad trigger lysosomal defects, elevated ROS, lipid dysregulation, and neurodegeneration in flies. eLife 11, e73812.

      Peng, Y.C., Sheng, C.W., Casida, J.E., Zhao, C.Q., Han, Z.J., 2017. Ryanodine receptor genes of the rice stem borer, Chilo suppressalis: Molecular cloning, alternative splicing and expression profiling. Pestic. Biochem. Physiol. 135, 69-77.

      Root, Cory M., Ko, Kang I., Jafari, A., Wang, Jing W., 2011. Presynaptic facilitation by neuropeptide signaling mediates odor-driven food search. Cell 145, 133-144.

      Zhang, Y., Wang, X., Yang, B., Hu, Y., Huang, L., Bass, C., Liu, Z., 2015. Reduction in mRNA and protein expression of a nicotinic acetylcholine receptor α8 subunit is associated with resistance to imidacloprid in the brown planthopper, Nilaparvata lugens. Journal of Neurochemistry 135, 686-694.

    1. Author Response

      The following is the authors’ response to the original reviews.

      eLife assessment

      This is an important study that leverages a human-chimpanzee tetraploid iPSC model to test whether cis-regulatory divergence between species tends to be cell type-specific. The evidence supporting the study's primary conclusion--that species differences in gene regulation are enriched in cell type-specific genes and regulatory elements--is compelling, although attention to biases introduced by sequence conservation is merited, and the case that is made for cell type-specific changes reflecting adaptive evolution is incomplete. This work will be of broad interest in evolutionary and functional genomics.

      Public Reviews:

      Reviewer #1 (Public Review):

      This study aims to identify gene expression differences exclusively caused by cis-regulatory genetic changes by utilizing hybrid cell lines derived from human and chimpanzee. While previous attempts have focused on specific tissues, this study expands the comparison to six different tissues to investigate tissue specificity and derive insights into the evolution of gene expression.

      One notable strength of this work lies in the use of composite cell lines, enabling a comparison of gene expression between human and chimpanzee within the same nucleus and shared trans factors environment. However, a potential weakness of the methodology is the use of bulk RNA-seq in diverse tissues, which limits the ability to determine cell-type-specific gene expression and chromatin accessibility regions.

      We agree that profiling single cells could lead to additional exciting discoveries. Although heterogeneity in cell types within samples will indeed reduce our power to detect cell-type-specific divergence, thankfully any heterogeneity will not introduce false positives, since our use of interspecies hybrids controls for differences in cell-type abundance. As a result, we think that the molecular differences we identified in this study represent a subset of the true cell-type specific cis-regulatory differences that would be identified with deep single-cell profiling. We have included a new paragraph in the discussion on future directions, highlighting the utility of single-cell profiling as an exciting future direction (lines 482-490): “In addition to following up on our findings on GAD1 and FABP7, there are other exciting future directions for this work. First, additional bulk assays such as those that measure methylation, chromatin conformation, and translation rate could lead to a better understanding of what molecular features ultimately lead to cell type-specific changes in gene expression. Furthermore, the use of deep single cell profiling of hybrid lines derived from iPSCs from multiple individuals of each species during differentiation could enable the identification of many more highly context-specific changes in gene expression and chromatin accessibility such as the differences in GAD1 we highlighted here. Finally, integration with data from massively parallel reporter assays and deep learning models will help us link specific variants to the molecular differences we identified in this study.”

      Another concern is the use of two replicates derived from the same pair of individuals. While the authors produced cell lines from two pairs of individuals in a previous study (Agloglia et al., 2021), I wonder why only one pair was used in this study. Incorporating interindividual variation would enhance the robustness of the species differences identified here.

      We agree that additional replicates, especially from lines from other individuals, would have improved the robustness of the species differences we identified. In our experience with these hybrid cells (as well as related work from many other labs), inter-species differences typically have much larger magnitudes than intra-species differences, so we expect that the vast majority of differences we identified would be validated with data from additional individuals. Unfortunately, differentiating additional cells and generating these data for this study would be cost-prohibitive. We now mention the use of additional replicates in lines 485-488 of the discussion: “Furthermore, the use of deep single cell profiling of hybrid lines derived from iPSCs from multiple individuals of each species during differentiation could enable the identification of many more highly context-specific changes in gene expression and chromatin accessibility such as the differences in GAD1 we highlighted here.”

      Furthermore, the study offers the opportunity to relate inter-species differences to trends in molecular evolution. The authors discovered that expression variance and haploinsufficiency score do not fully account for the enrichment of divergence in cell-type-specific genes. The reviewer suggests exploring this further by incorporating external datasets that bin genes based on interindividual transcriptomics variation as a measure of extant transcriptomics constraint (e.g., GTEx reanalysis by Garcia-Perez et al., 2023 - PMID: 36777183). Additionally, stratifying sequence conservation on ASCA regions, which exhibit similar enrichment of cell-type-specific features, using the Zoonomia data mentioned also in the text (Andrews et al., 2023 -- PMID: 37104580) could provide valuable insights.

      To address this, we used PhastCons scores computed from a 470-way alignment of mammals as we could not find publicly available PhastCons data from Zoonomia. When stratifying by the median PhastCons score of all sites in a peak, we observe very similar results to those obtained when stratifying by the constraint metric from the gnomAD consortium (see below). The one potential difference is that peaks in the top two bins have slightly weaker enrichment relative to the other bins when using PhastCons, but this is not the case when using gnomAD’s metric. We have elected to include this in the public review but not the manuscript as we are reluctant to add to the complexity of what is already complex analysis.

      Author response image 1.

      Finally, we think that comparisons of the properties of gene expression variance computed from ASE (as done by Starr et al.) and total expression (as done by Garcia-Perez et al.) is a very interesting, potentially complex question that is beyond the scope of this paper but an exciting direction for future work.

      Another potential strength of this study is the identification of specific cases of paired allele-specific expression (ASE) and allele-specific chromatin accessibility (ASCA) with biological significance.

      Prioritizing specific variants remains a challenge, and the authors apply a machine-learning approach to identify potential causative variants that disrupt binding sites in two examples (FABP7 and GAD1 in motor neurons). However, additional work is needed to convincingly demonstrate the functionality of these selected variants. Strengthening this section with additional validation of ASE, ASCA, and the specific putative causal variants identified would enhance the overall robustness of the paper.

      We strongly agree with the reviewer that additional work validating our results would be of considerable interest. We hope to perform follow-up experiments in the future. For now, we have been careful to present these variants only as candidate causal variants.

      Additionally, the authors support the selected ASE-ASCA pairs by examining external datasets of adult brain comparative genomics (Ma et al., 2022) and organoids (Kanton et al., 2019). While these resources are valuable for comparing observed species biases, the analysis is not systematic, even for the two selected genes. For example, it would be beneficial to investigate if FABP7 exhibits species bias in any cell type in Kanton et al.'s organoids or if GAD1 is species-biased in adult primate brains from Ma et al. Comparing these datasets with the present study, along with the Agoglia et al. reference, would provide a more comprehensive perspective.

      We agree with the reviewer’s suggestion that investigating GAD1 and FABP7 expression in other datasets is worthwhile. Unfortunately, the difference in human vs. chimpanzee organoid maturation rates and effects of culture conditions in Kanton et al. makes it unsuitable for plotting the expression of FABP7 as its expression is highly dependent on neuronal maturation. We therefore plotted bulk RNAseq data from multiple cortical regions from Sousa et al. 2017 (see below). This corroborates our claim that FABP7 has human-biased expression in adult humans compared to chimpanzees and rhesus macaques. We also investigated expression of GAD1 in the Ma et al. data as the reviewer suggested.

      Author response image 2.

      While there are differences in GAD1 expression between adult humans and chimpanzees, they are unlikely to be linked to the HAR we highlight as it is likely a transiently active cis-regulatory element (see below). In addition, some cell types seem to have chimpanzee-derived changes in GAD1 expression (e.g. SST positive neurons) whereas others seem to have human-derived changes in GAD1 expression (e.g. LAMP5 positive neurons).

      Author response image 3.

      While these are potentially interesting observations, we think that their inclusion in the manuscript might distract from our emphasis on the cell type-specific and developmental stage-specific of the changes in FABP7 and GAD1 expression we observe so we have not included them in the manuscript.

      The use of the term "human-derived" in ASE and ASCA should be avoided since there is no outgroup in the analysis to provide a reference for the observed changes.

      We agree with the reviewer that the term human-derived should be used with care and have changed the phrasing of line 230 to “human-chimpanzee differences in expression”. With regard to FABP7 we think that our analysis of the Ma et al. data—which includes data from rhesus macaques as an outgroup—justifies our use of “human-derived” in lines 360 and 457. As chimpanzee and macaque expression of FABP7 are similar but human expression is quite different, the most parsimonious explanation for our observations is that FABP7 upregulation occurred in the human lineage.

      Finally, throughout the paper, the authors refer to "hybrid cell lines." It has been suggested to use the term "composite cell lines" instead to address potential societal concerns associated with the term "hybrid," which some may associate with reproductive relationships (Pavlovic et al., 2022 -- PMID: 35082442). It would be interesting to know the authors' perspective on these concerns and recommendations presented in Pavlovic et al., given their position as pioneers in this field.

      We appreciate this question. Whether to refer to our fused cells as “hybrids” or not was indeed a question we considered at great length, starting from the very beginning of this project in 2015. From consultations with multiple bioethicists-- both formal and informal-- we have long been aware of the possibility of misunderstanding based on the word “hybrid”. However, we felt this possibility was outweighed by the long and well-established history of other scientists referring to interspecies fused cells as hybrids. This convention-- which is based on hundreds of papers about heterokaryons, somatic cell hybrids, and radiation hybrids-- goes back over 50 years (e.g. Bolund et al, Exp Cell Res 1969). Soon after the establishment of this nomenclature, cell fusion became widespread and ever since then it has become commonplace to generate interspecies hybrid cells from animals, plants and fungi.

      It is also important to note that in over two years since we published the first two papers on humanchimpanzee fused cells, we have been unable to find any misunderstanding of our use of the term “hybrid”. We have searched blogs, media articles, and social media, all with no evidence of misunderstanding. Therefore, in the current manuscript, rather than creating confusion by renaming a well-established approach, we have opted to clearly and prominently define hybrid cells: in the abstract of our paper we introduce the hybrid cells as “the product of fusing induced pluripotent stem (iPS) cells of each species in vitro.”

      Reviewer #2 (Public Review):

      In this paper, Wang and colleagues build on previous technical and analytical achievements in establishing tetraploid human-chimpanzee hybrid iPSCs to investigate the cell type-specificity of allelespecific expression and allele-specific chromatin accessibility across six differentiated cell types (here, "allele-specific" indicates species differences with a cis-regulatory basis). The combined body of work is remarkable in its creativity and ambition and has real potential for overcoming major challenges in understanding the evolutionary genetics of between-species differences. The present paper contributes to these efforts by showing how differentiated cells can be used to test a long-standing hypothesis in evolutionary genetics: that cis-regulatory changes may be particularly important in divergence because of their potential for modularity.

      In my view, the paper succeeds in making this case: allele (species)-specific expression (ASE) and allelespecific chromatin accessibility (ASCA) are enriched in genes asymmetrically expressed in one cell type, and many cases of ASE/ASCA are cell type-specific. The authors do an excellent job showing that these results are robust across a set of possible analysis decisions. It is somewhat less clear whether these enrichments are primarily a product of relaxed constraint on cell type-specific genes or primarily result from positive selection in the human or chimp lineage. While the authors attempt to control for constraint using several variables (variance in ASE in humans and the sequence-based probability of haploinsufficiency score, pHI), these are imperfect proxies for constraint. For the pHI scores, enrichments for ASE also appear to be strongest in the least constrained genes. Overall, the relative role of relaxation of constraint versus positive selection is unresolved, although the manuscript's language leans in favor of an important role for selection.

      We agree with the reviewer and apologize for the wording that indeed focused more on positive selection than relaxed constraint. We have added language clarifying that our stance is that our analyses suggest some role for positive selection, but that we do not claim that positive selection plays a larger role than reduced constraint (lines 432-437): “Overall, this suggests that broad changes in expression in cell type-specifically expressed genes may be an important substrate for evolution but it remains unclear whether positive selection or lower constraint plays a larger role in driving the faster evolution of more cell type-specifically expressed genes. Future work will be required to more precisely quantify the relative roles of positive selection and evolutionary constraint in driving changes in gene expression.”

      The remainder of the manuscript draws on the cell type-specific ASE/ASCA data to nominate candidate genes and pathways that may have been important in differentiating humans and chimpanzees. Several approaches are used here, including comparing human-chimp ASE to the distribution of ASE observed in humans and investigating biases in the direction of ASE for genes in the same pathway. The authors also identify interesting candidate genes based on their role in development or their proximity to human accelerated regions (where many changes have arisen on the human lineage in otherwise deeply conserved sequence) and use a deep neural network to identify sequence changes that might be causally responsible for ASE/ASCA. These analyses have value and highlight potential strategies for using ASE/ASCA and hybrid cell line data as a hypothesis-generating tool. Of course, the functional follow-up that experimentally tested these hypotheses or linked sequence/expression changes in the candidate pathways to organismal phenotype would have strengthened the paper further- but this is a lot to ask in an already technically and analytically challenging piece of work.

      We thank the reviewer for the kind words and strongly agree that follow-up experiments and orthogonal analyses will be key in validating our results and establishing links to human-specific phenotypes.

      As a minor critique, the present paper is very closely integrated with other manuscripts that have used the hybrid human-chimp cell lines for biological insight or methods development. Although its contributions make it a strong stand-alone contribution, some aspects of the methods are not described in sufficient detail for readers to understand (even on a general conceptual level) without referencing that work, which may somewhat limit reader understanding.

      We agree with the points the reviewer raises regarding the clarity of our methods. We have amended several sections to provide more conceptual information while pointing the reader to other publications for the technical details. For convenience, we include the text here as well as in the new draft.

      Lines 207-214 now provide more intuition for the method used to detect lineage-specific selection: “Next, we sought to use our RNA-seq data to identify instances of lineage-specific selection. In the absence of positive selection, one would expect that an approximately equal number of genes in a pathway would have human-biased vs. chimpanzee-biased ASE. Significant deviation from this expectation (as determined by the binomial test) rejects the null hypothesis of neutral evolution, instead providing evidence of lineage-specific selection on this pathway. Using our previously published modification of this test that incorporates a tissue-specific measure of constraint on gene expression, we detected several signals of lineage-specific selection, some of which were cell type-specific (Starr et al., 2023, Additional file 2).” This is also reflected in the Methods in lines 729-731: “Positive selection on a gene set is only inferred if there is statistically significant human- or chimpanzee-biased ASE in that gene set (using an FDR-corrected p-value from the binomial test).”

      Reviewer #3 (Public Review):

      The authors utilize chimpanzee-human hybrid cell lines to assess cis-regulatory evolution. These hybrid cell lines offer a well-controlled environment, enabling clear differentiation between cis-regulatory effects and environmental or other trans effects.

      In their research, Wang et al. expand the range of chimpanzee-human hybrid cell lines to encompass six new developmental cell types derived from all three germ layers. This expansion allows them to discern cell type-specific cis-regulatory changes between species from more pleiotropic ones. Although the study investigates only two iPSC clones, the RNA- and ATAC-seq data produced for this paper is a valuable resource.

      The authors begin their analysis by examining the relationship between allele-specific expression (ASE) as a measure of species divergence and cell type specificity. They find that cell-type-specific genes exhibit more divergent expression. By integrating this data with measures of constraint within human populations, the authors conclude that the increased divergence of tissue-specific genes is, at least in part, attributable to positive selection. A similar pattern emerges when assessing allele-specific chromatin accessibility (ASCA) as a measure of divergence of cis-regulatory elements (CREs) in the same cell lines.

      By correlating these two measures, the authors identify 95 CRE-gene pairs where tissue-specific ASE aligns with tissue-specific ASCA. Among these pairs, the authors select two genes of interest for further investigation. Notably, the authors employ an intriguing machine-learning approach in which they compare the inferred chromatin state of the human sequence with that of the chimpanzee sequence to pinpoint putatively causal variants.

      Overall, this study delves into the examination of gene expression and chromatin accessibility within hybrid cell lines, showcasing how this data can be leveraged to identify potential causal sequence differences underlying between-species expression changes.

      We appreciate this assessment.

      I have three major concerns regarding this study:

      1. The only evidence that the cells are indeed differentiated in the right direction is the expression of one prominent marker gene per cell type. Especially for the comparison of conservation between the differentiated cell types, it would be beneficial to describe the cell type diversity and the differentiation success in more detail.

      We appreciate this assessment. We agree that evidence beyond a single marker gene is necessary to demonstrate that the differentiations were successful and that a discussion of the limitations of these differentiations in the manuscript is worthwhile. We included figures showing additional marker genes and a thorough discussion of the differentiations in the supplement. For convenience, we have copied the supplemental figure and text here:

      “Before continuing with the analysis, we tested whether the differentiations were successful and contained primarily our target cell types. The very low expression of NANOG, a marker for pluripotency, across all differentiations indicates that the samples contain very few iPSCs (Agoglia et al., 2021). For cardiomyocytes (CM), NKX2-5, MYBPC3, and TNNT2 definitively distinguish CM from other heart cell types and their high expression indicates successful differentiations (Burridge et al., 2014). For motor neurons, the high expression of ELAVL2, a pan-neuronal marker, indicates a high abundance of neurons in the sample (Mickelsen et al., 2019). The expression of ISL1 and OLIG2 further demonstrates that these are motor neurons and not other types of neurons (Maury et al., 2015). For retinal pigment epithelium (RPE), the combined expression of MITF, PAX6, and TYRP1 provides strong evidence that the differentiations were successful in producing RPE cells (Sharma et al., 2019). For skeletal muscle, the very high expression of MYL1, MYLPF, and MYOG indicates that these samples contain a high proportion of skeletal muscle cells (Chal et al., 2016). In general, all these populations of cells contain some proportion of progenitors as there is detectable expression of MKI67 in all samples.

      The low expression of ALB (a marker for mature hepatocytes) and the high expression of TTR and GPC3 (markers for hepatocyte progenitors) combined with the high expression of HNF1B indicate that the bulk of the cells in the HP samples are hepatocyte progenitors rather than mature hepatocytes or endoderm cells, although there are likely some endoderm cells and immature hepatocytes in the sample (Hay et al., 2008; Mallanna & Duncan, 2013). Similarly, the combined expression of PDX1 and NKX6-1 and the low expression of NEUROG3 (a marker of endocrine progenitors which differentiate from pancreatic progenitors) in the PP samples indicates that these primarily contain pancreatic progenitors but likely contain some endocrine progenitors and endoderm cells (Cogger et al., 2017; Korytnikov & Nostro, 2016).

      Notably, HP and PP are closely related cell types that are derived from the same lineage. Indeed, heterogeneous multipotent progenitors can contribute to both the adult liver and adult pancreas in mice (Willnow et al., 2021). Progenitors that express PDX1 (often used as a marker for the pancreatic lineage) can differentiate into hepatocytes (Willnow et al., 2021). As a result, some overlap in the transcriptomic signature of both cell types is expected and we cannot rule out that the HP samples contain cells that could differentiate into pancreatic cells or that the PP samples contain cells that could differentiate into hepatocytes. However, the expression of NKX6-1 and GP2, markers for pancreatic progenitors, in the PP samples but not the HP samples indicates that these two populations of cells are distinct. Overall, the similarity of PP and HP likely explains the lower number of cell type-specific genes and genes showing cell type-specific ASE for these cell types. This similarity does not alter the conclusions presented in the main text.”

      Author response image 4.

      Author response image 5.

      Marker gene expression in different cell types. In order, the panels show: a marker for pluripotency, a marker gene for dividing cells, marker genes for cardiomyocytes, marker genes for hepatocytes and hepatocyte progenitors, marker genes for motor neurons, marker genes for pancreatic progenitors and more mature pancreatic cell types, marker genes for retinal pigment epithelial cells, and marker genes for skeletal myocytes. Hepatocyte progenitors and pancreatic progenitors generally show similar gene expression profiles. TPM: transcript per million.

      1. Check for a potential confounding effect of sequence similarity on the power to detect ASE or ASCA.

      We agree that checking for confounding by power to detect ASE or ASCA would increase confidence in our results. We have added supplementary figures 29-33 to show the results as well as a discussion of these figures in the text (lines 318-326):

      “Finally, it is possible that CREs and genes that are less conserved will have more SNPs, and therefore more power to call ASCA and ASE, leading to systematically biased estimates. There is a weak positive correlation between the number of SNPs and the -log10(FDR) for ASE and a weak negative or no correlation for ASCA (Supp Fig. 29). Similarly, we observe a weak relationship between the number of SNPs in CREs or genes and absolute log fold-change estimates (Supp Fig. 30). Although the relationship between the number of SNPs and ASE/ASCA is weak, we confirmed that cell type-specific genes and peaks are still strongly enriched for ASE and ASCA when stratifying by number of SNPs (Supp Fig. 31-32). Overall, our analysis suggests that the result that more cell type-specific genes and CREs are more evolutionarily diverged is robust to a variety of possible confounders.”

      Author response image 6.

      Relationship between number of SNPs and -log10(FDR) in a) ASE and -log10(pvalue) b) ASCA. These scatter plots show the relationship between the number of SNPs in a gene or peak and the -log10(FDR) for ASE or ASCA. Genes with significant ASE (FDR < 0.05) and peaks with significant ASCA (binomial p-value < 0.05) were annotated as blue dots, and all other genes and peaks were annotated as gray dots. All genes in each cell type in RNA-seq are shown. For clarity, the few outlier peaks with more than 200 SNPs are excluded from these plots.

      Author response image 7.

      Relationship between number of SNPs and absolute log2 fold-change in a) ASE and b) ASCA. These scatter plots show the relationship between the number of SNPs in a gene or peak and the estimated absolute log2 fold-change for ASE or ASCA. Genes with significant ASE (FDR < 0.05) and peaks with significant ASCA (binomial p-value < 0.05) were annotated as blue dots, and all other genes and peaks were annotated as gray dots. All genes in each cell type in RNA-seq are shown. For clarity, the few outlier peaks with more than 200 SNPs are excluded from these plots.

      Author response image 8.

      Cell type-specifically expressed genes are enriched for genes with ASE when stratifying by the number of SNPs per gene. a) Results when SKM is included. Genes were put into five bins with an equal number of genes in each bin. Genes with the fewest SNPs are in the 0-20% bin and genes with the most SNPs are in the 80-100% bin. Significance (using the Wald test) is indicated by asterisks where *** indicates p < 0.005, ** indicates p < 0.01, and * indicates p < 0.05. b) The same as in (a) but excluding SKM.

      Author response image 9.

      Cell type-specific peaks are enriched for ASCA when stratifying by the number of SNPs per peak. a) Peaks with an absolute log2 fold-change greater than or equal to 0.5 were called as having ASCA. Peaks were put into five bins with an equal number of peaks in each bin. Peaks with the fewest SNPs are in the 0-20% bin and genes with the most SNPs are in the 80-100% bin. Significance (using the Wald test) is indicated by asterisks where *** indicates p < 0.005, ** indicates p < 0.01, and * indicates p < 0.05. b) The same as in (a) but peaks with a binomial p-value less than or equal to 0.05 were called as having ASCA.

      1. In the last part the authors showcase 2 examples for which the log2 fold changes in chromatin state scores as inferred by the machine learning model Sei are used. This is an interesting and creative approach, however, more sanity checks on this application are necessary.

      We agree with the reviewer about the importance of sanity checks and apologize for omitting these from the manuscript. Below we highlight several such checks from previous publications:

      In the original Sei paper (Chen et al. 2022), the authors included several tests of their model’s ability to predict the effects on individual genetic variants. Using eQTL data from GTEx, they found that variants predicted to increase enhancer activity were more likely to be up-regulating eQTLs, and those predicted to increase polycomb repression had the expected repressive effect. These relationships became stronger when restricting the analysis only to fine-mapped eQTLs with >95% posterior probabilities of causality. Chen et al. also found that previously known disease-causing noncoding variants from the Human Gene Mutation Database were far more likely to reduce predicted enhancer/promoter activity than matched variants not linked to any disease.

      In addition, we note that a similar approach to ours was recently used to analyze all HARs and included considerable efforts to validate the utility of the Sei predictions in identifying causal variants (Whalen et al. 2023 in Neuron). For example, Whalen et al. found that the Sei output correlated with the effects of genetic variants on expression in a massively parallel reporter assay. They also found that the effect sizes predicted by Sei were much higher for variants in HARs than polymorphic variants in the human population, which is consistent with the idea that variants in HARs lie in highly conserved bases that are more likely to disrupt cis-regulatory elements. Finally, Whalen et al. found that effects on chromatin state predicted by Sei were generally highly correlated across tissues, supporting our approach that leverages all Sei outputs regardless of which cell type or tissue they correspond to. Overall, we think that Sei is a potentially powerful way to prioritize causal variants and that improved machine learning models trained on more extensive and context-specific data will be even more powerful.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the reviewers for their comments and provide answers /clarifications and new data; There were 3 important recurrent points we already address here: 

      (a) The reviewers were concerned that the observed motor defects (measured by startle induced negative geotaxis- “SING”) where a reasonable behavioral measure of DAN function.

      Previously, Riemensperger et al., 2013 (PMID: 24239353) already linked synaptic loss of the dopaminergic PAM neurons to SING impairments. Furthermore, in a separate paper that we recently posted on BioRxiv, we show that the SING defects in PD mutants are rescued when the flies are fed L-DOPA (Kaempf et al 2024; BioRxiv). In this same paper we also show a very strong correlation between SING defects and defects in dopaminergic synaptic innervation of PAM DAN onto Mushroom body neurons. Both experiments suggest that the motor defects are the result of defects in dopamine release. Altogether, these data suggest that the combination of the SING assay and a quantification of the synaptic region of PAM DAN onto Mushroom body neurons is a suitable measure for DAN function.

      (b) The reviewers asked if the OPN dysfunction in young animals is connected to dopaminergic neuron (DAN) dysfunction in later life; 

      We have conducted additional experiments and have included the results (new Figure 6): Our young PD mutants (we included Aux<sup>R927G</sup>, Synj<sup>R258Q</sup> and LRRK2<sup>G2019S</sup>) show olfactory defects, but normal DAN function (measured by assessing the TH-labeled synaptic area onto the Mushroom body neurons and by SING). Aged PD mutants show both olfactory defects and DAN dysfunction. When we express the wildtype PD gene in (a.o.) OPN of PD mutants using the GH146-Gal4 (that does not drive expression in DAN) we are able to rescue the DAN defects (synaptic area and SING) that occur later in life. This indeed suggests there is a cell non-autonomous positive effect on DAN dysfunction that occurs at later stages in the life of our PD mutants (new Figure 6a). 

      In a set of independent experiments, we also fed one of our mutants (LRRK2<sup>G2019S</sup>) nicotine, activating Nicotinic acetylcholine receptors (that are also activated by the release of acetylcholine from cholinergic neurons such as OPN). While nicotine does not rescue the olfactory preference defect, the OPN synapse morphology defect or the OPN-associated defects in Ca<sup>2+</sup>-imaging in LRRK2<sup>G2019S</sup> mutants (Figure 6b), it does rescue the DAN-associated defects, including SING, synapse loss and defects in Ca<sup>2+</sup>-imaging (Figure 6c).

      Finally, we generated human induced dopaminergic neurons derived from iPSC with a LRRK2<sup>G2019S</sup> mutation and incubated these neurons with nicotine. Again, this induced a rescue of a LRRK2-mutant-induced defect in neuronal activity measured by Ca<sup>2+</sup>-imaging. This is specific to nicotine since the rescue was absent when cells were also incubated with mecamylamine, a non-competitive antagonist of nicotinic acetylcholine receptors, trumping the effects of nicotine (Figure 6d-e").

      (c) The reviewers indicated that the GH146 Gal 4 driver is expressed in other cells than OPN and thus, they noted that the defects we observe may not only be the result of OPN dysfunction. 

      It is correct that GH146-dependent Gal expression includes OPNs (that are cholinergic) and one pair of inhibitory APL neurons (that are GABAergic) (Li et al., 2017 (PMID: 29149607), Lui et al., 2009 (PMID: 19043409)). We have adapted the text to explicitly state this. There are only 2 APL per fly brain and our single cell sequencing experiment does not have the resolution to allow us to test if these neurons had a significant number of DEG. However, as indicated above (in (b)), we are able to rescue DAN dysfunction by mimicking cholinergic output (application of nicotine). These data do not exclude that APL-neuron problems contribute to the defects we observe in our PD mutants, but they do suggest that cholinergic output is critical to maintain normal DAN function.

      Public Reviews:  

      Reviewer #1 (Public Review):  

      This is a fantastic, comprehensive, timely, and landmark pan-species work that demonstrates the convergence of multiple familial PD mutations onto a synaptic program. It is extremely well written and I have only a few comments that do not require additional data collection. 

      Thank you for this enthusiastic endorsement.

      Major Comments:  

      neurons and the olfactory system are acutely impacted by these PD mutations. However, I wonder if this is the case:  

      (1) In the functional experiments performing calcium imaging on projection neurons I could not find a count of cell bodies across conditions. Since the loss of OPNs could explain the reduced calcium signal, this is a critical control to perform. A differential abundance test on the single-cell data would also suffice here and be easy for the authors to perform with their existing data. 

      This is indeed an important number, and we had included this in the Supplemental figure 2a.

      Also, the number of DAN and Visual projection neurons were not significantly different between the genotypes (Supplemental Figure 2a in the manuscript). 

      (2) One of the authors' conclusions is that cholinergic

      a. Most Drosophila excitatory neurons are cholinergic

      and only a subpopulation appear to be dysregulated by these mutations. The authors point out that visual neurons also have many DEGs, couldn't the visual system also be dysregulated in these flies? Is there something special about these cholinergic neurons versus other cholinergic neurons in the fly brain? I wonder if they can leverage their nice dataset to say something about vulnerability. 

      Yes, the reviewer is right, and we have changed our wording to be more specific. The reviewer also noted correctly that neurons in the visual system rank high in terms of number of DEGs, but we did not conduct elaborate experiments to assess if these visual system neurons are functional. Of note, several of our mutants show (subtle) electroretinogram defects, that are a measure of visual system integrity, but further work is needed to determine the origin of these defects. 

      The question about the nature of the underlying vulnerability pathways is interesting. In preliminary work we have selected a number of DEGs common to vulnerable cells in several PD mutants, and conducted a screen where we manipulated the expression of these DEGs and looked for rescue of the olfactory preference defects in our PD mutants. The strongest genetic interaction was with genes encoding proteins involved in proteostasis (Atg8/LC3, Lamp1 and Hsc70-4) (Reviewer Figure 3). While interesting, these results require further work to understand the underlying molecular mechanisms. We present these preliminary data here but have not included them in the main manuscript. 

      b. As far as I can tell, the cross-species analysis of DEGs (Figure 3) is agnostic to neuronal cell type, although the conclusion seems to suggest only cholinergic neurons were contrasted. Is this correct? Could you please clarify this in the text as it's an important detail. If not, Have the authors tried comparing only cholinergic neuron DEGs across species? That would lend strength to their specificity argument. The results for the NBM are impressive. Could the authors add more detail to the main text here about other regions to the main text? 

      The reviewer is correct that we compiled the DEG of all affected cells, the majority of which are cholinergic neurons. 

      For the human data we focused on the NBM samples, because it contained the highest fraction of cholinergic neurons (as compared to the other 2 regions), but even so, it was not possible to analyze the cholinergic neurons alone because the fraction of cholinergic neurons in the human material was too low to be statistically analyzed independently. Note that both wildtype and PD samples contained a low number of cholinergic neurons (i.e. the DEG differences we detected were not the result of sequencing different types of cells - see also Supplemental Figure 3b and d). We have indicated this more clearly in the text.

      c. Uniquely within the human data, are cholinergic neurons more dysregulated than others? I understand this is not an early timepoint but would still be useful to discuss. 

      As indicated in the previous point, unfortunately the fraction of cholinergic neurons in the human material was low and we were not able to analyze these cells on their own. 

      Author response image 1.

      Upregulation of protein homeostasis rescues hyposmia across familial models of PD. Results of a behavioral screen for cell-specific rescue of olfactory preference defects of young PD fly models using up and downregulation of deregulated genes in affected cell types. Genes implicated in the indicated pathways are over expressed or knocked down using GH146-Gal4 (OPN>) and UAS-constructs (over expression or RNAi) . UAS-only (-) and OPN>UAS (+) were scored in parallel and are compared to each other. n.d. not determined; Bars represent mean ± s.e.m.; grey zone indicates the variance of controls; n≥5 independent experiments per genotype, with ~50 flies each; red bars: p<0.05 in ANOVA and Bonferroni-corrected comparison to UAS-only control.

      d. In the discussion, the authors say that olfactory neurons are uniquely poised to be dysregulated as they are large and have high activity. Is this really true compared to other circuits? I didn't find the references convincing and I am not sure this has been borne out in electron microscopy reconstructions for anatomy.  

      We agree and have toned down this statement.

      Reviewer #2 (Public Review):  

      Summary:  

      Pech et al selected 5 Parkinson's disease-causing genes, and generated multiple

      Drosophila lines by replacing the Drosophila lrrk, rab39, auxilin (aux), synaptojanin

      (synj), and Pink1 genes with wild-type and pathogenic mutant human or Drosophila cDNA sequences. First, the authors performed a panel of assays to characterize the phenotypes of the models mentioned above. Next, by using single-cell RNA-seq and comparing fly data with human postmortem tissue data, the authors identified multiple cell clusters being commonly dysregulated in these models, highlighting the olfactory projection neurons. Next, by using selective expression of Ca<sup>2+</sup>-sensor GCaMP3 in the OPN, the authors confirmed the synaptic impairment in these models, which was further strengthened by olfactory performance defects.  

      Strengths:  

      The authors overall investigated the functionality of PD-related mutations at endogenous levels and found a very interesting shared pathway through singlecell analysis, more importantly, they performed nice follow-up work using multiple assays.  

      Weaknesses:  

      While the authors state this is a new collection of five familial PD knock-in models, the Aux<sup>R927G</sup> model has been published and carefully characterized in Jacquemyn et al., 2023. ERG has been performed for Aux R927G in Jacquemyn et al., 2023, but the findings are different from what's shown in Figure 1b and Supplementary Figure 1d, which the authors should try to explain. 

      We should have explained this better: the ERG assay in Jacquemyn et al., and here, in Pech et al., are different. While the ERGs in our previous publication were recorded under normal endogenous conditions, the flies in our current study were exposed to constant light for 7 days. This is often done to accelerate the degeneration phenotype. We have now indicated this in the text (and also refer to the different experimental set up compared to Jacquemyn et al).

      Moreover, according to the authors, the hPINK1control was the expression of human PINK1 with UAS-hPINK1 and nsyb-Gal4 due to technical obstacles. Having PINK1 WT being an overexpression model, makes it difficult to explain PINK1 mutant phenotypes. It will be strengthened if the authors use UAS-hPINK1 and nsyb-Gal4 (or maybe ubiquitous Gal4) to rescue hPink1L347P and hPink1P399L phenotypes.

      The UAS-hPink1 was originally created by the Lu lab (Yang et al., 2003, PMID: 12670421) and has been amply used before in Pink1 loss-of-function backgrounds (e.g. in Yang et al., 2006, PMID: 16818890). In our work, the control we refer to was UAS-hPink1 expression (driven by nSyb-gal4) in a Pink1 knock-out background. For unknown reasons we were unable to replace the fly Pink1 with a human pink1 cDNA, we explained this in the methods section and added a remark in the new manuscript.

      In addition, although the authors picked these models targeting different biology/ pathways, however, Aux and Synj both act in related steps of Clathrin-mediated endocytosis, with LRRK2 being their accessory regulatory proteins. Therefore, is the data set more favorable in identifying synaptic-related defects? 

      We picked these particular mutants, as they were the first we created in the context of a much larger collection of “PD flies” (see also Kaempf et al 2024, BioRxiv). We have made adaptations to the text to tone down the statement on the broad selection of mutants. 

      GH146-GAL4+ PNs are derived from three neuroblast lineages, producing both cholinergic and GABAergic inhibitory PNs (Li et al, 2017). Therefore, OPN neurons have more than "cholinergic projection neurons". How do we know from singlecell data that cholinergic neurons were more vulnerable across 5 models? 

      The reviewer is correct that GH146 drives expression in other cells than OPN and we now clearly state this in the text. We do present additional arguments that substantiate our conclusion that cholinergic neurons are affected: (1) our single cell sequencing identifies the most DEGs in cholinergic neurons. (2) nicotine (a compound activating cholinergic receptors) rescues dopamine-related problems in old PD-mutant flies. (3) Likewise, nicotine also alleviates problems we observed in LRRK2 mutant human induced dopaminergic neurons and this is blocked by mecamylamine, a non-competitive antagonist of nicotinic acetylcholine receptors.

      In Figure 1b, the authors assumed that locomotion defects were caused by dopaminergic neuron dysfunction. However, to better support it, the author should perform rescue experiments using dopaminergic neuron-specific Gal4 drivers. Otherwise, the authors may consider staining DA neurons and performing cell counting. Furthermore, the authors stated in the discussion, that "We now place cholinergic failure firmly ahead of dopaminergic system failure in flies", which feels rushed and insufficient to draw such a conclusion, especially given no experimental evidence was provided, particularly related to DA neuron dysfunction, in this manuscript. 

      Previously, Riemensperger et al., 2013 (PMID: 24239353) already linked synaptic loss of the dopaminergic PAM neurons to locomotion impairments (measured by SING). Furthermore, in a separate paper we show that the motor defects (SING) observed in PD mutants are rescued when the flies are fed L-DOPA, but not D-DOPA (Kaempf et al 2024; BioRxiv). In this same paper, we also show a significant correlation between SING defects and defects in dopaminergic synaptic innervation of PAM DAN onto Mushroom body neurons. We have referred to both articles in the revised manuscript.

      The statement on cholinergic failure ahead of dopaminergic failure was made in the context of the sequence of events: young flies did not show DAN defects, but they did display olfactory defects. The statement was indeed not meant to imply causality. However, we have now conducted new experiments where we express wild type PD genes using GH146-Gal4 (that does not express in DAN) in the PD mutants and assess dopaminergic-relevant phenotypes later in life (see also new Figure 6 in the manuscript). This shows that GH146Gal4-specific rescue is sufficient to alleviate the DAN-dependent SING defects in old flies. Likewise, as indicated above, application of nicotine is also sufficient to rescue the DAN-associated defects (in PD mutant flies and human induced mutant dopaminergic neurons).  

      It is interesting to see that different familial PD mutations converge onto synapses. The authors have suggested that different mechanisms may be involved directly through regulating synaptic functions, or indirectly through mitochondria or transport. It will be improved if the authors extend their analysis on Figure 3, and better utilize their single-cell data to dissect the mechanisms. For example, for all the candidates listed in Figure 3C, are they all altered in the same direction across 5 models?  

      This is indeed the case: the criteria for "commonly deregulated" included that the DEGs are changed in the same direction across several mutants. We ranked genes according to their mean gene expression across the mutants as compared it to the wildtype control: i.e. only if the DEGs are all up- or all down-regulated they end up on the top or bottom of our list. We added a remark in the revised manuscript. In preliminary work we also selected a number of the DEGs and conducted a screen where we manipulated the expression of these genes looking for rescue of the olfactory preference defects in our PD mutants. The strongest genetic interaction was with genes encoding proteins involved in proteostasis (Atg8/LC3, Lamp1 and Hsc70-4; and we also show a genetic interaction between EndoA and Lrrk in this work and in Matta et al., 2012) (Author response image 1 above). While interesting, these results require further work to understand the underlying molecular mechanisms. We present these preliminary data here, but have not included them in the main manuscript. 

      While this approach is carefully performed, the authors should state in the discussions the strengths and the caveats of the current strategy. For example, what kind of knowledge have we gained by introducing these mutations at an endogenous locus? Are there any caveats of having scRNAseq at day 5 only but being compared with postmortem human disease tissue?  

      We have included a “strengths and caveats section” in the discussion addressing these points.

      Reviewer #3 (Public Review):  

      Summary:  

      This study investigates the cellular and molecular events leading to hyposmia, an early dysfunction in Parkinson's disease (PD), which develops up to 10 years prior to motor symptoms. The authors use five Drosophila knock-in models of familial PD genes (LRRK2, RAB39B, PINK1, DNAJC6 (Aux), and SYNJ1 (Synj)), three expressing human genes and two Drosophila genes with equivalent mutations.  

      The authors carry out single-cell RNA sequencing of young fly brains and singlenucleus RNA sequencing of human brain samples. The authors found that cholinergic olfactory projection neurons (OPN) were consistently affected across the fly models, showing synaptic dysfunction before the onset of motor deficits, known to be associated with dopaminergic neuron (DAN) dysfunction.  

      Single-cell RNA sequencing revealed significant transcriptional deregulation of synaptic genes in OPNs across all five fly PD models. This synaptic dysfunction was confirmed by impaired calcium signalling and morphological changes in synaptic OPN terminals. Furthermore, these young PD flies exhibited olfactory behavioural deficits that were rescued by selective expression of wild-type genes in OPNs.  

      Single-nucleus RNA sequencing of post-mortem brain samples from PD patients with LRRK2 risk mutations revealed similar synaptic gene deregulation in cholinergic neurons, particularly in the nucleus basalis of Meynert (NBM). Gene ontology analysis highlighted enrichment for processes related to presynaptic function, protein homeostasis, RNA regulation, and mitochondrial function.  

      This study provides compelling evidence for the early and primary involvement of cholinergic dysfunction in PD pathogenesis, preceding the canonical DAN degeneration. The convergence of familial PD mutations on synaptic dysfunction in cholinergic projection neurons suggests a common mechanism contributing to early non-motor symptoms like hyposmia. The authors also emphasise the potential of targeting cholinergic neurons for early diagnosis and intervention in PD.  

      Strengths:  

      This study presents a novel approach, combining multiple mutants to identify salient disease mechanisms. The quality of the data and analysis is of a high standard, providing compelling evidence for the role of OPN neurons in olfactory dysfunction in PD. The comprehensive single-cell RNA sequencing data from both flies and humans is a valuable resource for the research community. The identification of consistent impairments in cholinergic olfactory neurons, at early disease stages, is a powerful finding that highlights the convergent nature of PD progression. The comparison between fly models and human patients' brains provides strong evidence of the conservation of molecular mechanisms of disease, which can be built upon in further studies using flies to prove causal relationships between the defects described here and neurodegeneration.  

      The identification of specific neurons involved in olfactory dysfunction opens up potential avenues for diagnostic and therapeutic interventions.  

      Weaknesses:  

      The causal relationship between early olfactory dysfunction and later motor symptoms in PD remains unclear. It is also uncertain whether this early defect contributes to neurodegeneration or is simply a reflection of the sensitivity of olfactory neurons to cellular impairments. The study does not investigate whether the observed early olfactory impairment in flies leads to later DAN deficits. Additionally, the single-cell RNA sequencing analysis reveals several affected neuronal populations that are not further explored. The main weakness of the paper is the lack of conclusive evidence linking early olfactory dysfunction to later disease progression.

      We agree that this is an interesting avenue to pursue and as indicated above in Figure 6 and in the reworked manuscript, we have now included data that strengthens the connection between early OPN defects and the later DAN dependent problems. Additional future work will be needed to elucidate the mechanisms of this cell-non autonomous effect. 

      The rationale behind the selection of specific mutants and neuronal populations for further analysis could be better qualified. 

      We have added further explanation in the reworked text.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):  

      Minor Comments:  

      (1) Questions about the sequencing methods and analysis approaches. From reading the methods and main text, I was confused about aspects of the Drosophila single-cell profiling. Firstly, did the authors multiplex their fly samples? 

      No, we did not. Genotypes were separately prepared and sequenced, but they were all processed in parallel to avoid batch effects. 

      Secondly, it seems like there are two rounds of dataset integration performed, Harmony and Seurat's CCA-based method. This seems unorthodox. Could the authors comment on why they perform two integrations? 

      Thanks for pointing this out, this was a mistake in the methods section (copied from a much older version of the manuscript). In this manuscript, we only used harmony for dataset integration and removed the methods on Seurat-CCA. 

      Finally, for all dataset integrations please state in the main text how datasets were integrated (by age, genotype, etc). 

      Datasets were integrated by sample id, corresponding to individual libraries.

      (2) The authors focus on OPNs with a really nice set of experiments. I noticed however that Kenyon cells were also dysregulated. What about Olfactory sensory neurons? Could the authors provide comments on this? 

      Olfactory sensory neurons are located in the antennae of the fly brain and were not captured by our analysis. However, the GH146-Gal4-specific rescue experiments indicate these sensory neurons are likely not severely functionally impaired. Kenyon cells are an interesting affected cell type to look at in future experiments, as they are directly connected to DANs.

      (3) There are several citations of Jenett et al 2012 that seem wrong (related to single-cell datasets).

      We are sorry for this and have corrected this in the text.  

      Reviewer #2 (Recommendations For The Authors):  

      (1) In the key resources table, a line called CG5010k.o. (chchd2k.o.) was mentioned, but was not used in the paper. The authors should remove it. 

      Sorry, this was from a previous older version of the manuscript. We fixed this.

      (2) Why did the authors use human CDS for LRRK2, Rab39B, and PINK1, but fly CDS for Aux and Synj1? Is it based on the conservation of amino acid residues? Although the authors cited a review (Kalia & Lang, 2015) to justify the selection of the mutations, for the interest of a broad audience, it is recommended that the authors expand their introduction for the rationale of their selection, including the pathogenicity of each selected mutation, original human genetics evidence, conservation between fly and human. 

      (a) We used Drosophila cDNA for rescue experiments with aux and synj since knockin of the human homologues at the locus of these genes did not rescue its loss-offunction (lethality). 

      (b) We expanded the introduction to provide further explanation on the selection of our mutants we analyzed in this work. We picked these particular mutants, as they were the first we created in the context of a much larger collection of “PD flies” (see also Kaempf et al 2024, BioRxiv). We have made adaptations to the text to tone down the statement on the broad selection of mutants. 

      (3) Supplemental Figure 1a, is mRNA level normalized to an internal control? If not, it is not appropriate to compare the results directly from two primer sets, since each primer set may have different amplification efficiency. 

      We are sorry for the lack of information. Indeed, mRNA levels were determined using the Δ-Δ-CT method, where Ct values were first normalized to the housekeeping gene Rp49, and next expressed as a percent of endogenous Drosophila gene expression. We expanded the methods section and now also enlist the primers for Rp49 along with the other qPCR primers in Supplemental File 1.

      (4) For Figure 2, it may be helpful to have a supplemental table or figure showcasing the clusters with significant changes (based on cell number-adjusted DEGs) for each model, i.e., what are those black cell clusters in Figure 2? "Thus, cellular identity and cellular composition are preserved in young PD fly models." In Figure S2A, the authors only show cell composition percentages for 3 cell clusters, are the bars 95% standard error? 

      The error bars in Supplemental Figure 2a represent the 95 % CI. We have included a new supplemental table with the number of cells per cell cluster for each mutant (Supplemental File 3).

      What about the remaining 183 cell clusters? Are there any KI-model cell clusters that are statistically different than controls? What about the annotated cell types (e.g., the 81 with cell identities)? Please consider at least providing or pointing to a table to state how many have significant differences, or if there are truly none. 

      As mentioned above, we have included a new supplemental table with the number of cells per cell cluster for each mutant (Supplemental File 3).

      (5) What are the rows in the sunburst plot in Figure 3a? Please be more descriptive in the figure legend or label the figure. 

      We have expanded on this in the figure legend and now also include a summary of the SynGO analysis in Supplemental File 7. In Figure 3a, a summary sunburst plot is presented, reflecting the GO terms (inner rings, indicated in a) with their subdivided levels (the complete list is provided in Supplemental File 7). In Figure 3a’ and a” the DEG data acquired from the different datasets (human vs fly) are applied to the sunburst plot where rings are color-coded according to enrichment Q-value.

      (6) In Table S4, which clusters (in the table) have normalized residuals that are outside of the 95% confidence interval of the regression model displayed in Figure S2e? They use this analysis to adjust for cell number bias and point out the "most significant cell clusters" affected in each model. This may be helpful for readers who want to grab a full list of responsive clusters. 

      We have included this information in Supplemental File 5 (Tab “Cell types outside of CIs”) in the supplemental data of the manuscript.

      (7) The human samples used all have different LRRK2 variants: for the crossspecies comparisons, do Lrrk flies have greater similarity to the human PD cases compared to the other fly models?

      No, comparing the vulnerable gene signatures from each of the fly mutants to the DEGs from the human samples does not show any greater similarity between the LRRK mutants compared to the other mutants.

      Reviewer #3 (Recommendations For The Authors):  

      Clarifications required:  

      Some of the mutations used are not common PD-associated genes, the authors should explain the rationale behind using these particular mutants, and not using well-established fly models of PD (like for example GBA flies) or SNCA overexpression.

      We opted to use knock-ins of mutations that are causal to Parkinsonism. Given flies do not express an alpha-synuclein homologue we were not able to add this ‘as such’ to our collection. Future work can indeed also include expression models or risk factor models (like GBA). As also requested by another reviewer, we did add further rationale and explanation to the genes we chose to analyze in this work.

      Why starvation rather than lifespan for PD models? For the lifespan data shown there are no error bars, if the stats test is a log-rank or Cox proportional hazards (usually used in survival analysis, this should be stated), it would also be good to have the survival plots for all the survival during starvation, not just PINK1. 

      While starvation assays can provide valuable insights into acute metabolic and physiological stress responses, we acknowledge that lifespan is a critical parameter and would provide a more comprehensive understanding of the PD models in our study. Based on this consideration and the reviewer’s feedback we have removed the starvation data from the manuscript. Unfortunately, we did not perform lifespan experiments, which is why these data were not included in the manuscript. However, based on our observations (though not detailed analysis), all genotypes tested—except for the PINK1 mutants—appeared to have a normal lifespan. For PINK1 mutants, most flies died by 25 days of age. Therefore, we conducted our assays using 15-day-old PINK1 mutant flies.

      Do the fly models used have different lifespans, and how close to death was the SING assay performed? Different mutations show different effects, most phenotypes are really mild (hRab39BG192R has no phenotype), and PINK1 has the strongest, are these simply reflections of how strong the model is?  

      The ages of flies we analyzed are indicated in the legend. As mentioned before, all but PINK1 mutants- had a normal life span: i.e. we did not detect abnormal low number of flies or premature death at 50 days of age, except for the PINK1 mutants tested in this manuscript where most flies died by 25 days of age. Therefore, we conducted our assays using 15-day-old PINK1 mutant flies.

      Rab39G192R has no phenotype in the tests presented, suggesting no degeneration, why use RabG192R for scRNA seq? Seems an odd choice, the authors should explain. 

      Single-cell sequencing was initiated before the full phenotypic characterization of all mutants was completed. Although basic characterization of the Rab39<sup>G192R</sup> mutant PD flies revealed either no significant phenotypes or only mild effects in the assays performed (Figure 1), the sequencing data provided additional insights into potential cellular and molecular alterations. Furthermore, all PD-mutant knock-ins, including Rab39<sup>G192R</sup> mutant PD flies, show dysfunctional synaptic terminals of their OPN neurons as they had significantly weaker Ca<sup>2+</sup>-responses, even though their synaptic area was increased (Figure 4 g-h). Furthermore, all mutants also had olfactory behavior defects (Figure 5 a). 

      When the authors state that “For example, in the NBM, an area associated with PD (Arendt et al., 1983), 20% of the DEG that has an orthologous gene in the fly are also found among the most deregulated genes across PD fly models" a test should be performed to confirm this is a significant overlap (such as a hypergeometric test). 

      We have performed this test, of the 2486 significantly differential human genes, 1149 have a fly orthologue, and of these, 28.46 % overlap with the deregulated fly genes (5 % top and bottom gene as shown in Supplemental Table 7). Performing a hypergeometric test confirms that this overlap is significant, with a p-value of 9.06e<sup>76</sup>. We have included this in the text.

      The authors speak of deregulation when speaking of the overlap between human and fly DE genes, but do the over-expressed genes in flies overlap with overexpressed genes in humans, or is the direction of transcription deregulation not concordant? If it is mostly not concordant, can the authors please comment as to why they might think that is the case? 

      In our fly experiments, we identified DEG in affected cell types and then defined common DEG by looking at the average change across the fly mutants. Genes that show a consistent change (all or mostly up, or all or mostly down) in the different mutants will end at the top of our list while genes that are up in some mutants and downregulated in others will average out and not end up in our commonly deregulated gene list. For comparison to the human data, we only looked for the presence of the human homologue, but did not assess if the change occurred in the same direction. More work will be needed to define the most relevant changes, but in a mini-screen we did select a number of DEG present in fly and human datasets from different functional categories and tested if they genetically interact with our PD mutants. As shown in Reviewer Figure 3, we find that modulating proteostasis pathway-encoding genes rescue the olfactory preference defect across many PD mutants. 

      Can the authors explain why only the NMB region was used for comparison with the fly data?  

      We used the NMB because this region has the highest number of cholinergic neurons to compare the deregulation in those neurons to the deregulation in the cholinergic OPN of mutant PD flies.

      In Figure 4, can the genotypes please be stated in full and why is the hPINK1 fly giving no detectable signal? 

      Despite several attempts, we failed to knock-in wild type hPink1 in the fly pink1 locus. Therefore, the hPink1 control used throughout the manuscript was the nSybGal4>UAS-hPink1 in Pink1 knock-out background, except for Figure 4. Particularly, for experiments in this figure, we could not use UAS-hPink1 with nSyb-Gal4, since we needed OPN-specific expression of Gal4 to drive UAS-GCamP expression.

      Therefore, this was labeled as “not determined” (“n.d.”), as indicated in the figure and the legend. We explained this better in the methods section, added a remark in the new manuscript and expanded the legend of Figure 4.

      The paper states that" These findings imply that factors affecting the function of cholinergic neurons might, by the absence of insufficient innervation, lead to DAN problems and degeneration, warranting further exploration of the underlying molecular mechanisms", this should be less strong, the paper never looks at DAN, only at OPN neurons. Fly neurons are mostly cholinergic, and human neurons are mostly glutamatergic, so jumping from one system to the other might not be as straightforward, the authors should comment on this. 

      We now included a new exciting experiment where we assessed DAN function in aged PD mutants where the wildtype gene was expressed in OPN using GH146-Gal4. We find this manipulation rescued DAN defects (measured by SING) in older flies. We further corroborated our observation by “replacing” cholinergic innervation with nicotine feeding in PD mutants. Also, this rescues the SING defect as well as the defects in neuronal activity in PAM DAN (based on live synaptic calcium imaging). Finally, we also show that incubating LRRK2<sup>G2019S</sup> mutant human induced dopaminergic neurons with nicotine is sufficient to rescue functional defects in these neurons (measured using calcium imaging). We included this data in the new manuscript and show them also in Figure 6 above (new Figure 6 in the revised manuscript). 

      Experiments that would improve the manuscript:  

      Does rescue of OPN function also rescue later progressive symptoms (geotaxis response)?  

      It does, as indicated in the previous point and shown in Figure 6.

      Do the fly PD models used show DAN degeneration? This could be assessed by stains with anti-TH stains. 

      We quantified DAN cell bodies using anti-TH, but see very little or no loss. There is, however, loss of synaptic innervation of the PAM onto the mushroom bodies. We included the data in a new Figure 6 (see also Figure 6). Furthermore, we have quantified this across the genetic space of familial Parkinsonism in Kaempf et al., 2024, BioRxiv. Note that this phenotype is also rescued by expressing wildtype CDS in their OPN using GH146-Gal4.

      Minor issues: 

      The final sentence on page 5 is repetitive with the introduction. 

      Indeed, we removed the redundant sentence.

      First line of the new section on page 6, the authors probably mean cholinergic olfactory projection neurons, not just cholinergic neurons. 

      Yes, and corrected.

      At the top of page 7 the authors state: "Additionally, we also found enrichment of genes involved in RNA regulation and mitochondrial function that are also important for the functioning of synaptic terminals", where is the data showing this? The authors should point to the supplemental file showing this.  

      We now included a reference to Supplemental File 7 that includes a summary of those data. Additionally, we also included references to back this claim.

      Just before the discussion, Rab39BG193R should be Rab39BG192R.  

      Sorry for this, it is now corrected.

      Stating "fifth row" in Fig 5c and d is confusing, can the figure be labelled more clearly?  

      We modified the figure (including extra marks and colors) and expanded the legend and the main text to differentiate better between expression of the rescues in OPN versus T1 neurons revealing that only expression in OPN neurons rescues the olfactory defects while expression in T1 neurons does not.

      In the methods, the authors describe clustering done both in Scanpy and Seurant, why were both run? Which clustering was used for further analysis?

      We only used Scanpy with Harmony and removed the methods on Seurat-CCA. Thanks for pointing this out, this was a mistake in the methods section (copied from a previous version of the manuscript).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1 (Public Comments):

      (1) The central concern for this manuscript is the apparent lack of reproducibility. The way the authors discuss the issue (lines 523-554) it sounds as though they are unable to reproduce their initial results (which are reported in the main text), even when previous versions of AlphaFold2 are used. If this is the case, it does not seem that AlphaFold can be a reliable tool for predicting antibody-peptide interactions.

      The driving point behind the multiple sequence alignment (MSA) discussion was indeed to point out that AlphaFold2 (AF2) performance when predicting scFv:peptide complexes is highly dependent upon the MSA, but that is a function of MSA generation algorithm (MMseqs2, HHbiltz, jackhmmer, hhsearch, kalign, etc) and sequence databases, and less an intrinsic function of AF2. It is important to report MSA-dependent performance precisely because this results in changing capabilities with respect to peptide prediction.

      Performance also significantly varies with the target peptide and scFv framework changes. By reporting the varying success rates (as a function of MSA, peptide target, and framework changes) we aim to help future researchers craft modified algorithms that can achieve increased reliability at protein-peptide binding predictions. Ultimately, tracking down how MSA generation details vary results (especially when the MSA’s are hundreds long) is significantly outside the scope of this paper. Our goal for this paper was to show a general method for identification of linear antibody epitopes using only sequence information, and future work by us or others should focus on optimization of the process. 

      (2) Aside from the fundamental issue of reproducibility, the number of validating tests is insufficient to assess the ability of AlphaFold to predict antibody-peptide interactions. Given the authors' use of AlphaFold to identify antibody binding to a linear epitope within a whole protein (in the mBG17:SARS-Cov-2 nucleocapsid protein interaction), they should expand their test set well beyond Myc- and HA-tags using antibody-antigen interactions from existing large structural databases.

      Performing the calculations at the scale that the reviewer is requesting is not feasible at this time. We showed in this manuscript that we were able to predict 3 of 3 epitopes, including one antigen and antibody pair that have not been deposited into the PDB with no homologs. While we feel that an N=3 is acceptable to introduce this method to the scientific community, we will consider adding more examples of success and failure in the future to optimize and refine the method as computational resources become available. Notably, future efforts that attempt high-throughput predictions of this class using existing databases should take particular care to avoid contamination.

      (3) As discussed in lines 358-361, the authors are unsure if their primary control tests (antibody binding to Myc-tag and HA-tag) are included in the training data. Lines 324-330 suggest that even if the peptides are not included in the AlphaFold training data because they contain fewer than 10 amino acids, the antibody structures may very well be included, with an obvious "void" that would be best filled by a peptide. The authors must confirm that their tests are not included in the AlphaFold training data, or re-run the analysis with these templates removed.

      First, we address the simpler question of templates.

      The reruns of AF2 with the local 2022 rebuild, the most reproducible method used with results most on par with the MMSEQS server in the Fall of 2022, were run without templates. This is because the MSA was generated locally; no templates were matched and generated locally. The only information passed then was the locally generated MSA, and the fasta sequence of the unchanging scFv and the dynamic epitope sequence. Because of how well this performed despite the absence of templates, we can confidently say the inclusion of the template flag is not significant with respect to how universally accurately PAbFold can identify the correct epitope. 

      Second, we can partially address the question of whether the AlphaFold models had access to models suitable, in theory, for “memorization” of pertinent structural details. 

      With respect to tracking the exact role and inclusion of specific PDB entries, the AF2 paper provides the following:

      “Structures from the PDB were used for training and as templates (https://www.wwpdb.org/ftp/pdb-ftp-sites; for the associated sequence data and 40% sequence clustering see also https://ftp.wwpdb.org/pub/pdb/derived_data/ and https://cdn.rcsb.org/resources/sequence/clusters/bc-40.out). Training used a version of the PDB downloaded 28 August 2019, while the CASP14 template search used a version downloaded 14 May 2020. The template search also used the PDB70 database, downloaded 13 May 2020 (https://wwwuser.gwdg.de/~compbiol/data/hhsuite/databases/hhsuite_dbs/).”

      Three of these links are dead. As such, it is difficult to definitively assess the role of any particular PDB entry with respect to AF2 training/testing, nor what impact homologous training structures given the very large number of immunoglobin structures in the training set. That said, we can summarize information for the potentially relevant PDB entries (l 2or9, which is shown in Fig. 1 and 1frg), and believe it is most conservative to assume that each such entry was within the training set.

      PDB entry 2or9 (released 2008): the anti-c-myc antibody 9E10 Fab fragment in complex with an 11-amino acid synthetic epitope: EQKLISEEDLN. This crystal structure is also noteworthy for featuring a binding mode where the peptide is pinned between two Fab. The apo structure (2orb) is also in the database but lacks the peptide and a resolved structure for CDR H3.

      PDB entry 1a93 (released 1998): a c-Myc-Max leucine zipper structure, where the c-Myc epitope (in a 34-amino acid protein) adopts an alpha helical conformation completely different from the epitope captured in entry 2or9.

      PDB entries 5xcs and 5xcu (released 2017): engineered Fv-clasps (scFv alternatives) in complex with the 9-amino acid synthetic HA epitope: YPYDVPDYA.

      PDB entry 1frg (released 1994): anti-HA peptide Fab in complex with HA epitope subset Ace-DVPDYASL-NH2.

      Since the 2or9 entry has our target epitope (10 aa) embedded within an 11aa sequence, we have revised this line in the manuscript:

      The AlphaFold2 training set was reported to exclude chains of less than 10, which would eliminate the myc and HA epitope peptides. => The AlphaFold2 training set was reported to exclude chains of less than 10, which would eliminate the HA epitope peptide from potential training PDB entries such as 5xcs or 5xcu”

      It is important to note that we obtained the best prediction performance for the scFv:peptide pair that had no pertinent PDB entries (mBG17). Specifically, doing a Protein Blast against the PDB using the mBG17 scFv revealed diverse homologs, but a maximum sequence identity of 89.8% for the heavy chain (to an unrelated antibody) and 93.8% for the light chain (to an unrelated antibody). Additionally, while it is possible that the AF2 models might have learned from the complex in pdb entry 2or9, Supplemental Figure 3 shows how often the peptide is “misplaced”, and the performance does not exceed the performance for mBG17.

      (4) The ability of AlphaFold to refine the linear epitope of antibody mBG17 is quite impressive and robust to the reproducibility issues the authors have run into. However, Figure 4 seems to suggest that the target epitope adopts an alpha-helical structure. This may be why the score is so high and the prediction is so robust. It would be very useful to see along with the pLDDT by residue plots a structure prediction by residue plot. This would help to see if the high confidence pLDDT is coming more from confidence in the docking of the peptide or confidence in the structure of the peptide.

      The reviewer is correct that target mBG17 epitope adopts an alpha helical conformation, and we concur that this likely contributes to the more reliable structure prediction performance.  When we predict the structure of the epitope alone without the mBG17 scFv, AF2 confidently predicts an alpha helix with an average pLDDT of 88.2 (ranging from 74.6 to 94.4). 

      Author response image 1.

      The AF2 prediction for the mBG17 epitope by itself.

      However, as one interesting point of comparison, a 10 a.a. poly-alanine peptide is also consistently folded into an alpha-helical coil by AF2. The A<sub>10</sub> peptide is also predicted to bind among the traditional scFv CDR loops, but the pLDDT scores are very poor (Supplemental Figure 5J). We also observed the opposite case; when a peptide has a very unstructured region in the binding domain but is nonetheless still be placed confidently, as seen in Supplemental Figure 3 C&D. Therefore, while we suspect peptides with strong alpha helical propensity are more likely to be accurately predicted, the data suggests that that alpha helix adoption is neither necessary nor sufficient to reach a confident prediction.

      (5) Related to the above comment, pLDDT is insufficient as a metric for assessing antibody antigen interactions. There is a chance (as is nicely shown in Figure S3C) that AlphaFold can be confident and wrong. Here we see two orange-yellow dots (fairly high confidence) that place the peptide COM far from the true binding region. While running the recommended larger validation above, the authors should also include a peptide RMSD or COM distance metric, to show that the peptide identity is confident, and the peptide placement is roughly correct. These predictions are not nearly as valuable if AlphaFold is getting the right answer for the wrong reasons (i.e. high pLDDT but peptide binding to a nonCDR loop region). Eventual users of the software will likely want to make point mutations or perturb the binding regions identified by the structural predictions (as the authors do in Figure 4).

      We agree with the reviewer that pLDDT is not a perfect metric, and we are following with great interest the evolving community discussion as to what metrics are most predictive of binding affinity (e.g. pAE, or pITM as a decent predictor for binding, but not affinity ranking). To our knowledge, there is not yet a consensus for the most predictive metrics for protein:protein binding nor protein:peptide binding. Intriguingly, since the antigen peptides are so small in our case, the pLDDT of the peptide residues should be mostly reporting on the confidence of the distances to neighboring protein residues.

      As to the suggestion for a RMSD or COM distance metric, we agree that these are useful -with the caveat that these require a reference structure. The goal of our method is to quickly narrow down candidate linear epitopes and thereby guide experimentalists to more efficiently determine the actual binding sequence of an antibody-antigen sequence. Presumably this would not be necessary if a reference structure were known. 

      It may also be possible to invent a method to filter unlikely binding modes that is specific to antibodies and peptide epitopes that does not require a known reference structure, but this would be an interesting problem for subsequent study.

      Reviewer 1 (Recommendations for the Authors):

      (1) "Linear epitope" should be more precisely defined in the text. It isn't clear whether the authors hope that they can use AlphaFold to predict where on a given protein antigen an antibody will bind, or which antigenic peptide the antibody will bind to. The authors discuss both problems, and there is an important distinction between the two. If the authors are only concerned with isolated antigenic peptides, rather than linear epitopes in their full length structural contexts, they should be more precise in the introduction and discussion.

      We thank the reviewer for the prompt towards higher precision. We are using the short contiguous antigen definition of “linear epitope” that depends on secondary rather than tertiary structure. The linear epitopes this paper considers are short “peptides” that form secondary structure independent of their structure in the complete folded antigen protein. We have clarified our definition of “linear epitope” in the text (lines 64-66). 

      (2) Line 101: "Not all portions of the antibody are critical". First, this is not consistent with the literature, particularly where computational biology is concerned.

      See https://pubs.acs.org/doi/10.1021/acs.jctc.7b00080 . Second, while I largely agree with what I think the authors are trying to say (that we can largely reduce the problem to the CDR loops), this is inconsistent with what the authors later find, which is that inexplicably the VH/VL scaffold used alters results strongly.

      We have adopted verbiage that should be less provocative: “Fortunately, with respect to epitope specificity, antibody constant domains are less critical than the CDR loops and the remainder of the variable domain framework regions.”

      (3) Related to the above comment, do the authors have any idea why epitope prediction performance improved for the chimeric scFvs? Is this due to some stochasticity in AlphaFold? Or is there something systematic? Expanding the test dataset would again help answer this question.

      We agree that future study with a larger test set could help address this intriguing result, for which we currently lack a conclusive explanation. Part of our motivation for this publication was to bring to light this unexpected result. Notably, these framework differences are not only implicated as a factor in driving AF2 performance, but also changing experimental intracellular performance as reported by our group (DOI: 10.1038/s41467-019-10846-1 ). We can generate a variety of hypotheses for this phenomenon. Just as MSA sub-sampling has been a popular approach to drive AF2 to sample alternative conformations, sequence recombination may be a generically effective way to generate usefully different binding predictions. However, it is difficult to discriminate between recombination inducing subtle structural tweaks that increase protein intracellular fitness and binding, from recombination causing changes to the MSA that affect the likelihood of sampling a good epitope binding conformation. It is also possible that the chimeras are more deftly predicted by AF2 due to differences in sequence representation during the training of the AF2 models (e.g. more exposure to models containing 15F11 or 2E2 structures). We attempted to deconvolute MSA differences by using single-sequence mode (Supplementary Figure 13) but this ablated performance.

      (4) Figure 2: The reported consensus pLDDT scores are actually quite low here, suggesting low confidence in the result. This is in strong contrast to the reported consensus scores for mBG17. Again, a larger test dataset would help set a quantitative cutoff for where to draw the line for "trustworthy" AlphaFold predictions in antibody-peptide binding applications.

      We agree that a larger dataset will be useful to begin to establish metrics and thresholds and will contribute to the aforementioned community discussion about reliable predictors of binding. Our current focus is not structure prediction per se. In the current work we are more focused on relative binding likelihood and increasing the efficiency of experimental epitope verification by flagging the most likely linear epitopes. Thus, while the pLDDT scores are low for Myc in Figure 2, it is remarkable (and worth reporting) that there is still useful signal in the relative variation in pLDDT. The utility of the signal variation is evident in the ability to short-list correct lead peptides via the two methods we demonstrate (consensus and per-residue max).

      (5) Figure 4: if the authors are going to draw conclusions from the actual structure predictions of AlphaFold (not just the pLDDT scores), the side-chain accuracy placement should be assessed in the test dataset (RMSD or COM distance).

      We agree with the reviewer that side-chain placement accuracy is important when evaluating the accuracy of AF2 structure predictions. However, here our focus was relative binding likelihood rather than structure prediction. The one case where we attempted to draw conclusions from the structure prediction was in the context of mBG17, where there is not yet an experimental reference structure. Absolutely, if we were to obtain a crystal structure for that complex, we would assess side-chain placement accuracy. 

      (6) Lines 493-508: I am not sure that this assessment for why AlphaFold has difficulty with antibody-antigen interactions is correct. If the authors' interpretation is correct (larger complicated structures are more challenging to move) then AlphaFold-Multimer (https://www.biorxiv.org/content/10.1101/2021.10.04.463034v2.full) wouldn't perform as well as it does. Instead, the issue is likely due to the incredibly high diversity in antibody CDR loops, which reduces the ability of the AlphaFold MSA step (which the authors show is quite critical to predictions: Figure S13) to inform structure prediction. This, coupled with the importance of side chain placement in antibody and TCR interactions, which is notoriously difficult (https://elifesciences.org/articles/90681), are likely the largest source of uncertainty in antibody-antigen interaction prediction.

      We agree with the reviewer that CDR loop diversity (and associated side chain placement challenges) are a major barrier to successfully predict antibody-antigen complexes. Presumably this is true for both peptide antigens and protein antigens. Indeed, the authors of AlphaFold-multimer admit that the updated model struggles with antibody-antigen complexes, saying “As a limitation, we observe anecdotally that AlphaFold-Multimer is generally not able to predict binding of antibodies and this remains an area for future work.” The point about how loop diversity could reduce MSA quality is well taken. We have included the following thanks to the guidance of the reviewer when discussing MSA sensitivity is discussed later on in lines 570-572.: 

      “These challenges are presumably compounded by the incredible diversity of the CDR loops in antibodies which could decrease the useful signal from the MSA as well as drive inconsistent MSA-dependent performance”.

      With respect to lines 493-508, we have also rephrased a key sentence to try to better explain that we are comparing the often-good recognition performance for short epitopes to the never-good performance when those epitopes are embedded within larger sequences. Instead of saying, “In contrast, a larger and complicated structure may be more challenging to move during the AlphaFold2 structure prediction or recycle steps.” we now say in lines 520-522 , “In contrast, embedding the epitope within a larger and more complicated structure appears to degrade the ability of AlphaFold2 to sample a comparable bound structure within the allotted recycle steps.”

      (7) Related to major comment 1: Are AlphaFold predictions deterministic? That is, if you run the same peptide through the PAbFold pipeline 20 times, will you get the same pLDDT score 20 times? The lack of reproducibility may be in part due to stochasticity in AlphaFold, which the authors could actually leverage to provide more consistent results.

      This is a good question that we addressed while dissecting the variable performance. When the random seed is fixed, AF2 returns the same prediction every time. After running this 10 times with a fixed seed, the mBG17 epitope was predicted with an average pLDDT of 88.94, with a standard deviation of 1.4 x 10<sup>-14</sup>. In contrast, when no seed is specified, AF2 did not return an *identical* result. However, the results were still remarkably consistent. Running the mBG17 epitope prediction 10 times with a different seed gave an average pLDDT of 89.24, with a standard deviation of 0.49. 

      (8) Related to major comment 2: The authors could use, for example, this previous survey of 1833 antibody-antigen interactions (https://www.sciencedirect.com/science/article/pii/S2001037023004725) the authors could likely pull out multiple linear epitopes to test AlphaFold's performance on antibody peptide interactions. A large number of tests are necessary for validation.

      We thank the reviewer for this report of antibody-antigen interactions and will use it as a source of complexes in a future expanded study. Given the quantity and complexity of the data that we are already providing, as well as logistical challenges for compute and personnel the reviewer is asking for, we must defer this expansion to future work.

      (9) Related to major comment 3: Apologies if this is too informal for a review, but this Issue on the AlphaFold GitHub may be useful: https://github.com/googledeepmind/alphafold/issues/416 .

      We thank the reviewer for the suggestion – per our response above we have indeed run predictions with no templates. Since we are using local AlphaFold2 calculations with localcolabfold, the use or non-use of templates is fairly simple: including a “—templates” flag or not.

      (10) Related to major comment 4: I am not sure if AlphaFold outputs by-residue secondary structure prediction by default, but I know that Phyre2 does http://www.sbg.bio.ic.ac.uk/~phyre2/html/page.cgi?id=index .

      To our knowledge, AF2 does not predict secondary structure independent of the predicted tertiary structure. When we need to analyze the secondary structure we typically use the program DSSP from the tertiary structure. 

      (11) The documentation for this software is incomplete. The GitHub ReadMe should include complete guidelines for users with details of expected outputs, along with a thorough step-by-step walkthrough for use.

      We thank the reviewer for pointing this out, but we feel that the level of detail we provide in the GitHub is sufficient for users to utilize the method described.

      Stylistic comments:

      (1) I do not think that the heatmaps (as in 1C, top) add much information for the reader. They are largely uniform across the y-axis (to my eyes), and the information is better conveyed by the bar and line graphs (as in 1C, middle and bottom panels).

      We thank the reviewer for this feedback but elect to leave it in on the premise of more data presented is (usually) better. Including the y-axis reveals common patterns such as the lower confidence of the peptide termini, as well as the lack of some patterns that might have occurred. For example, if a subset of five contiguous residues was necessary and sufficient for local high confidence this could be visually apparent as a “staircase” in the heat map.

      (2) A discussion of some of the shortcomings of other prediction-based software (lines 7177) might be useful. Why are these tools less well-equipped than AlphaFold for this problem? And if they have tried to predict antibody-antigen interactions, why have they failed?

      We agree with the reviewer that a broader review of multiple methods would be interesting and useful. One challenge is that the suite of available methods is evolving rapidly, though only a subset work for multimeric systems. Some detail on deficiencies of other approaches was provided in lines 71-77 originally, although we did not go into exhaustive detail since we wanted to focus on AF2. We view using AF2 in this manner is novel and that providing additional options predict antibody epitopes will be of interest to the scientific community. We also chose AF2 because we have ample experience with it and is a software that many in the scientific community are already using and comfortable with. Additionally, AF2 provided us with a quantification parameter (pLDDT) to assess the peptides’ binding abilities. We think a future study that compares the ability of multiple emerging tools for scFv:peptide prediction will be quite interesting. 

      (3) Similar to the above comment, more discussion focused on why AlphaFold2 fails for antibodies (lines 126-128) might be useful for readers.  

      We thank the reviewer for the suggestion. The following line has been added shortly after lines 135-137:

      “Another reason for selecting AF2 is to attempt to quantify its abilities the compare simple linear epitopes, since the team behind AF-multimer reported that conformational antibody complexes were difficult to predict accurately (14).”

      Per earlier responses, we also added text that flags one particular possible reason for the general difficulty of predicting antibody-antigen complexes (the diversity of the CDR loops and associated MSA challenges).

      (4) The first two paragraphs of the results section (lines 226-254) could likely be moved to the Methods. Additionally, details of how the scores are calculated, not just how the commands are run in python, would be useful.

      Per the reviewer suggestion, we moved this section to the end of the Methods section. Also, to aid in the reader’s digestion of the analysis, the following text has been added to the Results section (lines 256-264):

      “Both the ‘Simple Max’ and ‘Consensus’ methods were calculated first by parsing every pLDDT score received by every residue in the antigen sequence sliding window output structures. From the resulting data structure, the Simple Max method simply finds the maximum pLDDT value ever seen for a single residue (across all sliding windows and AF2 models). For the Consensus method, per-residue pLDDT was first averaged across the 5 AF2 models. These averages are reported in the heatmap view, and further averaged per sliding window for the bar chart below.

      In principle, the strategy behind the Consensus method is to take into account agreement across the 5 AF2 models and provide insight into the confidence of entire epitopes (whole sliding windows of n=10 default) instead of disconnected, per-residue pLDDT maxima.” 

      (5) Figure 1 would be more useful if you could differentiate specifically how the Consensus and Simple Max scoring is different. Providing examples for how and why the top 5 peptide hits can change (quite significantly) using both methods would greatly help readers understand what is going on.

      Per the reviewer suggestion, we have added text to discuss the variable hit selection that results from the two scoring metrics. The new text (lines 264-271) adds onto the added text block immediately above:

      “Having two scoring metrics is useful because the selection of predicted hits can differ. As shown in Figure 2, part of the Myc epitope makes it into the top 5 peptides when selection is based on summing per-residue maximum pLDDT (despite there being no requirement that these values originate in the same physical prediction). In contrast, a Consensus method score more directly reports on a specific sliding window, and the strength of the highest confidence peptides is more directly revealed with superior signal to noise as shown in Figure 3. Variability in the ranking of top hits between the two methods arises from the fundamental difference in strategy (peptide-centric or residue-centric scoring) as well as close competition between the raw AF2 confidence in the known peptide and competing decoy sequences.”

      (6) Hopefully the reproducibility issue is alleviated, but if not the discussion of it (lines 523554) should be moved to the supplement or an appendix.

      The ability of the original AF2 model to predict protein-protein complexes was an emergent behavior, and then an explicit training goal for AF2.multimer. In this vein, the ability to predict scFv:peptide complexes is also an emergent capability of these models. It is our hope that by highlighting this capacity, as well as the high level of sensitivity, that this capability will be enhanced and not degraded in future models/algorithms (both general and specialized). In this regard, with an eye towards progress, we think it is actually important to put this issue in the scientific foreground rather than the background. When it comes to improving machine learning methods negative results are also exceedingly important.

      Reviewer 2 (Recommendations for the Author):

      - Line 113, page 3 - the structures of the novel scFv chimeras can be rapidly and confidently be predicted by AlphaFold2 to the structures of the novel scFv chimeras can be rapidly and confidently predicted by AlphaFold2.

      The superfluous “be” was removed from the text.

      - Line 276 and 278 page 9 - peptide sequences QKLSEEDLL and EQKLSEEDL in the text are different from the sequences reported in Figures 1 and 2 (QKLISEEDLL and EQKLISEEDL). Please check throughout the manuscript and also in the Figure caption (as in Figure 2).

      These changes were made throughout the text. 

      - I would include how you calculate the pLDDT score for both Simple Max approach and Consensus analysis.

      Good suggestion, this should be covered via the additions noted above.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The authors bring together implanted radiofrequency coils, high-field MRI imaging, awake animal imaging, and sensory stimulation methods in a technological demonstration. The results are very detailed descriptions of the sensory systems under investigation.

      Strengths:

      - The maps are qualitatively excellent for rodent whole-brain imaging. - The design of the holder and the coil is pretty clever.

      Weaknesses:

      - Some unexpected regions appear on the whole brain maps, and the discussion of these regions is succinct.

      - The authors do not make the work and e ort to train the animals and average the data from several hundred trials apparent enough. This is important for any reader who would like to consider implementing this technology.

      - The data is not available. This does not let the readers make their own assessment of the results.

      Thank you for the comments on this manuscript. We have provided more detailed discussion of the unexpected regions(page 18 – line 491-494) and training procedures(page7-9 – line 172-236). We also uploaded the datasets to OpenNeuro 

      Whisker (https://doi.org/10.18112/openneuro.ds005496.v1.0.1),  Visual (https://doi.org/10.18112/openneuro.ds005497.v1.0.0) and Zenodo:

      SNR Line Profile Data & Data Processing Scripts:  (https://zenodo.org/doi/10.5281/zenodo.13821455). 

      Reviewer #2 (Public Review):

      Summary:

      The manuscript by Hike et al. entitled 'High-resolution awake mouse fMRI at 14 Tesla' describes the implementation of awake mouse BOLD-fMRI at high field. This work is timely as the field of mouse fMRI is working toward collecting high-quality data from awake animals. Imaging awake subjects o ers opportunities to study brain function that are otherwise not possible under the more common anesthetized conditions. Not to mention the confounding e  ects that anesthesia has on neurovascular coupling. What has made progress in this area slow (relative to other imaging approaches like optical imaging) is the environment within the MRI scanner (high acoustic noise) - as well as the intolerance of head and body motion. This work adds to a relatively small, but quickly growing literature on awake mouse fMRI. The findings in the study include testing of an implanted head-coil (for MRI data reception). Two designs are described and the SNR of these units at 9.4T and 14T are reported. Further, responses to visual as well as whisker stimulation recorded in acclimated awake mice are shown. The most interesting finding, and most novel, is the observation that mice seem to learn to anticipate the presentation of the stimulus - as demonstrated by activations evident ~6 seconds prior to the presentation of the stimulus when stimuli are delivered at regular intervals (but not when stimuli are presented at random intervals). These kinds of studies are very challenging to do. The surgical preparation and length of time invested into training animals are grueling. I also see this work as a step in the right direction and evidence of the foundations for lots of interesting future work. However, I also found a few shortcomings listed below.

      Weaknesses:

      (1) The surface coil, although o ering a great SNR boost at the surface, ultimately comes at a cost of lower SNR in deeper more removed brain regions in comparison to commercially available Bruker coils (at room temperature). This should be quantified. A rough comparison in SNR is drawn between the implanted coils and the Bruker Cryoprobe - this should be a quantitative comparison (if possible) - including any di erences in SNR in deeper brain structures. There are drawbacks to the Cryoprobe, which can be discussed, but a more thorough comparison between the implanted coils, and other existing options should be provided (the Cryoprobe has been used previously in awake mouse experiments(Sensory evoked fMRI paradigms in awake mice - Chen, Physiological e ects of a habituation procedure for functional MRI in awake mice using a cryogenic radiofrequency probe – Yoshida, PREVIOUS REFERENCE). Further, the details of how to build the implanted coils should be provided (shared) - this should include a parts list as well as detailed instructions on how to build the units. Also, how expensive are they? And can they be reused?

      Thank you for the comment. We did not use a Bruker Cryoprobe for this work but rather a Bruker 4array surface coil. We are unable to compare to a cryoprobe since we do not have access to one for our system. A comparison to previously published data using different scanners could be possible but would require the sequence contain identical parameters to avoid introducing an uncontrollable variable, we are planning to recruit different laboratories to test the implanted RF coils with their existing cryoprobes in the future study. 

      We have included an updated figure comparing SNR at different depths across the Bruker 4-array coil and the implanted RF coils. As shown in Supplementary Figure 7B, there is significant SNR enhancement up to 4 mm cortical depth for both single loop and Figure 8 implanted RF coils in comparison to the Bruker 4-array coil.

      Author response image 1.

      Comparison between implanted and commercial coils. A shows representative coils in the single loop (left) and figure 8 styles (right). Supplementary Table 1 provides a parts list and cost for making these coils and Supplementary Figure 1 provides a circuit diagram to assemble. B presents the SNR line profile values as a function of distance from Pia Matter for each coil tested at 9.4T: commercial phased array surface coil (4 Array), implanted single loop, and implanted figure 8. SNR values were calculated by dividing the signal by the standard deviation of the noise. C-E shows a representative FLASH image with line profile of SNR measurements from each of the coils used to create the graph seen in B. Clear visual improvement in SNR can be seen in figures C-E. C – Commercial phased array. D – Single loop at 9.4T. E – Figure 8 at 9.4T. (N4 array = 6, Nsingle loop = 5, Nfigure 8 = 5)

      Additionally, we have added a supplementary figure (supp fig 1) of a circuit diagram, in an effort to disseminate the prototype design of the coils to other laboratories. We have included a detailed parts list with the cost for construction of the coils configured for our scanner(supp table 1). These specifics though would need to be adjusted to the precise field strength/bore size/animal the coil was being built for. As for reusability, the copper wire is cemented to the animal skull and this implantable coil should be considered as consumables for the awake mouse experiments, though the PCB parts can be retrieved.  

      (2) In the introduction, the authors state that "Awake mouse fMRI has been well investigated". I disagree with this statement and others in the manuscript that gives the reader the impression that awake experiments are not a challenging and unresolved approach to fMRI experiments in mice (or rodents). Although there are multiple labs (maybe 15 worldwide) that have conducted awake mouse experiments (with varying degrees of success/thoroughness), we are far from a standardized approach. This is a strength of the current work and should be highlighted as such. I encourage the authors to read the recent systematic review that was published on this topic in Cerebral Cortex by Mandino et al. There are several elements in there that should influence the tone of this piece including awake mouse implementations with the Bruker Cryoprobe, prevalence of surgical preparations, and evaluations of stress.

      Thank you for the comment. We agree with the reviewer that the current stage of awake mouse fMRI studies remains to be improved.  And, we have revised the Introduction to highlight the state-of-theart of awake mouse fMRI (Page 4 – line 81-88). 

      (3) The authors also comment on implanted coils reducing animal stress - I don't know where this comment is coming from, as this has not been reported in the literature (to my knowledge) and the authors don't appear to have evaluated stress in their mice. 

      Since question 3 and 4 are highly related to the acclimation procedures, we will answer the two questions together.   

      (4) Following on the above point, measures of motion, stress, and more details on the acclimation procedure that was implemented in this study should be included.

      We thank the reviewer to raise the animal training issues.  

      During the animal training, we have measured both pupil dynamic and eye motion features from training sessions, of which the detailed procedure is described in Methods (page 7-9 – line 172236). 

      The training procedure is carried out over a total of 5 weeks with four phases of training: i. Holding animal in hands, ii. Head-fixation and pupillometry, iii. Head-fixation and pupillometry with mockMRI acoustic exposure, iv. Head-fixation and pupillometry with Echo-Planar-Imaging (EPI) in the MR scanner.

      Author response table 1.

      As shown in Supp Fig 2B, the spectral power of pupil dynamics (<0.02Hz) and eye movements gradually increased as a function of the training time for head-fixed mice exposed to the mock MRI acoustic environment during phase 3.  In phase 4, when head-fixed mice were put into the scanner for the first time, both eye movements and pupil dynamics were initially reduced during scanning but recovered to an acclimated state on Day 2, similar to the level on Day 8 of phase 3.  These behavioral outputs would provide an alternative way to monitor the stress levels of the mice. 

      Author response image 2.

      The eye movements (A) and power spectra of pupil dynamics (<0.02Hz) (B) change during different training phases.

      It should be noted that stress may be related to increased frequency of eye blinking or twitching movements in human subjects(1–3). Whereas, the eyeblink of head-fixed mice has been used for behavioral conditioning to investigate motor learning in normal behaving mice(4–6). Importantly, head-fixed mouse studies have shown that eye movements are significantly reduced compared to the free-moving mice(7). The increased eye movement during acclimation process would indicate an alleviated stress level of the head-fixed mice in our cases. Meanwhile, stress-related pupillary dilation could dominate the pupil dynamics at the early phase of training(8). We have observed a gradually increased pupil dynamic power spectrum at the ultra-slow frequency during phase 3, presenting the alleviated stress-related pupil dilation but recovered pupil dynamics to other factors, including arousal, locomotion, startles, etc. in normal behaving mice.  Despite the extensive training procedure of the present work in comparison to the existing awake mouse fMRI studies (training strategies for awake mice fMRI have been reviewed by Mandino et al. to show the overall training duration of existing studies(9)), the stress remains a confounding factor for the brain functional mapping in head-fixed mice. In particular, a recent study(10) shows that the corticosterone concentration in the blood samples of head-fixed mice is significantly reduced on Day 25 following the training but remains higher than in the control mice. In the discussion section, we have discussed the potential issues of stress-related confounding factors for awake mouse fMRI studies (Page 16 – lines 436-458). 

      (1) A. Marcos-Ramiro, D. Pizarro-Perez, M. Marron-Romera, D. Gatica-Perez, Automatic blinking detection towards stress discovery. ICMI 2014 - Proceedings of the 2014 International Conference on Multimodal Interaction 307–310 (2014). https://doi.org/10.1145/2663204.2663239/SUPPL_FILE/ICMI1520.MP4.

      (2) M. Haak, S. Bos, S. Panic, L. Rothkrantz, DETECTING STRESS USING EYE BLINKS AND BRAIN ACTIVITY FROM EEG SIGNALS. Lance 21, 76 (2009).

      (3) E. Del Carretto Di Ponti E Sessam, Exploring the impact of Stress and Cognitive Workload on Eye Movements: A Preliminary Study. (2023).

      (4) S. A. Heiney, M. P. Wohl, S. N. Chettih, L. I. Ru olo, J. F. Medina, Cerebellar-dependent expression of motor learning during eyeblink conditioning in head-fixed mice. J Neurosci 34, 14845–14853 (2014).

      (5) S. N. Chettih, S. D. Mcdougle, L. I. Ruffolo, J. F. Medina, Adaptive timing of motor output in the mouse: The role of movement oscillations in eyelid conditioning. Front Integr Neurosci 5, 12996 (2011).

      (6) J. J. Siegel, et al., Trace Eyeblink Conditioning in Mice Is Dependent upon the Dorsal Medial Prefrontal Cortex, Cerebellum, and Amygdala: Behavioral Characterization and Functional Circuitry. eNeuro 2, 51–65 (2015).

      (7) A. F. Meyer, J. O’Keefe, J. Poort, Two Distinct Types of Eye-Head Coupling in Freely Moving Mice. Current Biology 30, 2116-2130.e6 (2020).

      (8) H. Zeng, Y. Jiang, S. Beer-Hammer, X. Yu, Awake Mouse fMRI and Pupillary Recordings in the UltraHigh Magnetic Field. Front Neurosci 16, 886709 (2022).

      (9) F. Mandino, S. Vujic, J. Grandjean, E. M. R. Lake, Where do we stand on fMRI in awake mice? Cereb Cortex 34 (2024).

      (10) K. Juczewski, J. A. Koussa, A. J. Kesner, J. O. Lee, D. M. Lovinger, Stress and behavioral correlates in the head-fixed method: stress measurements, habituation dynamics, locomotion, and motor-skill learning in mice. Scientific Reports 2020 10:1 10, 1–19 (2020).

      (5) It wasn't clear to me at what times the loop versus "Figure 8" coil was being used, nor how many mice (or how much data) were included in each experiment/plot. There is also no mention of biological sex.

      Thank you for the comment. We have clarified sex and number. The figure 8 coil was only used as part of development to show the improvement of the coil design for cortical measurements. The detailed information is described in Method (Page 6 – line 127-129 & Page 10 – line 269-270). Additionally animal numbers have been included in the figure captions.

      (6) Building on the points above, the manuscript overall lacks experimental detail (especially since the format has the results prior to the methods).

      Thank you for the comment. We have modified the manuscript to increase the experimental detail and moved the methods section before the results.

      (7) An observation is made in the manuscript that there is an appreciable amount of negative BOLD signal. The authors speculate that this may come from astrocyte-mediated BOLD during brain state changes (and cite anesthetized rat and non-human primate experiments). This is very strange to me. First, the negative BOLD signal is not plotted (please do this), further, there are studies in awake mice that measure astrocyte activation eliciting positive BOLD responses (see Takata et al. in Glia, 2017).

      We thank the reviewer to raise the negative BOLD fMRI observation issue.  We added a subplot of the negative BOLD signal changes in the revised Figure 4. This negative BOLD signals across cortical areas could be coupled with brain state changes upon air-pu -induced startle responses. Our future studies are focusing on elucidating the brain-wide activity changes of awake mice with fMRI.  We also provide a detailed discussion of the potential mechanism underlying the negative BOLD fMRI signals. First, as reported in the paper (suggested  by the reviewer),  astrocytic Ca2+ transients coincide with positive BOLD responses in the activated cortical areas, which is aligning with the neurovascular coupling (NVC) mechanism. However, there is emerging evidence to show that astrocytic Ca2+ transients are coupled with both positive and negative BOLD responses in anesthetized rats(11) and awake mice(12). An intriguing observation is that cortex-wide negative BOLD signals coupled with the spontaneous astrocytic Ca2+ transients could co-exist with the positive BOLD signal detected at the activated cortex.  Studies have shown that astrocytes are involved in regulating brain state changes(13), in particular, during locomotion(14) and startle responses(15). These brain state-dependent global negative BOLD responses are also related to the arousal changes of both non-human primates(16) and human subjects(17).  The established awake mouse fMRI platform with ultra-high spatial resolution will enable the brain-wide activity mapping of the functional nuclei contributing to the brain state changes of head-fixed awake mice in future studies. (Page 17-18 – Line 478-490)

      (11) M. Wang, Y. He, T. J. Sejnowski, X. Yu, Brain-state dependent astrocytic Ca2+ signals are coupled to both positive and negative BOLD-fMRI signals. Proc Natl Acad Sci U S A 115, E1647–E1656 (2018).

      (12) C. Tong, Y. Zou, Y. Xia, W. Li, Z. Liang, Astrocytic calcium signal bidirectionally regulated BOLD-fMRI signals in awake mice in Proc. Intl. Soc. Mag. Reson. Med. 32, (2024).

      (13) K. E. Poskanzer, R. Yuste, Astrocytes regulate cortical state switching in vivo. Proc Natl Acad Sci U S A 113, E2675–E2684 (2016).

      (14) M. Paukert, et al., Norepinephrine controls astroglial responsiveness to local circuit activity. Neuron 82, 1263–1270 (2014).

      (15) R. Srinivasan, et al., Ca2+ signaling in astrocytes from IP3R2−/− mice in brain slices and during startle responses in vivo. Nat Neurosci 18, 708 (2015).

      (16) C. Chang, et al., Tracking brain arousal fluctuations with fMRI. Proc Natl Acad Sci U S A 113, 4518– 4523 (2016).

      (17) B. Setzer, et al., A temporal sequence of thalamic activity unfolds at transitions in behavioral arousal state. Nat Commun 13 (2022).

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      I really enjoyed this work. The maps shown are among the best-quality maps out there. Here are suggestions to the authors.

      (1) Both the ACA and VRA are rather unexpected. The authors explain these briefly as being part of the associative cortical areas. Both the ACA and VRA are not canonical associative areas (or at least not to us). This warrants a stronger discussion.

      To verify both ACA and VRA as associate areas, we provide the  connectivity map projections from the Allen Brain Atlas (seen below). These projections are derived from a Cre-dependent AAV tracing of axonal projections. We have included an explanation of this in the introduction. 

      Author response image 3.

      Representative images are shown indicating connections between the barrel cortex and retrosplenial area from an injection in the barrel cortex (Left panel) as well as the visual cortex and cingulate connection from an injection in the visual cortex (Right panel). Images are of connectivity map projections from the Allen Brain Atlas derived from a Cre-dependent AAV tracing of axonal projections

      (2) This is a lot of work. But looking at the figures, this is not obvious. We read in the caption that several hundred trials were used. It would be good to also specify how many mice. It would be clearer to represent this info in the figure as well to support the fact that this is not a trivial acquisition.

      Thank the reviewer to raise the e ort issue. We have edited the figure to include this information and included the numbers in the text as well

      (3) The training protocol is seemingly extensive, but this is only visible by following another reference. Including a description in this work would help the reader make sense of the effort that went into this work.

      We thank the reviewer to raise the training protocol issue. We have more thoroughly discussed the training method used for this study (page 7-9 – line 172-236)

      (4) I really would love to see that dataset made freely available - this should be the norm.

      The datasets have been uploaded to OpenNeuro 

      Whisker (https://doi.org/10.18112/openneuro.ds005496.v1.0.1),  Visual (https://doi.org/10.18112/openneuro.ds005497.v1.0.0) and Zenodo:

      SNR Line Profile Data & Data Processing Scripts: 

      (https://zenodo.org/doi/10.5281/zenodo.13821455). 

      (page 21 – line 573-579)

      Reviewer #2 (Recommendations For The Authors):

      (1) I'm a little confused about the stimulation paradigm and the effect of it causing an effective 2second TR (which is on the long side) - please elaborate (a figure might be helpful). The paradigm for visual stimulation also seems elaborate, can you please explain the logic and how it was developed?

      Thank you for raising the detailed stimulation paradigm issues. The stimulation paradigm is independent and does not interfere with the setup of the effective 2-second TR. The 2-second TR is based on the usage of 2-segment EPI, each with a TR of 1-second. The application of 2-segment paradigm enables the echo spacing with 0.52 ms with effective image bandwidth with 3858Hz, assuring less image distortion.  The stimulation paradigm was defined by an “8s on, 32s o ” epoch such to elicit a strong BOLD response and could be used for any reasonable TR duration. 

      We have included a figure outlining the stimulation paradigm (Supp Fig. 3)

      (2) I had difficulties viewing the movies (on my MAC).

      Thank you for this note. We have re-upload the videos in .mov format

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      This is a valuable study that describes the effects of T. pallidum on neural development by applying single-cell RNA sequencing to an iPSC-derived brain organoid model. The evidence supporting the claims of the authors is solid, although further evidence to understand the differences in infection rates would strengthen the conclusions of the study. In particular, the conclusions would be strengthened by validating infection efficiency as this can impact the interpretation of single-cell sequencing results, and how these metrics affect organoid size as well as comparison with additional infectious agents. Furthermore, additional validations of downstream effectors are not adequate and could be improved. 

      Thank you very much for your valuable comments. Since we used the organoid model for the first time to investigate the effects of T. pallidum on brain development, the study design is not perfect. As you have accurately mentioned, the results of the paper do not have more in-depth details, especially to verify the infection rate of T. pallidum. Your valuable comments will be very useful for us for carrying out further research. In addition, the downstream effector validation is inadequate, so we performed an analysis of single-cell sequencing data to strengthen our view in the revised manuscript (See Figure 5F for a description in current manuscript).

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This is an interesting study by Xu et al showing the effects of infection with the Treponema pallidum virus (which causes syphilis disease) on neuronal development using iPSC-derived human brain organoids as a model and single-cell RNA sequencing. This work provides an important insight into the impact of the virus on human development, bridging the gap between the phenomena observed in studies using animal models as well as non-invasive human studies showing developmental abnormalities in fetuses infected with the virus in utero through maternal vertical transmission.

      Using single-cell RNAseq in combination with qPCR and immunofluorescence techniques, the authors show that T. pallidum infected organoids are smaller in size, in particular during later growth stages, contain a larger number of undifferentiated neuronal lineage cells, and exhibit decreased numbers of specific neuronal subcluster, which the authors have identified as undifferentiated hindbrain neurons.

      The study is an important first step in understanding how T. pallidum affects human neuronal development and provides important insight into the potential mechanisms that underlie the neurodevelopmental abnormalities observed in infected human fetuses. Several important weaknesses have also been noted, which need to be addressed to strengthen the study's conclusions.

      Strengths:

      (1) The study is well written, and the data quality is good for the most part.

      (2) The study provides an important first step in utilizing human brain organoids to study the impact of T. pallidum infection on neuronal development.

      (3) The study's conclusions may provide important insight to other researchers focused on studying how viral infections impact neuronal development. 

      Thank you very much for your positive feedback. Below, you will find our detailed responses to your concerns, addressed point-by-point. I once again sincerely appreciate your time and effort in reviewing our manuscript.

      Weaknesses:

      (1) It is unclear how T. pallidum infection was validated in the organoids. If not all cells are infected, this could have important implications for the study's conclusions, in particular the single-cell RNAseq experiments. Were only cells showing the presence of the virus selected for sequencing? A detailed description of how infection was validated and the process of selection of cells for RNAseq would strongly support the study's conclusions. 

      Thank you for your valuable comment. We completely agree with your point. Exploring the infection rate of T. pallidum to brain organoids is a key factor that must be considered. We selected pluripotent stem cell-derived brain organoids to simulate the process of foetal brain neurodevelopment and cultured them mixed with T. pallidum to mimic T. pallidum invading brain tissue. Since brain organoids are three-dimensional structures formed by nerve cell aggregation, T. pallidum invades organoids from the periphery to the center of the organoids gradually. T. pallidum acts on organoids long enough to increase the infection rates; however, the pathogen is selective in invading human cells. If we only select cells present in T. pallidum for sequencing, the authenticity of simulating "real world" infections is somewhat weakened. To better carry out this study, selecting cells from intact organoids for sequencing, without eliminating cells without T. pallidum, can better simulate the effect of T. pallidum infection on the nervous system. Of course, we should also set up a blank control group.

      (2) The authors show that T. pallidum infection results in impaired development of hindbrain neurons. How does this finding compare to what has already been shown in animal studies? Is a similar deficit in this brain region observed with this specific virus? It would be useful to strengthen the study's conclusions if the authors added a discussion about the observed deficits in hindbrain neuronal development, and prior literature on similar studies conducted in animal models or human patients. Does T. pallidum preferentially target these neurons, or is this a limitation of the current organoid model system? 

      Thank you for your valuable comments. The finding that T. pallidum infection results in impaired development of hindbrain neurons has not been verified in animal experiments. Of course, it is better to further validate the findings in organoid studies through animal experiments. Unfortunately, due to the technical challenges, mature animal models have not been developed for the study of congenital syphilis. Although our team has been working on the development of animal models of congenital neurosyphilis, the current progress is still not satisfactory. After struggling hard in this field for many years, we decided to attempt to utilize human brain organoids instead of animal models to study the impact of T. pallidum infection on neuronal development.

      We also checked prior literature on similar studies that have referred to the content in human patients. Dan Doherty et al. reported that patients with pontocerebellar hypoplasia develop microcephaly at birth or over time after birth (PMID: 23518331). Based on your constructive suggestions, we have added some content related to hindbrain to the “Discussion” section.

      Our study found that T. pallidum could inhibit the differentiation of subNPC1B in brain organoids, thereby reducing the differentiation from subNPC1B to hindbrain neurons, and ultimately affecting the development and maturation of hindbrain neurons during pregnancy. Based on our results, T. pallidum does not preferentially target hindbrain neurons. Of course, there are limitations to the current organoid model system, see the "Limitations" section.

      PMID: 23518331- Dan Doherty et al, Midbrain and hindbrain malformations: advances in clinical diagnosis, imaging, and genetics.

      Revision in the “Discussion” section, line 343-352:

      “The vertebrate hindbrain contains a complex network of dedicated neural circuits that play an essential role in controlling many physiological processes and behaviors, including those related to the cerebellum, pons, and medulla oblongata (Shoja et al., 2018). Patients with pontocerebellar hypoplasia represent the less severe end of the spectrum with early hyperreflexia, developmental delay, and feeding problems, eventually developing spasticity and involuntary movements in childhood, while some patients represent the severe end of the spectrum characterised by polyhydramnios, severe hyperreflexia, contracture, and early death from central respiratory failure. Patients with pontocerebellar hypoplasia develop microcephaly at birth or over time after birth (Doherty et al., 2013).”

      (3) The authors show that T. pallidum-infected organoids are smaller in size by measuring organoid diameter during later stages of organoid growth, with no change during early stages. Does that represent insufficient infection at the early stages? Is this due to increased cell death or lack of cell division in the infected organoids? Experiments using IHC to quantify levels of cleaved caspase and/or protein markers for cell proliferation would be able to address these questions. 

      Thank you for your valuable suggestion. The concentration of T. pallidum in patients with syphilis was generally very low (PMID: 21752804, 35315702, 33099614). In this study, a low concentration of T. pallidum was applied to brain organoids to simulate early foetal transmission of syphilis. Nerve cells mainly establish intercellular connections to form brain organoids in the way of adhesion, which can easily cause organoids to divide and die if treated with a high concentration of T. pallidum. Furthermore, based on your suggestions, we performed additional immunostaining analyses to verify the apoptosis of brain organoids infected by T. pallidum. Cleaved caspase 3 (clCASP3) staining showed that the number of apoptotic cells increased following T. pallidum infection; however, the proportion of apoptotic cells in both groups of brain organoids was very low (Figure supplement 2) (N=12 organoids, each group from three independent bioreactors), which would be not enough to affect the results of the experiment, thereby suggesting that neural differentiation and development of brain organoids were mainly inhibited following T. pallidum infection (rather than promoting organoid apoptosis).

      PMID: 21752804-- Craig Tipple et al, Getting the measure of syphilis: qPCR to better understand early infection.

      PMID: 35315702-- Cuini Wang et al, Quantified Detection of Treponema pallidum DNA by PCR Assays in Urine and Plasma of Syphilis Patients.

      PMID: 33099614—Cuini Wang et al, A New Specimen for Syphilis Diagnosis: Evidence by High Loads of Treponema pallidum DNA in Saliva.

      Revision in the “Results” section, line 105-108:

      “… cleaved caspase 3 (clCASP3) staining showed that the number of apoptotic cells increased significantly following T. pallidum infection, but the proportion of apoptotic cells in both groups of brain organoids was very low (Figure supplement 2) (N=12 organoids, each group from three independent bioreactors) …”

      Revision in the “Materials and methods” section, line 446-447:

      “…anti-cleaved caspase 3 (rabbit, 1:100, Cell Signaling Technology, 9661S),”

      Revision in the “Supplementary File” section, line 78-81:

      Author response image 1.

      The number of clCASP3+ cells in the microscopic field of brain organoids. A nonparametric t-test was used to evaluate the statistical differences between the two groups. (**: P < 0.01).

      (4) In Figure 1D authors show differences in rosette-like structure in the infected organoids. The representative images do not appear to be different in any of the discussed components (e.g., the sox2 signal looks fairly similar between the two conditions). No quantification of these structures was presented. Authors should provide quantification or a more representative image to support their statement. 

      Thank you for your valuable suggestion. I have quantified the neural rosette structure and compared the number of intact rosette-like structures between the two groups (See Figure 1D for a description in current manuscript).

      (5) The IHC images shown in Figures 3E, G, and Figure 4E look very similar between the two conditions despite the discussed decrease in the text. A more suitable representative image should be presented, or the analysis should be amended to reflect the observed results. 

      Thank you for your valuable suggestion. I have replaced more representative images in Figure 3E, G, and Figure 4E in the manuscript.

      Reviewer #2 (Public Review):

      Summary:

      This study provides an important overview of infectious etiology for neurodevelopment delay.

      Strengths:

      Strong RNA evaluation.

      Weaknesses:

      The study lacks an overview of other infectious agents. The study should address the epigenetic contributors (PMID: 36507115) and the role of supplements in improving outcomes (PMID: 27705610). 

      Addressing the above - with references included - is recommended. 

      Thank you for your valuable comment. Our research is mainly inspired by other infectious agents, such as Zika virus; there are many descriptions of Zika virus in the “Discussion” section of the manuscript to better describe and demonstrate our point of view (See pages 12–13). I was unable to retrieve the article (PMID: 36507115), kindly help in confirming the PMID number. I will be very grateful if you can provide the full text. Secondly, I have carefully read the article (PMID: 27705610), which is a very rich and comprehensive review, and summarised and cited it in appropriate places in our manuscript.

      Revision in the “Discussion- limitation” section, line 375-379:

      “First, although several recent protocols have made use of growth factors to promote further neuronal maturation and survival (Lucke-Wold et al., 2018), the organoid culture scheme needs to be further improved owing to the lower percentage of mature neurons and the challenge of cell necrosis within the organoids at this stage in day 55 organoids.”

      Reviewer #3 (Public Review): 

      This article is the first report to study the effects of T. pallidum on the neural development of an iPSC-derived brain organoid model. The study indicates that T. pallidum inhibits the differentiation of subNPC1B neurons into hindbrain neurons, hence affecting brain organoid neurodevelopment. Additionally, the TCF3 and notch signaling pathways may be involved in the inhibition of the subNPC1B-hindbrain neuron differentiation axis. While the majority of the data in this study support the conclusions, there are still some questions that need to be addressed and data quality needs to be improved. The study provides valuable insights for future investigations into the mechanisms underlying congenital neurodevelopment disability. 

      I sincerely appreciate your comments on our paper. The comments have helped us greatly improve the quality of our paper. Thank you for your time and constructive critique.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Paired t-test analysis is not appropriate if two distinct groups are compared. 

      I sincerely apologize for our presentation. We used a nonparametric t-test to compare the two groups. I have confirmed and corrected the statistical method description of this manuscript (Revision in the “Materials and methods” section (line 553-555) and “Figures-legend” section (line 789-790, 817-818, 829-830) in current manuscript).

      Reviewer #3 (Recommendations For The Authors): 

      (1) Can the authors explain why the mean size of organoids infected with T. pallidum is smaller?

      Thank you for your valuable comment. In our study, T. pallidum infection resulted in brain organisational changes in neural rosette-like structures resembling the proliferative regions of the human ventricular zone and caused fewer and incomplete rosette-like structures. Next, the ventricular zone is also the main area where neural progenitor cells (NPCs) reside (PMID: 33838105); our results showed that the proportion of neural progenitor cells (NPC)1 was reduced after T. pallidum infection. Rosette-like structure size changes owing to NPC depletion. Therefore, the mean size of organoids infected with T. pallidum is smaller.

      Revision in the “Results” section, line 101-104:

      “T. pallidum infection resulted in brain organisational changes in neural rosette-like structures resembling the proliferative regions of the human ventricular zone where NPC reside (Krenn et al., 2021), and caused fewer and incomplete rosette-like structures (P < 0.01) (Figure 1D)”

      (2) Why was the target gene for qRT-PCR validation selected to be HOXA5、HOXC5、HOXA4?

      Thank you for your valuable comment. The qRT-PCR experiment was selected here to verify the analysis results of the scRNA-seq. HOX family genes are key factors controlling early hindbrain development, which are expressed in the hindbrain region during the gastrulation stage of early embryonic development and persist into the nerve cell stage, and are essential for the correct induction of hindbrain development and segmentation (PMID: 2571936, 1983472, 1673098, 15930115). Therefore, we selected the HOX family gene for verification.

      PMID: 2571936-WILKINSON D G, et al. Segmental expression of Hox-2 homoeobox- containing genes in the developing mouse hindbrain.

      PMID: 1983472-- FROHMAN M A, et al. Isolation of the mouse Hox-2.9 gene; analysis of embryonic expression suggests that positional information along the anterior-posterior axis is specified by mesoderm.

      PMID: 1673098--MURPHY P, et al. Expression of the mouse labial-like homeobox-containing genes, Hox 2.9 and Hox 1.6, during segmentation of the hindbrain.

      PMID: 15930115-- MCNULTY C L, et al. Knockdown of the complete Hox paralogous group 1 leads to dramatic hindbrain and neural crest defects.

      (3) Why was qRT-PCR not employed in other experimental validations, but solely to validate early neural-specific transcription factor changes?

      Thank you for your valuable comment. The qRT-PCR experiment was selected to validate early neural-specific transcription factor changes, indicating the reliability of the scRNA-seq. Then, validated scRNA-seq data were used to analyze for other neuro-specific gene differences, such as violin plots and heatmap showing differentially expressed genes (Figure 4D and Figure 5B, C). Of course, we also tested it with other experiments, such as immunohistochemistry and flow cytometric screening.

      (4) The authors found that T. pallidum might reduce the differentiation from subNPC1B to hindbrain neurons by inhibiting subNPC1B differentiation in brain organoids. Why were the subNPC1B-specific markers declining?

      Thank you for your valuable comment. scRNA-seq is aimed at complete brain organoids. Cluster analysis of cell types of organoids is performed according to specific marker genes of different cells. The decrease in the expression of marker genes of certain cell groups indicates that the cell proportion of such cell groups in the whole organoids is reduced. We analysed organoids following T. pallidum infection, uniform manifold approximation and projection (UMAP), and clustering of the NPC1 population demonstrated that T. pallidum downregulated the number of subNPC1B population. Therefore, the results demonstrated a decrease in the subNPC1B -specific markers.

      (5) In comparison to the other figures, Figure 5E letter size is excessively small and ambiguous.

      Thanks for your valuable comments, I have adjusted Figure 5E letter size.

      (6) Figure 5E shows that TCF3, more than one gene, is specifically enriched in subNPC1B of the T. pallidum group. It is best to confirm the impact of the other gene. 

      Thank you for raising this key issue that we had not addressed properly in our previous version of the manuscript; we have added further analytical data. The SCENIC analysis found that the transcriptional activity of 52 genes has significantly changed after T. pallidum infection. Furthermore, GO analyses demonstrated that 27 transcription factors were significantly enriched in four key pathways of neural differentiation and development. TCF3 is the sole transcription factor present in all four terms simultaneously, speculating that TCF3 is the key transcription factor for the inhibition of subNPC1B-hindbrain neuron differentiation caused by T. pallidum.

      Revision in the “Results” section, line 261-273:

      “Next, the single-cell regulatory network inference and clustering (SCENIC) analysis for the subNPC1B subcluster was performed to assess the differences in the transcriptional activity of the transcription factors between the two groups and found that the transcriptional activity of 52 genes significantly changed after T. pallidum infection (Figure 5E). Furthermore, GO analyses demonstrated that 27 transcription factors were significantly enriched in key pathways of neural differentiation and development in response to nervous system development, positive regulation of sequence-specific DNA-binding transcription factor activity, positive regulation of neuronal differentiation, and DNA templated transcription regulation. Remarkably, transcription factor 3 (TCF3) is the sole transcription factor present in all four terms simultaneously (Figure 5F), speculating that TCF3 is the key transcription factor for the inhibition of subNPC1B-hindbrain neuron differentiation caused by T. pallidum.”

      Revision in the “Materials and methods” section, line 540-543:

      “The Sankey diagram was created using SankeyMATIC (https://sankeymatic.com/) (Zhang et al., 2023), which was used to characterize the interactions between differential transcription factors and neural differentiation and development.”

      Revision in the “Figure and Figure Legend” section, line 832, 842-844:

      Author response image 2.

      Sankey diagram showing the correspondence between differential transcription factors and neural differentiation and development.

      (7) Are there other experiments demonstrating that TCF3 is a key transcription factor for the inhibition of subNPC1B-hindbrain neuron differentiation caused by T. pallidum

      Thank you for your valuable comment. In the previous experiment, we attempted to select a subNPC1B subcluster by flow sorting to verify the relevant molecular mechanism. Due to the small proportion of subNPC1B subcluster in the whole organoids, the selected cells were in a poor state and could not reach the number of cells required for the experiment. However, we used scRNA-seq data to further identify TCF3 as a key transcription factor that inhibits subNPC1B - hindbrain neuron differentiation induced by T. pallidum. The relevant results and descriptions of the analysis are detailed in the revised manuscript, please see our response to point (6) above.

    1. Author response:

      The following is the authors’ response to the original reviews.

      The reviewers found this manuscript to present convincing evidence for associative and non-associative behaviors elicited in male and female mice during a serial compound stimulus Pavlovian fear conditioning task. The work adds to ongoing efforts to identify multifaceted behaviors that reflect learning in classic paradigms and will be valuable to others in the field. The reviewers do note areas that would benefit from additional discussion and some minor gaps in data reporting that could be filled by additional analyses or experiments.

      We thank the reviewers and the editors for their thoughtful and constructive critiques of our manuscript. We have updated our manuscript with data from additional experiments as suggested by the reviewers, and we have significantly edited the text and figures to reflect these additions. Our detailed, point-by-point responses are below.

      Reviewer #1 (Public Review):

      The main goal of the study was to tease apart the associative and non-associative elements of cued fear conditioning that could influence which defensive behaviors are expressed. To do this, the authors compared groups conditioned with paired, unpaired, or shock only procedures followed by extinction of the cue. The cue used in the study was not typical; serial presentation of a tone followed by a white noise was used in order to assess switches in behavior across the transition from tone to white noise. Many defensive behaviors beyond the typical freezing assessments were measured, and both male and female mice were included throughout. The authors found changes in behavioral transitions from freezing to flight during conditioning as the tone transitioned into white noise, and a switch in freezing during extinction such that it became high during the white noise as flight behavior decreased. Overall, this was an interesting analysis of transitions in defensive behaviors to a serially presented cue consisting of two auditory stimuli during conditioning and then extinction.

      We thank the Reviewer for their supportive insight.

      There are some concerns regarding the possibility that the white noise is more innately aversive than the tone, inducing more escape-like behaviors compared to a tone, especially since the shock only group also showed increased escape-like behaviors during the white noise versus tone. This issue would have been resolved by adding a control group where the order of the auditory stimuli was reversed (white noise->tone).

      We appreciate this concern, and we have added two additional groups to address this possibility. We have conducted the same experimental paradigm with 2 reverse-SCS groups (WN—tone), one with paired (new PA-R group), and one with unpaired (new UN-R group), presentations to shock during conditioning. These experiments revealed that during conditioning day 2 in both reverse order groups, WN causes reductions in freezing and increases in locomotor activity (see revised Figure 2D), an effect that is stronger in the UN-R compared to the PA-R group. This locomotor effect is neither darting nor escape jumping in the PA-R group (revised Figure 3G, I; Figure 4G). In the UN-R group, WN induces more activity than the PA-R group (Figure 2D), including some jumping at WN onset (Figure 3H), but no darting (Figure 4G). It is worth noting that WN does not elicit defensive behavior before conditioning at the sound intensity we use (75dB; see Fadok et al. 2017, Borkar et al. 2020, Borkar et al. 2024). Together, these results suggest that WN is an inherently more salient stimulus than tone, and it can elicit defensive behaviors in shock-sensitized mice through non-associative mechanisms. Indeed, stimulus salience is a key factor in this paradigm for inducing activity (see Hersman et al. 2020).

      While the more complete assessment of defensive behaviors beyond freezing is welcomed, the main conclusions in the discussion are overly focused on the paired group and the associative elements of conditioning, which would likely not be surprising to the field. If the goal, as indicated in the title, was to tease apart the associative and non-associative elements of conditioning and defensive behaviors, there needs to be a more emphasized discussion and explicit identification of the non-associative findings of their study, as this would be more impactful to the field.

      We have rewritten the Discussion to provide a greater emphasis on the findings of the study that are more related to non-associative mechanisms. For example, we argue that cue-salience and changes in stimulus intensity can induce non-associative increases in locomotor behavior and tail rattling in shock-sensitized mice.

      Reviewer #2 (Public Review):

      Summary:

      The authors examined several defensive responses elicited during Pavlovian conditioning using a serial compound stimulus (SCS) as the conditioned stimulus (CS) and a shock unconditioned stimulus (US) in male and female mice. The SCS consisted of tone pips followed by white noise. Their design included 3 treatment groups that were either exposed to the CS and US in a paired fashion, in an unpaired fashion, or only exposed to the shock US. They compared freezing, jumping, darting, and tail rattling across all groups during conditioning and extinction. During conditioning, strong freezing responses to the tone pips followed by strong jumping and darting responses to the white noise were present in the paired group but less robust or not present in the unpaired or shock only groups. During extinction, tone-induced freezing diminished while the jumping was replaced by freezing and darting in the paired group. Together, these findings support the idea that associative pairings are necessary for conditioned defensive responses.

      Strengths:

      The study has strong control groups including a group that receives the same stimuli in an unpaired fashion and another control group that only receives the shock US and no CS to test the associative value of the SCS to the US. The authors examine a wide variety of defensive behaviors that emerge during conditioning and shift throughout extinction: in addition to the standard freezing response, jumping, darting, and tail rattling were also measured.

      We thank the Reviewer for their supportive appraisal of this study’s strengths.

      Weaknesses:

      This study could have greater impact and significance if additional conditions were added (e.g., using other stimuli of differing salience during the SCS), and determining the neural correlates or brain regions that are differentially recruited during different phases of the task across the different groups.

      In the revised manuscript, we have conducted experiments with 2 reverse-SCS groups (WN—tone): one with paired (new PA-R group), and one with unpaired (new UN-R group), presentations to shock during conditioning. These experiments revealed that during conditioning day 2 in both reverse order groups, WN causes reductions in freezing and increases in locomotor activity (see revised Figure 2D), an effect that is stronger in the UN-R compared to the PA-R group. This locomotor effect is neither darting nor escape jumping in the PA-R group (revised Figure 3G, I; Figure 4G). In the UN-R group, WN induces more activity than the PA-R group (Figure 2D), including some jumping at WN onset (Figure 3H), but no darting (Figure 4G). Indeed, stimulus salience is a key factor in this paradigm for inducing activity (see Hersman et al. 2020). Together, these results suggest that WN is an inherently more salient stimulus than tone, and it can elicit defensive behaviors in shock-sensitized mice through non-associative mechanisms. It is worth noting that WN does not elicit defensive behavior before conditioning at the sound intensity we use (75dB; see Fadok et al. 2017, Borkar et al. 2020, Borkar et al. 2024).

      We agree that determining the neuronal correlates and brain regions that are involved in defensive ethograms at various stages within this paradigm is of great importance, but we feel that those experiments are beyond the scope of the current study, which is focused on identifying behavioral differences based on associative and non-associative factors.

      Reviewer #1 (Recommendations For The Authors):

      In LINES 72-73, authors say they used a "truly random procedure" as one of their control groups. Then in LINES 113-116, they describe this group as "unpaired" where the "SCS could not reliably predict footshock". Combined, it is unclear if this group is random or unpaired. The "truly random procedure" is defined, by the cited Rescorla paper, as "the two events are programmed entirely randomly and independently in such a way that some "pairings" of CS and US may occur by chance alone". So, truly random would indicate that the shock may occur during the cue, while unpaired indicates the shock was explicitly unpaired from the cue. If the authors used a random procedure, the groups need to be labeled as random, not unpaired, and the # of cues that happened to coincide with footshock per animal needs to be reported somewhere. If the authors used an unpaired procedure (which appears to be the case based on 40-60s ITI between SCS and footshock being reported), it needs to be clearer and consistent throughout that it was explicitly unpaired, as well as removing the claim in LINE 72-73 that they used a "truly random procedure".

      We did indeed use an explicitly unpaired procedure. We have adjusted the text and figures to better reflect this, and we removed any mentions of randomness with regards to the presentations of SCS and footshock.

      Despite the lack of significant sex differences, it would still be helpful if data panels with individual data points (e.g. Fig 2E-J), were presented as identifiable by sex (e.g. closed vs open circles for males vs females).

      The revised manuscript now compares four or five groups per figure, making data presentation complicated. Providing the individual data points in each panel reduces figure clarity, therefore, we feel it is best to present the data as box-and-whisker plots without them. However, the source data files for each figure are available to the reader and the data are clearly labeled to be identifiable by sex.

      Is it not odd that all groups showed similar levels of contextual freezing during the 3min baseline? If shocks are unsignaled in the UN and SO groups, one would expect higher levels of contextual freezing compared to a paired group.

      We are not certain why one would expect higher levels of contextual freezing in the UN and SO groups compared to the PA group at the beginning of conditioning day 2. Another study also looked at baseline freezing in a contextual fear group (which is the same as shock only in our study) and in an auditory cued fear conditioning group within the conditioning context, and their data show that freezing during the baseline period is equivalent between groups (Sachella et al., 2022).

      During baseline on Extinction Day 1, it does seem that the unpaired and SO groups tend to have higher freezing levels compared to the paired groups. Author response image 1 shows baseline freezing during the first 3 minutes of extinction day 1. After two days of conditioning in the conditioned flight paradigm, contextual freezing either is, or trends to be significantly higher in the UN, UN-R, and SO groups than the PA and PA-R groups.

      Author response image 1.

      Baseline Freezing levels for all groups during the first extinction session. Baseline period is defined as the first 180 seconds of the session, before any auditory stimulus was presented. PA, Paired; UN, Unpaired; SO, Shock Only; PA-R, Paired Reverse; UN-R, Unpaired Reverse. *p<0.05, **p<0.01, ****p<0.0001.

      Do the tone and WN elicit similar levels of defensive behaviors in a naïve mouse? Or have the authors tested WN followed by tone? Is there a potential issue that the WN may be innately aversive which is then amplified with training? i.e. does a tone preferentially induce freezing while WN induces active behaviors, regardless of which sensory stimulus is temporally closer to the shock? If the change in behavior is really due to the pairing and temporal proximity to shock, then there should be increased jumps, etc to the tone if trained with WN->tone.

      WN can indeed be used as an aversive stimulus under certain conditions and at sufficiently high decibel levels. In the conditioned flight paradigm, WN is presented at 75dB, which is below the threshold for eliciting an acoustic startle response in a C57BL/6J mouse (Fadok et al. 2009). Also, during pre-exposure, when animals are naïve to the SCS, tone and WN stimuli do not elicit defensive behaviors (see Fadok et al. 2017, Borkar et al. 2020, 2024).

      As suggested by the Reviewer, during revision we have included reverse-SCS paired (PA-R) and unpaired (UN-R) groups to test for the role of stimulus salience and stimulus order on defensive ethograms. During conditioning day 2, the PA-R group exhibited little freezing to the WN, with a slightly elevated activity index, and they exhibited robust freezing during tone (revised Figure 2A-H). The activity during the WN in the PA-R group was significantly lower than that of the PA group (Figure 2L). The PA-R group also did not respond to WN with escape jumps or darting (Figure 3I, 4G). The UN-R group displayed greater activity during the WN than the UN and PA-R groups, but less activity than the PA group (Figure 2D, H). The UN-R group did not dart but this group displayed some jumping at WN onset (Figure 3H), like what was observed in the UN group.

      These data suggest that WN has inherent, salient properties that can induce some non-associative activity after the mouse has been sensitized by shock (see also Hersman et al. 2020 for more detailed analysis of stimulus salience in the conditioned flight paradigm). However, only in the PA group is robust flight behavior (comprised of high numbers of escape jumps and darting) observed. Therefore, both stimulus salience and temporal order are important for eliciting transitions from freezing to flight.

      Fig 3G/4G are hard for me to understand. The figure legends say they're survival graphs but the y-axis labels "Latency to initial jump/dart (% of cohort)" confuses me. What is the purpose of these graphs? Perhaps they are not needed. Or consider presenting them similar to Fig 7C, D as those were more intuitive and faster for me to grasp.

      We had intended these plots to show that a greater proportion of the paired group jumps and darts during WN compared to the unpaired group, and that the percentage of the cohort that jumps and darts increases across conditioning trials. Because these graphs were not clear, we have removed them, and we have replaced them with graphs comparing total cohort percentages that jumped (Figure 3I) or darted (Figure 4G) over the whole CD2 session.

      For the extinction data, I did not see within group analyses for within or between session fear extinction to the tone. So, for the paired group, were the last 4 trials of Ext 1 significantly lower than the first 4 trials? If not, then they did not show within-session extinction. Also, for the paired group, were the last 4 trials of Ext 1 significantly different than the first 4 trials of Ext 2? This would test for long-term retention and spontaneous recovery.

      In the original submission and in the revised manuscript, we calculated a delta change score for freezing during tone in the early versus late blocks of 4 trials, and then we statistically compared these differences across groups (Figure 5C, D). This allowed us to assess between-group differences in changes to tone-evoked freezing during extinction. Freezing to tone did decrease significantly over the first extinction session for the paired group (Early Ext1 vs Late Ext1, paired t-test, t(31) \= 6.23, p<0.0001), and when comparing late Ext1 and early Ext2, we found that tone-evoked freezing did significantly increase (Late Ext1 vs Early Ext2, paired t-test, t(31) \= 5.26, p<0.0001). This increase in cue-induced freezing between days of extinction is characteristic of C57BL/6J mice (Hefner et al., 2008). Our study did not test for more distal timepoints, so we cannot comment on the efficacy of long-term retention or spontaneous recovery.

      For the conditioning and extinction data across Figs 2, 5 and 6, what I gather from them is that freezing is high to the tone and low to the WN during conditioning, and then low to the tone, and high to the WN across extinction. Then for activity levels I see they are low to the tone and high to the WN during conditioning, and then low to the WN during extinction. The piece that is missing is what are activity levels like to the tone during extinction. Are they low like in conditioning and remain low in extinction? Or do they increase across extinction as freezing decreases? As I was going through these graphs I drew myself out step function summaries of the freezing and activity levels between tone/WN for conditioning vs extinction; maybe the authors could consider a summary figure.

      We thank the Reviewer for their interest. We found that within the paired group, activity to tone remained low throughout both days of extinction (though increased within each session) and did not return to normal activity levels. We present this data in Author response image 2. We thank the Reviewer for the suggestion of a summary figure, but we feel there are too many axes of classification (between-group, within-group, multiple behaviors, tone/WN, conditioning/extinction) to coherently present our findings in a single figure.

      Author response image 2.

      Trial-by-trial plot of activity index during the tone period of SCS across both extinction sessions for the PA group. SCS, Serial compound stimulus; Ext, extinction; PA, Paired.

      In the discussion (LINE 592-3), they discuss that shock sensitization in the SO group may prime a stressed animal to dart more readily to WN upon stimulus transition. Should this not also happen during the transition of silence to tone? What is special about a transition between two auditory stimuli that would result in panic like behavior in an animal that only received shock presentations? This also gets back to an earlier concern above regarding the potentially innately aversiveness of the WN.

      After 2 days of shock sensitization, we observe that mice exhibit freezing to the tone during the first three trials of extinction day 1 (Figure 5A). This non-associative freezing response is like that observed in other studies of non-associative fear processing (please see Kamprath and Wotjak, 2004). As trials progress during extinction day 1, mice do become mildly activated during the tone (Author response image 3). The transition to WN in the shock-only group during extinction induces non-associative darting responses, but it does not induce escape jumping behavior (Figure 7).  We hypothesize that the innate salience of the WN is a vital factor contributing to these escalated responses. The importance of stimulus salience in conditioned flight was also demonstrated by Hersman et al., 2020 for SCS conditioning, and by Furuyama et al., 2023 for single tone conditioning.  Just as with conditional freezing responses (Kamprath and Wotjak, 2004), we believe that conditional flight is controlled by summative components, one being associative and the other non-associative.

      Author response image 3.

      Trial-by-trial plot of activity index during the tone period of SCS across both extinction sessions for the SO group. SCS, Serial compound stimulus; Ext, extinction; SO, Shock Only.

      In the discussion (LINE 583), they say that the development of explosive defensive behaviors are "not achievable with traditional single-cue Pavlovian conditioning paradigms". The authors should include a caveat here that the current study did not compare their results to a group of mice that received just WN-shock pairings.

      We thank the reviewer for this comment. This statement was meant to highlight that traditional paradigms do not offer an element of signaling the temporal imminence of threat, only its inevitability. It was not our intention to state that defensive escape behaviors were unachievable in single-cue conditioning paradigms, and we regret not making this clear. Indeed, the supplement of Fadok et al. 2017 shows that WN-shock conditioning is capable of inducing flight, Furuyama et al. 2023 shows that tone-shock conditioning is capable of inducing flight under specific parameters, and Gruene et al. 2015 demonstrates that single CS-US pairings induce conditional darting behaviors in female rats. We have adjusted the text to better reflect our intent.  

      Minor comment to LINE 613-5: Speaking as someone who has done fear conditioning in both mice and rats, tail rattling may be specific to mice (I have seen this often) and likely not observable in rats (never seen it).

      We thank the Reviewer for this information. We have adjusted our text to mainly discuss mouse-specific tail rattling.

      Reviewer #2 (Recommendations For The Authors):

      The research questions in this study are novel and bring new insight to the field. However, there are some issues that can be addressed to improve the overall quality of the study, namely, the reader is left wanting to know more, especially about how neural circuits contribute to these different defensive behaviors during this task. Below are some recommendations for the authors that would greatly improve the impact and significance of this study.

      (1) What are the neural correlates or circuits recruited during these different defensive behaviors across the course of conditioning and extinction? How might they differ between the PA and UN groups? What differences might emerge when an animal is shifting their defensive behavior from freezing to darting, for example? Answering these questions would require intensive additional experiments, therefore more discussion of possible neural mechanisms that might be recruited during this task would be appreciated, given the scope of the subject area.

      We agree that understanding the neural circuits recruited during these behaviors and across conditioning and extinction is of vital importance. We are actively working on these questions, and we have published on the role of central amygdala circuits (Fadok et al. 2017) as well as on top-down control of flight by the medial prefrontal cortex (Borkar et al. 2024). Because the current manuscript is focused on learning mechanisms influencing defensive behavior, we would prefer to focus our discussion on that, rather than speculating on possible neural mechanisms. However, we have added a statement in the Discussion (LINES 706-707) emphasizing that future studies should investigate the neuronal mechanisms contributing to threat associations and different defensive behaviors.

      (2) Were any vocalizations observed during conditioning or extinction phases? If not, could you speculate how type and occurrence of vocalizations might correlate with the different defensive responses observed?

      Audible vocalizations were only observed during footshock presentations (squeaks). Unfortunately, we do not have the proper specialized recording equipment to monitor the full spectrum of mouse vocalizations, especially those in the ultrasonic range. Thus, we cannot speculate on the nuances of vocalizations in mice with respect to this behavioral paradigm. To the best of our knowledge, mice have not been reported to emit specific ultrasonic calls during conditioned threat like those of rats. That said, it would be of interest to determine if mice emit different vocalizations during different defensive behaviors.

      (3) The transition from freezing to flight during the SCS is thought to be due to the close proximity of threat imminence between the WN CS and shock US. What if you switched the order of the SCS stimuli to WN followed by tone stimuli? If the salience of the WN stimulus is truly driving the jumping behavior, then it would be observed even if the WN stimulus preceded the pure tone stimulus and that would bring additional evidence that it is the associative value of the stimuli rather than its salience that's driving the defensive behaviors. What do you predict you would observe in rodents that were given a WN-tone SCS paired and unpaired in the same design of this study?

      As suggested by the reviewer, we collected data from reverse-SCS paired and unpaired groups and reported our findings within the manuscript. Our detailed findings are also discussed above. Overall, we find that a combination of stimulus salience and temporal proximity, and a summation of non-associative and associative mechanisms, are necessary to elicit explosive flight behavior (escape jumping and darting).

      References

      Borkar CD, Dorofeikova M, Le QE, Vutukuri R, Vo C, Hereford D, Resendez A, Basavanhalli S, Sifnugel N, Fadok JP (2020) Sex differences in behavioral responses during a conditioned flight paradigm. Behavioural Brain Research 389:112623.

      Borkar CD, Stelly CE, Fu X, Dorofeikova M, Le QE, Vutukuri R, Vo C, Walker A, Basavanhalli S, Duong A, Bean E, Resendez A, Parker JG, Tasker JG, Fadok JP (2024) Top-down control of flight by a non-canonical cortico-amygdala pathway. Nature 625: 743-749.

      Fadok JP, Krabbe S, Markovic M, Courtin J, Xu C, Massi L, Botta P, Bylund K, Müller C, Kovacevic A, Tovote P, Lüthi A (2017) A competitive inhibitory circuit for selection of active and passive fear response. Nature 542:96-100.

      Furuyama T, Imayoshi A, Iyobe T, Ono M, Ishikawa T, Ozaki N, Kato N, Yamamoto R (2023) Multiple factors contribute to flight behaviors during fear conditioning. Scientific Reports 13:10402. 

      Gruene TM, Flick K, Stefano A, Shea SD, Shansky RM (2015) Sexually divergent expression of active and passive conditioned fear responses in rats. eLIfe 4:e11352.

      Hefner K, Whittle N, Juhasz J, Norcross M, Karlsson RM, Saksida LM, Bussey TJ, Singewald N, Holmes A (2008) Impaired Fear Extinction Learning and Cortico-Amygdala Circuit Abnormalities in a Common Genetic Mouse Strain. Journal of Neuroscience 6:8074-8085.

      Hersman S, Allen D, Hashimoto M, Brito SI, Anthony T (2020) Stimulus salience determines defensive behaviors elicited by aversively conditioned serial compound auditory stimuli. elife 9:e53803. 

      Kamprath K and Wotjak CT (2004) Nonassociative learning processes determine expression and extinction of conditioned fear in mice. Learning & Memory 11:770-786.

      Sachella TE, Ihidoype MR, Proulx CD, Pafundo DE, Medina JH, Mendez P & Piriz J (2022) A novel role for the lateral habenula in fear learning. Neuropsychopharmacology 47:1210-1219.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      The manuscript titled "Evolutionary and Functional Analyses Reveal a Role for the RHIM in Tuning RIPK3 Activity Across Vertebrates" by Fay et al. explores the function of RIPK gene family members across a wide range of vertebrate and invertebrate species through a combination of phylogenomics and functional studies. By overexpressing these genes in human cell lines, the authors examine their capacity to activate NF-κB and induce cell death. The methods employed are appropriate, with a thorough analysis of gene loss, positive selection, and functionality. While the study is well-executed and comprehensive, its broader relevance remains limited, appealing mainly to specialists in this specific field of research. It misses the opportunity to extract broader insights that could extend the understanding of these genes beyond evolutionary conservation, particularly by employing evolutionary approaches to explore more generalizable functions.

      Major comments:

      The main issue I encounter is distinguishing between what is novel in this study and what has been previously demonstrated. What new insights have been gained here that are of broader relevance? The discussion, which would be a good place to do so, is very speculative and has little to do with the actual results. Throughout the manuscript, there is little explanation of the study's importance beyond the fact that it was possible to conduct it. Is the evolutionary analysis being used to advance our understanding of gene function, or is the focus merely on how these genes behave across different species? The former would be exciting, while the latter feels less impactful.

      We thank the reviewer for the positive feedback. With regard to the major comment, we have now made changes throughout the revised manuscript to highlight the novel insights that emerge from our work, as well as the importance of using evolutionary and functional analyses to understand gene function. 

      Reviewer #2 (Public review):

      Summary:

      By combining bioinformatical and experimental approaches, the authors address the question of why several vertebrate lineages lack specific genes of the necroptosis pathway or those that regulate the interplay between apoptosis and necroptosis. The lack of such genes was already known from previous publications, but the current manuscript provides a more in-depth analysis and also uses experiments in human cells to address the question of the functionality of the remaining genes and pathways. A particular focus is placed on RIPK3/RIPK1 and their dual roles in inducing NFkB and/or necroptosis.

      Strengths:

      The well-documented bioinformatical analyses provide a comprehensive data basis of the presence/absence of RIP-kinases, other RHIM proteins, apoptosis signaling proteins (FADD, CASP8, CASP10), and some other genes involved in these pathways. Several of these genes are known to be missing in certain animal lineages, which raises the question of why their canonical binding partners are present in these species. By expressing several such proteins (both wildtype and mutants destroying particular interaction regions) in human cells, the authors succeed in establishing a general role of RIPK3 and RIPK1 in NFkB activation. This function appears to be better conserved and more universal than the necroptotic function of the RHIM proteins. The authors also scrutinize the importance of the kinase function and RHIM integrity for these separate functionalities.

      Weaknesses:

      A major weakness of the presented study is the experimental restriction to human HEK293 cells. There are several situations where the functionality of proteins from distant organisms (like lampreys or even mussels) in human cells is not necessarily indicative of their function in the native context. In some cases, these problems are addressed by co-expressing potential interaction partners, but not all of these experiments are really informative.

      A second weakness is that the manuscript addresses some interesting effects only superficially. By using host cells that are deleted for certain signaling components, a more focussed hypothesis could have been tested.

      Thus, while the aim of the study is mostly met, it could have been a bit more ambitious. The limited conclusions drawn by the authors are supported by convincing evidence. I have no doubts that this study will be very useful for future studies addressing the evolution of necroptosis and its regulation by NFkB and apoptosis.

      We thank the reviewer for the positive feedback. We agree that our study is limited by using HEK293 cells. However, we do not have appropriate cell lines for all species analyzed and therefore wished to use a single system to test all effects. As the reviewer points out, we do  co-express when possible, and are careful in the manuscript to not overextend our conclusions. We, like the reviewer, believe that many of the intriguingly findings in this study, which was intended to cover a broad range of species, will be useful for more in-depth studies in a given species.

      Reviewer #3 (Public review):

      This important study provides insights into the functional diversification of RIP family kinase proteins in vertebrate animals. The provided results, which combine bioinformatic and experimental analyses, will be of interest to specialists in both immunology and evolutionary biology. However, the computational part of the methodology is insufficiently covered in the paper and the experimental results would benefit from including data for additional species.

      We thank the reviewer for the positive feedback. As described below, we have now addressed the concerns about the description of the computational methods.

      (1) In the Methods section concerning gene loss analysis, the authors refer to the 'Phylogenetic analysis' section for details of RIPK sequence acquisition and alignment procedure. This section is missing from the manuscript as provided. In its absence, it is hard for the reviewer to provide relevant comments on gene presence/absence analysis.

      We have expanded the gene loss analysis methods to be more comprehensive. 

      (2) In the same section, the authors state that gene sequences were filtered and grouped based on the initial gene tree pattern (lines 448-449). How exactly did the authors filter the non-RIP kinases and other irrelevant homologs from the gene trees? Did they consider the reciprocal best (BLAST) hit approach or similar approaches for orthology inference? Did they also encounter potential pseudogenes of genes marked as missing in Figure 1C? Will the gene trees mentioned be available as supplementary files?

      We have expanded the gene loss analysis methods to be more comprehensive. 

      (3) The authors state the presence of additional RIPK2 paralog in non-therian vertebrates.

      The ramifications of this paralog loss in therians are not discussed in the text, although RIPK2 is also involved in NF-kB activation. In addition, the RIPK2B gene loss pattern is shunned from Figure 1C to Supplementary Figure 4, despite posing comparable interest to the reader.

      We are also intrigued by the RIPK2/RIPK2B data and felt it important to include our findings here, however we do not have functional data for RIPK2B at this point and feel it is better suited for a separate study. We therefore focused both the title and the main figures on RIPK3, for which we have functional data.

      (4) The authors present evidence for (repeated) positive selection in both RIPK1 and RIPK3 in bats; however, neither bat RIPK1/3 orthologs nor bat-specific RHIM tetrad variants (IQFG, IQLG) are considered in the experimental part of the work.

      We included a tetrad variant (VQFG) that is found in bats and multiple other species. We wanted to test a wide range of variant amino acids, so testing both IQFG (found only in bats) and VQFG (found in bats and multiple other diverse species) was not of high importance.

      (5) The authors present gene presence/absence patterns for zebra mussels as an outgroup of vertebrate species analyzed. From the evolutionary perspective, adding results for a closer invertebrate group, such as lancelets, tunicates, or echinoderms, would be beneficial for reconstructing the evolutionary progression of RIPK-mediated immune functions in animals.

      In our initial analyses, we searched for RIPK-like proteins in cnidarians, arthropods, nematodes, amoeba, and spiralia, with only spiralia species containing proteins with substantial homology to vertebrate RIPK1 proteins, as defined by a homologous N-terminal kinase domain and C-terminal RHIM and death domain. We have expanded this analysis to include lancelets, tunicates, and echinoderms and found several lancelet species with RIPK1 like proteins. These data have been added to the manuscript.

      (6) In the broader sense, the list of non-mammalian species included in the study is not explained or substantiated in the text. What was the rationale behind selecting lizards, turtles, and lampreys for experimental assays? Why was turtle RIPK3 but not turtle RIPK1CT protein used for functional tests? Which results do the authors expect to observe if amphibian or teleost RIPK1/3 are included in the analysis, especially those with divergent tetrad variants?

      We have added additional text to define our rationale for selecting which species were tested. 

      (7) For lamprey RIPK3, the observed NF-kB activity levels still remain lower than those of mammalian and reptilian orthologs even after catalytic tetrad modification. In the same way, switching human RIPK3 catalytic tetrad to that of lamprey does not result in NF-kB activation. What are the potential reasons for the observed difference? Does it mean that lamprey's RIPK3 functions in NF-kB activation are, at least partially, delegated to RIPK1?

      The function of lamprey RIPK3 is intriguing, albeit unknown. The reduced activation in human cells may be due to an incompatibility between lamprey RIPK3 and human NF-kB machinery, or it may not function in NF-kB at all. Considering that lamprey do not have other components of the known mammalian necroptosis pathway, it is unclear what function RIPK3 would serve in these species. It is possible lamprey may have a necroptosis pathway that is RIPK3-dependent but distinct from the mammalian pathway. It is an interesting question for future study. 

      (8) In lines 386-388, the authors state that 'only non-mammalian RIPK1CT proteins required the RHIM for maximal NF-kB activation', which is corroborated by results in Figure 4B. The authors further associate this finding with a lack of ZBP1 in the respective species (lines 388-389). However, non-squamate reptiles seem to retain ZBP1, as suggested by

      Supplementary Table 1. Given that, do the authors expect to observe RHIM-independent (maximal) NF-kB activation in turtles and crocodilians or respective RIPK1CT-transfected cells?

      While turtles and crocodiles do retain ZBP1, it is still unclear if they are able to activate ZBP1/RIPK3/MLKL-dependent necroptosis similar to mammals, especially given the divergence in the turtle ZBP1 RHIMs seen in Figure 4C. Future studies will be needed to further test our hypotheses and to continue to characterize innate immune function and evolution across a range of vertebrate species. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Minor comments:

      (1) The title is somewhat restrictive, as it only mentions RIPK3, despite the manuscript covering a broader range of RIPKs and associated proteins.

      We agree that a title that encompasses both the breadth of our study and the depth with which we analyzed RIPK3 would be ideal. However, we were unable to come up with a succinct title that conveyed both points appropriately, so opted for one that focused on our RIPK3 insights.

      (2) Several supplementary figures contain valuable information that could be incorporated into the main figures for greater clarity and emphasis.

      We agree that many interesting pieces of data are in the supplement. We felt it was important to include those data in the manuscript, but also wanted to keep the main manuscript figures as focused as possible.  

      Reviewer #2 (Recommendations for the authors):

      (1) I do not fully agree with the claim that caspase-8 is absent from fish. I briefly repeated this part of the analysis and found several fish proteins that cluster with caspase-8 rather than caspase-10 or cFLIP. From the method section, it does not really become clear how the Casp8/Casp10/cFLIP decision was made, and particularly, how cases were addressed where Genew predate the caspase-8/caspase-10 split. To name just a few examples, the authors might check uniprot:A0A444UA91, W5MXS4, or A0A8X8BKJ8 for being fish Caspase-8 candidates.

      We thank the reviewer for their critical analysis. CASP8 and CASP10 are very similar proteins in humans. We are distinguishing between the two based on vertebrate phylogeny with outgroup proteins (CASP2, CASP9, and CFLAR, see tree in Author response image 1 below) to help define the CASP8/CASP10 clade. Once we isolate CASP8/10, we build an additional tree to distinguish CASP8 and CASP10. Using this method, all fish CASP8/10-like proteins cluster with the mammalian CASP10 clade rather than the CASP8 clade, despite many fish proteins being annotated as CASP8 or CASP8-like. We do acknowledge that, because of the similarities between CASP8 and CASP10, there are likely proteins that can fall in either clade depending on which outgroups are included. To this end, we have updated our gene loss figure to only denote whether a species has no CASP8/10, a single CASP8/10 protein, or both CASP8 and CASP10. We have also updated our methods to better define how we completed our analyses. 

      Author response image 1.

      (2) While analyzing which RIPK3 protein causes cell death (lines 188ff), the underlying assumption is that the heterologous RIPK3 proteins can interact with human MLKL and activate it by phosphorylation. No attempts are being made to check if MLKL actually gets phosphorylated, and this issue is also not discussed. In Figure 2C, cell death is either measured by RIPK3 overexpression alone or by the additional overexpression of ZBP1 and MLKL. However, it is not shown if in all cases all the transfected proteins are expressed at a comparable level, or if the observed cell death might be caused by MLKL/ZBP1 overexpression alone.

      Cell death is dependent on expression of ZBP1, MLKL, and RIPK3, as shown in

      Supplementary Figure 6. We have attempted to detect phospho-MLKL via western blot. However, in these overexpression assays, we are able to detect phospho-MLKL in the presence of RIPK3 and MLKL alone, independent of activation of cell death. In fact, we see reduced phospho-MLKL and reduced expression of MLKL overall when ZBP1, MLKL, and RIPK3 are added, presumably due to cell death induced in these conditions (see blot in Author response image 2 below). We therefore felt these data were of limited use here.

      Author response image 2.

      (3) The manuscript describes a well-documented bioinformatical analysis and acknowledges the body of earlier published work on necroptosis evolution and associated gene losses. However, when discussing the RHIM-related aspects, the authors do not mention previous publications on RHIM conservation in invertebrates and even fungal proteins such as Het-S. They also fail to mention/discuss the amyloid-forming properties of RHIMs, which I consider crucial for understanding the function of RHIM-containing proteins.

      We thank the reviewer for their insight. We have added additional points on both RHIM conservation and amyloid formation.

      (4) Related to the above issue: In lines 226ff, the induction of NFkB by RIPK3 overexpression is described. While RIPK3 from other mammals requires endogenous (human) RIPK1 to be present, lizard and turtle RIPK3 do not require human RIPK1 but *do* require functional RHIMs. It is not checked (or at least discussed) if RHIM amyloid formation is required, nor if the RHIM of the heterologous RIPK3 might act through interaction with endogenous (human) RIPK3.

      We and others (PMID: 29073079) did not detect RIPK3 protein in HEK293T cells. This, combined with the requirement for exogenous RIPK3 to activate cell death, indicate that endogenous RIPK3 is not contributing to these assays. 

      (5) In lines 275ff, the authors observe that RIPK1s from other mammalian species do not require the RHIM for NFkB activation, while RIPK1 from non-mammalian species do require the RHIM. I wonder why the (in my opinion) most obvious explanation is not addressed: Maybe the mammalian RIPK1 proteins are similar enough to the human one so that they can signal on their own, while the more distant RIPK1 cannot and thus require human RIPK1 (associated via RHIMs) for NFkB activation? Since the authors used RIPK1-deficient cells in previous experiments, wouldn't it make sense to test them here, too?

      It is intriguing that the more diverged RIPK1 species require the RHIM for NF-kB signaling. In Supplementary Figure 12, we do test the mammalian and non-mammalian proteins in RIPK1 KO cells and all proteins are able to activate NF-kB. So while nonmammalian RIPK1 signaling is dependent on the RHIM, it is independent of endogenous RIPK1.  

      Minor comments:

      (1) In the legend of Figure 1, there is a typo "heat amp".

      This typo has now been corrected.

      (2) In Figure 3A, the term "FUBAR" is not explained at all.

      FUBAR has now been defined in the methods section.

      Reviewer #3 (Recommendations for the authors):

      A few typos and graph inconsistencies have been encountered in the course of the manuscript, e.g.:

      (1) Line 168: 'heat amp' -> 'heat map'.

      (2) Lines 290-291: 'known mediate' -> 'known to mediate' (?)

      We thank the reviewer for catching these mistakes. They have been corrected. 

      (3) Supplementary Figure 12: Are human RIPK1 results presented in both 'mammalian' and 'non-mammalian' parts of the figure? If so, why do human data differ between the graphs?

      Mammalian and non-mammalian data were collected in separate experiments with human RIPK1 used as a control for both. The human data shown in the two graphs represent two separate experiments.

    1. Author response:

      The following is the authors’ response to the original reviews

      We thank the reviewers for the constructive comments, which have improved the manuscript. In response to these comments, we have made the following major changes to the main text and reviewer response:

      (1) Added experimental and computational evidence to support the use of Cut&Tag to determine speckle location.

      (2) Performed new Transmission Electron Microscopy (TEM) experiments to visualize interchromatin granule clusters +/- speckle degradation.

      (3) Altered the text of the manuscript to remove qualitative statements and clarify effect sizes.

      (4) Performed new analyses of published whole genome bisulfite data from LIMe-Hi-C following DNMT1 inhibition to demonstrate that CpG methylation is lost at DNMT1i-specific gained CTCF sites.

      (5) Included citations for relevant literature throughout the text.

      These revisions in addition to others are described in the point-by-point response below.

      Reviewer #1 (Public review):

      Summary

      Roseman et al. use a new inhibitor of the maintenance DNA methyltransferase DNMT1 to probe the role of methylation on binding of the CTCF protein, which is known to be involved chromatin loop formation. As previous reported, and as expected based on our knowledge that CTCF binding is methylation-sensitive, the authors find that loss of methylation leads to additional CTCF binding sites and increased loop formation. By comparing novel loops with the binding of the pre-mRNA splicing factor SON, which localizes to the nuclear speckle compartment, they propose that these reactivated loops localize to near speckles. This behavior is dependent on CTCF whereas degradation of two speckle proteins does not affect CTCF binding or loop formation. The authors propose a model in which DNA methylation controls the association of genome regions with speckles via CTCF-mediated insulation.

      Strengths

      The strengths of the study are 1) the use of a new, specific DNMT1 inhibitor and 2) the observation that genes whose expression is sensitive to DNMT1 inhibition and dependent on CTCF (cluster 2) show higher association with SON than genes which are sensitive to DNMT1 inhibition but are CTCF insensitive, is in line with the authors' general model.

      Weaknesses

      There are a number of significant weaknesses that as a whole undermine many of the key conclusions, including the overall mechanistic model of a direct regulatory role of DNA methylation on CTCF-mediated speckle association of chromatin loops.

      We appreciate the reviewer’s constructive comments and address them point-by-point below.

      (1) The authors frequently make quasi-quantitative statements but do not actually provide the quantitative data, which they actually all have in hand. To give a few examples: "reactivated CTCF sites were largely methylated (p. 4/5), "many CTCF binding motifs enriched..." (p.5), "a large subset of reactivated peaks..."(p.5), "increase in strength upon DNMT1 inhibition" (p.5); "a greater total number....." (p.7). These statements are all made based on actual numbers and the authors should mention the numbers in the text to give an impression of the extent of these changes (see below) and to clarify what the qualitative terms like "largely", "many", "large", and "increase" mean. This is an issue throughout the manuscript and not limited to the above examples.

      Related to this issue, many of the comparisons which the authors interpret to show differences in behavior seem quite minor. For example, visual inspection suggests that the difference in loop strength shown in figure 1E is something like from 0 to 0.1 for K562 cells and a little less for KCT116 cells. What is a positive control here to give a sense of whether these minor changes are relevant. Another example is on p. 7, where the authors claim that CTCF partners of reactivated peaks tend to engage in a "greater number" of looping partners, but inspection of Figure 2A shows a very minor difference from maybe 7 to 7.5 partners. While a Mann-Whitney test may call this difference significant and give a significant P value, likely due to high sample number, it is questionable that this is a biologically relevant difference.

      We have amended the text to include actual values, instead of just qualitative statements. We have also moderated our claims in the text to note where effect sizes are more modest.

      The following literature examples can serve as positive controls for the effect sizes that we might expect when perturbing CTCF. Our observed effect sizes are largely in line with these expected magnitudes.

      https://pmc.ncbi.nlm.nih.gov/articles/PMC8386078/ Fig. 2E

      https://www.cell.com/cell-reports/pdf/S2211-1247(23)01674-1.pdf Fig. 3J,K

      https://academic.oup.com/nar/article/52/18/10934/7740592 Fig. S5D (CTCF binding only).

      (2) The data to support the central claim of localization of reactivated loops to speckles is not overly convincing. The overlap with SON Cut&Tag (figure 2F) is partial at best and although it is better with the publicly available TSA-seq data, the latter is less sensitive than Cut&Tag and more difficult to interpret. It would be helpful to validate these data with FISH experiments to directly demonstrate and measure the association of loops with speckles (see below).

      A recent publication we co-authored validated the use of speckle (SON) Cut&Run using FISH (Yu et al, NSMB 2025, doi: 10.1038/s41594-024-01465-6). This paper also supports a role of CTCF in positioning DNA near speckles. Unfortunately, the resolution of these FISH probes is in the realm of hundreds of kilobases. This was not an issue for Yu et. al., as they were looking at large-scale effects of CTCF degradation on positioning near speckles. However, FISH does not provide the resolution we need to look at more localized changes over methylation-specific peak sites.

      Instead, we use Cut&Tag to look at these high-resolution changes. In Figure 3C, we show that SON localizes to DNMT1i-specific peaks only upon DNMT1 inhibition. We further demonstrate that this interaction is dependent on CTCF. In response to reviewer comments, we have now also performed spike-in normalized Cut&Tag upon acute (6 hr) SON degradation to validate that our signal is also directly dependent on SON and not merely due to a bias toward open chromatin.

      Author response image 1.

      TSA-seq has been validated with FISH (Chen et. al., doi: 10.1083/jcb.201807108), Alexander et. Al 10.1016/j.molcel.2021.03.006) Fig 6. We include TSA-seq data where possible in our manuscript to support our claims.

      We also note that Fig 2F shows all CTCF peaks and loops, not just methylation-sensitive peaks and loops, to give a sense of the data. We apologize for any confusion and have clarified this in the figure legend.

      (3) It is not clear that the authors have indeed disrupted speckles from cells by degrading SON and SRRM2. Speckles contain a large number of proteins and considering their phase separated nature stronger evidence for their complete removal is needed. Note that the data published in ref 58 suffers from the same caveat.

      Based upon the reviewers’ feedback, we generated Tranmission electron microscopy (TEM) data to visualize nuclear speckles +/- degradation of SON and SRRM2 (DMSO and dTAG). We were able to detect Interchromatin Granules Clusters (ICGs) that are representative of nuclear speckles in the DMSO condition. However, even at baseline, we observed a large degree of cell-to-cell variability in these structures. In addition, we also observe potential structural changes in the distribution of heterochromatin upon speckle degradation. Consequently, we hesitate to make quantitative conclusions regarding loss of these nuclear bodies. In the interest of transparency, we have included representative raw images from both conditions for the reviewers’ consideration.

      We also note that in Ref 58 (Ilik et. Al., https://doi.org/10.7554/eLife.60579), the authors show diffusion of speckle client proteins RBM25, SRRM1, and PNN upon SON and SRRM2 depletion, further supporting speckle dissociation in these conditions.

      Author response image 2.

      Author response image 3.

      (4) The authors ascribe a direct regulatory role to DNA methylation in controlling the association of some CTCF-mediated loops to speckles (p. 20). However, an active regulatory role of speckle association has not been demonstrated and the observed data are equally explainable by a more parsimonious model in which DNA methylation regulates gene expression via looping and that the association with speckles is merely an indirect bystander effect of the activated genes because we know that active genes are generally associated with speckles. The proposed mechanism of a regulatory role of DNA methylation in controlling speckle association is not convincingly demonstrated by the data. As a consequence, the title of the paper is also misleading.

      While it is difficult to completely rule out indirect effects, we do not believe that the relationship between methylation-sensitive CTCF sites and speckles relies only on gene activity.

      We can partially decouple SON Cut&Tag signal from gene activation if we break down Figure 4D to look only at methylation-sensitive CTCF peaks on genes whose expression is unchanged upon DNMT1 inhibition (using thresholds from manuscript, P-adj > 0.05 and/or |log2(fold-change)| < 0.5). This analysis shows that many methylation-sensitive CTCF peaks on genes with unchanged expression still change speckle association upon DNMT1 inhibition. This result refutes the necessity of transcriptional activation to recruit speckles to CTCF.

      Author response image 4.

      We note the comparator upregulated gene set here is small (~20 genes with our stringent threshold for methylation-sensitive CTCF after 1 day DNMT1i treatment).

      However, we acknowledge that these effects cannot be completely disentangled. We previously included the statement “other features enriched near speckles, such as open chromatin, high GC content, and active gene expression, could instead contribute to increased CTCF binding and looping near speckles” in the discussion. In response to the reviewer’s comment, we have further tempered our statements on page 20/21 and also added a statement noting that DNA demethylation and gene activation cannot be fully disentangled. While we are also open to a title change, we are unsure which part of the title is problematic. 

      (5) As a minor point, the authors imply on p. 15 that ablation of speckles leads to misregulation of genes by altering transcription. This is not shown as the authors only measure RNA abundance, which may be affected by depletion of constitutive splicing factors, but not transcription. The authors would need to show direct effects on transcription.

      We agree, and we have changed this wording to say RNA abundance.

      Reviewer #2 (Public review):

      Summary:

      CTCF is one of the most well-characterized regulators of chromatin architecture in mammals. Given that CTCF is an essential protein, understanding how its binding is regulated is a very active area of research. It has been known for decades that CTCF is sensitive to 5-cystosine DNA methylation (5meC) in certain contexts. Moreover, at genomic imprints and in certain oncogenes, 5meC-mediated CTCF antagonism has very important gene regulatory implications. A number of labs (eg, Schubeler and Stamatoyannopoulos) have assessed the impact of DNA methylation on CTCF binding, but it is important to also interrogate the effect on chromatin organization (ie, looping). Here, Roseman and colleagues used a DNMT1 inhibitor in two established human cancer lines (HCT116 [colon] and K562 [leukemia]), and performed CTCF ChIPseq and HiChIP. They showed that "reactivated" CTCF sites-that is, bound in the absence of 5meC-are enriched in gene bodies, participate in many looping events, and intriguingly, appear associated with nuclear speckles. This last aspect suggests that these reactivated loops might play an important role in increased gene transcription. They showed a number of genes that are upregulated in the DNA hypomethylated state actually require CTCF binding, which is an important result.

      Strengths:

      Overall, I found the paper to be succinctly written and the data presented clearly. The relationship between CTCF binding in gene bodies and association with nuclear speckles is an interesting result. Another strong point of the paper was combining DNMT1 inhibition with CTCF degradation.

      Weaknesses:

      The most problematic aspect of this paper in my view is the insufficient evidence for the association of "reactivated" CTCF binding sites with nuclear speckles needs to be more diligently demonstrated (see Major Comment). One unfortunate aspect was that this paper neglected to discuss findings from our recent paper, wherein we also performed CTCF HiChIP in a DNA methylation mutant (Monteagudo-Sanchez et al., 2024 PMID: 39180406). It is true, this is a relatively recent publication, although the BioRxiv version has been available since fall 2023. I do not wish to accuse the authors of actively disregarding our study, but I do insist that they refer to it in a revised version. Moreover, there are a number of differences between the studies such that I find them more complementary rather than overlapping. To wit, the species (mouse vs human), the cell type (pluripotent vs human cancer), the use of a CTCF degron, and the conclusions of the paper (we did not make a link with nuclear speckles). Furthermore, we used a constitutive DNMT knockout which is not viable in most cell types (HCT116 cells being an exception), and in the discussion mentioned the advantage of using degron technology:

      "With high-resolution techniques, such as HiChIP or Micro-C (119-121), a degron system can be coupled with an assessment of the cis-regulatory interactome (118). Such techniques could be adapted for DNA methylation degrons (eg, DNMT1) in differentiated cell types in order to gauge the impact of 5meC on the 3D genome."

      The authors here used a DNMT1 inhibitor, which for intents and purposes, is akin to a DNMT1 degron, thus I was happy to see a study employ such a technique. A comparison between the findings from the two studies would strengthen the current manuscript, in addition to being more ethically responsible.

      We thank the reviewer for the helpful comments, which we address in the point-by-point response below. We sincerely apologize for this oversight in our references. We have included references to your paper in our revised manuscript. It is exciting to see these complementary results! We now include discussion of this work to contextualize the importance of methylation-sensitive CTCF sites and motivate our study.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      To address the above points, the authors should:

      (1) Provide quantitative information in the text on all comparisons and justify that the small differences observed, albeit statistically significant, are biologically relevant. Inclusion of positive controls to give an indication of what types of changes can be expected would be helpful.

      We have added quantitative information to the text, as discussed in the response to public comments above.  We also provide literature evidence of expected effect sizes in that response.

      (2) Provide FISH data to a) validate the analysis of comparing looping patterns with SON Cut&Tag data as an indicator of physical association of loops with speckles and b) demonstrate by FISH increased association of some of the CTCF-dependent loops/genes (cluster 2) with speckles upon DNMT1 inhibition.

      Please see response to Reviewer 1 comment #2 above. Unfortunately, FISH will not provide the resolution we need for point a). We have confidence in our use of TSA-seq and Cut&Tag to study SON association with CTCF sites on a genome-wide scale, which would not be possible with individual FISH probes. Specifically, since the submission of our manuscript several other researchers (Yu et al, Nat. Struct. and Mol. Biol. 2025, Gholamalamdari et al eLife 2025) have leveraged CUT&RUN/CUT&TAG and TSA-seq to map speckle associated chromatin and have validated these methods with orthogonal imaging based approaches.

      (3) Demonstrate loss of speckles upon SON or SRRM2 by probing for other speckle components and ideally analysis by electron microscopy which should show loss of interchromatin granules.  

      We have performed TEM in K562 cells +/- SON/SRRM2 degradation. Please see response to Reviewer 1 comment #3. Specifically, interchromatin granule clusters are visible in the TEM images of the DMSO sample (see highlighted example above), however, given the heterogeneity of these structures and potential global alterations in heterochromatin that may be occurring following speckle loss, we refrained from making quantitative conclusions from this data. We instead include the raw images above.

      (4) The authors should either perform experiments to clearly show whether loop association is transcription dependent or whether association is merely a consequence of gene activation. Alternatively, they should tone down their model ascribing a direct regulatory role of methylation in control of loop association with speckles and also discuss other models. Unless the model is more clearly demonstrated, the title of the paper should be changed to reflect the uncertainty of the central conclusion.

      Please see response to Reviewer 1 comment #4 above.

      (5) The authors should either probe directly for the effect of speckle ablation on transcription or change their wording.

      We have changed our wording to RNA abundance.

      Reviewer #2 (Recommendations for the authors):

      Major:

      ⁃ There was no DNA methylation analysis after inhibitor treatment. Ideally, genome bisulfite sequencing should be performed to show that the DNMT1i-specific CTCF binding sites are indeed unmethylated. But at the very least, a quantitative method should be employed to show the extent to which 5meC levels decrease in the presence of the DNMT1 inhibitor

      Response: We have now included analysis of genome wide bisulfite information from LIMe-Hi-C (bisulfite Hi-C) in K562 following DNMT1i inhibition. Specifically, we leverage the CpG methylation readout and find that DNTM1i-specific CTCF sites are more methylated than non-responsive CTCF peaks at baseline. In addition, these sites show the greatest decrease in CpG methylation upon 3 days of DNMT1 inhibition. We include a figure detailing these analyses in the supplement (Fig S1E). In addition, we have added CpG methylation genome browser tracks to (Fig S1D). In terms of global change, we have found that 3 days of DNMT1 inhibitor treatment leads to a reduction in methylation to about ~1/4 the level at baseline.

      I am not convinced that CUT&Tag is the proper technique to assess SON binding. CUT&Tag only works under stringent conditions (high salt), and can be a problematic assay for non-histone proteins, which bind less well to chromatin. In our experience, even strong binders such as CTCF exhibit a depleted binding profile when compared to ChIP seq data. I would need to be strongly convinced that the analysis presented in figures 2F-J and S2 D-I simply do not represent ATAC signal (ie, default Tn5 activity). For example, SON ChIP Seq, CUT&Tag in the SON degron and/or ATAC seq could be performed. What worries me is that increased chromatin accessibility would also be associated with increased looping, so they have generated artifactual results that are consistent with their model.

      As the reviewer suggested, we have now performed spike-in normalized SON Cut&Tag with DNMT1 inhibition and 6 hours of SON/SRRM2 degradation in our speckle dTAG knockin cell line. These experiments confirm that the SON Cut&Tag signal we see is SON-dependent. If the signal was truly due to artifactual binding, gained peaks would be open irrespective of speckle binding, however we see a clear speckle dependence as this signal is much lower if SON is degraded.

      Author response image 5.

      Moreover, in our original Cut&Tag experiments, we did not enrich detectable DNA without using the SON antibody (see last 4 samples-IgG controls). This further suggests that our signal is SON-dependent.

      Author response image 6.

      Finally, we see good agreement between Cut&Tag and TSA-seq (Spearman R=0.82).  The agreement is particularly strong in the top quadrant, which is most relevant since this is where the non-zero signal is.

      Author response image 7.

      Minor points

      ⁃ Why are HCT116 cells more responsive to treatment than K562 cells? This is something that could be addressed with DNA methylation analysis, for example

      K562 is a broadly hypomethylated cell line (Siegenfeld et.al, 2022 https://doi.org/10.1038/s41467-022-31857-5 Fig S2A-C). Thus, there may be less dynamic range to lose methylation compared to HCT116.

      Our results are also consistent with previous results comparing DKO HCT116 and aza-treated K562 cells (Maurano 2015, http://dx.doi.org/10.1016/j.celrep.2015.07.024). They state “In K562 cells, 5-aza-CdR treatment resulted in weaker reactivation than in DKO cells…”  In addition, cell-type-specific responsiveness to DNA methyltransferase KO depending upon global CpG methylation levels, has also been observed in ES and EpiLC cells (Monteagudo-Sanchez et al., 2024), which we now comment on in the manuscript.

      ⁃ How many significant CTCF loops in DNMTi, compared to DMSO? It was unclear what the difference in raw totals is.

      We now include a supplemental table with the HiChIP loop information. We call similar numbers of raw loops comparing DNMT1i and DMSO, as only a small subset of loops is changing.

      ⁃ For the architectural stripes, it would be nice to see a representative example in the form of a contact plot. Is that possible to do with the hiChIP data?

      As described in our methods, we called architectural stripes using Stripenn (Yoon et al 2022) from LIMe-Hi-C data under DNMT1i conditions (Siegenfeld et al, 2022). Shown below is a representative example of a stripe in the form of a Hi-C contact map.

      Author response image 8.

      ⁃ Here 4-10x more DNMT1i-specific CTCF binding sites were observed than we saw in our study. What are thresholds? Could the thresholds for DNMT1i-specific peaks be defined more clearly? For what it's worth, we defined our DNMT KO-specific peaks as fold-change {greater than or equal to} 2, adjusted P< 0.05. The scatterplots (1B) indicate a lot of "small" peaks being called "reactivated."

      We called DNMT1i-specific peaks using HOMER getDifferentialPeaksReplicates function. We used foldchange >2 and padj <0.05. We further restricted these peaks to those that were not called in the DMSO condition. 

      ⁃ On this note, is "reactivated" the proper term? Reactivated with regards to what? A prior cell state? I think DNMT1i-specific is a safer descriptor.

      We chose this term based on prior literature (Maurano 2015 http://dx.doi.org/10.1016/j.celrep.2015.07.024, Spracklin 2023 https://doi.org/10.1038/s41594-022-00892-7) . However, we agree it is not very clear, so we’ve altered the text to say “DNMT1i-specific”. We thank the reviewer for suggesting this improved terminology.

      ⁃ It appears there is a relatively small enrichment for CTCF peaks (of any class) in intergenic regions. How were intergenic regions defined? For us, it is virtually half of the genome. We did some enrichment of DNMT KO-specific peaks in gene bodies (our Supplemental Figure 1C), but a substantial proportion were still intergenic.

      We defined intergenic peaks using HOMER’s annotatepeaks function, with the -gtf option using Ensembl gene annotations (v104). We used the standard annotatepeaks priority order, which is TSS > TTS> CDS Exons > 5’UTR exons >3’ UTR exons > Introns > Intergenic.

      Maurano et. al. 2015 (http://dx.doi.org/10.1016/j.celrep.2015.07.024) also found reduced representation of intergenic sites among demethylation-reactivated CTCF sites in their Fig S5A. We note this is not a perfect comparison because their data is displayed as a fraction of all intergenic peaks.

      ⁃ We also recently published a review on this subject: The impact of DNA methylation on CTCF-mediated 3D genome organization NSMB 2024 (PMID: 38499830) which could be cited if the authors choose.

      We have cited this relevant review.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Prior research indicates that NaV1.2 and NaV1.6 have different compartmental distributions, expression timelines in development, and roles in neuron function. The lack of subtype-specific tools to control Nav1.2 and Nav1.6 activity however has hampered efforts to define the role of each channel in neuronal behavior. The authors attempt to address the problem of subtype specificity here by using aryl sulfonamides (ASCs) to stabilize channels in the inactivated state in combination with mice carrying a mutation that renders NaV1.2 and/or NaV1.6 genetically resistant to the drug. Using this innovative approach, the authors find that action potential initiation is controlled by NaV1.6 while both NaV1.2 and NaV1.6 are involved in backpropagation of the action potential to the soma, corroborating previous findings. Additionally, NaV1.2 inhibition paradoxically increases the firing rate, as has also been observed in genetic knockout models. Finally, the potential anticonvulsant properties of ASCs were tested. NaV1.6 inhibition but not NaV1.2 inhibition was found to decrease action potential firing in prefrontal cortex layer 5b pyramidal neurons in response to current injections designed to mimic inputs during seizure. This result is consistent with studies of loss-of-function Nav1.6 models and knockdown studies showing that these animals are resistant to certain seizure types. These results lend further support for the therapeutic promise of activity-dependent, NaV1.6-selective, inhibitors for epilepsy.

      Strengths:

      (1) The chemogenetic approaches used to achieve selective inhibition of NaV1.2 and NaV1.6 are innovative and help resolve long-standing questions regarding the role of Nav1.2 and Nav1.6 in neuronal electrogenesis.

      (2) The experimental design is overall rigorous, with appropriate controls included.

      (3) The assays to elucidate the effects of channel inactivation on typical and seizure-like activity were well selected.

      Weaknesses:

      (1) The potential impact of the YW->SR mutation in the voltage sensor does not appear to have been sufficiently assessed. The activation/inactivation curves in Figure 1E show differences in both activation and inactivation at physiologically relevant membrane voltages, which may be significant even though the V1/2 and slope factors are roughly similar.

      We have performed new experiments testing how YW->SR mutations affect spiking on their own. The reviewer’s intuition was correct; the small changes in voltage-dependence in NaV1.6 identified in heterologous expression systems translated into a ~2 mV hyperpolarization in threshold in neurons.

      (2) Additional discussion of the fact that channels are only partially blocked by the ASC and that ASCs act in a use-dependent manner would improve the manuscript and help readers interpret these results.

      We have updated text extensively to address this concern. Details are found in the author suggestions below.

      (3) NaV1.6 was described as being exclusively responsible for the change in action potential threshold, but when NaV1.6 alone was inactivated, the effect was significantly reduced from the condition in which both channels were inactivated (Figure 4E). Similarly, Figure 6C shows that blockade of both channels causes threshold depolarization prior to the seizure-like event, but selective inactivation of NaV1.6 does not. As NaV1.2 does not appear to be involved in action potential initiation and threshold change, what is the mechanism of this dissimilarity between the NaV1.6 inactivation and combined NaV1.6/ NaV1.2 inactivation?

      We believe the dissimilarity is due to interactions between NaV1.2 and other channel classes (e.g., potassium channels) throughout the cell, including the somatodendritic domain. NaV1.6 that initiates APs, localized to the AIS, do not live in isolation, and AP threshold can be affected by the recent membrane potential history. Loss of NaV1.2-mediated depolarization in the dendrites begets less potassium channel-mediated repolarization, as described in Figure 4.

      (4) The idea that use-dependent VGSC-acting drugs may be effective antiseizure medications is well established. Additional discussion or at least acknowledgement of the existing, widely used, use-dependent VGSC drugs should be included (e.g. Carbamazepine, Lamotrigine, Phenytoin). Also, the idea that targeting NaV1.6 may be effective for seizures is established by studies using genetic models, knockdown, and partially selective pharmacology (e.g. NBI-921352). Additional discussion of how the results reported here are consistent with or differ from studies using these alternative approaches would improve the discussion

      We agree; the concept of use-dependent block as a means to treat seizure is not new, and we have updated the discussion to include commentary on other medications currently in use. What is new here is our ability to explore the role of NaV1.2 and NaV1.6 in electrogenesis with a level of drug selectivity that could not be achieved without the addition of the YW->SR mutations. This approach in itself will not be useful in the clinic, but it may help guide drug design in the future. One major interpretation of this work is that NaV1.6 block is more effective than NaV1.2 block in general, and may even be effective for non-SCN8A genetic conditions. This is indeed one of the reasons that we believe that drugs like NBI-921352, itself an aryl-sulfonamide, is being tested in seizure models.

      Reviewer #2 (Public review):

      The authors used a clever and powerful approach to explore how Nav1.2 and Nav1.6 channels, which are both present in neocortical pyramidal neurons, differentially control firing properties of the neurons. Overall, the approach worked very well, and the results show very interesting differences when one or the other channel is partially inhibited. The experimental data is solid and the experimental data is very nicely complemented by a computational model incorporating the different localization of the two types of sodium channels.

      In my opinion the presentation and interpretation of the results could be improved by a more thorough discussion of the fact that only incomplete inhibition of the channels can be achieved by the inhibitor under physiological recording conditions and I thought the paper could be easier to digest if the figures were re-organized. However, the key results are well-documented.

      This is a concern raised by multiple reviewers, and we thank you all for your help in improving the way in which we discuss the results. We have revised the manuscript extensively, moving figures around per your advice and the advice of R1 in their comments to authors.

      Reviewer #3 (Public review):

      Summary:

      The authors used powerful and novel reagents to carefully assess the roles of the voltage gated sodium channel (NaV) isoforms in regulating the neural excitability of principal neurons of the cerebral cortex. Using this approach, they were able to confirm that two different isoforms, NaV1.2 and NaV1.6 have distinct roles in electrogenesis of neocortical pyramidal neurons.

      Strengths:

      Development of very powerful transgenic mice in which NaV1.2 and/or NaV1.6 were modified to be insensitive to ASCs, a particular class of NaV blocker. This allowed them to test for roles of the two isoforms in an acute setting, without concerns of genetic or functional compensation that might result from a NaV channel knockout.

      Careful biophysical analysis of ASC effects on different NaV isoforms.

      Extensive and rigorous analysis of electrogenesis - action potential production - under conditions of blockade of either NaV1.2 or NaV1 or both.

      Weaknesses:

      Some results are overstated in that the representative example records provided do not directly support the conclusions.

      We have swapped out example records to better capture the median effect observed and to better capture our discussion of these results. Please see below, in recommendations for authors, for details.

      Results from a computational model are provided to make predictions of outcomes, but the computational approach is highly underdeveloped.

      Modeling has been elaborated upon extensively, with more detail in methods, a new sensitivity analysis supplemental figure, and a deposition into ModelDB.  Please see below, in recommendations for authors, for details.

      Reviewer #1 (Recommendations for the authors):

      Regarding the concern about the potential impact of the YWàSR mutation: All results in Figures 2-6 report only within-subject changes before and after drug-activating protocols. These results show that the drug has no effect on the mutant channel, but whether the mutant channel itself has any effect on neuronal properties is not clear. This deficiency could be rectified by reporting raw values for AP threshold, spike rate, etc. in the pre-drug condition and statistically analyzing the apparent differences in the activation/inactivation curves.

      Data in our original submission only included data in the presence of GNE-4076. We now present new data showing how the YWàSR mutation affects baseline activity of neurons. These data are in Supplemental Figure 1. Compared to wildtype (no drug control) neurons, we observe no change in peak dV/dt. However, threshold is hyperpolarized by approximately 2 mV in dual knockin neurons (median values: -57.4 mV for dual knockin and -55 mV for wildtype). This is consistent with measures from heterologously expressed channels, where we observed somewhat subtle shifts in voltage-dependence of inactivation and activation in NaV1.6 as a result of YWàSR incorporation. 

      In addition to these data, we also include the baseline dataset from Figure 3, where GNE-4076 is present throughout recording, and report that neither threshold nor peak dV/dt are influenced by the presence of GNE at baseline. This suggests that any drug binding at baseline (i.e., before firing APs via somatic current injection) is negligible, consistent with the concept that GNE-4076 has low affinity for the closed channel state.

      Minor Comments:

      While the single-cell response to "seizure-like" input aptly demonstrates the change in action potential threshold and firing rate induced by NaV1.6 inhibition, this component of the paper could be enhanced by a network-level assay that assesses the impact of this drug on an actual seizure-like event in acute slices or on seizure susceptibility in vivo.

      This is an excellent thought, and the work near the end of this manuscript is an effort to mimic network-like activity in a controlled way in single cells. To expand this to bona fide seizure-like activity in acute slices or in vivo is something that we are considering for future studies. To do this properly requires extensive validation of dosing and seizure induction that will require several years’ effort.

      Fig 1e caption says "circles" but the markers are squares

      This has been corrected, thank you for catching it.

      Color scheme in S2B is not intuitive to me

      We’ve now updated the caption to better describe the color scheme used within.

      Fig S2: graph or show change in threshold

      Empirical threshold data are in main figure 3D. Changes in threshold related to modeling are now included in a new sensitivity analysis that is in a new Supplemental Figure 2.

      Fig 3A example of NaV1.6 inhibition does not show change in AP threshold apparent in the aggregate data

      We have updated the representative example to better illustrate the change in AP threshold for NaV1.6 inhibition.

      "AP initiation is mediated exclusively by NaV1.6" not corroborated by data; APs still occur when NaV1.6 is inhibited

      This was an over-interpretation of our data, indeed. We have updated the language to be more accurate to the following: “AP threshold and AP initiation appears to be initiated in an NaV1.6-rich region in control conditions; when NaV1.6 is inhibited, APs can occur at more depolarized potentials, likely mediated predominately by NaV1.2.”

      Fig S3C missing WT/Scn8aSR/SR significance marking. Chosen example makes it look like there is a small decrease.

      Please note that there is no difference between these two conditions when in delta dV/dt for AIS inflection point (p = 0.4344).

      Reviewer #2 (Recommendations for the authors):

      This manuscript presents a clever and powerful approach to examining differential roles of Nav1.2 and Nav1.6 channels in excitability of pyramidal cell excitability, by engineering mice in which a sulfonamide inhibitor of both channels has reduced affinity for one or the other. Overall, the results in the manuscript are interesting and give important information about differential roles of Nav1.6 and Nav1.2 channels.

      The paper makes an important contribution to better understanding distinct roles of Nav1.2 and Nav1.6 channels. This improved understanding could help guide design of anti-seizure drugs targeted to sodium channels.

      Having made it clear that I think this is an important and impressive piece of work for which the authors should be congratulated, I found reading and interpreting the manuscript a frustrating experience. I will be blunt about the ways in which I found the presentation and discussion to be frustrating and even annoying, in the spirit of frank feedback by one interested and appreciative reader that the authors can consider or reject as they wish.

      From the start, I had the feeling that the authors were presenting and discussing the results in a sanitized "never-mind-about the details" fashion such as might be appropriate for a seminar to a general audience not interested in details, but not appropriate for a research paper.

      Our intent certainly was not to frustrate or annoy readers. We are very grateful that you have provided these comments, which have certainly improved the manuscript, hopefully mitigating some of the frustration for future readers. We appreciate that there are complex drug and voltage effects occurring within these studies, and in an effort to distill these effects into digestible prose, we appear to have been too earnest. We have expanded on the requested topics below and please note that, for the aficionados, every figure displays individual data. Further, we have made a special effort to ensure that features of excitability are presented throughout the drug and manipulation timecourse, including time-points before and after periods subject to statistical comparison, so that the reader may draw their own conclusions.

      General:

      There were two major ways in which I found the presentation and discussion frustrating and even annoying: First, not clearly discussing early in the presentation the fact that it is impossible to achieve complete inhibition with this agent during measurements of physiological firing and second, presenting so much of the effects as deltas of various parameters rather than showing effects on absolute values of the parameters.

      Our response to the first issue will follow the next comment, as it relates to this statement. Regarding use of deltas and absolute values for changes in threshold and dV/dt across figures. Every cell has a unique AP threshold and peak dV/dt, and we found that displaying data zeroed to baseline values best illustrated the effects of GNE-4076. Without this, GNE-based effect could be buried within the cell-to-cell variability. This helped most when trying to make the case that threshold was unaffected in 2a/8a YWàSR knockin animals. We continue to believe that this is the best way to display the data in the primary figures, but to provide a more complete account, we now present absolute values in supplemental tables and supplemental figures.

      The first issue, the incomplete inhibition by the agent, was the most annoying because the authors obviously thought a lot about this and even closed the paper by proposing this as a positive feature of this class of inhibitors, yet discussed it only piecemeal - and with most of the key experimental data in the Supplement. There are two fundamental characteristics of this (and other) sulfonamide inhibitors that complicate interpretation of experiments, especially when applied in a slice experiment: they only bind to the channel when the channel is depolarized, and even when the channel is depolarized for many seconds, bind very slowly to the channel.

      That makes it almost impossible to know exactly what fraction of channels is being inhibited during measurements of firing. Obviously, the authors are well-aware of this issue and they allude to it and even make use of it in some of the protocols, but they never really discuss it in a very clear manner.

      We agree that it is impossible to know the precise fraction of channels inhibited in acute slice preparations. But the reason for this is likely different than what has been interpreted by this reviewer. To state that ASMs “only bind to the channel when the channel is depolarized, and even when the channel is depolarized for many seconds, bind very slowly to the channel.” is not consistent with prior data on ASM–channel interactions. Clarification on these points may help the reviewer and a broader audience better understand the effects occurring here, and we appreciate being able to both address this concept here and by revising the manuscript.

      First, ASMs bind activated channels and stabilize the inactivated state. It is correct that channels are more likely to enter these states when subject to voltage depolarization, but channel state is stochastic and can enter activated states near resting membrane potentials. The on-rate is fast enough that channels are blocked immediately in recordings in heterologous systems (Figure 1C). It is more likely that channel biophysical state stochasticity, along with drug concentration used herein, are likely dictating the rate at which channels accumulate block during repetitive spiking.

      To address this in text, we have revised the 3rd paragraph of the introduction to better incorporate these ideas. This also helps with comments in the reviewer paragraph below.

      The key experimental data on this is relegated to the Supplemental Figures. When the reader is first shown results of the effects of the inhibitor on firing in Fig 2, the presentation has been set up as if everything is perfect, and the inhibitor will be completely inhibiting either both or only one channel according to the mouse. With this presentation, it is then exceptionally striking that the cell in the middle panel of Fig 2A, labeled "Nav1.2/1.6 Inhibited" is firing action potentials very nicely even with both channels "inhibited". For a reader not already aware that there is likely only partial inhibition of each channel, the reaction will be "Huh? Shouldn't blocking both channels simply completely block excitability?". The authors do preface Fig 2 by a very brief allusion to the incomplete inhibition: "In spiking neurons, ASCs would therefore be predicted to exhibit use-dependence, progressively blocking channels in proportion to a neuron's activity rate" but this comes out of nowhere after the over-simplified picture of complete inhibition up to that point, and without any estimation of how much inhibition there is likely to be before activity, or how much induction of inhibition there is likely to be during the activity. Without this, interpreting the data in Fig 2 is basically impossible.

      The key experimental data on this issue is really in Supplemental Figures 1-2 and Fig 4, and I found myself immediately ping-ponging back and forth between the Supplemental figures and the main text trying to understand what is going on with the partial inhibition. This was frustrating.

      Thank you for these suggestions; they help with readability appreciably. We have re-organized the figures presented in the manuscript and emphasized details about ASCs to ensure readers can discern between near-complete blockade of channels (Figures 1-4) and activity-dependent ASC onboarding (Figures 5-7). We now present near-complete block experiments first, detailing the current clamp-> voltage clamp (-12 mV)-> current clamp experiments. We incorporated Supp. Fig. 1 into main Figure 1 and moved Supp. Fig. 2 into main Fig. 2.

      As the reviewer notes, there are clear time-dependent effects on channel function when stepping to -12 mV, independent of GNE-4076 block. As stated previously, “We therefore focused on the 12-20 sec after voltage-clamp offset for subsequent analysis, as it is a period in which most channel-intrinsic recovery has occurred, but also a period in which we would still expect significant block from GNE-4076.” We hope that reordering the manuscript as suggested and placing these results near the beginning will help with discerning between near-complete block and activity depending onboarding. By beginning with these experiments, which underscore that 100% block cannot be studied without “contamination” from native slow inactivation, we hope that the readers can better understand why data was done as presented.

      In my opinion, the paper would be greatly improved by a detailed discussion of the voltage- and time-dependence of the inhibitor at the very beginning of the paper. For me, reading and digesting the paper would have been far easier if Fig 1 included a discussion of the voltage- and time-dependence of inhibition, and next Figs were then Supplemental Figs 1-2, and main Fig 4. The key questions are: how much inhibition is there before a 10-s current injection from the resting potential, and how much additional inhibition is there produced during either the 10-s bout of firing or the "on-boarding" depolarization protocol, and how long does that additional inhibition last? The most direct information on that is in the plots in Fig. 4D and Fig 4F in combination with Supplemental Fig 1, which shows that the on-boarding depolarization reduces current to about 30% of current before on-boarding. This is so central to the interpretation of all the results that I think Supp Fig 1 should be in the main paper as the first piece of data in neurons.

      We originally had the nucleated patch data in supplement due to space constraints in an already large figure 1. Based on your recommendation we have moved it to the main figure. We have also changed the ordering of the paper and related figures to present data as suggested. Hopefully this better guides readers through the questions you are raising above, which are addressed in the (now reordered) figures mentioned above.

      Specific:

      (1) Fig.1 I can find no information on the voltage protocol used to generate the dose-response curves. In the literature characterizing sulfonamide blockers, most protocols use very unphysiological strong, long depolarization to induce inhibition, usually with equally unphysiological short hyperpolarizations to produce recovery from inactivation. One assumes something like that was used here. Obviously, the protocol needs to be explained.

      We updated the methods section to better describe the voltage protocol used to generate the dose response curves. In contrast to the literature characterizing sulfonamide blockers, we used pulses that closely mimic physiological activation from -80 mV (rest) to 0 mV (depolarized) for 20 msec. GNE-4076 was perfused onto cells at increasing concentrations throughout the experiment. At each successive dose, cells were held at 0 mV to allow adequate GNE-4076 onboarding.

      (2) Supp Fig1. This shows the effect of depolarization to enhance inhibition, but not how much inhibition there was before the depolarization. Presumably, there were measurements during the application of drug? How much inhibition is there before the depolarization? Why does the time only go to 20-s, when the times in Figs 4 go to 10 minutes?

      Nucleated patch recordings are notoriously difficult to maintain for long durations, especially when subjecting the patch to large voltage deflections. These recordings extend to 20s recovery periods because that is the duration for which we maintained all recordings, though some exhibited rather impressive longevity and allowed for several minutes of recording thereafter. Regardless, the goal here was to assess block within the 12-20 sec recovery window we utilized in current clamp recordings from intact neurons. This was achieved.

      Please note that GNE-4076 was present throughout all recordings. This was in part due to time constraints, as we could not maintain patches long enough to also perform wash-in. The degree of inhibition can be inferred by comparing peak dV/dt and threshold of cells in the absence and presence of GNE-4076. These data are presented in a new Supplemental figure 1, showing no difference in threshold or peak dV/dt.

      (3) Fig. 4. Similar question here - this is a very nice and informative figure, but we see only the delta in threshold and dv/dt, but how were the initial absolute values different in the drug compared to control?

      These data are presented in a new Supplemental Figure 1, showing no difference in threshold or peak dV/dt.

      (4) Fig 2. As far as I can tell, we have no idea how much inhibition there is at rest, before the current injection -what is the dv/dt in the drug compared to in the control? Were there experiments in which the current injections were delivered before and after applying drug? If not, at least it would be useful to see population data on dv/dt of the first spike in control and with drug.

      These data are presented in a new Supplemental Figure 1, showing no difference in threshold or peak dV/dt.

      (5). Fig. 2. Do the authors have any quantitative information on how much extra inhibition would be produced at 200 nM drug using physiological waveforms of firing?

      These types of analyses are part of later figures using EPSC-like waveforms to evoke spiking.

      I was unconvinced that the changes in threshold and dv/dt during the firing in the drug necessarily represent time-dependent use-dependent effects of drug. Partial inhibition by TTX would probably produce greater progressive changes in spike shape and reduced ability to fire robustly.

      TTX is not use-dependent, so it is a good contrast to GNE-4076. We experimented with a few cells at 2 and 10 nM TTX concentrations and found that concentrations required to mimic the block of spiking that occurs with 200 nM GNE-4076 in WT cells was associated with a marked use-independent elevation in AP threshold, with an inability to maintain ~10 Hz spiking rates with the baseline EPSC-like stimulation pattern. These effects are very different from those produced by GNE-4076, but were expected given the use-independence of TTX. We did not pursue this line of inquiry fully, so we present these data only as individual examples in the reviewer figure below:

      Author response image 1.

      Data from Figure 6B, D, E are replicated here with individual lines of 2 nM and 10 nM TTX shown in dashed lines. Note marked changes in threshold not observed with GNE-4076. TTX sourced from Alomone Labs.

      Minor:

      p. 5 and elsewhere: it seems unnecessary to give values of threshold and dv/dt to three decimal places, especially when the precision is not better than a single decimal place.

      We have reduced unnecessary precision throughout.

      Reviewer #3 (Recommendations for the authors):

      The computational model is highly underdeveloped. Without more rigorous development the results of the computational model appear to provides little additional insight beyond that expected from the known axodendritic localizations of NaV 1.2 and 1.6. If the authors wish to use the computational results to make rigorous predictions, then this section needs to be either be expanded to be more complete and promoted to a regular figure, with full details of the model, and how it was evaluated for accuracy. Alternatively, this point regarding computational insight could be de-emphasized and or removed from the paper.

      Modeling:

      (1) I don't see any methods describing the precise model parameters that were used.

      Apologies, this is a model that we have built and tested extensively over the years (PMID: 38290518, 35417922, 34348157, 31995133, 31230762, 28256214), though there have been some small updates over these works. We have deposited this model at ModelDB and provide data there regarding model construction (access #2019342).

      (2) There appears to be no robustness test to assess whether the particular results/conclusions were unduly dependent on particular model construction decisions.

      We have now generated a new supplemental figure 2 that explores the robustness of these observations to changes in NaV1.2 and NaV1.6 position within the AIS and changes in relative density of NaV1.2 and NaV1.6. As shown there, the model is tolerant to all but extreme, non-physiological manipulations to these parameters.

      (3) Figure S2 does not really provide convincing evidence of a biologically relevant model. Probably the model itself needs to be redesigned to better replicate the biological response and be validated by testing parameter sensitivity.

      a) All of the results in S2C show that there is a huge reduction in the first action potential (black?) followed by relatively little change in subsequent spikes. This is not seen in any of the models. The progressive changes in threshold as predicted by the model for dual and NaV1.6 block are not at all evident in the results of C, except perhaps for the the very first and the very last spikes.

      b) The baseline action potential in B is different than the recorded action potentials. In particular, the somatic depolarization occurs much later and over a more extended time frame than the real neuron, and the phase plot shows an actual dip in depolarization at the transition to the somatic spike, which is not representative of naturally occurring action potentials.

      To address both (a) and (b), please note that in empirical experiments there are two parallel processes occurring: block by GNE-4076 and channel recovery from inactivation. In the model we can isolate the effects of block to test that parameter fully and in isolation. This is something that we could never achieve biologically. The important take home here in both cases is to observe that with NaV1.6 block there is a change in threshold, whereas with NaV1.2 block there is none.

      (4) The one finding that seems to be robust is that the changes in NaV1.2 have little effect on threshold.

      Yes! This is a major take-home message from both the model and the use of these knockin mice in combination with GNE-4076. In mature pyramidal cells, NaV1.6 is the major determinant of AP threshold. And to editorialize on this observation, changes in threshold are a useful metric to test if other pharmacology are truly selective for NaV1.2 over NaV1.6. We note that phrixotoxin-3, which is described as NaV1.2 specific in multiple papers, was never tested for specificity over NaV1.6 in its original description, and we find that it fails this test in our hands.

      Data presentation:

      (1) The phase plots in Figure 3B (left and right) appear to be visually identical, and as such don't strongly support any particular conclusion.

      We changed the representative example record (specifically for Fig. 3A-B) to more directly support the conclusions.

      (2) It is unclear to me what is meant by AP speed (title of Figure 3 legend). Do the authors mean propagation speed along the axon, or perhaps the rate of action potential firing?

      Apologies, we are referencing dV/dt when we mention AP speed. We updated AP speed to AP velocity throughout the manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the reviewers and editor for their positive view and constructive valuable comments on the manuscript.  Following we address the suggestions of the reviewers.

      Reviewer #1 (Public Review):

      (1) It will be interesting to monitor the levels of another MIM insertase namely, OXA1. This will help to understand whether some of the observed changes in levels of OXPHOS subunits are related to alterations in the amounts of this insertase.

      OXA1 was not detected in the untargeted mass spectrometry analysis, most likely due to the fact that it is a polytopic membrane protein, spanning the membrane five times (1,2). Consequently, we measured OXA1 levels with immunoblotting, comparing patient fibroblast cells to the HC. No significant change in OXA1 steady state levels was observed.

      These results are now displayed (Fig. S3B and C) and discussed in the revised manuscript.

      Figure 3: How do the authors explain that although TIMM17 and TIMM23 were found to be significantly reduced by Western analysis they were not detected as such by the Mass Spec. method?

      The untargeted mass spectrometry in the current study failed to detect the presence of TIMM17 for both, patient fibroblasts and mice neurons, while TIMM23 was detected only for mice neurons and a decrease was observed for this protein but was not significant. This is most likely due to the fact that TIMM17 and TIMM23 are both polytopic membrane proteins, spanning the membrane four times, which makes it difficult to extract them in quantities suitable for MS detection (2,3).

      (2) How do the authors explain the higher levels of some proteins in the TIMM50 mutated cells?

      The levels of fully functional TIM23 complex are deceased in patients' fibroblasts. Therefore, the mechanism by which the steady state level of some TIM23 substrate proteins is increased, can only be explained relying on events that occur outside the mitochondria. This could include increase in transcription, translation or post translation modifications, all of which may increase their steady state level albite the decrease in the steady state level of the import complex.

      (3) Can the authors elaborate on why mutated cells are impaired in their ability to switch their energetic emphasis to glycolysis when needed?

      Cellular regulation of the metabolic switch to glycolysis occurs via two known pathways: 1) Activation of AMP-activated protein kinase (AMPK) by increased levels of AMP/ADP (4). 2) Inhibition of pyruvate dehydrogenase (PDH) complexes by pyruvate dehydrogenase kinases (PDK) (5). Therefore, changes in the steady state levels of any of these regulators could push the cells towards anaerobic energy production, when needed. In our model systems, we did not observe changes in any of the AMPK, PDH or PDK subunits that were detected in our untargeted mass spectrometry analysis (see volcano plots below, no PDK subunits were detected in patient fibroblasts). Although this doesn’t directly explain why the cells have an impaired ability to switch their energetic emphasis, it does possibly explain why the switch did not occur de facto.

      Author response image 1.

      Reviewer #2 (Public Review):

      (1) The authors claim in the abstract, the introduction, and the discussion that TIMM50 and the TIM23 translocase might not be relevant for mitochondrial protein import in mammals. This is misleading and certainly wrong!!!

      Indeed, it was not in our intention to claim that the TIM23 complex might not be relevant. We have now rewritten the relevant parts to convey the correct message:

      Abstract –

      Line 25 - “Strikingly, TIMM50 deficiency had no impact on the steady state levels of most of its putative substrates, suggesting that even low levels of a functional TIM23 complex are sufficient to maintain the majority of complex-dependent mitochondrial proteome.”

      Introduction –

      Line 87 - Surprisingly, functional and physiological analysis points to the possibility that low levels of TIM23 complex core subunits (TIMM50, TIMM17 and TIMM23) are sufficient for maintaining steady-state levels of most presequence-containing proteins. However, the reduced TIM23CORE component levels do affect some critical mitochondrial properties and neuronal activity.

      Discussion –

      Line 339 – “…surprising, as normal TIM23 complex levels are suggested to be indispensable for the translocation of presequence-containing mitochondrial proteins…”

      Line 344 – “…it is possible that unlike what occurs in yeast, normal levels of mammalian TIMM50 and TIM23 complex are mainly essential for maintaining the steady state levels of intricate complexes/assemblies.”

      Line 396 – “In summary, our results suggest that even low levels of TIMM50 and TIM23CORE components suffice in maintaining the majority of mitochondrial matrix and inner membrane proteome. Nevertheless, reductions in TIMM50 levels led to a decrease of many OXPHOS and MRP complex subunits, which indicates that normal TIMM50 levels might be mainly essential for maintaining the steady state levels and assembly of intricate complex proteins.”

      Reviewer #1 (Recommendations For The Authors):

      (1) Lines 25-26: The authors write "Strikingly, TIMM50 deficiency had no impact on the steady state levels of most of its substrates". Since the current data challenges the definition of some proteins as substrates of TIMM50, I suggest using the term "putative substrates".

      Changed as suggested

      (2) Line 27: It is not clear whether the wording "general import role of TIM23" it refers to the TIM23 protein or the TIM23 complex. This should be clarified.

      Clarified. It now states "TIM23 complex".

      (3) Line 72: should be "and plays".

      Changed as suggested.

      (4) It will be helpful to include in Figure 1 a small scheme of TIMM50 and to indicate in which domain the T252M mutation is located.

      We predicted the AlphaFold human TIMM50 structure and indicated the mutation site and the different TIMM50 domains. The structure is included in Fig. 1A.

      (5) I suggest labelling the "Y" axis in Fig. 1B as "Protein level (% of control)".

      Changed as suggested in Fig. 1C (previously Fig. 1B) and in Fig. 2C.

      (6) Line 179: since the authors tested here only about 10 mitochondrial proteins (out of 1500), I think that the word "many" should be replaced by "several representative" resulting in "steady state levels of several representative mitochondrial proteins".

      Changed as requested.

      (7) Line 208: correct typo.

      Typo was corrected.

      (8) Figure 4 is partially redundant as its data is part of Figure 3. The authors can consider combining these two figures. Accordingly, large parts of the legend of Figure 4 are repeating information in the legend to Figure 3 and can refer to it.

      We revamped Figures 3 and 4. Figure 3 now shows the analysis of fibroblasts proteomics while Figure 4 focuses on neurons proteomics. We also modified the legend of Figure 4.

      Reviewer #2 (Recommendations For The Authors):

      (1) Abstract: 'Strikingly, TIMM50 deficiency had no impact on the steady state levels of most of its substrates, challenging the currently accepted import dogma of the essential general import role of TIM23 and suggesting that fully functioning TIM23 complex is not essential for maintaining the steady state level of the majority of mitochondrial proteins'. This sentence needs to be rephrased. The data do not challenge any dogma! The authors only show that lower levels of functional TIM23 are sufficient.

      We have rewritten all the relevant sentences as suggested (details are also mentioned in response to reviewer 2 public review point 1)

      (2) Introduction: 'Surprisingly, functional and physiological analysis points to the possibility that TIMM50 and a fully functional TIM23 complex are not essential for maintaining steady-state levels of most presequence-containing proteins'. This again needs to be rephrased.

      Rewritten as suggested (details mentioned in response to reviewer 2 public review point 1)

      (3) Discussion: 'In summary, our results challenge the main dogma that TIMM50 is essential for maintaining the mitochondrial matrix and inner membrane proteome, as steady state level of most mitochondrial matrix and inner membrane proteins did not change in either patient fibroblasts or mouse neurons following a significant decrease in TIMM50 levels.' This again needs to be rephrased.

      Rewritten as suggested (details mentioned in response to reviewer 2 public review point 1)

      (4) The analysis of the proteomics experiment should be improved. The authors show in Figures 3 and 4 several times the same volcano plots in which different groups of proteins are indicated. It would be good to add (a) a principal component analysis to show that the replicates from the mutant samples are consistently different from the controls, (b) a correlation plot that compares the log-fold-change of P1 to that of P2 to show which of the proteins are consistently changed in P1 and P2 and (c) a GO term analysis to show in an unbiased way whether mitochondrial proteins are particular affected upon TIMM50 depletion.

      Figures 3 and 4 have been changed to avoid redundancy. Figure 3 now focuses on fibroblasts proteomics (with additional analysis), while Figure 4 focuses on neurons proteomics. PCA analysis was added in Fig S1, showing that the proteomics replicates of both patients (P1 and P2) are consistently different than the healthy control (HC) replicates. Correlation plots were added in Figure 3C and D, showing high correlation of the downregulated and upregulated mitochondrial proteins between P1 and P2. These plots further highlight that MIM proteins are more affected than matrix proteins and that the OXPHOS and MRP systems comprise the majority of significantly downregulated proteins in both patients. GO term analysis was performed for all the detected proteins that got significantly downregulated in both patients. The GO term analysis is displayed in Figure S3A, and shows that mitochondrial proteins, mainly of the OXPHOS and MRP machineries, are particularly affected.

      (5) Figure 1. The figure shows the levels of TIM and TOM subunits in two mutant samples. The quantifications suggest that the levels of TIMM21, TOMM40, and mtHsp60 are not affected. However, from the figure, it seems that there are increased levels of TIMM21 and reduced levels of TOMM40 and mtHsp60. Unfortunately, in the figure most of the signals are overexposed. Since this is a central element of the study, it would be good to load dilutions of the samples to make sure that the signals are indeed in the linear range and do scale with the amounts of samples loaded.

      The representative WB panels display the Actin loading control of the representative TIMM50 repeat (the top panel). However, each protein was tested separately, at least three times, and was normalized to its own Actin loading control.

      (6) Figure 2B. All panels are shown in color except the panel for TIMM17B which is grayscale. This should be changed to make them look equal.

      All the western blot panels were changed to grayscale.

      (7) Discussion: 'Despite being involved in the import of the majority of the mitochondrial proteome, no study thus far characterized the effects of TIMM50 deficiency on the entire mitochondrial proteome.' This sentence is not correct as proteomic data were published previously, for example for Trypanosomes (PMID: 34517757) and human cells (PMID: 38828998).

      We have corrected the statement to “Despite being involved in the import of the majority of the mitochondrial proteome, little is known about the effects of TIMM50 deficiency on the entire mitochondrial proteome.”

      (8) A recent study on a very similar topic was published by Diana Stojanovki's group that needs to be cited: PMID: 38828998. The results of this comprehensive study also need to be discussed!!!

      We have added the following in the discussion:

      Line 362 – “These observations are similar to the recent analysis of patient-derived fibroblasts which demonstrated that TIMM50 mutations lead to severe deficiency in the level of TIMM50 protein (6,7). Notably, this decrease in TIMM50 was accompanied with a decrease in the level of other two core subunits, TIMM23 and TIMM17. However, unexpectedly, proteomics analysis in our study and that conducted by Crameri et al., 2024 indicate that steady state levels of most TIM23-dependent proteins are not affected despite a drastic decrease in the levels of the TIM23CORE complex (7). The most affected proteins constitute of intricate complexes, such as OXPHOS and MRP machineries. Thus, both these studies indicate a surprising possibility that even reduced levels of the TIM23CORE components are sufficient for maintaining the steady state levels of most presequence containing substrates.

      (1) Homberg B, Rehling P, Cruz-Zaragoza LD. The multifaceted mitochondrial OXA insertase. Trends Cell Biol. 2023;33(9):765–72.

      (2) Carroll J, Altman MC, Fearnley IM, Walker JE. Identification of membrane proteins by tandem mass spectrometry of protein ions. Proc Natl Acad Sci U S A. 2007;104(36):14330–5.

      (3) Ting SY, Schilke BA, Hayashi M, Craig EA. Architecture of the TIM23 inner mitochondrial translocon and interactions with the matrix import motor. J Biol Chem [Internet]. 2014;289(41):28689–96. Available from: http://dx.doi.org/10.1074/jbc.M114.588152

      (4) Trefts E, Shaw RJ. AMPK: restoring metabolic homeostasis over space and time. Mol Cell [Internet]. 2021;81(18):3677–90. Available from: https://doi.org/10.1016/j.molcel.2021.08.015

      (5) Zhang S, Hulver MW, McMillan RP, Cline MA, Gilbert ER. The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility. Nutr Metab. 2014;11(1):1–9.

      (6) Reyes A, Melchionda L, Burlina A, Robinson AJ, Ghezzi D, Zeviani M.  Mutations in TIMM50 compromise cell survival in OxPhos‐dependent metabolic conditions . EMBO Mol Med. 2018;

      (7) Crameri JJ, Palmer CS, Stait T, Jackson TD, Lynch M, Sinclair A, et al. Reduced Protein Import via TIM23 SORT Drives Disease Pathology in TIMM50-Associated Mitochondrial Disease. Mol Cell Biol [Internet]. 2024;0(0):1–19. Available from: https://doi.org/10.1080/10985549.2024.2353652

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public Review):  

      Summary:

      In this study, Setogawa et al. employ an auditory discrimination task in freely moving rats, coupled with small animal imaging, electrophysiological recordings, and pharmacological inhibition/lesioning experiments to better understand the role of two striatal subregions: the anterior Dorsal Lateral Striatum (aDLS) and the posterior Ventrolateral Striatum (pVLS), during auditory discrimination learning. Attempting to better understand the contribution of different striatal subregions to sensory discrimination learning strikes me as a highly relevant and timely question, and the data presented in this study are certainly of major interest to the field. The authors have set up a robust behavioral task and systematically tackled the question about a striatal role in learning with multiple observational and manipulative techniques. Additionally, the structured approach the authors take by using neuroimaging to inform their pharmacological manipulation experiments and electrophysiological recordings is a strength.

      However, the results as they are currently presented are not easy to follow and could use some restructuring, especially the electrophysiology. Also, the main conclusion that the authors draw from the data, that aDLS and pVLS contribute to different phases of discrimination learning and influence the animal's response strategy in different ways, is not strongly supported by the data and deserves some additional caveats and limitations of the study in the discussion. 

      We appreciate the reviewer’s valuable feedback, which has been beneficial for improvement of our manuscript. In response to the reviewer’s comments, we have revised multiple parts of the manuscript, including explanations of electrophysiological data. We have also provided additional data to support our main conclusion and addressed caveats and limitations related to the data in the Discussion section. For more details, please refer to the responses to each comment.

      Comment 1: The authors have rigorously used PET neuroimaging, which is an interesting noninvasive method to track brain activity during behavioral states. However, in the case of a freely moving behavior where the scans are performed ~30 minutes after the behavioral task, it is unclear what conclusions can be drawn about task-specific brain activity. The study hinges on the neuroimaging findings that both areas of the lateral striatum (aDLS and pVLS) show increased activity during acquisition, but the DMS shows a reduction in activity during the late stages of behavior, and some of these findings are later validated with complementary experiments. However, the limitations of this technique can be further elaborated on in the discussion and the conclusions.

      As described in our response to the following two comments (a, b) from the reviewer, in the PET imaging study we first analyzed task-related activity by comparing <sup>18</sup>F-FDG uptake on different days of the auditory discrimination task with that on Day 4 of the single lever press task as a control. Next, we analyzed learning-dependent activity by comparing the uptake on different days of the discrimination task with that on Day 2 of the same task. Based on the results of both analyses, we concluded that the activity in the striatal subregions changes during the progress of discrimination learning. The behavioral significance of striatal subregions was tested by excitotoxic lesion and pharmacological blockade experiments. The explanation of imaging data analysis may have been insufficient to fully communicate dynamic changes in the activity of striatal subregions. Therefore, we have clarified our voxel-based statistical parametric analysis method to better explain the dynamic activity changes in the striatal subregions. Please refer to the following responses to comments 1 (a, b).

      Comment 1 (a): In commenting on the unilateral shifts in brain striatal activity during behavior, the authors use the single lever task as a control, where many variables affecting neuronal activity might be different than in the discriminatory task. The study might be better served using Day 2 measurements as a control against which to compare activity of all other sessions since the task structures are similar.

      We initially analyzed task-related activity by comparing <sup>18</sup>F-FDG uptake on one of Days 2, 6, 10, or 24 of auditory discrimination task with that on Day 4 of the single lever press task. This task was used as a control that does not require a decision process based on the auditory stimulus. We observed significant increases in the activity of the unilateral aDLS on Day 6 and in that of the bilateral pVLS on Day 10 of the discrimination task. We also observed a significant decrease in the unilateral DMS on Day 24 (see Figures 2F and 2G). Next, as suggested, we compared the uptake on one of Days 6, 10, or 24 with that on Day 2 as a control to evaluate learning-dependent activity. The activity showed significant increases in the bilateral aDLS on Day 6 and in the unilateral pVLS on Day 10, and a significant decrease in the bilateral DMS on Day 24 (see Figures 2H). 

      The reviewer has suggested a discrepancy in the activity of the unilateral or bilateral striatal subregions under certain conditions between the image data (shown in Figures 2F–H) and plot data (Figures 2J–L). This discrepancy is also suggested in the following Comment 1 (b). For example, in the image data the brain activity was increased in the unilateral (left) aDLS on Day 6 of the discrimination task as compared to Day 4 of the single lever task (Figure 2F). In the plot data, <sup>18</sup>F-FDG uptake reached a peak on Day 6 in both the left and right sides of the aDLS (Figure 2J), and the uptake in the left aDLS on Day 6 significantly increased relative to the value of the single lever press, whereas the value in the right aDLS on Day 6 tended to increase relative to that of the single lever press with no significant difference. The plot data showing the unilaterality in the aDLS activation relative to the single lever press are consistent with the image data. On the other hand, the <sup>18</sup>F-FDG uptake in the aDLS on Day 6 compared to the value on Day 2 was significantly increased in both sides. Similar observations were made in the activity in the pVLS on Day 10 compared to that on Day 2, as well as in the DMS activity on Day 24 relative to that of the single lever press. 

      Our analysis of both task-related and learning-dependent activities revealed dynamic changes in striatal subregions during discrimination learning. We investigated the brain regions in which <sup>18</sup>F-FDG uptake significantly increased or decreased during the learning processes, applying a statistical significance threshold (p < 0.001, uncorrected) and an extent threshold, by using a voxel-based statistical parametric analysis. In the image data, the voxels showing significant differences between two conditions are visualized on the brain template. The plot data show the amount of <sup>18</sup>FFDG uptake in the voxels, which was detected by the voxel-based analysis. The insufficient explanation of the data analysis of PET imaging in the initial manuscript may have led to a misunderstanding regarding the activity in the unilateral or bilateral striatal subregions. Therefore, we have revised the explanation for voxel-based statistical parametric analysis, adding a more detailed description of the thresholds in the text (page 7, lines 143–145) and Methods (page 27, lines 672–675).

      Comment 1 (b): From the plots in J, K, and L, it seems that shifts in activity in the different substructures are not unilateral but consistently bilateral, in contrast to what is mentioned in the text. Possibly the text reflects comparisons to the single lever task, and here again, I would emphasize comparing within the same task.

      Please see our response to the first comment (a) regarding our explanation of the consistency in the activity of the unilateral or bilateral striatal subregions between the image and plot data. We have also revised the explanation in the corresponding sections of the manuscript, as described above.

      Comment 2: In Figure 2, the authors present compelling data that chronic excitotoxic lesions with ibotenic acid in the aDLS, pVLS, and DMS produce differential effects on discrimination learning. However, the significant reduction in success rate of performance happens as early as Day 6 in both IBO groups in both aDLS and pVLS mice. This would seem to agree with conclusions drawn about the role of aDLS in the middle stages of learning in Figure 2, but not the pVLS, which only shows an increased activity during the late stages of the behavior.  

      Figure 3 shows the behavioral effects of ibotenic acid injections into striatal subregions in rats. For the aDLS injection, we performed two-way repeated ANOVA, which revealed a significant main effect of group or day and a significant interaction of group × day, and added the simple main effects between the treatments to the figure (Figure 3G). We observed significant differences in the success rate mainly at the middle stage of learning. In contrast, for the pVLS injection there was no significant interaction for group × day, although the main effects of group or day was significant by two-way repeated ANOVA (Figure 3H). Consequently, it was unclear as to when exactly the significant reduction occurred. These results indicate that the aDLS and pVLS are necessary for the acquisition of auditory discrimination, and that the aDLS is mainly required for the middle stage. Similar results were observed in the win-shift-win strategy in the aDLS and pVLS (Figures 3J and 3K).

      Next, we performed temporal inhibition of neuronal activity in striatal subregions by muscimol treatment in order to examine whether the activity in the subregions is linked with learning processes at different stages. In this experiment, muscimol was injected into the aDLS or pVLS at the middle or late stage, and the resultant effects on the success rate were investigated. The success rate in the muscimol-injected groups into the aDLS significantly decreased at the middle stage, but not at the early and late stages (Figure 4C). In contrast, the rate in the muscimol groups into the pVLS significantly decreased at the late stage, but not at the early or middle stages (Figure 4D). The results indicate that the aDLS and pVLS are mainly involved in the processes at the middle and late stages, respectively, and support the PET imaging data showing the activation of two striatal subregions at the various stages.

      We have now provided the results of simple main effects analysis for the aDLS lesion (Figures 3G and 3J) and revised the description of the Results section (page 8, lines 174–178, page 8, lines 186–188, and page 9, line 205-206) and Figure legend (page 44, lines 1000‒1003, and page 44, lines 1010–1013). We have also added the results of simple main effects analysis in Figure 3J.

      Comment 3: In Figure 4, the authors show interesting data with transient inactivation of subregions of the striatum with muscimol, validating their findings that the aDLS mediates the middle and the pVLS the late stages of learning, and the function of each area serves different strategies. However, the inference that aDLS inactivation suppresses the WSW strategy "moderately" is not reflected in the formal statistical value p=0.06. While there still may be a subtle effect, the authors would need to revise their conclusions appropriately to reflect the data. In addition, the authors could try a direct comparison between the success rate during muscimol inhibition in the mid-learning session between the aDLS and pVLS-treated groups in Figure 4C (middle) and 4D (middle). If this comparison is not significant, the authors should be careful to claim that inhibition of these two areas differentially affects behavior.

      In Figure 4E, aDLS inhibition showed a tendency to reduce slightly win-shift-win strategy at the middle stage (t[14] = 2.038, p = 0.061, unpaired Student’s t-test). In accordance with the reviewer’s comment, we changed the word “moderate” to “subtle” (page 12, line 272).

      In the temporal inhibition of the striatal subregions, the aDLS and pVLS experiments (panels C and D, respectively) were conducted separately. Since it is difficult to directly compare the data obtained from different experiments, we did not carry out a direct comparison of the success rate between the aDLS and pVLS injections. 

      Comment 4: The authors have used in vivo electrophysiological techniques to systematically investigate the roles of the aDLS and the pVLS in discriminatory learning, and have done a thorough analysis of responses with each phase of behavior over the course of learning. This is a commendable and extremely informative dataset and is a strength of the study. However, the result could be better organized following the sequence of events of the behavioral task to give the reader an easier structure to follow. Ideally, this would involve an individual figure to compare the responses in both areas to Cue, Lever Press, Reward Sound, and First Lick (in this order).

      We first showed changes in the proportion of event-related neurons during the acquisition phase (Figure S5). Next, we conducted a detailed analysis of the characteristics of aDLS and pVLS neuronal activity. Specifically, we found several types of event-related neurons, including: (1) reward sound-related neurons representing behavioral outcomes in the aDLS; (2) first licking-related neurons showing sustained activity after the reward in the aDLS and pVLS; and (3) cue-onset and cue-response neurons associated with the beginning and ending of a behavior in the pVLS.

      Descriptions of the characteristics of event-related neurons according to the sequence of events in a trial, as the reviewer has suggested, is another way to provide an easy structure for understandings on the electrophysiological data. However, we focused on the characteristics of aDLS neurons at the middle stage and pVLS neurons at the late stage of discrimination learning. Therefore, we explained the electrophysiological data based on the order of learning stages rather than the sequence of events in the trial, as described above.

      Comment 5: An important conceptual point presented in the study is that the aDLS neurons, with learning, show a reduction in firing rates and responsiveness to the first lick as well as the behavioral outcome, and don't play a role in other task-related events such as cue onset. However, the neuroimaging data in Figure 2 seems to suggest a transient enhancement of aDLS activity in the mid-stage of discriminatory learning, that is not reflected in the electrophysiology data. Is there an explanation for this difference?

      In the <sup>18</sup>F-FDG PET imaging study, the brain activity in the aDLS reached a peak at the middle stage of the acquisition phase of auditory discrimination (Figure 2J). In the multi-unit electrophysiological recording experiment, the firing activity of the aDLS neuron subpopulations related to the behavioral outcome showed no significant differences among the three stages (Figure 5E), while the proportion of these subpopulations were gradually reduced through the progress of learning stages (Figure 5F). The extent of the firing activity and length of the firing period of other subpopulations showing sustained activation after the reward appeared to show a learning-dependent decrease (Figures 6B and 6C), although the proportion of these subpopulations indicated no correlation with the progress of the learning (Figure 6D). Patterns of the temporal changes in brain activity in striatal subregions across the learning stages did not match completely the time variation in the property or proportion of specific event-related neurons. In our electrophysiological analysis, we identified well-isolated neurons from the striatal subregions during the auditory discrimination task, focusing on putative medium spiny neurons (Figures S4E–S4G). Based on the combinatorial pattern of the tone instruction cue (high tone/H or low tone /L), and lever press (right/R or left/L), we categorized the electrophysiological data into the four trials, including the HR, LL. LR, and HL. We identified HR or LL type neurons showing significant changes in the firing rate related to specific events, such as cue onset, choice response, reward sound, and first licking compared to the baseline firing rate. These neurons were further divided into two groups with increased or decreased activity relative to the baseline firing (Figures S5A and S5B). In the present study, we focused on event-related neurons with increased activity. Because of the analysis limited to neuronal subpopulations related to specific events with the increased activity, it is difficult to fully explain dynamic shifts in the brain activity of striatal subregions dependent on the progress of learning by the time variation of firing activity of individual event-related neurons. The activity of other subpopulations in the striatum may be involved in the shift in brain activity during the learning processes. In addition, recent studies have reported that the activity of glial cells influences the uptake of <sup>18</sup>FFDG (Zimmer et al., Nat Neurosci., 2017) and that these cells regulate spike timingdependent plasticity (Valtcheva and Venance, Nat Commun, 2016). Changes in glial cellular activity, through the control of synaptic plasticity, may partly contribute to the pattern formation of learning-dependent shifts in brain activity.

      To explain the difference in the time course between the brain activity and the firing activity of specific event-related neurons, we have added the aforementioned information to the Limitations section (pages 21 to 22, lines 512–539). 

      Comment 6: A significant finding of the study is that CO-HR and CO-LL responses are strikingly obvious in the pVLS, but not in the aDLS, in line with the literature that the posterior (sensory) striatum processes sound. This study also shows that responses to the highfrequency tone indicating a correct right-lever choice increase with learning in contrast to the low-frequency tone responses. To further address whether this difference arises from the task contingency, and not from the frequency representation of the pVLS, an important control would be to switch the cue-response association in a separate group of mice, such that high-frequency tones require a left lever press and vice versa. This would also help tease apart task-evoked responses in the aDLS, as I am given to understand all the recording sites were in the left striatum.

      We did not conduct an experiment switching cue-response association in the auditory discrimination task. However, the transient activity of cue onset-related neurons in the pVLS, as the reviewer has suggested, did not appear at the early stage of learning, but was observed in a learning-dependent manner (Figures 7A and S8E). In addition, the cue onset-HR activity showed a slight but notable difference between the HR and LL trials at the middle and late stages (Figure 7B), but there was no difference in activity in the HL and LR incorrect trials at the corresponding stages (Wilcoxon signed rank test; early, p = 0.375, middle, p = 0.931, and late, p = 0.668). These results suggest that the activity of cue onset-related neurons in the pVLS is associated with the stimulus and response association (task contingency) rather than the tone frequency.

      Reviewer #1 (Recommendations For The Authors):

      Minor comment 1: The readability and appeal of this study would be improved by explaining the various neuronal response types, and task-related events in slightly more detail in the results section, and minimizing the use of non-standard abbreviations wherever possible.

      As suggested, we have replaced the abbreviations related to electrophysiological events (CO, CR, RS, and FL) with the original terms, and improved the explanation for neuronal response types and event-related neurons. 

      Minor comment 2: It would be helpful to label DLS and VLS recordings more clearly on the figures instead of only in the figure caption.

      Thank you for pointing this out. The terms “aDLS” and “pVLS” have now been added to the panels showing firing pattern of neurons: “aDLS” in Figures 5D, 6A, S6A, S7A, S8A, S8B. S8C, and S8D; and “pVLS” in Figures 6F, 7A, 7D, S6D, S6E, S7F, S8E, and S8F.

      Minor comment 3: The authors suggest that aDLS HR- and LL- neurons are more sensitive to the behavioral outcome than those in pVLS (Fig 5 and S5). However, their conclusions are based on sample sizes as low as n=3 for each response type.

      We identified event-related neurons from single neurons detected in both the aDLS and pVLS using the same criteria. In the pVLS, we found a small number of neurons that increased their activity during the period when the reward sound is presented (Figures S6D and S6E) (6, 4, and 17 HR type neurons at the early, middle, and late stages, respectively; 3, 5, and 15 LL type neurons at the early, middle, and late stages, respectively). The number of LL type neurons at the early stage was particularly lower, as the reviewer has suggested. However, when we plotted the firing rates of these neurons around the event, their activity did not reflect behavioral outcome. In the aDLS, we detected a large number of reward sound-related neurons representing behavioral outcome (Figures 5 and S6A) (43, 37, and 44 HR type neurons at the early, middle, and late stages, respectively; 49, 62, and 59 LL type neurons at the early, middle, and late stages, respectively). These observations suggest that aDLS neurons are more sensitive to behavioral outcomes than pVLS neurons.

      Minor comment 4: Typo in Figure 4C and D, right plots, y-axis label: "subtracted".

      The typographic errors in Figures 4C–4H have now been corrected to “subtracted”.

      Reviewer #2 (Public Reviews):

      The study by Setogawa et al. aims to understand the role that different striatal subregions belonging to parallel brain circuits have in associative learning and discrimination learning (S-O-R and S-R tasks). Strengths of the study are the use of multiple methodologies to measure and manipulate brain activity in rats, from microPET imaging to excitotoxic lesions and multielectrode recordings across anterior dorsolateral (aDLS), posterior ventral lateral (pVLS)and dorsomedial (DMS) striatum. The main conclusions are that the aDLS promotes stimulus-response association and suppresses response-outcome associations. The pVLS is engaged in the formation and maintenance of the stimulus-response association. There is a lot of work done and some interesting findings however, the manuscript can be improved by clarifying the presentation and reasoning. The inclusion of important controls will enhance the rigor of the data interpretation and conclusions.

      We appreciate the reviewer’s valuable feedback, which has been beneficial in our endeavor to improve our manuscript. In response to the comments, we have revised the description of the experimental methods and underlying rationale, as well as the Results section. We have also provided additional data for some of the experiments that support the conclusions. For more details, please refer to the responses to each comment, included below.

      Reviewer #2 (Recommendations For The Authors):

      Comment 1: Generally, the manuscript is hard to read because of the cumbersome sentence structure, overuse of poorly defined acronyms, and lack of clarity on the methods used.

      According to the following comments (a)–(d), we have revised the corresponding text in the manuscript to clarify the sentence structure, definitions of terms, and methodology. 

      Comment 1 (a): For example, the single lever task used as a control for the auditory discrimination task could be introduced better, explaining the reasoning and the strategy for subtracting it from the images obtained during the discrimination phase at the start of the section.

      We analyzed task-related activity by comparing <sup>18</sup>F-FDG uptake on Days 2, 6, 10, or 24 of auditory discrimination task with that on Day 4 of the single lever press task. This task was used as a control that does not require a decision process based on the auditory stimulus. For clarification, we have provided a more detailed explanation of the flow of the single lever press task used in the PET experiment, including the rationale for employing this task as a control (page 6, lines 129–135). We have also revised the explanation of voxel-based statistical parametric analysis, adding a more detailed description of the thresholds (page 7, lines 143–145).

      Comment 1 (b): Another example is that important methodological information is buried deep in the text and complicates the interpretation of the results.

      We have revised the following sentences in the manuscript in order to provide clearer methodological information.

      (1) As described above, explanations for the single lever task (page 6, lines 129–135) and voxel-based statistical parametric analysis were added (page 7, lines 143–145). 

      (2) Definition of the early, middle, and late stages were described in the initial behavioral experiment (page 6, lines 113–119). 

      (3) Abbreviations related to behavioral strategies (WSW and LSL) and electrophysiological events (CO, CR, RS, and FL) were replaced with the original terms. 

      Comment 1 (c): The specie being studied is not stated in the abstract, nor the introduction, and only in the middle of the result section. Please include the specie in the abstract and the first part of the result also for clarity.

      We included the name of the species (rats) in the Abstract (page 3, line 47), at the end of the Introduction (page 5, lines 87–88) and at the beginning of the Results (page 5, line 109).

      Comment 1 (d): The last part of the intro is copied/pasted from the abstract. Please revise.

      The last part of the Introduction was revised accordingly (page 5, lines 97–104).

      Comment 2: The glucose microPET imaging is carried out 30 mins after the rats performed the task and it is expected to capture activation during the task. Is this correct? This assumption has to be validated with an experiment, which is a control showing a validation of the microPET approach used, and this way can report activation of brain areas during the task completed 20-30 minutes before. For example, V1 or A1 would be a control that we would expect to be activated during the task.

      Our PET experiment was conducted in accordance with previously established methods (Cui et al, Neuroimage, 2015), where rats received intravenous administration of <sup>18</sup>FFDG solution just before the start of the behavioral session, which lasted for 30 min. The <sup>18</sup>F-FDG uptake in the brain starts immediately and reaches the maximum level until 30 min after the administration, and the level is kept at least for 1 h (Mizuma et al., J Nucl Med, 2010). The rats were returned to their home cages, and a 30-min PET scan started 25 min after the session. The start time of the scan was chosen to allow for sufficient reduction of 18F radioactivity in arterial blood to increase the S/N ratio of the radioactivity (Mizuma et al., J Nucl Med, 2010). As shown in Table S1, we confirmed that the brain activity in the medial geniculate body (auditory thalamus) was increased on Days 6 and 10 in the acquisition phase, although the activity in the auditory cortex was not changed, which is consistent with the results of a previous study reporting that the auditory cortex does not show the causality for the pure-tone discrimination task (Gimenez et al., J Neurophysiol., 2015).

      Comment 3: Why are Days 2, 6, 10, and 13 chosen and compared for the behavior? Why aren't these the same days chosen in the other part of the study? It is unclear why authors focused on these days and why the focus changed later.

      We conducted daily training of the discrimination task. The success rate reached a plateau on Day 13 and was maintained until Day 24 (Figure 1B). Based on these results, we categorized the learning processes into the acquisition and learned phases, and then divided the acquisition phase into the early (< 60%), middle (60–80%), and late (> 80%) stages. In the PET experiment, we selected Days 2, 6, and 10 as the representatives of each stage during the acquisition phase. In addition, we also selected Day 24 for the learned phase.  However, no scan was performed on Day 13 due to the transition between the two phases.   

      Comment 4: (A) Is the learning and acquisition of the single lever press and discrimination task completed by day 4? Or are rats still learning? The authors claimed no changes in DMS activity between single lever press & discrimination, and therefore DMS isn't involved in learning. But to make this claim we should have measures that the learning has already happened, which I am not sure have been provided. (B) On this same point, the DMS activity is elevated on Day 4 of a single lever press compared to the aDLS and pVLS. So is it possible that the activity in DMS was already elevated on Day 4 of single lever press training? Especially given that DMS is supposedly involved in goal-directed behavior?

      (A) In the single lever press task, the number of lever presses plateaued on Day 2 (Figure 1C). In addition, we analyzed response time and its variability, which plateaued from Day 3 and Day 2, respectively (see Author response image 1). These results indicate that the learning in the task was completed by Day 4. In the auditory discrimination task, Day 4 corresponded to the transition period from the early-tomiddle stages of the acquisition phase, suggesting that learning was still progressing. 

      In the imaging analysis, we examined task-related activity by comparing <sup>18</sup>F-FDG uptake on either day of the discrimination task with that on Day 4 of the single lever press task, and did not find any changes in the brain activity in the DMS. In addition, we investigated learning-related activity, and the DMS activity did not change during acquisition phase. These results suggest that the DMS is not involved in the acquisition phase of learning. Furthermore, comparisons between Days 10 and Day 24 showed a decrease in DMS activity during the learned phase, suggesting that DMS activity was downregulated during the learned phase. In addition, chronic lesion in the DMS indicated that the success rate in the discrimination task was comparable between the control and lesioned groups (Figure 3I), whereas the response time lengthened throughout the learning in the lesioned group compared to the controls (Figure S1C). These results support our notion that the DMS contributes to the execution, but not learning, of discriminative behavior (Figure 3I and S1C).

      Author response image 1.

      Performance of single lever press task conducted before auditory discrimination task. (A) Number of lever presses. (B) Response time (Kruskal-Wallis test, χ<sup>2</sup> = 38.063, p = 2.7 × 10<sup>-8</sup>, post hoc Tukey–Kramer test, p = 0.047 for Day 1 vs. Day 2; p = 2.3 × 10<sup>-7</sup> for Day 1 vs. Day 3; and p = 4.0 × 10<sup>-6</sup> for Day 1 vs. Day 4; p = 0.019 for Day 2 vs. Day 3; p = 0.082 for Day 2 vs. Day 4; p = 0.951 for Day 3 vs. Day 4). (C) Response time variability (Kruskal-Wallis test, χ<sup>2</sup> = 28.929, p = 2.3 × <sup>-6</sup>, post hoc Tukey–Kramer test, p = 0.077 for Day 1 vs. Day 2; p = 5.7 × 10<sup>-6</sup> for Day 1 vs. Day 3; and p = 1.3 × 10<sup>-4</sup> for Day 1 vs. Day 4; p = 0.060 for Day 2 vs. Day 3; p = 0.253 for Day 2 vs. Day 4; p = 0.912 for Day 3 vs. Day 4). Data obtained from the task shown in Figure 2C are plotted as the median and quartiles with the maximal and minimal values. *p < 0.05, **p < 0.01, and ***p < 0.001.

      (B) We compared <sup>18</sup>F-FDG uptakes among striatal subregions on Day 4 of the single lever press task (334.8 ± 2.86, 299.0 ± 1.71, and 336.8 ± 2.18 for the aDLS, pVLS, and DMS, respectively; one-way ANOVA, F[2,41] = 104.767, p = 2.1 × 10<sup>-16</sup>). The uptake was comparable between the aDLS and DMS (post hoc Tukey-Kramer test, p = 0.058), but it was significantly lower in the pVLS compared to either of the other two subregions (post hoc Tukey-Kramer test, aDLS vs. pVLS, p = 5.1 × 10<sup>-9</sup>, post hoc Tukey-Kramer test, pVLS vs. DMS, p = 5.1 × 10<sup>-9</sup>). However, since we did not measure the brain activity in the single lever task outside of Day 4, it is unclear whether there was an increase in DMS activity during the acquisition of the task. Similarly, since we did not confirm the behavioral modes, which include goal-directed and habitual actions, it is difficult to conclude that the lever presses in the task were controlled by the goaldirected mode. However, our chronic lesion experiment suggests that the DMS is involved in the execution of discrimination behavior (Figure S1C). A clearer understanding of the DMS function in discrimination learning is an important challenge in the future.

      Comment 5: It seems like the procedure of microPET imaging affects performance on the task. The anesthesia used maybe? Figures 2C and D show evidence that the behavior was negatively affected on the days on which microPET imaging was performed after the training. Can the author clarify/comment?

      Isoflurane anesthesia may slightly reduce behavioral performance. We carried out anesthesia (median [interquartile range]: 6 [5–8] min) during the insertion of the catheter for FDG injection, and set a recovery period of at least 2 h until the beginning of the behavioral session, to minimize the impact of anesthesia. The performances in Figure 2E were similar to those in the intact rats (compared to Figures 1C–1F), suggesting that the procedure for PET scans does not affect the acquisition of discrimination. 

      We have added detailed information on the isoflurane anesthesia to the Methods section (page 26, lines 649–653).

      Comment 6: More on clarity. Section 3 of the results (muscimol inactivation) refers a lot to "the behavioral strategies" without really clarifying what these are - are they referring to WSW / LSL (which also could use a better introduction) or goal-directed/habitual or stimulus-response/stimulus-outcome?

      The dorsal striatum is involved in both behavioral strategies based on stimulus-response association and the response-outcome association during instrumental learning. To assess the impact of striatal lesions on the behavioral strategies, we analyzed the proportion of response attributed to two strategies in all responses of each session. One is the “win-shift-win” strategy, which is considered to reflect the behavioral strategy based on the stimulus-response association. In this strategy, after a correct response in the previous trial, the rats press the opposite lever in the current trial in response to a shift of the instruction cue, resulting in the correct response.  Another strategy is the “lose-shift-lose” strategy, which is considered to appear as a consequence of the behavioral strategy based on the response-outcome association. In this strategy, after an error response in the previous trial, the rats press the opposite lever in the current trial despite a shift of the instruction cue, leading to another error response.

      We have revised the explanations of the behavioral strategies in the section of the Results section (page 9, lines 192–201). 

      Comment 7: Related to WSW / LSL needing a better introduction, on lines 192/193 authors describe a result where they saw the WSW and LSL strategies increase and decrease, respectively, in saline-injected mice. Is the change in performance expected or an undesired effect of the saline injection? This is not clear now and it should be clarified.

      The explanations of the win-shift-win and lose-shift-lose strategies have been revised in the Results section on excitotoxic lesion experiment (page 9, lines 192–201) as described in our response to Comment 6. Win-shift-win is an indicator of correct responses, while lose-shift-lose indicates errors. Therefore, win-shift-win is predicted to increase, and lose-shift-lose decrease, as discrimination learning progresses. Indeed, in the results of the behavioral experiments, shown in Figure 1, both indicators change in a similar pattern to those in the results of the lesion experiments (Figure 3).

      We have added the explanation of the proportions of both strategies in intact rats (page 9, lines 203–204) with a supplementary figure (Figure S2) and accompanying legend (page 56, lines 1173–1177).

      Comment 8: Muscimol experiments - two questions/comments. How often do rats receive muscimol?

      In this section, muscimol is given on day 2 and on days after the animals hit a 60% or 80% success rate. Can the authors provide a mean and SEM for when are those injections?

      The first injection was conducted on Day 2 to target the early stage. The second and third injections were conducted on the days after the success rate had reached 60% and 80% for the first time through the training, respectively, to target the middle and late stage. respectively. These conditions are described in the Results (page 10, lines 234– 237) and Methods (page 26, lines 633–636). The mean and s.e.m. of the injection day at the middle and late stages were not significantly different between the saline and muscimol-injected groups into the aDLS (see Author response image 2A) and pVLS (see Author response image 2B).

      Author response image 2.

      Injection days during auditory discrimination learning. Injections with saline (SAL) and muscimol (MUS) into the aDLS (A) or pVLS (B) were performed after the success rate had reached 60% (middle stage) and 80% (late stage) for the first time through the training, respectively (A, Wilcoxon signed rank test, middle, Z = 65, p = 0.772, late, Z = 56.5, p = 0.242 for the aDLS; B, Wilcoxon signed rank test, middle, Z = 39, p = 1.000, late, Z = 43, p = 0.587). Data are indicated as the median and quartiles with the maximal and minimal values. 

      Comment 9: Muscimol experiments. Can the authors comment on the effects on performance vs learning? What happens on the days after Muscimol? Does performance bounce back or is it still impaired?

      We conducted a transient inhibition experiment with muscimol to examine whether the neuronal activity in the striatal subregions is linked with the processes at different stages. In this experiment, to lower the possibility that compensation of learning may occur during a session after the muscimol injection (Day N), we limited the session time to 15 min (45 trials) and evaluated the impact of the injection on the success rate at specific stages. The success rate in the muscimol-injected groups into the aDLS significantly decreased at the middle stage compared to the corresponding salineinjected groups, but not at the early and late stages (Figure 4C), and the rate in the muscimol groups into the pVLS significantly decreased at the late stage compared with the respective saline groups, but not at the early and middle stages (Figure 4D). Our results demonstrated that the aDLS and pVLS mainly function at the middle and late stages of the auditory discrimination task, respectively. 

      In addition, we here reply to comment 10 as for the comparison of success rates before (Day N-1) and after (Day N+1) the injections (see Author response image 3). We focused on two injections into the aDLS at the middle stage and into the pVLS at the late stage, in which the rate was reduced soon after the muscimol injection on Day N. The success rate for the two injections showed no significant main effect regarding group (saline/muscimol) or day (Days N-1/N+1) and no significant interactions for group × day. Moreover, the success rate was not significantly increased on Day N+1 as compared to Day N-1, even in the saline-injected control group, probably because of the limited session time soon after the injection. Therefore, we consider that it was difficult to define the effects of drug injection on the learning of auditory discrimination in our behavioral protocol for the transient inhibition experiment, and that the reduced rates observed in the muscimol-injected group on Day N mostly reflect the impacts of muscimol at least partly on the performance of discriminative behavior. 

      Author response image 3.

      Comparison of success rate between days before (Day N1) and after (Day N+1) the injections into striatal subregions. Success rate in the saline (SAL)- and muscimol (MUS)-injected groups into the aDLS (A) or pVLS (B) at the early, middle, and late stages of auditory discrimination learning (two-way repeated ANOVA; early, day, F[1,14] = 5.266, p = 0.038, group, F[1,14] = 0.276, p = 0.608, day × group, F[1,14] = 0.118, p = 0.736; middle, day, F[1,14] = 4.110, p = 0.062, group, F[1,14] = 0.056, p = 0.816, day × group, F[1,14] = 1.150, p = 0.302; late, day, F[1,14] = 6.408, p = 0.024, group, F[1,14] = 0.229, p = 0.640, day × group, F[1,14] = 1.277, p = 0.278 for the aDLS; and early, day, F[1,10] = 0.115, p = 0.746, group, F[1,10] = 2.414, p = 0.151, day × group, F[1,10] = 0.157, p = 0.700; middle, day, F[1,10] = 0.278, p = 0.610, group, F[1,10] = 0.511, p = 0.491, day × group, F[1,10] = 4.144, p = 0.069; late, day, F[1,10] = 0.151, p = 0.705, group, F[1,10] = 0.719, p = 0.416, day × group, F[1,10] = 0.717, p = 0.417 for the pVLS). Data are indicated as the mean ± s.e.m.

      Comment 10: Muscimol data has a pair before and after, can the authors show this comparison at early, middle, and late training? Not just the subtraction.

      The comparison of success rates before and after drug injection is shown in Author response image 3.

      Comment 11: Ephys recordings. These are complex figures and include a large number of acronyms. It would help to define them again and help the reader through these figures so the reader can focus on understanding the finding more than the figure presentation.

      We replaced the abbreviations related to electrophysiological events (CO, CR, RS, and FL) with the original terms, and improved the explanation in the text and figures. 

      Comment 12: Figure 7B/E - on correct trials, they see a difference in the cue response to high tone / low tone but no difference in the choice. This is the one that seemed like a topography issue.

      The transient activity of cue onset-related neurons in the pVLS did not appear at the early stage of learning, but was observed in a learning-dependent manner (Figures 7A and S8E). In addition, the cue onset-HR activity showed a slight but notable difference between the HR and LL trials at the middle and late stages (Figure 7B), whereas there was no difference between activities in the HL and LR incorrect trials at the corresponding stages (Wilcoxon signed rank test; early, p = 0.375, middle, p = 0.931, and late, p = 0.668). These results suggest that the cue onset-related neurons in the pVLS represents the stimulus and response association (task contingency) rather than the topography of tone frequency.

      Comment 13: Animals were normally trained for 60 minutes but on muscimol days only trained for 15 mins. On PET days only trained for 30 minutes. Ephys sessions were 60 mins. Is this correct? Why?

      We determined the session time for each experiment by considering both technical and behavioral aspects. In the initial behavioral experiment, the session time was set to 60 min per day. Under this condition, the rats acquired the discrimination learning within 13 days. In the imaging experiment, the session without a PET scan was conducted for 60 min, while the session with a PET scan was carried out for 30 min as described previously (Cui et al, Neuroimage, 2015). This time schedule produced a learning curve similar to that of the initial behavioral experiment. In the transient inhibition experiment, the sessions without drug injections lasted for 60 min. As described in our response to the comment 2, the time of the session soon after the injection was limited to 15 min to lower the possibility of compensation of learning during the session. In the chronic lesion and electrophysiological experiments, all sessions were conducted for 60 min, corresponding to the initial experiment. 

      References

      Mizuma, H., Shukuri, M., Hayashi, T., Watanabe, Y. & Onoe, H. Establishment of in vivo brain imaging method in conscious mice. Journal of Nuclear Medicine 51, 10681075 (2010).

      Cui, Y., et al. A voxel-based analysis of brain activity in high-order trigeminal pathway in the rat induced by cortical spreading depression. Neuroimage 108, 17-22 (2015).

      Zimmer, E.R., et al. [18 F] FDG PET signal is driven by astroglial glutamate transport. Nat Neurosci 20, 393-395 (2017).

      Valtcheva, S. & Venance, L. Astrocytes gate Hebbian synaptic plasticity in the striatum. Nature communications 7, 13845 (2016).

      Gimenez T.L., Lorenc M., Jaramillo S. Adaptive categorization of sound frequency does not require the auditory cortex in rats. J Neurophysiol 114:1137-1145 (2015).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Recommendations for the authors

      Reviewer #1 (Recommendations For The Authors):

      Below I summarize points that should be addressed in a revised version of the manuscript.

      • Page 6, first paragraph: I don't understand by the signals average out to a single state. If the distribution is indeed randomly distributed, a broad signal with low intensity should be present.

      We agree that this statement may cause confusion. We changed the text (marked in bold) to clarify the statement: The mobility of the undocked SBDs will be higher than the diffusion of the whole complex, allowing the sampling of varying interdomain distances within a single burst. However, these dynamic variations are subsequently averaged to a singular FRET value during FRET calculations for each burst, and may appear as a single low FRET state in the histograms.

      • Page 6, third paragraph: how can the donor only be detected in the acceptor channel? Is this tailing out?

      Donor only signal is not detected in the acceptor channel. As described in page 5 and in the Materials & Methods section, the dye stoichiometry value is defined for each burst/dwell using three types of photon counts: donor-based donor emission (FDD), donor-based acceptor emission (FDA) and acceptorbased acceptor emission (FAA).

      When no acceptor fluorophore is present FAA=0 and S=1.

      Some donor photons bleed through into the acceptor channel, but we correct for this by calculating the leakage and crosstalk factors as described in the Materials and Methods (page 20).

      We changed the text (marked in bold) in the manuscript to address the question: The FRET data of both OpuA variants is best explained by a four-state model (Figure 2A,B; fourth and fifth panel) (Supplementary File 3). Two of the four states represent donor-only (S≈1) or acceptor-only (S≈0) dwells. The full bursts belonging to donor-only and acceptor-only molecules were excluded prior to mpH2MM. This means that some molecules transit to a donor-only or acceptor-only state within the burst period, which most likely reflects blinking or bleaching of one of the fluorophores. These donoronly and acceptor-only states were also excluded during further analysis. The other two states reflect genuine FRET dwells that were analyzed by mpH2MM. They represent different conformations of the SBDs.

      • Page 7, "SBD dynamics ..": why was the V149Q mutant only analyzed in the K521C background and not also in the N414C background?

      The two FRET states were best distinguished in OpuA-K521C. Therefore, we decided to focus on OpuA-K521C and not OpuA-N414C. OpuA-V149Q was used to show that reduced docking efficiency does not affect the transition rate constants and relative abundances of the two FRET states, and we regarded it sufficient to test the SBD dynamics in OpuA-K521C only.

      • Page 8, second paragraph: why was the N414C mutant analyzed only from 0 - 600 mM and not also up to 1000 mM?

      In line with the previous answer, our main focus was on OpuA-K521C, since the two FRET states were best distinguished in OpuA-K521C. OpuA-N414C was used to prove that similar states are observed when measuring with fluorophores on the opposite site of the SBD. We studied how the FRET states change in response to different conditions that correspond to different stages of the transport cycle and how it changes in response to different ionic strengths. Initially, 600 mM KCl was used to study the dynamics of the SBD at high ionic strength. Later in this study, we tested a very wide range of different salt concentrations for OpuA-K521C to get detailed insights into the dynamics of the SBDs over a wide ionic strength range. Note that 1 M KCl is a very high, non-physiological ionic strength for the typical habitat of L. lactis and was only used to show that the high FRET state occurs even under very extreme conditions.

      • Page 8, third paragraph: why was the dimer (if it is the source of the FRET signal) only partially disrupted?

      We acknowledge that this is a very good point. However, we purposely did not speculate on this point in the manuscript, because we have limited information on the molecular details of the interaction. As we highlight on page 8, the SBDs experience each other in a very high apparent concentration (millimolar range). This means that the interactions are most likely very weak (low affinity) and not very specific. Such interactions are in the literature referred to as the quinary structure of proteins and they occur at the high macromolecular crowding in the cell and in proteins with tethered domains, and thus at high local concentrations. Such interactions can be screened by high ionic strength. In the revised manuscript, we now present the partially disrupted dimer structure in the context of the quinary structure of a protein (page 11):

      In other words, the high FRET state may comprise an ensemble of weakly interacting states rather than a singular stable conformation, resembling the quinary structure of proteins. The quinary structure of proteins is typically revealed in highly crowded cellular environments and describes the weak interactions between protein surfaces that contribute to their stability, function, and spatial organization (Guin & Gruebele, 2019). Despite the current study being conducted under dilute conditions, the local concentration of SBDs (~4 mM) mimics a densely populated environment and reveal quinary structure.

      • Page 9, second paragraph: according to the EM data processing, only 20% of the particles were used for 3D reconstruction. Why? Does it mean that the remaining 80% were physiologically not relevant? If so, why were the 20% used relevant?

      We note that it is a fundamental part of image processing of single particle cryo-EM data to remove false positives or low-resolution particles throughout the processing workflow. In particular when using a very low and therefore generous threshold during automated particle picking, as we did (t=0.01 and t=0.05 for the 50 mM KCl and 100 mM KCl datasets, respectively), the initial set of particles includes a significant amount of false positives – a tradeoff to avoid excluding particles belonging to low populated classes/orientations. It is thus common that more than 50% of ‘particles’ are excluded in the first rounds of 2D classification. In our case, only 30% and 52% of particles were retained after such first clean-up steps. Subsequently, the particle set is further refined, and additional false positives and low-resolution particles are excluded during extensive rounds of 3D classification. We also note that during the final steps, most of the data excluded represents particles of lower quality that do not contribute to a high-resolution, or belong to low population protein conformations. This does not mean that such a population is not physiological relevant. In conclusion, having only 5-20% of the initial automated picked particles contributing to the reconstruction of the final cryo-EM map is common, with the vast majority of excluded particles being false positives.

      • Page 11, third paragraph: the way the proposed model is selected is also my main criticism. All alternative models do not fit the data. Therefore, the proposed model is suggested. However, I do not grasp any direct support for this model. Either I missed it or it is not presented.

      Concerning the specific model in Figure 5, the reviewer is correct. We do not provide direct evidence for a side-ways interaction. However, we have evidence of transient interactions and our data rule out several scenarios of interaction, leaving 5C as the most likely model. This is also the main conclusion of this paper: In conclusion, the SBDs of OpuA transiently interact in a docking competent conformation, explaining the cooperativity between the SBDs during transport. The conformation of this interaction is not fixed but differs substantially between different conditions.

      Because the interaction is very short-lived it was not possible to visualize molecular details of this interaction. We present Figure 5 to hypothesize the most likely type of interaction, since many possibilities can be excluded with the vast amount of presented data. To make our point more clear that we discuss models and rule out several possibilities but not demonstrate a specific interaction between the SBDs, we now write on page 10 (changes marked in bold): We have shown that the SBDs of OpuA come close together in a short-lived state, which is responsive to the addition of glycine betaine (Figure 4A). Although the occurrence of the state varies between different conditions, it was not possible to negate the high-FRET state completely, not even under very high or low KCl concentrations, or in the presence of 50 mM arginine plus 50 mM glutamate (Figure 4A,B). To evaluate possible interdomain interactions scenarios we consider the following: (1) The SBDs of OpuA are connected to the TMDs with very short linkers of approximately 4 nm, which limit their movement and allow the receptor to sample a relatively small volume near its docking site. (2) in low ionic strength condition OpuA-K521C displays a high FRET state with mean FRET values of 0.7-0.8, which correspond to inter-dye distances of approximately 4 nm. (3) The high FRET state is responsive to glycine betaine, which points toward direct communication between the two SBDs. (4) The distance between the density centers of the SBDs in the cryo-EM reconstructions (based on particles with a low and high FRET state) is 6 nm, which aligns with the dimensions of an SBD (length: ~6 nm, maximal width: ~4 nm). These findings collectively indicate that two SBDs interact but not necessarily in a singular conformation but possibly as an ensemble of weakly interacting states. Hence, we discuss three possible SBD-SBD interaction models to explain the highFRET state:

      Reviewer #2 (Recommendations For The Authors):

      In the abstract and elsewhere the authors suggest that the SBDs physically interact with one another, and that this interaction is important for the transport mechanism, specifically for its cooperativity.

      I feel that this main claim is not well established. The authors convincingly demonstrate that the SBDs largely occupy two states relative to one another and that in one of these states, they are closer than in the other. Unless I have missed (or failed to understand) some major details of the results, I did not find any evidence of a physical interaction. Have the authors established that the high FRET state indeed corresponds to the physical engagement of the SBDs? I feel that a direct demonstration of an interaction is much missing.

      Along the same lines, in the low-salt cryo-EM structure, where the SBDs are relatively closer together, the SBDs are still separated and do not interact.

      See also our response to the final comment of reviewer 1. Furthermore, please carefully consider the following: (1) FRET values of 0.7-0.8 correspond to inter-dye distances of approximately 4 nm. (2) The high FRET state is responsive to glycine betaine, which points toward direct communication between the two SBDs. (3) The cryo-EM reconstruction is the average of all the particles in the final dataset, including both the particles with a low and high FRET state. Further, the local resolution of the SBDs in the cryo-EM map is low, indicative of high degree of flexibility. Thus, a potential interaction is possible within the observed range of flexibility. (4) The distance between the density centers is 6 nm, aligning with the dimensions of an SBD (length: 6 nm, maximal width: 4 nm). These factors collectively indicate SBD interactions, and we present these points now more explicitly in Figure 4 and the last part of the results section (page 9).

      Once the authors successfully demonstrate that direct physical interaction indeed occurs, they will need to provide data that places it in the context of the transport cycle. Do the SBDs swap ligand molecules between them? Do they bind the ligand and/or the transporter cooperatively? What is the role of this interaction?

      We acknowledge the intriguing nature of the posed questions, but they extend beyond the scope of this study. It is extremely challenging to obtain high-resolution structures of highly dynamic multidomain proteins, like OpuA, and to probe transient interactions as we do here for the SBDs of OpuA. We therefore combined cryo-TEM with smFRET studies and perform the most advanced and state-of-theart analysis tools as acknowledged by reviewer 1. We link our observations on the structural dynamics and interactions of the SBDs to a previous study, where we showed that the two SBDs of OpuA interact cooperatively. We do not have further evidence that connect the physical interactions to the transport cycle. In our view, the collective datasets indicate that the here reported physical interactions between the SBDs increase the transport efficiency.

      As far as I understand, the smFRET data have been interpreted on the basis of a negative observation, i.e., that it is "likely" that none of the FRET states corresponds to a docked SBD. To convincingly show this, a positive observation is required, i.e., observation of a docked state.

      The aim of this study was to study interdomain dynamics and not specifically docking. We have previously shown that docking can be visualized via cryo-EM (Sikkema et al., 2020), however the SBDs of OpuA appear to only dock in specific turnover conditions. We now show that the high FRET state of OpuA cannot represent a docked state, but that the SBDs transiently interact (see our response to the first comment). Importantly, a docked state was also not found in the cryo-EM reconstructions at low ionic strength, representing the smFRET conditions where we observe the interactions between the SBDs. The high FRET state occupies 30% of the dwells in this condition, and such a high percentage of molecules would have become apparent during cryo-EM 3D classification in case they would form a docked state. Therefore, we conclude that docking does not occur in low ionic strength apo condition. We discuss this point and our reasoning on page 11 of the revised manuscript.

      In this respect, I find it troubling that in none of the tested conditions, the authors observed a FRET state which corresponds to the docked state. Such a state, which must exist for transport to occur (as mentioned in the authors' previous publications), needs to be demonstrated. This brings me to my next question: why have the authors not measured FRET between the SBDs and the transporter? Isn't this a very important piece that is missing from their puzzle?

      We agree that investigating docking behavior under varied turnover conditions requires focused experiments on FRET dynamics between the SBDs and the transporter. As noted on page 5, OpuA exists as a homodimer, implying that a single cysteine mutation introduces two cysteines in a single functional transporter. To specifically implement a cysteine mutation in only one SBD and one transmembrane domain, it is necessary to artificially construct a heterodimer. We recently published initial attempts in this direction, and this will be a subject for future research but still requires years of work.

      Additionally, I feel that important controls are missing. For example, how will the data presented in Fig1 look if the transporter is labeled with acceptor or donor only? How do soluble SBDs behave?

      In the employed labeling method, donor and acceptor dyes are mixed in a 1:1 ratio and randomly attached to the two cysteines in the transporter. This automatically yields significant fractions of donor only and acceptor only transporters which are always present during the smFRET recordings. We can visualize those molecules on the basis of the dye stoichiometry, which we calculate by using three types of photon counts: donor-based donor emission (FDD), donor-based acceptor emission (FDA) and acceptorbased acceptor emission (FAA).

      Unfiltered plots look as follows (a dataset of OpuA-K521C at 600 mM KCl):

      Author response image 1.

      Donor only and acceptor only molecules have a very well discernible stoichiometry of 1 and 0, respectively. The filtering procedure is described in the materials and methods section, and these plots can be found in the supplementary database. We did not add them to the main text or supplementary materials of the original manuscript, as this is a very common procedure in the field of smFRET. We now include such a dataset in the revised manuscript.

      Soluble SBDs of OpuA have been studied previously (e.g. Wolters et al., 2010 & De Boer et al. 2019). For example, we have shown by SEC-MALLLS that soluble SBDs do not form dimers, which is consistent with our notion that the SBDs interact with low affinity. It is not possible to study interdomain dynamics between soluble SBDs by smFRET, because the measurements are carried out at picomolar concentrations (monomeric conditions). We emphasize that smFRET measurements with native complexes, with SBDs near each other at apparent millimolar concentrations, is physiologically more relevant.

      Additional comments:

      (1) "It could well be that cooperativity and transient interactions between SBDs is more common than previously anticipated" and a similar statement in the abstract. What evidence is there to suggest that the transient interactions between SBDs are a common phenomenon?

      On page 11, we write: Dimer formation of SBPs has been described for a variety of proteins from different structural clusters of substrate-binding proteins [33–38,51–53]. We cite 9 papers that report SBD/SBP dimers. This suggest to us that the phenomenon of interacting substrate-binding proteins could be more common. Moreover, the concentration of maltose-binding protein and other SBPs in the periplasm of Gram-negative bacteria can reach (sub)millimolar concentrations, and low-affinity interactions may play a role not only in membrane protein-tethered SBDs (like in OpuA) but also be important in soluble substrate-receptors. Such low-affinity interactions are rarely studied in biochemical experiments.

      (2) I think that the data presented in 1B-C better suits the supplementary information.

      Figure 1B-D is already a summary of the supplementary information that describes the optimization of OpuA purification. We think it is valuable to show this part of the figure in the main text. A very clean and highly pure OpuA sample is essential for smFRET experiments. Quality of protein preparations and data analysis are key for the type of measurements we report in this paper.

      (3) "the first peak in the SEC profile corresponds...." The peaks should be numbered in the figure to facilitate their identification.

      We have changed the figure as suggested.

      (4) "smFRET is a powerful tool for studying protein dynamics, but it has only been used for a handful of membrane proteins". With the growing list of membrane proteins studied by smFRET I find this an overstatement.

      We removed this sentence in the new version of the manuscript.

      (5) "We rationalized that docking of one SBD could induce a distance shift between the two SBDs in the FRET range of 3-10 nm (Figure 1E)" How and why was this assumed?

      We realize that this is one of the sentences that caused confusion about the aim of this study. In this part of the manuscript, we should not have used docking as an example and we apologize for that. We replaced the sentence by: These variants are used to study inter-SBD dynamics in the FRET range of 310 nm (Figure 1E).

      Also Figure 1E was adjusted to prevent confusion:

      Author response image 2.

      In addition, to avoid any confusion we changed the following sentence on page 4 (changes marked in bold): We designed cysteine mutations in the SBD of OpuA to study interdomain dynamics in the full length transporter.

      (6) "However, the FRET distributions are broader than would be expected from a single FRET state, especially for OpuA-K521C" Have the authors established how a single state FRET of OpuA looks? Is there a control that supports this claim?

      Below we compare two datasets from OpuA-K521C in 600 mM KCl with a typical smFRET dataset from the well-studied substrate-binding protein MBP from E. coli, which resides in a single state. Left: OpuA-K521C; Right: MBP

      Author response image 3.

      We agree that this cannot be assumed from the presented data. Therefore we rewrote this sentence: However, the FRET distributions tail towards higher FRET values, especially OpuA-K521C.

      (7) "V149Q was designed as a mild mutation that would reduce docking efficiency and thereby substrate loading, but leave the intrinsic transport and ATP hydrolysis efficiency intact." I find this statement confusing: How can a mutation reduce docking efficiency yet leave the transport activity unchanged?

      We rewrote the sentences (changes marked in bold): V149Q was designed as a mild mutation that would reduce docking efficiency and thereby substrate loading, but leave the ionic strength sensing in the NBD and the binding of glycine betaine and ATP intact. Accordingly, a reduced docking efficiency should result in a lower absolute glycine betaine-dependent ATPase activity. At the same time the responsiveness of the system to varying KCl, glycine betaine, or Mg-ATP concentrations should not change.

      (8) Along the same lines: "whereas the glycine betaine-, Mg-ATP-, or KCl-dependent activity profiles remain unchanged" vs. "OpuA-V149Q-K521C exhibited a 2- to 3-fold reduction in glycine betainedependent ATPase activity".

      See comment at point 7.

      (9) In general, I find the writing wanting at places, not on par with the high standards set by previous publications of this group.

      We recognize the potential ambiguity in our phrasing. We hope that after incorporating the feedback provided by the reviewers our manuscript will convey our findings in a clearer manner.

      Extra changes to the text:

      (1) Title changed: The substrate-binding domains of the osmoregulatory ABC importer OpuA physically transiently interact

      (2) Second part of the abstract changed: We now show, by means of solution-based single-molecule FRET and analysis with multi-parameter photon-by-photon hidden Markov modeling, that the SBDs transiently interact in an ionic strength-dependent manner. The smFRET data are in accordance with the apparent cooperativity in transport and supported by new cryo-EM data of OpuA. We propose that the physical interactions between SBDs and cooperativity in substrate delivery are part of the transport mechanism.

      (3) Page 6, third paragraph and Figure 2B: the wrong rate number was extracted from table 1. Changed this in the text and figure: 112 s-1  173 s-1. It did not affect any of the interpretations or conclusions.

      (4) Page 8, last paragraph, changed: smFRET was also performed in the absence of KCl and with a saturating concentration of glycine betaine (100 µM). The mean FRET efficiency of the highFRET state of OpuA-K521C increased to 0.78, which corresponds to an inter-dye distance of about 4 nm. This indicates that the dyes at the two SBDs move very close towards each other (Figure 4A) (Table 1) (Supplementary File 34).

      (5) Page 9, second paragraph changed: Due to the inherent flexibility of the SBDs, with respect to both the MSP protein of the nanodisc and the TMDs of OpuA, their resolution is limited. Furthermore, the cryo-EM reconstructions average all the particles in the final dataset, including those with a low and high FRET state. Nevertheless, in both conditions, the densities that correspond to the SBDs can be observed in close proximity (Figure 4D). The distance between the density centers is 6 nm and align with the dimensions of an SBD, providing further evidence for physical interactions between the SBDs.

    1. Author Response

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The association of vitamin D supplementation in reducing Asthma risk is well studied, although the mechanistic basis for this remains unanswered. In the presented study, Kilic and co-authors aim to dissect the pathway of Vitamin D mediated amelioration of allergic airway inflammation. They use initial leads from bioinformatic approaches, which they then associate with results from a clinical trial (VDAART) and then validate them using experimental approaches in murine models. The authors identify a role of VDR in inducing the expression of the key regulator Ikzf3, which possibly suppresses the IL-2/STAT5 axis, consequently blunting the Th2 response and mitigating allergic airway inflammation.

      Strengths:

      The major strength of the paper lies in its interdisciplinary approach, right from hypothesis generation, and linkage with clinical data, as well as in the use of extensive ex vivo experiments and in vivo approaches using knock-out mice.

      The study presents some interesting findings including an inducible baseline absence/minimal expression of VDR in lymphocytes, which could have physiological implications and needs to be explored in future studies.

      Weaknesses:

      The core message of the study relies on the role of vitamin D and its receptor in suppressing the Th2 response. However, there is scope for further dissection of relevant pathophysiological parameters in the in vivo experiments, which would enable stronger translation to allergic airway diseases like Asthma.

      To a large extent, the authors have been successful in validating their results, although a few inferences could be reinforced with additional techniques, or emphasised in the discussion section (possibly utilising the ideas and speculative section offered by the journal).

      The study inferences also need to be read in the context of the different sub-phenotypes and endotypes of Asthma, where the Th2 response may not be predominant. Moreover, the authors have referenced vitamin D doses for the murine models from the VDAART trials and performed the experiments in the second generation of animals. While this is appreciated, the risk of hypervitaminosis-D cannot be ignored, in view of its lipid solubility. Possibly comparison and justification of the doses used in murine experiments from previous literature, as well as the incorporation of an emphasised discussion about the side effects and toxicity of Vitamin D, is an important aspect to consider.

      In no way do the above considerations undermine the importance of this elegant study which justifies trials for vitamin D supplementation and its effects on Asthma. The work possesses tremendous potential.

      We thank the reviewer for their careful assessment of our paper and helpful suggestions. Please find the point-by-point responses to the reviewer recommendations below.

      Reviewer #2 (Public Review):

      Summary:

      This study seeks to advance our knowledge of how vitamin D may be protective in allergic airway disease in both adult and neonatal mouse models. The rationale and starting point are important human clinical, genetic/bioinformatic data, with a proposed role for vitamin D regulation of 2 human chromosomal loci (Chr17q12-21.1 and Chr17q21.2) linked to the risk of immune-mediated/inflammatory disease. The authors have made significant contributions to this work specifically in airway disease/asthma. They link these data to propose a role for vitamin D in regulating IL-2 in Th2 cells implicating genes associated with these loci in this process.

      Strengths:

      Here the authors draw together evidence from multiple lines of investigation to propose that amongst murine CD4+ T cell populations, Th2 cells express high levels of VDR, and that vitamin D regulates many of the genes on the chromosomal loci identified to be of interest, in these cells. The bottom line is the proposal that vitamin D, via Ikfz3/Aiolos, suppresses IL-2 signalling and reduces IL-2 signalling in Th2 cells. This is a novel concept and whilst the availability of IL-2 and the control of IL-2 signalling is generally thought to play a role in the capacity of vitamin D to modulate both effector and especially regulatory T cell populations, this study provides new data.

      Weaknesses:

      Overall, this is a highly complicated paper with numerous strands of investigation, methodologies etc. It is not "easy" reading to follow the logic between each series of experiments and also frequently fine detail of many of the experimental systems used (too numerous to list), which will likely frustrate immunologists interested in this. There is already extensive scientific literature on many aspects of the work presented, much of which is not acknowledged and largely ignored. For example, reports on the effects of vitamin D on Th2 cells are highly contradictory, especially in vitro, even though most studies agree that in vivo effects are largely protective. Similarly, other reports on adult and neonatal models of vitamin D and modulation of allergic airway disease are not referenced. In summary, the data presentation is unwieldy, with numerous supplementary additions, which makes the data difficult to evaluate and the central message lost. Whilst there are novel data of interest to the vitamin D and wider community, this manuscript would benefit from editing to make it much more readily accessible to the reader.

      Wider impact: Strategies to target the IL-2 pathway have long been considered and there is a wealth of knowledge here in autoimmune disease, transplantation, GvHD etc - with some great messages pertinent to the current study. This includes the use of IL-2, including low dose IL-2 to boost Treg but not effector T cell populations, to engineered molecules to target IL-2/IL-2R.

      We thank the reviewer for their careful assessment of our paper and helpful suggestions. Please find the point-by-point responses to the reviewer recommendations below. In addition, we have revisited the Introduction and Discussion, added additional subsection headings, and provided additional schematics to make the general flow of the paper more accessible to a wider audience.

      Reviewer #1 (Recommendations For The Authors):

      There are certain aspects of the manuscript which could be revisited in order to provide more clarity to the reader. Some of these are:

      1. In vivo experiments : The major inference and its impact is derived from the effect of VDR on Ikzf3 expression, and consequently on the Th2 response. While the study employs both in vivo and ex vivo approaches to validate this claim, pathophysiological aspects could have been explored in more detail, by using cytokine panels, possibly techniques to measure airway resistance, as well as by reducing the variations in the sample sizes used in different groups. Similarly, certain inferences from ex vivo studies may be important to demonstrate in the in vivo setting as well. A justification for the incorporation of both Balb/c and C57 Bl6 mice for the experiments could also be incorporated in the manuscript.

      2. Certain sections, especially those connecting VDR, Ikzf1/3 and IL2/STAT axis seem associative. This is indicated by Figure 5 H as well, where the effects of calcitriol administration in KO cells indicate additional pathways at play, possibly through indirect effects. The use of additional techniques like ChIP, co-IP and establishing STAT induction/activation would probably strengthen the findings, alternatively, a clear distinction between the speculative and the definitive results could be made in the discussion section, as the journal encourages. Similar considerations could be made for VDR and Ikzf3.

      3. Role of other cells :

      a. While the investigators have explored the phenotype on other cell types like Th1 and Treg, at places there remains a lacuna. For instance, the absence of neutrophil fractions from the DLC-BAL, as well inconsistencies in the groups selected for comparison. For eg. in Figure 3 Supplementary Figure 2, the figure suggests IL13 expression in CD4+ cells, yet the text reads incubated Th2 cells. This could be made more lucid.

      b. In Figure 3 Supplementary Figure 1 there is a trend towards an increase in IL-10 levels, whereas in Supplementary Figure 2 there is a drop in the IL13 level in the VDR KO group, which has not been explained.

      c. While 17q loci form the predominant loci associated with Asthma, other loci important in Asthma on chromosomes 2,6,9, 22 could be discussed in the manuscript as well, even if they can't be explored in depth.

      1. Quantification of histology and confocal images could provide an objective assessment to the readers. Possibly incorporation of co-localisation panels for the IF images showing membrane/cytoplasmic/ nuclear localisation of the VDR under various conditions.

      2. Structure of the manuscript: At places the manuscript has a disrupted flow, as well as mislabelled figures (Figure 2SF1B is 1C, Fig 2c is 2b in the results, ). Flow gates can be arranged sequentially and consistent labelling of the gates and axis would ease interpretation. In some places sample sizes mentioned do not match the dot graphs in the figures (figure 3K-L). In the same figure and others (Figure 5 Supplementary Figure 2), a comparison of all groups would be beneficial. A restructuring of the results and corrections, could assist the reader. Also, a visualization of the VDAART analysis in the main figures, corroborating with the results sections would do justice to the interesting approach and findings. The clearances and approvals for the study also need to be incorporated into the manuscript. If possible, the incorporation of a schematic showing the proposed pathway for VDR-induced Ikzf3 and subsequent suppression of the genes present on Chr 17 loci to mitigate allergic airway inflammation would help.

      Reviewer #2 (Recommendations For The Authors):

      A few specific points: A number of immune concepts are studied without reference to the broader literature and the data presented data on occasion counter these earlier findings. Examples of this include:

      • Vitamin D can both enhance and inhibit IL-13 synthesis, demonstrated both in vitro and ex vivo, and these effects are clearly context-specific. I am not questioning the validity of the present experimental findings in this specific experimental model), but the experimental context - the problem is that this is not discussed.

      • Short-term bulk Th2 cultures are used with no indication of their enrichment for lineage-specific markers or cytokine - their conclusions might be enhanced by this. Data on genes/markers of interest could be further enhanced by showing FACS plots of co-expression e.g. Th2 genes e.g. IL-13/GATA3 with these other markers.

      • Are human Th2 enriched for VDR, since the backdrop to this study is human clinical and genetic data? For a study that has based its rationale on human clinical/genetic studies it would be great to confirm these findings in human Th2 cells.

      • The Discussion might comment on some of these wider issues.

      • Minor typos throughout, including in figure legends

      Reviewer #1

      1. The study inferences also need to be read in the context of the different sub-phenotypes and endotypes of Asthma, where the Th2 response may not be predominant.

      We agree that asthma has many sub-phenotypes and endotypes and that the Th2 response may not be predominant in all of them, but we focus here on the origins of the disease in the first few years of life and the genetic and molecular mechanisms associate with disease onset where the Th2 response is important.

      1. Moreover, the authors have referenced vitamin D doses for the murine models from the VDAART trials and performed the experiments in the second generation of animals. While this is appreciated, the risk of hypervitaminosis-D cannot be ignored, in view of its lipid solubility. Possibly comparison and justification of the doses used in murine experiments from previous literature, as well as the incorporation of an emphasized discussion about the side effects and toxicity of Vitamin D, is an important aspect to consider.

      We appreciate this comment from the reviewers allowing us to review vitamin D toxicity in more detail. Given the length of this review we did not include this in the manuscript discussion but provide it here.

      Vitamin D supplementation in humans is debated due to possibility of intoxication from overdose. Vitamin D intoxication is a rare medical condition associated with hypercalcemia, hyperphosphatemia, and suppressed parathyroid hormone level and is typically seen in patients who are receiving very high doses of vitamin D, ranging from 50,000 to 1 million IU/d for several months to years 1,2. Intoxication observed at lower doses might be attributable to rare genetic disorders 1. By far the bigger problem in humans is vitamin D deficiency; this is especially true in pregnant women where dosage requirements are high due to the needs of the fetus. It is estimated that virtually all pregnant women are vitamin D insufficient or deficient 3. VDAART has shown that vitamin D in a dose of 4400 IC given to pregnant women can prevent asthma in their offspring. There were no adverse side effects in the mother or the infant from this dose 4.

      In rodents, a few studies have reported vitamin D intoxication with very high vitamin D doses 5(PMID: 23405058: 50.000 IU/kg 120d -> toxicity in females). In contrast there are several studies using 2-2.5 times higher doses of vitamin D than we use here, that do not report adverse events in mouse models of disease 6,7. Our doses of vitamin D are identical to those used in VDAART and are lower than those used in any of these other rodent studies. In addition, while we did not specifically assess specific signs of vitamin D intoxication, we can exclude any impact on animal well-being, health, reproduction, and behavior throughout the study.

      1. The major inference and its impact are derived from the effect of VDR on Ikzf3 expression, and consequently on the Th2 response. While the study employs both in vivo and ex vivo approaches to validate this claim, pathophysiological aspects could have been explored in more detail, by using cytokine panels, possibly techniques to measure airway resistance, as well as by reducing the variations in the sample sizes used in different groups.

      We have added the following sentence to the discussion: “Additional cytokine measurements in the mice as well as measurement of airway resistance would have added to the pathophysiological data linking IKFZ3 expression to TH2 response.”

      1. Similarly, certain inferences from ex vivo studies may be important to demonstrate in the in vivo setting as well. A justification for the incorporation of both Balb/c and C57 Bl6 mice for the experiments could also be incorporated in the manuscript.

      We agree with the reviewers that ex vivo results may require in vivo confirmation. We have added a sentence explaining the rationale for use of both Balb/c and C57BL/6 mice in the results section “Vitamin D suppresses the activation of the IL-2/Stat5 pathway and cytokine production in Th2 cells”: “To ensure that the above findings were not restricted to the C57BL/6 mouse strain, the inverse experiment was performed in Balb/c mice. This mouse strain is commonly used for type 2 driven inflammation.”

      1. Certain sections, especially those connecting VDR, Ikzf1/3 and IL2/STAT axis seem associative. This is indicated by Figure 5 H as well, where the effects of calcitriol administration in KO cells indicate additional pathways at play, possibly through indirect effects.

      We appreciate this comment. The RNA-Seq results showed an over representation of the IL-2/STAT5 pathway in Vit-D deficient Th2 cells compared to those under Vitamin D supplementation. We further show the induction of IKZF3 expression with calcitriol stimulation. High IKZF3 expression is known to suppress IL-2 expression. Lack of IKZF3 diminishes the suppressive activity of calcitriol on IL-2 expression. However, as pointed out by the reviewer, Figure 5 H implicates additional pathways regulated by calcitriol for the suppression of IL-2 and we note that in the text.

      1. The use of additional techniques like ChIP, co-IP and establishing STAT induction/activation would probably strengthen the findings, alternatively, a clear distinction between the speculative and the definitive results could be made in the discussion section, as the journal encourages. Similar considerations could be made for VDR and Ikzf3.

      We have added the following sentence to the discussion. We have focused here on establishing the relationship between VDR binding and IKFZ3 activation or repression and subsequent ORMDL3 and Il2 activation. Additional use of ChIP or co-IP to establish STAT induction and activation would have been of potential value.

      1. Role of other cells: a. While the investigators have explored the phenotype on other cell types like Th1 and Treg, at places there remains a lacuna. For instance, the absence of neutrophil fractions from the DLC BAL, as well inconsistencies in the groups selected for comparison. For e.g., in Figure 3 Supplementary Figure 2, the figure suggests IL13 expression in CD4+ cells, yet the text reads incubated Th2 cells. This could be made more lucid.

      We appreciate this comment and would like to clarify. Neutrophil numbers were assessed in the presented in vivo models and showed no differences in neutrophil number due to genotype or vitamin D diet. We added the graphs to the supplement in Figure 3 - figure supplement 1A and Figure 5 - figure supplement 1B and refer to the figures in the main text. All in vivo data were analyzed by Mixed-effect ANOVA analysis or Two-way ANOVA test with Holm-Šidák’s post-hoc analysis (factors: genotype & exposure). To keep the plots clear, we incorporated only the statistic for the groups of interest.

      1. b) In Figure 3 Supplementary Figure 1 there is a trend towards an increase in IL-10 levels, whereas in Supplementary Figure 2 there is a drop in the IL13 level in the VDR KO group, which has not been explained.

      We apologize for any confusion. Figure 3 supplementary Figure 1 shows cytokine positive CD4+ T cells isolated from saline and HDM exposed mouse lungs. These data were analyzed with a Mixed-effect ANOVA analysis or Two-way ANOVA test with Holm-Šidák’s post-hoc analysis (factors: genotype & exposure) and were not found significant. Figure 3 supplementary Figure 2 shows IL-13 levels in the system of in vitro polarization of naïve CD4+ T cells into Th2 cells. The difference between this result and the findings in Figure 3H is the in vivo setting in which additional factors such as IL-4 can aggravate the immune response.

      1. c) While 17q loci form the predominant loci associated with Asthma, other loci important in Asthma on chromosomes 2,6,9, 22 could be discussed in the manuscript as well, even if they can't be explored in depth.

      This is an excellent comment. Our preliminary results confirm that three asthma susceptibility loci: 2q12.1 (IL1RL1), 6p21.32 (HLA-DQA1/B1/A2/B2) and 22q12.3 (IL2RB) each have VDR and IKZF3 binding sites either in enhancers predicted by GeneHancer to target these genes or within these genes themselves. In particular, we found (i) VDR binding sites within IL18RAP and in the enhancer region GH02J102301 targeting IL1RL1, and IKZF3 binding sites within IL1RL1; (ii) VDR binding sites in the enhancer regions GH06J032940 and GH06J031813 targeting HLA-DQA2, and IKZF3 binding sites within HLA-DQA1; (iii) VDR and IKZF3 binding sites within IL2RB. In contrast, the region 9p24.1 (IL33) has no documented VDR or IKZF3 binding sites within IL33 or in the promoter regions targeting IL33. Investigating these additional genetic loci further, using the integrative approach taken here with 17q12-21, is beyond the scope of this current manuscript but based on these preliminary results, would be a worthwhile scientific endeavor.

      1. Quantification of histology and confocal images could provide an objective assessment to the readers. Possibly incorporation of co-localisation panels for the IF images showing membrane/cytoplasmic/nuclear localisation of the VDR under various conditions.

      We agree that quantification of histology and confocal images could provide an overview of VDR expression in the lungs. Given the knowledge on VDR expression in a variety of cell types, including structural cells in the lungs and the focus of this manuscript on CD4+ T cells, we focused on determining VDR expression in CD4+ T cells isolated from saline and HDM exposed lungs in the mouse models studied (Figure 2 C; Fig. 2- figure supplement 1 B & C, Figure 3 C; Figure 5 - figure supplement 1) as well as in vitro (Figure 2 - figure supplement 2; Figure 5 - figure supplement 2).

      1. Structure of the manuscript: At places the manuscript has a disrupted flow, as well as mislabeled figures (Figure 2SF1B is 1C, Fig 2c is 2b in the results, ). Flow gates can be arranged sequentially and consistent labelling of the gates and axis would ease interpretation.

      We appreciate this comment and have corrected the mislabeled figures and tried to improve the flow.

      1. In some places sample sizes mentioned do not match the dot graphs in the figures (figure 3K-L). In the same figure and others (Figure 5 Supplementary Figure 2), a comparison of all groups would be beneficial.

      We appreciate this comment and have checked the sample sizes. Each of these experiments compared two groups and these two groups were compared statistically. We corrected the sample size for Figure 5 Supplementary Figure 2 C in the manuscript.

      1. A restructuring of the results and corrections, could assist the reader.

      We have restructured both the results and the discussion, incorporating the changes noted here in the response to the reviewers, to make the flow of the manuscript easier to read.

      1. Also, a visualization of the VDAART analysis in the main figures, corroborating with the results sections would do justice to the interesting approach and findings.

      We have now added the below schematic to Figure 1-figure supplement 1C to summarize the analyses conducted on the VDAART data.

      Author response image 1.

      1. The clearances and approvals for the study also need to be incorporated into the manuscript.

      These were in the checklist and have been moved to the main text of the manuscript.

      1. If possible, the incorporation of a schematic showing the proposed pathway for VDR induced Ikzf3 and subsequent suppression of the genes present on Chr 17 loci to mitigate allergic airway inflammation would help.

      We have a figure for this (below) that we have incorporated into the manuscript as Figure 5 - figure supplement 3:

      Author response image 2.

      Cartoon Summarizing Vitamin D molecular genetics at 17q12-21

      Reviewer #2

      1. A few specific points: A number of immune concepts are studied without reference to the broader literature and the data presented data on occasion counter these earlier findings. Examples of this include:

      a. Vitamin D can both enhance and inhibit IL-13 synthesis, demonstrated both in vitro and ex vivo, and these effects are clearly context-specific. I am not questioning the validity of the present experimental findings in this specific experimental model), but the experimental context - the problem is that this is not discussed.

      We thank the reviewer for this comment. We have now included a sentence in the discussion section mentioning the contradictory results. It reads as follows:

      “We acknowledge that the impact of vitamin D on Th2 biology is conflicting in the literature. While several groups report Th2 promoting activity, we, and others, show inhibition of type 2 cytokine production 8–11. These discrepancies could be due to the model system studied, e.g., PBMC and purified CD4+ T cells, or the dose of vitamin D or the mouse strain.”

      b. Short-term bulk Th2 cultures are used with no indication of their enrichment for lineage specific markers or cytokine – their conclusions might be enhanced by this. Data on genes/markers of interest could be further enhanced by showing FACS plots of co-expression e.g., Th2 genes e.g., IL-13/GATA3 with these other markers.

      We appreciate this comment. The in vitro culture system used for Th2 cell differentiation has been well described in the literature. As shown in Figure 3 - figure supplement 2; Figure 4 E and Figure 5 - figure supplement 2 D & E the lineage specific IL-13 cytokine levels are detectable at high levels.

      c. Are human Th2 cells enriched for VDR, since the backdrop to this study is human clinical and genetic data? For a study that has based its rationale on human clinical/genetic studies it would be great to confirm these findings in human Th2 cells.

      We appreciate this comment and are curious to explore this in future research. The VDAART trial is a double-blinded multicenter trial in which an immediate processing of the blood samples and an enrichment of different immune cell populations was not feasible. Other publicly available data sets report gene expression derived from mixed and peripheral (blood) cells and not local (lung) tissues. Published in vitro studies on human Th2 cells do not report VDR expression in comparison to other Th subsets, which would allow the assessment of enrichment.

      1. The Discussion might comment on some of these wider issues.

      We have rewritten the discussion to incorporate many of the issues raised in this review.

      1. Minor typos throughout, including in figure legends.

      We have edited all of the figure legends.

      References

      1. Holick, M. F. Vitamin D Is Not as Toxic as Was Once Thought: A Historical and an Up-to-Date Perspective. Mayo Clinic proceedings 90, 561–564; 10.1016/j.mayocp.2015.03.015 (2015).

      2. Hossein-nezhad, A. & Holick, M. F. Vitamin D for health: a global perspective. Mayo Clinic proceedings 88, 720–755; 10.1016/j.mayocp.2013.05.011 (2013).

      3. Hollis, B. W. & Wagner, C. L. New insights into the vitamin D requirements during pregnancy. Bone research 5, 17030; 10.1038/boneres.2017.30 (2017).

      4. Litonjua, A. A. et al. Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years: The VDAART Randomized Clinical Trial. JAMA 315, 362–370; 10.1001/jama.2015.18589 (2016).

      5. Gianforcaro, A., Solomon, J. A. & Hamadeh, M. J. Vitamin D(3) at 50x AI attenuates the decline in paw grip endurance, but not disease outcomes, in the G93A mouse model of ALS, and is toxic in females. PloS one 8, e30243; 10.1371/journal.pone.0030243 (2013).

      6. Landel, V., Millet, P., Baranger, K., Loriod, B. & Féron, F. Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease. Molecular neurodegeneration 11, 22; 10.1186/s13024-016-0087-2 (2016).

      7. Agrawal, T., Gupta, G. K. & Agrawal, D. K. Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 43, 672–683; 10.1111/cea.12102 (2013).

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      The authors aim to address a critical challenge in the field of bioinformatics: the accurate and efficient identification of protein binding sites from sequences. Their work seeks to overcome the limitations of current methods, which largely depend on multiple sequence alignments or experimental protein structures, by introducing GPSite, a multi-task network designed to predict binding residues of various molecules on proteins using ESMFold.

      Strengths:

      • Benchmarking. The authors provide a comprehensive benchmark against multiple methods, showcasing the performances of a large number of methods in various scenarios.

      • Accessibility and Ease of Use. GPSite is highlighted as a freely accessible tool with user-friendly features on its website, enhancing its potential for widespread adoption in the research community.

      RE: We thank the reviewer for acknowledging the contributions and strengths of our work!

      Weaknesses:

      • Lack of Novelty. The method primarily combines existing approaches and lacks significant technical innovation. This raises concerns about the original contribution of the work in terms of methodological development. Moreover, the paper reproduces results and analyses already presented in previous literature, without providing novel analysis or interpretation. This further diminishes the contribution of this paper to advancing knowledge in the field.

      RE: The novelty of this work is primarily manifested in four key aspects. Firstly, although we have employed several existing tools such as ProtTrans and ESMFold to extract sequence features and predict protein conformations, these techniques were hardly explored in the field of binding site prediction. We have successfully demonstrated the feasibility of substituting multiple sequence alignments with language model embeddings and training with predicted structures, providing a new solution to overcome the limitations of current methods for genome-wide applications. Secondly, though a few methods tend to capture geometric information based on protein surfaces or atom graphs, surface calculation and property mapping are usually time-consuming, while massage passing on full atom graphs is memory-consuming and thus challenging to process long sequences. Besides, these methods are sensitive towards details and errors in the predicted structures. To facilitate large-scale annotations, we have innovatively applied geometric deep learning to protein residue graphs for comprehensively capturing backbone and sidechain geometric contexts in an efficient and effective manner (Figure 1). Thirdly, we have not only exploited multi-task learning to integrate diverse ligands and enhance performance, but also shown its capability to easily extend to the binding site prediction of other unseen ligands (Figure 4 D-E). Last but not least, as a “Tools and Resources” article, we have provided a fast, accurate and user-friendly webserver, as well as constructed a large annotation database for the sequences in Swiss-Prot. Leveraging this database, we have conducted extensive analyses on the associations between binding sites and molecular functions, biological processes, and disease-causing mutations (Figure 5), indicating the potential of our tool to unveil unexplored biology underlying genomic data.

      We have now revised the descriptions in the “The geometry-aware protein binding site predictor (GPSite)” section to highlight the novelty of our work in a clearer manner:

      “In conclusion, GPSite is distinguished from the previous approaches in four key aspects. First, profiting from the effectiveness and low computational cost of ProtTrans and ESMFold, GPSite is liberated from the reliance on MSA and native structures, thus enabling genome-wide binding site prediction. Second, unlike methods that only explore the Cα models of proteins 25,40, GPSite exploits a comprehensive geometric featurizer to fully refine knowledge in the backbone and sidechain atoms. Third, the employed message propagation on residue graphs is global structure-aware and time-efficient compared to the methods based on surface point clouds 21,22, and memory-efficient unlike methods based on full atom graphs 23,24. Residue-based message passing is also less sensitive towards errors in the predicted structures. Last but not least, instead of predicting binding sites for a single molecule type or learning binding patterns separately for different molecules, GPSite applies multi-task learning to better model the latent relationships among different binding partners.”

      • Benchmark Discrepancies. The variation in benchmark results, especially between initial comparisons and those with PeSTo. GPSite achieves a PR AUC of 0.484 on the global benchmark but a PR AUC of 0.61 on the benchmark against PeSTo. For consistency, PeSTo should be included in the benchmark against all other methods. It suggests potential issues with the benchmark set or the stability of the method. This inconsistency needs to be addressed to validate the reliability of the results.

      RE: We thank the reviewer for the constructive comments. Since our performance comparison experiments involved numerous competitive methods whose training sets are disparate, it was difficult to compare or rank all these methods fairly using a single test set. Given the substantial overlap between our protein-binding site test set and the training set of PeSTo, we meticulously re-split our entire protein-protein binding site dataset to generate a new test set that avoids any overlap with the training sets of both GPSite and PeSTo and performed a separate evaluation, where GPSite achieves a higher AUPR than PeSTo (0.610 against 0.433). This is quite common in this field. For instance, in the study of PeSTo (Nat Commun 2023), the comparisons of PeSTo with MaSIF-site, SPPIDER, and PSIVER were conducted using one test set, while the comparison with ScanNet was performed on a separate test set.

      Based on the reviewer’s suggestion, we have now replaced this experiment with a direct comparison with PeSTo using the datasets from PeSTo, in order to enhance the completeness and convincingness of our results. The corresponding descriptions are now added in Appendix 1-note 2, and the results are added in Appendix 2-table 4. For convenience, we also attach the note and table here:

      “Since 340 out of 375 proteins in our protein-protein binding site test set share > 30% identity with the training sequences of PeSTo, we performed a separate comparison between GPSite and PeSTo using the training and test datasets from PeSTo. By re-training with simply the same hyperparameters, GPSite achieves better performance than PeSTo (AUPR of 0.824 against 0.797) as shown in Appendix 2-table 4. Furthermore, when using ESMFold-predicted structures as input, the performance of PeSTo decreases substantially (AUPR of 0.691), and the superiority of our method will be further reflected. As in 24, the performance of ScanNet is also included (AUPR of 0.720), which is also largely outperformed by GPSite.”

      Author response table 1.

      Performance comparison of GPSite with ScanNet and PeSTo on the protein-protein binding site test set from PeSTo 24

      Note: The performance of ScanNet and PeSTo are directly obtained from 24. PeSTo* denotes evaluation using the ESMFold-predicted structures as input. The metrics provided are the median AUPR, median AUC and median MCC. The best/second-best results are indicated by bold/underlined fonts.

      • Interface Definition Ambiguity. There is a lack of clarity in defining the interface for the binding site predictions. Different methods are trained using varying criteria (surfaces in MaSIF-site, distance thresholds in ScanNet). The authors do not adequately address how GPSite's definition aligns with or differs from these standards and how this issue was addressed. It could indicate that the comparison of those methods is unreliable and unfair.

      RE: We thank the reviewer for the comments. The precise definition of ligand-binding sites is elucidated in the “Benchmark datasets” section. Specifically, the datasets of DNA, RNA, peptide, ATP, HEM and metal ions used to train GPSite were collected from the widely acknowledged BioLiP database [PMID: 23087378]. In BioLiP, a binding residue is defined if the smallest atomic distance between the target residue and the ligand is <0.5 Å plus the sum of the Van der Waal’s radius of the two nearest atoms. Meanwhile, most comparative methods regarding these ligands were also trained on data from BioLiP, thereby ensuring fair comparisons.

      However, since BioLiP does not include data on protein-protein binding sites, studies for protein-protein binding site prediction may adopt slightly distinct label definitions, as the reviewer suggested. Here, we employed the protein-protein binding site data from our previous study [PMID: 34498061], where a protein-binding residue was defined as a surface residue (relative solvent accessibility > 5%) that lost more than 1 Å2 absolute solvent accessibility after protein-protein complex formation. This definition was initially introduced in PSIVER [PMID: 20529890] and widely applied in various studies (e.g., PMID: 31593229, PMID: 32840562). SPPIDER [PMID: 17152079] and MaSIF-site [PMID: 31819266] have also adopted similar surface-based definitions as PSIVER. On the other hand, ScanNet [PMID: 35637310] employed an atom distance threshold of 4 Å to define contacts while PeSTo [PMID: 37072397] used a threshold of 5 Å. However, it is noteworthy that current methods in this field including ScanNet (Nat Methods 2022) and PeSTo (Nat Commun 2023) directly compared methods using different label definitions without any alignment in their benchmark studies, likely due to the subtle distinctions among these definitions. For instance, the study of PeSTo directly performed comparisons with ScanNet, MaSIF-site, SPPIDER, and PSIVER. Therefore, we followed these previous works, directly comparing GPSite with other protein-protein binding site predictors.

      In the revised “Benchmark datasets” section, we have now provided more details for the binding site definitions in different datasets to avoid any potential ambiguity:

      “The benchmark datasets for evaluating binding site predictions of DNA, RNA, peptide, ATP, and HEM are constructed from BioLiP”; “A binding residue is defined if the smallest atomic distance between the target residue and the ligand is < 0.5 Å plus the sum of the Van der Waal’s radius of the two nearest atoms”; “Besides, the benchmark dataset of protein-protein binding sites is directly from 26, which contains non-redundant transient heterodimeric protein complexes dated up to May 2021. Surface regions that become solvent inaccessible on complex formation are defined as the ground truth protein-binding sites. The benchmark datasets of metal ion (Zn2+, Ca2+, Mg2+ and Mn2+) binding sites are directly from 18, which contain non-redundant proteins dated up to December 2021 from BioLiP.”

      While GPSite demonstrates the potential to surpass state-of-the-art methods in protein binding site prediction, the evidence supporting these claims seems incomplete. The lack of methodological novelty and the unresolved questions in benchmark consistency and interface definition somewhat undermine the confidence in the results. Therefore, it's not entirely clear if the authors have fully achieved their aims as outlined.

      The work is useful for the field, especially in disease mechanism elucidation and novel drug design. The availability of genome-scale binding residue annotations GPSite offers is a significant advancement. However, the utility of this tool could be hampered by the aforementioned weaknesses unless they are adequately addressed.

      RE: We thank the reviewer for acknowledging the advancement and value of our work, as well as pointing out areas where improvements can be made. As discussed above, we have now carried out the corresponding revisions in the revised manuscript to enhance the completeness and clearness of our work.

      Reviewer #2 (Public Review):

      Summary:

      This work provides a new framework, "GPsite" to predict DNA, RNA, peptide, protein, ATP, HEM, and metal ions binding sites on proteins. This framework comes with a webserver and a database of annotations. The core of the model is a Geometric featurizer neural network that predicts the binding sites of a protein. One major contribution of the authors is the fact that they feed this neural network with predicted structure from ESMFold for training and prediction (instead of native structure in similar works) and a high-quality protein Language Model representation. The other major contribution is that it provides the public with a new light framework to predict protein-ligand interactions for a broad range of ligands.

      The authors have demonstrated the interest of their framework with mostly two techniques: ablation and benchmark.

      Strengths:

      • The performance of this framework as well as the provided dataset and web server make it useful to conduct studies.

      • The ablations of some core elements of the method, such as the protein Language Model part, or the input structure are very insightful and can help convince the reader that every part of the framework is necessary. This could also guide further developments in the field. As such, the presentation of this part of the work can hold a more critical place in this work.

      RE: We thank the reviewer for recognizing the contributions of our work and for noting that our experiments are thorough.

      Weaknesses:

      • Overall, we can acknowledge the important effort of the authors to compare their work to other similar frameworks. Yet, the lack of homogeneity of training methods and data from one work to the other makes the comparison slightly unconvincing, as the authors pointed out. Overall, the paper puts significant effort into convincing the reader that the method is beating the state of the art. Maybe, there are other aspects that could be more interesting to insist on (usability, interest in protein engineering, and theoretical works).

      RE: We sincerely appreciate the reviewer for the constructive and insightful comments. As to the concern of training data heterogeneity raised by the reviewer, it is noteworthy that current studies in this field, such as ScanNet (Nat Methods 2022) and PeSTo (Nat Commun 2023), directly compare methods trained on different datasets in their benchmark experiments. Therefore, we have adhered to the paradigm in these previous works. According to the detailed recommendations by the reviewer, we have now improved our manuscript by incorporating additional ablation studies regarding the effects of training procedure and language model representations, as well as case studies regarding the predicted structure’s quality and GPSite-based function annotations. We have also refined the Discussion section to focus more on the achievements of this work. A comprehensive point-by-point response to the reviewer’s recommendations is provided below.

      Reviewer #2 (Recommendations For The Authors):

      Major comments:

      Overall I think the work is slightly deserved by its presentation. Some improvements could be made to the paper to better highlight the significance of your contribution.

      RE: We thank the reviewer for recognizing the significance of our work!

      • Line 188: "As expected, the performance of these methods mostly decreases substantially utilizing predicted structures for testing because they were trained with high-quality native structures.

      This is a major ablation that was not performed in this case. You used the predicted structure to train, while the other did not. One better way to assess the interest of this approach would be to compare the performance of a network trained with only native structure to compare the leap in performance with and without this predicted structure as you did after to assess the interest of some other aspect of your method such as single to multitask.

      RE: We thank the reviewer for the valuable recommendation. We have now assessed the benefit of training with predicted instead of native structures, which brings an average AUPR increase of 4.2% as detailed in Appendix 1-note 5 and Appendix 2-table 9. For convenience, we also attach the note and table here:

      “We examined the performance under different training and evaluation settings as shown in Appendix 2-table 9. As expected, the model yields exceptional performance (average AUPR of 0.656) when trained and evaluated using native structures. However, if this model is fed with predicted structures of the test proteins, the performance substantially declines to an average AUPR of 0.573. This trend aligns with the observations for other structure-based methods as illustrated in Figure 2. More importantly, in the practical scenario where only predicted structures are available for the target proteins, training the model with predicted structures (i.e., GPSite) results in superior performance than training the model with native structures (average AUPR of 0.594 against 0.573), probably owing to the consistency between the training and testing data. For completeness, the results in Appendix 3-figure 2 are also included where GPSite is tested with native structures (average AUPR of 0.637).”

      Author response table 2.

      Performance comparison on the ten binding site test sets under different training and evaluation settings

      Note: The numbers in this table are AUPR values. “Pep” and “Pro” denote peptide and protein, respectively. “Avg” means the average AUPR values among the ten test sets. “native” and “predicted” denote applying native and predicted structures as input, respectively.

      • Line 263: "ProtTrans consistently obtains competitive or superior performance compared to the MSA profiles, particularly for the target proteins with few homologous sequences (Neff < 2)."

      This seems a bit far-fetched. If we see clearly in the figure that the performances are far superior for Neff < 2. The performances seem rather similar for higher Neff. Could the author evaluate numerically the significance of the improvement? MSA profiles outperform GPSite on 4 intervals and I don't know the distribution of the data.

      RE: We thank the reviewer for the valuable suggestion. We have now revised this sentence to avoid any potential ambiguity:

      “As evidenced in Figure 4B and Appendix 2-table 8, ProtTrans consistently obtains competitive or superior performance compared to the MSA profile. Notably, for the target proteins with few homologous sequences (Neff < 2), ProtTrans surpasses MSA profile significantly with an improvement of 3.9% on AUC (P-value = 4.3×10-8).”

      The detailed significance tests and data distribution are now added in Appendix 2-table 8 and attached below as Author response-table 3 for convenience:

      Author response table 3.

      Performance comparison between GPSite and the baseline model using MSA profile for proteins with different Neff values in the combined test set of the ten ligands

      Note: Significance tests are performed following the procedure in 12,25. If P-value < 0.05, the difference between the performance is considered statistically significant.

      • Line 285: "We first visualized the distributions of residues in this dataset using t-SNE, where the residues are encoded by raw feature vectors encompassing ProtTrans embeddings and DSSP structural properties, or latent embedding vectors from the shared network of GPSite. "

      Wouldn't embedding from single-task be more relevant to show the interest of multi-task training here? Is the difference that big when comparing embeddings from single-task training to embeddings from multi-task training? Otherwise, I think the evidence from Figure 4e is sufficient, the interest of multitasking could be well-shown by single-task vs. multi-task AUPR and a few examples or predictions that are improved.

      RE: We thank the reviewer for the comment. In the second paragraph of the “The effects of protein features and model designs” section, we have compared the performance of multi-task and single-task learning. However, the visualization results in Figure 4D are related to the third paragraph, where we conducted a downstream exploration of the possibility to extend GPSite to other unseen ligands. This is based on the hypothesis that the shared network in GPSite may have captured certain common ligand-binding mechanisms during the preceding multi-task training process. We visualized the distributions of residues in an unseen carbohydrate-binding site dataset using t-SNE, where the residues are encoded by raw feature vectors (ProtTrans and DSSP), or latent embedding vectors from the shared network trained before. Although the shared network has not been specifically trained on the carbohydrate dataset, the latent representations from GPSite effectively improve the discriminability between the binding and non-binding residues as shown in Figure 4D. This finding indicates that the shared network trained on the initial set of ten molecule types has captured common binding mechanisms and may be applied to other unseen ligands.

      We have now added more descriptions in this paragraph to avoid potential ambiguity:

      “Residues that are conserved during evolution, exposed to solvent, or inside a pocket-shaped domain are inclined to participate in ligand binding. During the preceding multi-task training process, the shared network in GPSite should have learned to capture such common binding mechanisms. Here we show how GPSite can be easily extended to the binding site prediction for other unseen ligands by adopting the pre-trained shared network as a feature extractor. We considered a carbohydrate-binding site dataset from 54 which contains 100 proteins for training and 49 for testing. We first visualized the distributions of residues in this dataset using t-SNE 55, where the residues are encoded by raw feature vectors encompassing ProtTrans embeddings and DSSP structural properties, or latent embedding vectors from the shared network of GPSite trained on the ten molecule types previously.”

      • Line291: "Employing these informative hidden embeddings as input features to train a simple MLP exhibits remarkable performance with an AUC of 0.881 (Figure 4E), higher than that of training a single-task version of GPSite from scratch (AUC of 0.853) or other state-of-the-art methods such as MTDsite and SPRINT-CBH."

      Is it necessary to introduce other methods here? The single-task vs multi-task seems enough for what you want to show?

      RE: We thank the reviewer for the comment. As discussed above, here we aim to show the potential of GPSite for the binding site prediction of unseen ligand (i.e., carbohydrate) by adopting the pre-trained shared network as a feature extractor. Thus, we think it’s reasonable to also include the performance of other state-of-the-art methods in this carbohydrate benchmark dataset as baselines.

      • Line 321: "Specifically, a protein-level binding score can be generated for each ligand by averaging the top k predicted scores among all residues. Empirically, we set k to 5 for metal ions and 10 for other ligands, considering that the binding interfaces of metal ions are usually smaller."

      Since binding sites are usually not localized on one single amino-acid, we can expect that most of the top k residues are localized around the same area of the protein both spatially and along the sequence. Is it something you observe and could consider in your method?

      RE: We thank the reviewer for the comment. We employed a straightforward method (top-k average) to convert GPSite’s residue-level annotations into protein-level annotations, where k was set empirically based on the distributions of the numbers of binding residues per sequence observed in the training set. We have not put much effort in optimizing this strategy since it mainly serves as a proof-of-concept experiment (Figure 5 A-C) to show the potential of GPSite in discriminating ligand-binding proteins. We have now revised this sentence to better explain how we selected k:

      “Specifically, a protein-level binding score indicating the overall binding propensity to a specific ligand can be generated by averaging the top k predicted scores among all residues. Empirically, we set k to 5 for metal ions and 10 for other ligands, considering the distributions of the numbers of binding residues per sequence observed in the training set.”

      As for the question raised by the reviewer, we can indeed expect that most of the top k predicted binding residues tend to cluster into several but not necessarily one area. For instance, certain macromolecules like DNA may interact with several protein surface patches due to their elongated structures (e.g., Author esponse-figure 1A). Another case may be a protein binding to multiple molecules of the same ligand type (e.g., Author response-figure 1B).

      Author response image 1.

      The structures of 4XQK (A) and 4KYW (B) in PDB.

      • Line 327: The accuracy of the GPSite protein-level binding scores is further validated by the ROC curves in Figure 5B, where GPSite achieves satisfactory AUC values for all ligands except protein (AUC of 0.608).

      Here may be a good place to compare yourself with others, do other frameworks experience the same problem? If so, AUC and AUPR are not relevant here, can you expose some recall scores for example?

      RE: We thank the reviewer for the valuable recommendation. We have conducted comprehensive method comparisons in the preceding “GPSite outperforms state-of-the-art methods” section, where GPSite surpasses all existing frameworks across various ligands. Here, the genome-wide analyses of Swiss-Prot in Figure 5 serve as a downstream demonstration of GPSite’s capacity for large-scale annotations. We didn’t compare with other methods since most of them are time-consuming or memory-consuming, thus unavailable to process sequences of substantial quantity or length. For example, it takes about 8 min for the MSA-based method GraphBind to annotate a protein with 500 residues, while it just takes about 20 s for GPSite (see Appendix 3-figure 1 for detailed runtime comparison). It is also challenging for the atom-graph-based method PeSTo to process structures more than 100 kDa (~1000 residues) on a 32 GB GPU as the authors suggested, while GPSite can easily process structures containing up to 2500 residues on a 16 GB GPU.

      Regarding the recall score mentioned by the reviewer, GPSite achieves a recall of 0.95 (threshold = 0.5) for identifying protein-binding proteins. This indicates that GPSite can accurately identify positive samples, but it also tends to misclassify negative samples as positive. In our original manuscript, we claimed that “This may be ascribed to the fact that protein-protein interactions are ubiquitous in living organisms while the Swiss-Prot function annotations are incomplete”. To better support this claim, we have now added two examples in Appendix 1-note 7, where GPSite confidently predicted the presences of the “protein binding” function (GO:0005515). Notably, this function was absent in these two proteins in the Swiss-Prot database at the time of manuscript preparation (release: 2023-05-03), but has been included in the latest release of Swiss-Prot (release: 2023-11-08). For convenience, we also attach the note here:

      “As depicted in Figure 5A, GPSite assigns relatively high prediction scores to the proteins without “protein binding” function in the Swiss-Prot annotations, leading to a modest AUC value of 0.608 (Figure 5B). This may be ascribed to the fact that protein-protein interactions are ubiquitous in living organisms while the Swiss-Prot function annotations are incomplete. To support this hypothesis, we present two proteins as case studies, both sharing < 20% sequence identity with the protein-binding training set of GPSite. The first case is Aminodeoxychorismate synthase component 2 from Escherichia coli (UniProt ID: P00903). GPSite confidently predicted this protein as a protein-binding protein with a high prediction score of 0.936. Notably, this protein was not annotated with the “protein binding” function (GO:0005515) or any of its GO child terms in the Swiss-Prot database at the time of manuscript preparation (https://rest.uniprot.org/unisave/P00903?format=txt&versions=171, release: 2023-05-03). However, in the latest release of Swiss-Prot (https://rest.uniprot.org/unisave/P00903?format=txt&versions=174, release: 2023-11-08) during manuscript revision, this protein is annotated with the “protein heterodimerization activity” function (GO:0046982), which is a child term of “protein binding”. In fact, the heterodimerization activity of this protein has been validated through experiments in the year of 1996 (PMID: 8679677), indicating the potential incompleteness of the Swiss-Prot annotations. The other case is Hydrogenase-2 operon protein HybE from Escherichia coli (UniProt ID: P0AAN1), which was also predicted as a protein-binding protein by GPSite (score = 0.909). Similarly, this protein was not annotated with the “protein binding” function in the Swiss-Prot database at the time of manuscript preparation (https://rest.uniprot.org/unisave/P0AAN1?format=txt&versions=108). However, in the latest release of Swiss-Prot (https://rest.uniprot.org/unisave/P0AAN1?format=txt&versions=111), this protein is annotated with the “preprotein binding” function (GO:0070678), which is a child term of “protein binding”. In fact, the preprotein binding function of this protein has been validated through experiments in the year of 2003 (PMID: 12914940). These cases demonstrate the effectiveness of GPSite for completing the missing function annotations in Swiss-Prot.”

      • Line 381: 'Despite the noteworthy advancements achieved by GPSite, there remains scope for further improvements. Given that the ESM Metagenomic Atlas 34 provides 772 million predicted protein structures along with pre-computed language model embeddings, self-supervised learning can be employed to train a GPSite model for predicting masked sequence and structure attributes, or maximizing the similarity between the learned representations of substructures from identical proteins while minimizing the similarity between those from different proteins using a contrastive loss function training from scratch. Additional opportunities for upgrade exist within the network architecture. For example, a variational Expectation-Maximization (EM) framework 58 can be adopted to handle the hierarchical graph structure inherent in proteins, which contains the top view of the residue graph and the bottom view of the atom graph inside a residue. Such an EM procedure enables training two separate graph neural networks for the two views while simultaneously allowing interaction and mutual enhancement between the two modules. Meta-learning could also be explored in this multi-task scenario, which allows fast adaptation to unseen tasks with limited labels.'

      I think this does not belong here. It feels like half of your discussion is not talking about the achievements of this paper but future very specific directions. Focus on the take-home arguments (performances of the model, ability to predict a large range of tasks, interest in key components of your model, easy use) of the paper and possible future direction but without being so specific.

      RE: We thank the reviewer for the valuable suggestion. We have now simplified the discussions on the future directions notably:

      “Despite the noteworthy advancements achieved by GPSite, there remains scope for further improvements. GPSite may be improved by pre-training on the abundant predicted structures in ESM Metagenomic Atlas, and then fine-tuning on binding site datasets. Besides, the hidden embeddings from ESMFold may also serve as informative protein representations. Additional opportunities for upgrade exist within the network architecture. For example, a variational Expectation-Maximization framework can be adopted to handle the hierarchical atom-to-residue graph structure inherent in proteins. Meta-learning could also be explored in this multi-task scenario, which allows fast adaptation to unseen tasks with limited labels.”

      • Overall there is also a lack of displayed structure. You should try to select a few examples of binding sites that were identified correctly by your method and not by others, if possible get some insights on why. Also, some negative examples could be interesting so as to have a better idea of the interest.

      RE: We thank the reviewer for the valuable recommendation. We have performed a case study for the structure of the glucocorticoid receptor in Figure 3 D-H to illustrate a potential reason for the robustness of GPSite. Moreover, we have now added a case study in Appendix 1-note 3 and Appendix 3-figure 5 to explain why GPSite sometimes is not as accurate as the state-of-the-art structure-based method. For convenience, we also attach the note and figure here:

      “Here we present an example of an RNA-binding protein, i.e., the ribosome biogenesis protein ERB1 (PDB: 7R6Q, chain m), to illustrate the impact of predicted structure’s quality. As shown in Appendix 3-figure 5, ERB1 is an integral component of a large multimer structure comprising protein and RNA chains (i.e., the state E2 nucleolar 60S ribosome biogenesis intermediate). Likely due to the neglect of interactions from other protein chains, ESMFold fails to predict the correct conformation of the ERB1 chain (TM-score = 0.24). Using this incorrect predicted structure, GPSite achieves an AUPR of 0.580, lower than GraphBind input with the native structure (AUPR = 0.636). However, the performance of GraphBind substantially declines to an AUPR of 0.468 when employing the predicted structure as input. Moreover, if GPSite adopts the native structure for prediction, a notable performance boost can be obtained (AUPR = 0.681).”

      Author response image 2.

      The prediction results of GPSite and GraphBind for the ribosome biogenesis protein ERB1. (A) The state E2 nucleolar 60S ribosome biogenesis intermediate (PDB: 7R6Q). The ribosome biogenesis protein ERB1 (chain m) is highlighted in blue, while other protein chains are colored in gray. The RNA chains are shown in orange. (B) The RNA-binding sites on ERB1 (colored in red). (C) The ESMFold-predicted structure of ERB1 (TM-score = 0.24). The RNA-binding sites are also mapped onto this predicted structure (colored in red). (D-G) The prediction results of GPSite and GraphBind for the predicted and native ERB1 structures. The confidence of the predictions is represented with a gradient of color from blue for non-binding to red for binding.

      Minor comments:

      • Line 169: "Note that since our test sets may partly overlap with the training sets of these methods, the results reported here should be the upper limits for the existing methods."

      Yes, but they were potentially not trained on the most recent structures in that case. These methods could also see improved performance with an updated training set.

      RE: We thank the reviewer for the comment. We have now deleted this sentence.

      • Line176: "Since 358 of the 375 proteins in our protein-binding site test set share > 30% identity with the training sequences of PeSTo, we re-split our protein-binding dataset to generate a test set of 65 proteins sharing < 30% identity with the training set of PeSTo for a fair evaluation."

      Too specific to be here in my opinion.

      RE: We thank the reviewer for the comment. We have now moved these details to Appendix 1-note 2. The description in the main text here is now more concise:

      “Given the substantial overlap between our protein-binding site test set and the training set of PeSTo, we conducted separate training and comparison using the datasets of PeSTo, where GPSite still demonstrates a remarkable improvement over PeSTo (Appendix 1-note 2).”

      • Figure 2. The authors should try to either increase Fig A's size or increase the font size. This could probably be done by compressing the size of Figure C into a single figure.

      RE: We thank the reviewer for the suggestion. We have now increased the font size in Figure A. Besides, the figures in the final version of the manuscript should be clearer where we could upload SVG files.

      • Have you tried using embeddings from more structure-aware pLM such as ESM Fold embeddings (fine-tuned) or ProstTrans (that may be more recent than this study)?

      RE: We thank the reviewer for the insightful comment. We have not yet explored the embeddings from structure-aware pLM, but we acknowledge its potential as a promising avenue for future investigation. We have now added this point in our Discussion section:

      “Besides, the hidden embeddings from ESMFold may also serve as informative protein representations.”

      Reviewer #3 (Public Review):

      Summary

      The authors of this work aim to address the challenge of accurately and efficiently identifying protein binding sites from sequences. They recognize that the limitations of current methods, including reliance on multiple sequence alignments or experimental protein structure, and the under-explored geometry of the structure, which limit the performance and genome-scale applications. The authors have developed a multi-task network called GPSite that predicts binding residues for a range of biologically relevant molecules, including DNA, RNA, peptides, proteins, ATP, HEM, and metal ions, using a combination of sequence embeddings from protein language models and ESMFold-predicted structures. Their approach attempts to extract residual and relational geometric contexts in an end-to-end manner, surpassing current sequence-based and structure-based methods.

      Strengths

      • The GPSite model's ability to predict binding sites for a wide variety of molecules, including DNA, RNA, peptides, and various metal ions.

      • Based on the presented results, GPSite outperforms state-of-the-art methods in several benchmark datasets.

      • GPSite adopts predicted structures instead of native structures as input, enabling the model to be applied to a wider range of scenarios where native structures are rare.

      • The authors emphasize the low computational cost of GPSite, which enables rapid genome-scale binding residue annotations, indicating the model's potential for large-scale applications.

      RE: We thank the reviewer for recognizing the significance and value of our work!

      Weaknesses

      • One major advantage of GPSite, as claimed by the authors, is its efficiency. Although the manuscript mentioned that the inference takes about 5 hours for all datasets, it remains unclear how much improvement GPSite can offer compared with existing methods. A more detailed benchmark comparison of running time against other methods is recommended (including the running time of different components, since some methods like GPSite use predicted structures while some use native structures).

      RE: We thank the reviewer for the valuable suggestion. Empirically, it takes about 5-20 min for existing MSA-based methods to make predictions for a protein with 500 residues, while it only takes about 1 min for GPSite (including structure prediction). However, it is worth noting that some predictors in our benchmark study are solely available as webservers, and it is challenging to compare the runtime between a standalone program and a webserver due to the disparity in hardware configurations. Therefore, we have now included comprehensive runtime comparisons between the GPSite webserver and other top-performing servers in Appendix 3-figure 1 to illustrate the practicality and efficiency of our method. For convenience, we also attach the figure here as Author response-figure 3. The corresponding description is now added in the “GPSite outperforms state-of-the-art methods” section:

      “Moreover, GPSite is computationally efficient, achieving comparable or faster prediction speed compared to other top-performing methods (Appendix 3-figure 1).”

      Author response image 3.

      Runtime comparison of the GPSite webserver with other top-performing servers. Five protein chains (i.e., 8HN4_B, 8USJ_A, 8C1U_A, 8K3V_A and 8EXO_A) comprising 100, 300, 500, 700, and 900 residues, respectively, were selected for testing, and the average runtime is reported for each method. Note that a significant portion of GPSite’s runtime (75 s, indicated in orange) is allocated to structure prediction using ESMFold.

      • Since the model uses predicted protein structure, the authors have conducted some studies on the effect of the predicted structure's quality. However, only the 0.7 threshold was used. A more comprehensive analysis with several different thresholds is recommended.

      RE: We thank the reviewer for the comment. We assessed the effect of the predicted structure's quality by evaluating GPSite’s performance on high-quality (TM-score > 0.7) and low-quality (TM-score ≤ 0.7) predicted structures. We did not employ multiple thresholds (e.g., 0.3, 0.5, and 0.7), as the majority of proteins in the test sets were accurately predicted by ESMFold. Specifically, as shown in Figure 3B, Appendix 3-figure 3 and Appendix 2-table 5, the numbers of proteins with TM-score ≤ 0.7 are small in most datasets (e.g., 42 for DNA and 17 for ATP). Consequently, there is insufficient data available for analysis with lower thresholds, except for the RNA test set. Notably, Figure 3C presents a detailed inspection of the 104 proteins with TM-score < 0.5 in the RNA test set. Within this subset, GPSite consistently outperforms the state-of-the-art structure-based method GraphBind with predicted structures as input, regardless of the prediction quality of ESMFold. Only in cases where structures are predicted with extremely low quality (TM-score < 0.3) does GPSite fall behind GraphBind input with native structures. This result further demonstrates the robustness of GPSite. We have now added clearer explanations in the “GPSite is robust for low-quality predicted structures” section:

      “Figure 3B and Appendix 3-figure 3 show the distributions of TM-scores between native and predicted structures calculated by US-align in the ten benchmark datasets, where most proteins are accurately predicted with TM-score > 0.7 (see also Appendix 2-table 5)”; “Given the infrequency of low-quality predicted structures except for the RNA test set, we took a closer inspection of the 104 proteins with predicted structures of TM-score < 0.5 in the RNA test set.”

      • To demonstrate the robustness of GPSite, the authors performed a case study on human GR containing two zinc fingers, where the predicted structure is not perfect. The analysis could benefit from more a detailed explanation of why the model can still infer the binding site correctly even though the input structural information is slightly off.

      RE: We thank the reviewer for the comment. We have actually explained the potential reason for the robustness of GPSite in the second paragraph of the “GPSite is robust for low-quality predicted structures” section. In summary, although the whole structure of this protein is not perfectly predicted, the local structures of the binding domains of peptide, DNA and Zn2+ are actually predicted accurately as evidenced by the superpositions of the native and predicted structures in Figure 3D and 3E. Therefore, GPSite can still make reliable predictions. We have now revised this paragraph to explain these more clearly:

      “Figure 3D shows the structure of the human glucocorticoid receptor (GR), a transcription factor that binds DNA and assembles a coactivator peptide to regulate gene transcription (PDB: 7PRW, chain A). The DNA-binding domain of GR also consists of two C4-type zinc fingers to bind Zn2+ ions. Although the structure of this protein is not perfectly predicted (TM-score = 0.72), the local structures of the binding domains of peptide and DNA are actually predicted accurately as viewed by the superpositions of the native and predicted structures in Figure 3D and 3E. Therefore, GPSite can correctly predict all Zn2+ binding sites and precisely identify the binding sites of DNA and peptide with AUPR values of 0.949 and 0.924, respectively (Figure 3F, G and H).”

      • To analyze the relatively low AUC value for protein-protein interactions, the authors claimed that it is "due to the fact that protein-protein interactions are ubiquitous in living organisms while the Swiss-Prot function annotations are incomplete", which is unjustified. It is highly recommended to support this claim by showing at least one example where GPSite's prediction is a valid binding site that is not present in the current Swiss-Prot database or via other approaches.

      RE: We thank the reviewer for the valuable recommendation. To support this claim, we have now added two examples in Appendix 1-note 7, where GPSite confidently predicted the presences of the “protein binding” function (GO:0005515). Notably, this function was absent in these two proteins in the Swiss-Prot database at the time of manuscript preparation (release: 2023-05-03), but has been included in the latest release of Swiss-Prot (release: 2023-11-08). For convenience, we also attach the note below:

      “As depicted in Figure 5A, GPSite assigns relatively high prediction scores to the proteins without “protein binding” function in the Swiss-Prot annotations, leading to a modest AUC value of 0.608 (Figure 5B). This may be ascribed to the fact that protein-protein interactions are ubiquitous in living organisms while the Swiss-Prot function annotations are incomplete. To support this hypothesis, we present two proteins as case studies, both sharing < 20% sequence identity with the protein-binding training set of GPSite. The first case is Aminodeoxychorismate synthase component 2 from Escherichia coli (UniProt ID: P00903). GPSite confidently predicted this protein as a protein-binding protein with a high prediction score of 0.936. Notably, this protein was not annotated with the “protein binding” function (GO:0005515) or any of its GO child terms in the Swiss-Prot database at the time of manuscript preparation (https://rest.uniprot.org/unisave/P00903?format=txt&versions=171, release: 2023-05-03). However, in the latest release of Swiss-Prot (https://rest.uniprot.org/unisave/P00903?format=txt&versions=174, release: 2023-11-08) during manuscript revision, this protein is annotated with the “protein heterodimerization activity” function (GO:0046982), which is a child term of “protein binding”. In fact, the heterodimerization activity of this protein has been validated through experiments in the year of 1996 (PMID: 8679677), indicating the potential incompleteness of the Swiss-Prot annotations. The other case is Hydrogenase-2 operon protein HybE from Escherichia coli (UniProt ID: P0AAN1), which was also predicted as a protein-binding protein by GPSite (score = 0.909). Similarly, this protein was not annotated with the “protein binding” function in the Swiss-Prot database at the time of manuscript preparation (https://rest.uniprot.org/unisave/P0AAN1?format=txt&versions=108). However, in the latest release of Swiss-Prot (https://rest.uniprot.org/unisave/P0AAN1?format=txt&versions=111), this protein is annotated with the “preprotein binding” function (GO:0070678), which is a child term of “protein binding”. In fact, the preprotein binding function of this protein has been validated through experiments in the year of 2003 (PMID: 12914940). These cases demonstrate the effectiveness of GPSite for completing the missing function annotations in Swiss-Prot.”

      • The authors reported that many GPSite-predicted binding sites are associated with known biological functions. Notably, for RNA-binding sites, there is a significantly higher proportion of translation-related binding sites. The analysis could benefit from a further investigation into this observation, such as the analyzing the percentage of such interactions in the training site. In addition, if there is sufficient data, it would also be interesting to see the cross-interaction-type performance of the proposed model, e.g., train the model on a dataset excluding specific binding sites and test its performance on that class of interactions.

      RE: We thank the reviewer for the suggestion. We would like to clarify that the analysis in Figure 5C was conducted at “protein-level” instead of “residue-level”. As described in the second paragraph of the “Large-scale binding site annotation for Swiss-Prot” section, a protein-level ligand-binding score was assigned to a protein by averaging the top k residue-level predicted binding scores. This protein-level score indicates the overall binding propensity of the protein to a specific ligand. We gathered the top 20,000 proteins with the highest protein-level binding scores for each ligand and found that their biological process annotations from Swiss-Prot were consistent with existing knowledge. We have now revised the corresponding sentence to explain these more clearly:

      “Exploiting the residue-level binding site annotations, we could readily extend GPSite to discriminate between binding and non-binding proteins of various ligands. Specifically, a protein-level binding score indicating the overall binding propensity to a specific ligand can be generated by averaging the top k predicted scores among all residues.”

      As for the cross-interaction-type performance raised by the reviewer, we have now conducted cross-type evaluations to investigate the specificity of the ligand-specific MLPs and the inherent similarities among different ligands in Appendix 1-note 6 and Appendix 2-table 10. For convenience, we also attach the note and table here:

      “We conducted cross-type evaluations by applying different ligand-specific MLPs in GPSite for the test sets of different ligands. As shown in Appendix 2-table 10, for each ligand-binding site test set, the corresponding ligand-specific network consistently achieves the best performance. This indicates that the ligand-specific MLPs have specifically learned the binding patterns of particular molecules. We also noticed that the cross-type performance is reasonable for the ligands sharing similar properties. For instance, the DNA-specific MLP exhibits a reasonable AUPR when predicting RNA-binding sites, and vice versa. Similar trends are also observed between peptide and protein, as well as among metal ions as expected. Interestingly, the cross-type performance between ATP and HEM is also acceptable, potentially attributed to their comparable molecular weights (507.2 and 616.5, respectively).”

      Author response table 4.

      Cross-type performance by applying different ligand-specific MLPs in GPSite for the test sets of different ligands

      Note: “Pep” and “Pro” denote peptide and protein, respectively. The numbers in this table are AUPR values. The best/second-best result in each test set is indicated by bold/underlined font.

    1. Author Response

      The following is the authors’ response to the original reviews.

      We are pleased to send you a revised version of our manuscript entitled “voyAGEr: free web interface for the analysis of age-related gene expression alterations in human tissues” and the associated shiny web app, in which we incorporate the referees’ feedback. We would like to express our gratitude for their time and valuable insights, which have contributed to the improvement of our work. We appreciate the rigorous evaluation process that eLife maintains.

      In this letter, we address each of the reviewers' comments and concerns, point-by-point, offering detailed responses and clarifications. We have made several revisions to our manuscript following their recommendations.

      We must note that the revised version of the manuscript has two novel joint first authors, Rita Martins-Silva and Alexandre Kaizeler, who performed all the requested reanalyses, given that the initial first author, Arthur Schneider, already left our lab. We must also point to the following minor unsolicited improvements we took the opportunity to make:

      • Added a comprehensive tutorial to the GitHub repository on how to navigate through voyAGEr’s features.

      • Implemented sample randomisation in the scatter plots depicting gene expression across the age axis to ensure data privacy.

      • Implemented minor adjustments within the web app to enhance user comprehension and clarity when visualizing the data.

      • Improved clarity of the methodological sections.

      Reviewer 1

      (1.1) While this may be obvious to others for some reason that escaped me, I was unsure what was the basis for the authors' choice of 16 years as the very specific sliding window size. If I'm not alone in this, it might add clarity for other readers and users if this parameter choice were explained and justified more explicitly.

      We apologise for our omission in providing the rationale behind our choice in the previous version. We chose 16 years as our sliding window size because this was the minimum needed to guarantee the presence of more than one sample per window, across all the tissues considered in the study (Figure R1 below).

      We added the following sentence to the manuscript (v. Methods, ShARP-LM):

      “This was the minimum age span needed to guarantee the presence of more than one sample per window, across all considered tissues.”

      (1.2) "In particular, tissue-specific periods of major transcriptional changes in the fifth and eighth decades of human lifespan have been revealed, reflecting the so-called digital aging and consistently with what is observed in mice" here I think that "consistently" should be "consistent".

      We thank the reviewer for the comment and following the suggestion, we have revised 'Consistently' to 'consistent' as it is the correct usage in our sentence.

      (1.3) "On a different note, sex biases have been reported in for the expression of SALL1 and KAL1 in adipose tissue and lung, respectively." Here I think that "in for" should be "in".

      As recommended by the reviewer, we have replaced ‘in for’ for ‘in’. As we substituted KAL1, the current sentence now stands as “On a different note, sex biases have been reported in the expression of SALL1 and DDX43 in adipose tissue and lung, respectively”.

      (1.4) "We downloaded the matrix with the RNA-seq read counts for each gene in each GTEx v7 sample from the project's data portal (https://www.gtexportal.org/)." In my pdf manuscript this hyperlink appears to be broken.

      We appreciate the reviewer's attention to the broken link, and we have rectified the issue. The link should now be fully operational, effectively directing users to the GTEx Portal.

      (1.5) Under methods, I might suggest "Development platform" or "Development platforms" over "Development's platform" as a heading.

      We have modified the heading of this section in the methods to 'Development Platforms', as we believe it better reflects the information conveyed.

      Reviewer 2

      (2.1) In this tool/resource paper, it is crucial that the data used is up-to-date to provide the most comprehensive and relevant information to users. However, the authors utilized GTEx v7, which is an outdated (2016) version of the dataset. It is worth noting that GTEx v8 includes over 940 individuals, representing a 35% increase in individuals, and a 50% increase in the total number of samples. The authors should check the newer versions of GTEx and update the data.

      When the development of the voyAGEr web application began, GTEx version 7 was the most up to date. Nevertheless, we agree that the version 8 offers a notably more extensive dataset, encompassing a larger number of individuals, samples, and introducing new tissues. Consequently, we have updated our application to incorporate the data from GTEx version 8.

      (2.2) The authors did not address any correction for batch effects or RNA integrity numbers, which are known to affect transcriptome profiles. For instance, our analysis of GTEx v8 Cortex tissue revealed that after filtering out lowly expressed genes, in the same way authors did, PC1 (which accounts for 24% of the variation) had a Spearman's correlation value of 0.48 (p<6.1e-16) with RNA integrity number.

      We acknowledge the validity of the reviewer’s comment and appreciate the importance of such corrections to enhancing data interpretation. In response, we conducted a thorough unbiased investigation into potential batch effects, with the COHORT variable emerging as the primary driver of those observed across most tissues. Furthermore, SMRIN (as the reviewer pointed), DTHHRDY, MHSMKYRS and the number of detected genes in each sample were consistently associated with the primary sources of variation. As a result, we implemented batch effect correction for those five conditions, in a tissue-specific manner.

      We provide a detailed explanation of the batch effect correction methodology and its importance in the biological interpretation of results in the Methods section, specifically under "Read count data pre-processing". Additionally, we have included two new supplementary figures, Sup. Figures 7 and 8, to illustrate a batch effect example in lung tissue and emphasise the critical role of this correction in data interpretation.

      (2.3) The data analyzed in the GTEx dataset is not filtered or corrected for the cause of death, which can range from violent and sudden deaths to slow deaths or cases requiring a ventilator. As a result, the data may not accurately represent healthy aging profiles but rather reflect changes in the transcriptome specific to certain diseases due to the age-related increase in disease risk. While the authors do acknowledge this limitation in the discussion, stating that it is not a healthy cohort and disease-specific analysis is not feasible due to the limited number of samples, it would be useful for users to have the option to analyze only cases of fast death, excluding ventilator cases and deaths due to disease. This is typically how GTEx data is utilized in aging studies. Alternatively, the authors should consider including the "cause of death" variable in the model.

      This comment is closely related to the prior discussion (point 2.2). Notably, two of the covariates selected for batch effect correction, namely, DTHHRDY (Death classification based on the 4-point Hardy Scale1) and COHORT (indicating whether the participant was a postmortem, organ, or surgical donor1), have a direct relevance to this issue, i.e., both relate to the cause of death of the individual.

      1 According to the nomenclature of variables described in https://www.ncbi.nlm.nih.gov/projects/gap/cgibin/ GetListOfAllObjects.cgi?study_id=phs000424.v9.p2&object_type=variable

      We therefore effectively account for their influence on gene expression, mitigating these factors' impact.

      This approach represents a compromise, as it is practically infeasible to ascertain the absence of underlying health conditions in the remaining samples, even if only considering cases of “fast death”. Hence, we opted to keep all samples, independently of the cause of death of its donor, to dilute potential effects associated with individual causes of death.

      (2.4) The age distribution varies across tissues which may impact the results of the study. The authors' claim that age distribution does not affect the outcomes is inconclusive. Since the study aims to provide cross-tissue analysis, it is important to note that differing age distributions across tissues can influence the overall results. To address this, the authors should conduct downsampling to different age distributions across tissues and evaluate the level of tissue-specific or common changes that remain after the distributions are made similar.

      We acknowledge that variations in age distributions are evident across different tissues, with brain tissues displaying a notably pronounced disparity (green density lines in Figure R2 below).

      To address this issue comprehensively, we conducted tissue-specific downsampling, by reducing the number of samples in a given age window to the minimum available sample size within all age windows for a given tissue. The histograms (density plots) of the number of samples per age window of 16 years considered in the ShARP-LM model, as well as the minimum number of samples in each age window, per tissue are illustrated in Figure R1. After performing downsampling, we computed the logFC and p-value of differential expression for each gene, per age window, and compared them (for all genes in a given age window) with those involving all samples.

      Despite changes in logFC with downsampling, a considerable positive correlation is maintained (Figure R3, top panel). This suggests that the overall trends in gene expression changes persist. However, the downsampling process expectedly results in a decrease of statistical power within each age window concomitant with the decreased sample size, evident from the shift of genes from the third to the first quadrant in Figure R3, bottom panel. Consequently, we have opted for maintaining results encompassing all samples and removing the paragraph in the Discussion that asserted the absence of age distribution impact on the overall outcomes (“Indeed, we found no confounding between the distribution of samples’ ages and the trend of gene expression progression over age in any tissue.”), as we deem it inaccurate, potentially leading to misinterpretation. We have added a supplementary figure (Supplementary Figure 8, identical to Figure R3) illustrating the effect of downsampling, and the following paragraph to the manuscript’s Discussion section:

      “When downsampling to ensure a balanced age distribution, a loss of statistical power is apparent but a considerable positive correlation with the original results is maintained and a substantial number of significant alterations remain so (Supplementary Figure 8).”

      We acknowledge that this limitation can be addressed with the growing accumulation of human tissue transcriptomes in publicly available databases, a trend we anticipate in the near future. We are committed to promptly updating voyAGEr with any new data releases that may offer a solution to this concern.

      Nonetheless, we want to underscore, as the reviewer has astutely pointed out, that while voyAGEr can facilitate cross-tissue comparisons, it must be done with caution. In this regard, we inserted the following paragraph into the Discussion:

      “Due to the tissue-specific nature of the pre-processing steps (v. Read count data preprocessing in the Methods section), and given that most of the plotted gene expression distributions are centred and scaled by tissue, it is important to note that voyAGEr may not be always suited for direct comparisons between different tissues. For instance, it does not allow to directly ascertain if a gene exhibits different expression levels in different tissues or if the expression of a particular gene in one tissue changes more drastically with age than in another tissue.”

      (2.5) The GTEx resource is extremely valuable, however, it comes with challenges. GTEx contains tissue samples from the same individuals across different tissues, resulting in varying degrees of overlap in sample origin across tissues as not all tissues are collected for all individuals. This could affect the similar/different patterns observed across tissues. As this tool is meant for broader use by the community, it is crucial for the authors to either rule out this possibility by conducting a cross-tissue comparison using a non-parametric model that accounts for the dependency between samples from the same individual, or to provide information on the degree of similarity between samples so that the users can keep this possibility in mind when using the tool for hypothesis generation.

      We agree that the variable degrees of overlap between tissues (Figure R4) could lead to a confounding between trends in a population of common individuals and those associated with age. We therefore examined the contributions of variables 'donor,' 'tissue,' and 'age' to the overall variance in the data (Figure R5, panel A), having normalised the data collectively across all tissues. Tissue and donor contribute approximately 90% and 10% of the variance, respectively. Age exhibits minimal impact (around 1%), which may be attributed to the relative subtlety of its effects on gene expression and to the tissue specificity of ageing-associated changes. Notably, removing the 'donor' variable does not transfer this variance to 'age', suggesting a limited confounding between these variables (see Figure R5, panel B).

      We also specifically examined the pairs of tissues exhibiting the lowest (Brain Amygdala / Small Intestine), median (Pancreas / Heart Left Ventricle), and highest (Kidney Cortex / Muscle Skeletal) percentages of shared donors. We identified and selectively removed samples from shared donors while maintaining the original sample size imbalance between tissues. Subsequently, we calculated each gene’s mean expression within each age window from the ShARP-LM pipeline, followed by each gene’s Pearson’s correlation of expression between tissue pairs. The resulting coefficients, both with and without the removal of common donors, were compared in scatter plots (Figure R6, left plots). As this process inherently involves downsampling, which may impact results (v. comment 2.4), we performed additional downsampling by randomly removing samples from both tissues according to the proportions defined for the removal of common donors (Figure R6, right plots).

      In the chosen scenarios, we note a similar impact between the targeted removal of common donors and random downsampling. Nevertheless, the effects of removing samples may vary according to the absolute number of remaining samples. Consequently, singling out individual cases may not provide conclusive insights. To systematically address this, we represented all tissue pairs in a heatmap, colour-coded based on whether the removal of common donors is more impactful (red) or less impactful (blue) than random downsampling (Figure R7). The values depicted in the heatmap, denoted as the Impact of Common Donors (ICD), are computed for each tissue pair. This calculation involves several steps: first, we determined the absolute difference in Pearson’s correlation for each gene’s mean expression within each age window from the ShARP-LM pipeline, between the original data and the subset of data without common donors (DiffWoCD) or with random downsampling (DiffRD). Subsequently, the medians of DiffWoCD and DiffRD are computed, and the difference between these median values provides the ICD for each tissue pair. Due to the unidirectional nature of correlation (i.e., the results for tissue 1 vs tissue 2 mirror those for tissue 2 vs tissue 1), the resulting matrix is triangular in form.

      We have added a supplementary figure (Supplementary Figure 4, a composition of Figures R4-R7, together with a scatterplot relating the values of heatmaps R4 and R7) that aims to provide guidance to users when interpreting specific tissue pairs, acknowledging inherent limitations (refer to comment 2.4). We have also inserted the following paragraph into the manuscript’s Discussion section:

      “Furthermore, we must emphasise that the majority of GTEx donors contributed samples to multiple tissues (Supplementary Figure 4A), potentially introducing biases and confounders when comparing gene expression patterns between tissues. Our analyses of variance (Supplementary Figure 4B) and downsampling to control for common donors (Supplementary Figures 4C-E) suggest very limited global confounding between the impacts of donor and age on gene expression and that any potential cross-tissue bias not to depend much on the proportion of common donors (Supplementary Figure 4E). However, this effect must be taken into account when comparing specific pairs of tissues (e.g., Colon – Transverse and Whole Blood, Supplementary Figure 4D).”

      (2.6) The authors aimed to create an open-source and ever-evolving resource that could be adapted and improved with new functionality. However, this goal was only partially achieved. Although the code for the web app is open source, crucial components such as the statistical tests or the linear model are not included in the repository, limiting the tool's customizability and adaptability.

      We greatly appreciate the reviewer’s concern and share their commitment to maintaining the principles of openness, reproducibility, and adaptability for voyAGEr. voyAGEr was primarily designed as a visualisation tool, displaying pre-processed results, and indeed only the code for the Shiny app itself was accessible through the project's GitHub repository.

      To address this shortcoming, we have made the entire data preprocessing script publicly available in the GitHub repository of voyAGEr. This script encompasses, among others, filtration, normalisation, batch effect correction, the ShARP-LM pipeline and statistical tests employed, and module definition. Moreover, the web app itself offers functionality to export relevant plots and tables.

      (2.7) Furthermore, the authors' choice of visualization platform (R shiny) may not be the best fit for extensibility and open-source collaboration, as it lacks modularity. A more suitable alternative could be production-oriented platforms such as Flask or FastAPI.

      We appreciate this thoughtful concern. The decision to use Shiny was primarily driven by our data having already been prepared in the R environment during pre-processing steps. Consequently, and as the web app serves the purpose of visualisation only (and not data processing), Shiny is as a natural and convenient extension of our scripts, enabling data visualisation seamlessly.

      We acknowledge that Shiny may lack the modularity required for optimal open-source collaboration. While we recognise the merits of alternative platforms like Flask or FastAPI, we decided to keep Shiny because the current iteration of voyAGEr offers significant value to the community. Transitioning to a different platform would be a time-consuming endeavour, that would postpone the release of such resource.

      However, the reviewer’s feedback regarding modularity and open-source collaboration is duly noted and highly valuable. We will certainly take it into account when developing new web applications within our laboratory.

      (2.8) To facilitate collaboration and improve the tool's adaptability, data resulting from the preprocessing pipeline should be made publicly available. This would make it easier for others to contribute and extend the tool's functionality, ultimately enhancing its value for the scientific community.

      As outlined in point 2.6 of this rebuttal letter, certain metadata used in our analysis are subject to restricted access. To address this, we have taken several measures to foster transparency and reproducibility of our analyses. First, we have made the scripts for data pre-processing publicly available, along with a comprehensive explanation of our methodology within the main manuscript. This empowers users to replicate our analyses and provides a foundation for those interested in contributing to the tool's development. Furthermore, we have created new issues on voyAGEr’s GitHub repository, outlining novel features and improvements we envision for the application in the future. We actively encourage users to engage with this section.

      (2.9) It is unfortunate that the manuscript has no line numbers, which makes pointing out language issues or typos cumbersome. Below are some minor typos present in the current version mostly due to inconsistent usage of British vs US English, and the authors would be advised to do a thorough proofreading for the final submission.

      • Page 12: Inconsistent spelling of "analyzed" and "analysed". Should be "analyzed", since US English is used throughout the rest of the paper.

      • Page 14: "randomised"

      • Page 15: "emphasise"

      We apologise for it and include line numbers in the revised version. We have opted for British English and corrected the manuscript accordingly.

      (2.10) Some figures in the supplemental material have a low resolution (e.g. S. Fig 5). Especially figures that are not based on screenshots would ideally be of a higher resolution.

      As voyAGEr is designed as a web application for visualisation, it is inherent that some screenshots of the final resource may have lower resolutions. In response to this concern, we re-generated the figures in this manuscript with a resolution that maintains clarity and readability. We also recreated figures not derived from screenshots, further improving their resolution.

      We saved all figures in PDF format and are sending them together with this letter and the revised manuscript, to address any potential issues related to low-resolution figures that may occur during the export of the Word document.

      <(2.11) In Fig. 1 in the bottom row the sex labels are hard to see.

      We have adapted the figure to address this concern.

      (2.12) Math symbols and equations are not well formatted. For example, the GE equation on p. 13, or Oiij equation should be properly typeset. Also, the Oiij notation might be confusing, I believe the authors meant to use a capital "I", i.e. OI_ij.

      We have incorporated these recommendations into the revised manuscript.

      (2.13) The Readme file in the git repo is very short. It would be helpful to have build and run instructions.

      We have updated the README file in the GitHub repository, which now contains, among other features, instructions for launching the Shiny app and building the associated Docker image. Additionally, a simple tutorial has also been included to assist users in navigating through voyAGEr's functionalities.

      (2.14> "Module" tab's UI inconsistent to other tabs (i.e. "Gene" and "Tissue"), since it contains an "About" page. Adding the "About" page in the actual "Module" page might make the UI clearer.

      We believed that the Modules section, due to its distinct methodology, would benefit from an additional tab explaining its underlying rationale. We relate to the reviewer’s concern regarding the use of tabs throughout the application and made changes to the app in order to ensure consistency.

      (2.15) I would suggest changing the type of the article to "Tools and Resources".

      We agree and followed the reviewer’s suggestion.

      Reviewer 3

      (3.1) In the gene-centric analyses section of the result, to improve this manuscript and database, linear regression tests accounting for the entire range of age should be added. The authors' algorithm, ShARP-LM, tests locally within a 16-year window which makes it has lower power than the linear regression test with the whole ages. I suspect that the power reduction is strongly affected in the younger age range since a larger number of GTEx donors are enriched in old age. By adding the results from the lm tests, readers would gain more insight and evidence into how significantly their interest genes change with age.

      We are grateful for the reviewer's thoughtful and pertinent recommendation and have thus conducted linear regression tests covering the entire age range. The outcomes of these tests have been integrated into the web application, denoted by a dotted orange line on the 'Gene Expression Alterations Over Age' plots. Additionally, a summary of statistics of overall changes, encompassing pvalues, t-statistics, and logFC per year, has been included below the plot title. We have also updated the manuscript to include such changes (v. Methods, Gene-centric visualisation of tissue-specific expression changes across age):

      “We also applied a linear model across the entire age range, thereby providing users with more insight and supporting evidence into how a specific gene changes with age. For visualisation purposes, we incorporated a dashed orange line, with the logFC per year for the Age effect as slope, in the respective scatter plots (Figure 3B c). We depict the Sex effect therein by prominent dots on the average samples, with pink and blue denoting females and males, respectively.”

      Concerning the observation about the potential reduction in statistical power due to the limited number of samples in younger ages, we acknowledge its validity. Indeed, we have addressed this issue in the manuscript's Discussion (v. Supplementary Figure 6).

      (3.1) In line with the ShARP-LM test results, it is not clear which criterion was used to define the significant genes and the following enrichment analyses. I assume that the criterion is P < 0.05, but it should be clearly noted. Additionally, the authors should apply adjusted p-values for multiple-test correction. The ideal criterion is an adjusted P < 0.05. However, if none or only a handful of genes were found to be significant, the authors could relax the criteria, such as using a regular P < 0.01 or 0.05.

      We apologise for any confusion regarding the terminology "significant genes." Our choice to use nonadjusted p-values for determining the significance of gene expression changes with Age, Sex, and their interaction was deliberate, and we would like to clarify our reasoning:

      (1) In the "Gene" tab of the application, individual genes are examined. When users inquire about a specific gene, multiple-testing correction of the p-value does not apply.

      (2) In the "Tissue" tab, using adjusted p-values and a threshold of 0.05 yielded very few differentially expressed genes, limiting the utility of Peaks. Our objective therein is not to assess the significance of alterations in individual genes but to provide a metric for global alterations within a tissue. We then determine significance based on the False Discovery Rate (FDR), using the p-values as a nominal metric of gene expression alterations.

      To avoid using the concept of “differential expression”, commonly linked to significance, we now refer to 'altered genes' in both the manuscript and the app. For clarity and to align with voyAGEr's role as a hypothesis-generation tool, we define 'altered genes' as those with non-adjusted p-values < 0.01 or < 0.05, as discriminated in the Methods section.

      (3.3) In the gene-centric analyses section, authors should provide a full list of donor conditions and a summary table of conditions as supplementary.

      We appreciate the suggestion and we have now included a reference that directs readers to those data, alternatively to including this information as an additional supplementary table. We would like to emphasise that the web app includes information on donor conditions we hypothesise to affect gene expression.

      3.4) The tissue-specific assessment section has poor sub-titles. Every title has to contain information.

      We agree and revised the sub-titles to more accurately reflect the information conveyed in each corresponding section.

      (3.5) I have an issue understanding the meaning of NES from GSEA in the tissue-specific assessment section. The authors performed GSEA for the DEGs against the background genes ordered by tstatistics (from positive to negative) calculated from the linear model. I understand the p-value was two-tailed, which means that both positive and negative NES are meaningful as they represent up-regulated expression direction (positive coefficient) and down-regulated expression direction (negative coefficient) with age, respectively, within a window. However, in the GSEA section of Methods, authors were not fully elaborate on this directionality but stated, "The NES for each pathway was used in subsequent analyses as a metric of its over- or downrepresentation in the Peak". The authors should clearly elaborate on how to interpret the NES from their results.

      We added the following paragraph to the manuscript’s Methods section, in order to clarify the NES’ directionality:

      “We extracted the GSEA normalised enrichment score (NES), which represents the degree to which a certain gene set is overrepresented at the extreme ends of the ranked list of genes. A positive NES corresponds to the gene set’s overrepresentation amongst up-regulated genes within the age window, whereas a negative NES signifies its overrepresentation amongst down-regulated genes. The NES for each pathway was used in subsequent analyses as a metric of its up- or down-regulation in the Peak.”

      (3.6) In the Modules of co-expressed genes section, the authors did not explain how or why they selected the four tissues: brain, skeletal muscle, heart (left ventricle), and whole blood. This should be elaborated on.

      We apologise for not providing a detailed explanation for this selection. As the ‘Modules of coexpressed genes’ section was primarily intended as a proof of concept, we opted to include tissues for which we had a substantial number of samples available and availability of comprehensive cell type signatures, those being the tissues that met such criteria. Nonetheless, as the diversity of cell type signatures increases (e.g., through the increasing availability of scRNA-seq datasets), we plan to encompass a wider range of tissues in the near future. However, as this task is time-demanding and in order to avoid a substantial delay in the release of voyAGEr, we opted to approach this issue in the next version of the App and included a dedicated issue in the projects’ GitHub repository so that users can share their preferences of the next tissues to include.

      We also added a brief sentence in this regard to the Methods section of the manuscript:

      “The four tissues (Brain - Cortex, Muscle - Skeletal, Heart - Left Ventricle, and Whole Blood) covered by the Module section of voyAGEr were selected due to their relatively high sample sizes and availability of comprehensive cell type signatures. The increasing availability of human tissue scRNA-seq datasets (e.g., through the Human Cell Atlas) will allow future updates of voyAGEr to encompass a wider range of tissues.”

      (3.7) In the modules of the co-expressed genes section, the authors did not provide an explanation of the "diseases-manual" sub-tab of the "Pathway" tab of the voyAGEr tool. It would be helpful for readers to understand how the candidate disease list was prepared and what the results represent.

      We greatly appreciate the reviewer's feedback, and in response, we have restructured the 'Modules of co-expressed genes' method section to provide a more comprehensive explanation of the 'diseases' sub-section. To clarify, we obtained a curated set of diseases and their associated genes from DisGeNET v.7.0. We assessed the enrichment of modules in relation to these diseases through two methods: a manual approach utilising Fisher’s tests (i.e. comparing the genes of a given module with the genes associated with a given disease) and another through use of the disgenet2r package, employing the function disease_enrichment. Significance of these enrichments were determined by adjusting p-values using the Benjamini-Hochberg correction.

      (3.8) Most figures have low resolutions, and their fonts are too small to read.

      As already mentioned in issue 2.10, we have recreated all of the images with better resolution to enhance legibility. We also exported such figures in PDF, which we attach to this revision.

      (3.9) Authors used GTEx V7, which is not latest version. Although researchers have developed a huge amount of pipelines and tools for their research, most of them were neglected without a single update. I am sure many users, including myself, would appreciate it if the authors kept updating the database with GTEx V8 for the future version of the database.

      We express our gratitude to the reviewer for their valuable suggestion, and, as already explained in issue 2.1, we have incorporated GTEx V8 into voyAGEr.

      (3.10) I would like to have an option for downloading the results as a whole for gene, tissue, and coexpressed genes. This would be a great option for secondary analysis by users.

      The implementation of such feature would be a time-demanding endeavour that would delay the release of voyAGEr, and we therefore chose not to perform it for this version. However, we agree that it would be a good resource for secondary analyses and acknowledge the possibility of adding this feature in the future. For now, voyAGEr allows the user to download all plots and corresponding data.

      (3.11) How the orders of tissues in the heatmaps (both gene and tissue section) were determined? Did the authors apply hierarchical clustering? If not, I would recommend the authors perform the hierarchical clustering and add it to display the heatmap display.

      We apologise for the oversight in explaining the process behind determining the order of tissues. To clarify, we employed hierarchical clustering to establish the tissue order for visualisation within the app. Although the reviewer suggested adding a dendrogram to illustrate this clustering, we decided against it. The reason for such is that including a dendrogram, while informative, is not essential for the app's primary purpose.

      (3.12) I understand that this is a vast amount of work, but I hope that the authors can expand the coexpressed module analysis to include other tissues in the future version of the database.

      Knowing what co-expressed genes in line with aging are and their pathway and disease enrichments across tissues would be highly informative, and I'm sure many users, including myself, would greatly appreciate it. <br /> We express our gratitude to the reviewer for the valuable suggestion and for acknowledging the extensive effort required to incorporate new tissues into the module section. We completely agree that understanding co-expressed genes across the aging process is of significant value, and we are committed to the ongoing inclusion of additional tissues. As already stated in issue 3.6, comprehensive list of tissues slated for integration in future voyAGEr versions is readily available on voyAGEr’s GitHub repository.

      Author response image 1.

      Density plots (“smoothed” histograms) of the distribution of numbers of samples per moving age window for the ShARP-LM pipeline, categorised by tissue. The numerical value within each rectangle represents the minimum number of samples observed across all age windows for that particular tissue.

      Author response image 2.

      Density lines (“smoothed” histograms) of the distribution of the age of donors per tissue. As depicted in the chart, there are more samples for older ages, particularly of brain tissues.

      Author response image 3.

      Effect of downsampling in ShARP-LM results. A – Per tissue violin plots of gene-wide distributions of Pearson’s correlation coefficients between original and downsampled logFC values for the Age variable across age windows, with tissues coloured by and ordered by increasing percentage of downsampling-associated reduction in the number of samples. B – Density scatter plots of comparison of associated original and downsampled p-values for each tissue, coloured by the downsampling percentage in each age window, highlighting the low range of p-values (from 0 to 0.1). Despite changes in logFC with downsampling, a considerable correlation in significance is maintained, although downsampling naturally results in a loss of statistical power, evident by the shift of points towards the first quadrant (dashed lines: p-value = 0.05).

      Author response image 4.

      Heatmap depicting the percentage of common donors between pairs of tissues. A given square illustrates the percentage of all samples of tissue in the x axis (Tissue 1) that is in common with the tissue in the y axis (Tissue 2)

      Author response image 5.

      Assessment of the relative contributions of different sources to the dataset’s variance. A - tissue accounts for approximately 90% of the total variance, while donor contributes around 10%; age has a minimal impact (1%), likely due to the relative subtlety of its effects on gene expression and to the tissue specificity of ageing dynamics. B - Removal of the donor variable does not transfer variance to age, suggesting limited confounding between the two variables.

      Author response image 6.

      Impact of the relative proportion of common donors on gene expression correlation between tissue pairs. Panels A, B, and C showcase the tissue pairs with the highest (Muscle Skeletal / Kidney Cortex), median (Pancreas / Heart Left Ventricle), and lowest (Small Intestine / Brain Amygdala) percentages of common donors, respectively. The left panels illustrate gene-bygene Pearson’s correlations of gene expression between the two tissues, comparing the scenarios with (x-axis) and without (yaxis) the removal of common donors. The ri ght panels depict the same comparisons, but with random downsampling (y-axis) in both tissues based on the proportions defined for common donor removal. The depicted examples show that the outcomes are comparable when removing common donors or employing random downsampling.

      Author response image 7.

      Comparison of the impacts of removing common donor samples and random downsampling across tissue pairs. The heatmap is coloured based on whether the removal of common donors has a greater (red) or lesser impact (blue) than random downsampling. The values depicted in the heatmap, denoted as the Impact of Common Donors (ICD), are computed for each tissue pair. This calculation involves several steps: first, by determining the absolute difference in Pearson’s correlation for each gene’s mean expression within each age window from the ShARP-LM pipeline, between the original data and the subset of data without common donors (DiffWoCD) or with random downsampling (DiffRD). Subsequently, the medians of DiffWoCD and DiffRD are computed, and the difference between these median values provides the ICD for each tissue pair. Due to the unidirectional nature of correlation (i.e., the results for tissue 1 vs tissue 2 mirror those for tissue 2 vs tissue 1), the resulting matrix is triangular in form. Grey tiles denote NA values, i.e., where the tissue-tissue comparison does not have a meaning, namely self-self and between sex-specific tissues. Top right insert: density line (“smoothed” histogram) of all ICD values.

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Fernandez et al. investigate the influence of maternal behavior on bat pup vocal development in Saccopteryx bilineata, a species known to exhibit vocal production learning. The authors performed detailed longitudinal observations of wild mother-pup interactions to ask whether non-vocal maternal displays during juvenile vocal practice or 'babbling', affect vocal production. Specifically, the study examines the durations of pup babbling events and the developmental babbling phase, in relation to the amount of female display behavior, as well as pup age and the number of nearby singing adult males. Furthermore, the authors examine pup vocal repertoire size and maturation in relation to the number of maternal displays encountered during babbling. Statistical models identify female display behavior as a predictor of i) babbling bout duration, ii) the length of the babbling phase, iii) song composition, and iv) syllable maturation. Notably, these outcomes were not influenced by the number of nearby adult males (the pups' source of song models) and were largely independent of general maturation (pup age). These findings highlight the impact of non-vocal aspects of social interactions in guiding mammalian vocal development.

      We thank Reviewer 1 for the time and effort dedicated to the revision of our study. The suggestions for the revision of our manuscript were very helpful and have improved our manuscript considerably. 

      Strengths:

      Historically, work on developmental vocal learning has focused on how juvenile vocalizations are influenced by the sounds produced by nearby adults (often males). In contrast, this study takes the novel approach of examining juvenile vocal ontogeny in relation to non-vocal maternal behavior, in one of the few mammals known to exhibit vocal production learning. The authors collected an impressive dataset from multiple wild bat colonies in two Central American countries. This includes longitudinal acoustic recordings and behavioral monitoring of individual mother-pup pairs, across development.

      The identified relationships between maternal behavior and bat pup vocalizations have intriguing implications for understanding the mechanisms that enable vocal production learning in mammals, including human speech acquisition. As such, these findings are likely to be relevant to a broad audience interested in the evolution and development of social behavior as well as sensory-motor learning.

      We thank reviewer 1 for this assessment. 

      Weaknesses:

      The authors qualitatively describe specific patterns of female displays during pup babbling, however, subsequent quantitative analyses are based on two aggregate measures of female behavior that pool across display types. Consequently, it remains unclear how certain maternal behaviors might differentially influence pup vocalizations (e.g. through specific feedback contingencies or more general modulation of pup behavioral states).

      In analyzing the effects of maternal behavior on song maturation, the authors focus on the most common syllable type produced across pups. This approach is justified based on the syllable variability within and across individuals, however, additional quantification and visual presentation of categorized syllable data would improve clarity and potentially strengthen resulting claims.

      We agree that our analysis of maternal behaviour does not investigate potential contingencies between particular maternal behavioural displays and pup vocalizations (e.g. particular syllable types). Our data collected for this study on maternal behaviour includes direct observations, field notes and/or video recordings. In the future, it will be necessary to work with high-speed cameras for the analysis of potential contingencies between particular maternal behavioural displays and specific pup vocalizations, which allow this kind of fine-detailed analysis. We have planned future studies investigating whether pup vocalizations elicit contingent maternal responses or vice versa. In the revision of our manuscript, we have included a comment pointing out that this special behaviour will be investigated in greater detail in the future. 

      As suggested by reviewer 1, in our revised manuscript we have included more information on methods to improve understandability. In particular, we have:

      -presented more information on different steps of our acoustic analyses

      -provided additional and clearer spectrogram figures representing the different syllable types and categorizations 

      -changed the figures accompanying our GLMM analyses following the suggestion of Reviewer 1

      Reviewer #2 (Public review):

      Summary:

      This study explores how maternal behaviors influence vocal learning in the greater sac-winged bat (Saccopteryx bilineata). Over two field seasons, researchers tracked 19 bat pups from six wild colonies, examining vocal development aspects such as vocal practice duration, syllable repertoire size, and song syllable acquisition. The findings show that maternal behaviors significantly impact the length of daily babbling sessions and the overall babbling phase, while the presence of adult male tutors does not.

      The researchers conducted detailed acoustic analyses, categorizing syllables and evaluating the variety and presence of learned song syllables. They discovered that maternal interactions enhance both the number and diversity of learned syllables and the production of mature syllables in the pups' vocalizations. A notable correlation was found between the extent of acoustic changes in the most common learned syllable type and maternal activity, highlighting the key role of maternal feedback in shaping pups' vocal development.

      In summary, this study emphasizes the crucial role of maternal social feedback in the vocal development of S. bilineata. Maternal behaviors not only increase vocal practice but also aid in acquiring and refining a complex vocal repertoire. These insights enhance our understanding of social interactions in mammalian vocal learning and draw interesting parallels between bat and human vocal development.

      We thank reviewer 2 for his/her time and effort dedicated to the revision of our study. The suggestions were very helpful in improving our manuscript. 

      Strengths:

      This paper makes significant contributions to the field of vocal learning by looking at the role of maternal behaviors in shaping the vocal learning phenotype of Saccopteryx bilineata. The paper uses a longitudinal approach, tracking the vocal ontogeny of bat pups from birth to weaning across six colonies and two field seasons, allowing the authors to assess how maternal interactions influence various aspects of vocal practice and learning, providing strong empirical evidence for the critical role of social feedback in non-human mammalian vocal learners. This kind of evidence highlights the complexity of the vocal learning phenotype and shows that it goes beyond the right auditory experience and having the right circuitry.

      The paper offers a nuanced understanding of how specific maternal behaviors impact the acquisition and refinement of the vocal repertoire, while showing the number of male tutors - the source of adult song - did not have much of an effect. The correlation between maternal activity and acoustic changes in learned syllable types is a novel finding that underscores the importance of non-vocal social interactions in vocal learning. In vocal learning research, with some notable exceptions, experience is often understood as auditory experience. This paper highlights how, even though that is one important piece of the puzzle, other kinds of experience directly affect the development of vocal behavior. This is of particular importance in the case of a mammalian species such as Saccopteryx bilineata, as this kind of result is perhaps more often associated with avian species.

      Moreover, the study's findings have broader implications for our understanding of vocal learning across species. By drawing parallels between bat and human vocal development (and in some ways to bird vocal development), the paper highlights common mechanisms that may underlie vocal practice and learning in both humans and other mammals. This interdisciplinary perspective enriches the field and encourages further comparative studies, ultimately advancing our knowledge of the evolutionary and developmental processes that shape vocal productive learning in all its dimensions.

      We thank reviewer 2 for this assessment. 

      Weaknesses:

      Some weaknesses can be pointed out, but in fairness, the authors acknowledge them in one way or another. As such, these are not flaws per se, but gaps that can be filled with further research.

      Experimental manipulations, such as controlled playback experiments or controlled environments, could strengthen the causal claims by directly testing the effects of specific maternal behaviors on vocal development. Certainly, the strengths of the paper will be consolidated after such work is performed.

      The reliance on the number of singing males as a proxy for social acoustic input. This measure does not account for the variability in the quality, frequency, or duration of the male songs to which the pups are exposed. A more detailed analysis of the acoustic environment, including direct measurements of song exposure and its impact on vocal learning, would provide a clearer understanding of the role of male tutors.

      Finally, and although it would be unlikely that these results are unique to Saccopteryx bilineata, the study's focus on a single species limits at present the generalizability of some of its findings to other vocal learning mammals. While the parallels drawn between bat and human vocal development are intriguing, the conclusions will be more robust when supported by comparative studies involving multiple species of vocal learners. This will help to identify whether the observed maternal influences on vocal development reported here are unique to Saccopteryx bilineata or represent a broader phenomenon in chiropteran, mammalian, or general vocal learning. Expanding the scope of research to include a wider range of species and incorporating cross-species comparisons will significantly enhance the contribution of this study to the field of vocal learning.

      Thank you for your suggestions and comments. 

      Regarding your main comment 1: In the future, we plan to implement temporary captivity experiments to investigate how maternal behaviours affect pup vocal development. This study provides the necessary basis for conducting future playback studies investigating specific behaviours in a controlled environment.

      Regarding your main comment 2: We completely agree that the number of singing males only represents a proxy for acoustic input that pups receive during ontogeny. In the future, we plan to investigate in detail how the acoustic landscape influences pup vocal development and learning. This will include quantifying how long pups are exposed to song during ontogeny and assessing the influence of different tutors, including a detailed analysis of song syllables of the adult tutors to compare it to vocal trajectories of song syllables in pups. 

      Regarding your main comment 3: We also fully agree that it is unlikely that these results are unique to Saccopteryx bilineata. We are certain that other mammalian vocal learners show parallels to the vocal development and learning processes of S. bilineata. Especially bats are a promising taxon for comparative studies because their vocal production and perception systems are highly sophisticated (due to their ability to echolocate). The high sociability of this taxon also includes a variety of social systems and vocal capacities (e.g. regarding vocal repertoire size, vocal learning capacities, information content, etc.) which support social learning and social feedback – as shown in our study. 

      As suggested, in our revised manuscript we have includes information on the validation of the ethogram. Furthermore, we have corrected all the spelling mistakes – thank you very much for pointing them out!

      Recommendations for the authors:  

      Reviewer #1 (Recommendations for the authors):

      The following comments and suggestions are offered to improve clarity and strengthen support for the paper's main claims.

      (1) Female displays as feedback:

      a) The authors rather broadly describe maternal behavior as feedback based on its occurrence during pup babbling. Feedback typically entails some degree of response contingency, which is not explicitly established here. Although the authors qualitatively describe a variety of female displays that only occur within the babbling context, they also state that "all these behaviors could occur singly or in an interactive way" (Line 102). The authors go on to use aggregate counts of these diverse female displays in their analyses. It would of course be interesting to know whether distinct female displays are evoked differentially by pup behavior and whether specific female behaviors, in turn, predict subsequent pup vocalizations. A display-specific approach might also reveal more about the mechanisms by which the female behavior shapes babbling (e.g. specific reinforcement signals vs. more graded social facilitation or 'audience effect'). However, even without identifying such finegrained contingencies, the main text should at least mention the results shown in Figure 1A. Namely, that pups initiate ~80% of interactive behavioral sequences, suggesting that subsequent maternal displays are likely to be pup-contingent responses (i.e. feedback) and not simply co-occurring behavior.

      We fully agree with Reviewer 1 that it would be very informative to investigate whether distinct female displays are evoked differentially by pup behavior, such as specific syllables within babbling. Or conversely, whether specific female behaviors precede particular pup vocalizations. For this study, we documented maternal behavior through direct observations, field notes, and/or video recordings. However, to capture potential contingencies between specific maternal behavioral displays and vocalization occurring in the millisecond range, other data collection methods (e.g. high-speed camera) will be required in the future. 

      Related to this, we have included the following statements (see below). Statement 1 also cites a very recent study in zebra finches, demonstrating that female calls can promote song learning success (Bistere et al. 2024, line 57, lines 304-305). 

      Lines 297-305: This finding serves as an initial indication that non-vocal interactions with the mother may influence a pup´s individual learning trajectories. Future studies will focus on the relationship between acoustic change, maternal feedback, and learning success, specifically investigating contingencies between particular pup vocalizations and maternal displays in natural settings. Playback experiments are an additional approach to test the impact of contingency on vocal learning. For example, one study in zebra finches demonstrated that contingent non-vocal maternal feedback affects imitation success (Carouso-Peck & Goldstein, 2019), while another recent study found that female calls can promote song learning but the role of contingency remains to be determined (Bistere et al., 2024).  

      Lines: 332-334: This might also apply to S. bilineata where pups initiated ~ 80% of social interactions, suggesting that maternal feedback is likely influenced by the pup´s vocal practice.  

      b) The authors claim that the number of maternal displays during babbling predicts the duration of babbling bouts (Figure 1D). I find this analysis - and others based on the raw number of behaviors during babbling - difficult to interpret given that the raw number of displays may depend upon the duration of the babbling bout over which they are counted. In other words, might the number of displays reflect the fact that more displays can occur within the interval of longer babbling bouts? It would be relatively straightforward to minimize this potential confound by testing whether female display *rates* predict longer bouts.

      We calculated the display rates (maternal displays per bout duration) and conducted a GLMM (the same analysis after log-transformation and scaling) like in our original manuscript (model 1).  

      GLMM

      summary(vocpracf)

      Generalized linear mixed model fit by maximum likelihood (Laplace Approximation) ['glmerMod']  Family: Gamma  ( log )

      Formula: bout_dur ~ age.z + behavioural_quotient.log.z + nomales.z + (1 | ID) Data: set1

      Author response table 1.

      Author response table 2.

      Author response table 3.

      Author response table 4.

      Author response table 5.

      Interpretation: Our analysis in the original manuscript shows that the bout duration increases with number of maternal displays. As reviewer 1 points out: more time offers more opportunities for the mother to show displays. The number of displays in longer bouts could just reflect that more displays are possible in a longer period. This could be a potential confounding factor. However, our analysis of display rates as an explaining factor shows that the relationship between bout duration and display rate is negative. This means that in longer bouts the displays increase (as seen in the first scenario), but they happen less frequently per time unit. This could indicate that in longer bouts, the mother takes breaks or longer periods of time between each display, which decreases the frequency of displays. This minimizes the risk of a potential confound, as it shows that the rate of displays tends to decrease rather than increase in longer bouts. In summary: The display rate does not appear to ‘favour’ longer bouts, as longer bouts are associated with a lower display rate. This speaks against the hypothesis that the number of displays only increases due to the longer bout duration. This also means that our analyses, which show that maternal displays influence song syllable production, are not biased or confounded by the bout duration. This suggests that maternal behaviour is targeted and selective, and represents a potentially contingent reaction to the pup´s vocal production, and is not simply determined by the duration of a bout.

      We added this analysis in our supplementary material (Table S2) and pointed this out in the revision of our main manuscript (lines 136-138). 

      c) The introduction states that "Pup babbling is not tied to a specific function." (Lines 75-78). This may be an important point worth exploring with this unique data set. For example, the termination of a babbling bout is defined in some cases by the onset of nursing. Have the authors (or others) tested whether babbling elicits nursing behavior? If so, this may represent a reinforcement mechanism that affects babbling rates and subsequent song outcomes. Similar functional shifts in developing vocal behavior have been reported in male chipping sparrows, in which juvenile begging calls - which initially elicit parental feeding behavior - can later be incorporated into 'sub-song' (i.e. babbling) during the development of courtship song (Lui, Wada, Nottebohm, PLOS ONE, 2009).

      Thank you for pointing out this interesting study on chipping sparrows! 

      To address your question: Strauss et al. (2010) conducted a study on pup and maternal behaviors, demonstrating that babbling did not consistently result in nursing.  When denied care, pups often returned to resting or grooming, a pattern we also observed in our study. While nursing might provide an additional reinforcement mechanisms, it is not the cause that evokes babbling – this is what we mean by stating “pup babbling is not tied to a specific function”. Babbling is not a begging behavior as described by Lui et al. 2009. As mentioned in the review of ter Haar et al. 2021, babbling differs structurally from begging in that it is composed of both adult-like and juvenile syllables and lacks context specificity. To solicit care (i.e. begging) pups produce several isolation calls in a fast repetitive manner. We added a more detailed explanation to make this distinction clear (lines 79-83).

      Another interesting fact and probably more comparable to the study of the chipping sparrows – in which begging calls are incorporated into subsong practice – might be the isolation call syllables of S. bilineata. Directly after birth, S. bilineata pups produce multisyllabic isolation calls (see Knörnschild & von Helversen 2008, Knörnschild et al. 2012, Fernandez & Knörnschild 2017) that serve to solicit maternal care. For the first 2.5 weeks, pups only produce innate vocalizations, including echolocation and isolation calls (Fernandez et al. 2021). During the babbling phase, the syllables encoding the individual (and group) signature of the isolation call are also incorporated into babbling bouts. The production of isolation calls might also mark an initial step in the vocal learning process. However, in contrast to the subsong of chipping sparrows, babbling bouts in S. bilineata also include syllables acquired through vocal imitation. Thus, although we find similarities in vocal practice and development between chipping sparrows and S. bilineata, there are also distinct differences. 

      (2) Are pups exposed to more male songs when the mother is present?

      The number of singing males in each colony was used as a reasonable proxy for the amount of social acoustic input. However, I wonder if pups are exposed to more adult male songs when the mother is present and, relatedly, if females tend to remain present for longer if a pup is babbling (potentially increasing its exposure to male songs during the babbling phase).

      The mother is always present when males are singing. In S. bilineata, males predominantly engage in territorial song twice daily: at dusk and dawn. After foraging at night, territorial singing males are the first to return to the roost, and females will only return when they hear male song. Pups are either attached to the mother´s belly or – when growing older – will fly into the roost followed by the mother. In the evening, males sing approximately half an hour before leaving for foraging. Females will usually leave first, followed by their pups, and males leave last. Hence, females/mothers are always present when pups are exposed to male acoustic input.  

      (3) Pup sex differences:

      The authors test for sex differences within a subset of pups and briefly mention that vocal development is considered in both males and females. This presumably means that female pups also exhibit vocal imitation of adult male territorial songs, even though they only produce these vocalizations during the babbling phase, after which they stop singing entirely. If so, this would, to my knowledge, be a unique phenomenon among vocal learners and would be interesting to discuss in greater detail.

      We followed your recommendation and discussed this topic in greater detail. We included the following part in our discussion (lines 257-269): An intriguing aspect of this species is that, unlike most song-learning songbird species, female pups show no differences from males in babbling behavior and vocal development (Fernandez et al. 2021). This study corroborated this finding: female pups received the same maternal feedback, and their song syllable imitation did not differ in any way from male pups (as observed as well in Knörnschild et al. 2010). This phenomenon is rare among vocal learners and raises the question of why female pups match male vocal development despite not using the learned vocalizations later in life. One potential explanation might lie in the function of the territorial song for adult females: it serves as an acoustic signal to help females locate new suitable colonies after dispersal. The territorial song exhibits different dialects, with females showing a preference for local over foreign dialects (Knörnschild et al., 2017). The own early practice and production of song might enhance the ability to evaluate male song and support mating decisions.

      (4) Characterization of song syllables:

      The authors explain their acoustic analyses in detail within the methods, however, descriptions of the syllable classification procedures and acoustic movement analyses need to be presented more clearly in the main text, so readers unfamiliar with bioacoustics or previous work can follow the logic. Also, given the qualitative descriptions of the data and the two spectrogram examples provided (Figures 2 and S1), it is difficult for the reader to fully evaluate the suitability and output of these critical procedures.

      Suggestions:  

      - Qualitative descriptions of syllable characteristics (i.e. buzz, pulse, trill, ripple, gap, smeared noisy, precursor syllable, mature syllable, adult-like syllable, early vs. late babbling phase, syllable name, etc) should all be clearly-labeled in example spectrograms and used consistently, without using different terms interchangeably (e.g. mature vs. adult-like).

      We understand that we should provide a clearer description of the various terms essential to understanding this study. We added a “Terminology” box (line 158) to the main manuscript, defining the acoustic terms we are using throughout our study. Additionally, we enhanced Figure S1 by providing more detailed information on the spectrogram that displays the five distinct song syllable types. Moreover, we included an additional spectrogram in the supplementary material (Fig. S2) displaying examples of precursor and mature syllables for syllable B2. In the method section, “The acoustic movement during ontogeny”, we added a sentence clarifying the terms “early” and “late babbling phase” (Lines 605-606). 

      - Show as you tell. Plot the data, at least from a representative pup, for each major step in the analyses (labeled spectrogram, PCA plots with distinct syllable clusters, high vs. low versatility, precursor vs. mature variants, early vs. late syllables with Euclidean distances between centroids and relation to "generic" adult male syllables, etc.)

      To illustrate the acoustic analysis more comprehensively, we have made the following additions:

      -we included a Figure (Fig. S3) in the supplementary materials showing an excerpt of a babbling bout with labelled syllables to illustrate how we analyzed a) total song syllable count per bout, b) versatility per bout, and c) the number of precursor versus mature B2 syllables (the most common syllable type).

      -Additionally, we included a spectrogram with three exemplary B2 syllables to illustrate the acoustic parameter extraction with Avisoft SASLab Pro software for subsequent analysis of vocal change during development (Fig. S4 A).

      Lastly, we included a DFA for one of the colonies with three exemplary pups to illustrate how we calculated each pup's acoustic change during ontogeny (Fig. S4 B). 

      (5) Minor Comments and Corrections:

      - Modeled data are log-transformed, however, the raw data are plotted on linear scales, and in most cases, data points are densely clustered and overlapping at lower values. Plotting the data on log scales would likely aid visibility.

      We appreciate this suggestion and changed the plots accordingly. 

      - Figure 1E displays 18 data points, (legend says n=19).

      The legend is correct; the figure includes 19 data points. Two mothers have the same activity score, so their points are at the same location and it looks like there are only 18 data points. 

      - Line 482: Is "VCL" media player meant to refer to "VLC" player?

      Yes, thank you for spotting that. We corrected it.  

      Reviewer #2 (Recommendations for the authors):

      I have only a couple of comments:

      - Perhaps it would be useful to briefly go over the validation used for the ethogram in Table S1.

      The behaviors listed in the ethogram were defined based on Strauss et al. (2010) and expanded based on our own observations. For consistency, we developed these definitions and trained the students analyzing behavioral data for this study. During the training phase, we validated their analyses until the inter-observer-reliability reached 100% (lines 507-508).  

      - The paper seems to be generally written in American English, yet there are some instances of British English spelling, e.g. "standardised"/"standardisation": table 1, table 2, lines 143, 228, 524, 525, 531, 546, 547, 554, 560, 561.

      Thank you for spotting these errors, we corrected them.  

      - Line 343: "at libitum" should be "ad libitum".

      Thank you for spotting this error. We corrected it.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      The authors present a modelling study to test the hypothesis that horizontal gene transfer (HGT) can modulate the outcome of interspecies competition in microbiomes, and in particular promote bistability in systems across scales. The premise is a model developed by the same authors in a previous paper where bistability happens because of a balance between growth rates and competition for a mutual resource pool (common carrying capacity). They show that introducing a transferrable element that gives a "growth rate bonus" expands the region of parameter space where bistability happens. The authors then investigate how often (in terms of parameter space) this bistability occurs across different scales of complexity, and finally under selection for the mobile element (framed as ABR selection).

      Strengths:

      The authors tackle an important, yet complex, question: how do different evolutionary processes impact the ecology of microbial ecosystems? They do a nice job at increasing the scales of heterogeneity and asking how these impact their main observable: bistability.

      We appreciate the reviewer for agreeing with the potential value of our analysis. We are also grateful for the constructive comments and suggestions on further analyzing the influence of the model structure and the associated assumptions. We have fully addressed the raised issues in the updated manuscript and below.

      Weaknesses:

      The author's starting point is their interaction LV model and the manuscript then explores how this model behaves under different scenarios. Because the structure of the model and the underlying assumptions essentially dictate these outcomes, I would expect to see much more focus on how these two aspects relate to the specific scenarios that are discussed. For example:

      A key assumption is that the mobile element conveys a multiplicative growth rate benefit (1+lambda). However, the competition between the species is modelled as a factor gamma that modulates the competition for overall resource and thus appears in the saturation term (1+ S1/Nm + gamma2*S2/Nm). This means that gamma changes the perceived abundance of the other species (if gamma > 1, then from the point of view of S1 it looks like there are more S2 than there really are). Most importantly, the relationship between these parameters dictates whether or not there will be bistability (as the authors state).

      This decoupling between the transferred benefit and the competition can have different consequences. One of them is that - from the point of view of the mobile element - the mobile element competes at different strengths within the same population compared to between. To what degree introducing such a mobile element modifies the baseline bistability expectation thus strongly depends on how it modifies gamma and lambda.

      Thus, this structural aspect needs to be much more carefully presented to help the reader follow how much of the results are just trivial given the model assumptions and which have more of an emergent flavour. From my point of view, this has an important impact on helping the reader understand how the model that the authors present can contribute to the understanding of the question "how microbes competing for a limited number of resources stably coexist". I do appreciate that this changes the focus of the manuscript from a presentation of simulation results to more of a discussion of mathematical modelling.

      We thank the reviewer for the insightful suggestions. We agree with the reviewer that the model structure and the underlying assumptions need to be carefully discussed, in order to understand the generality of the theoretical predictions. In particular, the reviewer emphasized that how HGT affects bistability might depend on how mobile genetic elements modified growth rates and competition. In the main text, we have shown that when mobile genes only influence species growth rates, HGT is expected to promote multistability (Fig. 1 and 2). However, when mobile genes modify species interactions, the effect of HGT on multistability is dependent on how mobile genes change competition strength (Fig. 3a to f). When mobile genes increase competition, HGT promotes multistability (Fig. 3c and e). In contrast, when mobile genes relax competition, HGT is expected to reduce multistability (Fig. 3d and f).

      In light of the reviewer’s comments, we have further generalized the model structure, by accounting for the scenario where mobile genes simultaneously modify growth rates and competition. The effect of mobile genes on growth rates is represented by the magnitude of 𝜆’s, and the influence on competition is described by another parameter 𝛿. By varying these two parameters, we can evaluate how the model structure and the underlying assumptions affect the baseline expectation. We performed additional simulations with broad ranges of 𝜆 and 𝛿 values. In particular, we analyzed whether HGT would promote the likelihood of bistability in two-species communities compared with the scenario without gene transfer (Fig. 3g-i). Our results suggested that: (1) With or without HGT, reducing 𝜆 (increasing neutrality) promotes bistability; (2) With HGT, increasing 𝛿 promotes bistability; (2) Compared with the population without HGT, gene transfer promotes bistability when 𝛿 is zero or positive, while reduces bistability when 𝛿 is largely negative. These results agree with the reviewer’s comment that the baseline bistability expectation depends on how HGT modifies gamma and lambda. In the updated manuscript, we have thoroughly discussed how the model structure and the underlying assumptions can influence the predictions (line 238-253). 

      We further expanded our analysis, by calculating how other parameters, including competition strength, growth rate ranges, and death/dilution rate, would affect the multistability of communities undergoing horizontal gene transfer (Fig. S2, S3, S9, S10, S11, S12, S13, S15). Together with the results presented in the first draft, these analysis enables a more comprehensive understanding of how different mechanisms, including but not limited to HGT, collectively shaped community multistability. In the updated manuscript, the reviewer can see the change of focus from exploring the effects of HGT to a more thorough discussion of the mathematical model. The revised texts highlighted in blue and the supplemented figures reflect such a change.

      Reviewer #2 (Public review):

      Summary:

      In this work, the authors use a theoretical model to study the potential impact of Horizontal Gene Transfer on the number of alternative stable states of microbial communities. For this, they use a modified version of the competitive Lotka Volterra model-which accounts for the effects of pairwise, competitive interactions on species growth-that incorporates terms for the effects of both an added death (dilution) rate acting on all species and the rates of horizontal transfer of mobile genetic elements-which can in turn affect species growth rates. The authors analyze the impact of horizontal gene transfer in different scenarios: bistability between pairs of species, multistability in communities, and a modular structure in the interaction matrix to simulate multiple niches. They also incorporate additional elements to the model, such as spatial structure to simulate metacommunities and modification of pairwise interactions by mobile genetic elements. In almost all these cases, the authors report an increase in either the number of alternative stable states or the parameter region (e.g. growth rate values) in which they occur.

      In my opinion, understanding the role of horizontal gene transfer in community multistability is a

      very important subject. This manuscript is a useful approach to the subject, but I'm afraid that a thorough analysis of the role of different parameters under different scenarios is missing in order to support the general claims of the authors. The authors have extended their analysis to increase their biological relevance, but I believe that the analysis still lacks comprehensiveness.

      Understanding the origin of alternative stable states in microbial communities and how often they may occur is an important challenge in microbial ecology and evolution. Shifts between these alternative stable states can drive transitions between e.g. a healthy microbiome and dysbiosis. A better understanding of how horizontal gene transfer can drive multistability could help predict alternative stable states in microbial communities, as well as inspire novel treatments to steer communities towards the most desired (e.g. healthy) stable states.

      Strengths:

      (1) Generality of the model: the work is based on a phenomenological model that has been extensively used to predict the dynamics of ecological communities in many different scenarios.

      (2) The question of how horizontal gene transfer can drive alternative stable states in microbial communities is important and there are very few studies addressing it.

      We thank the reviewer for the positive comments on the potential novelty and conceptual importance of our work. We are also grateful for the constructive suggestions on the generality and comprehensiveness of our analysis. In particular, we agree with the reviewer that a thorough analysis of the role of different parameter could further improve the rigor of this work. We have fully addressed the raised issues in the updated manuscript and below.

      Weaknesses:

      (1) There is a need for a more comprehensive analysis of the relative importance of the different model parameters in driving multistability. For example, there is no analysis of the effects of the added death rate in multistability. This parameter has been shown to determine whether a given pair of interacting species exhibits bistability or not (see e.g. Abreu et al 2019 Nature Communications 10:2120). Similarly, each scenario is analyzed for a unique value of species interspecies interaction strength-with the exception of the case for mobile genetic elements affecting interaction strength, which considers three specific values. Considering heterogeneous interaction strengths (e.g. sampling from a random distribution) could also lead to more realistic scenarios - the authors generally considered that all species pairs interact with the same strength. Analyzing a larger range of growth rates effects of mobile genetic elements would also help generalize the results. In order to achieve a more generic assessment of the impact of horizontal gene transfer in driving multistability, its role should be systematically compared to the effects of the rest of the parameters of the model.

      We appreciate the suggestions. For each of the parameters that the reviewer mentioned, we have performed additional simulations to evaluate its importance in driving multistability. 

      For the added death rate, we have calculated the bistability feasibility of two-species populations under different values of 𝐷. Our results suggested that (1) varying death rate indeed changed the bistability probability of the system; (2) when the death rate was zero, mobile genetic elements that only modify growth rates would have no effects on system’s bistability. These results highlighted the importance of added death rate in driving multistability (Fig. S2, line 136-142). 

      For the interspecies interaction strength, we first extended our analysis on two-species populations. By calculating the bistability probability under different values of 𝛾, we showed that when interspecies interaction strength was smaller than 1, the influence of HGT on population bistability became weak (Fig. S3, line 143-147). We also considered heterogenous interaction strengths in multispecies communities, by randomly sampling 𝛾<sub>ij</sub> values from uniform distributions. While our results suggested the heterogeneous distribution of 𝛾<sub>ij</sub> didn’t fundamentally change the main conclusion, the mean value and variance of 𝛾<sub>ij</sub> affected the influence of HGT on multistability. The effects of HGT on community multistability becomes stronger when the mean value of 𝛾<sub>ij</sub> gets larger than 1 and the variance of 𝛾<sub>ij</sub> is small (Fig. S12, line 190-196).

      We also analyzed different ranges of growth rates effects of mobile genetic elements. In particular, we sampled 𝜆<sub>ij</sub> values from uniform distributions with given widths. Greater width led to larger range of growth rate effects. We used five-species populations as an example and tested different ranges. Our results suggested that multistability was more feasible when the growth rate effects of MGEs were small. The qualitative relationship between HGT and community was not dependent on the range of growth rate effects (Fig. S13, line 197-205).

      (2) The authors previously developed this theoretical model to study the impact of horizontal gene transfer on species coexistence. In this sense, it seems that the authors are exploring a different (stronger interspecies competition) range of parameter values of the same model, which could potentially limit novelty and generality.

      We appreciate the comment. In a previous work (PMID: 38280843), we developed a theoretical model that incorporated horizontal gene transfer process into the classic LV framework. This model provides opportunities to investigate the role of HGT in different open questions of microbial ecology. In the previous work, we considered one fundamental question: how competing microbes coexist stably. In this work, however, we focused on a different problem: how alternative stable states emerge in complex communities. While the basic theoretical tool that we applied in the two works were similar, the scientific questions, application contexts and the implications of our analysis were largely different. The novelty of this work arose from the fact that it revealed the conceptual linkage between alternative stable states and a ubiquitous biological process, horizontal gene transfer. This linkage is largely unknown in previous studies. Exploring such a linkage naturally required us to consider stronger interspecies competitions, which in general would diminish coexistence but give rise to multistability. We believe that the analysis performed in this work provide novel and valuable insights for the field of microbial ecology. 

      With all the supplemented simulations that we carried out in light of the all the reviewer’s comments, we believe the updated manuscript also provide a unified framework to understand how different biological processes collectively shaped the multistability landscape of complex microbiota undergoing horizontal gene transfer. The comprehensive analyses performed and the diverse scenarios considered in this study also contribute to the novelty and generality of this work.  

      (3) The authors analyze several scenarios that, in my opinion, naturally follow from the results and parameter value choices in the first sections, making their analysis not very informative. For example, after showing that horizontal gene transfer can increase multistability both between pairs of species and in a community context, the way they model different niches does not bring significantly new results. Given that the authors showed previously in the manuscript that horizontal gene transfer can impact multistability in a community in which all species interact with each other, one might expect that it will also impact multistability in a larger community made of (sub)communities that are independent of (not interacting with) each-which is the proposed way for modelling niches. A similar argument can be made regarding the analysis of (spatially structured) metacommunities. It is known that, for smaller enough dispersal rates, space can promote regional diversity by enabling each local community to remain in a different stable state. Therefore, in conditions in which the impact of horizontal gene transfer drives multistability, it will also drive regional diversity in a metacommunity.

      Thanks. Based on the reviewer’s comments, we have move Fig. 3 and 4 to Supplementary Information. In the updated manuscript, we have focused more on analyzing the roles of different parameters in shaping community multistability.

      (4) In some cases, the authors consider that mobile genetic elements can lead to ~50% growth rate differences. In the presence of an added death rate, this can be a relatively strong advantage that makes the fastest grower easily take over their competitors. It would be important to discuss biologically relevant examples in which such growth advantages driven by mobile genetic elements could be expected, and how common such scenarios might be.

      We appreciate the suggestion. Mobile genetic elements can drive large growth rate differences when they encode adaptative traits like antibiotic resistance (line 197-198). 

      We also analyzed different ranges of growth rates effects of mobile genetic elements, by sampling 𝜆<sub>ij</sub> values from uniform distributions with given widths. Our results suggested that multistability was more feasible when the fitness effects of MGEs were small (Fig. S13b). The qualitative relationship between HGT and community was not dependent on the range of growth rate effects (Fig. S13a and b). We discussed these results in line 197-205 of the updated main text.

      Reviewer #3 (Public review):

      Hong et al. used a model they previously developed to study the impact of horizontal gene transfer (HGT) on microbial multispecies communities. They investigated the effect of HGT on the existence of alternative stable states in a community. The model most closely resembles HGT through the conjugation of incompatible plasmids, where the transferred genes confer independent growth-related fitness effects. For this type of HGT, the authors find that increasing the rate of HGT leads to an increasing number of stable states. This effect of HGT persists when the model is extended to include multiple competitive niches (under a shared carrying capacity) or spatially distinct patches (that interact in a grid-like fashion). Instead, if the mobile gene is assumed to reduce between-species competition, increasing HGT leads to a smaller region of multistability and fewer stable states. Similarly, if the mobile gene is deleterious an increase in HGT reduces the parameter region that supports multistability.

      This is an interesting and important topic, and I welcome the authors' efforts to explore these topics with mathematical modeling. The manuscript is well written and the analyses seem appropriate and well-carried out. However, I believe the model is not as general as the authors imply and more discussion of the assumptions would be helpful (both to readers + to promote future theoretical work on this topic). Also, given the model, it is not clear that the conclusions hold quite so generally as the authors claim and for biologically relevant parameters. To address this, I would recommend adding sensitivity analyses to the manuscript.

      We thank the reviewer for the agreeing that our work addressed an important topic and was wellconducted. We are also grateful for the suggestion on sensitivity analysis, which is very helpful to improve the rigor and generality of our conclusion. All the raised issues have been fully addressed in the updated manuscript and below.

      Specific points

      (1) The model makes strong assumptions about the biology of HGT, that are not adequately spelled out in the main text or methods, and will not generally prove true in all biological systems. These include:

      a) The process of HGT can be described by mass action kinetics. This is a common assumption for plasmid conjugation, but for phage transduction and natural transformation, people use other models (e.g. with free phage that adsorp to all populations and transfer in bursts).

      b) A subpopulation will not acquire more than one mobile gene, subpopulations can not transfer multiple genes at a time, and populations do not lose their own mobilizable genes. [this may introduce bias, see below].

      c) The species internal inhibition is independent of the acquired MGE (i.e. for p1 the self-inhibition is by s1).

      These points are in addition to the assumptions explored in the supplementary materials, regarding epistasis, the independence of interspecies competition from the mobile genes, etc. I would appreciate it if the authors could be more explicit in the main text about the range of applicability of their model, and in the methods about the assumptions that are made.

      We are grateful for the reviewer’s suggestions. In main text and methods of the updated manuscript, we have made clear the assumptions underlying our analysis. For point (a), we have clarified that our model primarily focused on plasmid transfer dynamics (line 74, 101, 517). Therefore, the process of HGT can be described by mass action kinetics, which is commonly assumed for plasmid transfer (line 537-538). For point (b), our model allows a cell to acquire more than one mobile genes. Please see our response to point (3) for details. We have also made it clear that we assumed the populations would not lose their own mobile gene completely (line 526-527). For (c), we have also clarified it in the updated manuscript (line 111-112, 527-528). 

      We have also performed a series of additional simulations to show the range of applicability of our model. In particular, we discuss the role of other mechanisms, including interspecies interaction strength, the growth rate effects of MGEs, MGE epistasis and microbial death rates in shaping the multistability of microbial communities undergoing HGT. These results were provided in Fig. S2, S3, S9, S10, S11, S12, S13 and S15.

      (2) I am not surprised that a mechanism that creates diversity will lead to more alternative stable states. Specifically, the null model for the absence of HGT is to set gamma to zero, resulting in pij=0 for all subpopulations (line 454). This means that a model with N^2 classes is effectively reduced to N classes. It seems intuitive that an LV-model with many more species would also allow for more alternative stable states. For a fair comparison, one would really want to initialize these subpopulations in the model (with the same growth rates - e.g. mu1(1+lambda2)) but without gene mobility.

      We appreciate the insightful comments. The reviewer was right that in our model HGT created additional subpopulations in the community. However, with or without HGT, we calculated the species diversity and multistability based on the abundances of the 𝑁 species (s<sub>i</sub> in our model), instead of all the p<sub>ij</sub> subpopulations. Therefore, although there exist more ‘classes’ in the model with HGT, the number of ‘classes’ considered when we calculated community diversity and multistability was equal. In light of the reviewer’s suggestion, we have also performed additional simulations, where we initialized the subpopulations in the model with nonzero abundances. Our results suggested that initializing the p<sub>ij</sub> subpopulations with non-zero abundances didn’t change the main conclusion (Fig. S11, line 188-189).

      (3) I am worried that the absence of double gene acquisitions from the model may unintentionally promote bistability. This assumption is equivalent to an implicit assumption of incompatibility between the genes transferred from different species. A highly abundant species with high HGT rates could fill up the "MGE niche" in a species before any other species have reached appreciable size. This would lead to greater importance of initial conditions and could thus lead to increased multistability.

      This concern also feels reminiscent of the "coexistence for free" literature (first described here http://dx.doi.org/10.1016/j.epidem.2008.07.001 ) which was recently discussed in the context of plasmid conjugation models in the supplementary material (section 3) of https://doi.org/10.1098/rstb.2020.0478 .

      We appreciate the comments. Our model didn’t assume the incompatibility between MGEs transferred from different species. Instead, it allows a cell to acquire more than one MGEs. In our model, p<sub>ij</sub> described the subpopulation in the 𝑖-th species that acquired the MGE from the 𝑗th species. Here, p<sub>ij</sub> can have overlaps with p<sub>ik</sub> (𝑗 ≠ 𝑘). In other words, a cell can belong to p<sub>ij</sub> and p<sub>ik</sub> at the same time. The p<sub>ij</sub> subpopulation is allowed to carry the MGEs from the other species. In the model, we used to describe the influence of the other MGEs on the growth of p<sub>ij</sub>.

      We also thank the reviewer for bringing two papers into our attention. We have cited and discussed these papers in the updated manuscript (line 355-362).

      (4) The parameter values tested seem to focus on very large effects, which are unlikely to occur commonly in nature. If I understand the parameters in Figure 1b correctly for instance, lambda2 leads to a 60% increase in growth rate. Such huge effects of mobile genes (here also assumed independent from genetic background) seem unlikely except for rare cases. To make this figure easier to interpret and relate to real-world systems, it could be worthwhile to plot the axes in terms of the assumed cost/benefit of the mobile genes of each species.

      Thanks for the comments. In the main text, we presented one simulation results that assumed relatively large effects of MGE on species fitness, as the reviewer pointed out. In the updated manuscript, we have supplemented numerical simulations that considered different ranges of fitness effects, including the fitness effect as small as 10% (Fig. S13a). We have also plotted the relationship between community multistability and the assumed fitness effects of MGEs, as the reviewer suggested (Fig. S13b). Our results suggested that multistability was more feasible when the fitness effects of MGEs were small, and changing the range of MGE fitness effects didn’t fundamentally change our main conclusion. These results were discussed in line 197-205 of the updated main text.

      Something similar holds for the HGT rate (eta): given that the population of E. coli or Klebsiella in the gut is probably closer to 10^9 than 10^12 (they make up only a fraction of all cells in the gut), the assumed rates for eta are definitely at the high end of measured plasmid transfer rates (e.g. F plasmid transfers at a rate of 10^-9 mL/CFU h-1, but it is derepressed and considered among the fastest - https://doi.org/10.1016/j.plasmid.2020.102489 ). To adequately assess the impact of the HGT rate on microbial community stability it would need to be scanned on a log (rather than a linear) scale. Considering the meta-analysis by Sheppard et al. it would make sense to scan it from 10^-7 to 1 for a community with a carrying capacity around 10^9.

      We thank the reviewer for the constructive suggestion. We have carried out additional simulations by scanning the 𝜂 value from 10<sup>-7</sup> to 1. The results suggested that increasing HGT rates started to promote multistability when 𝜂 value exceeded 10<sup>-2</sup> per hour (Fig. S9, line 337-346). This corresponds to a conjugation efficiency of 10<sup>-11</sup> cell<sup>-1</sup> ∙ mL<sup>-1</sup>∙ mL when the maximum carrying capacity equals 10<sup>9</sup> cellsmL<sup>-1</sup>, or a conjugation efficiency of 10<sup>-14</sup> cell<sup>-1</sup> ∙ hr<sup>-1</sup>∙ mL when the maximum carrying capacity equals 10<sup>12</sup> cellsmL<sup>-1</sup>.

      (5) It is not clear how sensitive the results (e.g. Figure 2a on the effect of HGT) are to the assumption of the fitness effect distribution of the mobile genes. This is related to the previous point that these fitness effects seem quite large. I think some sensitivity analysis of the results to the other parameters of the simulation (also the assumed interspecies competition varies from figure to figure) would be helpful to put the results into perspective and relate them to real biological systems.

      We appreciate the comments. In light of the reviewer’s suggestion, we have changed the range of the fitness effects and analyzed the sensitivity of our predictions to this range. As shown in Fig. S13, changing the range of MGE fitness effects didn’t alter the qualitative interplay between HGT and community multistability. We have also examined the sensitivity of the results to the strength of interspecies competition strength (Fig. S3, S10, S12). These results suggested that while the strength of interspecies interactions played an important role in shaping community multistability, the relationship between HGT rate and multistability was not fundamentally changed by varying interaction strength. In addition, we examined the role of death rates (Fig. S2). In the updated manuscript, we discussed the sensitivity of our prediction to these parameters in line 136-147, 190205, 335-354.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      Please find below a few suggestions that, in my opinion, could help improve the manuscript.

      TITLE

      It might not be clear what I 'gene exchange communities' are. Perhaps it could be rewritten for more specificity (e.g. '...communities undergoing horizontal gene transfer').

      We have updated the title as the reviewer suggested.

      ABSTRACT

      The abstract could also be edited to improve clarity and specificity. Terms like 'complicating factors' are vague, and enumerating specific factors would be better. The results are largely based on simulations, no analytical results are plotted, so I find that the sentence starting with 'Combining theoretical derivation and numerical simulations' can be a bit misleading.

      We appreciate the suggestions. We have enumerated the specific factors and scenarios in the updated abstract (line 18-26). We have also replaced 'Combining theoretical derivation and numerical simulations' with ‘Combining mathematical modeling and numerical simulations’.

      INTRODUCTION

      -  Line 42, please revise this paragraph. The logical flow is not so clear, it seems a bit like a list of facts, but the main message might not be clear enough. Also, it would be good to define 'hidden' states or just rewrite this sentence.

      We appreciate the suggestion. In the updated manuscript, we have rewritten this paragraph to improve the logical flow and clarity (line 46-52).

      -  Line 54, there is little detail about both theoretical models and HGT in this paragraph, and mixing the two makes the paragraph less focused. I suggest to divide into two paragraphs and expand its content. For example, you could explain a bit some relevant implications of MGE.

      We appreciate the suggestion. In the updated manuscript, we have divided this paragraph into two paragraphs, focusing on theoretical models and HGT, respectively (line 55-71). In particular, we have added explanations on the implications of MGEs (line 66-69), as the reviewer suggested.

      -  Line 72, as mentioned in the abstract, it would be better to explicitly mention which confounding factors are going to be discussed.

      Thanks for the suggestion. We have rewritten this part as “We further extended our analysis to scenarios where HGT changed interspecies interactions, where microbial communities were subjected to strong environmental selections and where microbes lived in metacommunities consisting of multiple local habitats. We also analyzed the role of different mechanisms, including interspecies interaction strength, the growth rate effects of MGEs, MGE epistasis and microbial death rates in shaping the multistability of microbial communities. These results created a comprehensive framework to understand how different dynamic processes, including but not limited to HGT rates, collectively shaped community multistability and diversity” (line 75-82).

      RESULTS

      -  The basic concepts (line 77) should be explained with more detail, keeping the non-familiar reader in mind. The reader might not be familiar with the concept of bistability in terms of species abundance. Also, note that mutual inhibition does not necessarily lead to positive feedback, as an interaction strength between 0 and 1 might still be considered inhibition. In any case, in Figure 1 it is not obvious how the positive feedback is represented, the caption should explain it. Note that neither the main text nor the caption explains the metaphor of the landscape and the marble that you are using in Figure 1a.

      We have rewritten this paragraph to provide more details on the basic concepts (line 86-99). We have removed the statement about ‘mutual inhibition’ to avoid being misleading. We have also updated the caption of Fig. 1a to explain the metaphor of the landscape and the marble (line 389396). 

      -  In the classical LV model, bistability does not depend on growth rates, but only on interaction strength. Therefore, I think that much of the results are significantly influenced by the added death rate. I believe that if the death rate is set to zero, mobile genetic elements that only modify growth rates will have no effect on the system's bistability. Because of this, I think that a thorough analysis of the role of the added death (dilution) rate and the distribution of growth rates is especially needed.

      We are grateful for the reviewer’s insightful comments. In the updated manuscript, we have thoroughly analyzed the role of the added death (dilution) rate on the bistability of communities composed of two species (Fig. S2). Indeed, as the reviewer pointed out, if the death rate equals zero, mobile genetic elements that only modify growth rates will have no effect on the system's bistability. We have discussed the role of death rate in line 136-142 of the updated manuscript.

      We have also expanded our analysis on the distribution of growth rates. In particular, we considered different ranges of growth rates effects of mobile genetic elements, by sampling 𝜆<sub>ij</sub> values from uniform distributions with given widths (Fig. S13). Greater width led to larger range of growth rate effects. We used five-species populations as an example and tested different ranges.

      Our results suggested that multistability was more feasible when the growth rate effects of MGEs were small (Fig. S13b). The qualitative relationship between HGT and community was not dependent on the range of growth rate effects (Fig. S13a). These results are discussed in line 197205 of the updated manuscript.

      -  The analysis uses gamma values that, in the absence of an added death rate, render a species pair bistable. Therefore, multistability would be quite expected for a 5 species community. Note that, multistability is possible in communities of more than 2 species even if all gamma values are smaller than 1. Analyzing a wide range of interaction strength distributions would really inform on the relative role of HGT in multistability across different community scenarios.

      We are grateful for the reviewer’s suggestion. In light of the reviewer’s comments, in the updated manuscript, we have performed additional analysis by focusing on a broader range of interaction strengths (Fig. S3, S10, S12), especially the gamma values below 1 (Fig. S10). Our results agreed with the reviewer’s notion that multistability was possible in communities of more than 2 species even if all gamma values were smaller than 1 (Fig. S10). 

      -  I would recommend the authors extend the analysis of the model used for Figures 1 and 2. Figures 3 and 4 could be moved to the supplement (see my point in the public review), unless the authors extend the analysis to explain some non-intuitive outcomes for niches and metacommunities.

      Thanks. In the updated manuscript we have performed additional simulations to extend the analysis in Figure 1 and 2. These results were presented in Fig. S2, S3, S9, S10, S11, S12, and S13. We have also moved Figure 3 and 4 to SI as the reviewer suggested.

      -  The authors seem to refer to fitness and growth rates as the same thing. This could lead to confusion - the strongest competitor in a species pair could also be interpreted as the fittest species despite being the slowest grower. I think there's no need to use fitness if they refer to growth rates. In any case, they should define fitness if they want to use this concept in the text.

      We are grateful for the insightful suggestion. To avoid confusion, we have used ‘growth rate’ throughout the updated manuscript.

      -  Across the text, the language needs some revision for clarity, specificity, and scientific style. In lines 105 - 109 there are some examples, like the use of 'in a lot of systems', and ' interspecies competitions' (I believe they mean interspecies interaction strengths).

      We appreciate the reviewer for pointing them out. We have thoroughly checked the text and made the revisions whenever applicable to improve the clarity and specificity.

      -  Many plots present the HGT rate on the horizontal axis. Could the authors explain why is it that the rate of HGT is relatively important for the number of alternative stable states? I understand how from zero to a small positive number there is a qualitative change. Beyond that, it shouldn't affect bistability too much, I think. If I am right, then other parameters could be more informative to plot in the horizontal axis. If I am wrong, I think that providing an explanation for this would be valuable.

      Thanks. To address the reviewer’s comment, we have systematically analyzed the effects of HGT on community multistability, by scanning the HGT rate from 10<sup>-7</sup> to 10<sup>0</sup>hr<sup>-1</sup> . In communities of two or multiple species, our simulation results showed that multistability gradually increased with HGT rate when HGT rate exceeded 10<sup>2</sup>hr<sup>-1</sup>. These results, presented in Fig. S9 and discussed in line 337-346, provided a more quantitative relationship between multistability and HGT rate.

      While in this work we showed the potential role of HGT in modulating community multistability, our results didn’t exclude the role of the other parameters. Motivated by the comments raised by the reviewers, in the updated manuscript, we have performed additional simulations to analyze the influence of other parameters in shaping community multistability. These parameters include death or dilution rate (Fig. S2), interaction strength (Fig. S3, S9, S10, S11, S12, S14, S15), 𝜆 range (Fig. S13, S15) and 𝛿 value (Fig. 3g, h, i). In many of the supplemented results (Fig. S2b, S3b, S13b, Fig. 3g, 3h and 3i), we have also plotted the data by using these parameters as the x axis. We believe the updated work now provided a more comprehensive framework to understand how different mechanisms, including but not limited to HGT, might shape the multistability of complex microbiota. These points were discussed in line 136-147, 190-205, 238-253, 334-354 of the updated main text. 

      -  My overall thoughts on the case of antibiotic exposure are similar to those of previous sections. Very few of the different parameters of the model are analyzed and discussed. In this case, the authors increased the interaction strength to ~0.4 times higher compared to previous sections. Was this necessary, and why?

      Thanks for the comments. In the previous draft, the interaction strength 𝛾=1.5 was tested as an example. Motivated by the reviewer’s comments, in the updated manuscript, we have examined different interaction strengths, including the strength ( 𝛾 = 1.1 ) commonly tested in other scenarios. The prediction equally held for different 𝛾 values (Fig. S15). We have also analyzed different 𝜆 ranges (Fig. S15). These results, together with the analyses presented in the earlier version of the manuscript, suggested the potential role of HGT in promoting multistability for communities under strong selection. The supplemented results were presented in Fig. S15 and discussed in line 293-295 of the updated manuscript.

      -  Line 195, if a gene encodes for the production of a public good, why would its HGT reduce interaction strength? I can think of the opposite scenario: the gene is a public good, and without HGT there is only one species that can produce it. Let's imagine that the public good is an enzyme that deactivates an antibiotic that is present in the environment, and then the species that produces has a positive interaction with another species in a pairwise coculture. If HGT happens, the second species becomes a producer and does not need the other one to survive in the presence of antibiotics anymore. The interaction can then become more competitive, as e.g. competition for resources could become the dominant interaction.

      We are grateful for pointing it out. In the updated manuscript, we have removed this statement.

      DISCUSSION

      -  L 267 "by comparison with empirical estimates of plasmid conjugation rates from a previous study [42], the HGT rates in our analysis are biologically relevant in a variety of natural environments". The authors are using a normalized model and the relevance of other parameter values is not discussed. If the authors want to claim that they are using biologically relevant HGT, they should also discuss whether the rest of the parameter values are biologically relevant. I recommend relaxing this statement about HGT rates.

      We appreciate the suggestion. We agree with the reviewer that other parameters including the death/dilution rate, interactions strength and 𝜆 ranges are also important in shaping community multistability. We have performed additional analysis to show the effects of these parameters. In light of the reviewer’s suggestion, we have relaxed this statement and thoroughly discussed the context-dependent effect of HGT as well as the roles of different parameters (line 334-354).

      -  Last sentence: "Therefore, inhibiting the MGE spread using small molecules might offer new opportunities to reshape the stability landscape and narrow down the attraction domains of the disease states". It is not clear what procedure/technique the authors are suggesting. If they want to keep this statement, the authors should give more details on how small molecules can be/are used to inhibit MGE.

      We appreciated the comments. Previous studies have shown some small molecules like unsaturated fatty acids can inhibit the conjugative transfer of plasmids. By binding the type IV secretion traffic ATPase TrwD, these compounds limit the pilus biogenesis and DNA translocation. We have provided more details regarding this statement in the updated manuscripts (line 376-379).

      METHODS

      -  Line 439, mu_i should be presented as the maximum 'per capita' growth rate.

      We have updated the definition of 𝜇i following the suggestion (line 529).

      -  Line 444, this explanation is hard to follow, please expand it to provide more details. You could provide an example, like explaining that all individuals from S1 have the MGE1 and therefore they have mu_1 = mu_01 ... After HGT, their fitness changes if they get the plasmid from S2, so a term lambda2 appears.

      Thanks. In the updated manuscript, we have expanded the explanation by providing an example as the reviewer suggested (line 534-537).

      -  The normalization assumes a common carrying capacity Nm (Eqs 1-4) and then it's normalized (Eqs. 5-8). It would be better to start from a more general scenario in which each species has a different carrying capacity and then proceed with the normalization.

      We appreciate the suggestion. In the updated manuscript, we have started our derivation from the scenario where each species has a different carrying capacity before proceeding with the normalization (section 1 of Methods, line 516-554). The same equations can be obtained after normalization.

      -  I think that the meaning of kappa (the plasmid loss rate) is not explained in the text.

      Thanks for pointing it out. We have explained the meaning of kappa in the updated text (line 108, 154, 539-541, 586-587, 607).

      SUPPLEMENT

      -  Figure S4, what are the different colors in panel b?

      In panel b of Fig. S4, the different colors represent the simulation results repeated with randomized growth rates. We have made it clear in the updated SI.

      Reviewer #3 (Recommendations for the authors):

      (1) Please extend your description of the model, so it is easier to understand for readers who have not read the first paper. Especially the choice to describe the model as species and subpopulations, as opposed to writing it as MGE-carrying and MGE-free populations of each species makes it quite complicated to understand which parameters influence each other.

      Thanks for the suggestion. We have extended the model description in the updated manuscript, which provides a more detailed introduction on model configurations and parameter definitions (line 86-99, 101-113, 151-159). We have also updated the Methods to extend the model description.

      (2) Please define gamma_ji in equation 13 and eta_jki in equation 14 (how to map the indices onto the assumed directionality of the interaction).

      We have defined these two parameters in the updated manuscript (line 584-586, 630-632).

      (3)  Line 511: please add at the beginning of this paragraph that you are assuming a grid-like arrangement of patches which will be captured by dispersal term H.

      We have updated this paragraph to make this assumption clear (line 636-637).

      (4)  Line 540: "used in our model" (missing a word).

      We have corrected it in the updated manuscript.

      (5)  Currently the analyses looking at the types of growth effects HGT brings (Figures 5-7) feel very "tacked on". These are not just "confounding factors", but rather scenarios that are much more biologically realistic than the assumption of independent effects. I would introduce them earlier in the text, as I think many readers may not trust your results until they know this was considered (+ how it changes the conclusions).

      We are grateful for the suggestion. We agree with the reviewer that these biologically realistic scenarios should be introduced earlier in the text. In the updated manuscript, we have moved these analyses forward, as sections 3, 4 and 5. We have also avoided the term “confounding factors”. Instead, in the updated manuscript, we have separated these analyses into different sections, and clearly described each scenario in the section title (line 217-218, 254, 275).

      (6)  In some places the manuscript refers to HGT, in others to MGE presence (e.g. caption of Figure 6). These are not generally the same thing, as HGT could also occur due to extracellular vesicles or natural transformation etc. Please standardize the nomenclature and make it clearer which type of processes the model describes.

      We appreciate the comment. The model in this work primarily focused on the process of plasmid transfer. We have made it clear throughout the main text. 

      (7)  In many figures the y-axis starts at a value other than 0. This is a bit misleading. In addition, I would recommend changing the title "Area of bistability region" to "Area of bistability" or perhaps even "Area of multistability" (since more than two species are considered).

      Thanks for the suggestion. We have updated all the relevant figures to make sure that their y-axes start at 0. We have also changed the title “Area of bistability region” to “Area of multistability”, whenever it is applicable.

      (8)  Figure 7: what are the assumed fitness effects of the mobile genes in the simulation? Which distribution were they drawn from? Please add this info to the figure caption here and elsewhere.

      In Figure 7, we explored an extreme scenario of the fitness effects of the mobile genes, where the population was subjected to strong environmental selection and only cells carrying the mobile gene could grow. Therefore, the carriage of the mobile gene changed the species growth rate from 0 to a positive value µ<sub>i</sub>. When calculating the number of stable states in the communities, we randomly drew the µ<sub>i</sub> values from a uniform distribution between 0.3 and 0.7 hr<sup>-1</sup>. We had added this information in the figure caption (line 505-508) and method (line 615-617) of the updated manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      Detection of early-stage colorectal cancer is of great importance. Recently, both laboratory scientists and clinicians have reported different exosomal biomarkers to identify colorectal cancer patients.

      Here, the authors exhibited a full RNA landscape for plasma exosomes of 60 individuals, including 31 colorectal cancer (CRC) patients, 19 advanced adenoma (AA) patients, and 10 noncancerous controls. RNAs with high fold change, high absolute abundance, and various module attribution were used to construct RT-qPCR-based RNA models for CRC and AA detection.

      Overall, this is a well-performed proof-of-concept study to highlight exosomal RNAs as potential biomarkers of early-stage colorectal cancer and its precancerous lesions.

      Thank you for your careful evaluation and valuable suggestions, which have provided valuable guidance for the improvement of our paper. In response to your feedback, we have implemented the following improvements.

      (1) Depicting the full RNA landscape of circulating exosomes is still quite challenging. The authors annotated 58,333 RNA species in exosomes, most of which were lncRNAs, but the authors do not explain how they characterized those RNAs.

      Author response and action taken: Thanks for your comments. In the Supplementary Methods section titled "Identification of mRNAs and lncRNAs", we have provided a comprehensive explanation on the characterization of mRNAs and lncRNAs to address the concerns you raised. Characterization of long-chain RNAs is a great challenge. For lncRNA analysis, the transcriptome was assembled using the Cufflinks and Scripture based on the reads mapped to the reference genome. The assembled transcripts were annotated using the Cuffcompare program from the Cufflinks package. The unknown transcripts were used to screen for putative lncRNAs.

      (2) The authors tested their models in a medium size population of 124 individuals, which is not enough to obtain an accurate evaluation of the specificity and sensitivity of the biomarkers proposed here. External validation would be required.

      Author response and action taken: Thanks for your comments. We fully acknowledge the significance of external validations in the evaluation of diagnostic model performance. Unfortunately, as a pilot study, we currently do not have the conditions for a multicenter investigation. To mitigate result bias and overfitting effects, we implemented a rigorous variable selection strategy and enhanced model stability through 10-fold cross-validation. In the meantime, we will persist in our efforts to elevate the quality of our research and seek additional resources for external validation in future studies.

      Reviewer #2:

      The authors present an important study on the potential of small extracellular vesicle (sEV)-derived RNAs as biomarkers for the early detection of colorectal cancer (CRC) and precancerous adenoma (AA). The authors provide a detailed analysis of the RNA landscape of sEVs isolated from participants, identifying differentially expressed sEV-RNAs associated with T1a stage CRC and AA compared to normal controls. The paper further categorises these sEV-RNAs into modules and constructs a 60-gene model that successfully distinguishes CRC/AA from NC samples. The authors also validate their findings using RT-qPCR and propose an optimised classifier with high specificity and sensitivity. Additionally, the authors discuss the potential of sEV-RNAs in understanding CRC carcinogenesis and suggest that a comprehensive biomarker panel combining sEV-RNAs and proteins could be promising for identifying both early and advanced CRC patients. Overall, the study provides valuable insights into the potential clinical application of sEV-RNAs in liquid biopsy for the early detection of CRC and AA.

      Major strengths:

      (1) Comprehensive sEV RNA profiling: The study provides a valuable dataset of the whole-transcriptomic profile of circulating sEVs, including miRNA, mRNA, and lncRNA. This approach adds to the understanding of sEV-RNAs' role in CRC carcinogenesis and facilitates the discovery of potential biomarkers.

      (2) Detection of early-stage CRC and AA: The developed 60-gene t-SNE model successfully differentiated T1a stage CRC/AA from normal controls with high specificity and sensitivity, indicating the potential of sEV-RNAs as diagnostic markers for early-stage colorectal lesions.

      (3) Independent validation cohort: The study combines RNA-seq, RT-qPCR, and modelling algorithms to select and validate candidate sEV-RNAs, maximising the performance of the developed RNA signature. The comparison of different algorithms and consideration of other factors enhance the robustness of the findings.

      Thank you for your careful evaluation and valuable suggestions. These comments have been highly valuable for the performance evaluation and clinical applications of our work. In response to your feedback, we have implemented the following improvements.

      (1). Lack of analysis on T1-only patients in the validation cohort: While the study identifies key sEV-RNAs associated with T1a stage CRC and AA, the validation cohort is only half of the patients in T1(25 out of 49). It would be better to do an analysis using only the T1 patients in the validation cohort, so the conclusion is not affected by the T2-T3 patients.

      Author response and action taken: Thanks for your comments. This feedback is essential for ensuring consistency in the results with our previous findings. In this context, we revalidated various diagnostic panels using exclusively Stage I patients (Figure 7—figure supplement 2). To minimize the potential overfitting effect due to the reduction in sample size after partitioning, we implemented a 10-fold cross-validation for each panel and these panels exhibit promising performance in Stage I colorectal cancer (CRC) patients.

      Author response image 1.

      The ROC analysis of different sEV-RNA signatures in the prediction of Stage I CRC patients by different algorithms (a: 6-gene panel; b: 7-gene panel; c: 8-gene panel; d: 9-gene panel).

      (2). Lack of performance analysis across different demographic and tumor pathology factors listed in Supplementary Table 12. It's important to know if the sEV-RNAs identified in the study work better/worse in different age/sex/tumor size/Yamada subtypes etc.

      Author response and action taken: Thanks for your comments. This feedback will be immensely beneficial for clinical diagnosis. Similarly, cross-validation was performed in this section. We assessed the discriminative effects of CRC on NC, taking into account different age groups, genders, tumor sizes, and anatomical locations (Figure 7—figure supplement 3). Overall, these sEV RNA panels perform better in individuals under the age of 55 and in female patients. There is no significant difference in discriminative effects across different tumor sizes. Compared to rectal cancer, the discriminative effects are better in colon cancer.

      Author response image 2.

      The ROC analysis of different sEV-RNA signatures for predicting CRC patients using the Lasso regression algorithm in different clinical parameters (ab: age; cd: gender; ef: tumor size; gh: anatomical position).

    1. Author response:

      The following is the authors’ response to the original reviews

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study puts forth the model that under IFN-B stimulation, liquid-phase WTAP coordinates with the transcription factor STAT1 to recruit MTC to the promoter region of interferon-stimulated genes (ISGs), mediating the installation of m<sup>6</sup>A on newly synthesized ISG mRNAs. This model is supported by strong evidence that the phosphorylation state of WTAP, regulated by PPP4, is regulated by IFN-B stimulation, and that this results in interactions between WTAP, the m<sup>6</sup>A methyltransferase complex, and STAT1, a transcription factor that mediates activation of ISGs. This was demonstrated via a combination of microscopy, immunoprecipitations, m<sup>6</sup>A sequencing, and ChIP. These experiments converge on a set of experiments that nicely demonstrate that IFN-B stimulation increases the interaction between WTAP, METTL3, and STAT1, that this interaction is lost with the knockdown of WTAP (even in the presence of IFN-B), and that this IFN-B stimulation also induces METTL3-ISG interactions.

      Strengths:

      The evidence for the IFN-B stimulated interaction between METTL3 and STAT1, mediated by WTAP, is quite strong. Removal of WTAP in this system seems to be sufficient to reduce these interactions and the concomitant m<sup>6</sup>A methylation of ISGs. The conclusion that the phosphorylation state of WTAP is important in this process is also quite well supported.

      Weaknesses:

      The evidence that the above mechanism is fundamentally driven by different phase-separated pools of WTAP (regulated by its phosphorylation state) is weaker. These experiments rely relatively heavily on the treatment of cells with 1,6-hexanediol, which has been shown to have some off-target effects on phosphatases and kinases (PMID 33814344).

      Given that the model invoked in this study depends on the phosphorylation (or lack thereof) of WTAP, this is a particularly relevant concern.

      We are grateful for the reviewer’s positive comment and constructive feedback. 1,6-hexanediol (hex) was considered an inhibitor of hydrophobic interaction, thereby capable of dissolving protein phase separation condensates. Hex (5%-10% w/v) was still widely used to explore the phase separation characteristic and function on various protein, including some phosphorylated proteins such as pHSF1, or kinases such as NEMO1-3. Since hydrophobic interactions involved in various types of protein-protein interaction, the off-target effects of hex were inevitable. It has been reported that hex impaired RNA polymerase II CTD-specific phosphatase and kinase activity at 5% concentration4, which led to the reviewer’s concern. In response to this concern, we investigated the phosphorylation level of WTAP under hex concentration gradient treatment. Surprisingly, we found that both 2% and 5% hex maintained the PPP4c-mediated dephosphorylation level of WTAP but still led to the dissolution of WTAP LLPS condensates (Figure 5-figure supplement 1H; Author response image 1), indicating that hex dispersed WTAP phase separation in a phosphorylation-independent manner. Consistent with our findings, Ge et al. used 10% hex to dissolve WTAP phase separation condensates5. Additionally, we found the phosphorylation level of STAT1 was not affected by both 2% and 5% hex, revealing the off-target and impairment function of hex on kinases or phosphatases might not be universal (Figure 5-figure supplement 1H). Collectively, since the 5% hex we used did not influence the de-phosphorylation event of WTAP, function of WTAP LLPS mediating interaction between methylation complex and STAT1 revealed by our results was independent from its phosphorylation status.

      Author response image 1.

      mCherry-WTAP-rescued HeLa cells were treated with 10 ng/mL IFN-β together with or without 2% or 5% hex and 20 μg/mL digitonin for 1 hour or left untreated. Phase separation of mCherry-WTAP was observed through confocal microscopy. The number of WTAP condensates that diameter over 0.4 μm of n = 20 cells were counted through ImageJ and shown. Scale bars indicated 10 μm. All error bars, mean values ± SD, P-values were determined by unpaired two-tailed Student’s t-test of n = 20 cells in (B). For (A), similar results were obtained for three independent biological experiments.

      Related to this point, it is also interesting (and potentially concerning for the proposed model) that the initial region of WTAP that was predicted to be disordered is in fact not the region that the authors demonstrate is important for the different phase-separated states.

      A considerable number of proteins undergo phase separation via interactions between intrinsically disordered regions (IDRs). IDR contains more charged and polar amino acids to present multiple weakly interacting elements, while lacking hydrophobic amino acids to show flexible conformations6. In our study, we used PLAAC websites (http://plaac.wi.mit.edu/) to predict IDR domain of WTAP, and a fragment (234-249 amino acids) was predicted as prion-like domain (PLD). However, deletion of this fragment failed to abolish the phase separation properties of WTAP, which might be the main confusion to reviewers. To explain this issue, we checked the WTAP structure (within part of MTC complex) from protein data bank (https://www.rcsb.org/structure/7VF2) and found that the prediction of IDR has been renewed due to the update of different algorithm. IDR of WTAP expanded to 245-396 amino acids, encompassing the entire CTD region. Our results demonstrate that the CTD was critical for WTAP LLPS, as CTD deficiency significantly inhibited the formation of liquid condensates both in vitro and in cells. Also, phosphorylation sites on CTD were important for the phase transition of WTAP. These observations highlight the phosphorylation status on CTD region as a key driving force of phase separation, consistent with the established role of IDR in regulating LLPS. We have revised our description on WTAP IDR in our article following the reviewers’ suggestion.

      Taking all the data together, it is also not clear to me that one has to invoke phase separation in the proposed mechanism.

      In this article, we observed that WTAP underwent phase transition during virus infection and IFN-β treatment, and proposed a novel mechanism whereby post translational modification (PTM)-driven WTAP LLPS was required for the m<sup>6</sup>A modification of ISG mRNAs. To verify the hypothesis, we first demonstrated the relationship between PTM and phase separation of WTAP. We constructed WTAP 5ST-D and 5ST-A mutant to mimic WTAP phosphorylation and dephosphorylation status respectively, and figured out that dephosphorylated WTAP underwent LLPS. We also found that PPP4 was the main phosphatase to regulate WTAP dephosphorylation. To further investigation, we introduced the potent PPP4 inhibitor, fostriecin. Consistent with our findings in PPP4 deficient model, fostriecin treatment significantly inhibited the IFN-β-induced dephosphorylation of WTAP and disrupted its LLPS condensates, indicating that PPP4 was the key phosphatase recruited by IFN-β to regulate WTAP, confirming that PTM governs WTAP LLPS dynamics (Figure 2-figure supplement 1C and H). Furthermore, fostriecin-induced impairment of WTAP phosphorylation and phase separation correlated with reduced m<sup>6</sup>A modification level and elevated ISGs expression level (Figure 4C and Figure 4-figure supplement 1E). These findings together emphasized that dephosphorylation is required for WTAP LLPS.

      As for the function of WTAP LLPS, we assumed that WTAP might undergo LLPS to sequester STAT1 together with m<sup>6</sup>A methyltransferase complex (MTC) for mediating m<sup>6</sup>A deposition on ISG mRNAs co-transcriptionally under IFN-β stimulation. Given that hex dissolved WTAP LLPS condensates without affecting dephosphorylation status (Figure 5-figure supplement 1H; Author response image 1), various experiments we performed previously actually confirmed the critical role of WTAP LLPS during m<sup>6</sup>A modification (Figure 4A), as well as the mechanism that WTAP phase separation enhanced the interaction between MTC and STAT1 (Figure 5E-F). Subsequent to reviewer’s comments, more experiments were conducted for further validation. We found the WTAP liquid condensates formed by wild type (WT) WTAP or WTAP 5ST-A mutant (which mimics dephosphorylated-WTAP) could be dissembled by hex, which also led to the impairment of the interaction between STAT1, METTL3 and WTAP (Figure 5-figure supplement 1E). In addition, in vitro experiments demonstrated that hex treatment significantly disrupted the interaction between recombinant GFP-STAT1 and mCherry-WTAP which expressed in the E. coli system (Figure 5F and Figure 5-figure supplement 1G). Notably, this prokaryotic expression system lacks endogenous phosphorylation machinery, resulting in non-phosphorylated mCherry-WTAP. For further validation, we performed the interaction of WTAP WT or 5ST-A with the promoter regions of ISG as well as the m<sup>6</sup>A modification of ISG mRNAs were attenuated by WTAP LLPS dissolution (Figure 4E and Figure 6E). These findings together revealed that WTAP LLPS were the critical mediators of the STAT1-MTC interactions, ISG promoter regions binding and the co-transcription m<sup>6</sup>A modification.

      Collectively, our results demonstrated that IFN-β treatment recruited PPP4c to dephosphorylate WTAP, thereby driving the formation of WTAP liquid condensates which were essential for facilitating STAT1-MTC interaction and m<sup>6</sup>A deposition, subsequently mediated ISG expression. Since we revealed a strong association between PTM-regulated WTAP phase transition and its m<sup>6</sup>A modification function, WTAP LLPS was a novel and functionally distinct mechanism that must be reckoned with in this study.

      Author response image 2.

      Wild type (WT) WTAP or 5ST-A mutant-rescued WTAP<sup>sgRNA</sup> THP-1-derived macrophages are stimulated with or without with 10 ng/mL IFN-β together followed with 2% or 5% 1,6-hexanediol (hex) and 20 μg/mL digitonin for 1 hour or left untreated. antibody and imaged using confocal microscope. Scale bars indicated 10 μm.

      Reviewer #2 (Public review):

      In this study, Cai and colleagues investigate how one component of the m<sup>6</sup>A methyltransferase complex, the WTAP protein, responds to IFNb stimulation. They find that viral infection or IFNb stimulation induces the transition of WTAP from aggregates to liquid droplets through dephosphorylation by PPP4. This process affects the m<sup>6</sup>A modification levels of ISG mRNAs and modulates their stability. In addition, the WTAP droplets interact with the transcription factor STAT1 to recruit the methyltransferase complex to ISG promoters and enhance m<sup>6</sup>A modification during transcription. The investigation dives into a previously unexplored area of how viral infection or IFNb stimulation affects m<sup>6</sup>A modification on ISGs. The observation that WTAP undergoes a phase transition is significant in our understanding of the mechanisms underlying m<sup>6</sup>A's function in immunity. However, there are still key gaps that should be addressed to fully accept the model presented.

      Major points:

      (1) More detailed analyses on the effects of WTAP sgRNA on the m<sup>6</sup>A modification of ISGs:

      a. A comprehensive summary of the ISGs, including the percentage of ISGs that are m<sup>6</sup>A-modified. merip-isg percentage

      b. The distribution of m<sup>6</sup>A modification across the ISGs. Topology

      c. A comparison of the m<sup>6</sup>A modification distribution in ISGs with non-ISGs. Topology

      In addition, since the authors propose a novel mechanism where the interaction between phosphorylated STAT1 and WTAP directs the MTC to the promoter regions of ISGs to facilitate co-transcriptional m<sup>6</sup>A modification, it is critical to analyze whether the m<sup>6</sup>A modification distribution holds true in the data.

      We appreciate the reviewer’s summary of our manuscript and the constructive assessment. We have conducted the related analysis accordingly to present the m<sup>6</sup>A modification in ISGs in our model as reviewers suggested. Our results showed that about 64.29% of core ISGs were m<sup>6</sup>A modified under IFN-β stimulation (Figure 3-figure supplement 1B; Figure 3G), which was consistent with the similar percentage in previous studies[7,8]. The m<sup>6</sup>A distribution of the ISGs transcripts including IFIT1, IFIT2, OAS1 and OAS2 was validated (Figure 3-figure supplement 1H).

      Generally, m<sup>6</sup>A deposition preferentially located in the vicinity of stop codon, while m<sup>6</sup>A modification was highly dynamic under different cellular condition. However, we compared the topology of m<sup>6</sup>A deposition of ISGs with non-ISGs, and found that m<sup>6</sup>A modification of ISG mRNAs showed higher preference of coding sequences (CDS) localization compared to global m<sup>6</sup>A deposition (Figure 3H). Similarly, various researches uncovered the m<sup>6</sup>A deposition regulated by co-transcriptionally m<sup>6</sup>A modification preferred to locate in the CDS [9-11]. Since our results of m<sup>6</sup>A modification distribution of ISGs was consistent with the co-transcriptional m<sup>6</sup>A modification characteristics, we believed that our hypothesis and results were correlated and consistent.

      (2) Since a key part of the model includes the cytosol-localized STAT1 protein undergoing phosphorylation to translocate to the nucleus to mediate gene expression, the authors should focus on the interaction between phosphorylated STAT1 and WTAP in Figure 4, rather than the unphosphorylated STAT1. Only phosphorylated STAT1 localizes to the nucleus, so the presence of pSTAT1 in the immunoprecipitate is critical for establishing a functional link between STAT1 activation and its interaction with WTAP.

      Thank you for the constructive comments. As we showed in Figure 4, we found the enhanced interaction between phase-separated WTAP and the nuclear-translocated STAT1 which were phosphorylated under IFN-β stimulation, indicating the importance of phosphorylation of STAT1. We repeated the immunoprecipitation experiments to clarify the function of pSTAT1 in WTAP interaction. Our results showed that IFN-β stimulation induced the interaction of WTAP with both pSTAT1 and STAT1 (Figure 5-figure supplement 1C), indicating that most of the WTAP-associated STAT1 was phosphorylated. Taken together, our data proved that LLPS WTAP bound with nuclear-translocated pSTAT1 under IFN-β stimulation.

      (3) The authors should include pSTAT1 ChIP-seq and WTAP ChIP-seq on IFNb-treated samples in Figure 5 to allow for a comprehensive and unbiased genomic analysis for comparing the overlaps of peaks from both ChIP-seq datasets. These results should further support their hypothesis that WTAP interacts with pSTAT1 to enhance m<sup>6</sup>A modifications on ISGs.

      Thank you for raising this thoughtful comment. In this study, MeRIP-seq and RNA-seq along with immunoprecipitation and immunofluorescence experiments supported that phase transition of WTAP enhanced its interaction to pSTAT1, thus mediating ISGs m<sup>6</sup>A modification and expression by enhancing its interaction with nuclear-translocated pSTAT1 during virus infection and IFN-β stimulation. However, how WTAP-mediated m<sup>6</sup>A modification was related to STAT1-mediated transcription remained unclear. Several researches have revealed the recruitment of m<sup>6</sup>A methyltransferase complex (MTC) to transcription start sites (TSS) of coding genes and R-loop structure by interacting with transcriptional factors STAT5B, SMAD2/3, DNA helicase DDX21, indicating the engagement of MTC mediated m<sup>6</sup>A modification on nascent transcripts at the very beginning of transcription [11-13]. These researches inspired us that phase-separated WTAP could be recruited to the ISG promoter regions via interacting with nuclear-translocated pSTAT1. To validate this mechanism, we have conducted ChIP-qPCR experiments targeting STAT1 and WTAP, revealed that IFN-β induced the comparable recruitment dynamics of both STAT1 and WTAP to ISG promoter regions (Figure 6A-B). Notably, STAT1 deficiency significantly abolished the bindings between WTAP and ISG promoter regions (Figure 6C). These findings established nuclear-translocated STAT1-dependent recruitment of phase separated WTAP and ISG promoter region, substantiated our hypothesis within the current study. We totally agree that ChIP-seq data will be more supportive to explore the mechanism in depth. We will continuously focus on the whole genome chromatin distribution of WTAP and explore more functional effect of transcriptional factor-dependent WTAP-promoter regions interaction in the future.

      Minor points:

      (1) Since IFNb is primarily known for modulating biological processes through gene transcription, it would be informative if the authors discussed the mechanism of how IFNb would induce the interaction between WTAP and PPP4.

      Protein phosphatase 4 (PPP4) is a multi-subunit serine/threonine phosphatase complex that participates in diverse biologic process, including DDR, cell cycle progression, and apoptosis[14]. Several signaling pathway such as NF-κB and mTOR signaling, can be regulated by PPP4. Previous research showed that deficiency of PPP4 enhanced IFN-β downstream signaling and ISGs expression, which was consistent with our findings that knockdown of PPP4C impaired WTAP-mediated m<sup>6</sup>A modification, enhanced the ISGs expression[15,16]. Since there was no significant enhancement in PPP4 expression level during 0-3 hours of IFN-β stimulation in our results, we explored the PTM that may influence the protein-protein interaction, such as ubiquitination. Intriguingly, we found the ubiquitination level of PPP4 was enhanced after IFN-β stimulation, which may affect the interaction between PPP4 and WTAP (Author response image 3). Further investigation between PPP4 and WTAP will be conducted in our future study.

      Author response image 3.

      HEK 293T transfected with HA-ubiquitin (HA-Ub) and Flag-PPP4 were treated with 10 ng/mL IFN-β or left untreated. Whole cell lysate (WCL) was collected and immunoprecipitation (IP) experiment using anti-Flag antibody was performed, followed with immunoblot. Similar results were obtained for three independent biological experiments.

      (2) The authors should include mCherry alone controls in Figure 1D to demonstrate that mCherry does not contribute to the phase separation of WTAP. Does mCherry have or lack a PLD?

      According to the crystal structure of mCherry protein in protein structure database RCSB-PDB, mCherry protein presents as a β-barrel protein, with no IDRs or multivalent interaction domains including PLD, indicating that mCherry protein has no capability to undergo phase separation. This characteristic makes it a suitable protein to tag and trace the localization or expression levels of proteins, and a negative control for protein phase separation studies. As the reviewer suggested, we include mCherry alone controls in the revised version (Figure 1D).

      (3) The authors should clarify the immunoprecipitation assays in the methods. For example, the labeling in Figure 2A suggests that antibodies against WTAP and pan-p were used for two immunoprecipitations. Is that accurate?

      Due to the lack of phosphorylated-WTAP antibody, the detection of phosphorylation of WTAP was conducted by WTAP-antibody-mediated immunoprecipitation. We conducted immunoprecipitation to pull-down WTAP protein by WTAP antibody, then used antibody against phosphoserine/threonine/tyrosine (pan-p) to detect the phosphorylation level of WTAP. To avoid the misunderstanding, we have modified the description from pan-p to pWTAP (pan-p) in figures and revised the figure legends.

      (4) The authors should include overall m<sup>6</sup>A modification levels quantified of GFP<sup>sgRNA</sup> and WTAP<sup>sgRNA</sup> cells, either by mass spectrometry (preferably) or dot blot.

      We thank reviewer for raising these useful suggestions. As we showed in Figure 3F and J-K, the m<sup>6</sup>A modification event and degradation of ISG mRNAs were significantly depleted in WTAP<sup>sgRNA</sup> cell lines, indicating that function of WTAP was deficient. Thus, we used the WTAP<sup>sgRNA</sup> #2 cell line to perform most of our experiment. Furthermore, we also found 46.4% of global m<sup>6</sup>A modification was decreased in WTAP<sup>sgRNA</sup> THP-1 cells than that of control cells with or without IFN-β stimulation (Author response image 4), further validating that level of m<sup>6</sup>A modification was significantly affected in WTAP<sup>sgRNA</sup> cells. Taken together, our data confirmed that m<sup>6</sup>A methyltransferase activity was efficiently inhibited in our WTAP<sup>sgRNA</sup> cells.

      Author response image 4.

      Control (GFP<sup>sgRNA</sup>) and WTAP<sup>sgRNA</sup> #2 THP-1-derived macrophages were treated with 10 ng/mL IFN-β for 4 hours. Global m<sup>6</sup>A level was detected and quantified through ELISA assays. All error bars, mean values ± SEM, P-values were determined by two-way ANOVA test independent biological experiments.

      Reviewer #3 (Public review):

      Summary:

      This study presents a valuable finding on the mechanism used by WTAP to modulate the IFN-β stimulation. It describes the phase transition of WTAP driven by IFN-β-induced dephosphorylation. The evidence supporting the claims of the authors is solid, although major analysis and controls would strengthen the impact of the findings. Additionally, more attention to the figure design and to the text would help the reader to understand the major findings.

      Strength:

      The key finding is the revelation that WTAP undergoes phase separation during virus infection or IFN-β treatment. The authors conducted a series of precise experiments to uncover the mechanism behind WTAP phase separation and identified the regulatory role of 5 phosphorylation sites. They also succeeded in pinpointing the phosphatase involved.

      Weaknesses:

      However, as the authors acknowledge, it is already widely known in the field that IFN and viral infection regulate m<sup>6</sup>A mRNAs and ISGs. Therefore, a more detailed discussion could help the reader interpret the obtained findings in light of previous research.

      We are grateful for the positive comments and the unbiased advice by the reviewer. To interpret our findings in previous research, we have revised the manuscript carefully and added more detailed discussion on ISG mRNAs m<sup>6</sup>A modification during virus infection or IFN stimulation.

      It is well-known that protein concentration drives phase separation events. Similarly, previous studies and some of the figures presented by the authors show an increase in WTAP expression upon IFN treatment. The authors do not discuss the contribution of WTAP expression levels to the phase separation event observed upon IFN treatment. Similarly, METTL3 and METTL14, as well as other proteins of the MTC are upregulated upon IFN treatment. How does the MTC protein concentration contribute to the observed phase separation event?

      We thank reviewer for pointing out the importance of the concentration dependent phase transition. Previously, Ge et al. discovered that expression level of WTAP was up-regulated during LPS stimulation, thereby promoting WTAP phase separation ability and m<sup>6</sup>A modification, indicating that WTAP concentration indeed affects the phase separation event. In our article, we have generated the phase diagram with different concentration of recombinant mCherry-WTAP in vitro (Figure 1-figure supplement 1C). For in cells experiments, we constructed the TRE-mCherry-WTAP HeLa cells in which the expression of mCherry-WTAP was induced by doxycycline (Dox) in a dose-dependent manner (Author response image 5A). We detected the LLPS of mCherry-WTAP at different concentrations by increasing the doses of Dox, and found that WTAP automatically underwent LLPS only in an artificially high expression level (Author response image 5B). However, the cells we used to detect the WTAP phase separation in our article was mCherry-WTAP-rescued HeLa cells, in which mCherry-WTAP was introduced in WTAP<sup>sgRNA</sup> HeLa cells to stably express mCherry-WTAP. We had adjusted and verified the mCherry-WTAP expression level precisely to make the protein abundance similar to endogenous WTAP in wild type (WT) HeLa cells (Author response image 5C). We also repeated the IFN-β stimulation experiments and found no significant increase of WTAP protein level (Figure 5-figure supplement 1A). These findings indicated the phase separation of WTAP in our article was not artificially induced due to the extremely high protein expression level.

      MTC protein expression level was crucial for m<sup>6</sup>A modification during virus infection event. Rubio et al. and Winkler et al. revealed that WTAP, METTL3 and METTL14 were up-regulated after 24 hours of HCMV infection[8,17]. Recently, Ge et al. proposed that WTAP protein was degraded after 12 hours of VSV and HSV stimulation5,18. However, these studies only focused on the virus infection event, how the MTC protein expression change after direct IFN-β stimulation was still unclear. Our study investigated the transition change of WTAP under IFNβ stimulation in a short time, we detected the expression level of MTC proteins within 6 hours of IFN-β treatment, and found no significant enhancement of WTAP, METTL3 or METTL14 protein level and mRNA level (Figure 5-figure supplement 1B and Figure 5-figure supplement 1A;). Our in vitro experiments showed that introducing CFP-METTL3 protein have no significant influence on WTAP phase separation (Figure 4H). Additionally, we performed in cells experiments and found that increased expression of METTL3 had no effect on WTAP phase separation event (Author response image 5D). Taken together, WTAP phase separation can be promoted by dramatically increased concentration of WTAP both in vitro and in cells, but the phase separation of WTAP under IFN-β stimulation in our study was not related with the expression level of MTC proteins.

      Author response image 5.

      (A) Immunoblot analysis of the expression of mCherry-WTAP in TRE-mCherry-WTAP HeLa cells treated with different doses of doxycycline (Dox). Protein level of mCherry-WTAP was quantified and normalized to β-actin of n=3 independent biological experiments. Results were obtained for three independent biological experiments. (B) Phase separation diagram of mCherry-WTAP in TRE-mCherry-WTAP HeLa cells treated with different doses of Dox were observed through confocal microscopy. Representative images for three independent biological experiments were shown in b while number of WTAP condensates that diameter over 0.4 μm of n=80 cells were counted and shown as medium with interquartile range. Dotted white lines indicated the location of nucleus. Scale bars indicated 10 μm. (C) Immunoblot analysis of the expression of endogenous WTAP in wildtype (WT) HeLa cells and mCherry-WTAP-rescued WTAP<sup>sgRNA</sup> HeLa cells. (D) mCherry-WTAP-rescued HeLa cells were transfected with 0, 200 or 400 ng of Flag-METTL3, followed with 10 ng/mL IFN-β for 1 hour or left untreated (UT). Phase separation of mCherry-WTAP was observed through confocal microscopy. The number of WTAP condensates that diameter over 0.4 μm of n = 20 cells were counted through ImageJ and shown. Representative images of n=20 cells were shown. All error bars, mean values ± SD were determined by unpaired two-tailed Student’s t-test of n = 3 independent biological experiments in (A). For (A, C), similar results were obtained for three independent biological experiments.

      How is PP4 related to the IFN signaling cascade?

      Both reviewer #2 and reviewer #3 raised a similar point on the relationship between PPP4 and IFN signaling. In short, protein phosphatase 4 (PPP4) participates in diverse biologic process, including DDR, cell cycle progression and apoptosis14 and several signaling pathway. Previous research showed that deficiency of PPP4 enhanced IFN-β downstream signaling and ISGs expression, which was consistent with our findings that knockdown of PPP4C impaired WTAP-mediated m<sup>6</sup>A modification, and enhanced the ISGs expression[15,16]. Since there was no significant enhancement in PPP4C expression level during 0-3 hours of IFN-β stimulation in our results, we tried to explore the post-translation modification which may influence the protein-protein interaction, such as ubiquitination. Intriguingly, we found the ubiquitination level of PPP4 was enhanced after IFN-β stimulation, which may affect the interaction between PPP4 and WTAP (Author response image 4). Investigation between PPP4 and WTAP will be conducted in our further study (also see minor points 1 of reviewer#2).

      In general, it is very confusing to talk about WTAP KO as WTAPgRNA.

      As we describe above, all WTAP-deficient THP-1 cells were generated using the CRISPR-Cas9 system with WTAP-specific sgRNA, and used bulk cells instead of the monoclonal knockout cell for further experiments. Since monoclonal knockout cells were not obtained, we refer it as WTAP<sup>sgRNA</sup> THP-1 cells rather than WTAP-KO THP-1 cells. We confirmed that WTAP expression was efficiently knocked down in WTAP<sup>sgRNA</sup> THP-1 cells, and the m<sup>6</sup>A modification level was significantly impaired (Figure 3I, Figure 3-figure supplement 1A and Author response image 4), which was suitable for mechanism investigation.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Related to the points raised in 'weaknesses' above, if the authors want to claim that this mechanism is reliant on WTAP phase-separated states, additional controls should be done to demonstrate this. Based on the available data it seems that it is just as likely that the phosphorylation state of WTAP is mediating interactions with other factors and/or altering its subcellular localization, which may or may not be related to phase separation.

      We are grateful for the constructive suggestions. As we showed in , Figure 5-figure supplement 1H; Author response image 1 along with the explanation above, 5% hex dispersed the phase separation condensates of WTAP without affecting its phosphorylation status, proving the interaction between STAT1 and methylation complex impaired by hex was depended on WTAP LLPS but not its phosphorylation status (Figure 5E-H). To further confirmed the recruitment of WTAP LLPS on ISG promoter region, we performed the immunoprecipitation and ChIP-qPCR experiments of wild type (WT) WTAP, 5ST-D and 5ST-A rescued THP-1 cells. Our results uncovered the interaction between de-phosphorylated-mimic WTAP mutant and STAT1, and its binding ability with ISG promoter regions were depleted by hex without affecting its phosphorylation status (Author response image 2, Figure 5-figure supplement 1 F, Figure 6E). Taken together, we identified the de-phosphorylation event that regulated phase transition of WTAP during IFN-β stimulation, and proposed that LLPS of WTAP mediated by dephosphorylation was the key mechanism to bind with STAT1 and mediate the m<sup>6</sup>A modification on ISG mRNAs.

      Reviewer #2 (Recommendations for the authors):

      The author order is different for the main text and the supplementary file.

      Thank you for pointing out this mistake. We have corrected it in our revised version.

      Reviewer #3 (Recommendations for the authors):

      Signaling molecules? Do you mean RNA or protein post-translational modification?

      Thank you for pointing out this problem. In this sentence, we mean the post-translational modification of signaling proteins. We have corrected this mistake in our revised version.

      Line 145: Do you mean Figure 1C?

      We have corrected it in our revised version.

      Line 214: Are the cells KO for WTAP? Do you mean CRISPR KO? In general, it is easier to present WTAPgRNA as WTAPKO.

      Thank you for the constructive suggestion. As we explained above, in this project, all WTAP-deficient THP-1 cells were generated using the CRISPR-Cas9 system with WTAP-specific sgRNA, and used bulk cells instead of the monoclonal knockout cells. We confirmed that WTAP expression was efficiently knocked down in WTAP<sup>sgRNA</sup> THP-1 cells, and the m<sup>6</sup>A modification level was significantly impaired (Figure 3I, Figure3-figure supplement 1A and Author response image 4). Since monoclonal knockout cells were not obtained, we refer it as WTAP<sup>sgRNA</sup> THP-1 cells rather than WTAP-KO THP-1 cells.

      Line 221: WTAP KO has no effect on the expression level of transcription factors?

      Thank you for pointing out the uncritical expression. We have corrected this in our revised version.

      Figure 3C: I would suggest removing the tracks and showing the expression levels in TPMs.

      According to the reviewer’s suggestion, we have analyzed the results and showed the ISGs expression levels in fold change of TPMs (Figure 3D).

      Figure 4C: It seems that the IP efficiency from METTL3 is lower in WTAP KO cells. That may impact the author's conclusions.

      We have repeated the immunoprecipitation experiments of METTL3 and confirmed the immunoprecipitation (IP) efficiency from METTL3 had no difference between WTAP<sup>sgRNA</sup> cells and the control cells (Figure 5C).

      I would suggest performing an IP of WTAP with the 5StoA mutation to confirm the missing interaction with WTAP.

      According to the reviewer’s suggestion, we investigated the interaction between STAT1 and WTAP in WT cells and WTAP 5ST-A-rescued THP-1 cells. Our results showed that interaction between STAT1, METTL3 and WTAP were enhanced with WTAP 5ST-A mutation, which was depleted by hex treatment (Figure 5-figure supplement 1E). Thus, the interaction of WTAP WT or 5ST-A with the promoter regions of ISG were attenuated by WTAP LLPS dissolution (Figure 6E). Taken together, the interaction between STAT1 and MTC were relied on LLPS of WTAP.

      In the graphical abstract, it is confusing to represent WTAP as a line. All other proteins are presented as circles. It is easy to confuse WTAP protein with an RNA. Additionally, m<sup>6</sup>A is too big in size. It should be smaller than a protein.

      We thank the reviewer for raising this suggestion. We have modified the graphical abstract to avoid the confusion in our revised version (Figure 6F).

      References

      (1) Wegmann, S., Eftekharzadeh, B., Tepper, K., Zoltowska, K.M., Bennett, R.E., Dujardin, S., Laskowski, P.R., MacKenzie, D., Kamath, T., Commins, C., et al. (2018). Tau protein liquid-liquid phase separation can initiate tau aggregation. The EMBO journal 37. 10.15252/embj.201798049.

      (2) Lu, Y., Wu, T., Gutman, O., Lu, H., Zhou, Q., Henis, Y.I., and Luo, K. (2020). Phase separation of TAZ compartmentalizes the transcription machinery to promote gene expression. Nat Cell Biol 22, 453-464. 10.1038/s41556-020-0485-0.

      (3) Zhang, H., Shao, S., Zeng, Y., Wang, X., Qin, Y., Ren, Q., Xiang, S., Wang, Y., Xiao, J., and Sun, Y. (2022). Reversible phase separation of HSF1 is required for an acute transcriptional response during heat shock. Nat Cell Biol 24, 340-352. 10.1038/s41556-022-00846-7.

      (4) Duster, R., Kaltheuner, I.H., Schmitz, M., and Geyer, M. (2021). 1,6-Hexanediol, commonly used to dissolve liquid-liquid phase separated condensates, directly impairs kinase and phosphatase activities. J Biol Chem 296, 100260. 10.1016/j.jbc.2021.100260.

      (5) Ge, Y., Chen, R., Ling, T., Liu, B., Huang, J., Cheng, Y., Lin, Y., Chen, H., Xie, X., Xia, G., et al. (2024). Elevated WTAP promotes hyperinflammation by increasing m<sup>6</sup>A modification in inflammatory disease models. J Clin Invest 134. 10.1172/JCI177932.

      (6) Hou, S., Hu, J., Yu, Z., Li, D., Liu, C., and Zhang, Y. (2024). Machine learning predictor PSPire screens for phase-separating proteins lacking intrinsically disordered regions. Nat Commun 15, 2147. 10.1038/s41467-024-46445-y.

      (7) McFadden, M.J., McIntyre, A.B.R., Mourelatos, H., Abell, N.S., Gokhale, N.S., Ipas, H., Xhemalce, B., Mason, C.E., and Horner, S.M. (2021). Post-transcriptional regulation of antiviral gene expression by N6-methyladenosine. Cell Rep 34, 108798. 10.1016/j.celrep.2021.108798.

      (8) Winkler, R., Gillis, E., Lasman, L., Safra, M., Geula, S., Soyris, C., Nachshon, A., Tai-Schmiedel, J., Friedman, N., Le-Trilling, V.T.K., et al. (2019). m(6)A modification controls the innate immune response to infection by targeting type I interferons. Nat Immunol 20, 173-182. 10.1038/s41590-018-0275-z.

      (9) Li, Y., Xia, L., Tan, K., Ye, X., Zuo, Z., Li, M., Xiao, R., Wang, Z., Liu, X., Deng, M., et al. (2020). N(6)-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2. Nat Genet 52, 870-877. 10.1038/s41588-020-0677-3.

      (10) Huang, H., Weng, H., Zhou, K., Wu, T., Zhao, B.S., Sun, M., Chen, Z., Deng, X., Xiao, G., Auer, F., et al. (2019). Histone H3 trimethylation at lysine 36 guides m(6)A RNA modification co-transcriptionally. Nature 567, 414-419. 10.1038/s41586-019-1016-7.

      (11) Barbieri, I., Tzelepis, K., Pandolfini, L., Shi, J., Millan-Zambrano, G., Robson, S.C., Aspris, D., Migliori, V., Bannister, A.J., Han, N., et al. (2017). Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control. Nature 552, 126-131. 10.1038/nature24678.

      (12) Hao, J.D., Liu, Q.L., Liu, M.X., Yang, X., Wang, L.M., Su, S.Y., Xiao, W., Zhang, M.Q., Zhang, Y.C., Zhang, L., et al. (2024). DDX21 mediates co-transcriptional RNA m(6)A modification to promote transcription termination and genome stability. Mol Cell 84, 1711-1726 e1711. 10.1016/j.molcel.2024.03.006.

      (13) Bhattarai, P.Y., Kim, G., Lim, S.C., and Choi, H.S. (2024). METTL3-STAT5B interaction facilitates the co-transcriptional m(6)A modification of mRNA to promote breast tumorigenesis. Cancer Lett 603, 217215. 10.1016/j.canlet.2024.217215.

      (14) Dong, M.Z., Ouyang, Y.C., Gao, S.C., Ma, X.S., Hou, Y., Schatten, H., Wang, Z.B., and Sun, Q.Y. (2022). PPP4C facilitates homologous recombination DNA repair by dephosphorylating PLK1 during early embryo development. Development 149. 10.1242/dev.200351.

      (15) Zhan, Z., Cao, H., Xie, X., Yang, L., Zhang, P., Chen, Y., Fan, H., Liu, Z., and Liu, X. (2015). Phosphatase PP4 Negatively Regulates Type I IFN Production and Antiviral Innate Immunity by Dephosphorylating and Deactivating TBK1. J Immunol 195, 3849-3857. 10.4049/jimmunol.1403083.

      (16) Raja, R., Wu, C., Bassoy, E.Y., Rubino, T.E., Jr., Utagawa, E.C., Magtibay, P.M., Butler, K.A., and Curtis, M. (2022). PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling. J Immunother Cancer 10. 10.1136/jitc-2022-005026.

      (17) Rubio, R.M., Depledge, D.P., Bianco, C., Thompson, L., and Mohr, I. (2018). RNA m(6) A modification enzymes shape innate responses to DNA by regulating interferon beta. Genes Dev 32, 1472-1484. 10.1101/gad.319475.118.

      (18) Ge, Y., Ling, T., Wang, Y., Jia, X., Xie, X., Chen, R., Chen, S., Yuan, S., and Xu, A. (2021). Degradation of WTAP blocks antiviral responses by reducing the m(6) A levels of IRF3 and IFNAR1 mRNA. EMBO Rep 22, e52101. 10.15252/embr.202052101.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The model of phosphotransfer from Y169 IKK to S32 IkBa is compelling and an important new contribution to the field. In fact, this model will not be without controversy, and publishing the work will catalyze follow-up studies for this kinase and others as well. As such, I am supportive of this paper, though I do also suggest some shortening and modification.

      We appreciate the reviewers candid response on the difficulty of this study and the requirement of follow-up studies to confirm a direct transfer of the phosphate. We also have edited the manuscript to make it shorter.

      Generally, the paper is well written, but several figures should be quantified, and experimental reproducibility is not always clear. The first 4 figures are slow-going and could be condensed to show the key points, so that the reader gets to Figures 6 and 7 which contain the "meat" of the paper.

      We have indicated the experimental reproducibility in the methodology section against each assay. We have shortened the manuscript corresponding to sections describing figures 1-4. However, when we talked to some of our colleagues whose expertise do not align with kinases and IKK, we realized that some description were necessary to introduce them to the next figures. Additionally, we added Fig. S6 indicating that the radiolabelled phospho-IKK2 Y169F is unable to transfer its own phosphate group(s) to the substrate IkBa.

      Reviewer #2 (Public Review):

      Phosphorylation of IκBα is observed after ATP removal, although there are ambiguous requirements for ADP.

      We agree with the reviewer that this observation is puzzling. We hypothesize that ADP is simultaneously regulating the transfer process likely through binding to the active site.

      It seems that the analysis hinges on the fidelity of pan-specific phosphotyrosine antibodies.

      We agree with the reviewer. To bolster our conclusion, we used antibodies from two different sources. These were Monoclonal mouse anti-Phospho-Tyrosine (catalogue number: 610000) was from BD Biosciences or from EMD Millipore (catalogue no. 05-321X).

      The analysis often returns to the notion that tyrosine phosphorylation(s) (and critical active site Lys44) dictate IKK2 substrate specificity, but evidence for this seems diffuse and indirect. This is an especially difficult claim to make with in vitro assays, omitting the context of other cellular specificity determinants (e.g., localization, scaffolding, phosphatases).

      We agree with the concerns that the specificity could be dependent on other cellular specificity determinants and toned down our claims where necessary. However, we would like to point out that the specificity of IKK2 towards S32 and S36 of IkBa in cells in response to specific stimuli is well-established. It is also well-established that its non-catalytic scaffolding partner NEMO is critical in selectively bringing IkBa to IKK from a large pool of proteins. The exact mechanism of how IKK2 choose the two serines amongst many others in the substrate is not clear.

      Multiple phosphorylated tyrosines in IKK2 were apparently identified by mass spectrometric analyses, but the data and methods are not described. It is common to find non-physiological post-translational modifications in over-expressed proteins from recombinant sources. Are these IKK2 phosphotyrosines evident by MS in IKK2 immunoprecipitated from TNFa-stimulated cells? Identifying IKK2 phosphotyrosine sites from cells would be especially helpful in supporting the proposed model.

      Mass spectrometric data for identification of phosphotyrosines from purified IKK2 is now incorporated (Figure S3A). Although we have not analyzed IKK2 from TNF-a treated cells in this study, a different study of phospho-status of cellular IKK2 indicated tyrosine phosphorylation (Meyer et al 2013).

      Reviewer #3 (Public Review):

      The identity and purity of the used proteins is not clear. Since the findings are so unexpected and potentially of wide-reaching interest - this is a weakness. Similar specific detection of phospho-Ser/Thr vs phospho-Tyr relies largely on antibodies which can have varying degrees of specificity.

      We followed a stringent purification protocol of several steps (optimized for the successful crystallization of the IKK2) that removed most impurities (PMID: 23776406, PMID: 39227404). The samples analysed with ESI MS did not show any significant contaminating kinase from the Sf9 cells.

      Sequence specific phospho-antibodies used in this study are very well characterized and have been used in the field for years (Basak et al 2007, PMID: 17254973). We agree on the reviewer’s concerns on the pan-specific phospho-antibodies. Since phospho-tyrosine detection is the crucial aspect of this study, we minimized such bias by using pan-specific phosphotyrosine antibodies from two independent sources.

      Reviewer #1 (Recommendations For The Authors):

      I understand that Figure 3 shows that K44M abolishes both S32/26 phosphorylation and tyrosine phosphorylation, but not PEST region phosphorylation. This suggests that autophosphorylation is reflective of its known specific biological role in signal transduction. But I do not understand why "these results strongly suggest that IKK2-autophosphorylation is critical for its substrate specificity". That statement would be supported by a mutant that no longer autophosphorylates, and as a result shows a loss of substrate specificity, i.e. phosphorylates non-specific residues more strongly. Is that the case? Maybe Darwech et al 2010 or Meyer et al 2013 showed this.

      Later figures seem to address this point, so maybe this conclusion should be stated later in the paper.

      We have now clarified this in the manuscript and moved the comment to the next section. We have consolidated the results in Figure 3 and 4 in the previous version into a single figure in Figure. The text has also been modified accordingly.

      Page 10: mentions DFG+1 without a proper introduction. The Chen et al 2014 paper appears to inform the author's interest in Y169 phosphorylation, or is it just an additional interesting finding? Does this publication belong in the Introduction or the Discussion?

      The position of Y169 at the DFG+1 was intriguing and the 2014 article Chen et al further bolstered our interest in this residue to be investigated. We think this publication is important in both sections. 

      To understand the significance of Figure 4D, we need a WT IKK2 control: or is there prior literature to cite? This is relevant to the conclusion that Y169 phosphorylation is particularly important for S32 phosphorylation.

      We have now added a new supplementary figure where activities of WT and Y169F IKK2 towards WT and S32/S36 mutants are compared (Figure S3F). At a similar concentration, the activity of WT-IKK2 is many fold higher than that of YtoF mutants (Fig. 4C). The experiments were performed simultaneously, although samples were loaded on different gels but otherwise processed in a similar way. The corresponding data is now included in the manuscript as Figure S3F.

      The cold ATP quenching experiment is nice for testing the model that Y169 functions as a phospho sink that allows for a transfer reaction. However, there is only a single timepoint and condition, which does not allow for a quantitative analysis. Furthermore, a positive control would make this experiment more compelling, and Y169F mutant should show that cold ATP quenching reduces the phosphorylation of IkBa.

      We thank the reviewer for appreciating our experimental design, and pointing out the concerns. We kept the ATP-time point as the maximum of the non-competition experiment. Also, we took 50mM ATP to compare its competition with highest concentration of ADP used. The idea behind using the maximum time and ATP (comparable to ADP) was to capture the effect of competitive-effect of ATP, if any, that would be maximal in the given assay condition in comparison with the phospho-transfer set up in absence of cold ATP. We agree that finer ranges of ATP concentration and time points would have enabled more quantitative analyses. We have now included data where different time intervals are tested (Figure S5D).

      Why is the EE mutant recognized by anti-phospho-serine antibodies? In Figure 2F.

      We anticipate Serine residues besides those in the activation loop to be phosphorylated when IKK2 is overexpressed and purified from the Sf9 cells. Since Glu (E) mimics phospho-Ser, the said antibody cross reacts with the IKK2-EE that mimics IKK2 phosphorylated at Ser177 and 181.

      Figure 7B is clear, but 7C does not add much.

      We have now removed the Fig. 7C in the current version. Figure 7 is now renumbered as Figure 6 that does not contain the said cartoon.  

      Reviewer #2 (Recommendations For The Authors):

      Regarding the specificity arguments (see above in public review), the authors note that NEMO is very important in IKK specificity, and - if I'm understanding correctly - most of these assays were performed without NEMO. Would the IKK2-NEMO complex change these conclusions?

      NEMO is a scaffolding protein whose action goes beyond the activation of the IKK-complex. In cells, NEMO brings IkBa from a pool of thousands of proteins to its bonafide kinase when the cells encounter specific signals. In other words, NEMO channels IKK-activity towards its bonafide substrate IkBa at that moment. Though direct proof is lacking, it is likely that NEMO present IkBa in the correct pose to IKK such that the S32/S36 region of IkBa is poised for phosphorylation. The proposed mechanism in the current study further ensures the specificity and fidelity of that phosphorylation event. We believe this mechanism will be preserved in the IKK-NEMO complex unless proven otherwise. As shown below, IKK2 undergoes tyrosine autophosphorylation in presence of NEMO.

      Author response image 1.

      The work primarily focuses on Y169 as a candidate target for IKK autophosphorylation. This seems reasonable given the proximity to the ATP gamma phosphate. However, Y188F more potently disrupted IκBα phosphorylation. The authors note that this could be due to folding perturbations, but this caveat would also apply to Y169F. A test for global fold perturbations for both Tyr mutants would be helpful.

      Y188 is conserved in S/T kinases and that in PKA (Y204) has been studied extensively using structural, biochemical and biophysical tools. It was found in case of PKA that Y204 participates in packing of the hydrophobic core of the large lobe. Disruption of this core structure by mutation allosterically affect the activity of the kinase. We also observed similar engagement of Y188 in IKK2’s large lobe, and speculated folding perturbations in analogy with the experimental evidence observed in PKA. What we meant was mutation of Y188 would allosterically affect the kinase activity. Y169 on the other hand is unique at that position, an no experimental evidence on the effect of phospho-ablative mutation of this residue exist in the literature. Hence, we refrained from speculating its effect on the folding or conformational allostery, however, such a possibility cannot be ruled out. 

      I struggled to follow the rationalization of the results of Figure 4D, the series of phosphorylation tests of Y169F against IκBα with combinations of phosphoablative or phosphomimetic variants at Ser32 and Ser36. This experiment is hard to interpret without a direct comparison to WT IKK2.

      We agree with the reviewer’s concerns. Through this experiment we wanted to inform about the importance of Tyr-phosphorylation of IKK2 in phosphorylating S32 of IκBα which is of vital importance in NF-kB signaling. We have now provided a comparison with WT-IKK2 in the supplementary Figure S3F. We hope this will help bring more clarity to the issue.

      MD simulations were performed to compare structures of unphosphorylated vs. Ser-phosphorylated (p-IKK2) vs. Ser+Tyr-phosphorylated (P-IKK2) forms of IKK2. These simulations were performed without ATP bound, and then a representative pose was subject to ADP or ATP docking. The authors note distortions in the simulated P-IKK2 kinase fold and clashes with ATP docking. Given the high cellular concentration of ATP, it seems more logical to approach the MD with the assumption of nucleotide availability. Most kinase domains are highly dynamic in the absence of substrate. Is it possible that the P-IKK2 poses are a result of simulation in a non-physiological absence of bound ATP? Ultimately, this MD observation is linked to the proposed model where ADP-binding is required for efficient phospho-relay to IκBα. Therefore, this observation warrants scrutiny. Perhaps the authors could follow up with binding experiments to directly test whether P-IKK2 binds ADP and fails to bind ATP.

      We thank that reviewer for bringing up this issue. This is an important issue and we must agree that we don’t fully understand it yet. We took more rigorous approach this time where we used three docking programs: ATP and ADP were docked to the kinase structures using LeDock and GOLD followed by rescoring with AutoDock Vina. We found that ATP is highly unfavourable to P-IKK2 compared to ADP. To further address these issues, we performed detailed MM-PBSA (Molecular Mechanics Poisson-Boltzmann Surface Area) analyses after MD-simulation to estimate binding free energies and affinities of ADP and ATP for each of the three differently phosphorylated states of IKK2. These analyses (Figure S4 E and F) clearly indicate that phosphorylated IKK2 have much higher preference for ADP over ATP. However, it does not negate ATP-binding by P-IKK2 in a different pose that may not support kinase activity.

      We could not perform any binding experiment because of the following reason. We incubated FL IKK2 WT with or without cold ATP for 30mins, and then incubated these samples with <sup>32</sup>P-ATP and analysed the samples by autoradiography after resolving them on a 10% SDS-PAGE. We found that even after pre-incubation of the kinase with excess cold ATP it still underwent autophosphorylation when radioactive ATP was added as shown below. This prevented us from doing direct binding experiment with ATP as it would not represent true binding event. We also noticed that after removal of bulk ATP post autophosphorylation, phosphorylated IKK2 is capable of further autophosphorylation when freshly incubated with ATP. We have not been able to come up with a condition that would only account for binding of ATP and not hydrolysis. 

      Author response image 2.

      The authors could comment on whether robust phosphorylation of NEMO was expected (Figure 1D). On a related note, why is NEMO a single band in the 1D left panel and double bands on the right?

      No, we did not expect robust phosphorylation of NEMO. However, robust phosphorylation of NEMO is observed only in the absence of IκBα. In presence of IκBα, phosphorylation of NEMO goes down drastically. These were two different preparations of NEMO. When TEV-digestion to remove His-tag is incomplete it gives two bands as the tagged and untagged versions cannot be separated in size exclusion chromatography which is the final step.

      Page 14, line 360. "...observed phosphorylation of tyrosine residue(s) only upon fresh ATP-treatment..." I'm not sure I understand the wording here (or the relevance of the citation). Is this a comment on unreported data demonstrating the rapid hydrolysis of the putative phosphotyrosine(s)? If so, that would be helpful to clarify and report in the supporting information.

      In our X-ray crystallographic studies with phosphorylated IKK2 we failed to observe any density of phosphate moiety. Furthermore, this IKK2 showed further autophosphorylation when incubated with fresh ATP. These two observations lead us to believe that some of the autophosphorylation are transient in nature. However, quantitative kinetic analyses of this dephosphorylation have not been performed.

      Figure S3 middle panel: The PKA substrate overlaid on the IKK2 seems sterically implausible for protein substrate docking. Is that just a consequence of the viewing angle? On a related note, Figure S3 may be mislabeled as S4 in the main text).

      It is a consequence of the viewing angle. Also, we apologize for this inadvertent mislabelling. It has been corrected in the current version.

      Reviewer #3 (Recommendations For The Authors):

      The detection of phosphorylated amino acids relies largely on antibodies which can have a varying degree of specificity. An alternative detection mode of the phospho-amino acids for example by MS would strengthen the evidence.

      We agree with the concern of specificity bias of antibodies. We tried to minimize such bias by using two different p-Tyr antibodies as noted previously and also in the methodology section. We were also able to detect phospho-tyrosine residues by MS/MS analyses, representative spectra are now added (Figure S3A).

      IKK2 purity - protocol states "desired purity". What was the actual purity and how was it checked? MS would be useful to check for the presence of other kinases.

      Purity of the recombinantly purified IKK2s are routinely checked by silver staining. A representative silver stained SDS-PAGE is shown (Figure S1C). It may be noted that, there’s a direct correlation of expression level and solubility, and hence purification yield and quality with the activity of the kinase. Active IKK2s express at much higher level and yields cleaner prep. In our experience, inactive IKKs like K44M give rise to poor yield and purity. We analysed K44M by LC MS/MS to identify other proteins present in the sample. We did not find any significant contaminant kinase the sample (Figure S1D). The MS/MS result is attached.

      Figure 1C&D: where are the Mw markers? What is the size of the band? What is the MS evidence for tyrosine phosphorylation?

      We have now indicated MW marker positions on these figures.

      MS/MS scan data for the two peptides containing pTyr169 and pTyr188 are shown separately (Figure S3A).

      Figure 2F: Why is fresh ATP necessary? Why was Tyr not already phosphorylated? The kinetics of this process appear to be unusual when the reaction runs to completion within 5 minutes ?

      As stated earlier, we believe some of the autophosphorylation are transient in nature. We think the Tyr-phosphorylation are lost due to the action of cellular phosphatases. We agree with the concern of the reviewer that, the reaction appears to reach completion within 5 minutes in Fig 2F. We believe it is probably due to the fact that the amount of kinase used in this study exceeds the linear portion of the dynamic range of the antibody used. Lower concentration of the kinase do show that reaction does not reach completion until 60mins as shown in Fig. 2A.

      Figure 3: Can the authors exclude contamination with a Tyr kinase in the IKK2-K44M prep? The LC/MS/MS data should be included.

      We have reanalysed the sample on orbitrap to check if there’s any Tyr-kinase or any other kinase contamination. We used Spodoptera frugiperda proteome available on the Uniprot website for this analysis. These analyses confirmed that there’s no significant kinase contaminant present in the fraction (Figure S1D).

      What is the specificity of IKK-2 Inhibitor VII? Could it inhibit a contaminant kinase?

      This inhibitor is highly potent against IKK2 and the IKK-complex, and to a lesser extent to IKK1. No literature is available on its activity on other kinases. In an unrelated study, this compound was used alongside MAPK inhibitor SB202190 wherein they observed completely different outcomes of these two inhibitors (Matou-Nasri S, Najdi M, AlSaud NA, Alhaidan Y, Al-Eidi H, Alatar G, et al. (2022) Blockade of p38 MAPK overcomes AML stem cell line KG1a resistance to 5-Fluorouridine and the impact on miRNA profiling. PLoS ONE 17(5):e0267855. https://doi.org/10.1371/journal.pone.0267855). This study indirectly proves that IKK inhibitor VII does not fiddle with the MAPK pathways. We have not found any literature on the non-specific activity of this inhibitor.

      Figure 6B: the band corresponding to "p-IkBa" appears to be similar in the presence of ADP (lanes 4-7) or in the absence of ADP but the presence of ATP (lane 8).

      Radioactive p-IκBα level is more when ADP is added than in absence of ADP. In presence of cold ATP, radioactive p-IκBα level remains unchanged. This result strongly indicate that the addition of phosphate group to IκBα happens directly from the radioactively labelled kinase that is not competed out by the cold ATP.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #1 (Public review):

      Summary:

      In the manuscript "Intergenerational transport of double-stranded RNA limits heritable epigenetic changes," Shugarts and colleagues investigate intergenerational dsRNA transport in the nematode C. elegans. By inducing oxidative damage, they block dsRNA import into cells, which affects heritable gene regulation in the adult germline (Fig. 2). They identify a novel gene, sid-1-dependent gene-1 (sdg-1), upregulated upon SID-1 inhibition (Fig. 3). Both transient and genetic depletion of SID-1 lead to the upregulation of sdg-1 and a second gene, sdg-2 (Fig. 5). Interestingly, while sdg-1 expression suggests a potential role in dsRNA transport, neither its overexpression nor loss-of-function impacts dsRNA-mediated silencing in the germline (Fig. 7).

      Strengths:

      • The authors employ a robust neuronal stress model to systematically explore SID-1 dependent intergenerational dsRNA transport in C. elegans.

      • They discover two novel SID-1-dependent genes, sdg-1 and sdg-2.

      • The manuscript is well-written and addresses the compelling topic of dsRNA signaling in C. elegans.

      Weaknesses:

      • The molecular mechanism downstream of SDG-1 remains unclear. Testing whether sdg-2 functions redundantly with sdg-1could provide further insights.

      • SDG-1 dependent genes in other nematodes remain unknown.

      We thank the reviewer for highlighting the strengths of the work along with a couple of the interesting future directions inspired by the reported discoveries. The restricted presence of genes encoding SDG-1 and its paralogs within retrotransposons suggests intriguing evolutionary roles for these proteins. Future work could examine whether such fast-evolving or newly evolved proteins with potential roles in RNA regulation are more broadly associated with retrotransposons. Multiple SID-1-dependent proteins (including SDG-1 and SDG-2) could act together to mediate downstream effects. This possibility can be tested using combinatorial knockouts and overexpression strains. Both future directions have the potential to illuminate the evolutionarily selected roles of dsRNA-mediated signaling through SID-1, which remain a mystery.

      Reviewer #2 (Public review):

      Summary:

      RNAs can function across cell borders and animal generations as sources of epigenetic information for development and immunity. The specific mechanistic pathways how RNA travels between cells and progeny remains an open question. Here, Shugarts, et al. use molecular genetics, imaging, and genomics methods to dissect specific RNA transport and regulatory pathways in the C. elegans model system. Larvae ingesting double-stranded RNA is noted to not cause continuous gene silencing throughout adulthood. Damage of neuronal cells expressing double-stranded target RNA is observed to repress target gene expression in the germline. Exogenous short or long double-stranded RNA required different genes for entry into progeny. It was observed that the SID-1 double-stranded RNA transporter showed different expression over animal development. Removal of the sid-1 gene caused upregulation of two genes, the newly described sid-1-dependent gene sdg-1 and sdg-2. Both genes were observed to be negatively regulated by other small RNA regulatory pathways. Strikingly, loss then gain of sid-1 through breeding still caused variability of sdg-1 expression for many, many generations. SDG-2 protein co-localizes with germ granules, intracellular sites for heritable RNA silencing machinery. Collectively, sdg-1 presents a model to study how extracellular RNAs can buffer gene expression in germ cells and other tissues.

      Strengths:

      (1) Very cleaver molecular genetic methods and genomic analyses, paired with thorough genetics, were employed to discover insights into RNA transport, sdg-1 and sdg-2 as sid-1-dependent genes, and sdg-1's molecular phenotype.

      (2) The manuscript is well cited, and figures reasonably designed.

      (3) The discovery of the sdg genes being responsive to the extracellular RNA cell import machinery provides a model to study how exogenous somatic RNA is used to regulate gene expression in progeny. The discovery of genes within retrotransposons stimulates tantalizing models how regulatory loops may actually permit the genetic survival of harmful elements.

      Weaknesses:

      (1) The manuscript is broad, making it challenging to read and consider the data presented. Of note, since the original submission, the authors have improved the clarity of the writing and presentation.

      Comments on revised version:

      This reviewer thanks the authors for their efforts in revising the manuscript. In their rebuttal, the authors acknowledged the broad scope of their manuscript. I concur. While I still think the manuscript is a challenge to read due to its expansive nature, the current draft is substantially improved when compared to the previous one. This work will contribute to our general knowledge of RNA biology, small RNA regulatory pathways, and RNA inheritance.

      We thank the reviewer for highlighting the strengths of the manuscript and for helping us improve the presentation of our results and discussion.


      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In the manuscript "Intergenerational transport of double-stranded RNA limits heritable epigenetic changes" Shugarts and colleagues investigate intergenerational dsRNA transport in the nematode C. elegans. They induce oxidative damage in worms, blocking dsRNA import into cells (and potentially affecting the worms in other ways). Oxidative stress inhibits dsRNA import and the associated heritable regulation of gene expression in the adult germline (Fig. 2). The authors identify a novel gene, sid-1-dependent gene-1 (sdg-1), which is induced upon inhibition of SID-1 (Fig. 3). Both transient inhibition and genetic depletion of SID-1 lead to the upregulation of sdg-1 and a second gene, sdg-2 (Fig. 5). The expression of SDG-1 is variable, potentially indicating buffering regulation. While the expression of Sdg-1 could be consistent with a role in intergenerational transport of dsRNA, neither its overexpression nor loss-of-function impacts dsRNA-mediated silencing (Fig. 7) in the germline. It would be interesting to test if sdg-2 functions redundantly.

      In summary, the authors have identified a novel worm-specific protein (sdg-1) that is induced upon loss of dsRNA import via SID-1, but is not required to mediate SID-1 RNA regulatory effects.

      We thank the reviewer for highlighting our findings on SDG-1. We found that oxidative damage in neurons enhanced dsRNA transport into the germline and/or subsequent silencing.

      Remaining Questions:

      • The authors use an experimental system that induces oxidative damage specifically in neurons to release dsRNAs into the circulation. Would the same effect be observed if oxidative damage were induced in other cell types?

      It is possible that oxidative damage of other tissues using miniSOG (as demonstrated in Xu and Chisholm, 2016) could also enhance the release of dsRNA into the circulation from those tissues. However, future experiments would be needed to test this empirically because it is also possible that the release of dsRNA depends on physiological properties (e.g., the molecular machinery promoting specific secretion) that are particularly active in neurons. We chose to use neurons as the source of dsRNA because by expressing dsRNA in a variety of tissues, neurons appeared to be the most efficient at the export of dsRNA as measured using SID-1-dependent silencing in other tissues (Jose et al., PNAS, 2009).

      • Besides dsRNA, which other RNAs and cellular products (macromolecules and small signalling molecules) are released into the circulation that could affect the observed changes in germ cells?

      We do not yet know all the factors that could be released either in naive animals or upon oxidative damage of neurons that influence the uptake of dsRNA into other tissues. The dependence on SID-1 for the observed enhancement of silencing (Fig. 2) shows that dsRNA is necessary for silencing within the germline. Whether this import of dsRNA occurs in conjunction with other factors (e.g., the uptake of short dsRNA along with yolk into oocytes (Marré et al., PNAS, 2016)) before silencing within the germline will require further study. A possible approach could be the isolation of extracellular fluid (Banse and Hunter, J Vis Exp., 2012) followed by characterization of its contents. However, the limited material available using this approach and the difficulty in avoiding contamination from cellular damage by the needle used for isolating the material make it challenging.

      • SID-1 modifies RNA regulation within the germline (Fig. 7) and upregulates sdg-1 and sdg-2 (Fig. 5). However, SID-1's effects do not appear to be mediated via sdg-1. Testing the role of sdg-2 would be intriguing.

      We observe the accumulation of sdg-1 and sdg-2 RNA in two different mutants lacking SID-1, which led us to conservatively focus on the analysis of one of these proteins for this initial paper. We expect that more sensitive analyses of the RNA-seq data will likely reveal additional genes regulated by SID-1. With the ability to perform multiplexed genome-editing, we hope in future work to generate strains that have mutations in many SID-1-dependent genes to recapitulate the defects observed in sid-1(-) animals. Indeed, as surmised by the reviewer, we are focusing on sdg-2 as the first such SID-1-dependent gene to analyze using mutant combinations.

      • Are sdg-1 or sdg-2 conserved in other nematodes or potentially in other species?  appears to be encoded or captured by a retro-element in the C. elegans genome and exhibits stochastic expression in different isolates. Is this a recent adaptation in the C. elegans genome, or is it present in other nematodes? Does loss-of-function of sdg-1 or sdg-2 have any observable effect?

      Clear homologs of SDG-1 and SDG-2 are not detectable outside of C. elegans. Consistent with the location of the sdg-1 gene within a Cer9 retrotransposon that appears to have integrated only within the C. elegans genome, sequence conservation between the genomes of related species is only observed outside the region of the retrotransposon (see Author response image 1, screenshot from UCSC browser). There were no obvious defects detected in animals lacking sdg-1 (Fig. 7) or in animals lacking sdg-2 (data not shown). It is possible that further exploration of both mutants and mutant combinations lacking additional SID-1-dependent genes would reveal defects. We also plan to examine these mutants in sensitized genetic backgrounds where one or more members of the RNA silencing pathway have been compromised.

      Author response image 1.

      Clarification for Readability:

      To enhance readability and avoid misunderstandings, it is crucial to specify the model organism and its specific dsRNA pathways that are not conserved in vertebrates:

      We agree with the reviewer and thank the reviewer for the specific suggestions provided below. To take the spirit of the suggestion to heart we have instead changed the title of our paper to clearly signal that the entire study only uses C. elegans. We have titled the study ‘Intergenerational transport of double-stranded RNA in C. elegans can limit heritable epigenetic changes’

      • In the first sentence of the paragraph "Here, we dissect the intergenerational transport of extracellular dsRNA ...", the authors should specify "in the nematode C. elegans". Unlike vertebrates, which recognise dsRNA as a foreign threat, worms and other invertebrates pervasively use dsRNA for signalling. Additionally, worms, unlike vertebrates and insects, encode RNA-dependent RNA polymerases that generate dsRNA from ssRNA substrates, enabling amplification of small RNA production. Especially in dsRNA biology, specifying the model organism is essential to avoid confusion about potential effects in humans.

      We agree with most statements made by the reviewer, although whether dsRNA is exclusively recognized as a foreign threat by all vertebrates of all stages remains controversial. Our changed title now eliminates all ambiguity regarding the organism used in the study.

      • Similarly, the authors should specify "in C. elegans" in the sentence "Therefore, we propose that the import of extracellular dsRNA into the germline tunes intracellular pathways that cause heritable RNA silencing." This is important because C. elegans small RNA pathways differ significantly from those in other organisms, particularly in the PIWI-interacting RNA (piRNA) pathways, which depend on dsRNA in C. elegans but uses ssRNA in vertebrates. Specification is crucial to prevent misinterpretation by the reader. It is well understood that mechanisms of transgenerational inheritance that operate in nematodes or plants are not conserved in mammals.

      The piRNAs of C. elegans are single-stranded but are encoded by numerous independent genes throughout the genome. The molecules used for transgenerational inheritance of epigenetic changes that have been identified thus far are indeed different in different organisms. However, the regulatory principles required for transgenerational inheritance are general (Jose, eLife, 2024). Nevertheless, we have modified the title to clearly state that the entire study is using C. elegans.  

      • The first sentence of the discussion, "Our analyses suggest a model for ...", would also benefit from specifying "in C. elegans". The same applies to the figure captions. Clarification of the model organism should be added to the first sentence, especially in Figure 1.

      With the clarification of the organism used in the title, we expect that all readers will be able to unambiguously interpret our results and the contexts where they apply. 

      Reviewer #2 (Public review):

      Summary:

      RNAs can function across cell borders and animal generations as sources of epigenetic information for development and immunity. The specific mechanistic pathways how RNA travels between cells and progeny remains an open question. Here, Shugarts, et al. use molecular genetics, imaging, and genomics methods to dissect specific RNA transport and regulatory pathways in the C. elegans model system. Larvae ingesting double stranded RNA is noted to not cause continuous gene silencing throughout adulthood. Damage of neuronal cells expressing double stranded target RNA is observed to repress target gene expression in the germline. Exogenous supply of short or long double stranded RNA required different genes for entry into progeny. It was observed that the SID-1 double-stranded RNA transporter showed different expression over animal development. Removal of the sid-1 gene caused upregulation of two genes, the newly described sid-1-dependent gene sdg-1 and sdg-2. Both genes were observed to also be negatively regulated by other small RNA regulatory pathways. Strikingly, loss then gain of sid-1 through breeding still caused variability of sdg-1 expression for many, many generations. SDG-2 protein co-localizes with a Z-granule marker, an intracellular site for heritable RNA silencing machinery. Collectively, sdg-1 presents a model to study how extracellular RNAs can buffer gene expression in germ cells and other tissues.

      We thank the reviewer for highlighting our findings and underscoring the striking nature of the discovery that mutating sid-1 using genome-editing resulted in a transgenerational change that could not be reversed by changing the sid-1 sequence back to wild-type.

      Strengths:

      (1) Very clever molecular genetic methods and genomic analyses, paired with thorough genetics, were employed to discover insights into RNA transport, sdg-1 and sdg-2 as sid-1-dependent genes, and sdg-1's molecular phenotype.

      (2) The manuscript is well cited, and figures reasonably designed.

      (3) The discovery of the sdg genes being responsive to the extracellular RNA cell import machinery provides a model to study how exogenous somatic RNA is used to regulate gene expression in progeny. The discovery of genes within retrotransposons stimulates tantalizing models how regulatory loops may actually permit the genetic survival of harmful elements.

      We thank the reviewer for the positive comments.

      Weaknesses:

      (1) As presented, the manuscript is incredibly broad, making it challenging to read and consider the data presented. This concern is exemplified in the model figure, that requires two diagrams to summarize the claims made by the manuscript.

      RNA interference (RNAi) by dsRNA is an organismal response where the delivery of dsRNA into the cytosol of some cell precedes the processing and ultimate silencing of the target gene within that cell. These two major steps are often not separately considered when explaining observations. Yet, the interpretation of every RNAi experiment is affected by both steps. To make the details that we have revealed in this work for both steps clearer, we presented the two models separated by scale - organismal vs. intracellular. We agree that this integrative manuscript appears very broad when the many different findings are each considered separately. The overall model revealed here forms the necessary foundation for the deep analysis of individual aspects in the future.

      (2) The large scope of the manuscript denies space to further probe some of the ideas proposed. The first part of the manuscript, particularly Figures 1 and 2, presents data that can be caused by multiple mechanisms, some of which the authors describe in the results but do not test further. Thus, portions of the results text come across as claims that are not supported by the data presented.

      We agree that one of the consequences of addressing the joint roles of transport and subsequent silencing during RNAi is that the scope of the manuscript appears large. We had suggested multiple interpretations for specific observations in keeping with the need for further work. To avoid any misunderstandings that our listing of possible interpretations be taken as claims by the reader, we have followed the instructions of the reviewer (see below) and moved some of the potential explanations we raised to the discussion section.

      (3) The manuscript focuses on the genetics of SDGs but not the proteins themselves. Few descriptions of the SDGs functions are provided nor is it clarified why only SDG-1 was pursued in imaging and genetic experiments. Additionally, the SDG-1 imaging experiments could use additional localization controls.

      We agree that more work on the SDG proteins will likely be informative, but are beyond the scope of this already expansive paper.  We began with the analysis of SDG-1 because it had the most support as a regulator of RNA silencing (Fig. 5f). Indeed, in other work (Lalit and Jose, bioRxiv, 2024), we find that AlphaFold 2 predicts the SDG-1 protein to be a regulator of RNA silencing that directly interacts with the dsRNA-editing enzyme ADR-2 and the endonuclease RDE-8. Furthermore, we expect that more sensitive analyses of the RNA-seq data are likely to reveal additional genes regulated by SID-1. Using multiplexed genome editing, we hope to generate mutant combinations lacking multiple sdg genes to reveal their function(s).

      We agree that given the recent discovery of many components of germ granules, our imaging data does not have sufficient resolution to discriminate between them. We have modified our statements and our model regarding the colocalization of SDG-1 with Z-granules to indicate that the overlapping enrichment of SDG-1 and ZNFX-1 in the perinuclear region is consistent with interactions with other nearby granule components.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      Major

      (1) As presented, the manuscript is almost two manuscripts combined into one. This point is highlighted in Figure 7h, which basically presents two separate models. The key questions addressed in the manuscript starts at Figure 3. Figures 1 and 2 are interesting observations but require more experiments to define further. For example, as the Results text describes for Figure 1, "These differences in the entry of ingested dsRNA into cells and/or subsequent silencing could be driven by a variety of changes during development. These include changes in the uptake of dsRNA into the intestine, distribution of dsRNA to other tissues from the intestine, import of dsRNA into the germline, and availability of RNA silencing factors within the germline." Presenting these (reasonable) mechanistic ideas detracted from the heritable RNA epigenetic mechanism explored in the later portion of the manuscript. There are many ways to address this issue, one being moving Figures 1 and 2 to the Supplement to focus on SID-1 related pathways.

      Since this manuscript addresses the interaction between intercellular transport of dsRNA and heritable epigenetic changes, it was necessary to establish the possible route(s) that dsRNA could take to the germline before any inference could be made regarding heritable epigenetic changes. As suggested below (pt. 2), we have now moved the alternatives we enumerated as possible explanations for some experimental results (e.g., for the differences quoted here) to the discussion section.

      (2) The manuscript includes detailed potential interpretations in the Results, making them seem like claims. Here is an example:

      "Thus, one possibility suggested by these observations is that reduction of sdg-1 RNA via SID-1 alters the amount of SDG-1 protein, which could interact with components of germ granules to mediate RNA regulation within the germline of wild-type animals."

      This mechanism is a possibility, but placing these ideas in the citable results makes it seem like an overinterpretation of imaging data. This text and others should be in the Discussion, where speculation is encouraged. Results sections like this example and others should be moved to the discussion.

      We have rephrased motivating connections between experiments like the one quoted above and also moved such text to the discussion section wherever possible.

      (3) A paragraph describing the SDG proteins will be helpful. Homologs? Conserved protein domains? mRNA and/or protein expression pattern across worm, not just the germline? Conservation across Caenorhabditis sp? These descriptions may help establish context why SDG-1 localizes to Z-granules.

      We have now added information about the conservation of the sdg-1 gene in the manuscript. AlphaFold predicts domains with low confidence for the SDG-1 protein, consistent with the lack of conservation of this protein (AlphaFold requires multiple sequence alignments to predict confidently). In the adult animal, the SDG-1 protein was only detectable in the germline. Future work focused on SDG-1, SDG-2 and other SDG proteins will further examine possible expression in other tissues and functional domains if any. Unfortunately, in multiple attempts of single-molecule FISH experiments using probes against the sdg-1 open reading frame, we were unable to detect a specific signal above background (data not shown). Additional experiments are needed for the sensitive detection of sdg-1 expression outside the germline, if any.  

      (4) Based on the images shown, SDG-1 could be in other nearby granules, such as P granules or mutator foci. Additional imaging controls to rule out these granules/condensates will greatly strengthen the argument that SDG-1 protein localizes to Z-granules specifically.

      We have modified the final model to indicate that the perinuclear colocalization is with germ granules broadly and we agree that we do not have the resolution to claim that the observed overlap of SDG-1::mCherry with GFP::ZNFX-1 that we detect using Airyscan microscopy is specifically with Z granules. Our initial emphasis of Z-granule was based on the prior report of SDG-1 being co-immunoprecipitated with the Z-granule surface protein PID-2/ZSP-1. However, through other work predicting possible direct interactions using AlphaFold (Lalit and Jose, bioRxiv, 2024), we were unable to detect any direct interactions between PID-2 and SDG-1. Indeed, many additional granules have been recently reported (Chen et al., Nat. Commun., 2024; Huang et al., bioRxiv 2024), making it possible that SDG-1 has specific interactions with a component of one of the other granules (P, Z, M, S, E, or D) or adjacent P bodies.

      Minor

      (1) "This entry into the cytosol is distinct from and can follow the uptake of dsRNA into cells, which can rely on other receptors." Awkard sentence. Please revise.

      We have now revised this sentence to read “This entry into the cytosol is distinct from the uptake of dsRNA into cells, which can rely on other receptors”

      (2) Presumably, the dsRNA percent of the in vitro transcribed RNA is different than the 50 bp oligos that can be reliably annealed by heating and cooling. Other RNA secondary structure possibilities warrant further discussion.

      We agree that in vitro transcribed RNA could include a variety of undefined secondary structures in addition to dsRNAs of mixed length. Such structures could recruit or titrate away RNA-binding proteins in addition to the dsRNA structures engaging the canonical RNAi pathway, resulting in mixed mechanisms of silencing. Future work identifying such structures and exploring their impact on the efficacy of RNAi could be informative. We have now added these considerations to the discussion and thank the reviewer for highlighting these possibilities.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this study, the authors engineer the endogenous left boundary of the Drosophila eve TAD, replacing the endogenous Nhomie boundary by either a neutral DNA, a wildtype Nhomie boundary, an inverted Nhomie boundary, or a second copy of the Homie boundary. They perform Micro-C on young embryos and conclude that endogenous Nhomie and Homie boundaries flanking eve pair with head-to-tail directionality to form a chromosomal stem loop. Abrogating the Nhomie boundary leads to ectopic activation of genes in the former neighboring TAD by eve embryonic stripe enhancers. Replacing Nhomie by an inverted version or by Homie (which pairs with itself head-to-head) transformed the stem loop into a circle loop. An important finding was that stem and circle loops differentially impact endogenous gene regulation both within the eve TAD and in the TADs bracketing eve. Intriguingly, an eve TAD with a circle loop configuration leads to ectopic activation of flanking genes by eve enhancers - indicating compromised regulatory boundary activity despite the presence of an eve TAD with intact left and right boundaries.

      Strengths:

      Overall, the results obtained are of high-quality and are meticulously discussed. This work advances our fundamental understanding of how 3D genome topologies affect enhancer-promoter communication.

      Weaknesses:

      Though convincingly demonstrated at eve, the generalizability of TAD formation by directional boundary pairing remains unclear, though the authors propose this mechanism could underly the formation of all TADs in Drosophila and possibly even in mammals. Strong and ample evidence has been obtained to date that cohesin-mediated chromosomal loop extrusion explains the formation of a large fraction of TADs in mammals. 

      (1.1) The difficultly with most all of the studies on mammal TADs, cohesin and CTCF roadblocks is that the sequencing depth is not sufficient, and large bin sizes (>1 kb) are needed to visualize chromosome architecture.  The resulting contact profiles show TAD neighborhoods, not actual TADs.

      The problem with these studies is illustrated by comparing the contact profiles of mammalian MicroC data sets at different bin sizes in Author response image 1.  In this figure, the darkness of the “pixels” in panels E, F, G and H was enhanced by reducing brightness in photoshop.

      Author response image 1.

      Mammalian MicroC profiles different bun sizes

      Panels A and C show “TADs” using bin sizes typical of most mammalian studies (see Krietenstein et al. (2023) (Krietenstein et al. 2020)).  At this level of resolution, TADs, the “trees” that are the building blocks of chromosomes, are not visible.  Instead, what is seen are TAD neighborhoods or “forests”.  Each neighborhood consists of several dozen individual TADs.  The large bins in these panels also artificially accentuated TAD:TAD interactions, generating a series of “stripes” and “dots” that correspond to TADs bumping into each other and sequences getting crosslinked.  For example, in panel A there is prominent stripe on the edge of a “TAD” (blue arrow).  In panel C, this stripe resolves into a series of dots arranged as parallel, but interrupted “stripes” (green and blue arrows).  At the next level of resolution, it can be seen that the stripe marked by the blue arrow and magenta asterisk is generated by contacts between the left boundary of the TAD indicated by the magenta bar with sequences in a TAD (blue bar) ~180 kb way.  While dots and stripes are prominent features in contact profiles visualized with larger bin sizes (A and C), the actual TADs that are observed with a bin size of 200 bp (examples are underlined by black bars in panel G) are not bordered by stripes, nor are they topped by obvious dots.  The one possible exception is the dot that appears at the top of the volcano triangle underlined with magenta.

      The chromosome 1 DNA segment from the MicroC data of Hseih et al. (2023) (Hsieh et al. 2020) shows a putative volcano triangle with a plume (indicated by a V in Author response image 1 panels D, F and H).  Sequences in the V TAD don’t crosslink with their immediate neighbors, and this gives a “plume” above the volcano triangle, as indicate by the light blue asterisk in panels D, F and H.  Interestingly the V TAD does contact two distant TADs, U on the left and W on the right. The U TAD is ~550 kb from V, and the region of contact is indicated by the black arrow.  The W TAD is ~585 kb from V, and the region of contact is indicated by the magenta arrow.  While the plume still seems to be visible with a bin size of 400 bp (light blue asterisk), it is hard to discern when the bin size is 200 bp, as there are not enough reads.

      The evidence demonstrating that cohesin is required for TAD formation/maintenance is based on low resolution Hi-C data, and the effects that are observed are on TAD neighborhoods (forests) and not TADs (trees).  In fact, there is published evidence that cohesin is not required in mammals for TAD formation/maintenance.  In an experiment from Goel et al. 2023 the authors depleted the cohesin component Rad21 and then visualized the effects on TAD organization using the high resolution region capture MicroC (RCMC) protocol.  The MicroC contact map in this figure visualizes a ~250 kb DNA segment around the Ppm1pg locus at 250 bp resolution.  On the right side of the diagonal is the untreated control, while the left side shows the MicroC profile of the same region after Rad21 depletion.  The authors indicated that there was a 97% depletion of Rad21 in their experiment.  However, as is evident from a comparison of the experimental and control, loss of Rad21 has no apparent effect on the TAD organization of this mammalian DNA segment.

      Several other features are worth noting.  First, unlike the MicroC experiments shown in Author response image 1, there are dots at the apex of the TADs in this chromosomal segment.  In the MicroC protocol, fixed chromatin is digested to mononucleosomes by extensive MNase digestion.  The resulting DNA fragments are then ligated, and dinucleosome-length fragments are isolated and sequenced. 

      DNA sequences that are nucleosome free in chromatin (which would be promoters, enhancers, silencers and boundary elements) are typically digested to oligonucleotides in this procedure and won’t be recovered. This means that the dots shown here must correspond to mononucleosome-length elements that are MNase resistant.  This is also true for the dots in the MicroC contact profiles of the Drosophila Abd-B regulatory domain (see Fig. 2B in the paper).  Second, the TADs are connected to each other by 45o stripes (see blue and green arrowheads).  While it is not clear from this experiment whether the stipes are generated by an active mechanism (enzyme) or by some “passive” mechanism (e.g., sliding), the stripes in this chromosomal segment are not generated by cohesin, as they are unperturbed by Rad21 depletion.  Third, there are no volcano triangles with plumes in this chromosomal DNA segment.  Instead, the contact patterns (purple and green asterisks) between neighboring TADs closely resemble those seen for the Abd-B regulatory domains (compare Goel et al. 2023 with Fig. 2B in the paper).  This similarity suggests that the TADs in and around Ppm1g may be circle-loops, not stem-loops.  As volcano triangles with plumes also seem to be rare in the MicroC data sets of Krietenstein et al. (Krietenstein et al. 2020) and Hesih et al. (Hsieh et al. 2020) (with the caveat that these data sets are low resolution: see Author response image 1), it is possible that much of the mammalian genome is assembled into circle-loop TADs, a topology that can’t be generated by the cohesin loop extrusion (bolo tie clip) /CTCF roadblock model.

      While Rad21 depletion has no apparent effect on TADs, it does appear to impact TAD neighborhoods.  This is in a supplemental figure in Goel et al. (Goel et al. 2023).  In this figure, TADs in the Ppm1g region of chromosome 5 are visualized with bin sizes of 5 kb and 1 kb.  A 1.2 Mb DNA segment is shown for the 5 kb bin size, while an 800 kb DNA segment is shown for the 1 kb bin size.  As can be seen from comparing the MicroC profiles in Author response image 2 with that in Goel et al. 2023, individual TADs are not visible.  Instead, the individual TADs are binned into large TAD “neighborhoods” that consist of several dozen or more TADs.

      Unlike the individual TADs shown in Goel et al. 2023, the TAD neighborhoods in Author response image 2 are sensitive to Rad21 depletion.  The effects of Rad21 depletion can be seen by comparing the relative pixel density inside the blue lines before (above the diagonal) and after (below the diagonal) auxin-induced Rad21 degradation.  The reduction in pixel density is greatest for more distant TAD:TAD contacts (farthest from the diagonal).  By contrast, the TADs themselves are unaffected (Goel et al. 2023), as are contacts between individual TADs and their immediate neighbors.  In addition, contacts between partially overlapping TAD neighborhoods are also lost.  At this point it isn’t clear why contacts between distant TADs in the same neighborhood are lost when Rad21 is depleted; however, a plausible speculation is that it is related to the functioning of cohesin in holding newly replicated DNAs together until mitosis and whatever other role it might have in chromosome condensation.

      Author response image 2.

      Ppm1g full locus chr5

      Moreover, given the unique specificity with which Nhomie and Homie are known to pair (and exhibit "homing" activity), it is conceivable that formation of the eve TAD by boundary pairing represents a phenomenon observed at exceptional loci rather than a universal rule of TAD formation. Indeed, characteristic Micro-C features of the eve TAD are only observed at a restricted number of loci in the fly genome…..

      (1.2) The available evidence does not support the claim that nhomie and homie are “exceptional.”  To begin with, nhomie and homie rely on precisely the same set of factors that have been implicated in the functioning of other boundaries in the fly genome.  For example, homie requires (among other factors) the generic boundary protein Su(Hw) for insulation and long-distance interactions (Fujioka et al. 2024).  (This is also true of nhomie: unpublished data.)  The Su(Hw) protein (like other fly polydactyl zinc finger proteins) can engage in distant interactions.  This was first shown by Sigrist and Pirrotta (Sigrist and Pirrotta 1997), who found that the su(Hw) element from the gypsy transposon can mediate long-distance regulatory interactions (PRE dependent silencing) between transgenes inserted at different sites on homologous chromosomes (trans interactions) and at sites on different chromosomes.

      The ability to mediate long-distance interactions is not unique to the su(Hw) element, or homie and nhomie.  Muller et al. (Muller et al. 1999) found that the Mcp boundary from the Drosophila BX-C is also able to engage in long-distance regulatory interactions—both PRE-dependent silencing of mini-white and enhancer activation of mini-white and yellow.  The functioning of the Mcp boundary depends upon two other generic insulator proteins, Pita and the fly CTCF homolog (Kyrchanova et al. 2017).  Like Su(Hw) both are polydactyl zinc finger proteins, and they resemble the mammalian CTCF protein in that their N-terminal domain mediates multimerization (Bonchuk et al. 2020; Zolotarev et al. 2016).  Figure 6 from Muller et el. 1999 shows PRE-dependent “pairing sensitive silencing” interactions between transgenes carrying a mini-white reporter, the Mcp and scs’ (Beaf dependent)(Hart et al. 1997) boundary elements, and a PRE closely linked to Mcp.  In this experiment flies homozygous for different transgene inserts were mated and the eye color was examined in their transheterozygous progeny.  As indicated in the figure, the strongest trans-silencing interactions were observed for inserts on the same chromosomal arm; however, transgenes inserted on the left arm of chromosome 3 can interact across the centromere with transgenes inserted on the right arm of chromosome 3. 

      Figure 5C (left) from Muller et el. 1999 shows a trans-silencing interaction between w#11.102 at 84D and w#11.16 approximately 5.8 Mb away, at 87D.  Figure 5C (right) shows a trans-silencing interaction across the centromere between w#14.29 on the left arm of chromosome 3 at 78F and w#11.102 on the right arm of chromosome 3 at 84D. The eye color phenotype of mini-white-containing transgenes is usually additive: homozygyous inserts have twice as dark eye color as the corresponding hemizygous inserts.  Likewise, in flies trans-_heterozygous for _mini-white transgenes inserted at different sites, the eye color is equivalent to the sum of the two transgenes.  This is not true when mini-white transgenes are silenced by PREs.  In the combination shown in panel A, the t_rans-_heterozygous fly has a lighter eye color than either of the parents.  In the combination in panel B, the _trans-_heterozygous fly is slightly lighter than either parent.

      As evident from the diagram in Figure 6 from Muller et el. 1999, all of the transgenes inserted on the 3rd chromosome that were tested were able to participate in long distance (>Mbs) regulatory interactions.  On the other hand, not all possible pairwise interactions are observed.  This would suggest that potential interactions depend upon the large scale (Mb) 3D folding of the 3rd chromosome.

      When the scs boundary (Zw5 dependent) (Gaszner et al. 1999) was added to the transgene to give sMws’, it further enhanced the ability of distant transgenes to find each other and pair.  All eight of the sMws’ inserts that were tested were able to interact with at least one other sMws’ insert on a different chromosome and silence mini-white.  Vazquez et al. () subsequently tagged the sMws’ transgene with LacO sequences (ps0Mws’) and visualized pairing interactions in imaginal discs.  Trans-heterozygous combinations on the same chromosome were found paired in 94-99% of the disc nuclei, while a trans-heterozygous combination on different chromosomes was found paired in 96% of the nuclei (Table 3 from Vazquez et al. 2006).  Vazquez et al. also examined a combination of four transgenes inserted on the same chromosome (two at the same insertion site, and two at different insertion sites).  In this case, all four transgenes were clustered together in 94% of the nuclei (Table 3 from Vazquez et al. 2006).  Their studies also suggest that the distant transgenes remain paired for at least several hours.  A similar experiment was done by Li et al. (Li et al. 2011), except that the transgene contained only a single boundary, Mcp or Fab-7.  While pairing was still observed in trans-heterozygotes, the frequency was reduced without scs and scs’.

      It is worth pointing out that there is no plausible mechanism in which cohesin could extrude a loop through hundreds of intervening TADs, across the centromere (ff#13.101_ßà_w#11.102: Figure 6 from Muller et el. 1999; w#14.29_ßà_w#11.02: Figure 6 from Muller et el. 1999 and 5) and come to a halt when it “encounters” Mcp containing transgenes on different homologs.  The same is true for Mcp-dependent pairing interactions in cis (Fig. 7 in Muller et al. (Muller et al. 1999)) or Mcp-dependent pairing interactions between transgenes inserted on different chromosomes (Fig. 8 in Muller et al. (Muller et al. 1999); Line 8 in Table 3 from Vazquez et al. 2006). 

      These are not the only boundaries that can engage in long-distance pairing.  Mohana et al. (Mohana et al. 2023) identified nearly 60 meta-loops, many of which appear to be formed by the pairing of TAD boundary elements.  Two examples (at 200 bp resolution from 12-16 hr embryos) are shown in Author response image 3.

      Author response image 3.

      Metaloops on the 2nd and 3rd chromosomes: circle-loops and multiple stem-loops

      One of these meta-loops (panel A) is generated by the pairing of two TAD boundaries on the 2nd chromosome.  The first boundary, blue, (indicated by blue arrow) is located at ~2,006, 500 bp between a small TAD containing the Nplp4 and CG15353 genes and a larger TAD containing 3 genes, CG33543, Obp22a and Npc2aNplp4 encodes a neuropeptide.  The functions of CG15354 and CG33543 are unknown.  Obp22a encodes an odorant binding protein, while Npc2a encodes the Niemann-Pick type C-2a protein which is involved sterol homeostasis.  The other boundary (purple: indicated by purple arrow) is located between two TADs 2.8 Mb away at 4,794,250 bp.  The upstream TAD contains the fipi gene (CG15630) which has neuronal functions in male courtship, while the downstream TAD contains CG3294, which is thought to be a spliceosome component, and schlaff (slf) which encodes a chitin binding protein.  As illustrated in the accompanying diagram, the blue boundary pairs with the purple boundary in a head-to-head orientation, generating a ~2.8 Mb loop with a circle-loop topology.  As a result of this pairing, the multi-gene (CG33543, Obp22a and Npc2a) TAD upstream of the blue boundary interacts with the CG15630 TAD upstream of the purple boundary.  Conversely the small Nplp4:CG15353 TAD downstream of the blue boundary interacts with the CG3294:slf TAD downstream of the purple boundary.  Even if one imagined that the cohesin bolo tie clip was somehow able to extrude 2.8 Mb of chromatin and then know to stop when it encountered the blue and purple boundaries, it would’ve generated a stemloop, not a circle-loop.

      The second meta-loop (panel B) is more complicated as it is generated by pairing interactions between four boundary elements.  The blue boundary (blue arrow) located ~4,801,800 bp (3L) separates a large TAD containing the RhoGEF64C gene from a small TAD containing CG7509, which encodes a predicted subunit of an extracellular carboxypeptidase.  As can be seen in the MicroC contact profile and the accompanying diagram, the blue boundary pairs with the purple boundary (purple arrow) which is located at ~7,013, 500 (3L) just upstream of the 2nd internal promoter (indicated by black arrowhead) of the Mp (Multiplexin) gene.  This pairing interaction is head-to-tail and generates a large stem-loop that spans ~2.2 Mb.  The stem-loop brings sequences upstream of the blue boundary and downstream of the purple boundary into contact (the strings below a bolo tie clip), just as was observed in the boundary bypass experiments of Muravyova et al. (Muravyova et al. 2001) and Kyrchanova et al. (Kyrchanova et al. 2008).  The physical interactions result in a box of contacts (right top) between sequences in the large RhoGEF64C TAD and sequences in a large TAD that contains an internal Mp promoter.  The second pairing interaction is between the brown boundary (brown arrow) and the green boundary (green arrow).  The brown boundary is located at ~4 805,600 bp (3L) and separates the TAD containing CG7590 from a large TAD containing CG1808 (predicted to encode an oxidoreductase) and the Dhc64C (Dynein heavy chain 64C) gene.  The green boundary is located at ~6,995,500 bp (3L), and it separates a TAD containing CG32388 and the biniou (bin) transcription factor from a TAD that contains the most distal promoter of the Mp (Multiplexin) gene (blue arrowhead).  As indicated in the diagram, the brown and green boundaries pair with each other head-to-tail, and this generates a small internal loop (and the final configuration would resemble a bolo tie with two tie clips).  This small internal loop brings the CG7590 TAD into contact with the TAD that extends from the distal Mp promoter to the 2nd internal Mp promoter.  The resulting contact profile is a rectangular box with diagonal endpoints corresponding to the paired blue:purple and brown:green boundaries.  The pairing of the brown:green boundaries also brings the TADs immediately downstream of the brown boundary and upstream of the green boundary into contact with each other, and this gives a rectangular box of interactions between the Dhc64C TAD, and sequences in the bin/CG3238 TAD.  This box is located on the lower left side of the contact map.

      Since the bin and Mp meta-loops in Author response image 3B are stem-loops, they could have been generated by “sequential” cohesin loop extrusion events.  Besides the fact that cohesin extrusion of 2 Mb of chromatin and breaking through multiple intervening TAD boundaries challenges the imagination, there is no mechanism in the cohesion loop extrusion/CTCF roadblock model to explain why cohesion complex 1 would come to a halt at the purple boundary on one side and the blue boundary on the other, while cohesin complex 2 would instead stop when it hits the brown and green boundaries.  This highlights another problem with the cohesin loop extrusion/CTCF roadblock model, namely that the roadblocks are functionally autonomous: they have an intrinsic ability to block cohesin that is entirely independent of the intrinsic ability of other roadblocks in the neighborhood.  As a result, there is no mechanism for generating specificity in loop formation.  By contrast, boundary pairing interactions are by definition non-autonomous and depend on the ability of individual boundaries to pair with other boundaries: specificity is built into the model. The mechanism for pairing, and accordingly the basis for partner preferences/specificity, are reasonably well understood.  Probably the most common mechanism in flies is based on shared binding sites for architectural proteins that can form dimers or multimers (Bonchuk et al. 2021; Fedotova et al. 2017).  Flies have a large family of polydactyl zinc finger DNA binding proteins, and as noted above, many of these form dimers or multimers and also function as TAD boundary proteins.  This pairing principle was first discovered by Kyrchanova et al. (Kyrchanova et al. 2008).  This paper also showed that orientation-dependent pairing interactions is a common feature of endogenous fly boundaries.  Another mechanism for pairing is specific protein:protein interactions between different DNA binding factors (Blanton et al. 2003).  Yet a third mechanism would be proteins that bridge different DNA binding proteins together.  The boundaries that use these different mechanisms (BX-C boundaries, scs, scs’) depend upon the same sorts of proteins that are used by homie and nhomie.  Likewise, these same set of factors reappear in one combination or another in most other TAD boundaries.  As for the orientation of pairing interactions, this is most likely determined by the order of binding sites for chromosome architectural proteins in the partner boundaries.

      …and many TADs lack focal 3D interactions between their boundaries.

      (1.3) The idea that flies differ from mammals in that they “lack” focal 3D interactions is simply mistaken.  One of the problems with drawing this distinction is that most all of the “focal 3D interactions” seen mammalian Hi-C experiments are a consequence of binning large DNA segments in low resolution restriction enzyme-dependent experiments.  This is even true in the two “high” resolution MicroC experiments that have been published (Hsieh et al. 2020; Krietenstein et al. 2020).  As illustrated above in Author response image 1, most of the “focal 3D interactions” (the dots at the apex of TAD triangles) seen with large bin sizes (1 kb and greater) disappear when the bin size is 200 bp and TADs rather than TAD neighborhoods are being visualized.

      As described in point #1.1, in the MicroC protocol, fixed chromatin is first digested to mononucloesomes by extensive MNase digestion, processed/biotinylated, and ligated to give dinucleosome-length fragments, which are then sequenced.  Regions of chromatin that are nucleosome free (promoters, enhancers, silencers, boundary elements) will typically be reduced to oligonucleotides in this procedure and will not be recovered when dinucleosome-length fragments are sequenced.  The loss of sequences from typical paired boundary elements is illustrated by the lar meta-loop shown in Author response image 4 (at 200 bp resolution).  Panels A and B show the contact profiles generated when the blue boundary (which separates two TADs that span  the Lar (Leukocyteantigen-related-like) transcription unit interacts with the purple boundary (which separates two TADs in a gene poor region ~620 kb away).  The blue and purple boundaries pair with each other head-to-head, and this pairing orientation generates yet another circle-loop.  In the circle-loop topology, sequences in the TADs upstream of both boundaries come into contact with each other, and this gives the small dark rectangular box to the upper left of the paired boundaries (Author response image 4A).  (Note that this small box corresponds to the two small TADs upstream of the blue and purple boundaries, respectively. See panel B.)  Sequences in the TADs downstream of the two boundaries also come into contact with each other, and this gives the large box to the lower right of the paired boundaries.  While this meta-loop is clearly generated by pairing interactions between the blue and purple boundaries, the interacting sequences are degraded in the MicroC protocol, and sequences corresponding to the blue and purple boundaries aren’t recovered.  This can be seen in panel B (red arrow and red arrowheads).  When a different Hi-C procedure is used (dHS-C) that captures nucleosome-free regions of chromatin that are physically linked to each other (Author response image 4C & D), the sequences in the interacting blue and purple boundaries are recovered and generate a prominent “dot” at their physical intersection (blue arrow in panel D).

      Author response image 4.

      Lar metaloop. Panels A & bB: MicroC. Panels C & D: dHS-C

      While sequences corresponding to the blue and purple boundaries are lost in the MicroC procedure, there is at least one class of elements that engage in physical pairing interactions whose sequences are (comparatively) resistant to MNase digestion.  This class of elements includes many PREs ((Kyrchanova et al. 2018); unpublished data), the boundary bypass elements in the Abd-B region of BX-C (Kyrchanova et al. 2023; Kyrchanova et al. 2019a; Kyrchanova et al. 2019b; Postika et al. 2018), and “tethering” elements (Batut et al. 2022; Li et al. 2023).  In all of the cases tested, these elements are bound in nuclear extracts by a large (>1000 kD) GAGA factor-containing multiprotein complex called LBC.  LBC also binds to the hsp70 and eve promoters (unpublished data).  Indirect end-labeling experiments (Galloni et al. 1993; Samal et al. 1981; Udvardy and Schedl 1984) indicate that the LBC protects a ~120-180 bp DNA segment from MNase digestion.  It is likely that this is the reason why LBC-bound sequences can be recovered in MicroC experiments as dots when they are physically linked to each other.  One such example (based on the ChIP signatures of the paired elements) is indicated by the green arrow in panel B and D of Author response image 4.  Note that there are no dots corresponding to these two LBC elements within either of the TADs immediately downstream of the blue and purple boundaries.  Instead the sequences corresponding to the two LBC elements are only recovered when the two elements pair with each other over a distance of ~620 kb.  The fact that these two elements pair with each other is consistent with other findings which indicate that, like classical boundaries, LBC elements exhibit partner preferences.  In fact, LBC elements can sometimes function as TAD boundaries.  For example, the Fab-7 boundary has two LBC elements, and full Fab-7 boundary function can be reconstituted with just these two elements (Kyrchanova et al. 2018).

      Reviewer #2 (Public Review):

      "Chromatin Structure II: Stem-loops and circle-loops" by Ke*, Fujioka*, Schedl, and Jaynes reports a set of experiments and subsequent analyses focusing on the role of Drosophila boundary elements in shaping 3D genome structure and regulating gene expression. The authors primarily focus on the region of the fly genome containing the even skipped (eve) gene; eve is expressed in a canonical spatial pattern in fly embryos and its locus is flanked by the well-characterized neighbor of homie (nhomie) and homie boundary elements. The main focus of investigation is the orientation dependence of these boundary elements, which had been observed previously using reporter assays. In this study, the authors use Crispr/Cas9 editing followed by recombination-mediated cassette exchange to create a series of recombinant fly lines in which the nhomie boundary element is either replaced with exongenous sequence from phage 𝝀, an inversion of nhomie, or a copy of homie that has the same orientation as the endogenous homie sequence. The nhomie sequence is also regenerated in its native orientation to control for effects introduced by the transgenesis process.

      The authors then perform high-resolution Micro-C to analyze 3D structure and couple this with fluorescent and colorimetric RNA in situ hybridization experiments to measure the expression of eve and nearby genes during different stages of fly development. The major findings of these experiments are that total loss of boundary sequence (replacement with 𝝀 DNA) results in major 3D structure changes and the most prominent observed gene changes, while inversion of the nhomie boundary or replacement with homie resulted in more modest effects in terms of 3D structure and gene expression changes and a distinct pattern of gene expression change from the 𝝀 DNA replacement. As the samples in which the nhomie boundary is inverted or replaced with homie have similar Micro-C profiles at the eve locus and show similar patterns of a spurious gene activation relative to the control, the observed effects appear to be driven by the relative orientation of the nhomie and homie boundary elements to one another.

      Collectively, the findings reported in the manuscript are of broad interest to the 3D genome field. Although extensive work has gone into characterizing the patterns of 3D genome organization in a whole host of species, the underlying mechanisms that structure genomes and their functional consequences are still poorly understood. The perhaps best understood system, mechanistically, is the coordinated action of CTCF with the cohesin complex, which in vertebrates appears to shape 3D contact maps through a loop extrusion-pausing mechanism that relies on orientation-dependent sequence elements found at the boundaries of interacting chromatin loops.

      (2.1) The notion that mammalian genome is shaped in 3D by the coordinate action of cohesin and CTCF has achieved the status of dogma in the field of chromosome structure in vertebrates.  However, as we have pointed out in #1.1, the evidence supporting this dogma is far from convincing.  To begin with, it is based on low resolution Hi-C experiments that rely on large bin sizes to visualize so-called “TADs.”  In fact, the notion that cohesin/CTCF are responsible on their own for shaping the mammalian 3D genome appears to be a result of mistaking a series of forests for the actual trees that populate each of the forests.

      As illustrated in Author response image 1 above, the “TADs” that are visualized in these low resolution data sets are not TADs at all, but rather TAD neighborhoods consisting of several dozen or more individual TADs.  Moreover, the “interesting” features that are evident at low resolution (>1 kb)—the dots and stripes—largely disappear at resolutions appropriate for visualizing individual TADs (~200 bp).

      In Goel et al. 2023, we presented data from one of the key experiments in Goel et al. (Goel et al. 2023).  In this experiment,  the authors used RCMC to generate high resolution (~250 bp) MicroC contact maps before and after Rad21 depletion.  Contrary to dogma, Rad21 depletion has absolutely no effect on TADs in a ~250 kb DNA segment—and these TADs look very much like the TADs we observe in the Drosophila genome, in particular in the Abd-B region of BX-C that is thought to be assembled into a series of circle-loops (see Fig. 2B).

      While Goel et al. (Goel et al. 2023) observed no effect of Rad21 depletion on TADs, they found that loss of Rad21 disturbs long-distance (but not short-distance) contacts in large TAD neighborhoods when their RCMC data set is visualized using bin sizes of 5 kb and I kb.  This is shown in Author response image 2.  The significance of this finding is, however, uncertain.  It could mean that the 3D organization of large TAD neighborhoods have a special requirement for cohesin activity.  On the other hand, since cohesin functions to hold sister chromosomes together after replication until they separate during mitosis (and might also participate in mitotic condensation), it is also possible that the loss of long-range contacts in large TAD neighborhoods when Rad21 is depleted is simply a reflection of this particular activity.  Further studies will be required to address these possibilities.

      As for CTCF: a careful inspection of the ChIP data in Goel et al. 2023 indicates that CTCF is not found at each and every TAD boundary.  In fact, the notion that CTCF is the be-all and end-all of TAD boundaries in mammals is truly hard to fathom.  For one, the demands for specificity in TAD formation (and in regulatory interactions) are likely much greater than those in flies, and specificity can’t be generated by a single DNA binding protein.  For another, several dozen chromosomal architectural proteins have already been identified in flies.  This means that (unlike what is thought to be true in mammals) it is possible to use a combinatorial mechanism to generate specificity in, for example, the long distance interactions in RFig 6 and 7.  As noted in #2.1 above, many of the known chromosomal architectural proteins in flies are polydactyl zinc finger proteins (just like CTCF).  There are some 200 different polydactyl zinc finger proteins in flies, and the function of only a hand full of these is known at present.  However, it seems likely that a reasonable fraction of this class of DNA binding proteins will ultimately turn out to have an architectural function of some type (Bonchuk et al. 2021; Fedotova et al. 2017).  The number of different polydactyl zinc finger protein genes in mammals is nearly 3 times that of flies.  It is really possible that of these, only CTCF is involved in shaping the 3D structure of the mammalian genome?

      Despite having a CTCF paralog and cohesin, the Drosophila genome does not appear to be structure by loop extrusion-pausing. The identification of orientation-dependent elements with pronounced structural effects on genome folding thus may shed light on alternative mechanisms used to regulated genome structure, which in turn may yield insights into the significance of particular folding patterns.

      (2.2) Here we would like to draw the reviewer’s and reader’s attention to Author response image 3, which shows that orientation-dependent pairing interactions have a significant impact on physical interactions between different sequences.  We would also refer the reader to two other publications.  One of these is Kyrchanova et al. (Kyrchanova et al. 2008), which was the first to demonstrate that orientation of pairing interactions matters.  The second is Fujioka et al. (Fujioka et al. 2016), which describes experiments indicating that nhomie and homie pair with each other head-to-tail and with themselves head-to-head.

      On the whole, this study is comprehensive and represents a useful contribution to the 3D genome field. The transgenic lines and Micro-C datasets generated in the course of the work will be valuable resources for the research community. Moreover, the manuscript, while dense in places, is generally clearly written and comprehensive in its description of the work. However, I have a number of comments and critiques of the manuscript, mainly centering on the framing of the experiments and presentation of the Micro-C results and on manner in which the data are analyzed and reported. They are as follows:

      Major Points:

      (1) The authors motivate much of the introduction and results with hypothetical "stem loop" and "circle loop" models of chromosome confirmation, which they argue are reflected in the Micro-C data and help to explain the observed ISH patterns. While such structures may possibly form, the support for these specific models vs. the many alternatives is not in any way justified. For instance, no consideration is given to important biophysical properties such as persistence length, packing/scaling, and conformational entropy. As the biophysical properties of chromatin are a very trafficked topic both in terms of experimentation and computational modeling and generally considered in the analysis of chromosome conformation data, the study would be strengthened by acknowledgement of this body of work and more direct integration of its findings.

      (2.3) The reviewer is not correct in claiming that “stem-loops” and “circle-loops” are “hypothetical.”  There is ample evidence that both types of loops are present in eukaryotic genomes, and that loop conformation has significant readouts in terms of not only the physical properties of TADs but also their functional properties.  Here we would draw the reviewer’s attention to Author response image 3 and Author response image 4 for examples of loops formed by the orientation-dependent pairing of yet other TAD boundary elements.  As evident from the MicroC data in these figures, circle-loops and stem-loops have readily distinguishable contact patterns.  The experiments in Fujioka et al. (Fujioka et al. 2016) demonstrate that homie and nhomie pair with each other head-to-tail, while they pair with themselves head-to-head.  The accompany paper (Bing et al. 2024) also provides evidence that loop topology is reflected both in the pattern of activation of reporters and in the MicroC contact profiles.  We would also mention again Kyrchanova et al. (Kyrchanova et al. 2008), who were the first to report orientation-dependent pairing of endogenous fly boundaries.

      At this juncture it would premature to try to incorporate computational modeling of chromosome conformation in our studies.  The reason is that the experimental foundations that would be essential for building accurate models are lacking.  As should be evident from RFigs. 1-3 above, studies on mammalian chromosomes are simply not of high enough resolution to draw firm conclusions about chromosome conformation: in most studies only the forests are visible.  While the situation is better in flies, there are still too many unknown.  As just one example, it would be important to know the orientation of the boundary pairing interactions that generate each TAD.  While it is possible to infer loop topology from how TADs interact with their neighbors (a plume versus clouds), a conclusive identification of stem- and circle-loops will require a method to unambiguously determine whether a TAD boundary pairs with its neighbor head-to-head or headto-tail.

      (2) Similar to Point 1, while there is a fair amount of discussion of how the observed results are or are not consistent with loop extrusion, there is no discussion of the biophysical forces that are thought to underly compartmentalization such as block-polymer co-segregation and their potential influence. I found this absence surprising, as it is generally accepted that A/B compartmentalization essentially can explain the contact maps observed in Drosophila and other non-vertebrate eukaryotes (Rowley, ..., Corces 2017; PMID 28826674). The manuscript would be strengthened by consideration of this phenomenon.

      (2.4) Compartments in mammals have typically been identified and characterized using lowresolution data sets, and these studies have relied on visualizing compartments using quite large bin sizes (>>1 kb).  Our experiments have nothing to do with the large-scale compartments seen in these Hi-C experiments.  Instead, we are studying the properties of individual TADs: how TADs are formed, the relationship between TAD topology and boundary:boundary pairing, and the impact of TAD topology on interactions between TADs in the immediate neighborhood.  There is no evidence to date that these large compartments or “block polymer co-segregation” have a) any impact on the properties of individual boundary elements, b) have a role in determining which boundary elements actually come together to form a given TAD, c) impact the orientation of the interactions between boundaries that generate the TAD or d) determine how TADs tend to interact with their immediate neighbors.  

      In more recent publications (c.f., Harris et al. 2023) compartments have shrunk in size and instead of being units of several hundred kb, the median length of the “compartmental” unit in mammalian cells is about12 kb. This is not too much different from the size of fly TADs.  However, the available evidence does not support the idea that block polymer co-segregation/co-repulsion drive the TAD:TAD interactions seen in MicroC experiments.  For example, according to this “micro-compartment” model, the specific patterns of interaction between TADs in the CG3294 meta-loop in Author response image 3 would be driven by block polymer co-segregation and co-repulsion. In this model, the TAD upstream of the blue boundary (which contains CG33543, the odorant binding protein gene Obp22a and the Npc2a gene which encodes a protein involved in sterol homeostasis) would share the same chromatin state/biophysical properties as the TAD upstream of the purple boundary, which has the fipi gene. While it is true that CG33543, Obp22a and also the fipi gene are not expressed in embryos, Npc2a is expressed at high levels during embryogenesis, yet it is part of the TAD that interacts with the fipi TAD.  The TAD downstream of the blue boundary contains CG15353 and Nplp4 and it interacts with the TAD downstream of the purple boundary which contains CG3294 and slfCG15353 and Nplp4 are not expressed in the embryo and as such should share a compartment with a TAD that is also silent. However, slf is expressed at a high level in 1216 hr embryos, while CG3294 is expressed at a low level.  In neither case would one conclude that the TADs upstream and downstream of the blue and purple boundaries, respectively, interact because of shared chromatin/biophysical states that drive block polymer co-segregation corepulsion. 

      One might also consider several gedanken experiments involving the long-range interactions that generate the CG3294 meta-loop in Author response image 3.    According to the micro-compartment model the patchwork pattern of crosslinking evident in the CG3294 meta-loop arises because the interacting  TADs share the same biochemical/biophysical properties, and this drives block polymer cosegregation and co-repulsion.  If this model is correct, then this patchwork pattern of TAD:TAD interactions would remain unchanged if we were to delete the blue or the purple boundary.  However, given what we know about how boundaries can find and pair with distant boundaries (c.f., Figure 6 from Muller et el. 1999 and the discussion in #1.2), the result of these gedanken experiments seem clear: the patchwork pattern shown in Author response image 3A will disappear.  What would happen if we inverted the blue or the purple boundary? Would the TAD containing CG33543, Obp22a and Npc2a still interact with fipi as would be expected from the compartment model?  Or would the pattern of interactions flip so that the CG33543, Obp22a and Npc2a TAD interacts with the TAD containing CG3294 and slf?  Again we can anticipate the results based on previous studies: the interacting TADs will switch when the CG3294 meta-loop is converted into a stem-loop.  If this happened, the only explanation possible in the compartment model is that the chromatin states change when the boundary is inverted so that TAD upstream of blue boundary now shares the same chromatin state as the TAD downstream of the purple boundary, while the TAD downstream of the blue boundary shares same state as the TAD upstream of the purple boundary.  However, there is no evidence that boundary orientation per se can induce a complete switch in “chromatin states” as would be required in the compartment model. 

      While we have not done these experimental manipulations with the CG3294 meta-loop, an equivalent experiment was done in Bing et al. (Bing et al. 2024).  However, instead of deleting a boundary element, we inserted a homie boundary element together with two reporters (gfp and LacZ) 142 kb away from the eve TAD.  The result of this gedanken “reverse boundary deletion” experiment is shown in Author response image 5.  Panel A shows the MicroC contact profile in the region spanning the transgene insertion site and the eve TAD in wild type (read “deletion”) NC14 embryos.  Panel B shows the MicroC contact profile from 12-16 hr embryos carrying the homie dual reporter transgene inserted at -142 kb.  Prior to the “deletion”, the homie element in the transgene pairs with nhomie and homie in the eve TAD and this generates a “mini-metaloop.”  In this particular insert, the homie boundary in the transgene (red arrow) is “pointing” in the opposite orientation from the homie boundary in the eve TAD (red arrow).  In this orientation, the pairing of the transgene homie with eve nhomie/homie brings the LacZ reporter into contact with sequences in the eve TAD.  Since a mini-metaloop is formed by homie_à _nhomie/homie pairing, sequences in TADs upstream and downstream of the transgene insert interact with sequences in TADs close to the eve TAD (Author response image 5B).  Taken together these interactions correspond to the interaction patchwork that is typically seen in “compartments” (see boxed region and inset).  If this patchwork is driven as per the model, by block polymer co-segregation and co-repulsion, then it should still be present when the transgene is deleted.  However, panel A shows that the interactions linking the transgene and the sequences in TADs next to the transgene to eve and TADs next to eve disappear when the homie boundary (plus transgene) is “deleted” in wild type flies.

      Author response image 5.

      Boundary deletion and compartments

      A second experiment would be to invert the homie boundary so that instead of pointing away from eve it points towards eve.  Again, if the compartmental patchwork is driven by block polymer co-segregation and co-repulsion, inverting the homie boundary in the transgene should have no effect on the compartmental contact profile.  Inspection of Fig. 7 in Bing et al. (Bing et al. 2024) will show that this prediction doesn’t hold either.  When homie is inverted, sequences in the eve TAD interact with the gfp reporter not the LacZ reporter.  In addition, there are corresponding changes in how sequences in TADs to either side of eve interact with sequences to either side of the transgene insert.  

      Yet another “test” of compartments generated by block polymer co-segregation/co-repulsion is provided by the plume above the eve volcano triangle.  According to the compartment model, sequences in TADs flanking the eve locus form the plume above the eve volcano triangle because their chromatin shares properties that drive block polymer co-segregation.  These same properties result in repulsive interactions with chromatin in the eve TAD, and this would explain why the eve TAD doesn’t crosslink with its neighbors.  If the distinctive chromatin properties of eve and the neighboring TADs drive block polymer co-segregation and co-repulsion, then inverting the nhomie boundary or introducing homie in the forward orientation should have absolutely no effect on the physical interactions between chromatin in the eve TAD and chromatin in the neighboring TADs.  However, Figures 4 and 6 in this paper indicate that boundary pairing orientation, not block polymer co-segregation/co-repulsion, is responsible for forming the plume above the eve TAD. Other findings also appear to be inconsistent with the compartment model. (A) The plume topping the eve volcano triangle is present in NC14 embryos when eve is broadly expressed (and potentially active throughout the embryo).  It is also present in 12-16 hr embryos when eve is only expressed in a very small subset of cells and is subject to PcG silencing everywhere else in the embryo.  B) According to the compartment model the precise patchwork pattern of physical interactions should depend upon the transcriptional program/chromatin state that is characteristic of a particular developmental stage or cell type.  As cell fate decisions are just being made during NC14 one might expect that most nuclei will share similar chromatin states throughout much of the genome.  This would not be true for 12-16 hr embryos.  At this stage the compartmental patchwork would be generated by a complex mixture of interactions in cells that have quite different transcriptional programs and chromatin states.  In this case, the patchwork pattern would be expected to become fuzzy as a given chromosomal segment would be in compartment A in one group of cells and in compartment B in another.   Unlike 12-16 hr embryos,  larval wing discs would be much more homogeneous and likely give a distinct and relatively well resolved compartmental pattern. We’ve examined the compartment patchwork of the same chromosomal segments in NC14 embryos, 12-16 hr embryos and larval wing disc cells.  While there are some differences (e.g., changes in some of the BX-C TADs in the wing disc sample) the compartmental patchwork patterns are surprisingly similar in all three cases. Nor is there any “fuzziness” in the compartmental patterns evident in 12-16 hr embryos, despite the fact that there are many different cell types at this stage of development.  C) TAD interactions with their neighbors and compartmental patchworks are substantially suppressed in salivary gland polytene chromosomes.  This would suggest that features of chromosome structure might be the driving force behind many of the “compartmental” interactions as opposed to distinct biochemical/biophysical of properties of small chromosomal segments that drive polymer co- segregation/co-repulsion.  

      (3) The contact maps presented in the study represent many cells and distinct cell types. It is clear from single-cell Hi-C and multiplexed FISH experiments that chromosome conformation is highly variable even within populations of the same cell, let alone between cell types, with structures such as TADs being entirely absent at the single cell level and only appearing upon pseudobulking. It is difficult to square these observations with the models of relatively static structures depicted here. The authors should provide commentary on this point.

      (2.5) As should be evident from Author response image 1, single-cell Hi-C experiments would not provide useful information about the physical organization of individual TADs, TAD boundaries or how individual TADs interact with their immediate neighbors.  In addition, since they capture only a very small fraction of the possible contacts within and between TADs, we suspect that these single-cell studies aren’t likely to be useful for making solid conclusions about TAD neighborhoods like those shown in Author response image 1 panels A, B, C and D, or Author response image 2.  While it might be possible to discern relatively stable contacts between pairs of insulators in single cells with the right experimental protocol, the stabilities/dynamics of these interactions may be better judged by the length of time that physical interactions are seen to persist in live imaging studies such as Chen et al. (2018), Vazquez et al. (2006) and Li et al. (2011).

      The in situ FISH data we’ve seen also seems problematic in that probe hybridization results in a significant decondensation of chromatin.  For two probe sets complementary to adjacent ~1.2 kb DNA sequences, the measured center-to-center distance that we’ve seen was ~110 nM.  This is about 1/3rd the length that is expected for a 1.2 kb naked DNA fragment, and about 1.7 times larger than that expected for a beads-on-a-string nucleosome array (~60 nM).  However, chromatin is thought to be compacted into a 30 nM fiber, which is estimated to reduce the length of DNA by at least another ~6 fold.  If this estimate is correct, FISH hybridization would appear to result in a ~10 fold decompaction of chromatin.  A decompaction of this magnitude would necessarily be followed by a significant distortion in the actual conformation of chromatin loops.

      (4) The analysis of the Micro-C data appears to be largely qualitative. Key information about the number of reads sequenced, reaps mapped, and data quality are not presented. No quantitative framework for identifying features such as the "plumes" is described. The study and its findings would be strengthened by a more rigorous analysis of these rich datasets, including the use of systematic thresholds for calling patterns of organization in the data.

      Additional information on the number of reads and data quality have been included in the methods section. 

      (5) Related to Point 4, the lack of quantitative details about the Micro-C data make it difficult to evaluate if the changes observed are due to biological or technical factors. It is essential that the authors provide quantitative means of controlling for factors like sampling depth, normalization, and data quality between the samples.

      In our view the changes in the MicroC contact patterns for the eve locus and its neighbors when the nhomie boundary is manipulated are not only clear cut and unambiguous but are also readily evident in the Figs that are presented in the manuscript.  If the reviewer believes that there aren’t significant differences between the MicroC contact patterns for the four different nhomie replacements, it seems certain that they would also remain unconvinced by a quantitative analysis.

      The reviewer also suggests that biological and/or technical differences between the four samples could account for the observed changes in the MicroC patterns for the eve TAD and its neighbors.  If this were the case, then similar changes in MicroC patterns should be observed elsewhere in the genome.  Since much of the genome is analyzed in these MicroC experiments there is an abundance of internal controls for each experimental manipulation of the nhomie boundary.  For two of the nhomie replacements, nhomie reverse and homie forward, the plume above the eve volcano triangle is replaced by clouds surrounding the eve volcano triangle.  If these changes in the eve MicroC contact patterns are due to significant technical (or biological) factors, we should observe precisely the same sorts of changes in TADs elsewhere in the genome that are volcano triangles with plumes.   Author response image 6 shows the MicroC contact pattern for several genes in the Antennapedia complex.  The deformed gene is included in a TAD which, like eve, is a volcano triangle topped by a plume.  A comparison of the deformed MicroC contact patterns for nhomie forward (panel B) with the MicroC patterns for nhomie reverse (panel C) and homie forward (panel D) indicates that while there are clearly technical differences between the samples, these differences do not result in the conversion of the deformed plume into clouds as is observed for the eve TAD.  The MicroC patterns elsewhere in Antennapedia complex are also very similar in all four samples.  Likewise, comparisons of regions elsewhere in the fly genome indicate that the basic contact patterns are similar in all four samples.   So while there are technical differences which are reflected in the relative pixel density in the TAD triangles and the LDC domains, these differences do not result in converting plumes into clouds nor do the alter the basic patterns of TAD triangles and LDC domains.  As for biological differences— the embryos in each sample are at roughly the same developmental stage and were collected and processed using the same procedures. Thus, the biological factors that could reasonably be expected to impact the organization of specific TADs (e.g., cell type specific differences) are not going to impact the patterns we see in our experiments. 

      Author response image 6.

      (6) The ISH effects reported are modest, especially in the case of the HCR. The details provided for how the imaging data were acquired and analyzed are minimal, which makes evaluating them challenging. It would strengthen the study to provide much more detail about the acquisition and analysis and to include depiction of intermediates in the analysis process, e.g. the showing segmentation of stripes.

      The imaging analysis is presented in Fig. 5 is just standard confocal microscopy.  Individual embryos were visualized and scored.  An embryo in which stripes could be readily detected was scored as ‘positive’ while an embryo in which stripes couldn’t be detected was scored as ‘negative.’   

      Recommendations for the authors:

      Editor comments:

      It was noted that the Jaynes lab previously published extensive genetic evidence to support the stem loop and circle loop models of Homie-Nhomie interactions (Fujioka 2016 Plos Genetics) that were more convincing than the Micro-C data presented here in proof of their prior model. Maybe the authors could more clearly summarize their prior genetic results to further try to convince the reader about the validity of their model.

      Reviewer #1 (Recommendations For The Authors):

      Below, I list specific comments to further improve the manuscript for publication. Most importantly, I recommend the authors tone down their proposal that boundary pairing is a universal TAD forming mechanism.

      (1) The title is cryptic.

      (2) The second sentence in the abstract is an overstatement: "In flies, TADs are formed by physical interactions between neighboring boundaries". Hi-C and Micro-C studies have not provided evidence that most TADs in Drosophila show focal interactions between their bracketing boundaries. The authors rely too strongly on prior studies that used artificial reporter transgenes to show that multimerized insulator protein binding sites or some endogenous fly boundaries can mediate boundary bypass, as evidence that endogenous boundaries pair.

      Please see responses #1.1 and #1.3 and figures Author response image 1 and Author response image 3.  Note that using dHS-C, most TADs that we’ve looked at so far are topped by a “dot” at their apex.

      (3) Line 64: the references do not cite the stated "studies dating back to the '90's'".

      The papers cited for that sentence are reviews which discussed the earlier findings.  The relevant publications are cited at the appropriate places in the same paragraph.  

      (4) Line 93: "On the other hand, while boundaries have partner preferences, they are also promiscuous in their ability to establish functional interactions with other boundaries." It was unclear what is meant here.

      Boundaries that a) share binding sites for proteins that multimerized, b) have binding sites for proteins that interact with each other, or c) have binding sites for proteins that can be bridged by a third protein can potentially pair with each other.  However, while these mechanisms enable promiscuous pairing interactions, they will also generate partner preferences (through a greater number of a, b and/or c).

      (5) It could be interesting to discuss the fact that it remains unclear whether Nhomie and Homie pair in cis or in trans, given that homologous chromosomes are paired in Drosophila.

      The studies in Fujioka et al. (Fujioka et al. 2016) show that nhomie and homie can pair both in cis and in trans.  Given the results described in #1.2, we imagine that they are paired in both cis and trans in our experiments.

      (6) Line 321: Could the authors further explain why they think that "the nhomie reverse circle-loop also differs from the nhomie deletion (λ DNA) in that there is not such an obvious preference for which eve enhancers activate expression"?

      The likely explanation is that the topology/folding of the altered TADs impacts the probability of interactions between the various eve enhancers and the promoters of the flanking genes.  

      (7) The manuscript would benefit from shortening the long Discussion by avoiding repeating points described previously in the Results.

      (8) Line 495: "If, as seems likely, a significant fraction of the TADs genome-wide are circle loops, this would effectively exclude cohesin-based loop extrusion as a general mechanism for TAD formation in flies". The evidence provided in this manuscript appears insufficient to discard ample evidence from multiple laboratories that TADs form by compartmentalization or loop extrusion. Multiple laboratories have, for example, demonstrated that cohesin depletion disrupts a large fraction of mammalian TADs. 

      Points made here and in #9 have been responded to in #1.1, #2.1 and #2.4 above.  We would suggest that the evidence for loop extrusion falls short of compelling (as it is based on the analysis of TAD neighborhoods, not TADs—that is forests, not trees) and given the results reported in Goel et al. (in particular Fig. 4 and Sup Fig. 8) is clearly suspect. This is not to mention the fact that cohesin loop-extrusion can’t generate circle-loops TADs, yet circle-loops clearly exist.  Likewise, as discussed in #2.4, it is not clear to us that the shared chromatin states, polymer co-segregation and co-repulsion account for the compartmental patchwork patterns of TAD;TAD interactions. The results from the  experimental manipulations in this paper and the accompanying paper, together with studies by others (e.g., Kyrchanova et al. (Kyrchanova et al. 2008), Mohana et al. (Mohana et al. 2023) would also seem to be at odds with the model for compartments as currently formulated.  

      The unique properties of Nhomie and Homie, namely the remarkable specificity with which they physically pair over large distances (Fujioka et al. 2016) may rather suggest that boundary pairing is a phenomenon restricted to special loci. Moreover, it has not yet been demonstrated that Nhomie or Homie are also able to pair with the TAD boundaries on their left or right, respectively.

      Points made here were discussed in detail in #1.2.  As described in detail in #1.2, It is not the case that nhomie and homie are in “unique” or “special.”  Other fly boundaries can do the same things.  As for whether nhomie and homie pair with their neighbors:  We haven’t done transgene experiments (e.g., testing by transvection or boundary bypass).  Likewise, in MicroC experiments there are no obvious dots at the apex of the neighboring TADs that would correspond to nhomie pairing with the neighboring boundary to the left and homie pairing with the neighboring boundary to the right. However, this is to be expected. As we discussed in in #1.3 above, only MNase resistant elements will generate dots in standard MicroC experiments.  On the other hand, when boundary:boundary interactions are analyzed by dHS-C (c.f., Author response image 4), there are dots at the apex of both neighboring TADs.  This would be direct evidence that nhomie pairs with the neighboring boundary to the left and homie pairs with the neighboring boundary to the right.

      (9) The comment in point 8 also applies to the concluding 2 sentences (lines 519-524) of the Discussion.

      See response to 8 above. Otherwise, the concluding sentences are completely accurate. Validation of the cohesin loop extrusion/CTCF roadblock model will required demonstrating a) that all TADs are either stem-loops or unanchored loops and b) that TAD endpoints are always marked by CTCF. 

      The likely presence of circle-loops and evidence that TAD boundaries that don’t have CTCF (c.f.,Goel et al. 2023) already suggests that this model can’t (either fully or not all) account for TAD formation in mammals. 

      (10) Figs. 3 and 6: It would be helpful to add the WT screenshot in the same figure, for direct comparison.

      It is easy enough to scroll between Figs-especially since nhomie forward looks just like WT.

      (11) Fig. 6: It would be helpful to show a cartoon view of a circle loop to the right of the Micro-C screenshot, as was done in Fig. 3.

      Good idea.   Added to the Fig.

      (12) Fig. 5: It would be helpful to standardize the labelling of the different genotypes throughout the figures and panels ("inverted" versus "reverse" versus an arrow indicating the direction).

      Fixed.

      Reviewer #2 (Recommendations For The Authors):

      Minor Points:

      (1) The Micro-C data does not appear to be deposited in an appropriate repository. It would be beneficial to the community to make these data available in this way.

      This has been done.

      (2) Readers not familiar with Drosophila development would benefit from a gentle introduction to the stages analyzed and some brief discussion on how the phenomenon of somatic homolog pairing might influence the study, if at all.

      We included a rough description the stages that were analyzed for both the in situs and MicroC. We thought that an actual description of what is going on at each of the stages wasn’t necessary as the process of development is not a focus of this manuscript.  In other studies, we’ve found that there are only minor differences in MicroC patterns between the blastoderm stage and stage 12-16 embryos.  While these minor differences are clearly interesting, we didn’t discuss them in the text.   In all of experiments chromosomes are likely to be paired.  In NC14 embryos (the stage for visualizing eve stripes and the MicroC contact profiles in Fig. 2) replication of euchromatic sequences is thought to be quite rapid.  While homolog pairing is incomplete at this stage, sister chromosomes are paired.  In stage 12-16 embryos, homologs will be paired and if the cells are arrested in G2, then sister chromosome will also be paired.  So in all of experiments, chromosomes (sisters and/or homologs) are paired. However, since we don’t have examples of unpaired chromosomes, our experiments don’t provide any info on how chromosome pairing might impact MicroC/expression patterns.

      (3) "P > 0.01" appears several times. I believe the authors mean to report "P < 0.01".

      Fixed.  

      References for Response

      Batut PJ, Bing XY, Sisco Z, Raimundo J, Levo M, Levine MS. 2022. Genome organization controls transcriptional dynamics during development. Science. 375(6580):566-570.

      Bing X, Ke W, Fujioka M, Kurbidaeva A, Levitt S, Levine M, Schedl P, Jaynes JB. 2024. Chromosome structure i: Loop extrusion or boundary:Boundary pairing? eLife.

      Blanton J, Gaszner M, Schedl P. 2003. Protein:Protein interactions and the pairing of boundary elements in vivo. Genes Dev. 17(5):664-675.

      Bonchuk A, Boyko K, Fedotova A, Nikolaeva A, Lushchekina S, Khrustaleva A, Popov V, Georgiev P. 2021. Structural basis of diversity and homodimerization specificity of zincfinger-associated domains in drosophila. Nucleic Acids Res. 49(4):2375-2389.

      Bonchuk A, Kamalyan S, Mariasina S, Boyko K, Popov V, Maksimenko O, Georgiev P. 2020. Nterminal domain of the architectural protein ctcf has similar structural organization and ability to self-association in bilaterian organisms. Sci Rep. 10(1):2677.

      Chen H, Levo M, Barinov L, Fujioka M, Jaynes JB, Gregor T. 2018. Dynamic interplay between enhancer–promoter topology and gene activity. Nat Genet. 50(9):1296.

      Fedotova AA, Bonchuk AN, Mogila VA, Georgiev PG. 2017. C2h2 zinc finger proteins: The largest but poorly explored family of higher eukaryotic transcription factors. Acta Naturae. 9(2):47-58.

      Fujioka M, Ke W, Schedl P, Jaynes JB. 2024. The homie insulator has sub-elements with different insulating and long-range pairing properties. bioRxiv. 2024.02.01.578481.

      Fujioka M, Mistry H, Schedl P, Jaynes JB. 2016. Determinants of chromosome architecture: Insulator pairing in cis and in trans. PLoS Genet. 12(2):e1005889.

      Galloni M, Gyurkovics H, Schedl P, Karch F. 1993. The bluetail transposon: Evidence for independent cis‐regulatory domains and domain boundaries in the bithorax complex. The EMBO Journal. 12(3):1087-1097.

      Gaszner M, Vazquez J, Schedl P. 1999. The zw5 protein, a component of the scs chromatin domain boundary, is able to block enhancer-promoter interaction. Genes Dev. 13(16):2098-2107.

      Goel VY, Huseyin MK, Hansen AS. 2023. Region capture micro-c reveals coalescence of enhancers and promoters into nested microcompartments. Nat Genet. 55(6):1048-1056.

      Harris HL, Gu H, Olshansky M, Wang A, Farabella I, Eliaz Y, Kalluchi A, Krishna A, Jacobs M, Cauer G et al. 2023. Chromatin alternates between a and b compartments at kilobase scale for subgenic organization. Nat Commun. 14(1):3303.

      Hart CM, Zhao K, Laemmli UK. 1997. The scs' boundary element: Characterization of boundary element-associated factors. Mol Cell Biol. 17(2):999-1009.

      Hsieh TS, Cattoglio C, Slobodyanyuk E, Hansen AS, Rando OJ, Tjian R, Darzacq X. 2020. Resolving the 3d landscape of transcription-linked mammalian chromatin folding. Mol Cell. 78(3):539-553.e538.

      Krietenstein N, Abraham S, Venev SV, Abdennur N, Gibcus J, Hsieh TS, Parsi KM, Yang L, Maehr R, Mirny LA et al. 2020. Ultrastructural details of mammalian chromosome architecture. Mol Cell. 78(3):554-565.e557.

      Kyrchanova O, Chetverina D, Maksimenko O, Kullyev A, Georgiev P. 2008. Orientation-dependent interaction between drosophila insulators is a property of this class of regulatory elements. Nucleic Acids Res. 36(22):7019-7028.

      Kyrchanova O, Ibragimov A, Postika N, Georgiev P, Schedl P. 2023. Boundary bypass activity in the abdominal-b region of the drosophila bithorax complex is position dependent and regulated. Open Biol. 13(8):230035.

      Kyrchanova O, Kurbidaeva A, Sabirov M, Postika N, Wolle D, Aoki T, Maksimenko O, Mogila V, Schedl P, Georgiev P. 2018. The bithorax complex iab-7 polycomb response element has a novel role in the functioning of the fab-7 chromatin boundary. PLoS Genet. 14(8):e1007442. Kyrchanova O, Sabirov M, Mogila V, Kurbidaeva A, Postika N, Maksimenko O, Schedl P, Georgiev P. 2019a. Complete reconstitution of bypass and blocking functions in a minimal artificial fab-7 insulator from drosophila bithorax complex. Proceedings of the National Academy of Sciences.201907190.

      Kyrchanova O, Wolle D, Sabirov M, Kurbidaeva A, Aoki T, Maksimenko O, Kyrchanova M, Georgiev P, Schedl P. 2019b. Distinct elements confer the blocking and bypass functions of the bithorax fab-8 boundary. Genetics.genetics. 302694.302019.

      Kyrchanova O, Zolotarev N, Mogila V, Maksimenko O, Schedl P, Georgiev P. 2017. Architectural protein pita cooperates with dctcf in organization of functional boundaries in bithorax complex. Development. 144(14):2663-2672.

      Li H-B, Muller M, Bahechar IA, Kyrchanova O, Ohno K, Georgiev P, Pirrotta V. 2011. Insulators, not polycomb response elements, are required for long-range interactions between polycomb targets in drosophila melanogaster. Mol Cell Biol. 31(4):616-625.

      Li X, Tang X, Bing X, Catalano C, Li T, Dolsten G, Wu C, Levine M. 2023. Gaga-associated factor fosters loop formation in the drosophila genome. Mol Cell. 83(9):1519-1526.e1514.

      Mohana G, Dorier J, Li X, Mouginot M, Smith RC, Malek H, Leleu M, Rodriguez D, Khadka J, Rosa P et al. 2023. Chromosome-level organization of the regulatory genome in the drosophila nervous system. Cell. 186(18):3826-3844.e3826.

      Muller M, Hagstrom K, Gyurkovics H, Pirrotta V, Schedl P. 1999. The mcp element from the drosophila melanogaster bithorax complex mediates long-distance regulatory interactions. Genetics. 153(3):1333-1356.

      Muravyova E, Golovnin A, Gracheva E, Parshikov A, Belenkaya T, Pirrotta V, Georgiev P. 2001. Loss of insulator activity by paired su(hw) chromatin insulators. Science. 291(5503):495498.

      Postika N, Metzler M, Affolter M, Müller M, Schedl P, Georgiev P, Kyrchanova O. 2018. Boundaries mediate long-distance interactions between enhancers and promoters in the drosophila bithorax complex. PLoS Genet. 14(12):e1007702.

      Samal B, Worcel A, Louis C, Schedl P. 1981. Chromatin structure of the histone genes of d. Melanogaster. Cell. 23(2):401-409.

      Sigrist CJ, Pirrotta V. 1997. Chromatin insulator elements block the silencing of a target gene by the drosophila polycomb response element (pre) but allow trans interactions between pres on different chromosomes. Genetics. 147(1):209-221.

      Udvardy A, Schedl P. 1984. Chromatin organization of the 87a7 heat shock locus of drosophila melanogaster. J Mol Biol. 172(4):385-403.

      Vazquez J, Muller M, Pirrotta V, Sedat JW. 2006. The mcp element mediates stable long-range chromosome-chromosome interactions in drosophila. Molecular Biology of the Cell. 17(5):2158-2165.

      Zolotarev N, Fedotova A, Kyrchanova O, Bonchuk A, Penin AA, Lando AS, Eliseeva IA, Kulakovskiy IV, Maksimenko O, Georgiev P. 2016. Architectural proteins pita, zw5,and zipic contain homodimerization domain and support specific long-range interactions in drosophila. Nucleic Acids Res. 44(15):7228-7241.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      This valuable study examines the role of a host in conditions that shift pathogenicity of opportunistic microbes. The use of single-cell microbial transcriptomics and metabolomics to demonstrate the host's effects on pathogen dynamics is interesting and convincing. However, the connection to host antimicrobial peptides driving these effects is incomplete and would benefit from additional evidence and improved explanation in the text. This paper has the potential to be of broad interest to those working in host-microbe (microbiome and pathogen) interactions.

      We appreciate the editors for organizing our manuscript and providing eLife assessment. We went through each comment and carried out some necessary experiments. According to the comments, we here provide additional evidence that further supports our findings in this revised manuscript.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this work, Wang and colleagues used Drosophila-Serratia as a host-microbe model to investigate the impact of the host on gut bacteria. The authors showed that Drosophila larvae reduce S. marcescens abundance in the food likely due to a combination of mechanical force and secretion of antimicrobial peptides. S. marcescens exposed to Drosophila larvae lost virulence to flies and could promote larval growth similar to typical Drosophila gut commensals. These phenotypic changes were reflected in the transcriptome and metabolome of bacteria, suggesting that the host could drive the switch from pathogenicity to commensalism in bacteria. Further, the authors used single-cell bacterial RNA-seq to demonstrate the heterogeneity in gut bacterial populations.

      Strengths:

      This is a valuable work that addresses an important question of the effect of the host on its gut microbes. The authors could convincingly demonstrate that gut bacteria are strongly affected by the host with important consequences for both interacting partners. Moreover, the authors used state-of-the-art bacterial single-cell RNA-seq to reveal heterogeneity in host-associated commensal populations.

      Weaknesses:

      Some of the conclusions are not fully supported by the data.

      Specifically, in lines 142-143, the authors claim that larva antagonizes the pathogenicity of S. marcescens based on the survival data. I do not fully agree with this statement. An alternative possibility could be that, since there are fewer S. marcescens in larvae-processed food, flies receive a lower pathogen load and consequently survive. Can the authors rule this out?

      Also, the authors propose that Drosophila larvae induce a transition from pathogenicity to commensalism in S. marcescens and provide nice phenotypic and transcriptomic data supporting this claim. However, is it driven only by transcriptional changes? Considering high mutation rates in bacteria, it is possible that S. marcescens during growth in the presence of larvae acquired mutations causing all the observed phenotypic and transcriptional changes. To test this possibility, the authors could check how long S. marcescens maintains the traits it acquires during growth with Drosophila. If these traits persist after reculturing isolated bacteria, it is very likely they are caused by genome alterations, if not - likely it is a phenotypic switch driven by transcriptional changes.

      We thank the reviewer for providing a feasible method to distinguish the shift in transcriptional profile from genomic mutations. According to this valuable suggestion, we checked phenotypic and transcriptional changes after re-culturing the bacterium that had coexisted with larvae. We found that all phenotypes can be recovered after re-culturing. The new data supported our previous result that a phenotypic switch was driven by transcriptional changes rather than genome mutations. We now add these results to the text with figure supplement 3 (line 147-151, 192-194). Please see the following text.

      “To rule out the possibility that phenotypic alterations could stem from genomic mutations, we examined the prodigiosin yield and CFUs of re-culturing S. marcescens that had coexisted with larvae. Our results showed that neither prodigiosin yield nor CFUs of re-culturing S. marcescens differed from the original strain (Figure 2-figure supplement 3A-C), suggesting that a phenotypic switch was driven primarily by transcriptional reprogramming.” “Consistent with the previous result that this phenotypic switch was driven by transcriptional changes, the expression of virulent and growth genes was recovered after re-culturing (Figure 3-figure supplement 3D, E).”

      For the first question, we admit the possibility that the high morality of flies could result from the acquirement of a higher pathogen load, because of an increase in the bacterial load of single S. marcescens. However, host pathogenesis is normally determined by the virulence of pathogens rather than the number of bacteria. For example, hosts constantly harbor astonishing commensals in their guts, but remain healthy. This evidence suggests that it was the property (virulence) of a pathogen that is more important to affect the health status of the hosts. Moreover, an increase in virulence of single S. marcescens was verified by real-time PCR (Fig. 2F) and TE (Fig. 2G). Taken together, we could draw a conclusion that the impaired survival of flies challenged with single S. marcescens mainly arose from an increase in the virulence of S. marcescens. Thanks for your understanding!

      Reviewer #2 (Public Review):

      Summary:

      While many studies have explored the impacts of pathogens on hosts, the effect of hosts on pathogens has received less attention. In this manuscript, Wang et al. utilize Drosophila melanogaster and an opportunistic pathogen, Serratia marcescens, to explore how the host impacts pathogenicity. Beginning with an observation that larval presence and density impacted microbial growth in fly vials (which they assess qualitatively as the amount of 'slick' and quantitatively as microbial load/CFUs), the authors focus on the impact of axenic/germ-free larvae on an opportunistic pathogen S. marcescens. Similar to their observations with general microbial load, they find that larvae reduce the presence of a pinkish slick of Sm, indicative of its secondary metabolite prodigiosin. The presence of larvae alters prodigiosin production, pathogen load, pathogen cellular morphology, and virulence, and this effect is through transcriptional and metabolic changes in the pathogen. Overall, they observe a loss of virulence factors/pathways and an increase in pathways contributing to growth. Given the important role the host plays in this lifestyle shift, the authors then examined host features that might influence these effects, focusing on the role of antimicrobial peptides (Amps). The authors combine the use of synthetic Amps and an Amp-deficient fly line and conclude much of the larval inhibitory effect is due to their production of AMPs.

      Strengths:

      This is a very interesting question and the use of Drosophila-Serratia marcescens is a great model to explore these interactions and effects.

      The authors have an interesting and compelling phenotype and are asking a unique question on the impact of the host on the pathogen. The use of microbial transcriptomics and metabolomics is a strength, especially in order to assess these impacts on the pathogen level and at the single-cell level to capture heterogeneity.

      Weaknesses:

      Overall, the writing style in the manuscript makes it difficult to fully understand and appreciate the data and its interpretation.

      The data on the role of AMPs would benefit from strengthening. Some of the arguments in the text of that section are also counterintuitive. The authors show that △AMP larvae have a reduced impact on Sm as compared to wt larvae, but it seems less mild of an effect than that observed with wt excreta (assuming the same as secreta in Figures 7, should be corrected or harmonized). Higher doses of AMPs give a phenotype similar to wt larvae, but a lower dose (40 ng/ul) gives phenotypes more similar to controls. The authors argue that this data suggests AMPs are the factor responsible for much of the inhibition, but their data seems more to support that it's synergistic- you seem to still need larvae (or some not yet defined feature larvae make, although secreta/excreta was not sufficient) + AMPs to see similar effects as wt. Based on positioning and color scheme guessing that AMP 40ng/ul was used in Figures 7D-H, but could not find this detail in the text, methods, or figure legend and it should be indicated. This section does not seem to be well supported by the provided data, and this inconsistency greatly dampened this reviewer's enthusiasm for the paper.

      We thank the reviewer’s valuable comments and suggestions. We admitted that some photos of the pinkish slick (prodigiosin) are counterintuitive in Figure 7 as well as figure supplement 2B. Here comes the reason. Single S. marcescens produced prodigiosin that only stayed on the surface of fly agar medium. As we know, larvae can agitate food and form a stratification of prodigiosin, even making higher prodigiosin yield inside food lighter than the surface slick of prodigiosin. We mentioned it in the previous manuscript line 166-168. This is why some photos treated with excreta and a lower dose of AMP seemed more intense than those with WT larvae. However, we precisely quantified the prodigiosin yield inside food with the spectrophotometer, so we provided a prodigiosin yield following the photos of the slick. Therefore, we drew our conclusions mainly relying on the quantification of the prodigiosin yield. We actually used cecropin A for our experiments, so we added this information in the text. We hope that our replies can reignite your enthusiasm for our manuscript, and thanks for your great support!

      Reviewer #3 (Public Review):

      In this study, Wang and coworkers established a model of Drosophila-S. marcescens interactions and thoroughly examined host-microbe bidirectional interactions. They found that:

      (1) Drosophila larvae directly impact microbial aggregation and density;

      (2) Drosophila larvae affect microbial metabolism and cell wall morphology, as evidenced by reduced prodigiosin production and EPS production, respectively;

      (3) Drosophila larvae attenuate microbial virulence;

      (4) Drosophila larvae modulate the global transcription of microbes for adaptation to the host;

      (5) Microbial single-cell RNA sequencing (scRNA-seq) analysis revealed heterogeneity in microbial pathogenicity and growth;

      (6) AMPs are key factors controlling microbial virulence phenotypes.

      Taken together, they concluded that host immune factors such as AMPs are directly involved in the pathogen-to-commensal transition by altering microbial transcription.

      General comments:

      In general, this study is intriguing as it demonstrates that host immune effectors such as AMPs can serve as critical factors capable of modulating microbial transcription for host-microbe symbiosis. However, several important questions remain unanswered. One such question is: What is the mechanism by which AMPs modulate the pathogen-to-commensal transition? One hypothesis suggests that antimicrobial activity may influence microbial physiology, subsequently modulating transcription for the transition from pathogen to commensal. In this context, it is imperative to test various antibiotics with different modes of action (e.g., targeting the cell wall, transcription, or translation) at sub-lethal concentrations to determine whether sub-lethal doses of antimicrobial activity are sufficient to induce the pathogen-to-commensal transition.

      Thank you for the important comments on our manuscript. We checked the effect of antibiotics (5 μg/μl kanamycin and 10 μg/μl ampicillin) on the virulence switch of S. marcescens. We found that the two antibiotics with the sub-lethal doses similarly resulted in a decrease in prodigiosin yield and virulence expression of S. marcescens. Intriguingly, the two antibiotics also resulted in a dramatic decline in the bacterial load and the expression of genes involved in cell growth. These results suggest that antibiotics reduced the virulence primarily through suppressing most activities of bacteria.

      We found that larvae and AMPs at 40 μg/μl modestly resulted in a decrease in bacterial load and an increase in the relative level of genes involved in cellular proliferation, suggesting that AMPs could maintain the exponential phase of bacterial growth. This result is consistent that Drosophila larvae can support the long-term persistence of commensals in the shared habitat (DOI: 10.1016/j.cmet.2017.11.011). The inhibition could prevent bacteria from rapidly exhausting their nutritional resources, and consequently maintain symbiosis. It is likely that AMPs could maintain S. marcescens at the exponential phase of cell growth and prevent bacteria from rapidly exhausting their nutritional resources.

      Author response image 1.

      (A) Representative images of surface slick with S. marcescens alone, with kanamycin (5 μg/μl) and ampicillin (10 μg/μl). (B) The prodigiosin production of S. marcescens alone, with kanamycin (5 μg/μl) and ampicillin (10 μg/μl). n = 6 for each. (C) Bacterial loads of S. marcescens alone, with kanamycin (5 μg/μl) and ampicillin (10 μg/μl). n = 6 for each. (D, E) RT-qPCR analysis of the expression levels of downregulated and upregulated genes in the S. marcescens alone, with kanamycin (5 μg/μl) and ampicillin (10 μg/μl). n = 3 for each. Means ± SEMs. All variables have different letters, they are significantly different (p < 0.05). If two variables share a letter, they are not significantly different (p > 0.05). ns, no significance. Kruskal-Wallis test followed by Dunn’s multiple comparisons test.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Here are some specific points that need to be addressed:

      (1) Lack of statistical analysis for many figures. The authors should perform and report the statistical analysis for all figures where it is currently lacking, specifically, Figures 2C, D, E, F, H; Figures 3E, F; Figures 7G, H; Figure S2E, Figures S3D, E.

      Thanks for your valuable suggestions. We re-checked the manuscript and performed the statistical analysis for these figures.

      (2) For graphs showing dots, it should be specified what exactly individual dots show and how many animals were used per replicate. Also, time points at which specific analysis was performed should be specified.

      We provided the important information in the legends in the revised manuscript.

      (3) Figure 2. No letters illustrating statistical significance are shown, although this is claimed in the legend (line 848).

      We added statistical significance in the updated Figure 2.

      (4) In Figure 7, the authors used AMPs of defined concentration, but it is not specified what exactly these AMPs are. Please provide the full composition of the AMP mix used.

      We used the antimicrobial peptide cecropin A produced by a silkworm. We added this information in the methods line 487-488 and Figure 7 legend.

      (5) Figure S2B. To me, it looks like that medium with larvae is redder than after mechanical force. I find it hard to believe the quantification in panel C that the medium with larvae has 3 times less pigment as compared to the mechanical force.

      Larvae could only agitate the surface of food (~0.4 cm), but sticks completely agitated the food up to 3 cm. Thus, the layer of food with pink pigment with agitation seemed much deeper than with larvae, which was responsible for the counterintuitively. We explained it in the previous manuscript (line 166-168). “Of note, the surface of the slick with agitation appeared lighter than that of larvae, mainly due to a stratification of prodigiosin following agitation.”

      (6) The authors need to proofread the manuscript as there are missing words, terms that need definition, and wrong terms. For example, L86 - naked eye?, L117 - what do the authors mean by co-culture?, L309 - not resist but rather combat, L347 - Species? or competition?, Figure 2A - 2nd?

      We have corrected these errors in the new manuscript. We added an "eye" in L86. Co-culture means “S. marcescens in co-culture”. Interspecies competition for nearly the same or similar nutrients and space occurs in the habitat.

      (7) The authors should reorganize either the text or the figures' order in a way that the figures are described in a consecutive order (Figure 1A, B ... and not Figure 1D first and then 1A).

      Thanks for your valuable advice. We reorganize the order of the text.

      (8) Do the authors have an idea which bacteria they quantified in Figures 1E to 1G? I didn't find the medium that was used for culturing. Also, in Figure 1F, Is the control group comprised of females or males?

      Mixed bacteria (bacteria in the living environment of Drosophila) were quantified in the NA medium that supports the growth of Drosophila microbiota (Jia Y, et al. Nat Commun. 2021) line 474-475. The control group comprised of both males and females with a 1:1 ratio. Similarly, the aged group contained 100 50-day-aged flies, male: female = 1:1. We provided details in Figure 1 legend line 849-850, 851-852.

      (9) L118-129. it is not possible to make all these statements without any statistical analysis. To me, at 96h both treatments have the same CFUs, while the authors claim they are different.

      We added statistical analysis in the current version. In fact, single S. marcescens became collapsed after 72 h post inoculation, and the CFU number of single S. marcescens declined step by step. The bacterial load of S. marcescens in co-culture was comparable (at 96 h post-inoculation, p>0.05) or higher (at 120 h post-inoculation, p<0.001) than S. marcescens alone, possibly explained by the possibility that bacteria rapidly exhausted the nutritional resources and collapsed through population suicide. We rewrote this sentence line 125-129 in the updated manuscript.

      (10) L136. term "symbionts" is not appropriate here.

      We change “symbionts” into “S. marcescens”.

      (11) In Figure 1, the authors used flies of different fitness: weak, strong, and infertile. They should be specific and describe exactly what these terms mean, are these mutants or treatments that affect the fitness?

      We apologize for this missing information and add them in the method and legend. Strong flies (wild-type fly CS), weak flies (yw; Sp/CyO; MKRS/TM6B), infertile flies (dfmr150M null mutant) Figure 1 legend line 849-850.

      (12) Figure S2. The title of this figure is misleading, please modify it. Mechanical force did affect S. marcescens but to a lesser degree as compared to larvae.

      Thank you for your suggestion. We admit that mechanical force affected S. marcescens but to a lesser degree as compared to larvae, so we changed the title to "Biological factors mainly determine S. marcescens lifestyle."

      Reviewer #2 (Recommendations For The Authors):

      General improvement to writing and presentation (see below):

      Describing confluent growth would make more sense than 'slick' and then using descriptions of broken, etc. "colour intensity of the surface slick".

      We used the slick to describe visible surface films of bacteria, which has been used in the previous study (DOI: 10.1038/s43705-023-00307-8). Slick is equal to confluent growth, but seems simple and easy than confluent growth. To make sense, we add this reference to the text.

      We reorganized the text of Figure 1.

      Suggest more specific language to describe observations. For example: Bacterial loading - S. marcescens growth (for example: the presence of dense fly populations reduced Sm growth).

      Thanks for the suggests. We replaced some of them.

      Symbiont, microbiota, microbiome, etc were all used interchangeably throughout the manuscript, but I am not sure I would call Sm part of the indigenous microbiome. Suggest to ensure proper usage and then harmonize throughout the ms.

      We used microbes and microbiome to replace symbiont and microbiota, respectively.

      Details missing from the message and Figure legends that would be helpful (including and especially Figure 7 - what AMP concentration?)

      Thanks for valuable comments. According to this comment, we provided concrete details in the Materials and methods and Figure 7 legend about AMPs, including the source and concentration of AMPs line 487-488, 954-955. Please see the response below.

      L73: define 'these issues" maybe or lead better with the prior sentence, it is not evident as currently written.

      Change "to address these issues" to " To investigate whether and/or how the host modulates bacterial lifestyles,” and merge two paragraphs.

      L74: repetitive sentence with the above.

      Thanks for pointing out this detail. We deleted it.

      L86: naked 'eye'.

      Added.

      L87: what is meant by 'weak flies'?

      Genotypes were added in the updated manuscript. Weak fly stocks display weaker activity and generate fewer eggs than WT flies.

      L96: bacterial load, not loading.

      Corrected.

      L128: no evidence to support, could be reflective of increased numbers in dying/dead larvae that impact total numbers in the vial.

      The number of CFUs of S. marcescens alone was gradually decreased at 96 h post-inoculation. In addition, we observed pale biofilm on the surface of the medium at the late stage. The numbers of CFUs of S. marcescens alone at the later stages were reduced (compared to the peak load at 48 h post-inoculation), so it was deterred that bacteria could undergo ecological suicide. Ecological suicide of the bacterial population was similarly examined by recording the number of CFUs in the medium over time (Ratzke C, et al. Nat Ecol Evol. 2018.). Taken together, we draw a conclusion that bacteria possibly underwent ecological suicide.

      L129: the prior sentence is in contradiction, reduced load only at early time points in the presence of larvae....

      Thanks for pointing out this detail. We added " before 72 h post-inoculation " in the sentence.

      L134: data is only focused on S marcescens, so inferring to 'symbionts' broadly is outside study.

      We change “symbionts” into “S. marcescens”.

      L139: sentence poorly written and confusing.

      We re-organized this sentence.

      To this end, we sought to examine the S. marcescens lifestyle switch from pathogenicity to commensalism by assessing the respective survival of flies on the fly medium that had been processed by single or coexisting S. marcescens.

      L189: evidence for long-term symbiosis is not well established in this paper, suggest editing this language throughout to more specifically reflect what the data supports and leave such interpretations to discussion points and future work.

      Thanks for your valuable advice. We deleted long-term and “thereby promoting the fitness of symbionts in the long maintenance.”.

      L192; used metabolomics to assess the impacts of larvae on bacterial metabolism, as currently written does not make sense.

      We rewrote this sentence. “Next, we investigated whether larvae could further elicit changes in the metabolism of S. marcescens using untargeted metabolomics.”

      L331: the use of monitored here is not correct/odd.

      We changed 'monitored' to 'reshaping’.

      L340: While the authors initially see a cost to Sm in reduced load (CFUs) at 120 h populations associated with larvae become higher - there is also a cost to producing virulence factors, which their RNASeq and metabolomics data support - trade-offs between growth and virulence.

      Thanks for your suggestion. We added “before 72 hours post inoculation” to define the early stage of the bacterial growth in the sentence.

      Reviewer #3 (Recommendations For The Authors):

      (1) Figures 1 A-D: What defines weak and strong flies, and what criteria determine the robustness of flies? How was the experiment conducted? The manuscript lacks details on this matter.

      We thank you for your comments. We lack a criterium, but the robustness of flies comes from daily experience. Weak fly stocks display weak activity and generate fewer eggs than WT flies. Genotypes with different robustness were added in the legend in the updated manuscript

      (2) The authors mentioned, "Noteworthily, the number of CFUs of S. marcescens alone was lower than S. marcescens in co-cultures at the late stage (at 96 h post inoculation), likely that bacteria rapidly exhausted their nutritional resources and underwent ecological suicide." How did they determine that the bacteria exhausted nutritional resources and underwent ecological suicide? One might speculate that larvae could have removed the bacteria simply by consuming them.

      Thanks for this comment. Virtually, there were no larvae inside the vials with single S. marcescens, so bacterial cells were not consumed. However, the numbers of CFUs of S. marcescens alone at the later stages were reduced (compared to the peak load at 48 h post-inoculation), so it was deterred that bacteria could undergo ecological suicide. Ecological suicide of the bacterial population was examined by recording the number of CFUs in the medium over time (Ratzke C, et al. Nat Ecol Evol. 2018.). A similar method was also applied to the number of CFUs of S. marcescens. Taken together, we draw a conclusion that bacteria possibly underwent ecological suicide.

      (3) Figure 2E: The experimental details should be provided in the text. What was the CFU of the bacteria used in this survival experiment?

      We provided further experimental details in the legend line 869-870. The same amount of inocula was used in both single and coculturing S. marcescens.

      (4) The experimental data in Figures 2G and 2H do not sufficiently prove the relationship between the width of the cell wall and virulence, as it lacks experimental validation.

      Previous studies (DOI: 10.1371/journal.ppat.1005946) reveal that glucosylating toxins on the surface are primary virulence determinants, so an increased surface-anchored polysaccharide and protein profile promotes the virulence of the pathogen. Alterations in cell surface (the width of the cell wall) can be examined by TE. Moreover, TE was used to observe changes in the virulence of S. marcescens (DOI: 10.1093/nar/gkab1186). We think that the width of the cell wall could be used to reflect virulence in S. marcescens.

      (5) While it's acknowledged that agitation decreases the color intensity of the bacteria, comparing mechanical agitation with larval crawling seems inappropriate, as the mechanical forces exerted by both methods are not of the same magnitude.

      Thanks for the suggestion. In fact, food was agitated more heavily by glass sticks than by larvae, because larvae merely agitated the surface of food (about 0.5 cm-depth). If the decrease in bacterial load and color was related to the magnitude of agitation, larvae would confer a less decrease (from the decrease in stick agitation) in bacterial load than the sticks. Consequently, it would further support our result that biofactors more importantly confer the inhibition of S. marcescens than force.

      (6) Figure 4D: with this metabolome data, they mentioned, "host suppresses differentiation of S. marcescens into the population with pathogenicity." What evidence supports the claim that downregulation of amino acid metabolism, phosphotransferase system, and ABC transporter directly correlates with decreased pathogenicity?

      Thanks for the comment. Earlier studies showed that amino acid-derived quorum sensing molecules are closely related to bacterial pathogenicity (Defoirdt T. PLoS Pathog. 2019; Wen J, et al. Microbiol Spectr. 2022). Moreover, the phosphotransferase system and ABC transporter can transport and/or produce virulence factors. Therefore, we claimed that downregulation of amino acid metabolism, phosphotransferase system, and ABC transporter directly were related to decreased pathogenicity. To support this claim, we add some references in the updated manuscript line 662-664, 827-830.

      (7) Serotonin: Does serotonin also reduce the virulence of S. marcescens?

      Our primary result showed that serotonin indeed could reduce the virulence of S. marcescens (figure supplement 4), because the survival rate of adult flies was increased and the expression levels of virulence-related genes of S. marcescens alone in the case of serotonin.

      (8) Figures 6D, E, H, I: The expression of key genes should be verified using quantitative real-time polymerase chain reaction (qRT-PCR), as scRNA-seq expression levels might not accurately reflect the true expression levels.

      Bacterial single-cell RNA-seq can evaluate alterations in gene expression in the single-cell resolution. The expression of key genes screened by scRNA-seq was changed only in subpopulations, so the average expression of these genes would be comparable when mixed with a large population. We are afraid that qRT-PCR could be illegible to verify the expression of genes in subpopulations.

      (9) Figure 7: The authors mentioned. "AMPs were supplemented to fly food". However, I could not find information regarding which AMPs and their respective concentrations (i.e., concentration of each AMP) were used in this study. This is a critical aspect of the research; therefore, details should be provided.

      Thanks for your important suggestions. We used the antimicrobial peptide cecropin A, which is produced by silkworms. We provided this information in the methods line 487-488. The concentrations of cecropin A were added in Figure 7 legend.

      (10) Figure 7: Delta AMP + AMP exhibited a stronger effect on the bacteria compared to AMP alone, indicating that immune effectors other than AMP may be involved. Since the IMD pathway is necessary for most immune effectors, including AMP, it would be interesting to test IMD pathway mutant animals and compare them with Delta AMP. Delta AMP + AMP exhibited a stronger effect on the bacteria compared to AMP alone. 

      We appreciate this important question. Indeed, Delta AMP + AMP exhibited a stronger effect on the bacteria compared to AMP alone. We admitted that immune effectors other than AMP may be involved. Alternatively, mechanical force, to a less extent, accounted for the stronger effect on the bacteria (Explained by larvae agitation in figure supplement 2). To rule out this possibility, we examined the effect of total immune effectors on the bacterial load and the prodigiosin yield of S. marcescens using the IMD pathway mutant (RelE20 larvae). Our result showed that the optical density and yield of prodigiosin in Delta AMP group did not significantly differ from the ones in RelE20 group. Moreover, the load of S. marcescens associated with Delta AMP mutant was comparable to that of S. marcescens associated with RelE20 mutant. These results suggested that AMPs play a major role in recapitulating the response of _S. marcescens t_o larvae.

      “To rule out the potential role of other immune effectors, we turned to the IMD pathway mutant RelE20 that is deficient in total immune effectors. Our result showed that the optical density and yield of prodigiosin in RelE20 group did not significantly differ from the ones in DAMP group (figure supplement 7A, B). Moreover, the load of S. marcescens associated with RelE20 mutant was comparable to that of S. marcescens associated with Delta AMP mutant (figure supplement 7C).”

      We now added these results in the text line 326-331.

    1. Author response:

      The following is the authors’ response to the original reviews

      List of major changes

      (1) We have emphasized the assumptions underlying our modeling approach in the third paragraph of the Introduction section.

      (2) We have included a new paragraph in the Discussion section to compare our model with a molecular mechanism-oriented model.

      (3) We have included a new paragraph at the end of the Introduction section to outline the main content of each subsection in Results and the logical connections between them. Correspondingly, the chapter hierarchy and section titles have been adjusted.

      (4) The Supplementary Material includes an additional table (Table S2) that provides detailed explanations of the symbols used in the model.

      (5) We have included a new paragraph in the Introduction section to explicitly emphasize the phenomenological nature of our model and its broad applicability.

      (6) In the Osmoregulation subsection, we have added a discussion on how our model can be directly generalized to scenarios involving the environmental uptake of osmolytes.

      (7) We have included a more detailed examination of the limitations inherent in our modeling approach in the second last paragraph of the Discussion section.

      (8) In the third last paragraph of the Discussion section, we have explicitly demonstrated that our model does not conflict with the observation that, in E. coli, cell wall synthesis is not directly regulated by the turgor pressure.

      Reviewer #1 (Public review):

      Summary:

      A theoretical model for microbial osmoresponse was proposed. The model assumes simple phenomenological rules: (i) the change of free water volume in the cell due to osmotic imbalance based on pressure balance, (ii) osmoregulation that assumes change of the proteome partitioning depending on the osmotic pressure that affects the osmolyte-producing protein production, (iii) the cell-wall synthesis regulation where the change of the turgor pressure to the cell-wall synthesis efficiency to go back to the target turgor pressure, (iv) effect of Intracellular crowding assuming that the biochemical reactions slow down for more crowding and stops when the protein density (protein mass divided by free water volume) reaches a critical value. The parameter values were found in the literature or obtained by fitting to the experimental data. The authors compare the model behavior with various microorganisms (E. coli, B. subtils, S. Cerevisiae, S. pombe), and successfully reproduced the overall trend (steady state behavior for many of them, dynamics for S. pombe). In addition, the model predicts non-trivial behavior such as the fast cell growth just after the hypoosmotic shock, which is consistent with experimental observation. The authors further make experimentally testable predictions regarding mutant behavior and transient dynamics.

      Strength:

      The theory assumes simple mechanistic dependence between core variables without going into specific molecular mechanisms of regulations. The simplicity allows the theory to apply to different organisms by adjusting the time scales with parameters, and the model successfully explains broad classes of observed behaviors. Mathematically, the model provides analytical expressions of the parameter dependences and an understanding of the dynamics through the phase space without being buried in the detail. This theory can serve as a base to discuss the universality and diversity of microbial osmoresponse.

      We would like to thank Reviewer 1 for thoroughly reading our work and appreciating our theoretical approach to investigating microbial osmotic response.

      Weakness:

      The core part of this model is that everything is coupled with growth physiology, and, as far as I understand, the assumption (iv) (Eq. 8) that imposes the global reaction rate dependence on crowding plays a crucial role. I would think this is a strong and interesting assumption. However, the abstract or discussion does not discuss the importance of this assumption. In addition, the paper does not discuss gene regulation explicitly, and some comparison with a molecular mechanismoriented model may be beneficial to highlight the pros and cons of the current approach

      We thank Reviewer 1 for their very helpful feedback. We have significantly revised the manuscript as suggested by Reviewer 1. See the detailed answers in the following.

      Reviewer #1 (Recommendations for the authors)

      (1) Explicitly stating the assumption (iv) in the abstract and discussing its role would help readers understand.

      In the revised manuscript, we have significantly rewritten the third paragraph of the Introduction section to emphasize our key assumptions as suggested by Reviewer 1, including the relationship between global reaction rate and crowding:

      “Our model assumes the following phenomenological rules: (1) the change in free water volume within the cell is driven by osmotic imbalance (Cadart et al., Nature Physics, 2019; Rollin et al., Elife, 2023), while the remaining volume changes in proportion to protein production; (2) osmoregulation influences the production of osmolyte-producing protein, governed by intracellular protein density (Scott et al., Science, 2010); (3) cell-wall synthesis is regulated through a feedback mechanism, wherein turgor pressure modulates the efficiency of cell-wall synthesis, enabling the cell to maintain a relatively stable turgor pressure; and (4) intracellular crowding slows down biochemical reactions as cytoplasmic density increases, with reactions ceasing entirely when protein density reaches a critical threshold.”

      We have also modified the abstract to mention the crowding effects explicitly. Additionally, we have added a few sentences in the first and second paragraphs of the Discussion section to emphasize the importance of crowding effects to our conclusions regarding the growth rate reduction in steady states and the non-monotonic dependence of the growth rate peak on the shock amplitude after a hyperosmotic shock.

      (2) I found [Shen W , Gao Z, Chen K, Zhao A, Ouyang Q, Luo C. The regulatory mechanism of the yeast osmoresponse under different glucose concentrations. Iscience. 2023 Jan 20;26(1)], which discusses the medium glucose concentration dependence of the response, focused on the gene regulatory circuit and the metabolic flux. As far as I understood, this paper considers the effect of the reallocation of resources but not the mechanical part of the osmoresponse such as pressure explicitly. It will be interesting to discuss the pros and cons in comparison with such a model. In principle, I will not be surprised if the current model does not differentiate the different glucose concentrations much since it is a more coarse-grained model, and I don't think it is a problem, but it will be good to have an explicit discussion.

      We appreciate Reviewer 1's insightful comment regarding the work by Shen et al. (iScience, 2023), which elucidates the two distinct osmoresponse strategies in yeast. By quantifying Hog1 nuclear translocation dynamics and downstream protein expression, the study reveals that in a rich medium, cells can leverage surplus glycolytic products as defensive reserves, reallocating metabolic flux to facilitate rapid adaptation to osmotic changes. Conversely, limited glycolytic intermediates in low-glucose environments necessitate increased enzyme synthesis for osmotic adaptation. 

      The paper highlighted by Reviewer 1 studies yeast's adaptive strategies under two stresses— nutrient limitation and osmotic pressure and provides an important complement to our study.

      In our simplified model, we did not include the interaction between cell growth and osmolyte production, assuming a constant fraction of ribosomes translating ribosomal proteins, supported by the experiments of E. coli (Dai et al., mBio, 2018). We remark that incorporating competitive dynamics for translational resources into our framework can be achieved by modifying the proportion of ribosomes translating themselves (X<sub>r</sub>), from a constant to a function related to the translation strategy of the osmolyte-producing enzyme ((X<sub>a</sub>).

      In the revised manuscript, we have included a new discussion in the third paragraph of the Discussion section to compare our approach with the molecular mechanism-oriented model:

      “We remark that our model is intrinsically a coarse-grained model with many molecular details regarding gene expression regulation neglected, which allows us to gain more analytical insights. In [Shen et al., iScience, 2023], the authors studied the responses to osmotic stress in glucose-limited environments and found that cells exhibited stronger osmotic gene expression response under glucose-limited conditions than under glucose-rich conditions. Using a computational model based on molecular mechanisms combined with experimental measurements, the authors demonstrated that in a glucose-limited environment, glycolysis intermediates were limited, which required cells to express more glycerol-production enzymes for stress adaptation. In the current version of our model, we do not account for the interaction between cell growth and osmolyte production; instead, we assume a constant fraction of ribosomes dedicated to translating ribosomal proteins. Our model can be further generalized to include the more complex interactions, including the coupling between biomass and osmolyte production, e.g., by allowing the fraction of ribosomes translating ((X<sub>r</sub>) to depend on the translation strategy of the osmolyte-producing enzyme ((X<sub>a</sub>).”

      (3) A minor comment: The authors call assumption (iii) (eq. 7) "positive feedback from turgor pressure to the cell-wall synthesis efficiency" (line 204). I have a hard time seeing this as positive feedback. It regulates the cell wall synthesis so that turgor pressure returns to the desired value; hence, isn't it negative feedback?

      We apologize for this confusion. We have removed the term "positive feedback" in the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      In this study, Ye et al. have developed a theoretical model of osmotic pressure adaptation by osmolyte production and wall synthesis.

      Strengths:

      They validate their model predictions of a rapid increase in growth rate on osmotic shock experimentally using fission yeast. The study has several interesting insights which are of interest to the wider community of cell size and mechanics.

      Weaknesses:

      Multiple aspects of this manuscript require addressing, in terms of clarity and consistency with previous literature. The specifics are listed as major and minor comments.

      Major comments:

      (1) The motivation for the work is weak and needs more clarity.

      We thank Reviewer 2 for this very helpful comment, which we believe has significantly improved our manuscript. We would like to clarify the two major motivations of our study. 

      First, we aim to construct a systems-level and coarse-grained model capable of elucidating the complex processes underlying microbial osmoresponse. By leveraging the separation of timescales associated with mechanical equilibrium, cell-wall synthesis regulation, and osmoregulation, our model facilitates in-depth analytical and numerical analysis of how these various processes interact during cellular adaptation. In particular, we demonstrate the key physiological functions of osmoregulation and cell-wall synthesis regulation.

      Second, we seek to apply this model to interpret the phenomenon of supergrowth observed in fission yeast Schizosaccharomyces pombe (Knapp et al., Cell Systems, 2019). This application addresses an essential challenge in experimental studies: exclusive knockout experiments can be difficult, and mechanistic interpretations of experimental observations are often lacking. Our theoretical framework offers a valuable tool for understanding such phenomena, contributing to the fundamental knowledge of microbial physiology and developing predictive models for microbial behavior under osmotic stress.

      In the revised manuscript, we have included a new paragraph at the end of the Discussion section to emphasize our motivations better:

      “In this work, we construct a systems-level and coarse-grained model capable of elucidating the complex processes underlying microbial osmoresponse. By leveraging the separation of timescales associated with mechanical equilibrium, cell-wall synthesis regulation, and osmoregulation, our model facilitates in-depth analytical and numerical analysis of how these various processes interact during cellular adaptation. In particular, we demonstrate the key physiological functions of osmoregulation and cell-wall synthesis regulation. We then apply this model to interpret the unusual phenomenon of supergrowth observed in fission yeast. This application addresses an essential challenge in experimental studies: exclusive knockout experiments can be difficult, and mechanistic interpretations of experimental observations are often lacking. Our theoretical framework offers a valuable tool for understanding such phenomena, contributing to the fundamental knowledge of microbial physiology and developing predictive models for microbial behavior under osmotic stress.”

      (2) The link between sections is very frequently missing. The authors directly address the problem that they are trying to solve without any motivation in the results section.

      We are grateful to Reviewer 2 for their valuable feedback. In the revised manuscript, we have included a new paragraph at the end of the Introduction section to outline the main content of each subsection in Results and the logical connections between them:

      “In the following “Results” section, we begin by outlining the primary assumptions and equations of our model in the subsection "Model Description," which includes four parts, each addressing one of the four phenomenological rules. Additional details can be found in Methods. We then proceed to the subsection “Steady states in constant environments”, where we employ our theoretical framework to analyze steady-state growth and examine how the growth rate varies with external osmolarity. In the “Transient dynamics after a constant osmotic shock” subsection, we investigate the time-dependent osmoresponse after a constant hyperosmotic and hypoosmotic shock. Finally, in “Comparison with experiments: supergrowth phenomena after osmotic oscillation”, we address the supergrowth phenomena observed in S. pombe, utilizing our model to elucidate these experimental observations.”

      (3) The parameters used in the models (symbols) need to be explained better to make the paper more readable.

      We apologize for this confusion. In the revised Supplementary Material, we have included an additional table (Table S2) to explain the meanings of the symbols employed in the model to help the reader better understand.

      (4) Throughout the paper, the authors keep switching between organisms that they are modelling. There needs to be some consistency in this aspect where they mention what organism they are trying to model, since some assumptions that they make may not be valid for both yeast as well as bacteria.

      We thank Reviewer 2 for this very helpful comment. We would like to clarify that our model is coarse-grained without including detailed molecular mechanisms; therefore, it presumably applies to various species of microorganisms. Indeed, the predicted steady-state growth curves derived from our model and the experimental data obtained from various organisms agree reasonably well (Figure 2A of the main text). 

      In the revised manuscript, we have explicitly emphasized the nature of our phenomenological model and its broad applicability in the fourth paragraph of the Introduction section:

      “We remark that our model is coarse-grained, without including detailed molecular mechanisms, and is therefore applicable across diverse microbial species. Notably, the predicted steady-state growth rate as a function of internal osmotic pressure from our model aligns well with experimental data from diverse organisms. This alignment allows us to quantify the sensitivities of translation speed and regulation of osmolyte-producing protein in response to intracellular density. Additionally, we demonstrate that osmoregulation and cellwall synthesis regulation enable cells to adapt to a wide range of external osmolarities and prevent plasmolysis. Our model also predicts a non-monotonic time dependence of growth rate and protein density as they approach steady-state values following a constant osmotic shock, in concert with experimental observations (Rojas et al., PNAS, 2014; Rojas et al., Cell systems, 2017). Moreover, we show that a supergrowth phase can arise following a sudden decrease in external osmolarity, driven by cell-wall synthesis regulation, either through the direct application of a hypoosmotic shock or the withdrawal of an oscillatory stimulus. Remarkably, the predicted amplitudes of supergrowth (i.e., growth rate peaks) quantitatively agree with multiple independent experimental measurements.”

      Furthermore, we have also included a comparison with a detailed molecular mechanism model in the third paragraph of the Discussion section:

      “We remark that our model is intrinsically a coarse-grained model with many molecular details regarding gene expression regulation neglected, which allows us to gain more analytical insights. In [Shen et al., iScience, 2023], the authors studied the responses to osmotic stress in glucose-limited environments and found that cells exhibited stronger osmotic gene expression response under glucose-limited conditions than under glucose-rich conditions. Using a computational model based on molecular mechanisms combined with experimental measurements, the authors demonstrated that in a glucose-limited environment, glycolysis intermediates were limited, which required cells to express more glycerol-production enzymes for stress adaptation. In the current version of our model, we do not account for the interaction between cell growth and osmolyte production; instead, we assume a constant fraction of ribosomes dedicated to translating ribosomal proteins. Our model can be further generalized to include the more complex interactions, including the coupling between biomass and osmolyte production, e.g., by allowing the fraction of ribosomes translating ((X<sub>r</supb) to depend on the translation strategy of the osmolyte-producing enzyme ((X<sub>a</sub>).”

      (5) The extent of universality of osmoregulation i.e the limitations are not very well highlighted.

      The osmoregulation mechanism described in our model primarily addresses changes in cytoplasmic osmolarity through the de-novo synthesis of compatible solutes, widely observed across bacteria, archaea, and eukaryotic microorganisms. This review article (GundeCimerman et al., FEMS microbiology reviews, 2018) provides an extensive summary and exploration of the primary compatible solutes utilized by organisms from all three domains of life, underscoring the prevalence of this osmoregulatory strategy. Furthermore, our model can be directly generalized to scenarios involving the direct uptake of osmolytes from the environment. One only needs to change the interpretation of the parameter, 𝑘<sub>𝑎</sub> in the production of osmolyte molecule, , from the synthesis rate to the uptake rate, and all the results are equally applicable. In the revised manuscript, we have briefly discussed this point in the subsection “Osmoregulation.”

      We agree with Reviewer 2 that our model's coarse-grained nature makes it broadly applicable to diverse microbial taxa; however, more specialized adaptations are beyond our model. In the revised manuscript, we have included a more detailed examination of the limitations inherent in our modeling approach in the second last paragraph of the Discussion section:

      “We remark several limitations of our current coarse-grained model. First, the high membrane tension that inhibits transmembrane flux of peptidoglycan precursors, leading to a growth inhibition before the supergrowth peak (Rojas et al., Cell systems 2017) is beyond our model. Second, in our current framework, the osmoregulation and cell-wall synthesis regulation rely on the instantaneous cellular states. However, microorganisms can exhibit memory effects to external stimuli by adapting to their temporal order of appearance (Mitchell et al., Nature 2009). Notably, in the osmoregulation of yeast, a short-term memory, facilitated by post-translational regulation of the trehalose metabolism pathway, and a long-term memory, orchestrated by transcription factors and mRNP granules, have been identified (Jiang et al., Science signaling 2020). Besides, our model does not account for the role of osmolyte export in osmoregulation (Tamas et al., Molecular microbiology, 1999) and the interaction between biomass and osmolyte production (Shen et al., Iscience 2023). Extending our model to include more realistic biological processes will be interesting.”

      (6) Line 198-200: It is not clear in the text what organisms the authors are writing about here. "Experiments suggested that the turgor pressure induce cell-wall synthesis, e.g., through mechanosensors on cell membrane [45, 46], by increasing the pore size of the peptidoglycan network [5], and by accelerating the moving velocity of the cell-wall synthesis machinery [31]". This however is untrue for bacteria as shown by the study (reference 22 is this paper: E. Rojas, J. A. Theriot, and K. C. Huang, Response of escherichia coli growth rate to osmotic shock, Proceedings of the National Academy of Sciences 111, 7807 (2014).

      We thank Reviewer 2 for pointing out this very important issue and apologize for the confusion. References 45 and 46 (Dupres et al., Nature Chemical Biology 2009; Neeli-Venkata et al., Developmental Cell 2021) discuss how Wsc1 acts as a mechanosensor in S. pombe, detecting turgor pressure and activating pathways that reinforce the cell wall. Reference 5 (Typas et al., Cell 2010) explains the role of LpoA and LpoB, the two outer membrane lipoprotein regulators in E. coli, which modulate peptidoglycan synthesis in an extracellular manner. Reference 31 (Amir and Nelson, PNAS 2012) is a theoretical paper showing that turgor pressure may accelerate the moving velocity of the cell wall synthesis machinery in E. coli. In the revised manuscript, we have been more explicit about the organisms we refer to in the subsection “Cell-wall synthesis regulation.”

      Meanwhile, we agree with Reviewer 2 that cell wall synthesis may not be directly regulated by turgor pressure in E. coli (Rojas et al., PNAS 2014). We would like to clarify that this scenario is also included in our model corresponding to H<sub>cw</sub> = 0 (Eq. (7) in the main text): the turgor pressure does not affect the cell-wall synthesis. Therefore, the supergrowth phenomenon observed in S. pombe does not manifest under hypotonic stimulation in E. coli.

      In the revised manuscript, we have emphasized this point more explicitly in the third last paragraph of the Discussion section:

      “Reference 22 (Rojas et al., PNAS, 2014) showed that the expansion of E. coli cell wall is not directly regulated by turgor pressure, and this scenario is also included in our model as the case of H<sub>cw</sub> \= 0. According to our model, the supergrowth phase is absent if H<sub>cw</sub> = 0 (Figure S8), consistent with the absence of a growth rate peak after a hypoosmotic shock in the experiments of E. coli (Rojas et al., PNAS, 2014). Meanwhile, our predictions are consistent with the growth rate peak after a hypoosmotic shock observed for B. subtilis (Rojas et al., Cell systems, 2017).”

      (7) The time scale of reactions to hyperosmotic shocks does not agree with previous literature (reference 22). Therefore defining which organism you are looking at is important. Hence the statement " Because the timescale of the osmoresponse process, which is around hours (Figure 3B), is much longer than the timescale of the supergrowth phase, which is about 20 minutes, the turgor pressure at the growth rate peak can be well approximated by its immediate value after the shock." from line 447 does not seem to make sense. The authors need to address this.

      We apologize for this confusion. In the revised manuscript, we have clarified that the cited time scales are for the fission yeast S. pombe after Eq. (13) in the main text.

      Reviewer #2 (Recommendations for the authors):

      (1) Inconsistency in nomenclature: On line 117, the equation reads V<sub>b</sub> = αm<sub>p where V<sub>b</sub> is the bound volume. Whereas bound volume has been referred to as V<sub>bd</sub> previously and in Figure 1.

      Answer: We apologize for this confusion. In our model, the total bound volumeV<sub>b</sub> comprises the volume of dry mass and bound water, V<sub>b</sub> \= V<sub>bd</sub> + V<sub>bw</sub>, where V<sub>bd</sub> is the volume occupied by dry mass and V<sub>bw</sub> is the volume of bound water. In the revised manuscript, we have added a brief discussion of this point in the caption of Figure 1.

      (2) Line 180: Please define 𝜌𝜌 for equation 4.

      We apologize for this confusion. In the text, the symbol 𝜌<sub>p</sub> denotes the mass of a given substance per unit volume of free water, and its unit is g/ml. The specific substance in consideration is indicated by a subscript. For example, 𝜌<sub>p</sub> in Eq. (4) represents the protein density, and 𝜌<sub>c</sub> stands for the critical protein density, above which intracellular chemical reactions cease according to Eq. (8) of the main text. In the revised manuscript, we have clarified the meaning of 𝜌<sub>c</sub> after Eq. (4).

      (3) Line 187: Equation 5 also needs to be explained better. Hence there is a need to be more specific while stating the assumptions.

      The elastic modulus 𝐺 defined in Eq. (5) of the main text is a measure of the cell wall's resistance to volume expansion. We assume a constant 𝐺 for simplicity, which is reasonable when the cell wall deformation is mild. In the revised manuscript, we have been more explicit about our assumptions regarding the turgor pressure in the subsection “Cell-wall synthesis regulation.”

      (4) Line 225: For a biological audience some elaboration on "glass transition" may be required- either as a reference to a review or to a 1 sentence statement of relevance.

      We appreciate Reviewer 2’s helpful comment. In the revised manuscript, we have added a brief introduction to the glass transition and a citation to a review paper (Hunter and Weeks, Rep. Prog. Phys. 2012) at the beginning of the subsection “Intracellular crowding.”

      (5) Line 247: "All growth rates in steady states of cell growth are the same: 𝜇<sub>𝑓</sub> \= 𝜇<sub>r</sub> \= 𝜇<sub>cw</sub>". The authors need to explain in a line or two why this is true. Since the processes are independent, it is safe to assume that all 𝜇's are constant, but it is not obvious why they should all be equal.

      We apologize for the lack of a clear explanation regarding the equality of steady-state growth rates in our previous manuscript. In the revised manuscript, we have added a brief explanation of the equality of the three growth rates at the beginning of the subsection “Steady states in constant environments”:

      “When cell growth reaches a steady state, the proportions of all components, including free water volume, cell mass, and cell wall volume, must be constant relative to the total cell volume to ensure homeostasis. Therefore, all growth rates in steady states of cell growth must be the same: 𝜇<sub>𝑓</sub> \= 𝜇<sub>r</sub> \= 𝜇<sub>cw</sub>.”

      (6) Line 264: "Because the typical doubling times of microorganisms are around hours, we can estimate 𝜇<sub>𝑓</sub>/k<sub>w</sub> ∼ 10 Pa [51, 52] ..." since the authors are generalizing for yeast and bacteria, specifically E. coli, this is not a valid assumption to make. There is also a need to explain the basis of "𝜇<sub>𝑓</sub>/k<sub>w</sub> ∼ 10 Pa".  

      We appreciate the need for clarity in the estimation and its implications. The rough estimation of 𝜇<sub>𝑓</sub>/k<sub>w</sub> ~ 10 Pa in the main text is given by:

      Here, the typical value of 𝜇<sub>𝑓</sub> (which equals to 𝜇<sub>r</sub> in steady state) is approximated by the inverse of the cell cycle, which is around hours. The estimation above is employed to justify the assumption that 𝜇<sub>𝑓</sub>/k<sub>w</sub> is much smaller than the cytoplasmic osmotic and turgor pressures, which can be several atmospheric pressures.

      For the case of E. coli, based on the experimental results from Boer et al. (Boer et al., Biochemistry 2011), an 800mM hypoosmotic shock leads to a rapid expansion of cell volume accomplished within a time scale of 0.1s, from which we obtain:

      .

      Therefore, our assumption that 𝜇<sub>𝑓</sub>/k<sub>w</sub> is much smaller than the cytoplasmic osmotic and turgor pressures is still valid. 

      In the revised manuscript, we have increased the estimation ranges to include the case of E. coli in the first paragraph of the subsection “Steady states in constant environments.”

      (7) Lines 279-283 need to be explained better.  

      We apologize for the confusion. In the revised manuscript, we have explained more explicitly the meaning of the growth curve in the second paragraph of the subsection “Steady states in constant environments”:

      “Intriguingly, the relationship between the normalized growth rate () and the normalized cytoplasmic osmotic pressure (), which we refer to as the growth curve in the following, has only one parameter 𝐻<sub>r</sub>/(𝐻<sub>𝑎</sub>) . Therefore, the growth curves of different organisms can be unified by a single formula, Eq. (10b), and different organisms may have different values of 𝐻<sub>r</sub>/(𝐻<sub>𝑎</sub> + 1).”

      (8) In Figure 3, an arrow representing the onset of osmotic shock would make the figure more intuitive to understand.

      We appreciate Reviewer 2 for this helpful suggestion. We have modified Figure 3 as suggested.

      (9) It is unclear to me if the growth rate 𝜇𝜇𝑟𝑟 is representative of the growth of total protein. This can be motivated better.

      We would like to clarify that the growth rate 𝜇𝜇𝑟𝑟 is defined as the changing rate of total protein mass divided by the total protein mass:

      Here, 𝑚<sub>𝑝,𝑟</sub> is the total mass of ribosomal proteins and 𝑘𝑘𝑟𝑟 is a constant proportional to the elongation speed of ribosome. The expression of 𝜇<sub>𝑟</sub> is a direct consequence of ribosomes being responsible for producing all proteins. In the revised manuscript, we have added more details in the introduction of the variable 𝜇<sub>𝑟</sub> in the last paragraph of the subsection “Cell growth”:

      “In this work, we assume that the dry-mass growth rate is proportional to the fraction of ribosomal proteins within the total proteome for simplicity, 𝜇<sub>𝑟</sub> \= 𝑘<sub>r</sub>𝑚<sub>𝑝,𝑟</sub>/𝑚<sub>𝑝</sub> \= 𝑘<sub>r</sub>𝜙<sub>𝑟</sub>. This assumption leverages the fact that ribosomes are responsible for producing all proteins. The proportionality coefficient 𝑘<sub>𝑟</sub> encapsulates the efficiency of ribosomal activity, being proportional to the elongation speed of the ribosome. We remark that 𝑘𝑘𝑟𝑟 is influenced by the crowding effect, which we address later.”

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #2:

      Line 295 – was the time post-infection, which varies considerably between groups and across samples, taken into consideration when comparison of response was between ChatCre mice (4-9 weeks post-infection) and WT mice (four to five weeks post-infection)?

      Thank you for your comment. We did not originally assess the effects of time post-injection on DREADD response. Generally, AAV transgene expression has been demonstrated to be long-term and stable in the CNS of mice.[1] However, there is some variation in the reporting time of peak transgene expression[2], and this may potentially impact our results.

      In investigating this issue further, we discovered an error in our reporting as we did have n = 1 wild-type mouse that underwent EMG recordings 62 days (~9 weeks) post-AAV injection. This has been corrected in the manuscript (lines 87-88).

      Addressing this question is challenging due to the uneven distribution of time points within the 4–9-week windows for each group. Essentially, there were two groups per cohort, one studied at 4-5 weeks and one at 8-9 weeks. More specifically:

      - Wild-type cohort: n = 10 animals were studied 28–33 days post-injection, and n = 1 at 62 days.

      - ChAT-Cre cohort: n = 4 animals were studied 28–30 days post-injection, and n = 5 at 56–59 days.

      We performed Pearson correlation analyses between time post-injection and diaphragm EMG response to DREADD activation (peak amplitude and area under the curve, AUC) for both cohorts (Author response image 1):

      - ChAT-Cre: No significant correlations were found (peak amplitude: r<sup>2</sup> = -0.117, r = -0.1492, p = 0.702, Figure 1a-b; AUC:r<sup>2</sup> = -0.0883, r = 0.2184, p = 0.572, Figure 1c-d).

      - Wild type: Initial analysis of all data showed significant correlations (peak amplitude:r<sup>2</sup> = 0.362, r = 0.6523, p = 0.0296, Figure 1a; AUC: r<sup>2</sup> = 0.347, r = 0.6424, p = 0.033, Figure 1c), suggesting a moderate positive correlation between time post-injection and EMG response. However, when the single 8–9-week wild-type mouse was excluded, these correlations were no longer significant (peak amplitude: r<sup>2</sup> = 0.172, r = 0.5142, p = 0.128, Figure 1b; AUC: r<sup>2</sup> = 0.23, r = 0.5614, p = 0.0913, Figure1d).

      Comparing wild-type and ChAT-Cre groups directly was unreliable due to the single wild-type mouse studied at the later time point. We attempted to model time post-injection as a continuous variable (i.e., exact days post-injection) using a restricted maximum likelihood mixed linear model in JMP; however, the analysis could not be performed because there were not sufficient overlapping time points between the two cohorts (i.e., not all days post-injection were represented in both groups). To mitigate this, we binned animals into two groups: 4–5 weeks and 8–9 weeks post-injection. This analysis returned a significant interaction between cohort and time post-injection (p = 0.0391), however there were no significant multiple comparisons upon Tukey post hoc test (i.e., p > 0.05).

      Based on these findings, we feel confident that time post-injection is unlikely to have a significant impact on diaphragm EMG response to DREADD activation in the ChAT-Cre cohort. However, in the wild-type cohort, it is difficult to draw definitive conclusions, as only one animal was studied at the 8–9-week time point. For similar reasons, it remains unclear whether the relationship between time post-AAV transduction and DREADD response differs between cohorts. Given the inconclusive nature of these results, we have elected not to include this analysis in the manuscript. Nevertheless, to ensure transparency, we have provided Author response image 1 below of peak amplitude and AUC plotted against time, allowing readers to evaluate the data independently.

      Author response image 1.

      Plots of diaphragm EMG peak amplitude (a-b) and area under the curve (c-d) vs. days post-AAV injection for wild-type (blue) and ChAT-Cre (orange) mice. Pearson correlation analyses were performed to assess the relationship between time post-AAV injection and diaphragm EMG DREADD response in wild-type and ChAT-Cre mouse cohorts. r<sup>2</sup>, r, and p-values are shown in each panel for both cohorts. Panels a and c display peak amplitude and AUC, respectively, including all animals. Panels b and d present the same variables with the n = 1 wild-type mouse at the 9-week time point excluded; ChAT-Cre data is unchanged between corresponding panels. Scatter points represent data from individual animals. Polynomial trendlines are displayed for each cohort with wild-type in blue and ChAT-Cre in orange.

      REFERENCES

      (1) Kim, J. Y., Grunke, S. D., Levites, Y., Golde, T. E. & Jankowsky, J. L. Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction. J Vis Exp, 51863 (2014). https://doi.org/10.3791/51863

      (2) Hollidge, B. S. et al. Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectors. Front Neurol 13, 1051559 (2022). https://doi.org/10.3389/fneur.2022.1051559


      The following is the authors’ response to the original reviews.

      Response to reviewer’s public reviews:

      We chose the dose of J60 based on a prior publication that established that off-target effects were possible at relatively high doses[1]. The dose that we used (0.1 mg/kg) was 30-fold less than the dose that was reported in that paper to potentially have off-target responses (3 mg/kg). Further, Author response image 1 shows the results of experiments in which J60 was given to animals that did not have the excitatory DREADD expressed in the spinal cord. This includes a sample of mice (n = 2) and rats (n = 3), recorded from using the same diaphragm EMG procedure described in the manuscript. The figure shows that there was no consistent response to the J60 at 0.1 mg/kg in the “control experiment” in which the DREADD was not expressed in the spinal cord.

      Author response image 1.

      Diaphragm EMG response to J60 administrated to naïve rats and mice. Panel a-b show raw EMG values at baseline, following vehicle (saline) and J60 administration for the left and right hemidiaphragm. Panel c-d shows EMG values normalized to baseline. Neither One-way RM ANOVA (panel a-b) nor paired t-test (panel c-d) returned significant p values (p < 0.05).

      Response to specific reviewer comments:

      Reviewer #1:

      How old were the animals at the time of AAV injection, and in subsequent experiments?

      The wildtype cohort of mice were 7-9 weeks old at time of AAV injection and DREADD experiments took place 4-5 weeks after AAV injection. ChAT-Cre mice were 6-10 weeks old at time of AAV injection and DREADD experiments took place 4-9 weeks after AAV injection. ChAT-Cre rats were 2-5 months old at time of AAV spinal injection. These animals underwent plethysmography recordings 3-4 months post-AAV injection and subsequently phrenic nerve recording 3-8 weeks later. These details have been added to the Method section.

      How many mice were excluded from electrophysiology experiments due to deteriorating electrode contact?

      No mice were excluded from electrophysiology experiments due to deteriorating electrode contact. If you are referring to the n = 1 excluded ChAT-Cre mouse (line 368) this animal was excluded because it showed no histological evidence of DREADD expression (lines 200-206).

      What was the urethane dose?

      The urethane dose for phrenic nerve recordings was 2.1 g/kg. See methods section line 395.

      A graphical timeline of the experimental progression for plethysmography and electrophysiology studies would enhance clarity.

      A graphical timeline has been added. See Figure S6.

      Significance indicators in the figures would greatly enhance clarity. It is a little awkward to have to refer to supplemental tables to figure out statistical differences.

      Significance indicators have been added. See Figures 1, 2, 4, and 5

      In Figures 1, 2, and 5, individual data points should be shown, as in Fig 4.

      Thank you for this suggestion. We agree that, in general, it is best practice to scatter individual data points. However, when we drafted the new figures, it was apparent that including individual scatter points, in this case, created very “cluttered” figures that were very difficult to interpret.

      More detail regarding the plethysmography studies is needed. Was saline/J60 infused via a tail vein catheter? Were animals handled during the infusion? How long is the "IV" period? What volume of fluid was delivered?

      All IV infusions were delivered via a tail vein catheter. Animals were not handled during infusion nor at any point during the recording. An IV catheter was externalized via a port in the plethysmograph allowing for IV infusion without handling of the animal or opening the plethysmograph. The infusion period for both saline and J60 was standardized to 2 minutes. The volume of fluid of both saline and J60 was standardized to 0.6 mL. This information has been added to the methods section (lines 408-410, 415-16, 419-420).

      Reviewer #2:

      The abstract could be improved by briefly highlighting the rationale, scope, and novelty of the study - the intro does a great job of highlighting the scope of the study and the research questions.

      A brief explanation of the rationale, scope, and novelty of the study has been added to the abstract. See lines 2-8.

      Line 18, specifies that this was done under urethane anesthesia.

      This detail has been added to the abstract (line 20).

      The methods section should be moved to the end of the manuscript according to Journal policy.

      The methods section has been moved to the end of the manuscript.

      The authors mention the use of both female and male rats but it is not indicated if they tested for and observed any differences between sexes across experiments.

      We included the use of both male and female animals in this study to improve the generalizability of the results. However, we were not adequately powered for sex comparisons and therefore did not perform any statistical analysis to assess differences between sexes across experiments. Text has been added to the methods section (lines 534-537) to clarify.

      Line 40, since delivery of J60 was performed in both IV and IP, this general statement should be updated.

      This detail has been revised to include both IV and IP. See line 43.

      Line 42. "First, we determined if effective diaphragm activation requires focal DREADD expression targeting phrenic motor neurons, or if non-specific expression in the immediate vicinity of the phrenic motor nucleus would be sufficient...." I don't think that in the experiments with wild-type mice the authors can claim that they selectively targeted the cervical propriospinal network (in isolation from the motoneurons). Given the fact that the histological analysis did not quantify interneurons or motoneurons in the spinal cord, authors should be cautious in proposing which neuronal population is activated in the non-specific approach.

      We agree, and this was a poorly worded statement in our original text. We agree that wild-type DREADD expression was not limited to the cervical propriospinal networks but likely a mix of interneurons and motoneurons. The text has been edited to reflect that (see lines 56-60).

      AAV virus source is not described.

      All AAVs were obtained from the UF Powell Gene Therapy Center. Details of virus source and production have been added to the methods section. See lines 336-347.

      Line 108-125. Because the diaphragm EMG recordings are only described for mice here, I would suggest editing this methods section to clearly state mice instead of vaguely describing "animals" in the procedure.

      “Animals” has been changed to “mice” to avoid ambiguity.

      Line 120, add parenthesis.

      Parenthesis has been added.

      Line 126. Whole body plethysmography protocol. Three hypercapnic hypoxic challenges are a lot for a rat within a 3-hour recording session in freely behaving rats. Did the authors verify with control/ vehicle experiments that repeated challenges in the absence of J60 do not cause potentiation of the response? I understand that it is not possible to invert the order of the injections (due to likely long-term effects of J60) or it is too late to perform vehicle and J60 injections on different days, but controls for repeated challenges should be performed in this type of experiment, especially considering the great variability in the response observed in Figure 4 (in normoxic conditions).

      We did not conduct control experiments to assess the impact of repeated hypercapnic hypoxic challenges on the naïve response (i.e., in the absence of J60). However, our experimental protocol was designed such that each experimental period (i.e., post-vehicle or post-J60 infusion) was normalized to baseline recordings taken immediately prior to the vehicle or J60 infusion. While repeated exposure to hypercapnic hypoxic challenges may have altered respiratory output, we are confident that normalizing each experimental period to its respective baseline effectively captures the impact of DREADD activation on ventilation, independent of any potential potentiation that may have occurred due to gas challenge exposure. We have included raw values for all plethysmography outcomes (see Figure 4, panels a-c) to ensure full data transparency. Still, we believe that the baseline-normalized values more accurately reflect the impact of DREADD activation on the components of ventilation.

      Furthermore, why the response to the hypercapnic hypoxic challenges are not reported? These could be very interesting to determine the effects of DREADD stimulation on chemosensory responses and enhance the significance of the study.

      Response to the hypercapnic hypoxic challenges has been added to the manuscript. See Figure S3 and results section lines 162-167. Briefly, there were no statistically significant (p < 0.05) differences in tidal volume, respiratory rate, or minute ventilation between J60 vs sham condition during hypercapnic-hypoxic ventilatory challenges.

      Line 200 - what is the reason behind performing a qualitative analysis of mCherry in various quadrants? This limits the interpretation of the results. If the authors used Chat-cre rats, the virus should only be in Chat+ MN. Knowing how selective the virus is, and whether its expression was selective for Phrenic MN versus other MN pools, could address several technical questions.

      We agree that detailed quantification of expression by motoneuron pool would be of value in future work.  However, for these initial proof-of-concept experiments, we performed the quadrant-based qualitative analysis of mCherry expression to provide a simple comparison of mCherry expression between groups (i.e., ChAT-Cre vs. wildtype mice). This analysis allowed us to: 1) show the reader that each animal included in the study showed evidence of mCherry expression and 2) give the reader an idea of patterns of mCherry expression throughout the mid-cervical spinal cord. Additionally, it is important to note that while ChAT is a marker of motoneurons some populations of interneurons also express ChAT(2-4).

      Given the increased values of Dia EMG AUC and no changes in respiratory rate, did the authors determine if there was a change in the inspiratory time with J60 administration?

      We did not assess inspiratory time.

      High death rate in DREADD WT mice - was histological analysis performed on these mice? Could it be due to the large volume injected into the spinal cord that affects not only descending pathways but also ascending ones? Or caused by neuronal death due to the large volume of viral solution in injected in mice.

      Histological analysis was performed on these animals to assess mCherry expression only (i.e., no staining for NeuN or other markers was performed). While the reviewer's speculations are reasonable, we feel these reasons are unlikely to explain the death rate in DREADD WT mice as ChAT-Cre mice received the same volume injected into their spine and lived up until and during diaphragm EMG recordings. Additionally, WT mice lived for 4-5 weeks post-injection which would be past the acute phase that a large immune response to the viral dose would have occurred.

      Line 299-304. Can you please clarify whether these rats were tested under anesthesia?

      These rats were assessed under anesthesia. This detail has been added (line 146).

      Given some of the unexpected results on cardiovascular parameters in urethane anesthetized rats, did the authors test the effects of J60 in the absence of AAV construct infection?

      A small cohort (n = 2) of urethane anesthetized naïve wildtype rats were given the J60 ligand (IV, 0.1 mg/kg dose). We did observe a sudden drop in blood pressure after J60 administration that was sustained for the duration of the recording. One animal showed a 12% decrease in mean arterial blood pressure following J60 administration while the other showed a 35% decrease. Thus, it does appear that in this preparation the J60 ligand is producing a drop in arterial blood pressure.

      Line 393. I believe this comment is referred to the intrapleural and diaphragmatic injection. Maybe this should clarified in the sentence.

      This sentence has been revised for clarity (see lines 248-250).

      Figures 1 and 2. It would be informative to show raw traces of the Diaphragm EMG to demonstrate the increase in tonic EMG. It is not possible to determine that from the integrated traces in Figures 1A and B.

      Thank you for bringing up this concern. While the mean data in Figures 1F and 2F do indicate that, on average, animals had tonic diaphragm EMG responses to DREADD activation, the examples given in Figures 1A and 2A show minimal responses. This makes it difficult to fully appreciate the tonic response from those particular traces. However, clear tonic activity can be appreciated from Figures 5A and S2. In these figures, tonic activity is evident from the integrated EMG signals, presenting as a sustained increase in baseline activity between bursts—essentially an upward shift from the zero point.

      References

      (1) Van Savage, J. & Avegno, E. M. High dose administration of DREADD agonist JHU37160 produces increases in anxiety-like behavior in male rats. Behav Brain Res 452, 114553 (2023). https://doi.org/10.1016/j.bbr.2023.114553

      (2) Mesnage, B. et al. Morphological and functional characterization of cholinergic interneurons in the dorsal horn of the mouse spinal cord. J Comp Neurol 519, 3139-3158 (2011). https://doi.org/10.1002/cne.22668

      (3) Gotts, J., Atkinson, L., Yanagawa, Y., Deuchars, J. & Deuchars, S. A. Co-expression of GAD67 and choline acetyltransferase in neurons in the mouse spinal cord: A focus on lamina X. Brain Res 1646, 570-579 (2016). https://doi.org/10.1016/j.brainres.2016.07.001

      (4) Alkaslasi, M. R. et al. Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord. Nat Commun 12, 2471 (2021). https://doi.org/10.1038/s41467-021-22691-2

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this manuscript, Eaton et al. examine the regulation of transcription directionality using a powerful genomic approach (more about the methodology below). Their data challenge the notion that the polyadenylation signal-reading Cleavage and Polyadenylation (CPA) complex is responsible for controlling promoter directionality by terminating antisense transcription. Namely, depletion of the required CPA factor RBBP6 has little effect on antisense transcription measured by POINT. They find instead that initiation is intrinsically preferential in the sense direction and additionally maintained by the activities of an alternative processing complex called Integrator, together with the kinase CDK9. In the presence of CDK9 activity, depletion of Integrator endoribonuclease INTS11 leads to globally increased transcription in the antisense direction, and minor effects in the sense direction. However, CDK9 inhibition reveals that sense transcription is also sensitive to INS11 depletion. The authors suggest that CDK9 activity is stronger in the sense direction, preventing INTS11-mediated premature termination of sense transcrpts.

      Strengths:

      The combination of acute depletion of the studied factors using degron approaches (important to limit possible secondary effects), together with novel and very sensitive nascent transcriptomics methods POINT and sPOINT is very powerful. The applied spike-in normalization means the analysis is more rigorous than most. Using this methodology allowed the authors to revisit the interesting question of how promoter/transcription directionality is determined.

      The data quality appears very good and the fact that both global analysis as well as numerous gene-specific examples are shown makes it convincing.

      The manuscript is well written and hence a pleasure to read.

      We appreciate this positive assessment.

      Weaknesses:

      I am slightly worried about the reproducibility of the data - it is unclear to me from the manuscript if and which experiments were performed in replicate (lack of table with genomic experiments and GEO access, mentioned in more detail in below recommendations to authors), and the methods could be more detailed.

      All sequencing data was deposited with GEO. Multiple biological replicates were performed for each sequencing experiment.  Bigwig files are presented as a table in the GEO submissions. This data has now been made public.

      A separate discussion section would be useful, particularly since the data provided challenge some concepts in the field. How do the authors interpret U1 data from the Dreyfuss lab in light of their results? How about the known PAS-density directionality bias (more PAS present in antisense direction than in sense) - could the differential PAS density be still relevant to transcription directionality?

      As suggested, we have expanded our discussion to relate our findings to existing data. We think the results from the Dreyfuss lab are very important and highlight the role of U1 snRNA in enforcing transcriptional elongation.  It does this in part by shielding PAS sequences.  Recent work from our lab also shows that U1 snRNA opposes the Restrictor complex and PNUTS, which otherwise suppress transcription (Estell et al., Mol Cell 2023).  Most recently, the Adelman lab has demonstrated that U1 snRNA generally enhances transcription elongation (Mimoso and Adelman., Mol Cell 2023).  Our work does not challenge and is not inconsistent with these studies.

      The role of U1 in opposing PAS-dependent termination inspired the idea that antisense transcriptional termination may utilise PASs.  This was because such regions are rich in AAUAAA and comparatively poor in U1 binding sites. However, our RBBP6 depletion and POINT-seq data suggest that PAS-dependent termination is uncommon in the antisense direction. As such, other mechanisms suppress antisense transcription and influence promoter directionality. In our paper, we propose a major role for the Integrator complex.

      We do not completely rule out antisense PAS activity and discuss the prior work that identified polyadenylated antisense transcripts. Nevertheless, this was detected by oligo-dT primed RT-PCR/Northern blotting, which cannot determine the fraction of non-polyadenylated RNA that could result from PAS-independent termination (e.g. by Integrator).  To do that requires an analysis of total nascent transcription as achieved by our POINT-seq.  Based on these experiments, Integrator depletion has a greater impact on antisense transcription than RBBP6 depletion. 

      I find that the provided evidence for promoter directionality to be for the most part due to preferential initiation in the sense direction should be stressed more. This is in my eyes the strongest effect and is somehow brushed under the rug.

      We agree that this is an important finding and incorporated it into the title and abstract.  As the reviewer recommends, we now highlight it further in the new discussion.

      References 12-17 report an effect of Integrator on 5' of protein-coding genes, while data in Figure 2 appears contradictory. Then, experiments in Figure 4 show a global effect of INST11 depletion on promoter-proximal sense transcription. In my opinion, data from the 2.5h time-point of depletion should be shown alongside 1.5h in Figure 2 so that it is clear that the authors found an effect similar to the above references. I find the current presentation somehow misleading.

      We are grateful for this suggestion and present new analyses demonstrating that our experiment in Figure 2 concurs with previous findings (Supplemental Figures 2A and B). Our original heatmap (Figure 2E) shows a very strong and general antisense effect of INTS11 loss. On the same scale, the effects in the sense direction are not as apparent, which is also the case using metaplots.  New supplemental figure 2A now shows sense transcription from this experiment in isolation and on a lower scale, demonstrating that a subset of genes shows promoter-proximal increases in transcription following INTS11 depletion.  This is smaller and less general than the antisense effect but consistent with previous findings.  Indeed, our new analysis in supplemental figure 2B shows that affected protein-coding genes are lowly expressed, in line with Hu et al., Mol Cell 2023. This explains why a sense effect is not as apparent by metaplot, for which highly expressed genes contribute the most signal.

      As a result of our analyses, we are confident that the apparently larger effect at the 2.5hr timepoint (Figure 4) that we initially reported is due to experimental variability and not greater effects of extended INTS11 depletion. Overlaying the 1.5h and 2.5h datasets (Supplemental Figure 4B) revealed a similar number of affected protein-coding genes with a strong (83%) overlap between the affected genes.  To support this, we performed qPCR on four affected protein-coding transcripts which revealed no significant difference in the level of INTS11 effect after 2.5h vs 1.5h (Supplemental Figure 4C).

      We now present data for merged replicates in Figures 2 and 4 which reveal very similar average profiles for -INTS11 vs +INTS11 at both timepoints. Overall, we believe that we have resolved this discrepancy by showing that it amounts to experimental variability and because the most acutely affected protein-coding genes are lowly expressed. As detailed above, we show this in multiple ways (and validate by qPCR) We have revised the text accordingly and removed our original speculation that differences reflected the timeframe of INTS11 loss.

      Conclusion/assessment:

      This important work substantially advances our understanding of the mechanisms governing the directionality of human promoters. The evidence supporting the claims of the authors is compelling, with among others the use of advanced nascent transcriptomics including spike-in normalization controls and acute protein depletion using degron approaches.

      In my opinion, the authors' conclusions are in general well supported.

      Not only the manuscript but also the data generated will be useful to the wide community of researchers studying transcriptional regulation. Also, the POINT-derived novel sPOINT method described here is very valuable and can positively impact work in the field.

      We are grateful for the reviewers' positive assessment of our study.

      Reviewer #2 (Public Review):

      Summary:

      Eaton and colleagues use targeted protein degradation coupled with nascent transcription mapping to highlight a role for the integrator component INST11 in terminating antisense transcription. They find that upon inhibition of CDK9, INST11 can terminate both antisense and sense transcription - leading to a model whereby INST11 can terminate antisense transcription and the activity of CDK9 protects sense transcription from INST11-mediated termination. They further develop a new method called sPOINT which selectively amplifies nascent 5' capped RNAs and find that transcription initiation is more efficient in the sense direction than in the antisense direction. This is an excellent paper that uses elegant experimental design and innovative technologies to uncover a novel regulatory step in the control of transcriptional directionality.

      Strengths:

      One of the major strengths of this work is that the authors endogenously tag two of their proteins of interest - RBBP6 and INST11. This tag allows them to rapidly degrade these proteins - increasing the likelihood that any effects they see are primary effects of protein depletion rather than secondary effects. Another strength of this work is that the authors immunoprecipitate RNAPII and sequence extracted full-length RNA (POINT-seq) allowing them to map nascent transcription. A technical advance from this work is the development of sPOINT which allows the selective amplification of 5' capped RNAs < 150 nucleotides, allowing the direction of transcription initiation to be resolved.

      We appreciate this positive assessment.

      Weaknesses:

      While the authors provide strong evidence that INST11 and CDK9 play important roles in determining promoter directionality, their data suggests that when INST11 is degraded and CDK9 is inhibited there remains a bias in favour of sense transcription (Figures 4B and C). This suggests that there are other unknown factors that promote sense transcription over antisense transcription and future work could look to identify these.

      We agree that other (so far, unknown) factors promote sense transcription over antisense, which was demonstrated by our short POINT.  We have provided an expanded discussion on this in the revision. In our opinion, demonstrating that sense transcription is driven by preferential initiation in that direction is a key finding and we agree that the identification of the underlying mechanism constitutes an interesting avenue for future study.

      Reviewer #3 (Public Review):

      Summary:

      Using a protein degradation approach, Eaton et al show that INST11 can terminate the sense and anti-sense transcription but higher activity of CDK9 in the sense direction protects it from INS11-dependent termination. They developed sPOINT-seq that detects nascent 5'-capped RNA. The technique allowed them to reveal robust transcription initiation of sense-RNA as compared to anti-sense.

      Strengths:

      The strength of the paper is the acute degradation of proteins, eliminating the off-target effects. Further, the paper uses elegant approaches such as POINT and sPOINT-seq to measure nascent RNA and 5'-capped short RNA. Together, the combination of these three allowed the authors to make clean interpretations of data.

      We appreciate this positive assessment.

      Weaknesses:

      While the manuscript is well written, the details on the panel are not sufficient. The methods could be elaborated to aid understanding. Additional discussion on how the authors' findings contradict the existing model of anti-sense transcription termination should be added.

      We have added more detail to the figure panels, which we hope will help readers to navigate the paper more easily. Specifically, the assay employed for each experiment is indicated in each figure panel. As requested, we provide a new and separate discussion section in the revision.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Congratulations on this important piece of work!

      Some specific suggestions.

      MAJOR

      -The data are not available (Accession "GSE243266" is currently private and is scheduled to be released on Sep 01, 2026.) This should be corrected and as a minimum, the raw sequencing files as well as the spike-in scaled bigwig files should be provided in GEO.

      We have made the data public. Raw and bigwig files are provided as part of the GEO upload.

      MINOR

      - It would be useful for readers if you could include catalog numbers of the reagents used in the study.

      We have included this information in our revision.

      - A table in experimental procedures summarizing the genomic experiments performed in this study as well as published ones reanalyzed here would be helpful.

      This is now provided as part of the resources table.

      - It would be easier for reviewers to evaluate the manuscript if the figure legends were included together with the figures on one page. This is now allowed by most journals.

      We have used this formatting in the revision.

      - Providing some captions for the results sections would be helpful.

      We have included subheadings as suggested.

      Reviewer #2 (Recommendations For The Authors):

      Generally, I would suggest writing the experiment-type above panels where it is not immediately obvious what they are so a reader can appreciate the figures without referencing the legend. E.g. write POINT-seq on Figure 1B just to make it obvious to someone looking at the figures what methodology they are looking at. Likewise, you could write RNAPII ChIP-seq for Supplementary Figures 3D and 3E.

      We have carried out this recommendation.

      Can a y-axis be indicated on POINT-seq genome browser tracks? This could make them easier to interpret.

      Y-axis scales are provided as RPKM as stated in the figure legends.

      The authors could address/speculate in the text why there is less POINT-seq signal for the antisense transcript in the treatment condition in Figure 1B? Or could consider including a different example locus where this is not the case for clarity.

      Acute depletion of poly(A) factors (like RBBP6) results in a strong read-through beyond the poly(A) signal of protein-coding genes as Figure 1 shows.  However, it also causes a reduction in transcription levels, which can be seen in the figure and is correctly noted by the reviewer in this comment.  We see this with other poly(A) factor depletions (e.g. CPSF73 and CPSF30 – Eaton et al., 2020 and Estell et al., 2021) and other labs have observed this too (e.g for CPSF73-dTAG depletion (Cugusi et al., Mol Cell 2022)).  Plausible reasons include a limited pool of free RNAPII due to impaired transcriptional termination or limited nucleotide availability due to their incorporation within long read-through transcripts. For these reasons, we have retained the example in Figure 1B as a typical representation of the effect. Moreover, the heatmap in Figure 1D fairly represents the spectrum of effects following RBBP6 loss – highlighting the strong read-through beyond poly(A) signals and the marginal antisense effects.

      "The established effect of INTS11 at snRNAs was detected in our POINT-seq data and demonstrates the efficacy of this approach (Figure 2B)." The authors could explain this point more clearly in the text and describe the data - e.g. As expected, depletion of INTS11 leads to increased POINT-seq signal at the 3' end of snRNAs, consistent with defects in transcriptional termination. This is highlighted by the RNU5A-1 and RNU5B-1 loci (Figure 2B).

      We agree and have added more context to clarify this.

      I would suggest adjusting the scale of the heatmap in Figure 2E - I think it would be easier to interpret if the value of 0 was white - with >0 a gradient of orange and <0 a gradient of blue (as is done in Figure 1C). I think making this change would make the point as written in the text clearer i.e. "heatmap analysis demonstrates the dominant impact of INTS11 on antisense versus sense transcription at most promoters (Figure 2E)." I'm assuming most of the sense transcription would be white (more clearly unchanging) when the scale is adjusted.

      We agree and have done this. The reviewer is correct that most sense transcription is unchanged by INTS11 loss.  However, as we alluded to in the original submission, a subset of transcripts shows a promoter-proximal increase after INTS11 depletion. We have expanded the analyses of this effect (see responses to other comments) but stress that it is neither as general nor as large as the antisense effect.

      The authors make the point that there is mildly increased transcription over the 5' end of some genes upon INST11 depletion and show a track (Supplementary Fig 2A). It is not immediately obvious from the presentation of the meta-analysis in Figure 2D how generalisable this statement is. Perhaps the size of the panel or thickness of the lines in Figure 2D could be adjusted so that the peak of the control (in blue) could be seen. Perhaps an arrow indicating the peak could be added? I'm assuming the peak at the TSS is slightly lower in the control compared to INST11 depletion based on the authors' statement.

      We have provided multiple new analyses of this data to highlight where there are promoter-proximal effects of INTS11 loss in the sense direction.  Please see our response to the public review of reviewer 1 and new supplemental figures 2A, 2B, 4A and 4B which highlight the sense transcription increased in the absence of INTS11.

      The authors label Figure 4 "Promoters lose their directionality when CDK9 is inhibited" - but in INST11 depleted cells treated with CDK9i they find that there still is a bias towards sense transcription. Suggested edit "Some promoter directionality is lost when CDK9 is inhibited" or similar.

      We agree and have made this change.

      The authors conclude that INTS11-mediated effects are the result of perturbation of the catalytic activities of Integrator, the authors should perform rescue experiments with the catalytically dead E203Q-INTS11 mutant.

      This is a very good suggestion and something we had intended to pursue.  However, as we will describe below (and shown in Supplemental Figure 4G), there were confounding issues with this experiment.

      The E203Q mutant of INTS11 is widely used in the literature to test for catalytic functions of INTS11.  However, we have found that this mutation impairs the ability of INTS11 to bind other Integrator modules in cells. Based on co-immunoprecipitation of flag-tagged WT and E203Q derivatives, INTS1 (backbone module), 10 (tail module), and 8 (phosphatase module) all show reduced binding to E203Q vs. WT. Because E203Q INTS11 is defective in forming Integrator complexes, rescue experiments might not fully distinguish the effects of INTS11 activity from those caused by defects in complex assembly. While this may at first seem unexpected, in the analogous 3’ end processing complex, catalytic mutants of CPSF73 (which is highly related to INTS11) negatively affect its interaction with other complex members (Kolev and Steitz, EMBO Reports 2005).

      We hypothesise that INTS11 activity is most likely involved in attenuating promoter-proximal transcription, but we cannot formally rule out other explanations and discuss this in our revision. Regardless of how INTS11 attenuates transcription, our main conclusion is on its requirement to terminate antisense transcription whether this involves its cleavage activity or not.

      The authors suggest that CDK9 modulates INTS11 activity/assembly and suggest this may be related to SPT5. Is there an effect of CDK9 inhibition on the snRNA's highlighted in Figure 2B?

      We believe that snRNAs are different from protein-coding genes concerning CDK9 function. Shona Murphy’s lab previously showed that, unlike protein-coding genes, snRNA transcription is insensitive to CDK9 inhibition, and that snRNA processing is impaired by CDK9 inhibition (Medlin et al., EMBO 2003 and EMBO 2005).  We reproduce these findings by metaanalysis of 15 highly expressed and well-separated snRNAs and by qRT-PCR of unprocessed RNU1-1, RNU5A-1 and RNU7-1 snRNA following CDK9 inhibition. We observe snRNA read-through by POINT-seq following INTS11 loss whether CDK9 is inhibited or not (left panel, below). Note the higher TES proximal signal in CDK9i conditions, which likely reflects the accumulation of unprocessed snRNA as validated by qPCR for three example snRNAs (right panel, below).

      Author response image 1.

      For Figure 4, would similar results be observed using inhibitors targeting other transcriptional CDKs such as CDK7,12/13?

      In response to this suggestion, we analysed four selected protein-coding transcripts (the same 4 that we used to validate the CDK9i results) by qRT-PCR in a background of CDK7 inhibition using the THZ2 compound (new Supplemental Figure 4E).  THZ2 suppresses transcription from these genes as expected.  Interestingly, expression is restored by co-depleting Integrator, recapitulating our findings with CDK9 inhibition.  As CDK7 is the CDK-activating kinase for CDK9, its inhibition will also inhibit CDK9 so THZ2 may simply hit this pathway upstream of where CDK9 inhibitors.  Second, CDK7 may independently shield transcription from INTS11.  We allude to both interesting possibilities.

      What happens to the phosphorylation state of anti-sense engaged RNAPII when INTS11 is acutely depleted and/or CDK9 is inhibited? This could be measured by including Ser5 and Ser2 antibodies in the sPOINT-seq assay and complemented with Western Blot analysis.

      We have performed the western blot for Ser5 and Ser2 phosphorylation as suggested.  Both signals are mildly enhanced by INTS11 loss, which is consistent with generally increased transcription.  Ser2p is strongly reduced by CDK9 inhibition, which is consistent with the loss of nascent transcription in this condition.  Interestingly, both modifications are partly recovered when INTS11 is depleted in conjunction with CDK9 inhibition. This is consistent with the effects that we see on POINT-seq and shows that the recovered transcription is associated with some phosphorylation of RNAPII CTD.  This presumably reflects the action(s) of kinases that can act redundantly with CDK9.

      We have not performed POINT-seq with Ser5p and Ser2p antibodies under these various conditions.  Our rationale is that our existing data uses an antibody that captures all RNAPII (regardless of its phosphorylation status), which we feel most comprehensively assays transcription in either direction. Moreover, the lab of Fei Chen (Hu et al., Mol Cell 2023) recently published Ser5p and Ser2p ChIP-seq following INTS11 loss. By ChIP-seq, they observe a bigger increase in antisense RNAPII occupancy vs. sense providing independent and orthogonal support for our POINT-seq data.  Interestingly, this antisense increase is not paralleled by proportional increases in Ser5p or Ser2p signals.  This suggests that the unattenuated antisense transcription resulting from INTS11 loss does not have high Ser5p or Ser2p.  Since CDK7 and 9 are major Ser5 and 2 kinases, this supports our model that their activity is less prevalent for antisense transcription.  We now discuss these data in our revision.   

      The HIV reporter RNA experiments should be performed with the CDK9 inhibitor added to the experimental conditions. Presumably CDK9 inhibition would result in no upregulation of the reporter upon addition of TAT and/or dTAG. Perhaps the amount of TAT should be reduced to still have a dynamic window in which changes can be detected. It is possible that reporter activation is simply at a maximum. Can anti-sense transcription be measured from the reporter?

      We have performed the requested CDK9 inhibitor experiment to confirm that TAT-activated transcription from the HIV promoter is CDK9-dependent (new supplemental figure 4F).  Consistent with previous literature on HIV transcription, CDK9 inhibition attenuates TAT-activated transcription.  Importantly, and in line with our other experiments, depletion of INTS11 results in significant restoration of transcription from the HIV promoter when CDK9 is inhibited. Thus, TAT-activated transcription is CDK9-dependent and, as for endogenous genes, CDK9 prevents attenuation by INTS11.

      While TAT-activated transcription is high, we do not think that the plasmid is saturated. When considering this question, we revisited previous experiments using this system to study RNA processing (Dye et al., Mol Cell 1999, Cell 2001, Mol Cell 2006). In these cases, mutations in splice sites or polyadenylation sites have a strong effect on RNA processing and transcription around HIV reporter plasmids. Effects on transcription and RNA processing are; therefore, apparent in the appropriate context. In contrast, we find that the complete elimination of INTS11 has no impact on RNA output from the HIV reporter. Our original experiment assessing the impact of INTS11 loss in +TAT conditions used total RNA.  One possibility is that this allows non-nascent RNA to accumulate which might confound our interpretation of INTS11 effects on ongoing transcription.  However, the new experiment described in the paragraph above was performed on chromatin-associated (nascent) RNA to rule this out.  This again shows no impact of INTS11 loss on HIV promoter-derived transcription in the presence of TAT.

      To our knowledge, antisense transcription is not routinely assayed from plasmids. They generally employ very strong promoters (e.g. CMV, HIV) to drive sense transcription.  Crucially, their circular nature means that RNAPII going around the plasmid could interfere with antisense transcription coming the other way which does not happen in a linear genomic context. This is why we restricted our use of plasmids to looking at the effects of stimulated CDK9 recruitment (via TAT) on transcription rather than promoter directionality.   

      The authors should clearly state how many replicates were performed for the genomics experiments. Ideally, a signal should be quantified and compared statistically rather than relying on average profiles only.

      We have stated the replicate numbers for sequencing experiments in the relevant figure legends. All sequencing experiments were performed in at least two biological replicates, but often three. In addition, we validated their key conclusions by qPCR or with orthogonal sequencing approaches.

      Reviewer #3 (Recommendations For The Authors):

      The authors provide strong evidence in support of their claims.

      ChIP-seq of pol2S5 and S2 upon INST11 and CDK9 inhibition will strengthen the observation that transcription in the sense direction is more efficient.

      We view the analysis of total RNAPII as the most unbiased way of establishing how much RNAPII is going one way or the other. Importantly, ChIP-seq was very recently performed for Ser2p and Ser5p RNAPII derivatives in the lab of Fei Chen (Hu et al., Mol Cell 2023). Their data shows that loss of INTS11 increases the occupancy of total RNAPII in the antisense direction more than in the sense direction, which is consistent with our finding. Interestingly, the increased antisense RNAPII was not paralleled with an increase in Ser2p or Ser5p. This suggests that, following INTS11 loss, the unattenuated antisense transcription is not associated with full/normal Ser2p or Ser5p. These modifications are normally established by CDK7 and 9; therefore, this published ChIP-seq suggests that they are not fully active on antisense transcription when INTS11 is lost. This supports our overall model that CDK9 (and potentially CDK7 as suggested for a small number of genes in new Supplemental Figure 4E) is more active in the sense direction to prevent INTS11-dependent attenuation. We now discuss these data in our revision.

      In Supplementary Figure 2, the eRNA expression increases upon INST11 degradation, I wonder if the effects of this will be appreciated on cognate promoters? Can the authors test some enhancer:promoter pairs?

      We noticed that some genes (e.g. MYC) that are regulated by enhancers show reduced transcription in the absence of INTS11. Whilst this could suggest a correlation, the transcription of other genes (e.g. ACTB and GAPDH) is also reduced by INTS11 loss although they are not regulated by enhancers.  A detailed and extensive analysis would be required to establish any link between INTS11-regulated enhancer transcription and the transcription of genes from their cognate promoters.  We agree that this would be interesting, but it seems beyond the scope of our short report on promoter directionality.

      Line 111, meta plot was done of 1316 genes. Details on this number should be provided. Overall, the details of methods and analysis need improvement. The layout of panels and labelling on graphs can be improved.

      We have now explained the 1316 gene set.  In essence, these are the genes separated from an expressed neighbour by at least 10kb.  This distance was selected because depletion of RBBP6 induces extensive read-through transcription beyond the polyadenylation site of protein-coding genes.  To avoid including genes affected by transcriptional read-through from nearby transcription units we selected those with a 10kb gap between them. This was the only selection criteria so is unlikely to induce any unintended biases. Finally, we have added more information to the figure panels and their legends, which we hope will make our manuscript more accessible.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary of the work: In this work, Fruchard et. al. study the enzyme Tgt and how it modifies guanine in tRNAs to queuosine (Q), essential for Vibrio cholerae's growth under aminoglycoside stress. Q's role in codon decoding efficiency and its proteomic effects during antibiotic exposure is examined, revealing Q modification impacts tyrosine codon decoding and influences RsxA translation, affecting the SoxR oxidative stress response. The research proposes Q modification's regulation under environmental cues reprograms the translation of genes with tyrosine codon bias, including DNA repair factors, crucial for bacterial antibiotic response.

      The experiments are well-designed and conducted and the conclusions, for the most part, are well supported by the data. However, a few clarifications will significantly strengthen the manuscript.

      Thank you.

      Major:

      Figure S4 A-D. These growth curves are important data and should be presented in the main figures. Moreover, given that it is not possible to make a rsxA mutant, I wonder if it would be possible to connect rsx and tgt using the following experiment: expression of tgt results in resistance to TOB (in B), while expression of only rsx lower resistance to TOB (in D). Then simultaneous overexpression of both tgt/rsx in the WT strain should have either no effect on TOB resistance or increased resistance, relative to the WT. Perhaps the authors have done this, and if so, the data should be included as it will significantly strengthen their model.

      We thank the reviewer for this suggestion, we have tried to overexpress both tgt and rsxA simultaneously. However, this appears to be toxic as cells form small colonies and cannot grow well in liquid. We think that the presence of 2 plasmids and corresponding selection antibiotics amplify the toxicity of overexpressing rsxA, and even tgt. In fact, it can be seen that tgt overexpression in WT is already slightly deleterious, in the absence of tobramycin (figure 1B).

      Figure S4 - Is there a rationale for why it is possible to make rsx mutants in E. coli, but not in V. cholerae? For example, does E. coli have a second gene/protein that is redundant in function to rsxA, while V. cholerae does not? I think your data hint at this, since in the right panel growth data, your double mutant does not fully rescue back to rsx single mutant levels, suggesting another factor in tgt mutant also acts to lower resistance to TOB. If so, perhaps a line or two in text will be helpful for readers.

      This point raised by the referee is an interesting one that we have also asked ourselves at multiple occasions. In fact, the Rsx operon is linked with oxidative stress and respiration. Vibrio cholerae and E. coli show differences on genes involved in these pathways. V. cholerae lacks the cyo/nuo respiratory complex genes, and does not encode a Suf operon. Moreover, deletion of the anaerobic respiration Frd pathway leads to strong decrease of V. cholerae growth even in aerobic conditions. (10.1128/spectrum.01730-23). We have previously also generally seen differences between the 2 species in response to stress (10.1128/AAC.01549-10) and the way they deal with ROS (10.1371/journal.pgen.1003421). Therefore, we think that the fact that rsx is essential in V. cholerae and not E. coli could either be due to the presence of an additional redundant pathway in E. coli as suggested by the referee, or to more general differences in respiration and treatment of ROS. We thank the referee for highlighting this and we have now included a comment about this in the manuscript.

      - For growth curves in Figure 2 and relative comparisons like in Figure 5D and Figure S4 (and others in the paper), statistics and error bars, along with replicate information should be provided.

      We had mentioned this in the methods section, we have now added the specific information also on figure legends.

      - Figure 6A - Is the transcript fold change in linear or log? If linear, then tgt expression should not be classified as being upregulated in TOB. It is barely up by ~2-fold with TOB- 0.6....which is a mild phenotype, at best.

      We think that 2-fold change of tgt expression can be sufficient to lead to changes in tRNA modification levels. We agree that this is a mild induction, we have thus changed “increase” to “mildly increase” in the results.  

      - Line 779- 780: "This indicates that sub-MIC TOB possibly induces tgt expression through the stringent response activation." To me, the data presented in this figure, do not support this statement. The experiment is indirect.

      We agree, we rephrased: “Tobramycin may induces tgt expression through stringent response activation or through an independent pathway. “

      - Figure 3B and D. - These samples only have tobramycin, correct? The legend says both carbenicillin and tobramycin.

      The legend is correct, samples also have carbenicillin because we are testing here the growth with 2 synonymous beta-lactamase genes in presence of beta-lactams.

      - Figure 5. The color schemes in bars do not match up with the color scheme in cartoons below panels B and C. That makes it confusing to read. Please fix.

      Fixed.

      - A lot of abbreviations have been used. This makes reading a bit cumbersome. Ideally, less abbreviations will be used.

      Fixed

      Reviewer #2 (Public Review):

      Fruchard et al. investigate the role of the queuosine (Q) modification of the tRNA (Q-tRNA) in the human pathogen Vibrio cholerae. First, the authors state that the absence of Q-modified tRNAs (tgt mutant) increases the translation of TAT codons and proteins with a high TAT codon bias. Second, the absence of Q increases rsxA translation, because rsxA gene has a high TAT codon bias. Third, increased RsxA in the absence of Q inhibits SoxR response, reducing resistance towards the antibiotic tobramycin (TOB). Authors also predict in silico which genes harbor a higher TAT bias and found that among them are some involved in DNA repair, experimentally observing that a tgt mutant is more resistant to UV than the wt strain. It is worth noting that authors employ a wide variety of techniques, both experimental and bioinformatic. However, some aspects of the work need to be clarified or reevaluated.

      (1) The statement that the absence of Q increases the translation of TAT codons and proteins encoded by TAT-enriched genes presents the following problems that should be addressed:

      (1.1) The increase in TAT codon translation in the absence of Q is not supported by proteomics, since there was no detected statistical difference for TAT codon usage in proteins differentially expressed. Furthermore, there are some problems regarding the statistics of proteomics. Some proteins shown in Table S1 have adjusted p-values higher than their pvalues, which makes no sense. Maybe there is a mistake in the adjusted p-value calculation.

      We appreciate the reviewer’s thorough examination of our findings. In our study, we employed an adaptive Benjamini-Hochberg (BH) procedure to control the false discovery rate in our list of selected proteins, as explained in the Data Analysis part of the Proteomics MS and analysis part of our material and methods. The classical BH procedure (10.1111/j.2517-6161.1995.tb02031.x) calculates the 𝑚×𝑝(𝑗) adjusted p-value for the i-th ranked p-value as min where 𝑝(𝑗) is the j-th ranked pvalue and 𝑚 is the number of tests (e.g. number of proteins) (see 10.1021/acs.jproteome.7b00170 for details). Since m/j > 1 and 𝑝(𝑗) > 𝑝(𝑖) for 𝑗≥𝑚, it follows that for 𝑗≥i, resulting in adjusted p-values being higher or equal than the original p-values. Therefore, contrary to the reviewer's comment, it is a mathematical property that the adjusted p-value is greater than the original p-value when using the classical Benjamini-Hochberg procedure. 

      However, we want to underline that we used an « adaptive » BH procedure, which calculates the adjusted p-value for the i-th ranked p-value as min , where 𝜋0 is an estimate of the proportion of true null hypotheses (see 10.1021/acs.jproteome.7b00170 for details). Indeed, the classical BH procedure makes the assumption that 𝜋0 \= 1, which is a strong assumption in MS-based proteomics context.  Consequently, the mathematical property that the adjusted p-value is greater than the original p-value does not always hold true in our approach (that depends also on the 𝜋0 parameter).

      In addition, it is not common to assume that proteins that are quantitatively present in one condition and absent in another are differentially abundant proteins. Proteomics data software typically addresses this issue and applies some corrections. It would be advisable to review that.

      We thank the reviewer for highlighting this point. Indeed, some software impute a random small value to replace missing values and then produces statistics based on this imputed data (10.1038/nmeth.3901). However, the validity and relevance of generating statistics in the absence of actual data is questionable. 

      There are no universally accepted guidelines for handling this situation, and we believe it is more logical to set these values aside as potential interesting proteins. It is well-established that intensity values are often missing due to the detection limits of the spectrometer, suggesting that the missing values observed in several replicates of a condition are actually due to low values (see 10.1093/bioinformatics/btp362 and 10.1093/bioinformatics/bts193 for instance). It is thus logical to consider the associated proteins as potentially differentially abundant when comparing their complete absence in all replicates of one condition to their presence in several replicates of another condition.

      (1.2) Problems with the interpretation of Ribo-seq data (Figure 4D). On the one hand, the Ribo-seq data should be corrected (normalized) with the RNA-seq data in each of the conditions to obtain ribosome profiling data, since some genes could have more transcription in some of the conditions studied. In other articles in which this technique is used (such as in Tuorto et al., EMBO J. 2018; doi: 10.15252/embj.201899777), it is interpreted that those positions in which the ribosome moves most slowly and therefore less efficiently translated), are the most abundant. Assuming this interpretation, according to the hypothesis proposed in this work, the fragments enriched in TAT codons should have been less abundant in the absence of Q-tRNA (tgt mutant) in the Rib-seq experiment. However, what is observed is that TAT-enriched fragments are more abundant in the tgt mutant, and yet the Ribo-seq results are interpreted as RNA-seq, stating that this is because the genes corresponding to those sequences have greater expression in the absence of Q. 

      As recommended by the reviewer, we normalized the RiboSeq data with the RNAseq data to account for potential RNA variations. The updated Figure 4 demonstrates that this normalization does not alter our findings, confirming that variations at the RNAseq level do not contradict changes at the translational level. 

      The reviewer's observation that pauses at TAT codons would lead to ribosome accumulation and subsequent categorization as "up" genes is accurate. We must emphasize, however, that this category of “up genes” is probably quite diverse. The effect of ribosome stalling at TAT codons on total mRNA ribosome occupancy is likely highly variable, depending on the location of the TAT codon(s) within the CDS and the gene's expression level. We therefore think that genes in the "Up" category mainly correspond to genes that are more translated because the impact of pausing at TAT codons is probably not strong enough. Note that unlike what is usually done in bacterial riboseq experiments, we did not use any antibiotics to artificially freeze the ribosomes.

      On the other hand, it would be interesting to calculate the mean of the protein levels encoded by the transcripts with high and low ribosome profiling data.

      While this is a common request, we believe that comparing RiboSeq and proteomics data is not particularly informative. RiboSeq data directly measures translation, while proteomics provides information about protein abundance at steady state, reflecting the balance between protein synthesis and degradation. Furthermore, the number of proteins detectable by mass spectrometry is significantly smaller than the number of genes quantified by RiboSeq. Given these factors, there is often a low correlation between translation and protein abundance, making a direct comparison less relevant 

      (1.3) This statement is contrary to most previously reported studies on this topic in eukaryotes and bacteria, in which ribosome profiling experiments, among others, indicate that translation of TAT codons is slower (or unaffected) than translation of the TAC codons, and the same phenomenon is observed for the rest of the NAC/T codons. This is completely opposed to the results showed in Figure 4. However, the results of these studies are either not mentioned or not discussed in this work. Some examples of articles that should be discussed in this work:

      - "Queuosine-modified tRNAs confer nutritional control of protein translation" (Tuorto et al., 2018; 10.15252/embj.201899777)

      - "Preferential import of queuosine-modified tRNAs into Trypanosoma brucei mitochondrion is critical for organellar protein synthesis" (Kulkarni et al., 2021; doi:10.1093/nar/gkab567.

      - "Queuosine-tRNA promotes sex-dependent learning and memory formation by maintaining codonbiased translation elongation speed" (Cirzi et al., 2023; 10.15252/embj.2022112507)

      - "Glycosylated queuosines in tRNAs optimize translational rate and post-embryonic growth" (Zhao et al., 2023; 10.1016/j.cell.2023.10.026)

      - "tRNA queuosine modification is involved in biofilm formation and virulence in bacteria" (Diaz-Rullo and Gonzalez-Pastor, 2023; doi: 10.1093/nar/gkad667). In this work, the authors indicate that QtRNA increases NAT codon translation in most bacterial species. Could the regulation of TAT codonenriched proteins by Q-tRNAs in V. cholerae an exception? In addition, authors use a bioinformatic method to identify genes enriched in NAT codons similar to the one used in this work, and to find in which biological process are involved the genes whose expression is affected by Q-tRNAs (as discussed for the phenotype of UV resistance). It will be worth discussing all of this.

      Thank you for detailed suggestions, we agree that this discussion was missing and this comment gives us a chance to address that in the revised version of the manuscript.

      About the references above suggested by the referee, 4 of these papers were not mentioned in our manuscript, these were published while our manuscript was previously in review and we realize we have not cited them in the latest version of our manuscript. We thank the referee for highlighting this. We have now included a discussion about this. 

      We included the following in the discussion:

      “However, the opposite codon preference was shown in E. coli {Diaz-Rullo, 2023 #1888}. In eukaryotes also, several recent studies indicate slower translation of U-ending codons in the absence of Q34 {Cirzi, 2023 #1887;Kulkarni, 2021 #1886;Tuorto, 2018 #1268}. It’s important to note here, that in V. cholerae ∆tgt, increased decoding of U-ending codons is observed only with tyrosine, and not with the other three NAC/U codons (Histidine, Aspartate, Asparagine). This is interesting because it suggests that what we observe with tyrosine may not adhere to a general rule about the decoding efficiency of U- or C-ending codons, but instead seems to be specific to Tyr tRNAs, at least in the context of V. cholerae. Exceptions may also exist in other organisms. For example, in human cells, queuosine increases efficiency of decoding for U- ending codons and slows decoding of C- ending codons except for AAC {Zhao, 2023 #1889}. In this case, the exception is for tRNA Asparagine. Moreover, in mammalian cells {Tuorto, 2018 #1268}, ribosome pausing at U-ending codons is strongly seen for Asp, His and Asn, but less with Tyr. In Trypanosoma {Kulkarni, 2021 #1886}, reporters with a combination of the 4 NAC/NAU codons for Asp, Asn, Tyr, His have been tested, showing slow translation at U- ending version of the reporter in the absence of Q, but the effect on individual codons (e.g. Tyr only) is not tested. In mice {Cirzi, 2023 #1887}, ribosome slowdown is seen for the Asn, Asp, His U-ending codons but not for the Tyr U-ending codon. In summary, Q generally increases efficiency of U- ending codons in multiple organisms, but there appears to be additional unknown parameters which affect tyrosine UAU decoding, at least in V. cholerae. Additional factors such as mRNA secondary structures or mistranslation may also contribute to the better translation of UAU versions of tested genes. Mistranslation could be an important factor. If codon decoding fidelity impacts decoding speed, then mistranslation could also contribute to decoding efficiency of Tyr UAU/UAC codons and proteome composition.”

      (1.4) It is proposed that the stress produced by the TOB antibiotic causes greater translation of genes enriched in TAT codons. 

      Actually, it’s the opposite because in presence of TOB, in the wt, tgt would be induced leading to more Q on tRNA-Tyr and less translation of TAT.

      On the one hand, it is shown that the GFP-TAT version (gene enriched in TAT codons) and the RsxATAT-GFP protein (native gene naturally enriched in TAT) are expressed more, compared to their versions enriched in TAC in a tgt mutant than in a wt, in the presence of TBO (Fig. 5C). 

      Figure 5C shows relative fluorescence, ie changes of fluorescence in delta-tgt compared to WT. So it’s not necessarily more expressed but “more increased”

      However, in the absence of TOB, and in a wt context, although the two versions of GFP have a similar expression level (Fig. 3SD), the same does not occur with RsxA, whose RsxA-TAT form (the native one) is expressed significantly more than the RsxA-TAC version (Fig. 3SA). How can it be explained that in a wt context, in which there are also tRNA Q-modification, a gene naturally enriched in TAT is translated better than the same gene enriched in TAC?

      We thank the referee for this question based on careful assessment of our data. We agree, there appears to be significantly more RsxA-TAT in WT than RsxA-TAC. This could be due to other effects such as secondary structure formation on mRNA when the wt RsxA is recoded with TAC codons. This does not hinder the conclusion that the translation of the TAT version is increased in delta-tgt compared to WT.  

      It would be expected that in the presence of Q-tRNAs the two versions would be translated equally (as happens with GFP) or even the TAT version would be less translated. On the other hand, in the presence of TOB the fluorescence of WT GFP(TAT) is higher than the fluorescence of WT GFP(TAC) (Figure S3E) (mean fluorescence data for RsxA-GFP version in the presence of TOB is not shown). These results may indicate that the apparent better translation of TAT versions could be due to indirect effects rather from TAT codon translation.

      This is now mentioned in the manuscript

      “We cannot exclude, however, that additional factors such as mRNA secondary structures also contributes to the better translation of UAU versions of tested genes. “

      (2) Another problem is related to the already known role of Q in prevention of stop codon readthrough, which is not discuss at all in the work. In the absence of Q, stop codon readthrough is increased. In addition, it is known that aminoglycosides (such as tobramycin) also increase stop codon readthrough ("Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides"; Wanger and Green, 2023; 10.7554/eLife.52611). Absence of Q and presence of aminoglycosides can be synergic, producing devastating increases in stop codon readthrough and a large alteration of global gene expression. All of these needs to be discussed in the work. Moreover, it is known that stop codon readthrough can alter gene expression and mRNA sequence context all influence the likelihood of stop codon readthrough. Thus, this process could also affect to the expression of recoded GFP and RsxA versions.

      We included the following in the revised version of the manuscript (results):

      “Q modification impacts decoding fidelity in V. cholerae.

      To test whether a defect in Q34 modification influences the fidelity of translation in the presence and absence of tobramycin, previously developed reporter tools were used (Fabret & Namy, 2021), to measure stop codons readthrough in V. cholerae ∆tgt and wild-type strains. The system consists of vectors containing readthrough promoting signals inserted between the lacZ and luc sequences, encoding β-galactosidase and luciferase, respectively. Luciferase activity reflects the readthrough efficiency, while β-galactosidase activity serves as an internal control of expression level, integrating a number of possible sources of variability (plasmid copy number, transcriptional activity, mRNA stability, and translation rate).  We found increased readthrough at stop codons UAA and to a lesser extent at UAG for ∆tgt, and this increase was amplified for UAG in presence of tobramycin (Fig. S2, stop readthrough). In the case of UAA, tobramycin appears to decrease readthrough, this may be artefactual, due to the toxic effect of tobramycin on ∆tgt.

      Mistranslation at specific codons can also impact protein synthesis. To further investigate mistranslation levels by tRNATyr in WT and ∆tgt, we designed a set of gfp mutants where the codon for the catalytic tyrosine required for fluorescence (TAT at position 66) was substituted by nearcognate codons (Fig. S2). Results suggest that in this sequence context, particularly in the presence of tobramycin, non-modified tRNATyr mistakenly decodes Asp GAC, His CAC and also Ser UCC, Ala GCU, Gly GGU, Leu CUU and Val GUC codons, suggesting that Q34 increases the fidelity of tRNATyr. 

      In parallel, we replaced Tyr103 of the β-lactamase described above, with Asp codons GAT or GAC. The expression of the resulting mutant β-lactamase is expected to yield a carbenicillin sensitive phenotype. In this system, increased tyrosine misincorporation (more mistakes) by tRNATyr at the mutated Asp codon, will lead to increased synthesis of active β-lactamase, which can be evaluated by carbenicillin tolerance tests. As such, amino-acid misincorporation leads here to phenotypic (transient) tolerance, while genetic reversion mutations result in resistance (growth on carbenicillin). The rationale is summarized in Fig. 3C. When the Tyr103 codon was replaced with either Asp codons, we observe increased β-lactamase tolerance (Fig. 3D, left), suggesting increased misincorporation of tyrosine by tRNATyr at Asp codons in the absence of Q, again suggesting that Q34 prevents misdecoding of Asp codons by tRNATyr.

      In order to test any effect on an additional tRNA modified by Tgt, namely tRNAAsp, we mutated the Asp129 (GAT) codon of the β-lactamase. When Asp129 was mutated to Tyr TAT (Fig. 3D, right), we observe reduced tolerance in ∆tgt, but not when it was mutated to Tyr TAC, suggesting less misincorporation of aspartate by tRNAAsp at the Tyr UAU codon in the absence of Q. In summary, absence of Q34 increases misdecoding by tRNATyr at Asp codons, but decreases misdecoding by tRNAAsp at Tyr UAU. 

      This supports the fact that tRNA Q34 modification is involved in translation fidelity during antibiotic stress, and that the effects can be different on different tRNAs, e.g. tRNATyr and tRNAAsp tested here.”

      Added figures: Figure S2, Figure 3CD

      (3) The statement about that the TOB resistance depends on RsxA translation, which is related to the presence of Q, also presents some problems:

      (3.1) It is observed that the absence of tgt produces a growth defect in V. cholerae when exposed to TOB (Figure 1A), and it is stated that this is mediated by an increase in the translation of RsxA, because its gene is TAT enriched. However, in Figure S4F, it is shown that the same phenotype is observed in E. coli, but its rsxA gene is not enriched in TAT codons. Therefore, the growth defect observed in the tgt mutant in the presence of TOB may not be due to the increase in the translation of TAT codons of the rsxA gene in the absence of Q. This phenotype is very interesting, but it may be related to another molecular process regulated by Q. Maybe the role of Q in preventing stop codon readthrough is important in this process, reducing cellular stress in the presence of TOB and growing better.

      FigS4F (now figure 5D) shows that rsxA can be toxic during growth in presence of tobramycin, but it does not show that rsxA translation is increased in E. coli in delta-tgt. However, we agree with the referee that there are probably additional processes regulated by Q which are also involved in the response to TOB stress. We already had mentioned this briefly in the discussion (“Note that, our results do not exclude the involvement of additional Q-regulated MoTTs in the response to sub-MIC TOB, since Q modification leads to reprogramming of the whole proteome. “), we further discussed it as follows:

      “As a consequence, transcripts with tyrosine codon usage bias are differentially translated. One such transcript codes for RsxA, an anti-SoxR factor. SoxR controls a regulon involved in oxidative stress response and sub-MIC aminoglycosides trigger oxidative stress in V. cholerae{Baharoglu, 2013 #720}, pointing to an involvement of oxidative stress response in the response to sub-MIC tobramycin stress.

      A link between Q34 and oxidative stress has also been previously found in eukaryotic organisms {Nagaraja, 2021 #1466}. Note that our results do not exclude the involvement of additional Qregulated translation of other transcripts in the response to tobramycin. Q34 modification leads to reprogramming of the whole proteome, not only for other transcripts with codon usage bias, but also through an impact on the levels of stop codon readthrough and mistranslation at specific codons, as supported by our data.”

      (3.2) All experiments related to the effect of Q on the translation of TAT codons have been performed with the tgt mutant strain. Considering that the authors have a pSEVA-tgt plasmid to overexpress this gene, they would have to show whether tgt overexpression in a wt strain produces a decrease in the translation of proteins encoded by TAT-enriched genes such as RsxA. This experiment would allow them to conclude that Q reduces RsxA levels, increasing resistance to TOB.

      We agree that this would be interesting to test, however, as it can be seen in figure 1B, delta-tgt pSEVAtgt (complemented strain) grows better than WT pSEVA-tgt (tgt overexpression). In fact, overexpression of tgt negatively impacts cell growth and yield smaller colonies, especially when cells carry a second plasmid (e.g with gfp constructs). We have also seen this with other RNA modification gene overexpressions in the lab (unpublished). We believe that the expression of tgt is tuned and since overexpression affects fitness, it is generally difficult to conduct experiments with overexpression plasmid for RNA modifications.  Nevertheless, we have done the experiment (with slow growing bacteria) and when we normalize expression of gfp in the presence of tgt overexpressing plasmid to the condition with no plasmid, we see little (1.5 fold) or no effect of tgt overexpression on fluorescence (see graph below). This is probably due to a toxic effect of ooverexpression and we do not believe these results are biologically relevant. 

      Author response image 1.

      (3.3) On the other hand, Fig. 1B shows that when the wt and tgt strains compete, both overexpressing tgt, the tgt mutant strain grows better in the presence of TOB. This result is not very well understood, since according to the hypothesis proposed, the absence of modification by Q of the tRNA would increase the translation of genes enriched in TAT, therefore, a strain with a higher proportion of Q-modified tRNAs as in the case of the wt strain overexpressing tgt would express the rsxA gene less than the tgt strain overexpressing tgt and would therefore grow better in the presence of TOB. For all these reasons, it would be necessary to evaluate the effect of tgt overexpression on the translation of RsxA.

      See our answer above about negative effect of tgt overexpression.

      (3.4) According to Figure 1I, the overexpression of tRNA-Tyr(GUA) caused a better growth of tgt mutant in comparison to WT. If the growth defect observed in tgt mutant in the presence of TOB is due to a better translation of the TAT codons of rsxA gene, the overexpression of tRNA-Tyr(GUA) in the tgt mutant should have resulted in even better RsxA translation a worse growth, but not the opposite result.

      We agree, we think that rsxA is not the only factor responsible for growth defect of tgt in presence of TOB (as now further discussed in the discussion). Overexpression of tRNAtyr possibly changes the equilibrium between the decoding of TAC vs TAT and may restore translation of TAC enriched genes. As also suggested by rev3, we have measured decoding reporters for TAT/TAC while overexpressing tTNA-tyr. This is now added to the results in fig S2C and the following:

      “We also tested decoding reporters for TAT/TAC in WT and ∆tgt overexpressing tRNATyr in trans (Fig. S1C). The presence of the plasmid (empty p0) amplified differences between the two strains with decreased decoding of TAC (and increased TAT, as expected) in ∆tgt compared to WT. Overexpression of tRNATyrGUA did not significantly impact decoding of TAT and increased decoding of TAC, as expected. Since overexpression of tRNATyrGUA rescues ∆tgt in tobramycin (Fig. 1I) and facilitates TAC decoding, this suggests that issues with TAC codon decoding contribute to the fitness defect observed in ∆tgt upon growth with tobramycin. Overexpression of tRNATyrAUA increased decoding of TAT in WT but did not change it in ∆tgt where it is already high. Unexpectedly, overexpression of tRNATyrAUA also increased decoding of TAC in WT. Thus, overexpression of tRNATyrAUA possibly changes the equilibrium between the decoding of TAC vs TAT and may restore translation of TAC enriched transcripts.” 

      Added figure: figure S1C

      (4) It cannot be stated that DNA repair is more efficient in the tgt mutant of V. cholerae, as indicated in the text of the article and in Fig 7. The authors only observe that the tgt mutant is more resistant to UV radiation and it is suggested that the reason may be TAT bias of DNA repair genes. To validate the hypothesis that UV resistance is increased because DNA repair genes are TAT biased, it would be necessary to check if DNA repair is affected by Q. UV not only produces DNA damage, but also oxidative stress. Therefore, maybe this phenotype is due to the increase in proteins related to oxidative stress controlled by RsxA, such as the superoxide dismutase encoded by sodA. It is also stated that these repair genes were found up for the tgt mutant in the Ribo-seq data, with unchanged transcription levels. Again, it is necessary to clarify this interpretation of the Ribo-seq data, since the fact that they are more represented in a tgt mutant perhaps means that translation is slower in those transcripts. Has it been observed in proteomics (wt vs tgt in the absence of TOB) whether these proteins involved in repair are more expressed in a tgt mutant?

      We agree that our results do not directly show that DNA repair is more efficient, but that delta-tgt responds better to UV. This has been modified in the manuscript. About oxidative stress, we did not see a better or worse response to H202 of delta-tgt. Moreover, since we see better response of deltatgt  to UV only in V. cholerae and not in E. coli, we did not favor the hypothesesi of response to stressox. In proteomics, we do not detect changes for DNA repair genes except for RuvA which is more abundant in delta-tgt. We have toned down the statement about DNA repair in the paper.

      (5) The authors demonstrate that in E. coli the tgt mutant does not show greater resistance to UV radiation (Fig. 7D), unlike what happens in V. cholerae. It should be discussed that in previous works it has been observed that overexpression in E. coli of the tgt gene or the queF gene (Q biosynthesis) is involved in greater resistance to UV radiation (Morgante et al., Environ Microbiol, 2015 doi: 10.1111/1462-2920.12505; and Díaz-Rullo et al., Front Microbiol. 2021 doi: 10.3389/fmicb.2021.723874). As an explanation, it was proposed (Diaz-Rullo and Gonzalez-Pastor, NAR 2023 doi: 10.1093/nar/gkad667) that the observed increase in the capacity to form biofilms in strains that overexpress genes related to Q modification of tRNA would be related to this greater resistance to UV radiation.

      We now mention the previous observations suggesting a link between tgt and UV. We thank the referee for the reference which we had overlooked. Note that in the case of our experiments, all cultures are in planktonic form and are not allowed to form biofilms. We thus prefer not to biofilmlinked processes in this study.

      Reviewer #3 (Public Review):

      Summary:

      In this manuscript the authors begin with the interesting phenotype of sub-inhibitory concentrations of the aminoglycoside tobramycin proving toxic to a knockout of the tRNA-guanine transglycosylase (Tgt) of the important human pathogen, Vibrio cholerae. Tgt is important for incorporating queuosine (Q) in place of guanosine at the wobble position of GUN codons. The authors go on to define a mechanism of action where environmental stressors control expression of tgt to control translational decoding of particularly tyrosine codons, skewing the balance from TAC towards TAT decoding in the absence of the enzyme. The authors use advanced proteomics and ribosome profiling to reveal that the loss of tgt results in increased translation of proteins like RsxA and a cohort of DNA repair factors, whose genes harbor an excess of TAT codons in many cases. These findings are bolstered by a series of molecular reporters, mass spectrometry, and tRNA overexpression strains to provide support for a model where Tgt serves as a molecular pivot point to reprogram translational output in response to stress.

      Strengths:

      The manuscript has many strengths. The authors use a variety of strains, assays, and advanced techniques to discover a mechanism of action for Tgt in mediating tolerance to sub-inhibitory concentrations of tobramycin. They observe a clear phenotype for a tRNA modification in facilitating reprogramming of the translational response, and the manuscript certainly has value in defining how microbes tolerate antibiotics.

      We thank the referee for their time and comments. 

      Weaknesses:

      The conclusions of the manuscript are mostly very well-supported by the data, but in some places control experiments or peripheral findings cloud precise conclusions. Some additional clarification, discussion, or even experimental extension could be useful in strengthening these areas.

      (1) The authors have created and used a variety of relevant molecular tools. In some cases, using these tools in additional assays as controls would be helpful. For example, testing for compensation of the observed phenotypes by overexpression of the Tyrosine tRNA(GUA) in Figure 2A with the 6xTAT strain, Figure 5C with the rxsA-GFP fusion, and/or Figure 7B with UV stress would provide additional information of the ability of tRNA overexpression to compensate for the defect in these situations.

      Thank you for the suggestions. Since overexpression of tRNA tyr is not expected to decrease decoding of TAT, we do not necessarily expect any effect for UV and rsxA expression. Overexpression of tRNA_GUA restores fitness of delta-tgt in TOB, but this is probably independent of RsxA. As ref2 also suggested above, we included in the discussion that the effect seen in delta-tgt with TOB is not only due to RsxA expression but also additional processes. However, these suggestions are interesting and we performed the following experiments in order to have an answer for these questions: 

      - “testing for compensation of the observed phenotypes by overexpression of the Tyrosine tRNA(GUA) in Figure 2A with the 6xTAT strain”: 

      This is now included in figure S2C and results as follows: 

      “We also tested decoding reporters for TAT/TAC in WT and ∆tgt overexpressing tRNA-Tyr in trans (Fig. S1C). The presence of the plasmid amplified differences between the two strains with decreased decoding of TAC (and increased TAT, as expected) in ∆tgt with empty plasmid compared to WT. Overexpression of tRNA_TyrGUA did not significantly impact decoding of TAT and increased decoding of TAC as expected. Since overexpression of tRNA_TyrGUA rescues ∆tgt in tobramycin (Fig. 1I) and facilitates TAC decoding, this suggests that issues with TAC codon decoding contribute to the fitness defect observed in ∆tgt upon growth with tobramycin. Overexpression of tRNA_TyrAUA increased decoding of TAT in WT but did not change it in ∆tgt where it is already high. Interestingly, overexpression of TyrAUA also increased decoding of TAC in WT. Thus, overexpression of tRNA_TyrAUA possibly changes the equilibrium between the decoding of TAC vs TAT and may restore translation of TAC enriched transcripts. “  

      -  Figure 5C with the rxsA-GFP fusion: 

      When we overexpress tRNA_GUA, rsxA fluorescence is 2-fold higher in delta-tgt compared to wt. However, the fluorescence is highly decreased compared to the condition with no tRNA overexpression. While we are not sure whether this apparent decrease is a technical issue or not (e.g. due to the presence of additional plasmid), we prefer not to further explore this in this manuscript. Note that we could not obtain delta-tgt strain carrying both plasmids expressing tRNA_GUA and rsxA, suggesting toxic overproduction of rsxA in this context.

      Author response image 2.

      - Figure 7B with UV stress: 

      Here again, delta-tgt overexpressing tRNA_GUA is still more UV resistant than WT overexpressing tRNA_GUA.

      Author response image 3.

      (2) The authors present a clear story with a reprogramming towards TAT codons in the knockout strain, particularly regarding tobramycin treatment. The control experiments often hint at other codons also contributing to the observed phenotypes (e.g., His or Asp), yet these effects are mostly ignored in the discussion. It would be helpful to discuss these findings at a minimum in the discussion section, or possibly experimentally address the role of His or Asp by overexpression of these tRNAs together with Tyrosine tRNA(GUA) in an experiment like that of Figure 1I to see if a more "wild type" phenotype would present. In fact, the synergy of Tyr, His, and/or Asp codons likely helps to explain the effects observed with the DNA repair genes in later experiments.

      We thank the referee for the suggestion. We agree that there could be synergies between these codons, and that’s probably why proteomics data does not clearly reflect tyrosine codons usage bias. This is now further discussed in the ideas and speculation section. 

      Moreover, we have added Figure S3G and the following result:

      “Since not all TAT biased proteins are found to be enriched in ∆tgt proteomics data, the sequence context surrounding TAT codons could affect their decoding. To illustrate this, we inserted after the gfp start codon, various tyrosine containing sequences displayed by rsxA (Fig. S3G). The native tyrosines were all TAT codons, our synthetic constructs were either TAT or TAC, while keeping the remaining sequence unchanged.  We observe that the production of GFP carrying the TEYTATLLL sequence from RsxA is increased in Δtgt compared to WT, while it is unchanged with TEYTACLLL. However, production of the GFP with the sequences LYTATRLL/LYTACRLL and EYTATLR/ EYTACLR was not unaffected (or even decreased for the latter) by the absence of tgt. Overall, our results demonstrate that RsxA is upregulated in the ∆tgt strain at the translational level, and that proteins with a codon usage bias towards tyrosine TAT are prone to be more efficiently translated in the absence of Q modification, but this is also dependent on the sequence context. “

      (3) Regarding Figure 6D, the APB northern blot feels like an afterthought. It was loaded with different amounts of RNA as input and some samples are repeated three times, but Δcrp only once. Collectively, it makes this experiment very difficult to assess.

      A different amount of RNA was used only for ∆tgt in which we have only one band because of the absence of modification. For all the other conditions, the same amount of RNA was used (0.9 µg). Additional replicates of crp were in an additional gel but only a representative gel was shown in the manuscript. This is now specified in the legend.

      We also attach below the picture of the gel with total RNA (syber Gold labelling of total RNA), where it can be seen that the lanes contain an equivalent quantity of RNA, except for ∆tgt.

      Author response image 4.

      Minor Points:

      (3) Fig S2B, do the authors have a hypothesis why the Asp and Phe tRNAs lead to a growth decrease in the untreated samples? It appears like Phe(GAA) partially compensates for the defect.

      Yes we agree, at this stage we do not have any satisfactory answer for this unfortunately. This would be interesting to study further but this is beyond the scope of the present study.

      (5) Lines 655 to 660 seem more appropriate as speculation in the discussion rather than as a conclusion in the results, where no direct experiments are performed. The authors might take advantage of the "Ideas and Speculation" section that eLife allows.

      Thank you very much for this suggestion, we added this section to the manuscript.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Minor.

      - Figure 6 - Fonts on several mutants is different size/type. fixed

      - What is the Pm promoter. Please expand and give enough details so reader can follow. Especially as it is less used in V. cholerae (typical being pBAD or pTAC promoters). done

      - Spacing where references are inserted should be checked. done

      - Line 860-863 - "V. cholerae's response to sub-MIC antibiotic stress is transposable to other Gramnegative pathogens" . This reads awkard. Consider rephrasing. done

      - Figure 7 - Text in A and C is very small and is very hard to read. Font for tgt is different.

      Fixed. Tgt is in italics.

      Reviewer #2 (Recommendations For The Authors):

      As specified in the public review, more evidence would be necessary to affirm that tRNAs not modified by Q have a greater preference for translating TAT codons, since there are several previous studies in which it is shown that Q-tRNAs have a greater preference for NAT codons (including TAT). For example, it is suggested to explore what happens with other recoded genes (enriched in TAT or TAC) if there is a high level of Q-tRNAs (overexpression of tgt in a wt context). It is also necessary to clarify how to interpret the Ribo-seq results, which apparently is different from how they have been interpreted in other studies.

      Please see above our responses and changes made to the manuscript.

      Minor corrections

      In Figure 8, replace "Epitranscriptomic adapation to stress" with "Epitranscriptomic adaptation to stress".

      Fixed, thank you for noticing!

      Reviewer #3 (Recommendations For The Authors):

      (1) Lines 48-50, and 110 to 112, the authors have a nice mechanism and story, yet the lines mentioned feel very qualified (e.g., "possibly", "plausibly") and lead to the abstract hiding the value and major conclusions of the study. The authors could consider to revise or even remove these lines to focus on the take-home message in the abstract and end of introduction/discussion. 

      Thank you for this comment, we modified the text.  

      (2) Additional description for the samples in the results section for Figure 1 would be helpful to the reader.

      Done

      (3) Figure S1, the line of experiments with rluF is interesting, but in the end the choice seems a little random. Have the authors assessed knockouts of other modifications on the ASL for effects? Since the modification is not well characterized in V. cholerae according to the authors, it might make sense to save this for a future paper.

      We removed S1, as we agree that this experiment does not really add something to the paper.

      (4) Line 334 and 353 are redundant.

      Fixed

      (5) It is likely beyond the scope of the study, but it would strengthen the paper to repeat Figure 3 with His and/or Asp based on the findings of 2C and 4E to better understand the contribution of His and Asp to Q biology.

      We repeated figure 3 with Asp. Based on Fig 2C (less efficient decoding of GAC in deta-tgt in TOB) and 4E (positive GAT codon bias in proteins up in riboseq in delta-tgt TOB), we would expect that beta-lactamase with asp GAC would be less efficiently decoded than GAT in delta-tgt. 

      This was added to the manuscript

      “Like Tyr103, Asp129 was shown to be important for resistance to β-lactams (Doucet et al., 2004; Escobar et al., 1994; Jacob et al., 1990). When we replaced the native Asp129 GAT with the synonymous codon Asp129 GAC, the GAC version did not appear to produce functional β-lactamase in ∆tgt (Fig. 3B), suggesting increased mistranslation or inefficient decoding of the GAC codon by tRNAAsp in the absence of Q. Decoding of GAT codon was also affected in ∆tgt in the presence of tobramycin.”

      Added figure: Figure 3B

      (6) The authors could consider replacing 5D with S4A-D, which is easier to understand in our opinion.

      Done

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      From the Reviewing Editor:

      Four reviewers have assessed your manuscript on valence and salience signaling in the central amygdala. There was universal agreement that the question being asked by the experiment is important. There was consensus that the neural population being examined (GABA neurons) was important and the circular shift method for identifying task-responsive neurons was rigorous. Indeed, observing valenced outcome signaling in GABA neurons would considerably increase the role the central amygdala in valence. However, each reviewer brought up significant concerns about the design, analysis and interpretation of the results. Overall, these concerns limit the conclusions that can be drawn from the results. Addressing the concerns (described below) would work towards better answering the question at the outset of the experiment: how does the central amygdala represent salience vs valence.

      A weakness noted by all reviewers was the use of the terms 'valence' and 'salience' as well as the experimental design used to reveal these signals. The two outcomes used emphasized non-overlapping sensory modalities and produced unrelated behavioral responses. Within each modality there are no manipulations that would scale either the value of the valenced outcomes or the intensity of the salient outcomes. While the food outcomes were presented many times (20 times per session over 10 sessions of appetitive conditioning) the shock outcomes were presented many fewer times (10 times in a single session). The large difference in presentations is likely to further distinguish the two outcomes. Collectively, these experimental design decisions meant that any observed differences in central amygdala GABA neuron responding are unlikely to reflect valence, but likely to reflect one or more of the above features.

      We appreciate the reviewers’ comments regarding the experimental design. When assessing fear versus reward, we chose stimuli that elicit known behavioral responses, freezing versus consumption. The use of stimuli of the same modality is unlikely to elicit easily definable fear or reward responses or to be precisely matched for sensory intensity. For example, sweet or bitter tastes can be used, but even these activate different taste receptors and vary in the duration of the activation of taste-specific signaling (e.g. how long the taste lingers in the mouth). The approach we employed is similar to that of Yang et al., 2023 (doi: 10.1038/s41586-023-05910-2) that used water reward and shock to characterize the response profiles of somatostatin neurons of the central amygdala. Similar to what was reported by Yang and colleagues we observed that the majority of CeA GABA neurons responded selectively to one unconditioned stimulus (~52%). We observed that 15% of neurons responded in the same direction, either activated or inhibited, by the food or shock US. These were defined as salience based on the definitions of Lin and Nicolelis, 2008 (doi: 10.1016/j.neuron.2008.04.031) in which basal forebrain neurons responded similarly to reward or punishment irrespective of valence. The designation of valence encoding based opposite responses to the food or shock is straightforward (~10% of cells); however, we agree that the designation of modality-specific encoding neurons as valence encoding is less straightforward.

      A second weakness noted by a majority of reviewers was a lack of cue-responsive unit and a lack of exploration of the diversity of response types, and the relationship cue and outcome firing. The lack of large numbers of neurons increasing firing to one or both cues is particularly surprising given the critical contribution of central amygdala GABA neurons to the acquisition of conditioned fear (which the authors measured) as well as to conditioned orienting (which the authors did not measure). Regression-like analyses would be a straightforward means of identifying neurons varying their firing in accordance with these or other behaviors. It was also noted that appetitive behavior was not measured in a rigorous way. Instead of measuring time near hopper, measures of licking would have been better. Further, measures of orienting behaviors such as startle were missing.

      The authors also missed an opportunity for clustering-like analyses which could have been used to reveal neurons uniquely signaling cues, outcomes or combinations of cues and outcomes. If the authors calcium imaging approach is not able to detect expected central amygdala cue responding, might it be missing other critical aspects of responding?

      As stated in the manuscript, we were surprised by the relatively low number of cue responsive cells; however, when using a less stringent statistical method (Figure 5 - Supplement 2), we observed 13% of neurons responded to the food associated cue and 23% responded to the shock associated cue. The differences are therefore likely a reflection of the rigor of the statistical measure to define the responsive units. The number of CS responsive units is less than reported in the CeAl by Ciocchi et al., 2010 (doi: 10.1038/nature09559 ) who observed 30% activated by the CS and 25% inhibited, but is not that dissimilar from the results of Duvarci et al., 2011 (doi: 10.1523/JNEUROSCI.4985-10.2011 ) who observed 11% activated in the CeAl and 25% inhibited by the CS. These numbers are also consistent with previous single cell calcium imaging of cell types in the CeA. For example, Yang et al., 2023 (doi: 10.1038/s41586-023-05910-2) observed that 13% of somatostatin neurons responded to a reward CS and 8% responded to a shock CS. Yu et al., 2017 (doi: 10.1038/s41593-017-0009-9) observed 26.5% of PKCdelta neurons responded to the shock CS. It should also be noted that our analysis was not restricted to the CeAl. Finally, Food learning was assessed in an operant chamber in freely moving mice with reward pellet delivery. Because liquids were not used for the reward US, licking is not a metric that can be used.

      All reviewers point out that the evidence for salience encoding is even more limited than the evidence for valence. Although the specific concern for each reviewer varied, they all centered on an oversimplistic definition of salience. Salience ought to scale with the absolute value and intensity of the stimulus. Salience cannot simply be responding in the same direction. Further, even though the authors observed subsets of central amygdala neurons increasing or decreasing activity to both outcomes - the outcomes can readily be distinguished based on the temporal profile of responding.

      We thank the reviewers for their comments relating to the definition of salience and valence encoding by central amygdala neurons. We have addressed each of the concerns below.

      Additional concerns are raised by each reviewer. Our consensus is that this study sought to answer an important question - whether central amygdala signal salience or valence in cue-outcome learning. However, the experimental design, analyses, and interpretations do not permit a rigorous and definitive answer to that question. Such an answer would require additional experiments whose designs would address the significant concerns described here. Fully addressing the concerns of each reviewer would result in a re-evaluation of the findings. For example, experimental design better revealing valence and salience, and analyses describing diversity of neuronal responding and relationship to behavior would likely make the results Important or even Fundamental.

      We appreciate the reviewers’ comments and have addressed each concern below.

      Reviewer #2 (Public review):

      In this article, Kong and authors sought to determine the encoding properties of central amygdala (CeA) neurons in response to oppositely valenced stimuli and cues predicting those stimuli. The amygdala and its subregional components have historically been understood to be regions that encode associative information, including valence stimuli. The authors performed calcium imaging of GABA-ergic CeA neurons in freely-moving mice conditioned in Pavlovian appetitive and fear paradigms, and showed that CeA neurons are responsive to both appetitive and aversive unconditioned and conditioned stimuli. They used a variant of a previously published 'circular shifting' technique (Harris, 2021), which allowed them to delineate between excited/non-responsive/inhibited neurons. While there is considerable overlap of CeA neurons responding to both unconditioned stimuli (in this case, food and shock, deemed "salience-encoding" neurons), there are considerably fewer CeA neurons that respond to both conditioned stimuli that predict the food and shock. The authors finally demonstrated that there are no differences in the order of Pavlovian paradigms (fear - shock vs. shock - fear), which is an interesting result, and convincingly presented given their counterbalanced experimental design.

      In total, I find the presented study useful in understanding the dynamics of CeA neurons during a Pavlovian learning paradigm. There are many strengths of this study, including the important question and clear presentation, the circular shifting analysis was convincing to me, and the manuscript was well written. We hope the authors will find our comments constructive if they choose to revise their manuscript.

      While the experiments and data are of value, I do not agree with the authors interpretation of their data, and take issue with the way they used the terms "salience" and "valence" (and would encourage them to check out Namburi et al., NPP, 2016) regarding the operational definitions of salience and valence which differ from my reading of the literature. To be fair, a recent study from another group that reports experiments/findings which are very similar to the ones in the present study (Yang et al., 2023, describing valence coding in the CeA using a similar approach) also uses the terms valence and salience in a rather liberal way that I would also have issues with (see below). Either new experiments or revised claims would be needed here, and more balanced discussion on this topic would be nice to see, and I felt that there were some aspects of novelty in this study that could be better highlighted (see below).

      One noteworthy point of alarm is that it seems as if two data panels including heatmaps are duplicated (perhaps that panel G of Figure 5-figure supplement 2 is a cut and paste error? It is duplicated from panel E and does not match the associated histogram).

      We thank the reviewer for their insightful comments and assessment of the manuscript.

      Major concerns:

      (1) The authors wish to make claims about salience and valence. This is my biggest gripe, so I will start here.

      (1a) Valence scales for positive and negative stimuli and as stated in Namburi et al., NPP, 2016 where we operationalize "valence" as having different responses for positive and negative values and no response for stimuli that are not motivational significant (neutral cues that do not predict an outcome). The threshold for claiming salience, which we define as scaling with the absolute value of the stimulus, and not responding to a neutral stimulus (Namburi et al., NPP, 2016; Tye, Neuron, 2018; Li et al., Nature, 2022) would require the lack of response to a neutral cue.

      We appreciate the reviewer’s comment on the definitions of salience and valence and agree that there is not a consistent classification of these response types in the field. As stated above, we used the designation of salience encoding if the cells respond in the same direction to different stimuli regardless of the valence of the stimulus similar to what was described previously (Lin and Nicolelis, 2008, doi: 10.1016/j.neuron.2008.04.031). Similar definitions of salience have also been reported elsewhere (for examples see: Stephenson-Jones et al., 2020, doi: 10.1016/j.neuron.2019.12.006,  Zhu et al., 2018 doi: 10.1126/science.aat0481, and  Comoli et al., 2003, doi: 10.1038/nn1113P). Per the suggestion of the reviewer, we longitudinally tracked cells on the first day of Pavlovian reward conditioning the fear conditioning day. Although there were considerably fewer head entries on the first day of reward conditioning, we were able to identify 10 cells that were activated by both the food US and shock US. We compared the responses to the first five head entries and last head entries and the first 5 shocks and last five shocks. Consistent with what has been reported for salience encoding neurons in the basal forebrain (Lin and Nicolelis, 2008, doi: 10.1016/j.neuron.2008.04.031), we observed that the responses were highest when the US was most unexpected and decreased in later trials.

      Author response image 1.

      (1b) The other major issue is that the authors choose to make claims about the neural responses to the USs rather than the CSs. However, being shocked and receiving sucrose also would have very different sensorimotor representations, and any differences in responses could be attributed to those confounds rather than valence or salience. They could make claims regarding salience or valence with respect to the differences in the CSs but they should restrict analysis to the period prior to the US delivery.

      Perhaps the reviewer missed this, but analysis of valence and salience encoding to the different CSs are presented in Figure 5G, Figure 5 -Supplement 1 C-D, and Figure 5 -Supplement 2 N-O. Analysis of CS responsiveness to CSFood and CSShock were analyzed during the conditioning sessions Figure 3E-F, Figure 4B-C, Figure 5 – Supplement 2J-O and Figure 5 – Supplement 3K-L, and during recall probe tests for both CSFood and CSShock, Figure 5 – Supplement 1C-J.

      (1c) The third obstacle to using the terms "salience" or "valence" is the lack of scaling, which is perhaps a bigger ask. At minimum either the scaling or the neutral cue would be needed to make claims about valence or salience encoding. Perhaps the authors disagree - that is fine. But they should at least acknowledge that there is literature that would say otherwise.<br /> (1d) In order to make claims about valence, the authors must take into account the sensory confound of the modality of the US (also mentioned in Namburi et al., 2016). The claim that these CeA neurons are indeed valence-encoding (based on their responses to the unconditioned stimuli) is confounded by the fact that the appetitive US (food) is a gustatory stimulus while the aversive US (shock) is a tactile stimulus.

      We provided the same analysis for the US and CS. The US responses were larger and more prevalent, but similar types of encoding were observed for the CS. We agree that the food reward and the shock are very different sensory modalities. As stated above, the use of stimuli of the same modality is unlikely to elicit easily definable fear or reward responses or to be precisely matched for sensory intensity. We agree that the definition of cells that respond to only one stimulus is difficult to define in terms of valence encoding, as opposed to being specific for the sensory modality and without scaling of the stimulus it is difficult to fully address this issue. It should be noted however, that if the cells in the CeA were exclusively tuned to stimuli of different sensory modalities, we would expect to see a similar number of cells responding to the CS tones (auditory) as respond to the food (taste) and shock (somatosensory) but we do not. Of the cells tracked longitudinally 80% responded to the USs, with 65% of cells responding to food (activated or inhibited) and 44% responding to shock (activated or inhibited).

      (2) Much of the central findings in this manuscript have been previously described in the literature. Yang et al., 2023 for instance shows that the CeA encodes salience (as demonstrated by the scaled responses to the increased value of unconditioned stimuli, Figure 1 j-m), and that learning amplifies responsiveness to unconditioned stimuli (Figure 2). It is nice to see a reproduction of the finding that learning amplifies CeA responses, though one study is in SST::Cre and this one in VGAT::cre - perhaps highlighting this difference could maximize the collective utility for the scientific community?

      We agree that the analysis performed here is similar to what was conducted by Yang et al., 2023. With the major difference being the types of neurons sampled. Yang et al., imaged only somatostatin neurons were as we recorded all GABAergic cell types within the CeA. Moreover, because we imaged from 10 mice, we sampled neurons that ostensibly covered the entire dorsal to ventral extent of the CeA (Figure 1 – Supplement 1). Remarkably, we found that the vast majority of CeA neurons (80%) are responsive to food or shock. Within this 80% there are 8 distinct response profiles consistent with the heterogeneity of cell types within the CeA based on connectivity, electrophysiological properties, and gene expression. Moreover, we did not find any spatial distinction between food or shock responsive cells, with the responsive cell types being intermingled throughout the dorsal to ventral axis (Figure 5 – Supplement 3).

      (3) There is at least one instance of copy-paste error in the figures that raised alarm. In the supplementary information (Figure 5- figure supplement 2 E;G), the heat maps for food-responsive neurons and shock-responsive neurons are identical. While this almost certainly is a clerical error, the authors would benefit from carefully reviewing each figure to ensure that no data is incorrectly duplicated.

      We thank the reviewer for catching this error. It has been corrected.

      (4) The authors describe experiments to compare shock and reward learning; however, there are temporal differences in what they compare in Figure 5. The authors compare the 10th day of reward learning with the 1st day of fear conditioning, which effectively represent different points of learning and retrieval. At the end of reward conditioning, animals are utilizing a learned association to the cue, which demonstrates retrieval. On the day of fear conditioning, animals are still learning the cue at the beginning of the session, but they are not necessarily retrieving an association to a learned cue. The authors would benefit from recording at a later timepoint (to be consistent with reward learning- 10 days after fear conditioning), to more accurately compare these two timepoints. Or perhaps, it might be easier to just make the comparison between Day 1 of reward learning and Day 1 of fear learning, since they must already have these data.

      We agree that there are temporal differences between the food and shock US deliveries. This is likely a reflection of the fact that the shock delivery is passive and easily resolved based on the time of the US delivery, whereas the food responses are variable because they are dependent upon the consumption of the sucrose pellet. Because of these differences the kinetics of the responses cannot be accurately compared. This is why we restricted our analysis to whether the cells were food or shock responsive. Aside from reporting the temporal differences in the signals did not draw major conclusions about the differences in kinetics. In our experimental design we counterbalanced the animals that received fear conditioning firs then food conditioning, or food conditioning then fear conditioning to ensure that order effects did not influence the outcome of the study. It is widely known that Pavlovian fear conditioning can facilitate the acquisition of conditioned stimulus responses with just a single day of conditioning. In contrast, Pavlovian reward conditioning generally progresses more slowly. Because of this we restricted our analysis to the last day of reward conditioning to the first and only day of fear conditioning. However, as stated above, we compared the responses of neurons defined as salience during day 1 of reward conditioning and fear conditioning. As would be predicted based on previous definitions of salience encoding (Lin and Nicolelis, 2008, doi: 10.1016/j.neuron.2008.04.031), we observed that the responses were highest when the US was most unexpected

      (5) The authors make a claim of valence encoding in their title and throughout the paper, which is not possible to make given their experimental design. However, they would greatly benefit from actually using a decoder to demonstrate their encoding claim (decoding performance for shock-food versus shuffled labels) and simply make claims about decoding food-predictive cues and shock-predictive cues. Interestingly, it seems like relatively few CeA neurons actually show differential responses to the food and shock CSs, and that is interesting in itself.

      As stated above, valence and salience encoding were defined similar to what has been previously reported (Li et al., 2019, doi: 10.7554/eLife.41223; Yang et al., 2023, doi: 10.1038/s41586-023-05910-2; Huang et al., 2024, doi: 10.1038/s41586-024-07819; Lin and Nicolelis, 2008, doi: 10.1016/j.neuron.2008.04.031; Stephenson-Jones et al., 2020, doi: 10.1016/j.neuron.2019.12.006; Zhu et al., 2018, doi: 10.1126/science.aat0481; and Comoli et al., 2003, doi: 10.1038/nn1113P). Interestingly, many of these studies did not vary the US intensity.

      Reviewer #3 (Public review):

      Summary:

      In their manuscript entitled Kong and colleagues investigate the role of distinct populations of neurons in the central amygdala (CeA) in encoding valence and salience during both appetitive and aversive conditioning. The study expands on the work of Yang et al. (2023), which specifically focused on somatostatin (SST) neurons of the CeA. Thus, this study broadens the scope to other neuronal subtypes, demonstrating that CeA neurons in general are predominantly tuned to valence representations rather than salience.

      We thank the reviewer for their insightful comments and assessment of the manuscript.

      Strengths:

      One of the key strengths of the study is its rigorous quantitative approach based on the "circular-shift method", which carefully assesses correlations between neural activity and behavior-related variables. The authors' findings that neuronal responses to the unconditioned stimulus (US) change with learning are consistent with previous studies (Yang et al., 2023). They also show that the encoding of positive and negative valence is not influenced by prior training order, indicating that prior experience does not affect how these neurons process valence.

      Weaknesses:

      However, there are limitations to the analysis, including the lack of population-based analyses, such as clustering approaches. The authors do not employ hierarchical clustering or other methods to extract meaning from the diversity of neuronal responses they recorded. Clustering-based approaches could provide deeper insights into how different subpopulations of neurons contribute to emotional processing. Without these methods, the study may miss patterns of functional specialization within the neuronal populations that could be crucial for understanding how valence and salience are encoded at the population level.

      We appreciate the reviewer’s comments regarding clustering-based approaches. In order to classify cells as responsive to the US or CS we chose to develop a statistically rigorous method for classifying cell response types. Using this approach, we were able to define cell responses to the US and CS. Importantly, we identified 8 distinct response types to the USs. It is not clear how additional clustering analysis would improve cell classifications.

      Furthermore, while salience encoding is inferred based on responses to stimuli of opposite valence, the study does not test whether these neuronal responses scale with stimulus intensity-a hallmark of classical salience encoding. This limits the conclusions that can be drawn about salience encoding specifically.

      As stated above, we used salience classifications similar to those previously described (Lin and Nicolelis, 2008, doi: 10.1016/j.neuron.2008.04.031; Stephenson-Jones et al., 2020, doi: 10.1016/j.neuron.2019.12.006; Zhu et al., 2018, doi: 10.1126/science.aat0481; and Comoli et al., 2003, doi: 10.1038/nn1113P). We agree that varying the stimulus intensity would provide a more rigorous assessment of salience encoding; however, several of the studies mentioned above classify cells as salience encoding without varying stimulus intensity. Additionally, the inclusion of recordings with varying US intensities on top of the Pavlovian reward and fear conditioning would further decrease the number of cells that can be longitudinally tracked and would likely decrease the number of cells that could be classified.

      In sum, while the study makes valuable contributions to our understanding of CeA function, the lack of clustering-based population analyses and the absence of intensity scaling in the assessment of salience encoding are notable limitations.

      Reviewer #4 (Public review):

      Summary:

      The authors have performed endoscopic calcium recordings of individual CeA neuron responses to food and shock, as well as to cues predicting food and shock. They claim that a majority of neurons encode valence, with a substantial minority encoding salience.

      Strengths:

      The use of endoscopic imaging is valuable, as it provides the ability to resolve signals from single cells, while also being able to track these cells across time. The recordings appear well-executed, and employ a sophisticated circular shifting analysis to avoid statistical errors caused by correlations between neighboring image pixels.

      Weaknesses:

      My main critique is that the authors didn't fully test whether neurons encode valence. While it is true that they found CeA neurons responding to stimuli that have positive or negative value, this by itself doesn't indicate that valence is the primary driver of neural activity. For example, they report that a majority of CeA neurons respond selectively to either the positive or negative US, and that this is evidence for "type I" valence encoding. However, it could also be the case that these neurons simply discriminate between motivationally relevant stimuli in a manner unrelated to valence per se. A simple test of this would be to check if neural responses generalize across more than one type of appetitive or aversive stimulus, but this was not done. The closest the authors came was to note that a small number of neurons respond to CS cues, of which some respond to the corresponding US in the same direction. This is relegated to the supplemental figures (3 and 4), and it is not noted whether the the same-direction CS-US neurons are also valence-encoding with respect to different USs. For example, are the neurons excited by CS-food and US-food also inhibited by shock? If so, that would go a long way toward classifying at least a few neurons as truly encoding valence in a generalizable way.

      As stated above, valence and salience encoding were defined similar to what has been previously reported (Li et al., 2019, doi: 10.7554/eLife.41223; Yang et al., 2023, doi: 10.1038/s41586-023-05910-2; Huang et al., 2024, doi: 10.1038/s41586-024-07819; Lin and Nicolelis, 2008, doi: 10.1016/j.neuron.2008.04.031; Stephenson-Jones et al., 2020, doi: 10.1016/j.neuron.2019.12.006; Zhu et al., 2018, doi: 10.1126/science.aat0481; and Comoli et al., 2003, doi: 10.1038/nn1113P). As reported in Figure 5 and Figure 5 – Supplement 3, ~29% of CeA neurons responded to both food and shock USs (15% in the same direction and 13.5% in the opposite direction). In contrast, only 6 of 303 cells responded to both the CSfood and CSshock, all in the same direction.

      A second and related critique is that, although the authors correctly point out that definitions of salience and valence are sometimes confused in the existing literature, they then go on themselves to use the terms very loosely. For example, the authors define these terms in such a way that every neuron that responds to at least one stimulus is either salience or valence-encoding. This seems far too broad, as it makes essentially unfalsifiable their assertion that the CeA encodes some mixture of salience and valence. I already noted above that simply having different responses to food and shock does not qualify as valence-encoding. It also seems to me that having same-direction responses to these two stimuli similarly does not quality a neuron as encoding salience. Many authors define salience as being related to the ability of a stimulus to attract attention (which is itself a complex topic). However, the current paper does not acknowledge whether they are using this, or any other definition of salience, nor is this explicitly tested, e.g. by comparing neural response magnitudes to any measure of attention.

      As stated in response to reviewer 2, we longitudinally tracked cells on the first day of Pavlovian reward conditioning the fear conditioning day. Although there were considerably fewer head entries on the first day of reward conditioning, we were able to identify 10 cells that were activated by both the food US and shock US. We compared the responses to the first five head entries and last head entries and the first 5 shocks and last five shocks. Consistent with what has been reported for salience encoding neurons in the basal forebrain (Lin and Nicolelis, 2008, doi: 10.1016/j.neuron.2008.04.031), we observed that the responses were highest when the US was most unexpected and decreased in later trials.

      The impression I get from the authors' data is that CeA neurons respond to motivationally relevant stimuli, but in a way that is possibly more complex than what the authors currently imply. At the same time, they appear to have collected a large and high-quality dataset that could profitably be made available for additional analyses by themselves and/or others.

      Lastly, the use of 10 daily sessions of training with 20 trials each seems rather low to me. In our hands, Pavlovian training in mice requires considerably more trials in order to effectively elicit responses to the CS. I wonder if the relatively sparse training might explain the relative lack of CS responses?

      It is possible that learning would have occurred more quickly if we had used greater than 20 trials per session. However, we routinely used 20-25 trials for Pavlovian reward conditioning (doi: 10.1073/pnas.1007827107; doi: 10.1523/JNEUROSCI.5532-12.2013; doi: 10.1016/j.neuron.2013.07.044; and doi: 10.1016/j.neuron.2019.11.024).

    1. Author response:

      The following is the authors’ response to the original reviews

      eLife Assessment

      This useful study integrates experimental methods from materials science with psychophysical methods to investigate how frictional stabilities influence tactile surface discrimination. The authors argue that force fluctuations arising from transitions between frictional sliding conditions facilitate the discrimination of surfaces with similar friction coefficients. However, the reliance on friction data obtained from an artificial finger, together with the ambiguous correlative analyses relating these measurements to human psychophysics, renders the findings incomplete.

      Our main goal with this paper was to show that the most common metric, i.e. average friction coefficient—widely used in tactile perception and device design – is fundamentally unsound, and to offer a secondary parameter that is compatible with the fact that human motion is unconstrained, leading to dynamic interfacial mechanics.

      We understand the Reviewers wanted, through biomechanical measurements, to demonstrate that humans using instabilities. This is seemingly reasonable, but in individual responses, we explain the significant challenges and fundamental unknowns to those experiments. We believe this paper sets forth an important step to approach this problem. At the same time, we have made several changes in the discussion, conclusion, and title to clarify that our study is correlative between mechanical characterization and human testing.

      In short, there are still several fundamental unknowns that prevented us from basing the study around biomechanical measurements: (1) a decision-making model would need to be created, but it is unknown if tactile decision making follows other models, (2) it is further unknown what constitutes “tactile evidence”, though at our manuscript’s conclusion, we propose that friction instabilities are better suited for to be tactile evidence than the averaging of friction coefficients from a narrow range of human exploration (3) in the design of samples, from a friction mechanics and materials perspective, it is not at this point, possible to pre-program surfaces a priori to deliver friction instabilities and instead must be experimentally determined – especially when attempting to achieve this in controlled surfaces that do not create other overriding tactile cues, like macroscopic bumps or large differences in surface roughness. (4) Given that the basis for tactile percepts, like which object feels “rougher” or “smoother” is not sufficiently established, it is necessary to use a 3-alternative forced choice task which avoids asking objects along a preset perceptual dimension – a challenge recognized by Reviewer 3. However, this would bring in issues of memory in the decision-making model. (5) The prior points are compounded by the fact that, we believe, tactile exploration must be performed in an unconstrained manner, i.e., without an apparatus generating motion onto a stationary finger. Work by Liu et al. (IEEE ToH, 2024) showed that recreating friction obtained during free exploration onto a stationary finger was uninterpretable by the participants, hinting at the importance of efference copies.[1] We believe that many of the above-mentioned issues constitutes a significant advance in knowledge and would require discussion and dissemination with the community.

      Our changes to the manuscript

      Page 1 & SI Page 1, Title

      “Alternatives to Friction Coefficient: Fine Touch Perception Correlates with Frictional Instabilities”

      Reviewer 1 (Public review):

      Summary:

      In this paper, Derkaloustian et. al look at the important topic of what affects fine touch perception. The observations that there may be some level of correlation with instabilities are intriguing. They attempted to characterize different materials by counting the frequency (occurrence #, not of vibration) of instabilities at various speeds and forces of a PDMS slab pulled lengthwise over the material. They then had humans make the same vertical motion to discriminate between these samples. They correlated the % correct in discrimination with differences in frequency of steady sliding over the design space as well as other traditional parameters such as friction coefficient and roughness. The authors pose an interesting hypothesis and make an interesting observation about the occurrences of instability regimes in different materials while in contact with PDMS, which is interesting for the community to see in the publication. It should be noted that the finger is complex, however, and there are many factors that may be quite oversimplified with the use of the PDMS finger, and the consideration and discounting of other parameters are not fully discussed in the main text or SI. Most importantly, however, the conclusions as stated do not align with the primary summary of the data in Figure 2.

      Strengths:

      The strength of this paper is in its intriguing hypothesis and important observation that instabilities may contribute to what humans are detecting as differences in these apparently similar samples.

      We thank Reviewer 1 for their time on the manuscript, recognizing the approach we took, and offering constructive feedback. We believe that our conclusions, in fact, are supported by the primary summary of the data in Fig. 2 but we believe that our use of R<sup>2</sup> could have led to misinterpretation. The trend with friction coefficient and percent correct was indeed statistically significant but was spurious because the slope was negative. In the revision, we add clarifying comments throughout, change from R<sup>2</sup> to r as to highlight the negative trend, and adjust the figures to better focus on friction coefficient.

      Finally, we added a new section to discuss the tradeoffs between using a real human finger versus a mock finger, and which situations may warrant the use of one or the other. In short, for our goal of characterizing surfaces to be used in tactile experiments, we believe a mock finger is more sustainable and practical than using real humans because human fingers are unique per participant, humans move their fingers at constantly changing pressures and velocities, and friction generated during free exploring human cannot be satisfactorily replicated by moving a sample onto a stationary finger. But, we do not disagree that for other types of experiments, characterizing a human participant directly may be more advantageous.

      Weaknesses:

      Comment 1

      The most important weakness is that the findings do not support the statements of findings made in the abstract. Of specific note in this regard is the primary correlation in Figure 2B between SS (steady sliding) and percent correct discrimination. Of specific note in this regard is the primary correlation in Figure 2B between SS (steady sliding) and percent correct discrimination. While the statistical test shows significance (and is interesting!), the R-squared value is 0.38, while the R-squared value for the "Friction Coefficient vs. Percent Correct" plot has an R-squared of 0.6 and a p-value of < 0.01 (including Figure 2B). This suggests that the results do not support the claim in the abstract: "We found that participant accuracy in tactile discrimination was most strongly correlated with formations of steady sliding, and response times were negatively correlated with stiction spikes. Conversely, traditional metrics like surface roughness or average friction coefficient did not predict tactile discriminability."

      We disagree that the trend with friction coefficient suggests the results do not support the claim because the correlation was found to be negative. However, we could have made the comparison more apparent and expanded on this point, given its novelty.

      While the R<sup>2</sup> value corresponding to the “Friction Coefficient vs. Percent Correct” plot is notably higher, our results show that the slope is negative, which would be statistically spurious. This is because a negative correlation between percent correct (accuracy in discriminating surfaces) and difference in friction coefficient means that the more similar two surfaces are (by friction coefficient), the easier it would be for people to tell them apart. That is, it incorrectly concludes that two identical surfaces would be much easier to tell apart than two surfaces with greatly different friction coefficients.

      This is counterintuitive to nearly all existing results, but we believe our samples were well-positioned to uncover this trend by minimizing variability, by controlling multiple physical parameters in the samples, and that the friction coefficient — typically calculated in the field as an average friction coefficient — ignores all the dynamic changes in forces present in elastic systems undergoing mesoscale friction, i.e., human touch, as seen in Fig. 1 in a mock finger and Fig. 3 in a real finger. By demonstrating this statistically spurious trend, we believe this strongly supports our premise that an alternative to friction coefficient is needed in the design of tactile psychophysics and haptic interfaces.

      We believe that this could have been misinterpreted, so we took several steps to improve clarity, given the importance of this finding: we separated the panel on friction coefficient to its own panel, we changed from R<sup>2</sup> to r throughout, and we added clarifying text. We also added a small section focusing on this spurious trend.

      Our changes to the manuscript

      Page 1, Abstract

      “In fact, the typical method of averaging friction coefficients led to a spurious correlation which erroneously suggests that distinct objects should feel identical and identical objects should feel distinct.”

      Page 7

      “As Fig. 1 was constructed from friction measurements, we can also calculate an average friction coefficient, µ, by averaging the friction coefficient obtained at each of the 16 combinations of masses and velocities (Table 1). This calculation is a standard approach in tactile studies for summarizing friction measurements, or in some cases, surfaces are never characterized at multiple masses and velocities. However, summarizing friction data in this manner has been considered as conceptually questionable by others from a mechanics perspective.[3] Fig. 1 shows that the type of instabilities and friction forces encountered on a single surface can vary widely depending on the conditions. As a result, large variations in the friction coefficient are expected, depending on the mass and velocity — even though measurements originate from the same surface. This variability in friction coefficient can be seen with the large interquartile range of friction coefficients, which shows that the variation in friction coefficient across a single surface is similar, or even larger, than the differences in average friction coefficient across two different surfaces. The observation that friction coefficients vary so widely on a single surface calls into question the approach of analyzing how humans may perceive two different objects based on their average friction coefficients.”

      Page 9, Fig. 2 Caption

      “D) GLMM of accuracy vs. difference in average friction coefficient , showing a negative correlation. E) GLMMs of accuracy vs. other commonly used material properties or parameters: ΔAverage roughness R<sub>a</sub>, ΔHurst exponent H, and ΔWater contact angle hysteresis (º) (N = 10 participants_, _n = 600 total trials).”

      Page 9

      “Considering all instabilities individually, we found that only steady sliding was a positive, statistically significant predictor. (r \= 0.62, p < 0.05, shown in Fig. 2B).”

      Page 10

      “To compare the value of looking at frictional instabilities, we also performed GLMM fits on common approaches in the field, like a friction coefficient or material property typically used in tactile discrimination, shown in Fig. 2D-E. Interestingly, in Fig. 2D, we observed a spurious, negative correlation between friction coefficient (typically and often problematically simplified as across all tested conditions) and accuracy (r = -0.64, p < 0.01); that is, the more different the surfaces are by friction coefficient, the less people can tell them apart. This spurious correlation would be the opposite of intuition, and further calls into question the common practice of using friction coefficients in touch-related studies. Interestingly, this spurious correlation was also found by Gueorguiev et al.[21] The alternative, two-term model which includes adhesive contact area for friction coefficient[32] was even less predictive (see Fig. S6A of SI). We believe such a correlation could not have been uncovered previously as our samples are minimal in their physical variations. Yet, the dynamic changes in force even within a single sample are not considered, despite being a key feature of mesoscale friction during human touch.

      We investigate different material properties in Fig. 2E. Differences in average roughness R<sub>a</sub> (or other parameters, like root mean square roughness R<sub>rms</sub> (Fig. S6A of SI) did not show a statistically significant correlation to accuracy. Though roughness is a popular parameter, correlating any roughness parameter to human performance here could be moot: the limit of detecting roughness differences has previously been defined as 13 nm on structured surfaces[36] and much higher for randomly rough surfaces,[49] all of which are magnitudes larger than the roughness differences between our surfaces. The differences in contact angle hysteresis – as an approximation of the adhesion contributions[50] – do not present any statistically significant effects on performance.”

      Page 11-12

      “Despite the correlative nature of this study, we still obtained high correlations compared to existing biomechanical studies[4,19,21], which we speculate is because instabilities are an important predictive phenomenon for models of human touch. We believe that biomechanical studies, including more sophisticated techniques, like spatially resolved force maps from digital image correlation[5,42] may yield stronger correlations and results if they analyze data based on instabilities.

      Added References

      (2) Khamis, H. et al. Friction sensing mechanisms for perception and motor control: passive touch without sliding may not provide perceivable frictional information. J. Neurophysiol. 125, 809– 823 (2021).

      (6) Olczak, D., Sukumar, V. & Pruszynski, J. A. Edge orientation perception during active touch. J. Neurophysiol. 120, 2423–2429 (2018).

      Comment 2, Part 1

      Along the same lines, other parameters that were considered such as the "Percent Correct vs. Difference in Sp" and "Percent Correct vs. Difference in SFW" were not plotted for consideration in the SI. It would be helpful to compare these results with the other three metrics in order to fully understand the relationships.

      We have added these plots to the SI. We note that we had checked these relationships and discussed them briefly, but did not include the plot. The plots show that the type of instability was not as helpful as its presence or absence.

      Our changes to the manuscript

      Page 9

      “Furthermore, a model accounting for slow frictional waves alone specifically shows a significant, negative effect on performance (p < 0.01, Fig. S5 of SI), suggesting that in these samples and task, the type of instability was not as important.”

      “Fig. S5. GLMM fits of participant accuracy vs. the differences in instability incidence for individual instability types. Left: accuracy vs. differences in formation of slow frictional waves (SFW) between pairs. P1 and P5 have the same x-axis value and are shifted for clarity. Right: accuracy vs. differences in formation of stiction spikes (Sp).”

      SI Page 4

      “and no correlation between accuracy and stiction spikes (Fig. S5).”

      Comment 2, Part 2

      Other parameters such as stiction magnitude and differences in friction coefficient over the test space could also be important and interesting.

      We agree these are interesting and have thought about them. We are aware that others, like Gueorguiev et al., have studied stiction magnitudes, and though there was a correlation, the physical differences in surface roughness (glass versus PMMA) investigated made it unclear if these could be generalized further.[3] We are unsure how to proceed here with a satisfactory analysis of stiction magnitude, given that stiction spikes are not always generated. In fact, Fig. 1 shows that for many velocities and pressures, stiction spikes are not formed. In ongoing work, however, we are always cognizant that if stiction spikes are a dominant factor, then a secondary analysis on their magnitude would be important. We offer some speculation on why stiction spikes may be overrepresented in the literature:

      (1) They are prone to being created if the finger was loaded for a long time onto a surface prior to movement, thus creating adhesion by contact aging which is unlike active human exploration. We avoid this by discarding the first pull in our measurements, which is a standard practice in mechanical characterization if contact aging needs to be avoided.

      (2) The ranges of velocities and pressures explored by others were small.

      (3) In an effort to generate strong tactile stimuli, highly adhesive or rough surfaces are used.

      (4) Stiction spikes are visually distinctive on a plot, but we are unaware of any mechanistic reason that mechanoreceptors would be particularly sensitive to this low frequency event over other signals.

      We interpret “difference in friction coefficient over the test space” to be, for a single surface, like C4, to find the highest average friction for a condition of single velocity and mass and subtract that from the lowest average friction for a condition of single velocity and mass. We calculated the difference in friction coefficient in the typical manner of the field, by averaging all data collected at all velocities and masses and assigning a single value for all of a surface, like C4. We had performed this, and have the data, but we are wary of overinterpreting secondary and tertiary metrics because they do not have any fundamental basis in traditional tribology, and this value, if used by humans, would suggest that they rapidly explore a large parameter space to find a “maximum” and “minimum” friction. Furthermore, the range in friction across the test space, after averaging, can be smaller than the range of friction experienced at different masses and velocities on a single surface. We have tabulated and newly included these values (the interquartile range of friction coefficients of different masses and velocities per surface) in Table 1.

      Fig. 2D shows a GLMM fit between percent correct responses across our pairs and the differences in friction coefficient for each pair, where we see a spurious negative correlation. As we had the data of all average friction coefficients for each condition for a given material, we also looked at the difference in maximum and minimum friction coefficients. For our tested pairs, these differences also lined up on a statistically significant, negative GLMM fit (r = -0.86, p < 0.005). However, the values for a given surface can vary drastically, with an interquartile range of 1.20 to 2.09 on a single surface. We fit participant accuracy to the differences in these IQRs across pairs. This also led to a negative GLMM fit (r = -0.65, p < 0.05). However, we are hesitant to add this plot to the manuscript for the reasons stated previously.

      Comment 3, Part 1

      Beyond this fundamental concern, there is a weakness in the representativeness of the PDMS finger, the vertical motion, and the speed of sliding to real human exploration.

      Overall, this is a continuous debate that we think offers two solutions, and we are not advocating for an “either-or” case. There is always a tradeoff between using a synthetic model of a finger versus a real human finger, and there is a place for both models. That is, while our mock finger will be “better” the more similar it is to a human finger, it is not our goal to fully replace a human finger. Rather our goal is to provide a consistent method of characterizing surfaces that is sufficiently similar to human touch as to be a useful and predictive tool.

      The usefulness of the mock finger is in isolating the features of each surface that is independent of human variability, i.e., instabilities that form without changing loading conditions between sliding motions or even within one sliding motion. Of course, with this method, we still require confirmation of these features still forming during human exploration, which we show in Fig. 3. We believe that this method of characterizing surfaces at the mesoscale will ultimately lead to more successful human studies on tactile perception. Currently, and as shown in the paper, characterizing surfaces through traditional techniques, such as a commercial tribometer (friction coefficient, using a steel or hard metal ball), roughness (via atomic force microscopy or some other metrology), surface energy are less or not at all predictive. Thus, we believe this mock finger is better than the current state-of-the-art characterizing surfaces (we are also aware of a commercial mock finger company, but we were unable to purchase or obtain an evaluation model).

      One of the main – and severe – limitations of using a human finger is that all fingers are different, meaning any study focusing on a particular user may not apply to others or be recreated easily by other researchers. We do not think it is feasible to set a standard for replication around a real human finger as that participant may no longer be available, or willing to travel the world as a “standard”. Furthermore, the method in which a person changes their pressures and velocities is different. We note that this is a challenge unique to touch perception – how an object is touched changes the friction generated, and thus the tactile stimulus generated, whereas a standardized stimulus is more straightforward for light or sound.

      However, we do emphasize that we have strongly considered the balance between feasibility and ecological validity in the design of a mock finger. We have a mock finger, with the three components of stiffness of a human finger (more below). Furthermore, we have also successfully used this mock finger in correlations with human psychophysics in previous work, where findings from our mechanical experiments were more predictive of human performance[4–7] than other available methods.

      Our changes to the manuscript Added (Page 2-3)

      “Mock finger as a characterization tool

      We use a mechanical setup with a PDMS (poly(dimethylsiloxane)) mock finger to derive tactile predictors as opposed to direct biomechanical measurements on human participants. While there is a tradeoff in selecting a synthetic finger over a real human finger to modeling human touch, human fingers themselves are also highly variable[23] both in their physical shape and their use during human motion. Our goal is to design a consistent method of characterization of samples that can be easily accessed by other researchers and does not rely on a standard established around single human participant. We believe that sufficient replication of surface, bulk properties, and contact geometry results in characterization that isolates consistent features of surfaces that are not derived from human-to-human variability. We have used this approach to successfully correlate human results with mock finger characterization previously.[8,9,24]

      The major component of a human finger, by volume, is soft tissue (~56%),[25] resulting in an effective modulus close to 100 kPa.[26,27] In order to achieve this same softness, we crosslink PDMS in a 1×1×5 cm mold at a 30:1 elastomer:crosslinker ratio. In addition, two more features in the human finger impart significant mechanical differences. Human fingers have a bone at the fingertip, the distal phalanx,[26–28, 8–10]which we mimic with an acrylic “bone” within our PDMS network. The stratum corneum, the stiffer, glassier outer layer of skin,[29] is replicated with the surface of the mock finger glassified, or further crosslinked, after 8 hours of UV-Ozone treatment.30 This treatment also modifies the surface properties of the native PDMS to align with those of a human finger more closely: it minimizes the viscoelastic tack at the surface, resulting in a comparable non-sticky surface. Stabilizing after one day after treatment, the mock finger surface obtains a moderate hydrophilicity (~60º), as is typically observed for a real finger.[11,31]

      The initial contact area formed before a friction trace is collected is a rectangle of 1×1 cm. While this shape is not entirely representative of a human finger with curves and ridges, human fingers flatten out enough to reduce the effects of curvature with even very light pressures.[31–33] This implies that for most realistic finger pressures, the contact area is largely load-independent, which is more accurately replicated with a rectangular mock finger.

      Lastly, we consider the role of fingerprint ridges. A key finding of our previous work is that while fingerprints enhanced frictional dynamics at certain conditions, key features were still maintained with a flat finger.[11] Furthermore, for some loading conditions, the more amplified signals could also result in more similar friction traces for different surfaces. We have observed good agreement between these friction traces and human experiments.[8,9,22,34]”

      Page 3-4, Materials and Methods

      “Mock Finger Preparation

      Friction forces across all six surfaces were measured using a custom apparatus with a polydimethylsiloxane (PDMS, Dow Sylgard 184) mock finger that mimics a human finger’s mechanical properties and contact mechanics while exploring a surface relatively closely.[8,9] PDMS and crosslinker were combined in a 30:1 ratio to achieve a stiffness of 100 kPa comparable to a real finger, then degassed in a vacuum desiccator for 30 minutes. We are aware that the manufacturer recommended crosslinking ratio for Sylgard 184 is 10:1 due to potential uncrosslinked liquid residues,[35] but further crosslinking concentrated at the surface prevents this. The prepared PDMS was then poured into a 1×1×5 cm mold also containing an acrylic 3D-printed “bone” to attach applied masses on top of the “fingertip” area contacting a surface during friction testing. After crosslinking in the mold at 60ºC for 1 hour, the finger was treated with UV-Ozone for 8 hours out of the mold to minimize viscoelastic tack.

      Mechanical Testing

      A custom device using our PDMS mock finger was used to collect macroscopic friction force traces replicating human exploration.[8,9] After placing a sample surface on a stage, the finger was lowered at a slight angle such that an initial 1×1 cm rectangle of “fingertip” contact area could be established. We considered a broad range of applied masses (M \= 0, 25, 75, and 100 g) added onto the deadweight of the finger (6 g) observed during a tactile discrimination task. The other side of the sensor was connected to a motorized stage (V-508 PIMag Precision Linear Stage, Physikinstrumente) to control both displacement (4 mm across all conditions) and sliding velocity (v \= 5, 10, 25, and 45 mm s<sup>-1</sup>). Forces were measured at all 16 combinations of mass and velocity via a 250 g Futek force sensor (k \= 13.9 kN m<sup>-1</sup>) threaded to the bone, and recorded at an average sampling rate of 550 Hz with a Keithley 7510 DMM digitized multimeter. Force traces were collected in sets of 4 slides, discarding the first due to contact aging. Because some mass-velocity combinations were near the boundaries of instability phase transitions, not all force traces at these given conditions exhibited similar profiles. Thus, three sets were collected on fresh spots for each condition to observe enough occurrences of multiple instabilities, at a total of nine traces per combination for each surface.”

      Added References

      (23) Infante, V. H. P. et al. The role of skin hydration, skin deformability, and age in tactile friction and perception of materials. Sci. Rep. 15, 9935 (2025).

      (24) Nolin, A., Lo, C.-Y., Kayser, L. V. & Dhong, C. B. Transparent and Electrically Switchable Thin Film Tactile Actuators Based on Molecular Orientation. Preprint at https://doi.org/10.48550/arXiv.2411.07968 (2024).

      (25) Murai, M., Lau, H.-K., Pereira, B. P. & Pho, R. W. H. A cadaver study on volume and surface area of the fingertip. J. Hand Surg. 22, 935–941 (1997).

      (26) Abdouni, A. et al. Biophysical properties of the human finger for touch comprehension: influences of ageing and gender. R. Soc. Open Sci. (2017) doi:10.1098/rsos.170321.

      (27) Cornuault, P.-H., Carpentier, L., Bueno, M.-A., Cote, J.-M. & Monteil, G. Influence of physico-chemical, mechanical and morphological fingerpad properties on the frictional distinction of sticky/slippery surfaces. J. R. Soc. Interface (2015) doi:10.1098/rsif.2015.0495.

      (28) Qian, K. et al. Mechanical properties vary for different regions of the finger extensor apparatus. J. Biomech. 47, 3094–3099 (2014).

      (29) Yuan, Y. & Verma, R. Measuring microelastic properties of stratum corneum. Colloids Surf. B Biointerfaces 48, 6–12 (2006).

      (30) Fu, Y.-J. et al. Effect of UV-Ozone Treatment on Poly(dimethylsiloxane) Membranes: Surface Characterization and Gas Separation Performance. Langmuir 26, 4392–4399 (2010).

      Comment 3, Part 2

      The real finger has multiple layers with different moduli. In fact, the stratum corneum cells, which are the outer layer at the interface and determine the friction, have a much higher modulus than PDMS. The real finger has multiple layers with different moduli. In fact, the stratum corneum cells, which are the outer layer at the interface and determine the friction, have a much higher modulus than PDMS.

      We have approximated the softness of the finger with 100 kPa crosslinked PDMS, which is close to what has been reported for the bulk of a human fingertip.[9,10] However, as mentioned in the Materials and Methods, there are two additional features of the mock finger that impart greater strength. The PDMS surrounds a rigid, acrylic bone comparable to the distal phalanx, which provides an additional layer of higher modulus.[8] Additionally, the 8-hour UV-Ozone treatment decreases the viscoelastic tack of the pristine PDMS by glassifying, or further crosslinking the surface of the finger,[12] therefore imparting greater stiffness at the surface similar to the contributions of the stratum corneum, along with a similar surface energy.[13] This technique is widely used in wearables,[14] soft robotics,[15] and microfluidics[16] to induce both these material changes. Additionally, the finger is used at least a day after UV-Ozone treatment is completed to generate a stable surface that is moderately hydrophilic, similar to the outermost layer of human skin.[17]

      Comment 3, Part 3

      In addition, the slanted position of the finger can cause non-uniform pressures across the finger. Both can contribute to making the PDMS finger have much more stick-slip than a real finger.

      To ensure that there is minimal contribution from the slanted position of the finger, an initial contact area of 1×1 cm is established before sliding and recording friction measurements. As the PDMS finger is a soft object, the portion in contact with a surface flattens and the contact area remains largely unchanged during sliding. Any additional stick-slip after this alignment step is caused by contact aging at the interface, but the first trace we collect is always discarded to only consider stick-slip events caused by surface chemistry. We recognize that it is difficult to completely control the pressure distribution due to the planar interface, but this is also expected when humans freely explore a surface.

      Comment 3, Part 4

      In fact, if you look at the regime maps, there is very little space that has steady sliding. This does not represent well human exploration of surfaces. We do not tend to use a force and velocity that will cause extensive stick-slip (frequent regions of 100% stick-slip) and, in fact, the speeds used in the study are on the slow side, which also contributes to more stick-slip. At higher speeds and lower forces, all of the materials had steady sliding regions.”

      We are not aware of published studies that extensively show that humans avoid stickslip regimes. In fact, we are aware familiar with literature where stiction spike formation is suppressed – a recent paper by AliAbbasi, Basdogan et. al. investigates electroadhesion and friction with NaCl solution-infused interfaces, resulting in significantly steadier forces.[18] We also directly showed evidence of instability formation that we observed during human exploration in Fig. 3B-C. These dynamic events are common, despite the lack of control of normal forces and sliding velocities. We also note that Reviewer 1, Comment 2, Part 2 was suggesting that we further explore possible trends from parameterizing the stiction spike.

      We note that many studies have often not gone at the velocities and masses required for stiction spikes – even though these masses and velocities would be routinely seen in free exploration – this is usually due to constraints of their equipment.[19] Sliding events during human free exploration of surfaces can exceed 100 mm/s for rapid touches. However, for the surfaces investigated here, we observe that large regions of stick-slip can emerge at velocities as low as 5 mm/s depending on the applied load. The incidence of steady sliding appears more dependent on the applied mass, with almost no steady sliding observed at or above 75 g. Indeed, the force categorization along our transition zones is the main point of the paper.

      Comment 3, Part 5

      Further, on these very smooth surfaces, the friction and stiction are more complex and cannot dismiss considerations such as finger material property change with sweat pore occlusion and sweat capillary forces. Also, the vertical motion of both the PDMS finger and the instructed human subjects is not the motion that humans typically use to discriminate between surfaces.

      We did not describe the task sufficiently. Humans were only given the instruction to slide their finger along a single axis from top to bottom of a sample, not vertical as in azimuthal to gravity. We have updated our wording in the manuscript to reflect this.

      Page 4

      “Participants could touch for as long as they wanted, but were asked to only use their dominant index fingers along a single axis to better mimic the conditions for instability formation during mechanical testing with the mock finger.”

      Page 11

      “The participant was then asked to explore each sample simultaneously, and ran over each surface in strokes along a single axis until the participant could decide which of the two had “more friction”.”

      Comment 3, Part 6

      Finally, fingerprints may not affect the shape and size of the contact area, but they certainly do affect the dynamic response and detection of vibrations.”

      We are aware of the nuance. Our previous work on the role of fingerprints on friction experienced by a PDMS mock finger showed enhanced signals with the incorporation of ridges on the finger and used a rate-and-state model of a heterogenous, elastic body to find corresponding trends (though there is no existing model of friction that can accurately model experiments on mesoscale friction).[11] The key conclusion was that a flat finger still preserved key dynamic features, and the presence of stronger or more vibrations could result in more similar forces for different surfaces depending on the sliding conditions.

      This is also in the context that we are seeking to provide a reasonable and experimentally accessible method to characterize surfaces, which will always be better as we get closer in replicating a true human finger. But our goal here was to replicate the finger sufficiently for use in human studies. We believe the more appropriate metric of success is if the mock finger is more successful than replacing traditional characterization experiments, like friction coefficient, roughness, surface energy, etc.

      Comment 4

      This all leads to the critical question, why are friction, normal force, and velocity not measured during the measured human exploration and in a systematic study using the real human finger? The authors posed an extremely interesting hypothesis that humans may alter their speed to feel the instability transition regions. This is something that could be measured with a real finger but is not likely to be correlated accurately enough to match regime boundaries with such a simplified artificial finger.

      We are excited that our manuscript offers a tractable manner to test the hypothesis that tactile decision-making models use friction instabilities as evidence. However, we lay out the challenges and barriers, and how the scope of this paper will lead us in that direction. We also clarify that our goals are to provide a method to characterize samples to better design tactile interfaces in haptics or in psychophysical experiments and raise awareness that the common methods of sample characterization in touch by an average friction coefficient or roughness is fundamentally unsound. Throughout the paper, we have made changes to reflect that our study, at this point, is only correlative.

      As discussed in the summary, and with additional detail here, to further support our findings through observation on humans would require answering:

      (1) Which one, or combination of, of the multiple swipes that people make responsible for a tactile decision? (There is a need for a decision-making model)

      (2) Establish what is, or may be, tactile evidence.

      (3) Establish tactile decision-making models are similar or different than existing decision-making models.

      (4) Design a task that does not require the use of subjective tactile descriptors, like “which one feels rougher”, which we have seen causes confusion in participants, which will likely require accounting for memory effects.

      We elaborate these points below:

      To successfully perform this experiment, we note that freely exploring humans make multiple strokes on a surface. Therefore, we would need to construct a decision-making model. It has not yet been demonstrated whether tactile decision making follows visual decision making, but perhaps to start, we can assume it does. Then, in the design of our decision-making paradigm, we immediately run into the problem: What is tactile evidence?

      From Fig. 3C, we already can see that identifying evidence is challenging. Prior to this manuscript, people may have chosen the average force, or the highest force. Or we may choose the average friction force. Then, after deciding on the evidence, we need to find a method to manipulate the evidence, i.e., create samples or a machine that causes high friction, etc. We show that during the course of human touch, due to the dynamic nature of friction, the average can change a large amount and sample design becomes a central barrier to experiments. Others may suggest immobilizing the finger and applying a known force, but given how much friction changes with human exploration, there is no known method to make a machine recreate temporally and spatially varying friction forces during sliding onto a stationary finger. Finally, perhaps most importantly, in addition to mechanical challenges, a study by Liu, Colgate et al. showed that even if they recorded the friction (2D) of a finger exploring a surface and then replicated the same friction forces onto a finger, the participant could not determine which surface the replayed friction force was supposed to represent.[1] This supports that the efference copy is important, that the forces in response to expected motion are important to determine friction. Finally, there is no known method to design instabilities a priori. They must be found through experiments. Especially since if we were to introduce, say a bump or a trough, then we bring in confounding variables to how participants tell surfaces apart.

      Furthermore, even if we had some consistent method to create tactile “evidence”, the paradigm also deserves some consideration. In our experience, the 3-AFC task we perform is important because the vocabulary for touch has not been established. That is, in 3-AFC, by asking to determine which one sample is unlike the others, we do not have to ask the participant questions like “which one is rougher” or “which one has less friction”. In contrast, 2-AFC, which is better for decision-making models because it does not include memory, requires the asking of a perceptual question like: “which one is rougher?”. In our ongoing work, taking two silane coatings, we found that participants could easily identify which surface is unlike the others above chance in a 3-AFC, but participants, even within their own trials, could not consistently identify one silane as perceptually “rougher” by 2-AFC. To us, this calls into question the validity of tactile descriptors, but is beyond the scope of this manuscript.

      This is not our only goal, but in the context of human exploration, in this manuscript here, we believed it was important to identify a mechanical parameter that was consistent with how humans explore surfaces, but was also a parameter that could characterize to some consistent property of a surface – irrespective of whether a human was touching it. We thought that designing human decision-making models and paradigms around the friction coefficient would not be successful.

      Given the scope of these challenges, we do not think it would be possible to establish these conceptual sequences in a single manuscript. However, we think that our manuscript brings an important step forward to approach this problem.

      Reviewer 2 (Public review):

      Summary:

      In this paper, the authors want to test the hypothesis that frictional instabilities rather than friction are the main drivers for discriminating flat surfaces of different sub-nanometric roughness profiles.

      They first produced flat surfaces with 6 different coatings giving them unique and various properties in terms of roughness (picometer scale), contact angles (from hydrophilic to hydrophobic), friction coefficient (as measured against a mock finger), and Hurst exponent.

      Then, they used those surfaces in two different experiments. In the first experiment, they used a mock finger (PDMS of 100kPA molded into a fingertip shape) and slid it over the surfaces at different normal forces and speeds. They categorized the sliding behavior as steady sliding, sticking spikes, and slow frictional waves by visual inspection, and show that the surfaces have different behaviors depending on normal force and speed. In a second experiment, participants (10) were asked to discriminate pairs of those surfaces. It is found that each of those pairs could be reliably discriminated by most participants.

      Finally, the participant's discrimination performance is correlated with differences in the physical attributes observed against the mock finger. The authors found a positive correlation between participants' performances and differences in the count of steady sliding against the mock finger and a negative correlation between participants' reaction time and differences in the count of stiction spikes against the mock finger. They interpret those correlations as evidence that participants use those differences to discriminate the surfaces.

      Strengths:

      The created surfaces are very interesting as they are flat at the nanometer scale, yet have different physical attributes and can be reliably discriminated.

      We thank Reviewer 2 for their notes on our manuscript. The responses below address the reviewer’s comments and recommendations for revised work.

      Weaknesses:

      Comment 1

      In my opinion, the data presented in the paper do not support the conclusions. The conclusions are based on a correlation between results obtained on the mock finger and results obtained with human participants but there is no evidence that the human participants' fingertips will behave similarly to the mock finger during the experiment. Figure 3 gives a hint that the 3 sliding behaviors can be observed in a real finger, but does not prove that the human finger will behave as the mock finger, i.e., there is no evidence that the phase maps in Figure 1C are similar for human fingers and across different people that can have very different stiffness and moisture levels.

      We have made changes throughout the manuscript to acknowledge that our findings are correlative, clarifying this throughout, and incorporating into the discussion how our work may enable biomechanical measurements and tactile decision making models.

      The mechanical characterization conducted with the mock finger seeks to extract significant features of friction traces of a set of surfaces to use as predictors of tactile discriminability. The goal is to find a consistent method to characterize surfaces for use in tactile experiments that can be replicated by others and used prior to any human experiments. However, in the overall response and in a response to a similar comment by Reviewer 1 (recreated below), we also explain why we believe experiments on humans to establish this fact is not yet reasonable.

      First, we discuss the mock finger. The PDMS finger is treated to have comparable surface and bulk properties to a human finger. We have approximated the softness of the finger with 100 kPa crosslinked PDMS, which is close to what has been reported for the bulk of a human fingertip.[9,10] However, as mentioned in the Materials and Methods, there are two additional features of the mock finger that impart greater strength. The PDMS surrounds a rigid, acrylic bone comparable to the distal phalanx, which provides an additional layer of higher modulus.[8] Additionally, the 8-hour UV-Ozone treatment decreases the viscoelastic tack of the pristine PDMS by glassifying, or further crosslinking the surface of the finger,[12] therefore imparting greater stiffness at the surface similar to the contributions of the stratum corneum, along with a similar surface energy.[13] Additionally, the finger is used at least a day after UV-Ozone treatment is completed in order for the surface to return to moderate hydrophilicity, similar to the outermost layer of human skin.[17] We also discuss the shape of the contact formed. To ensure that there is minimal contribution from the slanted position of the finger, an initial contact area of 1×1 cm is established before sliding and recording friction measurements. As the PDMS finger is a soft object, the portion in contact with a surface flattens and the contact area remains largely unchanged during sliding. Any additional stick-slip after this alignment step is caused by contact aging at the interface, but the first trace we collect is always discarded to only consider stick-slip events caused by surface chemistry. We recognize that it is difficult to completely control the pressure distribution due to the planar interface, but this is also expected when humans freely explore a surface. Finally, we consider flat vs. fingerprinted fingers. Our previous work on the role of fingerprints on friction experienced by a PDMS mock finger showed enhanced signals with the incorporation of ridges on the finger and used a rate-and-state model of a heterogenous, elastic body to find corresponding trends.[11] The key conclusion was that a flat finger still preserved key dynamic features, and the presence of stronger or more vibrations could result in more similar forces for different surfaces depending on the sliding conditions. We note that we have subsequently used this flat mock finger in correlations with human psychophysics in previous work, where findings from our mechanical experiments were predictive of human performance.[4–7] We have added these details to the manuscript.

      With this adequately similar mock finger, we collected friction traces at controlled conditions of normal force and velocity in order to extract the signals unique to each material that are not caused by the influence of human variability. For example, we observe the smallest regions of steady sliding on our phase maps (Fig. 1C) for short-chain alkylsilanes C4 and C5, while the increased intermolecular forces of other silanes increase the incidence of steady sliding. We have also previously shown that comparisons of similarly collected mechanical data is predictive of human performance, using the crosscorrelations between signals of two different materials.[4–7] While different participants produce different raw signals, we see that broad categories of stick-slip, i.e. instabilities, can be extracted (Fig. 3B-C) and used as a cue in a tactile discrimination task. As mentioned above, we have provided an additional section about the usefulness of our mock finger, as well as its structure, in the main manuscript.

      Second, we lay out the challenges and barriers to demonstrating this in humans in the manner requested by the reviewer, and how the scope of this paper will lead us in that direction. We also clarify that our goals are to provide a method to characterize samples to better design tactile interfaces in haptics or in psychophysical experiments and raise awareness that the common methods of sample characterization in touch by an average friction coefficient or roughness is fundamentally unsound.

      As discussed in the summary, and with additional detail here, to further support our findings through observation on humans would require answering:

      (1) Which one, or combination of, of the multiple swipes that people make responsible for a tactile decision?

      (2) Establish what is, or may be, tactile evidence.

      (3) Establish tactile decision-making models are similar or different than existing decision-making models.

      (4) Test the hypothesis, in these models, that friction instabilities are evidence, and not some other unknown metric.

      (5) Design a task that does not require the use of subjective tactile descriptors, like “which one feels rougher”, which we see cause confusion in participants, which will likely require accounting for memory effects.

      We elaborate these points below:

      To successfully perform this experiment, we note that freely exploring humans make multiple strokes on a surface. Therefore, we would need to construct a decision-making model. It has not yet been demonstrated whether tactile decision making follows visual decision making, but perhaps to start, we can assume it does. Then, in the design of our decision-making paradigm, we immediately run into the problem: What is tactile evidence?

      From Fig. 3C, we already can see that identifying evidence is challenging. Prior to this manuscript, people may have chosen the average force, or the highest force. Or we may choose the average friction force. Then, after deciding on the evidence, we need to find a method to manipulate the evidence, i.e., create samples or a machine that causes high friction, etc. We show that during the course of human touch, due to the dynamic nature of friction, the average can change a large amount and sample design becomes a central barrier to experiments. Others may suggest immobilizing the finger and applying a known force, but given how much friction changes with human exploration, there is no known method to make a machine recreate temporally and spatially varying friction forces during sliding onto a stationary finger. Finally, perhaps most importantly, in addition to mechanical challenges, a study by Liu, Colgate, et al. showed that even if they recorded the friction (2D) of a finger exploring a surface and then replicated the same friction forces onto a finger, the participant could not determine which surface the replayed friction force was supposed to represent.[1] This supports that the efference copy is important, that the forces in response to expected motion are important to determine friction. Finally, there is no known method to design instabilities a priori. They must be found through experiments, especially since if we were to introduce, say a bump or a trough, then we bring in confounding variables to how participants tell surfaces apart.

      Furthermore, even if we had some consistent method to create tactile “evidence”, the paradigm also deserves some consideration. In our experience, the 3-AFC task we perform is important because the vocabulary for touch has not been established. That is, in 3-AFC, by asking to determine which one sample is unlike the others, we do not have to ask the participant questions like “which one is rougher” or “which one has less friction”. In contrast, 2-AFC, which is better for decision-making models because it does not include memory, requires the asking of a perceptual question like: “which one is rougher?”. In our ongoing work, taking two silane coatings, we found that participants could easily identify which surface is unlike the others above chance in a 3-AFC, but participants, even within their own trials, could not consistently identify one silane as perceptually “rougher” by 2-AFC. To us, this calls into question the validity of tactile descriptors, but is beyond the scope of the current manuscript.

      This is not our only goal, but in the context of human exploration, in this manuscript here, we believed it was important to identify a mechanical parameter that was consistent with how humans explore surfaces, but was also a parameter that could characterize to some consistent property of a surface – irrespective of whether a human was touching it. We thought that designing human decision-making models and paradigms around the friction coefficient would not be successful.

      Given the scope of these challenges, we do not think it would be possible to establish this conceptual sequence in a single manuscript.

      See Reviewer 1, comment 3part 3 for changes to the manuscript

      Comment 2

      I believe that the authors collected the contact forces during the psychophysics experiments, so this shortcoming could be solved if the authors use the actual data, and show that the participant responses can be better predicted by the occurrence of frictional instabilities than by the usual metrics on a trial by trial basis, or at least on a subject by subject basis. I.e. Poor performers should show fewer signs of differences in the sliding behaviors than good performers.

      To fully implement this, a decision-making model is necessary because, as a counter example, a participant could have generated 10 swipes of SFW and 1 swipe of a Sp, but the Sp may have been the most important event for making a tactile decision. This type of scenario is not compatible with the analysis suggested — and similar counterpoints can be made for other types of seemingly straightforward analysis.

      While we are interested and actively working on this, the study here is critical to establish types of evidence for a future decision-making model. We know humans change their friction constantly during real exploration, so it is unclear which of these constantly changing values we should input into the decision making model, and the future challenges we anticipate are explained in Weaknesses, Comment 1.

      Comment 3

      The sample size (10) is very small.

      We recognize that, with all factors being equal, this sample size is on the smaller end. However, we emphasize the degree of control of samples is far above typical, with minimal variations in sample properties such as surface roughness, and every sample for every trial was pristine. Furthermore, the sample preparation (> 300 individual wafers were used) became a factor. Although not typically appropriate, and thus not included in the manuscript, a post-hoc power analysis for our 100 trials of our pair that was closest to chance, P4, (53%, closest to chance at 33%) showed a power of 98.2%, suggesting that the study was appropriately powered.

      Reviewer 2 (Recommendations for the authors):

      Comment 1

      Differences in SS and Sp (Table 2) are NOT physical or mechanical differences but are obtained by counting differences in the number of occurrences of each sliding behavior. It is rather a weird choice.

      We disagree that differences in SS and Sp are not physical or mechanical, as these are well-established phenomena in the soft matter and tribology literature.[20–22] These are known as “mechanical instabilities” and generated due to the effects of two physical phenomena: the elasticity of the finger (which is constant in our mechanical testing) and the friction forces present (which change per sample type). The motivation behind using these different shapes is that the instabilities, in some conditions, can be invariant to external factors like velocity. This would be quite advantageous for human exploration because, unlike friction coefficient, which changes with nearly any factor, including velocity and mass, the instabilities being invariant to velocity would mean that we are accurately characterizing a unique identifier of the surface even though velocity may be variable.

      This “weird choice” is the central innovation of this paper. This choice was necessary because we demonstrated that the common usage of friction coefficient is fundamentally flawed: we see that friction coefficient suggests that surface which are more different would feel more similar – indeed the most distinctive surfaces would be two surfaces that are identical, which is clearly spurious. Furthermore, Table 1 now includes the range of friction generated on a surface, the range of friction coefficients of a single surface is large – of order the differences in friction between two surfaces. This is expected in soft sliding systems and emphasizes our issue with the use of average friction coefficient in psychophysical design. One potential explanation for why we were able to see this is effect is because our surfaces have similar (< 0.6 nm variability) roughness, removing potential confounding factors from large scale roughness, and this type of low roughness control has not been widely used in tactile studies to the best of our knowledge.

      Comment 2

      Figures 2B-C: why are the x-data different than Table 2?

      The x-data in Fig. 2B-C are the absolute differences in the number of occurrences measured for a given instability type or material property out of 144 pulls. Modeling the human participant results in our GLMMs required the independent variables to be in this form rather than percentages. We initially chose to list percent differences in Table 2 to highlight the ranges of differences instead of an absolute value, but have added both for clarity.

      Our changes to the manuscript

      Page 7

      “To determine if humans can detect these three different instabilities, we selected six pairs of surfaces to create a broad range of potential instabilities present across all three types. These are summarized in Table 2, where the first column for each instability is the difference in occurrence of that instability formed between each pair, and the second is the percent difference.”

      “Thus, when comparing C4 versus C4-APTMS, they have a difference in steady sliding of 20 out of a maximum 144 pulls, for a |ΔSS| of 13.9%. The absolute value is taken to compare total differences present, as the psychophysical task does not distinguish between sample order.”

      Comment 3

      We constructed a set of coated surfaces with physical differences which were imperceptible by touch but created different types of instabilities based on how quickly a finger is slid and how hard a human finger is pressed during sliding." Yet, in your experiment, participants could discriminate them, so this is incoherent.

      To clarify the point, macroscopic objects can differ in physical shape and in chemical composition. What we meant was that the physical differences, i.e., roughness, were below a limit (Skedung et al.) that participants, without a coating, would not be able to tell these apart.[23] Therefore, the reason people could tell our surfaces apart was due to the chemical composition of the surface, and not any differences in roughness or physical effects like film stiffness (due to the molecular-scale thinness of the surface coatings, they are mechanically negligible). However, we concede that at the molecular scale, the traditional macroscopic distinction between physical and chemical is blurred.

      We have made minor revisions to the wording in the abstract. We clarify that the surface coatings had physical differences in roughness that were smaller than 0.6 nm, which based purely on roughness, would not be expected to be distinguishable to participants. Therefore, the reason participants can tell these surfaces apart is due to differences in friction generated by chemical composition, and we were able to minimize contributions from physical differences in the sample our study.

      Our changes to the manuscript

      Page 1, Abstract

      “Here, we constructed a set of coated surfaces with minimal physical differences that by themselves, are not perceptible to people, but instead, due to modification in surface chemistry, the surfaces created different types of instabilities based on how quickly a finger is slid and how hard a human finger is pressed during sliding.”

      “In one experiment, we used a mechanical mock finger to quantify and classify differences in instability formation from different coated surfaces. In a second experiment, participants perform a discrimination task using the same coated surfaces. Using the data from these two experiments, we found that human discrimination response times were faster with surfaces where the mock finger produced more stiction spikes and discrimination accuracy was higher where the mock finger produced more steady sliding. Conversely, traditional metrics like surface roughness or average friction coefficient did not relate to tactile discriminability. In fact, the typical method of averaging friction coefficients led to a spurious correlation which erroneously suggests that distinct objects should feel identical and identical objects should feel distinct—similar to findings by others. Friction instabilities may offer a more predictive and tractable framework of fine touch perception than friction coefficients, which would accelerate the design of tactile interfaces.”

      Reviewer 3 (Public review):

      Strengths

      The paper describes a new perspective on friction perception, with the hypothesis that humans are sensitive to the instabilities of the surface rather than the coefficient of friction. The paper is very well written and with a comprehensive literature survey.

      One of the central tools used by the author to characterize the frictional behavior is the frictional instabilities maps. With these maps, it becomes clear that two different surfaces can have both similar and different behavior depending on the normal force and the speed of exploration. It puts forward that friction is a complicated phenomenon, especially for soft materials.

      The psychophysics study is centered around an odd-one-out protocol, which has the advantage of avoiding any external reference to what would mean friction or texture for example. The comparisons are made only based on the texture being similar or not.

      The results show a significant relationship between the distance between frictional maps and the success rate in discriminating two kinds of surface.

      We thank Reviewer 3 for their notes and interesting discussion points on our manuscript. Below, we address the reviewer’s feedback and comments on related works.

      Weaknesses:

      Comment 1

      The main weakness of the paper comes from the fact that the frictional maps and the extensive psychophysics study are not made at the same time, nor with the same finger. The frictional maps are produced with an artificial finger made out of PDMS which is a poor substitute for the complex tribological properties of skin.

      A similar comment was made by Reviewers 1 and 2. We agree in part and have made changes throughout that our study is correlative, but presents an important step forward to these biomechanical measurements and corresponding decision making models.

      We are not claiming that our PDMS fingers are superior to real fingers, but rather, we cannot establish standards in the field by using real human fingers that vary between subjects and researchers. We believe the mock finger we designed is a reasonable mimic of the human finger by matching surface energy, heterogeneous mechanical structure, and the ability to test multiple physiologically relevant pressures and sliding velocities.

      We achieve a heterogeneous mechanical structure with the 3 primary components of stiffness of a human finger. The effective modulus of ~100 kPa, from soft tissue,[9,10] is obtained with a 30:1 ratio of PDMS to crosslinker. The PDMS also surrounds a rigid, acrylic bone comparable to the distal phalanx, which provides an additional layer of higher modulus.[8] Additionally, the 8-hour UV-Ozone treatment decreases the viscoelastic tack of the pristine PDMS by glassifying, or further crosslinking the surface of the finger,[12] therefore imparting greater stiffness at the surface similar to the contributions of the stratum corneum, along with a similar surface energy.[13] The finger is used at least a day after UV-Ozone treatment is completed in order for the surface to return to moderate hydrophilicity, similar to the outermost layer of human skin.[17] We also discuss the shape of the contact formed. To ensure that there is minimal contribution from the slanted position of the finger, an initial contact area of 1×1 cm is established before sliding and recording friction measurements. As the PDMS finger is a soft object, the portion in contact with a surface flattens and the contact area remains largely unchanged during sliding. We recognize that it is difficult to completely control the pressure distribution due to the planar interface, but this variation is also expected when humans freely explore a surface. Finally, we consider flat vs. fingerprinted fingers. Our previous work on the role of fingerprints on friction experienced by a PDMS mock finger showed enhanced signals with the incorporation of ridges on the finger and used a rate-andstate model of a heterogenous, elastic body to find corresponding trends.[11] The key conclusion was that a flat finger still preserved key dynamic features, and the presence of stronger or more vibrations could result in more similar forces for different surfaces depending on the sliding conditions. We note that we have subsequently used the controlled mechanical data collected with this flat mock finger in correlations with human psychophysics in previous work, where findings from our mechanical experiments were predictive of human performance.[4–7] Ultimately, we see from our prior work and here that, despite the drawbacks of our mock finger, it outperforms other standard characterization technique in providing information about the mesoscale that correlates to tactile perception. We have added these details to the manuscript.

      We also note that an intermediate option, replicating real fingers, even in a mold, may also inadvertently limit trends from characterization to a specific finger. One of the main – and severe – limitations of using a human finger is that all fingers are different, meaning any study focusing on a particular user may not apply to others or be recreated easily by other researchers. We cannot set a standard for replication around a real human finger as that participant may no longer be available, or willing to travel the world as a “standard”. Furthermore, the method in which a single person changes their pressures and velocities as they touch a surface is highly variable. We also note that in the Summary Response, we noted that a study by Colgate et al. (IEEE ToH 2024) demonstrated that efference copies may be important, and thus constraining a human finger and replaying the forces recorded during free exploration will not lead to the participant identifying a surface with any consistency. Thus, it is important to allow humans to freely explore surfaces, but creates nearly limitless variability in friction forces.

      This is also against the backdrop that we are seeking to provide a method to characterize surfaces. Indeed, the more features we replicate in the mock finger to a human finger, the more likely it is that the mechanical data will correlate to human performance. However, we have used this technique several times to achieve stronger correlations to human data than other available techniques. We believe the metric of success should be in comparison to the available characterization technique, rather than a 1:1 reconstruction of forces of an arbitrary human finger. Indeed, a 1:1 reconstruction of forces of an arbitrary human finger would be limited to the finger of a single individual, perhaps even to that individual on a given day.

      See Reviewer1 weaknesses, comment 2 part 2 for changes to the manuscript

      Comment 2

      The evidence would have been much stronger if the measurement of the interaction was done during the psychophysical experiment. In addition, because of the protocol, the correlation is based on aggregates rather than on individual interactions.

      We agree that this would have helped further establish our argument, but in the overall statement and in other reviewer responses, we describe the significant challenges to establishing this.

      To fully implement this, a decision-making model is necessary because, as a counter example, a participant could have generated 10 swipes of SFW and 1 swipe of a Sp, but the Sp may have been the most important event for making a tactile decision. We also clarify that our goals are to provide a method to characterize samples to better design tactile interfaces in haptics or in psychophysical experiments.

      As discussed in the summary, and expanded on here, in our view, to develop a decision-making model, the challenges are as follows:

      (1) Which one, or combination of, of the multiple swipes that people make responsible for a tactile decision?

      (2) Establish what is, or may be, tactile evidence.

      (3) Establish tactile decision-making models are similar or different than existing decision-making models.

      (4) Test the hypothesis, in these models, that friction instabilities are evidence, and not some other unknown metric.

      (5) Design a task that does not require the use of subjective tactile descriptors, like “which one feels rougher”, which we see cause confusion in participants, which will likely require accounting for memory effects.

      (6) Design samples that vary in the amount of evidence generated, but this evidence cannot be controlled directly. Rather, the samples indirectly vary evidence by how likely it is for a human to generate different types of friction instabilities during standard exploration.

      We elaborate these points below:

      To successfully perform this experiment, we note that freely exploring humans make multiple strokes on a surface. Therefore, we would need to construct a decision-making model. It has not yet been demonstrated whether tactile decision making follows visual decision making, but perhaps to start, we can assume it does. Then, in the design of our decision-making paradigm, we immediately run into the problem: What is tactile evidence?

      From Fig. 3C, we already can see that identifying evidence is challenging. Prior to this manuscript, people may have chosen the average force, or the highest force. Or we may choose the average friction force. Then, after deciding on the evidence, we need to find a method to manipulate the evidence, i.e., create samples or a machine that causes high friction, etc. We show that during the course of human touch, due to the dynamic nature of friction, the average can change a large amount and sample design becomes a central barrier to experiments. Others may suggest to immobilize the finger and applying a known force, but given how much friction changes with human exploration, there is no known method to make a machine recreate temporally and spatially varying friction forces during sliding onto a stationary finger. Finally, perhaps most importantly, in addition to mechanical challenges, a study by Liu, Colgate et al. showed that even if they recorded the friction (2D) of a finger exploring a surface and then replicated the same friction forces onto a finger, the participant could not determine which surface the replayed friction force was supposed to represent.[1] This supports that the efference copy is important, that the forces in response to expected motion are important to determine friction. Finally, there is no known method to design instabilities a priori. They must be found through experiments, especially since if we were to introduce, say a bump or a trough, then we bring in confounding variables to how participants tell surfaces apart.

      Furthermore, even if we had some consistent method to create tactile “evidence”, the paradigm also deserves some consideration. In our experience, the 3-AFC task we perform is important because the vocabulary for touch has not been established. That is, in 3-AFC, by asking to determine which one sample is unlike the others, we do not have to ask the participant questions like “which one is rougher” or “which one has less friction”. In contrast, 2-AFC, which is better for decision-making models because it does not include memory, requires the asking of a perceptual question like: “which one is rougher?”. In our ongoing work, taking two silane coatings, we found that participants could easily identify which surface is unlike the others above chance in a 3-AFC, but participants, even within their own trials, could not consistently identify one silane as perceptually “rougher” by 2-AFC. To us, this calls into question the validity of tactile descriptors, but is beyond the scope of the current manuscript.

      This is not our only goal, but in the context of human exploration, in this manuscript here, we believed it was important to identify a mechanical parameter that was consistent with how humans explore surfaces, but was also a parameter that could characterize to some consistent property of a surface – irrespective of whether a human was touching it. We thought that designing human decision-making models and paradigms around the friction coefficient would not be successful.

      Given the scope of these challenges, we do not think it would be possible to establish this conceptual sequence in a single manuscript.

      Comment 3

      The authors compensate with a third experiment where they used a 2AFC protocol and an online force measurement. But the results of this third study, fail to convince the relation.

      With this experiment, our central goal was to demonstrate that the instabilities we have identified with the PDMS finger also occur with a human finger. Several instances of SS, Sp, and SFW were recorded with this setup as a participant touched surfaces in real time.

      Comment 4

      No map of the real finger interaction is shown, bringing doubt to the validity of the frictional map for something as variable as human fingers.

      Real fingers change constantly during exploration, and friction is state-dependent, meaning that the friction will depend on how the person was moving the moment prior. Therefore, a map is only valid for a single human movement – even if participants all were instructed to take a single swipe and start from zero motion, humans are unable to maintain constant velocities and pressures. Clearly, this is not sustainable for any analysis, and these drawbacks apply to any measured parameter, whether instabilities suggested here, or friction coefficients used throughout. We believe the difficulty of this approach emphasizes why a standard map of characterization of a surface by a mock finger, even with its drawbacks, is a viable path forward.

      Reviewer 3 (Recommendations for the authors):

      Comment 1

      It would be interesting to comment on a potential connection between the frictional instability maps and Schalamack waves.

      Schallamach waves are a subset of slow frictional waves (SFW). Schallamach waves are very specifically defined in the field. They occur when pockets of air that form between a soft sliding object and rigid surface which then propagate rear-to-front (retrograde waves) relative to motion of the sliding motion and form buckles due to adhesive pinning. Wrinkles then form at the detached portion of the soft material, until the interface reattaches and the process repeats.[24] There is typically a high burden of proof to establish a Schallamach wave over a more general slow frictional wave. We note that it would be exceedingly difficult to design samples that can reliably create subsets of SFW, but we are aware that this may be an interesting question at a future point in our work.

      Comment 2

      The force sensors look very compliant, and given the dynamic nature of the signal, it is important to characterize the frequency response of the system to make sure that the fluctuations are not amplified.

      Thank you for noticing. We mistyped the sensor spring constant as 13.9 N m<sup>-1</sup> instead of kN m<sup>-1</sup>. However, below we show how the instabilities are derived from the mechanics at the interface due to the compliance of the finger. The “springs” of the force sensor and PDMS finger are connected in parallel. Since k<sub>sensor</sub> = 13.9 kN m<sup>-1</sup>, the spring constant of the system overall reflects the compliance of the finger, and highlights the oscillations arising solely from stick-slip. A sample calculation is shown below.

      Author response image 1.

      Fitting a line to the initial slope of the force trace for C6 gives the equation y = 25.679x – 0.2149. The slope here represents force data over time data, and is divided by the velocity (25 mm/s) to determine the spring constant of the system k<sub>total</sub> == 1027.16 N/m. This value is lower than k<sub>sensor</sub> = 13.9 kN/m, indicating that the “springs” representing the force sensor and PDMS finger are connected in parallel:

      . The finger is the compliant component of the system, with k<sub>finger</sub> = 1.11 kN/m, and of course, real human fingers are also compliant so this matches our goals with the design of the mock finger.

      Our changes to the manuscript

      (Page 4) (k = 13.9 kN m<sup>1</sup>)

      Comment 3

      The authors should discuss about the stochastic nature of friction: - Wiertlewski, Hudin, Hayward, IEEE WHC 2011 Greenspon, McLellan, Lieber, Bensmaia, JRSI 2020.

      We believe that, given the references, this comment on “stochastic” refers to the macroscopically-observable fluctuations (i.e., the mechanical “noise” which is not due to instrument noise) in friction arising from the discordant network of stick-slip phenomena occurring throughout the contact zone, and not the stochastic nature of nanoscale friction that occurs thermal fluctuations nor due to statistical distributions in bond breaking associated with soft contact.

      We first note that our small-scale fluctuations do not arise from a periodic surface texture that dominates in the frequency regime. However, even on our comparatively smooth surfaces, we do expect fluctuations due to nanoscale variation in contact, generation of stick-slip across at microscale length scales that occur either concurrently or discordantly across the contact zone, and the nonlinear dependence of friction to nearly any variation in state and composition.[11]

      Perhaps the most relevant to the manuscript is that a major advantage of analysis by friction is that it sidesteps these ever-present microscale fluctuations, leading to more clearly defined classifiers or categories during analysis. Wiertlewski et. al. showed repeated measurements in their systems ultimately gave rise to consistent frequencies[25] (we think their system was in a steady sliding regime and the patterning gave rise to underlying macroscopic waves). These consistent frequencies, at least in soft systems and absent obvious macroscopic patterned features, would be expected to arise from the instability categories and we see them throughout.

      Comment 4

      It is stated that "we observed a spurious, negative correlation between friction coefficient and accuracy".

      What makes you qualify that correlation as spurious?

      We mean this as in the statistical definition of “spurious”.

      This correlation would indicate that by the metric of friction coefficient, more different surfaces are perceived more similarly. Thus, two very different surfaces, like Teflon and sandpaper, by friction coefficient would be expected to feel very similar. Two nearly identical surfaces would be expected to feel very different – but of course, humans cannot consistently distinguish two identical surfaces. This finding is counterintuitive and refutes that friction coefficient is a reliable classifier of surfaces by touch. We do not think it is productive to determine a mechanism for a spurious correlation, but perhaps one reason we were able to observe this is because our study, to the best of our knowledge, is unique for having samples that are controlled in their physical differences in roughness and surface features.

      See response to Reviewer 1 weaknesses, comment 1 for changes to the manuscript

      Comment 5

      The authors should comment on the influence of friction on perceptual invariance. Despite inducing radially different frictional behavior for various conditions, these surfaces are stably perceived. Maybe this is a sign that humans extract a different metric?

      We agree – we are excited that frictional instabilities may offer a more stable perceptual cue because they are not prone to fluctuations (as discussed in Comment 3) and instability formation, in many conditions, is invariant to applied pressures and velocities – thus forming large zones where a human may reasonable encounter a given instability.

      Raw friction is highly prone to variation during human exploration (in alignment with Recommendations for the authors, Comment 3), but ongoing work seeks to explain tactile constancy, or the ability to identify objects despite these large changes in force. Very recently published work by Fehlberg et. al. identified the role of modulating finger speed and normal force in amplifying the differences in friction coefficient between materials in order to identify them,[26] and we postulate that their work may be streamlined and consistent with the idea of friction instabilities, though we have not had a chance to discuss this in-depth with the authors yet.

      We think that the instability maps show a viable path forward to how surfaces are stably perceived, and instabilities themselves show a potential mechanism: mathematically, instabilities for given conditions can be invariant to velocity or mass, creating zones where a certain instability is encountered. This reduces the immense variability of friction to a smaller, more stable classification of surfaces (e.g., a 30% SS surface or a 60% SS surface). A given surface will typically produce the same instability at a specific condition (we found some boundaries of experimental parameters are very condition sensitive, but many conditions are not), whereas a single friction trace which is highly prone to variation is not a stable metric.

      Added Reference

      (53) M. Fehlberg, E. Monfort, S. Saikumar, K. Drewing and R. Bennewitz, IEEE Trans. Haptics, 2024, 17, 957–963.

      References

      (1) Liu, Z., Kim, J.-T., Rogers, J. A., Klatzky, R. L. & Colgate, J. E. Realism of Tactile Texture Playback: A Combination of Stretch and Vibration. IEEE Trans. Haptics 17, 441–450 (2024).

      (2) Waters, I., Alazmani, A. & Culmer, P. Engineering Incipient Slip Into Surgical Graspers to Enhance Grasp Performance. IEEE Transactions on Medical Robotics and Bionics 2, 541–544 (2020).

      (3) Gueorguiev, D., Bochereau, S., Mouraux, A., Hayward, V. & Thonnard, J.-L. Touch uses frictional cues to discriminate flat materials. Sci Rep 6, 25553 (2016).

      (4) Carpenter, C. W. et al. Human ability to discriminate surface chemistry by touch. Mater. Horiz. 5, 70– 77 (2018).

      (5) Nolin, A. et al. Predicting human touch sensitivity to single atom substitutions in surface monolayers for molecular control in tactile interfaces. Soft Matter 17, 5050–5060 (2021).

      (6) Nolin, A. et al. Controlling fine touch sensations with polymer tacticity and crystallinity. Soft Matter 18, 3928–3940 (2022).

      (7) Swain, Z. et al. Self-Assembled Thin Films as Alternative Surface Textures in Assistive Aids with Users Who are Blind. J. Mater. Chem. B (2024) doi:10.1039/D4TB01646G.

      (8) Qian, K. et al. Mechanical properties vary for different regions of the finger extensor apparatus. J Biomech 47, 3094–3099 (2014).

      (9) Abdouni, A. et al. Biophysical properties of the human finger for touch comprehension: influences of ageing and gender. Royal Society Open Science (2017) doi:10.1098/rsos.170321.

      (10) Cornuault, P.-H., Carpentier, L., Bueno, M.-A., Cote, J.-M. & Monteil, G. Influence of physicochemical, mechanical and morphological fingerpad properties on the frictional distinction of sticky/slippery surfaces. Journal of The Royal Society Interface (2015) doi:10.1098/rsif.2015.0495.

      (11) Dhong, C. et al. Role of fingerprint-inspired relief structures in elastomeric slabs for detecting frictional differences arising from surface monolayers. Soft Matter 14, 7483–7491 (2018).

      (12) Fu, Y.-J. et al. Effect of UV-Ozone Treatment on Poly(dimethylsiloxane) Membranes: Surface Characterization and Gas Separation Performance. Langmuir 26, 4392–4399 (2010).

      (13) Yuan, Y. & Verma, R. Measuring microelastic properties of stratum corneum. Colloids Surf B Biointerfaces 48, 6–12 (2006).

      (14) Yu, G. et al. A wearable pressure sensor based on ultra-violet/ozone microstructured carbon nanotube/polydimethylsiloxane arrays for electronic skins. Nanotechnology 29, 115502 (2018).

      (15) Zheng, L. et al. Dual-Stimulus Smart Actuator and Robot Hand Based on a Vapor-Responsive PDMS Film and Triboelectric Nanogenerator. ACS Appl. Mater. Interfaces 11, 42504–42511 (2019).

      (16) Ma, K., Rivera, J., Hirasaki, G. J. & Biswal, S. L. Wettability control and patterning of PDMS using UV–ozone and water immersion. Journal of Colloid and Interface Science 363, 371–378 (2011).

      (17) Mavon, A. et al. Sebum and stratum corneum lipids increase human skin surface free energy as determined from contact angle measurements: A study on two anatomical sites. Colloids and Surfaces B: Biointerfaces 8, 147–155 (1997).

      (18) AliAbbasi, E. et al. Effect of Finger Moisture on Tactile Perception of Electroadhesion. IEEE Trans. Haptics 17, 841–849 (2024).

      (19) Corniani, G. et al. Sub-surface deformation of individual fingerprint ridges during tactile interactions.

      eLife 13, (2024).

      (20) Israelachvili, J. N. Intermolecular and Surface Forces. (Academic Press, 2011).

      (21) Das, S. et al. Stick–slip friction of gecko-mimetic flaps on smooth and rough surfaces. J R Soc Interface 12, 20141346 (2015).

      (22) Persson, B. N. J., Albohr, O., Creton, C. & Peveri, V. Contact area between a viscoelastic solid and a hard, randomly rough, substrate. The Journal of Chemical Physics 120, 8779–8793 (2004).

      (23) Skedung, L. et al. Feeling Small: Exploring the Tactile Perception Limits. Sci Rep 3, 2617 (2013).

      (24) Viswanathan, K., Sundaram, N. K. & Chandrasekar, S. Stick-slip at soft adhesive interfaces mediated by slow frictional waves. Soft Matter 12, 5265–5275 (2016).

      (25) Wiertlewski, M., Hudin, C. & Hayward, V. On the 1/f noise and non-integer harmonic decay of the interaction of a finger sliding on flat and sinusoidal surfaces. in 2011 IEEE World Haptics Conference 25–30 (2011). doi:10.1109/WHC.2011.5945456.

      (26) Fehlberg, M., Monfort, E., Saikumar, S., Drewing, K. & Bennewitz, R. Perceptual Constancy in the Speed Dependence of Friction During Active Tactile Exploration. IEEE Transactions on Haptics 17, 957–963 (2024).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Introduction to the revised manuscript:

      We thank all three reviewers for their time and insightful comments on our original submission. We are submitting a substantially revised manuscript that includes several new experiments, analyses, discussion points, and clarifications that we believe address all of the main concerns of the reviewers.

      To address the request of Reviewers 2 and 3 to reinforce key findings in a more physiologically intact preparation, we performed recordings of YH-HET SST neurons in brain slices and found that these neurons show impairments in AP generation similar to those observed in YH-HET SST cultured neurons. These data are summarized in a new figure (Fig. 9). Along these lines, we performed additional recordings in cultured neurons at room temperature compared with physiological temperature and found that WT and YH-HET PV neuronal properties were similarly altered by temperature increases, suggesting that our YH variant-induced neuronal phenotypes are not temperature dependent. These data are shown in a new supplemental figure (Supplemental Fig. 4-3). To address concerns of Reviewer 1 regarding our KNa and NaP current recordings, we performed new experiments to further assess the specificity of the VU170 blocker in KNa KO neurons (summarized in Supplemental Fig. 5-2) and to better characterize the time course over which TTX blocks the persistent Na+ current and the KNa current (summarized in Supplemental Fig. 7-1). These latter two experiments provide further clarity and confidence in the accuracy of our measurements of both KNa and NaP currents. Lastly, to address the concern of Reviewer 3 regarding statistical analyses of the modeling data, we’ve added a new table with the results of a repeated measures ANOVA analysis (Supplemental Table 6), and two new figures illustrating the relative changes in each neuron group compared to their controls (Supplemental Figures 6-2 and 7-2). 

      In addition to the new experiments and analyses, we’ve added three new paragraphs to the Discussion section. As the hyperexcitability phenotype in YH-HET PV neurons is somewhat unexpected, we’ve added a paragraph comparing our findings with those found in PV neurons in another KCNT1 GOF model. We’ve also added a paragraph to speculate on the contribution of YH-HET variant-induced alterations in SST and PV neurons to network behavior and seizure propensity. Lastly, we’ve added a paragraph to include the additional limitations and caveats of our study requested by the reviewers.  

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This manuscript reports the effects of a heterozygous mutation in the KCNT1 potassium channels on the properties of ion currents and the firing behavior of excitatory and inhibitory neurons in the cortex of mice expressing KCNT1-Y777H. In humans, this mutation as well as multiple other heterozygotic mutations produce very severe early-onset seizures and produce a major disruption of all intellectual function. In contrast, in mice, this heterozygous mutation appears to have no behavioral phenotype or any increased propensity to seizures.

      Regarding the last sentence above, we wanted to clarify a point that we neglected to emphasize in the initial submission. In the Results section from our previous paper (Shore et al., 2020), we failed to observe seizures in 14 heterozygous mice, whereas 23/25 homozygous mice showed seizures by video-EEG. However, in the fifth paragraph of the Discussion section from that paper, we further stated that “during the preparation and review of [that] article, we observed seizures in two Kcnt1-Y777H heterozygous mice, one during a widefield Ca2+ imaging experiment and the other during a video-EEG experiment”. Thus, we concluded that “heterozygous expression can result in seizures in a rodent model, but apparently at a much lower frequency than that observed with homozygous expression”. To emphasize these findings, we’ve added a sentence to the Introduction in this manuscript about the occurrence of infrequent seizures in Kcnt1-Y777H heterozygous mice, along with a reference to the Discussion of our previous paper.

      A relevant phenotype is, however, evident in mice with the homozygous mutation, and the authors have previously published the results of similar experiments with the homozygotes. As perhaps expected, the neuronal effects of the heterozygous mutation presented in this manuscript are generally similar but markedly smaller than the previously published findings on homozygotes. There are, however, some interesting differences, particularly on PV+ interneurons, which appear to be more excitable than wild type in the heterozygotes but more excitable in the heterozygotes. This raises the interesting question (which could be more explicitly discussed by the authors) as to whether the reported changes represent homeostatic events that suppress the seizure phenotype in the mouse heterozygotes or simply changes in excitability that do not reach the threshold for behavioral outcomes.

      That is an interesting question. We have added a new paragraph to the Discussion speculating about whether the alterations in SST and PV excitability suppress seizures or do not reach the threshold for behavioral outcomes. This seems to be requested by the second reviewer as well in Weaknesses point #2.

      Strengths and Weaknesses:

      (1) The authors find that the heterozygous mutation in PV+ interneurons increases their excitability, a result that is opposite from their previous observation in neurons with the corresponding homozygous mutation.

      We would like to provide a minor clarification to the above statement that, in this manuscript, we show that “the heterozygous mutation in PV+ interneurons increases their excitability, a result that is opposite from their previous observation in neurons with the corresponding homozygous mutation”. In our previous manuscript, we assessed YH-HOM phenotypes in NFS and FS GABAergic neurons, but did not specifically mark PV neurons. Although the YH-HOM FS neurons showed an increase in rheobase and a decrease in AP firing, the magnitudes of these effects were far less than those observed in the NFS population. More importantly, the FS GABAergic population likely consists of PV- and SST-expressing neurons; thus, we can not directly compare the results from the NFS and FS groups to the PV and SST groups, respectively (please see our response to Weaknesses point #3, Reviewer #2). We apologize for the confusion.

      They propose that this results from the selective upregulation of a persistent sodium current INaP in the PV+ interneurons. While the observations are very interesting, there are three issues concerning this interpretation that should be addressed:

      A) The protocol for measuring the INaP current could potentially lead to results that could be (mis)interpreted in different ways in different cells. First, neither K currents nor Ca currents are blocked in these experiments. Instead, TTX is applied to the cells relatively rapidly (within 1 second) and the ramp protocol is applied immediately thereafter. It is stated that, at this time, Na currents and INaP are fully blocked but that any effects on Na-activated K currents are minimal. In theory, this would allow the pre- to post-difference current to represent a relatively uncontaminated INaP. This would, however, only work if activation of KNa currents following Na entry is very slow, taking many seconds. A good deal of literature has suggested that the kinetics of activation of KNa currents by Na influx vary substantially between cell types, such that single action potentials and single excitatory synaptic events rapidly evoke KNa currents in some cell types. This is, of course, much faster than the time of TTX application. Most importantly, the kinetics of KNa activation may be different in different neuronal types, which would lead to errors that could produce different estimates of INaP in PV+ interneurons vs other cell types.

      First, we’d like to point out that we did not want to block K+ currents (which would also block KNa) when measuring INaP for these experiments, because our hypothesis was that the increased KNa current in YH-HET PV neurons was somehow causing an increase in INaP, and it is possible that this increase depends on an intact KNa. Thus, we decided to use a method based on the observation in our experiments, and previously made by others (Budelli et al., 2009), that the reduction of outward current after TTX addition is slow relative to the rapid reduction in Na+ current. We understand and agree with the reviewer that, if KNa currents were blocked more quickly by TTX in some neuron types than others, then our estimate of INaP using this method would be contaminated in these neuron types, which would lead to inaccurate measurements. To assess this possibility among the main neuron types used in this study, we performed new experiments in which we monitored the time course of INaP block and subsequent IKNa loss following TTX application in PV and SST neurons during slow voltage ramps. We note that action potentials are not present in the slow voltage ramps due to inactivation of the transient Na+ current. These new experiments show that, in SST and PV (both WT and Het) neurons, the block of INaP is nearly complete at the 6s time point, whereas the decay in IKNa is far slower (V50 of ≈ 25s), and importantly, these results do not differ substantially by cell type or genotype. These data suggest that our measurements of INaP are not significantly contaminated by IKNa, and that this method allows for the effective separation of these two currents. These data have been added as a supplemental figure (Supplemental Fig. 7-1) and are briefly described and referenced in the Results section.

      B) As the authors recognize, INaP current provides a major source of cytoplasmic sodium ions for the activation. An expected outcome of increased INaP is, therefore, further activation of KNa currents, rather than a compensatory increase in an inward current that counteracts the increase in KNa currents, as is suggested in the discussion.

      We agree that the increase in INaP could theoretically further increase IKNa, as veratridine was previously shown to increase IKNa (Hage & Salkoff, 2012). However, we do not believe that this would necessarily be the case, because as the reviewer notes in their next comment, there is insufficient information on the relative locations of the INaP and KCNT1 channels, as well as the kinetics of sodium transfer to KCNT1 channels, and even less is known in the context of KCNT GOF neurons. Thus, there are a couple of plausible reasons that increased INaP may not alter KNa currents in YH-HET PV neurons: (1) In YH-HET PV neurons, the particular sodium channels that are responsible for the increased INaP may not be located within close proximity to the KCNT1 channels. (2) Homeostatic mechanisms that alter the AIS length, or move the AIS further from the soma, in response to altered neuronal excitability are well described (Grubb & Burrone, 2010; Kuba et al., 2010); thus, it is possible that in YH-HET PV neurons, the length or location of the AIS is altered, leading to uncoupling of the sodium channels that are responsible for the increased INaP to the KCNT1 channels.

      C) Numerical simulations, in general, provide a very useful way to evaluate the significance of experimental findings. Nevertheless, while the in-silico modeling suggests that increases in INaP can increase firing rate in models of PV+ neurons, there is as yet insufficient information on the relative locations of the INaP channels and the kinetics of sodium transfer to KNa channels to evaluate the validity of this specific model.

      We completely agree; thus, we have described each of these limitations in the Discussion. We state that the model neurons may “lack more detailed features of ion channels, such as post-translational modifications and subcellular localizations”, and that our KCNT1 model conductance is “hampered by an incomplete understanding of the relationship between Na+ influx, membrane voltage, and channel gating in neurons”.  

      (2) The greatest effect of TTX application would be expected to be the elimination of large transient inward sodium currents. Why are no such currents visible in the control (pre-TTX) or the difference currents (Fig. 2)? Is it possible I missed something in the methods?

      We apologize for the confusion and our mistake in failing to mention this important feature of the displayed traces. To include all of the representative traces in the figures, and prevent overlap of the traces, we removed the large inward sodium currents using the masking tool in Adobe Illustrator in Figure 2 and Supplemental Figure 5-1. We have added that information to the relevant figure legends. We have also provided unmasked images of the representative traces from Figure 2 and Supplemental Figure 5-1 to illustrate the large transient inward sodium currents, and the significant reduction of these currents with TTX treatment.

      (3) As expected, the changes in many of the measured parameters are smaller in the present study with heterozygotes than those previously reported for the homozygous mutation. Some of the statements on the significance of some of the present findings need to be stated more clearly. For example, in the results section describing Fig. 2, it is stated that "In glutamatergic and NFS GABAergic YH-HET neurons, the overall KNa current was increased ...as measured by a significant effect of genotype ...." Later in the same paragraph it is stated that the increases in KNa current are not significant. Apparently, different tests lead to different conclusions. Both for the purpose of understanding the pathophysiological effects of changes in KNa current and for making further numerical simulations, more explicit clarifying statements should be made.

      We apologize for the confusion on the description of these statistics. The results come from the same test, which is a Generalized Linear Mixed Model (GLMM). The factors in our GLMM were voltage step, genotype, and a voltage step x genotype interaction term. The overall effect of genotype is significant in glutamatergic neurons, but pairwise tests at each voltage step show no significant effect of genotype at any given voltage. This is somewhat analogous to running a traditional ANOVA on multiple groups and finding a significant ANOVA p-value but no significant post-hoc multiple comparisons tests, and is not uncommon. Our interpretation of this is that heterozygous expression of the YH variant in glutamatergic neurons likely increases KNa currents across positive potentials (as was seen with the YH-HOM glutamatergic neurons), but only a small amount at each positive step; thus, we lack the statistical power to determine any particular voltage step where this occurs.

      (4) The effects of the KCNT1 channel blocker VU170 on potassium currents are somewhat larger and different from those of TTX, suggesting that additional sources of sodium may contribute to activating KCNT1, as suggested by the authors. Because VU170 is, however, a novel pharmacological agent, it may be appropriate to make more careful statements on this. While the original published description of this compound reported no effect on a variety of other channels, there are many that were not tested, including Na and cation channels that are known to activate KCNT1, raising the possibility of off-target effects.

      We agree and thank the reviewer for making this point. To address this question, we measured KNa currents in WT vs. Kcnt1/Kcnt2-dKO neurons using VU170 to illustrate the extent of outward current due to off-target effects of the drug. These data have been included as a supplemental figure (Supplemental Fig. 5-2). We have also added several sentences to the Results section referencing this figure. Interestingly, in Kcnt1/Kcnt2-dKO neurons, VU170 seems to be quite specific across the negative potentials, as no outward currents are apparent until approximately -10 mV onward, whereas across positive potentials, there is a VU170-senstive outward current reaching ~1 nA by +50 mV. We have also included a note of caution in interpreting these data and added the possibility of off-target effects of VU170 as an alternative explanation for the differences observed on KNa currents between TTX and VU170 to the Discussion section.

      (5) The experiments were carried out at room temperature. Is it possible that different effects on firing patterns in heterozygotes and homozygotes would be observed at more physiological temperatures?

      Yes, it is reasonable to assume that an increased temperature would affect neuronal firing patterns in cultured neurons, as temperature differences have been shown to alter synaptic transmission and neuronal function, as assessed in both cultured neuron and slice recordings. All of our recordings were performed at room temperature in this study, and although they are valid with regard to between-group comparisons, this additional caveat is worth mentioning. We have added this to the paragraph describing study limitations in the Discussion section.

      To better understand the effects of temperature in our recordings, we have now compared membrane and AP generation parameters at room temperature (~22°C) and at a more physiological temperature (35°C) in a before-after study of 16 WT neurons, including both glutamatergic and GABAergic neuron types. Not surprisingly, we found robust alterations in all parameters assessed, excluding resting membrane potential and capacitance. We further assessed the effect of temperature on WT and YH-HET PV neurons, as the PV neurons expressing the YH variant showed the most unexpected phenotypes in our study. In our room temperature recordings, we showed that the YH-HET variant decreased the rheobase current, increased the AP amplitude, and increased the AP firing. In our before-after comparison (22°C-35°C) of PV neurons (WT; n=11, YH-Het; n=10), the WT and YH-HET neurons showed the same temperature-dependent effects on these parameters, including increased rheobase, decreased AP amplitude, and a higher maximal firing rate, at 35°C compared to those at 22°C. These data have been added to the manuscript as a supplemental figure (Supplemental Fig. 4-3) and are briefly referenced and described in the Results section.     

      Moreover, in our original manuscript, we showed that the effects of the homozygous YH variant on glutamatergic and NFS GABAergic neuron excitability were highly similar between cultured recordings at room temperature (~22°C) and slice recordings at 32°C. Taken together, these data suggest that the reported neurophysiological phenotypes downstream of the YH variant are likely not temperature dependent. 

      Reviewer #2 (Public Review):

      Summary:

      In this manuscript, Shore et al. investigate the consequent changes in excitability and synaptic efficacy of diverse neuronal populations in an animal model of juvenile epilepsy. Using electrophysiological patch-clamp recordings from dissociated neuronal cultures, the authors find diverging changes in two major populations of inhibitory cell types, namely somatostatin (SST)- and parvalbumin (PV)-positive interneurons, in mice expressing a variant of the KCNT1 potassium channel. They further suggest that the differential effects are due to a compensatory increase in the persistent sodium current in PV interneurons in pharmacological and in silico experiments.

      Strengths:

      (1) Heterozygous KCNT1 gain of function variant was used which more accurately models the human disorder.

      (2) The manuscript is clearly written, and the flow is easy to follow. The authors explicitly state the similarities and differences between the current findings and the previously published results in the homozygous KCNT1 gain of function variant.

      (3) This study uses a variety of approaches including patch clamp recording, in silico modeling, and pharmacology that together make the claims stronger.

      (4) Pharmacological experiments are fraught with off-target effects and thus it bolsters the authors' claims when multiple channel blockers (TTX and VU170) are used to reconstruct the sodium-activated potassium current. Having said that, it would be helpful to see the two drug manipulations used in the same experiment. Notably, does the more selective blocker VU170 mimic the results of TTX for NFS GABAergic cells in Figure 2? And does it unmask a genotype difference for FS GABAergic cells like the one seen in PV interneurons in Figure 5C3.

      To illustrate the two drug manipulations in the same experiment, we recorded from WT SST and PV neurons (5 neurons/group) and blocked KNa currents first using TTX and then VU170, following wash out between the two drugs, in the same neurons. Below, we have plotted the points at each voltage step for each SST and PV neuron, and for each drug treatment, on the same graph to show how they vary directly. At each voltage step, lines connect the points representing the TTX-sensitive and VU-sensitive currents for each neuron to show the individual effects (left-most graphs). Summary data are shown across all voltages (middle graphs) and across negative voltages (right-most graphs).

      Author response image 1.

      We have not used VU170 on FS and NFS populations of GABAergic neurons. However, for reasons that are explained more extensively below in response to Weaknesses #3, we would not predict KNa currents recorded from SST- and PV-GABAergic neurons to mimic those of NFS- and FS-GABAergic neurons, respectively.

      Weaknesses:

      (1) This study relies on recordings in dissociated cortical neurons. Although specific WT interneurons showed intrinsic membrane properties like those reported for acute brain slices, it is unclear whether the same will be true for those cells expressing KCNT1 variants. This reviewer highly recommends confirming some of the key findings using an ex vivo slice preparation. This is especially important given the discrepant result of reduced excitability of PV cells reported by Gertler et al., 2022 (cited here in the manuscript but not discussed in this context) in acute hippocampal slices for a different KCNT1 gain of function variant.

      We thank the reviewer for this suggestion. To test whether SST-expressing YH-HET neurons show similar impairments to those observed in culture, we crossed the FVB-Tg(GadGFP)45704Swn/J transgenic mouse line (Jackson Labs #003718), also known as the GIN line, to the Kcnt1-YH line. Mice from the GIN line express eGFP in a subpopulation of SST-expressing neurons in the hippocampus and cortex. We performed slice recordings of cortical layer 2/3, GFP-expressing neurons from P21-30, WT and YH-HET GIN mice. Although the input resistance was not significantly decreased, the rheobase was higher in the YH-HET neurons, and they fired fewer APs across increasing current steps, than WT neurons, supporting the main findings from the SST-expressing neurons in culture. These data have been added to the manuscript in a new figure (Fig. 9).

      Regarding the previously published results on the effect of KCNT1 GOF on PV neuron excitability by Gertler et al., we have written a new paragraph in the Discussion section (last paragraph of the section, “Neuron-type-dependent KCNT1 GOF effects”) that discusses the differences between the findings by Gertler et al. and the current study. 

      To further investigate the effects of heterozygous YH variant expression on SST- vs. PV-expressing neuron excitability in ex vivo slice recordings, we are now crossing a cre-inducible, Td-Tomato Red reporter line (Ai9) to the Kcnt1-YH line. After obtaining Ai9Tg/Tg; Kcnt1m/+ mice, we will cross these to Sst-Cre and Pvalb-Cre lines to be able to record from marked SST and PV, WT and YH-HET neurons in slice. We plan on submitting results from these recordings as an eLife Research Advances article linked to this article.

      (2) It is unclear how different pieces of results fit together to form a story about the disease pathophysiology.

      We have added a paragraph to the Discussion to speculate on how these various GABAergic subtype-specific effects downstream of the YH variant may contribute to overall network/brain pathology and seizure propensity in heterozygous mice.

      For example, hyperexcitability of PV cells would suggest more inhibition which would counter seizure propensity. However, spontaneous inhibitory postsynaptic currents show no change in pyramidal neurons. Moreover, how do the authors reconcile that the reductions in synaptic inputs onto interneurons in Figure 3B with the increases in Figure 8? This should be discussed.

      Generally, network and synaptic alterations downstream of the heterozygous variant were quite minimal compared with those of the homozygous variant. Although there were reductions in the frequency of synaptic inputs onto inhibitory neurons, the changes were relatively small. Thus, we concluded that the neuronal effects downstream of the heterozygous YH variant were below some threshold to result in broader network effects on synaptic activity and connectivity similar to those in the homozygous YH model. The discrepancies between our GABAergic vs. FS/NFS vs. VIP/SST/PV data will be discussed in more detail in response to Weakness #3.   

      (3) Similarly, the results in this work are not entirely internally consistent. For example, given the good correspondence between FS and NFS GABAergic cells with PV and SST expression, why are FS GABAergic cells hyperexcitable in Figure 1? If anything, there is a tendency to show reduced excitability like the NFS GABAergic cells.

      In our neuron cultures, 76-80% of Neu-N-expressing neurons are GFP+ (from the CamKII-eGFP virus used to mark glutamatergic neurons), and of the remaining ~20-24%, the majority are GABAergic (verified using the Dlx5/6-mRuby virus to mark GABAergic neurons and using electrophysiology to assess AP parameters and analyze evoked responses). In our original experiments, recordings sampled from this larger GABAergic population were used (Fig. 3), or this population was sorted almost equally into FS and NFS (Figs. 1 and 2).

      In later experiments, we isolated and cultured neurons from VIP-Cre, SST-Cre, and PV-Cre mouse lines and marked these neuron types in vitro with a Cre-inducible mCherry virus. In the VIP-Cre cultures, ~6% of the GFP- population, or 1.2% of the Neu-N-population, was mCherry+. In the SST-Cre cultures, ~20.5% of the GFP- population, or 4.7% of the Neu-N-population, was mCherry+. In the PV-Cre cultures, less than 1% of the Neu-N-population was mCherry+, which is not surprising considering the relatively late onset of PV expression compared with those of VIP and SST. Thus, we would estimate that we are marking and recording from less than 30% of the total GABAergic population in these in vitro experiments, rather than the 80-90% that these three populations would sum to in vivo.  

      Furthermore, using our original criteria for sorting GABAergic neurons into FS and NFS subtypes, all VIP recorded neurons were of the NFS type, PV of the FS type, whereas SST were of the FS (38%) and NFS (62%) types, which is not far off from the significant fraction of SST neurons that have been shown to be fast-spiking in slice experiments (Kvitsiani et al., 2013; Urban-Ciecko & Barth, 2016). Therefore, the FS group consists of both PV and SST neurons, and the NFS group consists of both VIP and SST neurons, and likely also contains immature PV neurons that have not yet developed a fast-spiking phenotype. Taken together, this suggests that the data from these two sets of experiments (FS/NFS vs. VIP/SST/PV) are not directly comparable.

      Also, why do the WT I-V curves look so different between Figures 2 and 5? This reviewer suggests at least a brief explanation in the discussion.

      As to the differences in appearance between the WT I-V curves in Figures 2 and 5, those plots are from different neuron types (Fig. 2: Glutamatergic, FS GABAergic, and NFS GABAergic vs. Fig. 5: VIP-, SST-, and PV-expressing), and the KNa currents are isolated using different methods (Fig. 2: TTX-subtraction vs. Fig. 5: VU170-subtraction). TTX blocks an inward Na+ current, which is apparent across subthreshold voltages in Fig. 2C1-3, whereas VU170 does not block this current, making it not apparent in Fig. 5C1-3. Also, the bottom three panels in Fig. 2C1-3 show the KNa current from -80 to 0 mV, whereas those in Fig. 5C1-3 show from -80 to -30 mV, to better illustrate the areas spanning KNa current increases, so their appearance is not directly comparable.

      (4) Given the authors' claim that the KCNT1 activation curve is a major contributor to the observed excitability differences in specific GABA cell subtypes, it would be helpful to directly measure the activation curve in the variants experimentally as was done for WT KCNT1 in Figure 6A and use the derived kinetics in the compartmental model.

      We apologize for the confusion. Although the activation curves among different GABAergic subtypes from WT KCNT1 are distinct, and we believe that these varying kinetics contribute to the neuron-type-specific phenotypes of KCNT1 GOF, we didn’t intend to suggest that the heterozygous Y777H variant itself causes neuron-type-specific alterations to the activation curves of the GABAergic subtypes. To clarify this point, below, we show the high similarity of the activation curves between WT KCNT1 and YH-HET KCNT1 in each of the GABAergic subtypes.

      Author response image 2.

      Reviewer #3 (Public Review):

      Summary:

      The present manuscript by Shore et al. entitled Reduced GABAergic Neuron Excitability, Altered Synaptic Connectivity, and Seizures in a KCNT1 Gain-of-Function Mouse Model of Childhood Epilepsy" describes in vitro and in silico results obtained in cortical neurons from mice carrying the KCNT1-Y777H gain-of-function (GOF) variant in the KCNT1 gene encoding for a subunit of the Na+-activated K+ (KNa) channel. This variant corresponds to the human Y796H variant found in a family with Autosomal Dominant Nocturnal Frontal lobe epilepsy. The occurrence of GOF variants in potassium channel encoding genes is well known, and among potential pathophysiological mechanisms, impaired inhibition has been documented as responsible for KCNT1-related DEEs. Therefore, building on a previous study by the same group performed in homozygous KI animals, and considering that the largest majority of pathogenic KCNT1 variants in humans occur in heterozygosis, the Authors have investigated the effects of heterozygous Kcnt1-Y777H expression on KNa currents and neuronal physiology among cortical glutamatergic and the 3 main classes of GABAergic neurons, namely those expressing vasoactive intestinal polypeptide (VIP), somatostatin (SST), and parvalbumin (PV), crossing KCNT1-Y777H mice with PV-, SST- and PV-cre mouse lines, and recording from GABAergic neurons identified by their expression of mCherry (but negative for GFP used to mark excitatory neurons).

      The results obtained revealed heterogeneous effects of the variant on KNa and action potential firing rates in distinct neuronal subpopulations, ranging from no change (glutamatergic and VIP GABAergic) to decreased excitability (SST GABAergic) to increased excitability (PV GABAergic). In particular, modelling and in vitro data revealed that an increase in persistent Na current occurring in PV neurons was sufficient to overcome the effects of KCNT1 GOF and cause an overall increase in AP generation.

      Strengths:

      The paper is very well written, the results clearly presented and interpreted, and the discussion focuses on the most relevant points.

      The recordings performed in distinct neuronal subpopulations are a clear strength of the paper. The finding that the same variant can cause opposite effects and trigger specific homeostatic mechanisms in distinct neuronal populations is very relevant for the field, as it narrows the existing gap between experimental models and clinical evidence.

      Weaknesses:

      My main concern is in the epileptic phenotype of the heterozygous mice investigated. In fact, in their previous paper the Authors state that "...Kcnt1-Y777H heterozygous mice did not exhibit any detectable epileptiform activity" (first sentence on page 4). However, in the present manuscript, they indicate twice in the discussion section that these mice exhibit "infrequent seizures". This relevant difference needs to be clarified to correctly attribute to the novel pathophysiological mechanism a role in seizure occurrence. Were such infrequent seizures clearly identified on the EEG, or were behavioral seizures? Could the authors quantify this "infrequent" value? This is crucial also to place in the proper perspective the Discussion statement regarding "... the increased INaP contribution to ... network hyperexcitability and seizures".

      We apologize for the confusion. Indeed, in the Results section from our previous paper, we failed to observe seizures in 14 heterozygous mice, whereas 23/25 homozygous mice showed seizures by video-EEG. However, in the fifth paragraph of the Discussion section from that paper, we further stated that “during the preparation and review of [that] article, we observed seizures in two Kcnt1-Y777H heterozygous mice, one during a widefield Ca2+ imaging experiment and the other during a video-EEG experiment”. Thus, we concluded that “heterozygous expression can result in seizures in a rodent model, but apparently at a much lower frequency than that observed with homozygous expression”. To emphasize these findings, we’ve added a sentence to the Introduction in this manuscript about the occurrence of infrequent seizures in Kcnt1-Y777H heterozygous mice, along with a reference to the Discussion of our previous paper.

      Of the two observed seizures, one seizure was captured in the Weston Lab at the University of Vermont from a Kcnt1-Y777H heterozygous mouse expressing a calcium indicator (after it was bred to the Snap25-GCaMP6s line) during a Ca2+ widefield imaging experiment, and it was accompanied by a time-locked video of the seizure event. The other seizure was recorded as a control during a drug study using video-EEG. This Kcnt1-Y777H heterozygous mouse had multiple tonic seizures, as evidenced by EEG traces and the accompanying video, which were recorded and analyzed in the Frankel Lab at Columbia University. The seizures from heterozygous mice have not been officially quantified, as they have only been rarely observed across multiple different experiments using heterozygous mice at multiple institutions, making quantification quite difficult.

      Lastly, regarding attributing the role of the identified pathological mechanisms to seizure occurrence mentioned by the reviewer, we have added a paragraph to the Discussion to speculate on how the various GABAergic subtype-specific effects downstream of the YH variant may contribute to the general lack of network/brain pathology and seizure generation in heterozygous mice.  

      Also, some statistical analysis seems to be missing. For example, I could not find any for the data shown in Fig. 6. Thus, the following statement: "the model PV neurons responded to KCNT1 GOF with decreased AP firing and an increased rheobase" requires proper statistical evaluation.

      We thank the reviewer for this suggestion. We were initially hesitant to apply a formal statistical analysis to the modeling data because it differs in important ways from the experimental data. However, we have now provided statistical analyses of these data, with some caveats. Because we applied each KCNT1 GOF level (40, 35, and 30 mM) to the same set of neurons for each data set, we performed repeated measures ANOVA analyses to assess differences due to GOF in each subtype. We note that some changes are statistically significant, but may not be physiologically relevant. For example, there are changes in input resistance and rheobase in VIP neurons only at the higher GOF level (30 mM), but the magnitude of each change is quite small relative to those in SST neurons (Rin: 1.7 MΩ in VIP vs. 23.2 MΩ in SST, rheo: 1.7 pA in VIP vs. 52.5 pA in SST), and likely as a consequence, there are no downstream effects on the AP firing rate at either GOF level in VIP neurons. It is important to examine the magnitude of the effects and interpret them in the context of the changes in other neuron types and in the experimental data, thus, we’ve provided two new figures to better illustrate the relative changes in each neuron type (Supplemental Figures 6-2 and 7-2). We have also added these statistical results to Figures 6E2, 6F2, 6G2, and 7E, and Supplemental Fig. 6-1, and we have described them in the Results section. A summary of the statistics has also been added in Supplemental Table 6.

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      In addition to addressing the weaknesses highlighted in the public review, this reviewer recommends using a KCNT1 agonist such as loxapine to see if activating the potassium channel mimics the KCNT1 GOF in SST and PV cells.

      Although we appreciate this suggestion, we’re not sure whether treating GABAergic subtypes with loxapine would provide much clarity in the absence of many supporting experiments. First, the amount of channel activation and any changes in kinetics caused by loxapine would need to be measured and compared to the YH-HET GOF effects in order to interpret the results. In addition, the aforementioned caveat about off-target effects of small molecules would also have to be considered, as loxapine inhibits many other channels at nanomolar concentrations.

      More importantly, we hypothesize that several of the GABAergic subtype-specific effects of KCNT1 GOF result from homeostatic or adaptive mechanisms due to long-term increases in KNa currents. For instance, PV-expressing YH-HET neurons had a lower rheobase, increased AP amplitude, and increased AP firing frequency, effects that we believe are due, not to increased KNa currents themselves, but to a compensatory increase in a persistent Na+ current. For the SST neurons, we hypothesize that the increased capacitance and soma size, together with the increased electrical coupling, exacerbate the hypoexcitability phenotype downstream of the YH variant. Thus, we would not necessarily expect that opening KCNT1 channels by acute loxapine treatment would mimic many of these effects.

      Indeed, in a previous study using a different KCNT1 GOF mouse model, loxapine treatment mimics KCNT1 GOF effects in some neuron types (reduced AP firing frequency in loxapine-treated, WT PV neurons mimics that observed in heterozygous KCNT1 GOF PV neurons), but not in others (reduced AP firing frequency in loxapine-treated, WT pyramidal neurons does not mimic the unaltered AP firing frequency observed in heterozygous and homozygous KCNT1 GOF pyramidal neurons) (Gertler et al., 2022).  

      Related to this suggestion by the reviewer, we are currently performing studies using a KCNT1 blocker in WT and Kcnt1-KO neurons to better understand the role of KCNT1 among cortical neuronal subtypes that will be published in a future manuscript.

      Reviewer #3 (Recommendations For The Authors):

      Though I realize that primary cultures allow for efficient identification of neuronal subclasses, it would have been useful to show that similar changes also occur in neurons with conserved in vivo connectivity, such as those recorded from brain slices.

      We thank the reviewer for this suggestion. We have added an additional figure (Fig. 9) showing that the hypoexcitability phenotype observed in SST neurons in culture recordings is conserved in SST neurons in slice recordings from GIN mice, which express GFP predominately in SST-expressing neurons.

      In addition, further experiments in PV neurons from Kcnt1-Y777H homozygous mice would provide evidence for a gene-dosage role in the changes found in heteros.

      For this manuscript, we chose to focus our efforts on understanding the effects of heterozygous Kcnt1 variant expression in various neuronal subtypes with the goal of better modeling GOF variant effects in human disease. However, we’re very interested in investigating the effects of homozygous expression of the YH variant on each of the GABAergic subtypes to compare with those found in this study, but this requires more rounds of breeding to get homozygous mice with GABAergic subtype-specific expression of cre recombinase. We look forward to reporting the results from these experiments in a future manuscript.

      Also, when addressing the issue regarding the different effects of the same GOF variant on the excitability of distinct neuronal populations in the Discussion or Introduction sections, the authors may want to cite the recent work on KCNQ2 and KCNQ3 by the Tzingounis group (https://pubmed.ncbi.nlm.nih.gov/37607817/).

      We thank the reviewer for bringing this manuscript to our attention. We have added this citation to a new paragraph in the Discussion section regarding neuron-type specific effects of ion channel variants (the last paragraph focusing on the effects in PV neurons).

      Budelli, G., Hage, T. A., Wei, A., Rojas, P., Jong, Y. J., O'Malley, K., & Salkoff, L. (2009). Na+-activated K+ channels express a large delayed outward current in neurons during normal physiology. Nat Neurosci, 12(6), 745-750. https://doi.org/10.1038/nn.2313

      Gertler, T. S., Cherian, S., DeKeyser, J. M., Kearney, J. A., & George, A. L., Jr. (2022). K(Na)1.1 gain-of-function preferentially dampens excitability of murine parvalbumin-positive interneurons. Neurobiol Dis, 168, 105713. https://doi.org/10.1016/j.nbd.2022.105713

      Grubb, M. S., & Burrone, J. (2010). Activity-dependent relocation of the axon initial segment fine-tunes neuronal excitability. Nature, 465(7301), 1070-1074. https://doi.org/10.1038/nature09160

      Hage, T. A., & Salkoff, L. (2012). Sodium-activated potassium channels are functionally coupled to persistent sodium currents. J Neurosci, 32(8), 2714-2721. https://doi.org/10.1523/JNEUROSCI.5088-11.2012

      Kuba, H., Oichi, Y., & Ohmori, H. (2010). Presynaptic activity regulates Na(+) channel distribution at the axon initial segment. Nature, 465(7301), 1075-1078. https://doi.org/10.1038/nature09087

      Kvitsiani, D., Ranade, S., Hangya, B., Taniguchi, H., Huang, J. Z., & Kepecs, A. (2013). Distinct behavioural and network correlates of two interneuron types in prefrontal cortex. Nature, 498(7454), 363-366. https://doi.org/10.1038/nature12176

      Shore, A. N., Colombo, S., Tobin, W. F., Petri, S., Cullen, E. R., Dominguez, S., Bostick, C. D., Beaumont, M. A., Williams, D., Khodagholy, D., Yang, M., Lutz, C. M., Peng, Y., Gelinas, J. N., Goldstein, D. B., Boland, M. J., Frankel, W. N., & Weston, M. C. (2020). Reduced GABAergic neuron excitability, altered synaptic connectivity, and seizures in a KCNT1 gain-of-function mouse model of childhood epilepsy. Cell Rep.

      Urban-Ciecko, J., & Barth, A. L. (2016). Somatostatin-expressing neurons in cortical networks. Nat Rev Neurosci, 17(7), 401-409. https://doi.org/10.1038/nrn.2016.53

    1. Author Response

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary

      The authors investigated the antigenic diversity of recent (2009- 2017) A/H3N2 influenza neuraminidases (NAs), the second major antigenic protein after haemagglutinin. They used 27 viruses and 43 ferret sera and performed NA inhibition. This work was supported by a subset of mouse sera. Clustering analysis determined 4 antigenic clusters, mostly in concordance with the genetic groupings. Association analysis was used to estimate important amino acid positions, which were shown to be more likely close to the catalytic site. Antigenic distances were calculated and a random forest model was used to determine potential important sites.

      This has the potential to be a very interesting piece of work. At present, there are inconsistencies in the methods, results and presentation that limit its impact. In particular, there are weaknesses in some of the computational work.

      Strengths

      (1) The data cover recent NA evolution and a substantial number (43) of ferret (and mouse) sera were generated and titrated against 27 viruses. This is laborious experimental work and is the largest publicly available neuraminidase inhibition dataset that I am aware of. As such, it will prove a useful resource for the influenza community.

      (2) A variety of computational methods were used to analyse the data, which give a rounded picture of the antigenic and genetic relationships and link between sequence, structure and phenotype.

      Weaknesses

      (1) Inconsistency in experimental methods

      Two ferret sera were boosted with H1N2, while recombinant NA protein for the others. This, and the underlying reason, are clearly explained in the manuscript. The authors note that boosting with live virus did not increase titres. Nevertheless, these results are included in the analysis when it would be better to exclude them (Figure 2 shows much lower titres to their own group than other sera).

      As an exercise, we have excluded the H1N2 boosted ferrets sera and no major impact was observed in the antigenic grouping (see Author response image 1a). Another way to control for differences in immunogenicity is to normalize the NAI values with the homologous ELISA titers for each antigen. Clustering based on these ELISA normalized NAI titers reveals the same 4 distinct antigenic groups but with one change: Kan17 is shifted from group 1 to group 2 (Author response image 1b). Note that a homologous ELISA titer is not available for A/West-Virginia/17/2012 and thus this serum sample is not included in Author response image 1b.

      Author response image 1.

      Antigenic and phylogenetic relatedness of N2 NAs. Phylogenetic tree based on the N2 NA head domain amino acid sequences and heat-map representing the average of normalized neuraminidase inhibition titer per H6N2 [log2 (max NAI/NAI)] determined in ferret sera after the boost (listed vertically). The red-to-blue scale indicates high-to-low NAI observed in ELLA against the H6N2 reassortants (listed at the bottom). UPGMA clustering of H6N2s inhibition profiles are shown on top of the heat map and colored according to the phylogenetic groups.(a) Based on the ferret sera with exclusion of the sera that were obtained following prime-boost by infection with H1N2 (A/Estonia/91625/2015 and A/Stockholm/15/2014). (b) Based on serum NAI titers that were normalized by the homologous ELISA titer.

      (2) Inconsistency in experimental results

      Clustering of the NA inhibition results identifies three viruses which do not cluster with their phylogenetic group. Again, this is clearly pointed out in the paper. Further investigation of this inconsistency is required to determine whether this has a genetic basis or is an experimental issue. It is difficult to trust the remaining data while this issue is unresolved.

      We understand the concern of the reviewer. It is important to keep in mind that discrete grouping of antigens allows to visualize major antigenic drifts. However, within closely related groups the cross reactivity of antisera is more likely distributed in a spectrum. When we constructed an antigenic map based on the antigenic cartography algorithm (as described by Smith D. et al, 2004), Kansas17, Wis15, and Ala15 are positioned more closely to antigenic group 1 than the majority of other antigens that were classified as group 2 (Author response image 2a). Similar results were obtained when individual ferret sera from the biological duplicates were used (Author response image 2b). This antigenic cartography map is now added as Figure 2. Figure supplement 3 to the revised manuscript.

      Author response image 2.

      The antigenic cartography was constructed using averaged data from pairs of ferrets (a). Similar analysis was performed on individual ferrets sera (b).

      (3) Inconsistency in group labelling

      A/Hatay/4990/2016 & A/New Caledonia/23/2016 are in phylogenetic group 1 in Figure 2 and phylogenetic group 1 in Figure 5 - figure supplement 1 panel a.

      Our apologies: there was indeed a mistake in labeling of Figure 5. A new antigenic cartography was constructed and included in the revised manuscript. As a result Figure 5 - figure supplement has now become redundant and was removed from the manuscript.

      A/Kansas/14/2017 is selected as a representative of antigenic group 2, when in Figure 2 it is labelled as AC1 (although Figure 2 - supplement 4 which the text is referring to shows data for A/Singapore/Infimh-16-0019/2016 as the representative of AC2). A/Kansas/14/2017 is coloured and labelled as AC2 in Figure 2 - supplement 5.

      Thank you for pointing out this inconsistency. Kan17 clustered antigenically in group 1 based on the NAI values that were normalized relative to the serum with the maximal NAI value against the H6N2 virus that was tested. When using NAI titers that are normalization with the homologous ELISA titer, Kan17 is positioned in group 2. Likewise, antigenic cartography mapping positions Kan17 in group 2. Therefore, we conclude that A/Kansas/14/2017 NA is a representative of group 2.

      The colouring is changed for Figure 3a at the bottom. A/Heilongjiang-Xiangyang/1134/2011 is coloured the same as AC4 viruses when it is AC1 in Figure 2. This lack of consistency makes the figures misleading.

      We apologize for this mistake. The coloring in Figure 3a has been corrected.

      (4) Data not presented, without explanation

      The paper states that 44 sera and 27 H6N2 viruses were used (line 158). However, the results for the Kansas/14/2017 sera do not appear to be presented in any of the figures (e.g. Figure 2 phylogenetic tree, Figure 5 - figure supplement 1). It is not obvious why these data were not presented. The exclusion of this serum could affect the results as often the homologous titre is the highest and several heatmaps show the fold down from the highest titre.

      Serum against A/Kansas/14/2017 was not prepared. For that reason, it is not included in the analysis. We agree that such homologous serum ideally should have been included and in the NAI assay would have resulted in a high if not the highest titer. However, we noticed that homologous sera did not always have the highest titers, especially in panels like ours were some antigens are closely related. The highest titer obtained against Kan17 H6N2 was from A/Bris/16 sera: 1/104, a titer that is in the range of other, homologous titers observed in the panel (Table S3). The Bris16 and Kan17 NAs have five amino acid differences. In summary, inclusion of Kan17 homologous sera would likely not impact the analysis and interpretation of the results because there are multiple highly cross-inhibiting heterologous serum samples against Kan17.

      (5) The cMDS plot does not have sufficient quality assurance A cMDS plot is shown in Figure 5 - figure supplement 1, generated using classical MDS. The following support for the appropriateness of this visualisation is not given. a. Goodness of fit of the cMDS projection, including per point and per titre. b. Testing of the appropriate number of dimensions (the two sera from phylogenetic group 3 are clustered with phylogenetic group 2; additional dimensions might separate these groups). c. A measure of uncertainty in positioning, e.g. bootstrapping. d. A sensitivity analysis of the assumption about titres below the level of detection (i.e. that <20 = 10). Without this information, it is difficult to judge if the projection is reliable.

      We agree with these comments. We have removed Figure 5 – figure supplement 1, and added new figure 2 – figure supplement 3 (antigenic cartography) instead.

      (6) Choice of antigenic distance measure

      The measure of antigenic distance used here is the average difference between titres for two sera. This is dependent on which viruses have been included in the analysis and will be biased by the unbalanced number of viruses in the different clusters (12, 8, 2, 5).

      To verify the impact of the number of antigens on our analysis, the matrix of differences was generated with only 4 H6N2s representing at least one phylogenetic group (Per09, Sin16, Hel823 and Ind11) (Author response image 3a). This matrix is very similar to the one calculated based on all 27 antigens (Author response image 3b). The obtained matrix (Author response image 3a) was used in random forest to model antigenic distances and the result of prediction was plotted against real differences calculated based on the full data. The correlation coefficient (R2) of predicted vs observed values dropped from 0.81 to 0.71, suggesting that the number of antigens tested does not drastically affect the antigenic differences calculated based on serum values (Author response image 3e). Importantly, amino acid substitutions potentially associated with increased antigenic distances are similarly identified (Author response image 3c, d and f).

      Author response image 3.

      Matrix of differences was calculated using only 4 H6N2 antigens (a) or the full panel (b). The matrixes from (c) 4 or (d) 27 antigens were used in random forest modeling to estimate the impact of amino acid changes, respectively. The rf modeling data generated from 4 H6N2 only was plotted and correlated with values calculated from the full panel of 27 H6N2s (e). The multi-way importance plot indicates in red that 7 out of the 10 most important substitutions were identified by the analysis using only 4 H6N2s (f).

      Interestingly, when matrix of differences is calculated using only 4 H6N2s data but not including at least one representative of antigenic group 1 and 2, the correlation coefficient between the predicted values and values obtained from the full panel is dramatically impacted (R2 values drops from 0.81 to 0.5 and 0.57. It is important to note that most of the sera also belong to phylogenetic antigens from groups 1 and 2. As a consequence, poorer prediction of those antigens would more drastically impact the correlation. No drastic drop was observed when representative H6N2s from group 3 or 4 were excluded from the data (from 0.81 to 0.75 and 0.73, Author response image 4 c and d).

      Author response image 4.

      Random forest analysis was repeated using only 4 antigens, but excluding representatives of one of the phylogenetic groups (a) no group 1, (b) no group 2, (c) no group 3, and (d) no group 4.

      We also used Euclidean distances as a measure of differences (Author response image 5). The predictive values obtained in rf have a slightly reduced R2 compared to the values obtained using average of differences.

      In conclusion the unbalanced number of antigens used per group and metric of distance does not seem to impact per se our analysis.

      Author response image 5.

      Antigenic distances were calculated using Euclidian distances of sera to sera. Those antigenic distances were used in rf for estimation of antigenic distance and importance of each amino acid substitution.

      (7) Association analysis does not account for correlations

      For each H6N2 virus and position, significance was calculated by comparing the titres between sera that did or did not have a change at that position. This does not take into account the correlations between positions. For haemagglutinin, it can be impossible to determine the true antigenic effects of such correlated substitutions with mutagenesis studies.

      Most of the potential correlated effects cannot be addressed with the panel of N2s, except for combinations of substitution that are included in the panel, such as 245/247 with or without 468. Only mutagenesis studies would shed light on the epistatic effects. However, it is important to keep in mind that those individual substitutions in such kind of study likely do not reflect natural evolution of N2 (cfr. the importance of the NA charge balance (Wang et al., 2021: 10.7554/eLife.72516).

      (8) Random forest method

      25 features are used to classify 43 sera, which seems high (p/3 is typical for classification). By only considering mismatches, rather than the specific amino acid changes, some signals may be lost (for example, at a given position, one amino acid change might be neutral while another has a large antigenic effect). Features may be highly, or perfectly correlated, which will give them a lower reported importance and skew the results.

      The number of features were optimized in the range from 5 to 80, with 25 being optimal (best R-value in predicted vs observed antigenic distances). Those features refer to the number of amino acid substitutions used in each tree. The number of trees was also optimized in the range of 100 to 2000.

      In random forest the matrix of differences is made considering only position based and not the type of substitution in pairs of NA. Indeed, substitutions with distinct effects may skew results by indicating lower reported importance.

      We have highlighted such potential bias in our discussion:

      “Also, our modelling does not consider that substitution by other amino acids can have a distinct impact on the antigenic distance. As a consequence, predictions based on the model could underestimate or overestimate the importance of a particular amino acid residue substitution in some cases.”

      Reviewer #2 (Public Review):

      Summary:

      The authors characterized the antigenicity of N2 protein of 44 selected A(H3N2) influenza A viruses isolated from 2009-2017 using ferret and mice immune sera. Four antigenic groups were identified, which correlated with their respective phylogenic/ genetic groups. Among 102 amino acids differed by the 44 selected N2 proteins, the authors identified residues that differentiate the antigenicity of the four groups and constructed a machine-learning model that provides antigenic distance estimation. Three recent A(H3N2) vaccine strains were tested in the model but there was no experimental data to confirm the model prediction results.

      Strengths:

      This study used N2 protein of 44 selected A(H3N2) influenza A viruses isolated from 2009-2017 and generated corresponding panels of ferret and mouse sera to react with the selected strains. The amount of experimental data for N2 antigenicity characterization is large enough for model building.

      Weaknesses:

      The main weakness is that the strategy of selecting 44 A(H3N2) viruses from 2009-2017 was not explained. It is not clear if they represent the overall genetic diversity of human A(H3N2) viruses circulating during this time. A comprehensive N2 phylogenetic tree of human A(H3N2) viruses from 2009-2017, with the selected 44 strains labeled in the tree, would be helpful to assess the representativeness of the strains included in the study.

      The selection of antigens was performed using the method described by Bien and Tibshirani 2011 (doi: 10.1198/jasa.2011.tm10183). This method calculates MinMax distances to identify a central representative among distinct clusters.

      To facilitate visualization of in a phylogenetic tree, only 180 representative N2 proteins from 2009-2017 were randomly selected (20 strains per year, unlabelled). Those 180 representatives and 44 readout panel strains (labelled) are shown in the phylogenetic tree below. Readout strains cover the major branches of the tree. The tree has been built using PhyML 3.0 using JTT substitution model and default parameters (Guindon S. et al, Systematic Biology 59(3):307-21, 2010) and visualized using ETE3 (Huerta-Cepas J. et al, Mol. Biol. Evol 33(6):1635-38, 2016).

      Author response image 6.

      The second weakness is the use of double-immune ferret sera (post-infection plus immunization with recombinant NA protein) or mouse sera (immunized twice with recombinant NA protein) to characterize the antigenicity of the selected A(H3N2) viruses. Conventionally, NA antigenicity is characterized using ferret sera after a single infection. Repeated influenza exposure in ferrets has been shown to enhance antibody binding affinity and may affect the cross-reactivity to heterologous strains (PMID: 29672713). The increased cross-reactivity is supported by the NAI titers shown in Table S3, as many of the double immune ferret sera showed the highest reactivity not against its own homologous virus but to heterologous strains. Although the authors used the post-infection ferret sera to characterize 5 viruses (Figure 2, Figure Supplement 4), the patterns did not correlate well. If the authors repeat the NA antigenic analysis using the post-infection ferret sera with lower cross-reactivity, will the authors be able to identify more antigenic groups instead of 4 groups?

      This is a very valuable remark. In their paper, Kosikova et al. (CID 2018) report that repeated infection of ferrets with antigenically slightly different H3N2 viruses results in a broader anti-HA response, compared to a prime infection of an influenza naïve ferret, which results in a narrower anti-HA response. In our ferret immunizations the boost was performed with recombinant, enzymatically active NA that was homologous to the NA of the H1N2 virus that was used for the priming by infection. We determined the NAI responses in sera from ferrets after H1N2 infection against 5 different H6N2 viruses (Figure 2 – figure supplement 5). Compared to NAI responses in sera from H1N2 infected and subsequently NA protein boosted ferrets, the NAI titers obtained after a single infection were considerably lower. Although the normalized NAI titers of day 14 and day 42 sera correlated well, we cannot exclude a degree of broadening of the NAI response in the NA protein boost sera (Author response image 7). On the other hand, repeated influenza antigen exposure is the reality for the majority of people.

      Author response image 7.

      Correlation obtained on NAI data from ferrets at day 14 after infection vs data from day 42 after boost.

      Another weakness is that the authors used the newly constructed model to predict the antigenic distance of three recent A(H3N2) viruses but there is no experimental data to validate their prediction (eg. if these viruses are indeed antigenically deviating from group 2 strains as concluded by the authors).

      Indeed, there is no experimental data from A/Hong_Kong/45/2018, A/Tasmania/503/2020, or A/Darwin/9/2021. The generation of data to determine experimental values for A/Hong_Kong/45/2018, A/Tasmania/503/2020, or A/Darwin/9/2021 would require the generation of new reassortant viruses (H1N2s), recombinant protein and immunization of new ferrets. The ferrets sera would have to be analyzed against all 27 H6N2s, including duplicated control sera for normalization. The major point of the modeling was to evaluate if it is possible to predict the antigenic behavior based on amino acid substitutions.

      As an exercise we have run the model again but this time excluding the Swe17 and HK17 antigens from the data set. Sequences of Sw17 or HK17 were then used to predict antigenic distances. The modeled versus experimental data are plotted in Author response image 8 and show a robust predictive outcome with R2 values of 0.94 and 0.91 for Sw17 and HK17, respectively.

      Author response image 8.

      Antigenic distances from Swe17 and HK17 calculated using the random forest algorithm that was constructed without experimental data from Swe17 and HK17. The predicted distances were plotted side by side to the experimental distances in (a) and correlations are shown in (b).

      Reviewer #3 (Public Review):

      Summary:

      This paper by Portela Catani et al examines the antigenic relationships (measured using monotypic ferret and mouse sera) across a panel of N2 genes from the past 14 years, along with the underlying sequence differences and phylogenetic relationships. This is a highly significant topic given the recent increased appreciation of the importance of NA as a vaccine target, and the relative lack of information about NA antigenic evolution compared with what is known about HA. Thus, these data will be of interest to those studying the antigenic evolution of influenza viruses. The methods used are generally quite sound, though there are a few addressable concerns that limit the confidence with which conclusions can be drawn from the data/analyses.

      Strengths:

      • The significance of the work, and the (general) soundness of the methods.

      • Explicit comparison of results obtained with mouse and ferret sera.

      Weaknesses:

      • Approach for assessing the influence of individual polymorphisms on antigenicity does not account for the potential effects of epistasis.

      Indeed, possible epistatic effects or individual polymorphisms were not assessed, which is limited by the nature of the panel of N2s selected in the study. We now emphasize this in the discussion as follows:

      “Also, our modelling does not consider that substitution by different amino acids can have distinct impact on antigenic distance. As a consequence, predictions based on the model could underestimate the importance of a particular amino acid residue substitution in some cases.”

      • Machine learning analyses were neither experimentally validated nor shown to be better than simple, phylogenetic-based inference.

      This is a valid remark and indeed we have found a clear correlation between NAI cross reactivity and phylogenetic relatedness. However, besides achieving good prediction of the experimental data (as shown in Figure 5 and in FigureR7), machine Learning analysis has the potential to rank or indicate major antigenic divergences based on available sequences before it has consolidated as new clade. ML can also support the selection and design of broader reactive antigens.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Major corrections

      No major corrections, beyond the issues I touched on in the public review, for which I give a little more detail below:

      Point 2. If there's not a putative genetic basis for the unexpected clustering seen in the NAI, then reiterating a small subset of the data would show the reliability of the experimental methods and substantiate this unexpected finding.

      We thank the reviewer for this pertinent point and suggestion. We have modified our analysis by reiterating individual ferret data normalized with the homologous ELISA titers. This reiteration is shown in figure R1b. In this case both Kan17 and Wis15 are switched to antigenic group 2. The profile of sera inhibition against those 2 strains that shift from antigenic cluster 1 to 2, is clearly an intermediate between profiles observed in those 2 groups. Considering that antigenic evolution occurs gradually, it is not unexpected that those intermediate profiles would swing from one side to another when pushed to forced discrimination. Antigenic cartography mapping, as in Smith et al. (2004), also indicated that those H6N2s are located closer to G1 than overall antigens from G2. Raw data distribution (max and min EC50) also do not indicate potential bias in analysis.

      Point 5. If you want to use antigenic cartography (Smith et al 2004), there is the R CRAN package (https://CRAN.R-project.org/package=Racmacs) which can handle threshold titres (like <20) and has functions for the diagnostic tools I describe, in order to quality assure the resulting plot. It does use a different antigenic distance metric than the paper currently uses, so you might not want to take that route.

      Thank you for this suggestion. We have performed antigenic cartography using the methodology described by Smith et al made accessible by Sam Wilks. The outcome of this analysis has been added to the manuscript as Figure 2 – Figure supplement 3.

      Point 6. More robust measures of antigenic distance take into account the homologous titre, homologous and heterologous titres (Archetti & Horsfall, 1950) or use the highest observed titre for a serum (Smith et al 2004). A limitation of the first two is that the antigenic distance can only be calculated when you have the homologous titre, which will limit you as you only have this for 26/43 sera. They may give similar results to your average antigenic distance, in which case your analysis still stands. Calculating antigenic distance using the homologous or maximum titre only gives the antigenic distance between the antigen and the serum. If you want the distance between all the sera, then further analysis is required (making an antigenic map and outputting the serum-serum distances, see the point above).

      We thank the reviewer for these suggestions. A complete set of 43 H6N2 viruses that matches all 43 sera would have been ideal. This would require the generation of 17 additional H6N2 viruses and their testing in ELLA, a significant amount of work in terms of time and resources. Instead, we have generated an antigenic map of the 27 antigens and homologous sera (cfr. our response to point 5 above). Despite different methods the outcome showing 4 major antigenic groups is consistent.

      Minor corrections

      Table S1

      A/New_Castle/67/2016 should be A/Newcastle/67/2016

      A/Gambia/2012 is not the full virus name

      Corrected.

      Table S3 has multiple values of exactly 10.0. I think these should be <20 as they are below the threshold of detection for the assay.

      All the values lower than 20 in Table S3 were replaced by “< 20”.

      Line 376: A/Sidney/5/1997 should be A/Sydney/5/1997

      Corrected.

      Line 338: "25 randomly sampled data" is a bit vague, "25 randomly sampled features" would be better

      Corrected.

      Include RMSE of the random forest model.

      RMSE=19.6 RMSE/mean = 0.207 is now mentioned in the manuscript.

      Figure 5 - supplement 1: These plots are difficult to interpret as the aspect ratio is not 1:1, and panels a & b are difficult to compare as they have not been aligned (using a Procrustes analysis). It would be neater if they were labelled with short names.

      We have generated an antigenic cartography map instead. As a consequence, the MDS has become redundant and Figure 5 – supplement 1 was removed.

      Line 562: 98 variable residues, where it is 102 elsewhere in the text.

      There are 4 mutations near the end of the NA stalk domain, which are not resolved in the N2 structure. Therefore, amino acid distances to these residues cannot be calculated.

      No data availability statement. Some of the raw data is available in Table S3 and there is no link to the code.

      The data and code used for generation of rf modelling was uploaded to Github and made available. The following statement has been added to the manuscript: “The data and code used for the generation of the rf model is available at https://github.com/SaelensLAB/RF..”

      Reviewer #2 (Recommendations For The Authors):

      (1) More than 42,000 NA sequences are available for the mentioned period on GISAID, it is therefore important to understand the selection criteria for the 44 strains and if these strains represent the overall genetic diversity of N2 of human A(H3N2) viruses. To demonstrate the representativeness of the 44 selected strains, please construct a representative N2 phylogenetic tree for human A(H3N2) viruses circulated in 2009-2017 and label the 44 selected strains on the tree.

      The selection of antigens was performed using the method described by Bien and Tibshirani 2011 (doi: 10.1198/jasa.2011.tm10183). This method uses MinMax distances to identify a central representative among distinct clusters.

      To facilitate visualization tree only of 180 representative N2 proteins from 2009-2017 were randomly selected (20 strains per year, unlabelled). Those 180 representatives and 44 readout panel strains (labelled) are shown in the phylogenetic tree below. Readout strains cover the major branches of the tree. The tree has been built using PhyML 3.0 using JTT substitution model and default parameters (Guindon S. et al, Systematic Biology 59(3):307-21, 2010) and visualized using ETE3 (Huerta-Cepas J. et al, Mol. Biol. Evol 33(6):1635-38, 2016).

      Author response image 9.

      (2) Double immune ferret sera may increase antibody binding affinity and cross-reactivity against heterologous strains. Using single-infection ferret sera may yield different antigenic grouping results (eg. may identify more antigenic groups). Can the authors repeat the NA antigenic grouping using single-infection ferret sera? Although data from a subset of 5 strains was presented (Figure 2, Figure Supplement 4), the information was not sufficient to support if the use of single-infection or double immune ferret sera will yield similar antigenic grouping results.

      In our ferret immunizations the boost was performed with recombinant, enzymatically active NA that was homologous to the NA of the H1N2 virus that was used for the priming by infection. We determined the NAI responses in sera from ferrets after H1N2 infection against 5 different H6N2 viruses (Figure 2 – figure supplement 5). Compared to NAI responses in sera from H1N2 infected and subsequently NA protein boosted ferrets, the NAI titers obtained after a single infection were considerably lower. Although the normalized NAI titers of day 14 and day 42 sera correlated well, we cannot exclude a degree of broadening of the NAI response in the NA protein boost sera (Figure R6). On the other hand, repeated influenza antigen exposure is the reality for the majority of people.

      (3) NA antigenicity data is presented in heat maps and the authors would often describe the heat map patterns matches without further explanations. Line 234-235, the heat map of mouse sera (Figure 2. Figure supplement 5) was described to match the results of ferret sera (Figure 2), but this tends to be subjective. A correlation analysis of 7 selected antigens showed a positive correlation, what about the other 37 antigens?

      The interpretation of heatmaps is indeed very subjective, for this reason the correlation of the 7 selected antigens was also provided. The other 37 antigens were not tested. Considering the results using post boost sera, a simulation of using random forest modeling indicate that the data from one antigen of each antigenic group is sufficient to achieve a reliable predictive output (R2=0.71) (Figure R3 of this rebuttal).

      (4) Can the authors explain in more detail how data in Figure 4a was generated? According to the authors, residues close to the catalytic pocket are more likely to impact NAI. Can the authors explain how they define if a residue is close to the catalytic pocket?

      The correlation of distances of amino acid residues with significance values is explained as follows. Consider 7 distinct elements that are distributed horizontally as shown by the squares in the figure below (Author response image 10a). The elements highlighted in yellow have a numerical propriety (in case of N2 neuraminidase this was the significance values obtained in the association study). Taking P1 as reference we can calculate the distance (red arrows) between P1 and P2, P4 and P7, those distances can them be correlated to intrinsic values of P2, P4 and P7, which enables the calculation of the correlation coefficient Tau. This same process is repeated for each position (or each amino acid), as a consequence every position will have a correlation coefficient calculated (Author response image 8b). This correlation coefficient can be represented as a heat map at the surface of N2.

      Author response image 10.

      The 2D scheme represents the strategy used to calculate the correlation (i.e. the Tau values) between distances and p-values. Tau values can then be presented in a heat map.

      (5) Can the authors provide experimental data using the three recent A(H3N2) viruses as antigens and perform NAI assay to confirm if they are antigenic all deviating from group 2 viruses?

      The generation of data to determine experimental values for A/Hong_Kong/45/2018, A/Tasmania/503/2020, or A/Darwin/9/2021 would require the generation of new reassortant viruses (H1N2s), recombinant protein and immunization of new ferrets. The ferrets sera would have to be analyzed against all 27 H6N2s, including duplicated control sera for normalization. The major point of the modeling was to evaluate if it is possible to predict the antigenic behavior based on amino acid substitutions.

      As an exercise we have run the model again but this time excluding the Swe17 and HK17 antigens from the data set. Sequences of Sw17 or HK17 were then used to predict antigenic distances. The modeled versus experimental data are plotted in Author response image 7 and show a robust predictive outcome with R2 values of 0.94 and 0.91 for Sw17 and HK17, respectively.

      (6) According to Ge et al. 2022 (PMID: 35387078), N2 NA's before 2014 (2007-2013) showed a 329-N-glycosylation and E344, and they were subsequently replaced by H3N2 viruses with E344K and 329 non-glycosylation changing the NI reactivity in ferret antisera towards later strains. Were these residues also predicted to be important to N2 antigenicity from your machine-learning method?

      Three of the N2 NAs used in our panel, A/Victoria/361/2011, A/Hong_Kong/3089/2017, and A/Tennessee/18/2017, lack this N-glycosylation motif. The E344K substitution is present in another 3 NAs, derived from A/Nagano/2153/2017, A/Minnesota/11/2010, and A/Indiana/08/2011. The importance of those mutations is among the lowest ones predicted in our modeling. However, the differences in NAI reported by Ge et al. are low (not even twofold). The experimental variability in our study potentially limits the identification of substitutions with a subtle impact NAI. We have added the following to the discussion in our revised manuscript:

      “It has been reported that an N-glycosylation site at position 329 combined with E344 in NA from human H3N2 viruses from 2007 to 2013 was gradually lost in later H3N2 viruses (Ge et al., 2022). This loss of an N-glycosylation site at position 329 combined with an E344K substitution was associated with a change in NAI reactivity in ferret sera. Three N2 NAs in our panel, derived from A/Victoria/361/2011, A/Hong_Kong/3089/2017, and A/Tennessee/18/2017, lack this N-glycosylation motif. The E344K substitution is present in three other NAs, derived from A/Nagano/2153/2017, A/Minnesota/11/2010, and A/Indiana/08/2011. The importance of those mutations is among the lowest ones predicted by our modeling. However, the differences in NAI reported by Ge et al. are very modest (lower than twofold). The experimental variability in our study potentially limits the identification of substitutions with a subtle impact NAI.”

      Reviewer #3 (Recommendations For The Authors):

      Specific suggestions:

      Line 132: Did the authors confirm the absence of compensatory mutations due to a heterologous H6 background that could potentially confound downstream NAI results?

      All NAs genes of the rescued H6N2 viruses were fully sequenced and were found to be identical to the expected NA sequences, with the only exception being the A/Tasmania/1018/2015 were a mixed population of wt and M467I was found. This substitution is located at the surface and at the top of the NA head domain, and thus could potentially impact NA antigenicity. However, A/Tasmania/1018/2015 H6N2s had a similar inhibition profile as other H6N2s in phylogenetic and antigenic group 1. This indicates that, at least in this mixed population, antigenicity was not drastically affected by the M467I substitution.

      Line 96: how do these data rule out variation in the fraction of properly folded protein across NAs? They certainly show that properly folded NA protein is present, but not whether amounts vary between the different NAs.

      SEC-MALS (size exclusion chromatography-Multiangle light scattering) data and enzymatic activity were considered as a proxy for correctly folded NA. Although the specific activity of the recombinant N2 NAs is expressed per mass unit (microgram), we cannot exclude that the fraction of properly folded protein across the different recombinant NAs may vary.

      Lines 262-269: this analysis approach (based on my reading) seems to consider each polymorphism in isolation and thus does not seem well suited for accounting for epistatic interactions within the NA. For example, the effect of a substitution on NAI may be contingent upon other alleles within NA that are not cleanly segregated between the two serum comparator groups. Can the authors address the potential of epistasis within NA to confound the results shown in Figure 3?

      Unfortunately, epistatic interactions cannot be solved using the panel of N2 selected for the study. This limitation is mentioned in our discussion:

      “It is important to highlight that co-occurring substitutions in our panel (the ones present in the main branches of the phylogenetic tree) cannot be individually assessed by association analysis or the random forest model. The individual weight of those mutation on NA drift thus remains to be experimentally demonstrated.”

      Line 331: is there a way to visualize and/or quantify how these two plots (F5 supplement 1a/b) reflect each other or not? Without this, it is hard to ascertain how they relate to each other.

      We have generated an antigenic cartography map instead. As a consequence, the MDS has become redundant and Figure 5 – supplement 1 was removed.

      Figure 4B structural images are not well labelled.

      The active site in 1 of the protomers is now indicated with an arrow in the top and side views of the NA tetramer.

      Lines 339-359: the ML predictions are just predictions and kind of meaningless without experimental validation of the predicted antigenic differences between recent NAs. This section would also be strengthened by an assessment of whether the ML approach obtains more accurate results than simply using phylogeny to predict antigenic relationships.

      Indeed, there is no experimental data from A/Hong_Kong/45/2018, A/Tasmania/503/2020, or A/Darwin/9/2021. The generation of data to determine experimental values for A/Hong_Kong/45/2018, A/Tasmania/503/2020, or A/Darwin/9/2021 would require the generation of new reassortant viruses (H1N2s), recombinant protein and immunization of new ferrets. The ferrets sera would have to be analyzed against all 27 H6N2s, including duplicated control sera for normalization. The major point of the modeling was to evaluate if it is possible to predict the antigenic behavior based on amino acid substitutions.

      As an exercise we have run the model again but this time excluding the Swe17 and HK17 antigens from the data set. Sequences of Sw17 or HK17 were then used to predict antigenic distances. The modeled versus experimental data are plotted in figure R7 and show a robust predictive outcome with R2 values of 0.94 and 0.91 for Sw17 and HK17, respectively. A major advantage of antigenic modeling is the potential to rank or indicate major antigenic divergences based on available sequences before it has consolidated as new clade. The support in selecting or designing broader reactive antigens is another advantage of machine learning analysis.

      Lines 416-421: appreciate the direct comparison of results obtained from ferrets versus mice.

      We thank the reviewer for expressing this appreciation.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      R1-01 - Does ank-G-GFP label all isoforms (190, 270 and 480kDa) of ankG? From the images of the AIS and noR it appears that the large forms (270 and 480 kDa) are probably tagged with GFP. Did the authors check for puncta along dendrites and in dendritic spines, which are thought to be formed by the small (190 kDa) isoform? Perhaps a western blot to show that Ank-G-GFP labels all isoforms would be a useful addition to this study.

      We believe that AnkG-GFP indeed labels the major Ank3 transcripts in the brain, including the 190, 270, and 480 kDa isoforms, based both on known mRNA exon usage and on Western blot analysis (data not shown). Thus, theoretically, this model would be useful for examining the localization of 190 kD ankyrin-G to dendritic spines. While we attempted to examine this in sections from tissue, it was difficult to separate punctate ankyrinG-GFP labeling from the background. However, these experiments were done in genetic crosses that would label most pyramidal neurons in a given area (i.e. CaMKIIa-Cre). Given the Cre-dependence of this model, future experiments could utilize sparse transduction with a Cre virus that also fills neurons with soluble fluorophores (i.e. mCherry or tdTomato) to mark isolated neurons and identify dendritic spines, as exemplified in Fig. 2D. This would allow examination of subcellular localization of ankyrin-G within single pyramidal cells before and after induction of synaptic plasticity.

      R1-02 - In Figure 2, does all the native Ank-G get replaced by Ank-G-GFP? In Fig. 2E the GFP signal along the AIS of CamKII +ve neurons does not appear to be very homogeneous compared to the BIV-spectrin label. Have the authors carried out more experiments like those in 2F, using antibodies that label AnkG together with the GFP fluorescence of the labeled AnkG? It would also be informative to know if, as one might expect, the total levels of ankG-GFP correlate with the levels of ankG at the AIS.

      We agree that this is an important point and conducted additional experiments to address your concerns. Of course, we cannot exclude that some unmodified ankyrin-G remains in the AIS or other structures. We expect the turnover of the protein to be rather slow, and native ankyrin-G likely remains to some degree. However, our quantification demonstrates that the ankyrin-G-GFP labeling is sufficiently homogeneous to accurately represent AIS size, indicating proportional levels of GFP to native ankyrin-G. Animals were crossed with a CaMKIIa-Cre driver line and ex vivo slices were imaged live and after immunolabeling. We found a strong correlation between live ankyrin-G-GFP (patch clamp chamber), postfix ankyrin-G-GFP, postfix ankyrin-G, and βIV-spectrin immunosignals of the same AIS. Furthermore, our measurements of AIS length using the intrinsic GFP signal in combination with ankyrin-G, or βIV-spectrin antibodies showed significant overlap (see R103). We now included these graphs as supplemental Fig. S2 in the manuscript (pp. 8-9, ll. 173-177).

      R1-03 - Does the length and position of the AIS change when Ank-G is tagged with GFP? This seems like important information that is needed to make sure that there are no structural differences in AIS morphology when compared to native Ank-G.

      This is a very important point. We used the βIV-spectrin signal to compare the length of AIS with and without GFP modification in acute slices after patch-clamp recordings (N= 3 animals, 27 GFP+ and 48 GFP- AIS). As secondary control, we plotted the measurements of 160 AIS from a Thy1-GFP mouse line (N = 3 animals, 160 AIS). We found no significant difference in the length and position of the βIV-spectrin signal between GFP positive and negative AIS (p=0.3364 unpaired t-test, p=0.6138 non-parametric Mann-Whitney test, respectively). We have now included this analysis as Supplemental Fig. S2A in the manuscript (pp. 8-9, ll. 173-177). 

      R1-04 - How was node length measured in Figure 3? Was this done using the endogenous ank-G signal? In this figure, it would be informative to also quantify the number of noRs with a Nav1.6 stain. Perhaps even check if there are correlations between Ank-G-GFP and Nav1.6 levels. In this figure, it appears that comparisons are carried out between Ank-G-GFP +ve and -ve neurons in the same cryosections, from Ank-G-GFP mice crossed with CamKIIa-Cre. I worry that this may not be comparing the same types of axons. What cells do the CamKIIa -ve axons belong to? Also, the labels on the bar graph are confusing - perhaps GFP+ve and GFP-ve would be clearer?

      The reviewer raises an important point. We forgot to declare the signal which was used to measure node length in the manuscript. We have corrected this error and clearly state now in the Fig.3C legend that we used the ankyrin-G signal to quantify node length. Furthermore, using CaMKIIa-Cre mediated expression triggers ankyrin-G-GFP only in a genetically defined subset of neurons. Nodes that do not belong to this subgroup might very well have different node properties. Yet, we cannot assign potential differences in node length to the presence or absence of the GFP label, since we do not have an independent labeling technique for the very same subset of neurons. Since node lengths were similar and showed the same spread of lengths in our sample (Fig. 3C), we assume that the GFP length does probably not affect node length to a significant degree. We have now discussed this limitation in the result (p. 7, ll. 159-165) and method section (p. 30, ll. 644-645) and provide Supplementary Fig. S1 for more clarity. As suggested by the reviewer, we have measured mean fluorescence intensities between 91 GFP+ and 141 GFP- nodes using automated image processing in Imaris. The nodes were again defined by the ankyrin-G signal. We found no difference in length and ellipticity between the groups. We repeated this analysis and compared fluorescence intensities of Nav1.6 and ankyrin-G antibodies and again found no statistical differences between both groups. As suggested by the reviewer, we investigated whether ankyrin-G-GFP interferes with the fluorescence intensities of sodium channels (Nav1.6) and ankyrin-G in general. While the GFP signal showed a strong correlation with ankyrin-G, we found no interdependence with the Nav1.6 signal, indicating that the GFP label does not interfere with the general molecular composition of the nodes. We included these new analyses in Supplemental Fig. S1 (p. 7, ll. 159-165).

      R1-05 - In Figure 4 it would also be important to show the distribution of AIS molecules along the AIS, compared to the GFP signal, to establish whether this spatial arrangement of AIS-specific molecules remains intact. For example, Nav1.6 has been described as a more distally-located channel. As the authors point out, the example in A appears to show precisely this feature, but there is no quantification. The same applies to Kv1.2. This would also allow the authors to provide some quantification across multiple AISs, rather than just example images.

      We agree that quantifying and comparing AIS-associated proteins would be informative. We measured the intensity profiles of Nav1.6 and Kv2.1 in neighboring AIS and found no preferences for either end of the AIS, neither of GFP-positive nor GFP-negative AIS. We want to note that not all neurons exhibit a distal localization of Nav1.6 and hypothesize that our samples (neocortex layer II) also fall into this group. We included this new graph as Supplemental Fig. S2D and E in the manuscript (p. 9, ll. 180-184).

      R1-08 - In Figure 4, did the +Cre condition result in all cells showing a GFP-labelled AIS? If not, were the autocorrelations for +Cre-treated neurons done specifically on cells that expressed AnkG-GFP?

      We assume the reviewer refers to the autocorrelation in Figure 6. In this in vitro paradigm, we used virus-induced Cre expression which triggered ankyrin-G-GFP in almost all neurons. The orange boxplots describe the autocorrelation of all ankyrin-G, using a C-terminal antibody as in Fig.6C, but in neurons that also express ankyrin-G-GFP. The green samples use the GFP signal of ankyrin-GFP. We clarified this in the graph and legend of Fig. 6C (pages 14-15).

      R1-09 - As mentioned above in Figure 3, the comparisons in Figure 5 (GFP +ve and -ve neurons) may not be comparing like-for-like neurons. I imagine that many of the CamKII+ve cells in the cortex and hippocampus will be GABAergic interneurons, whereas presumably all of the CamKII+ve neurons will be pyramidal cells. Have the authors made sure that they are comparing across the same cell types? The fact that the number of axo-axonic synapses is similar across the two populations (Fig. 5B) does suggest that similar neuron types (presumably pyramidal cells) were compared in the hippocampus, but some other way of making sure would be a nice addition.

      We agree with the reviewer that the grey and green boxes are not sampled from the same subset of neurons, since only CaMKIIa-positive principal cells will express ankyrin-G-GFP. However, we are confident that the selected AIS belong to pyramidal neurons in both cases. Principal neurons can be well distinguished from interneurons not only by the size, shape, and position of their somas but also by the length and thickness of their AIS. We have performed previous studies on the AIS of interneurons using genetic GAD and parvalbumin markers. Thus, we are confident that the plots in 5A and 5B are sampled from pyramidal neurons, though certainly from genetically different subsets. We now highlight and discuss this limitation in the result section (p. 11, ll. 215-217) and modified the graph in Fig. 5A and 5B for clarity.

      R1-10 - In Figure 6, what was the promoter for the DCre and Cre+ lentivirus? Was this also driven by CamKIIa? In culture it is not always easy to be sure of neuronal identity - did the authors try to bias their analysis to specific neuronal types?

      Indeed, the nature of the promotor was not stated in the legend or method section, which we now corrected. We used lentiviral FUW-nGFP-Cre and FUW-nGFP-ΔCre constructs to trigger ankyrin-G-GFP expression. Both viruses use the CMV (Cytomegalovirus) promoter, which drives constitutively high levels of gene expression in a wide range of cell types, including neuronal cells. The majority of neurons in dissociated hippocampal cultures are excitatory, especially larger cells with larger AIS, which were preferably used in the analysis. Thus, we cannot claim that AIS nanostructure is intact in cultured interneurons, but this is also true for in vivo conditions in general. Since mice did not show any obvious behavioral phenotypes, we are positive that interneuron functionality is preserved. We also note that the parallel expression of nuclear GFP in the infected neurons was undesired, but did not impact STED imaging due to that technique’s high resolution. 

      R1-11 - The ability to visualize the plasticity of the AIS in real-time is an important advance in the field. The loss of proximal Ank-G-GFP signal upon local application of 15 mM KCl is particularly interesting. The fact that neighboring AISs are not affected is surprising - do the authors know how local their KCl application was? Also, although the neighboring AISs are a nice control, the one control lacking here is the local application of normal solution (preferably 15 mM NaCl to account for osmolarity changes) to make sure that this does not affect the properties of the AIS.

      We used KCl puffs in previous, unrelated experiments where we observed that only cells directly in front of the pipette are visibly depolarized by an acute KCl puff (measured by patch-clamp). Due to technical limitations, patched and live imaged neurons were generally in the first 2-5 cell layers of the brain slice, which is well perfused by the constant flow of oxygenated ACSF. KCl is thus quickly diluted and carried away. We have visualized the concentration gradients via puff application by puffing the fluorescent marker fluorescein in the same recording condition. The cone of fluorescence was only visible in front of the pipette and vanished in less than a second post-pressure application. To verify that it is indeed KCl and not the mechanical stress that lead to the loss of proximal Ank-G-GFP, one would indeed need an ACSF puff control, which we did for other studies. However, this is not the point we wanted to make. Instead of studying live single-cell AIS plasticity, we want to demonstrate that such investigations are generally possible using the ankyrin-G-GFP line.

      Author response image 1.

      R1-12 - The ability to be able to image AISs in vivo is another important finding. Were the authors able to image noRs as well?

      We believe that this is indeed the case. The panels in Figure 9C contain densely labeled puncta that also remain in position from week 1 to week 2. These are likely nodes of Ranvier, although we do not have the means to verify their presence at this time.

      Reviewer #2:

      R2-01 - Are there indeed different Ank-G-GFP isoforms expressed in this model and could they correspond to classical neuronal Ank-G isoforms?

      This is an important issue that was also raised by reviewer #1. Please consult the respective section R1-01 above for our response.

      R2-02 - What is the rationale of doing Ank-G co-labelling in the case of Ank-G-GFP expression, rather than Pan-Nav staining for example? The co-staining with Nav1.6 antibody, when present, is however convincing.

      We used the co-labeling to emphasize that the ankyrin-G-GFP construct allows reliable investigation of the whole AIS. This is why we wanted to demonstrate that the ankyrin-G-GFP signal overlaps with other AIS markers, as well as all ankyrin-G in general (including potentially remaining native and unlabeled ankyrin-G). This was also a point raised by Reviewer 1, which is why we provided some additional graphs (see response R1-02). However, we agree that staining with another independent marker, such as Nav1.6 or βIVspectrin was necessary. 

      R2-03 - Figure 2D and F: what is the rationale for not using betaIV-Spectrin staining as in the other panels of this figure? Furthermore, could betaIV-Spectrin localization be affected by Ank-GGFP expression, as betaIV-Spectrin is known to depend on Ank-G for its AIS targeting? Are there any other AIS markers, which localization is known to be independent of Ank-G, that could have been used?

      We have compiled this figure from a multitude of different experimental setups from different labs to showcase the reliability and robustness of the ankyrin-G-GFP label. This is why the type of staining is not consistent among panels. However, we provide some quantification on the possible impact of ankyrin-G-GFP expression on the βIV-spectrin signal and the composition of the AIS in general. The STED image verifies that the basic subcellular arrangement of the cytoskeleton, including βIV-spectrin, remains intact (Fig. 6). Most AIS markers are at least in some way dependent on ankyrin-G expression, but FGF14 and neurofascin may be the most independent candidates (Fig. 4).

      R2-04 - Did the authors measure the mean AIS length and distance from cell soma in Ank-G-GFPexpressing neurons versus non-expressing ones (considering the same neuronal subtypes) to assess whether these were unaffected by Ank-G-GFP expression?

      This is an important point that was also raised by Reviewer 1 (see also our comments to R1-03). We have included this analysis now in the manuscript as Supplemental Fig. S2A (pp. 8-9, ll. 173-177).

      R2-05 - Figure 5C: the microglial staining and 3D reconstruction could have been clearer.

      We have modified the image and 3D rendering to make Figure 5C clearer to the reader. We hope that our changes suffice.

      R2-06 - Figure 8: do hippocampal neurons retain their electrophysiological properties after 20 DIV? It could strengthen this part of the work to have access to the electrophysiological data mentioned in the text. 

      This is an important issue. We did not perform any electrophysiological recordings in OTCs in the course of this study. Panel E uses acute hippocampal slices like in Fig. 7. We have performed patch-clamp experiments up to DIV 10 for an unrelated study (see graph for action potential firing, Author response image 2). There are not many studies performing electrophysiology in slice cultures due to the formation of a glial scar on top of the slices. However, multielectrode array (MEA) recordings demonstrated that hippocampal organotypic slice cultures remain viable and show electric activity past DIV 20 (though with decreased viability and activity). We kindly refer to the following publications on that matter:

      Author response image 2.

      Sample traces of action potentials triggered by cuttrent injections

      Gong W, Senčar J, Bakkum DJ, Jäckel D, Obien ME, Radivojevic M, Hierlemann AR. Multiple SingleUnit Long-Term Tracking on Organotypic Hippocampal Slices Using High-Density Microelectrode Arrays. Front Neurosci. 2016 Nov 22;10:537. doi: 10.3389/fnins.2016.00537. PMID: 27920665; PMCID: PMC5118563.

      Mohajerani MH, Cherubini E. Spontaneous recurrent network activity in organotypic rat hippocampal slices. Eur J Neurosci. 2005 Jul;22(1):107-18. doi: 10.1111/j.1460-9568.2005.04198.x. PMID: 16029200.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public review):

      Summary:

      This manuscript by Tesmer and colleagues uses fiber photometry recordings, sophisticated analysis of movement, and deep learning algorithms to provide compelling evidence that activity in hypothalamic hypocretin/orexin neurons (HONs) correlates with net body movement over multiple behaviors. By examining projection targets, the authors show that hypocretin/orexin release differs in projection targets to the locus coeruleus and substantia nigra, pars compacta. Ablation of HONs does not cause differences in the power spectra of movements. The movement-tracking ability of HONs is independent of HON activity that correlates with blood glucose levels. Finally, the authors show that body movement is not encoded to the same extent in other neural populations.

      Strengths:

      The major strengths of the study are the combination of fiber photometry recordings, analysis of movement in head-fixed mice, and sophisticated classification of movement using deep learning algorithms. The experiments seem to be well performed, and the data are well presented, visually. The data support the main conclusions of the manuscript.

      We thank the reviewer for their supportive feedback.

      Weaknesses:

      The weaknesses are minor, mostly consisting of writing and data visualization throughout the manuscript. To some degree, it is already known that hypocretin/orexin neurons correlate with movement and arousal, although this manuscript studies this correlation with unprecedented sophistication and scale. It is also unfortunate that most of the experiments throughout the study were only performed in male mice. Taken together, this study is likely to be impactful to the field and our understanding of HONs across behavioral states.

      We agree that disentangling movement from arousal is an important aspect, and in the revised manuscript, we now include new data and analyses towards this (pupillometry to directly assess arousal, and multivariate analysis to assess contributions of arousal vs movemement to HON activity). In addition, we now implement many of the reviewer’s recommendations regarding writing, data presentation, and visual clarity (see our replies in the “recommendations for authors” section).

      Reviewer #1 (Recommendations for the authors):

      Some recommendations for the authors:

      (1) The first sentence of the Introduction states: "Neural activity related to body movement recently received much attention." I would rephrase or clarify this statement, as neuroscientists have been studying neural activity related to body movement for decades.

      The reviewer is correct. Our intention was to highlight the resurgence of movementrelated neurosciences enabled by modern techniques such as deep learning applied to video data (e.g. DeepLabCut, etc). The passage has been updated for clarity.

      (2) The Introduction also states that HONs orchestrate "consciousness and arousal." I would delete the word "consciousness," as consciousness represents a lofty, global concept that is challenging to define and quantify in humans, let alone mice.

      We used the word consciousness to be consistent with current literature on the function of the mouse hypothalamus (e.g. Nat Neurosci 2016 Feb;19(2):290-8). But we agree it is not necessary here, and so we followed the advice to delete it.

      (3) The authors state that HON dynamics were recorded while mice were head-fixed while on a running wheel. For clarity, it would be helpful to visualize this head-fixation in Figures 1A and 5B. It would also be helpful to clarify how certain behaviors (e.g. grooming, chewing) were performed and recorded while the mouse was head-fixed.

      In the revised manuscript, updated graphics with a head-fixed mouse have now been added to relevant figures. Representative RGB frames (colors representing sequential frames) of each behaviour have been added to Figure 2A.

      (4) In the legend for Figure 1A, the reference to Gonzalez et al. 2016 seems out of place (at least the reader should be informed why the text is referring to this previous study). Additionally, because the references are ordered by number instead of alphabetically, it would be more helpful to refer to a numbered reference rather than a name.

      Gonzalez et al. 2016 references the source of the AAV construct used in this figure. This has been moved to the methods. Following eLife formatting guidelines, references will be alphabetized upon publication.

      (5) In Figure 3F, it would be helpful to show visual validation that the HON-DTR method indeed ablates all HONs. This is depicted conceptually, but representative figures would be much more convincing.

      A representative histological slice is now included for both wild type (WT) and HON-DTR mice in the new Figure 4B.

      Reviewer #2 (Public review):

      Summary:

      Despite several methodological strengths, the major and highly significant drawback is the confound of arousal with movement. This confound is not resolved, so the results could be explained by previously established relationships between orexin and arousal/wakefulness.

      This an excellent point, and we agree. To address this directly in the revised manuscript, we now include new data and analyses towards this (pupillometry to directly assess arousal, and multivariate analysis to assess contributions of arousal vs movemement to HON activity).

      Strengths:

      The authors show that orexin neuron activity is associated with body movement and that this information is conveyed irrespective of the fasted state. They also report differences in different orexin target brain regions for orexin release during movement. This paper contains an impressive array of cutting-edge techniques to examine a very important brain system, the orexin-hypocretin system. The authors offer an original perspective on the function of this system. The authors showed that orexin neuron activity scales to some degree with the magnitude of body movement change; this is unaffected by a fasted state and seems to be somewhat unique to orexin neurons.

      The investigation of other genetically defined subcortical neuron populations to determine the specificity of findings is also a strength, as is the ability to quantify movement and use deep learning to classify specific behaviors adds sophistication to analysis. The authors also show heterogeneity in orexin projections to specific target nuclei, which is interesting.

      The authors "speculate that narcolepsy-cataplexy, caused by HON loss-of-function, is perhaps explained by oscillations into unwanted sleep-states and motor programs due to impaired control loops for wakefulness and movement". This is quite an interesting aspect of their work and deserving of further study.

      We thank the reviewer for their supportive feedback.

      Weaknesses:

      Despite the strengths, there are several major and minor weaknesses that detract significantly from the study.

      My main concern with this work is the confound of arousal with movement so that correlations with one might reflect a relationship instead with the other. The orexin system is well known to play an important role in arousal, with elevated activity of orexin neurons reported for waking and high arousal. Orexin signaling has also been strongly associated with motivation, which also is associated with arousal and movement. The authors offer no compelling evidence that the relationships they describe between different movements and orexin signaling do not simply reflect the known relationship between arousal and motivation.

      The authors could address this concern by including classical arousal measurements, eg, cortical EEG recorded simultaneously with movements. Often, EEG arousal occurs independently of movement, so this could provide one approach to disentangling this confound. The idea that orexin signaling plays a role in arousal rather than movement is supported by their finding that orexin lesions using the orexin-DTR mouse model did not impact movements. In contrast, prior lesion and pharmacologic studies have found that decreased orexin signaling significantly decreases arousal and waking.

      Another way they could test their idea would be to paralyze and respirate animals so that orexin activity could be recorded without movement. Alternatively, animals could be trained to remain motionless to receive a reward. Thus, there are several ways to test the overall hypothesis of this work that have not been examined here.

      The authors propose that "a simple interpretation of their results is that, via HON movement tracking, the brain creates a "wake up" signal in proportion to movement". This seems to argue for the role of the orexin system in arousal and motivation rather than in movement per se.

      Thank you. We agree that disentangling between arousal and movement is indeed critical. A classic approach is a multivariate analysis, wherein multiple simultaneously recorded “predictors” of HON activity – such as arousal and movement - can be directly compared. While EEG arousal is an option, another well-accepted metric for arousal is pupil diameter. Using n = 7 mice, we now simultaneously record HON activity, movement, running speed, pupil size fluctuations, and ocular movements:

      We then fit a partial least squares multivariate regression (a regression type more robust to collinearity) using the movement metric, pupil size, and ocular movements as predictors of orexin neuron activity. Consistent with previous publications, we found that pupil size alone has a positive correlation with hORX.GCaMP6s (~0.45). However, using a drop-one feature analysis in multivariate regression, we found that movement had the highest % contribution to statistically explaining orexin neuron activity. Here are the new results (which we now added as Fig. 7A-B).

      Author response image 1.

      Furthermore, we also expanded this analysis to incorporate the different frequencies found in HON dynamics, using empirical mode decomposition. We found that pupil size had a maximum correlation at lower HON frequencies than the movement metric, while ocular movements were maximally correlated in higher frequencies (now added as Fig. 7D,E).

      Overall, this analysis suggests that – while HONs encode both movement and arousal – arousal and movement do not always co-fluctuate at the same timescales, and their impacts on HONs can be disentangled in a number of ways. We now mention this in revised text on page 5.

      There are several studies that have examined the effect of orexin antagonist treatment in rodents on locomotor and other motor activities. These studies have largely found no consistent effect of antagonizing orexin signaling, especially at the OxR1 receptor, on simple motor activity. These studies are not referenced here but should be taken into account in the authors' conclusions.

      We agree. Prior studies found that orexin antagonism – or optogenetic silencing of HONs – evokes either reduced locomotion, or no effect on locomotor movements. We now added text and references to paragraph 4 of Discussion, summarising this.

      Figure 3, panel F: I understand HON-DTR is a validated model but a picture of HONs ablation is necessary, including pictures of HONs outputs ablation within the SNc and LC.

      A representative histological slice is now included for both wild type (WT) and HON-DTR mice in the new Figure 4B. Because HONs are only found in the hypothalamus, somatic deletion of HONs in this region will result in axonal degradation in output regions.

      The discussion lacks a more extensive paragraph on the distinct signal and role of Ox>SNc and Ox-LC projections.

      We now added sentences discussing potential implications of this to Discussion (middle of paragraph 4).

      Reviewer #2 (Recommendations for the authors):

      Minor weaknesses

      A very important movement in rodents is head orientation, especially given the limitation in ocular movement. However, this paper used a fixed head model which obviated this movement and did not attempt to analyze ocular movements.

      Analysing ocular movements is something we had not considered but is very easy to check using pupillometry. In n = 7 mice, we recorded both orexin neurons, and ocular movements captured through an infrared camera under constant lighting. Ocular movements had a small positive correlation with orexin neuron photometry (r = ~0.26). See response to the public review above.

      Author response image 2.

      The "HON" abbreviation is not commonly used for orexin neurons, and I suggest replacing that with a more well-known abbreviation.

      To the best of our knowledge, there is no universally agreed or best-known abbreviation for hypocretin/orexin neurons (we agree it would be nice if there was one!). “HONs” is a simple first letter abbreviation of hypocretin/orexin neurons, which acknowledges the two names for this peptide given by the original discoverers (de Lecea et al, and Sakurai et al, in 1998). Although this may not be the perfect abbreviation, we have kept it for now, also to be consistent with the large number (>10) of other published studies that recently used this abbreviation.

      The graphs showing Pearson's r values do not demonstrate a very strong correlation between neural activity and movement change; they also lack validation of genetic expression/ablation in some cases. The results would more strongly support the conclusions if statistically significant correlations could be demonstrated between activity and movement.

      We agree that a correlation of ~0.68 is probably not worthy of a “very strong” classification. While there is no universal ruleset for categorizing the strength of a correlation, we have toned down our language throughout the manuscript.

      Comment regarding statistical testing of correlations: we are cautious to stand behind correlation significance testing for large sample sizes (~48’000 photometry & video samples in a 40-minute session). In our case, correlations were always extremely significant p<0.0001. The reason for this is that correlation p-values become “too big to fail” (see Lin et al. 2013) with inflated sample size. We therefore refrain from commenting on p-values and rather report between or within-subjects statistical tests, or tests against zero. See four example experiments below.

      Author response image 3.

      Citation: Lin, M., Lucas, H. C., Jr & Shmueli, G. Research Commentary—Too Big to Fail: Large Samples and the p-Value Problem. Information Systems Research 24, 906–917 (2013).

      The rationale for looking at running speed, general movement, and specific types of nonlocomotor movements could be clarified and explained more thoroughly in the introduction. Why is it important to distinguish between locomotion (represented here with running) and all other movements? Presumably, this is because orexin is known to regulate arousal/locomotion. What evidence is there for orexin's role in other types of movements, which are being grouped together in Figure 1? This could be laid out in more detail in the Introduction. Relatedly, it is not very clear in the text whether the correlation between movement and orexin neuron activity includes movement related to running.

      The main focus of our paper is on movement in general (i.e. video pixel difference, described in Results and Methods). This movement metric includes everything captured by the video, it is agnostic to the type of movement or behaviour.  To connect this to some of the specific innate movements/behaviours typically studied in mouse literature (running, grooming, sniffing, etc), we also performed plots in Figure 2. We attempted to explain this better in revised section 1 of Results.

      What exactly is being correlated in Figure 1C (and throughout the rest of the paper?) Is this the average signal correlated with the average movement change over the entire recording time? This could be more explicitly stated in methods/results. The correlations themselves/p-values could be shown in addition to/instead of Pearson's r values. Are the correlations themselves significant? This would strengthen the claim that orexin activity is strongly coupled to the magnitude of body movement change. As another example, in Figure 2D, there are no statistics reported on the correlation between movement metric and average neural signal. In Figure 6G, orexin neuron activity is more strongly correlated with movement than MVe glut neurons, but are either of these correlations significant? The correlation between MVe glut activity and movement overall seems similar to that of orexin neurons, and may be worth noting more explicitly.

      Throughout the paper, we have recorded both neural activity (photometry) and movement at 20 Hz. This would generate, for example, 48’000 samples of photometry and movement from a 40-minute session. All the samples were used to calculate a pearson’s r between variables. To clarify this, we now added the subtext “wholesession” to relevant figures, as well as a clarification in the methods.

      Individual experiment correlations for orexin neurons and MVe glut neurons were always significant p<0.0001, even after a Bonferroni multiple comparisons correction was applied to each population. See the “too big to fail” nature of correlation hypothesis testing above.

      It could be made clearer at the end of Figure 2 that orexin neuron activity is tracking the magnitude of movement change (shown in Figure 2D), not that it is encoding different types of movement.

      We intended for original Figure 2E to illustrate this concept, however this panel has caused a great deal of confusion to several readers and was perhaps ill conceived. We have replaced Figure 2E with a new panel more directly addressing the reviewer’s statement. We can construct three models where orexin neuron activity is predicted from the behavioral classification (sometimes called “one-hot” encoding) and/or the movement metric.

      Model 1 predicts orexin neuron activity using only a categorical predictor of behavioral state. Model 2 only uses the movement metric, and model 3 allows a different movement-metric correlation within each behavioral state. We can compare these models using AIC (Akaike Information Criterion) which is a point estimate. While the most complex model 3 was the best, model 2 was much closer to model 3 than model 1. Similarly, model 2 was much better than model 1. From this we conclude that the magnitude of movement change is a more powerful predictor than behavioral state (“type of movement”). This is now Figure 2E.

      It would be interesting to see the raw movement metric data as shown in Figures 1 and 2 in the DTR mice to show that ablating orexin neurons does not impair the movement profile seen in Figures 1 and 2.

      The requested visualization has been added to Figure 4B.

      Validation that orexin was selectively ablated in these mice would be ideal.

      Histology (see response to public review) was added to a new Figure 4B.

      Figure 4A - OxLight expression in SNc does not look very robust.

      Please note this is a membrane-targeted indicator, the staining this produces is thus much weaker than cyctosolic indicators such as calcium indicator GCaMP.

      Figure 4 - It would be beneficial to see the same correlations that were done in Figures 1 and 2 to show OxLight activity vs. movement metric. Are they correlated?

      Individual traces had significant correlations with OxLight and movement, and the population averages revealed similar trends:

      Author response image 4.

      Figure 6B - Targeting of MVe neurons does not look very specific. The sample size for orexintargeted mice should be re-stated in the figure legend for clarity.

      Legend has been updated to clarify n = 15 for orexin targeted mice.

      Some citations didn't seem to match what was being referenced in the text. Similarly, in the legend for Figure 1C, the statistics do not match what is reported in the text. In Figure 1, the sample size is not noted in the text. When referring to running in Figure 1, is this referring to running speed? Perhaps the language could be more consistent.

      These typos (due to a rounding error) in the legend and text have been corrected. Sample size has been added to the text, and we have changed Figure 1D to clarify we are referring to running speed. We moved some citations to improve clarity.

      Methods - where were Cre mice obtained from?

      Sources now better referenced in Methods (JAX or Parlato et al).

      Figure 1, panel C: The authors compared Pearson's r-coefficient results for each animal and for each variable. However, it would be interesting to show the correlation curves for each variable. However, it would be interesting to show the correlation curves for each variable as well here. Also, there is mention of a strong correlation but it is unclear whether these correlations are significant.

      See below for an example mouse.

      Author response image 5.

      Figure 3, panel F: I understand HON-DTR is a validated model but a picture orexin ablation is necessary, including pictures of orexin fibers ablation within the SNc and LC.

      See our reply to the public review above.

      Figure 5, Panel A: Same comment as Figure 1, panel C.

      We have similarly clarified the panel and legend.

      Page 4: The authors mention "Within the 1st and 4th quartile of blood glucose, movement-HON correlations were not significantly different. Please add the figures.

      The requested plot has been added to Figure 6, panel G.

      Reviewer #3 (Public review):

      Summary

      The study presents an investigation into how hypothalamic orexin neurons (HONs) track body movement with high precision. Using techniques including fiber photometry, video-based movement metrics, and empirical mode decomposition (EMD), the authors demonstrate that HONs encode net body movement consistently across a range of behaviors and metabolic states. They test the ability of HONs to track body movement to that of other subcortical neural populations, from which they distinguish HONs activity from other subcortical neural populations.

      Strengths:

      The study characterizes HONs activity as key indicators of movement and arousal, and this method may have potential implications for understanding sleep disorders, energy regulation, and brain-body coordination. Overall, I think this is a very interesting story, with novel findings and implications about sensorimotor systems in animals. The manuscript is clearly written and the evidence presented is rigorous. The conclusions are well supported by experimental data with clear statistical analyses.

      We thank the reviewer for their supportive feedback.

      Weaknesses/suggestions:

      There are a couple of issues I think the authors could address to make the paper better and more complete:

      (1) The study primarily focuses on steady-state behaviors. It would be interesting if the authors' current dataset allows analyses of HON dynamics during transitions between behavioral states (e.g., resting to running or grooming to sniffing). This could provide additional insights into how HONs adapt to rapid changes in body movement.

      This is a fantastic idea, and easy to check using our classification CNN. We identified the six most frequent behavioral transitions and plotted them in Figure 2H. HONs show rapid dynamics in activity aligned with behavioral changes.

      These changes are very similar to the movement magnitude along these transitions, which is now also plotted in Figure 2G.

      (2) Given the established role of HONs in arousal and wakefulness, the study could further investigate how movement-related HON dynamics interact with arousal states. For example, does HON encoding of movement differ during sleep versus wakefulness?

      To further investigate how movement encoding interacts with arousal, we now include quantification and analysis of pupil-linked arousal (see new Figure 7). We agree it would be interesting to look at what happens during sleep, especially REM sleep when some HONs are thought to be active where there is no/little body movement, but this is beyond the scope of the present study.

      (3) Although HON ablation experiments suggest that HONs do not shape movement frequency profiles. It would be more compelling if the authors could investigate whether HONs contribute to specific types of movements (e.g., fine motor vs. gross motor movements) or modulate movement initiation thresholds.

      We performed this analysis using the k-means classifier for small/large movements. Consistent with previous results, we found no significant effect (p = 0.2767) of genotype on the frequency of identified small (fine) or large (gross) movement clusters. This plot has been added to Figure 4E.

      (4) The heterogeneous movement-related orexin dynamics observed in the LC and SNc raise intriguing questions about the circuit-level mechanisms underlying these differences. Optogenetic or chemogenetic manipulation of these projections could validate the functional implications of these dynamics.

      We agree. We now discuss some implications of this in revised Discussion (paragraph 4). Please note that previous work already demonstrated that orexin action in the SNc can produce locomotion (referenced in the paragraph), though we agree that further work would be valuable.

      Reviewer #3 (Recommendations for the authors):

      Additional feedback:

      (1) Figure 1C: the individual data points are hard to track or see. Consider using a larger marker face to help data visualization. Similar issues can be found in Figures 2C, 2E, 5E, 6C, 6F, and 6G.

      Thickness of the lines and scatterplots have been increased.

      (2) First Section of Results: the authors claim to use a deep-learning network to automatically classify video recordings into five distinct behaviors. However, several issues need to be addressed here:

      a. In Results, the corresponding sentence lacks a reference to the Methods Section.

      Reference has been added to the text.

      b. In Methods, the description of the CNN model is quite limited, lacking many basic, necessary components including necessary references to published papers, the model training, characterization (only an overall accuracy is not enough), as well as dataset definition, preparation, augmentation (if any), etc.

      We have expanded the methods section regarding the CNN model.

      (3) First Section of Results: in the second paragraph, the authors claim that "Overall, these results reveal HON population activity precisely tracks a general degree of body movement across recorded behaviors." This is not accurate. To indicate that HONs activity tracks the general degree of body movement across behavior states, they need to further show that behavioral states with similar levels of movement metrics can be differentiated via HON activities. However, as they showed in Figure 2D, some behaviors with similar values of movement metric do not seem to be easily discerned by HON activity levels.

      We agree with you, and this is also what we originally intended to convey – now reworded for clarity.

      (4) Technical issue: Figures 3B, 3C, 3G, using local regression to plot the solid lines makes them touch negative values, which does not make sense for "power proportion" (this quantity is always non-negative).

      This is a good point. To fix this, we first log-transformed the power metric, then performed a local regression, and used the link function to transform the model predictions back to %-units for visualization. This has been noted in the methods.

      (5) Figure 3G: For a better comparison, consider combining the two plots into a single plot.

      The two plots have been merged as shown in Figure 4C.

      (6) Figure 5E: For a better data visualization, the current pair of plots can be consolidated into one single plot where the x-axis is Move and the y-axis is dGlu. In this way, it is easier to understand and the orthogonality as claimed in the manuscript can be more apparent.

      The requested plot has been added as Figure 6F.

    1. Author response:

      The following is the authors’ response to the original reviews

      Reviewer #1 (Public review):

      Summary:

      This study takes a detailed approach to understanding the effect of menopausal hormone therapy (MHT) in the brain aging of females. Neuroimaging data from the UK Biobank is used to explore brain aging and shows an unexpected effect of current MHT use and poorer brain health outcomes relative to never users. There is considerable debate about the benefits of MHT and estrogens in particular for brain health, and this analysis illustrates that the effects are certainly not straightforward and require greater consideration.

      Strengths:

      (1) The detailed approach to obtaining important information about MHT use from primary care records. Prior studies have suggested that factors such as estrogen/progestin type, route of administration, duration, and timing of use relative to menopause onset can contribute to whether MHT benefits brain health.

      (2) Consideration of type of menopause (spontaneous, or surgical) in the analysis, as well as sensitivity diagnoses to rule out the effect being driven by those with clinical conditions.

      (3) The incorporation of the brain age estimate along with hippocampal volume to address brain health.

      (4) The complex data are also well explained and interpretations are reasonable.

      (5) Limitations of the UK Biobank data are acknowledged

      We thank the reviewer for their time and the positive evaluation of our manuscript.

      Weaknesses:

      (1) Lifestyle factors are listed and the authors acknowledge group differences (at least between current users and never users of MHT). I was not able to find these analyses showing these differences.

      We highlighted and tested for group differences in lifestyle scores, and the results are shown in Table 1-3, column p-value. As highlighted in the method section (page 9): “The lifestyle score was calculated using a published formula (69), and included data on sleep, physical activity, nutrition, smoking, and alcohol consumption (see supplementary Note 3, Table S2)”. In line with reviewer 1 suggestion to the authors, we now included an additional table testing for group differences in the specific lifestyle factors constituting the lifestyle score in the supplementary materials (Table S2). Please find a more detailed response below (Recommendations for the authors, Response to Comment 1).

      (2) The distribution of women who were not menopausal was unequal across groups, and while the authors acknowledge this, one wonders to what extent this explains the observed findings.

      We agree with the reviewer that the unequal distribution of women across groups can influence the observed findings. We have made minor edits to highlight this important topic more explicitly in the discussion:

      Discussion (page 21): “Current MHT users were significantly younger than past- and never-users, and around 67 % were menopausal relative to over 80% in the past- and never-user groups. The unequal distribution of age and menopausal status across groups may have influenced the observed findings. For instance, a larger proportion of the current users might be in the perimenopausal phase, which is often associated with debilitating neurological and vasomotor symptoms (1). MHT is commonly prescribed to minimize such symptoms. Although MHT initiation during perimenopause has been associated with improved memory and hippocampal function, as well as lower AD risk later in life (15), the need for MHT might in itself be an indicator of neurological changes (71); here potentially reflected in higher BAG and lower hippocampal volumes. After the transition to menopause, symptoms might subside and some perimenopausal brain changes might revert or stabilize in the postmenopausal phase 5. Although the UK Biobank lacks detailed information on menopausal symptoms and perimenopausal staging, our results might be capturing subtle disturbances during perimenopause that later stabilize. This could explain why the largely postmenopausal groups of past MHT users and never-users present with lower GM and WM BAG than the current user group. Considering the critical window hypothesis emphasizing perimenopause as a key phase for MHT action (29,43), future longitudinal studies are crucial to clarify the interplay between neurological changes and MHT use across the menopause transition.”

      Discussion (page 25): “In addition, previous studies highlight that UK Biobank participants are considered healthier than the general population based on several lifestyle and health-related factors (89, 90). This healthy volunteer bias increases with age, likely resulting in a disproportionate number of healthier older adults. Together with the imbalance in age distributions across groups, this might explain the less apparent brain aging in the older MHT user groups. We have previously highlighted that age is negatively associated with the number of APOE ε4 carriers in the UK Biobank (21), which is indicative of survivor bias.”

      (3) While the interpretations are reasonable, and relevant theories (healthy cell & critical window) are mentioned, the discussion is missing a more zoomed-out perspective of the findings. While I appreciate wanting to limit speculation, the reader is left having to synthesize a lot of complex details on their own. A particularly difficult finding to reconcile is under what conditions these women benefit from MHT and when do they not (and why that may be).

      We thank the reviewer for this comment. As the presented data is cross-sectional and does not enable causal inference, we have refrained from a more zoomed-out interpretation of the results to avoid undue speculations. However, where applicable, we have discussed our findings in a broader context such as the effects of MHT use on the brain across the menopausal transition (discussion page 21) and the effects of MHT use on the brain in the presence and absence of bilateral oophorectomy and/or hysterectomy (discussion page 25).

      To best inform the reader about the scope of our paper, we would like to highlight the following sentences in our discussion (page 24):

      “The current work represents the most comprehensive study of detailed MHT data, APOE ε4 genotype, and several brain measures in a large population-based cohort to date. Overall, our findings do not unequivocally support general neuroprotective effects of MHT, nor do they indicate severe adverse effects of MHT use on the female brain. The results suggest subtle yet complex relationships between MHT’s and brain health, highlighting the necessity for a personalized approach to MHT use. Importantly, our analyses provide a broad view of population-based associations and are not designed to guide individual-level decisions regarding the benefits versus risks of MHT use.”

      And the conclusion (page 25): “In conclusion, our findings suggest that associations between MHT use and female brain health might vary depending on duration of use and past surgical history. Although the effect sizes were generally modest, future longitudinal studies and RCTs, particularly focused on the perimenopausal transition window, are warranted to fully understand how MHT use influences female brain health. Importantly, considering risks and benefits, decisions regarding MHT use should be made within the clinical context unique to each individual.”

      Reviewer #1 (Recommendations for the authors):

      Can the authors provide:

      (1) More information about which aspects of lifestyle factors were different between the groups, and how these factors may have contributed to the observed findings (if possible, without burying this information in the supplemental)?

      We thank the reviewer for this suggestion. We now added a table comparing lifestyle factors contained in the lifestyle score by MHT user status using t-tests (continuous variables) or χ2 tests (see Table S2). The results are referred to in the main manuscript result section under “Sample characteristics”, and the table (Table S2) is provided in the supplements not to overburden the main text, in line with input from reviewer 3.

      We updated the main text to refer to Table S2 and updated the supplementary Note 3 (page 2-3) to include the results of the comparison of the lifestyle factors contained in the lifestyle score by MHT user status.

      Methods, page 9:“The lifestyle score was calculated using a published formula (69), and included data on sleep, physical activity, nutrition, smoking, and alcohol consumption (see supplementary Note 3, Table S2).”

      Results, page 13: “Sample demographics including lifestyle score, stratified by MHT user group, surgical history among MHT users, and estrogen only MHT or combined MHT use, are summarized in Table 1, 2 and 3, respectively. MHT user group differences for each lifestyle factor contained in the lifestyle score are shown in Table S2.”

      “Note 3| Lifestyle Score

      The lifestyle score was calculated based on sleep duration, time spent watching television, current and past smoking status, alcohol consumption frequency, physical activity level (number of days per week of moderate/vigorous activity for at least 10 minutes), intake of fruits and vegetables, and intake of oily fish, beef, lamb/mutton, pork and processed meat (for details see (10)). Each unhealthy lifestyle factor was scored with 1 point (e.g., smoking), and participants points were summed to generate an unweighted score (from 0-9): the higher the lifestyle score, the unhealthier the participant’s lifestyle.

      A comparison of the lifestyle factors contained in the lifestyle score by MHT user status is presented in Table S2. In summary, we found that current MHT were more often smokers than never-users, had a higher alcohol intake than never- and past MHT users, reported the lowest fruit and vegetable intake relative to never-users and past MHT users, and stated lower moderate activity levels relative to past MHT users. Past MHT users reported higher alcohol intake than never-users, spend more time watching TV relative to never- and current-users, consumed more beef, pork, lamb/mutton, and processed meat than never-users, and reported lower vigorous activity levels relative to never-users. However, oily fish intake and fruit and vegetable intake was higher among past MHT users relative to never-and current-users. Self-reported sleep duration did not differ between MHT user groups.”

      (2) A greater description of the 2 main theories of MHT effects on the brain (healthy cell vs critical window). Can the authors also provide a more thorough explanation for how the findings fit with these theories.

      We thank the reviewer for this comment. We have described our findings in the context of the critical window hypothesis (discussion, page 21, paragraph 2), the healthy cell bias hypothesis (discussion, page 22, paragraph 3), and healthy user bias hypothesis (discussion, page 22, paragraph 4). We refrained from a more thorough explanation to avoid undue speculations.

      (3) Reflect more on what the findings may indicate as to who benefits from MHT, and why. There are some references that the authors may want to add, particularly related to recent findings from premenopausal bilateral oophortectomies that also speak to when (and for whom) MHT use might benefit.

      We thank the reviewer for this feedback. We have included additional references in the revised manuscript as follows:

      Discussion, page 23: “It is also possible that the timing between MHT use and surgery is more tightly controlled and therefore more beneficial for brain aging (43). For instance, studies suggest that MHT may mitigate the potential long-term adverse effects of bilateral oophorectomy before natural menopause on bone mineral density as well as cardiovascular, cognitive and mental health (79-81). In addition, a 2024 UK Biobank study found that ever used MHT was associated with decreased odds of Alzheimer’s disease in women with bilateral oophorectomy (82).”  

      (79) Blumel JE, Arteaga E, Vallejo MS, et al. Association of bilateral oophorectomy and menopause hormone therapy with mild cognitive impairment: the REDLINC X study. Climacteric 2022;25:195-202.

      (80) Kaunitz AM, Kapoor E, Faubion S. Treatment of Women After Bilateral Salpingo-oophorectomy Performed Prior to Natural Menopause. JAMA 2021;326:1429-1430.

      (81) Stuursma A, Lanjouw L, Idema DL, de Bock GH, Mourits MJE. Surgical Menopause and Bilateral Oophorectomy: Effect of Estrogen-Progesterone and Testosterone Replacement Therapy on Psychological Well-being and Sexual Functioning; A Systematic Literature Review. J Sex Med 2022;19:1778-1789.

      (82) Calvo N, McFall GP, Ramana S, et al. Associated risk and resilience factors of Alzheimer's disease in women with early bilateral oophorectomy: Data from the UK Biobank. J Alzheimers Dis 2024;102:119-128.

      Reviewer #2 (Public review):

      Summary:

      In this observational study, Barth et al. investigated the association between menopausal hormone therapy and brain health in middle- to older-aged women from the UK Biobank. The study evaluated detailed MHT data (never, current, or past user), duration of mHT use (age first/last used), history of hysterectomy with or without bilateral oophorectomy, APOEE4 genotype, and brain characteristics in a large, population-based sample. The researchers found that current mHT use (compared to never-users), but not past use, was associated with a modest increase in gray and white matter brain age gap (GM and WM BAG) and a decrease in hippocampal volumes. No significant association was found between the age of mHT initiation and brain measures among mHT users. Longer duration of use and older age at last MHT use post-menopause were associated with higher GM and WM BAG, larger WMH volumes, and smaller hippocampal volumes. In a sub-sample, after adjusting for multiple comparisons, no significant associations were found between detailed mHT variables (formulations, route of administration, dosage) and brain measures. The association between mHT variables and brain measures was not influenced by APOEE4 allele carrier status. Women with a history of hysterectomy with or without bilateral oophorectomy had lower GM BAG compared to those without such a history. Overall, these observational data suggest that the association between mHT use and brain health in women may vary depending on the duration of use and surgical history.

      Strengths:

      (1) The study has several strengths, including a large, population-based sample of women in the UK, and comprehensive details of demographic variables such as menopausal status, history of oophorectomy/hysterectomy, genetic risk factors for Alzheimer's disease (APOE ε4 status), age at mHT initiation, age at last use, duration of mHT, and brain imaging data (hippocampus and WMH volume).

      (2) In a sub-sample, the study accessed detailed mHT prescription data (formulations, route of administration, dosage, duration), allowing the researchers to study how these variables were associated with brain health outcomes. This level of detail is generally missing in observational studies investigating the association of mHT use with brain health.

      We thank the reviewer for their time and the positive evaluation of our manuscript.

      Weaknesses:

      (1) While the study has many strengths, it also has some weaknesses. As highlighted in an editorial by Kantarci & Manson (2023), women with symptoms such as subjective cognitive problems, sleep disturbances, and elevated vasomotor symptoms combined with sleep disturbances tend to seek mHT more frequently than those without these symptoms. The authors of this study have also indicated that the need of mHT use which might be associated with these symptoms may be indicators of preexisting neurological changes, potentially reflecting worse brain health scores, including higher BAG and lower hippocampal volume and/or higher WMH. However, among current users, how many of these women have these symptoms could not be reported in the study. Women with these vasomotor symptoms who are using mHT are more likely to stay longer in the healthcare system compared with those without these symptoms and no MHT use history. The authors noted that the UK Biobank lacks detailed information on menopausal symptoms and perimenopausal staging, limiting the study's ability to understand how these variables influence outcomes.

      We thank the reviewer for the succint synopsis of the limitations highlighted in discussion, page 21. We have now added the mentioned reference, 2023 editoral by Kantarci & Manson, to the discussion as well (see reference 71).

      Discussion (page 21): “Current MHT users were significantly younger than past- and never-users, and around 67 % were menopausal relative to over 80% in the past- and never-user groups. The unequal distribution of age and menopausal status across groups may have influenced the observed findings. For instance, a larger proportion of the current users might be in the perimenopausal phase, which is often associated with debilitating neurological and vasomotor symptoms (1). MHT is commonly prescribed to minimize such symptoms. Although MHT initiation during perimenopause has been associated with improved memory and hippocampal function, as well as lower AD risk later in life (15), the need for MHT might in itself be an indicator of neurological changes (71); here potentially reflected in higher BAG and lower hippocampal volumes. After the transition to menopause, symptoms might subside and some perimenopausal brain changes might revert or stabilize in the postmenopausal phase 5. Although the UK Biobank lacks detailed information on menopausal symptoms and perimenopausal staging, our results might be capturing subtle disturbances during perimenopause that later stabilize. This could explain why the largely postmenopausal groups of past MHT users and never-users present with lower GM and WM BAG than the current user group. Considering the critical window hypothesis emphasizing perimenopause as a key phase for MHT action (29,43), future longitudinal studies are crucial to clarify the interplay between neurological changes and MHT use across the menopause transition.”

      (2)  Earlier observational studies have reported conflicting results regarding the association between mHT use and the risk of dementia and brain health. Contrary to some observational studies, three randomized trials (WHI, KEEPS, ELITE) (Espeland et al 2013, Gleason et al 2015; Henderson et al 2016) demonstrated neither beneficial nor harmful effects of mHT (with varying doses and formulations) when initiated closer to menopause (<5 years). While strong efforts were made to run proper statistical analyses to investigate the association between mHT use and brain health, these results reflect mainly associations, but not causal relationships as also stated by the authors.

      We thank the reviewer for pointing that out.

      (3)  Furthermore, observational studies have intrinsic limitations, such as a lack of control over switching mHT doses and formulations, a lack of laboratory measures to confirm mHT use, and reliance on self-reported data, which may not always be reliable. The authors caution that these findings should not guide individual-level decisions regarding the benefits versus risks of mHT use. However, the study raises new questions that should be addressed by randomized clinical trials to investigate the varying effects of MHT on brain health and dementia risk.

      We thank the reviewer for making our efforts in providing proper disclaimers in the discussion visible.

      Reviewer #2 (Recommendations for the authors):

      (1) The study could benefit from extending these findings by adding plasma biomarkers of AD and PET imaging markers to further study the association of mHT variables with brain health.

      We agree with the reviewer that such markers would be beneficial for elucidating the association between MHT variables and brain health. Unfortunately, these markers are not readily available in the UK Biobank.

      (2) The study's reliance on a predominantly white cohort limits the generalizability of the findings to more diverse populations. This homogeneity may not capture the full spectrum of responses to MHT across different ethnic and genetic backgrounds.

      We fully agree with the reviewers statement and state this limitation in the discussion (page 25) as follows:

      “In addition to these inherent biases in aging cohorts, the ethnic background of the sample is homogeneous (> 96% white), further reducing the generalizability of the results.”

      (3) The study may benefit by editing the following information in the introduction: "In summary, WHIMS, HERS, and KEEPS mainly relied on orally administered CEE in older-aged or recently postmenopausal females." KEEPS used two routes and formulations (transdermal estradiol and oCEE, both with micronized progesterone).

      We thank the reviewer for catching this oversight. We removed the sentence to avoid ambiguities and revised the sentence specifically refering to the KEEPS study as follows:

      Introduction, page 3: “In contrast, administering oral CEE or transdermal estradiol plus micronized progesterone in recently postmenopausal females did not alter cognition in the Kronos Early Estrogen Prevention Study (KEEPS) (28).”

      (4) The study may benefit by editing the following statement in the introduction: "oral CEE use in combination with MPA seems to increase the risk for AD regardless of timing": I would suggest revising this statement, which is based on review article 29. The statement of the adverse effect of oCEE regardless of the time of start contradicts earlier randomized clinical findings. I think it is important to make a distinction between the outcomes of randomized control trials and observational studies. The WMIHS (Shumaker et al., 2003) (randomized control trial) reported that there was an increased risk of dementia for women (who were more than 10 years from the onset of menopause when the therapy was initiated) in oCEE + MPA compared to placebo. Two other long-duration randomized trials tested the effect of oral oestrogen and progesterone treatment on cognitive function in women who started treatment shortly after menopause (within 3 or 6 years) did not find evidence that treatment benefits or harms cognitive function compared with placebo (Gleason et al., 2015; Henderson et al., 2016). A short-term (4 months) randomized trial (Maki et al 2007 (Maki et al., 2007) (mentioned in ref 29) reported a potential negative effect of CEE/MPA on verbal memory in women who started HT shortly after menopause (within 3 years). The study did not investigate the risk of dementia, and the duration of use of HT was short-term.

      We thank the reviewer for this detailed input. After checking the provided references, we rephrased the sentence as follows:

      Introduction, page 4:“Although emerging evidence supports this hypothesis (30, 31), oral CEE use in combination with MPA has been found to increase the risk for memory decline regardless of timing (26, 29, 32).”

      We believe this formulation is more in line with the evidence provided by Shumaker et al. 2003, Maki et al. 2007 and the other references provided in the review paper by Maki and colleagues (mentioned in ref. 29). The reviewer further refers to Gleason et al. 2015 and Henderson et al. 2016, however both RCTs use micronized progesterone, not MPA, thereby not supporting the statement.

      (26) Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003;289:2651-2662.

      (29) Maki PM. Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause 2013;20:695-709.

      (32) Maki PM, Gast MJ, Vieweg AJ, Burriss SW, Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 2007;69:1322-1330.

      Reviewer #3 (Public review):

      In this study Barth et al. present results of detailed analyses of the relationships between menopausal hormone therapy (MHT), APOE ε4 genotype, and measures of anatomical brain age in women in the UK Biobank. While past studies have investigated the links between some of these variables (including works by the authors themselves), this new study adds more detailed MHT variables, surgical status, and additional brain aging measures. The UK biobank sample is large, but it is a population cohort and many of the MHT measures are self-reported (as the authors point out). However, the authors present a solid analysis of the available information which shows associations between MHT user status, length of MHT use, as well as surgical status with brain age. However, as the authors themselves state, the results do not unequivocally support the neuroprotective or adverse effect of MHT on the brain. I think this work strengthens the case for the need of better-designed longitudinal studies investigating the effect of MHT on the brain in the peri/post-menopausal stage.

      Strengths:

      (1) The authors addressed the statistical analyses rigorously. For example, multiple testing corrections, outlier removal, and sensitivity analysis were performed carefully. Ample background information is provided in the introduction allowing even individuals not familiar with the field to understand the motivation behind the work. The discussion section also does a great job of addressing open questions and limitations. Very detailed results of all statistical tests are provided either in the main text or in the supplementary information.

      We thank the reviewer for their time and the positive evaluation of our manuscript.

      Weaknesses:

      (1) For me, the biggest weakness was the presentation of the results. As many variables are involved and past studies have investigated several of these questions, it would have helped to better clarify the analysis and questions that are addressed by this study in particular and what sets this work apart from past studies. The information is present in the manuscript but better organization might have helped. For example, a figure depicting the key questions near the beginning of the manuscript would have been very helpful for me. The Tables also contain a lot of information but I wonder if there might be a way to capture the most relevant information more succinctly (either in Table format or in a figure) for the main text.

      We thank the reviewer for this comment. We do agree that with the large number of analyses it can be hard to keep an overview. We now added a Figure summarizing the main and sensitity analyses by sample.

      (2) Another concern I had was the linear models investigating the effects of these MHT variables on the brain age gap. The authors have included "age" as one of the parameters in this analysis. I wonder if adding a quadratic age factor age2 in the model might have improved the fit since many brain phenotypes tend to show quadratic brain age effects in the 40 to 80-year age range.

      We thank the reviewer for this suggestion. We have rerun the main analysis in the whole sample (model 1) with age squared as an additional covariate, and compared the gray matter brain age gap model fits using the corrected Akaike Information Criterion (AIC). All models with age squared had a better model fit than models without age squared (see Author response table 1). Hence, in the revised manuscript, we added a sensitivity analysis rerunning the model 1 with age squared to account for potential non-linear effect. The results were largely consistent. The manuscript was revised as follows to reflect the added analysis:

      Sensitivity analysis (Methods, Page 11): “To test whether the results were influenced by the inclusion of participants with ICD-10 diagnosis or by non-linear effects of age, the main analyses (models 1-2) were re-run excluding the sub-sample with diagnosed brain disorders (see supplementary Note 2) or adding age(2) as additional covariate, respectively.”

      Sensitivity analysis (Results, Page 20): “The results were consistent after removing participants with ICD-10 diagnoses known to impact the brain (see Table S9 for model 1 analyses and Table S10 for model 2 analyses), after additionally adjusting for age(2) (see Table S11), and after removing extreme values (see Table S12 for model 1 analyses).”

      Author response table 1.

      Gray matter brain age gap model selection based on corrected Akaike Information Criterion (AICc)

      Abbreviations and explanations of parameters: MHT = menopausal hormone therapy, K = number of estimated parameters for each model, AICc = the information criterion requested for each model, ΔAICc = the appropriate delta AIC component depending on the information criteria selectedModelLik = the relative likelihood of the model given the data, AICcWT = Akaike weights to indicate the level of support in favor of any given model being the most parsimonious among the candidate model sets, LL = log-likelihood of each model.

      Reviewer #3 (Recommendations for the authors):

      (1) Please note typo in Figures 2 and 3 legend "GM WM".

      We thank the reviewer for catching this typo and we changed it to BAG GM and BAG WM for all Figures for consistency.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      This manuscript investigated the mechanism underlying boundary formation necessary for proper separation of vestibular sensory end organs. In both chick and mouse embryos, it was shown that a population of cells abutting the sensory (marked by high Sox2 expression) /nonsensory cell populations (marked by Lmx1a expression) undergo apical expansion, elongation, alignment and basal constriction to separate the lateral crista (LC) from the utricle. Using Lmx1a mouse mutant, organ cultures, pharmacological and viral-mediated Rock inhibition, it was demonstrated that the Lmx1a transcription factor and Rock-mediated actomyosin contractility is required for boundary formation and LC-utricle separation.

      Strengths:

      Overall, the morphometric analyses were done rigorously and revealed novel boundary cell behaviors. The requirement of Lmx1a and Rock activity in boundary formation was convincingly demonstrated.

      Weaknesses:

      However, the precise roles of Lmx1a and Rock in regulating cell behaviors during boundary formation were not clearly fleshed out. For example, phenotypic analysis of Lmx1a was rather cursory; it is unclear how Lmx1a, expressed in half of the boundary domain, control boundary cell behaviors and prevent cell mixing between Lmx1a+ and Lmx1a- compartments? Well-established mechanisms and molecules for boundary formation were not investigated (e.g. differential adhesion via cadherins, cell repulsion via ephrin-Eph signaling). Moreover, within the boundary domain, it is unclear whether apical multicellular rosettes and basal constrictions are drivers of boundary formation, as boundary can still form when these cell behaviors were inhibited. Involvement of other cell behaviors, such as radial cell intercalation and oriented cell division, also warrant consideration. With these lingering questions, the mechanistic advance of the present study is somewhat incremental.

      We have acknowledged the lingering questions this referee points out in our Discussion and agree that the roles of differential cell adhesion and cell intercalation would be worth exploring in further studies. Despite these remaining questions, the conceptual advances are significant, since this study provides the first evidence that a tissue boundary forms in between segregating sensory organs in the inner ear (there are only a handful of embryonic tissues in which a tissue boundary has been found in vertebrates) and highlights the evolutionary conservation of this process. This work also provides a strong descriptive basis for any future study investigating the mechanisms of tissue boundary formation in the mouse and chicken embryonic inner ear. 

      Reviewer #2 (Public review):

      Summary:

      Chen et al. describe the mechanisms that separate the common pan-sensory progenitor region into individual sensory patches, which presage the formation of the sensory epithelium in each of the inner ear organs. By focusing on the separation of the anterior and then lateral cristae, they find that long supra-cellular cables form at the interface of the pansensory domain and the forming cristae. They find that at these interfaces, the cells have a larger apical surface area, due to basal constriction, and Sox2 is down-regulated. Through analysis of Lmx1 mutants, the authors suggest that while Lmx1 is necessary for the complete segregation of the sensory organs, it is likely not necessary for the initial boundary formation, and the down-regulation of Sox2.

      Strengths:

      The manuscript adds to our knowledge and provides valuable mechanistic insight into sensory organ segregation. Of particular interest are the cell biological mechanisms: The authors show that contractility directed by ROCK is important for the maintenance of the boundary and segregation of sensory organs.

      Weaknesses:

      The manuscript would benefit from a more in-depth look at contractility - the current images of PMLC are not too convincing. Can the authors look at p or ppMLC expression in an apical view? Are they expressed in the boundary along the actin cables? Does Y-27362 inhibit this expression?

      The authors suggest that one role for ROCK is the basal constriction. I was a little confused about basal constriction. Are these the initial steps in the thinning of the intervening nonsensory regions between the sensory organs? What happens to the basally constricted cells as this process continues?

      In our hands, the PMLC immunostaining gave a punctate staining in epithelial cells and was difficult to image and interpret in whole-mount preparations, which did not allow us to investigate its specific association to the actin-cable-like structures. It is a very valuable suggestion to try alternative methods of fixation to improve the quality of the staining and images in future work. 

      The basal constriction of the cells at the border of the sensory organs was not always clearly visible in freshly-fixed samples, and was absent in the majority of short-term organotypic cultures in control medium, which made it impossible to ascertain the role of ROCK in its formation using pharmacological approaches in vitro (see Figure 7 and corresponding Result section).  On the other hand, the overexpression of a dominant-negative form of ROCK (RCII-GFP) in ovo using RCAS revealed a persistence of basal constriction in transfected cells despite a disorganisation of the boundary domain (Figure 8). We conclude from these experiments that ROCK activity is not necessary for the formation and maintenance of the basal constriction. We also remain uncertain about the exact role of this basal constriction. It could be either a cause or consequence of the expansion of the apical surface of cells in the boundary domain, it could contribute to the limitation of cell intermingling and the formation of the actin-cable-like structure at the interface of Lmx1a-expressing and non-expressing cells, and may indeed prefigure some of the further changes in cell morphology occurring in non-sensory domains separating the sensory organs (cell flattening and constrictions of the epithelial walls in between sensory organs). 

      The steps the authors explore happen after boundaries are established. This correlates with a down-regulation of Sox2, and the formation of a boundary. What is known about the expression of molecules that may underlie the apparent interfacial tension at the boundaries? Is there any evidence for differential adhesion or for Eph-Ephrin signalling? Is there a role for Notch signalling or a role for Jag1 as detailed in the group's 2017 paper?

      Great questions. It is indeed likely that some form of differential cell tension and/or adhesion participates to the formation and maintenance of this boundary, and we have mentioned in the discussion some of the usual suspects (cadherins, eph/ephrin signalling,…) although it is beyond the scope of this paper to determine their roles in this context. 

      As we have discussed in this paper and in our 2017 study (see also Ma and Zhang, Development,  2015 Feb 15;142(4):763-73. doi: 10.1242/dev.113662) we believe that Notch signalling is maintaining prosensory character, and its down-regulation by Lmx1a/b expression is required for the specification of the non-sensory domains in between segregating sensory organs. Although we have not tested this directly in this study, any disruption in Notch signalling would be expected to affect indirectly the formation or maintenance of the boundary domain. 

      A comment on whether cellular intercalation/rearrangements may underlie some of the observed tissue changes.

      We have not addressed this topic directly in the present study but we have included a brief comment on the potential implication of cellular intercalation and rearrangements in the discussion: “It is also possible that the repositioning of cells through medial intercalation could contribute to the straightening of the boundary as well as the widening of the nonsensory territories in between sensory patches.”

      The change in the long axis appears to correlate with the expression of Lmx1a (Fig 5d). The authors could discuss this more. Are these changes associated with altered PCP/Vangl2 expression?

      We are not sure about the first point raised by the referee. We have quantified cell elongation and orientation in Lmx1a-GFP heterozygous and homozygous (null) mice, and our results suggest that the elongation of the cells occurs throughout the boundary domain, and is probably not dependent on Lmx1a expression (boundary cells are in fact more elongated in the Lmx1a mutant).  We have not investigated the expression of components of the planar cell polarity pathway. This is a very interesting suggestion, worth exploring in further studies.

      Reviewer #3 (Public review):

      Summary:

      Lmx1a is an orthologue of apterous in flies, which is important for dorsal-ventral border formation in the wing disc. Previously, this research group has described the importance of the chicken Lmx1b in establishing the boundary between sensory and non-sensory domains in the chicken inner ear. Here, the authors described a series of cellular changes during border formation in the chicken inner ear, including alignment of cells at the apical border and concomitant constriction basally. The authors extended these observations to the mouse inner ear and showed that these morphological changes occurred at the border of Lmx1a positive and negative regions, and these changes failed to develop in Lmx1a mutants. Furthermore, the authors demonstrated that the ROCK-dependent actomyosin contractility is important for this border formation and blocking ROCK function affected epithelial basal constriction and border formation in both in vitro and in vivo systems.

      Strengths:

      The morphological changes described during border formation in the developing inner ear are interesting. Linking these changes to the function of Lmx1a and ROCK dependent actomyosin contractile function are provocative.

      Weaknesses:

      There are several outstanding issues that need to be clarified before one could pin the morphological changes observed being causal to border formation and that Lmx1a and ROCK are involved.

      We have addressed the specific comments and suggestions of the reviewer below. We wish however to point out that we do not think that ROCK activity is required for the formation or maintenance of the basal constriction at the interface of Lmx1a-expressing and nonexpressing cells (see previous answer to referee #2)

      Reviewer #1 (Recommendations for the authors):

      Specific comments:

      (1) Figures 1 and 2, and related text. Based on the whole-mount images shown, the anterior otocyst appeared to be a stratified epithelium with multiple cell layers. If so, it should be clarified whether the x-y view of in the "apical" and "basal" plane are from cells residing in the apical and basal layers, respectively. Moreover, it would be helpful to include a "stage 4", a later stage to show if and when basal constrictions resolve.

      In fact, at these early stages of development, the otic epithelium is “pseudostratified”: it is formed by a single layer of irregularly shaped cells, each extending from the base to the apical aspect of the epithelium, but with their nuclei residing at distinct positions along this basal-apical axis as mitotic cells progress through the cell cycle.  The nuclei divide at the surface of the epithelium, then move back to the most basal planes within daughter cells during interphase. This process, known as interkinetic nuclear migration, has been well described in the embryonic neural tube and occurs throughout the developing otic epithelium (e.g. Orr, Dev Biol. 1975, 47,325-340, Ohta et al., Dev Biol. 2010 Sep 15;347(2):369–381. doi: 10.1016/j.ydbio.2010.09.002; ). Consequently, the nuclei visible in apical or basal planes in x-y views belong to cells extending from the base to the apex of the epithelium, but which are at different stages of the cell cycle. 

      We have not included a late stage of sensory organ segregation in this study (apart from a P0 stage in the mouse inner ear, see Figure 4) since data about later stages of sensory organ morphogenesis are available in other studies, including our Mann et al. eLife 2017 paper describing Lmx1a-GFP expression in the embryonic mouse inner ear.

      (2) Related to above, the observed changes in cell organization raised the possibility that the apical multicellular rosettes and basal constrictions observed in Stage 3 (and 2) could be intermediates of radial cell intercalations, which would lead to expansion of the space between sensory organs and thinning of the boundary domains. To see if it might be happening, it would be helpful to include DAPI staining to show the overall tissue architecture at different stages and use optical reconstruction to assess the thickness of the epithelium in the presumptive boundary domain over time.

      We agree with this referee. Besides cell addition by proliferation and/or changes in cell morphology, radial cell intercalations could indeed contribute to the spatial segregation of inner ear sensory organs (a brief statement on this possibility was added to the Discussion). It is clear from images shown in Figure 4 (and from other studies) that the non-sensory domain separating the cristae from the utricle gets flatter and its cells also enlarge as development proceeds. We do not think that DAPI staining is required to demonstrate this. Perhaps the best way to show that radial cell intercalations occur would be to perform liveimaging of the otic epithelium, but this is technically challenging in the mouse or chicken inner ear. An alternative model system might be the zebrafish inner ear, in which some liveimaging data have shown a progressive down-regulation of Jag1 expression during sensory organ segregation (and a flattening of “boundary domains”), suggesting a conservation of the basic mechanisms at play (Ma and Zhang, Development,  2015 Feb 15;142(4):763-73. doi: 10.1242/dev.113662).

      (3) Similarly, it would be helpful to include the DAPI counterstain in Figures 4, 7, and 8 to show the overall tissue architecture.

      We do not have DAPI staining for these particular images but in most cases, Sox2 immunostaining gives a decent indication of tissue morphology. 

      (4) Figure 2(z) and Figure 4d. The arrows pointing at the basal constrictions are obstructing the view of the basement membrane area, making it difficult to appreciate the morphological changes. They should be moved to the side. Can the authors comment whether they saw evidence for radial intercalations (e.g. thinning of the boundary domain) or partial unzippering of adjoining compartments along the basal constrictions?

      The arrows in Figure 2(z) and Figure 4d have been moved to the side of the panels. 

      See previous comment. Besides the presence of multicellular rosettes, we have not seen direct evidence of radial cell intercalation – this would be best investigated using liveimaging. As development proceeds, the epithelial domain separating adjoining sensory organs becomes wider. The cells that compose it gradually enlarge and flatten, as can be seen for example at P0 in the mouse inner ear (Figure 4g). 

      (5) Figures 3 and 5, and related text. It should be clarified whether the measurements were all taken from the surface cells. For Fig. 3e and 5d, the mean alignment angles of the cell long axis in the boundary regions should be provided in the text.

      The sensory epithelium in the otocyst is pseudostratified, hence, the measurement was taken from the surface of all epithelial cells labelled with F-actin. 

      We have added histograms representing the angular distribution of the cell long axis orientations in the boundary region to Figure 3 and Figure 5 Supplementary 1. We believe that this type of representation is more informative than the numerical value of the mean alignment angles of the cell long axis for defined sub-domains. 

      (6) It would be helpful to also quantify basal constrictions using the cell skeleton analysis. In addition, it would be helpful to show x-y views of cell morphology at the level of basal constrictions in the mouse tissue, similar to the chick otocyst shown in Figure 2.

      The data that we have collected do not allow a precise quantification of basal constrictions with cell skeleton analysis, due to the generally fuzzy nature of F-actin staining in the basal planes of the epithelium. However, we have followed the referee’s advice and analysed Factin staining in x-y views in the Lmx1a-GFP knock-in (heterozygous) mice. We found that the first signs of basal F-actin enrichment and multicellular actin-cable like structures at the interface of Lmx1a-positive and negative cells are visible at E11.5, and F-actin staining in the basal planes increases in intensity and extent at E13.5. (shown in new Figure 4 – Supplementary Figure 1).

      (7) Figure 5 and related text. It would be informative to analyze Lmx1a mutants at early stages (E11-E13) to pinpoint cell behavior defects during boundary formation.

      We chose the E15 stage because it is one at which we can unequivocally recognize and easily image and analyse the boundary domain from a cytoarchitectural point of view. We recognize that it would have been worth including earlier stages in this analysis but have not been able to perform these additional studies due to time constraints and unavailability of biological material. 

      (8) Figure 5-Figure S1, the quantifications suggest that Lmx1a loss had both cellautonomous and non-autonomous effects on boundary cell behaviors. This is an interesting finding, and its implication should be discussed.

      It is well-known that the absence of Lmx1a function induces a very complex (and variable) phenotype in terms of inner ear morphology and patterning defects. It is also clear from this study that the absence of Lmx1 causes non-cell autonomous defects in the boundary domain and we have already mentioned this in the discussion: “Finally, the patterning abnormalities in Lmx1a<sup>GFP/GFP</sup> samples occurred in both GFP-positive and negative territories, which points at some type of interaction between Lmx1a-expressing and nonexpressing cells, and the possibility that the boundary domain is also a signalling centre influencing the differentiation of adjacent territories.”

      (9) Figure 6 and related text. To correlate myosin II activity with boundary cell behaviors, it would be important to immunolocalize pMLC in the boundary domain in whole-mount otocyst preparations from stage 1 to stage 3.

      We tried to perform the suggested immunostaining experiments, but in our hands at least, the antibody used did not produce good quality staining in whole-mount preparations. We have therefore included images of sectioned otic tissue, which show some enrichment in pMLC immunostaining at the interface of segregating organs (Figure 6).

      (10) Figures 7 and 8. A caveat of long-term Rock inhibition is that it can affect cell proliferation and differentiation of both sensory and non-sensory cells, which would cause secondary effects on boundary formation. This caveat was not adequately addressed. For example, does Rock signaling control either the rate or the orientation of cell division to promote boundary formation? Together with the mild effect of acute Rock inhibition, the precise role of Rock signaling in boundary formation remains unclear.

      We absolutely agree that the exact function of ROCK could not be ascertained in the in vitro experiments, for the reasons we have highlighted in the manuscript (no clear effect in short term treatments, great level of tissue disorganisation in long-term treatments). This prompted us to turn to an in ovo approach. The picture remains uncertain in relation to the role of ROCK in regulating cell division/intercalation but we have been at least able to show a requirement for the maintenance of an organized and regular boundary. 

      (11) Figure 8. RCII-GFP likely also have non-autonomous effects on cell apical surface area. In 8d, it would be informative to include cell area quantifications of the GFP control for comparison.

      It is possible that some non-autonomous effects are produced by RCII-GFP expression, but these were not the focus of the present study and are not particularly relevant in the context of large patches of overexpression, as obtained with RCAS vectors. 

      We have added cell surface area quantifications of the control RCAS-GFP construct for comparison (Figure 8e).

      (12) The significance of the presence of cell divisions shown in Figure 9 is unclear. It would be informative to include some additional analysis, such as a) quantify orientation of cell divisions in and around the boundary domain and b) determine whether patterns of cell division in the sensory and nonsensory regions are disrupted in Lmx1a mutants.

      These are indeed fascinating questions, but which would require considerable work to answer and are beyond the scope of this paper. 

      Minor comments:

      (1) Figure 1. It should be clarified whether e', h' and k' are showing cortical F-actin of surface cells. Do the arrowheads in i' and l' correspond to the position of either of the arrowheads in h' and k', respectively?

      The epithelium in the otocyst is pseudostratified. Therefore, images e’, h’, k’ display F-actin labelling on the surface of tissue composed of a single cell layer. We have added arrows to images e”, h”, and k” to indicate the corresponding position of z-projections and included appropriate explanation in the legend of Figure 1: “Black arrows on the side of images e”, h”, and k” indicate the corresponding position of z-projections.”

      (2) Figure 3-Figure S1. Please mark the orientation of the images shown.

      We labelled the sensory organs in the figure to allow for recognizing the orientation. 

      (3) Figure 4. Orthogonal reconstructions should be labeled (z) to be consistent with other figures.

      We have corrected the labelling in the orthogonal reconstruction to (z). 

      (4) Figure 4g. It is not clear what is in the dark area between the two bands of Lmx1a+ cells next to the utricle and the LC. Are those cells Lmx1a negative? It is unclear whether a second boundary domain formed or the original boundary domain split into two between E15 and P0? Showing the E15 control tissue from Figure 5 would be more informative than P0.

      In this particular sample there seems to be a folding of the tissue (visible in z-reconstructions) that could affect the appearance of the projection shown in 4g. We believe the P0 is a valuable addition to the E15 data, showing a slightly later stage in the development of the vestibular organs.

      (5) Figure 5a, e. Magnified regions shown in b and f should be boxed correspondingly.

      This figure has been revised. We realized that the previous low-magnification shown in (e) (now h) was from a different sample than the one shown in the high-magnification view. The new figure now includes the right low-magnification sample (in h) and the regions shown in the high-magnification views have been boxed.

      (6) Figure 8f, h, j. Magnified regions shown in g, i and k should be boxed correspondingly.

      The magnified regions were boxed in Figure 8 f, h, and j. Additionally, black arrows have been placed next to images 8g", 8i", and 8k" to highlight the positions of the z-projections. An appropriate explanation has also been added to the figure legend.

      (9) Figure 8. It would be helpful to show merged images of GFP and F-actin, to better appreciate cell morphology of GFP+ and GFP- cells.

      As requested, we have added images showing overlap of GFP and F-actin channels in Figure 8.

      Reviewer #2 (Recommendations for the authors):

      The PMLC staining could be improved. Two decent antibodies are the p-MLC and pp-MLC antibodies from CST. pp-MLC works very well after TCA fixation as detailed in https://www.researchsquare.com/article/rs-2508957/latest . As phalloidin does not work well after TCA fixation, affadin works very well for segmenting cells.

      If the authors do not wish to repeat the pMLC staining, the details of the antibody used should be mentioned.

      We used mouse IgG1 Phospho-Myosin Light Chain 2 (Ser19) from Cell Signaling Technology (catalogue number #3675) in our immunohistochemistry for PMLC. This is one of the two antibodies recommended by the reviewer #2. Information about this antibody has now been included in material and methods. This antibody has been referenced by many manuscripts, but unfortunately, in our hands at least, it did not perform well in whole-mount preparations.

      A statement on the availability of the data should be included.

      We have included a statement on the data availability: “All data generated or analysed during this study is available upon request.”

      Reviewer #3 (Recommendations for the authors):

      Outstanding issues:

      (1) Morphological description: The apical alignment of epithelial cells at the border is clear but not the upward pull of the basal lamina. Very often, it seems to be the Sox2 staining that shows the upward pull better than the F-actin staining. Perhaps, adding an anti-laminin staining to indicate the basement membrane may help.

      Indeed, the upward pull of the basement membrane is not always very clear. We performed some anti-laminin immunostaining on mouse cryosections and provide below (Figure 1) an example of such experiment. The results appear to confirm an upward displacement of the basement membrane in the region separating the lateral crista from the utricle in the E13 mouse inner ear, but given the preliminary nature of these experiments, we believe that these results do not warrant inclusion in the manuscript. The term “pull” is somehow implying that the epithelial cells are responsible for the upward movement of the basement membrane, but since we do not have direct evidence that this is the case, we have replaced “pull” by “displacement” throughout the text. 

      (2) It is not clear how well the cellular changes are correlated with the timing of border formation as some of the ages shown in the study seem to be well after the sensory patches were separated and the border was established.

      For some experiments (for example E15 in the comparison of mouse Lmx1a-GFP heterozygous and homozygous inner ear tissue; E6 for the RCAS experiments), the early stages of boundary formation are not covered because we decided to focus our analysis on the late consequences of manipulating Lmx1a/ROCK activity in terms of sensory organ segregation. The dataset is more comprehensive for the control developmental series in the chicken and mouse inner ear. 

      (3) The Lmx1a data, as they currently stand could be explained by Lmx1a being required for non-sensory development and not necessarily border formation. Additionally, the relationship between ROCK and Lmx1a was not investigated. Since the investigators have established the molecular mechanisms of Lmx1 function using the chicken system previously, the authors could try to correlate the morphological events described here with the molecular evidence for Lmx1 functioning during border formation in the same chicken system. Right now, only the expression of Sox2 is used to correlate with the cellular events, and not Lmx1, Jag1 or notch.

      These are valid points. Exploring in detail the epistatic relationships between Notch signalling/Lmx1a/ROCK/boundary formation in the chicken model would be indeed very interesting but would require extensive work using both gain and loss-of-function approaches, combined with the analysis of multiple markers (Jag1/Sox2/Lmx1b/PMLC/Factin..). At this point, and in agreement with the referee’s comment, we believe that Lmx1a is above all required for the adoption of the non-sensory fate. The loss of Lmx1a function in the mouse inner ear produce defects in the patterning and cellular features of the boundary domain, but these may be late consequences of the abnormal differentiation of the nonsensory domains that separate sensory organs. Furthermore, ROCK activity does not appear to be required for Sox2 expression (i.e. adoption or maintenance of the sensory fate) since the overexpression of RCII-GFP does not prevent Sox2 expression in the chicken inner ear. This fits with a model in which Notch/Lmx1a regulate cell differentiation whilst ROCK acts independently or downstream of these factors during boundary formation. 

      Specific comments:

      (1) Figure 1. The downregulation of Sox2 is consistent between panels h and k, but not between panels e and h. The orthogonal sections showing basal constriction in h' and k' are not clear.

      The downregulation is noticeable along the lower edge of the crista shown in h; the region selected for the high-magnification view sits at an intermediate level of segregation (and Sox2 downregulation). 

      The basal constriction is not very clear in h, but becomes easier to visualize in k. We have displaced the arrow pointing at the constriction, which hopefully helps. 

      (2) Figure 2. Where was the Z axis taken from? One seems to be able to imagine the basal constriction better in the anti-Sox2 panel than the F-actin panel. A stain outlining the basement membrane better could help.

      Arrows have been added on the side of the horizontal views to mark the location of the zreconstruction. See our previous replies to comments addressing the upward displacement of the basement membrane.

      (3) Figure 4

      I question the ROI being chosen in this figure, which seems to be in the middle of a triad between LC, prosensory/utricle and the AC, rather than between AC and LC. If so, please revise the title of the figure. This could also account for the better evidence of the apical alignment in the upper part of the f panel.

      We have corrected the text. 

      In this figure, the basal constriction is a little clearer in the orthogonal cuts, but it is not clear where these sections were taken from.

      We have added black arrows next to images 4c’, 4f’, and 4i’ to indicate the positions of the zprojections.  

      By E13.5, the LC is a separate entity from the utricle, it makes one wonder how well the basal constriction is correlated with border formation. The apical alignment is also present by P0, which raises the question that the apical alignment and basal restriction may be more correlated with differentiation of non-sensory tissue rather than associated with border formation.

      We agree E13.5 is a relatively late stage, and the basal constriction was not always very pronounced. The new data included in the revised version include images of basal planes of the boundary domain at E11.5, which reveal F-actin enrichment and the formation of an actin-cable-like structure (Figure 4 suppl. Fig1). Furthermore, the chicken dataset shows that the changes in cell size, alignment, and the formation of actin-cable-like structure precede sensory patch segregation and are visible when Sox2 expression starts to be downregulated in prospective non-sensory tissue (Figure 1, Figure 2). Considering the results from both species, we conclude that these localised cellular changes occur relatively early in the sequence of events leading to sensory patch segregation, as opposed to being a late consequence of the differentiation of the non-sensory territories.  

      I don't follow the (x) cuts for panels h and I, as to where they were taken from and why there seems to be an epithelial curvature and what it was supposed to represent.

      We have added black arrows next to the panels 4c’, 4f’, and 4i’ to indicate the positions of the z-projections and modified the legend accordingly. The epithelial curvature is probably due to the folding of the tissue bordering the sensory organs during the manipulation/mounting of the tissue for imaging.

      (4) Figure 5 The control images do not show the apical alignment and the basal constriction well. This could be because of the age of choice, E15, was a little late. Unfortunately, the unclarity of the control results makes it difficult for illustrating the lack of cellular changes in the mutant. The only take-home message that one could extract from this figure is a mild mixing of Sox2 and Lmx1a-Gfp cells in the mutant and not much else. Also, please indicate the level where (x) was taken from.

      Black arrows have been placed next to images 5e and 5l to highlight the positions of the zprojections. The stage E15 chosen for analysis was appropriate to compare the boundary domains once segregation is normally completed. We believe the results show some differences in the cellular features of the boundary domain in the Lmx1a-null mouse, and we have in fact quantified this using Epitool in Figure 5 – Suppl. Fig 1. Cells are more elongated and better aligned in the Lmx1a-null than in the heterozygous samples.  

      (5) Figure 7. I think the cellular disruption caused by the ROCK inhibitor, shown in q', is too severe to be able to pin to a specific effect of ROCK on border formation. In that regard, the ectopic expression of the dominant negative form of ROCK using RCAS approach is better, even though because it is a replication competent form of RCAS, it is still difficult to correlate infected cells to functional disruption.

      We used a replication-competent construct to induce a large patch of infection, increasing our chances of observing a defect in sensory organ segregation and boundary formation. We agree that this approach does not allow us to control the timing of overexpression, but the mosaicism in gene expression, allowing us to compare in the same tissue large regions with/without perturbed ROCK activity, proved more informative than the pharmacological/in vitro experiments.

      (6) Figure 8. Outline the ROI of i in h, and k in j. Outline in k the comparable region in k'. In k", F-actin staining is not uniform. Indicate where (x) was taken from in K.

      The magnified regions were boxed in Figure 8 f, h, and j. Region outlined in figures k’-k” has also been outlined in corresponding region in figure k. Additionally, black arrows have been placed next to images 8g", 8i", and 8k" to highlight the positions of the z-projections. An appropriate explanation has also been added to the figure legend.

      Minor comments:

      (1) P.18, 1st paragraph, extra bracket at the end of the paragraph.

      Bracket removed

      (2) P.22, line 11, in ovo may be better than in vivo in this case.

      We agree, this has been corrected. 

      (3) P.25, be consistent whether it is GFP or EGFP.

      Corrected to GFP.

      (4) P.26, line 5. Typo on "an"

      Corrected to “and”

      Author response image 1.

      Expression of Laminin and Sox2 in the E13 mouse inner ear. a-a’’’) Low magnification view of the utricle, the lateral crista, and the non-sensory (Sox2-negative) domain separating these. Laminin staining is detected at relatively high levels in the basement membrane underneath the sensory patches. At higher magnification (b-b’’’), an upward displacement of the basement membrane (arrow) is visible in the region of reduced Sox2 expression, corresponding to the “boundary domain” (bracket). 

    1. Author response:

      The following is the authors’ response to the current reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The authors demonstrated that NINJ1 promotes TF-positive MV release during pyroptosis and thereby triggers coagulation. Coagulation is one of the risk factors that can cause secondary complications in various inflammatory diseases, making it a highly important therapeutic target in clinical treatment. This paper effectively explains the connection between pyroptosis and MV release with Ninj1, which is a significant strength. It provides valuable insight into the potential of targeting Ninj1 as a therapeutic strategy.

      Although the advances in this paper are valuable, several aspects need to be clarified. Some comments are discussed below. 

      (1) Since it is not Ninj1 directly regulating coagulation but rather the MV released by Ninj1 playing a role, the title should include that. The current title makes it seem like Ninj1 directly regulates inflammation and coagulation. It would be better to revise the title.

      Thanks for the thoughtful comments. We show that the release of procoagulant MVs by plasma membrane rupture (PMR) is a critical step in the activation of coagulation. In addition, the release of cytokines and danger molecules by PMR may also contribute to coagulation. In choosing the title, we are trying to emphasize NINJ1-dependent PMR as a common trigger for these biological processes.

      (2) Ninj1 is known to be an induced protein that is barely expressed in normal conditions. As you showed in "Fig1G" data, control samples showed no detection of Ninj1. However, in "Figure S1", all tissues (liver, lung, kidney and spleen) expressed Ninj1 protein. If the authors stimulated the mice with fla injection, it should be mentioned in the figure legend. 

      We respectfully disagree with the comment that “Ninj1 is known to be an induced protein that is barely expressed in normal conditions”. NINJ1 protein is abundantly expressed (without induction) in tissues including liver, lung, kidney, and spleen, as shown in Fig S1. Consistently, other groups have shown abundant NINJ1 expression at baseline in tissues and cells such as liver (Kayagaki et.al. Nature 2023) and BMDM (Kayagaki et.al. Nature 2021; Borges et.al. eLife 2023). Fig 1G shows fibrin deposition as an indicator of coagulation, not NINJ1 protein.

      (3) In "Fig3A", the Ninj1 protein expression was increased in the control of BMDM +/- cell lysate rather than fla stimulation. However, in MV, Ninj1 was not detected at all in +/- control but was only observed with Fla injection. The authors need to provide an explanation for this observation. Additionally, looking at the MV β-actin lane, the band thicknesses appear to be very different between groups. It seems necessary to equalize the protein amounts. If that is difficult, at least between the +/+ and +/- controls. 

      Thanks for the valuable comments. In Fla-stimulated Ninj1+/- BMDMs, most of the NINJ1 is released in MVs, therefore, not in the cell lysate, as shown in Fig 3A. The difference in beta-actin band intensity correlated with MV numbers shown in Fig 3B. We ensure consistency by using the same number of cells.

      (4) Since the authors focused Ninj1-dependent microvesicle (MV) release, they need to show MV characterizations (EM, NTA, Western for MV markers, etc...). 

      Thanks for the suggestion. We now add NTA analysis of MV for BMDMs in Fig S4C.

      (5) To clarify whether Ninj1-dependent MV induces coagulation, the authors need to determine whether platelet aggregation is reduced with isolated +/- MVs compared to +/+ MVs. 

      Thanks for the suggestion. We agree that platelet aggregation is closely linked to blood coagulation but would argue that one does not directly cause the other. While it would be interesting to examine whether MVs induce platelet aggregation, we hope the reviewer would agree that the outcome of this experiment would neither significantly support nor challenge our statement that NINJ1-dependent PMR promotes coagulation.

      (6) Even with the authors well established experiments with haploid mice, it is a critical limitation of this paper. To improve the quality of this paper, the authors should consider confirming the findings using mouse macrophage cell lines, such as generating Ninj1-/- Raw264.7 cell lines, to examine the homozygous effect. 

      Thanks for the valuable comments. We acknowledge the limitation of using haploid mice in this study. However, our data provides strong evidence supporting the role of NINJ1-dependent plasma membrane rupture in blood coagulation using primary macrophages.

      (7) There was a paper reported in 2023 (Zhou, X. et al., NINJ1 Regulates Platelet Activation and PANoptosis in Septic Disseminated Intravascular Coagulation. Int. J. Mol. Sci. 2023) that revealed the relationship between Ninj1 and coagulation. According to this paper, inhibition of Ninj1 in platelets prevents pyroptosis, leading to reduced platelet activation and, consequently, the suppression of thrombosis. How about the activation of platelets in Ninj1 +/- mice? The author should add this paper in the reference section and discuss the platelet functions in their mice.

      Thanks for the valuable comments. We examine PT time, plasma TAT, and tissue fibrin deposition as direct evidence of blood coagulation in this manuscript. We acknowledge that platelets play a key role in thrombosis; however, we hope the reviewer would agree that tissue factor-induced blood coagulation and platelet aggregation are linked yet distinct processes. Therefore, the role of NINJ1 in platelet aggregation falls beyond the scope of this manuscript.


      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Referring to previous research findings, the authors explain the connection between NINJ1 and MVs. Additional experiments and clarifications will strengthen the conclusions of this study.

      Below are some comments I feel could strengthen the manuscript: 

      (1) The authors mentioned their choice of using heterozygous NINJ1+/- mice on page 4, because of lethality and hydrocephalus. Nonetheless, there is a substantial number of references that use homozygous NINJ1-/- mice. Could there be any other specific reasons for using heterozygous mice in this study? 

      Thanks for the thoughtful comments. We are aware that a few homozygous NINJ1-/- mouse strains were used in several publications by different groups, including Drs. Kayagaki and Dixit (Genentech), from whom we obtained the heterozygous NINJ1+/- breeders. We do not have experience with the homozygous NINJ1-/- mice used by other groups. It’s reasonable to assume that homozygous NINJ1-/-, if healthy, would have even stronger protection against coagulopathy than heterozygous NINJ1+/-. The only reason for not using homozygous mice in this study is that a majority of our homozygous NINJ1-/- develops hydrocephalus around weaning and these mice are required to be euthanized by the rules of our DLAR facility. Although our homozygous NINJ1-/- mice develop hydrocephalus (the same reported by Drs. Kayagaki and Dixit, PMID: 37196676, PMCID: PMC10307625), heterozygous NINJ1+/- mice remain healthy.

      (2) Figure S2 clearly shows the method of pyroptosis induction by flagellin. It is also necessary as a prerequisite for this paper to show the changes in flagellin-induced pyroptosis in heterozygous NINJ1+/- mice.

      Thanks for the valuable suggestions. We agree that a plasma LDH measurement as an indicator of pyroptosis in vivo would add to the manuscript. Therefore, we have made several attempts to measure plasma LDH in flagellin-challenged WT and NINJ1+/- mice using CytoTox96 Non-Radioactive Cytotoxicity Assay (a Promega kit commonly used for LDH, Promega#G1780). Flagellin-challenged WT and NINJ1+/- mice develops hemolysis, which renders plasma red. Because plasma coloring interferes with the assay, we could not get a meaningful reading to make an accurate comparison. We also tried LHD-Glo Cytotoxicity Assay (Luciferase based, Promega#J2380) with no luck on both plasma and serum. We hope the reviewer would agree that reduced plasma MV count (Fig 3C) would serve as an alternative indictor for reduced pyroptosis.

      (3) IL-1ß levels controlled by GSDMD were not affected by NINJ1 expression according to previous studies (Ref 37, 29, Nature volume 618, pages 1065-1071 (2023)). GSDMD also plays an important role in TF release in pyroptosis. Are GSDMD levels not altered in heterozygous NINJ1 +/- mice?  

      Thanks for raising these great points. It’s been reported that IL-1β secretion in cell culture supernatant were not affected by NINJ1 deficiency or inhibition when BMDMs were stimulated by LPS (Ref 29, 37, now Ref 29, 35) or nigericin (Ref 29). As GSDMD pore has been shown to facilitate the release of mature IL-1β, these in vitro observations are reasonable given that NINJ1-mediated PMR is a later event than GSDMD pore-forming. However, we observed that plasma IL-1β (also TNFα and IL-6) in Ninj1+/- mice were significantly lower. There are a few differences in the experimental condition that might contribute to the discrepancy: 1, there was no priming in our in vivo experiment, while priming in BMDMs were performed in both in vitro observations before stimulating with LPS or nigericin; 2, the flagellin in our study engages different inflammasome than either LPS or nigericin. Priming might change the expression and dynamics of IL-1β. More importantly, there might be unrecognized mechanisms in IL-1β secretion in vivo. We now add discussion on this in the main text.

      We examined GSDMD protein levels in liver, lung, kidney, and spleen from WT and NINJ1+/- mice by Western blotting. The data is now presented in the updated Fig S1, we did not observe apparent difference in GSDMD expression between the two genotypes.

      (4) In Fig 1 F, the authors used a fibrin-specific monoclonal antibody for staining fibrin, but it's not clearly defined. There may be some problem with the quality of antibody or technical issues. Considering this, exploring alternative methods to visualize fibrin might be beneficial. Fibrin is an acidophil material, so attempting H&E staining or Movat's pentachrome staining might help for identify fibrin areas.

      Thanks for the valuable suggestions. The fibrin-specific monoclonal antibody in our study is mouse anti-fibrin monoclonal antibody (59D8). This antibody has been shown to bind to fibrin even in the presence of human fibrinogen at the concentration found in plasma [Hui et al. (1983). Science. 222 (4628); 1129-1132]. We apologize that we did not cite the reference in our initial submission. We obtained this antibody from Dr. Hartmut Weiler at Medical College of Wisconsin and Dr. Rodney M. Camire at the University of Pennsylvania, who were acknowledged in our initial submission.

      We performed H&E staining on serial sections of the same tissues for Figure 1F. The data is now presented as Fig S3.

      Reviewer #2 (Public Review): 

      Summary: 

      The author's main goal is to understand the mechanism by which pyroptosis (through the formation of Gasdermin D (GSDMD) pores in the plasma membrane) contributes to increased release of procoagulant Tissue Factor-containing microvesicles (MV). Their previous data demonstrate that GSDMD is critical for the release of MV that contains Tissue Factor (TF), thus making a link between pyroptosis and hypercoagulation. Given the recent identification of NINJ1 being responsible for plasma membrane rupture (Kayagaki et al. Nature 2011), the authors wanted to determine if NINJ1 is responsible for TF-containing MV release. Given the constitutive ninj1 KO mouse leads to partial embryonic lethality, the authors decided to use a heterozygous ninj1 KO mouse (ninj1+/-). While the data are well controlled, there is limited understanding of the mechanism of action. Also, given that the GSDMD pores have an ~18 nm inner diameter enough to release IL-1β, while larger molecules like LDH (140 kDa) and other DAMPs require plasma membrane rupture (likely mediated by NINJ1), it s not unexpected that large MVs require NINJ1-mediated plasma cell rupture. 

      Strengths: 

      The authors convincingly demonstrate that ninj1 haploinsufficiency leads to decreased prothrombin time, plasma TAT and plasma cytokines 90 minutes post-treatment in mice, which leads to partial protection from lethality. 

      Weaknesses: 

      - In the abstract, the authors say "...cytokines and protected against blood coagulation and lethality triggered by bacterial flagellin". This conclusion is not substantiated by the data, as you still see 70% mortality at 24 hours in the ninj1+/- mice. 

      Thanks for the thoughtful comments. We corrected the text to “partially protected against blood coagulation and lethality triggered by bacterial flagellin”.

      - The previous publication by the authors (Wu et al. Immunity 2019) clearly shows that GSDMDdependent pyroptosis is required for inflammasome-induced coagulation and mouse lethality. However, as it is not possible for the authors to use the homozygous ninj1 KO mouse due to partial embryonic lethality, it becomes challenging to compare these two studies and the contributions of GSDMD vs. NINJ1. Comparing the contributions of GSDMD and NINJ1 in human blood-derived monocytes/macrophages where you can delete both genes and assess their relevant contributions to TF-containing MV release within the same background would be crucial in comparing how much contribution NINJ1 has versus what has been published for GSDMD? This would help support the in vivo findings and further corroborate the proposed conclusions made in this manuscript.  

      Thanks for the valuable question. We have shown that plasma MV TF activity was reduced in both GSDMD deficient mice (Ref 23) and Ninj1+/- mice (present manuscript). Given that TF is a plasma membrane protein, MV TF most likely comes from ruptured plasma membrane. In flagellin-induced pyroptosis, both GSDMD and NINJ1 deficiency equally blocked LDH release (plasma membrane rupture) in BMDMs (Ref 29). Further, in pyroptosis glycine acts downstream of GSDMD pore formation for its effect against NINJ1 activation (Ref 35). Therefore, GSDMD pore-forming should be upstream of NINJ1 activation in pyroptosis (which may not be the case in other forms of cell death) and there are likely equal effects of GSDMD and NINJ1 on MV release in flagellin-induced pyroptosis. As the reviewer suggested, experiments using human blood-derived monocytes/macrophages will enable a direct comparison to determine the relative contribution. However, this approach presents a few technical difficulties: it’s not easy to manipulate gene expression on primary human monocytes/macrophages (in our experience); variable efficiency in gene manipulation of GSDMD and NINJ1 will complicate the comparison. I hope the reviewer would agree that a direct comparison between GSDMD and NINJ1 is not required to support our conclusion that NINJ1-dependent membrane rupture is involved in inflammasome-pyroptosis induced coagulation and inflammation.

      - What are the levels of plasma TAT, PT, and inflammatory cytokines if you collect plasma after 90 minutes? Given the majority (~70%) of the ninj+/- mice are dead by 24 hours, it is imperative to determine whether the 90-minute timeframe data (in Fig 1A-G) is also representative of later time points. The question is whether ninj1+/- just delays the increases in prothrombin time, plasma TAT, and plasma cytokines. 

      Thank for the valuable question. The time point (90 min) was chosen based on our in vitro observation that flagellin-induced pyroptosis in BMDMs largely occurs within 60-90 min. 

      Because our focus on the primary effect of flagellin in vivo, potential secondary effects at later points may complicate the results and are hard to interpret. As the reviewer suggested, we have measured plasma PT, TAT at 6 hours post-flagellin challenge. The significant difference in PT sustained between Ninj1+/+ and Ninj1+/- (Fig A), suggesting coagulation proteins remained more depleted in Ninj1+/+ mice than in Ninj1+/- mice. However, plasma TAT levels were diminished to baseline level (refer to Fig 1B in main text) in both groups and showed no significant difference between groups (Fig B), which could be explained by the short half-life (less than 30 min) in the blood. Since flagellin challenge is a one-time hit, there might not a second episode of coagulation after the 90-minute time point, at least not triggered by flagellin, supported by the plasma TAT levels at 6 hours. We now comment on this limitation at the end of the main text.

      Based on our previous studies, plasma IL-1β and TNFα peaked at early time point and diminished over time, but plasma IL-6 levels maintained. As shown below, plasma IL-6 appeared higher in Ninj1+/+ compared with Ninj1+/-, but not statistically significant (partly because one missing sample, n = 4 not 5, in Ninj1+/+ group decreased the statistical power of detecting a difference).

      Author response image 1.

      Mice were injected with Fla (500 ng lFn-Fla plug3 ugPA). Blood was collected 6 hours after Fla injection. Prothrombin time (A), plasma TAT (B), and plasma IL-6 (C) were measured. Mann-Whitney test were performed.

      Recommendations for the authors:  

      Reviewer #1 (Recommendations For The Authors): 

      - Fig 1F: are there lower magnification images that capture the fibrin deposition? The IHC data seems at odds with the WB data in Fig. 1G where there is still significant fibrin detected in the heterozygous lungs and liver. Quantitating the Fig. 1G Western blot would also be helpful.

      IHC surveys a thin layer of tissue section while WB surveys a piece of tissue, therefore fibrin deposition may be missing from IHC and but found in WB. That is why we used two methods. Below we provide lower mag images of fibrin deposition (about 2 x 1.6 mm area).

      Author response image 2.

      - Fig1H - lethality study uses 5x dose of Fla used in earlier studies. In the lethality data where there is a delay in ninj1+/- mortality, are the parameters (prothrombin time, plasma TAT, and plasma cytokines) measured at 90 minutes different between WT and ninj+/- mice? This would be critical to confirm that this is not merely due to a delayed release of TF-containing MVs.

      We used 5x lower dose of Fla in coagulation study than lethality study because it’s not as easy to draw blood from septic mouse with higher dose of flagellin. We need to terminate the mice to collect blood for plasma measurement and therefore the parameters were not measured for mice in lethality study.

      - What is the effect of ninj+/- on E. coli-induced lethality in mice? How do these data compare to E. coli infection of GSDMD-/- mice? 

      We did not examine the effect of Ninj1+/- on E. coli-induced lethality. After the initial submission of our manuscript, we have focused on Ninj1 flox/flox mice instead of Ninj1+/- for NINJ1 deficiency. We are using induced global Ninj1 deficient mice for polymicrobial infectioninduced lethality in our new studies.

      - Fig 2 - in the E. coli model, the prothrombin time, plasma TAT, and plasma cytokines are measured 6 hours post-infection. How were these time points chosen? Did the authors measure prothrombin time, plasma TAT, and plasma cytokines at different time points?  

      The in vivo time point for flagellin and E.coli were chosen based on our in vitro observation of the timelines on BMDM pyroptosis induced by flagellin and bacteria. This disparity probably arises from distinct dynamics between purified protein and bacterial infections. Purified proteins can swiftly translocate into cells and take effect immediately after injection. Conversely, during bacterial infection, macrophages engulf and digest the bacteria to expose their antigens. Subsequently, these antigens initiate further effects, a process that takes some time to unfold. 

      Our focus is on the primary effect of flagellin in vivo, potential secondary effects at later points may complicate the results and are hard to interpret. As the reviewer suggested, we have measured plasma PT, TAT at 6 hours post-flagellin challenge. The significant difference in PT sustained between Ninj1+/+ and Ninj1+/- (Fig A), suggesting coagulation proteins remained more depleted in Ninj1+/+ mice than in Ninj1+/- mice. However, plasma TAT levels were diminished to baseline level (refer to Fig 1B in main text) in both groups and showed no significant difference between groups (Fig B), which could be explained by the short half-life (less than 30 min) in the blood. Since flagellin challenge is a one-time hit, there might not a second episode of coagulation after the 90-minute time point, at least not triggered by flagellin, supported by the plasma TAT levels at 6 hours. We now comment on this limitation at the end of the main text.

      Based on our previous studies, plasma IL-1β and TNFα peaked at early time point and diminished over time, but plasma IL-6 levels maintained. As shown below, plasma IL-6 appeared higher in Ninj1+/+ compared with Ninj1+/-, but not statistically significant (partly because one missing sample, n = 4 not 5, in Ninj1+/+ group decreased the statistical power of detecting a difference).

      - Fig 3 - the sequence of figure panels listed in the legend needs to be corrected. Fig 3A requires quantitation of NINJ1 levels compared to beta-actin. Fig 3C - needs a control for equal MV loading. 

      Thanks for the recommendations. The figure sequence has been corrected. There remain no common markers or loading controls for MV, so we use equal plasma volume for loading control.

      Additional comments: 

      (1) In Fig 3A, the size of NINJ1 appears to be increased in the NINJ+/- group.  

      This discrepancy is likely attributed to a technical issue when running the protein gel and protein transfer, which makes the image tilt to one side.

      (2) Describe the method of BMDM isolation.

      Thanks for the recommendations. We now include the method of BMDM isolation. In brief, mouse femur and tibia from one leg are harvested and rinsed in ice-cold PBS, followed by a brief rinse in 70% ethanol for 10-15 seconds. Both ends of the bones are then cut open, and the bone marrow is flushed out using a 10 ml syringe with a 26-gauge needle. The marrow is passed through a 19-gauge needle once to disperse the cells. After filtering through a 70-μm cell strainer, the cells are collected by centrifugation at 250 g for 5 minutes at 4 °C, then suspended in two 150 mm petri dish, each containing 25 ml of L-cell conditioned medium (RPMI-1640 supplemented with 10% FBS, 2mM L-Glutamine, 10mM HEPES, 15% LCM, and penicillin/streptomycin). After 3 days, 15 mL of LCM medium is added to each dish cells. The cells typically reach full confluency by days 5-7.

      (3) According to this method, BMDMs are seeded without any M-CSF or L929-cell conditioned medium. How many macrophages survive under this condition? 

      BMDMs are cultured and differentiated in medium supplemented with 15% L929-cell conditioned medium. For the experiment, the cells were seeded in Opti-MEM medium (Thermo Fisher Scientific, Cat# 51985034) without M-CSF or L929-cell conditioned medium. BMDMs can survive under this condition, as evidenced by low LDH and high ATP measurement (Fig S5).

      Reviewer #2 (Recommendations For The Authors): 

      - There is significant information missing in the methods and this makes it unclear how to interpret how some of the experiments were performed. For example, there is no detailed description or references in the methods on how the in vivo experiments were performed. The methods section needs significantly more details so that any reader is able to follow the protocols in this manuscript. References to previous work should also be included as needed.

      Thanks for the recommendations. We had some of the details in the figure legend. We now add details in the methods for better interpretation of our data. 

      - Line numbers in the manuscript would be helpful when resubmitting the manuscript so that the reviewer can easily point to the main text when making comments. 

      Thanks for the recommendations. We now add line numbers in the manuscript.